<SEC-DOCUMENT>0001558370-23-003963.txt : 20230316
<SEC-HEADER>0001558370-23-003963.hdr.sgml : 20230316
<ACCEPTANCE-DATETIME>20230316073047
ACCESSION NUMBER:		0001558370-23-003963
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		166
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230316
DATE AS OF CHANGE:		20230316

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AC Immune SA
		CENTRAL INDEX KEY:			0001651625
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37891
		FILM NUMBER:		23737142

	BUSINESS ADDRESS:	
		STREET 1:		EPFL INNOVATION PARK, BUILDING B
		CITY:			1015 LAUSANNE
		STATE:			V8
		ZIP:			00000
		BUSINESS PHONE:		41 21 345 91 21

	MAIL ADDRESS:	
		STREET 1:		EPFL INNOVATION PARK, BUILDING B
		CITY:			1015 LAUSANNE
		STATE:			V8
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>aciu-20221231x20f.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.2.0.4 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 3/15/2023 5:38:47 PM -->
      <!-- iXBRL Library version: 1.0.8405.27969 -->
      <!-- iXBRL Service Job ID: fef27143-c528-44ea-be74-38675c6df248 -->

  <html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:aciu="http://acimume.com/20221231" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="text/html" http-equiv="content-type" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" sign="-" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" name="ifrs-full:DilutedEarningsLossPerShare" id="Hidden_KsMgbS3xG0qi3jvsMdG5Ow">0.85</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" sign="-" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="2" name="ifrs-full:DilutedEarningsLossPerShare" id="Hidden_jsBeHvTR-kSgucIdm-PyEA">0.97</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" sign="-" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" name="ifrs-full:DilutedEarningsLossPerShare" id="Hidden_tmBaFLxF8EqhVJkDdhdDFw">0.86</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" name="ifrs-full:AdjustedWeightedAverageShares" id="Hidden_E9IAUiBXwEe80tmH-4EHnA">83554412</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="INF" name="ifrs-full:AdjustedWeightedAverageShares" id="Hidden_ygCYsmYiB06ntb7irePY4g">74951833</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="INF" name="ifrs-full:AdjustedWeightedAverageShares" id="Hidden_i-Hoy8t6aUGmNrMEVl37eA">71900212</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" sign="-" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" name="ifrs-full:DilutedEarningsLossPerShare" id="Hidden_qNCRjMCoBEWX70xtv--h7w">0.85</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" sign="-" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="2" name="ifrs-full:DilutedEarningsLossPerShare" id="Hidden_5par6rAS-0SS1VELqhjwGg">0.97</ix:nonFraction><ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" sign="-" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" name="ifrs-full:DilutedEarningsLossPerShare" id="Hidden_aZVD85ojDUemcKl4x6wfKw">0.86</ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:EntityCentralIndexKey" id="Tc_Z_ZwThMSSU2XUg1LCvHu2A_2_1">0001651625</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:CurrentFiscalYearEndDate" id="Tc_Ap4lYaip50e7PGHKMBYU-Q_3_1">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:DocumentFiscalYearFocus" id="Tc_fxGJv6qQdUW3iNWmqRRb1Q_4_1">2022</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:DocumentFiscalPeriodFocus" id="Tc_BBa5r-ClgkyjiVsisgUdcQ_5_1">FY</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:AmendmentFlag" id="Tc_3TLN0YpSu0iZgBG4nXIAzg_6_1">false</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g" name="aciu:MaturityPeriodOtherCurrentReceivables" id="Hidden_P_0I_UaePkyj8OXHk3ZeUg">P3M</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_FirstCapitalPartnerGmbHMember_C_e589-KYkWofUUwrPs_Ng" decimals="0" name="aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" id="Hidden_7EVt20oUeEOLG5MQiq_Hiw">1513317</ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_AnT6Y1xoZUO8xgP2BhtXpg" name="aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod" id="Hidden_K168Qe9Bi02hpV05wXH75Q">P3M</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__hddlRQFkkqifIU3xGWEIw" name="aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod" id="Hidden_EdaFR7KmDE28JCeL6L0nxw">P3M</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_10_1_2017_To_12_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_MJWKVhi5Mke2_vbucOqWPQ" decimals="-6" name="ifrs-full:RevenueFromContractsWithCustomers" id="Hidden_751hiZiX7EinZNcM4zz_ew">14000000</ix:nonFraction><ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_7_1_2016_To_7_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_GqrdTpaZwEmYea7JqiwIuQ" decimals="-6" name="aciu:CollaborativeAgreementMilestonePaymentReceived" id="Hidden_5oAu63RdGkGFjzGDsCTBog">14000000</ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_8iFSlULEHU-tuNl09k6RZA" name="aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod" id="Hidden_lTC6TFzT5kGupQPYn0M3yQ">P3M</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_Ssvb6k-KGUuY9cOGiA1XzQ" name="aciu:CollaborativeAgreementJointResearchCollaborationPeriod" id="Hidden_CDAuGzNdHk259o1JNxYdiA">P2Y</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-5" name="ifrs-full:DeferredTaxLiabilities" id="Hidden_bwx-SbM9sEqAKiboMtvBTg">0</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="aciu-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_1_1_2019_To_12_31_2019__3yCVTKZ40i5IsvT7P2jug"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_Zmu3hDypz0e9GA3GfssWMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LeaseholdImprovementsAndFixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312029Member_QW1lvp6gWEmt2TrWCNAUrg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312028Member_yPNEVvCqsUC9xeMHzwQNIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312027Member_8GigSLJKwkiTlMz-iLjIGQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312026Member_aD29x0JbzEyAG4T_DshrpQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312025Member_luIzCS1YKk2F6EECmOmb-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312024Member_1EtLVXZQK0KhtJMXjvu1hg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312029Member_-U2cl_yo202fnY3GwpirTA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312028Member_IyrHXjhaIkqLqkdVnSu1Fg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312027Member_YDYkyf-UMU2_t8n-OPDZOw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312026Member_pgGd2X_5zkuQ-hULGalqJw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312025Member_iFzt3h4AUU63S9gjge_aaA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312024Member_YtAAUPDrRUyZqBsdM7bZLg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312029Member_L1w97ZJiBU-clbQi3YmL-Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312028Member_KCaq0o_GCU-ldbixSPpiMw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312027Member_ng3b4z76MU6jDCmNuN3LKQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312026Member_GVWpRLlroE6SQnZZlZUS2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312025Member_n-US4waEG0KkXB44U7M1XA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312024Member_QmNnwUouwUmJ-s32bbnIQQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_VYzjzXZlKEGZio3O0wX8zQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RegulatoryAndSalesBasedMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_kiAkuYc_KUS-yeLR_XxzfA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:RegulatoryAndSalesBasedMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsCommercialMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_gCSsL-ubc0eIq6zJNtwUCg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:MilestonePaymentsCommercialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_Y_oiYfNYLEWs_ZiE9phKFg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:MilestonePaymentsClinicalAndRegulatoryMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_y5HiWeAgl0qm7JANOOw7-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ClinicalMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_350QXz6QwEuA8d1zj8O5MA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_VADeMQ-kG0C2-xdkdCMoZg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_OOBltWlETEyOu2fA06kbxw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:IprDIntangibleAssetAssociatedWithAci7104.056Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_I4XyGj16C0a9vD480ormzw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_MzzzRCGt_kGIsmMdhb2czw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_HnlGa1Cxjk2eh1urgNWWVw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_xamDkF4k5UGlV-TCDgu2Lg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_P7gp9D6sWEu1SR6hOkR0lQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_b6irc3wm8kOfDWxn7KoryA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_QcaBM9HUnUiKIdtAR3VBHA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_AwHLCp1Cek68-TW5KoaDqA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_8Nxn7kPDD0muRctLMCmLRQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_bV6SNnGs5EKwPEWegvAkHA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_IESnhrGhEk-QtuGTRv7ddw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_NSSv8GcEaEejbU2PgDrGqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_P-n3rHIzjEG1HspwzCx_Og"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_UeTtu2AuZkiuL6oBS69STw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_wQPmFr31yUS_jOij507kbA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_YRhyIua2j02nlUUm4X31Sw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2022_To_9_30_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_exnjXylyHUGgFwmQMBb9bQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_DHftPCO4NE2baGCu__fDLw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_OXAjfAuKLkGrxwLJeL_h4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_cTOwJWsTfU2wP__TQVaSgw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_E0eBhnZuvkCP7QsmGzZ-7g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_DhDLnGHqvEOBmhLvYjbgNQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_gScL_dC77kCsTG776ERWNA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_WmrQJ8yOykaDFuA8S-ALTg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_p0DVrOsbeESsVkNWccV14A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_cyiz-Q_qC0uLMdJoM0Mbdw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_S211XVhLiUqZCj3v114p0Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_PrKPmhCrP0ePfbwTC-yXHA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_UUY8TErzyUuTQ6n10-1E8g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_z90wXTf3ike4CAeXE1FQtA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_UT-qr7yDeESe7RDDN5ti-Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_qwYRZkjqJkCgDZXe1ke0Iw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_JA3yekIlVkiUYduc0Mu4Qw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_R5HPjrhD7kOQFT3FLpl0VQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_HVTIaNw_0UOjUkO5CiRYEA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_X7pFxFGHnkKllf5M2sGd6w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:RightOfUseLicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_IS1IteWIxESboEBvGakY4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_23_2019_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_boFHM2vJ60aWug_NKJAQTA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-23</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_23_2019_To_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_1Vi83gAQRUCn92QFpovc7Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:RightOfUseLicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-23</xbrli:startDate><xbrli:endDate>2019-01-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2016_To_6_30_2016_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_otQ-b1w0b0OqUhWtsoKp6Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-04-01</xbrli:startDate><xbrli:endDate>2016-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_31_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_9CqaxvHCr0-iuqlmAvYvdw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-12-31</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_1_2014_To_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_Of8RE1HgdEy1bhmDA0BgDw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-12-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_1_2014_To_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_Z_bscP2Znk-KSY2VCxYJ7g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-05-01</xbrli:startDate><xbrli:endDate>2014-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_8_31_2022_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_d5f6dTO6oUOtx2ATln4mKQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aciu:SkaneUniversityHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2020_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_EU9FlszNzkOBH2Bx99PAbQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aciu:SkaneUniversityHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2020_ifrs-full_CounterpartiesAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7QQTH7tA1kOhyo9N6XlPwQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:SkaneUniversityHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_Bwy5dQAXAEWqqXyDPqgE6Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillySecondAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_g8PQeK6MBUOy01cnGHEgHg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:March312020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillySecondAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_UrnH6A3xZ0GUsbQYZdWO-A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:March312020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_Quarter32019Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_pnlTLBAOqUyJSsbJhyKKYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:Quarter32019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_3QZoZDHthk6fXZD1NuNlOg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:March312020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_cOXYr6K5yUCrOP0RZAWdQA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember__8JB9cGo30u4RAuroNxHDw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_8IXKK-Pok0S7I58W7DYXDA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_nA1-BCOTy0m_IaGz1dZgKQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_U0WcEJ-m006w1FYFbGzFkg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_t0ttw0E3hEGRszBl1CyKPw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_kGz2G5hG2EuGvNwjXNMtGA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_kqXlzseNsUiz1AZXFdEaQA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_mXP7xiRLEUu8xic9Xuihlw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_aJviOm4nfE-pOaFV9E4vvw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_6conGXdyckSywzGr6GYvYw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_TH62pZBB7kqAgUulrAHeSg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fhXMqa9W-EWHXNdjUYd4iQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_W-8vm1symkWu1TlXlu9m7A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_JOWNVGG_6E2-S4NAWhBdqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_hqctdwrQN0uGHFmoDmoBSw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_5w-XoX-NLkKHmafT1-bTSA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_6aK9qrKczkWLN0-zGicz-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_83P7y6bpZ0ylYnfrkgwFyw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_mkfTmtvQQUWvXn7SCNipKA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:AssetsUnderConstructionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_imtm7cUr8kaCmHg-oP5Uew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_ue4pbGVEbUiq7HJx_qTxVA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_pC0gtLj5kE29rdJ-dYf0BA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_GKWsPI-X0kGuJ_LvETs99g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_gFCLb69mDUaqMTblzP_RkQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_gixeq8TJOUiwQnCqzoWt6w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_nVWm-PIICk2ruKe56loHrQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_SVIwZpKI3kGqF_IYNCWEhg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_j5TopbyK0kGaK2cIgBD9LA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_IQoL60CqzUKkayULIGl1UQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:AssetsUnderConstructionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_k8dVeftSAkW4_0WfOoafTQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_yBmrsz9Gz0-30C8ID2gxpA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Hnlt3D1SKEW7_IrRvWNKhg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_omADz3BlkU228JQA39U9eA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_624VtAuprEmOudOGdH0CPQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:AssetsUnderConstructionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9GjiWU9dvUSudZWJ_vB8OQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_9-9lvpw-wEGlSeFf0lhfgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_rNFrcrnlfke5jyKkmnfYew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_U-F3h1Ni3kikwgDZTjR8Ag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9sg6mWi1F0CGpbkEmid_yw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_at5lR_LjGEWOpLXOSdQYAQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Y1uZQ6hoDkCelbD4WC21cw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember__RC_i4sK7Eajf16KAEb9Lw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_Q_e4dEXGxkup2NsrXRT1FQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_TY4Gkd3GwUKatV9IO3cpXg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_MiutPukQMU-yrYKpy0R5CQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:AssetsUnderConstructionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_H4N7gZJ3j0Kt81LUUCEMUg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_wxgSXXB0oEWC6elN_wYlOw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_6EKzgKAJoUG3jfS4LKnOcA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_g3mEpN007U6ktZW8iOkmGg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_5kIFcqQdLECCxjdGCPTLvw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_NC-GY6fYlkqMWQ13ktqxIQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_4fT5bJuBykulzw1ivTHO9Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForEmployeeBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_kNbENWSt0ES3TXF_cT2ONw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_4oE23j2SoEGdWq3PS9cPew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_nMf-S3Qo30yK_F2kNXsH8Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_t849aft53kyGDr1KoWgmHg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_11_1_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_8NZA0QmhLU-9P-5sBxKJYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_1_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_u_sWTIPrdUK25sXxSWqZ-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:EmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_1_2016_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_vLy61BZC6kiaUiucvTN5rA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:StockOptionPlanC1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd5.04ToUsd12.30Member_gtKWlOCngE27VpysbvaH2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Usd5.04ToUsd12.30Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd2.76ToUsd4.57Member_m38zUhm5wkSL12bhBb3aJA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Usd2.76ToUsd4.57Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf9.53Member_HuWh2wiS0UufmuyDmPt1XQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Chf9.53Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf0.15Member_Mjn-Ndi9XEOlgiCMgrFRAQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Chf0.15Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_11_16_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_8IofwfDJNUGt5LoOfv2Txw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-16</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_16_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_EUWOkY3BskaxAia9Z8ewEQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-16</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_0QrduY45dEG6M-eOa0J7zw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_s2KGkJGHQE24IlcU01BatQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_kCoLjsydz025fO14lloWZg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_V6HzKpLdRUKQbql6k-eSiw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_eZxk80f7rkOIMW9Uz-QjMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_UV3ix4h--E6wHiAOGaJNtA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_uTemqh0x5kCnk8dGyhg2yw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_QO4vamUaPEWTe-Dnq2T7Yw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_K6sJGDsSb0Ki6Q9DK_HssA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_9SsycfPkpUG2RWbLatkFMg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_VCafjbK1YkmLYTpqX9O2Qg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_Rm5syNGJAkK02zxsPeiygw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_LpgnYOYCIE6nbkxvmDUYKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_OwVmQS-jlUGVZMlyx50qAA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_tvR74klj-EuU1efHxw9Lag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_nL6LiSdtTEm6pKYWuxJXrQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_-0isfSi3C0iv0Hr9h6SsDw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_IE1TM485zUWn_r_T4BeXIQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_MbfX1IXrrEG58WLwK0Know"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:TradeAndOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_XuWosC4Fe0qG8LleE6GLdg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:AccruedExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_Cts4m1NVYEm1s8XilN-05w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:TradeAndOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_cmRGUa_u70epa2FW1Q5Q3Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:ShortTermLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_o6gi3zRMsky95yqQAXrXPA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:LongTermLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_grbXW83sNUKs9oRc5DlqvA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_AsEKpSzsIUOKQll1k7zGDw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:TradeAndOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_iojyYGBhoEmu6MX20T28CA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:ShortTermLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_pWcmO-NRyEKwdZu9PbvzLQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:LongTermLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_BhAuKtG8w0aQWiwhMKyIUA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_C2-Rix-rrUWBxTMIugjLZw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:ShortTermFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_jyOi4fu8akSFRaaUIvyLtQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:RightOfUseFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_5zN3E_yoh02M-AfcBPl9vA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:OtherCurrentReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_Oa3BLbYryUWJpolylXf_QQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:LongTermFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_FcEj2KvmMkOH2QDFyl4MuA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:CashOnHandAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_DhXQ_kkBwUi5-evVk0nMVg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:ShortTermFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_3Jy3_8RbZUWAnkkvJgLO9w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:RightOfUseFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_Bl-K4Rg37EyEPpGUWgJdww"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:OtherCurrentReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_tJzQntMdsU6d1iyuTo4P6w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:LongTermFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_4ePuupbrrEqstdW7npGYxg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:CashOnHandAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_hgoBF8GS-k-cs9msKZyyhA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_8sJpe0LyAECOfOJdgZOKPQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_y4uYlYwmHUaTK3M_16Tcuw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_GwujP39d00mK3lHW3oUw4A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_gp09PWsb8EavwbWAh0p_Sg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Vs0uaVlFREaW6ng6T8fgEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_dfNJO7LfcEOZT4w2RTRitw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_frCDFRM6oU2SCVSiDhf4Lw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_fNeupebFFUOPOyeQrvkYqA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember__r0D1g51PUiGX0X1UUsNSA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_vuCe_vLKgECevKYNBCd4Lw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_ktuzkw64AEa5vdg54I-VCQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_6vGDOwBrDUW56Z7aTT9Kzg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_utVQr_YxtkaiCKmZyUEcCw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_os5Hp8MAI02VjWPk90WB7w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_BAlgAaqeAE69FaWxkpf59A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_-v01eNbu4EqyiH1CP4pFSw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_KQlk7o6AQ0uDnZr3pfWlIg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_ZFh_VMBp4USCi-ehy5idcg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_XSLfDSRIbEupuWixpadOuw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_bdfGLGB28E2kpb5ujlICfA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:AssetsUnderConstructionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_dIb050VtY0uPI1cKwRn8HA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_3yeVGHwDfEeZEDJ901taIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_o09LprTCLE6hH9f1Mj3oqQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_IvbcDwQUuEm16jkIYakaCg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_v887EZj_rEmNcfMBDtK6TA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Jvt1fjwr5USz9GJD5wEKOQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_-tmtXopEr0G-p32hjhwk6Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_E57IJ4sHdEW4PL45jFGApQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_hZnR1ixhfkeMTt56nYyaxw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fkSn02nK3EO6v-wrUGc0vg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_X7iW-2Dlq0SBvALqlsP7Iw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_XIymoY2OjEyn8SkwhnAMgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_AmEhYNpaWkGu_syMP9yeMg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_XbtQeThTw0KgJUgpaxvnvg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_59E483uZ40Gsz3BGEndqFA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember__QV6BS-X-EirLtUuhoaxaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Cu7DGnbLpU-gF7D6W8XXoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_htkFexGKi0SyGdCClk5r-A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_uLVqkw8R0Ey9u3gY5ML4tg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hYMeoCWTDUeHBblD-WbM1g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_sfVRDOORkUqhr6UilmXrJw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_pxqAUVjcWEiJf_4UkIPnRg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lnas20UeVUe0l9IofWvilw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_E-R1Y--G10q88hvRsrSnzA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hnNvq_N4vkyRlPiVGvD9xg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_HHYHWrkgo0um-ugZPCUcJA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_ITqbxgmA8kaKhSS6Qx6Lag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_CIf08U-iBESSEaFfP0e5oQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Ky5hPC5l-kqMi9huZQTdgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8YTwmrejmUmiuJSTgOn0zQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember__6JmM8XcBUip-56hZCA8ig"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_HYAe7T3bM0uPnVmhnuk0NQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_EoGHAaH_W0-vpWcrDQJuvg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_A7q7sukpmEWmgYEeU6xd9A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RightOfUseAssetsAndLeaseLiabilitiesNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_e71liqGpk0eD9wSTTRy_TA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RetirementBenefitPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_e7xgizML2UqtqmEk-xbYOg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_qNySDLxJmUaC4_AlxO6kDw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RightOfUseAssetsAndLeaseLiabilitiesNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_wwQem1YNxUG0LWJSPUL00w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RetirementBenefitPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_nBhQeOZ19k-ztz29OTwlBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_MB9hMQrj1E-MnICLBN--Tg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RightOfUseAssetsAndLeaseLiabilitiesNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_X_YAkgPZKU2ZgwftPJ68hQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RetirementBenefitPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_YpfuJbR9Jku9LQlMY-CQVg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_KqUnpfq9E0mC3M7Pc6ReGA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_Aq4Gh5QzC0O-z-Hkxgg7bw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_3B9uzJLVRE-wKxtJvPSkOg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_OgtSEFz6OUOEyh01YeW-4Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_IDSltZ9zlUuxs8MqNPseTA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_EG_KIXGerkW5heSXWG1y5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_93lXqdNkAkGE1eTi254vCQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_pevi1fpI-0qT5MFTaLocdA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_bmdNVxjd7kCcxLTi4MiPYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2012_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_p2DjH8za9kC0HB1u8L2hcw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_WVjiu2AWkUC7_73wPEZNAg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_CurrencyAxis_currency_USD_15GIrBDN9Uil-oruYpMkuQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_CurrencyAxis_currency_EUR_V7Jj-YDCCEGGn-_yEgdDMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_CurrencyAxis_currency_CHF_38ToDnEBNEuS9ddM0NrYgg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_CurrencyAxis_currency_USD_Ukgt6dYs9EGXQlarniLKig"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_CurrencyAxis_currency_EUR_o_IBIzyApEiyeRWQLrx-UA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_CurrencyAxis_currency_CHF_iiYbXla8tU-iyk_i32DP4A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_C854zoDUpkSi-bE7TYeEJw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_JZHuDFkEnky2R3mcEBTRxw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_GeographicalAreasAxis_country_CH_O7nfFWb_I0mZqhS-eJcjZg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_hGZYF059eky85mjSvMDTyw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_5cL5m8nGCEqTrf8_CtRG_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_o6mJetXegkqD7qoBcZZJvQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_CH__P8ouC3DKUKhYNxSsLCgfg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2021_zfFR7ittfki9YYbWT5hYdg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_EEXqAl-oB0aAgMV2CcairA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_1pD5gJTd5k6uFaeNrpHvig"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_EjvNM_4FNkWLoJE65UD5VQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_mo8rLVJA4Uq7FhG33cplbQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember__-gTB9L7ZEG7ut5ju4_TaA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_3oznLzHXWUmnOSp1oShnUQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_sn3ARiGlaESnktZbl7jycA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_w37wZNsSyU6H8HKH0QpE5A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_-BoX8YxE_EaZXZMovx0g2A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_1wINY-2riE6PzcI88FzqMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_M05pHmbc10iqCZT547GuuA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9ZTaVEBXDUiyQ4EQFRSYhQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Mexed_kNUESyEPioMdSpUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_OgqSUQcKz0SKU75eNdUCVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_amPvhMdQjUCNH0XSkOd83g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_BknOUverm029TXOB6lUTWA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:AssetsUnderConstructionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_aBSKY_-UsUGANDeuLjypnQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_8n96kGPIAEKNlTtnDkaFpA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_dxwmB62u-UWekqoEuPazhg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_nWByIEwhSEGf6j1j19xN3w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_qn53IASnuk6FLPf7LUu5zw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_YWfuOV2LMUGsWQqsGR6J5w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_qvzjOcNNJ0e61xUNnj-VJQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_o6xYJQLm0U2_P1h1Nvrt4Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_i1QiIMeQy0WwrJUKG5kvUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_gs4FuwKFqUy6IZN8tQRJ-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanVestingTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsSecondVestingConditionsMember_tIRug6aVk0eTDxYXCAEY0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsSecondVestingConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsFirstVestingConditionsMember_gGDNEFbPMkKnisGaecdtgg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsFirstVestingConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ZVoQVJGhW0GvwsXTKPLhYw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:BoardOfDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_QuVxNqREZ0mnvgP8iz8Hbw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_StatementScenarioAxis_aciu_IfNotesAreConvertedMember_-lcYAWhYg0-zLgqjshlyjw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">aciu:IfNotesAreConvertedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_wv9xrxx7O0K2GfFqTGYv0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_IhkhXgeEj0KYRe-nXMqtgw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForEmployeeBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_7CFGeyENHkKB9xvCXPYVaA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_Jgm2mZ4FRUuDSrQ2ymoSAg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember_0GfBuDA_dU26TA2qx6IcSA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJ.FoxFoundationAndTargetAlsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_vFwwP69K-kujKmPJkq_WBw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_VKLmDDFNFkKleBMvIA9FfQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_Xwss63i4rkeKVevtj3Tcag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_my1TIm6ojUaJIKTSB0t2ng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_T-iM5RqNsUG9c1FH7HG0Xg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AdvanceSmallMoleculePdProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_CuCfm2CCOUSB6f8RZI257g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_UZGF3O0NRECj0iuX4vHtKQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_0Lc-koCQpEeU6K6OjBCTKA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_c832R2YNRkeTmCmOUNmglA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_nm_abkjtNku82k2BFZcwmA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:EmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_qes1Nya84kCyFEAE3XIdpQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:StockOptionPlanC1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember__MJ0ad-Uz0G9j3cZ1MV7Iw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_BZyLB7dngU2QjWI8noII-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:IprDIntangibleAssetAssociatedWithAci7104.056Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_7Z_nhIBrX0a27ZxFck0DEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_FirstCapitalPartnerGmbHMember_C_e589-KYkWofUUwrPs_Ng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:FirstCapitalPartnerGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_AthosServiceGmbHMember_MrNll2L240y5mdXUd6AkjQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:AthosServiceGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_jtRNTBzMHEaZ7YlAIWrXwg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2021_To_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_hFMd3XCjHE2krVkPJCUtig"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_GjUP2pWxo0OYX2B-S44KPA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_hAdDmGPrWE6JWyIjdtUDJA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_cPKR_v8WT0anxPEPSrhgGA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_v5r8G2UC80OzCevY1QNAVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_2QmGkCKydUCnCVZUxjhf3w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_BOCVhHLarUK1ofHh5lJzgQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_6CpwH38OB0GxFoomh9oxsw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7U3WtCFvFkm-psn0Ha35Tw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OfficeEquipmentMember_9AyXpdV_hkmm2dtMcUeW5w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Ozer3KElnU6POId_CcOTBg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_Wu9NkzJdPUaZrVXUx5z-UA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_V234l1xFRUG6YB4I0Vptfw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_IzCNAkBBO0a8Nlx67vKOBg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">aciu:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9o_550cVrU6jieJwj_AJUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_rUIgTjQ7OkGwKJ7QeHVyyw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">aciu:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6WGIoNrd4USstG13uKvUOQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_LMCpazElS0WvFLxSamO-Xw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">aciu:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_LgP-ND0OA0CGPBZ4f_J4DA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_D82Lcnr-PUGdxCD-xTUAMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_Ot-xQ2KPP06Rv7mi7NpE9w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_NiF-yrOtAky2RdqkvIAwfw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_-yIL5uUOREqnWUjN-WEKug"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_z3C9c0ddSEGQe_CGaFlGBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_jTjTRUZmlk6W61qANQJmqg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:SecondOpenMarketSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_tyfTe8DeCUaagdCn6T7Ejg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zNVkSV70P0yTTv0hw3xQ6Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_VzztEIOlRE2c1SoXK6RQgg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_4CLZPTp1GUqRjsICkJnChA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AdvanceSmallMoleculePdProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_8o7ayFkxUESxL5ih3O1fWA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_COp1pU_2c0K0ifwsTtZrJw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_gQeJGG83pUqW7L5LjJMSiw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2012_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_W_xvSn3aIUSy0b2g6uFBPw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_H7MVafWwHEm7SebhAlCksg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_vJPsPHg5JUivymFY6lpR6A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_AnT6Y1xoZUO8xgP2BhtXpg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_8iFSlULEHU-tuNl09k6RZA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__hddlRQFkkqifIU3xGWEIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_3_31_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_bzzbrZyzREe8dKLr1q4pcA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_10_1_2017_To_12_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_MJWKVhi5Mke2_vbucOqWPQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2017_To_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_p7AlCw_1wU-ARo-yBLe5DA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2016_To_7_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_GqrdTpaZwEmYea7JqiwIuQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_1_2016_To_5_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_GSgSGJWKA0qol0w8MEEp6A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-05-01</xbrli:startDate><xbrli:endDate>2016-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_FNJ-cLjT602Qc6SGy47cbA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_6_1_2012_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_wmwel6uA20-BMX_QzPDtJg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-06-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_1_2006_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesAchievedPriorTo1January2017Member_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_bi-vVw0ymkK92cjHErDo8Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ClinicalMilestonesAchievedPriorTo1January2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2006-11-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_1_2006_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__PSR-FnhukSI5DOP7kxVxw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2006-11-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_31_2020_To_3_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_POa8drBe6UafiI7IoFhEXw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillySecondAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-31</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_g_GGnY_Mek66JNJPv8qF7g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_Ssvb6k-KGUuY9cOGiA1XzQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_Xs05KeXY_USgX2n0OcnZ7Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_AEaXqV6uYU2YSJVL94SJpg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_uJn6GJFgd0C7AUHONVqWvA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_4_28_2021_To_4_28_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_S6KglnLJ6EOK616omN_TFQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-28</xbrli:startDate><xbrli:endDate>2021-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_Z8Cvgi6srkG50kHoFl7dWQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="Unit_Standard_Institution_SROTVTXUBkGGrhJAF8DeMQ"><xbrli:measure>aciu:Institution</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_payment_b5_XsToWrkW99sPOvgoheg"><xbrli:measure>aciu:payment</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g"><xbrli:measure>aciu:EquityInstruments</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ"><xbrli:measure>aciu:person</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_segment_9jTtSCng3EmNVBiAOMwlNw"><xbrli:measure>aciu:segment</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw"><xbrli:measure>aciu:employee</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Divide_CHF_EUR_oaL03aUr-0uB3BBQW7LmbA"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA"><xbrli:measure>aciu:Y</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A"><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA"><xbrli:measure>aciu:Options</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_installment_mxjM2Rh-sk6ny-HGf2rDww"><xbrli:measure>aciu:installment</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_agreement_6AbCKkYWeEm1dt5Jp7cROw"><xbrli:measure>aciu:agreement</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ"><xbrli:measure>aciu:item</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_plan_lCCE6LMjkEKlKdQ1vpJjNA"><xbrli:measure>aciu:plan</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div style="max-width:100%;padding-left:4.47%;padding-right:4.47%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.19;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;">,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_7e2e2c55_a2ac_47b6_ac1b_274c1bbf4ca3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">UNITED STATES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">SECURITIES AND EXCHANGE COMMISSION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Washington, D.C. 20549</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:DocumentType" id="Narr_eLLKO5k3x0KgJch5rmuInQ"><b style="font-weight:bold;">20-F</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 5pt 0pt;">(Mark One)</p><a id="_88e1fb7c_77b4_4da7_86d2_2b9c3dc3756a"></a><a id="Tc_Z4GznNXb-0O4esHofbIt4Q_1_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:0.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:96.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:0.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:DocumentRegistrationStatement" id="Tc_oHdYDI2r4E6rcLGlgoZu3Q_1_1"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">REGISTRATION STATEMENT PURSUANT TO SECTION&#160;12(b)&#160;OR (g)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:5pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">OR</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_3d47ba62_f733_427f_a99d_2b7eabf70caf"></a><a id="Tc_uWIF1B0yi0Ccfcj-6zOrqg_1_1"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:2.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:DocumentAnnualReport" id="Tc_wBYyx1_LrESjj2YH5YPfjQ_1_0"><span style="font-family:'Segoe UI Symbol';">&#9746;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">ANNUAL REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal&#160;year ended </b><ix:nonNumeric format="ixt:datemonthdayyearen" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:DocumentPeriodEndDate" id="Narr_uzT3TJlyPkuT2E-TDKBaAw"><b style="font-weight:bold;">December&#160;31, 2022</b></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">OR</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_4f604c73_3a6d_40ed_ad19_932c8e6eadf2"></a><a id="Tc_8-QS91ZNQkmZEE_iyvajTg_1_1"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:DocumentTransitionReport" id="Tc_9UzHUMS7x0msQXVlVVxEdg_1_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">OR</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_d713b36b_4603_48dd_8609_7a8c5b0e95d6"></a><a id="Tc_PzC-uuAq20Ce8wyQguRg6Q_1_1"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:3.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:96.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:3.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:DocumentShellCompanyReport" id="Tc_mX_-c-NtFkWOOJh7ZEzDbQ_1_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">SHELL COMPANY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Commission file number: <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:EntityFileNumber" id="Narr_n48-cDBvzEe7qAFIxr7n-w">001-37891</ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:EntityRegistrantName" id="Narr_SjRL44o-40GZowDzsKpLNg"><b style="font-weight:bold;">AC IMMUNE SA</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">(Exact name of Registrant as specified in its charter)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:edgarprovcountryen" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:EntityIncorporationStateCountryCode" id="Narr_sAX1e0SewEGOs_py3fkdeQ"><b style="font-weight:bold;">Switzerland</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">(Jurisdiction of incorporation)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:EntityAddressAddressLine1" id="Narr_ZeGaG5ls-Eykvl0ncjpYyQ"><b style="font-weight:bold;">EPFL INNOVATION PARK</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:EntityAddressAddressLine2" id="Narr_cTwfrbEPnkG_XlwXNDxLww"><b style="font-weight:bold;">Building B</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:EntityAddressPostalZipCode" id="Narr_ahi79EkJV0SKnHu_ZcOpDw"><b style="font-weight:bold;">1015</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:EntityAddressCityOrTown" id="Narr_Q-jpVCBXmUii2yYtj-flig"><b style="font-weight:bold;">Lausanne</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:countrynameen" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:EntityAddressCountry" id="Narr_p7HvuHC6SkWloCPcN0m8Dw"><b style="font-weight:bold;">Switzerland</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">(Address of principal executive offices)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA" name="dei:ContactPersonnelName" id="Narr_V77s93hBzEeyuBGBBGW3bg"><b style="font-weight:bold;">Andrea Pfeifer</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Tel: +</b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA" name="dei:CityAreaCode" id="Narr_U4-pwQHuh0KKsE5tIJWK0A"><b style="font-weight:bold;">41</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA" name="dei:LocalPhoneNumber" id="Narr_TaLkVPqnCk-EPn5VThyc5Q"><b style="font-weight:bold;">21 345 91 21</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA" name="dei:EntityAddressAddressLine1" id="Narr_vWQQodNdYESqSXf0Kmby3Q"><b style="font-weight:bold;">EPFL INNOVATION PARK</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA" name="dei:EntityAddressAddressLine2" id="Narr_COkZeAXgLUuuVPHHn-ud4A"><b style="font-weight:bold;">Building B</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA" name="dei:EntityAddressPostalZipCode" id="Narr_T3-aTzC1F0qairn4n7LKjg"><b style="font-weight:bold;">1015</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA" name="dei:EntityAddressCityOrTown" id="Narr_rv3lJVAhNEurixVmD16FGw"><b style="font-weight:bold;">Lausanne</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:countrynameen" contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA" name="dei:EntityAddressCountry" id="Narr_ajFeHY5Q2Ue1jmUySAiDAg"><b style="font-weight:bold;">Switzerland</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">Copies to:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:100%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:middle;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Derek J. Dostal</b><br /><b style="font-weight:bold;">Davis Polk&#160;&amp; Wardwell LLP</b><br /><b style="font-weight:bold;">450 Lexington Avenue</b><br /><b style="font-weight:bold;">New York, NY 10017</b><br /><b style="font-weight:bold;">(212) 450-4000</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:5pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Securities registered or to be registered pursuant to Section&#160;12(b)&#160;of the Act:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_bac46a70_3741_4d17_acf3_1bf29b7370b0"></a><a id="Tc_LqGP-gQ3KEiwuuxogowSog_1_0"></a><a id="Tc_bzSt-DavH0uHa_n7CpFGEw_1_2"></a><a id="Tc_o2kBvhiGLUq9kcAHr6Xr-w_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:31.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:31.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Title of each class</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Trading Symbol</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Name of each exchange on which registered</p></td></tr><tr><td style="vertical-align:top;width:31.99%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:Security12bTitle" id="Tc_w1mnrZKTgEyKpwdPJw-JLw_2_0">Common Shares, nominal value CHF 0.02 per share</ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:TradingSymbol" id="Tc_Ol0nwcTsoUqHqmtjoH6sxw_2_2">ACIU</ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:exchnameen" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:SecurityExchangeName" id="Tc_e4kHbhUmg0yhZrykURqoBA_2_4">The Nasdaq Global Market</ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:5pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:91.06%;border:0;margin:30pt 4.47% 30pt 4.47%;"></div><div style="max-width:100%;padding-left:4.47%;padding-right:4.47%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Securities registered or to be registered pursuant to Section&#160;12(g)&#160;of the Act:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">None</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Securities for which there is a reporting obligation pursuant to Section&#160;15(d)&#160;of the Act:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">None</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital stock or common stock as of the close of the period covered by the annual report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Common shares: <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="Narr_WKciTITyvUSo57UuFf753g">83,620,364</ix:nonFraction></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> Yes <span style="font-family:'Segoe UI Symbol';">&#9746;</span> <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:EntityWellKnownSeasonedIssuer" id="Narr_DoE_TAQd6EGrp04nSoHrKQ">No</ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act&#160;of&#160;1934.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> Yes <span style="font-family:'Segoe UI Symbol';">&#9746;</span> <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:EntityVoluntaryFilers" id="Narr_JNbpzXoVuEeXB_I1j2nlNQ">No</ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Note&#160;&#8211; Checking the box above will not relieve any registrant required to file reports pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 from their obligations under those Sections.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9746;</span> <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:EntityCurrentReportingStatus" id="Narr_dtVfqo3szkK5zESpzQLOxA">Yes</ix:nonNumeric> <span style="font-family:'Segoe UI Symbol';">&#9744;</span> No</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9746;</span> <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:EntityInteractiveDataCurrent" id="Narr_dnorbpp9AUGDq3rGykPpgQ">Yes</ix:nonNumeric> <span style="font-family:'Segoe UI Symbol';">&#9744;</span> No</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Large accelerated filer <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="Narr_yIbwWcTp9kG9PrF95R2gkg">Accelerated filer</ix:nonNumeric> <span style="font-family:'Segoe UI Symbol';">&#9746;</span></p></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Non-accelerated filer <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td></tr><tr><td style="vertical-align:top;width:34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Emerging growth company <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_61EaPGLda02D7xykPhoOuw"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section&#160;404(b)&#160;of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="Narr_WO4uJzai90WES6zXu0vXww"><span style="font-family:'Segoe UI Symbol';">&#9746;</span></ix:nonNumeric> Yes <span style="font-family:'Segoe UI Symbol';">&#9744;</span> No</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167; 240.10D-1(b).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:91.06%;border:0;margin:30pt 4.47% 30pt 4.47%;"></div><div style="max-width:100%;padding-left:4.47%;padding-right:4.47%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">U.S. GAAP <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:top;width:33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:DocumentAccountingStandard" id="Narr_2sZgeK2tv0a8rMJJU12zhQ">International Financial Reporting Standards</ix:nonNumeric> as issued by the International Accounting Standards Board <span style="font-family:'Segoe UI Symbol';">&#9746;</span></p></td><td style="vertical-align:top;width:33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Other <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">If &#8220;Other&#8221; has been checked in response to the previous question indicate by check mark which financial statement item the registrant has elected to follow.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> Item&#160;17 <span style="font-family:'Segoe UI Symbol';">&#9744;</span> Item&#160;18</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="Narr_XLmgvd6LsUywSx1tXamCmQ"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric> Yes <span style="font-family:'Segoe UI Symbol';">&#9746;</span> No</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><p style="display:none;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:91.06%;border:0;margin:30pt 4.47% 30pt 4.47%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_37ceaa38_d7a3_4f73_bb83_78424073c633"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;">AC IMMUNE SA</p><a id="TOC"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">TABLE OF CONTENTS</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#FORWARDLOOKINGSTATEMENTS_785824"><span style="font-style:normal;font-weight:normal;">FORWARD-LOOKING STATEMENTS</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">1</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#PARTI_417258"><span style="font-style:normal;font-weight:normal;">PART I</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM1IDENTITYOFDIRECTORSSENIORMANAGEMENT"><span style="font-style:normal;font-weight:normal;">ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ADirectorsandseniormanagement_945095"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ADirectorsandseniormanagement_945095"><span style="font-style:normal;font-weight:normal;">Directors and senior management</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BAdvisers_224952"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BAdvisers_224952"><span style="font-style:normal;font-weight:normal;">Advisers</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CAuditors_712026"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CAuditors_712026"><span style="font-style:normal;font-weight:normal;">Auditors</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM2OFFERSTATISTICSANDEXPECTEDTIMETABLE"><span style="font-style:normal;font-weight:normal;">ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AOfferstatistics_380962"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AOfferstatistics_380962"><span style="font-style:normal;font-weight:normal;">Offer statistics</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BMethodandexpectedtimetable_121512"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BMethodandexpectedtimetable_121512"><span style="font-style:normal;font-weight:normal;">Method and expected timetable</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM3KEYINFORMATION_215446"><span style="font-style:normal;font-weight:normal;">ITEM 3. KEY INFORMATION</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AReserved_203174"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AReserved_203174"><span style="font-style:normal;font-weight:normal;">[Reserved]</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BCapitalizationandindebtedness_75989"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BCapitalizationandindebtedness_75989"><span style="font-style:normal;font-weight:normal;">Capitalization and indebtedness</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CReasonsfortheofferanduseofproceeds_6854"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CReasonsfortheofferanduseofproceeds_6854"><span style="font-style:normal;font-weight:normal;">Reasons for the offer and use of proceeds</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DRiskfactors_669294"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DRiskfactors_669294"><span style="font-style:normal;font-weight:normal;">Risk factors</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM4INFORMATIONONTHECOMPANY_87372"><span style="font-style:normal;font-weight:normal;">ITEM 4. INFORMATION ON THE COMPANY</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">53</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AHistoryanddevelopmentofthecompany_39409"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AHistoryanddevelopmentofthecompany_39409"><span style="font-style:normal;font-weight:normal;">History and development of the company</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">53</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BBusinessoverview_517701"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BBusinessoverview_517701"><span style="font-style:normal;font-weight:normal;">Business overview</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">53</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#COrganizationalstructure_904091"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#COrganizationalstructure_904091"><span style="font-style:normal;font-weight:normal;">Organizational structure</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">124</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DPropertyplantandequipment_864198"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DPropertyplantandequipment_864198"><span style="font-style:normal;font-weight:normal;">Property, plant and equipment</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">124</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM4AUNRESOLVEDSTAFFCOMMENTS_558751"><span style="font-style:normal;font-weight:normal;">ITEM 4A. UNRESOLVED STAFF COMMENTS</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">125</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM5OPERATINGANDFINANCIALREVIEWANDPROSP"><span style="font-style:normal;font-weight:normal;">ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">125</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AOperatingresults_466589"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AOperatingresults_466589"><span style="font-style:normal;font-weight:normal;">Operating results</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">125</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BLiquidityandcapitalresources_635978"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BLiquidityandcapitalresources_635978"><span style="font-style:normal;font-weight:normal;">Liquidity and capital resources</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">143</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CResearchanddevelopmentpatentsandlicense"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CResearchanddevelopmentpatentsandlicense"><span style="font-style:normal;font-weight:normal;">Research and development, patents and licenses, etc.</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">145</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DTrendinformation_775981"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DTrendinformation_775981"><span style="font-style:normal;font-weight:normal;">Trend information</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">145</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ECriticalAccountingEstimates_860985"><span style="font-style:normal;font-weight:normal;">E.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ECriticalAccountingEstimates_860985"><span style="font-style:normal;font-weight:normal;">Critical Accounting Estimates</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">145</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM6DIRECTORSSENIORMANAGEMENTANDEMPLOYE"><span style="font-style:normal;font-weight:normal;">ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">145</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ADirectorsandseniormanagement_124887"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ADirectorsandseniormanagement_124887"><span style="font-style:normal;font-weight:normal;">Directors and senior management</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">145</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BCompensation_249678"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BCompensation_249678"><span style="font-style:normal;font-weight:normal;">Compensation</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">150</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CBoardpractices_883818"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CBoardpractices_883818"><span style="font-style:normal;font-weight:normal;">Board practices</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">152</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DEmployees_312467"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DEmployees_312467"><span style="font-style:normal;font-weight:normal;">Employees</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">155</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#EShareownership_36027"><span style="font-style:normal;font-weight:normal;">E.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#EShareownership_36027"><span style="font-style:normal;font-weight:normal;">Share ownership</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">155</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a href="#Item6F"><span style="font-style:normal;font-weight:normal;">F.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#Item6F"><span style="font-style:normal;font-weight:normal;">Disclosure of a registrant&#8217;s action to recover erroneously awarded compensation</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">155</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM7MAJORSHAREHOLDERSANDRELATEDPARTYTRA"><span style="font-style:normal;font-weight:normal;">ITEM 7. MAJOR SHAREHOLDERS AND RELATED-PARTY TRANSACTIONS</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">155</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AMajorshareholders_980950"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AMajorshareholders_980950"><span style="font-style:normal;font-weight:normal;">Major shareholders</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">155</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BRelatedpartytransactions_285369"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BRelatedpartytransactions_285369"><span style="font-style:normal;font-weight:normal;">Related-party transactions</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">158</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CInterestsofexpertsandcounsel_884840"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CInterestsofexpertsandcounsel_884840"><span style="font-style:normal;font-weight:normal;">Interests of experts and counsel</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">158</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM8FINANCIALINFORMATION_353349"><span style="font-style:normal;font-weight:normal;">ITEM 8. FINANCIAL INFORMATION</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">159</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AConsolidatedstatementsandotherfinancial"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AConsolidatedstatementsandotherfinancial"><span style="font-style:normal;font-weight:normal;">Consolidated statements and other financial information</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">159</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BSignificantchanges_559132"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BSignificantchanges_559132"><span style="font-style:normal;font-weight:normal;">Significant changes</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">159</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM9THEOFFERANDLISTING_667173"><span style="font-style:normal;font-weight:normal;">ITEM 9. THE OFFER AND LISTING</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">159</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AOfferingandlistingdetails_815430"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AOfferingandlistingdetails_815430"><span style="font-style:normal;font-weight:normal;">Offering and listing details</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">159</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BPlanofdistribution_857538"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BPlanofdistribution_857538"><span style="font-style:normal;font-weight:normal;">Plan of distribution</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">159</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CMarkets_858091"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CMarkets_858091"><span style="font-style:normal;font-weight:normal;">Markets</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">159</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DSellingshareholders_381670"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DSellingshareholders_381670"><span style="font-style:normal;font-weight:normal;">Selling shareholders</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#EDilution_693805"><span style="font-style:normal;font-weight:normal;">E.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#EDilution_693805"><span style="font-style:normal;font-weight:normal;">Dilution</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#FExpensesoftheissue_68420"><span style="font-style:normal;font-weight:normal;">F.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#FExpensesoftheissue_68420"><span style="font-style:normal;font-weight:normal;">Expenses of the issue</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">i</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM10ADDITIONALINFORMATION_834727"><span style="font-style:normal;font-weight:normal;">ITEM 10. ADDITIONAL INFORMATION</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ASharecapital_904810"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ASharecapital_904810"><span style="font-style:normal;font-weight:normal;">Share capital</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BMemorandumandarticlesofassociation_4543"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BMemorandumandarticlesofassociation_4543"><span style="font-style:normal;font-weight:normal;">Memorandum and articles of association</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CMaterialcontracts_220743"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CMaterialcontracts_220743"><span style="font-style:normal;font-weight:normal;">Material contracts</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DExchangecontrols_45681"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DExchangecontrols_45681"><span style="font-style:normal;font-weight:normal;">Exchange controls</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ETaxation_74576"><span style="font-style:normal;font-weight:normal;">E.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ETaxation_74576"><span style="font-style:normal;font-weight:normal;">Taxation</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#FDividendsandpayingagents_343344"><span style="font-style:normal;font-weight:normal;">F.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#FDividendsandpayingagents_343344"><span style="font-style:normal;font-weight:normal;">Dividends and paying agents</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">168</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#GStatementbyexperts_563927"><span style="font-style:normal;font-weight:normal;">G.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#GStatementbyexperts_563927"><span style="font-style:normal;font-weight:normal;">Statement by experts</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">168</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#HDocumentsondisplay_893312"><span style="font-style:normal;font-weight:normal;">H.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#HDocumentsondisplay_893312"><span style="font-style:normal;font-weight:normal;">Documents on display</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">168</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ISubsidiaryinformation_453406"><span style="font-style:normal;font-weight:normal;">I.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ISubsidiaryinformation_453406"><span style="font-style:normal;font-weight:normal;">Subsidiary information</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">168</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#JAnnualReportToSecurityHolders"><span style="font-style:normal;font-weight:normal;">J.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#JAnnualReportToSecurityHolders"><span style="font-style:normal;font-weight:normal;">Annual report to security holders</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">168</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM11QUANTITATIVEANDQUALITATIVEDISCLOSU"><span style="font-style:normal;font-weight:normal;">ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">168</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM12DESCRIPTIONOFSECURITIESOTHERTHANEQ"><span style="font-style:normal;font-weight:normal;">ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">170</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ADebtsecurities_509592"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ADebtsecurities_509592"><span style="font-style:normal;font-weight:normal;">Debt securities</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">170</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BWarrantsandrights_307246"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BWarrantsandrights_307246"><span style="font-style:normal;font-weight:normal;">Warrants and rights</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">170</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#COthersecurities_247673"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#COthersecurities_247673"><span style="font-style:normal;font-weight:normal;">Other securities</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">170</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DAmericandepositaryshares_477448"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DAmericandepositaryshares_477448"><span style="font-style:normal;font-weight:normal;">American depositary shares</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">170</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#PARTII_983451"><span style="font-style:normal;font-weight:normal;">PART II</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">171</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM13DEFAULTSDIVIDENDARREARAGESANDDELIN"><span style="font-style:normal;font-weight:normal;">ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">171</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ADefaults_798645"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ADefaults_798645"><span style="font-style:normal;font-weight:normal;">Defaults</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">171</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BArrearsanddelinquencies_675487"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BArrearsanddelinquencies_675487"><span style="font-style:normal;font-weight:normal;">Arrears and delinquencies</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">171</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM14MATERIALMODIFICATIONSTOTHERIGHTSOF"><span style="font-style:normal;font-weight:normal;">ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">171</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM15CONTROLSANDPROCEDURES_751037"><span style="font-style:normal;font-weight:normal;">ITEM 15. CONTROLS AND PROCEDURES</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">171</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ADisclosurecontrolsandprocedures_342570"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ADisclosurecontrolsandprocedures_342570"><span style="font-style:normal;font-weight:normal;">Disclosure controls and procedures</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">171</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BManagementsAnnualReportoninternalcontro"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BManagementsAnnualReportoninternalcontro"><span style="font-style:normal;font-weight:normal;">Management&#8217;s Annual Report on internal control over financial reporting</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">171</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CAttestationreportoftheregisteredpublica"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CAttestationreportoftheregisteredpublica"><span style="font-style:normal;font-weight:normal;">Attestation report of the registered public accounting firm</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">172</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DChangesininternalcontroloverfinancialre"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DChangesininternalcontroloverfinancialre"><span style="font-style:normal;font-weight:normal;">Changes in internal control over financial reporting</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">172</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16RESERVED_843348"><span style="font-style:normal;font-weight:normal;">ITEM 16. [RESERVED]</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">172</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16AAuditcommitteefinancialexperts_94"><span style="font-style:normal;font-weight:normal;">ITEM 16A. Audit committee financial experts</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">172</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16BCodeofEthics_857383"><span style="font-style:normal;font-weight:normal;">ITEM 16B. Code of Ethics</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">172</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16CPrincipalaccountantfeesandservice"><span style="font-style:normal;font-weight:normal;">ITEM 16C. Principal accountant fees and services</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">172</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16DExemptionsfromthelistingstandards"><span style="font-style:normal;font-weight:normal;">ITEM 16D. Exemptions from the listing standards for audit committees</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">173</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16EPurchasesofequitysecuritiesbythei"><span style="font-style:normal;font-weight:normal;">ITEM 16E. Purchases of equity securities by the issuer and affiliated purchasers</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">173</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16FChangeinregistrantscertifyingacco"><span style="font-style:normal;font-weight:normal;">ITEM 16F. Change in registrant&#8217;s certifying accountant</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">173</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16GCorporategovernance_299481"><span style="font-style:normal;font-weight:normal;">ITEM 16G. Corporate governance</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">173</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16HMinesafetydisclosure_873677"><span style="font-style:normal;font-weight:normal;">ITEM 16H. Mine safety disclosure</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">174</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16IDisclosureregardingforeignjurisdi"><span style="font-style:normal;font-weight:normal;">ITEM 16I. Disclosure regarding foreign jurisdictions that prevent inspections</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">174</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#PARTIII_805425"><span style="font-style:normal;font-weight:normal;">PART III</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">175</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM17Financialstatements_563714"><span style="font-style:normal;font-weight:normal;">ITEM 17. Financial statements</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">175</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM18Financialstatements_869202"><span style="font-style:normal;font-weight:normal;">ITEM 18. Financial statements</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">175</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM19Exhibits_807810"><span style="font-style:normal;font-weight:normal;">ITEM 19. Exhibits</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">175</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="display:none;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">ii</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ed3b135f_205d_489f_8958_eb434bbbe048"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">PRESENTATION OF FINANCIAL AND OTHER INFORMATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Unless otherwise indicated or the context otherwise requires, all references in this annual report on Form&#160;20-F (the &#8220;Annual Report&#8221;) to &#8220;AC Immune,&#8221; &#8220;ACIU,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; &#8220;us&#8221; or similar terms refer to AC Immune SA together with its subsidiary. The Company owns various registered and unregistered trademarks, for some of which protection has been obtained or is being sought, including Morphomer&#8482;, SupraAntigen<sup style="color:#222222;font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">&#174;</sup> and its corporate name, logo and Nasdaq Global Market symbol. All other trademarks, trade names and service marks of other companies appearing in this Annual Report are the property of their respective owners. Solely for convenience, the trademarks and trade names in this Annual Report may be referred to without the respective <sup style="color:#222222;font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">&#174;</sup> and &#8482; symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. The Company does not intend to use or display other companies&#8217; trademarks and/or trade names to imply a relationship with, or endorsement or sponsorship of the Company by, any other companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Financial statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our consolidated financial statements are presented in Swiss Francs and in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting Standards Board (IASB). None of the consolidated financial statements was prepared in accordance with generally accepted accounting principles in the United States (U.S.). The terms &#8220;dollar&#8221; and &#8220;USD&#8221; refer to U.S. dollars, and the terms &#8220;Swiss Franc&#8221; and &#8220;CHF&#8221; refer to the legal currency of Switzerland, unless otherwise indicated. We have made rounding adjustments to some of the figures included in this Annual Report. Accordingly, any numerical discrepancies in any table between totals and sums of the amounts listed are due to rounding.</p><a id="_2f3f01e1_7d02_4927_9e0c_8c39ccf09648"></a><a id="FORWARDLOOKINGSTATEMENTS_785824"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">FORWARD-LOOKING STATEMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This Annual Report contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this Annual Report, including statements regarding our future results of operations and financial position, business strategy, product candidates, product pipeline, ongoing and planned clinical studies, including those of our collaboration partners, regulatory approvals, research and development (R&amp;D) costs, timing and likelihood of success, as well as plans and objectives of management for future operations, are forward-looking statements. Many of the forward-looking statements contained in this Annual Report can be identified by the use of forward-looking words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;should,&#8221; &#8220;plan,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;will&#8221; and &#8220;potential,&#8221; among others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Forward-looking statements appear in a number of places in this Annual Report and include, but are not limited to, statements regarding our intent, belief or current expectations. Forward-looking statements are based on our management&#8217;s beliefs and assumptions, and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified under &#8220;Item&#160;3. Key information&#8212;D. Risk factors&#8221; in this Annual Report. These risks and uncertainties include multiple factors:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the success of our and our collaboration partners&#8217; clinical studies, and our and their ability to obtain and maintain regulatory approval and to commercialize our vaccines (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn PET tracer ACI-12589) and to a lesser extent our preclinical candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the preclinical and clinical safety, efficacy and utility of our product candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the ability of our competitors to discover, develop or commercialize competing products before or more successfully than we do;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our plans to research, develop and commercialize our product candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the identification of serious adverse, undesirable or unacceptable side effects related to our product candidates;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">1</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to maintain our current strategic relationships with our collaboration partners;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to protect and maintain our, and not infringe on third parties&#8217;, intellectual property rights throughout the world;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to raise capital when needed in order to continue our product development programs or commercialization efforts;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to attract and retain qualified employees and key personnel;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the acceptance by the Food and Drug Administration (FDA) and applicable foreign regulatory authorities of data from studies that we and our collaboration partners conduct within and outside the U.S. now and in the future;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our foreign private issuer (FPI) status, the loss of which would require us to comply with the Exchange Act&#8217;s domestic reporting regime, and cause us to incur significant legal, accounting and other expenses;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our incorporation in Switzerland, the laws of which govern our corporate affairs and may differ from those applicable to companies incorporated in the U.S.; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the other risk factors discussed under &#8220;Item&#160;3. Key information&#8212;D. Risk factors.&#8221;</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">These forward-looking statements are applicable only as of the date of this Annual Report, and are subject to a number of risks, uncertainties and assumptions described under the sections in this Annual Report entitled &#8220;Item&#160;3. Key information&#8212;D. Risk factors&#8221; and &#8220;Item&#160;5. Operating and financial review and prospects,&#8221; and elsewhere in this Annual Report. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">2</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ce614aed_18d1_4f74_8a36_3cc0f9e7c419"></a><a id="PARTI_417258"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">PART&#160;I</p><a id="ITEM1IDENTITYOFDIRECTORSSENIORMANAGEMENT"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</p><a id="ADirectorsandseniormanagement_945095"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Directors and senior management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="BAdvisers_224952"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Advisers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="CAuditors_712026"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Auditors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_125f7126_de1d_48b8_88b0_30f63354949d"></a><a id="ITEM2OFFERSTATISTICSANDEXPECTEDTIMETABLE"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;2. OFFER STATISTICS AND EXPECTED TIMETABLE</p><a id="AOfferstatistics_380962"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Offer statistics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="BMethodandexpectedtimetable_121512"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Method and expected timetable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_89230ad0_a110_4e67_9e9b_194ad070fd9c"></a><a id="ITEM3KEYINFORMATION_215446"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;3. KEY INFORMATION</p><a id="AReserved_203174"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>[Reserved]</p><a id="BCapitalizationandindebtedness_75989"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Capitalization and indebtedness</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="CReasonsfortheofferanduseofproceeds_6854"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Reasons for the offer and use of proceeds</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="DRiskfactors_669294"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Risk factors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">You should carefully consider the risks and uncertainties described below and the other information in this Annual Report before making an investment in our common shares. Our business, financial condition or results of operations could be materially and adversely affected if any of these risks occurs, and as a result, the market price of our common shares could decline and you could lose all or part of your investment. This Annual Report also contains forward-looking statements that involve risks and uncertainties. See &#8220;Forward-Looking Statements.&#8221; Our actual results could differ materially and adversely from those anticipated in these forward-looking statements as a result of certain factors.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">The below provides a summary of our principal risk factors:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our business:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We depend heavily on the success of our clinical and, to a lesser extent, preclinical products:</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">3</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our ability to generate product revenues, which we do not expect to occur for several&#160;years, will depend on clinical and regulatory success which have low probabilities of success in the central nervous system (CNS) space in which we operate.</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Results of early preclinical and clinical studies may not be predictive of future results:</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Products that show positive or timely preclinical or early clinical results may not show sufficient safety or efficacy in later-stage clinical studies and therefore may fail to obtain regulatory approvals.</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our products may not gain market acceptance or may be preempted by competitors:</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Even if our products obtain regulatory approval, they may not be accepted by healthcare providers, patients or the medical community.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our success is dependent on the ability to discover, develop and obtain marketing approval for our products. We face and will continue to face intense competition from a variety of businesses, including large fully integrated biopharmaceutical and pharmaceutical companies and others that may have greater financial, technical and human resources.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A competitor may enter with a generic of an approved innovator product.</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may not be successful in using and expanding our Morphomer and SupraAntigen proprietary technology platforms.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We operate in highly competitive and rapidly changing industries, which may result in others discovering, developing or commercializing competing products before or more successfully than we do.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our future growth and ability to compete depends on retaining our key personnel and recruiting additional qualified personnel including members of our Executive Committee.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our relationships with third parties:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If we fail to maintain, or realize the benefits from, our current strategic relationships with our current and potential future license and collaboration partners our financial condition may be materially adversely affected.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may seek to form additional strategic alliances in the future with respect to our product candidates, and if we do not realize the benefits of such alliances, our business, financial condition, commercialization prospects and results of operations may be materially adversely affected.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our collaboration agreements may make us an attractive acquisition target under certain circumstances.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to intellectual property:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We or our licensing or collaboration partners may not have sufficient patent terms to protect our products and business effectively which may adversely affect our product sales and technology development.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If we fail to comply with the obligations to obtain and maintain patent protection such as compliance with intellectual property agreements, including those under which we license intellectual property and other rights to or from third parties, or otherwise experience disruptions to our business relationships with our licensees, our licensors and collaboration partners, we could lose intellectual property rights that are important to our business.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">4</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our financial condition and capital requirements:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We are a clinical stage biopharmaceutical company with a history of losses. We anticipate incurring losses for the foreseeable future. As such, if we fail to obtain additional funding via product revenues, license and collaboration agreements, equity offerings or other forms of financing, we may need to delay, reduce or eliminate certain of our product development programs.</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If we fail to obtain additional funding, we may delay, reduce or eliminate our product development programs or commercialization efforts.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to the regulatory environment:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We cannot give any assurance that any of our product candidates will receive regulatory approval, which is necessary before they can be commercialized.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Even if we obtain regulatory approvals in one jurisdiction, we may not be able to obtain approval in other jurisdictions. Additionally, we will be subject to ongoing obligations and review which may result in significant additional expense.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have conducted and may in the future conduct clinical studies for our product candidates outside the U.S., and the FDA and applicable foreign regulatory authorities may not accept data from such studies.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Enacted and future legislation may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates and may affect the prices we may set.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our common shares:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have limited free float in our common shares which may have a negative impact on the liquidity and market price of our common shares.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Certain of our existing shareholders exercise significant control over us, and your or other shareholders&#8217; interests may conflict with the interests of such shareholders.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We are a Swiss corporation. The rights of our shareholders may be different from the rights of shareholders in companies governed by the laws of U.S. jurisdictions.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We are an FPI and, as a result, we are not subject to U.S. proxy rules&#160;and are subject to Exchange Act reporting obligations that, to some extent, are more lenient and less frequent than those of a U.S. domestic public company.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As an FPI, and as permitted by the listing requirements of Nasdaq, we rely on certain home country governance practices rather than the corporate governance requirements of Nasdaq. Should we lose our FPI status, we would be required to comply with the Exchange Act&#8217;s domestic reporting regime, which would cause us to incur significant legal, accounting and other expenses.</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We were likely a passive foreign investment company (PFIC) for our 2022 taxable year and we may be a PFIC for 2023 or future taxable years. If we are a PFIC for any taxable year during which a U.S. investor owns our common shares, the investor generally will be subject to adverse U.S. federal income tax consequences.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 36pt;"><span style="color:#222222;font-size:10pt;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">5</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 9.35pt;"><span style="font-style:italic;font-weight:bold;">We depend heavily on the success of our clinical and, to a lesser extent, preclinical products. Our clinical product candidates include our vaccines (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn PET tracer ACI-12589). If our clinical studies are unsuccessful, if we or our collaboration partners do not obtain regulatory approval or if we or our collaboration partners are unable to commercialize our vaccines (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn PET tracer ACI-12589), or if we experience significant delays in doing so, our business, financial condition and results of operations will be materially adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We currently have no products approved for sale and have invested a significant portion of our efforts and financial resources in the development of our vaccines (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn PET tracer ACI-12589), all of which are in clinical development as well as other preclinical candidates such as our small molecule programs including therapeutics (Morphomer Tau), our TDP-43 antibody, Morphomer a-syn and inflammasome. Our ability to generate product revenues, which we do not expect will occur for at least the next several years, if ever, will depend heavily on successful clinical development, obtaining regulatory approval and eventual commercialization of these product candidates. In this regard, we rely heavily on our collaboration partners for clinical development of certain of our product candidates, and they may choose to discontinue the clinical development process in certain cases. In addition, we currently generate no revenues from sales of any drugs or diagnostics, and we may never be able to develop or commercialize a marketable drug or diagnostic. The success of our current and future product candidates will depend on several factors, including, but not limited to, the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">completing preclinical and clinical studies that demonstrate the efficacy, safety and clinical utility of our preclinical and clinical product candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">receiving marketing approvals from applicable regulatory authorities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establishing commercial manufacturing capabilities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">launching commercial sales, marketing and distribution operations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">acceptance of our product candidates by patients, the medical community and third-party payors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a continued acceptable safety profile following approval;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">competing effectively with other therapies or diagnostic approaches; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtaining, maintaining, enforcing and defending our intellectual property rights and claims and not infringing on third parties&#8217; intellectual property rights.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If we or our collaboration partners do not achieve one or more of these factors in a timely manner or at all, we could experience significant delays or an inability to successfully commercialize our current or future product candidates, which would materially adversely affect our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 9.35pt;">Results of early clinical studies may not be predictive of future study results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Positive or timely results from preclinical or early-stage clinical studies do not ensure positive or timely results in mid-to late-stage clinical studies or product approval by the U.S. FDA, the European Medicines Agency (EMA), or comparable foreign regulatory authorities. Products that show positive preclinical or early clinical results may not show sufficient safety or efficacy in later-stage clinical studies and therefore may fail to obtain regulatory approvals. In addition, preclinical and clinical data are often susceptible to varying interpretations and analyses. Many companies that </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">6</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">believed their product candidates performed satisfactorily in preclinical and clinical studies have nonetheless failed to obtain marketing approval for the product candidates. The FDA, the EMA and comparable foreign regulatory authorities have substantial discretion in the approval process and in determining when or whether regulatory approval will be obtained for any of our product candidates. Even if we believe that the data collected from clinical studies of our product candidates are promising, such data may not be sufficient to support approval by the FDA, the EMA or any other regulatory authority.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In some instances, there can be significant variability in safety and/or efficacy results between different studies of the same product candidate due to numerous factors, including changes in study procedures set forth in protocols, differences in the size and type of the patient populations, adherence to the dosing regimen and other study protocols, and the rate of dropout among clinical study participants. In the case of our later-stage clinical product candidates, results may differ in general on the basis of the larger number of clinical study sites and the additional countries and languages involved in these clinical studies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Clinical studies may include subject-reported outcomes, some of which may be captured with electronic diaries. We have no assurance and cannot rely on past experience that the high frequency of questioning is not influencing the measured outcome. In addition, low compliance with daily reporting requirements may impact the studies&#8217; validity or statistical power. We cannot assure you that any Phase 2, Phase 3 or other clinical studies that either we or our collaboration partners are conducting and may conduct will demonstrate consistent or adequate efficacy and safety to obtain regulatory approval to market our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If we or our collaboration partners are required to conduct additional clinical studies or other testing of any of our current or future product candidates that we or our collaboration partners develop, beyond the studies and testing that we or our collaboration partners contemplate, if we or our collaboration partners are unable to successfully complete clinical studies of our product candidates or other testing, if the results of these studies or tests are unfavorable or are only modestly favorable, or if there are safety concerns associated with our current or future product candidates, we may:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">be delayed in obtaining marketing approval for our product candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">not obtain marketing approval;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtain approval for indications or patient populations that are not as broad as intended or desired;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtain approval with labeling that includes significant use or distribution restrictions or significant safety warnings, including boxed warnings;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">be subject to conditional approval or otherwise to additional post-marketing studies or other requirements; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">remove the product from the market after obtaining marketing approval.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our product development costs will also increase if we experience delays in testing or receiving marketing approvals and we may be required to obtain additional funds to complete clinical studies. We cannot assure you that our clinical studies will begin as planned or be completed on schedule, if at all, or that we will not need to amend our studies after they have begun. Significant clinical study delays could also shorten any periods during which we or our collaboration partners may have the exclusive right to commercialize our product candidates, or allow our competitors to bring products to market before we do, which may harm our business and results of operations. In addition, some of the factors that cause, or lead to, clinical study delays may ultimately lead to the denial of regulatory approval of our product candidates.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">7</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may undertake one or more significant corporate transactions that may not achieve their intended results, may adversely affect our financial condition and our results of operations or result in unforeseeable risks to our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We continuously evaluate the acquisition or disposition of operating businesses and assets and may in the future undertake one or more significant transactions, such as our purchase in 2021 of Affiris AG&#8217;s (Affiris) program portfolio of therapeutics targeting a-syn, notably our ACI-7104.056, a clinically-validated active vaccine candidate for the treatment of Parkinson&#8217;s disease (PD). Any such transaction could be material to our business and could take any number of forms, including mergers, joint ventures and the purchase of equity interests, amongst others. The consideration for such&#160;acquisitive&#160;transactions may include, among other things, cash, common shares or equity interests in us or our subsidiary, or a contribution of equipment to obtain equity interests, and in conjunction with a transaction we might incur additional indebtedness. We also routinely evaluate the benefits of disposing of certain of our assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These transactions may present significant risks such as insufficient revenue to offset liabilities assumed, potential loss of significant revenue and income streams, increased or unexpected expenses, inadequate return of capital, regulatory or compliance issues, the triggering of certain covenants in our debt agreements (including accelerated repayment) and unidentified issues not discovered in due diligence. In addition, such transactions could distract management from current operations. As a result of the risks inherent in such transactions, we cannot guarantee that any such transaction will ultimately result in the realization of its anticipated benefits or that it will not have a material adverse effect on our business, financial condition and results of operations. If we were to complete such an acquisition, disposition, investment or other strategic transaction, we may require additional debt or equity financing that could result in a significant increase in our amount of debt and our debt service obligations or the number of outstanding common shares, thereby diluting holders of our common shares outstanding prior to such acquisition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Additional competitors could enter the market with generic versions of our products, which may result in a material decline in sales of affected products.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the Drug Price Competition and Patent Term Restoration Act of 1984, or the Hatch-Waxman Act, a pharmaceutical manufacturer may file an abbreviated new drug application (ANDA), seeking approval of a generic copy of an approved innovator product. Under the Hatch-Waxman Act, a manufacturer may also submit a new drug application (NDA) under Section&#160;505(b)(2)&#160;that references the FDA&#8217;s prior approval of the innovator product. A 505(b)(2)&#160;NDA product may be submitted for a new or improved version of the original innovator product. Hatch-Waxman also provides for certain periods of regulatory exclusivity, which preclude FDA approval (or in some circumstances, FDA filing and reviewing) of an ANDA or 505(b)(2)&#160;NDA. These include, subject to certain exceptions, the period during which an FDA-approved drug is subject to orphan-drug exclusivity. In addition to the benefits of regulatory exclusivity, an innovator NDA holder may have patents claiming the active ingredient, product formulation or an approved use of the drug, which would be listed with the product in the FDA publication, &#8220;Approved Drug Products with Therapeutic Equivalence Evaluations,&#8221; known as the &#8220;Orange Book.&#8221; If there are patents listed in the Orange Book, a generic or 505(b)(2)&#160;applicant that seeks to market its product before expiration of the patents must include in the ANDA what is known as a &#8220;Paragraph IV certification,&#8221; challenging the validity or enforceability of, or claiming non-infringement of, the listed patent or patents. Notice of the certification must also be given to the innovator, and if within 45&#160;days of receiving notice the innovator, in order to protect its patents, sues the company that manufactures the generic, approval of the ANDA is stayed for 30&#160;months, or as lengthened or shortened by the court.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Accordingly, if our vaccines (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn PET tracer ACI-12589) are approved, competitors could file ANDAs for generic versions of our vaccines (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn PET tracer ACI-12589) or 505(b)(2) NDAs that reference our vaccines (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn PET tracer ACI-12589), respectively. If there are patents listed in the Orange Book for our vaccines (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn PET tracer ACI-12589), respectively, those ANDAs and 505(b)(2) NDAs would be required to include a certification for each listed patent, indicating whether the ANDA applicant does or does not intend to challenge the patent. We cannot </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">8</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">predict whether any patents issuing from our pending patent applications will be eligible for listing in the Orange Book, how any generic competitor would address such patents, whether we would sue on any such patents or the outcome of any such suit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We may not be successful in securing or maintaining proprietary patent protection for products and technologies we develop or license. Moreover, if any patents that are granted and listed in the Orange Book are successfully challenged by way of a Paragraph IV certification and subsequent litigation, the affected product could immediately face generic competition and its sales would likely decline rapidly and materially. Should sales decline, we may have to write off a portion or all of the intangible assets associated with the affected product, and our results of operations and cash flows could be materially and adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">The successful commercialization of our product candidates will depend in part on the extent to which governmental authorities and health insurers establish adequate coverage and reimbursement levels and pricing policies.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The successful commercialization of our product candidates will depend, in part, on the extent to which coverage and reimbursement for our products will be available from government and health administration authorities, private health insurers and other third-party payors. To manage healthcare costs, many governments and third-party payors increasingly scrutinize the pricing of new technologies and require greater levels of evidence of favorable clinical outcomes and cost-effectiveness before extending coverage. For example, the Inflation Reduction Act (IRA) of 2022, among other things, incentivizes the renegotiation with the U.S. government of the prices of certain pharmaceutical drugs and imposes penalties for Medicare drugs that increase in price faster than the rate of inflation. See &#8220;&#8212;Enacted and future legislation may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates and may affect the prices we may set&#8221; below. In light of such challenges to prices and the requirement for increasing levels of evidence of the benefits and clinical outcomes of new technologies, we cannot be sure that coverage will be available for any of our current or future product candidates that we or our collaboration partners will commercialize or, if available, that the reimbursement rates will be adequate in each respective region. If we are unable to obtain adequate levels of coverage and reimbursement for our product candidates, their marketability will be negatively and materially impacted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Third-party payors may deny coverage and reimbursement status altogether for a given drug product, or may cover the product but also establish prices at levels that are too low to enable us to realize an appropriate return on our investment in product development. Because the rules&#160;and regulations regarding coverage and reimbursement change frequently, in some cases at short notice, even when there is favorable coverage and reimbursement, future changes may occur that adversely impact the favorable status. Further, the net reimbursement for drug products may be subject to additional reductions in the future depending on policy changes enacted by the U.S. Congress.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The unavailability or inadequacy and variability of third-party coverage and reimbursement could have a material adverse effect on the market acceptance of our product candidates and the future revenues we may expect to receive from those products. In addition, we are unable to predict what additional legislation or regulation relating to the healthcare industry or third-party coverage and reimbursement may be enacted in the future, or what effect such legislation or regulation would have on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our products may not gain market acceptance, in which case we or our collaboration partners may not be able to generate product revenues, which will materially adversely affect our business, financial condition and results of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Even if the FDA, the EMA or any other regulatory authority approves the marketing of any product candidates that we develop, physicians, healthcare providers, patients or the medical community may not accept or use them. Efforts to educate the medical community and third-party payors on the benefits of our product candidates may require significant resources and may not be successful. If any of our current or future product candidates does not achieve an adequate level of acceptance, we or our collaboration partners may not generate significant product or royalty revenues or any </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">9</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">profits from operations. The degree of market acceptance of our product candidates that are approved for commercial sale will depend on a variety of factors, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">how clinicians and potential patients perceive our novel products;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the timing of market introduction;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the number and clinical profile of competing products;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to provide acceptable evidence of safety and efficacy or clinical utility;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the prevalence and severity of any side effects;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">relative convenience and ease of administration;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">cost-effectiveness;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">patient diagnostics and screening infrastructure in each market;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">marketing and distribution support;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">availability of coverage, reimbursement and adequate payment from health maintenance organizations and other third-party payors, both public and private; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">other potential advantages over alternative treatment methods.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If our product candidates fail to gain market acceptance, this will have a material adverse impact on our ability to generate revenues to provide a satisfactory, or any, return on our investments. Even if some products achieve market acceptance, the market may prove to not be large enough to allow us to generate significant revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the potential market opportunity of our product candidates is difficult to estimate precisely. Our estimates of the potential market opportunity are predicated on several key assumptions such as industry knowledge and publications, third-party research reports and other surveys. These assumptions involve the exercise of significant judgment on the part of our management and are inherently uncertain, and the reasonableness of these assumptions could not have been assessed by an independent source in every detail. If any of the assumptions proves to be inaccurate, then the actual market for our product candidates could be smaller than our estimates of the potential market opportunity. If the actual market for our product candidates is smaller than we expect, or if any approved products fail to achieve an adequate level of acceptance by physicians, healthcare payors and patients, our product or royalty revenue may be limited and it may be more difficult for us to achieve or maintain profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We depend on enrollment of patients in our clinical studies for our product candidates. If we are unable to enroll patients in our clinical studies, our research and development efforts could be materially adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Successful and timely completion of clinical studies will require that we enroll a sufficient number of patient candidates. Studies may be subject to delays as a result of patient enrollment taking longer than anticipated or by patient withdrawal. Patient enrollment depends on many factors, including the size and nature of the patient population, the eligibility criteria for the study, the proximity of patients to clinical sites, the design of the clinical protocol, the existence of competing clinical studies, the availability of new drugs approved for the indication the clinical study is investigating, and clinicians&#8217; and patients&#8217; perceptions as to the potential advantages of the drug being studied in relation to other available therapies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Generally, the specific target population of patients and therapeutic time windows may make it difficult for us to enroll enough patients to complete clinical studies for our product candidates in a timely and cost-effective manner. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">10</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Delays in the completion of any clinical study of our product candidates will increase our costs, slow down our product candidate development and approval process, and delay or potentially jeopardize our or our collaboration partners&#8217; ability to commence product sales and generate revenue. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical studies may also ultimately lead to the denial of regulatory approval of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If serious adverse, undesirable or unacceptable side effects are identified during the development of our product candidates or following approval, if any, we may need to abandon our development of such product candidates, the commercial profile of any approved label may be limited, or we may be subject to other significant negative consequences following marketing approval, if any.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If our product candidates are associated with serious adverse, undesirable or unacceptable side effects, we may need to abandon their development or limit development to certain uses or subpopulations in which such side effects are less prevalent, less severe or more acceptable from a risk&#8211;benefit perspective. Many compounds that initially showed promise in preclinical or early-stage testing were later found to cause side effects that restricted their use and prevented further development of the compound for larger indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Occurrence of serious procedure- or treatment-related side effects could impede clinical study enrollment and receipt of marketing approval from the FDA, the EMA and comparable foreign regulatory authorities. Adverse events (AEs) could also adversely affect physician or patient acceptance of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, if one or more of our product candidates receives marketing approval, and we or others later identify undesirable side effects caused by such products, a number of potentially significant negative consequences could result, including the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">regulatory authorities may withdraw approvals of such product and require us or our collaboration partners to take any approved products off the market;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">regulatory authorities may require the addition of labeling statements, specific warnings, a contraindication or field alerts to physicians and pharmacies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we may be required to create a medication guide outlining the risks of such side effects for distribution to patients;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we may be required to change the way the product is administered, to conduct additional studies or to change the labeling of the product;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we or our collaboration partners may be subject to limitations in how we promote the product;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">sales of the product may decrease significantly;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we could be sued and held liable for harm caused to patients; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our reputation and physician or patient acceptance of our products may suffer.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any of these events could prevent us from achieving or maintaining market acceptance of the particular product candidate, if approved, and could significantly harm our business, results of operations and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We operate in highly competitive and rapidly changing industries, which may result in others discovering, developing or commercializing competing products before or more successfully than we do.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The biopharmaceutical and pharmaceutical industries are highly competitive and subject to significant and rapid technological change. Our success is highly dependent on our ability to discover, develop and obtain marketing approval </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">11</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">for new and innovative products on a cost-effective basis and to market them successfully. In doing so, we face and will continue to face intense competition from a variety of businesses, including large, fully integrated pharmaceutical companies, specialty pharmaceutical companies and biopharmaceutical companies, academic institutions, government agencies and other private and public research institutions in Europe, the U.S. and other jurisdictions. Many of our potential competitors, alone or with their strategic partners, have substantially greater financial, technical and human resources than we do and significantly greater experience in the discovery and development of product candidates, obtaining FDA and other regulatory approvals of treatments, and the commercialization of those treatments. Mergers and acquisitions in the pharmaceutical and biopharmaceutical industries may result in even more resources being concentrated among a smaller number of our competitors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The highly competitive nature of and rapid technological changes in the pharmaceutical and biopharmaceutical industries could render our product candidates or our technology obsolete or noncompetitive. The commercial opportunity for our products could be reduced or eliminated if our competitors:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">develop and commercialize products that are safer, more effective, less expensive, or more convenient or easier to administer;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtain quicker FDA or other regulatory approval for their products;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establish superior intellectual property and proprietary positions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">have access to more manufacturing capacity;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">implement more effective approaches to sales, marketing and distribution; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">form more advantageous strategic alliances.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Should any of these occur, our business, financial condition and results of operations could be materially adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We believe that our key competitor product candidates are (i)&#160;AADvac1 (Axon Neuroscience) for ACI-35.030; (ii)&#160;UB-311 (Vaxxinity) and ABvac-40 (Araclon Biotech) for ACI-24.060; (iii)&#160;UB-312 (Vaxxinity) for ACI-7104.056; (iv)&#160;bepranemab (UCB/Roche), E-2814 (Eisai) and JNJ63733657 (Janssen) for semorinemab; (v)&#160;ADUHELM (Biogen), Leqembi (BioArctic/Eisai), donanemab (Eli Lilly and Company) and solanezumab (Eli Lilly and Company) for crenezumab; (vi)&#160;HMTM (TauRx Pharmaceuticals) for Morphomer Tau; (vii)&#160;Tauvid (Eli Lilly and Company), florzolotau (Aprinoia Therapeutics), MK-6240 (Cerveau/Merck) and GTP1 (Genentech) for PI-2620; and (viii) UCB-2897 (UCB) for ACI-12589, as described under &#8220;Item&#160;4. Information on the Company&#8212;B. Business overview&#8212;Competition.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may not be successful in our efforts to use and expand our Morphomer and SupraAntigen proprietary technology platforms to build additional product candidates for our pipeline.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A key element of our strategy is to use and expand our Morphomer and SupraAntigen proprietary technology platforms to create unique therapies and diagnostics misfolded proteins in diseases, such as AD, PD and others (including NeuroOrphan diseases e.g. ALS and PSP), and progress these product candidates through clinical development. Although our research and development efforts to date have resulted in a pipeline of product candidates, we may not be able in the future to develop product candidates that are safe and effective. Even if we are successful in continuing to build our pipelines, the potential product candidates that we identify may not be suitable for clinical development, potentially as a result of having harmful side effects or other characteristics indicating they may be unlikely to receive marketing approval and achieve market acceptance.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">12</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our business is subject to economic, political, regulatory and other risks associated with international operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our business is subject to risks associated with conducting business internationally. We and a number of our suppliers and collaborative and clinical study relationships are located outside the U.S.. Accordingly, our future results could be harmed by a variety of factors, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">economic weakness, including inflation, or political instability in particular non-U.S. economies and markets;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">differing regulatory requirements for drug approvals in non-U.S. countries;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">potentially reduced protection for intellectual property rights;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">difficulties in compliance with non-U.S. laws and regulations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in non-U.S. regulations and customs, tariffs and trade barriers;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in non-U.S. currency exchange rates and currency controls;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in a specific country&#8217;s or region&#8217;s political or economic environment;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">trade protection measures, import or export licensing requirements or other restrictive actions such as sanctions by U.S. or non-U.S. governments;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">negative consequences from changes in tax laws;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">workforce uncertainty in countries where labor unrest is more common than in the U.S.;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">difficulties associated with staffing and managing international operations, including differing labor relations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">business interruptions resulting from geopolitical actions, including war and terrorism, or natural disasters including earthquakes, typhoons, floods and fires.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Moreover, at the end of 2021 and into 2022, tensions between the United States and Russia escalated when Russia amassed large numbers of military ground forces and support personnel on the Ukraine-Russia border and, in February&#160;2022, Russia invaded Ukraine. In response, NATO has deployed additional military forces to Eastern Europe, including to Lithuania, and the Biden administration announced certain sanctions against Russia. The invasion of Ukraine and the retaliatory measures that have been taken, or could be taken in the future, by the United States, NATO, and other countries have created global security concerns that could result in a regional conflict and otherwise have a lasting impact on regional and global economies, any or all of which could disrupt our supply chain, adversely affect our ability to conduct ongoing and future clinical trials of our product candidates, and adversely affect our ability to commercialize our products (subject to regulatory approval) in this region. Currently, none of our clinical development or business activities are conducted directly or otherwise in Russia or Ukraine.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">13</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Unfavorable global economic conditions could adversely affect our business, financial condition or results of </span><span style="font-style:italic;font-weight:bold;">operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our results of operations could be adversely affected by general conditions in the global economy and in the global financial markets. For example, rising interest rates and high inflation may cause our cost of doing business to materially increase and may adversely impact our ability to operate or may adversely impact other parties upon whom we rely for research and development capabilities to operate. The most recent global financial crisis caused extreme volatility and disruptions in the capital and credit markets. A severe or prolonged economic downturn, such as the most recent global financial crisis, could result in a variety of risks to our business, including our ability to raise additional capital when needed on acceptable terms, if at all. A weak or declining economy could strain our suppliers, possibly resulting in supply disruption, or cause delays in payments for our services by third-party payors or our collaborators. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">The Covid-19 pandemic has adversely impacted, and may continue to impact, our business, including preclinical and clinical trials and regulatory approvals.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Since the beginning of the Covid-19 pandemic, governments, public institutions, and other organizations in countries and localities where Covid-19 cases have been identified have taken certain preventative or protective measures to combat the transmission of the virus, including the implementation of travel restrictions or bans, closures of non-essential businesses, limitations of public gatherings, other social distancing and shelter-in-place measures, and delays or cancellations of elective surgeries. The Covid-19 pandemic poses the risk that the Company, our employees, contractors, suppliers, and other partners may be prevented from conducting business activities for an indefinite period of time due to shutdowns that may be requested or mandated by state and federal governmental authorities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As a result of Covid-19, we have experienced disruptions impacting our business and clinical trials and we may continue to experience disruptions that could materially impact our business and planned clinical trials, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">delays or difficulties in conducting preclinical research and clinical trials;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">interruption in global manufacturing and shipping that may affect the manufacturing and/or transport of clinical trial materials and other materials, including testing equipment and personal protective equipment, used at our or our contract research organizations&#8217; (CROs&#8217;) and contract manufacturing organizations&#8217; (CMOs&#8217;) facilities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in local regulations as part of a response to the Covid-19 coronavirus outbreak which may require us to change the way in which clinical trials are conducted and may result in unexpected costs; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">impact our ability to secure additional financing.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the outbreak of Covid-19 could disrupt our operations due to absenteeism by infected or ill members of Executive Management or other employees, or absenteeism by members of Executive Management and other employees who elect not to come to work due to the illness affecting others in our office or laboratory facilities, or due to quarantines. Covid-19 illness could also impact members of our Board and its ability to hold meetings. Further information concerning details of the impact of Covid-19 on our programs can be found under &#8220;Item&#160;5: Operating and financial review and prospects.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our ability to effectively monitor and respond to the rapid and ongoing developments and expectations relating to environmental, social and governance (ESG) matters, including related social expectations and concerns, may impose unexpected costs on us or result in reputational or other harm to us that could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">If we are not able to adequately recognize and respond to the rapid and ongoing developments and governmental and social expectations relating to ESG matters such as climate change and access to health care and affordable drugs, this failure could result in missed corporate opportunities, additional regulatory, social or other scrutiny of us and our </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">14</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">business, the imposition of unexpected costs or in damage to our reputation or our various relationships with governments, customers, employees, third parties and the communities in which we operate, in each case that could have a material adverse effect on our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We have no history of commercializing biologics or pharmaceutical products, which may make it difficult to evaluate the prospects for our future viability.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We began our operations in 2003. Our operations to date have been limited to financing and staffing our company, developing our technology and developing our product candidates as well as early-stage clinical trials. We have not yet demonstrated an ability to successfully complete a large-scale, pivotal clinical study, obtain marketing approval, manufacture a commercial-scale product, or conduct sales and marketing activities necessary for successful product commercialization. Consequently, predictions about our future success or viability may not be as accurate as they could be if we had a history of successfully developing and commercializing biologics or pharmaceutical products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our future growth and ability to compete depends on retaining our key personnel and recruiting additional qualified personnel.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our success depends upon the continued contributions of our key management, scientific and technical personnel, many of whom have substantial experience with or been instrumental for us and our projects. Members of our key management include Dr.&#160;Andrea Pfeifer, our Chief Executive Officer; Dr.&#160;Marie Kosco-Vilbois, our Chief Scientific Officer; Dr.&#160;Johannes Rolf Streffer, our Chief Medical Officer; Piergiorgio Donati, our Chief Technical Operations Officer; Jean-Fabien Monin, our Chief Administrative Officer; Christopher Roberts, our Vice President (VP) Finance and Interim CFO; Dr.&#160;Julien Rong&#232;re, our Senior Vice President (SVP) for Regulatory Affairs and Quality Assurance; Dr.&#160;Olivier Sol, our VP Head of Clinical Development; Dr.&#160;Bojana Portmann, our VP for Intellectual Property and Business Development (VP IP and BD); Alexandre Caratsch, our General Counsel; and Mark Danton, our VP Information Systems, Security and Digital Technologies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The loss of our key managers and senior scientists could delay our research and development activities. Laws and regulations on executive compensation, including legislation in our home country, Switzerland, may restrict our ability to attract, motivate and retain the required level of qualified personnel. In Switzerland, legislation affecting public companies is in force that, among other things, imposes an annual binding shareholders&#8217; &#8220;say on pay&#8221; vote with respect to the total compensation of executive management, including executive officers and the board of directors, and prohibits severance or similar payment, bonuses for company purchases and sales, and additional contracts as consultants to or employees of other companies in the group. In addition, the competition for qualified personnel in the pharmaceutical and biopharmaceutical field is intense, and our future success depends upon our ability to attract, retain and motivate highly skilled scientific, technical and managerial employees. We face competition for personnel from other companies, universities, public and private research institutions and other organizations. If our recruitment and retention efforts are unsuccessful in the future, it may be difficult for us to implement our business strategy, which could have a material adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may become exposed to costly and damaging liability claims, either when testing our product candidates in the clinic or at the commercial stage or as a result of claims against our directors and officers; and our liability insurance may not cover all damages from such claims.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are exposed to potential clinical trial liability and professional indemnity risks that are inherent in the research, development, manufacturing, marketing and use of pharmaceutical or biopharmaceutical products. Currently we have no products that have been approved for commercial sale, however, our current and future use of product candidates in clinical studies, and the sale of any approved products in the future, may expose us to liability claims. These claims might be made by patients that use the product, by healthcare providers, or by pharmaceutical or biopharmaceutical companies or others selling such products. Any claims against us, regardless of their merit, could be difficult and costly to defend and could materially adversely affect the market for our product candidates or any prospects for commercialization of our product candidates.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">15</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although the clinical study process is designed to identify and assess potential side effects, it is always possible that a drug, even after regulatory approval, may exhibit unforeseen side effects. If any of our product candidates were to cause adverse side effects during clinical studies or after approval of the product candidate, we may be exposed to substantial liabilities. Physicians and patients may not comply with any warnings that identify known potential adverse effects and patients who should not use our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We purchase liability insurance in connection with the clinical studies that we undertake and for the purpose of indemnifying our directors and officers for claims against them in amounts that we consider to be consistent with industry norms. It is possible that our liabilities could exceed our insurance coverage. For example, if we obtain marketing approval for any of our product candidates, we will intend to expand our insurance coverage to include the sale of commercial products. However, we may not be able to maintain insurance coverage at a reasonable cost or obtain insurance coverage that will be adequate to satisfy any liability that may arise. If a successful liability claim or series of claims is brought against us for uninsured liabilities or in excess of insured liabilities, our assets may not be sufficient to cover such claims and our business operations could be impaired.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Should any of the events described above occur, this could have a material adverse effect on our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may seek to obtain orphan-drug designation for certain of our product candidates. Orphan-drug designation may not ensure that we will enjoy market exclusivity in a particular market, and if we fail to obtain or maintain orphan-drug exclusivity for such product candidates, we may be subject to earlier competition and our potential revenue will be reduced.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the Orphan Drug Act, the FDA may designate a product as an orphan drug if it is intended to treat a rare disease or condition, defined as a patient population of fewer than 200,000 in the U.S., or a patient population greater than 200,000 in the U.S. where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the U.S.. In the European Union (EU), the EMA&#8217;s Committee for Orphan Medicinal Products grants orphan-drug designation to promote the development of products that meet the following criteria: a) they are intended for the diagnosis, prevention, or treatment of a life-threatening or chronically debilitating condition affecting not more than 5 in 10,000 persons in the EU or for products that are intended for the diagnosis, prevention or treatment of a life-threatening, seriously debilitating or serious and chronic condition when, without incentives, it is unlikely that sales of the drug in the EU would be sufficient to justify the necessary investment in developing the drug or biological product; and b) there is no satisfactory method of diagnosis, prevention, or treatment, or, if such a method exists, the medicine must be of significant benefit to those affected by the condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the U.S., orphan-drug designation entitles a party to financial incentives such as opportunities for grant funding toward clinical study costs, tax advantages and user-fee waivers. In addition, if a product receives the first FDA approval for the indication for which it has orphan designation, the product is entitled to orphan-drug exclusivity, which means that the FDA cannot approve any other application to market the same drug for the same indication for a period of 7&#160;years, except in limited circumstances, such as a showing of clinical superiority over the product with orphan exclusivity or if the manufacturer is unable to assure sufficient product quantity. In the EU, orphan-drug designation entitles a party to financial incentives such as reduction of fees or fee waivers and 10&#160;years of market exclusivity for the orphan indication following drug or biological product approval, provided that the criteria for orphan designation are still applicable at the time of the granting of the marketing authorization. This period may be reduced to 6&#160;years if at the end of the fifth&#160;year, the orphan-drug designation criteria are no longer met, including where it is shown that the product is sufficiently profitable not to justify maintenance of market exclusivity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We may not be able to obtain orphan-drug designation for any of our product candidates, and even if we do, we may not be the first to obtain marketing approval for any particular orphan indication due to the uncertainties associated with developing pharmaceutical or biopharmaceutical products. Further, even if we obtain orphan-drug designation for a product, that exclusivity may not effectively protect the product from competition because different drugs with different active moieties can be approved for the same condition. Orphan-drug designation neither shortens the development time or regulatory review time of a drug nor gives the drug any advantage in the regulatory review or approval process.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">16</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Due to our limited resources and access to capital, we must prioritize development of certain product candidates.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Because we have limited resources and access to capital to fund our operations, we must decide which product candidates to pursue and the amount of resources to allocate to each. Our decisions concerning the allocation of research, collaboration, management and financial resources toward particular compounds, product candidates or therapeutic areas may not lead to the development of viable commercial products and may divert resources away from better opportunities. Similarly, our potential decisions to delay, terminate or collaborate with third parties in respect of certain product development programs may also prove not to be optimal and could cause us to miss valuable opportunities. If we make incorrect determinations regarding the market potential of our product candidates or misread trends in the pharmaceutical or biopharmaceutical industry, in particular for neurological disorders, our business, financial condition and results of operations could be materially adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our research and development activities could be affected or delayed as a result of possible restrictions on animal testing.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain laws and regulations require us to test our product candidates on animals before initiating clinical studies in humans. Animal testing activities have been the subject of controversy and adverse publicity. Animal rights groups and other organizations and individuals have attempted to stop animal testing activities by pressing for legislation and regulation in these areas and by disrupting these activities through protests and other means. To the extent that the activities of these groups are successful, our research and development activities may be interrupted, delayed or become more expensive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">A breakdown or breach of our information technology systems and cybersecurity efforts, or those of our key business partners, CROs or service providers, could subject us to liability or reputational damage or interrupt the operation of our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are increasingly dependent upon technology systems and data. Our computer systems continue to increase in multitude and complexity due to the growth in our business, making them potentially vulnerable to breakdown, malicious intrusion and random attack.&#160;Despite the implementation of security measures, our internal computer systems and those of our key business partners, CROs and service providers may be vulnerable to damage from computer viruses, unauthorized access or other similar cyber-attacks or incidents. If such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our development programs and our business operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Data privacy or security breaches, cyber-attacks and other cybersecurity incidents, including those by individuals authorized to access our technology systems or others, may pose a risk that sensitive data, including intellectual property, trade secrets or personal information belonging to us, our patients, study subjects or other business partners, may be exposed to unauthorized persons or to the public. Cyber-attacks are increasing in their frequency, sophistication and intensity, and are becoming increasingly difficult to detect. They are often carried out by motivated, well-resourced, skilled and persistent actors, including nation states, organized crime groups, &#8220;hacktivists&#8221; and employees or contractors acting with malicious intent. Cyber-attacks could include the deployment of harmful malware and key loggers, ransomware, a denial-of-service attack, a malicious website, phishing attacks, computer viruses, social engineering and other means to affect the confidentiality, integrity and availability of our technology systems and data. Our key business partners, CROs and service providers face similar risks and any security breach of their systems could adversely affect our security posture. For example, the loss of clinical trial data from completed, ongoing or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Likewise, we rely on our third-party research institution collaborators for research and development of our product candidates and on other third parties for the manufacture of our product candidates and to conduct clinical trials, and similar events relating to their computer systems could also have a material adverse effect on our business. Our ability to evaluate and monitor our CROs&#8217;, contractors&#8217; and consultants&#8217; data security practices are limited, and due to applicable laws and regulations or contractual obligations, we may be held responsible for any security breaches or cybersecurity attack attributed to them as they relate to the information we share with them. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or systems, or inappropriate disclosure of confidential or proprietary information or personal data of our employees, partners or study subjects, we could incur liability </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">17</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">including notification obligations (including to the impacted individuals and applicable regulators or supervisory authorities), and the further development and commercialization of our product candidates could be delayed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although we continue to build and improve our systems and infrastructure, and to implement technical, organizational and legal security measures, and believe we have taken appropriate security measures to reduce these risks to our data and information technology systems, there can be no assurance that our efforts will prevent, detect or appropriately respond to breakdowns or breaches in our systems that could adversely affect our business and operations and/or result in the loss of critical or sensitive information, including personal information, which could result in financial, legal, business or reputational harm to us. We continue to invest in industry standard IS/IT solutions and managed services that often include the relevant, layered protection and monitoring practices surrounding our data and IT systems and related infrastructure. These investments reduce further these risks in that they enable organizations such as ours to leverage the resources necessary to monitor IT systems and infrastructure for any current or potential threats. We also regularly perform risk and impact assessments, the results of which generally lead to the implementation of certain measures designed to increase our level of data protection. These investments are costly, and as cyber threats continue to evolve, we may be required to expend significant, additional resources to continue to modify and/or enhance our protective, detective and responsive measures required to remediate any identified information security vulnerabilities. In addition, our liability insurance may not be sufficient in type or amount to cover us against claims related to security breaches, cyber-attacks and other related breaches. We may be required to expend significant capital and other resources to protect against and respond to any attempted or existing cybersecurity incidents. In addition, our remediation efforts may not be successful.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, certain global geo-political events can increase our cybersecurity risk. For example, due to the recent Russia-Ukraine conflict, there have been publicized threats to increase cyber-attack activity against the critical infrastructure of any nation or organization that retaliates against Russia for its invasion of Ukraine. Any such increase in such attacks on us or our key business partners, CROs or service providers could adversely affect our systems or other operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Changes in laws, rules&#160;or regulations relating to data privacy and security, or any actual or perceived failure by us to comply with such laws, rules, regulations and standards, or contractual or other obligations relating to data privacy and security, could result in claims, changes to our business practices, penalties, increased cost of operations and could have a material adverse effect on our reputation, results of operations, financial condition and cash flows.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are, and may increasingly become, subject to various laws, rules, regulations, treaties, decisions and standards, as well as contractual obligations, relating to data privacy and security in the jurisdictions in which we operate. The regulatory environment related to data privacy and security is increasingly rigorous, with new and constantly changing requirements applicable to our business, and enforcement practices are likely to remain uncertain for the foreseeable future. These laws, rules, regulations, treaties, decisions and standards may be interpreted and applied differently over time and from jurisdiction to jurisdiction and in a manner that is inconsistent with our data practices and that could have a material adverse effect on our results of operations, financial condition and cash flows. New laws, amendments to or reinterpretations of existing laws, rules, regulations, treaties, decisions, standards and other obligations may require us to incur additional costs and restrict our business operations, and may require us to change how we use, collect, store, transfer or otherwise process certain types of personal information and to implement new processes to comply with those laws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In the U.S., there are numerous federal and state laws and regulations related to the privacy and security of personal information. Regulations promulgated pursuant to the U.S. Health Insurance Portability and Accountability Act of 1996 (HIPAA) establish privacy and security standards that limit the use and disclosure of protected health information, and require the implementation of administrative, physical and technological safeguards to protect the privacy of protected health information and to ensure the confidentiality, integrity and availability of electronic protected health information. Determining whether protected health information has been handled in compliance with applicable privacy standards and our contractual obligations can be complex and may be subject to changing interpretation. Numerous states have enacted or are in the process of enacting state level data privacy laws and regulations governing the collection, use, and other processing of state residents&#8217; personal information, such as the California Consumer Privacy Act (CCPA) as </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">18</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">amended by the California Privacy Rights Act of 2020 (CPRA), which provides new and enhanced data privacy rights to California residents, such as affording California residents the right to access and delete their information and to opt out of certain sharing and sales of personal information. In addition, laws in all 50 states require businesses to provide notice to individuals whose personal information has been disclosed as a result of a data breach.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Internationally, laws, regulations and standards in many jurisdictions apply broadly to the collection, use, retention, security, disclosure, transfer and other processing of personal information. For example, the EU General Data Protection Regulation (GDPR), which became effective in May&#160;2018, greatly increased the European Commission&#8217;s jurisdictional reach of its laws and adds a broad array of requirements for handling personal data. EU Member States are tasked under the GDPR to enact, and to have enacted, certain implementing legislation that adds to and/or further interprets the GDPR requirements and potentially extends our obligations and potential liability for failing to meet such obligations. The GDPR, together with national legislation, regulations and guidelines of the EU Member States and Switzerland (via its Federal Data Protection Act) governing the processing of personal data, impose strict obligations and restrictions on the ability to collect, use, retain, protect, disclose, transfer and otherwise process personal data. In particular, the GDPR includes obligations and restrictions concerning the consent and rights of individuals to whom the personal data relates (and the obligations of sponsors of clinical trials acting as data controllers), the transfer of personal data out of the European Economic Area (EEA), the notification of security breaches and the security and confidentiality of personal data. The GDPR authorizes fines for certain violations of up to 4% of global annual revenue or EUR 20 million, whichever is greater. The GDPR also applies to our key business partners, CROs and service providers, whether or not they are located in Europe, with which we share personal data subject to the GDPR. Additionally, following Brexit, we also are subject to the UK General Data Protection Regulation (UK GDPR) (i.e., a version of the GDPR as implemented into UK law), exposing us to two parallel regimes with potentially divergent interpretations and enforcement actions for certain violations. While the European Commission issued an adequacy decision intended to last for at least four&#160;years in respect of the UK&#8217;s data protection framework, enabling data transfers from EU Member States to the UK to continue without requiring organizations to put in place contractual or other measures in order to lawfully transfer personal data between the territories, the relationship between the UK and the EU in relation to certain aspects of data privacy and security law remains unclear. Although we do not have material operations in the UK, we cannot rule&#160;out potential disruptions in relation to the clinical regulatory framework applicable to our clinical studies in the UK, and to data privacy and security rules&#160;with respect to personal data sharing with vendors and clinical investigators in the UK, and we cannot predict future implications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">All of these evolving compliance and operational requirements impose significant costs, which are likely to increase over time. In addition, such requirements may require us to modify our data processing practices and policies, distract management or divert resources from other initiatives and projects. For instance, the European Union Court of Justice and the Swiss Data Protection Authority have declared the U.S. Privacy Shield to be inadequate for transfers of personal data out of the EU and Switzerland, which increased our compliance burden. If we are unable to properly protect the privacy and security of personal information, including protected health information, we could be found to have breached our contracts. In addition, any failure or perceived failure by us to comply with any applicable federal, state or similar foreign laws and regulations relating to data privacy and security could result in damage to our reputation and our relationship with our customers, as well as proceedings or litigation by governmental agencies, customers, partners, collaborators and/or study subjects, including class action privacy litigation in certain jurisdictions, which would subject us to significant fines, sanctions, awards, penalties or judgments, all of which could have a material adverse effect on our business, results of operations, financial condition and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Our operations, and those of our third-party research institution collaborators, CROs, CMOs, suppliers, and other contractors and consultants, could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, medical epidemics, and other natural or man-made disasters or business interruptions, for which we are partly uninsured. In addition, we rely on our third-party research institution collaborators for conducting research and development of our product candidates, and they may be affected by government shutdowns or withdrawn funding. Moreover, at the end of 2021 and into 2022, tensions between the United States and Russia escalated when Russia amassed large numbers of military ground forces and support </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">19</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">personnel on the Ukraine-Russia border and, in February&#160;2022, Russia invaded Ukraine. In response, North Atlantic Treaty Organization, or NATO has deployed additional military forces to Eastern Europe, including to Lithuania, and the Biden administration announced certain sanctions against Russia. The invasion of Ukraine and the retaliatory measures that have been taken, or could be taken in the future, by the United States, NATO, and other countries have created global security concerns that could result in a regional conflict and otherwise have a lasting impact on regional and global economies, any or all of which could disrupt our supply chain, adversely affect our ability to conduct ongoing and future clinical trials of our product candidates, and adversely affect our ability to commercialize our products (subject to regulatory approval) in this region. Currently, none of our clinical development or business activities are conducted directly or otherwise in Russia or Ukraine. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses. We rely on third-party manufacturers to produce and process our product candidates. Our ability to obtain clinical supplies of our product candidates could be disrupted if the operations of these suppliers are affected by a man-made or natural disaster or by other business interruption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The vast majority of our operations including our corporate headquarters are located in Ecublens, near Lausanne, Canton of Vaud, Switzerland. Damage or extended periods of interruption to our corporate, development or research facilities due to fire, natural disaster, power loss, communications failure, unauthorized entry or other events could cause us to cease or delay development of some or all of our product candidates. Although we maintain property damage and business interruption insurance coverage on these facilities, our insurance might not cover all losses under such circumstances and our business may be seriously harmed by such delays and interruption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We have never commercialized a product candidate before and may lack the necessary expertise, personnel and resources to successfully commercialize our products on our own or together with suitable partners.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have never commercialized a product candidate, and we currently have no sales force, marketing or distribution capabilities. To achieve commercial success for our product candidates, we will have to develop our own sales, marketing and supply organization or outsource these activities to third parties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Factors that may affect our ability to commercialize our product candidates on our own include recruiting and retaining adequate numbers of effective sales and marketing personnel, obtaining access to or persuading adequate numbers of physicians to prescribe our product candidates, and other unforeseen costs associated with creating an independent sales and marketing organization. Developing a sales and marketing organization requires significant investment, is time-consuming and could delay the launch of our product candidates. We may not be able to build an effective sales and marketing organization. In addition, successful commercialization also requires an enhanced regulatory organization which we currently do not have. If we are unable to build our own distribution and marketing capabilities, are unable to find suitable partners for the commercialization of our product candidates or do not successfully obtain the necessary regulatory capabilities, we may not generate revenues from them or be able to reach or sustain profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our relationships with third parties</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If we fail to maintain our current strategic relationships with Genentech, a member of the Roche Group, Eli Lilly and Company (Lilly), Janssen Pharmaceuticals&#160;Inc. (Janssen)</span> <span style="font-style:italic;font-weight:bold;">part of the Janssen Pharmaceutical Companies of Johnson &amp; Johnson, Life Molecular Imaging SA (LMI) (formerly Piramal Imaging SA) and other of our current or future strategic partners, our business, commercialization prospects and financial condition may be materially adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We have two partnerships with Genentech. In 2006, we granted Genentech an exclusive, worldwide license for crenezumab. In 2012, we entered into a second partnership to commercialize anti-Tau antibodies for use as immunotherapies. In December&#160;2018, we signed a license agreement with Lilly to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases (NDD). This collaboration commenced in Q1 2019. We are in a partnership with Janssen to develop and commercialize therapeutic anti-Tau vaccines for the treatment of AD and potentially other Tauopathies. We also have a diagnostic partnership with LMI for one of our compounds from our Morphomer chemical library, which bind pathological Tau for use as a PET tracer. Our collaboration partners each have the right to terminate their agreements with us for any reason upon providing us with a </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">20</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">certain notice period. If Genentech, Lilly, Janssen, LMI or other of our current or future strategic partners terminates its agreement with us at any time, it could delay or prevent development of our product candidates and materially harm our business, financial condition, commercialization prospects and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Good relationships with Genentech, Lilly, Janssen, LMI and other of our current or future strategic partners are important for our business prospects. If our relationships with Genentech, Lilly, Janssen, LMI or other of our current or future strategic partners were to deteriorate substantially or if Genentech, Lilly, Janssen, LMI or other of our current or future strategic partners were to challenge our use of their intellectual property or our calculations of the payments we are owed under our agreements, our business, financial condition, commercialization prospects and results of operations could be materially adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Lastly, our collaboration agreements with Genentech, Lilly, Janssen and LMI provide each partner with control over, and responsibility for, the clinical development process, including obtaining regulatory and marketing approvals, manufacturing costs and sales and marketing costs. Future collaboration agreements may also relinquish development control to our partners. Genentech or our other current or future collaboration partners may and do separately pursue competing products, therapeutic approaches or technologies to develop treatments for the diseases targeted by us or our collaborative efforts. Even if our partners continue their contributions to the collaborative agreements to which we are a party, they may nevertheless determine not to actively pursue the development or commercialization of any resulting products. Our partners may also fail to perform their obligations under the collaboration agreements or may be slow in performing their obligations. Any of these circumstances could result in a material adverse impact on our business, financial condition, commercialization prospects or results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may seek to form additional strategic alliances in the future with respect to our product candidates, and if we do not realize the benefits of such alliances, our business, financial condition, commercialization prospects and results of operations may be materially adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our product development programs and the potential commercialization of our product candidates will require substantial additional liquidity to fund expenses and may require expertise, such as sales and marketing expertise, which we do not currently possess. Therefore, in addition to our relationships with Genentech, Lilly, Janssen and LMI, we may decide to enter into strategic alliances or to create joint ventures or collaborations with pharmaceutical or biopharmaceutical companies for the further development and potential commercialization of those and other of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We face significant competition in seeking appropriate collaborators. Collaborations are complex and time-consuming to negotiate, document and manage. Any delays in entering into new strategic partnership agreements related to our product candidates could delay the development and commercialization of our product candidates and reduce their competitiveness even if they reach the market. We may also be restricted under existing and future collaboration agreements from entering into strategic partnerships or collaboration agreements on certain terms with other potential collaborators. We may not be able to negotiate collaborations on acceptable terms, or at all, for any of our existing or future product candidates and programs because the potential partner may consider that our research and development pipeline is insufficiently developed to justify a collaborative effort, or that our product candidates and programs do not have the requisite potential to demonstrate safety and efficacy in the target population. If we are unsuccessful in establishing and maintaining a collaboration with respect to a particular product candidate, we may have to curtail the development of that product candidate, reduce the scope of or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of our sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense, for which we have not budgeted. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we will not be able to bring our product candidates to market and generate product revenue. Even if we are successful in establishing a new strategic partnership or entering into a collaboration agreement, we cannot be certain that, following such a strategic transaction or license, we will be able to progress the development and commercialization of the applicable product candidates as envisaged, or that we will achieve the revenues that would </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">21</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">justify such transaction, and we could be subject to the following risks, each of which may materially harm our business, commercialization prospects and financial condition:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we may not be able to control the amount and timing of resources that the collaboration partner devotes to the product development program;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the collaboration partner may experience financial difficulties;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we may be required to grant or otherwise relinquish important rights such as marketing, distribution and intellectual property rights;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a collaboration partner could move forward with a competing product developed either independently or in collaboration with third parties, including our competitors; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">business combinations or significant changes in a collaboration partner&#8217;s business strategy may adversely affect our willingness to continue any arrangement.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We rely on third parties to conduct our nonclinical and clinical studies and perform other tasks for us. If these third parties do not successfully carry out their contractual duties, meet expected deadlines or comply with regulatory requirements, we may not be able to obtain regulatory approval for or commercialize our product candidates, and our business could be substantially harmed.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have relied upon and plan to continue to rely upon third-party clinical CROs, to monitor and manage data for our ongoing preclinical and clinical programs, including the clinical studies of our product candidates. We rely on these parties for execution of our nonclinical and clinical studies and control only certain aspects of their activities. Nevertheless, we are responsible for ensuring that each of our studies is conducted in accordance with the applicable protocol, legal, regulatory and scientific standards and our reliance on the clinical CROs does not relieve us of our regulatory responsibilities. We and our clinical CROs and other vendors are required to comply with current Good Manufacturing Practice (cGMP), current Good Clinical Practice (cGCP), and current Good Laboratory Practice (cGLP), which are regulations and guidelines enforced by the FDA, the Competent Authorities of the Member States of the EU and comparable foreign regulatory authorities for our product candidates in nonclinical and clinical development (where applicable). Regulatory authorities enforce these regulations through periodic inspections of study sponsors, principal investigators, study sites and other contractors. If we or any of our clinical CROs or vendors fail to comply with applicable regulations, the data generated in our nonclinical and clinical studies may be deemed unreliable and the EMA, FDA, other regulatory authorities may require us to perform additional nonclinical and clinical studies before approving our marketing applications. We cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will determine that all of our clinical studies comply with cGCP regulations. In addition, our clinical studies must be conducted with products produced under cGMP regulations. Our failure to comply with these regulations may require us to repeat clinical studies, which would delay the regulatory approval process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If any of our relationships with these third-party clinical CROs terminates, we may not be able to enter into arrangements with alternative clinical CROs or do so on commercially reasonable terms. In addition, our clinical CROs are not our employees, and except for remedies available to us under our agreements with such clinical CROs, we cannot control whether or not they devote sufficient time and resources to our ongoing nonclinical and clinical programs. If clinical CROs do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the data they obtain is compromised due to their failure to adhere to our protocols, regulatory requirements, or for other reasons, our clinical studies may be extended, delayed, or terminated and we may not be able to obtain regulatory approval for or successfully commercialize our product candidates. Clinical CROs may also generate higher costs than anticipated. As a result, our results of operations and the commercial prospects for our product candidates would be harmed, our costs could increase, and our ability to generate revenue could be delayed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Switching or adding additional clinical CROs involves additional cost and requires management time and focus. In addition, there is a natural transition period when a new clinical CRO commences work. As a result, delays occur, which </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">22</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">could materially impact our ability to meet our desired clinical development timelines. Though we carefully manage our relationships with our clinical CROs, there can be no assurance that we will not encounter similar challenges or delays in the future or that these delays or challenges will not have a material adverse impact on our business, financial condition and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We currently rely on third-party suppliers and other third parties for production of our product candidates and our dependence on these third parties may impair the advancement of our research and development programs and the development of our product candidates.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We currently rely on, and expect to continue to rely on, third parties for the manufacturing and supply of chemical and biological compounds and formulations for the clinical studies of our current and future product candidates. For the foreseeable future, we expect to continue to rely on such third parties for the manufacture of any of our product candidates on a clinical or commercial scale, if any of our product candidates receives regulatory approval. Reliance on third-party providers may expose us to different risks than if we were to manufacture product candidates ourselves. The facilities used by our contract manufacturers to manufacture our product candidates must be approved by the FDA or other regulatory authorities, pursuant to inspections that will be conducted after we submit our NDA or comparable marketing application to the FDA or other regulatory authority. We do not have control over a supplier&#8217;s or manufacturer&#8217;s compliance with these laws, regulations and applicable cGMP standards and other laws and regulations, such as those related to environmental health and safety matters. If our contract manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or others, they will not be able to secure and/or maintain regulatory approval for their manufacturing facilities. In addition, we have no control over the ability of our contract manufacturers to maintain adequate quality control (QC), quality assurance (QA) and qualified personnel. If we are compelled or we wish to find alternative manufacturing facilities, this could significantly impact our ability to develop, obtain regulatory approval for or market our product candidates. Any failure to achieve and maintain compliance with these laws, regulations and standards could subject us to the risk that we may have to suspend the manufacturing of our product candidates or that obtained approvals could be revoked, which would adversely affect our business and reputation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Third-party providers may breach agreements they have with us because of factors beyond our control. Contract manufacturers often encounter difficulties involving production yields, QC and QA, as well as shortages of qualified personnel. They may also terminate or refuse to renew their agreements because of their own financial difficulties or business priorities, potentially at a time that is costly or otherwise inconvenient for us. If we are unable to find adequate replacement or another acceptable solution in time, our clinical studies could be delayed or our commercial activities could be harmed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the fact that we are dependent on our suppliers and other third parties for the manufacture, storage and distribution of our product candidates means that we are subject to the risk that our product candidates and, if approved, commercial products may have manufacturing defects that we have limited ability to prevent or control. The sale of products containing such defects could result in recalls or regulatory enforcement action that could adversely affect our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Growth in the costs and expenses of components or raw materials, in particular as a result of rising inflation, may also adversely influence our business, financial condition and results of operations. Supply sources could be interrupted from time to time and, if interrupted, we cannot be certain that supplies could be resumed (whether in part or in whole) within a reasonable timeframe and at an acceptable cost or at all. Our current and anticipated future dependence upon others for the manufacturing of our current and future product candidates may adversely affect our future profit margins and our, or our collaboration partners&#8217;, ability to commercialize any products that receive marketing approval on a timely and competitive basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our collaboration arrangements with our strategic partners may make us an attractive target for potential acquisition under certain circumstances.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Under certain circumstances, due to the structure of our collaboration arrangements with our strategic partners, our strategic partners may prefer to acquire us rather than pay the milestone payments or royalties under the collaboration </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">23</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">arrangements, which may bring additional uncertainties to our business development and prospects. For example, under our collaboration arrangements with Genentech, Lilly and Janssen, we may become entitled to substantial milestone payments and royalties. As a result, rather than paying the milestone payments or royalties, Genentech, Lilly or Janssen, or one of their affiliates including Roche or Johnson&#160;&amp; Johnson, may choose to acquire us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to intellectual property</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">We may not have sufficient patent terms to protect our products and business effectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Patents have a limited lifespan. In the U.S., the natural expiration of a patent is generally 20&#160;years after it is filed. Although various extensions or adjustments may be available, such as adjustments based on certain delays caused by the U.S. Patent and Trademark Office (USPTO) the life of a patent, and the protection it affords, is limited. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned, co-owned and licensed patent portfolios may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours or otherwise provide us with a competitive advantage. Even if patents covering our product candidates are obtained and unchallenged, once the patent life has expired for a product, we may be open to competition from generic medications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although patent term extensions under the Hatch-Waxman Act, in the U.S. and under supplementary protection certificates (SPCs) in Europe may be available to extend the patent exclusivity term for our products, we cannot provide any assurances that any such patent term extension will be obtained and, if so, for how long. The Hatch-Waxman Act permits a patent extension term of up to 5&#160;years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14&#160;years from the date of product approval, only one patent may be extended, and only those claims covering the approved drug, a method for using it or a method for manufacturing it may be extended. However, we may not be granted any extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. It is not possible to base an SPC in Europe on a patent in a European Member State if that patent expires before the Market Authorization (MA) of the clinical product, protected by the patent, is obtained. As the &#8220;product&#8221; (active ingredient(s)) must be &#8220;protected by a basic patent in force,&#8221; only a granted patent that is in force, and remains in force until it reaches the end of its full term, can serve as a &#8220;basic patent&#8221; upon which an SPC can be based. Therefore, expired patents and pending patent applications cannot serve as the basis for an SPC. Given the relatively long clinical development timelines of biologicals and new chemical entities for therapeutic purposes, we may not be granted any patent extensions as we might fail to apply for the extensions prior to expiration of relevant patents. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or if the term of any such extension is less than we request, such result could have a material adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We or our licensing or collaboration partners may become subject to intellectual property-related litigation or other proceedings to protect or enforce our patents or the patents of our licensors or licensees and collaborators, any of which could be expensive, time-consuming, and unsuccessful, and may ultimately result in our loss of ownership of intellectual property.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Competitors may infringe our patents or the patents of our licensors or collaborators. To counter such infringement, we may be required to file infringement claims against those competitors, which can be expensive and time-consuming. If we or one of our licensing or collaboration partners were to initiate legal proceedings against a third party to enforce a patent covering one of our product candidates, the defendant could counterclaim that the patent covering our product candidate is invalid or unenforceable or that the defendant&#8217;s products do not infringe our or our licensing collaborators&#8217; patents or that we or our licensing collaborators infringe the defendant&#8217;s patents. In patent litigation in the U.S., defendant counterclaims alleging invalidity, unenforceability and non-infringement are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, obviousness-type double patenting, lack of written description, or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">24</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">relevant information from the USPTO, or made a misleading statement, during prosecution. In addition, third parties may raise similar claims before administrative bodies in the U.S. or abroad, even outside the context of litigation. Such mechanisms include re-examination, post-grant review<i style="font-style:italic;">, inter partes</i> review, interference and derivation proceedings as well as equivalent proceedings in foreign jurisdictions, such as opposition proceedings in Europe. The outcome following legal assertions of invalidity and unenforceability is unpredictable. Such proceedings or patent litigations could result in the revocation or cancellation of or amendment to our patents in such a way that they no longer cover our product candidates or otherwise provide any competitive advantage. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which the patent examiner and we or our licensing or collaboration partners were unaware during prosecution. A court may also refuse to stop a third party from using the technology in question on the grounds that our patents do not cover that technology. An adverse result in any proceeding could put one or more of our patents at risk of being invalidated or interpreted narrowly, which could have a material adverse effect on our business and financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Interference, derivation or other proceedings provoked by third parties, brought by us or declared by the USPTO may be necessary to determine the priority of inventions with respect to our patents or patent applications or those of our licensors, licensees or collaborators. An unfavorable outcome could require us or our licensing or collaboration partners to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be materially harmed if the prevailing party does not offer us or our licensing or collaboration partners a license on commercially reasonable terms or at all. If we or our licensing or collaboration partners are unsuccessful in any interference, derivation or other proceedings, we may lose our ownership of intellectual property or our patents may be narrowed or invalidated. There can be no assurance as to the outcome of the interference, derivation or other proceedings, and any of the foregoing could result in a material adverse effect on our business, financial condition, results of operations or prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our defense of litigation, interference, derivation or other proceedings or other intellectual property-related proceedings may fail and, even if successful, may result in substantial costs and distract our management and other employees from their normal responsibilities. Such litigation or proceedings could substantially increase our operating losses and could substantially reduce the funds necessary to continue our clinical studies and research programs or force us to license necessary technology from third parties, or enter into development partnerships that would help us bring our product candidates to market. We may not be able to prevent, alone or with our licensing or collaboration partners, misappropriation of our intellectual property rights, particularly in countries where the laws may not protect those rights as fully as in the U.S..</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions, decisions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If we or our licensing or collaboration partners are unable to obtain and maintain effective patent rights for our technologies, product candidates or any future product candidates, or if the scope of the patent rights obtained is not sufficiently broad, our competitors could develop and commercialize products and technology similar or identical to ours, and our, or our collaboration partners&#8217; ability to successfully commercialize our products and technology may be adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We rely upon a combination of patents, trade secret protection and confidentiality agreements to protect the intellectual property related to our technologies and product candidates. Our success depends in large part on our and our licensing or collaboration partners&#8217; ability to obtain and maintain patent and other intellectual property protection in the U.S., the EU and other countries with respect to our proprietary technologies and product candidates. In particular, Genentech, Lilly, Janssen or our other licensing or collaboration partners may be dependent on a license with a third party for the development and future commercialization of our product candidates. If such license is not granted or is terminated, Genentech, Lilly, Janssen or other licensing or collaboration partners may be required to cease development and commercialization of our product candidates, any of which could have a material adverse effect on our business, financial condition, results of operations or prospects.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">25</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have sought to protect our proprietary position by filing patent applications in the U.S. and abroad related to any of our novel technologies and products that are important to our business. This process is expensive, time-consuming, and complex, and we may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost, in a timely manner or in all jurisdictions. It is also possible that we will fail to identify patentable aspects of our or our licensing or collaboration partners&#8217; research and development output before it is too late to obtain patent protection. Moreover, in some circumstances, we do not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the patents, covering technology that we license to or from third parties. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The patent position of pharmaceutical and biopharmaceutical companies generally is highly uncertain and involves complex legal and factual questions for which legal principles remain unsolved. As a result, the inventorship, issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. The pending or future patent applications that we own, co-own or in-license may fail to issue, fail to result in issued patents with claims that cover our product candidates in the U.S. or in other foreign countries, or fail to effectively prevent others from commercializing competitive technologies and product candidates. Changes in either the patent laws or interpretation of the patent laws in the U.S. and other countries may diminish the value of our patents or narrow the scope of our patent protection.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We may not be aware of all third-party intellectual property rights potentially relating to our technologies or product candidates. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the U.S. and other jurisdictions remain confidential for a period of time after filing, and some remain so until issued. Therefore, we cannot be certain that we were the first to file any patent application related to our product candidates or technologies, or whether we were the first to make the inventions claimed in our owned or co-owned patents or pending patent applications, nor can we know whether those from whom we license patents were the first to make the inventions claimed or were the first to file.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There is no assurance that all potentially relevant prior art relating to our patents and patent applications has been found, which can invalidate a patent or prevent a patent from issuing from a pending patent application. Even if patents do successfully issue, and even if such patents cover our product candidates, third parties may challenge their validity, enforceability, or scope, which may result in such patents being narrowed, found unenforceable or invalidated, which could allow third parties to commercialize our technology or products and compete directly with us, without payment to us, or result in our or our collaboration partners&#8217; inability to manufacture or commercialize products without infringing third-party patent rights. Furthermore, even if they are unchallenged, our patents and patent applications may not adequately protect our intellectual property, provide exclusivity for our product candidates, prevent others from designing around our claims or provide us with a competitive advantage. Any of these outcomes could impair our ability to prevent competition from third parties, which may have a material adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We may be subject to claims that former employees, collaborators or other third parties have an interest or title in our patents or other intellectual property as an inventor or co-inventor. For example, we may have inventorship disputes arise from conflicting obligations of consultants, CROs, CMOs, academic institutions or others who are involved in developing our product candidates. Litigation may be necessary to defend against these and other claims challenging inventorship or our ownership of our patents or other intellectual property. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or the right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">26</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Patent policy and rule&#160;changes could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, thereby impairing our ability to protect our technologies and products.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Changes in either the patent laws or interpretation of the patent laws in the U.S., EU or elsewhere could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. Assuming the other requirements for patentability are met, in the U.S. prior to March&#160;15, 2013, the first to make the claimed invention is entitled to the patent, whereas outside the U.S., the first to file a patent application was entitled to the patent. After March&#160;15, 2013, under the Leahy-Smith America Invents Act (the Leahy-Smith Act), enacted on September&#160;16, 2011, the U.S. has moved to a first-to-file system. Under a first-to-file system, assuming the other requirements for patentability are met, the first inventor to file a patent application generally will be entitled to the patent on an invention regardless of whether a third party was the first to invent the invention. The Leahy-Smith Act also includes a number of significant changes that affect the way patent applications are prosecuted and may also affect patent litigation. These include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by the USPTO administered during post grant proceedings, including re-examination proceedings, <i style="font-style:italic;">inter partes </i>review, post-grant review and derivation proceedings. Therefore, the Leahy-Smith Act and its implementation increases the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects. In addition, future actions by the U.S. Congress, the federal courts and the USPTO could cause the laws and regulations governing patents to change in unpredictable ways. Any of the foregoing could harm our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In Europe, the Unified Patent Court (UPC) and Unified Patent are expected to enter into force in June 2023, assuming that Germany deposits its ratification in February 2023, as anticipated. The UPC will provide a new centralized forum for pan-European litigation in contracting EU Member States (17 out of 27 EU Member States). Litigation of European patents in European Patent Convention countries outside of the EU (e.g. Switzerland, UK, Turkey) and in non-contracting EU countries (e.g. Spain, Poland) will continue to be on a country-by-country basis in front of national courts, as currently. During a transition period (initially seven-years), patent owners can elect to keep their European patents outside of the jurisdiction of the UPC (&#8220;opt-out&#8221;). Whilst European patents may be opted-out of the UPC during such transition period, after expiry of such transition period EU legislation provides that the UPC jurisdiction will apply, in respect of the UPC contracting states for all European patents. Accordingly, the emergence of the UPC and its implementation increase the uncertainties surrounding the enforcement or defense of issued patents and related costs, which could have a material adverse effect on our business, financial condition, results of operations and prospects.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the patent positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. This combination of events has created uncertainty with respect to the validity and enforceability of patents, once obtained. Depending on future actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce our intellectual property in the future in the U.S..</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If we are unable to maintain effective proprietary rights for our technologies, product candidates or any future product candidates, we may not be able to compete effectively in our markets.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In addition to the protection afforded by patents, we rely on trade secret protection and confidentiality agreements to protect proprietary know-how that is not patentable or that we elect not to patent, processes for which patents are difficult to enforce, and any other elements of our product candidate discovery and development processes that involve proprietary know-how, information or technology that is not covered by patents. However, trade secrets can be difficult to protect and some courts inside and outside the U.S. are less willing or unwilling to protect trade secrets. The EU has introduced a Directive on trade secrets increasing the standards for protection. Because we rely on our advisors, employees and third-party contractors and consultants to research and develop and to manufacture our product candidates, we must, at times, share our intellectual property with them. We seek to protect our intellectual property and </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">27</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">other proprietary technology in part by entering into confidentiality agreements and master service agreements, if applicable, material transfer agreements, consulting agreements or other similar agreements with our advisors, employees, contractors, consultants, licensing and collaboration partners, and other third parties with confidentiality provisions. These agreements typically limit the rights of these third parties to use or disclose our confidential information, including our intellectual property and trade secrets. These agreements also typically restrict the ability of third parties to publish data potentially relating to our intellectual property, although our agreements may contain certain limited publication rights. For example, any academic institution that we may collaborate with in the future may expect to be granted rights to publish data arising out of such collaboration, provided that we may have the right to be notified in advance and given the opportunity to delay publication for a limited time period in order for us to secure patent protection of intellectual property rights arising from the collaboration, in addition to the opportunity to remove confidential or trade secret information from any such publication. We also conduct joint research and development programs that may require us to share intellectual property under the terms of our research and development or similar agreements. However, we cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or other confidential information or proprietary technology and processes, or that such agreements will not be breached or that our trade secrets or other confidential information will not otherwise be disclosed. Despite the contractual provisions employed when working with these advisors, employees and third-party contractors and consultants, the need to share intellectual property and other confidential information increases the risk that such confidential information becomes known by our competitors, is inadvertently incorporated into the product development of others or is disclosed or used in violation of these agreements. Additionally, our grant agreements typically provide for dissemination of results to academic institutions and to the general public. As a result, our information may be disseminated with the loss of protection status.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We also seek to preserve the integrity and confidentiality of our data and trade secrets by maintaining the physical security of our premises and the physical and electronic security of our information technology systems. Despite our efforts to protect our intellectual property, our competitors may discover our trade secrets through breach of our agreements by third parties, for which we may not have adequate remedies for any breach, or publication of information by any of our CROs, academic partners, funding organizations or our licensing or collaboration partners. Additionally, if the steps we take or that we impose on our CROs maintain our trade secrets are deemed inadequate by law, we may have insufficient recourse against third parties for misappropriating such trade secrets. Misappropriation or unauthorized disclosure of our trade secrets could impair our competitive position and may have a material adverse effect on our business. Moreover, if any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent such competitor or other third party from using that technology or information to compete with us. A competitor&#8217;s or other third party&#8217;s discovery of our intellectual property would impair our competitive position and have a material adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, the laws of some foreign countries do not protect proprietary rights to the same extent or in the same manner as the laws of the U.S.. As a result, we may encounter significant problems in protecting and defending our intellectual property both in the U.S. and abroad. If we are unable to prevent material disclosure of the intellectual property related to our technologies to third parties, we will not be able to establish or maintain a competitive advantage in our market, which could materially adversely affect our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Despite confidentiality clauses within our employment and other agreements with employees, we cannot ensure that departing employees will not breach any post-termination commitments in such agreements by allowing others to access our trade secrets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Obtaining and maintaining our patent protection depends on compliance with various procedural, document-submission, fee-payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for noncompliance with these requirements.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Periodic maintenance fees, renewal fees, annuity fees and various other government fees on a patent and patent application are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime of the patent and patent application. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee-payment and other similar provisions during the patent application process. We employ reputable law firms and other professionals to help us comply with these requirements and we are also dependent on our </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">28</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">licensors or collaboration partners to take the necessary action to comply with these requirements with respect to certain of our intellectual property. Although an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, nonpayment of fees and failure to properly legalize and submit formal documents. In such an event, our competitors might be able to enter the market, which would have a material adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">The patent protection and patent prosecution for some of our product candidates is dependent on third parties.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although we normally seek to obtain the right to control prosecution, maintenance and enforcement of the patents relating to our product candidates, there may be times when the filing and prosecution activities for patents relating to our product candidates are controlled by our licensors or collaboration partners. If any of our current or future licensing or collaboration partners fail to prosecute, maintain and enforce such patents and patent applications in a manner consistent with the best interests of our business, including by payment of all applicable fees for patents covering our product candidates, we could lose our rights to the intellectual property or our exclusivity with respect to those rights, our or our collaboration partners&#8217; ability to develop and commercialize those product candidates may be adversely affected and we may not be able to prevent competitors from making, using, and selling competing products. In addition, even where we have the right to control patent prosecution of patents and patent applications we have licensed to and from third parties, we may still be adversely affected or prejudiced by actions or inactions of our licensees, our licensors and their counsel that took place prior to the date upon which we assumed control over patent prosecution.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, we may be adversely affected or prejudiced by actions or inactions of our external and internal patent counsels working solely on our projects or our joint patent counsels representing us and our collaboration partners.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If we fail to comply with the obligations in our intellectual property agreements, including those under which we license intellectual property and other rights to or from third parties, or otherwise experience disruptions to our business relationships with our licensees, our licensors and collaboration partners, we could lose intellectual property rights that are important to our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a party to a number of intellectual property license and co-ownership agreements and research and development collaborations that are important to our business and expect to enter into additional such agreements in the future. Under certain circumstances, the royalties payable to us under these agreements are subject to certain reductions, which may have a materially adverse effect on our business, financial condition, results of operations and prospects. In addition, our existing agreements impose, and we expect that future agreements will impose, various diligence, commercialization, milestone payment, royalty and other obligations on us. If we fail to comply with our obligations under these agreements, we may be required to make certain payments to the licensor, we may lose the exclusivity of our license or the licensor may have the right to terminate the license, in which event we would not be able to develop or market products covered by the license.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Licensing of intellectual property is of critical importance to our business and involves complex legal, business and scientific issues. Disputes may arise regarding intellectual property subject to a licensing or co-ownership agreement, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the scope of rights granted under the agreement, any restrictions in licensed fields and other interpretation-related issues;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the extent to which our technology and processes infringe or otherwise violate the intellectual property of any third parties;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the sublicensing of patents and other IP rights;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">29</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the diligence, development and commercialization obligations under the agreement and what activities satisfy those obligations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the ownership of inventions and know-how resulting from the joint or mutual creation or use of intellectual property by our licensors or collaboration partners and us;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">non-compete commitments; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">consequences for changes in control.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If disputes over intellectual property and other rights that we own, have licensed or co-own prevent or impair our ability to maintain our current licensing or exclusivity arrangements on acceptable terms, we or our collaboration partners may be unable to successfully develop and commercialize the affected product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, certain provisions in the agreements under which we currently license intellectual property or technology to and from third parties may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, increase what we believe to be our financial or other obligations under the relevant agreement, or decrease the third party&#8217;s financial or other obligations under the relevant agreement, any of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We or our licensors or licensees and collaborators may not be successful in obtaining or maintaining necessary rights to our product candidates through acquisitions and in-licenses.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our or our licensors or licensees and collaborators programs may require the use of proprietary rights held by third parties in the future, and the growth of our business will likely depend in part on our ability to acquire, in-license, maintain or use these proprietary rights. In addition, our product candidates may require specific processes and/or formulations to work effectively and efficiently and the rights to these processes and/or formulations may be held by others. We or our licensors or licensees may be unable to acquire or in-license from third parties any compositions, methods of use, processes, or other third-party intellectual property rights that we identify as necessary for our product candidates. The licensing and acquisition of third-party intellectual property rights is a competitive area, and a number of more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, cash resources, and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We or our licensors or licensees also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For example, we sometimes collaborate with U.S. and foreign academic institutions to accelerate our preclinical research or development under written agreements with these institutions. Typically, these institutions provide us with an option to negotiate a license to any of the institution&#8217;s rights in technology resulting from the collaboration. Regardless of such option, we may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual property rights to other parties, potentially blocking our ability to pursue our applicable product candidate or program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If we are unable to successfully obtain a license to third-party intellectual property rights necessary for the development of a product candidate or program, we may have to abandon development of that product candidate or program and our business and financial condition could suffer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Third-party claims of intellectual property infringement may expose us to substantial liability or may prevent or delay our or our collaboration partners&#8217; development and commercialization efforts.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Numerous U.S.- and foreign-issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing product candidates. For example, we are aware of third-party patents or patent </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">30</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">applications that may be construed to cover one or more of our product candidates. If these patents are asserted against us or our licensing or collaboration partners and either we or our licensing or collaboration partners are found to infringe any of these patents, and are unsuccessful in demonstrating that such patents are invalid or unenforceable, then we and our licensing or collaboration partners could be required to pay substantial monetary damages or cease further development or commercialization of one or more of our product candidates or be compelled to enter into onerous licenses with such third parties. There may also be other third-party patents or patent applications with claims to materials, formulations, methods of manufacture or methods of treatment related to the use or manufacture of our product candidates and technology. Although we generally conduct a freedom-to-operate search and review with respect to our product candidates, we cannot guarantee that our search and review is complete and thorough, nor can we be sure that we have identified each and every patent and pending application in the U.S. and abroad that is relevant or necessary to the manufacturing or commercialization of our product candidates or use of our technology. Because patent applications can take many&#160;years to issue, there may be currently pending patent applications that may later result in issued patents that our product candidates may infringe. In addition, third parties may file and obtain additional patents in the future and claim that use of our technologies infringes upon these patents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Third parties may assert infringement claims against us based on existing patents or on patents that may be granted in the future, regardless of merit. Even if we believe such claims are without merit, a court of competent jurisdiction could hold that these third-party patents are valid, enforceable and infringed, which could materially and adversely affect our or our collaboration partners&#8217; ability to commercialize our product candidates or technologies covered by the asserted third-party patents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Parties making claims against us may also obtain injunctive or other equitable relief, which could effectively block our or our collaboration partners&#8217; ability to further develop and commercialize one or more of our product candidates. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of management and employee resources from our business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys&#8217; fees for willful infringement, pay royalties, redesign our infringing products or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure. Any of the foregoing could have a material and adverse effect on our business, financial conditions, results of operations and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business, financial condition, results of operations and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There could also be public announcements of the results of hearings, motions, decisions, or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Some of our competitors may have substantially greater resources and more mature and developed intellectual property portfolios than we do, and may be able to sustain the costs of complex intellectual property litigation to a greater degree and for longer periods of time than we could. In addition, patent-holding companies that focus solely on extracting royalties and settlements by enforcing patent rights may target us. As the pharmaceutical and biopharmaceutical industries expand and more patents are issued, the risk increases that our product candidates may be subject to claims of infringement of the patent rights of third parties. The uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may be subject to claims that our employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties or that our employees have wrongfully used or disclosed alleged trade secrets of their former employers.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We employ and utilize the services of individuals who were previously employed or provided services to universities or other pharmaceutical or biopharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants, and independent contractors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our employees, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">31</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of any of our employees&#8217;, consultants&#8217; or independent contractors&#8217; former employers or of other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel, which could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, although it is our policy to require our employees, consultants and independent contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">We may not be able to protect our intellectual property rights throughout the world.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Filing, prosecuting and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the U.S. may be less extensive than those in the U.S.. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as the laws in the U.S.. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the U.S., or from selling or importing products made using our inventions in and into the U.S. or other jurisdictions. In the ordinary course of prosecution and maintenance activities, we determine whether to seek patent protection outside the U.S. and in which countries. This also applies to patents we have acquired or in-licensed from third parties. In some cases, we, or our predecessors in interest or licensors of patents within our portfolio, have sought patent protection in a limited number of countries for patents covering our product candidates. Competitors may use our technologies and products in jurisdictions where we have not obtained or are unable to adequately enforce patent protection to develop their own products and further, may export otherwise infringing products to territories where we have patent protection but enforcement is not as strong as that in the U.S.. These products may compete with our products and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing, which would have a material adverse effect on our business and financial positions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets, and other intellectual property protection, particularly those relating to biotechnology products, which could make it difficult for us to stop the infringement, misappropriation or other violations of our intellectual property and proprietary rights. Proceedings to enforce our patent rights in foreign jurisdictions, whether or not successful, could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest, our names and brands may be misappropriated by third parties, and our business may be adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We have filed trademark applications seeking protection for our corporate name, logo, Nasdaq Global Market symbol and selected names of our technology platforms in selected geographies. While we have been granted registrations in certain geographies for certain trademarks, there is no guarantee that our trademark applications will be approved by the respective authorities at all or that we will not be required to narrow the scope of protection in certain or all geographies. Our applications have in the past faced and may in the future face opposition from third parties, potentially resulting in the lack of protection or narrower protection. Our trademarks or trade names may be challenged, infringed, circumvented, declared generic or determined to be infringing on other marks. We may not be able to protect </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">32</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">our rights to these trademarks and trade names, which we need to build name recognition among potential partners or customers in our markets of interest. At times, competitors or other third parties may adopt trade names, domain names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our trademarks or trade names. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trademarks and domain names may be ineffective and could result in substantial costs and diversion of resources, and could adversely affect our business, financial condition, results of operations and growth prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our financial condition and capital requirements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">We are a clinical-stage company and have a history of operating losses. We anticipate that we will continue to incur losses for the foreseeable future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a clinical-stage biopharmaceutical company. Since 2003, although we have received upfront and milestone payments from our collaboration partners and certain other contract revenue, we have also incurred significant operating losses. We incurred net losses (defined as net loss attributable to owners of the Company) of CHF 70.8 million for the&#160;year ended December&#160;31, 2022. In addition, we had accumulated losses of CHF 264.0 million as of December&#160;31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our losses have resulted principally from research and development expenses and from general business and administrative expenses. We expect to continue to incur significant operating losses in the future as we continue our research and development efforts for our current and future product candidates and seek to obtain regulatory approval and commercialization of such product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, the Company has financed its liquidity requirements primarily from its public offerings, share issuances, contract revenues from license and collaboration agreements and grants. We have no products approved for commercialization and have never generated any revenues from product sales. Biopharmaceutical and pharmaceutical product development is a highly speculative undertaking and involves a substantial degree of risk. It may be several&#160;years, if ever, before we or our collaboration partners complete pivotal clinical studies and have a product candidate approved for commercialization and we begin to generate revenue or royalties from product sales.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Although we have generated revenues from upfront and milestone payments related to our license and collaboration agreements, we have never generated any revenue from product sales and may never be profitable.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although we have generated contract revenue from upfront and milestone payments related to our license and collaboration agreements, we have no products approved for commercialization and have never generated any revenue from product sales. Our ability to generate revenue and achieve profitability depends on our and our licensors&#8217; and collaboration partners&#8217; ability to successfully complete the development of, and obtain the marketing approvals necessary, to commercialize one or more of our product candidates. We do not anticipate generating revenue from product sales unless and until we or our collaboration partners obtain regulatory approval for, and commercialize, our product candidates. Our ability to generate future revenue from product sales depends heavily on our and our collaboration partners&#8217; success in many areas, including but not limited to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">successfully completing research and clinical development of our product candidates, by us or our collaboration partners, as the case may be;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtaining marketing approvals for our clinical product candidates, including our vaccines (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn PET tracer ACI-12589), for which we or our collaboration partners complete clinical studies;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">33</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">developing a sustainable and scalable manufacturing process for any approved product candidates, and maintaining supply and manufacturing relationships with third parties that can conduct the process and provide adequate (in amount, quality and time) products to support clinical development and the market demand for our product candidates, if approved;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">launching and commercializing product candidates for which we obtain marketing approval, either directly or with a collaborator or distributor;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtaining market acceptance of our product candidates as viable treatment or diagnostic options;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">addressing any competing technological and market developments;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">identifying, assessing, acquiring and/or developing new product candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">negotiating favorable terms in any collaboration, licensing, or other similar arrangements into which we may enter;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">maintaining, protecting, acquiring and expanding our portfolio of intellectual property rights, including patents, trade secrets and know-how; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">attracting, hiring and retaining qualified personnel.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Because of the numerous risks and uncertainties with biopharmaceutical and pharmaceutical product development, we are unable to accurately predict the timing or amount of increased expenses and when, or if, we will be able to achieve profitability. Our expenses could increase beyond expectations if we are required by the FDA, the EMA or other regulatory agencies, domestic or foreign, to change our manufacturing processes, or to perform clinical, nonclinical or other types of studies in addition to those that we currently anticipate. In cases where we are successful in obtaining regulatory approvals to market one or more of our product candidates, our revenue will be dependent, in part, upon the size of the markets in the territories for which we gain regulatory approval, the accepted price for the product, the ability to obtain coverage and reimbursement at any price, and whether we own the commercial rights for that territory. If the number of our addressable patients is not as significant as we estimate, the indication approved by regulatory authorities is narrower than we expect, the treatment population is narrowed by competition, physician choice or treatment guidelines or other commercial related factors we may not generate significant revenue from sales of such products, even if approved. Accordingly, we may not be profitable in the future from the sale of any approved products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We or our collaboration partners may be unable to develop and commercialize any of our current or future product candidates and, even if we do, may not achieve profitability in the future. Even if we do achieve profitability in the future, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to be profitable in the future would decrease the value of our company and could impair our ability to raise capital, expand our business or continue our operations. A decline in the value of our company could cause you to lose all or part of your investment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If we fail to obtain additional funding, we may delay, reduce or eliminate our product development programs or commercialization efforts.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are currently advancing our clinical product candidates through clinical development, either together with a collaboration partner (ACI-35.030, semorinemab, crenezumab and PI-2620) or independently (ACI-24.060, ACI-7104.056 and ACI-12589). We expect our research and development expenses to continue to increase in connection with our ongoing activities, particularly as we and/or our collaboration partners continue our ongoing studies and initiate new studies of ACI-35.030, ACI-24.060, ACI-7104.056, Morphomer Tau, PI-2620 and ACI-12589 and initiate preclinical and clinical development of our other product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">As of December&#160;31, 2022, we had cash and cash equivalents of CHF 31.6&#160;million and short-term financial assets of CHF 91.0 million resulting in a total liquidity position of CHF 122.6 million. We currently believe that our existing </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">34</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">capital resources, not including potential milestone payments, will be sufficient to meet our projected operating requirements into Q3 2024. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our capital resources sooner than we currently expect. In addition, changing circumstances, including inflation, may cause us to adjust our projected spending to amounts more than currently expected. We may also need to raise additional funds sooner than we anticipate due to various factors such as the scope and rate of progress of our development activities, regulatory approval outcomes and emergence of competing technologies, among others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We expect that we will require additional capital to develop and commercialize certain of our product candidates. If we receive regulatory approval for our current and future product candidates, and if we have not already licensed such product candidate to a collaboration partner and choose to commercialize such product candidate independently, we expect to incur significant commercialization expenses related to product manufacturing, sales, marketing, distribution and establishing a regulatory structure, depending on where we choose to commercialize. Additional funds may not be available on a timely basis, on favorable terms, or at all, and such funds, if raised, may not be sufficient to enable us to continue to implement our long-term business strategy, in particular as a result of inflation. Additionally, we may be dependent on the status of the capital markets at the time such capital is sought. In addition, our ability to raise sufficient capital under our &#8220;at the market&#8221; program may be diminished depending on the market price of our shares. If we are not able to raise capital when needed, we could be forced to delay, reduce or eliminate our product development programs or commercialization efforts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Raising additional capital may cause dilution to our shareholders, restrict our operations or require us to relinquish rights to our intellectual property or future revenue streams.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Until such time, if ever, as we can generate substantial product royalty revenue, we expect to finance our liquidity needs through a combination of equity offerings, debt financings, grants, and license and development agreements in connection with collaborations. In September&#160;2020, the Company established an &#8220;at the market offering&#8221; (ATM) for the sale of up to USD 80.0 (CHF 74.6) million worth of our common shares from time to time by entering into an Open Market Sale Agreement (Sales Agreement) with Jefferies LLC (Jefferies). In Q2 2021, we filed a new registration statement on Form&#160;F-3 and entered into a new Sales Agreement to replace and extend the ATM program. We do not have any material committed external source of funds. In the event we need to seek additional funds, we may raise additional capital through the sale of equity, convertible debt or other securities. In such an event, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a holder of our common shares. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or proposing dividends to our shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If we raise additional funds through collaborations, strategic alliances, or marketing, distribution or licensing arrangements with third parties, we may have to grant or otherwise relinquish valuable rights to our intellectual property or future revenue streams.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Our ability to use tax loss carry-forwards in Switzerland may be limited.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2022, we reported tax loss carry-forwards from financial&#160;years 2016 until 2022 for purposes of Swiss corporate income tax in the aggregate amount of CHF 264.1 million, which could be available to offset future taxable income. If not used, these tax losses will expire 7&#160;years after the&#160;year in which they were incurred. Due to our limited income, there is a high risk that the tax loss carry-forwards will expire partly or entirely and we will not be able to use them to offset future taxable income thereafter for Swiss corporate income tax purposes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Exchange rate fluctuations may materially affect our results of operations and financial condition.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Under our existing agreements, we receive and make a significant amount of payments in Swiss Franc, USD and EUR. As a result, changes and fluctuations in currency exchange rates between the Swiss Franc and other currencies, especially the USD and EUR, could have a materially adverse effect on our operating results. As our reporting currency is the Swiss Franc, financial line items are converted into Swiss Francs at the applicable exchange rates. We also expect that in the future, a significant portion of our revenues and expenses will be denominated in Swiss Franc, USD and EUR. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">35</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Therefore, unfavorable developments in the value of the Swiss Franc as compared to the USD and EUR or any other currency could have a material adverse effect on our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Our significant in-process research and development (IPR&amp;D) asset may become impaired.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our consolidated balance sheet contains a material IPR&amp;D asset. For an IPR&amp;D asset, the risk of failure is significant, and there can be no certainty that the asset will become a successful candidate. Our ability to realize value on this significant investment is often contingent upon, among other things, regulatory approvals and market acceptance. As such, this IPR&amp;D may become impaired and/or be written off at some time in the future if the associated R&amp;D effort is abandoned or is curtailed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to the regulatory environment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We cannot give any assurance that any of our product candidates will receive regulatory approval, which is necessary before they can be commercialized.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our future success is dependent on our and our collaboration partners&#8217; ability to successfully develop, obtain regulatory approval for, and then successfully commercialize one or more product candidates. We currently have two product candidates that have completed Phase 2 clinical studies and six that are in a Phase 2 clinical study. We are not permitted to market or promote any of our product candidates before we receive regulatory approval from the FDA, EMA or comparable foreign regulatory authorities, and we may never receive such regulatory approval for any of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We cannot be certain that any of our product candidates will be successful in clinical studies or receive regulatory approval. Applications for our product candidates could fail to receive regulatory approval for many reasons, including but not limited to the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the FDA, EMA or comparable foreign regulatory authorities may disagree with the design or implementation of our clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the population studied in the clinical program may not be sufficiently broad or representative to assure safety in the full population for which we seek approval;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the FDA, EMA or comparable foreign regulatory authorities may disagree with our interpretation of data from nonclinical or clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the data collected from clinical studies of our product candidates may not be sufficient to support the submission of an NDA or other submission or to obtain regulatory approval in the U.S. or elsewhere;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we may be unable to demonstrate to the FDA, EMA or comparable foreign regulatory authorities that a product candidate&#8217;s benefit-risk ratio for its proposed indication is acceptable;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the FDA, EMA or other regulatory authorities may fail to approve the manufacturing processes, test procedures and specifications, or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the approval policies or regulations of the FDA, EMA or comparable foreign regulatory authorities may change significantly in a manner rendering our clinical data insufficient for approval.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We generally plan to seek regulatory approval to commercialize our product candidates in the U.S., the EU and in additional foreign countries where we have commercial and typically intellectual property rights. To obtain regulatory approval in other countries, we must comply with numerous and varying regulatory requirements of such other countries regarding safety, efficacy, chemistry, manufacturing and controls, clinical studies, commercial sales, pricing, marketing </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">36</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">and distribution of our product candidates. Even if we are successful in obtaining approval in one jurisdiction, we cannot ensure that we will obtain approval in any other jurisdictions. Failure to obtain marketing authorization for our product candidates will result in our being unable to market and sell such products, which would materially adversely affect our business, financial condition and results of operations. If we fail to obtain approval in any jurisdiction, the geographic market for our product candidates could be limited. Similarly, regulatory agencies may not approve the labeling claims that are necessary or desirable for the successful commercialization of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Clinical drug development involves a lengthy and expensive process with uncertain timelines and uncertain outcomes. If clinical studies of our product candidates are prolonged or delayed, we may be unable to obtain required regulatory approvals, and therefore be unable to commercialize our product candidates on a timely basis or at all.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To obtain the necessary regulatory approvals to market and sell any of our product candidates, we must demonstrate through extensive preclinical and clinical studies that our products are safe and effective in humans. Clinical testing is expensive and can take many&#160;years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the clinical study process. The results of preclinical and early clinical studies of our product candidates may not be predictive of the results of later-stage clinical studies. For example, the positive results generated to date in clinical studies for our product candidates do not ensure that later clinical studies will demonstrate similar results. Product candidates in later stages of clinical studies may fail to show the desired safety and efficacy traits despite having progressed through preclinical studies and initial clinical studies. A number of companies in the pharmaceutical or biopharmaceutical industry, including us, have suffered significant setbacks in advanced clinical studies due to lack of efficacy or adverse safety profiles, notwithstanding promising results in earlier studies. Our future clinical study results may not be successful.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Clinical studies must be conducted in accordance with the legal requirements, regulations and guidelines of the FDA, EMA and comparable foreign regulatory authorities, and are subject to oversight by these governmental agencies and Institutional Review Boards (IRBs) at the medical institutions where the clinical studies are conducted. In addition, clinical studies must be conducted with supplies of our product candidates produced under cGMP and other requirements. We depend on medical institutions and CROs to conduct our clinical studies in compliance with cGCP standards. To the extent the CROs fail to enroll participants for our clinical studies, fail to conduct the study to cGCP standards or are delayed for a significant time in the execution of studies, including achieving full enrollment, we may be affected by increased costs, program delays or both, which may harm our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, neither we nor our collaboration partners have completed all clinical studies required for the approval of any of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The completion of clinical studies for our product candidates may be delayed, suspended or terminated as a result of many factors, including but not limited to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the delay or refusal of regulators or IRBs to authorize us to commence or amend a clinical study at a prospective study site or changes in regulatory requirements, policies and guidelines;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">delays or failure to reach agreement on acceptable terms with prospective CROs and clinical study sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and study sites;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">delays in patient enrollment and variability in the number and types of patients available for clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the inability to enroll a sufficient number of patients in studies to ensure adequate statistical power to detect statistically significant treatment effects;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">negative or inconclusive results, which may require us to conduct additional preclinical or clinical studies or to abandon projects that we expected to be promising;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">37</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">safety or tolerability concerns, which could cause us to suspend or terminate a study if we find that the participants are being exposed to unacceptable health risks;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">regulators or IRBs requiring that we or our investigators suspend or terminate clinical research for various reasons, including noncompliance with regulatory requirements or safety concerns, among others;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">lower than anticipated retention rates of patients and volunteers in clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our CROs or clinical study sites failing to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all, deviating from the protocol or dropping out of a study;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">delays relating to adding new clinical study sites;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">difficulty in maintaining contact with patients after treatment, resulting in incomplete data;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">delays in establishing the appropriate dosage levels;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the quality or stability of the product candidate falling below acceptable standards;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the inability to produce or obtain sufficient quantities of the product candidate to complete clinical studies; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">exceeding budgeted costs due to difficulty in accurately predicting costs associated with clinical studies.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any delays in completing our clinical studies will increase our costs, slow our product candidate development and approval process, and jeopardize our ability to commence product sales and generate sales revenues. Any of these occurrences may significantly harm our business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical studies may also ultimately lead to the denial of regulatory approval of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Even if we obtain and maintain approval for our product candidates from one jurisdiction, we may never obtain approval for our product candidates in other jurisdictions, which would limit our market opportunities and adversely affect our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Sales by us of our approved drugs will be subject to U.S. and non-U.S. regulatory requirements governing clinical studies and regulatory approval, and we plan to seek regulatory approval to commercialize our product candidates in the U.S., the European Economic Area (EEA), and other countries. Clinical studies conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory approval in one country does not ensure approval in any other country, while a failure or delay in obtaining regulatory approval in one country may have a negative effect on the regulatory approval process in others. For example, approval in the U.S. by the FDA does not ensure approval by the regulatory authorities in other countries or jurisdictions, and similarly, approval by a non-U.S. regulatory authority, such as the EMA, does not ensure approval by regulatory authorities in other countries, including by the FDA. Approval processes and regulatory requirements vary among countries and can involve additional drug testing and validation and additional administrative review periods. Even if a drug is approved, the FDA or EMA, as the case may be, may limit the indications for which the drug may be marketed, require extensive warnings on the drug labeling, or require expensive and time-consuming clinical studies or reporting as conditions of approval. In many countries outside the U.S., a product candidate must be approved for reimbursement before it can be approved for sale in that country. In some cases, the price that would be charged for a drug is also subject to approval. Regulatory authorities in other countries also have their own requirements for approval of product candidates with which we must comply prior to marketing in those countries. Obtaining non-U.S. regulatory approvals and compliance with such non-U.S. regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our current and any future drugs, in certain countries. If we fail to comply with regulatory requirements in international markets or to obtain and maintain required approvals, or if regulatory approvals in international markets are delayed, our target market will be reduced and our ability to realize the full market potential of our product candidates will be unrealized.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">38</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Even if our product candidates obtain regulatory approval, we will be subject to ongoing obligations and continued regulatory review, which may result in significant additional expense. Additionally, our product candidates, if approved, could be subject to labeling and other restrictions and market withdrawal and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our products.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If a marketing authorization is obtained for any of our product candidates, the product will remain subject to continual regulatory review and therefore authorization could be subsequently withdrawn or restricted. Any regulatory approvals that we receive for our product candidates may also be subject to limitations on the approved indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including Phase 4 clinical studies and surveillance to monitor the safety and efficacy of the product candidate. In addition, if the FDA or a comparable foreign regulatory authority approves any of our product candidates, we will be subject to ongoing regulatory obligations and oversight by regulatory authorities, including with respect to the manufacturing processes, labeling, packing, distribution, adverse event reporting, storage, advertising and marketing restrictions, and record-keeping and, potentially, other post-marketing obligations, all of which may result in significant expense and limit our or our collaboration partners&#8217; ability to commercialize such products. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as continued compliance with cGMP and cGCP requirements for any clinical studies that we conduct post-approval. Later discovery of previously unknown problems with a product, including AEs of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">restrictions on the marketing or manufacturing of the product, withdrawal of the product from the market, or voluntary or mandatory product recalls;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fines, warning letters or holds on clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">refusal by the FDA or an applicable foreign regulatory authority to approve pending applications or supplements to approved applications filed by us or our collaborations partners, or suspension or revocation of product license approvals;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">regulatory constraints in promotion and distribution of drug products in various markets;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">product seizure or detention, or refusal to permit the import or export of products; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">injunctions or the imposition of civil or criminal penalties.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If any of these events occurs, our ability to sell such product may be impaired, and we may incur substantial additional expense to comply with regulatory requirements, which could materially adversely affect our business, financial condition and results of operations. The FDA&#8217;s or those of an applicable foreign regulatory authority&#8217;s policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained, which would adversely affect our business, prospects and ability to achieve or sustain profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We have conducted and may in the future conduct clinical studies for our product candidates outside the U.S., and the FDA and applicable foreign regulatory authorities may not accept data from such studies.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We have conducted and may in the future choose to conduct one or more of our clinical studies outside the U.S., including in Germany, Austria, Denmark, Sweden, Finland, the UK, Poland, Spain and the Netherlands. The acceptance of study data from clinical studies conducted outside the U.S. or another jurisdiction by the FDA or applicable foreign regulatory authority may be subject to certain conditions. In cases where data from foreign clinical studies are intended </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">39</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">to serve as the basis for marketing approval in the U.S., the FDA will not approve the application on the basis of foreign data alone unless the following are true: the data are applicable to the U.S. population and U.S. medical practice; the studies were performed by clinical investigators of recognized competence; and the data are considered valid without the need for an on-site inspection by the FDA or, if the FDA considers such an inspection to be necessary, the FDA is able to validate the data through an on-site inspection or other appropriate means. Additionally, the FDA&#8217;s clinical study requirements, including sufficient size of patient populations and statistical powering, must be met. Many foreign regulatory bodies have similar requirements. In addition, such foreign studies would be subject to the applicable local laws of the foreign jurisdictions in which the studies are conducted. There can be no assurance that the FDA or any applicable foreign regulatory authority will accept data from studies conducted outside of the U.S. or the applicable jurisdiction. If the FDA or any applicable foreign regulatory authority does not accept such data, it would result in the need for additional studies, which would be costly and time-consuming and delay aspects of our business plan, and which may result in our drugs or product candidates not receiving approval or clearance for commercialization in the applicable jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Enacted and future legislation may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates and may affect the prices we may set.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the U.S., the EU and some foreign jurisdictions, there have been a number of adopted and proposed legislative and regulatory changes regarding the healthcare system that could prevent or delay regulatory approval of our product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell any of our product candidates for which we obtain regulatory approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the U.S., the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (&#8220;MMA&#8221;) changed the way Medicare covers and pays for pharmaceutical products. Cost reduction initiatives and other provisions of this legislation could limit the coverage and reimbursement rate that we receive for any of our approved product candidates. While the MMA only applies to drug benefits for Medicare beneficiaries, private payors often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates. Therefore, any reduction in reimbursement that results from the MMA may result in a similar reduction in payments from private payors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the Health Care Reform Law), was enacted. The Health Care Reform Law was intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against healthcare fraud and abuse, add new transparency requirements for healthcare and health insurance industries, impose new taxes and fees on the health industry and impose additional health policy reforms. The Health Care Reform Law increased manufacturers&#8217; rebate liability under the Medicaid Drug Rebate Program by increasing the minimum rebate amount for both branded and generic drugs and revised the definition of &#8220;average manufacturer price&#8221; (&#8220;AMP&#8221;), which may also increase the amount of Medicaid drug rebates manufacturers are required to pay to states. The legislation also expanded Medicaid drug rebates and created an alternative rebate formula for certain new formulations of certain existing products that is intended to increase the rebates due on those drugs. The Centers for Medicare &amp; Medicaid Services, which administers the Medicaid Drug Rebate Program, also has proposed to expand Medicaid rebates to the utilization that occurs in the territories of the U.S., such as Puerto Rico and the Virgin Islands. Further, beginning in 2011, the Health Care Reform Law imposed a significant annual fee on companies that manufacture or import branded prescription drug products. Legislative and regulatory proposals have been introduced at both the state and federal level to expand post-approval requirements and restrict sales and promotional activities for pharmaceutical products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are not sure whether additional legislative changes will be enacted, or whether the FDA regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals of our product candidates, if any, may be. In addition, increased scrutiny by the U.S. Congress of the FDA&#8217;s approval process may significantly delay or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing approval testing and other requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In addition, there has been heightened governmental scrutiny in the U.S. of pharmaceutical pricing practices in light of the rising cost of prescription drugs and biologics. Such scrutiny has resulted in several recent congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">40</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. At both the federal and state level, legislatures are increasingly passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. One significant example of recent legislative action is the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;), which has been considered a scaled-back version of the Build Back Better Act. The IRA was signed into law on August 16, 2022. While the IRA is still subject to rulemaking (with more information to come via guidance documents from the responsible federal agencies), the IRA, as written, will, among other changes, give HHS the ability and authority to directly negotiate with manufacturers the price that Medicare will pay for certain high-priced drugs. The IRA will also require manufacturers of certain Part B and Part D drugs to issue to HHS rebates based on certain calculations and triggers (i.e., when drug prices increase and outpace the rate of inflation). At this time, we cannot predict the implications the IRA provisions will have on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, in the EU, the new clinical trial regulation came into force on January&#160;31, 2022. This new legislation enforces the centralization of clinical trial applications (CTAs) and approvals, which eliminates redundancy, but in some cases, this may extend timelines for clinical study approvals, due to potentially longer wait times. Austerity measures in certain European nations may also affect the prices we are able to seek if our products are approved. Both in the U.S. and in the EU, legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for pharmaceutical and biopharmaceutical products. We do not know whether additional legislative changes will be enacted, whether the regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals of our product candidates, if any, may be.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We could be subject to liabilities under environmental, health and safety laws or regulations, or fines, penalties or other sanctions, if we fail to comply with such laws or regulations or otherwise incur costs that could have a material adverse effect on the success of our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are subject to numerous environmental, health and safety laws, regulations, and permitting requirements, including those governing laboratory procedures, decontamination activities, and the handling, transportation, use, remediation, storage, treatment and disposal of hazardous materials, human substances and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological materials that produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials or wastes either at our sites or at third-party disposal sites. In the event of such contamination or injury, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties. Although we maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, human substances or other work-related injuries, this insurance may not provide adequate coverage against potential liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws, regulations or permitting requirements. Such laws, regulations and requirements are becoming increasingly more stringent and may impair our research, development or production efforts. Failure to comply with these laws, regulations and permitting requirements also may result in substantial fines, penalties or other sanctions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our relationships with clinical centers are, and potentials customers and payors will be, subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which, if violated, could expose us to criminal sanctions, civil penalties, exclusion from government healthcare programs, contractual damages, reputational harm and diminished profits and future earnings.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Healthcare providers, physicians and others play a primary role in the recommendation and prescription of any products for which we obtain marketing approval. Our future arrangements with third-party payors and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations, which constrain the business or financial arrangements and relationships through which we market, sell and distribute our products for which we obtain marketing approval. Restrictions under applicable healthcare laws and regulations include the following:</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">41</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the U.S. healthcare Anti-Kickback Statute prohibits, among other things, persons from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made under U.S. government healthcare programs such as Medicare and Medicaid;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the U.S. False Claims Act imposes criminal and civil penalties, including civil whistleblower or </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">qui tam</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> actions, against individuals or entities for knowingly presenting, or causing to be presented, to the U.S. government, claims for payment that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the U.S. HIPAA imposes criminal and civil liability for executing a scheme to defraud any healthcare benefit program or making false statements relating to healthcare matters;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, imposes obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the transparency requirements under the Health Care Reform Law require manufacturers of drugs, devices, biologics and medical supplies to report to the U.S. Department of Health and Human Services information related to payments and other transfers of value made by such manufacturers to physicians and teaching hospitals, and ownership and investment interests held by physicians or their immediate family members; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">analogous laws and regulations, such as state anti-kickback and false claims laws, will apply to sales or marketing arrangements, consultancy and service agreements, and claims involving healthcare items or services reimbursed by nongovernmental third-party payors, including private insurers, and some state laws require pharmaceutical and biopharmaceutical companies to comply with the pharmaceutical and biopharmaceutical industries&#8217; voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, in addition to requiring manufacturers to report information related to payments to physicians and other healthcare providers or marketing expenditures.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available under the U.S. federal Anti-Kickback Statute, it is possible that some of our future business activities could be subject to challenge under one or more of such laws. In addition, recent healthcare-reform legislation has strengthened these laws. For example, the Health Care Reform Law, among other things, amends the intent requirement of the federal anti-kickback and criminal healthcare fraud statutes. A person or entity no longer needs to have actual knowledge of this statute or specific intent to violate it. Moreover, the Health Care Reform Law provides that the government may assert that a claim including items or services resulting from a violation of the federal anti-kickback statute constitutes a false or fraudulent claim for purposes of the False Claims Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Jurisdictions outside of the U.S. have enacted laws and regulations defining the framework of business practices of pharmaceutical organizations in their interactions with government offices, medical institutions and healthcare professionals (HCP) in order to safeguard the independence of medical judgement and of prescription and purchasing decisions. These regulations typically prohibit illegitimate payments and other transfers of values to institutional players and HCPs and regulate the bases for their remuneration, such as for consultancy and other service arrangements, as well as the reimbursement of costs; in certain jurisdictions, regulations prescribe the disclosure of the existing relationships and/or the remunerations paid. In addition to government regulations, pharmaceutical industry associations, such as the European Federation of Pharmaceutical Industries and Associations (EFPIA), of which we have been a member since 2021, have enacted industry codes of conduct providing their own rules&#160;of compliance for their members&#8217; interactions with government offices, medical institutions and HCPs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">42</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, exclusion from U.S. government-funded healthcare programs, such as Medicare and Medicaid, other foreign healthcare reimbursement and procurement programs, and the curtailment or restructuring of our operations. If any of the physicians or other providers or entities with whom we expect to do business with is found to be not in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government-funded healthcare programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Risks from the improper conduct of employees, agents, contractors, or collaborators could adversely affect our reputation and our business, prospects, operating results, and financial condition.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We cannot ensure that our compliance controls, policies, and procedures will in every instance protect us from acts committed by our employees, agents, contractors, collaborators, or other parties, which would violate the laws or regulations of the jurisdictions in which we operate, including, without limitation, healthcare, employment, foreign corrupt practices, environmental, competition, and patient privacy and other privacy laws and regulations. Such improper actions could subject us to civil or criminal investigations, and monetary and injunctive penalties, and could adversely impact our operating results, our ability to conduct business and our reputation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are exposed to the risk of employee fraud or other misconduct. Misconduct by employees could include intentional failures to comply with FDA or EMA regulations, to provide accurate information to the FDA or the EMA, or intentional failures to report financial information or data accurately or to disclose unauthorized activities to us. Employee misconduct could also involve the improper use of information obtained in the course of clinical studies, which could result in regulatory sanctions and serious harm to our reputation. In April&#160;2022, we amended our code of conduct, but it is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant fines or other sanctions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our business activities may be subject to the Foreign Corrupt Practices Act (FCPA), and similar anti-bribery and anti-corruption laws.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our business activities may be subject to the FCPA and similar anti-bribery or anti-corruption laws, regulations or rules&#160;of other countries in which we operate, including the UK Bribery Act. The FCPA generally prohibits offering, promising, giving or authorizing others to give anything of value, either directly or indirectly, to a non-U.S. government official in order to influence official action, or otherwise obtain or retain business. The FCPA also requires public companies to make and keep books and records that accurately and fairly reflect the transactions of the corporation, and to devise and maintain an adequate system of internal accounting controls. Our business is heavily regulated and therefore involves significant interaction with public officials, including officials of non-U.S. governments. Additionally, in many other countries, the healthcare providers who prescribe pharmaceuticals or biopharmaceuticals and the investigators who perform our studies are employed by their government, and the purchasers of pharmaceuticals are government entities; therefore, our dealings with these decision makers are subject to regulation under the FCPA. The Securities and Exchange Commission (SEC) and the Department of Justice have increased their FCPA enforcement activities with respect to pharmaceutical companies. There is no certainty that all of our employees, agents, contractors, collaborators, or other parties or those of our affiliates, will comply with all applicable laws and regulations, particularly given the high level of complexity of these laws. Violations of these laws and regulations could result in fines, criminal sanctions against us, our officers or our employees, the closing down of our facilities, requirements to obtain export licenses, cessation of business activities in sanctioned countries, implementation of compliance programs, and prohibitions on the conduct of our business. Any such violations could include prohibitions on our ability to offer our products in one or more countries and could materially damage our reputation, our brand, our international expansion efforts, our ability to attract and retain employees, and our business, prospects, operating results and financial condition.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">43</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our common shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">The price of our common shares is volatile and may fluctuate due to factors beyond our control.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The share prices of publicly traded pharmaceutical, biopharmaceutical and drug discovery and development companies have been highly volatile and are likely to remain highly volatile in the future. The market price of our common shares may fluctuate significantly due to a variety of factors, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">positive or negative results of testing and clinical studies by us, strategic partners, or competitors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">delays in entering into strategic relationships with respect to development and/or commercialization of our product candidates or entry into strategic relationships on terms that are not deemed to be favorable to us;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the sentiment of retail investors, including the perception of our clinical trial results by such retail investors, which investors may be subject to the influence of information provided by social media, third party investor websites and independent authors distributing information on the internet;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">technological innovations or commercial product introductions by us or our collaboration partners or competitors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in government regulations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">developments concerning proprietary rights, including patents and litigation matters;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">public concern relating to the commercial value or safety of any of our product candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">financing or other corporate transactions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">publication of research reports or comments by securities or industry analysts or key opinion leaders;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">general market conditions in the pharmaceutical or biopharmaceutical industry or in the economy as a whole; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">other events and factors beyond our control.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Broad market and industry factors may materially affect the market price of companies&#8217; stock, including ours, regardless of actual operating performance. Furthermore, issuers such as ourselves, whose securities have historically had limited trading volumes and/or have been susceptible to relatively high volatility levels, can be particularly vulnerable to short-seller attacks and trading in our common shares by non-fundamental investors such as hedge funds and others who may enter and exit positions in our common shares frequently and suddenly, causing increased volatility of our share price. Short selling is the practice of selling securities that the seller does not own but rather has borrowed or intends to borrow from a third party with the intention of buying identical securities at a later date to return to the lender, and profit from a decline in the value of the securities in the process. The publication of any commentary by short sellers with the intent of creating negative market momentum may bring about a temporary, or possibly long-term, decline in the market price of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">There is only a limited free float of our common shares; this may have a negative impact on the liquidity of and the market price for our common shares.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of the date hereof, certain principal shareholders controlling 5% or more of our common shares as well as our executive officers and directors together beneficially own approximately 60.1% of our common shares. The limited free float may have a negative impact on the liquidity of our common shares and result in a low trading volume of our common shares, which could adversely affect the price of our common shares.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">44</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Certain of our existing shareholders exercise significant control over us, and your interests may conflict with the interests of such shareholders.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain principal shareholders as well as our executive officers and directors together beneficially own approximately 60.1% of our common shares. Depending on the level of attendance at our general meetings of shareholders, these shareholders may be in a position to determine the outcome of decisions taken at any such general meeting. To the extent that the interests of these shareholders may differ from the interests of the Company&#8217;s other shareholders, the latter may be disadvantaged by any action that these shareholders may seek to pursue. Among other consequences, this concentration of ownership may have the effect of delaying or preventing a change in control and might therefore negatively affect the market price of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Future sales, or the possibility of future sales, of a substantial number of our common shares could adversely affect the price of our common shares.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Future sales of a substantial number of our common shares, or the perception that such sales will occur, could cause a decline in the market price of our common shares. If certain of our shareholders sell substantial amounts of common shares in the public market, or the market perceives that such sales may occur, the market price of our common shares and our ability to raise capital through an issue of equity securities in the future could be adversely affected. We also entered into a registration rights agreement in connection with the Series&#160;E Private Placement with certain investors in the Series&#160;E Private Placement, pursuant to which we agreed under certain circumstances to file a registration statement to register the resale of the common shares held by certain of our existing shareholders, as well as to cooperate in certain public offerings of such common shares. In October&#160;2020 and August&#160;2018, we filed registration statements on Form&#160;F-3 to register the resale of two of our shareholder&#8217;s common shares pursuant to the requirements of their registration rights agreements. In addition, in 2019, we adopted a new omnibus equity incentive plan under which we have the discretion to grant a broad range of equity-based awards to eligible participants. These shares were registered pursuant to the registration statement on Form&#160;S-8 that we filed with the SEC and, therefore, can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates. If a large number of our common shares are sold in the public market after they become eligible for sale, the sales could reduce the trading price of our common shares and impede our ability to raise future capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We have broad discretion in the use of our cash and cash equivalents and short-term financial assets (liquidity) and may not use them effectively.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our management has broad discretion in the application of our cash and cash equivalents and short-term financial assets. Our or our collaboration partners&#8217; decisions concerning the allocation of research, development, collaboration, management and financial resources toward particular product candidates or therapeutic areas may not lead to the development of any viable commercial product and may divert resources away from better opportunities. If we make incorrect determinations regarding the viability or market potential of any of our programs or product candidates or misread trends in the pharmaceutical or biopharmaceutical industry, in particular for neurodegenerative diseases, our business, financial condition and results of operations could be materially adversely affected. As a result, we may fail to capitalize on viable commercial products or profitable market opportunities, be required to forego or delay pursuit of opportunities with other product candidates or other diseases and disease pathways that may later prove to have greater commercial potential than those we choose to pursue, or relinquish valuable rights to such product candidates through collaboration, licensing or other royalty arrangements in cases in which it would have been advantageous for us to invest additional resources to retain sole development and commercialization rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">We do not expect to pay dividends in the foreseeable future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We have not paid any dividends since our incorporation. Even if future operations lead to significant levels of distributable profits, we currently intend that any earnings will be reinvested in our business and that dividends will not be paid until we have an established revenue stream to support continuing dividends. Based on Swiss law and our articles of association, the declaration of dividends requires a resolution passed by a simple majority of the votes cast at a shareholders&#8217; meeting regardless of abstentions and empty or invalid votes. The proposal to pay future dividends to shareholders will in addition effectively be at the discretion of our board of directors after considering various factors </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">45</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 10pt 0pt;">including our business prospects, liquidity requirements, financial performance and new product development. In addition, payment of future dividends is subject to certain limitations pursuant to Swiss law or by our articles of association compliance with which must be confirmed by our auditors. Accordingly, investors cannot rely on dividend income from our common shares and any returns on an investment in our common shares will likely depend entirely upon any future appreciation in the price of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:2pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We are a Swiss corporation. The rights of our shareholders may be different from the rights of shareholders in companies governed by the laws of U.S. jurisdictions.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">We are a Swiss corporation. Our corporate affairs are governed by our articles of association and by the laws governing companies, including listed companies, incorporated in Switzerland. The rights of our shareholders and the responsibilities of members of our board of directors may be different from the rights and obligations of shareholders and directors of companies governed by the laws of U.S. jurisdictions. In the performance of its duties, our board of directors is required by Swiss law to consider the interests of our Company first, then of our shareholders, our employees and other stakeholders, in all cases, with due observation of their fiduciary duties of care and loyalty. It is possible that some of these parties will have interests that are different from, or in addition to, your interests as a shareholder. Swiss corporate law limits the ability of our shareholders to challenge resolutions made or other actions taken by our board of directors in court. Our shareholders generally are not permitted to file a suit to reverse a decision or an action taken by our board of directors but are instead only permitted to seek damages for breaches of their fiduciary duties by the directors. As a matter of Swiss law, shareholder claims against a member of our board of directors for breach of fiduciary duty would have to be brought in Lausanne, Switzerland, or the country in which the relevant member of our board of directors is domiciled. In addition, under Swiss law, any claims by our shareholders against us must be in principle brought exclusively in Lausanne, Switzerland (except for certain U.S. securities and other claims that may be brought in U.S. federal court).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:2pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our common shares are issued under the laws of Switzerland, which may not protect investors in a similar fashion afforded by incorporation in a U.S. state.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are organized under the laws of Switzerland. There can be no assurance that Swiss law will not change in the future in a way detrimental to shareholders or that it will serve to protect investors in a similar fashion afforded under corporate law principles in the U.S., which could adversely affect the rights of investors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:2pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our status as a Swiss corporation may limit our flexibility with respect to certain aspects of capital management and may cause us to be unable to make distributions without subjecting our shareholders to Swiss withholding tax.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The Swiss law effective at the time according to which our current Articles were established allowed our shareholders to authorize share capital that can be issued by the board of directors without additional shareholder approval. This authorization is limited to 50% of the existing registered share capital and must be renewed by the shareholders once expired. As of January 1, 2023, the new Swiss corporate law introducing the capital band mechanism has come into force. It will no longer be possible to renew the Company&#39;s current Authorized Share Capital beyond June 24, 2024. Instead, the Company can only introduce the capital band pursuant to Article 653s et seq. of the revised Swiss Code of Obligations which requires an amendment of the Articles of Association by way of a resolution of a duly convened general meeting of shareholders of the Company. Under the capital band mechanism, the general meeting of shareholders can authorize the board of directors at any time within a maximum of five years to increase or decrease the share capital by a maximum amount of 50% of the current share capital. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Additionally, as a principle, Swiss law grants pre-emptive subscription rights to existing shareholders to subscribe to any new issuance of shares. Any common share capital increase resolution preserving pre-emptive subscription rights expires after 3 months and requires a simple majority of the votes cast at the shareholder&#8217;s meeting regardless of abstentions and empty or invalid votes. Swiss law also does not provide as much flexibility in the various terms that can attach to different classes of shares as do the laws of some other jurisdictions. Swiss law also reserves for approval by shareholders certain corporate actions over which a board of directors would have authority in some other jurisdictions. For example, dividends must be approved by shareholders. These Swiss law requirements relating to our capital </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">46</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 10pt 0pt;">management may limit our flexibility, and situations may arise in which greater flexibility would have provided substantial benefits to our shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under Swiss law, a Swiss corporation may pay dividends only if the corporation has sufficient distributable profits from previous fiscal years, or if the corporation has distributable reserves, each as evidenced by its audited statutory balance sheet. Freely distributable reserves are generally booked either as &#8220;free reserves&#8221; or as &#8220;capital contributions&#8221; (<i style="font-style:italic;">apports de capital</i>, contributions received from shareholders) in the &#8220;reserve from capital contributions.&#8221; Distributions may be made out of issued share capital&#8212;the aggregate nominal value of a company&#8217;s issued shares&#8212;only by way of a capital reduction. To the extent the Company introduces the capital band, only net proceeds from capital increase using the capital band (less certain expenses and net of repayments from the Company) will be recognized as reserves from capital contributions at the end of validity period of the respective capital band). As of December&#160;31, 2022, the Company has CHF 432.6 million of reserves from capital contributions confirmed by the Swiss Federal Tax Administration and CHF 1,794,907 of issued share capital (consisting of 89,745,365 common shares each with a nominal value of CHF 0.02 and no preferred shares) on its audited statutory balance sheet. Of the total issued shares and issued share capital, the Company holds 6,214,021 fully paid-in treasury shares representing CHF 124,280 of issued share capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Generally, Swiss withholding tax of 35% is due on dividends and similar distributions to our shareholders, regardless of the place of residency of the shareholder, unless the distribution is made to shareholders out of (i) a reduction of nominal value or (ii) assuming certain conditions are met, reserves from capital contributions accumulated on or after January 1, 1997. We expect the aggregate of the reserves from capital contributions confirmed by the Swiss Federal Tax Administration and share capital, less the total losses brought forward (to the extent set off against reserves from capital contributions or share capital), less the treasury shares (to the extent booked against reserves from capital contributions), less the lowest legally possible issued share capital and legal reserve of together CHF 150,000 to represent the maximum amount potentially available for future dividends or capital reductions on a Swiss withholding tax-free basis. We would also be able to pay dividends out of distributable profits or freely distributable reserves but such dividends would be subject to Swiss withholding taxes. There can be no assurance that we will have sufficient distributable profits, free reserves, reserves from capital contributions or registered share capital to pay a dividend or effect a capital reduction, that our shareholders will approve dividends or capital reductions proposed by us, or that we will be able to meet the other legal requirements for dividend payments or distributions as a result of capital reductions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">A U.S. investor who qualifies for benefits under the Convention Between the United States of America and the Swiss Confederation for the Avoidance of Double Taxation with Respect to Taxes on Income, which we refer to as the &#8220;U.S.-Swiss Treaty,&#8221; may apply for a refund of the tax withheld in excess of the 15% treaty rate (or in excess of the 5% reduced treaty rate for qualifying corporate shareholders with at least 10% participation in our voting stock, or for a full refund in the case of qualified pension funds). There can be no assurance that we will have sufficient reserves from capital contributions to pay dividends free from Swiss withholding tax, or that Swiss withholding tax rules will not be changed in the future. In addition, we cannot provide assurance that the current Swiss law with respect to distributions out of reserves from capital contributions will not be changed or that a change in Swiss law will not adversely affect us or our shareholders, in particular as a result of distributions out of reserves from capital contributions becoming subject to additional corporate law or other restrictions. If we are unable to make a distribution through a reduction in nominal value or out of confirmed reserves from capital contributions, we will not be able to make distributions without subjecting our shareholders to Swiss withholding taxes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:2pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">U.S. shareholders may not be able to obtain judgments or enforce civil liabilities against us or our executive officers or members of our board of directors.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We are organized under the laws of Switzerland and our registered office and domicile is located in Ecublens, near Lausanne, Canton of Vaud, Switzerland. Moreover, a number of our directors and executive officers are not residents of the U.S., and all or a substantial portion of the assets of such persons are located outside the U.S.. As a result, it may not be possible for investors to effect service of process within the U.S. upon us or upon such persons or to enforce against them judgments obtained in U.S. courts, including judgments in actions predicated upon the civil liability provisions of the federal securities laws of the U.S.. We have been advised by our Swiss counsel that there is doubt as to the enforceability in Switzerland of original actions, or of actions for enforcement of judgments of U.S. courts, for civil liabilities to the extent solely predicated upon the federal and state securities laws of the U.S.. Original actions against persons in Switzerland based solely upon the U.S. federal or state securities laws are governed, among other things, by </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">47</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 10pt 0pt;">the principles set forth in the Swiss Federal Act on Private International Law. This statute provides that the application of provisions of non-Swiss law by the courts in Switzerland shall be precluded if the result is incompatible with Swiss public policy. Additionally, certain mandatory provisions of Swiss law may be applicable regardless of any other law that would otherwise apply.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Switzerland and the U.S. do not have a treaty providing for reciprocal recognition and enforcement of judgments in civil and commercial matters. The recognition and enforcement of a judgment of the courts of the U.S. in Switzerland is governed by the principles set forth in the Swiss Federal Act on Private International Law. This statute provides in principle that a judgment rendered by a non-Swiss court may be enforced in Switzerland only if:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the non-Swiss court had jurisdiction pursuant to the Swiss Federal Act on Private International Law;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the judgment of such non-Swiss court has become final and non-appealable;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the judgment does not contravene Swiss public policy;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the court procedures and the service of documents leading to the judgment were in accordance with the due process of law; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">no proceeding involving the same parties and the same subject matter was first brought in Switzerland, or adjudicated in Switzerland, or was earlier adjudicated in a third state for which the decision is recognizable in Switzerland.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:2pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our status as a Swiss corporation means that our shareholders enjoy certain rights that may limit our flexibility to raise capital, issue dividends and otherwise manage ongoing capital needs.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Swiss law reserves for approval by shareholders certain corporate actions over which a board of directors would have authority in some other jurisdictions. For example, the payment of dividends and cancellation of treasury shares must be approved by shareholders. Swiss law also requires that our shareholders themselves resolve, or authorize our board of directors, to increase our share capital. Although under the current Swiss law our shareholders may resolve a capital band which authorizes the board of directors to increase or decrease the share capital without additional shareholder approval, Swiss law limits this authorization to 50% of the issued share capital at the time of the authorization. The authorization, furthermore, has a limited duration of up to five years and must be renewed by the shareholders from time to time thereafter. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Since January 1, 2023, the new Swiss corporate law introducing the capital band mechanism has come into force. It will no longer be possible to renew the Company&#39;s current Authorized Share Capital beyond June 24, 2024. Instead, the Company can only introduce the capital band pursuant to Article 653s et seq. of the revised Swiss Code of Obligations which requires an amendment of the Articles by way of a resolution of a duly convened general meeting of shareholders of the Company. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Additionally, subject to specified exceptions, including exceptions explicitly described in our articles of association, Swiss law grants pre-emptive subscription rights to existing shareholders to subscribe for new issuances of shares. Swiss law also does not provide as much flexibility in the various rights and regulations that can attach to different categories of shares as do the laws of some other jurisdictions. These Swiss law requirements relating to our capital management may limit our flexibility, and situations may arise where greater flexibility would have provided benefits to our shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Swiss law restricts our ability to pay dividends.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item&#160;10. Additional information&#8212;E. Taxation&#8212;Swiss tax considerations&#8221; for a summary of certain Swiss tax consequences regarding dividends distributed to holders of our common shares.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">48</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Shareholders in countries with a currency other than Swiss Francs face additional investment risks from currency exchange rate fluctuations in connection with their holding of our common shares.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any future payments of dividends, if any, will likely be denominated in Swiss Francs. The foreign currency equivalent of any dividend, if any, paid on our common shares or received in connection with any sale of our common shares could be adversely affected by the depreciation of the Swiss Franc against such other currency.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We are a foreign private issuer and, as a result, we are not subject to U.S. proxy rules&#160;and are subject to Exchange Act reporting obligations that, to some extent, are more lenient and less frequent than those of a U.S. domestic public company.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are reporting under the Exchange Act as a non-U.S. company with foreign private issuer status. Because we qualify as a foreign private issuer under the Exchange Act and although we are subject to Swiss laws and regulations with regard to such matters and intend to furnish quarterly financial information to the SEC, we are exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including (i)&#160;the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act; (ii)&#160;the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and their liability for insiders who profit from trades made in a short period of time; and (iii)&#160;the rules&#160;under the Exchange Act requiring the filing with the SEC of quarterly reports on Form&#160;10-Q containing unaudited financial and other specified information, or of current reports on Form&#160;8-K, upon the occurrence of specified significant events. In addition, foreign private issuers are not required to file their annual report on Form&#160;20-F until 4&#160;months after the end of each financial&#160;year, whereas U.S. domestic issuers that are accelerated filers are required to file their annual report on Form&#160;10-K within 75&#160;days after the end of each fiscal&#160;year. Foreign private issuers are also exempt from the Regulation Fair Disclosure, aimed at preventing issuers from making selective disclosures of material information. As a result of the above, you may not have the same protections afforded to shareholders of companies that are not foreign private issuers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">As a foreign private issuer and as permitted by the listing requirements of Nasdaq, we rely on certain home country governance practices rather than the corporate governance requirements of Nasdaq.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">We are a foreign private issuer. As a result, in accordance with Nasdaq Listing Rule 5615(a)(3), we comply with home country (in this case, Swiss) governance requirements and certain exemptions thereunder rather than complying with certain of the corporate governance requirements of Nasdaq. Swiss law does not require that a majority of our board of directors consist of independent directors. Our board of directors therefore may include fewer independent directors than would be required if we were subject to Nasdaq Listing Rule 5605(b)(1). In addition, we are not subject to Nasdaq Listing Rule 5605(b)(2), which requires that independent directors regularly have scheduled meetings at which only independent directors are present.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">While Swiss law also requires that our board of directors elects an audit and finance committee from among its members, as a foreign private issuer, the independence of the members of such committee is determined by home country regulations and the conditions of Section 10B of the Securities Exchange Act, excluding any Nasdaq Listing Rules. Section 10B of the Securities Exchange Act also prescribes qualification requirements for the audit and finance committee. Swiss law also requires that we elect a compensation committee, we follow home country requirements with respect to such committee and our compensation, nomination and corporate governance committee is tasked with certain director nomination and governance responsibilities. As a result, our practice varies from the requirements of Nasdaq Listing Rule 5605(d), which sets forth certain requirements as to the responsibilities, composition and independence of compensation committees, and from the independent director oversight of director nominations requirements of Nasdaq Listing Rule 5605(e).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Furthermore, in accordance with Swiss law and generally accepted business practices, our articles of association do not provide quorum requirements generally applicable to general meetings of shareholders. Our practice thus varies from the requirement of Nasdaq Listing Rule 5620(c), which requires an issuer to provide in its bylaws for a generally applicable quorum, and that such quorum may not be less than one-third of the outstanding voting stock. Our articles of association provide for an independent proxy holder elected by our shareholders, who may represent our shareholders at </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">49</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 10pt 0pt;">a general meeting of shareholders, and we must provide shareholders with an agenda and other relevant documents for the general meeting of shareholders. Our practice varies from the requirement of Nasdaq Listing Rule 5620(b), which sets forth certain requirements regarding the solicitation of proxies. In addition, we have opted out of shareholder approval requirements for the issuance of securities in connection with certain events such as the acquisition of stock or assets of another company, the establishment of or amendments to equity-based compensation plans for employees, a change of control of us, and certain private placements. To this extent, our practice varies from the requirements of Nasdaq Listing Rule 5635, which generally requires an issuer to obtain shareholder approval for the issuance of securities in connection with such events.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For an overview of our corporate governance principles, see &#8220;Item&#160;16G. Corporate governance.&#8221; As a result of the above, you may not have the same protections afforded to shareholders of companies that are not foreign private issuers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may lose our foreign private issuer status, which would then require us to comply with the Exchange Act&#8217;s domestic reporting regime and cause us to incur significant legal, accounting and other expenses.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">We are a foreign private issuer and therefore we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers. We may no longer be a foreign private issuer as of June 30, 2023 (or the end of our second fiscal quarter in any subsequent fiscal year), which would require us to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers as of January 1, 2024 (or the first day of the fiscal year immediately succeeding the end of such second quarter). In order to maintain our current status as a foreign private issuer, either (a) a majority of our common shares must be either directly or indirectly owned of record by non-residents of the U.S. or (b) (i) a majority of our executive officers or directors may not be U.S. citizens or residents, (ii) more than 50 percent of our assets cannot be located in the U.S. and (iii) our business must be administered principally outside the U.S.. If we lost this status, we would be required to comply with the Exchange Act reporting and other requirements applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We may also be required to make changes in our corporate governance practices in accordance with various SEC and stock exchange rules. The regulatory and compliance costs to us under U.S. securities laws if we are required to comply with the reporting requirements applicable to a U.S. domestic issuer may be significantly higher than the cost we would incur as a foreign private issuer. As a result, we expect that a loss of foreign private issuer status would increase our legal and financial compliance costs and would make some activities highly time-consuming and costly. We also expect that if we were required to comply with the rules and regulations applicable to U.S. domestic issuers, it would make it more difficult and expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These rules and regulations could also make it more difficult for us to attract and retain qualified members of our board of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, shareholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our common shares.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our management is responsible for establishing and maintaining adequate internal controls over financial reporting. Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud, among other objectives. Any failure to implement any required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404 of the Sarbanes-Oxley Act of 2002, or any testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financial reporting, which are deemed to be material weaknesses or that may require prospective or retroactive changes to our consolidated financial statements or identify other areas for further attention or improvement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Moreover, if we are not able to comply with the requirements of Section 404 applicable to us in a timely manner, or if we or our independent registered public accounting firm identifies deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our common shares could decline, and we could be subject to sanctions or investigations by the SEC or other regulatory authorities, which would require additional </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">50</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 10pt 0pt;">financial and management resources. Furthermore, investor perceptions of our company may suffer if deficiencies are found, and this could cause a decline in the market price of our common shares. Irrespective of compliance with Section 404, any failure of our internal control over financial reporting could have a material adverse effect on our stated operating results and harm our reputation. If we are unable to implement these requirements effectively or efficiently, it could harm our operations, financial reporting, or financial results and could result in an adverse opinion on our internal control over financial reporting from our independent registered public accounting firm.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If securities or industry analysts do not publish research, or publish inaccurate or unfavorable research, about our business, the price of our common shares and our trading volume could decline.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The trading market for our common shares will depend in part on the research and reports that securities or industry analysts publish about us or our business. If no or too few securities or industry analysts cover our company, the trading price for our common shares would likely be negatively affected. In addition, if one or more of the analysts who cover us downgrade our common shares or publish inaccurate or unfavorable research about our business, the price of our common shares would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, demand for our common shares could decrease, which might cause the price of our common shares and trading volume to decline.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 10pt 9.35pt;">We were likely a passive foreign investment company (PFIC) for our 2022 taxable year and we may be a PFIC for 2023 or future taxable years. If we are a PFIC for any taxable year during which a U.S. investor owns our common shares, the investor generally will be subject to adverse U.S. federal income tax consequences.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">As discussed in our Annual Report on Form 20-F for 2019 and 2020, we were likely a PFIC for these years. We were also likely a PFIC for 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), we will be a PFIC for any taxable year in which, after the application of certain look-through rules with respect to subsidiaries, either (i) 75% or more of our gross income consists of passive income (the &#8220;income test&#8221;) or (ii) 50% or more of the average value of our assets (generally determined on a quarterly basis) consists of assets that produce, or are held for the production of, passive income (the &#8220;asset test&#8221;). Passive income generally includes dividends, interest, certain non-active rents and royalties, and gains from financial investments. Cash is generally a passive asset. Goodwill (the value of which may be determined by reference to the excess of the sum of a corporation&#8217;s market capitalization and liabilities over the value of its assets) is generally an active asset to the extent attributable to business activities that produce active income. For purposes of the above calculations, we will be treated as if we hold our proportionate share of the assets of, and directly receive our proportionate share of the income of, any other corporation in which we directly or indirectly own at least 25% of the shares of such corporation by value. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="white-space:pre-wrap;"> We have not obtained valuations of our assets (including goodwill or going concern value) for 2022 and thus are not in a position to make a definitive determination regarding whether we were a PFIC for 2022. However, we believe that we were likely a PFIC for 2022 due to the decline and volatility of our market capitalization in 2022. If the value of our goodwill or going concern value is determined by reference to our market capitalization then we were a PFIC for 2022. For the same reason there is a significant risk that we will also be a PFIC for 2023, and possibly other taxable years. Because our PFIC status is a factual annual determination that can be determined only after the end of the relevant taxable year, we cannot express a view regarding our PFIC status for 2023 or any future taxable year. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In addition, the application of the income test to a company like us (whose overall losses from research and development activities significantly exceed its gross income) is not entirely clear. We will be a PFIC for any taxable year under the income test if 75% or more of our gross income (as determined for U.S. federal income tax purposes) for such year consists of interest and other passive income. Prior to the commercialization and sales of any of our product candidates, our gross income may consist primarily of upfront or milestone payments and grants (which we believe are likely to be treated as active income) and interest (which is passive income). The receipt of upfront payments is non-recurring in nature, and the receipt of grants or milestone payments is subject to various conditions. Therefore, there can be no assurance as to the amount of grants, milestone payments or upfront payments (if any) that we will receive for any taxable year. Moreover, we may earn income from sublicensing, which may be passive unless certain conditions are satisfied. There is no assurance that the Internal Revenue Service (&#8220;IRS&#8221;) will not challenge the classification of any of </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">51</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 10pt 0pt;">our income items for PFIC purposes for any taxable year. Accordingly, there is no assurance that we will not be a PFIC for any taxable year under the income test.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><span style="white-space:pre-wrap;">If we are a PFIC for any taxable year and a U.S. investor owns our common shares during any portion of that year, we will continue to be treated as a PFIC with respect to the U.S. investor, even if we are not a PFIC for any subsequent taxable year, unless the U.S. investor makes a &#8220;deemed sale&#8221; election with respect to our common shares.    </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">U.S. investors that own our common shares during any taxable year in which we are (or were) a PFIC generally will be subject to adverse U.S. federal income tax consequences, including (i) the treatment of all or a portion of any gain on disposition of our common shares as ordinary income, (ii) the application of a deferred interest charge on such gain and the receipt of certain dividends and (iii) the requirement to file certain reports to the IRS. We do not intend to provide the information that would enable investors to make a &#8220;qualified electing fund&#8221; election which, if available, could materially affect the U.S. federal income tax consequences if we are a PFIC for any taxable year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For further discussion, see &#8220;Item&#160;10. Additional information&#8212;Section&#160;E. Taxation.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><span style="font-size:10pt;line-height:1.28;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">52</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_b872cafc_7ed2_4814_bc51_50aa698e026f"></a><a id="ITEM4INFORMATIONONTHECOMPANY_87372"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;4. INFORMATION ON THE COMPANY</p><a id="AHistoryanddevelopmentofthecompany_39409"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>History and development of the company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a Swiss stock corporation (<i style="font-style:italic;">soci&#233;t&#233; anonyme</i>) organized under the laws of Switzerland. We were formed as a Swiss limited liability company (<i style="font-style:italic;">soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e</i>) on February&#160;13, 2003 with our registered office and domicile in Basel, Switzerland. We converted to a Swiss stock corporation (<i style="font-style:italic;">soci&#233;t&#233; anonyme</i>) under the laws of Switzerland on August&#160;25, 2003. Our Swiss enterprise identification number is CHE-109.878.825. Our domicile and registered office is in Ecublens, at the &#201;cole Polytechnique F&#233;d&#233;rale Lausanne (EPFL) Innovation Park Building B, 1015 Lausanne, Vaud, Switzerland. Our common shares were admitted to trading on Nasdaq Global Market on September&#160;23, 2016, and trade under the symbol ACIU.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our general telephone number is (41) 21 345 91 21 and our internet address is www.acimmune.com. <span style="background:#ffffff;">References to our website address do not constitute incorporation by reference of the information contained on the website, and the information contained on the website is not part of this document or any other document that we file with or furnish to the SEC. </span>The SEC maintains an internet site that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC, which can be found at http://www.sec.gov. Our agent for service of process in the United States is Cogency Global&#160;Inc. located at 122 East 42nd Street, 18th Floor, New York, New York 10168. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our principal expenditures since January&#160;1, 2020 have been our research and development expenses, as more fully described elsewhere in this Annual Report.</p><a id="BBusinessoverview_517701"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Business overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune is a leading, clinical stage biopharmaceutical company advancing one of the broadest portfolios focused on pioneering Precision Medicine for neurodegenerative diseases. Our highly differentiated approach integrates novel therapeutics and diagnostics to overcome the fundamental challenge in this therapeutic area&#160;&#8211; the high number of co-pathologies driving disease development and progression and the urgent need for more tailored therapeutic regimens.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Leveraging our dual proprietary technology platforms, SupraAntigen and Morphomer, we have built a comprehensive pipeline of first-in-class or best-in-class candidates spanning multiple treatment modalities and targeting both established and emerging neurodegenerative pathologies. We are currently advancing 16 therapeutic and diagnostic programs, with seven currently in clinical trials, targeting five different types of misfolded pathological proteins related to Alzheimer&#8217;s disease (AD), Parkinson&#8217;s disease (PD) and other neurodegenerative disorders. Our pipeline assets are further validated by the multiple partnerships we have established with leading global pharmaceutical companies. We believe our clinically validated technology platforms and multi-target, multimodal approach position AC Immune to revolutionize the treatment paradigm for neurodegenerative disease by shifting it towards Precision Medicine and disease prevention.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">53</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:252pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 1: AC Immune investment highlights</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f001.jpg" alt="Graphic" style="display:inline-block;height:251.5pt;left:0%;padding-bottom:0.5pt;position:relative;top:0pt;width:474.85pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) As of December 31, 2022; excluding treasury shares; (2) As of December 31, 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Our Team</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have assembled an outstanding management team with relevant scientific, clinical and regulatory expertise. Our scientific founders, Jean-Marie Lehn, Claude Nicolau, and Fred van Leuven, are regarded as pioneers in their respective scientific domains, including in the study of AD. Our co-founder and Chief Executive Officer, Andrea Pfeifer, a Pharmacologist with a Ph.D. in cancer research and a former National Institute of Health researcher, has a 30-year track record in product innovation and implementation, and was formerly Head of Nestl&#233; Global Research and the co-founder of Nestl&#233; Venture Fund. Marie Kosco-Vilbois, our Chief Scientific Officer, brings more than 20&#160;years of experience in various aspects of discovery research and drug development, including work on multiple drug development programs. Johannes Rolf Streffer, our Chief Medical Officer, is a Neurologist and Psychiatrist with extensive expertise in AD including biomolecular modalities such as PET, volumetric and functional MRI, genetics, cognition and cerebrospinal fluid (CSF) marker.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Unmet need in neurodegenerative diseases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Neurodegenerative diseases, including dementias and motor disorders associated with protein misfolding, are prevalent, but there is currently an absence of reliable, early-stage diagnosis and disease-modifying treatments for these diseases. The growth in the number of people with neurodegenerative diseases has been significant, as evidenced by the prevalence of people affected by AD and PD, two of the most common neurodegenerative diseases.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The World Health Organization recognizes dementia as a global public health priority</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">. </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Worldwide, there is a new case of dementia every 3 seconds, with an estimated global patient population of greater than 50&#160;million in 2020. This is predicted to increase to 139&#160;million by 2050 (Alzheimer&#8217;s Disease International).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The estimated total healthcare costs for the treatment of Alzheimer&#8217;s disease in the United States in 2022 is USD 321 billion per the Alzheimer&#8217;s Association. The worldwide cost for dementia is expected to increase to </span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">54</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:252pt;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approximately USD 2.8 trillion annually by 2030 as the population ages (Alzheimer&#8217;s Disease International). If the estimated global costs of dementia were a country, it would be the 14</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> largest economy in the world.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 2: Neurodegenerative diseases represent a large and growing market</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f002.jpg" alt="Graphic" style="display:inline-block;height:251.95pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:485.3pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(1) Alzheimer&#8217;s Disease International; (2) Parkinson&#8217;s disease; (3) Michael J Fox Foundation; (4) Limbic-predominant age-related TDP-43 encephalopathy; (5) Nelson et al. Brain 2019; (6) Gustavsson et al. Alzheimer&#39;s Dement. 2022; 1- 13. https://doi.org/10.1002/alz.12694; (7) Alzheimer&#8217;s disease; (8) Neurodegenerative disease</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Diagnosis typically takes the form of observation of cognitive, functional and behavioral impairment and other symptoms of the diseases, which are generally only apparent after irreversible neuronal damage has already occurred. In the United States, through Q1 2023, there were seven approved therapies for AD, five addressing symptoms and two being disease-modifying treatments. These provided incomplete clinical efficacy, presented non-negligible safety risks and failed to halt disease progression. Despite these shortcomings, marketed therapies, such as Eisai and Pfizer&#8217;s Aricept, have achieved peak annual global sales of approximately USD 2.4&#160;billion prior to loss of exclusivity. Similarly, in the treatment of PD, the current standard of care is intended only to alleviate clinical symptoms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In July 2022, the FDA accepted Eisai Co., Ltd.&#8217;s Biologics License Application (BLA) for lecanemab, an investigational anti-amyloid beta protofibril antibody for early AD that is partnered with Biogen Inc. In September 2022, Eisai and Biogen announced that lecanemab&#8217;s confirmatory Phase 3 AD study met its primary endpoint. As a result, lecanemab was granted accelerated approval as a treatment for AD in the U.S. by the U.S. FDA on January 6, 2023. Eisai submitted a Supplemental BLA to the FDA for approval under the traditional pathway on the same day. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Europe, Eisai submitted marketing authorization application to the EMA on January 9, 2023. In China, Eisai initiated submission of data for BLA to the National Medical Products Administration (NMPA) on December 23, 2022. On January 16, 2023, Eisai filed its marketing authorization application in Japan. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Neurodegenerative disease overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Folding and unfolding of proteins are important ways of regulating the biological activity and cellular location of those proteins. Misfolding of proteins occurs due to a breakdown of cellular quality control systems and is a common feature of many neurodegenerative diseases. Misfolded proteins are unable to carry out their normal functions and aggregate to form insoluble deposits in the brain, which eventually lead to neuronal damage and cell death. The </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">55</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:184.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">progression of neurodegenerative diseases, such as AD and PD, is linked to the spread of misfolded, pathological protein aggregates throughout the brain. Figure 3 shows how misfolded proteins play a key role in the pathology of neurodegenerative diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Figure 3: Misfolded proteins key impact on the pathology of neurodegenerative diseases</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 8pt 0pt;"><img src="aciu-20221231x20f003.jpg" alt="Graphic" style="display:inline-block;height:184pt;left:0%;padding-bottom:0.5pt;position:relative;top:0pt;width:468.62pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Typically, protein misfolding occurs in response to cellular stress, which can be triggered by many different, largely unknown, causes. A cascade of molecular events begins with the misfolding of single proteins within a cell, which then aggregate and ultimately form larger aggregates including plaques and tangles. These misfolded proteins are then exported or shed from dying neurons where they can spread to healthy cells nearby. Once inside, misfolded proteins can interact with normal proteins and cause them to misfold in a process known as &#8220;seeding,&#8221; leading to spreading of the disease pathology throughout the brain, increased neuronal death and a progressive decline in cognitive function.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Figure above also shows how our therapies are designed to intervene and prevent key pathological steps in the progression of neurodegenerative diseases. They are designed to (i)&#160;prevent initial misfolding; (ii)&#160;promote disaggregation of misfolded proteins; (iii)&#160;inhibit spreading of pathological protein to healthy cells; (iv)&#160;prevent seeding of new misfolded protein aggregates inside healthy cells; and (v)&#160;inhibit downstream neurodegeneration. This robust approach to targeting neurodegenerative diseases is enabled by our two validated technology platforms, SupraAntigen and Morphomer, which generate highly specific biologics and small molecule inhibitors that can distinguish normal from misfolded proteins and inhibit key disease pathways both inside and outside of cells.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Our strategic vision</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our goal is to continue leveraging our proprietary discovery platforms, SupraAntigen and Morphomer, to shift the treatment paradigm for neurodegenerative disease towards Precision Medicine and disease prevention. We are executing a clear business strategy built on three pillars: (i)&#160;accelerate development of novel therapeutics in AD with our partners; (ii)&#160;expand our strategic focus in Parkinson&#8217; disease (PD) and non-AD neurodegenerative diseases, including NeuroOrphan indications and limbic-predominant age-related TDP-43 encephalopathy (LATE); and (iii)&#160;a continued focus on diagnostics enabling Precision Medicine to be an ultimate differentiator for the Company.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">56</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:204.1pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 4: AC Immune&#8217;s three-pillar strategy</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f004.jpg" alt="Graphic" style="display:inline-block;height:204.1pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:485.3pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) Alzheimer&#8217;s disease; (2) Down syndrome; (3) alpha-synuclein; (4) TAR DNA-binding protein 43</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our three-pillar execution strategy reflects our unique Precision Medicine approach, which ultimately creates differentiation due to our ability to address the high levels of co-pathologies present in AD and other neurodegenerative diseases. Much like cancer, neurodegenerative diseases are heterogeneous and may require multiple therapeutic interventions tailored to patients&#8217; specific disease drivers, to be used in combination in order to slow or stop the disease course. Ultimately, it is our belief that Precision Medicine will increase the chance of treatment success by enabling clinical trial participants to be better defined by their various proteinopathies, allowing for treatment with the right therapies at the right time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune has established itself as a leader in developing Precision Medicines for neurodegenerative diseases by utilizing our diagnostic capabilities to enable improved diagnosis of co-pathologies, patient selection and assessment of clinical trial outcomes. Our dual technology platforms allow for a multi-modal approach encompassing a portfolio of vaccines, antibodies and small molecules tailored to the underlying pathology driving patients&#8217; disease. In addition to generating targeted monotherapies, this approach creates the potential for combination regimens, which may treat a broader spectrum of disease and offer greater efficacy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Precision Medicine for neurodegenerative diseases</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The development of therapeutics for neurodegenerative diseases is moving towards treating early-stage disease to delay or prevent progression by preserving neurological function before it is irretrievably lost. Therefore, early detection of neurodegenerative diseases will be critical to enhancing the effectiveness of both symptomatic and disease-modifying therapies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">This begins with a real challenge. The commonly used approach of taking a biopsy of the affected tissue to detect the corresponding pathology is not possible with diseases of the brain. Given these complexities, it becomes more important that we develop improved methods to fully characterize the underlying pathologies in different patients to ultimately provide better opportunities for therapeutic intervention at all stages of disease. Samples of blood or cerebrospinal fluid can be used to monitor biomarker levels indirectly but neither of these fluids provide exact anatomical information on where protein misfolding and aggregation occur. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">At AC Immune, we have a strong track record in discovering highly sensitive and specific imaging agents to detect and quantify pathological proteins and their aggregated forms directly in patients&#8217; brains using PET scans. These agents </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">57</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:204pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">can provide critical information to confirm or exclude certain diagnoses and thus to determine which might be the most appropriate therapeutic strategy for a patient. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We are developing an integrated diagnostic and therapeutic strategy to deliver, for the first time, Precision Medicine for patients with neurodegenerative conditions. This will lead to a combination therapy approach to treat each patient&#39;s unique disease by addressing the right proteinopathy, in the right patient, at the right time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Vaccines for Alzheimer&#8217;s and Parkinson&#8217;s disease</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Consistent with this approach, we are progressing our vaccines targeting the hallmark proteins driving neurodegenerative diseases such as amyloid beta, Tau, and alpha-synuclein. Our clinical stage vaccine programs, ACI-35.030 (anti-pTau vaccine), ACI-24.060 (anti-Abeta vaccine) and ACI-7104.056 (anti-a-syn vaccine) have been shown to stimulate a patient&#8217;s own immune system to produce antibodies directed specifically against the pathological species of these target proteins. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt;">We believe that these antibodies will modify the course of disease by supporting clearance of toxic protein aggregates (as recent clinical data from certain monoclonal antibodies have shown), or by preventing their spreading and accumulation, thereby preserving neuronal health and function. Importantly, the use of vaccines over the longer-term and in people identified as &#8220;at risk&#8221; before symptomatic disease development will provide the rational, targeted approach consistent with our Precision Medicine strategy. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:17.85pt;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Key elements of our approach include:</p><div style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-left:18pt;margin-top:0pt;text-indent:0pt;"><span style="display:inline-block;font-size:10pt;font-style:italic;font-weight:bold;min-width:18pt;white-space:nowrap;">1.</span><span style="font-size:10pt;font-style:italic;font-weight:bold;">Execution on advancing our product candidates, in partnership or alone, from clinical development to regulatory approval and potential commercialization</span></div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 5: Our broad and robust clinical stage pipeline</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f005.jpg" alt="Graphic" style="display:inline-block;height:203.75pt;left:0%;padding-bottom:0.25pt;position:relative;top:0pt;width:471pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt;">(1) Alzheimer&#8217;s disease; (2) Open label extension study is ongoing; (3) Positron emission tomography; (4) Progressive supranuclear palsy; (5) Prevention trial API-ADAD in Colombia; (6) Down syndrome-related Alzheimer&#8217;s disease; (7) alpha-synuclein; (8) Parkinson&#8217;s disease; (9) Multiple system atrophy</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.28;margin:0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.28;margin:0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.28;margin:0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">58</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our clinical stage product candidates include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">ACI-35.030</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">.</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">AC Immune and Janssen Pharmaceuticals, Inc. (Janssen), part of the Janssen Pharmaceutical Companies of Johnson &amp; Johnson, are evaluating the anti-phosphorylated-Tau (anti-pTau) vaccine candidate ACI-35.030 in a Phase 1b/2a study in subjects with early AD (NCT04445831). Interim results show that ACI-35.030 vaccination generated a strong antigen-specific antibody response against pTau in 100% of participants, achieving anti-pTau antibody levels of about two orders of magnitude higher than pre-vaccination levels, whereas anti-ePHF (enriched paired helical filaments) antibody titers increased by one order of magnitude from baseline as early as two weeks after the second injection at week 8 of the mid-dose of ACI-35.030. Based on these results, the second highest dose cohort was expanded in Q2 2021 to facilitate plans for further late-stage development. The safety and the tolerability have been good in the study, and so far the Data Safety Monitoring Board has always stated that the trial may continue without modification. Two serious adverse events (SAEs) (injection site rash and dizziness occurring on one occasion) were considered probably/possibly related to the study active immunotherapy while none of the other 6 SAEs that occurred in the study to date were considered to be possibly or probably related to the study active immunotherapy. ACI-35.030 specifically targets pathological pTau species and is eventually intended as a disease-modifying treatment for AD and other Tauopathies. </span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><span style="font-size:10pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;">In Q4 2022, it was announced that, based on the Phase 1b/2a interim data, ACI-35.030 had been selected for further development. New clinical data from the Phase 1b/2a trial showed that ACI-35.030 treatment rapidly leads to the strong and durable induction of antibodies specific for pathological forms of Tau such as pTau and its aggregated form, ePHF. The ACI-35.030-induced antibody response was sustained and could be periodically boosted over a period of 72 weeks. The decision to select ACI-35.030 follows the comparison demonstrating its strengths relative to an alternative anti-pTau protein conjugate vaccine, JACI-35.054<span style="background:#ffffff;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><span style="font-size:10pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">ACI-24.060 for </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">AD and for AD in DS</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">.&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The original formulation of our wholly owned anti-amyloid-beta vaccine candidate was shown to be safe and well tolerated along with preliminary evidence of immunogenicity and pharmacodynamic effects in patients with AD and in people with DS.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> Based on </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">these results, the optimized formulation, ACI-24.060, which incorporates Abeta unrelated T-helper cell epitopes to increase the magnitude and the boost-ability of the antibody response, was advanced into the ABATE Phase 1b/2 trial.</span></td></tr></table><div style="margin-top:8pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 8pt 36pt;">ABATE is a multicenter, adaptive, double-blind, randomized, placebo-controlled study designed to assess the safety, tolerability, immunogenicity, and pharmacodynamic effects of ACl-24.060 in subjects with prodromal AD and subsequently in adults with DS is ongoing. The CTA has been approved by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) and by the Spanish Agency for Medicines and Health Products (AEMPS) with the first patient dosed in Q2 2022. AC Immune plans for an Investigational New Drug (IND) application in the USA in H1 2023 for the global development of the vaccine candidate<span style="background:#ffffff;">.</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">ACI-7104.056.</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"> </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">The optimized formulation of the clinically-validated PD vaccine candidate PD01, will advance into an adaptive, biomarker-based Phase 2 study</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> following the recent clearance of the CTA.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> This trial will evaluate an initial dose-response of ACI-7104.056 focusing on safety and immunogenicity against a-syn and pathological a-syn species. Additionally, the identification or verification of disease-specific biomarkers and progression of motor and non-motor symptoms of Parkinson&#8217;s disease will be monitored, together with digital, imaging and fluid biomarkers, in the second part of the study. The trial initiation is anticipated in</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> H1</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> 2023</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Semorinemab</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">.</b><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">&#160;</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Our collaboration partner, Genentech, a member of the Roche Group, is developing semorinemab for the treatment of AD. A</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Phase 2 study (Lauriet) conducted in patients with mild-to-moderate AD was completed in Q3 2021 and data showed a statistically significant reduction on one of two co-primary endpoints, ADAS-Cog11. The second co-primary endpoint, ADCS-ADL, and secondary endpoints were not met. Safety data showed that semorinemab is well tolerated with no unanticipated safety signals. At CTAD 2022, Genentech presented CSF and plasma biomarkers. These data confirmed peripheral target engagement </span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">59</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">and reduction in CSF total Tau, pTau181 and pTau217, observed after semorinemab treatment but not with placebo. Genentech reported that the open label portion of the study will continue as planned and that further analyses are ongoing. Semorinemab is designed to slow the spreading of Tau pathology, which coincides with both clinical symptoms and disease progression in AD.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><span style="font-size:10pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;background:#ffffff;">Crenezumab</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;background:#ffffff;">.</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">&#160;In August 2022, the Company provided an update on the Alzheimer&#8217;s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer&#8217;s disease, a specific genetic mutation which causes early-onset Alzheimer&#8217;s disease. While numerical differences favoring crenezumab over placebo were observed across the co-primary, multiple secondary and exploratory endpoints, none of these effects were statistically significant. Initial data was presented at the Alzheimer&#39;s Association International Conference (AAIC) on August 2, 2022. Further plasma biomarker analyses presented at the CTAD 2022 conference further favored crenezumab over placebo. All participants in the study were offered up to one year of continued treatment (crenezumab for all carriers and placebo for all non-carrier) following the end of the double-blind period while primary results and additional analyses were pending. Final efficacy visits have begun.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><span style="font-size:10pt;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Morphomer Tau aggregation inhibitors.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;background:#ffffff;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">In collaboration with our partner, Lilly, we are researching and developing small molecule Tau aggregation inhibitors with plans to evaluate candidates in AD and NeuroOrphan tauopathies. We completed a Phase 1 clinical study in healthy volunteers with ACI</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">-</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">3024, in Q2 2020, which showed a dose-dependent exposure and brain penetration, achieving the desired levels of ACI</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">-</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">3024 in the CSF. Continued candidate characterization across the research program has also identified new and highly differentiated candidates with excellent cerebrospinal fluid exposure, selectivity for pathological aggregated Tau.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><span style="font-size:10pt;font-style:italic;font-weight:bold;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">PI-2620</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">.</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">PI</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">-</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">2620 is the Tau-PET imaging agent discovered during the collaboration of AC Immune and LMI. We are working with our partner, LMI, to advance PI</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">-</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">2620 as a highly differentiated, best-in-class Tau diagnostic for AD as well as non-AD Tauopathies such as progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Results have demonstrated PI</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">-</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">2620&#8217;s differentiated characteristics as a diagnostic tool for studying Tau-related diseases. Results on the use of PI-2620 in AD patients from an investigator sponsored Phase 2 trial at the Asan Medical Center (NCT03903211) were presented at the 2022 AAIC. Following these, LMI moved PI-2620 into late-stage clinical development in AD and made a milestone payment.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;"> </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">The first Alzheimer&#8217;s patient in ADvance, the pivotal Phase 3 histopathology study in AD </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(NCT05641688) </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">was imaged in January 2023</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. </span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;"><span style="font-size:10pt;font-style:italic;font-weight:bold;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;background:#ffffff;">ACI-12589.&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Our next-generation a-syn PET imaging tracer, derived from our Morphomer platform, has shown significant potential to reliably detect and map deposits of pathological alpha-synuclein protein in the brain. Supported by the Michael J. Fox Foundation for Parkinson&#8217;s Research (MJFF), ACI-12589, our latest diagnostic imaging agent, completed a first-in-human study and an investigator-initiated study in 2022. The readouts of these trials in patients with PD, multiple system atrophy (MSA) and other synucleinopathies </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">were reported at the </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">AD/PD and AAIC 2022 conferences</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> These images provided the first clinical proof-of-concept for an a-syn PET tracer, as ACI-12589 clearly distinguished patients with MSA from those with other alpha-synucleinopathies and healthy controls</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. Moreover, our Morphomer platform is delivering additional candidates with improved binding properties and the potential to image a-syn pathology in patients with PD</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.</span></td></tr></table><div style="margin-top:8pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Expand product development into NeuroOrphan and additional neurodegenerative diseases</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Beyond AD, we are pursuing additional neurodegenerative diseases such as Parkinson&#8217;s disease (PD) and NeuroOrphan indications, specifically Tau-, a-syn- and TDP-43-driven diseases, such as FTLD-Tau (e.g., PSP, CBD, FTLD-MAPT), MSA, and ALS and FTLD-TDP, respectively. As part of this strategic move, AC Immune acquired certain a-syn assets from Affiris in 2021, gaining an advanced, clinical stage and validated a-syn vaccine candidate for development against PD in the process.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">60</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:169.8pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuing NeuroOrphan indications may enable us to obtain a streamlined regulatory approval pathway and favorable reimbursement for any approved products. In addition, we are accelerating our novel therapeutic and diagnostic candidates targeting a-syn as a primary pathology in Parkinson&#8217;s disease and other a-synucleinopathies. See below for a summary of our early-stage diversified novel targets pipeline including non-AD neurodegenerative diseases, with an in-house focus on NeuroOrphan indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 6: Robust novel targets pipeline: diversification into non-AD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">1</sup><b style="font-weight:bold;"> and non-CNS</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">2</sup><b style="font-weight:bold;"> diseases</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20221231x20f006.jpg" alt="Graphic" style="display:inline-block;height:169.8pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:479.5pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 12pt 0pt;">(1) Alzheimer&#8217;s disease; (2) Central nervous system; (3) Parkinson&#8217;s disease; (4) TAR DNA-binding protein 43; (5) Limbic-predominant age-related TDP-43 encephalopathy; (6) Positron emission tomography; (7) (NOD)-like receptor protein 3; (8) Apoptosis-associated speck-like protein containing a CARD, also PYCARD</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Accelerating the advancement of our diagnostic portfolio</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Early detection of neurodegenerative diseases may be critical to enhancing the effectiveness of both symptomatic and disease-modifying therapies. As a result, therapeutic development for AD increasingly focuses on treating early-stage disease to delay or prevent progression and to preserve the maximum amount of cognitive function before it is irreversibly lost. Most clinical studies now target mild or even preclinical stages of the disease increasing the need for accurate diagnosis that is independent of potentially subjective cognitive metrics. At least one study estimates that as many as one-third of patients in previous AD studies did not in fact have AD. Accurate and early diagnosis of AD is thus a substantial unmet market need, and diagnostic products will have a key role in generating a new treatment paradigm, including by selecting more uniform and stage-specific clinical study subjects, tracking patient progress and results, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">61</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:211.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">managing patients who are receiving treatment, and ultimately diagnosing disease at its earliest stage for immediate treatment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 7: The need for Precision Medicine in AD: improved clinical trials, diagnosis and treatment of neurodegenerative diseases</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f007.jpg" alt="Graphic" style="display:inline-block;height:211.3pt;left:0%;padding-bottom:0.2pt;position:relative;top:0pt;width:479.85pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) alpha-synuclein; (2) TAR DNA-binding protein 43; (3)&#160;Amyotrophic lateral sclerosis; (4)&#160;Limbic-predominant age-related TDP-43 encephalopathy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 3pt 0pt;">Refs: Attems <i style="font-style:italic;">et al.</i>, Newcastle University, AAIC 2017; Nelson et al. Brain. 2019 </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.28;margin:0pt 0pt 3pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are developing a suite of diagnostics designed to be first-in-class or best-in-class, which will enable improved diagnosis of pathologies, patient selection and assessment of clinical trial outcomes. We currently have four diagnostic programs in our pipeline, developed using our proprietary technology platforms and targeting the therapeutic targets: Tau, a-syn and TDP-43.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Leveraging our Morphomer platform, we are developing proprietary PET imaging diagnostics for diseases resulting from the misfolding of a-syn and TDP-43 proteins. No such diagnostics are currently available for these important pathologies and AC Immune has identified promising compounds with high affinity and target specificity, as well as favorable central nervous system (CNS) pharmacokinetic properties. In 2020, the a-syn-PET tracer won the Ken Griffin Alpha-synuclein Imaging Competition from MJFF. In 2022, the Company received a continuation grant from the MJFF for this tracer. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our novel TDP-43-PET tracer and our antibody-based immuno-assay for biofluid detection of TDP-43 also were awarded highly competitive grants from the EU Joint Programme&#160;&#8211; Neurodegenerative Disease Research&#8217; (JPND) in 2020, The Target ALS Foundation (Target ALS) in 2020 and 2022 and the MJFF in Q1 2023. Our diagnostics for a-syn and TDP-43, if validated clinically, could become the first in the world to effectively diagnose these proteinopathies, which are highly relevant for multiple neurodegenerative diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">4.</span></span><span style="font-style:italic;">Continuing to optimize our long-term growth by selectively partnering product candidates for global development and commercialization</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We have a strong track record of establishing value-driving collaboration agreements with leading pharmaceutical companies, including two collaborations with Genentech, one with Janssen and one with Lilly. This strategy allows us to leverage our partners&#8217; scientific, development, manufacturing and commercialization expertise and other resources while </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">62</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:162.02pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">partially monetizing our investments, de-risking and accelerating the development of our product candidates. This strategy also enables us to use non-dilutive partnership revenue to bolster our investment into our early-stage proprietary programs and fuel our continued growth. We have five current collaboration agreements with leading global pharmaceutical companies, summarized in the table below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 8: External validation and cash generation through external collaborations</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">1</sup></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f008.jpg" alt="Graphic" style="display:inline-block;height:161.27pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:474.5pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) Disclosure limited due to confidentiality agreements with collaboration partners; (2) In millions; (3) Positron emission tomography; (4) In Alzheimer&#8217;s disease; (5) Phase 1 completed; (6) Equity investment; (7) Converted to CHF on date of receipt; (8) Excludes convertible note agreement of USD 50 million</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For any additional product candidates targeting large markets, we may, if appropriate, selectively partner with leading companies that we believe can contribute development, manufacturing and marketing expertise, geographic reach and/or other resources that can enhance the value of our wholly-owned products. We will continue to seek to retain certain indications (e.g., NeuroOrphan) and/or geographies, such that we could begin to grow our own marketing capabilities as we develop AC Immune into a fully integrated pharmaceutical company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, in this respect, we established a strategic partnership with WuXi Biologics for its expertise in manufacturing biologicals in China and potential collaborations regarding AC Immune&#8217;s SupraAntigen platform.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">The benefits of our clinically-validated, proprietary technology platforms</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The engines that drive our growth are our two unique proprietary and versatile technology platforms: our SupraAntigen platform, which is our biological and immunological platform, and our Morphomer platform, which is our chemical platform. These platforms generate biologics (vaccines and antibodies) and small molecules, respectively, which are designed to selectively interact with the misfolded proteins that are common in a broad range of neurodegenerative diseases. These clinically-validated platforms form the basis of our ongoing pipeline development and the value-driving strategic partnerships we have established to date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The key aspect of both our SupraAntigen and Morphomer technology platforms is conformational specificity, which we believe is central to the development of effective and safe therapeutics for neurodegenerative diseases. Our SupraAntigen platform targets misfolded proteins through antigens displayed on the surface of liposomes, which mimic the targeted pathological form of the protein. In a complementary approach, our Morphomer platform uses small molecular weight compounds to target the aggregation and seeding process, which prevents the misfolded proteins from aggregating inside the cell and prevents the formation of new misfolded proteins in healthy neighboring cells through a seeding mechanism. Small molecules derived from our Morphomer platform, which we refer to as Morphomers, not only inhibit aggregation of pathological proteins, but also promote disaggregation of already formed aggregates, thereby potentially enhancing their therapeutic potential even in established disease states.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">63</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:185.19pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 9: SupraAntigen and Morphomer platforms: an integrated approach to CNS-specific therapies</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;"><img src="aciu-20221231x20f009.jpg" alt="Graphic" style="display:inline-block;height:185.19pt;width:474.78pt;" /></b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) Nanomolar; (2) Picomolar; (3) Central nervous system; (4)&#160;Blood-brain barrier; (5)&#160;alpha-synuclein; (6) TAR DNA-binding protein 43</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The SupraAntigen platform was first developed by AC Immune&#8217;s scientific co-founders to overcome a challenge common to neurodegenerative diseases: the lack of immunogenicity of disease-causing self-proteins. The SupraAntigen platform uses liposomes (small spherical vesicles formed by a lipid bilayer) to present specific antigens designed to evoke an immune response. SupraAntigen is used to generate conformation-specific antibodies for immunotherapy in neurodegenerative diseases. The overarching idea behind the platform is that antibodies, which are large in size, are well-suited to target extracellular proteins, interrupt spreading of pathological proteins, and break up and clear aggregates of misfolded proteins through phagocytosis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune has acquired advanced mastery of the design and manipulation of liposomes to develop either passive or active immunization techniques to generate antibodies targeting neurodegenerative diseases. When pursuing active immunization approaches, we use liposomes carrying a specific antigen as a vaccine. After vaccination with a liposome, antigen and confirmation-specific antibodies are produced naturally by the host with very high affinity without further optimization. This immune response can be long-lasting and may be ideal to prevent the onset of a disease, as the immune system is now primed to rapidly identify disease-causing misfolded proteins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Product candidates generated utilizing the SupraAntigen platform include vaccines (i) ACI-35.030, which has been selected for further development based on supporting data from the Phase 1b/2a in early AD, and (ii) ACI-24.060 ABATE Phase 1b/2, study in subjects with prodromal AD and subsequently in adults with DS. Additionally, antibodies include: crenezumab in Phase 2 for AD prevention and the preclinical candidates targeting a-syn and TDP-43 for PD and NeuroOrphan indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Morphomer platform is designed to enable the development of small molecules (Morphomers) able to bind/interact with beta-sheets containing fibrillary aggregates from candidate selection through preclinical proof-of-concept. Morphomers can target pathological protein aggregates in any brain compartment and are equally well suited for therapeutic and diagnostic applications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The first key component of the Morphomer platform is its library of rationally designed, CNS-optimized non-dye compounds. AC Immune&#8217;s extensive know-how has enabled the identification of CNS compounds that penetrate the brain and demonstrate high selectivity for the target. This knowledge has been used to focus the Morphomer library to approximately 15,000 compounds that display these favorable characteristics, making this library an ideal starting point when developing molecules to target human proteinopathies of the CNS. Thus, rather than using the non-directed trial and error strategy of the typical drug development process, the Morphomer platform utilizes its bias for successful CNS candidates to improve efficiency and accelerate the early stages of the drug development process. Extensive expertise in </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">64</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:210pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">medicinal chemistry and a suite of proprietary assays developed to screen and validate candidate compounds enables AC Immune to rapidly optimize multiple, highly diversified lead compounds for further preclinical and clinical development.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Therapeutic product candidates generated by the Morphomer platform include our Morphomer Tau candidates, including ACI-3024. We also have Morphomer a-syn candidates and the diagnostic programs PI-2620 in Phase 3 and Phase 1 in AD and PSP, respectively, and ACI-12589 in a Phase 1 clinical trial in PD, MSA and other synucleinopathies. Finally, we also have TDP-43-PET imaging agents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Shifting the current treatment paradigm for neurodegenerative diseases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Modifying the progression of the disease requires targeting the specific underlying biological processes that drive disease progression. Unfortunately, these processes evolve over the course of many&#160;years prior to manifestation of symptoms and a high&#160;percentage of neurons may be lost prior to clinical manifestation. Earlier intervention or prevention of the disease could have a major impact, but it requires accurate disease detection prior to developing symptoms. Due to recent advancement in biomarker research, people at risk of developing AD can be diagnosed 10-20&#160;years before symptoms occur, opening a completely new market segment for the prevention of NDD when active vaccination will play an important role. This early, and potentially preventative, Precision Medicine approach may ultimately lead to better disease management for patients with neurodegenerative diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 10: Vaccines as a new class of treatment for neurodegenerative diseases</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f010.jpg" alt="Graphic" style="display:inline-block;height:209.65pt;left:0%;padding-bottom:0.35pt;position:relative;top:0pt;width:482.3pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Given the inherent advantages of vaccines compared to monoclonal antibodies, we believe that our programs could have a profound global social and economic impact as a new class of therapy for neurogenerative diseases in various settings. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In regard to treatment, vaccines have potentially improved safety and efficacy profiles. By stimulating the patient&#8217;s own immune system to produce antibodies, we believe tolerability would be enhanced by avoiding the need to introduce repeated large doses of externally manufactured antibodies. Additionally, due to their ability to target multiple epitopes with a long-lasting and consistent immune response, the polyclonal antibody response generated by a vaccine permits covering multiple pathological species of the targeted protein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Vaccines are also much simpler to administer. They are amenable to convenient annual or biannual dosing whereas monoclonal antibodies require frequent intravenous infusions (up to twice per month). These dosing regimens position vaccines as an obvious solution for a maintenance therapy for patients who have previously achieved plaque clearance </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">65</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:164.2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">with antibodies. This approach will reduce the burden for infusion centers and enhance access to a broader patient population.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition to these advantages, vaccines allow for more simplified distribution logistics and cost-effectiveness. These factors are crucial to enable their global application as preventative therapies. Given the irreversible nature of neuronal damage, earlier intervention, even before symptoms become visible, promises to be the best strategy to preserve patient function and quality of life.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 11: Market opportunities targeting key primary and co-pathologies</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f011.jpg" alt="Graphic" style="display:inline-block;height:164.2pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:485.3pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(1) Alzheimer&#8217;s Association; (2)&#160;(NOD)-like receptor protein; (3)&#160;Apoptosis-associated speck-like protein containing a CARD, also PYCARD; (4)&#160;GBD 2016 Parkinson&#8217;s Disease Collaborators <i style="font-style:italic;">Lancet Neurology</i> 2018; (5) Limbic-predominant age-related TDP-43 encephalopathy; (6)&#160;Nelson et. al. <i style="font-style:italic;">Brain</i> 2019; (7)&#160;TAR DNA-binding protein43; (8)&#160;National Institute of Neurological Disorders and Stroke (NINDS) Progressive Supranuclear Palsy Fact Sheet; (9)&#160;NINDS Multiple System Atrophy Fact Sheer; (10)&#160;ALS Association <i style="font-style:italic;">Rare Disease </i>2013; (199) NINDS Amyotrophic Lateral Sclerosis Fact Sheer; (12) Knopman and Roberts <i style="font-style:italic;">J. Mol. Neurosci. </i>2011</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Due to the high level of co-pathologies involved in neurodegenerative diseases, future treatment paradigms may involve different combinations of disease modifiers at various stages of a disease. Therefore, combination therapies may include combinations of immunotherapies or combinations of small and large molecules targeting proteinopathies and neuroinflammation. Our therapeutic product candidates seek to modify the course of AD by intervening at an earlier stage of the disease progression, prior to irreversible neuronal damage. Beyond AD, we believe that we can leverage our proprietary platforms to generate and employ molecules that address the pathologies of other neurodegenerative diseases (See Figure above).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In support of shifting the current treatment paradigm from treatment to prevention, we are the leader in discovering new PET imaging agents to improve the timing and accuracy of diagnoses in neurodegenerative diseases. In our pipeline, we have three families of diagnostic candidates that were developed through our Morphomer platform, which target Tau, a-syn and TDP-43. We believe our Tau-PET imaging program has received external validation through our partnership with LMI, a leader in imaging agents, as well as from several investigator-sponsored trials. We are also developing a-syn and TDP-43 PET imaging agents for PD and other neurodegenerative diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">With our unique integrated approach focused on Precision Medicine, we believe that our diagnostic product candidate pipeline will complement our disease-modifying treatment product candidate pipeline and potentially reshape the clinical course and treatment of neurodegenerative diseases.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">66</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:207pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f012.jpg" alt="Graphic" style="display:inline-block;height:206.8pt;left:0%;padding-bottom:0.2pt;position:relative;top:0pt;width:485.25pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Our clinical programs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Anti-pTau vaccine</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In collaboration with Janssen, we are advancing the anti-pTau vaccine program with ACI-35.030 that is directed against a key component of the pathology of AD: phosphorylated Tau proteins, found in Tau tangles. Developed using our SupraAntigen technology, our vaccine is designed to stimulate a patient&#8217;s immune system to produce antibodies against misfolded and phosphorylated, pathological Tau protein, which aggregates to create the neurofibrillary tangles that characterize AD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Potential advantages of Tau vaccination over other therapeutic approaches</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-35.030 Tau vaccine, which is able to induce a long-lasting and boost-able antibody response, has the potential to be even more advantageous in some aspects than other anti-Tau therapeutic modalities such as small molecules or monoclonal antibodies, which typically show much shorter half-lives <i style="font-style:italic;">in vivo</i>, requiring more frequent administration. ACI-35.030 may thus offer a more cost effective and less burdensome approach for the treatment or prevention of Tau pathology, which may be particularly relevant for addressing slow-progressing chronic neurodegenerative Tauopathies such as AD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Clinical development</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ACI-35.030</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-35.030 is an optimized liposomal anti-pTau vaccine formulation designed to elicit antibodies against extracellular pTau protein in order to prevent and reduce the spread and development of Tau pathology within the brain. In preclinical studies, ACI-35.030 showed that it retains the excellent non-clinical safety profile and the highly specific antibody response against pTau observed with the initial formulation, ACI-35, while demonstrating an enhanced and more uniform antibody response. We are developing ACI-35.030 with Janssen in accordance with our collaboration agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Mechanism of action</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ACI-35.030 comprises a pTau peptide and a T-cell epitope capable of binding to human leukocyte antigen-major histocompatibility complex, class II (HLA-DR) molecules.</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">67</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:166.5pt;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In rhesus monkeys, ACI-35.030 induced IgG antibodies with a strong specificity towards the pTau peptide with a very low to absent binding to the non-pTau peptide (Figure 12). This is meaningful as Tau hyper-phosphorylation is considered an early event in the development of Tau pathology, occurring even several decades before the onset of Tau deposits.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt 0pt 8pt 36pt;"><b style="font-weight:bold;">Figure 12: pTau-specific IgG titers in Non-Human Primate (NHP) induced by ACI-35.030 and JACI-35.054</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f013.jpg" alt="Graphic" style="display:inline-block;height:166.5pt;width:320pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Kosco-Vilbois<i style="font-style:italic;">,</i> CTAD 2022</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Sera from rhesus monkeys immunized with ACI-35.030 binds specifically to pathological Tau in brain sections with AD as compared to healthy human brain tissue (Kosco-Vilbois, KOL event &#8216;Untangling&#8217; Tau Pathology to Treat Alzheimer&#8217;s and Neurodegenerative Diseases NYC, Nov 2019)</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Epitope mapping analyses revealed that immunization of NHPs with ACI-35.030 induces a wide range of antibodies covering the pTau antigenic sequence (Kosco-Vilbois, CTAD 2022).</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">JACI-35.054</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">JACI-35.054 is an alternative pTau vaccine, which is developed with Janssen in accordance with our collaboration agreement. In preclinical studies, JACI-35.054 showed good safety, and induced a strong antibody response against pTau. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Mechanism of action</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">JACI-35.054 is an alternative anti-pTau vaccine comprising a pTau peptide antigen conjugated to an immunogenic carrier protein CRM197, combined with adjuvants.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">CRM197 is a well-defined recombinant protein that is a commercially available version of a non-toxic mutant of diphtheria toxin (DT) A chain and has been shown to be a safe carrier protein in commercial prophylactic vaccines and clinical trials for a plethora of different vaccine candidates.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Immunization of rhesus macaques with JACI-35.054 induces antibodies that bind to pathological Tau structures in human AD brain, and bind similarly to pTau and non-pTau peptides (Figure 12).</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q4 2022, it was announced that, based on the Phase 1b/2a interim data, ACI-35.030 has been selected over JACI-35.054 for further development.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">68</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Clinical development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Phase 1b/2a study</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Phase 1b/2a study (NCT04445831) is a randomized, multicenter, double-blind, placebo-controlled clinical study with a primary objective to assess the safety, tolerability and immunogenicity of different dosages of ACI-35.030 and JACI-35.054 in participants with early AD. Secondary objectives assess additional immunogenicity parameters, while exploratory endpoints include notable biomarkers of progression of AD as well as clinical assessments. This Phase 1b/2a study evaluating ACI-35.030 and JACI-35.054 was initiated in Q3 2019 and is currently ongoing in Europe.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Safety</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The recruitment has been completed in the Phase 1b/2a study where 57 subjects have been randomized, of which 41 subjects have been randomized into the Cohort 1 (low-, mid-, or high- dose levels of ACI-35.030 or placebo), and 16 subjects have been randomized into the Cohort 2 (low- or mid-dose levels of JACI-35.054 or placebo). The active/placebo ratio is 3:1 in each Cohort. To-date, eight SAEs have been reported in 6 out of total 57 participants in this study. Two SAEs (injection site rash and dizziness occurring on one occasion) were considered probably/possibly related to the study vaccine. None of the other SAEs were considered to be possibly or probably related to the study vaccine. These SAEs were acute diverticulitis, flare of diverticular disease/diverticulitis, left calf pain due to thrombosed popliteal aneurysm, popliteal aneurysm (both popliteal aneurysms occurred in the same participant), sick sinus syndrome, and lumbar disc prolapse. These SAE were observed in cohort 1 where subjects are receiving either ACI-35.030 or placebo, except the case of lumbar disc prolapse that was observed in cohort 2 where subjects are receiving either JACI-35.054 or placebo.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Antibody response (interim)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Based on interim results from all three dose-level sub-cohorts, in all patients after the first injection ACI-35.030 treatment led to the strong induction of antibodies specific for pathological forms of Tau such as pTau and its aggregated form, ePHF (Figure 13). Anti-pTau IgG titers increased by two orders of magnitude from baseline two weeks after the first injection of the mid-dose of ACI-35.030 and boostable following additional dosing at weeks 8, 24 and 48. Anti-ePHF IgG titers increased by approximately one order of magnitude from baseline as early as two weeks after the second injection at week 8 of the mid-dose of ACI-35.030. The anti-ePHF IgG response was high and boostable following additional dosing at weeks 8, 24 and 48, with a sustained response up to week 74. In contrast, the anti-Tau IgG response decreased from week 2 onwards. Together these data indicate that ACI-35.030 preferentially targets pathological Tau species over non-pathological Tau. Immunization with ACI-35.030 showed class-switching from IgM to IgG. Interim safety data further support ACI-35.030&#8217;s favorable safety and tolerability profile.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">69</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:199.65pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Figure 13: </b><b style="font-weight:bold;">ACI-35.030: Potent antibody response with preference for pathological Tau</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fast, high, phospho-Tau-specific, and boostable antibody response</b><span style="font-size:11pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f014.jpg" alt="Graphic" style="display:inline-block;height:199.65pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:485.3pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt;">(1) phosphorylated Tau; (2)&#160;Enriched paired helical filaments; (3)&#160;at weeks 2 and 10; (4) at week 10</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:7pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Streffer<i style="font-style:italic;">,</i> CTAD 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">High responder rates were observed after the first, and all following vaccinations, across all dose levels. A 100% response rate for pTau was observed at the mid-dose at all time points measured. A higher responder rate on ePHF was observed for the mid-dose compared to the high dose at all time points measured.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Figure 14: Comparison of the anti-Tau and anti-ePHF IgG antibody response profiles to ACI-35.030 and JACI-35.054</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f015.jpg" alt="Graphic" style="display:inline-block;height:193.86pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:446.28pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt;">(1) ACI-35.030 original sub-cohort 1.2 data; (2) Enriched paired helical filaments; (3) phosphorylated Tau; (4) Alzheimer&#8217;s disease; (5) Antibody</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:7pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Streffer<i style="font-style:italic;">,</i> CTAD 2022</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">70</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:145.8pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As seen in the Figure above, the antibody response induced by ACI-35.030 mid-dose preferentially targets pathological Tau species (ePHF) over normal Tau, whereas the antibody response induced by JACI-35.054, a conjugate vaccine, targets both normal Tau and pathological Tau. ACI-35.030 induced anti-ePHF antibodies with longer apparent half-lives, less variability and lower peak-to-trough ratios than those induced by JACI-35.054. ACI-35.030 induced anti-ePHF antibodies in 100% of patients after 1st injection of ACI-35.030 compared to 50% with JACI-35.054.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Binding analyses show that the polyclonal antibodies induced by ACI-35.030 bind preferentially to pTau peptide without binding to the truncated C-terminal end of the peptide (see Figure below). In contrast, JACI-35.054 induces antibodies mostly binding to the very C-terminus of the peptide in a non-phospho specific manner. Together, these data indicate that the presentation of the B-cell peptide upon the surface of the liposomes in ACI-35.030 drives the antibody response towards pathological Tau species.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Figure 15: Mode of binding of antibodies induced by ACI-35.030 and JACI-35.054 towards pTau and Tau peptides</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f016.jpg" alt="Graphic" style="display:inline-block;height:145.8pt;width:428.65pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Streffer<i style="font-style:italic;">,</i> CTAD 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The polyclonal sera from 7/8 subjects immunized with either ACI-35.030 (mid-dose) or Placebo, and from 8/8 subjects immunized with JACI-35.054 (low dose) or Placebo, were analyzed for their binding profiles to the pTau or Tau peptide, either without or including 1 additional amino acid (1aa) onto the C-terminal end of the peptide.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ACI-24.060</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-24.060 derives from an original AC Immune anti-amyloid-beta vaccine, ACI-24, that was assessed in patients with AD and in subjects with DS. As ACI-24 was shown to be safe and well tolerated with preliminary evidence of immunogenicity and pharmacodynamic effects in these two study populations, the optimized version ACI-24.060 was created. ACI-24.060 contains additional Abeta unrelated T-helper cell epitopes and has demonstrated similar safety and tolerability in NHPs with superior immunogenicity in mouse and NHP studies as compared to the original ACI-24.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The aim of the vaccine is to stimulate the patient&#8217;s immune system to produce and maintain antibodies that bind and remove pathological Abeta with the goal to prevent plaque accumulation and enhance clearance of toxic Abeta species. The Company is pursuing clinical development of ACI-24.060 in early AD as well as the population of people living with DS exhibiting the presence of brain amyloid pathology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-24.060 is proprietarily owned.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">71</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:184.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Mechanism of Action</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ACI-24.060 consists of an immunogenic peptide (Pal1-15) containing the amino acid sequence 1-15 of the human Abeta1-42 protein, an antigenic peptide with Abeta unrelated T-helper cell epitopes and an adjuvant, formulated together as a liposomal suspension. In this formulation, the immunogenic peptide, Pal1-15, is presented to B cells of the immune cells on the surface of the liposomes in a conformational format mimicking the pathological form of the protein. This presentation optimally drives antigen-specific antibody responses that bind to the pathological forms of Abeta (i.e. oligomeric and pyroglutamate (pyroGlu) Abeta). The incorporation of the Abeta unrelated T-helper cell epitopes aims to prime, boost and maintain a strong anti-Abeta IgG response while preserving the well tolerated safety profile observed with the original formulation of ACI-24;</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In preclinical proof of concept studies in models of Abeta pathology, vaccination with the immunogen, Pal1-15 in the original ACI-24 formulation demonstrated anti-Abeta IgG titers with concomitant plaque reduction and restoration of memory; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In preclinical safety studies, vaccination of NHPs with ACI-24.060 led to the anticipated enhanced anti-Abeta IgG&#160;titers (as compared to ACI-24) while maintaining with boosting effect the favorable safety profile, confirming the suitability to add the Abeta-unrelated T-helper cell epitopes to the vaccine;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Furthermore, assessment of the kinetics and binding profile of the antibodies elicited by vaccination of NHPs with ACI-24.060 demonstrated enhanced antigen specific antibody titers with immunization as well as target binding to Abeta oligomers and pyroGlu Abeta (antibody titers against pyroGlu Abeta shown in the Figure 16);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Target engagement was confirmed </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">in situ</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> using sections from AD patients in which sera from the NHPs vaccinated with ACI-24.060 bound to the Abeta plaques while showing no reactivity to other tissues.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 16: Abeta1-42 and pyroGlu Abeta IgG titers in NHP vaccinated with ACI-24.060</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:11pt;"><img src="aciu-20221231x20f017.jpg" alt="Graphic" style="display:inline-block;height:184.5pt;width:365.18pt;" /></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref : Fiorini, AAIC 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ABATE Phase 1b/2</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">ABATE Phase 1b/2 study design</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The ABATE clinical study (NCT05462106) is a multicenter, adaptive, placebo-controlled, dose-escalation, double-blind, randomized study containing two parts.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">72</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:17.85pt;margin:0pt 14.45pt 12pt 0pt;"><i style="font-style:italic;">Study part 1:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Study part 1 is currently conducted in subjects with prodromal AD to assess the effect of study treatment (ACI-24.060 or placebo) administered over 48 weeks. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The study drug is being administered via intramuscular injections. Initially, a low dose of ACI-24.060 will be tested. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Randomized AD subjects receive five study drug injections (ACI-24.060 or placebo) at weeks 0, 4, 12, 24, and 48. For each study subject, the treatment period will be followed by a 26-week follow-up period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Up to four cohorts may be included in study part 1. Each cohort will differ from the others in terms of the dose per injection and/or the administration regimen with the possibility to expand any cohort at any time point to better understand antibody response and/or safety and tolerability. The initiation of randomization in the subsequent cohort(s) will be based on interim safety and tolerability data review from the previous cohort(s) and Data and Safety Monitoring Board (DSMB) approval. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Interim analyses will be conducted in each cohort at different predefined study time points.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Study part 1 is conducted in several centers located in the UK and Europe.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:17.85pt;margin:0pt 14.45pt 12pt 0pt;"><i style="font-style:italic;">Study part 2:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Study part 2 will be conducted in up to 80 non-demented adult subjects with DS and with confirmed presence of amyloid pathology by PET scan to assess the effect of study treatment (ACI-24.060 or placebo) administered over 74 weeks. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Randomized subjects with DS will receive their first five injections (ACI-24.060 or placebo) according to the same schedule administered in part 1, at weeks 0, 4, 12, 24, 48, plus an additional injection at week 74 in order to boost/maintain the response. For each study subject, the treatment period will be followed by a 26-week follow-up period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Randomization in study part 2 will be initiated with a dose of ACI-24.060 that has been shown to be immunogenic, safe and well tolerated in AD subjects. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The dose level of ACI-24.060 may need to be adjusted in the DS study population based on immunogenicity and safety/tolerability data. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Interim analyses may be conducted at different predefined study time points, during the treatment period and during the follow-up period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Study part 2 will be conducted in the UK, Europe and the U.S. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s CTA received approval from the UK MHRA in Q2 2022 and from the AEMPS in Q3 2022 to initiate development of the optimized formulation of ACI-24 in patients with prodromal AD and in adult subjects with DS with presence of brain amyloid pathology. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The first dosing in study part 1 occurred in Q2&#160;2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ACI-24 development in AD in DS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The AD pathology that commonly develops in people with DS bears remarkable similarities to familial and sporadic forms of AD and is characterized by a progressive accumulation of brain Abeta amyloid plaques leading to the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">73</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">appearance of AD-related cognitive decline and a modification of other relevant biomarkers. The Company is pioneering the development of its anti-amyloid-beta vaccine in AD patients and subjects with DS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Individuals with DS have an extra copy of chromosome 21, which is where the gene for amyloid precursor protein (APP) resides. These individuals develop AD at a rate that is three to five times that of the general population and develop the disease at a much younger age. At autopsy, AD pathology has been reported in 80% of people with DS over the age of 40 and 100% over the age of 60 years. The prevalence of AD in people with DS is more than 50% over the age of 50 and 75&#8211;100% over the age of 60 years (Strydom, 2018). It is estimated that there are six million people with DS worldwide, with 250,000 in the U.S.. Preclinical results published by AC Immune in collaboration with Dr. Mobley of the University of California, San Diego in March 2016, showed, in a DS mouse model (Ts65Dn), a significant 20% memory improvement and a 27% reduction of Abeta in the brain following vaccination with ACI-DS-01, the mouse equivalent of ACI-24.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ACI-7104.056&#160;&#8211; anti-a-syn vaccine</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Neurodegenerative conditions with a-syn accumulation, such as PD, are increasingly linked to dementia and movement disorders in the aging population.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-7104.056 is an optimized peptide-conjugate vaccine formulation designed to induce a-syn-specific antibodies recognizing aggregated a-syn species that have been demonstrated to be toxic to neurons. In contrast, ACI-7104.056-induced antibodies do not bind to the monomeric, physiological form of a-syn and do not cross-react with other members of the synuclein family such as beta- and gamma-synuclein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A substantial package of preclinical and clinical data has been generated with PD01 (predecessor of ACI-7104.056). This candidate was tested in two different transgenic mouse models of PD and Dementia with Lewy bodies (DLB), the mThy1- and the PDGF-human a-syn transgenic mice. Active vaccination with PD01 resulted in decreased a-syn pathology in brain areas most affected by transgene overexpression, including the substantia nigra and the striatum. This decrease was accompanied by a reduced neurodegeneration in both <i style="font-style:italic;">in vivo</i> models and by improvements in motor and memory deficits in the mThy1 and the PDGF-human a-syn transgenic mice, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">PD01 was the first vaccine candidate against pathological a-syn to be tested in a clinical study involving patients with early PD. A series of Phase 1 studies were completed in June&#160;2018. The start of the Phase 2 trial in early PD patients to evaluate ACI-7104.056 is scheduled to commence in H1 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Mechanism of action</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ACI-7104.056 comprises a short engineered antigenic a-syn peptide. This peptide coupled to a carrier protein facilitates the induction of an a-syn-specific antibody response that binds to toxic aggregated a-syn species with high selectivity (</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Mandler-M </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">et al</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">., Acta Neuropathol. 2014</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Vaccination of wild-type and transgenic mice, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">resulted in high antibody titres in plasma, which crossed into the cerebrospinal fluid (CSF) and recognized </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a-syn</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> aggregates. Vaccination resulted in a decreased aggregation and accumulation of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a-syn</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> oligomers in brains of transgenic animals (Mandler-M </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">et al</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">., Acta Neuropathol. 2014).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Clearance of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a-syn</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> was accompanied by reduced neurodegeneration in both </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">in vivo</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> models and by improvements in motor and memory deficits</span><span style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the mThy1 and the PDGF-human a-syn transgenic mice, respectively (Mandler-M </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">et al</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">., Acta Neuropathol. 2014).</span><span style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;"> </span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Clinical development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Phase 1 study design</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The safety, tolerability and immunogenicity of the ACI-7104.056 predecessor a-syn vaccine were studied over a three-and-a-half-year period in 24 early PD subjects and have been previously published (Volc<i style="font-style:italic;"> et al</i>., The Lancet </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">74</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:185.06pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Neurology 2020). There were four consecutive studies in this group of patients, with patients randomized to receive a lower or higher dose of the alpha synuclein vaccine. After four priming doses, subjects were re-randomized to receive a booster injection at one of the two doses, followed by a second booster injection at the high dose.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Safety</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This Phase 1 study series demonstrated a favorable long-term safety profile for PD01.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Antibody response</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">PD01 induced a long lasting and boostable antibody response (Figure 17, left). Such induced antibodies have been shown to bind preferentially the aggregated species of a-syn. The induced antibodies were also demonstrated to bind to a-syn aggregates in human PD and DLB brain tissue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Pharmacological and clinical effect</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Evidence for <i style="font-style:italic;">in vivo </i>target engagement and signals for clinical efficacy have been observed in these Phase 1 studies in PD, as immunization was associated with a decrease in oligomeric a-syn in CSF of treated patients and with a stabilization of clinical scores as shown by the MDS-UPDRS part 3 scores (Volc <i style="font-style:italic;">et al</i>., The Lancet Neurology, 2020). Post hoc analyses of this study series delivered highly encouraging data with respect to target engagement and identification of a potential biomarker for PD, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">I</i><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">n vivo </i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">target engagement of induced antibodies was demonstrated by lowering of oligomeric a-syn in CSF of vaccinated subjects (Figure 17, middle).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A highly significant correlation between oligomeric a-syn concentration in CSF and MDS-UPDRS 3 score (motor-symptoms) in PD patients at baseline was shown for the first time.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The reduction of oligomeric a-syn in CSF correlated significantly with clinical improvement, the changes in MDS-UPDRS 3 score over time (Figure 17, right)</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 17: Pharmacokinetic and pharmacodynamic effect of PD01 vaccination in early PD patients</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f018.jpg" alt="Graphic" style="display:inline-block;height:185.06pt;width:475.69pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(3) Data from 75 ug dose group; (4) Cerebrospinal fluid; (5) Change in oligomeric a-syn calculated at week 26, change in UPDRS III calculated at week 100; (6) Unified Parkinson&#8217;s Disease Rating Scale</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Volc <i style="font-style:italic;">et al</i>., Lancet Neurology, 2020</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">75</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:105.03pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These combined data provide a validation of the role of a-syn in disease progression and demonstrate that a-syn directed vaccination has the potential to positively impact clinical outcome. These data also provide an excellent basis for design of the planned Phase 2 study of ACI-7104.056.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Semorinemab</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Semorinemab is a humanized high-affinity IgG4 isotype antibody candidate that binds all forms of Tau. Semorinemab is designed to intercept extracellular Tau, stopping or slowing cell-to-cell spread and propagation of pathological Tau in the brain. Semorinemab is in Phase 2 clinical development for AD as part of an ongoing collaboration, which was established in 2012, with Genentech.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Lead characterization</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our anti-Tau monoclonal antibody program successfully generated multiple humanized antibodies for potential use as passive immunotherapies, which are highly specific for pathological forms of Tau found in AD and other Tauopathies. Results from preclinical studies demonstrated a reduction in pathological Tau and improvement of long-term spatial memory. Efficacy studies run in mouse models of AD and other Tauopathies exhibited dose&#8211;response alleviation of Tau pathology with behavioral improvements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 18: Alleviation of Tau pathology in models of AD</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20221231x20f019.jpg" alt="Graphic" style="display:inline-block;height:104.98pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:408.69pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 0pt 18pt;">Representative images of hippocampal coronal sections from human Tau-P301L transgenic mice treated with <b style="font-weight:bold;">(A)</b>&#160;control antibody or <b style="font-weight:bold;">(B)</b>&#160;semorinemab, and immunostained for pathological Tau deposits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Ayalon <i style="font-style:italic;">et al.,</i> Science Trans. Med., 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Clinical development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A Phase 1 clinical trial involving 75 subjects evaluated the safety, tolerability, pharmacokinetics and preliminary data on therapeutic activity of semorinemab in people with AD and in healthy volunteers. This trial was completed in the second quarter of 2017. Semorinemab was administered at single doses of up to 16,800 mg to healthy volunteers, and at multiple doses of 8,400 mg to healthy volunteers and patients with mild-to-moderate AD. No dose-limiting toxicities and no SAEs were observed. No participant withdrawals, modifications or interruptions due to an adverse event were reported. Results were presented at multiple conferences, including the 13<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> International Conference on Alzheimer&#8217;s&#160;&amp; Parkinson&#8217;s Diseases and Related Neurological Disorders (AD/PD) in 2017, the AAIC in 2017, and the 10<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> international CTAD conference in 2017.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Semorinemab exhibited a dose-proportional pharmacokinetic profile and CNS exposure, with a median half-life of 32.3&#160;days. Plasma total Tau concentration increased with increasing drug doses and was doubled in participants with AD compared with healthy volunteers, suggesting a pharmacodynamic signal as shown in the Figure below.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">76</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:106.53pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 19: Phase 1 pharmacokinetic and plasma Tau results</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20221231x20f020.jpg" alt="Graphic" style="display:inline-block;height:106.48pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:467.94pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Kerchner <i style="font-style:italic;">et al.,</i> CTAD 2017</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A Phase 2 clinical trial (Tauriel) commenced in Q4 2017 with the dosing of the first patient. This multicenter trial, which enrolled 457 participants, assessed the safety, tolerability and efficacy of semorinemab in people with prodromal-to-mild AD. Participants received one of three active doses or a placebo for 72 weeks, followed by a 96-week optional open-label extension (OLE). Primary endpoints included safety assessment and the composite functional and cognitive endpoint CDR-SB score.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In September 2020, the Company reported that Genentech informed us of top line results which showed that semorinemab did not meet its primary efficacy endpoint of reducing decline on CDR-SB compared to placebo. Two secondary endpoints, Alzheimer&#8217;s Disease Assessment Scale-Cognitive Subscale 13 (ADAS-Cog13) and Alzheimer&#8217;s Disease Cooperative Study Group&#160;&#8211; Activities of Daily Living Inventory (ADCS-ADL), were also not met. The primary safety endpoint was however met.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further analyses revealed a dose-dependent increase in serum pharmacokinetics and evidence of target engagement, measured by an increase in plasma Tau levels, which is consistent with previous Phase 1 study results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A second Phase 2 trial (Lauriet) was initiated in Q1 2019. This was a multicenter study enrolling 272 participants, and was designed to evaluate the clinical efficacy, safety, pharmacokinetics and pharmacodynamics of semorinemab in patients with moderate AD [Mini Mental State Examination (MMSE) 16&#8211;21, CDR-GS 1 or 2]. The study consisted of a screening period, a double-blind treatment period of 49 or 61 weeks, an optional OLE period, and a follow-up period, with the 11-item Alzheimer&#8217;s Disease Assessment Scale-cognitive subscale (ADAS-Cog11) and Alzheimer&#8217;s Disease Cooperative Study-Activities of Daily Living tools serving as the primary endpoints, and CDR-SB, MMSE and safety as secondary endpoints. Primary completion (last patient, last visit of the double-blind portion of the study) was in Q3 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In August 2021 the Company reported that Genentech had informed the Company that the Lauriet study had met one of its co-primary endpoints, ADAS-Cog 11. The second co-primary endpoint, ADCS-ADL, was not met. Safety data showed that semorinemab was well tolerated with an acceptable safety profile and no unanticipated safety signals. In November 2021, the Company reported that Genentech had presented the full top-line data from the Lauriet study during a late-breaking session at the 14<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Clinical Trials on Alzheimer&#8217;s Disease conference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">272 subjects were randomized into the study and 267 dosed. 49 study centers participated in the U.S., France, Spain and Poland. In a modified intent to treat (mITT) population of all trial participants who had received at least one dose of study drug and had at least one post-baseline ADAS-Cog 11 assessment, there was a 42.2% slowing of cognitive decline compared to placebo, the result being highly statistically significant (p=0.0008).</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">77</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:207pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 20: Positive effect of semorinemab on cognition assessed by ADAS-Cog11</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;width:18pt;"></span><img src="aciu-20221231x20f021.jpg" alt="Graphic" style="display:inline-block;height:206.45pt;left:0%;padding-bottom:0.55pt;position:relative;top:0pt;width:206.85pt;" /><span style="display:inline-block;width:9pt;"></span><img src="aciu-20221231x20f022.jpg" alt="Graphic" style="display:inline-block;height:204.75pt;width:192.7pt;" /><span style="display:inline-block;width:5.3pt;"></span><span style="display:inline-block;width:18pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Monteiro <i style="font-style:italic;">et al.</i>, CTAD 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effect on ADAS-Cog 11 was consistently seen at around the same magnitude in subgroup analyses looking at subjects with higher or lower baseline severity assessed by MMSE, brain Tau load assessed by GTP1-PET and different ApoE genotypes. The effect on ADAS-Cog11 was driven by an effect on memory items in the scale. No changes were apparent in the reported functional measures including the co-primary endpoint ADCS-ADL, and the secondary endpoint, CDR-SB, and there was no significant effect in the other secondary endpoint, the MMSE. The reason for the lack of functional effects is unclear. Regular interim analyses in the ongoing extension study are being made to test for later effects on function.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Plasma Tau rose markedly during the study confirming peripheral target engagement, with serum levels of semorinemab in the expected range. The ratio of CSF to plasma semorinemab concentration was 0.29%, in the expected range for similar monoclonal antibodies (Figure 21). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 21: Plasma pharmacodynamics from all patients of the Lauriet study</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f023.jpg" alt="Graphic" style="display:inline-block;height:174.54pt;width:375pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Schauer <i style="font-style:italic;">et al.</i>, CTAD 2022</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">78</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:295.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There was no apparent effect on global or regional brain Tau load assessed by GTP-1 PET. However, CSF biomarker data were presented by Genentech at CTAD 2022 (Figure 22) and showed statistically significant reduction in pTau181, pTau217 and total Tau, but not N-terminal Tau. These results were similar to those observed in the Tauriel study. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 22: CSF Tau pharmacodynamics pre- and post-treatment with semorinemab (at week 49 or week 61)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f024.jpg" alt="Graphic" style="display:inline-block;height:295.35pt;left:0%;padding-bottom:0.15pt;position:relative;top:0pt;width:480.95pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Schauer <i style="font-style:italic;">et al.</i>, CTAD 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Safety data indicated that semorinemab was well tolerated, with no difference in the frequency of serious or non-serious adverse events or discontinuations due to adverse events. Infusion related reactions were more common in the semorinemab group compared to placebo (10.4% vs 3.8%, respectively). None were Grade 3 or higher (i.e. severe) in intensity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Semorinemab&#8217;s results provide the first positive cognitive results for an anti-Tau mAb therapy in AD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Crenezumab</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Crenezumab is a humanized, conformation-specific monoclonal antibody that targets misfolded Abeta and has a broad binding profile. Crenezumab was developed using our proprietary SupraAntigen platform. In 2006, we licensed crenezumab to Genentech, a company with a long history of developing and commercializing innovative biologics.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Mechanism of action</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Crenezumab binds to multiple forms of Abeta, particularly oligomeric forms, which it binds to with ten times higher affinity than to monomers. This is a desirable property since oligomeric forms of Abeta are believed to be principally responsible for neurotoxicity in AD.</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">79</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Crenezumab localizes to brain regions rich in oligomers, including the halo around plaques and hippocampal mossy fibers, but not to vascular Abeta (Maloney </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">et al.</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, 2019).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Crenezumab was designed with an IgG4 backbone to reduce effector function on microglia compared with an IgG1 backbone, and to clear Abeta from the brain while limiting inflammation by minimizing Fc&#947;R-mediated inflammatory activation of microglia (Adolfsson </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">et al</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">., J. Neurosci 2012).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The potential for a better safety profile derived from a human IgG4 rather than a IgG1 backbone has been born out in practice by the safety findings from multiple Phase 1, 2 and 3 clinical studies of crenezumab, in which, following either single or multiple doses, no increase in ARIA-E was reported (Cummings et al., 2014 and Cummings et al., 2018).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Due to its capacity to bind to multiple forms of Abeta, with 10-fold higher specificity for oligomers, which are thought to be the most toxic species, crenezumab also protects against oligomer-induced neurotoxicity.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Linked to its unique epitope, crenezumab has been shown to promote disaggregation of existing Abeta aggregates and to disrupt their assembly, preventing amyloid plaque formation. The crystal structure reveals binding interactions that are consistent with this flexible binding profile and provides further explanation for crenezumab&#8217;s ability to block aggregation and to promote disaggregation. </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(Adolfsson </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">et al.</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, J. Neurosci 2012 and Ultsch </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">et al.</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, Sci. </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Rep.,2016).</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Summary of activity in patients with milder AD (MMSE 22&#8211;26) in Phase 2 clinical trials</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In the proof-of-concept Phase 2 studies of crenezumab, a positive trend in cognition was observed, with a greater effect on cognition in patients with a milder stage of AD (MMSE 22&#8211;26).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In the ABBY cognition study, there was a statistically significant 35% reduction in the rate of cognitive decline in the non-pre-specified milder AD patient population (MMSE 22&#8211;26) for the high-dose arm.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In the BLAZE biomarker study, the high-dose arm showed a consistent trend of reduced Abeta accumulation in the brain over time, as shown in two independent exploratory analyses of florbetapir-PET data. In addition, results have shown that crenezumab has the ability to enhance the removal of these proteins from the brain as evidenced by a significant increase in CSF Abeta, confirming target engagement by crenezumab.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Favorable safety profile allowing for higher dosing</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 2 data from ABBY and BLAZE studies suggested that there were no imbalances in overall rate of AEs, and these were not dose-related, with only one case of asymptomatic ARIA-E (0.4% in ABBY, 0.3% on active pooled) in patients treated with crenezumab. AEs also included inflammation of the throat and nasal passages, urinary tract infections and upper respiratory infections. However, no patients in the studies experienced SAEs that were believed related to the administration of crenezumab.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A Phase 1 study with higher doses of crenezumab up to 120 mg/kg showed good tolerability with no investigator assessed drug-related SAEs and no events of ARIA-E, supporting the dose of 60 mg/kg in the Phase 3 CREAD clinical trials.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The good safety profile and lack of induction of ARIA-E was confirmed in the Phase 3 CREAD and CREAD 2 studies, as well as the API prevention study in which there was no increase in incidence of SAEs compared with placebo.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As of 2019, two Phase 3 clinical trials, CREAD and CREAD 2, in patients with prodromal-to-mild AD were discontinued after an interim analysis of the CREAD study conducted by our collaboration partner Genentech (Ostrowitzki et al., JAMA Neurology 2022). Crenezumab has also been evaluated in a Phase 2 clinical </span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">80</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:142.52pt;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">prevention trial in Colombia, which has enrolled 252 cognitively healthy individuals of whom 169 are genetically predisposed to develop early AD.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Clinic</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Phase 2 studies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Phase 2 study design overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Crenezumab has been studied in two Phase 2 clinical studies, the ABBY proof-of-concept study and the BLAZE biomarker study. These two studies enrolled a total of 522 patients. The purpose of these studies was to investigate whether crenezumab could delay cognitive and functional decline and reduce the accumulation of brain amyloid in patients with mild-to-moderate AD. The sample size of the studies was not expected to have adequate power to detect a modest but clinically significant difference between active medication and placebo at the 5% significance level (as is commonly the case in Phase 2 studies in AD). Instead, consistent trends across different endpoints and dose dependencies were considered indicators of a response in this learning phase of development, with confirmation to then be sought in Phase 3. Both studies had two active arms: a low-dose arm receiving 300 mg subcutaneous injection, every 2 weeks and a higher-dose arm receiving 15 mg/kg intravenously every 4 weeks. The primary analysis was conducted at 73 weeks, after 68 weeks of treatment. Safety and tolerability measures included repeated MRI scans to assess for the development of ARIA, both vasogenic edema (E)&#160;and hemorrhages (H).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">ABBY study results</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the ABBY study, a positive trend in cognition was observed with a greater effect on cognition in patients with a milder stage of AD (MMSE 22&#8211;26), although the study did not meet its co-primary endpoints in patients with mild-to-moderate AD (MMSE 18&#8211;26). There was no significant change in cognition in patients who received low-dose subcutaneous crenezumab. Results of an exploratory analysis of the high-dose intravenous arm demonstrated that patients with the mildest cognitive impairment at screening (MMSE 22&#8211;26) showed a statistically significant 35% slowing of the rate of cognitive decline over 73 weeks. The effect became greater over time as shown by the increasing separation of the crenezumab (solid line) and placebo (dashed line) curves in the Figure below. The milder group was not pre-specified, meaning the group of patients with milder AD was not identified before commencing the Phase 2 clinical studies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 23: ABBY high-dose arm: Change in ADAS-Cog 12</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20221231x20f025.jpg" alt="Graphic" style="display:inline-block;height:141.92pt;left:0%;padding-bottom:0.6pt;position:relative;top:0pt;width:459.46pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Cummings <i style="font-style:italic;">et al.</i>, AAIC 2014</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">An exploratory subanalysis in a non-pre-specified subgroup of patients with milder symptoms (MMSE&#160;22&#8211;26) showed a 35.4% reduction in cognitive decline. The sample size of the study was not expected to have adequate power to detect a modest but clinically significant difference between active medication and placebo at the 5% significance level (as is commonly the case in Phase 2 studies in AD). Instead, consistent trends across different endpoints and dose </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">81</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">dependency are considered indicators of a response in this learning phase of development, with confirmation then sought in Phase&#160;3. In the pre-specified subgroup analysis in patients with mild AD (MMSE 20&#8211;26), treatment with high-dose intravenous crenezumab led to a 23.8% reduction in cognitive decline. In patients with mild-to-moderate AD (MMSE 18&#8211;26) treated with high-dose intravenous crenezumab, there was a 16.8% reduction in cognitive decline. Effect sizes and p-values for exploratory analyses were not adjusted for multiplicity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">BLAZE study design</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The BLAZE study was a randomized, double-blind, parallel-group, placebo-controlled study to evaluate the effects of crenezumab on brain amyloid burden as assessed by amyloid PET imaging and other biomarker endpoints in patients with mild-to-moderate AD. The primary endpoint was the change in brain amyloid load using florbetapir-PET. The terms &#8220;brain amyloid burden&#8221; and &#8220;brain amyloid load&#8221; refer to the total amount of amyloid deposited in the brain. In total, 91 patients were included in the study.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">BLAZE study results</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The primary endpoint of change in brain amyloid load by florbetapir-PET was not met, but the study was not powered to detect statistically significant results. However, positive trends were observed as shown below in exploratory analyses of the BLAZE amyloid PET results using a white matter reference region, which is considered a more sensitive approach for longitudinal studies. These analyses, conducted independently by two laboratories, the Banner Alzheimer&#8217;s Institute and MNI Laboratories, produced analogous results, with a trend in the reduction of Abeta accumulation observed in the high-dose arm. As described below, a similar result was obtained in the Phase 3 studies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The BLAZE biomarker study high-dose intravenous cohort showed a consistent trend of reduced Abeta accumulation in the brain over time as shown by two independent exploratory analyses of florbetapir-PET data. Using white matter rather than cerebellum as the key reference region in the brain is generally considered a more robust method of showing treatment effects of AD therapies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the BLAZE study, patients also showed a statistically significant increase in CSF Abeta<sub style="font-size:7.5pt;vertical-align:sub;">1&#8211;42</sub>, which we believe confirms target engagement by crenezumab. Similar results were observed in the ABBY study, which assessed CSF Abeta<sub style="font-size:7.5pt;vertical-align:sub;">1-42</sub> level in 49 patients. These results suggest that Abeta is being eliminated from the brain when treated with crenezumab.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The BLAZE study results suggest that Abeta is being eliminated from the brain as patients showed a statistically significant increase in CSF Abeta<sub style="font-size:7.5pt;vertical-align:sub;">1&#8211;42</sub>, which confirms target engagement by crenezumab.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Safety data from ABBY and BLAZE studies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Crenezumab demonstrated favorable safety and tolerability in Phase 2 clinical studies even at high doses. Crenezumab&#8217;s safety profile is especially reflected in a low incidence of ARIA-E (0.3%) in Phase 2 clinical studies. ARIA-E was observed in only one patient who received high-dose intravenous crenezumab in the ABBY study. No case of ARIA-E was reported in the placebo arm or the BLAZE study. Favorable pharmacokinetic properties coupled with a favorable safety and tolerability profile enables crenezumab to penetrate the brain more readily at therapeutically relevant doses. As dose-limiting toxicities are a potential reason for the failure of other antibodies to demonstrate efficacy, crenezumab&#8217;s potential safety at high doses is a distinguishing product feature.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At AAIC in 2014, it was reported that in the combined Phase 2 study populations, SAEs occurred at similar rates in patients treated with crenezumab (16.5%) and in patients given a placebo (11.9%).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Phase 1b study to explore higher doses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">To explore safety at higher doses, crenezumab was tested in a Phase 1b dose-escalation clinical study (NCT02353598) conducted in the U.S.. This randomized, placebo-controlled, double-blind, four parallel-arm study evaluated the safety and tolerability of at least four doses of intravenous crenezumab in 77 patients with mild-to-</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">82</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:213pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">moderate AD (MMSE 18&#8211;28) between the ages of 50 and 90&#160;years. An optional OLE stage was offered to patients after completion of the double-blind stage of the study. At the 2017 AAIC meeting, Genentech presented the results of the four cohorts with mild-to-moderate AD. No dose-limiting toxicities were observed at crenezumab doses of 30, 45, 60 and 120 mg/kg. No events of ARIA-E were observed and only few patients (6 of 75) showed asymptomatic ARIA-H. The pharmacokinetic profile of crenezumab was dose-proportional up to the 120 mg/kg dose, with the 60mg/kg dose being selected for the Phase 3 CREAD and CREAD 2 studies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Phase 2 AD prevention study</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There is increasing understanding from studies in patients at risk of AD due to genetic mutations that the accumulation of Abeta in the brain is a very early event in the condition, starting approximately 25&#160;years before symptoms develop (McDade <i style="font-style:italic;">et al.</i> 2018). To treat the underlying amyloid pathology effectively it may therefore be necessary to use anti-amyloid therapies in a preventive mode, starting in patients in whom symptoms have not yet emerged.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2012, crenezumab was independently selected from among 25 product candidates for use in the first-ever AD prevention study of its kind. The study, a collaboration worth USD 100 million between the NIH, Banner Alzheimer&#8217;s Institute and Genentech, is the cornerstone of the global Alzheimer&#8217;s Prevention Initiative (API). Family members usually develop symptoms before the 45&#160;years of age. 252 subjects were enrolled.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 24: Crenezumab AD prevention trial (Alzheimer&#8217;s Prevention Initiative AD/AD): unique population to study prevention treatment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20221231x20f026.jpg" alt="Graphic" style="display:inline-block;height:212.95pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:476.55pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) Mild cognitive impairment; (2)&#160;Alzheimer&#8217;s disease; (3)&#160;Presenilin-1</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: McDade et al., Neurology, 2018</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">169 carriers of the PSEN1 E280A mutation, who did not have mild cognitive impairment or dementia, were randomized to receive crenezumab (85 subjects) or placebo (84 subjects). A separate group of non-carriers (83 subjects) received a placebo. The mean age of the mutation carriers was 37 years old. This was approximately seven years before the median age for development of mild cognitive impairment. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Subjects were followed under treatment for 5-8 years, with the double-blind treatment continuing until the last subject received treatment for 5 years. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">83</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Primary endpoints were the annualized rate of change in the API autosomal dominant AD (ADAD) composite score and the Free and Cued Selective Reminding Test Cueing Index (FCRST). The latter scale was promoted to a coprimary endpoint after a blinded interim analysis had indicated less decline than expected on the composite endpoint.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Numerical differences favoring crenezumab were observed consistently across a wide range of clinical and biomarker endpoints. Plasma Abeta40 and Abeta42 rose throughout the study indicating peripheral target engagement. Only a small difference favoring crenezumab was observed in amyloid PET scan measures of fibrillary amyloid. Numerical differences favoring crenezumab compared to placebo were seen for clinical scales including both the two primary endpoints (i.e. API ADAD composite score, FCRST). Results did not reach statistical significance. However, the power to detect differences with statistical significance was low due to the lower and more variable rate of decline observed compared to that predicted at the start of the study. This effect may have been related to the younger and earlier stage of the condition in the subjects recruited compared to the population in the natural history study used to power the study.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Numerical changes favoring crenezumab were also seen for the secondary endpoints including time to MCI/dementia due to AD, CDR-SB, time to non-zero score on CDR Global Score and RBANS total score. Similarly, numerical differences favoring crenezumab were seen across all reported biomarkers including Tau and FDG measures, CSF biomarkers, including pTau 181 and t-Tau, NfL and plasma pTau 181, pTau217, NfL, GFAP, YKL-40 and sTREM2. Only plasma GFAP reached statistical significance (p=0.04, not corrected for multiplicity). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">The dose of crenezumab was raised seven-fold during the study in response to emerging data from Phase 2 that higher doses may be more effective. The initial dose of 300mg subcutaneously injected every two weeks was increased to a maximum dose of 60mg/kg injected intravenously once monthly. On average, subjects were exposed to intravenous dosing for less than half of the treatment period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Tolerability was good, with low rates of ARIA, no instances of ARIA-E and no macrohemorrhages. All mutation carriers may continue to receive crenezumab while the data are further analyzed. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Phase 3 studies (CREAD and CREAD 2)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The randomized, double-blind, placebo-controlled, parallel-group Phase 3 CREAD study enrolled about 750 participants with prodromal or mild AD at the age of 50&#8722;85&#160;years. A high dose of crenezumab (60 mg/kg) was administered intravenously once every 4 weeks for 100 weeks. The primary outcome measure was the change from baseline to week 105 in CDR-SB score. An exposure&#8211;response model to evaluate the best dose of crenezumab for the treatment of AD was established, which predicted an improved outcome of the Phase 3 CREAD study by using the higher dose of 60 mg/kg relative to the Phase 2 trials (Polhamus <i style="font-style:italic;">et al.</i>, CTAD 2016).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In January 2019, we announced that Roche, the parent company of our collaboration partner, is discontinuing the CREAD and CREAD 2 (BN29552 and BN29553) Phase 3 studies of crenezumab in people with prodromal-to-mild sporadic AD. The decision came after an interim analysis of the first CREAD study conducted by the IDMC, which indicated that crenezumab was unlikely to meet its primary endpoint of change from baseline in CDR-SB score.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As presented at CTAD 2019, target engagement was observed with increases in levels of Abeta<sub style="font-size:7.5pt;vertical-align:sub;">1&#8211;42</sub> in blood and CSF. As shown in the Figure below, the number of subjects available for analysis fell significantly after the baseline. Due to the early termination of the studies, data at the 2-year time point was only available for 17 of the 139 crenezumab subjects in whom CSF Abeta was analyzed at baseline.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">84</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:198.29pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 25: CSF total Abeta42 and total Abeta change from baseline, pooled CREAD/CREAD2 results</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f027.jpg" alt="Graphic" style="display:inline-block;height:194.75pt;left:0%;padding-bottom:0.25pt;position:relative;top:0pt;width:475.1pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Bittner <i style="font-style:italic;">et al.,</i> CTAD 2019</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Reduced accumulation of Abeta in the brain on florebetapir amyloid PET scans was observed, with a pattern very similar to that observed in the Phase 2 BLAZE studies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 26: [18F] Florbetapir amyloid PET standard uptake value ratio (SUVR) change from baseline, pooled CREAD/CREAD2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f028.jpg" alt="Graphic" style="display:inline-block;height:198.29pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:455.65pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Bittner <i style="font-style:italic;">et al.,</i> CTAD 2019</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A numerical trend to reduction in level of total Tau and phospho-Tau 181 (pTau181) in the CSF in patients on crenezumab compared with placebo was observed although the small numbers in the analysis due to early termination of the studies preclude firm conclusions from being drawn.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">85</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:205.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 27: CFS total Tau and pTau181 change from baseline, polled CREAD/CREAD2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f029.jpg" alt="Graphic" style="display:inline-block;height:185.2pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:442.42pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Bittner <i style="font-style:italic;">et al.,</i> CTAD 2019</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Positive trends on a range of biomarkers associated with AD in CSF including neurogranin, neurofilament light chain (NFL), Glial fibrillary acidic protein (GFAP), soluble Triggering receptor expressed on myeloid cells 2 (sTREM2), Chitinase-3-like protein 1(YKL-40) and a-syn were reported by Roche at the CTAD 2019 conference, although again the small numbers due to early termination of the studies limit interpretability of the results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 28: Exploratory biomarkers: Roche NeuroToolkit</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f030.jpg" alt="Graphic" style="display:inline-block;height:205.35pt;left:0%;padding-bottom:0.15pt;position:relative;top:0pt;width:446.13pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Bittner <i style="font-style:italic;">et al.,</i> CTAD 2019</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Safety in the CREAD and CREAD 2 studies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The decision to terminate the CREAD and CREAD 2 was not related to safety. No safety signals for crenezumab were observed in this analysis and the overall safety profile was similar to that seen in previous trials. There was no </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">86</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">difference in the rate of newly developing ARIA-E (0.3%) between the active and placebo arms and the rates of ARIA-H were also similar (8.8% on crenezumab vs 6.8% on placebo).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Morphomer Tau</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Approximately 2,200 compounds have been screened thus far for the Morphomer Tau program. This has allowed for the identification of several chemical series of orally bioavailable small molecules with suitable CNS properties. The lead compounds displayed selectivity for binding to pathological Tau aggregates in preference to other protein aggregates. In addition, the lead compounds were able to prevent Tau aggregation and promote its disaggregation. Further characterization using multiple orthogonal <i style="font-style:italic;">in vitro</i>, <i style="font-style:italic;">ex vivo</i> and <i style="font-style:italic;">in vivo</i> tests addressing pharmacology absorption, distribution, metabolism, and excretion (ADME), and safety properties led to the identification of the first clinical candidate ACI-3024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ACI-3024</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-3024 is a potent Tau aggregation inhibitor active against the 3R and 4R human Tau isoforms as well as the mutant forms associated with human Tauopathies, such as FTLD-Tau (e.g., PSP, Pick&#8217;s disease, corticobasal degeneration). ACI-3024 selectively binds to aggregated Tau and does not bind to the monomeric forms of Tau. Moreover, the binding to Tau aggregates is selective, with no cross-reactivity to aggregates of Abeta and a-syn.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-3024 showed a potent and dose-dependent reduction in spontaneous intracellular Tau aggregation and misfolding as measured by immunocytochemistry in human neuronal-like cells over-expressing Tau. Furthermore, ACI-3024 promoted <i style="font-style:italic;">ex vivo</i> disaggregation of Tau neurofibrillary tangles on human AD brain sections.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The <i style="font-style:italic;">in vivo</i> efficacy of ACI-3024 was evaluated in the Tg4510 mouse model (Ramsden <i style="font-style:italic;">et al.</i>, 2005). <i style="font-style:italic;">In vivo</i> treatment of Tg4510 transgenic mice with ACI-3024 reduced aggregated and insoluble hyper-phosphorylated Tau. Immunohistochemistry analysis of misfolded Tau using an MC1 antibody in Tg4510 brain sections of the same mice treated with ACI-3024 showed reduction of misfolded Tau. These effects were proportional to the plasma concentration of ACI-3024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Total Tau concentration in cerebrospinal fluid (CSF) was inversely correlated with ACI-3024 exposure in plasma, suggesting the possibility of exploring CSF Tau concentrations as a biomarker of target engagement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Preclinical safety</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-3024 has a good <i style="font-style:italic;">in vitro</i> and <i style="font-style:italic;">in vivo</i> ADME profile, including low clearance, long half-life and good CNS disposition as assessed by brain and CSF concentrations. ACI-3024 was negative in <i style="font-style:italic;">in vitro</i> and <i style="font-style:italic;">in vivo</i> genotoxicity assays [Ames, micronucleus test (MNT) and mouse lymphoma cell mutagenesis (MLY)] and has undergone an extensive toxicology and safety pharmacology assessment. The no observed adverse effect level has been established at 300 mg/kg in rodent and at 450 mg/kg in non-rodent animals after 4 weeks of treatment (Poli, CTAD 2018).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Effect on neuroinflammation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-3024 efficacy on pathological Tau-induced neuroinflammation was assessed <i style="font-style:italic;">in vitro</i> and <i style="font-style:italic;">in vivo</i>. <i style="font-style:italic;">In vitro</i>, ACI-3024 induced a potent reduction of Tau-induced neuroinflammation markers. <i style="font-style:italic;">In vivo,</i> in Tg4510 mice, treatment with ACI-3024 overall reduced microgliosis, most likely as a downstream consequence of reducing Tau pathology, by reducing the derived pathological Tau-induced microglial activation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">87</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Clinical development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 36pt;">Phase 1 study</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This Phase 1 study was a first-in-human (FiH), randomized, placebo-controlled, double-blind, sequential single and multiple ascending dose study. The study assessed the safety, tolerability, pharmacokinetics, and pharmacodynamics of ACI-3024. Part&#160;I included five single ascending doses in healthy volunteers, with a food effect assessment in the fourth dose cohort. In Part&#160;II, three escalating multiple dose regimens were evaluated; regimen two was assessed in different populations of healthy volunteers. CSF samples were collected from the highest multiple dose group.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The study was executed as planned and all single and multiple dosing regimens were completed in healthy young, elderly, and Japanese subjects. ACI-3024 was administered following single or multiple oral doses and dose-dependent plasma exposure was observed. ACI-3024 showed a long half-life (47.5 to 101 h), with steady state reached after 12-13&#160;days. Low renal clearance was shown. After multiple doses, ACI-3024 concentrations in CSF exceeded target concentrations based on animal studies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-3024 will not be further developed under the collaboration and the Companies have decided to pursue other promising Tau Morphomer candidates from AC Immune&#8217;s research platform for potential clinical development in AD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Tau diagnostics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The severity of cognitive impairment in patients with AD is correlated with the presence of Tau protein tangles, leading us to believe that an imaging agent for Tau is equally, if not more important than Abeta-PET to assess spreading of pathology in the brain. In May&#160;2020, Eli Lilly received FDA approval for the first Tau-PET tracer TAUVID (flortaucipir F18 injection). However, TAUVID received approval only for a pathology indication (i.e., correlation with histopathology findings in Braak 5 and 6 patients), but has not received a prognostic label (i.e., prediction of cognitive deterioration based on a positive Tau-PET scan.)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our Tau-PET tracers are designed to bind specifically to the pathological forms of human Tau in AD and other Tauopathies. They have demonstrated an excellent PET tracer profile with their ability to cross the blood brain barrier and a high selectivity to pathological Tau even in the early-stage disease.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May 2014, we established a license and collaboration agreement for our Tau-PET imaging program with LMI. The Phase 1 clinical study of our clinical candidate PI-2620 in AD was completed in Q1 2018. The Phase 2 longitudinal study in AD in South Korea (Asan Medical Center, NCT03903211) was completed in Q4 2021 and results presented at AAIC 2022. The pivotal ADvance Phase 3 histopathology study in AD (NCT05641688) was initiated in December with FPFV in December 2022. The first Alzheimer&#8217;s patient was imaged with PI-2620 scan in January 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">PI-2620 is selective for Tau over Abeta and other &#8220;off-target&#8221; binding compared with current published Tau-PET agents in development, as no binding to Abeta <i style="font-style:italic;">in vivo </i>and no &#8220;off-target&#8221; retention in basal ganglia or choroid plexus was observed. In addition, PI-2620 was shown to be suitable for measuring longitudinal Tau accumulation. A major differentiator for PI-2620 is its ability to bind 4-repeat (4R) Tau isoforms, which are present in varying amounts in different neurodegenerative diseases. Most Tau-PET tracers in development are not able to bind 4R Tau and are of limited use for certain diseases driven by these Tau species.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Tau PET tracer <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 was included into a sub-study of the MissionAD trial of elenbecestat to evaluate Tau deposition in amyloid-beta positive subjects with a diagnosis of mild cognitive impairment (MCI) due to AD or mild AD dementia. The findings support the hypothesis that <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 PET imaging of neuropathologic Tau deposits may reflect underlying neurodegeneration in AD. Significant correlations were observed with hippocampal volume and CSF biomarkers, and an association between Tau and Abeta load. Quantifiable increases in <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 PET SUVR over 1 year were observed in regions with early Tau deposition and the results are consistent with the hypothesis that cortical Tau is associated with cognitive impairment. This study supports the utility of <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 PET to assess Tau load in an early AD population. Quantifiable Tau load and its corresponding increase in early AD could be a relevant target engagement marker of anti-Tau but also anti-amyloid clinical trials.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">88</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:246pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 29: PI-2620 &#8211; Ability to detect Tau deposits in an early AD population</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f031.jpg" alt="Graphic" style="display:inline-block;height:245.35pt;left:0%;padding-bottom:0.65pt;position:relative;top:0pt;width:393.15pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Bullich <i style="font-style:italic;">et al.</i>, Alzheimer&#39;s Research &amp; Therapy, 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Figure 29 shows <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 SUVR PET images (scalp stripped) registered to the T1-weighted MRI illustrating the tracer distribution in a Tau negative subject (upper row), a Tau-positive subject with uptake in the mesial temporal cortex (center row), and a Tau-positive subject with extensive neocortical uptake (bottom row).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A recent study (Malarte <i style="font-style:italic;">et al.</i>, Mol. Psychiatry, 2022) showed that <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup>H-PI-2620 has comparable binding affinity in AD, CBD and PSP brain tissue, although the binding site density can vary between these pathologies in the order: AD &gt; CBD &gt; PSP. Competitive binding studies indicate that PI-2620 can detect multiple binding sites in AD, CBD and PSP brain tissue. Importantly, in CBD and PSP brains, PI-2620 displayed high specificity which was not observed with other tracers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Franzmeier <i style="font-style:italic;">et al.</i> (Nat. Communications, 2022) compared <i style="font-style:italic;">in vivo </i>Tau-PET analyses to independent post-mortem samples thereby providing further evidence that PI-2620 binds to 4R Tau. This study demonstrated a close link between 4R Tau deposition patterns and connectivity supporting the concept of trans-neuronal Tau spreading in 4R Tauopathies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Tau diagnostics are a major market opportunity that will be driven by the growth in the aging population and the testing and availability of disease-modifying drugs. We believe a best-in-class Tau tracer has the potential to achieve a substantial global market share in this large and growing market, which includes AD as well as other important Tauopathies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">A-syn diagnostics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are also developing PET imaging agents to detect a-syn, which progressively accumulates in the brains of PD patients and is believed to be central to the neurodegenerative process of PD, as well as several other disorders, including Lewy body dementia and MSA, making it a priority target for development of therapeutics and diagnostics. We have identified molecules leveraging our Morphomer technology that selectively bind to a-syn pathological structures from human PD brain with affinity in the low-nanomolar range.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">89</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:180.7pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the same timeframe, we have also initiated the clinical development of our third-generation candidate, ACI-12589. ACI-12589 is the first molecule capable to detect pathological a-syn in the brain of patient with MSA and to differentiate those from controls, other synucleinopathies and more generally other neurodegenerative diseases (Figure 30). Additionally, ACI-12589 showed some signal retention in familial PD cases in brain areas compatible with the expected distribution of pathological a-syn. The preclinical and clinical data obtained within the program were presented at AD/PD 2022 and AAIC 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The FiH clinical evaluation of ACI-12589 in PD, MSA and other a-synucleinopathies was completed in 2022. In preparation to further steps in clinical development, in Q4 2022 a dosimetry study in healthy volunteers was completed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 30: ACI-12589 PET signal in patients with MSA compared to controls</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20221231x20f032.jpg" alt="Graphic" style="display:inline-block;height:180.7pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:208.3pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Capotosti, AAIC 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Currently there are no imaging products in the market that target a-syn. This provides us with the opportunity to become the market leader in a-syn PET imaging. We believe the ability to image a-syn deposits in the brain will enable a fundamental change in the approach toward diagnosing and treating a-syn-associated diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2020, the Company&#8217;s a-syn-PET tracer won the Ken Griffin Alpha-synuclein Imaging Competition from the MJFF. In 2022, the Company received a continuation grant from the MJFF.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Our preclinical programs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Using our SupraAntigen and Morphomer platforms, we have generated additional discovery and preclinical stage molecules targeting key pathologies that drive a range of neurodegenerative diseases, including TDP-43, a-syn, and NLRP3. We are accelerating the development of several therapeutic product candidates currently in preclinical development, including several programs focused on indications outside of AD as a critical part of our expansion strategy.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">90</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:205.52pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 31: Key pathologies for further pipeline expansion</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f033.jpg" alt="Graphic" style="display:inline-block;height:205.47pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:449.94pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(1) Frontotemporal lobar degeneration; (2)&#160;Amyotrophic lateral sclerosis; (3)&#160;Limbic-predominant age-related TDP-43 encephalopathy; (4)&#160;TAR DNA-binding protein 43; (5)&#160;alpha-synuclein; (6)&#160;NOD-like receptor protein 3</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Based on the data to date, our technology platforms can be applied to misfolded proteins across a broad range of indications. See our novel targets pipeline above at Figure 6.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:20%;margin:0pt;padding:1.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:19.99%;margin:0pt;padding:1.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:19.99%;margin:0pt;padding:1.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:19.99%;margin:0pt;padding:1.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:19.99%;margin:0pt;padding:1.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">A-syn antibody</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The a-syn antibodies generated using our SupraAntigen platform have unique binding properties allowing them to bind preferentially to the pathological forms of a-syn. Leveraging the wide collection of anti-a-syn antibodies generated with diverse binding epitopes and sub-nM binding affinities to aggregated a-syn, new immunoassays are being developed for the detection of pathological a-syn in biofluids. A-syn aggregation and spreading are established targets for PD, MSA and other synucleinopathies. Antibodies that interfere with the aggregation and spreading mechanisms of a-syn provide a therapeutic option for the treatment of PD. The a-syn antibodies were able to significantly delay the seeded aggregation of pathological a-syn in an <i style="font-style:italic;">in vitro</i> aggregation assay, and were able to significantly decrease pathological a-syn spreading in an <i style="font-style:italic;">in vivo</i> animal model of PD. Characterization using multiple orthogonal <i style="font-style:italic;">in vitro</i> and <i style="font-style:italic;">in vivo</i> tests addressing binding, specificity, functionality and pharmacological properties has led to the identification of the lead candidate ACI-5755.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Lead characterization</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-5755 selectively binds to pathological forms of a-syn with low-nanomolar affinity and shows a significant preference over monomeric a-syn. Additionally, ACI-5755 shows strong recognition for pathological a-syn in patient-derived tissues in both PD and MSA. ACI-5755 showed a potent and dose-dependent reduction in the seeding capacity of pathological a-syn in a proprietary <i style="font-style:italic;">in vitro</i> aggregation assay. Moreover, ACI-5755 substantially reduced the propagation of a-syn aggregates in a cell-based model. The <i style="font-style:italic;">in vivo</i> efficacy of ACI-5755 was evaluated in the M83 propagation mouse model (Luk <i style="font-style:italic;">et al</i>., 2012). Treatment of mice with ACI-5755 significantly decreased pathological a-syn spreading <i style="font-style:italic;">in vivo</i>. Furthermore, a significant reduction in the rate of body weight loss compared with the vehicle-treated control group was observed for mice treated with ACI-5755.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">91</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Morphomer a-syn</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Leveraging our Morphomer platform, we discovered and characterized the first biologically active small molecule inhibitors targeting intracellular a-syn aggregates. Identified compounds, from several distinct chemical series, which significantly decrease a-syn aggregate accumulation in neurons by interfering with the seeding and fibrillation processes. Iterative medicinal chemistry optimization led to the identification of orally available compounds with favorable CNS-penetrant pharmacokinetic properties, which progressed into <i style="font-style:italic;">in vivo</i> proof-of-concept study in an animal model of alpha-synucleinopathies. Treatment with hit compound resulted in significant, dose-dependent decrease of pathological a-syn aggregates <i style="font-style:italic;">in vivo</i>, Medicinal chemistry efforts will continue on improving properties of lead chemical series, in parallel to identifying structurally diverse compounds fulfilling the target product profile.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2021, the Company received a grant from the MJFF to fund the optimization of the current compound series and declare a preclinical lead, which commenced in Q1 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">TDP-43 antibody</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">TDP-43 is a recently identified target of growing interest for NeuroOrphan indications such as frontotemporal dementia (FTD) and ALS. Interestingly, TDP-43 also plays an important role in other significant neurodegenerative indications such as AD or LATE.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Anti-TDP-43 antibodies binding to various regions of TDP-43 were generated by our SupraAntigen platform. A subset displayed conformational selectivity to misfolded TDP-43, while others recognized all TDP-43 isoforms (Figure 32A). Multiple antibodies were generated and characterized <i style="font-style:italic;">in vitro</i>, from which two pan-TDP-43 antibodies (ACI-5891 and ACI-5886) were selected for the evaluation of their efficacy in mitigating TDP-43 aggregation <i style="font-style:italic;">in vitro</i> and <i style="font-style:italic;">in vivo </i>(Figure 32B-C). ACI-5891 showed a high binding affinity for TDP-43 and ability to reduce TDP-43 aggregation <i style="font-style:italic;">in vitro and in vivo</i>. ACI-5891 was successfully humanized and clinical lead selected (ACI-5891.9). The lead molecule shows excellent pharmacokinetics in non-human primates and good developability profile.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Lead characterization</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To evaluate the functional efficacy of TDP-43 antibodies <i style="font-style:italic;">in vitro</i>, the ability of ACI-5891 to inhibit TDP-43 aggregation was tested. In an <i style="font-style:italic;">in vitro</i> assay with recombinant TDP-43, ACI-5891 significantly inhibited TDP-43 aggregation by 98% compared with the isotype control and significantly promoted their phagocytosis by mouse primary and ALS patient-derived microglia. Using FTLD-TDP patient-derived brain extracts to induce templated TDP-43 aggregation <i style="font-style:italic;">in vitro</i>, ACI-5891, which binds to the C-terminal domain of TDP-43, was able to substantially interfere with this process of seeding (Figure 32B). Moreover, ACI-5891 demonstrated functional efficacy <i style="font-style:italic;">in vivo</i> by reducing pathological TDP-43 in two different mouse models of ALS and FTD (Figure 32C). Importantly, these beneficial effects are achieved while preserving physiological TDP-43 activity. Our findings demonstrate, for the first time, that a monoclonal antibody targeting the C-terminal region of TDP-43 limits pathology and neurotoxicity by enabling clearance of misfolded TDP-43 through microglia engagement and support the clinical strategy to target TDP-43 by passive immunotherapy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Clinical lead declaration and initiation of IND-enabling studies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-5891 was successfully humanized on a human antibody framework. Several variants had a similar binding capacity for TDP-43 while retaining the potency for inhibition of TDP-43 aggregation as compared to the chimeric monoclonal antibody. The target values were achieved for the lead candidates in terms of target affinity, functional efficacy, and&#160;percentage humanness. These variants were then evaluated for pharmacokinetics in non-human primates. The selected clinical lead (ACI-5891.9) shows excellent pharmacokinetics in non-human primates. Developability of clinical lead candidates was further confirmed in manufacturability assessment studies. Dose-range finding study to evaluate safety of clinical lead in non-human primates is ongoing.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">92</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:249.01pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">TDP-43 antibody-based biofluid assay</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Since the levels of TDP-43 are low in biofluids, a real-time quaking-induced conversion (RT-QuIC) assay was developed for the detection of pathological TDP-43 seeds. Using this assay, the presence of seeding-competent TDP-43 species was confirmed in CSF of sporadic ALS donors compared to healthy controls. In addition, to evaluate target engagement of the clinical lead in vivo, novel assays to measure free TDP-43 in biofluids were established using SIMOA technology. The assay allows the measurement of free TDP-43 in serum and CSF from animals dosed with the clinical lead.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 32: Key results for TDP-43 antibodies program</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f034.jpg" alt="Graphic" style="display:inline-block;height:248.96pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:274.46pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Afroz, AD/PD 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Neuroinflammation and the NLRP3-ASC inflammasome pathway</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Microglial cells are the main resident immune cells in the brain, which maintain a healthy environment by removing damaged cells and misfolded protein aggregates. When overstimulated, microglia can drive neuroinflammation, leading to increased neuronal death and disease progression. A key molecular pathway that is activated by misfolded proteins related to neurodegenerative and other diseases, is the NLRP3 inflammasome, a multi-protein complex that forms within microglia leading to production of pro-inflammatory factors that exacerbate neuronal atrophy. A critical component of the NLRP3 pathway is ASC (apoptosis-associated speck-like protein containing a C-terminal caspase recruitment domain), which is formed and released by activated microglia. Intracellularly, ASC specks participate in the production of pro-inflammatory cytokines, whereas extracellular ASC specks cause acute inflammatory reactions. ASC specks have been identified in microglia within the CNS of patients with NDD (Venegas, 2017) as well as patients&#8217; body fluids.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As illustrated in Figure 33, pathological species of Abeta, Tau, a-syn and TDP-43 induce NLRP3 inflammasome activation and ASC speck formation. AC Immune is developing multiple small molecule and antibody-based candidates with the potential to inhibit the NLRP3 pathway. Recent <i style="font-style:italic;">in vitro</i> studies and <i style="font-style:italic;">in vivo</i> experiments in animal models of AD, PD and ALS have validated this approach.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">93</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:251.21pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 33: Proteinopathies exacerbate NLRP3-driven neuronal damage and promote further neurodegeneration</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f035.jpg" alt="Graphic" style="display:inline-block;height:251.21pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:449.94pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) Amyotrophic lateral sclerosis; (2)&#160;Frontotemporal lobar dementia; (3)&#160;TAR DNA-binding protein 43; (4)&#160;NOD-like receptor protein 3; (5)&#160;Apoptosis-associated speck-like protein containing a CARD, also PYCARD; (6)&#160;Neurofibrillary tangle</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Targeting NLRP3-ASC in neurodegenerative diseases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In AD, Abeta peptides, which accumulate to form the characteristic plaques in AD activate the NLRP3 inflammasome (Halle, 2008). The downstream pro-inflammatory factors, IL-1b and IL-18, are increased in cells isolated in these patients (Saresella, 2016). Further validation of these targets in AD involve crossing NLRP3 or ASC knockout mice to models of Abeta-driven pathology. In these models, neuroinflammation decreased and neuronal and memory function improved (Heneka, 2013; Demspey, 2017; Venegas, 2017). Recently, ASC speck and IL-18 levels were shown to be higher in human Mild Cognitive Impairment (MCI) and AD brain samples indicating that ASC is a promising biomarker of MCI and AD (Scott, 2020).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Parkinson&#8217;s disease, NLRP3 is activated and ASC formation is upregulated (Gordon, 2018 and Anderson, 2021). Exome sequencing analysis identified multiple single-nucleotide polymorphisms of NLRP3 including rs7525979, which was associated with a significantly reduced risk of developing PD (von Herrmann, 2018). In vitro, NLRP3 inhibition decreases a-syn-mediated inflammasome activation in mouse microglial cells and extracellular ASC release. In multiple PD animal models, targeting NLRP3 effectively mitigates motor deficits, nigrostriatal dopaminergic degeneration and accumulation of a-syn aggregates (Gordon 2018). Taken together, NLRP3 is responsible for driving neuroinflammation that results in progressive dopaminergic neuropathology, highlighting NLRP3 as a potential target for PD disease-modifying treatments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As illustrated in Figure 33, extracellular Tau activates NLRP3 and ASC formation in microglia. In patients with frontotemporal dementia, elevated cleavage of caspase-1, increased ASC levels and mature IL-1b are observed (Ising, 2019). Furthermore, in preclinical models, injection of fibrillar Abeta induces Tau pathology in an NLRP3-dependent manner (Ising, 2019) and the absence of ASC or inhibition of NLRP3 decreases seeding by Tau <i style="font-style:italic;">in vivo</i> and <i style="font-style:italic;">in vitro</i> (Stancu, 2019). Finally, NLRP3 inhibition ameliorates inflammation and ER stress signaling in a model of Tau-driven pathology, as well as partially normalizes phospho-Tau levels (Hull, 2020).</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">94</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:232.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Concerning ALS, TDP-43-mediated activation of microglia causes motor neuron cell death <i style="font-style:italic;">in vitro</i> (Zhao, 2015) with downstream activation of NF-kB and NLRP3 (Clark, 2020) and involves CD14. This finding is clinically relevant as increased CD14 expression by microglia is observed in postmortem spinal cord tissue from patients with ALS, a TDP-43-driven disease (Clark, 2020). Furthermore, wildtype and mutant forms of TDP-43 activate microglia to generate IL-1b, which is abolished by NLRP3 inhibition (Deora, 2019).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Microglia isolated from the ALS mouse model, SOD1G93A, express elevated levels of NLRP3 (Deora, 2019). When microglia are incubated with soluble or aggregated SOD1G93A, NLRP3 is activated, ASC specks are formed and IL-1b is secreted which is prevented by treatment with an NLRP3 inhibitor (Deora, 2019).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Our strategy for targeting the NLRP3-ASC inflammasome</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune is exploring this key pathway in order to reduce the unwanted progression of inflammation in diseases and syndromes caused by the hyper-activation of the NLRP3 inflammasome. Our aim is to develop therapeutics that decrease production of pro-inflammatory factors yet maintain normal phagocytosis of debris and misfolded proteins as well as allow the function of other pathogen-sensing pathways. Currently, AC Immune is targeting the NLRP3-ASC pathway using two complementary approaches, derived from our two technology platforms (Figure 34):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 34: Strategy to use our dual proprietary technology platforms to target NLRP3-ASC</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20221231x20f036.jpg" alt="Graphic" style="display:inline-block;height:232.5pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:485.3pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) (NOD)-like receptor protein 3; (2) Neurodegenerative disease; (3) Central nervous system; (4) Nanomolar; (5) Parkinson&#8217;s Disease; (6) picomolar affinity to human and mouse ASC; (7) Apoptosis-associated speck-like protein containing a CARD, also PYCARD; (8) Alzheimer&#8217;s Disease; (9) Down syndrome; (10) Multiple sclerosis; (11) Cryopyrin-associated periodic syndrome; (12) Hidradenitis suppurativa</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Adapted from Ransohoff<i style="font-style:italic;">,</i> Nature, 2017</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Small molecule inhibitors of NLRP3</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Leveraging our proprietary Morphomer platform, the Company has successfully identified various chemical series of potent small molecule NLRP3 inhibitors. The Company has established biological activity for these compounds in multiple functional assays (Figures 35 and 36), and initial animal studies show highly potent target inhibition in a model of peripheral inflammation (Figure 37), providing the first evidence of <i style="font-style:italic;">in vivo</i> activity. AC Immune is currently evaluating potential lead compounds for further <i style="font-style:italic;">in vivo</i> efficacy and optimization for CNS delivery.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">95</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:170.2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2021, the Company received a grant from the MJFF to fund the development of novel<span style="letter-spacing:0.05pt;"> </span>brain<span style="letter-spacing:0.05pt;"> </span>penetrant<span style="letter-spacing:0.05pt;"> </span>NLRP3<span style="letter-spacing:0.05pt;"> </span>inflammasome<span style="letter-spacing:0.5pt;"> </span>inhibitors<span style="letter-spacing:-0.1pt;"> </span>as<span style="letter-spacing:-0.05pt;"> </span>potential<span style="letter-spacing:-0.05pt;"> </span>therapeutics for<span style="letter-spacing:-0.05pt;"> </span>Parkinson&#8217;s<span style="letter-spacing:-0.15pt;"> </span>disease, which commenced in Q1 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 35: Screening assay to quantify the compound-mediated inhibition of IL-1&#946; production </b><span style="font-style:italic;font-weight:bold;">in vitro </span><b style="font-weight:bold;">using human microglia</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20221231x20f037.jpg" alt="Graphic" style="display:inline-block;height:170.2pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:406.15pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) NOD-like receptor protein 3; (2)&#160;Interleukin 1 beta</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Adapted from Choi <i style="font-style:italic;">et al.,</i> Mol Cell 2014</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the Figure above, the left panel illustrates the signal transduction pathway leading to NLRP3 inflammasome activation. The right panel shows the dose dependent inhibition by a small molecule candidate (cmpd 1) and reference molecule (MCC950) of the NLRP3 pathway post stimulation with monosodium urate (MSU) crystal that induced interleukin-1&#946; production by human macrophages. IC50 (inhibition concentration at 50%); DMSO (negative vehicle control).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 36: Secondary assays involving</b><b style="font-weight:bold;"> NLRP3</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">1</sup><b style="font-weight:bold;"> inhibition in primary mouse microglia and</b><b style="font-weight:bold;"> human whole blood demonstrate potent hit compounds active </b><span style="font-style:italic;font-weight:bold;">in vitro</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20221231x20f038.jpg" alt="Graphic" style="display:inline-block;height:165.1pt;width:304.6pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) NOD-like receptor protein 3; (2) Interleukin 1 beta; (3) lipopolysaccharide; (4) adenosine triphosphate</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.7pt;margin:0pt 0pt 12pt 0pt;">Ref: AC Immune unpublished data</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">96</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:183.45pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 37: In a mouse model of peritonitis, several of the initial hits targeting NLRP3</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">1</sup><b style="font-weight:bold;"> show significant inhibition of IL-1&#946;</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">2</sup><b style="font-weight:bold;"> production </b><span style="font-style:italic;font-weight:bold;">in vivo</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20221231x20f039.jpg" alt="Graphic" style="display:inline-block;height:148.25pt;left:0%;padding-bottom:0.25pt;position:relative;top:0pt;width:443.25pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) NOD-like receptor protein 3; (2)&#160;Interleukin 1 beta</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: AC Immune unpublished data</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Therapeutic monoclonal antibodies for neuroinflammation (mAb-ASC)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Apoptosis associated speck like protein containing CARD (ASC) is widely researched and recognized as an adaptor protein participating in inflammasome assembly and pyroptosis. It contains a bipartite structure comprising of a pyrin (PYD) and a caspase recruitment domain (CARD) domain. These two domains help ASC function as an adaptor molecule. ASC plays pivotal role in various inflammatory diseases in the CNS as well as peripherally. Thus, the use of antibodies against ASC is an attractive therapeutic approach. It has been shown in the APP/PSI mouse model of AD, intracellular and extracellular ASC specks are present. Treatment using an anti-ASC antibody, which targets extracellular ASC specks, decreases the Abeta load in these mice (Figure 38).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 38: ASC</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">1</sup><b style="font-weight:bold;"> specks in AD patients and mouse model of AD</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20221231x20f040.jpg" alt="Graphic" style="display:inline-block;height:183.45pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:328.35pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) Apoptosis-associated speck-like protein containing a CARD; (2)&#160;Amyloid precursor protein/presenilin 1</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Venegas&#160;<i style="font-style:italic;">et al.,</i>&#160;Nature, 2017</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">97</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:198pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Using our SupraAntigen platform, AC Immune generated and characterized a novel class of anti-ASC monoclonal antibodies. ASC mAbs recognize either the PYD or the CARD domain of the protein, and show picomolar affinity (Figure 39A). Specificity of ASC detection was assessed in cell lysates of human and mouse macrophages by western blot experiment and confirmed the absence of signal in human macrophages lacking ASC proteins (Figure 39B). Furthermore, immunofluorescence analysis revealed the ability of our ASC mAbs to recognize ASC proteins in both free cytosolic form and aggregated as specks (arrows in the immunofluorescence images, Figure 39C).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Efficacy of selected antibodies was evaluated <i style="font-style:italic;">in vivo</i> using mouse models of neuroinflammation and demyelination. ASC mAbs significantly slowed down the progression of the disease (decreases clinical score on Figure 40A), decreased demyelination (black arrows; Figure 40B) and infiltration of T-cells in the spinal cord (black arrows in Figure 40C).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The efficacy of ASC mAbs will be further tested in other relevant mouse models of CNS and non-CNS disease for lead declaration. These innovative, potentially disease-modifying antibodies are designed to have the highest potential to prevent inflammation and modify the downstream exacerbation of various proteinopathies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 39: </b><b style="font-weight:bold;">Binding affinity and target engagement of neutralizing anti-ASC antibodies recognizing murine and human ASC</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20221231x20f041.jpg" alt="Graphic" style="display:inline-block;height:197.55pt;left:0%;padding-bottom:0.45pt;position:relative;top:0pt;width:469.7pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(1) monoclonal antibody; (2) caspase activation and recruitment domain; (3) Pyrin domain (4) Apoptosis-associated speck-like protein; (5)&#160;<span style="white-space:pre-wrap;">recombinant: (6) knock-out; (7) molecular weight, (8)  4&#39;,6-diamidino-2-phenylindole</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Seredenina, 4th Inflammasome Therapeutics Summit, 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">98</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:138.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 40: </b><b style="font-weight:bold;">Anti-ASC mAb shows functional improvement in the model of neuroinflammation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20221231x20f042.jpg" alt="Graphic" style="display:inline-block;height:138.5pt;width:477.15pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(1) Myelin basic protein; (2)&#160;Immunohistochemistry</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Seredenina, 4th Inflammasome Therapeutics Summit, 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">TDP-43 imaging diagnostics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To complement our pipeline of PET imaging tracers, we also selected TDP-43 as a third target (after Tau and a-syn). Using proprietary assays, a set of small molecular weight compounds from four chemically distinct series were identified. These bind to patient-derived pathological TDP-43. Several of these compounds demonstrated favorable pharmacokinetic profiles in rodents suggesting suitable properties for further development as PET ligands. We identified candidates showing nanomolar affinities on TDP-43 aggregates enriched from patients with TDP-43 proteinopathies. A selected compound is able to differentiate FTLD-TDP pathology from control cases by classical autoradiography and shows target engagement on TDP-43 inclusions in FTLD-TDP brain sections by high resolution autoradiography. This compound is selective over Abeta and a-syn in AD and PD brain homogenates respectively. Pharmacokinetic profile of this compound in non-human primate brain is suitable for FiH evaluation. Medicinal chemistry optimization is ongoing to explore SAR and enrich our TDP-43 PET tracer library with additional candidates to deliver a potential first-in-class PET tracer for TDP-43.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">99</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:243.9pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 41: TDP-43 PET imaging tracer demonstrates target engagement in FTLD-TDP brain sections and promising PK profile</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20221231x20f043.jpg" alt="Graphic" style="display:inline-block;height:243.9pt;width:456.6pt;" /></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Seredenina, ISFDT Conference, 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There are no imaging products in the market today targeting TDP-43. This provides us with a unique opportunity to become the first company to provide a TDP-43-PET tracer to the market. We believe the ability to image TDP-43 deposits in the brain will enable fundamental change in the approach toward treating primary and secondary TDP-43 proteinopathies including improved design for AD clinical trials to provide better outcomes for patients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In February 2023, the Company announced that it had been awarded USD 500 thousand in new grants from the MJFF to support the development of its TDP-43 PET tracer program. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">License agreements and collaborations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our SupraAntigen and Morphomer platforms have generated large numbers of clinical assets that address multiple diseases related to protein misfolding. Selected key assets in the product pipeline have been licensed for upfront payments, milestones and royalties to help offset the cost of our research and internal product development. We have signed a number of licensing agreements with leading pharmaceutical companies to assist and accelerate the development of our product pipeline, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a worldwide licensing agreement with Genentech signed in November&#160;2006 (and amended in March&#160;2009, January&#160;2013, May&#160;2014 and May&#160;2015) for anti-Abeta antibodies for AD and potentially other indications, under which we may become eligible to receive payments potentially greater than USD 340 (CHF 317) million, excluding royalties;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a worldwide licensing agreement with Genentech signed in June&#160;2012 (and amended in December&#160;2015) for anti-Tau antibodies to treat AD and potentially other indications, under which we may become eligible to receive payments potentially greater than CHF 400 million, excluding royalties;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a worldwide licensing agreement with Janssen signed in December&#160;2014 (and amended in April&#160;2016, July&#160;2017, January&#160;2019, November&#160;2019 and December 2022) for therapeutic anti-Tau vaccines for AD, and </span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">100</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">potentially other Tauopathies, under which we may become eligible to receive payments totaling up to CHF 500&#160;million, excluding royalties;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a worldwide licensing and collaboration agreement (LCA) with LMI (formerly Piramal Imaging SA) signed in May&#160;2014 (and amended in June 2022) for small-molecule Tau ligands for use as PET tracers under which we may become eligible to receive payments totaling up to EUR 160 (CHF 159)&#160;million, excluding royalties; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a worldwide license agreement with Lilly to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases, which was entered into in December&#160;2018 (and amended in September&#160;2019 and March&#160;2020). The agreement was deemed effective on January&#160;23, 2019. Under this agreement, we may become eligible to receive payments up to approximately CHF 1.9 billion, excluding royalties.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further information concerning details of our agreements and collaborations can be found under &#8220;Item&#160;5: Operating and financial review and prospects.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Competition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The pharmaceutical and biopharmaceutical industries are highly competitive across all therapeutic fields. In the field of neurodegenerative diseases, there are many public and private companies or institutions that are actively engaged in the discovery and development of therapeutic and diagnostic products. Some of these products may have a similar target to our product candidates or address similar markets. The industry is still in its infancy in terms of defining the pathology of neurodegenerative diseases. As disease understanding progresses, the number of novel product candidates may well increase and broaden the therapeutic and diagnostic options in our product markets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Currently, there are two approved disease-modifying products for AD. Most currently approved therapies seek to treat the symptoms of AD, such as cognitive decline, but do not slow or stop the progression of the disease. In addition, commonly, there is off-label prescription of antidepressant and antipsychotic agents for more patients with advanced AD who may have agitation, aggressive behaviors, psychosis and depression.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We expect there to be several classes of disease-modifying agents that will enter the AD market. Among our monoclonal antibodies, semorinemab targets extracellular Tau and crenezumab targets pathologic Abeta oligomers. Therapeutic vaccines are another class of potentially disease-modifying immunotherapies targeting pathologic protein species, and include our candidate products ACI-35.030, which targets aggregated, phosphorylated Tau protein and ACI-24.060, which targets oligomeric and pyroglutamate Abeta. A further class of disease-modifying therapies, small molecules, include our Morphomer Tau program, which inhibits Tau aggregates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The availability of novel diagnostic agents to visualize the disease development in patients with AD is critical for successful clinical development of disease-modifying products in AD. At the forefront of this new diagnostic effort are PET agents for imaging of disease pathology, and in particular, Tau-targeting PET agents, which we believe will allow precise assessment of disease in patients with AD. A similar situation is developing in other NDD, such as PD, where PET imaging is becoming available.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">ACI-35.030.</span> ACI-35.030, if approved, would potentially compete with other Tau-targeting therapeutic vaccines currently being developed. This could include, for example, the AADvac1 vaccine being developed by Axon Neuroscience, which completed a Phase 2 study in 2019 and AV-1980R (Nuravax) which is expected to enter phase 1 clinical development in the near future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">ACI-24.060 for AD. </span>ACI-24.060, if approved, would potentially compete with other anti-Abeta-targeting therapeutic vaccines currently being developed. This includes the ABvac 40 (Araclon Biotech), which is currently being evaluated in a Phase 2 study and UB-311(Vaxxinity), which has completed a Phase 2a study. In addition, ABvac 42 (Araclon Biotech) has completed a Phase 1 study and ALZ-101 (Alzinova) is currently being evaluated in a Phase 1b study and AV-1959D (Nuravax) in Phase 1 clinical development.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">101</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">ACI-24.060 for DS.</span> ACI-24.060 is the first disease-modifying vaccine candidate addressing DS-related AD, with a potential preventive and therapeutic application. Although there are symptomatic treatments of DS in clinical development, to our knowledge there are currently no other disease-modifying treatments in clinical development for AD in DS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">ACI-7104.056. </span>ACI-7104.056, if approved, would potentially compete with other a-syn-targeting therapeutic vaccines. This includes the UB-312 vaccine developed by Vaxxinity, which is being evaluated in a Phase 1b study.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Semorinemab.</span> Semorinemab is one of several Tau-targeting monoclonal antibodies in development to potentially act as disease-modifying agents. Bepranemab (UCB/Roche) and JNJ-63733657 (Janssen) are being evaluated in Phase 2 studies. E-2814 (Eisai) is being evaluated in a Phase 2/3 prevention study. Lu AF87908 (Lundbeck), APNmAb005 (Aprinoia Therapeutics), MK-2214 (Merck/Teijin Pharma) and PRX005 (Prothena/BMS) are being evaluated in Phase 1 studies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Crenezumab. </span>Crenezumab is the first monoclonal antibody candidate that targets Abeta in cognitively healthy individuals at risk of developing familial AD. However, Lilly&#8217;s solanezumab and donanemab (Eli Lilly) are being evaluated in studies of presymptomatic AD. ADUHELM (Biogen) and Leqembi (BioArctic/Eisai/Biogen) have been approved by FDA under the accelerated approval pathway for the treatment of patients with mild cognitive impairment and mild dementia.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Morphomer Tau. </span>In collaboration with Lilly, we are researching and developing small molecule Tau aggregation inhibitors with plans to evaluate candidates in AD and NeuroOrphan tauopathies. We completed a Phase 1 study in healthy volunteers with ACI-3024 in Q2 2020. Continued candidate characterization across the research program also identified new and highly differentiated candidates with excellent cerebrospinal fluid exposure and selectivity for pathological aggregated Tau. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Tau-PET tracer.</span> Tauvid (previously known as Flortaucipir) was developed by Eli Lilly and approved by FDA in May&#160;2020. However, should the Company&#8217;s PI-2620 be approved, it would also compete with (i)&#160;18F-florzolotau (previously known as APN-1607), a product candidate in a Phase 3 study and being advanced by Aprinoia; (ii)&#160;18F-MK-6240, which is being evaluated by Cerveau/Merck in a Phase 2 clinical trial in patients with ADAD; (iii)&#160;18F-GTP1, which is being developed by Genentech and has completed a Phase 2 study in subjects at risk of developing ADAD, (iv)&#160;18F-RO6958948, for which Roche has completed a Phase 1 study in patients with AD and (v)18F-JNJ-067, for which Janssen has completed a Phase 1 study in patients with AD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">ACI-12589.</span> ACI-12589, if approved, would potentially compete with other a-syn-targeting PET tracers. This includes the 18F-UCB-2897 tracer developed by UCB, which is being evaluated in a Phase 1 study. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">A-syn antibody. </span>Several a-syn antibodies are currently in development. Roche/Prothena entered a Phase 2 with prasinezumab in June&#160;2017 and in May&#160;2021, began a Phase 2b study in PD patients with more advanced symptoms; AstraZeneca/Takeda started a Phase 1 study in patients with PDf with MEDI1341 in August&#160;2020 and a Phase 2 study in MSA in November, 2022; Lundbeck/Genmab entered a Phase 2 in MSA with Lu AF82422 in November&#160;2021; and UCB7853 (UCB/Novartis) entered a Phase 1 study in December&#160;2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">TDP-43 antibodies. </span>To our knowledge, there are no TDP-43 antibodies in the clinic.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Many of our competitors have significantly greater financial, technical and human resources than we have. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Our commercial opportunities and our success will be based in part on our ability to identify, develop and manage a portfolio of product candidates that are safer and more effective than competing products. However, this opportunity could be eroded or even eliminated if our competitors develop and/or market products that are novel and have superior safety and efficacy profiles, that may be brought to the market more rapidly due to greater available resources, or that are less costly than our current or future product candidates.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">102</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Commercialization strategy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our strategy to date has been to focus on identifying partnerships for our early-stage product candidates as both a way to secure non-dilutive capital to fund our other research and development programs and also as a way to accelerate the development of these partnered products by leveraging our partners&#8217; extensive knowledge in clinical studies, drug development, manufacturing and commercialization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">With greater financial resources at our disposal and the significant knowledge acquired by our scientists and scientific leadership, we intend to retain selected promising product candidates in-house for a longer period of time and fund their development from our own resources. This will allow us to generate greater value from these product candidates, allowing us to demand more significant terms from a prospective partner. For example, while we ultimately plan to seek a strategic partner for our Abeta vaccine program in AD, we currently plan to retain full control of this asset for development in the DS population. We have commenced a Phase 1b/2 study for AD in advance of potentially partnering this program and intend to fund further clinical development in DS with our own financial resources. In the field of diagnostics, the parallel development of therapeutic compounds and companion diagnostics is of growing importance to the pharmaceutical and biopharmaceutical industries. The development timeframe of a PET diagnostic agent is significantly shorter than for a therapeutic product, providing the prospect for potential diagnostic product revenues to be realized quicker than potential therapeutic product revenues. Our Morphomer platform is particularly well suited to generate molecules for use in the development of diagnostics for NDDs which provides additional partnering opportunities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Given our current stage of product development, we currently do not have a commercialization infrastructure. If any of our product candidates is granted marketing approval, we intend to focus our initial commercial efforts in the U.S. and select European markets, which we believe represent the largest market opportunities for us. In those markets, we expect our commercial operations to potentially include our own specialty sales force that will target Neurologists and Gerontologists, both in hospitals and in private practice. In other markets, we expect to seek partnerships that would maximize our products&#8217; commercial potential.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Intellectual property</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We strive to protect the proprietary technology that we believe is important to our business, including seeking and maintaining U.S. and foreign patents intended to cover our products and compositions, their methods of use and processes for their manufacture, and our proprietary technology platforms, diagnostic candidates and any other inventions that are commercially important to the development of our business. We also rely on trade secrets and know-how to protect aspects of our business that are not amenable to, or that we do not consider appropriate for, patent protection.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our success will significantly depend on our and our collaboration and licensing partners&#8217; ability to obtain and maintain patent and other proprietary protection for commercially important technology, inventions and know-how related to our business, to defend and enforce patents, to preserve the confidentiality of our trade secrets and to operate our business without infringing any patents and other intellectual property or proprietary rights of third parties. See the section titled &#8220;Risk factors&#8212; Risks related to intellectual property&#8221; for additional information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2022, we owned or co-owned with our collaboration and licensing partners, approximately 48 issued U.S. patents and 399 issued patents in other jurisdictions, as well as 34 pending U.S. patent applications and 565 pending foreign patent applications. As of December&#160;31, 2022, we licensed approximately 32 issued U.S. patents and 282 issued patents in other jurisdictions, as well as 16 pending U.S. patent applications and 317 pending foreign patent applications.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">103</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The patent portfolios for our most advanced product candidates as of December&#160;31, 2022 are summarized below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Anti-Tau vaccines</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio for anti-Tau vaccines includes a patent family with composition-of-matter claims (including claims directed to the ACI-35 antigenic peptide and a pharmaceutical composition comprising such an antigenic peptide), claims directed to treating certain indications using ACI-35 including AD, and claims directed to using ACI-35 to induce an immune response. This patent family currently contains approximately 28 issued patents and two pending patent applications in 27 countries. The issued patents in this patent family, if the appropriate maintenance, renewal, annuity or other governmental fees are paid, are expected to expire in 2030, excluding any additional term for patent term adjustments or patent term extensions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio for anti-Tau vaccines also includes a patent family relating to therapeutic Tau vaccine claims (including claims directed to a pharmaceutical composition comprising an antigenic Tau peptide), claims directed to using such vaccines to induce an immune response in a subject, and claims directed to methods for preventing or treating a neurodegenerative disease or disorder, including AD, among others. This patent family currently contains 1 issued patent and approximately 46 pending patent applications in 38 countries. The issued patent and any patents issuing in this patent family, if the appropriate maintenance, renewal, annuity or other governmental fees are paid, are expected to expire in 2038, excluding any additional term for patent term adjustments or patent term extensions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;">ACI-24</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio for ACI-24 includes a patent family with composition-of-matter claims (including claims directed to the ACI-24 antigenic construct), claims directed to treating certain indications using ACI-24 including AD, and claims directed to using ACI-24 to induce an immune response. As of December 31, 2022, in this patent family, we owned approximately 27 issued patents and 6 pending patent applications in 30 countries. With respect to the U.S., we owned two issued U.S. patents. The issued patents in this patent family, if the appropriate maintenance, renewal, annuity or other governmental fees are paid, are expected to expire in 2026, excluding any additional term for patent term adjustments or patent term extensions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio for ACI-24 also includes a patent family directed to the use of the ACI-24 vaccine in the treatment and/or prevention of memory and/or cognitive impairments or abnormalities in the DS population, among others. As of December&#160;31, 2022, in this patent family, we owned approximately 14 issued patents and 4 pending patent applications in 18 countries. Issued patents in this patent family, if the appropriate maintenance, renewal, annuity or other governmental fees are paid, are expected to expire in 2032, excluding any additional term for patent term adjustments or patent term extensions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio for ACI-24 also includes a patent family relating to therapeutic anti-Abeta vaccine claims (including claims directed to a pharmaceutical composition comprising an antigenic peptide), and claims directed to using such vaccines in treating, preventing, inducing a protective immune response against or alleviating the symptoms associated with an Abeta-associated disease in a subject, among others. As of December 31, 2022, in this patent family, we owned one issued U.S. patent and approximately 33 pending patent applications in 32 countries. Any issued patents in this patent family, if the appropriate maintenance, renewal, annuity or other governmental fees are paid, are expected to expire in 2039, excluding any additional term for patent term adjustments or patent term extensions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;">ACI-7104</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to ACI-7104 includes patents and patent applications with composition-of-matter claims (including claims directed to the peptide, as well as pharmaceutical formulations comprising the peptide), and claims directed to the use of compounds comprising the peptide in treating or preventing synucleinopathies including PD and MSA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Our patent portfolio relating to ACI-7104 includes patents and patent applications that we own in two different patent families. As of December&#160;31, 2022, in these patent families, we owned approximately 13 issued patents and 17 </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">104</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">pending patent applications, in 11 countries. With respect to the U.S., we owned two issued U.S. patents. Issued patents in the basic patent family, if the appropriate maintenance, renewal, annuity or other governmental fees are paid, are expected to expire in 2029, excluding any additional term for patent term adjustments or patent term extensions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Semorinemab</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our global patent portfolio relating to semorinemab includes patents and patent applications with claims directed to compositions of matter, methods of treatment for certain indications including AD, and methods of use, among others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Crenezumab</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to crenezumab includes patents and patent applications with claims directed to composition of matter (including claims directed to the crenezumab antibody or a fragment thereof, a polynucleotide encoding the crenezumab antibody or a fragment thereof, a cell line used to produce the crenezumab antibody as well as pharmaceutical compositions comprising the crenezumab antibody), claims directed to treating certain indications using the crenezumab antibody including AD, claims directed to a method of manufacturing the crenezumab antibody and claims directed to diagnostic and prognostic uses of the crenezumab antibody.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to crenezumab includes patents and patent applications that we own or co-own in four different patent families. As of December&#160;31, 2022, we owned or co-owned approximately 50 patents (not including the patents in the individual countries where the issued European patent was validated) and 12 patent applications in 34 countries in our main patent family directed to the crenezumab antibody and methods of using the crenezumab antibody to treat certain indications, including AD. This patent portfolio includes three issued U.S. patents and one pending U.S. patent applications, which, if the appropriate maintenance or other governmental fees are paid, are expected to expire in 2027, excluding any additional term for patent term adjustments or patent term extensions. This patent portfolio also includes a PCT patent application that was filed on July&#160;13, 2007. If the appropriate maintenance, renewal, annuity, or other governmental fees are paid, national-stage applications claiming priority from this PCT patent application, if issued, are expected to expire in 2027, excluding any additional term for patent term adjustments or patent term extensions, as applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Morphomer Tau</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to Morphomer Tau therapeutics includes patent applications with claims directed to composition of matter (including claims directed to the molecule, a pharmaceutical composition comprising such molecule and a mixture comprising such molecule), and claims directed to prevention and treatment of certain indications using such molecules including AD and PSP, among others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to the Morphomer Tau therapeutic program includes patent applications that we own or co-own in four different patent families. As of December&#160;31, 2022, we owned or co-owned approximately 48 pending patent applications and 4 issued patents, including one U.S. issued patent in our main patent family directed to the ACI-3024 small molecule Tau aggregation inhibitor. If the appropriate maintenance, renewal, annuity, or other governmental fees are paid, national-stage applications claiming priority from this PCT patent application, if issued, are expected to expire in 2039, excluding any additional term for patent term adjustments or patent term extensions, as applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;">PI-2620</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to PI-2620 includes patent applications with claims directed to composition of matter (including claims directed to the molecule, its precursor and a diagnostic composition comprising such molecule), claims directed to diagnosis of certain indications using PI-2620 including AD and PSP, and claims directed to a method of manufacturing PI-2620, among others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Our patent portfolio relating to PI-2620 includes patent applications that we own or co-own in three different patent families. As of December&#160;31, 2022, we owned or co-owned 6 patents and approximately 12 patent applications in 16 </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">105</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">countries in our main patent family directed to the PI-2620 molecule, its precursor and methods of using the PI-2620 to diagnose certain indications, including AD and PSP. This main patent family includes one issued U.S. patent. If the appropriate maintenance, renewal, annuity, or other governmental fees are paid, national-stage applications claiming priority from this PCT patent application, if issued, are expected to expire in 2037, excluding any additional term for patent term adjustments or patent term extensions, as applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">ACI-12589</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to a-syn diagnostics includes composition of matter claims (including claims directed to the ACI-12589 molecule, its precursor, and diagnostic compositions comprising the molecule), and claims directed to use of the molecule in imaging and in diagnostics of a-synucleinopathies including PD and MSA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to a-syn diagnostics includes patents and patent applications that we own in three different patent families. As of December 31, 2022, we owned or co-owned approximately 17 patent applications in 17 countries in our main patent family directed to the ACI 12589 molecule, its precursor, diagnostic compositions, and methods of using ACI-12589 for imaging and diagnostics of a-synucleinopathies including PD and MSA. If the appropriate maintenance, renewal, annuity or other governmental fees are paid, any issued patents are expected to provide protection up to 2041, excluding any additional term for patent term adjustments or patent term extensions, as applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Manufacturing and supply</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We do not own or operate facilities for the manufacture, testing, packaging, labeling, storage or distribution of preclinical or clinical supplies of any of our product candidates. We instead contract with and rely on third-party CMOs to manufacture, package, label, store, test and distribute all preclinical and clinical supplies of our product candidates, and we plan to continue to do so for the foreseeable future. We have established relationships with CMOs such as WuXi AppTec (WuXi STA), WuXi Biologics, Avecia, Almac Clinical Services, Bachem AG, Evonik Industries AG, Polymun Scientific Immunbiologische Forschung GmbH, piCHEM Forschungs-und Entwicklungs GmbH, Baccinex SA, Solvias AG and Pfenex&#160;Inc. among others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Compliance with governing rules&#160;and quality requirements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The facilities used by our collaboration partners and CMOs to manufacture our product candidates are systematically audited by local authorities and occasionally inspected by competent authorities where the clinical studies are ongoing. The facilities where the commercial productions are performed will have to be approved by the FDA or other relevant regulatory authorities, pursuant to inspections that are conducted after we submit our NDA or comparable marketing applications. We perform periodic quality audits of the manufacturing facilities and CMOs to monitor their compliance with the regional laws, regulations and applicable cGMP standards and other laws and regulations, such as those related to environmental health and safety matters. The scope of our audits also involves monitoring the ability of our providers to maintain adequate QCs and QA systems including personnel qualification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">After manufacturing, our products are submitted to extensive characterization and QC testing plans performed by using properly developed analytical methods that are qualified or validated; this ensures the accuracy of the results generated and provides evidence of the quality of our products. In addition, our products are submitted to detailed and standardized stability programs aimed at demonstrating product stability during the storage period; this, in addition to guaranteeing the safety of the products, supports the definition of a suitable supply chain that may encompass the distribution of the products in different continents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Contractual framework</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We have established, with CMOs supplying and testing active pharmaceutical ingredients, drug substances or drug products under cGMP, quality agreements and master service agreements. Quality agreements define the quality standards required to develop, produce and supply the product, and also define the responsibilities related to the collaboration with regards to the quality related aspects. Manufacturing service agreements define the commercial and </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">106</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">financial framework under which product manufacturing and testing under cGMP is performed. Any failure to achieve and maintain compliance with the laws, regulations and standards, suspension of the manufacturing of our product candidates or withdrawals of cGMP permissions, which would adversely affect our business and reputation, are defined in the master service agreements and quality agreements. The risk that any third-party providers may breach the agreements they have with us because of factors beyond our control and the possibility that they may also terminate or refuse to renew their agreements because of their own financial difficulties or business priorities, potentially at a time that is costly or otherwise inconvenient for us, is managed by us with constant investments toward maintaining reserve stocks and in-depth process know-how. The latter is supported by continuous in-house process development and production activities of small-scale/research grade materials, which may offer the chance to rapidly identify alternative contract manufacturers to whom the manufacturing process could be transferred providing continuity for the clinical study. Finally, our contracts may also offer us limited remedies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Interaction with CMOs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Finally, our partnerships with CMOs are managed through an efficient project management platform in which teams are formed with the representatives of each key function from both parties. Meetings occur either through telephone conferences aimed at updating short-term actions or face-to-face conferences when mid- to long-term development plans are discussed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Government regulation and our regulatory department</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our regulatory department has a strong culture of regulatory compliance, operating under three guiding principles, to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">provide constructive regulatory input for development products;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ensure smooth regulatory approvals by anticipating hurdles; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">build confidence with regulators by continuous communication.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The QA group is included within the regulatory department with the mission to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">create and maintain a corporate quality management system; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ensure cGCP, cGMP, cGLP and current Good Distribution Practice (cGDP) compliance.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A science-driven approach is the cornerstone of our interactions and this has helped us to build and maintain a high level of trust with regulators. Besides informal conversations with the authorities, our regulatory department has conducted several pre-Investigational New Drug (pre-IND), Type B and Type C meetings with the FDA (ACI-24.060 for AD and DS, ACI-7104.056 and PI-2620) and Scientific Advice meetings, which are the European equivalent of pre-IND meetings (with the German Paul-Ehrlich-Institut, Swedish Medical Products Agency; UK Medicine&#160;&amp; Healthcare Products Regulatory Agency, Finnish Medicines Agency, the Spanish Agency of Medicines and Medical Devices and the EMA). Since 2008, our regulatory department has filed a total of 24 clinical trial applications in the EU (one each in Austria, Denmark, the Netherlands and Poland, two in Spain, three in Germany, three in Sweden, four in Finland and eight in the UK) and 4 INDs in the U.S.. Given the seriousness of AD and public pressure for new therapeutics, we consider regulatory agencies to be important stakeholders in our product development strategies. We are committed to working closely with global regulatory authorities to adhere to and achieve the highest levels of safety and quality of our product candidates in the most timely and efficient manner. The transparency we have achieved and our goal of a close working relationship with the regulatory agencies, in particular the FDA and the EMA, are intended to facilitate expeditious execution through the regulatory approval process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Our regulatory department contains a QA group. As every quality issue ultimately requires regulatory involvement and input, this approach is intended to lead to rapid resolution of issues and ensure full compliance to satisfy both the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">107</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">reviewers and the inspectors at the government health authorities. Our regulatory department is charged with keeping our entire organization, directly or indirectly involved in the clinical study application process, in a state of &#8220;inspection readiness.&#8221; To that end, we ensure that the Trial Master Files are complete and regularly updated. Our regulatory department is also tasked with generating our annual quality plan. The personnel tasked with QA have issued a set of approximately 109 standard operating procedures and working instructions and continuously train the relevant staff. Our QA personnel conduct regular audits, including in-person audits of the contract manufacturers, contract research organizations and laboratories conducting primary endpoint analysis. In addition, we have a full-time QA documentation assistant to ensure good documentation practice and archiving.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Product approval process</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The clinical studies, manufacturing, labeling, storage, distribution, record-keeping, advertising, promotion, import, export and marketing, among other things, of our product candidates are subject to extensive regulation by governmental authorities in the U.S. and other countries. The U.S. FDA, under the Federal Food, Drug, and Cosmetic Act (FDCA), regulates pharmaceutical products in the U.S.. The steps required before a drug may be approved for marketing in the U.S. generally include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the completion of preclinical laboratory tests and animal tests conducted under cGLP regulations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the submission to the FDA of an IND application for human clinical testing, which must become effective before human clinical studies commence;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtaining a positive opinion from the ethics committee (Europe)/institutional review board (U.S.) to commence study on human subjects;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the performance of adequate and well-controlled human clinical studies to establish the safety and efficacy of the product candidate for each proposed indication and conducted in accordance with cGCP requirements;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">pre-NDA submission meeting with FDA (highly recommended);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the submission to the FDA of an NDA;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the FDA&#8217;s acceptance of the NDA;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">satisfactory completion of an FDA Pre-Approval Inspection (PAI) of the manufacturing facilities at which the product is made to assess compliance with cGMP requirements;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the FDA&#8217;s review and approval of an NDA prior to any commercial marketing or sale of the drug in the U.S.; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">having parallel scientific advice from the EMA or Health Technology Assessment body whereby the payors are involved at the outset (Phase 2), which is intended to facilitate the design of clinical studies to target primarily populations with a high chance of obtaining reimbursement and accelerate the process of time to reimbursement.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The FDA has various programs, including Fast Track, Priority review, Accelerated Approval and Breakthrough Therapy designation, which are intended to increase agency interactions, expedite or facilitate the process for reviewing product candidates, and/or provide for initial approval based on surrogate endpoints. We believe that one or more of our product candidates may qualify for some of these expedited development and review programs. However, even if a product candidate qualifies for one or more of these programs, the FDA may later decide that the product candidate no longer meets the conditions for qualification.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">108</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Fast Track program is intended to expedite or facilitate the process for reviewing new drugs that meet certain criteria. Specifically, new drugs are eligible for Fast Track designation if they are designed to treat a serious or life-threatening condition and demonstrate the potential to address unmet medical needs for the condition. Fast Track designation applies to the combination of the product and the specific indication for which it is being studied. The sponsor of a new drug may request the FDA to designate the drug as a Fast Track product at any time during the clinical development of the product. AD, for example, meets both pre-requisites&#8212;it is life-threatening and constitutes an unmet medical need. Unique to a Fast Track product, the FDA may consider for review sections of the marketing application on a rolling basis before the complete application is submitted if the sponsor provides a schedule for the submission of the sections of the application, the FDA agrees to accept sections of the application and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the application.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any product submitted to the FDA for marketing, including under a Fast Track program may be eligible for other types of FDA programs intended to expedite development and review, such as Priority Review and Accelerated Approval. Any product is eligible for priority review if it has the potential to provide safe and effective therapy where no satisfactory alternative therapy exists or it provides a significant improvement in the treatment, diagnosis or prevention of a disease compared with marketed products. The FDA will attempt to direct additional resources to the evaluation of an application for a new drug designated for Priority Review to facilitate the review. Additionally, a product may be eligible for the Accelerated Approval program. Product candidates that are studied for their safety and effectiveness in treating serious or life-threatening illnesses and that provide meaningful therapeutic benefit over existing treatments may receive Accelerated Approval, which means that they may be approved on the basis of adequate and well-controlled clinical studies establishing that the product has an effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit, or on the basis of an effect on a clinical endpoint other than survival or irreversible morbidity. As a condition of approval, the FDA may require that a sponsor of a drug receiving Accelerated Approval perform adequate and well-controlled post-marketing clinical studies. Failure to conduct required post-approval trials, or the inability to confirm a clinical benefit during post-marketing trials, may allow the FDA to withdraw the drug from the market on an expedited basis. In addition, as a condition for Accelerated Approval the FDA currently requires pre-approval of promotional materials, which could adversely impact the timing of the commercial launch of the product. The Fast Track, Priority Review and Accelerated Approval programs do not change the standards for approval but may expedite the development or approval process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Food and Drug Administration Safety and Innovation Act of 2012 also amended the FDCA to require the FDA to expedite the development and review of a breakthrough therapy. A drug can be designated as a breakthrough therapy if it is intended to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that it may demonstrate substantial improvement over existing therapies in one or more clinically significant endpoints. A sponsor may request that a drug be designated as a breakthrough therapy at any time during the clinical development of the product. If so designated, the FDA shall act to expedite the development and review of the product&#8217;s marketing application, including by meeting with the sponsor throughout the product&#8217;s development, providing timely advice to the sponsor to ensure that the development program to gather nonclinical and clinical data is as efficient as practicable, involving senior managers and experienced review staff in a cross-disciplinary review, assigning a cross-disciplinary project lead for the FDA review team to facilitate an efficient review of the development program and to serve as a scientific liaison between the review team and the sponsor, and taking steps to ensure that the design of the clinical trials is as efficient as practicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The testing and approval process requires substantial time, effort and financial resources, and the receipt and timing of any approval is uncertain. Given this paradigm, AD has been given Life-Threatening Disease status by the FDA and therefore AD therapies are eligible for the expanded access program for investigational drugs and other pathways such as Breakthrough Therapy, Accelerated Approval and Priority Review. Additionally, a single well-designed, well-conducted, pivotal clinical study could be sufficient to trigger market approval pending a successful PAI.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Preclinical studies include laboratory evaluations of the product candidate, as well as animal studies to assess the potential safety and efficacy of the product candidate. The results of the preclinical studies, together with manufacturing information and analytical data, are submitted to the FDA as part of the IND, which must become effective before clinical studies may be commenced. The IND will automatically become effective 30&#160;days after receipt by the FDA, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">109</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">unless the FDA raises concerns or questions about the conduct of the studies as outlined in the IND prior to that time. In this case, the IND sponsor and the FDA must resolve any outstanding concerns before clinical studies can proceed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Clinical studies involve the administration of the product candidates to healthy volunteers or patients with the disease to be treated under the supervision of a qualified principal investigator. Clinical studies are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety and the efficacy criteria to be evaluated. A protocol for each clinical study and any subsequent protocol amendments must be submitted to the FDA as part of the IND. Further, each clinical study must be reviewed and approved by an independent IRB, either centrally or individually at each institution at which the clinical study will be conducted. The IRB will consider, among other things, ethical factors, the safety of human subjects and the possible liability of the institution. There are also requirements governing the reporting of ongoing clinical studies and clinical study results to public registries. The FDA, the IRB or the clinical study sponsor may suspend or terminate clinical studies at any time on various grounds, including a finding that the subjects or patients are being exposed to an unacceptable health risk. Additionally, some clinical studies are overseen by an independent group of qualified experts organized by the clinical study sponsor, known as a Data Safety Monitoring Board/Committee. This group provides authorization for whether or not a study may move forward at designated checkpoints based on access to certain data from the study. We may also suspend or terminate a clinical study based on evolving business objectives and/or competitive climate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Clinical studies are typically conducted in three sequential phases prior to approval, but the phases may overlap. These phases generally include the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Phase 1. Phase 1 clinical studies represent the initial introduction of a product candidate into human subjects, frequently healthy volunteers. In Phase 1, the product candidate is usually tested for safety, including adverse effects, dosage tolerance, absorption, distribution, metabolism, excretion and pharmacodynamics.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Phase&#160;2. Phase 2 clinical studies usually involve studies in a limited patient population to (i)&#160;evaluate the efficacy of the product candidate for specific indications, (ii)&#160;determine dosage tolerance and optimal dosage, and (iii)&#160;identify possible adverse effects and safety risks.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Phase&#160;3. If a product candidate is found to be potentially effective and to have an acceptable safety profile in Phase 2 studies, the clinical study program will be expanded to Phase 3 clinical studies to further demonstrate clinical efficacy, optimal dosage and safety within an expanded patient population at geographically dispersed clinical study sites.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Phase 4. Phase 4 clinical studies are conducted after approval to gain additional experience from the treatment of patients in the intended therapeutic indication and to document a clinical benefit in the case of drugs approved under Accelerated Approval regulations, or when otherwise requested by the FDA in the form of post-marketing requirements or commitments. Failure to conduct any required Phase 4 clinical studies promptly could result in withdrawal of approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The results of preclinical studies and clinical studies, including negative or ambiguous results as well as positive findings, together with detailed information on the manufacture, composition and quality of the product, are submitted to the FDA in the form of an NDA requesting approval to market the product. The NDA must be accompanied by a significant user-fee payment. The FDA has substantial discretion in the approval process and may refuse to accept any application or decide that the data is insufficient for approval and require additional preclinical, clinical or other studies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We estimate that it generally takes 10 to 15&#160;years, or possibly longer, to discover, develop and bring to market a new pharmaceutical or biopharmaceutical product in the U.S.. Several&#160;years may be needed to complete each phase, including discovery, preclinical, Phase 1, 2 or 3, or marketing authorization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In addition, under the Pediatric Research Equity Act, an NDA or supplement to an NDA must contain data to assess the safety and effectiveness of the drug for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. Recently, the Food and Drug Administration Safety and Innovation Act (FDASIA), which was signed into law on July&#160;9, 2012, amended the FDCA. The FDASIA requires that a sponsor who is planning to submit a marketing application for a drug </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">110</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">or biological product that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration submit an initial Pediatric Study Plan within 60&#160;days of an end-of-Phase-2 meeting or as may be agreed between the sponsor and the FDA. The initial Pediatric Study Plan must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA and the sponsor must reach agreement on the Pediatric Study Plan. A sponsor can submit amendments to an agreed-upon initial Pediatric Study Plan at any time if changes to the pediatric plan need to be considered based on data collected from nonclinical studies, early-phase clinical trials, and/or other clinical development programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The cost of preparing and submitting an NDA is substantial. Under federal law, NDAs are subject to substantial application user fees and the sponsor of an approved NDA is also subject to annual product and establishment user fees. Under the Prescription Drug User Fee Act (PDUFA), as amended, each NDA must be accompanied by a user fee. The FDA adjusts the PDUFA user fees on an annual basis. PDUFA VI eliminates fees for supplements as well as for establishments, although applicants will be assessed for annual prescription drug program fees for prescription drug products, rather than the prescription drug product fee assessed under the previous iteration of PDUFA. According to the FDA&#8217;s fee schedule for the 2022 FY, the user fee for each NDA application requiring clinical data is USD 3,242,026 and the annual program fee is USD 393,933. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Additionally, no user fees are assessed on NDAs for products designated as orphan drugs, unless the product also includes a non-orphan indication.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Once the NDA submission has been submitted, the FDA has 60&#160;days after submission of the NDA to conduct an initial review to determine whether it is sufficient to accept for filing. Under the PDUFA, the FDA sets a goal date by which it plans to complete its review. This is typically 12&#160;months from the date of submission of the NDA application. The review process is often extended by FDA requests for additional information or clarification. Before approving an NDA, the FDA will inspect the facilities at which the product is manufactured and will not approve the product unless the manufacturing facility complies with cGMP regulations and may also inspect clinical study sites for integrity of the data supporting safety and efficacy. The FDA may also convene an advisory committee of external experts to provide input on certain review issues relating to risk, benefit and interpretation of clinical study data. The FDA is not bound by the recommendations of an advisory committee, but generally follows such recommendations in making its decisions. The FDA may delay approval of an NDA if applicable regulatory criteria are not satisfied and/or the FDA requires additional testing or information. The FDA may require post-marketing testing and surveillance to monitor safety or efficacy of a product.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">After the FDA evaluates the NDA and conducts inspections of the manufacturing facilities where the drug product and/or its API will be produced, it may issue an Approval Letter or a Complete Response Letter. An Approval Letter authorizes commercial marketing of the drug with specific prescribing information for specific indications. A Complete Response Letter indicates that the review cycle of the application is complete and the application is not ready for approval. A Complete Response Letter may require additional clinical data and/or an additional pivotal Phase 3 clinical study or studies, and/or other significant, expensive and time-consuming requirements related to clinical studies, preclinical studies or manufacturing. Even if such additional information is submitted, the FDA may ultimately decide that the NDA does not satisfy the criteria for approval. The FDA could also approve the NDA with a Risk Evaluation and Mitigation Strategy (REMS), plan to mitigate risks, which could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to proposed labeling, development of adequate controls and specifications, or a commitment to conduct one or more post-marketing studies or clinical studies. Such post-marketing testing may include Phase 4 clinical studies and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">111</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Special protocol assessment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The FDA and an IND sponsor may agree in writing on the design and size of clinical studies intended to form the primary basis of a claim of effectiveness in an NDA. This process is known as a special protocol assessment (SPA). Upon a specific request for a SPA by an IND sponsor, the FDA will evaluate the protocol. If an SPA agreement is reached, however, it is not a guarantee of product approval by the FDA or approval of any permissible claims about the product. The FDA retains significant latitude and discretion in interpreting the terms of the SPA agreement and the data and results from any study that is the subject of the SPA agreement. In particular, the SPA agreement is not binding on the FDA if previously unrecognized public health concerns later come to light, other new scientific concerns regarding product safety or efficacy arise, the IND sponsor fails to comply with the agreed-upon protocol, or the relevant data, assumptions, or information provided by the IND sponsor when requesting a SPA agreement change, are found to be false statements or misstatements, or are found to omit relevant facts. An SPA agreement may not be changed by the sponsor or the FDA after the study begins except with the written agreement of the sponsor and the FDA, or if the FDA determines that a substantial scientific issue essential to determining the safety or effectiveness of the drug was identified after the testing began.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Orphan-drug designation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biological product intended to treat a rare disease or condition, which is a disease or condition that either affects fewer than 200,000 individuals in the U.S., or affects more than 200,000 individuals in the U.S. but there is no reasonable expectation that the cost of developing and making a drug product available in the U.S. for this type of disease or condition will be recovered from sales of the product in the U.S.. Orphan-product designation must be requested before submitting an NDA. After the FDA grants orphan-product designation, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. Orphan-product designation does not convey any advantage in or shorten the duration of the regulatory review and approval process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If a product that has orphan designation subsequently receives the first FDA approval for the disease or condition for which it has such designation, the product is entitled to orphan-product exclusivity, which means that the FDA cannot approve any other applications to market the same drug or biological product for the same indication for 7&#160;years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan exclusivity. The designation of such drug also entitles a party to financial incentives such as opportunities for grant funding toward clinical study costs, tax advantages and user-fee waivers. Competitors, however, may receive approval of different products for the indication for which the orphan product has exclusivity or obtain approval for the same product but for a different indication for which the orphan product has exclusivity. Orphan-product exclusivity also could block the approval of one of our products for 7&#160;years if a competitor obtains approval of the same drug or biological product as defined by the FDA or if our product candidate is determined to be contained within the competitor&#8217;s product for the same indication or disease. If a drug product designated as an orphan product receives marketing approval for an indication broader than what is designated, it may not be entitled to orphan-product exclusivity. Orphan-drug status in the EU has similar but not identical benefits in that jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Disclosure of clinical trial information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Sponsors of clinical trials (other than Phase 1 trials) of FDA-regulated products, including drugs, are required to register and disclose certain clinical trial information. Information related to the product, comparator, patient population, phase of investigation, trial sites and investigators and other aspects of the clinical trial is made public as part of the registration. Sponsors are also obligated to disclose the results of their clinical trials after completion. Disclosure of the results of certain trials may be delayed until the new product or new indication being studied has been approved. However, there are evolving rules&#160;and increasing requirements for publication of trial-related information, and it is possible that data and other information from trials involving drugs that never garner approval could be required to be disclosed in the future. In addition, publication policies of major medical journals mandate certain registration and disclosures as a pre-condition for potential publication, even when this is not presently mandated as a matter of law. Competitors may use this publicly available information to gain knowledge regarding the progress of development programs.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">112</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Post-approval requirements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to record-keeping, periodic reporting, product distribution, advertising and promotion and reporting of adverse experiences with the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing, annual user-fee requirements for any marketed products and the establishments at which such products are manufactured, as well as new application fees for supplemental applications with clinical data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and state agencies, and are subject to periodic unannounced inspections by the FDA and these state agencies for compliance with cGMP requirements. Changes to the manufacturing process are strictly regulated and often require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting and documentation requirements upon the sponsor and any third-party manufacturers that the sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money, and effort in the areas of production and QC to maintain cGMP compliance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Once an approval is granted, the FDA may withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including AEs of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information, imposition of post-marketing studies or clinical studies to assess new safety risks, or imposition of distribution or other restrictions under a REMS program. Other potential consequences include, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fines, warning letters or holds on post-approval clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">refusal of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or revocation of product license approvals;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">product seizure or detention, or refusal to permit the import or export of products; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">injunctions or the imposition of civil or criminal penalties.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Drugs may be promoted only for the approved indications and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Patent term restoration and marketing exclusivity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Depending upon the timing, duration, and specifics of FDA approval of the use of our product candidates, some of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, referred to as the Hatch-Waxman Act. The Hatch-Waxman Act permits a patent term to be extended up to 5&#160;years as compensation for patent term effectively lost due to the FDA&#8217;s pre-market approval requirements. However, patent term restoration cannot extend the remaining term of a patent beyond a total of 14&#160;years from the product&#8217;s approval date. The patent term restoration period is generally one-half of the time between the effective date of an IND and the submission date of an NDA, plus the time between the submission date of an NDA and the approval of that application, except that the review period is reduced by any time during which the applicant failed to </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">113</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">exercise due diligence. Only one patent applicable to an approved drug is eligible for the extension. Extensions are not granted as a matter of right and the extension must be applied for prior to expiration of the patent and within a 60-day period from the date the product is first approved for commercial marketing. The USPTO, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. Where a product contains multiple active ingredients, if any one active ingredient has not been previously approved, it can form the basis of an extension of patent term provided the patent claims that ingredient or the combination containing it.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the future, we may apply for patent term restoration for some of our presently owned patents to add patent life beyond their current expiration date, depending on the expected length of clinical studies and other factors involved in the submission of the relevant NDA; however, there can be no assurance that any such extension will be granted to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Biologics Price Competition and Innovation Act of 2009 provides up to 12&#160;years of non-patent data exclusivity within the U.S. to the first applicant to gain approval of a Biologics License Application for a new biologic product that has not previously been approved by the FDA, which we refer to as a reference product. This 12-year data exclusivity does prohibit the FDA from approving a biosimilar or interchangeable product of such reference product until 12&#160;years after the licensure of such reference product. In addition, the FDA will not accept a biosimilar or interchangeable product application for review until 4&#160;years after the date of first licensure of such reference product. Under 21CFR314.108, 5&#160;years&#8217; exclusivity is also granted to new chemical entities that contain no active moiety that has been approved by the FDA under section 505(b). This market exclusivity bars the FDA from accepting for review any ANDA or 505(b)(2)&#160;application for a drug containing the same active moiety for (i)&#160;5&#160;years if an ANDA or 505(b)(2)&#160;application does not contain a paragraph IV certification to a listed patent, or (ii)&#160;4&#160;years if an ANDA or 505(b)(2)&#160;is submitted containing a paragraph IV certification to a listed patent. Moreover, pediatric exclusivity, if granted, may add 6&#160;months of exclusivity if the reference product has been studied with respect to a pediatric indication in accordance with certain regulatory requirements. A reference product may also be granted 7&#160;years of orphan-drug exclusivity for the treatment of a rare disease or condition under section 527(a)&#160;of FDCA, which would run in parallel with the 12&#160;years of data exclusivity of the reference product, if applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Non-U.S. regulation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In order to market any product outside of the U.S., we would need to comply with numerous and varying regulatory requirements of other countries and jurisdictions regarding quality, safety and efficacy, and governing, among other things, clinical studies, marketing authorization, commercial sales and distribution of our products. Whether or not we obtain FDA approval for a product, we would need to obtain the necessary approvals by the comparable foreign regulatory authorities before we can commence clinical studies or marketing of the product in foreign countries and jurisdictions. Although many of the issues discussed above with respect to the U.S. apply similarly in the context of the EU, the approval process varies between countries and jurisdictions and can involve additional product testing and additional administrative review periods, as described in greater detail below. The time required to obtain approval in other countries and jurisdictions might differ from and be longer than that required to obtain FDA approval. Regulatory approval in one country or jurisdiction does not ensure regulatory approval in another, but a failure or delay in obtaining regulatory approval in one country or jurisdiction may negatively impact the regulatory process in others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">EU drug review approval</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the EEA, which is comprised of the 27 Member States of the EU plus Norway, Iceland and Liechtenstein medicinal products can only be commercialized after obtaining a marketing authorization. There are two types of marketing authorization: the Community Marketing Authorization, which is issued by the EC through the Centralized Procedure based on the opinion of the Committee for Medicinal Products for Human Use (CHMP), a body of the EMA, and which is valid throughout the entire territory of the EEA; and the National Marketing Authorization, which is issued by the competent authorities of the Member States of the EEA and authorizes marketing only in that Member State&#8217;s national territory and not the EEA as a whole.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Centralized Procedure is compulsory for human medicines for the treatment of human immunodeficiency virus or acquired immune deficiency syndrome (AIDS), cancer, diabetes, neurodegenerative diseases, autoimmune and other immune dysfunctions, and viral diseases; for veterinary medicines for use as growth or yield enhancers; for medicines </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">114</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">derived from biotechnology processes, such as genetic engineering; for advanced-therapy medicines, such as gene-therapy, somatic cell-therapy or tissue-engineered medicines; and for officially designated &#8216;orphan medicines&#8217; (medicines used for rare human diseases). The Centralized Procedure is optional for products containing a new active substance not yet authorized in the EEA, or for products that constitute a significant therapeutic, scientific or technical innovation, or for products that are in the interest of public health in the EU. The National Marketing Authorization is for products not falling within the mandatory scope of the Centralized Procedure. Where a product has already been authorized for marketing in a Member State of the EEA, this National Marketing Authorization can be recognized in another Member State through the Mutual Recognition Procedure. If the product has not received a National Marketing Authorization in any Member State at the time of application, it can be approved simultaneously in various Member States through the Decentralized Procedure. Under the Decentralized Procedure, an identical dossier is submitted to the competent authorities of each of the Member States in which the marketing authorization is sought, one of which is selected by the applicant as the Reference Member State (RMS). If the RMS proposes to authorize the product, and the other Member States do not raise objections, the product is granted a National Marketing Authorization in all the Member States in which the authorization was sought. Before granting the marketing authorization, the EMA or the competent authorities of the Member States of the EEA assesses the risk&#8211;benefit balance of the product on the basis of scientific criteria concerning its quality, safety and efficacy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Regulation in the EU</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Product development, the regulatory approval process, and safety monitoring of medicinal products and their manufacturers in the EU proceed in much the same manner as they do in the U.S.. Therefore, many of the issues discussed above apply similarly in the context of the EU. In addition, drugs are subject to the extensive price and reimbursement regulations of the various EU Member States.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Clinical studies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As is the case in the U.S., the various phases of preclinical and clinical research in the EU are subject to significant regulatory controls. The new Clinical Trials Regulation (Regulation (EU) No 536/2014) came into force on 31 January 2022. The new Regulation repealed the Clinical Trials Directive (EC) No. 2001/20/EC and national implementing legislation in the EU Member States, which regulated clinical trials in the EU until the Regulation&#39;s entry into application. A transition period applies to new clinical trial submissions under the Regulation. New clinical trial applications may be submitted under the Clinical Trials Directive until 30 January 2023, after which all new clinical trial applications will need to be submitted under the Regulation. Ongoing clinical trials under the Clinical Trials Directive have until 30 January 2025 to transition to the Regulation. The Regulation, provides a system for the approval of clinical studies in the European Union via a single online platform known as the Clinical Trials Information System (CTIS) for approval to run a clinical trial in several European countries, making it more efficient to carry out such multinational trials. Under this system, a single application dossier is submitted through CTIS to all Concerned Member States (CMS) where it is intended to conduct the trial. Using a harmonized format, the dossier consists of two parts, Part I contains the more scientific documents, whereas Part II contains the national documents. The review and evaluation is coordinated by one of the Member States, referred to as the Reference Member State (RMS). The Reference Member State is responsible for the evaluation of Part I whereas Part II assessment will be conducted separately by each individual CMS for its own country, including the review by the Ethics Committee. A clinical trial may only be started after the positive assessment by the RMS, and the approval by each CMS. A clinical trial may only be undertaken if provision has been made for insurance or indemnity to cover the liability of the investigator or sponsor. In certain countries, the sponsor of a clinical trial has a strict (faultless) liability for any (direct or indirect) damage suffered by trial subjects. The sponsor of a clinical trial, or its legal representative, must be based in the EEA. European regulators and ethics committees also require the submission of AE reports during a study and a copy of the final study report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Marketing approval</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Marketing approvals under the EU regulatory system may be obtained through a centralized or decentralized procedure. The centralized procedure results in the grant of a single marketing authorization, which is valid for all (currently 27) EU Member States and the three European Free Trade Association (EFTA) members (Norway, Iceland and Liechtenstein).</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">115</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to Regulation (EC) No.&#160;726/2004, as amended, the centralized procedure is mandatory for drugs developed by means of specified biotechnological processes, advanced-therapy medicinal products, drugs for human use containing a new active substance for which the therapeutic indication is the treatment of specified diseases, including but not limited to AIDS, neurodegenerative disorders, auto-immune diseases and other immune dysfunctions, as well as drugs designated as orphan drugs. The CHMP also has the discretion to permit other products to use the centralized procedure if it considers them sufficiently innovative or they contain a new active substance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the marketing authorization application, the applicant must properly and sufficiently demonstrate the quality, safety and efficacy of the drug. Under the centralized approval procedure, the CHMP, possibly in conjunction with other committees, is responsible for drawing up the opinion of the EMA on any matter concerning the admissibility of the files submitted in accordance with the centralized procedure, such as an opinion on the granting, variation, suspension or revocation of a marketing authorization, and pharmacovigilance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The CHMP and other committees are also responsible for providing guidelines and have published numerous guidelines that may apply to our product candidates. These guidelines provide additional guidance on the factors that the EMA will consider in relation to the development and evaluation of drug products and may include, among other things, the preclinical studies required in specific cases, the manufacturing and control information that should be submitted in a marketing authorization application, and the post-approval measures required to monitor patients and evaluate the long-term efficacy and potential adverse reactions. Although these guidelines are not legally binding, we believe that our compliance with them is likely to be necessary to gain approval for any of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The maximum timeframe for the evaluation of a marketing authorization application by the CHMP under the centralized procedure is 210&#160;days after receipt of a valid application. This period will be suspended until such time as the supplementary information requested by the CHMP has been provided by the applicant. Likewise, this time limit will be suspended for the time allowed for the applicant to prepare oral or written explanations. When an application is submitted for a marketing authorization in respect of a drug that is of major interest from the viewpoint of public health and in particular therapeutic innovation, the applicant may request an accelerated assessment procedure. If the CHMP accepts such a request, the time limit of 210&#160;days will be reduced to 150&#160;days, but it is possible that the CHMP can revert to the standard time limit for the centralized procedure if it considers that it is no longer appropriate to conduct an accelerated assessment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the CHMP concludes that the quality, safety and efficacy of the product are sufficiently proven, it adopts a positive opinion. This is sent to the EC, which drafts a decision within approximately 67&#160;days following the CHMP opinion. After consulting with the Member States, the EC adopts a decision and grants a marketing authorization, which is valid for the whole of the EEA. The marketing authorization may be subject to certain conditions, which may include, without limitation, the performance of post-authorization safety and/or efficacy studies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The EMA has various programs, including accelerated assessment, conditional approval and PRIority MEdicines (PRIME), which are intended to increase agency interactions, expedite or facilitate the process for reviewing product candidates, and/or provide for initial approval on the basis of surrogate endpoints. One or more of our product candidates may qualify for some of these expedited development and review programs. However, even if a product candidate qualifies for one or more of these programs, the EMA may later decide that the product candidate no longer meets the conditions for qualification. Eligibility to the PRIME scheme is limited to products considered to offer a major therapeutic advantage in populations with high unmet need. PRIME is a voluntary scheme aimed at enhancing interaction and early dialogue with developers of promising medicines through achieving the early appointment of the Rapporteur for the product, optimizing development plans and speeding up evaluation so these medicines can reach patients earlier. Products benefiting from PRIME can expect to be eligible for accelerated assessment at the time of application for a marketing authorization application.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">EU legislation also provides for a system of regulatory data and market exclusivity. According to Article&#160;14(11) of Regulation (EC) No.&#160;726/2004, as amended, and Article&#160;10(1)&#160;of Directive 2001/83/EC, as amended, upon receiving marketing authorization, new chemical entities approved on the basis of a complete independent data package benefit from 8&#160;years of data exclusivity and an additional 2&#160;years of market exclusivity. Data exclusivity prevents regulatory authorities in the EU from referencing the innovator&#8217;s data to assess a generic (abbreviated) application. During the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">116</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">additional 2-year period of market exclusivity, a generic marketing authorization can be submitted, and the innovator&#8217;s data may be referenced, but no generic medicinal product can be marketed until the expiration of the market exclusivity. The overall 10-year period will be extended to a maximum of 11&#160;years if, during the first 8&#160;years of those 10&#160;years, the marketing authorization holder (MAH) obtains an authorization for one or more new therapeutic indications that, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies. Even if a compound is considered to be a new chemical entity and the innovator can gain the period of data exclusivity, another company nevertheless could also market another version of the drug if such company obtained marketing authorization based on a marketing authorization application with a completely independent data package of pharmaceutical test, preclinical tests and clinical studies. However, products designated as orphan medicinal products enjoy, upon receiving marketing authorization, a period of 10&#160;years of orphan market exclusivity. See also &#8220;&#8212;Orphan drug regulation&#8221; below. Depending upon the timing and duration of the EU marketing authorization process, products may be eligible for an SPC of up to 5&#160;years&#8217;, pursuant to Regulation (EC) No.&#160;469/2009. Such SPCs extend the rights under the basic patent for the drug.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the EU, the pediatric regulation [Regulation (EC) No 1901/2006 as amended] requires sponsors to submit a pediatric investigation plan at the end of Phase 1. This plan will provide the details of the quality, non-clinical and clinical studies required to support the authorization of a pediatric indication. Additional rules&#160;apply to medicinal products for pediatric use under Regulation (EC) No.&#160;1901/2006. Potential incentives include a six-month extension of any supplementary protection certificate granted pursuant to Regulation (EC) No.&#160;469/2009, but not in cases in which the relevant product is designated as an orphan medicinal product pursuant to Regulation (EC) No.&#160;141/2000, as amended. Instead, a medicinal product designated as an orphan medicinal product may enjoy an extension of the 10-year market exclusivity period granted under Regulation (EC) No.&#160;141/2000 to 12&#160;years subject to the conditions applicable to orphan drugs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Orphan drug regulation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the EU, Regulation (EC) No.&#160;141/2000, as amended, states that a drug will be designated as an orphan drug if its sponsor can establish:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">that it is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition affecting not more than 5 in 10,000 persons in the EU when the application is made, or that it is intended for the diagnosis, prevention or treatment of a life-threatening, seriously debilitating or serious and chronic condition in the EU and that without incentives it is unlikely that the marketing of the drug in the EU would generate sufficient return to justify the necessary investment; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">that there exists no satisfactory method of diagnosis, prevention or treatment of the condition in question that has been authorized in the EU or, if such method exists, that the drug will be of significant benefit to those affected by that condition.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Regulation (EC) No.&#160;847/2000 sets out further provisions for implementation of the criteria for designation of a drug as an orphan drug. An application for the designation of a drug as an orphan drug must be submitted at any stage of development of the drug before filing of a marketing authorization application.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">If an EU-wide community marketing authorization in respect of an orphan drug is granted or if all the EU Member States have granted marketing authorizations in accordance with the procedures for mutual recognition, the EU and the Member States will not, for a period of 10&#160;years, accept another application for a marketing authorization, or grant a marketing authorization or accept an application to extend an existing marketing authorization, for the same therapeutic indication, in respect of a similar drug. This period may, however, be reduced to 6&#160;years if, at the end of the fifth&#160;year, it is established, with respect to the drug concerned, that the criteria for orphan-drug designation are no longer met; in other words, when it is shown on the basis of available evidence that the product is sufficiently profitable not to justify </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">117</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">maintenance of market exclusivity. Notwithstanding the foregoing, a marketing authorization may be granted, for the same therapeutic indication, to a similar drug if:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the holder of the marketing authorization for the original orphan drug has given its consent to the second applicant;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the holder of the marketing authorization for the original orphan drug is unable to supply sufficient quantities of the drug; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the second applicant can establish in the application that the second drug, although similar to the orphan drug already authorized, is safer, more effective or otherwise clinically superior.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Other incentives available to orphan drugs in the EU include financial incentives such as a reduction of fees or fee waivers and protocol assistance. Orphan-drug designation does not shorten the duration of the regulatory review and approval process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Manufacturing and manufacturers&#8217; license</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to Directive 2003/94/EC, as transposed into the national laws of the Member States, the manufacturing of investigational medicinal products and approved drugs is subject to a separate manufacturer&#8217;s license and must be conducted in strict compliance with cGMP requirements, which mandate the methods, facilities and controls used in manufacturing, processing and packing of drugs to assure their safety and identity. Manufacturers must have at least one qualified person permanently and continuously at their disposal. The qualified person is ultimately responsible for certifying that each batch of finished product released onto the market has been manufactured in accordance with cGMP and the specifications set out in the marketing authorization or investigational medicinal product dossier. cGMP requirements are enforced through mandatory registration of facilities and inspections of those facilities. Failure to comply with these requirements could interrupt supply and result in delays, unanticipated costs and lost revenues, and subject the applicant to potential legal or regulatory action, including but not limited to warning letters, suspension of manufacturing, seizure of product, injunctive action, or possible civil and criminal penalties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Wholesale distribution and license</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to Directive 2001/83/EC, the wholesale distribution of medicinal products is subject to the possession of an authorization to engage in activity as a wholesaler in medicinal products. Possession of a manufacturing authorization includes authorization to distribute by wholesale the medicinal products covered by that authorization. The distribution of medicinal products must comply with the principles and guidelines of cGDP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Advertising</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the EU, the promotion of prescription medicines is subject to intense regulation and control, including EU and national legislation as well as self-regulatory codes (industry codes). Advertising legislation <i style="font-style:italic;">inter alia</i> includes a prohibition on direct-to-consumer advertising. All advertising of prescription medicines must be consistent with the product&#8217;s approved Summary of Product Characteristics, and must be factual, accurate, balanced and not misleading. Advertising of prescription medicines pre-approval or off-label is not allowed. Some jurisdictions require that all promotional materials for prescription medicines be subjected to prior review and approval, either internal or regulatory.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Other regulatory requirements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">An MAH for a medicinal product is legally obliged to fulfill a number of obligations by virtue of its status as an MAH. The MAH can delegate the performance of related tasks to third parties, such as distributors or marketing partners, provided that this delegation is appropriately documented and the MAH maintains legal responsibility and liability.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">118</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 36pt;">The obligations of an MAH include the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Manufacturing and batch release</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;MAHs should guarantee that all manufacturing operations comply with relevant laws and regulations, applicable GMPs, and the product specifications and manufacturing conditions set out in the marketing authorization, and that each batch of product is subject to appropriate release formalities.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Availability and continuous supply</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;Pursuant to Directive 2001/83/EC, as transposed into the national laws of the Member States, the MAH for a medicinal product and the distributors of the said medicinal product actually placed on the market in a Member State shall, within the limits of their responsibilities, ensure appropriate and continued supplies of that medical product to pharmacies and persons authorized to supply medicinal products so that the needs of patients in the Member State in question are covered.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Pharmacovigilance</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;MAHs are obliged to establish and maintain a pharmacovigilance system, including a qualified person responsible for oversight, to submit safety reports to the regulators and to comply with the good pharmacovigilance practice guidelines adopted by the EMA.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Advertising and promotion</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;MAHs remain responsible for all advertising and promotion of their products, including promotional activities by other companies or individuals on their behalf, and in some cases must conduct internal or regulatory pre-approval of promotional materials. Regulation in this area also covers interactions with healthcare practitioners and/or patient groups, and in some jurisdictions legal or self-regulatory obligations to disclose such interactions exist.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Medical affairs/scientific service</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;MAHs are required to disseminate scientific and medical information on their medicinal products to healthcare professionals, regulators and patients.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Legal representation and distributor issues</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;MAHs are responsible for regulatory actions or inactions of their distributors and agents.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Preparation, filing and maintenance of the application and subsequent marketing authorization</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212; MAHs must maintain appropriate records, comply with the marketing authorization&#8217;s terms and conditions, fulfill reporting obligations to regulators, submit renewal applications and pay all appropriate fees to the authorities. We may hold any future marketing authorizations granted for our product candidates in our own name, or appoint an affiliate or a collaboration partner to hold marketing authorizations on our behalf. Any failure by an MAH to comply with these obligations may result in regulatory action against an MAH and ultimately threaten our ability to commercialize our products.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Pricing and reimbursement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the EU, the pricing and reimbursement mechanisms by private and public health insurers vary largely by country and even within countries. The public systems reimbursement for standard drugs is determined by guidelines established by the legislator or responsible national authority. The approach taken varies by Member State. Some jurisdictions operate positive and negative list systems under which products may only be marketed once a reimbursement price has been agreed. Other Member States allow companies to fix their own prices for medicines, but monitor and control company profits and may limit or restrict reimbursement. The downward pressure on healthcare costs in general, particularly prescription drugs, has become very intense. As a result, increasingly high barriers to the entry of new products are being erected and some EU countries require the completion of studies that compare the cost-effectiveness of a particular product candidate with that of currently available therapies in order to obtain reimbursement or pricing approval. Special pricing and reimbursement rules&#160;may apply to orphan drugs. Inclusion of orphan drugs in reimbursement systems tend to focus on the medical usefulness, need, quality and economic benefits to patients and the healthcare system as for any drug. Acceptance of any medicinal product for reimbursement may come with cost, use and often volume restrictions, which again can vary by country. In addition, results based rules&#160;of reimbursement may apply.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">119</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Other U.S. healthcare laws</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition to FDA restrictions on marketing of pharmaceutical or biopharmaceutical products, federal and state healthcare laws restrict certain business practices in the pharmaceutical and biopharmaceutical industries. These laws include, but are not limited to, anti-kickback, false claims, data privacy and security, and transparency statutes and regulations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The U.S. federal Anti-Kickback Statute prohibits, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration, directly or indirectly, to induce, or in return for, purchasing, leasing, ordering or arranging for the purchase, lease or order of any good, facility, item or service reimbursable under Medicare, Medicaid or other federal healthcare programs. The term &#8220;remuneration&#8221; has been broadly interpreted to include anything of value, including for example, gifts, discounts, the furnishing of supplies or equipment, credit arrangements, payments of cash, waivers of payment, ownership interests and providing anything at less than its fair market value. The Anti-Kickback Statute has been interpreted to apply to arrangements between pharmaceutical and biopharmaceutical manufacturers on the one hand and prescribers, purchasers and formulary managers on the other. Although there are a number of statutory exceptions and regulatory safe harbors protecting certain common activities from prosecution, the exceptions and safe harbors are drawn narrowly, and our practices may not in all cases meet all the criteria for a statutory exception or safe harbor protection. Practices involving remuneration that may be alleged to be intended to induce prescribing, purchases or recommendations may be subject to scrutiny if they do not qualify for an exception or safe harbor. Failure to meet all the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct <i style="font-style:italic;">per se</i> illegal under the Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all its facts and circumstances. Several courts have interpreted the statute&#8217;s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal healthcare-covered business, the statute has been violated. The Patient Protection and Affordable Care Act as amended by the Health Care and Education Reconciliation Act (collectively, the Health Care Reform Law), amended the intent requirement under the Anti-Kickback Statute and criminal healthcare fraud statutes (discussed below) such that a person or entity no longer needs to have actual knowledge of the statute or the specific intent to violate it in order to have committed a violation. In addition, the Health Care Reform Law provides that the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act (discussed below). Further, the Civil Monetary Penalties Law imposes penalties against any person or entity that, among other things, is determined to have presented or caused to be presented a claim to a federal health program that the person knows or should know is for an item or service that was not provided as claimed or is false or fraudulent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The federal false claims laws prohibit, among other things, any person or entity from knowingly presenting, or causing to be presented, a false or fraudulent claim for payment or approval to the federal government or knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim to the federal government. As a result of a modification made by the Fraud Enforcement and Recovery Act of 2009, a claim includes &#8220;any request or demand&#8221; for money or property presented to the U.S. government. Recently, several pharmaceutical and other healthcare companies have been prosecuted under these laws for, among other things, allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product. Other companies have been prosecuted for causing false claims to be submitted because of the companies&#8217; marketing of the product for unapproved, and thus non-covered, uses. The federal HIPAA created new federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors, and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of, or payment for, healthcare benefits, items or services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, the Health Care Reform Law also included the federal Physician Payments Sunshine Act, which requires that certain manufacturers of drugs, devices, biologicals and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) to report information related to certain payments or other transfers of value made or distributed to physicians and teaching hospitals, or to entities or individuals at the request of, or designated on behalf of, the physicians and teaching hospitals and to report annually certain ownership and investment interests held by physicians and their immediate family members.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">120</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, many states have similar healthcare statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payor. Certain states require the posting of information relating to clinical studies, and require pharmaceutical companies to implement a comprehensive compliance program that includes a limit on expenditures for, or payments to, individual medical or health professionals and to track and report gifts and other payments made to physicians and other healthcare providers. If our operations are found to be in violation of any of the health regulatory laws described above or any other laws that apply to us, we may be subject to penalties, including potentially significant criminal, civil and/or administrative penalties, damages, fines, disgorgement, individual imprisonment, exclusion of products from reimbursement under government programs, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations. To the extent that any of our products will be sold in a foreign country, we may be subject to similar foreign laws and regulations, which may include, for instance, applicable post-marketing requirements, including safety surveillance, anti-fraud and abuse laws, implementation of corporate compliance programs and reporting of payments or transfers of value to healthcare professionals.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Data privacy and security laws</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, we may be subject to international, federal and state data privacy and security laws, regulations, rules&#160;and standards. Internationally, laws, regulations and standards in many jurisdictions, such as the GDPR, the Swiss Federal Data Protection Act and the UK GDPR, apply broadly to the collection, use, retention, security, disclosure, transfer and other processing of personal information. At the federal level, HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (HITECH), and its implementing regulations, imposes certain requirements relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#8217;s privacy and security standards directly applicable to business associates&#8212;independent contractors or agents of covered entities that receive or obtain protected health information in connection with providing a service on behalf of a covered entity. HITECH also created four new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and to seek attorneys&#8217; fees and costs associated with pursuing federal civil actions. In addition, state laws, (such as the CCPA and the CPRA,) govern the privacy and security of health and other personal information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. Non-compliance with these laws, regulations, rules&#160;and standards could result in significant penalties or legal liability. Although we take steps to comply with applicable laws, rules&#160;and regulations, we cannot ensure that we will not be subject to regulatory or private actions, investigations, disputes and litigation, which may include substantial fines or other legal liability for noncompliance of data privacy and security laws, rules&#160;and regulations, including in the event of a cybersecurity breach or other security incident. We could be adversely affected if legislation or regulations are expanded to require changes in our or our third-party service providers&#8217; business practices or if governing jurisdictions interpret or implement their legislation or regulations in ways that negatively affect our business, results of operations or financial condition. See &#8220;Risk Factors&#8212; <i style="font-style:italic;">Changes in laws, rules&#160;or regulations relating to data privacy and security, or any actual or perceived failure by us to comply with such laws, rules, regulations and standards, or contractual or other obligations relating to data privacy and security, could have a material adverse effect on our reputation, results of operations, financial condition and cash flows.</i>&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Pharmaceutical coverage, pricing and reimbursement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In both domestic and foreign markets, our or our collaboration partners&#8217; sales of any approved products will depend in part on the availability of coverage and adequate reimbursement from third-party payors. Third-party payors include government authorities, managed care providers, private health insurers and other organizations. Patients who are prescribed treatments for their conditions and providers performing the prescribed services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Patients are unlikely to use our products, if approved, unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost of our products. Sales of our products will therefore depend substantially, both domestically and abroad, on the extent to which the costs of our products will be paid by third-party payors. These third-party payors are increasingly focused on containing healthcare costs by challenging the price and examining the cost-effectiveness of medical products and services.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">121</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, significant uncertainty exists as to the coverage and reimbursement status of newly approved healthcare product candidates. The market for our product candidates for which we may receive regulatory approval will depend significantly on access to third-party payors&#8217; drug formularies, or lists of medications for which third-party payors provide coverage and reimbursement. The industry competition to be included in such formularies often leads to downward pricing pressures on pharmaceutical or biopharmaceutical companies. Additionally, third-party payors may refuse to include a particular branded drug in their formularies or otherwise restrict patient access to a branded drug when a less costly generic equivalent or another alternative is available. Because each third-party payor individually approves coverage and reimbursement levels, obtaining coverage and adequate reimbursement is a time-consuming, costly and sometimes unpredictable process. We may be required to provide scientific and clinical support for the use of any product to each third-party payor separately with no assurance that approval would be obtained, and we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the cost-effectiveness of our products. This process could delay the market acceptance of any product and could have a negative effect on our future revenues and operating results. We cannot be certain that our product candidates will be considered cost-effective. Because coverage and reimbursement determinations are made on a payor-by-payor basis, obtaining acceptable coverage and reimbursement from one payor does not guarantee we will obtain similar acceptable coverage or reimbursement from another payor. If we are unable to obtain coverage of, and adequate reimbursement and payment levels for, our product candidates from third-party payors, physicians may limit how much or under what circumstances they will prescribe or administer them and patients may decline to purchase them. This in turn could affect our ability to successfully commercialize our products and impact our profitability, results of operations, financial condition and future success.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Furthermore, in many foreign countries, particularly the countries of the EU, the pricing of prescription drugs is subject to government control. In some non-U.S. jurisdictions, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from country to country. For example, the EU provides options for its Member States to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. A Member State may approve a specific price for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. We may face competition for our product candidates from lower-priced products in foreign countries that have placed price controls on pharmaceutical or biopharmaceutical products. In addition, there may be importation of foreign products that compete with our own products, which could negatively impact our profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Healthcare reform</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the U.S., EU and other jurisdictions, there have been, and we expect there will continue to be, a number of legislative and regulatory changes to the healthcare system that could affect our future results of operations as we begin to commercialize our products directly.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In particular, there have been and continue to be a number of initiatives at the U.S. federal and state level that seek to reduce healthcare costs. Initiatives to reduce the federal deficit and to reform healthcare delivery are increasing cost-containment efforts. We anticipate that Congress, state legislatures and the private sector will continue to review and assess alternative benefits, controls on healthcare spending through limitations on the growth of private health insurance premiums and Medicare and Medicaid spending, the creation of large insurance purchasing groups, price controls on pharmaceuticals and other fundamental changes to the healthcare delivery system. Any proposed or actual changes could limit or eliminate our spending on development projects and affect our ultimate profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are not sure whether additional legislative changes will be enacted, or whether the FDA regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals of our product candidates, if any, may be. In addition, increased scrutiny by the U.S. Congress of the FDA&#8217;s approval process may significantly delay or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing approval testing and other requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In addition, there has been heightened governmental scrutiny in the U.S. of pharmaceutical pricing practices in light of the rising cost of prescription drugs and biologics. Such scrutiny has resulted in several recent congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">122</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. At both the federal and state level, legislatures are increasingly passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. One significant example of recent legislative action is the IRA, which has been considered a scaled-back version of the Build Back Better Act. The IRA was signed into law on August 16, 2022. While the IRA is still subject to rulemaking (with more information to come via guidance documents from the responsible federal agencies), the IRA, as written, will, among other changes, give HHS the ability and authority to directly negotiate with manufacturers the price that Medicare will pay for certain high-priced drugs. The IRA will also require manufacturers of certain Part B and Part D drugs to issue to HHS rebates based on certain calculations and triggers (i.e., when drug prices increase and outpace the rate of inflation). At this time, we cannot predict the implications the IRA provisions will have on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the future, there may continue to be additional proposals relating to the reform of the U.S. healthcare system, some of which could further limit the prices we are able to charge for our products candidates, or the amounts of reimbursement available for our product candidates. If future legislation were to impose direct governmental price controls and access restrictions, it could have a significant adverse impact on our business. Managed care organizations, as well as Medicaid and other government agencies, continue to seek price discounts. Some states have implemented, and other states are considering, price controls or patient access constraints under the Medicaid program, and some states are considering price-control regimes that would apply to broader segments of their populations that are not Medicaid-eligible. Due to the volatility in the current economic and market dynamics, we are unable to predict the impact of any unforeseen or unknown legislative, regulatory, payor or policy actions, which may include cost-containment and healthcare-reform measures. Such policy actions could have a material adverse impact on our profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Moreover, the federal Drug Supply Chain Security Act imposes new obligations on manufacturers of pharmaceutical or biopharmaceutical products, among others, related to product tracking and tracing. Among the requirements of this new federal legislation, manufacturers will be required to provide certain information regarding the drug product to individuals and entities to which product ownership is transferred, label drug product with a product identifier, and keep certain records regarding the drug product. Further, under this new legislation, manufacturers will have drug product investigation, quarantine, disposition and notification responsibilities related to counterfeit, diverted, stolen and intentionally adulterated products, as well as products that are the subject of fraudulent transactions or that are otherwise unfit for distribution such that they would be reasonably likely to result in serious health consequences or death.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Physician Payment Sunshine Act and transparency</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Physician Payment Sunshine Act requires most pharmaceutical and biopharmaceutical manufacturers to report annually to the Secretary of Health and Human Services any and all financial arrangements, payments, or other transfers of value made by that entity to physicians and teaching hospitals. The payment information is made publicly available in a searchable format on a content management system website. Once we have an approved product, we will need to dedicate significant resources to establish and maintain systems and processes in order to comply with these regulations. Failure to comply with the reporting requirements can result in significant civil monetary penalties. Similar laws have been enacted or are under consideration in foreign jurisdictions, including France, which has adopted the Loi Bertrand, or French Sunshine Act, which became effective in 2013. In addition, the Code of Ethics from the EFPIA requires certain disclosures of interactions with institutions and healthcare professionals, depending on the jurisdictions in which we operate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Environmental, health and safety laws and regulations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We are subject to numerous environmental, health and safety laws and regulations and permitting requirements, including those governing laboratory procedures, decontamination activities, and the handling, transportation, use, remediation, storage, treatment, and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, and the risk of injury, contamination or noncompliance with environmental, health </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">123</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">and safety requirements cannot be eliminated. Although compliance with such laws and regulations and permitting requirements has not had a material effect on our capital expenditures, earnings or competitive position, environmental, health and safety laws, and regulations and permitting requirements have tended to become increasingly stringent and, to the extent that legal or regulatory changes may occur in the future, they could result in, among other things, increased costs to us or the impairment of our research, development or production efforts.</p><a id="COrganizationalstructure_904091"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Organizational structure</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a Swiss stock corporation (<i style="font-style:italic;">soci&#233;t&#233; anonyme</i>) organized under the laws of Switzerland. We were formed as a Swiss limited liability company (<i style="font-style:italic;">soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e</i>) on February&#160;13, 2003 with our registered office and domicile in Basel, Switzerland. We converted to a Swiss stock corporation (<i style="font-style:italic;">soci&#233;t&#233; anonyme</i>) under the laws of Switzerland on August&#160;25, 2003. Our Swiss enterprise identification number is CHE-109.878.825. Our domicile and registered office is in Ecublens, at the &#201;cole Polytechnique F&#233;d&#233;rale Lausanne (EPFL) Innovation Park Building B, 1015 Lausanne, Vaud, Switzerland. Our common shares were admitted to trading on Nasdaq Global Market on September&#160;23, 2016, and trade under the symbol ACIU.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our general telephone number is (41) 21 345 91 21 and our internet address is www.acimmune.com. <span style="background:#ffffff;">References to our website address do not constitute incorporation by reference of the information contained on the website, and the information contained on the website is not part of this document or any other document that we file with or furnish to the SEC. </span>The SEC maintains an internet site that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC, which can be found at http://www.sec.gov. Our agent for service of process in the United States is Cogency Global&#160;Inc. located at 122 East 42nd Street, 18th Floor, New York, New York 10168. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company controls a fully-owned subsidiary, AC Immune USA,&#160;Inc. (&#8220;AC Immune USA&#8221; or &#8220;Subsidiary&#8221;), which was registered and organized under the laws of Delaware, USA in Q2 2021. The Company and its Subsidiary form the Group.</p><a id="DPropertyplantandequipment_864198"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s capital expenditures were CHF 0.9 million in 2022 with CHF 0.8 million for laboratory equipment, additional laboratory space and leasehold improvements. These investments were made to enhance our research facilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Facilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We do not own any real property. The table below details the sizes and uses of our leased facilities as of December&#160;31, 2022:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.56%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3.35%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:31.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3.35%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:28.55%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style="height:12.25pt;"><td style="vertical-align:top;width:33.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Location</b></p></td><td style="vertical-align:top;width:3.35%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Primary Function</b></p></td><td style="vertical-align:top;width:3.35%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:28.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Approximate Size </b></p></td></tr><tr style="height:12.8pt;"><td style="vertical-align:top;width:33.56%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">&#201;cole Polytechnique F&#233;d&#233;rale Lausanne (EPFL) </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Innovation Park Building B,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">1015 Lausanne, Vaud, Switzerland</p></td><td style="vertical-align:top;width:3.35%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.15%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Headquarters</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Research, discovery, preclinical and clinical development</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Chemistry manufacturing and control</p></td><td style="vertical-align:top;width:3.35%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:28.55%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">27,000 square feet</p></td></tr><tr style="height:3.5pt;"><td style="vertical-align:top;width:33.56%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">1230 Avenue of the Americas</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Suite&#160;1634</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">New York, New York 10020</p></td><td style="vertical-align:top;width:3.35%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">U.S. operations</p></td><td style="vertical-align:top;width:3.35%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:28.55%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">1,600 square feet</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">124</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_Hlk114777300"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Innovation Park of the EPFL serves as our corporate headquarters, our research facility and laboratories. We believe that using the EPFL facilities instead of building our own infrastructure helps us to maximize the value of our research and development capital and make efficient use of our funds as we continue to build and develop our pipeline. We believe that the space of our existing facilities is sufficient to meet our current needs.</p><a id="_1aa193b8_0fb4_4b67_841d_0e14376b2788"></a><a id="ITEM4AUNRESOLVEDSTAFFCOMMENTS_558751"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;4A. UNRESOLVED STAFF COMMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">None.</p><a id="_11cc6eb0_cbd4_4a67_991b_2c3b689cc1fb"></a><a id="ITEM5OPERATINGANDFINANCIALREVIEWANDPROSP"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements, including the notes thereto, included in this Annual Report. The following discussion is based on our financial information prepared in accordance with IFRS as issued by the IASB, which might differ in material respects from generally accepted accounting principles in other jurisdictions. The following discussion includes forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including but not limited to those described under &#8220;Item&#160;3. Key information&#8212;D. Risk factors&#8221; and elsewhere in this Annual Report.</p><a id="AOperatingresults_466589"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Operating results</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, we have primarily financed our operations through the proceeds from our public offerings, share issuances, contract revenues from license and collaboration agreements and grants. We have no products approved for commercialization and have never generated any revenues from product sales. Pharmaceutical and biopharmaceutical product development is a highly speculative undertaking and involves a substantial degree of risk. It may be several&#160;years, if ever, before we or our collaboration partners complete pivotal clinical studies and have a product candidate approved for commercialization, and we begin to generate revenue and royalties from product sales. Since our inception, we have received upfront and milestone payments from our collaboration partners and certain other revenue. However, we have also incurred significant operating losses. We incurred net losses of CHF 70.8&#160;million for the fiscal&#160;year ended December&#160;31, 2022 and have an accumulated losses balance of CHF&#160;264.0 million as of December&#160;31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Strategic collaborations and licensing agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Since our inception, we have entered into strategic collaboration agreements with a range of partners covering a number of our product candidates. We entered into a strategic collaboration with Genentech in November&#160;2006 (as amended in March&#160;2009, January&#160;2013, May&#160;2014 and May&#160;2015) regarding the development, manufacture and commercialization of anti-Abeta antibodies including crenezumab, and we refer to this agreement as the 2006 Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In June&#160;2012, we entered into an additional strategic collaboration agreement with Genentech regarding the development, manufacture and commercialization of anti-Tau antibodies, which covers semorinemab, and we refer to this agreement as the 2012 Agreement. We expect to capitalize on Genentech&#8217;s drug development and regulatory expertise and commercial capabilities to bring our partnered therapeutic products to market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2014 (as amended in June 2022), we entered into a license and collaboration agreement with LMI (formerly Piramal Imaging SA) covering our Tau-PET Imaging tracers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In December&#160;2014 (as amended in April&#160;2016, July&#160;2017, January&#160;2019, November&#160;2019 and December 2022), we entered into a strategic collaboration agreement with Janssen regarding the development, manufacture and commercialization of anti-Tau vaccines, which covers ACI-35. We expect to capitalize on Janssen and Johnson&#160;&amp; </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">125</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Johnson&#8217;s extensive regulatory expertise and experience in developing, manufacturing and, if approved, commercializing vaccines to bring ACI-35 to market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We entered into a license agreement with Lilly in December&#160;2018 (as amended in September&#160;2019 and March&#160;2020) to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases. Under the terms of this agreement, we have completed a Phase 1 clinical study with ACI-3024. Lilly is responsible for leading and funding further clinical development for small molecule Tau aggregation inhibitors with plans to evaluate candidates in AD and NeuroOrphan tauopathies. Lilly will also retain global commercialization rights for all indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Genentech, a member of the Roche Group</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have two partnership agreements with Genentech, a company with a reputation for scientific excellence and a history of bringing innovative protein therapeutics to market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Anti-Abeta antibody in AD&#160;&#8211; 2006 agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In November&#160;2006, we signed an exclusive, worldwide licensing agreement for crenezumab, our humanized monoclonal therapeutic antibody targeting misfolded Abeta. The agreement was amended March&#160;2009, January&#160;2013, May&#160;2014 and May&#160;2015. The agreement also provides for the development of a second therapeutic product for a non-AD indication based on the same intellectual property and anti-Abeta antibody compound. The value of this partnership is potentially greater than USD 340 (CHF 317) million. The structure of the collaboration agreement is as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A right-of-use license;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Clinical milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon commencement of each of Phase 1 and Phase 2 of clinical developments, and upon the earlier of Genentech&#8217;s decision to authorize Phase 3 or the commencement of Phase 3 of clinical developments. In addition, for a second indication, clinical milestone payments would be payable upon commencement of Phase 2 of clinical developments and upon the earlier of Genentech&#8217;s decision to authorize Phase 3 or the commencement of Phase 3 of clinical developments;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Regulatory milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon making regulatory filings in the U.S. and Europe, respectively, and milestone payments upon obtaining marketing approval in each of the U.S. and Europe. In addition, for a second indication, additional regulatory and approval milestones would be payable.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Royalties</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable on sales, with different royalty rates applicable in the U.S. and Europe. Royalty levels are tied to annual sales volumes. We may receive royalties on sales of crenezumab with the&#160;percentage rates ranging from the mid-single digits to mid-teens.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, we have received total milestone payments of USD 65 (CHF 70.1) million comprised of an upfront payment of USD 25 (CHF 31.6) million and of USD 40 (CHF 38.2) million for clinical development milestones achieved, all prior to January&#160;1, 2017.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the terms of the agreement, Genentech bears all the costs of developing crenezumab through the clinical phases. In addition, Genentech is responsible for the costs associated with seeking and obtaining regulatory and marketing approvals, along with manufacturing sales and marketing costs. The agreement will terminate by its terms on the date on which all obligations between the parties with respect to the payment of milestones or royalties for licensed products have passed or expired. Either party may terminate the agreement for any material breach by the other Party, provided a cure period of 90&#160;days from the date when that notice is given.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In January 2019, we announced that Roche, the parent of Genentech, is discontinuing the CREAD and CREAD 2 (BN29552 and BN29553) Phase 3 studies of crenezumab in people with prodromal-to-mild sporadic AD.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">126</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 8pt 0pt;"><span style="background:#ffffff;">In August 2022, the Company provided an update on its Alzheimer&#8217;s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer&#8217;s disease. Crenezumab did not statistically significantly slow or prevent cognitive decline in people with a specific genetic mutation which causes early-onset Alzheimer&#8217;s disease. However, numerical differences favoring crenezumab over placebo were observed across the co-primary, multiple secondary and exploratory endpoints. Initial data was presented at the Alzheimer&#39;s Association International Conference (AAIC) on August 2, 2022. All participants in the study were offered up to one year of continued treatment (crenezumab for all carriers and placebo for all non-carrier) following the end of the double-blind period while primary results and additional analyses were pending. Final efficacy visits have begun.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Anti-Tau antibody in AD&#160;&#8211; 2012 agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In June&#160;2012, we entered into a second agreement with Genentech to research, develop and commercialize our anti-Tau antibodies for use as immunotherapeutics and diagnostics. The agreement was amended in December&#160;2015. The value of this exclusive, worldwide alliance is potentially greater than CHF 400 million and includes upfront and clinical, regulatory and commercial milestone payments. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the mid-single digits to low-double digits. The agreement also provides for collaboration on at least one additional therapeutic indication outside of AD built on the same anti-Tau antibody program as well an anti-Tau diagnostic product.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, we have received payments totaling CHF 59 million, including a milestone payment of CHF 14 million received and recognized in Q4 2017 associated with the first patient dosing in a Phase 2 clinical trial for AD with an anti-Tau monoclonal body known as semorinemab, a milestone payment of CHF 14 million recognized in Q2 2016 and received in July&#160;2016, associated with the announcement of the commencement of the Phase 1 clinical study of semorinemab, and a milestone payment of CHF 14 million received in 2015 in connection with the ED-GO decision.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The structure of the collaboration agreement is as follows.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A right-of-use license.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Preclinical and clinical milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon selection of a lead candidate and commencement of each of Phase 1, 2 and 3 of clinical development. In addition, for a second indication, clinical milestone payments would be payable upon commencement of each of Phase 2 and 3 of clinical development.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Regulatory milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon making regulatory filings for marketing approvals in each of the U.S., Europe and Japan. In addition, for a second indication, similar regulatory milestones would be payable.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Commercialization milestones</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon making a first commercial sale in each of the U.S., Europe and Japan. For a second indication, commercialization milestones exist for each of the U.S., Europe and Japan, which are triggered by the first commercial sale for the second indication in each of those jurisdictions.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Royalties</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable on sales with royalty rates differing based on the source of the intellectual property underlying the commercial product. We may receive royalties on sales at a&#160;percentage rate ranging from the mid-single digits to low-double digits.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the terms of the agreement, Genentech bears all the costs of developing semorinemab through the clinical phases. In addition, Genentech is responsible for the costs associated with seeking and obtaining regulatory and marketing approvals, along with manufacturing, sales and marketing costs. The agreement will terminate by its terms on the date on which all obligations between the parties with respect to the payment of milestones or royalties for licensed products have passed or expired. Either party may terminate the agreement for any material breach by the other Party, provided a cure period of 90&#160;days from the date when that notice is given.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In September 2020, the Company reported that Genentech informed us of top line results from a Phase 2 trial of the anti-Tau antibody, semorinemab, in early (prodromal to mild) Alzheimer&#8217;s disease (AD) which show that semorinemab </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">127</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">did not meet its primary efficacy endpoint of reducing decline on Clinical Dementia Rating-Sum of Boxes (CDR-SB) compared to placebo. The primary safety endpoint was however met. Two secondary endpoints, ADAS-Cog13 and ADCS-ADL, were not met.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In August 2021, the Company reported that Genentech had informed the Company that the Lauriet study had met one of its co-primary endpoints, ADAS-Cog 11. The second co-primary endpoint, ADCS-ADL, was not met. Safety data showed that semorinemab was well tolerated with an acceptable safety profile and no unanticipated safety signals. In November 2021, the Company reported that Genentech had presented the full top-line data from the Lauriet study during a late-breaking session at the 14<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Clinical Trials on Alzheimer&#8217;s Disease conference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Janssen Pharmaceuticals,&#160;Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Tau Vaccine in AD&#160;&#8211; 2014 agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2014, we entered into an agreement with Janssen Pharmaceuticals,&#160;Inc. (Janssen), part of the Janssen Pharmaceutical Companies of Johnson&#160;&amp; Johnson, to develop and commercialize therapeutic anti-Tau vaccines for the treatment of AD and potentially other Tauopathies. The value of this collaboration is potentially up to CHF 500 million and includes upfront and clinical, regulatory and commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the high-single digits to the mid-teens for the phospho-Tau vaccine program. In April&#160;2016, July&#160;2017, January&#160;2019, November&#160;2019 and December 2022, the companies entered into the first, second, third, fourth and fifth amendments, respectively. These amendments allow for the alignment of certain payment and activity provisions with the Development Plan and Research Plan activities. We and Janssen have completed the co-development of the second-generation lead therapeutic vaccines, ACI-35.030 and JACI-35.054, through Phase 1b/2a. In November 2022, it was announced that ACI-35.030 was selected to advance into further development based on interim data from the ongoing Phase 1b/2a trial. AC Immune and Janssen will jointly share research and development costs until the completion of the first Phase 2b (AC Immune&#8217;s contribution to the first Phase 2b trial is capped). From Phase 2b and onwards, Janssen will assume responsibility for the clinical development, manufacturing and commercialization of ACI-35.030.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company received an upfront, non-refundable license fee of CHF 25.9 million, which we recognized as revenue in 2014. In May&#160;2016, we received a payment of CHF 4.9 million for reaching a clinical milestone in the Phase 1b study. As we met all performance obligations on reaching the milestone, we recognized this milestone as revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The structure of the collaboration agreement is as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A right-of-use license.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Clinical milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon reaching certain milestones in the Phase 1b study, commencement of the first Phase 2b or 2b/3 of clinical development, upon reaching enrollment thresholds in the first Phase 2b or Phase 2b part of the first Phase 2b/3, commencement of the first Phase 3 or Phase 3 part of a Phase 2b/3 study. In addition, for a second indication, clinical milestone payments would be payable upon commencement of a Phase 3 clinical study, which would be payable concurrently with the first regulatory milestone, if Janssen were to file for regulatory approval based on Phase 2 clinical data.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Regulatory milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon making regulatory filings in the U.S., Europe, and Japan, respectively. In addition, for a second indication, similar regulatory milestones would be payable. For a second indication, additional regulatory milestone payments are payable by Janssen to us upon receipt of each of the regulatory approvals in the U.S., Europe and Japan.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Commercialization milestones</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon making a first commercial sale in each of the U.S., Europe and Japan, and upon achieving certain commercial milestones.</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">128</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Royalties</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable on sales, with royalty rates differing based on the level of annual sales. We may receive royalties on sales at a&#160;percentage rate ranging from the high-single digits to the mid-teens for the phospho-Tau vaccine program.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the terms of the agreement, Janssen may terminate the agreement at any time after completion of the first Phase 1b clinical study in 2016 by providing 90&#160;days&#8217; notice to us. If not otherwise terminated, the agreement shall continue until the expiration of all royalty obligations as outlined in the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">LMI (formerly Piramal Imaging SA)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Tau-PET imaging agent&#160;&#8211; 2014 agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2014 (as amended in June 2022), we entered into an agreement, our first diagnostic partnership, with LMI, the former Piramal Imaging SA. The partnership with LMI is an exclusive, worldwide licensing agreement for the research, development and commercialization of the Company&#8217;s Tau protein PET tracers supporting the early diagnosis and clinical management of AD and other Tau-related disorders and includes upfront and sales milestone payments totaling up to EUR 160 (CHF 159) million, plus royalties on sales at a&#160;percentage rate ranging from mid-single digits to low-teens. LMI may terminate the LCA at any time by providing 3&#160;months&#8217; notice to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The structure of the collaboration agreement is as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A right-of-use license.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Clinical milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon the commencement of the Phase 1, 2 and 3 studies for generation of data intended to support a regulatory submission in the U.S. or the EU. We would be entitled to further clinical milestone payments for the commencement of a Phase 2 and 3 study for a second indication.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Regulatory milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon acceptance of Regulatory filing (NDA) and Regulatory approval for Commercialization in the U.S. or the EU.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Commercialization milestones</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: tied to specific annual net sales amounts.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Royalties: </i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">payable on sales, with royalty rates differing based on the level of annual sales. We may receive royalties on sales at a&#160;percentage rate ranging from the mid-single digits to the low-teens.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Eli Lilly and Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Morphomer Tau small molecule&#160;&#8211; 2018 license agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2018, we entered into an exclusive, worldwide licensing agreement with Eli Lilly and Company (Lilly) to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases. Per the terms of the agreement, the Company received an initial upfront payment of CHF 80 million in Q1 2019 for the rights granted by the Company to Lilly. To date, the Company has completed a Phase 1 clinical study with ACI-3024. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, the Company and Lilly have continued candidate characterization across the research program, identifying new and highly differentiated candidates with desired cerebrospinal fluid exposure and selectivity for pathological aggregated Tau. These will be broadly developed in Tau-dependent neurodegenerative diseases by Lilly. Lilly is responsible for leading and funding further clinical development and will retain global commercialization rights for all indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Per the terms of the agreement, the Company may become eligible to receive additional milestone payments totaling up to approximately CHF 1.9 billion.&#160;In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the low double-digits to the mid-teens. The agreement became effective in January 2019 </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">129</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">when the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired. In Q3 2019, the Company and Lilly entered into the first amendment to divide the first discretionary milestone payment under the agreement of CHF 60 million into two installments with the first CHF 30 million paid in Q3 2019 and the second CHF 30 million to be paid on or before March&#160;31, 2020 unless Lilly terminated the agreement earlier. In Q1 2020, the Company and Lilly entered into a second amendment to replace the second CHF 30 million to be paid on or before March&#160;31, 2020 with two milestone payments, one of CHF 10 million to be paid on or before March&#160;31, 2020 and the other of CHF 60 million following the first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or the EU.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company received an initial upfront payment of CHF 80 million in February&#160;2019. We used the residual approach to estimate the selling price for the right-of-use license and an expected cost plus margin approach for estimating the research and development activities. The right-of-use license was delivered on the effective date. The research and development activities were delivered over time as the services were performed. For these services, revenue was recognized over time using the input method, based on costs incurred to perform the services, as the level of costs incurred over time is thought to best reflect the transfer of services to Lilly.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The structure of the collaboration agreement is as follows.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">A</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">n </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">exclusive license: </i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">granted by us to Lilly under certain of our intellectual property to develop, manufacture and commercialize products containing Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases throughout the world in any indication.</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Clinical milestone payment</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">s: payable upon completion of the Lilly preclinical activities period and following the first patient dosed in a Phase 2 and Phase 3 clinical study of a licensed product in the U.S. or the EU.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Regulatory milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable within 60&#160;days after obtaining regulatory approval for any licensed product in the first indication and any licensed product in certain additional indications in the U.S., Europe and Japan, respectively.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Commercialization milestones</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon achieving certain commercial sales milestones.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Royalties</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable on sales with royalty rates differing based on the level of annual sales of licensed products. We may receive royalties on sales at a&#160;percentage rate ranging from the low double-digits to the mid-teens.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The agreement will terminate by the date of expiration of the last royalty term for the last licensed product. However, under the terms of the agreement, Lilly may terminate the agreement at any time after March&#160;31, 2020 by providing 3&#160;months&#8217; notice to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We and Lilly also entered into a convertible note agreement that became effective in January 2019 for USD 50 (CHF 50.3) million from Lilly. In Q2 2019, the Convertible Note&#160;Agreement with Lilly automatically converted in line with the terms of the agreement. As a result of this conversion, 3,615,328 of our common shares were issued to Lilly. This note is now fully settled and there is no further equity or cash consideration due to Lilly thereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Grants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Michael J. Fox Foundation for Parkinson&#8217;s Research</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In May&#160;2020, the Company, as part of a joint arrangement with Sk&#229;ne University Hospital (Sk&#229;ne) in Sweden, was awarded a USD 3.2 (CHF 3.0) million grant from the MJFF&#8217;s Ken Griffin Alpha-synuclein Imaging Competition. As part of this grant, AC Immune is eligible to receive USD 2.5 (CHF 2.3) million directly from the MJFF. Sk&#229;ne will receive USD 0.7 (CHF 0.7) million of the total grant directly from the MJFF over two&#160;years to conduct and support the clinical arm of the project. <span style="background:#ffffff;">In August 2022, the Company received follow-on grant funding as part of its joint arrangement with Sk&#229;ne totaling USD&#160;0.5&#160;(CHF&#160;0.5) million for the continued development of its alpha-synuclein PET </span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">130</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">imaging diagnostic agent. As part of this grant, the Company received USD&#160;0.4&#160;(CHF&#160;0.4) million directly from the MJFF. Sk&#229;ne will receive USD&#160;0.1&#160;(CHF&#160;0.1) million of the total grant directly from the MJFF over the duration of the grant period.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2021, the Company announced that it had been awarded two grants totaling USD 1.5 (CHF 1.4) million to advance small molecule PD programs. One award will support an existing early-stage program to develop small molecules that can prevent intracellular aggregation and spreading of a-syn. The other award will fund research on the therapeutic potential of chemically and mechanistically novel, brain penetrant small molecule inhibitors of NLRP3 inflammasome activation for the treatment of PD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Grant from the Target ALS Foundation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q1 2021, AC Immune was awarded a USD 0.3 (CHF 0.2) million grant from Target ALS. This grant funds a collaboration between the Company and the Investigators at the Healey Center for ALS at Massachusetts General Hospital (MGH) to accelerate the development of the Company&#8217;s proprietary immunoassays to detect disease-associated forms of TDP-43 in CSF and blood samples. The Company was awarded an additional one-year grant in December 2022 for USD 0.1 (CHF 0.1) million to continue the project.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Critical accounting policies and significant judgments and estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Revenue recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2014, the IASB issued IFRS 15 <i style="font-style:italic;">Revenue from Contracts with Customers, </i>which amends the guidance for accounting for revenues from contracts with customers. This IFRS replaces all current revenue standards in IFRS including IAS 11 <i style="font-style:italic;">Construction Contracts</i>, IAS 18 <i style="font-style:italic;">Revenue </i>and various interpretations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under IFRS 15, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of IFRS 15, the entity performs the following five steps: (i)&#160;identify the contract(s)&#160;with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of IFRS 15, the Company assesses the goods or services promised within each contract, and determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Contract revenue</i>. The Company enters into LCAs, which are within the scope of IFRS 15, under which it licenses certain proprietary rights to its product candidates and intellectual property to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees, development, regulatory and/or commercial milestone payments,&#160;payments for research and clinical services the Company provides through either its full-time employees or third-party vendors, and royalties on net sales of licensed commercialized products depending on the Company&#8217;s intellectual property. Each of these payments results in license, collaboration and other revenues, which are classified as contract revenue on the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><i style="font-style:italic;">Licenses of intellectual property</i>.&#160;If the license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are sold in conjunction with a related service, the Company uses </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">131</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If the performance obligation is settled over time, the Company determines the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, upfront fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Milestone payments</i>.&#160;At the inception of each arrangement that includes development, regulatory and/or commercial milestone payments, the Company evaluates whether the milestones are considered highly probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant cumulative revenue reversal would not occur in future periods, the associated milestone value is included in the transaction price. These amounts for the performance obligations under the contract are recognized as they are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments recorded would affect contract revenues and earnings in the period of adjustment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Research and development services</i>.&#160;The Company has certain arrangements with our collaboration partners that include contracting our employees for research and development programs. The Company assesses if these services are considered distinct in the context of each contract and, if so, they are accounted for as separate performance obligations. These revenues are recorded in contract revenue as the services are performed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Sublicense revenues</i>.&#160;The Company has certain arrangements with our collaboration partners that include provisions for sublicensing. The Company recognizes any sublicense revenues at the point in time it is highly probable to obtain and not subject to reversal in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Contract balances:</i>&#160;The Company receives payments and determines credit terms from its customers for its various performance obligations based on billing schedules established in each contract. The timing of revenue recognition, billings and cash collections results in billed other current receivables, accrued income (contract assets), and deferred income (contract liabilities) on the consolidated balance sheets. Amounts are recorded as other current receivables when the Company&#8217;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be 1&#160;year or less.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Accrued research and development costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We record accrued expenses for estimated costs of our research and development activities conducted by third-party service providers, which include among others the conduct of preclinical studies and clinical studies and contract manufacturing activities. We record accrued expenses for estimated costs of our research and development activities based upon the estimated amount of services provided but not yet invoiced, and we include these costs in accrued expenses on the consolidated balance sheets and within research and development expenses in the consolidated statements of income/(loss). These costs are a significant component of our research and development expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We record accrued expenses for these costs based on the estimated amount of work completed in accordance with agreements established with these third parties, which involves the following process:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">communicating with our applicable personnel to identify services that have been performed on our behalf and estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of actual costs;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">estimating and accruing expenses in our consolidated financial statements as of each balance sheet date based on facts and circumstances known to us at the time; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">periodically confirming the accuracy of our estimates with selected providers and adjusting, if necessary.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">132</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Examples of estimated research and development expenses that we accrue include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees paid to CROs in connection with preclinical and toxicology studies and clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees paid to investigative sites in connection with clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees paid to CMOs in connection with the production of our product candidates prior to qualifying for capitalization as inventory; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">professional service fees for consulting and related services.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We base our expense accruals related to clinical studies on our estimates of the services received and efforts expended pursuant to contracts with multiple research institutions and clinical CROs that conduct and manage clinical studies on our behalf. The financial terms of these agreements vary from contract to contract and may result in uneven payment flows. Payments under some of these contracts depend on factors such as the successful enrollment of patients and the completion of clinical study milestones. Our service providers predominantly invoice us&#160;monthly in arrears for services performed. In accruing service fees, we estimate the time period over which the services will be performed and the level of effort to be expended in each period. If we do not identify costs that we have begun to incur or if we underestimate or overestimate the level of services performed or the costs of these services, our actual expenses could differ from our estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, we have not experienced significant changes in our estimates of accrued research and development expenses after a reporting period. However, due to the nature of estimates, we may be required to make changes to our estimates in the future as we become aware of additional information about the status or conduct of our clinical studies and other research activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Options</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates an equity-settled, share-based compensation plan. The fair value of the employee services received in exchange for the grant of equity-based awards is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the instruments granted, excluding the impact of any non-market vesting conditions. Non-market vesting conditions are included in assumptions about the number of instruments that are expected to become exercisable. At each balance sheet date, the Company revises its estimates of the number of instruments that are expected to become exercisable. It recognizes the impact of the revision of original estimates, if any, prospectively in the consolidated statements of income/(loss), and a corresponding adjustment to equity over the remaining vesting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We estimate the fair value of all time-vested options as of the date of grant using the Black-Scholes option-pricing model. Key assumptions in determining the fair value of share options granted utilizing the Black-Scholes valuation method include the following:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:51.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:43.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:51.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assumption</b></p></td><td style="vertical-align:bottom;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:43.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Method of estimation</b></p></td></tr><tr><td style="vertical-align:bottom;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:51.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Estimated expected term of options</p></td><td style="vertical-align:bottom;width:2.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:43.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Simplified method</p></td></tr><tr><td style="vertical-align:bottom;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:51.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Expected volatility</p></td><td style="vertical-align:top;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:43.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">The Company&#8217;s actual volatility for the period congruent with the expected term of the underlying option</p></td></tr><tr><td style="vertical-align:bottom;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:51.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:top;width:2.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:43.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Yields of long-dated U.S. Treasury notes</p></td></tr><tr><td style="vertical-align:bottom;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:51.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Expected dividends</p></td><td style="vertical-align:top;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:43.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Zero percent as dividends have not been paid</p></td></tr><tr><td style="vertical-align:bottom;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:51.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Forfeiture rates</p></td><td style="vertical-align:top;width:2.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:43.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Historical and expected forfeiture data</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">133</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Restricted share units</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We estimate the fair value of restricted share units using a reasonable estimate of market value of the common shares on the date of the award. We classify our share-based payments as equity-classified awards as they are settled in our common shares. We measure equity-classified awards at their grant date fair value and do not subsequently re-measure them. Compensation costs related to equity-classified awards are equal to the fair value of the award at grant date amortized over the vesting period of the award using the graded method. We reclassify that portion of vested awards to share premium as the awards vested.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Right-of-use assets and lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 16 <i style="font-style:italic;">Leases</i>, which provides the model for lessee accounting in which all leases, other than short-term and low-value leases, are accounted for by the recognition on the consolidated balance sheet of a right-of-use asset and a lease liability, and the subsequent amortization of the right-of-use asset over the earlier of the end of the useful life or the lease term. In accordance with IFRS 16, the Company (i)&#160;does not recognize right-of-use assets and lease liabilities for leases of low value (i.e. approximate fair value of USD 5,000). For a complete discussion of accounting, see &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">In-process research and development (IPR&amp;D) asset</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s acquired IPR&amp;D asset is stated at cost less any impairments. Our IPR&amp;D asset is subject to impairment testing at least annually or when there are indications that the carrying value may not be recoverable until the completion of the development process. At that point, the capitalized amounts are amortized over their estimated useful life. The determination of the recoverable amounts include key estimates which are highly sensitive to, and depend upon, key assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company will not capitalize future development costs in respect to this IPR&amp;D asset until they meet the criteria for capitalization of research and development costs in accordance with IAS 38 <i style="font-style:italic;">Intangible Assets</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Net employee defined benefit liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates the mandatory pension schemes for its employees in Switzerland. The schemes are generally funded through payments to insurance companies. The Company has a pension plan designed to pay pensions based on accumulated contributions on individual savings accounts. However, this plan is classified as a defined benefit plan under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The net defined benefit liability is the present value of the defined benefit obligation at the balance sheet date minus the fair value of plan assets. Significant estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. The defined benefit obligation is calculated annually with the assistance of an independent actuary using the projected unit credit method, which reflects services rendered by employees to the date of valuation, incorporates assumptions concerning employees&#8217; projected salaries and pension increases as well as discount rates of highly liquid corporate bonds that have terms to maturity approximating the terms of the related liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To the extent that the fair value of the plan assets is greater than the present value of the defined benefit obligation as calculated by our independent actuary, the Company accounts for the effect of the asset ceiling test under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Re-measurements of the net defined benefit liability, which comprise actuarial gains and losses and the return on plan assets (excluding interest) are recognized immediately in the consolidated statements of other comprehensive income/(loss). Past service costs, including curtailment gains or losses, are recognized immediately as a split in research and development and general and administrative expenses within the operating results. Settlement gains or losses are recognized in either research and development and/or general and administrative expenses within the operating results. The Company determines the net interest expense/(income) on the net defined benefit liability for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period or in case of any </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">134</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">significant events between measurement dates to the then-net defined benefit liability, considering any changes in the net defined benefit liability during the period as a result of contributions and benefit payments. Net interest expense/(income) and other expenses related to defined benefit plans are recognized in the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Results of operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Covid-19 global pandemic has impacted various countries in which AC Immune currently operates clinical trials and business operations. The extent to which Covid-19 may impact us will depend on future developments, which are currently uncertain and cannot be predicted with confidence, such as the duration of the outbreak, the severity of Covid-19, or the effectiveness of actions to contain and treat Covid-19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company continues to effect its business continuity plan and adapt as the situation evolves. Since 2021, we have resumed normal operations at full capacity, with minimal disruption to our business. We are continuously assessing and adapting our working practices and business operations to ensure compliance with official guidance and orders related to the pandemic and are working proactively with our partners and other stakeholders to take steps intended to mitigate and minimize any negative impact to our research, clinical programs and other business operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company does not currently have or project material impacts to the ongoing key trials. Additionally, the Company has drug supplies that are expected to be sufficient to complete ongoing trials as well as additional drug substance supplies expected to be sufficient to support ongoing cohorts of clinical trials for a period of at least three to six&#160;months. The Company will refrain from starting new clinical trials if a minimum of a six-month supply on hand cannot be secured. Finally, the Company currently does not expect delays to its clinical trials due to manufacturing or supply-chain issues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Financial operations overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Contract revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Given our stage of development, we have not generated any revenue from product sales. Our contract revenues to date have been derived primarily from separate license and collaboration agreements on some of our product candidates in various stages of preclinical and clinical development.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our contract revenues have experienced fluctuations over the past three&#160;years as a result of the timing of milestone achievement and the size of each milestone payment. We expect that any revenue we generate from our collaboration agreements with each of Lilly, Genentech, Janssen and LMI and/or from any other current or future collaboration partners will fluctuate from&#160;year to&#160;year as a result of the timing and amount of milestones and other payments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Research and development costs are expensed as incurred, and consist of salaries and benefits, laboratory supplies, materials, intellectual property, facility and information technology (IT) costs, as well as fees paid to other non-employees and entities that conduct certain research and development activities on our behalf and all other allocated expenses. Amounts incurred in connection with license and collaboration agreements are also included in research and development expense. Payments made prior to the receipt of goods or services to be used in research and development are capitalized until those goods or services are received.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Clinical trial costs are a component of research and development expenses. We accrue and expense clinical trial activities performed by third parties based upon actual work completed in accordance with agreements established with clinical CROs and clinical sites. We determine the actual costs through monitoring patient enrollment and discussions with internal personnel and external service providers as to the progress or stage of completion of trials or services and the agreed-upon fee to be paid for such services.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">135</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Manufacturing start-up costs are a component of research and development expenses. Additionally, manufacturing costs incurred after regulatory approval but in connection with significant changes and/or enhancements to the approved manufacturing process are recorded as research and development expenses. We accrue and expense the manufacturing activities performed by third parties based upon actual work completed in accordance with agreements established with contract manufacturers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our investment in research and development activities, including the clinical development of our product candidates has historically been and is projected to be more than 75% of our total annual operating costs. Research and development expenses represent costs incurred to conduct research, such as the discovery and development of our product candidates, as well as development of new product candidates from our SupraAntigen and Morphomer platforms and the development of product candidates pursuant to our collaboration agreements with Lilly, Genentech, Janssen and LMI. We recognize all research and development costs as they are incurred. Clinical study costs, contract manufacturing and other development costs incurred by third parties are expensed as the contracted work is performed. At present, most of our research activities comprise three major areas:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">AD;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">focused non-AD NDD including Parkinson&#8217;s disease, ALS and NeuroOrphan indications; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">diagnostics.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We expect our research and development expenses to continue to increase in the future and expect to fund a broader number of projects, which will impact our research strategy in four key ways:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we expect to undertake later-stage research and development for certain of our product candidates and, if approved, to take some of those product candidates into commercialization;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we will allocate more funding to existing programs to advance the development of these programs;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(iii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we will increase our research and development efforts on non-AD indications including NeuroOrphans and diagnostics; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(iv)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we will initiate a number of new research initiatives that are complementary to our existing and planned research initiatives.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We expect that our total future research and development costs will increase over current levels in line with our three-pillar strategy that focuses on (i)&#160;AD, (ii)&#160;focused non-AD NDD including Parkinson&#8217;s disease, ALS and NeuroOrphan indications and (iii)&#160;diagnostics.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">General and administrative expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">General and administrative expenses include personnel costs, expenses for outside professional services and all other allocated expenses. Personnel costs consist of salaries, cash bonuses, benefits and share-based compensation. Outside professional services consist of legal, accounting and audit services, IT and other consulting fees. Allocated expenses consist of certain IT, facilities and depreciation expenses. We continue to incur additional expenses as a result of operating as a public company, including expenses related to compliance with the rules&#160;and regulations of the SEC, and those of any national securities exchange on which our securities are traded (Nasdaq), additional insurance expenses, investor relations activities and other administrative and professional services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Other operating income/(expense), net</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Other operating income/(expense) consists primarily of income associated with foundation grants such as those from the MJFF or Target ALS.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">136</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Finance result, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial income and expenses include bank fees associated with charges levied by banks on foreign payments, interest income and expense associated with our cash balances and interest expense associated with lease liabilities. For the&#160;year ended December&#160;31, 2021, we recognized a gain on the change in fair value of derivative financial assets associated with two convertible notes sold to certain Affiris affiliated entities that did not occur in the current or comparable prior period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Exchange differences consist of foreign exchange transactions and re-measurement gains and losses that arise from our cash being held in currency other than Swiss Francs, certain collaboration agreements such as the collaboration agreements with Genentech and LMI being denominated in currencies other than Swiss Francs, and selected purchases, which we effect in foreign currencies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Taxation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune is subject to corporate Swiss federal, cantonal and communal taxation, respectively, in Switzerland, Canton of Vaud, Commune of Ecublens, near Lausanne. We are also subject to taxation in other jurisdictions in which we operate, in particular, the United States where our wholly-owned subsidiary is incorporated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are entitled under Swiss laws to carry forward any losses incurred for a period of 7&#160;years and can offset our losses carried forward against future taxes. As of December&#160;31, 2022, we had tax loss carry-forwards totaling CHF 264.1 million (provisional amount; tax loss is definitively recognized by Swiss tax authorities once set-off against taxable income). There is no certainty that we will make sufficient profits to be able to utilize these tax loss carry-forwards in full.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effective corporate income tax rate (federal, cantonal and communal) where we are domiciled is currently 13.6%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of January&#160;1, 2020, the Company may request for 2020 and future tax&#160;years a tax relief of 60%, which would be applied to income from patents and similar rights at the communal and cantonal levels. This relief would first require the reintegration of all expensed and deducted research and development costs related to the concerned patents and similar rights for consideration in our taxable results from the prior ten&#160;years. The Company has not currently made any decision to enter this patent box system. Additionally, a &#8220;super-deduction&#8221; may be granted for payroll and other expenses of research and development of Swiss origins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">However, the aforementioned tax relief based on the patent box and deductions for research and development may not exceed 50% of the overall taxable profit before these tax relief and deductions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Notwithstanding the corporate income tax, the corporate capital is taxed at a rate of 0.1305% (cantonal and communal tax only, as there is no federal tax on capital).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Value added tax (VAT) is charged on all qualifying goods and services supplied by VAT-registered businesses. Rates vary based on category, but the Company applies a standard rate of 7.7% (the standard rate will increase to 8.1% as of January 1, 2024) on the value of the goods or services to all sales invoices, which is payable to the Swiss tax authorities. Similarly, VAT paid on purchase invoices is reclaimable from the Swiss tax authorities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Results of operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The numbers below have been derived from our audited consolidated financial statements included elsewhere in this Annual Report. The discussion below should be read along with these consolidated financial statements and it is qualified in its entirety by reference to them.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">137</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Comparison of the&#160;years ended December&#160;31, 2022 and 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Contract revenue</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;year ended December&#160;31, 2022, AC Immune generated CHF 3.9 million in contract revenues compared with nil for the comparable period in 2021. This represents an increase of CHF 3.9 million. The following table summarizes our contract revenues during the&#160;years ended December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Contract revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,935</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,935</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,935</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,935</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our contract revenues experience fluctuations as a result of securing new collaboration agreements, the timing of milestone achievements and the size of each milestone payment. For the&#160;year ended December&#160;31, 2022, our contract revenues were wholly related to the progression of the Tau-PET Tracer PI-2620 into late-stage development in AD per our agreement with LMI.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Research and development activities are essential to our business and represent the majority of our costs incurred. Costs for certain development activities, such as clinical trials, are recognized based on an evaluation of the progress to completion of specific tasks using information from the clinical sites and our vendors. Our collaboration arrangements have different arrangements to share costs for the development of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have completed our R&amp;D spending in both of our Genentech collaborations. Additionally, we have completed our co-development costs with Janssen for the Phase 1b/2a studies for our therapeutic vaccines, ACI-35.030 and JACI-35.054. AC Immune and Janssen will jointly share research and development costs until the completion of the first Phase 2b (AC Immune&#8217;s contribution to the first Phase 2b trial is capped). From Phase 2b and onwards, Janssen will assume responsibility for the clinical development, manufacturing and commercialization of the second-generation vaccines. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We intend to increase our R&amp;D costs associated with the advancement of ACI-7104.056 in Parkinson&#8217;s disease and our ACI-24.060 vaccine through mid- and late-stage clinical development. Finally, we expect to incur additional R&amp;D expenditures associated with the expansion of our Morphomer Tau program into AD and potentially NeuroOrphan indications, as well as, investments in our diagnostic programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Finally, we intend to further characterize our other clinical and preclinical candidates. In addition to these arrangements and proprietarily held assets, we expect that our total future R&amp;D costs will increase over current levels, in line with our three-pillar strategy that focuses on (i)&#160;AD, (ii)&#160;focused non-AD NDD including Parkinson&#8217;s disease, ALS and NeuroOrphan indications and (iii)&#160;diagnostics.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The table below provides a breakdown of our research and development costs, including direct research and development costs, manufacturing costs related to research and development and other research and development costs not allocated directly to programs for the periods covered by this Annual Report. The research and development costs not allocated to specific programs include employment costs, regulatory, QA and intellectual property costs. We do not assign our internal costs, such as salary and benefits, share-based compensation expenses, laboratory supplies, and other direct expenses and infrastructure costs to individual R&amp;D projects, because the employees within our R&amp;D groups are typically deployed across multiple research and development programs.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">138</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2022, research and development expenses totaled CHF 60.3 million compared with CHF 62.3 million for the comparable period in 2021. This represents a decrease of CHF 2.0 million. The following table presents the research and development expenses during the&#160;years ended December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Detailed research and development expenditures by major development category</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Discovery and preclinical expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 16,889</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 19,963</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3,074)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Clinical expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 13,089</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14,872</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1,783)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Group function expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,574</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 929</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 645</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total direct R&amp;D expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 31,552</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 35,764</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (4,212)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 17,548</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 16,465</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,083</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,622</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,528</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 94</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other non-allocated</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 9,614</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8,525</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,089</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total R&amp;D expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 60,336</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 62,282</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1,946)</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Operating expenses<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 41,166</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 44,289</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3,123)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Salaries and related costs<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 19,170</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 17,993</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,177</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total R&amp;D expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 60,336</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 62,282</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1,946)</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup>Includes depreciation expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup>Includes share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Discovery and preclinical expenses decreased CHF 3.1 million, primarily due to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a decrease in ACI-24.060 for DS of CHF 2.3 million for the development costs due to the completion of the vaccine formulation which has been advanced into clinical studies and CHF 0.6 million for our anti-TDP-43 antibody due to</span><span style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the completion of </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">in vivo</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> efficacy studies in the prior year and CHF 1.3 million for certain other discovery programs, </span></td></tr></table><div style="margin-top:8pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">partially offset by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an increase of CHF 1.1 million associated with investments in our ACI-7104.056 vaccine, our alpha-synuclein vaccine for Parkinson&#8217;s disease acquired in Q4 2021.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Clinical expenses decreased by CHF 1.8 million, primarily due to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a decrease of CHF 5.9 million for the clinical development of ACI-35.030 driven by timing of activities across various cohorts started in prior years and expenses associated with the R&amp;D cost sharing, CHF 1.1 million for ACI-24.060 for AD as the prior clinical trial completed and CHF 0.6 million for Morphomer Tau program as we expand the development of other preclinical candidates,</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">139</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:12.65pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">partially offset by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an increase of CHF 3.2 million for the clinical development of ACI-7104.056, which were largely not incurred in the prior period as the asset was acquired in H2 2021 and CHF 2.6 million for the initiation of our Phase 1b/2a ABATE study for our ACI-24.060 vaccine.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The variances in Group function expenses relate to regulatory and quality assurance, intellectual property and other non-allocated costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Total salaries and related costs increased by CHF 1.2 million, primarily due to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an increase in salary- and benefit-related costs of CHF 1.1 million primarily related to new hires during the</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 36pt;">year and annualization of 2021 hires.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The CHF 1.1 million increase in other non-allocated expenses relate to certain non-allocated functional expenses, primarily due to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an increase of CHF 0.8 million associated with targeted IT investments such as our electronic laboratory notebook implementation and maintenance as well as R&amp;D consultants; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;"> CHF 0.3 million in other items.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">General and administrative expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">General and administrative expenses consist primarily of salaries and related costs, including share-based compensation, professional fees such as legal and accounting related services, infrastructure expenses, and other operating expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;year ended December&#160;31, 2022, general and administrative expenses totaled CHF 15.8 million compared with CHF 17.9 million for the comparable period in 2021. This represents a decrease of CHF 2.1 million. The following table presents the general and administrative expenses during the&#160;years ended December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Operating expenses<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 6,207</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,031</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (824)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Salaries and related costs<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 9,582</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 10,879</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1,297)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total general and administrative expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 15,789</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 17,910</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2,121)</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:11.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup>Includes depreciation expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup>Includes share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2022, this decrease is primarily due to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:17.85pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:17.85pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">CHF 1.1 million for transaction costs associated with our asset acquisition in the prior year for a portfolio of therapeutics targeting alpha-synuclein from Affiris which did not repeat in 2022; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:17.85pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:17.85pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a decrease of CHF 1.3 million in personnel expenses, largely driven by a CHF 0.9 million decrease in share-based compensation expense associated with the forfeiture of awards to a former member of management,</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">partially offset by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a CHF 0.3 million increase driven largely by increased audit and reporting fees as well as professional services.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">140</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Other operating income/(expense), net</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;year ended December&#160;31, 2022, other operating income/(expense) totaled CHF 1.3 million in income compared with CHF 1.2 million in income for the comparable period in 2021. This represents an increase of CHF 0.1 million. The following table presents the other operating income/(expense) during the&#160;years ended December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:16.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:16.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other operating income/(expense), net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,343</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,182</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 161</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other operating income/(expense), net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,343</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,182</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 161</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2022, this increase is primarily due to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an increase of CHF 0.1 million associated with ongoing grants from the MJFF.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Finance result, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;year ended December&#160;31, 2022, finance result was a CHF 0.1 million gain compared with a CHF 6.0 million gain for the comparable period in 2021. This represents a decrease of CHF 5.9 million. The following table presents the finance result during the&#160;years ended December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 69</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 6,485</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (6,416)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (355)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (581)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 226</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exchange differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 393</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 113</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 280</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Finance result, net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 107</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 6,017</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (5,910)</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Net finance result was a gain, which primarily decreased related to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a decrease of CHF 6.4 million in financial income, predominantly related to a CHF 6.5 million gain associated in the change of fair value of derivative financial assets associated with two convertible notes sold to certain Affiris affiliated entities in the prior period which did not repeat in the current period,</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;">partially offset by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:17.85pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:17.85pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a CHF 0.2 million decrease in financial expense due to the transition from negative to positive interest rates during the year for our interest-bearing deposit accounts; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:17.85pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:17.85pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a CHF 0.3 million increase in favorable foreign currency exchange differences related to movement in the CHF versus foreign currencies, predominantly the US Dollar and Euro.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 35.7pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Non-IFRS financial measures</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition to our operating results, as calculated in accordance with IFRS, as adopted by the IASB, we use adjusted loss and adjusted loss per share when monitoring and evaluating our operational performance. Adjusted loss is defined as loss for the relevant period, as adjusted for certain items that we believe are not indicative of our ongoing operating performance. Adjusted loss per share is defined as adjusted loss for the relevant period divided by the weighted-average number of shares for such period.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">141</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We believe that these measures assist our shareholders because they enhance the comparability of our results each period and provide more useful insight into operational results for the period. The Company&#8217;s executive management uses these non-IFRS measures to evaluate our operational performance. These non-IFRS financial measures are not meant to be considered alone or as substitutes for our IFRS financial measures, and should be read in conjunction with our consolidated financial statements prepared in accordance with IFRS. The most directly comparable IFRS measure to these non-IFRS measures is net loss. The following table reconciles net loss to adjusted loss and adjusted loss per share for the periods presented:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Reconciliation of loss to adjusted loss and</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">loss per share to adjusted loss per share</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands, except for share and per share data</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (70,753)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (72,996)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (61,921)</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjustments:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Non-cash share-based payments<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,330</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,126</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,088</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Foreign currency (gains)/losses<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (521)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 70</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 703</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Change in fair value of derivative financial assets<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (6,459)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Transaction costs<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">4</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,144</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjusted loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (67,944)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (74,115)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (57,130)</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Loss per share &#8211; basic and diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (0.85)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (0.97)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (0.86)</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Adjustment to loss per share &#8211; basic and diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 0.04</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (0.02)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 0.07</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Adjusted loss per share &#8211; basic and diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (0.81)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (0.99)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (0.79)</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted-average number of shares outstanding Adjusted loss &#8211; basic and diluted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 83,554,412</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 74,951,833</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 71,900,212</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup>Reflects non-cash expenses associated with share-based compensation for equity awards issued to directors, management and employees of the Company. This expense reflects the awards&#8217; fair value recognized for the portion of the equity award which is vesting over the period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup>Reflects foreign currency re-measurement gains and losses for the period, predominantly impacted by the change in the exchange rate between the U.S. Dollar and the Swiss Franc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup>Reflects the change in the fair value of the derivative financial instruments associated with two convertible notes sold to certain Affiris affiliated entities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">4</sup>Reflects transaction costs associated with our asset acquisition for a portfolio of therapeutics targeting alpha-synuclein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company also discloses liquidity, which is defined as a financial indicator comprised of cash and cash equivalents and short-term financial assets. See &#8220;Note&#160;3. Summary of significant accounting policies<b style="font-weight:bold;">&#8221; </b>to our consolidated financial statements for further definition.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">142</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="BLiquidityandcapitalresources_635978"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Liquidity and capital resources</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Cash flows</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Comparison of the&#160;years ended December&#160;31, 2022 and 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes our cash flows for the periods indicated:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net cash provided by/ (used in):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (73,568)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (65,689)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (7,879)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Investing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 23,763</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (53,664)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 77,427</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1,346)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 40,746</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (42,092)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net decrease in cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (51,151)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (78,607)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 27,456</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Operating activities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Net cash used in operating activities was CHF 73.6 million for the&#160;year ended December&#160;31, 2022 compared with net cash used in operating activities of CHF 65.7 million for the&#160;year ended December&#160;31, 2021. The change in cash used in operating activities for the&#160;year ended December&#160;31, 2022 was due to the Company incurring a net loss of CHF 70.8 million for the&#160;year ended December&#160;31, 2022 compared with net loss of CHF 73.0 million for the same period in 2021, which was driven by (i)&#160;an increase of CHF 1.7 million in prepaid expenses (ii)&#160;a CHF 6.1 million decrease in accrued expenses, offset by (i)&#160;a CHF 6.5 million gain on the change in fair value of derivative financial assets associated with two convertible notes sold to certain Affiris affiliated entities in 2021 which did not repeat in the current period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Investing activities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Net cash provided by investing activities was CHF 23.8 million for the&#160;year ended December&#160;31, 2022 compared with net cash used in by investing activities of CHF 53.7 million for the&#160;year ended December&#160;31, 2021. CHF 25.0 million of short-term financial assets matured for the&#160;year ended December&#160;31, 2022, compared to a net investment of CHF 51.0 million of short-term financial assets in the prior period. Additionally, the Company spent CHF 1.2 million on property, plant and equipment, predominantly to enhance its laboratory and facilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Financing activities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Net cash used in financing activities was CHF 1.3 million for the&#160;year ended December&#160;31, 2022, compared with net cash provided by financing activities of CHF 40.7 million for the&#160;year ended December&#160;31, 2021. The decrease of CHF 42.0 million is predominantly related to prior year&#8217;s (i)&#160;CHF 23.5 million received from two convertible notes sold to certain Affiris affiliated entities, (ii)&#160;CHF 4.6 million for the issuance of shares as part of the Company&#8217; acquisition with Affiris for the program portfolio of therapeutics targeting a-syn, notably ACI-7104 (see &#8220;Note&#160;6. Asset acquisition.&#8221;) and (iii)&#160;CHF 12.1 million received from proceeds from the sale of treasury shares in public offerings, net of underwriting fees and transaction costs, which did not repeat in the current period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Operating capital requirements and plan of operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We do not expect to generate revenues from royalties based on product sales unless and until our partners obtain regulatory approval of, and successfully commercialize, our current or any future product candidates. As of December&#160;31, 2022, we had cash and cash equivalents of CHF 31.6 million and short-term financial assets of CHF 91.0 million, resulting in CHF 122.6 million of liquidity. The decrease relative to December&#160;31, 2021 was predominantly related to R&amp;D spending on our major discovery and R&amp;D programs, and the strengthening of the Company&#8217;s </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">143</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">infrastructure, systems and organization. This was offset by the receipt of CHF 3.9 million in contract revenue from LMI linked to the progression of the Tau-PET Tracer PI-2620 into late-stage development in AD. There can be no certainty as to the exact timing of future milestone payments, or in fact, whether any of these will ever be made, given that they are contingent on clear milestones being reached. Accordingly, assuming that we do not receive potential milestone payments and based upon our currently contemplated R&amp;D strategy, we believe that our existing capital resources will be sufficient to meet our projected operating requirements into Q3 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We expect to generate losses for the foreseeable future, and these losses could increase as we continue product development until we successfully achieve regulatory approvals for our product candidates and begin to commercialize any approved products. We are subject to all the risks pertinent to the development of new products, and we may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may harm our business. We expect to incur additional costs associated with operating a public company and we anticipate that we will need substantial additional funding in connection with our continuing operations. If we need to raise additional capital to fund our operations and complete our ongoing and planned clinical studies, funding may not be available to us on acceptable terms, or at all.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our future funding requirements will depend on many factors, including but not limited to the following:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The scope, rate of progress, results and cost of our preclinical and clinical studies and other related activities, according to our long-term strategic plan;</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The cost of manufacturing clinical supplies and establishing commercial supplies of our product candidates and any other products we may develop;</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The cost, timing and outcomes of regulatory approvals;</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The costs and timing of establishing sales, marketing and distribution capabilities;</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The terms and timing of any collaborative, licensing and other arrangements that we may establish, including any required milestone and royalty payments thereunder;</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The emergence of competing technologies or other adverse market developments; and</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The potential cost and timing of managing, protecting, defending and enforcing our portfolio of intellectual property.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Contractual obligations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the Company has been a tenant at our current location in the EPFL Innovation Park since shortly after our inception in 2003. We have entered into long-term rental lease agreements with respect to these facilities. However, our lease agreements are structured such that we can exit these lease agreements without penalty provided we give the owner of our premises sufficient notice. We have capitalized a portion of our lease liabilities in accordance with IFRS 16. See &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company currently projects CHF 1.0 million in undiscounted short-term lease obligations and CHF 2.4 million in undiscounted long-term lease obligations. Additionally, the Company projects CHF 23.0 million in short-term purchase commitments and CHF 29.2 million in long-term purchase commitments predominantly driven by R&amp;D activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">ATM program</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Commencing in September&#160;2020, the Company established an &#8220;at the market offering&#8221; (ATM) for the sale of up to USD 80.0 (CHF 74.6) million worth of our common shares from time to time by entering into an Open Market Sale </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">144</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Agreement (Sales Agreement) with Jefferies LLC (Jefferies). In Q2 2021, we filed a new registration statement on Form&#160;F-3 and entered into a new Sales Agreement in Q2 2021 to replace and extend the ATM program. To date, the Company has sold 1,179,139 common shares previously held as treasury shares pursuant to the new Sales Agreement, raising USD 13.3 (CHF 12.1) million, net of underwriting fees and transaction costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Comparison of the&#160;years ended December&#160;31, 2021 and 2020</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For a discussion of the financial results and condition for the fiscal&#160;year ended December&#160;31, 2020, please refer to &#8220;Item&#160;5. Operating and financial review and prospects&#8212;A. Operating results&#8212;Comparison of the&#160;years ended December&#160;31, 2021 and 2020&#8221; of our Annual Report on Form&#160;20-F for the&#160;year ended December&#160;31, 2021 filed on March&#160;22, 2022.</p><a id="CResearchanddevelopmentpatentsandlicense"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Research and development, patents and licenses, etc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item&#160;4. Information on the Company&#8212;B. Business overview&#8221; and &#8220;Item&#160;5. Operating and financial review and prospects&#8212;A. Operating results&#8212;results of operations.&#8221;</p><a id="DTrendinformation_775981"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Trend information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item&#160;5. Operating and financial review and prospects.&#8221;</p><a id="ECriticalAccountingEstimates_860985"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">E.</b></span>Critical Accounting Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We prepare our consolidated financial statements in accordance with IFRS as issued by the IASB. See &#8220;Note&#160;3. Summary of significant accounting policies&#8221; to our consolidated financial statements for a description of the most significant accounting policies applied in the preparation of our consolidated financial statements.</p><a id="_19044427_ae19_48c7_82d4_64c2b322fe63"></a><a id="ITEM6DIRECTORSSENIORMANAGEMENTANDEMPLOYE"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</p><a id="ADirectorsandseniormanagement_124887"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Directors and senior management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Executive Officers, other key employees and board of directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following table presents information about our executive officers, other key employees, and directors and director nominees, including their ages, as of March&#160;1, 2023. The term of each of our directors is 1&#160;year and, accordingly, will expire at our 2023 annual shareholder meeting to be held in June&#160;2023.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Initial&#160;year&#160;of&#160;</b></p></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:28.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:49.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Position</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:3.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Age</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">appointment</b></p></th></tr><tr><td style="vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Executive Officers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Andrea Pfeifer, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chief Executive Officer and Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">65</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2003</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Marie Kosco-Vilbois, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chief Scientific Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">65</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2019</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Johannes Rolf Streffer, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chief Medical Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">54</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2020</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Piergiorgio Donati</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chief Technical Operations Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">52</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2019</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Christopher Roberts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">VP Finance, Interim Chief Financial Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">34</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Howard Donovan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chief Human Resources Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">48</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Jean-Fabien Monin</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chief Administrative Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">52</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2009</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other Key Employees</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Julien Rong&#232;re, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">SVP Regulatory Affairs and Quality Assurance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">45</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2017</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Olivier Sol, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">VP Head of Clinical Development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">56</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2016</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Alexandre Caratsch</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">General Counsel</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">57</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2018</p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">145</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Initial&#160;year&#160;of&#160;</b></p></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:28.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:49.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Position</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:3.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Age</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">appointment</b></p></th></tr><tr><td style="vertical-align:bottom;width:28.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Bojana Portmann, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">VP IP and Business Development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">43</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2011</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Julian Gray, M.D., Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Clinical Advisor</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">65</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2007</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Mark Danton</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">VP Information Systems, Security and Digital Technologies</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">59</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2019</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-Executive Directors</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Douglas Williams, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chair and Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 64</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2018</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Thomas Graney</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 58</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2016</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Werner Lanthaler, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 54</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2018</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Roy Twyman, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 66</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2019</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Carl June, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 68</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2020</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Alan Colowick, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 60</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2021</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Monika B&#252;tler, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 61</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2021</p></td></tr><tr><td style="vertical-align:bottom;width:28.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Monica Shaw, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 44</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2021</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The current business addresses for our executive officers, other key employees, directors and director nominee is AC Immune SA, EPFL Innovation Park, Building B, 1015 Lausanne, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Executive Officers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Andrea Pfeifer, Ph.D., Co-Founder, Chief Executive Officer and Director: </b>Andrea Pfeifer co-founded AC Immune SA in 2003, successfully leading it to an IPO in 2016, since when she has served as a Director on the Board. Under her leadership, multiple transformative partnerships have been established with leading pharmaceutical companies, yielding a potential value of up to CHF 3.3 billion plus additional royalties. Before founding the Company, she was the Head of Nestl&#233; Research Centre in Lausanne, Switzerland where she played a major role in connecting science and business. Whilst at Nestl&#233; she led the scientific development of a number of highly innovative, critically acclaimed products from laboratory to market, established the microbiome as a major cross-category product development platform and co-founded the Life Science focused Nestl&#233; Venture Capital Fund. Prior to this she was a Visiting Fellow at the Human Carcinogenesis Branch of The National Institute of Health, Bethesda, USA. She currently serves as the Chair of Investment Fund BioMedInvest, Basel and AB2 Bio SA, Lausanne, and is a member of the Supervisory Board of Symrise AG, Holzminden, Germany. She is also a key member of the CEOi initiative on Alzheimer&#8217;s Disease and the Davos Alzheimer&#8217;s Collaborative (DAC).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Prof. Pfeifer holds a Ph.D. in Toxicology (Cancer Research) from the University of W&#252;rzburg, Germany and is a registered Toxicologist and Pharmacist. She received her Habilitation from the University of Lausanne, Switzerland and is an Honorary Professor at the Ecole Polytechnique F&#233;d&#233;rale de Lausanne (EPFL).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Marie Kosco-Vilbois, Ph.D., Chief Scientific Officer</b>: A U.S. citizen, Marie&#160;Kosco-Vilbois has extensive experience in the biopharmaceutical industry and served as Chief Scientific Officer of Novimmune since 2005. Prior to joining Novimmune in 2002, Dr.&#160;Kosco-Vilbois was Head of Immunology and Preclinical Pharmacology at the Serono Pharmaceutical Research Institute, a Senior Scientist and then Head of Immunology at the Glaxo Wellcome Research Institute in Geneva, and a Scientific Member of the Basel Institute for Immunology. During her career, she has taken numerous biologicals from discovery into preclinical studies and clinical development, most notably filing market applications of a biological for an orphan indication. Dr.&#160;Kosco-Vilbois gained her Bachelor&#8217;s Degree in Biology from Rutgers University, New Jersey, U.S., and a PhD in Anatomy and Immunology from the Medical College of Virginia/Virginia Commonwealth University School of Medicine, U.S..</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">Johannes Rolf Streffer, M.D., Chief Medical Officer: </b>Johannes Streffer joined AC Immune in January&#160;2021 as Chief Medical Officer from UCB Biopharma SPRL where he was VP, Head of Translational Medicine Neuroscience. Prior to this he was a member of the Alzheimer Disease Area Leadership Team at Janssen R&amp;D and the industrial lead for EMIF-AD, where 14 countries are combined to foster understanding of early biomarkers and change in the predementia AD spectrum. His recognized expertise and standing in the scientific and medical community provide an </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">146</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">invaluable asset as we work to develop innovative treatments for neurodegenerative diseases based on our proprietary technology platforms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Prof. Streffer graduated from the University of T&#252;bingen, Germany with a medical degree. He completed graduate studies on neuro-oncology and is Board certified in Psychiatry and Neurology. Currently he is a visiting Professor in the Department of Biomedical Sciences, University of Antwerp.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Piergiorgio Donati, Chief Technical Operations Officer: </b>Piergiorgio&#160;Donati joined AC Immune in June&#160;2018 as Director, Global Program Management, having previously worked for AC Immune from 2011 to 2015 as Head of Manufacturing and Project Management. Between 2015 and 2018, Mr.&#160;Donati was Head of CMC program development at Glenmark Pharmaceuticals and Biotech CMC Lead at Merck KGaA. Prior to 2011, he held R&amp;D positions at Abiogen, Merck Group and Serono. Mr.&#160;Donati holds a degree in Analytical Chemistry from the Technical Institute G.L. Bernini.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Christopher Roberts, Vice President Finance, Interim Chief Financial Officer: </b>Christopher Roberts joined AC Immune in 2019 serving in various roles within the Company&#8217;s finance leadership team prior to his promotion in 2022. Previously, Mr. Roberts worked as a Senior Manager for Ernst &amp; Young for more than 10 years and supported the AC Immune IPO. During that time, he served high-growth life science companies in Switzerland, the San Francisco Bay Area, and the UK, focusing on initial and follow-on offerings, SEC reporting, and SOX 404 implementation projects. Mr. Roberts is a Trustee and Treasurer of Msizi Africa, a charity dedicated to sustainably improving the lives of children in Lesotho.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Mr. Roberts is a Chartered Accountant with the Institute of Chartered Accountants in Scotland (ICAS) and holds a Bachelor of Science in Accounting, Auditing and Finance with first class honours from Lancaster University.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Howard Donovan, Chief Human Resources Officer: </b>Howard Donovan joined AC Immune in 2022 and is an internationally experienced, commercially focused leader who has competencies in all aspects of employee services, well-being, benefit design, international mobility, talent management, operations and HR business partnering. He has been at the World Economic Forum since 2015, where he led People Services and was responsible for global reward, employee experience, people insights, strategic sourcing, new office launches, and business partnering with the Board of Directors across its locations in Switzerland, United States, China, Japan and India. Howard previously worked as the inhouse Global Head of Reward for Puma Energy and prior to that he held senior HR leadership roles with a strong reward focus with multinational companies, including SGS Group and Xerox Corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Jean-Fabien Monin, Chief Administrative Officer:</b> Jean-Fabien&#160;Monin was nominated Chief Administrative Officer in July&#160;2015 following his role as our Chief Financial Officer from March&#160;2009 to July&#160;2015. Prior to AC Immune, he held several positions during his tenure of 14&#160;years at bioM&#233;rieux, a leading international <i style="font-style:italic;">in vitro</i> diagnostics group, culminating in his nomination as Chief Financial Officer. His last position was CFO of bioM&#233;rieux Central Europe based in Vienna, Austria from December&#160;2006 to March&#160;2009. Mr.&#160;Monin holds a Masters in Finance and International Business from the University of Paris-Dauphine, France.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Other key employees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Julien Rong&#232;re, Ph.D., SVP Regulatory Affairs and Quality Assurance</b>: Julien&#160;Rong&#232;re joined AC Immune in July&#160;2017 as Head of European Regulatory Affairs and Quality Assurance. Prior to joining AC Immune, Dr.&#160;Rong&#232;re held positions of increasing responsibility at Celgene in Switzerland. Most recently, he served as Director, Regulatory Affairs, leading the development of regulatory strategies for small molecules and CAR-T cell therapies and contributed to the development and approval of Revlimid in multiple myeloma and mantle cell lymphoma. Prior to Celgene, Dr.&#160;Rong&#232;re served as a Regulatory Expert at Apoxis, SA in Switzerland. During his career, Dr.&#160;Rong&#232;re gained specific expertise in the development of regulatory strategies for taking products from Phase 1 through to commercialization in the field of hematology/oncology and immunology/inflammation, including fast-to-market approaches, orphan drugs and pediatric development. Dr.&#160;Rong&#232;re gained his Master&#8217;s Degree in Medical Genetics from the University of Aberdeen, UK, and holds a Ph.D. in Molecular Biology from the University of Lausanne, Switzerland.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">147</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Oliver Sol, M.D., VP Head of Clinical Development</b>: Prior to joining AC Immune,&#160;Olivier Sol was Clinical Director of Exonhit (Paris) and thereafter Medical&#160;&amp; Regulatory Affairs Director for Diaxonhit, where he was responsible for the development and medical validation of <i style="font-style:italic;">in vitro</i> diagnostic products in cancer, infectious diseases and Alzheimer&#8217;s disease. Dr.&#160;Sol spent his over 20-year career as a Medical Expert in several therapeutic areas with a strong focus on central nervous system diseases, within pharmaceutical companies as Janssen, UCB-Pharma, GlaxoSmithKline and Sanofi. He contributed to the clinical development of currently marketed drugs in epilepsy (topiramate and levetiracetam) and galantamine in Alzheimer&#8217;s disease. He has also gained significant experience in the field of biological biomarkers. Dr.&#160;Sol holds an M.D. from the Paris-Sud University (Paris-Saclay) with a specialization in Medical Biology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Alexandre Caratsch, General Counsel: </b>Alexandre Caratsch is a Swiss-qualified attorney with 30&#160;years&#8217; experience in private practice, multinational companies and in ventures. He initially worked as an in-house lawyer for E&amp;Y and the SGS Group before specializing in healthcare, holding senior legal positions at Novartis and Medtronic. Before joining AC Immune, he led the Corporate Legal Affairs and Intellectual Property group for Medtronic&#8217;s Europe, Middle East and Africa (EMEA) region. Mr.&#160;Caratsch has also co-founded two start-up companies in the field of information technology and medical technology, respectively, and has supported other start-up companies with strategic, transactional and general counsel. Mr.&#160;Caratsch holds a Master&#8217;s degree in Law from the University of Neuch&#226;tel, Switzerland and is admitted to the Bar of Geneva, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Bojana Portmann, Ph.D., VP IP and Business Development</b>: Bojana&#160;Portmann joined AC Immune in 2011 as Intellectual Property Manager and has held multiple roles within the IP department with increasing responsibility over the past&#160;years, during which her work was mainly focused on creating and strengthening patent portfolios for biologicals, small molecules and liposomal technology. Dr.&#160;Portmann holds a Ph.D. degree from the EPFL University in Switzerland, and a LL.M. degree, Master of Intellectual Property Law and Management (MIPLM), from the CEIPI in France. She also received a M.Sc. (Dipl. Ing.) degree in Polymer and Chemical Engineering from the University of Belgrade in Serbia.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Julian Gray, M.D., Ph.D., Clinical Advisor</b>: Julian&#160;Gray has served as Clinical Advisor to our programs in neurodegenerative diseases since January&#160;2007 and works in this function exclusively for AC Immune. He has previously held the position of Head of CNS Therapeutics at Eisai Ltd in London leading the global development of early and late-stage CNS projects in Alzheimer&#8217;s disease, Parkinson&#8217;s disease and other CNS areas. Prior to this he served as Head of Alzheimer Clinical Research at Hoffmann-La Roche in Basel where he conducted large-scale clinical trials in the U.S. and Europe. After his studies he was Medical Expert at Sandoz Pharmaceuticals in Basel undertaking clinical studies of different compounds in dementia and Parkinson&#8217;s disease. Dr.&#160;Gray holds the title of a Specialist in Pharmaceutical Medicine (Switzerland). He received his medical degree (MBBS) from the University of London, a B.A. and Ph.D. from the University of Oxford and an MBA from Oxford Brookes University.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Mark Danton, VP Information Systems, Security and Digital Technologies:</b>&#160;Mark Danton is a globally recognized and experienced executive in Information Systems/Information Technology (IS/IT) with extensive experience in developing, launching and managing business-relevant IS, cybersecurity and digital technology solutions and services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Prior to joining AC Immune, Mr.&#160;Danton served as IS/IT Global Manager at Nestl&#233; and held a number of global roles at BT Global Services and in Dimension Data&#160;PLC. Mr.&#160;Danton holds an Executive MBA from the Business School Lausanne, graduating&#160;cum laude&#160;and as the Executive MBA Student of the&#160;Year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Non-Executive Directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">Douglas Williams, Ph.D., Chair and Director: </b>Douglas E. Williams is currently the President, CEO and member of the Board of Directors of Codiak BioSciences. He was previously Biogen&#8217;s Executive Vice President, Research and Development, serving in this role from January&#160;2011 to July&#160;2015. He joined Biogen from ZymoGenetics, where he was most recently CEO and member of the Board of Directors. ZymoGenetics was purchased for $985 million by Bristol Myers Squibb during Dr.&#160;Williams&#8217; tenure. Previously, he held leadership positions within the biotechnology industry, including Chief Scientific Officer and Executive Vice President of Research and Development at Seattle Genetics, and </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">148</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Senior Vice President and Washington Site Leader at Amgen. Dr.&#160;Williams served in a series of scientific and senior leadership positions over a decade at Immunex, including Executive Vice President and Chief Technology Officer and a member of the Board of Directors. During his 30+&#160;year career in the biotechnology industry he has played a role in the development of several novel drugs including Enbrel, Tecfidera, and Spinraza. He has served on the board of numerous biotechnology companies and is currently Chair of the Board of AC Immune, and is a Director for Panacea II.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Thomas Graney, Director: </b>Thomas Graney is currently the CEO, CFO, and member of the Board of Directors of Oxurion NV. Prior to Oxurion, he was CFO of Generation Bio, Senior Vice President and CFO at Vertex Pharmaceuticals&#160;Inc. and CFO and SVP of Finance&#160;&amp; Corporate Strategy at Ironwood Pharmaceuticals. Prior to Ironwood Pharmaceuticals, Mr.&#160;Graney spent 20&#160;years working with J&amp;J and its affiliates, serving for 4&#160;years as worldwide VP of Finance and CFO of Ethicon. Mr.&#160;Graney has extensive global experience that spans corporate development, commercial strategy, portfolio management and supply chain management, communication, and investor relations. Mr.&#160;Graney is currently on the Board of Directors of Mogrify LTD and Chair of the Audit Committee. A Chartered Financial Analyst charterholder, Mr.&#160;Graney holds a B.S. in accounting from the University of Delaware and an MBA in Marketing, Finance and International Business from the Leonard N. Stern School of Business at New York University.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Werner Lanthaler, Ph.D., Director:</b>&#160;Werner Lanthaler is the CEO of Evotec AG, a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. Since joining Evotec in 2009, Dr.&#160;Lanthaler has focused the company on collaborating with biotech and pharma companies and academia, supporting biotech innovation. He previously served as Chief Financial Officer at Intercell AG where he played a key role in many of that company&#8217;s major milestones. During his tenure, Intercell undertook an IPO and developed from a venture-backed biotechnology company into a global vaccine player. Dr.&#160;Lanthaler has also served as Director of the Federation of Austrian Industry, and from 1995 to 1998 was a Senior Management Consultant at McKinsey&#160;&amp; Company. Dr.&#160;Lanthaler is a Non-Executive Member of the Board of Directors of arGEN-X and is a member of the Supervisory Board of Topas Therapeutics GmbH. He holds a Doctorate in Economics from Vienna University, a Master&#8217;s degree in Business Administration from Harvard University, and a degree in Psychology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Roy Twyman, M.D., Director</b>: Roy&#160;Twyman is a Neurologist and is founder and current CEO of Amron Neuroscience, LLC, a private consulting company focused on neuroscience drug development. Prior to this, Dr.&#160;Twyman spent almost 20&#160;years at Janssen Research&#160;&amp; Development, LLC (a Johnson&#160;&amp; Johnson company) and was a member of the Neuroscience Therapeutic Area Leadership team responsible for clinical R&amp;D and strategic planning of CNS neurology and psychiatry pipeline products. From 2012 to March&#160;2018, Dr.&#160;Twyman was a Senior Vice President in the Neuroscience Therapeutic Area overseeing the Alzheimer&#8217;s Disease Area. He currently participates as an independent Board Member or as a Scientific Advisory Board Member for a number of small biotech or pharmaceutical companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Carl June, M.D., Director: </b>Carl June&#160;is Richard W. Vague Professor in Immunotherapy, Director of the Center for Cellular Immunotherapies and Director of the Parker Institute for Cancer Immunotherapy at the Perelman School of Medicine at the University of Pennsylvania. Due to his lifelong work on lymphocyte activation, Prof. June&#160;is considered a world authority on mechanisms related to immune tolerance and adoptive immunotherapy in the fields of chronic inflammation and cancer. He and his team pioneered the groundbreaking work in immunotherapy in which patients with refractory and relapsed chronic lymphocytic leukemia are treated with genetically engineered versions of their own T cells. This CAR-T therapy approach, which trains the immune system to attack and destroy cancer cells, has opened a new era of innovative treatments and personalized medicine for cancer patients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Prof. June&#160;is a graduate of the Naval Academy in Annapolis, USA, and Baylor College of Medicine in Houston, USA, where he received his medical degree. Prof. June&#160;also completed graduate training in immunology and malaria with Dr.&#160;Paul-Henri Lambert at the World Health Organization, Geneva, Switzerland, and post-doctoral training in transplantation biology with E. Donnell Thomas and John Hansen at the Fred Hutchinson Cancer Research Center in Seattle, USA. He has published more than 500 manuscripts and is the recipient of numerous honors and prizes.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">149</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Alan Colowick, M.D., Director: </b>Alan Colowick is currently a Managing Director at Matrix Capital Management and has served in executive and Board roles for numerous large and emerging biotech companies. From 2017 until January&#160;2021, he was a Partner at Sofinnova, where he led investments for several clinical-stage companies. Previously, Dr.&#160;Colowick was Executive Vice President and served in various leadership roles at Celgene Corporation, including President for Celgene&#8217;s EMEA regions and Senior Vice President of Global Medical Affairs. Before Celgene, he was the Chief Executive Officer at Gloucester Pharmaceuticals,&#160;Inc. which was acquired by Celgene in 2010. Dr.&#160;Colowick also served as the President of Oncology at Geron Corporation, as Chief Medical Officer of Threshold Pharmaceuticals, and in numerous positions of increasing responsibility at Amgen culminating with his role as VP, Medical Affairs Europe.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Dr.&#160;Colowick serves on the Board of Directors for several biopharma companies, and his prior roles as Chair include VelosBio (sold to Merck in 2020 for $2.75 billion) and Principia Biopharma (sold to Sanofi in 2020 for $3.7 billion). He received his medical degree from Stanford University, a Master&#8217;s in Public Health from Harvard University, and a B.S. in Molecular Biology from the University of Colorado. He completed specialty training in Hematology-Oncology at Harvard Medical School, the Dana Farber Cancer Institute, and Brigham and Women&#8217;s Hospital in Boston, USA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Monika B&#252;tler, Ph.D., Director: </b>Monika B&#252;tler is a leading Swiss economist and former Vice President of the independent Swiss Covid-19 Science Taskforce. She is a member of the Board of Directors and of the audit committees of both Schindler Holding AG and Swiss Life Holding AG, and a member of the Board of Directors and of the compensation and nomination committee of Huber&#160;&amp; Suhner AG. Her international economic expertise is in public policy and managerial economics, including an advisory role to the World Bank and visiting appointments in the U.S., Australia and Europe. Dr.&#160;B&#252;tler is a Vice President of the Foundation Board of the Gebert R&#252;f Foundation, a science and innovation foundation that supports entrepreneurial projects which are committed to achieving an impact.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Prof. B&#252;tler holds a Ph.D. in Economics from the University of St. Gallen, a Doctorate Honoris Causa from the University of Lucerne, and a Diploma in Mathematics/Physics from the University of Zurich.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Monica Shaw, M.D., Director: </b>Monica Shaw is a pharmaceutical industry expert who has held senior leadership positions and was involved in advancing more than 15 therapeutic products from first-in-man studies through regulatory approvals and commercialization across multiple geographies. She also played key business development roles in company acquisition and integration and co-development partnerships. Through her work, Dr.&#160;Shaw gained extensive specialty experience in the fields of dermatology, immuno-inflammation, HIV, neurology and oncology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Currently, Dr. Shaw is the Chief Executive Officer for Oncopeptides AB. Dr. Shaw has previously held other broad leadership roles at other leading pharmaceutical companies, including as Executive Vice President Head Region Europe, Canada, Australia for Leo Pharma, Vice-President Commercial Head Asia Pacific region at GSK/ViiV Healthcare, and Medical Director and Chief Scientific Officer UK for Novartis, in addition to previous leadership positions at Norgine, Shire and Merck KGaA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Monica Shaw holds an M.D. from the University of Oxford Medical School and is a Member of the Royal College of Physicians.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Family Relationships</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">None of our directors or executive officers has a family relationship as defined in Item&#160;401 of Regulation S-K.</p><a id="BCompensation_249678"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Compensation of directors and executive officers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2022, the aggregate compensation accrued or paid to the members of our board of directors and our executive officers for services in all capacities was CHF 6.5 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During the&#160;year ended December&#160;31, 2022, the total fair value of equity awards granted to directors and executive officers was CHF 2.0 million.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">150</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The amount set aside or accrued by us to provide pension, retirement or similar benefits to members of our board of directors and executive officers amounted to a total of CHF 0.3 million in the&#160;year ended December&#160;31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We incorporate by reference into this Annual Report the information in &#8220;Item&#160;1. C&#8212;2021 Board Compensation&#8221; and &#8220;Item&#160;2. C&#8212;2021 Executive Compensation&#8221; of Exhibit&#160;99.4 to our report on Form&#160;6-K filed with the SEC on March&#160;22, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Equity incentive plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2016, we ceased issuing new grants under our prior equity incentive plans, which we refer to as the Prior Plans, and adopted a new omnibus equity incentive plan under which we have the discretion to grant a broad range of equity-based awards to eligible participants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Prior plan: C1</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Since our inception in 2003, we have had four separate Prior Plans under which stock options were granted (Prior Plans A, B and C2 have terminated): Options granted under Plan C1 from 2013 through the adoption of the current 2016 Stock Option and Incentive Plan (SOIP) were taxed upon exercise instead of at grant due to a change in taxation rules.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Plan administration</i>. Under Plan C1, an option, which can only be granted with the approval of our board of directors, is evidenced by an option agreement signed by the participant to indicate his or her acceptance of the option and is subject to the terms and conditions of the applicable Prior Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Eligibility</i>. Under Plan C1, options were granted to our directors, employees, advisors and agents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Options exercise price</i>. The exercise price of all options issued under the Prior Plan is CHF 0.15.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0.15pt;margin:0pt 0pt 12pt 17.85pt;"><i style="font-style:italic;">Vesting period</i>. Under Plan C1, the options vesting period was 4&#160;years with 25% of the options vesting each&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Expiration period. </i>The expiry dates for each plan are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Plan C1: 10&#160;years</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Amendment</i>. Our board of directors has the authority to amend each of the Prior Plans.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">2016 SOIP</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the November&#160;15, 2016 AGM of the Company, our board of directors approved the 2016 SOIP (as amended and restated the &#8220;2016 SOIP&#8221;). The maximum number of shares available for issuance under the 2016 SOIP is 4,800,000 common shares.&#160;The shares available for issuance under the 2016 SOIP were initially registered with the SEC on a Form&#160;S-8 on March&#160;8, 2017, and additional shares were registered on a Form&#160;S-8 on August&#160;5, 2019. As of December&#160;31, 2022, there were a total of 2,345,648 shares underlying options that were exercisable and 4,261,017 shares underlying outstanding options and 216,486 shares underlying outstanding restricted share units issued from both our Prior Plans and the 2016 SOIP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Plan Administration</i>. The 2016 SOIP is administered by either our board of directors or the compensation committee, or a similar committee performing the functions of the compensation committee. Approval of the plan administrator is required for all grants of awards under the 2016 SOIP, but the administrator may delegate to our CEO the authority to grant awards, subject to certain limitations set forth on the plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Awards. </i>Awards may be granted in the form of incentive stock options, non-qualified stock options, stock appreciation rights, restricted share units, restricted share awards, unrestricted share awards, performance share awards and dividend equivalent rights.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">151</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Eligibility. </i>Under the 2016 SOIP, full or part-time officers and other employees, non-employee directors and consultants of the Company and its subsidiaries who are selected by the administrator are eligible to participate in the plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Options exercise price. </i>Under the 2016 SOIP, the option exercise price is determined by the plan administrator at the time of grant, but will not be less than fair market value (as defined in the 2016 SOIP) on the grant date, and for incentive stock options granted to any employee who is a 10&#160;percent owner in the Company, will not be less than 110&#160;percent of the fair market value on the grant date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Vesting period. </i>Vesting conditions are determined by the administrator at the time of grant and are specified in the applicable award certificate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Accelerated vesting. </i>The administrator may accelerate the exercisability or vesting of all or any portion of any award in circumstances involving the grantee&#8217;s death, disability, retirement or termination of employment, or a change in control.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Amendment</i>. Our board of directors has the authority to amend the 2016 SOIP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Amendment and restatement to the 2016 SOIP</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In June&#160;2019, the Board authorized, and the shareholders approved, an increase in the maximum number of shares reserved for issuance under the 2016 SOIP. In October&#160;2019, the Board authorized a second amendment and restatement to the 2016 SOIP. These amendments were made to align certain elements with Swiss statutory requirements and had no financial impact for the Company in 2022, 2021 or 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Equity compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the fiscal&#160;year ended December&#160;31, 2022, the Company has granted our directors and executive officers, in the aggregate, options for the right to acquire 633,060 shares at an exercise price of USD 3.15 per share, which vest either over a 1&#160;year or 3&#160;year period with vesting to occur quarterly or annually depending on the nature of the award. The expiration date for these options granted in 2022 is 2032. The Company also granted to our directors and executive officers a total of 239,194 restricted share units in 2022. Restricted share units granted to directors vest over a 1&#160;year period with vesting to occur annually. Restricted share units granted to executive officers vest over a 3 year period with vesting to occur quarterly or semi-annually. Please see &#8220;Note&#160;18. Share-based compensation&#8221; for further detail.</p><a id="CBoardpractices_883818"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Board practices</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Composition of board of directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our board of directors is composed of nine directors. Each director is elected for a 1-year term, no later than the next Annual General Meeting (AGM). The current members of our board of directors were appointed at shareholders&#8217; meetings held on June&#160;24, 2022 to serve until the 2023 AGM to be held in June&#160;2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a foreign private issuer. As a result, in accordance with the Nasdaq stock exchange listing requirements, we rely on home country governance requirements and certain exemptions thereunder rather than relying on the stock exchange corporate governance requirements. For an overview of our corporate governance principles, see &#8220;Item&#160;16G. Corporate governance.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Board meetings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our Board of Directors met in accordance with their respective mandate both physically (as was practicable under current pandemic circumstances), by video-conference and telephonically throughout 2022. The Board members analyzed the scientific, business, financial, organizational and legal risks of the Company based on the external factors and internal changes that could potentially impact the risks for the Company in the future.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">152</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Director independence</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As a foreign private issuer, under the listing requirements and rules&#160;of Nasdaq, we are not required to have independent directors on our board of directors, except to the extent that our audit and finance committee is required to comply with independence requirements, subject to certain phase-in schedules. However, our board of directors has determined that, under current listing requirements and rules&#160;of Nasdaq (which we are not subject to) and considering any applicable committee independence standards, Douglas Williams, Thomas Graney, Werner Lanthaler, Roy Twyman, Carl June, Alan Colowick, Monika B&#252;tler and Monica Shaw are &#8220;independent directors.&#8221; In making such determination, our board of directors considered the relationships that each non-employee director has with us and all other facts and circumstances our board of directors deemed relevant in determining the director&#8217;s independence, including the number of common shares beneficially owned by the director and his or her affiliated entities, if any.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Committees of the board of directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our board of directors established two separate permanent committees: an audit and finance committee and a compensation, nomination and corporate governance committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Audit and finance committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The audit and finance committee, which consists of Monika B&#252;tler (Chair), Thomas Graney (Member), and Werner Lanthaler (Member), assists our board of directors in overseeing our accounting and financial reporting processes and the audits of our consolidated financial statements. In addition, the audit and finance committee is directly responsible for the appointment, compensation, retention and oversight of the work of our independent registered public accounting firm. The audit and finance committee consists exclusively of members of our board who are financially literate, and Monika B&#252;tler, Thomas Graney and Werner Lanthaler are considered to be &#8220;audit committee financial experts&#8221; as defined by the SEC. Our board of directors has determined that Monika B&#252;tler, Thomas Graney and Werner Lanthaler satisfy the &#8220;independence&#8221; requirements set forth in Rule&#160;10A-3 under the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The audit and finance committee is governed by a charter that complies with Nasdaq rules. The audit and finance committee has the responsibility to, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review and assess the qualifications, independence, performance and effectiveness of the independent auditor;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review the scope of the prospective audit by the independent auditor, the estimated fees, and any other matters pertaining to the audit;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approve any audit and non-audit services proposed to be provided by the independent auditor to ensure independent auditor independence;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review and assess the independent auditor&#8217;s report and management letters and take notice of all comments of the independent auditor on accounting procedures and systems of control, and review the independent auditor&#8217;s reports with management;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">be responsible for the resolution of disagreements between the management and the independent auditor;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review and evaluate the lead audit partner of the independent audit team and confirm and evaluate their rotation;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review and discuss all (i)&#160;consolidated financial statements, (ii)&#160;reports intended for publication and (iii)&#160;any other financial statements intended for publication to consider significant financial reporting issues and judgments made in connection with the preparation of our consolidated financial statements, including any significant changes in our selection or application of accounting principles;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">153</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approve the quarterly condensed consolidated financial statements;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review with the management, personnel responsible for the design and implementation of the internal audit function, and the independent auditor in separate meetings any analysis or other written communication prepared by the management and/or the independent auditor setting forth significant financial reporting issues and judgments made in connection with the preparation of the consolidated financial statements, including critical accounting policies, the effect of regulatory and accounting initiatives, and off-balance sheet transactions and structures on our consolidated financial statements;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review in cooperation with the independent auditor and the management whether the accounting principles applied are appropriate in view of our size and complexity;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">periodically review our policies and procedures for risk management and assess the effectiveness thereof, including discussing with management our major financial risk exposures and the steps that have been taken to monitor and control such exposure;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">discuss with management and external advisors any legal matters that may have a material impact on our consolidated financial statements and any material reports or inquiries from regulatory or governmental agencies that could materially impact our contingent liabilities and risks;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review our disclosure controls and procedures and internal control over financial reporting, including significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establish procedures for the receipt, retention and treatment of complaints received regarding accounting, internal accounting controls or auditing matters, and the confidential, anonymous submission by employees of concerns regarding questionable accounting or auditing matters; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review and approve or ratify any related-person transaction in accordance with our related-person transaction policy.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The audit and finance committee will meet as often as it determines is appropriate to carry out its responsibilities, but in any event will meet at least four times per&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Compensation, nomination and corporate governance committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The compensation, nomination and corporate governance committee, consists of Douglas Williams (Chair), Roy Twyman (Member) and Thomas Graney (Member).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The compensation, nomination and corporate governance committee is governed by a charter that complies with SEC and home country governance rules. The compensation, nomination and corporate governance committee has the responsibility to, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">recommend to the board the guidelines for the overall compensation and equity awards for the board of directors and executive officers along with the rationale for such recommendations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">recommend to the board the compensation of executive officers;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">propose the maximum total compensation of the board of directors and executive officers for approval at the Annual General Meeting;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">periodically review policies and principles for the Company&#8217;s corporate governance;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">154</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establish the process for assessment of the performance of members of the board, its committees and individual members;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">prepare and reviews the Company&#8217;s succession plan for members of the board and the executive committee;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">periodically review the Company&#8217;s code of conduct and recommends changes as needed;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">recommend for presentation to our shareholders the compensation report for shareholder vote; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">define guidelines for the selection of candidates for election or re-election as members of the board and our executive officers.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Swiss law requires that we adopt a compensation committee, so in accordance with Nasdaq Listing Rule&#160;5615(a)(3), we will follow home country requirements with respect to the compensation, nomination and corporate governance committee. As a result, our practice will vary from the requirements of Nasdaq Listing Rule&#160;5605(d), which sets forth certain requirements as to the responsibilities, composition and independence of compensation committees, and from the independent director oversight of director nomination requirements of Nasdaq Listing Rule&#160;5605(e). We will be subject to the Swiss Ordinance Against Executive Compensation (Say on Pay) Rule. In addition, this committee will also be responsible for director and board committee nominations as well as reviewing and amending, if required, our corporate governance framework and guidelines.</p><a id="DEmployees_312467"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Employees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2022, we employed 156 employees, 30 of whom were part-time employees. 72 of our employees hold Ph.D. degrees and 50 hold M.Sc. degrees. Our 156 employees are from 30 countries. The average number of employees (calculated on full-time equivalents) in 2022 was 149. As of December&#160;31, 2021 and 2020 we had 143 and 149 employees, respectively. We have never had a work stoppage, and none of our employees is represented by a labor organization or under any collective-bargaining arrangements. We consider our employee relations to be good.</p><a id="EShareownership_36027"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">E.</b></span>Share ownership</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item&#160;7. Major shareholders and related-party transactions&#8212;A. Major shareholders.&#8221;</p><a id="Item6F"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">F.</b></span>Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>Not applicable.</p><a id="_a896d4b6_4237_4af1_857b_6cac6e0eacd8"></a><a id="ITEM7MAJORSHAREHOLDERSANDRELATEDPARTYTRA"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 10pt 0pt;">ITEM&#160;7. MAJOR SHAREHOLDERS AND RELATED-PARTY TRANSACTIONS</p><a id="AMajorshareholders_980950"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Major shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The following table presents information relating to the beneficial ownership of our common shares as of the date of this Annual Report by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each person, or group of affiliated persons, known by us to own beneficially 5% or more of our outstanding common shares;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each of our executive officers and directors; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all executive officers and directors as a group.</span></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The number of common shares beneficially owned by each entity, person, executive officer or director is determined in accordance with the rules&#160;of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any common shares over which the individual has sole or </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">155</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 10pt 0pt;">shared voting power or investment power as well as any common shares that the individual has the right to acquire within 60&#160;days of March&#160;1, 2023 through the exercise of any option, warrant or other right. Except as otherwise indicated, and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all common shares held by that person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The&#160;percentage of outstanding common shares is computed on the basis of 83,620,364 common shares outstanding as of March&#160;1, 2023. Common shares that a person has the right to acquire within 60&#160;days of March&#160;1, 2023 are deemed outstanding for purposes of computing the&#160;percentage ownership of the person holding such rights, but are not deemed outstanding for purposes of computing the&#160;percentage ownership of any other person, except with respect to the&#160;percentage ownership of all executive officers and directors as a group. Unless otherwise indicated below, the address for each beneficial owner is AC Immune, EPFL Innovation Park, Building B, 1015 Lausanne, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares&#160;beneficially</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shareholder</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">owned&#160;(%)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">5% Shareholders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">dievini Hopp BioTech holding GmbH &amp; Co KG<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 16,316,742</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 19.5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Varuma AG<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,999,999</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Affiris AG<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 10,133,474</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 12.1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Biotechnology Value Fund (BVF) Inc.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">4</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,428,379</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executive Officers and Directors</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Andrea Pfeifer<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">5</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,007,933</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Marie Kosco-Vilbois<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">6</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Johannes Rolf Streffer<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">7</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Piergiorgio Donati<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">8</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Christopher Roberts<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">9</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Howard Donovan<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">10</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Jean-Fabien Monin<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">11</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Douglas Williams<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">12</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Thomas Graney<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">13</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Werner Lanthaler<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">14</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Roy Twyman<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">15</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Carl June<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">16</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Alan Colowick<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">17</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Monika B&#252;tler<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Monica Shaw<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">19</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">All executive officers and directors as a group (15 persons)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,379,159</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5.2</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;">Indicates beneficial ownership of less than 1% of the total issued and outstanding common shares.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup><span style="white-space:pre-wrap;">Based on information set form in a Schedule 13G filed with the SEC by dievini Hopp BioTech holding GmbH &amp; Co KG (&#8220;dievini&#8221;) on February 10, 2023. These shares consist of 16,316,742 shares held by dievini.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">DH-Capital GmbH &amp; Co. KG (&#8220;DH-Capital&#8221;) and OH Beteiligungen GmbH &amp; Co. KG (&#8220;OH Beteiligungen&#8221;) are collectively the holders of 100% of the limited partner interest in dievini and therefore, control the voting and dispositive decisions of dievini together and may be deemed to beneficially own the shares held by dievini. Dietmar Hopp, Oliver Hopp and Daniel Hopp are the ultimate controlling persons of dievini, DH-Capital and OH Beteiligungen, and control the voting and investment decisions of the ultimate parent company of dievini and therefore, may be deemed to beneficially own the shares held by dievini by virtue of their status as controlling persons of dievini.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt;">The address of the principal business office of dievini and Dietmar Hopp is c/o dievini Hopp BioTech holding GmbH &amp; Co. KG, Johann-Jakob-Astor Stra&#223;e 57, 69190 Walldorf, Germany. The address of the principal business office of DH-</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">156</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">Capital GmbH &amp; Co. KG and OH Beteiligungen GmbH &amp; Co. KG is Opelstra&#223;e 28, 68789 St. Leon-Rot, Germany. The address of the principal business office of Oliver Hopp is Johann-Jakob-Astor-Stra&#223;e 59, 69190 Walldorf, Germany. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup>Represents 11,999,999 shares held by Varuma AG set forth in a Schedule 13G/A filed with the SEC on February&#160;12, 2019. The address for Varuma AG is Aeschenvorstadt 55, CH-4051 Basel, Switzerland. Rudolf Maag controls the voting and investment decisions of Varuma AG.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup>Based on information set forth in a Schedule 13G filed with the SEC by Affiris on February&#160;14, 2023, (i)&#160;these shares consist of 6,724,840 shares held of record by Affiris AG, as well as 1,513,317 shares that were issuable upon the conversion of notes held by Santo Venture Capital GmbH and 1,895,317 shares that were issuable upon the conversion of notes held by FCPB Affi GmbH; and (iii)&#160;the address of Affiris AG is Karl-Farkas-Gasse 22, 1030 Vienna, Austria, the address of by Santo Venture Capital GmbH is Bergfeldstrasse 9, 83607 Holzkirchen, Germany and the address of FCPB Affi GmbH is Freihamer Strasse 2, 82166 Gr&#228;felfing, Germany. The convertible notes held by Santo Venture Capital GmbH and FCPB Affi GmbH were fully settled in Q4 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">4</sup>Based on information set forth in a Schedule 13G filed with the SEC by BVF on February&#160;14, 2023, these shares consist of 7,428,379 shares held of record by BVF&#160;Inc. The address of BVF&#160;Inc. is 44 Montgomery St., 40<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Floor, San Francisco, California 94104.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">5</sup>Consists of 2,364,918 of our common shares and options to purchase 643,015 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">6</sup>Consists of 68,995 of our common shares and options to purchase 143,438 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">7</sup>Consists of 198,200 of our common shares and options to purchase 78,777 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">8</sup>Consists of 9,547 of our common shares and options to purchase 93,220 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">9</sup>Consists of 2,500 of our common shares and options to purchase 10,800 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">10</sup>Consists of 5,096 of our common shares and options to purchase 11,180 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">11</sup>Consists of 298,156 of our common shares and options to purchase 82,813 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">12</sup>Consists of 12,818 of our common shares and options to purchase 58,803 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">13</sup>Consists of 15,851 of our common shares and options to purchase 47,329 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">14</sup>Consists of 11,906 of our common shares and options to purchase 47,329 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">15</sup>Consists of 0 of our common shares and options to purchase 65,511 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">16</sup>Consists of 0 of our common shares and options to purchase 37,826 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">157</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">17</sup>Consists of 0 of our common shares and options to purchase 20,511 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>Consists of 0 of our common shares and options to purchase 25,310 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">19</sup>Consists of 0 of our common shares and options to purchase 25,310 of our common shares exercisable within 60&#160;days of March&#160;1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Holders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of March&#160;1, 2023, we had approximately 250 shareholders of record of our common shares. The actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust or by other entities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Significant changes in ownership by major shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have experienced significant changes in the&#160;percentage ownership held by major shareholders as a result of our IPO. Prior to our IPO in September&#160;2016, our principal shareholders were dievini Hopp BioTech holding GmbH&#160;&amp; Co KG and Varuma AG, which held shares representing 36.5% and 23.1% prior to our IPO, respectively. As of March&#160;1, 2023, dievini Hopp BioTech holding GmbH &amp; Co KG and Varuma AG held 19.5% and 14.4% of our outstanding common shares, respectively. BVF&#160;Inc. increased its holdings from 8.5% to 8.9% of our outstanding common shares. Affiris, Santo Venture Capital GmbH and FCPB GmbH became major shareholders in 2021 and continue to own 12.1% of our outstanding common shares as of December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In September&#160;2016, we completed our IPO and listed our common shares on the Nasdaq Global Market. In the IPO, we issued and sold 6,900,000 common shares, including 900,000 common shares sold to the underwriters pursuant to the underwriters&#8217; over-allotment option. While none of our existing shareholders sold common shares in the IPO, the&#160;percentage ownership held by certain shareholders decreased as a result of the issuance of the common shares sold by us in the IPO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In July&#160;2018, we completed three offerings of our common shares. In these offerings, we issued and sold 10,000,000 common shares, including 1,108,695 sold to the underwriters pursuant to the underwriters&#8217; over-allotment option. The&#160;percentage ownership held by certain shareholders decreased as a result of the issuance of the common shares sold by us in these offerings.</p><a id="BRelatedpartytransactions_285369"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Related-party transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">None.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Indemnification of directors and executive management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our Articles of Association require us to indemnify our executive officers and directors to the fullest extent permitted by law. We entered into indemnification agreements with our executive officers and directors.</p><a id="CInterestsofexpertsandcounsel_884840"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Interests of experts and counsel</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">158</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_6ab37c0b_aa5d_4237_b037_ae611b7c5f11"></a><a id="ITEM8FINANCIALINFORMATION_353349"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;8. FINANCIAL INFORMATION</p><a id="AConsolidatedstatementsandotherfinancial"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Consolidated statements and other financial information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Financial statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item&#160;18. Financial statements,&#8221; which contains our consolidated financial statements prepared in accordance with IFRS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Legal proceedings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">From time to time we may become involved in legal proceedings that arise in the ordinary course of business. As of the date of this Annual Report, we have not been a party to or paid any damages in connection with litigation that has had a material adverse effect on our financial position. No assurance can be given that future litigation will not have a material adverse effect on our financial position. When appropriate in the executive management&#8217;s estimation, we may record reserves in our consolidated financial statements for pending litigation and other claims.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Dividends and dividend policy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have never declared or distributed dividends on our capital stock. We intend to retain all available funds and any future earnings, if any, to fund the development and expansion of our business and we do not anticipate distributing any dividends in the foreseeable future. Any future determination related to dividend policy will be made at the discretion of our board of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under Swiss law, any dividend must be approved by our shareholders. In addition, our auditors must confirm that the dividend proposal of our board of directors conforms to Swiss statutory law and our articles of incorporation. A Swiss corporation may pay dividends only if it has sufficient distributable profits brought forward from the previous business years (<i style="font-style:italic;">report des b&#233;n&#233;fices</i>) or if it has distributable reserves (<i style="font-style:italic;">r&#233;serves &#224; libre disposition</i>), each as evidenced by its audited standalone statutory balance sheet prepared pursuant to Swiss law and after allocations to reserves required by Swiss law and its articles of association have been deducted. Distributable reserves are generally booked either as &#8220;free reserves&#8221; (<i style="font-style:italic;">r&#233;serves libres</i>) or as &#8220;reserve from capital contributions&#8221; (<i style="font-style:italic;">apports de capital</i>). Distributions out of nominal share capital, which is the aggregate nominal value of a corporation&#8217;s issued shares, may be made only by way of a share capital reduction.</p><a id="BSignificantchanges_559132"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Significant changes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A discussion of the significant changes in our business can be found under &#8220;Item&#160;4. Information on the Company&#8212;A. History and development of the Company&#8221; and &#8220;Item&#160;4. Information on the Company&#8212;B. Business overview.&#8221;</p><a id="_191a9f9c_6cee_48e7_ac5e_0fa993eeb1d5"></a><a id="ITEM9THEOFFERANDLISTING_667173"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;9. THE OFFER AND LISTING</p><a id="AOfferingandlistingdetails_815430"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Offering and listing details</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item&#160;9&#8211;C. Markets&#8221; below.</p><a id="BPlanofdistribution_857538"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Plan of distribution</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="CMarkets_858091"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Markets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our common shares trade on the Nasdaq Global Market under the symbol &#8220;ACIU.&#8221;</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">159</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="DSellingshareholders_381670"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Selling shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="EDilution_693805"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">E.</b></span>Dilution</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="FExpensesoftheissue_68420"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">F.</b></span>Expenses of the issue</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_4370e2d9_ec1a_4702_9942_dd5ab984c083"></a><a id="ITEM10ADDITIONALINFORMATION_834727"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;10. ADDITIONAL INFORMATION</p><a id="ASharecapital_904810"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Share capital</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="BMemorandumandarticlesofassociation_4543"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Memorandum and articles of association</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We incorporate by reference into this annual report on Form 20-F the description of our Articles of Association incorporated herein by reference to Exhibit 99.3 to the Company&#8217;s Report on Form 6-K, filed with the SEC on June 24, 2022.</p><a id="CMaterialcontracts_220743"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Material contracts</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Except as otherwise disclosed in this Annual Report on Form&#160;20-F (including the Exhibits), we are not currently, and have not been in the past 2&#160;years, party to any material contract, other than contracts entered into in the ordinary course of business.</p><a id="DExchangecontrols_45681"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Exchange controls</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There are no Swiss governmental laws, decrees or regulations that restrict, in a manner material to us, the export or import of capital, including any foreign exchange controls, or that generally affect the remittance of dividends or other payments to non-residents or non-citizens of Switzerland who hold our common shares.</p><a id="ETaxation_74576"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">E.</b></span>Taxation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following summary contains a description of the material Swiss and U.S. federal income tax consequences of the acquisition, ownership and disposition of common shares, but it does not purport to be a comprehensive description of all the tax considerations that may be relevant to a decision to purchase common shares. The summary is based upon the tax laws of Switzerland and regulations thereunder and on the tax laws of the United States and regulations thereunder as of the date hereof, which are subject to change.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Swiss tax considerations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This summary of material Swiss tax consequences is based on Swiss law and regulations and the practice of the Swiss tax administration as in effect on the date hereof, all of which are subject to change (or subject to changes in interpretation), possibly with retroactive effect. The summary does not purport to consider the specific circumstances of any particular shareholder or potential investor and does not relate to persons in the business of buying and selling common shares or other securities. The summary is not intended to be, and should not be interpreted as, legal or tax advice to any particular potential shareholder, and no representation with respect to the tax consequences to any particular shareholder is made.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">160</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Current and prospective shareholders are advised to consult their own tax advisors in light of their particular circumstances as to the Swiss tax laws, regulations and regulatory practices that could be relevant to them in connection with the acquiring, owning and selling or otherwise disposing of common shares and receiving dividends and similar cash or in-kind distributions on common shares (including dividends on liquidation proceeds and stock dividends) or distributions on common shares based upon a capital reduction (<i style="font-style:italic;">remboursements de la valeur nominale</i>) or reserves paid out of capital contributions (<i style="font-style:italic;">r&#233;serves sur les apports en capital</i>) and the consequences thereof under the tax laws, regulations and regulatory practices of Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Taxation of AC Immune</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune is subject to corporate Swiss federal, cantonal and communal taxation in Switzerland, Canton of Vaud, Commune of Ecublens, near Lausanne, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are entitled under Swiss laws to carry forward any losses incurred for a period of 7&#160;years and can offset our losses carried forward against future taxes. As of December&#160;31, 2022, we had tax loss carry-forwards totaling CHF 264.1 million (provisional amount; tax loss is definitively recognized by Swiss tax authorities once set-off against taxable income). There is no certainty that we will make sufficient profits to be able to utilize these tax loss carry-forwards in full.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effective corporate income tax rate (federal, cantonal and communal) where we are domiciled is currently 13.6%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of January&#160;1, 2020, the Company may request a tax relief of 60%, which would be applied to income from patents and similar rights at communal and cantonal levels. Additionally, a so-called &#8220;super-deduction&#8221; may be granted for payroll and other expenses of research and development of Swiss origins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">However, the aforementioned tax relief based on the patent box and deductions for research and development may not exceed 50% of the overall taxable profit before these tax relief and deductions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Notwithstanding the corporate income tax, the corporate capital is taxed at a rate of 0.1305% (cantonal and communal tax only, as there is no federal tax on capital). As of January&#160;1, 2020 the capital attributable to patents and similar rights is considered with 50% relief in the capital tax calculation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Federal, cantonal and communal individual income tax and corporate income tax</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Non-resident shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Except as described in &#8220;&#8212;<i style="font-style:italic;">Swiss federal withholding tax&#8221;</i> below, shareholders who are not resident in Switzerland for tax purposes, and who, during the relevant taxation&#160;year, have not engaged in a trade or business carried on through a permanent establishment or fixed place of business situated in Switzerland for tax purposes (all such shareholders for purposes of this section termed, &#8220;Non-resident shareholders&#8221;), will not be subject to any Swiss federal, cantonal and communal income tax on dividends and similar cash or in-kind distributions on Shares (including liquidation proceeds and stock dividends) (for the purposes of this section, &#8220;dividends&#8221;), distributions based upon a capital reduction (<i style="font-style:italic;">remboursements li&#233;s &#224; la r&#233;duction de la valeur nominale des actions</i>) and distributions paid out of reserves from capital contributions (<i style="font-style:italic;">apports de capital</i>) on shares, or capital gains realized on the sale or other disposition of shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Resident private shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Swiss-resident individuals who hold their shares as private assets are required to include dividends, but not distributions based upon a capital reduction (<i style="font-style:italic;">remboursements li&#233;s &#224; la r&#233;duction de la valeur nominale des actions</i>) and distributions paid out of reserves from capital contributions confirmed by the Swiss Federal Tax Administration (<i style="font-style:italic;">apports de capital</i>), in their personal income tax return and are subject to Swiss federal, cantonal and communal income tax on any net taxable income for the relevant taxation period, including the dividends, but not the distributions based upon a capital reduction (<i style="font-style:italic;">remboursements li&#233;s &#224; la r&#233;duction de la valeur nominale des actions</i>) and distributions paid out of </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">161</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">reserves from capital contributions confirmed by the Swiss Federal Tax Administration (<i style="font-style:italic;">apports de capital)</i>. Shareholders holding shares representing at least 10% of the nominal share capital of the Company may be able to decrease the taxable dividend basis by 30% (70% taxable) at the federal level and up to 50% at the cantonal level, depending on their respective cantonal rates, as partial relief from economic double taxation. Capital gains resulting from the sale or other disposition of shares are, subject to a few exceptions such as in case of Taxable Repurchases as described in &#8220;&#8212;<i style="font-style:italic;">Swiss federal withholding tax&#8221;</i> below, not subject to Swiss federal, cantonal and communal income tax, and conversely, capital losses are not tax-deductible for resident private shareholders (the shareholders referred to in this paragraph for the purposes of this section, &#8220;Resident private shareholders&#8221;). See &#8220;<i style="font-style:italic;">Domestic commercial shareholders</i>&#8221; below for a summary of the taxation treatment applicable to Swiss-resident individuals, who, for income tax purposes, are classified as &#8220;professional securities dealers&#8221; or are otherwise deemed to hold Company shares in their commercial wealth.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Domestic commercial shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Corporate and individual shareholders who hold their shares as part of a trade or business carried on in Switzerland, in the case of corporate and individual shareholders not resident in Switzerland, through a permanent establishment or fixed place of business situated, for tax purposes, in Switzerland, are required to recognize dividends, distributions based upon a capital reduction (<i style="font-style:italic;">remboursements li&#233;s &#224; la r&#233;duction de la valeur nominale des actions</i>) and distributions paid out of reserves from capital contributions (<i style="font-style:italic;">apports de capital</i>) received on shares and capital gains or losses realized on the sale or other disposition of shares in their income statement for the relevant taxation period and are subject to Swiss federal, cantonal and communal individual or corporate income tax, as the case may be, on any net taxable earnings for such taxation period. The same taxation treatment also applies to Swiss-resident private individuals who, for income tax purposes, are classified as &#8220;professional securities dealers&#8221; for reasons of, <i style="font-style:italic;">inter alia</i>, frequent dealing, or leveraged investments, in shares and other securities (the shareholders referred to in this paragraph for purposes of this section, &#8220;Domestic commercial shareholders&#8221;). Domestic commercial shareholders who are natural persons holding shares representing at least 10% of the nominal share capital of the Company may be able to decrease the taxable basis by 30% (70% taxable) at the federal level and up to 50% at the cantonal level, depending on their respective cantonal rates, as partial relief from economic double taxation (in the case of capital gains provide the shares have been held for at least one year). Domestic commercial shareholders who are corporate taxpayers may be eligible for tax relief (<i style="font-style:italic;">r&#233;duction pour participations</i>) in respect of dividends and distributions based upon a capital reduction (<i style="font-style:italic;">remboursements li&#233;s &#224; la r&#233;duction de la valeur nominale des actions</i>) and distributions paid out of reserves from capital contributions (<i style="font-style:italic;">apports de capital</i>) if the shares held by them as part of a Swiss business have an aggregate market value of at least CHF&#160;1 million or represent 10% or more of the outstanding share capital or the dividend rights, of the Company. Capital gains relief is generally available only if the sold shares represent 10% or more of the outstanding share capital or the dividend rights, of the Company and provided that the shares have been held for at least one&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Swiss cantonal and communal private wealth tax and capital tax</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Non-resident shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Non-resident shareholders are not subject to Swiss cantonal and communal private wealth tax or capital tax.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Resident private shareholders and domestic commercial shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Resident private shareholders and Domestic commercial shareholders who are individuals are required to report their shares as part of their private wealth or their Swiss business assets, as the case may be, and will be subject to Swiss cantonal and communal private wealth tax on any net taxable wealth (including shares), in the case of Domestic commercial shareholders to the extent the aggregate taxable wealth is allocable to Switzerland. Domestic commercial shareholders who are corporate taxpayers are subject to Swiss cantonal and communal capital tax on taxable capital to the extent the aggregate taxable capital is allocable to Switzerland.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">162</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Swiss federal withholding tax</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Dividends (including scrip or stock dividends) that the Company pays on the shares are subject to Swiss Federal withholding tax <i style="font-style:italic;">(imp&#244;t anticip&#233;)</i> imposed on the gross amount of the taxable distribution at the then prevailing rate (currently, at a rate of 35% of the gross amount of the taxable distribution). The Company is required to withhold the Swiss federal withholding tax from the dividend and remit it to the Swiss Federal Tax Administration. Distributions based upon a capital reduction (<i style="font-style:italic;">remboursements li&#233;s &#224; la r&#233;duction de la valeur nominale des actions</i>) and distributions paid out of reserves from contributions confirmed by the Swiss Federal Tax Administration (<i style="font-style:italic;">apports de capital</i>) are not subject to Swiss federal withholding tax. Capital gains realized on the sale of the shares are not subject to the Swiss federal withholding tax (other than in case of a sale to the Company (i) for cancellation, (ii) if the total of repurchased shares exceeds 10% of the Company&#39;s share capital or (iii) if the repurchased shares are not resold within the applicable time period after the repurchase, if and to the extent the redemption price less the nominal value of the redeemed shares is not booked against reserves from capital contributions confirmed by the Swiss Federal Tax Administration (&quot;Taxable Repurchases&quot;)).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Swiss federal withholding tax on a dividend will be refundable in full to a resident private shareholder and to a Domestic commercial shareholder, who, in each case, <i style="font-style:italic;">inter alia,</i> as a condition to a refund, is the beneficial owner of the shares and the dividends or the distributions made or paid on the share and duly reports the dividend in his individual income tax return as income or recognizes the dividend in his income statement as earnings, as applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A Non-resident shareholder may be entitled to a partial or full refund, as the case may be, of the Swiss federal withholding tax on a dividend if the country of his or her residence for tax purposes has entered into a bilateral treaty for the avoidance of double taxation with Switzerland and the conditions of such treaty are met. Such shareholders should be aware that the procedures for claiming treaty benefits (and the time required for obtaining a refund) might differ from country to country. A holder of the shares who is a resident of the U.S. for purposes of the Convention between the United States of America and the Swiss Confederation for the Avoidance of Double Taxation with Respect to Taxes on Income (Treaty), without taxable presence in Switzerland to which the shares are attributable or who is a qualified U.S. pension fund and who, in each case, is the beneficial owner of the shares and the dividend or distribution and who meets the other conditions of the Treaty may (i) in the case of qualified U.S. pension funds, apply for a full refund of the Swiss federal withholding tax, (ii) if the holder is a corporation owning at least 10% of the voting rights of the Company, apply for a refund of the Swiss federal withholding tax withheld in excess of the 5% reduced treaty rate, or (iii) apply for a refund of the Swiss federal withholding tax withheld in excess of the 15% treaty rate in all other cases. The applicable refund request form may be filed with the Swiss Federal Tax Administration following receipt of the dividend and the relevant deduction certificate, however no later than 31&#160;December&#160;of the third&#160;year following the calendar&#160;year in which the dividend was payable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Swiss federal stamp taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company will be subject to and pay to the Swiss Federal Tax Administration a 1% Swiss federal issuance stamp duty (droit de timbre <i style="font-style:italic;">d&#8217;&#233;missions</i>) on the consideration received for the issuance of the shares less certain costs incurred in connection with the issuance (in case of the implementation of the capital band, the issuance stamp duty is payable based on the net-principle at the end of the period of the validity of the capital band). The issuance and delivery of the shares to the initial shareholders at the settlement date is not subject to Swiss federal securities transfer stamp duty (<i style="font-style:italic;">droit de timbre de n&#233;gociation</i>).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any subsequent dealings in the shares, for which a bank or another securities dealer in Switzerland or Liechtenstein, as defined in the Swiss Federal Stamp Tax Act, acts as an intermediary, or is a party, to the transaction, are, subject to certain exemptions provided for in the Swiss Federal Stamp Tax Act, subject to Swiss securities transfer stamp duty tax at an aggregate tax rate of up to 0.15% of the consideration paid for such shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Additional tax considerations associated with our ATM program</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">As of December&#160;31, 2022, the Company held in total 6,214,021 fully paid-in treasury shares as part of its ATM offerings. These shares were established via two tranches (one in September&#160;2020 and one in September&#160;2021, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">163</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">respectively). Under present Swiss tax laws, repurchases of shares for the purposes of cancellation are treated as a partial liquidation and are subject to 35% Swiss withholding tax on the difference between the repurchase price and the nominal value of the shares except, since January&#160;1, 2011, to the extent these are booked against the reserves from capital contributions confirmed by the Swiss Federal Tax Administration (<i style="font-style:italic;">apports de capital</i>) if any. No partial liquidation treatment applies and no withholding tax is triggered if the shares are not repurchased for cancellation but held by the Company as treasury shares, provided the limitations imposed by corporate law are respected (the nominal value of such shares does not exceed 10% of the outstanding share capital and the purchase price is covered by freely disposable equity). However, regarding the above-mentioned 6,214,021 treasury shares and given the specificities of the ATM offering, the Company sought and obtained a tax ruling from the Swiss Federal Tax Administration confirming that their acquisition by the Company did not constitute a direct partial liquidation and therefore does not trigger withholding tax. Further, the Company has obtained a tax ruling from the concerned Cantonal Tax Authority at its place of incorporation, to obtain confirmation that the placement of these treasury shares for a subscription price superior to their nominal value will not trigger any corporate income tax for the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Of the remaining treasury shares, 2,600,000 shares have been reserved by the board of directors for use only under the Company&#8217;s current Stock Option and Incentive Plan per a further tax ruling with the concerned Cantonal Tax Authority without corporate income tax consequences for the Company. 1,220,861 shares from the first tranche have not been sold and are still recorded as treasury shares as of December 31, 2022. In addition, 2,393,160 fully paid in treasury shares issued as part of second tranche for the ATM for future subscription (or, possibly, as part of a future share-dividend program, should the Company become profitable and have enough earnings carried forward to cover such distribution) have not been sold and are still recorded as treasury shares as of December&#160;31, 2022. All these shares are covered by the same above-mentioned tax rulings (i.e. their acquisition does not trigger any withholding tax and their placement will not trigger any corporate income tax).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Material U.S. federal income tax considerations for U.S. Holders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following is a description of material U.S. federal income tax consequences to the U.S. Holders described below of owning and disposing of our common shares. It does not describe all tax considerations that may be relevant to a particular person&#8217;s decision to own common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This discussion applies only to a U.S. Holder that holds common shares as capital assets for U.S. federal income tax purposes. In addition, it does not describe all of the U.S. federal income tax consequences that may be relevant in light of a U.S. Holder&#8217;s particular circumstances, including alternative minimum tax consequences, the potential application of the provisions of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) known as the Medicare contribution tax and tax consequences applicable to U.S. Holders subject to special rules, such as:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">certain financial institutions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">dealers or electing traders in securities that use a mark-to-market method of tax accounting;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">persons holding our common shares as part of a straddle, integrated transaction or similar transaction;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">U.S. Holders whose functional currency for U.S. federal income tax purposes is not the U.S. dollar;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">entities classified as partnerships for U.S. federal income tax purposes;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">tax-exempt entities, &#8220;individual retirement accounts&#8221; or &#8220;Roth IRAs;&#8221;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">persons that received their common shares as compensation;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">persons that own or are deemed to own 10% or more of our shares, by vote or value; and</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">164</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">persons holding our common shares in connection with a trade or business conducted outside of the United States.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If an entity that is classified as a partnership for U.S. federal income tax purposes holds common shares, the U.S. federal income tax treatment of a partner will generally depend on the status of the partner and the activities of the partnership. Partnerships and their partners should consult their tax advisers as to the particular U.S. federal income tax consequences of owning and disposing of the common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This discussion is based on the Code, administrative pronouncements, judicial decisions, final, temporary and proposed Treasury regulations, and the Treaty, all as of the date hereof, any of which is subject to change or differing interpretations, possibly with retroactive effect.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A &#8220;U.S. Holder&#8221; is a person that, for U.S. federal income tax purposes, is a beneficial owner of common shares and is any of the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a citizen or individual resident of the United States;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States, any state therein or the District of Columbia; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an estate or trust the income of which is subject to U.S. federal income taxation regardless of its source.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">U.S. Holders should consult their tax advisers concerning the U.S. federal, state, local and non-U.S. tax consequences of owning and disposing of common shares in their particular circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Passive foreign investment company rules </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">As discussed in our Annual Report on Form 20-F for 2019 and 2020, we were likely a PFIC for these years. We were also likely a PFIC for 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We will be a PFIC under the Code for any taxable year in which, after the application of certain look-through rules with respect to subsidiaries, either (i) 75% or more of our gross income consists of passive income (the &#8220;income test&#8221;) or (ii) 50% or more of the average value of our assets (generally determined on a quarterly basis) consists of assets that produce, or are held for the production of, passive income (the &#8220;asset test&#8221;). Passive income generally includes dividends, interest, certain non-active rents and royalties, and gains from financial investments. Cash is generally a passive asset. Goodwill (the value of which may be determined by reference to the excess of the sum of a corporation&#8217;s market capitalization and liabilities over the value of its assets) is generally an active asset to the extent attributable to business activities that produce active income. For purposes of the above calculations, we will be treated as if we hold our proportionate share of the assets of, and directly receive our proportionate share of the income of, any other corporation in which we directly or indirectly own at least 25% of the shares of such corporation by value. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have not obtained valuations of our assets (including goodwill or going concern value) for 2022 and thus are not in a position to make a definitive determination regarding whether we were a PFIC for 2022. However, we believe that we were likely a PFIC for 2022 due to the decline and volatility of our market capitalization in 2022. If the value of our goodwill or going concern value is determined by reference to our market capitalization then we were a PFIC for 2022. For the same reason there is a significant risk that we will also be a PFIC for 2023, and possibly other taxable years. Because our PFIC status is a factual annual determination that can be determined only after the end of the relevant taxable year, we cannot express a view regarding our PFIC status for 2023 or any future taxable year. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In addition, the application of the income test to a company like us (whose overall losses from research and development activities significantly exceed its gross income) is not entirely clear. We will be a PFIC for any taxable year under the income test if 75% or more of our gross income (as determined for U.S. federal income tax purposes) for such year consists of interest and other passive income. Prior to the commercialization and sales of any of our product candidates, our gross income may consist primarily of upfront or milestone payments and grants (which we believe are </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">165</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">likely to be treated as active income) and interest (which is passive income). The receipt of upfront payments is non-recurring in nature, and the receipt of grants or milestone payments is subject to various conditions. Therefore, there can be no assurance as to the amount of grants, milestone payments or upfront payments (if any) that we will receive for any taxable year. Moreover, we may earn income from sublicensing, which may be passive unless certain conditions are satisfied. There is no assurance that the IRS will not challenge the classification of any of our income items for PFIC purposes for any taxable year. Accordingly, there is no assurance that we will not be a PFIC for any taxable year under the income test.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under a rule commonly referred to as the &#8220;once a PFIC always a PFIC&#8221; rule, if we are a PFIC for any taxable year and a U.S. Holder owns our common shares during any portion of that year, we will continue to be treated as a PFIC with respect to the U.S. Holder even if we cease to be a PFIC for any subsequent taxable year. If we are a PFIC for any taxable year during which a U.S. Holder owns our common shares but cease to be a PFIC thereafter, a U.S. Holder may make a &#8220;deemed sale&#8221; election with respect to our common shares, in which case the U.S. Holder may be required to recognize income under the rules described in the subsequent paragraph without receiving any corresponding cash.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If a U.S. Holder owns our common shares in any&#160;year in which we are a PFIC, subject to the discussion above regarding the deemed sale election and the discussion below regarding the mark-to-market election, any gain recognized by the U.S. Holder on a sale or other disposition (including certain pledges) of the common shares will be allocated ratably over the U.S. Holder&#8217;s holding period for the common shares. The amounts allocated to the taxable&#160;year of the sale or other disposition and to any&#160;year before we became a PFIC will be taxed as ordinary income. The amount allocated to any other taxable&#160;year will be subject to tax at the highest rate in effect for individuals or corporations, as appropriate, for that taxable&#160;year, and an interest charge will be imposed on the amount of tax allocated to that taxable&#160;year. Further, to the extent that distributions received by a U.S. Holder on its common shares during a taxable&#160;year exceed 125% of the average of the annual distributions on the common shares received during the preceding three taxable years or the U.S. Holder&#8217;s holding period, whichever is shorter, the excess distribution will be subject to taxation in the same manner.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A U.S. Holder may be able to avoid the rules&#160;described above by making a mark-to-market election with respect to the common shares, provided that the common shares are regularly traded on Nasdaq or any other qualified exchange. If a U.S. Holder makes the mark-to-market election, it generally will recognize as ordinary income any excess of the fair market value of the common shares at the end of each taxable&#160;year in which we are a PFIC over their adjusted tax basis, and will recognize an ordinary loss in respect of any excess of the adjusted tax basis of the common shares over their fair market value at the end of the taxable&#160;year (but only to the extent of the net amount of income previously included as a result of the mark-to-market election). If a U.S. Holder makes this election, the U.S. Holder&#8217;s tax basis in the common shares will be adjusted to reflect the income or loss amounts recognized. Any gain recognized on the sale or other disposition of common shares in a&#160;year in which we are a PFIC will be treated as ordinary income and any loss will be treated as an ordinary loss (but only to the extent of the net amount of income previously included as a result of the mark-to-market election, with any excess treated as capital loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We do not intend to provide the information necessary for U.S. Holders to make a &#8220;qualified electing fund&#8221; election, which if available could materially affect the tax consequences to U.S. Holders of the ownership and disposition of our common shares if we are a PFIC for any taxable&#160;year. Therefore, U.S. Holders will not be able to make such elections.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, if we are a PFIC (or are treated as a PFIC with respect to a particular U.S. Holder under the &#8220;once a PFIC always a PFIC&#8221; rule) for the taxable&#160;year in which we pay a dividend or for the prior taxable&#160;year, the preferential tax rate discussed below with respect to &#8220;qualified dividend income&#8221; received by certain non-corporate U.S. Holders will not be available.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If a U.S. Holder owns common shares during any&#160;taxable year in which we are a PFIC, the U.S. Holder generally must file annual reports on IRS Form&#160;8621 with respect to us with the U.S. Holder&#8217;s federal income tax return.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">U.S. Holders should consult their tax advisers concerning our PFIC status for any taxable year and the consequences thereof.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">166</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Taxation of distributions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following is subject to the discussion under &#8220;&#8212;<i style="font-style:italic;">Passive foreign investment company rules</i>&#8221; above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As discussed under &#8220;Item 8. Financial Information&#8212;Section A. Consolidated statements and other financial information&#8212;Dividends and dividend policy,&#8221; we do not currently expect to make distributions on our common shares. In the event that we do make distributions of cash or other property on our common shares, other than certain <i style="font-style:italic;">pro rata</i> distributions of our common shares, they will generally be treated as dividends to the extent paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles). Because we do not maintain calculations of our earnings and profits under U.S. federal income tax principles, we expect that distributions generally will be reported to U.S. Holders as dividends. Dividends paid to certain non-corporate U.S. Holders may be eligible for taxation as &#8220;qualified dividend income&#8221; and therefore, subject to applicable limitations, may be taxable at rates applicable to long-term capital gains, provided that we are not a PFIC (and are not treated as a PFIC with respect to a particular U.S. Holder under the &#8220;once a PFIC always a PFIC&#8221; rule) for our taxable year in which the dividend is paid or the preceding taxable year. Non-corporate U.S. Holders should consult their tax advisers regarding the availability of the reduced tax rate on dividends, if any, in their particular circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Dividends will not be eligible for the dividends-received deduction generally available to U.S. corporations under the Code. Dividends will be included in a U.S. Holder&#8217;s income on the date of receipt. The amount of any dividend income paid in Swiss Francs will be the U.S. dollar amount calculated by reference to the exchange rate in effect on the date of actual or constructive receipt, regardless of whether the payment is in fact converted into U.S. dollars at that time. If the dividend is converted into U.S. dollars on the date of receipt, a U.S. Holder should not be required to recognize foreign currency gain or loss in respect of the dividend income. A U.S. Holder may have foreign currency gain or loss if the dividend is converted into U.S. dollars after the date of receipt.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Dividends will be foreign-source income. The amount of dividend income will include any amounts withheld by us in respect of Swiss income taxes. Subject to applicable limitations, some of which vary depending upon the U.S. Holder&#8217;s particular circumstances, Swiss income taxes withheld from dividends on our common shares (at a rate not exceeding the applicable Treaty rate in the case of U.S. Holders eligible for Treaty benefits) may be creditable against the U.S. Holder&#8217;s U.S. federal income tax liability. The rules&#160;governing foreign tax credits are complex. For example, Treasury regulations provide that, in the absence of an election to apply the benefits of an applicable income tax treaty, in order for foreign income taxes to be creditable the relevant foreign income tax rules must be consistent with certain U.S. federal income tax principles, and we have not determined whether the Swiss income tax system meets this requirement. U.S. Holders should consult their tax advisers regarding the creditability of any Swiss taxes in their particular circumstances (including the U.S. Holder&#8217;s eligibility for Treaty benefits). In lieu of claiming a credit, U.S. Holders may be able to elect to deduct any Swiss income taxes in computing their taxable income, subject to generally applicable limitations under U.S. law. An election to deduct foreign taxes instead of claiming foreign tax credits applies to all creditable foreign taxes paid or accrued in the taxable&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Sale or other disposition of common shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following is subject to the discussion under &#8220;&#8212;<i style="font-style:italic;">Passive foreign investment company rules</i>&#8221; above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Gain or loss realized on the sale or other disposition of common shares will be capital gain or loss, and will be long-term capital gain or loss if the U.S. Holder owned the common shares for more than one&#160;year, or short-term capital gain or loss otherwise. The amount of the gain or loss will equal the difference between the U.S. Holder&#8217;s tax basis in the common shares disposed of and the amount realized on the disposition, in each case as determined in U.S. dollars. This gain or loss will generally be U.S.-source gain or loss for foreign tax credit purposes. The deductibility of capital losses is subject to various limitations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Information reporting and backup withholding</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Payments of dividends and sales proceeds that are made within the United States or through certain U.S.-related financial intermediaries generally are subject to information reporting, and may be subject to backup withholding, unless </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">167</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(i)&#160;the U.S. Holder is a corporation or other exempt recipient (and establishes that fact if required to do so) or (ii)&#160;in the case of backup withholding, the U.S. Holder provides a correct taxpayer identification number and certifies that it is not subject to backup withholding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The amount of any backup withholding from a payment to a U.S. Holder will be allowed as a credit against the U.S. Holder&#8217;s U.S. federal income tax liability and may entitle the U.S. Holder to a refund, provided that the required information is furnished in a timely manner to the IRS. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain U.S. Holders who are individuals (or certain specified entities) may be required to report information relating to our common shares or non-U.S. accounts through which they may be held. U.S. Holders should consult their tax advisers regarding their reporting obligations with respect to the ownership and disposition of our common shares.</p><a id="FDividendsandpayingagents_343344"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">F.</b></span>Dividends and paying agents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="GStatementbyexperts_563927"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">G.</b></span>Statement by experts</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="HDocumentsondisplay_893312"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">H.</b></span>Documents on display</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are subject to the informational requirements of the Exchange Act. Accordingly, we are required to file reports and other information with the SEC, including annual reports on Form&#160;20-F and reports on Form&#160;6-K. In addition, the SEC maintains an Internet website that contains reports and other information about issuers, such as us, that file electronically with the SEC. The address of that website is www.sec.gov.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, pursuant to Swiss law, any shareholder of record has the right to receive a free copy of this Annual Report and to inspect this Annual Report at any time at our registered office in Ecublens, near Lausanne, Canton of Vaud, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules&#160;prescribing the furnishing and content of proxy statements, and our executive officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section&#160;16 of the Exchange Act. In addition, we will not be required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.</p><a id="ISubsidiaryinformation_453406"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">I.</b></span>Subsidiary information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="JAnnualReportToSecurityHolders"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">J.</b></span>Annual report to security holders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_3d9cbc72_7333_4190_84a8_928b302b331e"></a><a id="ITEM11QUANTITATIVEANDQUALITATIVEDISCLOSU"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s activities expose it to the following financial risks: market risk (currency and interest rate risk), credit risk and liquidity risk. The Company&#8217;s overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company&#8217;s financial performance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Market risk arises from our exposure to fluctuation in currency exchange rates. We are exposed to market risks in the ordinary course of our business, which are principally limited to foreign currency exchange rate fluctuations and to a lesser degree, interest rate fluctuations.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">168</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Market risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Foreign exchange risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is exposed to foreign exchange risk arising from currency exposures, primarily with respect to the EUR, USD and to a lesser extent to GBP, DKK and SEK. The currency exposure is not hedged. However, the Company has the policy of matching its cash holdings to the currency structure of its expenses. As of December&#160;31, 2022, the Company holds approximately 77% of its overall cash and cash equivalents balance in CHF with the remainder predominantly in EUR and USD (see &#8220;Note&#160;8. Cash and cash equivalents and short-term financial assets&#8221; of the consolidated financial statements). The Company holds almost 94% of its liquidity (cash and cash equivalents plus short-term financial assets) in CHF.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have a number of collaboration agreements for which the upfront payments, milestone payments and future royalty payments are not denominated in Swiss Francs, our reporting currency. Furthermore, many of our research and development activities are subcontracted to parties outside of Switzerland and we purchase materials from suppliers outside of Switzerland. As a result, we are exposed to foreign exchange risk. Approximately 44% of our total costs are incurred in currencies other than the Swiss Franc. Due to the size of some of the income received from collaboration agreements and also the high&#160;percentage of our costs indirectly being in foreign currencies, a hypothetical 10% change in exchange rates relative to the Swiss Franc could have a material impact on our consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Interest rate risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We maintain financial instruments in accordance with our treasury management policy. The primary objectives of our policy are to preserve principal, maintain proper liquidity and meet operating needs. Our financial assets are subject to interest rate risk and will decrease in value if market interest rates increase. Due to the current negative interest rates in Switzerland and our policy to maintain the majority of our cash and cash equivalents in our functional currency. However, due to the conservative nature of our investments and relatively short duration, interest rate risk is mitigated. We do not own derivative financial instruments. Accordingly, we do not believe that there is any material market risk exposure with respect to derivative or other financial instruments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Credit risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company maintains a formal treasury risk and investment management policy to limit counterparty credit risk. As of December&#160;31, 2022, the Company&#8217;s cash and cash equivalents and short-term financial assets are held with four financial institutions, each with a high credit rating assigned by international credit-rating agencies. The maximum amount of credit risk is the carrying amount of the financial assets. Receivables are fully performing, not past due and not impaired (see &#8220;Note&#160;8. Cash and cash equivalents and short-term financial assets&#8221; and &#8220;Note&#160;10. Other current receivables&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Liquidity risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Inherent in the Company&#8217;s business are various risks and uncertainties, including the high uncertainty that new therapeutic and diagnostic concepts will succeed. AC Immune&#8217;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;acquire and keep key personnel employed, and (iv)&#160;acquire additional capital to support its operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s approach of managing liquidity is to ensure sufficient cash to meet its liabilities when due. Therefore, management closely monitors the cash position on rolling forecasts based on expected cash flow to enable the Company to finance its operations for at least 18&#160;months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Based on the Company&#8217;s current liquidity position, comprised of cash and cash equivalents and short-term financial assets, the Company is financed into Q3 2024, excluding any potential milestones.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">169</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Safe Harbor</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Forward-looking Statements.&#8221;</p><a id="_ead76e92_733a_4340_b7de_aacf1390d409"></a><a id="ITEM12DESCRIPTIONOFSECURITIESOTHERTHANEQ"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</p><a id="ADebtsecurities_509592"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Debt securities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="BWarrantsandrights_307246"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Warrants and rights</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="COthersecurities_247673"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Other securities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="DAmericandepositaryshares_477448"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>American depositary shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">170</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_62e01d09_623d_4909_8077_9efd463a0388"></a><a id="PARTII_983451"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">PART&#160;II</p><a id="ITEM13DEFAULTSDIVIDENDARREARAGESANDDELIN"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</p><a id="ADefaults_798645"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Defaults</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">No matters to report.</p><a id="BArrearsanddelinquencies_675487"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Arrears and delinquencies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">No matters to report.</p><a id="_01524398_bd0b_40a2_9b99_ba52e3808514"></a><a id="ITEM14MATERIALMODIFICATIONSTOTHERIGHTSOF"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_d5618f68_a101_416b_ad0b_6c589c38a506"></a><a id="ITEM15CONTROLSANDPROCEDURES_751037"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;15. CONTROLS AND PROCEDURES</p><a id="ADisclosurecontrolsandprocedures_342570"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Disclosure controls and procedures</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2022, under the supervision and with the participation of our management, including our Chief Executive Officer and VP Finance and Interim Chief Financial Officer, we performed an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule&#160;13a-15(e)&#160;under the Exchange Act). There are inherent limitations to the effectiveness of any disclosure controls and procedures system, including the possibility of human error and circumventing or overriding them. Even if effective, disclosure controls and procedures can provide only reasonable assurance of achieving their control objectives.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our Chief Executive Officer and VP Finance and Interim Chief Financial Officer concluded that our disclosure controls and procedures were effective in recording, processing, summarizing and reporting on a timely basis the information required to be included in periodic filings under the Exchange Act and that such information is accumulated and communicated to management, including our Chief Executive and Chief Financial Officers, as appropriate to allow timely decisions regarding required disclosure.</p><a id="BManagementsAnnualReportoninternalcontro"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Management&#8217;s Annual Report on internal control over financial reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule&#160;13a-15(f)&#160;of the Exchange Act. Our internal control over financial reporting is supported by written policies and procedures. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the supervision and with the participation of our Chief Executive Officer and VP Finance and Interim Chief Financial Officer, management conducted an evaluation of the effectiveness of our internal control over financial reporting based upon criteria established in&#160;<i style="font-style:italic;">Internal Control&#160;&#8211; Integrated Framework&#160;</i>(2013) by the Committee of Sponsoring Organizations of the Treadway Commission. Based on that evaluation, our management, including our Chief Executive Officer and VP Finance and Interim Chief Financial Officer concluded that our internal control over financial reporting was effective as of December&#160;31, 2022.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">171</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="CAttestationreportoftheregisteredpublica"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Attestation report of the registered public accounting firm</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effectiveness of our internal control over financial reporting as of December&#160;31, 2022 has been audited by PricewaterhouseCoopers SA, an independent registered public accounting firm. Their report is included on page&#160;F-2. PricewaterhouseCoopers SA is a member of the Chamber of Public Accountants, Lausanne, Switzerland.</p><a id="DChangesininternalcontroloverfinancialre"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Changes in internal control over financial reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There have been no changes in the Company&#8217;s internal control over financial reporting during the&#160;year ended December&#160;31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</p><a id="_dbb80fea_a290_477a_9dd0_288812fb839a"></a><a id="ITEM16RESERVED_843348"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">ITEM&#160;16. [RESERVED]</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_6392eb25_a8d0_4683_8ee3_1f39869e33cd"></a><a id="ITEM16AAuditcommitteefinancialexperts_94"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16A. Audit committee financial experts</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our board of directors has determined that Monika B&#252;tler, Thomas Graney and Werner Lanthaler are audit committee financial experts, as that term is defined by the SEC, and are independent for the purposes of SEC rules.</p><a id="_5df097fb_660f_4129_8c0e_db1debc969bd"></a><a id="ITEM16BCodeofEthics_857383"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16B. Code of Ethics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Code of Business Conduct and Ethics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have adopted a Code of Business Conduct and Ethics, which covers a broad range of matters including the handling of conflicts of interest, compliance issues and other corporate policies such as insider trading and equal opportunity and non-discrimination standards. Our Code of Business Conduct and Ethics applies to all of our directors, executive officers and employees. We have published our Code of Business Conduct and Ethics on our website, <i style="font-style:italic;">www.acimmune.com</i>. The information contained on our website is not a part of this Annual Report.</p><a id="_d70b18aa_c511_4393_81a3_792cc0125001"></a><a id="ITEM16CPrincipalaccountantfeesandservice"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">ITEM&#160;16C. Principal accountant fees and services</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:12pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Audit fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 725</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 668</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Audit-related fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 15</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total fees</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 730</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 683</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:12pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2022, PwC was the Company&#8217;s auditor for the IFRS and statutory accounts. At the ordinary Annual General Meeting on June&#160;24, 2022, the shareholders appointed PwC as the Company&#8217;s auditor for a term of office of 1&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#0d0e00;">Audit fees i</span>nclude fees for audit services primarily related to the integrated audit of (i)&#160;our annual consolidated financial statements and our internal control over financial reporting as required by Section&#160;404(b)&#160;of the Sarbanes-Oxley Act of 2002, (ii)&#160;the review of our quarterly condensed consolidated financial statements, (iii)&#160;comfort letters, consents and assistance with and review of documents relating to our securities offerings, including our registration statement on Form&#160;F-3 related to our follow-on shelf registration in Q2 2021 and (iv)&#160;other accounting and financial reporting consultation billed as audit fees or necessary to comply with the standards of the Public Company Accounting Oversight Board (United States).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Audit-related fees consisted of fees billed for assurance and related services that were reasonably related to the performance of the audit or review of our financial statements or for services that were traditionally performed by the external auditor.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">172</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Pre-approval policies and procedures</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with the requirements of the U.S. Sarbanes-Oxley Act of 2002 and rules&#160;issued by the SEC, we review and pre-approve any services performed by PwC. The procedure requires that all proposed future engagements of PwC for audit and permitted non-audit services are submitted to the Audit and Finance Committee for approval prior to the beginning of any such services. In accordance with this policy, all services performed by and fees paid to PwC in this Item&#160;16C, were approved by the Audit and Finance Committee.</p><a id="_7fadac53_1582_4b34_ba67_ed6a57b58863"></a><a id="ITEM16DExemptionsfromthelistingstandards"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16D. Exemptions from the listing standards for audit committees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_5ff116d2_d356_4b9c_b4ab_5ad2db0aabce"></a><a id="ITEM16EPurchasesofequitysecuritiesbythei"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16E. Purchases of equity securities by the issuer and affiliated purchasers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2022, no purchases of our equity securities were made by or on behalf of AC Immune SA or any affiliated purchaser.</p><a id="_9a8c85a4_f8fd_435b_9aed_058b69eddc56"></a><a id="ITEM16FChangeinregistrantscertifyingacco"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16F. Change in registrant&#8217;s certifying accountant</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_b5f177d0_5fa7_429c_8ca5_774dfaf9da89"></a><a id="ITEM16GCorporategovernance_299481"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16G. Corporate governance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Summary of Significant Corporate Governance Differences from Nasdaq Listing Standards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our common shares are listed on the Nasdaq Global Market. We are therefore required to comply with certain of the Nasdaq&#8217;s corporate governance listing standards (Nasdaq Standards). As a foreign private issuer, we may follow our home country&#8217;s corporate governance practices in lieu of certain of the Nasdaq Standards. Our corporate governance practices differ in certain respects from those that U.S. companies must adopt in order to maintain a Nasdaq listing. A brief, general summary of those differences is provided as follows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Independent directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Swiss law does not require that a majority of our board of directors consist of independent directors. Our board of directors therefore may include fewer independent directors than would be required if we were subject to Nasdaq Listing Rule&#160;5605(b)(1). In addition, we are not subject to Nasdaq Listing Rule&#160;5605(b)(2), which requires that independent directors must regularly have scheduled meetings at which only independent directors are present.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Compensation, nomination and corporate governance committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As Swiss law requires that we have a compensation, nomination and corporate governance committee, we will follow home country requirements with respect to such committee. As a result, our practice will vary from the requirements of Nasdaq Listing Rule&#160;5605(d), which sets forth certain requirements as to the responsibilities, composition and independence of compensation, nomination and corporate governance committees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Quorum requirements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with Swiss law and generally accepted business practices, our articles of association do not provide quorum requirements generally applicable to general meetings of shareholders. Our practice thus varies from the requirement of Nasdaq Listing Rule&#160;5620(c), which requires an issuer to provide in its bylaws for a generally applicable quorum, and that such quorum may not be less than one-third of the outstanding voting stock.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">173</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Solicitation of proxies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our articles of association provide for an independent proxy holder elected by our shareholders, who may represent our shareholders at a general meeting of shareholders, and we must provide shareholders with an agenda and other relevant documents for the general meeting of shareholders. However, Swiss law does not have a regulatory regime for the solicitation of proxies, and company solicitation of proxies is prohibited for public companies in Switzerland. Thus, our practice will vary from the requirement of Nasdaq Listing Rule&#160;5620(b), which sets forth certain requirements regarding the solicitation of proxies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Shareholder approval</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have opted out of shareholder approval requirements for the issuance of securities in connection with certain events such as the acquisition of stock or assets of another company, the establishment of or amendments to equity-based compensation plans for employees, a change of control of us and certain private placements. To this extent, our practice varies from the requirements of Nasdaq Listing Rule&#160;5635, which generally requires an issuer to obtain shareholder approval for the issuance of securities in connection with such events.</p><a id="_ed999b2c_e7fa_4e79_b30e_c6bd8e45b3d6"></a><a id="ITEM16HMinesafetydisclosure_873677"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16H. Mine safety disclosure</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_d644d954_2336_47d8_9057_446900128544"></a><a id="ITEM16IDisclosureregardingforeignjurisdi"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16I. Disclosure regarding foreign jurisdictions that prevent inspections</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">174</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_b75f8db1_01b9_4986_96af_f69075152b42"></a><a id="PARTIII_805425"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">PART&#160;III</p><a id="ITEM17Financialstatements_563714"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;17. Financial statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have responded to Item&#160;18 in lieu of this item.</p><a id="_0b9326f5_0748_4485_ab3d_dc856e48897e"></a><a id="ITEM18Financialstatements_869202"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;18. Financial statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial Statements are filed as part of this Annual Report, see page&#160;F-1.</p><a id="_c6277f33_ef79_447c_968a_b8e9f0f790a4"></a><a id="ITEM19Exhibits_807810"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;19. Exhibits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 36pt;">(a) The following documents are filed as part of Annual Report on Form&#160;20-F:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">3.1</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010322011230/dp175826_ex9903.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Articles of Association of AC Immune SA (incorporated herein by reference to Exhibit 99.3 to the Company&#8217;s Report on Form 6-K, filed with the SEC on June 24, 2022)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.1</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000119312516607922/d16439dex101.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Research Collaboration and License Agreement between AC Immune SA Corporation and Genentech,&#160;Inc. dated November&#160;6, 2006 (incorporated herein by reference to Exhibit&#160;10.1 to the Company&#8217;s Registration Statement on Form&#160;F-1 (File No.&#160;333-211714) filed with the SEC on May&#160;31, 2016)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.2</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000119312516607922/d16439dex102.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Amendment to the Research Collaboration and License Agreement between AC Immune SA Corporation and Genentech,&#160;Inc. dated May&#160;7, 2015 (incorporated herein by reference to Exhibit&#160;10.2 to the Company&#8217;s Registration Statement on Form&#160;F-1 (File No.&#160;333-211714) filed with the SEC on May&#160;31, 2016)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.3</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000119312516607922/d16439dex103.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Research Collaboration and License Agreement between AC Immune SA Corporation and Genentech,&#160;Inc. dated June&#160;15, 2012 (incorporated herein by reference to Exhibit&#160;10.3 to the Company&#8217;s Registration Statement on Form&#160;F-1 (File No.&#160;333-211714) filed with the SEC on May&#160;31, 2016)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.4</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000119312516607922/d16439dex104.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">License and Collaboration Agreement between Piramal Imaging&#160;Ltd., Piramal Imaging SA and AC Immune SA, dated May&#160;9, 2014 (incorporated herein by reference to Exhibit&#160;10.4 to the Company&#8217;s Registration Statement on Form&#160;F-1 (File No.&#160;333-211714) filed with the SEC on May&#160;31, 2016)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.5</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000119312516607922/d16439dex105.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">License, Development and Commercialization Agreement between Janssen Pharmaceuticals,&#160;Inc. and AC Immune SA, dated December&#160;24, 2014 (incorporated herein by reference to Exhibit&#160;10.5 to the Company&#8217;s Registration Statement on Form&#160;F-1 (File No.&#160;333-211714) filed with the SEC on May&#160;31, 2016)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.6*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20221231xex4d6.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form&#160;of Indemnity Agreement</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.7</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000119312516607922/d16439dex107.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">AC Immune SA 2013 Equity Incentive Plan (incorporated herein by reference to Exhibit&#160;10.7 to the Company&#8217;s Registration Statement on Form&#160;F-1 (File No.&#160;333-211714) filed with the SEC on May&#160;31, 2016)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.8</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010316017052/dp69421_ex9908.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">AC Immune SA 2016 Stock Option and Incentive Plan (incorporated herein by reference to Exhibit&#160;99.08 to the Company&#8217;s Report on Form&#160;6-K, filed with the SEC on October&#160;13, 2016)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.9</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010319004949/dp105140_ex0414.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">License Agreement between AC Immune SA and Eli Lilly and Company, dated December&#160;11, 2018 (incorporated herein by reference to Exhibit&#160;4.14 to the Amendment No.&#160;1 to the Company&#8217;s Annual Report on Form&#160;20-F/A, filed with the SEC on April&#160;19, 2019)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.10</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010319003578/dp103711_ex0415.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Convertible Note&#160;Agreement between AC Immune SA and Eli Lilly and Company, dated December&#160;11, 2018 (incorporated herein by reference to Exhibit&#160;4.15 to the Company&#8217;s Annual Report on Form&#160;20-F, filed with the SEC on March&#160;21, 2019)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.11</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010319012523/dp112992_ex1001.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">First Amendment to License Agreement between AC Immune SA and Eli Lilly and Company, dated September&#160;19, 2019 (incorporated herein by reference to Exhibit&#160;10.1 to the Company&#8217;s Report on Form&#160;6-K, filed with the SEC on September&#160;20, 2019)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.12</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010320005734/dp124366_ex1001.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Amendment to License Agreement between AC Immune SA and Eli Lilly and Company, dated March&#160;20, 2020 (incorporated herein by reference to Exhibit&#160;10.1 to the Company&#8217;s Current Report on Form&#160;6-K (File No.&#160;001-37891) filed with the SEC on March&#160;23, 2020)</span></a></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">175</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.13</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010321006778/dp1150581_ex0101.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Open Market Sale Agreement, dated as of May&#160;5, 2021, between AC Immune SA and Jefferies LLC (incorporated herein by reference to Exhibit&#160;1.1 to the Company&#8217;s Current Report on Form&#160;6-K (File No.&#160;001-37891) filed with the SEC on May&#160;5, 2021)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.14</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010321011884/dp155670_ex1001.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Asset Purchase and Contribution in Kind Agreement, dated as of July&#160;26, 2021, between AC Immune SA and Affiris AG (incorporated herein by reference to Exhibit&#160;10.1 to the Company&#8217;s Current Report on Form&#160;6-K (File No.&#160;001-37891) filed with the SEC on August&#160;4, 2021)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.15</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010321011884/dp155670_ex1002.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Convertible Note&#160;Agreement, dated as of July&#160;26, 2021, between AC Immune SA and Santo Venture GmbH (incorporated herein by reference to Exhibit&#160;10.2 to the Company&#8217;s Current Report on Form&#160;6-K (File No.&#160;001-37891) filed with the SEC on August&#160;4, 2021)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.16</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010321011884/dp155670_ex1003.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Convertible Note&#160;Agreement, dated as of July&#160;26, 2021, between AC Immune SA and FCPB Affi GmbH (incorporated herein by reference to Exhibit&#160;10.3 to the Company&#8217;s Current Report on Form&#160;6-K (File No.&#160;001-37891) filed with the SEC on August&#160;4, 2021)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.17*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20221231xex4d17.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Description of Securities</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">8.1*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20221231xex8d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">List of subsidiaries</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">12.1*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20221231xex12d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Andrea Pfeifer pursuant to 17 CFR 240.13a-14(a)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">12.2*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20221231xex12d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Christopher Roberts pursuant to 17 CFR 240.13a-14(a)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">13.1*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20221231xex13d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Andrea Pfeifer pursuant to 17 CFR 240.13a-14(b)&#160;and 18 U.S.C.1350</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">13.2*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20221231xex13d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Christopher Roberts pursuant to 17 CFR 240.13a-14(b)&#160;and 18 U.S.C.1350</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">15.1*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20221231xex15d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of PricewaterhouseCoopers SA</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">101.INS</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">XBRL Instance Document</p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">101.SCH</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">XBRL Taxonomy Extension Schema Document</p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">101.CAL</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">XBRL Taxonomy Extension Calculation Linkbase Document</p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">101.DEF</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">XBRL Taxonomy Extension Definition Linkbase Document</p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">101.LAB</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">XBRL Taxonomy Extension Label Linkbase Document</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;">Filed herewith</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 36pt;">(b) Financial Statement Schedules</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">None.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">176</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_1193dfbc_26ac_4570_a0cd_afa8c3334f77"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Signatures</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The registrant hereby certifies that it meets all of the requirements for filing on Form&#160;20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on its behalf.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:99.89%;"><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">AC IMMUNE SA</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Date: March&#160;16, 2023</p></td><td colspan="3" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:top;width:46.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">/s/ Andrea Pfeifer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.56%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:40.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Andrea Pfeifer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Chief Executive Officer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:top;width:46.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">/s/ Christopher Roberts</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.56%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:40.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Christopher Roberts</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Vice President Finance and Interim Chief Financial Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><span style="font-size:10pt;line-height:1.28;visibility:hidden;">&#8203;</span></p><p style="display:none;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">177</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_d3cc209f_eb8d_4b99_8ddd_03d928c2a3cb"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Audited consolidated financial statements&#160;&#8212; AC IMMUNE SA</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt 5pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:4.99%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:95%;background:#cceeff;margin:0pt;padding:0pt 5pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="font-size:10pt;" href="#ReportofIndependentRegusteredPublicAccou"><span style="font-style:normal;font-weight:normal;">Report of independent registered public accounting firm</span></a><span style="font-size:10pt;"> </span><b style="font-size:10pt;font-weight:bold;">(PCAOB ID </b><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:AuditorFirmId" id="Narr_sg9wkt23cEWsLTcmrNbXFA"><b style="font-size:10pt;font-weight:bold;">1358</b></ix:nonNumeric><b style="font-size:10pt;font-weight:bold;">)</b></p></td><td style="vertical-align:bottom;width:4.99%;background:#cceeff;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">F-2</p></td></tr><tr><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt 5pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="font-size:10pt;" href="#ConsolidatedBalanceSheets_928033"><span style="font-style:normal;font-weight:normal;">Consolidated Balance Sheets as of December&#160;31, 2022 and 2021</span></a></p></td><td style="vertical-align:bottom;width:4.99%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">F-5</p></td></tr><tr style="height:23pt;"><td style="vertical-align:top;width:95%;background:#cceeff;margin:0pt;padding:0pt 5pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="font-size:10pt;" href="#ConsolidatedStatementsofIncomeLoss_50901"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Income/(Loss) and Consolidated Statements of Comprehensive Income/(Loss) for the fiscal&#160;years ended December&#160;31, 2022, 2021 and 2020</span></a></p></td><td style="vertical-align:bottom;width:4.99%;background:#cceeff;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">F-6</p></td></tr><tr><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt 5pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="font-size:10pt;" href="#ConsolidatedStatementsofChangesinEquity_"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Changes in Equity for the fiscal&#160;years ended December&#160;31, 2022, 2021 and 2020</span></a></p></td><td style="vertical-align:bottom;width:4.99%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">F-7</p></td></tr><tr><td style="vertical-align:top;width:95%;background:#cceeff;margin:0pt;padding:0pt 5pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="font-size:10pt;" href="#ConsolidatedStatementsofCashFlows_14317"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Cash Flows for the fiscal&#160;years ended December&#160;31, 2022, 2021 and 2020</span></a></p></td><td style="vertical-align:bottom;width:4.99%;background:#cceeff;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">F-8</p></td></tr><tr><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt 5pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="font-size:10pt;" href="#NotestotheConsolidatedFinancialStatement"><span style="font-style:normal;font-weight:normal;">Notes&#160;to the Consolidated Financial Statements</span></a></p></td><td style="vertical-align:bottom;width:4.99%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">F-9</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><span style="font-size:10pt;line-height:1.28;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-1</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_3677b3aa_f48e_430d_9a25_d873ebd1e6f5"></a><a id="ReportofIndependentRegusteredPublicAccou"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-style:normal;font-weight:bold;">Report of Independent Registered Public Accounting Firm</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">To the Board of Directors and Shareholders of AC Immune SA</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">We have audited the accompanying consolidated balance sheets of AC Immune SA and its subsidiary (the &#8220;Company&#8221;) as of December 31, 2022 and December 31, 2021,<b style="color:#ff0000;font-weight:bold;"> </b>and the related consolidated statements of income/(loss), comprehensive income/(loss), changes in equity and cash flows for each of the three years in the period ended December 31, 2022, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). We also have audited the Company&#8217;s internal control over financial reporting as of December 31, 2022, based on criteria established in<b style="color:#ff0000;font-weight:bold;"> </b><i style="font-style:italic;">Internal Control - Integrated Framework</i><span style="color:#ff0000;"> </span>(2013)<span style="color:#ff0000;"> </span>issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and December 31, 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022<b style="color:#ff0000;font-weight:bold;"> </b>in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in <i style="font-style:italic;">Internal Control - Integrated Framework</i> (2013)<span style="color:#ff0000;"> </span><span style="white-space:pre-wrap;">issued by the COSO.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="color:#ff0000;font-size:10pt;font-style:italic;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Basis for Opinions</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">The Company&#39;s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management&#8217;s Annual Report on Internal Control over Financial Reporting appearing under Item 15B. Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company&#39;s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="white-space:pre-wrap;">  </span><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="white-space:pre-wrap;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Definition and Limitations of Internal Control over Financial Reporting</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii)&#160;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="white-space:pre-wrap;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Critical Audit Matters</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated<b style="color:#ff0000;font-weight:bold;"> </b>financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><i style="font-style:italic;">Intangible asset &#8211; valuation</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">As described in Notes 6 and 7 to the consolidated financial statements, the Company has CHF&#160;50,416 thousand of an in-process research and development (IPR&amp;D) intangible asset as of December 31, 2022. The asset is defined as an intangible asset not yet ready for use. Therefore, in accordance with IAS 36 &#8216;Impairment of asset&#8217;, the IPR&amp;D asset is reviewed at least annually for impairment by assessing the fair value less costs to sell (recoverable amount) and comparing this to the carrying value of the asset. To determine the recoverable amount, management estimated the fair value less costs to sell of the intangible asset, using the same model used at the acquisition date. The significant assumptions used in the model include anticipated research and development costs, anticipated costs of goods and sales and marketing expenditures, probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks, target indication prevalence and incidence rates, anticipated market share, general commercialization expectations such as anticipated pricing and uptake, expected patent life and market exclusivity periods, and the discount rate used to discount future cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="OLE_LINK1"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">The principal considerations for our determination that performing procedures relating to the intangible asset &#8211; valuation is a critical audit matter are the significant judgment by management when determining the value of the intangible asset. This in turn led to a high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating the audit evidence obtained related to the valuation of the intangible asset and management&#8217;s assumptions related to anticipated research and development costs, anticipated costs of goods and sales and marketing expenditures, probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks, target indication prevalence and incidence rates, anticipated market share, general commercialization expectations such as anticipated pricing and uptake, expected patent life and market exclusivity periods, and the discount rate used to discount future cash flows. In addition, the audit effort involved the use of professionals with specialized skill and knowledge.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management&#8217;s valuation of the intangible asset. These procedures also included, among others, (i) testing management&#8217;s process for developing the fair value estimate; (ii) evaluating the appropriateness of the discounted cash flow model; (iii) testing the completeness and accuracy of underlying data used in the model; and (iv) evaluating the reasonableness of the significant assumptions used by management related to anticipated research and development costs, anticipated costs of goods and sales and marketing expenditures, probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks, target indication prevalence and incidence rates, anticipated market share, general commercialization expectations such as anticipated pricing and uptake, expected patent life and market exclusivity periods, and the discount rate. Evaluating management&#8217;s assumptions related to anticipated research and development costs, anticipated costs of goods and sales and marketing expenditures, probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks, target indication prevalence and incidence rates, anticipated market share, general commercialization expectations such as anticipated pricing and uptake, expected patent life and market exclusivity periods, involved evaluating whether the assumptions used by management were reasonable considering (i) the consistency with market and industry data; and (ii) whether these assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in the evaluation of the Company&#8217;s discounted cash flow model and the discount rate assumption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;">/s/ </span><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:AuditorName" id="Narr_srqwE32MOk-DUHtQaFV4VA"><span style="font-size:10pt;">PricewaterhouseCoopers SA</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="dei:AuditorLocation" id="Narr_fCIkblbIc0So8CT1xj0QJw"><span style="font-size:10pt;">Lausanne, Switzerland</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">March 16, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">We have served as the Company&#8217;s auditor since 2018.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><span style="font-size:10pt;line-height:1.28;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_d1b938d7_182f_411d_8c40_51114d9e4a12"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Consolidated Financial Statements (IFRS)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">AC Immune SA</p><a id="ConsolidatedBalanceSheets_928033"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Consolidated Balance Sheets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">(In CHF thousands)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_e666ccfc_fc4d_4f50_a6e5_3c96fab0f902"></a><a id="Tc_9P0-BR9i2EKJjH_XU4btVg_1_4"></a><a id="Tc_f3PjiOD0GEyBMwwC8PlnEA_2_4"></a><a id="Tc_o4F4csIF6kCFMmm0pK2TDw_3_2"></a><a id="Tc_WHdhNkgqs0qUU0EMl-g-yQ_3_4"></a><a id="Tc_rmzjtcdLlU69JsUKoIFw7Q_3_6"></a><a id="Tc_ynSGJa09rEqHwLa8hW7chQ_4_0"></a><a id="Tc_tsagq2DqskCZypJOBe-uvQ_5_0"></a><a id="Tc_mXu1MvYQmkW--VN1FD5M4w_6_0"></a><a id="Tc_Re5INryAa0Kf-xXImHTM0g_6_2"></a><a id="Tc_Ax2ON6Uob0654gnPE-vpQA_7_0"></a><a id="Tc_YHU7N86AHku2twjx5Q5N0w_7_2"></a><a id="Tc_32r92g-E1Ei2jP7se8sftg_8_0"></a><a id="Tc_ASeXgRcOn0G0m6qu4_bl3w_8_2"></a><a id="Tc_2z-ssnjnZUWRFapV7m9zQQ_9_0"></a><a id="Tc_KAa3c7R2YU-p3cKqSiSIQA_9_2"></a><a id="Tc_WUwlAAoB5E-nvTt-mgwK5A_10_0"></a><a id="Tc_wgAyHtM7Y06gWJ2GBzhdTA_12_0"></a><a id="Tc_SkcVT4UkFU-ltXHDobdUNA_13_0"></a><a id="Tc_VDPZUXYWX0WdTc5UD92avw_13_2"></a><a id="Tc_yuEk23sEJECERkM7Tq5OqQ_14_0"></a><a id="Tc_eRrfnCpA2EmxQ2Hzckk6cw_14_2"></a><a id="Tc_CZ4RCkMKJUSkPk40VC5i4w_15_0"></a><a id="Tc_j3iTGORWr0ywoKJDTirHtg_15_2"></a><a id="Tc_D2Xnon2GAkqiptTO_DtN5w_16_0"></a><a id="Tc_VXEs3zNfRUG3D1kLn6fmPQ_16_2"></a><a id="Tc_rJfS5fJtgEynC9AHL6Y9mA_17_0"></a><a id="Tc_ZVVMWlP6-EGmpIiWn1Zndw_17_2"></a><a id="Tc_bssrpoAM5EuY6zI9asaS0g_18_0"></a><a id="Tc_gkrSV5ya9EKf2pa5W-nXSw_19_0"></a><a id="Tc_62QnD0GVZ0WyvrDIAwPzNg_21_0"></a><a id="Tc_0y2Wt0eZ4UWNPo_7aefl1g_23_0"></a><a id="Tc_eL3MY_2rqkimzQolv0IbgQ_24_0"></a><a id="Tc_WQ94glpElkaxsTDtIv2-Ow_24_2"></a><a id="Tc_tIFcF5JDcE6QPUdn_UyOKw_25_0"></a><a id="Tc_YSgWEXMujE-igNV0fpEtDQ_25_2"></a><a id="Tc_zxbUABe6pUGyPoXUdn8nQQ_26_0"></a><a id="Tc_OJ2k314N6UCS_keEFvNALg_26_2"></a><a id="Tc_fdBbQCLW9Uq_1GkkWxzN1g_27_0"></a><a id="Tc_TN04xD0Z906LRb4wW1DynA_27_6"></a><a id="Tc_KDmvPkDd00yf97Oj4nbq6w_28_0"></a><a id="Tc_lZ6ZtfPxG0ubTXZaMk4SZA_29_0"></a><a id="Tc_6dyOIUAn10-I76L_1bdoJA_31_0"></a><a id="Tc_fnxl5qiOs0qIjt3WFs2mfg_32_0"></a><a id="Tc_EnzOZks3KEKE3DnGGt5G6A_32_2"></a><a id="Tc_jDz8IIcW8UeIiF53QGe16w_33_0"></a><a id="Tc_N6gR7xCvW06qnQK8_oH_TQ_33_2"></a><a id="Tc_9Rmh3FHCdkaOr2GX0W5LLA_34_0"></a><a id="Tc_3t0W7nNO2Ued0-dJeSdbNg_36_0"></a><a id="Tc_sC_8BIUNgkeLopWQzOLgkw_37_0"></a><a id="Tc_2srRI1I5JEmNHIZRzFR3vA_37_2"></a><a id="Tc_MYbmxi7LzEmgaKg92zQp3g_38_0"></a><a id="Tc_HxwcGJzp5EChdm8D0QcgjA_38_2"></a><a id="Tc_jUqZf3tAbE6UX4PNuvIsEw_39_0"></a><a id="Tc_u_TPRGrIo0uxvZyv37TlYA_39_2"></a><a id="Tc_RtxDaYmAKkaNTP_6rSJZOQ_40_0"></a><a id="Tc_6-OA_-z00UurYNrUIRQSmg_40_2"></a><a id="Tc_3cT2rB8FB0Wawq9tkBbOuA_41_0"></a><a id="Tc_uLTf2kQ2jEOH8GI8bbGjYw_42_0"></a><a id="Tc_-UN__W5DkkqK1leNWv3HZA_43_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_2-ZOv6Hbf0mzJ9KgV1fPYQ_6_4">4,259</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_NbbRfwD2REuMeX9PoHO0TQ_6_6">5,116</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_mpPDb92PmUiPA2rEj1_XrA_7_4">2,808</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_GKl3o0pObEu4P82cZYgxkw_7_6">2,914</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Intangible asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">6/7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_fW47LL3ksEqoDEKFSwOIKA_8_4">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_IXxAKemAS0e324vtsTB8mA_8_6">50,416</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term financial assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentRestrictedCashAndCashEquivalents" scale="3" id="Tc_qneZma9WaUGBOtsGXroDMA_9_4">361</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentRestrictedCashAndCashEquivalents" scale="3" id="Tc_LHK-6rXjxU2hVUfOB7-XoQ_9_6">363</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total non-current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentAssets" scale="3" id="Tc_oQeneVC400K5S4w9nrg5SQ_10_4">57,844</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentAssets" scale="3" id="Tc_0pDnZisVS0mG0ceIdALtOQ_10_6">58,809</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Prepaid expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaidExpenses" scale="3" id="Tc_Ea9G5s4PAkm3nAufnAg7IA_13_4">4,708</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaidExpenses" scale="3" id="Tc_KdKmlHF5d0OV4apVmmEGOA_13_6">3,015</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">9/13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets" scale="3" id="Tc_TR716T28K0S8_2Ll-YkEwA_14_4">408</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets" scale="3" id="Tc_sDjjWVQARk-nmq-ew4WNKQ_14_6">975</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivables </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherCurrentReceivables" scale="3" id="Tc_kthV6bBFskCKlG3P_Be0mA_15_4">392</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherCurrentReceivables" scale="3" id="Tc_Qrb7iyA9-kGc-3oXIdo2fw_15_6">428</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_Irw1PvhWi0Kb1Ra8EPJLfg_16_4">91,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_mzQ_Qb4V70uwINMSed67RA_16_6">116,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_bxFInVj8dkWUONz-P3jDlg_17_4">31,586</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_MaW4aEqYwkS0c8pmucSVVQ_17_6">82,216</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAssets" scale="3" id="Tc_t4-7eXFyiEulNG0M-IgJLw_18_4">128,094</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAssets" scale="3" id="Tc_FMoDPyxId0yeWMSrMdhN-Q_18_6">202,634</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total assets </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Assets" scale="3" id="Tc_OKIqVYwoHE6WJ36d0W3HsQ_19_4">185,938</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Assets" scale="3" id="Tc_Kak4bkmS1EeNYlk4y86IMQ_19_6">261,443</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shareholders&#39; equity and liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shareholders&#8217; equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share capital </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssuedCapital" scale="3" id="Tc_-7VjQF-lgUal_3CHl4V_Kg_24_4">1,797</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssuedCapital" scale="3" id="Tc_yWgrh8BnF02C5yIZMraAhw_24_6">1,794</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share premium </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SharePremium" scale="3" id="Tc_--Efd-lxfU6K400INIO5_Q_25_4">431,323</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SharePremium" scale="3" id="Tc_1LIdr7G1Sk2aD-jtSTBN2Q_25_6">431,251</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Treasury shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TreasuryShares" scale="3" id="Tc_C_faaBwOrkeF5qgNvG-FFQ_26_4">124</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TreasuryShares" scale="3" id="Tc__c26yhL85UaqZFl_64zNLQ_26_6">124</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Currency translation differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="3" id="Tc_i-2bBNWg7kOUyoJ4cteB-Q_27_4">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accumulated losses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RetainedEarnings" sign="-" scale="3" id="Tc_rf9UpMWVnEeLl3XU8E7xwg_28_4">264,015</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RetainedEarnings" sign="-" scale="3" id="Tc_-Dj7nSafIEeLbemj4AzHFg_28_6">200,942</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total shareholders&#8217; equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_x86t9yur5U27IO_xNvqmjw_29_4">168,991</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_yPE0xMvjjUe5NB4tfuJqiQ_29_6">231,979</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" id="Tc_fM74czxBh0CxwquF6v2itw_32_4">2,253</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" id="Tc_ubE288h4z0Cnq_biGgl9Uw_32_6">2,340</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net employee defined benefit liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" scale="3" id="Tc_UE8Qt0l5U0SwUDlTOWMMzQ_33_4">3,213</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" scale="3" id="Tc_eUBmXI3gj0mP4JSPko8gew_33_6">7,098</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total non-current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLiabilities" scale="3" id="Tc_yvyTixviGUGzbLgogB9_VQ_34_4">5,466</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLiabilities" scale="3" id="Tc_34yXTa7ouE6y42cl9Sl-ww_34_6">9,438</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_Z7nnRURb80evWTcW_GU98g_37_4">929</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_ju4KSQWeZECM0jF2liFj0Q_37_6">2,003</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="3" id="Tc_KbaDIzmyek6FUVdQB_wmhA_38_4">9,417</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="3" id="Tc_-i5c1WzU1Eito3X4fee7Gw_38_6">16,736</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Deferred income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities" scale="3" id="Tc_-nMusDDJ7UiANdDrbFwsDg_39_4">587</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities" scale="3" id="Tc_FZRbKzN3a0qGW5PwPInfhQ_39_6">717</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" id="Tc_xFLxYtWq0Uq2IgVfaVOh_A_40_4">548</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" id="Tc_Cor0qHEEgECYSz4930fAqQ_40_6">570</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLiabilities" scale="3" id="Tc_PDcmw1Qyb0SrU95rPM4dPA_41_4">11,481</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLiabilities" scale="3" id="Tc_BTkmvSj6SkCrYWJrpYS0tQ_41_6">20,026</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Liabilities" scale="3" id="Tc_-QyconXJnEaOrwYCzxJWhw_42_4">16,947</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Liabilities" scale="3" id="Tc_3CrbmMNjNEueeZp-yDY-WQ_42_6">29,464</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total shareholders&#8217; equity and liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EquityAndLiabilities" scale="3" id="Tc_whRwxFqqtkSvgLIBo3KiXw_43_4">185,938</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EquityAndLiabilities" scale="3" id="Tc_sx638RD_7EuMsELsqH5zog_43_6">261,443</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these consolidated financial statements.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_f0d14edf_2cc9_4794_8caf_07e20355ad73"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">AC Immune SA</p><a id="ConsolidatedStatementsofIncomeLoss_50901"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Consolidated Statements of Income/(Loss)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">(<b style="font-weight:bold;">In CHF thousands, except for per-share data)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_1344c316_02ba_4627_9fab_c2a0473bce7b"></a><a id="Tc_OyqPDZnVgUiqCmehK41VdA_1_2"></a><a id="Tc_uSTC-AJf_ESkntvzw1MLFg_2_2"></a><a id="Tc_udscN92knkuwn1vYvUhQeQ_3_2"></a><a id="Tc_8PlMMpXTHUKBy7Ai3P2RSQ_3_4"></a><a id="Tc_ic1gFM8JvkqLxOw22Yj6zQ_3_6"></a><a id="Tc_w5FnyYKFOkajY8V1GKLORQ_3_8"></a><a id="Tc_bjFYu0KkGEWHeVQTFJvj0w_4_0"></a><a id="Tc_jCTcq85fZUmEG4Ifaw_KHQ_5_0"></a><a id="Tc_NHJQHSGyNkeZzz5ii5aQKw_5_2"></a><a id="Tc_y8263p3y6EqMhmuydK-DHw_6_0"></a><a id="Tc_XE8mSRQWj0iIJBPQubQIJQ_8_0"></a><a id="Tc_CIvg10x2fUe9nvd6VVrX3w_9_0"></a><a id="Tc_pmB4V-3N2UGqT0rILBse1Q_9_2"></a><a id="Tc_5XGmtT3wdkqR6gsu4dBd_A_10_0"></a><a id="Tc_Yy6CX5GQdU6c1vlxiGXgAQ_10_2"></a><a id="Tc_3u3kUydtm0-TZdHhVqxgGg_11_0"></a><a id="Tc_zQvC8JEOTkqSbZul9q0J6A_11_2"></a><a id="Tc_jkPhcmwNJ0KzkAliy7iHpg_12_0"></a><a id="Tc_4icXxs8YpEW23Ef8ik-WKA_13_0"></a><a id="Tc_XjSaQNLAakewCBQdB3EbIw_15_0"></a><a id="Tc_Empn4GhpukqbgwiSoCIoHw_15_2"></a><a id="Tc_1hs6IVvUiEecxeAoAWFzKw_16_0"></a><a id="Tc_wUFR7sRNJkiSUtgj95MXUw_16_2"></a><a id="Tc_WScdS89bSkOw1fQPEeT1qQ_17_0"></a><a id="Tc_oGxEF4eHeke76lKOr0hS7g_17_2"></a><a id="Tc_naf7Wu3rr0yOtyYdiceZQw_18_0"></a><a id="Tc_VGhKxNFd0E-AfctRZqFkSA_20_0"></a><a id="Tc_EPzeFVISakKif4pGHdA-Cw_21_0"></a><a id="Tc_ej20U4qACEyQk_k09S4x9w_21_2"></a><a id="Tc_F24WBcUdgkmhL29zHb5sGw_22_0"></a><a id="Tc_Zw2i5eaqF0GcuhSAXktM7g_24_0"></a><a id="Tc_x_OzzdvT_UKz5_g3eW0Ujw_25_0"></a><a id="Tc_IuEN_kG-G06cAxlKgQgfNQ_25_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:38.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:38.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Contract revenue </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_zGy4PAQr-0SUJCIG9LKSPw_5_4">3,935</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_x8pm2bZqOUe6evhjShOF9w_5_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_8XvCTimeXkifiR_atqFqAQ_5_8">15,431</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Revenue" scale="3" id="Tc_jtRnHz--z0Wv3dE5_qXwCg_6_4">3,935</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:zerodash" name="ifrs-full:Revenue" scale="3" id="Tc_07z2sT7HlE-yVkIYPM4Q4g_6_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Revenue" scale="3" id="Tc_b-GE7--kwEKl-7fCt77kPA_6_8">15,431</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Operating expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Research &amp; development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_Dm_bdN2CMEKI4ITJzmZkyQ_9_4">60,336</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_t9mO7yJRP0e7glgxhtaK4Q_9_6">62,282</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_YKuqxe2PCUiubUwWu9kzSg_9_8">59,487</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">General &amp; administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="3" id="Tc_K4Kx6uVzsUOj3FVyL76-vA_10_4">15,789</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="3" id="Tc_t6EmHf3rnUyHxC9EA7NGVA_10_6">17,910</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="3" id="Tc_pTlHOpcu3UGkBi0cp861cw_10_8">18,557</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other operating income/(expense), net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">13.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="3" id="Tc_D0izSft0Mkybn8jsOLZcFA_11_4">1,343</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="3" id="Tc_c52I9JdQukKsBuz8Mo-pJA_11_6">1,182</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="3" id="Tc_uc8CVjwiu0yA4csr11bN5g_11_8">1,353</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total operating expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_dZOaXkBos06l57Ojo_vB6Q_12_4">74,782</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_xImgqJ1qxUKIpl0eTsU9Bg_12_6">79,010</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_9D7DTdZoHkiRHpDciinrFA_12_8">76,691</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Operating loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossFromOperatingActivities" sign="-" scale="3" id="Tc_qfm7iC3ZoEypEm-WQKvqCA_13_4">70,847</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossFromOperatingActivities" sign="-" scale="3" id="Tc_Uf6TufWmyUafxx-2gDRO3w_13_6">79,010</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossFromOperatingActivities" sign="-" scale="3" id="Tc_TeWvDWvfQUC6WBuwONuxrg_13_8">61,260</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncome" scale="3" id="Tc_yNra75o6kkq_3FVeTwkCog_15_4">69</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncome" scale="3" id="Tc_z1B0yH2cckqNS1yeqdVZVQ_15_6">6,485</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncome" scale="3" id="Tc_aC-VIhjCmEeyepTeNEubGw_15_8">78</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCosts" scale="3" id="Tc_yHdHqJYuZkyZMwddYw8aMw_16_4">355</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCosts" scale="3" id="Tc_NR12Qz9kEUWNqDbvtyzTGg_16_6">581</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCosts" scale="3" id="Tc_9dYQQnAAiUK-8pq-1QBrkA_16_8">184</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exchange differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="Tc_y_nhqxqBXEm9qG4NYW2OlQ_17_4">393</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="Tc_D6qQheInL0Wkxsq7Dxylcw_17_6">113</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" sign="-" scale="3" id="Tc_B0zQyi6_ok2pkymzYHgsEg_17_8">555</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Finance result, net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" scale="3" id="Tc_8XrOY3eTxEKrZSzzNA1aWA_18_4">107</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" scale="3" id="Tc_h8gd-wogqUSbvLgUdD7AwA_18_6">6,017</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" sign="-" scale="3" id="Tc_xwsSwlfw00uArpUUpIbXVw_18_8">661</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss before tax</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossBeforeTax" sign="-" scale="3" id="Tc_l5tneeEbRUiCDtOGwc8rmg_20_4">70,740</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossBeforeTax" sign="-" scale="3" id="Tc_TOwCXRLRY0uIBizf7Y1mFA_20_6">72,993</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossBeforeTax" sign="-" scale="3" id="Tc_qHIGwX4gFUuhKn0OS0TuQA_20_8">61,921</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Income tax expense </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">16</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_ggdVEg2yF0anGsfm2JoYfQ_21_4">13</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_XTAyLgX7ikO-yELYi4WdMg_21_6">3</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_Fisy5jlSU0GybsHNhPHO5g_21_8">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss for the period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_RuglUhmD90W1pCpHVMtZng_22_4">70,753</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_WxKZkx0Om0qmujFqrYWwIQ_22_6">72,996</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_MggWWFeQ_EqWLKyXUNe6yg_22_8">61,921</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Loss per share:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted loss for the period attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_pFqEk1xse0mkr4in5PqK1A_25_4">0.85</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_y6gmuG6thECk1AgCH1DO1w_25_6">0.97</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_3zNPYG4rHk2DCOyiPSif8w_25_8">0.86</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_af0e5bcc_3183_4a90_9c74_3d88a158e40c"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Consolidated Statements of Comprehensive Income/(Loss)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">(In CHF thousands)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_f4767c4d_8acc_4c14_9f5a_2abf981cc067"></a><a id="Tc_KqMNAwbpw0-s1xR_g42fxA_1_2"></a><a id="Tc_a2wl7INMhk-xSt_ZhnYXjg_2_2"></a><a id="Tc_JHM1sqVYxkSVwApoGVu29Q_3_2"></a><a id="Tc_RV-PXqqKrkqgdTfws13mtQ_3_4"></a><a id="Tc_aTNwG04QJU6LlbpvN77NJA_3_6"></a><a id="Tc_zK5oBbykukWHTivl64AoFQ_3_8"></a><a id="Tc_MDozDvWny0KuetuKoWkipw_4_0"></a><a id="Tc_gkg1VHBf7EO9EzBt9l7bsA_5_0"></a><a id="Tc_4OGXQrNjBUeTudgu06075Q_6_0"></a><a id="Tc_GmDfOwKgS02hYROp6j_ZGg_7_0"></a><a id="Tc_eW3Ek5KuzUeYhkHekBuQzg_8_0"></a><a id="Tc_QcSriJ-zv0Gk943h-bjPaQ_8_2"></a><a id="Tc_tKtXWWYNRE2vS0SYW_b4lg_9_0"></a><a id="Tc_UqxGBkCzC0mwyfU6OwsUSQ_10_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:38.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:38.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Loss for the period </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_6yYWy9YNd0aTCpDlRgvGjw_4_4">70,753</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_GLlOcKNLhkmdrx18wRATpw_4_6">72,996</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_bevJVIw_uUy7UdIjW2lV0A_4_8">61,921</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Items that may be reclassified to income or loss in subsequent periods (net of tax):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Currency translation differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" id="Tc_pbzXn30En0yDNWxEjqu5zQ_6_4">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" id="Tc_vc2D0XuXL0S3OBVcN6kRTQ_6_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" id="Tc_MT-LyDaVjk6A9A7IwGauAg_6_8">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Items that will not to be reclassified to income or loss in subsequent periods (net of tax):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Remeasurement gains on defined-benefit plans (net of tax)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> 17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="Tc_wbo21fUAlkmd2PjX13nqIg_8_4">4,426</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="Tc_AKgaIN69N0WQ3v7lKOONOw_8_6">956</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="Tc_p2SZvCfVVUS6mLhVQnnlSg_8_8">726</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_5vwg_9jr-0Sd6zzOvqdxJA_9_4">4,436</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_eDWd93WdfkOnLef4ZqC1JA_9_6">956</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_1LtWIx51C0GEzC1TmzplLw_9_8">726</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total comprehensive loss, net of tax </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_PzJy0XKXyES8Qmp1ppQoxA_10_4">66,317</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_N4A8kAu8SkWpFeb72PQlVQ_10_6">72,040</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_ETwqHeLwVUuPSr7xjKIwQA_10_8">61,195</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these consolidated financial statements.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_508494f5_0241_4803_a980_e7c45abc93c8"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">AC Immune SA</p><a id="ConsolidatedStatementsofChangesinEquity_"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Consolidated Statements of Changes in Equity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">(In CHF thousands)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_7d1b9b74_d44d_4518_b6c7_3ffaded049fc"></a><a id="Tc_oZP5WDUqo0OF9GxVrQqFdg_1_12"></a><a id="Tc_Po9gD85940ySXDcNqp-JZA_2_4"></a><a id="Tc_fM5KCBPlDUaHsncD6TNy5g_2_6"></a><a id="Tc_p67NuUKGBEGQspMSVVsasg_2_8"></a><a id="Tc_H7NoIO9_X02cpONWrkwgKw_2_10"></a><a id="Tc__5a5LjX7r0uB5J8PK1tXrA_2_12"></a><a id="Tc_mfZ0_DxSxEO-8CmSekZchg_3_2"></a><a id="Tc_pBxJKEMvGEez5d7_KyQZDQ_3_4"></a><a id="Tc_V80wic6w4E6AWoGkxcVa5g_3_6"></a><a id="Tc_1zoYyPlFWUyfQuqOyWz7Mw_3_8"></a><a id="Tc_SQFNeoVbQU2lFopeMtDdbQ_3_10"></a><a id="Tc_a_ZjWVlarEmiFRoknO8M8w_3_12"></a><a id="Tc_RnCmQSxuE0SkePhIQFX8lg_3_14"></a><a id="Tc_RdpglhCCJUGXlGWagCgO-A_4_0"></a><a id="Tc_ROLrN2mUQkWnG93MQOTi0g_5_0"></a><a id="Tc_fB8qSVLpQEG6U3WGseRYzw_6_0"></a><a id="Tc_7Ik0q6ZJqE-6xEWQySn9NA_6_2"></a><a id="Tc_0C1PgZRjtECevbUajzNaog_7_0"></a><a id="Tc_FkD-xw_ivEGKXP_8kJMQUg_9_0"></a><a id="Tc_xfxAA3OnBUGF1IaFIFqgWg_9_2"></a><a id="Tc_YXmEV1rpNEePsKtpmxMUvg_10_0"></a><a id="Tc_EBpOdRaIIUubG1wQmHRiBQ_11_0"></a><a id="Tc_WWI0eNwdp0yoxNWFYBihRw_11_2"></a><a id="Tc_GsNOMS9z2USS32VFOVuvDA_12_0"></a><a id="Tc_6X5eTRXEqk6Ga_jkanEWxw_12_2"></a><a id="Tc_WQK8kvO1p0uE9t16-Mrkzw_13_0"></a><a id="Tc_5wWlao-TZUe0SoVcArJ3Sw_13_2"></a><a id="Tc_3N_XoNPnckO-DlVNL9HTDQ_14_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">translation </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">premium</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">losses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">differences</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of January 1, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_XSLfDSRIbEupuWixpadOuw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_X6qRsCvZ0EuidDrUU9tEUg_4_4">1,437</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_-v01eNbu4EqyiH1CP4pFSw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_0d6C_ATSokSMF3KQmDhoFQ_4_6">346,526</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_BAlgAaqeAE69FaWxkpf59A" decimals="-3" format="ixt:zerodash" name="ifrs-full:Equity" scale="3" id="Tc_NZhNw4x4Jk2aGBu9Sw65uQ_4_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_KQlk7o6AQ0uDnZr3pfWlIg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_RpVQ59j_9kSGuCGBPYmhuA_4_10">75,521</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_ZFh_VMBp4USCi-ehy5idcg" decimals="-3" format="ixt:zerodash" name="ifrs-full:Equity" scale="3" id="Tc_ENyiFIfTXUKigkTyW_j0ww_4_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2019_C854zoDUpkSi-bE7TYeEJw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_1WHGtyPQCUWFXACJwtX9Pw_4_14">272,442</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net loss for the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProfitLoss" scale="3" id="Tc_CzSdTG_ePE-z6sIutDc9Ng_5_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProfitLoss" scale="3" id="Tc_Rd_e2ZF7HkyrzR7s72wNDg_5_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProfitLoss" scale="3" id="Tc_AQUQ2V-P30OCpUyU1Jrweg_5_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_M3_Kbpc0V0uFEQWQxYA0ZQ_5_10">61,921</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProfitLoss" scale="3" id="Tc_aqTryChCtkWvA-GZk9iGxg_5_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_Pudn4ZcCl0yeiQ9d2ejK-w_5_14">61,921</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc__7Fa9kuTGUi6a17401Kyyg_6_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_C938x7RSj0eltV0AdP-WGA_6_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc__gG5j5IStUWWSlVKmKv_KA_6_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_9TiifR4CWE2DltEdQqYIuw_6_10">726</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_JF6Wed0a-U-qCC3GbiRklw_6_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_5wb5JB3aY0uuLA3gqVbs9g_6_14">726</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total comprehensive loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng" decimals="-3" format="ixt:zerodash" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_vzoeYoDSOUSioDYk3QU0FQ_7_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg" decimals="-3" format="ixt:zerodash" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_XTdhRss8j0mrL0LNMqxVFg_7_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g" decimals="-3" format="ixt:zerodash" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_njp_5cRFbEiGOSXZCJH0eQ_7_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_VYdRtxkkM0OATl2ZBvFhJg_7_10">61,195</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw" decimals="-3" format="ixt:zerodash" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_6RVC6K_ofUKOliDsM7zuew_7_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_M7btXXswg0aW_1QGWwT5-w_7_14">61,195</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_gJolmr2l4k2WdNGg6RRb3Q_9_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_sIPvr7e0-06ERaqn4AHZdg_9_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_w4zmgsgou02lzcDX2AIlKA_9_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_m-X3T41Ia0eBu1ZaXvjiiA_9_10">4,088</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_jxWsKCZh80Wu8NVDwbOm0g_9_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_d2ochesFOEq8wq2_fZlWlw_9_14">4,088</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares, net of transaction costs:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Held as treasury shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="Tc_tse7WfVDEky-ZqVj00vvIg_11_4">100</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="Tc_rRvAt_FAwkmVyBcmM9gi6A_11_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" sign="-" scale="3" id="Tc_NSMaZZV6QUiD70j5wq7SuA_11_8">100</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="Tc_q74yVGyJ40-Sxk8hlukZhg_11_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="Tc_tGc-U5q-S0CszqJhxijybA_11_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="Tc_gTtdyxHK4EGaw0xvDeYbBg_11_14">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Restricted share awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng" decimals="-3" format="ixt:zerodash" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_QPeDsoPFA0e4qDTsbpmF4A_12_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_DdozEVcglk2b_U4OdIRzSw_12_6">222</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g" decimals="-3" format="ixt:zerodash" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_qYpCv7j7OEKH3ksz8z-BbQ_12_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" sign="-" scale="3" id="Tc_4s7MpvmNU06P7dlZ0sRMmA_12_10">222</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw" decimals="-3" format="ixt:zerodash" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_ufR7PoMsf0W-elNXhk_qKw_12_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:zerodash" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_rCmHQP3g50aEFO1gld5j0g_12_14">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Exercise of options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_ZhQ0qUTU0ES7tKq2Z962eA_13_4">1</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_uu2Z7QSUyUm-Ly7p9satEw_13_6">142</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_CeGZdeVUn02wU6ggvg-wuw_13_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_vAxKqltp90W1tdgapWtWsg_13_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_0RUpU4cMoUCN8ShaPKgn2Q_13_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_kSH4KALevUCIKyhk_V7Zkg_13_14">143</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_os5Hp8MAI02VjWPk90WB7w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_BWHPZg-PNk6YjCzbPuVinA_14_4">1,538</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_ktuzkw64AEa5vdg54I-VCQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_7-KRUKz1f0u-98BKYW-GJg_14_6">346,890</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_vuCe_vLKgECevKYNBCd4Lw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_yxHNmr73JUKu_6eBFYbeiw_14_8">100</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_6vGDOwBrDUW56Z7aTT9Kzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_GDNHf8CUB0GhJ_fS1tKeYQ_14_10">132,850</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_utVQr_YxtkaiCKmZyUEcCw" decimals="-3" format="ixt:zerodash" name="ifrs-full:Equity" scale="3" id="Tc_5AhjIGPeNEWVbUv6kvPJEg_14_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_1tnn4HYDlkaNZJFuArG1Iw_14_14">215,478</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_d1b12acc_d421_4da4_94a1_f149e4304d10"></a><a id="Tc_Fmlf5uUJv0SROShk4JR6AA_1_12"></a><a id="Tc_AT0kWOKFjUWHHcr2gjitNw_2_4"></a><a id="Tc_iBiP1Y3UW0uC_O6wuid4QQ_2_6"></a><a id="Tc_cgLxW3kQ106BVB1MQCwMvg_2_8"></a><a id="Tc_UFdCxi6UEEyK5bxPAiSKUw_2_10"></a><a id="Tc_wUH6f-5yVU-1onbBDYQTTQ_2_12"></a><a id="Tc__ss_93StMUOc2CSQr6npBA_3_2"></a><a id="Tc_UntMhTjJ9kiWyftRye5JWg_3_4"></a><a id="Tc_TJgtdhhg3k634q4gsOL4kw_3_6"></a><a id="Tc_VV_XTpG0vEGcKMvjlNibaQ_3_8"></a><a id="Tc_UtVZeamOc0OQJxMMihk0TA_3_10"></a><a id="Tc_Evh2Jlowy0u0vRoXrZumyg_3_12"></a><a id="Tc__UZdngZoI0eK1H9mHG5-OQ_3_14"></a><a id="Tc_Nikugc_rokeAIWNdQRObvw_4_0"></a><a id="Tc_YouPCeT-8ki-nFDMWH8hYA_5_0"></a><a id="Tc_eRsXmmpqsEyaDMXmjzmBQA_6_0"></a><a id="Tc_Cf1GaT5Yb06Ruqv1TRCemA_6_2"></a><a id="Tc_JduGWiHFEESj0VAyJo7ZgA_7_0"></a><a id="Tc_QCz26briZUiBv102hE-Dkw_8_4"></a><a id="Tc_8u2kyP9CW0Om1_pd43s3iQ_8_6"></a><a id="Tc_VHNSwOn5CUC7z9I4opDHRQ_9_0"></a><a id="Tc_IZX7SAc0QEOhC1Krdlp5JQ_9_2"></a><a id="Tc_XKQxxkj7REyWxpqgh5YJjg_10_0"></a><a id="Tc_pQOs2ynAV0yI9JN0SL6L-A_10_2"></a><a id="Tc_87KwNnrxbEKV-lSr2erhWA_10_4"></a><a id="Tc_tJHyT2xPoEuEi-AUbHu8TQ_10_10"></a><a id="Tc_3CTLL4JEVEKqg4T5rRtu_g_10_12"></a><a id="Tc_ras3_u0FnU-7PfcO0XANzA_11_0"></a><a id="Tc_zhnqZiW3lUaxtKV6pAi-rQ_11_14"></a><a id="Tc_5AgaugduXEOmqXrQuCpZYw_12_0"></a><a id="Tc_Uw_VzoMch0mjBOgOaDYN-A_12_2"></a><a id="Tc_cGUQCxN4BE6FwLRL1Abk0w_12_8"></a><a id="Tc_2lzUf4X9QUGp9jkvUsMs0g_12_10"></a><a id="Tc_iQofketRBECiSwHN6FTTLA_12_12"></a><a id="Tc_sfYqWjVISU-IX4knSnS5hw_13_0"></a><a id="Tc_5Hn2qXUqiUOtPowLEOfUvw_13_2"></a><a id="Tc__SKRGKWvJEqHBaZJU4fHyQ_13_8"></a><a id="Tc_yf2Okv5eWku1ZZ9KrWIQnA_13_10"></a><a id="Tc_pLDTPZZJRkeZlr3iVtPDWg_13_12"></a><a id="Tc_Urg6fiTzw0298oCiNLck4g_14_0"></a><a id="Tc_UyVuBK5oSU-HT4xUhLnUwA_14_2"></a><a id="Tc_aEEPL3c7qk64pLjwii0w3A_14_8"></a><a id="Tc_i-6EEzxxMEebOgV3v2HFsQ_14_10"></a><a id="Tc_i99ePiRL10OOo6Rows2GCw_14_12"></a><a id="Tc_6BUsr-QG2U6UCQkj2LBLGA_15_0"></a><a id="Tc_uW7l6dJWnUSOcBNg_BeFDg_15_2"></a><a id="Tc_wN4pT5f5jUO23M9yCvYO2w_16_0"></a><a id="Tc_32ZOTsBjV0aE_Our64R2iw_16_2"></a><a id="Tc_lBJsjRXl2EqQ5A9xDeBiiw_17_0"></a><a id="Tc_cWsIjlwJ30qRAZtzResN-Q_17_2"></a><a id="Tc_v5k9VeTfm0-1_UdU578XcA_18_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:35.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:35.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">translation </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">premium</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">losses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">differences</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of January 1, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_os5Hp8MAI02VjWPk90WB7w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_yEHdSyC6lUSoJ06BsZFgyA_4_4">1,538</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_ktuzkw64AEa5vdg54I-VCQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_kD3B1QYvqUaqh4-E2Wavqw_4_6">346,890</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_vuCe_vLKgECevKYNBCd4Lw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_aXxV3pdxaUum16emqIrHdw_4_8">100</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_6vGDOwBrDUW56Z7aTT9Kzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_d97wFLRmfEKFI7c1IRndQw_4_10">132,850</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_utVQr_YxtkaiCKmZyUEcCw" decimals="-3" format="ixt:zerodash" name="ifrs-full:Equity" scale="3" id="Tc_-vbf7oAS_0WcpQoxyDm24A_4_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_h0si_71kuEKxFqulBvS2zA_4_14">215,478</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net loss for the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProfitLoss" scale="3" id="Tc_D94LqDzy-0uPRM8JML_7ag_5_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProfitLoss" scale="3" id="Tc_w6ek7D7Z8Umpk3VXXM9ONw_5_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProfitLoss" scale="3" id="Tc_AkhAmxwzJUexraWEh4mHAg_5_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_blQNSs2K902AJHq-IV5rlQ_5_10">72,996</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProfitLoss" scale="3" id="Tc_mwHLvt4ixEGWaoDzzL4cmA_5_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_-Abn1Of3ekWf3BWt740NKA_5_14">72,996</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_j1wkb5eoJUy9ciCISIJ8Vw_6_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_fFPo5t2cyUCzfRhpSZpo7Q_6_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_lTMj8Ja3mUuz42HCQTR8Sw_6_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_Y93sGMdMoEeTrYJGhRWuAQ_6_10">956</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_f8dPJe_u1UeJRGo-xfWVsQ_6_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_a54UcHq6FkqjyX1uhYaC0g_6_14">956</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total comprehensive loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:zerodash" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_MdCPb6suPEi1ENY3ehhBzg_7_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:zerodash" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_1_qiMQsxEEansi9pFiGvIg_7_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg" decimals="-3" format="ixt:zerodash" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_gjc9h8r2FEKlZwlYopuCtA_7_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_5_kKSrCPKUim4zSWplHxaQ_7_10">72,040</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw" decimals="-3" format="ixt:zerodash" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_5ObIe81dU0aRuoPdtVjRFQ_7_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_oN7Xpi8W_0eBNu1Dy6zkJQ_7_14">72,040</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_njMNCq0OeEmC_ZldWBWn8A_9_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_RkV2uheB-EOonCG5HrEIRg_9_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_tNd6m9zixEys7VfVLuioqA_9_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_zVr9TtfrekGruehRzOiYfA_9_10">4,126</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_P2kqqsXn1k2tPXpzV8DyUw_9_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_FKQa7BUKhUexxj1e4R8Rsg_9_14">4,126</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_neFRkkVFZUqacgyUsdw1xA_10_6">12,097</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_RuQPaoTvgkei3N0ab3Y9Vw_10_8">24</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_fyj7dD-ujkS1LeME0hJhiw_10_14">12,121</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares, net of transaction costs:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">IPR&amp;D asset purchase</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">6/11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" scale="3" id="Tc_EZEFlSAlwkCVC_QfBB0XUQ_12_4">130</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" scale="3" id="Tc_6kjQW5yaL0ekZNlzisQ7xA_12_6">49,741</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" scale="3" id="Tc_z7iCSsG0i0q3wBODBQ7Ujw_12_14">49,871</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Asset acquisition - common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">6/11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity" scale="3" id="Tc_66qmzsKjg0WTog3tbeZGNQ_13_4">12</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity" scale="3" id="Tc_ZG0ykchD3kep7AMvB2CKug_13_6">4,587</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity" scale="3" id="Tc_9fTfucUu10y5dGpDMwfBGg_13_14">4,599</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Conversion note agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments" scale="3" id="Tc_0Ui67obYOUChbnLEuSYKHg_14_4">61</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments" scale="3" id="Tc_GC2WBh5faUaGZkazymkjWQ_14_6">16,683</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments" scale="3" id="Tc_fyrTHDiFfEe633fEGd1tbw_14_14">16,744</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Held as treasury shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="Tc_CnI7VZnkhUqacVynTyV8oQ_15_4">48</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="Tc_CFUY_O38J0e-8bvYZdBkhw_15_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" sign="-" scale="3" id="Tc_lxeRYKDl8EyPDMf4YXiCFg_15_8">48</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="Tc_cQ32CGRS0UmBrG19jx3TEQ_15_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="Tc_4ucqKmLIY0-c54n8F-iwlw_15_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="Tc_MULY12MZRUevHchHACZ4rw_15_14">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Restricted share awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_kKsJ49Ty_UycL3Hcj_EqUA_16_4">1</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_eO9qauTaHUK4MfqVXHNJRQ_16_6">171</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg" decimals="-3" format="ixt:zerodash" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_-PfYVXgaCUyL0KNqiNFVbA_16_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" sign="-" scale="3" id="Tc_I0mmp2xRaEGjDH4xJQBEJw_16_10">178</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw" decimals="-3" format="ixt:zerodash" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_SwJNGNrcGUyn3NHEp0j1KA_16_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" sign="-" scale="3" id="Tc_QIHqVaC3uUaK3xDnROVArw_16_14">6</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Exercise of options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_v6AD0xlmM0ym4_sFTjpDGw_17_4">4</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_vocwJyXei0SnKAij_slR4A_17_6">1,082</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_zJeCtDpNvECZMzltRYhnEw_17_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_UA3ZTXZOPUyGAbeNTYOqXQ_17_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_72jnHeK4_Umq7gd6ghRyww_17_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_Cag5IKgQT0C_kON-m5jOCw_17_14">1,086</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember__r0D1g51PUiGX0X1UUsNSA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_IafOP9CfhECxgvOBPTdyzw_18_4">1,794</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_dfNJO7LfcEOZT4w2RTRitw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_9H2fQiHn1EqiAfUTqZjxDQ_18_6">431,251</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Vs0uaVlFREaW6ng6T8fgEg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_q04YeUnzTE2GKYfkb8sRAg_18_8">124</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_frCDFRM6oU2SCVSiDhf4Lw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_mO_KMzY-90ihRHdiLBen_Q_18_10">200,942</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_fNeupebFFUOPOyeQrvkYqA" decimals="-3" format="ixt:zerodash" name="ifrs-full:Equity" scale="3" id="Tc_FO4Es08wxUOJCOqu7xxpgg_18_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.33%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_WKTpB7g7XEOG2KJx7MncuQ_18_14">231,979</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_c5200fb1_5ba2_4295_a170_9632b5f92be2"></a><a id="Tc_WTdDBtc8NEeawbqAz-jxvA_1_12"></a><a id="Tc_3ZNUzvL0REmd-ywuvgFmBw_2_4"></a><a id="Tc_TQjJuIVixUqrSQntT7UJYw_2_6"></a><a id="Tc_qbNqrBKUYUGwwKsZt9m1pg_2_8"></a><a id="Tc_D2wyC42waUqUgYDt8V-hXw_2_10"></a><a id="Tc_Vhqz5CVcKUSQoX5i3mIUCw_2_12"></a><a id="Tc_nwOemJH-gkKH3_WvFoXxtQ_3_2"></a><a id="Tc_Mmw3_ydrqEygo67wOkWT7w_3_4"></a><a id="Tc_RknAIraodkmIL2nKF-hl9Q_3_6"></a><a id="Tc_7wCXqO1BR0yX0NGvqI7rhA_3_8"></a><a id="Tc_MmVPG3EDnUeJmn_gK-ueLA_3_10"></a><a id="Tc_xX-DxEsxLEeu-LD0hUb18g_3_12"></a><a id="Tc_jM2ZT4olpUaZZFyAKrzUQQ_3_14"></a><a id="Tc_PdxeSGtdN0OGv3JJoTOcFA_4_0"></a><a id="Tc_o6FH9w19SUybLkE3C7fFLw_4_12"></a><a id="Tc_hxOqOv5r6UCxl-5iVRoA8w_5_0"></a><a id="Tc_pOLpdEK8DUOPrZBSzWGKmA_6_0"></a><a id="Tc_jxhbAlvyzki4mdmD3cx6NA_6_2"></a><a id="Tc_9TLSpAbxhEKdoVU66-1sCA_7_0"></a><a id="Tc_tHTeeAv6EUalugYtFIvk3g_9_0"></a><a id="Tc_3E1I9PlHzk66bvM0wzXxwg_9_2"></a><a id="Tc_pkSCEduEI0m-RaZibTfizg_10_0"></a><a id="Tc_PPa678Ls7EuG7bOLBZYw5w_10_2"></a><a id="Tc_L-h68SKjf0yoqXMT3BVKng_10_4"></a><a id="Tc_dlQg80oI90yOLyZsrC2HXw_10_10"></a><a id="Tc_FCFNxFMOP0Sr3bFCBZIHvQ_10_12"></a><a id="Tc_n8GSVmDxJUqbNdamGsFWNA_11_0"></a><a id="Tc_2e7mjps1v0aDWcCCgQM9IQ_12_0"></a><a id="Tc_gCPMlcfmdECvppA6Y15hjA_12_2"></a><a id="Tc_Vj1kGXzAlUuwWAgwyldR5g_13_0"></a><a id="Tc_aSxwi1aJn02xmaM7SvUNOQ_13_2"></a><a id="Tc_blmReu4WEUyHwjHfOXv1aA_14_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:35.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:35.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">translation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">premium</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">losses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">differences</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of January 1, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember__r0D1g51PUiGX0X1UUsNSA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_GSnM5QoEcUOnMb4CITl5og_4_4">1,794</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_dfNJO7LfcEOZT4w2RTRitw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_ArXjdvLQhEqaCcLoETvrDw_4_6">431,251</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Vs0uaVlFREaW6ng6T8fgEg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_vllY7o38gES0MbS4V3ZsBw_4_8">124</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_frCDFRM6oU2SCVSiDhf4Lw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_rHoWR73bZkq0IqRMUdFM9Q_4_10">200,942</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_zjIzU5NTPEG8eUz-qyunDA_4_14">231,979</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net loss for the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProfitLoss" scale="3" id="Tc_0LRBTY0SiEisj4f6z-lGHg_5_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProfitLoss" scale="3" id="Tc_NUgsBS8ZCUuDR_RwoCPWqg_5_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProfitLoss" scale="3" id="Tc_CFif-0qX0E6Imx8WM3eUDA_5_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_9u9rBN0CekW7EAFdEa_ovA_5_10">70,753</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProfitLoss" scale="3" id="Tc_6QdmQ4T8tEOrBCOoJ7BKmQ_5_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_XGfOX-sirUWUZxvJmuy-AQ_5_14">70,753</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_Pqg3JbflT0-CRcSn8DeYjQ_6_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_68intEz-0E2g1uinUmaX3Q_6_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_llSECF-pzUKZ-fCW9ojqXQ_6_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_gyPDElpKD0a-yuEa_sOiTQ_6_10">4,426</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_zWcC3hsGf0aDTwY2kxopfQ_6_12">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_6-aSYkFJd0e18fBnhbDyUw_6_14">4,436</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total comprehensive loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg" decimals="-3" format="ixt:zerodash" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_FpWcOPXZiEOu4Oi0AbyGLw_7_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA" decimals="-3" format="ixt:zerodash" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_Bu11iqjuLESfkM025mr6rA_7_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg" decimals="-3" format="ixt:zerodash" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_6-zGBWXOiEapS56RuWjnAQ_7_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_pwfnKWAdEEWs-V9h0qpK2g_7_10">66,327</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_y9T-p4euL0WAq5nXVzHH7g_7_12">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_v6VIzMJJ1E-ZYV1NFLiopw_7_14">66,317</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_bFskihkLIkquZcH4Hy4Rww_9_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_54Lu0b8pLkWtNeuPpgKrpg_9_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_iEklsXiXL0mtoKpQhtY83A_9_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_sZtzBhzQrEerpNZ0bJhHNA_9_10">3,330</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_AYNEpqePv0OT1O95Hv4dJA_9_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_cokNQePFsUOq2qNB0NN2WQ_9_14">3,330</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" sign="-" scale="3" id="Tc_QMMoW1Ze8k6LOuyaxonqPg_10_6">8</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_jjsso6_xAUCBImYeAeOs7A_10_8">0</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" sign="-" scale="3" id="Tc_wcH4j-ITVEi6bsHbbMubsA_10_14">8</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares, net of transaction costs:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:35.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Restricted share awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_kcjRqYzywEOaEvgN89OUsQ_12_4">0</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_S_Ngp913RkqOaEriSRai3w_12_6">76</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg" decimals="-3" format="ixt:zerodash" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_b9Q2T3tLB0qr5zORDF0vlw_12_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" sign="-" scale="3" id="Tc_-b71oSXtLUSNGFLNum3-5w_12_10">76</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ" decimals="-3" format="ixt:zerodash" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_b83Ti97n90Occaw_GaP_Fw_12_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_Wy-ykgQlNUK7y6-GSDxbiA_12_14">0</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Exercise of options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_-94iye2yGUGiyYwX0JZiaQ_13_4">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_oxVpqoXzJkekWd7OSzTuLg_13_6">4</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_aPiSd82fgkSdzuIlu1oVeA_13_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_mBmvsexDF0-Vdf8TcDVJLA_13_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_X4tfOvxyh0WFcmXEdyeNBw_13_12">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_cbeHiSeYm0a6lVZReNrExg_13_14">7</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_gp09PWsb8EavwbWAh0p_Sg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_d8bwB5EvlkqEZhFBTKOxIA_14_4">1,797</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_8sJpe0LyAECOfOJdgZOKPQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_m5xdQSbcP0q8kw4LYOnqBA_14_6">431,323</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_hgoBF8GS-k-cs9msKZyyhA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_yWwx4K2Xuk6QeoZYbwZLAQ_14_8">124</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_y4uYlYwmHUaTK3M_16Tcuw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_k6Pu_ZRSFUmwhdEo__MXyw_14_10">264,015</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_GwujP39d00mK3lHW3oUw4A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_WI7YPVo6O0CoHE8JQJ8UrA_14_12">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_qrWSjihy2EWSFFHSF3gsfQ_14_14">168,991</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The accompanying notes are an integral part of these consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_6219582c_bf07_4b0b_ab31_8c8694d1f3bc"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">AC Immune SA</p><a id="ConsolidatedStatementsofCashFlows_14317"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Consolidated Statements of Cash Flows</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">(In CHF thousands)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_b809213e_e5a9_4e6b_8cb0_ab394d9550d1"></a><a id="Tc_hyoXzICNP0mRfp_-tlt-0A_1_2"></a><a id="Tc_FXXgZ_fEcEC2hVz4RpiJrQ_2_2"></a><a id="Tc_wT--Kl4JBUW2dhDWdekPyw_3_2"></a><a id="Tc_52g15i36gUKHm76pFLJ7pg_3_4"></a><a id="Tc_5GmTePvWWkupx1rOXZbZRA_3_6"></a><a id="Tc_4N4FRHM0q0OOiD4jEQmIuA_3_8"></a><a id="Tc_qBV8R_VGrUSP4yvDk-o3hQ_4_0"></a><a id="Tc_kxHKiLnfNkKNNfC0POxtSA_5_0"></a><a id="Tc_bDNtiNx9GEy1yt8UM2y_NQ_6_0"></a><a id="Tc_xvS7mydbJEK_FkULedKiHg_7_0"></a><a id="Tc_m0vwTLI3jUS6aue0uRtzBw_7_2"></a><a id="Tc_sli2J0yy_0yy5JiGZ0l1Jg_8_0"></a><a id="Tc_OJM6mzbBsEi23f1umdjVTQ_8_2"></a><a id="Tc_2_2p1gCgLEibpsu6Wy6T4w_9_0"></a><a id="Tc_TYJcP7cDDEeENox2WryySA_9_2"></a><a id="Tc_DNPxUGIk9EiMXDUA70tPtg_10_0"></a><a id="Tc_LjUwBUwtHUi-NArF7j6p7A_10_2"></a><a id="Tc_bIk8BBrop02dPPGdTAsIcA_11_0"></a><a id="Tc_qZ0i9n94iUG2ozginP6uhA_11_2"></a><a id="Tc_mA68Ate0F063dg9msm--PA_12_0"></a><a id="Tc_KZ5TkpTFEk2bQoJ_zfnpuQ_12_2"></a><a id="Tc_LAIcvQdJck2Ue5VtwRBvzQ_13_0"></a><a id="Tc_WFkAc8deiUyMahRC-ro6rw_14_0"></a><a id="Tc_AEb0oQnLikeR4dDo8N2wSQ_15_0"></a><a id="Tc_dAzy5bNiIkKLxqasiesw2A_15_2"></a><a id="Tc_-L3t6cz4zEyWTvzb2xAcIA_16_0"></a><a id="Tc_utl6OBHdtk6zAO7p1swnlQ_16_2"></a><a id="Tc_x56sdMBsq0ifns83UZKajg_17_0"></a><a id="Tc_kb9H5B42rUKfI8cfJKwilQ_17_2"></a><a id="Tc_yD39eH9-uEWQbd-5icpsJA_18_0"></a><a id="Tc_dwGAknO4hkSoE4DeHCn3SA_18_2"></a><a id="Tc_aGqFc6Mqt0SkA_tdZ1auXQ_19_0"></a><a id="Tc_mkW4_AYevEKPG5iMCF_QYw_19_2"></a><a id="Tc_9iTHRTpFsky4BdK5oJdddw_20_0"></a><a id="Tc_HkmPPs3WJEyK4Uvq1uTN1A_20_2"></a><a id="Tc_lq0ycXuMH0CbUlX0Njz_KQ_21_0"></a><a id="Tc_6umdvHIvRk6nh5ghVC0lrw_22_0"></a><a id="Tc_p3V2NtHAyEiOIGHyJYryNw_22_2"></a><a id="Tc_KdWKFWp950yEbY14hSl1ag_23_0"></a><a id="Tc_foOELKGlSEirLcZOPwNWoQ_23_2"></a><a id="Tc_k9Z4oOzHzUWylhMFpMQn_w_24_0"></a><a id="Tc_AIjHnxCq5ke2_4fjiclFXQ_24_2"></a><a id="Tc_i66VvvzOu0eLMLhzUadbtg_25_0"></a><a id="Tc_Hk0lj6by60eJMmKdJD8-JQ_27_0"></a><a id="Tc_wy55m_QgS06-XWu68jL2wQ_28_0"></a><a id="Tc_hMs90BCatky7UcNg5TULNg_28_2"></a><a id="Tc_OcitmLYxrEyNLbL4HvYhgw_29_0"></a><a id="Tc_eysU7m2mEEuqCH3B_qpZag_29_2"></a><a id="Tc_ZfU4SMv8Wki3MfeoVer0Vg_30_0"></a><a id="Tc_5ksilA_gskiwOf6Qte6Tzw_30_2"></a><a id="Tc_FUMr7BXzA0GtkeO8QjxkWA_31_0"></a><a id="Tc_LzM9b6Ip40Guq9sPLmMs-w_31_2"></a><a id="Tc_FWIx4BadpUqsmwbfDYw7qQ_32_0"></a><a id="Tc_eR553v57BUmG79EkzDYq7g_34_0"></a><a id="Tc__4715mCKdECrXB9wjmllJQ_35_0"></a><a id="Tc_yGYRaBe7BUqR_H9pO08ziQ_35_2"></a><a id="Tc_Dq0DG4hMFkmfSSueOMD-rg_36_0"></a><a id="Tc_EpgMIsFHQ0u3fynCoF1bag_36_2"></a><a id="Tc_IZXKVnBpjECKINoU5NjyMA_37_0"></a><a id="Tc_Su2cJQGLbUu2K_yoiEgexQ_37_2"></a><a id="Tc_YqTiRyDd-UiI55_gLi1XPA_37_6"></a><a id="Tc_eSZ1WukwfUes_3t6p_3APg_37_8"></a><a id="Tc_YaJYHNfEL0O_Hu7oaesN8w_38_0"></a><a id="Tc_0idqbFzyiUCQzB4EycvOUw_38_2"></a><a id="Tc_2_UVYtKa7kCYptsQ48O4jQ_39_0"></a><a id="Tc_j3K1VPQJqU-uvik3qap8LQ_39_2"></a><a id="Tc_dyUeHhkDi0GS08hs-dc8nA_40_0"></a><a id="Tc_Z4q2pXNf8k-YZkwx7uPSBw_40_2"></a><a id="Tc_iF5zHOFRekCzLrqcbAFM8A_41_0"></a><a id="Tc_W132NGXDXU-vdH_sWzGudA_41_2"></a><a id="Tc_z7WFInoOFkiBum2Q954yNg_42_0"></a><a id="Tc_3yP6ldOTrECFeNtU-Pt4fg_42_2"></a><a id="Tc_dO4jo1238U2Psw-yXliiag_42_6"></a><a id="Tc_x_3EjJ0bnECAG9i9q6IdfA_42_8"></a><a id="Tc_Ml2ITbWnmEWD-9tof4e57Q_43_0"></a><a id="Tc_782CUMsxxEC83thiC0moiQ_44_0"></a><a id="Tc_w8rOYEwXb0qXlKghmXXYGw_44_2"></a><a id="Tc_vOjWAvH0aEKeE1lVLID3IA_45_0"></a><a id="Tc_4gbljYmBWEqzxemSLcTh1w_47_0"></a><a id="Tc_ArTe4X_byUeBXJHvGcPKxw_49_0"></a><a id="Tc_yrkl-hJka0WE22wCoLEfrA_50_0"></a><a id="Tc_bu2_NKBFSkCtoOPmYjluYQ_51_0"></a><a id="Tc_1X3lEweK30-i24dyDxcWfg_53_0"></a><a id="Tc_cLBJrc0O4Ui1QrdaiUcwyQ_55_0"></a><a id="Tc_Gd345EZal02UQ6ecLBepEw_56_0"></a><a id="Tc_5d-Hpjrm2kqFNT4O1_waMg_56_2"></a><a id="Tc_oHJnXxoZZk-Gt_FJq3YaLQ_57_0"></a><a id="Tc_dGVGqX-ogE2uhDFayVgFeg_57_2"></a><a id="Tc_FCFRkPil-U69FIKEdEBztg_58_0"></a><a id="Tc_2_YElLMAWUy3-QZXeJ4Uvw_58_2"></a><a id="Tc_dCtuf37U40-ply3BDQnITw_59_0"></a><a id="Tc_X50ZJ3GVf0O8E9lNUO1KEQ_59_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:25.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:25.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Operating activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Loss for the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_Jb0TEZFDG0q0m6tjBpwBZA_5_4">70,753</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_gGLhwZq_5U-F2wMelrX7Mw_5_6">72,996</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_R_7CXlykbEGdspOFLUCqfw_5_8">61,921</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjustments to reconcile net loss for the period to net cash flows:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Depreciation of property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" id="Tc_Bk5wApfHa02ZNB5lZrKyyg_7_4">1,793</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" id="Tc_3pIuv-CWW0uEouy-bqgy5Q_7_6">1,897</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" id="Tc_NR3cK3PpfkqmrqZDCHiMwQ_7_8">1,535</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Depreciation of right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets" scale="3" id="Tc_Oo5nrX8SvU--MfvhGE7GLw_8_4">566</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets" scale="3" id="Tc__LLCZAnz7kaLqeGttgYBCA_8_6">509</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets" scale="3" id="Tc_j0kaEsZimEKmRYtl5rfCbA_8_8">432</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Finance (income)/expense, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForFinanceIncomeCost" scale="3" id="Tc_tpaJJfjqzU2xjvY1abWcUw_9_4">559</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForFinanceIncomeCost" scale="3" id="Tc_czEWj6theEWedHzFTlTXvw_9_6">6,769</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForFinanceIncomeCost" sign="-" scale="3" id="Tc_JCgBVRBLt06d19KwHxloAQ_9_8">376</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Share-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" id="Tc_6ghfBa8FUEGg0ChoxrnmWw_10_4">3,330</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" id="Tc_2bZzZ-Y-c0mvIxtVP_cJeA_10_6">4,126</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" id="Tc_JU7YBoDHZUi4bF5fKDWfvA_10_8">4,088</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Change in net employee defined benefit liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="3" id="Tc_KxC4W4qaaU-dzrRSZtEQXg_11_4">541</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="3" id="Tc_-IVNNSq1E0mmRfm5cjpuZQ_11_6">590</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="3" id="Tc_vAuDaKtrc0a8DnFGRgyShQ_11_8">705</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Interest expense </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5/14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForInterestExpense" scale="3" id="Tc_Bz6kAY0FnkKQOM9EGlD7Pg_12_4">355</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForInterestExpense" scale="3" id="Tc_dMO4SuUYP0yGrheZIZQTSw_12_6">573</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForInterestExpense" scale="3" id="Tc_m3JFBs6_aEyCj9tpae0HRA_12_8">175</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">(Gain)/loss on sale of fixed assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:zerodash" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" scale="3" id="Tc_GP_fos7N7EC0vSUla65_nQ_13_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_3Espc9q0ikegNRyqXspHJw_13_6">13</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" scale="3" id="Tc_0w--WwpQoEaGTkyPtO2mag_13_8">64</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Changes in working capital:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">(Increase)/decrease in prepaid expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" sign="-" scale="3" id="Tc_Llq7Jn61aEa7P-KGMEdnxA_15_4">1,718</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" scale="3" id="Tc_a_aOJ0ZZrEOM8Weq9H54nA_15_6">791</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" sign="-" scale="3" id="Tc_TRvqMRAg5kWI-LGNiUWSJg_15_8">1,304</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Decrease/(increase) in accrued income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" scale="3" id="Tc_yfoP8bnYqkif0_yfSXUCcg_16_4">567</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" scale="3" id="Tc_3aMIepX9NEyjkA28STiLww_16_6">594</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" sign="-" scale="3" id="Tc_Y_koJJ9S1E670NK_KBIZ4w_16_8">507</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Decrease/(increase) in other current receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" scale="3" id="Tc_zyXUz1fHRUmxVmlQ0vs7sg_17_4">36</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" sign="-" scale="3" id="Tc_Z5FWMU8NGU-gp39rqCGtnQ_17_6">99</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" sign="-" scale="3" id="Tc_PtyK2GksPEG0ekyR5tqRqg_17_8">25</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">(Decrease)/increase in accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses" scale="3" id="Tc_FIksIYNNUUSlEZXH4q3gpg_18_4">6,114</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses" sign="-" scale="3" id="Tc_MYKakNCa4ESYsoKjd8SI7Q_18_6">5,214</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses" scale="3" id="Tc_Dx02XaqAdUySLGPBSRQJVw_18_8">757</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">(Decrease)/increase in deferred income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" sign="-" scale="3" id="Tc_7hTgbaSdM0W4vPqQOWkVfg_19_4">130</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" scale="3" id="Tc_LFVWfMGY0Eq4hWkQEGFfuw_19_6">425</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" sign="-" scale="3" id="Tc__OfjjOKPW0OgFyb_SDwekA_19_8">4,157</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">(Decrease)/increase in trade and other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" sign="-" scale="3" id="Tc_B0bGHioph0aCPEhswrK3FQ_20_4">1,073</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" sign="-" scale="3" id="Tc_27yR8Sk6f0CFxNyrrFmpug_20_6">84</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="3" id="Tc_tjC46Kj2hEu3d3rFHJ4lPg_20_8">2,177</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash used in operating activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperations" sign="-" scale="3" id="Tc_29NYA65vakqrHJwrrPk5DQ_21_4">73,159</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperations" sign="-" scale="3" id="Tc_aV9EPP_go0yeK4t6Y7Wc4Q_21_6">65,216</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperations" sign="-" scale="3" id="Tc_HiCmfqpSdU6UrowAPTjVVw_21_8">59,247</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Interest received</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" scale="3" id="Tc_XK9tstmekUKtvxt0mDj7hw_22_4">69</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:zerodash" name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" scale="3" id="Tc_KjrmxMVfi0KvqWR-UGyICQ_22_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" scale="3" id="Tc_K47NNx-OE06-Jju74Kf7Cg_22_8">78</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Interest paid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5/14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" scale="3" id="Tc_l6JyDBcF2EWZSK2B24WyTA_23_4">470</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" scale="3" id="Tc_u9X0U3kfHEuP4AtMOHe0hQ_23_6">465</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" scale="3" id="Tc_C2pzzByMi0eGHA7r5rh4oQ_23_8">339</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Finance expenses paid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities" scale="3" id="Tc_6lAhCdscRUam8i67Xu8Pug_24_4">8</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities" scale="3" id="Tc_EYUQsnKCPEW3ZNJz-jM-kQ_24_6">8</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities" scale="3" id="Tc_F92KR8zIlkizV7J6jtrAuQ_24_8">9</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net cash flows used in operating activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" sign="-" scale="3" id="Tc_mHZzbsh1J0G2xfYzIJEFtw_25_4">73,568</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" sign="-" scale="3" id="Tc_-DCvnVTR3EOdsaCFQQbAvw_25_6">65,689</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" sign="-" scale="3" id="Tc__vAi909cF0eS3lzFpk-lsA_25_8">59,517</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Investing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Short-term financial assets, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" sign="-" scale="3" id="Tc_bGUfPTCHjUqDqJbYJFCIBg_28_4">25,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_xleZWOXAkkaQVE3kidyRsA_28_6">51,000</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" sign="-" scale="3" id="Tc_1nToXc_850iMTezDhqfeHw_28_8">30,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Purchases of property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_zoRI0ArPNkmF9p21v8sVkA_29_4">1,239</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_TcAW1ttxwE2Il16g57_7dw_29_6">2,635</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_2JI8xQKnm0u2ZVhVkNnTrA_29_8">1,706</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Proceeds from sale of property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_mvMiIWA3TUeVAJ3a1YM0fQ_30_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_VO2OSxoHDECL-azDgQUd3w_30_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_oh6Q3E1wak6lgrtitWDXkQ_30_8">64</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Rental deposits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="aciu:CashAdvancesForRentDeposit" sign="-" scale="3" id="Tc_uWxUx0j_0kSK71WIWUrhmg_31_4">2</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:CashAdvancesForRentDeposit" scale="3" id="Tc_bIeVtMNHeEyuzhUXi0ql0A_31_6">29</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="aciu:CashAdvancesForRentDeposit" scale="3" id="Tc_2QVJHGEWoE2Xnb5tB7FzFw_31_8">29</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net cash flows provided by/(used in) investing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" id="Tc_dIz5NWlIrEmzDak_uLQ88w_32_4">23,763</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" sign="-" scale="3" id="Tc_zzT-m4R_dEi_x0vpfBxmdQ_32_6">53,664</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" id="Tc_0y2dSahD7kOzcd3sRPTsNg_32_8">28,329</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Proceeds from issuance of convertible loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:zerodash" name="aciu:ProceedsFromIssueOfConvertibleDebt" scale="3" id="Tc_QZhhRSjvhEmT1OobCnQJmQ_35_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:ProceedsFromIssueOfConvertibleDebt" scale="3" id="Tc_q96bxHxuckau9K3M1i8Wgw_35_6">23,463</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:zerodash" name="aciu:ProceedsFromIssueOfConvertibleDebt" scale="3" id="Tc_h5sz9faHik2yKBuJlgYF8Q_35_8">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Transaction costs on issuance of shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:zerodash" name="ifrs-full:PaymentsForShareIssueCosts" scale="3" id="Tc_-ebijTdP2EadkdoWm5V05g_36_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PaymentsForShareIssueCosts" scale="3" id="Tc_cKsl0j2ubEW_4cye_qx8vw_36_6">6</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:zerodash" name="ifrs-full:PaymentsForShareIssueCosts" scale="3" id="Tc_wLno5Ojqq0mklcr32hcwnQ_36_8">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="aciu:ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" sign="-" scale="3" id="Tc_J9J9dc415EmwMGLCHED9bw_37_4">8</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:zerodash" name="aciu:ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_kNk4ATLHV06Vs4JwFFbj5A_38_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_WV1nIi95zkqMnBBURykA2g_38_6">12,121</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="aciu:ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_jR2g8RKuCUCg-J_NwB9aJw_38_8">100</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Proceeds from issuance of common shares &#8211; asset acquisition, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" scale="3" id="Tc_uToFqYoUikeNNwonmJDHdw_39_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" scale="3" id="Tc_UpF887K7K0eIBX_wHdO3xQ_39_6">4,599</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:zerodash" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" scale="3" id="Tc_vX3JpusWjkSuLKOdqVpMLg_39_8">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Proceeds from issuance of common shares &#8211; option plan, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="3" id="Tc_7uD3iMpqVEW7ejbg7Q5diA_40_4">7</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="3" id="Tc_zgmmGdxlok2DttzMn-vfZg_40_6">1,082</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="3" id="Tc_FZbuednykE21cifOkwulnA_40_8">143</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Principal payments of lease obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" id="Tc_EbqHtP3NRUqGxM4qJDl72Q_41_4">569</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" id="Tc_SCopM4SsmUazoKIzhKLrLw_41_6">513</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" id="Tc_68OwILXl-kCVfS84sclqKw_41_8">432</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Transaction costs associated with issuance of shares in relation to asset acquisition previously recorded in Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="aciu:PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" scale="3" id="Tc_Ye5XrSCPkUq221QYHoRamg_42_4">776</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Repayment of short-term financing obligation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:zerodash" name="ifrs-full:RepaymentsOfCurrentBorrowings" scale="3" id="Tc_VTazu9e4OU6sMUv1tfP-4g_43_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:zerodash" name="ifrs-full:RepaymentsOfCurrentBorrowings" scale="3" id="Tc_6jSEDb7WikWPDnsmnfTndQ_43_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RepaymentsOfCurrentBorrowings" scale="3" id="Tc_x5zB42bD3EGkCL3qUegF_A_43_8">514</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Payment for the issuance of treasury shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:zerodash" name="ifrs-full:PaymentsToAcquireOrRedeemEntitysShares" scale="3" id="Tc_5-7ESsswkkeRZcxiUkqX8g_44_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:zerodash" name="ifrs-full:PaymentsToAcquireOrRedeemEntitysShares" scale="3" id="Tc_wWUlsS2z-k2n9WsQ9gvr0w_44_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PaymentsToAcquireOrRedeemEntitysShares" scale="3" id="Tc_llEAIngy2E2cC45E1gIsww_44_8">100</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net cash flows (used in)/provided by financing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" sign="-" scale="3" id="Tc_ePQrpzLf4UOT2mWr6RYJkQ_45_4">1,346</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" id="Tc_3lER2wGtWk-1ljk0XSSeUA_45_6">40,746</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" sign="-" scale="3" id="Tc_sK0xjiGvs0aN_3KTTGWkBw_45_8">803</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net decrease in cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" sign="-" scale="3" id="Tc_P4bbh3pQhUOaGxPki8YjAQ_47_4">51,151</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" sign="-" scale="3" id="Tc_jKD6pdZuI0qpzGDi4OeEVQ_47_6">78,607</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" sign="-" scale="3" id="Tc_74jnoyJsJ02AVttvG3TA4A_47_8">31,991</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Cash and cash equivalents at January 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_bG-uh7pWPUiTAToHMPg3Mw_49_4">82,216</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_Fd88g__d20usrKCPjPUo5A_49_6">160,893</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2019_C854zoDUpkSi-bE7TYeEJw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_00j80jzGm0C8-5iv7O-fCg_49_8">193,587</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Exchange gain/(loss) on cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" id="Tc_tBqlLMYc-02_wLXtVXA7Hg_50_4">521</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" sign="-" scale="3" id="Tc_fsA1cu_pvk2tYH09rLyTiA_50_6">70</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" sign="-" scale="3" id="Tc_cmUKNpwrBkuRg_BTNdKTaw_50_8">703</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Cash and cash equivalents at December 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_TL0hcvlzpkmN7J2cnyO31Q_51_4">31,586</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_maWG9rf1YUaDJrNK_s-SLg_51_6">82,216</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_xiVxEAOjDUCAIBso4M6fAQ_51_8">160,893</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net decrease in cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" sign="-" scale="3" id="Tc__daJV9dXlkyRZBji0464eQ_53_4">51,151</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" sign="-" scale="3" id="Tc_Z5VcVcDJtEmm3_pUd0rO2g_53_6">78,607</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" sign="-" scale="3" id="Tc_OmM2vtQEz02vrrZxPEQxIw_53_8">31,991</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Supplemental non-cash activity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Capital expenditures in Trade and other payables or Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:zerodash" name="aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" scale="3" id="Tc_Q_E9miQUg0uBPA4dv0rjiA_56_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" scale="3" id="Tc_xMBIJnPB50mtRUP5AUo3iA_56_6">303</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" scale="3" id="Tc_qXvtUNk4z0u-J5HZivw5wQ_56_8">328</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Issuance of shares for purchase of IPR&amp;D asset in asset acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">6/7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:zerodash" name="aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" scale="3" id="Tc_PMsSI_ol7ES7NJrfIxVDIQ_57_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" scale="3" id="Tc_NpopDYkDeUKc8EA1GiZGTA_57_6">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:zerodash" name="aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" scale="3" id="Tc_2GHe9E0MSEKvivT8YJTyYA_57_8">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Transaction costs associated with issuance of shares in relation to the asset acquisition recorded in Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:zerodash" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Tc_juqXW8GvvkmMXGBx7XF0VA_58_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Tc_dmkkK1vk_ki91fI1kbkYaA_58_6">776</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:zerodash" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Tc_K2aKAre_kkaS2eLnXl6-0w_58_8">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Settlement of convertible notes recorded within Shareholders&#8217; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:zerodash" name="aciu:RepaymentOfConvertibleDebtEquitySettlementAmount" scale="3" id="Tc_fPytKBSij0O3I5qzc4cm_A_59_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:RepaymentOfConvertibleDebtEquitySettlementAmount" scale="3" id="Tc_3dujkd8DDky6-uuynQe1hA_59_6">16,920</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:zerodash" name="aciu:RepaymentOfConvertibleDebtEquitySettlementAmount" scale="3" id="Tc_oZRhjB8Dtk6BLBqzpnweHQ_59_8">&#8212;</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these consolidated financial statements.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="NotestotheConsolidatedFinancialStatement"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" id="Tb_gF2eBXaQV0aFWJwKhncuZw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">AC Immune SA</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Notes&#160;to the Consolidated Financial Statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">(In CHF thousands except for share and per share data)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">1.</b></span>General information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune SA was founded in 2003. The Company controls a fully-owned subsidiary, AC Immune USA,&#160;Inc. (&#8220;AC Immune USA&#8221; or &#8220;Subsidiary&#8221; and, together with AC Immune SA, &#8220;AC Immune,&#8221; &#8220;ACIU,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; &#8220;us&#8221;), which was registered and organized under the laws of Delaware, USA in June&#160;2021. The Company and its Subsidiary form the Group.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune SA is a clinical-stage biopharmaceutical company leveraging our <ix:nonFraction unitRef="Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfTechnologyPlatforms" scale="0" id="Narr_wLnwBUdHf0GfBvNsNzHLQQ">two</ix:nonFraction> proprietary technology platforms to discover, design and develop novel proprietary medicines and diagnostics for prevention and treatment of neurodegenerative diseases (NDD) associated with protein misfolding. Misfolded proteins are generally recognized as the leading cause of NDD, such as Alzheimer&#8217;s disease (AD) and Parkinson&#8217;s disease (PD), with common mechanisms and drug targets, such as amyloid beta (Abeta), Tau, alpha-synuclein (a-syn) and TDP-43. Our corporate strategy is founded upon a three-pillar approach that targets (i)&#160;AD, (ii)&#160;focused non-AD NDD including Parkinson&#8217;s disease, ALS and NeuroOrphan indications and (iii)&#160;diagnostics. We use our <ix:nonFraction unitRef="Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfTechnologyPlatforms" scale="0" id="Narr_tOmYt-Dpx0G5Lv6GFHjzNQ">two</ix:nonFraction> unique proprietary platform technologies, SupraAntigen (conformation-specific biologics) and Morphomer (conformation-specific small molecules), to discover, design and develop novel medicines and diagnostics to target misfolded proteins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company was initially incorporated as a limited liability company on February&#160;13, 2003 in Basel, and effective August&#160;25, 2003 was transformed into a stock company. The Company&#8217;s corporate headquarters are located at EPFL Innovation Park Building B, 1015 Lausanne, Switzerland.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" id="Tb_i1fEu7DHnEyVMyyxznD9LA" continuedAt="Tb_i1fEu7DHnEyVMyyxznD9LA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.</b></span>Basis of preparation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Going concern</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company believes that it will be able to meet all of its obligations as they fall due for at least 12&#160;months from the filing date of this Form 20-F, after considering the Company&#8217;s cash position of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="6" id="Narr_UVysGpVs1UWArFpZYJFcjQ">31.6</ix:nonFraction> million and short-term financial assets of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="6" id="Narr_C-mVVDe-ckCvj2iVbTayTg">91.0</ix:nonFraction> million as of December&#160;31, 2022. Hence, these consolidated financial statements have been prepared on a going-concern basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, the Company has financed its cash requirements primarily from its public offerings, share issuances, contract revenues from license and collaboration agreements (LCAs) and grants. The Company is a clinical stage company and is exposed to all the risks inherent to establishing a business. Inherent to the Company&#8217;s business are various risks and uncertainties, including the substantial uncertainty as to whether current projects will succeed and our ability to raise additional capital as needed. These risks may require us to take certain measures such as delaying, reducing or eliminating certain programs. The Company&#8217;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;successfully move its product candidates through clinical development, (iv)&#160;attract and retain key personnel and (v)&#160;acquire capital to support its operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Statement of compliance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). These consolidated financial statements were approved for issue by the Board of Directors on March&#160;15, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Basis of measurement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements have been prepared under the historical cost convention except for items that are required to be accounted for at fair value.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_i1fEu7DHnEyVMyyxznD9LA_cont1"></ix:continuation><a id="_9fba7a65_626e_4bd1_b41b_53b1dec3c591"></a><a id="Tc_YVWO7vRa3Ua8V5ZQ2sbviA_1_2"></a><a id="Tc_vjkmj6oIDUeLWmV1G47hVQ_2_2"></a><a id="Tc_NA8vj7g8nU2O3DCRBojzHA_3_2"></a><a id="Tc_auc2LlvwMk-whK32e4sZhQ_3_4"></a><a id="Tc_wvCFCIDI8UyXiy70uDu08A_3_6"></a><a id="Tc_mCraU7bI7EeNHLtl9Pyoiw_4_0"></a><a id="Tc_30kaWtNESUS8tn76KZyoaQ_5_0"></a><a id="Tc_unDFJKgX8UCqX7mn2SH7ng_5_6"></a><a id="Tc_ryl42sYgcEmZ1iUan0jZxw_6_0"></a><a id="Tc_Cv2dlAueZECygAVS-SQXAg_6_6"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" id="Tb_kWrgqHMI4E-AERaRyItnUQ" continuedAt="Tb_kWrgqHMI4E-AERaRyItnUQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">3.</b></span>Summary of significant accounting policies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The principal accounting policies adopted in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the&#160;years presented, unless otherwise stated.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" id="Tb_RhEZkc_5gE6jmYPrsz5rUg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Functional and reporting currency</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These consolidated financial statements and accompanying notes are presented in Swiss Francs (CHF), which is AC Immune SA&#8217;s functional currency and the Group&#8217;s reporting currency. The Company&#8217;s subsidiary has a functional currency of the U.S. Dollar (USD). The respective functional currency represents the primary economic environment in which the entities operate.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" id="Tb_uCL6uChV7EapB8Yt8z1Bdg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following exchange rates have been used for the translation of the financial statements of AC Immune USA:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">CHF/USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Closing rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_63MihMDHe0-xX0RnZGeOCQ_5_2">0.933</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_env1iXWA60-2HjWUJVcFNA_5_4">0.923</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">N/A</p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted average exchange rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_99abvZrbwEafptuMAvlXPA_6_2">0.965</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_R71Pb4pNxki02QzmCzvsvw_6_4">0.929</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">N/A</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The results and financial position of AC Immune USA are translated into the presentation currency as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">i.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">assets and liabilities for each balance sheet presented are translated at the closing rate at the date of that balance sheet;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">ii.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">income and expenses for each statement of income/(loss) are translated at average exchange rates; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">iii.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all resulting exchange differences are recognized in other comprehensive income/(loss), within cumulative translation differences.</span></td></tr></table><div style="margin-top:12pt;"></div></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfBasisOfConsolidationExplanatory" id="Tb_EQ76wnftH0iu7zlCU7hNiQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Basis of consolidation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The annual closing date of the individual financial statements is December&#160;31. The Company fully-owns its Subsidiary and fully consolidates its financial statements into these consolidated financial statements. All intercompany transactions have been eliminated.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" id="Tb_3Cb0RXBV80y1gJYX8fFErA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Foreign currency transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Foreign currency transactions are translated into the respective functional currency using prevailing exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at&#160;year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the consolidated statements of income/(loss). Any gains or losses from these translations are included in the consolidated statements of income/(loss) in the period in which they arise.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" id="Tb_Ga6O9dWCdUext4nxr1Ls_Q" continuedAt="Tb_Ga6O9dWCdUext4nxr1Ls_Q_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Current vs. non-current classification</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company presents assets and liabilities in the consolidated balance sheets based on current/non-current classification. The Company classifies all amounts to be realized or settled within 12&#160;months after the reporting period to be current and all other amounts to be non-current.</p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_kWrgqHMI4E-AERaRyItnUQ_cont1" continuedAt="Tb_kWrgqHMI4E-AERaRyItnUQ_cont2"><ix:continuation id="Tb_Ga6O9dWCdUext4nxr1Ls_Q_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue" id="Tb_D9nzu-m90USUkzobHLAf8w" continuedAt="Tb_D9nzu-m90USUkzobHLAf8w_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Revenue recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 15&#160;<i style="font-style:italic;">Revenue from Contracts with Customers</i>. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under IFRS 15, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of IFRS 15, the entity performs the following five steps: (i)&#160;identify the contract(s)&#160;with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of IFRS 15, the Company assesses the goods or services promised within each contract, and determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company enters into LCAs which are within the scope of IFRS 15, under which it licenses certain rights to its product candidates and intellectual property to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees, development, regulatory and/or commercial milestone payments;&#160;payments for research and clinical services the Company provides through either its full-time employees or third-party vendors, and royalties on net sales of licensed products commercialized from the Company&#8217;s intellectual property. Each of these payments results in license, collaboration and other revenues, which are classified as contract revenue on the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Licenses of intellectual property</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are sold in conjunction with a related service, the Company uses judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If the performance obligation is settled over time, the Company determines the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, upfront fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Milestone payments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the inception of each arrangement that includes development, regulatory and/or commercial milestone payments, the Company evaluates whether the milestones are considered highly probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant cumulative revenue reversal would not occur in future periods, the associated milestone value is included in the transaction price. These amounts for the performance obligations under the contract are recognized as they are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments recorded would affect contract revenues and earnings in the period of adjustment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development services</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has certain arrangements with our collaboration partners that include contracting our employees for research and development programs. The Company assesses if these services are considered distinct in the context of each contract and, if so, they are accounted for as separate performance obligations. These revenues are recorded in contract revenue as the services are performed.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_kWrgqHMI4E-AERaRyItnUQ_cont2" continuedAt="Tb_kWrgqHMI4E-AERaRyItnUQ_cont3"><ix:continuation id="Tb_D9nzu-m90USUkzobHLAf8w_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Sublicense revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has certain arrangements with our collaboration partners that include provisions for sublicensing. The Company recognizes any sublicense revenues at the point in time it is highly probable to obtain and not subject to reversal in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Contract balances</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company receives payments and determines credit terms from its customers for its various performance obligations based on billing schedules established in each contract. The timing of revenue recognition, billings and cash collections results in billed other current receivables, accrued income (contract assets), and deferred income (contract liabilities) on the consolidated balance sheets. Amounts are recorded as other current receivables when the Company&#8217;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be 1&#160;year or less.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For a complete discussion of accounting for contract revenue, see &#8220;Note&#160;13. Contract revenues.&#8221;</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" id="Tb_zeyFHlPGa0GE-Ceq8kY8AA" continuedAt="Tb_zeyFHlPGa0GE-Ceq8kY8AA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Given the stage of development of the Company&#8217;s products, all research and development expenditure is expensed as incurred as it does not meet the capitalization criteria outlined in IAS 38 <i style="font-style:italic;">Intangible Assets</i>. The Company has not capitalized any R&amp;D expenses to date. Research and development expenditures include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the cost of acquiring, developing and manufacturing active pharmaceutical ingredients for product candidates that have not received regulatory approval, clinical trial materials and other research and development materials;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees and expenses incurred under agreements with contract research organizations, investigative sites and other entities in connection with the conduct of clinical trials and preclinical studies and related services, such as administrative, data-management and laboratory services;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees and costs related to regulatory filings and activities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">costs associated with preclinical and clinical activities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">employee-related expenses, including salaries and bonuses, benefits, travel and share-based compensation expenses; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all other allocated expenses such as facilities and information technology (IT) costs.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For external research contracts, expenses include those associated with contract research organizations, or CROs, or contract manufacturing organizations, or CMOs. The invoicing from CROs or CMOs for services rendered do not always align with work performed. We accrue the cost of services rendered in connection with CRO or CMO activities based on our estimate of the &#8220;stage of completion&#8221; for such contracted services. We maintain regular communication with our CRO or CMO vendors to gauge the reasonableness of our estimates and accrue expenses as of the balance sheet date in the consolidated financial statements based on facts and circumstances known at the time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Registration costs for patents are part of the expenditure for research and development projects. Therefore, registration costs for patents are expensed when incurred as long as the research and development project concerned does not meet the criteria for capitalization.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_kWrgqHMI4E-AERaRyItnUQ_cont3" continuedAt="Tb_kWrgqHMI4E-AERaRyItnUQ_cont4"><ix:continuation id="Tb_zeyFHlPGa0GE-Ceq8kY8AA_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForExpensesExplanatory" id="Tb_eV-gsG9iAkSC2TV6lTCjZQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">General and administrative expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">General and administrative expenses are expensed as incurred and include personnel costs, expenses for outside professional services and all other allocated expenses. Personnel costs consist of salaries, cash bonuses, benefits and share-based compensation. Outside professional services consist of legal, accounting and audit services, IT and other consulting fees. Allocated expenses consist of certain IT, facilities and depreciation expenses.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:GrantIncomePolicyTextBlock" id="Tb_Q--lkoTAyEyQIwo2hoLqMA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Grant income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has received grants, from time to time, from the Michael J. Fox Foundation (MJFF), the Target ALS Foundation (Target ALS) and other institutions to support certain research projects. Grants are recorded at their fair value in the consolidated statements of income/(loss) within other operating income/(expenses), net when there is reasonable assurance that the Company will satisfy the underlying grant conditions and the grants will be received. In certain circumstances, grant income may be recognized before formal grantor acknowledgement of milestone achievements. To the extent required, grant income is deferred and recognized on a systematic basis over the periods in which the Company expects to recognize the related expenses for which the grants are intended to compensate.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory" id="Tb_j-2-iEGRSkq2eo06E8ATtg" continuedAt="Tb_j-2-iEGRSkq2eo06E8ATtg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 16 <i style="font-style:italic;">Leases</i>, which provides the model for lessee accounting in which all leases, other than short-term and low-value leases, are accounted for by the recognition on the consolidated balance sheet of a right-of-use asset and a lease liability, and the subsequent amortization of the right-of-use asset over the earlier of the end of the useful life or the lease term. In accordance with IFRS 16, the Company (i)&#160;does not recognize right-of-use assets and lease liabilities for leases of low value (i.e. approximate fair value of USD 5,000). For a complete discussion of accounting, see &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Right-of-use assets and lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception of a leasing contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#8217;s incremental borrowing rate. The lease liabilities are classified as current or non-current based on the due dates of the underlying principal payments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Lease payments generally are fixed for the contract term. The lease liability is measured at amortized cost using the effective interest method. The lease liability is re-measured if there is a change in the estimated lease term, a change in future lease payments arising from a change in an index or rate, a change in the Company&#8217;s estimate of the amount expected to be payable under a residual value guarantee or a change in assessment of whether it will exercise a purchase, extension or termination option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception, the right-of-use asset comprises the initial lease liability and any initial direct costs. The right-of-use asset is depreciated over the shorter of the lease term or the useful life of the underlying asset. The right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain re-measurements of the lease liability performed on as certain potential triggering events may arise (e.g. lease modifications). When the lease liability is re-measured, a corresponding adjustment is made to the carrying amount of the right-of-use asset or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_Kxd0F6zgJEqcgtdJ3shSmA_1_0"></a><a id="Tc_GHAm_gFpukaqSRTwzS83BA_1_3"></a><a id="Tc_mjD8oKGieUG0XopKwo2rMQ_2_0"></a><a id="Tc_qwYBJf73UkirDw-e8MLRyA_2_3"></a><a id="Tc_y8XuSblJ7Em1dXj3PqYAzQ_3_0"></a><a id="Tc_gf-0Wyim3USfFfxDca6fPQ_3_3"></a><a id="_c2a33482_52c5_4d96_8967_1333ff745b3e"></a><a id="Tc_KOGNbwyrv0GSF8QoyKPYSg_1_0"></a><a id="Tc_8zFFaKo24kmSqFIY6qYuow_1_3"></a><a id="Tc_o_40Dtxf7kemvQNrLFltHg_2_0"></a><a id="Tc_8vfobn18wEypLmkfYnXApA_2_3"></a><a id="Tc_39rErl8hh0K5u6vv7-uSjA_3_0"></a><a id="Tc_tXruEgN7FE-mWpLoiCZBdQ_3_3"></a><ix:continuation id="Tb_kWrgqHMI4E-AERaRyItnUQ_cont4" continuedAt="Tb_kWrgqHMI4E-AERaRyItnUQ_cont5"><ix:continuation id="Tb_j-2-iEGRSkq2eo06E8ATtg_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The estimated lease term by right-of-use asset categories are as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" id="Tb_rSFAXGobG0mW9eOGYEv7tQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Buildings</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_Wu9NkzJdPUaZrVXUx5z-UA" format="ixt-sec:duryear" name="aciu:EstimatedLeaseTerm" id="Tc_l6gA2bgxX0CyIIP2xWeEBQ_1_2"><span style="font-size:10pt;">5</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Office equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OfficeEquipmentMember_9AyXpdV_hkmm2dtMcUeW5w" format="ixt-sec:duryear" name="aciu:EstimatedLeaseTerm" id="Tc_6Al0dUJZUESDxv3fwrRybw_2_2"><span style="font-size:10pt;">5</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Ozer3KElnU6POId_CcOTBg" format="ixt-sec:duryear" name="aciu:EstimatedLeaseTerm" id="Tc_iVzKsYCaIUOHsiK6ZBpj6w_3_2"><span style="font-size:10pt;">5</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Both the right-of-use-assets and lease liabilities are recognized in the consolidated balance sheets.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" id="Tb_lcFyl4Tiq0mfLKr3RSfv2w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Equipment is shown at historical acquisition cost, less accumulated depreciation and any accumulated impairment losses. Historical costs include expenditures that are directly attributable to the acquisition of the property, plant and equipment. Depreciation is calculated using a straight-line method to write off the cost of each asset to its residual value over its estimated useful life as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" id="Tb_bHQ63vCDdkmIoEqzQlv_9w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Ozer3KElnU6POId_CcOTBg" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="Tc_776nTVusEEiFw67mRGEo1w_1_2"><span style="font-size:10pt;">3</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Laboratory equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_VKLmDDFNFkKleBMvIA9FfQ" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="Tc_yLm5tlCSh0q6N_zU4wselg_2_2"><span style="font-size:10pt;">5</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Leasehold improvements/furniture</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_Zmu3hDypz0e9GA3GfssWMQ" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="Tc_k7Gtlx8I7kKC8b8U-nGgrg_3_2"><span style="font-size:10pt;">5</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The assets&#8217; residual values and useful lives are reviewed, and adjusted if appropriate, at each balance sheet date. Where an asset&#8217;s carrying amount is greater than its estimated recoverable amount, it is written down to its recoverable amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Gains and losses on disposals are determined by comparing the disposal proceeds with the carrying amount and are included in the consolidated statements of income/(loss).</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" id="Tb_txXVR-n1CEykgzV8oZdNiA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune&#8217;s acquired in process research and development (IPR&amp;D) asset is stated at cost less any impairments. The Company does not deem this asset ready for use until the asset obtains market approval. Therefore, during the development period after the date of acquisition until market approval, the IPR&amp;D asset is not amortized. Upon market approval, the Company will determine the useful life of the asset, reclassify it from IPR&amp;D and commence amortization. If the associated R&amp;D effort is abandoned, the related IPR&amp;D will likely be written off and we will record the relevant impairment charge. Finally, the Company will not capitalize future development costs in respect to this IPR&amp;D asset until they meet the criteria for capitalization of research and development costs in accordance with IAS 38 <i style="font-style:italic;">Intangible Assets</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our IPR&amp;D asset is subject to impairment testing at least annually or when there are indications that the carrying value may not be recoverable until the completion of the development process. The determination of the recoverable amounts include key estimates which are highly sensitive to, and dependent upon, key assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company uses a discounted cash flow method to determine the fair value less costs to sell (recoverable amount) of our IPR&amp;D intangible asset. The Company starts with a forecast of all the expected net cash flows, which incorporates the consideration of a terminal value and then the Company applies a discount rate to arrive at a risk-adjusted net present value amount.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any impairment losses are recognized immediately in the consolidated statements of income/(loss).</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" id="Tb_HUQmUFo2w0evTvUZSQkebQ" continuedAt="Tb_HUQmUFo2w0evTvUZSQkebQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Fair value of financial assets&#160;and liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s financial assets and liabilities are composed of receivables, short-term financial assets, cash and cash equivalents, trade payables and lease liabilities. The fair value of these financial instruments approximates their </p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_kWrgqHMI4E-AERaRyItnUQ_cont5" continuedAt="Tb_kWrgqHMI4E-AERaRyItnUQ_cont6"><ix:continuation id="Tb_HUQmUFo2w0evTvUZSQkebQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">respective carrying values due to the short-term maturity of these instruments, and are held at their amortized cost in accordance with IFRS 9, unless otherwise explicitly noted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Receivables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Receivables are recognized at their billing value. An allowance for doubtful accounts is recorded for potential estimated losses when there is evidence of the debtor&#8217;s inability to make required payments and the Company assesses on a forward-looking basis the expected credit losses associated with these receivables held at amortized cost.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Short-term financial assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Short-term financial assets are held with external financial institutions and comprise fixed-term deposits with maturities ranging from more than 3 through 12&#160;months in duration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company assesses whether there is objective evidence that financial assets are impaired annually or whenever potential impairment triggers may occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents include deposits held with external financial institutions and cash on hand. All cash and cash equivalents are either in cash or in deposits with original duration of less than 3&#160;months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Trade payables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Trade payables are amounts due to third parties in the ordinary course of business.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" id="Tb_5mrLbQytm0GCdQJyq21Z2Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share capital and public offerings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Common shares are classified as equity. Share issuance costs are capitalized as incurred and will be shown in equity as a deduction, net of tax, from the proceeds received from existing or future offerings. Should a planned equity offering not be assessed as probable, the issuance costs would be expensed immediately in the consolidated statements of income/(loss). See &#8220;Note&#160;11. Share capital.&#8221;</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory" id="Tb_TOiAQ_sEN0CrkWR6dCyW6Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Treasury shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Treasury shares are recognized at acquisition cost and deducted from shareholders&#8217; equity at the time of acquisition, until they are subsequently resold, distributed or cancelled. Where such shares are subsequently sold, any consideration received is included in shareholders&#8217; equity. See &#8220;Note&#160;11. Share capital.&#8221;</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" id="Tb_8wRQY5EgqES2yY4bCcZaJw" continuedAt="Tb_8wRQY5EgqES2yY4bCcZaJw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Employee benefits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Post-employment benefits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates the mandatory pension schemes for its employees in Switzerland. The schemes are generally funded through payments to insurance companies. The Company has a pension plan designed to pay pensions based on accumulated contributions on individual savings accounts. However, this plan is classified as a defined benefit plan under IAS 19.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_kWrgqHMI4E-AERaRyItnUQ_cont6" continuedAt="Tb_kWrgqHMI4E-AERaRyItnUQ_cont7"><ix:continuation id="Tb_8wRQY5EgqES2yY4bCcZaJw_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The net defined benefit liability is the present value of the defined benefit obligation at the balance sheet date minus the fair value of plan assets. Significant estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. The defined benefit obligation is calculated annually with the assistance of an independent actuary using the projected unit credit method, which reflects services rendered by employees to the date of valuation, incorporates assumptions concerning employees&#8217; projected salaries and pension increases as well as discount rates of highly liquid corporate bonds that have terms to maturity approximating the terms of the related liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To the extent that the fair value of the plan assets is greater than the present value of the defined benefit obligation as calculated by our independent actuary, the Company accounts for the effect of the asset ceiling test under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Re-measurements of the net defined benefit liability, which comprise actuarial gains and losses and the return on plan assets (excluding interest) are recognized immediately in the consolidated statements of other comprehensive income/(loss). Past service costs, including curtailment gains or losses, are recognized immediately as a split in research and development and general and administrative expenses within the operating results. Settlement gains or losses are recognized in either research and development and/or general and administrative expenses within the operating results. The Company determines the net interest expense/(income) on the net defined benefit liability for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period or in case of any significant events between measurement dates to the then-net defined benefit liability, considering any changes in the net defined benefit liability during the period as a result of contributions and benefit payments. Net interest expense/(income) and other expenses related to defined benefit plans are recognized in the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates an equity-settled, share-based compensation plan. The fair value of the employee services received in exchange for the grant of equity-based awards is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the instruments granted, excluding the impact of any non-market vesting conditions. Non-market vesting conditions are included in assumptions about the number of instruments that are expected to become exercisable. At each balance sheet date, the Company revises its estimates of the number of instruments that are expected to become exercisable. It recognizes the impact of the revision of original estimates, if any, prospectively in the consolidated statements of income/(loss), and a corresponding adjustment to equity over the remaining vesting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Stock options granted under the Company&#8217;s stock option plans C1 and the 2016 Stock Option and Incentive Plan are valued using the Black-Scholes option-pricing model (see &#8220;Note&#160;18. Share-based compensation&#8221;). This valuation model as well as parameters used such as expected volatility and expected term of the stock options are partially based on management&#8217;s estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We estimate the fair value of restricted share units using a reasonable estimate of market value of the common shares on the date of the award. We classify our share-based payments as equity-classified awards as they are settled in common shares. We measure equity-classified awards at their grant date fair value and do not subsequently re-measure them. Compensation costs related to equity-classified awards are equal to the fair value of the award at grant date amortized over the vesting period of the award using the graded method. We reclassify that portion of vested awards to share capital and share premium as the awards vest.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory" id="Tb_WS7gneyR70aQGYmjCMJOPg" continuedAt="Tb_WS7gneyR70aQGYmjCMJOPg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Provisions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events where it is more likely than not that an outflow of resources will be required to settle the obligation, and a reliable estimate of the amount can be made.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_kWrgqHMI4E-AERaRyItnUQ_cont7" continuedAt="Tb_kWrgqHMI4E-AERaRyItnUQ_cont8"><ix:continuation id="Tb_WS7gneyR70aQGYmjCMJOPg_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory" id="Tb_Ue8KFD5BuEOpVQhKcPg9-w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Taxation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Current income tax assets and liabilities for the period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the tax amounts are those that are enacted or substantively enacted, at the reporting date in accordance with the fiscal regulations of the respective country where the Company operates and generates taxable income. Deferred tax is provided using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the&#160;year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date. If required, deferred taxation is provided in full using the liability method, on all temporary differences at the reporting dates. It is calculated at the tax rates that are expected to apply to the period when it is anticipated the liabilities will be settled, and it is based on tax rates (and laws) that have been enacted or substantively enacted at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized. Although the Company has substantial tax loss carry-forwards, historically, due to the fact that the Company had limited certainty on the achievement of key milestones, it has not recognized any deferred tax assets as the probability for use is low.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As disclosed in &#8220;Note&#160;16. Income taxes,&#8221; the Company has tax losses that can generally be carried forward for a period of <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" format="ixt-sec:duryear" name="aciu:IncomeTaxLossCarryforwardPeriod" id="Narr_5kt15i-T6UKV15TaoAVoMQ">7</ix:nonNumeric>&#160;years from the period the loss was incurred. These tax losses represent potential value to the Company to the extent that the Company is able to create taxable profits before the expiry period of these tax losses. The Company has <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt-sec:numwordsen" name="ifrs-full:DeferredTaxAssets" scale="3" id="Narr_SoEuX3Grh0y03C0i5WZDsg">no</ix:nonFraction>t recorded any deferred tax assets in relation to these tax losses.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" id="Tb_Vm4ysA5Gf0mcb3YIjLEZGA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Earnings per share</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company presents basic earnings per share for each period in the consolidated financial statements. The earnings per share are calculated by dividing the earnings of the period by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential dilution that could occur if dilutive securities such as share options or non-vested restricted share units were vested or exercised into common shares or resulted in the issuance of common shares that would participate in net income. Anti-dilutive shares are excluded from the dilutive earnings per share calculation.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" id="Tb_r9_t3pYhfEip7ZHJUA9ITQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Critical judgments and accounting estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The areas where AC Immune has had to make judgments, estimates and assumptions relate to (i)&#160;revenue recognition on LCAs, (ii)&#160;clinical development accruals, (iii)&#160;net employee defined benefit liability, (iv)&#160;income taxes, (v)&#160;share-based compensation, (vi)&#160;right-of-use assets and lease liabilities and (vii)&#160;our IPR&amp;D asset. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory" id="Tb_JHq8NfyNOUyTv7Fxf3mabg" continuedAt="Tb_JHq8NfyNOUyTv7Fxf3mabg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Segment reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has <ix:nonFraction unitRef="Unit_Standard_segment_9jTtSCng3EmNVBiAOMwlNw" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt-sec:numwordsen" name="aciu:OperatingSegmentsNumber" scale="0" id="Narr_6aEdC-5jD06U1rUgSxiaXQ">one</ix:nonFraction> segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_kWrgqHMI4E-AERaRyItnUQ_cont8"><ix:continuation id="Tb_JHq8NfyNOUyTv7Fxf3mabg_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is managed and operated as <ix:nonFraction unitRef="Unit_Standard_segment_9jTtSCng3EmNVBiAOMwlNw" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt-sec:numwordsen" name="aciu:ReportableSegmentsNumber" scale="0" id="Narr_AQYgmpEPE0mgk25SWbe4Ow">one</ix:nonFraction> business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. Accordingly, the Company views its business and manages its operations as <ix:nonFraction unitRef="Unit_Standard_segment_9jTtSCng3EmNVBiAOMwlNw" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt-sec:numwordsen" name="aciu:OperatingSegmentsNumber" scale="0" id="Narr_qYi4gEK4CEOeEbgB-0JzWg">one</ix:nonFraction> operating segment. Non-current assets are located in, and revenue is allocated and recorded within, the Company&#8217;s country of domicile, Switzerland.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" id="Tb_9jMhvq6Uhk6qxpdXhOMdfQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Accounting policies, new standards, interpretations and amendments adopted by the Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">There are no new IFRS standards, amendments or interpretations that are mandatory as of January 1, 2022 that are relevant to the Company. Additionally, the Company has not adopted any standard, interpretation or amendment that has been issued but is not yet effective. Such standards are not currently expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions.</p></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_1c5b8bed_6a4b_4a40_8977_7137d5f14906"></a><a id="Tc_0gc2NUfVfEOsOmEiFSc7Vg_1_2"></a><a id="Tc_UuiS0l2jvEyINXYqmfgPMA_2_4"></a><a id="Tc_pQj65LD4F0-FKNt7dy9oMA_2_6"></a><a id="Tc_2il0YF2ipUafLGEDaWX4mg_2_8"></a><a id="Tc_BnLjCMiuykKgWxM-3hKVfQ_2_10"></a><a id="Tc_vbuL18nA5kqUmn48VoziNA_3_0"></a><a id="Tc_J9NoJSkRDEuBu8BraHrtqw_3_2"></a><a id="Tc_hcLiVAWlb0S9YQt9wk-Jvw_3_4"></a><a id="Tc_yauCt7c7BE-OWUgMqIITYw_3_6"></a><a id="Tc_IlvG76VMpkqHeyg5TG_5xA_3_8"></a><a id="Tc_B4A1EIVvEkaPyppHVGWS0w_3_10"></a><a id="Tc_KLE4zNz4VkqHsB3KMAbxEg_3_12"></a><a id="Tc_mFJvPLmITEGbHSF1KdW_kA_4_0"></a><a id="Tc__DlFa90ce0iwMrbymd8oPA_5_0"></a><a id="Tc_xc82BWAGgEiPlQAhDt2isg_6_0"></a><a id="Tc_jxm4NocuhUubky2uV7IKGA_7_0"></a><a id="Tc_4JjLMIlEq0mi2ulDKHszfA_8_0"></a><a id="Tc_vP1D_Zwmik6sjfpd15084A_10_0"></a><a id="Tc_E5vn21rnjk6wFUjfqjmgCA_11_0"></a><a id="Tc_9jJ1R692zkyZaA-Ur9t3iA_11_10"></a><a id="Tc_pyI_HiZTT06Rd3wTEG2xtg_12_0"></a><a id="Tc_wUKGml8ygUuUwGevpw4fKA_12_10"></a><a id="Tc_FL-pbFWpe0C-FWg03qNZzg_13_0"></a><a id="Tc_K0fa198NM0SrRI0Flfw2Qg_13_10"></a><a id="Tc_UQ9hrlc1BE6dqnc1rNF_YA_15_0"></a><a id="Tc_S2aFDKbyQkWzJ8jQr9XOiQ_16_0"></a><a id="Tc_vr2Be0JWmk6P6cQT6ohzFQ_17_0"></a><a id="_f3fa9b62_869d_4eeb_a89e_7f2e72c7e950"></a><a id="Tc_tro_hd58YE6qEjTK4Ce0Ag_1_2"></a><a id="Tc_kaTVOOKb8U2SUi3hmAZ0Yg_2_4"></a><a id="Tc_4Tf25hVAd0OPZPZvgHcM2A_2_6"></a><a id="Tc_E_a7YGDzCkyBRNDNUmyS3w_2_8"></a><a id="Tc_7Jvpk2TtAUWkf0xNUKC2lw_2_10"></a><a id="Tc_Z0yFPJdU4UW91JmjzhecyA_3_0"></a><a id="Tc_g5qSMqqX906oKG9idgNI2Q_3_2"></a><a id="Tc_hgnQ9b_4ZEmUbUGZxpWwpw_3_4"></a><a id="Tc_Wcqv-BG0CUWSHAL6ETfhXg_3_6"></a><a id="Tc_L0Aaq9jy-Ee3e-_O-dk92Q_3_8"></a><a id="Tc_2F1u8eyh5k6Kfc0Q7ItQgg_3_10"></a><a id="Tc_wLKXZ3HfsUi5cHv4BIeAHA_3_12"></a><a id="Tc_sij1VC5lw0Ge_f6cBZAwZw_4_0"></a><a id="Tc_jSxYbAf2P0ORg9uqLPPNgw_5_0"></a><a id="Tc_u0X2_GYW1EaVyFaF16-UPg_6_0"></a><a id="Tc_HKdVK0gIX0qjRHtEDz0XXg_7_0"></a><a id="Tc_Jd9gH4dXiE24ONemYDLcig_7_2"></a><a id="Tc_wOXwC1cRWEaMix0KtQjztg_7_8"></a><a id="Tc_zBifE4Ob2ky2nGibL1OvpQ_7_12"></a><a id="Tc_4XaXePQGDUKColFnf_Sp4Q_8_0"></a><a id="Tc_KB-t1uLXAky6EdnAIAUdeg_9_0"></a><a id="Tc_m7tMbz4c8k2KnUzOAVfalQ_11_0"></a><a id="Tc_EMoHOfKYUUabTqyTP1po9g_12_0"></a><a id="Tc_zabXZqEVfEe9vo_Oh8V4_A_12_10"></a><a id="Tc_mBOfLA6I80Of0643MBglbA_13_0"></a><a id="Tc_QulPB24NY0KemIU-cxGBuA_13_10"></a><a id="Tc_yQom3AvqO0SyGHl7xEoM7w_14_0"></a><a id="Tc_Gl57G1ebU0yqR6YIZtSkZA_15_0"></a><a id="Tc_xc5yYmUbdEy6smnE4ewd-g_15_10"></a><a id="Tc_3qyYLifxpkezD4if2tK26w_17_0"></a><a id="Tc_LSSOvA5nGUy_7MO7wOFqvw_18_0"></a><a id="Tc_-jlPTJW9N0CekVOrbY7hqA_19_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory" id="Tb_A_wfoBWaTUOP4cScMwFkiQ" continuedAt="Tb_A_wfoBWaTUOP4cScMwFkiQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">4.</b></span>Property, plant and equipment</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" id="Tb_AEOLhy4R-E-4o9Kwo3bUdQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables show the movements in the net book values of property, plant and equipment for the&#160;years ended December&#160;31, 2022 and 2021, respectively:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Laboratory</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Leasehold</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets under</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">improvements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">construction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquisition cost:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_hqctdwrQN0uGHFmoDmoBSw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_VrcbeYaGdEKrOECL2G87zQ_5_2">265</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_6aK9qrKczkWLN0-zGicz-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_MHMt6R1VRkGyFgWQGPBFfQ_5_4">1,754</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_83P7y6bpZ0ylYnfrkgwFyw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_3d-7V_zJqESIADRy0Id8uA_5_6">9,142</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_JOWNVGG_6E2-S4NAWhBdqw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_6jjX2zxTIky0eLgiZ0n3MA_5_8">810</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_5w-XoX-NLkKHmafT1-bTSA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_tH34vYA4ykKWSEvkjJjHLA_5_10">695</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_tvR74klj-EuU1efHxw9Lag" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_Edlg30mI_EK6u6DUc4hyjQ_5_12">12,666</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_sn3ARiGlaESnktZbl7jycA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_yFzLefc8G0GAFoaSEq84cA_6_2">20</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_-BoX8YxE_EaZXZMovx0g2A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_Aytzubu_xkqstpG2MNlu2A_6_4">151</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_1wINY-2riE6PzcI88FzqMQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_MqPRKUkMQkW7HOYrxqTrYQ_6_6">576</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_3oznLzHXWUmnOSp1oShnUQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_3fEpXa82nkSFoVW9-voifQ_6_8">184</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_w37wZNsSyU6H8HKH0QpE5A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_rgbRUvNKcUOi6A3b2xFY1A_6_10">5</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_M05pHmbc10iqCZT547GuuA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_6j4OwFmtok6tHrSrkHDd1A_6_12">936</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Transfers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_sn3ARiGlaESnktZbl7jycA" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="3" id="Tc_HIegY4VcjUC_VxY5BXAliA_7_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_-BoX8YxE_EaZXZMovx0g2A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="3" id="Tc_paP2oN2rKkmzdczytIh0RA_7_4">4</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_1wINY-2riE6PzcI88FzqMQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="3" id="Tc_MjZi7j9r-0CvW8KFhWfAlQ_7_6">47</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_3oznLzHXWUmnOSp1oShnUQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="3" id="Tc_z3jZqw8BsU6UZZoin1u6Gg_7_8">646</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_w37wZNsSyU6H8HKH0QpE5A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_AYUgaVPIuECw2tULEyk-Bw_7_10">697</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_M05pHmbc10iqCZT547GuuA" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="3" id="Tc_8tz4HS4GE0W_ioJzzM9JhQ_7_12">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember__8JB9cGo30u4RAuroNxHDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_Jd7qI6tei0OD9SihKZ7sXA_8_2">285</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_nA1-BCOTy0m_IaGz1dZgKQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_UlqeueFcuk6mUvuKp4l7LQ_8_4">1,909</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_U0WcEJ-m006w1FYFbGzFkg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_wbKnAb-j9kaLhulv2dNXsQ_8_6">9,765</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_cOXYr6K5yUCrOP0RZAWdQA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_raJKBzdZwE28wtqyIMKusw_8_8">1,640</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_8IXKK-Pok0S7I58W7DYXDA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_oYhk6VVthkKtePyw1UQ2MA_8_10">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_9SsycfPkpUG2RWbLatkFMg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_n6SedwwhLUqs-jIzSHHV2g_8_12">13,602</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_ue4pbGVEbUiq7HJx_qTxVA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_hnA5lQL96kysBPnJ3XDHzA_11_2">106</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_pC0gtLj5kE29rdJ-dYf0BA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_zwnKc2bbqEWXM_sJdHMAyw_11_4">1,316</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_GKWsPI-X0kGuJ_LvETs99g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_EcurSRdFwE2hi4S-54Yjtg_11_6">5,739</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_imtm7cUr8kaCmHg-oP5Uew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_AF-4NBs0v0KWvTP7g5TZ8w_11_8">389</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_nL6LiSdtTEm6pKYWuxJXrQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_pfFv00GopEmmoAfQgvL9mw_11_12">7,550</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_IvbcDwQUuEm16jkIYakaCg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_YK6ec9H6bEi7yCcjGZ0mMw_12_2">53</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_v887EZj_rEmNcfMBDtK6TA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_g0LNC66p6Uq6D8VJRw9eMQ_12_4">283</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Jvt1fjwr5USz9GJD5wEKOQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_AlskLzatS0eBHbOmt-mu1g_12_6">1,278</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_o09LprTCLE6hH9f1Mj3oqQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_pgXMuLq9m0Sg1c8aV8Ecjw_12_8">179</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_-tmtXopEr0G-p32hjhwk6Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_K-6oZ_C15kyiJ5C_ggyG-A_12_12">1,793</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_kGz2G5hG2EuGvNwjXNMtGA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_2wu1nkgYM0u6exQDCTMjOQ_13_2">159</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_kqXlzseNsUiz1AZXFdEaQA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_E1xEsVJL20ei7la6wNriZA_13_4">1,599</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_mXP7xiRLEUu8xic9Xuihlw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_nzxJfSJwrkWMAVp_269d2Q_13_6">7,017</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_t0ttw0E3hEGRszBl1CyKPw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_7jwVYGypskyLGJhc1kiFLA_13_8">568</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_VCafjbK1YkmLYTpqX9O2Qg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_GszK_ctfpUuqJ1Qo2P73Pw_13_12">9,343</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amount:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_gixeq8TJOUiwQnCqzoWt6w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_PO4f66Stx0SnpAhcWFcmtg_16_2">159</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_SVIwZpKI3kGqF_IYNCWEhg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_S6ZzXXvFYka6KYiwikUQtQ_16_4">438</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_j5TopbyK0kGaK2cIgBD9LA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_1_DYdtYySEKEwiNF4qJLdQ_16_6">3,403</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_gFCLb69mDUaqMTblzP_RkQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_cE3-Hr_CFUmqdcJEXXYzpw_16_8">421</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_nVWm-PIICk2ruKe56loHrQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_THGTVeieaUmZfcOnPZ1cUw_16_10">695</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_adIBrbuiOk2yEv2kYHxe-w_16_12">5,116</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_6conGXdyckSywzGr6GYvYw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_eRzIWfwQQE2686h4DIxVFg_17_2">126</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fhXMqa9W-EWHXNdjUYd4iQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_G7ToucfHlEublfuXvoItlg_17_4">310</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_W-8vm1symkWu1TlXlu9m7A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_Eo-7Qaq2J0Wko5JLFU6ZDA_17_6">2,748</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_aJviOm4nfE-pOaFV9E4vvw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_hPo506_kXkCosJzhh67i3Q_17_8">1,072</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_TH62pZBB7kqAgUulrAHeSg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_KJY8Rcn0nUKMQueC2Y_0Ig_17_10">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_t0uMbLxOAkqdszXhVVv7Gw_17_12">4,259</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Laboratory</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Leasehold</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets under</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">improvements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">construction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquisition cost:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_yBmrsz9Gz0-30C8ID2gxpA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_X-GAMaHq6kWcLQyRHSnOHg_5_2">214</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Hnlt3D1SKEW7_IrRvWNKhg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_t3zSwJQVV0-looJCSeYsUQ_5_4">1,497</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_omADz3BlkU228JQA39U9eA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_yKbal18FNkicZ31vKOOkwQ_5_6">7,681</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_k8dVeftSAkW4_0WfOoafTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_kLq3pjNbpkuLBRn8mABkeA_5_8">464</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_624VtAuprEmOudOGdH0CPQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_C0uawgasD0q-5GGLwAEbFg_5_10">277</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_at5lR_LjGEWOpLXOSdQYAQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_1pGAXRvCXU62pv3hlM2zeQ_5_12">10,133</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Mexed_kNUESyEPioMdSpUw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_qFq-_Xu3TkqKM5JD03CbBA_6_2">51</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_OgqSUQcKz0SKU75eNdUCVQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_H1IlR89X1Ue2OkWZuXJSLQ_6_4">250</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_amPvhMdQjUCNH0XSkOd83g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_GTaGQKEcaU68Pvg0IXqPMQ_6_6">1,268</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9ZTaVEBXDUiyQ4EQFRSYhQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_sr_cg99CCUGLJRGfLYU4zw_6_8">346</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_BknOUverm029TXOB6lUTWA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_rgWJAqmREEGNOydsYATUvA_6_10">695</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_aBSKY_-UsUGANDeuLjypnQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_v3ZP0VR6qkm8yVqY6-Te5A_6_12">2,610</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Transfers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_OgqSUQcKz0SKU75eNdUCVQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="3" id="Tc_vTyH8sOFqU2MTVEC6A94xA_7_4">7</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_amPvhMdQjUCNH0XSkOd83g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="3" id="Tc_TCsaU2mC1ECcOyoPPV9Ang_7_6">270</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_BknOUverm029TXOB6lUTWA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_oV-yiim1e0aw-nAvfA_yOQ_7_10">277</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Disposals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Mexed_kNUESyEPioMdSpUw" decimals="-3" format="ixt:zerodash" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_60Pl1ZJOWU-gu-y3IZ7vig_8_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_OgqSUQcKz0SKU75eNdUCVQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_BqH0Wx7Tmka0GWc6E_6_Pg_8_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_amPvhMdQjUCNH0XSkOd83g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_eFpEVWwBHkCOb9-zkUNlcA_8_6">77</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9ZTaVEBXDUiyQ4EQFRSYhQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_4tK3BOSJDUKVuoNpD-esaw_8_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_BknOUverm029TXOB6lUTWA" decimals="-3" format="ixt:zerodash" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_1KPdZ1-BjkCCtnNJrjcUAg_8_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_aBSKY_-UsUGANDeuLjypnQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_DTRtvMJGO0GGTUFx4-WnCg_8_12">77</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_hqctdwrQN0uGHFmoDmoBSw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_ZxGFKcdR1E-XDIyfKb6Ptw_9_2">265</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_6aK9qrKczkWLN0-zGicz-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_YuDeMgwD7ES1PRvozlpCqQ_9_4">1,754</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_83P7y6bpZ0ylYnfrkgwFyw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_E3sSdMV61ESPF1dc80Pvsw_9_6">9,142</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_JOWNVGG_6E2-S4NAWhBdqw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_mU1cvS5gmEuzjqFirkpHaw_9_8">810</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_mkfTmtvQQUWvXn7SCNipKA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_PftQmIGR2US3PCch7cl0zQ_9_10">695</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_tvR74klj-EuU1efHxw9Lag" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_GLFrmFYgI0etsWWKmdAorA_9_12">12,666</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_9-9lvpw-wEGlSeFf0lhfgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_49Q1PxBXfUyqmwAhvBuE7g_12_2">61</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_rNFrcrnlfke5jyKkmnfYew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_1EcOZ-A3vESorH9JE056cQ_12_4">970</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_U-F3h1Ni3kikwgDZTjR8Ag" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_4oYDLY5YvUuhbCVTcmlVng_12_6">4,405</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9GjiWU9dvUSudZWJ_vB8OQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_y30Sd1vVMEuhnaC_dC7Hvw_12_8">281</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_Q_e4dEXGxkup2NsrXRT1FQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_7WN4J3-Olk6g3eCoVeUXoQ_12_12">5,717</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_hZnR1ixhfkeMTt56nYyaxw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_8Pkir6A0rUCz0czCXoxORA_13_2">45</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fkSn02nK3EO6v-wrUGc0vg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_KBTmZFqxkUSfXoWMV3OHVQ_13_4">346</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_X7iW-2Dlq0SBvALqlsP7Iw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_qar8h0ofKUWH_Tvk9Bec8A_13_6">1,398</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_E57IJ4sHdEW4PL45jFGApQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_aAC69eBiiEG_qKfPFbin5Q_13_8">108</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_XIymoY2OjEyn8SkwhnAMgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_VWCzuxOQA0OEZpqme-unYw_13_12">1,897</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Disposals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_hZnR1ixhfkeMTt56nYyaxw" decimals="-3" format="ixt:zerodash" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_-ZZH9KMqC06S32CM26DVqg_14_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fkSn02nK3EO6v-wrUGc0vg" decimals="-3" format="ixt:zerodash" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_nMDtKQuZ90i4Z81dYA_89A_14_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_X7iW-2Dlq0SBvALqlsP7Iw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_SUlGOyK_AUadSnHyp4dcTw_14_6">64</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_E57IJ4sHdEW4PL45jFGApQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_xYSEsf_ykk-ZiGb1kMIwGw_14_8">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_bdfGLGB28E2kpb5ujlICfA" decimals="-3" format="ixt:zerodash" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_TAAivu6syUCX6nX-Q-fxrQ_14_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_XIymoY2OjEyn8SkwhnAMgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_N144x_P_9kiCVjLARfpsnA_14_12">64</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_ue4pbGVEbUiq7HJx_qTxVA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_kKgREdpylEuxUYbVxpyE6A_15_2">106</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_pC0gtLj5kE29rdJ-dYf0BA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_EDbCA0zbUEiybOZKXtvr3A_15_4">1,316</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_GKWsPI-X0kGuJ_LvETs99g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_S8Wyn8m0gkG3sf46SZL_dQ_15_6">5,739</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_imtm7cUr8kaCmHg-oP5Uew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_BVCDzKZqV0aNBMV8LWzM-A_15_8">389</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_nL6LiSdtTEm6pKYWuxJXrQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_XsUkNnb3-Em-T_flmYSKcg_15_12">7,550</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amount:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Y1uZQ6hoDkCelbD4WC21cw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_rpnYsHbpWkCJb6dxnTV_Qw_18_2">153</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember__RC_i4sK7Eajf16KAEb9Lw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_gHoXSP8v8EqOzpGQsW2-AA_18_4">527</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_TY4Gkd3GwUKatV9IO3cpXg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_D9J35jF8yUeFM5Ay2kxhMA_18_6">3,276</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9sg6mWi1F0CGpbkEmid_yw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_jdiST5zCaU6XNtFmeXjisg_18_8">183</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_MiutPukQMU-yrYKpy0R5CQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_Ch_O-1gHPUyiS8O9ZLO_Iw_18_10">277</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_D6sYlwJ1K02nmv393EYbYw_18_12">4,416</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_gixeq8TJOUiwQnCqzoWt6w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_GJNJTyFyO0KIsoRxboqprw_19_2">159</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_SVIwZpKI3kGqF_IYNCWEhg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_8S8K9kYZlEGiWd9nxb3RVA_19_4">438</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_j5TopbyK0kGaK2cIgBD9LA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_mo9nHhquXU-jv-ZREd92vA_19_6">3,403</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_gFCLb69mDUaqMTblzP_RkQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_pMu-_KhqK0iMdedO4St3SQ_19_8">421</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_IQoL60CqzUKkayULIGl1UQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_V1fqgjUgUECZsLFv3x9V5g_19_10">695</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_lqjClVXbokG9NhC9AUxaTw_19_12">5,116</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune continues to enhance its laboratory equipment to support its R&amp;D functions. This effort has continued for the&#160;year ended December&#160;31, 2022, with CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_VKLmDDFNFkKleBMvIA9FfQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="Narr_a8oHZ1OWFEC0FPY8ddgasA">0.8</ix:nonFraction> million invested in lab equipment, including the expansion of our leased lab space, and IT equipment, representing an increase of <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_VKLmDDFNFkKleBMvIA9FfQ" decimals="3" format="ixt:numdotdecimal" name="aciu:PercentageIncreaseInPropertyPlantAndEquipment" scale="-2" id="Narr_RfIsmD7ad0-ahHKd7rLoOg">7</ix:nonFraction>%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company incurred CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_-tmtXopEr0G-p32hjhwk6Q" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="Narr_mWggt8_yQUGEP8szc_aH_w">1.8</ix:nonFraction> million, CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_XIymoY2OjEyn8SkwhnAMgA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="Narr_OTX8lKcNVUyBOd8AiL363A">1.9</ix:nonFraction> million and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_AmEhYNpaWkGu_syMP9yeMg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="Narr_MTph0V8YuUOUh9iaijNE5g">1.5</ix:nonFraction> million in depreciation expenses, respectively.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_A_wfoBWaTUOP4cScMwFkiQ_cont1"></ix:continuation><a id="_fee1e3ce_8645_4a9a_ab6d_58b848b7d83f"></a><a id="Tc_Itd0QegNLkGVP4gCvbgyWA_1_4"></a><a id="Tc_9n9YzZK4VUedkL7DiYTx1g_1_6"></a><a id="Tc_S113oiKGSEmCAuY2YHYaEA_2_0"></a><a id="Tc_v-8FbN-h5UGb7LAIT8DW0w_2_2"></a><a id="Tc_U1i-Dm6NJ0eofO8crV2lww_2_4"></a><a id="Tc_IZj4zTq7k0yCEsChdjge9Q_2_6"></a><a id="Tc_FpvYlt5XA0Os37L-q4AhAg_2_8"></a><a id="Tc_vygm0S0mRkyoM-bV984Ggg_3_0"></a><a id="Tc_stMQxP9A-kuaXYH8FcyBrw_4_0"></a><a id="Tc_ar4BPP78N0-rd_Tia5Rp8Q_5_0"></a><a id="Tc_R_YR6SpAOUWDUaZyoQo_bQ_6_0"></a><a id="_34e1da34_00dc_41b9_8d2f_461e287b5847"></a><a id="Tc_nYJgt3wBg0GBbJsXQtFo9w_1_4"></a><a id="Tc_luHQMmlce02gQbB_C--zng_1_6"></a><a id="Tc_vIuwT8HHIk2vvLcEMFYxig_2_0"></a><a id="Tc_ORQjTJbNQEy6YmwtmhSC2w_2_2"></a><a id="Tc_8TS1hxfPJ0SC_w7dxrN2wA_2_4"></a><a id="Tc_n4f1oHDy5kWp8jDJXhJqkA_2_6"></a><a id="Tc_f7GL7nzizU2JgMVDoGx79w_2_8"></a><a id="Tc_DFkH-gKaS02NTbGgCNhTzg_3_0"></a><a id="Tc_cKjaIogWMEGmADcNBDxy8w_4_0"></a><a id="Tc_oq-ox-h5tUGmfsLQLldr6A_5_0"></a><a id="Tc_dOabxqjp406e2PSo10gy8g_5_2"></a><a id="Tc_UjNRbUkzvU-dTnPdJPoOFw_5_6"></a><a id="Tc_UgsUQeIFz0eo_sOo8tKdAQ_6_0"></a><a id="Tc_XdQzlRlOW0an4_8c_vAE4g_7_0"></a><a id="_a3a6db8e_cb85_4941_b7bb_7fd329480864"></a><a id="Tc_uFDpDKoKAkWA6X9RijxKJQ_1_2"></a><a id="Tc_oa2qZGZkXkeWaeXKC9bmjA_2_2"></a><a id="Tc_wi9NgCbP6kiHcr89-zQE2g_3_0"></a><a id="Tc_TJX-Bv3dP0WjLiKzt4eI4Q_3_2"></a><a id="Tc__N0dBpNw-EKyLlZPsgyxXg_3_4"></a><a id="Tc_2frc2aSeu0SDgS_PchX9FA_4_0"></a><a id="Tc_U4kvNg5RC0KqZFLsPIB-4w_5_0"></a><a id="Tc_Atnrkt9OzUep3y0UzO0euw_6_0"></a><a id="Tc_W9SQ93a9ZEK3FS1bWye0MA_7_0"></a><a id="Tc_BrmmVRug_0Wi0LxuLzl-rQ_8_0"></a><a id="Tc_aMLzeBBem0ew85I_Amhe9Q_10_0"></a><a id="Tc_bWRJTCW1v0Go-E5y9arkgA_11_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfLeasesExplanatory" id="Tb_0EodyhH9o0WY4TilYe4pfA" continuedAt="Tb_0EodyhH9o0WY4TilYe4pfA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">5.</b></span>Right-of-use assets, long-term financial assets and lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company recognized additions and remeasurements of right-of-use of leased assets for buildings or for office equipment totaling CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="6" id="Narr_FIp5qixj4UG9Gcba9J_vXA">0.5</ix:nonFraction> million and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="6" id="Narr_wlNsA65W00myre8ZLtEJSw">1.2</ix:nonFraction> million for the&#160;years ended December&#160;31, 2022 and 2021, respectively. In 2022, these increases are predominantly associated with the remeasurement of our leased office space.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Regarding lease liabilities, the amortization depends on the rate implicit in the contract or the incremental borrowing rate for the respective lease component. The weighted averages of the incremental borrowing rates as of December&#160;31, 2022 are <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_bV6SNnGs5EKwPEWegvAkHA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_N8krS655BEKavcUz9_7Lcw">3.5</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_P-n3rHIzjEG1HspwzCx_Og" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_hIxAwPAl3UeMrPVIYQ9K_w">2.5</ix:nonFraction>% for 2021) for buildings, <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_AwHLCp1Cek68-TW5KoaDqA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_7Pf-7Cg-cE28PjXr_YS8FQ">5.3</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_IESnhrGhEk-QtuGTRv7ddw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_aNKr_jo9jUS8EvMwHoFD-g">5.3</ix:nonFraction>% for 2021) for office equipment and <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_8Nxn7kPDD0muRctLMCmLRQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_WVGuh67xVkqKIM6ir71uYg">2.6</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_NSSv8GcEaEejbU2PgDrGqw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_UXzXmz3G6UGrVWhm9ZOnig">2.6</ix:nonFraction>% for 2021) for IT equipment.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" id="Tb_3x1W27H1cUGjqeg1VxjdKw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables show the movements in the net book values of right-of-use of leased assets for the&#160;years ended December&#160;31, 2022 and 2021, respectively:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Office</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_P-n3rHIzjEG1HspwzCx_Og" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_NRgL1j08dECBh2E5e19zCQ_3_2">2,776</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_IESnhrGhEk-QtuGTRv7ddw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_Mu3BItdYEUK__oNIpsK9Ww_3_4">98</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_NSSv8GcEaEejbU2PgDrGqw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_aoVd0jlTIEuGbZbTZ142HA_3_6">40</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_NaJkhwjyT0OhjpXLEyUBUw_3_8">2,914</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions and remeasurements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_EjvNM_4FNkWLoJE65UD5VQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_umGhIgReAUCq3ULy3hylSw_4_2">460</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_EEXqAl-oB0aAgMV2CcairA" decimals="-3" format="ixt:zerodash" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_-b92U9XPmUe6VEi4T_aUuQ_4_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_1pD5gJTd5k6uFaeNrpHvig" decimals="-3" format="ixt:zerodash" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_kw6RS0j4f0yqq6Jxf8o3WA_4_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_WMF8yvwu6kKLQpmOTnftxw_4_8">460</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_EjvNM_4FNkWLoJE65UD5VQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_AX1_A6z9fE-7pKcfPrsPlg_5_2">528</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_EEXqAl-oB0aAgMV2CcairA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_xcpVk52eFEeAC9FOHBYMig_5_4">24</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_1pD5gJTd5k6uFaeNrpHvig" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_xlJPyhTIyU-5Cp38uk9grg_5_6">14</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_lhvg5h5jAESxHn6cA06a2A_5_8">566</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_bV6SNnGs5EKwPEWegvAkHA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_jhA1veOwy0ehuA9yaSl5dQ_6_2">2,708</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_AwHLCp1Cek68-TW5KoaDqA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_L2I3YTQBYUuUrrymjwwv9g_6_4">74</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_8Nxn7kPDD0muRctLMCmLRQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_7ZEZztBg5EuYXRPMnTnbgQ_6_6">26</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_Z7rmoIyuQUmOBD1Ysx4V2A_6_8">2,808</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Office</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_YRhyIua2j02nlUUm4X31Sw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_nZA-hHRD9UWsRfT32Im2-g_3_2">2,106</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_UeTtu2AuZkiuL6oBS69STw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_88kEY0Yya0e6kR-AjDcWYA_3_4">63</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_wQPmFr31yUS_jOij507kbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_vMC3kJdUMkifILAUjXT0jQ_3_6">54</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_gB9yIbrzZU6VYsRj7CnUVA_3_8">2,223</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions and remeasurements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember__-gTB9L7ZEG7ut5ju4_TaA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_ClW-S6EJZEOyAZxhQQ-khQ_4_2">1,144</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_LgP-ND0OA0CGPBZ4f_J4DA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_l7EQeaaf206-3Ki6SFEZ8g_4_4">71</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_mo8rLVJA4Uq7FhG33cplbQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_P0LMM3FolEaA_Sr8jR3Dsw_4_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_Iws6tlZuj0qxEa2XyBNuQQ_4_8">1,215</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Dispositions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_LgP-ND0OA0CGPBZ4f_J4DA" decimals="-3" format="ixt:numdotdecimal" name="aciu:DispositionsOfRightOfUseAssets" scale="3" id="Tc_2d_uKV-GtUyPxM9FTBIuTA_5_4">15</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:DispositionsOfRightOfUseAssets" scale="3" id="Tc_Q4sEEy_0t06oGiy8lBXktA_5_8">15</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember__-gTB9L7ZEG7ut5ju4_TaA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc__7eigLo5XUaVvpjTpncMHA_6_2">474</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_LgP-ND0OA0CGPBZ4f_J4DA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_8ZuoYibKbEypt7KX6D4Y_w_6_4">21</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_mo8rLVJA4Uq7FhG33cplbQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_vOlOPyzULU6279ZSAy34hQ_6_6">14</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_1LvUL4e3ME2HMiAVt1izjw_6_8">509</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_P-n3rHIzjEG1HspwzCx_Og" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_0lcizEg-iUyro0ESZJtm1A_7_2">2,776</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_IESnhrGhEk-QtuGTRv7ddw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_egWqfXBjX0iXTOBM3unrSQ_7_4">98</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_NSSv8GcEaEejbU2PgDrGqw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_hv70Stad4k6s5HC8kf6JHA_7_6">40</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_BYR-Id2wQU2NY_kJrr8fOw_7_8">2,914</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" id="Tb_TzN4NnkGsEWj6w_OMbFVXA" continuedAt="Tb_TzN4NnkGsEWj6w_OMbFVXA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;years ended December&#160;31, 2022, and 2021, the impact on the Company&#8217;s consolidated statements of income/(loss) and consolidated statements of cash flows is detailed in the table below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Statements of income/(loss)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation of right-of-use assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_so3VFZXgl0WoL2MxRSTC9w_5_2">566</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_jRL9H_oqHkSe5NcV1CEadg_5_4">509</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest expense on lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="Tc_Sqn9xnxsM02eDnuj7ZumAw_6_2">68</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="Tc_KZBtanU9jUe2vsXLVUkyvA_6_4">63</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expense for short-term leases and leases of low value </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" scale="3" id="Tc_PeaBqcJt-kaozJllxR-GNA_7_2">750</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" scale="3" id="Tc_1h50MezXl0qOrOudiG7k7g_7_4">723</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="aciu:ExpenseRelatingToLeases" scale="3" id="Tc_6ITzFlqIXE6yCLMOufdlaw_8_2">1,384</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:ExpenseRelatingToLeases" scale="3" id="Tc_jJ7a_MjRakmrMJFswzVhzQ_8_4">1,295</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Statements of cash flows</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total cash outflow for leases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashOutflowForLeases" scale="3" id="Tc_jMpimJHyFUKgR5cdz1hZuQ_11_2">1,388</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashOutflowForLeases" scale="3" id="Tc_YkzUMvOFUkStaIOWpu9RaA_11_4">1,299</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-20</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_168ad3cd_f1de_4d3d_a673_6462d565b868"></a><a id="Tc_kPghpeeqOUOevR_mx4F92A_1_2"></a><a id="Tc_Lk2kKm65bEuBwFpzsqONeg_2_2"></a><a id="Tc_qU9G8PUJEEeIA17hJOXvxg_3_0"></a><a id="Tc_KeplgT4ySkGaEUpcFmEdgg_3_2"></a><a id="Tc_env0JUAchU2LYZu7kvM1KQ_3_4"></a><a id="Tc_UahaymzAXE-KfzcWwSZG3Q_4_0"></a><a id="Tc_zj3Ougzk0Empwszf3lEJnA_5_0"></a><a id="Tc_TpRgCGivj0OeZo13VLZLNQ_6_0"></a><a id="Tc_DbjDK_4M5EKbgAkN3tcw5A_7_0"></a><ix:continuation id="Tb_0EodyhH9o0WY4TilYe4pfA_cont1"><ix:continuation id="Tb_TzN4NnkGsEWj6w_OMbFVXA_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" id="Tb_Xl3q1d-0EkWXx0yyD2k9vA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table presents the contractual undiscounted cash flows for lease liabilities as of December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Less than one year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_-yIL5uUOREqnWUjN-WEKug" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_-MvLZYXC7UOWAL-MgzGRbg_4_2">638</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_IDSltZ9zlUuxs8MqNPseTA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_Cr6Y6hafL0GiLFWfTCq0rA_4_4">638</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">1-3 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_3B9uzJLVRE-wKxtJvPSkOg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_-C4V_yfO0U-3ChIFW9xgyA_5_2">1,230</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_93lXqdNkAkGE1eTi254vCQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_Qogy4zxgREWwaVz8NREgIg_5_4">1,260</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">3-5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_Aq4Gh5QzC0O-z-Hkxgg7bw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_XlOzdJlZ30mD8FR0t5aZyw_6_2">1,187</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_EG_KIXGerkW5heSXWG1y5Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_ru9U41tS90SJdxL5Dm7AuQ_6_4">1,203</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_cFy6uE7XU0-O26lG3kJGXg_7_2">3,055</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_Rmgpp10UuU-uaiUP9-0ZwA_7_4">3,101</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company also has <ix:nonFraction unitRef="Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfDepositsInEscrowAccounts" scale="0" id="Narr_YseDLFMFpUGiVgxQ86EwHQ">two</ix:nonFraction> deposits in escrow accounts totaling CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-5" format="ixt:numdotdecimal" name="aciu:EscrowDepositAmount" scale="6" id="Narr_HJoKn331BUyOeyB7Bbw8IA">0.4</ix:nonFraction> million for the lease of the Company&#8217;s premises as of December&#160;31, 2022 and 2021, respectively.</p></ix:continuation><a id="_f79381b7_d143_4c58_b45d_26a5c5b56a0c"></a><a id="Tc_ew2ucPtI2EiRCbpcuBwfqw_1_0"></a><a id="Tc_CdxHJ60KwU-e44fyO_udEg_2_0"></a><a id="Tc_1LcYk3mg3ESuEqL_GQyhtg_3_0"></a><a id="Tc_CZWYvXxOpkGy_ykB2yxLUg_4_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfAssetAcquisitionsTextBlock" id="Tb_gva7C9vLE0ucMcfamAdkHg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">6.</b></span>Asset acquisition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2021, the Company closed its acquisition with Affiris AG (Affiris) for the program portfolio of therapeutics targeting a-syn, notably ACI-7104.056 (previously PD01), a clinically-validated active vaccine candidate for the treatment of Parkinson&#8217;s disease (the Transferred Assets). The Company acquired the Transferred Assets and USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA" decimals="-5" format="ixt:numdotdecimal" name="aciu:CashAcquiredAsPartOfAssetAcquisition" scale="6" id="Narr_RUxMdWLTqEi9IImfsGnP9A">5.0</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA" decimals="-5" format="ixt:numdotdecimal" name="aciu:CashAcquiredAsPartOfAssetAcquisition" scale="6" id="Narr_cxxEyz4flkuZb7niT00X0Q">4.6</ix:nonFraction>) million in cash in exchange for <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_QuVxNqREZ0mnvgP8iz8Hbw" decimals="INF" format="ixt:numdotdecimal" name="aciu:SharesTransferredAsConsiderationInAssetAcquisition" scale="0" id="Narr_N5c23Ijv1k2vh950ZEteeg">7,106,840</ix:nonFraction> shares of the Company at closing, for a total value of USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA" decimals="-5" format="ixt:numdotdecimal" name="aciu:TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" scale="6" id="Narr_Br9iDBJtK0u4UrNEloupQQ">58.7</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA" decimals="-5" format="ixt:numdotdecimal" name="aciu:TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" scale="6" id="Narr_bIreZjyfdEqmWsLs7ZBKyQ">55.1</ix:nonFraction>) million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">With the closing of this transaction, the Company recorded an IPR&amp;D intangible asset associated with ACI-7104.056 for USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_BZyLB7dngU2QjWI8noII-w" decimals="-5" format="ixt:numdotdecimal" name="aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition" scale="6" id="Narr_xnnzh4zyH0W6EvjxROZNQA">53.7</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_BZyLB7dngU2QjWI8noII-w" decimals="-5" format="ixt:numdotdecimal" name="aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition" scale="6" id="Narr_H1FzRuc_BUOmmLQdSq3Lsw">50.4</ix:nonFraction>) million. The Company used a risk-adjusted discounted cash flow method to determine the fair value of the intangible asset using a discount rate of <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_OOBltWlETEyOu2fA06kbxw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:SignificantUnobservableInputAssets" scale="-2" id="Narr_ZPmtHxUfsEyt4F3TEhFs3w">15</ix:nonFraction>%. See &#8220;Note&#160;7. Intangible assets&#8221; for further details on assumptions used.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As the Company transferred its own equity instruments in consideration for the asset transferred, the acquisition was assessed in accordance with IFRS 2 <i style="font-style:italic;">Share-based Payment</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company determined that the acquisition of the Transferred Assets did not qualify as a business combination in accordance with IFRS 3 <i style="font-style:italic;">Business Combinations</i> and therefore was accounted for as an asset acquisition. Most of the fair value of the Transferred Assets is attributable to a single identifiable asset which is the in-process research and development asset. The purchase consideration for the Transferred Assets was allocated based on their relative fair values.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfAssetAcquisitionsTableTextBlock" id="Tb_1RkswImw0U-QQra2XBR3IQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes the amounts of the Transferred Assets acquired:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:86.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA" decimals="-3" format="ixt:numdotdecimal" name="aciu:CashAcquiredAsPartOfAssetAcquisition" scale="3" id="Tc_H-zTrs3Cp0WZrCT_1okATQ_2_2">4,634</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IPR&amp;D asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition" scale="3" id="Tc_Xs4lhzfbU0iY6pe14uBR1g_3_2">50,416</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA" decimals="-3" format="ixt:numdotdecimal" name="aciu:TotalAssetsAcquiredInAssetAcquisition" scale="3" id="Tc_l7Vv7kiuTUiQSew49BfqLA_4_2">55,050</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-21</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ad65134c_019e_44cb_a963_9abc52c1f73c"></a><a id="Tc_9Y16uIK7x0qkoOOy9FjEwg_1_2"></a><a id="Tc_gtvZ36ftGUm8w25k3wtkOA_1_8"></a><a id="Tc_WwzU4Zv7sU6tsbYSLejJLA_2_2"></a><a id="Tc_TbcMNOWSSUCrAcCiGsfh_w_2_8"></a><a id="Tc_McrhS1zO-EWMSlmjmaj43A_3_2"></a><a id="Tc_tEh5LDeBWEi1sCPsnJ68BQ_3_4"></a><a id="Tc_7C2PIZ5ITk6MdgvAMMkUFg_3_6"></a><a id="Tc_VZy71f58Ckq4dM9wyKRT-A_3_8"></a><a id="Tc_ZUMABQckEEesBfC9cgAcpQ_3_10"></a><a id="Tc_SIr45h4aZk-osR_m3V71Fw_3_12"></a><a id="Tc_IHH-S9_apk6AMqdN-XdWqA_4_0"></a><a id="Tc_Puf_bYFVskGI8xgEX6k6Rg_4_2"></a><a id="Tc_7gkh_8ia-UOsIzo7iSULHg_4_4"></a><a id="Tc_J17z_Dd_q0C8ub2hjz-vUA_4_6"></a><a id="Tc_1bui3iK_ikCBbYLfFOnG_A_4_8"></a><a id="Tc_8Pzpw1WDu0qbs4OGs3i1HA_4_10"></a><a id="Tc_Y_0bMGpxrEerilliuH2ohw_4_12"></a><a id="Tc_Ocuqqj8wWUuCdul33V7K5w_5_0"></a><a id="Tc_yMOcZX5gd0CRZNjhe7qwrw_6_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfIntangibleAssetsExplanatory" id="Tb_k3XvDAnGZk-lWQ4rINaeag" continuedAt="Tb_k3XvDAnGZk-lWQ4rINaeag_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">7.</b></span>Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">AC Immune&#8217;s acquired IPR&amp;D asset is a clinically-validated active vaccine candidate for the treatment of Parkinson&#8217;s disease. The asset is not yet ready for use until the asset obtains market approval. The carrying amount and net book value are detailed below:</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" id="Tb_4R2HpvyLbkOcG1FhGmvlMg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net book</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net book</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> value</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Acquired IPR&amp;D asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_QO4vamUaPEWTe-Dnq2T7Yw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_UYT5Z1tXsEi1FBuGzgqdAA_5_2">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_K6sJGDsSb0Ki6Q9DK_HssA" decimals="-3" format="ixt:zerodash" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_0iBEqFKeCkSIluE-3PfxJg_5_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_Rm5syNGJAkK02zxsPeiygw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_Prqgx6vnfUSU9h_DKTzeJg_5_6">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_LpgnYOYCIE6nbkxvmDUYKg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_o6hlNH6BIEu0Qyz55AA5kg_5_8">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_OwVmQS-jlUGVZMlyx50qAA" decimals="-3" format="ixt:zerodash" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_Y6ohjPaYMEy5vdv1rkBG4g_5_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_-0isfSi3C0iv0Hr9h6SsDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_2Nap76AmR0uHL1EkRCIwHg_5_12">50,416</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total intangible assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_9SsycfPkpUG2RWbLatkFMg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_BzgPBAgypESnDUYGw5Py0A_6_2">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_VCafjbK1YkmLYTpqX9O2Qg" decimals="-3" format="ixt:zerodash" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_0XXxFi0Ua0mOJyDqpDvAeg_6_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_6CvkkqwKmE6iBA_oVeCHXg_6_6">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_tvR74klj-EuU1efHxw9Lag" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_KASx9z0eEkSR-T3aPylU4Q_6_8">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_nL6LiSdtTEm6pKYWuxJXrQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_ANudIXLPPEaM6ZVTzOvemw_6_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_3YHXYyJotEeSdHi61O9WbQ_6_12">50,416</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with IAS 36 <i style="font-style:italic;">Impairment of Assets</i>, the IPR&amp;D asset is reviewed at least annually for impairment by assessing the fair value less costs to sell (recoverable amount) and comparing this to the carrying value of the asset. The valuation is considered to be Level&#160;3 in the fair value hierarchy in accordance with IFRS 13 <i style="font-style:italic;">Fair Value Measurement</i> due to unobservable inputs used in the valuation. The Company has determined the IPR&amp;D asset was not impaired as of December&#160;31, 2022 and 2021, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The key assumptions used in the valuation model in accordance with an income approach to determine the recoverable amount include observable and unobservable key inputs as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Anticipated research and development costs;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Anticipated costs of goods and sales and marketing expenditures;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Target indication prevalence and incidence rates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Anticipated market share;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">General commercialization expectations such as anticipated pricing and uptake;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Expected patent life and market exclusivity periods; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Other metrics such as the tax rate.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s valuation model calculates the risk-adjusted, net cash flows through the projected period of market exclusivity across target sales regions. The Company uses a discount rate of <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_VADeMQ-kG0C2-xdkdCMoZg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:SignificantUnobservableInputAssets" scale="-2" id="Narr_SzdwxVq5EUywcsIasmZJ_w">17</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_I4XyGj16C0a9vD480ormzw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:SignificantUnobservableInputAssets" scale="-2" id="Narr_QDCBHXTXdkGnhEj2vQv7NQ">15</ix:nonFraction>% for 2021), based on the assumed cost of capital for the Company over the forecast period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Note&#160;6. Asset acquisition&#8221; for further details.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-22</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_k3XvDAnGZk-lWQ4rINaeag_cont1"></ix:continuation><a id="_aea4a2d5_f835_473e_9dc3_ddd661d6622b"></a><a id="Tc_q5GUyM7mlUevm1PNdPjDKg_1_2"></a><a id="Tc_nZWlOSE1VU-C7jSSmCk1ww_2_2"></a><a id="Tc_wurdM2kGd0aHCS4_MSrltg_3_0"></a><a id="Tc_RK_VY-G_ik2erz0CEljasQ_3_2"></a><a id="Tc_AqCVkhcC5UaGQgS-yoxiwA_3_4"></a><a id="Tc_K2s-ZHpb2Eavu8BLefeLhQ_4_0"></a><a id="Tc_4Yvtv1rSRE2cwi9csq2PIA_5_0"></a><a id="Tc_2AJLGCzHfEOfnjbz9QerAg_6_0"></a><a id="Tc_8KDAQrGVYEWztJWJEAUJJw_7_0"></a><a id="Tc_vro9EL5kv0uIZTgpHVgGlw_8_0"></a><a id="Tc_osu6JSajK02CtdhJ5MFZuA_9_0"></a><a id="Tc_fmuK1DwP10e8ppUIUlcsfQ_10_0"></a><a id="_180b70ac_a2d6_4f2e_b332_87d0d531c92e"></a><a id="Tc_3Jkf1AEco0ilWRwTISr5bg_1_2"></a><a id="Tc_iRtWyp28l0WOA0VP-vJCfg_2_2"></a><a id="Tc_QijQ1O-7LEuxyAfo_Y6PtQ_3_0"></a><a id="Tc_S7W0yScPMUOfmDNpaYkmDA_3_2"></a><a id="Tc_0coGcVwRe0C_6Q-JDPzg3Q_3_4"></a><a id="Tc_wnLdMACXh0yDOZ12PhQj9Q_4_0"></a><a id="Tc_rggB0qQmmEuwTEnpCZv4HA_5_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" id="Tb_uS1DNd8IRE2-4C12MYpIzQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.</b></span>Cash and cash equivalents and short-term financial assets</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" id="Tb_OBAlHBuKYEW9UidZrx_wDQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s cash and cash equivalents are maintained in the following respective currencies as of December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_7hGhpHX2jkWfRh3CM-Miig_4_2">31,586</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_fX6FdGAk2EC4YggutkZS_A_4_4">82,216</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_Lba80mEkwEO3efItmCpeUQ_5_2">31,586</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_ZOYDfmj_U0qlmomjvg4nZw_5_4">82,216</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">By currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_CHF_38ToDnEBNEuS9ddM0NrYgg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_KB6N50PcBkWmOsiUMQX5oQ_7_2">24,418</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_srt_CurrencyAxis_currency_CHF_iiYbXla8tU-iyk_i32DP4A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_8xGaJIShdEiipmSj4Tasig_7_4">64,941</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">EUR</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_EUR_V7Jj-YDCCEGGn-_yEgdDMA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_Sq6kkkXReUKfFg7qhM4IrA_8_2">1,313</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_srt_CurrencyAxis_currency_EUR_o_IBIzyApEiyeRWQLrx-UA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_GqojWA9J7UmEfsbqosjuUQ_8_4">2,253</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_USD_15GIrBDN9Uil-oruYpMkuQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_5bZfGhU-LE2EHuASOMw3gg_9_2">5,855</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_srt_CurrencyAxis_currency_USD_Ukgt6dYs9EGXQlarniLKig" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_LHK7p3D2OE2VDkrdZN8aTg_9_4">15,022</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_O4QJkw9V1UimihuBf0vmWA_10_2">31,586</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_1lKsKH0ZmUqB3wUE_934yg_10_4">82,216</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, the Company&#8217;s funds were held in CHF, EUR and USD currencies. Funds held in EUR and USD were translated into CHF at a rate of <ix:nonFraction unitRef="Unit_Divide_CHF_EUR_oaL03aUr-0uB3BBQW7LmbA" contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_EUR_V7Jj-YDCCEGGn-_yEgdDMA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Narr_hHWVNZhzHEiaXEzUB0EqPw">0.994</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w" contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_USD_15GIrBDN9Uil-oruYpMkuQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Narr_848M0jbHSEusCzxGxXv95A">0.933</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Divide_CHF_EUR_oaL03aUr-0uB3BBQW7LmbA" contextRef="As_Of_12_31_2021_srt_CurrencyAxis_currency_EUR_o_IBIzyApEiyeRWQLrx-UA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Narr_0mys_ltbtE6Qr2XMnFVlWg">1.045</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w" contextRef="As_Of_12_31_2021_srt_CurrencyAxis_currency_USD_Ukgt6dYs9EGXQlarniLKig" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Narr_aCz-yb-VeUOdcI_xKxSCkA">0.923</ix:nonFraction>, respectively, for each currency and&#160;year.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" id="Group_ZSDw2PgY9kWELP1OP4W0dg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes the Company&#8217;s short-term financial assets as of December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets due in one year or less</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_r5LpckzLpUiOGvTWM7QXkQ_4_2">91,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_qTRKlJO2OkOesJnULtv3DQ_4_4">116,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total short-term financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_GQN18YsdZkG9IXfTsQqPCw_5_2">91,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_Y0Vhh3GCLk-GeF4-F24vLw_5_4">116,000</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="Tc_Xrt4k8AbPU6Q26YqArGqpg_1_2"></a><a id="Tc_Emq536cfkkewvanq5IFdEQ_2_2"></a><a id="Tc_GMbtkddIqESsvFFaNqIRdw_3_0"></a><a id="Tc_vwJQBzmyI02--eApukIT-w_3_2"></a><a id="Tc_NkFjNsoilUyu1eqT4sgc9w_3_4"></a><a id="Tc_8ouRrjGL4U2iVdzGjuFAWQ_4_0"></a><a id="Tc_z-4fPIJCkk6tlvPiWxy_HA_5_0"></a><a id="Tc_AU7A1oK6yESC-iFgVhfAxw_6_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" id="Tb_VI538uIptUW1hvvRcJIwdQ" continuedAt="Tb_VI538uIptUW1hvvRcJIwdQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">9.</b></span>Prepaid expenses and accrued income</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" id="Tb_NL1qT6EpS0GomV-uibT6oA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Prepaid expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaidExpenses" scale="3" id="Tc_SAlY7xyjKUiGwJWL3AY7iA_4_2">4,708</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaidExpenses" scale="3" id="Tc_h9UTrVNP5EeqMjeaNWo2dw_4_4">3,015</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets" scale="3" id="Tc_xXWMzx38ZEKd9MJ71Dsrig_5_2">408</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets" scale="3" id="Tc_xUx1tgijVEKviC_oywoVVA_5_4">975</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total prepaid expenses and accrued income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" scale="3" id="Tc_xoM0lk5l9E-dI31VbzR3MA_6_2">5,116</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" scale="3" id="Tc_-rVEsPLY_0GtZE8W7VdpFA_6_4">3,990</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s prepaid expenses relate mainly to research contracts with down-payments at contract signature with the related activities to start or continue into 2023 as well as prepaid payroll-related expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Accrued income consists of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember_0GfBuDA_dU26TA2qx6IcSA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets" scale="6" id="Narr_C5PSZIHACkiuh6m8SmGU_Q">0.4</ix:nonFraction> million as of December&#160;31, 2022 associated with our MJFF grants and Target ALS (see &#8220;Note&#160;13.2. Grant income&#8221;). This amount represents <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember_0GfBuDA_dU26TA2qx6IcSA" decimals="2" format="ixt:numdotdecimal" name="aciu:PercentageOfAccruedIncome" scale="-2" id="Narr_hJeXgm9XNkm1KNfKek8Anw">100</ix:nonFraction>% of our total accrued income as of December&#160;31, 2022. As of December&#160;31, 2021, the Company recorded CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_vFwwP69K-kujKmPJkq_WBw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets" scale="6" id="Narr_3Aa4nQwrXEW8Mqr3OrKiGA">0.9</ix:nonFraction> million of accrued income associated with our MJJF grants. This amount represented <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_vFwwP69K-kujKmPJkq_WBw" decimals="3" format="ixt:numdotdecimal" name="aciu:PercentageOfAccruedIncome" scale="-2" id="Narr_y_rsJsty6kW-PDGqSxpSXQ">87</ix:nonFraction>% of our total accrued income as of December&#160;31, 2021.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-23</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_VI538uIptUW1hvvRcJIwdQ_cont1"></ix:continuation><a id="Tc_ehV4BpHtFE6aABoV7KK-RQ_1_2"></a><a id="Tc_H89zRZzNpEmUfvoleXk1-g_2_2"></a><a id="Tc_7DSml0hElESuSVzXnNaxtg_3_0"></a><a id="Tc_cU1tNSa8qEuV9epizHPAfQ_3_2"></a><a id="Tc_kWRoj03-PEqi4jpub6BloQ_3_4"></a><a id="Tc_zP3u_uqqK0CNyMLPfo48Hw_4_0"></a><a id="Tc_cTcdHwOoJUSfZon0KfiCTA_5_0"></a><a id="Tc_Unuq3-yX4k6oWFXCt_x_QA_6_0"></a><a id="Tc_upctI6NohUiZE3bCpkmKZA_7_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfOtherCurrentReceivablesTextBlock" id="Tb_Ov5Db8SGT0acbXYDfECVOw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">10.</b></span>Other current receivables</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" id="Tb_BVxvDoE-U0KU-oiDEMSgww" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="aciu:MiscellaneousOtherCurrentReceivables" scale="3" id="Tc_U0aCk0osC0aAV43h5_8ShQ_4_2">124</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="aciu:MiscellaneousOtherCurrentReceivables" scale="3" id="Tc_ph3M4LoGwkaajxNY3zHN9g_4_4">101</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Swiss VAT</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentValueAddedTaxReceivables" scale="3" id="Tc_X6gEgxepPEKg1zgpuEf3oA_5_2">249</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentValueAddedTaxReceivables" scale="3" id="Tc_NYXAxHmfkECharSx3VAK4A_5_4">327</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Withholding tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="aciu:WithholdingTaxReceivables" scale="3" id="Tc_k4NP3TY6dk2Vkhij_slpJA_6_2">19</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:zerodash" name="aciu:WithholdingTaxReceivables" scale="3" id="Tc_X1CVtInW4EWIdU9thXAfww_6_4">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other current receivables</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherCurrentReceivables" scale="3" id="Tc_1PF25hlXP0CB5JQMgg9hsw_7_2">392</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherCurrentReceivables" scale="3" id="Tc_nRfzGzpuW0qxfArSIpbY_A_7_4">428</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The maturity of these assets is less than <span style="-sec-ix-hidden:Hidden_P_0I_UaePkyj8OXHk3ZeUg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3&#160;months</span></span>. The Company considers the counterparty risk as low and the carrying amount of these receivables is considered to approximate their fair value.</p></ix:nonNumeric><a id="_2bd71fac_36b1_4741_85c6_4646dacd3dfc"></a><a id="Tc_lCAAAEZ2jkSd3BbmsTzEJg_1_6"></a><a id="Tc_jNNLkXj2bUi7b6FAj9fU3g_2_2"></a><a id="Tc_ulzV2Ajc5ESAeAZUtdgz0w_2_4"></a><a id="Tc_YqKRqT4zj0KkSUCd3hqHZg_2_6"></a><a id="Tc_CPMth5k8d0i4M2PEuYJPPg_2_8"></a><a id="Tc_650ObleBuEe6vfWFUCpeCw_2_10"></a><a id="Tc_EcB6YuoyQ0u-pjKiHL4BPQ_3_2"></a><a id="Tc__A_6gDUtIUW_w4Z86i-iGw_3_4"></a><a id="Tc_OQCTrOfuq0GB_Wf4LsGeOA_3_6"></a><a id="Tc_aWGITvce4EmmeJ1H56Vwdw_3_8"></a><a id="Tc__PyTgZeRc0-EQ4EYW3v3oA_3_10"></a><a id="Tc_QEeMK-_BK065WRQXg-KzaQ_4_0"></a><a id="Tc_lwpVDfZT2ky8LAlnlq0CzA_5_0"></a><a id="Tc_3Z-4xvxSUU6MLhu4gNENQQ_5_2"></a><a id="Tc_LYylzBLm4kOKQNT32G_iUQ_5_6"></a><a id="Tc_u66SCctnL0G85XmFXuXT6Q_6_0"></a><a id="Tc_waqdst1pAEioeIWDhqRh9g_6_4"></a><a id="Tc_a_58DXuq5UOr6xbgt-6D_w_6_10"></a><a id="Tc_zQU6VmGZt0aXkePJwrRQiQ_7_0"></a><a id="Tc_sAQ4ZKCw4kSpjV4MS2kETQ_7_4"></a><a id="Tc_Lzd1_8mEeEm709hjoZCO2A_7_10"></a><a id="Tc_QMKd6EMvak648V6a0FVW0A_8_0"></a><a id="Tc_LddTWQMQhEW1AACj8ExxuA_8_4"></a><a id="Tc_gQYLwyBMvUyUdpYbTT_lQA_8_10"></a><a id="Tc_c0bnlZ3rok6mRG6RHrTdCA_9_0"></a><a id="Tc_KJL7WIByRU2O9BctyZ6_SQ_9_8"></a><a id="Tc_qa25MiRq90O0HGsx3hkFxw_10_0"></a><a id="Tc_0PNABrOvN0CoM-xtQ76Yog_11_0"></a><a id="Tc_qBJKe7-v2kedzaTYB6CNxQ_11_2"></a><a id="Tc_odo0VDwAa0G-gislfsW6XQ_11_6"></a><a id="Tc_VzblzaxM7UGCxxI5CU27rQ_12_0"></a><a id="Tc_SykyUltwwECS20N3PHONwQ_12_4"></a><a id="Tc_Ca36oeWl0UKV1whMk0zL_g_12_10"></a><a id="Tc_brXPI_QANk2nFcXnxIfCrA_13_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" id="Tb_6yMr3JttsUWsS4TKUWVe0g" continuedAt="Tb_6yMr3JttsUWsS4TKUWVe0g_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">11.</b></span>Share capital</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2022 and 2021, the issued share capital amounted to CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_UV3ix4h--E6wHiAOGaJNtA" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:IssuedCapital" scale="0" id="Narr_FqPysMG9MkyzhLFlajziGw">1,796,675</ix:nonFraction> and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_uTemqh0x5kCnk8dGyhg2yw" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:IssuedCapital" scale="0" id="Narr_2vthpQh9a0aEDV3kLYEnaA">1,794,013</ix:nonFraction>, respectively, and is composed of outstanding common shares of <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_UV3ix4h--E6wHiAOGaJNtA" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesIssued" scale="0" id="Narr_tptvr67UsUy_r1hbnxlIig">83,620,364</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_uTemqh0x5kCnk8dGyhg2yw" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesIssued" scale="0" id="Narr_DjgMUPirFkW6h1QmpHUQ7w">83,479,013</ix:nonFraction>, respectively, and treasury shares of <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" scale="0" id="Narr_QTcmf9e1xUGY08QJczlM2A">6,214,021</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" scale="0" id="Narr_ql5hF6WyZk-Gwb0x3dSboA">6,221,617</ix:nonFraction>, respectively.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory" id="Tb_dnExLU16tUCbxeU8U4M9NQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The table below summarizes the Company&#8217;s capital structure:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">premium</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_t849aft53kyGDr1KoWgmHg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" id="Tc_0UOI49X-XkKvz53r0e_mDA_4_2">76,936,738</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_xamDkF4k5UGlV-TCDgu2Lg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" scale="0" id="Tc_r4YY55CkG0yShudceXqp0A_4_4">5,000,000</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_os5Hp8MAI02VjWPk90WB7w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_7b2nn_qlhkmgJjyYwSNNVQ_4_6">1,538</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_ktuzkw64AEa5vdg54I-VCQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_xSDpVm-tkUuXf3yyL4JQEA_4_8">346,890</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_vuCe_vLKgECevKYNBCd4Lw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_l3h7anFUREq8F963Fp3hVA_4_10">100</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_Ot-xQ2KPP06Rv7mi7NpE9w" decimals="INF" format="ixt:numdotdecimal" name="aciu:DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" scale="0" id="Tc_QJTdpKLQA0axmRjREQFT4w_5_4">1,171,543</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_d5FMtPcZWUWGR45BEwdLwQ_5_8">12,097</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_MA1k6pqrWUOXPbYsjsp02A_5_10">24</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Asset purchase agreement, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_GjUP2pWxo0OYX2B-S44KPA" decimals="INF" format="ixt:numdotdecimal" name="aciu:IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions" scale="0" id="Tc_QtlyYrr17ECYAiciACmirw_6_2">7,106,840</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseThroughIssuanceOfSharesInAssetAcquisitions" scale="3" id="Tc_uQiN_s06rEq_bYCkwkoS3w_6_6">142</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseThroughIssuanceOfSharesInAssetAcquisitions" scale="3" id="Tc_9i56Jai7gE2ulCd8DzWsPA_6_8">54,328</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Conversion of note agreements, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_GjUP2pWxo0OYX2B-S44KPA" decimals="INF" format="ixt:numdotdecimal" name="aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" scale="0" id="Tc_XnByor3ukUKoBdambxnVXg_7_2">3,026,634</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments" scale="3" id="Tc_PxDma2vlaUCcMRluSGr7lQ_7_6">61</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments" scale="3" id="Tc_9V8g_oIWeEiQ6RahMz97Jg_7_8">16,683</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares &#8211; incentive plans, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_GjUP2pWxo0OYX2B-S44KPA" decimals="INF" format="ixt:numdotdecimal" name="aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" scale="0" id="Tc_2BOPfH1vJEWNMGKLycBrBA_8_2">237,258</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseThroughSharesIssuedUnderIncentivePlans" scale="3" id="Tc_64sv2Yh_9U-rXzgBWUri6Q_8_6">5</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseThroughSharesIssuedUnderIncentivePlans" scale="3" id="Tc_ubvfwfqoEEu71Qt3bsIdHQ_8_8">1,253</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares to be held as treasury shares, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_GjUP2pWxo0OYX2B-S44KPA" decimals="INF" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" scale="0" id="Tc_xUYPBcYgfUKn-4iNcDEsJQ_9_2">2,393,160</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_Ot-xQ2KPP06Rv7mi7NpE9w" decimals="INF" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" scale="0" id="Tc_7RdNn3bBkE-2dZyMBsuetg_9_4">2,393,160</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="Tc_XAbgNXRupk-zcm66seMkDA_9_6">48</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" sign="-" scale="3" id="Tc_frCB5lHKAUaaRsbWV64N1Q_9_10">48</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_uTemqh0x5kCnk8dGyhg2yw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" id="Tc_S9Ificgr9kmr_O2HzHPG2Q_10_2">89,700,630</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_HnlGa1Cxjk2eh1urgNWWVw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" scale="0" id="Tc_6YETfa1lU0G--Ag1eWKGQw_10_4">6,221,617</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember__r0D1g51PUiGX0X1UUsNSA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_IHKV4_Q2lES5pWEtIWp4Vw_10_6">1,794</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_dfNJO7LfcEOZT4w2RTRitw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_HOfIvV-3x064gttFvejWFA_10_8">431,251</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Vs0uaVlFREaW6ng6T8fgEg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_0ExwMC-k-E2TXLCEKvgtXg_10_10">124</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_D82Lcnr-PUGdxCD-xTUAMA" decimals="INF" format="ixt:numdotdecimal" name="aciu:DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" scale="0" id="Tc_RgCD8CPQ1kW0w9xnveCesA_11_4">7,596</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" sign="-" scale="3" id="Tc__3guI930LUSIvDP9icGfxw_11_8">8</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_f2x9ViGgyUqA1eoDl_toTA_11_10">0</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares &#8211; incentive plans, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_7Z_nhIBrX0a27ZxFck0DEg" decimals="INF" format="ixt:numdotdecimal" name="aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" scale="0" id="Tc_zlGMZiFbMUeh6WwLxKdO5A_12_2">133,755</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseThroughSharesIssuedUnderIncentivePlans" scale="3" id="Tc_XReT9migu06fJwnNkCoKxw_12_6">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseThroughSharesIssuedUnderIncentivePlans" scale="3" id="Tc_67d_UtGa1UuAnubbLJA1vQ_12_8">80</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_UV3ix4h--E6wHiAOGaJNtA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" id="Tc_czGiRLXjzES5E6XZisUIJQ_13_2">89,834,385</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_MzzzRCGt_kGIsmMdhb2czw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" scale="0" id="Tc_yxKGsnkmgEqW7xEoKM5fuQ_13_4">6,214,021</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_gp09PWsb8EavwbWAh0p_Sg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_ExmZ0JIanEOX6IlPfYzFxA_13_6">1,797</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_8sJpe0LyAECOfOJdgZOKPQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_D7Kc_kF9XUW-Jc0Mec2J5g_13_8">431,323</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_hgoBF8GS-k-cs9msKZyyhA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_1Q0T5E7LDEe2zn7cCI7k3g_13_10">124</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The common shares and treasury shares have nominal values of CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_kJfiqlk2z0ianf_yQvx0YQ">0.02</ix:nonFraction> per share. All shares have been fully paid. These treasury shares held by the Company are not considered outstanding shares as of December&#160;31, 2022 or 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Authorized capital</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s Board of Directors is authorized to increase the share capital, in one or several steps, until June 24, 2024, by a maximum amount of CHF&#160;<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="0" format="ixt:numdotdecimal" name="aciu:AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" scale="0" id="Narr_rhX6qfL3-ECFvmIN5yvw4Q">400,000</ix:nonFraction> by issuing a maximum of <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="INF" format="ixt:numdotdecimal" name="aciu:NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" scale="0" id="Narr_xIbsfZeXwEGURhLUnHrDdw">20,000,000</ix:nonFraction> registered shares with a par value of CHF&#160;<ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_w7E1ZyDVsUSmEaXao3kMHg">0.02</ix:nonFraction> each, to be fully paid up. An increase of the share capital (i) by means of an offering underwritten by a financial institution, a syndicate or another third party or third parties, followed by an offer to the then-existing shareholders of the Company and (ii) in partial amounts, shall also be permissible.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-24</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_6yMr3JttsUWsS4TKUWVe0g_cont1" continuedAt="Tb_6yMr3JttsUWsS4TKUWVe0g_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Conditional share capital for bonds and similar debt instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s share capital may be increased by a maximum aggregate amount of CHF&#160;<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_7CFGeyENHkKB9xvCXPYVaA" decimals="0" format="ixt:numdotdecimal" name="aciu:PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" scale="0" id="Narr_WdCUAXRzJ0aObNucAenxqA">100,000</ix:nonFraction>&#160;through the issuance of a maximum of <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_wv9xrxx7O0K2GfFqTGYv0g" decimals="INF" format="ixt:numdotdecimal" name="aciu:PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" scale="0" id="Narr_34b4m79zhUy9uekbTr4FvQ">5,000,000</ix:nonFraction> registered shares, payable in full, each with a nominal value of CHF&#160;<ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_kNbENWSt0ES3TXF_cT2ONw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_tRIbUa8_5EC2J3AVDvxCFA">0.02</ix:nonFraction>&#160;per share, through the exercise of conversion and/or option or warrant rights granted in connection with bonds or similar instruments, issued or to be issued by the Company or by subsidiaries of the Company, including convertible debt instruments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Conditional share capital for employee benefit plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s share capital may be increased by a maximum aggregate amount of CHF&#160;<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_IhkhXgeEj0KYRe-nXMqtgw" decimals="0" format="ixt:numdotdecimal" name="aciu:PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" scale="0" id="Narr_SUxiy2t5GUeePbn7lybSYA">96,000</ix:nonFraction>&#160;through the issuance of not more than&#160;<ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_IhkhXgeEj0KYRe-nXMqtgw" decimals="INF" format="ixt:numdotdecimal" name="aciu:PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" scale="0" id="Narr_liw6WEwtrUG1_W4s9YAPVA">4,800,000</ix:nonFraction>&#160;common shares, payable in full, each with a nominal value of CHF&#160;<ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_4fT5bJuBykulzw1ivTHO9Q" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_vQCa0Apja02euzeDPVJPEw">0.02</ix:nonFraction>&#160;per share, by the exercise of options rights that have been granted to employees, consultants, members of the board of directors, or other person providing services to the Company or a subsidiary.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Shelf registration statement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April&#160;28, 2021, the Company filed a Shelf Registration Statement on Form&#160;F-3 (Reg. No.&#160;333-255576) (the &#8220;Shelf Registration Statement&#8221;) with the SEC. The Shelf Registration Statement was declared effective by the SEC on May&#160;5, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Shelf Registration Statement allows the Company to offer and sell, from time to time, up to USD <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_4_28_2021_To_4_28_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_S6KglnLJ6EOK616omN_TFQ" decimals="0" format="ixt:numdotdecimal" name="aciu:CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" scale="0" id="Narr_VpXtBg_FkUKaWKypePq81w">350,000,000</ix:nonFraction> of common shares, debt securities, warrants, purchase contracts, units, subscription rights or any combination of the foregoing in one or more future public offerings. The terms of any future offering would be determined at the time of the offering and would be subject to market conditions and approval by the Company&#8217;s Board of Directors. Any offering of securities covered by the Shelf Registration Statement will be made only by means of a written prospectus and prospectus supplement authorized and filed by the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">At the market equity offering</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q3 2020, AC Immune issued <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_z3C9c0ddSEGQe_CGaFlGBA" decimals="INF" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" scale="0" id="Narr_SRUOyuoTrkGi3sx-z8Yzug">5,000,000</ix:nonFraction> common shares with a nominal value of CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_nMf-S3Qo30yK_F2kNXsH8Q" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_qiwBxBjvA0qwR7dyEXVKLA">0.02</ix:nonFraction>, which became treasury shares. The Company also established an &#8220;at the market offering program&#8221; (&#8220;ATM&#8221;) for the sale of up to USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_z3C9c0ddSEGQe_CGaFlGBA" decimals="-5" format="ixt:numdotdecimal" name="aciu:CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" scale="6" id="Narr_nSVpmmVESECgHzxoQmKMXA">80.0</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_z3C9c0ddSEGQe_CGaFlGBA" decimals="-5" format="ixt:numdotdecimal" name="aciu:CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" scale="6" id="Narr_aZcJJaSJbkOp3XBSr8FORw">74.6</ix:nonFraction>) million worth of our common shares issued from time to time by entering into an Open Market Sale Agreement (&#8220;Sales Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;) as the sales agent under a prior registration statement on Form&#160;F-3 which expired in Q2 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q2 2021, the Company filed a new registration statement on Form&#160;F-3 and an accompanying prospectus supplement in order to renew its ATM program. The Company also entered into a second Open Market Sale Agreement (the &#8220;new Sales Agreement&#8221;) with Jefferies to continue the ATM program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q3, 2021, the Company issued <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_7_1_2021_To_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_hFMd3XCjHE2krVkPJCUtig" decimals="0" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" scale="0" id="Narr_7f8QJcmkeEu6O2QOW3z_Aw">2,393,160</ix:nonFraction> common shares with a nominal value of CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_4oE23j2SoEGdWq3PS9cPew" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_wZe_5nUSV0yUCKqLCFs1lg">0.02</ix:nonFraction> to be held as treasury shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Through December 31, 2022, the Company has sold <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_jTjTRUZmlk6W61qANQJmqg" decimals="INF" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesShares" scale="0" id="Narr_nhAfIrTrMUmtc3xBjCOP_w">1,179,139</ix:nonFraction> common shares previously held as treasury shares pursuant to the new Sales Agreement, raising USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_jTjTRUZmlk6W61qANQJmqg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares" scale="6" id="Narr_MIu9WO8xwkanL0DvjDZ2Mg">13.3</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_jTjTRUZmlk6W61qANQJmqg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares" scale="6" id="Narr_EHqrFnlFpkyhrfkjIgT6ww">12.1</ix:nonFraction>) million, net of underwriting fees and transaction costs. We have paid commissions to Jefferies totaling USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_jTjTRUZmlk6W61qANQJmqg" decimals="-5" format="ixt:numdotdecimal" name="aciu:CommissionsPaidForIssuanceOrdinaryShares" scale="6" id="Narr_YjZQkRZ7WUuVfLcyUrZo1g">0.4</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_jTjTRUZmlk6W61qANQJmqg" decimals="-5" format="ixt:numdotdecimal" name="aciu:CommissionsPaidForIssuanceOrdinaryShares" scale="6" id="Narr_eeQH422p6E6CoK5ZBU6qfQ">0.4</ix:nonFraction>) million through December 31, 2022, for share issuances in accordance with our ATM programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, the Company has expensed issuance costs of <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_P7gp9D6sWEu1SR6hOkR0lQ" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:ShareIssueRelatedCost" scale="6" id="Narr_5z6cSj7QO0S-r9xi5P6w7g">nil</ix:nonFraction>, <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_b6irc3wm8kOfDWxn7KoryA" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:ShareIssueRelatedCost" scale="6" id="Narr_b7FkudKMv0CwEvCEhJVJKg">nil</ix:nonFraction> and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_QcaBM9HUnUiKIdtAR3VBHA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ShareIssueRelatedCost" scale="6" id="Narr_h_hP2FinEkySbcBeMSBMTw">0.5</ix:nonFraction> million, respectively, in the consolidated statements of income/(loss).</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-25</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_6yMr3JttsUWsS4TKUWVe0g_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Convertible note agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Concurrently with the Asset Purchase Agreement, the Company entered into <ix:nonFraction unitRef="Unit_Standard_agreement_6AbCKkYWeEm1dt5Jp7cROw" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_Z8Cvgi6srkG50kHoFl7dWQ" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfConvertibleNoteAgreements" scale="0" id="Narr_QXkXCybEyUawf8X0WskJ4w">two</ix:nonFraction> separate Convertible Note&#160;Agreements with entities affiliated with each of Athos Service GmbH and First Capital Partner GmbH, both of which entities are shareholders of Affiris.&#160;Each Convertible Note&#160;Agreement provided for the sale of an unsecured subordinated Convertible Note&#160;of the Company with an aggregate principal amount of USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_Z8Cvgi6srkG50kHoFl7dWQ" decimals="-5" format="ixt:numdotdecimal" name="aciu:AggregatePrincipalAmountOfEachConvertibleNote" scale="6" id="Narr_1bEcS20ZnEmxeWmtX36Ziw">12.5</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_Z8Cvgi6srkG50kHoFl7dWQ" decimals="-5" format="ixt:numdotdecimal" name="aciu:AggregatePrincipalAmountOfEachConvertibleNote" scale="6" id="Narr_D449JaK3A0iFWIFaFJH03w">11.7</ix:nonFraction>) million for total net proceeds of USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_StatementScenarioAxis_aciu_IfNotesAreConvertedMember_-lcYAWhYg0-zLgqjshlyjw" decimals="-6" format="ixt:numdotdecimal" name="aciu:ProceedsFromIssueOfConvertibleDebt" scale="6" id="Narr_cBXarKp7f02gWc7L32fzXA">25</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_StatementScenarioAxis_aciu_IfNotesAreConvertedMember_-lcYAWhYg0-zLgqjshlyjw" decimals="-5" format="ixt:numdotdecimal" name="aciu:ProceedsFromIssueOfConvertibleDebt" scale="6" id="Narr_8enWReTRS0OYyZqmfnDtng">23.5</ix:nonFraction>) million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2021, the affiliated entities exercised their options to convert their respective USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_jtRNTBzMHEaZ7YlAIWrXwg" decimals="-5" format="ixt:numdotdecimal" name="aciu:ProceedsFromConversionOfConvertibleDebtPerIndividualNote" scale="6" id="Narr_1QkJttEqdEW6uZTWBpQaew">12.5</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_jtRNTBzMHEaZ7YlAIWrXwg" decimals="-5" format="ixt:numdotdecimal" name="aciu:ProceedsFromConversionOfConvertibleDebtPerIndividualNote" scale="6" id="Narr_CZAmA-h0CU6FP_unfGeskw">11.7</ix:nonFraction>) million notes. As a result of these conversions, <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_AthosServiceGmbHMember_MrNll2L240y5mdXUd6AkjQ" decimals="0" format="ixt:numdotdecimal" name="aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" scale="0" id="Narr_lIb5WAX2mEiQM2JFh6WI8A">1,513,317</ix:nonFraction> <span style="-sec-ix-hidden:Hidden_7EVt20oUeEOLG5MQiq_Hiw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">common</span></span> shares were issued to each Investor, totaling <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_jtRNTBzMHEaZ7YlAIWrXwg" decimals="0" format="ixt:numdotdecimal" name="aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" scale="0" id="Narr_939GZs7RqE2HOHHh8bldoQ">3,026,634</ix:nonFraction> common shares. The Company recorded an increase to its share capital for the nominal value of its shares and share premium for the difference associated with settlement of this liability. The Company also settled its derivative financial assets, which were embedded conversion features associated with the convertible debt, via an offset to its share premium. These convertible notes and derivative financial assets were fully settled in 2021 and there is <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_Xwss63i4rkeKVevtj3Tcag" decimals="0" format="ixt-sec:numwordsen" name="aciu:OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" scale="0" id="Narr_eMojipr1SUmHNSCp4Z-wVg">no</ix:nonFraction> further equity or cash consideration due to the affiliated entities thereunder.</p></ix:continuation><a id="Tc_WaTIjxxB5kalsZzURouIfw_1_2"></a><a id="Tc_2xn57z0GlEqlMK-z_JWAWg_2_2"></a><a id="Tc_Dg8Xuiu_9EyU-C8nPewqOw_3_0"></a><a id="Tc_Lijjh6Eyc0mC1KsoFkXF5Q_3_2"></a><a id="Tc_N-tiTVluY0WV5K95qXimxg_3_4"></a><a id="Tc_9FvleY4DSE-hQgFnaWsQpg_4_0"></a><a id="Tc_HktSbuhujEKz8mEaUGNEwg_5_0"></a><a id="Tc_QVfPvjbmcEmSm8qM6KF7JA_7_0"></a><a id="Tc_Ksjlp3aBDkeSH-eqBEIDTw_8_0"></a><a id="Tc_Gjnehhv_vUKw0xRKim8tPg_9_0"></a><a id="Tc_cRC3eq2fuEaktdt0BcHaJA_10_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" id="Tb_atY-H4C3m0ieX__rfuJHvQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">12.</b></span>Trade and other payables and accrued expenses</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" id="Tb_h6qxRYqIc0CkeWw6A5AC9A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_QdyjAvhK9EKJJghRDgYhlQ_4_2">929</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_jzjitRYHZ0-HR7Ac6uFb6Q_4_4">2,003</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total trade and other payables</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_bnB3IX2JIEOCN_UMCCifJg_5_2">929</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_upJNMoxnDUiANwnAzvS-mA_5_4">2,003</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued research and development costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="aciu:CurrentAccruedResearchAndDevelopmentCosts" scale="3" id="Tc_Qter3VD0KkymaWh8A3J_Hw_7_2">5,360</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="aciu:CurrentAccruedResearchAndDevelopmentCosts" scale="3" id="Tc_mhkFD4bFRky6Ng38A-cABA_7_4">10,361</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" scale="3" id="Tc_MzhHPA6nxEqSj22h0XH0XA_8_2">2,898</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" scale="3" id="Tc_dFsRI-tlhUaBXGDrsoC1Tw_8_4">3,562</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other accrued expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="aciu:OtherAccruedExpenses" scale="3" id="Tc_BDd_SZYUAUiuKRQsKRi7tw_9_2">1,159</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="aciu:OtherAccruedExpenses" scale="3" id="Tc_wqV2dHG3kEq5gjgnBFYYlA_9_4">2,813</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total accrued expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="3" id="Tc_BE71bd5MgEGh6hPiI95BCA_10_2">9,417</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="3" id="Tc_Z4qCjp3HYU--rRKa4VS7iQ_10_4">16,736</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">An accrual of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-5" format="ixt:numdotdecimal" name="aciu:AccrualsForPerformanceRelatedRemuneration" scale="6" id="Narr_bRRgxfTxeU-KBBE8mnL3wQ">2.1</ix:nonFraction> million and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-5" format="ixt:numdotdecimal" name="aciu:AccrualsForPerformanceRelatedRemuneration" scale="6" id="Narr_jRApHMiejE-5wTEzBABZfA">2.3</ix:nonFraction> million was recognized for performance-related remuneration within accrued payroll expenses for 2022 and 2021, respectively. In 2021, an accrual of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_NiF-yrOtAky2RdqkvIAwfw" decimals="-5" format="ixt:numdotdecimal" name="aciu:CurrentAccruedResearchAndDevelopmentCosts" scale="6" id="Narr_ePTbrCeEI0KqOMTjNjeebQ">3.7</ix:nonFraction> million was recorded as part of our cost sharing arrangement with Janssen within accrued research and development costs and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-5" format="ixt:numdotdecimal" name="aciu:AccruedStampDuty" scale="6" id="Narr_FsJxE8TG_kKAMCrHCSS_rA">0.8</ix:nonFraction> million was recorded as accrued stamp duty for the issuance of shares as part of the Company&#8217;s asset acquisition within other accrued expenses.</p></ix:nonNumeric><a id="_819a6eed_ef19_41e0_b1f2_46f360c1b489"></a><a id="Tc_5A7gA45Ixk-WIrPp42cKiQ_1_2"></a><a id="Tc_JJvpKOdyZEuvJJAlWU_2_Q_2_2"></a><a id="Tc_W7B5e1KL8kSouhebZytB0w_3_0"></a><a id="Tc_-0nf-OTxmUiU_0QXr-Onzg_3_2"></a><a id="Tc_-OWb0uXLPEWr--U83iKnEQ_3_4"></a><a id="Tc_2OZ1xUvZKUCASXkdHu9JhA_3_6"></a><a id="Tc_yVsFgP8coky0-u1947LWWg_4_0"></a><a id="Tc_RXhLOBYJhUKLkPng6NMhSQ_5_0"></a><a id="Tc_gXlGEywnKkSdZF4fpb_52A_6_0"></a><a id="Tc_9NqzL04z5EePDWxpVgH3bg_7_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfRevenueExplanatory" id="Tb_IYFZWAySZ0aXb2pUAxAitw" continuedAt="Tb_IYFZWAySZ0aXb2pUAxAitw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">13.</b></span>Contract revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, AC Immune generated contract revenues of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_vo9mI_8pH0OzU2yTF2pC7g">3.9</ix:nonFraction> million, <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_tyAd-OYe5ky-EjaHZBrU0Q">nil</ix:nonFraction> and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_RiFt_Cc8cEq66zDLEF3I8w">15.4</ix:nonFraction> million, respectively. </p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory" id="Tb_IrTso-g8kkeLlIHkXs5rEQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables provide contract revenue amounts from its LCAs for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Lilly</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_OXAjfAuKLkGrxwLJeL_h4g" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_ep8Z4z_sTUa90H8CFxilAA_4_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_NC-GY6fYlkqMWQ13ktqxIQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_ZHbcREX1cECjqfXRYi6xVg_4_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_R5HPjrhD7kOQFT3FLpl0VQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_R025y4xIwUmXOCkm9T4y9A_4_6">14,348</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Janssen </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_cTOwJWsTfU2wP__TQVaSgw" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_O1ir0WPI-E60Y6c-GH89MQ_5_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_cyiz-Q_qC0uLMdJoM0Mbdw" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_Or72Zub9CkyomvR8Zvhg4w_5_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_HVTIaNw_0UOjUkO5CiRYEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_r3UTzTUuvUuQ4bdD9_QXng_5_6">1,083</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Life Molecular Imaging</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_5kIFcqQdLECCxjdGCPTLvw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_vA6fHyqxtUqH_a4XVULPUg_6_2">3,935</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_WmrQJ8yOykaDFuA8S-ALTg" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_zHdvynl-8U-j920giK70bA_6_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_qwYRZkjqJkCgDZXe1ke0Iw" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_gvpTMlEV10GABgR62A4ljg_6_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total contract revenues</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_DLwdtCkPQ0eAp_FHhorfMA_7_2">3,935</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_8iJ56c-I4UCApjN2GEtAAA_7_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_jJJR1Fvk9kSVz14IiLDD1w_7_6">15,431</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">LMI accounted for <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_5kIFcqQdLECCxjdGCPTLvw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="Narr_rB7Rx2ZcZ0Kt06CQK2-PoQ">100</ix:nonFraction>% of our contract revenues in 2022 and Lilly accounted for <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_NC-GY6fYlkqMWQ13ktqxIQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" id="Narr_wmnqxICdW0GZYQni4WrxBQ">93</ix:nonFraction>% of our contract revenues in 2020.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-26</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ab909c02_971f_43c9_8a1b_cce70bd2453e"></a><a id="Tc_YBpSGlAlLE6gdlqQRiSPJQ_1_2"></a><a id="Tc__Z8iSLOGaEa2HNUD8CtDTw_2_2"></a><a id="Tc_vIPDOgHMW0eIgP5BrL34dw_3_0"></a><a id="Tc_qzWqt4ydxkO3llhwkfjtzw_3_2"></a><a id="Tc_uREy0FsmAE2RdLrVDef5Ag_3_4"></a><a id="Tc_1tOg9Zqm-kGB9XPsXpwybQ_3_6"></a><a id="Tc_MieTE5mRNkyzVe9qz2pTHw_4_0"></a><a id="Tc_Gan1xZBkk0CmdjqzbCROmg_5_0"></a><a id="Tc_hVoLWF5H_0CAqMc_Ky6W7Q_5_4"></a><a id="Tc_XaKk56gkN0-Tblbz6mFJ7w_6_0"></a><a id="Tc_XEpkpNXmHkOG1t6WmCekDA_6_4"></a><ix:continuation id="Tb_IYFZWAySZ0aXb2pUAxAitw_cont1" continuedAt="Tb_IYFZWAySZ0aXb2pUAxAitw_cont2"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory" id="Tb_WTpBIBaDhEO4HOpdfl4Hrw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">During the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company recognized the following contract revenues as a result of changes in the contract asset and the contract liability balances in the respective periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Revenues recognized in the period from:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Amounts included in the contract liability at the beginning of the period </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" scale="3" id="Tc_lQzDCjqqp0yBD4cQu9x1mA_5_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" scale="3" id="Tc_QFLBBnp-mUiW6RglGrULjg_5_6">4,477</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Performance obligations satisfied in previous periods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" scale="3" id="Tc_lgM3oTo8i0umOYBGFwX1Ng_6_2">3,935</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" scale="3" id="Tc_7mErEwNUaE68laGlCAUS1A_6_6">10,000</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">13.1</b></span> Licensing and collaboration agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Morphomer Tau small molecule&#160;&#8211; 2018 license agreement with Eli Lilly and Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2018, we entered into an exclusive, worldwide licensing agreement with Eli Lilly and Company (Lilly) to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases. More specifically, this is an exclusive license with the right to Lilly to grant sublicenses under the ACIU Patents, the ACIU know-how, and ACIU&#8217;s interests in the Joint Patents and the joint know-how to Exploit the Licensed Compounds and Licensed Products. The agreement became effective on January&#160;23, 2019 (the &#8220;effective date&#8221;) when the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired. In Q3 2019, the Company and Lilly entered into the first amendment to divide the first discretionary milestone payment under the agreement of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_COp1pU_2c0K0ifwsTtZrJw" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_FiA59yKKUkSyYLMzDW9GMg">60</ix:nonFraction> million into <ix:nonFraction unitRef="Unit_Standard_installment_mxjM2Rh-sk6ny-HGf2rDww" contextRef="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_g_GGnY_Mek66JNJPv8qF7g" decimals="INF" format="ixt-sec:numwordsen" name="aciu:CollaborativeAgreementMilestonePaymentNumberOfInstallments" scale="0" id="Narr_M-4rc_hzzka6KkVDZi2zBw">two</ix:nonFraction> installments, with the first CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_Quarter32019Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_pnlTLBAOqUyJSsbJhyKKYA" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_OlwSC1OUrUO_wCoS0efpqQ">30</ix:nonFraction> million paid in Q3 2019 and the second CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_3QZoZDHthk6fXZD1NuNlOg" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_kXrWS5DCR0Ca2Jm5Qld5Fg">30</ix:nonFraction> million to be paid on or before March&#160;31, 2020 unless Lilly terminated the agreement earlier. In Q1 2020, the Company and Lilly entered into a second amendment to replace the second CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_UrnH6A3xZ0GUsbQYZdWO-A" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_dTPvIpdjDUuhvZO3xf-gDA">30</ix:nonFraction> million to be paid on or before March&#160;31, 2020 with <ix:nonFraction unitRef="Unit_Standard_installment_mxjM2Rh-sk6ny-HGf2rDww" contextRef="Duration_3_31_2020_To_3_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_POa8drBe6UafiI7IoFhEXw" decimals="INF" format="ixt-sec:numwordsen" name="aciu:CollaborativeAgreementMilestonePaymentNumberOfInstallments" scale="0" id="Narr_kWCDh8vj70CEU9TRsm5HTQ">two</ix:nonFraction> milestone payments, one of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_g8PQeK6MBUOy01cnGHEgHg" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_YN1v5ClHXUS19uni9P2fYg">10</ix:nonFraction> million to be paid on or before March&#160;31, 2020 and the other of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_Bwy5dQAXAEWqqXyDPqgE6Q" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_P7vm4Zj-DUygbxMA8i05fA">60</ix:nonFraction> million following the first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Per the terms of the agreement, the Company received an initial upfront payment of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2019_To_3_31_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_bzzbrZyzREe8dKLr1q4pcA" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_-HJONFkrb0ClKUe1xEzBhQ">80</ix:nonFraction> million in Q1 2019 for the rights granted by the Company to Lilly. To date, the Company has completed a Phase 1 clinical study with ACI-3024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, the Company and Lilly have continued candidate characterization across the research program, identifying new and highly differentiated candidates with desired cerebrospinal fluid exposure and selectivity for pathological aggregated Tau. These will be broadly developed in Tau-dependent neurodegenerative diseases by Lilly. Lilly is responsible for leading and funding further clinical development and will retain global commercialization rights for all indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Per the terms of the agreement, the Company may become eligible to receive additional milestone payments totaling up to approximately CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_Y_oiYfNYLEWs_ZiE9phKFg" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_l38hPz-9RUeXOHsBNm5OAg">880</ix:nonFraction> million for clinical and regulatory milestones and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsCommercialMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_gCSsL-ubc0eIq6zJNtwUCg" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_Rxu-nr8Y8k6izh-NV2crNw">900</ix:nonFraction> million upon achievement of certain commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the low double-digits to the mid-teens. The agreement will terminate by the date of expiration of the last royalty term for the last licensed product. However, under the terms of the agreement, Lilly may terminate the agreement at any time by providing <span style="-sec-ix-hidden:Hidden_K168Qe9Bi02hpV05wXH75Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3&#160;months</span></span>&#8217; prior notice to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Lilly is a customer. The Company identified the following significant performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;research and development activities outlined in the development plan. Per the agreement, the Company was responsible for the preclinical and Phase 1 activities for the first clinical candidate, ACI-3024, which the Company determined was distinct and capable of being completed by Lilly or a third party. Preclinical activities for which AC Immune was responsible prior to their completion in Q2 2019 included final manufacturing of materials for use in the regulatory submission of the protocol and in the Phase 1 study. For the completed Phase 1, AC Immune was responsible for leading the study design, obtaining relevant regulatory agency approvals, arranging necessary third-party contracts, completing patient selection, ensuring patient treatment, following up with patients, drafting the clinical study report </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-27</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_IYFZWAySZ0aXb2pUAxAitw_cont2" continuedAt="Tb_IYFZWAySZ0aXb2pUAxAitw_cont3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">development and other relevant clinical activities to ensure that the primary objective of the study was completed. The Company used CMOs for certain of its preclinical activities and CROs to complete certain Phase 1 activities and to issue the final clinical study report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s preclinical and Phase 1 activities did not represent integrated services with the licensed intellectual property for which Lilly contracted. Lilly purchased a license to the Company&#8217;s Tau therapeutic small-molecule program, which was delivered at commencement of the agreement, and AC Immune&#8217;s preclinical and Phase 1 activities did not affect the form or functionality of this license. The Company&#8217;s objective for the Phase 1 activity was to assess safety and tolerability and did not modify or customize ACI-3024. The completion of these preclinical and Phase 1 activities does not affect the licensed intellectual property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Finally, per the agreement, each party has <ix:nonFraction unitRef="Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_AnT6Y1xoZUO8xgP2BhtXpg" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfRepresentativesInJointSteeringCommitteeByEachParty" scale="0" id="Narr_3jgZ3FZ0PUutj7aJyYJmnQ">three</ix:nonFraction> representatives on a joint steering committee (JSC). Depending upon the agenda, additional field experts can attend the JSC to provide the technical and scientific contribution required. The JSC meets on a regular basis depending on agreements between the representatives. The JSC is responsible for serving as the forum to (i)&#160;discuss, review and approve certain activities by reviewing and discussing the development progress with updates on back-up candidates, (ii)&#160;discuss, review and approve all amendments to the global development plan, (iii)&#160;periodically discuss and review commercialization of licensed products and (iv)&#160;review and approve reports related to development costs among other activities. The JSC is intended to ensure that communication between the parties remains consistent and that the development plan is progressing as intended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The valuation of each performance obligation involves estimates and assumptions with revenue recognition timing to be determined by either delivery or the provision of services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company used the residual approach to estimate the selling price for the right-of-use license and an expected cost plus margin approach for estimating the research and development activities. The right-of-use license was delivered on the effective date. The research and development activities were delivered over time as the services were performed. For these services, revenue was recognized over time using the input method, based on costs incurred to perform the services, as the level of costs incurred over time is thought to best reflect the transfer of services to Lilly. The Company determined the value of the research and development activities to be CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_WVjiu2AWkUC7_73wPEZNAg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ContractAssets" scale="6" id="Narr_1n_acJep70eZL_duseG90g">6.9</ix:nonFraction> million and deferred this balance from the effective date. To date, the Company has cumulatively recognized CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_23_2019_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_boFHM2vJ60aWug_NKJAQTA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_TQvfTNrFm0OA0jN2AQpHuw">6.9</ix:nonFraction> million in contract revenue, resulting in <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_YpfuJbR9Jku9LQlMY-CQVg" decimals="-6" format="ixt-sec:numwordsen" name="ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities" scale="6" id="Narr_JtO6ykEKv0eBBzazgkk2JA">no</ix:nonFraction> deferred income (contract liability) on the consolidated balance sheets. The remaining CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_23_2019_To_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_1Vi83gAQRUCn92QFpovc7Q" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_pvfmMFImMkaZjMaI8PMAVQ">73.1</ix:nonFraction> million from the upfront payment was allocated to the right-of-use license and recognized on the effective date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception of the agreement, none of the clinical, regulatory or commercial milestones had been included in the transaction price, as all milestone amounts were fully constrained. To date, the Company has recognized CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_7_1_2019_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_X7pFxFGHnkKllf5M2sGd6w" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_Mut-PwUrykKUMojVTSp0mQ">40</ix:nonFraction> million from milestone payments triggered in Q3 2019 and Q1 2020 related to the right-of-use license for intellectual property as there were no further constraints related to these milestones. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors to determine that these milestones are not highly probable to obtain, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Lilly and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we have recognized <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_AnT6Y1xoZUO8xgP2BhtXpg" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_iw2sIEGDUk6kYP8S2qJ_Dg">nil</ix:nonFraction>, <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_gScL_dC77kCsTG776ERWNA" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_pI2mEGEijESpx7kxVUUw-Q">nil</ix:nonFraction> and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_UT-qr7yDeESe7RDDN5ti-Q" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_-GzRdPOK9EWhNfR5igtCUw">14.3</ix:nonFraction> million, respectively, from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Anti-Abeta antibody in AD&#160;&#8211; 2006 agreement with Genentech, a member of the Roche Group</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In November&#160;2006, we signed an exclusive, worldwide licensing agreement for crenezumab, our humanized monoclonal therapeutic antibody targeting misfolded Abeta. The agreement was amended March&#160;2009, January&#160;2013, May&#160;2014 and May&#160;2015. The agreement also provides for the development of a second therapeutic product for a non-</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-28</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_IYFZWAySZ0aXb2pUAxAitw_cont3" continuedAt="Tb_IYFZWAySZ0aXb2pUAxAitw_cont4"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">AD indication based on the same intellectual property and anti-Abeta antibody compound. The value of this partnership is potentially greater than USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_VzztEIOlRE2c1SoXK6RQgg" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_K2dsqN__fUGYSMICn5Xpzg">340</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_VzztEIOlRE2c1SoXK6RQgg" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_4ohJ8SM42UKnXVMzQHRjeA">317</ix:nonFraction>) million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The term of the agreement commenced on the effective date and, unless sooner terminated by mutual agreement or pursuant to any other provision of the agreement, terminates on the date on which all obligations between the parties with respect to the payment of milestones or royalties with respect to licensed products have passed or expired. Either party may terminate the agreement for any material breach by the other party, provided a cure period of <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__hddlRQFkkqifIU3xGWEIw" format="ixt-sec:durday" name="aciu:CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" id="Narr_XThi9KlNvkq5DaoZuwWQZQ">90</ix:nonNumeric>&#160;days from the date when that notice is given.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Genentech commenced a first Phase 3 clinical study in March&#160;2016 for crenezumab&#160;(CREAD). In March&#160;2017, Genentech started a second Phase 3 clinical trial (CREAD 2). Since 2013, crenezumab has also been studied in a Phase 2 preventive trial in individuals who carry the PSEN1 E280A autosomal-dominant mutation and do not meet the criteria for mild cognitive impairment due to AD or dementia due to AD and are, thus, in a preclinical phase of&#160;AD&#160;(autosomal dominant AD (ADAD)). In 2019, Genentech initiated a Tau Positron Emission Tomography (PET) substudy to the ongoing Phase 2 trial in ADAD to evaluate the effect of crenezumab on Tau burden, which may also increase the understanding of disease progression in the preclinical stage of ADAD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If crenezumab receives regulatory approval, we will be entitled to receive royalties that are tied to annual sales volumes with different royalty rates applicable in the U.S. and Europe ranging from the mid-single digits to mid-teens. To date, we have received total milestone payments of USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_AEaXqV6uYU2YSJVL94SJpg" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementCumulativePaymentsReceived" scale="6" id="Narr_gFBwD0n52U2GP3UZsII3dQ">65</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_AEaXqV6uYU2YSJVL94SJpg" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementCumulativePaymentsReceived" scale="6" id="Narr_LYMAcbl27EC4BGZgt72A2Q">70.1</ix:nonFraction>) million comprised of an upfront payment of USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__PSR-FnhukSI5DOP7kxVxw" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementUpfrontPaymentsReceived" scale="6" id="Narr_XT9gxTKjHkq5xoNv_PdqtA">25</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__PSR-FnhukSI5DOP7kxVxw" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementUpfrontPaymentsReceived" scale="6" id="Narr_NdAoD8DnxUOGNaWr9jMQSA">31.6</ix:nonFraction>) million and of USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesAchievedPriorTo1January2017Member_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_bi-vVw0ymkK92cjHErDo8Q" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_XoRMprpRkU-BEoBnLB4jKQ">40</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesAchievedPriorTo1January2017Member_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_bi-vVw0ymkK92cjHErDo8Q" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_bRtagAdsL0uk_8r2L5TWFA">38.2</ix:nonFraction>) million for clinical development milestones achieved all-in prior to January&#160;1, 2017. Genentech may terminate the agreement at any time by providing <span style="-sec-ix-hidden:Hidden_EdaFR7KmDE28JCeL6L0nxw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3&#160;months</span></span>&#8217; notice to us. In such event all costs incurred are still refundable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Genentech is a customer. The Company identified the following performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;conducting of research under a research plan. The Company considered the research and development capabilities of Genentech and Genentech&#8217;s right to sublicense to conclude that the license has stand-alone functionality and is distinct. The Company&#8217;s obligation to perform research does not significantly impact or modify the licenses&#8217; granted functionality.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At execution of the agreement, the transaction price included the upfront consideration received of USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_bmdNVxjd7kCcxLTi4MiPYg" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ContractLiabilities" scale="6" id="Narr_kzTgRojOYUeVMb_5UunyEQ">25</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_bmdNVxjd7kCcxLTi4MiPYg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ContractLiabilities" scale="6" id="Narr_7W4psCdHiUC1nBAdGVuVNw">31.6</ix:nonFraction>) million. At inception, none of the clinical or regulatory milestones had been included in the transaction price, as all milestone amounts were fully constrained. The Company has received <ix:nonFraction unitRef="Unit_Standard_payment_b5_XsToWrkW99sPOvgoheg" contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__PSR-FnhukSI5DOP7kxVxw" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfMilestonePaymentsReceived" scale="0" id="Narr_upVaXWhVgkiyNK9TVOX2fQ">three</ix:nonFraction> milestone payments since inception, totaling USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__PSR-FnhukSI5DOP7kxVxw" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_F3ZNKQsKhUiSDeOMyL10Aw">40</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__PSR-FnhukSI5DOP7kxVxw" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_0joF8rPjTEGN8pA9IrYV-g">38.2</ix:nonFraction>) million. The Company could receive greater than USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_VzztEIOlRE2c1SoXK6RQgg" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_vpBYDTVG9k2XsQ_ukht8Rg">275</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_VzztEIOlRE2c1SoXK6RQgg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_QcCySBJ6Uk-C8x-Mx42FMw">256.4</ix:nonFraction>) million or more for further regulatory milestones for this exclusive, worldwide alliance. In assessing that future regulatory milestones are fully constrained, the Company considered numerous factors, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts. Any consideration related to royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Genentech and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In January 2019, we announced that Roche, the parent of Genentech, is discontinuing the CREAD and CREAD 2 (BN29552 and BN29553) Phase 3 studies of crenezumab in people with prodromal-to-mild sporadic AD. The decision came after an interim analysis conducted by the Independent Data Monitoring Center (IDMC) indicated that crenezumab was unlikely to meet its primary endpoint of change from baseline in CDR-SB Score. This decision was not related to the safety of the investigational product. No safety signals for crenezumab were observed in this analysis and the overall safety profile was similar to that seen in previous trials.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we have recognized <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="Duration_1_1_2020_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_PrKPmhCrP0ePfbwTC-yXHA" decimals="-6" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_nSV4O9pDqEu-KEGsokwdtA">no</ix:nonFraction> revenues from this arrangement.</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-29</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_IYFZWAySZ0aXb2pUAxAitw_cont4" continuedAt="Tb_IYFZWAySZ0aXb2pUAxAitw_cont5"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Anti-Tau antibody in AD&#160;&#8211; 2012 agreement with Genentech, a member of the Roche Group</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In June&#160;2012, we entered into a second agreement with Genentech to research, develop and commercialize our anti-Tau antibodies for use as immunotherapeutics and diagnostics. The agreement was amended in December&#160;2015. The value of this exclusive, worldwide alliance is potentially greater than CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_6_30_2012_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_W_xvSn3aIUSy0b2g6uFBPw" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_OEGzmAvYc0WNqhP3bhrQNA">400</ix:nonFraction> million and includes upfront and clinical, regulatory and commercial milestone payments. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the mid-single digits to low-double digits. The agreement also provides for collaboration on at least one additional therapeutic indication outside of AD built on the same anti-Tau antibody program as well an anti-Tau diagnostic product.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The term of the agreement commenced on the effective date and, unless sooner terminated by mutual agreement or pursuant to any other provision of the agreement, terminates on the date on which all obligations between the parties with respect to the payment of milestones or royalties with respect to licensed products have passed or expired. Either party may terminate the agreement for any material breach by the other party, provided a cure period of <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_8iFSlULEHU-tuNl09k6RZA" format="ixt-sec:durday" name="aciu:CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" id="Narr_JnIwxikGckOxHBrwqfP47A">90</ix:nonNumeric>&#160;days from the date when that notice is given.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, we have received payments totaling CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_Xs05KeXY_USgX2n0OcnZ7Q" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementCumulativePaymentsReceived" scale="6" id="Narr_fSIwXQiqykuebiyjvAo9gw">59</ix:nonFraction> million, including a milestone payment of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_10_1_2017_To_12_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_MJWKVhi5Mke2_vbucOqWPQ" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_pHFaluSoz0awOQWB2OQCBQ">14</ix:nonFraction> million received and <span style="-sec-ix-hidden:Hidden_751hiZiX7EinZNcM4zz_ew;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">recognized</span></span> in Q4 2017 associated with the first patient dosing in a Phase 2 clinical trial for AD with an anti-Tau monoclonal body known as semorinemab, a milestone payment of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_4_1_2016_To_6_30_2016_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_otQ-b1w0b0OqUhWtsoKp6Q" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_z2DiRnP55k6sCGtGM_Qaig">14</ix:nonFraction> million recognized in Q2 2016 and <span style="-sec-ix-hidden:Hidden_5oAu63RdGkGFjzGDsCTBog;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">received</span></span> in July&#160;2016, associated with the announcement of the commencement of the Phase 1 clinical study of semorinemab, and a milestone payment of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_FNJ-cLjT602Qc6SGy47cbA" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_jq6dKrbkckiAyKKDpUtmIg">14</ix:nonFraction> million received in 2015 in connection with the ED-GO decision. As we met all performance obligations on reaching these milestones, we have recognized revenue in the respective periods. Genentech may terminate the agreement at any time by providing <span style="-sec-ix-hidden:Hidden_lTC6TFzT5kGupQPYn0M3yQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3&#160;months</span></span>&#8217; notice to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Genentech is a customer. The Company identified the following performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;conduct of research under a research plan. The Company considered the research and development capabilities of Genentech and Genentech&#8217;s right to sublicense to conclude that the license has stand-alone functionality and is distinct. The Company&#8217;s obligation to perform research does not significantly impact or modify the licenses&#8217; granted functionality.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At execution of the agreement, the transaction price included an upfront consideration received of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_6_30_2012_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_p2DjH8za9kC0HB1u8L2hcw" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ContractLiabilities" scale="6" id="Narr_FUCrKKqDjUG3GOWUKsRtwQ">17</ix:nonFraction> million. At inception, none of the clinical or regulatory milestones had been included in the transaction price, as all milestone amounts were fully constrained. The Company has received <ix:nonFraction unitRef="Unit_Standard_payment_b5_XsToWrkW99sPOvgoheg" contextRef="Duration_6_1_2012_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_wmwel6uA20-BMX_QzPDtJg" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfMilestonePaymentsReceived" scale="0" id="Narr_Nkd6uw4egUWFY_NPfSms7A">three</ix:nonFraction> milestones since inception totaling CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_6_1_2012_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_wmwel6uA20-BMX_QzPDtJg" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_E3w-67vVQ06z02026zPFUA">42</ix:nonFraction> million. The Company could also receive up to an additional CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_350QXz6QwEuA8d1zj8O5MA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_uyqhMEqqGUCDzPLmR7M6dQ">368.5</ix:nonFraction> million in clinical, regulatory and commercial milestones. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Genentech and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In September 2020, the Company reported that Genentech informed us of top line results from a Phase 2 trial of the anti-Tau antibody, semorinemab, in early (prodromal to mild) Alzheimer&#8217;s disease (AD) which show that semorinemab did not meet its primary efficacy endpoint of reducing decline on CDR-SB compared to placebo. The primary safety endpoint was however met. Two secondary endpoints, Alzheimer&#8217;s Disease Assessment Scale-Cognitive Subscale 13 (ADAS-Cog13) and Alzheimer&#8217;s Disease Cooperative Study Group&#160;&#8211; Activities of Daily Living Inventory (ADCS-ADL), were not met.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In August 2021, the Company reported that Genentech had informed the Company that the Lauriet study had met one of its co-primary endpoints, ADAS-Cog 11. The second co-primary endpoint, ADCS-ADL, was not met. Safety data showed that semorinemab was well tolerated with an acceptable safety profile and no unanticipated safety signals. In November 2021, the Company reported that Genentech had presented the full top-line data from the Lauriet study during a late-breaking session at the 14<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Clinical Trials on Alzheimer&#8217;s Disease conference.</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-30</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_IYFZWAySZ0aXb2pUAxAitw_cont5" continuedAt="Tb_IYFZWAySZ0aXb2pUAxAitw_cont6"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we have recognized <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_S211XVhLiUqZCj3v114p0Q" decimals="-6" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_wHYm6jx7U0y52cahY_kDlw">no</ix:nonFraction> revenues from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Tau vaccine in AD&#160;&#8211; 2014 agreement with Janssen Pharmaceuticals,&#160;Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2014, we entered into an agreement with Janssen Pharmaceuticals,&#160;Inc. (Janssen), part of the Janssen Pharmaceutical Companies of Johnson&#160;&amp; Johnson, to develop and commercialize therapeutic anti-Tau vaccines for the treatment of AD and potentially other Tauopathies. The value of this collaboration is potentially up to CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zNVkSV70P0yTTv0hw3xQ6Q" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_YSG_8QkNpUmwDswacIHToA">500</ix:nonFraction> million and includes upfront and clinical, regulatory and commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the high-single digits to the mid-teens for the phospho-Tau vaccine program. In April&#160;2016, July&#160;2017, January&#160;2019, November&#160;2019 and December 2022, the companies entered into the first, second, third, fourth and fifth amendments, respectively. These amendments allow for the alignment of certain payment and activity provisions with the Development Plan and Research Plan activities. We and Janssen have completed the co-development of the second-generation lead therapeutic vaccines, ACI-35.030 and JACI-<span style="white-space:pre-wrap;">35.054, through Phase 1b/2a. In November 2022, it was announced that ACI-35.030 was selected to advance into further development based on interim data from the ongoing Phase 1b/2a trial. AC Immune and Janssen will jointly share research and development costs until the completion of the first Phase 2b (AC Immune&#8217;s contribution to the first Phase 2b trial is capped). From Phase 2b and onwards, Janssen will assume responsibility for the clinical development, manufacturing and commercialization of ACI-35.030.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the terms of the agreement, Janssen may terminate the agreement at any time after completion of the first Phase 1b clinical study in 2016 by providing <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_H7MVafWwHEm7SebhAlCksg" format="ixt-sec:durday" name="aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod" id="Narr_ZIRQcI2ZvUS1zKIsTpw2hQ">90</ix:nonNumeric>&#160;days&#8217; notice to us. If not otherwise terminated, the agreement shall continue until the expiration of all royalty obligations as outlined in the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The agreement also allows for the expansion to a second indication based on the same anti-Tau vaccine program and based on intellectual property related to this program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company received an upfront, non-refundable license fee of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_12_1_2014_To_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_Of8RE1HgdEy1bhmDA0BgDw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_UBOwX4kClkK80gl-C_pjqQ">25.9</ix:nonFraction> million, which we recognized as revenue in 2014. In May&#160;2016, we received a payment of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_5_1_2014_To_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_Z_bscP2Znk-KSY2VCxYJ7g" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_ph_g5pxk9EmCUKoLDu4x4w">4.9</ix:nonFraction> million for reaching a clinical milestone in the first Phase 1b study. As we met all performance obligations on reaching the milestone, we have recognized this income as revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Janssen is a customer. The Company identified the following performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;research and development services including a development and chemistry, manufacturing and controls work plan. The Company considered the research and development capabilities of Janssen, Janssen&#8217;s right to sublicense, and the fact that the research and development services are not proprietary and can be provided by other vendors, to conclude that the license has stand-alone functionality and is distinct. The Company&#8217;s obligation to perform research and development services does not significantly impact or modify the licenses&#8217; granted functionality. Based on these assessments, the Company identified the license and the research and development services as the performance obligations at the inception of the arrangement, which were deemed to be distinct in the context of the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At execution of the agreement, the transaction price included only the upfront consideration received of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_12_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_tyfTe8DeCUaagdCn6T7Ejg" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementUpfrontPaymentsReceived" scale="6" id="Narr_1JJdv4MkjE-HCnmszcfGfg">25.9</ix:nonFraction> million. At inception, none of the clinical, regulatory or commercial milestones has been included in the transaction price, as all milestone amounts were fully constrained. The Company did receive a payment of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_5_1_2016_To_5_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_GSgSGJWKA0qol0w8MEEp6A" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_AFB3G1nUIUi8RrBOuwhSsA">4.9</ix:nonFraction> million for reaching a clinical milestone in the first Phase 1b study in May&#160;2016. The Company could also receive up to more than CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_VYzjzXZlKEGZio3O0wX8zQ" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_lAP1Tzh7TEG3xIgtQ3mymw">458</ix:nonFraction> million in clinical, regulatory and commercial milestones as well as tiered, high-single digits to mid-teen royalties on aggregate net sales for the phospho-Tau vaccine program. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors to determine that these milestones are not highly probable to obtain, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Janssen and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-31</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_IYFZWAySZ0aXb2pUAxAitw_cont6" continuedAt="Tb_IYFZWAySZ0aXb2pUAxAitw_cont7"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we have recognized <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_H7MVafWwHEm7SebhAlCksg" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_EYIkTJ5Or0WAwhB-_238tA">nil</ix:nonFraction>, <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_E0eBhnZuvkCP7QsmGzZ-7g" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_grPIrSQO7UepoL-NxkKUcw">nil</ix:nonFraction> and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_UUY8TErzyUuTQ6n10-1E8g" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_BhX9AqrYA0e3jJPzigELMA">1.1</ix:nonFraction> million, respectively, from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Tau-PET imaging agent&#160;&#8211;2014 agreement with Life Molecular Imaging (LMI) (formerly Piramal Imaging SA)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2014 (as amended in June 2022), we entered into an agreement, our first diagnostic partnership, with LMI, the former Piramal Imaging SA. The partnership with LMI is an exclusive, worldwide licensing agreement for the research, development and commercialization of the Company&#8217;s Tau protein PET tracers supporting the early diagnosis and clinical management of AD and other Tau-related disorders and includes upfront and sales milestone payments totaling up to EUR <ix:nonFraction unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA" contextRef="As_Of_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_gQeJGG83pUqW7L5LjJMSiw" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_Znq3tDIaSEyK3XZCsxbWTw">160</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_gQeJGG83pUqW7L5LjJMSiw" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_wBQ1cydFXUWRYgAiC1HU2g">159</ix:nonFraction>) million, plus royalties on sales at a&#160;percentage rate ranging from mid-single digits to low-teens. LMI may terminate the LCA at any time by providing <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_vJPsPHg5JUivymFY6lpR6A" format="ixt-sec:durmonth" name="aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod" id="Narr_jvXdHUTIuEyusIjK4UfzQw">3</ix:nonNumeric>&#160;months&#8217; notice to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with this agreement, AC Immune received a payment of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA" contextRef="Duration_12_31_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_9CqaxvHCr0-iuqlmAvYvdw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Narr_VVaLq2sNs0ahHnqW0Tx4LQ">500</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_12_31_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_9CqaxvHCr0-iuqlmAvYvdw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Narr_k3hhQv8XgEuQoIopsLnvBA">664</ix:nonFraction>) thousand, which was fully recognized in 2015. In Q1 2017, we recorded a milestone payment of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA" contextRef="Duration_1_1_2017_To_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_p7AlCw_1wU-ARo-yBLe5DA" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_x3QSRP4VYU2AsjhW0-b1gg">1</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2017_To_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_p7AlCw_1wU-ARo-yBLe5DA" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_MdSDnuJ5Vkas_wFAX_Nd0A">1.1</ix:nonFraction>) million related to the initiation of &#8220;Part&#160;B&#8221; of the first-in-man Phase 1 study. In Q3 2019, the Company recognized EUR <ix:nonFraction unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA" contextRef="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_IS1IteWIxESboEBvGakY4g" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_Pee-0a9_hESEFehyjBUxZg">2</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_IS1IteWIxESboEBvGakY4g" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_OAsQjtjdakuj1QnS_guPuQ">2.2</ix:nonFraction>) million in connection with the initiation of a Phase 2 trial of Tau-PET tracer in patients with mild cognitive impairment and mild&#8211;to-moderate AD in comparison with non-demented control participants. In Q3 2022, the Company recognized EUR <ix:nonFraction unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA" contextRef="Duration_7_1_2022_To_9_30_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_exnjXylyHUGgFwmQMBb9bQ" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_pYrfD9Hoh0KeTX6FbSnmYQ">4</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_7_1_2022_To_9_30_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_exnjXylyHUGgFwmQMBb9bQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_dUdj_8jm8EGAK5Oln49Tdw">3.9</ix:nonFraction>) million linked to the progression of the Tau-PET tracer into late-stage development in AD. The Company is eligible to receive additional variable consideration related to the achievement of certain clinical milestones totaling EUR <ix:nonFraction unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA" contextRef="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_y5HiWeAgl0qm7JANOOw7-w" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_GR8EB6bEJU2wAil-xowniQ">4</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_y5HiWeAgl0qm7JANOOw7-w" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_FQFo9pbZIUubyNFFkJTbQw">4</ix:nonFraction>) million should the compound make it through Phase 3 clinical studies. We are also eligible to receive potential regulatory and sales-based milestones totaling EUR <ix:nonFraction unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA" contextRef="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RegulatoryAndSalesBasedMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_kiAkuYc_KUS-yeLR_XxzfA" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_HdkCcyGAP0SQr_wGBG7vsQ">148</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RegulatoryAndSalesBasedMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_kiAkuYc_KUS-yeLR_XxzfA" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_x-PoUfxfOECJtMGGde95kA">138</ix:nonFraction>) million. Finally, the Company is eligible for royalties from the mid-single digits to low-teens.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that LMI is a customer. The Company has identified that the right-of-use license as the only performance obligation. The Company determined that transaction price based on the defined terms allocated to each performance obligation specified in the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The upfront payment constitutes the amount of consideration to be included in the transaction price and has been allocated to the license. None of the clinical, regulatory or commercial milestones has been included in the transaction price as these variable consideration elements are considered fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as these amounts have been determined to relate predominantly to the license granted to LMI and therefore are recognized at the later of when the performance obligation is satisfied or the related sales occur. The Company considered LMI&#8217;s right to sublicense and develop the Tau protein PET tracers, and the fact that LMI could perform the research and development work themselves within the license term without AC Immune, to conclude that the license has stand-alone functionality and is distinct. The Company believes that the contracted amount represents the fair value. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company has recognized CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_vJPsPHg5JUivymFY6lpR6A" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_3I_bAhLDGkis-jAqRnfL2A">3.9</ix:nonFraction> million, <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_DhDLnGHqvEOBmhLvYjbgNQ" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_LxGw5KY_yUWL1lS6Zbmygg">nil</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_z90wXTf3ike4CAeXE1FQtA" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_6loym18mGkaGQeoZsaFp9A">nil</ix:nonFraction>, respectively, from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">13.2</b></span> Grant income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Grants from the Michael J. Fox Foundation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In May&#160;2020, the Company, as part of a joint arrangement with Sk&#229;ne University Hospital (Sk&#229;ne) in Sweden, was awarded a USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_8o7ayFkxUESxL5ih3O1fWA" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_lfdfmU23-0ea_kf4pEJiuw">3.2</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_8o7ayFkxUESxL5ih3O1fWA" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_PNE-7wwlL0qTcMz7G_bQyQ">3.0</ix:nonFraction>) million grant from the MJFF&#8217;s Ken Griffin Alpha-synuclein Imaging Competition. As part of this grant, AC Immune is eligible to receive USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_8o7ayFkxUESxL5ih3O1fWA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_Lz1r-spvx02OPKuJXvAoww">2.5</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_8o7ayFkxUESxL5ih3O1fWA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_pR96c5Eevkmt4BAyWm4k5g">2.3</ix:nonFraction>) million directly from the MJFF. Sk&#229;ne will receive USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_5_31_2020_ifrs-full_CounterpartiesAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7QQTH7tA1kOhyo9N6XlPwQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_i4fUPCrVrkmT7uI-FmQZbg"><ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_5_31_2020_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_EU9FlszNzkOBH2Bx99PAbQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_tW60-YQtv02qoHCD1Vle4w">0.7</ix:nonFraction></ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_5_31_2020_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_EU9FlszNzkOBH2Bx99PAbQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_bJCRdDLvIEOKdb_uBg7Wow">0.7</ix:nonFraction>) million of the total grant directly from the MJFF over <span style="-sec-ix-hidden:Hidden_CDAuGzNdHk259o1JNxYdiA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two</span></span>&#160;years to conduct and support the clinical arm of the project. In August 2022, the Company received follow-on grant funding as part of its joint </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-32</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_IYFZWAySZ0aXb2pUAxAitw_cont7"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">arrangement with Sk&#229;ne in Sweden totaling USD&#160;<ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7U3WtCFvFkm-psn0Ha35Tw" decimals="-5" format="ixt:numdotdecimal" name="aciu:FollowOnGrantFundingReceivedTotalForJointArrangement" scale="6" id="Narr_exbe_TyoZ0GRTho0v0CNGA">0.5</ix:nonFraction>&#160;(CHF&#160;<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7U3WtCFvFkm-psn0Ha35Tw" decimals="-5" format="ixt:numdotdecimal" name="aciu:FollowOnGrantFundingReceivedTotalForJointArrangement" scale="6" id="Narr_ICoY_7ZCzUOx0wX63v2o-Q">0.5</ix:nonFraction>) million for the continued development of its alpha-synuclein PET imaging diagnostic agent. As part of this grant, AC Immune received USD&#160;<ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7U3WtCFvFkm-psn0Ha35Tw" decimals="-5" format="ixt:numdotdecimal" name="aciu:FollowOnGrantFundingReceived" scale="6" id="Narr_PsA0wTXFLkGuSz4BHA3MRA">0.4</ix:nonFraction>&#160;(CHF&#160;<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7U3WtCFvFkm-psn0Ha35Tw" decimals="-5" format="ixt:numdotdecimal" name="aciu:FollowOnGrantFundingReceived" scale="6" id="Narr_G6WDFU6ZKUOkdA4BmKTyKg">0.4</ix:nonFraction>) million directly from the MJFF. Sk&#229;ne will receive USD&#160;<ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_8_31_2022_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_d5f6dTO6oUOtx2ATln4mKQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_-nqhMscUEEaZNsWr9TFVSA">0.1</ix:nonFraction>&#160;(CHF&#160;<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_8_31_2022_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_d5f6dTO6oUOtx2ATln4mKQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_az5aHRAwj0CuQ3YcVDpG0g">0.1</ix:nonFraction>) million of the total grant directly from the MJFF over the duration of the grant period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The MJFF expects that AC Immune and Sk&#229;ne will complete tasks according to the agreed timelines. AC Immune&#8217;s funding is variable depending on the satisfactory achievement of these specific tasks within a specific period of time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2021, the Company announced that it had been awarded <ix:nonFraction unitRef="Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_T-iM5RqNsUG9c1FH7HG0Xg" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfGrants" scale="0" id="Narr_VTgmtoSWDUmvxfW9MKC6iw">two</ix:nonFraction> grants totaling USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_4CLZPTp1GUqRjsICkJnChA" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_jHk3xpEgaECFoRgoBcIw1g">1.5</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_4CLZPTp1GUqRjsICkJnChA" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_jUWk6oqSO0CIOONGgOpG-w">1.4</ix:nonFraction>) million to advance small molecule PD programs. One award will support an existing early-stage program to develop small molecules that can prevent intracellular aggregation and spreading of a-syn. The other award will fund research on the therapeutic potential of chemically and mechanistically novel, brain penetrant small molecule inhibitors of NLRP3 inflammasome activation for the treatment of PD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company has recognized CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_DHftPCO4NE2baGCu__fDLw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_ZlvMCyEhd06v36FLBAxB1w">1.2</ix:nonFraction> million, CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_p0DVrOsbeESsVkNWccV14A" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_Cj5rqhDj_EeUWvUOP5yDGQ">1.1</ix:nonFraction> million and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_JA3yekIlVkiUYduc0Mu4Qw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_WAnCPO56Rk2o9gbKPmKdZg">1.3</ix:nonFraction> million, respectively, from its MJFF grants. As of December&#160;31, 2022, the Company recorded CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_KqUnpfq9E0mC3M7Pc6ReGA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets" scale="6" id="Narr_mxDckugLT0C1KM3N-nAdxw">0.3</ix:nonFraction> million in accrued income and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_KqUnpfq9E0mC3M7Pc6ReGA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities" scale="6" id="Narr_YSD3OZZgNEyTfs8gPTmFmQ">0.5</ix:nonFraction> million in deferred income, respectively.</p></ix:continuation><a id="_312f105c_3db6_4036_b359_e34751e1a777"></a><a id="Tc_EHbJnQQinEegnc9vd0K0Wg_1_2"></a><a id="Tc_OPb3rQzZcUaNcKaQYsBWvg_2_2"></a><a id="Tc_hLczs9SFVUqF2Sgb-hyVLQ_3_0"></a><a id="Tc_sPSaF2u9cUq0lxv0zYuGGQ_3_2"></a><a id="Tc_bYUvBNLwfkO0pUer-yhBrg_3_4"></a><a id="Tc_cBW1-9do9EK2AO-fuK-wSQ_3_6"></a><a id="Tc_B-LCLaG2VUyYLTBmDcXc0w_4_0"></a><a id="Tc_KyxPF_5U4keS9gkvvDiXiA_5_0"></a><a id="Tc_gC565cHEh02_HkTWgI1Vnw_6_0"></a><a id="Tc_ebu3ACpQ7UCT6u2Y2Cng5Q_7_0"></a><a id="_5fe3fca3_65d6_41c5_95b4_f7ed198f2e4c"></a><a id="Tc_x7CbnlrboUiiCQCjQ_B1bw_1_2"></a><a id="Tc_UiIM1VV52kCI2oNprh-0Nw_2_2"></a><a id="Tc_33GnycBPYkiX3B3zlHN4DQ_3_0"></a><a id="Tc_WO44wkhmKkqaK5NxaSaAGQ_3_2"></a><a id="Tc_UItqpc4V40O36J_Seu0k5w_3_4"></a><a id="Tc_kliRbhDcOkOFOemcMiRswg_3_6"></a><a id="Tc_xAkZjqQbBkm841gxaBYfVQ_4_0"></a><a id="Tc_8ARlSXwnikm7dIsZ7Op9oA_5_0"></a><a id="Tc__BwexVwgzEiC_3fM5sUd4A_6_0"></a><a id="Tc_-gISLjaZPkmjPNhs0wJbig_7_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfExpensesExplanatory" id="Tb_lBe-O8TBzEq8ENE1bIhtPg" continuedAt="Tb_lBe-O8TBzEq8ENE1bIhtPg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">14.</b></span>Expenses by category</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory" id="Tb_pbd7FUdXiEy4AWrLDlU5cQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">Research and development</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Operating expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_IzCNAkBBO0a8Nlx67vKOBg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_T0kmEycIC0yihek8aQD9Dg_4_2">41,166</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_rUIgTjQ7OkGwKJ7QeHVyyw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_ysdDdUr3Uk2wl7yiGBo47g_4_4">44,289</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_LMCpazElS0WvFLxSamO-Xw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_IDHVLAnhpU2s3eOBeEH61g_4_6">43,787</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_IzCNAkBBO0a8Nlx67vKOBg" decimals="-3" format="ixt:numdotdecimal" name="aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation" scale="3" id="Tc_Evn2pSkHOUuEhPY5xH_ZXw_5_2">17,548</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_rUIgTjQ7OkGwKJ7QeHVyyw" decimals="-3" format="ixt:numdotdecimal" name="aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation" scale="3" id="Tc_diET6wtgmU-d3uEDOj051A_5_4">16,465</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_LMCpazElS0WvFLxSamO-Xw" decimals="-3" format="ixt:numdotdecimal" name="aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation" scale="3" id="Tc_ws_xy6Hv6k-wvM01hX_pTQ_5_6">14,424</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_IzCNAkBBO0a8Nlx67vKOBg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_Z6Zc1SPmqEiaVifqvqjqvQ_6_2">1,622</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_rUIgTjQ7OkGwKJ7QeHVyyw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_qUBEmJEwAUy22FgHoBgXLg_6_4">1,528</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_LMCpazElS0WvFLxSamO-Xw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_mr1Pk2cJ0kal0SjXyLphVA_6_6">1,276</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total research and development expenses </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_IzCNAkBBO0a8Nlx67vKOBg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseByNature" scale="3" id="Tc_1tCT0s8pGkeDoyC6VoeblQ_7_2">60,336</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_rUIgTjQ7OkGwKJ7QeHVyyw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseByNature" scale="3" id="Tc_kZuGGGtYyEqvkvtjcZN6bw_7_4">62,282</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_LMCpazElS0WvFLxSamO-Xw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseByNature" scale="3" id="Tc_QB5yyJYS5E68k40yH7l6PQ_7_6">59,487</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company incurred CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="Narr_nM4rZRaSu0mznLzAxZKkHA">60.3</ix:nonFraction> million, CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="Narr_pKUKZWogpki1FrEKFCnaqQ">62.3</ix:nonFraction> million and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="6" id="Narr_2nrtzDBNUE24ceJ5QIhCbA">59.5</ix:nonFraction> million in research and development expenses, respectively. The decrease in 2022 is mainly driven by decreases in direct R&amp;D expenditures across various programs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company had <ix:nonFraction unitRef="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_IzCNAkBBO0a8Nlx67vKOBg" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="Narr_2PadqyOau0uJvgdq5YvIGA">122.4</ix:nonFraction>, <ix:nonFraction unitRef="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_rUIgTjQ7OkGwKJ7QeHVyyw" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="Narr_MMl4T5bx1U-T7FQshrql8A">108.6</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_LMCpazElS0WvFLxSamO-Xw" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="Narr_VGIe3gCyQEGbsi7mVB5UKQ">115.3</ix:nonFraction> FTEs in our research and development functions.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory" id="Tb_-MBbQvsxa0eLFcj9V4OJvg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">General and administrative</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Operating expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_V234l1xFRUG6YB4I0Vptfw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_qLS4gVlzZ0itDc0681ZUUg_4_2">6,207</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9o_550cVrU6jieJwj_AJUw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_mjHhn26aJECuFxcoRtDhKA_4_4">7,031</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6WGIoNrd4USstG13uKvUOQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_kH7GA4MniUGO6Pcf0VaOKA_4_6">7,471</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_V234l1xFRUG6YB4I0Vptfw" decimals="-3" format="ixt:numdotdecimal" name="aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation" scale="3" id="Tc_-LwA9eIxgUqvEz4bkimLpA_5_2">7,874</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9o_550cVrU6jieJwj_AJUw" decimals="-3" format="ixt:numdotdecimal" name="aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation" scale="3" id="Tc_7B1gVkpHbUibO48DL04t1g_5_4">8,281</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6WGIoNrd4USstG13uKvUOQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation" scale="3" id="Tc_ZJsVx8DWEUuMh8ZSu08HAg_5_6">8,274</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_V234l1xFRUG6YB4I0Vptfw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_eqaYs6cY-UKaEAg8wEo6qQ_6_2">1,708</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9o_550cVrU6jieJwj_AJUw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_3SuOcixZakGVbyjJ2_GJpQ_6_4">2,598</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6WGIoNrd4USstG13uKvUOQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_9fdtctSSxEaKmbpB--I6ew_6_6">2,812</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total general and administrative expenses </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_V234l1xFRUG6YB4I0Vptfw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseByNature" scale="3" id="Tc_9PMsn0gad0eC5JKLMsFkAw_7_2">15,789</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9o_550cVrU6jieJwj_AJUw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseByNature" scale="3" id="Tc_ZSgXB6QYu0KnaMfmOQWHlA_7_4">17,910</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6WGIoNrd4USstG13uKvUOQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseByNature" scale="3" id="Tc_fI_q3FBuQ02jrnO4g4AN8w_7_6">18,557</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company incurred CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="6" id="Narr_XnHFjtYB40Cm9QQMtHdpkQ">15.8</ix:nonFraction> million, CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="6" id="Narr_aXIv4EB-AEizHDKhki-uQA">17.9</ix:nonFraction> million and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="6" id="Narr_KV0f1HutGUKvc4chBeQfEg">18.6</ix:nonFraction> million in general and administrative expenses, respectively. The decrease in 2022 compared with the prior&#160;year predominantly relates to certain transaction costs associated with our prior year asset acquisition which did not repeat in 2022 as well as a reduction in headcount.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-33</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ce958e8c_1680_4386_816d_ee5d747e635d"></a><a id="Tc_NYj1UD41BkGR5-MGG16DCw_1_2"></a><a id="Tc_HHLLimaKeEyE1IfeK6GVnQ_2_2"></a><a id="Tc_35845q4J6US-1kMzDIOeWA_3_0"></a><a id="Tc_uKyfVyXGIEGjvW2ffU5wWA_3_2"></a><a id="Tc_DLac1xNgvEO7_-Cp4-e9vA_3_4"></a><a id="Tc_bVaFELYXMEWWx3wyEheipQ_3_6"></a><a id="Tc_WJZaplu39EGAUVunN8yUqg_4_0"></a><a id="Tc_n8nuGOv8NE6SM56B0EAXyA_5_0"></a><a id="Tc_NkLWfFxYSkKmIUlsWe7wBA_6_0"></a><a id="Tc_85WaRT_kQESGfKHgShl6sQ_7_0"></a><ix:continuation id="Tb_lBe-O8TBzEq8ENE1bIhtPg_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company had <ix:nonFraction unitRef="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_V234l1xFRUG6YB4I0Vptfw" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="Narr_9yCeSwJN_UC7zkCHREYJCA">22.5</ix:nonFraction>, <ix:nonFraction unitRef="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9o_550cVrU6jieJwj_AJUw" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="Narr_rQHNz9147U6jaj60kDBpxQ">27.3</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6WGIoNrd4USstG13uKvUOQ" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="Narr_SwE4FO_UKkODcV2fX9rfcQ">26.7</ix:nonFraction> FTEs in our general and administrative functions.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory" id="Tb_4vQDI36Wbk-Rg0lHZVsemA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">Financial result, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncome" scale="3" id="Tc_GqiOtIIl_ka68DZGuuWCzg_4_2">69</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncome" scale="3" id="Tc_u024CqwldkasNGEIiQggXg_4_4">6,485</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncome" scale="3" id="Tc_SVonLTx5U0-Ym9SLY0uchw_4_6">78</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCosts" scale="3" id="Tc_HdR6YtRd_k6hdnTVIu7b0A_5_2">355</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCosts" scale="3" id="Tc_hgtUvHjh10-Y65DdV_-w_w_5_4">581</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCosts" scale="3" id="Tc_zLbEtnkUDEWNd2gl6K_2ig_5_6">184</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exchange differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="Tc_zHEXnwGeb0qhUS_GHHtrNw_6_2">393</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="Tc_zLJPzvSD0EWgG4QuncdMZw_6_4">113</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" sign="-" scale="3" id="Tc_9irVMPJn50OgwEDyxRnnqw_6_6">555</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Finance result, net </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" scale="3" id="Tc_sG9CRE1Sj0aJNDS9iTMrpQ_7_2">107</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" scale="3" id="Tc_DEN3mbQSPEm1LUBpaxaQKA_7_4">6,017</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" sign="-" scale="3" id="Tc_YvcFw7HDZ0OagGLELbjEig_7_6">661</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our finance result primarily consists of interest expense associated with our short-term financial assets and lease liabilities as well as foreign currency exchange differences.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2022, the decrease in financial result, net related primarily to the prior year CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-5" format="ixt:numdotdecimal" name="aciu:GainsLossesOnConversionFeaturesRelatedToConvertibleNotes" scale="6" id="Narr_jZ5tIgo-kEyZVDAXpZxfsw">6.5</ix:nonFraction> million gain on the conversion features related to the Company&#8217;s convertible notes due to certain Affiris affiliated entities that did not recur.</p></ix:continuation><a id="_167a5eea_21f7_498e_9f36_5aa9e3b59c22"></a><a id="Tc_zcc9fMpPDkKZfDys77T5hw_1_2"></a><a id="Tc_aPLI6fkkxUWzBP5d2HHjYw_2_2"></a><a id="Tc_FJj0ALmvgU6sP6a4vSPPHg_3_0"></a><a id="Tc_BZ5pFot64EeoAKHgBOQ5Hg_3_2"></a><a id="Tc_3XXyA7RaxEaX7LPJERWLEw_3_4"></a><a id="Tc_eXrodaiQEEKI-Jv56TfmRg_3_6"></a><a id="Tc_alNNCsuhMkq1lNZ_oj7UoQ_4_0"></a><a id="Tc_9hI697JNnke7weunQXCNZw_5_0"></a><a id="Tc_e2e7ybMeOEWM0jMVPqLdNw_6_0"></a><a id="Tc_xTHn9PuPUEqTFQK4PxRthg_7_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfRelatedPartyExplanatory" id="Tb_-BxnynLuu0CsXKBsImkr8A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">15.</b></span>Related-party transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Board of directors and executive management compensation</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" id="Tb_UzmqImMQj0OHA-D2jT8Tsg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Key management includes the board of directors and executive management. For 2022, there were <ix:nonFraction unitRef="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfPersonsKeyManagementBoardOfDirectors" scale="0" id="Narr_H1LMswPBeUGQmHDgTcGSfQ">eight</ix:nonFraction> members (2021: <ix:nonFraction unitRef="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfPersonsKeyManagementBoardOfDirectors" scale="0" id="Narr_aRf8JRXQuEKDukf84uK1YA">eight</ix:nonFraction> and 2020: <ix:nonFraction unitRef="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfPersonsKeyManagementBoardOfDirectors" scale="0" id="Narr_RB54QVLe8EOrwXZHbFSC9A">seven</ix:nonFraction>) of the Board (excluding the CEO) and <ix:nonFraction unitRef="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfPersonsKeyManagementExecutiveManagement" scale="0" id="Narr_tTZpGBQVA06Vgya0Yoz33A">seven</ix:nonFraction> members (2021: <ix:nonFraction unitRef="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfPersonsKeyManagementExecutiveManagement" scale="0" id="Narr_RrFGPndjBEqibfvN85Znow">six</ix:nonFraction> and 2020: <ix:nonFraction unitRef="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfPersonsKeyManagementExecutiveManagement" scale="0" id="Narr_Jg3NeT7BdUixJjclH7d2TA">five</ix:nonFraction>) of executive management (including the CEO). Compensation was as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term employee benefits </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" id="Tc_VOQPVM0hl0KSK9x3W8B1xQ_4_2">4,187</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" id="Tc_rtjW9UHcLk-kO0uQcyvvOQ_4_4">4,403</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" id="Tc_kr3UpyXIUEu23Tq2LVwbLA_4_6">3,497</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Post-employment benefits </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" id="Tc_RQsjdRP_Jku4LRiwYBQZJA_5_2">295</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" id="Tc_edTRhZEeO0CKpzyCBlKrEg_5_4">266</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" id="Tc_F-aMii67zkW_cqtwkDkRTw_5_6">214</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" id="Tc_YmuV8gw9hk2m76X4RCSEwQ_6_2">2,503</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" id="Tc_8V9u1X04pka2gdGhxNmpKQ_6_4">2,997</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" id="Tc_39RHW3a_fUGtGU_WKLoKEA_6_6">2,578</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" id="Tc_9rsjFocyakmpqInZZAN0WQ_7_2">6,985</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" id="Tc_xJkIL-794EuLDkWg9fEmmA_7_4">7,666</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" id="Tc_pAix2GJgsEmmNKKILBmKuQ_7_6">6,289</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfIncomeTaxExplanatory" id="Tb_wbqLh1pvOke2iytedDMh3w" continuedAt="Tb_wbqLh1pvOke2iytedDMh3w_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">16.</b></span>Income taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Group recognized less than CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="Narr_kB8Ymrarskir7WrcrZdsrg">0.1</ix:nonFraction> million, less than CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_hGZYF059eky85mjSvMDTyw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="Narr_tpP2LIh-mkGnZX-JuaFK-A">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="Narr_JZF2WpAqD02lSa-D1GdKng">nil</ix:nonFraction> in income taxes and <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:DeferredTaxAssets" scale="6" id="Narr_YqN7677pqEaE6FJMzoxmfQ">no</ix:nonFraction> deferred tax asset or <span style="-sec-ix-hidden:Hidden_bwx-SbM9sEqAKiboMtvBTg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">liability</span></span> positions for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively. The Group&#8217;s expected tax expense for each&#160;year is based on the applicable tax rates in each jurisdiction. In 2022, these rates ranged from <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_GONhTQbn6ky4CGqEbp70Mw">13.6</ix:nonFraction>% to <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_ozXdQtBqSEqfIWo4OfsYXQ">33.8</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_5cL5m8nGCEqTrf8_CtRG_A" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_VLizXDiSiUGLQKer9MKkpA">13.6</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_hGZYF059eky85mjSvMDTyw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_kfDp3U1zoU2wgHcwW0lOig">32.9</ix:nonFraction>% for 2021 and <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_qa5L2FOrxk22L1wLg9D8VQ">13.6</ix:nonFraction>% for 2020) in the Group&#8217;s respective tax jurisdictions. The weighted average tax rate applicable to the Group was <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_JZHuDFkEnky2R3mcEBTRxw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_UVk5zujjCUW9S4Yr9oXjJg">13.6</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2020_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_o6mJetXegkqD7qoBcZZJvQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_77t889k2_ke9-dx2TfZUdA">13.6</ix:nonFraction>% for 2021 and 2020, respectively). </p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-34</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_64a97536_e11a_4ae3_9dd4_8ca9e5c17dc3"></a><a id="Tc_iIgWq6iceUGlXgIpxM0Bpg_1_2"></a><a id="Tc_OG4YJNLYlUii7TgnJq3nhA_2_2"></a><a id="Tc_pr_O0Nd3okWMEiKPmbrang_3_0"></a><a id="Tc_7_79N-dR60Kfo3BwjUZsZg_3_2"></a><a id="Tc_1eDDPMy7BkuSCtjJF1N--w_3_4"></a><a id="Tc_xs2MA4cGgkmaycMzxjlcCQ_3_6"></a><a id="Tc_fAj_Tcl6H0GYgUON9d70iA_4_0"></a><a id="Tc_BZF1_zdR_Uy4wbRCMXWh-A_5_0"></a><a id="Tc_rOfAcX7Tpk-Ito0grFFuIw_6_0"></a><a id="Tc_3YqjA6bajkaEdAsGjhYtJQ_7_0"></a><a id="Tc_mOJrBQK2wk-VKlsCK5VP0Q_8_0"></a><a id="_a28ac5f1_0518_4782_aa93_f98ab4483e02"></a><a id="Tc_E6_RKn1QT02rx0GFmfuPBw_1_2"></a><a id="Tc_2oZ-4OmCDkS9OBfWwNJgAw_2_2"></a><a id="Tc_b-AtJ1WsOEihXeCWxy7xPg_3_0"></a><a id="Tc_HzlOcbeDR0SOZ0Oz_z8Zcg_3_2"></a><a id="Tc_us13fn3ObUmCdGmohd3o7w_3_4"></a><a id="Tc_osYhOZwFk0m2AciozQCAyQ_3_6"></a><a id="Tc_e_9VSawwhEqkoFp73qirCA_4_0"></a><a id="Tc_svieY51rykqbH85atDpWCg_5_0"></a><a id="Tc_WFWKw4rKrkmD_nWNHnUmHA_6_0"></a><a id="Tc_XcCQHkHiP0KPyFvxnm7MKQ_7_0"></a><a id="Tc_oMObzx0ChUWCsYLgYlVrFw_8_0"></a><a id="Tc_dYBWabCNGkenPdNTRXqnRg_9_0"></a><a id="Tc_R1LeskDfjUORi-DjhgK4XA_10_0"></a><a id="_6a658abf_3768_4301_b6d9_87cba248c55a"></a><a id="Tc_uzHqufuta0mQooUAkcK6Zw_1_2"></a><a id="Tc_D9WOsOIcEkSdeQUKXKyyjA_2_2"></a><a id="Tc_TCIEjWT5MESm7IU0eYwHcw_3_0"></a><a id="Tc_HBp0Y0lqu0qM3MxLgAoGKA_3_2"></a><a id="Tc_-uv5UlXXN0urgoYS9wbQfg_3_4"></a><a id="Tc_Er0DuVKfgUSrbKaGVSnCwA_3_6"></a><a id="Tc_MGYUAmHy5Uaro5W0NSEbxg_4_0"></a><a id="Tc_VKrE2Yt9QUiFxkA9tc9BrQ_5_0"></a><a id="Tc_i7rpXkSweEGpJ-7jTkfnzw_6_0"></a><a id="Tc_GZ8k1eBqN0Ghk5Xwdg5YCg_7_0"></a><a id="Tc_zR8j6RAshUWG1WzqhM8Jcw_8_0"></a><a id="Tc_Xe_F5Gn1G0eRPEJR2gqZZw_9_0"></a><a id="Tc_k_UDHr_wakebwfVkvYNbRQ_10_0"></a><a id="Tc_Q8Ged5QDYE-GhCRxR4yBQQ_11_0"></a><ix:continuation id="Tb_wbqLh1pvOke2iytedDMh3w_cont1" continuedAt="Tb_wbqLh1pvOke2iytedDMh3w_cont2"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" id="Tb_N97X4lXGNUyXPXdBn_eGGQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Group&#8217;s income tax expense for each&#160;year can be reconciled to loss before tax as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Loss before income tax </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AccountingProfit" sign="-" scale="3" id="Tc_4QfJemKJD0-t8n6KrJcGPQ_4_2">70,740</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AccountingProfit" sign="-" scale="3" id="Tc_N5gcNv3XvUS35dBMNUAecw_4_4">72,993</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AccountingProfit" sign="-" scale="3" id="Tc_jOsoy-b42Eq0XcPkSN4lbw_4_6">61,921</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Tax benefit calculated at the domestic rates applicable in the respective countries </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" sign="-" scale="3" id="Tc_6fXIsKu-AUOmDYYWFvfJEg_5_2">9,616</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" sign="-" scale="3" id="Tc_ee8gb4r8QUOtYStIsPS2hA_5_4">9,930</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" sign="-" scale="3" id="Tc_AN1D1Yh_AEy-6MVUUV_CYw_5_6">8,441</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">(Income not subject to tax)/expenses not deductible for tax purposes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" scale="3" id="Tc_vTrdM2tackeqpRIk3aUgTw_6_2">455</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" sign="-" scale="3" id="Tc_MVAjInqsAUiKl0sdJ8VwGg_6_4">375</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" scale="3" id="Tc_qfENDo3eQkGqz0aSStCKWA_6_6">462</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of unused tax losses and tax offsets not recognized as deferred tax assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" id="Tc_RmmLlQNdAUGjSGARq3mHlw_7_2">9,174</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" id="Tc_pDcmXRxpUE6lWQDu2n7YIQ_7_4">10,308</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" id="Tc_IyxnY5mpIkatLSNe_9sVag_7_6">7,979</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Effective income tax rate (benefit)/expense </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_Y14rfSaDqU6j3hyO-ppzLg_8_2">13</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_K95qW4kHOUuki4i6N0T19Q_8_4">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:zerodash" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_ELZzG1yjeUWbkAFFJ8gcLg_8_6">&#8212;</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Swiss tax rate used for the 2022 reconciliations is the corporate tax rate of <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_GeographicalAreasAxis_country_CH_O7nfFWb_I0mZqhS-eJcjZg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_qMO4qSqRMUCXkqeR1hCQxA">13.6</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2020_To_12_31_2021_zfFR7ittfki9YYbWT5hYdg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_qdxmTB01b0iWgON4QeU6WQ"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2020_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_CH__P8ouC3DKUKhYNxSsLCgfg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_ixzrf86-qESNW7FDotwbnQ">13.6</ix:nonFraction></ix:nonFraction>% in 2021 and 2020, respectively) payable by corporate entities in the Canton of Vaud, Switzerland on taxable profits under tax law in that jurisdiction.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" id="Tb_c-IvpZYKlUKY9Yvo6xuAjw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The below table details the total unrecognized deductible temporary differences, unused tax losses and unused tax credits:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrecognized deductible temporary differences, unused tax losses and unused tax credits</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Tax losses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_EoGHAaH_W0-vpWcrDQJuvg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_0uCW8194GE-RhZc7QQhfXQ_6_2">264,089</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_e7xgizML2UqtqmEk-xbYOg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_AnM7hW-0EketA_ziTZhghQ_6_4">197,152</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_nBhQeOZ19k-ztz29OTwlBA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_eTEnW3ku-0SVsDskxRO8xg_6_6">121,948</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Deductible temporary differences related to:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;">Right-of-use assets and lease liabilities, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_A7q7sukpmEWmgYEeU6xd9A" decimals="-3" format="ixt:zerodash" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_qD37tc4-xkKUEbVZhTzLKQ_8_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_qNySDLxJmUaC4_AlxO6kDw" decimals="-3" format="ixt:zerodash" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_7dgse28RCkiY7eeMwUblZQ_8_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_MB9hMQrj1E-MnICLBN--Tg" decimals="-3" format="ixt:zerodash" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_qENPF0cfuE-HOdXVQu_bFw_8_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;">Retirement benefit plan </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_e71liqGpk0eD9wSTTRy_TA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_ibQ9wLbgDEuo06SifTw_6Q_9_2">3,213</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_wwQem1YNxUG0LWJSPUL00w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_kyfi51RJHkKZ7fp0jiMegQ_9_4">7,098</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_X_YAkgPZKU2ZgwftPJ68hQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_P1WWmHDm5U2wTJU4_zbFwA_9_6">7,464</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_6PC9ATSN20-lP9c3SNLFbQ_10_2">267,302</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc__sN1im9TbEexjcBBALjynA_10_4">204,250</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_d1r6oklXcUmi1uHFx9Ca5A_10_6">129,412</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" id="Tb_BdfpwG3yuUeRFQ3Hali-xw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table details the tax losses carry forwards of the Company and their respective expiry dates:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Tax losses split by expiry date:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312024Member_1EtLVXZQK0KhtJMXjvu1hg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_u0CcR6Ns1kaQvg91ls_lDQ_5_2">15,231</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312024Member_YtAAUPDrRUyZqBsdM7bZLg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc__rkk-2PWvEa3J9CUR_JqTw_5_4">15,231</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312024Member_QmNnwUouwUmJ-s32bbnIQQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_eTlPu1fDI0iP7hLCoptfcw_5_6">15,231</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312025Member_luIzCS1YKk2F6EECmOmb-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_q1jvs9YTx0G3Rt72eho_8Q_6_2">48,894</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312025Member_iFzt3h4AUU63S9gjge_aaA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_iPqREpbbgUO41GIKosb0wg_6_4">48,894</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312025Member_n-US4waEG0KkXB44U7M1XA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_osr2ZrWcU0KzL80h_VZQFQ_6_6">48,894</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312026Member_aD29x0JbzEyAG4T_DshrpQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_O5048nm0_kC0kKMD4_KULw_7_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312026Member_pgGd2X_5zkuQ-hULGalqJw" decimals="-3" format="ixt:zerodash" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_HeYrJycNv021TwCkqta2Vw_7_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312026Member_GVWpRLlroE6SQnZZlZUS2g" decimals="-3" format="ixt:zerodash" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_tTX1KVfGPEeoadRn11lztw_7_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312027Member_8GigSLJKwkiTlMz-iLjIGQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_uiDgMJMBBESsmMsZCa3waw_8_2">57,824</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312027Member_YDYkyf-UMU2_t8n-OPDZOw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_YVm8KHoLPUmH4AIhH0wfTg_8_4">57,824</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312027Member_ng3b4z76MU6jDCmNuN3LKQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_qFg_gc8Qe0iq_f07gt_6dA_8_6">57,824</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312028Member_yPNEVvCqsUC9xeMHzwQNIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_1H3VjhqPJkSyv5USqKDqwg_9_2">75,204</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312028Member_IyrHXjhaIkqLqkdVnSu1Fg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_EwJbH7izEEeX5PhmzajQmg_9_4">75,204</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312028Member_KCaq0o_GCU-ldbixSPpiMw" decimals="-3" format="ixt:zerodash" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_BSBs3B-ugE2UP_bZBQT_0A_9_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312029Member_QW1lvp6gWEmt2TrWCNAUrg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_76N1AD8VLk2pjSlp7KBg4Q_10_2">66,936</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312029Member_-U2cl_yo202fnY3GwpirTA" decimals="-3" format="ixt:zerodash" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_nmTI7LUtz0WLW2s5j9hsNw_10_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312029Member_L1w97ZJiBU-clbQi3YmL-Q" decimals="-3" format="ixt:zerodash" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_LLWQvu-tDUinJ2rJ6bKXFw_10_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total unrecorded tax loss carryforwards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_aaDa8c4sr0uEBAu51eAWeg_11_2">264,089</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_aZtXOiHbg0qBVptP2VYtQA_11_4">197,153</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_laFisiXUuki4RbAWMpElpQ_11_6">121,949</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The tax losses available for future offset against taxable profits have increased by CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-5" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" scale="6" id="Narr_rXs1Nh5KeEutfQdt2K5qeg">66.9</ix:nonFraction>&#160;million from 2021, representing the amount of tax losses that are additionally available as an offset, subject to expiration as disclosed in the table above, against future taxable income.</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-35</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_wbqLh1pvOke2iytedDMh3w_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Consistent with prior&#160;years, the Company has not recorded any deferred tax assets in relation to the past tax losses available for offset against future profits as the recognition criteria were not met at the balance sheet date.</p></ix:continuation><a id="_751b3081_98bc_4025_a362_ba56cd939f83"></a><a id="Tc_T313XqcBMU2w2eJOGDRRaA_1_2"></a><a id="Tc_YvZglLCgDUS98vq3hLSAHA_2_2"></a><a id="Tc_kFxDzm22nkm5ExmEj7AUJQ_3_0"></a><a id="Tc_qHTtgdSEJUu7E5fIxn6GZQ_3_2"></a><a id="Tc_69yi3P-vw0S6X8JIZZK6pA_3_4"></a><a id="Tc_55qjsT8F_EmUNsSc4DFR7Q_3_6"></a><a id="Tc_9gYEGMLsA0mojkLlPbjVIw_4_0"></a><a id="Tc_873yVDKROkWhwhKeHDWQVA_5_0"></a><a id="Tc_ctaBUMOCr0yubEODliyqxw_6_0"></a><a id="_7874535a_4702_4728_a83b_95a5a6503f44"></a><a id="Tc_PedKt1G6NEKlvUKsdkSUnQ_1_2"></a><a id="Tc_-LiDR23AEEmz5afB8xkMJA_2_2"></a><a id="Tc_dPexcDdR5UGfT6zz7TVHqw_3_0"></a><a id="Tc_1ZQrlGEgQkSz3jYVD3tNkQ_3_2"></a><a id="Tc_QuG9wgCDt06b4iVTr3F5sw_3_4"></a><a id="Tc_EjUCp0dD6km3UFfbWAN04w_3_6"></a><a id="Tc_pwa5N8I2OkmTb9sYxs5HWQ_4_0"></a><a id="Tc_4Txhf_F8TkStuQwOHaDk6Q_5_0"></a><a id="Tc_DQcUTF7spk-lR_ss7mjWsQ_6_0"></a><a id="Tc_hFVz_Qy_xUeDu-T1DlN3fQ_7_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory" id="Tb_BKxrJjx3A0mxMNfgsqIkOQ" continuedAt="Tb_BKxrJjx3A0mxMNfgsqIkOQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">17.</b></span>Retirement benefit plan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company participates in a collective foundation covering all of its employees including its executive officers. In addition to retirement benefits, the plan provides death or long-term disability benefits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Contributions paid to the plan are computed as a&#160;percentage of salary, adjusted for the age of the employee and shared approximately <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" format="ixt:numdotdecimal" name="aciu:DefinedBenefitPlansPercentageOfContributionsByEmployees" scale="-2" id="Narr_A6kI9KwAYUytauxzdQJ0XA">47</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" format="ixt:numdotdecimal" name="aciu:DefinedBenefitPlansPercentageOfContributionsByEmployer" scale="-2" id="Narr_wo2ufb79WEWNaJCgqEGjnw">53</ix:nonFraction>% by employee and employer, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This plan is governed by the Swiss Law on Occupational Retirement, Survivors and Disability Pension Plans (BVG), which requires contributions to be made to a separately administered fund. The fund has the legal form of a foundation and it is governed by a board of trustees, which consists of an equal number of employer and employee representatives of its members. The board of trustees is responsible for the administration of the plan assets and for the definition of the investment strategy. The Company has no direct influence on the investment strategy of the foundation board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The assets are invested by the pension plan, to which many companies contribute, in a diversified portfolio that respects the requirements of the Swiss BVG. Therefore, disaggregation of the pension assets and presentation of plan assets in classes that distinguish the nature and risks of those assets is not possible. Under the plan, both the Company and the employee share the costs. The structure of the plan and the legal provisions of the BVG mean that the employer is exposed to actuarial risks. The main risks are investment risk, interest risk, disability risk and the life expectancy of pensioners. Through our affiliation with the pension plan, the Company has minimized these risks, as they are shared between a much greater number of participants. On leaving the Company, a departing employee&#8217;s retirement savings are transferred to the pension institution of the new employer or to a vested benefits institution. This transfer mechanism may result in pension payments varying considerably from&#160;year to&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The pension plan is exposed to Swiss inflation, interest rate risks and changes in the life expectancy for pensioners. For accounting purposes under IFRS, the plan is treated as a defined benefit plan in accordance with IAS 19.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" id="Tb_-DrVMqy1C0S26flgu-tYMQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table sets forth the status of the defined benefit pension plan and the amount that is recognized in the consolidated balance sheets:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_pxqAUVjcWEiJf_4UkIPnRg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_Ri475JBjGES8RvdJDhZjEQ_4_2">32,410</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember__6JmM8XcBUip-56hZCA8ig" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_oVwP3CDMdUa-WCiW9gcVhQ_4_4">33,889</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_HYAe7T3bM0uPnVmhnuk0NQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_o_T8-Xm2vU2hYW-6YxwSFQ_4_6">30,213</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Fair value of plan assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_pxqAUVjcWEiJf_4UkIPnRg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PlanAssetsAtFairValue" scale="3" id="Tc_tG6oEwTTS0aggCsLTY9ahA_5_2">29,197</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember__6JmM8XcBUip-56hZCA8ig" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PlanAssetsAtFairValue" scale="3" id="Tc_NbXDhe5r70muVlaBMTOauw_5_4">26,791</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_HYAe7T3bM0uPnVmhnuk0NQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PlanAssetsAtFairValue" scale="3" id="Tc_d44YZKMhhECGvwygp_R7AQ_5_6">22,749</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total liability </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_pxqAUVjcWEiJf_4UkIPnRg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SurplusDeficitInPlan" sign="-" scale="3" id="Tc_YBQ25jnCkUmMW2mm3MuS3g_6_2">3,213</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember__6JmM8XcBUip-56hZCA8ig" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SurplusDeficitInPlan" sign="-" scale="3" id="Tc_HwU8UbPuLU-omajHwKgmIg_6_4">7,098</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_HYAe7T3bM0uPnVmhnuk0NQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SurplusDeficitInPlan" sign="-" scale="3" id="Tc_UX38vcXu2k6NiTuEF1zMYA_6_6">7,464</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" id="Tb_UQGLWWCuVUShtXuIKZy7jQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following amounts have been recorded as net pension cost in the consolidated statements of income/(loss):</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Service cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="aciu:CurrentAndPastServiceCostGainDefinedBenefitPlans" scale="3" id="Tc_Sr0bPHyDjkeGcpmq2hWK-Q_4_2">1,712</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="aciu:CurrentAndPastServiceCostGainDefinedBenefitPlans" scale="3" id="Tc_nbH1mS2phEKoZ0-I6g_NfA_4_4">1,648</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="aciu:CurrentAndPastServiceCostGainDefinedBenefitPlans" scale="3" id="Tc_gfb7XdTCjk6TmW8GYATQOw_4_6">1,626</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseDefinedBenefitPlans" scale="3" id="Tc_oDdet3vyIkO6jjM2n4iLEA_5_2">126</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseDefinedBenefitPlans" scale="3" id="Tc_T7sslvVzU0Sf8sAAO2TQJw_5_4">79</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseDefinedBenefitPlans" scale="3" id="Tc_0putQUiytEu9GNR-iQ6dNQ_5_6">71</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestIncomeDefinedBenefitPlans" scale="3" id="Tc_LKJRNrnlPEKl5CmVnsQE8g_6_2">87</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestIncomeDefinedBenefitPlans" scale="3" id="Tc_OfqQUiR4NEeomuxudVwp0Q_6_4">48</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestIncomeDefinedBenefitPlans" scale="3" id="Tc_-YjpNS9FhU2G4D81n6PuYQ_6_6">42</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net pension cost </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="3" id="Tc_oZuUVNynnker7w2XZwqmEA_7_2">1,751</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="3" id="Tc_IqG_ILDaR0ut7-3ki94uxw_7_4">1,679</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="3" id="Tc_sr_uAtLn_kyhOpqWRSECmQ_7_6">1,655</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" id="Tb__W5_MtXYPUO8d12QVZjL8Q" continuedAt="Tb__W5_MtXYPUO8d12QVZjL8Q_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-36</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_b1bcb0a5_511f_4a8f_bc5d_8cd9bb0f6c7a"></a><a id="Tc_fJhZS1LtB0aMMOrmclHA5g_1_2"></a><a id="Tc_uWkPg5Bw20eXu_lh5dGQEg_2_2"></a><a id="Tc_kzk9Nl5c-06Z4vyqeo_9Dw_3_0"></a><a id="Tc_RYiwsHnH2kqIfBAvZAcLrw_3_2"></a><a id="Tc_LDbDvGojI0CuX2p3tpxCZw_3_4"></a><a id="Tc_199F3YydMU2njGatvvq96g_3_6"></a><a id="Tc_s0HvEs-ci0q9N_vWoM69Fw_4_0"></a><a id="Tc_uDuZHJoxREC5tCllq0yZyQ_5_0"></a><a id="Tc_SFzX5eLd_ESeIRa4Is3R7Q_6_0"></a><a id="Tc_R8umjkhnd0qgyHFi0_rLlQ_7_0"></a><a id="Tc_hi4t9yuLGUG0ioPHkGHHwQ_8_0"></a><a id="Tc_8pWqJDSMfEePbF9iTsuhKQ_9_0"></a><a id="Tc_h_Ax5yHYzUK9axlpqOneng_10_0"></a><a id="Tc_UMrScCkb8kmQC8yD1uSL5A_11_0"></a><a id="Tc_GAVV4UKxhkmaDHBfpuyJxA_12_0"></a><a id="_ee253468_ce52_486d_9dd4_15eb0c0ba0ff"></a><a id="Tc_nIRuLjtMYkyfWNAuvEFDAA_1_2"></a><a id="Tc_WqtESJRQyEynPG9OklWrLQ_2_2"></a><a id="Tc_cvmzeVjvw0We3Ogsaw2phw_3_0"></a><a id="Tc_xGaddNIOf0ye_qWev-Ej1Q_3_2"></a><a id="Tc_p7Y3tk-dLUS7i0DVBbFFBQ_3_4"></a><a id="Tc_DAMpC280gE65pZgRSJnlpQ_3_6"></a><a id="Tc_fZozl68etU65J99a-3lDhg_4_0"></a><a id="Tc_82NyTvXXtUyC8mcVR7ZjBA_5_0"></a><a id="Tc_MHL1CEH_kU-UmQyBK5LFCw_6_0"></a><a id="Tc_qrVre_LIMEaZ2IkrDZ94aA_7_0"></a><a id="Tc_kAXDECfJQ02TtGA6S1nuHw_8_0"></a><a id="Tc_3-h5Y0NuQESEVogSGzim5g_9_0"></a><a id="Tc_JGhHY1viaUWFIWv63DcabA_10_0"></a><a id="_6c905d6c_849d_4dc5_8f3e_f6308d71dfa0"></a><a id="Tc_2me2HJKksUOwQcxcatdmKg_1_2"></a><a id="Tc_NckSOGyZ-kuw4a6OHmNeTA_2_2"></a><a id="Tc_O8XzYIPtbUSxybQq5EpZxQ_3_0"></a><a id="Tc_Sn0Cr5Twc0WsCZOp5fiXdw_3_2"></a><a id="Tc_c0MaCqjMp0mdC5boe_O52w_3_4"></a><a id="Tc_mD8hWkzAlE6HLP3fFQ5pGA_3_6"></a><a id="Tc_LiQE8qYGUEiDRjoxXgLfBQ_4_0"></a><a id="Tc_swbTGtwmi0Cjiot96HgN5w_5_0"></a><a id="Tc_gK3McYAWLkWSJ7UGQAPUAg_6_0"></a><a id="Tc_UUK6sj1U3kGNt8rqrg2R_g_7_0"></a><a id="Tc_NYoLp9NiB0KvEnl3q6QfPA_8_0"></a><ix:continuation id="Tb_BKxrJjx3A0mxMNfgsqIkOQ_cont1" continuedAt="Tb_BKxrJjx3A0mxMNfgsqIkOQ_cont2"><ix:continuation id="Tb__W5_MtXYPUO8d12QVZjL8Q_cont1" continuedAt="Tb__W5_MtXYPUO8d12QVZjL8Q_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The changes in defined benefit obligation, fair value of plan assets and unrecognized gains/(losses) are as follows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">A. Change in defined benefit obligation</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Defined benefit obligation as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember__6JmM8XcBUip-56hZCA8ig" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_lj--de1MlUy6XX_2IRstng_4_2">33,889</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_HYAe7T3bM0uPnVmhnuk0NQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc__4Ew7VaFzkq3ehv9NGTuDg_4_4">30,213</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2019_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_V6HzKpLdRUKQbql6k-eSiw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_jSPDOKBQdUG_GR-0ekVgcg_4_6">26,624</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Service cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome" scale="3" id="Tc_EnmlQGRmQ06GF6-I9B64yA_5_2">1,712</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome" scale="3" id="Tc_YV0RQ8lH60qpRNDH4S0XgA_5_4">1,648</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome" scale="3" id="Tc_FabK-5aeYE6gR3ng1Idctw_5_6">1,626</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_CjJdIjUvQU-s7WdhJ6ihVQ_6_2">126</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_Q72mQHPto0CQuG8eZKboZw_6_4">79</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_U-qvuQffOEqPvx1qqUneqw_6_6">71</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in demographic assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_7b2dA4MpGUKLK1daCUtpjQ_7_2">29</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_vVDyU83tCU6UbnPLsFoGKg_7_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_Wmzv6ywDeEOocgJXaQEwfw_7_6">1,428</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in financial assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_Q4uD5rBEB0qFy0UvZQnc8A_8_2">8,397</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_Ip6UYXm4KU-QjPxGrUPZtA_8_4">156</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_v9_k4RqW-kOm-4DReqmPnw_8_6">71</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in experience assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_VSARNLRWi0yM0ZUxoRTcyQ_9_2">1,726</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_gC31Z88ZuEmQb8dbP78kHg_9_4">252</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_QOrRJSsf_UeO4eB_aCJP7g_9_6">931</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Benefits deposited </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" scale="3" id="Tc_Ot_w3LYZ3Eu3f3vPC5huEw_10_2">2,327</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" scale="3" id="Tc_1653RACepUWJLXB4h3JH6g_10_4">894</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" scale="3" id="Tc_s-sI3S1BKkuMUwH0ynje8g_10_6">1,467</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees&#8217; contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_AxnW45dbqESU7HiND3NEpw_11_2">1,056</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_yjwGKmoBYUS8DO0kikfV7g_11_4">959</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_3RgEq1uiE0CV_cz20trtWw_11_6">851</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Defined benefit obligation as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_pxqAUVjcWEiJf_4UkIPnRg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_ajqTJlsexU6vsn6p1fhHPA_12_2">32,410</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember__6JmM8XcBUip-56hZCA8ig" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_iCt8eSmm80q9ZQcRZXbELw_12_4">33,889</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_HYAe7T3bM0uPnVmhnuk0NQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_tzDswNjcCkO83TFplf0FmQ_12_6">30,213</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Change in fair value of plan assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of plan assets as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_s2KGkJGHQE24IlcU01BatQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" sign="-" scale="3" id="Tc_Zr1ZjESfp0m5adu5tTq-XA_4_2">26,791</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_kCoLjsydz025fO14lloWZg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" sign="-" scale="3" id="Tc_-aPhp42RnEq-GDAGBnhVvQ_4_4">22,749</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2019_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_eZxk80f7rkOIMW9Uz-QjMQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" sign="-" scale="3" id="Tc_e0BTUG3osUKPJvy_-rMnmg_4_6">19,139</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_2QmGkCKydUCnCVZUxjhf3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_NwIycw2h6kKoMzVJRFJiuQ_5_2">87</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_BOCVhHLarUK1ofHh5lJzgQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_xPnGT0dFY0-2JYb-9QkmJQ_5_4">48</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_6CpwH38OB0GxFoomh9oxsw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_Wc9MkTTg9UaDGIjzHwSrdQ_5_6">42</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees&#8217; contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_2QmGkCKydUCnCVZUxjhf3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_nDVJBRieGUWvoj75HlTiJw_6_2">1,056</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_BOCVhHLarUK1ofHh5lJzgQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_CgVABafuV06Yk1FKwAqE7w_6_4">959</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_6CpwH38OB0GxFoomh9oxsw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_Lb0MdrghfkO9E4YI79cwaQ_6_6">851</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employer&#8217;s contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_2QmGkCKydUCnCVZUxjhf3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_aoxc5Ez5e02sFEaJ05CPmg_7_2">1,210</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_BOCVhHLarUK1ofHh5lJzgQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_RtfKPl9OZkGAXJInFzYyPQ_7_4">1,089</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_6CpwH38OB0GxFoomh9oxsw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_0dwXqSAWB0mE9822LtSAmQ_7_6">950</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Benefits deposited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_2QmGkCKydUCnCVZUxjhf3w" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" sign="-" scale="3" id="Tc_VxwKUFKCmkGzQ2pW-F1-Rw_8_2">2,327</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_BOCVhHLarUK1ofHh5lJzgQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" sign="-" scale="3" id="Tc_BdxG26sBrE6InA29ow_lSA_8_4">894</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_6CpwH38OB0GxFoomh9oxsw" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" sign="-" scale="3" id="Tc_xBKjRpiNBE-JyCspfxOsJw_8_6">1,467</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Return on plan assets excluding interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_2QmGkCKydUCnCVZUxjhf3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_NZ8Wjs4zOE6ds6UX8RRzgQ_9_2">2,274</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_BOCVhHLarUK1ofHh5lJzgQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc__fxvo00DI02C_9YWmvW2YQ_9_4">1,052</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_6CpwH38OB0GxFoomh9oxsw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_yuU9a4n-mkuCjNXsGzIWWA_9_6">300</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of plan assets as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_0QrduY45dEG6M-eOa0J7zw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" sign="-" scale="3" id="Tc_j0kYKqZkh0qfCLP6w2MpzQ_10_2">29,197</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_s2KGkJGHQE24IlcU01BatQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" sign="-" scale="3" id="Tc_3XgXH6LhYUeViDu-4N2WFg_10_4">26,791</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_kCoLjsydz025fO14lloWZg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" sign="-" scale="3" id="Tc_PItMXpydjUacRNRrW8-vOA_10_6">22,749</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period amount to approximately CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan" scale="6" id="Narr_ek67CRoqC0Ce8d6gBfGciw">1.2</ix:nonFraction> million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Change in net defined benefit liability</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net defined benefit liabilities as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_G_8DqSTBgUCYR6nT9-4X1g_4_2">7,098</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_RViinZEPJEq46ibkp-dWNA_4_4">7,464</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2019_C854zoDUpkSi-bE7TYeEJw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_JmxERBy35UmytEcSz3INYQ_4_6">7,485</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net pension cost through statement of income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="3" id="Tc_z9cw1K0SjUWd5rBpWhVjcw_5_2">1,751</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="3" id="Tc_5VYka6zk_Em0RYOYkp1zFw_5_4">1,679</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="3" id="Tc_18waOaoCP0C9gcpnf2pZog_5_6">1,655</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Remeasurement through other comprehensive income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_SqJFxlssFkKHoEO0FovTBg_6_2">4,426</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_8bpW-5sA7EqlEIxUPRyfaQ_6_4">956</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_B5zfoNUnZk23wGNbuA9otw_6_6">726</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employer&#8217;s contribution </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_dNNIRdMcIUC_fjquJzvZDA_7_2">1,210</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_v9khCxeN5UOh3JWoVMCIAg_7_4">1,089</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_mitwugzfUEGHHqyR91dNZA_7_6">950</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net defined benefit liabilities as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_eUFh8B5_YUOEolSfzhv5CQ_8_2">3,213</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_xkokMCFD3024Z4749bbvcQ_8_4">7,098</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_0zKfXFkvqkuHyuvXvtVMVQ_8_6">7,464</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:continuation></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-37</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_d5b41c1a_39d1_4f8a_8171_7ebd0c352df4"></a><a id="Tc_5mS7AdaOkES8vGx4LhTTdw_1_2"></a><a id="Tc_1J159055aEeRcCxku2wm5Q_2_2"></a><a id="Tc_6t4VaeV2skm-Tbvs237BSQ_3_0"></a><a id="Tc_n_DaiCC-KUO_5oIj6xz5jQ_3_2"></a><a id="Tc_xpzRKsa6Y02MrsrAmPUvuQ_3_4"></a><a id="Tc_7nKiTgb1LkmWHMdisDDKug_3_6"></a><a id="Tc_FaulnpA7kkGp64rPdYV2mA_4_0"></a><a id="Tc_2LVUKRNVhUGYOLOgzN_DaA_5_0"></a><a id="Tc_RmQwKsukikKtF4ZjhzOVJw_6_0"></a><a id="Tc_tHM5iP8daUiEBahTnj_Ntw_7_0"></a><a id="Tc_wyRTVSy75EGsf_DHCzpCKw_8_0"></a><a id="_85f9a9cd_729c_4d85_a434_4c913cdcd59f"></a><a id="Tc_Q9DPB382i0KZ-o1oWtTzKg_1_2"></a><a id="Tc_bLGW19nVzUOYCoLVp7pk5w_2_2"></a><a id="Tc_K-hzqNtguUu_hCsJZZzixQ_3_2"></a><a id="Tc_N8OhgklKNk-LmTMyelusfw_3_4"></a><a id="Tc_NbzMYhjPTEuM3OYVS6tlaQ_3_6"></a><a id="Tc_NC9Hum_ZOESn3a2ugQP_Nw_4_0"></a><a id="Tc_0qptstiduUaJPwGuZAq-Pw_4_3"></a><a id="Tc_o0P44EBoMkmpESO0yHC1YQ_4_5"></a><a id="Tc_kuD3gt9OSECrHx79zR3pgA_4_7"></a><a id="Tc_3uPRmJL-R0e_OIMVNjwXLQ_5_0"></a><a id="Tc_1GxDlIL3J0SoyFSvh-urdA_5_3"></a><a id="Tc_Y3a9V9oVZkOd3_PflobyQA_5_5"></a><a id="Tc_2Wb4jwP6hkeEjLh50LZ7UA_5_7"></a><a id="Tc_PVk4oa-2VU2eof5OIz1oBA_6_0"></a><a id="Tc_rELLUapBQECb6_BiHlc_Xw_6_3"></a><a id="Tc_orJNn2EBJ0SjlMyNWfRU0g_6_5"></a><a id="Tc_P_cHtR_zQU2NxDIKt5NXOQ_6_7"></a><a id="Tc_l7YE1TwLv0SDmxRMD0fY4Q_7_0"></a><a id="Tc_zx3w9fYi80yS9f9ImCwrUQ_7_3"></a><a id="Tc_2DaP3Ytqh0aTc_jYoWiL5Q_7_5"></a><a id="Tc_3SVhiYmfZE2jujBXvowysg_7_7"></a><a id="Tc_Euks1NI_pEKOI5OA76TjGA_8_0"></a><a id="Tc_5BfMzmv0BU6e6xvOdKjX2g_8_2"></a><a id="Tc_EWdUOhpqMUumjI4txpfqMw_8_4"></a><a id="Tc_G8pzFvGCbEazVoZEw7XGMw_8_6"></a><a id="_bbb3d597_2f4d_4d60_a549_3c701b818360"></a><a id="Tc_EjR9JbH1qUa69d8m7dDO5A_1_14"></a><a id="Tc_ff0MzHeWN0ONXIzML00GaQ_2_2"></a><a id="Tc__2VChOsJCUmf-vRWHgLT-Q_2_6"></a><a id="Tc_UZ1KYdWdr0uKtgVvTjFFcg_2_10"></a><a id="Tc_Ny1C72sSJEWV1oCaVjfIlQ_2_14"></a><a id="Tc_weMPTn4cxE6XBKkMMynivw_4_0"></a><a id="Tc_l2r8fUfe1U-qFeFwVEIIVw_4_2"></a><a id="Tc_pcJG6lIPG0e6lPBhHxzqYA_4_4"></a><a id="Tc_Vi5anvXW2kGtsMeb3wFQhw_4_6"></a><a id="Tc_bsDjjPNBdEiczWLj3e6iuA_4_8"></a><a id="Tc_Eh8INJ4THkO7rRj4wTUbcw_4_10"></a><a id="Tc_JFFdqGTWJUCmVo6Zeg08Fg_4_12"></a><a id="Tc_ONn99hoQVEK4sC7qI247Hg_4_14"></a><a id="Tc_KzSMcuLkPUmZNLiumKsQSw_4_16"></a><a id="Tc_Nvo9ycP-qk2Q_8ZReDV16Q_5_2"></a><a id="Tc_pdxMEmA2UUOOX9MfFP_Nrg_6_0"></a><a id="Tc_aLx_DNxwJkqF7sBPErXMTA_7_0"></a><ix:continuation id="Tb_BKxrJjx3A0mxMNfgsqIkOQ_cont2" continuedAt="Tb_BKxrJjx3A0mxMNfgsqIkOQ_cont3"><ix:continuation id="Tb__W5_MtXYPUO8d12QVZjL8Q_cont2"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" id="Tb_wAZDuW16bUeCJmXRrAGZOw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Other comprehensive gains/(losses)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in demographic assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="Tc_6N2K_SGJykKVY8cVF5hxlw_4_2">29</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:zerodash" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="Tc_HGpVqFAkQUy7sibEOn2szw_4_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="Tc_Ktn7LVOM0UWvvcjiswlHxg_4_6">1,428</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in financial assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="Tc_M14iQxDBw0Op4Ik0tlv-0w_5_2">8,397</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="Tc_CfHKUa7hFk6iGeSm1qqzCg_5_4">156</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" sign="-" scale="3" id="Tc_R8zUYspdE0KZoCa5eyVueQ_5_6">71</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in experience assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" sign="-" scale="3" id="Tc_rD0z-8sOoEStJ0RKSJ_uqw_6_2">1,726</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" sign="-" scale="3" id="Tc_FpKpICinxU2lBiRxsZuBjw_6_4">252</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" sign="-" scale="3" id="Tc_b4qNw_hjHUmhNdzZTz8_aw_6_6">931</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Return on plan assets excluding interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" sign="-" scale="3" id="Tc_ihGa2zb-OEey2PNWY_8ltA_7_2">2,274</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" scale="3" id="Tc_wjKsthBuVEKd3w-AUDMe5A_7_4">1,052</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" scale="3" id="Tc_WiPNCmCw7UKbF6xEe2CXnA_7_6">300</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other comprehensive gain</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="Tc_zoCDvAQJdUGXp3WL6rjoMA_8_2">4,426</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="Tc_ZbkINlwyR0yG3pXnzSYQzQ_8_4">956</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="Tc_tC_G9yLT4EqE2pdZBxU05A_8_6">726</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The change in experience assumptions results from an increased sum of insured salaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the plan assets is the cash surrender value of the insurance with the insurance company (AXA). The investment strategy defined by the board of trustees follows a conservative profile.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The plan assets are primarily held within instruments with quoted market prices in an active market, with the exception of real estate and mortgages.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The weighted-average duration of the defined benefit obligation is <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" id="Narr_Ofvm7oroMEec2bGmAq_JzQ">14.9</ix:nonNumeric>&#160;years and <ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" id="Narr_2cuQtji2akiO6SV2DgTbMQ">17.1</ix:nonNumeric>&#160;years as of December&#160;31, 2022 and 2021, respectively.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" id="Group_nNF-lzH50UOSL4ATmZIL1g" continuedAt="Group_nNF-lzH50UOSL4ATmZIL1g_2" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The actuarial assumptions used for the calculation of the pension cost and the defined benefit obligation of the defined benefit pension plan for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively, are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:48.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:48.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Discount rate </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="Tc_pG40Qxk5n0WR0Nv9HiPqzg_4_2">2.25</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="Tc_InRyTT6K8UW-wErx_HD1XA_4_4">0.30</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="Tc_Lnb8yxB6R0iMpztrmf2fTw_4_6">0.20</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Rate of future increase in compensations </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="Tc_E6pFC8uCb0Wn5WbS0qEJ-g_5_2">1.75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="Tc_sCsO_7vX6UqNZHddnS8TaA_5_4">1.75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="Tc_rSKztFVHWEOMcKngJjnxeQ_5_6">1.75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Rate of future increase in current pensions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="Tc_asF69yBlNkq9g1LG91HfGg_6_2">0.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="Tc_wlWtTsLMtUaUmD7ploHDqA_6_4">0.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="Tc_Zp0caYtWAE-GlPU-ybh6Hg_6_6">0.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest rate on retirement savings capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="4" format="ixt:numdotdecimal" name="aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" scale="-2" id="Tc_nQNSLv56kUKdTJYw7fkWJQ_7_2">2.25</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="4" format="ixt:numdotdecimal" name="aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" scale="-2" id="Tc_njUC2T8hu06BAMWyOcyUsA_7_4">0.75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="4" format="ixt:numdotdecimal" name="aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" scale="-2" id="Tc_Y0PZOvC9VUOtDmMPWYg_Yw_7_6">0.50</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Mortality and disability rates </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In defining the benefits, the minimum requirements of the Swiss BVG and its implementing provisions must be observed. The BVG defines the minimum pensionable salary and the minimum retirement credits.</p><ix:continuation id="Group_nNF-lzH50UOSL4ATmZIL1g_2" continuedAt="Group_nNF-lzH50UOSL4ATmZIL1g_2_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2022 is shown below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interest&#160;rate&#160;on</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Discount&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;salary&#160;increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;pension&#160;cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">savings&#160;capital</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_htkFexGKi0SyGdCClk5r-A" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_HAZhg8UoF0aolUQ6FQme2g_3_2">0.5</ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_6EKzgKAJoUG3jfS4LKnOcA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_vRpaRy5BA0eCxRPDvPnoBQ"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_uLVqkw8R0Ey9u3gY5ML4tg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_r87LdrBWGUyKfXRqbrVNeQ_3_4">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_H4N7gZJ3j0Kt81LUUCEMUg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_4PebLXd4MES-hqQd6xXlpA"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_XbtQeThTw0KgJUgpaxvnvg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_vxNpMC3aNEa_krrMt0c2zQ_3_6">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_6EKzgKAJoUG3jfS4LKnOcA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_HK-Qf6w2L0-QAQXgzh8gxg"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_59E483uZ40Gsz3BGEndqFA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_IwfvqEe8t0etPce7z2vbvg_3_8">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_H4N7gZJ3j0Kt81LUUCEMUg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_LL8mb7sq50OvRfSfZ3iOPA"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember__QV6BS-X-EirLtUuhoaxaw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_iyEPY0f5PkGV2n3cwqioBA_3_10">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_6EKzgKAJoUG3jfS4LKnOcA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_IW6NVtZ6p0eg2Aei5m1Cpw"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Cu7DGnbLpU-gF7D6W8XXoQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_eYmSrQU31kyG_1J_Sf2dIA_3_12">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_H4N7gZJ3j0Kt81LUUCEMUg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_rHpYkTZag0WQPVR-5a1l9Q"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hYMeoCWTDUeHBblD-WbM1g" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_RjdAgbVPW0WC5e0HhI-a8A_3_14">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_6EKzgKAJoUG3jfS4LKnOcA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_RWHVl7VxL02auERqNMXG7g"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_sfVRDOORkUqhr6UilmXrJw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_ai7wU3eUEEe_oIL24ASP3g_3_16">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assumptions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="17" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In&#160;CHF&#160;thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Potential defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_htkFexGKi0SyGdCClk5r-A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_YY43nj-Rxkyvq3q_z8t0Wg_6_2">30,201</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_uLVqkw8R0Ey9u3gY5ML4tg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_1qLmyjGg9kOgoRlBK-gqVg_6_4">34,916</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_XbtQeThTw0KgJUgpaxvnvg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_mrGa_qvgekefUGfXdDekfQ_6_6">32,940</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_59E483uZ40Gsz3BGEndqFA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_GLydYEp_PEGfkviKDL5EQA_6_8">31,841</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember__QV6BS-X-EirLtUuhoaxaw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_KumCu_qOl0y_93HQCNMdXA_6_10">33,601</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Cu7DGnbLpU-gF7D6W8XXoQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_gxuaYwKMrEm7KFobjFt-kg_6_12">31,322</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hYMeoCWTDUeHBblD-WbM1g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_Dj-odfi8kkeZmPPrQNJbnw_6_14">33,322</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_sfVRDOORkUqhr6UilmXrJw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_EJyv2oIvBkCTu6QFWodW5w_6_16">31,545</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Decrease/(increase) from actual defined benefit obligation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_htkFexGKi0SyGdCClk5r-A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" sign="-" scale="3" id="Tc_f1Dpk6Yr-0eFsekUFdEWYw_7_2">2,209</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_uLVqkw8R0Ey9u3gY5ML4tg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="Tc_bSDcWYzS-Ey-5q4x-EeWHA_7_4">2,506</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_XbtQeThTw0KgJUgpaxvnvg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="Tc_7LeFgJ8lkU-oRFtYmF-Spg_7_6">530</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_59E483uZ40Gsz3BGEndqFA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" sign="-" scale="3" id="Tc_5GysAOu-4UqRIbtl-t1HgA_7_8">569</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember__QV6BS-X-EirLtUuhoaxaw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="Tc_XxUE55DhcEecqVB8RG9DWw_7_10">1,191</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Cu7DGnbLpU-gF7D6W8XXoQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" sign="-" scale="3" id="Tc_s01Qnyyr90mbnVKh1LX-hA_7_12">1,088</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hYMeoCWTDUeHBblD-WbM1g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="Tc_Nf9p9DTv-kOHJFNDyjUB1A_7_14">912</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_sfVRDOORkUqhr6UilmXrJw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" sign="-" scale="3" id="Tc_SY2r2N3LgkuIJLi2dGQvkw_7_16">865</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-38</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_028c189a_2265_4330_b4dd_7ed064599e91"></a><a id="Tc_pEpLWbIYZkWu7-fIfzOR-Q_1_14"></a><a id="Tc_4wDvxIwAaUW-o0RHyD8PEQ_2_2"></a><a id="Tc_Zt45_l2DlUKQaJD43ZdUWQ_2_6"></a><a id="Tc_YYfPnQSQKUaM33N1V0GXSQ_2_10"></a><a id="Tc_Fv0SnjsMm0iiuQe2kTFsPQ_2_14"></a><a id="Tc_nQVm97NRhkafFbgW6tu7CQ_4_0"></a><a id="Tc_cFZha9g-d0OIdCOqxu435Q_4_2"></a><a id="Tc_flWZwcsepkuwjfHTBdx-ew_4_4"></a><a id="Tc_n3EDe--PnkOh78jRb8emWw_4_6"></a><a id="Tc_zvLGUfwF1US8hVff2dMBDg_4_8"></a><a id="Tc_fqbzBnYvP0WE1MZfVzfd-g_4_10"></a><a id="Tc_AwtzDsYDKUW-yDR8wxojWg_4_12"></a><a id="Tc_mgv3HdZHtUGM0NdRRA9H5A_4_14"></a><a id="Tc_gtZ6mnDgNECVtu0sgAaOYw_4_16"></a><a id="Tc_R3_my_mwzk6rjvaae6Xjbg_5_2"></a><a id="Tc_mxydYN6VwUyiouHB5Z2z6w_6_0"></a><a id="Tc_rp4xH5iWJkyZjRWAjre6PQ_7_0"></a><ix:continuation id="Tb_BKxrJjx3A0mxMNfgsqIkOQ_cont3"><ix:continuation id="Group_nNF-lzH50UOSL4ATmZIL1g_2_cont1" continuedAt="Group_nNF-lzH50UOSL4ATmZIL1g_3"></ix:continuation><ix:continuation id="Group_nNF-lzH50UOSL4ATmZIL1g_3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2021 is shown below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interest&#160;rate&#160;on</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Discount&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;salary&#160;increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;pension&#160;cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">savings&#160;capital</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_wxgSXXB0oEWC6elN_wYlOw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_V8NYy2yU_UmDNTvwekatng"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_ITqbxgmA8kaKhSS6Qx6Lag" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_5rhxnM_21k6ggIJm63vQ7A_3_2">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_g3mEpN007U6ktZW8iOkmGg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_ev9R2Q5PekOOyjzxu3P5tQ"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_CIf08U-iBESSEaFfP0e5oQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_syGmnNjjHEaha-RjuQvLAA_3_4">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_wxgSXXB0oEWC6elN_wYlOw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_X1XW-tblWk6Qu1g989rE1g"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lnas20UeVUe0l9IofWvilw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_VsWYrGUCnk-3MxwKGnlg7A_3_6">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_g3mEpN007U6ktZW8iOkmGg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_Q8twMEkSsE2Vfxl-UT4H6A"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_E-R1Y--G10q88hvRsrSnzA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_AP2QtZ5XcE-0BIXeMnwFGw_3_8">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_wxgSXXB0oEWC6elN_wYlOw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_Sdogre-1JUuakgUQcAOrGg"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hnNvq_N4vkyRlPiVGvD9xg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_muEEL1K-cEGZE3oJyoAwZA_3_10">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_g3mEpN007U6ktZW8iOkmGg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_Xapfq1JBf0OE0F2TgLmn5w"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_HHYHWrkgo0um-ugZPCUcJA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_WdO5skX1D0-WPuZMLPRuFA_3_12">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_wxgSXXB0oEWC6elN_wYlOw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_M8_2oYBldE2yuDXguksavw"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Ky5hPC5l-kqMi9huZQTdgA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_cMBsviTYN0mCwjue0Bj2Ew_3_14">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_g3mEpN007U6ktZW8iOkmGg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_wURb92puo0qg3Bkwv-NvFA"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8YTwmrejmUmiuJSTgOn0zQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_FQVZqufKx0Kit3zU1DpMeQ_3_16">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assumptions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="17" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in&#160;CHF&#160;thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Potential defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_ITqbxgmA8kaKhSS6Qx6Lag" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_xYN6lm1OGE-EnhC0J8W0qQ_6_2">31,190</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_CIf08U-iBESSEaFfP0e5oQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_sEXVTx8iLEWRA5iIJvncRA_6_4">37,006</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lnas20UeVUe0l9IofWvilw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_xp6l8ufBVEajtdspLQuOcQ_6_6">34,578</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_E-R1Y--G10q88hvRsrSnzA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_NqG1Yyy6b0iAOYTM_K6t3A_6_8">33,176</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hnNvq_N4vkyRlPiVGvD9xg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_JgV5q5wqDkSkhm1XEan9FQ_6_10">35,497</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_HHYHWrkgo0um-ugZPCUcJA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_TNKtgR0WDUyvRj0m_HaXPg_6_12">32,435</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Ky5hPC5l-kqMi9huZQTdgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_PxPgeJaNo0SoL42yZyjWiA_6_14">34,822</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8YTwmrejmUmiuJSTgOn0zQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_DJgnjWsnQE2rDN9jI57p7A_6_16">33,007</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Decrease/(increase) from actual defined benefit obligation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_ITqbxgmA8kaKhSS6Qx6Lag" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" sign="-" scale="3" id="Tc__QiroZcNnkSedLDDGt-Jdg_7_2">2,699</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_CIf08U-iBESSEaFfP0e5oQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="Tc_KpG3KDFjGEmLRdoxPPzqmg_7_4">3,117</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lnas20UeVUe0l9IofWvilw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="Tc_U_HlW48pCE6BQJzch8nEeQ_7_6">689</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_E-R1Y--G10q88hvRsrSnzA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" sign="-" scale="3" id="Tc_8PWs4mSI5U-e-DbdhXjNQA_7_8">713</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hnNvq_N4vkyRlPiVGvD9xg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="Tc_1Yk0ziO0RUWkKYB2_RQNVQ_7_10">1,608</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_HHYHWrkgo0um-ugZPCUcJA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" sign="-" scale="3" id="Tc_35LT4jx5S0a9LFzk3wzy0g_7_12">1,454</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Ky5hPC5l-kqMi9huZQTdgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="Tc_VXNNU9lqGkSXQnsRCx4mDw_7_14">933</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8YTwmrejmUmiuJSTgOn0zQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" sign="-" scale="3" id="Tc_YDgng3it_0OYec0UI-PNHg_7_16">882</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The sensitivity analyses above are subject to limitations and have been determined based on a method that extrapolates the impact on net defined benefit obligation as a result of reasonable changes in key assumptions occurring at the end of the reporting period.</p></ix:continuation><a id="_03b26153_e976_46ab_88dd_4af9b936df64"></a><a id="Tc_FaYQT2CPtEWp7PwVt9ZyEg_1_2"></a><a id="Tc_-k5QRW1-hEiBzePupXG1ow_2_2"></a><a id="Tc_VQHtn2dB_0iVsv7K5rt2Mw_2_6"></a><a id="Tc_LRwwXi0zKEeG9udDpDS8NA_3_0"></a><a id="Tc_yO-Nu4Yvy0C8uIZYnU8voQ_3_2"></a><a id="Tc_k9kkxEsxDEibdw_AzHDZBA_3_4"></a><a id="Tc_DGQTX3PixUGYsRNLg6W7RQ_3_6"></a><a id="Tc_PIU5OTr_cE6nIfUctZaO2w_4_0"></a><a id="Tc_hCC17mnYVkqChDLcQob_Cw_4_4"></a><a id="Tc_obW7mOJ4KE-1T9YCnxmoJg_5_0"></a><a id="Tc_mcUeR06kFkqvkudNB5uTdw_6_0"></a><a id="Tc_h-edP4TbZ0SUOD6cjqK1Cg_6_4"></a><a id="Tc_igkg-xaiIU2zI-1q6eB77A_7_0"></a><a id="Tc_bin5yEOYt0iOmYggHZhx6Q_7_4"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory" id="Tb_iFJK4IV2S0a-M7_Izzp38Q" continuedAt="Tb_iFJK4IV2S0a-M7_Izzp38Q_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">18.</b></span>Share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Share-based option awards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2022, there are equity-based instruments outstanding that the Company has granted under <ix:nonFraction unitRef="Unit_Standard_plan_lCCE6LMjkEKlKdQ1vpJjNA" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfEquityBasedInstrumentPlans" scale="0" id="Narr_xa_5K5xyCkeabyj-ii_awQ">two</ix:nonFraction> different plans.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s 2016 Share Option and Incentive Plan (SOIP) was approved by the shareholders at the ordinary shareholders&#8217; meeting in November&#160;2016. The 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights. The Company only grants equity-based instruments from the SOIP as of December&#160;31, 2022.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" id="Tb_TiQv_NV-CkWstgq9B5zzTg" continuedAt="Tb_TiQv_NV-CkWstgq9B5zzTg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes equity-settled share option grants for plans that existed during the period:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">options&#160;awarded</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td></tr><tr><td style="vertical-align:bottom;width:40%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plan</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(since&#160;inception)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vesting&#160;conditions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">life&#160;of&#160;options</b></p></td></tr><tr><td style="vertical-align:bottom;width:40%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share option plan C1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="Duration_11_1_2016_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_vLy61BZC6kiaUiucvTN5rA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Tc_bPzGByeq1kSUF5_Abow77A_4_2">6,775,250</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_qes1Nya84kCyFEAE3XIdpQ" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_0vHVoj24NE-OpXay55ZxdA"><span style="font-size:10pt;">4 years</span></ix:nonNumeric><span style="font-size:10pt;">&#8217; service from grant date</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_qes1Nya84kCyFEAE3XIdpQ" format="ixt-sec:durwordsen" name="aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" id="Tc_ci-7QyW4RESqqPl9kBezNA_4_6"><span style="font-size:10pt;">10 years</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">2016 SOIP:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:top;width:40%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executives and directors</p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="Duration_11_1_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_8NZA0QmhLU-9P-5sBxKJYg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Tc_bZ6td8dXY0C35JP_mjmSVw_6_2">3,277,044</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_gs4FuwKFqUy6IZN8tQRJ-w" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_fEE2GYVyLUupgtMx0MWJHA"><span style="font-size:10pt;">1 year</span></ix:nonNumeric><span style="font-size:10pt;">, </span><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_o6xYJQLm0U2_P1h1Nvrt4Q" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_lJ7m_vj9dkmPQCcFCHSDNQ"><span style="font-size:10pt;">3 year</span></ix:nonNumeric><span style="font-size:10pt;"> and </span><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_i1QiIMeQy0WwrJUKG5kvUw" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_gDC_lU_q-kGM1hnq6bYpsg"><span style="font-size:10pt;">4 years</span></ix:nonNumeric><span style="font-size:10pt;">&#8217; service from the date of grant, quarterly and annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_c832R2YNRkeTmCmOUNmglA" format="ixt-sec:durwordsen" name="aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" id="Tc_gA5_35cX40mqkJgjAl_puw_6_6"><span style="font-size:10pt;">10 years</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees</p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="Duration_11_1_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_u_sWTIPrdUK25sXxSWqZ-g" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Tc_0vOWNDUYEk6sdcZYyd-d5g_7_2">1,811,687</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_nm_abkjtNku82k2BFZcwmA" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_TEght7r9eUOm5RFRmyVQCw"><span style="font-size:10pt;">4 years</span></ix:nonNumeric><span style="font-size:10pt;">&#8217; service from the date of grant, annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_nm_abkjtNku82k2BFZcwmA" format="ixt-sec:durwordsen" name="aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" id="Tc_aZF9lu9SkEavNcLhEjy88w_7_6"><span style="font-size:10pt;">10 years</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-39</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_45d65cc2_ddc0_4902_bad6_0b2690679c76"></a><a id="Tc_YjdfEDpkKUS8PX-n5Nfcrw_1_4"></a><a id="Tc_Wvu86GDoo0CuSjznM5coFg_1_6"></a><a id="Tc_gEm9NSprJ0yp19U-KIhUMw_2_4"></a><a id="Tc_RiyX53i_40ixtqquMJ8RCQ_2_6"></a><a id="Tc_ctCzMX1O-0-4ez8ZL3ZzZA_3_2"></a><a id="Tc_TuzPbbv3a028NaHqLP90Mw_3_4"></a><a id="Tc_WHGt2ye_M06Mf8MPUPWOGw_3_6"></a><a id="Tc_ISDZCRDbjku_UZZPFksvJw_4_2"></a><a id="Tc_Sq8g20PZgUe17MyamJHE4w_4_4"></a><a id="Tc_u256tKlzCUC2o5dsVEXW3A_4_6"></a><a id="Tc_6vYuFcn8O0GvorDmMqqqPQ_5_0"></a><a id="Tc_4P80gQffeUCvC2AtSwJK8w_6_0"></a><a id="Tc_caGFMQ2Uqkaohf-nDeWOTg_6_6"></a><a id="Tc_2ig4sQE9IUyTz9mBXf97kg_7_0"></a><a id="Tc_UtmGZvAgeUWb0TXEWR9hlQ_7_6"></a><a id="Tc_UzWJ-jfjBkeA21yLoO497g_8_0"></a><a id="Tc_y1kDokLowUWXAhVyxCxs4A_8_6"></a><a id="Tc__2b3LgICVUGq1UfwcKtA0w_9_0"></a><a id="Tc_QdlfRXv5aU2kGi3_ER6mCQ_9_6"></a><a id="Tc_Q6xqi7PHkU6O5WNvBfD9NA_10_0"></a><a id="Tc_swI3-X9rkk-8tDJ3HdZJcQ_11_0"></a><a id="Tc_GAWsPzWSl0uTE0X-xyicxg_12_0"></a><a id="Tc_l1kjMYgceUid4YoZBqz2NQ_13_0"></a><a id="Tc_j4ZolU30QEy5gQx5ZLo2WQ_13_6"></a><a id="Tc_NyfwTmMeqkuX0pVf51H67A_14_0"></a><a id="Tc_SpQyZtqJPkyLAA9BlOufhg_14_6"></a><a id="Tc_8I809_Mm-kq6Co4Uu_jX6w_15_0"></a><a id="Tc_76LMjuE9FUW_PD19kaw7ZQ_15_6"></a><a id="Tc_hDmgj_ALwk--MsuyezmPtQ_16_0"></a><a id="Tc_Uchjn0k-uUaDXt_bKEfZ7Q_17_0"></a><a id="Tc_8yNV3AZkiUa4fCTgjcKUUA_18_0"></a><a id="Tc_Fq24t0ZTdUWCCVt2R3bqtQ_19_0"></a><a id="Tc_uDzoqV_mkkyt2YIqbBofPg_19_6"></a><a id="Tc_QAs3GzXg10C-hMGYcc4RKA_20_0"></a><a id="Tc_4Seqpf-kZEK-POJTZOGKuA_20_6"></a><a id="Tc_qlZMNbHK10G4-4_AbtgiTQ_21_0"></a><a id="Tc_-XrNg0rEHkWQ4ewIvV_SXQ_21_6"></a><a id="Tc_aIIPvEv93U6JilW07KZHwQ_22_0"></a><a id="Tc_TdERvugMgUOrxQw9Iwu5KQ_23_0"></a><a id="_666dc2df_ae13_453f_a9e2_11a39bae7c80"></a><a id="Tc_qJTLO4hBNEOw0SwTKfthJQ_1_4"></a><a id="Tc_t73T_MxG9keNGuBURnqf4A_2_4"></a><a id="Tc_nUr3yfoAHEGbLnkeN5pO1w_3_2"></a><a id="Tc_aQEpCrYQcUuFa5GVtjdj3w_3_4"></a><a id="Tc_bkIoeiBI1k2Oh_80QuLZHg_4_0"></a><a id="Tc_GFO7GUV26Uax2lphKJkOPg_5_0"></a><a id="Tc_nf2qhxGfJk6vhRx2FLKlbA_5_4"></a><a id="Tc___xwanPF-k6CRdsKybrbvA_6_0"></a><a id="Tc_81ABUHRizUWeqUq7aRQ82g_6_4"></a><a id="Tc_XJ6I5hjW2Eu7tdh80XEH3g_7_0"></a><a id="Tc_kA1DmQOntEKZNcNMVChOqg_7_4"></a><a id="Tc_Sj2HQIlQoEi-qR_d7iJU6Q_8_0"></a><a id="Tc_wbFuxqCWbkCPdL6fKsH-tA_8_4"></a><a id="Tc_imjE__E_bEisjXo0KXlwRg_9_0"></a><ix:continuation id="Tb_iFJK4IV2S0a-M7_Izzp38Q_cont1" continuedAt="Tb_iFJK4IV2S0a-M7_Izzp38Q_cont2"><ix:continuation id="Tb_TiQv_NV-CkWstgq9B5zzTg_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" id="Tb_CA0Wc0mdkE6shXg1hOP62w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The number and weighted-average exercise prices (in CHF) of options under the share option programs for Plans C1 and the 2016 SOIP are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">exercise&#160;price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">remaining</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(CHF)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">term&#160;(years)</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2019_C854zoDUpkSi-bE7TYeEJw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_Ya2G58Z8TUCAJpM0DjM7nA_5_2">1,981,629</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_12_31_2019_C854zoDUpkSi-bE7TYeEJw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_AIbRGxEuIEypDzpZ0KBebQ_5_4">5.93</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2019_To_12_31_2019__3yCVTKZ40i5IsvT7P2jug" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Tc_FS20OUKh5kqf-xu-k7H26w_5_6"><span style="font-size:10pt;"> 8.3</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" scale="0" id="Tc_tBPbdUzigU24pX-KqP9bUA_6_2">53,591</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="Tc_yzoTogEqbEWBgdEKR8vBEQ_6_4">6.03</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expired during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" scale="0" id="Tc_KrM27KCDuUeGu8J22aeNmQ_7_2">26,729</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" scale="0" id="Tc_Vd-ZVqoYqE2Zn3pxjCF74w_7_4">4.38</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" id="Tc_I400CApmzk6QiWcAcCrZPw_8_2">73,669</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="Tc_uEQ9quZdsUKOnRRUawdI-A_8_4">2.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Tc_4I6yX8uJqUCvR0hpphjK7A_9_2">1,073,027</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Tc_xKoC_RMJbEGbQAzuHoNLNQ_9_4">6.29</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_FvSW3VPs8EO_DvbiXzNUsQ_10_2">2,900,667</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_ir1stb9W90CXx9b0yl84uA_10_4">5.90</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Tc_Sg3KaYP1skG_IWVSaIq9fQ_10_6"><span style="font-size:10pt;"> 8.2</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_wwGQwrmsGUyywj4Tv3Wj0w_11_2">1,099,015</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="Tc_qdhRinHYX0-VYT5UgNENKA_11_4">5.49</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" format="ixt-sec:duryear" name="aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" id="Tc_Xnixj8WcKEuPAK-KX6eonQ_11_6"><span style="font-size:10pt;"> 7.0</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_NjqX1u-JPUGYS1hRn0R_dA_12_2">2,900,667</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_W8KP5BPg0UyJHGJXU3FP5w_12_4">5.90</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Tc_dHTcy-pfp0ucNc1V0h9JvQ_12_6"><span style="font-size:10pt;"> 8.2</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" scale="0" id="Tc_rcDcLKQr8UCELprswB0vqg_13_2">207,331</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="Tc_6fC12UrF7UKD0atxlpGluw_13_4">6.13</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" id="Tc_3yVmoz0saUCEav2VpP8N1g_14_2">218,561</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="Tc_kcaToJmEyUu2aQLMg0Oe2w_14_4">4.97</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Tc__P9kzsyNg0-IJTRLyPhsKQ_15_2">1,110,914</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Tc_GmDthJbadU-8het2KByMoA_15_4">6.34</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_NrN9yjLJn0qOjEIoGKoQlQ_16_2">3,585,689</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_wI4BbPAfwkO6JkcKhhH-SQ_16_4">6.21</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Tc_h1dlIi5WUEmESSiuEF_1gQ_16_6"><span style="font-size:10pt;"> 7.8</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_mwymqKw4g0mPBn-CAs7GQw_17_2">1,613,242</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="Tc_6JJJ63mwWEuC_PRLBhisZQ_17_4">6.13</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" format="ixt-sec:duryear" name="aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" id="Tc_wWqjQUuk4Uusp2xo2SwsOQ_17_6"><span style="font-size:10pt;"> 6.8</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_hcTqrIXCLEGBiCXXu9zy6w_18_2">3,585,689</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_QaPAlMD_WUirpkY03GCM3Q_18_4">6.21</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Tc_BlRgVzK7Ckq4qP1q2tsN1w_18_6"><span style="font-size:10pt;"> 7.8</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" scale="0" id="Tc_A4A5DHBqp0uyZnudhcAQDg_19_2">304,738</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="Tc_XYdOkmUTSUW0VcdcFChBxg_19_4">6.32</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" id="Tc_GzW3LbbxgkmGdJoLD-tnDw_20_2">110,250</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="Tc_ON0aP1DpPUSEi3_x8bBHzA_20_4">0.15</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Tc_AqzF4Cws80ixBUAQHj8_5Q_21_2">1,090,316</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Tc_xwEMJe1v50mDqrlV2a5yZw_21_4">3.18</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_xcuTfsOOYE-mw8TfjPU9RQ_22_2">4,261,017</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_QYVyLuj0Hk-d5JKVoFiOrg_22_4">5.65</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Tc_dQWlnM8D-kC9X4vMkmN_Eg_22_6"><span style="font-size:10pt;"> 7.6</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc___bIXKYnw0Sd4uxF8pzJIg_23_2">2,345,648</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="Tc_StINWgIm20KD66pkjObXtQ_23_4">6.41</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" format="ixt-sec:duryear" name="aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" id="Tc_q8D5bQQI7EKSozmTTjKxmQ_23_6"><span style="font-size:10pt;"> 6.6</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" id="Tb_QTFbSEkhuEWYXo0qSg0nrw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The outstanding stock options as of December&#160;31, 2022 have the following range of exercise prices:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">expiration</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&#160;options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">dates</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range of exercise prices</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF 0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf0.15Member_Mjn-Ndi9XEOlgiCMgrFRAQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_UXNNI-xnd0ilI51m5GFCSg_5_2">97,875</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2022&#8211;2026</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF 9.53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf9.53Member_HuWh2wiS0UufmuyDmPt1XQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_bgLtAIMdb0m_cudiCdaf4g_6_2">223,646</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2027</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 5.04 to USD 12.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd5.04ToUsd12.30Member_gtKWlOCngE27VpysbvaH2g" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_xW1ib7YKtkm_xF5YRCBiNQ_7_2">2,864,408</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2028&#8211;2031</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 2.76 to USD 4.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd2.76ToUsd4.57Member_m38zUhm5wkSL12bhBb3aJA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_6Qa3wMrKaUmlukQjeif08A_8_2">1,075,088</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2032</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total outstanding options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_GZiqpKpyE0unreCBv-2LVA_9_2">4,261,017</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The weighted-average exercise price for options granted in 2022, 2021 and 2020 is USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr__0_f0sTPbECyFaKA6wdZ-w">3.44</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_2-9YSXjCFkSo8wM09mPVuQ">3.18</ix:nonFraction>), USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_X7nD34nJykOA7GKJKv0kpA">6.95</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_HIXS77qQP0uNVdWJI_-bVg">6.34</ix:nonFraction>) and USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_gvIRFIExRE6PrvKwsAsXkg">7.11</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_T1L34eAFlEyKCz_VXRw8bw">6.29</ix:nonFraction>), respectively. The range of exercise prices for outstanding options was CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_bUz70ksDa0GFXt0fOkzTMA">0.15</ix:nonFraction> to CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_qyR-D-rylUSAtWsm2FGzhg">9.53</ix:nonFraction> for awards previously granted in CHF (prior to 2018) and USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_NTnBRf1g5kmKX6S3XVxhmQ">2.76</ix:nonFraction> to USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_DPfxS_VUnkG_YBv2XMXn0w">12.30</ix:nonFraction> for awards granted in USD as of December&#160;31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For awards issued in 2022, the volatility is based on the Company&#8217;s actual volatility for the period congruent with the expected term of the underlying option. The risk-free interest rate is based on yields of long-dated U.S. Treasury notes that align with the expected term of the award. The weighted-average share price of common share options exercised in 2022 is USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" scale="0" id="Narr_1qFPCv3pXkKCMHcaPqfv_g">3.55</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" scale="0" id="Narr_871i4RhqWkKM_TKyivJ9JQ">3.28</ix:nonFraction>).</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-40</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_6e10bf45_c3d2_4642_83b4_086ee10baee5"></a><a id="Tc_GfeY7N6RiEakmzeSDPCzSA_1_2"></a><a id="Tc_KjI1QdxssEeDFaRDWRBpbA_2_2"></a><a id="Tc_uzkSD77lz0KzmV-LDM7i0w_3_2"></a><a id="Tc_KaShlTlrEU2LvZW3qelspg_3_4"></a><a id="Tc_ZxqoYDTNOEWfmes7-uuVdA_3_6"></a><a id="Tc_dKB27rF0DEqC6ZNqyIgYhA_4_0"></a><a id="Tc_ZsLlw7keIEedevZ2iTW0iw_4_2"></a><a id="Tc_upFsqdRk2U2OtEcEmuUlHA_4_4"></a><a id="Tc_cMr20JFF6UO_wsscUWIw-w_4_6"></a><a id="Tc_EL524hVxqk-qX9SBiI-j0A_5_0"></a><a id="Tc_o-eSluZ4f0qou7u6vEM-Sg_6_0"></a><a id="Tc_IcuGmmpMQkWQb5nC8F0FBA_6_2"></a><a id="Tc_tsmxUx_UXk-VqFczzmOsTg_6_3"></a><a id="Tc_VoRdvBzGu0qeCDvVQRBgmA_6_5"></a><a id="Tc_Odxjx-sV60K0AmaGPrnFVQ_6_7"></a><a id="Tc_0EObwKJXWE2uSsgcPIZDxA_7_0"></a><a id="Tc_wn7uiiX4y0amMZJqxzhBzQ_7_2"></a><a id="Tc_YGttIpRBrEKxo01CqfVivA_7_3"></a><a id="Tc_wYymIIWjFk2j-gOKKeE29g_7_5"></a><a id="Tc_RAbE3TlrvUW_pMFkNpg_yA_7_7"></a><a id="Tc_GWlKtB2O6kqb6t9oxi39-A_8_0"></a><a id="Tc_fdpa_CKw20yZWUx1h-1k7A_8_2"></a><a id="Tc_KXehVJ07G02NDVZb7bibCQ_8_4"></a><a id="Tc_NgHQY6xvfUqTeaJBlLsoqQ_8_6"></a><a id="Tc_bFiGHCGn7Uq8I25w9kVJfg_9_0"></a><a id="_ea8de387_1a07_45da_a8c8_268e18d01d72"></a><a id="Tc_w0PQMc8iP0G_gf0gHPB2NQ_1_6"></a><a id="Tc_eCvZ_szaLEi5mJY0SBDExg_2_2"></a><a id="Tc_MFm7NzTC0kCoxmEqg5Gypg_2_6"></a><a id="Tc_XPjeTH9rgU-kDSHnqmW93A_3_2"></a><a id="Tc_RPJRXJMaM0y5G1-vE9OoNg_3_6"></a><a id="Tc_n4PCrEOYeUyvQM7fIimaEA_4_0"></a><a id="Tc_oju6Em-HEEaanYUwoLHtPA_4_2"></a><a id="Tc_motnbnMFRk22zT3GUpncjQ_4_4"></a><a id="Tc_agEktHpO_UyJHENV0XW0tQ_4_6"></a><a id="Tc_b9DclzwAi0mEROb_tR97YA_5_0"></a><a id="Tc_x1yz6pi4UkCDWHwHUhPj_g_6_0"></a><a id="Tc_em2IdtQM7U-n239QeN422Q_6_4"></a><a id="Tc_zX5WncmVCEGGGd-KZb3UJw_7_0"></a><a id="Tc_7Oa77cbOJkWbW1CFgBFOww_7_4"></a><a id="_1eb82027_bc96_4755_a4c0_b7a0ba6da7e4"></a><a id="Tc_-Amg5YxMVUaunc3lmA9rtA_1_4"></a><a id="Tc_t1KJj2f1mUa68TcNc0o5WA_2_2"></a><a id="Tc_mA7EQpzhYUK2JjXFUjayew_2_4"></a><a id="Tc_qJcibbBvn0SFg8Qkh7RyLA_3_2"></a><a id="Tc_8Av5gDrpGk63GffmvPPQZw_3_4"></a><a id="Tc_W7EKGfGzmkiu2zL1IReIog_4_2"></a><a id="Tc_kRvpmQur9U-o5UHBuscuqA_4_4"></a><a id="Tc_A50nuwwqhUyaQiSFfL2KKg_5_0"></a><a id="Tc_WKPy05oJQ0WsNrbn2zLhMA_6_0"></a><a id="Tc_pj15Aum29ESV2cV3YpG9_Q_7_0"></a><a id="Tc_76ZA_O1eLUuX31FOkXYDYQ_8_0"></a><a id="Tc_07OjI_Z2yEC5vzTsjKPJmg_9_0"></a><a id="Tc_SvNPiPZPE0Kr6IQbJNa0Uw_10_0"></a><a id="Tc_l6fJwrBR6kKQi8pH-yV8_g_11_0"></a><a id="Tc_aafEVB02_kW2dUk-wQTpxQ_12_0"></a><a id="Tc_1RLOWmqrokCrGPk0Meq69w_13_0"></a><a id="Tc_Ed9qljSSwEyi9-qVdqdn1w_14_0"></a><a id="Tc_Lki4NS4EYkykbWRH01ePvQ_15_0"></a><a id="Tc_581XVFsw2kiOsOgoxgwMFQ_16_0"></a><a id="Tc_bA4jc0T5DUKC4ouD_aG45Q_17_0"></a><a id="Tc_2y9IBmA_BEKLiZTog3xwZg_18_0"></a><a id="Tc_SUfKG_lJ60WYVrdfRjBgJw_19_0"></a><a id="Tc_twwgM_lxIUSnSzVhrlisaQ_20_0"></a><a id="Tc_Z55WAdPlKkO7jBlThSmo0w_21_0"></a><a id="Tc_XD3cCcu6H06fPvyJ81pNGQ_22_0"></a><ix:continuation id="Tb_iFJK4IV2S0a-M7_Izzp38Q_cont2" continuedAt="Tb_iFJK4IV2S0a-M7_Izzp38Q_cont3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The weighted-average grant date fair values of the options granted in 2022, 2021 and 2020 are USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" id="Narr_FynhiRmPGEOlxNML8gzVdw">2.38</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" id="Narr_v0_MyjvDdUOdgOCQLxzV2g">2.20</ix:nonFraction>), USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" id="Narr_7tSj1iS7r0at2dO31B9HlA">5.23</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" id="Narr_-EZ0I-1LtUuctfQFoxyzCA">4.78</ix:nonFraction>) and USD <ix:nonFraction unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" id="Narr_R10XUplMgUuIYirpDPoANA">5.25</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" id="Narr_Be6CGiVATkqKZeOR8ogXuw">4.65</ix:nonFraction>), respectively. The following table illustrates the weighted-average assumptions for the Black-Scholes option-pricing model used in determining the fair value of these awards:</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" id="Tb_uJxApwuJikGRHfD_2jihYA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercise price (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Narr_0kl8QiMF40WHmEqylYw6sg">2.76</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Narr_YQpbiH6Knk6SlRQxM4VDhw">4.57</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_5cL5m8nGCEqTrf8_CtRG_A" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Narr_2fbGwGRFAkeHCnl80nXKRg">5.31</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_hGZYF059eky85mjSvMDTyw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Narr_WWbdPx-5gUWEz2AuRN9Zpg">7.72</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_3yeVGHwDfEeZEDJ901taIw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Narr_eiZhk7b4V0aJf7XDs4f09A">5.04</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_dIb050VtY0uPI1cKwRn8HA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Narr_3if4zJBzO0abn-4omDajBA">9.16</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share price (weighted average)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" id="Tc_FS7qpTTRoU6kvfUoUlCVUA_5_2">3.44</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" id="Tc_H5dlbjwPwEaGleTKpT8EPg_5_4">6.95</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" id="Tc_PlwKWOtJlkeUp_sxKyY4TA_5_6">7.11</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="Narr_OJo-GCc96Ee4PqpluJtRFg">0</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="Narr_ntEGZJBVmkSFzKtgDHc0yQ">2.4</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="Tc_9Lg_-BSZNkmZew4rWzPdrw_6_4">0</ix:nonFraction> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="Tc_9SPV6XUJ2kuTKjKdXkkz_A_6_6">0</ix:nonFraction> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="Narr_tHOeZ7-vv06Ml1gvM1y_hQ">67</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="Narr_V9Jki2qIg0y5TK0Q0B6mvA">80</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="Tc_Gek5OCj_bEuWiyleiYtiVQ_7_4">80</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="Tc_vylN4i3q3ECiwFgMzpCAdw_7_6">80</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expected term (in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Narr_4FZGbDyCZEWRhn_tlPuaXw">5.5</ix:nonFraction> - <ix:nonFraction unitRef="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Narr_9-mNsytaHUWLmiB6aZ4UzQ">6.25</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_5cL5m8nGCEqTrf8_CtRG_A" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Narr_FDoTS-Qb00G8LqcU7L_0Aw">5.1</ix:nonFraction> - <ix:nonFraction unitRef="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_hGZYF059eky85mjSvMDTyw" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Narr_rJLx-OSwl0eaLdsfPi8ljA">6</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_3yeVGHwDfEeZEDJ901taIw" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Narr_nW-UPrPhOUGqdJvKNzs9xQ">5.5</ix:nonFraction> - <ix:nonFraction unitRef="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_dIb050VtY0uPI1cKwRn8HA" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Narr_OrCpYgE_KE-0FHtgKbNdlg">6</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" format="ixt:zerodash" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" id="Tc_23IFDKxwMkqIDQDF3ryjYg_9_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="2" format="ixt:zerodash" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" id="Tc_dRJ1KMTUTk6GnqFwvhBw-w_9_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" format="ixt:zerodash" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" id="Tc_GDZVqdUJy0WqYNhfDn6nlg_9_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Restricted share awards</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" id="Tb_2y0M8vvn0UOb4nPgx1cxYg" continuedAt="Tb_2y0M8vvn0UOb4nPgx1cxYg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A summary of non-vested share awards (restricted share and restricted share units) activity as of&#160;December&#160;31, 2022&#160;and changes during the&#160;year then ended is presented below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">life&#160;of&#160;non-</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">share&#160;awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">vested&#160;share</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grantee type</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">granted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vesting&#160;conditions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">awards</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restricted share units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Directors</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="Duration_11_16_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_EUWOkY3BskaxAia9Z8ewEQ" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc_l7fOZp6fi0eGABMseXuvMA_6_2">159,025</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ZVoQVJGhW0GvwsXTKPLhYw" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_ku4Zq9V1GUGUe5grb_aR-A"><span style="font-size:10pt;">1 year</span></ix:nonNumeric><span style="font-size:10pt;"> service from date of grant, annually</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_0Lc-koCQpEeU6K6OjBCTKA" format="ixt-sec:durwordsen" name="aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" id="Tc_WGS0iNeFQEujkyvxZWvpew_6_6"><span style="font-size:10pt;">10 years</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executives</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="Duration_11_16_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_8IofwfDJNUGt5LoOfv2Txw" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc_Prc-TVdP80mSdeyvV4qBeg_7_2">274,872</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsFirstVestingConditionsMember_gGDNEFbPMkKnisGaecdtgg" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_r7E4FY0CJEm40jkEMn5dxQ"><span style="font-size:10pt;">3 year</span></ix:nonNumeric><span style="font-size:10pt;"> and </span><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsSecondVestingConditionsMember_tIRug6aVk0eTDxYXCAEY0g" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_i0nUyrzBVEeBzWTL8JGFng"><span style="font-size:10pt;">4 years</span></ix:nonNumeric><span style="font-size:10pt;">&#8217; service from the date of grant, quarterly and semi-annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_UZGF3O0NRECj0iuX4vHtKQ" format="ixt-sec:durwordsen" name="aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" id="Tc_ZmDE7Fh9u0WWKst7FYr-rg_7_6"><span style="font-size:10pt;">10 years</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">non-vested</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">grant</b>&#160;<b style="font-weight:bold;">date&#160;fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">value&#160;(CHF)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at January 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_YWfuOV2LMUGsWQqsGR6J5w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="Tc_NPrhgMEWqEuMMpDfkOf3Uw_5_2">42,763</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_YWfuOV2LMUGsWQqsGR6J5w" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Tc_QMr6C4OrgEasjt7lHKO7BQ_5_4">9.52</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" scale="0" id="Tc_X40iCP-7-ky7YQ_5gWBcMQ_6_2">11,828</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" scale="0" id="Tc_WUDZrttuH0CDm5zJDPT68g_6_4">9.47</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expired during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" scale="0" id="Tc_yO5uRSrsgE60aeTC_r93aw_7_2">7,804</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired" scale="0" id="Tc_uyzkRcb0TEqBV1QZbZ-QeQ_7_4">9.52</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw" decimals="INF" format="ixt:numdotdecimal" name="aciu:NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" scale="0" id="Tc_tiwbgKu_mkadW6-d8w06Lg_8_2">84,638</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" scale="0" id="Tc_336WtSVjCESqk6Dej_RxHQ_8_4">9.51</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw" decimals="INF" format="ixt:zerodash" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc_O3CBsPG2CkONsG_xuWgcTg_9_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw" decimals="2" format="ixt:zerodash" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" scale="0" id="Tc_FBYwf54jY0qK9qOcgKbsjg_9_4">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" scale="0" id="Tc_I2bof4Q_IkOPXOIWsHMz-Q_10_2">23,269</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" scale="0" id="Tc_8azCLBOEHUeSqGZy5LQwMQ_10_4">9.52</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="Tc_gJowsJnot0yTm3WzRIvhLw_11_2">19,494</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Tc_ckpzeVjHkEyL667RMidE1Q_11_4">9.51</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_hrrQ_gAosUCJ7tPj3yddpg_12_2">49,289</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" scale="0" id="Tc_GhuHuFLrCki_8fqTqXad6g_12_4">9.47</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="Tc_QrXijpK56Eim6DZB6yOB9Q_13_2">19,494</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Tc__ZLtCM_US0G1PWfB6m8VfA_13_4">9.51</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_my1TIm6ojUaJIKTSB0t2ng" decimals="INF" format="ixt:numdotdecimal" name="aciu:NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" scale="0" id="Tc_wVmnPtM4YEu29MArsYiwmA_14_2">2,471</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_my1TIm6ojUaJIKTSB0t2ng" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" scale="0" id="Tc_D0FZG29Ci0m1nGq0rw6P4g_14_4">9.46</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_my1TIm6ojUaJIKTSB0t2ng" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" scale="0" id="Tc_uIsqZkweqUuPQ-QKOCXZlQ_15_2">18,697</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_my1TIm6ojUaJIKTSB0t2ng" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" scale="0" id="Tc_ircD4vKY30WmPgwBE6u6zA_15_4">9.52</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="Tc_zO3X0bY8TUSaDbgyidgBNw_16_2">797</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Tc_B4GoMEKFyk2XMrhuGeGFLg_16_4">9.41</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_x1w2UH_LREiUrI7d7DI3JA_17_2">65,515</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" scale="0" id="Tc_M93Q_TIgTUWI0RAhlyvcaQ_17_4">9.48</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="Tc_CSugA_FL3kadsI2iM_treg_18_2">797</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Tc_uAqhSRPENEyovMwAEstoQQ_18_4">9.41</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_qvzjOcNNJ0e61xUNnj-VJQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc_yF5hVpkOh0SLDRmtEjF0mA_19_2">239,194</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_qvzjOcNNJ0e61xUNnj-VJQ" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" scale="0" id="Tc_u2MHEbu9uEy2wUT44OJCiA_19_4">3.06</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_qvzjOcNNJ0e61xUNnj-VJQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" scale="0" id="Tc_5gaouFNaik6y4nYR6B-HTA_20_2">23,505</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_qvzjOcNNJ0e61xUNnj-VJQ" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" scale="0" id="Tc_93PZJA1BjkKnCs3VRB8qvw_20_4">3.28</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_dxwmB62u-UWekqoEuPazhg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="Tc_nVrqrCtKOUCC8pxl_igvsQ_21_2">216,486</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_dxwmB62u-UWekqoEuPazhg" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Tc_cfjZjYi8jkSzAFJrABA64w_21_4">3.06</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_dxwmB62u-UWekqoEuPazhg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_BjcOUkDVtkK-WcZrk36cAg_22_2">89,020</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_dxwmB62u-UWekqoEuPazhg" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" scale="0" id="Tc_Vi_lTNOCBke7g_HA3k4VxA_22_4">7.84</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-41</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_iFJK4IV2S0a-M7_Izzp38Q_cont3"><ix:continuation id="Tb_2y0M8vvn0UOb4nPgx1cxYg_cont1"></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The weighted-average grant date fair values of the remaining non-vested share awards as of the respective&#160;year end for the restricted share units were CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_8n96kGPIAEKNlTtnDkaFpA" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Narr_dTKaz9acx0Sk77cMfUDffQ">3.06</ix:nonFraction>, CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_nWByIEwhSEGf6j1j19xN3w" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Narr_5B9fen5Cd0Cytn7umILlrA">9.41</ix:nonFraction> and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_qn53IASnuk6FLPf7LUu5zw" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Narr_OXjglx-EdE2hJf53LvS6Gw">9.51</ix:nonFraction> for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively. The fair values of these non-vested share awards granted were determined using a reasonable estimate of market value of the common shares on the date of the award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The expense charged against the income statement was CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="Narr_OG54UZ9MqEmq9RxV12ZV4g">3.3</ix:nonFraction> million, CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="Narr_qqabJaNL-U-6_PwM02DL0Q">4.1</ix:nonFraction> million and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="Narr_utWBOaScT02JbnsXwhvi4A">4.1</ix:nonFraction> million for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively. The expense is revised by the Company based on the number of instruments that are expected to become exercisable.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="Tc_QoGBm_KgaE-p3P9N07c4CQ_1_2"></a><a id="Tc_0BbJfNWXCk-dK8TFyPG7kg_2_2"></a><a id="Tc_6g9OieXTzk-A0H5MR2UUJg_3_0"></a><a id="Tc_uTGlOkw6ZECn_A8Rt-aTvQ_3_2"></a><a id="Tc_GBrmK6KAK0-i17ibnYN50A_3_4"></a><a id="Tc_zPxFv0DfikKTD10MnCk-Vg_4_0"></a><a id="Tc_W0Ms9iFvpUm6R-ZsmFca0Q_5_0"></a><a id="Tc_wwjeErvwJE-z9qmDI2EhPw_6_0"></a><a id="Tc_E6TMDpzwFECaX7PBZ1JNPw_7_0"></a><a id="Tc__laTINxteEihxJA6Rj2ohA_8_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" id="Tb_Lz7jZzGuZkOEYXn86xFIdQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">19.</b></span>Commitments and contingencies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s commitments and contingencies relate to its ongoing operating activities, mainly research and development programs, as well as its leased corporate space.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the normal course of business,&#160;we conduct product research and development programs through collaborative programs that include, among others, arrangements with universities, contract research organizations and clinical research sites. We have contractual arrangements with these organizations. As of December&#160;31, 2022, we have contractual obligations, other than for leases (see below), totaling CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_-yIL5uUOREqnWUjN-WEKug" decimals="-5" format="ixt:numdotdecimal" name="aciu:ContractualCapitalCommitmentsOtherThanForLeases" scale="6" id="Narr_iFi2z1mVZEOJfJ8Vu8a7iw">23.0</ix:nonFraction>&#160;million for 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We lease our corporate, laboratory and other facilities under multiple leases at the EPFL Innovation Park in Ecublens, near Lausanne, Canton of Vaud, Switzerland. Our lease agreements have no termination clauses longer than a <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" format="ixt-sec:durmonth" name="aciu:RentalContractPeriodForNoticeOfCancellation" id="Narr_R78Z8_fPIkqSiRFtghoi8A">12</ix:nonNumeric>-month contractual notice period. The Company recognizes a right-of-use asset for its leases, except for short-term and low-value leases as indicated in Note&#160;3<i style="font-style:italic;">.</i> See &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities&#8221; for the contractual undiscounted cash flows for lease obligations.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfCommitmentsExplanatory" id="Tb_yHHKoNvxR0CB6_dlFwzzkQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Within 1 year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_-yIL5uUOREqnWUjN-WEKug" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_Q-Ok58MWzEmAmSbcuFt69w_4_2">23,336</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_IDSltZ9zlUuxs8MqNPseTA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_7Cf9XS77IkuBP5bXwZd3Sg_4_4">19,785</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Between 1 and 3 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_3B9uzJLVRE-wKxtJvPSkOg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_VRS36rnWXku0uyHQHbAPXg_5_2">18,516</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_93lXqdNkAkGE1eTi254vCQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_rbksl_JmXUeupgLBmGj1Ug_5_4">3,620</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Between 3 and 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_Aq4Gh5QzC0O-z-Hkxgg7bw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_5BM20r1aGU2y3f4Qs5Ky8g_6_2">9,229</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_EG_KIXGerkW5heSXWG1y5Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_lYRapN9LXU-ngnyOxzREAg_6_4">243</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">More than 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_OgtSEFz6OUOEyh01YeW-4Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_3BfYxbpIFEiZ0j4owOrBLQ_7_2">1,407</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_pevi1fpI-0qT5MFTaLocdA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_0NJ17RlJ_0mljkZeZJ1YLA_7_4">51</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_ABh-75yGc0SArjIsbfwx0g_8_2">52,488</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_HuVi2pfAWEq7W9dRJ3o92g_8_4">23,699</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="font-weight:normal;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="Tc_MUJCil8Ps0CTbZYxWmB_kQ_1_2"></a><a id="Tc_6sLaO4v9LUqSGxGA2T8y-Q_2_2"></a><a id="Tc_lPgk0mi4yUafn6o56_h1hw_3_0"></a><a id="Tc_lGBxNSRUc0aNUXhlPIOUcQ_3_2"></a><a id="Tc_9oBnLjtsJUKV6iTWJT536w_3_4"></a><a id="Tc_gvzM8kSeska3r_ShVxYarg_3_6"></a><a id="Tc_AA974qmiO0WeojQG_tJxjQ_4_0"></a><a id="Tc_57_9YVy78UC1yBxinZ3gtQ_5_0"></a><a id="Tc_BofPrF8pCUijWubPJ3r-Eg_6_0"></a><a id="Tc_UGBKR7_m3kSHk0fWd5npoQ_7_0"></a><a id="Tc_7GsLi_uUJU-fBIrUIm_--g_8_0"></a><a id="Tc_SGoU_FKdy0COlC1yc7RgTw_9_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory" id="Tb_Cv6kUMUpsEu4_xtrLKBk9Q" continuedAt="Tb_Cv6kUMUpsEu4_xtrLKBk9Q_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">20.</b></span>Earnings per share</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:EarningsPerShareExplanatory" id="Tb_UFiKnaOMtE6NtiXbVBIvtA" continuedAt="Tb_UFiKnaOMtE6NtiXbVBIvtA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.07212067%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands except for share and per share data</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss per share (EPS)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerator</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net loss attributable to equity holders of the Company</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" sign="-" scale="3" id="Tc_NtJbh4l_k0SshP693G1NNQ_6_2">70,753</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" sign="-" scale="3" id="Tc_lJc1J6n-5U-3ySk2jOOEfQ_6_4">72,996</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" sign="-" scale="3" id="Tc_Nuvcl4eRK0eMoPc7fB3uQw_6_6">61,921</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominator</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted-average number of shares outstanding used to compute EPS basic and diluted attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageShares" scale="0" id="Tc_KP10tQaXQkKXBT02eQzppw_8_2">83,554,412</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageShares" scale="0" id="Tc_KzXpem7sQEODF6qeLRviOQ_8_4">74,951,833</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageShares" scale="0" id="Tc_gy7MNbpffkWpTk7hdVksLg_8_6">71,900,212</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted loss per share for the period attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_cgp8j1AeEUmfZpatouq7ZA_9_2">0.85</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_6lkk_ENClEutyAUziECTYg_9_4">0.97</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_9G0jXxEEEEeDDYr3mRS2UA_9_6">0.86</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-42</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_qSa30_m-QUqJPJ-jtUZumw_1_3"></a><a id="Tc_uHCQFL_5k0-wVhbq1D17yw_2_3"></a><a id="Tc_hvA6CoM1YE28gUAIxcsy5Q_3_3"></a><a id="Tc_nT6m4ZnveEi2_nJ6NhXT4w_3_5"></a><a id="Tc_pm5Sxp3XiU-K9u9g6Rlj0A_3_7"></a><a id="Tc_T8nzfEzkHkOcTY7WAW7SHg_4_0"></a><a id="Tc_7fqXpOQdSEG4HI9SA2RClw_5_0"></a><a id="Tc_3cWDxoiueESlNzNrXikUBA_6_0"></a><a id="Tc_NPvRHhoNR0aeneuNUkXXGA_7_0"></a><ix:continuation id="Tb_Cv6kUMUpsEu4_xtrLKBk9Q_cont1"><ix:continuation id="Tb_UFiKnaOMtE6NtiXbVBIvtA_cont1"></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In periods for which we have a loss, basic net loss per share is the same as diluted net loss per share. We have excluded from our calculation of diluted loss per share all potentially dilutive in-the-money (i)&#160;share options, (ii)&#160;non-vested restricted share awards and (iii)&#160;shares that were issued upon conversion of two different convertible notes as their inclusion would have been anti-dilutive. The weighted-average number of potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DilutiveEffectOfConvertibleInstrumentsTextBlock" id="Tb_ADJEDSvG2kuUnMa9cu4B2A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share options issued and outstanding (in-the-money)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt:numdotdecimal" name="aciu:DilutiveEffectOfShareOptionsIssuedAndOutstanding" scale="0" id="Tc_1WCco1uqf0GFoqA8Acw9uw_4_3">135,827</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="INF" format="ixt:numdotdecimal" name="aciu:DilutiveEffectOfShareOptionsIssuedAndOutstanding" scale="0" id="Tc_a6MeE9OglE6Dq4sB_2F7uw_4_5">1,140,388</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="INF" format="ixt:numdotdecimal" name="aciu:DilutiveEffectOfShareOptionsIssuedAndOutstanding" scale="0" id="Tc_GsBwmmyxFk612I-E55EWWw_4_7">412,191</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Restricted share awards subject to future vesting</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt:numdotdecimal" name="aciu:DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting" scale="0" id="Tc_mzcEHNGT_kqdzS5ML2HVlg_5_3">117,292</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="INF" format="ixt:numdotdecimal" name="aciu:DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting" scale="0" id="Tc_Csjpm3-o50GZPSPcSwNMYA_5_5">6,264</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="INF" format="ixt:numdotdecimal" name="aciu:DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting" scale="0" id="Tc_KVRCWHEU50O1Vvn2YYP64Q_5_7">28,418</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Convertible shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt:zerodash" name="ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" scale="0" id="Tc_Agdtt9RtkEGh2L2lFFeaIA_6_3">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" scale="0" id="Tc_OdYb_qblYEmvv3-H3Leg3g_6_5">41,461</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="INF" format="ixt:zerodash" name="ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" scale="0" id="Tc_p27p7x0vh0uJ8CjW_0UyMQ_6_7">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total potentially dilutive securities </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" decimals="INF" format="ixt:numdotdecimal" name="aciu:DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" scale="0" id="Tc_Xmb9SYSVnkWKF3yN66Q5cQ_7_3">253,119</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA" decimals="INF" format="ixt:numdotdecimal" name="aciu:DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" scale="0" id="Tc_UFdXa1PTdkmTkWDycyHH6w_7_5">1,188,113</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg" contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w" decimals="INF" format="ixt:numdotdecimal" name="aciu:DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" scale="0" id="Tc_cHL_TpnICkGK6yGgyqgcOw_7_7">440,609</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_27fb36d1_0b1b_45d3_b4c5_bdfdbbe3534d"></a><a id="Tc_R4VaDfLuM0uZYfqLmOZUwA_1_2"></a><a id="Tc_3vRKAA9nx0aGehzWFJ730Q_2_2"></a><a id="Tc_bDzjwzfiOUiQkoggse0vUQ_3_0"></a><a id="Tc_kJ6Y-9_p5k-PvLKOeoKZ8Q_3_2"></a><a id="Tc_80bqPz2OW06WypccLL7GtQ_3_4"></a><a id="Tc_Zft3eA0CZkugm2BRdwsIlw_4_0"></a><a id="Tc_um09hqf5hkS4cjOjYG0KZw_5_0"></a><a id="Tc_Sc0AV2jQTk6u2RgqnoNyow_6_0"></a><a id="Tc_9R7-cwYkJkSJ0yXgM3EFEw_7_0"></a><a id="Tc__ja_KytLbUu91KoWI9sIRg_8_0"></a><a id="Tc_-1KhzU0EXUWeF3hA3pZIfA_9_0"></a><a id="Tc_ZG-CuBE_cEaow7BYFPTOjQ_10_0"></a><a id="_09240381_049c_4c2a_9328_abe9e5830cd9"></a><a id="Tc_Bmy9EJmqYEeTJqeqcCZW_w_1_2"></a><a id="Tc_KvFAB1sg6UySvhjqxqNt9w_2_2"></a><a id="Tc_fOguL8XICEWXhnh6o4F7NQ_3_0"></a><a id="Tc_t_DP79QjvEile5bbu7MgAA_3_2"></a><a id="Tc_IOUHK2KK80GGBlqSMUkK8w_3_4"></a><a id="Tc_ZSV09tNr8Uu26eetIpNYlQ_4_0"></a><a id="Tc_QIJnhw9_cU2QeuV9woDEzA_5_0"></a><a id="Tc_0BMfuptxIEiEtgMtRbfnhw_6_0"></a><a id="Tc_LJcNcFWQG0Ol_82-uvPguw_7_0"></a><a id="Tc_TlPNRrj-EUWS5tnHGvXRKw_8_0"></a><a id="Tc_zO6A0-udzUC7cHF5C8PmhQ_9_0"></a><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfFinancialRiskManagementExplanatory" id="Tb_1QdQk0hoTE2R6ogBGrLHsA" continuedAt="Tb_1QdQk0hoTE2R6ogBGrLHsA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">21.</b></span>Financial instruments and risk management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s activities expose it to the following financial risks: market risk (foreign exchange and interest rate risk), credit risk and liquidity risk. The Company&#8217;s overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company&#8217;s financial performance.</p><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" id="Tb_-KXK7j3-sU6Dk8BJilnTRQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table shows the carrying amounts of financial assets and financial liabilities:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_jyOi4fu8akSFRaaUIvyLtQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc__XVhnRtqpkySY4HdeJjphg_5_2">2,808</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_3Jy3_8RbZUWAnkkvJgLO9w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_yDK3kwfzLEekTvTZnMqWyQ_5_4">2,914</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_Oa3BLbYryUWJpolylXf_QQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc__wjWzbsFgE6D7mx50VaTXw_6_2">361</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_tJzQntMdsU6d1iyuTo4P6w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_jwB6uA_t6UGIFtVSgV9uLw_6_4">363</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_5zN3E_yoh02M-AfcBPl9vA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_FYtzZsXCb0SLAsC4MAPXVw_7_2">392</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_Bl-K4Rg37EyEPpGUWgJdww" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_NcDeslUdEkyDXVV9b3yN7A_7_4">428</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_C2-Rix-rrUWBxTMIugjLZw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_h6vzZ-ae5kWDybQG4Y_A_A_8_2">91,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_DhXQ_kkBwUi5-evVk0nMVg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_rgb2aUlwbEi3MbOjwQhesg_8_4">116,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_FcEj2KvmMkOH2QDFyl4MuA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_wYdSBatQj0GiVLje6ltOEA_9_2">31,586</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_4ePuupbrrEqstdW7npGYxg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_H3yI67VmV02zhr0tXs0_nw_9_4">82,216</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_-eIIzzKDR0CF7BK6DDLmWQ_10_2">126,147</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_m8t3f3UkY0GVBV9qnIO1vQ_10_4">201,921</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_o6gi3zRMsky95yqQAXrXPA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_HELm0CoaWkmM-Cr6-gIttw_5_2">2,253</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_pWcmO-NRyEKwdZu9PbvzLQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_I2vLEZM7pUGp-NAClyfRbA_5_4">2,340</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_Cts4m1NVYEm1s8XilN-05w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_811PNfDrYUeSxR40zJladA_6_2">929</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_AsEKpSzsIUOKQll1k7zGDw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_j20ne54LBE2Ap1fo-A_gnA_6_4">2,003</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_grbXW83sNUKs9oRc5DlqvA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_q1hPTHbzrUmYFd0R8kU9Vg_7_2">9,417</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_BhAuKtG8w0aQWiwhMKyIUA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_mAGA8771OEipZ7tWrt_xXA_7_4">16,736</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_cmRGUa_u70epa2FW1Q5Q3Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_oLJiS4A3Hk62ZNPDaSA6qw_8_2">548</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_iojyYGBhoEmu6MX20T28CA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_9-mkgk6EAU6gHEJNvxxpJg_8_4">570</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_Qirll4KWYEWMJhPGCzZuwQ_9_2">13,147</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_0m60w6svCEiBBiWWTMFKbA_9_4">21,649</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Foreign exchange risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is exposed to foreign exchange risk arising from currency exposures, primarily with respect to the EUR, USD and to a lesser extent to GBP, DKK and SEK. The currency exposure is not hedged. However, the Company has a policy of matching its cash holdings to the currency structure of its expenses, which means that the Company holds predominately CHF, with lesser balances of EUR and USD (see &#8220;Note&#160;8. Cash and cash equivalents and short-term financial assets&#8221;). The Company recognized a gain of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_hAdDmGPrWE6JWyIjdtUDJA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="6" id="Narr_4er9bB0waEqnUdA3yq-y2g">0.5</ix:nonFraction> million and losses of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_cPKR_v8WT0anxPEPSrhgGA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" sign="-" scale="6" id="Narr_MtKW5JnfdUmmt5ORT9HZrg">0.1</ix:nonFraction> million and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_IE1TM485zUWn_r_T4BeXIQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" sign="-" scale="6" id="Narr_ZRxLZDBp_ECnMpTKgYxnyQ">0.7</ix:nonFraction> million for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively, within &#8220;Finance result, net.&#8221;</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-43</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_1QdQk0hoTE2R6ogBGrLHsA_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2022, if the CHF had strengthened/weakened by <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_hAdDmGPrWE6JWyIjdtUDJA" decimals="2" format="ixt:numdotdecimal" name="aciu:PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" scale="-2" id="Narr_hRZTvxPKg0mdIWC7Pk5Wdw">10</ix:nonFraction>% against the EUR and the USD with all other variables held constant, the net loss for the period would have been lower/higher by CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_hAdDmGPrWE6JWyIjdtUDJA" decimals="-5" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" scale="6" id="Narr_jeOLE6sW_U2mUx8aQiBzLQ">0.7</ix:nonFraction> million (2021: CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_cPKR_v8WT0anxPEPSrhgGA" decimals="-5" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" scale="6" id="Narr_UHVebD-rSkKdE4Gl0c0SUA">1.7</ix:nonFraction> million), mainly as a result of foreign exchange gains/losses on predominantly EUR/USD denominated cash and cash equivalents and short-term financial assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Interest rates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s CHF cash holdings (inclusive of those held in short-term financial assets) were subject to negative interest rates at certain counterparty thresholds through the first three quarters of 2022. However, with the increase in interest rates, <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_uJn6GJFgd0C7AUHONVqWvA" decimals="-5" format="ixt-sec:numwordsen" name="aciu:CashAndCashEquivalentsSubjectToNegativeInterestRates" scale="6" id="Narr_CLSfpr8QFk2487tqQrYQlg">no</ix:nonFraction> current CHF cash holdings (inclusive of those held in short-term financial assets) are subject to negative interest rates with our counterparties. As of December&#160;31, 2022 if the interest rates charged by the counterparties had increased/decreased by <ix:nonFraction unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_Jgm2mZ4FRUuDSrQ2ymoSAg" decimals="2" format="ixt:numdotdecimal" name="aciu:PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" scale="-2" id="Narr_dSiY6hDwMkCFv3ZSU4j5Wg">10</ix:nonFraction>%, the net income for the period would have been higher/lower by less than CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_v5r8G2UC80OzCevY1QNAVQ" decimals="-5" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" scale="6" id="Narr_aRlRIIuX7Ei-XIPzRk9R3g">0.2</ix:nonFraction> million. Interest income and interest expense are recorded within finance results, net in our consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Credit risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company maintains a formal treasury risk and investment management policy to limit counterparty credit risk. As of December&#160;31, 2022, the Company&#8217;s cash and cash equivalents and short-term financial assets are held with <ix:nonFraction unitRef="Unit_Standard_Institution_SROTVTXUBkGGrhJAF8DeMQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_CuCfm2CCOUSB6f8RZI257g" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" scale="0" id="Narr_yhW1O6JC6k-yTxR1UcngzQ">five</ix:nonFraction> financial institutions, each with a high credit rating ranging from A+ to BBB assigned by international credit-rating agencies. The maximum amount of credit risk is the carrying amount of the financial assets. Other receivables are fully performing, not past due and not impaired (see &#8220;Note&#160;8. Cash and cash equivalents and short-term financial assets&#8221; and &#8220;Note&#160;10. Other current receivables&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Liquidity risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Inherent in the Company&#8217;s business are various risks and uncertainties, including the high uncertainty that new therapeutic concepts will succeed. AC Immune&#8217;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;acquire and keep key personnel employed and (iv)&#160;acquire additional capital to support its operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s approach of managing liquidity is to ensure sufficient cash to meet its liabilities when due. Therefore, management closely monitors the cash position on rolling forecasts based on expected cash flow to enable the Company to finance its operations for at least <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember__MJ0ad-Uz0G9j3cZ1MV7Iw" format="ixt-sec:durwordsen" name="aciu:LiquidityManagementRollingForecastPeriod" id="Narr_3gwVKpT1SkajwQ3sCiyyBw">18&#160;months</ix:nonNumeric>. The Company has CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_MbfX1IXrrEG58WLwK0Know" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="6" id="Narr_D5OEfsXeAU29Z1EC9RhWDA">0.9</ix:nonFraction> million in trade and other payables, and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_XuWosC4Fe0qG8LleE6GLdg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="6" id="Narr_0sAIN8rauUminvTEKfuc9Q">9.4</ix:nonFraction> million in accrued expenses which are due within 12&#160;months from the reporting date. Finally, as it relates to the Company&#8217;s lease liabilities please see &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities&#8221; for detail of when corresponding lease liabilities are due.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" id="Tb_aUcBFX7aP0C7T96E9QXCfw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">22.</b></span>Capital risk management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s objectives when managing capital are to safeguard the Company&#8217;s ability to continue as a going concern and to preserve the capital on the required statutory level in order to succeed in developing a cure against (i)&#160;AD, (ii)&#160;focused non-Alzheimer&#8217;s neurodegenerative diseases including NeuroOrphan indications and (iii)&#160;diagnostics.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory" id="Tb_Kad823u_V0qBxqOuNEbDEA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">23.</b></span>Subsequent events</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Management has evaluated subsequent events after the balance sheet date, through the issuance of these consolidated financial statements, for appropriate accounting and disclosures. The Company has determined that there were no other such events that warrant disclosure or recognition in these consolidated financial statements.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-44</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.6
<SEQUENCE>2
<FILENAME>aciu-20221231xex4d6.htm
<DESCRIPTION>EX-4.6
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 3/15/2023 05:38:27 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:6.05%;padding-right:6.05%;position:relative;"><div style="width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;text-align:justify;text-indent:-76.55pt;margin:0pt 0pt 62pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:76.55pt;"></font><font style="display:inline-block;width:274.5pt;"></font><font style="font-size:8.5pt;line-height:1.43;margin-top:14pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.79;text-align:right;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Exhibit 4.6</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.79;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';line-height:1.43;margin-top:14pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Verdana';font-size:10pt;line-height:1.79;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:center;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">INDEMNITY AGREEMENT</b><font style="font-family:'Times New Roman','Times','serif';"> (&#8220;the Agreement&#8221;)</font></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.79;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:center;"><font style="font-family:'Times New Roman','Times','serif';margin-right:0pt;visibility:hidden;">&#8203;</font></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.79;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:center;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">BETWEEN</b></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.79;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-right:0pt;visibility:hidden;">&#8203;</font></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.79;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;"><font style="font-family:'Times New Roman','Times','serif';">AC Immune SA, EPFL Innovation Park, b&#226;timent B, 1015 Lausanne, Switzerland (the </font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#8216;&#8216;Company&#8220;)</b></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.79;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-right:0pt;visibility:hidden;">&#8203;</font></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.79;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">AND</b></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.79;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-right:0pt;visibility:hidden;">&#8203;</font></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.79;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;"><font style="font-family:'Times New Roman','Times','serif';">[</font><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Name of Indemnitee</i><font style="font-family:'Times New Roman','Times','serif';">] (the </font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#8216;&#8216;Indemnitee&#8220;)</b></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.79;margin-bottom:0pt;margin-left:0pt;margin-top:5.65pt;"><font style="font-family:'Times New Roman','Times','serif';margin-right:0pt;visibility:hidden;">&#8203;</font></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.79;margin-bottom:0pt;margin-left:0pt;margin-top:5.65pt;"><font style="font-family:'Times New Roman','Times','serif';">the Company and the Indemnitee each a Party and together the &quot;</font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Parties</b><font style="font-family:'Times New Roman','Times','serif';">&quot;</font></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.79;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</font></div><div style="font-family:'Verdana';font-size:14pt;line-height:1.43;margin-bottom:7pt;margin-left:0pt;margin-top:14pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Recitals</font></div><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:28.35pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">A)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">Both the Indemnitee and the Company recognize the increased risk of litigation</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-1.65pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">and other claims being asserted against members of the board of directors and officers of public</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.45pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">companies;</font></p></td></tr></table><div style="margin-top:14pt;"></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;padding-left:28.35pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">B)</font><font style="display:inline-block;width:18.35pt;"></font><font style="font-family:'Times New Roman','Times','serif';">The shareholders of the Company have approved article 29 of the articles of association of the Company pursuant to which the Company may, to the extent permitted by law, indemnify members of board of directors and of the executive management for any disadvantages suffered in connection with proceedings, suits or settlements relating to their activity for the Company, advance the respective amounts and enter into respective D&amp;O insurances;</font></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:0pt;margin-top:14pt;padding-left:28.35pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">C)</font><font style="display:inline-block;width:18.35pt;"></font><font style="font-family:'Times New Roman','Times','serif';">The board of directors of the Company (the &quot;</font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Board</b><font style="font-family:'Times New Roman','Times','serif';">&quot;) has determined that enhancing the ability of the Company to retain and attract as directors and officers the most capable persons is in the best interests of the Company and that the Company therefore should seek to assure such persons that full indemnification and D&amp;O insurance coverage is available;</font></div><div style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:0pt;margin-top:14pt;padding-left:28.35pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">D)</font><font style="display:inline-block;width:17.8pt;"></font><font style="font-family:'Times New Roman','Times','serif';">In</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.5pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">recognition</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.45pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">of</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.45pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">these</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.35pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">considerations</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.4pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">and</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.45pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">in</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.35pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">order</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.35pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">to</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.4pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">provide</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.4pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">such</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.4pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">protection,</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.4pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">the Company wishes to provide in this Agreement for the indemnification of, and the advancement of legal fees to, Indemnitee as set forth in this Agreement and to the extent insurance is maintained for the coverage of Indemnitee under the Company&#39;s D&amp;O insurance</font><font style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.95pt;"> </font><font style="font-family:'Times New Roman','Times','serif';">policies.</font></div><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">1. Definitions</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Agreement</b><font style="display:inline-block;width:137.1pt;"></font><font style="font-family:'Times New Roman','Times','serif';">means this Indemnity Agreement.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Board</b><font style="display:inline-block;width:157.63pt;"></font><font style="font-family:'Times New Roman','Times','serif';">has the meaning as defined in Recital C.</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:184.3pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Claim</b></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">means any threatened, pending or completed action, claim, suit or proceeding, whether civil, criminal or administrative or governmental or regulatory investigation.</font></p></td></tr></table><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Company</b><font style="display:inline-block;width:142.63pt;"></font><font style="font-family:'Times New Roman','Times','serif';">has the meaning as defined on page one.</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:184.3pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Expenses</b></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">means all reasonable costs, charges, fees (including court fees, retainers, attorneys&#39; fees and experts&#39; fees) and expenses (other than regular or overtime wages, salaries, lost revenues or fees of a member of the Board) incurred in defending or investigating any Claim.</font></p></td></tr></table></div><div style="clear:both;width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:6.05%;margin-right:6.05%;margin-top:30pt;page-break-after:always;width:87.91%;border-width:0;"><div style="max-width:100%;padding-left:6.05%;padding-right:6.05%;position:relative;"><div style="width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;text-align:justify;text-indent:-76.55pt;margin:0pt 0pt 62pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:76.55pt;"></font><font style="display:inline-block;width:274.5pt;"></font><font style="font-size:8.5pt;line-height:1.43;margin-top:14pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:184.3pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Losses</b></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">are all costs, charges, losses, damages (including monetary judgments, fines, penalties, amounts paid in settlement) arising out of or relating to a Claim, including all Expenses.</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:184.3pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Indemnitee</b></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">has the meaning as defined on page one.</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:184.3pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Recital</b></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">means a recital of this Agreement.</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:184.3pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Section</b></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">means a section of this Agreement.</font></p></td></tr></table><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">2. Construction</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Unless a contrary indication appears, any reference in this Agreement to:</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(i)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">a &quot;person&quot; includes any individual, company, corporation, firm, partnership, joint venture, association, organization, trust or agency (in each case, whether or not having separate legal personality);</font></p></td></tr></table><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:29.75pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(ii)</font></font><font style="font-family:'Times New Roman','Times','serif';">a provision of law is a reference to that provision as amended.</font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">3. Indemnification</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Company shall indemnify and hold harmless the Indemnitee, to the fullest extent permitted by applicable law, out of the assets of the Company from and against all Losses, provided that:</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(i)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">the Losses which the Indemnitee has incurred or sustained resulted from any act done or omitted in or about the execution of the Indemnitee&#39;s duty, or supposed duty as a member of the Board or as a member of the executive committee of the Company (or is serving at the request of the Company for any affiliates of the Company); and </font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(ii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">with respect to any act or omission giving rise to such Losses, the Indemnitee had a reasonable belief that [he/she] was at all relevant times acting in good faith and in the best interests of the Company; and</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(iii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">in the case of a criminal or regulatory action, investigation or proceeding, the Indemnitee had no reasonable cause to believe that his conduct giving rise to such Losses was unlawful; and</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(iv)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">the Indemnitee cooperates with the Company in relation to the Claim in respect of which indemnification is sought hereunder.</font></p></td></tr></table><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The conclusion of any Claim by judgment, order, settlement or conviction, or up-on a plea of </font><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">nolo contendere</i><font style="font-family:'Times New Roman','Times','serif';"> or its equivalent, against an indemnified person shall not in itself create a presumption that the Indemnitee did not meet the criteria set forth in clauses (ii) and (iii) above. Without limitation, in determining whether an indemnified person meets the criteria set forth in clauses (ii) and (iii) above, it is relevant whether the Indemnitee&#39;s acts or omissions giving rise to such Losses were the result of knowingly fraudulent or deliberate dishonest behavior, willful or grossly negligent misconduct, or resulted in the Indemnitee&#39;s personal gain or a financial profit or other advantage to which the Indemnitee was not legally entitled.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Notwithstanding the foregoing, the Company will not indemnify the Indemnitee where to do so would or might, in the reasonable judgment of the Company, be contrary to applicable mandatory law. With respect to claims for breach of the fiduciary duty of care under Swiss law, this means inter alia that no indemnification will be made if the Indemnitee acted with willful intent or with gross negligence.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:6.05%;margin-right:6.05%;margin-top:30pt;page-break-after:always;width:87.91%;border-width:0;"><div style="max-width:100%;padding-left:6.05%;padding-right:6.05%;position:relative;"><div style="width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;text-align:justify;text-indent:-76.55pt;margin:0pt 0pt 62pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:76.55pt;"></font><font style="display:inline-block;width:274.5pt;"></font><font style="font-size:8.5pt;line-height:1.43;margin-top:14pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">4. Indemnification Process</b></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">4.1 Notification</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Upon becoming aware of any Claim, the Indemnitee must promptly notify the chair of the Board (or, if the Indemnitee is the chair of the Board, the vice-chair of the Board) in writing that [he/she] is seeking indemnification under this Agreement.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Any failure or delay to notify will not relieve the Company of the obligation to indemnify the Indemnitee under this Agreement provided however that the Company shall not be held liable for any damages, losses, damages or costs to the extent caused by the Indemnitee&#8217;s failure to give due and timely notice.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Company shall give prompt written notice to the applicable insurers in accordance with the procedures set forth in the applicable D&amp;O policies. The Company shall provide to Indemnitee a copy of such notice delivered to the applicable insurers, and copies of all subsequent correspondence between the Company and such insurers regarding the Claim, in each case substantially concurrently with the delivery or receipt thereof by the Company.</font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">4.2 Determination of Entitlement to Indemnification</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In accordance with article 29 of the articles of association and article 9 of the Organizational Rules of the Company, indemnification under this Agreement (unless ordered differently by a court) is made by the Company as per this Agreement. Where the Company has to make assessments, decisions or a judgment on the behavior of the Indemnitee hereunder, the respective decisions are made as follows:</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(i)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">by a majority vote of the members of the Board who are not parties to such Claim, even though less than a quorum;</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(ii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">by a committee of such members of the Board designated by a majority vote of the Board, even though less than a quorum; or</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(iii)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">if there are no such members of the Board, or if such members of the Board so direct, by independent legal counsel in a written opinion.</font></p></td></tr></table><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Subject to the other provisions of this Agreement, where an Indemnitee is entitled to indemnification, the Company will pay any Expenses incurred by the Indemnitee in defending any Claim, and to the extent such Expenses are not directly paid by the Company, advance to the Indemnitee such Expenses within five (5) business days of a notification to the Company by the Indemnitee that such Expenses are payable, provided that such advances may not exceed the limit provided in article 39 of the articles of association.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Company&#39;s obligation to pay or advance such Expenses is subject to receipt of an undertaking from the Indemnitee to repay any Expenses that the Company paid in accordance with Section 8 if it is subsequently determined that the Indemnitee is not or was not entitled to be indemnified by the Company. In addition, the Indemnitee is obliged to repay any Expenses paid or advanced by the Company if they are subsequently reimbursed to the Indemnitee by any other person or if advances are not used.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Company will not indemnify the Indemnitee in respect of the Expenses of enforcing any indemnification right under this Agreement, unless the Indemnitee is successful in enforcing a right to indemnification.</font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">5. Conduct of Claims</b></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">5.1 General</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">After notification of a Claim in accordance with Section 4.1, the Company may elect in writing to assume the defense of the Claim at its own expense and to engage legal counsel. Upon such election, the Company shall not be liable for any other attorney&#39;s fees subsequently incurred by the Indemnitee in connection with the Claim unless:</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">a)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">the Indemnitee&#39;s engagement of its own legal counsel has been authorized by the Company;</font></p></td></tr></table><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:29.75pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">b)</font></font><font style="font-family:'Times New Roman','Times','serif';">the Company has failed to timely engage reputable legal counsel;</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:6.05%;margin-right:6.05%;margin-top:30pt;page-break-after:always;width:87.91%;border-width:0;"><div style="max-width:100%;padding-left:6.05%;padding-right:6.05%;position:relative;"><div style="width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;text-align:justify;text-indent:-76.55pt;margin:0pt 0pt 62pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:76.55pt;"></font><font style="display:inline-block;width:274.5pt;"></font><font style="font-size:8.5pt;line-height:1.43;margin-top:14pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">c)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:0pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">in circumstances where the Company has assumed the defense of the Claim, the nature of such defense risks damaging the good name or reputation of the Indemnitee; or</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">d)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">the legal counsel whom the Company has engaged reasonably determined that his/her representation of the Indemnitee would present him/her with a conflict of interest and the Company has not provided an alternative.</font></p></td></tr></table><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">5.2 Retention of Outside Counsel</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">If the Company does not elect to defend the Claim on behalf of the Indemnitee or in case of any circumstances of Section 5.1.a) to d) above, the Indemnitee may retain outside counsel.</font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">5.3 Settlement of Claims without Consent</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Indemnitee must not settle the Claim without the prior written consent of the Company, such consent not to be unreasonably withheld. The Company shall not be liable to indemnify the Indemnitee under this Agreement for any amounts paid in settlement of any Claim without its written consent.</font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">6. D&amp;O Insurance</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><a name="_Hlk64381544"></a><font style="font-family:'Times New Roman','Times','serif';">For the duration of Indemnitee&#39;s service as a member of the Board or of the executive committee of the Company, and for at least a period of six years thereafter (or for a longer period to the extent that such D&amp;O insurance can be obtained thereafter for so long as Indemnitee shall be subject to any pending Claim) the Company will purchase D&amp;O insurance against any liability asserted against Indemnitee in [his/her] capacity as such and continue to maintain in effect policy of Indemnitee&#39;s D&amp;O insurance providing coverage that is at least substantially comparable in scope and amount to that provided by the Company&#39;s current policies of D&amp;O insurance.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In all policies of D&amp;O insurance maintained by the Company, the Indemnitee shall be considered as an insured in such a manner as to provide the Indemnitee the same rights and benefits as are provided to the most favorably insured of the Company&#39;s directors, if the Indemnitee is a director, or of the Company&#39;s member of the executive committee, if the Indemnitee is a member of the executive committee (and not a director) by such policy.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Upon request, the Company will provide to the Indemnitee copies of all D&amp;O insurance applications, binders, policies, declarations, endorsements and other related materials.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 12pt 0pt;"><a name="_Hlk66373412"></a><font style="font-family:'Times New Roman','Times','serif';">Notwithstanding the foregoing, the Indemnitee acknowledges that:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Verdana';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Upon change of control of the Company as a result of a merger or acquisition by a third party, the D&amp;O Insurance may expire for Losses arising from causes occurring after such change of control event, and the Company will use commercially reasonable efforts to buy D&amp;O insurance to cover events occurring after such change in control and, should the Company fail in its efforts, the Company will in any case use best efforts to purchase &#8220;Run-off Coverage&#8221; insurance for a period up to six years from the end of the D&amp;O insurance; and</font></td></tr></table><p style="font-family:'Verdana';font-size:12pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Verdana';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">prior to a renewal of a D&amp;O insurance, the Company&#8217;s Audit &amp; Finance Committee will make a determination on the economic reasonableness of the premium for a D&amp;O insurance extension considering the overall coverage (including limits and deductible). Where the Audit &amp; Finance Committee considers the extension of the coverage to be excessively onerous relative to the coverage, the Company shall have no obligation to extend any D&amp;O insurance, provided that in such event, the Company will immediately inform the Indemnitee thereof, and provided further that the Company shall then be compelled to purchase &#8220;Extended Reporting Coverage&#8221; insurance for a period of three years from the end of the then current D&amp;O insurance period as provided in the existing D&amp;O insurance policy.</font></td></tr></table><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">For the avoidance of doubt, the maintenance of a D&amp;O insurance by the Company does not limit the Indemnitee&#39;s right to be fully indemnified and held harmless as set forth under Section 3 or as set forth in article 29 of the articles of association of the Company. Any Loss not covered by D&amp;O insurance shall be borne by the Company.</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:6.05%;margin-right:6.05%;margin-top:30pt;page-break-after:always;width:87.91%;border-width:0;"><div style="max-width:100%;padding-left:6.05%;padding-right:6.05%;position:relative;"><div style="width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;text-align:justify;text-indent:-76.55pt;margin:0pt 0pt 62pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:76.55pt;"></font><font style="display:inline-block;width:274.5pt;"></font><font style="font-size:8.5pt;line-height:1.43;margin-top:14pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">7. Scope, Term and Termination</b></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">7.1 Scope and Term of Agreement</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This Agreement (and in particular the rights of the Indemnitee under Section 3) is applicable to all Claims against the Indemnitee or Losses incurred by the Indemnitee resulting from acts done or omitted in or about the execution of the Indemnitee&#39;s duty or supposed duty as a member of the Board or of the executive committee of the Company during the entire period the Indemnitee is a member of the Board or of the executive committee of the Company (or is serving at the request of the Company for any affiliates of the Company), beginning with date of election as a member of the Board or of the executive committee and not with the date of this agreement and shall continue thereafter (i) for so long as the Indemnitee may be subject to any possible Claim (including any rights of appeal thereto) and (ii) throughout the pendency of any proceedings (including any rights of appeal thereto) commenced by the Indemnitee to enforce or interpret his or her rights under this Agreement, even if, in either case, the Indemnitee may have ceased to serve in such capacity at the time of any Claim. This Agreement shall be binding upon the Company and its successors and assigns and shall inure to the benefit of the Indemnitee. The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all the business or assets of the Company, to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.</font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">7.2 Termination of Indemnification</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Notwithstanding the forgoing, an Indemnitee is no longer entitled to indemnification in case the Indemnitee ceases to comply with the requirements set out in Section 3 (i) to (iv).</font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">8. Repayment of Expenses</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">If the Company determines, applying the criteria in Section 3(i) &#8211;(iv), that the Indemnitee is no longer entitled to indemnification, the Company will immediately cease to pay the Expenses and the Company may require the Indemnitee to reimburse all advancements.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">For the avoidance of doubt, the Indemnitee&#39;s obligation to reimburse the Company is unsecured and free of interest.</font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">9. General Provisions</b></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">9.1 Duplication of Payments</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Without limiting the rights of the Indemnitee to be indemnified under this Agreement at any time, this Agreement constitutes secondary coverage if the Indemnitee is entitled to recover under any other indemnification arrangement provided by a third party or under any D&amp;O insurance policy purchased for the benefit of the Indemnitee. The Indemnitee is not entitled to multiple indemnifications.</font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">9.2 Successors</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This Agreement is binding upon the Company and its successors. References to the Company include all constituent corporations in a consolidation or merger in which the Company or a predecessor to the Company by consolidation or merger was involved. Any rights of indemnification passes to the benefit of the heirs, executors and administrators of the Indemnitee.</font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">9.3 Subrogation</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In the event of any indemnification under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, and Indemnitee shall execute all documents reasonably required and shall take such action that may be reasonably necessary to secure such rights.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:6.05%;margin-right:6.05%;margin-top:30pt;page-break-after:always;width:87.91%;border-width:0;"><div style="max-width:100%;padding-left:6.05%;padding-right:6.05%;position:relative;"><div style="width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;text-align:justify;text-indent:-76.55pt;margin:0pt 0pt 62pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:76.55pt;"></font><font style="display:inline-block;width:274.5pt;"></font><font style="font-size:8.5pt;line-height:1.43;margin-top:14pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">9.4 Confidentiality</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Parties shall keep confidential all matters relating to indemnification. This includes, but is not limited to, the Indemnitee&#39;s intention to apply for indemnification pursuant to this Agreement, any communications with the chair of the Board or other representatives of the Company regarding indemnification. The Indemnitee shall not discuss such information with or disclose documents relating to it to anyone apart from the relevant legal advisers of the Company, [his/her] legal counsel, financial advisers and accounting (if any), and [his/her] spouse/partner, if applicable, provided that such persons shall have agreed to maintain the confidential nature of all matters relating to the indemnification. Notwithstanding the foregoing, nothing will prevent the Indemnitee from disclosing such information:</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">a)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">where the Indemnitee is under a legal or regulatory obligation to disclosure such information (but only to the extent of such obligation); or</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">b)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">to the extent that it is already in the public domain (other than as a result of disclosure by the Indemnitee); or</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">c)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">with prior written consent of the Company (who shall not unreasonably withhold its consent).</font></p></td></tr></table><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Where the Indemnitee believes that a) or b) applies, the Indemnitee shall notify the Company in advance of any disclosures unless Indemnitee is legally prohibited from such notification.</font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">9.5 Entire Agreement</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This Agreement constitutes the entire Agreement between the Parties with respect to the subject matter of this Agreement and supersedes all other prior agreements or understandings of the Parties relating hereto. </font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">9.6 Severability</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The provisions of this Agreement shall be severable in the event that any of the provisions (including any provision within a particular paragraph or sentence) are held by a court of competent jurisdiction to be invalid, illegal, void or otherwise unenforceable, and the remaining provisions shall remain legally valid and enforceable to the fullest extent permitted by law.</font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">9.7 Amendment</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">No amendment or termination of this Agreement shall impair the rights of the Indemnitee under this Agreement in respect of any Losses incurred after such amendment or termination to the extent that such Losses arise from events occurring:</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:29.75pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a)</font></font><font style="font-family:'Times New Roman','Times','serif';">before such amendment or termination; or</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:29.75pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">b)</font></p></td><td style="padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:14pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">in the case of the Indemnitee holding an external function for the Company, after such amendment or termination but before the earliest time at which the Indemnitee could reasonably have resigned from that external function for the Company.</font></p></td></tr></table><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;padding-left:29.75pt;text-align:justify;text-indent:-29.75pt;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;padding-left:29.75pt;text-align:justify;text-indent:-29.75pt;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;padding-left:29.75pt;text-align:justify;text-indent:-29.75pt;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;padding-left:29.75pt;text-align:justify;text-indent:-29.75pt;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;padding-left:29.75pt;text-align:justify;text-indent:-29.75pt;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;padding-left:29.75pt;text-align:justify;text-indent:-29.75pt;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:6.05%;margin-right:6.05%;margin-top:30pt;page-break-after:always;width:87.91%;border-width:0;"><div style="max-width:100%;padding-left:6.05%;padding-right:6.05%;position:relative;"><div style="width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;text-align:justify;text-indent:-76.55pt;margin:0pt 0pt 62pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:76.55pt;"></font><font style="display:inline-block;width:274.5pt;"></font><font style="font-size:8.5pt;line-height:1.43;margin-top:14pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">9.8 Notices</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">All notices, requests or other communications to be given to any Party under or in connection with this Agreement shall be made in English and in writing and shall be delivered by (i) registered mail (return receipt requested), (ii) an internationally recognized courier, such as Federal Express, DHL or UPS, or (iii) e-mail to the following addresses:</font></p><div style="margin-left:-5.4pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:auto;width:76.41%;"><tr style="height:1pt;"><td style="vertical-align:top;width:37.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:62.26%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:37.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">if to the Indemnitee:</font></p></td><td style="vertical-align:top;width:62.26%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">[</b><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Name of Indemnitee</i><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">]</b><font style="font-family:'Times New Roman','Times','serif';"> [Address and e-mail]</font></p></td></tr><tr><td style="vertical-align:top;width:37.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">if to the Company:</font></p></td><td style="vertical-align:top;width:62.26%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Chair of AC Immune SA,</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">EPFL Innovation Park, Building B</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">1215 Lausanne, Switzerland</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">[e-mail]</font></p></td></tr><tr><td style="vertical-align:top;width:37.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">with a copy to:</font></p></td><td style="vertical-align:top;width:62.26%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Chief Administrative Officer at AC Immune SA</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">EPFL Innovation Park, Building B</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">1215 Lausanne, Switzerland</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Jean-fabien.monin@acimmune.com</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Notices delivered by hand shall be deemed delivered when actually delivered. Notices given by courier shall be deemed delivered on the date delivery is promised by the courier. Notices given by facsimile or by electronic transmission shall be deemed given on the date of receipt (if a business day), otherwise the first business day following receipt; provided that a notice delivered by facsimile or electronic transmission shall only be effective if such notice is also delivered by hand, registered mail, or given by courier on or before 2 business days after its delivery by facsimile or electronic transmission.</font></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.43;text-indent:0pt;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">9.9 Governing Law and Jurisdiction</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This Agreement is governed by and construed in accordance with the laws of Switzerland.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Parties hereto submit to the exclusive jurisdiction of the competent courts at the registered seat of the Company (currently Lausanne, Switzerland).</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:center;margin:14pt 0pt 0pt 0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">[Signatures on the next page]</i></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;line-height:1.43;margin-top:14pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:6.05%;margin-right:6.05%;margin-top:30pt;page-break-after:always;width:87.91%;border-width:0;"><div style="max-width:100%;padding-left:6.05%;padding-right:6.05%;position:relative;"><div style="width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;text-align:justify;text-indent:-76.55pt;margin:0pt 0pt 62pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:76.55pt;"></font><font style="display:inline-block;width:274.5pt;"></font><font style="font-size:8.5pt;line-height:1.43;margin-top:14pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Signatures</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">AC Immune SA</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">_______________________</font><font style="display:inline-block;width:4pt;"></font><font style="display:inline-block;width:29.75pt;"></font><font style="font-family:'Times New Roman','Times','serif';">_______________________</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Name:</font><font style="display:inline-block;width:150.64pt;"></font><font style="font-family:'Times New Roman','Times','serif';">Name:</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Title:</font><font style="display:inline-block;width:155.64pt;"></font><font style="font-family:'Times New Roman','Times','serif';">Title:</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:14pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:14pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:14pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:14pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Date :____________ 2021</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">[</b><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Name of Indemnitee</font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">]</b></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">_______________________</font><font style="display:inline-block;width:4pt;"></font><font style="display:inline-block;width:29.75pt;"></font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Name:</font><font style="display:inline-block;width:150.64pt;"></font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Title:</font><font style="display:inline-block;width:155.64pt;"></font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Date :____________ 2021</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.43;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:6.05%;margin-right:6.05%;margin-top:30pt;page-break-after:avoid;width:87.91%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.17
<SEQUENCE>3
<FILENAME>aciu-20221231xex4d17.htm
<DESCRIPTION>EX-4.17
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 3/15/2023 05:38:27 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Exhibit 4.17</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">EXCHANGE ACT OF 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><i style="font-style:italic;">The following is a summary of the material terms of our securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), as of March 16, 2023. The following description of the terms of our common shares is not meant to be complete and is qualified by reference to our articles of association (&#8220;articles of association&#8221;), which is incorporated by reference as an exhibit to our Annual Report on Form 20-F, of which this exhibit is a part. We encourage you to read our articles of association and the applicable provisions of Swiss law for additional information.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">The Company</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">We are a Swiss stock corporation (<i style="font-style:italic;">soci&#233;t&#233; anonyme</i>) organized under the laws of Switzerland. We were formed as a Swiss limited liability company (<i style="font-style:italic;">soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e</i>) on February 13, 2003 with our registered office and domicile in Basel, Switzerland. We converted to a Swiss stock corporation (<i style="font-style:italic;">soci&#233;t&#233; anonyme</i>) under the laws of Switzerland on August 4, 2003. Our domicile and registered office is in Ecublens, near Lausanne, Canton of Vaud, Switzerland. Our head office is currently located at EPFL Innovation Park, Building B, 1015 Lausanne, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Share Capital</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">As of March 16, 2023, our issued share capital is CHF 1,794,907.30, consisting of 89,745,365 common shares with a nominal value of CHF 0.02 each. We have no dividend rights certificates (<i style="font-style:italic;">bons de jouissance</i>).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Articles of Association</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">On June 24, 2022, we adopted the articles of association and when we refer to our articles of association, we refer to the articles of association as filed as Exhibit 99.3 to our report on Form 6-K filed with the SEC on June 24, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Purpose</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under our articles of association, our purpose is the research, study, development, manufacture, promotion, sale and marketing of products and substances within the pharmaceutical and nutrition industry as well as the purchase, sale and exploitation of patents and licenses in this field. We may engage in any activities which are apt to favor our purpose directly or indirectly. We may also acquire and sell real estate. We may open branch offices in Switzerland and abroad and may also acquire participations in other companies. We may provide securities to our subsidiaries and supply guarantees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Ordinary Capital Increase, Authorized and Conditional Share Capital</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under Swiss law, we may increase our share capital (<i style="font-style:italic;">capital-actions</i>) with a resolution of the general meeting of shareholders (ordinary capital increase) that must be carried out by the board of directors within three months of the general meeting of shareholders in order to become effective. Under our articles of association, in the case of an increase of capital against payment of contributions in cash, a resolution passed by a simple majority of the votes cast at the general meeting of shareholders regardless of abstentions and empty or invalid votes is required. In the case of the limitation or withdrawal of subscription rights or in the case of an increase of capital out of equity, against contribution in kind, or for the purpose of acquisition of assets and the granting of special benefits, a resolution passed by at least two-thirds of the shares represented at a general meeting of shareholders and the absolute majority of the nominal amount of the shares represented is required.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Furthermore, under the Swiss Code of Obligations, or the CO, effective at the time when our current Articles were adopted, our shareholders, by a resolution passed by at least two-thirds of the shares represented at a general meeting of shareholders and the absolute majority of the nominal amount of the shares represented, may empower our board of directors to issue shares of a specific aggregate nominal amount up to a maximum of 50% of the share capital in the form of:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">conditional capital (</font><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">capital conditionnel</i><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">) for the purpose of issuing shares in connection with, among other things, (i) the exercise of conversion and/or option or warrant rights granted in connection with bonds or similar instruments, issued or to be issued by the Company or by one of our subsidiaries or (ii) the exercise of option rights granted to employees of the Company or a subsidiary, members of our board of directors or any consultant of the Company, or other persons providing services to the Company or a subsidiary; or</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">authorized capital (</font><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">capital-actions autoris&#233;</i><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">) to be utilized by the board of directors within a period determined by the shareholders but not exceeding two years from the date of the shareholder approval.</font></td></tr></table><div style="margin-top:10pt;"></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Pre-Emptive Rights</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Pursuant to the CO, shareholders have in principle pre-emptive subscription rights (<i style="font-style:italic;">droit pr&#233;f&#233;rentiel de souscription</i>). With respect to conditional capital in connection with the issuance of conversion rights, convertible bonds or similar debt instruments, shareholders have in principle advance subscription rights (<i style="font-style:italic;">droit de souscrire pr&#233;alablement</i>).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">A resolution passed at a general meeting of shareholders by at least two-thirds of the shares represented and the absolute majority of the nominal value of the shares represented may authorize our board of directors to withdraw or limit pre-emptive subscription rights or advance subscription rights in certain circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">If pre-emptive subscription rights are granted, but not exercised, the board of directors may allocate the non-exercised pre-emptive subscription rights as it elects but has to follow the principle of equal treatment of the shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Our Authorized Share Capital</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under Article 3a of our articles of association, board of directors is authorized to increase the share capital, in one or several steps until June 24, 2024, by a maximum amount of CHF 400,000 by issuing a maximum of 20,000,000 registered shares with a par value of CHF 0.02 each, to be fully paid up. An increase of the share capital (i) by means of an offering underwritten by a financial institution, a syndicate or another third party or third parties, followed by an offer to the then-existing shareholders of the Company and (ii) in partial amounts shall also be permissible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">For the currently effective Authorized Share Capital, the board of directors will determine the time of the issuance, the issue price, the manner in which the new registered shares have to be paid up, the date from which the registered shares carry the right to dividends, the conditions for the exercise of the preemptive rights and the allotment of preemptive rights that have not been exercised. The board of directors may allow the pre-emptive rights that have not been exercised to expire, or it may place with third parties such rights or registered shares, the pre-emptive rights of which have not been exercised, at market conditions or use them otherwise in the interest of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The board of directors is authorized to withdraw or limit the pre-emptive rights of the shareholders and to allot them to third parties:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if the issue price of the new registered shares is determined by reference to the market price (with a customary discount); </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">for the acquisition of an enterprise, part of an enterprise or participations, or for the financing or refinancing of any of such acquisition, or in the event of share placement for the financing or refinancing of such placement; or</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">for raising of capital (including private placements) in a fast and flexible which probably could not be reached without the exclusion of the statutory pre-emptive right of the existing shareholders.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">As of January 1, 2023, the new Swiss corporate law introducing the capital band mechanism has come into force. It will no longer be possible to renew the Company&#39;s current Authorized Share Capital beyond June 24, 2024. Instead, the Company can only introduce the capital band pursuant to Article 653s et seq. of the revised Swiss Code of Obligations which requires an amendment of the Articles by way of a resolution of a duly convened general meeting of shareholders of the Company. Under the capital band mechanism, the general meeting of shareholders can authorize the board of directors at any time within a maximum of five years to increase or decrease the share capital by a maximum amount of 50% of the current share capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Our Conditional Share Capital</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;"><i style="font-style:italic;">Conditional Share Capital for Bonds and Similar Debt Instruments</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under Article 3b of our articles of association, our share capital may be increased by a maximum aggregate amount of CHF 100,000 through the issue of a maximum of 5,000,000 common shares, payable in full, each with a nominal value of CHF 0.02, through the exercise of conversion and/or option or warrant rights granted in connection with bonds or similar instruments, issued or to be issued by the Company or by one of our subsidiaries, including convertible debt instruments. Shareholders do not have pre-emptive subscription rights in such circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Shareholders&#8217; subscription rights are excluded. Shareholders&#8217; advance subscription rights with regards to new bonds or similar instruments may be restricted or excluded by decision of the board of directors in order to finance or re-finance the acquisition of companies or holdings, or new investments planned by the Company, or in order to issue convertible bonds and warrants on the international capital markets or through private placement. If advance subscription rights are excluded, then (i) the instruments are to be placed at market conditions&#894; (ii) the exercise period is not to exceed ten years from the date of issue for warrants and twenty years for conversion rights&#894; and (iii) the conversion or exercise price for the new shares is to be set at least in line with the market conditions prevailing at the date on which the instruments are issued. The respective holders of conversion and/or option or warrant rights are entitled to subscribe the new shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;"><i style="font-style:italic;">Conditional Share Capital for Employee Benefit Plans</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under Article 3c of our articles of association, our share capital may, to the exclusion of the pre-emptive subscription rights of shareholders, be increased by a maximum aggregate amount of CHF 96,000 through the issue of a maximum of 4,800,000 common shares, payable in full, each with a nominal value of CHF 0.02, in connection with the exercise of option rights granted to employees of the Company or one of our subsidiaries, members of the board of directors or any consultant, or other persons providing services to the Company or one of our subsidiaries. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Shareholders&#8217; subscription rights are excluded. These new registered shares may be issued at a price below the current market price. The board of directors specifies the precise conditions of issue including the issue price of the shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Uncertificated Securities</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our shares are uncertificated securities (<i style="font-style:italic;">droits-valeurs</i>, within the meaning of Article 973c of the CO) and, when administered by a financial intermediary (<i style="font-style:italic;">d&#233;positaire</i>, within the meaning of the Federal Act on Intermediated Securities, &#8220;FISA&#8221;), qualify as intermediated securities (<i style="font-style:italic;">titres interm&#233;di&#233;s</i>, within the meaning of the FISA). In accordance with Article 973c of the CO, we maintain a non-public register of uncertificated securities (<i style="font-style:italic;">registre des droits-valeurs</i>). We may at any time convert uncertificated securities into share certificates (including global certificates), one kind of certificate into another, or share certificates (including global certificates) into uncertificated securities. Following entry in our share register, a shareholder may at any time request from us a written confirmation in respect of the shares held by such shareholder, as reflected in the share register.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">General Meeting of Shareholders</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;"><i style="font-style:italic;">Ordinary/Extraordinary Meetings, Powers</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The general meeting of shareholders is our supreme corporate body. Under Swiss law, ordinary and extraordinary general meetings of shareholders may be held. Under Swiss law, an ordinary general meeting of shareholders must be held annually within six months after the end of a Company&#8217;s financial year. In our case, this generally means on or before June 30.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The following powers are vested exclusively in the general meeting of shareholders:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">adopting and amending the articles of association, including change of a company&#8217;s purpose or domicile&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">electing and removal of the members of the board of directors, the chairman of the board of directors, the members of the compensation committee, the auditors and the independent proxy&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approving the management report and the consolidated accounts&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approving the annual accounts and resolutions on the allocation of the disposable profits, and in particular setting the dividend and the shares of profit to board members;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approving the total compensation paid to members of the board of directors and executive management&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">resolving the interim dividend and approve the interim account required therefor;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">resolving on repaying the statutory capital reserve;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">discharging the members of the board of directors and executive management from liability with respect to their tenure in the previous financial year&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">dissolving a company with or without liquidation&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">resolving to delist the equity securities of the company; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">passing resolutions concerning all matters which are reserved to the authority of the general meeting of shareholders by law or by the articles of association.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">An extraordinary general meeting of shareholders may be called by a resolution of the general meeting, the board of directors or, under certain circumstances, by a company&#8217;s auditor, liquidator or the representatives of convertible bond holders, if any. In addition, according to our current Articles, the board of directors is required to convene an extraordinary general meeting of shareholders if shareholders representing at least 10% of the share capital request such general meeting of shareholders in writing. Such request must set forth the items to be discussed and the proposals to be acted upon. The board of directors must convene an extraordinary general meeting of shareholders and propose financial restructuring measures if, based on a company&#8217;s stand-alone annual statutory balance sheet, half of the share capital and reserves are not covered by its assets.</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Voting and Quorum Requirements</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Shareholder resolutions and elections (including elections of members of the board of directors) require the affirmative vote of the simple majority of the votes cast at the general meeting of shareholders regardless of abstentions or empty or invalid votes, unless statutory law or the articles of association state otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">A resolution of the general meeting of the shareholders passed by at least two-thirds of the shares represented at the meeting, and the absolute majority of the nominal value of the shares represented is required for:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">amending a company&#8217;s corporate purpose&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the consolidation of shares, unless the consent of all the shareholders concerned is required;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">creating shares with privileged voting rights&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">restricting the transferability of common shares&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">creating conditional share capital or a capital band&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">increasing the share capital out of equity, against contributions in-kind or for the purpose of acquiring assets and granting of special benefits&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">limiting or withdrawing shareholder&#8217;s pre-emptive subscription rights&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changing a company&#8217;s domicile&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changing in the currency of the share capital;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">introducing a casting vote for the person chairing the general meeting;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">introducing a provision on holding the general meeting abroad;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">resolving the delisting of the equity securities of the company;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">introducing an arbitration clause in the articles of association;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">alleviating or withdrawing of restrictions upon the transfer of common shares and the removal of the voting cap of 33 1/3% as contained in article 4 of the articles of association;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">removing the indemnification provision for the board of directors and executive management as contained in article 29 of the articles of association;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">converting participation certificates into shares&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">dissolving or liquidating a company; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">amending or eliminating article 17 (</font><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">resolutions and elections</i><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">) of the articles of association.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The same voting requirements apply, subject to mandatory law, to resolutions regarding transactions among corporations (including a merger, demerger or conversion of a corporation) based on Switzerland&#8217;s Federal Act on Mergers, Demergers, Transformations and Transfer of Assets, or the Merger Act, see &#8220;&#8212;Compulsory Acquisitions&#894; Appraisal Rights.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In accordance with Swiss law and generally accepted business practices, our articles of association do not provide quorum requirements generally applicable to general meetings of shareholders. To this extent, our practice varies from the requirement of NASDAQ Listing Rule 5620(c), which requires an issuer to provide in its bylaws for a generally applicable quorum, and that such quorum may not be less than one-third of the outstanding voting stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Notice</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">General meetings of shareholders must be convened by the board of directors or, if necessary, by the auditors at least 20 days before the date of the meeting. The general meeting of shareholders is convened by way of a notice appearing in our official publication medium, currently the Swiss Official Gazette of Commerce. Registered shareholders may also be informed by ordinary mail or e-mail. The notice of a general meeting of shareholders must state the items on the agenda, the proposals to be acted upon and, in case of elections, the names of the nominated candidates. Except in the limited circumstances listed below, a resolution may not be </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">passed at a general meeting without proper notice. This limitation does not apply to proposals to convene an extraordinary general meeting of shareholders or to initiate a special investigation. No previous notification is required for proposals concerning items included in the agenda or for debates that do not result in a vote.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">All of the owners or representatives of our shares may, if no objection is raised, hold a general meeting of shareholders without complying with the formal requirements for convening general meetings of shareholders (a universal meeting). This universal meeting of shareholders may discuss and pass binding resolutions on all matters within the purview of the ordinary general meeting of shareholders, provided that the owners or representatives of all the shares are present at the meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Agenda Requests</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Pursuant to our current Articles, one or more shareholders, whose combined shareholdings represent the lower of (i) at least one tenth of the share capital or (ii) an aggregate nominal value of at least CHF 1,000,000, may request that an item be included in the agenda for an ordinary general meeting of shareholders. A request for inclusion of an item on the agenda must in principle be requested in writing delivered to or mailed and received at the registered office of the Company at least 120 calendar days before the first anniversary of the date that the Company&#39;s proxy statement was released to shareholders in connection with the previous year&#39;s ordinary general meeting of shareholders. The request must contain, for each of the agenda items, the following information:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a brief description of the business desired to be brought before the ordinary general meeting of shareholders and the reasons for conducting such business at the ordinary general meeting of shareholders&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the name and address, as they appear in our share register, of the shareholder proposing such business&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the number of shares of the Company which are beneficially owned by such shareholder;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the dates upon which the shareholder acquired such shares;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">documentary support for any claim of beneficial ownership;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any material interest of such shareholder in such business; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a statement in support of the matter and, for proposals sought to be included in the Company&#39;s proxy statement, any other information required by Securities and Exchange Commission Rule 14a-8.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In addition, if the shareholder intends to solicit proxies from the shareholders of the Company, such shareholder shall notify the Company of this intent in accordance with Securities and Exchange Commission Rule 14a-4 and/or Rule 14a-8.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our annual business report, the compensation report and the auditor&#8217;s report must be made available for inspection by the shareholders at our registered office no later than 20 days prior to the general meeting of shareholders. Shareholders of record may be notified of this in writing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Voting Rights</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Each of our shares entitles its holder to one vote, regardless of its nominal value. The shares are not divisible. The right to vote and the other rights of share ownership may only be exercised by shareholders (including any nominees) or usufructuaries who are entered in our share register at cut-off date determined by the board of directors. Those entitled to vote in the general meeting of shareholders may be represented by the independent proxy holder (annually elected by the general meeting of shareholders), another registered shareholder or third person with written authorization to act as proxy or the shareholder&#8217;s legal representative. The chairman has the power to decide whether to recognize a power of attorney.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our articles of association state that no individual or legal entity may, directly or indirectly, formally, constructively or beneficially own or otherwise control voting rights (&#8220;Controlled Shares&#8221;) with respect to 33 1&#8725;3% or more of the registered share capital recorded in the Commercial Register except if such individual or legal entity submits prior to the acquisition of such Controlled Shares an orderly tender offer to all shareholders with a minimum price of the higher of (i) the volume weighted average price of the last 60 trading days prior to the publication of the tender offer or (ii) the highest price paid by such individual or legal entity in the 12 months preceding to the publication of the tender offer. Those associated through capital, voting power, joint management or in any other way, or joining for the acquisition of shares, will be regarded as one person. The common shares exceeding the limit of 33 1/3% and not benefitting from the exemption regarding a tender offer will be entered in our share registered as shares without voting rights. The board of directors may in special cases approve exceptions to the above regulations. Additional voting caps apply to shareholders acquiring shares for other persons (nominees).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Dividends and Other Distributions</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our board of directors may propose to shareholders that a dividend or other distribution be paid but cannot itself authorize the distribution. Dividend payments require a resolution passed by a simple majority of the votes cast at a general meeting of shareholders regardless of abstentions or empty or invalid votes. In addition, our auditors must confirm that the dividend proposal of our board of directors conforms to Swiss statutory law and our articles of association.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under Swiss law, we may pay dividends only from the disposable profit and from reserves formed for this purpose, each as evidenced by our audited stand-alone statutory balance sheet prepared pursuant to Swiss law, and after allocations to reserves required by Swiss law and the articles of association have been deducted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Distributable reserves are generally booked either as &#8220;free reserves&#8221; (<i style="font-style:italic;">r&#233;serves libres</i>) or as &#8220;reserve from capital contributions&#8221; (<i style="font-style:italic;">apports de capital</i>). Under the CO, if our general reserves (<i style="font-style:italic;">r&#233;serve g&#233;n&#233;rale</i>) amount to less than 20% of our share capital recorded in the Commercial Register (i.e., 20% of the aggregate nominal value of our issued capital), then at least 5% of our annual profit must be retained as general reserves. The CO permits us to accrue additional general reserves. Further, a purchase of our own shares (whether by us or a subsidiary) reduces the distributable reserves in an amount corresponding to the purchase price of such own shares. Finally, the CO under certain circumstances requires the creation of revaluation reserves which are not distributable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Distributions out of issued share capital (i.e. the aggregate nominal value of our issued shares) are not allowed and may be made only by way of a share capital reduction. Such a capital reduction requires a resolution passed by a simple majority of the votes cast at a general meeting of shareholders regardless of abstentions or empty or invalid votes. The resolution of the shareholders must be recorded in a public deed and a special audit report must confirm that claims of our creditors remain fully covered despite the reduction in the share capital recorded in the Commercial Register. The share capital may be reduced below CHF 100,000 only if and to the extent that at the same time the statutory minimum share capital of CHF 100,000 is reestablished by sufficient new fully paid-up capital. Upon approval by the general meeting of shareholders of the capital reduction, the board of directors must give public notice of the capital reduction resolution in the Swiss Official Gazette of Commerce three times and notify creditors that they may request, within two months of the third publication, satisfaction of or security for their claims. The reduction of the share capital may be implemented only after expiration of this time limit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our board of directors determines the date on which the dividend entitlement starts. Dividends are usually due and payable shortly after the shareholders have passed the resolution approving the payment, but shareholders may also resolve at the ordinary general meeting of shareholders to pay dividends in quarterly or other installments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Transfer of Shares</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Shares in uncertificated form (<i style="font-style:italic;">droits-valeurs</i>) may only be transferred by way of assignment. Shares that constitute intermediated securities (<i style="font-style:italic;">titres interm&#233;di&#233;s</i>) may only be transferred when a credit of the relevant intermediated securities to the acquirer&#8217;s securities account is made in accordance with the relevant provisions of the FISA. Article 5 of our articles of association provides that the transfer of intermediated securities and the pledging of these intermediated securities are based on the provisions of the FISA and that transfer of propriety as collateral by means of written assignment are not permitted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Voting rights may be exercised only after a shareholder (or usufructuaries) has been entered in our share register (<i style="font-style:italic;">registre des actions</i>) with his or her name, first name and address (in the case of legal entities, the registered office) as a shareholder with voting rights. Our articles of association state that no individual or legal entity may, directly or indirectly, formally, constructively or beneficially own or otherwise control voting rights (&quot;Controlled Shares&quot;) with respect to 33 1&#8725;3% or more of the registered share capital recorded in the Commercial Register except if such individual or legal entity submits prior to the acquisition of such Controlled Shares an orderly tender offer to all shareholders with a minimum price of the higher of (i) the volume weighted average price of the last 60 trading days prior to the publication of the tender offer or (ii) the highest price paid by such individual or legal entity in the 12 months preceding to the publication of the tender offer. Those associated through capital, voting power, joint management or in any other way, or joining for the acquisition of shares, will be regarded as one person. The common shares exceeding the limit of 33 1/3% and not benefitting from the exemption regarding a tender offer will be entered in our share registered as shares without voting rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Additional voting caps apply to shareholders acquiring shares for other persons (nominees).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Inspection of Books and Records</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under the CO, a shareholder has a right to inspect our share register with respect to his own shares and otherwise to the extent necessary to exercise his shareholder rights. No other person has a right to inspect our share register. Our books and correspondence may be inspected with the express authorization of the general meeting of shareholders or by resolution of the board of directors and subject to the safeguarding of our business secrets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;"><i style="font-style:italic;">Special Investigation</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">If the shareholders&#8217; inspection rights as outlined above prove to be insufficient in the judgment of the shareholder, any shareholder may propose to the general meeting of shareholders that specific facts be examined by a special commissioner in a special investigation. If the general meeting of shareholders approves the proposal, we or any shareholder may, within 30 calendar days after the general meeting of shareholders, request the competent court sitting in Lausanne, Switzerland, our registered office, to appoint a special commissioner. If the general meeting of shareholders rejects the request, one or more shareholders representing at least 5 percent of the share capital may request that the court appoint a special commissioner. The court will issue such an order if the petitioners can make a <i style="font-style:italic;">prima facie case</i> that the board of directors, any member of the board of directors or our executive management infringed the law or our articles of association and such infringement is likely to harm the Company or the shareholders. The costs of the investigation would generally be allocated to us and only in exceptional cases to the petitioners.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Compulsory Acquisitions&#894; Appraisal Rights</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Business combinations and other similar transactions (i.e. mergers, demergers, transformations and certain asset transfers) that are governed by the Swiss Merger Act are, if approved in accordance with the applicable provisions of the Swiss Merger Act, binding on all shareholders of the involved companies. A statutory merger or demerger requires approval by at least two-thirds of the shares represented at a general meeting of shareholders and the absolute majority of the nominal value of the shares represented. If the merger agreement provides, however, only for a compensation payment, or in the event of an asymmetrical demerger, at least 90 percent of all shareholders of the transferring company who are entitled to vote must approve the merger agreement and the asymmetrical demerger, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Swiss corporations may be acquired by an acquirer through the direct acquisition of shares of the Swiss corporation. The Swiss Merger Act provides for the possibility of a so-called &#8220;cash-out&#8221; or &#8220;squeeze-out&#8221; merger if the acquirer controls 90% of the outstanding shares. If such a squeeze-out merger under the Swiss Merger Act occurs, a minority shareholder subject to the squeeze-out merger could seek to claim, within two months of the publication of the squeeze-out merger, that the consideration offered is &#8220;inadequate&#8221; and petition a Swiss competent court to determine what &#8220;adequate&#8221; consideration is.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In addition, under Swiss law, the sale of &#8220;all or substantially all of our assets&#8221; by us may require the approval of at least two-thirds of the number of shares represented at a general meeting shareholders and the absolute majority of the nominal value of the shares represented. Whether a shareholder resolution is required depends on the particular transaction, including whether the following test is satisfied:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a core part of our business is sold without which it is economically impracticable or unreasonable to continue to operate the remaining business&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our assets, after the divestment, are not invested in accordance with our statutory business purpose&#894; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the proceeds of the divestment are not earmarked for reinvestment in accordance with our business purpose but, instead, are intended for distribution to our shareholders or for financial investments unrelated to our business.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">If in a merger, demerger or transformation, equity or shareholder rights are not adequately preserved or the compensation paid is unreasonable, within two months after the publication of the merger, demerger or transformation resolution, each shareholder may demand that the competent court determines what is a reasonable amount of compensation. The decision of the court is legally binding on all shareholders of the company involved, provided that they are in the same legal position as the plaintiff. The costs of proceedings shall be borne by the acquiring company. If the particular circumstances justify it, the court may decide that the plaintiff shall bear all or part of the cost. An action to obtain a review of the protection of equity or shareholder rights does not affect the legal validity of the merger, demerger or transformation resolution.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Board of Directors</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our articles of association provide that the board of directors shall consist of at least three and not more than nine members.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The members of the board of directors and the chairman are elected annually by the general meeting of shareholders for a period until the completion of the subsequent ordinary general meeting of shareholders and are eligible for re-election. Each member of the board of directors must be elected individually.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;"><i style="font-style:italic;">Powers</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The board of directors has the following non-delegable and inalienable powers and duties:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the overall management of the Company and the issuing of all necessary directives&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the determination of the Company&#39;s organization&#894;</font></td></tr></table></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the organization of the accounting, financial control and financial planning systems are required for management of the Company&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the appointment and dismissal of persons entrusted with managing and representing the Company&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the overall supervision of the persons entrusted with managing the Company, in particular with regard to compliance with the law, articles of association, operational regulations and directives&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the compilation of the annual report, and the preparation for the general meeting of shareholders and implementing its resolutions&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the preparation of the compensation report and to request approval by the general meeting of shareholders regarding the compensation of the board of directors and the executive committee; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the notification of the court in the event that the Company is over-indebted.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The board of directors may assign responsibility for preparing and implementing its resolutions or monitoring transactions to committees or individual members. It must ensure appropriate reporting to its members. Furthermore, the board of directors may, while retaining such non-delegable and inalienable powers and duties, delegate, in part or entirely, the management and the representation of the Company, within the limits of the law, to a one or more individual directors (Delegates) or to third parties pursuant to the organizational regulations issued by the board of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Pursuant to Swiss law and Article 25 of our articles of association, details of the delegation and other procedural rules such as quorum requirements must be set in the organizational rules issued by the board of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The board of directors assigns the persons with signatory power for the Company and the kind of signatory power.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;"><i style="font-style:italic;">Indemnification of Executive Management and Directors</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Subject to Swiss law, Article 29 of our articles of association provides for indemnification of the current and former members of the board of directors, executive management and their heirs, executors and administrators, against liabilities arising in connection with the performance of their duties in such capacity, and permits us to advance the expenses of defending any act, suit or proceeding to our directors and members of the executive management.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In addition, under general principles of Swiss employment law, an employer may be required to indemnify an employee against losses and expenses incurred by such employee in the proper execution of their duties under the employment agreement with the employer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Conflict of Interest, Management Transactions</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Swiss law does not have a general provision regarding conflicts of interest. However, the CO contains a provision that requires our directors and the members of the executive management to safeguard the Company&#8217;s interests and imposes a duty of loyalty and duty of care on our directors and the members of the executive management. This rule is generally understood to disqualify directors and members of the executive management from participating in decisions that directly affect them. Our directors and executive officers are personally liable to us for any breach of these provisions. In addition, Swiss law contains provisions under which directors and all persons engaged in the Company&#8217;s management are liable to the Company, each shareholder and the Company&#8217;s creditors for damages caused by an intentional or negligent violation of their duties. Furthermore, Swiss law contains a provision under which payments made to any of the Company&#8217;s shareholders or directors or any person associated with any such shareholder or director, other than payments made at arm&#8217;s length, must be repaid to the Company if such shareholder or director acted in bad faith.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our board of directors has adopted a Code of Business Conduct and Ethics that covers a broad range of matters, including the handling of conflicts of interest.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Principles of the Compensation of the Board of Directors and the Executive Management</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Pursuant to Swiss law, our shareholders must annually approve the compensation of the board of directors and the persons whom the board of directors has, fully or partially, entrusted with the management of the Company. The board of directors must issue, on an annual basis, a written compensation report that must be reviewed together with a report on our business by our auditor. The compensation report must disclose all compensation (as defined in section 14 of the Swiss Ordinance against Excessive Compensation in Listed Companies) granted by the Company, directly or indirectly, to current members of the board of directors and executive management as well as to former members of the board of directors and executive management but in the latter case only to the extent if such compensation is related to their former role within the Company or if such compensation is not on customary market terms.</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The disclosure concerning compensation must in particular include the aggregate amount for the board of directors and the aggregate amount for the executive management, as well as the particular amount of compensation for each member of the board of directors and the highest paid member of the executive management, specifying the name and function of each person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Certain forms of compensation are prohibited for members of our board of directors and executive management, such as:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">severance payments provided for either contractually or in the articles of association (compensation due until the termination of a contractual relationship does not qualify as severance payment)&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">advance compensation&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">incentive fees for the acquisition or transfer of corporations, or parts thereof, by the Company or by companies being, directly or indirectly, controlled by the us&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">loans, other forms of indebtedness, pension benefits not based on occupational pension schemes and performance-based compensation not provided for in the articles of association&#894; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">equity securities and conversion and option rights awards not provided for in the articles of association.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Compensation to members of the board of directors and executive management for activities in entities that are, directly or indirectly, controlled by the Company is prohibited if the compensation (i) would have been prohibited if it was paid directly by the Company, (ii) is not provided for in the articles of association or (iii) has not been approved by the general meeting of shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The general meeting of shareholders annually votes on the proposals of the board of directors with respect to:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the maximum aggregate amount of non-performance-related compensation of the board of directors for the next term of office&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the maximum aggregate amount of a possible additional compensation of the board of directors for the preceding business year&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the maximum aggregate amount of non-performance-related compensation of the executive management for the 12-month period starting on 1 July following the ordinary general meeting of shareholders;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the maximum aggregate amount of variable compensation for the executive management for the current year; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the maximum aggregate amount of options or shares in the Company granted to the board of directors and the executive management.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The respective total compensation amounts include social security and occupational pension contributions for the benefit of the members of the board of directors, the executive management and the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">If the general meeting of shareholders refuses to approve a respective motion by the board of directors, the board of directors may either submit a new motion at the same meeting or determine a maximum total remuneration or several maximum partial remunerations, subject to the relevant principles of the compensation, or submit a new motion to the next general meeting of shareholders for approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In addition to fixed compensation, members of the executive management may be paid in cash a variable compensation, depending on the achievement of certain performance criteria. The performance criteria may include individual targets, targets of the Company or parts thereof and targets in relation to the market, other companies or comparable benchmarks, taking into account the position and level of responsibility of the recipient of the variable compensation. The board of directors or, where delegated to it, the compensation committee determines the relative weight of the performance criteria and the respective target values.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Compensation may be paid in cash or granted in form of options or shares in the Company. The board of directors or, to the extent delegated to it, the compensation committee determines grant, vesting, exercise and forfeiture conditions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Borrowing Powers</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Neither Swiss law nor our articles of association restrict in any way our power to borrow and raise funds. The decision to borrow funds is made by or under the direction of our board of directors, and no approval by the shareholders is required in relation to any such borrowing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Repurchases of Shares and Purchases of Own Shares</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The CO limits our right to purchase and hold our own shares. We and our subsidiaries may purchase shares only if and to the extent that (i) we have freely distributable reserves in the amount of the purchase price&#894; and (ii) the aggregate nominal value of all shares held by us does not exceed 10 percent of our share capital. Pursuant to Swiss law, where shares are acquired in connection with a transfer restriction set out in the articles of association, the foregoing upper limit is 20 percent. If we own shares that exceed the threshold of 10 percent of our share capital, the excess must be sold or cancelled by means of a capital reduction within two years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">We currently hold 6,214,021 fully paid up common shares of par value CHF 0.02 each, as treasury shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Shares of the Company held by us or our subsidiaries are not entitled to vote at the general meeting of shareholders but are entitled to the economic benefits applicable to the shares generally, including dividends and pre-emptive subscription rights in the case of share capital increases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In addition, selective share repurchases are only permitted under certain circumstances. Within these limitations, as is customary for Swiss corporations, we may purchase and sell our own shares from time to time in order to meet imbalances of supply and demand, to provide liquidity and to even out variances in the market price of shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Notification and Disclosure of Substantial Share Interests</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The disclosure obligations generally applicable to shareholders of Swiss corporations under the Swiss Financial Market Infrastructure Act, FinMIA, do not apply to us since our shares are not listed on a Swiss stock exchange.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Stock Exchange Listing</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our common shares are listed on the NASDAQ Global Market under the symbol &#8220;ACIU.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Transfer Agent and Registrar of Shares</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Computershare Trust Company, N.A. acts as transfer agent and registrar for our common shares. The share register reflects only record owners of our shares. Swiss law does not recognize fractional share interests.</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>4
<FILENAME>aciu-20221231xex8d1.htm
<DESCRIPTION>EX-8.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 3/15/2023 05:38:27 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Exhibit 8.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Subsidiaries of AC Immune SA</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Name of Subsidiary</b></p></td><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Jurisdiction of Organization</b></p></td></tr><tr><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">AC Immune USA, Inc.</p></td><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;United States</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>5
<FILENAME>aciu-20221231xex12d1.htm
<DESCRIPTION>EX-12.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 3/15/2023 05:38:27 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 12.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">I, Andrea Pfeifer, certify that:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1. I have reviewed this annual report on Form 20-F of AC Immune SA;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4. The company&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(c) Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(d) Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5. The company&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: March 16, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Andrea Pfeifer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Andrea Pfeifer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>6
<FILENAME>aciu-20221231xex12d2.htm
<DESCRIPTION>EX-12.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 3/15/2023 05:39:00 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 12.2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">I, Christopher Roberts, certify that:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1. I have reviewed this annual report on Form 20-F of AC Immune SA;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4. The company&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(c) Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(d) Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5. The company&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: March 16, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Christopher Roberts</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Christopher Roberts</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Vice President, Finance and Interim Chief Financial Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>7
<FILENAME>aciu-20221231xex13d1.htm
<DESCRIPTION>EX-13.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 3/15/2023 05:39:01 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 13.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The certification set forth below is being submitted in connection with AC Immune SA&#8217;s annual report on Form 20-F for the year ended December 31, 2022 (the &#8220;Report&#8221;) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Andrea Pfeifer, the Chief Executive Officer of AC Immune SA, certifies that, to the best of her knowledge:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of AC Immune SA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: March 16, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Andrea Pfeifer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: Andrea Pfeifer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>8
<FILENAME>aciu-20221231xex13d2.htm
<DESCRIPTION>EX-13.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 3/15/2023 05:39:04 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 13.2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The certification set forth below is being submitted in connection with AC Immune SA&#8217;s annual report on Form 20-F for the year ended December 31, 2022 (the &#8220;Report&#8221;) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Christopher Roberts, the Vice President, Finance and Interim Chief Financial Officer of AC Immune SA, certifies that, to the best of his knowledge:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of AC Immune SA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: March 16, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Christopher Roberts</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: Christopher Roberts</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Vice President, Finance and Interim Chief Financial Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>9
<FILENAME>aciu-20221231xex15d1.htm
<DESCRIPTION>EX-15.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 3/15/2023 05:39:04 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">EXHIBIT 15.1</b></p><p style="border-top-style:none;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="border-top-style:none;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:center;margin:0pt;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</p><p style="border-top-style:none;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;">We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-249655 and No. 333-255576) and on Form S-8 (No. 333-233019) of AC Immune SA of our report dated March 16, 2023 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.</p><p style="border-top-style:none;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;">/s/ PricewaterhouseCoopers SA </p><p style="border-top-style:none;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;">Lausanne, Switzerland<br>March 16, 2023</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>aciu-20221231x20f001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'W [8# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUVG@:..'X*:+'&H5%T2, #M^Y%?#MWI=S=_LE:'>K+-#86/B^:6[F@7+1(6
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4 <CX-^'EMX3O+W49;Z[UG6KT*MSJ5^RF1U7[J * JJ/0 5:\>^";?QYH?\
M9\]S<63I*EQ#=6NWS(I$.58;@0>1T(KI** .1TGP +'Q/;Z_<ZI=:AJ$=A]@
M9IEC7S1NW;R% PWTP/:J?B#X7)J.ORZ[I&M:CX9U:=!%<3Z?Y;+<*.F^.164
MD=FQFNZHH \[;X)Z))X9N])DGOI+FZN5O9M5:4&[>X7&V3=C&1@8&, <55N?
M@H=4O])U'5O%.LZMJ>F7*7%M/<&)53:?N^6B!>>A;&?>O3J* .0LOA^-,\=7
MOB.SU:]MUOPOVO3@(V@F95(5B2NX$ ]C5_QSX0@\=>')]'N9Y;:&9D8R0@%A
MM8-WX[5T%% '->)_!-OXH&BB:XFA_LN\BO8_+"_.R=%;(Z'VK&UCX5";7;S5
M]#U_4_#%Y? ?;!I_E-'<$# 8I(K -CC<,&N^HH X%_@UH+^"Y_#O^E>7/-]J
MEOO-S=/<9W><7Q][(';'%5K3X.#_ (2'0]<U/Q+J^M:EI,C-#)=F(*5*D;=J
M* /4MU..37H]% '->%O!-OX5GUJ2&>6X_M2\:\D64#",0!M&!TX[UR]Q\$H0
MU[:Z=XCUG2-"OI&EN=(M)(_*8L?GVLREXPW<*17IM% '$Z[\*=+U+3-'MM/F
MN-"N-'&W3[W3V EMQC!'S A@1U# @U4\-_"&UT+Q/<Z_=ZOJ&N:C=V9L[E]0
M*$2J6!SM50%Z8VJ .3WKT&B@#R__ (4;#%9RZ3:^)M<M/#,K$OHD<L9B"DY*
M+(4,BH?[H:L+XF0Z5X7\0Z$#'J?A.SM+-H;7Q)I">8D(&!]GDB\M@5(&06!Y
M%>VTW;0!X?\ "+PA#JWB'QAJDB:AJ6B:K!%:B\U="LFH$ [Y-I PO( P /2N
MB3X&0-91Z1<>)=<NO#"$;=$EEC\K:#D1F0)YA0?W2W3BO3P,4M ',V?@>TLO
M&<GB&*21)6L$T\6H"B)$5MP(XSGMZ53'PPTJ6X\4M>>9?V_B$H;FWEP%3:NT
M;2.>^<]<UV5% 'F<7P4CG6TM-5\3:UK>AV;I)!I-Z\7E94Y0.RH'D P.&)Z5
MU&F>"K?2_%^K>((YY6GU"&*%X&"[$"9P1@9[UTE% 'G4GP?$6IZC+IOB76=(
MTW4IC<7>FVCQB.1V&&*NR%TSWVD5#!\#M,M? <WA:'4+Z*T^V&]MKA2AEMGW
M!EVD@A@"/XLY[UZ710!R&G_#X6WB73M=NM5N]0U"TLGLFDG6-?.#,"78*H /
M'; IFD_##3-'\?:IXLBDF:^OXA&T+X\N(\;F48SE@ #]*[*B@#@=6^%(EUR]
MU;0]?U/PQ=WV/M@T_P IH[@@8#%)$8!L<;A@UT'@SP;I_@?2#86"R-OD:>>X
MG??+/*QRSNW<FMZB@"EK&D6NNZ7=:?>PK<6ES&8I8VZ,I&"*\SO_ ( Q:MI\
M.G7WBO7KS3;1T>RM9I(RMOM((&0H,F ,#>3BO6:* .6G\ V-SXJO];G>2<WN
MGC3I;5POE&/=G/KD]*Y=?@;'_9ZZ,_BC7)?#"\+HKR1>7LSD1F39YA3MC=TX
MKU&B@#AM?^%EOJ&KQ:OH^J7WAC5D@%LUSINPB6(?=5XY%96QV.,BJJ_!;1I?
M#NJZ;>3WU]=:I(L]WJLTH^U22KC8P(&%VXX &!Z5Z'10!Y=J'P1.NBPDUGQ7
MK>K7=A<1W%K-<&)5B*G/^K1 K$]"S9//6M+5?A29-=OM6T/Q#J?AFXU J;V.
MP$3QSL!@.5D1@K8XRN*[^B@#@)/@QH3^%H=%#7D;0W)O4U)9\7:W).3-OQ]X
M_3&.,4_1?A6EKKMMK&MZWJ/BB_M%9+1M1$2I;AA@E4C106(XW')KO** /,V^
M"JVZW=GIGB?6M'T*[=Y)M)M6A,>7.7".R%T!R>%/>N\T/1;3P[I-IIEA (+*
MUC$42#G"BM"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^#_T,5]7_P#!13_6^"?K<_R6OE#X?<>.?#__ %_P?^ABOE<9_O7W']'<*_\
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M'KWKI<UT,53EN<[=01!A/9,;6XP/+CW;E!&,Y5E[^_ZUD:Q#<1:BDZS;(Y@
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M8QVMTK2M#L;(1,9.T Y&<54*LF]R9PTV*'A7PE!XEU"SMY-2N+>RG1F-P0%
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M?HMQ-IC&8@R*@;9F4'GI]:Y/P??Z19Z3J3:I?ZU'K.J;@]HFGY:#!.!&%&"
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M !-'_#1WQ2_Z&W4_^^$_^)IW_#3/Q&_Z#L7_ ( 6_P#\11_PTS\1O^@[%_X
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M/449H \HTG]FOPQHVNZ1J4.I:_+'H]Y]LTS3KC43):63<Y2*,KPAR>"21T!
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M?#*Z\>:]>"]O;""QL!Y7]HM\R2D'A(Y-N"?KVQ7I=W\"=#\9:M]LU'6C>F&
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M+D% -QZ8SVXK.2;6Y=DGH<O=_"^X\5:G/IO@N*?4YE/[R6;8D04?Q;@.<XP
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MRJCDT9- %[[5;^C?E1]JM_1ORJCDTF<T 7OM=OG[K?E2_:K;^ZW_ 'S5"C-
M%_[5;^C?E1]JM_1ORJCDT9- %[[5;^C?E1]K@]&_*J.31DT 7Q=P#LWY4?;;
M<?PO^59Y/K1B@#0%] /X7_*G?;[?^Z_Y5FXHH T1J$ _A?\ *E_M&#^X_P"5
M9M% &F-1@'\+?E2_VG!_=?\ *LO%&* -3^TX?[K_ )4?VI#_ '7_ "K+Q10!
MJ_VI#Z/^5']J0^C?E651F@#6_M6'T>C^U8O1ORK)S1F@#6_M6+T;\J/[5B]&
M_*LG-&: -;^U8O1ORH_M6+T;\JR<T9H UO[5B]&_*C^U8O1ORK)S1F@#6_M6
M+T;\J/[5B]&_*LG-&: -;^U8O1ORJU%()4##H1D5S];MI_Q[1_[M $U%%% !
M1110 5\>_P#!0W4(K+1/!RN;D22WLJH]OMPO[H\G-?8)KYB_;=\!MXZT3PS"
MMZMF(;N1\M&6W9C(QP:Y<2[49#47-\L=SY*\)W(G\-SVEF\T%W8)Y@>9U+MG
MJ>. "<_G7G]AX?#ZMKEQI.IZAI5K?A?/MO.0QMDC  ^\3NZ <UZAH/POF\!7
MC7QU)+NV9?*EB6 J-I[YSV/-<CXZTN?3M9E=-,FDA*E_.M4^X<CJ/US7!2J.
M5)=+%SA*G;G1J>$;SPEI7ALV/BJVM_$LT4[9FOAPH!^53&['E<GG%:.I?&OX
M<:; ?L<CVK1+@):6(F"JO8$#@"L2R\:0^(;&"SU&SCU.UA4B*>XTL74@;N-V
M V.N<,,&N1\5ZG\-8(YH+_0[BVO0<2-H]VT:\CO'.#L_,U[5'%TU!(XY4N9N
M5S1U7]KGP/;QEK>RU35"O0?)$!_P$XK,_P"%FZ?\8=)CMM"M'35;AGB%C+=0
MAUXP#EF7.?137/:1X&\#>*;MFTCPG#J$\0VN-8\1NC,,9SY<48W=>H-=9;>!
M-/\ #85K?PSX)T<[>)!8/=R1YZ$F>0Y/_ :Z7BX-:$*B^YO^&?"^LZ*S?\)!
MI\EO86L&QC;2BXE5P.,1J<X]<$X]Z]%\%>$=3\;1O_PB5[9ZJY1AY4V()QM'
M*X<*P//&:J? >]NO$7B_36;Q#)J^FV;8N(+>UMK2TV\CYD"9(!]&&*]WE\#Z
M-=W<.I:)>2Z/J,3,JWE@ZO@GJ&#AA^'O7.JBGK<Z5&R/"]?\$>+]&CE75M!O
M8)6PA@OFQ$0.X)^0_7->4^-_#,L=[;75WX9B%B()!,I0.'Q@@!QDKGU!K[AT
MO5_&^GPO;66NZ=K\:MMCB:/R&;GY@Q!>,G_@(JP][H.M0NVO>&+*PO"[1E$E
M6VG<@<[70A7/X52E;=7)<>;8^,;CX-^'8O#UHT&LRV]CJ%NMTUD"PAB)Y 60
M@Y(X'/)K.@^%GP^T[3R\FL,B,ZLP6X(DW \?*3G&?:OKW7_@KX1UJ;S4U:^T
MF<H&QJ$(E1?3;(FUL\^]>&_$;]CS6=0UH76G:\NI3R@2),LZ.7'8?-L(/?&:
MYY16_+<O5*R/)W^&G@B&]EEO/$6HSHS$YMK?&T>@^4CI[50O_@[:SZ3J%^WB
M>UM;")?,BBGR9 K-\@VKU8XQ@ \^E==XC^'GC+X<V,VCZSIB:@_VA?EENO*?
M,BDJ6).P\(>%;COBLCP]X\U)M&:SO?#_ (<-O9!VA.HRS2'/.%&,\D],G%7[
M&G-)M:D['DNNZ9IWAZYECN&E@F" QAU"!@W3&#GCT-;-[\%[W1;DRQS6<FH7
M%LL@C68JA#*'!PP X!KKM0^(/BB>P2VN[OPY;#*@6MY91(VT]-CXWX'T)]*6
MR\>:5+87UAKU]INM>81MMX;PS_O/X=H?!_!3FN=X91>NQJE=7N<AH_PRN?%<
M&W4=3LK*>$?,;R<") !P2^0"./>KNE^"/#L=@HU37Y]/O1(8D"61G@8=F#JQ
M 'U]JW=*M?",6IP2ZAH-DLD1,)LKNZ,)+Y_VRQSSBNAC\(6IEEO$\-VM@93M
MB59)G\D#H,H5'TYK54HP]"G",HMI[')6_P -=(O78Z=X@LM;$(\PQ12B%V ^
M^><XV^A'.>*Z#X3ZY<:<EU%I/@.ZU5=[2"YDV%U7[I[<KQD#K5;5_#UUH%F^
MJ7>IA;15+--<PY4,3@$\EL=NM3/HEWXHCAOK6TT>X&W8$TO494PH'^MV&3DG
MWZ414$[L3J)0Y'8Z75?BK>P(C7$8T)C+M6Z:TD0!1][ 90&/;EJX#7YK'6;J
M:X_M277)+@G88M/$AP>Q*%0 /7<:=>Z9H\,\<&KI- P&\.\KWXC4#&" [;03
M[+UJ"WO!HFHV]M;PP6FC)%EDM8T4A^N[8=I /T-.;Y=%&Y5.TKW=O4N^#? 5
M]/K4:G3(+=C&=DES([Q$$=-FT@GV)S74Z=X"MW:X2*=M-N8N<06#[6!&21R%
M_,5YO'\=[FTTO4F;46M]52X(MT$;C='G ;))'Y5KZ#\</%=A9P&QO?[9B>22
M*Y,39NFC*\[@00,9PK#M6,:[@GI;Y&4XQ35G<]//POU6[O+7.IZI%:.Z1G^T
M?* (X#*HP.Q[&L_X@?!#P;_I^H3VM]&-/G\O[,EZ 9D5L9.Y01G_ &<FN)L_
M&=KXCT]OM%UKMM<0NVRUO(?M,:G/7(Y!/7I5V]UAGAL=2U*RU232)2T)CM8_
M(#X^^0K=><$G%7[53U8E;H>O_$"Z3PW\#3I=DO\ H<&LQLLP829#CF/L3M'?
MGWKG?"7Q7\)V_P (O$7ARZU:&WU2_O8Y(3]FD*E!CC@$YZUYCK/Q!U3Q-X+/
MAZ#3+R_M4NVNA=21,3)QM"L<#./6L5;!_#6FRP2QBP2Y!(@O-/\ .9B.3M8X
M*K[UR3JSYO=6A=F>GV?BC4/#]E&Z3ZC:6MPV(Y()/,BF).!@!CWXYZ5Z5:>,
MK?P[\,]*U;2=2L)_$\U\Z7,#(DC% 3C?%P#]<9KYST?1_$VLZ#I\5F]S#83*
MTCI91_/",_W"O Z'DFL#3(BOB#4;%"\TEC*HCEE_<RS. #C&1R/UIRKR232&
MHWT/J_\ X6_;Z?81W_B?1[W59+^W:80Z/.L*1/O(!V.V-N!T'>N3\3^-]2\3
M-H=Q!\/)[?2+J)X[C4M0MQ*_DL=H"2I]Q0<G.1DCM7%>'?"=WK6C)=>(+QKX
M--Y%I#/*(=X/+(3Q@ X[]3Q7O?A#7-+/A_2="O-(O?#D-L!:132;5M]SDD8#
M$G!Z5<).NWS.T61RR5V>*3:"\_B2WO-,U"_L;&VND2XLE<S1W0C4A7.6R/4D
MDCGO7H/@F"+1O#&J>*Y+?[,;976UC973<&;&\AL#<Q)Z#BN+\4V=MI_BI]/N
M;2\O+;1KDW5W#9HB2D]000<*,E1T-9OBCQW>_P!GD:DJ-"V95A>=,,V,!G7H
M2!CMP:B5.G&4G&R1K2E9>]N(?"NA>*$O-0\966H2-J$;W&FWL,OEJN/E))<A
M2JGG(Y[5S/@S2+4VE[9WZQZI,,BQAM[QE@<[L^;*VTJ #@8X/O6_X;\5?#N^
M\%ZY!#'X@LM133T;;]M\^"20."Q$: !$(Y.[OC'-8'B+Q?>:;I5GMU47_P!J
MM\MJL<S"Y6, ;8954X55'08.><\UKL@=FR.S\(S:@TO]J:MIDBVMPXU"%XA*
M+(8&V96S\ZGIA>F*PVT&/2M=U66VU:'Q'ID!5[>\M8BD<C8R0%*\ =.0,]JB
ML+/PWJ^D_P!KKJ$MAK3SM)>-<0L;:>$?=\H#)W==P)'7CUJ]XPTR:Q\)'QCH
M$\6GP@A+B!"#O&<!DCRQ4C\*.72Q"C=-F4-*EUGSKS5$-A;R@@" K&P/^Z1Q
MUJIKT%K9:9;26-W+I%L) KFX1E%P_9B1[?A67JWBV^UJSTNS@GMI;9)%GWM:
MB&21L9PS_P 6,GJ:[N/Q(NHZ?;6(T[2XM6>7[0(9MZK'C[J;G;80>HQSVJ+6
MV9ERW>Y#I]_$+ SR:G(K+^Y"$%EQC((;.<5]@_\ !/2RU&W\;>*Y;V>">&73
MH6A,!SQY@)SQ[U\1ZGXR6_\ $\,%_I2V-E&%C,%LQ*EAC?ACGKU_E7W7^P1\
M1K?Q;XW\5:3I<;+HFE6,:6[S8,C$R#)^Z"!U^4]Z*5)QES,M6V/MRBBBNX H
MHHH **** /GG]JW[_A[_ +:_R%?/]?0'[5OW_#W_ &V_D*^?Z_/LV_WN7R_(
M_;^&?^193]7^;'Q1//*D<:EW<A551DD]A7I*>']!^&MG!<^(X?[7U^4"2+2%
M?$<([&4_TJM\+;6WT>UU?Q9>1"5-*BQ;(W1IVX7\JX;4M2N=8OY[V[E:>YG<
MN[L>237/!+#TU-J\GM?HNYW5.?'5I4(R:A#XK;MOI?HDMSOK7XX:^NIVGER6
M^DZ8DJE[73[9479GD>IXJ_XM^.FKR>*KV71[U;G178>7;7ENK(1CG@C/)KS;
M2-#U'7[G[-IME/?3]=D"%CCU]JGUSPKJ_AIU75--N;$O]TS1E0WT/2K6)Q7L
MV[NU]]3)Y;EBKJ+C'FM:VFOG;>_F=S GAKXI[H([:'PSXF<?NQ$?]$N6],?P
MDUYYJFEW6BZA/97D+07,#%'C8<@BJR2-&ZNA*LIR"#R#7H_BQQXX^'UEXF;G
M5=/D%E?./^6B_P #GW[5+:Q,&WI-:^J_S+2EEU6$4[TI.VNO*WM9[V?X,\VK
MK/A1_P E'\._]?B?SKDZZSX4?\E'\._]?B?SK##?QX>J.W,?]SJ_X7^1]=3?
MZU_]XUP'QW\6:GX%^#_BO7]'F2WU/3[%Y[>22,2*KCH2IX/XUW\W^M?_ 'C7
MFW[1>AZCXE^"'C+2]*LYM1U&ZT^2."UMTW22N1P%'<U^GG\[GC\'[1/BGXHW
M7A+P1\.KVQ?Q7-I]O?\ B'7YX$DMM/0HI<+'T9R3]T<#I]/9O&/QG\(_"AM/
MTSQ3XA9M5D@W[8K.2::15&&F:.%&V+GJ2 HKYZU+]G74_A9\/?AWXV^''AZY
MA\<:#'%+JFEQJ3<:BD@'GQN.I8$\#L,BI?B-X,\9M\6[OQY9Z9XYM],\0:%#
M;BW\+PP&]M9EY-O<I,C[4/\ > % 'T=IWQA\(:OKNCZ19:S'=7FL63:A8&*-
MS%<P+]YEDQM)'=<Y]JT?!'C_ $+XBZ;<ZAX?O&O[*WNI+-YO)>-?-0X<+N W
M 'N.*^3OB#\,M8^#G[.7A#Q596\NG^)O"=X]Z;6[NUN'CBN6VR0F140'[P.
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M1Z@Q'"\>^.W7TK%8F4-E^!F[]#D_#\&L7NOQ74WAV6]M6N//@6X >)UR3@R
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M"GC&^CTRXU*S;P5=R2AC$,M!(CDD,1R&'!P>!0!]&=L=J,9'M7B7P-^,>O\
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MIO\ 6O\ [QKC_BQX,N/B'\.=>\.6MQ%:7&HVS0)/.&*(3W('./I782_ZU_\
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M/#%YOA6ST=[0JWFQ2H-S%CTQSC'7(KU:2UAEE25X8GE3[LCQJ67Z$C(_"I:
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M)_$5MD>HINW\: ,,PSC_ )8M^8_QII28?\L&_,5N-&#3# #VH PR91_R[O\
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M\F_,4HLK@_\ +(_F*V@M+MH Q?L-Q_SR/YBE^P3_ //,_F*V@*6@#$^P3_\
M/,_F*/L$_P#SS/YBMNB@#$^P7'_/,_F*UK=2D"*PP0.14M% !1110 4444 %
M?(O_  40%Q=>"?#MA:H/.NKN1%D)P ?+. ?K7UU7R3_P4/TM[[X=Z3+%*T,L
M%P\@=2>FPYSCMBL:SM!L:5W8_/B#P/K=NJ6PTF6+MD *"?Q/6K-W\/-4@MGD
M^TZ?"W58Y+U2?Q"Y/X5T?PWTPQV0UN2,2303[HXH-\:[0>6P3E@>>O6MCQ7:
M-\.?&HUFPMK>_P!,U)#+ MRI\MMW) P<C'4?B*\:&$C*5I?F/V4;79Q'_"#9
MLYO(UJTN;J*+S7MX(I#(5'7:"!NKJ_ 2:1H%W!>27&IVGF0>3,)K4K%)D\EB
M23@<'@<8S4?B*^U6\UA/$$.FI:1^0C$01A0$'!#<YYR?J*BTUK>_W>'[@-]C
MO87N-*>1VWQK_'#N/(9#R/\ 9/M79]4A%IPL'(EL>MVB67B!'DO$L-;L#&'/
MG1;E=>@E7'*L.C5P?BK0=%T*]E>/PA837K12W"I! -L<4:[FD,C-@*%YSW]*
MH_#KQ0O@F^@\/:QJ%J9P/,#12M*(G/ W;@.''#?G7IE[=V\4MO/:EB\+%EM;
MA]IMY?\ GFQQS&P)&<X(.#52U35M3113/F6?XY7]KJL<EA9PVM@$,444 #;L
MGDE..?>O9OA9 OQ!O-0TW4YFL]1N;$RP,S%)$96 !!5N>#T&>O0UY-\3/#__
M  B[OKVDV,,.C7%P\-]I%Q'YHTVY()V+T)1NL;@].,Y%0>&_B%%<0VLVH7-V
M]W#'LC7[,X,!& H20'=SGOQFHH5.[^1EJF>_ZGX"\<>'(G!B@\3Z?%PT<LHA
MN@!W$@ 5C[.JFH+#QS;PWAM+::YT36PH_P!#OI)+:4D=-FX["/=.M:6A?'RQ
MM=(TV34- U?^T85:WE6]NMI9_P"%DW $-U& P!]ZZ]M6\&?%2!+6\6QN6*'=
M8WJJ'BX], $@X_N'_:-=T9*_NLJ]_B1H>%?BUXD0!=92[O+;(CE:?!<>^5Z@
M#N:WX-2G\66-\ITV34]*D@D;,<IM?*QP620,&8@9Z8!YYKB8?A#HW@[PKK3V
MNI:LUFT#G[!>S%[2$@?>7>0=O_ \>]4_&/Q5U3X3? &R\0>'8[/5+I)([>*V
MF4,LL;R;6"A",<$X(Z>IK1R2,W<X;3/@S!)XBCU3PY>7L.M*K,BS2R3PQ#IO
MR#O'7DD,/>K'Q&T.^U1M/M/%FN1^(;VSC"Q?V7#&%C'H9 I;CN=H^M5?AI\<
M2^L:5'=:A::/=7\A6YNK=WD@0DX\F7 R/3+ CGWJQ\5]9OK;5)3IFCBRT9"(
MEN+;:\*LI())7.T_50?<UC"-&HF]S2-:K=11<\*> H?$'B#0=+\.^)8-%\07
M'FS1&&T>0$1QLQCGD9CO.!Z<>E7=1UCQ\[7%C?ZVMIIT+'?<Z1$9""."S *9
M$Z?W1]:Y/0=6MM">'61XHN;7503MEM1'MC##;D,22?0CY>.U=-X+\0ZQJFO)
M:Q:3)J<)DXU2Q3RU#?WEWLN#SSL<=ZTCRMV@#4X7E,P?#7B3Q3;I=#0M4U74
MI#(?-5V,UG*#UW.^T+]<YJA\6M2O]9\*Z=<ZG=1:?-:ZC!+<?8\S(Z D$!B
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M$C!^7R\\A1Z]SDUZ>NCGPOJ#VUOIPTN['WAY?[[!Z;G))Y'.-Z_2D^)GA_\
MX3+XD7=OXAEBTFZT_P /13VL<<^X3R%CM4[ADX +,<>V>]<>*P$>1..Y,JCD
M[1."LO'$6L>%+FR\1::^L6%DI-OJT*E;FS9ONH9,'>K-_"WKP:L:#HKWLPT^
M0"!#$)]3E0_ZF$<K;J?4\%O4D#M5#3M$N;W2M0GL)GC\/Z(\<\T+SE4N+D_+
M&X3N_H.P-7=;FU3PSX-N ^$6]8;I"H#R,PR26ZX]/<U="$<+3<I:LNS6XZ31
MO[?\467VVTN[/PK!NNI8C"Z;HHU+9R0,Y"X!KZ4TNY\+>++&VN[>6"XAF 59
M;:8+AL?+& .<X]1VK@_@.FK>)_AS<RWVMZF(?-:",27A>'RU4?)L.?? '7%>
ME^'[75=#O+*WMM0LIE' BN+.-R@( X8#(R/<YKFIOG]^^YWT8M+F2W+&E:9I
M!\,)-=AHG9R_GAR6C4+G&,$X-1ZEIKZ.D[BZ,L "22). 2.05&2<'@ ^GKVK
MB]3^&L/B75)-3T75-7TW5O->+[19W+?*RN>5C)(V@] .U0VFE^(M)^TZ;XG\
M6PR:%L813"T NI7 )*EB!M#>A!-5[YJZBOJCG[U]2\137.J:GIE[IFAZ<\ER
M]PMVO[UL;0I,;$,N.>O/2O&O''BW5O&8$US<.(83MM;+I%"G^.*U-;^(B:GH
M":)'8?V1%;2K&J*<"7YL[0@'R #DY.3U-<CJ'B&SLI6M)!&TF[:RMP5/7'MF
MN"K*4WRT_F<$G[1N[,--,GD##=N!Y(ZG\*S+J,V\C(,@CUKJ7FMFB66)00>,
MYY!]#4UY':FQ07)^Z<GCD>U80K2C*TD<%2DEU.-2>1%SYC*#P,-UJ1+A]X,B
MI,",8=0:GNA#*Q9!E%.!C^52V%HI5IG*F3^%3]W/^ KN]II<Y5%O0GM6M+<(
MT\#9_B\M\$#VSD5[)\'O@U'XMU*&[U&YA:U$;7,%DS#=+M&X!E!SCC\:X/X>
MZ#:ZA=W&LZRA?1=.^=U'_+>3L@_+\J]BTGQK9>(_#LNJVSZ=I:)-Y887@@U*
M$[<!U4=8^G Y&.M%&,:DKS^1WT:2W9SOCNX34M(U*VU_3KN'4M/G:6VE@*-$
MBJO0J&SZ#&"*S/BAXZL_'_PP\(176BPVNO?9GFL9S&(5B@7&Y< X.2>XSWJE
MI'QPT:PMM?M_%]C<:O%<31;/,D$330IR1\P(968]CEJYW7_%N@:KX@M+?28K
MA_#-O"L4%I.,QX+$E ,_*H) '3I6TYQI>\^YVN4;'*"^D:+^U-.6]M8XX0K.
MTH!A<#!=67!P3R,]/>K^GZ+K5UX>2'2KAEGFF9T.%&7(Y<ECDD^N:Z/0/ .F
MWEO?7,-Q=:<S2,5E#C 0G[K*1C'U[5SK:@F@:K_9VGZQY\$+'$B0"/8W1L,"
M<_@*Y*=2G4G*FNAV3P56A1C7J?#+;4L>%/!-]XNL[I=21=5CT>;YY[K"R1D]
M0#GUXXK[ _X)P:;I.D?%/QQ;:4TB*NF0^;!)D[&\T=">OO7P_9/KC7]\MF+F
MYCG?>[#&UU'3+=Z^X/\ @FC8Q/XW\9W[3A[E]/AB:)6R$Q)DYSSG('->I3J7
MJJ&EC@:2B?H/124M>H8A1110 4444 -9PAYI/-7UKQ;]HNYE@DT7RYI(@?,S
ML<KG@>E>+C4;OJ;NY_[_ #?XU^29[X@4\DQ\\#+#N;C;7FMNK[69]MEO#,LQ
MPT<2JMKWTM_P3[2\Q?6D\Q?6OB[^TKO_ )_;G_O\W^-']I7?_/[<_P#?YO\
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MKGM[?WF_.C>W]YOSH Z'-&:Y[>W]YOSHWM_>;\Z .AS2USZNVX?,>OK6^.E
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M#878?H65(L8C/. XW>M 'T?X-\;:)\0=!BUKP]J$>J:7*[QI<Q*P5F4X8?,
M>#[5N5\X_LD7DUA^RLMU;OY<\+ZC)&^ =K!V(//O7G.C_%SXHZ1\"O#7Q6OO
M&J:N)-02UN-!?3X%AGA:;RR3(H#^;SGC XZ4 ?:E%?'OQO\ CGXSLM:\:W/A
M7Q+?>1X;@BD%AHNC)/;0,5#/]ON9E !Y^Y$<X]:Z#5_B+X\\;?%#X8:!I'BB
M3PQ9>(?#AU+4'L[*&8B0*&)C\Q3@]0,Y ST- 'TY]L@^U?9O.C^T[-_D[QOV
MYQG'7'O4U?)?@+P[K>G_ +77Q!,GC+4[Q]/T6WFD::WM\W:$<1/A %53SE #
MZUS-G\5_BJ/V=&^*,OCLO<6&J/;C2CIEOY-S$)Q&1*X7=G!XV[>!WH ^VJ*^
M3/B7\=_%FI_%*Z\,Z/J&MZ!9:;HT%^S^'?#YU::XN)5# 2 JWEQ#.,X!/K5?
M5/C+\3/$^D_!NUAOIO!FM^(]1GT_5"VGH2P3@2K'*#MR/F SU]10!]=U@ZKX
MZT'1/$^C^';[48[?6M7#FQLV5MT^P9;! P,#U(KYI^-GC[XE?#GQ3%IO]N>)
M3X8M=-5E\0Z+H]I?32W.3N:\3;^[3&.$4'TS7/:KXKU?XK?$?]G_ %/3O$=@
MNL7D%]'+K%A:LT2NJ@.RPRA</C^%A@$]Q0!]>>+_ !EHW@+P[=Z[X@U"/3-)
MM0#-=2@E4!( SM!/4CM6G9W<.H6<%U;N);>>-98Y!T96&0?Q!KXZ\6_%[QSX
M<\&?&S0KSQ NMWGA.6S^P:O=Z?;^:RRE21)'L,38SQ\M=;?^,/'GBGXY>'_!
M>D>,6\-Z7=^%(M2GDAL8)9!+M!+1AUP"?Q ':@#Z>HKXKF^/'Q7O?"SV5N;[
M4&T/Q!<Z3K&M>'-/@FU":%!E)(K>3*9[,0"![5[/^RU\5;SXE>'-9BU+7TUZ
M]TV\\H23V+65['&PRHN82H4/P>4RIH ]MHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@!4^\*Z$5SR?>%="* %HHHH *
M*** "O@?_@JR;!/#WPZ?4VO([--6D9Y+ JLR_NC]UB#M/O7WQ7P;_P %5O#G
M_"1^$?!,)NDLXUOIR\K*257R6R16%::IP<GT ^<I9?AYXI;2M,MICJ6RV$L(
M$V^X2#&3YA^O)W'Z5R5E\%[G4-6E\K4[#1M$EW3P37#-(XBST" 98]?0>]<K
M\.M6\*^"I+C3&D^S^&)[1EOK[RB;AI@ 4*,,G@@$ <'.#4NH6FKZ>T>K-_:4
MUA=,6M-0G5X9)$'1N?F7CL:\C$SA)*7+==PDEHY(]WTCPI\*_P"QK. ^.);2
M_LH6%U'<V;0BX.[I$K8PQ7U)YKQ_XDZAI%]XI\[PI8MI?AR.V6W%K+&BR2N"
M292V<Y.1U.?I6M8?#_XA?$?P;!J'A][;7H!*Z&R\V(ZDI3!)5#AW3!'(S4>B
M_ 'Q5K6EZ_JUXLGA_3].1R(-;A87<SHFYT5!SG.0"1@Y%7/#5:E*\+-?B75K
M.45%(\,U?P8/$%ZAN7BM+2,Y,04,S'/L>GXUT.F:-8:=&D<,6X1_<\T[@I]A
MT%=(?!/B"TTVVOI-"OX8IHU<++#EP".-RCE?QK,:'[',5N()()3_  2*0?R-
M>'4G57NRTL<KYMVBW8:C<V-U#-!*T4\;AXY4.THPZ8KWKPUXQL_&6D20WBQI
M?*O^E6Y'RR \>;&/0_Q+^(KP6WL9;JTGECMI9C$1N%LF]N3@ #U-8GCO6M?^
M'KZ6L2S:+JHW7#V\A#.$/";L<'(SP*WP:K*?DSKIIK5['N>I^#+:)(]+U29D
MT!LKI^H [_[+F8Y!D[M"QX)[9SU%>5ZM)XD^&&K:II<EW+I.I).DC,6&Q2""
MKHP^\K#!!SR*['X/_&+_ (2&SMM.U6*>X-TCNUS)"$C&3@QA&Y9>V><Y]LUZ
M)XL^'&D_$/2+?1KW9";9-NEZBYW?93GB"4_Q6['[K]4/7BO0KTI4WSP>PW34
ME>)F_"W]I!XY;]?&*^=&I$=OK'$<]P".4EXVR+SQO#?4=:]1^*'QX^&$_P .
M-'2"T%SK<> EW;VL:/"I)RGF-OQ^&<=L5\KM\*/$.E7=W#J=E_84.GL5EN-1
M_=IN_NI_?)[! <UQ'$FH2N1(P4[VZ%#CI6=+&5?@D915MSWWPG\:A)J,P@TI
MEME<J+L.S,QQ_',V7Z=EVUF^%;OPI:^)?%FM>*K=]3M+R8WUE#'?RH?M (VQ
MF/) 3(.6KRB_UO6ET:TG,,%M8RER#E?WK<<CG/XFI-&N('T]+%;K?=9,D\C1
M HG.3\W4^@P:S>)KJ+<MC:/*WJC[%_X6CX6\4:CYNCHN@7*1[VTU[@9WXY=>
M=I4_[+*?:I-6^*6E>$/!HUG3=0M]7U:ZD-M-I\8,<B-DX>3)4%<=RI/N:^.]
M<\6Z]I=HEK;W<D-J5,,)6!45AG<>E4+C6[_6-+73Y;@K#!^\F9>2JGC '7/T
MKLACZBLW:QI6A2D_W:LCJ?$WQ!EO-2634994*R%XT60A!DD@\ #'L *YS7M8
MN/%]R^MRRW<CPMM<EB=Z@<$_T%9=WIFGS K::A([@X:.=06;T.>WTJI:6]Y9
MZC#!]H6-&3.]&!Q@GIZUQU7&K^\A+7S(459#]/U-;N;$,T@D=PBHPP3^/:KE
MGKVJ:-/-!-+;F/E?+*Y;<.Q/O6OH=G;:S)+'=2Q0M"28IX%"2$GID]^:YGQ%
MIQTG6!-/.UPH7<TP&-[>A'K65.<*\_926IIHCMM,L8[];>6,;8Y''F%?X.Y'
M6M:[N(Y[RXN2@,,0VX'/ Y/'Y"N \ ZGYVI74XWF*.V.YP/E+9'?UQ7>Z5$\
M^R(J09' .1@'/S-C_P =%>Q0H^SCROJSE=KZ';:5J#FUENY5C2\= #(B"/ (
MVX ' X!S7,1^,?%374]H)OMUK'D1VCRE@B9Y;:V1]VM?>MQ"@8E!*S$+C^%?
ME'U[_G6SX)TB2^\4Q31Q3B*.&2.5HU.'7;DQGL<X'%>?7JMU^7H6NB/.WFA3
M5991:BR7[K!>Q]>1P/85/+X3@O;NTU0ZS.MV#O%M#""D2*>#OSR2>W8"OL[P
MU^UAX3L/#>EV/C#X;ZA:-;JL,ES/I<,UNP!X.XG(.!W'6OF3XC>+K3Q%XBO]
M0T?PQ)I%C-=22QI;S&6,JQX8+TC& #@<=:TQ=50I*,-V;-\RLD9-E(U[-JRW
ME]%I[C$MM,5PLH Y0@*<,3@^E<WX?NI)?%< 50%F8*RR9"Y]2",?TJ0:I%?Z
MA&D!\S>2I'F*@4]L@G)S[9KK+S3Y_"$^GR/>Z9J<K 2-;QOYPBX^Y(I_EFN.
M"K5HV:T*BYRCRV,GQ%,SZ^ME<WEG:ZC=8$;AMJ8SC\/KTK9L_@_<^(;Z\L5U
MRVDO]-0.\N2(GC8@#<X)&03U]*\J^+E[]K\3Z3?KIQM9+61H;KRF"+M)#*5&
M>/3.:6Z^(>KZ;JAO=(DGAMF01L5&X,O^V.^*Z\-&G%:[D72=F>U:9\$O%6G7
M,=I>16]MIDKJ9-1M9@T?EE2VWY<]0*X[QG%HDFO7KV=VT6GJ?W04_-M7Y<E6
MP>HZ]\TR'Q_XHNO#<6CZF9&TR8"81"W 9V[,'!W@]NN*Y2PTJ?6_%,T[QQWT
M5\!;&!V(DB _OC&3SW'K4UYQJ^ZD*=YV31Z#\(=FIRWD6H%AH\0WW,<R_N6
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MQ&)3:VM['+*$(R&VJQ.".]:.I:SI^B11R:A>V]A')((D:YE6,,YZ*"2,D^E
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MG8CE5<D!B#D<=Q0!U%%9&H^+]"T>VM[F_P!:T^RM[A#)#-<72(DB@9+*2<$
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M1 +W3K.]%N0T(N;9)?*/8KN!V_A4[6=N]RERT$37$:E$F,:EU4]0&QD ^@H
M\G_9D@ALO!OB&RMD2&TM/$FH0P01@!(DW@[5 Z#)/'O61\;RH^).CYQG_A&]
M8Z_]<A7M]M9V]FKK;P16ZNYD80QJ@9CU8X R3Z]:2>PM;J4236T$T@5D#R1*
MS!3U )&<'N.] 'R]X3\*Z+X9T[]G2]TO3+.QO;B54ENH(56659+=RX9P,MD^
MN:[K]JTZ2/"'A=M>42:,/$5D;M6!*^7N^;=CMZ^U>RC2[(+;*+.W"VO-N!"N
M(>,?)Q\O'IBN;^(7@4^.H]#0726JZ;JD&HN'BWB41G)3KQGUYH ^:O'PTG5K
MCXE7?@".WG\'?8=.35&T,#[+,RW&9A'Y?REA!D-M[5U&H3>!/$GQ.\,I\.DT
M>^MXM(OEU?\ L2*-K<69@(B2<(-I/F;<*W.0:^DK'3;/2[86UE:6]E; DB"V
MB6.,9Z_*H J/3M%T[1UE73]/M+!96WR"UMTB#MZMM R?<T ?%,<UI/X1^#4E
MIK7AG1]!MX+J&ZO-8L!>Z?;ZC_"L\:NBK)MR TAXJ]<^'=/O?!U_;G7M)\4Z
M/?>,=,61-%TEK+3!)N D$.7=9-PV[BAQD5]B#P[I(LI[/^RK#['.Q>6V^RQ^
M5(QZLR;<,?<C-2+HVGI:06JV%HMK 0T4 MT$<9'(*KC"D>H% 'RE\8O#VD:+
MKGQDLK'3+&RL!X>L;M[:"V18ED65AYFT# (7OCI4WCS7M'M6^(5]IMG8ZUHT
MGA;3$2.WE*VGEM*REV,)!\M3DL%(R 17U5)IEG-)/))9V\DDZ>5*[PJ6D3^Z
MQQ\P]CQ45KH>FV41CM].L[>,QB(I#;(BE!T0@#[O)XZ<T ?&5G)86GQ2TE+3
MQ7X=\1M)X=U.%V\*Z5%9V4(\C*QET9B[':3AF)&W.!7U#\$,'X)^".A!T2V/
M_D(5U-OX;TBTABB@TG3X(HBQCCBM(T5"PPQ "X&1P<=>]78+>*U@C@@B2&"-
M0J11*%50.@ ' 'M0!\;GP)X>F^#_ (2O)=)LY;N]\=[9[EHAYLBM>,K(7Z[2
MO&W..O%:GCK3+'0_%_Q)L=.M;?3[)-7\/2+;6L:Q1*QD()"*  3@<X["OJW^
MR+#R(X?L-KY,<GFI'Y";5?.=P&,!L\Y'-$ND6$\DLDMC:RR2E6D9X$8N5^Z6
M)')';/3M0!\6Z]'=FZT^>?5-(T?0(_&VL>??:_8M>:?%<$+Y)FC#H/[P#,<
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M,C]!D KP>>.N>:]2^%'B36)+&&TUBS:UU G='"L3H)!_"P;&!)_.OV'X]Z,
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M+#KEE/FML#G?06BD%+7I$!1110 4444 >(?M'QM))HNU6;_6=!GTKQ;R)?\
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MKFKAU1O^>2_G1_:;?\\E_.@#/.A*?X::="7^[6E_:9_YY*?QI/[2/_/)?SH
MS#H*_P!W]*:= 7^[6J-2;_GDOYTO]IG_ )Y+^= &/_PCZ_W:3_A'E]/TK8_M
M'_IBOYT?VB?^>*_G0!D?\(^O]W]*0>'P?X1^5;']HG_GBOYT?VC_ -,5_.@#
M(_X1Y?0?E2_\(^N?NBM;^T3_ ,\E_,T?VD?^>2_F: ,H: O]RE&@+G[M:O\
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MFC^UG_YYK^9H T\T9K,_M9_^>:_F:/[6?_GFOYF@#3S2UF#56) \L?F:TA0
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MS7C.SQF%BJS+@ ,1AN-PKV5?NB@!:*** "BBB@ HHHH **** "BBB@ HHHH
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M=L_/L"[<'.3@\>E=-X5^.7P^\<:LFF:!XRT?5M0<%DM;:Z5I& ZX'>NYS[T
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MKM&,9KV"R_9^A>ZL&U_QOXK\6V%C-'/#IFK7, MO,0@H66*)"V"!P3BI-?\
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MYZY^"^BW7ACQ;H375Z+3Q+=R7EVX9-\;N%!"?+@#Y1U!H K2_'KPU%J;:/\
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M5M'\8Z:EKJ%KS@MO1561"<#@''KS6S'^SUH4NB:O9ZEJVN:SJ6J/%)/KMY>
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M;W[2EIJ%_:>!;;2[\:7?S>)+5(KPQA_))#?,%/!('3/>MCP=\!M-\(^+-/\
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MH01UI]S=1V=O)/,PCBC4N['H .IH FHK)T+Q3I?B70X=8TZ[2XTV52ZW'*C
M)!SG!&,'K6#IGQA\)ZQJT>G6NJ!YY6V1.T,B0S-Z)*5",?8$T =I16!=>.=&
ML_[0\ZZV?8)HX+C]VQV/)C8.G.<CI5[4=?LM)NK*VN92DU[(8H$"EM[!2Q'
MXX!ZT :-%4M)UBUURT^TV<HEAW,A.""&4X((/(((J[0 4444 %%%% !1110
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M.EPG_?D?XU ^I:NO2Y3_ +\#_&@#JZ*XYM6U@=+E/^_ _P :A;6M;&<74?\
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M7_@0G^-'_"5Z-_T%;+_P(3_&@#6HK)_X2O1O^@K9?^!"?XT?\)7HW_05LO\
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MS[9\-?%S+J%QJD"^(+Q(;JZF:5WC ^4[B><CG]:^?/A5<7I\!>)+>+X_Z?\
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MYK'4K.WU"RG7;+;W42R1N/0J1@T ?&'PNUN]T:S^+'A&_P!-O-'N$\/27O\
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M3M-2L?#6FV^L7D-_J<<"+/<P6Y@1VQVC+-MP,#&3TH UJ*** "BBB@ HHHH
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MZ_:?_ =J;_PGNE#O<_\ @.U '1CBBN;/Q!TE?^?H_P#;NU-_X6)I'_3U_P"
M[4 =-17,'XBZ/ZW0_P"W=J0_$?1E/6Z/_;LW^% '445RI^)6BCO=?^ S4G_"
MS-%];O\ \!FH ZNBN4_X67HG]Z[_ / 9J!\3-%/>Z_\  9J .KHKE?\ A96B
M^MU_X#-1_P +*T7UNO\ P&:@#JJ*Y;_A9.C'O=?^ S?X4H^(^C'O=?\ @,U
M'445S'_"QM'];K_P&:E'Q#T@][K_ ,!FH Z:BN;'Q!T@_P#/U_X#M2CQ[I)_
MY^O_  ':@#HZ*Y\>.=+/3[3_ . [4H\:Z:?^?G_P':@#?HK#7QAI[=/M'_?A
MJD7Q59-T$_\ WY:@#8HK+7Q):-T6;_OR:D77;9NBS'_MDU &A15(:O W1)O^
M_9IZW\;=%E_[]F@"U14*W*M_!)_WP:>)0?X)/^^#0 ^BD#$_P2?]\&E 8_\
M+.3_ +Y- !12^6__ #S?_ODTOE2?\\W_ .^30 VBG^1)_P \W_[Y- @E/_+-
M_P#ODT ,HJ3[/+_SS?\ [Y-'V>7_ )YO_P!\F@".N@B_U:?[HK#^SR_\\W_[
MY-;D8PB_04 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH 3%+110 4E%% !BC;110 FVEP*** # HVT44 &T4FT
M444 &T4;1110 ;11M%%% !M%&T444 &T4NVBB@ VT8%%% !@4FVBB@!=M&**
M* "BBB@!:2BB@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
*BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>aciu-20221231x20f002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'X \L# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&66[56RL@Y#8,8R.A!/K74^+['XZ_&33HO#-UHNG?#W2I94-_JMMJ/GSR(K
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M%N RDC@C.,9 7TKJIHOB'XL_:&\%>-;?X6:AX/\ )E%GK%U]LBF%S;.0I,F
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M3$YOAJT,+BO:IU:\Z;J_W?9>[K_B^+Y7/C_X@Z3%KW[/G[.^FS@&&ZO_ "9
M>ZLV"/RKZF_:)\+:2/V=/%^G#3X!96&D2R6L(C 6%HD)C*CL00.E>8ZQ^SYX
MOO?AM\&-%B@M3?>%KX3ZBIN %5=V?E./FKWCXO\ AJ]\9?"SQ7H6FJCZAJ.F
MSVT"R-M4NR$#)[#)IT:,E"IS1WBE_P"2F>9YG1GB,%[*LN6%:K)V>UZUTWZQ
MU3['RO\ $G7+^']A+P+!'<.B:FUI9W4VXY$)9R<GT^517U=9_#SP]:?#Q/",
M>F6R^'Q9_93:-&"A3;R6'<D\D]2>>M>6R?!^Q?\ 98TOP)XXU&RT.6"SC@:]
MFG0107 <F,AF(!YP,=\UCV&E?M!V/A,>%I[CPP;6*W^S?\)2TKO<" #&_P O
MH9 O<_4Y-.FI4I7G%N\4O2VZ?J98R5+,:+IX:O&GR5ZLM7924G'EG%_:<;6L
MM=59:E3]@6RCTWX>>,K2$YAM_$]S$A]56&$#]!7T]7S%_P $_P#3I+#X4^)"
M\AF5_$=R$F/_ "U"Q0KO_$@_E7T[75@?]VAZ'@<7.^>XK6_O?HCY*_8>\+:>
M=>^)7B%[9'U,:S+9QW##+)'N9F4>F3C/TIO@GP=I%Q^WGXTD>QA/V+3DOH5*
M#"S.D(9P/7YV.?>O2_V9/A5KWPNM?&2:['!&VJ:S)>VWDR[\QG.,^A]J3PK\
M*M>TG]J3Q=XYN(X!H&I:7':V[K+F0NHASE>P^1JXX4)*E13CM*[_ !/I\7FU
M*>99G5C67+.CRQ=]'_#5E\N;3U.0^+]G!9?ME?"&]@B2*ZN+>X2:5!AI $D
M!/?@D5;^)7CCP%\.OCK)J]GH>M>-/B5+9)"=/TP><MG#M&.#Q&2.>,GYB<#=
MSU/Q(^%NN^)OV@OAQXML8X6T?0XYUO'>7:X+*P&U>_45R6L?#?X@?"_X[^(O
M'O@[1;/Q?IWB*%%N;*XNA;SV[ */E9N",KGZ'':G.,XN34=Y7O:]M%JEZF>%
MKX/$0P\*E9<T<.X\O/R*3]I)\DI=%RN]KJ]DKH\L^//CKQ9XV\6?##5-;^'<
M_@F&#Q!!%:WMY<J]U+N=2T>T ,JX /(ZUW'Q1\)6'C/]N#P)9:I;17EC#I3W
M4EO,NY)#&LK(".X#[3@\'%'Q5^$WQ>^,>I^&O$6I6VDZ4-"U*&>U\.V]UO\
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M;TNOS$/(" J], 9XK.^ EQ82_%?X@K8:G<ZM!Y5H%O+R4R/-C>&8'NN>F.*
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M[@Y7 YH ]?\ %OQ*L/#"Z7%!;7.M:CJ@)LK&P4-),H );)( 4 CDG%4=/^*
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MFMVBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]9FE>++34Y=11XIK#['=FS+WH5%F8*&W1_,<K@]\'@\5XAK7AGR/'.MS^(O
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M6]>_5X#^P!_R1'7O^P[<?^DUO7<?&/XMS?".VTF_?0+S6=,N)7CNY;,$M;
M;6/&.<G@D9Q7U^'FH8:,I;6/Y?SW#5<7GU>A15Y.3LM%T\ST:BN)^'WQG\'_
M !.M@^A:S#-<<;[.?]U<(?0HW)^HR/>O /VB?B Y^.ECH%QXZU;P3X?L]-#7
M=SID\RDRL68?)&<L2"@Z5I4Q$(04UJF>?@<EQ.,Q<L)-.$HIMWBV[+R6KOTL
M?6M%>"^%_$%K\./@KXF\7:9X[U#X@VZP^=;W.J3/(T4F JIASN7YF&5(!]J\
MOOM7^(?PZ\ ^&OBQ<>-=1UAM2FCDO=$N9";0129*JB9VK\H'0#!/%1+$J*3:
MZ7>VB.RAP_/$3E&%5+WN2-U).4[7M9J\?G;6Q]E45FSZ@M[X<DOK9R$FM#-&
MX." 4R#7R%^R5\3/$VH?$I[+7_$&IZMI^I0SPVZ:A>23JDT>'^7>3CY=W2M*
ME>-.<8-?$<."RBKC<+B,3&27L4FUU>^WHDS[/HKX=G^)OB[6_P!HS3KJ#Q#J
ML/AF\\1_V?#917TBV[+$T8=?+#;<$.N>.<FOH+PWK]G<?M'^(M+37]?N+R+3
M/,?2+@C^S81NB^>,;S\_(_A'WFY]<Z>*C4=DNMCNQG#U7!14IS3O#GT3TLTF
MGZ-[['L%%?,GP/\ %VNZMI7QE>^UK4;U[":<6C7%U)(;8!9L>7D_)C Z8Z"H
M? _C&ZNOV1WUGQ!XEU^&83R"35K*=I;Y0)\ *S.#[?>Z41Q2DD[=&_N)J\/U
M:4Y0<T[3A#1/[<>9.WEV/J&BO.[7XE^'? GPC\/>(-;UJY.G26%MY5U?@O=W
M1:-2N5!8M(W4X)[DG )K,\ _M,^#/B#KL>CV[W^E:E-_Q[P:K;^3]H_W"&()
M]B0:W]M332;U9Y7]EXR4)U:=*4H0;3=G;3?[NO;J>KT5YEXV_:'\)?#[Q;-X
M>UIKV"\CM1="1( \<@/1%PVXN?3;^-6/A9\>/"_Q<N;ZTT<WEK?V8W2V>H0B
M*7;TW  D$9XZY]J%6IN7)S:BEE>-C0^M.E+V=D[VTL]F>BT5RVI?$73=)^(6
MC^#KB&Z74M5M)KNUG"+Y#+$1O0MNSN&0<;<8/6JGA7XN:!XQ\=^*?"6GO/\
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M0_$'X]^&_AKXIL/#^J0ZE<:G?V;WEI%I]K]H:XPX41(JG<TA)R !C )) !H
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M1T.1D9QD5\YZ%\0/%$W[/?PCU&3Q)J[ZA?>-H[2ZNVOI3+<0F:8&*1]V63
MVDD<"@#[7HKDO"7Q-TGQCXI\4^'K6*ZMM4\.7"07D5TBKN#KN22/#'*$="<'
MVJA;>,5^)UGXITOPS?W6CW.DWW]FSZH]NCKO 5I/)^8Y(!V[B.&['% '>45Y
M9^R\TK_ KPN9IY+F;;<;YIFW.Y^TR_,Q[DUZG0 4444 %%%% !1110 4444
M.C^^OU%=#7/1_?7ZBNAH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HKJZAL;=Y[B:.
MW@C&7EE8*JCU)/ J6N#^.W_)(?%7_7FW\Q0!W:LKJ&4AE(R"#D$4M4-!_P"0
M'IW_ %[1_P#H(J_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %?GO\ \%!/^2TZ3_V 8/\ THN*_0BOSW_X
M*"?\EITG_L P?^E%Q7F9C_ ^:/T+@7_D<+_#(^9****^5/Z./T"_8 _Y(CKW
M_8=N/_2:WKN?C'\2]3^']EIMOHOA>Y\5:KJCO%#:P9V(% RSD _+\P]O4BN&
M_8 _Y(CKW_8=N/\ TFMZ]^KZ_#)RPT5%VT/Y?SZI3HY]7J58<\5)Z7:OIW6I
M\K^'?V;?%7CSQK8>+_&+:5X3:WG2X33= M521BI! 9\G'3DDL>O2O2M8\9_"
M>V^*&H:;KMOIEEXG2 &:\U6W2-'3 ( E?@\8Q]*]>KE?&?PL\)_$)X7\1:%:
M:I+"-L<LJE74>FY2#CVSBJ6']G']WO?6_4PEG+QM9/'.2@HN,53LN7[]UW3?
MS/D[PKH3^(_ 7QY7PS%N\,S3^9IJ1*0C>7*7(0'ML _2K'Q(^(.C>+/V7/!7
MAW3+Z"^U^=[6V_LZ!PTZ.@*D%.HR<8SUR,5]A:%X=TSPSI,.EZ5806&GQ+M2
MW@0*@'?CN3W)ZUSFD?!?P/H/B,Z]I_AFPM=6W%Q<(A^1CU*KG:I]P!7.\)-1
MY8M:JS^^^A[4>),-*LZM6G+W)J<-5JU!1]]^=DVUUN;%O8/I7@B*RD(,EMIP
MA8CN5BP?Y5\&>%Y;OPK\'K/QKIZAKO1O%##KCY)(=I!/H>GXU^ADL23Q/'(-
MR.I5AZ@]:XZ+X,^"X/"MUX;30+==#NIA<36>Y]KR @AL[LYX'>ML1AY56N5V
MLG^ECS,FSJEET:D:\7+GE%NUOA7,I+?JI:'RAIWAU]#M_P!GR:9#]IO]4GO9
MW(/S-)-$PS[[<?E7JG@G_D]3QE_V _\ V:WKVN]^''AO4&T(W&DQ2'0F#:;E
MF'V8C&-N#S]T=<]*FM/ F@V'BV[\3V^FQQZ]=0_9YKT,VYX_E.TC./X5[=JB
M&%E!JSV:?W*QUXGB&EB834HN\H5(]-YU.===DM#YL_9__P"0/\=/^NUQ_P"@
M3UA:/_R8E>?]?$G_ *45]4Z)\-O#7AR+6(]-TF*T36"S7ZJS'SRP(.<GC[QZ
M8ZU#%\*O"D'@UO"B:-"OAYF+&PWOL)+;CSG/7GK4K"S4;7Z-?>RY\0X:5=U5
M"5G4I3Z;0C9K?=]#Y>^);1:;H'[/NJZS&TGA:WM+070(S&&\N,G</]T?B%-=
M#^TSXGT#QYJG@'3?!VH6>K^)SJ2/;2Z9*LC0)D?>92=O.#@],$U])2^#M$N/
M#,/AZ?2[:XT2&%($L9T\R-40 *,-GI@8/7BLGPA\(O!O@*\DN] \/6>G74@P
M9T4LX'H&8D@>PIO#3=XIJSM?OIV)I9_A8NG6E"7/2Y^5*W*^=M^]U5KZVO<\
M5UBRAO?VW=(%Q$DPCTHR*&&0&$38/X5<\)6\=M^VIXP$2",2:1'(P7@%BD.3
M7MS^ ] D\7Q^*6TV,Z_'%Y"WVYMP3&,8SCH?2G6_@?0K7Q;<^)XM.C37KF$0
M37H9MSH  %QG'\([=JM8>5[_ -ZYQRSJDZ?)9_P%2Z?%S7OOM^/D>8_M*3IX
M4?P-X\<^7!X<UE/M<@&=MK./*E)]@2C'_=KY[L_$=[\--/T#XE_9G%]\1+/5
MX)%ZG[1/*)K('\!M'H*^VO%/A72?&V@W>BZY8QZCI=VH2>VER%<9![$'J!TK
M.U+X:>&-7T70](O-&MY]-T26&;3K9MVVW>)2L97GG:I(YS7>?'GA7B_PE'X$
MUK]G'0(_^7'4VB<_WG^SL78^Y8L?QK<^%/R_M'_'13PQATH@'J1Y4_->SZUX
M/T?Q%J>D:CJ5BEU>Z1,;BQF8L#!(5VEA@X/!(YS65>_";PCJ/CB#QC<:%;/X
MFA3RTU$;EDVX(YP<'@D9(- 'B7[,%O$O[(-[B-!YD>J,_'WCOD&3Z\ #\*]'
M_9:<O^SSX"+')_LN(<UV?A[P#X?\*>%V\.:3ID=EHC"0&S1F*D2$E^22>23W
M[U>\.>'--\(Z'9:-I%JMCIEE&(K>W0DB-!T ))- 'C'PLO+71?VD/BU8:K/%
M!J^H?8KRR69@&FM%B8'9GJ%;.<=,UXMK-Q%XPT+]J2;P3*+B&:>V826@#+*J
M*OVHKCA@0LWUS[U]9>/_ (0>#/BD+;_A*O#MEK36W^IDG4B1!Z!U(;'MG%6_
M"?PV\,>!9]0ET#1;726OQ&+E;92JR"- B#;G  48X H ^:+OPGKOB/X#Q7VK
M_'ZP@\!7FGQQ2*WA:T"1H5 \H%7W;@>./FR*ZG2]"BT[]I'X4V<UVVKR:=X(
MF6._FB,;RLI1/-*')4LI/!Y&XBO2+?\ 9K^%]IXD_MZ+P3I::H)?.$OEDJ'S
MG<(\[ <\]*[.?PCH]SXJM?$DMBCZW:VSV<-X6;<D+$,R 9Q@D ]* /&/A?!'
M_P -;?&67RU\P6NEJ'QR ;9,C/X"O#/%45\/A1XHN+6_.EV=G\47GO+W[.LZ
M6T.<"1HVX95=D8@\<5]L:=X,T72?$NK>(+2PC@UG55C6]NU9MTPC4*@()P,
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M^+KTNB@#S3_A'OBG_P!#?H?_ (*F_P#BZ/\ A'OBG_T-^A_^"IO_ (NO2Z*
M/-/^$>^*?_0WZ'_X*F_^+H_X1[XI_P#0WZ'_ ."IO_BZ]+HH \T_X1[XI_\
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M_P#H;]#_ /!4W_Q=>ET4 >:?\(]\4_\ H;]#_P#!4W_Q='_"/?%/_H;]#_\
M!4W_ ,77I=% 'FG_  CWQ3_Z&_0__!4W_P 77/\ CS4?B;\/_"]SKMQXDT:]
M@MI8%>"/32C,))DCX);C&_/X5[77G/[0EK->_"76(;>&2>9IK,B.)2S'%W"3
MP/8$T >C4444 %?GO_P4$_Y+3I/_ & 8/_2BXK]"*_/?_@H)_P EITG_ + ,
M'_I1<5YF8_P/FC]"X%_Y'"_PR/F2BBBOE3^CC] OV /^2(Z]_P!AVX_])K>O
M?J\!_8 _Y(CKW_8=N/\ TFMZ]^K[+"?P(>A_*W$__(YQ/^(****ZSY@****
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M*%51@*!@ 5SM_P#\E'T/_L$ZA_Z.LZZ2N;O_ /DH^A_]@G4/_1UG0!TE%%%
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M1MHH/:@#S]X=1_Z"-]_X$/\ XU"T6I_]!*__ / A_P#&O0CH:_W:C;05/\-
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M_M"2O3?V>+MYOB-&K=/LLO\ 2LJ4[S2/2S'"1AA*LNR9]24445[1^4!1110
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M$4J[75BGS*?0C]* /$/A=*GA']H[PI9>%_#WBKP5X7US3[OS]+\1W,C"Z>(
MB00RN\D97(&6(SQCO5OX4?!;2/BQ_P +/O?$U_J]XMOXGU*'3[>'49H([)A(
MW[Q51@&;I][(P ,5WNF?!+Q]??&/PI\1/$WB32;Z^L(9[6ZTVQADAM;>%E^0
M6^[<S-N+%F<C/RXZ5VGP?^&6H_#RQ\80W]S:W#:SKE[JD!MBQ"1S.2JME1\P
M[XR/>@#YMU[Q%KOBS]DCX?F76KM-7_X2F'3!JA<F;"7<L4;L?XB%"]>N.:[S
MQI\-]/\ @7\3?AAK'A;4-7AGUG6?[*U9;O4IKE;]'B=B\@D8C=E<_+@<].!6
ME;?LU^(8/@QX7\'G4=,.H:5XE76II@\GE-$+IYMJG9G=M8#D 9[UZ/\ %SX:
MZC\0-:\!7EC<VT$?A_6TU.X6X+ R1B-UVI@'YLL.N![T <O\'KF:7X^_&F)Y
M7>..\L B,Q(7-JN<#M7 ^"=:2S\!?'F?4/%L_A*VC\5749UE%,LMLA2+B)<Y
MW'.!CG)XYKO]>^%/C_P_\4M>\5?#_6]!M[;Q&D*ZE::];S2>3)&H02P^61D[
M0/E8@9^O',:7^RGK3?##QUX8U3Q+!+J6M:\=<LM5CC+[7 C*F5" .60Y ) !
M')Q0!X[XRDT;PUIFA>*?A_X7^(.@:A;ZI9I/XGUVXN(HKN.2148-'-(1*),_
MP*!ZX'%?06D,7_;&UACU/A"U/_D>2N?^(/P2^+_Q?\-6UGXI\4^&;.73KJ"\
MM;+1K>=(+J6-P=]Q(^6&%W85%QD@]J]+TSX::G:?'2\\;RW-H=/GT&#2Q C-
MYHE21G+8VXVX;CG/M0!SO[1=]?ZOK?P_\"VFI7.DV?B?498]0N;*7RIFMH8]
M[1JXY7<6 ..P-7?"'PD7X+^*-4U#PWJ<T?@^?36>7P_>74URR72<B:)I&8@%
M00PSSQZ5N_&+X87?Q#LM&O-&U--&\3:#>"_TR\EC,D0?!5HY%!!*,#@XYZ&L
M+P/\*?%%_P"/G\;_ !'O]&U#68;%M-L+#0X95M+6)SF1\RDLSMT]AGUX //?
MA=\%;+XZ_#]/'OBW6M;G\5:XTUQ9WMIJ4UN-*02,L201HP3@*"=RGG-8NH^(
M/'7Q*_9W\+7#P:KXC2PUF2S\36^B2-%>ZC:P,\9V%<,<D*6"\G\Z[K3O@_\
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MP*\9Z):?%70+;4M"F\,>+FOKNU>59EO(+FXB6,!\ IY8V]LGO[5!<?L^^,=
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MH?\ 0K^'O_!O)_\ &:/[:^*'_0K^'O\ P;R?_&:]$HH \[_MKXH?]"OX>_\
M!O)_\9H_MKXH?]"OX>_\&\G_ ,9KT2B@#SO^VOBA_P!"OX>_\&\G_P 9H_MK
MXH?]"OX>_P#!O)_\9KT2B@#SO^VOBA_T*_A[_P &\G_QFC^VOBA_T*_A[_P;
MR?\ QFO1** /._[:^*'_ $*_A[_P;R?_ !FC^VOBA_T*_A[_ ,&\G_QFO1**
M /._[:^*'_0K^'O_  ;R?_&:/[:^*'_0K^'O_!O)_P#&:]$HH \[_MKXH?\
M0K^'O_!O)_\ &:/[:^*'_0K^'O\ P;R?_&:]$HH \[_MKXH?]"OX>_\ !O)_
M\9H_MKXH?]"OX>_\&\G_ ,9KT2B@#SO^VOBA_P!"OX>_\&\G_P 9H_MKXH?]
M"OX>_P#!O)_\9KT2B@#SO^VOBA_T*_A[_P &\G_QFC^VOBA_T*_A[_P;R?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OG?\
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M*E6'% &5@^A_*EV-_=;\JV5CQ3PM &)Y;_W&_*CRG_N-^5;H&*<%H P?*?\
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M_P"1>O\ $OR9Z=1117W)^.!1110 4444 %%%% !1110 4444 %%%% !1110
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M7_>7Z/\ -'Q7%W_(O7^)?DSTZBBBON3\<"BBB@ HHHH **** "BBB@ HHHH
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M%?:'\H!1110 4444 >#?M7?\@OP[_P!=IO\ T%:^<J^C?VKO^07X=_Z[3?\
MH*U\Y5^?YM_OD_E^2/V_AG_D5T_^WO\ TIA1117CGU(4444 %?7'[.?_ "2Z
MR_Z[S?\ H9KY'KZX_9S_ .2767_7>;_T,U[^2_[R_1_FCXKB[_D7K_$OR9Z=
M1117W)^.!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7SK^T1_R.]I_P!@]/\ T9)7T57SK^T1
M_P CO:?]@]/_ $9)7Y=XD?\ (AE_CB?9<)_\C)?X6>74445_)I^UGT#\!/\
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M'W?E/.?PKE]9^#7B_P 0Z'JD5S_94%[<Z#;:3&L5P[)OBN-^XDIG!3'X\>]
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M,H O?(!P<X^4^AK'USX=W.LZ;XA@,\<<E[J4.H6I25TP8Q&0KLN&7)C(RIR
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MOC_OK^=+OC_OI_WU0!"L&*>(JD\R/_GHOYBE\V/_ )Z+^8H :(\4X+1YL?\
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M?]Y?H_S1\5Q=_P B]?XE^3/3J***^Y/QP**** "BBB@ HHHH **** "BBB@
MHHHH **** "BJ.B:Y8>(],BU#3+J.\LI2P2:(Y5BK%6_)E(_"KU !1110 44
M44 %%%% !1110 4444 %%%% !1110 5^;?QE_P"2L^,/^PM<_P#HQJ_22OS;
M^,O_ "5GQA_V%KG_ -&-0!QM%%% 'Z(?";_DC?@W_L'P_P#H-='7.?";_DC?
M@W_L'P_^@UT= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M35^/M?/9I\4/F?N'AU_!Q/K'\F%%%%>&?L 4444 %?0W["G_ "7J#_L'7/\
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MT4S7/^_$'_Q-'_"K/$W_ $4S7/\ OQ!_\30!Z717FG_"K/$W_13-<_[\0?\
MQ-'_  JSQ-_T4S7/^_$'_P 30!Z717FG_"K/$W_13-<_[\0?_$T?\*L\3?\
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M10?04ZB@#C=2^+OA;2-0N+*ZU!X[FW<QR(+>0X8'!&0N*K?\+N\'_P#03?\
M\!I?_B:\ ^(G_(]Z_P#]?LO_ *$:YZOYGQOB5G&'Q56C"G3M&32]V6R=OYS]
M<P_"6 JT85)2G=I/==5_A/J#_A=W@_\ Z";_ /@-+_\ $T?\+N\'_P#03?\
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M0 445Q/QG\6W_@7X9:WKNEF,7UHD9B,R;E^:5%.1WX8T =M17PQ_PV%\0?\
MGIIG_@)_]E1_PV%\0?\ GIIG_@)_]E0!]ST5\,?\-A?$'_GIIG_@)_\ 94?\
M-A?$'_GIIG_@)_\ 94 ?<]%?#'_#87Q!_P">FF?^ G_V5'_#87Q!_P">FF?^
M G_V5 'W/17CG[-/Q3USXJ>'M7O-<:W::UNEAC^SQ;!M* \\GO7L= !1110
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M?>-/B?:Z=#]CT'3?LCN^[^U9I=^X ?\ /JN.E><_\,O>-/\ GZT'_P #)O\
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M?W]!_P# Z;_Y'H_X9[\:?W]!_P# Z;_Y'H_U!XD_Z!?_ ">G_P#)!_K-E/\
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M;'HW_?1KU/\ X1U1_#1_PCH_N_I0!Y9_PC?^RW_?1_QIP\. G[K?]]&O4O\
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M:BCZI#^:7_@4O\P]O+LON7^1D^1KO_/]IW_@%)_\=H\C7?\ G^T[_P  I/\
MX[6M11]4A_-+_P "E_F'MY=E]R_R,GR-=_Y_M._\ I/_ ([1Y&N_\_VG?^ 4
MG_QVM:BCZI#^:7_@4O\ ,/;R[+[E_D9/D:[_ ,_VG?\ @%)_\=H\C7?^?[3O
M_ *3_P".UK44?5(?S2_\"E_F'MY=E]R_R,GR-=_Y_M._\ I/_CM'D:[_ ,_V
MG?\ @%)_\=K6HH^J0_FE_P"!2_S#V\NR^Y?Y&3Y&N_\ /]IW_@%)_P#':/(U
MW_G^T[_P"D_^.UK44?5(?S2_\"E_F'MY=E]R_P C)\C7?^?[3O\ P"D_^.T>
M1KO_ #_:=_X!2?\ QVM:BCZI#^:7_@4O\P]O+LON7^1D^1KO_/\ :=_X!2?_
M !VCR-=_Y_M._P# *3_X[6M11]4A_-+_ ,"E_F'MY=E]R_R,GR-=_P"?[3O_
M  "D_P#CM'D:[_S_ &G?^ 4G_P =K6HH^J0_FE_X%+_,/;R[+[E_D9/D:[_S
M_:=_X!2?_':/(UW_ )_M._\  *3_ ..UK44?5(?S2_\  I?YA[>79?<O\C)\
MC7?^?[3O_ *3_P".T>1KO_/]IW_@%)_\=K6HH^J0_FE_X%+_ ##V\NR^Y?Y&
M3Y&N_P#/]IW_ (!2?_':/(UW_G^T[_P"D_\ CM:U%'U2'\TO_ I?YA[>79?<
MO\C)\C7?^?[3O_ *3_X[1Y&N_P#/]IW_ (!2?_':UJ*/JD/YI?\ @4O\P]O+
MLON7^1D^1KO_ #_:=_X!2?\ QVCR-=_Y_M._\ I/_CM:U%'U2'\TO_ I?YA[
M>79?<O\ (R?(UW_G^T[_ , I/_CM'D:[_P _VG?^ 4G_ ,=K6HH^J0_FE_X%
M+_,/;R[+[E_D9/D:[_S_ &G?^ 4G_P =H\C7?^?[3O\ P"D_^.UK44?5(?S2
M_P# I?YA[>79?<O\C)\C7?\ G^T[_P  I/\ X[1Y&N_\_P!IW_@%)_\ ':UJ
M*/JD/YI?^!2_S#V\NR^Y?Y&3Y&N_\_VG?^ 4G_QV@0:YD9OM/([XLW_^.UK4
M4?5(?S2_\"E_F'MY=E]R_P A!TI:**[3G"OD/X@?\CSK_P#U_3?^AFOKROD/
MX@?\CSK_ /U_3?\ H9K\0\5/]PPW^-_^DGZ'P9_O-7_"OS,"BBBOYK/UH***
M* "BBB@ HHHH **** -;PQXGO_"6JQW]A)LD7AD;[LB]U8>E?4G@GQM8^-]*
M6[M#LE7 FMV.6B;T]QZ&OD6M;POXGOO".K17]A*4D7AT/W9%[JP[BOT3A'BZ
MMP]6]E5O+#R>J[?WH^?==?4^6SS(Z>:4^>&E5;/OY/\ K0^M=:T2VUVR:VN4
MR#]UQ]Y#ZBO'->T&Y\/WIM[A<J>4D X<>HKU'P3XVL/&^DI=VC;)EXGMV/S1
M-_4>AK2UO1;;7;%K:Y7(/*L.J'U%?T7F66X7B#"QQF#DG)J\9+9KL_ZNF?E6
M$Q=;*ZSH5TTD]5V\U_6IX35_1M:N="O5N;9\,/O*?NL/0U)K^@7/A^^:WG&5
MZI*!PX]:S*_(FJV"K6=XSB_FF?<IT\13OO%GN>@:_;>(;(3P'##B2,GE#Z5=
MN;9+J,HX^A[BO#M%UFYT*^2YMFPPX93T8>AKV/P_X@MO$-BL\!VN.)(C]Y#_
M )[U^PY)G=/-:?L*^E1;K^;S7ZH^#S#+I8.7M*?P?D9US;/:R%''T/K4-=+<
MVR7491Q]#Z5@7-L]K(4<?0^M=6*PKH/FC\)E1K*HK/<2WN'MI Z'GN.QKH+6
MZ2[CW+U[CTKFJEM[A[:0.AY[CUI87%.@[/X0K4545UN=-14-K=)=QAEZ]U]*
MFKZ6,E)<T=CR6FG9A1115""BL#QUXI?P;X8N]6CLCJ,D)14M5E$9D9F"@;B"
M!R>]<OIWQ0UZVUG3;/Q/X'N_#EMJ$XM8+T7\%W'YQ!*JXC.5SC /K0!Z/15<
M:C:&Z-J+J$W(_P"6/F#?^76J6GZZ);6274$ATQEEDC57N4<,JM@-D' R,''4
M9P: -6BLG3==^TK=->QQ6 CN)(HBURC^:B]).#\N1SM/([U?^WVWV7[3]HB^
MS8SYV\;,>N>E $]%06U];7H)M[B*<#&3$X;'ITI+B_M;-T2>YA@9SA%DD"EC
M[9ZT 6**@N[^VL$#W-Q%;H3@-*X4'\Z2;4;6W53+<PQA@&!>0#()P#^M %BB
MN7\,>-)?$\6GSQ:;Y5M<FY5Y#<J3&8I3&!MX+;L$Y X[UT$&H6MS-)%#<PRR
MQ_?1) 67Z@=* +%%007]M=.4AN(I7 R5C<,0/7BLWQ3XGMO"^BZC?2-'+-:6
MLET+7S0KR!%+8'Y=<4 ;-%87A_Q++K:+/)9+:6CV<%VDS7"-GS%+%2HY7;QR
M>#GCI6K:W]K>HSV]S#<(IPS1.& ^N* +%%5(=6L;C/E7MO+@$G9*IX'7H>U/
M@U"UNI#'#<PRR!0Q1) Q /0X':@"Q15=-1M9;EK=+F%[A?O1+("X^HZT#4;4
MW7V87,)N?^>/F#?^76@"Q1638:X98KZ74(8M-CM[IX$=[E'$BC&'R#\N?[IY
M%:'VR#[/]H\^/R,9\W>-N/7/2@":BHS<1"0QF5!(%WE=PR%]<>GO7,:O\0;7
MP_-*VH0B*Q-U:VEM<QW$;^>TQ W%<Y15)Y)Z@9% '5T5SVA^,K76;W5+=O+M
M39WALT+S ^>=B/N4<?WQQS70T %%5[?4+6[DDC@N89I(^'6.0,5^H'2D34;2
M2Y:V2ZA:X7K"L@+C\.M %FBN;\2^-[3P^NF^7Y=\]Y?P66R.8 Q^8VW>>O /
M:MX7D!B603QF-FVA]XP3G&,^N: )J*CDGCB>-'D1'D.$5F +'&<#UJ.6_M8!
M*9+F&,18\PM(!LSTSZ?C0!8HJ!;^V>U^TK<1-;@9\X.-F/KTI4O;>2V^T)/$
M]OC/FJX*8]<]* )J*R]0UEH;.WN+"*/4EEGCB)2X1%56;#,&)P<==HY/05;&
MI69G6$74!F8D+'Y@W$CJ ,T 6:*KR:C:17*V[W,*7#?=B:0!S]!UKGT\>6U_
M-J=OID(O;K3KY+*>)YXXNH0LZDGD /TZD@@4 =115>34;6&X2WDN88YW^[$T
M@#'Z#K23:E9V\FR6Z@B?(7:\@!R>@QGO0!9HHZ5!;7UM>AS;W$4X0X;RG#;3
MZ'% $]%58=4L[@RB*[@E,0S($D4[/K@\4Z#4+6ZD:.&YAFD4!BL<@8@'H<"@
M"Q14%U?6UB@>YN(K="<!I7"@G\:JW.J31ZIIUO#;+<6UTLC/<B=%\K: 5PIY
M?=G^'ICF@#1HJJNJV3SF%;RW:8-L,8E4MN],9Z\4J:E:23+$EU"TK E4$@+'
M'!P,^QH LT5POBSXER^%=$2Y?1Q<ZE<7YL+33UOHE,YR<.9"=J# R<],@&NA
MT77IKRQNKC4[2/2/)F:+#7<<JE1C#%EX7)/0\\4 ;-%0&]MUMOM)N(A;XSYI
M<;,>N>E-74K1X$F6ZA:%SM602 J3Z YH LT5@Z_XVTKP[I]K>W%PLMO<W<5F
MCPNK#?(X0$G.,#.3Z 4:!XM@UV\U6WV+ ;*\-FK&0'SCY:OE?P;ISTH WJ*8
MDT<CNB.K,APR@Y*GKSZ5$=0M1="V-S"+DC/D^8-^/IUH L45 ;VW5)&,\06-
MMKL7&%/H?0\BF-JEFD@C:[@61FV!#(N2WIC/7D<4 6J*KW.H6MDR+<7,,#/P
MHED"EOIGK27&I6EH2)[J&$C'$D@7KTZGO0!9HJ"XOK:T5&GN(H5<X4R.%#'T
M&>M8GAGQ>OB3P_=:HMJ8%@FN(?*+[MWE.RYSCOMS^- '145Y[X?^,5EXB^&N
MH>+(+*2.2PADEGTZ1\.I5=P&['1EP0V.AJ#6?BEKL?B%=)T#P9+XAD6P@OYG
M74H;;RQ*6"KB0#/W#R* /2:*\]3XM_\ %):]J4VAW5GK&C86ZT:XE57#'&W$
M@RI5L\,..M5;;XLZWIMU9GQ5X(N_#>F74J0+J(OX;N*-W.$\P1G*@D@;NF3S
M0!Z917&V'C:XN_&)THK:F(RRPF!-WGQ!%R)&/W2K= !@\CD\UU5Q?VMIGS[F
M&'&,^9(%QGIU]: +%%0+>V[7!MQ/$9P-WE!QNQZXZXIJ:C:2W+6R74+W"]8E
MD!<?AUH LT5S?B7QO:: -,$?EWSWM_!8[(IAF/S&*ASUR!CI6Z;ZV"2N;B()
M"=LC%QA#Z'T_&@">BL3Q#XQTSPWH$NL7$ZRV2,J[H&5MQ9@H YQU/KV-;$4J
M31K)&P=& 964Y!% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVX'88QQ6A10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %?(?Q _Y'G7_P#K^F_]#-?7E?(?Q _Y'G7_ /K^F_\ 0S7XAXJ?[AAO
M\;_])/T/@S_>:O\ A7YF!1117\UGZT%%%% !1110 4444 %%%:.@:!>^)=4A
ML+"$S7$A[=%'=B>P%:TJ52O4C2I1<I2=DENV1.<:<7.;LENPT#0+WQ+JD-A8
M0F6XE./91W)/8"OJ#P!X!LO NE^3%B:\E ,]R1RY]!Z >E'@#P!9>!=+$40$
MM[( 9[DCESZ#T ]*WM5U6WT:R>YN7"1KT]6/H/>OZFX0X0H\/T?K^/LZ[5_*
M"[+S[OY+3?\ &L\SRIFE3ZMAK^SO\Y/_ "[+YOR-5U6VT:RDNKI]D:CIW8^@
M'K7COB3Q)<>([WS924A7B.('A1_C[T>)/$ESXCO3+*=D*G$<0Z*/\:QZ\W/L
M^EF,G1HZ4E_Y-YOR[+^EUY;EJPB]I4UF_P  JWI>EW&L7L=M;)OD<_@H]3[4
M:7I=QK%XEM;1EY&_(#U/M7L7AKPU;^'+(1Q@/.PS),>K'^@KDR7):F:U.:6E
M-;O]%Y_D;YAF$,'"RUF]E^K%\->&K?PY9^7& \[\R2D<L?\ "M2>=+:,NYP!
M^M$\Z6\9=S@#]:Y^[NWNY-S<*.B^E?L,I4<OHJC15K;+^OZ9\(E/%3=2H[WW
M87=V]W)N;A1T7TJ"BI((7N) B#)/Z5X+<JDKO5L]))07D$,#W$@1!DG]*W[.
MS2TCP.6/5O6BSLTM(\#ECU;UJQ7T.%PJHKFE\7Y'EUJSJ.RV"BBBO1.4****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT45\Y_J?E_\ //[U_P#(GJ?V[B?Y8_<_\STGPUX:M_#EGY<?SSM_K)2.6/\
MA6N3@$@9]A117V5"A3PU-4:*M%;(\&I4G5FYS=VS'N[6\NY-S1X Z+N'%0?V
M5=?\\_\ QX?XT45RRP-.;<I-W_KR-EB915DD-DTR[1&80%R!D*K+D^PR<4ZS
MU&[M(\+X=U(L>K>9:\_^1J**A8",)<U.I*+_ .W?UBRGB7)6E%/[_P!&B?\
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MJ/[=O?\ H7=2_P"_EK_\>HHH^K5?^?\ +[H?_(![6'_/M?\ DW_R0?V[>_\
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M_G_+[H?_ " >UA_S[7_DW_R0?V[>_P#0NZE_W\M?_CU']NWO_0NZE_W\M?\
MX]111]6J_P#/^7W0_P#D ]K#_GVO_)O_ )(/[=O?^A=U+_OY:_\ QZC^W;W_
M *%W4O\ OY:__'J**/JU7_G_ "^Z'_R >UA_S[7_ )-_\D']NWO_ $+NI?\
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MJ7_?RU_^/4?V[>_]"[J7_?RU_P#CU%%'U:K_ ,_Y?=#_ .0#VL/^?:_\F_\
MD@_MV]_Z%W4O^_EK_P#'J/[=O?\ H7=2_P"_EK_\>HHH^K5?^?\ +[H?_(![
M6'_/M?\ DW_R0?V[>_\ 0NZE_P!_+7_X]1_;M[_T+NI?]_+7_P"/444?5JO_
M #_E]T/_ ) /:P_Y]K_R;_Y(/[=O?^A=U+_OY:__ !ZC^W;W_H7=2_[^6O\
M\>HHH^K5?^?\ONA_\@'M8?\ /M?^3?\ R0?V[>_]"[J7_?RU_P#CU']NWO\
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#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>aciu-20221231x20f003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %Q ZL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5?-4=PHHHK0R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>[_JQRUZD96IT_AC^/=_,****Z#E"BBB@ HHHH **** "BBB@ HHHH ****
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M^82IROADI+;16?XF=XI\5:MX%\10Q1VD44D<>]4NX]^&)/S @\_6H?\ A?\
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M !1_=L/^_!_^*K)D^&YMQ=23ZS:16T$4,OG>7(0XDSL"@#.?\:GNOA'JENL
M6>-Y7DCCD1HG18R_0AB,.!WV]*?UKBEIM59NW:2?5K:_=/[GT3%[#)%:\(_<
M_)]O-?>B_P#\+_\ %']VP_[\'_XJC_A?_BC^[8?]^#_\56-_PKY9/LLEOK,%
MU;SSO;B2*VE9@R#)^0#)]L5>NOAM!H]AJ[W^H8N+:.&6 ")U#!SC#+C(/&,=
MJ(XOB:2<O;RLNO.K?#S=^J6G0'0R9-+V2N^G*^]NW<M_\+_\4?W;#_OP?_BJ
M/^%_^*/[MA_WX/\ \56;J'P_2+4+CSKZVTFV\Y+: .))1)(4#8SC('/)/K45
MM\-)Y/)BN-2MK2[FDEABMVC=BSQ]1N P ?6D\9Q,IN"KS=M/B7>W5IJ[VO9O
MH-8?)N52=./_ (#Y7Z=NMMNIV/@SXT>(=>\4Z;I]R+,6]Q,$?9"0V#Z'=7O%
M?)GPU4KX_P!%!ZBY45]9U^I\"8_%9A@ZT\74<VI65W?2R/B.)\+0PN(IQH04
M4X]/4***XZXUC4/"VM,NH3-=Z7<OF.4J,Q>W'IZ>E?H]2HJ=G+;\CY6C1E6;
M47KV[^AV-9>K>(K31;BVBNBZ"<D"0+E%_P!X]JTD=9$5U(96&00<@BJNJ:5;
M:Q:-;W4>]#R#T*GU![&JGS<ON;D4^137M=O(DN[*UU.#R[B&.XB/.'4,/J*Y
M77/!QMH_M-@TCB+YO(+G>H]8W^\#[9Q4>F7MUX/U-=,OI3-I\G^HF/\  /\
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M/K5M?B-K"W@N1]G\T7)NN8>-Y39TSTQVKWC_ (4GX/\ ^@6W_@1)_P#%4?\
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MDD #V13WK"K[[5-?/T.S#+V495WTV]1J?#FSD0"YEP0<_P"API;G\'4&0?\
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M_@<?\P_LG'_\^)?^ O\ R._HK@/^%Y>$?^?^;_P&D_PH_P"%Y>$?^?\ F_\
M :3_  H_U@RC_H+I_P#@<?\ ,/[)Q_\ SXE_X"_\COZ*X#_A>7A'_G_F_P#
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MAE>V2&?3M&;RIKL#G_2Y5X<^N,D^M?3>A:MH5G':Z-IDB1);H((;=%8!548
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MCC![]/:NE5,DB_X;?_@6U_\ %O;?I?;0PY,R?VDON[>FU]NMM]2>T\ SW5O
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M'->A_K9E+_Y>/_P&7^1S_P!DXM?9_%?YGIMGK6I:<H6VU"=$' 1R)%'X-FM
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MLXK*TTK=KI+[D>_T8 .<<U\N7?Q;UF^NTN)]LDBL& $C*!@]  <"NE'[1NK
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MZ1-(A_?O^[A'JYX'Y=?PKSV*,0QHB\A0!GUKR,=.[4%ZGO9=3M&51]=/\_T
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MP0?W*=#[FO6X0:_MS#>K_P#26<.?_P#(LK>B_-'OE%%%?U<?A@4444 %%%%
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M\/5I47SRNWVTM;L4=,\:Z7J"A9+F.UG_ (HI7'Z-T(J#7]8T*^M3;SSK=O\
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MH^VQKRO03*/X3[^AK@PPD4,,^F",$>H/O7L=<1XS\-F%I-3M$RIYN8E'7_;
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MFL Q^TK&)2N.-N<=:MTDT]BG%QW04444R0HHHH **** "BBB@ HHHH ****
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MO/5**R=/\4Z7J<JQ07:&9ND;@HQ^@(&:UJ]B,XS5XNYX$X3INTU9^844459
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MC"-?F2"%8K73XA#$B !0[?,Q^N-M=#UK"?[7HFI7<T=E)?6ETPD/V<KYD;
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M4 %%%% &+XM;&E;?[TBC]:R)6BM/#,:+DSW;9('5N?Y5L^*86ETIF49\M@Y
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M/P K5CB2% D:*B#@*HP!^%/HJU&,=D92J3G\3N%%%%49A1110 4444 %%%%
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MMNLWQ(H;0-0!&1Y#_P JVJ+W6<M%_O%Y_J<?\0O@OHGQ#D^VN[V&I%0/M=N
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MNF:WHWBCP9/=,$MY?$9N[:&0GH/,\T@9]\"O<%^%/AEU#+;7+*1D$:E<X/\
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M_@W_ +"$O_I+-75T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/VP7;X#[^GED8P:V;CP_HNM>,]0N([&XM-2L+VT!NHKDXDW@9&S&%Q[<UWK
M3?VE^/\ 7];GB2SJE%_PW:U^G=)==FWZ^1\^AR!\KD#V- E8_P#+1O\ OJO?
MY/"5EX@T32[:\T:ZNX/.O0^IQ3,@M<.Q#/@8;./XN*CO-*M(M$UR$:9)K%PN
MB6[(QD8R;<D?+M&0._%/ZA):\VGH^U_ZM<E9W3;LH.][;K^:U_\ A[?=J>"^
M8_\ ?;_OHT>8_P#?;_OHTAZTE>5<^D'>8_\ ?;_OHU>T.1_[;T_YV_X^(_XC
M_>%9]7M#_P"0WI__ %\1_P#H0JX_$B*B]R7H?>T?W%^@IU-C^XOT%.K]5/YK
M"BBB@ I#TI:0]* /COX\?\E/U;Z)_P"@UY]7H/QX_P"2GZM]$_\ 0:\^K\RQ
M?^\5/5_F?T+E?^XT?\,?R1K/X6U%=#M-6$(DM+J1XH_*.]RR]<J!D#WIVF^$
M]4U2'4)(;9E^PQ">9)04?:3@;5(RWX5Z!X%^(ND>'O#FE6T]U-#>6K7;-Y<+
M':73"$$>_P"56!\6+7_A%F!U2\.OG2S;?:=C^9YOF;A^\^G?-=$:&':4G/IM
MIV7ZG#/&8Y2<(T;^]9/7:[UVVLM[]3SW1/!>I:^ZQVP@29IQ;B&XE\N3<1G[
MI'3WJO;^&+Z>_FLV5+>:)'<FX8QJP7KM)'S>V.M>P1_%GPZ9[::2\N&D^TVL
M\[FV<EBD>UV/')S^=0#XIZ):HT<FMWVKS,EVR7D]LZM")!A(AG)QGOT%:?5L
M-9?O/R_S,/[0Q]W^X?EH_P [6_(\DUSPWJ/APVHU"W-N;F$3Q@GJIZ9]#[4]
M/"NI/H=QJYMS'9P2)&QDRK$MTVJ1R/<5U'C7QG9Z]>>&;X7D^H?8X8DN+.='
M&UE(W89N&S[5W$WQ:\/Q&>:75;W68YK^*ZBL9[5U%H@!!12QVG:>1C -9QH4
M)3DG.R6VW;^M$=%3&8R%*FU1O)[Z/H]MM+KJ]/4\0>PNHF*O;3HP7<0T3 A?
M7D=/>E73KMW*K:7#, &*B%B0#T.,=*]BA^*6B6]U86E]JE[XBLY)9_ME[=6[
MJR0OTB"G+'!_#TK1'QLT$7=E=1F6UN#,4N72%B!#&I$6..<Y'':FL+0>]5?U
M\[?TS.68XU;89O[_ -5?IV[=SPLZ?=B9(C:W E<96,PMN8>H&,FK]KX3U:]T
MB[U**RE:TM9%BE;:=P<]@N,GW]*]/T3XLV2P:7)>ZO<?VE$+B.2ZN+:2?:C-
ME02K*^,?W3D5=B^*N@B[U..+6M2MK>2[M[E99(Y'\[;_ *Q0!R 3_>YXYS3C
MAL.]74_+M?N%3,,:GRQH/3U?VK/IU6J_(\6.F7H?8;.Y#[=VTP/G;ZXQT]ZC
M2TGDA>9()7A0X:18R54^YQ@5[/X>^,EE#J6O2WVISAY[P36MU<033@0C_EF%
M1U*^N"=OJ*--^*'AZ'PY>VK7MQ%)=Q3A[5K:38LC'*E0K; I]PS>]2L+0>JJ
MKKV_S*>88R+L\.^FU^JN^G3;\SQS^R[W*C['<Y8X7]P_)]N.:K,I5B""".""
M,$5[9>_&6U:6^%OK%\D1DL_LX59%"H@ E ';.#]:\N\<:I:ZUXNU:_LF+6EQ
M<-)&Q382#['I6%:C2IJ\)W_KU_JYVX3%8BO+EK4N56OU\M-EW_!F'7US^SK_
M ,DOLO\ KM-_Z&:^1J^N?V=?^27V7_7:;_T,UZ>2_P"\OT?YH^>XN_Y%Z_Q+
M\F>FT445]R?CH4444 %%%% !1110 5GZZSK8821XRTB*6C;:<%AG!K0K.UW_
M (\D_P"NT?\ Z$* .&UKXD>%] U2XT^[O=6%S;ML<(\K#/L<U2_X7!X/_P"?
M[6?SE_QKSGXD>%-;O?'&L3V^CW\\#SDI)%:NRL/4$#FN:_X0KQ#_ - '4_\
MP#D_^)K^=,PXWXCP^,JT:5!.,9-+W);)Z=3]5PW#V4U:$*DZCNTF_>6[7H>U
M_P#"X/!__/\ :S^<O^-;UGXL\.WGA:^\1'4M0M])LE=[B>>64;%098X!)./8
M5\[?\(5XA_Z .I_^ <G_ ,37JWA?P/JVN?!+Q'X>\@Z?J.H1W$,0OT>)06&
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MF-O<FSDVZD1MF'6/EN6]A71Z+H]IH.DVFGV-K!96EM&L4=O;1B.*-0. J@
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M;XDGP@O@9=.B%W+I[E!]IWAO,W1AF8,!LQ&V[/8 ^[:*^"/#/[0_Q8U'X>^
MM:UWXAZ-H5AX\U^ZTU=??184@T&"V>Y4+N=MDDLYB10TGRKZ$FN9TO\ :'^(
M.M?$WPIXEN_%<-ZFFZ-XGALK2TMUBL_%+64\:Q30IO\ O3@@#9NP8WV<,< '
MZ.$XI:_,N7]J#XA^./@WXDG\1W6@>)]/>PT+51]H^P.UG<3ZA A@\FTG<^5M
M9BAF*R*T?S YQ7KVD_M _$Y_'>GZE<>)M.F\.3?%.?P*="&E1J3:[<K*9]V_
MS%/3  /?.> #ZK\6_P#(S^#?^PA+_P"DLU=77*>+?^1F\&_]A"7_ -)9JZN@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *\K_:1_P"2:S?]?,/_ *%7JE>5_M(_\DUF_P"OF'_T*N''?[K4
M]&>QD_\ R,:'^)?F?)M%%%?FI_0 H4L> 3]!3XGEA/F1L\9'\:$K^HKT;X0^
M,;#PO'J$=WJ$.G^>R$N\4N]D'4+)&&P?]EE*GO7;6_BG3=&\,Z/>'7)+;1Y)
MKMFL9;8LU\A)PI"KM!R>^!7HTL+"I!3=2W?;36W<\'$YC5H5735%M7LGKKHW
MI[K[6_-H\'^TW60WG3YQMSO;./3.>GM0MW=!V*SS[S@L1(V3CIGFO9K/XKZ5
M'XATE'OB-(AT[RT1DD\NVN.<$A0&X'&Y>G:K^F?$OPY%XBOK]]8BMIF$"-)#
M!<)%<JOWCGYI&(_VBH/?-:1PM)_\OEO^GJ8RS'$1O?"O:_7O:WP[]?\ @:GB
M^C6FK:_>)IUC)/-++NQ$9RJMW.<G'YTW4+74='G1)IV$CQ#!@N?,PG]TE2<?
M[I_*O9]+^(WA^UND:V\0II=G'<7+W%HMI(1>[_N,"%[>^"*RKWXF6%C::E+I
M.JM!?/86\,+QQL&WJY+ $KQQWIO#45&[JZ_+MVO\NA,<?BI5++#Z:;I[MVU?
M+;;71/3KV\;VDD\$D>U!&#@\&OI;0-1_X2EYM0T"_:W5;Z"2]N(+<L;E0@W(
MR@9 SU+ +[UX)XXGCN?&.M2Q.LD;W<A5U.01GM6&(PJHP4U*]_Z[G9@LQEBZ
MLJ4H<KBM=7=>3T7Y_<8=7M#_ .0WI_\ U\1_^A"J-7M#_P"0WI__ %\1_P#H
M0KBC\2/6J?!+T/O:/[B_04ZFQ_<7Z"G5^K'\UA1110 4AZ4M(>E 'QW\>/\
MDI^K?1/_ $&O/J]!^/'_ "4_5OHG_H->?5^98O\ WBIZO\S^A<K_ -QH_P"&
M/Y(ZKPS\.K_Q1IHOH+W3K.!K@6J_;;@QEY".% VG.:OI\&?$SZ9<7OV>$"$O
M^Y,A\QPIPS+A<8^I!]JR-)\:7.D:3;6$=O"\<%\M\KN6R6'\)QVK<O\ XQ:G
MJ.GS6\UE:EV+^7-YDO[H,<D! P5L=BP)%:P^JN/OWO;\?N.:L\R53]U;EO\
MA]Z^?X%*/X6:S+J%[9J]GYUH(6D)E;;^\QMP=O/7FIY/A)J<5U<POJFC*ELX
MBFN&O"(HY2>(BVS[Y]/UJY_PN:[ E==$TY+N80B>Z5I \OEXVY&<#IV%9>G_
M !(N+674A<Z99:C:7UR+QK2X+A4E!R&4J0?P/6JMA%9)O\?.WZ7,T\S:;:2M
M;MKM?KZVOY7-7PY\&]0O-8MH-9GMM+MWNFMBCW"K-*5&6\H8(;MUJK=?!SQ
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M2X10I*JJX15 4 8K5_L;QI_T,^E?^"1O_DFC^QO&G_0SZ5_X)&_^2: +M[X
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M5HU#=VD5] 89EW1D@X!(.0<CD<T 2CI2UG?V#:>MQ_X%2_\ Q5']@VOK<?\
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>BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>aciu-20221231x20f004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &9 \L# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 45@^.[^XTOP9K5W:R&&Y@M))(Y%ZJP7@U
M\G7WC[Q'J6?M.M7LH/;SB!^0H ^Q[C4+6T!,US%"!U+N!BL*_P#B3X6TS/VC
M7;($=524.WY+DU\=SW4UT<S322GU=BW\ZBH ^I-0_:#\(V6?)GNKXC_GA;D?
M^A[:YR^_:;LUR+/19Y/1II0OZ '^=?/U% 'K]]^TIKDV?LNGV=MZ%MS_ -17
M/7_QR\8WV0-36U4]H(4'ZD$UP-% &SJ'C/7]6S]LUF_N%/\ "]PY7\LXK(9V
M?[S$_4TVB@ HHHH **** "BBB@ HKJ]-^%GBK5[&&]L]'EGMIEWQR"1 &'KR
MU8VO>&]3\,78M=4LI;*<KN"R#[P]01P?PH S:*** "BBM+3?#NHZQ97UY9VK
M3VUBH>XD! $8.<$Y/L>E &;116CH_A[4=?%T;"U:Y%K$9IMI V(.IY- &=11
M10 4444 %%%% !1110 45IZ3X;U+7+:]N+&U:XALD$EPRL!Y:\\G)]CTIMUX
M>U"RTBTU2:V:.PNV989R1AR#@\9SV- &=116DWAS4DT)-9:U8:8TODK<9&"_
M/&,Y['M0!FT444 %%%% !1110 4444 %/CFDB8,CLC#H5.,4RB@#?T_Q_P")
M-*P+77;^-1T0W#,O_?))%=)8_'GQA9XWWT5V!_SW@7_V7%>>44 >RV/[2^K1
M8%WI=K..YC9D/]:Z&Q_::TR3 O-'NH?4PR*_Z'%?/-% 'U5I_P >_!U]CS+V
M:R8]KBW;^:AA726'C_PWJ>/LVN6,A/\ #YZAOR/-?&-% 'W3#=07 S%-'(/]
MA@:EKX9M]0NK,CR+F6''_/-RO\JW+'XC^)]-Q]GUR]4#^%I2P_(T ?95%%%
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MU+[F?*]%?5']I_"K^]X5_P"_<'^%']I_"K^]X5_[]P?X4>WI?SK[T'U/$_\
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MO\*/:T_YE]X?V?C/^?,O_ 7_ )'S?17TA_PL/X'?]!CP5^=M_A1_PL/X'?\
M08\%?G;?X4>UI_S+[P_L_&?\^9?^ O\ R/F^BOI#_A8?P._Z#'@K\[;_  H_
MX6'\#O\ H,>"OSMO\*/:T_YE]X?V?C/^?,O_  %_Y'S?17TA_P +#^!W_08\
M%?G;?X4?\+#^!W_08\%?G;?X4>UI_P R^\/[/QG_ #YE_P" O_(^;Z*^D/\
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MJ7W,^4**^K_.^&/_ #S\,_\ ?F#_  H\[X8_\\_#/_?F#_"C^U,!_P!!$/\
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M$5?&9[_%AZ?J?K'!W^[5?\7Z!1117S1^@!1110 4444 %%%% !1110 4444
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M]9OY"N[ _P"]4_5'CYQ_R+J_^%_D?,W[57_)P7C3_K[7_P!%)7E%>K_M5?\
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M/-EA<@!D!ZG@>E.\*_M#>&/%VN6.FP6FMV":B6&FZCJ6F2VUI?D G$,K##'
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MJ,C$*X!!V-@X^E<E?_ OQ?\ $&7Q1-XWU;1UEUO18-.1-(CD:*TDBG:50%<
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M.M/\'?M P>*]4T*&;POK&C:=KB,=/U.]$8AG=5+,N Q8<*Q!( (&17GO@?\
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MM&BOS>^%H"\@N7 ;;/*L;M&BJ1CY<,3U&*L:5\//C%?^#K;P9K&I^#](\/\
MV1;">^T?[5->F$*%8*)%5 S+D;NV<X-=9XD\"^,_#VHVE_\ #O5=,CACLXK"
M30_$!F-GLC!"21M'ED< X( PW&3Q0!B>$M"U+XA^ 6M-.^(UGXJT-;\/!J%S
M;&XEN+<*";:[$;Q$D,<GD%A@,,$@^OZ-:W-EIEO!>2VTT\:A6>SMS!%QTVQE
MW*C';<:XSX5^ =6\+7.OZUXAO;*Z\0:]/'<7<6EQ-':0[$V*J!OF8XZNV"?3
MBO0*!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% '+?%+_DG'B3_KPE_P#037SC\#+_ $GPYJ6K>(-3N[:*33[1S;6\
MLJK),Y!X12<DX&./6OH[XI?\DX\2?]>$O_H)KXBKY/-JOL<33J)7:1^F\,X=
M8O+Z]!NRE+7TLK_?L>^^"OC9H^LZ]-I^H>'])T&TU17CN[Z(K&6R#]]L#/)/
M)/>L#1[C2]#^&OQ T7^UK&29KM$M=MPA-P@=<,@S\PP,\5Y#17B_7ZDDN=7:
MNK[:-6Z?>?5_V-0A)NDW%-Q=M]8NZ>OW'T(-/TSP_P##9="\,>*/#T-_J W:
MC>W6I1HY!'*+C) [8[<]R:Y6UN['1?@MXGT5]6L)M0_M!-D=O<JWG*"F60=6
M7@\@=J\ML=.NM4N!;V=M-=SD$B*",NQ_ <U)_8U_]EGN?L-S]GMW\N:;R6V1
MM_=8XP#[&JEBW+6,+:./E:W],B&61A>-2K=N2F[I7;3TOY=%^!ZI#XMTW2/A
MW\/'-S;W-QIVI/<7%FDJF5%$K')7.1QR,UVVI^.M,TR_U;Q!::KX6%M+"6MC
M:VH;49F8?<D (8<]2:^::*<,PG!62[?@K"JY)1JRYG)ZN5]MI2YK?\$]MM?$
M6E_\([\+HVU*S66SO7>Y3SUS "^<N,_*/K5R+Q-I*ZU\5Y!JMF%O;9UM7^T)
MB<E",(<_-^%>#45*Q\E;W=O_ )'E+>34W?WWK?\ &?/^>A[E:>-](T+PC\-Y
MI+NWN)-/NG:YMXI%>6)2",E1R.M;NN^-=-T:/Q%JMMJOA<Q7J,MJNFVH:^N-
M_.V;# CW)[\]>*^<**M9C42LEV_!6,Y9%1G+F<GN[[:IRYK??U['J7CS6[&\
M^$7@JQM[ZVFNH-YGMXY5:2/KC<H.1^-<K\-M4AT;QC87<^IR:.B,1]L2(2!"
M1CYE/53T-<O17'+$2E4C5MJK?@>I3P4*>'GA[Z2<GT^TV_3KU/H+QUXFT;4?
M!>KIX@NO#VHZJZ[;";0Y-\S-G@OC[@[D$XZUR'[-O_)38O\ KUF_D*\LKU/]
MFW_DIL7_ %ZS?R%=]+$/$XNE)JUFOSZGBXG QP&5XB$97NF_):=%T/F;]JK_
M )."\:?]?:_^BDKS71-0&DZS87S(9%MKB.8H#@L%8''Z5Z5^U5_R<%XT_P"O
MM?\ T4E>45T5M*LO5_F?IF5)2RW#Q?6$?_24=]\<OB5!\6_B3J7B>VL9-.AN
MTB46\KAV7:@7J /2MCX>?&73]%\ :IX%\5Z)+KOAB\G6[C%K<>1<6TPQ\R,0
M1SCN/7UKRFBE[6?.YWU9J\NPSPT,)R^Y"W+J[KEV:>]UWN>U>(?VD[I=5\%#
MPII2Z#H?A%M^GV4LIF:5C]\RMQG<"P./[QJQXB^-W@2_N/$>M6/P]23Q/KD1
M2275IDN[2U=OOR0Q%.&SR"2<=L<YH_#W]F?4O'7@2W\67'BCP_X9TNXN)+>%
MM:N3!YA0X)!Q@\Y'7/!KG/B]\%=8^#MWIBZA>6.J6.IPF:SU#39?,AF48W8)
M Z;A^==#E74>=K3Y>GR/!I4LFJ8A86E+]Y&ZLG)-V?-)-_:UNW=OKYG4Z=\;
M_#.J?"SP_P"$/%WA>[U5O#\SRV-S8WHMPP8DE) 5.0<X.,'@<BM?QG^T[I7B
MKXC^'/$;^"K*\T[3=,&G3Z5JBI<1N-S'<A93M(R,'KQ7S]6_X"\&WGQ"\8Z3
MX<L)(XKO49Q!')-G8F>2S8!.  3Q6:KU7:*\NG;8[ZF49?2YL14327.W[TK+
MFUDTKZ7WT/6M;_:-TRR^&^M>$?"FEZS;6VKLOF/K>J&\6U0'.R!=HV#]>G7
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M"5.02.GTIU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK_0,_F(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQAT8JP]".M,I7=I'9F)9F.23W-)7EGZ,O,****!GWI_P3Q_Y)YXH_P"PJO\
MZ)6J/C[_ )'C7_\ K_G_ /0S5[_@GC_R3SQ1_P!A5?\ T2M4?'W_ "/&O_\
M7_/_ .AFO@/$C_D4X/\ Q/\ )GX]AO\ DH\=\OT,&BBBOYX/K@HHHH ****
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MGF*K'@-LW8]\5J_"_0/&7Q0^.VI_$_Q#X5N_!NGVFDG2[*POLBXF)W9)4@'
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MG\=EN5PR7ZQ1LJL6MY7<O>:=K2:VLW%PBTE>[3U^@J***]4_.PHHHH ****
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#[T_X)X_\D\\4?\
M857_ -$K5'Q]_P CQK__ %_S_P#H9J]_P3Q_Y)YXH_["J_\ HE:H^/O^1XU_
M_K_G_P#0S7P'B1_R*<'_ (G^3/Q[#?\ )1X[Y?H8-%%%?SP?7!1110 4444
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M)?\ T$U\15\9GO\ %AZ?J?K'!W^[5?\ %^@4445\T?H 4444 %%%% !1110
M4444 %%%% !7J?[-O_)38O\ KUF_D*\LKU/]FW_DIL7_ %ZS?R%=V!_WJGZH
M\?./^1=7_P +_(^9OVJO^3@O&G_7VO\ Z*2O**]7_:J_Y."\:?\ 7VO_ **2
MO**].O\ Q9>K_,^ZRC_D78;_  0_])04445B>L%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 ?>G_!/'_DGGBC_ +"J_P#HE:H^/O\ D>-?
M_P"O^?\ ]#-7O^">/_)//%'_ &%5_P#1*U1\??\ (\:__P!?\_\ Z&:^ \2/
M^13@_P#$_P F?CV&_P"2CQWR_0P:***_G@^N"BBB@ HHHH **** "BBB@ HH
MHH **** /MNBBBO] S^8@HHHH **** "BJNJ:E;Z-IMU?W<@BM;6)II9#T55
M&2?R%9O@GQEIGQ \,6.OZ1(\FGWBEHS(NUU(8JRLO8@@@CVH W**Q?$'BVP\
M-7NBVMYYOFZO>"QMO+3</,*,_P WH,(>:VJ "BBB@ HHHH **** "BBN?TWQ
MQINM?V9)IBW.I6E_-/ EY;6[-#$T)8/YC8^0;D903U/ ZT =!1110 4444 %
M5_[0M1>_8_M,/VO;O\CS!YFWUV]<>]6*\J\17.C77Q9\/VVG36#:S;WYEU"Q
MCA\N^*FV<+.6)W-" 57A=I) W94K0!ZK1110 4444 %%%4-*U==5>^5;2[M?
MLEPUL3=0&,2D '?'G[R'=@,.,@^E %^BBB@ HJC=:JMKJEC8FUNI6NUD83Q0
MEH8M@!Q(_12<\9ZX/I5N65((GED8+&BEF8]@.IH ?15+1=8L_$.DVFIZ?,+F
MQNXUFAF4$!T(R#SS5V@ HK(TGQ/9:SK&L:;;^9]ITJ6.*XWKA=SH'&T]^"*G
MUK7K#P];0SZA<+;137$5K&S G=+(X1%X]6(% &A1110 445GZ#K]AXFTR/4=
M,N5N[*1G5)E! 8JQ5NONI% &A1110 4444 %%8:>,=/D\:R>%AYO]J1V U%O
MD_=^49#&/FSUW#I6Y0 444G2@!:*QO"'BNQ\;:#!K&F^8;.9Y8U\Y=K9CD:-
MN/\ >0ULT %%%% !1110 45GZEKMAH]SI]O>7"PS7\WV>V0@DR2;2VT8]E)Y
M]*T* "BBB@ HHHH **** "BBB@ HHHH Y;XI?\DX\2?]>$O_ *":^(J^W?BE
M_P DX\2?]>$O_H)KXBKXS/?XL/3]3]8X._W:K_B_0****^:/T **** "BBB@
M HHHH **** "BBB@ KU/]FW_ )*;%_UZS?R%>65ZG^S;_P E-B_Z]9OY"N[
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MP00?E'88H^%OPFB\"Z3J\6HG3[ZZU:57NH;*P2VLE14")%' ,@* #UR3DYH
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M3#>3V$^F229_T:Y&)% ..1VS7EEYX1O]%_X5U8O!)<M:7&ZX>-"ZQDN&.3V
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M8W8\<>HSW%>@S2B&&20C(12V/H*\O\?:7<S^$?!\4%I-*\-U;%T2,L4 3DD
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M_0A^)_\ P3W'_P 11[.?9A]=PO\ S]C_ .!+_,XRBNS_ .%*?$/_ *$/Q/\
M^">X_P#B*/\ A2GQ#_Z$/Q/_ .">X_\ B*/9S[,/KN%_Y^Q_\"7^9QE%=G_P
MI3XA_P#0A^)__!/<?_$4?\*4^(?_ $(?B?\ \$]Q_P#$4>SGV8?7<+_S]C_X
M$O\ ,XRBNS_X4I\0_P#H0_$__@GN/_B*/^%*?$/_ *$/Q/\ ^">X_P#B*/9S
M[,/KN%_Y^Q_\"7^9QE%=G_PI3XA_]"'XG_\ !/<?_$4?\*4^(?\ T(?B?_P3
MW'_Q%'LY]F'UW"_\_8_^!+_,XRBNS_X4I\0_^A#\3_\ @GN/_B*/^%*?$/\
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M_A?/@O\ Z"<G_@++_P#$T?\ "^?!?_03D_\  67_ .)KY2HH ^K?^%\^"_\
MH)R?^ LO_P 31_POGP7_ -!.3_P%E_\ B:^4J* /JW_A?/@O_H)R?^ LO_Q-
M'_"^?!?_ $$Y/_ 67_XFOE*B@#ZM_P"%\^"_^@G)_P" LO\ \31_POGP7_T$
MY/\ P%E_^)KY2HH ^K?^%\^"_P#H)R?^ LO_ ,31_P +Y\%_]!.3_P !9?\
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M:WI'B:30/"?@V?QAJ5K EU??Z?'9Q6\;DA1O<'<YVD[0.G>K'A3XP6OB^_\
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M0Y''% '0_#GXF>(?&FHA-5\!ZAX;TRZM_M>GZC+=1SK-'D8$JKS#(0P(4[N
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MT?\ "T/AC_SZVO\ X+/_ +&@#YKHKZ4_X6A\,?\ GUM?_!9_]C1_PM#X8_\
M/K:_^"S_ .QH ^:Z*^E/^%H?#'_GUM?_  6?_8T?\+0^&/\ SZVO_@L_^QH
M^:ZWO%?C*]\8-8->QP1FRMUMH_(4C*CH3DGFO=O^%H?#'_GUM?\ P6?_ &-'
M_"T/AC_SZVO_ (+/_L: /FNBOI3_ (6A\,?^?6U_\%G_ -C1_P +0^&/_/K:
M_P#@L_\ L: /FNBOI3_A:'PQ_P"?6U_\%G_V-'_"T/AC_P ^MK_X+/\ [&@#
MYKHKZ4_X6A\,?^?6U_\ !9_]C1_PM#X8_P#/K:_^"S_[&@#YKHKZ4_X6A\,?
M^?6U_P#!9_\ 8T?\+0^&/_/K:_\ @L_^QH ^:Z*^E/\ A:'PQ_Y];7_P6?\
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MD_L]);"VMF0NA0F62-0\QVGJQZ\UZ]10,**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .:^)?_ "3_ ,0_]>4O
M_H)KXVK[)^)?_)/_ !#_ ->4O_H)KXVH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBO5/@W;V_B71O$GAJ:.(W%U;F:VD= 61
MP,<'KUVG\* /*Z*]6^&>EQ>'O"7BKQ)J%NC26\9L[=)D!Q(>O![YVC\ZQ/#O
M@'2=8@TO[;XEAM;_ %.39#:6\0G*$G \PAALSZ8H X2BO7?AYX7_ +!\1^,]
M+O4AN9;/390'*@C/&&&>E<9=>"5MOA[:>)_MA9I[O[+]E\O 7ACNW9_V>F.]
M '*T5W]W\)KD1>%18W?VJYUV(2"-H]@A&T,<G)R ">PZ5<U;X06D.GZF^D>(
MX-6O],4O=V:PE"@'7!R<XYH \THKTFS^$EM'H^DWNK:R^G?VE&)8G%H7@B##
M*^9+N 7.17 ZK8?V7J5S:>?#="%R@FMW#QN/52.HH J4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'W=1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S7Q+_Y)_P"(?^O*
M7_T$U\;5]D_$O_DG_B'_ *\I?_037QM0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %=)\//$O\ PB?C#3=18D0)($F_ZYMPWY Y
M_"N;HH ]B^-/BS1I='L]&\/74-S;3W,E[=- V1O)X!^I)/X"MCPUXIT#2-(\
M-R:3K.FZ+;Q*G]J1R0DW<K#&0#@D@G/.> <BO!:* /;+7Q1H\/Q"\<7;:E;?
M9;RP=+>82#;(Q484'UK.\+WOAWQ-\+%\.ZGK<>B75M=_: \R;MPYZ#(SP2.M
M>244 >\ZS\0?#_A_5/ \^FWJZA8Z=$UO+L_UB(4";B.Q[X]J3QEXMM(M,U6Y
M@^($^H)<J1:Z9;11Y7<#\KD@_+S[5X/10![IX&\9QZ5H^CI9^++2.QC0+>Z?
MK(_>1>JQ%5^8=<9/I]*\K\?:CINK>,-3N](B$.G229B54V@\ $@=@2"?QKGZ
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M ^[J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#)_A1_PC&C_] FQ_\!D_PK3HH S/^$8T?_H$V/\ X#)_A1_PC&C_ /0)L?\
MP&3_  K3HH S/^$8T?\ Z!-C_P" R?X4?\(QH_\ T";'_P !D_PK3HH S/\
MA&-'_P"@38_^ R?X4?\ ",:/_P! FQ_\!D_PK3HH S/^$8T?_H$V/_@,G^%'
M_",:/_T";'_P&3_"M.B@#,_X1C1_^@38_P#@,G^%'_",:/\ ] FQ_P# 9/\
M"M.B@#,_X1C1_P#H$V/_ (#)_A1_PC&C_P#0)L?_  &3_"M.B@#,_P"$8T?_
M *!-C_X#)_A1_P (QH__ $";'_P&3_"M.B@#,_X1C1_^@38_^ R?X4?\(QH_
M_0)L?_ 9/\*TZ* ,S_A&-'_Z!-C_ . R?X4?\(QH_P#T";'_ ,!D_P *TZ*
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MS_A&-'_Z!-C_ . R?X4?\(QH_P#T";'_ ,!D_P *TZ* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>aciu-20221231x20f005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &8 ZX# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\V-=P.#RN11:?=?=_P $.?"?R2_\"7_R W_A>'@#_H<-&_\  M:/^%X> /\
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M54*1$Y'#L*+3[K[O^"'/A/Y)?^!+_P"0-;_A>'@#_H<-&_\  M:/^%X> /\
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MPO#P!_T.&C?^!:T?\+P\ ?\ 0X:-_P"!:UVOE+_='Y4>4O\ ='Y46GW7W?\
M!#GPG\DO_ E_\@<5_P +P\ ?]#AHW_@6M'_"\/ '_0X:-_X%K7:^4O\ ='Y5
MYSX__: ^'_POUM-(\2ZR]AJ#PB?R8].N;C$9.-Q:*-@H^I%%I]U]W_!#GPG\
MDO\ P)?_ "!H_P#"\/ '_0X:-_X%K1_PO#P!_P!#AHW_ (%K4,GQO\ PV\5P
MWB.R%K+IQU5+D!C$;4':9-X7;UXQG.>U,\'_ !V^'_CO3-4U#1_$=K-:Z8GF
MWK7,;VK0)V=EE56"GLV,'L:+3[K[O^"'/A/Y)?\ @2_^0+/_  O#P!_T.&C?
M^!:T?\+P\ ?]#AHW_@6M4?!/Q^^'?Q$U"ZL=!\26UU=VT33R130R6Q,8ZR+Y
MJ+O0?WER/>JWAW]H_P"&?BS79-&TKQ1;7>H*'*Q_9Y46;;G=Y3L@64C!X0M1
M:?=?=_P0Y\)_)+_P)?\ R!K_ /"\/ '_ $.&C?\ @6M'_"\/ '_0X:-_X%K2
MM\8/!B^%-.\2?VO&='U"Y6TMIUMY"TDS,5"; N\'(/4<=ZYW0OVG_AEXE\11
M:'INNSW6HRSM;HBZ1>",R+G(\PP[!C!Y+8HM/NON_P""'/A/Y)?^!+_Y Z'_
M (7AX _Z'#1O_ M:/^%X> /^APT;_P "UKF=)_:K^%.MZ[#I%KXG'VV:<VL?
MGZ==0Q/*#C8)7B"$Y&/O<UT)^-?@<:))JIUE%M(]0&E,#;2B471;:(O*V;]V
M?]G&.>E%I]U]W_!#GPG\DO\ P)?_ "!+_P +P\ ?]#AHW_@6M'_"\/ '_0X:
M-_X%K7:*B.H8*,$9Y7!I?*7^Z/RHM/NON_X(<^$_DE_X$O\ Y XK_A>'@#_H
M<-&_\"UH_P"%X> /^APT;_P+6MSQCXMT7P!X;O=>UZZ6PTFR4//<&)I-@) '
MRH"QY(Z UPFE_M/?"_6=#UG5K7Q*C6>CQI+?>987$4L*,<*WE-&'(). 0IHM
M/NON_P""'/A/Y)?^!+_Y W_^%X> /^APT;_P+6C_ (7AX _Z'#1O_ M:P_#?
M[2_PR\6QZD^F^(E<Z=;->7,=Q87-O(L*_>=4DC5G _V0:E\$_M&?#KXAW\MG
MH6MR7$L4#73O<:9=6L2Q+RS&26)4P![T6GW7W?\ !#GPG\DO_ E_\@:__"\/
M '_0X:-_X%K1_P +P\ ?]#AHW_@6M97A?]HSX:>,]:FTG1_$]M=7\<;RB-H)
M8A*B_>:)G0+*!C^ M70?\+-\*CP"_C3^TD_X1E(3<-?>1)@)G&=FW=U]J+3[
MK[O^"'/A/Y)?^!+_ .0*G_"\/ '_ $.&C?\ @6M'_"\/ '_0X:-_X%K3(?C/
MX'G'B$QZW"Q\/PK<:DGDR;K>-EW!MNW+ C^[FDG^-?@2UL=5O+C7[:VMM+CA
MENY9XW01B50T>,K\Q8$85<GMC-%I]U]W_!#GPG\DO_ E_P#($G_"\/ '_0X:
M-_X%K1_PO#P!_P!#AHW_ (%K3? GQH\#_$NTU"X\.ZY!?+IZ[KN.2&2"6!<$
M[FCE57 P#@XP<4>&/C/X(\9>$=4\3Z-K<5]H>F&07ETD$B^3Y8R^5*AC@<\#
MGMFBT^Z^[_@ASX3^27_@2_\ D!W_  O#P!_T.&C?^!:T?\+P\ ?]#AHW_@6M
M=5I&I66O:7:ZC8NL]G=1K-#+L*[D89!P0"./6K?E+_='Y46GW7W?\$.?"?R2
M_P# E_\ ('%?\+P\ ?\ 0X:-_P"!:T?\+P\ ?]#AHW_@6M=KY:?W1^5>6+^T
MY\,#XN;PRWB18M8%X;#RYK"XCB^T9V^7YS1B/=G@?-S1:?=?=_P0Y\)_)+_P
M)?\ R!O?\+P\ ?\ 0X:-_P"!:T?\+P\ ?]#AHW_@6M/G^+?@ZV\-ZGKTNJHN
MDZ;=FPN[C[/)^[G$@C*;=NX_,0,@$>^*=XA^+7@WPIXGT'P]JVLP66LZYSI]
MJ\3DS_B%(7H0-Q&:+3[K[O\ @ASX3^27_@2_^0(O^%X> /\ H<-&_P# M:/^
M%X> /^APT;_P+6JGCOX\?#[X9ZU!I/B7Q#;Z;?RH)/*,$DOEH3@-(R(PC4^K
MD"L[Q=^TK\-? VMG2-7UYH]0$,=P8K33+J['EN-R-NAB=<$<]:+3[K[O^"'/
MA/Y)?^!+_P"0-S_A>'@#_H<-&_\  M:/^%X> /\ H<-&_P# M:Z6#7-,N-#3
M6!<1Q:8\(N/M-P/)58\9W-O *C'KC%5?!WB[0_'_ (?MM;T"\34=*N=WE7*1
MLH?!*G 8 ]0>U%I]U]W_  0Y\)_)+_P)?_(&)_PO#P!_T.&C?^!:T?\ "\/
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M&L_$\B1:1)Y$G^DLR%U&-N5RJD_-CI1:?=?=_P $.?"?R2_\"7_R!7_X7AX
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M:Z7X<?%OP=\6H+V7PKJ\>I_875+J)K>2":$L"5W1RHK@$ X)&#@T6GW7W?\
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MW6WNKSY,>8T0)9>> 'YX%:/_  LNT_Z GB/_ ,$ES_\ $T?\++M/^@)XC_\
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MC\CQ9X?2RL8&4*"(Y1&I)&" "3D5Z_\ \++M/^@)XC_\$ES_ /$T?\++M/\
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M#*)"=KLO"\>M>K#XIV#,RC2/$)*G!']BW'!_[YI?^%H6/_0'\1?^"6Y_^)H
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MQG\.=:\'"\^)C:C=:$T$-OXJT!+'3HY%"G8LPC4Y."HRW(/-?3?_  M"Q_Z
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M4BB1I)7M955%&2Q*$  5SLGQ5T^)=SZ1XA5<@9.BW'<X'\/O3O\ A:%C_P!
M?Q%_X)+G_P")H \#^$?P!\4O\//"&M^+/$>H7LN@:'<?V3X8;28[1[&:6V:(
MI(PS)*0I*@,!SS6!X0^$'C/0-"^ FH7VJ^)]5@LKV"6\T&[L8Q%I"BTDR2$C
M$B[3A!O)^]CK7TW_ ,+1L?\ H#^(O_!)<_\ Q-'_  M"Q_Z _B+_ ,$MS_\
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MJ$JN[=<Z5/$IY X++UYZ4 >=6H_<CZM_Z$:FQ45K_J1]6_\ 0C4M !BC%%%
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M:\(Z;X(CNO#>K>'K_78M;^W6^M1S(5M/L\#%GM@C;7<D(3R/FXH ]_\ @?\
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M#TW%&*\SD_:6^&,*Z,TOC/3(5UC/V(RNR>:H;;OY7Y4W<!VPIR,$U>U+X]>
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M)_Z'O7__  .:C^U*?\K#_B'F-_Y_P_'_ "/U"X]J./:OR]_X7Y\2?^A[U_\
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MVK_PP!H7_0YZK_X!0_XT?\, :%_T.>J_^ 4/^-']GXC^7\4'^NN2?\_7_P"
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M/5?_  "A_P :/[/Q'\OXH/\ 77)/^?K_ / 9?Y'Q517VK_PP!H7_ $.>J_\
M@%#_ (T?\, :%_T.>J_^ 4/^-']GXC^7\4'^NN2?\_7_ . R_P CXJHK[5_X
M8 T+_H<]5_\  *'_ !H_X8 T+_H<]5_\ H?\:/[/Q'\OXH/]=<D_Y^O_ ,!E
M_D?%5%?9R_L$:&U[+!_PF.J81%?/V*'G.??VJ?\ X8 T+_H<]5_\ H?\:/[/
MQ'\OXH/]=<D_Y^O_ ,!E_D?%5%?:O_# &A?]#GJO_@%#_C2?\, :'CCQGJH/
M_7C#_C1_9^(_E_%!_KKDG_/U_P#@,O\ (Q?V#?!NJ)=Z]XH::6#2'C%BD/\
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M+J4V=8BL+>RO]0L;^73V6WU>*RS]J-FV?WI3:>"%S@E<@9H ]KV:M_SUL_\
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MP#_AM_X:?]1W_P %O_V='_#;_P -/^H[_P""W_[.I^M4/YT;?ZN9O_T"S_\
M 6>_T5X!_P -O_#3_J._^"W_ .SH_P"&W_AI_P!1W_P6_P#V='UJA_.@_P!7
M,W_Z!9_^ L]_HKP#_AM_X:?]1W_P6_\ V='_  V_\-/^H[_X+?\ [.CZU0_G
M0?ZN9O\ ] L__ 6>_P!%> ?\-O\ PT_ZCO\ X+?_ +.C_AM_X:?]1W_P6_\
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M_9T?6J'\Z#_5S-_^@6?_ ("SW^BO /\ AM_X:?\ 4=_\%O\ ]G1_PV_\-/\
MJ._^"W_[.CZU0_G0?ZN9O_T"S_\  6>_T5X!_P -O_#3_J._^"W_ .SH_P"&
MW_AI_P!1W_P6_P#V='UJA_.@_P!7,W_Z!9_^ L]_HKP#_AM_X:?]1W_P6_\
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M;?\ AI_U'?\ P6__ &='UJA_.@_U<S?_ *!9_P#@+/?Z*\ _X;?^&G_4=_\
M!;_]G1_PV_\ #3_J._\ @M_^SH^M4/YT'^KF;_\ 0+/_ ,!9[EJ__'BW_72/
M_P!&+5T]:X/P3\5O#_Q<\*7&J^'IYI((;I()8[F+RI8W#H>5R>"#D'O7>'K7
M1&2FN:+NCPJU&IAJDJ5:+C);I[H****HQ"BBB@ HHHH ****  ]*IZ=UO/\
MKZD_I5P]*IZ=UO/^OJ3^E %RBBG-&Z#+(RCU*D4 ,"A1@  >@%! 8$$9!Z@T
MM%   !VHHHH **** "K6G?ZYO]VJQ!4X((/N*LZ=_KF_W: /+;7_ %(^K?\
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M8U/Y7]S#^T\!_P _X?\ @4?\SSNBO1/^&=_B=_T(FN?^ W_UZ/\ AG?XG?\
M0B:Y_P" W_UZ/8U/Y7]S#^T\!_S_ (?^!1_S/.Z*]$_X9W^)W_0B:Y_X#?\
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MV(NK5SEH9O)=?,3/.&S@YQU-=K_8%G_=E_[_ ,G_ ,51_8%G_=E_[_R?_%4
M<7;_  "\&6VB7FDIITILKQ[%YT:ZD)<6BQK;KG.=JB-<KT.6SG<:S;S]F/P%
MJ$.K075C?W-OJ0OUF@EU.X9$6\96N5C&_P#=ARF<+C&Y\8W&O1O[ L_[LO\
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MO_?^3_XJ@#1HK._L"S_NR_\ ?^3_ .*H_L"S_NR_]_Y/_BJ -&L_2P1/?_\
M7?\ ]E6D_L"S_NR_]_Y/_BJHZ;H=FTU\"DG$^/\ 7R?W5_VJ .5\9?!^#Q5X
MTEU1WC.F:II,NC:S:F1XY)H"=\;1NO1E8$=N';G.*NZG\$O"6KQ:O'<V$I35
M+.VL+E4N9%#6\&?+C&#\J\G('7O75_V!9_W9?^_\G_Q5']@6?]V7_O\ R?\
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M;!#X<GM8I-F7'RR-'O!4QY)F60HK?+G(Y /J>BOE[]M37OBM\./#L/C+P/\
M$6T\/:8ES8Z:^BW'AV&]+R3W*Q&;SW<$8$@.S;SMZC/&AXP_:9M_V8=-TG0O
MB9?ZMXSU58UEOO$UAI5MIUL5DF*1[86G!D89 *0>8P W$#- 'TC17B/BG]K3
MPGX3L?B)=W6FZQ-%X(O[+3[_ ,B*(F9[E4:-H<R#*@2#.[:>N :]M5MP!]:
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MK_GZG_[^M_C1_:%U_P _4_\ W];_ !JO11[>K_._O8>SAV18_M"Z_P"?J?\
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M72VFN>(;.ROF&5LE+37!_P"V2!F_2NIL+Z'4[&WO+9R]O<1K+&Q4J2K#(R"
M1]#S4*<9-Q3U1U5,+B*-.-:I3DH2V;32?H]G\B>BO'O&?[36@>'[C5+70=,U
M'QI<Z5&TNH2:0%%K9JOWO,N&.P$>@S7H/@#QE;_$+P9I'B.TMI[.VU* 3I!<
M@"1!DC!QQVZCJ,5G"O3J2<(N[1VXG*,=@\/'%8BDXPD[)NU[M76FZNM5=:K8
MZ"BBBMSR JUIW^N;_=JK5K3O]<W^[0!Y;:_ZD?5O_0C4M16O^I'U;_T(U+0
M4H."".HYI** .1N/A)X.NO"K^&I?#]H^AM>-J'V/+@+<M(96F5@VY7WDMN5@
M02<8JF?@9X!_L-=&'A:R33$OSJB01M(GEW1 !F1@X9&(')4C/.<Y-=U10!B^
M$O!>A^ ]*;3/#VEV^D:>T\ER;:V!">8YR[8).,G\*VJ** "F3_ZE_I3Z9/\
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M6U>TU?Q#JFG:U#>6KQ+)I=Y91[();?*$=.HD# Y(Z&O+?'/[;?B;X??$"_\
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M 9W]MK_SYWO_ (#FC^VU_P"?.]_\!S6CQ[4A=0P7(R>@S0!G_P!MK_SYWO\
MX#FD_MM?^?*]_P# <UI<>U'% &=_;:_\^=[_ . YH_MM?^?.]_\  <UH,RJ
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M+V/Q5\7:_8Z;XUE^($D7B6R\,ZU;V[V\EG+;7$D-Y&B/CR5$IVD$E H;:"
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MV/?_ //C=?\ ?A_\*_C#BO#UI9YBW&#:YWT9^_9+4@LNH)R7PHJ45;_L>_\
M^?&Z_P"_#_X4?V/?_P#/C=?]^'_PKY3ZM7_D?W,]KVM/^9?>5**M_P!CW_\
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MN03!)@X..M24R?\ U+_2@#U86-__ -!(_P#@.M+]AU#_ *"1_P"_"UHCI2T
M9OV'4/\ H)'_ +\+1]AU#_H)'_OPM:5% &;]AU#_ *"1_P"_"T?8=0_Z"1_[
M\+6E10!F_8=0_P"@D?\ OPM'V'4/^@D?^_"UI44 9OV'4/\ H)'_ +\+1]AU
M#_H)'_OPM:5% &;]AU#_ *"1_P"_"T?8=0_Z"1_[\+6E10!F_8=0_P"@D?\
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MAS4>I_$_PAH^L76CW?B?1X=9MK=KJ72WOX1=+$ 27,1;=C /.,4 :OV'4/\
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M%_>,/^?FR_\  -:/[;PW9_<O\P_U1S#O'[W_ )'T]O;^\WYT;V_O-^=?,/\
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M0;35K2WOK6WN5+1Q:C9R6DX&2,M%(JNN<9&0.,&M:@ HHHH **** "L_2_\
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M/^_J_P"-']JV7_/W!_W]7_&@"W153^U;+_G[@_[^K_C1_:ME_P _<'_?U?\
M&@#Y,_:"_P"2FW__ %SC_E7F]?07Q(^$>H>/_&5_JEAJ-C%;G9'B4L3D#_9!
M%<S_ ,,VZ[_T%=-_*7_XFOA<9@,34Q$YQA=-G[+E6<Y?0P-&E4JI244FM?\
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MW7?^@KIOY2__ !-']FXO_GV_P#^WLL_Y_+\?\CR.BO7/^&;==_Z"NF_E+_\
M$T?\,VZ[_P!!73?RE_\ B:/[-Q?_ #[?X!_;V6?\_E^/^1Y'17KG_#-NN_\
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M^(_'DOA:^AOO TNG:I86*)8MJ.M6UQ_:$P7;F1HON<@,Q]SBO1$18D5$ 5%
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M#6G?^!D?_P 57QAM7^Z/RHVK_='Y5S_V[/\ Y]K[SN_U-H_\_G]R_P S[/\
M^$LT/_H-:=_X&1__ !5'_"6:'_T&M._\#(__ (JOC#:O]T?E1M7^Z/RH_MV?
M_/M?>'^IM'_G\_N7^9]G_P#"6:'_ -!K3O\ P,C_ /BJ/^$LT/\ Z#6G?^!D
M?_Q5?&&U?[H_*C:O]T?E1_;L_P#GVOO#_4VC_P _G]R_S/L__A+-#_Z#6G?^
M!D?_ ,51_P )9H?_ $&M._\  R/_ .*KXPVK_='Y4;5_NC\J/[=G_P ^U]X?
MZFT?^?S^Y?YGV?\ \)9H?_0:T[_P,C_^*JI?>*=%:6S(UC3R!,"<7<? P?\
M:KX[VK_='Y4NT>@_*C^W9_\ /M?>'^IM'_G\_N7^9]G?\)9H?_0:T[_P,C_^
M*H_X2S0_^@UIW_@9'_\ %5\8;5_NC\J-J_W1^5']NS_Y]K[P_P!3:/\ S^?W
M+_,^S_\ A+-#_P"@UIW_ (&1_P#Q5'_"6:'_ -!K3O\ P,C_ /BJ^,-J_P!T
M?E1M7^Z/RH_MV?\ S[7WA_J;1_Y_/[E_F?9__"6:'_T&M._\#(__ (JC_A+-
M#_Z#6G?^!D?_ ,57QAM7^Z/RHVK_ '1^5']NS_Y]K[P_U-H_\_G]R_S/L_\
MX2S0_P#H-:=_X&1__%4?\)9H?_0:T[_P,C_^*KXPVK_='Y4;5_NC\J/[=G_S
M[7WA_J;1_P"?S^Y?YGV?_P )9H?_ $&M._\  R/_ .*H_P"$LT/_ *#6G?\
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MNH;AP\D,A"9V;@"-I5AC[U>K?:]1_P"?"+_P)_\ L:/M>H_\^$7_ ($__8T
M?*OB/]E#Q(WC?3-*T+;9>"86TXO>#7I5,B6A^7[19^21-*  JNLB*1]]3@5[
M1)^S;X-N;#3K*ZCO;NTLC?E(9KCA_M>_S@V "?OG;C&.*]"^UZC_ ,^$7_@3
M_P#8T?:]1_Y\(O\ P)_^QH \KT_]EOP_8:=?QGQ+XNN=6N$ABAUV766^WV<4
M3;HHH9%4 (I R&5MV/GW5&W[)_A)[&SA;4M>:ZCDNI;J^-\IGOVN$"2F<[-I
MR%7[JKC:,5ZQ]KU'_GPB_P# G_[&C[7J/_/A%_X$_P#V- 'GFC_LZ>'= \6V
MVMV&J^(;:*)H9I-(BU1TL+B>.,1I/)$ "S[5&1G:< E37JM9OVO4?^?"+_P)
M_P#L:/M>H_\ /A%_X$__ &- &E16;]KU'_GPB_\  G_[&C[7J/\ SX1?^!/_
M -C0!I45F_:]1_Y\(O\ P)_^QH^UZC_SX1?^!/\ ]C0!I45F_:]1_P"?"+_P
M)_\ L:/M>H_\^$7_ ($__8T :5%9OVO4?^?"+_P)_P#L:/M>H_\ /A%_X$__
M &- &E16;]KU'_GPB_\  G_[&C[7J/\ SX1?^!/_ -C0!\I_M @GXFW_ !_R
MSC_E7G&#Z&OKS4/!&B>)=7OKS6-$M;B\\P)OD)<X X&1BH?^%4>#_P#H7;'_
M +Y;_P"*KY/$Y/6K5I5(R5F_/_(_2\!Q3A<)A:="=.3<4EI;_,^2<'T-&#Z&
MOK;_ (51X/\ ^A=L?^^6_P#BJ/\ A5'@_P#Z%VQ_[Y;_ .*KF_L.O_,OQ_R/
M0_UQP?\ S[E^'^9\DX/H:,'T-?6W_"J/!_\ T+MC_P!\M_\ %4?\*H\'_P#0
MNV/_ 'RW_P 51_8=?^9?C_D'^N.#_P"?<OP_S/DG!]#1@^AKZV_X51X/_P"A
M=L?^^6_^*H_X51X/_P"A=L?^^6_^*H_L.O\ S+\?\@_UQP?_ #[E^'^9\DX/
MH:,'T-?6W_"J/!__ $+MC_WRW_Q5'_"J/!__ $+MC_WRW_Q5']AU_P"9?C_D
M'^N.#_Y]R_#_ #/DG!]#1@^AKZV_X51X/_Z%VQ_[Y;_XJJU[\+?",<EH%\/6
M0#RA6PK<C!]Z/[#K_P R_'_(/]<<'_S[E^'^9\I8/H:,'T-?6W_"J/!__0NV
M/_?+?_%4?\*H\'_]"[8_]\M_\51_8=?^9?C_ )!_KC@_^?<OP_S/DG!]#1@^
MAKZV_P"%4>#_ /H7;'_OEO\ XJC_ (51X/\ ^A=L?^^6_P#BJ/[#K_S+\?\
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MGOI]R_R#V,%_P[_S.#O?AQK-W9:;&OQ U^"ZM/-\R\C6$/<;RN-R[=H"A<#
M[D]36/=_"CQG<WD:_P#"UM8;36W>?#)8V_F,-H"A650 ,\DD<]L5ZI125::[
M?<O\@=*+[_>SC?!O@_Q'X>UW4+G5O&E[XDTV6%8[6SN[>-&A;=EG9T W$]!P
M,#UKO-._US?[M5:M:=_KF_W:SE)R=V:1BHJR/+;7_4CZM_Z$:EJ*U_U(^K?^
MA&I:DH**** "BBB@ HHHH *9/_J7^E/ID_\ J7^E 'LTD@BB9V^ZHR:^:/!7
M[07Q<^*4MKXM\&_#?0M4^&%SJ4EC;R7&OF#5[F".9H7O%C:/R5C#*Q$;/O(7
MW%?2\D8EC9&Y5A@U\U>#?V;_ (H?#.6#POX/^*UEHOPSM]3DO[:S;P^D^JVT
M+S&9[-+AY#&8RS, [1EPK8YP* /09?VI_AA#/XICD\2F,>&)7M]7G?3[H0VL
MRNJ>3YIBV/*6=0L:%F;/R@T77[4WPPL?#UCK5QXF\BRO=5.AQ))I]TMP+\(7
M-L\!B\V.7:,[70$Y&.HSYKK_ .QG-XD^&/Q&\,7/B2.*[\1^,G\7V-W%;R*E
ML^Z%XXI5616<9AP61D.&RN"!57PG^Q?>Z#!X.N9==TU=3TSQK'XMU#[+;7+1
MS*EN\"0(T\\DK, ^?,D<D],  4 >JK^U)\,9?"=KXCB\2FXT^ZOY=+AAM]/N
MI;UKN,$RP?9%B,XD0 EE,>5 R<#FJOBS]K?X5>"?#^EZ]JWB2>/0-3MX[FUU
M>UTB^NK)T=BB SQ0M&K%@5V,P8'@BO'/$O[".H:L+K4K?Q/9G6X_&&J^)+-)
MXKN*V,%]$D302&WGBF#J$#!T< D8*D$BB[_8T\::4?AE8:-XF\,W_ACP5&UW
M'H&KZ7<BTN=4>1W:\9(Y^=I?Y$8G:<DEB: /?-4_:)^'FBZ;XEU"^\1+;6GA
MNYM;/5G>TGS:S7 1H4(V9)82I]T'&><8.,'5?VP?A)HNNW>C7?BMDU*UO)=.
MD@32[R3-U&H9X%982'DP<A%)9OX0<5Y5\1_V.O&WC2?X@VUEXUT2PT?QO?:9
MJ^HPS:1-)/#=6HB#1Q.)@!$_E Y92PSCWK=LOV1-3M?%%OJK>)+5XXO'M[XQ
M\D6K\QSVGV<0_>^\I^;=T]J /0-2_:S^%&EZ#HVM2^+8Y=,U>T>_M9[2RN;C
M%LC['GE6.)C#&K_*SRA0#P2#7)6O[9/A?2/BYXY\*^*[VTT72=';3!IVJQQW
M$T=PMU&6WS2*ACA3=L4.[*IW#FO)=<_X)\^*]5\ :+X5_P"%@:?/I]KHE[I4
MMM>Z?<-;PS374DZW<,:7" R@.$_>[P-NY1FNEUO]C#QEJMQXRL(/&^CV?AWQ
ME9:3I^KP'299+F..SA$;M YE"AG^8#<I #9ZCD ^OE8, 000>A%+4%E9QZ?9
MP6T61%"BQH"<G &!_*IZ "BBB@ HHHH **** "L_2_\ 7ZA_UW_]E6M"L_2_
M]?J'_7?_ -E6@#0HKY__ &GOCS??">]T&VTC4]+L9X@^KZE%J,L2FXL82HDA
MCWL#YCEE (R1R:;J^M>,OB7\8+O2?"OQ#F\+:!;Z!9ZK;_8])M+L7)F9\,S3
M(6V[0O"D=>M 'T%17B/AWX\:A8? _P 1^+-=T]=6U;PQ<75C>0Z6/)6]D@?
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MX<,I )'- 'TK16%X'O;C4?"6E7-U;W-I<2VZL\-X^^52?[S8!)^H!]0#6[0
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MK_D_'_@!_P 0YA_T%/\ \ _^V/UT_MW3/^@G8_\ @7'_ /%4?V[IG_03L?\
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M,_Z"=C_X%Q__ !5?D7Y4?_/-/^^11Y4?_/-/^^11_:K_ )/Q_P" '_$.8?\
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M?^ '_$.8?]!3_P# /_MC]=/[=TS_ *"=C_X%Q_\ Q5']NZ9_T$['_P "X_\
MXJOR+\J/_GFG_?(H\J/_ )YI_P!\BC^U7_)^/_ #_B',/^@I_P#@'_VQ^NG]
MNZ9_T$['_P "X_\ XJC^W=,_Z"=C_P"!<?\ \57Y%^5'_P \T_[Y%'E1_P#/
M-/\ OD4?VJ_Y/Q_X ?\ $.8?]!3_ / /_MC]:(]<TS^U[@_VG8X\F/G[5'ZM
M_M5<_MW3/^@G8_\ @7'_ /%5^1?E1_\ /-/^^11Y4?\ SS3_ +Y%']JO^3\?
M^ '_ !#F'_04_P#P#_[8_73^W=,_Z"=C_P"!<?\ \51_;NF?]!.Q_P# N/\
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M@< T/ W[2VI-JUW<^.5?1M.A>_NHAI*&_CDM!>"UM=Z1VYFW,R3."O&%RW!
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MAZ)_WX/^-8_V74_F7XGJ_P#$0\!_SYG_ .2_YGYC;3Z&C:?0U^G/_#.7PO\
M^A#T3_OP?\:/^&<OA?\ ]"'HG_?@_P"-']EU/YE^(?\ $0\!_P ^9_\ DO\
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MG_Y+_F?F-M/H:-I]#7Z<_P##.7PO_P"A#T3_ +\'_&C_ (9R^%__ $(>B?\
M?@_XT?V74_F7XA_Q$/ ?\^9_^2_YGYC;3Z&C:?0U^G/_  SE\+_^A#T3_OP?
M\:/^&<OA?_T(>B?]^#_C1_9=3^9?B'_$0\!_SYG_ .2_YGYC;3Z&C:?0U^G/
M_#.7PO\ ^A#T3_OP?\:CN/V<_A@L$I'@3100C$$0'T/O1_9=7^9?B'_$0\!_
MSYG_ .2_YGYE;3Z&C:?0U^F5C^SK\,9+.%F\"Z*S,@))@//ZU/\ \,Y?"_\
MZ$/1/^_!_P :/[+J?S+\0_XB'@/^?,__ "7_ #/S&VGT-&T^AK].?^&<OA?_
M -"'HG_?@_XT?\,Y?"__ *$/1/\ OP?\:/[+J?S+\0_XB'@/^?,__)?\S\QM
MI]#1M/H:_3G_ (9R^%__ $(>B?\ ?@_XT?\ #.7PO_Z$/1/^_!_QH_LNI_,O
MQ#_B(> _Y\S_ /)?\S\QMI]#1M/H:_3G_AG+X7_]"'HG_?@_XT?\,Y?"_P#Z
M$/1/^_!_QH_LNI_,OQ#_ (B'@/\ GS/_ ,E_S/S&VGT-&T^AK].?^&<OA?\
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M-K5K&LT^G1W"-<11G&UVC!W*#D8)'<5=N[J&QM9KFX<1V\,;2RN?X44$L?P
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M&@D!&01@BI*9/_J7^E 'JX\/:?C_ (]4_,_XT?\ "/:?_P ^J?F?\:T1TI:
M,W_A'M/_ .?5/S/^-'_"/:?_ ,^J?F?\:TJ* ,W_ (1[3_\ GU3\S_C1_P (
M]I__ #ZI^9_QK2HH S?^$>T__GU3\S_C1_PCVG_\^J?F?\:TJ* ,W_A'M/\
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M_P"3\?\ @!_Q#FG_ -!3_P# /_MC]<?^$GT;_H,Z;_X&Q?\ Q5'_  D^C?\
M09TW_P #8O\ XJOR.\B+_GE'_P!\"CR(O^>4?_? H_M5_P GX_\  #_B'-/_
M *"G_P" ?_;'ZX_\)/HW_09TW_P-B_\ BJ/^$GT;_H,Z;_X&Q?\ Q5?D=Y$7
M_/*/_O@4>1%_SRC_ .^!1_:K_D_'_@!_Q#FG_P!!3_\  /\ [8_7'_A)]&_Z
M#.F_^!L7_P 54=SXFT8V\O\ Q.-./R-_R^Q>A_VJ_)+R(O\ GE'_ -\"CR(O
M^>4?_? H_M5_R?C_ , /^(<T_P#H*?\ X!_]L?K3I_B;1A8P ZQIP.P=;V+T
M_P!ZK'_"3Z-_T&=-_P# V+_XJOR.\F+_ )Y1_P#? H\B+_GE'_WP*/[5?\GX
M_P# #_B'-/\ Z"G_ . ?_;'ZX_\ "3Z-_P!!G3?_  -B_P#BJ/\ A)]&_P"@
MSIO_ (&Q?_%5^1WD1?\ /*/_ +X%'D1?\\H_^^!1_:K_ )/Q_P" '_$.:?\
MT%/_ , _^V/UQ_X2?1O^@SIO_@;%_P#%4?\ "3Z-_P!!G3?_  -B_P#BJ_([
MR(O^>4?_ 'P*/(B_YY1_]\"C^U7_ "?C_P  /^(<T_\ H*?_ (!_]L?KC_PD
M^C?]!G3?_ V+_P"*H_X2?1O^@SIO_@;%_P#%5^1WD1?\\H_^^!1Y$7_/*/\
M[X%']JO^3\?^ '_$.:?_ $%/_P  _P#MC]<?^$GT;_H,Z;_X&Q?_ !5 \3:,
M?^8QIO\ X&Q?_%5^1WD1?\\H_P#O@4>1%_SRC_[X%']JO^3\?^ '_$.:?_04
M_P#P#_[8_7:(AM7N"#D&&/D?5JNUX'^R-\4W^(?@Q[.^E\S6-'BBM)F8_-+&
M-WER?EP?<5[Y7MTJBJP4X]3\@Q^"JY=BJF%K?%%V]>S^:U"BBBM3@"BBB@ H
MHHH **** *6K_P#'BW_72/\ ]&+5T]:I:O\ \>+?]=(__1BU=/6@ HHHH **
M** "BBB@ HHHH #TJGIW6\_Z^I/Z5</2J>G=;S_KZD_I0!<HHHH **** "BB
MB@ HHHH *M:=_KF_W:JU:T[_ %S?[M 'EMK_ *D?5O\ T(U+45K_ *D?5O\
MT(U+0 4444 +GC':C<3W/YTE% "@D=#BDHHH *9/_J7^E/ID_P#J7^E 'M&<
M"OC[0OVM/$]]^U-)I$\FDGX3W>OS^"[*95 NUU:*V64NQSDHTF^$#&-PZU]=
MW<+W-I-%'*87="JR  E21P<'KBOEJ+_@G-\,K3P!9Z9:1/;>-[:Z34%\?I;Q
M?VN;M;GSS*6QM))^7&,;>* )M-^(7QM^-?B'QGJWPXUCPAX?\.^&->GT"UTC
M7]-GN)=5FM]HG>:=)!Y"%F*KL1CQD]J[GX-_%[6/%/Q"^+.C>([G3X+?PWK%
MKI]B(P(P ]E%,X+,07^=VP< XQQ61X@_9(EN?$^O7OA?XG^,/ >B^)+K[=K>
MAZ!);I%<W!"B2:*1XVDMWD"C>8V&2,UII^R!\/\ 4]8\57OBC3(/&<>MZG!J
MJ6^N0+.MG-%;);AD)Y8E4!+-DDDT <1-\8?BKX,_:-T#P[XGU3PA?Z+K\]]*
M?#VCV\IN]'TN&-FCOY[IF ^8JJLK(%RV%)QQH?L[_M)^(OC9\;?'>GS:8--\
M$6FF6>H>'7E@*3WMO)++']J8GD)(8F9 0/DVM_%3_"O['=YH/C7Q3JU_\3-:
MUS1_%4\KZWHEWIUDJ7T+(8UMS<+'YZQ(A"JJ. H'&,FF>#OV#? _PJ\9:YXF
M^'E_J?@S5+W3$TVSDMYWNQI^"=TD8N&D#E@0NUP54#Y0,F@#CM8_:F\?VOQ9
MNM2MSHO_  KFP\<6_@2?2'LW-_(\D:%KL7&_ VO(H$>S!4'G-<;\.?V^?$7B
M*_\ %GB"^U#0I-%M](UC4K/PQ)I-W9W<8LB=@BNWS%=LRKNE52OE[AC."![O
M=?L<:%>?%6/Q9+XGUQM(.KP^(KCPN#"+"?58HA&ET2$\P<*K% VTL ?:LW0?
MV%/"6EZ_<2WOB#7=9\-10:E;Z3X:NY(A::4M^&%WY;*@=MV]]H=B%W''K0 W
M]F7XS^/_ !)X]N_!_P 0KK1M4OKKPS8>+;*[T6R>T2"*Y8JULZL[[RAVX?C(
MSD5],5XO\!_V9[+X)ZK?ZM/XIUGQCK$UA;Z/;WNM>2'M-/M\^3;((D4$#.2Q
MR6(&:]HH **** "BBB@ HHHH **** "L_2_]?J'_ %W_ /95K0K#M=0>WN]0
M1;*YG'G_ 'XU7;]U?5A0!PWBC]F_P9\0?&.L>(/&>C:9XNFN[6.SLH=7TZ&=
M=.C7=N\G>#AG+ EN#\J^E<=I/[,?BCPA>V-QX5^*%SI+PZ7'H\C76B6]V[P1
M2.T.&=AM95<)G!SM!(KW3^UY?^@9>_\ ?*?_ !=']KR_] R]_P"^4_\ BZ .
M&A^!FEV?P=U3P#;ZC>B+4H9Q=:M-L>YFGF):2=N I8L<XP     !7.3_ +,%
MCJ_@GQ/H6LZ]<:A<:[/:WCWZVD*&"X@C14D6(AD(R@;:P([=*]<_M>7_ *!E
M[_WRG_Q=']KR_P#0,O?^^4_^+H \'N/V29KK0=-CE\8JVNV&H_VA#=KX<L%L
ME_=M'L%D$$?W6)#L2P;!!XQ4<7['@M=(BTZ+QQJ+Q-!J%K=27%A [W$5U*LK
M#@*$*NH(*@#'&*]\_M>7_H&7O_?*?_%T?VO+_P! R]_[Y3_XN@#RS5OV;-/U
M>^UJXFUFYVZIJNG:G)%Y"84VHP(QST<=3U':N7TG]CFUTFPUK2HO%<R:)=6T
M]K96L.C644MNLI)/FW"QB2?;DA=Q';.XC->]_P!KR_\ 0,O?^^4_^+H_M>7_
M *!E[_WRG_Q= 'D^N_LW+J.NC6;+Q-<Z?J,<FERPO]DCE1&LMP&5)^8.&(/3
M':NE^*WA+4M4U7P?XAT>W-Y?:!J7G-;*55I8)$,<NTL0,A6R!GG%=G_:\O\
MT#+W_OE/_BZ/[7E_Z!E[_P!\I_\ %T >+^&_V:-5LEN=)USQ[<ZSX/FOY=0?
M1(=*@M#.[R&39-.I+NF2 0-N0!DTL/[+3317-AJ7C;4]0T*WBNTT733:01KI
MS7&[>[.HW3,N]MN[&/<\U[/_ &O+_P! R]_[Y3_XNC^UY?\ H&7O_?*?_%T
M>(Z1^Q_HFCQW2)KM]*MS#902"2)""L)#2G_>F8 L>V,"O1;7X6BSL?&20:Y>
MVNH>)+E[EM1MDC66UR@5%0,&4A<?Q YR:ZG^UY?^@9>_]\I_\71_:\O_ $#+
MW_OE/_BZ /FC5/V6=<LM#B\+V.J37BZQK,&J:EKUI%;:9!IZPY+>3:1<>;*"
M0S*!DG)Q7IU]^SQIES;ZQ;6^HS65IJ+6*>3# F(K:U^[ /4-W)YKTG^UY?\
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MGP?^!=Q_\<JM>?LK?"J*2U"^$( 'E"M_I=QR,'_II1_9E;NOQ_R#_B(66?\
M/JI]T?\ Y(_./!]#1@^AK])?^&4/A1_T)\'_ (%W'_QRC_AE#X4?]"?!_P"!
M=Q_\<H_LRMW7X_Y!_P 1"RS_ )]5/NC_ /)'YM8/H:,'T-?I+_PRA\*/^A/@
M_P# NX_^.4?\,H?"C_H3X/\ P+N/_CE']F5NZ_'_ "#_ (B%EG_/JI]T?_DC
M\VL'T-&#Z&OTE_X90^%'_0GP?^!=Q_\ '*/^&4/A1_T)\'_@7<?_ !RC^S*W
M=?C_ )!_Q$++/^?53[H__)'YM8/H:,'T-?I+_P ,H?"C_H3X/_ NX_\ CE'_
M  RA\*/^A/@_\"[C_P".4?V96[K\?\@_XB%EG_/JI]T?_DC\VL'T-&#Z&OTE
M_P"&4/A1_P!"?!_X%W'_ ,<H_P"&4/A1_P!"?!_X%W'_ ,<H_LRMW7X_Y!_Q
M$++/^?53[H__ "1^;6#Z&C!]*_27_AE#X4?]"?!_X%W'_P <ID_[*7PI2"1A
MX0@!",0?M=QZ'_II1_9E;NOQ_P @_P"(A99_SZJ?='_Y(_-W!]*,'T-?H_9?
MLJ?"F6TA=_"$!9D!)^UW')_[^5-_PRA\*/\ H3X/_ NX_P#CE']F5NZ_'_(/
M^(A99_SZJ?='_P"2/S:P?0T8/H:_27_AE#X4?]"?!_X%W'_QRC_AE#X4?]"?
M!_X%W'_QRC^S*W=?C_D'_$0LL_Y]5/NC_P#)'YM8/H:,'T-?I+_PRA\*/^A/
M@_\  NX_^.4?\,H?"C_H3X/_  +N/_CE']F5NZ_'_(/^(A99_P ^JGW1_P#D
MC\VL'T-&#Z&OTE_X90^%'_0GP?\ @7<?_'*/^&4/A1_T)\'_ (%W'_QRC^S*
MW=?C_D'_ !$++/\ GU4^Z/\ \D?FU@^AHP?2OTE_X90^%'_0GP?^!=Q_\<H_
MX90^$_\ T)\'_@7<?_'*/[,K=U^/^0?\1"RS_GU4^Z/_ ,D><_L1_#)_#N@7
MOBB^A,=YJ\2"U#9!6V#'!Q_M$9^F*^H*S-.LH-.O&M;:)8+>&VBCCC085%&X
M #Z"M.OH*-)4::@NA^*YKF%3-,94Q=3[3T79=%\D%%%%;'DA1110 4444 %%
M%% %+5_^/%O^ND?_ *,6KIZU2U?_ (\6_P"ND?\ Z,6KIZT %%%% !1110 4
M444 %%%%  >E4].ZWG_7U)_2KAZ53T[K>?\ 7U)_2@"Y1110 4444 %%%% !
M1110 5:T[_7-_NU5JUIW^N;_ ': /+;7_4CZM_Z$:EJ*U_U(^K?^A&I: "BB
MB@ HHHH **** "F3_P"I?Z4^F3_ZE_I0![,[B.,L>@&:^4_$?[1'B70/"[^(
M-,DBO=8UV>^O[;3;FSN+J+3](LY&B\WRXWC4%CM9Y'E7!F ^8*!7U:RAT*GD
M$<UY_!\!/ TWA_3M&UGPYIGB>STVYN+FQ&N6,-T;8S2O(RIN3@#>5'? &<XH
M \;3]I?X@:[!IVK:1X?\/6^BQQ: M_#?3SM=2W>H;&>V@VX5=B31-O?/WL%3
MU$'PR^,OC!M9NKW7K/4/&:*E[JMM#X6CE,@M9KW[/9H8'E$;KY<$LFXG*C&.
M2Q/T?#X#\-V]ND$6@:9'"EQ%=+&MI&%$T2JD4@&/O(J(JGJ J@=!1X:\!>&O
M!J3)H'A_3-%28;9%T^TC@#C>[X(4#(W22-]78]S0!\O>/_V@M1USXV:%_9,O
MBG2_#N@ZSIVFSBVTRY_LZ]GN952[2ZN40P 6Z2(NQG_UC-W45/:?M(^)O M_
MXB\1:H^E^(O"E_J6MR66GVM[))J5O%81,NX+S&D)>V92O!#3JQ;G;7T^O@W0
M4T3^QET6P&D^89OL(MD\G>9/,+;,8W%R7SC.XYZUGZ1\*_!?A^^U&\TSPEH>
MG7>I1>1>SVNG0QO=1YR5D8+EQDG@YH ^7XOVB_BIXTTXZ/+ING^#=:_M?3@U
MS<V\B*EM())YX2@G=BRPP,?-RH=22%4X-=_\#_VB_$GQ.^)^H:%>:5:1Z+/I
M#:WIEW%:7%LYMS,J0DF9LRK(K[@PCCQM. PYKUG2_@YX"T32K+3-.\%^'[#3
MK*\&H6UI;:9#'%!<C@3(H7"R8.-PYQWJQX2^%?@SP#=W-UX9\):'X>N;D$3S
M:7IT5L\H+;B&**"1GGGO0!XFW[4^JRZ%=SPZ=I_VW2OM%GJ8V3RH-1:Z>VLK
M.)8PSL\C+O(P<+MZ;P1C>$?VH/'/B[3&TB.P\-Z1XG34KZVFU/7/-L["&WM8
M8I)7:#S6</NF6/;YO&&8D;2M?15W\-O"=_HVK:1<^&='N-*U:9KG4+*6QB:&
M\E;&Z25"N'8[5RS9/RCTK-D^"'P[FT2UT9_ GAI](M;C[7!8-I$!@BFP!YBI
MLVA\ #<!F@#RG3/CWXTUK4XYXH_ ]CI&G3VUAJ,5QK#M-?W#P+/(;&0 *46-
MU9 RDR?,/DQNKE],_:$^(7]EQ7VCZ1H<FCP+IL]X-3O+N:ZGGU"9F6VA.3MV
MQ/$06)"E@H7&,?1ES\+_  =>>(I-?G\*Z+-KLEL;-]3DL(C<M 1@QF3;NVX)
M&,XP<5<@\"^'+6)8H=!TV*-9X;D(EH@ EB"K$^,?>0(@4]0%&.E 'S%:?M3^
M*_&FMZ[8R>'I/#_A2ZM-4&GZLH,4\26H=?M(E,I#AG3;M6-2A9<L>17TQ\.]
M1O=8\ >&;_4MW]HW6F6L]SN&#YK1*SY';DFL#5/@5X*U"?49K?P_I^DS:M.D
MVKS:;9PP2ZF%;=Y=Q(J[G0D#<,\].]=^JA0 !@#TH 6BBB@ HHHH *S]+_U^
MH?\ 7?\ ]E6M"L_2_P#7ZA_UW_\ 95H L75_;6)A%Q<10&:011^:X7>YZ*,]
M2?05D:[X_P##/A>]BL]8\0Z5I5W* 8X+Z^BA=P3C(5V!/X5\T_M5S>)/B)XS
M70/"?AB]\3R>%++^UFFL;^UMQ8:B^?LKMYLBEBJI*VU<G..*S- ^(_PK\>_%
MJX\3>.YO"=M;ZGX0L)8XO$CVHV2B659XT\[DE7#*=O<4 ?8;W4,=OY[2HL&W
M=YA8!<>N>F*>LBNH96# C((.<BOD2+37U#]B3QVD5U>:5X?)U";1)+=_*9-.
M$N8MI8'$9^;;QC85QQBN:U;QQXTT/P/\0?$N@>.]4U6UT-M.TS3UDO(#:6]M
M+#$9KMY1"X+ ,6\PAE7!.TT ?<.X8SD8]:C:ZA6=83*@E8%EC+#<0.I KX,7
MXT^+[?P&=+N?B%:/;W.N)9VFL67B^UE6-/(>22&XUAK)8TY4%?+B=SG;D9%<
MW9?$;7M9TS3/%UU\1+N+Q3;>&M:L[&ZM[Z(Q7#PW<:H0KQ+YS;"&SM7=M5BH
MH _1O</449'//2OB=?%7CSPAXDUB0?$77]<&A^(M)LH+&^-L8KE+Q<S)-MB5
MF&?N %=N>,UQFA_'7XEWMAXDU"3QS807TVF:C+=Z:NOPWEUITL981F.R2R0V
MA0@*1+*P8?WB10!^@\MS%!L\R5(][!%W,!ECT ]ZEKX3\0S:K'XHT'1O$GQ&
MUZ\T_3M<\/:DNHWUY;PO')<J_F*SK$J^664%5/0\ U]UCI0 M%%% !1110 4
M444 %%%% !1110 4444 ?,7QD_:KL/@Y\0+_ $"Y\-W>JR;4N/M$-VD2X8=,
M%2:XG_AX#I/_ $).H?\ @QB_^(KRS]MS_DO%_P#]>D'\C7@5?-8C&UX591C+
M1/LC]^R7A/*,9EU#$5J5Y2BFWS26OR9]H?\ #P'2?^A)U#_P8Q?_ !%'_#P'
M2?\ H2=0_P#!C%_\17Q?17/_ &AB/YOP1[7^I61_\^7_ .!2_P S[0_X> Z3
M_P!"3J'_ (,8O_B*/^'@.D_]"3J'_@QB_P#B*^+Z*/[0Q'\WX(/]2LC_ .?+
M_P# I?YGVA_P\!TG_H2=0_\ !C%_\11_P\!TG_H2=0_\&,7_ ,17Q?11_:&(
M_F_!!_J5D?\ SY?_ (%+_,^T/^'@.D_]"3J'_@QB_P#B*/\ AX#I/_0DZA_X
M,8O_ (BOB^BC^T,1_-^"#_4K(_\ GR__  *7^9]H?\/ =)_Z$G4/_!C%_P#$
M5#<_M\Z3.\##P7J"^6^__D(1<\?[E?&M%']H8C^;\$'^I61_\^7_ .!2_P S
M[0_X> Z3_P!"3J'_ (,8O_B*/^'@.D_]"3J'_@QB_P#B*^+Z*/[0Q'\WX(/]
M2LC_ .?+_P# I?YGVA_P\!TG_H2=0_\ !C%_\11_P\!TG_H2=0_\&,7_ ,17
MQ?11_:&(_F_!!_J5D?\ SY?_ (%+_,^T/^'@.D_]"3J'_@QB_P#B*/\ AX#I
M/_0DZA_X,8O_ (BOB^BC^T,1_-^"#_4K(_\ GR__  *7^9]H?\/ =)_Z$G4/
M_!C%_P#$4?\ #P'2?^A)U#_P8Q?_ !%?%]%']H8C^;\$'^I61_\ /E_^!2_S
M/M#_ (> Z3_T).H?^#&+_P"(H_X> Z3_ -"3J'_@QB_^(KXOHH_M#$?S?@@_
MU*R/_GR__ I?YGVA_P / =)_Z$G4/_!C%_\ $4V7]O[29(G0>"=0!92N?[1B
M[C_<KXQHH_M#$?S?@@_U*R/_ )\O_P "E_F?9EM^WWI-O;QQGP5J#%%"Y_M&
M+G_QRI/^'@.D_P#0DZA_X,8O_B*^+Z*/[0Q'\WX(/]2LC_Y\O_P*7^9]H?\
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M&(_F_!!_J5D?_/E_^!2_S/M#_AX#I/\ T).H?^#&+_XBC_AX#I/_ $).H?\
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M- &C16<-/NCTU28_]LXO_B:!IUT?^8I/_P!^HO\ XF@#1HK._L^ZQ_R%9O\
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M^SKO_H*3_P#?J/\ ^)H T:*SO[.N_P#H*3_]^H__ (FC^SKO_H*3_P#?J/\
M^)H T:*SO[.N_P#H*3_]^H__ (FC^SKO_H*3_P#?J/\ ^)H ^%?VMOA/XS\9
M_&>_U#0?"^IZO8_9H8_M%I!O3<!R,YZUXS_PSU\3?^A#UW_P%_\ KU^FMO"T
M5Y?K)*T[>=]]E /3V %6,#T%>54RZG4FYN3U/TC <<8S 86GA84HM025W>^G
MS/S"_P"&>OB;_P!"'KO_ ("__7H_X9Z^)O\ T(>N_P#@+_\ 7K]/<#T%&!Z"
MLO[+I_S/\#N_XB'CO^?,/_)O\S\PO^&>OB;_ -"'KO\ X"__ %Z/^&>OB;_T
M(>N_^ O_ ->OT]P/048'H*/[+I_S/\ _XB'CO^?,/_)O\S\PO^&>OB;_ -"'
MKO\ X"__ %Z/^&>OB;_T(>N_^ O_ ->OT]P/048'H*/[+I_S/\ _XB'CO^?,
M/_)O\S\PO^&>OB;_ -"'KO\ X"__ %Z/^&>OB;_T(>N_^ O_ ->OT]P/048'
MH*/[+I_S/\ _XB'CO^?,/_)O\S\PO^&>OB;_ -"'KO\ X"__ %Z:_P"S]\2H
MRH;P-KBEC@9M>I_.OT_P/053U #S;+@?ZX?R-']ET_YG^ ?\1#QW_/F'_DW^
M9^9W_#/7Q-_Z$/7?_ 7_ .O1_P ,]?$W_H0]=_\  7_Z]?I[@>@HP/04?V73
M_F?X!_Q$/'?\^8?^3?YGYA?\,]?$W_H0]=_\!?\ Z]'_  SU\3?^A#UW_P !
M?_KU^GN!Z"C ]!1_9=/^9_@'_$0\=_SYA_Y-_F?F%_PSU\3?^A#UW_P%_P#K
MT?\ #/7Q-_Z$/7?_  %_^O7Z>X'H*,#T%']ET_YG^ ?\1#QW_/F'_DW^9^87
M_#/7Q-_Z$/7?_ 7_ .O1_P ,]?$W_H0]=_\  7_Z]?I[@>@HP/04?V73_F?X
M!_Q$/'?\^8?^3?YGYA?\,]?$W_H0]=_\!?\ Z]'_  SU\3?^A#UW_P !?_KU
M^GN!Z"C ]!1_9=/^9_@'_$0\=_SYA_Y-_F?F%_PSU\3?^A#UW_P%_P#KTC?L
M]_$Q5)/@370 ,DFU_P#KU^GV!Z"H[D#[--P/N-_(T?V73_F?X!_Q$/'?\^8?
M^3?YGYBI^SY\2Y$#+X%UQE(R"+7K^M+_ ,,]?$W_ *$/7?\ P%_^O7Z:Z<!]
M@M^!]P?RJQ@>@H_LNG_,_P  _P"(AX[_ )\P_P#)O\S\PO\ AGKXF_\ 0AZ[
M_P" O_UZ/^&>OB;_ -"'KO\ X"__ %Z_3W ]!1@>@H_LNG_,_P  _P"(AX[_
M )\P_P#)O\S\PO\ AGKXF_\ 0AZ[_P" O_UZ/^&>OB;_ -"'KO\ X"__ %Z_
M3W ]!1@>@H_LNG_,_P  _P"(AX[_ )\P_P#)O\S\PO\ AGKXF_\ 0AZ[_P"
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MI0!<HHHH **** "BBB@ HHHH *M:=_KF_P!VJM6M._US?[M 'EMK_J1]6_\
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M\%?M1?$"RTK2M(T?0K_Q.-*L[>2_EDT6^U&:^>:23*_:T<1VVU5X:0/GT %
M'V]17R,WQY^(*ZSJ&E^%K;0+58SJVH3RZZMY=MMMO**QJ!."I8,0<':O4+V.
ML/VE_&^KZ1J/BW2].\/V_A?0H[ ZEIUX)C>W33QH\AAE#A(PN\;0R/OP>5H
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MUX>_\&,?^-?EMFC-']J5/Y4'_$.\'_S_ )?<C]2?^%X_#O\ Z'KP]_X,8_\
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MD:XG^S?:=NT3FW#^5YF !Y@3?@=:[_[3#_SU3_OH4?:8?^>J?]]"@#RKX:_
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MWX=?]"+X>_\ !?'_ (4?\*-^'7_0B^'O_!?'_A1_9=3^9!_Q$3!_\^)?>O\
M,_+;%&*_4G_A1OPZ_P"A%\/?^"^/_"JE]\$/AXDMH%\#Z H:4 XT^/D8/M1_
M9=3^9!_Q$3!_\^)?>O\ ,_,'%&*_4G_A1OPZ_P"A%\/?^"^/_"C_ (4;\.O^
MA%\/?^"^/_"C^RZG\R#_ (B)@_\ GQ+[U_F?EMBC%?J3_P *-^'7_0B^'O\
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M9P"2*%Q&;>.5R[22*I(+\ ')R  : /6**JZ9J,&KZ;:WULQ>VN8DFB8C!*L
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M:/\ A='C/_H-O_WXB_\ B:/[<P_\LOP_S#_4_'?SP^]__(GU;FJ>H'][9?\
M78?R-?+W_"Z/&?\ T&W_ ._$7_Q--D^,?C&4H6UIR4;<O[B+@_\ ?-']N8?^
M67X?YA_J?COYX?>__D3ZOS1FOE+_ (71XS_Z#;_]^(O_ (FC_A='C/\ Z#;_
M /?B+_XFC^W,/_++\/\ ,/\ 4_'?SP^]_P#R)]6YHS7RE_PNCQG_ -!M_P#O
MQ%_\31_PNCQG_P!!M_\ OQ%_\31_;F'_ )9?A_F'^I^._GA][_\ D3ZMS1FO
ME+_A='C/_H-O_P!^(O\ XFC_ (71XS_Z#;_]^(O_ (FC^W,/_++\/\P_U/QW
M\\/O?_R)]6YHS7RE_P +H\9_]!M_^_$7_P 31_PNCQG_ -!M_P#OQ%_\31_;
MF'_EE^'^8?ZGX[^>'WO_ .1/JW-&:^4O^%T>,_\ H-O_ -^(O_B:/^%T>,_^
M@V__ 'XB_P#B:/[<P_\ ++\/\P_U/QW\\/O?_P B?5N:BN3_ *--_N-_(U\K
M_P#"Z/&?_0;?_OQ%_P#$TC?&;QDZE3K;D$8(\B+_ .)H_MS#_P LOP_S#_4_
M'?SP^]__ ")]2Z<?] M_]P?RJSFOE"/XR^,HHU1-:<*HP!Y$73_OFG?\+H\9
M_P#0;?\ [\1?_$T?VYA_Y9?A_F'^I^._GA][_P#D3ZMS1FOE+_A='C/_ *#;
M_P#?B+_XFC_A='C/_H-O_P!^(O\ XFC^W,/_ "R_#_,/]3\=_/#[W_\ (GU;
M17F'P5^)%SXPM+JQU6X$VJ6Y\Q9"H4R1GV  X/'Y5Z?7M4*\,1356&S/DL;@
MZN KRP];=?=ZH****Z#B"BBB@"G'_P ABY_ZXQ_S:KE4X_\ D,7/_7&/^;5<
MH **** "BBB@ HHHH **** *6K_\>+?]=(__ $8M73UJEJ__ !XM_P!=(_\
MT8M73UH **** "BBB@!/#W_(P:K_ -<+?_VI70S0QSQ-'*BR1MP5< @_@:Y[
MP]_R,&J_]<+?_P!J55^+-_?:9\/-;NM-EF@O8X08I+?.]3O7ICVS6562A3E*
M2NDF;T*;K5H4HNSDTK^K-_\ L33?^?&U_P"_*?X5*^GV9L);1K>'['(C))"4
M&QE(PP(Z8(SFOC@_$/Q]D_\ $YUO_OEO_B:]Z^'U]J_B#X(ZC)J4EU?:E+!>
MQ@SJ3*W#A1C&3V KR,%C*&(J\E.GRNV]D?29IDF(RZ@JU6JI*Z5E?S[^ATVD
M_#WPM8(TEK&\ZHT062>_EN/)$<BR1HA=VV*'53M7 .!D&KNH_#[0=5MC!<6;
M,FZ9U*3R(R-+*LKLK*P*MO56!!RI'&*\LM+"P\FRN/"/AR;3A#IRPZ@PT5[6
M.9S+!L0QR1J)'7$C;MIVC/(S4-MXT\;OJFMK<S:O;::[)F3^RRTUDOVG8XA!
MA"R/Y9!VKYO]X%B,'W3Y0]5TWX:^'M):)K>SDWQR^>KRW4LK&3S/,+%F8DDO
MECGUJY>>"M%O]374)[(27:7"W2R%VXE6(Q!L9Q]QB,=.AZ@&O*M-\0>+]6TO
M[99:SJLT-DMRZF338U>[9+THJ2KY>5/E @JH5N_!&*M7'B'QBTVM+;7FK+>K
M%>>?#/H^;:Q*R 6[0,L>9BR]@9,@EL C:4!W8^&?AJWO;6\^QO&]LD2(OVJ4
M1$QJ$C9H]VQW5< ,P+#CG@5):_#7P]97\%W#9RQO#&D:Q"ZE\EMJ!%9XMVQV
M"@#<P)P.M>4V=YXGU0Z-?WHUF28V\UL([BS$D,^+NW8.P-NA'[O<5+)&?W9.
M..?1/AQJFJ:A<:D-4NM4FNU;,UM>Z<+>"UDWL-D,FQ?,7;MYR_8[N<4 7(_A
M7X<CT\60MKKR%F2>,_;[C?$54JJH^_<B!69=BD+@D8P:)?A5X:>SAMDLIK=(
M=HC>VO)H9%"QK&%#HX;:4101G!QSS7744 16UM'9VT4$*[(HD"(H[*!@"I:*
M* .:\0_\C!I7_7*?^2U<T[_7-_NU3\0_\C!I7_7*?^2U<T[_ %S?[M 'EMK_
M *D?5O\ T(U+45K_ *D?5O\ T(U+0 4444 %%%% !1110 4R?_4O]*?3)_\
M4O\ 2@#V2X9EMI"BEW"DJJG!)QTK\_OV?E^,H^,\>J#2?$^E76IZ1K2WMEXK
MCU1].BU%9@UFES<R,8I!MZ/;11H$^5=YSC]!1THQ0!^?O[2VA_'J]UC1]2U.
M._FUZ#2I!#IO@>/5I=(EN1/NC,%S;NLMO=E>"UW$UOMQS]ZMU;#Q_)^U'HG@
M6\N=6L]"U$1?$6>)-3>1[62*S:WGL&*D;HS=- ^  A).%QQ7W*1FN8T7X9^&
M/#WC+6O%EAHUO!XCUA$BOM3^9II8T^ZFYB=J#&=JX&><9YH ^,?@-X$^)WA2
MX_9_UG9XR.N:E::W;^*5U^[OIK9-L<S6:W<<C,L*AQ'M(56.>"<UN?$+X=_M
M ^.?C;\);G4M4T3P9X@L[?6TD\2>$=*GU;3K2!XH-D<JW80+)(0X&3VXR<U]
MM44 ?G7\7/@EK_P \:_"B+P_J7Q+U"WL[/7)]6\5>"/#::E>R7EW-#(^^$1O
M%&CD-A0. O'<UZ_\7[;Q!\2/V$M9M+"S\:>(->N+;REC\1Z,;/6;EA<@YDM8
MT7''3"C*@'WKZUHH ^=/VX?AUJ'Q)_99\1Z3IVDWVMZJD5O<0V-D9#/(R2(S
M81""YVAOEYR>V<5Y/:^#O$Z:U\:O$^C:'X[N8-.T'3H_!FG27VH69)>SD2;R
M8YB<S [02Z,ZG'\1K[CHH _-WP5I'QAM/!/Q&T^VM?'C:!)?:!=K;K;:G:W<
MMB21J:V7VN5[CS, ;L.KMR55<KGIOBCH7C2X\)^&8?!.G?$:U^&ZZW>F^M?$
M<>J7%[M, ^SLD-K(NH"U$N2JR,"&P6&ROOO%&* /BOX)_#GX@ZY\6?ARWQ%D
M\6WEGIG@MKF:>ZFNK2![\7H,"W*QRE'F6$C*NS$[<MDYK[5HHH **** "BBB
M@ K/TO\ U^H?]=__ &5:T*S]+_U^H?\ 7?\ ]E6@"IJ'BS3]/\2Z;H4C2OJ5
M]')-'%$A8)$@^:1ST5<E5SZL!5O2=?TSQ!',^F:C:ZBD,AAE:TG641N.JL5)
MPP]#S7@?Q2\+ZQKGQ3\;Z7I]U]@U3Q#X*>ST6X>38!*DI\U5/8_.A^BYZ UR
MW[,GP[UOX6WVK:S<^%/%]F#IUMIDEG=6VBVRR2JXRT<-BJ"18_F_?2ON*DX4
MDF@#Z U[1/"?C#Q?I'V_44NM5T.X%Q#IJ:D0JS%<H\ENKX=EP67<#C&15KXG
M?$K1/A%X,OO%'B&2>'2;+:9GMXC*X!8*"%')Y-?('PYCTVP^./@M(/!]O=:_
M::SKUQ=>*M.N;2=M64QS':I20R,RY2-A*%"% ,\BOHS]H;PWJOQ*^"\ECI>C
M74][>26DK:=-L69%\Q6=7^;:"HSG#'IQF@#HO$/QK\)^&=1\(V5Y?R&;Q2W_
M !+3%$S*Z^7YF]CT1=N.3ZXK$\)_M(>%O%OB*RTR"RUVRM=2E>#2]8U#3)(;
M#4I%SE8)CU^ZV-P4-CY<\5X9H7P4^(2>+=&N=3T/SX?#^OBQTJ2697C&F+YL
M@F8;LA27C0@<XBZ5:\)>%O'_ (0\0::_ACP/XH\)W-I-+-KNFC5HKKPS=)AB
M?L,,D[NCNV"H18MI8[N!R >_6_QQ\*W6L>,]*@N+B6^\*1K+J$?DD9!7=^[)
MX?' .. 2,TSP?\<-!\6S:=;^7<:?=WL[VJ13E'43+&LOEF2-F7<48,,'GD=:
M\,\%_ KXD^!_$_A#Q'J&JC78-2%Q9ZYI6GZ?'9S645X?,=VG$S&;RI-HR .$
MXS7<_$'X?:?X,T_P'X<\/K*^J77BJTOEGD"F5A&0TTAV*J@"-.<*!^))(!['
MXB\&:7XIN]'N=0A>672;M;VT*RLFR4 @$X/S#GH>*V]H]_SH'2EH 3'U_.C%
M+10 FWC'/YT4M% !1110 4444 %%%% !1110!\@_M!?\E-O_ /KG'_*O-Z^C
M_B)\&IO'?C"_U)-6CLERL?E-;ESP.N0PKG/^&9KC_H88?_ 1O_BZ^'Q>78JK
MB)SA"Z;[K_,_8,KSW+L/@J5*K5M)))JTO\CQ.BO;/^&9KC_H88?_  $;_P"+
MH_X9FN/^AAA_\!&_^+KD_LO&?R?BO\SU/]8\J_Y_?A+_ "/$Z*]L_P"&9KC_
M *&&'_P$;_XNC_AF:X_Z&&'_ ,!&_P#BZ/[+QG\GXK_,/]8\J_Y_?A+_ "/$
MZ*]L_P"&9KC_ *&&'_P$;_XNC_AF:X_Z&&'_ ,!&_P#BZ/[+QG\GXK_,/]8\
MJ_Y_?A+_ "/$Z*]L_P"&9KC_ *&&'_P$;_XNC_AF:X_Z&&'_ ,!&_P#BZ/[+
MQG\GXK_,/]8\J_Y_?A+_ "/$Z*]L_P"&9KC_ *&&'_P$;_XNH9_V;KB!X5_X
M2"%O,?9_QZ-QQ_O4?V7C/Y/Q7^8?ZQY5_P _OPE_D>,T5[9_PS-<?]###_X"
M-_\ %T?\,S7'_0PP_P#@(W_Q=']EXS^3\5_F'^L>5?\ /[\)?Y'B=%>V?\,S
M7'_0PP_^ C?_ !='_#,UQ_T,,/\ X"-_\71_9>,_D_%?YA_K'E7_ #^_"7^1
MXG17MG_#,UQ_T,,/_@(W_P 71_PS-<?]###_ . C?_%T?V7C/Y/Q7^8?ZQY5
M_P _OPE_D>)T5[9_PS-<?]###_X"-_\ %T?\,S7'_0PP_P#@(W_Q=']EXS^3
M\5_F'^L>5?\ /[\)?Y'B=%>V?\,S7'_0PP_^ C?_ !='_#,UQ_T,,/\ X"-_
M\71_9>,_D_%?YA_K'E7_ #^_"7^1XG17MG_#,UQ_T,,/_@(W_P 739/V:;B.
M-W_X2&$[5+8^R-V&?[]']EXS^3\5_F'^L>5?\_OPE_D>*T5[1;_LV7%Q!')_
MPD$*[U#8^R-Q_P"/5)_PS-<?]###_P" C?\ Q=']EXS^3\5_F'^L>5?\_OPE
M_D>)T5[9_P ,S7'_ $,,/_@(W_Q='_#,UQ_T,,/_ ("-_P#%T?V7C/Y/Q7^8
M?ZQY5_S^_"7^1R'P4TV_OO'MG+9.8DM@9+B3&1Y>,%3]37U-7'_#;X=P_#[3
M)X!.MY=SOOEN FS('W5 R>!785]=EN%EA:'+/=ZOR/R_/\QAF.,<Z7PQ5D^_
MF%%%%>J?-A1110!3C_Y#%S_UQC_FU7*IQ_\ (8N?^N,?\VJY0 4444 %%%%
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M%_X%?_8T44 'VS4_^@?%_P"!7_V-'VS4_P#H'Q?^!7_V-%% !]LU/_H'Q?\
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M_ K_ .PH^RZG_P ^,/\ X%?_ &%%% !]EU/_ )\8?_ K_P"PH^RZG_SXP_\
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M);+5)(G064(+*1_Q]>H_W*** &VNGZI!;11FRA)10"1=?_85+]EU/_GQA_\
M K_["BB@ ^RZG_SXP_\ @5_]A1]EU/\ Y\8?_ K_ .PHHH /LNI_\^,/_@5_
M]A1]EU/_ )\8?_ K_P"PHHH /LNI_P#/C#_X%?\ V%'V74_^?&'_ ,"O_L**
M* #[+J?_ #XP_P#@5_\ 84?9=3_Y\8?_  *_^PHHH @33=46^EG^QP[714 ^
MU>F?]CWJ?[+J?_/C#_X%?_8444 'V74_^?&'_P "O_L*/LNI_P#/C#_X%?\
MV%%% !]EU/\ Y\8?_ K_ .PH^RZG_P ^,/\ X%?_ &%%% !]EU/_ )\8?_ K
M_P"PH^RZG_SXP_\ @5_]A110 ?9=3_Y\8?\ P*_^PH^RZG_SXP_^!7_V%%%
M%>^TS5+JW,:V<*DLC9-UZ,#_ '/:K!M=3S_QXQ?^!7_V%%% !]EU/_GQA_\
M K_["C[+J?\ SXP_^!7_ -A110 ?9=3_ .?&'_P*_P#L*/LNI_\ /C#_ .!7
M_P!A110 ?9=3_P"?&'_P*_\ L*/LNI_\^,/_ (%?_8444 'V74_^?&'_ ,"O
M_L*/LNI_\^,/_@5_]A110 AM-3_Y\8?_  *_^PJ&UTW5(#/FRA/F3-(,770'
M''W/:BB@"?[+J?\ SXP_^!7_ -A1]EU/_GQA_P# K_["BB@ ^RZG_P ^,/\
MX%?_ &%'V74_^?&'_P "O_L*** #[+J?_/C#_P"!7_V%'V74_P#GQA_\"O\
M["BB@ ^RZG_SXP_^!7_V%'V74_\ GQA_\"O_ +"BB@ ^RZG_ ,^,/_@5_P#8
659L(;^*5C+:1HNW&1<9_]EHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>aciu-20221231x20f006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %4 \ # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *XGXR''P\U/''W/_0A7;5@>.?#DGBSPS=Z7%,MO)-MQ(X)
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MFLZ8^IPRR7]ZEV)S&1@@Y((']*O?%&W2PL=#U#SIK:[T^<&*ZCMS-&F0 WF
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MG>I=[I)VN^6]FU>UNOKJ>%CG0==_5E:.G>U[:VO9[A1117LG %%%% !1110
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MX:=_W^D_^(KD=0_:!\":7\/+'QQ<ZV(_#%[<BTBOOL\A_>%V3#+MW+AE;)(
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MS,CS->_YX:=_W^D_^(H\S7O^>&G?]_I/_B*UZ*/JTO\ G[+\/\@]LOY%^/\
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M>!_%7BSXT_#N?PUJ]_X96UL-36?7+33X[M(-WD;8V$JL@+X.,\_*<5P/B_\
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MWN"?W<K\-L4!N<'IBOKVB@#X5_9_TR]\%7^A6VL:+\<K34X=6F9[.SAF3P\
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MA<?_ !='_"':;ZWO_@PN/_BZVZ* ,3_A#M-];W_P87'_ ,71_P (=IOK>_\
M@PN/_BZVZ* ,3_A#M-];W_P87'_Q='_"':;ZWO\ X,+C_P"+K;HH Y37O"EA
M!IX=&O5;SX5S_:%QT,J _P ?H:T/^$.TWUO?_!A<?_%U8\1_\@P?]?%O_P"C
MDK3H Q/^$.TWUO?_  87'_Q='_"':;ZWO_@PN/\ XNMNB@#$_P"$.TWUO?\
MP87'_P 71_PAVF^M[_X,+C_XNMNB@#$_X0[3?6]_\&%Q_P#%T?\ "':;ZWO_
M (,+C_XNMNB@#$_X0[3?6]_\&%Q_\71_PAVF^M[_ .#"X_\ BZVZ* ,3_A#M
M-];W_P &%Q_\71_PAVF^M[_X,+C_ .+K;HH Q/\ A#M-];W_ ,&%Q_\ %T?\
M(=IOK>_^#"X_^+K;HH Y/Q%X4L+?1KJ2-KU751@_VA<>H_VZT?\ A#M-];W_
M ,&%Q_\ %U/XH_Y -W_NC_T(5J4 8G_"':;ZWO\ X,+C_P"+H_X0[3?6]_\
M!A<?_%UMT4 8G_"':;ZWO_@PN/\ XNC_ (0[3?6]_P#!A<?_ !=;=% &)_PA
MVF^M[_X,+C_XNC_A#M-];W_P87'_ ,76W10!B?\ "':;ZWO_ (,+C_XNC_A#
MM-];W_P87'_Q=;=% &)_PAVF^M[_ .#"X_\ BZ/^$.TWUO?_  87'_Q=;=%
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M5\6/!/Q5\?>+]2N/"?B+5M%\&Z+J=]:Z$+AK(Z<U]*UP4C:4E)U@9F#%F!"
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M_P"?9_\ O_)_\50!LT5C?\(AI/\ S[/_ -_Y/_BJ/^$0TG_GV?\ [_R?_%4
M;-%8W_"(:3_S[/\ ]_Y/_BJ/^$0TG_GV?_O_ "?_ !5 &S16-_PB&D_\^S_]
M_P"3_P"*H_X1#2?^?9_^_P#)_P#%4 ;-%8W_  B&D_\ /L__ '_D_P#BJ/\
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MB&D_\^S_ /?^3_XJ@#9HK&_X1#2?^?9_^_\ )_\ %4?\(AI/_/L__?\ D_\
MBJ -FBL;_A$-)_Y]G_[_ ,G_ ,51_P (AI/_ #[/_P!_Y/\ XJ@#9HK&_P"$
M0TG_ )]G_P"_\G_Q5'_"(:3_ ,^S_P#?^3_XJ@#9HK&_X1#2?^?9_P#O_)_\
M51_PB&D_\^S_ /?^3_XJ@#9HK&_X1#2?^?9_^_\ )_\ %4?\(AI/_/L__?\
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M-6E66^NK9\@P//*\OED'H5#@$>H->KT4 %%%% !7I7PC_P"0?J7_ %W7_P!
M%>:UZ5\(_P#D'ZE_UW7_ - % 'RW_P %#?BUX\^%'Q"^%6J>$->O].TW38K[
M7-9TNUD(CU&UM9;1I(Y%R P\MY/P)KSWPC^V+K=E^TMX]\<W>OZIKWPO/AB^
MU+1=!M[C-O((;R&UC>-2=H+N'^;T;-?<OQ&^!OA'XJZO9ZEXCL9;RXM=-O\
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M,<+Y@&XXX]9^$C2:'X[^('A*VO[S4=$T>:SFM#?7+7#VCSPEY+;S')=@,)(
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MS7<]9_X7Y)_T!%_\"O\ ["C_ (7Y)_T!%_\  K_["O)J*_-/]?>(_P#H*_\
M)(?_ ")];_JUE7_/G_R:7^9ZS_POR3_H"+_X%?\ V%'_  OR3_H"+_X%?_85
MY-11_K[Q'_T%?^20_P#D0_U:RK_GS_Y-+_,]9_X7Y)_T!%_\"O\ ["C_ (7Y
M)_T!%_\  K_["O)J*/\ 7WB/_H*_\DA_\B'^K65?\^?_ ":7^9ZS_P +\D_Z
M B_^!7_V%'_"_)/^@(O_ (%?_85Y-11_K[Q'_P!!7_DD/_D0_P!6LJ_Y\_\
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M?_(,'_7Q;_\ HY*TZS/$?_(,'_7Q;_\ HY*TZ "BBB@ HHHH **** "BBB@
MHHHH **** ,OQ1_R ;O_ '1_Z$*U*R_%'_(!N_\ ='_H0K4H **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110!E^*/\ D W?^Z/_ $(5J5E^*/\
MD W?^Z/_ $(5J4 %%%% !1110 4444 %%%% !1110 4444 9?BK_ )%G5?\
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M[/\ ^!$G^-'_  B]A_=G_P# B3_&M:B@#)_X1>P_NS_^!$G^-'_"+V']V?\
M\")/\:UJ* ,G_A%[#^[/_P"!$G^-'_"+V']V?_P(D_QK6HH R?\ A%[#^[/_
M .!$G^-'_"+V']V?_P ")/\ &M:B@#)_X1>P_NS_ /@1)_C1_P (O8?W9_\
MP(D_QK6HH R?^$7L/[L__@1)_C1_PB]A_=G_ / B3_&M:B@#)_X1>P_NS_\
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M]HN+N L?WAE_=QHY5NC$@$9'6O>[CX*>!;K2K#39?"^G/96$CS6T9B_U;O\
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M_P"!L_\ \71_PB&F_P!VZ_\  V?_ .+H VJ*Q?\ A$--_NW7_@;/_P#%T?\
M"(:;_=NO_ V?_P"+H 73?^1DUG_=@_\ 06K9KD-/\*Z>_B#5D*W.U%AQB\F!
MY5N^_FM7_A$--_NW7_@;/_\ %T ;5%8O_"(:;_=NO_ V?_XNC_A$--_NW7_@
M;/\ _%T ;5%8O_"(:;_=NO\ P-G_ /BZ/^$0TW^[=?\ @;/_ /%T ;5%8O\
MPB&F_P!VZ_\  V?_ .+H_P"$0TW^[=?^!L__ ,70!M45B_\ "(:;_=NO_ V?
M_P"+H_X1#3?[MU_X&S__ != &U16+_PB&F_W;K_P-G_^+H_X1#3?[MU_X&S_
M /Q= &U16+_PB&F_W;K_ ,#9_P#XNC_A$--_NW7_ (&S_P#Q= &U16+_ ,(A
MIO\ =NO_  -G_P#BZ/\ A$--_NW7_@;/_P#%T ;5%8O_  B&F_W;K_P-G_\
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M* "BBB@ HHHH **** ,SQ'_R#!_U\6__ *.2M.LSQ'_R#!_U\6__ *.2M.@
MHHHH **** "BBB@ HHHH **** "BBB@#+\4?\@&[_P!T?^A"M2LOQ1_R ;O_
M '1_Z$*U* "BBB@ HHHH **** "BBB@ HHHH **** ,OQ5_R+.J_]>LG_H)K
MMZXCQ5_R+.J_]>LG_H)KMZ .,^)/_'OIO_79O_037&5V?Q)_X]]-_P"NS?\
MH)KC* "BBB@ HHHH **** "BBB@ HHHH *[/X;?ZG5/^NR_^@"N,KL_AM_J=
M4_Z[+_Z * +/CCXK>"?ABMHWC'QCH'A-;LL+8ZYJD%D)BN-VSS67=C(SCID5
MSC_M0?!N/3XK]OBUX%6QEE>&.Y/B2S$3R*%+(&\W!8!T)'4!E]163^UOX0T'
MQ)^SQ\1[O5]$T[5+K3_#&J36<][:1S/;/]ED.Z-F!*-E0<C!X'I7QYXO7X6_
M"Z;]C;5?&&F^'M&\*7&@7UQJDEWI\9MYYFT^R"R2J$.]RV/F()S0!]Z:A\9_
MA]I/A&S\5WWCKPU9>%[R016VMW&KV\=E.Y!(5)R^QB0K' /\)]*U?!WCSPS\
M1-).J^%/$6D^)]+$AB^VZ-?17<.\=5WQLRY&1QFOS+^(VD6_B;3Y+[X7Z7HS
M>!M>^+^AMX8MM8L9$T:[F^PRK/)Y0 )MVEX.T#.#BOICX3?!OXK?L[P^-_&%
MGX2\'^+O%WBR_M?-\*>$[QM"T>P@AB*>;&\T;EG;@D;1UZF@#ZGU#Q+I&D:G
MINFWVJV5EJ.I,Z6-I<7"1S73(-SB)"07*CD[0<#K530?'GAGQ5JFJZ;HGB+2
M=8U'29?)U"TL+Z*>:SDY^29$8F-N#PP!XK\_/%'B7QUJ7[</PQ\2^-?AWXIT
MV_;5+S2]+M$FMY;".Q%JH/D,) 7?S&DDD=E7Y1&%'RU>_9_\2Z3%^TSXKUKX
M/^ /M\R>$I[:3PQ-!_8CZ)>)>*6L[R?$B/),P,@=LLH7 &,T ?;GC+XW_#GX
M=:O'I7BOQ_X7\,:I)&)DLM9UFVM)F0D@,$D=6*D@@'&.#3/%GQW^&O@*ZM+;
MQ-\0_"GAVYN[=;NWAU;6[:U>:%B0LJ"1P60E6 8<'!]*^+_'?@_XI_&C]IO5
MD@\#_#C2?$<W@6S74]*\<-)K$5@K7EVBM:S0HH+D88DJ!R!VKS7XN?#_ $7X
M&_''P'X,\2?%;PWX.31OAI:6@UKQ-X3AUN"\D%_<DI'!*V(NI(;).T8H _1'
M5?VBOA3H5CIE[J7Q.\&Z=9ZG";BPN+O7[2*.[B#%2\3-( ZA@1E<C(Q5K1?C
MI\-O$ATT:1\0?"NJG4IVM;$66M6TWVJ90"T<6USO< C*KDC(KYF^.?A[P/XN
M_P""?NOZ[9/X:\<26'AV6.R\36&A0V2,0_S-!$ ?(&[/RJ<9S7>ZE^S1<CQC
MX5\0^!H]%\.:8+:P2_M8XQ!&HAN%G9Q;I$4G9Q\OSM'L8*X)*@4 ?2>1G&>?
M2EKX+_:HU?4?A_\ M1^(M;B\?:]HES+\+]5OM#TZ.=1:O>P0SY1%\L_="+,>
M<[@#G&%KE/BE\3?$GPU^ OP]2Z^*WQ$N?&WBW1YO$%GJ"36T5J]RMM$5LRRV
M<CL"22D2C+%G+.!@@ _1^BOS@T[]HOQ7XGU7P;=^,/BSK7@*]NO"V@ZEX?L]
M%T<7EOXCNYT#7GF0A,S$-A?+1TV;B<XXK-TK]I+XW:C^V1-X:DOI[.XA\5_8
M?^$;O-0BBM9M%#@>9'8FV,A<Q'S!/]HVYSE<"@#],:*^8_V*F\4^,]&\0^-_
M$WCO7M?>;6M5TNWT:[>+[#:Q0WCHC(H0.7PN,ER,'&.,U].4 %%%% !1110
M4444 %%%% &-IO\ R,FL_P"[!_Z"U9/C3XP> OAO=P6OBWQMX<\+75Q'YL,&
MM:M;V;R)G&Y5D=21GC([UK:;_P C)K/^[!_Z"U<+^TW_ ,D<U7_K[L?_ $LA
MH T+K]HOX46-A9WUS\3_  ;;V5Z'-M<R^(+18Y]IPVQC)AL'@XS@UL:_\6?
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M_"[?&G_0:_\ )6#_ .(H_P"%V^-/^@U_Y*P?_$5PU%'UO$_\_)?>P_LO ?\
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M 4444 %%%% !1110 4444 9GB/\ Y!@_Z^+?_P!')6G69XC_ .08/^OBW_\
M1R5IT %%%% !1110 4444 %%%% !1110 4444 9?BC_D W?^Z/\ T(5J5E^*
M/^0#=_[H_P#0A6I0 4444 %%%% !1110 4444 %%%% !1110!E^*O^19U7_K
MUD_]!-=O7$>*O^19U7_KUD_]!-=O0!QGQ)_X]]-_Z[-_Z":XRNO^*$_D6VFG
MRWD_?-PBY/W37"?VD/\ GVN?^_1H N453_M(?\^US_WZ-']I#_GVN?\ OT:
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M S4__ 4T ;-%8W_"3+_T#-3_ / 4T?\ "3+_ - S4_\ P%- &S16-_PDR_\
M0,U/_P !31_PDR_] S4__ 4T ;-%8W_"3+_T#-3_ / 4T?\ "3+_ - S4_\
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M $#-3_\  4T ;-%8W_"3+_T#-3_\!31_PDR_] S4_P#P%- &S16-_P ),O\
MT#-3_P# 4T?\),O_ $#-3_\  4T 8GQ<T(^)O!SZ6)A;FZN(8_-*[MOS#G&1
MFO&_^&9Y?^AA3_P#/_Q=>T>)-<%Y!8Q"QOH<WD/SS0%5'S>M7:X:^"H8F2G5
MC=[;L]C!YOC<OINEAIV3=]D]?FGV/"O^&9Y?^AA3_P  S_\ %T?\,SR_]#"G
M_@&?_BZ]UHKF_LG!_P GXO\ S.__ %ES7_G[_P"2Q_R/"O\ AF>7_H84_P#
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M!QGQ)_X]]-_Z[-_Z":XRNS^)/_'OIO\ UV;_ -!-<90 4444 %%%% !1110
M4444 %%%% !79_#;_4ZI_P!=E_\ 0!7&5V?PV_U.J?\ 79?_ $ 4 =G17CO[
M3_QJUGX+>"+.]\,:+#XC\37UT8K32IF8>=''&\\^-I!W"*)]O^T5S5'QA^V=
M\*? BZ.=7URZ1]6T-/$=HEIIMQ<E[%F \W]TC8QU(/( )/ H ]PHKYA\:_MT
M^%;'7_$7ASP\LDNH67A,^)[+7;^RNGTF1&@,T>]H8V?R_+&XL.I^5<MP.Q_:
M)^.>K_![]EW6/B9I%GI^JZO96-I=16TPD^S2M++$AP,J^,2$C.#TS0![;17R
M'J?[<%_>:5X)O]#T>Q!UCPUX@U/4[._$GG6&H:;;HYMCAA@>8S!LC)&"",UZ
M5K'QYUC3OV-T^+\>GV+:Z?"4/B#["P?[-YSVZRE/O;MF6(^]G'>@#W*BOC7X
M8?M;_$B[^(7ACP_XQ3X::Y:^)M,O+VTE\ ZI<W4^GO!;&?\ TM)!\JL!LX/#
M'K6-\$_VV/B1XK\3?#,>*K3X<:AHOCN5K>WL?"6J7#ZOIS^4TBM<P2Y55^3!
M /!/6@#[CHKY-\"_M1?$75/'_P 2O"?C/1?"WA";PUHIUT7]C<2:HFF1^80M
MO>QAXO,F:,&0&)PN!SR<5[Y\&=<\5^)?AIHFL^-;6PL->OX?M4EKIT3QQPQ.
M2T2LKNY$GEE=XW$!BP!(&2 =M17@_P #OVCKWXI^._&6D7VE6]EIMNTMWX:N
M;<L6U*QBN);661\G&\30MPO&V1/>O,/@'^VKXL^(EUXKUOQ3HOA6R\&Z-8WM
M[=6VCZFYUK1C;DGR;VUF"EG=1PT0V@]3S0!]CT5\N_#+XX_'GQ9?^$?%&K_#
M3PY'\,O%2">#^S-5D?5=)MWB,D,]YYBK$RE0,B/D;O7@]A^S5\==;^,AU==:
ML[&U:&VM;ZW%I!)#^[G\S"_O';SE&P8G7:KY.%&* /<J*\LF_:7\!6OQ3@^'
MMS?W]IXCN)6M[<7.EW,5K/*%+F..X:,1.V 3@,>AKB])_;U^#OB&WE?2M;U"
M_E&F7.JP0+I%TC7<5N"9EA+Q@.ZXY4'(ZG H ^AZ*^0(OV[3XL\"3^+/#%A9
M6MN/ ^J>)X]'UJVNTO#<6KQA0&"+$\&),,P;))&S(!->A> ?VUOAAXM\+:AJ
M5[XA72+C1]*AU35$O[*>T1(GP/,A\U1YL9<[0R;@3@9- 'OM%>)Z7^V5\)]5
M\':YXE7Q#-:V6BO#'>VM[IUQ;WL;3'$(%LZ"5O,/"X4[NU<I\+OVV?#/CCQA
MXBL-1E_LW21KL>BZ#.]A<PRW$AL5NG2X5Q^ZD&) %8+G;C!- 'TO16#X%\;:
M5\1_".E^)M#EEGTC4XO/M99H7A9X\D!MC@, <9&1R"#WK>H **** ,;3?^1D
MUG_=@_\ 06K9K&TW_D9-9_W8/_06KSWXK?&>^^&WQ2\ :$-/M[GP_K<%_-JE
MXY836:PM:QQN@'!7?<C=D< 9!&.0#UNBO(M._:!L+74_$5AK4$SWMGKEUIEA
M8Z/937=S<00PPR/*8T#-A?- +8"C*CJ>>@'QS\&/HNLZM'JIFT_2-(CUR[GC
M@=@EI()"KC ^8_NI,J.1C!% '>T5YHO[0_@Z4:BT4NI3QV5V=.>2+2[AEENP
MX7[/$0G[R3D':N3CGI5'4_C:/$MWX?T+P+]GF\0ZU)=@MK,$L::;%:E%N7G@
MRDC.K2Q*(LIN,@)90,T >LT5XY=?'*3X8ZCJVE?$J6R66TCM+BTU71+2<1WT
M=Q.MNB_9B9'B=9G5"!)(""K97)5=*R_:1\%7OB2?0C+JEK?VUU;6-U]KTFXA
MBM+BXC22"*:1D"QLXD0 ,1R<=: /4:*\7^&O[2VC>*K2&'6X[C2]2ENM0MXY
M%T^X6TF-K)(&6.8J5=Q'&6*@D\-@<5JS_M*>"K&TOI[]M7TMK,6C/;W^CW,,
MSK<S"&!DC9 SAI"%R <'KB@#U.BN9\#?$/1OB':ZC+I+7*2:==FQO;6^M9+:
MXMI@BOL>.0!AE'1AQR&!%=-0 4444 %%%% !1110 4444 %%%% !1110!S'Q
M"U.ST;1(+W4+N"QLX;N%I+BYD$<:#=C)8D <GO7+_P#"W/ O_0Z>'O\ P:P?
M_%U@?MF?\F\^(_\ ?M__ $>E?F57E8O&2P\U!*^A^D<-<*T<]PD\14JN+4G&
MR2?1/]3]5/\ A;G@7_H=/#W_ (-8/_BZ/^%N>!?^AT\/?^#6#_XNORKHKB_M
M2?\ *CZS_B'>&_Z")?<C]5/^%N>!?^AT\/?^#6#_ .+H_P"%N>!?^AT\/?\
M@U@_^+K\JZ*/[4G_ "H/^(=X;_H(E]R/U4_X6YX%_P"AT\/?^#6#_P"+H_X6
MYX%_Z'3P]_X-8/\ XNORKHH_M2?\J#_B'>&_Z")?<C]5/^%N>!?^AT\/?^#6
M#_XNC_A;G@7_ *'3P]_X-8/_ (NORKHH_M2?\J#_ (AWAO\ H(E]R/U4_P"%
MN>!?^AT\/?\ @U@_^+H_X6YX%_Z'3P]_X-8/_BZ_*NBC^U)_RH/^(=X;_H(E
M]R/U4_X6WX&/_,Z>'O\ P:P?_%UU:.LBAE(96&00<@BOR K] ?V/?BRWCOP"
M-#OY_,U?1 L.YC\TEOTC;\/N_@*[,+CO;SY)*Q\MQ#P?_8^%6+H5'-)VE=;)
M[/[]'ZGM?B+_ (\K?_K\MO\ T<E:E9?B+_CRM_\ K\MO_1R5J5ZQ^:!1110
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M1_\ X9&^$_\ T*I_\&-W_P#':/\ AD;X3_\ 0JG_ ,&-W_\ ':/[,K=U^/\
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MO_@/'_A1_96I_P#0;E_\!X_\*UZ* ,C^RM3_ .@W+_X#Q_X4?V5J?_0;E_\
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M^%^1?] 5_P#P)'_Q-'_"_(O^@*__ ($C_P")KQ_]?.'/^@K_ ,EG_P#(G?\
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MD>JU?^V?].UY_P" DO\ \30!8HJO]L_Z=KS_ ,!)?_B:/MG_ $[7G_@)+_\
M$T 6**K_ &S_ *=KS_P$E_\ B:/MG_3M>?\ @)+_ /$T 6**K_;/^G:\_P#
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M\LG&[>2AR2"NWG/WK#\(O!EOIUY81^&[!+.\TV+1[B$1?++9Q*5C@(_N*&(
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M:##XD6[-^-36U F$Y8L9-W][))S0!^9?P#TEIM#^$,UIX1USPAXVU_7\Z?\
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M9?\ @+_R/N?K-#^=?>C*HK5_X136_P#H#ZA_X"O_ (4?\(IK?_0'U#_P%?\
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M?^@I9?\ @0G^-7/LL'_/&/\ [Y%'V6#_ )XQ_P#?(H I_P#"1Z3_ -!2R_\
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MDC9(.2!T/;FNDCD2:-9(V#HP#*RG((/0BO+[CX.7#VTNS4O](-VMPACFGM@
M+2*W(+0R*_\ RRW=<<X(KT;1M-CT;2+*PB_U=K"D*X)/"@#N2>W<GZT 7*PM
M?_Y"6G?[LO\ [+6[6%K_ /R$M._W9?\ V6@#%\5?\BSJO_7K)_Z":[>N(\5?
M\BSJO_7K)_Z":[>@#C/B3_Q[Z;_UV;_T$UQE=G\2?^/?3?\ KLW_ *":XR@
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M.Z_9P\!>$_&WPT\4>*M9\&:C=Z5#XC\(:C'9:O9);DQV=]:1N<2)+%L# R#
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M7Q5_R+.J_P#7K)_Z":[>N(\5?\BSJO\ UZR?^@FNWH XSXD_\>^F_P#79O\
MT$UQE>@>-]%OM9ALELHXY&BD+-YDFP ;<>AKF/\ A"M=_P"?:V_\"/\ [&@#
M&HK9_P"$*UW_ )]K;_P(_P#L:/\ A"M=_P"?:V_\"/\ [&@#&HK9_P"$*UW_
M )]K;_P(_P#L:/\ A"M=_P"?:V_\"/\ [&@#&HK9_P"$*UW_ )]K;_P(_P#L
M:/\ A"M=_P"?:V_\"/\ [&@#&HK9_P"$*UW_ )]K;_P(_P#L:/\ A"M=_P"?
M:V_\"/\ [&@#&HK9_P"$*UW_ )]K;_P(_P#L:/\ A"M=_P"?:V_\"/\ [&@#
M&KL_AM_J=4_Z[+_Z *Q?^$*UW_GVMO\ P(_^QK:\+:;K?A];Q7TZ";SG5P5N
ML8PH']V@#LZ*R?M^K_\ 0)B_\"Q_\31]OU?_ *!,7_@6/_B: -:LY?#NE)K\
MFNKIEFNMR6RV;ZD+=/M+0*Q98C)C<4#,S!<X!)..:B^WZO\ ] F+_P "Q_\
M$T?;]7_Z!,7_ (%C_P")H UJ*R?M^K_] F+_ ,"Q_P#$T?;]7_Z!,7_@6/\
MXF@#6HK)^WZO_P! F+_P+'_Q-'V_5_\ H$Q?^!8_^)H UJ*R?M^K_P#0)B_\
M"Q_\31]OU?\ Z!,7_@6/_B: -:BLG[?J_P#T"8O_  +'_P 31]OU?_H$Q?\
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M_P"@3%_X%C_XFC[?J_\ T"8O_ L?_$T :U%9/V_5_P#H$Q?^!8_^)H^WZO\
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MV/GS_A4WBK_H%_\ DQ%_\51_PJ;Q5_T"_P#R8B_^*KZ#^SZU_P! V#_P+_\
ML:/L^M?] V#_ ,"__L:^:_XA=DW_ #]J_P#@4/\ Y ]?_7''_P D/NE_\D?/
MG_"IO%7_ $"__)B+_P"*H_X5-XJ_Z!?_ ),1?_%5]!_9]:_Z!L'_ (%__8T?
M9]:_Z!L'_@7_ /8T?\0NR;_G[5_\"A_\@'^N./\ Y(?=+_Y(^?/^%3>*O^@7
M_P"3$7_Q5'_"IO%7_0+_ /)B+_XJOH/[/K7_ $#8/_ O_P"QH^SZU_T#8/\
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M $#8/_ O_P"QH GHJ#[/K7_0-@_\"_\ [&C[/K7_ $#8/_ O_P"QH I^(_\
MD&#_ *^+?_T<E:=9NJ:7KE_:")=/@4^;&^3=?W75O[OM5O[/K7_0-@_\"_\
M[&@">BH/L^M?] V#_P "_P#[&C[/K7_0-@_\"_\ [&@">BH/L^M?] V#_P "
M_P#[&C[/K7_0-@_\"_\ [&@">BH/L^M?] V#_P "_P#[&C[/K7_0-@_\"_\
M[&@">BH/L^M?] V#_P "_P#[&C[/K7_0-@_\"_\ [&@">BH/L^M?] V#_P "
M_P#[&C[/K7_0-@_\"_\ [&@">H;9[ZPFNC;O;F.>02XE1B0=BKC(8?W?UI/L
M^M?] V#_ ,"__L:/L^M?] V#_P "_P#[&@!-3\0ZIIMC+<D6<@C .W8XSSC^
M]5G^U-5_O6?_ '[?_P"*K+U?2M<U'3I[9=/MT:0  FZZ<@_W:N?9]:_Z!L'_
M (%__8T 6/[4U7^]9_\ ?M__ (JC^U-5_O6?_?M__BJK_9]:_P"@;!_X%_\
MV-'V?6O^@;!_X%__ &- %C^U-5_O6?\ W[?_ .*H_M35?[UG_P!^W_\ BJK_
M &?6O^@;!_X%_P#V-'V?6O\ H&P?^!?_ -C0!8_M35?[UG_W[?\ ^*H_M35?
M[UG_ -^W_P#BJK_9]:_Z!L'_ (%__8T?9]:_Z!L'_@7_ /8T 6/[4U7^]9_]
M^W_^*H_M35?[UG_W[?\ ^*JO]GUK_H&P?^!?_P!C1]GUK_H&P?\ @7_]C0!8
M_M35?[UG_P!^W_\ BJ/[4U7^]9_]^W_^*JO]GUK_ *!L'_@7_P#8T?9]:_Z!
ML'_@7_\ 8T 6/[4U7^]9_P#?M_\ XJH)6O+R[@EN7@VQ*P"Q(03G'J3Z4GV?
M6O\ H&P?^!?_ -C1]GUK_H&P?^!?_P!C0!2\5?\ (LZK_P!>LG_H)KMZXG6-
M*US4M*O+1=/@1IX7C#&ZZ9!']VNVH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>aciu-20221231x20f007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &G \ # 2(  A$! Q$!_\0
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M<FR''Y]4G2P$5)Q5W=I:?,^WJ*^ ?^'D7BG_ *%'2/\ O_+_ (T?\/(O%/\
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MTY'K6K!/%=01S0R)-#(H=)(V#*RD9!!'4$=Z -32/OR?05IUF:1]^3Z"M.@
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M^D\]?GA5YM_O3]$<?AO_ ,D_#_%+\SZ7_8!_Y+1JG_8"G_\ 1\%?2O[9O_)
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M1<83T4J+:7*E[^J2I.D^5\ONMWYD^CTL]SXYTG1-*\41?&6YTEKS2OACJ%O
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MO(O@CHVC:'JVJ?V5=:<_V^SM[O[-HFF#3[%$WRQAO*#'$I9&#9P<*H/2O7:
M"OQY^.G_ "6WXA?]C#J'_I3)7[#5^//QT_Y+;\0O^QAU#_TIDKYS.OX</4_<
M_"G_ 'W%?X%^9P]>K_LJ_P#)PW@;_K__ /9&KRBNI^%_CI_AGX_T3Q1'9KJ#
MZ9/YXMFD\L2<$8W8..OI7S%&2A5C)[)H_H+-*,\3@*]"DKRE"27JXM(^YO\
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M9O#>ZE^[* 3N6Q@@Y;'4^E0VOP#\0:9H_P#PC-AJ^CVWA];KS8]1&G_\36.
MR^88A)G:>Z[R,X- 'N,$\=U!'-$V^*10ZL.X(R#4E-BC6&)(USM10HSZ"G4#
M"BBB@ HHHH **** -#2/OR?05IUF:1]^3Z"M.@ HHHH *K:E_P @ZZ_ZY/\
MR-6:K:E_R#KK_KD_\C0!Y5X2_P"14T7_ *\H?_1:UK5D^$O^14T7_KRA_P#1
M:UK4 %%%% !1110 51&MZ<=8_LG[=;_VIY/VC['YJ^=Y><;]F<[<D#-7'=8T
M9F8*JC)8G  KY8N?%TUSKB_$F'1M9#Q:SYB7PM#]D;2=OD,"^>X_>=, T"/I
M^WU.SN[R[M(;J&6ZM"HN(4<%XMPW+N'49'(SU%6J\,:R\0WWQ&^).H^'_$L6
MB0P)8W&PVD<XN&%H&4.7^ZF.I7!YZ\5CS_&;Q+XPU*&#39M5T.*WTNUO)6T?
M0CJ;33SIOVO\K!(P!QC!///' %SZ)\Q/,";AO(W;<\X]<4ZOG3P_KVOZO\4;
M#Q#JNHR^'YD\(27=S8WMH(X8]DX5E8,N]4+ 29SN[ XJYX3^)7B(>.O"5M-K
MU]K^F:V98YFNM"^PVH81%PUM(45W7(_BSQ0![_1110,**** "BBB@#)\2?\
M'OIG_88TS_TN@KUZO(?$G_'OIG_88TS_ -+H*[;XD>/(/AMX3O->N=-U'5(;
M89:#3;<S2?4@?=4=V/ I2DHQYGL;4:-3$5(TJ2O*3LEYLZBBO@^U_P""@NH:
MCX[2ZO=$NK7PQ:HQCTO32K3W$AX4S2-T4<G:@&3C)(KMO^'BOA[_ *$G7/\
MOY'7FQS+#2^T?<UN!,_HN*6'YKJ^CCIY/5:^EUYGUU17R+_P\5\/?]"3KG_?
MR.C_ (>*^'O^A)US_OY'5?VAA?Y_S.?_ %*X@_Z!7]\?_DCZZHKY%_X>*^'O
M^A)US_OY'1_P\5\/?]"3KG_?R.C^T,+_ #_F'^I7$'_0*_OC_P#)'UU17R+_
M ,/%?#W_ $).N?\ ?R.C_AXKX>_Z$G7/^_D=']H87^?\P_U*X@_Z!7]\?_DC
MZZHKY%_X>*^'O^A)US_OY'1_P\5\/?\ 0DZY_P!_(Z/[0PO\_P"8?ZE<0?\
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M)--]3XDHHHKX4_K\*];_ &:O"UUK'C:]UNWTR;5AX<L9=26TA@,IFG VP)M
M.<R,#CT4GM7DE=GI'Q)GT#X;:EX5TZT^R7&I:A%>7>J1S$221QJ1'" !PH9F
M;.>_2MJ,HQFI2Z?TCRLTI5\1A94,/O.R;[)OWGNNE]M;GOU]X3GMOC_HWB2\
MT>321XH\/7VHSV%Q;F+R+L6,RSIM8#&)%W#V8'N*\U\/_#3X>ZQ\/M6\3W.M
M^(M,@TZ!4,EQ:0>5<WC#BWAPY9SG)S@849.*I>"OV@+KPOX:L]+OM*_MJXL;
MB[FL[Z:Z*R1)<6SP21\JV5.Y7ZCE!6AK_P <O!WB/PUI.B77PU\NTTJV,-I'
M;Z[-'&CD?-*4"?,Y/)+$D^M=[J4)IMM=79WW=NWG<^.A@\VPTXTXQE9*,>:#
MA\,)3:TG+=Q<5KMJ];*_HWCWX9>%?B/XK\&Z$VL7VF^*KSPC;2VD4-FC6F8[
M>23$C[@V6"-T'ISFN4\)_LNP:SI?AB*_N-?CUCQ%;+<P3V.E&?3[,.2(A/+G
M()(R=H.T$$URL'[0,\'Q+\+^+_[%C,FAZ.NDK:?:3B8""2'>6V\?ZW.,'IC-
M7_#O[1\>G:+HL&L>%8]>U/1K?[)9WDFJ7$$+1*28UF@0[)=I8\\$C /2J]IA
MIR<IK\]M/QW,OJ>?86A&EAI.R2_D;4O?NE=I<J]QN[?E?5'2?\*5EUJS\)Z3
MXE\03VMM8Z)JEX\<%G$QM?LTY$D:E<&3)!.6.?PK/L?@?X!U%?!LT7B?74A\
M72/;Z<CZ?%OAE63RRTV),;"V,;<GK7/VO[0]U#9Z?%)HL,DEKH^H:2SK/M#_
M &IR[2;=O&TGA>_J*R--^,<NG0_#R,:6DG_"(7$DZ$SD?:MTWFX/R_+Z=ZAS
MP_:^W?R_2YUQPF=I-*;CK+2/(EK[1I[/>7)YZN_5G;^%OV9[>[\/Z'>ZQ+XA
M:?6YY4MFT72OM4%M$LIB$MPV1M!(+87)V\^U8WB;X)Z-\/\ P!<ZQXBU:_76
MEU2]TB"SL;='B:> #:SNS A"3S@$^U/\._M&)9:+I^GZ[X8_M_\ LN:633Y!
MJMQ:"-'D,GE2K&<2J&)QG!P<9Q7*^,/BU<>,?!-GX?GTV"V,&K76JF>!R%)F
M !C"8X"XXY-3*6&4/=6MO/?3_@FU"EGLL5:O)JGSZVY/A]ZUM6]N5.Z3OMU9
MZ'X9^'EM\=K#5?'.L3ZJ\S:@E@^G^'+%+J>VC6)/W\J94E,=T4\AOI7B/B;2
MX-$\0ZEI]K=->VUM</%%<M"\)E4,0&*. RDCL1D5VWPW^*NC^"=)-IJ7@^#6
M;B.Y^TP:C;:A-872< >6\D7+ID9"GH2>?3E_B!XTO/B+XTUCQ+?Q0P7>I7#3
MO% ,(F>@&?0 <GK6%65.5--?%UW/5R^CC:&,J4YI^P2M#X;*UK))7D]+ZOE]
M'N<]1117(?2GL/[(7_)Q_@G_ *^9?_1$E?J[7Y1?LA?\G'^"?^OF7_T1)7ZN
MU]CDW\"7K^B/Y>\5/^1M0_Z]K_TJ050U#0[+5+S3[NYA+W-A*9;:579&C8J5
M/W2,@@D%3D'CC@5?K@OC9]HN?A_J5C:0WDES<*A0VMO+,,+*C,K"+YL,,C P
M2">17OGXP;.C:!H&F>+=6O=-T_[/JE[#&]Y<Q!A%* SA1UV;\[B<#=R">HKI
M*\;_ &?X(X)=9V>&HO#[L(R3':7<'F]?^>_7'^SZ\U[)0 5^//QT_P"2V_$+
M_L8=0_\ 2F2OV&KX\\=?\$]O^$U\;^(?$/\ PGWV/^UM1N+_ .S?V-O\KS96
M?9N\\;L;L9P,XZ"O%S3#U<1"*I*]GY?J?J_A]GF7Y'BJ]3,*G(I126DGK?\
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MY8Y_X%_]:HFO)5_Y=_\ Q[_ZU %NBL]M2F7_ )=<_P# _P#ZU1MJ\Z_\N?\
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M^7+_ ,B?_6J5=5G/_+GC_MI_]:@#3HJBE_,W_+MC_@?_ -:IEN)6_P"6&/\
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M^#/AC1M1TN^@@O)+K3&W6;W%]-+Y(VE=JAF("X/3IP/2NYHH **** "BBB@
MHHHH R?$G_'OIG_88TS_ -+H*Z[XL3^)K+P1?WGA&5%UFT7STADA$HF5?O)@
M]R.F.XKD?$G_ ![Z9_V&-,_]+H*]>H ^&/@O\6H=<^+EKJ^IIX<\)7\B&.;4
M;>VEA-Z&(S'(%D\LY(!W, 0>0:^YE(8 @@@\@CO7F?BC]G;P7XJT.XTZYTU8
M"\\MQ#<VX"2V[.=S!2/X<Y.T\<UXY'<_$K]EJY$5PK^,_ 2-A9%W>9;Q_KY9
M [<K[CLHQC'X58WJUZM>SJR<K*RN[Z=O0^L**Y'X>?%7PW\4-,%WH5^LS  R
MVLGRS1'T9?ZC(]ZZZF8!1110 4444 %%%% !1110 4444 %%%% !15+5M9L-
M"LWN]2O;>PM4&6FN95C0?B37B?CC]M?X7^#/-BBU6;Q!=IT@TF+S 3Z;V*K^
MM8U*U.DKU))'J8+*\=F4N7!T93?DF_O>R^9[S3)IX[:)Y9I%BB099W8!0/4D
MU\@R?M"_'+XLR&+P#\/#H-@YPM_J2EFP>AW.%4?@#]:GM?V0O'_Q.5+CXK?$
MJ\N8CACI.F,6C'IDG" CV0_6N3ZVZG\"#EY[+[V?2_ZLT\'KFV+IT?[J?M)_
M^ PT7SDCUCQS^UK\,/ 9DBN/$D.I7:$@V^EC[0V?3<ORC\Z\?UG]LGQSXYLK
MB3X;?#Z>/3HE+2:[K7^HC4?>8G*QK@>KGZ5:\7Z!\ ?V6K4>?HD/B/Q. &M[
M"<B[N'?L6#?+&,\Y(SZ ]*\>^*_B3QEX^T!/$7Q.NY/"/@MN=*\*6/[N>^8?
M<54/11QF5QP/NJ3Q7G8C$UU>+FD^T>GK)[?<?;Y+D64U>2K2PTI0;LIUG;F?
M:G2A9S^<N5=6>5_$CX]_$/QC=3VVK^,;B\ASAX=/D\JW]P @ (_,5;^'?P"U
M#Q;\+_%_CZ_+VFB:/92/:G'S7=P,8 _V5SDGN<#U(E^ _P &KW]H3XB)906_
M]F>'K0B6^E@!*P19X12>KMC&3SU/:OOOX]>'=.\(_LP^+=&TFU2STZRT=X8(
M(QPJC'YGN3W->;AL++$QG7JNZ2=O-GWN><08?(:V&R;+H1A4G*'-RI)1BVNV
MG,U]RU['Y1T445X9^MA1110 5V'@3X3>*OB,LL^@Z)<ZE:02+'/-%M55)_A!
M8C+8[#)]JX^O8_"4FD^,/A+I?AU_%=AX8U+2-;EU"1=49XXYXI(XU#QLJMET
M,9^4C^+@UO1A&<K2_P CR<RQ%;#45*CNVDVTY)+76T;-]%OI>XGQ)^"MOX7\
M0^)M%T33]<U*ZL-3L-/M)6:)TW3P;S%(H4,9&;A=H P#GG%<AXH^#7C7P8^G
MKK'AR\M3J$WV>UV@2^;+Q^[&PGYN?N]:]_USXH>'_P#A,_%=WI_C6"Q>?Q+H
MUU:ZN(#<92*T=))C%D;E#$!AD?>-6+3XB>!?!6N^%]:U*^T5M0M]?-W)#X/N
M+B6S:-H61[F:"3"K("5QLYP,5Z$J%&3=I6U[KO\ Y'Q.'SG-:%.$947-\J=N
M67,Y>SB]]$O>WTD[WNEN_GCQ9\&_&O@9+-]<\.7EBMY,+:!B X>4](_E)PY[
M*>3SQQ4_B7X&^//"&EC4=7\,WEI9^:D!D^5]DC'"JP4DJ2>!D#D@=Z]SOO%?
MA'2/#]SI%SXA\-6%EJVMV<\S^%)+VXN2D<A9KEI)9,0N >RLQSU& :MW_B+P
M7X>\$>/;/3_$7ARPOM2NK":TN]+N[F_O)UBOHY6FG:7:'D R^T8).ZI>%I:^
M]T[KS\O\C>.?YC^[3H[R2?N2LTW%7^)VM=WMS[=-E\]^+/@UXU\#Z;%J&N>'
MKO3[.6585E?:P$A&0A"DE6.#P<&D\4_!OQKX*T5-6UOP[=Z=I[%5\Z0*=A89
M4. 24)'3<!7O7B/QSX0TM6UK5-2\/:GJ2ZY8ZA&?"DUPAU)8[@/+)=VS_NU;
MR]Q&#D,<<]:K_$?QSX;B\,_$&YL-0\(3-XC4+$NFF]GOKO=,'#2I)($A9<;B
M?FY& .:4L-12DU+\5Y^1I0SS,IRI1E0W=F^623UCM[S:LFW=WO;51L[?+5%%
M%>6?H(4444 >P_LA?\G'^"?^OF7_ -$25^KM?E%^R%_R<?X)_P"OF7_T1)7Z
MNU]CDW\"7K^B/Y>\5/\ D;4/^O:_]*D%<+\;H[>7X8:TMUY_V<^3O^SP&=L>
M?'UC!!=?[R@@E=U=U7G/QATGQ#JL>D#1;/4;^VC:9KF#3-26QD+%,1,7+IE0
MQ)*YYXR*]\_&#E_V<_"NB^';S7WT;4+2YMY5B18;72)K$J@>1E:4R']X_P ^
MW*X&$7C/->W5Y1\%?#WB/0KJ]_M?2K[2;:2RMPZ7VIK>&>\!D\Z9<2/MW IQ
MQ]WI7J] !5*36M/BD9'O[9'4E65IE!![@C-7:^&OB)_R4#Q-_P!A2Z_]&M7E
MX_&O!1C)1O<^CR7*5FU2<'/EY5?:_P"J/M;^WM,_Z"-I_P!_U_QH_M[3/^@C
M:?\ ?]?\:^"**\3^W9?\^_Q_X!];_J9#_G^__ ?^"?>_]O:9_P!!&T_[_K_C
M1_;VF?\ 01M/^_Z_XU\$44?V[+_GW^/_   _U,A_S_?_ (#_ ,$^_+?5+*[<
MI!>03.!DK'*K''KP:L>8G]Y?SKY._9S_ .1YN_\ L'R?^C(Z^D*^@P6)>+I>
MU:L?$9MEZRS$O#J7-HG>UMSH?,3^\OYT>8G]Y?SKGJ*[SQCH-Z?WA^=(60_Q
M#\ZP** -X[/[R_G32(S_ !#\ZPZ* -HI&?XA^=-,,9[C\ZQZ* -9K>(]U_.F
M&TB/=?SK,HH T#91'NOYTTZ=">Z_G5'%&* +1TR$_P!VFG28#W7\ZKX%)@4
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MC_A7>K?]#*?_   3_P"*KO** .#_ .%=ZM_T,I_\ $_^*H_X5WJW_0RG_P
M$_\ BJ[RB@#@_P#A7>K?]#*?_ !/_BJ/^%=ZM_T,I_\  !/_ (JN\HH X/\
MX5WJW_0RG_P 3_XJC_A7>K?]#*?_   3_P"*KO** .#_ .%=ZM_T,I_\ $_^
M*H_X5WJW_0RG_P  $_\ BJ[RB@#@_P#A7>K?]#*?_ !/_BJ/^%=ZM_T,I_\
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M_,3Q^)<E-S=TVUZM)/\ !)6VMH5/"O@ZV\+O>SK<37U]>R>9<7=P1O<]N@
M]JEE\*02^,8O$1FD%S'9_8Q#QL*[BV?7/-+H/C7P_P"*5G;1];T_5%@YE-I<
MI+Y?^]M)Q^-<AKGQKT>'Q/X7TC0[_3-;?5-1-E<BWNU=[8;&;=A2>ZXYJU1@
MHJ*6BU,I8JM*<JCEK)6?IM8TM9^%=GJFH:C<1:C>V$6I;?MMM;L D^/7(X_"
MM!_ %@->T;4X7DM_[*@^SPVZ ;"O/7OWJK\3?B38?#32].N[Z6W3[9J%O9J)
MYA& KR*KR<]0BDL?I5_4OB+X6T86AO\ Q'I=G]KC6:W\^\C3S4(R&7)Y!R.1
M4?5J*=^7S_&_YZFSS#$M*+F[)6^35ORT]#!A^#NGV^CV-E#J%Y#-8W3W<%VF
MW>C-C(QC'\(_*GK\(K(6>N6[ZE>R_P!KJGVB64JS[E8,6!QW(_6N[BE2:-9(
MW62-AN5E.01Z@UYM\5/C?HW@+PWJEQI^HZ9JFN64D$9THW:^9\\\<;94'<,!
MR>G:H^IT/Y?ZM;\M#7^U<9UJ/>_3O?MWU-;2_A?:V&H:9<3ZG>ZA%I@_T2WN
M&&R(^O R?QI)/A3I<]KK<$T\\BZI<BZ9L@-"XS@J0/>M%/&,%GJOB--4U'1[
M33M+: >8+P>;"'C#'[0K ",DGY>3E>:O:-XPT+Q%93WFEZQ8ZC:0?ZV>VN$D
M2/C/S$' X]:KZK1M;E_JUOR(>98MRYO:.^GX._YZE#PYX&@T'5)]3GO;G5=2
MEC$/VJ[(++&/X1@#T&34GBOP7;>*I+&X:XGL;ZR??!=6Q =/4<@@BIM!\<^'
M?%-Q+!HVNZ=JD\0W/'9W22LHZ9(4FH5^(OA5]9&D+XCTHZH7\H68O(_-+_W=
MN<Y]JOV%/D]G;0Q^N5_:JOS>\M/E:UK;6MTV,BU^%%I FO"34KRYDUB+RIY9
M=I8>K#CK0_PIM4FTZXL]4OM/N[2U%F9[=E#21C/7(X//45M:C\0/#&CZJ-,O
MO$.F6>HD@"UGNXTER>@VDYYI^O>.?#OA>:*'6-=T[2Y91NCCO+I(F8>H#$9K
M/ZI1VY?ZO?\ ,W_M/%WO[3\NUNW;0XSQ!\.H_#_@<Z=IUK>ZQLOA=Q"*98YH
M#S\RG!SCT]ZJ>#?"NHZEXWOM7O8=4AM6L&M?.U0(LTCM@<*O  &>G]:]7@GC
MN84FAD66)U#(Z'*L#T(/>LD^,] 67RSK5@)-YCV&Y3.X=5QGK[5SSPE&,XR;
MLE;3T_X<[J>9XNI2G34>:4KW>K>MK^70P&^%%@W@VW\.?;;C[-#<_:1-A=Y.
M2<=,8YJUJ?PZ@NM5DU*PU*\T>\GB$-P]FP'G # )!!YP!R*W-0\2:3I,HBO=
M2M+20IY@2:94.W^]@GI[TVZ\4Z-9& 7&JV<!G4-$))U7>#T(R>16KHX9*VFE
MNNUMCF6*Q\GS)MWN]M[V;Z6>R^XR4^'UO9:)9:=I>HWVDBT<R+-:RX,C'J7!
MX?/N*I+\*[)M-UJ">_NKFZU;:+F]DV[R%.0  ,#\JZQ=7L6OUL1>0&\9/-%N
M)!O*?WMO7'O48U_3&BNI1J%L8K5S'._FKB)AU#'/!]C5.AAWNEV_"WY$1Q>-
M6S>KOMKO=:VOOKVN85UX#D:&TCL]?U/3U@M4M2D4@:-U50N=C J#@=0!6IX4
M\+V?@_1X].LM[1JQ=GD.6=CU)JQ:^(=+OK*6\MM1M9[6$$R3QS*R(!UR0<"H
MK;Q9HM[<QV]OJUE-/(-R1QW"LS#KD 'FJC"A"2FK7Z:_D14JXRK!TI)V6^GY
MZ=+]=CD]6^#6G:OX.\8^'9+^Z2V\37TM]<3*%WPL^S*IQC \L=?4U:UWX3Z9
MXBU[2]2O+BX86.EW.D_9U("RQ3(%<DXR#@<8]:GA^)NDZEJ&KV%C=6_VFQ@:
M19;F8)#(P!)P>3M7'+=JV++Q#;IH%MJ.HWMA DBY::&X!@)_V7.,BKC7IS^%
M_P!(QJ8.O2MSP:;MIUU5UH>=Q?L^(=(T/2KKQ;K-YIFB303:?:.(E2+RB-@;
M:@+X4%?F/?/6HAX0/C7X^P^)+C1-0TZR\/VSP+/>JJ1WUQN98WC4$[E17D(8
MXY<5ZC'XBTN;3GU"/4;5[%/OW*S*8U^K9P*9:>)](U"[6UMM4L[BY9=PABG5
MG(QG. ?2M/:0TU6IC["IJ^5Z;Z;&G1115F(4444 :&D??D^@K3K,TC[\GT%:
M= !1110 56U+_D'77_7)_P"1JS5;4O\ D'77_7)_Y&@#RKPE_P BIHO_ %Y0
M_P#HM:UJR?"7_(J:+_UY0_\ HM:UJ "BBB@ HHHH *9--';Q/+*ZQ1("S.YP
M%'J3VI]1SP174+PS1I-#(I5XY%#*P/4$'J* ,H>-/#Y( UW3"3V%Y'_C6P"&
M (.0>017CK>%-!L_BWXE":)HRQ6WAVVN(TN+:-($?S;CYF^7Y1P,MCH/:L[2
M?C+JL?B/3].;5]%UR.[MKAF&F6DR);21Q%UQ*QVR+QCC!H$>Z45YAI?Q(U6\
M\,_#6_D2V$_B*ZCAO J':%,$LAV#/'*+USWKT^@84444 %%%% !1110!D^)/
M^/?3/^PQIG_I=!7KU>0^)/\ CWTS_L,:9_Z705UOQ9.N'P1?1>'=;T[P]JDP
M\M-1U(X2$'J5_P!KTS2D^6-[7-J--5:D:;DHINUWLO-VOH6S\1_#JZSJNFMJ
M<$<FE(C7TTDBK%;L^=B,Q(^<A6.!T YQD9\P\>?MH_##P0)(HM6D\0WRY MM
M'C\W+>A<D(/S_"ODSPC^S8UW\2+?3?%/B>S\56-_*3<+X7U43W7F9^_(KKDC
MKD\D9K[@\ _LZ_#OX:HAT3PO9+=*<_;;M/M%QGU#R9*_1<#VKRZ=3%UD_=4/
M6[_ _0<9@.&<JE%RKSQ+:3M#EC&_7FD[M:]%&]OO/!F_:0^-?Q8=HOA[\.&T
MFSD^Y?:C\V!Z[WV)_/\ &ID_9'^(WQ29)OBK\2KBXMMV_P#LK3&9XE_,*@/T
M0_6OKI5"*%4!5'  & *6M/J:G_'FY?@ON1P/BF6%TRG#4\/_ 'DN>?\ X'.[
M^Y(\9\"_LB?"_P "^7)%X;AU>\3_ )>=6_TDY]0C?(/RKV.*&.WB2.)%CC0;
M51!@ >@%/HKLITH4E:$4CY;&9AB\PG[3%U93?]YM_=?8****U. \<^+?[-.@
M_$:=]6TY_P#A'O$P/F+J%J,+(XY!=1CG/\0P?K7 ^'OCMXQ^#&L0^'?BKI\M
MU8LVR'7K<%\C^\3@>8/R8=P:^H:SO$'AW3/%6ESZ;J]C#J%C,NUX9UW _3T/
MN.13 -!\1:9XHTR+4-)OH-0LI1E9H'#*?\#[5HU\K^*?@SXL^ 5W=>*OAKJ[
MRZ/'F2\T:]E!7RQR?O8#@#OPX[$U@>(_VU/$GBG2=,T7P+X7(\6:B?(,TTBO
M%$YX!0$@'URV .^:RJ5%3BY/6W;5GH8' U,?7C0IM1YNLFHQ775O3;Y]D?1_
MQ3^,WA3X.Z,U_P")-16!BI,-G%A[B<^B)_4X'J:^8_[8^+/[8UPUM8Q2^ OA
ML[8EG.1)=)_=SP9,CL,+ZDUVGPH_8[!UI?%_Q5U%O&'BB5O.-I._F6T3>C9X
MDQZ8VCT-?3D$$=M"D4,:Q1( JHB@*H] !TK@]G6Q6M7W8]EN_5_HC[#Z[EG#
MWNY<E7Q"_P"7LE[D7_T[B]VOYI>J1YY\'O@#X0^">G&+0;!6U"1-D^J7 #7$
MP]-W\*Y_A&!7H]%>+_M%_M'Z=\%-*CLK.(:MXNOAMLM-C^8J3P'D YQGH.I-
M=;=+#4[[11\S2IYAQ!CE%-U:TWNW^+?1+[DB;]HK]HK3/@?H2Q1(-3\4WPV6
M&F(<DD\"1\<A0?Q)X'<CSS]G[]G;4;W76^*GQ3D^W^*[IA=6UI<_=L@/NLP/
M 8#&!T4 =^D_[._[-^I?V^WQ-^)LG]J^,KX_:+>TN/G6RST)!XW@< #A.W(X
MSOVH/B[JOC?Q)!\&OAZS7&MZDPBU6\B;"6\9ZQEATXY<]AQR217F3DVOK%=:
M?9CY]+^?Y'WV%HPI2>29--<S7[^OT45\2B^D%U>\WY'->/\ Q%JO[8WQ83P-
MX<GE@^'>BS"74]1A^[<,"1G/?N$'U;MQ]@>&/#.F^#?#]AHFCVJ66FV40A@@
MC'"J/YD]2>Y)-<O\%_A%I/P6\#6GA_3 )''[RZNRN&N)B/F<_P @.P KO*[L
M/1E"]2IK.6_EY(^2SS-:6*Y,#@%RX:EI%=9/K.7]Z7X+0****[3Y0*YWXA>#
M+;XB>"=9\-7<\MK;:G;M;R308WH#W&>,UT5%*24DXO9FM*K.A4C5INTHM-/L
MUJCY%_X=P>#_ /H:M<_[YA_^)H_X=P>#_P#H:M<_[YA_^)KZZHKS_P"S\+_(
MC[+_ %VXA_Z"Y?='_(^1?^'<'@__ *&K7/\ OF'_ .)H_P"'<'@__H:M<_[Y
MA_\ B:^NJ*/[/PO\B#_7;B'_ *"Y?='_ "/D7_AW!X/_ .AJUS_OF'_XFC_A
MW!X/_P"AJUS_ +YA_P#B:^NJ*/[/PO\ (@_UVXA_Z"Y?='_(^1?^'<'@_P#Z
M&K7/^^8?_B:/^'<'@_\ Z&K7/^^8?_B:^NJ*/[/PO\B#_7;B'_H+E]T?\CY%
M_P"'<'@__H:M<_[YA_\ B:/^'<'@_P#Z&K7/^^8?_B:^NJ*/[/PO\B#_ %VX
MA_Z"Y?='_(^1?^'<'@__ *&K7/\ OF'_ .)H_P"'<'@__H:M<_[YA_\ B:^N
MJ*/[/PO\B#_7;B'_ *"Y?='_ "/D7_AW!X/_ .AJUS_OF'_XFC_AW!X/_P"A
MJUS_ +YA_P#B:^NJ*/[/PO\ (@_UVXA_Z"Y?='_(^1?^'<'@_P#Z&K7/^^8?
M_B:/^'<'@_\ Z&K7/^^8?_B:^NJ*/[/PO\B#_7;B'_H+E]T?\CYM^&'[#WAG
MX7>/-(\4V/B'5KRZTZ1I(X+A8MCDHR<X4'HQKZ2HHKJI4:=!<M-61\]F6:XW
M-ZJK8ZHYR2LF[;:NVEN["N+^,8T]OAOK U0SBS/D@_9PA;?YR>7PY"XW[<[N
M,9SQ7:5P'QMMG/@.]O!?:C:):@;XK&2-%E#LJ?O2\<@\M=VYB!P 3S6YY)S_
M ,$;^'5]?\0W\\EQ-JL\%N3.UO!!%/:AIEBD58F/)(D^_P#-MVD<$5Z_7B'[
M-NJOJ0U4M?3ZD3;V[O/Y\4T*-\Z>5E(H\, @(!S\C)TKV^@ KX:^(G_)0/$W
M_84NO_1K5]RU\-?$3_DH'B;_ +"EU_Z-:OF,]_AP]3]"X-_WBMZ+\SI_@)X3
MMO$_CJ*2]57L[!#<LCGAV!P@/MGG\*^J];TO3O$6F3:??_O;.88DC29H]P],
MJ0<>V:^#**\C!YC'"TG3]G>^^N_X'U&:9%4S+$K$*NX\NRMMYWNM3[!_X43\
M/O\ H#)_X'3_ /QROF;XFZ/9>'_'FL:?IT0@LH)0L48<OM&T'J22>2>IKEZ*
MPQ6+I8B"C"DH>:_X9'9EN68G!57.MB95$U:SOIYZR9ZG^SG_ ,CS=_\ 8/D_
M]&1UVO[3VCZGK'PS1=/CFFAM]2M;F^C@@\]C:H^9#Y61Y@'#%>X4UQ7[.?\
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M@0,K1R$J,-N'3VS7T[10%CS#]H1K>V\&Z7?7<8-I9:YIUS<2&,N(H5N$,C$
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M#Y-Q=64[6J^4?F'E.20<8'!J.*![31/A[JFH0/<:!:Q.+E!&76-R3AF4=O\
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MFG]VGCPH@_@% %W[;;G_ );Q?]]BE^UP'_EM'_WV*J#PL@_A'Y5*OAE!_"*
M)OM4/_/:/_OH4OVB(_\ +5/^^A35\.QC^&I5T%!_#0 WSHS_ !K^=+YBG^(?
MG4ZZ*@_AJ9=*0=J *>X'N*7K6@NG*.U2K9*.U &7M)[&EV-_=/Y5KBV IXA
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M\>?] ?P[_P"#R?\ ^0Z/[!\>?] ?P[_X/)__ )#KU*B@#RW^P?'G_0'\._\
M@\G_ /D.C^P?'G_0'\._^#R?_P"0Z]2HH \M_L'QY_T!_#O_ (/)_P#Y#H_L
M'QY_T!_#O_@\G_\ D.O4J* /+?[!\>?] ?P[_P"#R?\ ^0Z/[!\>?] ?P[_X
M/)__ )#KU*B@#RW^P?'G_0'\._\ @\G_ /D.C^P?'G_0'\._^#R?_P"0Z]2H
MH \M_L'QY_T!_#O_ (/)_P#Y#H_L'QY_T!_#O_@\G_\ D.O4J* /*)O"'C35
M)]/CNM/T&UM8K^TNI98=6FE<)%<1RL%0VJ@DA"!EAUZUZO110 4444 %%%%
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MK9H^\X2PU#$UZJKP4DDMTGU\S<_X73XS_P"@S_Y*P_\ Q%'_  NGQG_T&?\
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M]_\ 05!10!/]MF_O_H*/MLW]_P#\=%044 3_ &V;^_\ ^.BD^V3?W_T%0T4
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M#O\ H;-#_P#!E#_\57.T4 =%_P +.\'?]#9H?_@RA_\ BJ/^%G>#O^ALT/\
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MK_A>X\;Z7)I7C'5)=3O;B[T]M#O FGW2S* %GY_=D'AB>H Q0%SU!?B@]O\
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M !NC_AK7X6_]#%)_X+[G_P"-UZMC\Z;;=V>PT5X]_P -:_"W_H8I/_!?<_\
MQNC_ (:U^%O_ $,4G_@ON?\ XW0(]AHKQ[_AK7X6_P#0Q2?^"^Y_^-UY%^T!
M^V[I<.A#1?AK>/?ZY>922_:W>-;-?]D.HRY[<8'6L:U:-"///_A_0];*\KQ&
M;8A8?#+7=MZ**6\I/HE_6IU_[1G[2MQX=U!? /P^B;6?'M\WDG[.N\66>Y[%
M_;HO4UM?LW_LVVWPFLWU[7W76/'>H9DO-0E;S/)+<E$8_JW<^U>2_LY>(_@_
M\&]/?5M4\2MJWC2_4O>ZC)87+F,MRR(3'TSU;J:]N_X:U^%O_0Q2?^"^Y_\
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MV1#<3 9*Q%%;=@8.< <]: ,[2OBIX@T=K'R)K=X[2P;34AGMDDC>W,AD*.K
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MZ; ,VG^CB*>,%F)#X.UASP0!WKKZ "OC_P <_P#([>(/^PA<?^C&K[ KX_\
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MBBB@#0TC[\GT%:=9FD??D^@K3H **** "JVI?\@ZZ_ZY/_(U9JMJ7_(.NO\
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M56NK[07V8_-ZG(_\*?\  ?\ T)/AW_P50?\ Q%-?X1> 8T9F\%^'%51DDZ5
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M$%UHO]CW]CJ-O92WS6]S:2K)L120-NW.6.%'')(%5KGPMK%H=/TS3K36WO\
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M\.\5?]RPO^)_D?HO!G^\5O\ "OS,2NJT/XG^)?#UJMM9ZDX@486.55D"CVW
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M/^A9G_\  R#_ .+KT^B@#S#['XD_Z%F?_P #(/\ XNC['XD_Z%F?_P #(/\
MXNO3Z* /,/L?B3_H69__  ,@_P#BZ/L?B3_H69__  ,@_P#BZ]/HH \P^Q^)
M/^A9G_\  R#_ .+H^Q^)/^A9G_\  R#_ .+KT^B@#S#['XD_Z%F?_P #(/\
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M[,/XFZ+CUZ>E?L\_L\:3\#/#V-R:CXENU!U#5"O+L>2B9Y" _B>I]!+^S_\
ML]Z)\"_#QCMPM]K]VH-_JCK\\AZ[5SR$![=^IKUBN>C1E*7MZ_Q=%T7_  >[
M/9S3-L/1P_\ 9.4W5!?%)Z2JR75]HK[,?F]0HHKB/C!\6-'^#7@F\\0ZN^[R
MU*6UJI^>YF(^5%^IZGL,FNZ4HPBY2=DCY3#X>KBZT:%"/-.3LDNK9P_[4/Q^
MC^#OA9-/TDBZ\9:N##IMI&-[ID[?-*]\$X4=SZX-5/V6?@%)\,=%N/$?B3-Y
MXYUO]]>W$QWO K'=Y8/J3RQ[GZ5PO[,OPGUCXC>+9_C1\05$NI7K;]'L9%.(
M(Q]V3!Z #A!]3W%?6E>?0C+$3^L5%I]E>7?U9]KFV(I9-A7DF"E>3UK37VI+
M["?\L>O=A1117I'P04444 %%%% !117C7Q:_:6T3P [Z3HZ?\)'XG<^7'8VI
M++&YZ;R._P#LCD^U 'J?B+Q)IGA/29M3U>]AL+&$9>:9L#V ]2?05\X:_P#'
M3QA\:]3E\/?"W3I;33P=EUKMPNTJ#Z'H@_-CVQ3O#GP-\8?&K4XO$/Q4U":V
ML%.^UT& [=H/J.B?JQ[D5]&>'?#6E^$]*ATW1[&'3[&(82&!=H^I]3[GFF!Y
M;\)_V9]!\ 2KJVK.?$?B9SYDE]=C<B.>NQ3GG_:.3].E>RT44@"O/?V@O^2*
M^,/^P>_]*]"KSW]H+_DBOC#_ +![_P!* /S3HHHJP/ISPYK;6NJ_#36O^$RT
MZV\.:-H\"ZC8'45#J0',B&#.79@5&,$]CTJK!KD>M:YX(US0/%6GZ!X:TM%^
MUZ=/?K ]OME9I 8<YDW*1T!STKYMHI6 ^CH-<A\2WOA>_P#"OBC3_#>DZ=J5
MS+=65S>K9F,-=-(K^62-X,15>,XVXJ3PU>Z-XNU_QM'J5S'-8^&]?NO$UO*I
M#I/ )'WQJ1D$.PA/N.G6OFVMVT\9ZC8>%+WP];^1#8WLBO<ND*B:4*051I.I
M4$ [>F10!TGPU\8VD/QGTSQ)X@D"V\E\]Q/-(N\1NX;:Y_W796S[5Z?H&J?\
M(?X>N_\ A,?%FG>(K5O$.GWBVEOJ*WCF-9'\V7:"< _*=O7Y>0.,_-]% 'UE
MXC\7Z);QZ_,9+"2'4[V!HYIO%?VXR$3AEE2W$7[HJ 3\Q4 '&:YOQ;\1W,WQ
MO>U\2AC-+:)IABO0=Z?: K^1@\_(3G;VKYQHH ^J=(\;Z#?:4+.ZO(+_ %F\
M\-:7&SG618-(4+&6)KG#;7'RDJ<$XQ5?Q#X]TR"+6TL[NQTW4[;PFUHL]MK7
MVV61S,"D?G[$WR*I;[N[@CGBOEZBBP'TAX<\7V]WIG@99?$%O'J<GA_5[&6>
MXO55HY'!$*RN6^7DY&[ZTS0&TNZFT"WO?%*6UW9^&[BWECLM6BMS=S?;)"86
MN6W*@(^;/4C!'6OG*B@#VOX_:AIEWX7\&6]C/:M/:+<QS00ZJ-1>'+A@&FX+
M9!STQV'2O%*** /4/V9/^2Z^$_\ KO)_Z)DK]'J_.']F3_DNOA/_ *[R?^B9
M*_1ZDP"N(^-1MQ\,M:^TW5S91$1#S[0(9 WG)M W_+@M@$MP 3GBNWKC?BUK
MNG:+X'U/^T9YHHYHMHCMO*\V0;E# "7Y"/F .[C!-(#D/@%XEN=;;4HKV_FN
M[D6]O.4>&T544[T'S0(N2#$PPW8*1P:]AKQG]G&_>6PU>V1?#%O9K(LD-MH"
MQB9<C!:X\I%CW''&T'IUKV:@ KD;WX4>%-1O;B[N-)62XGD:61_.D&YF.2<!
ML=3775\Z>*?VJK[P[XGU?2D\/V\R6-Y-:B5KE@7".5R1MXSBN+%8#"X]*.*I
M1J);<T5*WI=,Z*.(K8=MT9N+?9M?D>K_ /"F_!W_ $!E_P"_\O\ \51_PIOP
M=_T!E_[_ ,O_ ,57BG_#86H?]"U;?^!3?_$T?\-A:A_T+5M_X%-_\37G_P"K
MV4?] =+_ ,%P_P CK_M/'_\ /^?_ (%+_,]K_P"%-^#O^@,O_?\ E_\ BJ/^
M%-^#O^@,O_?^7_XJO%/^&PM0_P"A:MO_  *;_P")H_X;"U#_ *%JV_\  IO_
M (FC_5[*/^@.E_X+A_D']IX__G_/_P "E_F>]Z)\.O#OAR[:YT[35MIV0QEQ
M+(V5)!QRQ]!6W_9]O_SS_4UXY\*/VA+OXC>(Y],FT:&R6.U:X\Q)RY)#(N,$
M#^]^E>L_VNW_ #S'YUZF'PE#!P]EAJ:A'M%)+[D<56M5KRYZLG)]V[O\2U_9
M]O\ \\_U-!T^#_GG^IJK_:[?\\Q^=']KM_SS'YUTF)8.GP?\\_U-(=/A_N?J
M:@_M=O\ GF/SH_M=O^>8_.@"0V$?]W]:8U@G84G]K'_GD/SI/[6/_/(?G0 A
ML!4;6)[$U+_:I_YYC\Z3^U3_ ,\Q^= %=K&3LQ_*HFL9^SD?A5W^TS_SR'YT
MG]IG_GD/SH SVLKGM(?R'^%1-97G:8_D/\*U?[1_Z9#\Z3^T,_\ +(?G0!CM
M:7W_ #V/_?(_PJ-K74.TY_[Y'^%;?V__ *9#\Z/MP_YY#\Z ,!K74O\ GX;_
M +Y7_"FFVU/_ )^6_P"^5_PKH/MH_P">0_.C[:/^>0_.@#G#;:KVNF_[X7_"
MD\C5?^?EO^^%_P *Z/[6O_/(?G1]K7_GD/SH YOR-5/_ "]-_P!\+_A1Y&J_
M\_3?]\+_ (5TGVM?^>0_.C[6O_/(?G0!SGD:K_S]-_WPO^%*+?5?^?IO^^%_
MPKHOM:_\\A^='VM?^>0_.@#GQ;ZG_P _+?\ ?*_X4\6NI?\ /RW_ 'RO^%;O
MVP?\\A^=+]M'_/(?G0!B"TU'_GX8_P# 1_A4BVE_WG/_ 'R/\*V/MP_YY#\Z
M/M__ $R'YT 9:V5X>LQ_[Y'^%2+977_/4_D/\*T1J&/^60_.E_M'_ID/SH I
M+8S]Y#^0J5;&3NQ_*K']IG_GD/SI?[4/_/(?G0!&M@W<DU(M@.]']J'_ )YC
M\Z7^U3_SS'YT /6P3N*>-/B_N_K4/]K'_GD/SI?[7/\ SR'YT 3C3X?[GZFE
M&GP?\\_U-5_[7;_GF/SH_M=O^>8_.@"U_9T']S]31_9]O_SS_4U5_M=O^>8_
M.C^UV_YYC\Z +7]GV_\ SS_4T?V?;_\ //\ 4U5_M=O^>8_.C^UV_P">8_.@
M"]#;1P$E%VD]>:EJI9WINF8%0N!ZU;H **** "D) !). .]+5;4O^0==?]<G
M_D: *G_"5:+_ -!BP_\  E/\:/\ A*M%_P"@Q8?^!*?XUY5X4T>P?PMH[-96
MS,;.$DF)<GY![5J?V+I__/A;?]^5_P * /0?^$JT7_H,6'_@2G^-'_"5:+_T
M&+#_ ,"4_P :\^_L73_^?"V_[\K_ (4?V+I__/A;?]^5_P * /0?^$JT7_H,
M6'_@2G^-'_"5:+_T&+#_ ,"4_P :\^_L73_^?"V_[\K_ (4?V+I__/A;?]^5
M_P * /0?^$JT7_H,6'_@2G^-'_"5:+_T&+#_ ,"4_P :\^_L73_^?"V_[\K_
M (4?V+I__/A;?]^5_P * /0?^$JT7_H,6'_@2G^-'_"5:+_T&+#_ ,"4_P :
M\^_L73_^?"V_[\K_ (4?V+I__/A;?]^5_P * /0?^$JT7_H,6'_@2G^-'_"5
M:+_T&+#_ ,"4_P :\^_L73_^?"V_[\K_ (4?V+I__/A;?]^5_P * /0?^$JT
M7_H,6'_@2G^-'_"5:+_T&+#_ ,"4_P :\^_L73_^?"V_[\K_ (4?V+I__/A;
M?]^5_P * /0?^$JT7_H,6'_@2G^-'_"5:+_T&+#_ ,"4_P :\^_L73_^?"V_
M[\K_ (4?V+I__/A;?]^5_P * /0?^$JT7_H,6'_@2G^-'_"5:+_T&+#_ ,"4
M_P :\^_L73_^?"V_[\K_ (4?V+I__/A;?]^5_P * /0XO$FD3RI%%JME)([!
M51+A"6)Z #/)K2KQ?7]+L[=-*DBM((Y%UC3,,D:@C_38.^*]HH *0D*"2< =
M2:"0H))P!R2:^1OCE\>=<^+7BIOA1\)G-U<W#&'5-;MS^[B0??59!P%'1G[]
M%ZUSUZ\:$;O=[+JV>YE.45\WKNG2M&,5>4G\,(]6W^2ZD_QS^/NO?$CQ2WPK
M^$9>[U*X/DZEK5NV$MUZ.%?^$ 9W./HN37L'P#^ .A_ KPT;6S5;S6KH!K_5
M'7YYF_NKZ(#G _$\U/\  GX$:'\#?"RV&GH+K59P'OM3D'[R=_3V4=A^/4FO
M3*PHT).7MJVLOP7DOU9ZV:YO0C0_LK*4XX=/WG]JK)?:EY?RQZ;O78HHI&8(
MI9B%4#))/ KO/C2AX@U^P\+:+>ZMJES'9Z?9Q---/(<*B@<U\<>#-(U/]M+X
MM/XKUZ&2W^&N@3&.PT]\A;I@<X/J3@%SZ86IOBIXIU7]KGXII\./"%R\7@G2
M)O-UC5(\B.8JV#@]& .0@_B.6Z#-?7/A'PIIG@?PW8:%H]JEIIUE$(HHD';N
M3ZDG))[DUY3_ -MJ6_Y=Q_\ )G_DC]$C_P 8K@^=_P"^UEIWI0?7RG);=8KS
M-6&&.VA2**-8HD4*B(,*H'0 #H*?117JGYWOJPHHHH ***:[K&A9V"J!DL3@
M"@!U8'C+QYH/@#2I-1U[4H=/MU&0'.7<^BJ.6/L*\B^)?[4MGI>J-X<\#61\
M5>(W;RE: %X$?V(^^1[<>]9/@W]F?5O&6LIXG^*^J2ZOJ#$2+I22?ND[A7(X
MP/[J8'N:8&/>_$3XB?M(7LFE^";6;PMX38E)]7G)1W3O\PYR1_"GXG%>N_";
MX >&?A1")[:'^T=:8?O-3NE!D]P@_@'TY]37HMC86VEVD5K9V\=K;1+M2&%
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M;S%K10'B+&0B!CO8OM0H2W #.PYQQ[+0)!7Y_?$S_DI'BO\ ["UW_P"CGK]
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MG;VC7,IGG:")4,LA !=L#YFP!R>>*MT#-#2/OR?05IUF:1]^3Z"M.@ HHHH
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M444 %%%% &3XD_X]],_[#&F?^ET%>N2(LJ,CJ'1@0RL,@CT->1^)/^/?3/\
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M PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** -#2/OR?05IUF:1]^3Z"M.@ HHHH
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MV_\ \<H_X9R^(G_0O?\ D[;_ /QRKN@/-:*]*_X9R^(G_0O?^3MO_P#'*/\
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M2MS_ !G_ +X;_"@"S14 O83T8_\ ?)_PIXN$/0G\C0!)12!PW3/Y4X*3T!H
M2BGB%ST6G"UE/\'ZT 145,+.8_P?J*7[#/\ W/U% $%%6/L$_P#SS_44O]GW
M'_//_P >% %:BK/]G7'_ #S_ /'A1_9UQ_SS_P#'A0!/I'WY/H*TZH:=;20,
MYD7:"..0:OT %%%% !115;4O^0==?]<G_D: +-%>">%_ ?AJX\-:3++X=TJ2
M5[2%G=[&(LQ* DD[>36G_P *^\+?]"UH_P#X 1?_ !- 'M%%>+_\*^\+?]"U
MH_\ X 1?_$T?\*^\+?\ 0M:/_P" $7_Q- 'M%%>+_P#"OO"W_0M:/_X 1?\
MQ-'_  K[PM_T+6C_ /@!%_\ $T >T45XO_PK[PM_T+6C_P#@!%_\31_PK[PM
M_P!"UH__ ( 1?_$T >T45XO_ ,*^\+?]"UH__@!%_P#$T?\ "OO"W_0M:/\
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M\U86BBBNLP"N8^)W_(@:[_U[-73US'Q._P"1 UW_ *]FKR,X_P"1;B?\$_\
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M5KJ!64X(,@!!_.K-?E_\7_\ DK7C;_L-WO\ Z/>F!^FW]JV7_/Y;_P#?U?\
M&C^U;+_G\M_^_J_XU^3=%%@/UD_M6R_Y_+?_ +^K_C1_:ME_S^6__?U?\:_)
MNBBP'ZSPWMO<N5BGBE8#.$<$X_"IZ^"_V,6*_%34""0?[(EZ?]=H:^T_-?\
MOM^=(#H:0C-<_P":_P#?;\Z/-?\ OM^= &_MI"F:P?-?^^WYT>:_]]OSH W#
M$*:8 :Q?-?\ OM^='FO_ 'V_.@#7-JIIALE/:LOS7_OM^='FO_?;\Z -$Z>I
M[4PZ8A["J/FO_?;\Z/-?^^WYT 6FTE#V%1MHL9_A%0^:_P#?;\Z/,?\ O-^=
M #CH<9["F-X?C/\ "*7S'_O-^='F/_>;\Z (F\.QG^$?E3#X;B_NBK'F/_>;
M\Z/,?^\WYT 5CX9B/\(_*F_\(O%_='Y5;\Q_[S?G1YC_ -YOSH J?\(O'_='
MY4?\(O'_ '?TJWYC_P!YOSH\Q_[S?G0!4_X1B/\ N_I2CPS%_=%6O,?^\WYT
M>8_]YOSH KCPU%_=%/'AR(?PBI?,?^\WYT>8_P#>;\Z &CP]'_=%/708Q_"*
M3S'_ +S?G1YC_P!YOSH E71(Q_"*D&CQCM5;S'_OM^='FO\ WV_.@"ZNEH.P
MJ0:<H[5G>:_]]OSH\U_[[?G0!J"R4=J>+5161YK_ -]OSH\U_P"^WYT ;0@
MIXBQ6%YK_P!]OSH\U_[[?G0!O!*7;6!YK_WV_.CS7_OM^= '08Q2USWFO_?;
M\Z/-?^^WYT =#17/>:_]]OSH\U_[[?G0!T-%4-*8LDF23R.IJ_0 4444 %5M
M2_Y!UU_UR?\ D:LU6U+_ )!UU_UR?^1H \J\)?\ (J:+_P!>4/\ Z+6M:LGP
ME_R*FB_]>4/_ *+6O-OC?XD\3:!XJ\$GPY))(?\ 3;FZT]6P+R**-&*8[MC=
MCWH ]?HKR%OBS8S>-+#6X=3D?PJ_A.XU1HU.5+K<0J"5_O@,RX]216[:?%Q!
M*T6JZ!J.B3264M]:)=F,_:4C7<Z@JQPP&#M./TH ]!HKD8?B/9SP^$I!:S@>
M(U9H 2/W6(3+\W/H,<=ZY[3_ (X)J&B6.IIX9U58M2D6#38R8]]Y(=V0HW<
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M_P CL:*X[_A;_A#_ *#47_?J3_XFC_A;_A#_ *#47_?J3_XFC^WLI_Z"Z?\
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MS?;(-'GLOL4\:[@&W\,C<@'.<KS0%SW6HTGBEDDC21'DC(#JK E21D9';BO
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M&0>U>HT4#/(;KX4^)-=GNM5U:^TP:Q=ZEI]S)#:>8+>&"U+D(K,-S,?,8Y(
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M_P"!/_,Y3_A5?A/_ * =M_X]_C1_PJOPG_T [;_Q[_&NKHH_L7*_^@6G_P"
M1_R#^T,9_P _I?\ @3_S.4_X57X3_P"@';?^/?XT?\*K\)_] .V_\>_QKJZ*
M/[%RO_H%I_\ @$?\@_M#&?\ /Z7_ ($_\SE/^%5^$_\ H!VW_CW^-'_"J_"?
M_0#MO_'O\:ZNBC^Q<K_Z!:?_ (!'_(/[0QG_ #^E_P"!/_,Y3_A5?A/_ * =
MM_X]_C6%XZ^'_A[1O!NLWEEI4%O<QVS[)$SD=O6O2*YCXG?\B!KO_7LU>7FN
M49=3R_$3AAH)J$FFH1NGROR.W!8[%SQ5*,JLFG)?:?=>9\ET445_%)_0(444
M4 %;W@;2;;7?%5C8W:E[>4OO56P3A&(Y^H%8-=!X!U2UT7Q=I]Y>R^1:Q%]\
MFTMMRC#H.3R17I98J3QU!5[<G/&]]K75[WTM;>YR8OG6&J>SOS<KM;>]M+>9
MAS1A;B1%' 8@#\:[C7_"FEZ3HMO/!&\]]ILL2:K"9" XD4,,?W<$,IQWJ'3M
M.\+Z?KMI?3^(X[VWCG\V2!;*92P&6 R5QR0!]":LZ?\ $--9O=1M]:BL[2QU
M*)TFN+>T42*W5&8J-S8;%?28+"X/#PJ4\7.'/4?+'6,U&RNFVI-13DXJ[^RI
M+8\K$5J]6494(RY8:O1QO?2R35WI?YM,+M/#5OX3L=8'AYB]S<20>5]ODPNT
M YSCGK4UWX?L=/L]*,/A"]U;[180W$ES%-*%+LN2/E4BN>O]8M)O FF::DNZ
M\@O)I73:>%8#!SC':NCO-7T_4[+2#%XRFT@V]A!;R6J0W!"NJX;E>#7HTJV&
MKN2M3NH4VM*,?>:7/\:4;WW6ZZ6U.2=.M3M\=N:76H]$_=^%WV^3*>@^&;*]
MT?Q#>2VJ).(9FMK5YQNM=C#[P)!SS@$CL?6N$J_?2FQU"[6SU%[N*0%&N4WQ
M^<IP3D'G&>Q]*H5\=CJ]*K&G2ITU%PNFU9\SO>^FGYJUDM#WL-3G!RG*5U*S
M6^FFVO\ P_?4****\D[0HHHH [#X1?\ )1M$_P"NC_\ HMJ^JZ^5/A%_R4;1
M/^NC_P#HMJ^JZ_I[PM_Y%-;_ *^/_P!)B?D'&7^^T_\ !^K"N#^.<%S=?"K7
MHK2&6>=UB4)#&\K$><FX[$^9P!DE1C< 1D UWE>>?';6=/TWX?7MIJ%Q>VJ:
M@T=LLEG:27')D0;7"8^1L[6&1E2P'/%?LI\"8?P"TFTTW^U7M'MG641\VWAV
M;2AQGJ9)7W_AC'XUZ_7A_P"S?H\&ARZO;13%BEM;H8[?39K*V"JT@4[9CN:3
M'RD@ !509.*]PH *_+_XO_\ )6O&W_8;O?\ T>]?J!7Y?_%__DK7C;_L-WO_
M */>F@*'@#13XC\<^'M* 8_;-0@@.SJ TB@G\!DU^BWQ>^&0^*OA >'CJ#Z7
M;M.DLDD:;B57.%QGUQ^5?G5X"UK6O#GBW3]4\/0-<ZO:N7@C6#S\D@J?DP<\
M$UZ3\6?CE\4O$&GV-GXAMKGPQ;.'*I;VDUG]JZ9)+G+8R.%P.>1TI@>@>-OV
M'+O3M(FN?#6MMJEY$I;['=1",RX'16!QGZU\MW-M-97,MO<1/!/$Q22*12K(
MP.""#T(-?9O[%/Q#UOQ/I_B#1=6O);^#3O)EMI9V+.@?>&3<>2/E!'IS7B'[
M6FE6VE?&W5_LT8B%Q%%<2!>A=E^8_CB@#6_8S_Y*IJ'_ &")?_1T-?47Q1^'
MB_$OP];Z9_:4NE26][#?174,2R%9(FW+\K<$9]:^7?V,_P#DJFH?]@B7_P!'
M0U]I$@#). .YI,#S,?!_4-:U?2[OQ;XQOO$]KIMPMW;Z>UI!:P><OW7<1J"^
MT\@$XS4GB'X*V?B"U\602:G/"/$-W;W<A6,'R3$% "^H.WOZUZ,DJ2@E'5P/
M[IS2":-G*!U+#^$'FD!Q5S\)M,U#5O%]U?3275OXEM(;.YM2 H1(U9<J1SD[
MOTK-TGX/7<6HZ--K7BW4=>M-%!^P6DT4<01MNQ6D9 #*57IN[\G)KT8W$2D@
MR("#@@L.M.$J,^P.I;^Z#S0!Y[#\%-)/PK7P-=W5Q<6B.\T=XA$<T4AF:974
MCH59N/I[TNF?"F\.LKJFO^*[_P 174%G+96BRPQP1P+(,.Y1  SD ?,?2I_A
M?\7+#XH)KS6UI+I_]DZ@^G.+AU/F,H!++CMS70ZAKU_9^)=/TV'1)[NQN49I
M=22>)8[<CHK(6#MG_9!ZT <S#\'[2'X>^&?"@U&8P:'/;3QW/EC=*86W $=!
MFM7PSX#;POXM\1:M!JDLMGK4PN9-/DB3;'-M52ZO][!"]#QS74"YB.,2H<\#
MYAS2R31Q8WNJ9Z;CB@#D=:^'K:GXZMO$MMJTUC*MDVGW%L(4=+B$L6 R>5()
MZBJT/PJMH?!GA/PZ+^4P^'KJTNHY]@W3&!MP##MGOBM?QC\0M"\!P6$FLWRV
MYO[F.TM8U!9YI'8   ?7))X JQ9:]?77BF_TQ]%F@T^WB22+53/$T=PQ"Y54
M#;P1D\L /EX[4 <3J?P0EF;7+32_%>HZ-H.MS/<7VEP11OEW_P!:8Y&&Z/?W
M ]3CK70Z)\-+'0O%]YKEO/)LN-+M]*%F?NQQQ9VD-G).#C\*ZU9HW8JKJS#J
M >:1KB)209$!!P<L.* /&I?V;FD\(3>$D\8ZC%X8\UIH;!+:$,A\TR@/*%WR
M*'.<$CMV&*@LOASXDOOBO\0+JRU[4O#-I<0Z=;QW,=HDD=VHM]KE#("-RD8W
M+TS7N&01G/'K7GFN?'+PWIN@^,-2L9FU?_A%@!?16W'SG^!6/!([D<4"&6GP
M-T&SFTB-&D?3;#2+C1VLY.1/',1YC.W7<<'/U-5='^"<]A_8=E>^+M3U/P_H
MDRS6.ERQQI@H"(Q)*H#2*H/ /H,]!7;>#O%-OXR\,Z7K,"&!+^W2X6"1@70,
M,X.*US-&KA"ZAC_"3S0,\KU'X##4(;W2SXFOE\+7=X;V32'@BD*DR"1D2=@7
M5"PZ \#C-=IX]\#6/Q \%W_AN]DEM[2[1%\R X>,HZNA&>N&13@]<8KH&GC0
MD-(JD#)!8"AIXU8*TB!CT!89H \XT_X07H\6:!X@U?Q9>:Q=:,)4@A:UA@AV
M.A5OE0#YNAW<],<5O?#CP(_P\T6725U674K$3/):I-"B- K,6*97[W)/)YKJ
M7FCC.&D53C."<<4>='A3O7#?=YZ_2@#S+Q%\$I-4D\10Z7XIO]"TKQ S2ZA8
M6\,<@:1EVLZ.PW)NP,@=>>F:LK\%;-;<1?VG/@>&E\-Y\L?ZL #S?][CITKT
M7S%W[-PW]=N>:'D2/[SJO&>3B@5CB=+^%=IINK>&;XWLLW]B:/+HZQ,@ F1_
M+RS>A_=#CWK!L_@0;6SL=%;Q5J4OA&RN5N8-$\N-<!6WK$9@-YC!_ASTXSBO
M4_/C^7]XOS=/F'/TH>:.(@.ZH3TW'% SD],^&NGV<?C&&YD:_M?$UV]U<P2*
M $#0I$4!'LF<]<FN=T?X)7%F^@VNH>+]4U;0M"E6:PTR:.-,% 5C$LB@-(%!
MX!]LUZ@'4MM# MC.,\XH#!LX(.#@X/2@#A;?X46MOX.\9>'Q?S&+Q+=7]U+,
M4&Z W6=P4=]N>,]:L6OPZ:P\<:?XBM=6FB\C2H])N+,PHR7$4;.R'<>5(9R>
M.N*M>!_B!:>-QKODP/:'2=7N='<3,,R/"0"ZX['/'>NG>5(L;W5,]-QQ0!R/
MC/X?S>)-8T[6--UNYT'5K*.2 311)-'+$^"4>)\J>0"#U'-<_P#\*,@@\-6]
MC9ZY=6VJQ:S_ &\=5\B-F>ZPP),6-@7#D;0,#BO4 01D'(I@FC+;0ZEO3/-
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MI#^QM/QJ>?MP^RI_I>>OF\?/U/WLT'PIHC/IK'1[ MIBA;%C:IFT & (N/D
M  ^7'2@+'P=81>"9/!/Q?EUR[BA\46VISRZ0DDY20/GY6B4'EBPPV.P&>*]2
MTRYU*\^,7P'GUAI&U*30':=IOODX;D^^,5])M\.O"C-N;PQHQ;SC<9.GQ9\T
MXS)]W[QP.>O%:5SH.F7FJ6VI7&G6D^HVRE8+R2!6FB!ZA7(RH/L: L?!6E>#
M-*;]ESQ-XK\AU\06&LYM+Y9&#P8F083G SN.?6NR^.6MV?C7QR]AJ3Z+HS67
MAR*\:_UUI91*70-LM8=X3?EL9P6.#Z5]<)X)\.QZ/-I*Z#IBZ5,_F2V(LXQ
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M #QU3_P5W7_QNE_:."_Y_1_\"7^8_JN(_P"?;^YF_17/_:[#_GCJO_@KNO\
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M5_\ !1=__&J/[1P7_/Z/_@2_S#ZKB/\ GV_N9N45A_\ "86'_/OJO_@HN_\
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MPL/^??5?_!1=_P#QJC_A,+#_ )]]5_\ !1=__&J/[1P7_/Z/_@2_S#ZKB/\
MGV_N9N45A_\ "86'_/OJO_@HN_\ XU1_PF%A_P ^^J_^"B[_ /C5']HX+_G]
M'_P)?YA]5Q'_ #[?W,W**P_^$PL/^??5?_!1=_\ QJC_ (3"P_Y]]5_\%%W_
M /&J/[1P7_/Z/_@2_P P^JXC_GV_N9N45A_\)A8?\^^J_P#@HN__ (U1_P )
MA8?\^^J_^"B[_P#C5']HX+_G]'_P)?YA]5Q'_/M_<S<HK#_X3"P_Y]]5_P#!
M1=__ !JC_A,+#_GWU7_P47?_ ,:H_M'!?\_H_P#@2_S#ZKB/^?;^YFY5+6M(
M@U[2KK3[K=]GN$,;[#AL'T-4/^$PL/\ GWU7_P %%W_\:H_X3"P_Y]]5_P#!
M1=__ !JLZF-P%6$J=2K!Q:LUS+5/YE1P^)A)2C"2:\F<E_PH#PMZWW_?\?\
MQ-'_  H#PMZWW_?\?_$UUO\ PF%A_P ^^J_^"B[_ /C5'_"86'_/OJO_ (*+
MO_XU7S']B\*_\^J/_DO^9[']H9S_ #S_ !.2_P"% >%O6^_[_C_XFC_A0'A;
MUOO^_P"/_B:ZW_A,+#_GWU7_ ,%%W_\ &J/^$PL/^??5?_!1=_\ QJC^Q>%?
M^?5'_P E_P P_M#.?YY_B<E_PH#PMZWW_?\ '_Q-'_"@/"WK??\ ?\?_ !-=
M;_PF%A_S[ZK_ ."B[_\ C5'_  F%A_S[ZK_X*+O_ .-4?V+PK_SZH_\ DO\
MF']H9S_//\3DO^% >%O6^_[_ (_^)H_X4!X6];[_ +_C_P")KK?^$PL/^??5
M?_!1=_\ QJC_ (3"P_Y]]5_\%%W_ /&J/[%X5_Y]4?\ R7_,/[0SG^>?XG)?
M\* \+>M]_P!_Q_\ $T?\* \+>M]_W_'_ ,376_\ "86'_/OJO_@HN_\ XU1_
MPF%A_P ^^J_^"B[_ /C5']B\*_\ /JC_ .2_YA_:&<_SS_$Y+_A0'A;UOO\
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M<E.NI2:TU3-RN<\8_#[0_'L=JFM6TTXMBQB:WO)K9EW###=$ZD@@#@G%3_\
M"86'_/OJO_@HN_\ XU1_PF%A_P ^^J_^"B[_ /C5>C_:."_Y_1_\"7^9R_5<
M1_S[?W,K>#?AWH7@&.:/1(+JWCE559+B_N+E0%Z!1+(VWKVQ72UE67B2TO[E
M((H;]7;.#-IUQ$G3/+.@ _$UJUU4JU*O'FI24EY._P"1C.G.F[333\PKX_\
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M&$PD.:<ME^K[)=6<V)Q-+!TI5JTK11J_!#PUK5[XB34[.5[*P@^6>8CB4?\
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M &$+C_T8U%%?AWBK_N6%_P 3_(_1>#/]XK?X5^9B4445_-I^L!1110 4444
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M+3?_ !%'_"WO"7_06_\ ):;_ .(HHH_XB1FW_/JG]TO_ ),/]4\#_//[U_\
M(A_PM[PE_P!!;_R6F_\ B*/^%O>$O^@M_P"2TW_Q%%%'_$2,V_Y]4_NE_P#)
MA_JG@?YY_>O_ )$/^%O>$O\ H+?^2TW_ ,11_P +>\)?]!;_ ,EIO_B***/^
M(D9M_P ^J?W2_P#DP_U3P/\ //[U_P#(A_PM[PE_T%O_ "6F_P#B*/\ A;WA
M+_H+?^2TW_Q%%%'_ !$C-O\ GU3^Z7_R8?ZIX'^>?WK_ .1#_A;WA+_H+?\
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M_5/ _P \_O7_ ,B'_"WO"7_06_\ ):;_ .(H_P"%O>$O^@M_Y+3?_$444?\
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MM_SZI_=+_P"3#_5/ _SS^]?_ "(?\+>\)?\ 06_\EIO_ (BC_A;WA+_H+?\
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4Q.=Y?2RW$1I46VFKZV[M=$NQ_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>aciu-20221231x20f008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %# [8# 2(  A$! Q$!_\0
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M!_\ $UV5%'LX]@^N5_YOP1QO_"MO^II\2_\ @P'_ ,31_P *V_ZFGQ+_ .#
M?_$UV5%'LX]@^N5_YOP1QO\ PK;_ *FGQ+_X,!_\31_PK;_J:?$O_@P'_P 3
M7944>SCV#ZY7_F_!'&_\*V_ZFGQ+_P"# ?\ Q-'_  K;_J:?$O\ X,!_\379
M44>SCV#ZY7_F_!'&_P#"MO\ J:?$O_@P'_Q-'_"MO^II\2_^# ?_ !-=E11[
M./8/KE?^;\$<;_PK;_J:?$O_ (,!_P#$T?\ "MO^II\2_P#@P'_Q-=E11[./
M8/KE?^;\$<;_ ,*V_P"II\2_^# ?_$T?\*V_ZFGQ+_X,!_\ $UV5%'LX]@^N
M5_YOP1QO_"MO^II\2_\ @P'_ ,31_P *V_ZFGQ+_ .# ?_$UV5%'LX]@^N5_
MYOP1QO\ PK;_ *FGQ+_X,!_\31_PK;_J:?$O_@P'_P 37944>SCV#ZY7_F_!
M'&_\*V_ZFGQ+_P"# ?\ Q-'_  K;_J:?$O\ X,!_\37944>SCV#ZY7_F_!'&
M_P#"MO\ J:?$O_@P'_Q-'_"MO^II\2_^# ?_ !-=E11[./8/KE?^;\$<;_PK
M;_J:?$O_ (,!_P#$T?\ "MO^II\2_P#@P'_Q-=E11[./8/KE?^;\$<;_ ,*V
M_P"II\2_^# ?_$T?\*V_ZFGQ+_X,!_\ $UV5%'LX]@^N5_YOP1QO_"MO^II\
M2_\ @P'_ ,31_P *V_ZFGQ+_ .# ?_$UV5%'LX]@^N5_YOP1QO\ PK;_ *FG
MQ+_X,!_\31_PK;_J:?$O_@P'_P 37944>SCV#ZY7_F_!'&_\*V_ZFGQ+_P"#
M ?\ Q-'_  K;_J:?$O\ X,!_\37944>SCV#ZY7_F_!'&_P#"MO\ J:?$O_@P
M'_Q-'_"MO^II\2_^# ?_ !-=E11[./8/KE?^;\$<;_PK;_J:?$O_ (,!_P#$
MT?\ "MO^II\2_P#@P'_Q-=E11[./8/KE?^;\$<;_ ,*V_P"II\2_^# ?_$T?
M\*V_ZFGQ+_X,!_\ $UV5%'LX]@^N5_YOP1QO_"MO^II\2_\ @P'_ ,31_P *
MV_ZFGQ+_ .# ?_$UV5%'LX]@^N5_YOP1QO\ PK;_ *FGQ+_X,!_\31_PK;_J
M:?$O_@P'_P 37944>SCV#ZY7_F_!'&_\*V_ZFGQ+_P"# ?\ Q-'_  K;_J:?
M$O\ X,!_\3795XC^US\0_$GPT^%\&J>%=0_LS5)-1AMA-Y$<WRMNR-LBL.P[
M9H]G'L'URO\ S?@CO/\ A6W_ %-/B7_P8#_XFC_A6W_4T^)?_!@/_B:^8OBW
M^T[XSTSX>_#Z?P_JR6.MW,#3:W)]EAD;*3"W(VLA5=THDZ ?</3I6]XQ^/'B
MO3M-\;/INO7"W6E^(]-T^/SK*VVPQ2_ZQ$^0[@?5N1V(I^SCV#ZY7_F_!'O_
M /PK;_J:?$O_ (,!_P#$T?\ "MO^II\2_P#@P'_Q-<!XA_:KT3P[XDU.TDTF
MZN-"TB]CT[4]=2XA5+:=B P$);S)%0D!F53C!_&6;]IF*;QUJ6@Z3X2U37+/
M3+]-.O+ZQEB>5)",EEML^:Z+SE@,<&CV<>P?7*_\WX([K_A6W_4T^)?_  8#
M_P")H_X5M_U-/B7_ ,& _P#B:\KT3]I+5H?B+\28/$NA_P!E^%/"<(,EQ%/$
M[Q$ D%ANR[2Y 4+P. >36[I/[2L;W$MKX@\)ZGX8OIM'FUO3(;R6*07\$<9D
M90R$['VC.UL$<YP>">SCV#ZY7_F_!';_ /"MO^II\2_^# ?_ !-'_"MO^II\
M2_\ @P'_ ,37GG@O]J>W\3ZIX5CU#PEJ7A_2_$T,\FG:I=SQ-%(85W2 A3E0
M!_$V,]<8I_A3]JW1?$NNZ7;RZ-=Z;HVLO-'I6K37$+BZ:,$X:)6+Q;@IV[P,
M\>M'LX]@^N5_YOP1Z!_PK;_J:?$O_@P'_P 31_PK;_J:?$O_ (,!_P#$UQ7P
MO_:07XGZU8P6GA#5+?1K_P [[-J\<L5Q&/+8K^_2,EX 2I +@<X['->STO9Q
M[!]<K_S?@CC?^%;?]33XE_\ !@/_ (FC_A6W_4T^)?\ P8#_ .)KLJ*/9Q[!
M]<K_ ,WX(XW_ (5M_P!33XE_\& _^)H_X5M_U-/B7_P8#_XFNRHH]G'L'URO
M_-^".-_X5M_U-/B7_P & _\ B:/^%;?]33XE_P#!@/\ XFNRHH]G'L'URO\
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MZ86T-SNVA'EQM7/;)Z#- 'K]%>$#]HJ/Q#XG\?Z"IN?!]IX86$R:[?Z<\J*
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M[5C>!OVGKKQY;^!+F+3[?1D\0:O<V$EO?V]P2\:9*?9Y  C-C&YC\N<C@C%
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M@9+LQ]">];OPVT:_\)_$OPYI?AFWOM6MEU.9)-)\3^&%AO='5B2]R+U058C
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M%>A_#71[/QK??VAXC17-Q,7#L 7)168<,RJ0"1Z=^M=Q110 4444 <-\<O\
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M]#SX<_\ !K!_\51[2'\R#ZEBO^?4O_ 7_D=I17%_\+K^'O\ T//AS_P:P?\
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MO^?4O_ 7_D=I6/XO\*V/C?PQJ6@ZEYAL-0A:";R6VOM/7![&L/\ X77\/?\
MH>?#G_@U@_\ BJ/^%U_#W_H>?#G_ (-8/_BJ/:0_F0?4L5_SZE_X"_\ (Z+P
MWH-KX5\.Z5HECO\ L6FVL5G!YC;F\N- BY/<X4<UI5Q?_"Z_A[_T//AS_P &
ML'_Q5'_"Z_A[_P!#SX<_\&L'_P 51[2'\R#ZEBO^?4O_  %_Y':45Q?_  NO
MX>_]#SX<_P#!K!_\51_PNOX>_P#0\^'/_!K!_P#%4>TA_,@^I8K_ )]2_P#
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MI8K_ )]2_P# 7_D=I17%_P#"Z_A[_P!#SX<_\&L'_P 51_PNOX>_]#SX<_\
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M[.M?^?:'_OV*L4460<TNY7_LZU_Y]H?^_8H_LZU_Y]H?^_8JQ119!S2[E?\
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MK7_GVA_[]BC^SK7_ )]H?^_8JQ119!S2[E?^SK7_ )]H?^_8H_LZU_Y]H?\
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M$CVQG&<5U4<+4KJ4H)6CNVTDK[;G+6Q<*#C&;=Y;)7;=M]CZ"_LZU_Y]H?\
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MG_H]*[71?^0/8?\ 7"/_ -!%<5^V?_R035?^ONT_]'I7:Z+_ ,@>P_ZX1_\
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M10 4444 %?.B?$SQ2/V>?C-XA?5)1K6AZOXDM].NC$@:WBMKF9+< ;<$*JJ
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M'4@D]:XJ^9JM"<+.SC&*79IK7\#LH98Z,X3NKJ4I-]TT]/Q,GXQ_\DL\4_\
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MCTRU>RM1'>W"%(')+1DB0%P23][->K?\(^?^>X_[X_\ KT?\(^?^>X_[X_\
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M+"3+@GLQ(':O5_\ A'S_ ,]Q_P!\?_7H_P"$?/\ SW'_ 'Q_]>@#R+4?V>O
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MZ?'JT$LO]GW:7UK);W4MM)#,H90RO$RMT9@1G!#$$$&NS_X1\_\ /<?]\?\
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MBL6#PTD.N)JIG9[G$JN2.&5BN!UXV[!78_\ "/G_ )[C_OC_ .O1_P (^?\
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M7 ]\R%L]B!5:+X<VL4$D/VJ1HY8]DBE!R2Y9B/[N0=IQVQ^/HW_"/G_GN/\
MOC_Z]'_"/G_GN/\ OC_Z] '!^'_ ]MH%RLRSO<E8O+02*,IDDL01TR3SBJ]E
M\/+6UBLK>2ZEN;.SCBAAMY -NR,DKN[,>0"<=%'O7HG_  CY_P">X_[X_P#K
MT?\ "/G_ )[C_OC_ .O0!YD_PPMS RKJ%RLC$[Y %RXPJ[3QW"D$]3N/TK4\
M'^%_^$>MGDG9&OI\F8Q_<!+L_' SR[<FNY_X1\_\]Q_WQ_\ 7H_X1\_\]Q_W
MQ_\ 7H \V^,?_)+/%/\ UX2_RKV*O,?C5H9A^$WBN3SL[=/E.-OM]:].K-?&
M_1?J=T_]TI_XI_E ****T.$**** ."^._B'5/"OPC\3:IHT22ZA;VI*;XO,5
M%) =RG\6U2QQ[5X;IWQ#\+ZI\1OA6W@[7M#\3^(PRZ=K#VFA+%<7$'E -<&7
M&Z(($X0''S$=!BO6OCWK'B;PIX=NM?TKQ-9>'M'LK1Q=-<Z>;MO-9T".%"DD
M %@1[^U?,7PZ^/\ #X?\8:?>7WQ%\/0:;)*'O5LO!LMO+<19RRAT@SSZUXV*
MJJ-91D[;=N^ZU7Y'ZGP]EL\1EE2M2ASM<^RD[WC;EE:E*]OB24EJ^CLU] _M
MG?\ )!=4_P"ORS_]'I7L>A?\@33O^O>/_P!!%>'?M9:Y8>)?V;KG5-+NH[[3
M[NXLI8+B(Y613.F"*]QT+_D":=_U[Q_^@BN^#3K2:[+]3XW$1E#*J,9*S52I
M^5,O4445U'SP5A^./&.G_#_PGJGB+56=;#3X3-+Y:[F('0 >I.!^-;E<Q\3-
M-U/5_ >M6>CZ?IVK:A-;E8[#5E)MKCUC?##J,@'. 2,\4 8?@?XV:1XM77EO
M[2Z\*7.AQQ3WT.MM%&(H9%+)+O5V380K<[N,<XKH7^(_A./2+75G\4:*NEW3
M.L%\=0A$$Q4$L$?=M8@*Q.#Q@^E?+=Q\ O'VI>!_%.D:5HU]X8\.2M8RV7A2
M\UJ*[E=XGW3>3,6=(E8< .2"W)  J[X<_9NUNV_X1<S>';W^S_\ A*TU._T[
M6=3L[LQ6ZPE/,98D2/+'&43>2%7Z4 ?3FF^//#.LWMI9Z?XBTF^N[R W5M;V
MU]%))/""09$56)9,J1N''!]*6T\=>&[^]U.SMO$.E7%WI@9K^WBO8FDM N=Q
ME4-E ,'.[&,5\N>&OV</%6D/X1EMM ATB^MO$>JW-W?030"2"TFC*0/E7RR\
M\(N2/04GA[X!>,H[7P[IX\&V7AZX\.Z9J5K=:U;WL#-K;S1ND84*=V&)#$R[
M<9]J /HE/C'X6O=<TK3=*UG3-:-\9 T]AJ=M(MOLC\S+KYFXY7D;0>!DX'-;
M&B?$#POXFOS8Z/XDTC5;U8A.;:QOXII!&0"'VJQ.TA@<].1ZUX/X;^!NN:#H
MWPACM_#T%G=:/97ZZT89(%99I;8(A9@W[PELC(W8]A6)X=_9T\2Z5H?PXM[+
M1;?0]3M="U6QUB^CEA#PSSV[K$79&)D^<CE=V/:@#Z/M_B1X2N]/O[Z#Q3HL
MUCI[!+RYCU"%H[9B< 2,&PASQ@XIL'Q,\'W36ZP^*]$F:XN390B/486,EP,9
MA7#<OR/E'/(XKY)TK]F+Q=;> ?%=M%X<U2WUBYT.#3$@OM9L98KJ07$4CF-(
MD4*H$;;6EDW88C!)S72_$']FS5[R3XH2Z#X1LDEO6TG^P&A>WB($6?M'EY8>
M7R%SG;NQQF@#Z:E\<^'8=?;06U[3/[>5"_\ 97VR/[7C;NSY6[=]WGITYK#^
M''QC\,_$W3[273M0M[?4;E9I!I%Q<1?;42.5HB[1*Q.TE,@],$5\^ZM\%/'^
MJ?&FT\0S>'=MO:^*?MPO+2YLHK=[$@ ,5XG>08.XNW0X533_ (9? _Q?I^K?
M#RWO?!-KX<DT#5KO4[_Q$MY;R2743M)LA*QL7+$,HYRH4#G.10!];T444 %%
M%% !1110 445R'Q#^*WASX6Q:2VOS:@)-6NC96-OI>DW>I7%Q,(WD*K%:Q2/
MPD;L3MP IYH Z^BN$T#XX>#?$JV/V34;J&>\U(Z1'9ZAIEU9W278B,WE2P31
M))$3&I<&15!&""<C/=T %%%% !17#^/?C3X0^&E_%9:_J%S%=O;->O%8Z;=7
MQMK93AKBX^SQOY$(.1YLNU/E;YOE..SMKF&\MXKBWE2>"5!)'+&P974C(((X
M((YS0!+1110 4444 %%%% !17&>-_B_X7^'U[#9:M<WTM])'YYM-)TF[U.:&
M+)'FRI:Q2-%'D$>8X5<@C/!K0T3XA^'/$NKQZ9I6JPZA=RZ=%J\?V<,\<EI*
MQ6.59 -C!BIX!SWQB@#HZ*\UUW]HGP+X?GM;>:]U2^NKJ]O=/AM=(T#4-1G>
M>S8)<KY=O!(P",P!8C:<\$UV7A3Q39>,]%BU73X=2M[65F58]6TNYTZX!4D'
M,%S''(HXX)4 CD9% &Q17%7?QG\%V,GBZ.77X#)X3:%-:6-'D-H\RAHHR%4[
MY&!7")N;+*,9(!JK\=?!C>$)/$GV^^6QCNQ8/:OI%XNH"Y/2#["8OM/F$$,$
M\O<5(8 J<T =_161X5\5Z5XVT&UUG1KK[7I]R"4=HWB=2"0R/&X#QNI!5D<!
ME(((!!%:] !1110 4444 %%%% !117!^,?CAX-\!ZM)IVL:C=+<0(LEV]EI=
MW>0V",,J]W-#$\=JI'S;IF0;03G )H [RBL72/&.CZ]KFK:187JW.H:4L#W<
M2(V(UF0O$0Q&U@R@GY2<=\5P]U^TQX!MVTE(+S6M7EU2S>_M8M$\-:GJ,C6Z
M2F)I&6WMW,8$@*_.!D]* /4J*SM$UZU\0:);:M;I=6]I<1^:JZC9S64RK_MP
MS(DD9]G4'VKDU^./@^Z\)MXETR\U#Q%HRZA+I9N/#NCWNJL9XF=9 ([6&1R@
M9&'F!=F<?-R,@'>T5ROPY^)OA_XK:'/J_AR:]GLH+J6RE-_IMS82)-&<2(8K
MB.-_E/!.W&01U!KJJ "BBB@ HHHH **** "BBLWQ'XCTSPEHUUJVL7L6GZ=;
M+NDGE/ R<  =68D@!1DDD  D@4 :5%>=V7[0'@>\T?4]2?4KW3HM,>!+RVU;
M1[VPNX?/D$<+&VGA2;8[G"OLVDAN?E..@\5_$7P]X(N(H-:U#[%++97>H(OD
M229@MD5YW^13]U64XZG/ - '245P?@3XV>&_B/>PVVBVWB8>=!]IBN=3\)ZK
MIUL\?!!6>YMHXSD$$ -DCH#BMWQ9X]\/^!I-%CUW4X=.DUG4(]+T^.0,6N;J
M0$K&@4$DX5CGH "20* -^BN%L?C;X.U+QFWA:#4KEM4%S)9+(^FW264MS&"9
M+>.[:,6\DRA6S&LA<;&R/E..ZH **** "BBB@ HHHH *YKQA\2/#/P_NM!M_
M$6L6^DRZ[?#3=.%QD"XN2K,(P0, D*WWB!QCKBNEKYH_;*\&W?CS6OA!I%DC
MFXFUS4?*E521#*-$U Q.3VQ)LY]<4 >XZU\2/#GA_P 46GAN]U(#Q!=V%QJ=
MOID$,DUQ+;0;1*ZHBL3@NH  RQ.%!(-7/$/C+1_"FC0:KJ]Y_9]A//;VR231
M.#YL\BQ1(5QN!9W5>0,$\XYKX/\ %OB?7_B1<:5\3AIFI:-J&L?#WQJ+6(H\
M=Q:^1:Z?$@XY1C.EPR]R""*T_'=W;:GX:M+?Q-<ZI)X_3Q?X9;3+-YIRTFF^
M=8LLBQ [6ASY^]R"!(#N(.!0!][U66_B?4)+(+-YR1K*6,#B(@D@ 28V%N#E
M0<C@D8(KP/X\WVKZC9>'GUV[TKP5;V^K92#5[^X;3-5C\J0/'<7, C^RN$RT
M9<LI< ;7(Q7D5YXDU_QGHEO(EIXA\.65WH_AJ(6#7]P\D:'7'BD99CM=A)"H
M.]@':-E+=Z /N*LJ7Q1I</B:W\//=JNLSVCWT=IM;<T*.J,^<8P&=1USS7RY
M?E?#WCNYT/6[N\TWX7V/C":&ZDN+Z9(80VE126ZR3%LK 9VDZL%W[!W KR*?
M6/%5QX,T[5O!EQK6J.ND:K#]NG,YO!IO_"1VZSG<5:4.MH),<&0!20"P H _
M16L?7_%VD^%[G2K?4KO[/<:K<-:640C=VGE6)Y2BA0>=D4A]]N.I KR#]FJ^
MGO-<\:BRO+>[\+(]G]C_ +.O)[ZP2?RCYPM[F8 OD>475055]W.XL!\^WUZF
MH7OPVEU"XUF3XJV^LZZWB*W>6X86LBV-\J,Z?<B4YB^SD8W1EBFX!B #[QL+
MV/4K&WNXEE2*>-946XA>&0!@" T;@,C<\JP!!X(!K/@\7:5<:M!I?VDPZE<"
M=H;2XA>&61(659'574$H"Z?./E.X$$@U^?\ <^*&M/V?8[KQ;X@U[3_B&-.\
M)G0@;RYCEFLY+>Q#LB@@.&F-X)F.2#]XCY >_P!/T\7GQ!CU;7M3U#2[D?\
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M4LWS=3MZ4 =_XP_:S\):-8:%=:,\VL1ZAK TJ?\ T.YC>TV\R%HS'O+ 8 3
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MZIIGPW\-V7@Z[TWQ=H&H:_\ VAXOVQK!NNK.^5+E9@V]_/EEAD; RK##8(%
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M<2QBN_$NEVUKJMDZ3Y@L1/ <7,21M)DD$*R!@[F1J /H^BBB@ HHHH ****
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MT: .MHKDO/D_YZ/_ -]&CSY/^>C_ /?1H ZVBN2\^3_GH_\ WT://D_YZ/\
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M1H\^3_GH_P#WT: .MHKDO/D_YZ/_ -]&CSY/^>C_ /?1H ZVBN2\^3_GH_\
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M'_[Z-'GR?\]'_P"^C0!UM%<EY\G_ #T?_OHT>?)_ST?_ +Z- '6T5R7GR?\
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MK&&U?8(\Q+CY1T%,M?"^DV4XF@T^"*12"K*GW<%B,>@!9C@>IK&\^3_GH_\
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M_P#R035?^ONT_P#1Z5VNB_\ ('L/^N$?_H(KNC_'EZ+\V?&UO^110_Z^5/\
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MOWOQ+\4:=XM7X>'6A+K$^OV^GPZZUI$)5M'L9;MV,8'EF0&!HP=N,.I()!R
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M"M_[S_G1_85O_>?\ZTJ* ,W^PK?^\_YT?V%;_P!Y_P ZTJ* ,W^PK?\ O/\
MG1_85O\ WG_.M*B@#-_L*W_O/^=']A6_]Y_SK2HH S?["M_[S_G1_85O_>?\
MZTJ* ,W^PK?^\_YT?V%;_P!Y_P ZTJ* ,W^PK?\ O/\ G1_85O\ WG_.M*B@
M#-_L*W_O/^=']A6_]Y_SK2HH S?["M_[S_G1_85O_>?\ZTJ* ,W^PK?^\_YT
M?V%;_P!Y_P ZTJ* ,W^PK?\ O/\ G1_85O\ WG_.M*B@#-_L*W_O/^=']A6_
M]Y_SK2HH S?["M_[S_G1_85O_>?\ZTJ* ,W^PK?^\_YT?V%;_P!Y_P ZTJ*
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M_85O_>?\ZTJ* ,W^PK?^\_YT?V%;_P!Y_P ZTJ* ,W^PK?\ O/\ G1_85O\
MWG_.M*FM(J%0S!2QP 3C)]J ,_\ L*W_ +S_ )T?V%;_ -Y_SJ^\J1G#.JG!
M/)QP.II3(JJ&+ *<8)/'/2@#/_L*W_O/^=']A6_]Y_SK2I-PW%<C<!G&>: ,
M[^PK?^\_YT?V%;_WG_.M*DW+NVY&[&<9YH SO["M_P"\_P"=']A6_P#>?\ZT
MJ:SJF-S!<],G&: ,_P#L*W_O/^=']A6_]Y_SK15@ZAE(92,@CH:19%;HP/4<
M'TZT 9_]A6_]Y_SH_L*W_O/^=:5("#G!SB@#._L*W_O/^=']A6_]Y_SK2HH
MS?["M_[S_G1_85O_ 'G_ #K2HH S?["M_P"\_P"=']A6_P#>?\ZTJ* ,W^PK
M?^\_YT?V%;_WG_.M*B@#-_L*W_O/^=!T&W(P2Y'H36E10!A/X-TV2_CO7C9K
MB.,Q(S-D*I.3@= 3QD]>!5C_ (1NS_N?H/\ "M6BE9%.<G:[V,5/"6GI<R7
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M7D:^,M2\RY\4SA-251=-G8#$PP!]WYASZ5Z9\4_AOX2U#]H+X;?:O#&CW/\
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MU:TU>'5M=.IVDUM"8W*&TMH6:4'@2,\+$@$CD'.6( !Z]1110 4444 %%%%
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MM]K@W3+YT>Z$9E&\9C&,_-Z<<\U4A\1:3<:9)J,6IV<FGQY#W:7"&)<=<OG
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MY'^R_P"$I-!^%-AK>HZ?;:;XC\6$>(=6@MD"+#-<*'6 8[0Q^7$/^N?O7KE
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M-2USPYXQO_$$OB6RM+._FLO$%MIVZ%)A(NZ"XL (982\3[0RB1=OS9R*\M\
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MUYK7^1YTJDOKBIWTY;_.YM?#GX^_$3R?B7J7Q'\$Q>&M'\/.[:9+'N4WB@L
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M4VP\&^']*.DFRT/3;,Z1:&PTXV]I&GV*V(0&&' _=QD1Q@HN!\B\<"MBB@#
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MUP_Q0\(:EX@'A_5]#^S2:YX>OSJ%K;7DACAN<PR1/$SJ"4RDK8;!PP&01D4
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MIKUI/9)9PZ#?:64G=Q)YLRD*P 4C:,\G.?8UTW_"V?"?_077_OQ+_P#$T?\
M"V?"?_077_OQ+_\ $T>TA_,@^HXO_GU+_P !?^1X\/V8M9OM,TC3KS4K"V@M
M_"CZ%/+;,[-YYE,@=5*+N3D9R0>O%3:[\!O&GC'3-2;5[OP_::B-$AT2QCT]
MYO)=%G21I)6:,$'"8"JI SUKUO\ X6SX3_Z"Z_\ ?B7_ .)H_P"%L^$_^@NO
M_?B7_P")H]I#^9!]1Q?_ #ZE_P" O_(\AN_V8KZ;XB3ZLZZ1J.FW=]!?RSWE
MW>I<6Y11N1(HF6-_F4;68Y [''/2>$_A1XN\+M>Z#'<Z!+X4FN[RY6\ECE?4
M,3AOEVX"*06^^&.0.G-=U_PMGPG_ -!=?^_$O_Q-'_"V?"?_ $%U_P"_$O\
M\31[2'\R#ZCB_P#GU+_P%_Y'CNF? 3QX;'P[IVHWGA[[#H.D:EI=L]M+/YDO
MVB'8COF/ YQD#H <%LXJGK/[*NJZA=:?*W]BZHKZ39Z=>+?7E[$MNT*A6:)8
M"GFJP'W7*\\]Z]N_X6SX3_Z"Z_\ ?B7_ .)H_P"%L^$_^@NO_?B7_P")H]I#
M^9!]1Q?_ #ZE_P" O_(\RU/X#>(3\4+37M(N=*TG3TO8+B>YM;FZCN)XD4 Q
M20'=$Y^4?O,J?4'O[W7(_P#"V?"?_077_OQ+_P#$T?\ "V?"?_077_OQ+_\
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M_P +9\)_]!=?^_$O_P 31_PMGPG_ -!=?^_$O_Q-'M(?S(/J.+_Y]2_\!?\
MD==17(_\+9\)_P#077_OQ+_\31_PMGPG_P!!=?\ OQ+_ /$T>TA_,@^HXO\
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M_P"%L^$_^@NO_?B7_P")H_X6SX3_ .@NO_?B7_XFCVD/YD'U'%_\^I?^ O\
MR.NHKD?^%L^$_P#H+K_WXE_^)H_X6SX3_P"@NO\ WXE_^)H]I#^9!]1Q?_/J
M7_@+_P CKJ*Y'_A;/A/_ *"Z_P#?B7_XFC_A;/A/_H+K_P!^)?\ XFCVD/YD
M'U'%_P#/J7_@+_R.NHKD?^%L^$_^@NO_ 'XE_P#B:/\ A;/A/_H+K_WXE_\
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MD'.5X4>W^#_V?-1TG]I7QS\0=;FTO6]&UO0M+TRU$Z[[OSK8.)9)$\L1J&W
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MWO\ S#_A3G@C_H6-._[\BC_A3G@C_H6-._[\BBBCV<.R#Z[BO^?LOO?^8?\
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MKN*_Y^R^]_YA_P *<\$?]"QIW_?D4?\ "G/!'_0L:=_WY%%%'LX=D'UW%?\
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M?^8?\*<\$?\ 0L:=_P!^11_PISP1_P!"QIW_ 'Y%%%'LX=D'UW%?\_9?>_\
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*6[ML****HQ/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>aciu-20221231x20f009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %S [<# 2(  A$! Q$!_\0
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M^P$\;QP1G(Y2ST[6OC?H>E^*;G0;;1H;BWAD@L)M5D+7,+%9%9I(HPT+*P!
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MUPECYR +CC8.<_G5PXAR^<E'F:OW6@GAZB5[&O16?_;=O_=D_+_Z]']MV_\
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M#UK<16MQJ-J]NDTRED0D=2!SBO@=_P#@LGI_\/PKO/QUJ/\ ^-4S_A\G9?\
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M,;;85?R\*PZDC8>GK4&N?"/Q9%<^*K'PYK^F66@>*9#/?)>V;R7%G*\2Q2M
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MB'PS_P"@9XF_\ 8O_CU'_#Q#X9_] SQ-_P" ,7_QZJ^O8;_GXCE_U0S_ /Z
MY_<?4-%?+W_#Q#X9_P#0,\3?^ ,7_P >H_X>(?#/_H&>)O\ P!B_^/4?7L-_
MS\0?ZH9__P! <_N/J&BOE[_AXA\,_P#H&>)O_ &+_P"/4?\ #Q#X9_\ 0,\3
M?^ ,7_QZCZ]AO^?B#_5#/_\ H#G]Q]0T5\O?\/$/AG_T#/$W_@#%_P#'J/\
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MMUT?+M>^^@*K%GI-+UKS+1OC'=7GBQ/#>H^%KC2]8N+![^TMQ>QS&0*"?+?
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M,#+/:JS2*.,.68XYR,\UP/C7X,7D$EEJ_A%K;7M-U F6VMM-D,Q !(.U6))
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MPCX;N_"GAZVT:YNM1:&:2%Y&+H(7;:=S$=0#^%?'E???_!2+_D1/"'_85?\
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M82P_@C! Q]/?.UI^N?"_P'\3_$WA^#PA8:#J>FS2VVF:_KES=:I:K/&X*M+
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M2S6>N72%S_%O"2@_E(!^%<CKOP=US66N[<:CIL5DMW>WUHY20RF2XD$FR0=
MJD$94DGTKT;X?>&;_2(M8O=9EM6GO[]KZ5;/<8E)CC0(I;!/$8).!UKKJN&*
MHQHTI)O\E?1OR4;W(C>#NT=+>_NX+6(]53<1]:R-7>\CTJ\;3HTEOQ"YMTD;
M:K28.W)[#.*T+F<W$S2'N>GI45>%B:L:E=SA\*LE?LDDOP1TQ34;,\!\*_LP
M!O!,EMKVO:Q!K%\));VWL-0_T-Y6)P63;A_X<D]:=!\)O'">$/ ]SOTX>*_"
M-Q(MO#/.7@NK<\ %P,J0..G05[Y17>\WQ4FW-IW=]5W337HT[&?L8]#R>_\
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M7]]U)QD'G(HM9Z'''V7UNZ5DM/*Z_P"'_,\ ?[[?6DI7&'8'KFDJCW0HHHH
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M]N@JQ/I\5QM#;@JC 53@"K5)G%=%/*\%2INE"DK/?K?UON2ZLV[ME'^Q;?\
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MUSXBUNPTJS0R7=[.EM$H[L[!1^IK]E_!OAJW\&^$]'T*UQ]GTZTBM4(&,A%
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M_P &9_\ B:^EZ*/J6&_Y]K[@_P!;<^_Z#*G_ ($SYH_X=]_"STUW_P &9_\
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M=I1%SX7U%?$4&M6^A76A+-$TL<TZ%X71\['C9=I#9'!.<8-0R_"7QC%%H7B
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MY\0_A[I6C6 NM/U6]FCO/](CC,@6!VV_,"1MQYF1UV;>IK(T#X;_ ! ?Q?X
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M?Y:(H?L\_!O3M=\5^%/$/]FV]AJZW4326UY'-!('\[<+@@R=)%#X#*<<$97
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M&3K_  :^$^H> -;UW4KBVT?0K744A1-#\/22O9QLA8M-^\5<.VX#"J  HZT
M>L4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KBM1^,W@S2O$_\
MPC]WKL4.IB=+5E,4AB29P"D33!?+5SD84L#R..17:5\S^.?#_B*T\:ZV/"V@
M^)=/U2^U:&X-JRPWOAW4EW1;KF;S!^X?:AR%PP9%(R<&@1ZW>_'?P)IVNSZ/
M<^(88;^WNA93JT,NR"8D!4DDV;(]Q8 %B W8FK/B3XS>#/".NMH^K:[#:7Z"
M,S)Y<CI;ASA#-(JE(MW;>5S7A5U/J6NZ1\:?!FE^$;_4[W7]?N[2WU*&-#:*
M[P0*6GD+9C\K(;D<C&WFF^*?AUKND:WX^TR[LO'&LP^(;@S6:^';F&.QOHY+
M>.)H[AW0F%@4(+-D;<$9Z4!<]X\7?&/P=X$U%;'6];BL[HPBX=%BDE\F(G D
ME**PC0D'YG('!YXKC/B5\?T\"66OO;-I^I74%_8V%E%$MTX1KA4;?<%(F& K
M[QY>XL  /F(%8\5GK?PK\0>,$C\%:CXHBUZPL4TX6@6YA9X;06YMKEV*[5W
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MU]0U8\:Y\H9/K1DT?_JHI##-&:** "BBB@!02.A(^AI.E%% !0><9YQZT44
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M5TYEW%?.A>3][&S'JK<$ $=": /4[GQ]HMKXP@\,&:>36981.88+261(XR2
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M,9D">6'V[<;@GRY].*GLO ?AO3='M]*M- TVVTRWG6YALX;1$BCE5MRR*H&
MP(!SUS7BUE^T/XBG\+>*Y+:RL]=OM&ELRFK:?IMXEHUO.Y5Y6MVS*3#L8LB,
M<@J01DXDC^._B:Y\#2ZCI-QX6\37YUVRTJTN=/>6.&99V52)H68R6[J2>&)R
M!D#G% 'L<WP^\,7'B1/$,OAW2I-=0@KJ;6<9N 0, ^9C=D#C.:T->\/:7XHT
MR73M8TZUU73Y<>9:WL*RQM@Y&58$'!KQO6OC/XL\#W>M>'=:LM(U7Q,HT_\
MLB>Q66VM;@W<Y@42JS.R>6ZDDACN7I@\5#XN^,GC/X<6WBK3M:@T34]:L-".
MNZ==6$,L-O*BS+%)%+&SLP(9EPP;!#=!B@#U6U^&?A*QM);6V\,:1;VTJ1QR
M0Q64:HZQOOC! &"%<EAGH>:UY-#TZ;49-0>QMGOI+?[(]RT2F1H<[O++8R5R
M2=O3)KR>3XD^._#>N:GI>JZ5I6N7LGARYU[3+71DEC<R0O&IM6WLV_)F3#J%
MS@_+TKF='_:7OK3PMXHUK4;WP]K\6E:8MX+?3$GL;N"X9P@@FMIRT@3<R_O1
M@<$8SB@#VCP_\-O"?A.\^UZ+X:TC2+K:Z^=8V4<+X8@L,J <' X]A4GB/X?>
M&/%\PFUWP[I>L2B,1"2_LXYF"!MP7+ \;N<>M>8?"SXWZGXG\<P>'M1N=*UN
M.[LI+I;W1-/N[9+22,KNBD\_(8,&RK@@G:V5%>WT#,36_!'A[Q+I,&EZMH>G
M:EIL&WRK2[M4DBCP,#:I&!@<<4FH^!O#NKZ##HE]H6FW>C0A1%I\UI&T$>W[
MNU",#'; K<HH P+SP!X9U#P]#H-SX>TNXT2#!BTZ2SC:WC(Z%8\;1C)Z#O23
M?#_PQ/H=IHTGA[2WTFTD6:WL39Q^3"ZG*LB8PK Y.1SS7044 <J/A5X,&H7-
M^/">BB^N91-/<BPB$DD@8.'9MN2=P#9]0#4J?#3PE'KB:ROAC2!JZ3/<+?BQ
MC\\2,<L^_;G<3WSFNEHH QKOP9H%_::E:W.BZ?<6VIR>;>PRVR,ER^ -T@(P
MQPJC)_NCTJ;P]X9TCPEIRZ?HFEV>D6*L7%M8P+#'N/4[5 &3ZUIT4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>7?$[X.P^)O,U+1UC
MM=4ZR1_=2X^OHWOW[^M>HT5X^:Y3A,YPSPN,AS1?WI]T^C_IZ'=@L;7P%55L
M/*S_  ?DSXKO;&XTV[EM;N%[>XB.UXI%PRFMWP9X_P!6\$76^QE\RV<YEM)2
M3&_^!]Q7T=XW^'6E>.+7%W'Y-X@Q%=Q >8OL?4>Q_2OG7QG\.=8\$S$WD/G6
M9.$O(03&?K_=/L:_F+.N%LVX2Q"QN#DW36TX[KRDNG_I+_ _8,OSG!9W2^KU
MTE)[Q>S]/ZNOQ/H+P3\4=&\:QK'%*+34,?-9SL W_ 3_ !#Z<^U=@0"*^)E9
MD964E64Y# X(/J*])\(?'/6= "6^I#^U[->,R-B91[-W_'\Z^\R#Q,IS2H9Q
M'E?\\5H_6.Z^5_1'S>9\(SBW4P#NOY7O\GU^?WL;\>_V ?A1\=WNM1FTD^%_
M$LV2=9T,+"[OZRQXV2>Y(W'UK\^_C)_P2[^+7PY>:Z\,I:_$'25)*G33Y-XJ
MYXW0.>3_ +C-]*_6OPQ\4/#WBL*MM?+!<G_EVN?W<F?;/!_ FNKX-?M>%QF%
MQ]-5L+44XOJFF?GM:A6PT_9UHN+[-6/YM_$7AK5_"&IR:;KVE7NB:A&=KVFH
MVSV\H/\ NN :S2,5_1]XK\">&_'=@;+Q)H.FZ_9D$>1J5I'<)^ <'%?.7CC_
M ()F_ ?QF[R6_AR[\+SMDF30;YX5R>_EOO3_ ,=KKY3&Y^)U%?J!XF_X(Y:+
M,TC^'OB5J5F/X(M3TV*X ^K(R']*\\U+_@CQX_B8_P!G^/O#=VO8W-K<0$_@
M-]*S"Y\!45]SG_@D%\7 W'BKP61ZFYN__D>M"P_X(]_$>1E^V^.?"ULO<P17
M,Q'X%4HLPN?!%&,U^F7AW_@C? "K:]\3YI #\T>F:0L>?^!22-C\J]I\%?\
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M #^[N1P01VL*0PQK%$BA41%PJ@=  .@J2BBOJC\X;OJPHHHH$%%%% !1110
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MS;CD],#F.'X@^+;CXAZUXFTRV^W6A\'6^IV_AUX)1.&<N1']_ <.#N(3)4
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MC'BY4<1.\=XVVL]G_P $****]H^3"BBB@ HHHH **** "BBB@ HHHH ****
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MC6-&N_!NFZGX*D\S09HWN-<N_$]Q/9/Y*%8Y;6U$QP[<$*Z*J L.>*W?@_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)_\ $T?\+D\'?]!N/_OS)_\ $U\L44?\12S?_GS3^Z7_ ,F'^IN!_GG]Z_\
MD3ZG_P"%R>#O^@W'_P!^9/\ XFC_ (7)X._Z#<?_ 'YD_P#B:^6**/\ B*6;
M_P#/FG]TO_DP_P!3<#_//[U_\B?4_P#PN3P=_P!!N/\ [\R?_$T?\+D\'?\
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MP=_T&X_^_,G_ ,37RQ17N?\ $4LW_P"?-/[I?_)GG?ZFX'^>?WK_ .1/J?\
MX7)X._Z#<?\ WYD_^)H_X7)X._Z#<?\ WYD_^)KY8HH_XBEF_P#SYI_=+_Y,
M/]3<#_//[U_\B?4__"Y/!W_0;C_[\R?_ !-'_"Y/!W_0;C_[\R?_ !-?+%(>
MAIKQ1S?_ )\T_NE_\F'^IN!_GG]Z_P#D3[7MKF.\MXIX6WQ2J'1AW!&0?RJ6
MLSPS_P BYI?_ %ZQ?^@"M.OZ7H3=6E"H]VD_O1^15(J$Y171A1116YF)TKB+
MOXV>"K"[GMI]=BCG@D:*1##*=K*<$?=]17;GI7PEXQ/_ !5^N_\ 7_<?^C6K
MQLRQM3!QBZ:3OW/J\@RFCFLZD:TFN5+:W7U3/K#_ (7OX$_Z&"'_ +\R_P#Q
M%'_"]_ G_0P0_P#?F7_XBOCC-&:\+^W,1_+'\?\ ,^S_ -3\#_//[U_\B?8_
M_"]_ G_0P0_]^9?_ (BC_A>_@3_H8(?^_,O_ ,17QQFC-']N8C^6/X_YA_J?
M@?YY_>O_ )$^Q_\ A>_@3_H8(?\ OS+_ /$4?\+W\"?]#!#_ -^9?_B*^.,T
M9H_MS$?RQ_'_ ##_ %/P/\\_O7_R)[W\<O%G@GQYX?BGT[6H)=8LFW0KY4@,
MJ'[R9*X]QGN/>M/X/_''1K#PE%IOB/419W5D?*BDD1V\V+^'E0>1TY]J^<<T
M5QK,JJKO$123:L][/\3TWP_AIX-8*<I.*=T]+KTTV^1]C_\ "]_ G_0P0_\
M?F7_ .(H_P"%[^!/^A@A_P"_,O\ \17QQFC-=G]N8C^6/X_YGF?ZGX'^>?WK
M_P"1/L?_ (7OX$_Z&"'_ +\R_P#Q%'_"]_ G_0P0_P#?F7_XBOCC-&:/[<Q'
M\L?Q_P P_P!3\#_//[U_\B?8_P#PO?P)_P!#!#_WYE_^(H_X7OX$_P"A@A_[
M\R__ !%?'&:,T?VYB/Y8_C_F'^I^!_GG]Z_^1/L?_A>_@3_H8(?^_,O_ ,11
M_P +W\"?]#!#_P!^9?\ XBOCC-&:/[<Q'\L?Q_S#_4_ _P \_O7_ ,B?8_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?Z_#HLJLB0I+'O,Q;/3YATP/SK6\8_#;3_#"2P6WB%-4U>-U3^S8K?$IS@]
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MCV49Y^M<*.!7K7BSX;^-O%5\DCZ=9VEG GE6MG%=+Y<">@]_4UA_\*-\7?\
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M!R 0H!Y_"KU?VGA8N-"G%[I+\C^?JS3J2:[L****Z3$0]*^$O&/_ "-^N_\
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M>B?\,[>-_P#GPM/_  ,2C_AG;QO_ ,^%I_X&)3^IXK_GW+[F+^U,N_Y_0_\
M D>=&\N&6)3<3%8N8U,C$)_NC/'X5)+J=[,KK)>7,BN &#SNP;'3.3S^->@_
M\,[>-_\ GPM/_ Q*/^&=O&__ #X6G_@8E'U/%?\ /N7W,7]J9=_S^A]Z//?[
M3O#*9/MEQYA787\YMVWTSG./;I4,,TEO(LD4CQ2+T>-BI'T(KTC_ (9V\;_\
M^%I_X&)1_P ,[>-_^?"T_P# Q*/J>*_Y]O[F-9IERT]M#_P)'G7VRXV2I]HE
MV2G=(OF-ASZL,\GZTDMU-<!!+-+*(QA!(Y;:/09/'X5Z-_PSMXW_ .?"T_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBU:ZM6:X9AQL\F5QGM@D$]A6Y+K>G0?;/,O[:/[& ;G=,H\@$9!?GY<CGG%
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M>2/G/XD?#5_"/B+X;7G_  E7B?70WBNTC-OK&H"XA7Y9/FVA!\PQP<]S7+:
M=&TR;P=J/C*W@/@V'4?$T?F7T&^T@OVU*7RFE!!4$QB0*S<9)[D5]1^)/$FE
M^$=#N]8UF]AT[3+1/,GNIVPD:YQDG\:X_P"(<>EZKX=L?&,?C>\\)V&G6[W2
MZQ8S1FW>WE523(DB/&ZD!2"5R#T(R:U/-/GSX<>'_#GB;7/"%E#ID4WAL^/-
M=EM[*> B/8MG(T>8V'"Y (4CICBMZRTR#2O$T.FV5LMIIUM\4E$-K FV.)6T
MXLP51P 69CQQDFO6O NM^#O .GV.BZ?J=YJ(OI4O)=6GBDF6XGNVW))+,%"*
MTI(VC@<J !D9] TK6+'7K62>PNH[F))9(':(YV2(Q5U/H0000: /GGX;:#</
M\2[/P!-$?['\!7MWJT.Y<QO'/_QX*/\ <6:X^AB'M6Y^TA:Z0-<\*7VH:Q::
M)<VRW0MI=?TO[;I$I94#1S9(\N0@?(V<X# 9Z5Z=X(\ P^#9]7O)-3O=:U;5
M9Q-=:AJ!C\Q@HVQQ@1JJJB+P !W).2374\&@#X^TW4_",.H?"*[\6Z+8:1H4
M-CK*00RI++8H5G01S@3 LL3C+IOX7>HXXJC=Z9-#I7A>]W6VC?#C_A)=6N+*
M76=+>[L+:%T46CO;[DVQE_/V%L*N]#CD5]6ZCX*M=2\;Z/XF>XF6[TRUN+2.
M%=OENLQ0L6XSD>6,8/<UT7!H ^0]*T[1[#2-%U'4+Q=<^'0\82W=])%HSV>E
MQ V96-XXB\@:V%QM8O\ <WDG&!FNC@/A+6O&?@H^%=#%IX=G\2:@-YBQ:WS'
M37$DL*'@1$_+P K,K$ YR?IGBF331V\3R2,$1 69CT '6@#X\\*Z+<1>$/AE
M'H%HMMJ]QH?B,P-;1B-S<%"J-D#[W"C)]!Z5Z'\&K_X<S:GX(L_#>@[_ !/:
M:6\=]<V<#0/I_P"[42K>_=+.T@P ^XELL.YKW?1M8LO$&D66J:=<QWFGWD*7
M%O<1'*21L 58'T((-7.!0!Y9?'_C).Q%QGR_^$5N/L>_IYGVJ+S=OOMV?A7B
M/@!]!TF7P3J/CV&W/A0:5J4-C-J4/F6<-\=0D+[\@JKM%PI;J P')KZDU_PC
M::]K&AZJTLMM?Z1.TL$T.,LCJ4DB;(.48$9'JJD<BKU_KNGZ7?Z;975W%!=:
MC*T-I"YPTSJC2,J^I"(S?0&@#Y O(]3\%>!=)\4Z78W$-G>7VKZ#I$'DLDBV
M-ZQ^Q?*?F5!*BE0>BOVS79? ?PO/IWQ/_P"$2E@D.F_#>&Z@LYI%X=KQU:(@
M]R(1(/\ @9%?3E'% 6/&/$7A72/%'[24*ZQI=KJD4'A1WCCO(5E16-T 3M8$
M9P2/Q/K7CNE^$G\7>%?AWH,09)'TGQ'!9L03Y#QW \@C_<*)CV&*^O=3UBQT
M:."2^NX;19YDMHC*X7?([;40>I). *S8_'GA^6_BL5U6V-W+>R:<D.XAFN$3
MS'C''W@GS'VH ^9[/6+CXB^(O 7CV\MI+>:^\46.F01R1E3'';VL_G8]C</*
M,]P@]J^G-'\+PZ/KFMZI'-)))JLD4DD;@;4*1A %QSR!GFMK@T4#/E7XTZ="
M/'WQ(MK.S']L7_A[3Y8H[6';=74"3R?;!$0-S-Y/! .2-H]*ZOP'/X5UGXTZ
M->?#6WM(]#M]$N(=:FTNV,-L<M']EB?  ,JD2'!&Y1NSUKU_4_B!X=TB[U&V
MO-6MH+C3HX9KJ-F.Z%)6*1,PQP&8$#Z5T'% A:*3-+0,**** "BBB@ HHHH
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MY) QM4+@CY37UX<#GCBJ>E:O8ZY:?:]/NH;VVWO%YT#AE+(Q5AD>C @^XJC
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M")$54".]E,S8=6 *JP+9#=.:]L\'?#1?#6OW>O:CKVI>)=<GMULQ>:CY2>5
M&W>6B1(BC+8).,G YXKM: L+129K"TOQUH&M>(]0T&PU6VN]6T]0UU:PMN:'
MI][L#R.,YYH&;U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M82# R[94@YXP16IYIH:[\0?'.@:78-J&D>&-)GN?,FEOM2UIH;&UC 79$S%
M[S-ELA5VC:3GD"M;X9_&/2_''@?3]<OY[#1Y[B6>W,1OD>)WBD,;-$YQO0D
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M\$-X \.RZ8UX+XO>W5WYHC\O'G3-)MQD]-V,]\=JZN@84444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO'_Q/\9>'/&MW-=ZE-X8T!7MFTZ:?13=:5=1,JF3[3<H&DB?<64?= PIYYH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
F%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>aciu-20221231x20f010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %; QX# 2(  A$! Q$!_\0
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M_"7:%_T&M._\"X_\:/\ A+M"_P"@UIW_ (%Q_P"-?'=%'_$5<5_T"Q_\"?\
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M,?-6/Z/3X@TL==2M!]9U_P ::?$ND#KJMD/K<)_C7\X1UG4#UOK@_P#;5O\
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MC_AH#X7_ /12/"/_ (/;7_XY7\\6:,T<P6/Z'?\ AH#X7_\ 12/"/_@]M?\
MXY1_PT!\+_\ HI'A'_P>VO\ \<K^>+-&:.8+']#O_#0'PO\ ^BD>$?\ P>VO
M_P <H_X: ^%__12/"/\ X/;7_P".5_/%FC-',%C^AW_AH#X7_P#12/"/_@]M
M?_CE'_#0'PO_ .BD>$?_  >VO_QROYXLT9HY@L?T._\ #0'PO_Z*1X1_\'MK
M_P#'*/\ AH#X7_\ 12/"/_@]M?\ XY7\\6:,T<P6/Z'?^&@/A?\ ]%(\(_\
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M_%5\*4N:/[=J?R+[P_U-H_\ /Y_<C[J_X3?P[_T']+_\#(__ (JC_A-_#O\
MT']+_P# R/\ ^*KX5S1FC^W:G\B^\/\ 4VC_ ,_G]R/NK_A-_#O_ $']+_\
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M$\?XUQ6I^)M0O[6XMBBI;%SG$8W*-Q(4MC. >U='<:TMKJUMIUK^[.09]O\
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M **** "BBB@"UI/_ "%+/_KLG_H0K[-M_P#CWB_W1_*OC+2?^0I9_P#79/\
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MN!;-+]IC*Q.?X7(;Y3]:Z/4OA5'X<UG7[%[4ZW':::UPDL5VD;0L$!,C*#G
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M "R^Y?YGS+17TU_PHSPG_P ^DW_?]_\ &C_A1GA/_GTF_P"_[_XT?\0QSO\
MGI_^!/\ ^1#_ %OR_P#EE]R_S/F6BOIK_A1GA/\ Y])O^_[_ .-'_"C/"?\
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M+_,^9:*^FO\ A1GA/_GTF_[_ +_XT?\ "C/"?_/I-_W_ '_QH_XACG?\]/\
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MP8S*J]>O*I!JS_KL>UE7$F#P6#IX>HI<T5T2[^I\BT5]=?\ #.W@O_GQG_\
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M,Y0^<4W[=KJW3(],=: ///'?QPCL+W3(=)>_M(Y8[B2XDO-&N(R D>X%?.5
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M!IPU,V]S;A)&C+;=H&[[X;C'3D<UO:KXMMM&\.0ZS<VMTMM)Y6Z,(OF1B0@
ML-V!@L,X)KSGQ7X#O==\2^#-(/\ :-VVFYFU'6YU7R[F'J8BV<DE@"%Q@8KT
MSQ;X?3Q5X9U+2'D, O(&B$H&?+8CY6QWP<'\*!G#:A\?O#JV^M1P+?BZL+XZ
M8 +=6+R["V]%+C<@P>3CI7,3?&S6A%K/V>,S06GAJ/5H;N2W1"\I<C)0.< @
M8V\\U>T?]G"+2[_2KN36?M+VFC2Z=*&M\">=@0+D_-PP!Z<GWJR?@/=1Q210
MZ]&L,^@KHLZM9Y+%6W+(IW\=3E><^HH$;GA_XOPZEY5E<Z'K$.K_ -F1:C]G
M:*(M,C$*2FV0C.3G!QQ7H4;;T5L%<@'#=1]:X)OAK?6WB:#6[#6(K>Z@T>/2
MXQ):[U!5@3(1N'49&/?K7>QA@BAR&< 9(&,F@8ZBBB@ HHHH **** "BBB@
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M6:A#F>R5QPBY2MW,RBOHG_A5'PW_ .A<^+7_ (*(O\*/^%4?#?\ Z%SXM?\
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M&CPA$D&[4I?.FNFLDM193FX\Y4WE#%LW@[3GD<BN@T/Q5IOB;1&U72[C[1:
MR*6='C*LA*NK*P#*0RD$$9&*\NT_X2>(;KXH6WC/43IUN[ZFUU-96\S2"*);
M3R$VL4&]R>3D+^-=[X0\+7>@Z+K=I<-"TE[J5_=QF-B0$FGD= >!SAAGW]:
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M<G\*_!T_@'P%I>AW5PES=0>;)-)$,)YDDKRL%!_A!<@>P%=90 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X'\=/ 9L+W^W;./%O,
M<3A?X7]?QK6^!_Q 6[@_X1[4) 9%!^SL_P#$O=:]<U/38-7L)[.Z0203*593
M7RUXT\*WOP\\2A49U0/YEM.O&1GC\17X+Q%A,1PCF\<_P$;T:CM4BMM=_D]T
M^DC])RNO2SS O+,2_P!Y'X7Z?Y;/R/B[_@HY^R'+\)/&$OC[PS9D^$-:F+7$
M4*86PN#R5XZ(W)'IR*^)*_H+T+5-"^.7@/4/#?B*UAO$N8#;WEI* 1(I&-P]
M^^>QK\?_ -L;]D/6OV9/&;M#'+?^#;^1FT[4MI(09_U4AQ@./U'-?L^!QV'S
M/#0Q>%ES0DKK_)^:ZGP.)PU7"594*RM)'SI1117<<X4444 %:6E:))JF6#K'
M&."W4_E6;3XYY(E94=E#<$ XS6-6-24+4W9]]ST<OJX2CB(SQM-U*:WBGRW[
M:]NYNWVFZ58*$>61Y,\[""1[$5] >$M?T[X@?LTZMX(T+P/?>)?%4$Z2P75A
MHR9L8P1EGG4EG+8;J,\^U?+Y))YYKZ _96_:D\2_ 6]NM&T73--U*#6[B--M
M_N3RY20JMO4@[>>0:BA1=/6<W)_UT._,\UI8URCA\-"E!VT2N]/[SU];6OUT
M.^_8/^,L7A;Q1J/PT\6WEU#X<UO=''8"(G-T<*8VP-ZAAP0"!Z]:\[_:B^!N
MJ_L[_% 7>GJ;#2[V1K_2C!*S26J;SM1V[.,>I^M=-^V'\#O$?P<\7Z7XWO/$
M%K>:KXBGDOV_LV(VYM9P0Q*#<3M!88:O8O@W^UC\/?B1\)K#P!\59Y9M7O;@
M17NJ:FIDBE0-O#M*#N4X4)[9]*[7%23A,^=3:?-$^/?^%_\ Q%_Z'+5__ IO
M\:/^%_\ Q%_Z'+5__ IO\:^NM3_X)OZ)XZN+?7O!7CFWM_#VIW3-;6YMC.L<
M!R5VR;_F.!W'>HM%_P""9MAHES9WOC#Q]#'I'VMX)Q;PBW)7D)B1V(4DCI@^
ME>3_ &-@/^@>'_@,?\CM^OXG_G[+[V?.GP=^$?C;]J7Q\EQ.M_K%C!)$NJZH
M\BEXH>!@%B,MM' KW;]O7XEP>%] \/\ PG\/:C9:EHUI:Q&Y+1@WD#1Y58I&
M& ..<8!]:Z#Q]\?_  /^R7X*N? _PEO!/XOL[PI/?^2D\,T9R=TC]'<9 X'&
M#VKYK^''PY\?_'OQI/XZD\.7OC#3X-12YUB2(HIF&X-(BAB-S%<\"O3A3A1@
MJ=-62Z+9>1R2E*<G.3NSV+]G/X;^+_AO^SOXA^,7A#X@VVC7<D,BRZ6\"2Q.
MD;%=KELXDSDKQW]Z^/-7U:[UW5+O4;^=[J]NI6FFFD.6=V.23^-?0G[87Q3\
M >,M<TNR^'&D3^'[.U@,6I0+;BTCFE#<!HEX++R-QY_*OG"G+LA(***GL;&X
MU.]@M+2&2YNIY%BBAB4L[N3@* .I).*D9<\,>&M3\9>(-/T31K.6_P!4OYE@
MM[>%2S.[' Z=NY/89-?M]^R]\ M#_8^^"S)>O%)KERHNM7OE)/G38P(TSSM'
M0#ZGN:\P_8%_8J@^ N@_\)WXV@A/C.\AWQQ2X(TN C)7.<;S_$1TZ#N3TGQI
M^*<GCO5O[/T]V_LBW;$87(\YO[Q'\JX<;BXX.GS/XGLCW,HRN>:8A06D%\3\
MO\V<YJM_JGQ9\<EU0R7-Y*$CC7D1IV_ "OKWP;X7MO!WAVSTNV'RPI\SXY=N
MY->>? 7X6GPKIHUG48L:G=+\B..84/;ZFO7JY<LPDJ<77J_'+\CTN(<RA7G'
M!X;^%3TTZO\ R6R"BBBO=/C@HHHH **XOXSZG=:-\*?%-]974EC=V]A))%<Q
M,5>)@.&!'<5X5XP\3ZCH^G75AX:\=ZEK=K=V=A<7&H"^\^2SGDO(HQMD7[@D
M1G^3I\O3!H ^J:*^5?$.O^(M!U_Q-9KXKN+%O#\D$>FG4];D1I5=$</)#Y3M
M<AW9EZDC& !C-=%9^-;W3_BLDNH:[=ZC#<:P=/C@TW4P$@RN!#+8R*#@'GS4
MR2!GI0*Y]$45\L>&_'GBG4+^QU6YUR.TU:\O[FVNM(EU=WV(@DS$MFL7[IT"
MJV\L.G+?-5_1=?USX:^!_!GCF]\0:MKMKK&DE+VWO[IYD%U) );8HI)"DLAC
MSW+C/6@+GTQ67X@\4:3X5MX)]6OX;"*>401&9L>8Y!(51U)P#T]*^7O 7B+Q
MEI\FFOJ?BEI-?AUL:;/::AK4C^9'YI5D^QB)CEH_F#[O0Y"\5Z+^TEHLFIZA
MX*FAO=0M+F*YNS%]AN7B.];.9U/RGKE0/H2.] 'MX(8 CH:6OEGQE\5;RY\-
M: NC>*I)+W_A"KR\N3:7FYUG"P!)'P>'!+\GGK6KXNUG7?AU>W.FV_BG59K.
M_P!/T^XNM0U"?SGLA+>>3/-&2,1CRR3QPI ( H"Y]$7VIVFF)"UW<1VZS2K!
M&9& WR,<*H]2?2FZ?JUGJOVC['<)<?9YFMY=ASLD4X93[BOG+QMI^FW5E864
M/C_4=<T^P\4V"B7[:^^T\Q065KD'$AS\PYRF[%67\47^H>*UT'4_$][HF@76
MNZLCW\5T8)&,)3R8!-G*##.V 1G;B@+GT?17SCX7N]8^(&L:1IDGB_5_[*BL
MM7,=[I]R89+Y(+V.*WE9UQGY#G</O?0G/<^%/']PO[.MOXJUJ[N6N8M(>>>[
MMD5IBRJ1O4$;=W /(QGKQ0!ZK17R!JWCG7M/_MK3M+\37\8GT^RNPYUO^T9K
M>5[Z&/.\*!&2CG,8)7&/6NMUS5]7\*>+=2\)/XKU6/P_)?Z8+C5;N[+7%I%/
M%<%]LYY0-)#$H.>/,.,9H"Y]#V6J6FHS7D5M<)-)9S?9[A4.3%)L5]I]]KJ?
MH15NO)O@ UKYOQ!2RUA]>MH_$C1I?R3"9I,65H,%Q]XC&W/4XYR:\]T/Q7J-
M[?\ @_4[CQE?CQ%JFOW5IJ/AW[5B.)$CN<1B#J@39'S_ !9!.3B@9]-U3U?6
M++0=/EOM0N8[2SBV[YI3A5R0HS]20/QKYLM/C*;3PK\,;B;Q-<W%TNE:E=:O
M':3B:Y8Q6;MF1#G+*ZY&\8R/8US/B7Q1>3:7KVE#6;K4+*[T2'49+>[UH:D\
M<@OK548X4+$2LC916(/' P,@KGUA'XJTB6Y%NNHVYG-TUB(]XW&=4WM&!W8+
MSCTK5KYEU\/KOQ!\/R:CK%]!':>/;RUA*7C1*B"QW*@P1W&,>CL/XC76>"-7
MU^_\<6?@VXU:ZE?PQ?7MSJ5P\A,EU;L!]B1V_B#+<9.>IMSZ4 >V/&LJE74.
MI[,,BLJ_\1:-I6KZ=I5U=V\&HWFXVEJ?]8X&-Q4#L,CGI7"_%+4!/XU\-Z#?
M^);GPOHEW9WER]Q:W/V5Y[B-H1'%YW! VR2MM!&=OM7G?P;%YXP^*.A:]J>K
M:A>SQ:)?+!/Y[)'=0Q7WDQ2%!A2'3:YXP3AJ /?KCQ=HUIJ,MA-J,$=Y%+!"
M\+-\RO-GRE/NVTX^E.TGQ5I&O7^H66G:A#>76GR>3=1PMN\E\D%6/3(((([8
MKP_Q)J-UIWQF\2_9;B6V,^K^&+>0Q,5+1L9PRG'8CM7G_AT:CH?B#4-%AUZ_
ML=)N=4UNY,]UX@>Q,TT-^\8 F*/DA#O91C<6W'.* /L6BN0^$FL:CK_PXT+4
M-6NH+Z^G@+/=6P81SKN(1QN5#\RA2?E R3CC%=?0,**** "BBB@ HHHH *R?
M%>J7>C>'[V]L;?[7=0INCAVEMQ],#FM:BL*\)5:4H0ERMII/L^_R-*<E":E)
M72>W?R.?\#:Y?^(O#\5[J5G]ANF9@8=C)@#IPW->,>-M4G\+_M'1^(-Y%A:V
M5O;7N6PJQ2DC>?\ =(S7T-TKFM>^''A[Q-)JLFI6/VAM4M5L[O,KJ)(E.0O!
MXY[C!J<-2G0H0I5)N<DDG)[M]_F.M.-2I*<(\J;V[>1\\>%O%&L>'OB#XW\1
MF99KG4ULY8XY<LD<+S;%4#_=&?QKK_BOXIO]0^)&E:&)(XH+'5[%H75?F#.C
M$[N>1GM7J$WPH\+W"WBOIN1=VD5C*!,XS%']P#GY2/[PP?>J6G_!+PCIMZEY
M%83O=I/'<^?/>S2NTB A&8LY)P">M=)C8\D\)>(]6\.^&M+N+J6UU2Z:^U62
M*>:W^:(QHS#:<GJ1^7%3Z]XV\87?PYA?7[S3+NW\0:)-<JEE;M"]M(BJV,EC
MN!!Z\<UZI??![0%TN^BT^U>&YD%S) 9+F5HXIIHRK,%+$ '/0#'M6;X+^ WA
MWP]X7@T^]M&N[MK 65Q(UU,ZA<?,(MS?NP3V7% 'G2_'/Q';R7,>F64IT[1#
M;6DD)TQYEN#L3>S7 <"/KQP?>O2?B_\ $F^\%Z#HDFE6S/>ZO=QVT;>09VA#
M#<2(U(+G';-:M]\'O"FHZA#>3:?)YD?EYC2ZE2*4Q@!#)&&"R$8'+ UN^)O"
M>E^+]-%AJMJ+BW5A(FUF1XV'1D=2&4CU!!H \<T'XH>./$^H6&B6[66GWSWU
MQ;RWM_8/&6B2,.K>07RK\XP3@UROBCXCZSXJTKQ!:31V-MJUEI%_;S:C! =S
MF*3:2ASE58=LG!KU>_\ @3H,UWHD5M;O#IUG+<7$Y^US"YDED0*LGG;MY88/
M);-;D?PC\*16P@72E$0M)+$KYK_-$YRX//))YW'GWH \^L_%_C$:;_9^EZAI
M< T+P_;7UQ+=VK.UT[1;@N XV+@8SR<U1L/BYXTUW2==\26LVE6ND:1%;S-8
M26[/)-O0,ZB3>-O4X.#7HU]\%/"6HPV4<]A.PM;9;-66]G5I(1TCD8/F1?9\
MUDZ=\"=$_P"$GUC4M0MA);SS0M:VMO/)'$J1H %DC4A7P1D @T <':?M!^)-
M9U>6]L=.=-'BU)++[(^GNRLA(#,;G>%5LMG&W'%=O\:!J3>(_AT+&_6SC?74
M613'NW?(QYY';/'O71W/PA\*7>OC6)--/VKSA<&-)Y%@>4=)&A#;&;W*YK9\
M2^$-+\6K8C4H'E-E<+=V[Q3/$T<B]"&4@_AT- 'B^I?&_P 0:9XJTY(KB#5-
M+O=0>R)ATJ6*",;6*[;AV&]@5YPI%6_#'COQ[XFFT&Q75=)MKS5[674!,VGL
MR0Q(Q41@>8-S$]6R..U=O_PHGP:;Z*Z.G3F2&X-W"AOI_+BD.<E$W[5SDY
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M[OX#:AJ?CN#4)CIMII4&IC4M]I)<"20C. 82YB5CGEP,G% 'N-%%% PHHHH
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M)<PK(RF4'NIYV_K1:_M\^,=%\6^.=8TC2-,MX?%$@D:WG5I/L["/RPRL",G
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MAZ?&90RR;;9!O#8W \<YP,_2M";2+&X=WEM()&>'[.Q>,$M'_</^SR>*MT4
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MS*T_E2P*R^8Q)9\$?>)))/?-:M% #(HDAC6.-0D: *JJ,  = *?110 4444
M%%%% !1110 4444 %%%54U2SEU&6P2YB:]B02/;AQO53T8CK@T 6J*** "BB
MJMUJ=I8W%M!<7,4,URQ2".1P&D8#)"CN<4 6J**AO+R#3[9[BZFCMX(QEY96
M"JOU)H FHJO;ZA:W<\T,%Q'++#M,B(P)3<,KD=LCD58H **:[K&C.Q"JHR2>
M@%16-_;:G:1W5I/'<VTHRDL3!E8>H(H GHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ KC?B?\ "G0OBQH#Z9K,!R!F
M&YB.V6%O53_2NRHJ914ERR6AM1K5,/456E)QDMFC\Q_C/^SQXR^"NI->))<:
MAHP?=!J5J6^3TW@?=/Z5WWP0_;=U;PHMOI/C)'UC3%PBWJ_\?$0]_P"^/UK[
MTO+*#4+62VNH4N+>12KQ2*&5@>Q!KY<^,G[#>C>*'GU+P=,NB:@V6-DXS;N?
M;NO\J\:>$JT)>TPS^1^K83B7+\YHK!Y]35^DU^>FJ?IIY'6>.OA+\&/VR?#0
MGO;>RU6XV8BU*S;R;ZV]!D?,.OW6!'M7P/\ '3_@E5X\\$R7>H> +R/QGI"9
M=;.0K!?(OI@D(^/8@GL*UM<\(?$#X"Z^)9X;_0KF-L)>6[$1R?1AP1[5[7\-
M?V]M?T40VGBS3X]:ME&TW4'[N?ZGL:NGCXM\M9<K./'\$5N7V^55%5IO;57^
M_9_AZ'Y8>*?!NO>"-3;3O$.C7VB7R];>_MVA?Z@,!D>]8]?N[!\9/@E\?=+3
M3_$":5=!N18^(+9/E/<@L"OX@UYOXZ_X)B_!'XA'[=H*WWAAI1NW:->>9 V>
MX23>!]%P*]&,HU%>#N?GN)P>)P<N3$TW!^::/QJHK]%_&?\ P1WUNW:23PK\
M0+*]0_<M]5LFA(^LB,V?^^17E^J_\$J/C98;OLW_  C^H =/)OV4G_OI!5V9
MQW/CBBOJ>;_@F=\?8GPOA>SE']Y-3@Q^K"K=C_P3 ^/%X0)-%TNS]Y]23_V7
M-*S ^3:*^Y- _P""1WQ4U"5/[4U_PYI4)/S,DLL[@>RA #^8KVOP9_P1^\*:
M>L<GBOQUJ>JN.6CTZW2U3Z9;>?U%.S"Y^6%>Q_!_]D7XJ?&ZYA'AWPK=QZ?)
M@G5-04V]JJ^N]OO?\!!K]3="^#?[,7[-T22KIVB-J5N=PGOF-_=EQZ;MQ4_3
M K ^('[?ME:1/:>"M#+$?*MU?@*H]"$7^IKGJ8BE2^.1]!@,AS+,FOJ]%V[O
M1?>_T..^"?\ P3!\!_"RV@\1?%36H?$5Y;XE:T9O(T^(CLV3F3'O@'^[7<_$
M[]L[PYX"TH>'/AEIMLXMU\F.Y2$1VL '&(T &[^7UKYC\2>/_B!\==;6WN+F
M_P!;GD;,=C;*3&GT0< <]:]U^$'["&I:HT&H^.+G^SK4X;^S;9@9F]G;H/PS
M]:\YXJMB'RX>-EW/OZ/#>59#%8C.ZRE+I!;?=N_P7<\,T'1?'_[0?C%_L[WF
MKZA,V9;F5R(H1ZLW11[5]W_ 7]F/1_A#;1W][*=8\1NHWW<N2D1[B-3T^O6O
M4/!_@?0O 6DIIN@Z;!IMHO\ #"N"Q]6/4GW-;M=>'P4:3YYZR/FL\XKK9E'Z
MMA8^RHK2RW:\[=/)?B%%%%>D?!A1110 4444 %%%>?7/PLEN/BI%XP_M7;&@
M'^@^2><1;/O;OQZ5E4E.-N2-]>]K+N=-"G2J.7M9\MDVM&[OHM-K]SM]4U*V
MT;3;J_O)5@M+6)IYI6Z(B@EB?H :XC3OBZES<:0;WPYJ^D:;JTHAL[^\6,(S
ML"4#JKEDW <;@/0X-;?Q,\,3>-/A_K^B6\@BN;VT>*)B<#?C*@^Q( /L37(6
MWQ#U[6K+3]%TWP?JECK#;8KR34H?+M;-0,.ZS XD/]W;G.><5J<IZ/;Z[IMW
M?7%E!J-I->6_,UO'.K21?[R@Y'XUBZ]\2?#N@>%M4U]]4M;NPTY"T[6EPDA!
M'\'WL;CTP37@NC^#;FXT+P[HEOX'U&T\1Z5:W<>LZB0+=;K=:RQNB7'(D,LK
M(P/.W&32:7X3UB_\">.-*MO#L]Q:R:*L<4U]H\=C>/.F[;#A,+-M&2'"CDX!
M- 'TS8:G:ZGIL-_;3QRVDT8E29'#(5(SG<.,5RWC+XL^'?!WA.;Q ]];ZC:)
M<1VBBSN8FWS.P4(&+!0><G)X )[5PGCOPOXT\5?#"_@T&]M[32;BRB^SZ(-+
M:VO0@9"\9=I-H)4.-I09S@\9KSVX\ WFM:=J<]IH6JR6K7.D1F.\TN*S$C1W
M0+LL"("=D;$&0]0<=!F@#W'P9\9]#\86FI7ADATNRL9_LKW-W>V^QI<D%05<
M]U."<;L9&177WWB#2],2W>\U*TM$N"%A:>=4$I/0+D\]>U?-.L_#J]TC6+/4
M_P"Q+N+1HM0UE)([#2X[MU:2Z)@D\AU.Y3&& 8#@$= :F\/^#9/#%G:GQ3X-
MU;Q%IMUHGV2PL?(2YELW,\SM"VP 1;EDBPPX7;C/RC(![7>_%?1K?7=>T6!A
M=ZIH\$-Q/;K<11EED; P7< 8XSG'WAW(KJ#K6GK:FY:^MEMQ)Y)E,R[!)NV[
M,YQNW<8ZYXKYS\:^$-0%WXYC@\,WD5WJ>A:9]E:&)K@9CE42Q><!EF'R]>6"
MY[55^,7PQ\9^(=0U_P *Z%;2C0KQQXE2X4[5,X54>T!/&YVW28/&30!]+:9K
M6GZW$\NG7]M?QHVQGM9ED"MZ$J3@^U,NO$.E6.H0V%SJ=G;WTV!%;2W"++)G
MIM4G)_"O(/@=X?GMO&&IZE%8:I86']GPVKF^T^'3TDE5B0!"B L4!(\PG!W8
M&<9KBOC=HNMZYK'BZ"U\-78O3<6TEE/I^CI+]KC01,97NFR5*D, B8;Y1USP
M!<^DE\2:0VH+8+JED;YF95M1<)YI*_> 7.<COZ5FZOX^TC2M8TS3!<QW=[?7
MXT\PV\J,\#F&64&1<Y48A8?4BO'9/AW+_9^JZG'H3C6Y?'5O=QW1MSYWV<7D
M67!QG9Y>_/;!;WK+\'^&;C3M9^'FF3^#M0A\1:3K5Q-JVNFVS#(K0W(W^=_&
M)&9#G^'&#@D"@#Z.U/6=/T6))=0OK:PC=@B/<S+&&8] "Q&3[5E6?CC3+_Q)
M=Z1!*LGV;3XM1:[1U,!C>26/A@>H,+9[=*X'XJ06MO\ $?1-0UG09_$NCC2K
MJW2SMK=;EX9VDC_>&,G.UE&W?C"]R,UY!X(\)ZMKGPZAFL]&NKNP?0M+:2T4
M[?M4,6J74L]NK="QB.,9YW#UH ^E=9^)&AZ18Z9?)>07]E?7Z:>MS:3(\<;L
M&.68'  "G-:S^)]&CTI=3;5K%=-8X6\-R@A)]GSC]:^:_%7AG^V]:;6]-\":
ME#X3.I:49]*-EY<ER\/V@S3?9SC"A7B7G&[9WJ2^TC5+>_FO[7PC<6GA+4M9
MDN;>)M(%U<V.+9$,B6IXC\UP_)!QC) W4 ?0L?C*PG\2Z;H]NWVIK^PGU&&Y
MA97A,<3Q(?F!Y),RXQQP:O:IX@TO0S"-2U*ST\S';$+J=(O,/HNXC)^E>&_
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M\B!C&2,$J3TXH ^9++XBZS'J4=S9>)KR*UU+2[RY675=0BN"A504D^SQ(?)
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M:]0LO"6B:=JT^J6ND65MJ4_$MW%;JLLGU8#)JXVF6;Z@M^UK";Y8_)6Y*#S
MF<[=W7&><4 ?+FA_$/Q:FG0WS^)A#-J6FSSS?:]06Z6%QC#I%'%F$*3@YX^N
M*U[#QWJMI\/_ !=:RZ_J=IJ]K;VMQ]MGOH;V.!9)44R1S*!P1D[7 QZ8KWVR
M\&Z#IMU>7-IHMA;7%X"+F6*V16F!Z[R!\WXUF:I\,]"NO"]]H5AI]KH]G>.D
MDJV5NB!BKJ_( P<[<<^M 'B>L>,M8T'Q(/#=EXUN[WP_=S68N?$$LB2R69D#
M;D64#:N[:I'INXJU'JVM:GXRL_"EAXVU*[TA-4>#^U()%,\D?D*[1&0##%6.
M-W6O=;7P9H-CI,^EP:-80Z=/DS6B6R"*0GJ64#!J2P\*Z-I4-I%9:596D5F2
MUND,"H(2>I4 <9]J /FG4/''B8V\%F_B>\ECTZ2_CD2&]2TO9$BE*I-O=-DN
M ,%"PS^-:/B_XD:]K6HVRV&LW>FZ;#H4>HP7$E[%8O-(<YDD!1A(!CE%X_.O
M?K[P-X=U.W6"[T+3KJ%9FN%CFM491*QRSX(^\3U/6IM7\):)KZ6RZGI%CJ"V
MQ#0"YMTD$1'=<CC\* *O@#5+S6_!>C7^H/')>W%LCRO$"%9B.H! //T%=!34
M18U"J J@8  X IU PHHHH **** "BBB@ HHHH **** "BBB@ HHHH I:MHMA
MKUE)9ZC9PWMK(,/#.@=6'N#7SW\1?V&O!7BR62ZT26;PW=-SL@^>$G_=/(_
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MG^XX!)]WRK\DW^)^:'A']E#XF>-9 _\ 8LFGPM@F?4G\H8]0#R?RKZ"^'_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-$8]2J@$U)0,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7_),_"O_ &#+?_T6M=57W4/A1_'.+_WBI_B?YA1115G*%%%% !1110 4444
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MSC<3B@#TFBO.=1^+'V+4TMHDL;N-]2:P\R*=_P!T!$9-SY3KQT7<,=ZSK/\
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MRB-QQD;]O!%>KZ]XJ?1? E]XA%J)GMK%KS[,LH(8A-VT.,@^F119!SR[FO\
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MYA.\DEO!++93K;RS*"2BRE A/'9JN^#?&/\ ;'P_LO$>K-!9![=KBX9,K'&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=W8[+::5$9BJY;=T1B,J =O!KG],^/NGVV@:7)<66M:]=2Z3%J\]QI^FJJI
MS.ID=?,(3'EL=NXG'3=S@ ]<HJMIVH0:K86][:R"6VN(UEC<=&4C(-6: "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C
M/B!\'?"/Q2FT^7Q-I1U*2P):W(N98MA)!/W&7/3OFNPAA2WACBC&U$4*HSG
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#YKTGPS=^'9?#^H>(O!VH>(M,72I;-;.&T%P]M.96)W1'H'4@;NV.:Q;G
MX1^*7T[3-#.EW,-MJ&GI>73(VY;>XMU<11LPSSS%CG^"OJZB@5CSGX':-J-G
MX6N-5UNTDLM;U>Y:[N8)@0\8^ZBG/HH%>%>$_#S>(_A]HMMH7@Z]L]2M(KZ>
M[U4VJHERCQ2KL20',A=F4[>VWG%?7=5-*TFST2PBLK"VCM+2(82&)=JJ/84
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MC_T$?^2__;'VI]OMO^?B+_OL4?;[;_GXB_[[%?%>:,T?\17G_P! 2_\  _\
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M5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\
MZ!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_
M .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_
M  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R
M(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_R
MK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY
M7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_
M *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH
M_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI
M_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?
MTO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30
MHK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]
MW]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)
M_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"C
MFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!U
MI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$
M?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^
M5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\
MZ!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_
M .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_
M  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R
M(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_R
MK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY
M7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_
M *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH
M_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI
M_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?
MTO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30
MHK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]
MW]W_  3C?CM_R3VX_P"N\7\Z^9J^F?CM_P D]N/^N\7\Z^9J_E_Q-_Y'<?\
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M%5X-1M;IE6&YAF9E+*(Y Q(!P2,=L\4 6**** "BBB@ HHHH **** "BBB@
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MT/\ W[%6**/94_Y5]P<\NY7_ +.M?^?:'_OV*/[.M?\ GVA_[]BK%%'LJ?\
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MV5/^5?<'/+N5_P"SK7_GVA_[]BC^SK7_ )]H?^_8JQ11[*G_ "K[@YY=RO\
MV=:_\^T/_?L4?V=:_P#/M#_W[%6**/94_P"5?<'/+N5_[.M?^?:'_OV*/[.M
M?^?:'_OV*L44>RI_RK[@YY=RO_9UK_S[0_\ ?L4?V=:_\^T/_?L58HH]E3_E
G7W!SR[E?^SK7_GVA_P"_8H_LZU_Y]H?^_8JQ11[*G_*ON#GEW/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>aciu-20221231x20f011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %) \L# 2(  A$! Q$!_\0
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M_H-7G_?PT?\ "Q/$O_0:O/\ OX: /LNBOC3_ (6)XE_Z#5Y_W\-'_"Q/$O\
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M_P +$\2_]!J\_P"_AH ^RZ*^-/\ A8GB7_H-7G_?PT?\+$\2_P#0:O/^_AH
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M_#1_PL3Q+_T&KS_OX: /LNBOC3_A8GB7_H-7G_?PT?\ "Q/$O_0:O/\ OX:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KI= \%/KOA?7-96[6%=+"%H2F3)NST.>.E<U7K/PKTRZ
MUCX;^-K.RA:XNI1"J1KU8X:@#R<#)J66TG@4-)#)&IZ%E(%=[X2^&7B"R\7Z
M,FHVKZ0DL_R7$Z)(-RJ6P%.03QQFO2_%<LFH?#CQ6EQ::D%MI=L<VJD%W(/+
M(H "KZ8]: /G=K.=$+M!(J@9+%"!B@65P0I$$I##*G8>?I7M?Q/UR:+5_".D
MSW30Z-<VUL;R,<*Z;USN]0 *ZFPF\1#XH:I;30NOAZ*T<6X,8$*C8-NP],GG
M..V: /FJ*VFGSY<3R8Z[%)Q49!!P>#7OW@XP6'P^T:73X]7:XGO9%N6T7R]Y
MDWD 2[P?EQCVQUKS#XL_9_\ A.]1^S6PLQE?,A#*=KX^;[I(ZT 5_$W@6?P[
MIVA70N/MAU6U%RL<<9!C! ..ISUKG'MIHD#O$Z(> S*0*^CM XUWX;?]@5__
M $6M<NFLW?B7X<>.AJ4OVI;.['V<,HQ%\W1?3I0!Y5X;\/3>(M9L+%2T"7<R
MPB<H6523C-:.N^$+;0AJ\4NJA[VQN?(6W%J^)AQ\V_[J]3P3GBO:6?6;?Q5X
M*MM @8^%FMXG?RD!B/\ >+GU P03SFL[75A?PMXW6X.(#K\0D/\ LYBS^E '
M@IMIA%YOE/Y7]_:=OYT16LTZDQ0R2 =2BDU[YXI;Q7'XKO+#1[&VN?#!L%\N
M&[3%EY6P;FR"!NSGO4OP_MKK0-!\+K&=1U%;Z1FV:?LCMH1D9\U@NYOQ..*
M/$-&\*ZGK\%]/9VS20V4333R'@* ,X]R?04S4]*M;'3K">&^-Q<7 ;SK8V[Q
M^01C W,,-G)Z=,5[I9W5[9:Y\3K/3&EBECB,]M#;C!60I]Y0.YXZ57MHK>^'
MPP761OW_ &HNMP/O2_+@,#WW4 >"26LT*AI(G13T+*0#3ELKA\;8)6R,C"'D
M>M>VQR:WJ&E>-8_&43IIL$+FV-PFU8Y03L$7'TZ58O?$>H:._P -+:SN#!#<
MPJ)@H'[P948)].3Q0!X/'!+,Y2.-W8=552339(WB<JZ,C#J&&#7OMC<KHOC/
MQO;PZ5?FVEG7=?:0%,]L2 3A>3@D]@?I7#_&72;RTNM)O;K46U".[A;R3<VP
M@N452.)0 "3SU/O0!YQ1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!]!?LQ?\ (*UW_KM%_P"@M7ME>)_L
MQ?\ (*UW_KM%_P"@M7ME 'A_[3?_ !YZ+_OR?R%> U]3_%WPA!XO.G0SSR0+
M%N<&,#)Z#O7G/_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_  I+
M3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\ ^@A<_DO^% 'CU%>P
M_P#"DM/_ .@A<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2_P"%
M'_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_  I+3_\ H(7/Y+_A
M0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_ .@A
M<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\ ^@A<
M_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/_"DM
M/_Z"%S^2_P"%'_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_  I+
M3_\ H(7/Y+_A0!X]17K[?!73EQF_NCDXZ+_A3O\ A26G_P#00N?R7_"@#QZB
MO8?^%):?_P!!"Y_)?\*/^%):?_T$+G\E_P * /'J*]A_X4EI_P#T$+G\E_PH
M_P"%):?_ -!"Y_)?\* /'J*]A_X4EI__ $$+G\E_PH_X4EI__00N?R7_  H
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M_P#00N?R7_"@#QZM#2_$.JZ(LBZ=J=YIZR$%Q:SO&&QTSM(S7J/_  I+3_\
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M<_DO^%'_  I+3_\ H(7/Y+_A0!YA:>)=7L+5+:VU6]M[>-_,2&*X=45LYW
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M .@A<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\
M^@A<_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/
M_"DM/_Z"%S^2_P"%'_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_
M  I+3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\ ^@A<_DO^% 'C
MU%>P_P#"DM/_ .@A<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2
M_P"%'_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_  I+3_\ H(7/
MY+_A0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_
M .@A<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\
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M]ZL,P12S$  9)/:O.-5_Y+SHG_8(G_\ 0Q6G\8_$Z^%/A[JMT'V32I]GA/\
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M^:/[-O/^?67_ +YH K459_LV\_Y]9?\ OFC^S;S_ )]9?^^: *U%6?[-O/\
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M"K1O"^I0WL$M_=26R&.U2]NFE2V4]5C4\*.U=C5G^S;S_GUE_P"^:/[-O/\
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M\/>.=<?5M1DODNFC6,_9Y@BX7IQM-;?@7P#IOP]TV>QTM[AX9I?.8W,@=MV
M.#@<<"NM_LV\_P"?67_OFC^S;S_GUE_[YH K459_LV\_Y]9?^^:/[-O/^?67
M_OF@"M15G^S;S_GUE_[YH_LV\_Y]9?\ OF@"M15G^S;S_GUE_P"^:/[-O/\
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MM+O1_+>\TN>%%N8XW(Q)C?M*\YR#6Y-\2]*7Q3I6A01SWES?V+:B)8%5HX8
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M!]T5T.M?%74;7XZ>'O!=E:VLND75K,]]=R!C*LWEM)&D9!"C"KEL@\.F,<T
M>H45ROB;QYI_A+4;K^T;U8;6TTJ?59X5M7>3RHB"[APV.!GY-I)['M2^$/B3
MHOC:]N;33VNH[JWABN3#>6SP,\,F[RY5# ;D;:W(]* .IHKD/#GC"\UCQGXV
MTB:*!+?0Y;9+=T!WN)+=96WY.#R<# '%9OASXD7^H_!I/&4VFK>:@+.6Y-A9
M;E$C*6 5<[B,X'K].U 'H-%>9_#SQEXB\2WUG/\ VSX7\5:)<P[KB704:"73
MG*[D5P\\OF \KTC((SMZ@;OBK6-9TWQEX0M[:6UBT>^O)+:Z1HR\\K?9IY%
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MZ31110 4444 %%%% !1110!5TO\ Y!UM_P!<U_E5JJNE_P#(.MO^N:_RJU0
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ME8/"KQMN*@8RP&"6Y"XH ]<HK"UCQ%%I.N:-837<<3WJSD0FV9VE\M QVN&
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MY)P<8KZ HH ^=_#OPNGL/%GPYT2YN[.6XT?3Q+K5I;OYF?*D+VK'I@>:Q()
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M1M.BAVB# LJG."1U .#S[5E>-?%EKX%\)ZKX@O89[BTTZ!KB2*U4-*ZCLH)
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M)(@8>=B@9^;VK3JC%_R%/^V/_LU7J *,_P#R$T_ZY'^8J:H9_P#D)I_UR/\
M,5-0 4444 %%%% !1110 4444 >%>"]1_LF'XUWOV9[S[/J%Q+]GC=D:3$3'
M:&7D9]1R.U>9> YM/3XD?#2YTN^T9)KKS?M%CHUOL-NI482>0EGD<\CYSD8]
MZ^N;;3K2R>=[>UA@>X??,T484R-ZMCJ?<U5M_"^C6I0P:18PE)?.4QVR+MD_
MOC X;WZT >%?!SPO:SZ+\1=:M-/@F\20ZKJ,=E=O&&DC;:=H0GE<ENW6O.[P
M^#/^%7^!3IK6I\8'58#>>6?]*+;SO\_OC.W&[OC'>OK^+2+2TMKF&R@CL/M!
M9G>U18R78<OP.6]S7EEM\!KZ:]MAJ_BL:GID-ZM\T":5%!<3R(24\V93E\9/
M\(_"@#PK1-/.I6]P=2\1:%HGBA==8E[BRFEUD7 D^4*4)8H>F-NWUYKV3]GV
MRT73O%?CRV$.GP:]'JTP6-$1;@6V(_NC[PCW8]L^]>QG0M-.I#4#IUH;\# N
MC OF@?[^,_K3HM'L(-0EOXK&VCOI1MDN4A42./0MC)Z4 7**** "BBB@ HHH
MH **** *M[]ZU_Z[#^1JU56]^]:_]=A_(U:H **** "BBB@ HHHH **** "B
MBB@#R/XGZ;JTGB;7;O3]%N-7SX1N[>*%/,1)YB_$/F*00S#T8-Z8ZUY3!HNO
MZG?^.#;Z3K%U!?\ A>U2T/\ PCTNEP/+;SN7A2)UW!@KKCS#N?G;E1Q]944
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MCVH HS#S_P"A4_[)=_\ /U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\
M/U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN
M_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\
M/U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN
M_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\
M/U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN
M_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\
M/U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN
M_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\
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M?7</_-^8?ZIYW_T#O[X_YGV%17Q[_P /$M*_Z%&\_P# A*/^'B6E?]"C>?\
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M/^'B6E?]"C>?^!"4?7</_-^8?ZIYW_T#O[X_YGV%17Q[_P /$M*_Z%&\_P#
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ME^;"BBBO./O HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_"E_'?\ T*6K?^ K?X4?\*7\=_\ 0I:M_P" K?X4>RJ?RO[@_M#!_P#/Z/\
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MC_A2_CO_ *%+5O\ P%;_  H]E4_E?W!_:&#_ .?T?_ E_F<717:?\*7\=_\
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M%;_"CV53^5_</^T,'_S^C_X$O\SBZ*[3_A2_CO\ Z%+5O_ 5O\*/^%+^._\
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MQ_>:]!X>O;:SF\*-X>CM!*A,;E@0V>Z@#'K7C/\ PI?QW_T*6K?^ K?X4?\
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MG_"E_'?_ $*6K?\ @*W^%'_"E_'?_0I:M_X"M_A1[*I_*_N#^T,'_P _H_\
M@2_S/J;_ ()U_P#(.\9_]=;?^3U]DU\F_L&^$-;\(V?BR/6M+NM+DGD@:);J
M(H7 #9(S]:^LJ^LP2:H13_K4_FKBJI"KG.(G3::;6JU7PHY#QS_Q\6G^ZW\Q
M7,5T_CG_ (^+3_=;^8KF*N?Q'!A?X2"BBBH.L**** "BBFRRI!&TDKK'&HRS
MN< #W- #J*;'(DT:R1LKHP#*RG((]0:=0 45#)>V\,IBDGB20(9"C. =HZMC
MT]Z?#-'<Q++%(LL;#*NA!!'L12'9I7'T44$A022 !R2:8@HJ+[5 9Q!YT?G%
M=XCW#<5]<=<5+2&TUN%%%%,04444 %%%% !1110 G\8^E+2?QCZ4M#)74***
M*"@HHHH IZSK%GX?TJZU+4)Q;65K&99IF!(11U.!DUR6@_'#P+XFU2#3M-\1
MVUQ>SG;'$5=-Y] 64#/M2_'#_DD7BW_L'R_RKP[P[\./&/C>S\*P3>"O#_AK
M3+9[:\.MVIC%S-&H!&=C%B6'/('/7%<E6K.,U&*N?2Y?E^$Q&%E7Q$^6S:WB
MNE]GK+T1]4T5XCX0TR[\3_%SQT]YKFK_ &71[^![:QAO72'.P-@J#RIQRO0Y
MKE&U?6+OX8:I\16\3:E!K]O?/LL5N2+5 LNT0&'H21WZTW7LKV[_ ($1RCFD
MH*IK[G1[S5XK_-]#Z9HKQ%Y[_P ??%35;&^UK4="M=*TJWNK>WLKDP!I)$#-
M(V.&"DXP>.*X+2=:UO6O ?P_A;Q'J:S7_B.XMI[V&Z<22QY;C.>1Z \"DZ]G
MM_5[%4\FE-)NHD]+Z/3FBY+7KHCZKHKYT\=IXAL_'MEX,T9=;U?3K333=B./
M7A9W$KM(V7:=SEPO3;69J@^)=[I'A][];S4X+:&9+K3M%UJ.*]D(8A)6>(G?
M\N!QGD'(&:'7LVN5Z%0R7GC"7MHKFUU:3MK;2_6W6RU6K/IZLS7O$NF>&(+:
M;4[I;2.XG2VB9E)W2-G:O /7!KYVFUSQ#XN\(>'9O#]UKNMV-E+<0:EIKZ@M
MGJCR+T&].7"Y[ D\9&<XM2^-KB[^&>@&QU/7(;NW\3P6-TNI2XN8^I,+.N-Z
MX(Z\GO2>(71%QR.2:YIW]ZS2W6^^[5[=5;71GTE17S9XT\5Z[X0U;Q3X$M=0
MO9M2UR_MVT:XDF=I(H9SB0*Q.0$((&#QUK/UF[\:ZSXJ\46.EKJUV- ,5K:S
M1:]'9I;X3_62HY_?;B,DL<=10\0EI8FGD<YI2=5*+5TWIH^6SU:ZRM\GUT/J
M.BLKPG<:A=^&-*FU:-(M3DM8VN5B=742;1NP5)!&<]"16K76G=7/FYQY).+Z
M!1113("BBB@!/XQ]*6D_C'TI:&2NH4444% 2 "3T%<[X4^(?AWQO-?0Z'JD6
MH2V3!;A$5E,9)(&=P']T]/2N@E_U3_0U\6>#M;F^%ULGB> /Y6M?VEID@C&?
MWZN# ?KDG\ :YJM5TG'MU/H,LRV.84JMFU-6Y>S;NW?Y)V\SZS\+_$3P[XTN
M[VUT35(]0GLCB=8U8;#DCJ0 >0>E=%7R'X>TJY\":?\ %VTL9IK2[LM,M6$T
M$A617*(S,&'(.23QZUZ;>>)KQO$WP8MX]3N"+RTDDNT6=L3_ +F/!D&?FYW=
M>^:B%=M>\M?^#8ZL7DT(5/\ 9YWA:ZOOI34^G?9'J&F^/?#^K:?]NM=5@>U^
MU_8!(V4S/N"^6 P!)R0.*N:;XFTS6-4U+3K.[6>]TUE2[B"D&(L"5!)&#G!Z
M5\E6NCQZIX3\,B2>Y@$GCB2W)MYFC*AI$!8$=&'9NHKK_%>MZMI&D?%^WM]9
MU$#3&L8K21KN0O",$$JV<@G')'6H6(E:[7]6;.FID5)2Y*<W=NVO3WXQ^>_E
M_G],LP523P!R:S?#WB/3?%>F+J&E72WEFS,@E52 2IP1@@'K7C5N+WP9XZ\#
M):>(]2UR+Q!;2B^AO+HS(^(=XF1>B#/]WBO/M+\1:]:> ? V@Z-'=21ZKJ-]
MYZ6=ZMG+-L<;8UF/W,[B?4X%6\1RO5?UI_F<M+)/:QO&IO:SV5O?YKW[<FFJ
M7?R^N*XVY^,G@JTU\Z+-XCLH]2$GE&(L<!^FTOC:#GC&:P?@HWBBUL-<M/$D
M4L5M;SYLUN-0COKB.,@[HWD0DD@CC< :\0NM%TW3/"6L7EG#X8\8^%Y+F29Y
MI6-EJ\(+99074'(/3U]*)UI**E%?>&#RFC4K5*-:;?+9)Q:L[^;O&_E=7UL]
M#Z_!R,CD45X/JWQ&3P#KFG>(6NKP^&]:\."6UMKJ5FV7$489% / 9U(!QU(K
M-U?1_',7PW\(-;7]]JEU<R27VJ6,.I&VO)U<!E6)R<A5SC:OJ.*IUUK97L<\
M<GD^5SFHJ6B;TZ.Z[:-6WW:/H#5-4L]%L)KV_N8K.TA&Z2:9@JJ/J:M @@$=
M#7R5XRU>+Q'\#=6MI;K7UOM*U>%)[369MTMN6/"%Q@R*.Q;D&MWQ=+XGN/B!
M=>%-'&LZC8:1ID<D"0Z\ME+N;DSR2/S* 3C!X'>H^L>7;]?\CK61:6=2S3E>
M]DK+EUNVEKS+K;L^_P!,45\Z13>*_$7B3X:Z1K^K7FE75U:7JWW]EWRXG"9V
ML6C)4L5 R1R"3C%<\MWKMAX#U771XHUJ6[T3Q%_9UHLEVQ0P^:H(D'_+0D-U
M;--XCKR_U9,RCD;E9>U5W;9-K64HK7M>/W'U913(6+PQL>I4$T^NP^8"BBB@
M!/X_PI:3^/\ "EH9*ZA6':^.-"O?%-SX<@U&*36[:/S9;,!MRKQSG&/XAP#W
MK3U+4(=)TZZOKEQ';VT332.>@5023^0KXS\/_$>SL_%VD>+38:K;ZM-J\TU_
M>2VX%L]G-A50/N).T =L<FN6M6]DTNY]%E>5O,(59:^ZM+?S:M7\M.G='VK1
M7SIXN34==\;?%9D\1:O96ND:5%>6<%E>/'&L@M@X. >F1R!C.>:B\,W^M6WB
M+X8W<WB'5+QO$UG<#4(I[@F([47:43HA&>HYXI>WUM;^KV-/[&O34_:*]KVL
M_P"3GM]U_F?2%%?,UMXIUW4;2S^&+:M>Q^(HM?>VGOEG?S_L*$R^9OSGE3@<
M] !74W,=YX\\?^-[.]\1:EHEMX>@B6QM[&[: <HQ,SX^^,J.O'--5T]E_P .
M3/)Y4F_:5$DDWLW[MU&+2_O-_<CV>ZU.TL;FUM[BYCAGNG,<$;L TK %B%'?
M !-6:^5["6[^)FL?"._UJ[OH;NZ^VVTEQ:W#0,XB$@612OW2VT9(Z\]J[3P#
M97VL>(_'>KW6LZQ<_P!BZK*+/3UO7$/RQAMI7/S \#;TI1K\ST7]6N77R=4(
MWE4U2=].O.X))^JZGNE%?+YUS6K+X46/Q)3Q3J,_B&:_&^P:X)M6!G*>0(>@
MPH^OO6[#9W?C3XF_$.TO?%.KZ3:V%O!/;V=K?-$$8HQ+\'@+CD#@[N>U"Q%[
M66__  ?\@EDKASRE45HW3T>\7&+5NOQ*S_(]PU'Q-IFDZKIVFW=VL-[J+,EK
M"5),I49(! P,#UHU[Q+IGAB&VEU.Z6TCN9TMHF92=TC?=7@'K@U\WV6IZG\1
M(?@]+J-]<P7L]S>0/?0$++(J!UW ]BRKC/N32W^OZSH4^K:%#KFIS6VF^++&
MW@FGNW:8Q2*Y:-GSEERO0U'UC2]M/^!<Z5D:4E!S]Y7YEZ3<-';R73N?459O
MB#Q)IOA:SCN]5NEL[>25(%=E)R['"KP#U->+NM[X_P#%'CV;4/%U_P"&%T"[
M2"S^S7)BA@C !,DB9 ?=C^+UK<_:!D4?#71G-T+I1JEB3<Y&)/G'S\<<]:U=
M5\LI);'GPRV*Q%*C.=W)J]D]+I/1O1Z/^MSUX'(R**YS7?&.DZ;X;U.]&IQ$
M6MG+.QM9$DE4*A)*KGDC'?BOG[P?JWB6S\>>")9;W4H=,\1+,&AO=7:[EFCV
M@B0H $B^]QM[Y]*<ZJ@TM[F6$RRIBJ<ZC?+RWWZV3;_!>9]-6.JV>J-<BSN8
MKDVTI@F\I@VR0 $J<=QD9%6J^/\ 1;S4?!/PM\2W^BWE\E]=^)7TMF-WA8X]
MP^8;OE1VZ&0^OM7<:%)XX\/V7C""^M[W3='_ +'DG@6]UR._NH)P!AE=6WA6
M!)Y& 0,&LHXB]KH]*OD7L^9PJJR=E>R;VOI>_7I?Y:7^B*SO$'B'3O"VE2ZE
MJMRMG91$!YF4D#)P. ">IKYX*W>G?#WP5+_;?B75O$'B98$%O'JOD+)\N[;Y
MC9\L8(Y7YCCDUBWFIZV_PM^).CZQ>/=_V7J%K'"'NFNC'N8%D\UN6Q@=?>AX
MBRVZ?I<=+(U*2;J77,D^CMS*+:^?E;\CZQC=945U.58 @^HI:KZ=_P @^V_Z
MY+_(58KL/E&K.PG\?X4M)_'^%+39"ZG&^*?C%X.\%:LVF:WKD5A?*BR&%XI&
M.T]#E5(K=\,>*M*\9:3'J>C7BWUA(S*LR*R@D'!&& ->!>/?"NO^*_C[K4.@
M0Z!-/%I=LT@\06WG1A>?N#8V#^%:WCG2=<T#1?AQH<M]#HEY=ZL8;UO#>;:%
MP5).U0%_4=:XE6G>3:T7^9];+*\*Z=&,*EJDTF[N]ERN3T2OZ:L]\HKQ75])
MGF^(^B> O[=UBST2+39;[SEOG%U=R&0_*9L[B%SG'IBN.UGQ7KS?#C6-/CUR
M]9],\40Z;;:M',1-)"6'!8?>(S@YZ]\U;K\M[HY:64.MR\E1:VZ/:3:3_#5?
M\$^FF8(I9B%4#))Z"H-.U*UU>SCN[*XCNK63)2:)MRM@XX/?I7@VI:=>:-XT
M\6>%O[<U:^TN[\,O?E;J\>21)@6!*,>5!QT''.*P?##W>D?#;X9Z+9:K?Z?9
M^);L_;;U;EMT(4#$43'_ %8;T'H?6E[=IVM_5[&L<GC*FI*IJ[6TZ.+DWZJS
MT_S/INZNH;*VEN+B5(((E+R2R,%5%')))Z"DM+N&_M8;FWD66"9!)'(O1E(R
M"/PKYH^(*W>G:;\2O"/]KZCJND6&FP7\,ES<M)+#(6&8F<\LIZX.:@U&XU^U
MN? WA'11J^HV,^BKJ+V\&LBSFGD8<@3OSM3'"#L?04GB+.UO^'O8TAD:G!25
M5:ZZZ+EY5*^K6NNST\[:GU'17S#H+>,]9\7^"_#_ (BU?4-,607R,;'4DDDF
M@504$CQDJ7'*[NO&>#5%+O7;#P'JFNCQ1K4MWHGB+^SK19+MBAA\U01(/^6A
M(;JV:/K'7E_K</["=U'VR;=MM5K)Q6OJCZLHKPF\L+GQE\<?$FD7?B75=-T^
M'2K>=+6QO6@!<J,L,'C'4XZYYKEO"'B_7O'>H>#_  IJ6N7UKITIO?-U*UF,
M4U_Y+E442#D< $XQG--UTG:WE^-C".3.4.=5%HE)Z/1.+EIW=D_ZO;Z?HKY>
M\6>*]=TKP%\0M'@UV^N8M$U6V@LM4\]A.$=E+1F08+%>GYUM>,M.N['Q!I'A
M/2-6\1:IJES:/J-QY^M&UA4$!?,:3!? *D^6N!R:/K'9?UL6LE>G-46M^G11
MC*[NU;22WZGNE[XETS3M:L-)N;I8M1OPYMH"I)D"C+8(&!@>M(/%&EGQ(= %
MXO\ ; M_M1M=K9\K.-V<8Z^]?-GPK\0ZIXD\5?#.?5[M[ZZAFU.W$\C;F950
MXRQY/ID^E>A3WUM8?M0O)=7$5M&?#F \KA1GS1QDTHUW)<WFE^ Z^41P]25&
M4FVH2EIW4FNVVGJ>RU6U/4[;1M/N+Z]E$%I;H9)92"0JCJ>.:\S^,_BV=;#P
MYI^D:N+*VU?5HK&[U*SE4M!&QY 8?=)]:XOQ#=7WA;6O''@^'5+W6-%/AU[\
M&_G,\MK+G;MWGG!!S@^U7.MRMI(YL+E4J\8SE*U];>2:3UV3UT7_  +_ $!I
M>IVNM:;:ZA92B>SNHEFAE (#HPRIP>>0:LU\TZ,;SP1X;^%>M:7XCO\ 4)=4
MFM+&YL9+DO;/$ZA2B1]%*=,@9R.:R/&WBKQ!<2:OXJT2_P!4AL;+5UM5NKO5
M=J2$2!3%':H-N!ZMR1S6?UBRNUJ=BR)U*O+3J+E;:3>FO-RV>WX?=N?5M%>)
M3Z;=^,OCGJ^F7.N:M9:;!I-K<"UL+UX5,A/7@\>^.O>O;0, #TKIA/GOH>'B
ML,L-R+FNY)/;:ZNCI? __'Y=?]<Q_.NQKCO _P#Q^77_ %S'\Z[&NZ'PH^2Q
M/\61R'CG_CXM/]UOYBN8KI_'/_'Q:?[K?S%<Q6$_B/4PO\)!1114'6%%%% !
M7'?&+_DEOBC_ *\)/Y5V-9?BGP_%XJ\.ZCI$\KPPWL+0O)'C<H/<9J)*\6D=
M.&G&E7A.6R:?W,\6TS7O%=QJ/P_\,:#K<6CVMYX9CGEEDLTG*,J* ZAOXNV"
M<=<@T6_Q=\41?#.?S+BVF\2#7CH$>H- %3.[_6L@^7(&>.F<<5Z3I7POL=)U
M_0-5CO+AY='TO^RXHV"[9$P!N;CKQVXJA_PI/1W\,:QHLMU=21:AJ+ZH)P0L
MEO,2""A [$<9KD]G46S_ !\D?3/&X"37/!-)I_"KWYI7N]WHUHW9GF.N6GB#
M0_BG>QZYJMOKMQ%X1O7BO/L:1%QR2'C&4.#[8(ZBM'P[XT\1:GHWP[\)Z%>V
MNAWFJZ9)>7&I+9QMY2)G"QQ8"#)!SQ]*[.U^!MNNMW6KW_B'5-5U"YTR72Y)
MKHI_JW&,@!0 1_\ KJ>?X)Z=_8_ARWL]4OM.U+08FAL]5MRHF"-]X,""I!],
M5*I5$VU^?H;3S#!3C"$VFTM^7W4^66O+;9-IVM\NAB>*_$_C'PCX'TRTU;6K
M2W\27=Z;9+G3[ W,\\?8QPXVF3'7/RUYYKOCSQ;X@^$GCZQU349[?4-$NH(V
MN6M8X)YX7SE'5#M4^Z]N/6O5Y?@1IQT73K6'6M5AU*PO6OX=5\X/,)F^\<,"
MH!],8Z^M+:? G3(=%\4Z;<:KJ%]'XA\M[F6X93(LBY^=3CJ2>G3@42IU9:=+
M=_+_ #"AC<NHQ4FDY*2=^2VTUMIHN6^C>_1'*:;J^H^$/B%:#5[Z/6WLO"DM
M[+=_888II KE@H*KD +A< X.,D9-16WQ \<:3X;T'QSJ.KVEYH^JW<44NA)9
MJHMXY6VJ4E'S,PXSFO0=$^$]OINN6NJWNK7>LW,.FOIC?:U3$L3,6^;:!R =
MOT%9NF_ C3;&>PAEUC4[W0]/N/M-IHL\BFWB<$E>VY@"> 3@57LZBV_/T^\R
M>-P,G>:3=E?W=U[UU'3W6VU9Z?A9\;K7C#QYJ.L_$MM*\20Z=8>&L7$$+6$4
MKN!#O,>XC@'!Y()]"*]@\ >(9O%?@O1M8N$2.>\MDED6/A0Q'./;-9"?"NQ2
M7QI(+RXSXI0I<#"_N08S'\G'H<\UT'A/P[#X2\-Z=HUO*\\-E"(4DDQN8#N<
M5K3C.,KR??\ /_(\W'8C"UJ*A2BDUR[12TY$I7=M?>[FM11172>"%%%% !11
M10 G\8^E+2?QCZ4M#)74***\ ^.5[K$?CZQ@U+6/$'A[P:UIE+[08V;%QGD2
M%/FQCV/;CJ:RJ3]G&]CTL#@WC:WLE*VC??;HDM6_(]_HKP/2_B;J_@?X.W>M
M+KFG^-?(U!;>TN]\F\PLP $P*J5D'ISUZFN_UKXBW>F?$FW\-I:P/;2:-+J1
MF8G>'4D!>N,<5*K1:^[\3HJ977A)I:I<VNWPI-Z.SZK<Z_7-$LO$FD7>EZC#
M]HL;N,Q31;V7>IZC*D$?@:GT^P@TJPMK*UC\JVMXUBB3).U5& ,GD\#O7A6F
M?'SQ8?!UAXQU'PYIT?AA[O[+</#</]HQYA3S44C&T'C!.20>@.:ZJ+XC>*=<
M^)6M>&]$TS2Y++3!;RR7MW-(I\MQD@!0<L><=!P<U*K0>JW?D:U,KQE-2A-K
MEC=OWE9--)]=]5YG>:3X3TK0]6U74[*U\B]U219;N7S';S648!P20./0"L.;
MX/>#KC73K$FAQ-?-+Y['S)/*:3^^8MVPM[E<UYSK7[1&J:!XD2&\L=&_LXZB
M+%K2"]:>^C4M@2-L#1+Z[2V>WO6SKGQ5\6CQ=XMT?0]%TRYAT&WCNGN+R>1,
MJ5+%<*#EC@XZ 8.:GVE)Z6V\CH6 S*F^93MS1WYK72LK7OTNE;[B3XF> =7U
M_P 7P:E;^%M#\06L=N(XWGO)K2X1NXD*DK*G^R5[UI?#[X.V.A>$=!L-;@BO
M-0TR[DU")H)'2.&9R3\H!&0 <8.157P3\99_&?B;PY8QV$5O9ZKHSZDY9B9(
MY%DV% >A&0><5G+\<=2N-/2"TTNUN-<O=<GTBQA:1DAVQGF20\G &,X]:E.E
M?G[_ / _X!O*&9NFL(ER\MNNOVEWLOM7M;SN>@>+?ASX=\<R6\FM:<+J: %8
MYDFDAD4'J-T;*<>V<51U+X.>#=5L;&TGT.)(;)#';FVED@=%/)7?&RL03S@F
MO-OBCXQ\8K\-;E]6L)/#>J6NL6]NMUIMTPBNHRW+1G(;:??K^8%OQK^T-/H7
MB36;'3DT46VB[5N$U2^,-Q=L1EEMU P2!Q\W4D?2G*I2N^9?A_78BC@<R<(+
M#U&[-V2EHK6U33MKS=/._4[Z[^#G@V]TBRTU]#B2TLRQ@\B62*1"WWOWB,'.
M>^3SWJPGPL\+1Z)9Z0FDHFGVETM[%$LL@(F7.'9MVYCS_$3GO7G7C7X_W^E0
MPWVD6^C#3GT^/4$&HW3?:;D.N[;'%$&9<=,N%&>^.:OZM\9=<N[_ ,$6GAW2
M+*XF\2V<ER%OYG182H!Y91T&3GC)Q3YZ-WI^!'U/-7&+<W9W>LMFDV[ZZ.U_
MQZGHVH>#-%U3Q)IVOW5BDVKZ>K):W)=@8PPP> <'J>H..U97B/X2>$O%NK'4
MM5T=+F]8!7D6:2,2@= ZHP#C_>!KS#X_:U<Z=<>!H==\1WGA:VN/-_M*ZT26
M4!6$>?E"Y9AOP!D=#6;\'?&E[;>)_$L6AZ]JGC7PM::;]I2ZUAC&1<@C""27
M& 1NZX''MS,JL.?D<?ZMV-J67XM858NE6:LG;XDK<UK*6V^MK^9]&P01VL$<
M,*+%%&H1$08"@#  %/KQ7P/\=-1\0>,[3P_J,6CR_;[:2:&;1KB240LJ[BCL
MRA6.,\H2,CK7->&OC)JGA'X:>&S))%>7^JW]U#_:6N7$@MH%1_\ EI( 6[@
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M.0A4S"_!C!P.AV]?4^E835--0:W/6PDL=*E+%PJ-JFT[-O5W3VZVLF_DSO\
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MS_PB.I?\\X_^_@H_X1'4O^><?_?P4<DNP?6*7\QC45L_\(CJ7_/./_OX*/\
MA$=2_P"><?\ W\%')+L'UBE_,8U%;/\ PB.I?\\X_P#OX*/^$1U+_GG'_P!_
M!1R2[!]8I?S&-16S_P (CJ7_ #SC_P"_@H_X1'4O^><?_?P4<DNP?6*7\QC4
M5L_\(CJ7_/./_OX*/^$1U+_GG'_W\%')+L'UBE_,8U%;/_"(ZE_SSC_[^"C_
M (1'4O\ GG'_ -_!1R2[!]8I?S&-16S_ ,(CJ7_/./\ [^"C_A$=2_YYQ_\
M?P4<DNP?6*7\QB_QCZ4M:I\+:A]H$?EINV[OOCIFI/\ A$=2_P"><?\ W\%/
MDEV)6(I:^\8U>6_$#X9>*=0\4GQ#X.\4_P!AWL\ M[JVNH_.@D Z,%(8 ]!]
MW\:]K_X1'4O^><?_ '\%'_"(ZE_SSC_[^"HE2<U9H[,-F*PL^>G)=FFKIKS3
M5CYXM_V=KE_AYX@TB]UU;C7=9NDO9;T0!84D0Y4!!CCKR,=>G'-VV^&WBF/Q
MA)XM\0ZMIMW)#HLU@8+&%XPO!((W$Y[DDXY/2O>O^$1U+_GG'_W\%'_"(ZE_
MSSC_ ._@K+ZJE:R/0?$%67-S33YK]%U232TTT2V['R7\*_AOXA^('PBT/3)]
M;M(O",UY)<SVXMV^U@)</F)7SMVDJ6R1D$]P,5[)X9\ 7&A>/_%>NO<1-::O
M%;QPPQY#Q^6K Y[=^,5ZA_PB.I?\\X_^_@H_X1'4O^><?_?P40PW(EW08O/I
M8J52S48ROI;NU+>RN]%KUL?,DW[/'B=-#_L*WUW2CI%OJ8U& R6K"XF._=ME
M?D8&3C /7TKT"T^&U[;^*O'6JM=0&+Q!:1V\,8W;HBJ.I+<=/F'2O6_^$1U+
M_GG'_P!_!1_PB.I?\\X_^_@HCAE'9?U_3)JY_5K)J<UKY);N+?3O%'SWHOP4
M\2>%$\)WFC:QIB:MI-C+I]Q]K@D>&2-Y"^Y=I5LC/0XZ4FF_ ;6-.\/VA36[
M7_A)-/UB;5;6\,+&%_,^\DB=0#@9P>,5]"_\(CJ7_/./_OX*/^$1U+_GG'_W
M\%'U6*Z%OB&LW=S5WY+7?1Z;>\]/,\&\1?"CQ?XP\)WMEK7B2TNM0N=1AO$B
MCB9+6V1#RD><OS[G_&I-8^$FOVOBG6M1\-:EI%M;:TR27"ZG8_:)+:0#!>'M
MDCLPQ7NO_"(ZE_SSC_[^"C_A$=2_YYQ_]_!3^K)]/Q_KN9QSVI%64HVUTY5;
M6W2UOLK^KGS[K7P0\0R:QK\NE:]I\=IKMC':7DMY9;IX]L0C)BV850P'(Q@9
M.!P*T]$^$6I:=K7P_OIKVT9?#=C-:SI&&_>EQ@%..GUKV_\ X1'4O^><?_?P
M4?\ "(ZE_P \X_\ OX*7U9)WM_5[CEGU64.1S5K6V7\O+V_ET/,O&'@&3Q3X
MS\*:NSV[6>D23//;SKN,H>,J,#&."0>:T/&'@JV\3>#=6T"W*::E]"T?F01@
M!2>^!C-=[_PB.I?\\X_^_@H_X1'4O^><?_?P5I['?3<XO[3:]G:?P;?>W^;/
M!/#7PD\4V?BOPSJ^K:IH\L.C6LEDMK86S1 HT>T/DYRY.,]!Z4_3/A'XDT/P
M)I^BV6K:5-+;W$\L]IJ%D)[.Z5V) ;(#J5S_  D9R:]X_P"$1U+_ )YQ_P#?
MP4?\(CJ7_/./_OX*S6&2Z?UI_D=LL^J3:;E'I]E6TYNEO[S_ .'1\X77P^TC
MX8?"KQ?'XIU"UMX]==BT>G6[+;02E3Y:0IR>",\^@KI?V<_"EWX;^'5O<ZF)
M?[6U1_MERT_W^0 @.>>% _.O:O\ A$=2_P"><?\ W\%'_"(ZE_SSC_[^"B.&
MY9*26R'6SSV]"=&<M9R4F_1622MITOJ[V78QJ*V?^$1U+_GG'_W\%'_"(ZE_
MSSC_ ._@K?DEV/&^L4OYC%_C'TI:U3X6U#[0(_+3=MW??'3-2?\ "(ZE_P \
MX_\ OX*?)+L2L12U]XQJ*V?^$1U+_GG'_P!_!1_PB.I?\\X_^_@I<DNQ7UBE
M_,8U%;/_  B.I?\ /./_ +^"C_A$=2_YYQ_]_!1R2[!]8I?S&-16S_PB.I?\
M\X_^_@H_X1'4O^><?_?P4<DNP?6*7\QY-\:_!^L>/O"D&@Z4R107EW$+Z9I-
MI2W#9;;ZGIQ[5Q5E^SQ+\/O&'AW7_"FIZCJ+V\YBO8M6ND;_ $8K@A"$7IZ?
MX5]'?\(CJ7_/./\ [^"C_A$=2_YYQ_\ ?P5C+#*<N9K4]:AGM3#4?J].2Y-;
MJV]U9W^6Q\P7WP=\7'P-XO\ "T-K9207VK_VC9W9NL%U,BDJR[?EPJ]<]:]%
M^)/@;4]='AG5M&,!UO0+CSXH+EBL4ZE0'0L.A.!@^U>M?\(CJ7_/./\ [^"C
M_A$=2_YYQ_\ ?P4EADDT7//ISG&;:NFWL]>9*+OZI?F?,GQ \'ZW_P (C\1/
M%_B..ULM0OM,2TAL+.4RK#$C _,Y W$GT K0\+^#_%OC.+X?/K,6GVFAZ''%
M>I<6TK/+=MY0$8V$#9@'GDYKZ$OO 5SJEI+:7EE;7=K*-LD$^UT<>A4C!%20
M>"KZU@CAAMX888U")'&P554<  #H*GZJ^:_3_@W-_P#6"/L>1)<UW9VV7*HV
M7R[W[[ZGSJWP@\0GX5>.] \NW_M#6-6DO+4><-IC,J,-Q['"GBN?^-GAXW7B
M'P1I.EZG##X@O+5=%U*S@<-(;8JK%F Z 8;DXSD>E?5O_"(ZE_SSC_[^"J(^
M&>W5FU0:58C4V3RS>A$\XK_=WXW8]LTI86ZLB\/Q%[.K[6HT[<S5N[BHZWOI
MHGZF;I]E%IMA;6D"A(;>-8D4= JC 'Y"IZV?^$1U+_GG'_W\%'_"(ZE_SSC_
M ._@KJY)=CYQXFFW=R,:BMG_ (1'4O\ GG'_ -_!1_PB.I?\\X_^_@HY)=@^
ML4OYC&HK9_X1'4O^><?_ '\%'_"(ZE_SSC_[^"CDEV#ZQ2_F,:BMG_A$=2_Y
MYQ_]_!1_PB.I?\\X_P#OX*.278/K%+^8Q?X_PI:U?^$6U#[1Y?EINV;OOCIF
MI/\ A$=2_P"><?\ W\%/DEV)6(I:^\8U%;/_  B.I?\ /./_ +^"C_A$=2_Y
MYQ_]_!2Y)=BOK%+^8QJ*V?\ A$=2_P"><?\ W\%'_"(ZE_SSC_[^"CDEV#ZQ
M2_F,:@C((K9_X1'4O^><?_?P4?\ "(ZE_P \X_\ OX*.278/K%+^8^8?$OPR
M^)=Q'J>B Z!XGTB[D<PZGK:&2\MD8\ $GJO;(//3TKH9?A3XA\*S>"M7T.:W
MUG5-!L7L+BVO)3$MRC=U?!VX)/4=,5[[_P (CJ7_ #SC_P"_@H_X1'4O^><?
M_?P5SK"K?4]V7$,Y14?=MK=)6O=6=_EVMWW/!M5\$>-_%$?@^YUN33YKW3M<
M%_.EL=BPVX.0F?XV XR .W7K6#'\$=3TG6M4MX/"WA?7+.]OVNHM6U="\MO&
MYRR-& "^.<88=>]?2_\ PB.I?\\X_P#OX*/^$1U+_GG'_P!_!3>%3U8H<03I
MKE@XI=DFEO?HUM_P]SR?1/!.H:;\7=7\0,D*:5<:9;VD/EM@AT/(V]AZ5RMW
M\/?&6A)XKT308=-N]&\0W$EPMY=3LDEF9!B0% #O]L$?C7T%_P (CJ7_ #SC
M_P"_@H_X1'4O^><?_?P4WA[K^NIA#.G"7,VGI%6:=O=V?JOZT/GSQ?\ ".\;
M1M$T>#PSHOBO3-/L([1'O)Y+.\C=1@N)5SE3UV@#ZU4\'_!OQ/X<\2>%KV>Z
MMKM-.TRZMY9)W:18Y)"Q1,$AG09 SD5]'?\ "(ZE_P \X_\ OX*/^$1U+_GG
M'_W\%3]55[V-UQ#55)TN96=[[]4T^MEN]DK];GS3I'P:UQO'.C:K_86C^%9+
M*Z$]WJ.BWDFV]0'.P6YX0-WR2>37OM;/_"(ZE_SSC_[^"C_A$=2_YYQ_]_!6
MD*'L[V1Q8S-OKKBZLE[JLM_UN_QLNEC&HK9_X1'4O^><?_?P4?\ "(ZE_P \
MX_\ OX*TY)=C@^L4OYC&HK9_X1'4O^><?_?P4?\ "(ZE_P \X_\ OX*.278/
MK%+^8QJ*V?\ A$=2_P"><?\ W\%'_"(ZE_SSC_[^"CDEV#ZQ2_F,7^/\*6M7
M_A%M0^T>7Y:;MF[[XZ9J3_A$=2_YYQ_]_!3Y)=B5B*6OO&-16S_PB.I?\\X_
M^_@H_P"$1U+_ )YQ_P#?P4N278KZQ2_F,:BMG_A$=2_YYQ_]_!1_PB.I?\\X
M_P#OX*.278/K%+^8^>=6^%7Q%L_&GB/5_"OBW3]'L]8G69X9;82O\J!1DLC8
M[]#5M_V?RG@*+3(]6\_Q"FHC5VU2ZBWK+<]#N7NI4XQ^->]_\(CJ7_/./_OX
M*/\ A$=2_P"><?\ W\%8?55KI^)[3X@JVBHR2M;512;Y597=KO3N>&ZCX#U-
M_ WBQ/%MU:7$=[:E%M/#NF!1;A1D,@QYDC9 ;!)Z<5Y9X=UB^\>^+OAQ91ZY
M;^(%T:<F2&RL98?L\*J!ON&?^,X"X&!P>I-?8O\ PB.I?\\X_P#OX*/^$1U+
M_GG'_P!_!4RPSDU;^M;]S>AQ!"E&:DDV[VV25X\NW+V[-7MK<\ T3X+>(?#-
MU)IVEZSI4/AQKYKL23:<LU]&C-DPAG!3'^T1GO[5TEI\-;RW\4^.M4-U 8?$
M%I';P1@'=$51U);CI\PZ5ZW_ ,(CJ7_/./\ [^"C_A$=2_YYQ_\ ?P5:PZ6R
M..IG=2JVY35VK/1:ZIZZ;W2/GV#X&:KI?A[P<=/O]-;7_#\4L!^VP-+:7,<C
M$E67AN,CD5I3?";7-07PM-?ZM83WFF:L=1N/(M%MXMFW CC"+DX]7R3ZU[A_
MPB.I?\\X_P#OX*/^$1U+_GG'_P!_!26&2Z%RSZK)W<U?76ROK>ZO;;5G@WBW
MX.:_J?BCQ1>Z/K.GVEEXCMEM[LWEJTL\ $>PB(@@ ,.N>F3@4L'P@UW3+KP#
MJ&GZAIRZCX>M7LKA;B-VBFC;@E,8(.,]>YKWC_A$=2_YYQ_]_!1_PB.I?\\X
M_P#OX*?U97O;^KW!9]54%#F5DK;+;EY==-?=T/GZQ^ M_;>#5L1JT%MKEGK3
MZS87L49>.-RP(5U.,CCFFZY\$-=\86WB/4==U;3Y?$>IV2:?;_9(GCM;:(.&
M. 26)) Y/3\:^@_^$1U+_GG'_P!_!1_PB.I?\\X_^_@I?58VM8I<05E+G4U>
M][V5]T[;;-I:?YL\JO/AY=W/CKP?K@NH1!HEG+;2Q$'=(63:"O&,?6N\K9_X
M1'4O^><?_?P4?\(CJ7_/./\ [^"M8TG&]EN>95Q\:ZBIR^%67I=O\VS&HK9_
MX1'4O^><?_?P4?\ "(ZE_P \X_\ OX*KDEV,/K%+^8QJ*V?^$1U+_GG'_P!_
M!1_PB.I?\\X_^_@HY)=@^L4OYBYX'_X_+K_KF/YUV-<SX8TJXTN_G6X55+Q
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M,/F=1&,8 &Y48E%]5H **** "BBB@"I_S%!_UQ_]FJW53_F*#_KC_P"S5;H
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M"C[9!_SVC_[Z% $U%0_;(/\ GM'_ -]"C[9!_P ]H_\ OH4 1'_D*+_UQ/\
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MT@V+P@AEDE20ONS_ +&-N.<]:Z;[9!_SVC_[Z%'VR#_GM'_WT* .4\"> )O
MNFZIH\.JM=Z#),[Z99RPX?3HG&6@$FX[T#$E 0"H.W) &.?T3X(+HVGS6O\
M;)F\SPO%X:W?9MN AE/G8W]_-^[_ +/7FO2_MD'_ #VC_P"^A1]L@_Y[1_\
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M?\]H_P#OH4 1?\Q0?]<?_9JMUG_:X?[3!\Y,>3UW#^]5K[9!_P ]H_\ OH4
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M]L@_Y[1_]]"@#S*R^#-_-9RP:WXD353;Z//HFF21:?Y#6\,J;#)+^\82R85
M2OEJ<'Y1GC0N?A((K7P?/I6IKINN^&X8K2/4A:[Q<VP4++!)'O&4? (^;Y6
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M_OD5+10!%]EA_P">,?\ WR*/LL/_ #QC_P"^14M% $7V6'_GC'_WR*/LL/\
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MP?$;PK<ZE>:?#XDTJ:_LT:2YM8[R-I85498LH.0 .N:S?AA\7?#OQ;T^]N]
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M_A1]EN?^?U_^_:_X5;HH J?9;G_G]?\ []K_ (4?9;G_ )_7_P"_:_X5;HH
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M^_:_X4?9;G_G]?\ []K_ (5;HH H?V?/YPE^VON"[?N+T_*I/LMS_P _K_\
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MO^%6Z* *GV6Y_P"?U_\ OVO^%'V6Y_Y_7_[]K_A5NB@"I]EN?^?U_P#OVO\
MA1]EN?\ G]?_ +]K_A5NB@"A_9\_G>;]M?=MV_<7IG/I4GV6Y_Y_7_[]K_A5
MNB@"I]EN?^?U_P#OVO\ A1]EN?\ G]?_ +]K_A5NB@"I]EN?^?U_^_:_X4?9
M;G_G]?\ []K_ (5;HH J?9;G_G]?_OVO^%'V6Y_Y_7_[]K_A5NB@"I]EN?\
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<_A5NB@"K!9O'<&:2=IFV[ "H&!G/:K5%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>aciu-20221231x20f012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &> \L# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX593_P  ;#?I78]:ZHR4E>+N?-UJ%7#RY*T'%]FFG^(M%%%48!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/W*]Q[C(KW*&+I5](NS['XUG'#&8Y->=:/-3_FCJOGU7S.^HHHKM/D@HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\7Z***^"/[;"BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M??%31?AW)8V]\MW?:G?-MM=,TZ'SKF;M\JY'ZD5P7[1J*-?^&<F!O&O1@-W
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MLBAAD!ADX/XU?HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#\7Z***^"/[;"BD4AC@')]!4RVD[C
M*P2L/4(30)M+<BHI7C:+[ZLG^\,4T$'H<T#%HHHH **** "BBB@ HHHH ***
M* "BBB@!58HP8=0<BOUK^"_B8>,?A1X5U</O:XL(A(?]M1L?_P >4U^2=?HK
M^PGX@.K?!3["[[FTV_EA ]%;#@?FS5Z^63M5<>Z/ROQ#POM<MIXA;PE^$E_F
MD?1=%%%?3'\\!1110 4444 %%%% !1110 4444 %%%% !1110 57O["WU2RG
ML[N%+BUG0QRQ.,JZD8(-6** /%K?]G:^\.231^$?'VL^'--E)8V&T7$:$_W,
ML-OUZ^]=1\.O@YI_@/4[O6;C4;WQ!XANT\N;5-1??)MX^5?[HX'<]!7H-% '
M'^%/AS!X5\9^*_$,=[)<2Z_)"\D#( L/EA@,'/.=WZ4MQ\.H+CXH6OC0WL@G
M@L&L!:;!M(+$[MV<YYZ5U]% '!Z1\*+?2-:\;ZBNH2R-XI55E0Q@"#"NORG/
M/W^_I5CPS\+K'0/A>G@B:YEOK#[/-;O.0$=ED9F)XS@C?^E=I10!XY;_ +/4
MH^'FK>#KOQ??WVEW?D"V\Z%2;-8Y-^U1GG. #TZ5U<OPMMY/'V@>*/M\HFTB
MP-BEOY8VR @C<3G@\]*[BB@#COB!\.(/'UYX=N)KV2T.C7RWR*B!O-(Q\IR>
M!Q7%_%UO!^K^.]$TK6M0OO"WB"*$W&G>(()5@0#.#'YA.#R.A'?KSS[+63XA
M\*:-XLM5M]9TRUU.%#E4N8@X4^V>E 'S3XJ\,Z;=_%3P+9:?XIN_&_B/^T%F
MN[F6Y686MNF&V[4^5!P6QU_.OJRL'PUX$\.^#O,.B:-9Z8T@P[6T05F'H3UK
M>H Y?XD> ;+XE^$KK0KZ:6WCE99$GA^_&ZG*L/7_ .O7,W'P8N=5TKPQ;:QX
MIO=6NM#U5-36\GB&^;:01&W/ XZ\FO3J* .9^)'@B+XC>#;_ ,/SW3V45WLS
M/&H9EVN&Z'Z53\8_"W2?'/A*ST+4FF LQ&;>[@;9+%(BX#J>Q]J[*B@#R&Y^
M ^H^(DM;+Q5XZU3Q#HENZN-.:!(!+MZ"5UY?\:];@ACMH8X8D6.*-0B(@P%
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MVXHL2\#<0N6Y/RBNQU_X<P:]\0_#?BQ[V2*;18YHTME0%9?,4J<G/&,UV%%
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M]K-+$A]W5"OY$T >E45YA\5OBSI^B_"2\\0Z)K$?FWD1BTV[A0R!I3GCH0"
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M:\//KFI7J6NE(BNUR5)&&("\ $G.1V[T ;%%<QXI^)7AKP586EYK6JQV$5V
MT"NCF20''2, L>H[5F^$_C7X.\:ZJ-+TS5]VI$$K:7,$D$C >@=1GCGB@#N:
M*XGQ)\9_!GA*[U"TU;6X[2ZL-@GA,4C,I<94 !3NR/3/O4E[\8/!^G>%K'Q%
M<ZU%#I-]G[-*T;[YL'!VQ[=YP1Z4 =E17SK\3/BMH_C+Q%\.O^$:UJ23;KJ1
MW4">9!(%.W =& .#[C%>Q^,OB7X:\ ?9UUW5$LY;C/DP*CRRR?1$!8CWQ0!T
M]%<KX-^)_AGQ_+<1:'JB7EQ;@-+;M&\4J#U*. ?TKJJ "BBB@ HHHH ****
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M )$N*O\ R_JC[^HHHK[$_DX**** "BBB@ HHHH **** "BBB@ HHHH ****
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MX+B^NY9[AI#&#(S)*Z( 2.,;./3-;_PR^#ES\/?#WBS2FU(7RZO/))#/)DN
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MW%M(>K1%/Y' X%:/PH^$>H_#[Q5XFU?4-:&M2:RL+/,Z;9#*NXN2.@!+< =
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M:9JVOS_M$^-]1L/#$7BB]TU(K2W%QJ"VQM(B.J;D;.[GIC&3ZUNW&B>-=?\
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M ;OP%>D?!SX$M\+?%7B#4WOH[RVNAY&G1*&W6\'F,^QL]^5Z>A]:3X:_ ?\
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M\CU^F #D/VA-"L5\=_#/5UAC346UF*V:4##/'N5@">^#T],FK_Q)\&>+M/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:,.&!0C<&!XQZYKYG\"Q^%K/P#::?>_"GQ)K4UW )+O4'TN&5[AV&2ZRM+N
MY^4C&/K6/J>L>)?"?[/6KZ/<6^J:2CZR-/L9-03R[C[#(0P!Y//#*<''.,T
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ME,XZJ!QUJ[\2M<CUS]H*+3-8T+4_$^BZ)8K/#I.G0+*&F?!,DB,RA@,@<Y'
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MS8')/J>: /8K?4K;1?#EI<ZIJEOY4<">;?S2JD<AVC+[B<8/7\:CT+QIX?\
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M7C9D#CZCOFI?CY\-]7\<:1IM]X9=8/$FF3,8)6D"9BD4K(NX].Q'T]Z]4HH
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MVEO=BYGNW7H-P&T+U'KR>O&/;Z* /,O$O@/5=1^-WA#Q+;11?V1IEI/#.QD
M9696"@+U/44OQJ\"ZMXVD\('2XXY!INLPWMQYD@3$:GDC/4^U>F44 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,H
MHHH **** "BBB@ HHHH **** "BBB@ J*Z&ZVF!Z%"/TJ6HKMMEI,QZ!&/Z4
M#6Z/QUU]!'K^J(.BW<RCZ!S5&KNN2";7-2D'1[J5A^+DU2KX)[G]K4_@5^P4
M444&A]??\$]?!S7.O^)?$\L?[JUA2Q@<CJ[G<^/H%7_OJON*O%?V0/!I\'_
MS1#)'Y=QJ>[49,CDA\;/_'0M>U5]C@Z?LZ$5\_O/Y0XJQOU_.*]1/1/E7I'3
M\7=A11178?)A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 ,HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,
MHHHH **** "BBB@ HHHH **** "BBB@ KYC_ &^O$_\ 9GPIT[1D?#ZK?IN7
MU2,;S_X]LKZ<K\^_V]/&RZ]\4[+087W0Z+: 2 'CSI/F(_!=GYUY^.GR4)>>
MA]OP9@WB\ZHZ:0O)_+;\;'S-1117R1_4@J*78*HRQ. *_5#]F[X<I\,_A'HN
MFM'LOKB/[9=DCDROS@_08'X5\(_LI?#(?$OXNZ;%<0F72]-/VZ[R/E(4C:I^
MK8'TS7Z> 8%>_EE'>J_1'X?XB9I=TLMIO;WI?E%?F_N%HHHKWC\4"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!E%%<5\2OC'X3^$U@;GQ%JL=M*5+16<?SW$O^Z@Y_
M$\5,I**O)V1O0H5<345*A%RD]DE=G:D@ DG %?.WQY_;"T'X:+=:1X>,6O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!\%_%?]O'7->22Q\%67]A6AX-
M_<XDN6'^R/NI^IKY?UC6;_Q!J,U_J=Y/J%[,=TEQ<R%W8^Y-4Z*^)JUZE9WF
M[G]A9;E&!RF')@Z:CW>[?JWJ%%:WA;PEK'C768-*T/3Y]2OYC\L,";CCN3Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>aciu-20221231x20f013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %- H # 2(  A$! Q$!_\0
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MZUL>)='O;_4;>T#6UQ"GV\E8SYLN0=T3EC\HP>OM7T+*IDC=%8HS @,!T]Z
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M<D#..:\[U'P-K5G?N?!G@CQIX'\7M=_*ME<B31]A;EFF/&-O;[O;D<5]G4E
M&;?#5$\-W M3%)K(M&\HMQ&T^SY<_P"SNQ^%?'7B30_&WBWP?IPU7PIXQU'Q
M-9:FEQJ-]?L[VX0.P"VL"G!!!4DJF!MZ\U]L44 >+^'/#^HK^U)XGUJ33;M-
M*GT.&*&^D@987?,.5#$8+<'CKP:XGP_X"\0S_#7XU:=_8UY%>:GJMS+90S0F
M,W*[L@Q[L;@0.".M?3U%(#Y:U33M=\4^#_@W'%X5URRFT/6;6"\BN[)E9%C6
M+=-@9Q'UPS8Z&O5G^ FEO\0_^$O.NZ\+O[8+S[$+M?LNX'.W9MSM]LUZ?13
M\:^,GA_4]5^*_P *;RRTZZN[2QOYGNIX(6=(%/EX+L!A1P>OI7._$V3QC/\
M%'4K.^T/Q+KGA::R6/2;709V@MGF*C=]J=67 W;OO' &, U]#TE(#Y!MOAIX
MJE_9GTW3HM!OO[:T7Q ;Z33I(6265%+<H"/F'S@C&<X.,UV$UWXB\?\ Q]^'
MOB(^"]<T31;.*YB>;4;?:RL8WR7"D^6N2H4L1N]*^CZ* /"/VR=W_"IK;8 7
M_M:VP&Z9P]4=<_X2;XO_ !$\"0R^#]4\-V_AN]&H:C>:BJK"77:=D#J2) 2F
M,CU' Q7K?Q&^'.E_%#08](U>2YBM4N$N0;20(^Y,XY(/')[5U.,4P/CF#X4-
MX2U/Q#H_B#P/XM\227-_)+8WF@W+K9SP.1@288*C8SG(/7!P!D]!XV@E\!?&
M;X41Z'H5W=_V?I$P326F5[@1[9-Z!B2K.JEL#/)& :^IZY35OAOI6L^/M%\7
M3R70U3289(+=$D B*N&!W+C)/S'N.U 'E7@[P]KOCOXF^+_&]QH%]X=L+C1C
MI-C::HGE7$[$#+LG\(ROZC&<&O.6\/>)KO\ 9:O?!I\(:]!K6F7L;%)+)B+D
M-.[$PXR7"CJ<8Y')K[%I: /G[5[+7_AG\9F\8Q^&=3\2Z-J^CPV,R:3%YMQ:
MRH$X,9(X.P<Y Y/<8/':=\-/%OCK0?C1;WF@W.A:CK=U:WMG;W7"2%7>3RUD
M^ZQQ@$@X!-?65% 'RY\,O >EW_B;PXMU\/O&NGZCISI/-?ZE>,MI;SI@[DW/
M\ZDK_".F!@BO0/VK= U/Q+\)IK+2=/NM3O#>P.+>TA:5\ G)VJ"<"O8Z*0'S
M_JZ:W\-OCIJ'BF'PWJ7B?2=9TR&TD71T$T]I*BH &3(VJ=@.3@<]>,5R7PU\
M(7GQ2LOCCH^H6ZZ/J&IZBC>6S"1;><-(X4L.#A@ 2/>O;O&WP5T+QMKL>MM=
MZKHFLI&(6O\ 1;UK:61!T5B 0<9],]JV/ 'PYT7X;:3+8:/%+B>4SW%Q<RF6
M:XD/5W8]3Q["F!\X:W+XLU?P5I/@?QI\)]8\03Z2RK;7FF731V\VQ#&C-(BD
M#Y3SS[X%>P?LU?#[5OAO\-ETW6H8[6]GNY;LV\<@<Q*P4!6(X+?+VS7JU% !
M1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKIYM+:XDN?MBQ 2SQ;%86@7[HD3<2S#G Z T >VT444 %%%% !1110 4444
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MGU^9_P#P2,T9/#WQ4_:%TZ/4= U9+:728Q>^%W+Z;-S>?-;D@93TX]:_3"@
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M#XV_&C0O@1X&F\2:Y'>7>Z5;2RT[3K=Y[F_NG5C'!$B@Y9MC<G  !)( K@/
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MQV&2<#TQ7F?QXT'P'\5-8M]:TGQ]HFGZF(A!,ES,3'*HSM;*@D,,XZ<C'3%
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MLH5@ -RD \$ <5J^"O@KXC^'\%S%HWBRT@%RP:5Y-*#LV!@#)DZ#)_,UTO\
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MJJA0@_A '2GX'H*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK3_!^@66C:7#]GL+./RXDSD^I)/<DDDGN2:U* "BBB@ HHHH **** "BBB@
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M)O[(]DO\5^E[[6W\[_(=1117W)\<%%%% !1110 4444 %%%% !1110 4444
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MW2%;5A<+%&&/EGS>6RH+$@Y/8 ]FHHHH **** "BBB@ HHHH **** "BBB@
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MR_!7C;0_B+X6T[Q)X;U*'5]#U"/S;6]M\[)5R5R,@'J"/PKDOV@/A3H/Q?\
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M?VC?AKIEY\2/AS\0].\.> -"T6V74M-$<9NIKLW+(TD:O;N,$2PCF0?=/'J
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M3_$ISJ,"_P"E_+/P/GSGMW%?I=0 4444 %%%% !1110 4444 %%%% !1110
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MU!O'-W871L!;>6;(6]N80I?>?,W<MG"XZ<]: /5:*** "BBB@ HHHH ****
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M5LL5W*!D)N;"=3G;TZ_EBO6/^%H>$]<\177A"#7-NNN9;9H(5=)$=5.[:^W
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MZ;>:XTKW\MXK7-K$[ 1%44D%5P.^3GM5W]I_QG)XKTO7=%TV_A@TO05AEO\
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M:*\3_9S_ &OOAU^U--K\7@.^OKQM$6!KS[99/;[1,9 F-W7_ %3_ $XKVR@
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M--_Z!]K_ -^$_P */[ TW_H'VO\ WX3_  J_10!0_L#3?^@?:_\ ?A/\*/[
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MYM/\.:O+>2'^RK&Y8 7,:P%6=D!57 P3N)/WA0 4444 %%%% !1110 4444
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MH **** "BBB@ HHHH *2FS2K!"\CYVHI8[5+' ]AR?PKXL\+?M;:WXI_:?\
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MX_\ A+XI^#KNUTW4[5!:^(8=5LUO3JT:Q[1<J[?-%>9"[IU(+;F+9)8-]*4
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M8NIFTA9%=MDJQOQY[(RB20 !BO ZD^WT %%%% !1110 4444 %%%% !1110
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M/!'B/P]\/O UEI6N?%#Q&'GT_3-;NGM+1;:-'>69Y IW']WL$:G<2P)PH)H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% "8I:** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
:BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>aciu-20221231x20f014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &0 \L# 2(  A$! Q$!_\0
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M_ WA?XD1QR^']*26VM3+HWAJ[E=;/?($EEV,BB+=$2?EP/ESBOH#Q%X!\/\
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MDL+AT8>H(X-3T %%%5VOK>.\2U>>-;B12Z0EQO91C) ZD#(S]10!8I",T4M
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M^(-*GN)&VI%'>QLS'T #9)H W**05SGCWQ'?>%M"^W6-BE\XFC2022!%C1F
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MW,-DCVKU_P"&&DV_BCX/^';37] @6!K1 VE7T)F1 I(4%9<GH ?FYKT$)M
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MM&TZ6XE@B34@RC>64QYD.<KB-EQ@=<U];E/>@IGO0!\^W.O^,=1L_B3JD'C
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M0!XM^SI>ZWYFMV&IRZSJ=M (C%JVJR7($S<A@L=PH9#P"=I*\C%>UTW!S3J
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"KJ=U-9
M:?<SV]LUY<1QLT=NK!3*P'"Y/ R>,FO'M0^)WBZPU)H+O5/ FFWBNH.CW%],
MTR@_PM(!C=VX7%>TN<+ZU\\ZIX@B\,^.-8L[36]#<W6I^:;:71))Y1(Q12GF
M@X+9*CGH2!Q0![MH%]?W^E0S:G8+IM\<B6V682JI!QPX R#UZ=ZTJ:HX!IU
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M5WL<'GM7Z!Q-OC5CW&:RHU56CS(]/,\OGE>)EA:DDVK;>:N/HHHK8\H****
M"DSS2TT]: &M)CTIP;-?#/[8/CWQ'X9_:"\/V^F:_JFGV26EI*UI:7LL4+DS
M.&W(K -D  Y!K[#\"^()/$>A0WD@"LXZ"L*=55)2BEL>KB\OG@Z%"O)IJJKK
MRUMJ=(*6LW7KC4+?1;Z72XHYM02!WMXY@2CR 953@C@G Z]ZY6W^(EQJ]WH[
M:38M>V<^EG5+L(,RJ&P(84!8 .S;\[N (R.^1N>4=Y17FFE?'32M<BD73K&Y
MU&_6\-DEE9SVT[2.(C*Q61)3'@(#G+9S@8R:Z:V\:"^U^33;?3+Z58"BW-V%
M01V[LF\(P+;LXQD@$ L!F@#I:*\PT'XV6VIV-C.^FW\T3QV/VF^2&.*&-KH*
M8_D,K-U8 @%MOJ>M7- ^./AKQ)XH70[*[B>XDEEAB(NH&9WCSN!B5S(OW6P6
M4 X]Q0!Z'17#ZE\2!IFO7&EII]UJ=V;U;*""TC1#N-L)SEWD (QGGY>PP>IQ
M+KX]Z)IX^T7;M:V\MI;2Q0W(CA(EEEN$*M*\H08,#9S@#'WFW   ]3HKS[1?
MC)I?B5;$:+:W.L23F3S4L7AE%NJ2*C,S"3:P!8?<+9 )'2J-C\7)H;K5VUBS
M:PM+&^O8%98U<R101J^01)D-S_=YR ,=: /3Z*\_O/BY#IUS#976@ZI!JT\\
M,,.GGR3(XE60HX82%=N8G!RV01R,<UT_A+Q+#XMT6/4((9K8&26"2"<#?')'
M(T;J<$CAD(R"1[T ;-5[VXEM[2>2" W,R(62$,%+D=%R>F?6K%(0#VH \6U/
MXF>+M.U1[>[U/P+I-V&7;I%W?3/.H(!VNX  ;G(PN.17JWAS4-0U+2HIM4T]
M=,OLD26Z3B91@]5< 9!ZC@=:\.\0Z_#X8^(FO0P:YHF^YO4GEM9]'EN98VV1
MIM\T'&?N^P+8XS7T##]P'U H DHHI#0 A; ]Z;YOI@GTI>G6OSV3XJ>)]&_:
MVU2)M?U6XTZ/6+F :?)?2M;[,, HB+;0!]*PJU52<4^NAZV7Y;/,(UI0DE[.
M+D[]4C]"MU!)JCHMZVHZ;!<-PTBAJMSMMMY#W"FM]CR4KNP]6R>U.K\_/V0_
MBSXFF^(FJ0ZKKNJ:Q#<P*!%?WLLZHWF'YE#L0O<<8K[_ ('\R)&]16-&JJT.
M=(]7,\OGEF(>&J--I)Z>:N24445L>4%-=MM.KP+]MO7M3\._ ^>YTG4;O2[I
MM0MH_M%E.\,FTOR RD$ _6LYS]G%R?0[,'AI8S$0P\79R:5_4]ZWY&>U/KY:
M_8F^(NK>)/ PL=6OKK5)X;F<"YO9WFE(WY +,22!VYKZEHIS52*DNH8S#2P>
M(GAY.[BVKKR"BBBM#C"BBB@ II.#3J:XR#]* $#Y]*?7Y^_#'XK>)M/_ &FO
M$$%UKVJ7UA]MOH5L;F]ED@0"7"[8RQ48Q@8'%??-C<&ZLHY3P64&L*5554VN
M]CU<QR^>6U(TJC3;BI:>>I9HKSR;X@ZHEA>6<=K;OXBCUE=*CA(81%78.LQ&
M<E1;MYAP1DJ1Q3+_ .-^C:3KFH:5J%O/9W=G:S7C1F:"20QQX/,:2%U+!E*[
MU7.16YY1Z-17'S_$"6W2QB;P_JAU.[\UETT>3YJI'C<^?,V$?,N,,2<].M9]
MW\5!9>([W1TTV]U.\2Y:&&"UBCC("VT,[;F>7!XEZ_+Z8.,D ] HKRZ^_:(\
M*:?)9)-<K$;BUAO'6:Y@A>*.7[OR/(&<\<A V/RKHO%_C^W\'O!+<++/;&RN
M;QD@B#.ZQ>7T)< 'Y^F#GU&.0#KZ*\YU#XPVFFRQK?VMUHQBNQ#=1W<:2D1F
MUFN P9), %8CS\QR,;><BOH_Q^\/:Y',MCF]O5,(BL[2ZMIY)O-;:@!CE95.
M>H<J1UH ].HKS36/BAJ.F^(5M)-)FL[,Z2E^[SHC2PR&98]C*)1GKC@]3G)%
M7;_XO6&F07-Y/IM^NEQFZCBOP(S'<2P*Y=%&_<"?+DP6 !V'GD9 .^HKEO"?
MCN'Q7?7=G_9]YIMS!;P7?EW@3+PS;_+<;&;&?+<$'!&.E=30 4444 5=2O)+
M#3[BYCMI;R2*-G6W@QOD('"KD@9/3D@5Y7>?%+Q99Z@8KBR\(V$F0/[*O/$
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M],4\'(K\]-"^*WB?2/VK-2BD\0:K=Z<-4NX!837TK6X4;@H$9;:,<8P*^_\
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M_MH?#[Q1X^^&R1^'[CSK:TE%Q=Z4(E+W(7E61L9#*?X>X)[@9^A*CFB$R%6
M*GJ*SJ052+B^IV8/%3P6(AB::3<7?78^-OV,/#&N^$)+B'4XY(XYV+QVCQ@-
M#GD[CUR?3/%?9@Z5GV.@V>G2M)! B.YRQ ZUHT4X*G!070,9BIXW$3Q-16<G
M=V"BBBM#C"BBB@ JIJ4=Q-9W,=K*EO<-$PBFDCWJCD'#%<C< <'&1GUJW32,
MF@+V/SA\/?"WQUX8^.MY>:Q;+'*M\\US=QPGR+D2-N/D\]\_AT-?H;H$C2Z/
M;%E*ML'!^E+=Z#9WLZS30(\B<JQ%:"((U"@  < "L:5)44TCULRS*KF=2-2K
M%)Q2CIV1SLW@>PF\91>)"9A>I;^1Y:N!&^-P5R,9W .X!ST8^U<Q%\"='2)K
M>2_OI;+RKF);4"&-%$^-[92,,SY (=B3D#DUZ716QY)QTWP^EG6RF;Q!JG]J
M6IE"ZD/)\UDD #(5\O8!\JXPH(QG.2:?!\-["'Q3+KWVFZ:[DE>5E9EV$M;Q
M0'^'/W85/7J3[ ==10!PVF?"R#0A:KI6LZGIRQVT-K/Y)B/VE8@0A;=&=K8)
M&4V\&M/Q9X$LO&(3[9-<1%+6>T'DLH^679N/(/(\L8^IKIJ* /-/%_PP&N^)
M].E6&2XLKB[$VI-+*JHL:6<]NJH!\VYO.'MP>1QG8;X<M<::+2[\0:K>&)X9
M+6>4P[[9XCE67;& Q]2P;(ZUV=% '$ZC\,+?59H)KK5=0EG6S^Q32,8LW"^8
M)0S?)P0R_P .!SC'2J^H?"#3]4M[JTN-2U!M,E-R\-@&C\NWDG5U>1#LW$CS
M9,!B0"W3ICOJ* ,'1_"%KHNM7&IPRS/--96U@R2$;0D!D*D<9R?-;/T' [[U
M%% !1110 AZ&O _$<WA"?Q#<PSKKD%M:ZDSS75N8Q!([SPB2/^^4$OEDX&02
M<' Q7M7B./4I=!U%-(FC@U5H'%K+,,HDNWY2PP>,X[5\JS17FF_$S3CXQU;3
M;/Q1)-&5:VT*VNS(V[@Y27>IX^\R#VZ< 'UP6" LV !S^%<1;?&#0KVRUNZA
M%RT.EW,-HY:$J9I)=HC" X)R67!..N>G-=R!D&O,=8^%6H:C/XOF2YMUDU+4
M['4K(,6P#;K%E),#C<8R,C.-V><8H W'^(ULVFVM_#93O;/<26UR\GRBS9'V
M,)",X^;\.^<5X/\ MR?#7Q;XTT/2=0T9FU'2M.<O/I4,(,JN05\U2!EA@D%<
M]@?6O>/#?P[AM-&\G5@EQ=27EQ?2K#(PC#2RF0IVW*/E'(YVYP,XKS[XI>&)
M- \<^#K^RU#5%@U/Q!!#=PR7<[PMO9F* &78J\'Y GX@#!RJTU5@X,]#+\;/
M+L3#%4TG*/?8X_\ 8UT'6?"F@M8:H3(1]R/8 (5SG;D#D\YS[U]1XP*I:?HU
MKIFX6T*1YZX%7MN!BKC%0BHHY\37EBJTJ\U9R=]#XA_;;^%_C3Q/X]TG5K2%
M=1T4PBTMC;Q'?:M]YO-.>02"0W QQUP3]"?LZ1W]KX'MK?4"KW2*!)*B;%8]
M\"O4;S38;^$Q3H)$/!4^E%CIL&G0B*",1H.PK*%)0G*I?<[\3F57%86CA)Q2
MC3O9]=2TO3VI:0#%+6YY 56U&&6YLIXH)VM9G1E2=5#&-B.& ((..O/%6:0C
M- 'YJ:A\'/'N@?&^YEU)G^TK>&ZEUB.V AN%<G)12-H)Y^7^'\L_H?X-EDE\
M/VGF(8V"#(-7+[0K/49$DGA61TY!(J]'&L2!% "CL*PHT5132ZGL9EFE7-)P
MG5BERI1T\A]%%%;GCA1110 4UQFG4UEW?2@#Y%_;M^'/C#QBOA^_TJ%-2T6Q
MWH;6WB/GQ2R8!<G/S(0%Z ;>IXKN_P!DS3]3T3P=#8:H4DN(D"%XTVJ   ![
MX'?O7O-S9QW<31RH&5A@@U%IVDVVF1E+>)8P3GY16"I*,W46[/6K9E5K8*G@
M7%<L&VGUU+;=..M<A/\ ##2KB?Q-*TER#KT#6TX$@_<HP(?RN/EW%MQSG) ]
M,5V %+6YY)YQ9_!2QL;A[F+5M02Z$=M'!)$EO&MMY#2&/RXUB"#_ %K@@J00
M>E;=OX"%MK<&JQ:QJ27?D0V]VVZ,B^6)F9/,^3@@N_W-N0V.@&.LHH \]O/@
MMH][9^(+9[N^":WIKZ7<%73*1M+-*63Y>&S<..<C 7CKG:TWP/\ V/JCW%IJ
M^H0V+W#W3:8#'Y!D8?,<E-^"?FV[L9[5U%% '*ZO\/;'6/%$&NRSW"74)MBJ
M(R[/W+3,N01GDSOGGL.G.>9O/A-'?ZX;=A<Q:9$L]U'?><@E2ZENDN5,8 XV
M,F?F&#D#GFO4** .-G^'TUPUM<OXBU4ZI TFV_'D;PC@!HPOE[ ORJ>%SD9S
M4=_\+-.U'6Y]1GNKR03W$=S+;ED\MG2V>WR?EW<H_(SU /'.>VHH X)_A)9W
M4*I?:IJ-^T2VR6\DS1!H8X9TF5%VH,@M&@);)('7O72Z'X;@T&\UBX@DE=]4
MO/MLHD((5_*2/"X XQ&.N>2?PV** "BBB@ HHHH **** "BBB@ HHHH S_$&
MC6_B+1+[2KO?]EO87MY?+;:VU@0<'L<&N!T#X(>'_"R1V^EZMJ]A&KC]S#?[
M QZX("\\?I7H>JZA%I6G7%Y.',-O&TKB)"[8 R<*!DGV%?/FOI8WGBF]M1K-
M[#I=[JD.HSQ_\(_.]PDJ["%2<8 'RX!Q\H)% 'T:O04M)T7U^E>9#XSE(?$[
MSZ)-:R:3>6ME##/,%>X>?:$+#'R#+ ]6..?:@#TZO%OCUIYD\8_#6\%O=-Y>
MOVD7GKY?D+NE4[6R-^X[>-IVX!SVK<O_ (JW8M=-DBM8;1VOIK6_\T-,D0BE
M5'VD%3SN!#8..,J><4OCCI]O/J7P_OR\GVF'Q/80J@F;9M9\G*9P3E1@D9'.
M,9- 'K(Z"EI!T%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !535=-@UC3;JQN0S6]S&T4@4X)5A@
M\]JMU6OKV.PM)[F7=Y42%VV*6; Y. .3]!0!YSI'P6\*^& EMI^HZII\:.H$
M$6J21J6/0%0><_K7ID8P,>G'-?//BR'3-0\5ZG NMZA;Z;JEY;W=Y9GP[),_
MF*J;=D^/E&%7'!V\U]"P_<&"<8&,T 245@>./$\G@_PU>ZK%I\VIO;QE_L\!
M"DX!.2Q^ZHQR?YURUY\73:K8NNF>;&^G6VI79,^# DSA%"C;\Y!))^[P/?%
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M\,5S8?:O[7@*ADD-WLW\[6^X(\XR#\V=N.,U[D>E>3_&S^T3K_PZVM;#2?\
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M)FEIK4 +N%+5=KJ)9/*,J"3^YN&?RJ<4:/8+-;BT444 %%%% !1110 4444
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M*^>]<.N_\+%NO+LKM]4&J1K:Z;_8<;:?-:%EW2O=;,YVEF+;LAAC% 'T"S;
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M'\D?0 C#<D5F7?A/1[_58-3N--MI=1@.8KIHAYB?1NO>N9A\/>.X/B9+JO\
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M/B"V=6WC!7:_S#V]Z]#OM-M-5M'M[RVBNK=QAHID#*WU!KYO_:?^#<WB:_\
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M** "BBB@ HHHH **** "FNZJK%B% &23VIU97BBR&I>'-4M//%KY]M)%Y['
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M_$EG?P++&WOM8'GGKUK;HKT3C//-=\'^,;'Q'X9G\'^(K#2_#-@B6E_X<O\
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MM3EEB^R6\-O+YF^ J279B6Q]>>] 'T0M.J*WGCN8_,B=9$)(#(<@D'!_6I:
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M*WD:6%'92A8 E3U7VJ6J,FK:!1110(*CGMXKF&2*:-98I%*NCC(8'J"*DI*
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M2TUOK0!Y?X!_9U\,_#GXD>)/&^EW^OSZWX@_X_Q?ZM+<028(V8C8X&P#:O\
M=4D#BO4J\V\$W.JR_$WQG8W?B"YU&STXVX@LI$C54\U/,/(4'Y>@YZ'GFO2!
MTH 6BDI: "BF,X# 9Y/(%<]X9^(&@^,+V\M-)O6NKBSP+A#!)'Y9]"64#/TH
M Z2BBB@ HHHH **** "BBB@ HHHH P?$/C31_#%S!!J5V+:6<9C7RW;=SCJ
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MCCG^QVQL8U\R+YI)R=X8J90P."#LP#FO9?%FI+H_AC5;YT21;>VDE*23>4I
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M"C,7#>;OP"G"[<'.[M0!Z$FN:=);SSI?VSP0$K+*LRE8R.H8YP/QJS;74-Y
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MY&>]=-28'I5&!\A_![5X- ^/'C77=0\4W+Z7,69H[F^F<2%R/+W1M&"?+"[
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MC/:O<X0 @QTP,4 +)&)%96 92,$$9!%,-K&6C/EH?+^YD?=^GI3WD$8)8A5
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MC!_SP\#_ /?^\_\ B*](3/.3FN1^(WC2[\":3+JRV$%SIEK$9;J::[\EE (
M6-=C;W.3C)4<=: .8TK6?BYK%I]IAMO!:IYLL6))KL'*2,AZ*>,J<>V.E7?-
M^,'_ #P\#_\ ?^\_^(K1;Q[:V?Q#TOPE9:?D7,,US<7"_(D#X\P)@#EVRS'D
M8R#SNKN&Z>E 'DOB+Q!\6?#.@:EJ]U:^"WMK"VENI5BFNR[*BEB%!4#.!QDB
MI=(U?XMZSI-EJ$-MX*6&[A2=%DFNPP5E# '"D9Y]:Z3Q!XFGMO$]CH%]I%M=
M:5JY>V1FGWO*/*9I-T)3&P<*<MSN'%-\.^+YF\52>%[O3;73IH+$7<,5E<^:
M(X=Y14==BA#@ @#(QD=LD R?-^,'_/#P/_W_ +S_ .(K"\5^,_BIX0CTI[RT
M\'2#4=1@TV+R);H[9)20K-E1\HQSC)]J]F[5YCK?Q/TF?6_$-E<Z2FH67ANT
M74TNI@&#W*,PVQ C 96  <'ALCC&: )!+\8.\'@C_O\ WG_Q%+YOQ@_YX>!_
M^_\ >?\ Q%='X'\7R^*$U."ZLUL=0TVX%O<11S>;&=T:2*RN54D%77.0,$$<
M]3TDCK&C,S!549))X H \JEUKXMPZO:Z<UMX*\ZYAEG1O.N]H6,H#GY>O[Q<
M?0U>\WXP?\\/ _\ W_O/_B*S9_C5#/I6H:S;Z*A%GJB:7;W-W+Y2>5*$83N^
MTE(V^0X .?DZ9X]#\'Z^?%/AG3=6:V>S-Y LWD.<E<CU[CN#@<'H* ..\WXP
M?\\/ _\ W_O/_B*QK+Q;\5K[Q1JFA):>#5N].@@N)7:6[\MEEW[=IVYR/+.<
M@=1UKT7QOXDD\)^'+C4H;1KZ9&CCCMUW?.SNJ#[H)P-V3@'I7&3?$NTM;S3I
M+2ST>76=4AD>>X>]^SIY<,@C$9D:,,S[I" C 8._GU )_-^,'_/#P/\ ]_[S
M_P"(I#+\8 /]1X(_[_WG_P 17I6<K[XKC/'WQ#7P==Z;8116DM]?K-(GV^\%
MK"J1A=V9"K8)+JH&.<GGB@#D?#'BSXK>*[6]GM+3P;&EK>SV+B:6[!+Q2%&(
MPI^4D''?V%;'F_&#_GAX'_[_ -Y_\16AJ/C.Q\+>*M#\.V6FQBXU:=I+HP81
M+<NKOO? ^9W*.??:QSZ]R.E 'FK3?&  GR/ XQ_TWO/_ (BF>%-:^)^MQ:/J
M-W;^$H](NUAN)1#)=>>(7PS;05V[PIX!.,UO>*_%6KZ#K6CV5GI]G?+J5RMO
M&)+IXY  -TCE1&1M51GKSP.]1:5XMEM?&%OX6N--M+$-:R7%K':7/F-'#&P1
M=Z!%"!@?E )'RD=J .T!R,TM(O2EH **** "J&M"5M*O%A$K2F)@@MV"R$XX
MVD\ ^A-7Z9)&LL;(XRK J1Z@T ?.]YH<\=WJ:M'XHNK$7,37\S:Q;K"9%"']
MXI[CY0<]<#KQ7T-!C8N/05\US>#;.+QIKECIUMHZV=MJ""2/6M?G265BB.2(
MUX*\@#.3QSZ#Z6B&$'0<=NE ')_%C1QK?P^UVW+W"D6DD@6VD*-(0A(4XY()
MQD=Z\IUG2[N3^Q/,M)'N3X?TZ+3&\IF,4XFC,@4X^5L!2>AP/05]"TF!0!Q\
M_A:_TC6?$^MZ$NG_ -I:I;6R11W:LL9EB,N6D9,D@B0#C^[7F'AB3XFCXH>-
M?LT/A,ZG]GT_[6)9KKR NV;RO+(7).-V[(';%>_-@#->??#_ .*A\;:JEL;%
M;>WO+)]1L)HY2YD@6=H3O!4;6R$; R/GQVY (/-^,'_/#P/_ -_[S_XBD,OQ
M@ )\CP/_ -_[S_XBO2JR/%FN/X:\,ZKJT=JU[)96LEPMNK;3(54G;GMTZ\T
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M%+%<1+,@>>\# , 1GY/>NEU+Q9J>E>-=-TB:PMFL-19X[>>.Y)F)6(NS,A4
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M".18RF64MO+-C! QM:@"3S?C!_SP\#_]_P"\_P#B*0R_&  GR/ __?\ O/\
MXBO24.17%_$#X@CP??:=8Q"R^U7D<TRMJ%W]FA5(PN<OM/)+J!Q@<D]* .2\
M+>+?BMXML)[RTM/!L4<-U/:,LTMV"7BD:-B,*>"5./;L*V?-^,'_ #P\#_\
M?^\_^(K4UGXC1:9XYT#PS%;_ &FYO\M<RJWRVJ['9,GN7\M\#T0GTKM0<T >
M9377Q?AC=S!X(PH+'$UY_P#$T_PQJGQ0U<:3>W=OX132KKR9IA!-=>>(6P6V
M@KMW[2<9.,UM^*_$VL:/XAT;3K&UL[P:E<"()([K)'&J[I9#@$84=NY('>DT
MWQG>OXW'AW4+2UBGDM9+Q!:W!E:*-9 J^8"HQN!R,>A'.,T =C1110!Q?B;P
MIXEU7Q98ZCIGC%]'TN!4$VE"P299R&)8ERP(W @=.,5Q'A[X>_$^V^*ESK^H
M>*-/BT&ZN?,GL+5I)"T2@B.-59 %XP"0WJ>37M6*,#TH Q/#VDZIIM_JTNH:
MR=4@NK@RVL)MUB^R1XXC!!._ZG%9?Q=&[X<ZZODI<[K<CR9#A9.1\I.#P>G0
MUU]'6@#R75O"&O:W=2ZK;:3!9223JRZ?>O&ZX6RN(MT@4LI#-*BX!/R@9QT%
M&T\$^(_[:N]4ETZXDB!T^18+J>V$LOD23%HPL9V( ) 5!;'RC)%>TT@ '08H
M \AUWP1JMY>O<Q:+-'9WVDI8_P!EZ?>P0I:,'=MDA92 C"0$M$&(*<!^#5F/
MP9JXU"ZLUTU;:*36(]275Q.C$HD:K\W1S(=NWIC!R2.E>JD ]J,4 >;>"/"N
MIZ=J.@&ZTV+3(]%TM].EF25&%Z[,F&4*<[!Y9;YP#F3IU->E4F!Z4M !1110
M!2UK5(=$TJ[U"X$C06L3S2")"[E5!)PHY)P.E?/T?B3P_P#$;Q19-X;\$:)<
M7FH3.[:GJ\J"12F&9FBCW.#CH6*_2OHTC(KF]<^&_AKQ%>QWU]I%L]_&P=+R
M-/+G5AT.]<']: .D7H,=*6D P,4M !7%>,?AG;^+M6-X]V]LD]O%:7<:("9H
MHYO.50W\/S9!//#'ZUVM% "4$9%+10!PL'PM@A\8IKGV^9HTOI=12U91D3O#
MY+$OU*;<X7L3UP,5W*@@<TM% &=XAT@:_H6H::TAA6\MY(#(!DJ&4C.._6N.
MOOA#!>1:>BZ@\(AT^WTZYQ"&,\<+*ZD'/R-E3SSP>G ->A44 -5=N:XKQW\.
MY_&VM:+=MJB0V6F.9QITUMYL,TW\+N ZYV]A[UV]% '%CX9VJ^+].\0)>7$=
MQ;23S2PAB4FDE15)Y/RC"#CGL.U=DP)4@4ZD- ',ZMX0N-:UNRNI]3;[#:7"
MW<5F(5RLBJ5'S]2O.2,=>^.*SO 'PXF\%7^JWD^I1ZI=:E,T]S=/:E)Y&)^5
M2V\C:HX  %7_ !-XZB\*ZYI]I>6V+*ZMKJ=KTRX$1A4.5*XYRI8YS_">*Y3P
M?\=8_%>E:)<OHYL+F_OIK2XMY;K(M%CB\UI&;8,C84.,#[XYH ]38;E(]1CB
MO/I?@QICW6I,MY=BTO=-?3FMF??LW2,Y<$]3N;.#WYK2M/B[X.OM'O\ 58/$
M-E)I]@P6YGWX\LGH"",\]L#GMFH9?BQHIGT:6UN+>ZT;4(+FX;4UGQ'"L*Y;
M(QSW!Y&,4 :?@[P@/"JZC))=M?7NH3B>XG*",$K&L:A5!. %1>YR<FM;5M,B
MUC3[FRN-WD7$;12;&*MM88.".AP>M<[>?%KPEI][IUG=:Y;6USJ$:RVT4VY&
M=6^Z2"/ESVW8KK@<B@#S?_A2]M#)/+;:M=1R_P!I0:G;>:!(D3QQ"(*RD_.N
M ?0]/2NO\(>&8?"'AZQTB"5YXK6,H))/O,222?;DGCM6U10!2U:TNKRS:.SO
M/L%QD%9O+$@&#R"IZ@].H/O7G]U\$+6XM"%U.1+V=;Q+RY:%6\];J02387/R
M'<!M/.!US7IM% $<$(@A2-2=J*%&3D\5R?COX>0^-FM93=&RNH(+FT$PC$F8
M9T"2K@D<X5<'L1WY%=A10!PDWPDT\:GI%[;7EW;26%S%<,/,+";RX3$@/I\I
M_GQS7=#I2T4 85WX86]\6Z=K<DY)L;::WB@*\ R%"SY]<(!BL'P;\-9?"OB;
M6=;FU*/4[S5)2\T\UJ1,$_@B5]Y 1?0+S7=T4 (!@<TM%% !1110 57U"^33
MK&XNI%D=(8VD98E+,0!G  ZGVJQ28H ^;7\>Z'\1?&>F6V@^"M ;4-3N)$;4
M-;$37"-$A=B\* NORH0I8CG%?2$8PH'' QQTK!\0> /#WBJ9)M5TBTO+B,@I
M.\0$JX.1AQS^M;Z($4 = ,4 .HHHH 0C(KC/!OPOL?!FI_:[>YEG$-LUE:0N
MJJMO TIE*C Y^8CD]E'N3VE% ""LGQ7X;MO%_AS4=%O&D2UOH6@D:)L, 1U'
MO6O10!@>$O"B^%TOV-T][<WUQ]HGF=%7+;%08 Z#:@_'-;]%% &'K'A:+6/$
M&BZJ\S(^EM,R1@ B3S(RAS] <UF>%_AY;^&-2CNHKJ6:.""2VMH655$4;RF0
M@D?>.3C/H/QKKZ* &L"0,5Y_I'PB@LM1\0W5_J#ZLVNL?M;31;9/+P-L2N#D
M(N.!7H5% '->#/!$'@I=56WN9[E;^]>](G8G86"C:/\ OGKUKH+F)I[>2-)&
MA9U*B1,94XZC/'YU+2'H: /./$'PB?Q)IFHVUWK]UYFI2P&\E6)0)HHE(6(J
M", GEB.3TX%=SH>G#1]*MK(-$4MT$:"&(1(JCA5"@D  8'X5Y/XK^/=SX7M9
M4ETB.;4H=9GL);993Q:Q)YC7 XS_ *LHVW_:ZUT;_&+2=,U+5X]4E2SM+:Z6
MSM'0-))=/Y2R2$(H)PNX GI^F0#LM<T&U\0VJ6]VKF-)4F7RY"A#J<J<CT-<
M#'\"=-CT6QT]=3NQY-M<6,TV%+3V\T@D9#G..0,$=,GUK>N/B]X2MKFPA;6(
MG:]BCGB:-6= DAPC,P&%#'IG%0:3\4=/GU:_TZ_=+2[AOKBVAC7+%HHE4M*W
M'RJ W)/% ':Q1"%%11A%&T#T%<WX\^']AX^TR2UO))H9/L\UO%-"Y!C$J[6.
MWHW [^_K4WA/Q]HOC82G2+F2X6,!MSP/&&4]&4L!N'N/:NBH X&+X16<&MQ7
MZ:A=%!+:7$L#X;S);=2L;;CR!SR,\X'3G/>L"1Q2T4 <OXK\%-XN=8+K4IX]
M*9H7FL$1-LC1R"13NQN&2JY]AQCK5;0/AM:^'M;BOH;J5X;<7(MK4JH6+SY!
M))DCEOF'&>@-=C10 G:N#_X5#IAUBZNGN)VM)Y;J?[$,*JR7"!)B&'S8(&0,
M\$GVQWM% ',^$/ MKX.O-8GM;B>5=1F24QS.6$>V-4 'KPH_EVKI32T4 <)/
M\+5?P#?^&(-7N;7[=/--<7\:CS7\V8R./;(;;]*Z/PMX?7PQHMMIL1A^SVR[
M(E@A$2JOI@$^YSWS6Q10 4444 %%%% !1110!3UC4ET?2;R^>&>X6VA>4PVT
M9>5]H)VJHZDXP!7S]8^,]-^(OC.QM=%\(^%M/NKN5Y9KO6(HI;Y2F"Q:)5RC
M]AN8]*^C"#ZUAZ]X'T'Q/+%+JFDVE[/$0T<TL0\Q"#D8;J.0.] &VO2G4@&*
M6@!#TKCO$_PVM?$VKM>R74MN)XX(;N*-5(G2*7S4&2,CYL].Q/3J.RHH 11@
M4M%% '%VOPRM;7Q8NM"]G9$O)M02T(&U9Y(_+9MV,XVYPO;)]J[2BB@#,\2:
M*GB3P_J6E22-#'>VTENTBC)4,I4D#\:Y6^^$EE>M9'[;-$L5E;6$ZJJG[1'"
MX=/]TY!R1U!QV%=[10 AZ5QGC/X='QAKVBZC+J/EPZ4QEAL9(!)"TQZ2,"1D
MKQCTYKM** .0C^&UC!XIL-<AN+B*>W:XD>(2,4E>4*&8C/'W!P/Z5UPZ4M%
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M&,XYKND7:,>E.Q2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<IL,@10-V,G&<=,FH_#7A!?#FL>)=0%TTYUJ]6]:,H%\HB&./:#GG[F<\=:
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M^[>EM.;;?0R?!7Q URS\,Z/I.CZ3_P )%K=S)?W,AO+SR8XX$NY$R9"K$G)
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MJ6J>$(M=T71]6T31-%EL3:S(\R).SQL#&LQ=MN%899B?K6WXY^$5C>^!M/\
M#?AG2M,TNRAU>QOI+1(A%"T<5Q'))P%(+%4/!Z\ X%48&=?_ !GTC7OB3X-T
M;PKXNTC6+>\-Z;^VTV[@N6VI;,\9;:2RC<!R",]/:O./ /BWQ!XS&FR3?M$Z
M59:I>3E3X=_L_3&G1O,($&#ARQP!TSS7K^M_#*%_'OA#6M(T_3M/M]+:[^U>
M3$L4CB6W:- -J\_,>Y%3_#'X:6?@_P (Z1::AIFF/K%HK&2ZA@5F+EV(8.5#
M$\CF@"[H?B&]C\?Z[X;U";[0%@BU*PFV*I$#DHT9Q@$K(IP>N'&<D$GKJX'2
MHO[8^,VM:E$<VVEZ9%IC.#D-.[^:RY]54QY_W\5WU !1110 4444 M HHHH
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M^#?Q$N/#7@K4)[C6;O6M(BN[>>WT#5K:POA'+(&C+3.GE.P4 .1C)Y!/?OO
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M'_GJG_?5'VJ'_GJG_?5 &'L;^Z?RHV-_=/Y5N?:H?^>J?]]4?:H?^>J?]]4
M8>QO[I_*C8W]T_E6Y]JA_P">J?\ ?5'VJ'_GJG_?5 &'L;^Z?RHV-_=/Y5N?
M:H?^>J?]]4?:H?\ GJG_ 'U0!A[&_NG\J-C?W3^5;GVJ'_GJG_?5'VJ'_GJG
M_?5 &'L;^Z?RHV-_=/Y5N?:H?^>J?]]4?:H?^>J?]]4 8>QO[I_*C8W]T_E6
MY]JA_P">J?\ ?5'VJ'_GJG_?5 &'L;^Z?RHV-_=/Y5N?:H?^>J?]]4?:H?\
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M^3_T!*[IOO&N%_9D_P"2>3?]?\G_ * E=TWWC7Z5@?\ =:?HC\ SG_D8U_\
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MA%IDBM<2R%K:-65(]S,3P)&&1SSUX%9>H_ GP+JKV;W.A!WM-,&C1%;J9/\
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M_P DVD_Z^HOYU\FCI7UE^TC_ ,DVD_Z^HOYU\FCI7PV=?[RO1'[#PC_N$O\
M$_T"O:/V>9?#NBO?ZOJ^H6MK>;O(MTG<!E7&68?7('X&O%Z/\YKR<-7^K5%4
M2O8^GQ^#^O8>6'<G%/JCZH\7V_PY\<:A'=ZKXACEDC0(B)>;40=\#WKQ#XKZ
M+X9T35[2/PO=+=6KPEI667S/GR1C/TQ7#8HKKQ..^LIITTF^O4\K 9-+ 33C
M7E**^R]@HHHKRF?2GU5^S)_R3R;_ *_Y/_0$KNF^\:X7]F3_ ))Y-_U_R?\
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MUO6W_'O%_N#^0H D-?%?C/\ Y'#7?^O^?_T8U?:AKXK\9_\ (X:[_P!?\_\
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MBJTJ]3>3NS"^QS_\\S1]CG_YYFMVBM3F,+['/_SS-'V.?_GF:W:* ,+['/\
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M10!SF.,=/I171T4 <X!CIQ171T4 <Y171T4 <Y171T4 <Y171T4 <Y171T4
M<Y171T4 <Y171T4 <Y171T4 <Y171T4 <Y171T4 <Y171T4 <Y171T4 <Y17
?1T4 <Y6QIO\ QZCZFK=% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>aciu-20221231x20f015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &$ WT# 2(  A$! Q$!_\0
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M"<9P>: .THJ&TN!=VD,X1HQ*BOL<8*Y&<'WJ:@ HHHH **** "BBB@ HHHH
M**Y7XB^.'\ Z!)J2:3<ZMLR62%@B1J,99W/W1SZ$GTKJ$;>BMC&1G% #J***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#71:'\.[JP^*WBCQ-=FSGT_4[:WA@BY:5&088L"N /3!-=ZB+&@5%"J. %&
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MYS_=)R.M?60GA\9@?85'RN"O%Z*_]=3Y:<*^$QOMH+F4W9K>W]=#ZZHHHKY
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M2"3@Y()))!&!@<U4N-*T_P 4ZQK&H)JLUMI_V0&=[-E567YE4]#R C_,,$Y
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M;E,,#<E#AO)P=V/QVY]LUP8^K[#"5:EF[1>B]#MP5+VV)IT[VNUJ_4W?!/\
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MKR,SJ1IPIN;M[\?S/?R;!5\;4JQH1NU"7;JK?FSZ%HI <C(Z4M>P?/!1110
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M_KQ7_P!"->B5YW^SS_R13PA_UXK_ .A&O1*PP_\ !AZ+\CU<X_Y&6)_QS_\
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MP*R?C7\<M!^"?A];S4F-WJ=R&%CI<+#S;E@.O^R@)&6/3/<X!^// _@+QO\
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MW D0.I(A<\JP((]B"#73U3UG2;;7M(OM,O4,EG>P/;3(&*ED=2K#(Y'!/(H
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MJE)3BTM'KMYFF$QTL/5C.HE.*<;J23NHN]KM.W;3H?-'[&GCW7O$6G:UI>I
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M%2>\E^3/2P<9-57%;1?YHK_"_P .Z=I5]XCFM;58I8]0EM4;))6($$*,]J]
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MU..ZU&RSYT*HPQ@X8JQ #@'@E2<'@UIW>N6-CJECITTX6^O0Y@A"EF<( 6/
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M?T5K*-[XJD\EXS (@8-E=H/.5 Y[$U3N_C-)8VLUS<> ?&$4$*-))(UE!A5
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MT(S4] !1110 4444 %%%% $%S96]X83<6\4YAD$L9D0-L<=&7/0C/45/110
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MQ&%YX=DT[2]/TRVGLK.SCG5KR_W.&DGD!)?8"/EW<G)/3% 'O=%%% !1110
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M6:/\Z^\V_L#-O^@6?_@+_P CWNBO!/\ AM_X4?\ 06OO_!?+_A1_PV_\*/\
MH+7W_@OE_P */K-'^=?>']@9M_T"S_\  7_D>]T5X)_PV_\ "C_H+7W_ (+Y
M?\*O:%^V+\,O$>MZ?I-CJ=X][?W$=K K6,B@R.P5021QR1S36)HO137WDRR+
M-8IREAII+^Z_\CVVBBJ\M]%#(48D,/:N@\(L454_M.#^\?RH_M.#^\?RH MT
M54_M.#^\?RH_M.#^\?RH MT54_M.#^\?RH_M.#^\?RH MT54_M.#^\?RH_M.
M#^\?RH MT54_M.#^\?RH_M.#^\?RH MT54_M.#^\?RH_M.#^\?RH MT54_M.
M#^\?RH_M.#^\?RH MT54_M.#^\?RH_M.#^\?RH MT54_M.#^\?RH_M.#^\?R
MH MT54_M.#^\?RH_M.#^\?RH MT54_M.#^\?RH_M.#^\?RH MT54_M.#^\?R
MH_M.#^\?RH MT54_M.#^\?RH_M.#^\?RH MT54_M.#^\?RH_M.#^\?RH MT5
M4_M.#^\?RH_M.#^\?RH MT54_M.#^\?RH_M.#^\?RH MT54_M.#^\?RH_M.#
M^\?RH MT54_M.#^\?RH_M.#^\?RH MT54_M.#^\?RH_M.#^\?RH X'3O@?I=
MEJGCN\>=IAXJC:&2,H!]G5@V\*<\Y9MWU JE_P *"L8_ 'A_P]!J+Q7>BW#7
M5OJ#VZ2[Y&9B^^-LA@=V,'T%>E_VG!_>/Y4?VG!_>/Y4 >>ZU\%(=8TK15.H
MQ0ZQI4LDL5\FG0")A( '5H,;""%7W^7K4U_\%=.UF?2&U*:.\BL;&ZLWB6TC
MB20SXRX50 A&.,#OUKO/[3@_O'\J/[3@_O'\J /./$7P8OO$>BZ?IL_BF8PP
MV:V4XELHIA* >)%W@^7)C@LIYKTG3;%-+TZULHV=X[>)(5:0Y8A0 "3W/%-_
MM.#^\?RH_M.#^\?RH MT5'!.EPA9#D XYJ2@ HHKB=5^,7AG1M2N;&ZN9EN+
M=S'(JP,0&'7FO/QF883+HJ>,JQIIZ)R:5W\SJH86OBI.-"#DUV5SMJ*\^_X7
MKX2_Y^Y__ =O\*/^%Z^$O^?N?_P';_"O)_UGR3_H,I_^!Q_S.W^Q\Q_Y\2_\
M!9Z#17GW_"]?"7_/W/\ ^ [?X4?\+U\)?\_<_P#X#M_A1_K/DG_093_\#C_F
M']CYC_SXE_X"ST&BO/O^%Z^$O^?N?_P';_"C_A>OA+_G[G_\!V_PH_UGR3_H
M,I_^!Q_S#^Q\Q_Y\2_\  6>@T5S'A;XC:)XRO9;73)Y)9HH_-8/$4&W('4^Y
M%=/7MX7&8?'4E6PM13AW3NOO1Y]:A5P\_9UHN,NST"BH/ML _P"6@H^W0?\
M/05UF!/14'VZ#_GH*/MT'_/04 3T5!]N@_YZ"C[=!_ST% $]%0?;H/\ GH*/
MMT'_ #T% $]%0?;H/^>@H^W0?\]!0!/14'VZ#_GH*/MT'_/04 3T5!]N@_YZ
M"C[=!_ST% $]%0?;H/\ GH*/MT'_ #T% $]%0?;H/^>@H^W0?\]!0!/14'VZ
M#_GH*/MT'_/04 3T5!]N@_YZ"C[=!_ST% $]%0?;H/\ GH*/MT'_ #T% 'F_
MASX#Z7H"^-E^U/.GB8R!@T8'V9&+D*O/."Y/X53M_P!GRRL_!6B:-!JCK?Z3
M=27<.H2VR2AWDSO#QOE6!! Y] :]4^W0?\]!1]N@_P">@H \NOO@%;W&E:.L
M.L-%K&GRS2_V@]E#(DWF@!U:$KLQ@*!@<;1WYJ1/V?\ 2)Y]'.HW3ZI!8V-S
M9RI/"BF<S$EI/EP$(S@8'''.>:]-^W0?\]!1]N@_YZ"@#RO5_@9?:MH%CI,G
MBZY>V@L_L,B7-E#.KID@.H<$I)MP-RGL#P:]-T32H]"T>QTZ*226*TA2!7E.
M78*  2?7BI_MT'_/04?;H/\ GH* )Z*@^W0?\]!1]N@_YZ"@">BH/MT'_/04
M?;H/^>@H GHJ#[=!_P ]!1]N@_YZ"@">BH/MT'_/04?;H/\ GH* )Z*@^W0?
M\]!1]N@_YZ"@">BH/MT'_/04?;H/^>@H GHJ#[=!_P ]!1]N@_YZ"@">BH/M
MT'_/05,K!U# Y!Y!H _/K_@H/_R6?1?^P!#_ .E-S7S%7T[_ ,%!_P#DL^B_
M]@"'_P!*;FOF*OC<9_'GZG]4\,?\B;#?X0HHKJ?AQ\-==^*?B:VT70K*2YFD
M8>;*!^[@3/+NW0 ?KVKEC%R=EN?15:M.A3=6K*T5JV]D<M17T5^U/^SGH/P,
MT3PS<:1>7MW<ZA)+%<&Z=2N45#E0%&.6/7-?.M:5:<J,G"6YQY?CZ&9X>.*P
M[O%WM?39V"NP^#G_ "5WP/\ ]AVQ_P#2A*X^NP^#G_)7? __ &';'_TH2II_
M&O4UQG^[5?\ "_R/USK%U'_C\D_#^0K:K%U'_C\D_#^0K[H_CLK445P4/C&Y
MM/B=XMLKZ\":'I>C6=\L;(H$3,UQYC;L9.1&O!.!CCJ: .]HKR3X,^/O$6MZ
MK?6'BR1%N]0MEUW2H1$L9BLI'($/ !9H_P!WN)YS(.:HZ!)\0OBEHH\7:/XR
MB\.6-TTDFF:.NF0W$4L*L1&;B1QOR^,G85P#@<C- 'M-%<%I_B+7O^%B:!I&
MI-#;B?P_->7EI;X>,7*RPKE7(W8&]P.W/2K/Q1'B+^Q8WT/6D\/6L1:6_P!1
MBLS>7:1JN0L$!1E=B>N0< < D\ ':45\WW?QAU^;X-Z/>'Q))I^JWGB Z4=9
MCTU'NA;H[%G:TV,%F:-/]7MSEAP"<#T[X+^(%U_P[>2GQG=>,Y8KDI)->Z<E
MA/;':#Y3PK&A4]_F7/- 'H5%>!Z!XY\:7NG:!X_G\01/X<UG5HK)?#GV&,)#
M;37'D1N)L>89!E6.3MY(P*S+3XHWFJ?$G4TOOB9?>'M/BUUK"UTJ/0HI+21$
M9$\M[MH3M:1]XP7!Y&.U 'T?17CWB#XH:O>_%3PKINA3Q+X7.JR:7J%P$5S=
MSBVFD,:,0<+&4 8CG<=N?E8'L/&?C6S\(^(=)^WZA<V=D;*_O)TC@1X6C@1&
M9G8_.I4$D!.N3GH* .QHKA/AO\7;'XEO*+70]=TA1$)X9=5M%CCN8B<;XW1W
M4CD<$AN>E9VK?'[0M%\;0>';O2M<B6:\6P75WLPED9R<! S.';YB!N5"N3UH
M ],HKE?'WQ&T[X=P:;)J%K?WC:A<&UMXM/@\Z1I/+9PNW(/.S QGDC.!DCE)
M/VB] @\/G4)M&U^"]348]*FT22R5;^&XD0O&K1[\$,!P58CD>^ #U6BO*M8_
M:'TG1966;PUXGF2U@CGU26VTY94TD.@?;<$/PRJ<L(]^*H67[0=O'XY\9VNH
MV5W!X8T:PM+RWU1;<-'-YH.,$.2YD)01@+DX;VR >R45Y3<_&VSU3PGXDG?3
M_$7@_4=.LC>>3J.GQ+=&'./.B1G:-QGC#'@XR!D4_7OVB- \.:[?:;=:5KTD
M.G7D5E?ZI#8A[.T:14*/)(&^Z?, X!(/4 8) /4Z*Y;Q]\1+#X?6=G)<6>H:
MM>WTOD6>F:3!YUS<N 68(I(& H))8@ #KTK%U/XWZ/IOAO2-3_LG7;F]U:22
M&TT*&P(U%Y(\^8IB8@#;@Y8MMZ8)R,@'H=%>8R_M Z#%H5AJ']E:Z]S=W[Z7
M_9*6.;V&Z6,R&*2/=P2 ,$$CY@<A<D5+;XX:5KTGAR^M7UC34EN;^VN]*GLH
MEE$MO;M))%/N;*%0-P,9.3@$XS0!ZS17%-\7-"AM/#-W<"XM+77M/EU.&>=4
M"P0QQ+*YE.[Y3M<=-W(/-8?A?]H'2/%'B33M'7P]XDTLZE'+/8WNI:>(K>ZB
MC0N9$.\M@C& 5#<C@4 >HT5XZ_[2^CSWFHZ;#H'B"UU-+&XO-/2^L5C&H")"
MQ\I?,W=.<.$XSWJ#PO\ M&)=^!/"=[>^&M?U3Q+JVG)>RZ3I%BKR[,*&N #(
M%6%F/R$MD@].#@ ]IHKEI_B-I<?P_F\80175YI<4#7#QPQ 3JJG#@HQ7#+AL
M@G/RFJFN?%;2]#O+VW^Q:EJ#6EA%?R'3[<39$KE(HP VXNQ#$<;0 26% ':4
M5Y5I'[2'AG5/#^L:C)8ZQI]WI=Q%:3:-<VJF]>:7_4HB1NRL7(('S<8.<5H_
M\+OTF'P?)KM[H^O:;.MVM@NBW=@4OY;E@"D4<8)5RP.058KP<D8. #T2BO/8
MOB;#KECX;NTM];\/27FL#3Y+"_L$2??Y4C&.4,2 AVYWQDG( '4UG^#OVA]
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M7*?6L[1O%_Q'M-:TH>)O"6EPZ/J4HAW:-?R7-Q8,P)4SJT:J5R-I9"0"<]*
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M%7QN,_CS]3^J>&/^1-AO\(5]*?#S]JS_ (5W\+_#_@WPKHD5KK;RE;_5YD4
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M?:R)\^W^)VZ]_1OB+XXO/"2:19:1I0UK7M8NC:V5I)/Y,651G=Y'P=J*JDG
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M. TC'*\?+@YKT]OO'ZTE?IQ\@>"VWP:\0Z)8>-O#%MJ5UK%EJC0Z[8:KJ?E
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M*I'E9VX/%2P=558I/1JSVLU8\VC\ ^)?#GP\TV_T/3[@^*[&[NIK>WOKB%Y
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MIC)\]3>[?WMO\V%%%%:'$%%%% !6[:?\>T7^Z*PJW;3_ (]HO]T4 ?G_ /\
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M7'_/0_D* -+^SK?_ )Y_^/&C^SK?_GG_ ./&LW^T+C_GH?R%']H7'_/0_D*
M-+^SK?\ YY_^/&C^SK?_ )Y_^/&LW^T+C_GH?R%']H7'_/0_D* -+^SK?_GG
M_P"/&C^SK?\ YY_^/&LW^T+C_GH?R%']H7'_ #T/Y"@#2_LZW_YY_P#CQH_L
MZW_YY_\ CQK-_M"X_P">A_(4?VA<?\]#^0H TO[.M_\ GG_X\:/[.M_^>?\
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M-_$S_H:)/_ 2W_\ C=>'_JAD/_0)#[CT?[=S+_G_ "/K3_AG?PW_ ,_FJ?\
M?Z/_ .-T?\,[^&_^?S5/^_T?_P ;KY+_ .&F_B9_T-$G_@);_P#QNC_AIOXF
M?]#1)_X"6_\ \;H_U0R'_H$A]P?V[F7_ #_D?6G_  SOX;_Y_-4_[_1__&Z/
M^&=_#?\ S^:I_P!_H_\ XW7R7_PTW\3/^AHD_P# 2W_^-T?\--_$S_H:)/\
MP$M__C='^J&0_P#0)#[@_MW,O^?\C[4\%_"W2? NH37EA/>2RRQ>2PN'5AC(
M/&%'/ KL:^8OV6?B[XN^(7C35;'Q!K#:C:PZ>9HXV@B3:_F(,Y10>A/YU].U
M]%@L#ALNHK#X2"A!=%MJ>7B,36Q53VM>7-+NRD=*A)SN?\Q_A1_94/\ >?\
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M  JW&@C14'11@9K)_M2?_9_*M2!S)"C'J0": /GS]K#_ (^/#/\ NW/\XJ\
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MKR38&8X"* 2S'V"@G\*PJW/!?C#4? 7B2TUS2C&M_:[_ "S,F]?F4J<CZ,:
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M>#3X2@UR-[H78U/5;G4O]7MV"5L[.ISCU[^E==_9]Q_SS/YBC^S[C_GF?S%
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MU;5+Z2Y-YJ&G1R/%$0J1PH7W$*B*.A'))P,UZC_9]Q_SS/YBC^S[C_GF?S%
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MI4(RH70\>7CE<5]9CPY;C6FU<61_M%K<6IN,'<8@Q8+Z8R2?QJ[]FF_YY/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
%110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>aciu-20221231x20f016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $D UH# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M78XHY(VAAM9BQ^QR.=^#L^?IU.:\P_:"2VU<?M2^([JVB?QMIFM^%CX>N;M
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M/CS\/_!EEJ-IH?PK^(NEVVHWDVH7D5M\-M61;BXE.997_<?,[8&2>N*^CZ*
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M1\#_ /DC/@/_ + %A_Z31UV] !1110 4444 %%%% !1110 4444 %%%(>AH
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MA\<?"#7=&\)^#_$/B;3_ /A%M+TZ&RBBANWBU0!L2R1P06[1,H"@-YTVU 0
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M - %?F!^T=_R)'P)_P"Q,LO_ $%:_3_P]_R =-_Z]HO_ $ 5^E<8_P"XX/\
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ML^6C!'S;\_I7QS\ ?^0M\>?^P;=?^E!KJM2_Y/FT;Z6W_HBN4^ /_(6^//\
MV#;K_P!*#7QG&^7T,!6P#HW_ 'E-R=^[3/ZSR/!4L'P[F3I?;I49/U<V?4?[
M"?\ R2J__P"P@_\ Z"*^DJ^;?V$_^257_P#V$'_]!%?25>-E7^Y4O0_#\?\
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M_P#7I#_Z M?F<O\ D>9A_C_5G[/QQ_R363^M?_TM&I7F/[1W_)*-4_ZZ0?\
MHU:].KS']H[_ ))1JG_72#_T:M<7$'_(HQ?_ %[G_P"DL_)\C_Y&F&_QQ_\
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M.3[1Y[^:I@'$6&X"CC ![UY)^V?\%/$_Q2\1:1<>'OAJ_B5K:V*R:QI_C9M
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M&?UQEO\ R3F._P"O%#_TMGU'^PG_ ,DJO_\ L(/_ .@BOI*OFW]A/_DE5_\
M]A!__017TE7R>5?[E2]#\ Q_^\U/4\[^/G_)+]7_ -U?_0A7PS^U+_R0WP!_
MV$KG_P!!K[F^/G_)+]7_ -U?_0A7PS^U+_R0WP!_V$KG_P!!K\^SK_D>R_Z\
M?^WHUS[_ )(BM_U]7Y(_0/X8_P#)./"W_8+MO_12TSXI_P#)./$O_8/G_P#0
M#3_AC_R3CPM_V"[;_P!%+3/BG_R3CQ+_ -@^?_T U^F_\N/E^AR95_'P_K'\
MT?*O_!,S_D4/&7_7[#_Z :^JK^_AC^(FF6AFL!-)93.L3VK-<D!ADK+T5?53
MUKXM_85^(6G?"_X2>._$&J17$UG!?VZLEJH9R64@8!('ZU]5^"_B58?$?7?#
M^JZ9=WUK97MC.Z6%Q9KA]K ;FD!.TCLO>O)R:K3^J4Z5_>M>WE=GZ-XDTY?Z
MT8VI;3FBO_)(GJ->,?M2?\B/:_\ 7VO\C7L]>,?M2?\ (CVO_7VO\C7)Q5_R
M)<5_A/E>&_\ D;X?_$?'G[3G_(]_!W_KS@_]'BN9M?\ E*#XD_WKC_TE%=-^
MTY_R/?P=_P"O.#_T>*YFU_Y2@^)/]ZX_])17ZQX-_!G'_8)_[;$_-ZG_ "/<
M=_U^7ZEKX5_\DG^.G_7F/_1M2:)_R:'H?_8Q3_\ H%1_"O\ Y)/\=/\ KS'_
M *-J31/^30]#_P"QBG_] KY'Q,_Y*&O_ ->E^43^NL=_R3F)_P"PBG_Z:1^B
M7P@_Y)AX8_Z\(O\ T&NPKC_A!_R3#PQ_UX1?^@UV%84/X4/1?D?S;5_B2]6%
M%%%;F04444 (>AKYB^!?_)WGQV_W=._]%FOIT]#7S%\"_P#D[SX[?[NG?^BS
M0!]/4444 %%%% &5XKN=7L_#.JSZ!96^HZW%:R/8VEW.8(9IPI,:/( 2BEL
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M_KI!_P"C5KBX@_Y%&+_Z]S_])9^3Y'_R-,-_CC_Z4CXX_:*_Y-2T'_L:&_\
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M]%/@PHHHH *^=/VM/O\ AS_MM_[+7T77SI^UI]_PY_VV_P#9:^&XV_Y$-?\
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MZ_\ B)^Q;\._B?XPU#Q+K0U8ZE?,K2_9[W8F0H487:<< 5S?_#N_X3>FN?\
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MAM=6N[:WNC$28FEABD6.1D)."RG\:T/^&?/ [:]>ZM+I,D]Q>W4E[/%/=2O
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M_P!>DG\JX,?_ +G6_P ,OR9VX+_>J7^)?FCX6^,/_)JNL_\ 89MJ^>_VHO\
MD1/V:O\ KRF_]*EKZ$^,/_)JNL_]AFVKY[_:B_Y$3]FK_KRF_P#2I:]CP _Y
M*' _]>:GY3/%XP_Y*W&_X8_FCZ(U+_D^;1OI;?\ HBN4^ /_ "%OCS_V#;K_
M -*#75ZE_P GS:-]+;_T17*? '_D+?'G_L&W7_I0:[O$3^+EG_7G]&?TWEO_
M "3F._Z\4/\ TMGU'^PG_P DJO\ _L(/_P"@BOI*OFW]A/\ Y)5?_P#80?\
M]!%?25?)Y5_N5+T/P#'_ .\U/4\[^/G_ "2_5_\ =7_T(5\,_M2_\D-\ ?\
M82N?_0:^YOCY_P DOU?_ '5_]"%?#/[4O_)#? '_ &$KG_T&OS[.O^1[+_KQ
M_P"WHUS[_DB*W_7U?DC] _AC_P DX\+?]@NV_P#12TSXI_\ )./$O_8/G_\
M0#3_ (8_\DX\+?\ 8+MO_12TSXI_\DX\2_\ 8/G_ /0#7Z;_ ,N/E^AR95_'
MP_K'\T?G3\$/^36OB5_V$[/^M?7O[*H?_A7_ (1PNK^7]EN,F)A]ASO_ .6@
MZ[_[OMFOD+X(?\FM?$K_ +"=G_6OK3]EB.4^#O!KBUE:(65R#<"^VHI\P84P
M9^8G^]CBOD<F_CT_^O?_ +<S]7\2?^1YC?\ KY'_ --Q/HRO&/VI/^1'M?\
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M?^DT==O7$? __DC/@/\ [ %A_P"DT==O0 4444 %%%% !1110 4444 %%%%
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MU 7S'5"FV,"(AN0,8(!]:44@Z4M !1110 4444 %%%% !1110 4444 %%%%
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M@Q_^YUO\,OR9VX+_ 'JE_B7YH^%OC#_R:KK/_89MJ^>_VHO^1$_9J_Z\IO\
MTJ6OH3XP_P#)JNL_]AFVKY[_ &HO^1$_9J_Z\IO_ $J6O8\ /^2AP/\ UYJ?
ME,\7C#_DK<;_ (8_FCZ(U+_D^;1OI;?^B*Y3X _\A;X\_P#8-NO_ $H-=7J7
M_)\VC?2V_P#1%<I\ ?\ D+?'G_L&W7_I0:[O$3^+EG_7G]&?TWEO_).8[_KQ
M0_\ 2V?4?["?_)*K_P#["#_^@BOI*OFW]A/_ ))5?_\ 80?_ -!%?25?)Y5_
MN5+T/P#'_P"\U/4\[^/G_)+]7_W5_P#0A7PS^U+_ ,D-\ ?]A*Y_]!K[F^/G
M_)+]7_W5_P#0A7PS^U+_ ,D-\ ?]A*Y_]!K\^SK_ )'LO^O'_MZ-<^_Y(BM_
MU]7Y(_0/X8_\DX\+?]@NV_\ 12TSXI_\DX\2_P#8/G_] -/^&/\ R3CPM_V"
M[;_T4M,^*?\ R3CQ+_V#Y_\ T U^F_\ +CY?H<F5?Q\/ZQ_-'YT_!#_DUKXE
M?]A.S_K7UG^RQ90/X/\ !MTRZ:9TLKE%:2X878!D&=D>=I3U)&17R9\$/^36
MOB5_V$[/^M?6?[+%_#'X/\&VAEL!-)97+K%):LUR0)!DI+T5?53UKY')OX]/
M_KW_ .W,_5_$G_D>8W_KY'_TW$^C:\8_:D_Y$>U_Z^U_D:]GKQC]J3_D1[7_
M *^U_D:[>*O^1+BO\)\)PW_R-\/_ (CX\_:<_P"1[^#O_7G!_P"CQ7,VO_*4
M'Q)_O7'_ *2BNF_:<_Y'OX._]><'_H\5S-K_ ,I0?$G^]<?^DHK]8\&_@SC_
M +!/_;8GYO4_Y'N._P"OR_4M?"O_ ))/\=/^O,?^C:DT3_DT/0_^QBG_ /0*
MC^%?_))_CI_UYC_T;4FB?\FAZ'_V,4__ *!7R/B9_P E#7_Z]+\HG]=8[_DG
M,3_V$4__ $TC]$OA!_R3#PQ_UX1?^@UV%<?\(/\ DF'AC_KPB_\ 0:["L*'\
M*'HOR/YMJ_Q)>K"BBBMS(**** $/0U\Q? O_ ).\^.W^[IW_ *+-9G[:?BS6
M_#GB3P?'I.LZAI<<P;S4LKJ2$2?./O!2,_C4W[-[M)^U'\:'=BSM;:62S'))
M\GK7#2Q2JUZE!+X+?B=-2@Z=*%6_Q7_ ^JZ***[CF"BBB@#'\8>%--\=>%-8
M\.:Q"UQI6K6DMC=Q)(T;/%(A1P&4@KD$\CD5\3:[^RU^SN\UQH/@"ZL?&7CV
MQGA\KPK=?$:Z3.R5/,WH)G(,:!FV[3R@!QU'V-\6=!UCQ3\+O%^C>'KS^SM>
MU#2+NTT^[WE/)N'A=8WW#D88@Y'3K7P#%X+M?%?PV\#_  T\(_LV>(? ?Q2T
MF\TSS?%MUHD-I:Z3+;S1/<W@U%6S.'6.3&"2^_UQ0!^E-%(.GI5./6M/FU6;
M2TOK9]2AB6>2S693,D;$A79,Y"DJP!(P2#Z4 >)_M4_\A+X*?]E%TO\ ]$W-
M>[Q_<7Z"O"/VJ?\ D)?!3_LHNE_^B;FO=X_N+]!0!ROQ7_Y)MXF_[!\W_H!K
MXL\=?\FG?$C_ *_=/_\ 1RU]I_%?_DFWB;_L'S?^@&OBSQU_R:=\2/\ K]T_
M_P!'+7Y7G_\ R4&'_P"O53_TF1]36_Y(O,O5?H?/?Q>_Y1]:%_V/C_\ I*U=
M)XN_Y,G^ /\ W$O_ $<:YOXO?\H^M"_['Q__ $E:ND\7?\F3_ '_ +B7_HXU
M_;7!'_)%9/\ ]A$__350^6\/O^1EA/\ !_[:R[^U'_R)OP1_[%.'_P!"%?I]
MX6_Y%K2?^O2'_P! 6OS!_:C_ .1-^"/_ &*</_H0K]/O"W_(M:3_ ->D/_H"
MU_,TO^1YF'^/]6?NG''_ "363^M?_P!+1J5YC^T=_P DHU3_ *Z0?^C5KTZO
M,?VCO^24:I_UT@_]&K7%Q!_R*,7_ ->Y_P#I+/R?(_\ D:8;_''_ -*1\<?M
M%?\ )J6@_P#8T-_Z(:O"/VR/^37_ -G3_KEJW_HV.O=_VBO^34M!_P"QH;_T
M0U>$?MD?\FO_ +.G_7+5O_1L=?6> W_)5Y;_ ->G_P"FY'Q?$_\ R5>8>G_M
MT3O/VCO^1(^!/_8F67_H*UO_ +1?_)VOA#_KEH_\Q6!^T=_R)'P)_P"Q,LO_
M $%:W_VB_P#D[7PA_P!<M'_F*^G\3O\ D4X'_KY4_P#2S^K_  ]^'#_]@];\
MX'Z$^#+1[;4O%;/9WEJ)M6,BO=3"19A]G@&^(8&Q,J5V\_,KG/.!U%<QX-6W
M74O%1@M[*!SJQ,K6ER96D?[/!\TH/^KDQM&S^ZJ'^*NGKXP_F@\1_:M_Y$O2
M_P#K_'_HMZ[/X&_\DJ\/_P#7%_\ T8]<9^U;_P B7I?_ %_C_P!%O7&:O^TQ
MI7[._P */ ;:EHUYJW]JQ7 3[)(B[-DASG=Z[OTK\TI5J=#BO%5*CLE2C^<3
M[7,:]/#<)T*M9VBJKU^3/J&BLCPAXCB\7^%=(UR&%[>'4K2*[2*0@L@=0P!Q
MQD9K7K]*34DFCXB,E)*2V84444R@KYT_:T^_X<_[;?\ LM?1=?.G[6GW_#G_
M &V_]EKX;C;_ )$-?_MW_P!*B?8\(_\ (ZH_]O?^DL]N\"_\B7H/_7A!_P"@
M"MVL+P+_ ,B7H/\ UX0?^@"MVOKL'_NU/_"OR/F,5_O%3U?YA7G7[17_ "0?
MX@?]@*]_]$/7HM>=?M%?\D'^('_8"O?_ $0]=9RE[X'_ /)&? ?_ & +#_TF
MCKMZXCX'_P#)&? ?_8 L/_2:.NWH **** "BBB@ HHHH **** "BBB@ HHI#
MT-  0N><4F%]J_/K]I7]JOXF_#[XT>(M!T+Q MGI=H\8AA-G"^T&-2>64D\D
MUYB/VWOC&3_R-*?^"^W_ /B*_1\+P)F>+H0Q$)PM-)J[E>S5_P"4^YP_"&/Q
M-&%:$X6DDUJ^NO\ *?JH.G%!./7\JX7X%^)M1\9?"/POK>KSBZU*]LQ+/,$"
M;FR1G   Z=J^</B_I;>)?C_XVM7\$^.O&MU;:/IO]FR>%]=;3X-.E<W.6DS=
MPJ"Q53NVOPA^A_/Z]&6'JSHSWBVG\G8^,K4G1J2I2WBVON/LJDKXV^(/[3?Q
M'^"5EI.D'3K#Q5/X?TO3O^$DN'@N)7$\ORL)+L,D,38&0<2,YR=J\9;'\;O%
MO@GQ!XAU7Q2;3Q+9Z=XIUE-/CM6N(9;>&WTLS"(#S-C _*,,I +.1SC&!B?9
ME%?&ND_M??$N\\&:O<R^#["+6=NFS:9-?:??:=9NMU.D1C<3?.^P.")8_E;G
MY1T._;_%/XJZ[\3O".@WE[X=TR;3?%=QI.L+I\5R;?4(18?:$*!GW(0K$88L
M-RJ>F10!]5TF:^'/VS/BCXV\._$T:;X?\3>)--M;;2&GCM=*\'27\1GE/D(#
M<*XSN\P]OE(7J2*S/"6L^*8?&-MXO\0-KSV6D>(;'P^M^?$4EC=1QE(51#HY
M5HBDC.3()&\T[OE^Z* /O>BD'(I: "BBB@ HHHH **** "BBB@ HHHH ****
M "BBD/2@#X]^-7[/O[,.C^/+[4?'?B2+PWXEUZ8W;VUSXTN-.\^0@#<(A,H4
M' &<8KW']FSP+;?#KX5:?HUEHMMH5DDTTMO;6NK2:FCQ.Y*2^>_+%UPQZXS7
MS5XITEOA;\4OB8_C#]GS7?BY+XHO?M.E>(-(TFWU-&MS$J"UE,C VX1@?8[L
M]J^A?V2_ 6O?#;X%>']$\16HTS4(S/,-+6;S1I\4DK/';!Q][8K <4 >Q5R?
MQ9_Y)AXK_P"P7<_^BFK<U3Q!IFB3646H:C:V,M[,+>U2YF6-IY3T1 3\S>PY
MK#^+/_),/%?_ &"[G_T4U &7^SY_R0GX>_\ 8OV/_HA*V_B1_P B)KO_ %Z2
M?RK$_9\_Y(3\/?\ L7['_P!$)6W\2/\ D1-=_P"O23^5<&/_ -SK?X9?DSMP
M7^]4O\2_-'PM\8?^35=9_P"PS;5\]_M1?\B)^S5_UY3?^E2U]"?&'_DU76?^
MPS;5\]_M1?\ (B?LU?\ 7E-_Z5+7L> '_)0X'_KS4_*9XO&'_)6XW_#'\T?1
M&I?\GS:-]+;_ -$5RGP!_P"0M\>?^P;=?^E!KJ]2_P"3YM&^EM_Z(KE/@#_R
M%OCS_P!@VZ_]*#7=XB?Q<L_Z\_HS^F\M_P"2<QW_ %XH?^EL^H_V$_\ DE5_
M_P!A!_\ T$5])5\V_L)_\DJO_P#L(/\ ^@BOI*OD\J_W*EZ'X!C_ />:GJ>=
M_'S_ ))?J_\ NK_Z$*^&?VI?^2&^ /\ L)7/_H-?<WQ\_P"27ZO_ +J_^A"O
MAG]J7_DAO@#_ +"5S_Z#7Y]G7_(]E_UX_P#;T:Y]_P D16_Z^K\D?H'\,?\
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MOVG/^1[^#O\ UYP?^CQ7,VO_ "E!\2?[UQ_Z2BOUCP;^#./^P3_VV)^;U/\
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M?_ZYWW_HQ:^N/VK?^1+TO_K_ !_Z+>OD?]LG_DDOP?\ ^N=]_P"C%K\>Q_\
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M_"OR/F,5_O%3U?YA7G7[17_)!_B!_P!@*]_]$/7HM>=?M%?\D'^('_8"O?\
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M'C;P3IHU :U8:?="8S6X6+Y$.[#;CG\J]2^&?_)-_"__ &"[;_T4M?!?P_\
M^3B_BS_UX:E_Z":_<\IRZCC<OQE6K>]*GS*W?S/3X8P5+%7J5+WIJ+7K=;G-
M_!#_ )-:^)7_ &$[/^M?6'[+-B'\*>"[K^SS(4L;I/MOVL*(\R#Y?*ZMG^]V
MKY/^"'_)K7Q*_P"PG9_UKZS_ &6+&!_!_@VZ9--,Z65RBM)<,+L R#.R/.UD
M]21D<5^5Y-_'I_\ 7O\ ]N9]SXD_\CS&_P#7R/\ Z;B?1M>,?M2?\B/:_P#7
MVO\ (U[/7C'[4G_(CVO_ %]K_(UV\5?\B7%?X3X3AO\ Y&^'_P 1\>?M.?\
M(]_!W_KS@_\ 1XKF;7_E*#XD_P!ZX_\ 245TW[3G_(]_!W_KS@_]'BN9M?\
ME*#XD_WKC_TE%?K'@W\&<?\ 8)_[;$_-ZG_(]QW_ %^7ZEKX5_\ ))_CI_UY
MC_T;4FB?\FAZ'_V,4_\ Z!4?PK_Y)/\ '3_KS'_HVI-$_P"30]#_ .QBG_\
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M_2T:E>8_M'?\DHU3_KI!_P"C5KTZO,?VCO\ DE&J?]=(/_1JUQ<0?\BC%_\
M7N?_ *2S\GR/_D:8;_''_P!*1\<?M%?\FI:#_P!C0W_HAJ\(_;(_Y-?_ &=/
M^N6K?^C8Z]W_ &BO^34M!_[&AO\ T0U>$?MD?\FO_LZ?]<M6_P#1L=?6> W_
M "5>6_\ 7I_^FY'Q?$__ "5>8>G_ +=$[S]H[_D2/@3_ -B99?\ H*UO_M%_
M\G:^$/\ KEH_\Q6!^T=_R)'P)_[$RR_]!6M_]HO_ ).U\(?]<M'_ )BOI_$[
M_D4X'_KY4_\ 2S^K_#WX</\ ]@];\X'Z'^$[BXGU#Q*)_P"TMD>IE(OMZ*J;
M/(A/[C &8LEN3D[_ #!T KHJYSPEILMAJ'B:22VN(%NM4,Z-/=+,LJ^1 NY
M!^[7*$;#SE6;HPKHZ^,/YH/$?VK?^1+TO_K_ !_Z+>OD?]LG_DDOP?\ ^N=]
M_P"C%KZX_:M_Y$O2_P#K_'_HMZ^1_P!LG_DDOP?_ .N=]_Z,6OQ['_\ (_QG
M_7J/_I4#V>*_^2$A_P!??U9X7^WN?^*J^"__ &)>G_\ HQJ_8_33C3;8_P#3
M)/\ T$5^.'[>_P#R-7P7_P"Q+T__ -&-7ZU2?$OPGH=U9Z+J'B32[+5I(H@M
MC<7:),Q8 +A"<\]J_L;B>E.KPEP\J<6W[.ILK]8'R.5TYU')03>D=O0^<5_:
MK\9G]K4_#;R=*_X1\:FMIO\ LS>?L,8;[^_&<GKBOKT'(!K\WD_Y2*M_V'4_
M]$BOTA7[H^E?S[E5:I6]M[25[3:7H?M7'N6X/+O[-^J4E#GP].4K+>3W;\V+
M7SI^UI]_PY_VV_\ 9:^BZ^=/VM/O^'/^VW_LM>'QM_R(:_\ V[_Z5$^;X1_Y
M'5'_ +>_])9[=X%_Y$O0?^O"#_T 5NUQ'A_QOX=\.>%O#MKJVO:9IEU)I\#I
M#>7D4+L-@ (5F!(SQ6?KW[17PV\,>.8/!VJ>,--LO$\[Q1QZ9*Y\UFDQY8&!
MCYLC'/>OMLKP];&480PT'-QBFU%-M*RU=MEYGRF*J0^L5%=?$_S/1Z\L_:!U
MW3;WX(_$*VM]0M9[E="OLPQSHSC$+YX!SQ7I\_\ J7^AK\G_  ?_ ,E2^,'
M_P"01XA[?],Y:X,5C'AJM*FHWYW;T/L,AX=CG6!Q^,E5Y?JT.>UK\V^E[JVW
MF?I;\#_^2,^ _P#L 6'_ *31UV]<1\#_ /DC'@/_ + &G_\ I-'7;UZ1\2%%
M%% !1110 4444 %%%% !1110 4AI:* /@[]HG]BGX@_%+XOZ_P")M'FT5-.O
MGC:(7-XZ28$:J<@1G'(/>O-Q_P $Z/BH#_Q\>'O_  /?_P"-5^G&:,U\]4R+
M"59RJ2O=N^Y^Q8+Q5XBP&%I82CR<E.*BKQULE9=?(XKX*^#[_P  ?"OPUX>U
M,PM?Z?:"&8V[ETW D\$@9'/I7">(OV6_#GQ!^+/B;Q1XQLEU;3[^QLK2TM8K
M^Z@V^49C()4C=4=6\Q,!MW0_C[C5&ZUS3K*Y6VN+^U@N&QMBEF57.>F 3FO>
MA!4X*$=EH?D^*Q$\77J8FI\4VY/U;NSY1_:%_9+\:?$WQ#=Q^'[S0X/#;VEE
M;6-O=:A?6:Z<L#'*"UMP(K@$;=IF)"8X6MKQ!^RUXF\3ZOKL%SJ>EV>C7^L:
MCJ,5Q;-(;E4N]--J592H7<CX.0W*D]#7U%4;SQQR(CR*KR$A%8@%CC/ [\59
MRGQUX6_8V\6Q:!?VVO7VE7%X_P#9=M&9-5O-0CDM[6X25LB90(P0F%C52!DY
M;%>EM\"/$>F?$U?$^EMHCVI\6_VT]M.TD;"U>P%J^W:A'F@Y8 \' R17OU)0
M!\[?'#]ES4_C#XYFU?\ X2[6M(L)+*"P^R6&LSVZ^69U:X^11M&Y% ]SC/05
MZ%HWPNN[#XJ6WB.ZOVU#3M-T)=*TX7DK37*NT@::5W8<LP1!NSD\YKT26XB@
M*B21$+9P&8#.!D_I3!?6[31Q">,RR+O1 XW,OJ!W'O0!/1110 4444 %%%%
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M^9G[2WCKPWJ?A/X-Q6?B+2+R2T\+Q0W"6^H0R&%\CY7"L=I]CS7Z0>&OCO\
M#:'P]I<;_$'PJKK:Q*0=<M>"$'_32M-?@-\-4+%?A_X64L<G&B6HS_Y#J(_L
M^_"\G_DG/A+_ ,$5K_\ &Z_.713QM?&WUJN]NQ]KG7$U3.<NPF72I**H<]G>
M]^=WVMI8D_X7W\-/^BA>%/\ P>6O_P <KSKX_?&GX?:K\,=2M[/QUX9NIV>$
MB*+6K9F.)5S@"3)KT'_AGSX7_P#1.?"7_@BM/_C=.3X ?#*)@R?#OPHC#NNA
MVH/_ *+K''X58["5<*W93BXW[75CY;!8EX/$T\2E=P:=N]G<^"/C]\0O"NH?
MLQZ+86OBC1+F^C\2&5K:'4X'E">2WS%0^<>^*\0_:X\9:!J_[-_P!L;#7=+O
MKVRBU3[3;VU]%+)!NE3&]58E<^]?HK^U!^S7X<\1_ SQ;8>#?ASH$WB>XM0E
MFMEI5I#.6\Q#A7*KCC/<5ZFGP&^&RLS#X?>%@S=2-$M<G_R'7J<#U'P3FF'S
M.E^]=&+C9Z7]UQO?7N>1F6'68YI7S.3LZJV[:I[_ "/S1_: \<>&]4\&_!..
MS\1Z/=26GA"SAN$@U&!S"X5<JX#_ "D>AYZUM?'_ .(/A;4?VI?"E]:>)=&N
MK&*/20]U#J,+Q)M(W9</@8[\\5^BJ? ;X:QYV_#[PLNXY.-$M1G_ ,ATB_ 7
MX:HA5?A]X553U4:):X_]%UZ?$F8OB+"T,+4CR>SE*5T[WYG>W38_4<AXRJY$
MJ:A14N2G.&KM?GMKMTL<]X5^-WPRM+_Q(X\:^"K0SZF92]MXCMI6G/D0KYD@
M,GR/\NW:.,(I_BKH?^%]_#3_ **%X4_\'EK_ /'*8?V?OA@<9^'7A,XX'_$B
MM?\ XW2?\,^?"_\ Z)SX2_\ !%:?_&Z\<_.3R']IKXQ^ M9\'Z;'8>-_#5Y(
MM\&9(-8MG8#8W. _2OEC]K;X@^%M:^%WPHMK#Q/HM[<6J7HGBM]2@D:++KC<
M%<D?C7Z$1_ +X9PDF/X>>%$)[KH=J/\ VG7EOQX_9J\.:R/ I\,?#G0)&M_%
MNEW6I&TTJTB(LDFS,7)4;D"]5YR.QKY*OP_"OCJV.]HTZD5&UMK-.^_D=>:8
MAYGDBR62Y8J7-S;OTL?F[^W%XOT'7?%'PA;3=<TS44M?!]A#.UG>Q3")P[$J
MQ5CM(]#S7N/Q_P#'_A;4OVL?#VH6GB?0[JPC;3-]U#J=N\2[2-V7#X&._-?H
M)'\!OAL@.WX?>%ESR<:):C)_[]T+\!?AJB%%^'WA54/\(T2UQ_Z+K]XH\;5:
M6!P6!]@FL/3G33O\7/RZ[:6Y=BLCQ+R6M.K%<W-'E[?/J?GPGQ$\*C]OQM7_
M .$GT7^RO[:23[=_:,/D;?* SYF[;C/'6OT&7X]_#0*/^+A>%/\ P>6O_P <
MI?\ A0OPT\OR_P#A7WA79TV_V):X_+RZC_X9\^%__1.?"7_@BM/_ (W7Y)A,
M&L)SV=^9M_>?1<1<13X@^J\]-0]A3C35G>_+U\K]B3_A??PT_P"BA>%/_!Y:
M_P#QRO _VH?B]X%UI_#_ -@\:^'+SR_.W^1K%L^W[O7#U[Q_PSY\+_\ HG/A
M+_P16G_QNGQ_ /X9PY\OX>^%4SUVZ':C/_D.N7.<LCG&!G@I2Y5*VMK[-/\
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MH **** "BBB@ HHHH **** "BBN*^)?Q,M_AWIRSBWBU.Y7$T]BEVD=PEJ&
MEG6,Y:0(#G:H)/0<T :'C+XB^'_ ?A_5]8U?48XK32HQ)=+%^]E3/W1Y:Y8E
MCP!CFL7X1_&OP_\ &73[^XT:+4+"YL+AK6[T_5K4VUS!(,9#*201R.03Z'!X
MKX1^+>L0_%_XHZ[JVAM)=7GB6&WL="TBRTV0Z5XPTEP/-$]U&I*3Q/N^9BIA
M*CCK7V;\ /V=-$^"-@UQ;7&IZAJUU:0VKRZK<QSO:PIEEMHVCCC4HK,WS;<L
M>2: /8**** "BBB@ KBOBM\7O#GP;\.KJ_B&:Y*2R"&VL["V>ZNKJ0C.R*%
M6<X!)QT ).*P_BK^T7X1^#7B[PIH/BFXET__ (2.5X;;4&4?9H77H)6SE Q(
M ;&,GDBOD;XBWWQ4\>_':^\ WVM6^LW%\ISH\5G&HTFVDW>7?:?</#C]W&N)
M/-8^87VK0!]Q_#;XD^'/BWX.T_Q1X5U.+5=&O5W1S1\%2/O(ZGE7!X*GD5T]
M><?!'X(Z1\%/#]S:64BWVK:A+]IU/5?LT=LUY-C ;RHP$0   *H  '<UZ/0
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M>5#@F$A>>W&*[V@!% 4 #@"EHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC[X:^&VJW6BWYNI-?72YM4M-/6W<?;EB&6CAD(VLXZE020.<5Y1\!/VA+/\
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M[6)(8_.E:5]J@ ;G<EF.!R6))ZDFK5%% !1110 4444 %%%% !1110 4444
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M4FM&B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M2EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
..BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>aciu-20221231x20f017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %Q ML# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTB3>$,7E[O\ CYQG'-=U$GE1(F<[0!F@!]%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %5;;2[.RNKFYM[2""XN2#/-%$JO*1G!8@9;&3U]
M:M44 5;G2[.]N;:XN+2">XMB6@EEC5GB)ZE21E<X[5:HHH **** "BBB@ HH
MHH ***YGQIK>I:5<>';33'M8IM4U+[&\MW TRH@MYY20JNG.8@.O<\4 =-17
M'7VJ>(]$U_PS;7=]I=Y::I?R6<RPZ?)#(H%I<3!E8SL,[H5'*G@GZU!X2U/Q
M5XHT1-2_M+1[823SHL7]EROM5)G1<G[2,G"C)P.>PH [BBO-="\:>(_$0\$0
MPSZ7:3ZQH5QJ=Y(]E)(OFQM:*%C43*54_:'."6/"\]<GB_QIXC\&1ZZ9YM+O
MVM/#E]J]OY=E)"!+!MVJ^9FW*=W(&#QUH ]*HKAO&FH^+?"W@[7M:CU319Y-
M-L)[Q8GTJ8!S'&SA2?M/ .W%=S0 4444 %%%% !1110 4444 %%%% !1110
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M71'R230W6K/*@]U6>$G_ 'Q0!D_\+D\7?]$)^('_ ('>'O\ Y:T?\+D\7?\
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M2T/41IE]IFM-:M-'*;:"Y4AK:>:-E,5S$00^<D@@$4 =E1110 4444 %%%%
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MABFQ%+R,1D9)Z\@<5VU !1110 4444 %%%>,>&OVB-;\8^'-*U_1?@IX_O\
M1]5M(KZRNA=:!&)H)4#QOM?5%9<JP.& (SR >* /9Z*\J_X7)XN_Z(3\0/\
MP.\/?_+6C_A<GB[_ *(3\0/_  .\/?\ RUH ]5HKRK_A<GB[_HA/Q _\#O#W
M_P M:/\ A<GB[_HA/Q _\#O#W_RUH ]5HKRK_A<GB[_HA/Q _P# [P]_\M:/
M^%R>+O\ HA/Q _\  [P]_P#+6@#U6N7\2>&-4U#Q)I6M:1JEGI]S96EU9LE[
M8O=)(DSP.2 LT94@VX[G.XUR7_"Y/%W_ $0GX@?^!WA[_P"6M'_"Y/%W_1"?
MB!_X'>'O_EK0!KZI\/-8\3-J#:YKEC,;C1[S2(O[/TU[?RQ<>7N=M\\FXCRE
MP!MZGFC7_!OC#Q%X9U+0[GQ+HD=K?V<EE(\6A3!PCH4)4F\(S@\9!K(_X7)X
MN_Z(3\0/_ [P]_\ +6C_ (7)XN_Z(3\0/_ [P]_\M: .FO/"NO0>*M2U?1M:
MTZSCOX8(I+>^TR2Y*F+?@JRW$?!#]"#TZUG7'PXU>^TO6ENM=LFU74-5L=42
MYATUT@B-L]NRH8C.68'[/R=X^][<Y7_"Y/%W_1"?B!_X'>'O_EK1_P +D\7?
M]$)^('_@=X>_^6M '0WOA3Q/K<M@FJ:]I,ME;7D%XT=GH\L,CF)PZJ':Z<#)
M49^4\5VE>5?\+D\7?]$)^('_ ('>'O\ Y:T?\+D\7?\ 1"?B!_X'>'O_ ):T
M >JT5Y5_PN3Q=_T0GX@?^!WA[_Y:T?\ "Y/%W_1"?B!_X'>'O_EK0!ZK17E7
M_"Y/%W_1"?B!_P"!WA[_ .6M'_"Y/%W_ $0GX@?^!WA[_P"6M 'JM%>5?\+D
M\7?]$)^('_@=X>_^6M'_  N3Q=_T0GX@?^!WA[_Y:T >JT5Y5_PN3Q=_T0GX
M@?\ @=X>_P#EK71_#7XDCXC0Z\LOAW5_"VI:'J(TR^TS6FM6FCE-M!<J0UM/
M-&RF*YB((?.200"* .RHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#Y'_X*@?!#Q'\</V7[JT\*VL5[JFAZC%K<ELS;9)K>**99%C]6 DW;
M<C.P@9. ?PZTOX2>.=<L(+[3?!GB'4+*X7?#<VNE3RQR+ZJRH01]*_I>^(&B
MS^)? 7B32+4LMUJ&F7-I$48*0[Q,JX)X!R1S7Y:?LL?MZ^*_V.KC3?@K\?\
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M)&202>M>DZ?XIU.\O88)O!^M6,3MAKFXFLC'&/5@ERS8^BDT 8OP5^!O@O\
M9\\%1>%? VC)H^DK(9Y!O:26>4@ R2.Q)9B !D]  !@#%=[110 4444 <C\0
M+R6SNO"7E:U#HWFZY#$ZRQ;_ +8IBES;KP=K-USQ]T\UUU<GX]%S]I\*FV@T
MJ<#6H?-_M3;E(_+ERT&XC]\#C&.<%O>NLH **** "BBB@ K@/V?="O\ PO\
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M8/0X(//!%'[/'[./@O\ 9C\!CPKX*LI(+628W-U=W+^9<7<Q &^1N_   &
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MH/+?L,_\$_\ 2OV/)=;UJY\0'Q3XLU:!;1[U+?[/#;6P8.8XTW,2695+,3_
MN .<@$O[6G[.%U:_LX^/9_AQJ?C^?QC%IYDLX3X\UV[\U0ZF9!#+>,DA:$2@
M(5.20 "<5^07[%7@3QEXQ_:<\':5X836K2=-1C&KSZ5=7%C+;V(<?:=\\+(\
M0*!E^\IR0.IQ7]%U>6_!^UA@^(/QL>.&.-CXNMP650"?^)%I)_F2?Q- #/\
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MXLV>E>!_^%<6$?B]/+\->19P_9,Z+I9/R6<DD WDF3Y'/W\G#9 ]YH ****
M"BBB@ HHHH **** "BBB@#DOBWX2O?'WPN\6^&M-O?[-U#5]*N;&WO,D>3))
M&RJ_'H2#7X2^!O\ @GA^T!??%W3_  U+X%U?0G@OD$VORIML;=%?)G2X^X^
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M2_\ !)W]DWXA_ 6W\9^*?'FGR^'#KL5O:VFBSNIF*QL[&:503LY;:H/S<L2
M",_H;10 4444 %%%% !117\^G[7G[1WQ>O?VG_&LFI>*]>T&\T/6KBST^PL[
MV6WCLH8I66+RT5@.5"MN_BW9Z&@#^@NBO)_V3_&7B;XA?LW_  \\1^,(GC\2
M:EI$,]VTD>QI2<[92O8N@5_3Y^*]8H **** "BBB@#B?B7<6MO=^"_M.H7]@
MTGB"!(18C(N)#%-B*7D?NR,D]>5'%=M7)^/K^>QN?"@@UR+11/K<,,B21E_M
MJ&.7-N.#@M@-GC&SK764 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M7EGC7]J7X1?#GQ>GA?Q/\1?#VA:\<;K.^ODC,6>GF,3MC_X&13?^&L?@A_T6
M3X?_ /A46/\ \=H \%_;A_X*/:9^R5XGT[PCI7AG_A+/%5S;+>W"377V>WLX
M68A-Q"L7=MK':,8&"3R!7JO[''[6FB_M>_#*?Q+I^FRZ'JFGW/V+4]*ED\WR
M)=H961\#>C \' /!!'%?(G[=GP-^!O[5WC#3_&GAW]HGX<>&_$T5JEC=Q7WB
M&SDMKJ)"Q1LK-N1UW$="",=,<^M_L4VW[/\ ^R!\,KKP_%\>? &NZUJ=T+W4
MM1_X2.RB1W"A52-/..$4 XR<DDGC.  5O^"O7AWQOX@_9CM1X4AO+O2;;5HY
M]>MK%69VM0C[6<+R8UDV%O0[2>%R/CW_ ((V>'/&[_M":EK.F07D/@J/2IX=
M8N&#"VE<E?)CR>&D#_,,9(4-T!Y_4\_M8? ]@0?C'\/R#U!\46/_ ,=KL_!'
MC+PCXUTV6[\'ZYHNO:>C[))]#NX;F)7ZX+1$@&@#HZ*** "BBB@ KSKQ!\>O
M#7AK6;O2[O3/&DUS:OY<CZ?X&UN\@8_[$T-F\<@]T8CWKT6B@#RK_AI;PC_T
M"/B!_P"&X\0__(-<+\._CCH>A>+_ (H7M]X?^($%KK7B.&_L)/\ A7FOMYT"
MZ1IUN7P+(E?WMO,N&P?DSC!!/T?10!Y5_P -+>$?^@1\0/\ PW'B'_Y!KL/
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MH?&7POK-G:7>AZ'))K&FWY95N+>V1Y?,A=0W[S9E=I !PO(YS]!_L%_LAO\
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% #)YX[:&2::18HHU+O(Y
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MW$4L%P'Q_JY!!C=T!;#8P< 'J_[7O[5'[47[/.I>%_"_Q&U;PWH&AZ[,9?\
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M3]MSP6G[1O[/'BGP'H[:S9ZW,T5Q9O+H&H>1+-#*KB-V6 C:VTC<,@$@\@4
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M$2JTK1MRF\C@'!^3..10!]RT444 %%%% !1110 4444 %%%% !1110 4444
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M< L<>IZU-10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MIX._Z5U]<3\2Q9&[\%_;8M2E(\00& Z<0 LOE3;3-D<Q=<XP<E:[:@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(D&YRS8 7.U547_^&:?"/_07^('_ (<?Q#_\G4 >JT5Y5_PS3X1_Z"_Q _\
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M_P#)U'_#-/A'_H+_ ! _\./XA_\ DZ@#U6BO*O\ AFGPC_T%_B!_X<?Q#_\
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M/_#C^(?_ ).H ]5HKRK_ (9I\(_]!?X@?^''\0__ "=1_P ,T^$?^@O\0/\
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M,A"[MN[&[ SC.!7Y(Q_ KP-<?\$KM8^,4\UP_P 2]5GDEO\ 77OY6FNG;5A
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M03QZ5I5C^+]=T3PSX7U35?$ES:V6@6EN\M]<7N/)CA ^8OGC;CKF@#X\M_\
M@JAX/5-,U_4_AMX\T;X::G>_8+3QQ>:<HL9'W,N[ 8_+E'^Z6;"M\N00/?\
M]H7]JCX=_LQ>%+77?&^L&%;XD:?I]C'Y]U?$ %O*0$# !&68JHR,G)&?B?\
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M-O\ X)D?M?\ C/\ :H\$>++?QS;03:SX:GM8QK-K ($O4G60@,B_*)$,1SM
M!#I\HZD ^TZ*** "BBB@ HHHH ^=_CS^V=HGP:^(VE_#O1_"7B+XC>/[^U-\
M-"\-6ZR/!;\_/*Q/RYVL0 #P,G *YVO@I^U[X"^-/PO\0>-HI[KPO:^&9)H?
M$%AK\8@N=)>)=SB503Q@'!'7!& P*CPGXT_"_P ?>#/VYK3XI_">Z\(^)_$6
MJ^'O[-U/P=KFKI:7@B7://C7.XQ_NXB2 <%6&"&XXG_@G/%>S?%_]K35_&]S
MHEUI\NLPG6;JW_Y!)N5DO7N?+:7@Q)N(W-U7:3UH ]!TO_@J%H/Q$UO4;#X5
M?"7X@_$V+3R/M%[I>G*D*@D[6ZLRAL' =5)P>.*Z+X1?\%*/AW\1OBC#\-O$
M.@>)?AMXXFN5LXM-\3V:Q![AL;(=RL2KMD8#JH.5 )) KSGQ'_P4!T_5/%-]
M\/\ ]E3X7K\0?$SG]_JMK9BTTF$@[1*VW89%!XWNT:<C#,#4?P!_X)T^*]5^
M.,7QR_: \4V_B'QR+R+4X-'TH8@AN(@H@:60!01$$0+&BA047YF&00#] :**
M* "BBB@ HHHH *\4_:H_:GT/]E'PCHFO:YH>K:_'J^IKI=O:Z.L;3>:T;N.'
M9<@[",#)R1Q7M=? G_!822ZB^%'PM>RB2:]7QM;&".0X5Y/(FV@GL"<4 =_I
M/_!2'PU9^+-#T7Q]\,?B-\*H=;N19V6K>+M#-K9M,2 %9RV0.1R 0,Y.!DU]
M:3:A:VPD,US#$(L;R\@&S/3.>F<BO@?XM? S]I7]LR7PIX3^*'A_P;\/O >E
MZQ%K%_<:5?O=WEP45TV1C<P!VR2#G:,D$DXP>:@^ _A?X_\ _!3SX]:#XSBN
MK_PU9Z5I&HR:5;W<MM'<W"V5FL32-$RL0F^1@N0"Q!.<8H _1VZU"UL?+^TW
M,-OYC;$\V0+N;T&>IJ665((GDD=8XT!9G<X"@=237Y)6NB>(_P!H[]K+]HT:
M_P#""#XUOH>I/H=C:ZGXL71ET.R$MQ'&T".C!BZQ*V]<;2">3)47Q6L/B;I'
M[,_[//PD^*>K&/2]:\=+I.IWEGJT=T)],62'R4DGB9@0HGEPI/'D(<?** /O
M_P :_M1Q>$_VH_AK\'H/#Z:G%XTT^ZOUU^/4 JVHABG?:(1&?,W>1C.]<;NA
MQS[=<ZC:6<T,4]S#!+,=L:22!6<^B@]>HZ5^<&L_!OP;\#O^"H_P"\/^![8Z
M1H\FB:A=G15N9)HK61K2^4N@=F*"38,@'!*D]22>;_9F^"G@O]K[P#\??B1\
M9(I=8\;Q:YJ%BEU>7DJ-H=O#;K)$8E# ($9W !!&(0,8W9 /U)DD6)&=V"(H
M)9F. !ZFHK._MM1A\ZTN(KJ+./,A<.N?3(K\K/"OA[XI_M4_\$\OA;!;ZG;Z
M_J.E>)I%ET+7=4-G_P )/8P2,L=LTQ=2^TG9@L,A<[@RK7IW['6I^$/ /[4<
MOA/4/A#XB^ WQ!UC0V9/#]OJXO=!U2*)F9IE&.)0$;# E0$89!)W 'Z#W%S#
M9P/-/*D$*#+22,%51[DU'8ZG9ZFC/9W<%VBG#-!(' /H<&OPH\">,_'7[5_[
M8][%X]\*3?%6]MYKV2W\!ZEXC_L:TMS$2!"A96 $0R3&H!?:2Q/S9]P^-?[*
M_P 4T\1>&O$?PM^"VE_L]^)K.5@;_2OB+;,MZORD+Y1$0!4]2"0P8A@>, 'Z
MX45R/PCOO$VI?"_PK<^-(+>W\6R:; =52SE22$W.P"1D9"5*LV6&"0 <5UU
M!7EG[1O[1WA/]F'X?CQ5XL^V7$<]REC8Z=IT0ENKVX8$K'&I('16))(  ]2
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M^ !A2 0 "#BO$T_X)I?"I-%_L+^W/'K>&/N_\(\?%-Q]@VYSM\H=OQKZQHH
MX?X1?!+P-\!_"X\/> O#EIX<TLOYDD=ON:29\8WR2.2\C8XRS$XXZ5W%%% !
M5/6-(LO$&DWNEZG:0W^G7L#VUS:W"!XYHG4JZ,IX*D$@@]C5RB@#Y(L?^"6W
MP#LM;@NSHVL76EP7/VN+P_=:Q-)IR29_YYDY(]BQR.#D<5[U\6_@1X!^.OA6
M/PYXY\,66OZ3$=T$<JF-[9L8W12(5>,XXRI'''2N]HH ^/6_X)6?!"6WCL96
M\6S:)&_F)HTGB"8V:G.>$ZCZYS[U](_"KX0>#?@AX3A\->!O#]IX=T6-S)]G
MM029'( +R.Q+R.0 -S$G  SP*[&B@ HHHH **** "BBB@#Q'X^?L=?#?]HW7
M-*UWQ19ZA:>(M,A-M;:SHM\]G="$DDQ%EX9<LV,C(W-@C)S)9?L>_##2/@'J
M?P>TO19=*\%ZF0U[':7+K<W$F]',CS'+,Q,: D_P@*,  #VJB@#XUL?^"3GP
M&TLO]BA\46F_&_R-=E3=CIG YZFM?1O^"8_P;T+5['4K:?Q:;FSGCN(O,\03
M,NY&##([C('%?6=% !1110 4444 %%%% !7F?QS_ &>?!_[1&DZ%IWC&&[FM
MM%U*/5K06EP82)T5E4L1U&&/%>F44 %><^'/@'X3\+?&KQ9\5+"&Z7Q;XGM8
M+/49)+@M"T<*1HFV/HIQ"F3]?6O1J* /G_XJ_L/?#+XL>.KWQC=QZWX=\1ZC
M +74[WPUJTU@=1AP%V3A#AQ@ '@$@#).!C3\4_L9_"3Q9\$-.^$UQX72T\&Z
M;(+BQ@LYGCGM9QN_?++DL9#O?+,3NW'.:]MHH ^?? W[#/PO^'_Q$\+^.M/B
MUN[\6^'UF6'5=3U:6[GN/-B:$F=I"2^(V*J!@*.@ZYH?$+_@G]\(_B)XNUSQ
M#/:ZWH=QX@;?KEGH.L365IJS9))N(D.UB223C&223R23](T4 >.>._V1OA;\
M0/AQX;\$7GAP:=HOAEUET-M)N)+2XTR1?XX9D.X,3R22=QPQR0#5;X1?LA^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MX'^U+^S=XH_:3TZT\/6OQ3OO!/@BXB\G7-$T_2H9Y-47>& %RS!H>!@@!E;/
M(/2O?** ,3P1X,TCX=^#]%\+Z#:K9:-I%I%96ENISLBC4*N3W.!DD\DY)ZUM
MT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>aciu-20221231x20f018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %S [D# 2(  A$! Q$!_\0
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M8$IC],C(%'_ _&W^8?\ !_"_^1]4T5\L6\MZ^G:%!J]SK*_#8ZK?*)PTXE:
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MK$E96"BBBD,*:[K&C.[!449+$X %.K \?Z5=Z[X(UW3[!MM[<V<L4/.,L5(
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MPI:* &E%8@E02.A(Z4ZBB@ HHHH *15"?= '?@4M% !1110 FT;MV!GIFC:
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MS6_J/[/EU-X@N]4LO%<]J;N_BO9H##)A@CW#",,DRD+_ *1D=0&7=@[L#F_
MO[/'BEO"4-GXH\4S1Z@,&9K9Y6\UQ!(F\D2C^.0-_M>6"0"W !U,O[,GAJ36
M'O/M-RMNV[%B$C\E,YR%&WA3N;(Z$G-;M_\ #72(+;P/I4^MRVL6C7,9L(&:
M)9+J2(>8J*2,_=C;*K_ &Z=:YQ/V>KL:K+*_C"]DTYF.RR(G!C0W7G>6&$^"
MNW]WRI/ (('RUO77P?EO=8^'FIS>([Q[KPCC(,*,E[_HTD#L=V61F\P$D,>%
MQU(8 'I%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!14=Q.EK;RS2';'&I=CC. !DUYG-\>=-C\):SK_]FW*06&H)IZ0SLL+S,Q7#
M?-C8,-GGL*5_Z_ =CU"BO+;_ ..T&G6-A<OH=S*LMM]MNO(N(I!:V_F^6)-P
M.'R><+VS2^&?C9<ZO\3AX+U;P?J?AZ>YM)[[3[ZYG@EAO(8G1691&Y9?]8I
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MNJ+M0=> !QQ7S_/H?C^9=#AO+G7XWFM5FC>W\V1H+EYV9Q)B5 -BE1A\KM!
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M][CJ^#7T-6CZ$+J%%>?_ !I\1:[X?\'SMH%I=274B2%[NUB$AME5"V[!(ZD
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MFODK_@GGXA^)_P /O ]G:^-?#-]8_#"^A\[2]7NI86:RF+8.] YE$4AW'<Z
M*0"3A\U]@?&^Z6R^#'CRX<,R1:#?.0O4@6[]*\W_ &,/BY9?&3X*0'R-MSI<
MTEA=Q2;65N2RD8)!!1ES[@UU5/9_58I6YW)]7LDM+7LU=[VNK*SLV>IA4UAZ
MM24>:G>"?DWS--/H]&NJ:;NM$>\LL-[;E6"3P2KR" RNI'Y$&O+]>M;KX%Z1
MJ6NZ.?M?@RRCDO+W0YI@K648!:1[1W.%4#)\EB%ZA2O K ETOXI^!?C&O_",
MZ19ZE\)S:$2:8]^B7$-PWS%[<,N5 ("B,MM^<XVX%>JZ/XDT;QQ87-N@$IP8
MKO3;Z$I-'V*2Q.,C\1@CD$@YK/#8R5%N$E=/>+V=OU[-6:^9A6P;475I/FAW
M6ZO_ #+6WY/HV97P>^+?A[XY?#S2?&?A>X:XTG44)42@+)$ZDJ\<BY.&4@@C
M\L@@UVE?./P=NO&GP:\1^+;'QWH6E>'_  #JFMR7'AZYTJ59(=/$I_U5QA1L
M#L-P=N TA7(&P#Z-5@ZAE((/(([UMBJ'LI\T/@?PO?3M=:777S."+OON+17S
MC/\ M$^,K?\ :SU[X;OX>TA/!^EZ)'J9U:>_6*4%U/EER20H9U9-NW(V[NA%
M<-<?MUW]O^UOH'PRDT[0O^$5U"W42ZO9W[712=PVP"10%'("[=O<'/-=D,IQ
ME1<U.-_=YM&GHU?H][=-R74BMS['HHKY%_:Q_;8U/X$_%7P5X1\+:-IWB=[^
M=5UE))V5[17D5(TWCY8V;=D%\].G>N+#86MC)NG1C=I-OLDNK>R^?70IR4=6
M?75%?)_[4?CC]HVWT[PK%\.? L$4=SJ]L]Y<66H"ZN$C5MWERKL54B<@!W!(
MP"#PV:^J[5I7M86N$6.<H#(JG(#8Y /IFG7PTL/&+E*+O?124K6MO9NV^GHP
M4KDM%%%<904444 %%%% !1110 4444 >=?&.WO;K28%$>S3XY4F^TVVI)9W4
M<JD[=AD79_X\#4WPAUBRO](N8H=3U6^N4E)D36KB.6=.!]TH2"ON">:B^.:V
MX\&Q37$D!,%Y%)':W%JURETX)Q$8UY.?;TKC_@KX2BU'Q#_PE,$EE9-"UQ%<
MZ;:6#VKQ22"/$;!L': N[D=6)%$.J_KH$NC/=**** "O&O%/_)V'@+_L6=6_
M]'6M>RUXUXI_Y.P\!?\ 8LZM_P"CK6@#V6BBJMSJEE92!+B[@@<C(6655./7
M!- %JBL__A(-+_Z"5G_W_7_&C_A(-+_Z"5G_ -_U_P : -"OES]CW_DK7[2W
M_8]/_P"B$KZ3_P"$@TO_ *"5G_W_ %_QKYA_9!UBPA^+'[2327UM&LGCEV0M
M*H##R$Y'/- 'U=16?_PD&E_]!*S_ ._Z_P"-'_"0:7_T$K/_ +_K_C0!H45G
M_P#"0:7_ -!*S_[_ *_XU=BE2:-9(W61&&593D$>QH ?1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?-'C+0M0U7QAXGL]1"
MWUA;2SZG+ FL(CW(V!+:,)O!B$>YB2< ]>:]U^'2SKX"\/"YNUOYQ80[[E'W
MB4[!\P;^+Z]^M>#^.?!D\?CYFO3X1D5M4GODM]1U?[//=QR !8Y%V9*@J#CD
M'%?1NC+*FD62SP06LPA0/!:MNBC.!E4.!E1VX%$?@^[^OT^02^/[_P"OU^9=
MKSKXYZIKVB>"WOM%OX]/2&:'[1(%)E96E10J'H,[CD^GUKT6JNHZ9::Q9O:7
MUK#>6KD%H9T#HQ!!&0>." ?PI#3LSQ36O'>O6_Q4NUCU21+:UUBTTN/2 %V2
MPRP[GD(QN)R<@YXQ7BO[9GQ<\>:A\$YM-E^$NKOH]Q)H\\GB5=2LEMR[3V\A
M40F7S1\_R<J.>3@5]E2^%=&GUR/69-+M'U:-=B7K0J90.F-V,]"?SKQ3]ND
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M]7I]LCW%W*>P2",-(Q^BFN;G\&>./&R[?$?BC_A&]-;[^E^%,I-(O=7O''F
M>\*QL.S5U?A/X?>'/ T!CT/2+:P+<R3*I>:4]S)*V7<GN6))H V[2X%Y:PSJ
MDD:RHKA)D*.N1G#*>0?4'I4U%% !1110 4444 %%%% !6;XCOUTS0KZZ>VN;
MQ(X6+06D?F2N,<A5[FM*H;P;K2<>;Y&48>;_ '..OX5,OA94=T>#_!67R=7T
M*#3'\='3##(SV^L0+'80*4) #>6-WS$ 8/IVKWZOF?X*O9O\2[2&W\1:9<O
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MY9.RLO7]#S\355:E%RFI23?V;.VEFWUOYZKN;5%%%;'FA1110 4444 %%%%
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M\6_]@F[_ /1+5]A_L<_\FK_"O_L7K3_T6*B0'L=%%%2 4444 %%%% !1110
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M"Q.2HSP.E6?$.F6J>*O#=\L(%V]V\;2Y.2OV>7C]*ZFL#Q'_ ,AKPQ_U_/\
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M]6-;=>5!/64MW^1>)G3M"E1;Y8K7LY/=I=.B\TKZ7LBBBBM3A"BBB@ HHHH
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M>A['VB]O?DZVM?Y7T*?_  G.@?\ 05M_^^J/^$YT#_H*V_\ WU3?^$!\/?\
M0)@_\>_QH_X0'P]_T"8/_'O\:C_:/[OXGM7R7M5^^'^0[_A.= _Z"MO_ -]4
M?\)SH'_05M_^^J;_ ,(#X>_Z!,'_ (]_C1_P@/A[_H$P?^/?XT?[1_=_$+Y+
MVJ_?#_(=_P )SH'_ $%;?_OJC_A.= _Z"MO_ -]4W_A ?#W_ $"8/_'O\:/^
M$!\/?] F#_Q[_&C_ &C^[^(7R7M5^^'^1S?Q/\;:%+\-O%4:ZI;EWTJZ506Q
MDF)@!7V]^QS_ ,FK_"O_ +%ZT_\ 18KX=^*?@'P\/AIXK;^R;<E=+N77()P1
M$Q!Z]B!7W%^QS_R:O\*_^Q>M/_18JX^TM^\M\CS,7]4YE]4YK=>:U[_(]CHH
MHJCA"BBB@ HKE?B9X7USQCX0NM+\.^*KCP9JLK(8]7M;9+AX@&!("/P<CBO#
M_P#AFKXS_P#1R^N?^$]:?XT ?35%?"OQC\%_&_X7^)OAMI4/[0NL7Z^+=>&C
M222:':H;=3#))O !.X_)C!QUKU#_ (9J^,__ $<OKG_A/6G^- 'TU17C'PH^
M#?Q%\#^*AJ7B?XS:IXYTSR7C_LJZTFWMD+G&'WH2>,'CWKV>@ HHHH ****
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M$\?>(9&.I^$)WEM8K>%0MPA^9$E+9)V/A@1CG/'- 'JMI;3RV%O,^IWD>^!
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M:2W3:/,8NQ'+"0 8Z<YH ]]TGPG!X?TN'3=*F.F6$ *PVUG!#%'$N& 555,
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M^RS\!K/]F[X'^&O ULT,UY9P"34+J$';<7;\RN,@';NX&0#M S7K- !1110
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M:_\ @CN?_CE>[_#*U\8V7@ZRA\>7^EZGXF4M]HN=&MW@MF&X[=J.Q(.,9YH
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M?#[1-;T&]TC[*MA:WDB2S-8HL3NR.'!)P<\J.H]:Z2B@=['$WOPDT6^\:?\
M"1O+>+,TB7$EFLN+:69%*)*RXSN"GUQP.*\4_;;^'GAG3?V=M0N(-!TX7EM=
MZ3!'=M:H9@BWD" ;\9^Z,=>E?4-> ?MU?\FWZU_V$=+_ /2^"FFU'EZ$M)OF
MZGO]%%%(85%<W4-E;R3W$J001J6>21@JJ/4D]!4M>.?'[]ISX4? C[#I7Q-U
ME=,BUB)VAAGTZ>YAG12 P)2-EZD?*>?:@#9F^-4&O7DMCX%T:\\;7,9*R7UK
MB#2X3T^:\?".0>JP^8P[@4V?P#XO\;@+XL\4MI6F-]_1_"A>U,H_NR79/G$?
M]<O*/N>E=%\+?B'X;^*O@+2/%/A"Y-WX;U"-C93?9I+<,B.T9Q&ZJP&4..,$
M8(R"#754 >4_$?\ 9L\$^/O@[XF^'L>CVFDZ=K5H\!GM80)(Y>L<Q;JS*X5L
MD\XYZFO*O^">G[)LW[*/PCOK?Q#%;IXSUN],VI3QR*X$:$I;Q!QP5 +..^93
M]!]-W.J$326UG"UU=(@<C[L:YW!<L?4HPP,D<9 R*(M*\V4RWTHO) ^Y$*!8
MXL=-HY/8'DGGD8Z  9'J%QJ3(;*-5M&!/VJ0_>^[C8HZ@@OR<8*C@@U\MV__
M  4(^&>D?'.3X32:%XVO/'*:J=$>2;3H2)9@P3S ?.&(FVB0;452#N"C-?6]
M>*M^REX1?]J)?C@R;M?723IRVAB'EB;./M6[/W_*S'C'0D]<8 /:J*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)\5Z@^E^
M'[VXB2UEE$95(KR<012,> I<@@9SBM:N'^,MS=VG@6:6QMTN[H75J$@D VR9
MG08)((&?7''6IEJK%+<\K^#6D[?&FC7)31XIDAD\V&/Q"+UX_P!T1M@@'W,=
M#EGPN1FOHRO-O!6F:G;^(89;KX;:'X<BVOG4;*]BDE0[3P%6%2<]#SWKTFM&
M[V,T%%%5=4LO[2TZXM1/-;>:A3S;=MLBY_NGL?>I*+58'B/_ )#7AC_K^?\
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M@,]!WQ5HVUUJFTW)^S6A# VR_?<$$#>V>!@\J!G('S8X/AUG\5_BU9L9/^%
M7TURV-]Q+XHLR[?*J_W<#(49 P,\XK \+?M:?$GQ=XP\8>&[#X"WKZCX6N+>
MVOU_X2:U&QYH%F09* 'Y6!X)[=^  ?4$%O%;1[(HUC3).U1@9/4U)7@W_"Z_
MC!_T0"\_\*BS_P#B:/\ A=?Q@_Z(!>?^%19__$T >\T5X-_PNOXP?]$ O/\
MPJ+/_P")H_X77\8/^B 7G_A46?\ \30!W/Q _:!^&WPIU:'3/&'C?0_#>HS1
M>?':ZE>I%(T>2-P4G.,@\^U=;X:\2Z5XQT&QUO0]0M]6TB^B$]K>VD@DBF0]
M&5AP17YK_P#!1;P-XT^.?A+POXF\0?!N[\,R>'M4MK>>_77;6X:XMKF>.#[/
MA0""99(MK<A<MD<Y'UCX;^)?Q2\)^'M,T32_V>;FUTW3;:.TMH$\3V86.*-0
MJJ!M[ "@#Z*HKP;_ (77\8/^B 7G_A46?_Q-'_"Z_C!_T0"\_P#"HL__ (F@
M#WFBO!O^%U_&#_H@%Y_X5%G_ /$T?\+K^,'_ $0"\_\ "HL__B: />:*^8O"
MO[5/Q-\7ZWXHTNP^ MX]UX=OET^]7_A)[4;96ACE Y0 _+(O3-=)_P +K^,'
M_1 +S_PJ+/\ ^)H ]YHKP;_A=?Q@_P"B 7G_ (5%G_\ $T?\+K^,'_1 +S_P
MJ+/_ .)H ]YHKP;_ (77\8/^B 7G_A46?_Q-<UX[_:J^)GP\L=+N]5^ E[%%
MJ.JVFD0G_A)K4YGN)5BC'"'JS <\>I% 'T]17@W_  NOXP?]$ O/_"HL_P#X
MFC_A=?Q@_P"B 7G_ (5%G_\ $T >\T5X-_PNOXP?]$ O/_"HL_\ XFC_ (77
M\8/^B 7G_A46?_Q- 'O-%>#?\+K^,'_1 +S_ ,*BS_\ B:V/V=_CSJOQND\<
MP:MX*F\%WGA76CHDT$VHQWGFRB))&(**NW D3U!R,'J  >PT444 %%%% !6!
MXY\4GP=X<GU)+0WTX>.&&V#A/,D=PB@L>@RPYK?K(\6Z)8^(?#M]8ZE%YMG)
M&6<!BI!7Y@0PY!! ((]*3=E<:U9QNC_$G79/B(F@:OH,=AIUW)/#97:RDO(\
M2!VRI&-I!;##N*])KY:\+^-+[PIJFF>(-1TF76?M%K(]I=7_ (B%S+!;C!?8
MA7Y6((X.">G7BOJ*&031)(N0'4,,^]7:R1-]6/HHHJ1A7.>++B.TU+P[/*=L
M45Y(['&< 6TQ-8'C;XI)X;\;^'O#T C\R\G07<DV0$C?(0+ZL2/P ]Q6WXAN
MRWB?PW;^1, MX[><5'EG_1Y> <]?PH6JN#T=CE+#]H;PYJ$%M(D-XGGZ;<:C
MM>(Y58FVE#_M'DCMT]16]H_Q6T;6]9T#3;=9Q-K.GMJ$!>,@*HV_(WHW)_[Y
M]Q7EWA8#^SM'X_YDO5__ $IAKN/"@_XJWP3_ -BE+_Z':4 >FT444 %%%% !
M1110 4444 %%%% !1110!@>-O&ECX#T9=2U!96@:>.W B7<VYV !QZ#K^%;P
M(8 @Y![UR/Q2_P"18A_["-E_Z41UU] !1110 5SGA3QUI_B_4-=L[-95DTB[
M^R3&1" YV@[E]N2/P]Q71UQ/PX_Y"OCO_L8'_P#26VH [:BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH \S^,GB&PM;6"PN'U*VO(6COK:ZT_R2RN
M&*CY9'4-WR,8QWS6=\)/#UCKFH_\)2;_ %:[OH'F1AJ*PH&DD"!G"Q,P'RHJ
M@9[&I/B9IP\8>.['P[9Z-X?N-033VO)-1UVR6Y*1>9M$<:D9/.2><"MKX0%+
M73]8TIM*TK2[O3;XV]P=&A$5O.VQ6#A0!@X8 @]"*(=7Z_G;_@!+>W]=SOZ*
M** "O&O%/_)V'@+_ +%G5O\ T=:UB?"[5KNY^)Z;]0N[C4YYM275K66=V6%$
MD M_D)PO&,8'()IOB/X+_%K5_BC9^,K3XB>';673[:ZLK*VD\./($@F=&(<_
M:1N8>6O/'?BCHGW#JUV/H*BO%_\ A#OCM_T4GPG_ .$M)_\ )5'_  AWQV_Z
M*3X3_P#"6D_^2J /:**\7_X0[X[?]%)\)_\ A+2?_)5'_"'?';_HI/A/_P )
M:3_Y*H ]HHKQ?_A#OCM_T4GPG_X2TG_R57)?#^?]H#QI/XHCNO%_AO1QH^LS
MZ7"T_A>4_:XXPA$ZYN!\K;B!U^[UH ^E:*\7_P"$.^.W_12?"?\ X2TG_P E
M4?\ "'?';_HI/A/_ ,):3_Y*H ]HHKQ?_A#OCM_T4GPG_P"$M)_\E4?\(=\=
MO^BD^$__  EI/_DJ@#VBBO%_^$.^.W_12?"?_A+2?_)5'_"'?';_ **3X3_\
M):3_ .2J /:**\7_ .$.^.W_ $4GPG_X2TG_ ,E4?\(=\=O^BD^$_P#PEI/_
M )*H ]HHKQ?_ (0[X[?]%)\)_P#A+2?_ "51_P (=\=O^BD^$_\ PEI/_DJ@
M#VBBOF[Q8?C_ .&_$?A/3(/&7AK48M;O9+6:ZB\+R[;)5A>02/\ Z2>"4"\D
M<M74_P#"'?';_HI/A/\ \):3_P"2J /:**\7_P"$.^.W_12?"?\ X2TG_P E
M4?\ "'?';_HI/A/_ ,):3_Y*H ]HHKQ?_A#OCM_T4GPG_P"$M)_\E4?\(=\=
MO^BD^$__  EI/_DJ@#VBBN0^'>D^-=*M;Q?&GB'2_$$[NIMY-,TUK(1KCD,#
M*^XDXYXKKZ "BBB@ HHHH **** "BBB@ HHHH *R]9\*Z+XC:)M6T>PU1H@1
M&;VU28IGKC<#BM2B@#+B\+:-!J%O?1Z391WMO%Y,-PEN@DCCZ;5;&0/85PG[
M2/POU3XQ?";4/"^C7%G:W]Q=V<ZRWSNL06&YCE8$JK')5"!QUQTZUUFO^(9A
M>2Z)IHDAUF6 R07,]I(]JGNS@8SP?ESZ5Y'>>(O%=W\+?#OV76&?5KC4KB.X
MNGO8[1Y4C:7A6<$#H. #P*3=E?\ K<=CW^BOFG3?B9K&JZA9WMMK5_#%;?V5
M'!I]RZ%KL3NRS-)@?.>.",8QFOI:J:L3?6P444C':I)Z#FD,6N=\/^ -#\+^
M)?$VOZ;9BWU7Q)/#<ZG/O)\^2*%88S@G PB*.*X/XG^-M5O/#,&I>'[RYTFT
MMM2MK>Z$]H\,\VZ9%VH6 PN&.2,YZ5SNH^/]?MOB-J;Q:I,_D:P^FQZ+QY9@
M%IY@DVXSG=SN_"E?^ON_S0[?U]_^1] 45XQ\#_%>K:MKT]I>:Q-K5O/H]MJ3
MM,RM]GGD9PT:D#@8 ^7MBO9ZIJW]?(F]PHHJ&\NDLK6:X<.R1(781J68@#/
M')/M2&9'C7P3H_Q"\/2:)KUH+W39)[>Y:$L5S)#,D\1R.>)(T/X5NUX%X_\
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MLU3Q-J6J6$&MZ6;NQG>-HTM6.Y <;P=^#SD''0CFNC^Q>)!_S%+#_P !&_\
MBZY[P'\-+OPCK]Q=SW\5U;(D\=JJ1E7VRSF9BYS@D$X&.U>@$9&#R*.B#JSS
M'6?B++I5B;M?$FDS6\5^+">1;5R(V #2=&YVJ03CBM33_%%SJNM2Z3:>)=+G
MU"-=[0I9OTP"<-NP<!ER 3C(S6-KWP<NKNUU)--O;2T:ZO[FX1'A/EQQ36RP
M,N ?O#:6';FKG@_X4W/A?Q+;71OXI].LQ,UN@0B4M*D:MO.<8'E<8]?:E'7?
M^M"I66P>-K75TETG^U?$.DV^EO<JCV\UHX::;<IAVX?.0X''3GGI5<_$:6VU
M'6+.]\1Z7:R:<^&!LY&+K\JD@!N2'8+@9.<>M=CXQ\+)XJL;6+,4<UO=0W"2
MR)N*[)%9@/3(7%<5KGPNU[6]?U+4YM1TUF:6.33\P/FW5)5<1GG&&*Y8@9)Q
MV %+6X65CJ=,N=9UG38-0LM<TVXLIT\R.=+1MK+Z_?K$N_&UU'X>GUFV\1Z1
M<6$%TMI)/]F8(&\Q4?!+\XR3QG..*Z;P/X5'A/PA8Z+-*MV8482OMPKLS%FP
M/3+'CTKA-;^!<NK:'=V$.M?8 VH75[!'%;HT*^:W 96!Y49 (QU.*;^)KI_P
M1+8Z'2O$MYKVHWFG:=XCTNYOK7/FQ+9N-I!P>2V#@\'&<'BJ%M#J?P^TBXOM
M9UW1[&:_N_.NIA;2%99WVHNT%\YVJ@P .F<=:F\!?#.]\):X]U<ZC%>6\4<\
M=L$C*R$2S>:YD[9!.!BM_P ?^$%\:^')=.#113F2-XYY4W>65D5CCZA2/QI]
MA=SFI/'EQ9ZCK%I>>(M+MFTTYD8V;D%0B$G(;&07QM'/3CD5N:->ZOXATZ*^
MT_6].N;63.V1;-QR#@@@N""".AKBM8^!EY?ZUK5W;:K';Q7LSW2 B1BTA:-E
M61=VTJK1YX /S5Z%X(\.3^&-$-M=31SW4MQ-=3/$I";Y'+$*#S@9Q26RON-[
MZ'/:]XMOM#FN[63Q!I37]K;?;);8VK;DA#JI<_/QRPXZGM4,?Q!25[)%\5:7
MOO',<*M8R@[@VPA@6^3YOE^;'/%6O&?PS;Q+J][?6UQ#9M=:3+IS_NN79I8W
M#,1VQ'M]>>*YBR^!VH6CPA=2M8[>5_\ 28%1V\M!<B=5B8G)Y&"6]:(ZM7_K
M4):+0[Z\&O:?:37-SK&G0V\*%Y)&M&PJ@9)/SUREI\4(GN8WE\3:6+&218DD
M-G(K,^?G4@G*8RGS, /G%>C:K#<W&F745F\4=V\3+$\Z;D5B."P[C/:O(Y/@
MAK-UIJ0SZI8FZG$L5]<K"Y:=)'C=I.6_UF8\#L!@ <4=0['IVA^,-&\275W;
M:;?QW<]J<3(@(V\D9&1R,@C(R,@ULUP/P]^'-WX/U2>XN;V&YBCM196JQ(5;
MRO->7+Y/+9DQQZ>]=]0(****!A1110 4444 %%%% ',^,OASH/CP6S:M:N\]
MMGR;FWF>&:,'J Z$'!].E7O"WA/2O!>DIIND6HM;56+D;BS.QZLS,26)]2:V
M**%IL&X4444 1);0QS/*L2+*_P!YPH#-]3WJ6BB@ HHHH J:M)<PZ7>26:JU
MVD+M"KC*EP#M!_&O"+?]I.]=M/NI+*W&F2:86N9AGY+_ ,IY!%UZ?(1CKR*^
M@J\X?X!^%7T&\T@I="TN=3_M5B)%W++G.U3MX3!(QZ'K2UO_ %_76_JD/3^O
MZ\OQ97LOCEIME?Z=I.LPS17[1P1WMW$J_9H+F2(2",@MO_$*0,C)K)UK]HK3
MV\-ZA?:9:RVTUL8)HVOU79-;O.L;2#8Q(QDG#8/0XKJ[[X/:)?\ BMM<::\C
M:1TDFLXI0L$SJFQ688W?=QP& .!D5FV_P"\/PZ9=Z<]WJ4]E/Y2I%)*F(4CE
M$BHOR<C( );)QQFGOK_7]?IYBV_K^O\ AS7G^)EO+\-]2\7VEE<?8[>"6:W6
MX"J;A5SM<8)PK'IG!QVJ'X8>-]3\43:SI^LPVT>HZ:\)9[3=Y;I+&)%X/.1R
M#]*U+#X>Z58>&=3\/KY\ND7[3%K:5QB%9/O)'@ JN22!S@GK1X%^']AX"M;N
M.TN+N^GNY%DGN[Z022OM4*@R !A5  &*:M=^B$]EZG3T444AA1110 5'<%UM
MY3%CS IVYZ9QQ4E%)@>#VG[0]V-1T=;JUMTL1:2'5IUS^XN090B#GC)A/7U%
M=!H/QXLB^CZ?K%K,FI7,5L;N>!5%O;23\Q(=S;CD8R0"!D9K0O/@'X6O=)U_
M3W%VL.M7JWUPZ2*'1P<@(=O"\G@Y^\>:O7?P>T2Y\4PZY'->6LJ^3YMM!(%A
MG,0Q&6&,\#@@$ X&::\_Z_K;Y!+R.;U7]H739]%UZ32;:9;RSM);NSDNU7R;
MM8W",R[6+  GHP4X.:[?PIXXA\;:%=ZEH]O)/%$SQ02RE4CNG4<E#DG;NXR0
M*YRW^ GAZWMM5M5NM1^QWT#VRV_G*$MT=MS!!MZY[MNP.*Z?1_ MAH%EJUII
MTUS9V^HL7:.)U @8KM+1?+\I.,]^>:7V?.WXCZZ;7_ \SU'XT>(/#FGZJNJ6
M^F2W<-Q:VL=Q9B1X(9I=Q>-\9+F,+D[>N17I7P\\2R^+/"EKJ,\]E<S.SH\E
MAO\ +)5B/NNJLK<<J1P>*YC3/@)HVE:!<Z0FL:[<6LDB3P_:+Q6-K*C%A)%A
M %;)Y)SFNQ\'>$;+P3HBZ;9//,GF//)/<OOEED=BSNQXY)/852ZW_K^M27Y&
MW1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !UK'O?!^A:EI:Z;=:
M-83Z>KF06LELAC#DDE@N, DDG/N:V** ,A_"&A/?65ZVC6!N[)!';3_9DWPJ
M.@0X^4#L!6O110 45RGB_P")6D^#;R&SNH[Z^O98VG^RZ=:O<2)$.#(P4?*H
M]34VF_$30=6OHK6"^7?-:1WL;R?(KQR$A<$X^;(/'6A:[ ]-S<O]-M-5M_(O
M;6"\@W*_E7$8==RG*G!&,@@$'L154^&=(.M?VP=+LSJNSR_MOD+YVWIC?C/3
MBK1U.S%V;4W4 N0NXP^8-^/7'7%-CU>QE$I2]MW$0W2%95.P>IYXH @T;PUI
M'ATW!TO3+33C</YDQM8%C\QO5L#FM*J1UG3Q;&X-];?9UP#+YJ[1GISG%,U?
M7+?1K&.[E66:*22.)?LZ&0DNP .!VYY/I0!H456CU.SFN3;QW4#W !)B60%L
M#@\9S2RZA:P7,=O)<PQW$GW(FD 9OH.IH I:CX5T;6-0MK^^TJRO+VU.8+B>
M!7>/_=8C(IUEX9TC3=4NM2M-+L[;4+K_ %]U# JR2_[S 9-9FD_$+2=:U(V5
MJ+EG6>YMFD:$B-'@($@+=!UX]:VH]8L)8'F2]MWA09:195*J/4G/%'2X>1<H
MJH^KV,5ND[WMND#C*R-*H5AZ@YI!K%@T<T@O;<I#_K6$JX3_ 'CGB@"Y151]
M6LD2-C=P8E&8_P!X/G]-O//X54TKQ1I^JZ?97:R_91>#,,-W^ZE;G&-AYS0!
M)IGAK2=%N[NZT_3+2RN;MM]Q-;P*CRGU8@<]3U]:TJKWE_:Z?&)+JXBMD)VA
MIG" GTR:?+<PP0&>25(X0-QD9@% ]<T 2T56AU*TN45XKJ&5&4N&20$%1U/T
M]Z:NK6+S)"MY;M*_W8Q*I9N,\#//% %NLB/PCH<.JW&IIH]BFH7*E)KH6Z"2
M13U#-C)SW]:FO=?LM/U2ST^:3;=72R2(H' 1!EF8]@,@9]ZE75[!XII5O;=H
MH?\ 6.)5PGU.>* (]%\/:7X;M6MM)TZUTVW9RYBM(5C4L>IP .:T*RK_ ,3Z
M;I\5I(]RDB7,ZV\;1$."Y!/)'0  DGTJPNMZ<[!5O[9F+! !,O+'H.O6@"[1
M6+I/BVPUNRU.ZM/-DCT^XFM9AY>&\R(X<*._3CUJ]H^K6NO:7:ZC92B:TNHU
MEBD'=2,_A]*-]0))]/M;FZMKF:VAEN+8L8)GC!>(L-K%2>5R"0<=0:SH/!N@
MVLFH/#HNGQOJ (NRML@^T ]0_'S ^];-% %+2-%L- L4LM,LK?3[1,E8+:,1
MH">O XJ[110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !116#X
MXTF+6/#%_%+-<P".)IE>UG:%PRJ2/F4@X]JF3Y5<:5W8WJ*^>="U>Z\,^ OA
MYJL5Q<WM[JLC37+WMW-("RVTK<#>!C*C@Y'MGFIT^+_CA=-_M"7^P_)72[/5
MVC2VER8Y7"&($R=><[OPQWJVK-KL[?J3T3[_ .=CW^BO&_"WQCUK7OB0VDR6
MEG'I37UQ8+#D+<1F)-WF$E_FR1]T)P"#D\T_Q9\0=5\/>*O%6IQA9--T V$$
MULX8C[/+\TTJ@$?,-PP3D80\5/9OJ/NET/8:*^>X/VB/$,VA:M=_V1:+<Z5:
MM/<HR.%4R2*+8_>Z;&+-ZXX(J:[^./B>#2[6!8M,&H/>7$#7Y0&!DBB20 H)
MOD8[\'+\ $XI[*X=;'OU%?/OAWXM:Y/\0 KPQVUEJJZ>9IYW,UM:%H9&,:%6
MQND(X;...<\46'Q<U[Q-H_B>VU"XL;2[@TZ34K%M.!( CDZB4.RR+]T'.T\G
MBAZ?UV!:_A^)]!453T>\;4=(L;MT\MYX$E93_"64''ZU<IM6=F).ZN@HHHI#
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S[Q-X:\1V/C:7Q
M)X=BL;Z2ZT\6$UO?2M%Y95MRNI"G(Y.5[^M<YXE^$>L^)/[2N;X:=>:E-HD-
MG#.%\M4N5D+,RC!VCD8(KV2BETM_77_,.M_ZZ?Y'@UY\(O%=[\15UN3[$+>.
MX<JT4B1[HFMS&-P$>]GR>2SD8Z 5D^+?A%?>&?!B7(BMH(K71;:WODME=_M$
MR7"NP<*N60C(+8X';%?1]%/9:#W=V?,/A_P-JOCO3]5U/1[2WL[0:[]ICM(0
MJPS)]G5#Y?G1,IPQ[IC.<8KU*;X=:G_PJW0_#T<B/>V=Q:RR&:;< J2AV 8*
M,X P/E%>F44[VV\OP)MW\_Q/(?#WPDO]'\3Z-JWDV<<T&JZC=74T;?.\,Q/E
MKG'/;([4WQA\+]9UGQ5JMQ;VUE/'J%Q:30ZI-*1/8+$1N5%QSG!Q@C[QS7L%
M%):6\AO6_F> :W\(]=M(]6OI)HHX,ZS-O@9GE"W&#'A0,DX!R!^M<YX8\+7G
MC^[U"[T?3+""TM6TV22QCWI:WABW[XF9D')R"?EP"!FOJ*BA:6\K?@-ZW\[_
M (GANG_!/4Y7@>_MK VQDU&<:=OWQ6AG0+%&F1@@$$D\8)XK+OO@'KR6<"V'
MV2V"6.GI-#%(H%Q-#(S29W(RG((P64@XY%?0U%';Y?A_PXOZ^\\8\(?!F\T_
M6M!O-5A@N8;"UNL1SR)(T,TDH=-H6-%P,'H!@]*S?#?P>U_P])IINM*TC7<6
M%O:G[9,=MD\<K,S)\N2"&!XP<@5[S10M'=?UO_F#UO?K_7Z'C'Q/^%7BOQ.L
M4$&LC6;.26=V2\B@BDM0RX18W\IOE!//&X@#FKFH?"W7[[X>II-SJTMZPTRV
MM?[)\Q(H8YH_+)D2;86)^0X#94[N17K=%*VEAWU3/F36?!.O>&]&\-Z29H4\
M27U[<V216L(R;"<8D:1HT5=RD!BV!SZUV$?P2O+/Q ;ZU@LD\KQ#97T$N[$B
MVD42HZYQP3M/R]#7M=%4G9W_ *Z/]/Q8O+^NO^?X(\K^*%A/'XAO;SRWE@N?
M#-]9QE5)"R@%\?5A_P"@UYA=> ]2TWPI;>([K3;/3-.BL].233X=\B7QCDWL
M\X5,J"" >#CO7U'14I6V_K5O]1MWW_K;_(^?/ ?@_4/%^@ZG-;6EM9:9->:E
M/;QH66-I)($BB*94$H,R<X'L*GM_@%?6UBXCM-.2Z73M-ABD5L%;B%\S/G;P
M2 .>IKWRBJ6FWE^!+U5GY_B[GF7A#3/%'@F[UR.YTRPFT6YU.ZU!KQ;P^:D3
ML6_U>SDX[9K7^#6DW6B_#G2H+Q&BFD\VX$3<&-9)6D52.V%8#%=M126BMZ?@
M-ZNX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-=
M%D1D=0R,,%6&01Z4ZB@"B="TTV]M;G3[4P6W^HB\E=L7!'RC&%X)''K2?\(_
MI9B,?]FVGEF)82GD+CRU.53&/N@]!T%7Z* *$6@:9!JCZE'I]JFHNNQKM85$
MI7T+8SCBJTOA73YM9N]2DA$DEY;+:7,+@-%,BDE=RD<D;B/H:V** **Z'IR+
M<*NGVJK<H(Y@(5'FJ!@*W'( XP>U56\':"^F)IK:-8-IZ/YBVIMD\M6]0N,9
M]ZV** *+:%IK[]VGVK;RA;,"_,4^YGC^'MZ=JS+_ , Z%>V-_;)I\%DM_C[5
M):1+&\PSDAB!R#W^IKH:* &HBQHJJ,*HP .PIU%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M OQ8UN?2/#&L/J%_#;M=/$UI-%B,,JDY= .KKQUYK\HJ^G?^"?'_ "6?6O\
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MQQ1976O5?=?<+O7T?W]C9B_:#\.'2-3NKBQUFQO].O(;&;1KFR*WIFF&855
M2#O&2#NQP<D8KJO!'CFT\<V=W-!8ZCIEQ:3FWN++5+8P31/@-R,D$$$$%21[
MUYQXK^$VMZIXD\?:A'INBZS8ZW)I;16&J.X$J6Z.LHW+S$^6!5QG&.E;_P %
M/ FM^!X=<74I#:Z==W"/8:.-0EOEL4"8<":3YCN/.WH,<=:4=;W_ *V_X/\
M6[EI:W];_P# _K;TNBBBD 4444 :6D?=E^HK1K.TC[LOU%:- !1110 4444
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M#LW;CZ_.,5I+J;G6GL#9W"QK )OMA \DDMC8#G.[OTZ5\T> 9_AY/\?O O\
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M %=PSM(JK6NNS(4KJ+[GH-%%%24:6D?=E^HK1K.TC[LOU%:- !1110 4444
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M0E1V+7>(8G!DR?F())!/3-3'WE_7>2_0<O=_KR7^9[9J?C#3=*\0V.B3R/\
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M1HUXRE*.B[GU)7/2??;ZFNAK.;2=S$^;U/\ =_\ KU]2?SL9M%:/]D?]-?\
MQW_Z]']D?]-?_'?_ *] &=16C_9'_37_ ,=_^O1_9'_37_QW_P"O0!G45H_V
M1_TU_P#'?_KT?V1_TU_\=_\ KT 9U8,G@^TD\<1>*#++]NCL#IXCR/+\LR;\
MXQG.?>NO_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>CK<.EC.HK1_LC_ *:_^.__
M %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.HK1
M_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\
MCO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__
M %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.HK1
M_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\
MCO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__
M %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.I"
MP((R#P0:TO[(_P"FO_CO_P!>C^R/^FO_ ([_ /7H RH+>*UB$<,:11KT1%"@
M?@*);:&=XWDB21HSN1F4$J?4>E:O]D?]-?\ QW_Z]']D?]-?_'?_ *] &'J]
ME-J.EW5K!>2Z=--&42[@"F2(D<,H8$9'N"*S?!7A"T\#>'+;2+.26>.)GD>X
MG(,DTCL7>1R !N9F)Z5UW]D?]-?_ !W_ .O1_9'_ $U_\=_^O0!G45H_V1_T
MU_\ '?\ Z]']D?\ 37_QW_Z] &=16C_9'_37_P =_P#KT?V1_P!-?_'?_KT
M9U%:/]D?]-?_ !W_ .O1_9'_ $U_\=_^O0 ND?=E^HK1JM9VGV4,-V[=[8JS
M0 4444 %%%% !4-[_P ><_\ US;^535'<1F6"1!@%E*C/N*B:O%I%1TDCXHH
MKU+_ (9V\2?\_NE?]_9/_C='_#.WB3_G]TK_ +^R?_&Z_C#_ %/S_P#Z!)?A
M_F?OW]NY9_S_ $>6T5ZE_P ,[>)/^?W2O^_LG_QNC_AG;Q)_S^Z5_P!_9/\
MXW1_J?G_ /T"2_#_ ##^W<L_Y_H\MHKU+_AG;Q)_S^Z5_P!_9/\ XW1_PSMX
MD_Y_=*_[^R?_ !NC_4_/_P#H$E^'^8?V[EG_ #_1Y;6WX&_Y';P__P!A"W_]
M&+7;_P##.WB3_G]TK_O[)_\ &ZT?#?P'U_1_$6EW\UYIK0VMU%.ZQRR%BJN&
M(&4'.!7;@>$L]IXJE.>%DDI1;V[KS.?$9WETZ,XQK*[3_(]XK&U+_C[;Z"MF
ML^[T^2XG+JR@$#J37]BGX.<9:>"[.S\<:CXI268WU]90V,D9(\L)&SLI QG.
M7.>?2N@J[_9,W]Y/S/\ A1_9,W]Y/S/^%'2P=;E*BKO]DS?WD_,_X4?V3-_>
M3\S_ (4 4J*N_P!DS?WD_,_X4?V3-_>3\S_A0!R'C+PC-XJBLC:Z[J6@7=G*
M98[C3W4;LC!5T8%77V(X/(IG@7P-;>!K"\ACO+K4KN^N6O+R^O"IEGE8 %CM
M  X50    *[+^R9O[R?F?\*/[)F_O)^9_P *%H&Y2HJ[_9,W]Y/S/^%']DS?
MWD_,_P"% %(C(P>E87@[PC;>"M/N-/L9I7L'NI;F""3&+<2-N:-,#[NXL0#T
MW8Z 5U7]DS?WD_,_X4?V3-_>3\S_ (4 4JY7QAX)NO$M]97MAXDU7P[=VR/'
MNL'1HY5;&0\<BLI(QPV,C)YYKM_[)F_O)^9_PH_LF;^\GYG_  I <IX)\'6?
M@3P]#I-E)-/&CO+)/<MNEFD=BSNQXY+$G@5O5=_LF;^\GYG_  H_LF;^\GYG
M_"F!2HJ[_9,W]Y/S/^%']DS?WD_,_P"% %*BKO\ 9,W]Y/S/^%']DS?WD_,_
MX4 <II_@ZUL?%VJ>)'EEN=1OH8K53+C;;P)DB- !P"S,Q)Y)/L*WJN_V3-_>
M3\S_ (4?V3-_>3\S_A1Y!YE*F31F6&1%=HF92 ZXRI]1FM#^R9O[R?F?\*/[
M)F_O)^9_PH XOP-X%A\$P:@QO[K5]1U&X-U>:A>[?-F?:%4$*  %50  .@KI
MZN_V3-_>3\S_ (4?V3-_>3\S_A0!2HJ[_9,W]Y/S/^%']DS?WD_,_P"% %*B
MKO\ 9,W]Y/S/^%']DS?WD_,_X4 4J.M7?[)F_O)^9_PH_LF;^\GYG_"@#-M[
M6&T0I!#'"I.XK&H4$^O%2U=_LF;^\GYG_"C^R9O[R?F?\* *5%7?[)F_O)^9
M_P */[)F_O)^9_PH I45=_LF;^\GYG_"C^R9O[R?F?\ "@"E15W^R9O[R?F?
M\*/[)F_O)^9_PH I45=_LF;^\GYG_"C^R9O[R?F?\* *5%7?[)F_O)^9_P *
M/[)F_O)^9_PH 9IO_'VOT-;-9]II\EO.'9E( /0FM"@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK_P#ZDJH=3A!(^;CVJW7/2??;ZFOL#\L-7^U(?\ :_*C^U(?]K\JR** -?\
MM2'_ &ORH_M2'_:_*LBB@#7_ +4A_P!K\J/[4A_VORK(HH U_P"U(?\ :_*C
M^U(?]K\JR** -?\ M2'_ &ORH_M2'_:_*LBB@#7_ +4A_P!K\J/[4A_VORK(
MHH U_P"U(?\ :_*C^U(?]K\JR** -?\ M2'_ &ORH_M2'_:_*LBB@#7_ +4A
M_P!K\J/[4A_VORK(HH U_P"U(?\ :_*C^U(?]K\JR** -?\ M2'_ &ORH_M2
M'_:_*LBB@#7_ +4A_P!K\J/[4A_VORK(HH U_P"U(?\ :_*C^U(?]K\JR**
M-?\ M2'_ &ORH_M2'_:_*LBB@#7_ +4A_P!K\J/[4A_VORK(HH U_P"U(?\
M:_*C^U(?]K\JR** -?\ M2'_ &ORH_M2'_:_*LBB@#7_ +4A_P!K\J/[4A_V
MORK(HH U_P"U(?\ :_*C^U(?]K\JR** -?\ M2'_ &ORH_M2'_:_*LBB@#7_
M +4A_P!K\J/[4A_VORK(HH U_P"U(?\ :_*C^U(?]K\JR** -VWNDN0Q3/'7
M(J:L[2/NR_45HT %%%% !1110 4R:00Q/(1D*I;'TI]07O\ QYS_ /7-OY4
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M[0P'55"E<GTR3^AKYRKFQU*%#$3ITWHCIR7%UL;@85JZ]YW^=GN%>Q?LM_\
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M/*^A?VF3NT#1#ZW#'_QROGJLT]6:-:(*WO /_(]>'/\ L)6W_HU:P:WO /\
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MW.@ZM96%_>"QM]1N8E2-Y22%!7=O 8@X)6KGPMUR\\0>%Y;N_F\^=;^\A#D
M?(D[JHX]  *\SM_@1XD;5M$O+M]$N+K3-6BOI-5DGN);N\C63<0=RE8CM[+D
M$@#(%>J_#[PM<^%/#LNGWDD4LCWEU<;H"2NV29W4<@<X89]Z=)U6[R7?]/\
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MJ[W][2VBM;EUNM>O1=)!\9-,O='TVZL]/U"[O]0N9K.+2HXU^T"6(D2ALMM
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M  !; YK \9_#7QSK6O:IK^G^'H3=7&MZ%JL-E=7L0&VVAQ,K,"<;6^7(!SU
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M>P>N_P#6B7Z+[D>7WGPQU+7-0^*\$X6RMO$MO#;V=WO#9Q;E"2 <@!CW_"N
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MT44UHD@>K<@HHHH **** "BBB@ HHHH TM(^[+]16C6=I'W9?J*T: "BBB@
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MA2>I]*:WU_X;5?I<;VT_K1_\ ^A;[QUX>TRSU&ZN]8M+:VTZ86UW)+*%$,I
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M[2VS6WEO $ !9&SG<?[GZUV8/+<52Q$)SCHGW1Y6:Y_E^)P56C2J7E)::/\
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M_9#_ //1?RH_LA_^>B_E0!0HJ_\ V0__ #T7\J/[(?\ YZ+^5 %"BK_]D/\
M\]%_*C^R'_YZ+^5 %"BK_P#9#_\ /1?RH_LA_P#GHOY4 4**O_V0_P#ST7\J
M/[(?_GHOY4 4**O_ -D/_P ]%_*C^R'_ .>B_E0!0HJ__9#_ //1?RH_LA_^
M>B_E0!0HJ_\ V0__ #T7\J/[(?\ YZ+^5 %"BK_]D/\ \]%_*C^R'_YZ+^5
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>aciu-20221231x20f019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ", B$# 2(  A$! Q$!_\0
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M$[4^\H./NC]:BDU"/3X$\^<*Z_>088@'HO';WK&4YO2[%S/H5AX4T&':ITV
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MSDAI8P"X(^X@'8' 'K5K_A'-*NU406-NWJ8R,=,_SJTZS*8I8I5#.X!B5LY
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M#_3VJ762VO\ >5S,X^[\.0)%)Y>C%I(RI^51AO7'M_+%03:99Q>2%TV&5G/
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M4]\;52Z31/ME)5MA#*=JJ3QD]<#.,8K8\/Z3#8Z59V4:QR:9;PC[-$1DQ1]
MN<_,"!U/-<^'Q+@W8JI Z:VNH;VT7:-\##Y!,I92,=L]13!K5MIWRBWF>R&
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M@GH-^, 5W9O86M49I(Q-<R*CRPL<, >.>W ^G6F:KH:7^CQPS?OHU0;9-H#
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MM&,NT;XR'X)'8^W/]:RM2\2V6GKO,ZRQ']WY2@<'_(-<=K'Q DE(54^SV[L
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M]J(8,M&[ M(IY4+N"YZ<')XJY.)#:@)*KP$_,%&3CL.O/3FJHMXHK@F E-J
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MIX6E&2E5E?T_K<N4U:R,#POK]AJCP:_JUKI][IL\C".^CMP!9N&X(?HRMU)
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MR$G85;:A/7;\W&>]"H5%U"W0[S2/$.HZ+!_I,27]NI)EE@D#29)P/E QR,'
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>X2,9!YQUXK9TI+2XXTFI7;(=Q]#^=%&**] [#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>aciu-20221231x20f020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f020.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ". G # 2(  A$! Q$!_\0
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MWF(895E960=B 00>"* .7F_:'T6TFM4N=,OX?M,5S/&N8F?RXEF(<J'.T/\
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M[S]HO1=/A9I]+U!)=I1(AY;&6<7)MVBC*L0^UQDL/E"D'/-=1X$\;2^+[W5
M]M+:P1QVEU;QW$?ES)'-"&V2+DX<,&_ CZF<P>&#%Y9T6,Q^0+;9_9#X\D'(
MCQY?W<\[>E3:;<:)H\MU)9VEQ;O=,K2[+*;!VHJ* -O "JH ''YF@1T14$@D
M D=#Z4M9?_"267]V[_\  *;_ .(H_P"$DLO[MW_X!3?_ !% #?%7_(OWO^X/
MYBM:N;U[68+_ $BYMX(KN2:0!57['*,G([E<5TE 'D?[0L=S:Z9HFJ6K1QR6
M=T3YTZ221Q$J<,RJR@+GAF)X!/!S7J>FR7$VG6LEVD<5VT2M,D3;D5R!N /<
M9S7G_P 9FTU(M"CU.UDN8+J\^S;OM'EQ(2#]X;'R3T!"C&?O"O1+6VCL[:*W
MA79%$@1%SG  P!0!+7D^LVHC_:(\+3^0R%]/U$>:;1$#_+;<>:/F?Z'I^%>L
M5Y?KUL(_C[X0F^Q3Q%[#4A]J>?=')A;;A4W':1Z[1G'>@#U"BBO"?CS\4+7P
M9\7?A!HDEWJJSZMJ<R_8M/G6.*X&P(@FR06 E>,XSC ;K6=2?LX\UK[?BST<
MOP4\PK^PINSM)_\ @,7+\;6/7?$/B_2O"T^F0:C<-%/J=P+2TB2)I'FE()V@
M*#V!))X %6-3U1]/O-.B\N-HKJ5HWDDEV%,(SY QS]T]Q7R!^W%X^\5^#/$O
MPBU1D&G:='J[2O;Z;=&2\9@8U; V ']VS@ 9SNQZ5]$ZCX2\+ZYJ_A'5E#:N
M))VN;:ZEO&G1T:-V# ,Q!&67&!T/I65Z\N:2C[MTD_NOW?WI'M5<LPF&PV&K
MU:FM2,VTM4G%R2UO%=%LWK]QH^(/B9HNG:SH5G%K43/>7?D-':Q&X+YC+*,H
M#MR=O/\ M"M;_A-+1EW1V.K2C&?ETV<=B>ZCTQ]2!W%6[W3K=)]*$<MO9I;2
MDQPF-</\I7:O(QP>U:M6HU+MM_A_P3QJE3"<D%"#NEKJM[O^[VMU9P'BCX@Q
M6=WH49TOQ GVC4%A_<6C*"-F?GY'RY(_(^AK>'B\D_\ (#U@=.3:C_:_VO\
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MNWF:8(89!R/:EK"D\#:!(^[^RK>-L@YB7RSG);^''=B?QIB>!M+AB"6[7UJ
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MZ:]&KQW6K35%_:4T&5)4GTW^SG9XRZK)#E91P#RR$KR>QZ=3GO?'.JZ]I5C
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MB7P]XT^'_A[&AZ];>(+*QL]JV>OPXFPB<;;B%1GIT:,Y]17 _'[X66'B;5_
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MK&H^#+J*V\;:S9R&:)@P@BDX\W.-L<:M_$._1!GN:ZN'PSK\%M%''XON9&1
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M"NK76@I?WR^&[\:E$RQRH\$TSCH@*X!SG[W(]Z[*XDBLHY#%XF$8P3MNGBD
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M17.>+](U!IM$\K5F^2^1CY]BLY*X.>5 QVY./K3Y'CLG7&F:_IV.IM6\Y/\
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M6/\ ;M;_ .@3:_\ @<?_ (W1]NUO_H$VO_@<?_C= &Q16/\ ;M;_ .@3:_\
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M;P2FW@NG"QS,I21]_(8H$1@RKU5CG@8I-V&>D45S'AFZT[PQX-TW[3K5K-:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>aciu-20221231x20f021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f021.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &= 9X# 2(  A$! Q$!_\0
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M<Y]778__  .OSS^&?B3P[\7+;Q')\9/C7XP\ ?&HWTZ007<SVUE:.&_=!1C
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MUWT].FXGB_P+';?%:Z\(Z)%<!DOAI\0O"%=WW;=Q] 3R/;%?27B_X5:!X*\
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MX1_#3Q%XG\&^,K_Q4NI>"M2\5ZXVJK:Z;?&.ZLX0B(B-+&?O$)D@''-<//\
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MH[Z6UTO;8]=^-WAG1)_!?Q M[?1K/33X1U.SMM/FMX@CO'(H5D8_Q<_-6?\
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MA\+O^Q?U7_V2OH"OG_QW_P GH?"[_L7]5_\ 9* /H"L/Q1X3M?$T$9=FMKZ
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M HHHH **** "BBB@ HHHH **** (KK_CVF_W#_*O&_V+_P#DU7X8?]@.W_\
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M\>TW^X?Y5XW^Q?\ \FJ_##_L!V__ *#7LEU_Q[3?[A_E7C?[%_\ R:K\,/\
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ME64=LLK#: 6" 9('K7U'7S_X[_Y/0^%W_8OZK_[)0!] 4444 %%%% !1110
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M&_V+_P#DU7X8?]@.W_\ 0:]DNO\ CVF_W#_*O&_V+_\ DU7X8?\ 8#M__0:
M/::*** "BBB@ HHHH \5_:I;7K/P=H>J:3'=7>G:;J\-WJUA83>3/=6RJV$5
MLC^/82,\@5XS^SIH&IVGQ>\-:BUU-_;6HZ=?:GXGGDU'SHYY)I$:"V2/>1F$
M!@2H& 1ZU[%^U'X2G\::/X2LT@75K"VUR"YU+0O/$;7]KM96&,C(4LKD?[->
M$?LN^![70OCC86?A[PG!IW_".V^H66L:Y%.DL5[$\B&UV88D-@/GIZ4 ?5WQ
M?\:>%_"'@ZXB\5SLMAJX;2UM85+S732J5,<:KR3M+'CH 37S/\1?!WB/PSH'
MAKX3^.?'>GI\,]<*:6MVNF2+<O;(T8CMII?]7&TG";N_.!FO8?VC/"NN-KGP
M_P#'V@Z5)XCG\&WUQ<3Z)"0);F&>'RF://&]."!W!:O-OC%\0=6_:?\  ^H?
M"[P]X$\0:5=ZYY,5YJNLVPMXM+B$JNTW)RS#8=N/XL4 ?6D4:Q1(B<*H"CZ4
M^HX(_)ACCR6V*%R>^!4E !1110 5\_\ CO\ Y/0^%W_8OZK_ .R5] 5\_P#C
MO_D]#X7?]B_JO_LE 'T!1110 4444 %%%% !1110 4444 %%%% !1110!ROP
MW_Y%^Y_["5]_Z525J>(O#&G^)[58;V++QG=%.AVR1-V96'(-9GPX&/#]S_V$
MK[_TJDKJ: .%CUS5_ TBP:[NU+22<)JL:_-&.PE4=/\ >'%=I:7D%_;1W%M*
MD\+C*NAR"*DDC2:-D=0Z,,%6&017%77A2_\ "L[7OAAQ]G)+2Z1(?W;^I0_P
MG]* .WHK"\-^+[/Q$K1*&M;^+_764_$D9^G<>XK=H ^6/CK\$V^+0\7:A#?"
MUO\ 1+@RQB7)1XQ%N9?;I5G]E[]FO0M-\$Q:YK]O;:W<ZQ$DT<<B$K GI]:]
M.;_CS^*?^Y)_Z3FM?X&_\DA\)?\ 8/C_ )5\Y/+L+/,U7E"\G%OYW2V]#Y:I
ME>$J9LL1.%Y.+>NUTTKVVV'_ /"E/ O_ $*^G?\ ?JC_ (4IX%_Z%?3O^_5=
MM17L_5,/_P ^X_<CW?J6%_Y]1^Y?Y'$_\*4\"_\ 0KZ=_P!^J/\ A2G@7_H5
M]._[]5VU%'U3#_\ /N/W(/J6%_Y]1^Y?Y'G/B#]G_P #:[H=_IZ^'[.S:YA:
M(7$,>'C)& P]Q7SC\%?V2O[.^+FHOJNJ17=IX9NX6\N-"#.S)YB=>@'&:^U*
M\Z^'W_)2_B3_ -?=G_Z3BO'QF5X.MB*$Y4U=/IIT;Z>:/$QV48&MB</4E25U
M+II]EO6V^J1Z+1117T1].%%%% !1110!%=?\>TW^X?Y5XW^Q?_R:K\,/^P';
M_P#H->R77_'M-_N'^5>-_L7_ /)JOPP_[ =O_P"@T >TT444 %%%% !1110!
M^>7[2FM:?/XN^-XU^/67\400VMOX3EM+:X;R4\M2YB9!M!)+Y-=U\#K[P8/C
MU\/X_AYIMWI\)\-W<.O-]AF@2653 8S(74!GR9.>O)KZ8^*_Q)T7X7:597NH
MZ=/JM[J-TME8V%C LEQ=3$$A%S@=%)Y(Z5D_#SXJW?B_Q"+";X<^(/#">4S_
M &[4H(4BXQ\N4<G)SZ=J .E^(?Q.T#X8:=:7>N7+QM>SBUM+:"-I9KF4@G8B
M+R3@$GT KQ+5_C#X2\(?M.:[K5WJM]+91Z58>'-0DBM6:RTVZ,\LJ>=+G"LP
MN(U(QQD9-=I^T#\/O$^O:WX%\9>#[>SU/7/"5W<3)I5_(8XKJ.>'RW^?!VLN
M 0<>M>"?$;X9ZUX/^ ]_X,\0WNBZ???$G6;G5/%_B"XO5BCT[S9XG*0JWS2M
ML C3'0H#0!]O@@@$<@TM1VZ+%;Q(IW*J@ GN,5)0 5YS\7/C/:_"F?0+,:-J
M'B+5M:GD@M-.TM5:9MD9=W^8@;0%ZUZ-7S)^U+9?#V7XD>![SXB3:YI&GP6U
MW';:O8SR0VD;N%!CE:/Y@S#..W6@#W/X>>,;OQQH!U&\\/:CX:E\UHQ9ZFJB
M4@8^;Y21@Y]>U>3^._\ D]#X7?\ 8OZK_P"R5@_LX0^*O$/PX\8VWA?Q+?6^
MAKKC+X9UC7(&N)6LPJ[AB3!9-V0I-9]MH7BW0_VQ?ARGBSQ)!XCGDT+4S!)!
M9"V$2X7((!.>: /JZBBB@ HHHH **** "BBB@ HHHH **** "BBB@".&".W0
MK$BQJ26(48Y)R3^)J2BB@ HHHH Y_P 2^#K3Q!MG5FLM2C_U-[!PZ'W]1[&L
MBU\8W?AF86/BE!"@XCU5!^YE_P![^Z:[>N=^(7A^7Q1X,U73(-HGGA*Q[NF[
MM0!YK8^-M$U2/XD06VH122W<,KP+G'F*(""179_ W_DD/A+_ +!\?\J^:_"?
MPW\0#7+SS--N/*L-\5WY6"Z!D(X&>3@YQ7U#\+HM.L/ ^DZ;IMY]MAL8%MR[
M#:X*]F7L?:N-TY?654Z<K7SNCA=*7UM5>G*U\[IG64445V'<%%%% !7G7P^_
MY*7\2?\ K[L__2<5Z+7+^&?"D^B>+/%>JR2H\6KS02QHO5 D00Y_&N2M"4JE
M)I;-W_\  6OU..O"4JE*26BDV_\ P&2_-G44445UG8%%%% !1110!%=?\>TW
M^X?Y5XW^Q?\ \FJ_##_L!V__ *#7LEU_Q[3?[A_E7C?[%_\ R:K\,/\ L!V_
M_H- 'M-%%% !1110 4444 ?//[:LKV_@/PS-)?W.CZ='K]NUYJNG0&6]LH]K
M_O( %;#9P"<'@FLS]G_Q)X>U7QVL.F?%SQ9XTN/LKG^S=8M#'#C*Y?/DIR/K
MW-=3^UIJ%_I_@/2"+J^T_P ,R:K"GB&]TLL+J"QVMN:,J"P&X(&*\@$UYO\
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MZ$5X)X[_ .3T/A=_V+^J_P#LE 'T!1110 4444 %%%% !1110 4444 %%%%
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M@FAVA!.\F0,HS# )YS7UA7FWQ/\ @AI_Q&UW2?$$&JW_ (<\2:9&\-OJFFL
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M'_8#M_\ T&O9+K_CVF_W#_*O&_V+_P#DU7X8?]@.W_\ 0: /::*** "BBB@
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MB[X5\5^$OBYX4^)WA3PS)XM>UTN?1=2TJVG2*<QR%721"Y"G:R8(ST-?0%%
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M?$)]:N;"^T]%O+FWFTQ8([L6Z#:Q20ABBC(QSR#6I\5/!/B3X@^+O#_CK1O
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M*9^(7_16;_\ \ (_\:]KHH \4_X4S\0O^BLW_P#X 1_XT?\ "F?B%_T5F_\
M_ "/_&O:Z* /%/\ A3/Q"_Z*S?\ _@!'_C1_PIGXA?\ 16;_ /\  "/_ !KV
MNB@#Q3_A3/Q"_P"BLW__ ( 1_P"-'_"F?B%_T5F__P# "/\ QKVNB@#X[_:#
M@^*/PA3X<FP^)EW>_P#"2^,],\-S^98I^ZAN2X:08/4;17K/_"F?B%_T5F__
M / "/_&N(^,WQ=\8Z9)KGB:Z^'MC??#WP3J)N99]3EVW<K6^-UU;(>/EW/M[
MG''6MOXD?M$Z_HWQ?U3P5X:L]"E&F:?8W-Q/K&H"W)FN6GVQ(.Y"0AC_ +XH
M W/^%,_$+_HK-_\ ^ $?^-'_  IGXA?]%9O_ /P C_QKU_1IKNXTBQEOXXXK
MYX(VGCB;<BR%06"GN <X-7* /%/^%,_$+_HK-_\ ^ $?^-'_  IGXA?]%9O_
M /P C_QKVNB@#Y?^-/A'XE_#3X4^*/%-G\4KRZNM*L7NHX7L8]KLO8\UT'A7
MX7_$;7O"^CZG+\5KZ.2]LX;ED%C'A2Z!B.OO61\1/CEXITGQ'-:Z[X-L7\ 7
M.IKHQBNI\WEV'8+YJ1?Q)D_D#5CXQ?&+XF?"(C^S_"&C7VE37L>G:1;K>E;B
MYW$!%"8XP,D^@% '2?\ "F?B%_T5F_\ _ "/_&C_ (4S\0O^BLW_ /X 1_XU
M[!I4MS/IEK)>Q+!=O$K31*<A'(Y /L:MT >*?\*9^(7_ $5F_P#_   C_P :
M/^%,_$+_ **S?_\ @!'_ (U[710!XI_PIGXA?]%9O_\ P C_ ,:X'P!X;^)O
MBWQ[\0]"G^*%Y#!X;OK:U@D6QCS*LENDI)Y[%B*^D?%_BO3? _AO4-<U>X6U
MT^RB,LLC>W0#U)/ 'J:^</"G[4RZG\';SQYIG@X6OB36O%#>';;3'8(\]T)1
M!$9F[8&,^F* .\_X4S\0O^BLW_\ X 1_XT?\*9^(7_16;_\ \ (_\:M_"#XO
M:[K_ (RUCP)XVTRUTKQCIEE%J3)8R^9!-;2,45E)Y!##!%>P4 >*?\*9^(7_
M $5F_P#_   C_P :/^%,_$+_ **S?_\ @!'_ (U[710!XI_PIGXA?]%9O_\
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MAMDF,RQ%$ *!SRP'3/?% '7T444 %%%% !1110 4444 %%%% !1110 4444
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MI7BL_A#QGK/@/QK;>'X]8E\(I=VLME!J@)NID1@90 >2.^#UP*^V2 >HS0
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00HHHKL.X**** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>aciu-20221231x20f022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f022.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &: 8(# 2(  A$! Q$!_\0
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MM_5OF-)6N_Z_K?Y'WU\;_P!HWPK\!?A'_P +'UV+4-1\/$P!!I,4<LSB;[A
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M1:!KGB#3K/[.+4R2-Y]VCXP^XJJ"0<?O00<XJ4_=3[I/[[?YEVO)I=&_PO\
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M,15]L535BNK"BBBI **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-&%CV;MS@;5/SK@$@GG&<&GZQKEAX?TB^U34+J.UT^RA>XN)W/RQQJ"S,?H
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M]*LY_LLMPAW1()9Y63=E<G&#Q7V3JFM:/X;_ +-BO[JUT\7EREG9)*RIYD[
M[8T'=B V /0U?FL[>YC>.:".6-SEE= 0Q]2#UI:Z6>VGKM_E^(]KM]?^#_F?
M'_P\\73ZS?>"(;+^TM"T]-,\60LL-^VI1%HVLRDMM+M4S1+O;R\C/45P/AZ]
MM;KP=XR\,F&Q\17%]X$U&>76O#.KW$]O.8EC*M?6DHW6]RQ;CYFS^\';C] (
M[:*)45(D14&U0J@!1Z#TJ."PM;8R&&VAB,GW]D87=]<=:<O>5GVM^?\ F1%<
MK;7>_P"7^1\+:_KFC7GB.XBFU/P^O@J#PS9/X=GU/Q!=V4>?WWVJ2V:)'\R9
M90%/.Y=J@#FO1?#?@VX^(_C31M,\<:C?:W]G^'&GW,ZI+-:Q7%VTTRFY:/Y6
M$F!GG!!8\=,?43Z79ND:-:0,D1S&IC4A#[<<58V+NW;1NQC..<>E.]K^=_U_
MS_ &MO*WX6_R/D7X2+ILGQ-^!^L>(;IY-7O?!&HVMM=WMPV^XN([JSV)DGYG
MV&0XZGD]JZ3]I+Q!I$WQ)TCP_J=I82M_94ERDGB/79=.TWF0*?+2.-FGN!CA
M>, ]>:^DS:PDQDQ(3'RA*CY?IZ4VXLK>Z9&G@BF9#E#(@8J?;/2H4;)*_?\
M&Y=]6_3\+'Q-\%--E^*TGPUTSQ7>:CJ-DO@/5YYK9KN>(23Q:G%#$T@W!BR(
M2!OY'4\BEMM)UCPG\./A;XG\+7.IW/CG6-+U2WEN;B[DG>[<:=<20HZL2#MD
MCCV\<8QWK[<6&-""L:J0",@#H>30(D 4!% 3[O'3Z4TFE:_]7;_4)/F=_P"N
MA\@>";_PO;^(_AF_P]UV^U/5[RQNCXI#7;SRM$+)V,EXK$^7*+@1@9"G)8 8
MK&\&Z#J'A+PM^S]XA\/7>IR>*O$FAWD.HS7%Y)*;Y_[&FN(Q(K$@E9HHRIQQ
MC'>OM2&QMK>222*WBB>3[[(@!;ZGO275A#>6CVSJ4C9&C!C.QD!&#M(Y4X/4
M4Y.Z=M+_ /!T)BK-7Z?\ ^,_ FK>%(?&_P #5\/ZW?S>*;ZYF7Q'!+=RM))*
M+.1I!=(3@.)!P" <9QQ7J/[1&H>&XOBU\,;'QCJTFF>&;J#5/M$;W306L\BI
M"46=@0-@RQ&2!NV^N#U_A/X#1:!XDT?5M3\4ZOXF&B+(-*@U(1?Z.7387=U0
M/,^PE0SD\$]2<UUVN^ --\1>,-!\0WFZ2YT>&Y@AA(!C=9P@?<".<>6,5;:=
MOF1RO7Y'R-HFD-X]\=?##PY=WVIW/@*ZUSQ(-/1+V9/MEA%!&\ 9PP9HP^[;
MSR .U9&BZAJTFNL;S5]'TOX@Q>+6MP;G5KUM46!;PK'"MFL14P-;A0"&V[3O
M)SFOO)8(D"!8T41C"84#:/;TIAL;8W(N#;Q&X P)2@WX^O6IO9I_UT_R-'K&
MW]=?\SP?XXWOCK4/A;XVM]?;2O!&E*T L=;TR]N+YV072<7,2Q1M'$Z#;(R.
M2JNYS\N:\-;QCIT/PV\0:?.ZZ%I-GXK\/K?:GX8UR6]TR:*:=5D%M(55X_E3
M]Y'SC>.>37W>Z+(A5U#*1@J1D&N8\8_#K2?&>D6&G7"?9;6SU&UU-$ME509(
M)5D0$8Q@E1GVI+1KY?F)ZJWK^1\@>.]:GTP^,K?X;Z@;GX6_;]#6]NEOYOL4
M,C//]M2.= [)$4%IYA3(4LW3)I+K4M1LO#GB--&URQ3P$VN:'#K$7A34+F\@
ML;-K@"]>.Y>-=JM'L$@0G:I8\9K[CBL[>& P1P1QPG_EFJ +^72DAL;:V@,,
M5O%%">L:( I_ 4[_ -?=^ 'RO=WOA"'5_#5A\/-7U"[T.7QOIT%VL-T\VGC?
M9W.^."3G(.%+J&(#8Z&N.^%NFWW@_0O!X\)Q2PZE=ZIXU9(/,9DGFBN;P6X9
M2<'!"U]LPV5O;1K'#!%%&IW*B(  ?4 5(L,:[<(HVDD8'3/6ET:_K9+]"NW]
M=_\ ,^#_ (*:KK=Q=> +K1-:TH>+YM,NI-<M8=4O+S4+V7[%(76]@>)4@=;C
M8P)(P5*+D&M?P W@ZZ\8_L_7.G:O<WOCF2_GDU^WDNY)9!/_ &;<^:UPA)$<
M@DRJY ."P'%?:L5C;03/-';Q1RO]^1$ 9OJ>]$=C;0RM*EO$DC'<SJ@!)]2:
MJ^MR;:6)Z***D84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'E_[15]XCL?AVI\+:A;V.JRZA;1;)KM+5[J,O\\$,K@JDK@8
M4L,?2O'O!WQ?U6SU+P=I-UJ6O:;,OCI-)U6Q\2>0T\$,FDWLT<)GB9DE1I8X
MF5@<YP#Z5]/>(_#.E>+](FTO6M/M]3T^;&^VN4#HQ!R#@]P><U@#X-^!QX8E
M\._\(MIAT6687#V;6X*-*.DA[[AV;J*:=G_7D*2YE8^9OBOXHN?'NMM8R^(V
MM+/3/B]I^FV=] R9M(_[-AD95)&,[Y).3G!:M#4/'WB;2/'NI_#B'Q=>W/AL
M>)-.L3XG9D-U91SV4L\EJTN-I;?%& V,@3@=<&OHB3X,^!9=$;1W\*:4VF-<
MK>-:FU789UC$:RD8^^$55W=< 5B>,_@M9W/@!?#?A"VT;08$O%O'L[O3EN+.
M[Q]Y)4R&YX.\'<"HZCBLXKECR^?^7^1O*:D]NG^?^9X!XQ\;^*M*N]5\+Z-\
M0KZ\@'Q \/\ A^+4U\I[BVMKJ,>=$6VX9OFSN(]*V]1U+Q$FC?%R\N/B#J^F
M7OP_8VFE6\DD0^TK%8Q7"SW"E?WIF>1E[#"@#G->J_"G]GW3?!=GJ,FN0:5J
MFH7VJ0:L(;.Q$-G930(%@,"$L04QG>3DDD\=*['Q#\)_!WBS6XM8UCPWIVHZ
MG&%5;JX@5G(4Y4$_Q 'IG.*<4XJS=W?]%^5G]Y,I1:5E_5V>6Z=\7-2;5/&T
MNL7ZZ0MMX'TS6HK.9@OV6>5+LS,,]<%$!_W17">!O%/B#XD/;+J_Q O]#%M\
M/=$UP+:21Q%[N:&1I9WRIW+E!E>G/TKZ1\0_##PEXLU>TU36?#VGZEJ%JGEP
MW%Q K.J9SMSW&><'BN,?]FSPE??$"]U[4M)T^_TTZ58Z78Z9);#99I;&7&WM
MM(D4;<8^04Y:R;77\-_\U]Q,/=ARO5_\-_DSY]U[XM^/]1TC2_%-[J.I2:/#
MX4LM1O8_"UU;1W>F3DSF2ZGM)B#/#(JQE0C9'EN,<@U]GZ'J4.LZ+I^H6\AF
MM[NWCGCD9=I=64,"1VR#TKG_ !'\(_!GBZ\M;K6/#.FZA<6L2P0R36ZDK&#D
M)[J,G /'-=9'&L2*B*$10 JJ, #TJNA#WNAU%%%(84444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (3@4U9HW.%
MD5CZ @UG^)F*>&]692586DI!'4'8:\I^')OM%\$6FN7FAV6G1PZ*MPNKR7SR
MF1O*!#/'C(SU.,USU*O)-1MYG%6Q/LJL:=M&F[ZZ6^7YV/::*\DT[XAZRLNK
M!Y3=0V$-K?.T]F8',32,)0%)/&U<@U=M/&FM>(M4L[:VNK;3;/4&NKFUNWBW
MDV\11$&"0"6)9O\ =Q4+$P>W]:V,ECZ4DK)W?^=N]MSTTD $DX [FEZUXK;_
M !%USQ'X=UZ\D-K##I^C37,D"QEEN'4SIPV00I\L,,<X-:R^,]>ALY=6,]N;
M&VU.*P%DL)S(CLBD[L\,"W'':DL5!ZI.Q$<QI25TG:U_EW_#U\CU2F/*D9&]
MU7/3)QFO-?#_ (SUF]U'PQ-/>VDMOK9E+V:1X>W"H2 #GGI@Y'6H_&^FW5YX
MMNKBW@L]<BAMHUETZXNVMY;?[Q\R,_=)/OCIUJG73CS17]6OYFCQB=/GA&^M
MOO5^E^GS/4:*\2A^)VJ2VA31(KMK6PLH)8Q<P>:\[,"2)7R-HX R,YY-:<GC
M;Q+<S2W$=Q:VT']N)I"6[0%BJM&C%RV[D@L<#':H6+@]DS-9E1DM$V>M4A(4
M9)P/4UY?IWBS7M3UV;P^=1M;66S-P9+]X,F8(RA0%S@<-SS6&GQ%U[Q#IWB.
M=VM8;72["WG: 1%O/>0R _-D87Y,CZTWBH+H_P#AMP>8TET?7\%=_=_PUSVV
MBO*-,\<Z]=7%S>-/;BQMO$']C_9!"<O&=OS[L]1N].U9&F?%KQ%<Z'_:[6Q,
M=UIUS=B.2WV);LD32( V[+CC:>!R:7UNFM[@\RHJUT]?+Y7/;J*\BO/&'BFR
M@U.8W]HZ6>E6NKX^S$%C*S@Q?>Z#RSSUYJ2X^)FH+XDLQ!<+<6<NJIIKPQVK
M") ?E;]Z2,N#G( QV]Z?UJ"W0_[0I+=-?=W:[^1ZP"",@Y%->5(L;W5<],G%
M>9^"=:U33IO#EM/?V]_::I-=0^2J?O(-GF2*V[)R/DVG('+"F?%6"]O/&_A&
MWL]+CUDM;7[-:371MT./(PQ8=QG]:WIU%4C>W];G70K*O#F2M_PR?ZGJ".KK
MN4AAZ@TZO*=>\1ZAX6LK'3K14T:Y2R>[DL+:%KPHVX]7) "9SR>:;I_Q1U:Z
MM+"WDAB74]7CLI[ *I*[)4W39YYV!)#_ -\^M:G2>L4FX9QD9]*\I_X3S7+7
M2+#6I+NTN(]1::,6"18-OM1V4[LY)&T;@1WK*USQSXAT:QTB^\VSNM2O]-BN
MHV>$JD1EF@79PW('F'GK0![917E6I>-=>TC77\/27EO+/+J%M;+J30;5A26*
M20DINP2/*VCGJPKH/">O7VM:!XC%]<0W,UC=W%FD]NNT.J("#C)YYH [%)XY
M#A9%8^@-/!# $'(/<5X?X/\ #6K:EH'A&]L]+;1Q%#!=76I->[VNH_*^9=@8
M_?)!YQBJNF_$34M)\%Z<;2_,CV.GP2R1"U:;)8$_O9"0%R.F.: />Z0D*"2<
M =S7F(\<ZQ+9:AKHN[*&TL[J6W&ERH1)(J#J&SG>Q&0,8P17'ZSX_P#$.L^!
MM5:X5UAOM$ENQ+Y'DBW?:I 1MQ++R>>#Q0![_17E6H>-M=T35UT1[VTO);HV
M@CU!8L);>:SAMR[N<;/EY&<\UU?@G7+[4+W7=-OYHKR32[E(5NX5VB56C5^1
MDX89(.#Z4 =51110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 R:%+B&2*50\<BE64]"#P158:19+I(TP6L7]GB$6XMBN4\L#;MQZ8XJY
M12LF2XI[HQ[#PAHVEK.MKIT$(GC\F7"_?3GY3GJ.3^=<UK?B3X<6ZQZ-JFK:
M%!]@_=K:374:-!QC&,Y'%=[7RK^S'\"?AUX[^&5UK7B/P/H&NZQ<>(=:$U]J
M&G1332!=2N%7<[*2<*H ]@*GDC:UB/94[<O*K>A[./'/PQ6WG@77_#JPSVXM
M9(UO(@K1 $;",].3^=//Q ^&OV9K?_A(] $+2B<H+V/'F @ANO4$ _A6=_PR
MU\'O^B8>$_\ P3P?_$T?\,M?![_HF'A/_P $\'_Q-/ECV'[.'9&)H-_X%TOQ
M-#J]SXY\/7#6[2-%Y4L43NS\9D8/@D GH!ZFNGU;QK\+]<G6:_U_P_<S*NP.
M]['NV^F0W(JG_P ,M?![_HF'A/\ \$\'_P 31_PRU\'O^B8>$_\ P3P?_$U$
M:4(KE2T,H8:E3BX1CH]>_P"98O/%OPJU!X&N-:\.2&%!''F[B&%!R%P#R!Z5
M9_X3_P"&F"/^$B\/X-P+O'VR/_7  !^O7 %9W_#+7P>_Z)AX3_\ !/!_\31_
MPRU\'O\ HF'A/_P3P?\ Q-5R1[&OLJ:=^5?<6K[QA\+-2#?:==\.S;I&F)-Y
M'G>PPQSN[@#-2+XX^&"1W4:Z_P"'52ZB2&91>1 .B9V*>>@R<?6J/_#+7P>_
MZ)AX3_\ !/!_\31_PRU\'O\ HF'A/_P3P?\ Q-')'>PO94[WY5]QH1>/?AG
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M*O:3\1_AQH5J;>P\2Z#:PEBY6.]C&6/4GGDUE?\ #+7P>_Z)AX3_ /!/!_\
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M1)HI^+^K#0AI8NQJ7]CP;3/YNTQ>F=O-?45% '@?_"C/BI_T7/5/_!1;T?\
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M?^#U_P#XW7T'10!\^?\ "9?M(?\ 1//"'_@]?_XW1_PF7[2'_1//"'_@]?\
M^-U]!T4 ?/G_  F7[2'_ $3SPA_X/7_^-T?\)E^TA_T3SPA_X/7_ /C=?0=%
M 'SY_P )E^TA_P!$\\(?^#U__C='_"9?M(?]$\\(?^#U_P#XW7T'10!\^?\
M"9?M(?\ 1//"'_@]?_XW1_PF7[2'_1//"'_@]?\ ^-U]!T4 ?+/Q#^.WQT^$
M_@_4/%GB7X>>&1H.F>7)>&SUIWF$9D5"44IR?FKZ@L[@7=I!.!M$J*X![9&:
M\-_;I_Y-.^(G_7G%_P"E$5>UZ+_R!K#_ *]X_P#T$4 7:*** "BBB@ HHHH
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M7;X8*7"8X[_*: /OS_AG_P"&O_0BZ#_X 1_X4?\ #/\ \-?^A%T'_P  (_\
M"N9@_:K\&SP1R"UUP!U# ?V5+W'TJ3_AJ;P=_P ^NN?^"J;_  H Z+_AG_X:
M_P#0BZ#_ . $?^%'_#/_ ,-?^A%T'_P C_PKG?\ AJ;P=_SZZY_X*IO\*/\
MAJ;P=_SZZY_X*IO\* .JT_X+^ ] O(]0TWP?H]E?V^7AN+>S1)$;'56 X-=)
MX:79H%BIBD@Q$/W<S;G7V)[FJOACQ59>-?#4>KZ>EP+6=6VI<1&*3C(/RGD5
M9\+H(_#U@HAEMP(@/*G;+K[$^M &I1110 4444 %%%% !1110 4444 %%%%
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M_$T >O\ EI_=7\J/+3^ZOY5Y!_PUA\./^@K<_P#@%+_\31_PUA\./^@K<_\
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M/[*LO^?.W_[]+_A7DG_#7OPI_P"AF_\ )2;_ .(H_P"&O?A3_P!#-_Y*3?\
MQ% 'K?\ 95E_SYV__?I?\*PO&OPW\/?$#P]-HFL:=%-83212NB*$):.19%Y
M_O**X'_AKWX4_P#0S?\ DI-_\11_PU[\*?\ H9O_ "4F_P#B* /6O[*LA_RY
MP?\ ?I?\*7^RK+_GSM_^_2_X5Y)_PU[\*?\ H9O_ "4F_P#B*/\ AKWX4_\
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M;2/_  3C_&@#UO\ L73O^?"U_P"_*_X4?V+IW_/A:_\ ?E?\*\D_X0;XT?\
M11M(_P#!./\ &C_A!OC1_P!%&TC_ ,$X_P : /6)]%T_R9,6-H/E/)A7'3Z5
M0\-Z-8-H5D7M+"9C&,O! H1O=>.E>9R^!_C0(G)^(VD8P>NCC'\ZM?#_ ,*?
M%&UNM(N=5\;Z1?Z.A#36=GI@C$B>BL#Q]: /5/[%T[_GPM?^_*_X4?V+IW_/
MA:_]^5_PJ[10!2_L73O^?"U_[\K_ (4?V+IW_/A:_P#?E?\ "KM% %+^Q=._
MY\+7_ORO^%']BZ=_SX6O_?E?\*NT4 4O[%T[_GPM?^_*_P"%']BZ=_SX6O\
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MT5X3_P ,JQ?]%%\:_P#@T;_"C_AE6+_HHOC7_P &C?X4 >[45X3_ ,,JQ?\
M11?&O_@T;_"NK^&_P33X<Z[-J:^+/$6N&2W:W^S:M>F:)<LIW!?[WRXSZ$T
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M'&:]5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>aciu-20221231x20f023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f023.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $! B<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "O,?CEX5T?QH/ VD:]IMMJ^ES^(H_-L[R,2128M+HC<IX/(!Y]
M*].KAOB7_P AGX?_ /8Q+_Z1W5 &-_PRS\'_ /HF?A;_ ,%</_Q-'_#+/P?_
M .B9^%O_  5P_P#Q->I44 >6_P##+/P?_P"B9^%O_!7#_P#$T?\ #+/P?_Z)
MGX6_\%</_P 37J5% 'EO_#+/P?\ ^B9^%O\ P5P__$T?\,L_!_\ Z)GX6_\
M!7#_ /$UZE10!Y;_ ,,L_!__ *)GX6_\%</_ ,31_P ,L_!__HF?A;_P5P__
M !->I44 >6_\,L_!_P#Z)GX6_P#!7#_\31_PRS\'_P#HF?A;_P %</\ \37J
M5% 'EO\ PRS\'_\ HF?A;_P5P_\ Q-'_  RS\'_^B9^%O_!7#_\ $UZE5.YU
MBRL]0M+":ZBBO;L.;>!FP\H498@=\ C-)M+<3:CJV><_\,L_!_\ Z)GX6_\
M!7#_ /$T?\,L_!__ *)GX6_\%</_ ,37J5%,9Y;_ ,,L_!__ *)GX6_\%</_
M ,31_P ,L_!__HF?A;_P5P__ !->I44 >6_\,L_!_P#Z)GX6_P#!7#_\31_P
MRS\'_P#HF?A;_P %</\ \37J5% 'EO\ PRS\'_\ HF?A;_P5P_\ Q-'_  RS
M\'_^B9^%O_!7#_\ $UZE10!Y;_PRS\'_ /HF?A;_ ,%</_Q-'_#+/P?_ .B9
M^%O_  5P_P#Q->I44 >6_P##+/P?_P"B9^%O_!7#_P#$T?\ #+/P?_Z)GX6_
M\%</_P 37J5% 'EO_#+/P?\ ^B9^%O\ P5P__$T?\,L_!_\ Z)GX6_\ !7#_
M /$UW?BSQ-:>#?#E_K5\LCVMG&976(9<@=@/6M2)S)$CE"A902K=1[&IYDY<
MM]2%.+DX7U6OW_\ #,\P_P"&6?@__P!$S\+?^"N'_P")KDO"'PV\*_#?]J6"
MW\*^'M.\/07/@^Z>:+3K=85D87EJ 2% R1DU[_7DD_\ R==I_P#V)MY_Z6VM
M46>MT444 %%%4FUK3D:\5K^V5K)0]T#,N8 02"_/R@@$\XZ4; 7:S_$(SH&I
M@]#:R_\ H!JE;^//#-WX=DU^#Q%I,V@QYWZI'?1-:KCKF4-M&/K4E[JEEK?A
M&[OM.NX+^QGM)'BN;659(Y%VGE64D$>XH \?^%W[,WPFU+X9^$;N[^'/AJYN
MKC2+266:738F>1VA0LS$C)))))KI_P#AEGX/_P#1,_"W_@KA_P#B:Z7X0_\
M))_!7_8$LO\ T0E=;0!Y;_PRS\'_ /HF?A;_ ,%</_Q-'_#+/P?_ .B9^%O_
M  5P_P#Q->I44 >6_P##+/P?_P"B9^%O_!7#_P#$T?\ #+/P?_Z)GX6_\%</
M_P 37J5% 'EO_#+/P?\ ^B9^%O\ P5P__$T?\,L_!_\ Z)GX6_\ !7#_ /$U
MZE10!Y;_ ,,L_!__ *)GX6_\%</_ ,31_P ,L_!__HF?A;_P5P__ !->I44
M>6_\,L_!_P#Z)GX6_P#!7#_\31_PRS\'_P#HF?A;_P %</\ \37J5% 'EO\
MPRS\'_\ HF?A;_P5P_\ Q-'_  RS\'_^B9^%O_!7#_\ $UZE10!Y;_PRS\'_
M /HF?A;_ ,%</_Q-'_#+/P?_ .B9^%O_  5P_P#Q->I44 >6_P##+/P?_P"B
M9^%O_!7#_P#$T?\ #+/P?_Z)GX6_\%</_P 37J5% 'EO_#+/P?\ ^B9^%O\
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MHHHKL.\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHR5JB.:".X39+&DJ==KJ"/UJGX@_Y .I?]>TO_H!K0K/\0?\@'4O^O:7_P!
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M?W)+_P!N/0:***[#O"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KR2?_ ).NT_\ [$V\_P#2VUKUNO))_P#DZ[3_ /L3;S_TMM:
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M%V'"[""&Y)(XKU7QC\2?#6M>-/AYX?AUW37\2C6(KN;1X[I#=1(;&X.XQYW
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MZ_!KXS_$"'XG":PDN/%&I:N2DVGW4P N"J$K\S<)MQGC P,5]CKXW\=A1O\
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M (4EHUS_ ,A+6/$VL#NMYKMR%_[Y1U'Z4 =U?7]MIEK)<W<\=O!&I9I)&"@
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M3-9U7XAP> ;+4M,\)>'[SQRP5;C2[C69(K2($_.%NA;LS8 !_P!6,GTKOZ*
M.#UG6OB/!\/+.]TSPKH-WXU?9]ITBXUN2*RCY^;;<BW9FP,$9C&?:N+\.7.L
MWG[1F@3^(;"TTO6G\$W9NK.QNC<PQ/\ ;;7A)61"PQCDJ/I7N%>23_\ )UVG
M_P#8FWG_ *6VM 'K=%%% !1110!\A?M!WWAO3/'WQ.@\7O9+?:IX5M8/#4=]
MM\RXD#S>9':AN6DWF E4^;[I[5[AXHT7QO?_  ITJ#1_$5GX?UF'3D.HRZCI
MAOO.(@PZ "6/:V[G=D_2O2GACE9&=%=D.5+#)4^H]*I>(/\ D ZE_P!>TO\
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M0!YE_P ,[>#_ /GY\6_^%KK/_P ET?\ #.W@_P#Y^?%O_A:ZS_\ )=>FTC9
M..32;MJ!XCHO[,]G;^+O$5SJ6M^);GP_.8/[*LX_&.L"2V C EWG[0"=SY(R
MS<'MTKHO^&=O!_\ S\^+?_"UUG_Y+KP?X3Q10Z_\*O%4=S,?&/B36M4M?$$I
MN'9[B)4F9HY$)QMBD2)5&/DS@8S7U)\0[N2P\ ^)+F&]MM-EBTZX=+V\<I#
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MG_Y+H_X9V\'_ //SXM_\+76?_DNN0_9JTR+P1XI\;^!WT71+'4-*BT^\EO\
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MMH$6**&'QEK")&@&%55%W@    "I?^&=O!__ #\^+?\ PM=9_P#DNO3:* /
M?&'P1\'Z5XL\+(_CG6O#]M+/(LVEWOC?5%EU/*$(D1>\W95BK?+R<8KL?^&=
MO!__ #\^+?\ PM=9_P#DNO#?V@+[PYIOCSXH6_BU[)=2U3PW:0^&H[T+YMQ(
M'DWQVH/+2;S$2$Y^Z>U?5/A*.\A\*Z-'J)8Z@EE"MP7Z^:(QOS[YS1'WH<W]
M=?RMKZA+W9<O];)_K^!XE\3/@UX)T2'2XO\ A/M6\'7#WD4KMJ?CG4U^U0*P
M\R)1)>=6'&X<C-=I#^SWX,N(DEBO/%<L3J&1T\;:R58'D$'[7R*\>_:<ET+3
M/B<=:U#QUIOAW6]/T!_[,T?7-%@N8+]C*K%8GF/SN2JJ4B <9SFOI?P9?W6J
M>#]"O;VS&G7MS8033V:J5$$C1J6C /3:21CVHC[T>;^MVOT^0Y+EE;^MD_U.
M+_X9V\'_ //SXM_\+76?_DNC_AG;P?\ \_/BW_PM=9_^2Z]-HH$>9?\ #.W@
M_P#Y^?%O_A:ZS_\ )='_  SMX/\ ^?GQ;_X6NL__ "77IM% 'F7_  SMX/\
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K %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>aciu-20221231x20f024.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f024.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" )/ \(# 2(  A$! Q$!_\0
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M85NH3,Q*B,2#<2.HQGMWK!\,?$?0?%^N>)-)TR\6>\\/W*VE\O "2&-9./4
M.,GUR.U+R&=/156/5+*6V%PEW ]N6VB595*9SC&<XSGBL7QY\0=$^&_AC5->
MUNZ\JRTZ$33)$-\I!;:@5!R2S$*!W)I/0:U.DHKS?P7\;]-\3Z_?:'J>D:GX
M1UBUL1JAM=<1(O,M-VTS*RL5PK8# G(R,U7\'?M">'?B-H_B_4O"=O?>(X/#
M=Z+&06$89KR3RT?,&2-RXD'/ ."1QBG_ ,/^-OST%_PWZ_EJ>H45Y5X%^/\
M:^-OB%-X-?PIXAT/5X;+[?+_ &G;HL<<6[:NYE=L%CG /7!]*]5IVT3%?6P4
M444AA1110 4444 %%%% !1110 4444 %%%% !1110 45YA\5OB=K7A[Q1X;\
M&^$=/LM1\6Z\D]Q$VIR.MK9VT.WS)I=GS-RZJ%&,D]1BL.X^*/Q$^'OAKQK>
M^-_"]AJ;:#I3ZI::CX<,B6M]M4DPF.0L\;C&2<L,'/M4N247)[*_X;_U\BN5
MMJ*WT_';^OGL>UT5X/\ "WXJ_$+Q9?Z#?W \%^+?"VK?+/<^$+J0RZ22A93-
MYCL)%R-IVA2#VK%^%_Q9^,'Q:T637-,'P_T_33J=Y8Q6U\;S[3M@N7AR=K8R
M=F>/6M.5I\K_ *_JY%TUS=/^'_R9])45YW\</B_#\%/!MMKMSIUQJAGO[:P$
M-K&[X,L@4L=BL< 9(XY.!U(J'5?VC/A_H>NG2;[71;74;Q17#O;2^1:22@&.
M.>7;LB<[A\KD'GFI6NB]/Z^\>RNSTJBO'[#]I7P\/&OC_1=7BGT6Q\)>09=2
MN()?*F\Q1T.S&[<RA5!);J*SO'G[4&BZ?\,/%WB#PJXOM:\/K;O-I>JVL]K(
MBRRJBLT;A'VD,2".#BA>]:W7]0>FY[C17GGQS^+\'P3\"#Q'/IUQJFZ\MK-+
M>WC=N99%3<2BL0 "3TY.%ZD55\1_M(> /">H26>J:S+;30)%)>,+*=TL!* 8
M_M+JA6$D$'#D'FA:[>@>9Z;17*S?$_PW!#XFF?45\OPV@DU-@I(@4Q^8#TY^
M0YXKH=.U"#5=/MKVU?S+:YC6:)\8W*PR#^1H LT444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7B'[0&AZSI'CCX<_$G2-&O/
M$</A2YNXM2TO3D\RZ:UNH?+:6%,_.R,%.T<D$XKV^BEK=-=/Z_X ]-F>'0?%
MWQ?\4;S5X/ _@R[MM%MM)G87_C#3Y;!;R^(_=01Q2 .R?>WN5QR ,UXKX>\(
MS6_B'PT_PQ^&GCKX6>+FU*WDUNU9'MO#JP!P;H.#(8)5*[@GE#.2I %?;=%5
M'W9*2\OP=_N>S7;[R7[T7%_UI;[^J?<^9?@O^SW;ZC?^--9\0GQ5H]_+XNO[
MFV@AUB]L8)H?,4QR"%'5&5N?FQAO>O0/VK-!U+Q-\ ?%>F:187.IZC.EN(K6
MTB:663%S$QPH!)P 3] :]:HJ;>XH=$DON27Z%)VFY]W?\;GR+\5O@_XK\(?%
M3PE-X1TVXU/P-K_B6SU75;&WC9O[(O8_OW( '$4J_?[!E!_BKIOCK\._B/=_
M!;QM;WVN-XZEEELKFRTO3M*6&=%BO(I7"A6)D;8AP.IQQUKWK2O%VFZWK^L:
M/92O/=Z08EO&5#Y<;R*6$>[H6"X) Z!ESUK:HVBDN]U^%ONLK>0EI*_HONO^
M=]?,^$O&'@OQ+J.N_$I+S0_'=S;^-;B*\L+?3-#@>.Z@:)%2&XGE0M:/$RMD
M2%0O5<DFO2?^%9ZM;:=^T27T*]GU#4]#MK.PN'@,DM\R:0(BL;A?WA\S*G;_
M !$U]245,HIP<.ZM\BHR<9J?9W_4^7?"OPB^Q?%WX1W3^$3%IVE_#VYLIIFL
M,1VUT6M@(G.W"R$&;Y3SR_O7EB?"[Q@/@W'IQ\+:Q]K7X;:WIHMOL4F\3O<L
M8H-N,[V7&U>I'05]FW'Q*T"UOO%%I+>%)_#5M%=ZF"AQ#'(CNA![Y5&Z>E'@
M[XD:%X[O=6L])N));K2C;B\BDB9#$9H5FC!SW*.I]JN;]HFO7_R;G_\ D_P1
M,/W;3]/_ "7E_P#D5]Y\Z?$#X<ZSHWB'P;/X9\$'4$M/ASJ>F2V:VIC@DE/V
M0Q6LK# !)$F%)!)#>]>=WWAOQIXIU)+A/#WBBZM8? VLZ4OVCPO_ &9#;SO;
M#R[6&,#S&&00"WRDX"DDFOM_3O%FFZIXAU70X9B-3TQ8GN('4J0D@)1US]Y3
MM89'=2*V**G[Q._6_P"+D_\ VY_U<(?NVK=+?@H__(K^K'BOB;PMJ^H?L@R^
M'[?3KB36V\(Q6HT_RR)C,+908]IYW9!&/6O&/&ESXNU_6+A[+P5XBTNWU/PE
M:V%K<6WAC[1>7[;9!):7+S'9:*KGHX (;=D\5]HT4JO[V4I/K_DU^H4_W48Q
M73_-/]#XK^$]MXI^%&CZ'<:IX&\4ZB^J_#ZPT:.+3]->62"]@\P-#.IP8<[Q
MAGPO!YKZ,_9QTG4-!^!?@G3]5L9M-U*WTR*.XM+E"DD+@<JP/0BO2**TE-R<
MF^K_ %;_ %(44K6Z?Y)?H%%%%06%%%% !1110 4444 %%%% !1110 5POQR\
M#7/Q+^$/BSPQ9.L=[J5A)#;LYPOF_>0$^A8 'V-=U14RCS)Q[E1?*TUT/GK2
M_P!H'Q)J>C:'X;T/X=>)+;QQO@M;V#6-+E@T^Q52!+,]S_JW3 8KL8EN.*X?
MXJ^&M/O?B!XCN_%'PJ\7?\)6)B-#\8?#N&99+JWVCREEFBD79(I^4^:-O'!Q
M7U[152]Y\SWU_'MV_P""R8^ZK+;^M^__  $?(FE_!?Q7XZ^*?PWD^((U]9[/
MP3/#J&JZ7?3VF+LW,96*2X@907V9)7."03CBOJ#PMX6M/!?AN#1[&>]N+:W#
M[)-1O)+N<Y)8[I9&9FY/&3P,#M2Z5XNTW6M?UC1[.5Y[O23$MXRH?+C>12RI
MNZ%@N"1V#+GK6R0&!!Z&FW[MEYO[VW^HNMWY?@DOT/AKX9P3>-?AYX=\):#X
M#U>TU>W\9R:M)XB:P"6,:1WKM)<"ZS@NR Q[!\_.",5;MK+Q;X9T$Z4? ^LI
M+IGC_5M1FU?_ (1^347M89YIY+>ZM(1Q/D.%+*&V;LD9KZ_T+P_HOP\\.R6N
MG0)IVE6QEN67<2%W,TDC9/N6-6O#7B"T\6>'M-UJP,C6.H6Z74!E0HQC=0RD
MJ>1D$4EIM_7P_P#R'YE-WT?7_P"V_P#DCXM\,>%_&6EV-_XDO?"OB>^73_B1
M:^()(9=*6*^NK,V9B:>.WCX8[F!*+EA@Y&<BO<?V>AK&I_$'XN^(M1\.:MX<
MLM:U6SGL(]7MC#+-"EE%'OV\XR4.1G*YP0""!Z[XK\4:=X*\-ZEKVK3&WTS3
MX&N+B4*6*HHR3@<FI+C7[:W\.R:TJS3V:6INP((R\CIMW?*HY)(Z"DFH)OR_
M2*_]L7XBLVUW?^;?_MWY?/Y;OO WB7_ADT:)+H&I3(WB"676=)BMC]MGTTW\
MCRB)&&2Q0JPQR1G;SBNH_9B\,V>A^//&UUX.T'6=!^'5[#:O"-?M9X)[G4 &
M$TD8N!YYC$8B7+\;@=O%>_Z%KECXFT6QU;3+A+O3[V%9X)XSE71AD'\C5^J2
M<&T_ZT2U\M+I='J#?.K_ -;W^_I?MH>4_L]Z'J.A:;XU34;&XL&N?%>I7,*W
M,31F2)Y<I(N1RI'((X->K444NB79)?<K!U;[MO[W<**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "L7QMH\WB'P=KFEVTGE7%[8S6\;YQM9T*@_F:VJ*F4
M5.+B^I49.+4ET/EOX??M(>&_AW\$]'\,W%G=3?$'1;--*_X0U;61;N>[0; B
MC;@HQ /F?=P<YJC\5-2\,0?$^]O?&%UXF^$GB-]/MOLGB/P]<7#V^I)LRT,N
MR-HY&B<LH5UR001UQ7U<;>(S"4QH90,!]HW8],U)5R;F^9[_ -;?UY$12BN5
M;?UN?%SVWC7XGW?P);7=7UC2M1;5-:$.N6]HMM>26JPX@FDC="L;2(!D%1UZ
M"OJ_P/X6O/".D/97OB+4_$TS2F07FJF,R@$#Y1L51@8].YK2EU_3H-<M]&>[
MC&J7$#W,=KG+M$A4,^.P!91D]S6A1?>W7_AOT"VU^G_!?ZGY_P"LV?@749OB
MM;0:-)=?&"3Q;*- NTL)9+J-P\9C:WG"D1QJ2Q?# ==W45=\76'A[P=>_&C2
M[KPE9O?ZEXFTN2\'V22" 6,D-N7GN&A3=);><)"Z*?F).>I-?:/@_P "Z9X'
M.L_V;YW_ !-M0EU.X\Y]W[Z3&[;P,#Y1Q6CH?B+3?$D%S-IEY'>PV]S+9RO%
MR%FC8I(GU5@0?<&HBK**[))_^2W_ !5F_/H6W=R?=M_G;\'HC\_M'L([/3_B
M['H5C9'0(+CPWJR1>&-$EL+!UCNF-Q-;P'._"H-SH.=OM7KUU\>O#.C_ !4^
M)7Q%BMK_ %GPUI_A33XHGALI%^W3"XGPD.]1N^9U4MT!!YX-?5]S<Q6=M+<3
MN(H8D,CNW15 R2?PJOHNM6/B+2+35-,NH[W3[N)9H+F$Y21&&0P/H15/7;I^
MJM^6WH2K*]^OZ-/\]_4^=_V>_$'AKXL>,-:\2:WKVG>(O&NI:9]GDT6VAD:U
MTS3]X)MU,B 2$NREV_B(&!@5T7[/MC_9?Q(^.H%L;6U'BB PJ(]B;!IMH/E'
M3 QCCTKV30]=L/$FFQ:AIEU'>6<A8++&>"5)5A[$$$$'N*OT[V^'31K\4_T^
M=V[BW5GWO^#7Z_A8\7_9<LY=9\(ZIX^U&)TUCQCJ$VH/YRD/';*[1VT7/("Q
MJ./5B>]>T444=DN@^K?<****0!1110 4444 %%%% !1110 4444 %%%% !11
M10!XU\8O"GB73/B+X2^)/A/13XFO='M;K3+_ $6.XC@FN;68HVZ)I"$WH\8.
MUB,@GFJD.J_&+XA6?B>^LM(A^'D'V!8M$T_7##<W$UT&W-)/Y+.L<9 V;<D\
MEL< 5[A122LN7U^5_P#@MOU'?6_I^']6]#Y.T+X/:YKOQ4\+>)+'X/6/PDU;
M3[S[1K'B"PU.U*:C#M8/ L5LV9 [$',JJ1CUK:_9V_9-\+^&_#T6K^-/A]HR
M^.HM=OM134)X89[A0;V22VD$J%N0AC(YR. <$8KW_P 8>*[#P1X9U#7=3D,=
ME91&5]HRS>BJ.[$X 'J15BPUNWN[2TDF*V5Q/'&QM)Y%$D;,N0A /WOIZ<52
M=MNGZV_RZ?J2U=6?7]+_ .?]6//_ -H[PIKGB_X926OAW3O[7U6VU"ROX[ 3
MQPM.(;A)&17D(4$A3C<0/>O%]7^%WQ)3P-\3?A]9>"H;VS\>:C=ZA'XAN-3M
MUBTY;P*9%N8]QD>2$Y"F(.K;5P17UG/=06I3SIHXMYVKO8+N/H,]:Y_7/'VF
MZ%KGA_2Y"TTNLF9HI8F7RXXXX][2.Q/"]!D9Y85"2U7?];7_ "7W%\S5FNFO
MW7_S?WGSSXM^&WQ/T#5?'UGX6\/_ -IP:JFDW%KK+75GE_LRQQS1+'.WRSE0
MSH[+L!'+ XKC=?\ @1\3_$UG\3)Y/#^L2R:]H6GV=@NNZ[:7=VTL-YYDB2,C
MB./Y26"J2N/XMQ(K[4.I6@25S=0!(B!(WF#"$] >>*P)OB%IT/Q'M?!9CF.J
M7.FOJB2!1Y7E+($(SG.<GTK1-\Z>[_X'^1#2Y;=-/S7ZG,?M'>$M;\:?"34-
M.\/6 U35TNK*[ALO.2$S^3<Q2L@=R%!*H<;B!GO7SY\9_AC\9?B):?$K3X?#
M>IQ6^OP;M+ATS6-/LK(*;=%,=[@^=-.&#+G)C(V_,%!-?5WB#QW8^&?%'A[1
M;^.:$ZZ\L%I>8'D^>B;Q"QSD,RARO&#L(SG&>DK/E33\_P#@?Y+^F6I.-O(^
M3_$WP^^)FDZ=\2-'T;P1_;2>--(MHX;[^U;:%+&9;00R1S*S[B01P4#*<\D#
MFOI;P5I]QI'@[0[&[C\JZMK&&&6/<&VNJ $9&0>1VK:HK1R;;;Z_\'_,R45%
M)+I_P/\ (****DL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *0]*6B@#XIU?5Q;?L_1:AJ&OWGAR34?B-*NKZG:73
M6\T8-\\; R @J/+5%SV 'I69\3=6ET;0OB!H'@;Q?J]SX2M]1\.+;:C%J\UX
MUE=3W\:SQ17+NS8*;6*[B 6/KBOHS7OV>+'6[_4@-5:#1KW7+3Q"VF&V5U2Z
MC_UV&)Y24*F5QP0QR=V!Z/;^$="M-+&FP:+I\.G"02BSCM8UA#A@P;8!C((!
M!QU -$%9*_1K[DHZ>FCL.3NW;S_%R?WZJY\>>,/ CZ+JOQTT^T\5^+HM/\(Z
M/9:OHT!\17C?9[R6&5WE+F3<^3"IV.2@RV%YINL^);7Q';?$S6O''CK5_#7B
M;0K"VG\.6]IK4UD$1K&.6.:*!'5;AI9F=2&5\_<QVK[.ET33IWO'DT^UD:]0
M1W3/"I,Z $!7X^8 $@ YZFJUYX2T+4;JTN;K1=/N;FT %M--:QN\('0(2,KC
MVJ;-W5^EO3S7GT]!II-.W7[]M'Y;OU?K?X_L-7U?Q%K?C32]70P>(?%L'A+3
MKN';M8/)!-)<9';")*2.U>C_  J\8^&_!WQZ^.EKJVNZ9H[-J>E^3%?7<<)9
M1IT(R Q&17OTGAW2IM2347TVU:_1Q(+HPKYNX*R [L9R%9@/0,?6LW5OAOX2
MUZ_EOM3\+:+J-[+CS+F[T^&61\# RS*2<  ?A5M^\Y);W_\ ;?RL_O(2M%)]
M+??K_P  \Q\37HB_:S^&\^ES+*FJ^&-52^:%MR26Z26SP.2." [D _[9]:]Q
MKD-%^'%II7C[4?%3RK-=2V,.EV4"0B..QM$.XQ( ?XG^8GC[JC'%=?1M%1[7
M_%M_J-_$WZ?DE^GW!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ I#TI:* /B_6M8>R_9EUC5;K6[OP_=7OCV3^U-4M)VAFA!U+RV.\<KB-
M5&>P K+\?>*9_!>H^)=$\!>,=7G^'K2Z(NL:Q%J\U^VD)/=[+IHKEW=HR8MK
M-AODW;ABOHGQ%^SW9Z[_ &]:IJSVNCZMK%GKK6 M@XBNH75I2&+<I+L3*XX(
M8Y.[ Z;Q=\,;36? ][X>\/W(\&F=UE2YTFUB55<,&P\1&V1&QM93]Y21D=:F
M/NI-J^VG=)15O31C>K:[WU[7;=_4^49]4TK1/B)\3?"7@WQ=J'B'2;_0=)TR
MTAN-8EU%+6XNKF:.01R.[D_(=QY./H,#2^+OAB<ZI\=KJ#Q#K^F?\(9X9L+G
M1(-,U:>UAM9X[-V60)&X5CE ,,",9XKW7X5?L^67@+6M4U[6+VT\0Z]?"W03
M6^E16%K:QP;S&L,"%@IS*[%BQ))[5Z=/H>FW)O3-I]K+]M01W6^%6^T(!@+)
MD?,,$C!SP:<U>"BGKKK]]ONN$7:;DUIII]U_OL?$?Q'MKSPC;>*M*BUW6=1L
MM?\ A9/K>H1:KJ,UTLEZLT2^<BR,1&2LC J@5<8XX%?6/PU\?>&->\.Z'I^F
M^(M*U"^%A#FUM;V.208C7/RJQ/%=1<^'-)O23<:793DVYM#YMNC9@)!,7(^Y
MD#Y>G'2L3_A6>@Z3:WDGAK1=%\.:U);R0V^IVNEQ;H&92 V%"E@#@[=PSBKE
M+1V7?\Y-+[FE\B%'57?]6BG^,;_,XK]EEROPYU*U0DV5GXAU6ULQV6!;J3:J
M^PY ^E>PUS_@'P58?#OPAI?A[32[VMC$(_-E.7E;J\C'NS,2Q]S704K6T[%7
MNV[;A1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^3
M_&7B?4]-M?VD_&-GJ#:;X@T=K72+"[.";2WB@252 >@9[B1CZ_A3/&GQ(\7_
M  6FU#^S_%MWX_\ M/@V]UTK?I"_V6YA";)4\I%Q$V\G8<_=X/6O1OBI\ +[
MQE=^.3HVHVMC9^,M'CL=2@NE8A;J%OW,Z@#G,;.C@X^ZA'0UU>F?!/PYX3\-
MZU9^$M,T_P -ZKJ5BUJ=0AM%EVL4(4E&X903G9T/2H=^33>UOG9K\7[W_!VM
M6Y]>]_E=/\%[O_ W\)O_ !SX@^%'C_P//=_$R^\7:3J?AK5=8OK"[$&&EB@B
M='3RT4B,LY"J<X(X/6F^'?#/BRQUW2/!5IXSU7PQ;6_@MM=O1I@B\R;49KAY
M))"SHW'F.Q('4<9K=^'?[(TEOXUM-<\86'A.WM=/T^:QAT_PQ:S1I>/*T9>:
M=I#\H C 6)!M&YN:^AW\*:0^LOJS:? =2>T^PM<[?G,&<^7G^[DDXJYJZ]U[
MW^7Q6_-/Y+KH1%VT?E\_AO\ DU\_F?(WASQSXX;2?AAJNL^,;W7(O'GAS57U
M/3KB"%+:)XK/S(WA"(&0YR#\QSGZ8]Z_9=NX#^SQ\-XQ-&9/["M!LW#.?*':
MNMC^&'A2*UT2V30;-8-$AEM].C"<6L<B;)%3T#+P?:L'PU^SO\./!NK6>IZ)
MX2L=-OK-MUO+!O'EG&.!NQT/I577-+L_TO\ YDVTCW2?Z?Y&'\$)WLOB'\6]
M#B/_ !+K+7([F!1]V-IX$DE4?\#RW_ J]BKBOA=X"G\$V.KSZC/%=:WK6HRZ
ME?SP9V;V.$1<@$JB*B@D#.,]Z[6I6R7DOR*ZM^;_ #"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#QO\ :FWCP'HC-G["OB32S>>G
MD_:4SGVSMS7A'Q:;X7/\<_C%%X\TMM3U>32+!-%4V4MP_G&W;:MJ44[)R^S!
M7#>^ :^Q/%OA;3_&WAO4=#U6(S6%]"8954X8 ]"I[$'!![$"LOPK\.-.\):_
MJVM6]Q=W6I:K!:P7<UU(K>9]GC\M&P% #$<GL3V%0XW3B^[_ !5M/2WXE\UG
M=>7X._\ 7H?'.K:?HNGS:O\ \+]T^?4-;/@W3T\.RWEK+<;)E@?[4MNR@A+K
MSMA8C#]#G&:?:Q2^*_V:];GCCFDA\.?":&QAR"6-Q<VGFN!ZL(TB_P"^J^I?
M'GP/L_'6M7FH?\)/XDT(7]JMG?VFDWPC@NXES@,K(VTX9AN3:2#UZ5W'A_P_
M8>%M%LM*TRV2UL;.".VAB3^%$4*HSWP !^%5/]Y&:>E__ME_[=]Y$/<E!K6W
M_P!K_P#(GQ_IW[/W@<_&#1M(D\*6DNC7/PZ;4+RTDAW07=\LR*EQ.IXDG DD
MP[Y8;B0:S_A9\2-%^&OBGX1:MXSU;^R;5_A^]H+J]5VRXN5VH2 3G:O?TK[A
MHK1R]ZZ\_P >?\E*WR(4?=L_+\.7_P"1_$^?_CSXST;Q_P#"KPGK'A?4(]3:
MY\5Z4NEW, (W3+=+NVY /$8ES[9KZ KG==\"Z=XC\4:!KE^TTTNAM++9VI8>
M0LSKL\XKC)=5+*IS@!VXSR.BJ%HFN[;_  2_0MZM/RM^+?Z_F%%%% !1110
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M=.UGP5HGAG4;32;C7-0EMYKNZM/M&Q$@>3Y5W+R2H'6H?^$.^*O_ $472_\
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M472__"?'_P =H_X0[XJ_]%%TO_PGQ_\ ':]2HH \M_X0[XJ_]%%TO_PGQ_\
M':P_'5C\5_!_@K7M=3Q]I5RVF6$]X(6T  .8XRVW/F\9QBO;JXKXV_\ )&_'
M7_8#O?\ T0] '0^%]2EUGPSI&H3A1-=V<,[A!@!F0,<>V36I6#X!_P"1$\.?
M]@VV_P#12UO4 %%%% !1110 5Y3\6O$OBNW^('@+PMX7U2ST8ZX-0DN;NZL_
MM)"P1QLH5=R@9+G)KU:O)/B'_P G"_"'_KWUO_T1!0!9_P"$.^*O_11=+_\
M"?'_ ,=H_P"$.^*O_11=+_\ "?'_ ,=KU*B@#RW_ (0[XJ_]%%TO_P )\?\
MQVC_ (0[XJ_]%%TO_P )\?\ QVO4J* /+?\ A#OBK_T472__  GQ_P#':/\
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MO(1=N+O9]IB),)38YC5L!05(RI7 Q9B_9<\*V>L176GZGK^EZ?NM9;C1[2_
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MM/+0YL'.B^:$)J4D_>:[O^K+LE8*\N_:5_Y)%J7_ %]V7_I5%7J->7?M*_\
M)(M2_P"ONR_]*HJ[3T3T]/N+]*=34^XOTIU !114-W=P6%K-<W,J06\*&226
M1MJHH&223T %)NVK#<FHKSOP5^T%X!^(.I7-AH?B"*XN8+=KLB6*2%9(%.#-
M&SJ!)&/[RY'O4O@#X\>!?B?J\^F>&]>BU"^BA^TB$QO&9H=VWS8MZCS$S@;E
MR.1SS3WT#8S/BI_R4WX3?]A:Z_\ 2.6O4J\M^*G_ "4WX3?]A:Z_](Y:]2H
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M?^21:E_U]V7_ *514QGIZ?<7Z4ZFI]Q?I3J "O)?VLH=1G_9L^(R:2C27_\
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MOC[_ )+E\*_]S5?_ $0E>I5Y;X^_Y+E\*_\ <U7_ -$)7J544%%%% !1110
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MW!<,.A&&)]00/?/JM<3\:/\ DF.N?]<T_P#1BT 5+72O'/A&!$L]1MO%^GH
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MTZ;Q9X4BTO3K1WB*R.[Q@99DRBY[M[U]<5L](Q79?JS-?%)^84445!04444
M>2?LZ?\ 'C\0O^QWUC_T?7K=>2?LZ?\ 'C\0O^QWUC_T?7K= !7 >.O^2E_#
M7_K\OO\ TBEKOZX#QU_R4OX:_P#7Y??^D4M '?T44UW6-&=V"JHR68X % '.
M^+? ECXK$=P9)=.U>WYM=4LR%GA/UZ,OJK9!KF)?BC-\/0EEX_\ +MF(*VVL
M6D;&WO2!TV#)CD(_AY!/0U=O/B%>>)+Z33/!5JNI21G9<:S."+"V/H&ZS/\
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MO$8_[YK:-2<%>C0=WW:7WN[;^9T0JU*<;X?"RN^LG%/YN[;^9'\=?C%X7L]
MLK2VU!=6N1JUD[QZ?^^"".=)#N8< X0@#.237MD$PN((Y5!"NH8!A@@$9Y%?
M,GB#PO\ $WQA%-I'AVXTR+1M&U94(2.*T$CPE7&$53@!L'\*]Q\">,;[Q'=Z
MUIVJ::FG:CI$T4,RQ7 F1]\2R!@P [-6.#Q$ZF(FZJ:O9+2RTNW9W=_P,,!B
MZE7%5'632E91]VR;7,W9W=_P\CKJ\N_:5_Y)%J7_ %]V7_I5%7J->7?M*_\
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MBML+J7'48ZYKUK]F+3[+3%\60Z;K%SKUD9[.2+4+L$22AK6-N0>1C. .P%>
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M!IUMX?\ #N@W2VUO*8+[SIE1#),%= K$DG:0?F'"@]Z]P7PU\0;SFZ\:Z=9
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M%R2MWTZ'R-&HZ>+G",K<K22]VW*YI-6MS:='MJD>LUYA^TQ_R0[Q1_USA_\
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M%9%APQ3;Q@D9]>>:]?H *RO%G_(K:S_UY3?^@&M6LCQ@6'A+6R@#/]AGV@G
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M"0#WP*]HJ2PKYA^%5Q:^'OAT^DZOX:FUC4==C/V*6)3(NHKN(6,MTB,9Y(X
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MNQ,YE1XMOGP9W'.,8SU[4%-#3Q;\.!X<^PG1ME_]G.G%3 1Y2YVE>#SG\<T
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M74)D)_NM:2$?SKIOA]_R(7AK_L&6W_HI:IJSLR4TU='04444AA1110 4444
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M1]WZ5'_PN_PC;L$U*\NM"E)P4U>PGM,?BZ!?UH [Q5"@   #H!7B_A[X?_\
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M'_A./%FD:%K7@S6/!<OB#3Y-5\/3:G+!*FI6R;2_$3L8I0LB/Y;\[6SG@BO
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M%L8)RN /?)]_=*^??VFO _BC5$E\0V6OVMGH6GV1#VDT"LP<L!NR0>I(YXP
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M(A!]#GBM3]F/X8Q^$?"MKX@76+^_?6;"W<VMRP,<&%Z+_(>@P.>M 'ME%%%
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M4I$6R,!CW&<9H6MK ]-S1^/_ /R0?XD?]BUJ7_I+)6[\/O\ D0O#7_8,MO\
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M_1]>MT %9UAX<TO2]2O=0L]/MK:^O2#<W$405YB.FXCDUHT4 %%%% !1110
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MTL/"U.I3L^E]5\F_RT?D94J.%IVI5:2B^E]4_1O\M'Y'2V5A;:;;K!:6\5K
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MOAB;1M1TJ_\ #MO%:7!O8MBNX&#CTP0>#VKV&FK&J,S*H!;EB!U^M #J***
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MQGOBN\\(_$6SUYX]-U&*71/$:*//TN^7RWW=S&<E9%/8J3[XJEK'_):_#/\
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M1)/!(-KQR*&5AZ$&O!/'7PHO/"_CGPYK&E:Y/;>%O[3ME/A\NYB25FQN0$X
MZ''8]*\C&X-0H2IJ-XO331KS?1V]+^IX68Y>H8:5)0YH2TT?*U?JTK*5O2_K
MN>N?#:QUG3/ .@6?B J=9M[..&Y*R>9EE7'+?Q-@#)[G/6NDHHKZ&$%3@H+I
MH?5TX*E"--.]DEKOH>6^/O\ DN7PK_W-5_\ 1"5ZE7EOC[_DN7PK_P!S5?\
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ME-^$W_86NO\ TCEKU*O+?BI_R4WX3?\ 86NO_2.6O4J "BBB@ HHHH ****
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MY(WXZ_[ =[_Z(>NUKBOC;_R1OQU_V [W_P!$/7Z$?JQK^ ?^1$\.?]@VV_\
M12UO5@^ ?^1$\.?]@VV_]%+6]0 4444 %%%% !7DGQ#_ .3A?A#_ ->^M_\
MHB"O6Z\D^(?_ "<+\(?^O?6__1$% 'K=%%% !1110 4444 %%%% !1110 44
M44 >/_%_Q1J/@3XB>#M;M?#]]K]M+!=:=(EBA9D,CPL#TQG"' .,\\\5T8^+
ML*?\?'A/Q9;#N6T:20#_ +XW5WM%<*H58U)SA4TD[VLM-$OT/-6&K0JSJ0JV
M4FG:R=M$O76QP@^-/AE.+C^U[-O2XT6\7]?*Q7,>(O$_PZU_4EU6V\0GP_XA
M1=BZI!#)!*5[+(&0"1?]E@?;%>Q4UT5QAE##T(S1.C6J+EG*+_[=?_R0JF'K
MU8\LY1:_PO\ ^3T?FCQW2?V@-,T2_AT[Q+JVF7<,AVQ:WI<H:$GTFBR6B/OR
MON*M_%7XB>&&T/1KQ-?TZ6VAU>TFDDBN5<*@?EN">*],FT33KD$36%K*#UWP
MJ?YBO%?C!^SI8ZGI%U?^$M-M8M2\Q;B;2I!BUO=IS@@8*M[JRY[UP8F&-IT)
M*#4_OO\ \'\_5GF8NGF-'#34&JGR:?YN_P"?FV>X6-];ZG907=I,ES:SHLL4
MT3;E=",A@>X(-3UR/PH_MA/A]HL6NZ3;:'J,,(B:PM.(XE4[4 &3CY0.,FNN
MKV*4W4IQFU:Z/H*-1U:4:C5KI/M^9Y;X^_Y+E\*_]S5?_1"5ZE7EOC[_ )+E
M\*_]S5?_ $0E>I5J;!1110 4444 %%%% !1110 4444 %%%% '@WQ"T[Q=\/
M_C=<^//#W@V^\;V&KZ FCSVFEW-O%/;SQ2O)$S">1!Y;>806!)7&<&M7X4?
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M)9\0_P#P40__ !^O0_#'A73?"%C/::7"T,$]U->.K.7S+*Y=SDGNS$X[5KT
M>2_\- 7'_1+/B'_X*(?_ (_1_P - 7'_ $2SXA_^"B'_ ./UZU10!Y+_ ,-
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MOX;^/[[3KR,36]S%I,)21#T8'S^E>RRQK-&\;#*L"I'L:R_"7AC3?!7AK3M
MT>(P:9IL*VUO$TA<HBC@%B23QZT >>?\- 7'_1+/B'_X*(?_ (_1_P - 7'_
M $2SXA_^"B'_ ./UZU10!Y+_ ,- 7'_1+/B'_P""B'_X_1_PT!<?]$L^(?\
MX*(?_C]>M44 >+:9^T[;ZS/?PV7PW\?W,MA.;:Y5-)A)BE #;3^_ZX8'\:O_
M /#0%Q_T2SXA_P#@HA_^/UW?A/1=$L/[3U/1&2:/6;IKVXGBF,J2R[0A93D@
M#" 8''%;] 'DO_#0%Q_T2SXA_P#@HA_^/T?\- 7'_1+/B'_X*(?_ (_7K5%
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MQ#X4TSQ+/I%QJ,1E?2+Q=0M6$A4),J.@8X/(VNW!XYH \^_X: N/^B6?$/\
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M=+H]9_9Z36K[7_$.M^(OA]9Z#KNHPV[W?BNPOUN+77,+B-[=2Q>.+9M;:P4
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MZ?\  5ONV_$****0PKG_ !WX"\/_ !-\+7WASQ/I<&KZ->H8YK:<<>S*1RK
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MXJU2]%]<:!#I&L:K*+F[TT:A=FVF_>,/GV[&==V<%O05Z7X UF]^$_QR\4>
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M6_\ "Z-9_P"B7>+_ /OW;?\ QZC_ (71K/\ T2[Q?_W[MO\ X]7J5% 'EO\
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M;&YMS<(HP,9R2>#JD'1OL?1%%?$GB/Q]XOG^&WQ'^-T/BS5K6\\+^*[FRL-
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M .A%\6_^ 4/_ ,>H_P"%K3_]"+XM_P# *'_X]7?44 <#_P +6G_Z$7Q;_P"
M4/\ \>H_X6M/_P!"+XM_\ H?_CU=]10!P/\ PM:?_H1?%O\ X!0__'J/^%K3
M_P#0B^+?_ *'_P"/5WU% ' _\+6G_P"A%\6_^ 4/_P >H_X6M/\ ]"+XM_\
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M^[;_ ./5ZE14E'EO_"Z-9_Z)=XO_ ._=M_\ 'J/^%T:S_P!$N\7_ /?NV_\
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M[;_X]7J5% 'EO_"Z-9_Z)=XO_P"_=M_\>H_X71K/_1+O%_\ W[MO_CU>I44
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MLSH/A$?!UOXCD@U*WUJ77].UE;09M;HW+7"9B+$.JEBI&X;AGIFO;J*5NO\
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M^O-?_1J5ZU0 4444 %%%% !1110 5@S>.-&M_&7_  BTEWMUK^SCJOV<J?\
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M@ HHHH \E_:M_P"3?_%O^Y;_ /I3%7K5>2_M6_\ )O\ XM_W+?\ ]*8J]:H
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M](?!WXE6_P 7/AOHWBJ&U;3S>HZS6;OO-O/'(T4L>[ SM=&&<#.,U@?LP?\
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M-_Z : .6^ 7_ "1/P/\ ]@BV_P#18KOJX'X!?\D3\#_]@BV_]%BN^H ****
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M>8_M)>(?^$8^#6OWPTO2]8?$,"6^MPB6R#22I&))E/5$+;C_ +M>G5Y[\?\
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M(YR>W"FD]T-'->.O'GCC7_BA#X#\"WVE:+=VFA#7+_4=5LFNU;?(8X85173
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M!)&_;@D$$$$$@BE^&GPPTKX7:3>6FG37E]<W]T][?:CJ,WFW-W.P +R-@9.
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MBB@#R7]K#_DW?QO_ ->:_P#HU*]:KR7]K#_DW?QO_P!>:_\ HU*]:H ****
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MHFG(/D$9RN<]3SD^IS7&>%-0NOV:?"UIH5TOA^);NZ=A+>:RYDDE(7=PMO\
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MWGQIOKSP)9^"S?"*=)IV@U)666.)P9%#!  & (#!N]>?6Q=)QE"+][:UGO\
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M-V,%G@O+HZAY'FCRR4,8CW_=W#=@<X)KZ;KR7]K#_DW?QO\ ]>:_^C4KUJ@
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MAJY7PYIT8L[R:*5V47%V0^8V88))&,Y^4U[?4E!1110 4444 %%%% !1110
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M'_(OZ=_V%['_ -'I7D_[8OAS0;[1M'U*_P!1CLM6BD:"VBF9]DR'EA\JM@C
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M)QB:2565"C CYQC*]3UKZ]U[QO\ "SQ28#K5QH6KF#=Y1O[59_+SC.W<IQG
MSCT%0:[\6_AOIWA.\L([W2+RTALW$6C;%$4JJI(B"%=N#@#&,4 >%>"?VC/%
MP\7IX;\*^&= O]'@FBMQ;Z$?.MXMW\1GC)7!PQR1_">N*])\1?$V36?'7A#0
MM0OO"T=[:^((A-9Z;K0N+N)PDB[7B**5Y8 Y[D#O5+]GOXZ>#]2T+4Y[S2M!
M\$WWV@(\6FP"%;A ,HQ"C)(W,.??'4BMGQ+>^ /$'C/PA<>'[?1[G7)->CGG
MN+2T43NHCE+,SA03\VTDD]<&@#U3Q/X]\,^"3;#Q#XATO0C<[O(&I7D=OYNW
M&[;O(SC<N<=,CUJV?%&CCP__ &\=5LAHGD_:/[2^T)]G\K&=_F9V[<=\XJ/7
MO".A>*3 =:T73M7,&[ROM]I'/Y><;MNX'&<#./058.@Z8='_ +(.G6ATKRO)
M^P^0OD>7TV;,;=OMC% %'PQX\\->-A<GP]X@TO71;;?/_LV\CN/*W9V[MA.,
M[6QGK@^E<UXU\?Z#J]GJOA31?'.B:;XQG5K.V@.H1"XCN#P%V!MP;MP,BF>-
M]!T[P+X-O'\+V-IX9N+NYM899])M8H'(,RKV7!(#MC(.,FO*/C#I/A/X/:WI
M&JWHUK4-6U"X:07]O'9B=&4C+^88,E^>.<GUKEK5HTT^;:VK]3Q\=C:>'A-5
M4^5)7=[6YKI>=S3\37&I_"_X :AI'C;Q78W7B:Z61K$7E\#)-M93L0R$-)MR
M"?3(J_\ #_\ :&BT7X=Z3J?Q$OK:VO=2G8636*B4RVV!ME94)P,[AGN /6M7
MX@_##PE>Z7;3>,O%NI26P_U#:G);,ZEL9";H<@G SCTYKS_PQ^Q_I^LZ[<:I
MJ'B5=2\/.<V TW:'9/X0Q*E% Z848^G2N":K0FO8K6UM7^+/GZT<=AZT%@(W
M:BHVE)-)7;YI*]WV7](^A_#'C[PSXU:Y7P_XATO7&MMIG73KR.<Q;LXW;"=N
M<'KZ&JTGQ1\&PZ__ &%)XKT1-;\T0?V<VH1"X\P]$\O=NW>V,UP6J_"*R^&W
MA;7=6\.ZQJ6F745LT[?9DMHEE9 2H?9""PY/?N:[S3?!'AN]DL];G\/:3)K$
MBI<-?M8Q&<R8!W[]N<^^:]2,VWRM6/K:5:4YNG./*TD^G6_;T+GB?QSX<\$I
M;OXAU_3-"2X+"%M2NX[<2$8R%WD9QD9QZBK$/BC1KG0/[<BU6RET7RC/_:*7
M"&W\L=7\S.W;[YQ2:[X4T3Q2L*ZUHVGZNL))B%_:I.$)QG;N!QG Z>E31:#I
MD&D?V5'IUI'I?EF+["L"B#8>J[,;<>V*U.LSO#'Q!\+^-9)X_#WB/2M=>W :
M9=-O8[@Q@YP6",<9P>OI7F_[1GQ.\'V_PK\>Z%+XJT6+6_[)N8?[.?4(A<;S
M&<+Y>[=GVQ7J&A>#M \+O,^C:'IND/, )&L+2. N!T#;0,XR>M><?M%>!/#4
MWPC\>ZM)X>TJ35?[(N9/MS641GW",X;?MW9]\T >G>'/^1>TO_KUB_\ 0!6C
M6=X<_P"1>TO_ *]8O_0!6C0 4444 %%%% !65XJ_Y%?6/^O.;_T UJUE>*O^
M17UC_KSF_P#0#0!RWP"_Y(GX'_[!%M_Z+%=]7 _ +_DB?@?_ +!%M_Z+%=]0
M 4444 (5!() )'0D=*YO4/#UU+XYL-=C:-H+73KBU,1)WL[O&RX[8^0_G72T
M4 >4? _Q]XV\:WOB2/Q;X=;1(;*=4M)&B:/?DMN7YOO8 4[AQS7J]%% !111
M0 5P7Q>U"VTJR\,W=Y/':VL.NVKR32L%5!\_))Z5WM<!\8;RTT[3_#5S?RQP
M6<6NVK2R3$!%7Y^3GM6-;2FSAQSMAYN]O^'/"_VP/B'H7B#1_#EEHMY8:K<I
M=/<// %E,05<!=W8,6.5Z':/04SPA^U==>#?#^GP^([&RU.[DMVV+INV*6%5
M)$8E &P9P3@8(')49&?1_C'\9O!OA?PK%J.G6NB>*K]+E$BM=\;>5D$F0X!.
M!MQQW(KSC_A9_P //B]9:SJ^J^$K*S\1Z78EK.*\N@(KL@$A.-N<-V]#UKPZ
MLG&O*4*J4FEI;3]3\_QE2=+,*E6AC(JK)+2SY;)=]4WH[>IR-_\ %OQ/\8_$
MNA/JB:/IFD6E]'*R2S1P,@!!+;W828QW3&>G-?17Q3^(_A75O >H65CXATZ[
MNI6@6.&*Y5G<^<G &<GI7@O[/L*ZGXSC\9^*_%]CI\5L7C33YIE#3@H5 VYP
MJ#/ QV[=:]V^*'C?P=J?@>_M=.U?2KB]E>!8HK>5"['SDX '-/#2DZ,YREK+
MOOMZZ&F55*LL%7Q%6JN:HG\5KM):62>G70]>HHHKZ$_2@HHHH \E_:P_Y-W\
M;_\ 7FO_ *-2O6J\E_:P_P"3=_&__7FO_HU*]:H **** "BBB@ HHHH *\W_
M &B/"VH>-OA!K^B:6\)O;N- MM<7'D)=JLBL]N7_ (1(JLF?]JO2*^1/VFM1
M^'%Y^T;X=TCXOW5NO@N'PM/=6=M?M(+9KY[I4WX3JXC4X)Z<XJ):M1[_ *)O
M]"XZ)R[?JTOU,/\ 9Z^%_BYOBEHM[)\*Y?AKI.A:_K&IF\GFM5#V=U$R16$*
M0.VY Y1R>$'EC'-?:]?+/[%O[1'@[7_AEX1\%3^,(]0\71FZM(+*Y:1KF2&*
M:7RMS,.3Y"(<D\@5]35M+1)+9+3^OZ^\R7Q-O?\ X+_K_@!7.^/OA_H'Q.\,
MW/A_Q+IZZCI<Y5VCWM&Z.I#(Z.A#(ZD AE(((X-=%16;5]RT[;'F>A?LX_#_
M $+PCX@\.#1'U33_ !",:O+K%[/?75_QA?-GF=I#M &WYOEP"N#6I\,?@QX5
M^$,.H#P[:70N-1='N[[4K^>^NI]@VQJTT[NY5 2%7.!DX')KN**?6Y-NAY;H
MW_)R_BK_ +%?3/\ TIO*]2KRW1O^3E_%7_8KZ9_Z4WE>I4#"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "O+_VF?\ DAWBC_<@_P#2B.O4
M*\O_ &F?^2'>*/\ <@_]*(Z /38?]4G^Z*?3(?\ 5)_NBGT %%%% !1110!Y
M+^U;_P F_P#BW_<M_P#TIBKUJO)?VK?^3?\ Q;_N6_\ Z4Q5ZU0 4444 %%%
M% !1110 4444 %%%% #)8DF0I(BR(>JL,@UD:]X,T/Q/I<VG:GI=K=V<PPT;
MQ#\"#V(]16U7*_$_0M;\2^!M4T[P]J TS5YD AN"Q7&&!(W#D9&1D>M9SMRM
MVOY'/B$O92;ASZ/3OY:]SY-U#P[H'P@\7:EX)ETU]=NK^6U>'4[N!/\ 1EW@
MX0$$_,I(8@C.!Z5[3\)=2^&2?$OQ-H7AG0WM-65F,\TJ%HG"-AEC!)V@,>F!
MG\JY3Q=H?]I_!F3PKJ'BJRO_ !OI<L)NI(7\R5$:8*(V;ABHWJ2?4"O;?AW\
M-=.\!:5:JL4-UK(MUAN]4\L++<L.I)Z_YYS7CX>C)55RI<JUVVWT]?,^'RS!
M5(XI*E"*IJTM4FXI\WN)W;YD[W?R\CJ!IEFI!%I ".XC'^%6:**]P^_22V"B
MBB@85YE^TQ_R03QQ_P!@V3^E>FUYE^TQ_P D$\<?]@V3^E 'H]I_QZ0_[B_R
MJ:H;3_CTA_W%_E4U !1110 4444 %>6?LP?\D.\.?[UW_P"E<U>IUY9^S!_R
M0[PY_O7?_I7-0!ZG1110 4UXUDQN4-CU&:=10!XK^U-X[L/!?P\?3Y'N;6\U
MK=;07%F@S'C!8DY'&"!@')S7D]K^R+-?7'A)]0UZ_P!2CU"":*YN8(FVVJ>0
M[Q'+<A<E5P<9SCO7UEK/A[3/$4,46J:?;:A%$XD1+F(.%8=QGO5\    8 [4
M >4_!;]GK2/@U)J%Q;7UQJEW>HD;R7"A555). H]SUKU188U.5C4'U %/HH
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M5^DFMF[64FKN_P!WUQX_U.UU'X6Z]/;WEO>1R:;*5FMY R/\AY4@GBNET/\
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M/P/_ -@BV_\ 18KOJ "BBB@ HHHH **** "BBB@ IDL,<Z;)$61/[KC(I]%
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M>9Y"TKR-"X6-(U3T^][&E>]K=?\ )O\ 0=M_ZZI?J?7-97BK_D5]8_Z\YO\
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M_P#1J5ZU7DO[6'_)N_C?_KS7_P!&I7K5 !1110 4444 %%%% !1110 4444
M%%%% !1110!Y9I$BI^TQXJW,%_XI?3.IQ_R\WE>G^?'_ ,]$_P"^A7(^,?@W
MX'^(.IQZCXE\*Z5K=]'$($N+VV61Q&"2%R>P+,<>YK"_X9@^$W_1/?#_ /X!
M)_A0!Z7Y\?\ ST3_ +Z%'GQ_\]$_[Z%>:?\ #,'PF_Z)[X?_ / )/\*/^&8/
MA-_T3WP__P" 2?X4 >E^?'_ST3_OH4>?'_ST3_OH5YI_PS!\)O\ HGOA_P#\
M D_PH_X9@^$W_1/?#_\ X!)_A0!Z7Y\?_/1/^^A1Y\?_ #T3_OH5X5;?L@^
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MO"W_ ();;_XBC<6QV?GQ_P#/1/\ OH4>?'_ST3_OH5QG_"C?AO\ ]$^\+?\
M@EMO_B*/^%&_#?\ Z)]X6_\ !+;?_$4 =GY\?_/1/^^A1Y\?_/1/^^A7&?\
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M#L_/C_YZ)_WT*//C_P">B?\ ?0KC/^%&_#?_ *)]X6_\$MM_\11_PHWX;_\
M1/O"W_@EMO\ XB@#L_/C_P">B?\ ?0H\^/\ YZ)_WT*\?\8?LS^$-:\5>"]0
MT[P?X5L[#2;^:XU&W_LJ%/M436TL:IM6/#8D=&PV!\N>H%=;_P *-^&__1/O
M"W_@EMO_ (B@#L_/C_YZ)_WT*//C_P">B?\ ?0KC/^%&_#?_ *)]X6_\$MM_
M\11_PHWX;_\ 1/O"W_@EMO\ XB@#L_/C_P">B?\ ?0H\^/\ YZ)_WT*XS_A1
MOPW_ .B?>%O_  2VW_Q%'_"C?AO_ -$^\+?^"6V_^(H [/SX_P#GHG_?0KS/
M]I>:,_ 3QP ZD_V;)W^E;/\ PHWX;_\ 1/O"W_@EMO\ XBE7X'?#A6#+\/\
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M 'I?GQ_\]$_[Z%'GQ_\ /1/^^A7FG_#,'PF_Z)[X?_\  )/\*/\ AF#X3?\
M1/?#_P#X!)_A0!Z7Y\?_ #T3_OH4>?'_ ,]$_P"^A7FG_#,'PF_Z)[X?_P#
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M$G^% 'I?GQ_\]$_[Z%>??M"S1GX&>/ '4G^QKKO_ -,S57_AF#X3?]$]\/\
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M>5,J"?F167'?/- 'N7GQ_P#/1/\ OH4>?'_ST3_OH5YI_P ,P?";_HGOA_\
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MB2")(HQM1%"J/0#I5VM%7_K3[ON)O>3L/HHHI#"BBB@ HHHH **** "BBB@
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>'>.?'GQ \2_%;5?
MWP_U#P]H5UHFFP:G<SZ]9RW37AE9PD:(DB;$^0AGY.2 !7GO[16H^*;77[RZ
MT+QM+XA\ RW=O_PE?A[1[@#5='MDP));9H2)/+8 >8GW@,E3R17,?#7X3^!/
MBG\7KS_A#_%>N^(/!MEI*3V7B#3=:N/M&F3/(0]DEYNWO&ZC<8F+;".V:4;S
M:^?Y7^[MT=K>0Y>ZG\OS7X]^VY]-? [XE7?Q3\")JNI:<FDZQ;7=QIVH6D3[
MXDN()#')Y;=T)7(/7!YKT"L/P7X,TCX?>&[/0M"M!9Z;:@A(]Q9B2269F.2S
M,226)R22:W*MV;T)04445(PHHI.E "U\\ZU^T/XXNCXKU[PCX&LM?\%>%K^X
MT^_=]1,>I736^/M#6\.PKA#D .P+;3C'&>9^-O[0O]N^-='\)Z1JWB+P7X0&
MHO8ZM\0["SB>Q2Y\HF&U69BVW,A4,Y3;T4-UQE> OV??%>I^,O&.C>(M7U_P
M[%J:K<:AK?AB:)-*\4Q.NPRLC M:W94;9/+QN # \BI5Y:KL[=KZ/7RM?3?5
M-:%.T='W5_35:>=^NW1GU5X0\5:=XY\*:/XBTB8SZ7JUI%>VLI&"T4B!E)'8
MX(XK7JAH.AV/AC1-/T?2[9+/3;"WCM;:WC&%BB10JJ/8  5?K27+S/EV,X\W
M*N;<****DH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BH+R]M].M9+FZGCMK>,;GEF<*BCU)/ KROXV_&Z]^'5QI^C>&M#A\2^)
MKVTN-3\B[O5L[2TL8 OFW$TQ!PN715"@DLW8 FDVEN-)LY;XZ_%^Z\3^%?'7
MA#X?6NMZAXBT^W>&YU/3+<I;0.FUY[=;DX59_*+ 8SM9AD@U\X? [1/#OQ9U
MV+1='T(SZ/XGNY/^$E\,7,=WM\-V$,$H@9II"-M^\YB8N,MU X!)['X1ZIKW
MQCT+QUI_PWUC0;72/%4L\^O^$_&$,HU'P]<W2 3M$J#$\,@/F)NVJ=W#<D#[
M'\$>%XO!'@O0/#EO/+=0:/I]OI\<\QR\BQ1K&&;W(7)JHQY=9]4OOZ_):6[I
MZ/<4I7TB^K_2WS_)KT,OX6_"S0/@_P"$[?0/#UNT=O'\TMS.0UQ=28 ,LS@#
M>Y &6/I77T44-MN[$DEH@HHHI#"BBOBGXW3WWB#XV^)=,\2?#_QGX\U&VEM!
MX)TC299[/20AB1I+N:[1UCC=9=ZL7)*A0 #G-*_O*/\ 7_#^7KV';1L[W]H7
M]H?4=(U37?!VA>%;3Q''!]FTZ^AN-4>SN;R>[5C';6:QHS-)Y8+ER550.O4C
MD_@Y\+%\<^"H_A[JJ3>)/ &FRW!\-^,K*<6^K:#<P3,CVLCX!,T4@8+,HPZK
M\P/?/TKX9>(OB7^TK=R>*[FQ\%?$[2- AO$\1^!G^T1_9)I'B-K<+<QD"4;/
MED !*[NW%?6/P[\ :3\,?"-CX=T5)%LK;>YDF??+-*[EY99&/WG=V9B?5C51
M5H\SZ_H[?@[VZ]-KN4R=Y673]5^JMY6WULH[UG;FSM((#+)<&)%3S9CEWP,;
MF/<GJ:FHHH;OJ"5M HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BJFJZ
MK9Z'IEWJ.H7$=G8VD33SW$K;4CC4$LQ/8  FO(_C#\<IM$TWPI:^"+G1[W4/
M%*W$]GK6H3%M-M;2"$S37#LG+_+@*JGDMG( -)NW]?U_2&E<;\;/B$GB6U\3
M_"[PK)J<GC2^TN2#[=IUJSV^E231-Y+7$PXBW8R.X'..E?,WP5\#:YKGBFP^
MR?#ZY\)ZY>7T&GZY;'3$_L6T\/P[O,MDN&!6[DG8*3(OS$GJ #G2^"/Q-\<^
M,OBAXFN/#BZ-X>\<:_9VU[K/AGQ1'.ME?QK%Y=OJEA+&&;:\2J&A< @KSCK7
MUS\$_AL/A!\+/#WA 78OFTR!D>X2/RT9V=I&V)D[4#.0J]@ .U.,>5\S\OP;
M_#H^Z;3L[H4FI+E7]72_'9KLU=75F]+X??#?PU\*O#<.@>%-(@T;2869DMH
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M1112&%%%% !1110 4444 %%%% !1110 4444 %%%% 'RGXW^,'BGXO7OC]?
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>aciu-20221231x20f025.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f025.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "Z EH# 2(  A$! Q$!_\0
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MJMDAP-PX(ST/PL^(-I\5?A_HOBRQM9[&TU2$S1V]R5\Q!N*X;:2,_+V-?/\
M\"?@]\,/$VI_$>'0OB'-\0O#>IQZ=:/I<6NRRO9);Q[8\R1NK8)3",I VJ5!
M(S7HO[&T:P_LQ?#V-!A$T_8H)S@"1P.: .M^)VG:OJT_AJUTI))$>_D-THNI
MK:/RQ;3$>9)#\P&_9CL3BH/AY8Z[HE_>:=K6IW>H-"T:)<31.R7&+>+<5<YP
M Q89)RQSG)S6C\0=>NM'.AVT&H1Z-!J%X;>?5)55A;J(G< ;_E#.R!06R.>A
M)%9_A#QQ>ZQ?R6"76G:M:6B0[]8WF#[4TDDBC9&%(R!&>0V&)^7 JU@Y27MT
M_P"MO3?SOY6.O^U5&E]2<5:UK];WYK_=IM:W6Z5NRUNXN;31;^>SC\V[BMY'
MACV[MSA25&._..*XO0+_ ,:7'AC6HKD+-K4/DM9SO:B!7WPQNZ[2<':S.N<]
ML'D5VNLZA_9&CWU]L\W[+!)/LSC=M4G&?PKC]$^(>IZIX:UB]?18_P"T[#RF
M6SM9WF642Q1RJ 5CW9 DP<(>5XX-)8>=7WXO1:;]S.&-IX>+IR@FWKJK[:_=
MH[KK]Q#K=KXCOOAE-'J,=P?$3.$B&GSO"5=I-D;DPL"54,&89QA3FL3PK:>(
M=)^*'V&ZN-4O=/@S;1M</.R?95MH]DSR$^4[-*'!&/,W$G.T8KH]5\5Z]/\
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MC@ J0PSQS4?PR\67'CSX=^&_$=W8-I=SJNGP7DEFQ)\IG0,5!(!(YX) .,9
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M>HZ5:-I+1I[C62Z=2K&!E(P05.#^M)'#/%G8+=,XSM0C.!@=_2G_ &^'U?\
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M_"D,3%W_ 'H?^^3_ (U'+:2SQ-%+':R1L<E'C)!.<YQ]>:E^WP^K_P#?MO\
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M0Q"<&]N96OYQ;TDO-77F>D453MXH;J%)H+MYHG&5DCEW*P]013_L0_Y[3?\
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MC--OL_F=M15;[$/^>TW_ '\-'V(?\]IO^_AKF.DLT56^Q#_GM-_W\-'V(?\
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MEHMRHRC!\TE=(ZS7?CA>^&]'O-4U'X7^*[>QM(S+-)LLWVJ/9;@D_0 FN?\
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MW::L8PJ0J*\'<E\F/_GFOY4GV:+<&\I-P&,[1G%1_97_ .?F;_QW_"C[*_\
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M(Y+2Y:W=4?&]-T;J=K8&5S@X'H*I7/PY\/7-O%!_8DD$<4AEC^S7#0E2R*C
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M?,[);M&T6T;G^5 A*CTQZT7OPZ\+ZUJ]OJ4EC))=3/\ :T,5[@38=9 V _S
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M&O%O;VV4O+!"86WNJCEF"Y('?I53X#:$/#/P4\#:4MW+?K9Z-:0BYFMY+=I
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M0M*U6>YM8H(_)\4Q6J(Q$(,B;6!$D6V<_P *R%QN+ X4L@NS["_X63!MV_\
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MGL/%AGL_B%IVH^'K=[C['82^*8XV:$R3LL4\A8LQ=7A42<M'LX88R2R"[/K
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M CPM?L#R"#:D'_R-40^*NFF'SAX?N3#M+^;YUGLVYP6SYV,9XSTKQSX?>(M
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M>Z\1I(WF1@B"XVECL?:26VA>2>&X-.R"[/KV;XHV5E$9YO#.HPQ(06D'V8[
M2!G ESW[5Z'7P-K,WC36-9M+^3QOI-EIS7BR-I%IXA@F,2>=%E&Q@3!T5E"
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M@L<#DUX?X5_9@^)_PP\(1:#X4^/&H6.C6 F:RT\^%["8H&=Y-F]P6;YG/)-
M$6@?$?59KOP<NK/H$5W<K:BYL(]+2,:EYM]<P7+Q[B61;>*%)>"<!LN<$5G^
M.OBIJVA^*O$%G8+H%U:S7L5M9-:+;-%I5MYENCW%VSIF%F\TE&?<A!S@[>=;
MP#\+/CWXI\$Z!K&O?'"_T#6[RRBGN]+D\(::S6<KJ"\62N>#Q[XK>/P-^,IW
M9_:&NSO&UL^#M,^8>A^7D4 >C_#)+#Q=\/?#NLWFDV@NKZQBGE+6*1$L5&3M
MYP">1@D8(Q73?\(UI'_0*LO_  '3_"O%/^%)_&G_ *.*O_\ PD--_P#B:/\
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M'Z;D ]>=OL/RH ]L_P"$:TC_ *!5E_X#I_A1_P (UI'_ $"K+_P'3_"O%/\
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MR/)%9VSOJ>ZYNXO,CVX\Q8U@A+RPX12[$@C %CQ';0Q^(=41(8D1;J4!50
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M\.>%['2-6O5=);BW4_*KOYCI&I)6)6?YF5 H) )!(H [JBBB@ HHHH ****
M/%/@EJ'BH_%SXO:3XG\2-X@^PW6FR6B);_9[>SCEMBYBBCW,0!QEBQ+')..
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MKUBN=GN/#GPI\'6ZE+;P_P"&M+CAM8TABV06L998T&%&%0$J">@')( )KHJ
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MN=M?9U% 'RGXTT+Q+_PD/QANO#ME+J7Q T;Q%I7BO1+!9O)_M&T6QB@6#<2
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=2A(XHE"JBCH !P![4 2T444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>aciu-20221231x20f026.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f026.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #X BL# 2(  A$! Q$!_\0
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MP0_]"C+_ .!J_P#Q-%F!]1T5\N?\-P0_]"C+_P"!J_\ Q-'_  W!#_T*,O\
MX&K_ /$T68'U'17RY_PW!#_T*,O_ (&K_P#$TG_#<,//_%(S<>EZ/_B*+,#Z
MDHKY;_X;@A_Z%&7_ ,#1_P#$T#]N*W89'A&8CVO1_P#$468'U)17RY_PW!#_
M -"C+_X&K_\ $T?\-P0_]"C+_P"!J_\ Q-%F!]1T5\N?\-P0_P#0HR_^!J__
M !-'_#<$/_0HR_\ @:O_ ,319@?4=%?+G_#<$/\ T*,O_@:O_P 31_PW!#_T
M*,O_ (&K_P#$T68'U'17RY_PW!#_ -"C+_X&K_\ $T?\-P0_]"C+_P"!J_\
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M5\N?\-P0_P#0HR_^!J__ !-'_#<$/_0HR_\ @:O_ ,319@?4=%?+G_#<$/\
MT*,O_@:O_P 31_PW!#_T*,O_ (&K_P#$T68'U'17RY_PW!#_ -"C+_X&K_\
M$T?\-P0_]"C+_P"!J_\ Q-%F!]1T5\N?\-P0_P#0HR_^!J__ !-'_#<$/_0H
MR_\ @:O_ ,319@?4=%?+G_#<$/\ T*,O_@:O_P 31_PW!#_T*,O_ (&K_P#$
MT68'U'17RY_PW!#_ -"C+_X&K_\ $T?\-P0_]"C+_P"!J_\ Q-%F!]1T5\N?
M\-P0_P#0HR_^!J__ !-=_P#!C]H5/B_X@OM-31'TLVMM]H\QK@2;OF"XQ@>M
M%F![)1112 *\L_:<_P"2)^(_]R+_ -&K7J=>:?M&Z?=ZK\'=?M;*W>ZN9%C"
M11C+-^\4\4T!^?;C*FOH[XE^"] U7Q!XJUK61>+;:%H>F7"P:<R1F7>-I4Y!
M SQSVKQ0_#?Q2R_\@&]Y_P"F===JUY\3-;AUB*[TNX=-6M8+*["VBKOBAYC
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MXJ_Z -[_ -^Z/^%<>*O^@#>_]^Z .<HKH_\ A7'BK_H WO\ W[H_X5QXJ_Z
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ML;PI_P!#+I/_ (&1_P"-'_"Q_"G_ $,ND_\ @9'_ (T>UI_S(/J&,_Y\R_\
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MEX_B['\:]#/-5-5T^/5;":UE^Y*N,^A[&OH^'\VGD^84\3?W=I>CW_S/'S7
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M01D&OBZOH#X"^+SJFAR:+</FYL.8MQY:$GC\CQ^5)@>K5U_PS_Y#%U_UQ_\
M9A7(5U_PS_Y#%U_UQ_\ 9A4C1Z31114E!6!XY_Y%B\^B_P#H0K?K \<_\BQ>
M?1?_ $(4 >7:=_R$+7_KJG\Q7N%>'Z=_R$+7_KJG\Q7N%-B04444AA1110 4
M444 %8GC>\FT[PAK5W;2M#<064TD<B#+(P0D$#N16W4%]90ZC:36MQ&);>9#
M')&W1E(P0: /((]1U^],W]E:MJMW86\$]Q:3NF'N95BB.QLJ-RAV? XR<CM5
M74_$FH6UGJ#Q:YK']B0PRR66HB(F:6X$2GRV^3)0,6Z@#.1GBO;4C"*% X'
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M]GV<MQ)Y<3PR$1A<S,"0 YVG;CDGT)KG/&-G;6>K1"U2.%'B#-"BA6C.2,,
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M@',:N-RQT:J_ANR?=;I?+_(_&^*,)##8SVD'\:NUY_\ !'4445^EGQH4444
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M_B-_R,8_ZX+_ #-?FM\?/^2R^+?^OT_^@+7Z4_$;_D8Q_P!<%_F:_-;X^?\
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MBQ>?1?\ T(4 >6V'_(0M?^NJ?S%>XUX5;Q&:YAC#%-SJNX=1D]:]%_X0*?\
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M#:O_ -!*^Y_YA_KA2_Y\O[T?,FX>HHW#U%?3?_"G=._Y[#_OPM'_  IW3O\
MGL/^_"T?\0VK_P#02ON?^8?ZX4O^?+^]'S)N'J*\[^(NMB>ZCTV-QLB^>7!Z
MMV'X#^=?;DGP@TN)&:2X1$ R6:!0 /4FJ1^#'AR:Y:,O:27. [(;:,O@_P 1
M'7'O7T>0<$+*<;'&5ZJGR[*UM>YX^:<2?7\,\/2@XWW=^A\ @KZBC</45^@G
M_"B="_YY6_\ X!QT?\*)T+_GC;_^ <=?J_,?"V/S[W#U%&X>HK]!/^%$Z%_S
MQM__  #CH_X43H7_ #QM_P#P#CHY@L?GWN'J*-P]17Z"?\*)T+_GC;_^ <='
M_"B="_YXV_\ X!QT<P6/S[W#U%&X>HK]!/\ A1.A?\\;?_P#CH_X43H7_/&W
M_P# ..CF"Q^?>X>HHW#U%?H)_P *)T+_ )XV_P#X!QT?\*)T+_GC;_\ @''1
MS!8_/O</44;AZBOT$_X43H7_ #QM_P#P#CH_X43H7_/&W_\  ..CF"Q^?>X>
MHHW#U%?H)_PHG0O^>-O_ . <=,E^!_AZ!&>1;6-%&2S6D8 'N:.8+'Y_;AZB
MC</45]]1_![PK*(MDU@_G$B+;;Q'S".H7U_"K7_"BM"/2*W_ / ..GS(+'PS
MX&\,OXQ\3V>FIGR2WF3N/X8Q][_#\:^M;>".VACBB4)&BA54=  , 5M:_P##
MW3O!@@FLXHE><E&,<"QG YZBLFE>X!77_#/_ )#%U_UQ_P#9A7(5U_PS_P"0
MQ=?]<?\ V84@1Z31114E!6!XY_Y%B\^B_P#H0K?K \<_\BQ>?1?_ $(4 >7:
M=_R$+7_KJG\Q7N%>'Z=_R$+7_KJG\Q7N%-B04444AA1110 4444 %8_C"ZN;
M'PKJ]Q9LR7<5I*\+*NXAPIP0._/:MBB@#QG5M4\4Z#%J$EKJ=]J,D4\UM&EQ
M&I4)Y$<GF<)R0S/@\\#&#BLS7-=U34?#D]M>ZM.;-UD%G); R_;&$J#RV<QK
MOP">0!P<YXKWBN>U[QA!H=S]F%M->7.$V0P 99G8JB<D $X8Y/ "FF!YG+XO
MUFTU33K>WEN(2MRJ/!M"1NCS2 D($)?@#+$J%..N:ZCPCJFKVNE:I)J%Y>:@
MZZ5;7ZL\*EUE>-RZHH !Y5<*>_UK5M/B1:7^I6MG;V5Q+)+ 9IF+1K]F 9E(
M8%LD@HV0H/2K'AOQY:^)I8(H+::*60.[(^T^6@"D,2"?O;UQ^/I0!Y=!XVUI
MK"_-SK%Y:Z?$KRQ7T6)W,OD!DC+>6 06W9 &,C;FND\%>)=>U/QE%!>W0\M@
M_F6C$G$0C4QR!0F%R3G<7.<D8XK:\;W^G7U]]@GTC4-6^Q()KEK!]@@C?(PV
M&!?< <H,Y K:T;Q79ZA?FPAA>#8TL,990%<Q$!@/H&!Y[4 <C\1O^1B7_KBO
M\S7;^#O^19T__KG_ %-<1\1O^1B7_KBO\S7;^#O^19T__KG_ %-#$MS9HHK.
MU;6HM)>V1U>1[B0HB1C)X4LQQZ  TAE7Q>]@FA3G4XC+8AD\P>675?F&&91U
M4'!/L#FO)-*A6UN])NA/'<ZA$WDV5K)IP\F\C:[8M+"2#Y?RG.!C:%4Y(->@
M'XGP?9WSI%_]M1R&L,)YH3R_,+_>QC8<XSG/&,UJZUXMATG1[;4H;2XU&&=/
M-46RCB/9O+DL0  H]>3@"@#H!TI:Y%?B+:S7%PMO97=S;PQ&5KJ-5V9""0KC
M.X':PY(QGC.:ZJWG2Z@CFC8/'(H=6'0@C(- $E%%% !125REY\0K:T\F3[#=
M2VDDIC:[11Y:#S!&&.3DY<X &3@$XQ0!QWQ!%LWB*9M.MWFU-4G%U:I"RSRA
MK9@LJR_\\P,#:."WN*W?A#"(--U...:&[@%RI2ZMH/(AD_=(#M3M@C!]3FMS
M1?%KZOKM]I<FDWEC/:1K(\DYC9"&)"@%6/)P3@]J@NOB#8P7VJ64$$]W=6$D
M$!CB4#S99<[44D@9&#DG@4P.KHK#T#Q9;>('V11RPR>4)MDP .-S(PX[JRD'
M\/6MRD 4444 %%%8NI^*;329KU;@E8[*U^USR <(N2%'NQP<#VH Y'XT)JMU
MH\$-IIT]]IZ.L]P;>55;>LB>6I!()7.2<>@[4SPZ-7;XLWMWJ>E7%MY^GNB2
MF9'B2)91Y:@ \$\D^Y]!6_;_ !!M[F72<6%XEOJ*1,ERZ )&TH)1#SDMP<X!
M XS6CJWBJST?5])TR8LUWJ3NL2H,A0JEBS>@XQ]30!MT5R>A?$&WURVM[I;*
MXMK.XN!;Q3RO&P8D':<*Q(!QCG!Y%=70 M%%% !1167?:_;V%_\ 996VE;=[
MJ60_=BC4@9;ZG./H: .2^-4.IWG@ZZM;&QFO;62*5KO[/*J.%5"5 !(R"V,X
MYP,=ZPM+AG/Q&T\110K.;EKJZW1M]ICC:U \MFQM,8;;@@G)XQP:Z>U^*FGW
MEOI]Q%9WAMKJ))Y)F15%LCR&.,R G/S,#P,D=36KJWBZ/2M?L-(6SEN[N[0R
M?NGC41H&"Y.Y@3R>@R>#3 Z&EKD;+XCV5Y*P-M<0PED,4T@7;+$TAC$HP<A=
MX YP?F!Z&NM'2D M%%% !1110 4444 %%%% !1110 5S/Q&M8KWP?J%O<7$E
MK;2A%EGCA\XHN]<DIW&.OMFM75=8BTIK99 6>XE\I%7Z%F)]@JDFN8C^*5O-
MHT6HKI5X8IY"L"!XBTJA"[-P^!A03@D'IQ0!YYJ,4UP;,V:V<D\S+;V#BT:(
MLB70(F@"KM!8$[ON\*#R#BO>A7/:QXQMM*TNPO([>6\:] -O!%M5W&S>3\Q
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M3_OTO^%'_">:W_S]I_WZ7_"BP7/6:*\F_P"$\UO_ )^T_P"_2_X4?\)YK?\
MS]I_WZ7_  HL%SUFBO)O^$\UO_G[3_OTO^%'_">:W_S]I_WZ7_"BP7/6:X+Q
M%X?NK_6]7CB@29KN*UG@:21X@&A=@RB1>4;Y@01ZGBL/_A/-;_Y^T_[]+_A1
M_P )WK?_ #]+_P!^E_PHL%RSIGPSO=.;381!II6.6*XEOQN^TQ,LK2-&K$9=
M3NQDD<%L@YJZ_@74+;Q'!?:<T%A;_:LO!;N8U6%2I7Y0,,3^\RIXR^>U9/\
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ME4NI19DWQ$AL?>7FMO[9<9_U\N?]\T!H=-_PK;5/^>UM_P!]'_"C_A6VJ?\
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MZ^OS:6=NADFGFE*I&HZEB3P* T.O_P"%;:I_SVMO^^C_ (4?\*VU3_GM;?\
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MVJ?\]K;_ +Z/^%'_  K;5/\ GM;?]]'_  KF?M=QQ^_FY_VS0+NX/2>4_P#
MS0&ATW_"MM4_Y[6W_?1_PH_X5MJG_/:V_P"^C_A7,_:[C_GO-_WV:SM4\66^
MBW.FP7NH/;RZE<_9+1&=OWTVQGV#WVHQY]* T.W_ .%;:I_SVMO^^C_A1_PK
M;5/^>UM_WT?\*X_5?$$>B6,EYJ&H&SM(\;YIY2JKDA1DD]R0/J:9I7B6+6Q=
MFRO99OLES):3\NNR5#AUYZXSU'% :'9_\*VU3_GM;?\ ?1_PH_X5MJG_ #VM
MO^^C_A7,_:KC&?/EQ_OF@7=P>D\I^CF@-#IO^%;:I_SVMO\ OH_X4?\ "MM4
M_P">UM_WT?\ "N9^UW&,^?+C_?-9VH>++;2M3TO3KK4'AO=4>2.SA9FS,R)O
M<#Z*,\T!H=O_ ,*VU3_GM;?]]'_"C_A6VJ?\]K;_ +Z/^%<S]KN,9\^7'^^:
M/M=QC/GS8_WS0&ATW_"MM4_Y[6W_ 'T?\*/^%;:I_P ]K;_OH_X5Q">*[=_$
M$NAC4'_M6*U6]>UWMN6%G**_I@LI'X5H_;)Q_P MY?\ OLT!H=-_PK;5/^>U
MM_WT?\*/^%;:I_SVMO\ OH_X5S7VJX!QY\V?]\TGVJX)/[^7CK\YH#0Z;_A6
MVJ?\]K;_ +Z/^%'_  K;5/\ GM;?]]'_  KF#>7 7/GRX]=YJII_B.'5M-CU
M&SU'[58R(9$N8IBT;*,Y(.>G!_*@-#LO^%;:I_SVMO\ OH_X4?\ "MM4_P">
MUM_WT?\ "O(;CX\>$+;P!!XW?Q.K^%9Y1!%J47FR*\A<QA0J@L3N!&,5'HWQ
M[\*^)O#]WK&AZW<:W;6DZVT\%C#,US%(1N"M"0'7Y06R0!@$T >Q?\*VU3_G
MM;?]]'_"C_A6VJ?\]K;_ +Z/^%<AINN#5]/M;ZTO))K6YB6:*0.V&1@"I_(U
M9^US_P#/>7_OLT!H=-_PK;5/^>UM_P!]'_"MWP?X5O/#^H337#PNKQ[ (R2<
MYSZ5YY]KG_Y[R_\ ?9KK/AM+)+J]SOD=P(>C,3W% 'H]%%%24%8'CG_D6+SZ
M+_Z$*WZP/'/_ "+%Y]%_]"% 'BGB&^?2]"U*]BVF6VMI9D#="RJ2,^W%>%?L
M^_M >(?BKXQN-*U:#3XK>.R:Y#6D;*VX,H[L>.:^@YHDE1D=0Z,"&5AD$'J"
M*HV.@:7I<WFV>FV=G*1M+V\"1L1Z9 K"I3J2J1G&5DMUW/?P..P.'P5?#U\/
MSU)_#+^4\0TWQUX6^&GCOXSP^-]1LM-N+^YBOXX[]PK:AIQM$C2.('_6@,LB
M;%SRW3FN%U?QBT5]K6HV>KZGX7\2Z3?Z+;>$O!QN3 K64RP?NS: XEW[YE8\
M[/+ZC;7U'<6.A>(;_P#TBUTW5+W3)0,S11S26DA 8=02C$$'L<8-6IM&T^YU
M*WU&:RM9M0MP5ANY(5::('J%<C*@^QKJ/GKGR#8_$4>!?"'BB.X\0'1H9/"N
MLSZ9&]QY?F7BZK<KNA'\4H!3[O."*U[>PU3Q+KMI>77BSQ% UWXRMM">&UU)
MXHA9/8(\D:J. 6;G?]X9X(KZCN/#FD7GD?:-+L;@6[,T/FVT;>46^\5R/E)R
M<XZYJ==-LTP5MH%Q()1B-1AP,!NGWL<9ZT ?%!U+3VOKRX\0^.=4T;4-(\)Z
MI'I5T-3:&>YEM]3G6 ,W6=EVH ASNSR#6]JOQ!U+4]^E^)M1U"VU*[U621[/
M^VQH]I&8]+M))(Y+G[ZA))698H^6;/! KZOO/#^B3&![K3-/D,4@>)IK>,[)
M-V05)'#;B3QSDU)>^'M*U( 7FFV5V!,+C%Q;I)^]' DY'WA_>ZT!<^.-(\1Z
M_P"+/AQ?^*KKQ;K:ZCH?@_2-3L_LM^\<371GF5Y9%&/-+*@4AA@\Y&:]M^.U
MC:MXZ^$^KW-S?P&QOM1N/] F=3A--FE.$!PYRG0]1E>A->O+H^GI%)&MC:K'
M(H1T$*A67)(!&.1DDX]ZE,=M=/&^V*9H6.Q\!C&W0X/8XR#^5 'PU:^/]5GL
MM3M]&\3ZE:PZKH6FWQG_ .$C_M*[$DNIV\9G?:-EM*T<K Q(< 'D# KOEL=0
M\(>)KZ:T\4^(;A--\<3>'[6WO=2DFB6R:Q,K1L&^^?,;<';+#  ( KZ:M?"V
MB6$9CM='TZVC+%RD-I&@+$AB2 .I(!^H![5:;3;-R2UM Q,GG$F-3E\8W]/O
M8XSUQ0.Y\=^&?'NI>"M$U'XCW%[>7D.CQZ#=:U&'+&\MYM-,;%Q_$1(T; _6
MO6/%4_B'PC^S?H3:MK-Y::I=2V']NZLLI$UI#<7"M<LK_P  19"@;^$#/&*]
M%\=?#2Q\<Z3;Z2]R^EZ7]JAFOK6QBC47\41#+;R$C(3*K]W!P,=#73:K<64-
MA<R:D]NECM/G-=%1%M/!#;N,'..:!'R-XH\3Z#X6\1ZA+HGBW7-9T>RT34+*
M'4HKM7FMR][:*8H;N3(:-2^#,Q.W+<_+2>![^_\ &'B[3O!S^(M1M-!?Q<UI
M)#I/B*2];R#I;3- +W 9E\P;OE/!R :^LX?#FD16*6<>E6,=FL1@6V2V01B,
M\E N,;3W&,&H]&L-"-O%)I-MIP@@8QQO911A8V7*$*5'!7E>.G(H \6T/7=<
MG_9336AJM[<:MHK3W'VQI"9YXK.]<%9&'+;H8BK9ZUX_9_$KQGK.F>)EEUS4
MH?(T>]\:P3+(R;+6\5%LX ?[L9\P@=L5]L1V5M%;&WC@B2W.08E0!#GK\O3G
M)SZYJF8-'%V; Q6(N9+<#[,43>T"G &WJ4!./0$T ?)GAWP5I7B+XN1Z,VLZ
MI!)<>-]6DO4M-3D2X5#ID;* P.Z,/DG*XW!0,\5UGBW5M2UO]A:]NKJ^>^U/
M[*L O+PEVD:/4%CC:0CECA%R>IYKZ-CT73HKY[V.QM8[V3&ZY2%1*V!@9;&3
M@<=>G%2'3K,V9M#:P&T/_+#RE\OKG[N,=>?K0!\\?$WP_P")_"UMJ_COQ[XF
M@FU6:VMO#EDGA*,Z:L44UVC/YEQ.S%-[ *9#@(N2.37GVB>/=:&GZC86WBR3
M1K.SOO$-M#>1ZC)JT5FB:=!)&3-MW3K&[NP;!QDX)Q7V1>6EGJ]K/9W45O?6
MSCRYK>95D1A_=93D'Z&LNU;PW:1WOV4:3#%IF8[KR1$JVF(QE7Q]S]WC(./E
MQVH"Y\F:5X^C71!X7OM0U$3/K<*-]E\9A]*G!LFE(75&'F1QG;YABSOWX X.
M*[K3/&&M:K^Q:^L+KMTNK^6]O'JL%P7F55OC$K"0@%B$ &XC)ZD<UZ[H^J?#
M;7-"N[;2+GPIJ6BV)^UW$%BUM-;VY'/FLB9"GC.XBNAT2[T7Q'HJ3:9]DO-*
MF+$>7&/+9@WS94C@[NN1G- SYN?2=0\)>,M1DL?%/B.X72/&^F:19VMYJ<DT
M0MKJW1IXW5O]9N9R06R5P-N*X_Q7X]3QU\(M+T67Q--J%RO@'4[C68(+T^:E
MQ%/" 9\'*N,.,-SC/:OM Z=:,[,;>$LTBREC&I)<?=<G'WAV/45GVNE>'TOM
M0@MK'3%O'^>]CB@C$C>8.LH R=X'\77'>@1\J:EX^A_X6=H@T+Q!J$T,/B/3
MM",EUXC^_;O"@>.&R4'S(F#[OM$AR6.0>!7/^'/$4_A7P7H6E:5XEU"QT)[(
M1ZQ<Q7K2/I\;ZT8KB3<2?*98\*6_@#$\5]GP>%=#M9UGAT?3H9U1(EECM(U<
M(GW%! SA>P[=J?%H>CV[3Q1Z?81-<AS-&D" S!C\^X8^8$]<]3UH'<^8](#^
M+/B):>#;#Q?K=YX#37K^WM+VSU9S+<Q)IT<KP?:@=TB1S,<-N)'(SQ7376KW
MFO?LG^&+W4[N74+R2[TU);F<Y>79J,:!F/<D*,GN:][LM$T[38+:"SL+6T@M
M@1!%! J+"#UV #"Y[XZU+_9MK]F6V^S0_9E(*P^6NP$'(PN,=>?K0(^-_#7Q
M-\166H7VNZKXADM;UX-<DUJRM-8:\O$C@$FSR[!H]EJ\)$>UB0"#SNS5;1/&
MMY'JM_H;^([K3O"=S<Z"=4NHO$[:E):0SM<"5VNP (3(R0*X0[5W=1FOLR+0
MM-@OKJ]CT^TCO;M0EQ<K;H)9U'9VQEA[&H(/"FB6EA)8P:-IT%C)&8GM8[2-
M8G0G)4J!@C))P: N?&'_  DESH/AKQ5!X5\5ZA-IS7'B>2WU..Z+R2LEQ8JD
MOF?QL@=@'.<]><UW.NS/X1\=7G@S4/%FM67@%M>T_P#M'4KO5)!-;K-82RB(
MW1.Z*.6>-,\@ G (!Q7TW'X?TN&!88]-LHX54J(TMT"@'&0!C&#M&?H/2L/Q
MYX"_X3/34@M=4GT&[6=)S=VL$4PFVJ5\N:*12DJ8/W6'! (QB@9XG8W*^+?V
M,/';2ZY?Z_:>7KL<&J37#&>:"*YF$1+C!("HH]P/>N8LO%8M[@WMAXROY?%5
MAX@TK2M#T)=3:2*ZTMXX,GR<D3+(CS.9CD@IU&VOIOP-X$L/ GA"V\/6SR7M
MM&97FFNPK/<22NTDKN  OS,[' &!G &*T;?PSH]I<VMQ!I-A#<6L7D6\T=JB
MO#'_ '$8#*K[#B@1\^_M%Z5K_P 5?']SX3\,Z'#KRZ#H<MQ(\NH+:"SO[HXM
M902IW,BQ,P''WAZUYWJ7Q#T_Q??>)O&J^*;W0?&/_",:)<:=I5K>F'[1J"R3
M1R1F$?Z\^:&C*'. Q..]?:<=I#%-+*D2)+*09)%4!GP,#<>IP.F:HGPOHQN(
M;C^R+#[1 YEBF^RQ[XW.<LIQD'D\CU- 'R5HWB;Q/XD\:7B:EJ\=IJM]J6K:
M=J&E#7I&F-HD4NV%+!8\0[0(W67<,YZG=BN0O/'5KH7PM\/)X?\ $-^+O0?#
M>ESQ23>)/L\,$TDF6\F!<O=N<,C*WRH!MXYK[JCT33HM3EU)+"U3494$<EXL
M"B9T'12^-Q'L355?!V@1O$ZZ%IBO"KK&PLH\H'.7"_+P&.2<=<T >5?M&^(K
M>T_X1'29[R[MO[2DN9O+BUH:/:RB.'<?.NOO +N#+&G+$=P*\D\$>.T\4:+H
MM_XV\?:MH+V?AS3[O2);&\99+V=KF1)9!'@?:GRD<91@>&S@$YKZ[U#1=/U>
M&**_L+6_BB<21QW4"RJCCHP# X([$5'+X=TJ>2TDETRRDDLW,ELSVR$P,>IC
M./E)]1B@#Y&U3QH(?ASK?B#_ (3O6X_B)/!J+ZEHL-TSQVJP7: [H?\ EU$4
M8&U@!N#').:ZC6?%:_$WXS7>BZ5XNO9?#%SXGTVQ>31-0*(T1TB>66*.5#P&
M=5+%3U'7-?2::#IL=W=W:Z=:+=WBA+FX%N@DG7&,.V,L/8YIMCX=TK2XXH[+
M3+*RCB(,:6]ND80@$ J !C@D<>I]:!W/C>76/$/AGX>6&L0>+-?N[_4_#NM2
M7<MU?/+M%G>1)"Z+T1DCW L.6!);-==XK^)5EKGQ3N=1L=<.KZ'I&O6,D$NG
MN+E(B-'NY)/) RK-D X'4C!KZ@72;)%55L[=51610(EPJM]X#C@-W'?O4-CX
M<TK3(HXK+2[*SBB(:-+>V2-4(! (  P<$C\3ZT"N?"U_XB3Q'X9\2Z=/KE])
MH=SX<TS6YC-XG.H3>;_:,(-Q,Z82W<QN2T2':N!D# KT"Z\4PZKXNUS3/%'C
MG4M!\*VDNMSZ9>PZHUMY]Q#)&(E\X'Y_+C.Y8\D-N)P:^I(/"6AVMK+;0:+I
MT-M,'62&.SC5) QRX90N"&(!.>N*?<>%]&N[6.UGTBPGM8I!+'!+:QLB..C!
M2,!AZ]: N?)]IK7BC6-$U+QAJWB'6K37M(/AEHK..Z:&V5KA8A<>9 /E;S Y
MR&'&>,&O1?VHO$L&GZGI&CM?7EG*]A?7Z1KKO]CVI\L* [S %Y'0L"L29SDD
MC@5[K)IMI*92]M"_FE3)NC4[ROW2W'.,#&>E1ZCHNGZPUNU_86M\UN_F0FZ@
M64Q/_>7<#M/N* /D*R\0:]KWAV_\93^*M:&I:19>%I[6*&]:.V9[@1BX,D0X
M?S Q!W#WX-;'@74+/6OBW\.-2OO$]Y?>,Y]6UQ-4T2>]+I:;(Y$11;GB$*H1
M00!N#9YZU]2KHU@D3QK8VPC?:&00KM;;]W(QSCMZ4V/0M-BU&74$TZT34)<&
M2\6W03/@8&7QD\<=: /EWXL>+O$L7QG\100ZU!I%QI=QI46AQ76N26JLDVWS
M"+-8V^UB1RZ$\[=N/EQFL#7?B7=#Q[=7^CZYJ$3WEQKUI*+S7O,F806LY118
M(-MND<D:E'8AS@'G-?8=SHFGWM_;7UQ86MQ?6N?L]U+ K2PYZ['(RN?8U"OA
MG1UNKBY&DV N;AM\TXM4#RMC&6;&6."1SV- 7/E.TTW4?!CC7+'6]8U+4M/\
M&:1XEO;F]NVGFNE%VTEU&2?X&C,F$' P,5Z%#XK\2G]E[Q/XYMKJ[36-:CN]
M<LB07>QM)9/W(C4]-EN%<#'7)KU7QWX$B\:^%K_1(;^;0EOH1:37FGQQ^<;;
M/SP@L#A64LO'3.1@UOV.GV^FZ?;V-M$L-I;Q+!%$H^5(U4*J_0  4 ?*%Y>Q
MW'C2R\)>$_'.LZKX*N]9T2.74;?5GN)5EGCN3/ MSDG$B)$[*#\I;C&:YWQ7
MXIU;2/#T$<_BN[N;/0+K7(%L9]??3M0EAM[O;%/#.P*7,T2_((9,[@0>:^R;
M'P[I6EVR6]EIEE96Z2^>L5O;)&BR=W   #>_6DO/#6D:@L2W6E6-TL,QN(Q/
M;(X24\F1<CAO]H<T!<^4/#GC3Q)XF^*2S7&L_8K^Y\2OIG]G76MR1W#::8,K
M%_9JQX4M&1+Y^1\W.X=*WO#FK'PY^QAI&F^%[A]0UK6$.A6*27A=Q=SSM&R%
MR3LV+O)'\..E?2W]B:?_ &K_ &I]AM?[3\OROMOD+Y^S^[YF-V/;-);Z'IUH
MBI!86L"+,;@+' J@2GK( !PQR<MUH ^/+K5IOAG%>>$/$NFVG@RRM/%.@^(=
M/@.H+/!#9O,L4Q\W"@!98MQXX\RO1I8[?XT_&KQ;=>"/$ENFC_\ "/6>G:KK
M-B@N;>[G%R\@M]RLH8B$D,5;(5P,\U[[J&A:;J^1?Z=:7P*["+J!),KG./F!
MXSSCUJ33],L])MEMK&T@LK922L-M$L: GK\J@"@+CM/MC9V-M;GR\Q1+'^Z3
M8G Q\J_PCT':K%%% @KK_AG_ ,ABZ_ZX_P#LPKD*Z_X9_P#(8NO^N/\ [,*0
MT>DT445)05@>.?\ D6+SZ+_Z$*WZP?'/_(L7GT7_ -"% 'BVN:@VE:/?WRH)
M#;6\DP0G ;:I./TKQSX)_M%7/Q;\4SZ3-HD.FI':-<^;'.7)(8#&"!ZU[9=6
ML=Y;RP3()(95*.C=&4C!!_ USWASX:>%_!]\UYHFAV>F73(8FEMTPQ0D$K].
M!6%2%652+A*T5OYGO8'$Y;2P6(I8JBY5I?!*_P /KJ<=\+9X8/B9\9V>2.,C
M7;1CO8#@:?!S7B6K_&_QKI=EJ^H:=XAU*^M]0\.:IJ=A>ZEI]O!:>;!)&(I+
M2($RF,!R#YGWNM?1.L_ _P"'_B#Q5)XFU'PKIUWX@:6.9]0<-YI=  C'!QD!
M1U':FV?P(^'UDUX]OX2TN,WB2QS$1D[TD_UB#GA&QDJ,#VKJ/GSQCQCXH\=>
M&K;QHH^(\L-UX.@TLQ_:;*W4ZHUVP:1Y%V\ !O*39C!3)R:31/BY\0-4UZ;5
M5DFM=.N[_5=/6'5OLD6EVR6ZRB)T8/YY=6C5GW#!5FX  -=Y\6/V?I?BEXM@
MO;JZT<Z3LMXF^TZ;OO[58I-[+;S!@ 'P/OAMO)7&:[R+X5>#H?%=[XCB\.:<
MNN7BNL]V8LLX<;7RIXRPX8@98=<T#T/FA?$GBGQ79:%HGB+Q%KVGZ_9^)M!O
M);>]MK3*I,T@\R&>(&.:W=D)3@,,8.<UZG^T/XWUK0[Z*PT#6]6L;ZWT>\U>
M2ST2R@DD*QD!)IYISLC@5L@@?,Q/'2NUL_@3X!T[0[O1[;PKI\.FW4T5S- J
MM\TD1W1-NSD;#]T @#M6EXN^&/A/QY=6EUXCT.QU>:R5DAENESL1L;D//*G
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M6<4DS$L-Q=6D)3G [@UGW_Q1\9V=G>1Q:W#+KEA#=:;'K4UC$9WV:U#:K(P
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M NIZ)J4>EVZWVBV[6NG7" AK:%@ T:X/W2 .#GI0!T%%%% @HHHH **0D 4
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M ,/0OB/HL?PHU37=)L+VVLO#EI-$^EWT7E7,)MX0PB<9."4V'.3PP->9Z_\
M%[XB>#M%\.G6)]"N+KQ4ULUC<Z9IT]Q)IZO$\LJM:HQ><*JJ%<%<DG(&*]E\
M)_#W2O!_AJZT6$W&H6]Y))+>3:E+Y\MTTBA6,C8&?E55Z=%%<G:_LU^"[.Q>
M"(:OYX:$VNH-JDS7>GK#N\F.VE)S$B[FPHXPQSF@#@[#XL?$?QO)IFD:<NF:
M!<-I.IWFH7FI:;.KRBVF$2/!"S*T?F!PV&^Z1WKEK'XX^+O ?PU\&DZUI>IW
M%KX?TV]N[-=,N;JZN_.8 F:13MM@$(P[DEVR< 5]#^'/A-X<\*2V<MC;3F:V
ML9]/$MS<O*\L<T@DF,A8DN[.,ECS7(1_LK>!4L!89UMK VT5I-:G5YA'<1PL
M3 )0#\YBSA,]  .<4#T.'_X67XQCUO7-'\(Q:#I"V[:]JD\U];2S^8;6=% P
M'&#)N.X]!U [4WP_\5/$MEXRUOQ;>WEI_P (G=/X=-Y921MG3[>ZMSND1]V!
MM=U)XY&37LUI\(?#-CJ-[?1VLPN;R&\@F<W#'<ETZO/QV+%1@]NU<9\1?@';
MWO@_7-*\*VRBXU[2[;P]>)J%[)]FCLHQL$P3!W3(G"G@GC)H$3?\+@UM/@._
MCEK"U_M#4;C;I5K(&6)8I[KR;1I><_<9';&,YXQ7G7Q&O/%WBSQIX:\ ^);W
M1;V33/%>GO=30V,BV^H02VTTL8>+S/E*-$W&2#\C=L5]#ZCX%T76/!/_  B=
MY9K-H?V1++[/DK^[10%P1RI&T$$<@@&L#0/@EX8T!K25%O[Z^M]235O[0U&^
MDN+F6X2)HD:21CE@J,5"]!0!P/[0WBGQ7J=CX\\+^&9M-L;72O",NJ7\E_$[
MR7(E$J+%$RL/+PL;MOYYVC'6N3N_BSXB\':9JTFAV,&GV,6LF#4-933)]2\K
M9IMH\<DT,;[P'9]K2*,(%'RY.:]L^(OP4\,?%"X$VMQWRR/:/87!T^]DMOM=
MLQR8)MA&]-W(!Z'ZFJNJ_ 3PKJHE=#JFF74ER]TUYIFHRV\^7@C@D3<I^XT<
M48*]/ESUH \OM?VDO$6L>+$&E6MOJ>C6E[8:?/;Z;I5S<K>^?'$TUQ%>#$<:
MIYP*JPR0ISC(I\7Q_P#%S>+;NPTXZ3XI^U6FK/866GV,\4$<]JNZ&,7KD)<%
M\88*!@]#7ID'[/\ X-LM9L+^SL[NQBLS;,--M;V2.QF>W4+!)+ #M=T  !/7
M SG%5+3]FGP-;39>VU&[@2*[M[>SNM2FDM[6&Y!$\4,><(C9SQR"!@\"@-#R
MJU_:7\1S:;I^EC4+67Q!?:H;1YO^$:O%NM-C6V,T@GT_)<OD;496*E<MGBO1
MV^,.MQ? ,>+Y])2U\1,ZV26MU%)#"9VN1;I*4;#K&20^T\@'%:4?[.WA1+!X
MS<:Y)J37,=TNNR:M,VIQO'&8H]EQG<%6-F3;TPQSG-=(OPQ\.CP ?!;6)D\/
M& V[6\DK,[ G<6,A.XON^;?G.[F@#YYNOB+XR^&?Q"\5Z+?WMG=^(M:UJTMA
MJMEI-Q=0P01Z?YK.MFC%RYP%VAL=6)KIE_:*\2V'AR"[U32(;+4-1TJ<:9!+
M;R0FXU**\%OMV.=P219(I%4_,!N!Z5W4'[.7A&VL;F-9=;^WSWD>H'66U:8Z
M@EPD9B61)\[E/EDH0.".HK7_ .%*^$6T[PC9/ISRP^%;S^T-+,D[L\=QALR.
MQ.9"2Q8[LY.#VH \9@^/?BGQ+>:E;26/G:-<R:EI#P6^CW,9M?)BE7[4;L_N
MF#21ME!]T,.20:/!OQ@\6:;X#M=9LQIC>$_"PT?2;^RN(G:]OC-%;^;*DN["
M%?/3:I4[MIR1D5Z\GP*\*IXCN]8$=_NN'GF-A]OD^Q1S3H4FFC@SM61U)RP]
M21R:KI^SWX+CUC3;];2]1+/[+NL4OI!:736P"V\D\6=LKH%&&/\ =&<X% 'F
M-W\=O'_A[PPOB;4TT*ZT[4TUJ'3[*VMY%DMY;-9GA>1RQ#JXA(90!M)&#4A^
M+GQ/TB[U!]2N/#5Q::5_8UW=);64JO/%J#!3"A+D*8N2'.=W P*Z;X>_LSZ+
MI&@W47B/[5J6H78U&&2+[?*]M!'=RR&0P(>(W=&4,P'KBN]OOA/X<U$:B)[6
M9A?QV,5QMG8;ELSNM\>FTCGU[T >&Z?^TUXKU"WU/6(=,6XTF6SU6>UMSH]S
M"M@;5)&A>2Z;]W.)#&0P7&TL,9YIOC;QW\1KW2O[$O\ 5](M-2:X\-ZM#>:;
M:2HB0W=WL>V=3)E]K(/FR-RD@@9KUQ/V?O!XOM3G,.H/!?0W<'V![^4VEJMT
M"+@V\6=L3/DY(Z9.,9J_XD^#'AKQ3!=1WD5W&]Q:6=D9[:Z>*2-+60RVY1A]
MUE<D[NI[T 8GQ9\3^*7\1P>#_"LVF65Y/H=]JUW>:E \J-'%MC6%%5EVEF?E
M\G:!T.:\]\ ?%O7/#WP8NEACM9)/#V@>'7MFF#/O:Z55EWG/S8SQ7LOCSX4Z
M%\15L&U8WT5S9I)#'=Z?>/;3M%(H66)G0@LC@#<IZX!ZUSNH_LT^!M3%@CVV
MHPVMI96M@+6WU&6.&>*V;=;&90<2-&?ND_CF@#D?A[\>_$?C'X@64/\ 9[2>
M'=2U*^L([=-(N8VL8X&D6.=[MOW4N\Q$,J@;=ZX)P:K^-_&OB[PI\;O$D.EW
M]E/'J-IHFF:;:7L+F&UFN9YU,SX;G 1R0 "WR#(Q7J&C_!GPWH/C!_$5FE\M
MSYT]S#9/?2-96TTW^NEB@)VHSY.2/4XQDTWQ=\%O#/C?6KO5=4BO#=W5G%92
MFWNWB4B*0R0R *?EEC<DJXY&30!3\">.=9N=+\;6GB*33I-8\*7DEK-?P VU
MI<KY"SQR,&+&(;7 89.,$URWP,^,&N>.O&>HZ)J]W9:K -'@U>"^L-+N+&(%
MY3&\49F.9XQ@$2@#/I7H?A_X7>'_  [X4U+P]%!/>V&JF9M1DU"=IY[YI5VR
M-+(W+$KQ[ #&,51\"_!CP]\/=6.J:;)JEUJ1L4TPW6IZA)=/]F1MT<0WG 5#
MTQT&: /FE?!$_C+Q+XW70?AWJ=QXP'C2?[)X\2[2""R1)HV.6\W>0J!EV!"#
MNQ71S:!;^%?'O_"5:WH1UC3KGQ4L]M\2O#VHA[FUWSB-;.Z@;D0JQ\E@FY<<
MX!YKZ7\.>%-.\*+J*Z;$\7]H7TNHW&YRVZ>0@NPST!P..U<8W[/?@X^+6U_R
M=04M>C4WTI=0E&FO=@[A.UMG87W -TQGG&:!W/%?@)X#CU76%UFY^$%IJKCQ
M1J;'QE+JZ"5-E],!)Y!.X[,!0/:N&T+Q)JOA'X76GA_5K^>?3_$WB*WU;0[F
M5SNCE3652ZL]WI@+(H]&?TKZ<TG]G+POH&N#4]/U+Q19-]N?4?L<6O7"VAF>
M0R/^YSMVEF)*XQS6G?\ P,\':IX5T7P[=:8TVEZ-J2ZO8*TS>9!<K*TH</U^
M\S9'0@XH"YQWQC\3V_Q9^"GQ!'AK6M9T"/2K6Z^VR_8)+2:<)$[&*-I5!"L0
M,NF>,@$9K?T[PWJ%[XT\':W%IL45I:Z7&)]1$J9G#VVT1LN-^Y6(V\[<,Q/.
M*]"\1:+:^*M#U'2-25IK+4+>2UN$5RI:-U*L 1R.">:L6=I'865O:P@B&"-8
MHP3DA5  Y^@H$>'^)_BOXTMM?UF_TLZ/'X7T;Q-9>&[BSNH':[G\PQ>=.L@8
M!2/. 5-IR 237&6'[4'C"Z\.:KXACTN.YLI]&U#4[*%]'N;>/3W@&Z%)+A_D
MN%D7@E,8;ID5UGC7X%ZQXM^+,6K"RL;72#JUCJLFH0:E/&S_ &?:0LEG_JY)
MLKM$V1A#R,@5V,/[._@R-=5C,&HR6=_:W%D+&7497M[.&=MTR6T9.(@YZX^@
MP* T/.?$GQR\;^";VZ\.:N^EW>N7-WIJ6>I:9I4\T=M%=0SRR!K96+RM']G8
M+@C=N!.,&NTTOXKZ_/\  ;Q+XLN]/6'7M&BO1&MQ:2VT5VT.?+E\I_G17&#M
M/(YYKI_$OP>\-^*KF]NKR*[BO[D6F+VTNGAG@:VW^1)$ZG*,OF.,CJ&(.:MV
M7PPT&P\!W7A!(KB31KR.6.Z\^Y>2><RDF1WE)+%V))+4 >.O\5_B=HFJ7_\
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M7.,\B@-"E\'?VEK?XJ^*+72Q;:;'%J=C+J.GG3M0^U311QLH,=VFT"*0JZL
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MK;05$2P6KW082MO"[Y "[%$<D*3]* /)_A=\3/$7@W0M"TF#3)_$'B?65T:
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M&>^>;^'W[.<U_P"&C!XVU;5+N+.K1VVANT0AL/MDLJO*CH-S,8G^4,2$W'%
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M $#X_P S_C110 ?\(9HO_0/C_,_XT?\ "&:+_P! ^/\ ,_XT44 '_"%Z*?\
MF'Q_F?\ &C_A"]%_Z!\?YG_&BB@ _P"$,T7_ *!\?YG_ !H_X0S1?^@?'^9_
MQHHH /\ A"]%_P"@?'^9_P :/^$,T7_H'Q_F?\:** #_ (0S1?\ H'Q_F?\
M&C_A#-%_Z!\?YG_&BB@ _P"$,T7_ *!\?YG_ !H_X0S1?^@?'^9_QHHH /\
MA#-%_P"@?'^9_P :/^$,T7_H'Q_F?\:** #_ (0S1?\ H'Q_F?\ &C_A#-%_
MZ!\?YG_&BB@ _P"$,T7_ )\(_P S_C0/!>B@_P#(/C_,_P"-%% !_P (7HG_
M $#X_P S_C1_PAFB_P#0/C_,_P"-%% !_P (9HO_ $#X_P S_C1_PAFB_P#0
M/C_,_P"-%% !_P (9HO_ $#X_P S_C1_PAFB_P#0/C_,_P"-%% !_P (9HO_
M $#X_P S_C1_PAFB_P#0/C_,_P"-%% !_P (9HO_ $#X_P S_C1_PAFB_P#0
M/C_,_P"-%% !_P (9HO_ $#X_P S_C1_PAFB_P#0/C_,_P"-%% !_P (9HO_
M $#X_P S_C1_PAFB_P#0/C_,_P"-%% !_P (9HO_ $#X_P S_C1_PAFB_P#0
M/C_,_P"-%% !_P (9HO_ $#X_P S_C1_PAFB_P#0/C_,_P"-%% !_P (9HO_
M $#X_P S_C1_PAFB_P#0/C_,_P"-%% !_P (9HO_ $#X_P S_C1_PAFB_P#0
M/C_,_P"-%% !_P (9HO_ $#X_P S_C1_PAFB_P#0/C_,_P"-%%  ?!>BG_F'
MQ_F?\:/^$+T7_GPC_,_XT44 '_"&:+_T#X_S/^-'_"&:+_T#X_S/^-%% !_P
MAFB_] ^/\S_C1_PAFB_] ^/\S_C110 ?\(9HO_0/C_,_XT?\(9HO_0/C_,_X
MT44 '_"&:+_T#X_S/^-'_"&:+_T#X_S/^-%% !_PAFB_] ^/\S_C1_PAFB_]
M ^/\S_C110 ?\(9HO_0/C_,_XT?\(9HO_0/C_,_XT44 '_"&:+_T#X_S/^-'
M_"&:+_T#X_S/^-%% !_PAFB_] ^/\S_C1_PAFB_] ^/\S_C110 ?\(9HO_0/
MC_,_XT?\(9HO_0/C_,_XT44 '_"&:+_T#X_S/^-6M/\ #]AI4S2VELL+L-I*
,YY%%% &C1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>aciu-20221231x20f027.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f027.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #O D<# 2(  A$! Q$!_\0
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M6O%'P?;QGKL?CSQEX[UQ/B-)\-M"T_QGXA>;2(1*T'E75TH3<63+_,N"V0H
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M/(&,?-G[KIM6_KT?ZB3O;TO_ %]P4445(PHHHH **** "BBB@ HHHH ****
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M"/BK3]=N[%1)/#;2'<(R<"100-\9(P'7*D]#7=;AZBN@Q%HI 0>AS2&11C+
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MNA%IU_)ITINK=H"TB!22JL 2I#C#8&>HXP3T=( HHHH **** "BBB@ HHHH
M**** "BBB@ KYO\ CGX=^(O_  M:^U+PGJNO7,=SX!UZWT^RMP$L;+4A]E^S
M,"  9W8R%6D)P$PN &S](44?\'\K#3L?!NMZ)\16\-E=#L/',>@_:M4/A2W<
MWHN[>^,>G_8I+H.WF+")1J1!G_=@,=W!2M76='^);>*O%;/:^+6LGOYCXF,)
MN_+NK#^W+<VZV&T_,1I@G4BW^;:2I_>$5]NT55]4R>ECQWX56_Q"M/V<+&*W
M2%?'*P7']GQ^+6FVJGVB0VJW17,N1!Y0;^/(YYS3OV:/B;XP^)/ASQ6GCJTT
M2T\2>'?$=UH-Q_PCQF-G)Y*1,'3SCOY\T]<=.E>P5X1^RM_Q^_&O_LH^J?\
MHFUI,9[O1112 **** "BBB@ HHHH **** "BBN&T'XO:5X@\;3^&HM/U2WF5
MKJ."_N;<):W3VSHDZQ-N+'8SJ,E0#R 25(#2OL!W-%<9X5^)UEXQUC6;;3K2
M?[%I1:.>ZN"L3F56P4$!/F@<$AW50W&W<#FN0\%?&W5=0T'7=4\0Z3:6Z6_A
M^'Q591:;,[EK*59F2*0NH_?+Y!R5^4[ACIR@/8J*^>I?CWXW@ADTIM"T%O$]
MO$^IS8N9_L9LEM4N-JMLW><=XCY&WC=WVUZ-X5^)EWXG\>-H_P#9 M-)ET*U
MUJTO7G#2S^:Q!4Q@?(%P!DG).>  ":Y7>PKJUSOZ***D84444 %%%% !1110
M 4444 %%%% !1110 5F>)H+NZ\-ZK#I_F"_DM)4M_*G$#^84(7;(58(<XPQ5
ML=<'I6G10P/DOX":SJ.H?'G48]3U6#[9";F&ZTY/%]KJ(BGP&:-8DTZ!V*]\
M2G;SN!(.-[XO?M3W/@_X@:CX;T?Q'\.=,DTID6\M_$6IW;WA+(K@&*WA(A!#
M<%F8GKMKBO@HMM=?M2ZC<6?@W7;+3(+J_M ^H:E>26MA?!IWD>W@>)8E0QR+
MN;>0'OML>1NKR[]J>Q&K_M"^)Y+CQ7X5T./3S;M;KI$=_I.M7$ODP_Z,VH6U
MG*US<'S$(MXG+A'3Y<9P?RCM;F/T&\+7^IZIH%G=:Q8V^G:C(N9;>TN3<PCD
MX*2%4+*1@C*@\\BO'_C=^TO;?##XJ?#WP/9R:4;[7-3MDU1]1N1&;6RF:2.-
MHUW O(\B$#J%"L6'*Y]LTLL=,M"X=6\E,B0DL#M'7/.?KS536_"FC>)9;"35
M=+M-1DL+E+RU>YA5S!,F=DBD]&&3@^]-Z2^9*UB_0^6O#W[5_CGQ):Z391:?
MH%IJWB/^S+S3+F2"=[>PM[R/4)?*N$\P&25!IQ7<K("9<[1MPWMVB?'#3F^!
MGACXD:W8ZA:VNK:99WTMGI>GW&H31-/&K;5B@1Y& +?>"].3BM.3X&_#Z;1]
M6TIO!NC'3M6NA>WUL+- D\X.1(W'4'./3)QU-=G:6D%A:PVUM#';6T*+'%#$
MH5(T P%4#@    "C2S&]U8\+_8:NX]0_9G\.W<(<0W&HZS-&)8S&^UM6O&&Y
M6 *G!&5(!!X/->]5X9^Q0<_LZZ.?^HOKG_IXO*]SI %%%% !1110 4444 %%
M%% !6)XWT[4-8\&ZY8:4\<6IW=C-!;22N45)'0JK$@$C!(/0]*VZ*35]!IVU
M///A]\&K#P;H>I:?J=W_ ,)/_:%M#87!O;6)(6M(8S'#!Y**$VA2V<CYBS=!
M@"[JGPIT^\\#:CX8M;_4+.TG>.:UD><W+6+QLCQ>5YN[Y$>-6"'*]1P.*[:B
MJ;;=R5IH>4'X'W9\,G3O^$KG_M$WW]L_VG]ABW?VEYWF^?Y?W=F/D\O^[_%G
MFJND?LZP:/J^E7,?B2]DLXI;>\U.T:VA_P")E>0323QSEPN8_P![*6*)P0JC
M@ Y[?P9XUG\5ZGX@M)=+_L\:3=?9#)]I67S6QGH!\O!4_CCJ#755SX?$T\53
M56D[QN^C6SMLTGNOP7D;UJ,Z$W3J+7U3WUW7J8/A;PE#X6N->EBN)+@ZOJ3Z
MDXD 'ELT<:;1CMB,'GU-;U%%;F(4444 %%%% !1110 4444 %%%% !1110 5
MSWQ$\5GP+X \2>)%AAN6TC3;B_6&XN%MXY#%&SA6D;A 2N-QZ9S70U3UG1['
MQ#I%[I>IVD-_IM["]O<VMP@>.:)U*LC*>"""01[TG>V@U:^I\HP_MF>*5\(F
M^F\+Z:NIZ8-3O]5@G:XM6-E8BS9U2"1/-AG<7R;5E&,1[N5D7&U?_M9Z]#KU
M[I]OX>TXKJ=_-IGAV22:7*RPZQ#I4CW@"\*9)Q* G.U2IY.:]6'[-_PU_LFQ
MTUO"EK-:V5VU]&)I99'>9M@8R2,Y:4,(XP5D+*1&@(PBXMW7P%\ 7MWXBNIO
M#-H]QX@Q_:$H9PTA$@EW)AOW3>8JR%H]I+J')W &KTNB>GF4_ GQJL=9^"T7
MC_Q&B:':VZW*ZCY(DGCB>WGD@E9 J[V0O$Q7C."*X#]B[Q+IOC/2OBUKVC7/
MVS2=1^(.I7%K<>6T?F(8;;!VN PZ'@@&O=_#7AK2_!V@V.BZ+91:=I5E&(K>
MVA&%11^I).22>222<DUXY^RL<WWQK_[*/J?_ *(M:3&>[4444@"BBB@ HHHH
M **** "BBB@ KA_A]\(-!^'EQ/?VD<MWK5T93<:E<R,SN996EDVH3LC#.V6"
M!=Q52V2 :[BB@"J-+LQJ+7_V2#[>T7D&Z\M?-,><[-V,[<\XZ5ROA_X.^$/"
M\=S'IFDFVCN9!)+&;J9T8!758MK.0(0)9,0C]V-Q(4&NTKSV7Q1>1_&N+0CK
MT*Z:^FFY&G&*/<9MVW9O^]G'SX]!TQ7%BL7#"<G.G[\E%6MN^]VM/2[\CJH8
M>6(YN5_"G+KT]$_\O,B_X9W^'QT%-'.@L;%;@W/-_<F4L8Q$5,OF;S'Y8$?E
MEMFT!=N!BNT@\-Z9;:T-6ALXXM0%HMB)DR,0*Q98P.@ ))Z5IT5W7.4****0
M!1110 4444 %%%% !1110 4444 %%%% !11575--M]9TR[T^[0R6EW"\$R*[
M(61E*L-RD$<$\@@T ?'WP@TZ6+]JQM0'B'Q1?6%U/JT:WNM6^HBSU&X224-!
M:[YVMU6)0.?+3)@?R_E8X\]_:/U]OAI^T!JVL7EOXW\(V,>IC4-/\13:KI]G
MHLMW-8Q6TKP236,VUO+01D2/U!(QFO>O@AX4^$>D_%":3P/\//$^FW]HU[:I
MXCN[:^_LYV60I<!)9I"K%G0C.WYBN<GK7R_^U3IDGA?]J/Q%KMS9I;/?R6JV
M>H6&M2:C>G$$:_\ (.A#S0 $=4C(;[V>:2WCZ%?S'Z5:;+YVG6LF_P S?$K;
M]P;=D#G(P#]17.^(_BGX6\)>*-(\.ZOJR66KZJR):0O%(5=G<I&&D"E$+N"J
MAV&YN%R>*Z'3"3IMH22Q,*9+ @GY1U!P?SYKS7XM_"SQ!\2/%7A&:VUC3M/T
M/1M2M=5;?:R->PSPR%B86$GEL)8R8B)$.P,64[L8I_%\R%\)9'[2/PV;1]1U
M-/%$,MG87,=I*8K>9W>1R_E^4@0M,K>7(5>,,I$;D$A6QZ#I6JV>N:79ZEI]
MS%>V%Y"EQ;W,+!DEC=0RNI'4$$$'WKYBT7]D3Q)X<M+"ZLO$^E2:WX?.GVNA
M>=92_9FM+2.^C3[2!)N,K+J,N2A !C3'!->P:=\$[*T^"WA[X<MKNMVEII&G
MVEB-4T74)=.O'\A%4,)(F#*&V\J#C!QS1I9C>ZL<E^Q/_P FZZ-_V%M<_P#3
MQ>5[I7@O[#5JMA^S/X=M4DEE2#4=:A62>0R2.%U:\ +L>68XR6/).37O5( H
MHHH **** "BBB@ HHHH **** "N*\:>.)K2]7P[X?MUU3Q-<ID1;B(K2,\>;
M,P^Z/0=3VJMXF\9ZAK&KS>&?"&R75$XOM3<;K?3E/K_>E]$_.M_P=X,L/!>G
MO!:[Y[F=O-NKZX.Z>ZD/5W;O[#H.U>+4KU,;-T,*[16DI]N\8]Y=WM'S>B]6
M%&&%BJV(5Y/6,?UEV79;OR6K\A^%OP<N;*]\0?:-2\1:->1W 2&^A80)=1XY
M?:=V[Y]W7MM/<UZ!_P (AXUT\?Z!XX%VHZ1ZIIL<F?JZ%37>T5RX/(,)@J*H
MTG)6OJI2CNV];-7^=S;$YOB,35=2=G>VCC%[*W5.WR."-]\2--QYNEZ!K2#O
M:W4MLY_!U8?K1_PL?6;$XU3P)K< '5[%HKQ?_'6!_2N]HKM^HUH?PL3->3Y9
M+\8\W_DQS?6J4OCH1^7,OR=OP.#C^-GA5&V7US=:/)_<U*RF@Q^)7'ZUT.E^
M./#VM@?8-<TZ[)Z+%<HQ_+.:V9(UE0JZAU/56&0:Y_5/AUX6UK)O?#VFW#'J
M[6R!O^^@,T<N90VG"?\ V[*/X\TOR#FP,]XRC\U+\+1_,Z$$, 0<@]Q2UP;?
M!;P[ V[37U/1&['3=1FC _X"6(_2D_X0#Q)8$G3/'NI*O9-2MH;H?GA3^M+Z
MSC8?Q,/?_!-/_P!*Y ]AA9_!6M_BBU_Z3S'>UBMXRT9?%"^'3>J-::/S1:[&
MR4P3G.,=!ZUSGE_$K31\LWAW6D']])K60_D66N/T[Q1XGF^/%C%J/A@6DK:6
MUM((;GS46$R!S.'P 0& 7'7GUK@Q><.@Z4?9RBY3C%\T&U9[V<6U?MJ_1G7A
M\M555)<\9*,6])):KR>MOE\SVVBBBOISP@HHHH **** "H+Z^MM,LKB\O+B*
MTM+>-I9IYW"1QHHRS,QX  !))Z8J>N2^+O@9_B=\*_&'A".\_L^37M(NM-6[
MV[A"98F0.1D9 +9QGFD[I:#5F]3+M_V@?AQ<Z/IVJ)XSTG^S]1O#I]K.]P%$
MDXP2G.",!D.3@8=3G##-VZ^-/@2RN/$4$_BO2XI_#JAM5C:X7=:@D*-P[G<0
MN!D[B%ZD"OG2Y_9&\>ZAX:>SFU[2(WO;;4-'DL)+R[NX-,L;N.Q65[::5?,D
MD\RR>4(^U<W!4, @+:U_^REXKE\0W6H0:QI)BTK49]4T))7F#7<DVMP:L\=X
M0IV*K0"(,F\G=OP"-IMI72_K^OZZ$ZVOU/IK0=>T[Q1HUGJVD7L&HZ9>1":W
MNK9P\<J'H017B_[*W_'[\:_^RCZI_P"B;6NC\#_!BZT7X$KX"U'7[[3[ZX2Z
M>YU;PY<M:SV\MQ<23O\ 9I2-R[6E*JQ&< <#.*X3]B7PV/!V@_%;0EU/4M:&
MG^/]2@&HZS<FYO+C$-M\\TI WN<]<>E)C/H^BBBD 4444 %%%% !1110 444
M4 %%%<5XN\<W,.I#PYX:@34O$LJ[FW_ZBQ0_\M9B.GLO4URXC$T\+#GJ/R26
MK;Z)+JV=%"A/$3Y(?/LEW;Z(M>-/':>')(--T^V.K>([T'[)IL1P3_TTD/\
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ML7WVIZGI7Q:N]:TM-$U>;X@ZD]UIL=T+E;:3R;;*"4 !\<<@#K0QGT51112
M**** "BBB@ HHHH **0D 9/ KS?4_$.I?$J^GT;PM<M9:)"QBU#Q!'_$?XH;
M8]V[%^B]N:XL5BXX9)6YI2^&*W;_ ,N[>BZG7A\/*NWK:*W;V7]=%N^A:\1^
M,-1\0ZM/X:\'LAOHSMU#6&7=!IX/\([/+Z+V[UT7A#P=I_@O3#:V*N\DK>;<
MW<[;IKF0]7D;N3^G:K7ASPYIWA32(--TNV6UM(APJ\ECW9CU+'N3UK3K##X2
M7M/K.)=ZG3M%=H_K+>7DK):U\1'D]AAU:'XR?=_HMEYN[91117J'GA1110 4
M444 %%%% !1110!QWQ5\/:OXH\+K8:,EH]R;J"9OMDC(H6-Q)P5!Y)51]":Z
MZ(N8D,@42;1N"G(![XI]%<L,/&%>>(3=Y)+RLKVM][-Y5I2I1HM:1;?WVO\
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M51!@*!T '84^C"X3V+=6H^:I+>7Z)=(KHOFVW=BQ&)]JE3IKE@ME^K?5OO\
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M-;2..-0JHHU>\ 4 <     =*]WKPO]B?_DW71O\ L+:Y_P"GB\KW2D 4444
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ML+07%M^S'X:AN[G[;=Q:AK,<]UY8C\^0:K=AI-HX7<06VC@9P*]\KPO]B?\
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M_A#7'_Q5>]>#/!6B_#[P_#H?A^Q73=*AEGG2W5V<!YIGFE.6)/S22.W7^+C
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MY&>HY%?4=8>D>"=$T+Q-K_B&PL%M]9UXP'4KH.Q-QY*>7%D$D#:IQ\H&>^:
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M#?\ NA,8][H%\U8R':+.]5Y*BC<#SS_AJN?_ *(K\6?_  GHO_DBC_AJN?\
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MH/A#2;2ZUFSA\+Z+>Z)8S6]Z$F:.[6,3S2.%RTQ,0;<,#<S9!!Q65X>_8U\
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MP?\ QJC_ (1VY_Z#^J?G!_\ &J0S;HK$_P"$=N?^@_JGYP?_ !JC_A';D?\
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MVYCMH%=HY!"(IF$VQ4(.W@[L&OIC_A$H?^@CJO\ X'R_XT?\(E#_ -!'5?\
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MGZ0KS>+Q3X)N-:T?2(?&<T^I:Q;K=V%O#JLCM<0MNVNN"1M.Q\'OM/I75_\
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MNB#M(0;NH;Y<?WOEZ\4TP/3**PO^$2A_Z".J_P#@?+_C1_PB4/\ T$=5_P#
M^7_&D!NT5A?\(E#_ -!'5?\ P/E_QIR>%(4=6_M#5#M(.#?R$'Z\T ;=%%%
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MX1*'_H(ZK_X'R_XT?\(E#_T$=5_\#Y?\: -VBL+_ (1*'_H(ZK_X'R_XT?\
M")0_]!'5?_ ^7_&@#=J&[M(;^UFMKF))[>9#')%(,JZD8(([@BLC_A$H?^@C
MJO\ X'R_XU5U71],T/3;G4-1UR_L;"UC:6>YN-3=(XD R69BV  .YH XGPQ\
M)]4TKPMX$\-W"6,>BZ/J%Q>W]M;.51PKRO:1JH4 JKO&Y' !B7K7KM>61_$#
MX=R6FBW2_$!/(UF5H-/<ZTP^T.K!65?FZAB%.>A('4@5VW_")0_]!'5?_ ^7
M_&F[@;M%87_")0_]!'5?_ ^7_&C_ (1*'_H(ZK_X'R_XT@-VBL/_ (1*'_H(
MZK_X'R_XUMC@4 +1110 4453U+2K;5X5BND=T5MP"2,AS]5(/>@"Y16%_P (
M3I'_ #PG_P# N;_XNC_A"=(_YX3_ /@7-_\ %T <M^T1\.-0^+OP7\4>#]*N
M(;2_U:!(8IYW9%3$J,3N4$@X4X(!YQ7E7BW]DN_TBWM6^'^L-_:QBUF:]U?Q
M3?SW=U=7MU8QVL,CR ;B%6)%XQM500&.0??O^$)TC_GA/_X%S?\ Q='_  A.
MD?\ /"?_ ,"YO_BZ.X[['R[X7_95^(.@Z?HEK=7^G:O8Z??ZC-:Z5=Z_?+'I
MPGGMYK>YCEACC:22 1SQB,+&N)3M*@L#FS?L=?$28>(3J/B2S\2F\\0Z?JOD
MZGJ<RPW\<&I-=,SJD&8'\DK",&3H?F"!5'UI_P (3I'_ #PG_P# N;_XNC_A
M"=(_YX3_ /@7-_\ %T[[>0N_F?,4'[+'Q(6+P\C>);-6M!']EE75+LGPSC4I
M;IA: K_I0-L\=K^]V?+$O524KKOB[\'_ !)X]^*'B2.S#PV&L:9X>\K46FDA
MCB2QU9Y[RV+Q_,K2Q2J5 P&P02 ":]O_ .$)TC_GA/\ ^!<W_P 71_PA.D?\
M\)__  +F_P#BZ+[>0N_F>*?##X0^(/ OQ6\,0RH[:/HFG^(@+U97EB^SWNIQ
M2V-F'?YB8HHCE>0F% )!%?1%87_"$Z1_SPG_ / N;_XNC_A"=(_YX3_^!<W_
M ,71T2[#ZMG-^-OAI<^(_&-GK>EW<6AWBZ/J&F2:M;Q*;R)IO)\ETRI#;"CL
M W )'!R:\FL_V<?&WAG0[^SL]5T7Q!+>/JUFOVR/[ EO:7T5NAE AB8/(C0%
MBI W[S\X->^_\(3I'_/"?_P+F_\ BZ/^$)TC_GA/_P"!<W_Q=";7Y :>EV/]
MF:99V?F--]GA2'S'ZMM4#)]SBK587_"$Z1_SPG_\"YO_ (NC_A"=(_YX3_\
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M*MND=TKY)$+K&L;[2"=HQZ__ ,(3I'_/"?\ \"YO_BZ/^$)TC_GA/_X%S?\
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-\76X.!0 M%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>aciu-20221231x20f028.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f028.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $& EH# 2(  A$! Q$!_\0
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M_P GQ?LM_P#7'Q5_Z014V[DI6/I^BBBD,**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *0D*"2< <DFEK'\9:;?:SX1UO3]+FBM]2N[
M*:"VFG)"1R,A56;'. 2#QZ4G>V@UOJ8?@CXP^%OB-'>/H%[<7GV:WCO"LEC/
M"TT$@;9+$)$4RHQ1U#)D94CK4WA'XFZ9XR6_:VTW7]-2R022MK>A7>G!@<_<
M,\:;\8.0N<<9ZBL[X;_!W3OAY9SQMJ>H^(;B:R@TW[1J\B.T=G"K+%;H$10$
M&]SD@LQ8EF;C&AX+^$7@OX<F^/ACPSINA&^14N38P"/SE&<!L=<;C^=4[:V$
MO,P?A3\8[KXB:@;34= 706NM+@US3-M\+DW-C,S*CR (OE2#:-R L!O&&/.&
MGXMZOJDGCBVTCPO%#>>&;B&/_BH-2%C#<PO'YC3[TCE,: ;L;ER<9(4&I_ _
MP2M/ 4[367B/6[N5(K:RM7O6@D-I80N76SCQ$,QG<06;=(1CY^ 1IZW\*-*U
MV'QK'+=WT(\60QV]^89%!1$B\K$>5.,KD'.>O:AVMI_7](%OJ6OA9XMU3QWX
M"TCQ!J^BIX?N]0B,XL([HW(6(L?+;>40_.FU\%01NP>0:ZNFQQK%&J(H1% "
MJHP /2G4.U]!*]M0HHHI#"BBB@ HHHH **** "BBB@ HHHH ^??VM/BSK_P\
M_P"$$T;0/%VB> 9?$>H7,-QXEU^!)X+6."TEN @1W1<R.B)DMP&..<5F?L>_
M&GQ1\?=/_P"$P\1>+O"7EWVF026W@CPW<1W,^G _>N+N3<7$CG@1X"H, EFR
M:TOVS++PM)X%TF^\3^/]#\!"RO"]I)X@T>UU:UOI2A'DFUF4M*<<XA*N,<&N
M:_8M\2:IXBOO$;7?P@T7P=I\4<:VGC71-"?1(=>7/:TG19T ZY8LI[=LD-W_
M %T'+9?UU.6_:[\+7.F>,HKJ]'@#4K#7+D3V>DZE\,QKUZACCAAGN[B8W"*$
M0&)3(P&%,:#.!7T!^S.;-/@UHMO9'20MI+=VDL6B:$=$MH9H[F5)8Q9%F,+*
MZLK#)RP+=Z\@_;XUSP7I^A:#:^)M'UB^U22VOIM+N-"UQM)NC(#;QBT21>9/
M/EFMU,85L!2^/W8KUC]ENZTVX^"VD1:9HPT);2YO;.ZM!J+:B#=Q74L=S(+M
MOFN-\JR/YIY;=D\TXKW63+=,]8HHHI#&32I!$\LC!(T4LS'H .IKQCX&_M1:
M3\<-?N-+MO#NL>'S-IJ:[H]QJ@BV:MIC2M$MU'Y;L4^=?N2!6 =#CYN/9;JV
MCO;6:WE&Z*5#&X]01@U\T_"+]EOQG\(9)KZT\::1JNJ:/X?B\)^%C=:1(D-M
MIR7/G$W86;,TQ&U-R%%'E@XY-..^O];_ *V_$'MIO_PWZ7_ Z:R_:TT*[^*U
MYX0;P[K<6FQWM]I-KXC$<;VMYJ-G 9[JUCC5S+N6,-ABFUV1U4DCG#T_]M;3
MFT;7Y]7^'_BGP_K5E!IMWIV@WRV_VO5(M1G:WL=H64K#))*I5HY2K)@ENAPW
M3_V5=>T?XM3^)+3Q98OX=LM9U3Q5HVD3::WG0ZM?6S0R&:828>W4R2.J*JME
M\%B%%<WX:_9'^(3>"?$NF^*/&?AJ_P#$]]JMCXBMO%-GH]Q]LGU*UN%FB:\\
MRX99(0$6-8HQ&J(2%Q272_97_7_@?+O=$NMOZ[?UZ]M??_@]\5;3XO\ A&36
M(--O-$O;2^N-+U+2=0V&>QO()#'-"S(S(V&&0RDA@01UKQGX\ _\-P_LMG''
MD^*N?^X?%7K'P)^%EY\*/"%_::MJT6MZ_K&K7FNZK>VUN;>![JYD+NL499BL
M:_*J@L3A<DY-?.GCSX/>#OAE^WU^S]JOAG1(]*U'Q$WBFZU2=)I7-S)]B5@Q
M#L0OS2.?E ^]]*;$C[1HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ IDTGDPR2;&DV*6VH,L<=@/6GT4 <!\'_C'IWQF
MTG4=1TS1]9TF&QNVLI%UBV6%FE7[X7#-G:?E/H1BN_KQ']DK_D1/%'_8VZQ_
MZ5-7MU>CF-*G0Q=2E25HIV74XL%4G5P\)U'=M!1117G':%%%% !1110 4444
M %%%% !1110 4444 >(_M1:CH>CZ1X<OM7^+-C\(9H;US::O=VEC.TSF,@QQ
MF[1@AQSE,''&<5Q'[+_Q<U3Q9\6_$OA>S^*D/QI\(VFBV^H?\)'#86\/V"]:
M9T-H9;=5CDW1CS,8W+MYZUN?MA?$_4/A9;>!=2-H[^%SJDSZQ<Q:-_:<C".V
MDD@LU38WE_:956+S<?+GJ,YKE?V0?$OQ#7X@:KX9\6:U-K@3PW8ZSK=HVE16
M</A[6+EBYTZ)HD4,! R$J2[+L!+?/BG#5O\ KI_7X=]2>B7]=?Z_I:;W[9EM
MX\O(O"7_  A>FV[_ -G&[UB359/#,6N36D]NL;1K"DG$4CQM<%7 R7C1!@O7
M=_LJWFIWWP,\/R:M#+%<K)=)&\NC+H_GPK<RB&862@>0LD81PA&0&YR3FO)O
MVIO"OQ"^)WQ T73!\&KKQ[\/-'\Z26W7QE!I<&IRR1Q^7*T097S"PD4*YVG>
M6ZA:]/\ @EH/BGP1^SC%8>(-)U*#Q#:VU_(FB'5_MUS;H99FM[6.\&2^V,QH
MCDE@ N>123M%O^OZ]/S!ZM(]>:]MTNEMFGB6X8;EA+C>1Z@=:FK\P/"WB7X?
M:[XKTS1_%_[.GA[P9XAU*\CB>Z\?>*KRTUF1FD"EX[FYM0TTG4@)-DG&",U^
MEGAK0(/"VA66DVL]W<6UI'Y4<E_<O<S%0> TCDL^.F6). .:=M+BOK8TZ*9/
M,EM#)+*P2.-2[,>@ &2:\2^ _P"U':?&_P 0RZ9_PBVI^&EN]*3Q#H=Q?S12
M+JNEO*T2W $;$Q-N S&_(#H>YPEKHAO17/<**\(T;]K#3M5^,,O@Y_#.IVNA
MOJ5]H5GXH>6)H+K4K. SW-N(03(H5%?:Y&&:-@!TSC7'[;6@P?"CXH>/'\-:
MK8V'@G4H]+6SU;%C<7\DB6[1-MD ,(<W*8\P9 Y('0'2_E?^OO';6Q](5\P?
M'C_D^+]EO_KCXJ_]((J]>^!/Q6?XT?#FR\5MI]EIJ7<DBQQ:?K$&J1,JMC<)
MX?E))SE>JD8->/\ QUD5_P!N+]EP*RL1#XJ! .<?Z!%3:MHR4[GU#1112&%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(2%!)(
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M)-Y:E_.B=7 $:R(5'#"5LUTP\*Z-_9-GI9TJR?3;-%CMK1X%:.%57:H52,#
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M:V[_ ($J_4****DH**** "BBB@ HJIJ6JV6BVCW6H7EO8VJ?>FN95C1?JS$
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M'N,TGVKX]^-_]39^&/AK8OT:YD;5KY1_NKMBS]2:]/\ LRO#6NU3_P 3L_\
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M<^MK/=>NMMF>E5RZ> R^C%QY5S2TNKK2/3=;/^FC3HHHKZ \@**** "BBB@
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MO\C"K7I4%>K-1]6D>IT5XA_PT?JWB' \&_"KQ?KRM]RZU"W32[9O</,V<?\
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MZWEY]HTVK^%=9HGA'1/#:!-+TFSL .\$"J3]2!DT^?,JWPPA37FW-_<N5?\
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MD4Y/\>5?B+ZQ7G_#HO\ [>:2_#F?X';>*_CC\/O ^X:YXRT;3Y5ZPO>(TO\
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M7_QVD,]/HKS#_AJ3X,?]%=\"?^%+9?\ QVC_ (:D^#'_ $5WP)_X4ME_\=H
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M#D?^%0> _P#H2?#O_@I@_P#B*/\ A4'@/_H2?#O_ (*8/_B*ZZB@#D?^%0>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO-8GL=9BMFN);.ZLI8Y(G6V-T;=P5^6?R%,GEGYL>_%4U;<2UV/0O^$BOO\
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M_P =K=HH PO^$BOO^A<U/_ONW_\ CM'_  D5]_T+FI_]]V__ ,=K=HH PO\
MA(K[_H7-3_[[M_\ X[1_PD5]_P!"YJ?_ 'W;_P#QVMVB@#"_X2*^_P"A<U/_
M +[M_P#X[1_PD5]_T+FI_P#?=O\ _':W:* ,+_A(K[_H7-3_ .^[?_X[1_PD
M5]_T+FI_]]V__P =K=JCKFI2Z1I%U>06%QJDT*%DL[3;YLS=E7<RJ"?4D >M
M)Z:@4/\ A(K[_H7-3_[[M_\ X[1_PD5]_P!"YJ?_ 'W;_P#QVO+]5^-7C&;P
M3X%\2Z!X5T6[3Q,EH@TV_P!9EAN4N)OF,<>RV='5$#NSEE&(V.*U?A_\:;OQ
MK\3_ !%X;FL+#3;'3I;F&U:6>Y6]NS#*(W=8WMUB9,[CF.9R 4) W<79WMZ_
M@*^E_P"M3N_^$BOO^A<U/_ONW_\ CM'_  D5]_T+FI_]]V__ ,=K=HJ1F%_P
MD5]_T+FI_P#?=O\ _':/^$BOO^A<U/\ [[M__CM;M% &%_PD5]_T+FI_]]V_
M_P =H_X2*^_Z%S4_^^[?_P".UNT4 87_  D5]_T+FI_]]V__ ,=H_P"$BOO^
MA<U/_ONW_P#CM;M% &%_PD5]_P!"YJ?_ 'W;_P#QVC_A(K[_ *%S4_\ ONW_
M /CM;M% &%_PD5]_T+FI_P#?=O\ _':/^$BOO^A<U/\ [[M__CM;M% &%_PD
M5]_T+FI_]]V__P =H_X2*^_Z%S4_^^[?_P".UNT4 87_  D5]_T+FI_]]V__
M ,=H_P"$BOO^A<U/_ONW_P#CM;M% &%_PD5]_P!"YJ?_ 'W;_P#QVC_A(K[_
M *%S4_\ ONW_ /CM;M(<X..OO0!A_P#"17W_ $+FI_\ ?=O_ /':/^$BOO\
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M"W +8YXH [?P=X2L_!&@0:3923SQH\DTES=OOFN)I':2661L %G=V8X &3P
M,"MNN3T/0/!GB;2K;5-'@TK5=-N5WP7EDZ30RKG&5=201D$<'M5[_A _#W_0
M'M/^_=-@;U%8/_"!^'O^@/:?]^Z/^$#\/?\ 0'M/^_=(#>HK!_X0/P]_T![3
M_OW1_P ('X>_Z ]I_P!^Z -ZBL'_ (0/P]_T![3_ +]T?\('X>_Z ]I_W[H
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M110 4444 %%%% !1110 453U07YMQ_9QMA/N&?M08KM[_=YSTK+QXJ_OZ/\
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M,&GZQI>@7-Q?W6HMJFHV]U:7DDLV^%[-4Q)&>7WAU7 POSX##T_'BK^_H_\
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M_P"- '@GPD^".LVL?BG3O$WAZ8Z9=:,-->'4YK:2&24322^59B [OLF9"?\
M2?WA) .1NS[E\*]%N_#?PQ\(:1J$(MKZPTBTM;B$,&$<B0HK+D<'!!''%6<>
M*O[^C_\ ?,O^-&/%7]_1_P#OF7_&G?\ K[_\P>KO_73_ ".@HKG\>*O[^C_]
M\R_XT8\5?W]'_P"^9?\ &D!T%%<_CQ5_?T?_ +YE_P :,>*O[^C_ /?,O^-
M'045S^/%7]_1_P#OF7_&C'BK^_H__?,O^- '045BV0\0_:H_M;:8;;/S^0LF
M_&.V3BMJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>aciu-20221231x20f029.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f029.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #\ EH# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ5]K>G:8RK>
M7]K:,P)43S*A..N,F@"[14-I>07\"SVT\=Q"WW9(G#*>W!%34 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !16;%XFT>>X6"+5;&2=FVK&ERA8GT SG-:5 !13)94@B>
M21UCC0%F=C@*!U)/85')?VT)@\RXB3SR%BW.!YAQG"^IQZ4 3T5&]Q%'-'$T
MB++)DHA8!FQUP.^*DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"&\A>YM)X8Y
MWMI)$9%FC +1DC 89!&1UY!%?EM<?"_PCXO_ ."?\>O^))8O&OB_1/%8TPWV
MJ[&N]*$OB"-)K4E I7>CF1@^6_T@XPNT#]3ZJG2[(Q2Q&T@,<LGFR)Y2X=\@
M[B,<G(!S[4UH[AK:Q\%?%SXO1_LZ?%;2_ 'PT\1)X1T7P[JFAVK>"HM/M+>Q
ME@O[K-S+NEW7%QD2YWQ>6D3<,S,<5N:'^U%XCN?B?H'@J?QBC>(6^,&K:+?:
M.T,(N%T-(KEK9'79E8SMA*R<,^.&/S5]M7&F6=W(9)[2"9R@C+21AB5SNVY(
MZ9 ./44-IEFUP;@VD!G+*YE,8W%E!"G.,Y ) /N:(NUKZ_\ #K_+\1-7V_K?
M_/\  LT444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %?!7C7]H[QOHGQO\;Z=I_Q'\S5-(\=Z5HV
MB_#DZ?;,=5L;B*U^TX?R_..P2RR!E8"/82^0R@?>M<IX5^&'A_P=X@\2ZUIU
MHPU'Q!J']J7LLSF3]_Y$<!*9^X"D2 @>E"TE=_UJO^"#U5E_6C/BO5O@K\*O
MA/\ M,?%W7['P;I>DCPAX(T_Q-IL]KIK7;6%]YUZQNHX Z[WS'&=NY<[!R.3
M6!X8_:S\=1^&O&]S_P +%;7-%T#7_"%P?$%Q%8.\6GWTQ%^)7MD\D1 (1D;C
M'EE,A(R/T9%I )WF\F/SG4(TFT;F49P">XY/'O4":-I\<+1)8VRQ-&(600J%
M,?.$(Q]WD\=.30M$EV_SO_P >M_ZZ6_X)\'_ !+\7ZA^T7^RW^TYJ#^.-1G\
M/>&M;U?^RFT:2.&.\LH=-B>*V>14S);F60N<',@ !8H<'S_]LPV,VN>$&O'L
M8);;X;6CV:ZP&,UU*;J,[-"*_P"KU,!2-^&^5XOEP":_3,:=:"":$6L/DS<2
MQ^6-K\ ?,._  Y["EEL+:<P&2WBD,#;H2R ^6<8ROH<>E-:;>7X)K];C;;W\
M_P 6G_P#Y6\4^%GTS]O3X0Z_/K&KWTFM:!KGEZ;J,P,&FQQ068$<,8 VLS,[
M.Q)9B0,X50/K&HGM89)XYVB1IHP0DA4%E!Z@'MG J6AO1+^MVR4@HHHI#"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *Q[GQCH%E<207&N:;!/&=KQ2W<:LI]""
M<@UL5R]_\+_".JWL]Y=^'-.N+J=R\LTENI9V/4D]S7'BGBE%?55&_7FO^B9T
MT%0;?MV[>5OUL<'X@_:;\/Z/XIATZVADU'3E8I=:A ?E0_[ _C [G\LUZ';_
M !#\+W5O'/'XBTLQR*&4M=QJ<'U!.1]#7E>O_LLZ9J'BB&ZTZ_;3M&D8M<V8
M&YU]HF/0'WZ=L]!Z#;_!GP1;V\<(\,Z=($4+NEA#LWN2>2?<U\AET^)G6K_6
MXT^6_NZO;RM=V_Q:W/H\9'(U2I?5Y3YK:[?C>ROZ:%?XE_&?0/A>-)AO8=3U
MG5=7+C3M(T&QDOKR[5%#2.D: _(BE2S$@#<!G) -O0OB]X1U^QT*X36[;3I]
M;0/8:?JQ^PWLQW%=HMYMLFX,K#&WJ#7*?%3X6>)K[QIX5\;^ +[1[+Q%H-E=
M:5_9^N0R&QN;2X,3,NZ([XW1H(RI ((R".01S>K_ +.>N^//%*:]XRUC1[O5
MI/!%[X9DU#3;!HGM;JXFW?:+979M@5/E!W[B1VR17W*O97W_ .'/E':^FW_#
M'K$7Q2\&3Z/)JT?B[0I-*CN#9O?+J4)@6<9S$7W;0XP?ESG@\5+)\2/"4-AH
M]])XIT5++67$6F7+:A"([YST6!MV)"?1<U\Q^!/V)-2T3PYI%AK#^&II;;Q%
MHVHWD=LMW-!>6FGQR(NY)W8"5O,SM50J@ $M@$9_B#]A'5]5L] MDU'0;BTM
MAJ]C=:=<B[BMHK.\U)[Q7@$#QGS$5@A0D*< @C:,WUM_70FY]0M\7_ B:KJ.
MF-XU\.KJ6FB1KVS.JP>=:B/_ %AE3?E N1G<!C/-7M6^(7A;0$NFU/Q+H^FK
M:2+#<-=W\40AD:/S51]S#:QC!< \E1GIS7R_XB_9%\<>,?&/Q2OM7NO!IMO%
M.E76BZ7JD,,_V[2[0C,,>S:$<NX#S2%B[] <*!6Y8_LN>+?$?BI/$'CB[\*Z
MA/<>+[#Q)>V%C:S-:F&WTJ2R\E5ER6;>R.&;C /0X%):_P!>?^0_^#^7^9]"
M6?Q#\*ZBE^]IXFT>Z73X$N;QH;^)Q;1.NY)),-\BLO(8X!'(KF]7_:!^'^B7
M_A^&Z\4:8MEKD-U/9ZL+N(V!6W,8D#7&[8#F5 !GDY]*\!\._L5>(_!WA46>
MA:KX:TW5?^$.;P])<#3A+'-<G41="1T="K+Y8*!F5BC$,%.,&A;_ +&'CS3(
M[*ZBU/PAK]_;ZKKVH/#XH@FOH91J,=L@WD*I,B&&0E]H#9 P-QP/R_K7^F/^
MOP_I'V?'(DT:R1LKQN RLIR"#T(-.KE?A3X&_P"%8_#/PKX1%])J?]AZ9;Z=
M]LE&&F\J-4WXR<9QTR<=*ZJF[)Z$K;4****0PHHHH **** $) !). .YKCKG
MXS^ +2*627QOX=58E+/_ ,36 D => V?PKL64.I5@&4C!!Z&O,+C]E_X37,<
MJ/\ #[0%$@()CLU1AGT(P0?<=*[<,L*V_K+EY<J7SW:.6O\ 6-/J_+\[_H>3
MZ-_P4(\#:G\2I=#GM;FQ\,MB*W\0S<*TN3EGCQE(SQACSW( /'OMK\6/!%]<
MPVUMXR\/W%Q,XCCBBU2!G=B<!5 ;))/85\RZ+_P3F\/6/Q*EU"^UJ:^\%QD2
MP:005N';/^JDE'6,<<C#'.#C&3[]I_[./PNTJ^MKVT\!:#!=6TBS0S)8IN1U
M.58''4$ U]%F<<A3A]3E/X=>U_.]M>]M.QX>7RSEJ7UM0WT]/*W3M?7N8OQ)
M_:D\(_"SQ;J&A:QIWB*?^R[*#4=4U+3=(ENK/3;:9I%26>1,[%_=2$G!P%)K
MIK+XW^"[E?$$EUKEIH]MHFJ_V-<W6K3):PM<^3',%C=V <%)4((]_2N"\7_L
MJ:+\2_C1XB\6^+I)]1T#4-*T_3XM'M=1NK:.4P27#R"ZCC=4GC;S4PK[APW'
M//%?$C]E#QKXJ'BR'1O$^E:99:_KVH:C)'Y&V9+>XTZ"T11,8W9"K1.72/;Y
MB,%+KCGX_9?UW_R/J+*_W?E_F?2<_C;P[:Z]8Z)-KVF0ZU?1&:TTZ2\C6XN(
MQU>.,MN=?< BN=\1_'+P3X:T6?59/$%EJ%E;:I;:/=/IMQ'<?9+F:98D2;:W
M[O#.-V[&T9)Z5XKX8_92\3>'/%FFW9NO"&H:?/8:3%J-[?Z9)/J6GS65B+7_
M (E\A("*V-ZLV"C,YPV[CCO#O["/B+0?AQJ>@#4?#$NJ"31H+6\FCO)X;VUL
M+P7&;N&20IN?D;(P -S?.0V!32OO_7]?YD=/,^L9_B=X.M?#=MXAF\6:'#H%
MTXB@U634H5M9G)("I*6VL201@'J*Z1'61%=&#(PR&4Y!'K7R+_PQ[XLL["PU
M>WN/!%[XC&JZOJ%SH&HZ9+)H$2W\<,;"",'<'C$ (8CYS+*#MW9KZ/\ A+X"
M_P"%6_#'PMX0&H2ZM_8FG06'VV<8:;RT"[L9.!QP,G P,G%'3^OZT&=;1112
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M -O^-W_"4_V8?$/_  GDOVW^QO,^R;_[,T_'E^9\^-NW.[OGMBOHR@ HHHH
M**** "BBB@ HHHH **** /((?CC<W?QG?P?:VFE7-C%J#:9+Y=^3J*L+-;EI
MS;[<"%21&6+<LZX]#=T?XA^*[WXOW?ARYT58O#L32".__LR_0L%3*_OVB$!R
M>.'Y[<UW6B>$='\.W-Y<Z?81075Y-+//<8W2R-(Y=LN<G&XY"YP.P%;%/L'<
M\"\&?%+4I_B]=6>H>*8;JUENM7M[S0Y#;HNCQ6L\<=K+E5$BF56!)D8AC*NT
M  9YCQ5\7=<T^[\7/X9^(%OXDMH+J+3[LRRV-NFE3O?1PN82$8I'#&S+)).)
M5#[2,D.E?2SZ'ILEQ<SOI]J\]T$6>5H5+2A?NASC+8[9Z56M_"&A6L]W-!HN
MG0S7B-'<R1VD:M.K?>5R!\P/<'K1V#N<[\%?$=YXI^&^F7VH7;:A>AY[>6\9
MHW6<Q3/'O1XU5)$.S*R*JAQAMJYVCN:CM[>*T@C@@C2&&-0B1QJ%5% P  .@
M [5)0Q(****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ^+?"ESIE[^
MV'.++PKKHMK/6;B"[6YU>Y:QMK]UNW2X@M3$(\M&L\SYDVJ+Q"N6;%<I^V7\
M#O$'Q"^.TNH^&OA7<7-\VG6Z/XRCGM-2$ZJ3F(:7<R)&0F0"Y(SNKK_#_P!L
M_P"&OK:Y7QKXAO[&37+^"9K_ /M=-),JQS[=/M@?]#>15(#=-IM"5W,S >8_
MM>2Z3/\ M1W^G2?V1K.L/'IET]@XU5=1-@L$\<MB'M+63_1YVEW.JM\VW#*<
M@@^S#^NG]?(?6?\ 74^\OA3:M8_#'PG;2!5DATJUC8);0VX!$2@XBA9HX^1]
MV-F4= 2 #755SOPY9&^'_ALQ:7!HD9TZWVZ;:PO#%:#RUQ$B.B,JK]T*R*0!
M@J#Q7154OB9$=D%%?$/Q \8^*=2^)?Q9@\":GXNM6TK3+F">&\DNWDU*X:>W
M,CZ?"4\J**UA6=4>/$DCRMC?M#'W?X%7_BJ7X-:]<6J3ZC=)J&K?\(L/$4LZ
M/<60FD^P">20&8(5V#>X+[-I.322NKE/1V\RC\$_^3B_VB_^PQHW_IGM:]UK
MYE_9+N_%M]\6/CY-XYT_2]+\4MK.E?:[31;E[BT0#2K<1[)'56.4VDY P217
MTU2 **** "BBB@ HHHH **** "BBB@#PG0/ 'B;7OC??>+KRS_LK3[75YF@O
M9;^?[1/:I:BV6V6U(\M8GD!G,F3NPGRYPPZ/P_\  Y-"^+M_XX&H64C7;3-]
MF32DCF7>,<SAR3CZ<UZG13OL#U/%_#7P[\7>'?&AOC9:9/INDRZM-I\B:@ZS
M7YU"[2=EE4Q8B\H!AD,^\A3\O-.T_P"%.M:KXR\6W^O:;HT>EW^EOI<5HER]
MW!=8DWQ2"&2,"V ^;>BEP[MN/W03[-12>JL"T=UZF!\/]"N/"_@+PWHUXT;7
M>G:9;6<S1$E"\<2HVTD#(R#C@5OT44V[NXDK*P4444AA1110 5Q_B3XM>%_"
M7C30_"FJ:@]OKVM8^P6RVLKB;YBOWU4J.1SDC'4\5V%>-_%#_DXKX)?]QO\
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MES8B/P5-E)_8E_=2TWW//Q^(JRI1Y:,OBANXK[<?-ORV/L:BBBOF#Z ****
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M (T)&2?A-I,CCLGBJ,9^F8:8/B5\9@OS?!FT9O\ 9\66_P#\;KVBBI^N4?\
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M:TEL)IX4D>UG(,D+$ E&P2,C.#@D<5:HHKYEZNZ/>6B"BBBD,**** "BBB@
MJIJVJ6NAZ5>:E?2^196<+W$\N"=D:*68X&2< $\5;I&4,I! (/!![T!ZGQ;\
M%/$N@^,_VC+V]MI]-U_2IM<O[W1Y=+\=0RV,;-&_^DKI!D+BX(:16901\[2
M*6-=5\7?CRW@KXZ_V5KN@M=V%E<P1V5^GAJ[OG@L;C3[DW3I-#&PR;B.UC(Z
M[6(((Y%[P3\7/AG8_'BX\%Z-\/-&T758]5EL+?4K);%;MY]EPT\K6Z?OHTS
MPWD?,)$; 5@3B_M!:;\0KOXP2:2=:U&#P?K4*7-G;:1XC_LRYNELK.YEDT^
M+M:.::<Q2/<;POE1[,]BI?"NP)>]+N>Y?L\P&/X'^!II-'M= N[K1[2ZNM.L
MK(6<4,[PJTBB$ >7\Q/RXXKT.N'^!E]J&I_!CP+=ZKJ\6OZE/HEG+<ZI Q=+
MN0PJ6E#$ L&/.<#.<X&<5W%:3^)DQ^%"8&<XY]:  H    X %>=_M#>-]5^'
M'P9\4>(M$\M=3LK=#%-+'YB0;I$1IF7H1&K,^#Q\G/&:R?@E\1]8\0_##Q!J
MVJ&?Q3/HNJZM86UWI\,0FUB"UGD2*2-5*QF1P@7Y=J%@<;0>)2N4]#%^"?\
MR<7^T7_V&-&_],]K7NM?-G[+/BF7QK\8OC_K,^@ZMX8EN-9TD'2M=BCBO(=N
MDVZY=8W=1NQN&&/!'3I7TG2 **** "BO"_VD_P!HW4O@5J'A2UT_PG=:^-7N
MQ'+,H(CVYP88B,YG;.5!&,#OVHZC^T1XTDO]2L]%^'4U]>6Q3=9W$SQR6X(Y
M,I1'!)/0#MW-1CIPRV&'J8MJ,:[:@^C<=[]O5V*PD98V5:&'7,Z23DO7:W?Y
M'T%17R^WQB^+6J B\;PWX*CYR9=%U*^D7\<(M.74]5UHJ-:_:&N+-6/,&E:!
M#I^/8-*CM1];RJ.E3'T8OMS7?X)K\1>PS!_!@ZC\^6R_%K\CZ>K.U7Q%I6A1
ME]2U.ST] ,EKJX2(?FQ%>!6WPM^&VO876?BOXB\3DC#1ZAXL>)&_X!$8P*Z?
M0_V>O@C;2":T\->']2ESGS;R87K$^N97>NRG6RF?PXGG_P *C;[W/]#GG2S&
M/Q4.7U;_ "4?U-G6?VFOA5H+M'=>/=$>0'!CM;H7+?E'N-8__#5?A2_;;H.B
M>+O%!.0ITGP]<LK?\"D5!^M>EZ'X/\.:#&HT?1-+TY ,#[#:1Q ?]\@5MUU^
MTP$?AIR?K))?<H_J<W)C);SBO2+_ #<OT/&1\:?'VKG_ (DGP7UYE/236]1M
M+ #W(WNWX8IDNH_'W7H9%MM%\$>%=ZD*]Y?7%]+&>Q 1%4GZ\5[311]<I1_A
MX>"]>9_G*WX!]5J2^.M)_P#@*_)7_$^$O@[H7Q9T_P"$NHW\?Q&&A:</$TUM
M]GL]/BN)I)FNO*N)#(XPJF0NP7!]>,XKZ'7]G?4]0'_$[^+7CS4<YW):W\5B
MC?A#&#^M<!\//^3?+_\ [':Z_P#3L:^I:,=FV*_MO%TH\L8QY6K0BG=N:;O:
M[O9;L,'EV'_LK#U)7;?->\I/91:TO;J^AXU'^R1\.)CNU6QU3Q%)C!;6=9N[
MG/U!DQ^E=)HO[/GPS\/,&L/ ?A^%QC$C:?%(_P#WTP)KT&BLYYCC*BM.M)K_
M !/_ #+C@L+!WC2C?T13T_1[#28_+L;*WLT_NV\2QC\@*N445P-MN[.Q)+1!
M1112&%>-_%#_ ).*^"7_ '&__2-:]DKQ?XH6FO7'[0'PGO[#PUJ&I:1I7V[[
M;J5N8_)@^TQ"%=V6!^7;N.!T(QD\5ZF6V]M*[M[E3=VWA)+?S9YV/NZ2LK^]
M#\)Q;_ ]HHKS[X3)(+GQEYEW=W0AUR:VC%U<O*(XU52JKN)QR[=/;T%>@U\]
M@L3];H1K<MKWTWV;7Z'M8FC]7JNG>]K?BKA1117:<P4444 %%%% !1110!%=
M6L-[;2V]Q#'<6\JE)(I5#(ZD8((/!!':G0PQV\*11(L44:A41!A5 X  '05Y
MO\4_BO<>&H==T+PS9&^\;V^C2:M:1:C:W46F^6IVEI+I8FCRN"WE!M[ <  [
M@[P7\3+ZY_9X\.>/M3TV^UW4KCPW::O<V&@6GFW%S*]NDCI!#NY8ECM7=[9H
M6M_Z[_Y ]+?UV_S.3_9H_P"1U^/_ /V4"3_TUZ=7NM?-O[%WBO\ X3F;XUZ_
M_8VK>'OM_CR63^R]>M?LU];XTW3UVRQ9.QOESC)X(/>OI*@ HHHH 0@'&1TH
MQ2T4 )UK,U#PMHNK B]TBQN\]?/MD?\ F*U**SG3A47+.*:\]2XSE!W@[,X>
MY^"G@JX8NFA0VDA_CLG> C_OAA4/_"HH;0?\2SQ/XDTST6/43*@_X#(&KOJ*
M\QY1@&[JC%/NERO[U9G<LQQ:5G5;7F[K[G<X'_A#O&UB/]"\=_:5'1-2TR*3
M\V0J:/-^)FGCYH/#>KJ/[DDULY_,,*[ZBE_9D(_PJLX_]OR?X2<E^ _KTY?Q
M(0E_VZE_Z39G GQSXML<?;_ -TX[OIU_#./P!*F@_&/3K7_D)Z)XATCU:ZTN
M0J/^!)N%=]11]4QD/X>);_Q1B_\ TE0#ZQAI?'02_P ,I+\^8^/_  QXVTN'
MX9_%/3;IY;&_U/Q5=:G9V]U'L>>":>-T91SR%0Y':OK32=7LM=T^"^T^YCN[
M290Z2Q-D$'^7TKA/C[I-E>_#/59I[6*6: PO%(RC<A,J*2#U'!(_&KEQ\%O#
M D\[38+K0+D=)](NGMV_$ [3^(KSZF(S.IG%>M.,)WA3O;FAUJ6M?GUWO=]M
M4==.A@*>6T:47.-I3M>TND+WMR^73OH=W17G_P#PB_CK0N=*\5V^LPKTM]=M
M!NQZ>;%@_F*/^$^\3:+QKW@J\:,=;K1)ENT^NSY7'Y&O0_M*-/\ WBE.'JN9
M??#F2^=CE^HN?\&I&?SL_NE9OY7/0**X[2/B[X3UB<6ZZQ%9W?0VNH*UM*#Z
M;9 /TKKXY$E171@Z,,AE.0:[J&*H8I<U"HI+R:?Y''6P];#NU6#B_-6'4445
MU& 5XS^U$"WAKP2 "3_PF>C=/^OD5[-7&_$OX2>&OBW8V%IXEMKBZ@L;@74"
MV]Y+;E9 ,!LQLI..V>E=^ K4Z&)A5JWY4];:O\U^9QXRE.M0G3I[OOI_F:EC
MXWTC4?%%YX>@N)'U6S3S)H3 X"KQSN(VG[PZ'U]#6]7 >'_E^,OBQ1G TVP'
MZRUW]?/8"O4Q%.<JMKJ<TK*VD9-+J]=-?R/9Q=*%&<8POK&+U[N*;Z+N%%%%
M>D<04444 %%%% !1110!\&^,1XZO/V@?$MKX6\1W-MX]%]=O:QQZYH MY[18
MRUK;")HS>D@A#)'(  BR8;[AKZ3^*GPA^&'CCX@^$-7\::7977BBSBN7T]Y+
M<,9D2(^8&)4Y6/S-Z@D8;!&37B'@#QCI>D?M9WVCZ?+KD5E?^(+\'[5I6BQ6
MDETRW!E$<P/VYAYD$HSCJ!DA67/K?Q\^/FM?!Z\$$N@:!'HUY$8[36-:\7V^
MDF6;:2R)')&22O!R#WI/^&AKXVCT'X/#PY!\,?#=EX2OI=1\.V%C%965Q<;O
M->*) BE]RJ=V ,D@9Z]Z[*N)^""Z@OP:\##5M3CUK5!HEG]JU**Z^U)=2^2N
M^59O^6@8Y._OG/>M[Q=XNT;P%X;O]?\ $&H0Z3HU@GFW-[<'$<2Y R3]2/SJ
MYZ2=R8ZI&I/!'=020S1I-#(I1XY%#*RD8((/4$=JBT[3;32+&"RL+6&RLX$$
M<5O;QB..-1T55   ]A7SGXS_ &JM;\.:WX^6W\-6;Z+I/AS3]9T*\DN]YU/[
M7=/;I,X3_5P[@I"_?(5CQD >B_#;XNW&M_#CQ-K_ (EMDBN_"^H:II^I-I-O
M+(DYLI75I8(OFD.Y4!$8+-DE06/56=K_ -;V"_\ 7RN<U\$_^3B_VB_^PQHW
M_IGM:]UKYE_9+^(.E?%3XL?'SQ1H:WJ:7>ZSI2Q+J-G+:3Y32K=&W12JKKRI
MQD<C!'!KZ:I#"BBB@"*>UANO+\Z&.;RW$B>8H;:PZ,,]"/6G+#&DCR*BJ[XW
M,!RV.F3WI]%&X;!4<MO%.,21)(/1E!J2BDTGHQIVV,FY\):'>9^T:-I\^>OF
M6J-G\Q61=?"3P7>?ZSPOI?\ P"V5/Y 5UM%<=3!86K_$I1?K%/\ 0Z88K$4_
M@J->C9PC_ _P63NBT<VK?WK:ZFCQ_P!\N*9_PIC1X1BTU7Q!8_\ 7OJ\W'YD
MUWU%<G]CY=TP\%Z12_*QT?VEC>M:3]6W^9P3?"Z\B(-KXX\30XZ"6YCF'_CR
M4T^!_&-LC?9/B!<NV/E6\TV"09]R #7?T4_[)PJ^'F7I.:_*2#^T,0][/UC%
M_FCY;UCX:>.?A[\,SI\NIZ5]CEUH7;P6>]F,\T^\/YCJ./.?.W' QSVKV.+4
M?B5ID:+<:-H6M%5 9[2]>W9SZX="!3OC=_R),?\ V$K'_P!*8Z[^O+C@7/-,
M14C7J)N,'\3ENY_S\U]NM^IWO%*. HQE2@TI37PJ/2/\O+^!P/\ PL77K)L:
MEX!UF,#JUC+#=#_QU@?TH'QK\.P'&HPZMHQ[_;],F0#\0I'ZUWU)UKT_JV-A
M_#Q-_P#%!/\ ])<#@]OA9?'1M_ADU_Z5S'+:=\5/!^JD+;>)=-9CT5[A4;\F
MP:Z.UOK:^3?;7$5PA_BB<,/TJEJ'A71=6!%]I%C>9Z^?;(_\Q7.7/P5\%7#E
MUT&&TDZ[[-W@(_[X847S*'2$_G*'Z3"V!EUG'Y*7ZQ.WHK@?^%10V@_XEGB?
MQ)IGHJ:B94'_  &0-1_PA_C6Q'^A>.OM*@\)J6F1/_X\A4T?6\7#^)AF_P##
M*+_]*<7^ ?5L/+X*Z7^)27Y*2_$[ZBN!\WXF:>!N@\-ZNH_YYR36SG\PPH/C
MKQ988_M#P#>.HZOIM]#<?DI*FC^U*4?XE.<?^W)/\8IK\0^H5'\$XR_[>BOP
M;3_ 7X4_\?7C?_L8[G_T".N]KQ_X"^,?^$BU+QC#_9MW:&35)+[?*ORIO"KY
M3'LXV9Q[^U>P5SY#6IXC+Z=2F[IN7_I3-<VI3HXN4)JST_)!1117T!Y 4444
M %%%% !1110!'<6\5W;RP3QI-#*I1XW&592,$$'J"*BTW3;31M.M;"PMH;*Q
MM8E@M[:W0)'%&H"JBJ.%4   #@ 5YW\5/C+I7@\:IHECXE\.:5XML]-&LRQ>
M(99%@M=/60++=.J<L%&["AEW, -RYS3/ ?Q@N;[X"67Q$\8:/=:*_P!ADOKJ
MRM;.:28Q*S!)$@P91YD8201D%E#A3D@T(&<U^S1_R.OQ_P#^R@2?^FO3J]UK
MYM_8O\9Z=\0Y_C7XDT@72Z;J/CR66 7UK);3 #3=/4[XI &0Y4\,!Q@]Z^DJ
M "BBB@ HHHH **** "BBB@ HHHH **** .#^.7_)+-<^D/\ Z.CKO*Y_QUX/
MB\=^'I=(GO;FQ@E=7=[4J&8*<A3N!&,X/X"MJS@:UM((7F>X:-%0S28W.0,;
MCCC)ZUY=.E4CCZM9KW90@D_.+FWI_P!O([IU(/"4Z:?O*4FUY-12_)DU%%%>
MH<)GZOX?TS7X##J6GVM_$1C;<PK(/U%<C)\&=&LW:70KS4_#,QY_XE=XRQY]
MXVW+CVQ7?45P5\!A<2^:M33?>VJ]'NODSKI8O$4%RTYM+MT^:V9Y_P#V5\1-
M!_X]-9TOQ+ O_++4K<VTQ'H'CRI/N5H_X6?J6C\>(O!VK:<H^]<V(%] /?,?
MS ?5:] HKF^H5*7^[UY1\I>^O_)KR^Z2.CZY"I_&I1?FO=?X>[_Y*SF="^)?
MA;Q(_EV&N6DL_P#SPD?RY0?38V&_2NEZUC:]X+T'Q.A75='L[_/\<T*EA]&Z
MC\#7,GX0PZ62WASQ!K/AX]1#%<F>W'_;.7</R(H]IF%'XZ<:B[Q?*_\ P&5U
M_P"3AR8*K\,Y0?FN9?>K/_R4=H'_ "6?Q;_V#;'^<M=]7BOP^LO%]I\:_$$>
MK:A:7T:6</VF98@AEC^;R"BC[ISOSVZ]>*]JKFR2LZ^'J2<'']Y4T=K_ !M]
M&_3U3-<UIJE6@E)2]R&W^%>GKZ!1117T)XX4444 %%%% !4-W,]O:S2QPM<R
M(C,L*$!I"!D*"2!D].3BIJ* /D[X7MXL\0?'RWUOQ?H/B+2+C^T-0%A;W$_A
MQ[.S@:+/E$1%[SS-GE[]KDD[6;Y#@6/VN=??_A._!<.C:Q=Z?K6F1W?GQZ?K
M&GZ/=M'.L>P)/?QM%(A,9W1ISD*3C;@V_#VC_#4_M&?V;:_%+^T=4LM;O-8M
M_!4<5L?LVJ2PN+AS<+%YQPCR$Q-)@9 .0JJ%_;A\13^&=$\+W%SKUWI'AZ>2
MZMKRWT[7K#2Y[J5D3R,_;5,<L:X<L!R,J<%0PH;]V+&E[S/H'P*+H>"M!^W&
MX-Y]A@\XW<\4\V_8-V^2("-VSU9 %)Y  K<KR+]E_0/%OAKX9QV/BO4EU4)*
MATRY6[BN@UH;>'&V6)$5D\WSBGRY$909XKT[7=?TSPOI%SJNLZC::1I=JN^>
M]OYU@AB7.,N[$*HR0,D]ZJ6C(CJC)UOX:^%_$FH:K>ZIHEI?W6JZ:ND7LDZ;
MO/M%9W6%@>-H:1SZY:KOA+PAH_@30;;1=!L(M-TRW+%((LGYF8L[,Q)+,S,6
M+,222222:\)\:_M9W7@7Q1X@T^Y\/Z=JEG;Z,^LZ=)I.KBXD:$SP06KW6(]D
M*7+SYC*LYVQ2$@XX]*^&_P 6X?%7@77-=U^*U\/R^';[4-.UEA<&2UA>SD=)
MI5E95)B(3>"R@@'!&12L[?UW_P QO^ON_P CCO@G_P G%_M%_P#88T;_ -,]
MK7NM?-_[+WC?0/B-\9OV@/$/A?6+/7]"N]9TD6^H:?,)892FDVZ/M8<'#*0?
M<&OI"D,**** "BBB@ HHHH **** "BBB@ HHHH XKXM:#K'B3PS#9:+;6]S<
M?;()W%S,8E"QN).#@YR5 ^A)[5V41=HD,BA9"HW*#D ]^:?17)##1A7GB$W>
M22\O=O:WWLZ)5Y2I1HV5HMOSUM_D@HHHKK.<**** "BBB@ HHHH X+X4_P#'
MUXW_ .QCN?\ T".N]K@OA3_Q]>-_^QCN?_0(Z[VO%R?_ '*'K+_TIGI9C_O,
MOE^2"BBBO:/-"BBB@ HHHH **** .;^(7PZ\.?%7PM<>'/%FE1:UHEP\<DME
M,S*CLCAT)VD'AE4CGJ!6CX;\.6'A+1;;2=,CDBL;8$1)+/),P!8L<O(S,>2>
MI-<_XZ^(46@QWVEZ)<Z-J7C.*T%]%H5YJ(AE^S;PKW#1HKRF-1N/RQL6*[1R
M:QO WQSTG7O@/8?%'Q"J>%](;3VU"^$LIF6S1"0^2HSQM/!4,.C*K @"V!^9
MR_[-))\;?'_)S_Q<"3K_ -@K3J]TKYN_8Q\;Z'\2;CXU^)_#.HQ:OH.I^/)9
MK.^A5@DR#3=/4D!@#]Y6'([5](T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!P.@?\EG\6_P#8-L?YRUWU<#H'_)9_%O\
MV#;'^<M=]7CY7_"J?]?*G_I<CTL?_$A_@A_Z0@HHHKV#S0HHHH **** "BBJ
M^H7]OI5A<WMW*L%K;1---*W1$4$LQ^@!-&P'QWX*^(;Z3^UO+X?@/B?3M(U3
M7=02*TN_$=K]CN9@DYFDCT];;S?+$D18GS?E\R)V_P!8 ?0OVF7NY/$F@W,%
MG\0M)N=-BN([;7O!&A6NK^:EPJ++"Z.DKQX,:'.P#@'<<$#R_P"$7Q4N_B3^
MTVM]H/Q#M_$'A:_O9;FVGBN[V1);98KC;:1VKVHAAP'BW.)?F-N&Y9MH^VJ=
MO<C<5_>=CR_]F_0+SPO\*=,TJY;Q#]GM/W-DGB>VM+:\CME55C4QVP"JHP<!
MOG_O8X%>CZEIEGK-C-9:A:07UG,-LEO<QB2-QUPRD$'\:LT4-W!*QY+:?LN>
M ;34?%]TMGJ#P^+-QU>PDU.=K6<E552(MV$,:HBQ[<>6%&W%=WX*\#:/X \/
M+HNCP2)9^;+/*]S,\\UQ-*YDEEED<EG=W9F9F)))KSKQ5^T]H?@CQ-XHT;7-
M#UFQ?1=-?58YML+B^A6:. >6JR%DWRS(D9E""0AR#A&([/P%\4-+\<^$;W76
MCDT-=-N;JRU.VU)XU:PGMG9)UD=6*84H3O#%2N#FA7:&_,\X^!T20_M$?M%)
M&BH@UC1L*HP!_P 2>UKWBOEGX.?&7X?V7Q^^/]Y<>.O#4%I>ZMI#VL\NKVZI
M.JZ3;*Q1B^& 8%21T(([5[7_ ,+[^&7_ $47PG_X/+7_ .+I =W17"?\+[^&
M7_11?"?_ (/+7_XNC_A??PR_Z*+X3_\ !Y:__%T =W17"?\ "^_AE_T47PG_
M .#RU_\ BZ/^%]_#+_HHOA/_ ,'EK_\ %T =W17"?\+[^&7_ $47PG_X/+7_
M .+H_P"%]_#+_HHOA/\ \'EK_P#%T =W17"?\+[^&7_11?"?_@\M?_BZ5?CS
M\,VSM^(GA0X&>-;MO_BZ .ZHKA/^%]_#+_HHOA/_ ,'EK_\ %T?\+[^&7_11
M?"?_ (/+7_XN@#NZ*X3_ (7W\,O^BB^$_P#P>6O_ ,71_P +[^&7_11?"?\
MX/+7_P"+H [NBN$_X7W\,O\ HHOA/_P>6O\ \71_POOX9?\ 11?"?_@\M?\
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MX%_]%B\#?^%#:_\ QR@#UZBO(?\ AL#X%_\ 18O W_A0VO\ \<H_X; ^!?\
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M+P-_X4-K_P#'*/\ AK_X&#'_ !>'P-S_ -3#:_\ QR@#UZBO(?\ AL#X%_\
M18O W_A0VO\ \<H_X; ^!?\ T6+P-_X4-K_\<H ]>HKR'_AL#X%_]%B\#?\
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M95LK&#M!&!@< =*]PHH X'_AG_X7?]$V\(_^"*U_^-T?\,__  N_Z)MX1_\
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M%T/PK<>%K^ZNY4TS1X89+U)K*>V\LR(%*@&8/W!VXQW'L%%% !1110 4444
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M".Y:Y6.9855U$K?-)A@1N.2>O.:?<'I8SO\ A1'PU_Z)YX4_\$EM_P#$4?\
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M%R<GC!.5->[4-6$M0HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW1)U\(:?;:3/%X<>_234R]RAU6ZGM5\G8A20(T*N"6&Y6P,&N/\ ^&_]:O?
MNM:U#X6T?2-0CN[.#2K#5]553>R7+SQQV3[3F&X!@W,TFU53>2!LR7;_ "%<
M^NO[<U7_ *%RZ_\  F#_ .+H_MS5?^A<NO\ P)@_^+KP+7/VOYO#VMRZ'<6&
MB7&L0ZI!8F"UU(N)H7T)]2:YB^7+1>;&8E;&".<@_+6+X3_;+\27>K:2OB#P
MKHUEIES/90W,UAJ4T\L7VO1Y-3A*H81NV+"Z/CD[@5!P02V_E^H=O/\ 0^E_
M[<U7_H7+K_P)@_\ BZ/[<U7_ *%RZ_\  F#_ .+KXQM?VXO%7B[5O#,UF_AC
MPW#'JMS!=#4-47^SKZW?13?VYDFV,\+*2 5&"6&#CE1[CXC^.FK:CX<^#6L:
M;9SZ#'XP5]4O+6Y56DBABTN>]-J25X+-&BE@ =H;&">$_=O?I;\1KWFDNIZ[
M_;FJ_P#0N77_ ($P?_%T?VYJO_0N77_@3!_\77S3I/[5/B[Q)X1M=8N-*T[1
MKJ ^$=7-MI]R;I+NQUB;R6MV+QJ5D3+L&7@D)_M _6=.W^0D[F%_;FJ_]"Y=
M?^!,'_Q=']N:K_T+EU_X$P?_ !=<Y\=M=UWPQ\,]4U;P_J,&EWMH8I&GFMA.
M3'YBAE4$@!F!QN(.,DX)Q7F?Q*^)WB#PW\1M:M-#\86EVITJ^_XEDS6NS3+B
M*W\V(O%M$RC"NYGD8Q$O&FT9#4BK7/;_ .W-5_Z%RZ_\"8/_ (NC^W-5_P"A
M<NO_  )@_P#BZXK]GSQI?^-?#.KS75Q?7]G9ZB;6QO\ 4VM7N;F+R8G8R-:_
MN25D>1,IV0 \@UZE3:L2G<PO[<U7_H7+K_P)@_\ BZ/[<U7_ *%RZ_\  F#_
M .+K=HI#,+^W-5_Z%RZ_\"8/_BZ/[<U7_H7+K_P)@_\ BZW:* ,+^W-5_P"A
M<NO_  )@_P#BZ/[<U7_H7+K_ ,"8/_BZW:* ,+^W-5_Z%RZ_\"8/_BZ/[<U7
M_H7+K_P)@_\ BZ^>_'OQA\7:1\5?%MAINO6]M:VEM<PVEI=26P2-X[ 3B1H"
MGG+A][?:7?R2-J% 3NKU#]GWQG?^-?"^K3W=Q?7]G::BUK8W^IM:M<W,(AB<
MM(UK^Y)61Y$RG]P9Y!H6OY@]#M/[<U7_ *%RZ_\  F#_ .+H_MS5?^A<NO\
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MH'2O$.N^'DM8KZ\M;^\DCE$CWAW06T02&53"%B(>12K?/SRUJ[>GX@]%?U_
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M>UGEA-L1>^;N8L%#R!4P!TW EL*AGN5E=:GIMK';6GA:.UMHAM2&"ZB1$'H
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MC6_^A>/_ (&Q_P"%;U% &#_;&M_]"\?_  -C_P */[8UO_H7C_X&Q_X5O44
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M^V-;_P"A>/\ X&Q_X5O44 8/]L:W_P!"\?\ P-C_ ,*/[8UO_H7C_P"!L?\
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M 87]I:__ - .V_\ !A_]KH_M+7_^@';?^##_ .UUNT4 8]I?ZS+<QI<:3!!
M3\\BWN\J/]W8,_G6Q110 4444 %%%% !1110!E7U[J\-TZ6NEP7, QME>\\L
MGCGY=AQ^=5_[2U__ * =M_X,/_M=;M% &%_:6O\ _0#MO_!A_P#:Z/[2U_\
MZ =M_P"##_[76[10!@MJ&O-C.A6IP<C-_P!_^_=->\UN57#Z!:.'7:P:^SN'
MH?W?3FN@HH P5U#7D4*NA6JJ!@ 7^ !_W[I?[2U__H!VW_@P_P#M=;M% &%_
M:6O_ /0#MO\ P8?_ &NC^TM?_P"@';?^##_[76[10!A?VEK_ /T [;_P8?\
MVNC^TM?_ .@';?\ @P_^UUNT4 87]I:__P! .V_\&'_VNC^TM?\ ^@';?^##
M_P"UUNT4 <\;G629<^'K,^:,2?Z</GXQS^[YXXIZZAKR*%70K55 P +_ ('_
M )#K>HH PO[2U_\ Z =M_P"##_[71_:6O_\ 0#MO_!A_]KK=HH PO[2U_P#Z
M =M_X,/_ +71_:6O_P#0#MO_  8?_:ZW:* ,+^TM?_Z =M_X,/\ [71_:6O_
M /0#MO\ P8?_ &NMVB@#"_M+7_\ H!VW_@P_^UU7G?5;F5)9O#=A+(GW7>\#
M%?H3'72T4 <_'>ZY$7*:!:(7;<Q6^QN/J?W?)X%/_M+7_P#H!VW_ (,/_M=;
MM% &%_:6O_\ 0#MO_!A_]KH_M+7_ /H!VW_@P_\ M=;M% &7I][JT]R$N],A
8M8,$F1+OS"#V&W8/YUJ444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>aciu-20221231x20f030.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f030.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $6 EP# 2(  A$! Q$!_\0
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MV/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\
M\:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_
MX9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^
M"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1
M&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A_
M_P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$
MO8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:JGK'[,GP(T+2KK4;OX.> E
MMK:,RR&/PI9NVT#G"B$D_A7L-%3)2<6HNSZ=?\BHV37,M#Y2U?0?V9;#3IY[
M;X,^#KRX5?W<!\&6L0=NP+-#@#W_ )UPG@>P^#9UN>/Q-\$OAZVGW#DPR67A
M.R+VWHNWRLNOOU^O0?<%_86VJ6<UI>01W-K,I22&50RL#V(-<9X+^#'AGP+J
MUUJ5A:M)=2L3$]PV_P"S*?X8_3ZG)[9KX;&X#B*IC*%2ABXJ"^+W++YQYI<W
M;XE;RW/JL-B\FAAZL*N'ES/;WK_<[+E^YW_ \M\-?#+]FOQ9K,&EZ?\ "#P6
MUW,&*"7P7;(O ).6,&!P.]<AI/P_^'/B[QSJEEX6_9:\ :UX0TC6FT'4-<DT
M_3+:<3H5$\D-LUOB2*(M@DR*Q*MM4XY^O*\B3]G>'3O'5[KNA^-O%'AW2-1U
M0:UJ/AO3;B%;.[O/EWN6:(RHLFP%XT<*_.1R<_886&(A&V)FI/NH\JZ=.:7G
MU['S>(E1F[T(N*\W?OULO+H>-W>I?LCV5AJ=V_PE\+-%9:I)HP$?P]C=KN[C
M:0316X%O^^\L0NSE,A0 2>14U]=?LAV.K:79#X9^"[M-1M]/O(;^S\"13VBP
M7SE+6629;<I&KN-F7(PQ ->B^(_V1/#7B'PAIVC?VQJ-G=Z9KE_KUCJBPVL\
MD,MY+*\\9BFB>)T(F90&0D84@Y&:O7_[+7AZ]L]8M5U;4X(M2LM$LGV>2"BZ
M9<&>%@ @&YV8[^,?W0M=:Z7\ORU_$YI?W?ZUT_ \VCM?V3[OQ-KWA^P^%'A#
M5-8TA+AFM+#P'#,UZUNP2YCM-MOBX>)F"LL>2"?8XJ^$9?V3?&VFQ7VG_"7P
MG'!)#JDZB[\!P0,5T\1_:^&@'W#*H]R& Y4UW+_L;Z%:S^-9-'\5:[H(\2)>
M",V$=FDNFO=R>9<R03^1YQ+$L%#NP0.P4#C%4_L8V4G@_P /:"WQ \2P?V':
MWNEV=Y8PV%LZZ==0QQRV>Q+<)M_=(P?;YF<_-S2Z>=OQ_JQ2M?7:_P"!Q-[J
MO[(>GZI:6$WPK\*>=<Q6,J/%\/DEC'VR#SK1&=+8@/*ORJA.XM\N,UH7=K^R
MC:>!M+\7M\)/"CZ!?)-+)=1^ (C]A2&7R9VNA]GS!Y<GR,'PV0< @$CT/3?V
M4/#VES6\D6L:J?)O- O%4F+!;28A' /N='"@O[],5S/C7]A7PGXY\.VVC7WB
M'6Q9P?VH0F8)%#WMVUTTJH\95)4=MJR*-VSY2><U3M?3;] Z?U\SE?!EK^S7
MXB^(>K>#-2^"7@K1M6M_$%UH-E,_@^WDL[R6&-9%7[3]F$2RNA9A%N+80U[5
M_P ,G?!#_HC?P_\ _"7L?_C58VC_ +*^DZ;\0AXFG\4Z_J%HNO2^)T\/S20B
MQ34GB\D3@+&)/E0MA-^W)R02*]NHZ+N+JSRK_AD[X(?]$;^'_P#X2]C_ /&J
M/^&3O@A_T1OX?_\ A+V/_P :KU6BD!Y5_P ,G?!#_HC?P_\ _"7L?_C5'_#)
MWP0_Z(W\/_\ PE['_P"-5ZK10!Y5_P ,G?!#_HC?P_\ _"7L?_C5'_#)WP0_
MZ(W\/_\ PE['_P"-5ZK10!Y5_P ,G?!#_HC?P_\ _"7L?_C5<G\2_@[^SG\)
M?#J:WXA^#_@B*P>=;8&U\&VMPV]@2/E2$D#Y3R>/S%?0-%:4W!33J*\>J3L_
MOL[?<1-2<6H.S]+_ (77YGY]_%3XG_LR:!X8D;PA\#_!NKZ],2D"ZAX*MK6W
MBX^^Y>$%L?W5Y/J.M<Q\"/BE\![W3I--^)/P3\#+J4(+Q:KI?@NSD6X7/1XD
MA)1AGJ!M/L>OZ#?$'X=>'OBCX:N-"\2Z;%J.GS#(#C#Q-V>-NJL.Q'\JYSX+
M? 'PE\"M&DL_#UHTEY/_ ,?6IW>'N;CG@,P PH[* !WZ\U];3QF2+ RI2PTO
M:7T][7_P*VGIRZ_BOFIX7-WC(U(UX^SMK[NG_@-]?7F_X/E/PX\'?LR?%E=7
M'AKX/^#KB32X1-.+OP1;VRX.[: SP $_*>!7@WA?XE?!K5O#-_JU_P#LT_"I
M&_X1*\\665MHZZ=?R".W\LM!>*+16M7;S5VY# D,.HK]$KJ 75M-"Q*K(A0D
M=0",5Y#I7[+/@W0O@5?_  QTZ 6%IJ&C_P!C7FM6MM!%?W*;"OFR.J ._).6
M!YKY2M*G*<G1BXQZ)N[V?6RZZ[>1]+14XQBJLDW?5I6T]+OIYG!R>#_V8K'Q
M5#X>U/X1>"]*O9()I5N;SP5;QV3M# +B=$N&@".8XCO)!Q@'G(('/)?_ +)#
M^%I]=/PE\,16ZW4-I;VLWPZ6.ZO6F1I(6MX6M@TR/&CN&4$;5).*[ZZ_8O\
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MIZ\Q\ _"*^\*?$*]\2:IXANO$<HT*TT*TN[_ &&[D2.:>:66<HB(79YE V*
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M,-;_ ,7OB=%\)?!_]N2:5<:PSW4%G%:V\\-N"\KA5+RS.D<: GEF8#H.20*
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MNL>/9M4TNTM'CGL#/<N"6\W$ $DC+(B^9&WG2!IB8%!;:Q%>VU3U#R"BBBI
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M=?\ I/;UZ.'I4YX>M.:]Z*5M>[L_4XJU2<:]*$7H[W^2N>S4445YQVA1110
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MWPQI5M9V\5I;1VT82&",(B#:#@*.!7G'[6MS#;?LX>/C-*D0?37C7>P&YB0
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MG#SYG*'W]/\ MY11C_J_@JVN!C&?E91G]W7_ +=<F8#?LZWMNP;3_BQ\0K3
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M1]U;MZ17JW9?+<YJN)I47RR>KZ+5_<M2?XC<?M-?!SWL]<_]$PU[/7Q5X_\
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M***X+P'\9=%^(7B;6]$L+6^MYM-+M'/=1JL5[&EQ+;220D,3M6:"5#O"G@$
MJP-,7F<1X/\ ^3T/B=_V)OA[_P!*M4KW2OGJR\4:#X2_:B^(GB75M=TZRTFY
M\-Z1IR2R3=)[>>]>53QC(%Q%QG/)]#70W/[6?P]>=K?1[C5O%-TO'D:%H]S<
MMGZA OZU>$A+'J3PBYU%M/EULUNG;9KS%BFL%98GW+JZOI=/9J^Y[)17C/\
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MPW!JD.M>+KN^^(GB*,[EO_$<@FBB;_IC;C]U&/3"DCUKUM$6)%1%"(HP%48
M'H*=5#4=>TS1U+7^HVEDHY)N)UC_ )FN#$XRI5]_$3T7?1+T6R7DCLP^%C3]
MRA#5]MWZ]7\SP?XP^-M!TO\ :=^%5C=:O:V][#9:K&\#R8=6N(XD@!'J[*P7
MU*FO4/@G_P DI\,Y_P"?0?S-8_BKXO> K:UN[J.YM=;U&&(F-;*'SY,C./G
M(4 ]R>*G_9\UR'6?A=I,<44T;6*FUD,B$*S*<Y4_Q#D<^N1VKY^MF^"QV986
MAAYIRITIIVDGO.,NFV[T[(]JGE.-P> Q%>O!J,ZD&KIK[#CUWV6OF>D445P7
MQ-^,FC?"JZTF#5+2_NS?^9*[6,2N+6WC>))+B7<R_(K3P@A=S?/D*0#CV3R3
MO:^:_P!I3_DY/]F#_L8=5_\ 37-7J6H_&O1=.^,NG_#4V]P^M7=B+_[09(8X
M$0^;M0;Y \CGR7.V-6(&"<#)'D?[1VK6,_[4G[-&GQ7MM)?V^OZF\UHDRF6-
M6TN;:63.0#V)%'F'D?3U%%% !12,P49) 'O4%]J%KIMC->7=Q';VD*EY)I&"
MHJCJ2:ER44VW9(I1<FDEJRQ7@_QJ^+VL6^E7=QX*N6^P:1(J:KJ2Q(\),CK$
ML43MU=6<,2O3&,UTTEUJOQB++;27&A>!QGS+KF.YU->X3O'$?[W5A[5X;^T[
M\9K1OAS>^"OA7ID>NVEA+"NK7^GP&2STU4F0QQB0?(\C2!00"2!G/)XSRK#X
MCB#%PI4$XX>ZYI;<T7ORO[*>RE\3?P:VD=&8UJ&18:=6O:5>SY8[J+6W,OM-
M=8[+[?6)Z_\ !/P%;>#/&/BFSE,=]J5C!91O?^65+M)&7E9022H9L'&3TKV6
MOG#PE\-/C+=S_P!M2:OX8\"7^H1*;M;6WN=3N 3@D-YTWE[AT& 0O0'%=0/V
M?-;UH$^)_BUXRU;=]Z'39XM,A;VVPH&Q_P "J\KR>GEN'="M5IQ]Z;M#FDK2
MDVDO=C'1.V]M#GS#-*N85E6A3G+W8J\[+512?VF]6K[=1?VH_%^A^%/"'AUM
M9U.VT]7\2:5,!,W+1Q7<<DK!1DD*BLQX[>XKF;&+7_V@I6_X1FTD^'7PRF&R
M75X+=;?5=<C](!C,$!_OGYF!X R:POC=^RQ\.=*\-:)<1Z3=SWT_B'2[2:^N
MM2N)YY8IKJ.*5"[N>"KGICG!KZ@TW3;71].M;"Q@CM;*UB6""")<)&B@!5 [
M   5]14J8/#86E4PZ<ZB<K2E%>[\.J5WKMJWIO:]K?/TX8FOB:L*SY86C=1;
MUWW=EIOHOOMOE^"_!&A?#OP];:'X=TR#2M,MQ\D$"XR>[,>K,>[$DFMF>"*Z
M@DAFC2:&12CQR*&5E(P00>H([5)17SLIRG)SD[M]>I[D8QA%1BK)&7HGA71?
M#/G?V/H]AI7G;1)]AMDAW[<[=VT#.,G&>F36I112E*4W>3NPC%15HJR"OQ6_
MX+5_\G3^%O\ L3+7_P!+KZOVIK\5O^"U?_)T_A;_ +$RU_\ 2Z^J2C]5/V3O
M^36/@W_V)FC?^D,-6?VA9O"\?P\,?BK2-9URTGO;>*TM/#JS?VB;LO\ NF@>
M)D>-U.3O#+@ Y.#@UOV3O^36/@W_ -B9HW_I##53]JK0-3\4?"2?2])\,Z7X
MJN;B]M\VNLK*]K"JON\Z18I(W(4JO(<;<[CPI%)C1T'P,TW1M+^'EI%H?AS7
M/#%HTTTCV?B0.=0DE+DO-.[R2.[.>=S,21CV%?//[+MCK,_QNUN^7Q!JVK^'
M7>^GCU-])U>*'5W9TC+R37(^S#;Y8VB$D$@[-JY!]"_9\U/5_"W[-%U?OX<C
M\.7EC)>S6]BFBWT2.@D)61;-I);D[AGY=Q9CRHP17&_LS6?E_&35;FWTR]T^
MQN(;NXC6?3?$UJH\R97Y%^_V56.22$4'.=N!FK^U\OT)^S\SZ8\6^.="\#0Z
M>^MZG:Z<VI7D>G6$=Q,L;7=U)GRX(]Q :1L'"]Z\6/[4^IPZ=H5S=^#EL)[B
M[OEU2SFU$/)96]MJD.G'840K+,7N(W* A0%<!R=N?H22))=N]%?:=R[AG!]1
M7+W7PJ\'WT^FS7'AS3II=-OY=3LW> $P74LADDE7T9G.\_[0!Z@$2M]1O8Y;
MX)?&FX^*UKJTM[H\>D-:PVM_;B"Y-P)+.YC,D!?Y%VR@*P91D XPQS7G/[)'
MQ$T/XL?%'X^>*O#4\]SHM]KNF""6ZM);60F/2;:-\Q2JKK\RL.0,]1P:]\\*
M>!/#W@6*^C\/:-9Z/'?7+7=RMG$(Q+*W5CCZ >@[5Y1\$/\ DX7]HO\ [#FD
M?^F:TIOR ]UHHHI %%%% !7->,O!$/C3^S_.U*_L!8SBYB%DZ+F5?NN=RMRO
M..W)SFNEHKGKT*>)INE55XOH:TJLZ$U4INS0U%VJ 26P,9/4TZBBN@R*FJ:3
M9:W9O::A:07MJXPT-Q&'4_@:X9_A;>>&V,W@O79]% .?[,O,W-BWL%8[D^JG
M\*]$HKAQ&!H8EJ=2/O+:2NI+TDK/Y7L=V'QM?#)QIR]U[Q>L7ZIW7X7/.U^)
MVH^&&$7C30)M*C!Q_:NGYN;(^Y(&^/\ X$/QJQXXUK3]?\*Z7=Z;>P7UJ^KZ
M?MEMY ZG_28^XKNV4,I! (/!![UXG\:/@YI%Y!8ZEI1&AW4U_;V\XM%VQR^9
M*J!RHP-ZEL@_6OG\TAC\+@JO(U5C9Z.T9+YI<KMV:3\VSVLOE@,5BJ?M$Z,K
MK57E'[F^97[IM>21[;15?3[0V%A;6QGEN3#&L9FG;=))@8W,>Y/>K%?6Q;:3
M:L?,-)-I.X5Q7@KX0^'O /B/6];TI+K[7JK,72XN&DCMU:629XX5/W$:::60
M@?Q.>P ':T4Q>1\]Z)X8T'6OVI_'WA^\T*PETZQ\.Z5JD49CX\^YGO4F8C.W
MD6T?;KN/>O3)/@EX(=BRZ!# Q[V\DD7_ *"PK@_!_P#R>A\3O^Q-\/?^E6J5
M[I7E/*<OE?FP\'=W^%;OKL>HLTQZLE7FK*WQ/9;=3@#\$O#L6?LMQK%A_P!>
MVK7"X_-S2GX3O#C[+XR\4VV.@.H"0?DZFN^HJ?[(P"^&DH^GN_E8K^UL<_BJ
MN7KK^=S@!\/O$]OG[+\0]3'H+JSMYO\ V44I\-_$*W(\GQGI]T!VNM'"Y_[X
M<5WU%']EX=?#*:]*E3\N:P?VG7?Q1@_6G#_Y&YX%X]^%/Q.\2>*_#_BB+Q)I
M2W_AP2R6%K:V^Q':1"DF[>K9+(=O+ #J,'FK/P;_ .%AW'P\TY=..@VNGAI!
M!)?)*\S+YC9R$('WMV.]>VWM[;Z=9S75U-';6T*%Y)I6"JBCJ23T%<'\ K^V
MO?A=I*6]Q'.\!ECE$;!BC>8S8/H<,#]"*\G$X9SS/#T98B=E3J67-JES4W:]
MKV;;>_3U/0H8M0P->I'#PNYP;?+UY9+TZ);?H2CP_P#$2Y/[[Q=I=F#VM=)W
MX_%Y*0^ /%-SC[5\0]2/J+6RMX?_ &4UW]%>M_9=!_%*;_[B5/RYK?@>?_:=
M=?#&"_[AP_\ D;G _P#"IFF!^U^,?%-UGJ!J B'Y(HI!\$?#4A!NFU6_(_Y^
MM4N&S_X^*[^BC^R, _BI*7^+WOSN']K8Y?#5<?3W?RL</#\$O T!)_X1NSE)
MZF?=+G_OHFLKPIX#\/Z'\6M<FL-*M[5X-/M7A$:X6)G:97*#HI(11Q[^IKTV
MN0TG_DJ7B/\ [!MC_P"AW%<6(R_!T:V&=*C&/O\ 2*7V)OL=%+,,95I5U4K2
M:<>LF_M1\SKZ***^D/!/+9/V;O!<T^B2/#>LFE22N(#=MY=V'N3=!+A?^6BI
M.?,4'H0.HR#F0?LG>!(-,L['&K21V]SYS22:BYDN(0D*"TE;^.W"6UNH3TA7
MG)8GV6BFG;1!N?.'[>G@_0=6^ >JZ[?:)IUYKFEW>F_8-3N+2.2YL]^I6H?R
MI2-T>X<':1FOH^O!_P!N3_DV/Q3_ -?>E?\ ISM:]XI %%1W-S%9V\D\\J00
M1J7>61@JJHZDD\ 5XGJGQWU?X@WEQI'PCTN'6Q$QCNO%VI;H]'LR.NQNMPX_
MNIQZG%==#"U<1=P6BW;T2]7_ $WT.>K7A1LI;O9+5OT7]6ZGI?CWXC>'/ACH
M;:MXEU6#2[/.U/,.9)G[)&@RSL?[J@FO+?MGQ)^//%FMW\+/ LG_ "]3*!KF
MH)_L+R+52.YR_IBLKPMH'A+PQXG_ +9OKW4?B_\ $H<'4$B$R6A_NP*/W-L@
M]CN]37I']F^/O%_-]?6W@W3V_P"7;3\7-X1Z&5AL4_[H-<LLXP6%;IY?%XBH
MOM)7BGY7M%>LG?M!,[8Y1BZZ4\=)4*;Z-VDUYI7D_P#MU6[R:/)/&>D_#KX%
M>./AOINEV$5O-IU[<ZM?XA:>[F5[.XB2:25@2[-+M );K@\ 5U/P;^*$T7@"
MPTW3O"NLZO<VC21O);(@@R79A^\9@,X89%>B:3\._"W@I)]4DA66YC4R3ZKJ
MLOG3 #DL9'^Z/I@5F_ *\M;KX7:4EM-%*\+2I,L9!*.9&;#8Z'!!^A%?+X[$
MYAF&:X;V]54VJ=167OR?OP;;<DM6W_*[*+U>Z]W"4<OP.7U_8TG4O.#N_<BO
M=DDDHMZ*W\VM^FSE_MWXB:F<6OA?2M'0_P >IZB92/\ @,2_UI!X9\?ZF/\
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M &;=>M]'L+?7+W7-2ANM3BM46YN(TTN;8CR@;F5>P)(':OJBOFO]I3_DY/\
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M_%$7Q?\ $NBZ1J>E6$%KJ%M9:3)(Y2>\<VA1[9L1PK*A5RH9O-;<S;1CM/\
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M/HO_ ,A4?\*$^)'_ $<5XT_\$^B__(5 'NE%?+]A\%_CQ)\3]6L+OXY>)XO
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M_I=?4AGZJ?LG?\FL?!O_ +$S1O\ TAAKU6O*OV3O^36/@W_V)FC?^D,->JT
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M^BA2:L!Z9J'P\\*ZMJ5]J%]X:T>\O[^V-G=W5Q81/+<0$ &*1RN63Y1\I)'
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MT;_TAAK#_:<\">!M0TS3/&/C#Q)XH\+-HD@2&Z\*7]S!<W.YU98/*@#-,2R
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M(?\ L6K+_P!%"O6(M)LO#_AO^SM,M(=/L+2V,4%M;1B..) N JJ. ![5Y/\
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MX@OM(U#Q!I#ZU:6]E+%8ZM+$D$<"(EN(<',?EJ@"@';AGR#O;/JU%.X'%?\
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M9D6:=EP,IM_AVC(%>1? 3Q])%\1/"]OJOQTT3XA3BXUJ.72=*D9KH?:;E'M
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M=2-'^+K;0?E34O#5E-CVW((S7MM%>S3Q4J2M&$/_  "#_.)Y-2@JNLI2_P#
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MSV-VBBBO2.,**** /&?BS\/=6N/B%H7Q"D\9PZ-HWAN%XQIS:2)V=9BJ3CS
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M[V%?BM_P6K_Y.G\+?]B9:_\ I=?5^U-?BM_P6K_Y.G\+?]B9:_\ I=?5](>
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M (0*_P#R=1_PK'X]_P#1<]!_\(%?_DZD,]UHKPK_ (5C\>_^BYZ#_P"$"O\
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M0*@9B^W^Z"V-V.:])HI-7&<M\*Y=?G^&GA63Q2K)XE?2[9M2610K"X\M?,W
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C=,L= ATB2+7(8HIC,EQ<REE$4DB[=LZ $L#D-QT)** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>aciu-20221231x20f031.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f031.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'K Q,# 2(  A$! Q$!_\0
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M_/CHW_?A_P#XNOG.B@#Z,_X;H\>_\^.C?]^'_P#BZ/\ ANCQ[_SXZ-_WX?\
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M_GQT;_OP_P#\77SG10!]&?\ #='CW_GQT;_OP_\ \71_PW1X]_Y\=&_[\/\
M_%U\YT4 ?1G_  W1X]_Y\=&_[\/_ /%T?\-T>/?^?'1O^_#_ /Q=?.=% 'T9
M_P -T>/?^?'1O^_#_P#Q='_#='CW_GQT;_OP_P#\77SQ!:373;88FD;T49K4
MB\&:[. 8]*N7!Z$1F@#W/_ANCQ[_ ,^.C?\ ?A__ (NC_ANCQ[_SXZ-_WX?_
M .+KPN3P=K<)P^EW*GT,9JC=:3>6)Q<6TD)_VUQ0!]!?\-T>/?\ GQT;_OP_
M_P 71_PW1X]_Y\=&_P"_#_\ Q=?.>,44 ?1G_#='CW_GQT;_ +\/_P#%T?\
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M /Q=?.?2B@#Z,_X;H\>_\^.C?]^'_P#BZ/\ ANCQ[_SXZ-_WX?\ ^+KYSHH
M^C/^&Z/'O_/CHW_?A_\ XNC_ (;H\>_\^.C?]^'_ /BZ^<Z* /HS_ANCQ[_S
MXZ-_WX?_ .+H_P"&Z/'O_/CHW_?A_P#XNOG.B@#Z,_X;H\>_\^.C?]^'_P#B
MZ/\ ANCQ[_SXZ-_WX?\ ^+KYSHH ^C/^&Z/'O_/CHW_?A_\ XNC_ (;H\>_\
M^.C?]^'_ /BZ^<Z* /HS_ANCQ[_SXZ-_WX?_ .+H_P"&Z/'O_/CHW_?A_P#X
MNOG.B@#Z,_X;H\>_\^.C?]^'_P#BZ/\ ANCQ[_SXZ-_WX?\ ^+KYSHH ^C/^
M&Z/'O_/CHW_?A_\ XNC_ (;H\>_\^.C?]^'_ /BZ^<Z* /HS_ANCQ[_SXZ-_
MWX?_ .+H_P"&Z/'O_/CHW_?A_P#XNOG.B@#Z,_X;H\>_\^.C?]^'_P#BZ/\
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M]PQ@9XZFO*OVV?V>?^$,UIO%VBP'^R[Z3-PB+Q$_K]#Q^= 'R=1110 4444
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MR@&NG\2?M$^)=2T]X[5K;P_9L"!#:J)90/8\$5\Y^(/B9-)J,B7U[?WNUO\
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MRTEL;B2"9"DB'!!I 0T444 %%%% #ATHH'2B@#[Q_P""JO\ R4B[_P"PS/\
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MQ'H<!\0:C<Z;#(JA) QWR<\_48KYC;0^@1=\(:K-JOBC6?%',<_VADAF3[N
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MC6A7ASPV/A3I175?$[P?-X&\::EI,RE6AD(&1CC)KE:R-@HHHH <.E% Z44
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M->2U]'?MW^'O[)^-MQ=JNU+RW23ZG+9KYQKQ3TSWW]B:)W^..GNA(V0RD_\
M?#8KU;Q^EY??'J)8E2>193D'A0,BN3_X)]644_Q+UB=@#-#8DQ$]B0P-=-X,
MUIM=_:"UE6D*/9/,FX\[FW__ %JZ*$>:K%>9C7DXTI278]0TZ_UO3]<ME:VC
M-N7"OMY//X5[U??#RTTC3/[56W79-&)&8+T&,UQ/A#6AK6MI;WEIO0/@2 =,
M"O>M=T/[9X,ECMYBZR1;1%[8KZJW-?0^=J5'047S'RCXHAEN;F6YA5?LY.U4
MKBY_A#JOQ9U2+2M-M%=HQN>=N I/;/X5]!>%?!:ZMJDUCJDL5M#&#M+G&372
M?!B;2?AQXEUC0+V>))V?SK.8N,.&)RH/X#\ZYYT8P3G%785<PG"&Q\-?%']F
M/Q#X(UR/3+K8[,!MW$_-G'3BNKL/V7=7^'D5KJ6M6G_$M>('S#G[Q]?TK[P^
M(EAX<\6^(](U'4( 9;,@KC^/V-4/CMXTT'5?AM/9S*B74VR"&'(WY)QG'MFO
M#PE;&RJQ5;#<J>[OMYG,L;7OK.Z]'J?',=HMKE(6PJ ; @XKU/X:-9ZXKVEQ
M&V^-07<CALFM&S^$=KIOAV'==J]P\:LH89R<=*=X#\.'0=)U+5'.QE8+R.O(
MKWE1Y6>S];C.+:1I^/?&D/PXMH+)(#-92+N6-4')KX_^*^M12>)]-UN*&:T8
MS*RMC !)QBON?Q5:6NM>&8M1GMED=(@R+CGI7Q]\?])GNO"8U"6$6L=O/O1!
MU.*QQ=/GI/RU,<+42FG;5NS.N_:&L7\1?LOS3'?.\4\<B.>2PY))K\\B,$@]
M17ZA_"F2U\:?L\VT+@7*W4+H58< [1_+-?F;XDM19>(-2MUQB.XD08]F-?,G
MO&=1110 58T^T>^O88$&7D8*!5>O4?V;?#$/BCXK:3!<NJV\;>:^[T!'^- '
MMOC7P^_@KX;>!-*? NEG9VC'4':3D_A7C5YJDDOQ%$S6S3E'^:,<_+FO>/CU
MK$4_Q&\+Z2[[Q!&9Y !SDAEQ^0%<+XZ^%5W!J:>(-"\P *&:"9""?IG%5%V:
M8FKJQVNG6G_"0^?<V4WDNL8Q 5&2>.!6MNU/1/!:M8Q""^WEI-XY:O/?!GQ;
MTG0W3^W-/F6ZC^7 4CG\N:]!;XN>%_%MB8[=5@D Y\WY<$^YKZ6&)I5&HIGS
MLE4HSY>1VOOT/.KWXAZOK=^\<9:.6!=L@8X&:P9M:O[>S%I?70C2<DD%CD^U
M<OXA\2R:/XTO98'66-FQ\O((P*U-$CG\5:M_:$L)\N( *N*\_P!O.4N6/0]Q
M1@E>QJPVEOIUA/J3@I&!M2-F(W>Y'X5Z+X!\"6&IZ!/J=OYDLLJY.QB!GZ5%
MHGPFG\>M#!<*;>U!#,7ZD5]'^!/!%IX0TI-/CC4PD?+FO5IPD]]CS<3B84KI
M*[/+?A_\.+TSQW>IW<C>4Q:*$\8&>*[?QOHE[>^')/LDCK+G&5)KJKLV\5\<
M;8D0;3S6!K/C==*T^Y\AHYY%.%4\BNE))6/,]K*I/GBM[:'C=QX:CMA;K?A[
MF]8@C<>5K7OM+TXZ/>Q7X$MRT!\N(\A!CK5#5O$5OKMW')(#;SDY8KU^@HUV
M">^T6ZOX8GMTBB*^9)_&*RTY7V-ZR=1QOH[G$_LFDW?Q9CLA*8]]G+%(/[V%
M/'ZUX)\8-+&C_$C7K5>B73X_$DU[3^R();WX\Q38VH!*>/<5Y=^T6H7XQ>(P
M  /M!X%?(/<^EM8G_9[\!'QMX[M/,&+2U83R,>F%YQ^E>N?%&[7Q5X^\2"R0
MO#;6L4"LO8! ,?I7/_LM^*=(T?2M>M[MECO2J/$2.6YX J]\-'N;[Q'XJENF
M2SMKB9M]S=<  DXP#@GCTI 9/P8\-V%]]L:ZNS'<9(6/=@'Z#UKVRUN-'T+P
M_P#8WN'N)I#@J_)'ZUY^_P !=,EO!-HOC,174QR$2WD*,WH.*RM<\ ?$#X<:
MLE_>VHOA&NZ.8 E&7WYXKTZ.,5&GR<MSSJ^'JSES0EIV/7O%3VEIX2,2*WDL
MN2!VKS?P!'I<NH$*V_/&'Z@U>L?C):ZAI$6GW6G-'J#']\[J=E<!JWC&R\.>
M,))HU!$B@#9T%=L,1&I",I:-F6&A5Y'[16EK_P .>WVVGVNE3,R+OYSG%;MW
MOGM8YXDPOW<D5R?A'Q*;Z*WN;E,PN1V[5Z!<>,-(LHDC:163(_=+ZUVPBK-,
MBM4E&<905S&L?!LFJR)=SJR(KCD#K7?_ -EV&A0(\SQ!B!@R&F6OCFQU"S%I
M;P;7VY&T8%<EXE@TPPBZN[66_N"<!0V%%4G9['BU,;5E)04&KL[)5MM1E#I,
MFT_W#D"CQO:F_P!)AMF \K@%AW%<KH%XL-JB/ +4-]U/05T5_>F/26:XN%\M
M>>O05I%[V.NI"TH.3V.0\6:3#;:39I:09\G#$@<U\Q_'9Y--\7QW$)3_ $A$
M8J#RI!!Y]^*^FVU6;5;,:C8.'BA;88S_ !"OG;]HC4[?5O$NF)$JB7.UPOOF
MN''W= TP6F)LET9VO[4UY'XH^ _P^\0.<W,L(1B1WVI_C7R'7UW^TII;:)^S
M;\.[-@053)!_W4KY$KYH^D"BBB@#ZI^%=ZEI^RQXD4,!(]]& /7YHZK_  I\
M82:)'J,G]F2W2[P1*B JI&>M9_PJF.H_LX>*K*.+=+;W*SAN^,I_A4G[//BJ
M-);BPOF"64K@N64\9SGFN[!?QD<>+_A,EOOB5X@U_P ZZNK6X738G.0I("^F
M:[+X7L9KFUU7SC(6DW$D]!7?^)_"F@Z[X7N;'0[R(W5SR%R,YKG_ (0_"77_
M  S%+;7D"E5)(D)XQV[U] E.^NJ[GEJO0=.Z5GV/6=#==2^T1SW!Q*.".U<M
MKFD+ISD(3(AR#GG-=)% =$:"U=H3<GYL;AS[=:UF\-7&L%VB $I7E2.F:J37
M+SMZ=S*%:$+R<M&?/-II=J/$ES*L\DL@('E.Q(7]:]:\/Z=<,$9CR%Z&N6T3
MX1.GQ2O%6Z9YG4,T9.0.E>S:GX8'AS37N)YB/*7ENE<-.M#VGLYR5WMKNC>M
MBZ"BN65SS75YKVU$DC[O+8E2!7B_C4OI$L-S92B&ZDD /.."<<BO<Q=6_B6W
ME\BZ "OQN4KD\YZUYYXY^"M_K>I65PDR26JR!S@\X]*ZYQFD^4=&O2J?%W,V
MR\%Z[);Q7,6JNID8,1M %>3?$&-['QG=QSW@NYL(&DP!M.Y37OOQ NH=&T*'
M3H)FBDC4#]T><XKY=\7Z+?:=KVYQ+,;MAM,G7J/\*X<>K4DCIPTN>;GLNQT/
M[4,5\UQX;N;R=9UELD\HHQ(VXX^E>%5]#_M*:9+!X+\$S2J PMO+.!Z*O>OG
MBO /4"BBB@!PZ44#I10!]X_\%5?^2D7?_89G_P#1:U\&5]Y_\%5?^2D7?_89
MG_\ 1:U\&4 %%%% 'WS_ ,$_E$WPR\71CES(PQ_VR%<1\+X8='^*#"^*HDBB
M!2PY#+G<!^8K1_X)RZ^HU/Q/HDK@)-")54GJ<JO\J3Q[8VOA7XP7EE<+Y-K;
MZBUPN>,H[<<_\!K:E+EJ1?F9U$W"278^M_ WBSP_.)=*CO(XKH'A&QEJ]'T:
MTF:=+9("#U+D\5\BZ5;>'?#FN_;+=I[Z\N,.@3)49]Z^DO!WQ0TK3=/@6[FV
M7TD>/*/)%?71=V?,55RTW-:W.TOYK;2+B2,$F7@[>N:Q=3\206\7GO'Y2]-S
M'J?2I+'5X-5E-VZDJ < ]ZXSXJ^(&T/3+>>)(EC8G;&P/6AN["G&--7>K.6U
M4/J7Q#MQ BK#*@+DCKTKTW0];CALI-* 5F'\)["OG6#QU-K/B2SN%B9;B"-B
M5BZ,..*]*\">*+NY\3"ZDTJ0)(-I9A@5+=F=$8QG"7NII'M&G:9'/:@J=K(/
MFQT%3Z4+:W>>*><N2,*34$FH>0GG6V.5.5'>N<75%B#_ &AQ%(YP@SSFK;70
MY%3G/FYI63.$^.&L:AX$M_.TRW6]:1=VTC .?P-?%7Q;\3:UK6NZ?<ZCIT=@
MH.X"-L\X[\"OJSXQ:WXEU*9X]/M-Z0#:N_G=BOE?Q=/=>,=>=;Z%[.[55@6+
M@[I,C&,>P->7F$OW=NYZN!@E)MZL]>\?6T=O^Q1;?;_O-;Q,FYMQ!+C'7I7Y
MXK]X?6OT-_;9OX?"7P*T708B 965 HXX7::_/*OGCV3]%M0A%U^R/X7O@-[6
MD2,HQGEGV_UKROX,:G>:1%K@NF>*P:[8*X3@$DYYKUWX-64OC+]C^*S5PSPV
M^[GG[C;\?I7G?P"UFUN-2U2'4GB2S9A*L4G7+9)KOP;M61R8K^$WV/4-4\0^
M&=3L[&SNKI2X_B)P6S^-;VB?"\6GB32+S1;MUMR5:4 [@1QVK0T#PYX6\<:E
M]GAL%G\K!#J#C->X:%X8M= 6")HD*]/]WTKZ-1OJ>1+$*$59ZGRA^V#\1I/#
M\FD^&X&&+P%[AU.#M!(Q_*O4?V1_AO8:SX;C\2O,R33*4AAEX4*!UQ^-9/QD
M_9E?XK?$W3]6:Y6#2;=<2(>3USQ7M<M[I'@OPO\ 8=+@$<%I#Y:K%U(QBE&Z
M;1.(4:BBXMW1JZ[X<TG7+.]TM#'<2NGES>2_*&OA;XAZOK?[//Q(MH1)*\,C
MA7+$[7C)Z_S_ "KZ1^$/B"&?Q7? !T+OO(D;G_/-6OVD?@6/B[X:BDBF6SU&
MVR8Y",@CT-:2VT.6BYN<7/\ X<YSXIZ_-J'POM+[2(O[02YA24(O<LN<5Q]A
MX<N+;1K5[R2.VCE3S)548Q[5Z_\ #7P+-I7@K2=$O-LS6L*HYZY( %,\:_"Z
MSM8VNT$EPZ\[ >*R4;ZGI2FJ;45N?/6I?$CPMHT]W8_NHI@I!+8!/TKP'P_?
M1Q>.1<6T4DL)U)'5.I;([5[CX_TN[O;XLOAQIP,[96 4 ?F*\G^%EG<:K\7-
M%LI(O(9M4PT*C( $;'/Z5Y&/YERIG;AK.\EN=1_P42TV*6]\,:N 8YKA&1HG
M&&4 #&?S-?&-?8W_  46U**3Q5H=FLF9(XB[)Z9__57QS7C'>?1?["6I/9_'
M"VM@VV.ZMY4?WPC$5V&BRCP=^T)X@M'AWRW<\Y5^X+297]#7A?[/7C$^!OBW
MX?U+&4-PL#?1SMS^M?0_[3:KX*^-5OK5O$&MKJ..[,@'\(49P>_6M:,^2I&7
M8RJP]I!Q[GN_PJ\4SRZU$)H$+*_*>U?1<_B832-%8E 0-IC[8-?&_@O6K*ZU
M2QU/3;P3K-C"C/R^QKVNY\8QZ+XHM5ES'"T09Y.>N!7UR=UH?,^S4IN<O>\C
M$\<_;QKEP3,\$JONC4' /%>:>+/[?U*YM[IBB7UM.&C=7.6"D'TKZ%\4Z?8Z
MYIXOXV1Y,9WCN*^>O%5RUGXFACB<[48?>/RX8_\ UJ#1<R]W\T;F@_M&7^I:
MC%:W>FL1:$1NV2=Q^N.*3QKI&O>+/$,.OW*R6EHCJD4"L<JN>21]#77^$].T
MJ^EA^T111SCYFP.&]*Z[QA<0S:7+';*HD5-V!T9O05XU;&8BCBHTHPO!Z7\S
MP\35G&HXWMV_S//8?$VH6MX+(7#2+&F0\H[5Z9I-Y)?^"762-)BQR"HX;&#7
MC$MU>K/)9RVZQO*@);J0#7:W?B@>#/!UM8VP::Y8!C@9P.]>RI):,]6E2K2B
MG)W]#6\<>)+B'PU MJWV<L G)X'%?*_[0^M:Q%X=M[6[>,V]PV,;OF]>GIQ7
MT3_PDT/C;0'MQ:^6\7S;CW(ZU\O_ +2FH++XBTJP1@YA;80#GJ#_ (UQXQ\M
M%OOH=F$DYUU&VVI]#?!NZM? '[.6FZK-$9;5"99@.R, 2?TK\W?&-W;W_BK5
M;FU&+>6Y=T&<\%B:_1:*'_A#/V4[T:W<(L$EF3"AX(W)\HK\UKIQ)<S,OW6<
MD?3-?,GT1%1112 *ZGX9^*)/"/C+3[])#$BN%D8?W2>:Y:G1.(Y58\@'- 'U
MA\8O$?ASPWXJT_Q3!>?VGJLT"E;5@'5>O)R?Z5Z?\ _B%<?%>8&1+6[*MMGL
MY$ 9%]5&*^0/$\7_  F%E8WFFQNQB01NF>A_R:]J_9%\-^(]%\7_ &^VLY&;
M81M/"_C0![)\6O@=:IXDT]4MXH=/OF.\B,,ZGDX!/3I7R9\:=*M-&\:SZ7HR
MLEK;?*^T\ENY-?;7Q$L]8T>?28KR_-S=N[7$K#[L:D, !^E?*OCFWDT;Q9J%
MW/9_:;&XD+M+M+8;/.<4+<#S3P7X?DUC44B:WEG4MRV#7UMX'^'>FZ?IEO//
M#M8'D <5YA\-O%MK>7L%M:6<-M;AOFGQC\\U]!F>S?1L1SJ%.3N'2OHL#2AR
M<R=SP\=BW1_=V.#\8?$J?PKJ'DV$4:J!PQXS6II/Q,U7688+FYG6-%' 48KP
M7XT_$G3+6ZN+;3%%U>H=C3'[J?3WKSOP;\2?$']J1P1W1*.1N5NX]*TJ8NE2
MDX[LS>'J5J<916OF?:,OB:*\C-LTQ:>4$[AVKCHX+K3=4E25A-;R\C?VK(T/
MQ+$75C _GE!C<01G\*UM-U:634B;B)7C88W=EK>I.3@W25WT]3S6\33NE#;O
M^A8_LF'2O,O9420@EAO'"@5Q'QJ^->GW?A6'3M*+1W+#8Z 8SU[>E4/CYKRV
MUIIXL;DF1BRF,'&>G-<C\#O@Y>_$[Q7#+(C/:0R!I96Z=:\.MB:\H*%6/++K
M8]/!X95XQKU=T]%M]Y[%^PYX&NK._P!1\37D&((H"J,_7.#7RM\8=4_MCXE>
M(+K.=UW(!^#$5^GWC2UL/A5\+]8^QF*SM8K-E1<8^;:>?Y5^36K79OM4O+AC
MN,LSOGZDFO./?-OX<W<EEXML9$&Y0X+KZJ.OZ5T7Q3^)-QXL\33/;$65I#B-
M(H!L&5XR<=3QUK@=,U&72KV.YA.)$.?K75W/A.;7K-=1M )))B69%]2>U 'I
M7[,OQ;O/#/C^PLK]8]0L+J01LMP-Y0GH5)SCM7Z/^*M.TB]T&6;47CAT_P K
M+EP"NW'ITK\YO@#\%M4UGQ;;7EW T%E9$3RR.-H4+S^N,5])?$?]I/X<75HV
M@ZSYDQA)54C8X!' R1VH ^=/BQXAL?&&MKHOAT""SLI&S<K&(WEY/7'7KZ]J
MI:#\+/M-S#<7+-=28_CKHO$OAF36+"V\3Z!;K-;0J4FBBX(7<2&Y^HK+\+Z_
M/=W(N"YC1&Y4GTK:DXJ7O"9Z]:>%;N/1!:VD:B3:-I(X%/\ ^%=G3=/CO;Z=
M9;C[QB#=36/X1^(<6J:OY4]XEHD?!1S@MBO*_C=\9VU35)M)TJ>2WLHB0;E>
MLA]O:O;^LT(>ZW=H\6K*M*M[&DK=6^A[WX<\4K"TC?98P%^0@'I4KZ]>7U_(
M%C00 952H^4U\C_#KQM<:3J7FR++)^).3ZU]!Z+?7VNZ2LOVU4249X&"/SK>
MCBZ=2.UC.K@JSGS)IGH.GWT=[<1S7<B>8AV^6#C-5/$D=Q>K(L3%;=QC@Y%<
M_%I=G9V;XO\ $@'S<U!;^-+?3+">.3>\*@_O#SBBHIN7/3E;R>QY5?#8B,O:
MTI7:TL3:GX_T/X7^#S"+I+K4!G_1P1G<:\(^'WAO4_C#\4;9E@9U><,R_P *
MC.<5D""X^('C26&W<OYLS;">PS_6OOO]G+X*V'P^\.F^&&OY5'[YA]T=3C\J
M\*OB*E9VD]CZ3"894(N3=Y/=G@?[?VIP:7I7A;PS$1FU1B5'887'\J^+*]U_
M;-\5#Q-\;M56.3S(+4"!>>,@G->%5R'H!1110!]8?LHZ:=4^&OC6RD@8"6)7
M21A\K?,,@'\*9\,$T?3;G6M.N(X7N%<,D1P"1SDC]*P/V5_BI=:7>GPW+<I;
MV<H8IE"VYBN"#@9J;Q7KEI\/_B>]U?1.+>3=&0JXR"1R,]JZL-45.K&3.3%0
M=2E)1W/8O"=IH=SK:&WMYTF@.X!&.":[?Q-\3BL4MAI\92YB&3_M8ZBO*8_C
M)X)\%W8U.UN5NI& W1+GN*XG5/C_ *%=:]=7-K&XMYANY'.?2OH)5Z:TYMSP
MU1EB'%5*=TM?^ >VRK?^(;0:BS"VN0N <9Q@UZ7\+_'_ )-F3JB 3+\C.1P<
M=Z^0;WX_1M PL+>:(D;49^%S74_#;XAO<7$FDWMR#>G]Z-K @Y[9_"L:_P!7
MKT'1GK%JUB(8"3J+E7*D?14=YHWA_P ?_P!O1WLEP\G)BQ\HS[YKBOCQ\8+[
M4=8T_3+)HX;.\8[G[G'.*RX[S[3>[6;:H[YKQ#XN^)[>3Q7%;1W?E26*EU<\
MAFYX_2O,P^#PE&4:T8:I63;;9WQP$*>EV^MNE^YZ?.NHVL:V\,Z_O%W87J:U
MM"\<W>BZK9:3?XE#G+N[=/:O T^-PBGM)3;22SQJ Q5@!GCU-.U+]HFS;7HK
MXZ-(SQ#H[#D_G7JO$4HO68YTI-.*I[GT9XL\-1:GJ$]U J/$PW'+<BO"_$,'
M_"5_$K3;%;F)$MAF1LX4 9K+\2_M+0:UH]S;VEG-97$J8WAA@<=N:S/@:MZ[
MZKX@EM9-0C@)+KCGIUS7!C,3&HN2.P\%AJD).=16MHC=_:8^)V@^)]-L_#^F
M1M*-*C1!<$8R_1_Y"OG"NM^(/B-/$>HFX&G?8'9V9B1@M]:Y*O(/9"BBB@!P
MZ44#I10!]X_\%5?^2D7?_89G_P#1:U\&5]Y_\%5?^2D7?_89G_\ 1:U\&4 %
M%%% 'IO[.WQ*;X7_ !/TK5&)%J\@BG&<?*?_ *^*^P?VO/!UOJMEI'C?36$U
MM.%CE9!D../+/YDU^>*L58$'!'.:^^OV0OBKI?Q/^'DWPY\1NKW4,92%ICRZ
M8P,>XQ^M,!_PH\22>)M&M;:VM[>UGM_DD=B-Q_"O6_ G@VTOO%$FHWFH1W>%
MV^4N"%QGWKYD\;^ M?\ A#XJOTM+AX9DR\#_ ,%S'VQ[C@=NAKTC]GWXES:F
M(HWCQ>*079V #'OWKZ#"8J-1*G-ZGA8N@Z$95*>Q]->(?$FG>&(K9%/EB1MB
MKTR:YCQQ>Z?XQM[O1[O=;7L4/FP2#O\ 3\C6%\9O$$-Q9VV1&DC@",IS\^.U
M<;XIUQ-(U#0+Z[666Z$.R=%YXYQT^M>DTTSF@X5())F;X+TI[3Q-;P12M-*H
M8' QGD5]#:QXFM=#;2=/G")+<D(J1#G.#UKPZUU\Q^(+>XLM.:-V&0#@'!P?
M6MN.X;0;R77/$DHEN2W^BPYSMXQ@?K2<E+1,YZ$DI-)]6?0-@B/<,L-P'>,@
M,G=?K7E/Q#+ZEKJ2:-J,<UY;$EK9CT--\":S=6<&HZU,K^9=.=L#-R!SS^M>
M>_$.>+P]/%XJCG%M<QR9GMV?F1#V _(TVU%-OH:\TG*R=[D'C?XNWWA/PY<R
MZS%)'<RLR0B,$[F^OXUYW\ ?"=Y\1?BE;ZE=J[66G/\ ;+AF^[YG\"'_ ("Q
M_*N>\9>)=2^,'CZ"UT>.2:W:0+:VI4<'/,C>@'!_"O??$&MZ-^RW\%KB.>ZA
MEUZ:-FV@_/-*V3^0R17SF+Q'MIV6R/;PM%THWEN_ZL?-O[>_Q,A\2^-K7P[9
MNLEOI@R[*<C><@C]!7RE5[6]8N=>U6YOKN5I9YW+LS'))-4:\\[C[Z_X)_>.
M8-8\':SX0N9!YT1+HA/6-@%X_6N"UC3&^$OQHU&RU&U26QFN<Q[Q_ ['9^&*
M^>/@]\1[SX7>.M.UJU=@D<@$R \.AX/\Z^ZOC]X5L/C3\-[7QYX:D%U=00;I
M(H>6*8!8?[PQ5PDXR4ET)E%2BXOJ>G^#/$^A^$/"AO;>&.!Y1O&,"M+P!\1=
M8^(.I7MQ%;[;& $#<>I&>17QAX&^+MYIRV/A_5HOM41^6"8G!W<\'..G-?4_
MP>UR72KDP3%0]P,!5Z#-?5T*JKQ37S/FJM-8=RYM'T\SU/6O%DF@>&KF=83<
MS#A@#T%>+:C\0)8=4BD>0"VNB4(4_=/^375:)K[WVJ:]H]\?-C9B$]17G^@^
M!)6\5ZHT\1BM(N4\T\;LGD?I6KNT5"T')]SH/ +P)XCO+N&9Y47DG/?TKUO6
M?B9!%8QH6'S=5/6O'O#<DLVMWVG:1L7# 22-U.1SBMR.ST2SN)$GN'O]3A.Y
MHAT!]*:33TZF?-&I!.70]2B\2+I>BRZE!'Y@\G> W8XKF?#GQ2;Q-;2*@47*
MDDIFN>^('Q)O-+T2RCMM/$*31GS%8=ABO-H[ZPTN6'Q5'?)IUHP/G1LW&>1T
M&>]0Y):=C1I17M9;OYG0?M%>/&\+^#8I(H56YN"1@\'FO-OV1/!BZCKNJ^,[
M]2T-DK"*1NAD.&+#Z#(KA?'GB'5/C7XXM-.TR*2>$2>1;8Z$$X,A]AP:]A^-
MOC/3/V:O@7;^&M.=&U:[A,*@'YMS99G/XY%?.8NM[6IY(]?!T94:?O\ Q/4^
M//VI_B9%\3OBUJ=]:_\ 'G;_ .CPG/W@I//ZUX_2N[2,68EF)R2:2N$[B:RN
M&M+V"=3AHI%<'W!S7Z"_M >%C\1/V>/#/B>T3S;JPLH&D"C)=?+&X?F!7YZ5
M^BO[('Q!TOXG?!Z?P3?7 AU"U5H2K$;G1LX*@^@Q^= 'A_[-.L6]MJ-Q9W4[
M+MP\2=B/7^8KWNYUVZ\9>(WL@Z1(BB-0#R17@WQS^$>H?!3Q/%J&GR.()'^^
MO"[3WKW/X!Z18^(+"WUD7RW%PJ N,\D^]>[@:KFO8OH>9B81HMU['I6IW<GA
M[P0+1G_>#Y5<FO/+SP*_B;2;B6[N'%W(@\LQCE .E>@>,_$]C&@MIK)Y!C)"
MC.WWK%\*ZC?W4<<T< CLU?[\PQN6O46C.&I><>W8\3@UCQ9X-U);.XD+VT9V
MB5AEV7/:O>-%BOO$T5LD1>*)8]P#<[C5CQMH%G>7.GWT:I*9FV[5&1_GBM;3
M);JQD$J0"*TMH\+&.O2M-MD>+.5;$RM;8YC5K<Z?K%E)=HHE+^7L4Y)'T_"M
MWQW!%I5E+):PK<3D8V8Y -<?J=OJFN>)DU%K%UA0G;@__7K?\,66K2WUW=Z]
M)'!9*"Z!ST'O4WOJ>G)^P@N>6G8\EO/B=:>#K26UN&:&^<E]K#  _P FO$_!
M=I-\7_BW9(XDDAEG!7/.$!SG\P170_'/6X/B'\0DT#P_$+J0G:SP#.%X!KZ&
M^#'P;TCX%>%YO%>NW"17:0&1C+P$XZ?7_&OF\76=6;2>B/<PU-0CSVU9X9^W
MK\17M=0TSP'I\FRQLH5>95/WC@;0?I@U\=UVWQF\<GXB_$C6]<#$PW%PQASV
M3)V_I7$UP'8%%%% !113HEWR*/4T ?3'[/'PSGN] .JWQ(T]F+G,6X  =<]J
M]M\7?M">$/@KX7@70T74-4GPV(U&PX']X9]:]"^"OPWM[GX1:);2@)#/;%9=
MO!.X$9KXD_:K^&][\.?'W]FCSIM*6(&VE=>,$<CC\* /<OA1\1O$/[0UWK^H
M7K[9(8MD<$/ 1>#7-ZMJ-Y;F[TY[8,YC,<L<W.3C&<>M=5_P3FT/S;3Q->2J
M3&2(QGI_#73_ !-\&?V9\4V0Q""TO3A9&Z<GD_K0!\S:?X1U6Q&VWOHXFE8L
ML<J[4QGINS6LUWXN@@DL;F_6VMR-N;:3S/RZ8KW#XJ^!-*\-PVSR.;6X=0=@
M&1)QU%>8PZ7%J<RPP1LTHY4 \M5QG*/PNQ$H1GI)7/GCQOH%]HFJ'[2LA2?Y
MDE<??]353PZ6MM6AV @GGWKZD^.GP?N7\%Z%J V6RVD3,P<Y)).0M>:7'P;U
MF2"WN;)&EGV_,44';^ J"SM/!LL]Y8+<6L EF4A2IYQ75?9-9=5\U(K-.2[N
M>%&.M>5Z?X-\4Z.H-E<W+R _.#'L4'\0*T#X&\<>).-1U)[6U)P0&Y(KUZ6-
MC"'*XZGFU</5J2]V22]#F=:TJ[\;^.386]TMY;0':T\7W!GKC'TK[-_9Q\!G
MPZ\8ADDCB10&BVX##U_/O7E_PE^%6F&YCT6TBDDO9B&:Y/\ ".YK['\/>&X/
M#]M###PL40C^O?.:\R4G.3DST(QY8I'R3^WS\3I;+1[?PU;.T9F;,F#U Q7P
M57TO^W>P'Q6\OSO-_=[MN?NY)KYHJ&4*JEV"CJ3@5]:?#CX<Q:/\-5U+48+G
MR_),T4L2$X/I^M?*FE*'U2S4]#,@/YBOU&72?LOPQT&T\J(Z9=6D<,TF.8]R
M [J0'R?\8_B1=^ O#L>C:/?75M?7B_Z1OE.X)V&/X:^8IIGN)6DD8N[')9CD
MDUZI^T)\.-<\#^+Y)-2$\UK<_/!<2\[E]/TKRB@#Z;_9[\0:Q<:"UO9R)(6;
MR#',N4/&>?3ZTOB_X>ZIHFKW%Q&IT])W.0$WP[N^T\#%)^S'X5U2_P##&JWM
MM!*1;R"4,@[?+FNR^(?C*?Q+J,%NK,]M;QA<. ,-_%TH \)U30]3M[E]I>61
MR$\U>^?04LGP[O8E URTF@EA.75P0:^FOA3X.T;7+P27L>/*82 @$@X&:\X^
M-_BJU\;?$:[FTR<FR1_)6-%P.">?UH \J@GL],UFW"A8]BYY';TKVKPU<:?J
M>EI<PW()7@Q+U%=[\*_@3I-YX8CU#5[ZTM(+QQE+K&\@9'R\4_XA?LGVR@ZC
MX&U^"U"J3+;&0L& Y)& :Z:%;V3NU=&-2$IJT78XN:S\U=T:[PQY0'FL#QEX
MCT[2M".D:?$MQK-T-NQ.?+'<GTK'/A/6FN?L+:P\S[BICM%.X]NI'%=YHW@;
M1M"N+:U11+>'YKBXE)+9]/Y5URQMHM05FS"6'=1KG>B[%'X$_#W_ (1_5=.=
M8(IKV4AWDF4$=L 9KZ;^-'Q ;X2?#Z_OI[Z*,O:^7:VH4!O,)'.<_6I?A?X7
MANC;7<<*F&'!#D=2>H_#%>7?\%!K^SMOA_I]NZ W4LN$;T&#7F':?GYKVLW/
MB'5[K4;MS)<7,AD=CZFJ%%%( HHHH Z3P5XSN/!=U-<V<2-=NH6.5AS&<]17
MO/Q1TR7XA_"?3-<U&15URV0%6VX\U",\^XP*^98(9)W"Q(SOUPHR:][^%?C_
M %+5]+N/#NIZ?]K@B@.PLN&7 XH \-NK/[*VS>'?N!3M.EE1_P!U'YKGA0!G
MFNW\0>!M0NI@VF:?-(TKG*!.1]*M:3X2N_"EJLU_9O!>!MP20#\* ,6X\/:]
M!"DM[;31*P#!&4J"*LQ22Z'<P:A93".13GRU?Y@>_P"%>C>'=0&NZS:07L?G
M!N0K$X;CI7H/C_PKIFI> &FCL(K>\C4,"HP5(Y(XJU*VY+1YG;?&'7]0C\N"
M)/F4*9,8YKE+VTO?$.IR2W<9>5!C=$F<GWJ>S\-W0M/M-L)?-(R(PAQ_*O4?
M"FC:D/!2>2$^T2/OGDV@XSC/:M55M#D)<+RN<5XA^&>E/X0MY=-60:G''OFD
ME?!9NN M>,7T4T$QCF1DD'!W=:^B=;M6T522_G$C.&-<U%\+[_XG21RZ9$GF
M1OB6/^(+ZUSE1CRJQY!IT4)D47*-Y;' <'&*^E/#7Q5T7X9_#%M*2T.;@%B1
MPTK]MWJ/;VIJ_LVWOAW3W\\!T;ECMSMJO\0?AGI5WX=TT#4$>\B&YT6-QCJ-
MI^7KWH*/GKQ'XAN/$FHR74X5-QX1!@#\*RZ[+QSHNG:%;6L-O#(ERXR[/TQ[
M5QM !1110 X=**!THH ^\?\ @JK_ ,E(N_\ L,S_ /HM:^#*^\_^"JO_ "4B
M[_[#,_\ Z+6O@R@ HHHH *T?#_B"_P#"^K6^I:9</:WD#!DD0X(-9U% 'W]\
M,?CQX5_:+\+0^%/&)2RU]5"PW;$#+@8#*3T->=?$GX1^+OA1J1O+>*::V)^3
M4K%2R./5U&<?4FODJVNIK.=)H)7AE0Y5XV*D'ZBO>?A;^V!XK\#^79ZLRZ_I
M(X:WNP&./J>M-.P;G3P?&/5U\/\ ]FZC']OD5RT<X;+H<]?:NVA^.[W>H07,
M&@W%W=+$(U60':".YXJ:+]HCX*^/G5M?\,MIUPXVLT/[M1_WRPKJ=-^#7PE\
M;VRWGA[Q;/IA<;@B3$E/;YC75'%5HJRD<LL+2EO$\EUSXVZT?&RW5RK6UZ5V
M1VVT[ O'&W\JW-.^-NK17QG\2Z6=4CCYMEB& A_(^]=]#^Q]X#DU,7=YXVN+
MN7L7D4'^==/'\"O@_P"$%,VJ:P;E5'2>\<#]&K*%25.?/!ZDO"4&K<IY+K'[
M0FO:U>+#:);:/;RC9ON)02H]<<5EZ!X%\:_%;Q 5C%Q?Q*?^/R=#';*/49X;
M\#7IM_\ &CX"^ )&2RL8M1GB.,!?-S_WV:\O^)W[>%S>Z=/I?@O2TT:W8;1<
M; K >P&155*U2IK-FE.A3I?!&QZKK&O^#_V1?#LMS/-%KGC>Y4@LN-P]L<E5
M&3Q7P]\5?BMK7Q;\3S:QK$Y=F.(XA]V->P KG==\1:EXFU"2^U2\EO;J0Y:2
M5B36=7.= 4444 %?0G[*/[1,_P */$<>E:I.S^&[Q]LL9/$1)^\!^)KY[HH
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M-:W.NR)$PVL(B5R/SKR&B@"Q>ZA<ZC,TUS,\TC<EG.2:KT44 %%%% !1110
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MBU;@_P""<^D3'_D/S#_@-85K_P %$UMX]O\ PBT9_P"V[?X5:@_X*/K$V?\
MA%8R/^N[?X5^+YRL6[_V=\MOU/EL/2\2?;?OG[OK3.DA_P"":FCS #_A(I1G
M_9K6L_\ @EKH]R!_Q4\RY_V#7+1?\%-!#C'A*)L?]/#?X5J6?_!5+[-_S)D+
M?]O+?X5^+8^EXA.;^JO3UI_J?JV5QSQ6^O/\OT.OM?\ @DIHMSC_ (JR4?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4 ?>/_!57_DI%W_V&9__ $6M?!E?>?\ P55_Y*1=_P#89G_]%K7P90 4444
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M-;\736[R6DAB<Y,T@VQC^M>_7/[/7PU^%MI$?%GB>UBE')MX5W-].%_G7/\
MQ,_:NUW4[0V&B$>%=%Y5(H#^_=>V6&,9^E?,?B#QG-J=Q,^]I)7/S32'<[?C
M0!]6W/Q+^!GAE&$7AB_U-5'$J$8;Z#<*6Q\3_ ?QS"Y?1[S1"_&^;!"^^ QK
MY(TWQ)Y5K)%,ADE4%D8\U>TO1M;U&Q;4K63R@/X1QNH ^F?$?[&WA[QQH\M_
MX,\06FJ@C<L1^20>P&!7RC\1/@=K_@&[EBO+.5=F<@KV]:[OP-\4;_0=6C(E
METW4(B,7$1*OD>]?4>@?&70_BCI2:/X]LHY7E'EQ:M .4SP-XYQ]<T ?FO)&
MT9(((^M-KZQ_:+_9'O/!D3:WHI2_TB0;TGM_F5AU'2OE2ZM9+69HY%*,IP01
M@T 0T444 %%%% #ATHH'2B@#[Q_X*J_\E(N_^PS/_P"BUKX,K[S_ ."JO_)2
M+O\ [#,__HM:^#* "BBB@ KV#]FSX6)\2?'"I=G9IEG&;FYD/0*HR?Y&O'P,
MD5]3?"B >"O@+J>K6Y,>HZS+]EC8<':.O_H5 #OB7XAE\4ZTUMI3,MG$?LVG
MVB\(JK\I<CU)!_.JR?#"]M[6WOIHWDO(65I$8Y##/.*S?!4KQ>*+.3[/YD40
MP[D<!CR:^I]!TFTU73S(Y+NR\I7I87#JHG*1YV(Q+I3Y8GFF@^#5\0VZ7;';
M;J<&)U%3?$E8KW2!86<T**B;6!_E7H[6,=OI]S9P$0A03[UXKJ7A94AO;B:3
MY$RRNW<UZ,(1B[(PK59<J<MS4^'&@7FC6B(C++:S ;@.HJ7QEX8NSH.I0Q@,
MTF?+SUQC_P#75WX=RS:,+ 7'^D07&"I7MGM77?%33+D7^GQ6[&&WN#\V!SC%
M9U80J.S##XE)^SZGRAX>\+7MKI5W>PR-#=63$%?4#M^E=5X4\2SZD;:Y5C#?
M6S964<=.H->L:_X1?1+!;2RA1O/.^21^IKQ@6[Z%XPFTZ1A$+@;UVC !KRZ]
M'V;NMCTJ=3VBN+^T3\/4U*RLO'FDQK]CU-0;J.-<"&?JPQV'S"OG61"K'(K[
M9^&\R^*O"7BGP+>!6659+B D=' )4#\0*^._$FE2Z1J=U9RJ5DAD9"#Z@XKD
M-C'HHHH *]5_9PT(ZE\2;"\9<P:<?MDA(XPA!KRH#)KZ<_9Y\.?V7\*_%?B5
M_EDD*V4.!R=X8'^0H O^)_&>L>+?%E_#:R/+/=CR"XYV+D8QZ=*[KP5\/$\.
M>3;W41%^1E+D?Q?6N2^">H6]CJU_<W=JTTT*%ONY[BO9M(^)6E^+;E+>.W:W
ME1L .I']*]7!Q2]YH\C$U)U*GL4O=6[->+P=;6BI.B%97P6VG )]:Y;QTTTD
M\<"SOOB_Y9IU->G7VH6]I8JTCK&B ;F)Z5S&O:.FHVLNI:68[IW4X9&!KT6^
MICRMPY5I<X?P9K36<5R&C5KKS "#]\=:]%O;1[JUAN)D)=AN (SBO._ 7P_U
M#4M1:YU.!K67S2=^>H!XKV0:SI\L[VB21RR0K@A6!(^M8147&R+HT7AFHQ5^
MK/-?'&@3>(Q EQB*PB&9">X]*^=OB)<66@^(H[G2K@*RD*8H>!BOK<F#7+:]
MM7X#$J0>/6O)/$?PITU[>[6&VA,I!.\D$UCB(.<=%J=E%\K:>B1F_ WX@QZ;
MXG\I]TNG:FOE3QOR"#PV?SKYU^.GA+_A$O'^LV:)MB$V]!C^%AN'\Z[SP_\
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M(W8J>/7FH/?/CC'-=A\,O#,WBOQCI>FPIN>>95QC-<M;P--,$499C@"OM_\
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MKIAB4X&>15Z:]M-&TZUBD?R_*3YJRC>^FYTU.7E?-L2_$W7FT;P]-> ;FD8
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M>%+E(;@I<S#^(]J](TWP]K0O7D-ZL-ET*#TJY2CRFE2<H>]S*_0\M\+>%Y/
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M:1@^._B9;?#CP_;Q>8)M0D0*L;']37B&M_$*?Q#J4%N"LKN-S[>@^E5/C?\
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MO'_@JK_R4B[_ .PS/_Z+6O@ROO/_ (*J_P#)2+O_ +#,_P#Z+6O@R@ HHHH
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MH?L>?M56?]EGPAXKE5DD7R8VEP=RGZU5_:2^ $O@JXN/$?A5!=>'K@;V6/K
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M>WA59&4(X&W=COD]C7YKV=[-8S++"Y613D&NMM_C'XMM(RD&KSPC&WY&(P*
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MQ9CU)[U7HHH **** "BBB@!\4K1.&4D,#D$5]-_ +]KF_P#!L<.@^)&-_H3
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M*]N6&X7]DVI^]TUD?F>98KC"#?U.G?Y1_4Q[7_@GAXHNTW+XGTP?6&2K*?\
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M_P#)2+O_ +#,_P#Z+6O@ROO/_@JK_P E(N_^PS/_ .BUKX,H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:I<:??1&&Y@8JZ'L:HU[]\4_#[_$KX<:5\0+1!)?QQBWU1$'(<8^?\2Q_*O
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M_.D!^?\ 178?$?X=WW@'6)()XV^SLQ\N3';T-<?0 4444 %%%*B&1@JC+$X
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MDM?^"BK0>$8II].\S4DPF./O?G[5B?"Z[^(OQZ^(FF^*]6U":WTN*<21VP.
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M]:U_'?PWUSPB-&U*SLQ+%&5;*\MNR.V*^O?ASHUGX7U#788(@8;"+RR$&1C
MZ55TV"SU/3K;5+N+;8Q,8HA<+@,YXZ?B*]&.&IN'*O6YXRQ]6<G422BBS\.O
MVLM/LO"MC%J+AY+: +*#PX(&,8KQGQ9\>/'7C_5;K5=(5$T]"1& /F*>F*2X
M_9V&D^*KS5]5U!7LI?,N!"IPJAFR!^1JG^SG:3ZEX]OC,OD:! YC2-Q\K'_)
MKSXX:4FK=3TXXZE.+E!WLKG+67BYO%\4^GW7^AZQN+!7X^;L17VAH>N1_%']
MG'4[4H#>063P3Q8^ZZC(_3%?(O[2WP6UCP?XGE\7:9A=.W"1 G&.]>X?L?\
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M@.'Z_I7J7[=ND?9_$VD:@%V_:K=&R._RUR?QNL6O/VC?(3'FS7<8ROJ6KO\
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MZC %<Q\9;U[?P[?Q0IB:2%D4?4$574T3DI<CV,CX=_'+PWXUU>?3M'OTN+N
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MXC6NL>++M+I(VW@,V]B<CGK7Z(II"6MM%$-R)"HVX; .*\S\$VS"[MYU!9&
M92>XKTSQ(URVF&Y3CR\9 HHPC%,RQ<ZG/&*V9Y;\1_C-I.DR-;7#;#&=A+#
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MF5>'+1II?WGI^!A"C*:YY7?HOU.NT[P/X(U&].K6OA9GOB.9IDVD?7*UJP^
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M6[^R]8:QX:^'UM?V&HSQ)+<$&+!**03VKS3X*?$B^U+2+;0C+$VF_9VCFAV
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M 94ZG-/UW3=#M/"J#4X5-LJ[\RU@^,_CEX9T*ZM?M CNF641.< E#G%>0?M
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MGSH\9#>H->4>*M,T[5O&FFW6F3F=7D(D#2'CGFO0-=^(;>%S9:/8VWV@2D*
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MIH7)B4NS,.,X]<UQ5JGM)7.A)+8\^_;5\?)\,?AWI'@G0,:>;B+;<1Q<?+@
MC]37Y^LQ9B2<D\DU[W^V=X^7QK\8-12&426]DQA4CID'!_E7@=8%!1110!;T
MG39M8U*VLH%+RSR+&H'J3BOJC6_B=?\ [-FE:9X8@TR*:]$,=S)<LG]Y0VW_
M ,>_2O+OV3=%M-=^-FAV]ZN^(.7 ]P,C^5?:G[9'PA@\4^"=1O=/T^-M3L8P
MX?'SLFWGMVXH ^7/&G[9-WXBT98+'P_:6%^R;);L [C],&O,?"GQQ\7>'=2#
MVVLS0QRO^]!8D,#U!]J\\EB:&1D8893@BD7[PH _1"X\,V?C;X9QS7\GVRTD
M*[Y+:-@4<@'<,YP*X'PSKGB+X#^(-V]_$.@\%0G+**[KX2^,=8^'OP=M(M8L
MHC#J,.Z!R P*YQR".O!JOIWB;1I+*YBN[;S1*#Y91OND^U3*,9IQDB)PC./+
M)70_QY^U_;_\(J][X>L[F*^R%9"AQ&?5N*YOXGFQ^(/P4MO$PNVU+Q3)&CRB
M-B/*'!8A>O S6IJ7P^TVP\*7.I6MM.8G^:?S80(P/SY[5Y_IMRDVG7HTVX2V
MMI%:(E5!^7'/Z&N&E@*%*:J16J=[F$Z+<5"#LNQ#^RKXW73?&$.DZM<&\TJX
M8*'(/ROZ?SK[^?X9^';RT@GM@=SC<,#@?I7YX?"VWT3PYXM26WO$:0R8(E0,
MH/J >]?<'A;XN1V.FQ6DQ2;]WM$A %?6864:D.670X\0JE.:E"]O+8D\=>"8
M='M1+I@!)&'+$=:\GO;2.WE\RYN Q_YYI7HVK^/8+A)$DC:2/^(9[5YSKNJ:
M;"))3&( OS;F.1BIJ*4FI;([*:M'E;NSE?'WC6+PKH<M\=T!3A)%.*^0O$7B
MKQ/\4=5>TM7N[VV+X6) 2/QKL?BGXOU'XK>+?^$=T4F6R1]I*]#@X)^E?8G[
M-WP4TCX:>"Y=<U.UBQ!$96FE4$DCZUQ8BNZCY4]$.E1C3;DEJSYVO_!R? ;]
MG"[EU$B+Q)KSJ@A)PRQ_3_@1KY.9BS$GJ3FO8OVG_C+)\7?B)=74#D:5!^[M
MH@>  3SC\J\<KB.D**** .L^'.BZIK>M"/2K@0S1X=ANP6 /(%>L_&GP3XD\
M*S:5XJTN678]LJR3V_6-P!D$_7/Y5XI8#6/"]W::A"DUH[_-%)@@,/;UKZO.
MG^(O$OP9EU34)C%;K 99(MQ"MQD'%*U]P/DNX\4:Q=2.9M1N79CEMTAY-6-.
M\6:Q;RQQQZK<0H?ESO. *IP:;=ZA>W!M(&G*$EMHS@5U_AWP)9O:K+K;R6;3
M<Q,!Q_.CECV$TGN>]_LQ_%W_ (53XV@O=:OEO[.[01"9024R1UK[VGU=+B-;
M^SGCF@OAN1HSG(/O7YK>$K#3=8U2'16:*WTE.'O!$"Y/7K_]>O1;#XWWWPQU
M2[T2#5&U#P]'"1;,P^:/@@<YX/2O6I8JG*U%Z/\ KJ>-4A4A5YE'0^UO$'C:
MV\.:<UQJ-VL-E:KYDAE8#\*_-?\ :"^+H^,'Q0NM9TJ;^S+.!?*B?ID DY_6
MG_$'XO:I\4M7@TF;5)CI[#!C#%0Q_P!HY],U!XX^''A[PM):VEA?IJ5K>QAF
ME4\P/Z>_:LL1B+OV:.V$81:TU9Y-?^,=:N%>WEU:XGB#' +G!]ZQ'FD=LLS$
MGU->I77PXTVRM?+0275T1N&#@X^E>?:AHUYIUW&9[=XDD;Y"PP#7GV.Q)+8]
MS_9J\ #6]#\0:E>R&V@6,)$[<9;#5Y;\3-)TS0=5-I87[7\N29I-V5!ST'Z5
M]5>%_AE+JG[.=Y>Z%=R+J21%F@B<[2<'CCO7R4WPV\33V]_>MI=P8;7+3RLI
MPO/?\Z!G*T4=** "BBB@!PZ44#I10!]X_P#!57_DI%W_ -AF?_T6M?!E?>?_
M  55_P"2D7?_ &&9_P#T6M?!E !1110  X.1UK[0_9>\8V/Q1^'.H?#37)P?
M/B98-_\  V/E(_&OB^N@\"^,[[P)XBMM5L)"DL3 D XR* /<_ _C+5_V:?B)
M?>'M6$GV2.4@*W0KG(8?A7O_ (BN(/B^FG:_X6U#RM8@(#!#R%/7/X9KC]4A
M\,?M7^#4O&FCL?&%I&%BEX!E('W6_P ]J\5\$?$#Q-^SWXON+*\MA;WL3>6\
M4Z9##U&:Y:]'VB;AN>U@<SJ81<CUC^1]:? K4?$FE_$+5O[:U&:5=&:.0CH"
M&&[GBOIRS^,OAGQT?L\$R27:QEC'@Y Y_P *^$OAU^U)86GB;Q1JVO09_M.&
M,)#&O!*KMKRWP3^T'KO@_P ?:WK%E9J5U$&...1<K$N<@+QQ7@5L!5Q$M8V:
M\]Q8C'4<6H^VA=K\C[<\)PN?BO?ZA!*UK80OYDPQQ@'FNH^)WQ[>RM4O=))N
M;6/=&Z)U;@_UKXZ\*?M&>)?"QO;J?R[HW1=YHYDX 8YP"?3->;V7QT\6:9JV
MIR0K!-9W<AD6*<96,X_A]!Q6%/)JKFU.5E]Y\[73O>A!*SNC[#\(>)_!>J>&
M+?6->N8K?4)KHEH)GPR-D8!%>6?M5_%ZW70;:P\.ZK^_W8(@(/R\\?RKY9UO
MQ&?$FHS7.H3%KJ1MQAA.$+>PKVSX,? K?"OB[QZC6&B0?/9VDG#3D="0>W6O
M;P^ CAY-\UT>[3S+$1HNF]WU[>AV_P"SOX,MOA%\+]4^)&OD0ZW?0N+2.7AD
M4K]X#WW?I7QI\0/%=SXS\5W^J7,AE>:0D$^E>S_M*?M 3^-+K^QM-D2+3H5$
M>V$80 ?P@"OG:O5/+"BBB@ KZ!_9$^,C_#KQJFGW<H&EWQ"R(Y^7_/-?/U.A
ME>"59(V*.IR&'44 ?5GQH\/W/P#^,5KXQT.V,GAK56\],#*$$?,I_$$U]1_"
M+XVZ)>VVEZG8NAFN&4>6O+)TR#^=>!?!'XH:%\;_ (<R?#SQO*K72KML[AL!
MD;L0:\IU72?%G[+7CEXIE5[5\^3<,NZ.1/4'UQ7%B<.JR\_S/4P.,^K-PGK"
M6Y^J9^+=R/B9I^E!T%E=P!MH]<"N-^*.AC2/'%O>1W+6:7P,;,IP"3T!_.OG
M/P#^T1X>\5^.?!]U%=F.] "W7G<!.O /Y5]!_$SX@^&+](&UB\AC@C<20R%P
M 6&"/Y"O%P>4>WK6J)J"ZGS>>8J%.O&&&6ENQD7UE!X/@L#]J1]1>XR &Z@Y
M/^%07.JZD=:&M%_-2,8$1Z*/7->=?$#QQHM[HUG=6U[#]O>?]RZL#A 2,G]*
MWIM54:7%I)U>&.>\A#1@$#K^/M7T%/AK"*IS<[:['E?6:]6G[):+T/I/5/%-
M_P"(_AK'-ITBI=*JN &]NE8(\>2>*O!MS]I=+86Z%9RYPN1[UXGKGQ#E^&OP
MRN8+G4(H)8TPDA?.[ /-?+FL_M,^+?BIHD/@7PK8LL]ZQCN9H@2S_,><@<#
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M^7\TP]&8UCDDG)Y-(9T'B_QSJ_C?4'N]4NY+AV)(#'@5S]%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDE_X*B?%F="KFR(/;8/_ (FOCNBN3_4_AZ]_J-/_ ,!1[$*M2FK0E8^J+_\
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M$?\ T(>E?]\M_P#%4 ?SK?\ "L?%7_0"O/\ OBC_ (5CXJ_Z 5Y_WQ7]%/\
MPRE\(_\ H0]*_P"^6_\ BJ/^&4OA'_T(>E?]\M_\50!_.M_PK'Q5_P! *\_[
MXH_X5CXJ_P"@%>?]\5_13_PRE\(_^A#TK_OEO_BJ/^&4OA'_ -"'I7_?+?\
MQ5 '\ZW_  K'Q5_T KS_ +XH_P"%8^*O^@%>?]\5_13_ ,,I?"/_ *$/2O\
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M8^*O^@%>?]\5_13_ ,,I?"/_ *$/2O\ OEO_ (JC_AE+X1_]"'I7_?+?_%4
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M/_H0]*_[Y;_XJC_AE+X1_P#0AZ5_WRW_ ,50!_.M_P *Q\5?] *\_P"^*/\
MA6/BK_H!7G_?%?T4_P##*7PC_P"A#TK_ +Y;_P"*H_X92^$?_0AZ5_WRW_Q5
M '\ZW_"L?%7_ $ KS_OBC_A6/BK_ * 5Y_WQ7]%/_#*7PC_Z$/2O^^6_^*H_
MX92^$?\ T(>E?]\M_P#%4 ?SK?\ "L?%7_0"O/\ OBC_ (5CXJ_Z 5Y_WQ7]
M%/\ PRE\(_\ H0]*_P"^6_\ BJ/^&4OA'_T(>E?]\M_\50!_.M_PK'Q5_P!
M*\_[XH_X5CXJ_P"@%>?]\5_13_PRE\(_^A#TK_OEO_BJ/^&4OA'_ -"'I7_?
M+?\ Q5 '\ZW_  K'Q5_T KS_ +XH_P"%8^*O^@%>?]\5_13_ ,,I?"/_ *$/
M2O\ OEO_ (JC_AE+X1_]"'I7_?+?_%4 ?SK?\*Q\5?\ 0"O/^^*/^%8^*O\
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M_13_ ,,I?"/_ *$/2O\ OEO_ (JC_AE+X1_]"'I7_?+?_%4 ?SK?\*Q\5?\
M0"O/^^*/^%8^*O\ H!7G_?%?T4_\,I?"/_H0]*_[Y;_XJC_AE+X1_P#0AZ5_
MWRW_ ,50!_.M_P *Q\5?] *\_P"^*/\ A6/BK_H!7G_?%?T4_P##*7PC_P"A
M#TK_ +Y;_P"*H_X92^$?_0AZ5_WRW_Q5 '\ZW_"L?%7_ $ KS_OBC_A6/BK_
M * 5Y_WQ7]%/_#*7PC_Z$/2O^^6_^*H_X92^$?\ T(>E?]\M_P#%4 ?SK?\
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M?]\M_P#%4 ?SK?\ "L?%7_0"O/\ OBC_ (5CXJ_Z 5Y_WQ7]%/\ PRE\(_\
MH0]*_P"^6_\ BJ/^&4OA'_T(>E?]\M_\50!_.M_PK'Q5_P! *\_[XH_X5CXJ
M_P"@%>?]\5_13_PRE\(_^A#TK_OEO_BJ/^&4OA'_ -"'I7_?+?\ Q5 '\ZW_
M  K'Q5_T KS_ +XH_P"%8^*O^@%>?]\5_13_ ,,I?"/_ *$/2O\ OEO_ (JC
M_AE+X1_]"'I7_?+?_%4 ?SL#X8^*L?\ ("N_^^**_HG_ .&4OA'_ -"'I7_?
)+?\ Q5% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>aciu-20221231x20f032.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f032.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %J :$# 2(  A$! Q$!_\0
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MZ-'IT:JKTU5BK>3W7J9YHH)HKSC8**** "BBB@ HHHH **** "BBB@ HHHH
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M6EHIC3R?+#$8.3WIVF^!8=-T:2&V4+,5"ESS\QJG%I[:1JZ?:7$L:KLD(7!
MK]!RK#RI1<*<>:Z][T-<1AZ=2BZ51VO^9Y_XBT:[L;MEGB=6Z_-W]QZTF@:?
M=7MY%%%$SLYP% Y)KZ+\/:IHFHV@T37M.@U*,?-:W3=2I[9]1]:V;3P]H6CR
M[],TN&S;D;N2WZUYRIUJF8.4J+6MT^:/*_/?G7IRM^?4\OV^.B_9NA[VU[KE
M]>_R.7M[1[3PCK%O>RF-X;(#!/>N1^!UF-1\0;2?-$(+%3V%:_Q%UP6&G:M
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M#1=DENXE,ISMSQ71^&IIKN3]XC1#KDBN0\.S07N]/.*\;C$YR/PKMO#TPM9
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MJTH[I[K^NC6C,ENM,/6I&'-1D5! 4444 %%%% !1110 4444 %%%% !1110
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MS6[(RJ?O8(.*Y/Q/X[&H$1FR2';$$V@YZ=#5SX.2_P!H>-K*WDDV^:3&"YP
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MW/L#PIKZV5U!J$*;[:=,2QL,;T/52*^&/VW?A5:^$_';ZMI%N8]+U >?& .
M#U'X&OKWP;XHC\266"5%S$!O"]/J*Y_]ICP2?&7P4NKW:KOI,O4]0C#G]:^
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MP>S\66LP0/L/(85SLT)FN@54#: /QKV/X:>&(H85FD9&N9 &9<_,B_2O$RW
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MH?<&LVO5OVF[ZRU+XM7UQ8WL%VK6]N)4M9EFAMI!& T,<BY#*F, Y/U->4T
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M_O-KH>5@J<Y.>+K*TZG3M'HOU8E%%%<)Z@4444 %%%% !1110 4444 %%%%
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH [#P_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
B**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>aciu-20221231x20f033.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f033.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $2 E@# 2(  A$! Q$!_\0
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M_EIYGA/AK]F[4+L)+KVHI8(>3;6@$DGT+'@?AFO3M!^#WA+P]M:'28[J=?\
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MM>J_7I[U\Y6P&)P,O:T7==U^J_I'WV%SK+\XA]7Q44F^DMOD_P#AF?3OP_\
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M@D5AP4:-E)]13K/XX:K?>([_ $>/PI;13Z?=Q65U]IUZWB=96CCD.Q",N )
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M9'9AN!QGTXH X'3/VL-.U.&[NH]!G^PFUN+JRF-QM\U8G"8F+HJ0EMP8?,_
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MSO3_ )YM_2JR3!F*D%''56ZUTGECZ*** "BBB@ HHHH **** "BBB@ HHHH
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ME+.<!2QU'136W9[-?)_YGG8_!SR_$SPU3>/7NNC^:"BBBO9//"BBB@ HHHH
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M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS!GK_M3C2-&.J]I"/_@-D_R9^PY;_L?#[J/^63^^]OT/IJBBBOZF/QH****
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M7CSXQ6_@K4%LAILMY.T?F!O,"*.2/<]J\L\0_''Q)KH,-JT>EQ-QMM03(?\
M@1Y_+%?%9QQOE&3U)X>I)SJQWC%.]_5V7XF^ X>QV/C&K!*,'U;_ $5W^![9
MXW^).D>"+=A<2BXOR/W=G$<N3[_W1[G]:^>[V^UWXL>*%+#S9VX2->(K>/\
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M,<EL8VY9E_BRN1BO2"0,DG"CDD^E,AACMH8X8D6.*-0J(HP% Z 5S7Q,U_\
MX1WP7J,ZMMGF3[-#Z[GXS^ R?PKZJAA</D6'K8N3Z<TNUTFW9>;;W;>RO9)+
MQ*E:KF56G02ZV7?6R5_1);66[W;/GWQ'JO\ ;_B;5-1ZK/<,4_W1POZ 5[)^
MSAHY6VU?5&4_.ZVR'V W-_,5X5$@CB '85]:_#'0#X<\$:9:.NV=H_.E'^V_
MS'\L@?A7X)P%AYYMQ%4S&KKR<TG_ (I:+\V_D?IG$M6."RJ.%A]JR^2U_1?>
M=31117]0'XZ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 ?-O[=7PX;Q;\*8]?M8O,OO#TWVAL#DV[X64?A\K?\!-?GE;SR6\R2Q.8Y
M48.CKU5@<@C\:_9;4]-MM8TZZL+R)9[2ZB:&:)NCHP(8'Z@FOR4^+7P\NOA5
M\1-:\,W(8K9S$V\K#_6P-S&_XKC/N#7SN94N6:JKJ?NG 69*OAJF6U'K'5?X
M7NOD_P S]&_@S\0HOBA\-M%U]64W4D0AO$!^Y<)\K@_4_-]&%=M7PG^Q5\5E
M\*>,YO"E_,$TW72/(+GB.Z4?+_WV/E^H6ONSI7KX6M[>DI=>I^7\0Y6\IS"=
M"WNO6/H_\M@HHHKK/FPHHHH **** "BBB@ J"_T^UU6T>UOK6"]M7X:&YC61
M#^!!%3T4#3<7='D/B3]DWX7^)9'D;P[_ &9,W5],G> ?]\@E?TKU;X=>'[7P
MGX8M-$L3(;+3HEM83,VY]BC W'C)JQ5O0/\ 5W'^^:RC2A!\T8I,[J^88O%4
MXTJ]64XK9-MV^\X_Q%X!TCQ7K,EWJ*3221#RE5)-JXZ\X^M7](\):-H.#8:;
M! X_Y:;=S_\ ?1YK3'_'U=?[_P#2GUP1RO PQ$L5&A'VCU<N5<WW[D/&8F5)
M4'4?(NEW;[@ZT445ZAQA1110 4444 %%%% !1110 5X5\<?$?]I^(;?2(7W0
M6"[Y<=#*PZ?@N/SKU[Q9XCA\)^'[O4YL'REQ&A_CD/"K^?\ 6OEZ2>:\N)KJ
MX<R7$[F21SW8G)K\9\2<[6$P4<MI/WZNK\HK_-_DS[[A++W7Q#Q<U[L-%ZO_
M "7YG3?#?PT?%7C'3[)EW6ZOYT_^XO)_,X'XU]: 8%>5_ +PF=*\/RZQ.F+C
M4#B//41#I^9R?RKU6O8\/LG>5Y0JU16G6]Y^GV5]VOS.'BC'K&8YTX/W:>GS
MZ_Y?(****_3CX\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *^3?V[_AQ9^)M%TW7-.4R^)]-B=Y;6!"[RV(Y=VQT6,\@G^\PKZ.\6
M>+&T5[?3=-MQJ/B"]!^RV6["JHX,LI_AC7N>I/ R32^&?!L.C6UW)?RC5=6U
M 9U"]F0?ON,; O18P"0$Z >I))QK4E6@X2ZGJ99F%7*\73Q=+>+V[KJOFC\A
M+6XDMIXYH9&BEC8.DB'!5@<@@^H-?I7^SO\ &"'XP> (+N:11KMB%M]2A'7>
M!\LH'HXY^N17QI^U%\#9?@OX^D^Q0M_PC.J,T^G2=HSU> GU7/'JI'H:Y;X,
M?%?4/A!XVM=;L]TUJ?W5[9@X%Q"3ROU'4'L17S>&JRP=9PGMU_S/WG/<NH\3
MY9#%X-WDE>+_ #B_R\FC]1**S/#/B73?&.@6.M:1<K=Z=>QB6*5?3N".S \$
M=B*TZ^I335T?SI*,H2<9*S04444R0HHHH **** "BBB@ JWH'^KN/]\U4JWH
M'^KN/]\T 41_Q]77^_\ TI],'_'U=?[_ /2GT %%%% !1110 4444 %%%% !
M0!DT5YM\7_'_ /85DVBZ?+C4[I/WKJ>8(S_[,>WMS7E9IF6'RC"3QF)=HQ^]
MOHEYL[<'A*N.KQH4EJ_P\SA?BWXT'BG7186C[M,L&*AATEEZ,WT'0?C7/^&=
M'35M2'V@2KIML//O988V<QP@C<V!SW_KVK)MX"2D<:%G8A551DDGH!7U+\*?
M :^"O#H%P@.IW>)+D_W?1/H/YDU_,^38+$<<9]+%XM?ND^:7:WV8+UM;TN]S
M]<Q^(I<.Y:J-#XVK1]>LOEOZV.NTU[633[9K%HWLC&ODM"04*8^7:1VQBK-<
M%=6LWPPNI;ZQB>?PE*QDN[&)2S:<Q.3-$HZQ$\L@^[RR\9%=Q:W4-];17%O*
MD\$JAXY8V#*ZD9!!'45_5B2BK+8_%VVW=DM%%%,04444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% &9XHUV/POX:U;69HGFATZT
MENWBC(#.L:%R!GN<5Y_H7QSWWNFQ>*- D\(VVI:=+J=I>7-_!-$T4:HS[RAS
M&0)%/(P>1G-=UXTT*3Q1X.UW1H95@FU&PGM$E<$JC21LH8@=0,YKSNX_9]TO
M2_AQ/HWAFUTW0_$$UE;VLFJI;9,GELC.N>657V'D<@D,.0* .I/QF\$_8;6[
M7Q+I[174SVT $OS23( 6C"]=P#*2,="#TJKI'QDT36-#T6_CEAAGOX[6::SG
MN462T2=&9"_."V%.%')QD<5Q?@7X ZMX9\9QZ_>:I:3?Z==WK0HT\S*9K2&
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M>V\DELYO"][!.FUVSMPCW!.1RP4 X(YS]6_9FUC6)]4LQXBATO2-2M98+LV
ME#7.^V$0#PLQB!# ,94"NP !ZDT >KP_%SP9<:'-K$?B33WTV&58'G$PP)&&
M57'4EAR !R.1FG+\5_!SRZ5&OB33F?5%5K,+.#YP9MJX/;+ J,XR01UKR>+]
MG;Q'%_IT>K:?;ZB;FU,L,,]X5F@@CD4+]H>1IHR6E+ (1@#;D@DU!H?[-'B+
MP_'HRV7B&SL[FU;$VHV@N(YA']LDG*;2Y6=2LA4"8$J<L&YH ]LT;Q[X=\0Z
MQ>:5IFLV=[J-IN\^VAE#.F#M;ZX/!QT/!JO\1/'UE\.?#O\ :=W;W%]++-':
M6EC9J&FN[B0XCB0' R3W/  )[5YU\+?V?[GX?^*-,O)[^WN['1H;N"Q<27+S
MR"=PV75Y#''@#!$:_,>>,8KN?BIX"G\?:!:1:?J TG6M-O8M2TV]:/S$BN(R
M<;U_B4@LI'HU1/FY7R[G7A%1=>"Q#M"^O]+6W>VMMC$\/?%_5/\ A*]-T#QA
MX/N?"-UJP?\ LV<WL5W!<.J[FB+IC9)M!.".<'!KTZO'#\+_ !;\1?$6C7GQ
M'GT)M'T9WGM])T59BMS<%2@EE>3! 4,<*.YY-=C_ ,*>\&?]"_:?^/?XU%)R
M:?-\K[G5F$</&</8V3M[RBVXIW>S=WM:^KUZ]%V5%<;_ ,*>\&?]"_:?^/?X
MT?\ "GO!G_0OVG_CW^-;'E'95S?BWQ8^BO;Z=IMN-1\07H/V6SSA5 X,LI'W
M8USR>IX R35'_A3W@S_H7[3_ ,>_QK8\/>#-$\)M.VD:9!8-/@2-$O+ = 2>
MW)H @\)>$U\.QW%S=7!U'6KTA[W4)%PTK#HJC^&->BJ. /4DD]#110!QOQ:^
M%^D_%_P1?>'=67:DPWP7*C+VTP^Y(ON#V[@D=Z_*_P ?>!-8^&?BV_\ #NN0
M&"_M'QN'W)4/W9$/=6'(_+J*_8*O(/VCOV?=/^.?A<+&8[+Q+8J6T^_8<>IB
MDQU1OT/([@^7C<)[>//#XE^)^A<)\2?V16^K8E_N9O\ \!??T[_?TU^+/V:/
MVA9_A%K1TW5'DN/"E](#<1CDVKGCSD'_ *$.X]Q7Z$6-];:I96]Y9SQW5I<(
M)89XFW)(I&00?2OR8\1>'=3\(:[>:/K%G)I^IV<ACFMY1@J?4>H/4$<$5[1^
MSC^TQ>?">Y31M9,M_P"$YGR8U^:2R8]7C]5]4_$<]>#!XSV3]E5V_(^SXJX7
M6/C_ &CEZO-J[2^TNZ\_S/T&HJEHNM6'B/2K;4]+O(;_ $^Y3?#<P-N1Q_GM
MU%7:^CWU1^%M.+<9*S04444""BBB@ HHHH *MZ!_J[C_ 'S52K>@?ZNX_P!\
MT 41_P ?5U_O_P!*?3!_Q]77^_\ TI] !1110 4444 %%%% !117&_$'XD6?
M@JW,$>V[U>1<Q6P/"?[3^@]NIKAQN-P^74)8G%3481W;_K5]D=&'P]7%5%1H
MQO)DGQ$^(%OX)T[;'MGU6<$6]N>W^VW^R/UKYVGN)[ZZFN[J5I[F9B\DKGEB
M:??W]UK&H37]],UQ=S-N>1OY =@/2O2/A)\+'\57,>JZG&5T>)LI&W!N6';_
M '1W/?I7\OYOFN8<=YG#!8*+5-/W5T2ZRE_6FRN]_P!BP."PO#F$EB,0_>ZO
MO_=7]>;\M[X'?#8N\?B34XL*.;*%QU/_ #T(_E^?I7N--1%C1410B*,!5& !
MZ4ZOZ-R'),/D&"C@\/KUD^LI=6_T71:'Y3F685<SQ#KU?DNR[?UU$(R*X.ZM
M9OAA=2WUC$\_A*5C)=V,2EFTYB<M-$HZQD\L@^[RR\9%=[2=:^A/+*$/B'2[
MB%)8M2M)(W4,KK.I# ]".:?_ &WIW_/_ &O_ '^7_&LQ_A[X5E=G?PUH[NQ)
M9FL(B2?4_+3?^%=>$_\ H6-&_P#!?%_\30!J_P!MZ=_S_P!K_P!_E_QH_MO3
MO^?^U_[_ "_XUE?\*Z\)_P#0L:-_X+XO_B:/^%=>$_\ H6-&_P#!?%_\30!>
MOO$^DZ=9SW4VH6XBA0NVV52< 9X /)K B^(%W";6YU+P_<Z;I-TZI'>/*K%-
MQPID0<H#D>N,\U-J_P +?#.HZ9<VT&AZ983RH5CN;>RB62)NS A<\&J%WH_B
MKQ)9PZ-JL5A;6"NANKVWE+-<*C X1"/D)(&<DXKY?-:V/IU;8;FMR^[RQ34I
MW>DVT^6-K:IQW>MTD>S@J>&E"]:V^MVTU&V\5U>^FO335F1\9_BOJWPQUSPB
M++2X]4TJ\ENI-74!C<0VD,09Y80#\Q3.XJ0<JIQS6/!^TKI6GWVLP:D$O675
M)X-,CTQXP9K.*W@E,S-+(J'F< 8.6R  >:]/U?PA8ZWXDT/6KAI?M6D"X$"*
MP\MA,@1]XQSP..E>=V7[+GA#1DD_L>;4=)E-Y=74<L+QR&%;@()($$D;*(_W
M2%1C*D<$=*^H/&-FQ^/?A?5-.GO[(W=U91W>GV8FCB&)&O%C:%ER0=H$J[LX
M(P>#BJ&G?M#Z5K&E65[8^'/$5V;RVDU"&VCMHO.-FA :X*F3 0DX SN8]%-3
M2_L]^'S>120:CJ]I:+-8W,MC%<J8IYK0*(9'+(6)PBAL, V 2,\U8/P+TBWT
MC1;'3M6UC2'TO3FTA;RSG0336C8)CD+(0>0"& !!S@C- &=:_'_3)Y'^Q66I
M>)!<SR_8H]*LU#>3';03L6+R 'Y9UP?ER3MQD<\RO[0VKZM\1;&UTS3XX_"4
MUSIT*W-Q;DRW$=U:37&]2),J0(U 4H?XLG.!7H7AWX+>'?"NH076F_:H! )A
M%!YH,:+)!!"0.,\+;IC)ZECSFLR#]GCPS;V]M +C4FC@^R;?]( )^SVLEM'R
M%!&4E8DC!S@C&* *EK^TMX<NS/$FF:N;U&M!%8I'"\TPN93%$0JRG8=PP5D*
MLN<D4T_M+^'8+*>[O-'UVP@BAO9 T]K'^\DM&VW,*A9#EU/_  %L'#&IO#_[
M./AWP]>V-U'J&IW$MFMI'")&A10EM-YL0*QQ*"=Q.YCRV>3GFK6J_L_>&]7T
M]+.:XU%8EEU*4%)E!S>MNF_A[$_+Z=\T ):?'S2IM;72[O0==TR9;^/3)Y+N
MVCV6]Q+&)(58K(Q.]2,;0<$@-@US^K?M-V4D9MM#T+4+O5Q/8'['/Y(9K:XN
ME@\S E^1@6QL?:P++D8SCLM:^#6A:]>:E<7,U\'O]4M]6F$4P3$L,0B0*0,A
M2JC/.<\@BN<TW]F;P]I2)Y&K:NLT-K;V=O,K0(8$@N$N(B L0#,'099@2PSG
M- %O4?VB_#NE6-UJ%UI^L1Z2D=T]KJ ME,5\;<,94A^?<6PCD;@H8*<$UI6_
MQITQY+BVN])U;3=3BN+*W73KJ&,3RFZ8B)E"N05^5]QS\OEMGI6;?_LZ^'M3
MLI["YU'5Y=*V72VFGFX3R;$W&1*T7R9SAG"[BP4.P %:-_\ #:76/C%H_BJZ
MC@BL=$T^2VM=DS-+<RN>&D3:% C'F;3DG,K'CN 1>)OBY+X5\?ZCH]WHEY-I
M%EHL>IM>VJ*[O(\YB$87<#C@<D #DD@#-4--_:/\.ZK/;6]OI^J27#S7<5PL
M:PNEF+98FFDDD64IL"SH<JS9Y&,\5M>/O@YI/Q#U"6[OK[4+5IK..SDCM701
MNL<XGC+*R-DJXZ'Y2"0P(JAH7P%T'P]J%UJ$5Q>7]W<)>"1+UD\F0W,<"2 I
M&B@+BWCP%P!EO7@ SYOVEO#EE$\FH:7K6F(]G!?VC7EO&@O8IIA%#Y9\S 9F
M8</MV@Y;%2>&/CQ!XU\>Z-HFCZ7/+8W$%]]NN7:(FSN(&A'EDK(58$3 Y7<#
MO3!^]CE_#/[.>HZC>2-XNU!VM+73;;3M.AM[W[2]LT$XFCE1FA0 *54 .KD@
M'<37H?AWX/:9X9UC3=5MM2U&2_M&NFDEE>/;<BX\O>KH$"JH,494(%QM[Y.0
M#O:*** "BL+QWXMM? ?@W6O$5[S;:9:27+*.KE5)"#W8X ]R*^<?!7QH\0WN
MF:=H=QXADU'7X?$NEF:Z>W,'GV=WN9H=K(#M2421;@,X1><F@#ZKHKY[UCXM
M>/-4:'[!8:3':P^(K+2X=0L[R0P:A(SL)XLO%GRTP SJ#E@57H34NJ?M+ZMI
M\K:?'X66YUJPAO)]3A@>>:("WG:';"T<+'+E20T@15X!- 'O]%>"W'QUUFUE
MU3^R-%6_"-J%\_\ :M\8O)@MK>UE**%C)!;S\!3G!!)8@\0W?[3&J6$]OIMQ
MX9A&LZE]BET^.WGFN(Q#<PRR@R^7"7WH(6!"*V21@XR: /H"BO$O#/Q=\1?%
M74I/#VFZ2GAV1]'DGN]0N9G6>TE,LUN##&T?S8:,."^W@X(SQ6OX4^+U[J'Q
M)G\(ZC8P64<;SV]M<7,LBSWIA S+'^[\J0-\Q*I(63'S#K@ ]6HKYZ\9_&#Q
M-=W>F:C8VT>G>%OMVKVF^&\Q=W)M;.Z^^AC(0&6'<I!)&P9'.*GN_P!II_#$
MFH-K&D+;Z;8V$D\+33R?:;YH[=9<Q-Y7DR%B2I4/O7!)4<@ 'OU%>#0_M&ZL
MME/;W?AR*SUDW%M%;B8W*0RK,CM\J- )I'3RV!5(SG((.,XBTC]IR[U/_A'K
MB?0(-*TV]"I=WM]/,L4<OVF2!XU=8B$8&/<!-Y>[< .0: /?J*\<^&'Q]N?B
M'XDL;1O#T]EI6JQ7,]A>;)@56%P,2EXU0EP<CRV?'0^M>QT %%%% !1110 4
M444 %%%% !1110!XU^T1^S=I'QQT;SXS'IGBBU0BTU(+PP_YY2XY9#^:]1W!
M_-WQGX+UOX>>([K0]?L)-.U*W/S1N/E=>SHW1E/8BOV'K@?B]\%/#7QIT Z=
MKMKBXC!-KJ$&!/;-ZJW<>JG@_K7EXO!*M[\-)?F?HG#7%E3*;87%7E1_&/IW
M7=?=Y_G3\%OC[XA^#6I9L7^W:+,X-UI4['RW]60_P/[CKW!K[\^%WQ@\-?%W
M21>:%>#[2BYN-.G(6XMS_M+W'^T.*^ OC5^SWXI^".I,-3@^VZ)(^+;6+928
M7] __/-_8_@37!:%X@U'PSJ<&HZ5?3Z=?P',=Q;.4=?Q';VZ5Y5#%5<++V=1
M:=C]#S;AS <1TEC<#-*;VDMGZKO^*Z]C];Z*^1OA'^W!'(L.F^/K8HPPHUFR
MCR#[RQ#^:_E7U1H'B+2_%>F1ZCHVHVVJ6,@RL]K('7Z''0^QYKZ*E7IUE>#/
MQ#,<HQN53Y,5!KL^C]'_ $_(T:***W/'"BBB@ JWH'^KN/\ ?-5*MZ!_J[C_
M 'S0!1'_ !]77^__ $I],'_'U=?[_P#2GT %%%% !110!D\<T %(Q"J68A5
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M>)7BU36(V@TD'='">'N/\%]^_;UKZ'@@CM84AAC6**-0J(@P% Z "GA0H
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M]+(LD8(W ;TVY[X8=2: /K_.*6OD?4_B5X@UR[\(&WUE/',,-SI^J+<6ELL
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MY9$4HI$N[> %+* &P 2,8)IT'P1\#6K61A\-VD2V9S$B%E3B4R@,H.' D9F
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M"BBBK)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
K **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>aciu-20221231x20f034.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f034.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %, 6X# 2(  A$! Q$!_\0
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MO /J<<5J:C\5_%IT;[19WED/LMAJE\+QK(M'J,=K+&L;HN\;!(&/.2."1VH
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MG(X !ZGL7G@<]>*-BXQM'3'3M7B4OQ-\3-I5Y)83MJ4L+J1*NENOS^0)#"5
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MC;O&=H/ R0!G IZQ5I+?9_Y_\ =H.-VK/T_7I^)ZC!<W$6A-<7*E&(5_F89
M+=^P[5Y]XEUOQ-#K&A#3)M/AL'N<ZHUU&6D:WVDD1X'#9'6O0( \V@R)M\Q<
MA5##.1OKD+HR3N+?*))"!@JP) [9';/(K>F^5:),Y96O9GD/P$\&^#=(UGQ+
MKG@;Q;KFO6MS<>5-8ZG,TD=BV2^Q XSW[Y(&*]HNM3N9K:2..?;+G@JJ\,._
M3I65H?A^P\.S3+IMK%8Q7,KW,RPKM#RM@%C5N:/RY7E<AL*0J9QGN?Y5345I
M&]O-W_$N<W4GS-W^[]#Q[P#\*_B#HG[07B#QIJWCF;4M N;+[%8:23OSE@Q=
MTP%3;CC S\Q[5[C;75U#]Z3<Y 4EE!RM>>OXY\.Z]JOB#PY!J:_;=*6.74DM
MYQYECGD!\'*\<FNOT_4;;4;6SN+.6*ZL980\4D;[MZ-C:1ZY]:2HRI*TFWZ^
M>J_KYCJU95GS.RZ::;&O-X@N0JJ"<R.0N8U^7COQTJSX1UG^U]6F1IX;B6W5
MDD\G;B-OE.TD=#@@X/8@UX;^T7\?+3X">%8YDT;4=7UJ\AG;3[;3;)KB.)8M
MFZ6;'"(HD!YX8C;D9KT#X"ZC:WNE:%)9P75D+W2AJ<UKJ$>V[#S,K&28XQO9
MMQ/OTP *3BVK_P!?YF:B[<Q[)11161(C,%&20!G'-5X]2LY7B1+J!WEW>6JR
M E]IPV.><'KZ5C^-?"$/C+3K&WE9$>SU&TU&)W0L \,R28QD=0I7/;=FN%\-
M?!74=%U2UU(ZS:V.H>7.MS<Z3:&+.]7"B*)V:*-5W(0"C']RN2VYL@'K=1SP
M1W4+PS1I+%(I5XW4,K ]00>HKSWX,ZGK-T?&NFZUK=QX@?1?$#Z?;7MW##%,
MT/V6VE 80HB$AI7Y"CC'I7HU &>GA[2HC:E--LT-J2;<K @\G)R=G'R\\\5?
M90P((!!X(/>EHH K6&F6>E0&&RM(+.$G=Y=O&$7/K@"K-<I>?%;P;I]QX@@N
M?$^E03>'XEGU:-[I UDC?=:49^7/O[>M3V?Q)\*:AJVE:7;>(M,N-1U:T-]8
M6L=TC275N,?O8P#\R\]1Z'T. #I**** "H7LX);F*X>"-[B(,L<K("Z!L;@#
MU&<#/T%344 %8WC.WN+KPAK<-HDDEU)93+$L7WRY0[0/?.*V:* /*_MGC$07
M<MN^K26D%O*UK]HMHDN)GS$H\Q=A^Z3,5 &2%'#<9K:<_C74A 97O[)V$D;W
M:VL:RLBFY,>0R\9Q!_"#ST!)KT3QEXGA\%>%-6UZXM+N^@TZV>YDM[&,/-(J
MC)"@D#./4@>IKCM6^.%AI6J7VGG2;Z6[A<K;PG;&]XB0F:66+>0&C158%@<%
M@%_B&0"+Q=-XMO\ PY#%-!<P"YL9 RZ0@DE:<HFU)0R_NU.9,[3P0/F'&6VL
M_CB[U>ZAN)[BUMVOE1A!:+MAA\T@&.1@0P,8&3@X)['BNGTOXJ^#M8U:STBV
M\4:0VMW<:RQ:2;Z(7A#1^:/W.[?G8=V,=.>E=50!Y7'=>-[32?LMI:RK*EB;
MQ)&A3 DQY?V?'=@<RCUX&:AW^+;V/2X;Y]3F3[3;O&T%FL:RJMT#)]HS\R8C
M"D?=R,Y!/%>M44 <EXV\)VGB&_T*6?3EO3'>!9F(SMA\N3.?]G<5_'%<?=Z'
M.SWRZ=H^H6^L?:KYI[P1O&DMNWG;%#$X?.8PH&<'!XQ4_P 3/&'Q*T/XH^ ]
M+\)^$8-;\(ZC.RZ[JLDH5K% #@@;AGCGMR .2<4?"WQA\2M>^(WCO3?%_A&#
M0O"^GW*IH6I13!VOHRHY(#'''/?EB,@KB@#5\(^$M;\,6_VJVBTU9KB**.2Q
M1I885"AB9#G>3(2P!X P.IKG;S0M=?0==AU?3KV;4I[WSK6XLY6N464V\8W!
M?DVKD%5.,(>>"-Q]CHH X?Q+>>);76]!:PCGD@>,+<V<* IO)&2TQ4C !/!V
MYQD$GBN234OB,=%C9Y+A9VG_ 'SC3@7B?RR=BKGYX]^!NZ?[6"2/9:* /)-0
M;Q<^J7-QYFI0WD,$R$I9J]L@,\.P0[06):-3DG>5.>.U>D>&;B\N_#^GS:A!
M+;7SPJ9HIBI=6QSG: ,_0#Z"M.B@ JGJRH]A*C]'&WIZU<K-UZ4PV>\ D ]A
M_.@:W.;81"-_.<1[3@2#VX ^E?./Q6\&?$1/C?I>H>$]$\.^'[>:;;<^+UW3
MW MWA82R/$0$+J %3=D$D'GMZ]\2)/".J:,VC^,[W[+HFJPM%-YTKVZOC)9"
MX((XSP",BKJV^@>%_#\+7<RV>EZ; ((YM0<XBC0!5//7@  ]36<HRDTX+7T3
M7]?([Z<O9:M7NK=?\U?T9T&A6[:?8VMI>74NH-!"$:\EP9I^/ON% &X_[( Y
MJ2*\\^WAD9#;!QPLA&X'WQW]JX;Q%XJOK72]'7P7:)K2:CG[+?EV>T4]!O(^
M;;GKWXQ67X@GNS\-(-&\46T=IJ<Z$7BZ/<' D+$ P.0"JGKDC(Y!K2_O*+W_
M !_R^1"IW7-W?]:'?ZGX:TSQ'?QR:AIT-U( %\Z1!N1<Y !ZCIZUG^*/#UIJ
MEI9R3W>H:?#I4IE@:QN&CD5BI0$L#E@ Q.#G/?I69=-KFN_#Z&'PU<VNE:M+
M#%&OVTM,D>T@-EA@L=H//<UUD-F;>UM5OG^V7 C59Y%7 +  ;@.V3S4.$8W<
M7K?S7S_IB4I*UWL;%A;!?#@MEN&E,84>;*^YOOY&3ZUYAX=\(6&@>-O$WB"*
MR6#7-8,*7][N8^>D2;8]JYPH4'G &37I*:>EOX>NA;1>49)!*Q/)D._G.?88
MKR[Q/X\TGPMXO\,>&62\;5]=,D-D]O:--' J#),KCA$[9/U/K751525U"^VO
MFEJ[_=?Y',WNNYT\UO-*C%72W4$9V'(P.OYU%<0S%<QSNH#C!4!LKG)X(]J?
M<7<4*%I9%CMT!>Z=FP$C"G+9_#^=9ND37]Y#]MG'DI<SK+;VLBC=%;XPN[OO
M8?.<]-V.U2WK8J,7R\QE)\-O#6CZAXAUJ#181J>MH&U.XLX]L]^J]$?GYN"0
M>F<\UT%C]GTBUMK/3+54@MXEBBA4 A$ PJX] .U7%MWB+,[%@'PJJ<X'T[]*
M\)^)W[2VA_"WX^>$/ &J0*&\1VDUQ->*=OERYVP1Y)Q\Y5EZC!V]C513>B'[
MU3S-SX._"OQ=X(\=>.=6U_QI>^)-)UZX2:PT^[)/V)?F+*5Y4 ;@!CC"CO7N
MW@^%8M6D$8!C$)!/J<C_ .O7)^'M>L=?@DN=(OX[^!+B2T9UR52:-BLBGW5A
M@^]=IX0S).9&=2?+QM QZ9(]1FLN1Q6K;?=[DU)N<FY)+TT_ ZNBBO*OC;XV
MO/!(M+C^U;[3=-DMIA_H-@LK27 *>6IE8%4SDX7[QP<!L8$F9ZK17)>)9_$]
MAX6TA]+>*\U=;JQ2]S;<31M*BSE5W?N_E+-GYMH!X/6N#\,^*OB7-JUL+O2Y
M[FWV;EBGM!;+.3;NTJO)M/E;)Q'&A_C5BWSXS0!O_![_ )&#XI_]C8__ *06
M5>E5Y)^S[>:E?W'Q*N-7TU-'U%_%<AFLH[H7*Q'[#98Q(%4-D8/08SCM2_'_
M .,^N_"*3P-;>'/!-QX[U+Q+K@TK^S[2]BMI8XQ!-/+(ADPC,L<#D*S*#CEA
M0!ZO-*(8GD8,0BEB$4L3CT Y)]J\7_X:T\)_]"S\1?\ P@M8_P#D:N/L?VD/
MC;+=6*7/[,OB&*&35+BWN'C\0:<Q2T4'RI5!E ,A(&58JG'RNV13=(_:1^.%
MS)H@OOV9-?MQ<-=B_P#)\0Z<WD!,^1Y>Z5=V[C=OV8ZKOH @U#XA?!75;OQ5
M=7?PN\9W%QXJA6WUN1_AYK!:_C7[JR?Z/R!V^E6-/^*7P=TK7M"UJS^&?C6W
MU70K$Z9IEW'\/=8#VEJ1CRD/V;A<<8]SZFO5/V>?BIJ/QH^$^E>*M8\/-X4U
M:>>[M+S1VN!<&UFM[F6WD7> ,_-$>U>D4 >*?\-:>$_^A9^(O_A!:Q_\C5[/
M!,MQ!'*H95D4, ZE6 (SR#R#[&I** "BBB@ HKRSXY?&75?@[:Z==VGA&7Q1
M;7DHMU2TO-EP9B"0JQ"-BPVJ26R *[SPCKY\5>%='UHVKV)U"SBNC:RG+PET
M#%&/J,X/TH O:EIUMJ^G75A>0K<6=U$\$T+_ '71@593[$$BN=U'X6>%=6GN
M9KS1XIYKC =V=\@=PAW?(&_B"XW?Q9KJZ* /#OCA8VUK\5_V?O)MXHMOBRY4
M;$ P!HNH@#CMBO<:\5^._P#R5?X ?]C==?\ IEU&O:J "O/-9A^*YU6[.E7?
M@U-,\UOLRWEK=M,(\_+O*R %L=<#%=OJ6K6FD6[37<\<*A20&8 O@9(4'J?:
MO-OV>_VB_#O[1G@9/$VC66I:'&U[/9+8:Y$L%RS1-@L$#'*GU!ZA@>5- $WD
M?&?_ )_? G_@'>__ !VCR/C/_P _O@3_ , [W_X[7I]% 'G6DP_%D:I:'4[O
MP8VG>:OVE;2UNUF,>?FV%I" V,XR,9KT6BB@ HHHH **** "J&M2>58.P7<<
MCC..]7ZS/$1_XED@R #P<CJ.XH&MSR'XK6</B3P^FGW%V;&TNIU,KQP"X>2)
M#N9$!!"LQ"KNP<9XY.:Q?VCOA)JGQA^'-KX>T#Q&WA._FD21;HQ&1HEQAEP"
M#NP<#T-=]X1EN;S3K*XU&S$-XC2*KQ@$1!F.,$<9V;0<5)XH\0:;X;TO^U;R
M!C+&CJ(7DVJB+R[G&>@YSUZ5$82E)N&[[';SNFTNUSG=/\+O\+_A=H^AZ'J<
M6G0Z%;[7OK^$SK(<99W7(/+'( ))S@9--N?#VI>.-"M6O(X+'40RSQEH>$BR
M.'&2=Q!8X!PNX#DKD^=>%_$UE^V1X&_MC3M3U30O!-]YEG:P6Z&*\-U#*5:Y
M\X'[H&-@(Z\\$5[%)X975;"?3+>[NHT,"6_VAV.7V# )/!^I[FG:4:CC*ZL_
M)_/S]-C5N,()W3D]7H]/+S\R#2-/GT:&8R3YL-B-'#<J%>*52=S%EZAAM..V
M/>NALO+U6>W:";?;.2S%#U '4'ZUGGPY'<:-;Z1+([BS\OYTD*NSJ01D@YQD
M<CN.*T+9Y8H+K8%MF3*G:H(+'T_/]:3;N[NYRNS5UN:37UC<Z=J-C9722SV;
M*LZ!\F-B=P#>G%>;Z'K]G>WUSI0U"W?50[&XMXW'F!1@ LN<@' JKX7AL_@Q
M\/\ QCXB\4ZK)+IWVA)I[IHF>0+YFT$A1ELEP.!7G]_\ O#.D_$JW^)&@I>:
M3X@"2322QW#&*_,BY FC.>#N!^7'3GI759**G9N+Z^=E^7D#A'FE#F]--S7A
M\0:=\0O&&O\ @^ZO)K630=0@N&6UF"M<KMWB%A@_+D_,IZ@#M7I4QDENS,TH
M"O\ *BJ,'.>3G\/TKR7PE\*8O"_Q!N-;M[RZC^WEKZ:+S2Y:X. 02> ,8&?0
MFO798)+JQ4H"K,I*J&(YQ^G6LX6:YNO4JO)748OW5^N_WV*-_<7,%K<%'+L&
M(7@$IG^>/\FOG/\ :=_8UL/V@#'>P^()M)U>2[@G=;C#1I&J@2"-L;D8J,@'
M*Y'0=:^E;:QD(EDED4, %7')/'/)K(N3'H=Y?7^H7,<%A&BS[QN+':N&:7^'
M'3&/QJI:+31DTIN$KP_+<T]%T>VTG1[>SC9D55\L,S9)P,;C[D<FJ?PLL?%-
MOXX5KZX2#18;"6U:Q2/*2S+(ICN(VR2H*$J4;N 13?!FMZ3XJTR9--#K;V;+
MC>I!4GD?45V_A-S'K!MS&5*6Y;<&&WJ.,=??-6KTHN%C%O5W.RKR?XT^*9=)
MU#2M-OH,^';ORWN&1 SRLMQ%E<[@4")F3."#@ XS7K%>7>.])U+4?B-;_8;3
M5?*DT.>WFN[ 6Y3:TR?NB)QMR>O!SQR,8KG(/3H91-$DB@A74, >O-/K/\/Z
M5%H.@:;IL E\FRM8K>,3,&DVH@4;B."<#DCO7(Z;\8M+N]2^RWEK/H\0^T%K
MZ_DC2VQ"SJY$FX@_ZJ4_2-FZ<T 4_@]_R,'Q3_[&Q_\ T@LJPOCE_P E8^ 7
M_8V7?_IEU&K_ ,!-<TWQ)>_$S4M(U"UU73I_%<AAN[*99H9 +&R!VNI(."".
M#U!JA\<O^2L? +_L;+O_ -,NHT >ST444 >-?LE_\D?F_P"QF\1_^GJ]KV6O
M&OV2_P#DC\W_ &,WB/\ ]/5[7LM !1110 4444 >$_M=,\G@WP[9C2M0UZ.[
MU?R9=,TF+?>7"?9;@L(CY,I7 &6(494,-PSSWGP2\6:)XP^&.@77A\31V$%I
M%:_9[F-HYH&2-1Y;AE4Y *G.T @@@8(KBOVK?"FO>+/!-C9:'IUUK,T]_%&;
M>&*W=;8[)<3GS(V8+N90Q4@[<@=3FKXLL?$_@WX(^'6\-^%M1^W.L$NLZ3X?
MN8;*[WNJ^:P9('R0_58U7CH0HQ0![S17C?@?5_%>I_ #4M7L+R_3Q&]M>-96
MNK1?;+FSFB:1! _R0M(X:/&'7(8D98 9S?$?C#XC6VMW\5M!?QV"O<>9)!I?
MFFW54S9^3\A\WS6P)/O;/]CK0!<^._\ R5?X ?\ 8W77_IEU&O:J^;?B?K/B
MF^^,_P  K?6O#EOIUDGB25UU&+4%D:68Z'?ET\C9E &+C.X_='KQ[]XI\00>
M$_#.KZY=))+;:99S7LJ1 %V2-"[!<D#.%.,F@#F?B_\ $7P#\+/#4&O?$34M
M,TC1C=):176IQ[T\Z3.U1\I.2%))Q@!23@ FO//AK\6_!:_%Z/X71:!=+XKC
ML+G7$U./2U%EY!NI%"K./XL$=!M[;L\5R.L?M$/\6?"UBNK_ ++_ (^\4:!=
M>3J%M%J%AID\+D8>*4*]T1GD$'&>:G\%_M.>*[#0EB7]GGXF38N;D[XX=/QS
M/(=O-T.F<'CJ#0!]245YQ\$_C.GQFTSQ!,WA?6O!^H:'J9TJ]TK7DB6XCE\B
M&<']U(Z[2DZ$<UZ/0 4444 %%%% !1110 5D^);*74-.$$4C1[Y%#E%R2N?F
M'MD=ZUJ0G% T[.YYQX@\ WFN^!=5\.6%_=^&_M<#6]O?:>2)[0<;&0GN,<^H
M)JD/A=]O\*Z3X;U\R^(C'"D-YJ%TNUKH+][?CINZ8%>GW1<VTPB8"78=A)Q@
MXXKQJT\&>.M%T_0KZ/7+W7-4M+6-M0MH]2*Q7$WVFW9U"R,5YA%RN20,D8"\
M8=W;EOH:JI):K_@_?N=MX;\!6/A6SMM*TC3K72=)LXREO!9Q>7'&,]%4#BN7
M^('A/XH7US:#P)XJ\/\ AJU$+1W$>L:%+J+O)NX=&6>/8,=B#SS3;7P_X_OC
MXG22YN;"&]CNA#Y^IJTB2,\C6[6Y0'R@BF)&!.#@G'&6QY_ GQ,GO?L=GKMY
M968N5\^\O=2,PFA"+M\L)AU*D/NY7=D=1TE))61#FY.[,'P]\)/C_H,5PD7Q
M3\&SO<3-/)+=>#KAW)./ES]M&%   'I]:Y_X@6_[1_A*72H;;Q5X:U\7]XEM
M</IO@.ZD^QQMG]\V+L@A2!Z=>M>\-I'BFV\9Z,\E[<ZCI,%K%%)<1W,=NAD5
M7$SS0[3YA?,94+@*0>5_B[S</44QJ?O7DKG-Z3IE]9>&TL]3:/4[Q8(Q/,D6
MV.:7)WL$.<#/..< CDUS^J^$]1NX9,Q^9(YW#:Y&"!P,XX%>B9S2TT[*Q%];
MGC'@WP#XYCL)W\57>CW%Z;YVM%TN*2-([/C9')N!W28+9(XZ5UZ:!J$2RAT$
MNP!@V"2?8<5W%<?\3X/%]WH$,'@J6UMM5:Y1WN;Q@(TB3+E<8.=Y58S@<!V/
M& :TE4<I.5EKVT$56\+WC?O! BN1N"%B>?RX-1#P??/<%W6+RRIW1\D.#U#<
M>YZ5A1#XEWM_X:EDM+BS2"^F.HPO<VQBEA:?*'<I+$)"2H&W)(Y X<>N5#E?
M<=['DVB_#W5O"+:M=Z1% 8[E#+'8,"N) #A<]ESCZ5N> =/U=KFUO]>L%M=6
M:U83"(DI'EE^7/0D[<^U=[13Y[JS&Y7=^H5Y1^T-?3Z-X=TO4;>365>.\\AD
MTIY@K+(C)F7RG0X4L'!S]Y5'0FO5Z\?_ &D+03:-H4L4\EM?+=3+#)"J[ROV
M:5G7>_RH"$P<@D]!R:@D].\-%V\.:49'NI)#:1%GO5"SL=@R9 . _J!WS5:'
MP7H5O<V5Q'I=LDMFC);D)Q&#NS@=,_._/7YV]35/X9:]9^)OA_H.HV#,]K):
M(BE[?R#E!L8>7_#\RGCIZ5N6^K6-VZ)!>6\S/N"K'*K%MIPV,'L2,^F: //O
M@U&D6N_%)$140>+'PJC '^@658GQR_Y*Q\ O^QLN_P#TRZC6[\'O^1@^*?\
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MGC+Q#J]I+XBEM$T6^D@-C;E-#OE\V,+$) YV$G=(P^=N.F/:OC5_R1OQY_V
M+_\ ])Y* &_!'_DC'@'_ +%_3_\ TFCKM:XKX(_\D8\ _P#8OZ?_ .DT==K0
M!XM^S]_R4#X]?]CNO_IGTVO::\6_9^_Y*!\>O^QW7_TSZ;7M- 'DOCW6?BAX
M<^)%MK6G6^@W7PTL]-DBO+":[>/4+B[=TV2H?)*JJ ;=N[D.Q/(7&Q\&]4^)
M&IZ7K)^).A:3HE\NI3_V>NDWQN5>S+$PA_E&'52%)_B*YP,XK:^)O_(C:I_N
MI_Z,6NHH **** "BBB@ KP[XZ^ ]>\3_ !:^%&MV%R+?0M!;4Y=4'F[3)YD4
M*1+M_BRP;Z8KW&N+^(][JMHNGKIFE1ZD)=ZRF2Z$/E<I@X*G=GGIZ4FVE=,U
MI-J6GG^1AS9C2-64;6&<]3D'J*J:M'<SZ?<II\ZVMX,&+>NY-W7##T/0XYJC
M8W>N7.HO'J6E6EI9Y+>:MWYKY&-H"A1P>2<D8]*UBK-+A(P7 .-K9S[^U9O5
M:&[7*]?T/-/AI\79]>UC4?#7BJPB\-^+;&64_82Y,-W;J ?/MY" )%&>0#D8
MR0*D7_B[,UEJFE7,FD:3:S17$<S6:F2]5'W%&WC*H2/E7G'WSSMQ@V_@SQ/\
M1]6\2Z9\1-%TJ+2;2Y27P_K&D7#)<Q[D(WKGF.1#CD'G.,8%='\+?#OCS0M6
M\1V?BOQ);>)=*:2)M'NS$(KJ&(+AA,%4*6]QU]!6>DY14]UY:/\ R?=/3L^A
MUWA!2E#27KLNMM[W\W=+H]TS3O@1X3T;XCWOC2VTL)J5[$R7$;@-#)N/S,4(
MY)Z_6NH\=>,)?!OA?4=2MXXFU'Y+6T$X&&ED8)'Z<98$CT!KI8[&27[K9!'R
MD]#[BL'Q)X(M]<U1+S59)+FS@C'EZ4Y#6@D&X><PQEGP^!DX&,@9YIJ*IQY:
M:.=5/:33JN]OTZ':>"KZ6]T2^AGAE$UO,BO/(FV.=BB,6CYY&3CGN#5XD&*,
M+\\K'YL#)Q3/"UO%:>&FA1&6)2%"L23C [GK4EE=K$TCEALVD[^RX[DUNEI=
MG*]W8\^^)/P6T3XD:CINK3F2P\1:3N.G:E&=QM68@DB,_*Q^4<D5VEG'-+#Y
M<LA28#;YP')Q_%CMG^M<+XZ^->C^$%6*VMY?$-ZC![BSL'_TA8S_ ,M O4J"
M5S['/:OE.U_X*+:EI^NZE%\1/ 5]X1\)WZ26]EK6C%KPQ$C'SDX!(!SE>_8U
M47SOV7.K]$VD_DG^7ZG6J->I34N5N*ZVO;]?P_,^T5U&XU/76L;$QK::<V;V
M=QPTI'RP)_M#(=CV^4=2<<QJVK>*[+XG6-O#92WWA^5-KQ0J%120 6>0]U.3
M],#K7(_ ?]H3X4>,O"-Q!X4\6I=6N@Q(+HZFSK,-Y.UW9P"[.V>0"237J'AG
MQ=9^)IIS96M[' AXN+NW:**;L=F[!/Y"HE"I2=I+E?9K^OZU%*R<G&-XK2]O
MQ]?^&/*?&7PSM_'/QAO-6\:>%;&7P;H^AR6FG:W+?R9Q(ZR7"F$,%'*\LP/"
M#%>A_LU18\'W$J>+[CQE:R7<WV:[N81$;>,;<0 >BC&#Z'BNIU"RMM0MI;:Y
M1)X)%,3V[+E=K<$$=P>:U/!>F66AZ9'IVGV4-A9P B.&! J*.. !6GM9M<CV
M_KIW\U8QE*+IV2_KJ]=;OK;3\#HZX+XG^,+S1#9Z3INEKJ>HZBK>2KQ^8J;<
M;B5. WRENAS[$5WM%2<Q5LWF;38'F"K<&%2XB0A0V.<*><9['FO)O#'B#X@R
MZK8S36=[?6,\=P4L]1MULY$(#F-KB18RH)*H-J#@2C_6;&KV.B@#R7X 7.IW
M=S\2YM8L+?3-2;Q7(9K6UNC<QQG[#98Q(40MQ@_=&,X[9JE\<O\ DK'P"_[&
MR[_],NHUN_![_D8/BG_V-C_^D%E6%\<O^2L? +_L;+O_ -,NHT >ST444 >-
M?LE_\D?F_P"QF\1_^GJ]KV6O&OV2_P#DC\W_ &,WB/\ ]/5[72?%7XS6/PIO
M/#ME-H&O>)-2UZ::"RL- M4GF8Q1&5R0\B  *">M &;\:_BIXE\">&K\^$_"
M/_"0>)QL:QL;W4+:UANHQ+$LT@)EW[464<[?O%0< YKO]&U>ZU,N+G1KW2MJ
M@@W;PL&)Z@>7(_3WQ7R'\8?&NK^)/B7X8\=+\)?&5O9Z%87-C(+[0HFNF:>2
M+:8Y%O-JJ-F"I4[MYST4CO?AC\:/%G@WPI'IGB3P-\4_&>IK<SS'5I_#UG;.
MR22LZQE%NR,(&V Y^ZJ^E 'TG16#X#\96?Q"\&Z/XDL(+JUL]3MUN8H+V,)-
M&#_"Z@D!AT(!/UK>H \*_:KT_6+[P_HK:5J+0P)=,EY;2Z1%J5J$>*0"6>(V
MT\N,@Q@QKC,OS<5ZA\-();7X=>%X9[2YL)H],MD>UO HFA81*"C[550PZ'"J
M,C@#I61XH^$.G^+/&?\ PD5UJ^MV4PT]-/$.DZG/8@JLCR;F,+J6.7P <@8X
MZFNUL+-=/L;>U1Y94@C6-7GE:61@!C+.Q)8\<DDD]Z )Z*** /%?CO\ \E7^
M '_8W77_ *9=1KM_C5_R1OQY_P!@"_\ _2>2N(^._P#R5?X ?]C==?\ IEU&
MNW^-7_)&_'G_ & +_P#])Y* &_!'_DC'@'_L7]/_ /2:.NUKBO@C_P D8\ _
M]B_I_P#Z31UVM 'BW[/W_)0/CU_V.Z_^F?3:Z[XN?%FV^$FEZ+<RZ%J_B2[U
MC4X])LM.T1(6N)9WBEE'^MDC0*%A?)+>E<C^S]_R4#X]?]CNO_IGTVC]I+_D
M+_!O_L>K?IC_ )\+[UH YSXA?M!:_<^#M2B?X(?$6W5E3,DL>F!5^=>N+TGN
M.W]:V=2_:9UG1].N[^\^!_Q(@M+2%YYI3%I9"(H+,W%]V"GI_45#^T1IWB+5
M?A!KMKX1UVR\-ZY(8/+U.ZMUF6!1,A;" #+$;E&>/FD]!71^/!*OPV\2"X:(
MW@T:Z\PVBKCS/L[;C&",]0, ]O+SU- '?^$/$UKXT\)Z)XAL4ECLM6L8+^!)
MU"R+'+&KJ& ) .&&<$\UKUP7P!_Y(3\./^Q;TW_TECKO: "BBB@ K$\2H72$
M @'!QQGG*]JVZY[Q:TB) T8+$!CM'U6DRH[G+"/RY'C_ -8JL>IZU4L]!CTK
M[6ZK/.+B8S/N)8*3_=]![4?:"K-]X%N6)'4U/J/AB+Q/I0LI+VYMR)$E22"=
MHV##U*G)'M1MOL=%['SM^V9)XF\'_#;4/&?A3Q'-I5[9);6LENJ;D2)KA3+,
M>O(7 Z<#)R*]OTF^BT_PCI-QJEY'-=/:0R7)M_G^9E!X Z@UJZE\-M.NA&M]
M<R75FD!BEM78XF_WN<'C.01S7&_#CP9#HOP[LO#EW9',:2VL@9RS20B1@J$Y
MR1L"X!/3 K%-IN-V^J_7^O,V<HRII=4_S_RM^1C^#/CSJWQ&\87HT?3]*B\"
MZ7<3:?<WET["YEN4 X0' &#P1ST/->G27EQ<Q2Y<1!N54+GY>_\ 6N<M? >A
MV^E/80:5;164<QG,"KM4R'^+ ZGW-:[R$H<X,:XP/[M;WYHJZLS&2AS>YMYG
M::!(/^$?E:,E@6!&1TZ52U7PE;^*] 6SN;FYA5GWLUK,T1;@C!V]1ST-4F\.
MP^*?AWJ>BR75W80W&(OM%C(8ID&5(*MVZ8^E=+HSK]F$8/S)P??WH:3CY_UU
M(NX^]%ZW/C;XR?L@Z+I7C>R\76FLZ[8.MQ"]\T%^PCF@3.5<,<;>>^?0=:Z'
MP;X$M_%?AP3:7 )M)L;MTA6;]]%(=K*9 #D@C/(( )XQ7U/K=O87MJUM?PI<
MQ2#F%P#NK \/G2&T=(M 2W33_,8_Z.P8/)G#9/KD=Z\^IA?:Z3NUYMNWWGH+
M'3Y-?B[_ -=3Q?X1_LZ^$M"D@\1R^'$LM;6Y\\$H(V++O5&*I\I!#%@#TW>U
M>ZS^8(T"#=NP=N!TKG[7PS<VOB^]UIM2N)89HEB%@1\D9&.1S[?SK1M?$6G7
MVO/HZ7]M-J%M'ODMXY@TL:^K <CDBNFA14(V@MOZ^XY<16E6GS3E?^MC2:)4
MC+$^2YZ@#DGW-:6AB:69II)49%4HJ(,>AR?>L;36MKJ[:U\_SI8.9$&?E],F
MN@T58]DK(%SO(++_ !=,?X5O:QRMV-.BBB@@*Y3Q!\1]-\,^(H=,OUD@A,(F
MFOW95A@#+.Z[R3G!6VF).,#:,]:ZNJ,VAZ=<ZM;ZI+902:C;H8XKIHP9$4]0
M&Z]S^9]30!X-\*OCU\.-.USXDR77CC0;=+OQ.]Q;M+?QJ)H_L-FN]<GYEW*P
MR.,J1VK)^,'QP^'NL?$[X)7-EXUT*YMM.\375Q>31W\92WB.D7\8>1LX52[H
MN3W=1WKZ=KFO'7C:'P+8V-W/9SWL=S=?9REL-T@_=22950"7.(\!1R2: ,"7
M]HKX60QM))\1O"T<:C+,VKP  >I.^G_\-"_"_P#Z*'X8_P#!M!_\57*^./C%
MX3\9^$Y]!;3M5U:Q\0#^R9([$HCMYJQB9%</]]$G0D#N=H)8$#7;]I+PB(A<
M(NH36,KQ16]Y';@Q7,DA<1I&=V26\M\$@+\O)% 'FW[,GQR^'GAWX6S6>I^-
M=#L+K_A(M>F\FYOHXW\N35[N2-\$CY61E8'H0P(X-0_%CXW?#_5_C)\(+RS\
M:Z)<6=A<ZJUW<17\9C@5[!T0R'. &8@#/4D5])Z!K=KXET2QU6R+FTO(5GB\
MQ"C;6&1E3R#[5P&K?'6PT_QMJWAF*Q,]W:?9XK>8S;8[BXDEACDCSM.T1_:8
M&9N>&?C*'(!Y;\0?VC? =Y;3Z!!XN\(":[ DMYKCQ#;Q+(D<B,S$$';[ GW[
M'%[X7_M<_#WXD:(FLS:SI_A:!YI(TM=:OXHKG*2,A+1'!56"AU)^\K \<BNB
M\=2^&OB+#K]IKGA&QU/Q-I5NEI;-9W,37<AD=M\-O<%0Z#]W\P'.,@KD8J6?
M]I>U6YNDMM':ZM88@WV[SG2%F5(VG7_5D_(9 F "0V-P4,#0!D_ CX]_#C1?
MA!X5L=0\<Z#9WL%FJ2P7&H1K(C9/# GK7K/A+XI>#_'MU/;>&_$VEZ[<0)YD
ML5A=),R+G&2%)P,\4WP-X\'C:?6473IM/2PE@2,SNI:9);>*=7VC[G$NW:>?
MESQFNKH **** "N>\:^,[;P3IT%U/:W-Z\\K116]J%WL5BDF<_,R@ 1Q2-R>
M=N!R170UE>)/"VE^+K 66K6HNK=7\Q5WLC*VTJ2&4@C*LRG!Y#$'@D4 > _'
M+XJ>#9/BA\!I'\5:-;_9_$TUU<1W&H1126\4FB7Y1I59@4!WH!N Y=1U(KKO
MC#\9_A]>?"/QO;P>._#4T\NAWR1Q1ZQ;LSL;=P  'Y)/:O4CX7T9OO:38M\H
M3FW0_*  !TZ  ?E63XEM?#'A'0KW6;[1K,6EFGFR&&R1GQGL,<GF@#@_@U\9
M? %E\(/ UO<>.?#4$\6A6,<D4FKVZLC"W0$$%^"#VKL/^%W?#K_H?O"__@YM
MO_BZIWOQ!^'=AIC:A)>:6UJ%F97C@#;Q%C?MPO(R54'H68 $D@5S_@'6/AGX
M,\(Z1I\.K6,L-[)<7D#7T"K-^]FEG<.H4; A9Q\P& G/0F@#B_@5\7/ FG^.
M_CA+=>-O#EO'=>,UFMWEU:W42Q_V3IR[UR_S+N5AD<94CJ#1^T'\7/ FIZQ\
M(?LOC;PY<"W\;03S-%J\!$48L;T%V(?A<LHR>,D#O7M>B3>#?&#71TN/2-4:
MT?RIC%#&^P\X[=#@X(X.#@\5S@\>> X=8U;3;;2XIM2T^]ATXP6]@FZXFE#$
M+$< , 4D#$D!3&X)XH ^?_VP?C9\+)?@EXEL?$VL1:[X?=[;?'X>\0V_VBY;
MSXRJHL<_F8# ,>,8C8]#7?Z]\;/!.N?#/Q)&OBS184?1;A;87'B*T>2Y#6[A
M<%)R0QR.2 <N/[M=9X_NO!?C3X?^)K._LKK2H=/-JUXB:>B74;$Q3HBHP.2<
MJ#VY//>K<_Q?\ PZM_9B6"W-\8X'2*WM8I/,,IC"*&#;?^6R?,2%/S ,2I
M,CX%_&;X?V/P2^'UM<^.O#5O<0^'M/CDBEU>W5T86T8*D%\@@C&*]8\.>+M"
M\86TMSH.M:=K=O$_ER3:==1W"(V,[24) ."#CWKFO"6L^"?'5U=1:3I=M<>3
M:VMZTTFFB-)([A6:)D9E ?(0YQG!X/.1796.FV>F1M'9VL%HC'<RP1A 3ZD
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MHY])LIDBV[%>!2%VKM7''8<"N+^(]Y<#4-4MA<2K;_9-.;RU<A<M>LK'CU
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M"T'A.^O=)O[9IYM?C+>1;,!(=I^0KQY: [G5LS1[5?#[>XHH **** "BBB@
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M1^T;X%\*>)=5\&:QI>OZ_>VEK%<:A:Z5X:N]4@BAE#&/S6BB=!N$;G!_NFO
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M\*]$U-M4N]8@OUDO+6YOH9HYA;22L\$;><!(Q2-D3>_+[=V3G->3>-_B39>
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ML8_MW4>O_8(O*;\9;)K6ST?QB+R\E@\(SR:K-I.FZ.FHWFJ*(RHMH0WS(Q+
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MU^,-'\-^"?$-KJEZ+"XE\7^(;J..XC="\,NJ7,D4@R.5=&5@>A# ULV_Q/\
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DD5VBC"X(?:BKN)Y)4 &NRHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>aciu-20221231x20f035.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f035.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %/ E@# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"OMJ>%HY%*-7'0555(Z):V>CZZ/32Y]M3H4,AG?'0555(:6UY6[.^NCTTO\
M<;_PJ\93?$/X;>&?$US9G3[C5;"&[DMN<1LZ@D#/./3VQ754R&&.WB2*)%CB
M10JH@P% X  ["GU\7)IR;2LCXIM-W04445(@HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME8L[JCDX/.!SC '&0" #LY-+LIKV.\DLX'NXQA+AHE,BCV;&17D/[1?QPO\
MX46MG::/:PRZG=Q/-YURI:.-%(' !&22?7C\:]HKC/B9\)?#OQ9TN&RUZ"8F
M EH;FUE,4T>>H##L<#(((XKT\NK8>EBH3QD>>FMU\M/QZ'K977PM#%PJ8Z'/
M35[KY.WW/6QPG[+7Q^N_CMX<UIM4L(K+5]&NUMKAK;/DS*R;D=022#C((R>G
MO7MU<A\,/A3X;^#_ (<.B^&;(VMJ\K3S22N9)9Y3@%W<\DX 'H   !77USXN
M=&I7G.A'E@WHCAQ$J<ZTI45:+>B\@HHHKD.<**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKSK
M6OC?I&@ZQK%G<Z7J[6FCS1PZAJ<-LKVUL756!8AMVT!ADA>* /1:*S'\3Z/%
MJ46GOJMDE_+'YL=JUP@E=,9W!<Y(QSFE/B32!%YAU2R$?D"YW_:$QY1.!)G/
MW2>-W2@#2HK+M_%&C7>I#3H-6L9K\AC]ECN$:7Y3AOE!SP>OI6I0 4444 %%
M%% !1110 4444 %%%% !1110!Y=^T7X[U;X?_#TWVCMY%S-<I;M=%0WD*P)W
M#/&20 "?7Z5XA^R#\>/%_C+XD>(?"_B'47UC2H+-;J*[N=HDMYC($6+?QN#@
ML0IR?D..,U]1>/);>W\%:[/=:2NO0064T[:8RAOM6Q"WEX((R<8''6OR]^+?
MQYL/BGX7M-$\$^$;;X?>'8+I=3ECLW7[3<W2*0CNZ 8V9..ISWXKZ_+O9XK
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M7Y@PXYP<@L.,U[#10!X6?V=+N+P]?Z9'J=I-]HT6TTQ99H3\KQW+3.<=D.[
M4=,"K7B3X%ZI?Z[?:Q8:A:+/)JLM[#;2/+#'Y<EJD#!GC^8,"F>.""0>M>U4
M4 8W@SPZOA+PII.C(4*V5ND.8PP3('.W<2<>F2:V:** "BBB@ HHHH ****
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M48S:U3OLFWM;7=6./O\ Q%K6@^'M'OKNRM#IH9;:#3KE,W,L2H3O+_PGY>W
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M8]J;8:=::5;+;V5K#9VZDD101A$'X#B@"Q1110 4444 %%%% !1110 4444
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M.*H'7?BW?^,+;25L5L]+:[GE;5$A1%-KYTXC0EEDQ($2//RX8,I!4DX]OHH
M\]\#>%M;?7[G7O$&LW]U=V\MW86UM)''#";;SOW;[4 RQ50=W4Y[=*]"HHH
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M1RO*Z.7NI4I7]_N^W;R5WY^9B#PK,!_R,6MG_MO'_P#&Z7_A%IO^ABUO_O\
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M-TF[ 5V.<M.Z]03C SZFO0*^WK2DIJ]M.VWH?)6OH<[;:%KL=M$C>)7#*@!
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M7#DG(=U/(!XJOJWP)\;M>RZI9_$26/6VMTLX+V\EE9HU()<+S@$R%F''3"]
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MG;-H4CLT;-=0K);AEYP)%SG(YS@"OEKQII/B6SU::X\56E\E],PED?5$)\P
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M6I%Q,L8)9R"[%SG<3&6&W:-F%49.?;_#FF3:+H&G6-S=/?7-O D<MU*26F<
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MKSU"D!N]>@UA^-/%MIX(\.W.KWD<L\<3)&D%N 9)9'8(B*"0,EF Y- &'/\
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MF_97=E\SX[,<8L?B'74%&_3^K!1117OGF!1110 4444 %%%% !1110 4444
M%%%% !63XJ\+V'C+0KG2-21VM9]I)B<HZ,K!E=6'1E8 @^HK6HH X2Q^#>A6
M5RMR\^HW=W]O&I/<7-T6DDG$!@W$@#^ G@8P<8QBJ<?P&\-B&^$\VHWES=+
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MANAU@<;C_L-P?Z'\*S^E?*5Z7L:LJ:VW7H_^#=?(]FG/VD%)A1116)84444
M,EB2>)XI466)P5>-U#*P/4$'@BJKZ%I<R%'TRR(*",_Z.GW0, 9QT X'IVJ[
M13N)I/<H6_AO2+2V@MX=)L8X((Q#%&+9,(@Z*..!GG'KS5V.U@B21$@B1)&,
MDBK& '8]6([GW-.!Q3LT79/*ET' U3UO28=?T74-+N2ZVU];26LIC.&"NA4D
M'UP:M452DT[H#\\?"?\ P33\5V7Q=T:^U?Q#I?\ PB.DW\5X+FU=_M=TD3AT
M01E<(Q*@$EB!SC->X?\ !0;X>>+_ (B_"W2D\,65UJ]M97[7&HZ99 M),A0A
M'V#[X1LG'.-V<<5]/YHR0<YYKZ*>?XNMBZ6+K6DZ>RMIY_/^D91I1C*4ENSX
MB_X)H?"CQY\/+/QOJ/B33KW0/#NJ-;BPTV_0Q/),N[?.L9Y0;2JY(&[\*^RO
M$>L2:3IX-M&LU_<.+>TA;H\K=,_[( +'V4UIDDG).37/VZ_VIXRNYGYATJ%;
M>(=O-E&^1OJ$V+_P)O6O.QV-EF&*GBIQ2;Z+[O\ AR:=/V,.1,T-#TB/0M/6
MW1S-*S&6>X?[\\I^](WN3^0P!P*OT9Q2%J\UMO5FZ5M$+2$TA.:*DJP4444#
M"BBB@ JSHD7G:G/*>1 @1?JW)_0+5:M'PVO^CW4G]^X;GZ +_2NG"QY\1!/I
MK]R_SL95GRTY,UZ***^J/'"BBB@ HHHH *Y+Q/=>&/%]W-X*O[V*?49X3<&S
MB;,T2J01)Q]W!QC/7WK7\1>((]!M8]L37=_<-Y5I9QG#SR8Z>P'5F/  )JEX
M<\'Q:9>/K%_Y=WXBN$*W%ZJXPI(/E)Z1KM  ]B3R36=2G"M"5.HKQ:LT]FGN
MBX3E3DIP=FM4<[\/O@?H7P^UF;5K>6>^U%T,:37!'[I#U"@#J<<FO1:**Y<%
M@<-EU%8?"04(+HC;$8FKBJCJUI<TNX4445W',%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% $%_;B[LIX#_P M(V7\Q7,VLIFMHG/5D!/U[UUM<O>V
M_P#95XZ/\MM*Q>)ST!/)0^G/(^OM7AYE!IQJ]-G^GZ_>>AA973A\_P#,**.E
M%>0=H4444 %%%% !1110 49-%% "[J 23@#)I*\[^.9U;_A"U737FB@:<"]>
MW8K((L' R.0I;;GVKCQF)6#P]3$23:BF[+=V-Z%%XBK&DG;F=M3T7)&,CBN)
MTR&Z^'.F^)]9\2:L]Y:27CW,.V,;EBPJHO &Z0X5?P'O7B'PLN?%VD:-XO?2
M&NAIJ60,9<LZPS&107B!S\PC+D@>@)K&\)7.HZIXFDTN^UF[/A^YC:349KZY
M:2*!5&Y9R7.%*N%],YQWKY1<54YPI0I4GSUD^6^R:=E=]K[VV1[?]B2C*<IS
M7+3:O;>V[T[VV[L]U\#_ !TT?QMXB_L3[#>:5?R*SVXNBC+,%&2 5)PV.<'T
M/->D5\Y^%/#NA^'(]4\;Z9K]EXHN](C/V>TM@R!)'^17E!^8#YCV]>:M_#;X
MU^)M2^(-EHFM/;ZC::@S1JT%L(FMW"E@1CJO&#GGOFKR_/)TXT</FEE6J/3E
MU5KV3;3:U=T3BLNC)U*N"UIPWOH[[O>SVU/H&BBBOM#Y\**** "BBC!]*  =
M16KX;'_$HB;&-[._YL36(2UY)]EMB&F;AF7D1#NQ_H.YKJK>!+6".&,82-0J
MCV%>EET'*JZBV2M\W;\K?B<N*E:"CU>I)1117T)Y@4444 %9?B#Q#;^'K1))
M$>XN9F\NVM(1F6XD[*H_4D\ 9)( J#7_ !/%I$L=G;PMJ.KSC,%A"0&(Z;W/
M1$'=C^&3Q4>@^&Y+2[?5=4F6^UJ9=C2J"(X$Z^5"#]U?4]6/)[  ">'= N(;
MJ35]79)]:N$V$(<QVL><^5'GMW+=6//0 #H*** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "F2Q)/&T<B+(C#!5AD&GT4FDU9AL8
MESX>\H%K"3R\?\L)"3&?IW7\./:LY)3YC12(T,Z\M$_7ZCU'N*ZRJFHZ;%J4
M05\I(O,<J_>0^H_P[UX^(P":YJ&C[='_ )?E^9W4\2]JFOGU_P""85%,(EMY
MS;7("S@9!7[LB_WE_J.U/KQ?)GH!111B@04444 %%%% !7.?$74=1TKP1J]U
MI1*WT<7R2!=QC!8!G [D*2?PKHZ*RK0E4IRA&7*VFK]O/Y&D)*$U)JZ3V[^1
M\P?"'Q?K]A\1(K=]4N[K1)$EEU 7LY>*) A8S9;[F"!TP#G%=GXK\2>%OBEI
MLF@>%KJ%=6$ZW:VK6QMA?! V0K,H#D9W '^[7IGB'P;8ZQX;U;2K:"#3S?Q%
M&E@B"9.<C=@<C(Y'IFO)?!7P)UK3_'FGZSJ<MO;VNGR^>HAEWM*P!  ]!SSF
MOS]X+,<'3I99-.O3J<RE/6\4]+)W=M-;O?8^G6(PM><\9%^SE"SC'2S:UU[Z
MZ:>H_P"#?PCUC1_%&HZKKEH+6QELWLS:3$$W 8@G< ?NC'?N>*],T'X?>%_"
M>L?:[&TB@U&52J-+,6<*>H0,>/PKJZX[Q9X!GU_Q3H_B"RU1=/O],79&LUKY
M\;@DELC<IZ,0,'BOJ\!DV#P-*G24>9PO:4DFTWV=M/D>)BLPQ&(G*=[<UKI7
M2T_,ZFXU"TLSBXNH+<Y5?WLJKRQPHY/4D$#UQQ5BO*?'/P+'BV\@GBUAHI9'
MM_MUU=0K)-,L*3A&RNT%\S #/ "=#D@^GWJ"ZC-L8A</<@QB%NC@]<^V.M>Y
M+E2O<\V+DWJB2:98-H?.YCA4 RS'T ZFK$&EWUV Q"649_OC>_Y#@?F:H6/@
M2[\.J)-$U>2.7;AH+]3<0'_97)#H/8-CV-7!XFU73/EU;09]HX-SI;?:8S[[
M>)!_WR?K7JT<OYO>K/Y+]7_E][.2>)MI!?/^OU+Z>&X/^6L]Q,?>3:/R7%2C
MPYIP/-LK_P"^Q;^9JG:>._#]Z^Q-6MHI<X\JX?R9!_P%\']*V(KR"==T<\<B
M^JN"*]!8/#K_ )=KYJ_YG,Z]5_:8Z"WBMDV0QI$G]U% %253N=7L+($W%[;P
M =Y957^9K*F^(/AZ)_+35(;J3^Y9@W#?E&&KK2459&+;>K.AHKFO^$LO;S(T
MWP[J%QZ27@6UC_\ 'SO_ /':3^S?$NJ_\?FJ6^D0GK%ID?F28]/-D&/R2F(V
M-7US3]!MO/U"[BM(B<*9&P6/HHZL?8<UAG5-<\2_+IENVB6!ZZA?1_OW'_3.
M$]/]Z3'^Z:T-)\(:7H]S]JC@-Q?D8-[=N9IS_P #;) ]A@>U;5 &7H?ARR\/
MQ2BV5WGF.Z>ZG;?-.WJ['D^PZ#L *U*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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9** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>aciu-20221231x20f036.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f036.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" '1 \L# 2(  A$! Q$!_\0
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M5 ,[R[D#)[*,DUJ2?M!Z'_PJ_4/&B6EV(=.D\F]T^9?+N+>0,%96'/(SGWH
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MZ[N+6920/-CC#J#CL2N/QK<UCXF?\++_ &9?%E],IL]9L[&:TU&T/#07"##
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M-%&\>M #Z*9O']* ^?\ ]5 #Z*04M !11368+UH =13/,% D!&: 'T4PR#-
M?- #Z*:K!J-V#0 ZBBB@ HHIN_% #J**:6P/>@!U%(#FEH **;NQ2!\F@!]%
M%% !12$X&:;YG&<&@!]%-5MW3D4Z@ HHI"<4 +13-XS3Z "BBFLVV@!U%1^:
M*=OH =130X)H9MM #J*8'!-'F"@!]%,$@(S1O% #Z*0-D TM !1110 4444
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M_P# %O\ XNNOV#TH*@"CG8>S7=G(?V5XR_Z#VF_^ +?_ !=']E>,O^@]IO\
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M8Q\I&:CV57LBOK6'6\G^)Z?_ &5XR_Z#VF_^ )_^+H_LKQE_T'M-_P# $_\
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M-&Q>VGRX$4Z[&(4X+#/4>]:X;(R#GZ5TJ2>QP.+6Y)130<]Z4<=\U1(M%%%
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MLG_OFC[9/_?- &WP*./:L3[9/_?-'VR?^^: -O ]J./:L3[9/_?-'VR?^^:
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MR*Q/MD_]\U);74SW$:LY()Q0!L44@Z4M !6=JWW4^IK1K.U;[J?4T 9M%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %97BG_D6]2_Z]I/\
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M+JFGW,\1F,D<MJ%.-V,@@D=,=JY_XJZ?/XL\177B'3]5;Q!ID[%D(8E[8'^
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MP8#=SS31Q) K8)#.JEB>P&ZNE1MV#ZB@!U%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %2VG_'U
M%_O5%4MI_P ?<7^]0!NBEI!2T %9VK?=3ZFM&L[5ONI]30!FT444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5E>*?^1;U+_KVD_]!-:M97BG
M_D6]2_Z]I/\ T$U4=T1/X6=+X?\ ^0#IO_7M'_Z"*NO*B?><+]35'0#_ ,2#
M3O\ KWC_ /017SS\1/%=_;^/K[$TCP02 "W<G80!Z5U4,.\3-Q3L<&*QBPE.
M,FKW/9_&_P 2-/\  [0QW4<L\\P+(D?I[FCX??$*W\>VUT\5N]O);L ROSUZ
M5RT?@$?$7PY8W5U>W,"LFZ..50S1^VXC)%=%\,O ;^ K"]AEG6XEN)MY=1@!
M0,"M)PH1HM)^^<]*IBJF(4FOW;1XS^W?;WDWPYTJ2 ,;6.^4S[>F,'&?QQ7S
M?^S>OAR3XDV,/B6WCGLIE,<8F^X)#TS7Z(>+_"NF^-] N]'U.%;BSN4*.I[>
MX]"*^2]4_8=UBTUO.D:W#_9V_*/,I\U!GVZFOS?-\OQ$L7#%48\R70_>N&L_
MP,,HJY7BI^S;O:2\_-'I?Q0_92T'Q+;/?^&DCTK4 NX1I_JI?08[?A7REJ6B
M7WA_5+C2]0C>*YMG*/$QX!'I_C7Z->&=(ET+P]86$UPUW);Q+&TS_><@=:\#
M_:%^'?A#2-0?Q7K%S?K/>NL8MK7'[Q@OOTX%>7Q)D4*M#ZS02A)?%T5CGX:X
MEK4:_P!2Q,G4C]G2[N?.FBWMSI=RD]I,T$JGJIZ_4=Q7J7AGP_HOQ$AN'N"-
M"U"%3)).J_N) .O'8UR5MXK\/:9+G3O#D<I7H]_,93^72NL\*^);OQOK]K:7
MOD6FDP@R3QVZ"-%0<DG%?FF5T\)];A1QE3F@WJDF_P 7L?6YY4QKP\Z^$I<D
MXK=M+\%>YV?V$:XEK%H6GF2+2[8Q/JDB9.T<DJ/4]N]>9:_XRDM7EATZ)H93
MPUU<#,I^F?N_SKVNP^+^GZIH6K:/X6MAIMW;Q,UJ6 /G!>OXXKPO4?B/?WKN
M-0MK&^YP?.ME!_,<U]QQ#GN&I488?*:GLZ;T;BM[::O<^!X<R+$5<1+$9I3]
MK46MI/:^MTMC@=1DDN97>:1Y9&ZL[$DUT?A*P^(\6G_VCX975Q9+G#V[$I^
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M>+@Y)IVL[6?1G7YXKR?4;WQ#\1?&^MZ+I6MS>&])T7RXYKBS16GFF8;L9;(
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M@>4>'_-:Y616D2#[[(.H'K]*^4KSPWXATW2+J_ET-],L9W_?W"62P>:?]H@
MGGUKZ4\?Z5XY)DO[*YD;&G31/;6,GRF4D;"JGG=C/-8;Z9K>G_!I=,\5QR7$
MEW?I;B2:;=*D4C#:QZX(/;)K">'E)7C/?H>_E^<4L+4C"M032=^9K5>A-^S]
M9RP^"(KC0)+%IGD(OHKI&WF0'^\IX&W&!M-==X]M_%-]X:NY(HA:W%LIFA?2
MKB5YRX' "[0&R?X3QZT_X0_# _#33+NW>]^W27,OF%U7:JC& ,>M>A[01G%*
MBW"*NM4<^9.&)Q$YPDVI=3Q/4O@E=^/_  MHUQXCN(+;Q2 K7EW;0@;P?X2
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M2K:0(/F)WMDD,W;-3=L44E%(IR<M1 N!1T%+2$XQ5Q^)&4_A9],:;_QX6_\
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M_D6]2_Z]I/\ T$TX_$B9_"SI?#XSH.F_]>\?_H(K0"G-4/#O_(!TW_KWC_\
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ J6T_X^XO]ZHJEM/^/N+_ 'J
M-T4M(*6@ K"\7K(^C72PAC,89 @7KNVG&*W:S=7^XGUIIV=R9+F31\D^$?@G
M\0M5\.RSSZW/HDEW;Q1R6TMY.9799MS2-G_5G9E0%]:["Y^"GBN'Q4EQIOB$
MVFGQ7"26]RUU,T\,"PE#;;#\C*6.[<3G\:]SQQ0,5UO%3;O9'G1R^FE9MGS7
MI/[//C33WOKK^V+./4WLXK=;E;N>1IY$G60NY894, 00.E;.D_!OQO!=V5QJ
MFK6VK0K?3W,MB][<1QJLC J58#+%>0%/%>^< <4F*;Q4WV!9?2CLW]Y\\6OP
M$\5:/:1V^F:A9P&/5Y+[S'NIFCDB9@=KQXY(&<8/XUTGQ'^%?B[Q5XQAU+2M
M?6SM1%;QQ$SRQM9.DFYW1%^5]X&"&]:]CQ28]JCZQ*]RU@J2CRW=O4\=T[X+
MZKHWP^\6:/IFI)9:IK&HSWD=RDLF C/E59NJG;P<5Q%Q^SOXYCTZ^@TW5--T
MPWEZ;MEBN9F:+]V% 61@2<$9Z?E7TT,TN*I8J:N^Y,L!2DDM=#Y^U3X!>*=7
MU9;VY\12%FD E$=[.@:/R=I7 XSO :FR?!OXB'7?#%V/$]O&FE101SRQ2R>9
M*%4B3<,?/G((SCZ5]!X]:0C\J%BIWV0O[/I/J_O/DGP]\,_B'XBFUFQM+W4]
M%"Z>L#ZG?&>);VX%P68[7.1NCPI91@ XR:Z/Q+^SSXTU_P .V.G2:[#=1);3
M0O;75Y-LAD9PP=2JC?@?* PXKZ3X^E!]:IXN;V2(CEM-1LV_O/)O$?PS\1W^
MK^&9[7489+#3K(6TME)/+$JRX $Z[1AR,<!N*Y'1_@#XRABD35?$,>HM_:5O
M>!I9W975&<LVTK\KD,!UQQ7T/@XKYA_;=^+GBSX<:#HUGX;FDTV/4&?S]0A'
MSJ%Q\BG^'.<YZUKAIU:M14X65SGQM*A0I2K3O9=#H?A_\#_%O@O5/!['5+.2
MRTL2K>1^;(RNK22-^[3  ?YE^8GL>*\C_;_\0>+M/U?1;6TFN[;PU);EF>W)
M5'FW'(8CT&,9JC^Q7\=?'7B?XCGPWJ]_=Z_I-Q;R2O+=,9'M649#;SS@GC!]
M17VYJ=A9:A:/'?VT%S; 9:.= Z?D>*Z:DIX/$IU4I6.*E"GF>!DJ$G&[Z^1\
M;_L!^(/%^HWFM6M[+>77AN.(,CW)8HDN>BD^HZXK[3&<>E>%6/[6/PLTKQ4/
M"UG=?9"DWV<316VRV#YQC(]^_2O=(Y%EC5E.Y6&01W%<6,YI5/:2ARW/3RM0
MIT?91J<]MV.)XK*\4Y_X1S4_^O:3_P!!--\17.JVMB'TFUCNY]W*2-C _K7F
MWB#XA>(K>QN[/4M&6$31-'OVLH&01GN*FCAY5=8G1B<7"@W&:9[EX>/_ !(=
M._Z]X_\ T$5H YKQKP7\3M3U:TM[**72H;B*-4"3&0%L#'''M78#5/%7II/_
M )$_PK*I1G3E:6A='$PK0YH:G;T5Q)U7Q7GII/\ Y%_PH_M7Q7Z:3_Y%_P *
MRY;]3?VGDSMJ3(KBO[4\5^FD_P#D7_"LZS\5>*;O5;VR$>E*UMM)8F3!W#Z4
MU!]Q.K;HST>BN)_M7Q7Z:3_Y$_PH_M7Q7Z:3_P"1?\*7+YC]IY,[0H"<FF[*
MXW^U/%?II/\ Y%_PH_M3Q7Z:3_Y%_P *7+YA[3R9V10$\BEVXKC/[4\5^FD_
M^1?\*/[4\5^FD_\ D7_"CE\P]IY,[3;2@8KBO[4\5_W=)_\ (O\ A1_:GBOT
MTG_R+_A1R^8>T\F=M17$_P!J>*_32?\ R+_A1_:GBOTTG_R+_A3Y?,/:>3.V
MI.M<5_:GBOTTG_R+_A1_:GBOTTG_ ,B_X4<OF'M/)G9/&K#!&0>QJ**R@ASY
M<2IGD[5QFN2_M3Q7Z:3_ .1?\*/[4\5^FD_^1?\ "H=*+?,[7'[5[69V0C'I
M2[!GI7&?VIXK]-)_\B_X4?VIXK_NZ3_Y%_PJN3S%[3R9V904@C%<;_:GBOTT
MG_R+_A1_:GBOTTG_ ,B_X4<OF'M/[K'W(_XNG9^VEO\ ^C*[$')S7$Z+I>K7
MGBW^V-2DM!Y5H;98[8-SEMV3NKM%.0.*)= IN]VR2BD%+4FP4444 %%%% !1
M110 4AZ4M(>E 'S#\2/^1YU?_KM_[**YNND^)'_(]:Q_UV_]E%<W7P=?^++U
M/V7 _P"ZT_1?D%-/)XIQ([TL4;S2;8T9V]%&3626IV2:BFV>J;-;7P1 MU?V
ML*;$<0[/WK1Y &XYZ?A7%^/8M1BU^0:BR.Y4&,Q#"%.V!77Z?XITB^TM8M8T
MV]%RMNMLQ@0E712"/Y5QWCC7?[?UE94MVM;>.,111N.0HZ5[5>SIQ=^Q\A@%
M/ZS)2BEOV_ ]WTX_Z#;?]<U_E5C)JOI^386__7)?Y5\W^,O!WQ@NOVC;?5-*
MO-07P,+VT=HTU%4A\H*@E!BW=,AN,<U[[J.$(M*Y\MA<%'&UJD955#E3>O6W
M1>;/ICFN#\5?'3P7X*UV;1]7U6:#484622&'3[F?:K=,F.-AS]:[SM7A,L7B
MU_C=XQ'AC4-$L0+6T\X:M;R2[N&QMV.N/QKH/&>AZ):?&+PE>^%;OQ(FJLFC
M6S^7+<3VD\1#=E".@9B<CH#FJ;?'?P2)[.$:O(TUW;FZAB6PN6?RP"=S*(\I
MG:<!L$XX%<3\8_#NN:Y\-M-A\1:XJ:@FKVRF;PZ6MXV5I549#ESD9R/?G%<[
M)X'F\*^,_B1J-KXI\1S76E:! T;7%^&\TM#, 9,*"Q7;N7D8.3S0!])6=U'?
MVD-U 2T,Z+*C$$$JPR"0<$<>HJ:O V_MCX@ZS:Z;-XQU+PU!IV@V=\CV,ZQM
M<32+EGE8@EE&.1WS4GC_ %VZU6S\.:7%XEUZ^O9K0RR?\(@4A^TXX\UIFR$7
M/8=Z />**^7/!_C7Q/K/@FTT*Z\0W]@]SX@DTQ]6FECDNX(%4L%\T?+O.,;J
M[VXTC7]&\%^(].T?QC<^)-5T6>.^LQ)/OO-JXD^S3LN-^\!@..0PH ]F_P B
MJ$.MV<^LS:6DC&\AB$[QF-@ I. 0VW:>G3.:\^^'WBZ?XE^-K[6[*[F'ANQT
M^""&W5R$FN)@)9&<="44QJ/0EJY_XF^(M8LM<\;6]CJES9^1HL$MN8I"!#(9
M""ZCH#[T >X45XMX&L-;\'?$K2M-NO%>K>(K75M*:[G35)%<1S+CF, #8.>G
M-:/Q,M-6\0_$7PWH-CXAU'0+*[L;J2Z?3I DC!2F-I((5LD?-C.,CO0!ZQ2-
MP/\ ZU?,.EZCXKTS1O!GB>Y\8ZK?3GQ(GA][%V46TUM]H> M(N,O*=N[>3QV
M Q70ZAXTU&'X3:E='69TU%?$,EJDOGD2A!=8" ]<;>,>E 'L$/CG0YY)4748
MU>*[^PLKJR_O\9V#(&3SVXJ_8:W::G<WEO;R,TMI)Y<RM&RA6QG )&#]1Q7S
M9XB\.+KFI.3JNI:8$\8[?] N!%G*+R>#R,<5M>-?$>MVL.M6MMXAO-/*>([2
MRCNS*28XF3YASQCOZ9[4 >[:]XAL/"^E2ZCJ5Q]FLHF56EV,V"S!5X4$\E@.
MG>M$'=@CD8KYF\9+?^&],\7^&)/$6H>)M.BATZ^CFU.99IH'>[0,A< 9!P"!
MVYJKXCU[Q]XQ\;>*IM*;788M$OFLK*+3=4M;6W7:JD//'+\TFXG=U P<#O0!
M]245E^%KJ_O/#NG3ZI&L6HO;HUPB,&428&[!!((SZ&O(/C+JEQJGB]=&L-9\
M5)/;6@FDL?#+QVHCR>'EG?/4=!Q0![G17S1X8\5^(O&7@[P1HE[XDO\ 3&U2
M[O(;O5K>9!=E(?N()0"NYL\L.NVNKU'4-1\*Z!H-@/%SZY]F\4064E[YW[_R
M&#$0W## 9L8R>_'% 'L&JZK::+8RWE]<1VMK$,O+*<*OU-6HY%E174Y5@"#Z
M@U\[?%Z6;Q3'\1M/.MWT-G8PV4D:65SM",2VX=Q@\9 ]!5/QK<>++GQ)8^%-
M&N_$5Q8:=ID,XGT[5;>UN9W;^*220?.!TP />@#Z7HKC?A/>>(+OP19-XFCV
M:LA:-SYL<A=0?E9C&2I)'7%>*^.+_P 4Q6?Q+\4VGB[5+/\ X1C5E-AI\4@^
MSOA(69)5(^9"&X0$ $D]Z /IRCV[U\UZ]XC\3_"[Q+XHT^'Q-?ZV9O#Z:HLV
MIE9!:W#3^6S1J  J -G9TXK4OSK?PGU?0;JS\;:IXN75A(MS8ZE)',C,(RXE
MB"@%%!'W1QS0![9K?B33_#JVAU"Y^SB[N%M8#Y;-OD;.U?E!QT/)P*TMW2OE
MM[+4;W2_ 7B;4/&5_J]SJ^LP2SZ9<NAMXS\^!"@ *;>AZYJJ_B/XD>,-3UC7
M],;6HYK._FM[6&WU2U@T^-8WVA98)#N8D#DD]\CM0!].6/B73M2UK5-(MKCS
M=1TWRC=P[&'E>8NY.2,'(YX)]ZU!7S9X@'BF_P#$_P 1_P"P)S8:O-_8QN$@
MN$BF:,P$R1Q2/E5<\@&NN^ 7B"X:\UK0-0O_ !%+?6BQS?8O$H22>%"2"5G4
M#S%)'<<8H ]EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *EM/^/N+_>J*I;3_C[B_P!Z@#=%+2"EH *SM6^ZGU-:-9VK?=3ZF@#-
MHQ110 8HHHH **** "BBB@ HHHH *;FG4R5-\;+DC((XIJW43\CR3Q=^U3\/
M/!7B)]%U'6,WD;;9?)0NL9]&(KN+FR\-?%3PQ"\T-IKNC7:B2,NH=&'8CT-?
M"GQ0_8M\?W/C_4KC288M2L+RY>9+EI0I4,<_-GTS7V9\!?AM=?"GX9:7X?O;
MG[5=PJ6E=?NJS') ]ATKUL11H4:<9T9^\?.X+$XS%5ITL33M#H;W@[X;>&O
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M+31U5(J<7&2NF>P63>-+VWBECU:Q42J&"DKGFN$\?1:K!K*IJ\\4]T$',6,
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MGT%:M !1110 4444 %%%% !1110 4UC3J8V<T ?-?C6P?5/B-J5K')'&\D^
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MAG3Q/8><\#J-NZ-@C9&,?+P..M &QJ_QRG,VBP>&?#%QXFEU:R-["$NDMU0
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MBW".EZJ%.7/F@;<@L1MQU&W/>J?Q/^!FM_$#6KIVLO"<D,S?N-9DAF@U*S4
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MY( ' QG)''6@#KZ*:CK(BNIRK#(([TZ@ HHHH **** "BBB@ HHHH *EM/\
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M]Q:***X3TPHHHH **** "BBB@ HHHH **** +VD_ZR3Z"M6LK2?]9)]!6K0
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MX7U/3M4L=76XO+A[5ULEBC8D,DQX;(QP#G)KV'3M;CU*_O[1+:[A:S<(TEQ
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M>VUR6SMK")H=/LH_*B#=6]37- \CBOH?_A2WAP?\LIO^_IH_X4QX:_YXS?\
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M_:N@^RBG?910!A+IF.U2IIV#TK9%L*<( * ,I=/J5++GI6D(A3A&.PH H+:
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M<MGY8U^M8DGAF]/AP:T4)@:8QMD<]/O?3/%>Q_!U;9?"*&';YID;S2.N??\
M"OI)JE@Z/-35Y'QU*=?,<1R5G:+UL<7>?!+4X+4R174,\JC)C (/YUYAJU]!
MH=Q+!?31VTT8):*1L,,=>._2OKSD9%>._%/]G73OB'K[ZS]H:*X:$1/;LQ6-
M\$D,2.>]983,FY6KFN/R91AS85:]CQVVU[3[J*&2.]@9)0=A\P<\9Q3DUJPE
MV;;VW.\E5Q(#D_G3_$7[.PTB03W>ESB.,Y$D4I:-3MQG /' ]JY?3_A9I5K
M5N6GO':3S"SN5#=,*0#T&!^5?0PG":O%W/D:E.M2?+.-F=%/XATRV@::2_MT
MB7JQD&*>-9L&.%O(&;(&!(,\]*PYOAUI<\R&<2RQ);^0B,W(&<YW=2?2G?\
M"NM&\U9#'-O5@RGSFRN#GCTYK1F7OF]8:E;:H,6LRS-P=JGD?4=J]H\4)8_
M;X>1ZY_PCMSXIUR5TA2WMHO,8R/T'0[5&.M>$:%X5L/#=W+<V*R1RNJH=TA(
MP#D<>OO7MVOI>?%FST35_#OB1=!\4Z2,?8[ER()2<9W+W!QUP>#7D8]2?(KV
MCU/=RUQ2F[7GT,?P5\0_%?BSQ+::)X_^&EIX<TF^B9X+\7" 1<9 ()SD^@K'
M^('A-?"'B&2TA?S+9U\R%CS\I[5T6O\ PA_X69 M]\89].C_ +/.ZR?1[R2%
M@/X@V",@\>_TKEO&>NV^M:G&MDKII]I$MM;;V);8HP"2>:Y\'S>U]S;KV^1U
MX]?N?WFLNE]_F<EKQ_XDM_\ ]<'_ )&K=I_QZQ?[@_D*J:\?^))?_P#7!OY&
MK5H?]%B_W%_D*]X^96Y-1129% Q:3.>V?I174^ ]3T+2+N>ZUF![ET4>2@4,
M"?H2*RJ3<(N25S:E!5)J+=EW,G3-&U662.YL[2=F0@JZ(>#ZYKU+3/'WB6PA
M6._T*:Z('WU4J3]>*<GQMTU 1%IDX0=,,/Z"IK?XVZ5(V);"[C']Y=K#]2*\
M*O.K6?OTM#ZC"PH8;^'7L_30BN?B_>0DK_8$ZOC^,G_"L"^^*/B74CY=I9&W
M)Z>7$2:[RR^)GAG4#@W:PMW$\9&/QY'ZUNVNK:5>*3;75K)QU1UKCC*%)ZT3
MT)QG6BW'$?<>06'@;Q1XOG674YY((3@EYV.?P6O2?#/P[TGPX%9(A<7 _P"6
MLO)'TKEOAI\-O"NL?#OPQ?7WAS3+N]N=,MIIYYK5&>5VB4LS$CDDDDDUTW_"
MI?!1Y/A72,_]>:?X5G6Q//[E[>AOAL"J=JC7,WU9UF !@4F!WYKD_P#A4W@K
M_H5-(_\  ./_  H_X5-X*_Z%32/_  #3_"O/_==6>LG5>BBCK.^1VKP/QC\+
M_&VM_%-_&5I);*NG75O%8VC2$-+; $2G=T7.\\$'[HKO[SP+\-[*803Z%H,<
M[<"(VT9<_AC-:!^%/@6. 3S^&M$M8V&<W%I&A'UR*TIUJ5)MIF=?"UZZ491L
M>,0_!WQ?Y?BRTT^UATS3[_,L:W-UYLLS^;N9-ZJ"$8=CG&:[]M#UW_A6.H6.
MC:$/">LL%6)+&Y1BQ&,L&P/3OS4^IV/P4T4E;]O"=LPZATA%-T6V^"7B&Z^S
MZ9)X2O)_^><,<+$T/&T):<R*ADV-A%R5&5M=;/\ R/-;G3_BS?\ BF+3;:XN
M;:YMK2Q=[C[4?LL;[OWI8$'S,J",>IK5/A/XQ"3Q,PUDFYD\S[&1.HA=?,!0
M)QF-MF1GUKV ?!;P6ZAXO"^B2*1D%;.,Y_2HG^$'@M,AO">D#L<V:?X5T?68
M/I^!YBP-5/5N_J>.6_PW^(-O\1K7Q)9A[:P-I;V]Y;3WWF7$P60LR^8!V'/O
MTKZ-4Y Z"N3_ .%2^"O^A4TC_P  T_PI/^%2^"_^A4TC_P  T_PK"I.G4MS=
M#KH4:F'ORJ]_,[S2CAY._%:BG(KS/X=Z#I_AWQEXCL]+L8+"T\JW?R+>,(F2
M#DX%>ECCVKFG'D=D=E.?/&['"EHHJ38**** $S1FD/6F23+$I9V"J!DDU-UU
M <3DTQYL FLFXU]7NO(LXGNI=P5RG"Q9&0QSC(^F:IW-D607.MWJ)$FQ_*1]
MD:.ISG=P2/8UQ5,7&*;C][V1M&DWN6;GQ)O<PZ?"U_-LWC8<)C=M/S=,CGCV
MJMJ%DI1Y]9OU%L-X,8.R,H>@;U(QUKA/%'QRTS1 ]IH5N+N49_? ;8@?;N?P
MX]Z\Z/\ PEWQ2OU($UQ'GJ?D@C'\OYFOSK,N+,/"I]7PB=>KVCLO4^HPN259
MQ56NU2AW>_W'K4OQ-\'7-^=/=\*04%R%PHXQPW7\:Z:S-Q$$N-,N4OK%L?(3
MG:@7HI'4YQUKS ?LZS?V5N_M(?;^NW9^['MZ_C7'!O%WPLOF!\Z"+=W^:"3^
MG\C7EK/\VRV2J9OA>6F]I0^RO,[/[,P.+]S U[R7277T/H^RU^&X<139M;@*
MA>*7@J6Z#/0GZ5J*Q(KQ_P -_&G1_$#06^O6Z6<Z,'2<C='O'0YZJ??I[UWE
MJMU;V\<FEW::C:[!MCFDR22V2V_Z'I7W^6YYALP@IX>:FO+=>J/FL5@*V$GR
M5H\K_#[SIMV* W/6LBRU^WNI?(DW6UP2VV&X&QV ."P'I6LI[\5])"I&HKQ9
MY;BXNS)**0$'O2UH(****8!1110 4444 %%%% !1110 4444 %%%% !1110
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M*=-:V212\8>,](\"Z)<:IK%Y':6D*EB7/)]@.YKP^S^(?B[XX)<7FEW#>"/
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MZI6I+01D]U%?MO#U:57#-2Z'POB5A(4L;2Q$59S6OR,OPC_R4#Q'_P!<+?\
M]!-=WW%<+X2_Y*#XD_ZX6_\ Z":[KN*^RJ_%]Q^)T/A^;_,=1116)T!1110
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M-;WUI);.4/ =1(H++[CBM?7/%.G^'KC38;Z5HFU"X%K P0E3(02 2.!D ]:
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M_O?C7U+T[5^T9)A7AL,N;J?EG'V;4\PS)4Z+O&FK?/J8WA$Y^('B/_KA;_\
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MFU/3[N^\2VD>FO<3%K;3P0SV\7\(=AP6[GTKK-M*!B@ HHHH **** "BBB@
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M_P#KA;_^@FNZ[BN$\)'_ (N!XC_ZX6W\C7=]ZUJ;G-1^'YL=11161T!1110
MF!1M'I2T4 )M'I3608Z4^D- &7>Z+;7,B2;?+F5Q('3@[L8R?7K69)%>V=L+
M>\B&K6V%0L0-Y_O,W;\JZ7%!7VKAJX:%1.RM?[OFC6-1IZZGS;X@TS13K]W<
MV< \OS/EB52,=L[?K0L$LJ!>((^FU.O6NC\7Q(GB>_*H ?,QD#V%97;I7\ZX
MK"PI8JK9):O96ZGZIAZLIT8-OHMR&*VCA)VJ,DY/KFI<5:T_3YM4NTMX!F1N
M>>@'K6P/ ]X-/:Y,T0;G9&6Y?'I750P->M!RHPND8U<52HRY:DM3GP<BD(H7
M..>M*>E<]-6J1]3>7PNQZY:'_18?]T4UM0MHY_):YB$V<>67 ;/TSFG6G-K#
MQGY!7SGXP_9I\2^(/VA(/'EMK=O#I*7MK<FT8OO*Q*@88QC)VG\Z_HFG*<:-
M/D5]$?GN$PV'Q-:K'$5?9I)M>;['TCSQS7/ZMXRMM)\4:3HC1227&H))('!
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M[F8'R\<NB\["<]!G(JKK']CZK\*-!0:MI^A7MOJ+QZE:>(I7^SW-XJGS$N)
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M\51_PF\W_0N:S_X#C_XJNHV-Z'\J-C>A_*CGA_*/DG_/^!R__";S?]"YK/\
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M>**:8@RR(@#/CIN/?\:G=MH)/0<DGM7(#XO^"FNOLX\3Z9Y^_9Y9N%SNSC%
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M@5\[?M@?\@KP[_UWD_\ 0136H$O_  U[I'_0O7G_ '_3_"D_X:\TC_H7;O\
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M(_Z%Z\_[_I_A1_PU[I'_ $+UY_W_ $_PKY<HI<J ^H_^&OM('_,O7G_?]?\
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MY*A-_P!@Z7_T..OL&L]@"BBB@ HHHH **** "BBB@ I#TI:0]*3V \2\8_\
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M)IJ7B6IE+HJJ=L<8ZL<D^W-0^-O@_=>%O#&@Z=X4TK5-473I)6CN;'5%M;^
M.<D+(_!4]P>:L>!O@"TG@'[!KD]]I>J/JLFKP3VMYON;1V7:,R_Q-MSGMDT
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MSGOFKOA/PM:^#](&FV;R/ )99LRD$Y=V<_JQH VJ*** "BBB@ HHHH ****
M"I;3_C[B_P!ZHJEM/^/N+_>H W12T@I: "OG;]L#_D%>'?\ KO)_Z"*^B:^=
MOVP/^05X=_Z[R?\ H(IQW ^8C7HWPY^#\GQ&\+:[J=M>-'>:><16PCR)CMW8
M+9R.E><]Z]I^$GB9_"WPH\77UO<)%>0W=O)&A< O@C(QWSTK1@<'JG@+^SO
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M&<?'O_0(3_P(3_&BZ \RHKTW_AG'Q[_T"$_\"$_QII_9T\>#_F$+_P"!$?\
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M"R691L)QR>V*Y31([:6WA1M2N8'^8O'$"0H]>G>M(P:=*KB+7+R1P"=H!/\
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M?O+C1H)4>.YTV2\DFBNSC(;$CDAEQG([9KR?3OBUI/\ PN#_ (25O$<+&\U
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MJ_#JTOM7\::;X2N]\FG^!VD+229Q,3Q;9]2$)_[YH ^@ <TM(HP*6@ HHHH
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MB0RWLS;YI)'!W2,>YR:T;+PZ-*\,IH]C<-;^5;&WBN-N60[<!\=R#S^%;M%
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M:@#*-XX_Y99_X%_]:F-J#K_RP_\ 'O\ ZU:C6/M3&L0: ,HZHX_Y=_\ Q_\
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MJ* ,W^R/^FO_ ([_ /7IT6EF*57\S.TYQM_^O6A10 @Z4M%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(W2
MBB@!M%%% "'J*:U%% #:3UHHH ;3*** $;I33THHH ;2'J*** &OWIM%% !2
M'I110 VBBB@!QZ4VBB@!]%%%  .M.HHH 4=#3J** '#I2T44 .'2E7K110!(
M.E Z444 /'2E'6BB@!U%%% !1110 X=*6BB@ HHHH **** "BBB@ HHHH **
%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>aciu-20221231x20f037.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f037.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #[ E<# 2(  A$! Q$!_\0
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MQFKL/Q&T>XUUM+B^URNDOV=[I+20VR3; _EM+C:K;2#SQR!G/%>?S? K4_\
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M/2SLU^MRQ_\ 9*;_ ,)'JG_/"P_[_/\ _$U\UQ?M(RZ;:WEO?::CZG )Y_\
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M&Z1XV+A@0<_(P/\ >WG-=%+X,T.:WOK=M,M_(OH([:XB5=JR11@A$P.@4$@
M4 >=ZM\5-7L/%\,<+V][I+:P-+>&WT^8JHP0?]))"F8,#E%4@8QG/-9]S\6O
M$^C:-I'B"\;2KW3]4TB\U9+"WB=)8?+B62./S"YW#Y@&;:,'M7I$GPT\,2ZP
MVJMHUM_:!N%NA. <K,"") ,X#9') R>^:Y;PI\%HM%\2KJFH2Z?>"&&XA5+:
MP\DS^=C>TP+LO0'Y455)9CCT8&1'\2?&D5KJ%LVG+<7HBMYH)Y;'[*PWR[)4
M2!YLS$+\R?,NXY'4<]Y\./$TWBC0)9KJXCN+RWN9+:;;:26KQLN"%DBD)*/A
MER,D<@@X-);?"OPE9Z;=V$6@VBVMWL\Y"I8ML.4 8G("GE0"-IZ8K;T+P_IW
MAG3Q9:7:1V=L&+[(Q]YB<EB3R2?4\T@-"BBB@ HHHH *BNK6&]MY(+B))X9!
MM>.1<JP]"*EHH \XUOX+6%V6?2[ZXTPG_ED?WL7T /(_.N/U#X-^*[;/V6\L
M[Q>P$C1G\B"/UKW>B@#YOE^'/CNW?C32^.0T=TA_K6/H'P9\0^%HIXM%\)PZ
M3'<3M=2K:-%&))6^\YPW4U]2S31VT,DLKK%%&I=W<X50.22>PK&N_'7ARPO)
MK2YUW3H+J"W^URPR72*Z0XSYA!/"X[T ?/US\#/$7B'5=-U/4?#UC-J.FNTE
ME=WDR-);,WWF0C)&>/R!ZUV6F?!;Q#+C[;K%M:(?O+"&D;]<"O9;2[@O[6&Y
MMIH[BVF021S1,&1U(R""."".]34 <;X<^%>CZ#*EQ*9=3ND.5DNB"JGU"#@?
MJ:[%E#*58 @C!![TM5KW4[/31&;NZ@M1(2J>=($WD*6(&3SA59OHI/:@#DM:
M^%&E:BS26<LVE2L<D0$&//\ N'@?ABN/U'X0>(;<DV=_9WB]@^Z)OZBO8K>X
MBNX4FAD66)QE70Y!'L::]W#&)"TJ*(R%<D_=)Q@'\Q^= 'SIX@^&7BB^T^XL
M=0T(W]E, )(HYE<. 00#A@>H%<5X@^$":KKTNMZOX'NKG591*)+IX929/,C$
M4FX*<$E!C)&1R1@DFOL:F3SQVT,DTTBQ11J7>1SA54#)))Z 4 ?%5W\/-)>R
M:SN?"5QY+6DEB=\,X?R7E69T#_>&9$5]P.0R@@UG1?"[PM!8-8Q^$F2T:V^R
M&("?B/+'@YR&R['>#N!.<\"ON&TU"UO_ #/LUS%<>4YC?RG#;6P#@XZ'!''N
M*L4#:MN?%5AX4TG3+46MGX;,$ @>V$20RX\MXTB=??*1H">ORYSG)KE_$GP'
ML?$VFZ/IVFZ/>:5:V-W'/+LLIKB6X569MOFN=P8L[$N2V=QW X&/OB>YAM5#
M32I"I. 9&"@\$]_8$_@:I6/B72-3F2&SU6RNYG4LD<%PCLP'4@ \@4"/D*]^
M!-EXEFM)I_ %S.]H4,!V31A=@78#\PW!=B$!LC*@]1FNL\(? ;4_#M[>7>C>
M%TTJ>\1$FEENNJK]U0&=MB]R% !/)R>:^HZ\[^.'C:_\ >&M)U:RN!;Q)K%J
ME[F(2%[3<3.H!Z$HK8(Y% &!IOP>UZ<J;W4;2T7N(@TK?K@5V6A?"[2=)D2:
MX:74[A#D-<D; ?4(./SS7A_AOXU>*8M2TLZWX@@*SM;I<A8H5@MT#+YOG# >
M%_G&'.8W5E *LIS]!^ =2O-9\#>'M0U$[K^ZT^WGN#LV9D:-2WR]N2>* -ZB
MBB@ HHHH **** "BBOG;]M_XBZIX&^%MC8Z3<2V5QKM^MC+<PL5=(0C.X5AR
M"VT+D=B:Z<-0EB:T:,=V:4X.I-074^@[>[@NPY@FCF"-M;RW#;3Z''>G37$5
MOM\V5(]QPN]@,GVKX(_9YU6;P=XBT;4=.=K<37<%I>0HQV7,,KB,AEZ%E+!@
M>H(]":^K?CAX2UCQ+;Z#<:18?VD^FW1N98%F2-W4#@+N(&3C')%;8S"_59\J
M=U]Q=6G[*5D[GI-Q=0VD;23S1PQJI=GD8* H&223V ZFGQR)-&DD;J\;@,K*
M<@@]"#7B'QB\)Z_K=A::\VFMJ-Q#%- MG;82:.">:T(@*EF1W_=MN?[O'/RY
MSZ=\.M*O=#\#:'I^H1)!>6UJD4D4;9"X& ,CC.,9QQG..,5P&!T=%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 45R/Q!^+7A#X5064WBS7K71$O9
M#';^?N+2$8S@*"<#(R<8&1D\UU-K=0WMM#<6\J3V\R"2.6-@RNI&0P(X((YS
M4*<7)Q3U6Z.F>&KTZ4*\Z;4)WY9-.SMO9[.W6VQ+17F?[0_QRT_]GOX:W'BJ
M]TZXUJZ>Y@T_3M(M&"RW]Y,^R*%6/"Y.26.<!2<$\'C/"?QL^*'A_P 6#3OB
MQ\-K/P]H$^F7&J+XF\-:C)J5EIZP)ODAO"T2&-]H.&7(8C"@\D6<Q[_17@5O
M^WI\ +N&XDB^)VD.L%HEZ5V3!I(V( \M=F9'!."B!G4@@@8.-/7/VS_@IX<T
MK0]2O_B#IL5EKEB^I:;+''-+]K@63RV,81"2P<%2GWP5;Y?E. #VJBO)-?\
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M..0H/?%>AUXU\%/'GBFUUV]\ _$B2W/C*&'^U+2[MAM@O[20Y81^K0N3&P]
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M%YSV]>M:XC$SQ,^>952HZCNSYF\9?'KQS;7$EE:P:?9PS.SQ7R6TAQ"DX1B
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M9KUSX#?%_P"(=U-900>%;W0/#6E:5<13J[3O96317#,@.Y?G.<D<YR*^I:*
M"BBB@ HHHH **** "BBO%[WX>^-);VYD2YW(\SLI^WN/E+$CC''&* /:**\1
M_P"%<^-?^>Y_\&+_ .%'_"N?&O\ SW/_ (,7_P * /5O&%C-J/A?4[>W4O<-
M QC0=68<@?B1BOD'Q]XH261Y_P#EI@@$YR >V/7_ .O7M'_"NO&P_P"7@_\
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MU]Z-#]HK3O&'BSXJ>!-&\$KI%IKFF03Z]#J>H,ZR1B.2.)X05SE)%EVNI'(
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MC7_GN?\ P8O_ (4 >W45XC_PKGQK_P ]S_X,7_PH_P"%<^-?^>Y_\&+_ .%
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M]W0!]"45F^)/#FG>+] U#1-7MA>Z7?PM;W-NS,HDC889<J01D>AKY_\ V#/
MFA>%O@S<ZEI=B;:^U'6M6@NIVGEE:5+;4[N&!3O9L!(P%&,< 9S0!])4444
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MNJ$G)7,85(5J<9P35UU]7KZ6L6]]&^H=]-DG2&)Y972**-2[R.=JJH&223P
M!WJRCR_X=-C]H'XR^ACT(]._V67_  %>L;ZY+PG\2_!WC>_NX/#GB'2]7O81
MNG2SE#2%1QN]64=,C(&:ZC<<9QQZU<H2@^6:L_,;3B[-$N^K=BV0WUK/!+=
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M;YI5C:/C^%U8J1T.?:OJ_P <:KJ.A_%[P]<%M17PZ+?RIS;Q2RP>:WVD*'"
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MY67D<Y [2O5A.-2*E%Z'P&)PU7"594*\;27])I[--:IK1K5:!1115G,%%%%
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M\-L//F _N@_K7,>;+_>-;OA%V:[N-Q)^0?SH ZFBBB@ HHHH **** "BBB@
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M[G_O+7FNLS-_PTKX03(W#PCJS9[?\?=D/Z5Z#Y@]:\YO[:2__:B\&10C+?\
M"(:ODGH!]KL^: &_M-2LGP4UEF(*K?:42!_V$K6O5[KS6NY\8/[QN@/K7!_M
M0:%!8_ 37'9C--]NTG)/0?\ $SM>@KW8O''(^%4')S@4 <"4G'4?^.FFEI >
M64?A7H)N01S@_A56YM;2[7;+"C#UQ@_G0!Q&Y_[RT;G_ +R_E6MJ7ALQ!I+1
MC(HY,;?>'T]:P"^#@Y!% %G?(.C+FL^ZTJSNTCCGL+:=(B2@>,':2=QQZ9/)
M]:G\P>IIC3.&.W&*5KDRC&2M)7%M[:*SFGE@MH89;AM\KHN"Y]3_ )[T\H"6
M)AC.YQ(V5ZL!@,?? %1>?)[4>?)[46*C[FD=!ITZW-FEF;. VB-O6'9\H.<Y
MQ5:Y\.Z==QRI)IUN!(<N43!)R"?Y5;\^3VH\^3VI.,7NC:->K!WC-KKN]R+^
MQ[$2F0:=:B0D$L(QV&!5F*%8(88HX(TBA.8T"\(>>1^9_.H_/D]J//D]J%%+
M9$RJ3EI*3?S+:S/_ !<5GZU+FV(!S4PF8_>Q5>]Q(G3-49GD_P '= 9;[7-9
MEPSZA>L4<'(9%) (_$M^5>G^(;9;BP9&&5(P1[5F>#?#D7A;2(-/AD::.(N0
M[CD[F+?IFMR^ E@9<=JB$;128E2A0O3I.\4W9]7KO\SR?X0>)&NK[5["<".Z
MT^\>%E P=N2%/Z?RKVF.8,@.:\-M].M_"7Q2FO991!%KB".// :=<9'MD 8]
M2:]CM93Y2YZXK.C%0A[.*LEI\NGX$4U6Y%*O>[;U?57:OY_YFCY@SUI&F;^'
MFJWFTAF8?=Q6YH6?.D]!1YTGH*J^?)[4>?)[4 <%X.E<?'GXJ'')L- S_P!^
M;JO1_.D]!7E_@^9_^%\?%,\9^P:!_P"B;JO1O/D]J +7G2>@KHO!4C/>7(88
M_=C^=<GY\GM73> Y&>^NMW_/,?SH [6BBB@ HHHH **** "BBB@ K\]/'G[:
MGC?0/''B+2[?XZ?!#3K>RU&XMH[/4-,U1KF!4E91'*5^4NH&&*\9!QQ7Z%UE
M2^%-$FD>231["21R69VM4)8GJ2<4 ?.O[ *Q7GPY\<ZZ/&GAWQS>>(?&-]K%
MYJ'A>.9+.*>6* O"%F 8$8!QSPPY-?3]5K'3K33(3%9VL-I$3N*01A%)]<#O
M5F@ KY*_:*FU[XF_M0^&/A3!XO\ $/@[P['X-U#Q-/-X9OVLKBYNEF6"$-*O
MS%8^7V="3\V17UK7D'QN_9HT+XVZQH^N2:]X@\(>)-+MKBQAUKPS>+;W+VDX
M FMW+HZLC8!'&5/*D&@#S/\ 9L_:CUK6?V7?A;XH\2>%_%GC/7-9T^9;N\\.
M:3]K!>"=X-\V&4*SA W Y.ZM']A+Q$I^ FB(=.U)#JGB3Q$PWVI_T7&IW<F+
MC&1$>-O/\7%>[_#GX?:)\*? NA^$/#=K]BT/1K5+2UA+%F"*.K,>2Q.23W))
MKY5_9&_:4^%'PZ^$-QH/BCXC^&/#^MVWB37C/I^HZI#!/$&U6Z9=R,P(RK C
MV(H ^KM-\81ZFVE!=)U>V_M%9V4W-B\?D>40")L_ZLMG* _>'2DL/&,>H1:<
MXTG6(!>V4EZ%N+%T,(0I^ZE!^Y*=_"'D[6]*\Z_X;,^!'_18/!?_ (.[?_XJ
MC_ALSX$?]%@\%_\ @[M__BJ /0XO&D<L$,O]CZTHETLZJ$:P<,JC'[AAVG^;
M_5?>X/I1-XTCAAGD.D:RXATP:H52P<LZG=^X4=Y_E_U77D>M>>?\-F? C_HL
M'@O_ ,'=O_\ %4?\-F? C_HL'@O_ ,'=O_\ %4 >BZCXQCTZ+4G.DZQ<?8;.
M.]*V]B\AF#EQY<0'WY!L^9!R-R^M+J/B^/37U96TK5[C^SA 6-M8O(+CS3@>
M3C_6;?X\?='6O.?^&S/@1_T6#P7_ .#NW_\ BJ/^&S/@1_T6#P7_ .#NW_\
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M\/:K::WHUXI>VO["9989E!*DJZD@C((X[@T :U%%% !7CU_,!?W7[P_ZY_\
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MU:26[JHD8"+RXY?-9\O,I&WH>E_:_GNC9>'8+CX%V_QB\/K))-=7,UP,Z4X
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MC_3?$7A71--CTVWLHO#GV.X98XU2-FF%RXR O/R<^U %+XQ^-8=0^(EA\/\
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M_P#B*/\ AK+P9_T O'?_ (1][_\ $5ZW_:$W_/:3_OLT?VA-_P ]I/\ OLT
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=YI.ES^=9:796DV,>9!;HC8],@5HT4 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>aciu-20221231x20f038.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f038.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %+ F(# 2(  A$! Q$!_\0
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MS]CUJ58;4B [BQZ;AVK%UC]HSP7H.JWVG7EW=QW-E.()PMH[!/\ :+#C;[T
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MM*4KOMW1,1".100(64LQ?)/*Y /NJDS5+59 VDWA1@2(W&5/0X-?F9\(_/\
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MQ];ZOKTUSX*GL1J&AZ48HU2WA,[(C!@,MN50<DGK0!]NT444 %%%% !1110
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M@DUT'@']M37O&?B/PV]U\$O&.C^!/$MRMOI7BI]DX<-GRY9K>,%X8VX.YC@
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M:CX%_P"Q@M_Y-7&+>>&S^T&GB'_A"=3^V?V7]A_MG_A%IMWG>=_SW\O.-O\
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M?Q!#YNI064:7$F0V=T@7<<]\FO95^Z/I0 M%%% !1110 4444 %%%% 'S/\
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M_P"Q8F_]+(:P/ D>L>)?&OQ%\3>'(6T2UU.'3+:PN==TJ5$EFA20S.8"\4A
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MPVUE*G!['!KQSX!:E8^"?$VM_!K1=.>#0?!-A:"SN[FY,L\RS;V(?Y0.#W%
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MEUYI+_R<1;?]BQ-_Z60T >ET444 %%%% !1110 4444 %%%% !1110 4444
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M:G'&@+,[Z#J 50.I)-OP*;:_M'>!;ZWCGMK_ %&X@D&Y)8M#U!E8>H(M\$4
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MV^<^4&ZA<\XZ5QW_  T)X,_Y^-5_\$&H_P#R/1_PT)X,_P"?C5?_  0:C_\
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M;N=?\.:E+!#I]NTGV&TTU+E[B7<,>:SYV0@;BVW#=P>,4 +%^RQ\*(HK6-?
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MZ5\@_%^?6_B!XC?3O'2Z9X3M[*7S;.#P_JEH-86//R2&\D.^WW8SB)%/^V:
M/KFVF%U;Q3!)(Q(H;9*I5ESV(['VJ7'U_.L[PVJIX?TU4DFF06T862XG\Z1A
MM'+2?QGU;OUK2H 3'U_.C'U_.EHH 3'U_.C'U_.EHH X#X@?$#3;&:Z\,066
MK:YK%S9L\MCHEN)9887!02.7947G. 6R<=*E^$OB#2;[P^-$L6OXKS1%2UN[
M/58/)NH3MRN]1\IR.05)![&K/BOX7:7XHU9=72ZU+1-9$(MFU#1[MK:62('(
M1\95@#R,@D=C5WP;X TKP0MZ]E]IN+V_D$MY?WUPT]Q<,!@%W;T'  P!V% '
M1X^OYT8^OYTM% "8^OYT8^OYTM% "8^OYU2UO6++PYH][JFHSBUL+.%IYYFR
M0B*,D\<]!VJ]5/6-(L]?TJ\TW4(%NK&[B:">%^CHPPP/X&@#R*V^+WA*/7]1
M\67S:SI-[%I5O"=*U"R,4LMLUP?+N(ER=ZEI0#@_*.H!KV6&19XDD7.UP&&?
M0UPOB+X(>%/%WA32= UFTN-1M=*9&L[B:[D%S$4((Q,"&(^5003@@#(.*[N*
M)8(DC3A5 4?2@!V/K^=&/K^=+10 F/K^=&/K^=+10 F/K^=>>_$SXD>%=%G;
MP?K-WJD.IZU8S""'3=(O+V1XR"C,ODPN"5SG'7IQBO0ZP?&/@G2/'>E?8-7M
M?/1'$L$R,4FMI1]V6*0?,CCLP/MT)% '-_!'Q[X?\>>![.3PZVKR6%FHM1+J
MVF7%D[E/E) E10W3JN1]*]!Q]?SKE?AC\/+/X6^#;'PY8WU[J4%KN(NM1='G
MD+,6)<JJ@G)[ 5U= "8'O^=>%^+/CA\-/%FNS>%]6\3R^'-5T*_CNYH+Z(P,
M6BE=0/F'*L5)R.H((/->ZU\M_'K7K_7?B3;+X9\3VEPNAK'-?:9_;KZ6+80R
M,UR[28$<@,;HK MF/&<#=0!]*Z+K5AXATJWU'3;R.]L)TWQ7$3Y1U]0:\YUO
MQKX7U3Q;I&M03Z]J)T9;F+=H^B7EY;/YNP-F2.%@Q4Q]%)ZG-:?P#N[B_P#A
M%X;N;K7?^$GEEM0_]IAI'$X.<$/( T@QP'(^;&>]<9\4_P!H!?#FC:QHMSX?
MU'P_K-S8S)9-?:[HEFP9D94D7?J*N!NP=P&1B@#V#PYXFTOQ7I_VW2;M;NWW
M&-B 59&'!5E8!E8=P0"*U:YGX:I>IX!\/_VE/]IU#[##]HG,XG,C[!EC("0_
M/\0)SZUTU !1110 4444 %%%% !1110 4444 ?-/[1'A+PU9_%#PG?G2;.VU
M?Q"TUI>ZM:Z?<WNI/'#"7C58H'4^6#G<Y!"Y4=7R/7/@UI%GHG@Q+:R>YD@^
MT2-NNM/GLGR<9_=S$M^/0UXQ\5_B!;^)OB]:^$S=VVA^*=,UR"QT6Z.J26<A
MAN+%I99F4#,ZY5HQ&I"EMN2,9KU7X >)[CQ/X/OS<S37DUAJMUI[7SWANHKO
MRF \V&0JI*$DC'.UE=<MC) /3**** .0\>_"[0_B#I6HVE[$]C<WUN;675-.
MV0WJQ'[R+-M+ $9!'H36AX-\)#P;I:Z?'JE[J-M&%2!+P0J+>-5"K&@BC0!0
M .,5OT4 %4M7T33]?LS::G8VVHVI(8P7<*RH2#D':P(XKR;]HSX[:M\)4\,:
M)X2\,?\ "8>.?%5ZUCI&E270MH<JA>2:60@[411DXY^G6L?X=_'[QEHWA_QC
M>_''P5!\.8?#4:7+ZW9WAN]-OH6!_P!2V-Y<$8*8))([D"@#UZ7P/I<GB[3/
M$8C>/4-.L)M.MUC;;$L,K1LPV 8SF%,>G-=!7S_/^W!\,K'P;XA\1:C-K6D+
MH*VTU[IFI:1-;WZP7#JD,ZP. SQL6'S+G'?!XJA)^WY\*+9[Z.[D\26,FGW$
M,5^EUX=O(S912X\JXFRGR1/N7#'GD<4 ?1]<#XL^"OA[QCXA;5KYKZ,SK"E]
M9V]T8[:_6%R\0G3^+:2W0C(8@Y!Q7!^-_P!M7X;^ ?%^O^'=2;7)KO04MYM3
MN+#1I[JVM()@"L\DL8*K& 1ECTST/.-+X@?M=?#CX<ZQ#IU]?ZAJ,GV&/5+N
M;1M-FO8;"RD.$N;AXU(CC.>"><<XQ0![/TI:\CU7]J/P%I)\8,]]<W$/A;1H
M=>OKBUMS)&]I*I:-XF!_>9 S@>U<UXL_;A^&G@W5'T^]_M^XN8]%MO$$@L-%
MGN1%8S#(F<H"$"CEMV,>YXH ]\NK=+RVF@DSY<J%&P<'!&#65X,\(V'@/POI
MN@:6)1I^GPB"$3/O?:/4]SS7DWQ*_; \!^ [2R6VN;[7=0U#1CKUM%I6FW%V
ML5D4W)<W'EJ3%$>!EN>O'!JA!^TCJ\W[%TGQG_LBR_ME?#\NL#3-[_9S(@;"
M;L[MIV_6@#Z"IKKO1ER5R,97J*^7_A5^U3XHU?QEH.B>/]'T+PY%>>#G\5WE
MU974DD=NGF#8-S<8\M@3W!KN? O[7OPW\>W-Y#;ZA?Z2(;%]5@DUS39K%+ZR
M3[US;F11YL8QU'..<8H ZSX?_"*T^'-Y=S6&O:U=Q7<\MU<6]_+#(LLLAR7=
MA$'8C@#+'  '05WM>'?#O]L7X??$[QIH7A?2/[<AU76[>>\T\:CH\]I'<6\0
MR9D>0 %&&=I'7':K'Q6_:V\"?!WQE/X6UQ-<N=:ATW^UV@TG2)KS%L&(9R8P
M<!<$G.  /PH ]IKC?&OPNTWQQ>)<W.H:M8.;=[2==.OFA2X@8@M&Z\CG ^88
M8<X89-?//C+]N;^Q?C]\-O"VCZ;8ZIX$\66$-\^O,TB2P)*^Q&VG  R1D$9K
MCK[]O3Q]K/B+XPV'A7P;H-U;^"K9KZQEU&[FC^V6\4WE3LV.X*R;0,9*CF@#
M[@TS3;71M.M;"RA6WL[6)8(84^ZB* %4>P  JS7'_!_QM<?$CX7>%O%%W;Q6
MESJ^G0WLD$))2-G4,5!/.![UV% %74]*LM:LY+34+2"^M9.'@N8ED1OJK @U
M@>!/AIX>^&T>JQ^']/BL$U.\:^N%BC509& & % PH"C [9/K74T4 >!?&+X6
M?#NT\2R>(+R^TCPGKNJ*3<WTML[37FT8&XK(F=H[54^"/Q#N)O@-K)TI[2_\
M0:2MV88;6"2(2JK,(I?*D9V7<!G!)SCT->A:AX,\:7OCR^NAXXN;/PM/;J;>
MQM;>W6:VG!PPW-$V]&'/)R".X-=?::+/;:%)8W&L7MW*R,IOY#&DXR.HVJ%!
M';Y: /D6Q\5S_;[KQ1H6I6C:I:6NG6L-S:Z7:"XUK4Y_GGAD=80S[1\NU2-O
M?D9K[/C+&-2PPV.1Z&ODQ?$FJ>&/&EGH6C^*?%'Q<C%TL<[Z!= 7&GC=@FY9
M8OLI [_O(G_V6-?6B_='7IWZT +1110 4444 %%%% !7SOJQUOPS\:O&-XDV
MMZ%IVHPV9AN-)T);R&\=5()>1U8^8.@5<#'J:^A)XVE@D1)#$S*0'49*GUKP
MB#]F^X?PCJ4.I74&N^(YH;BWCN-2N)IK5V=R5NF1@2DZJ<?)Q\H&: /<M,=Y
M-/MFD>21VC4LTT?EN3CJR\;3[=JLUE^%])FT'PYIFFW%V]_/:6T<#W4GWI65
M0"Q^N,UJ4 %%%% !7,?$OXCZ%\)?!.J>*_$ET;/2-.B\V9U7>[=@JJ/O,3@
M5T]>.?M9_"[6_BY\%M2T;PWY4FO6]Q;ZE96\\OEQW$L$@D$3-V#8QD\4 <W\
M(?VS]%^*?CJU\)WW@7QMX$U/4+=KO2V\4:2;>*_A'5HW5F XYPV*]3T?XT^
M/$.M:MH^E^-?#^HZMI*-)?V-IJ4,LUJJ_>:1%8E0,')/3O7B7@SXF_''XNZA
M<>']0^$#?#71!I-Q;7NLZSJ4<DQNFC*I]E$1.4#<EB.G>O#?"/P(\>W^E_#C
MPTOPTO?"NK> [34AK/B.8VZQZR9(9$2.!XG+3>:S!CN  /7F@#[%C_:>^$$T
M%Q,GQ0\(-';PBXF;^V[?]W&3@,WS\#-:.O?'SX:^%[2PNM8\?>&],M=0M3>V
MD]WJL,<=Q #CS(V+89<\9%?%GPH_9@UZP7X(G6/AZ(WTKP[JL>IFXLHB8+M\
M^5YGJYR<$YZUP_AG0-9^%OQ1^ VG^(OAOJ/BG4-/\,ZMYOAN*"![A%-PVUEC
ME8*< @8!SAN* /T9UWXP>!?"_A.T\4:OXQT+3/#EWM-OJUUJ,4=K-NZ;)"VU
ML^QJW%\2/"EQ/H<,/B/2YI-<1I-+6.[1OMR@9+0X/S@#G(S7PQX(^ GCWX7:
M1\*O%&O_  _O?&&F:1+JTEWX0LC;7%QIHNY"\!6)V".47Y"%)QGTJ?PG\$_B
M-\)X_A'XJD\"ZAJT6F:UJ]Y<^'-%E@>YTR"[.8(\,ZIA>C;3A?I0!]C7OQ^^
M&FF:;;ZA>>/?#EI87#S10W5QJ<,<4CPG$JJQ8 E#P1VJ[=?&3P'8^#+?Q?<^
M,] @\*W!"PZU+J4*V<A)P LI;:3[ U\1?!K]GWQC+J7P1D\4> KN"VTOQ%KV
MH:C;:C#'*MFLSDPM)R5YSP1FGZ+\"/&7@WP]\/-9G^'=]KVE^%_&VM7UWX7M
MHH3.]M<.1!/%%(P1@.N,C .10!]A?!;XZZ%\<[;Q'<Z!'+]DT75)-+:Y:2.2
M.Y9,?O(F1B"ASP:\F\#?M[>'?'&JZ+:Q^"_$VFV^L>(9O#ME?7L<*P331*2\
MBD.=R#!''.>U6?V&_ VO^"O#_P 0&USPA<>"5U/Q/=7]GI5P(QY<#X*[?+)7
M'TXKYB_9_P#"^J>.O#'P?;0+0ZO_ ,(Y\1=8NM76UD1VL(G:0*\JYRH)/&1S
M0!^@]O\ %_P-=^-Y/!L/C#0I?%L8+/H::C$;Q0!DYB#;N!STJCJGQ\^&NB>(
MI] O_'OANSUR":."739M4A6X220X1#'NW!B> ,5\8:#\ O'R#0? $O@"[M/$
M&E^.Y/$MQ\16:#[++9><TGRS*WFM(ZL(S&5& .>*\T\9^'[OPWX8M/"E]X8M
M]5U=/BQ;W?\ PF]O<6<T-PLEPSK&KJYF\S;\K(1\H49[4 ?IGXQ^)'A3X>06
MD_BCQ)I7AV"[=HX)=4O([=)&"[B SD D#FO(OC/^VS\/?A#X*\-^+8+D^,]
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M$D85AE-PS[BO8O@IX4T1OA"-*^WVWB'1KV2Y,D2PM%;Q*\C;K=8G^9%3E=K
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M:*ZG2YN4C599HXO+5V Y(3)V@GMDX]:LU7L+&#3+*WM+9/+MX(UCC0L6PH&
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M% !1110 4444 ?.?Q:TOQ+H'C/5-9AT#[%H%U&@N-9T'5+U9I%4'/VNV@0G
MYQ)&&;'4@5WGPXDM_$GP2B7P3J>B0I/;2QV%]H<KW%JCDGYMS_,S;LEBWS9S
MGFLCXA_L_P"H?$7Q3<:CJGC&YOM&;;]G\.7]DLNGP8ZDQ*Z"4D\_O=WL*],\
M&^'G\+>'K73&DM9! "J_8K)+2(+V"Q(2% ]J /#D^&OBXZ#IEKI^@:AHOBR-
MXO/\2S>*9)XMP(\R4KO+3*V"?+9 .<<8KZ*0$* QW'')]:=10 4444 %%%%
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< !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>aciu-20221231x20f039.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f039.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $I W<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHO\ :TT^?5/V;_'UG;VTMY--IS(L$$;2/)EUR J@D\=A0!</[4?PA%OJ\_\
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MJ:7*7G]I+I(OG_LT7FS9]I\CIYFWC.<=\9KK_C2,?![QT<G_ ) 5]W_Z=WH
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M.G[.?B'Q-X_\$^$?"ES<V,>C?#YU\IK<FRU5H;J)A87+XP(Y2N& 8$CKQD$
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M#3+*)8+>VA&%C11@ 5'X4_Y%C2._^B0_^@"M6@ HHHH **** "BBB@ HHHH
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M_!&A-HD7@RSO%TG[$GV/[0[W"-.8,;/-*QH/,QNXX/)KSOX97G@ZYL?@C/\
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MJ3P9:>(-+L((]6U/3[V*PEDUZQL3)IUD+TXL_/ER"AERN,*=H=2VT,#7G_\
MP4N8']BWQ_S_ !Z=_P"G"WH ^GH_]6OT%.IL?^K7Z"G4 %%%% !112$X&30
MM%>5^'_VH_A=XI^*UW\-=*\6V]YXWM'FCFTA;>8.C1*6D&\H$. ">&[5S'PJ
M_;5^'7QB^,>O_#/P^=7_ .$ET5KI;K[79>7!F"3RY-K[CGYNG'(H ][HHHH
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M%$OQ?\7^!/!GAV\\3:=-=?;](FU&/4Y9YY@[^?;S.88PV&;" 8R,8!->P?\
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MBBBF(**** "BBB@ HHHH 0@,"",@]C6'H_@C0] U":^L-.BMKJ;.Z1<G@]0
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M?C;X)U+X@^ K_1+"WTK4X+M#%>:/K32Q6VH0D?-"TT)\R$GCYU##J"I!X /
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M/O"'BBY^)J?#;6]5;Q#-K41\,VUS:"_L%N!8BUDF#2B,!_L)\S:[%/-3KM;
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M@^)VA:[HO[,UQ\-K?3KV.[DUOQ-XVN)IAM.<Q6D,L@D?T\TA?6OOJ@ HHHH
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M /".QF]B2\UC^Q)=7^QP89BWV>(ACN94CW<A=^<<5Z77GWQGT?X@:MH.G_\
M"O/$-MH.IQ7T1N_M-C'=">U+!953>0%D4$NI/!*[3C=D 'D7PM_:.T./QPME
MJ7Q(U;Q6-;"A+6?PI=6EO8W;2*J0V[BU4^40S ^<S$;%);YFKZ=ZUYY\,O#W
MC'2[Z^G\1?$>#QO9X,"00:/!9>1,K88EHW8DC!4J>E>B4 )M'H*,#TI:* $Q
M7S!_P4O_ .3+/'_^_IW_ *<+>OJ"OE__ (*7_P#)EGC_ /W]._\ 3A;T ?3T
M?^K7Z"G4V/\ U:_04Z@ HHHH *^)?V^_^2S_ +/G_81U/_TF%?;5?$O[??\
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MM&TRD;/3Z\%%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %?/WQO\
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M*B5%+6/5O[O3J53K8-8*=.=-NJWI+I;^K]#6HHHKV3R0HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *^//VL?VG/&WPI^)L6A:'K_ (/\(6,.D#4(I/&
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M/?QBL?@'\*/$'CG4-+O]8M=)@\TV>G1%Y)"2 ,G!"+D_,YX49)Z5XM_P3/\
M^34](_["NI_^E3U[7\=OC!X5^!?PPUGQ?XR=_P"PK*,++#'#YKSLQVK$JG@E
MB0O.!SR0*R \?\=>.?BU\3/ASX=^(_PQ\4>'/ 'A.YT8ZC?VWC?29&GBXW;B
M> JA0>3P1AAP17G/[$_Q ^.WQP\*>&?&C>-OA_)X+^V31:CH&EZ.T5W#LD8-
M'N4[8W88D'M(#WKUFW_;=_9]\8> UE_X61X7MK74+ YTS4[R**6-63!BDA;H
M1]TKT^HKQ?\ 8$_:5^"_PR_96\):/K'C_P )^'];1[V6\LI[Z*"?<;N;874X
M))CV8)_AV]J /H;]GWXM_$CXD>*_B%I_CCX;S>"--T34S:Z3>R3[Q?18Z_[1
MQA]Z_+APO53GVZOFW]DS]L[3?VJO$OQ#T[3-"DTZS\,WRPVU^+J.>.\@8LJO
M\IX)*,1C*[2.<U](]* %HHI* %HI*\J_::\9^+_A_P#"/5=>\%065WK%H4/V
M:\MKF<S(3M*1K;JSB0Y 5B-H/+< T >K45\$Z)\8?VDK+]F35+R^T[33XQTZ
M\CT,:=/9ZA)JDDI!5F,JIY9D9I(F25085 .X]<6;WXO?M'2?LN6]];V&E/XT
MFO?^$?\ [/AL]0_M(2",PEC*4\L3><!)YQ'D;20#0!]VT5\'^+_C#^T?+^S+
MH5]IFFZ9-XRUB[?1Q865CJ":C P01AC*Z;$E62.1WD?$3 @*>03]/?LU>+O&
M/CSX3:7K_C>&PM-8O2SK:6-M<P?9XQA1'*MP YE5E<,V IZKQ@T >I4444 %
M%%% !1110 5ROCWP5I/BFWLM1O=(AU35="E.HZ2T@;?!=*A",I4@Y.<8S@@X
M-=57C/Q<^,_C_P  ^*$TSPS\%]>\?Z<UNLIU73=3L[>(.208]LK!LC .<8YH
M Z+]G_Q1XQ\8_"+P[JWQ!TA- \97,+MJ.FI"T(@82N%&QF8KE0IY8]:J?M'_
M  WT7XG_  CU[3-;TLZS!#;274-EN?;),BDQ[E4C>-V/E.0>X->9?L]IX^\6
M?'[QSXY\6?#S5/A]IU_H]E86MIJ=[!<F1XI'9F!A8@<,.H[5].4 ?GE<Z+JG
MA#P9\#=<UGP]K-YHD'@34-%F@M=)FO)+>^GB B22%$9DW8*[BN!G!(S7+>(?
MAOXO\*:#-X:USPUK6H:]XB\":+H^D/;Z7)<HEY%,6DA>1%982@922Y4?*>>*
M_37%&* /S[M_!?B2/XR6OA6?1=6E\4I\1K7Q(VK'3)3;'3DMT5Y_M6WRR/E9
M-F[=DXQS7I?[0/PK^/DOA7QSJ5O\=-,M_#+6MS,FB-X+MW=8-I/D^>9<DXXW
MXSWKZYQS7"?'C_DC7C3_ +!%S_Z+:@#@/V7/"6E>*?V7OABFJ6:77E:- 48D
MJPX/<<XKU"_^&'AO4KFVGETU%:!0JK&Q12!T! ZUP_['G_)L7PV_[ L'\C7L
M=<57 X6LW*K2BV[7ND[VV^X[*>,Q-%*-.I));6;Z[C8XUB1410J*  H& !Z4
MZBBNW8XPJI%I5E!>/=QVD$=TXP\ZQ*';ZMC)JW14N,96;6Q2DXWL]S@YQ_PA
MOQ&BF7Y-,\1#RI/[J7:CY&_X&N5]R!7>5S_CSPZ?$_AB[LXR4NE FMI%ZI,A
MW(P_$5)X*\1#Q3X9L=1("32)MGC'\$JG:Z_@P-42;E%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 53UBUGO=*O(+:;[/<RPND<H)&QBI .1SP<&K
ME?+_ .TI\4/$?@WQO;V>E?'CX;_#6V:U5SI7BVU22Y<Y_P!8"TR?*?I0!Z#^
MS]<7'@_1XOAQXG\7CQ3X_P!(MOMNH2-)/,YAED;RW,DHR1VZYXKU^ODW]DN&
M7Q+\7?&7C34OC)X(^*6LW>EVUC)#X/C6,6L<;L59U65^N<9KZRH **** "N,
M^-/_ "1WQU_V K[_ -)WKLZXSXT_\D=\=?\ 8"OO_2=Z .$_8D_Y-+^%?_8"
M@_D:]NKQ']B3_DTOX5_]@*#^1KVZ@ HHHH **** "BBB@!"0*\O^+_Q3\$Z%
MX2\20ZG?V.JWFEVQN)='M[M/M88$;2%!W(0Q!W8R.M?)W[6_@'XSZY\>;>[T
M&VUN^TUC'_9$^ELXAML8SN*G$; Y)+8]>E><:[^SWK_P/\<67BGXH7EM)X>:
MY\R>X@F%Q/J!(R\2Q9#$G.&+8 ]>E?,8G-:\)3A3HM*+MS/9>9^YY+P%E6(H
MX?$XO,8RE4ASJE#6<FK-PWO>VFB3O?31GTE^RO\ MGM\5=??PKXELH=/O0A:
MROA,2)P#@(^0!OQCD8W<\"OK85\]_LV>!?@MXA\(ZGK/P_T8?9-38P7JWI=I
MX2#GR_F8E,'!&T^A!Z5Z99ZO>^ ;N/3M=G>[T21Q'9:S*1NC)X6*X/KV63HW
M0X/7ULO]M]7BZTU-OJMK'Y]Q=_9RS>K#+,-*A3C9.$_B4DM=&W;TN^_4[FBD
M!# $'(-+7HGQH4444 %?/W[1G[%'@G]IKQ5H_B'Q)K/B;2-2TNT:R@?0-02U
M!C+ESNS$Q)RQZ$5] T4 ?+6B?\$[OAYHOPS\7>!F\2>--2T?Q.8#>2ZAJR33
MQ>4VY?*8PX7)ZY4YJM\,_P#@FI\(_AMXQTOQ*]QXF\6W^E2":PB\2ZJ+J"VD
M'1UC5$!(P,9R!@'' KZNHH ^'_&7PF\87WQG\36?@/1OB!H$^NW.I2^(-0UG
M4HSX=OK>6S>*(PQHY7?O\K;\@D4*=QQQ73?LA>!?%MEXW35M:\):IX/L]&\(
M:=X7ECU1(XS>W<#R-))$$9MT0#@*YQG)Q7US@9SCGUH  Z#% #)H([B)XY46
M2-U*LC#(8'J".XK%\(^ _#O@&TN;3PWHECH5I<SO=2V^GP+#&TK?>?:H !/?
M K>HH \]\9_!#0/'7Q/\$>/-0GOX]9\(&X.GQV\JK _G)L?S5*DMQTP1^-=;
MXK\-VOC#POJ^@WS2I9:I9S64[0,%D$<B%&*D@@'!.#@UJT4 >&0?L>^"(/#G
MPNT1;S6C:?#JZ^UZ0QN8]\CX Q.?+PXX_A"UG?$;]EG0IM.^+VL:3HQ\6ZWX
M^MX$U#0]:U'[-9S^3PJQR)&6A;&2&.[#!>@KZ$HH _-SX)_L9^/]4^-?A36_
M$7@_Q!X$T+PW8WUHVH^(?',7B"_N$FA:&.&U\M0D$<0=BH*#WSV^O;[]E#P7
M?>%_AEH)GU6&Q^'MW#>:28KA \DD2A1YY*'?G&3C;DD]*]FHH ^5?C/^R#I,
M?PU\>V'A/PU<^+QXGUA-<G\,W.NC38K:YYW3V$PB/D2YP</E#R.!P?./V0/V
M7O'OAO\ :&N?B7XN\+ZIX0MK;06T=(_$GBU?$6J:C,TBMY\DZ8555$"!0 ,
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M?LT+WNB3B["KG+Q=)4_%"?RH [6BH+&\AU&R@NK=Q)!/&LD;CHRD9!_(U/0
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M">'=3T=D@A,UU/:M'8W,S;A(MK(QW2+&R[68@<FO$_V^_P#DL_[/G_81U/\
M])A36X'-CH*#0.@H-: >J?\ !,__ )-3TC_L*ZG_ .E3U4_X*E_\F9>+_P#K
MYL/_ $KBJW_P3/\ ^34](_["NI_^E3U4_P""I?\ R9EXO_Z^;#_TKBKGG\)T
MX?\ BH_-"[BEGLY8X9OL\KH527;NV''!P>M9/@[1]1T/14M=3O\ ^T;D.S>;
MCH">F>I]>?6MP=!17XHJDE!T^C=]NWF?Z=2P5*>)AC&WSQBXKWG:TK-WC>S>
MBU:/K?\ X).?\E*^-7^YIG_H,E?I!>WL&G6<UU<R"&WA0R22-T50,DG\*_-_
M_@DY_P E*^-7^YIG_H,E?>GQFM-0O_A-XPM])NUL-3ETFZ2VNF&1%(8FVL1[
M&OUW NV$IO\ NK\D?YV<6J_$&-7_ $]J?^ER/D_X^_&7]C;]H6+3&\9_$#2[
MRYL-T=M/97MY;/M?&Z-VA )C)520?3/%?F=\-/!O@[4OBEXI@UOQKX63POIE
MVWV:SUS7[V&PU:+)6...6W5I@ I#!R#C:%;DFNL^#OP#\2^,OAG:ZQI.K0>&
MS>VAM81=A;U9H69Q.^TJ?*+$)@ Y&PGC-'@C]DOXH:-XMGOI/$&DV*6TRR07
M$\8NTN2JE%/E%<#"$CYNGZU\Q4XLP%*=:G.K!2IW5FWJUZ1?X<UNJ%#AK'5(
MTIPIR<9ZW26WS:_&Q^@'[*7[:WPUT*_\%? VTUZ?Q5J:(;*+Q#99?3VG=GD2
MWB\UO/:-%81+(R_PJ#7W+(HDB93P",5^,?[,7P?UKP%^WC\.K2UM(9W>6YNF
MOKJ.+R;FV6'=*Z*!E90S2=N,IC@5^SO\/X5]3@<93Q^'AB:3O&2NCYW&86I@
MJ\L/55I1W/S?\,^,KOX;?'?58] \._%3XF6/@35[^*&PM;72TT^VGO%>20*X
M"S$8E; =CTKR[QOK,?B']M?0?&ES\%_B;;ZI/;2:M)X>^V6XEN)H3&%EC7=@
M1 1KO4GDXKW[X;Z[_P (OX]_:5U<:;>:PUEXF286&G1B2XGQ: [(U.,L>PKY
M&\7?&3XJZI^U-8>/;'P3\2+31;)Q:P:6^@?O4LWV>;#]PK\^'R=W<8(KO.([
M7]KW]HVV\6?$>6]\:?##Q[X5N%T 6^D1374< MKMI\)<2^6Q#1Y^7!ZGM7ZN
M^!9'E\%: \C%G;3[<LQZD^4N:_)G]LOQAX7\?:=X?UJ_A\;^$=3U%;..]T*\
MTI L5BM[_K)VYV2;AE #\W%?K3X;>VM?".F-9>=<6<=C$8-R_O'01C;D?WB,
M<>M &S17RK\/?V[;+QY\:]>\ P^!/%B75@D)\C^R7%S:D[_-:Z4MMC0?NMI4
MDMY@JO\ "S]O6V^)/Q-\7>%8?A_XK:31]C+!;:4[75LHB9I!=J2!&V\*BA2V
MXL.E 'UE17RE\(_V\K+XI^(/&NG6?@/Q9=G0)93LL=)=I(42$-Y5P&8!)VD$
MB*BY!*]16Q^S)^V99_M%^)=?T>T\+:W:_P!G7T\/V\6#K:V\:*NQ+B1C\D['
MS!L (^3K0!]*T444 %%%% !1110 4444 %<'\>/^2->-/^P1<_\ HMJ[RN#^
M/'_)&O&G_8(N?_1;4 <Q^QY_R;%\-O\ L"P?R->QUXY^QY_R;%\-O^P+!_(U
M['0 4444 %%%% !4<\*7$+Q2*'C=2K*>A!ZBI** .%^&TS:)+J?A.X;]YI4F
M^U+'F2U<DH?^ G*^V!7;K,C2,@=2Z\E0>1^%>3?M ^+=,^%VEVGC2ZU2'2[J
MUW6F'RS74;CF-5'WF!PX^G-?$W[)^@?$7QI\?8/%VEW=]=Z0M\[:GK+R,(9H
MLDE&W'))&,+CCVKR<5CUAZU.A&/,Y=MTN]C] R+A*><9;B\TK5E1IT5=.2=I
MRU]U2T5]+:7=VM#]-:*04M>L?GX4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5QGQI_P"2.^.O^P%??^D[UV=<9\:?^2.^.O\ L!7W_I.]
M '"?L2?\FE_"O_L!0?R->W5XC^Q)_P FE_"O_L!0?R->W4 %%%% !1110 44
M44 %%%% !1110 4444 8WB7PCI?BRVCBU" M)"V^"YA<QSP/_>CD7#*?H>>^
M:YLW'B[P2V)XW\9Z,O\ RW@5(]2A'^TG"3_5=C?[+&N]HH P?#7CG0_%PD&E
MZA'/<1<36C@QW$!])(F =#_O 5N]:P?$W@30O%QBDU/3XY;N'_47L9,5S![Q
MS(0Z?@:R+#PQXJ\/7MNMEXF&L:4'426VN0;[A$[[+B/:2?\ ?5B>[4 =M111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'':[\8/!7AGQMI?A#5?$VFV'B;4PIM-,GG"S2[B0F!VW%6"@XW%2!DBO$/\
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MSQ[T ?IUX6\#:!X)_M,:#I-KI(U.\>_O%M8]@FN& #2,!QN(49^E?(7[??\
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MN+>XTV$H[,/^66PL0Q/8Y%7-)_X*:Z5/KIAU#P5<VNE-*%2ZBOE>5$SRS)L
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M_P )O^@IXA_\(W6O_D2C_AM?X3?]!3Q#_P"$;K7_ ,B5[EL'O^9HV#W_ #-
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MV*\]_9\\'ZG\/O@AX&\-:U$D.K:5I%M9W4<<@D59$C 8!AP>1U%>A4 %%%%
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M(_%TWB#16U:>X6WDL["UU"_:XM]+MWD\R2&V0CY%9^3DL> ,@ "@#U^BBB@
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MD$$=14E?/?["FLWNK?L^:?!=L[IIFHWVFVKN<EK>*=ECY[\<?A7T)0 4444
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M&,KV.G1>6LMP0996)+,[D  LQ))KJZ** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *3 I:* "L._\#Z#J?BG3O$EWI5M/
MKVG0O!::@Z9EAC?EU4]@<"MRB@!,"EHHH 3&*R+_ ,(:+J?B'3=>NM-MYM9T
MY)(K2^9/WL*28WJK=<':,CVK8HH CGMXKJ"2&:-)H9%*/'(H964C!!!Z@BO/
M_ ?[/'PT^&&O7&M>$_ ^A^']5G5D>[L+-8Y-K'+*I'W03R0N :]$HH ****
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MPU@^&WAQK9 D-W?2"]O[:TE<V27;J//:WC;_ %:.^Y]H &6)QDFNXH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2T4 )2T44
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
L% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>aciu-20221231x20f040.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f040.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $/ >4# 2(  A$! Q$!_\0
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M&O\ X&1?_%48^(/_ $ U_P# R+_XJ@#U;ST_O#\Z//3^\/SKRG'Q!_Z :_\
M@9%_\51CX@_] -?_  ,B_P#BJ /5O/3^\/SH\]/[P_.O*<?$'_H!K_X&1?\
MQ5&/B#_T U_\#(O_ (J@#U;ST_O#\Z//3^\/SKRG'Q!_Z :_^!D7_P 51CX@
M_P#0#7_P,B_^*H ]6\]/[P_.CST_O#\Z\IQ\0?\ H!K_ .!D7_Q5&/B#_P!
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 C?=->1?&7_CV@_Z[1_\
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M/]E7YFM)&WQ-SS@?PX]O6F!=N=6U^4,IU[65"]XM2N%Z>^_U%0_\)%JZD_\
M$_UM%)R VJ7!XZ==_2K-KJ5AX@*1K++9:AN :!QM.X] ,\$'_&HM4T-H1NV8
M< G"KW%%@,C7/%OB"VTN::W\2:Q%*BAE==3G/.Y>>6].WO7UEHG_ "/6O_\
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M]O0CW/IVJO;ZB(PJR88 $!@?U.*NI=QM+C>"S@,!G.5Z<"@#+O\ 2XK@@S(
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M;]RCKG;GO2 VZ*** "BBB@ HHHH **** "BBB@ HHHH 1ONFO(OC+_Q[0?\
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MY$DU;38KUUB:#+DC=&V-R-@C<IP#M.14R^$='1(U&GP[8[@72@C.)?+\K?\
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MZ\1$[+R21RENP.3E1U 7@>IK'M_AA:>'XXI/$]_-;E/]:(1MB)W8PK#+$GG
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MO_\ 7P/_ $!:^2[[2AI_AK4(H[B0 19$9&>!CD^I-?6FB?\ (]:__P!? _\
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M%WQG;_"JPU>RNM$UN]M]>@TO5=0DM;BQD@A:[AA*M92#?'<E91E&;:OW@6!
MH ^@**\]_P"%S:9_PMP^ _L.H_:Q9?:OM?V&X\K?YFS9N\O;MQSYF[;GC.:]
M"H **** "BBB@ HHHH **** "BBB@ HK)\7>(HO"'A76==N(9+B#3+.:]DBB
MQO=8T+D+GC)"G&:I_#[X@:%\4/"6G^)/#E\FH:5>IN21>&0_Q(Z]5=3P5/(-
M3S*_+?4V]C4=+VRB^6]K]+[V.BHHHJC$1ONFO(OC+_Q[0?\ 7:/_ -"%>NM]
MTUXS\>;Y=+T*:^=&D2U7[0R)]Y@GS$#W.,4 >SUX-X[01^._$*SVEX5FDA9'
M2SED1E\A!D%5(/((Z]JW/@;^T$OQF\0>,=#N/">I^$M6\+M9)>6NIS02DFY@
M\Y-IB=EP%([]Z]1U?6++0=.FO]1N8[2SA ,DTIPJY( _,D#\:>PDT]CYT0VE
ME;I#;6%[#&@P$BTV< ?0;,"LZ^9YW$*VVIJ#]^4:;/\ =YX'R5]26]Q'=V\4
M\3;XI%#HWJ",@UCW7CCP]97"P3ZW81S&Z-EL-PN1.%#&,\\, RG!_O#U%%PL
M?*NMM<M;&"ST743$'7:G]FW'[S'=CY? SS5_0])@\,VRW/V#4+W57!RXTV?:
M"3D_P?3 ]/4G-?5.BZU9>(M,@U'3KA;JRG!,<R@@, 2#C/N#5ZG<+'R+?B\U
MF9I[FTU$;A@(NG7 Q[<ITJI;:?,D\IETV^"JV(BFGW))7'<;.O7G-?8M%%PL
M?(\0># _LW4]B [!_9]QD\>R?XTD1N([FV']GZD%6U\Q\:;/CS78EESL_A4*
M/PKZYHHN%CY>2Z6:[<?V;J2V\.$#_P!G3AGX&YA\GJ3^5>5W?BSXM1W=T(/A
M/I5Q LQ6&676KM&=,D*Q3[&<9')&>^.:^]:*5PL?#6C>(OB?+.-.U;X;:7I.
MBRQ2B>?3-3NKB4?NVQLC-H@8EB,@L,Y)!XQ7HMV+K3-?U.*?3]24_:"P*6,S
M @JN.0I!'TKZ@HHN%CY>:Y)EC<Z?J$BY/)TZ?(XZ?<I1<'D"UU'UYTVXP?\
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M[F4I"0FYO,V@@"@#U/Q]J'A;Q3\*-8U6_9/$/A.*S?49ET^<.MU'!^]*JRL
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M9E4C:.*]!^+G@/6_',&A?V+JL.F2Z??&YE$JLIE0Q/'A94(DB(WYRA&X J2
MQH J^/KCX:_$:+2_#^O:]I<MU/+#?:8MMJXMKM9&5O)FMY(W612REPK(?F!8
M<@D5S_PJC^&_CKP:= \+V\E[X>FD75I+F>_,MQ<W,=X09)6:1IF?S;8'>_!
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MO/OB-XA_LCQK\/+3S]&B^W:G+&%U*"22X8B!_P#CU900DF"P); VEAWKT&@
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M>55^>;S(]@"Y )8*"<D'C':^#4@7PU8R6KSM;31B:-;B[^U,BL,A?-W-N Z
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M@UWE9E!1110 4444 %>?:'_R/.O_ /7P/_0%KT&O/M#_ .1YU_\ Z^!_Z M
M'H"_=%%"_=%% "T444 %%%% !1110 4444 %%%<KX\^(6G>!+)6N"9KV4'R+
M5#RWN3V7W_*@#JJ^>_VH[^V@\>? /S+B*,Q^.XF<,X&T?8+P9/H.:6Z^*7B'
MQ$D@:86%N^2$@^7 [#=U_E7A7QTN(;;Q=\'9+R\@M=_BZ.0O>SJGR_9;@%SN
M/W<D#/3) [T ?9=[\4_#EF^P7QN6'7[/&7 _'I5V?QYHEOX?76GO0-/9_+#[
M6W%^FW;C.>.E>&QZ9N\W$D,DJC<(U(+?E7+:W>SIH]Q:_:9?+6]618 Y*Y:$
M@X7US0!ZG\5?C!X7U;X3^-K5;YK>>;0;]42XB9-Q^SN  >F3Z9K6_9FUG3[O
MX ?#*WAOK>:=/#&FJT22J74BUC!!&<\'BOF;XH6R:=\-_$$^H7UI9.^D7>U;
MF94))A8 #/<D@?4XJE\('9_@]X*N+21+B--&LU::RE$GEN(4R&V_=8'@CJ#0
M!][YI:^1--^/?B_P8$'F+K5@&/[J[R[@?[X^8?K7T#\,OB]HOQ,LL6CBUU.)
M09["5AO7_:4_Q+[C\<4 =U1110 4444 %%%% !1110 4444 %%%% !1110 C
M?=->1?&7_CV@_P"NT?\ Z$*]=;[IKR+XR_\ 'M!_UVC_ /0A0!N?'*!;WP0]
MJ;#5[UWGCDC?1HO,FA=&#!O4=.M9N@^*M?T?X'VE_J=JWA_6[6%;<G6$,@)#
M!!(X5LJ'ZY<KMSEL &M#X^:E+I/PTO[F&]U.P=)(OWVD-MGQO'&[(*@]R#FN
M@^&XF7P%H(N)[RYG^QQ[YM04K.YQRS@DG)]R3[T):,?8R]#^)$EW%X1@O=)N
MTO=<LDN))(HB(;9RF660DY3)R%S][!':N5\3?%+Q5HOB&[T];&P"QZH;:UQ%
M,PO$*6Q2$-QMD(GE8L 0!"1@\FO8J*=];B/DCX@:CJM[XP^(%CX@@8:S9_#"
M\2[F6!EM9M]P[+Y+D 2 *0&QT/!YKXJ^/_C>T^(7C'QA\'M+\+W5WJ%CIZ7D
M5K9V=L$OI8HXYP@=4\X9W8(5OX?0U]]?'?\ Y*%XY_[)?>_^E#5P\448".(T
M$FT?/L&[IZ]::$SSG_@G[X8N/"US\,;34/"I\(ZI'8ZZ)K"5&\Y<RP$,Q;YL
M,,$ G [5^B%?)_PN_P"2]^#_ /L':I_*VKZPH>X(***RO%>O+X6\+:QK3PM<
MKIUG->&%6"F01H7V@GIG&,U(S4SFJUKJME>WEY:6]W!/=6;JES#'(&>!F4.H
M<#E258,,]00:^(_%OBKXK?L_V5Y+X:TS6M5F\0:ZFN7]M>7ZZHEG#<2 W+1R
MBR58XU53A=Q"?>P1G/IG[.WBO2)_$5AXETWPY:/_ ,+,$UW+XLL]7><ZE):H
MVUI(&BC$>%W("H'W0,=* /IJN4^*6B:KXC\ ZSIVC&V.H7%NR)'=Q>9'*,<H
M1O3!(X!W#!P:ZNN!^.%M/=?#V\6WCUF682QLJZ&NZ?[W4C<IV#J<'(QG#8P4
M]AK?0H_!_P  SZ/\*!X;UZSDCCE,\;QR.4GEA8D*92DK[9"N,[7/L1T'&_%;
MX >$M"^"WCI(XKR\L8O#NHD6%_=-<0-(8)")6#Y8N!\H).  .,C-=;^SG:WD
M?PXMKFXOX;B"[D:>"R@B*"P!)S <\E@?O @8;(Z5M?'+_DBGQ _[%[4/_2:2
MM)-W)L?)GA1BUIX-).2?AWX9))_ZXSUTR?>%<QX2_P"/+P9_V3OPS_Z)GKIT
M^\*:V$SZ(^ __)&O!O\ V#(?_0:[RO/?@G>0:?\  _PG=74\=M;0:3%)+-,X
M1(U"9+,QX  Y)-?/N@_M^P?#_1KRX^-VFV'AJYN=?DT[1CX8N4U.&YML QRR
M-'(VP]<DXR,':.E9E'V)6'XE\<^'O!L$DNN:W8:4J1&8BZN%1B@ZL%)R1P>@
MKR+]GKX\>)OBSXV\>6>NZ=X>TWP_:78/A>?3M6BN;O4;/+!I98DD8KC]V<X7
M!<C'&30^(_P&\/?&3]H>;4]7ENX=2\/^'(!IS0N#"KW#7L3M+$1B4 8P"<?S
MH R/#7[>_@1]/^(FI^*[B'P[IOAK4)8["02B:34[-53;,B*<AV8M^[.#@IZG
M'TKI>J6>MZ;:ZAI]S%>V-U$LT%Q X=)4895E(X(((.:^=_@[^Q'X?^$WC#2?
M$#Z]<^(I+'1O[(DM+^Q@$5T_F;OM<F%R;C&$+YY4 8KUWX,1)!\,]%CB18HT
M6551%"JH$KX  Z"@#M:\^T/_ )'G7_\ KX'_ * M>@UY]H?_ "/.O_\ 7P/_
M $!: /0%^Z**%^Z** %HHHH **** "BBB@ HHHH P_&?BJW\&Z!/J5P"Y7"1
MQKU=ST'T[GV!KYDU34KSQ+K3ZI?R>;<3=%Z >F!V ["O2OVA[J2:\T2Q4$HJ
MR3D=B3A1^0S^=>>>'X1<7KS% T<(P 3U- '2:1I"6J":Z95(3>0?X02%&/J6
M'6N-^(?P?\.?$O5?#VJ^)M!N]4UCPSJ9OM/"(I@D4 [(2W>(D(Y!YW)7H+VL
MS(MP-CH$W$[CR?X01Z9Q^('I53?#-<#S'9G_ +LAR >XH S9/%^KC"Z]X;O6
M5G40R:="[N')[9YQTY!^HJCJ7B+S;E+>*&)C++Y4>IA 5)W%2,XV^:&&W9GK
M[<5N74<JQNL4LL*RH4(#'C\,UY]JGA:%[&.T.GO]DCO6OU83883%0OF8SCMT
MH Y;Q?JT_P 1/#6L^%M+\!:MJVG:BDMGJ$VJ6DB,V>K 8W$AL%22 -HP#BMS
MP'X?T[X?_"_1/#]QIT_@RXTFV\FV<VLK+(5^\[G8/,$A)+!N<L<<@5I3ZK>3
MVZQG4+N2&'$91Y2'(SZ9Q_\ JJI'K:P:L\4>HRQ'=_JTE./88Z9^OM0!:N=#
MFU'0['6(;<V=U<1!YK24$%&*[BK#Z9(Z'BN3L;B?P]JUOK6CR&SU"U?S!M.0
M&[DC^[V([@UVSSWE[>V]Q$EQ']I6.YD88*9C5EP?J)#CW6N0UV.+3M7$\,8%
MO=\.K<>H_P _6@#[)^'OCBU\?^&;?5+<"*4_)<6Y8%H9!U4_S'J"*Z6OF_\
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M,=\4GL5'=$/PNEUN;P?;MX@%R=1\R0&2[14EE3<=KE !LR,?*<D=S57XY?\
M)%/B!_V+VH?^DTE8WPB\3ZU_PIT:KKS37FLVB3FXBU"1()U=,G9.2 L;#OV
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M =_7&?!W_DG&C_27_P!&O79UQGP=_P"2<:/])?\ T:] '9UY]H?_ "/.O_\
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M<;\7-2U/2O E_+I$6IS7[%8HTT>U^T7)W':=HW+M'.2^?E S@D8I/8J.Y@_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_OP_^%'_  MKPS_S_/\ ]^'_ ,* .QHKCO\ A;7AG_G^?_OP_P#A0OQ;\,D
M_;9![&!_\* .QHKC(_B[X9D7/VR5>2,- _\ 04[_ (6UX9_Y_G_[\/\ X4 =
MC17'?\+:\,_\_P __?A_\*/^%M>&?^?Y_P#OP_\ A0!V-%<=_P +:\,_\_S_
M /?A_P#"C_A;7AG_ )_G_P"_#_X4 =C7GVAC_BN=>_Z^!_Z M:L'Q2\.7#!4
HO')/_3!_\*CT.TCGUW4+^%MT5Q('4D8R-H']* .O7[HHH7I10!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>aciu-20221231x20f041.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f041.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &, ZP# 2(  A$! Q$!_\0
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M!8 C#'KTK'U;X2>.O&^G^)+^\\*6/AJ[7PJ?#]GIMM>Q2M?2;MPD++A448P
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#E?$_B\>'/$FAVMQ/;6NG7?G>?-<';MVIE<,3@9.!6/:?%
M2W_MC61*\=WI<%Q;V]K+9 .6,@ZD[L$ YZ5T>L^&/[7\2:-J3O&8+#S=\,B;
MM^]"H]N#S7-ZO\+I;^ZUJ>VO(;4WEQ;W-NHB^6-HAC# =0?:O@LP6>PK3J83
M6*FVEI=Q]CIN[<O/TM?FUO8^EPKRV5.,:^CY5=^?/Z7OR]>VFYJ:K\3])T>\
MOK:>&\>2SN(K:3RH@V6D!*[?FR1QZ9]C4-G\6='O+JWMS;:C;O+<"UD,]MM6
M"4G"K(<X!/;&??%9,GPMU.]O[J]O-3MGN+B^MKQ_*A95'E9RH&3Z\5;N/AG<
M3+>@7L0^T:NFICY#PJX^7Z\=:YOK/$LIN<::4;NR:C>UY-:J6[2BOF^NVWL<
MH45%SN[+6[WLK].]W\C7B^(FFR^(X]&,%['+)(T4=Q)#MAD=1R%;.3T/:J^B
M_%'2M<O[.UAM=0A%VS)#<3P;8F=<Y4-DY/':LJQ^%]Y;>)+34I;ZVG%M>/<K
M(T+>?(K9^1G)Z#(P  .M7-.^'=Q8V?AN$WD;'2KJ2X<A#^\#9X'IUK:CB>(I
MSO4IJ*4GI9:QO3T^+31U'?R7SSJ4LJC&T9MNWGO:6NW=1^\U/$_CZQ\*ZA#9
M7%K>W5Q+"TZK:0B3Y5ZYY'3KZ56TKXHZ+J]SY4:W<2FV:ZCEFMRJ2HOWMG<D
M<CIV.,U/KOA"75_$D.II<)&D=A-:>65))+@X;/H,U@+\*[M;72XEU-8GL]-F
ML3)&A!+.3AAZ#FML57X@ABINA!2IIZ*RU7N]>9;WD_\ MU?/.C3RR5&*J2:G
M;5W>^O2WDE\S7T_XI:/>V^HRRQ7FGFQB6>2.\AV.4/ *@$YR<#\122?%#38-
M*GOKBQU.V$,L<36\UMMER_W2!G!!]C6%8_"&=8M26YO;5#=V:6^;2 IAT8,K
MG).XG')/6MB^\'Z[KFGB#5-7MIG6Z@FC2&WV1HL9R?5B6]SCCBN6EB>(Y4OW
ME.TN65M(M-WE;F]]6TY;63O=WMNMIT<J4_<G=75]7MI>WNN_7=Z:?.:[^)NG
MV2Q"33M5\YHC/-;K:YDMH]Q >49^4'&1U.*34OBEI.GW+Q);7]^$MTNVELX/
M,01,,AR<C  ZY]:77_!VI76L7M]I.H06G]H6RVMTEQ"9.!G#)@C#8)'/'M7-
MIX(U:V\0:EI^E3"TL/[+M[(W%U;LZR@!@2I! WCKW'/2GB\7GV'G[.,;IRLF
MHQ=])-->]ULG*_+RO17"A0RVK'FD[:7:N^ZO?3I=I6O=:NQJ7?Q3BT[7KY)(
M)[S2X[2&ZB:RMR[A6!+.YR % Q^?>M'6?BAI&B30++%>S0RI'(;F&#,48?[N
MXDCZX&:KP_#IK1-7BANU\J[TJ/3H]RG*;4*[CZ]:P=6^#M]J09#J=N\;00(I
MGA9FA:, ?NSG"AL<\9YK"M6XFH4INE34I-MK;W=965W+5-<J79/YEPIY14G'
MGERI)7WUT7EH]_F='K7Q5TC1+J]A>"^N4LRJS7%M!NB5VZ(6) SSGT]\U*WQ
M.T9=<73#]IR95@-UY7[A96'"%L]>1VQSUKSKQ5H?B!-2U[1;'3KN2SU2>"42
M+;;XV<$9/FYPB\9P>>.W?K(/A0UMK[7*36+V;W*W3F:R22X!&,HKMD!21Z9'
M:N>EFW$&)Q,X4*5XQDD[QM;WIJRO)75E%MZ/7;4VG@LLHTHRJ3U:NM;WTCV6
MCNWIMIY&]IWQ#TS5/$$FDP0WGF+(\0N6A_<LZ]5#9Z]>H%=17!V_P\O$\60Z
MK)>VJQ17#S^9;V_E7$P(X20J0K >I7/OR:[ROM<IJ9A4A4_M"-FI/EV5XZ=$
MWUOU/G\;##0E#ZL[JVOK]R"BBBO=/-"BBB@ KBOBCXOU'PAIUA-ID<,LT]QY
M1692P(VD\8(YXKM:YWQ=X5;Q-+I!$RQ)97:W#JRYWJ 00/SKQ<YIXJK@:E/!
M-JH[6:W6JN_NN>A@)488F$L0KP5[W]'^IS'_  LZZNO'>D:9;+!_95Q KSRL
MI+!S$TF <\<;>WK6YIWQ+TG4[P0)%>Q)*LC6US- 4BN@@);RVSSP"><5@:%\
M'VTB>P>2]2807$\DORG+H\7EJH],"K^G?#J^CDTRVO\ 4XKC2]*$@M(XH2LI
MW*54NV<':#V Z<U\=@:G$L&W6A\4[V=FDGR:7YE9)<^J3?,MK/7W<1'*9:4Y
M;1MU5W[VNVK;Y=[:/[MBW\?:;<1:/(%G1-4BDEA9T'R*B[FW<\<>F:K:-\3]
M'UB&[GV7=E;VT)N#-=P[4DC!Y92"<_3KSTK)T?X<ZM8W6C"XU6W>TTJ.:* 1
M6^'*NI4$DD@D9';'%5[3X1SN=02\O[>*"YM6MMNGP&$.Q.1(Z9V[N!]T#-=*
MQG$;Y)1H+K=/E7V(]5+;GYOE]SR=#*ES)U/1J_\ ,^EM^6WS.I\*^/-.\72S
MPVL=S;7$2B0P7<>QBAZ.,$@C\:H:C\5=(TK4[FSN+>_"VLXMY[E+?=#&Q *Y
M(.><\<9X/%+X&\#S>%[B:>X>P,C1+"JV-FL(P,99F^\22.><>U5=2^'-Q?#6
MPMY&G]H:A!>+E#\@CQE3[G%=,J^?O+Z4XP2K7ES*RV2DXZ<UM6DM'UV73%4\
ML6*G%R?L[*VKW;5^G17>WWE^'XD:=+I-U>_8]022VG%M)9-;_P"D!R,@;,^G
M/7M3$^*&D2Z/;WT<-[+)/.UM'8QP;KAI%^\-H..!SU_7BL_6/AQ>W]QJD\%_
M"AN[^*\$,L;-&RJA4I( 02#G/6J]A\+;S2;6TDL]0MDU"RO9;J!C ?)VR !D
M* Y'3C!KFEB>(XU'!4DXI-7M'7W[<R7-OR7:3TO8V5'*7'F<];K37^79Z;<V
ME][&O+\3]-3^S5CLM2N9[]&>*"&VS("IPRLI(P1S[<=:?'\3='DU9;()=B)I
M_LHOS ?LQF_N;\]<\=,>])8^$=2&OZ1JVHZFE]<6D$L<I$(3<7Z;0.@'OS69
M'\-+Q)([#^TX_P"P$OOMX@\G]_NSN";\XVY]LUM*OQ K2C"Z;6CC%.W+'?WW
M9-N5VFW&RM>]S-4\L>CETWN^[V]W5I)6NE>[O8NV?Q7T>[U"*V^SW\*27+6G
MVJ6#$ E&0%+ GKCCZ\XJCX5^*D=_+!:ZG!-'<7%[):1W$,!%N&#$(A8G[QXZ
M>HZ5D>%? VL:I:F&^F^PZ5'J\EX;:2W*S.58[<,?X3P>E;"?#*Y72=.M!?QA
M[753J)D"'D%B=H]^>M>7AL5Q'B53Q*CHDW9I*]W'2W-M:]F[/?38[*M'*J3E
M2;U]6[;ZWMZ76VVIKV'Q&TR_UW^RQ#>02,)#%//!LBF"9W;3G)Z'J!T-0:=\
M4M)U*_M+9;>_A2[,GD7,\&R&144LSAL\C"FL;1_A7=Z=K-I?7%Y;77V?[0I9
M8F$TZR*P^=RQR1NXZ#%<]X6T37-6U31=+U"PO+;3],CNH2\EJ8@(WC9!^\)(
M<_,/N@?CUH>;9_1E2IUZ5I3G9+EO=7IZ-IV5E*>NK]V^RNQ8++)J<J<[J,>]
MM;3V36NT=//Y'=:;\5=#U$W9_P!*M8X(&N1)<0[5FB7JR8)S^AYK0\*>-;+Q
M>LWV:WN[5X@K%+N'865NC+@D$?C7.>'OA;/HZS(UUI\8%JUM#-;:?'YC$_QR
M%@=QQP1P#6AX&\"W7A?4KR[N+FV(FB6(6UE$T4((.2^TD@,?; Y/%>K@,3Q!
M*M06+I)1=^?1:::?:?73;;N<>)I98H5?83=U;EW^?3L=I1117W9\V%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 445YQXC^/?A;PWXI?097
MNKF\AW^>UM 7CB*QF0J6[MM'04 >CT52T76+3Q!I-IJ5A,+BRNHEFAE7HRD9
M!J[0 4444 %%%% $%[>P:=:375U,EO;0H7DED8*J*.I)/05R/A'XR^#O'.K2
M:9HVM1W5\@++$\;QF11U*;P-V/;Z]*N?%+1Y?$'P[\0:=!;2W<UQ:.B00N$=
MSZ D'FOE_P />!?%/C7Q;H-O87WB6P?3I"T^H:EI:VHL,+C"'/S-GC;0!]DT
M5D>$]'O- \/VEA?ZK-K=W"&$E_<*%>7+$C(!/0$#\*UZ "BBB@ HHHH **Y_
M5/B%X6T.]>SU+Q+H^GW:?>@NK^**1?JK,"*V+&_MM4LXKNRN8KNUF7='/ X=
M''J&'!'TH L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &=XBU-M
M%\/ZGJ"!6:TM99P&&02J%N>GI7Y;^(O^"J/QEL?$4UCIGACP;>6X4R1L=.O&
M8IZG%UC.:_3GXA?\B#XF_P"P9<_^BFK\3/ WB;2M/U)EG>&&>.,H96 S@CGV
MZ9KP\PK5:,X^S?1Z?<?%\0YCB,NE"I03>CNE\M3UW_A[;\<%EDC?PAX*1D.&
MW:=>C!]\W=6+;_@K-\:I@^[POX'3'0_8;O\ ^2Z^4_'$ESXI\>31Z)"UUI@;
M NT^7?CJ0OI5'Q)93Z;FV$;1*IW%FZGZUYRS"O)QA=)O\#CCF^(FH)NTI*]K
MZKU/M6R_X*V^//LMM'=:%X6>_9\3>38W(C ]LW)-:-S_ ,%._BS;WI9-'\%7
M&GRH&@9=/NU<>H?-WCTZ5^>L>GRRR84@DGUZ5W(N)]'\ W&JR1F8V=RD3Q*"
M7"G.6QU I5,16IM2C4;N[6?GL<^)QF+IN/LJS;D[6TZ[6['VW;?\%.OBC/"[
M_P!@^$>#@8L[K]?])KC?BG_P5P^+'@>_T^TT[0?!%S+-"99Q/I]X?+.< #%T
M*^4;_P"+?A,6=A+ID3VC+ %NK<R-*T\W.Y@"!M'3BO$O%'B"X\3ZO->W!/S'
M"*?X1Z5UX.KBZ]7FJ)QBN_4[LI>9U,1SXF4E!7T?4^XQ_P %H_C:3@>%O )/
M8#3K[_Y,JRW_  60^/2Q^8?!G@4)C.XZ9?8_]+*^*O"6G01*EY(H>0G"AAD*
M1WKNKCQC=S^&3X?>"U-FMY]L\\PKYQ;85V[^NSDG;Z\UZ=6M5A)*$;KU/;Q&
M8SI34*<;]^A])?\ #Z/XVYY\+> /_!???_)E>P?"K_@KOJOB[38[7Q+!X5\/
MZ^TP12UK=+:NI[Y,QVX]VK\P_%&EQ6MP)8<+&P)P.QK /S+@TJ].6)I\L9N#
M[K<VQ%.6/H6IU94WWCO^*9^P?Q3_ ."I=Q\.=#N8K>[\(:]XCF0FR@TV&>>"
M/T:9EGZ?[((-?.Y_X+2?&P' \+^ #_W#K[_Y,KX# V@XKZ>7_@G3\9+P?#>?
M3M ;4K'QM:074-Y "8]/\Q/,*W1_Y9X3YLG@]!SQ1A,/4P\.6I5<WW?Z!E^$
MJX.ER5*TJK[RM^%MCUW_ (?2?&W_ *%;P!_X+[[_ .3*/^'TGQM_Z%;P!_X+
M[[_Y,K/_ &]/V#?!?[*WPM\%:SI'BQIO$<P%EJ&G7KY?49>6>Y@4#Y%7(4J>
M,!.=V=WPI7;=H]-MH^^_^'TGQM_Z%;P!_P""^^_^3*ZCX<?\%F?B)?>,-.MO
M&7A[PA9Z!._EW%UIUC=K)#G@/\URPP#UXK\W*<&XZFHFG.#C>U^JW,:L95:<
MH*35UNMUYH_=31/VPO&_B"[%S96GAJX\/C=)_:"6T^UXAT=29L'\,UX+XN_X
M*D?$S2O$>HVFD:-X.O\ 38)F2&XDL+Q6=0>"0;E3^@K\Y]*^.OBO2/A_-X-@
MU"7^QV4K$OF$&'+;FVX]>E:FB_$;3KV&,:H6M[D+RR_,K'IS7SN!PV/H5)RQ
M59RCM'T[L_/,-@L^P,ZD\1B75C>T5Y=WYO\ 0_73]B?]M+QS^T?\3=8\.>*-
M)T"PL[/1Y-1CDTFVGCD+B:% "9)G&,2,>F>G/K]I5^4/_!)_Q?!K_P"T7XEM
M;=PZ1>%9WSC'_+W:#^M?J]7T-"4Y0O-69]WELJ\L.GB/B\PKX=_;^_;A\>_L
MK^._"VA^$-)\.ZC;:KISW<SZU;3R.KB4H ICGC &!W!K[BK\P/\ @K%\-/%/
MCOXM^!KCP]ICWJ6FB2[Y00%5O/8A<GC/M3K5H4(.=222[LVQN(AA:#JU)**7
M5NR/,W_X+&_&A&(_X1CP)Q_TX7O_ ,EU9TW_ (+&_%II7^W>&O!0C"';Y%A>
M9+=LYN^E?#7B'PYJ_AC59;#6].N=,OEY:*YC*$^XSU'TING:-)J%K<RHVTQ+
MN (^]STK/VL90YE+1]4>8\4Y4^=3T?5,_1RW_P""L'Q"U6%'T[0_",C[<O#)
M:76[/M_I-.O/^"EOQWTV=UO?#W@""-H#-$RV5XYSC.&Q=_+^-?'?PM\)Z?J%
MU#J!M CV%N)IHC*56<AN<GMP>U>XZG?Z?K5KY\5G#9PR?.+;!90@'(!/)KX[
M$YK6PU?V=-MKK<_.LPXCQ> K^RHR<EUO:Z.T'_!5OXY27*VZ>%O WFD DMI]
M[MYZ<_:Z9KG_  5;^.N@Q-+/X7\ O$K;6>.RO&"GT/\ I=?,NK>*K2'Q/JD8
M>..260;/-3RU"XX )_NUSVGW*>(O$-IHUO+YSWDZF9A@JJKR<9[FO;I8O$2C
M[22TM<^@I9MCI6J35HI7?I:[/IW_ (?&?&@D@>&/ O\ X+[W_P"2Z4?\%C/C
M/W\,^! /^O"]_P#DNN'\6?"#PEK/@>^U;[.VGZQ;#,+P#"/@'(9>QXJKX1\"
M?#WPY\(].U77-+.H:MJ,9N%).[=AL ?[(_PKC7$%)QO&#;ORV7<XH\949T?:
M0C)OFY;):WW^X],7_@L7\7/*Y\+^"3+ZBRO /_2JE'_!8;XO!0S>&_ _/0"P
MO,_^E=?%/CW2+31_$EQ'81M#9R8FBA<Y,8;G;GOBJGA_P]>>(]4M;.TMI9FG
M<("BDX]>:^@]K'V?M6[+<^J6,;HJNYM1:OJ?<VG_ /!73XWZRP@T[P9X.O[L
MG_5V^F7KD#Z"ZJUJO_!6#X\>'YTBU7P5X,T^1UWA)]-O5)'KS=UY_!X5L/#'
MAZQT_1;&:SO+2$Q7LY7:\SGDDD=JX'XCV+W'@'5KK4$,S6BHMN[\%&+CI[8S
M7@T,W>(FN1>ZW;S/CL/Q9/%8A4J:M%NVKUUT3['N$O\ P6!^,2KN3PYX%;V^
MP7N1_P"3=>O?L^?\%/O$_P 4I+O2/$5GX5TKQ('WVD4-O<1PW$6.0"\[?.#V
MSR.U?E9O.#\V/05+!;RW0(1'<@=4ZBO9Q=&I6HN$*C@^ZZ'U..CB,3AI4H5Y
M4Y/:2W7^9^ROBK]LKXE16,MMX?TKPK+K"RA=]Y#.T"#@D$+."3@]B*\0^)?_
M  4J^//PHU2W@UGP[X FMIP"DMM9W9;IG#+]K)7\:\P_9=\4V/BGP5:Z??W=
MO!?Z9F PRMB1P.0WOP?TI?VFM)T;5O =_8O;00:H+A);2YAY)48)W'T()K\X
MPN=8["9@L#B)N:O9NWXGY%EW$V<8#-_[+QU5SC>S;6NNS3[=3Z/^"_\ P4'^
M(_Q'\,:OX@U#0/#D5A:'R85M+.X1II,9/+7!  XK/^-?_!13XF?#OX?:/X@T
MO1O"3W5S>-:SVM[:7+@?+N!4K<+VZYS7Q[\ ?VA= ^$WAB^\.^(]/NI;9[CS
MHIK-1)_" 05/N/UKA/C[\>9OC3>:9I^FZ9_9/A_379K>WZR32-QO;'0XXP*]
MBA/-YYF^9M44[WZ6L?2X:MQ%4SR3E.2PR=[MJSC;;U;^X^DK3_@L+\8Y9T67
MPUX%6,G!(L+SC_R;K]7/ACXFNO&GPU\)^(;Z.&*]U;2+2_GCMP1&LDL*.P4$
MDA06.,DG'<U^"/BC]G#Q/X;^'EOXH^PS31"-9KB-8SNBC89#$=<#OZ5^Z7[.
MS;OV?OAD<YSX8TPY_P"W2*OL\+BZ.,3E1E=+0_2,JS"EF//4HU.9+3T:/0J*
M**[CZ$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHJ.*XBF>1(Y4D>)MKJK E#C.#Z'!%)M*R8[-DE%%%,04444 %%%% !
M1110 4444 %%%% !1110 5\K?%K0=&TCQGJVJZ=X]72%M]06XO++[']H>&ZF
MC*MY9!Y)7)*_P^O:OJFOE'Q3+X1T+XI>(KN?QO% T=Q<W$6FS63MY%^\1CWL
MP'S*IY _R0#Z,^'5AIFF>!="MM%G:ZTI+2/[/.W61",[C[G.?QKHJY/X46NF
MV7PY\/P:1=F_T^.U58KHJ5\WKEL'IDYXKK* "N*UWXS^"O#6OC1=2\06MKJ(
M(5XV)(C)Z!V PO7N:[6OCOXA^&]3M-?\5Z9%#K\,VI7<LL%A#HZ7<-WN PPN
M."H_#*^] 'V$CK(BNC!E89# Y!'K3J\V^#7@3Q+X-T>U&O>)9]54V<<2:;)"
M MHP X#@DM@<=*])H Y'XN7]QIGPS\275I>?V?<Q63M'<C@QG'7^GXUX=\,=
M3T&[\2^'GBO?B++=R21D#4)"UHS$?Q_+@I^-?07CGPR?&7A'5=$6Z%D;Z!H?
MM!B\T)GOMR,_F*XOPO\ #/QQH6IZ?+>_$N;5M/MG4R6<FEJAF0?PE_,)'UP:
M /4:*** /,/C?\5;OX;VVDV]@ME#=ZG(Z+>ZIO\ LT 5<DMMY)/  KF_AI^T
MQI6L27.F>*M1TRTU.&14ANK N;>[#=-H()4@\$&K_P"T=-I-OINC27FNRZ/J
M*S.;1%LOMJ3_ "_,'A[@<?-V]ZQOV?M#\*:M=:O<N[>(-<?RY)Y[S1Q:0Q*.
M%6)",#G.2.3QTH ]]HHHH ^;I/".KZ9XM\4S77PFA\5V]]J+W-O?7-]$L@4@
M#;R#\N1D=,9/6O>O",;1>&M.1M*70V$(!TY'#BW_ -@$<''M7S'\1_!7B.7Q
M9KFI:E9^*+Z)KRX1&TB5F7RFC4VK1J.RLKAAC^):^BOA=8W>F_#OP]:W]NUK
M>1V:":%V)96QSDGG- '4T45#=W45C:S7,[B."%&DD<]%4#)/Y"@":BO'+3]J
M;PEJ-Y%;V=GK%R99E@C=+([69C\O)/?J/:O8@<B@!:*** "BBB@ HHHH ***
M* "BBB@ HHHH P_'2+)X(\0JX)1M.N P'7'E-7XGP^%/#\TT\L5F)'4D+%,0
M2 #\I)[\&OVO\>-M\#^(CC=C3K@X'?\ =-7XRZ'XK\+1^?.EK()A*?W1.26!
M(ZGZ8KX?B5SBH2@F]'M\MS\LXUG6@Z+I7V>WJMS#OM.70Y%EFB>V$A)0J, *
M/3VYKG?%%B^LRQ7(B9B1M;(R3CG/Y5OZK\8K7Q9JUQ]LLM.F6,.L!EN?+5 @
M.0V.I.",>IKQ'Q/\0M8U74H[I62VMX&_=6L'RJJ_UKARO"U)T^9PM-;W/G<K
MR_&5I*4URR2ZO\#U;PKI-G96TU[=6 N(XHW"J!N9SM.W 'O7>^!O%UW;V:VE
MEI\%L[6N+I]G,A[!E/UK(\!Z9K?CKPWI6I: KW-H[>5(L'S&&4'E2!TXYK \
M2?&C0?A+\6-3TF]TR;5K98%CGNK>9?,CF*_,0#P<9Z5PXC"3Q;E&*YI[V3VM
MZGF5<-B,QJ5<-3AS5(W=K[6=NMNY=_:G^'?AV_\ ALOCF.QMM%U^*YCM2+(!
M([Q2 "2@X# \YKY%2W:5P%^8GH *]8^-/QVD^)D%GH>F6O\ 9_ABQF,\22',
MUQ*0 9).PX'"CI7*>&+*-+-KD<W#' XZ#O\ C7U^187$8;"QHXB7O-NU^BZ(
M_3,BI8O+,LC3QKO.[LKWLGLOZVV-CP)X2UK4]*U62+3I9+7385NYY<8"(7$8
M/_?3*/QK2;3"C.LC+$8DRWF<<XZ?4UGZ7K-Q8W#,K$(P D0' < YP1]1FO5[
MSX<'4='ANKJ^>UN[F(/Y>P'8I&02?4CM6N8RK86I&,GH]K'GX_&^PJJ59I*1
MX)XTN8I7BBB.Y8UPQ]6KFK>PGNLF*-G4?Q <5[EXC^ -SX?\(6GB"YGFNK.X
MN/+$@B(4@=3GUSQ6/ILYLU,<$8BB3  "X!^M>G@[XBBY4G>W?N>SA\UH>P7U
M;W[:=CF?@I\.KCXI?%[PAX1AB+R:OJD%HR@9^0N-Y^@7<3]*_I8TZQM]&TNV
MLX%6&UM(5AC7H%15 'Y 5^ /@KXAW?[-GBO0OBQHUGHFLZWY=S;6-I=N7^Q3
M%3&9I(U()^1GVC(&2#VP;EY\>OCA^V=XR@\.ZWXWO8M+NV)N;:T;[-90P]6+
MQI@,!VW9YQ2>(A1I2JU791O?RMN>U2S&@L*\74?+%7OY6W-O_@IQ +O]H[4-
M5B^)VG?$*TNP1;VUG<I(^CJIQ]E=4)1=IS@C!/5@#7R&1@U]W?%3]EOX4^!M
M.@CL/MTUT46*0&;<0V/]9[9STKY2\9_"^;PYXH^P6DK7.GS#S()I0 P3.,,/
M45Y>!SK#8^[IW7KU/%RSB; 9LY>P;5NZM>V]MSS]5W?RJ_\ V'="V\UD")C.
M6XKT6P\)V^A.9%5'D5<K)*1SZD UE>-[I4LD7S"7)(&X\D>HKM>)<Y*,%HST
M(YBJU50I+1]3S\C::,GUH(HP3VKT#VS] ?\ @BQS^TQXN_[%&?\ ]+;.OV<K
M\8_^"+'_ "<OXN_[%&?_ -+;.OV<JUL:QV"OS]_X*;ZGJFG:YX::PEDB7^SG
M),?8^8<&OT"K\R/^"K?B+5=%^*W@>+3[MH8I=%D,D?56_?MU%>=F-!XC#N"M
MNGKY,^>XAP[Q. E!6WB]=M&?'7C\W?CKP%ITNMW!GU6TE/V>[D/SE".4;V]*
M\_\ [=T_1M+2W3/G$8=%& ?J:Z"?5'O+)Q?RL[8^3)P%_"O-O$21IJ;E&R"
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M%%LHVNM1:V-J3(F6";=W.>.AZUT?C+PWJ/B.QT33(F:"U$JR7EPC+NC"+E0
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M.<@9((KJ?$?B.2ZT323JUFTEQ''Y F*D>8FX$ ^N.E>9.G4H5H1HOF5]NO\
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M68II]I*$;=&T@/(!XXSQG'-3WOQ4N/%EC;1SW:S7*?\ + KPA)Y5:\AN3+R
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M496XC\/2Q9)SM!N;<D?^.BOTEKZS++^PU=]6?M7#%O[.5G?WI?GT\@K\DO\
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MQ0@  =237R5HOA*_&N>%9=8^&_B2YTO3-,6VO+6"P=?M4ZN[*S<#<N6'7TH
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MX]^0*]:KS_XV^(];\,^#DN-!\-#Q3>RW*PFS:U>X55*L2Y1.2 0!VZT >'^
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M/_X[2)\=('QM\&^+#GI_H,7_ ,=K9U2,&[8@#.3],?TYI]O<J%  &1@^F.E
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M% !1110 4444 %>?_&OQX_@CP=="U2_.JWL,L5E+8V;W'ERA>"VT';U&":]
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MWM6?K=_]KE0*<HHK,]"<YI6/O6,*,86MT/)AAX4VK=!!GOUI1SQUI!VS78>
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M(P4__6[F@#KWUA'?!?<3D\#UZ_Y]J0ZN/.1 3\V/PKY:MOVQ? <LYVZW;%N
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M0^</A=XIT[QWXZ\+ZGJOQ$TK6=>)$BZ<OAY8IU<H<QBXW9&.>V..E?55>7^
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MTAMC<&+RH[>!!E88DR=HR26/5CC/05Z#3EH^5"B^9<S"BBBH+"BBB@ HHHH
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M\#_CEK_[4*_$;5[3X?>(?#NE2B#PYIVH:O?JVD0$XDN5A6U\MKIUR=S,0N0
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M\_K7D9K6=#!U)Q=G8\'/*\L-@*M6+LTG9^9Z?XB\#>'X==6TMKF2RN8V:-I
MH:-SZXZ@9X^E>9ZOI-S!K4VG7,?DRQ3-%)O&,8.,_CUKVJXTK1[[6Y-6CO7%
MO$Q=U*Y*Y/3WS7CWCKQ"[?'6ZGN9';3KV2*<F=0H5 H5A@>BK7QF7UN;]W%W
MM&[OW['Y3D]:K7E*%VW&-]=[KHOO.KL+[PA!I%MHFI:!!>VT5P)99+A<O(,
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M1P7NHY*]65./N1NRK-8VJP-!$<N!PQ'4U@1QXE*L0I!P:ZH6D2.TTDR>2.0
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M=;__ !--D^&_P^B^_P"%O#2?[VGVX_\ 9:_('XW_ !MT[Q5=6^@^'-=2S;3
M=0FU&.0JTK#A84([G.?PKR?4_%VI>)I(QJ-Y/?G& 9Y"V/>N7 YW7Q:A*K0Y
M.;N]5V^SU/)P7%&,Q%&%:OA/9WULY.Z73["W/W2_X5_\.!_S+?A;_P  +;_X
MFG'X=_#M0"?#/A@ \C-A;_\ Q-?SSZU;VAUJ"-2%P^6Q_2NNOI4FA4&5VBC0
M*H9L[0.P]!7M2QLK^["_S_X![U3._9J#5/?S_P" ?O2OP[^';G"^&/##'T%A
M;G_V6G/\.?AY'][POX97ZZ?;C_V6OYS-1\3WFAZ\\^EWDMLZX&^)BN:AUWXC
M:_XDB":CJ<]T!S\[=:T6(K2::@K>NOY?J>C'%8B;BXTURO\ O._W<OZG]&O_
M  @/PX_Z%SPM_P" -M_\30? 7PW/7PYX6_\  &V_^)K^:1I"Y))IF>*Z_:>1
MWJIY']+W_" _#?\ Z%SPM_X VW_Q-'_" _#?_H7/"W_@#;?_ !-?S0@T]6(/
M!H]IY#]IY']+G_"O_AS_ -"WX7_\ +;_ .)H_P"%?_#G_H6_"_\ X 6W_P 3
M7\Z'PZTN;Q-XMTK2A,R&\N$@##G&XXK]%/!G[/G@;P-:R1QZ/#JEU( )KJ_4
M2,Q'H.@%?+9MQ%1RF2A4@Y2:O9,^!XCXTPG#7+'$4W*4MDC]+_#OACPGHE[)
M-H.DZ-87;1E'DTZVBCD*9!()0 XR!Q["NBKX._8M^#'A[X?_ +1^K^(-"1K0
M:KX<NXY;(?ZN,BZLVRGH/:OO&O;RS,*>:8:.*I*R?Z'U.2YO0SS PQV'349=
M_+<*P/$?A[POK,\4FO:9I%],B[8VU&WBD95ST!<$@9]*WZ_(#_@MG-Y7Q=^'
M8_Z@4O\ Z4-7N4*<*L^6I+E7?<]I['ZE#P/\.T((T#PP".A%E;?_ !-66\->
M!78,VE>'F8=";> G^5?S#2RF5LDTRL:D(*34=5WL+DC+62/Z?CX>\$,NTZ9H
M!7T,$&/Y54/@?X=,<G0/"Y)[FRMO_B:_F,I\+!9%)Z44J<7-1VN)0C'X4?T[
M)X3\!1Q>6NC>'%C_ +@M;<#\L4DOA'P#.,2Z+X;D'H]K;G^E?S;ZCK/AR7P%
M;646FR1^)8[MGDOQ(2DD)'"E3P"#Z5R#,6/-;XBA2HU)0B[M.VRU\]&]#GH3
M]LG*5/ELVM;:VZJW1].I_3D?!'PZ;KH'A@_6RMO_ (FD_P"$&^'/_0O^%_\
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M:K7S1X9\&^,/"_\ P4@\/7GC/QC)XIO=6\,ZQ<VEM'"(;33+07$:PP1+W.T
MNYQN8].,D ^Y:*_,CQS\+O$WP7^/NI_&;XK?#GP?XG\.>(?B#!;VEU+>SOK>
MGP.PCLI82C>3MC"1DHP+$H1\H.X?IO0 4444 %%%% !1110 4444 <M\5?\
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MFTS39M*MI1,1&()6#."G0G*CFL/XLL&^(/P5P0?^*LN>G_8"U6O3Z /";/\
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MY(URZ*3D,OT.#^=7? ND>)[_ ,/ZS::18":QU )%<N\2ECM;<-C'D<^E>?\
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M 4#C(^W8_%WPX_90^%'AKP_XA\4:7X<TK0],@L8/MUPJ22K%&J;@F=S$D9.
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M\0-W9VMQY\44G<))@;E[@X'7I7+_ !N_Y$NP_P"QDT#_ -/%G0!YI_PHR/\
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M )45]$T4 ?/?A_PQIWPV^)'@C[5\%/AWX7N=:U"?3;/6O#5PDMW:2BPNK@D
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MZ.Z>C.3.,TF/SIQ-)WKZ8_4BYI6E7>L7T5E8VTMW=S-MCAA4LS'V KV#PM\
MO'GA?7M(U6^\/2PVT-Q%*XWJS!<YY /'%4_V8/%,?@SXHV6JR1K($1HR"!G:
MW!(]\5]Y%9[F>X4,SVDYW1.&XVGH17Y]Q%G>)P%3V%*FG%K5N_X'Y'Q?Q3BL
MGKK"TJ2<)1U;OK?=*W9'S]XTU7[7>W5U!GABS+CE?;%>4:KK]Q:RG=$'.]7
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M@   < #M7.WWQ(\):9XQLO"5YXHT6T\57T9EM="GU"%+ZX3#'=' 6WL,(YR
M1\K>AKHZ "BBB@ HHHH *Y'XD_$+PY\/])@E\1,TD5Y)Y,-I' 9Y)B!DX0=0
M!R3VX]:ZZO/?C%X;TV[TRP\3WVJ7>C2^&9&ODO+-0S^60!)'M/4. ![<5G-M
M1;B>?CYUJ>&G.A;F7?:W5[K97>Z]2EX8\9?#B2Z\/3:!:6)E\022I:S6EFJL
M'C4,ZOP"A&>AKT^OF'PU%X=\0?'+PSKRZ)K_ (*N[[SKNVM;^U46FI/Y?S.F
M&_=OM8$\<\<#.:^GJSHR<D[GG9+B9XFG4<U%)2LN5637*G>SU5VV[/I;=:OE
M_BDQ3X9>+F4X(T>\((_ZXO7\T$U_++(79V=R>6)R37],/Q.B,_PV\61K]Y])
MNU'XPO7\X.H?#75K*W,[QY7VK#$U:5.454=FSNQ=:C2G%59)-[&5I'B:\T6^
MCN[:9HYH_NL">*[35?CCKFKV(@9Q$Q3:SH3\W;.*\UDA:.0HP^8'!%)M8>U<
M\\/2J.\D<%;+\)B)*I4@FULS]$/V0/'&E^(?A-9Z7#=(-8TV2475O+)^\(9M
MP< ]1@X_"N)_:A^(6H:?J+V=C*R'9M5T/1:^/_"NL2:/JT,\5W/9N#@RP.5.
M/<^E?8>E?"3_ (6=X8L-0AU2.Y+IM+RON.<#//XU^89AEE#*LP^NUIWIR;=F
MMGZGXKFN08+(<Y>;UY7IU&W9K9O7<^8O#VCW>NZXLF6>5L[V'4BNVC\(R6,Y
M$L;Q@<D.,$?G7U+X+_9UTSPAI<UUYPN=4"D@D#9&/6O(_'WBW3]1O-8DO(IK
MS57DC6VN4<*BA00P9<<]L?2N^AGD,9B>6C'FA;H=E/B:.;XF5/!*\(JU_P"N
M@WX?^$XM1N8Y)5#*&QM8=>*]RN_ *1V"L(TCCCC+L/NJ@ZY)_K7@O@[XB0>%
M+&>]OXMR0G>C =_2N-^+/[5WB#QMILNCV,HT[2GRLGE#$DJ^A/I[5EC,#CL?
M6]A3ARQ[O:WZGBULDS;-\<HT7:FGJWLO\V7_ !;\4-/E\07>A:7<YL'D"R2J
MY\J9AT^H!)P:\L^(7AB&WQ>VHX)_> =/J*X5[IO,W D$=#72V/C%[BR-I>_O
M$(P&/6OL\/@/J,(JEJEN?KV'REY9R2PSNEOY^9R\4)EE51U)Q7HVA^$FATEK
MLQ,R @&0*2 3TY_STK@+A?LMTV.1G*GVKJ;#XB:A:Z-+I@G;['(RN\0/#%<A
M21[9/YUZLG=;73/5QT*]6$?8_,=>W1MKL* ,@]35E=5=+?<K$'VKF9]2?4)P
M%49)XKT[X)?"N_\ BE\3?"GA.U9FDU;48+=R%SLC+CS&/LJ;F/L*FAB)831=
M>ARSH1BHJ>Y]-Z-_P3?^)WB/0_AQKNAW%K>6'B>VBGU(SL(FTD.-V6!.779@
MY7G<<8[U],?'O]F_X:?L^_#3P^FB*(/%,"K"\Y):2^'):609PI!)P1VPO.!C
M[BN;W1O OAQ9+R\M-&T;3H%C,]W,L,,,:@*,LQ  Q@<U^0G[;_CSPS>_%S4-
M;^'_ ,1KOQ1:ZO\ -?6C[Y(;211@"*0@!D(Z =.>2#48W!>TIR=.'-)M7OT\
M_4QS[+:4L!.C3BN:=EKTUW76_P#3TT#QS\28-%\!WUM)<"74[H%;>(-]W'4U
M\[^#(]3UGQ/"X5@?,&6D' .:R'O+O6;Q3,TEU,2=O5B<<]*]Z^'P63P-%.D<
M;QQ.?.; W ]N>N*^7QF C@+SJ25ZF_=:'YA]5I\/8.481YI3>K[7/MC]B9;&
M_P#B_J6J6IA6:7PZRSQQC'SF>#)Q^'ZU]O5^='_!.K6$O/COXAMD;(3P[*V!
MT_X^;<9_6OT7KW>'Z"P^!C"+;5W:Y^F\%T94,HA"3ZR_,*_'K_@MR<?&'X<D
M?] &7_TH:OV%K\>?^"W7_)8?AU_V 9?_ $H:OI-C[D_.$W#E<9XJ.BBM9U9U
M+<[O8226P X.:E>Y9TVU%71?#GP==_$3X@>&O"UA&9+W6M2M]/A4#^*614'X
M?-50KU*<7&$K)[@TF8:6=Q)<QVRP2-<2,%2((=S$] !U.<BO1/C-^SG\0_@!
M)HJ^.O#=SHB:Q:+=V<L@#(ZD E"PX61<@,APPR.,$$_OW;?LD?"N+QAX1\6R
M^$;&;Q+X8LHK*QO]F#MC0*C.OW790/E9@2O8U^2O_!3S]K'Q1\9/BM>_#^?2
M;CPUX7\*W;1QZ?>1;+FYN ,&XDST!!^0#C:<Y.>,!GQ1#+Y9]JU(KWY M8]3
MPEC7T^3YG7PD_9TWHS&I!2U9JL59,TJS94!B3@8&>U5$R>M7HM-GEM)KI4W0
MPE0[9Z9Z5^C4L54JM5(QM8XI<L?B93GC)RP'%4))3DBNDFU#21X9E@:UF.LF
MX#)<B3]V(MIRI7'7..:Y9CDDU\'GU6$*G+1?J;X>3G?FC:SMKU\_0"2>M%%%
M?';G8% &:*T+.!2@)&<UZ6 P,\?5]E%V(G+E5RCL(0DTVM&YB4< 5!'9^83S
M7=B,HK1JJC25V2JB:NRK7],'[-?_ ";G\*_^Q4TK_P!(XJ_FDN+9K9]K CZU
M_2W^S7_R;G\*_P#L5-*_](XJ\2K2G1FZ<U9HT335T>D4445D,^-?BE^RS\5=
M5^.7C/QGX3M/A'J>E:^+7;#XXT>>^N83%"$)!"D+DCH#C@< YS]3_#G2-3\/
M^ _#^FZU%I,&K6EE%#=1:# 8+!)54!A!&>5CS]T'H,5T=% !1110 5F:WKFD
MZ1!MU6\MK:*57^6X8 .JJ6;@]0%!)]JTZPO$'@K2?$TD<E];DRIQYD3F-F&&
M&"5P2 &; /K37F)F$UW!=>/O#-S8W%J^D-IESY7DK@#+18(;.-N.@Q^-=K]J
M@_Y[1_\ ?0KGV^&WA:54\_0;"[=4">;<VZRR, ,#+,"3^--_X5?X/_Z%?2/_
M  "C_P *>C$KFS8Q6U@LP2=")96E.6'!/459^U0?\]H_^^A7G;_#_P !MX[B
MM_[#L1>)9,OV8:>OD$%E;);;C> O ZX)KHO^%7^#_P#H5](_\ H_\*;UU8EI
MHCHOM4'_ #VC_P"^A1]JA/\ RVC_ .^A7._\*O\ !_\ T*^D?^ 4?^%07GPC
M\&7T(BD\,Z6JAU?,=JBG*D$<@=.*G0K4ZG[5!_SVC_[Z%'VJ#_GM'_WT*YW_
M (5?X/\ ^A7TC_P"C_PH_P"%7^#_ /H5](_\ H_\*- U.B^U0?\ /:/_ +Z%
M'VJ'_GM'_P!]"N$\0^&_A]X9\L7_ (;TU#*K,@CTU7W8QP,+UY&!WK!\"Z1\
M,[Z.RT2QT:TOKA(LK/=:6%,BXW!BQ7'(R1Z@&JMI<5WL>L_:H/\ GM'_ -]"
MC[5!_P ]H_\ OH5SO_"K_!__ $*^D?\ @%'_ (4?\*O\'_\ 0KZ1_P" 4?\
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M*L#P00>HKC]"\&>!?$6GK>V?AC3#"S%?WNG(C CU!7-:/_"K_!__ $*^D?\
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MPS\0?$RR^(6H^"M(O/&EF8S#K,L&9@R+MC8]F91@*S D;5P1M&/1J "BBB@
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MZ+?\$N=7M-2_:&\3"VWN?^$9G8NWI]KM>,5^HU?DY_P2/$?_  OSQ.5(+_\
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MN[6Z >D4445(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7 _&[_D2[#_
M +&30/\ T\6==]6+XO\ "&E^.M!ET;6(IY;&26&<BVNY;659(94FB998F5T*
MR1HP*L.GIF@#:HKS[_A1GAO_ *"'B_\ \+36?_DNC_A1GAO_ *"'B_\ \+36
M?_DN@#T&BO/O^%&>&_\ H(>+_P#PM-9_^2Z/^%&>&_\ H(>+_P#PM-9_^2Z
M/0:*\^_X49X;_P"@AXO_ /"TUG_Y+H_X49X;_P"@AXO_ /"TUG_Y+H ]!HKS
M[_A1GAO_ *"'B_\ \+36?_DNC_A1GAO_ *"'B_\ \+36?_DN@#T&BO/O^%&>
M&_\ H(>+_P#PM-9_^2Z/^%&>&_\ H(>+_P#PM-9_^2Z /0:*\^_X49X;_P"@
MAXO_ /"TUG_Y+H_X49X;_P"@AXO_ /"TUG_Y+H ]!HKS[_A1GAO_ *"'B_\
M\+36?_DNC_A1GAO_ *"'B_\ \+36?_DN@#T&BO/O^%&>&_\ H(>+_P#PM-9_
M^2Z/^%&>&_\ H(>+_P#PM-9_^2Z /0:*\^_X49X;_P"@AXO_ /"TUG_Y+H_X
M49X;_P"@AXO_ /"TUG_Y+H @^,WPL'Q)TA(HV"W$8( /<5\\K^R3K-M(=A.,
M^M?1O_"C/#?_ $$/%_\ X6FL_P#R71_PHSPW_P!!#Q?_ .%IK/\ \ET ?-,G
M[)^O27L>0VT'UXKZF^%O@8^ O#4=@[AY3RV.U9__  HSPW_T$/%__A::S_\
M)='_  HSPW_T$/%__A::S_\ )= %+XM?\E!^"O\ V-ES_P"F+5:\#^)7PMT7
MP;^WK^S_ *EX=\/1V)U*Z\2:CJU];PLS3W$NGSDO+(<G)+8 )P!@*  !7T=I
MGP2\+Z7X@TG6@==O=0TF9[BR;5/$FI7T<$KPR0LXBGN'0MY<TJY*G <XKO*
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MA9_V*NE?^DD5=<JR>'C2MJFW?U)MK<]'HHHKD*"BBB@ HHHH **** "BBB@
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MX-6_^-5^W5%/D17LT?B+_P .@_CYZ^%O_!JW_P :H_X=!?'S/7PM_P"#5O\
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MH_X<[_'_ -?"O_@U;_XU7[CT5\^=9^''_#G?X_\ KX5_\&K?_&J/^'._Q_\
M7PK_ .#5O_C5?N/10!^''_#G?X_^OA7_ ,&K?_&JL1_\$@?V@$&#_P (J?\
MN*M_\:K]OZ*Z:&(JX:7-2=A-)[GX>2_\$>_C_(V?^*5_\&K?_&JC_P"'._Q_
M]?"O_@U;_P"-5^X]%8SG*I)SENP2L?AQ_P .=OC_ .OA7_P:M_\ &J/^'._Q
M_P#7PK_X-6_^-5^X]%0,_#C_ (<[_'_U\*_^#5O_ (U4UO\ \$>_C[&3N_X1
M;_P:M_\ &J_<&BMZ-:5"HJD-T)JZL?A]<?\ !'KX^2-E3X6_'56_^-5#_P .
M=_C_ .OA7_P:M_\ &J_<>BE6JNM-U)+5]@2MH?AQ_P .=_C_ .OA7_P:M_\
M&J_9?X.>%KWP-\(O _AO4_+_ +1T?0K'3[GR6W)YL5ND;[3QD;E.#7845B,*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>aciu-20221231x20f042.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f042.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $5 [L# 2(  A$! Q$!_\0
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MV@\';DYXQFOK_2-6L]?TJSU/3[A+NPO(4N+>XC.5DC=0R,/8@@_C0!<HHHH
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MTJ32J32OM=I=E^;2^:*C3G--PBW;^OT9L44F1ZT9%;F8M%%% !1110 4444
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M.2H/&<8S0!>HHHH **** "BD+ $#N:6@ HI.E'6@!:*** "BBB@ HHI,\XH
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MD'@\CN >*ZZOG&T_;T^ ]A;QV]OXFNH((P%2./PYJ2JH'8 6U>A_"?\ :,\
M_&^\U"U\':Q/J<]A&DMPLVFW5KM5B0I!FB0'D'@9H ]+HHHH **** "BBB@
MKROXCWB6OQ!T:-K>6=[FRDAC99)/+1M_1@!@$C.&)SP1BO5*\S^*NEQW5_%<
MVTJQ:G#:[MOFA?-C#Y"D'@8)RK'H=U;T;*:;,JE^5V(H +F9HG9C';N(UD/R
MD#/"'UR"#M&.,<9-3V6G>==>9Y;V3&3YA&J*+@?,H4D EE7.1SD9'O7+:.VN
M7UM>ZH]PEO!%S8+)M9KH8!\R;C(!<NH Z* >>*R/C#\5E^%WP@\5>*Y+.Y1M
M/T>ZOUDX$$<ZJJ1ID]2\CJ .X!/:N^;WOT.6/2Q6\3?M3?#;PU\,_%'C9O$]
MK<Z5H%W+IEX(C^^6^C9E^S>6<,9&(.T=".0=N33/V<OVE_"7[3OP]B\3^'X;
MRWFM[D6E[I]TFV6TN<9"[A\K*5.X,#CG!P>*_G^@N+[5K\PN;J^>ZN!++#&Q
M+SR9/..<M\S8.#]XU_0#^RU;^%M/^!WA*U\,>$]1\$:8EL&_L76(&@O(Y2?G
M:7< 9"[ L),?.,$8Z#EIS<V;3BHH]B@MD(.SY@<_ZWZ8&2>U-B$\5GOOI0DK
M#?(%*JL?<@$<$=>O)SS2VZ!W:3S'=%VE% !QC.>>^?2JVFV(BTYX3=O?!Y69
MY;@!W8%B64C@# .T>@]:W7F9EU-1\R -&DL\>0-BK\S=.0#Z?T-68I0J,NY]
MRY!)/?DXK-U+4K+2+/S;F>*R@&"S2'"JO^>_;O5M?)=0F_9$V!OC&=P^H[8Q
M4M:7L4GK8>L3Q33SI;H9I<#(;&Y0/E!/8\GI26]PUOO6282"1RT3+D@J,9R<
M8&"<52O;:.]@>T968V[1RH 2?XC@X!!Z ]_SK8:3S6<D\J<$'TQG\L4GYC7D
M><?$/Q#K[>,O">B:!K5IHL.H1ZC/=W4M@MVY^SB#:JJS*%YF8GOP*IW^B?$)
M3$B^.F5GE"DIX=ML!>?F8^;]W]<XJ?Q[ ?\ A:/@T110M*^FZT1YS!5W$60!
M8^O2NDN]3;3Y+1[?3Y[I[RZ2&8VQW>42IR[9Z@8'3UHBHVYK$R;O:YS#>&?'
M3.EQ#X]M967=\S^&8/DPO(!\WY<]\]J2U\.^-&B2^D^(4$<LB*[*?#]N^P8Q
MA<2]/IUJ?P\]U:W>IVVOW$EK9R:J\UD$D FECR""YZ$$Y&W^Z*NZG)IFH:I%
M;V5Z&6*[1)$;"@KGD9[C+ 8%;0IJ6BO_ , B4G$R=5L_&NGH\K_$)"(078KX
M;MQ[?\]?>H_[$\;V5MNTWQM!+')."2GAZV175B"\JYEY')X[UK:9>V-I=B&Z
M+7MY<&552-24="VYBN>"!P#Z=*NV=[!_:$<-N&NK5)#+<-R&C5N%"9_A7:>/
M0BJE14%LR%-R>YDG0O'(#O%\0H!@!N?#=N"Q/ _Y:]ZRHM)\>W&KH+WQY;1)
M)%F!&\,0[D*\ON;S=N.GXBNWNWM?+BMW02RRRB8*S<JHX,@'L<?G5=)GDN8X
MVG:YLY)8S$^S.\%3NW'TX'/N:B-*-KC<V>>>)OACX@\<P2BY^(S74!*S;H/#
MUJ%79AE (?D$J#SGD=177_LDW]_K'P6TG5-4D:;4-2"WL\K+MWO)%&Y(7L,G
M ]@*W</9VK110Q1V8BE5[:-0OE$ G(QVSV]Z;^S?+;R_ _P2;>02[=&L4D;_
M &Q;1 @_3I2K3DJ3IK8NE%.?/U/2J***\L[@HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH KZA<O9V-Q/'!)=211LZP18WR$ D*N<#
M)Q@9]:_.?X!:WXSN_P!O_1]?\>^$/$NE^+O$OA;4OMEM>)%]FTVV6[3[-'#A
MR?(CC159\;FEE)VX.:_2"JC:18OJ::BUE;MJ$<1@2[,2^:L9.2@?&0I(!QG%
M 'S'XL^*7Q\^%/BWP&?%L?P[OO#7B/Q59>'771H]06\B6X9\.#(VS(5#^-?1
MOBKQ(?"^C-J TK4M9(95^RZ5!YTQR>H7(X'?FO$/VQOO_!#_ +*AH7_M>OH=
M/N+]* /D?Q=^VQKNA?%^U\.6_@FYCTSS889;.^B=-3E+XY2,' /(VCG=ZC/'
MTKX*\:MXRANW;0-:T'[.RKMUFT\@RY&<H-QR!CFM.X\-Z3=ZO;ZK/I=G-JEN
MI6&]DMT::('J%<C('T-:- 'S#^TAK.H:-^U+^S_+I\@\Q+'Q7,+>>Y,-O*Z:
M<C()3G 7=_$?N\FO*OA_^V'\2O"7A?X@7WQ&^QW/B72/"=QXDM_"TFA2Z?+O
MC8+NMKE)98;RR^<9F5@XQG;C)K[.\2?#7PQXO\2:'KVM:-;:EJNB1W45A/<
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MQ/\ %GA_QI\,/A_X.O\ 3_#^K>.;^]MSXAU.S-Y%816MJUPP6#>@>1]H506
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M.1@XS7FGC7XL1^%-)\.Q^)!I^AV>JSV44>HZA9Q+8NTID\S<8Q\BNH1_F&5
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M !,US5_#5@NHZ?"=1L5N+R^MWMQ"9X?,"P>2"?FW@DD=,*PZE:V>*C3T\O\
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M%1-L)WODUFR%PV?+M2T-LPEDQSLR@4_[]=K=/=W\=_=PPZDD^Y8TLDV#SU0
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MSCS7B &TG S\PSQVQ2Z?J^DOX@N]&LM2$6MV=K#YEK= N(T8A@_0;B<XR.X
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M)>>(OC@OQ+\6^$M*O+#2K*T\.#2+<PO+''=3)(!BY :.-<*=JGD>M>Y?M4?
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MQZE8VUW$'$4\:RH)%*L P!&0>0>>AJQ45K:PV5M%;V\20P1((XXHUVJB@8
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M*OG#]N'X@0^#?AI9V%_<^"4TK7;M-.N;7QK)<I#-ODC"E/(4L"A;S&?C8%W
MY%?>'PQI?LI>+];\0Q>+=/\ $WB;Q7J_B#2[J".YTOQ?I-A8W5@KQEXROV,>
M7(D@.0VYL%".""*]]KY3_8,U#2TTGQIHVDKX.G@LKRVEDU#P==7U]#<R2Q,3
MYMW=Y>9U5$& QV# XX%?5E "8P#7G7PJ_P"1J^*?_8T?^XS3Z]%[5YU\*O\
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MYV'C*7X\7JCXVZ/X2T-]5L?[+TY]?>VG2]>.V5;:2 (05$274HC+8F:XC#8
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M/Q,NI?"+Z,EDW@^)7%MYWE!"0"Q4)O!E#8W;CCI0![]1136!92 <'U]* %#
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M]L)]Q?I7SQ^V-]_X(?\ 94-"_P#:]?0Z?<7Z4 .HHHH **** "BBB@ HHHH
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MG7SQ_P $^_\ DTGP-_O:C_Z<;JO;_&<.OS^%M23PM<:?;>(3$392ZM$\MJ)
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M5)9A:7,FT1QK&5R[;N3MZ<YQQ7G.I:%=:A>W>N:=K3^'(M=A/VR=[Q?-CC*
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M,!"TLF1([(8RQ,8QEL^M>M0I0IVB]7H_RO\ UV9YU>I*5Y-V7R^7_#=T=?\
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M(J#'3@>E?K-_P39\-^'K/X&:7+:^"=6\):_;L_VZ\U6!U_M61UQ]HB8@"2,
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MSTY[LMB]A^;D;@,E=HRR_*=XQT->[5\>?'1+@?&_]G0)\?T\,H7A#:+O9?\
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MWW2M;OT/"M?^!%UXA^(>GZCK&MJ\U]NN;M+6$H%,6P!(R22!@@9/(QFO2?\
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MD_Z/<#8 Y9AAH_F;##^/Z5!KDUGXMUKPU8Z197%K!I%I%%%#J-RJAHB?XFY
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MBGX+>'O"?BRPUO6(?B5HUQ):6S,76-&F#-R.@+#\Z^TD^XOTKYW_ &Q5"O\
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MB'38K=XY$GB+Y3,CA?WK ^G  X&#FONBZ^(4T.FP7;VD<2O)Y,D<CDLK8/!
M'7/&#6,?B9?66KM8ZKX>A\PLJQS6DHF+.<D;DP&0;0.>17D5<'A;64K7\K_\
M,>O2Q^);O*-[>=O^'^1XAX&T?POHNER_V?/=IJEL]O=!+>W=HKBYC8I(JLPR
MKNQ)"$@'(;'6BR\!P^'](TWQKIOAS^T=0EU)A;V]U=!9G0S@JB1CY5?@YW<
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MSL.#\P/&5P.N:EA\?2S61F^SQI\@=6+,R,",J00#D<=J['BHO=G$L-);([4
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M G:B@ 9))X'4FO43TKSKX5?\C5\4_P#L:/\ W&:?0!\U_P#!3_\ Y%OX2_\
M8UO_ .D%S7Q@.E?9_P#P4_\ ^1;^$O\ V-;_ /I!<U\8#I0!1U__ ) &J?\
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M?8O9RL]^_7R/?XG=:60P>(OS<VMTD_M=%IL?;5%%%?T,?AH4444 %%%% !2
M =!BEHH **** /G;]L;[_P $/^RH:%_[7KZ'3[B_2OGC]L;[_P $/^RH:%_[
M7KZ'3[B_2@!U%%% !1110 4444 %%%0W5W!90O-<2I#$@RSR,% 'N32;45=C
M2;=D9^H^*=,TJ[6VNKI8IVZ(0<GC/IZ5YU\<O$T5XMCX)COUL!JZ&?5;S?M-
MIIJD"4@]GE)$2]_F8C[M<)\7_P!I,>&_%=N=)>RN-.TQ#</-(Q(F)1@VTCL
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M%9 >V/IS[@TJ0F&%$#Q/!@*%*#Y@  ,GN1BFSSK8:8TLL7[J, >5 A8@9P,
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M0SP6K3Z;;M$$E1D?<H(SPQQSZ4 ?5^O_ /(#U#_KWD_] -?EW\ ?^2)>!O\
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MA9]<_MG5I@;K2[:=_LTFH7#VPW8/ @:( 9^4 #C&* /=_P#A9OA+_H9=)_\
M V/_ .*H_P"%F^$O^AETG_P-C_\ BJX37/V=/@7X:TJXU/5?AOX'L+"W7=+<
M3Z+;*B#.!DE/4@?C7SIX[\!_ 6_^/GPMU32/#?@9?!UA9:TFNK%I]LD+2R1V
MPM/,CVC>=RS;3@[>>F: /L;_ (6;X2_Z&72?_ V/_P"*H_X6;X2_Z&72?_ V
M/_XJO+O"'P?_ &=?'K7*Z!X$\!:H]N 94@T:V+(#T)&S.#@\^U=(?V5_@WC_
M ))5X-_\$5M_\10!UO\ PLWPE_T,ND_^!L?_ ,51_P +-\)?]#+I/_@;'_\
M%5\^_LM_L=>#/#?P+\,Z=X_^%OA=_%L/VG[:U[IEM<RG-U,T>Z0!MW[LQXYX
M&!VKU;_AE?X-_P#1*_!O_@BMO_B* .L_X6;X2_Z&72?_  -C_P#BJ/\ A9OA
M+_H9=)_\#8__ (JO"-9_8^\#3?M#^%M4M?A;X6'@N#PYJ=O?(NEVPA-Z]Q9M
M;EH\?,VQ)\-@X!89&:]+_P"&5_@W_P!$K\&_^"*V_P#B* .L_P"%F^$O^AET
MG_P-C_\ BJ/^%F^$O^AETG_P-C_^*KCKK]E;X/-;2B/X5>#=Y0A?^)';#G''
M\%>>_LY?L?\ @3P_\"_ VF^-OA;X5D\6VNDP1:H]WI5M/*UP%^<M)@[CGODT
M >Y_\+-\)?\ 0RZ3_P"!L?\ \56AH_B[1/$-P\&F:M97\R+O:.VN$D8+G&2
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M<)CHQ^7. >G0]"W<U#UV7]?U^@*ZW?\ 7]?J1Z>JLJQS222Z>=[F3+ G!R0
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MS#X9;58A:R:WIDIMKFWEOX0%WF.9&V@JH?RXW9>.0#Z^HHHH **** "BBB@
MJ"^M8;ZRN+:X4/;S1M'(I[J1@C\C4](1D4 ?-?AW5E\&W<EC/9"TM?/\L7#A
ME60-Q&(R20=H!R.,@9%>DPR-(A5MH)X&.>.V*?KNCPVFH7%L+='B#B6*-QD
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MTK2;32O FM>([32[K5YY%EN-1:2*622&./'[M$"#+DY+$ < UTW[.G[-%_\
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M/Q/XIM[O7V77M0^P^&;9XIFMK2:90T[+D%3L9=\@ +87G0\ 1OKME^S)K_Q
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M%Y# K+MW?*2V"<CUX&#VS0EV"Y-/!$D30R*)5*@-$PR&4GG/^>E/2V2S?-K
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M2XMC>:!=:7>$QW,16:*3:"4!R<$8. .A).37!^/;PMXHU*>.PCM76**SCLF
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MM% "8'H*,"EHH 3 ]*-H]!2T4 )@9Z4;1Z"EHH 3 ]!1BEHH **** "BBB@
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M, G.,\D@DXQC(JUJ\_VGSKW3KBUE\F0W-JEK"7\M4"LK,1]W [=0<^]?4_\
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*BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>aciu-20221231x20f043.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20221231x20f043.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'H Y(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBOF_X?:I)JG@3QGKWBKQ=K45E_:\NF@)<;([=%E39AE0M&&+!&;H%/;K0!](
M45\FM\4[_P )Z+\/KBZU^Z73(O$=[;7\\<K7$4MNCJ0J.,M-&%; ;DGFNBNO
MB_!\2OCOX8T?POXDO4T.ZT^ZBNEMT>'$OER%6 =1EAP0<$<4[ ?2%%>*_![Q
M9=:#X=^(D^OZQ>:M:^'M9N[=+F]<-+Y,0&!D #)QV'4UR7P$^)GBR7Q[%;>+
MKF1[+Q=9OJ>DQR$[;<K(_P"Z3/0;>W/ 3UI ?2]%>!0S>)_C5\1_%MG:>*KW
MPOX>\.S+90II@423S$'+LQ'0$=/IC')K/^)6I_$#X??"S2(M9UY)M6&O0VZ:
MA8Y1Y[4YP)!TW=<X[8[Y) /HVBH)KI4618RLLZJ2L(<!F.,XKQ3X>^+/&FI_
M'S5-.\3JFFVS:$+NWT>WF\Q+<&=54LPX:3&[)''- 'N5%?']U\8/$FFZ2WCV
M[\8,EW%X@>PG\*$((EM@2" GWMP'\1_G7H7QJ/BW0;7Q#XLG\:R>'].M4B&A
MZ=8[2+B0CE90PRQ)Z =OI3 ]^HKYZ^)T/BVW\ VWC>]\;:IX8NCIMMYNA6-L
M,&[9 "@RV02YQCG'O5/QKJ?C#X>^ O =GXF\5WEC'?7<@UW5[8J]W#E=T<48
MP=P!R"0#T':D!](T5Y9^SOXGU?Q/\/[F]U.^;5XX[^XBL+V3;YUQ;*0$:0#H
M^=PP<' &17/?"KXU:]KH\>7FN:)J,UOI5XZP16=NLCQ@!0+8(F69\G)/(YZX
M' ![I17F7A[XVIJ>O7&C:IX=U#0-0737U2&&[>-S-"O7[C':W^RV#65H'[2F
MF:SX4U'Q/<>']6TSP_9VWG#4+F-?+GD\P1^5&0?F;<<>G7TH ]BHKRC2_CY%
M/XJT/0-5\,:IH%YJT3W$+7QC"+$%+!V(8XX!R.H[XIFC_M%Z5K%YITBZ-J<&
M@:E>_P!GV6MR*GDRS$X V@[U!/ )&* /6J*\7^$/Q2\1>,_B?XYTK5--N(+#
M3Y8H[=2(PMGC?\KX.69^N1D?+VK=\7_'"S\-^)=0T2QT34?$%WIEL+O438;-
MMM&1GG<PW-CG:N30!Z717E^J_'S2K:X\+P:9I>H:Y+XDM7N=/2S50S[<?*P8
MC;U))/ "DFJUO^T;H7_"%ZMKM]I]_IUSIM\--FTJ5 ;@W)^[&N#@D\_D: /6
M:*\PT3XX)?\ C*'PQJ7AC5M%U5[*2_,=P$D'EJ,C;L)W$CL.AX/-5]+^/L<_
MB/1-,U7PMK&@1:W,\%A<WZHID=3C#1YWQYXQN ZYZ4 >KT5X[K'[25CIUGKF
MIVOAK5]3T#2)VM9M6MQ'Y33 X(4%@Q7/\6,5?U?X^65K?6UCI>@ZGKVH-IJ:
MM<V]D$S;0,H8;BQ&YL$?*N2>V: /4Z*\OU#X^Z3';>$)=*TR_P!=;Q0D[6,5
MHJAPT>S*ON("_?Y).!M))Q7/O^U+81:3>ZC)X5UE+;2[D6FK2'R]ME(7V@$[
MOGY_NYQQZB@#W"BO._%7QEL]$UFRTC2M)O?$FIW-C_:1M[$HOEVW9V+D#)YP
MO4_C69J/[1>A6VC^%=1L]/U#4X_$,TEM;PV\8$L<R':8V4D?-N^7]>G- 'J]
M%>&>+?V@[Y? GC*;3?#]_I7B;062&XM;Q8V^S;P2LQP=K+@=LYR#R#7?>!O&
M%Y??"S3=?U73KY+L6"32P+&)9YR$!WHJ9SOZ@>_:@#M:*\Q\+_&]=;\6Z;H&
MI^&M3\.W6IV[W-DU^8_WJKR0RJQ*-[, :YV']J?37T*'7I?#&LV_A[[7]BGU
M-Q'Y<,F<<#=N<>ZCCIUXH ]PHKS+Q-\;+?3?$VJ:#IFAZIKMQIEK]IU"XL%3
M9:H5R/O,"[8YVKD^F:D_9TUV_P#$OP<\/:EJ=W+?7TXF,D\QR[8GD R?H /P
MH ])HKYJ^&OQ\U#P_P"%-<OM?TS6=;TZRUN>&YUA K1VD990BX)W,!WP.-PS
MU%=ZOCZ"U^*WB(B^U&ZM;/PXFI"Q^7[-LR#O3G.\CCD8YH ]8HKQS1?VE+#5
MSX;N7\-ZO9Z-KLXM+75)50P^?T,9P<]01G&#M;&<&J?Q,^.;C1?&]EX?TG5+
MD:+$]K<ZW:[!%:W."  "VYMIZE0=O>@#V^BO!?ASXUN]1\4?#BTOM7U.:[O_
M  V;J6#*FWF;+9>0YW;^.PQ5N']J;37T2#79?#&LP: UX;&;4G$?EQ2;L# W
M;G'?*CCIUH ]OHKS7Q!\;;;2_%6I:'IN@ZGX@ETJW%SJ4U@J;+9"NX?>8%VQ
MSM7)],FND^'OCNU^(G@FP\36EO-;6MXLC+#* 9 $D9#PN<Y*$\>M '345Y/%
M\?HXM=TFTU+PIK.CV&JWAL;2^OD2/?)G W1$[U![$BO+8?B/XRU'QA\0M:-K
MXB6/0UDCMM-@F@%K;'R]H\Y2<LPSYGRG^'OTH ^JJ*^6O 'B[5XO#WP\O-9U
MCQ.MWK>K@;IY8GBN1L'  P5B]CELY]J]%UG]HRUTVZ\3Q6WAC5M23PY<&+49
MX/+$<2=I,EAG//RCGY2>E 'L%%>.WWQ&CO?B=X<ETVXU:YBOO#DNIV^E0[%A
MN/O,N[)R).P[=.:YSP'^T9J<'P_E\0^*M$O9+;^UC:&^A$:Q(KR,H 4'.(\
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ML3R.N#T%:7BSX\V'AS7=8TVTT34M<71(5GU6YL@FRS0C/.Y@6. 3@<X!/8T
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M9_\ %=OKG@G4KVTT:&ZT.]\Z^ODO)9KC4 3]]F=>,8&%Z<GITKV#QEXE\/\
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M$3SQ).DGRE@JEBIW8SCC(->^*ZN"58-@XX.:;/#%<Q/#,B2QN,-&X!##W!H
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M0=%ETZ9W)$LDKLS%E7&-N6/>NF^$O@34/ [>+CJ#P/\ VKKD^HP>2Q;$3J@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHKA4\1>)M,UW1+75%TF6UU&Y:W)M$E61"(GD!^9B/X,?C7=4 %%%% !1110
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MHHHH **** "BBB@ HHKY0_;\_:.^*7[/'ASPK=?#3P>/$<FHWCQ7MT]I)=)
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MN69OEP>,Y(QSCM^E(GRP!LLS*PZL>I/<?C3E/08.!R<=S3%"+;$E=O<@<EL
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M&-I']/\ /2D W%4<84@@D$G(Y[U(K*R(Z@D*"0/I2!,.,J<8W<^N1R?R% #
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MHC X)7!!['BH]J^8V0%DEY++\V0.GZ?SJ.6'<\)W,%C^=@RC,AVG&#V]?TH
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M_H(KYT_X*/\ _)E?Q+_ZX6?_ *76]?1>F?\ (-M/^N*?^@B@"U1110 4444
M%%%% !1110 445!%>V\UQ+;QSQ23Q8\R)7!9,],CJ* )Z*** "BBB@ HHHH
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MZTZ*,$G))!Q@>G'3\Q2W$;-"XC<Q2-]UP <'Z'B@!K*5<@=3R#Z#_)IJ.,\
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M&5)YKVBO ?@G\._"WPT_:*^+&F>$O#FE>&-.DT/P].]II%G';1-(9-3!<J@
M).!S[5[]0 4444 %%%% !1110 5^?G_!4W_D9_A'_P!>FN?^AZ=7Z!U^?G_!
M4W_D9_A'_P!>FN?^AZ=7D9O_ +C5]/U/T/P]_P"2IP/^/]&?$E%%%?D9_H@%
M5=6_Y!5[_P!<7_\ 035JJNK?\@J]_P"N+_\ H)JX?$CFQ/\  GZ/\C]NOA#_
M ,DF\%?]@2R_]$)775R/PA_Y)-X*_P"P)9?^B$KKJ_<#_+9[A6'XW\.W7BWP
MEJNCV6M7OAR[O8&ABU;32HN+5C_RTCW C</<5N4UW6-2SL%4<DDX H$?&]S_
M ,$[[RZT[7]-G^/OQ"DT_7[DW>JV9FMQ'>RL%#-(HCP2P10?[V.<U]<1Z%:O
MH4&E7T<>IVT<,<3K=QJXEV@8+*1C.0#TZU\)?%_PMX].K?%OP?#\//$WB+7?
M%OB.'5_#WC73_$"0Z?8HB(+5I,S*8?LWSYCV8DQW&TU]MZYKE_X,\#-J3:7J
M'BS4;*VC,EEHR1FYNW^57,2R.BYY+8+#@''.!0!^?NI_%V#6/C%XWLM:^)_@
MOP1=:7XHN=.AT6W^'\>J;X4E C=KQ8Y TCJ1ORP*/N!52,5^D5L0;>(A@X*#
MY@,9XZX[5\">$KR7P[XIUN6S^-&J_"^VU_7;C6I/#/B[P#' ;66XEWO"+F>,
MH221]R0@DDCDFOOR$YA3YQ)\H^<?Q>] '@_Q;_:"\3^!/CA\.O!>G>#W;P]K
M^KQ:;?>)-0;;$6>":416RA@S.!#EG(VKP,$G(P/#?[3OBG5?BOI=I=:3I \"
MZSXKU7P=9/"91J$-W9"7,LA)V,CF"4 * 0 O)S7K?Q.^$L'Q*\0^ -5FU"2R
M?PEK@UN...,,+AA!+#Y;$]!B4G(]*X?0OV5K71OBG;>)F\3WMSH-AK5]XCT_
MPV;:)(K?4;Q6$\IF WN,O*P4]#(W7C !Y%_P4)_:"^&.O?LN?$OPEIOQ"\,7
M_BC_ $>U_L:VU:"2[\V.^A\R/R@V[<NQLC&1M.>E?96F?\@VT_ZXI_Z"*^7_
M /@HQX3T.U_8[^)=_#HVGPWWE6C_ &J.U19=QOH,G<!G)R<GWKZ@TS_D&VG_
M %Q3_P!!% %JBBB@ HHHH **** "BL[6/$>D^'H3-JFIV>FQ#^.[N$B'YL17
M*S?'/P)&&,7B.WORO5=.22[;\!$K$_A0!W=?&W[.7["OB;X)?M3>,OBGJ7Q%
MFU_3-:6Z"6+*XFF\V0,GVAB2&\L# QWQC XKZ!U#XUQ^4C:%X)\9^*&/5+31
MFL=OI\U\UNI_X"326GC_ ,>ZW 9+#X77>D,,_)XHUNSMRWH1]D:[X^N#P>*
M/2:*X*UOOB==@?:-&\*:6<]4U6YO./I]GB_G3#8?%"63YM8\+6Z9_P"6>G7#
MD#\9A0!Z!17!GPW\0;A")/&VF6Q)_P"7;0>1]"\Y'Z55_P"%>>-9I]\_Q5U>
M),8\NRTG3D'YR02&@#T:BO/9OA9K-Y"T5U\3_&,Z,I4^6--MVYZX:*S1A]0<
MCMS6>G[/FE'FX\7^/;I^[-XNOXL_A%*@'X ?G0!ZE17C>J7WPN_9VUG3;OQ'
MX[U#1KW5";6SC\3^,-0NXYR2,[8;BX>/(./GVY&>HS7L2.LB*Z,&5AD,#D$4
M .HHHH **** "BBB@ HHHH **** /*OVB?$.I^'O".G-9:E<:'97.HPV^HZM
M:1EY;.W8G<X Y].1S7EWQ)\3^./A-X%U*PN=9OO$FB:I CZ1XDC&VYM9"RML
ME(YPRYPW7G'L/8?C=XWO_!OARPCTRWLI+[5KZ/3XY]3_ ./2W+_QR^PQ7C.H
M?$;XB^&;S7XM4\2>%_$=AHUK#>7%F+=!!/$[,/*1U (E&WA2#G(/M3 ^FM!G
M:3P]ITTSEF:UC=W8\D[ 22:\2^)NO6]QXPTGQ/X:^)'AGPX[6,EH9+W;*;J/
MS?F')P55T[<@@\]J]RTJXCO])LYUB$44\".(L<*"H.W]<5X/\:-7M?#&M1Z-
MH?@#P[JXL--;4KB34((U2"$S;3L&/[S%CCW-(#T#X-Z_J.OZ=J,FH^,-&\7O
M'*JI-H\:HL(Q]UL=SUKT2O*?@3?W<O\ PDEA?^']$\-WUC=1QR6>BH K!HPZ
MR,0,'<K COCK@\5ZM0!Y]\)&S\-/#@/!^Q*..W'_ ->NI+$_NPO4D*=W!XP?
M?C^M<K\)8R?AIX</_3F@&._K_GVKKC'D%?NYXX'%,!N76;"H'5B.2>G3M^=1
M$D1;!@2 [2HYQW(&",';TJ2=6$3B.0QN5PK+@D$\#@\=:4JX=?F  R=NT8^N
M?7-(!4VPJ2#PN.2<GTZTZ5R495Y;H,_SIJ %0"58_P 6.YI\BGRW<$AB.#Z&
M@"M<!@5"H61R4&>1G!Y/IWI+:/RHB-Q8 ].,J,=./I^M/A5HF9]S#+$D _>R
M>]0K&T4SLN[!.YD_A)QDGIG/-("P)?,^;;D,N[)&,^@_SZT;,2!MQ!!_/!H<
M!AM/W#E3SSS1$_G*K Y.3P1]W'K^.:8#P<N"?F)ZBD*D[ED5C\N#S@$$]J4-
M^\/(V$97U%2>8K#)/0\$=Z!$.?WH)R& QWQCBF2E%0.P+*N<G'3FGE8R1D#9
MD-\HY))_R:522HSCJ24'.#G^E(8VX9(R5) <9Z#DG_.:=(V<,1R 2.>*9-(8
MRSE@><?*O<\4T.);EH2K1K&_+-_$  >/;G'X4P&"$(2K)^Z4!5!)P%(Y %/C
MB19VFY_>$*<'C(SC\>:D9R5#9RP;\_8?K35@\LN_)9F[G) ]!0 Q2 &).YQD
M%!R<GI]>*5)&DD#*A6'R\_,"I+'G&.U3<Y7>V=H/W1SG!R*B8QO,\#$,S1AB
MC*<8SCZ4 <_\0A_Q2LP!_P"6T#<\_P#+9/\ &IOC'_R3'7_^N _]"6H/B$X;
MPM<$'($\ X_Z[+4WQC_Y)CK_ /U[C_T):8&E#:I&TLJA6=U(1LG*@@>IZ=.U
M2SW+0201A2Y=L%N,  '.<D>@Z9ZU(V[S510OE_Q9/..< 57O!9;K>]G\O,3;
M(I2>%+D#CMDGC].](180DREMS*Y #!B2N 3T[ \_RIRI'$TDI 1FP68GV _I
M4&'W;U7:"<%'XSSR<_2D$D+9D/F212 ?.'S'P<8 S@9SZ<X]J8#V@A>0NH7>
MK%P >"^".<=>#2M WFB59Y$.0S1[LJPVD8YY R<\8Y I+1%A5/EC4%B08^C=
M<?H!2330PL\AV[F"A@" 3[<FD!/&OE_*2#C@8/Z57FMUE\M/*1H6;,BD8YZA
MNOJ!^=3(S,6X50IQ\W?WJ)U6\A4K%%<XD4D2'A2&Y/0\@CCW':A RTNR3$B'
M(/(93P:@GGM6NX[9Y%-T%,Z19^8@<%@/JP'XU9"[>G ]*KSSPVD4LTA8! 69
MMI8X]!CKTZ"F2,CNI/[1,,B;8WC5XSR3GG<#@8&/E[\Y]JN$9! .#CK5.VU#
M[58)<I!*"Z;UAD 5_P">/UJT0692&*@') Q\W'^30@$57CB !,K@ %FP"WN<
M"A),R.I5P1CJO'X'\*;F1+@[F+QO]U0O"<=S39I0;B&$)N)RY+!L #OD#&<D
M<$C//I0,?'.LLLL81P8R 2R$ Y&>">#^%1M'"E[YC-NFV'8IP2J\;BO?^[G\
M*G1B0,J5/H>M5I+H+?1Q_9I2&C<_:@%V1@8^4G.<G.>!CY3TH BN[2&_2:RN
M(3-:NN'61\B3).5(SG&!WXYI;BV,KQ.8U:2+<$!Z!2,'Z\9XITLTIN8HDMY9
M%DR6D7:%09&,Y.<XSC ]:G(W+AER,TK7'L-MPFTC#@@D992,X.*'BC6)T"X!
M;=M0X).<]O>JIC:Q2]DC"E3F145<'=CG))P<FIK=Y>09$W9X" ?*.V??I1L(
MYWQ*TC^)_!1;&/[2DW#^Z?LTW'OWYKO:X;Q2I'B7P8222=3?G_MVGKN:!H**
M**!A1110 4444 %%%% !7BW[6?PC\)?%3X1:P_B@V-H^DVDUS9:IJ4TT<%C(
M5 ,CF-@<< 'J1V&:]IKS#]H?[==?#/7=.BT4:GI=UIMT;VY_MB'33;!$#+B6
M565=QS\YX3&30!Y9^POX1T7PUI/C6YT(Z#:V5_?6[?V9X>O+^\@MBD.TL9KQ
M$D+.<G:%VC QR37U%7SW^QKXWO\ QYX/UN_N[Z;4(4NUBAEF\4VNN]%^8;[>
M-!'V^5@2>M?0E 'D7@K_ ).?^*G_ &+WAW_T9JE>NUY%X*_Y.?\ BI_V+WAW
M_P!&:I7KM !1110 4444 %%%% !7Y^?\%3?^1G^$?_7IKG_H>G5^@=?GY_P5
M-_Y&?X1_]>FN?^AZ=7D9O_N-7T_4_0_#W_DJ<#_C_1GQ)1117Y&?Z(!575O^
M05>_]<7_ /035JJNK?\ (*O?^N+_ /H)JX?$CFQ/\"?H_P C]NOA#_R2;P5_
MV!++_P!$)775R/PA_P"23>"O^P)9?^B$KKJ_<#_+9[A7G?[1'@V_^(?P-\<>
M&]*:T74]2TJ:"V^W3-# 9"ORAW4@J"0!D=,UZ)6-XQ\'Z/X_\+ZGX<U^R74=
M%U*%K>[M6=D$L9ZJ2I!'X$4"/R]MO@EXM\6:]KNJ^*_V5=.U#5YM3DW3GXER
M6&U1M"@)]JPX&/OJ K=AQ7ZE^'H/LN@:9";869CM8D^S"3S!%A -F_)W8Z9[
MXS7YK?%SX??":Z7XT^,KKP-X$.K^$_$J646E:IKM[%?:A!"J&<E%E&)9=ZB$
M*-N1S[_HU'HUEXA\"1Z5Y5UIVG7NG+;B**5X9X(VCV[0X.Y74'&0<@B@#\_/
M&X^.?B3QOXZU.?4_%T&B^'O$%S)I5UIVJP+IEU<2ZA!#:1,JOL-K!;1OYR/\
MRR,V1N+5^CUON,$>_!?:-VWIG'.*_,[P_P#"7P-;:]KFA:)X(^/OQ%\.V'B2
M[M[N\37$&DW5S'=$S!HFN$\U5E!#.R[F*DG).:_3&W 6",*AC4*,(>J\=* )
M**** /FK_@H__P F5_$O_KA9_P#I=;U]%Z9_R#;3_KBG_H(KYT_X*/\ _)E?
MQ+_ZX6?_ *76]?1>F?\ (-M/^N*?^@B@"U117.>,_'ND^!;6V?4'DFO+QS#9
M:=:)YMU>2 9V11CECCDG@ <D@<T ='7"ZU\9/#VGWMQIVFF[\4ZS 2C:9H$'
MVJ57'\#OD1Q'M^\= .Y%947@GQ+\2K4S>.;Q]%TN?D>%=%NF4>7G(6ZNE"O(
MQ&-R1[4'*YD7+-S_ ,$/VE_@S\0O%FJ_#?X<:QIQO_#L;!M,T^U^SVXB1PC&
M#"A'56(!V<<@]* (/B;\7_&'@'X<ZYXZ\36VE?#SPQI=O]H=)\ZMJCC( C,4
M;)#'(20H"RRKD\L ":P/@+XF\+?MA?#2+Q=9>//&>K:3]JDMIK!+PZ'):SJ%
M+1O]A9'/RLC &5QAA7NWCSP)H/Q-\(:GX7\3:='JVA:E%Y-U9RDA9%R#U!!!
MR <@YXK)^$7P:\'_  )\&Q>%O!&C1:)HL<KSF"-F=GD;&YW9B2S' &2>@ Z"
M@!_A_P"#?@7PM<_:M,\(Z/;7Q&'OS9H]U+ZEYF!D<GN68D]S7706T5K'LAB2
M%/[L:A1^0J2B@ HHHH **** "BBB@ HHHH ^;OVLOV&?!_[76K^%]1\2:MJF
ME7&A[XU_L]DQ/"[!F1MP.#D?>'-?1&F:?#I&FVEC;@K;VL201ACDA5  Y^@J
MS10 4444 %%%% !1110 4444 %%%% 'G7QT\6>&O"G@IW\6Z%=Z_HEU(()8;
M2W67RR0<,VYUV^S Y!(Q7DF@_$/X9Z-H(TK3_A)XK.F2S)=%)-'682NO*,S/
M,2X&>,D@5]*ZMI5IKFF76GWT"7-G=1M#-#(,JZL,$&N%TS7W\)_$71/A[8V)
M.BIHK7:7<KN\B%9"@CR>",#OS3 [^RG6ZLX)DC:))(U<1N,,H(S@CL17A?QA
M\6>#= ^+6F1>-8+>/3Y-%N$BO%61Y=TC;&C=4_@*%R#@X(ZBO>J\A^(^O^.+
MSXE6/ACP9?:/:NVFM?W']JPLVU1($!! ).21P!V.:0$_[/MO\/[?1M57P#>3
MW\!N ;N>Y,A??M^49<#@#IBO5Z^;?"_Q8^(6D>,(K#Q'<Z!?6D>MIH=W;V*,
MLJR.A=9$.,,N!R.HZ$#M])4 ><_##[3+\*?#Z64L<%S]CCV231EU'KP".V>]
M=NGS1J6P3W(Z5Q/PBC"_#SP_*K2$_88P5W$J,<@@= 3D].O'I75P317\(\OY
MX&Z.> Q!QCUZBCJ!9?8'ZC/]WU%1%E1U!(+$$A,C./7_ #ZTKD;/F;+8.0>.
M"<'/YTTJD?[Q@JXX 4#C/% $<JN6B\MRH0EB-H.1@\$GW/:I"WF22QER#PP8
M9X!!]>#ZT$;\-G<,8(SD<_Y!H9@[;?USZ]_YT )# 888T:0S2*%7S6QN8]"3
MC SQV&*L ;<GJ?>H%/WMH*!3@@CJ.<8I)9=KA<DDYZ$^W^(H DP=X*\XR153
M5)+FUL+AK1%FNEC)BC8$!F]"0#@=.QQFKJ2 2 MM"XSNSS^50DK(@:13S@E.
MG?\ GT.*: BL_.^S[9PK2C'(.<C R>GJ&[>E2QQI%$L80!%[8XZTTW$3W0M\
ME7*;\;3C;D#KTIX4, 68Y5]RD,5X[#KSP>E2M$ \Y9LG VC (S[4TMER W3@
M@#J!_P#K%5V.R\;=EBR[XP$^XO ;+?7'Y>U601&C@%3M;"L?I_C0 D@8,Q
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MD)51N<$ 84=JVO$/QA\<^'?VD- \&-9>'K_PWK+3,EE9?:)-7M;2*W+OJ$[
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M]0,HQ(4.Y!D=> ":T/@-X[\/:E\'/"-QX#^ GB>7P@]A&--D4:*@>(<9Q-J
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M:2::]NS^\N)I&+.Y4<*.0 HZ #J<D^HT %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '!_&'XL6OPA\-1:K<V
M$^HF:7R(XH6"C<03EF/0<=:\8N?%OQ$^*OB_PWHLOB'3O"VC:W'<31CP[<)=
MRA(@&(DE#$;CG'RD#U%>U_%?XA:-\/\ 1;636M+NM7@OY_LJ6EK LS.Q!.-K
M$9Z5\V>)KSP#J&HIJ_ASPGXX\&:Y&2R7FD6.Q,GKF/?CIG[NWKSFF@/L6SM_
MLEI!!O:7RD5-[G+-@8R?>O#OCMX*UC7/%0O-!M]*UR^GTB33WTN^N4BG@5WR
M+B+<<9R,'\J[KX3_ !3L?B397T5M::E:7.E>5#<KJ<(BD9F3(;:&/4#//K7&
M?'O2+7Q-K-CIEIX%U'Q%XA,&ZWU:SN#:+9@L<;I\X'0G# B@#I/@SX-US0)O
M$FLZ_9V>EWVN727!TVQ?>D 5 G+#@LV,DCJ37IE>=?!/PEXO\(>'9[7Q=KG]
ML3M(&MD,AE:VCQ]PR$ N??\ *O1:0'GOPG&/ACX<.2,6:'I77L<R,0IP6(.#
MCL"/YUR7PD^;X9^'!G_ER08KK%;RUW.PX')Z4V P1LY;>X12W! P>V/QH94V
M')56)*X;K^'Y4LDB2NJ/'N (;YE)'!X/YCCZ4KB,J-PP$!R>N..WO2 JRDW2
M7$4_EF)L*491@CD'/U([U,FV-7*;]VW8K'H<#(]N_;VIC!5FBP,.$9%SDE@!
MU/XT^!9Y+5%N607&%W>5G83UX!H C5?."K)'\I54V]@>N<=JE4^2<JJE=PW,
MW&1Z_P"?6EF;RW\P)E64L^>JXQ@?SI5#(-DK!221E>G7C^= "S.@E0<!G)*D
M<\ ?_JJ)F #,K9)P%(!)![<40I\FTD8#DIM4C@'CJ>HQ4[@!X@,!BQQ]<?X9
MH :2%BY8PHIR6'IG/?M4%M<I=EMAPFYMO.">>H.>G-3*&.]6VH>B\< 8!_GF
MHX>&56!4<D[NY.>,_E0 \'.[<2I0$%L?*:4@^9D$;0I^4>O_ -:DD0YD64AE
M) 10O ]<_E[4@*AY=Q PN0PZ\XS0 YR-Q!0G=AO3 X&?Y4^.212$"AL+RQ..
M>W'OS2 I,5D!)C,>T#ZX/]*#C>S9Y8 'ZCI_.@0U9)2 V%1\@;>PSZ&GA=HC
M<)TR"N>3Z&FEGD.2R[0>!CT/6D0@.D>2RL2PR"<?C0,2WPC7#%N9)MP5CC;\
MH 'Z?K0A*2,&&T!3ANN3^'^>*>7C5F5BNU02=WU_D*2,AV!4Y4?)LQ@9]: .
M6\>W"OX0E<9!>Y@4A5.-PF4']1UJW\8_^28Z_P#]<!_Z$M1?$-F7PM,!C!FA
M#?43)4OQC_Y)CK__ %[C_P!"6F!J" RPE98E&QP8R&Y..A^M/:! $BV%AM*8
M8Y^7@<YY[?K3?.6XS&9"&!&Y%&#@Y]>Q(.#[5!.XTVTCEN7-Q)" 7F=4#%=W
M+'[H 7J?8=*0&7H7A#2/"]VLNG6 M)9XP'*.[* HX4 G"]?:M74<M8MYJ$Q;
M6>5H22Z8Y!4 $L>.G\ZS?"/CO0_B%HHU+PWJ5IK5@96B,UI,&4%6P<]P1SP:
MT7A=<0Q)L+ J&9BX3AL,03S_ )R:2DI+F3N54ISI2=.HFFMT]&OD55TVSUEK
M+4$E:?R6$UM(Q.$X(/ QV<C#9Q]16L9%C95+\L.A[X/;\P*IW,21:>JRR1QE
M=NURVU%<'Y>GN!QT[5,A,B+'."Q= 6)C.T$8R/KSTID#I3%"T18'>Q"+M!/T
MR!T'N>F:L)&H=C@;\!21[9X_4U#)/'#(GF?*6&<X..PZ]!UI;=V.%E7##OQ\
MWO0 ^#RFE:6) WF##2J>NTX _G3_ "L3&3<Y)7;MS\OUQZ\]:26#S()(U9HB
MZD!TZJ3W%,,31O'*TK,RKL89X/OCH#3$2,Q0,S$;.. IS_GI38Y_-52 2K#.
M3QCZ@\TDR>=%Y9;=QR2>OY5''$+.W1(8U1%' )P!P>/SQ0!.[GE47+@9&[('
MYTCPDEF5F4M@'!R!CT':E@+F-"X57(&X*<@'O4E/<"K-+")5\PIY@& >^#U^
M@XZ^PJ*\$ODN86,;[-YG7;V.<<@]?IZ]\5:54@B(4Y5%P!GD8'<D_P Z@N4>
M2UDA1GMRZ%5E0#>A/< @C/?D4AD!NO+G?<Q8;?,8,O*\<!<<G[A)')YZ]JKP
M:I!=%KBW>2>!T 1D0[#@]0W?EA],$G@&I]-5A911M(YE4 &60#S.W+<8SSZ=
M\U-<0,^UHBIG .W>QP5/WL@=>/UJ0$MU+;9?M+,9%4+@@H .N.O7UR?:I_-)
MD=2NQ1P"3U/T]*Y3PIXDMI9KK39//DO+.3RY9_*Q%*?,9<J5^4?-D$'!&.F,
M5MW4JW%];6\,L!EB<RRK)$Q9%VE?E88VDDC&<Y&[ /8ONAF7XE 'B;P;SDG5
M'(R?^G6:N\K@_$C[O$?@S&"!JD@R#GD6TP-=Y5, HHHI %%%% !1110 4444
M %<'\=KO7[/X0^*F\*K+)XE>QDBTZ*W6)I9)V&%5!*0A8Y.-W&>QZ5WE>$_M
M3?!;Q=\6[7PS/X-O=%M=3TJ6Z7_B>^;Y4/VB Q"ZBV*V9X<[D##!)/*G!H X
MC]D[Q7XOT;7;[PO>^!/'D7A.\N-]AK/B%]*E6Q986,ZSR6LH8[I5VJ CD$C)
M SCZMKQ+]FOX&7'P3G\90)8:7H^BWMW;1Z98:7(S[HH(%B-U-E0!-.P,C!<X
MXRS-DU[;0!Y%X*_Y.?\ BI_V+WAW_P!&:I7KM>1>"O\ DY_XJ?\ 8O>'?_1F
MJ5Z[0!YI\:?^/[X;_P#8VVO_ *(N*]$OK>2[M)88KF6RD=2JW$ 0O&?4!U9<
M_4$>U>=_&G_C^^&__8VVO_HBXKTN@#QOXZ?L^ZC\:_A/XC\$S_$7Q#I\.L6X
M@>=8;/  =6*L(X$8JVW:0&&02#P<5H_"KX)ZC\+OAOX<\)0?$+Q%>0Z-91V2
M3R161+!!@8WV[, .@!8X  SQ6M\=M-\?:Q\)_$5G\+]4L=%\=RP*-,OM20/#
M&^]2V0589*!P"5(!()&*T/A+8^+]-^&OARU\?:A9ZKXRBLD75;RPCV02SX^8
MJ,#CMD  D$X&<  ZBVB:"VBB>9[ET0*TTH4/(0.6.T 9/7@ >@%>:? 3_D&^
M-O\ L<-7_P#2EJ]0KR_X"?\ (-\;?]CAJ_\ Z4M0!ZA7Y^?\%3?^1G^$?_7I
MKG_H>G5^@=?GY_P5-_Y&?X1_]>FN?^AZ=7D9O_N-7T_4_0_#W_DJ<#_C_1GQ
M)1117Y&?Z(!575O^05>_]<7_ /035JJNK?\ (*O?^N+_ /H)JX?$CFQ/\"?H
M_P C]NOA#_R2;P5_V!++_P!$)775R/PA_P"23>"O^P)9?^B$KKJ_<#_+9[A1
M110(**** "BBB@ HHHH ^9_^"DSF/]B3XGL.JVUH1_X&V]?+W_!)=](^.'C/
MXD_%#Q7HNGWGQ*L+R!4UN"/R"(KB%D8"!,1*3Y+9<+N;>V3Z_1'_  5'\11Z
M#^Q9XWA=49M2DL[-0S <FYC?('?_ %?2L/\ X)/_ -EW_P"RO!K%EX/L?"UY
M=ZI<QW5S91L/[3,9 6<EB3@;F0+DJI1L8R10!]FT444 %%%% !1110 4444
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MT#I'(5!<X56.=Q'/%!4,"2,'Z8/7I3$,OVAF<QF$ %<## YP<_I^M# M 8'
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MV=CX!UW2]%T/68[K4=7U%K/[/+""T4;1>7.\GS22(1E%.#SCI7J?[&]SXT^
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MC_Z(SX[_ .^]*_\ DZO5J* /"?"W[4USXSO_ !%9Z3\)/'=S<>']1.E:BO\
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M[D\J,<^M,!S 2(54_=8!@1VX.!3$*H5+99U8C.,G'.*8[E"@,@CW]5(SNX/
M^N,T\3 1%W7@?>4GD9SC/I2 R-/T:YM"\\ET'8,K%(U(WX/5O? Q^%;%O%LC
MEC=_,7=NZ=B<@4V-GDF8L"JC( /?@9(_'-31H4(X )&6QZUG&"AHAMM[E:TM
M(["U,$.8U0!5!)/''K]:>$3R94BP@)^4CL>M2S AU&,ENAQTQ3-@++B4-C.0
M.<GBM!#2I>4':"RY8@=5Z8'UZTORH&<J4)();/6@,6=QCY2<#ZY.32).LL;,
MCJX#%1@Y&5Z_CG^5 "RQ91-RL03RN.H[U!(XC'$<@#!50*. .P/^>]3 Y&P-
MRG QT).",^]"*-F1\H(  /8CC)H:N!!9PRPQ*LA&Y&'^K& O'3'I4X1848!<
M*6W[57/).3^IS2CS-\GF( @Y#;OY\4LG[HM/O 3:0P/KUSGZ9_.I2LK#;N1L
M9'" *$PWS$C.?3'XU,TA0<KC&2?0TPQLS'<"W)QGCKT_2A2)"#(H!#%1N'.?
M4>E4(D9-CN23Y;K\WL?6H#&DI(F17$;"1=_S#(Y!&>^>?QJ8NYX!';_Z_P#2
MF)/%.'VJZK')L.]"OS9!XR.1TY'%,0KCS@\84G*[LGMC'%$D?GDR!AO*DJ#V
M."/\_2G^0RCY6&0#@GMDTD]M%<P2PSJ)8I5*2*PX((Q@B@#F?B*6;PM*R\@S
M6^[GI^]2IOC'_P DQU__ *X#_P!"6J?CMH6\)R&+)5)+=4;& 4,T>,?D!^%7
M/C%_R3+7_P#K@/\ T):!FN\0^SR!U$D94GRRN<]R/IVJ*U:66:=V6,1JVV%D
M;<S #E6XX(/H35F.7S"YV$%?4@L>Y''3M^=,A_=L8?+DR"3ELD$!O7GUZ=?R
MI"*ZW)M[H6PMI"A7>&0J0#N ;/.<C=G\#UJIXP\-V_C#PMJ>CW@#V]U$4.5!
M#=QPP(ZX_2M7?%&S@L@VC>_(''()/MP?RI+J580I(8DD(NWD9)X/X4T[.Z!G
M&?"A=3B\+"UU)+B%X))(8WN2/-*!CMSCC S@=. IP*S_ !?XUL_A;J6EVD5G
M+<0WTSO<Q6Z&298PK$NHX!_>,N23_$37H13S(U=4V<9&X?,H./QSP*X?QW;>
M(IKB*\\-QPZ@B#=+%-<!   <! 48,3EAR1C.>>E**LFD!IZ1X]T'5-<O]%L+
MR&37[54-SIYFP\ <;D)'/!'<#TKIIY?LT#RLKLJ#<50%FQWP._X5P&F?"_0]
M)\>77Q"%A]@UN>Q:&]RX?@LC'YV/ 7R^@ !SGM7>07T5[:K<0'[0CJK*J$$X
M(SG.<=".]2F^9WVZ QT0)G?.?FP5"\C@YSG'OC&>WUI+AUM4W[HT+N ?,?:"
M2<=>YQ@#U.!5HCY< [3UXZ]:B*^8(RX#./0<9]<'W%4A"L#&N45C@XVKC')Z
M\GMG-&Q)09.F. >AX/KZ9%+$Z;7C1U+H<$$[L=QGOTJ,7$97$HP2YC &&WX/
MH,^A^F#F@"5XA<Q!&P5(Y& 0PZ8/M4=SYT%K/);Q":=49HX=P7>P'"Y/3/ S
M4I/E\D@#.!DTI5GVXD( ;)&!R/3I_G%,%HS\X]._;B^)GPA^,^N:?\4-%D_L
MNYG/F:0!M>P3^ P/_&G3.<[N2"#7W5X0^)?ACQWI&EZUHNOP7VGZKN2T1&&3
M(HW."I^8,!U!Z"N:^/O[/WA3XY^%)[3Q#9RR7]I&YL]4M8@;N!L%@%P!N'^P
M>#['FOB[]E?]F+XL_#SXOZ3X@U#0IM+\/VOVG=+?W*1?*\3*&**S%"V$SU(Q
MWQ7A1EBL)65)^_&3WZK7J?J]:ED/$&73QM.V%Q%*.L=%&=D[<MWNVO-][Z,_
M1A9;34;5O,M3) =V!(@*R+C&<<\$-W]Z22TCNKJ*:XC29;=@8<X)1NA8<<<$
MBLR\LFO-/G<0M'&(Q(?L\Y1Y0@RH!& %/U]>N:V+2X>YMH'D*++)&'/E-N&/
M8D#CKU%>X?E(1,H<ACN:5&"[02 !COT[]>,YJ1K='ED9BS;E*E2?E()';\!^
M JM)>-96DT]QL;RV'RHIR 2![[C]![582=!$C.2@P/ED(&,_UH YWQ'G_A)O
M!NY5#?VFX.WD?\>LPKO:X#Q <>)?!RA]X&J,,Y).?LDW4]SS7?T#"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#F_B-\/](^*7@S4_"^NQS/IM^BAVMY3
M%+&RN'21''*NKJK ]BHKS6Z_98T_6O#S:?XB\=^,O$]]%JEGK.GZMJE[ UQI
MMU:/OMW@58%B&&SG=&V[/.>,>W44 >'VW[(_A*UM+Z-=2U=[G4--U?3[^\>2
M'S;MM2D1[FX?$87S,QJ%V@* ,;3@4R#]D3PK:>)XM:@U?6HI!J&C:I+;!X#%
M-<Z9 (+=VS%N^:-55@& .W( ->YT4 >%:U^Q]X.US5=2GN-2UH:9>:E?ZVFC
M)-$+2WU*\ADAGNT_=>87*RR$*SL@9R0O3'J7PW\#67PP^'OAGP?ILUQ<Z=H&
MFVVEVTUT5,LD<,:QJSE0 6(4$X &>PKHZ* .2^*'PVTWXL>$V\/ZK/<V]FUU
M;79>U*A]T,R2J/F5A@L@!XZ$]*B^*OPLTGXM_#G5_!FI2W%AIFIK&LLFG[$E
M79*D@V[E9>J#.0>,UV5% 'CGBG]G'^W/BOJ'C_2?'_BKPGJ>H6=K8WEKH[VG
MV>XCMV=HPPE@=L_O7SAAUK#\-?L;^'-$UW3[J_\ %'B7Q%HNF:Q<:]I_AO4I
MK?\ L^UO9I))#,%2%78JTTA7<YP3GJ!7O]% 'E.I?LT>"9_#?AW0=*LY?#NE
M:)XCMO%$%OIK@"2[A;< ^\-E6/4#!XX(K U_]DK1?$_C?7-:U#Q?XH?1=;U6
MVUF_\*Q7%O'IMQ<P)"L9?$/FE08(F*^9R5].*]UHH \W^%/P"\)?"&[U^^TB
MR2XU76=7OM8N-3NX(3=*]U,99(ED5%;R@QPJDG@<DUZ1110 4444 %%%% !1
M110 4444 ?,7[72Z=JGQ(^#FA^++B.W^'U_<ZJ^J_:;DVUM)<16H>U61PR]/
MWS $XR@/4"NZ_8[U;6==_9A^&]_K\T]SJL^CQ-+-=$F60<A&8GDDKM.3UKU#
MQ!X8T?Q98?8M;TJRUBSW!_L]_;I-'N'0[6!&:OV]O%:P1PP1I##&H1(XU"JJ
M@8  '0"@"2BBB@#YK_;D\"VGQ)\'>"="O?''A_P3!_PD<=Z7\2;S:Z@8K>?%
MLRK)'N!W[B"X^YZU\6:EXYM?&?PYTB^U:TA\%6&G_"_4M4\-:?IEY-;VJZQ'
MJOE?:;0,VYG8#<JDLRK*0"1R?U4\0>&='\6:?]AUO2K+6++<'^SW]NDT>X=#
MM8$9Y//O5?4? _AS5XM-COM TR\CTW!L4N+.-Q:X  \H$?)C Z8Z#TH /!%Q
MJMWX+T"?78Q#K<NGV[W\8& EP8U,HQVPVZMNBB@#SGX_>#]4\<?#'5=-TWQ1
MJ'A-/+>:[NM+51<SVZHQ>!)#_JM_ +K\P&<=<CXMU^71-7^$GP2LO&NK267A
MY/A;JNJ0O+?/;+_:,,-J8958,,S(K2LG4]2!Q7Z*RQ)/$\<B*\;@JRL,@@]0
M16+?^ _#6J:78:;>^']+O-/L"IM+2XLXWBMROW=BD87'M0!^;7B/Q/KE[J>I
MZ[X@U2ZM_B;I4O@2+PC%]K=+B2&YCMC?".$-^]5W>Z#G:<[,'[M?J%61>>$-
M"U#6;/5[K1=/N=5LUVVU]-:HT\ ]$<C*CD]#WK7H *^.=)T?7/!_[?OBZ?4_
M&5UJYO?AS?:G;-?H([73(O[3011)&O\ #&BKN8Y9B&8XS@?8U43H>G'6?[7-
MA;'5/L_V7[;Y2^=Y.[=Y>_&=NX9QTS0!^36DVA^#?A'6/!>CZ_X<\:6%YI.B
MZEK'Q!\+R31S)I\^JI%=6]U*9F&63YPXV,%#9'/'W/\ L72"'3/BGI>F3>?X
M.TGQM>67ATI,9H4LQ;VS%(7).Z-96EQ@D [AVP/;=.^'_A?2+*_L['PWI-E9
MZA_Q^6]O8Q)'<]?]8H7#]3USUK0T30=,\,Z;%IVD:?:Z7819\NULX5BB3)R<
M*H '- %^OG/]MG6? >A^!M#G\:PWNM7,M^;71/#%M?-;QZO?2QE(TFPR@QH3
MOW,0$(!ZX!^C*P_%'@7PYXWB@C\0Z#INNQP$M$FHVJ3B,GJ5# XS[4 ?F]\3
M](U+PC\/UTGQEXI74];\.?"Z;4_#-];ZHS#^V/MK#_1G#_OI(@885/+$?[QK
MH+37=2N/CE!K&IZC/'\3H_B5I.D06KW;I*='?3-\D0AW8,# F1CC&[!)S7WS
M_P *U\(FRTRS/A?1S::6Q>P@-A$4M6)W$Q#;A#DYXQS5Y_"6AR^(8]>?1K!]
M<CC\I-2:V0W*ITVB3&X#D\9H UJ*** /SVT.QT3Q%\3?B!K?PV\41^&/#&B:
M#KNG:MXOU[66G?7-2E7_ %[1;MQ@LV5B)< ?,P7@9KRK3Y[3P#HTOPXM[KP]
MJ?A4>*/!L6O^-?"C36UKJ&FW,I\ZWO':9P" &+,&4%7^8#I7Z8:)\(O WAJ]
M-WI/@[0M,NC&T1FM-.AC<HPPRY50<$<$=ZNV?P\\+:?H=WHUKX;TBVTB[8M<
M6$5C$L$Q/=T"[6/ ZCL* /(/V)[J2;X4ZY;V]PUYX:L?%6KV?AZX,YG#Z<ER
MPCVR$DLJOYJ+SPJ@#@5] 54TO2K+0]/@L-.LX+"Q@79%;6T:QQQKZ*J@ #Z5
M;H **** "BBB@ HHHH **** "BBB@#S;X4:A;6_@+PM:R7,"W<M@)(K9G422
M*F-Q5<Y(&Y<GMN'K70:+XDTSQ)'++HFJV&K003&&=[*=9Q&P'*$H2 PZX/K7
MC7A_P!/K6G>$-2TJV%O<7/AJ^L+C5%;:\4D@@$!/.<#:Y&/0^M;?PN\.:M:Z
MUJFL7>@R>%[8^'=.TB.TEDB9WEMC<M)(OE,R[,3HJDD,=I^4 #+ ]<8_NFVG
M+JROQQGGI^E1A<RNX+.20>>A!QV]L5\T> ]#\5_$&'0+^^TS5[31&T?3X6^T
MWRJ+EDM+P/)B.4G#-+!UP2<9'%>F?![PSJ_A$S+J,=Z+>[TW32YN+AIR;P+*
M+EB2Q(.!'D]#QCO2 ]1!,2QKM)]0O.#22(J2M+YI5",G=P,\<YZTX2!QC'5B
M,$'KR:9$6?+, &P5"@Y&W/7\1CZ4 "JUNH(,DC.=K9Y(]_UI ZQF) =Y;)'J
M ..3^-*9'8HNW!/._=^/YT_[2%(4Q[B3A<+D9/3_ /73 8P$R/$)0F6"DH02
M!P2.G'I^-.4/)@/@ 8((Z^X-,6)(PA?#2+D;PN#ECSQZ=/UIS.>2$W$L5Q_7
M^?Y4@))P$8,J_,PQCUQR*B9Q'&2T@PSC ) &> %'Z?G3OE0A%SN'0]C]"?K1
M(6:2- H8;AOR/NX7.<_7% @X,GRY*C.1C'ZT@MPL,AC7DL6^;@#C]*C"@*S(
M6*AB_+'+-]3V]JG90^!GN,C/2@9"T 7R4<DA>?GRQXQSG\OK3DC\MFPBID[M
MR]SZTI&Y/F/S CD'TZC]*7)#L&4$#!R.>>OX=*!!;H1$ -TBC^)CDGOS_*F#
M=-%E&\MW0D;AG9UP<&J^IZC_ &;;(TI7+R"%5!(7);"#ZDX'U-16MY)?VY9E
MEM+@QG:SH<J,E02"/7)P?05+E:2B.VES1V[AAQNQT+=CUS1% [,&?<Y#D@J<
M #G&14:1E/+W2N[ 8RQ WGG.0 *L0O\ /C(/?TJA')^/2LOA2XE7&'FMMJ=E
M'G+S]:L_&+_DF6O_ /7 ?^A+4'C^)4\*3%5*GSX25/49F0G]?YU-\8QGX8Z^
M/6W'_H2TQBZIXNTS2;6YO+[4]-L]-LY3'=7<]\D:POP0KYX#'/0D'IZU>M-6
MBEBMYHIXKVWO&W03VQ!C\LC*'=D@@@'D=:\GG\"7OA".6ZT_19'TFP\1MJ(T
MRS:$/-"8%02(9'5<JY+88@G!/I4&I6^J^!/ 7A/?IMV;IM?$LFE64L0E$<LE
MQ((LEE0D*XR-VWY>#TR@/:6F=9T54B^SMD,Q;!#'H.F.2>YSS1<L8?WOER2[
MMJE$.<<]0.G?D^@KYKT[X:^+KJ;3]0U>+4[-/ME@;@3:GM2&V_TDW*MLEP?O
M1 X)SP!D"O=_A]8:CIW@C1;+4GDCU"WMT682L)'!!X!;)SP,9Z^] C9N[$2R
MVS_.?*D,HVR%1G:1R!]X?,>#QG![5!J$2K-'Y**4F8+-G !4@X[9/.T8SWK0
M;_6JN< C(]??]*J&Z9C^Y53(S=),C*C ;:/QZCCI0!%;V48LFL9$N)('CPSS
M2Y.,8VY!SG'<5:4R(VT%9%W?.Q;E>IZ?D*I7EK8W-RD3JDEX8]P )# !@<\=
M.2#S6D85>;?S@ J.2!U[CUXZT 1%%DF?S%"D/B-@0&9>"<<YZ_3I4X5$?><*
MSC /KU('\Z 5$AP!G W;CT]/ZTU5;*J6#'D%NGMTH$5M*T\:;:_9T:1T5V(:
M9RS$ECGD]L]*L-)F$O'+&B]=S'(ZX/>G1AL9+9]0>V/2DDR",9"L<'OU!Q^N
M/SIC*\EVD%PT(!FN7'FB(>@P,YZ#IU]\5;8,D1V?,2<X=CW-1EG,68MC'=@A
MFX'/S<^HYXI[-(0Q4KMRO4_GQ2$5Y)S$R!F!X()'<\<^@[UGW^EMJ*>5YA=X
MV+K(\A*G.>&4$9'.,'CBK.J+"]IB[$C0J/.9H\MC;SCCD_3'-6(8EMW>21(8
MG"AI)$& /;/M@4QGFQT'QII7BN"X29;^S:^!6(.$BAM0IW94GAR6XVYX4#Y>
M37I:EH8P7()5<.^,'\ /J32PVFR1@?\ 4A0L<7!5<9R0<9R<X.2>@QWR](QN
MV[,(J@!LY!'I^%'6X%<M<)(@"K.C2??4;?+4+GG).XYXXQP?;E9X!(]N02/+
M??P.ORG_ .M1!#Y",J.9(WD=R22WWN>"3P*F"N-QVAA_"O3'MG_/6D!S'B-"
M/$_@PY) U.0?,<D_Z--_7-=]7 ^(E">)O!PPQ;^U9"6(( _T6;@>OUKOJ!A1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?,VN?M*7'Q>TGX
MEZ'\-GUWPMXC\%ZI-I3ZCJ-A9I#JEU TRO;6<L\C1%BT.277(0] 3E?IFOD;
M]CWP_P"'/&T7QZT?7=-TS7H8OBIK\[6&H01W"H?M3A7,;@X_BP<>M 'H7[//
M[4FB_&:70?#FVZE\5R>$-/\ $U_=1VGD63B=55A$&<N#YA;Y2,8_B-4-"_;<
M\&>(?%OA'0K;P]XK4>)]5N]%L]3DL(A9)=6\LT<D<D@F."?(=@ "2N"0.<>5
M^+/V7-6^(W[:GB6]AU;QG\._"=OX0L;6RU;P9?/I<<TB28^S;T&"JKSL[8'I
M7GWP^\(ZC\,/#W[.WAC7TO;;5[?XL:K<K#JC$WL]N8]0V7# _,V\$'?CDM[T
M ?7MS^U)X'M?VB[?X+&6]?Q?-9"\,J0J;.-BCR"W:3=N$QC0R!=N-N#GM6-\
M6?VS/ /PC\87/AFYM?$/B;5]/B2YU>/PQI3WRZ/ PRLMTRD!!@;MHW/C!VX(
MS\=:U\"_VB;SP_J/QBLM)T?^UF\9)XYM_#LUO<#Q!MB=88[0L"%\O[.IS%UP
M[@<MBO5M$\0>/?V;?BG\7]7B^$7BCQ[;?$6X@U_0[[1;:.0PRM!M-G?;W5H5
MC<XZ-@9.#G@ ^GO!WQ^\*>/O'Z^$]#DNKVYD\/6OB:&_6("UEL[B1XX]I+;]
M^8V)4J, CG/ J?&3]I;P-\#=3\.:5XCU!Y-:\07\&GV.E6(66Y8RMM$K(6&V
M('JY/L,DXKQSPEX+^*EY^T%K'B&73[#PMX@O?AII=E_:)LGNM*MM16\N'E@"
MAU+[%<<!QU!S4?[4/PB\8>(?AS\,I[[3K#Q=X^M?&NES:MK'A[2#;;K.*6X8
M$J7D=8XU=0<N1NR>,X !Z7XP_;#^'G@CXK+X"U)]6^VQW%O97NK0:<[Z;IUS
M. UO!<3CA'D#*5 !'(R14$W[9WP[@^+X^'K?VS]J_M+^Q#KHTUSI(U+&?L7V
MC_GMP>,;<@C=D8KY>_:O^!WC#QU\;?%/AKPEH'CZPLO&&HZ/>WE[8O;OX=N7
MA\H/=3N<20O%'%CRUR'958D8%=YXF\7Z_P#$?]J72M'\3?"_Q[;> ?"_B!9=
M&;2M#A^P7^H*6C&I7ERTJN(DW.45%.0V]LG 4 ]#\(_MX^&/$_Q#T;P=>_#W
MXC>$]0U2*>XBN?$FAQVEM'#"A>661O/)"*, L%(!8>M=?\%OVM/!'QU\13Z+
MH5OKNG7AM/[2L&UO3'LTU6RW[/M5J6^_'NXYVM_LUS7@KP-XFU?XL?'CQ[J&
MD!];>-?#7A2'5HR+=[.&V$F5!X\N:XF(<]_*_/YS_9(\$^+?@IXR7Q7J/A+Q
MM-I^C> KK_A(8-=ME8VMW%,\RV.CAV51&P#8C0^6=R_,.P!^BMS=0V<+2W$J
M01+@%Y&"J,G Y/O7G?QS^/GAGX ?"_5_'FOK>:EH^ES0P7$.CK'//OEE2)0%
M9U&0SC.6'%>7?MFVFJ?&[]BO6&\(:1J=_>Z]%I%[::?!&?M?E->VTK JA."L
M>XG!.,'FOG7X\_LW^(=,D^+^A^"?!6I+X=U6U\)7%M9V,#M!<7,5Y']J=5Z%
MPB;G(Y/+'))) /J3QK^VY\.O ]K\+9[I-7OA\1EADTA;&WC=HDD\O:T^Z1=@
MS( =N[D,.U?0%?E?=?LV_%#^VVL[_P .ZG=Z5X)\<Z;I_AI8;4L'TIK^[NY;
M@-CE0)H4;L/*4>N?U0H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MH[B>.U@DFE8)%&I=V/8 9)I-J*NQI-NR/*O &JW=E\(=)DTS3GU:^M[)2EF'
M$/FOMW!5D<;02, $G&3@D5@I\5_B+(VP?!75%(5D9/[?L-HVXSUD_P!H?4?2
MLB3Q]^SKI\CVK^)=.M7A8QM =3N4,; X*E=_&#VIO_"ROV<N?^*LTWG_ *BU
MS_\ %UY"SG+'JL3#_P #C_F=WU#%_P#/F7_@+_R/2_ASX@\0Z[:7?]N>"YO!
ML=OLCMK>:\M[@RK@[L>2Q"XP.#CKQFNF2QDBO5:/!@>!DP3]UMQ88^N3^0KP
M[_A97[.?_0VZ=_X-KG_XNC_A9?[.?_0VZ=_X-KG_ .+H><98_P#F)A_X%'_,
M/J&+_P"?4O\ P%_Y'O!64J"LF[#[B'X&WN./3/Z4YW*MUY//E]V&<9_45X+_
M ,+*_9S_ .AMT[_P;7/_ ,71_P +*_9SSG_A+=.S_P!A:Y_^+H_MC+/^@F'_
M (%'_,7U#%_\^I?^ O\ R/>Y"9B1& 2.ZGH1U'Y4V"5C(ZF/9$F-C@C#=?\
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M_9S_ .AMT[_P;7/_ ,71_P +*_9S_P"AMT[_ ,&US_\ %T?VSEO_ $$P_P#
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MPZCZTUE*$;@1D9Y':NW1GSC3B[-"4444R0HHHH **** "BBB@ HHHH ****
M/NS_ ((Z_P#)T=]_V!)O_1D=?MY7XA_\$=?^3H[[_L"3?^C(Z_;RO+PG^\8G
M_$O_ $B!V5OX5+T?_I3"BBBO4.,**** "BBB@ HHHH **** "BBB@ HHHH *
M\;^ ?_(U_%3_ +&%O_0!7LE>9_#_ .&NO>"_'GB?4WU:TGT+6KI[PV2PD2K(
M<!3O/8 'B@"KK/P2FU'PMIFEQ:K:F6QU&[OP+ZP^T6TPG>5MCPEQDKYO#9X*
MYQZ>7^(/ >L:=\;_  1X;T+Q-)IFH6?AQXQJTML)V8*S[AL+# /0#/ Q7U-5
M)]%L)=5CU-[.!M1CC,271C'F*AZJ&Z@>U,#QKXS:+K6@_LX>)[77M=_X2*_
M5C>_9A!E3*F%V@GIZYKK/C'_ ,D*\1_]@D_^@BE^-W@#7_B7X7_L+1]6M-+M
M+G*WOVJ R&1<J4"D?=P0<_6NX?2[>ZTD:?>0QW5NT0BDCD4,CC&""#U% 'S?
MX&^#GC#XD^ O!<'B/Q19MX.@AM;R'3;6TQ.R*@V1L_'8X)YKDO%/PR\1?$_X
ME_%^RT745MK6UEMKF:R(_P"/V94<PQGT'$G7C)'X?8EG9P:=:0VMK"EO;0H(
MXXHU"JB@8  '05!9Z-8:?>WEY;6<%O=7A5KB:- KS%<[2Q[XR>OK1<#C?@CX
M_L?B#X!L;FV@CL+JS L[S3T&W[-*@ *[>,#N/;CM7@$G_"-:Q\2/BY;>+?$<
MVFI:W#3V$+:@8%$@#8=!D;F!(P.>O2OJW2_#NEZ)<74^GZ?;64UVV^=X(@AE
M;DY;'4\GKZFO/O#_ ,"M,M/&'B[6=;BLM<AUJ\2[AM[BV#&W(SW.<]>WI0!X
MQI$6J?$K5/@KI_B>\U"+^TM,O_M?DSO#)<1(',98CGYD5,GN&/K6WKUGX<O_
M (J^)]!\<:]/HNC:'I]JN@P2W[6R[/)&Z5"2/,D!!&>3P1SCCZ/;0M.>]L[P
MV-N;JS0QVTWEC="I&"%/8$<<54U[P7H/BF6&35]'LM2DA_U;W,"N5]@2.GM0
M!\D1V%S\0]%^#UUXG>[NIKS5;C3UN7F=))K53E&R#][)(W=2 *[#Q2\D=[\?
M[3S9'M[?3+%8HW<L$'EOTS]*^DI] TVZ:Q,MA;2&Q.ZUW1#]P<8RG]W@=JCE
M\,Z1.^H/)IMJ[:@JI=EHE)N O0/Q\P&>] 'RAK6J75]J'PUT#456?P^?"UO<
MQ6=QJITV":?;@L9=IR5 &%_QY]P_9\O[^_\ A:CWVHIJB)<3QVMRDYG)@!^5
M6D*KN*\KG'.*[?5?!'A_7=/M;#4-&LKRSM0%@AF@5EB& ,*,<# '3TK2L-.M
M=+LHK.SMXK6TB78D,*!44>@ I ?'1N[Z]^#GPZC&HW<$MSXMD@:XBF82 &=A
MP<]NU>M?"K2D\'?'KQMX;TZ>Z_L=+"UNDM[BX>4+*P&Y@6).3DYKUM?!VA+:
M6UJ-(LA;VLWVB"(0+MBESG>HQPV><U=BT>Q@U.?48[.%+^=!'+<J@$CJ.@+=
M2!0!\\_%U-#N/VD/#]KXCU1M)TBYT26*:3[3]F23YF(C>3(VJ2 >HR0!WKSF
M^U;4;[X:2Z=::O>RZ);^/H[#2;];AF<VV)0-LF>0!M(K[#U;PIHVNO*^HZ7:
M7SRP_9W:>%7+1[@VPDCIN ./4 TP>#]#73+73AI%D+"UD$T%L(%\N*09PRC&
M >3S[T[@>#?$WP]X9\+ZOX:\$0P7]VDL5Q?BVOM=:SLL<[I)I"&9F!4D >_K
M7'>%=?O[OX4^!%;4))Q!X[@M$=)V<&$.<(&)R5P>,]L5]5Z[X1T3Q0T#:OI-
MGJ30$F(W4*R%,]<9'M38_!NA11A$T>R1!="]"K H G_YZXQ][WZT ?,NN^'8
MO%'BKX]7-]>7Y&B68N[.&*Z=(TF6"5E<J#R04X[<FO:?A;XEE;X":1K>K7-Q
M.\6D-<7%PIW3$(K$L/5L#\Z[<>&M)#ZDXTVUWZDNR];RES<K@C#_ -X8)'/J
M:M66F6FFV$=E:VT5O9QKL2"- J*OH!TQ2 ^.O#E];Q>./AUJ.D&6PCU^\:*X
M:?76O+V]@<E29T"JJ<Y&.>1[5!:_#/1?^$$^--VL=T9](O[B"U_TJ3 1&R-P
MSAC\O4YKZQL?AOX5TR:.6T\.Z;;RQRB='CM4#+(.0P.."*THO#>E00W\4>G6
MJ17[,]VBQ*!.S?>+C^(GWIW ^2M;OK:VT?X4:#IETEYX3U"R::]A.LFVAGN_
M+!:*2?YMNUB/D/0G&!V9JU]J]W\)]/M%UPR6G_";PVEC/8W[W#V\!60"+SB!
MOV<8;H< U]4-\._##Z&FC-H.GMI:2&5;0VZF-7/5@,<'WJTG@_0X]-M=/72+
M);&UE$\%N(%V12#.'48X;D\]>:+@9FG>$-/\">!]0TS21.ELD,\H,\[2ON92
M2=S$GK7S9HKWNL?#KX(VIU*]MS?:Q+!//!.R2M&20PW Y!*Y&>V>*^O)(UEC
M9'4,C JRD9!![5EP^$]%MX;&*+2K..*P<R6J+"H$#'^)!CY3]* /E;Q5X7@T
MNU^-7ABVFO9-&TNTM=0M+66Y=Q%*5W,1D].3D=\#/2K0T33=7'P4T/1M6G&E
MWZW2WK65ZS%B8@TT98'C^)2.JY.,5]2-X<TIY[^9M.MFEOX_*NW,2DSIC&U_
M[PQQ@U5TWP1X?T<68L=&LK7[&SO;^5 H,3,,,5XX)'6BX'SE\6K7P\GB'4?#
M5M#<3-X;T5-KZIKC6EK: KE'C0*6ED.Y<G/4@57A\5ZIX-\&?"[XH7%S=7]N
MMJ^EZPN\MYL9+B-F]2&4<GN!ZU]*ZMX)T#7M1BO]1T:QOKV)=B3W$"NX7TR1
M4W_"*:,-#_L7^R[3^R/^?'R5\G[V[[F,?>Y^M 'RAK\OB70OACX/O=1FF,'C
M'67O]8EDO3:KLD&Z&!I<'RT92S'C Q[4:M?7VG?"7XH6=I?Q)I=G/9BSM+/5
M6OC8N6/F()MHR#@' Z<BOK;4]$T_6M-?3[^R@O+%P UO-&&0@=.#QQ5&V\#^
M'K/1'T>#1;&+2Y#N>S6!?+8^I7')X'6BX'A5AHLW@3XQ^##I5Y?75UK6ASSW
MRW5T\BW<ZQ@JS G Y/;@=L5YQ'K6G_\ "L!XP/BJ\'Q9.H;!:B];SR_G;?)-
MOG[FW/&W'\J^RGT/3Y+ZUO&LH&N[5#'!.8QOB4]54]A5!? OAU-<_ME=#L!J
MN[=]L%NOF;O7=CK[T >':;XYM?#OQA^)I\1:M#I1;1[21(;JX"+O^SIN$8)Y
M.XXP.237GX-]K?PD^%D"ZQ9SS2I>,^C:O=RV\=_B9P#YH(&Y>P9NI'!Z5]:Z
MGX-T+6M4M]2O]'LKR_MP!%<SP*SH <C!(['FHKSP)X<U#2(-+N=#L)].@),-
MJ]NI2,DY.T8XR2>E '!?LU>);37O ]W;VEM?VPTZ]DMG2]OOMJJPP=L4V &0
M=AV]^M>MU3TG1K#0;%++3;."PM$R5AMXPB#/7@5<I %%%% !1110 4444 %%
M%% !1110 4444 %<QXI^(VC>#KR*UU*25)94WJ(XBPQG%=/7!^-TU+1?$5IK
MUA-IS@6[6KV^I3"( $[MR,2.> #7A9UB<1A,(ZN&T::N^7FLKZOE3BW;R9Z.
M I4J]?DJ[6?6UWT5[.WW%K0OBUX;\0ZC%8VMVZW$IVQK+$5#'T!]:W_$W_(M
MZM_UZ2_^@&O.=!\-ZIKUU;7C7NE3(^J?VC=QV$H=8"J!55<$\MDDUZ-XF_Y%
MO5O^O27_ - ->5E>,QV,P%:>.2V?*U'ENK=N:7Y[Z6NF=N,H8:AB:<<.^UU>
M]G?O9?UKU/YGOC=_R6?Q]_V,&H?^E,E<77:?&[_DL_C[_L8-0_\ 2F2N+KZ/
M+_\ <Z/^&/Y(\K$_QZGJ_P PHHHKO.8**** "BBB@ HHHH **** "BBB@ HI
MX\L0MGF0GCVIA! ![&D 4444P"BBB@#Z_P#^"57_ "=WHW_7C-_Z''7[:_&?
M_DE?BC_KR>OQ*_X)5?\ )W>C?]>,W_H<=?MK\9_^25^*/^O)Z^5Q_P#!S#_!
M_P"V,]K"_P 3"_XO_;D?S%T445]4>* QGGI1110!N6OBN6T\%:AX=2W3RKV]
M@O9+@L=V8DD55 Z8_>L<]:U? ?C6ZT>\AL9I$?3W;!$SA1%[@GI]*XZBN6KA
MJ56$H27Q:_/:YZV6YIBLJQ4,5AIM2CVZJ^J?=,]%^)NLZ/JNGVXL;F*:Z2?<
MXB'4%2"2<8/1:N?!+X??\+2\6WDFO"ZFT+3=)N;R^O/.V&&*&#;&0S9SM/E
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M:],^*7PIU#QMX@\,:K8W6GN-',F[3]6MVFM9MRX#E01\R]1[@5R*_LWZI%X
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MMRI=?Y4H_<CEQ2Y<>T^ZWOY=[O[S^9[XW?\ )9_'W_8P:A_Z4R5Q==I\;O\
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MXPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ=A@CZYKJ_$W_(MZM_UZ2_\ H!KDOA&]K<6NJ7,6HWNJ7,LR^=/>0>4>%PH
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MK9>^E)V6EY)-VN]Q8GE^O>XK*ZVMY:^ZVM=[)V6Q_,]\;O\ DL_C[_L8+_\
M]*9*XNNT^-W_ "6?Q]_V,&H?^E,E<77K9?\ [G1_PQ_)'#B?X]3U?YBAB 0.
MXP:2BBN\Y@HHHH **** "BBB@ HHHH **** "BBB@ HHHH 5DV@9ZGG%)3BP
M8$G);UIM 'U__P $JO\ D[O1O^O&;_T..OU'_;_^%?C'XE_"9)/#>LK;Z?I+
M-=W^C$;#? 8VGS,]4Y(0\'=G.0*_+C_@E5_R=WHW_7C-_P"AQU^VOQG_ .25
M^*/^O)Z^7QDN2&.FND4_NBV?3Y3BZF!Q>#Q%)*ZEU5UJTOZ>ZW6I_.[XO^'$
M.IH=0T39O<;C A&R3W4]!_*O.-4TR?1[U[6Y79,@!8>F1FND\&>.SX8@FBG\
M^ZB./+A! 53W.3S^%7++2];^.'C>VTO1;>$W\L3"W@N+F*!<(I=AYCE5Z*QP
M3ZUVT'B,(Y1Q#7LXJ_,]/O\ 3^F>_G]7(\SPL,?@(NGB9M<U-:KK=K2VKMU^
M5[G"45TOCCX;>)?AQ>16WB+2IM.:8%H)20\4Z@XW1R*2KKGNI(KFJ]>G5A6@
MJE.2:?5:H_.Y0E!\LE9A1116A(44K$84#M[=Z2@ HHHH **** "BBB@ HHI0
MQ (XY]J $HI=YV%>Q.>E)0 444<8Z\^E 'W9_P $=?\ DZ.^_P"P)-_Z,CK]
MO*_$/_@CK_R='??]@2;_ -&1U^WE>7A/]XQ/^)?^D0.RM_"I>C_]*84445ZA
MQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9'B[3;O6/"VKV-A
M]B^W7-I+%!_:4!FMM[*0OFQ@@NF2,KD9&:UZ* /AKQ5\6OB)\&]4/AK7OCC\
M!O"=_ BL=,GT6>W>-3TRGVH8S]*^H?@H;+Q%X(T7Q9)>>&O$.MZA:;9_$?AJ
MU$5M>+O/^K)+-LRHX+'D5\4?$/XD6/A']I;XO6H^)_PX^';R:C:O)9>*] .I
MSW3?8XAYXEWIL!X7R\G&W.!NY^X/@;JZ:]\)_#>H)KND>)DGM]PU;0;3[+97
M/S,-T46YMB]L9/(- '87>E65_<VEQ<VD%Q/:.9+>66,,T+$$%D)^Z<$C([&O
M(?VO_P#DB9_[&;PU_P"GVPKVC/..]>+_ +7_ /R1,_\ 8S>&O_3[84 ?*_\
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M/[4-KX'N-:%WHDNIK%J/V>QAM)8+=C ME;7+M(TTBJ6S<;0JY)R.,!F"Z?\
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M7M%>U/E5HP24G+FWW6BU?1,^GP4GB*$:480]UVO*^KDW9*WZZ>9ZM"7,,9E
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M]\8)XOATGQ%ID=_<KK+": (@BA?,;6"(P=P !P2&!6O3?VK-=^)LWA1[*_\
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M10 4444 ?7__  2J_P"3N]&_Z\9O_0XZ_;7XS_\ )*_%'_7D]?B5_P $JO\
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MJ/<:;IO]DVK(@^R^>9@KA '(8@'#,&8 YP#C)QFLZIBVTFU8;"BBK$\$4-K
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M/<_ GPAX>\2:OKUAI:6UUKVZ&^F+,XC=W#;U5LA0SX##&.0> #GY(^"GQ?\
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MZ\9O_0XZ_;7XS_\ )*_%'_7D]?*X_P#@YA_@_P#;&>UA?XF%_P 7_MR/YCC
MP@$WR["Q7[PSD>V<]^M(R 1JP=2Q)R@SE?KQCGV]*]&^#WAWPOXBLO&::Y;7
MMUJEIH=U>Z8(9 D$<D<98O)_$Q&%PHX.3GI@]IXS\!>%-.^'6M6EEHGD:SHN
MDZ3JQUXW<KR7C7>PO$T98QJB^: NQ0W[L[BV>/J=3QCP.BOH'P+^R[;>+M:T
MVSN/$,EC!=66EWCSBV#^6+N"65N,C.SRL>^>U9?Q3^!'A[P5X(&OZ+XDU#59
M&MM+O_L]YIZ6X2WOH9'C4LLKYD4Q'( VX88)(-,1XE3I)&E;<V,X X '0>U-
MIT4IA?<H4G!'S*&'Y&@!M%3VL\,0<36XGR/E^8K@Y'/'7C/YU!2 ****8!11
M10 4444 .CE>%MT;LC=,J<&KFD:I+IFLV6H"2426TZ3!XVPX*L#D$@@'CN#5
M&BI<4TTRE*25KGW%XH_9K^$7Q<\(^)_&WP_\1&R_T62_M[%9(UAM'1&DEADB
M(,@P%P   ,Y!<5\.T^*XE@W>7(\>X%6VL1D$8(/M3*\3*LOQ&71G3JXB56+:
MY>9*\5:UK]?4[L7B:>)<90IJ#ZVV;[VZ!15F0V\MFC*HBGCPK $D29S\W/0C
MH>W2JU>XG<X#[L_X(Z_\G1WW_8$F_P#1D=?MY7XA_P#!'7_DZ.^_[ DW_HR.
MOV\KS,)_O&)_Q+_TB!UUOX5+T?\ Z4PHHHKU#C"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#Y2\6^"+[0/V[/AAKU[XHU;6CK%AK
MBP:?=.JVFG01Q6^V.&-0!DEV+.V6;Y03A15#]N&?XB6?P>U^XUN#PG>^ (M<
MT9Y;6V2Z.HRP#5[0HAR=FXG:&P.A..<5]=E02#@9'0U\\?\ !0+6;3P[^R=X
MOU6]BGGMK&[TBZ,=M]\E-4M&7'_ @,^V:J.ZTN7"+E)15KOOHOGY'D?_  2M
MU/PIJ'@#QLOAOP^VD20ZJ!+.[NYDB(8PQ@L3@(O& <Y))YY/W)7Q]_P3$O\
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M,.US*_O0O:+:M)-<UNGO:;]'M]->$/VI(/$/QGUGP!?^&K_1I-.0@WMP009
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MIK/_ (%'_&CZW6_Z!Y_?#_Y,/8T_^?L?NE_\B?B!17[?_P##GOX)?\]-9_\
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M11]D_:Z_Z"OP4_\ !9J__P D52E);,[Z6/Q=%35.K)*2Y79O5+H_+R.Q\*?
M2Y\,_&37_&[>+]2O;;4X/*&G2]4^[@-)GYE7:0HV@@$9)P<Y^G?LXS6/QPUG
MQ^WB%;F&]A98M/N+)9 KLBK\Y)^91M[!2<CGKGGOLG[77_05^"G_ (+-7_\
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M?Z+_ ,*^T3QQJ'CNTNXI93J,\]RLP6U>(H$54-P_[P.2=J_*,FOK>@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>53
<FILENAME>aciu-20221231.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.2.0.4 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/15/2023 5:39:21 PM-->
<!--Modified on: 3/15/2023 5:39:21 PM-->
<xsd:schema targetNamespace="http://acimume.com/20221231" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:aciu="http://acimume.com/20221231" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:fact-explanatoryFact="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2021-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:attributeFormDefault="unqualified" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets" id="StatementCondensedConsolidatedBalanceSheets">
        <link:definition>00100 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss" id="StatementCondensedConsolidatedStatementsOfIncomeLoss">
        <link:definition>00200 - Statement - Condensed Consolidated Statements of Income/(Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss" id="StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss">
        <link:definition>00300 - Statement - Condensed Consolidated Statements of Comprehensive Income/(Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" id="StatementCondensedConsolidatedStatementsOfCashFlows">
        <link:definition>00500 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" id="DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails">
        <link:definition>40502 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureAssetAcquisitionDetails" id="DisclosureAssetAcquisitionDetails">
        <link:definition>40601 - Disclosure - Asset acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails" id="DisclosurePrepaidExpensesAndAccruedIncomeDetails">
        <link:definition>40901 - Disclosure - Prepaid expenses and accrued income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" id="DisclosureOtherCurrentReceivablesDetails">
        <link:definition>41001 - Disclosure - Other current receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" id="DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails">
        <link:definition>41201 - Disclosure - Trade and other payables and accrued expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureExpensesByCategoryDetails" id="DisclosureExpensesByCategoryDetails">
        <link:definition>41401 - Disclosure - Expenses by category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails" id="DisclosureRelatedPartyTransactionsDetails">
        <link:definition>41501 - Disclosure - Related-party transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" id="DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails">
        <link:definition>41601 - Disclosure - Income taxes - Summary of Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" id="DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails">
        <link:definition>41701 - Disclosure - Retirement benefit plan - Summary of Benefit Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" id="DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails">
        <link:definition>41702 - Disclosure - Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" id="DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails">
        <link:definition>41706 - Disclosure - Retirement benefit plan - Change in other comprehensive gains (losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureEarningsPerShareDetails" id="DisclosureEarningsPerShareDetails">
        <link:definition>42001 - Disclosure - Earnings per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity" id="StatementCondensedConsolidatedStatementsOfChangesInEquity">
        <link:definition>00400 - Statement - Condensed Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails">
        <link:definition>40302 - Disclosure - Summary of significant accounting policies, Right-of-use assets and lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails">
        <link:definition>40303 - Disclosure - Summary of significant accounting policies, Property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails" id="DisclosurePropertyPlantAndEquipmentDetails">
        <link:definition>40401 - Disclosure - Property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" id="DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails">
        <link:definition>40501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" id="DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails">
        <link:definition>40503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIntangibleAssetsDetails" id="DisclosureIntangibleAssetsDetails">
        <link:definition>40701 - Disclosure - Intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" id="DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails">
        <link:definition>40801 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalNarrativesDetails" id="DisclosureShareCapitalNarrativesDetails">
        <link:definition>41101 - Disclosure - Share capital - Narratives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails" id="DisclosureShareCapitalCapitalStructureDetails">
        <link:definition>41102 - Disclosure - Share capital - Capital Structure (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails" id="DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails">
        <link:definition>41104 - Disclosure - Share capital - Conditional share capital for bonds and similar debt instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" id="DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails">
        <link:definition>41105 - Disclosure - Share capital - Conditional share capital for employee benefit plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails" id="DisclosureShareCapitalShelfRegistrationStatementDetails">
        <link:definition>41106 - Disclosure - Share capital - Shelf registration statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails" id="DisclosureShareCapitalAtMarketEquityOfferingDetails">
        <link:definition>41107 - Disclosure - Share capital - At the market equity offering (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails" id="DisclosureShareCapitalConvertibleNoteAgreementDetails">
        <link:definition>41108 - Disclosure - Share capital - Convertible note agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" id="DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails">
        <link:definition>41301 - Disclosure - Contract revenues, Contract Revenue Attributable to Licensing Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails" id="DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails">
        <link:definition>41302 - Disclosure - Contract revenues and other operating income - Licensing and collaboration agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" id="DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails">
        <link:definition>41303 - Disclosure - Contract revenues, Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails" id="DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails">
        <link:definition>41304 - Disclosure - Contract revenues, Anti-Abeta Antibody in AD - 2006 Agreement with Genentech (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails" id="DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails">
        <link:definition>41305 - Disclosure - Contract revenues, Anti-Tau Antibody in AD - 2012 Agreement with Genentech (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" id="DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails">
        <link:definition>41306 - Disclosure - Contract revenues, Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" id="DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails">
        <link:definition>41307 - Disclosure - Contract revenues, Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" id="DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails">
        <link:definition>41308 - Disclosure - Contract revenues - Grants from the Michael J. Fox Foundation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" id="DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails">
        <link:definition>41602 - Disclosure - Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" id="DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails">
        <link:definition>41703 - Disclosure - Retirement benefit plan, Changes in Defined Benefit Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" id="DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails">
        <link:definition>41704 - Disclosure - Retirement benefit plan, Changes in Fair Value of Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails" id="DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails">
        <link:definition>41705 - Disclosure - Retirement benefit plan, Change in Net Defined Benefit Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" id="DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails">
        <link:definition>41707 - Disclosure - Retirement benefit plan, Actuarial Assumptions and Sensitivity Analysis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails" id="DisclosureShareBasedCompensationPlansOutstandingDetails">
        <link:definition>41801 - Disclosure - Share-based compensation, Plans Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" id="DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails">
        <link:definition>41803 - Disclosure - Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" id="DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails">
        <link:definition>41804 - Disclosure - Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails" id="DisclosureShareBasedCompensationNonVestedShareAwardsDetails">
        <link:definition>41805 - Disclosure - Share-based compensation, Non-vested Share Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails" id="DisclosureCommitmentsAndContingenciesDetails">
        <link:definition>41901 - Disclosure - Commitments and contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails" id="DisclosureFinancialInstrumentsAndRiskManagementDetails">
        <link:definition>42101 - Disclosure - Financial instruments and risk management (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureGeneralInformation" id="DisclosureGeneralInformation">
        <link:definition>10101 - Disclosure - General information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureBasisOfPreparation" id="DisclosureBasisOfPreparation">
        <link:definition>10201 - Disclosure - Basis of preparation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPolicies" id="DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>10301 - Disclosure - Summary of significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipment" id="DisclosurePropertyPlantAndEquipment">
        <link:definition>10401 - Disclosure - Property, plant and equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities" id="DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities">
        <link:definition>10501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureAssetAcquisition" id="DisclosureAssetAcquisition">
        <link:definition>10601 - Disclosure - Asset acquisition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIntangibleAssets" id="DisclosureIntangibleAssets">
        <link:definition>10701 - Disclosure - Intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets" id="DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets">
        <link:definition>10801 - Disclosure - Cash and cash equivalents and short-term financial assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome" id="DisclosurePrepaidExpensesAndAccruedIncome">
        <link:definition>10901 - Disclosure - Prepaid expenses and accrued income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivables" id="DisclosureOtherCurrentReceivables">
        <link:definition>11001 - Disclosure - Other current receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapital" id="DisclosureShareCapital">
        <link:definition>11101 - Disclosure - Share capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses" id="DisclosureTradeAndOtherPayablesAndAccruedExpenses">
        <link:definition>11201 - Disclosure - Trade and other payables and accrued expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenues" id="DisclosureContractRevenues">
        <link:definition>11301 - Disclosure - Contract revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureExpensesByCategory" id="DisclosureExpensesByCategory">
        <link:definition>11401 - Disclosure - Expenses by category</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactions" id="DisclosureRelatedPartyTransactions">
        <link:definition>11501 - Disclosure - Related-party transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>11601 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlan" id="DisclosureRetirementBenefitPlan">
        <link:definition>11701 - Disclosure - Retirement benefit plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensation" id="DisclosureShareBasedCompensation">
        <link:definition>11801 - Disclosure - Share-based compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingencies" id="DisclosureCommitmentsAndContingencies">
        <link:definition>11901 - Disclosure - Commitments and contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureEarningsPerShare" id="DisclosureEarningsPerShare">
        <link:definition>12001 - Disclosure - Earnings per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement" id="DisclosureFinancialInstrumentsAndRiskManagement">
        <link:definition>12101 - Disclosure - Financial instruments and risk management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCapitalRiskManagement" id="DisclosureCapitalRiskManagement">
        <link:definition>12201 - Disclosure - Capital risk management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>12301 - Disclosure - Subsequent events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>20302 - Disclosure - Summary of significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>30303 - Disclosure - Summary of significant accounting policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables" id="DisclosurePropertyPlantAndEquipmentTables">
        <link:definition>30403 - Disclosure - Property, plant and equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables" id="DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables">
        <link:definition>30503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureAssetAcquisitionTables" id="DisclosureAssetAcquisitionTables">
        <link:definition>30603 - Disclosure - Asset acquisition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIntangibleAssetsTables" id="DisclosureIntangibleAssetsTables">
        <link:definition>30703 - Disclosure - Intangible assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables" id="DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables">
        <link:definition>30803 - Disclosure - Cash and cash equivalents and short-term financial assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables" id="DisclosurePrepaidExpensesAndAccruedIncomeTables">
        <link:definition>30903 - Disclosure - Prepaid expenses and accrued income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivablesTables" id="DisclosureOtherCurrentReceivablesTables">
        <link:definition>31003 - Disclosure - Other current receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalTables" id="DisclosureShareCapitalTables">
        <link:definition>31103 - Disclosure - Share capital (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables" id="DisclosureTradeAndOtherPayablesAndAccruedExpensesTables">
        <link:definition>31203 - Disclosure - Trade and other payables and accrued expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesTables" id="DisclosureContractRevenuesTables">
        <link:definition>31303 - Disclosure - Contract revenues (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureExpensesByCategoryTables" id="DisclosureExpensesByCategoryTables">
        <link:definition>31403 - Disclosure - Expenses by category (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactionsTables" id="DisclosureRelatedPartyTransactionsTables">
        <link:definition>31503 - Disclosure - Related-party transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>31603 - Disclosure - Income taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanTables" id="DisclosureRetirementBenefitPlanTables">
        <link:definition>31703 - Disclosure - Retirement benefit plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensationTables" id="DisclosureShareBasedCompensationTables">
        <link:definition>31803 - Disclosure - Share-based compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables" id="DisclosureCommitmentsAndContingenciesTables">
        <link:definition>31903 - Disclosure - Commitments and contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureEarningsPerShareTables" id="DisclosureEarningsPerShareTables">
        <link:definition>32003 - Disclosure - Earnings per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables" id="DisclosureFinancialInstrumentsAndRiskManagementTables">
        <link:definition>32103 - Disclosure - Financial instruments and risk management (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureGeneralInformationDetails" id="DisclosureGeneralInformationDetails">
        <link:definition>40101 - Disclosure - General information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails" id="DisclosureBasisOfPreparationGoingConcernDetails">
        <link:definition>40201 - Disclosure - Basis of preparation - Going concern (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails">
        <link:definition>40301 - Disclosure - Summary of significant accounting policies - Functional and reporting currency (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesDetails">
        <link:definition>40304 - Disclosure - Summary of significant accounting policies, Income taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails">
        <link:definition>40305 - Disclosure - Summary of significant accounting policies, Segment reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" id="DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails">
        <link:definition>40802 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails" id="DisclosureShareCapitalAuthorizedCapitalDetails">
        <link:definition>41103 - Disclosure - Share capital - Authorized capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails" id="DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails">
        <link:definition>41802 - Disclosure - Share-based compensation, Weighted Average Exercise Prices (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="aciu-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aciu-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aciu-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aciu-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://acimume.com/role/DisclosureStandardAndCustomAxisDomainDefaults" id="DisclosureStandardAndCustomAxisDomainDefaults">
        <link:definition>99900 - Disclosure - Standard And Custom Axis Domain Defaults</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xsd:element name="OtherCurrentReceivablesAbstract" id="aciu_OtherCurrentReceivablesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfOtherCurrentReceivablesTextBlock" id="aciu_DisclosureOfOtherCurrentReceivablesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ExpensesOperatingAbstract" id="aciu_ExpensesOperatingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IssueOfEquityRestrictedShareAwards" id="aciu_IssueOfEquityRestrictedShareAwards" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="IncreaseDecreaseThroughAcquisitionOfAssetsEquity" id="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" id="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="CashAdvancesForRentDeposit" id="aciu_CashAdvancesForRentDeposit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ProceedsFromIssueOfConvertibleDebt" id="aciu_ProceedsFromIssueOfConvertibleDebt" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="RepaymentOfConvertibleDebtEquitySettlementAmount" id="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ChangesInWorkingCapitalAbstract" id="aciu_ChangesInWorkingCapitalAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AdjustmentsForIncreaseDecreaseInAccruedExpenses" id="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="AdjustmentsForDepreciationExpenseRightOfUseAssets" id="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="SupplementalNonCashActivityAbstract" id="aciu_SupplementalNonCashActivityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" id="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" id="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ExpensesByCategoryAbstract" id="aciu_ExpensesByCategoryAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CommitmentsAndContingenciesAbstract" id="aciu_CommitmentsAndContingenciesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LaboratoryEquipmentMember" id="aciu_LaboratoryEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PercentageIncreaseInPropertyPlantAndEquipment" id="aciu_PercentageIncreaseInPropertyPlantAndEquipment" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ConditionalShareCapitalForEmployeeBenefitPlansMember" id="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ConditionalShareCapitalAbstract" id="aciu_ConditionalShareCapitalAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" id="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" id="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="TaxLossesSplitByExpiryDateAbstract" id="aciu_TaxLossesSplitByExpiryDateAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AtTheMarketEquityOfferingAbstract" id="aciu_AtTheMarketEquityOfferingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CommissionsPaidForIssuanceOrdinaryShares" id="aciu_CommissionsPaidForIssuanceOrdinaryShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" id="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="AtTheMarketEquityOfferingMember" id="aciu_AtTheMarketEquityOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SecondOpenMarketSalesAgreementMember" id="aciu_SecondOpenMarketSalesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SaleOrIssueOfTreasurySharesShares" id="aciu_SaleOrIssueOfTreasurySharesShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfOtherCurrentReceivablesTable" id="aciu_DisclosureOfOtherCurrentReceivablesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfOtherCurrentReceivablesLineItems" id="aciu_DisclosureOfOtherCurrentReceivablesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" id="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" id="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract" id="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" id="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EscrowDepositAmount" id="aciu_EscrowDepositAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="NumberOfDepositsInEscrowAccounts" id="aciu_NumberOfDepositsInEscrowAccounts" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="RightOfUseLeasedAssetsAbstract" id="aciu_RightOfUseLeasedAssetsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DispositionsOfRightOfUseAssets" id="aciu_DispositionsOfRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ExpenseRelatingToLeases" id="aciu_ExpenseRelatingToLeases" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CollaborationAndLicenseRevenueAgreementsMember" id="aciu_CollaborationAndLicenseRevenueAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborationAgreementOf2012GenentechMember" id="aciu_CollaborationAgreementOf2012GenentechMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborationAgreementWithLillyMember" id="aciu_CollaborationAgreementWithLillyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ContractRevenueAbstract" id="aciu_ContractRevenueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" id="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborationAgreementOf2014JanssenPharmaceuticalsMember" id="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeAgreementMilestonePaymentReceived" id="aciu_CollaborativeAgreementMilestonePaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeAgreementPotentialValue" id="aciu_CollaborativeAgreementPotentialValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="CollaborativeAgreementNoticeOfContractTerminationPeriod" id="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AntiAbetaAntibodyInADMember" id="aciu_AntiAbetaAntibodyInADMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeAgreementCumulativePaymentsReceived" id="aciu_CollaborativeAgreementCumulativePaymentsReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="CollaborationAgreementOf2006GenentechMember" id="aciu_CollaborationAgreementOf2006GenentechMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfMilestonePaymentsReceived" id="aciu_NumberOfMilestonePaymentsReceived" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeAgreementJointResearchCollaborationPeriod" id="aciu_CollaborativeAgreementJointResearchCollaborationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SkaneUniversityHospitalMember" id="aciu_SkaneUniversityHospitalMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="GrantRevenueMember" id="aciu_GrantRevenueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="GrantsMichaelJFoxFoundationMember" id="aciu_GrantsMichaelJFoxFoundationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfGrants" id="aciu_NumberOfGrants" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfRepresentativesInJointSteeringCommitteeByEachParty" id="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeAgreementMilestonePaymentNumberOfInstallments" id="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TauMorphomerSmallMoleculeMember" id="aciu_TauMorphomerSmallMoleculeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RightOfUseLicenseMember" id="aciu_RightOfUseLicenseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ResearchAndDevelopmentMember" id="aciu_ResearchAndDevelopmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MilestonePaymentsClinicalAndRegulatoryMilestonesMember" id="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MilestonePaymentsCommercialMember" id="aciu_MilestonePaymentsCommercialMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborationAgreementWithLillyFirstAmendmentMember" id="aciu_CollaborationAgreementWithLillyFirstAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborationAgreementWithLillySecondAmendmentMember" id="aciu_CollaborationAgreementWithLillySecondAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="BasisOfPreparationAbstract" id="aciu_BasisOfPreparationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="GoingConcernAbstract" id="aciu_GoingConcernAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" id="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" id="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AntidilutiveSecuritiesAbstract" id="aciu_AntidilutiveSecuritiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting" id="aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DilutiveEffectOfShareOptionsIssuedAndOutstanding" id="aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" id="aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TauVaccineInADMember" id="aciu_TauVaccineInADMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="GeneralInformationAbstract" id="aciu_GeneralInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" id="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfTechnologyPlatforms" id="aciu_NumberOfTechnologyPlatforms" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="ConvertibleNoteAgreementAbstract" id="aciu_ConvertibleNoteAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AthosServiceGmbHMember" id="aciu_AthosServiceGmbHMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" id="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ConvertibleNoteAgreementMember" id="aciu_ConvertibleNoteAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FirstCapitalPartnerGmbHMember" id="aciu_FirstCapitalPartnerGmbHMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FinancialResultNetAbstract" id="aciu_FinancialResultNetAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfInformationAboutCommitmentsAndContingenciesTable" id="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" id="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CommitmentsAbstract" id="aciu_CommitmentsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RentalContractPeriodForNoticeOfCancellation" id="aciu_RentalContractPeriodForNoticeOfCancellation" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="WeightedAverageAssumptionsAbstract" id="aciu_WeightedAverageAssumptionsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OtherComprehensiveGainsLossesAbstract" id="aciu_OtherComprehensiveGainsLossesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EstimatedLeaseTerm" id="aciu_EstimatedLeaseTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LeaseholdImprovementsAndFixturesAndFittingsMember" id="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" id="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OperatingSegmentsNumber" id="aciu_OperatingSegmentsNumber" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ReportableSegmentsNumber" id="aciu_ReportableSegmentsNumber" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" id="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" id="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TauPETImagingAgentMember" id="aciu_TauPETImagingAgentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TradeAndOtherPayablesAndAccruedLiabilitiesTable" id="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" id="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AccruedStampDuty" id="aciu_AccruedStampDuty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="CurrentAccruedResearchAndDevelopmentCosts" id="aciu_CurrentAccruedResearchAndDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="NumberOfPersonsKeyManagementBoardOfDirectors" id="aciu_NumberOfPersonsKeyManagementBoardOfDirectors" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfPersonsKeyManagementExecutiveManagement" id="aciu_NumberOfPersonsKeyManagementExecutiveManagement" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DilutiveEffectOfConvertibleInstrumentsTextBlock" id="aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" id="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfNonVestedSharesAbstract" id="aciu_NumberOfNonVestedSharesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" id="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedPaymentArrangementAbstract" id="aciu_ShareBasedPaymentArrangementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" id="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RestrictedStockUnitsMember" id="aciu_RestrictedStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="BoardOfDirectorsMember" id="aciu_BoardOfDirectorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ExecutiveManagementMember" id="aciu_ExecutiveManagementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="WeightedAverageExercisePriceAbstract" id="aciu_WeightedAverageExercisePriceAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RestrictedSharesAndRestrictedShareUnitsMember" id="aciu_RestrictedSharesAndRestrictedShareUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SensitivityAnalysisActuarialAssumptionsAbstract" id="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" id="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" id="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ChangesInFairValueOfPlanAssetsAbstract" id="aciu_ChangesInFairValueOfPlanAssetsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AntiTauAntibodyInADMember" id="aciu_AntiTauAntibodyInADMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfOptionsAbstract" id="aciu_NumberOfOptionsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="WeightedAverageRemainingAbstract" id="aciu_WeightedAverageRemainingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FinancialAssetsAndLiabilitiesAbstract" id="aciu_FinancialAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AccruedExpensesMember" id="aciu_AccruedExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TradeAndOtherPayablesMember" id="aciu_TradeAndOtherPayablesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FinancialRisksAbstract" id="aciu_FinancialRisksAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LiquidityManagementRollingForecastPeriod" id="aciu_LiquidityManagementRollingForecastPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" id="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LongTermFinancialAssetsMember" id="aciu_LongTermFinancialAssetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CashOnHandAndCashEquivalentsMember" id="aciu_CashOnHandAndCashEquivalentsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShortTermFinancialAssetsMember" id="aciu_ShortTermFinancialAssetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShortTermLeaseLiabilitiesMember" id="aciu_ShortTermLeaseLiabilitiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RightOfUseFinancialAssetsMember" id="aciu_RightOfUseFinancialAssetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" id="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" id="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfEquityBasedInstrumentPlans" id="aciu_NumberOfEquityBasedInstrumentPlans" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StockOptionPlanC1Member" id="aciu_StockOptionPlanC1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Two016ShareOptionAndIncentivePlanMember" id="aciu_Two016ShareOptionAndIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" id="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" id="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedPlansOutstandingAbstract" id="aciu_ShareBasedPlansOutstandingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" id="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EmployeesMember" id="aciu_EmployeesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" id="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncomeTaxLossCarryforwardPeriod" id="aciu_IncomeTaxLossCarryforwardPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PrepaidExpensesAndAccruedIncomeTable" id="aciu_PrepaidExpensesAndAccruedIncomeTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PrepaidExpensesAndAccruedIncomeLineItems" id="aciu_PrepaidExpensesAndAccruedIncomeLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PrepaidExpensesAndAccruedIncomeDisclosureAbstract" id="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfAccruedIncome" id="aciu_PercentageOfAccruedIncome" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" id="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" id="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="GrantIncomePolicyTextBlock" id="aciu_GrantIncomePolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" id="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CashAndCashEquivalentsTable" id="aciu_CashAndCashEquivalentsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CashAndCashEquivalentLineItems" id="aciu_CashAndCashEquivalentLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="InProcessResearchAndDevelopmentIPRDAssetMember" id="aciu_InProcessResearchAndDevelopmentIPRDAssetMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember" id="aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" id="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" id="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncreaseThroughSharesIssuedUnderIncentivePlans" id="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" id="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" id="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="WithholdingTaxReceivables" id="aciu_WithholdingTaxReceivables" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="AccruedExpensesAbstract" id="aciu_AccruedExpensesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AssetsUnderConstructionMember" id="aciu_AssetsUnderConstructionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AlphaSynucleinPetImagingDiagnosticAgentMember" id="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="FollowOnGrantFundingReceived" id="aciu_FollowOnGrantFundingReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="FollowOnGrantFundingReceivedTotalForJointArrangement" id="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" id="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" id="aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" id="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="AssetAcquisitionsAxis" id="aciu_AssetAcquisitionsAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SignificantAssetAcquisitionsTotalDomain" id="aciu_SignificantAssetAcquisitionsTotalDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CashAcquiredAsPartOfAssetAcquisition" id="aciu_CashAcquiredAsPartOfAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="IntangibleAssetsAcquiredAsPartOfAssetAcquisition" id="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="TotalAssetsAcquiredInAssetAcquisition" id="aciu_TotalAssetsAcquiredInAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="SharesTransferredAsConsiderationInAssetAcquisition" id="aciu_SharesTransferredAsConsiderationInAssetAcquisition" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" id="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="IprDIntangibleAssetAssociatedWithAci7104.056Member" id="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="AssetAcquisitionsAbstract" id="aciu_AssetAcquisitionsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SignificantAssetAcquisitionsAxis" id="aciu_SignificantAssetAcquisitionsAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="AllSignificantAssetAcquisitionsDomain" id="aciu_AllSignificantAssetAcquisitionsDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" id="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="MiscellaneousOtherCurrentReceivables" id="aciu_MiscellaneousOtherCurrentReceivables" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="MaturityPeriodOtherCurrentReceivables" id="aciu_MaturityPeriodOtherCurrentReceivables" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" id="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions" id="aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" id="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="IncreaseThroughIssuanceOfSharesInAssetAcquisitions" id="aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" id="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" id="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" id="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" id="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" id="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="NumberOfConvertibleNoteAgreements" id="aciu_NumberOfConvertibleNoteAgreements" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="IfNotesAreConvertedMember" id="aciu_IfNotesAreConvertedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="AggregatePrincipalAmountOfEachConvertibleNote" id="aciu_AggregatePrincipalAmountOfEachConvertibleNote" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ProceedsFromConversionOfConvertibleDebtPerIndividualNote" id="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" id="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="OtherAccruedExpenses" id="aciu_OtherAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="AccrualsForPerformanceRelatedRemuneration" id="aciu_AccrualsForPerformanceRelatedRemuneration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="Quarter32019Member" id="aciu_Quarter32019Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="March312020Member" id="aciu_March312020Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" id="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CollaborativeAgreementUpfrontPaymentsReceived" id="aciu_CollaborativeAgreementUpfrontPaymentsReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ClinicalMilestonesAchievedPriorTo1January2017Member" id="aciu_ClinicalMilestonesAchievedPriorTo1January2017Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" id="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ClinicalMilestonesMember" id="aciu_ClinicalMilestonesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="RegulatoryAndSalesBasedMilestonesMember" id="aciu_RegulatoryAndSalesBasedMilestonesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="AdvanceSmallMoleculePdProgramsMember" id="aciu_AdvanceSmallMoleculePdProgramsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ResearchAndDevelopmentExpensesMember" id="aciu_ResearchAndDevelopmentExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="EmployeeBenefitsExpenseExcludingShareBasedCompensation" id="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="GainsLossesOnConversionFeaturesRelatedToConvertibleNotes" id="aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" id="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="RightOfUseAssetsAndLeaseLiabilitiesNetMember" id="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="RetirementBenefitPlanMember" id="aciu_RetirementBenefitPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="December312024Member" id="aciu_December312024Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="December312025Member" id="aciu_December312025Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="December312026Member" id="aciu_December312026Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="December312027Member" id="aciu_December312027Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="December312028Member" id="aciu_December312028Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="December312029Member" id="aciu_December312029Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" id="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="DefinedBenefitPlansPercentageOfContributionsByEmployees" id="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DefinedBenefitPlansPercentageOfContributionsByEmployer" id="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="CurrentAndPastServiceCostGainDefinedBenefitPlans" id="aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome" id="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" id="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" id="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" id="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" id="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="Chf0.15Member" id="aciu_Chf0.15Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="Chf9.53Member" id="aciu_Chf9.53Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="Usd5.04ToUsd12.30Member" id="aciu_Usd5.04ToUsd12.30Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="Usd2.76ToUsd4.57Member" id="aciu_Usd2.76ToUsd4.57Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="RestrictedStockUnitsFirstVestingConditionsMember" id="aciu_RestrictedStockUnitsFirstVestingConditionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="RestrictedStockUnitsSecondVestingConditionsMember" id="aciu_RestrictedStockUnitsSecondVestingConditionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" id="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" id="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired" id="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" id="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" id="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" id="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" id="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ContractualCapitalCommitmentsOtherThanForLeases" id="aciu_ContractualCapitalCommitmentsOtherThanForLeases" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="OtherCurrentReceivablesMember" id="aciu_OtherCurrentReceivablesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="LongTermLeaseLiabilitiesMember" id="aciu_LongTermLeaseLiabilitiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" id="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" id="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" id="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" id="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="CashAndCashEquivalentsSubjectToNegativeInterestRates" id="aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="DisclosureOfAssetAcquisitionsTextBlock" id="aciu_DisclosureOfAssetAcquisitionsTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DisclosureOfAssetAcquisitionsTableTextBlock" id="aciu_DisclosureOfAssetAcquisitionsTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" id="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" id="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" id="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" id="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="GrantsMichaelJ.FoxFoundationAndTargetAlsMember" id="aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" id="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" id="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" id="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" id="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" id="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" id="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>54
<FILENAME>aciu-20221231_cal.xml
<DESCRIPTION>EX-101.CAL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.2.0.4 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/15/2023 5:39:21 PM-->
<!--Modified on: 3/15/2023 5:39:21 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#StatementCondensedConsolidatedStatementsOfIncomeLoss" roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss" roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#StatementCondensedConsolidatedStatementsOfCashFlows" roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureAssetAcquisitionDetails" roleURI="http://acimume.com/role/DisclosureAssetAcquisitionDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosurePrepaidExpensesAndAccruedIncomeDetails" roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureOtherCurrentReceivablesDetails" roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureExpensesByCategoryDetails" roleURI="http://acimume.com/role/DisclosureExpensesByCategoryDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRelatedPartyTransactionsDetails" roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" roleURI="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureEarningsPerShareDetails" roleURI="http://acimume.com/role/DisclosureEarningsPerShareDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <calculationLink xlink:role="http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - Condensed Consolidated Balance Sheets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="Assets" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets_638144987573126766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="ifrs-full_NoncurrentAssets_638144987573126766" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets_638144987573126766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets_638144987573126766" xlink:to="ifrs-full_RightofuseAssets_638144987573126766" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment_638144987573126766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets_638144987573126766" xlink:to="ifrs-full_PropertyPlantAndEquipment_638144987573126766" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_638144987573126766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets_638144987573126766" xlink:to="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_638144987573126766" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_638144987573126766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets_638144987573126766" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_638144987573126766" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets_638144987573126766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="ifrs-full_CurrentAssets_638144987573126766" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_638144987573126766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_638144987573126766" xlink:to="ifrs-full_CashAndCashEquivalents_638144987573126766" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses_638144987573126766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_638144987573126766" xlink:to="ifrs-full_CurrentPrepaidExpenses_638144987573126766" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638144987573126766" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_638144987573126766" xlink:to="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638144987573126766" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638144987573136767" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_638144987573126766" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638144987573136767" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="ifrs-full_OtherCurrentReceivables_638144987573136767" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_638144987573126766" xlink:to="ifrs-full_OtherCurrentReceivables_638144987573136767" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="EquityAndLiabilities" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_638144987573136767" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EquityAndLiabilities" xlink:to="ifrs-full_Equity_638144987573136767" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital_638144987573136767" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_638144987573136767" xlink:to="ifrs-full_IssuedCapital_638144987573136767" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasuryShares" xlink:label="ifrs-full_TreasuryShares_638144987573136767" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_638144987573136767" xlink:to="ifrs-full_TreasuryShares_638144987573136767" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharePremium" xlink:label="ifrs-full_SharePremium_638144987573136767" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_638144987573136767" xlink:to="ifrs-full_SharePremium_638144987573136767" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings_638144987573136767" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_638144987573136767" xlink:to="ifrs-full_RetainedEarnings_638144987573136767" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_638144987573136767" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_638144987573136767" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_638144987573136767" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Liabilities" xlink:label="ifrs-full_Liabilities_638144987573146765" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EquityAndLiabilities" xlink:to="ifrs-full_Liabilities_638144987573146765" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities_638144987573146765" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities_638144987573146765" xlink:to="ifrs-full_NoncurrentLiabilities_638144987573146765" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_638144987573146765" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities_638144987573146765" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_638144987573146765" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_638144987573146765" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities_638144987573146765" xlink:to="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_638144987573146765" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities_638144987573146765" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities_638144987573146765" xlink:to="ifrs-full_CurrentLiabilities_638144987573146765" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities_638144987573146765" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_638144987573146765" xlink:to="ifrs-full_CurrentLeaseLiabilities_638144987573146765" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_638144987573146765" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_638144987573146765" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_638144987573146765" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_638144987573146765" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_638144987573146765" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_638144987573146765" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638144987573156772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_638144987573146765" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638144987573156772" order="4" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss" xlink:type="extended" xlink:title="00200 - Statement - Condensed Consolidated Statements of Income/(Loss)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ProfitLoss" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax_638144987573156772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="ifrs-full_ProfitLossBeforeTax_638144987573156772" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_638144987573156772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax_638144987573156772" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_638144987573156772" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue_638144987573156772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_638144987573156772" xlink:to="ifrs-full_Revenue_638144987573156772" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638144987573156772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Revenue_638144987573156772" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638144987573156772" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="ifrs-full_OperatingExpense_638144987573156772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_638144987573156772" xlink:to="ifrs-full_OperatingExpense_638144987573156772" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="ifrs-full_OtherOperatingIncomeExpense_638144987573156772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OperatingExpense_638144987573156772" xlink:to="ifrs-full_OtherOperatingIncomeExpense_638144987573156772" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_638144987573156772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OperatingExpense_638144987573156772" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_638144987573156772" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_638144987573156772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OperatingExpense_638144987573156772" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_638144987573156772" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost_638144987573166770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax_638144987573156772" xlink:to="ifrs-full_FinanceIncomeCost_638144987573166770" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638144987573166770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeCost_638144987573166770" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638144987573166770" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome_638144987573166770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeCost_638144987573166770" xlink:to="ifrs-full_FinanceIncome_638144987573166770" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts_638144987573166770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeCost_638144987573166770" xlink:to="ifrs-full_FinanceCosts_638144987573166770" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_638144987573166770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_638144987573166770" order="2" use="optional" weight="-1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:type="extended" xlink:title="00300 - Statement - Condensed Consolidated Statements of Comprehensive Income/(Loss)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ComprehensiveIncome" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome_638144987573166770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_638144987573166770" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_638144987573166770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherComprehensiveIncome_638144987573166770" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_638144987573166770" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_638144987573166770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherComprehensiveIncome_638144987573166770" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_638144987573166770" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_638144987573166770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ComprehensiveIncome" xlink:to="ifrs-full_ProfitLoss_638144987573166770" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00500 - Statement - Condensed Consolidated Statements of Cash Flows" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987573176769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987573176769" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfCurrentBorrowings" xlink:label="ifrs-full_RepaymentsOfCurrentBorrowings_638144987573176769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987573176769" xlink:to="ifrs-full_RepaymentsOfCurrentBorrowings_638144987573176769" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_638144987573176769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987573176769" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_638144987573176769" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:label="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_638144987573176769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987573176769" xlink:to="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_638144987573176769" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromIssueOfConvertibleDebt" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_638144987573176769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987573176769" xlink:to="aciu_ProceedsFromIssueOfConvertibleDebt_638144987573176769" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_638144987573176769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987573176769" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_638144987573176769" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_638144987573176769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987573176769" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_638144987573176769" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_638144987573176769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987573176769" xlink:to="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_638144987573176769" order="7" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="ifrs-full_PaymentsForShareIssueCosts_638144987573176769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987573176769" xlink:to="ifrs-full_PaymentsForShareIssueCosts_638144987573176769" order="8" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_638144987573176769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987573176769" xlink:to="aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_638144987573176769" order="9" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" xlink:label="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_638144987573186772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987573176769" xlink:to="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_638144987573186772" order="10" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_638144987573186772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_638144987573186772" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_638144987573186772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities_638144987573186772" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_638144987573186772" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_638144987573186772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities_638144987573186772" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_638144987573186772" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAdvancesForRentDeposit" xlink:label="aciu_CashAdvancesForRentDeposit_638144987573186772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities_638144987573186772" xlink:to="aciu_CashAdvancesForRentDeposit_638144987573186772" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" xlink:label="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_638144987573186772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities_638144987573186772" xlink:to="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_638144987573186772" order="4" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_638144987573186772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_638144987573186772" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="ifrs-full_InterestPaidClassifiedAsOperatingActivities_638144987573186772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_638144987573186772" xlink:to="ifrs-full_InterestPaidClassifiedAsOperatingActivities_638144987573186772" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:label="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_638144987573186772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_638144987573186772" xlink:to="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_638144987573186772" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_638144987573196779" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_638144987573186772" xlink:to="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_638144987573196779" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperations" xlink:label="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_638144987573186772" xlink:to="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets" xlink:label="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_638144987573196779" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_638144987573196779" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_638144987573196779" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="ifrs-full_ProfitLoss_638144987573196779" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_638144987573196779" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_638144987573196779" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_638144987573196779" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense_638144987573196779" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="ifrs-full_AdjustmentsForFinanceIncomeCost_638144987573196779" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="ifrs-full_AdjustmentsForFinanceIncomeCost_638144987573196779" order="5" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_638144987573206802" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_638144987573206802" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_638144987573206802" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_638144987573206802" order="7" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="ifrs-full_AdjustmentsForInterestExpense_638144987573206802" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="ifrs-full_AdjustmentsForInterestExpense_638144987573206802" order="8" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_638144987573206802" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_638144987573206802" order="9" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses" xlink:label="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_638144987573206802" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_638144987573206802" order="10" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_638144987573206802" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_638144987573206802" order="11" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_638144987573206802" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_638144987573206802" order="12" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_638144987573216770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_638144987573216770" order="13" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_638144987573216770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638144987573196779" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_638144987573216770" order="14" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" xlink:type="extended" xlink:title="40502 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ExpenseRelatingToLeases" xlink:label="ExpenseRelatingToLeases" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets_638144987573216770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ExpenseRelatingToLeases" xlink:to="ifrs-full_DepreciationRightofuseAssets_638144987573216770" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_638144987573216770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ExpenseRelatingToLeases" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_638144987573216770" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_638144987573216770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ExpenseRelatingToLeases" xlink:to="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_638144987573216770" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureAssetAcquisitionDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Asset acquisition (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TotalAssetsAcquiredInAssetAcquisition" xlink:label="aciu_TotalAssetsAcquiredInAssetAcquisition" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition_638144987573226772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aciu_TotalAssetsAcquiredInAssetAcquisition" xlink:to="aciu_CashAcquiredAsPartOfAssetAcquisition_638144987573226772" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_638144987573226772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aciu_TotalAssetsAcquiredInAssetAcquisition" xlink:to="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_638144987573226772" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Prepaid expenses and accrued income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses_638144987573226772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xlink:to="ifrs-full_CurrentPrepaidExpenses_638144987573226772" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638144987573226772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638144987573226772" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" xlink:type="extended" xlink:title="41001 - Disclosure - Other current receivables (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="ifrs-full_OtherCurrentReceivables" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MiscellaneousOtherCurrentReceivables" xlink:label="aciu_MiscellaneousOtherCurrentReceivables_638144987573226772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherCurrentReceivables" xlink:to="aciu_MiscellaneousOtherCurrentReceivables_638144987573226772" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables_638144987573226772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherCurrentReceivables" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables_638144987573226772" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WithholdingTaxReceivables" xlink:label="aciu_WithholdingTaxReceivables_638144987573226772" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherCurrentReceivables" xlink:to="aciu_WithholdingTaxReceivables_638144987573226772" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" xlink:type="extended" xlink:title="41201 - Disclosure - Trade and other payables and accrued expenses (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="CurrentAccruedExpensesAndOtherCurrentLiabilities" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CurrentAccruedResearchAndDevelopmentCosts" xlink:label="aciu_CurrentAccruedResearchAndDevelopmentCosts_638144987573236770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="aciu_CurrentAccruedResearchAndDevelopmentCosts_638144987573236770" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OtherAccruedExpenses" xlink:label="aciu_OtherAccruedExpenses_638144987573236770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="aciu_OtherAccruedExpenses_638144987573236770" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_638144987573236770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals_638144987573236770" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureExpensesByCategoryDetails" xlink:type="extended" xlink:title="41401 - Disclosure - Expenses by category (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseByNature" xlink:label="ifrs-full_ExpenseByNature" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="ifrs-full_OperatingExpense_638144987573236770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ExpenseByNature" xlink:to="ifrs-full_OperatingExpense_638144987573236770" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_638144987573236770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ExpenseByNature" xlink:to="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_638144987573236770" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_638144987573236770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ExpenseByNature" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_638144987573236770" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails" xlink:type="extended" xlink:title="41501 - Disclosure - Related-party transactions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="KeyManagementPersonnelCompensation" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_638144987573236770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_638144987573236770" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_638144987573236770" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_638144987573236770" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_638144987573246771" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_638144987573246771" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" xlink:type="extended" xlink:title="41601 - Disclosure - Income taxes - Summary of Income Tax Expense (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_638144987573246771" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_638144987573246771" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_638144987573246771" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_638144987573246771" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="ifrs-full_TaxEffectOfTaxLosses_638144987573246771" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_TaxEffectOfTaxLosses_638144987573246771" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" xlink:type="extended" xlink:title="41701 - Disclosure - Retirement benefit plan - Summary of Benefit Plan (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SurplusDeficitInPlan" xlink:label="SurplusDeficitInPlan" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_638144987573246771" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SurplusDeficitInPlan" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue_638144987573246771" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="ifrs-full_PlanAssetsAtFairValue_638144987573246771" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SurplusDeficitInPlan" xlink:to="ifrs-full_PlanAssetsAtFairValue_638144987573246771" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" xlink:type="extended" xlink:title="41702 - Disclosure - Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans" xlink:label="aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans_638144987573256769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:to="aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans_638144987573256769" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:label="ifrs-full_InterestExpenseDefinedBenefitPlans_638144987573256769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:to="ifrs-full_InterestExpenseDefinedBenefitPlans_638144987573256769" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestIncomeDefinedBenefitPlans" xlink:label="ifrs-full_InterestIncomeDefinedBenefitPlans_638144987573256769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:to="ifrs-full_InterestIncomeDefinedBenefitPlans_638144987573256769" order="3" use="optional" weight="-1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" xlink:type="extended" xlink:title="41706 - Disclosure - Retirement benefit plan - Change in other comprehensive gains (losses) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_638144987573256769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_638144987573256769" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_638144987573256769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_638144987573256769" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_638144987573256769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_638144987573256769" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_638144987573256769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_638144987573256769" order="4" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureEarningsPerShareDetails" xlink:type="extended" xlink:title="42001 - Disclosure - Earnings per share (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding" xlink:label="aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding_638144987573256769" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:to="aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding_638144987573256769" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting" xlink:label="aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting_638144987573266776" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:to="aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting_638144987573266776" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_638144987573266776" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:to="ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_638144987573266776" order="3" use="optional" weight="1" />
  </calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>55
<FILENAME>aciu-20221231_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.2.0.4 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/15/2023 5:39:21 PM-->
<!--Modified on: 3/15/2023 5:39:21 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DocumentDocumentAndEntityInformation" roleURI="http://acimume.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#StatementCondensedConsolidatedStatementsOfChangesInEquity" roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosurePropertyPlantAndEquipmentDetails" roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureAssetAcquisitionDetails" roleURI="http://acimume.com/role/DisclosureAssetAcquisitionDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureIntangibleAssetsDetails" roleURI="http://acimume.com/role/DisclosureIntangibleAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosurePrepaidExpensesAndAccruedIncomeDetails" roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureOtherCurrentReceivablesDetails" roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalNarrativesDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalNarrativesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalCapitalStructureDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalShelfRegistrationStatementDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalAtMarketEquityOfferingDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalConvertibleNoteAgreementDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureExpensesByCategoryDetails" roleURI="http://acimume.com/role/DisclosureExpensesByCategoryDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" roleURI="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" roleURI="http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareBasedCompensationPlansOutstandingDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareBasedCompensationNonVestedShareAwardsDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureCommitmentsAndContingenciesDetails" roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureFinancialInstrumentsAndRiskManagementDetails" roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureStandardAndCustomAxisDomainDefaults" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureEarningsPerShareDetails" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureEarningsPerShareDetails" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureBasisOfPreparationGoingConcernDetails" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureGeneralInformationDetails" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureGeneralInformationDetails" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureEarningsPerShareTables" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureEarningsPerShareTables" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureContractRevenuesTables" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesTables" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureIntangibleAssetsTables" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureIntangibleAssetsTables" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosurePropertyPlantAndEquipmentTables" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureSubsequentEvents" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSubsequentEvents" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureEarningsPerShare" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureEarningsPerShare" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlan" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlan" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureContractRevenues" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenues" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosurePrepaidExpensesAndAccruedIncome" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureIntangibleAssets" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureIntangibleAssets" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipment" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosurePropertyPlantAndEquipment" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureGeneralInformation" xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureGeneralInformation" />
  <link:roleRef roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:type="simple" xlink:href="aciu-20221231.xsd#StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss" />
  <link:roleRef roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss" xlink:type="simple" xlink:href="aciu-20221231.xsd#StatementCondensedConsolidatedStatementsOfIncomeLoss" />
  <link:roleRef roleURI="http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="aciu-20221231.xsd#StatementCondensedConsolidatedBalanceSheets" />
  <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureGeneralInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosurePropertyPlantAndEquipment" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureIntangibleAssets" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureContractRevenues" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlan" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureEarningsPerShare" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureSubsequentEvents" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureIntangibleAssetsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureContractRevenuesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureEarningsPerShareTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureGeneralInformationDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureEarningsPerShareDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureStandardAndCustomAxisDomainDefaults">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="EntityAddressesAddressTypeAxis" xlink:title="EntityAddressesAddressTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="AddressTypeDomain" xlink:title="AddressTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="EntityAddressesAddressTypeAxis" xlink:to="AddressTypeDomain" xlink:title="definition: EntityAddressesAddressTypeAxis to AddressTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ComponentsOfEquityAxis" xlink:title="ComponentsOfEquityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="EquityMember" xlink:title="EquityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ComponentsOfEquityAxis" xlink:to="EquityMember" xlink:title="definition: ComponentsOfEquityAxis to EquityMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ClassesOfPropertyPlantAndEquipmentAxis" xlink:title="ClassesOfPropertyPlantAndEquipmentAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="PropertyPlantAndEquipmentMember" xlink:title="PropertyPlantAndEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="PropertyPlantAndEquipmentMember" xlink:title="definition: ClassesOfPropertyPlantAndEquipmentAxis to PropertyPlantAndEquipmentMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ClassesOfAssetsAxis" xlink:title="ClassesOfAssetsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ClassesOfAssetsMember" xlink:title="ClassesOfAssetsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassesOfAssetsAxis" xlink:to="ClassesOfAssetsMember" xlink:title="definition: ClassesOfAssetsAxis to ClassesOfAssetsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:title="CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="CarryingAmountMember" xlink:title="CarryingAmountMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="CarryingAmountMember" xlink:title="definition: CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis to CarryingAmountMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="MaturityAxis" xlink:title="MaturityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="AggregatedTimeBandsMember" xlink:title="AggregatedTimeBandsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="MaturityAxis" xlink:to="AggregatedTimeBandsMember" xlink:title="definition: MaturityAxis to AggregatedTimeBandsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="BusinessCombinationsAxis" xlink:title="BusinessCombinationsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="EntitysTotalForBusinessCombinationsMember" xlink:title="EntitysTotalForBusinessCombinationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessCombinationsAxis" xlink:to="EntitysTotalForBusinessCombinationsMember" xlink:title="definition: BusinessCombinationsAxis to EntitysTotalForBusinessCombinationsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:title="ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="IntangibleAssetsOtherThanGoodwillMember" xlink:title="IntangibleAssetsOtherThanGoodwillMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="IntangibleAssetsOtherThanGoodwillMember" xlink:title="definition: ClassesOfIntangibleAssetsOtherThanGoodwillAxis to IntangibleAssetsOtherThanGoodwillMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="CurrencyAxis" xlink:title="CurrencyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="AllCurrenciesDomain" xlink:title="AllCurrenciesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CurrencyAxis" xlink:to="AllCurrenciesDomain" xlink:title="definition: CurrencyAxis to AllCurrenciesDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="TypesOfContractsAxis" xlink:title="TypesOfContractsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="TypesOfContractsMember" xlink:title="TypesOfContractsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypesOfContractsAxis" xlink:to="TypesOfContractsMember" xlink:title="definition: TypesOfContractsAxis to TypesOfContractsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="RangesMember" xlink:title="RangesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangesMember" xlink:title="definition: RangeAxis to RangesMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ClassesOfShareCapitalAxis" xlink:title="ClassesOfShareCapitalAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ClassesOfShareCapitalMember" xlink:title="ClassesOfShareCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassesOfShareCapitalAxis" xlink:to="ClassesOfShareCapitalMember" xlink:title="definition: ClassesOfShareCapitalAxis to ClassesOfShareCapitalMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ProductsAndServicesAxis" xlink:title="ProductsAndServicesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ProductsAndServicesMember" xlink:title="ProductsAndServicesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ProductsAndServicesAxis" xlink:to="ProductsAndServicesMember" xlink:title="definition: ProductsAndServicesAxis to ProductsAndServicesMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="PerformanceObligationsAxis" xlink:title="PerformanceObligationsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="PerformanceObligationsMember" xlink:title="PerformanceObligationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PerformanceObligationsAxis" xlink:to="PerformanceObligationsMember" xlink:title="definition: PerformanceObligationsAxis to PerformanceObligationsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis" xlink:label="CounterpartiesAxis" xlink:title="CounterpartiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember" xlink:label="CounterpartiesMember" xlink:title="CounterpartiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CounterpartiesAxis" xlink:to="CounterpartiesMember" xlink:title="definition: CounterpartiesAxis to CounterpartiesMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="BorrowingsByNameAxis" xlink:title="BorrowingsByNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="BorrowingsByNameMember" xlink:title="BorrowingsByNameMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BorrowingsByNameAxis" xlink:to="BorrowingsByNameMember" xlink:title="definition: BorrowingsByNameAxis to BorrowingsByNameMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:title="TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:title="TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:title="definition: TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis to TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="DefinedBenefitPlansAxis" xlink:title="DefinedBenefitPlansAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="DefinedBenefitPlansMember" xlink:title="DefinedBenefitPlansMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DefinedBenefitPlansAxis" xlink:to="DefinedBenefitPlansMember" xlink:title="definition: DefinedBenefitPlansAxis to DefinedBenefitPlansMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="NetDefinedBenefitLiabilityAssetAxis" xlink:title="NetDefinedBenefitLiabilityAssetAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="NetDefinedBenefitLiabilityAssetMember" xlink:title="NetDefinedBenefitLiabilityAssetMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="NetDefinedBenefitLiabilityAssetAxis" xlink:to="NetDefinedBenefitLiabilityAssetMember" xlink:title="definition: NetDefinedBenefitLiabilityAssetAxis to NetDefinedBenefitLiabilityAssetMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="ActuarialAssumptionsAxis" xlink:title="ActuarialAssumptionsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsMember" xlink:label="ActuarialAssumptionsMember" xlink:title="ActuarialAssumptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ActuarialAssumptionsAxis" xlink:to="ActuarialAssumptionsMember" xlink:title="definition: ActuarialAssumptionsAxis to ActuarialAssumptionsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="TypesOfRisksAxis" xlink:title="TypesOfRisksAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="TypesOfRisksMember" xlink:title="TypesOfRisksMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypesOfRisksAxis" xlink:to="TypesOfRisksMember" xlink:title="definition: TypesOfRisksAxis to TypesOfRisksMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="TypesOfSharebasedPaymentArrangementsAxis" xlink:title="TypesOfSharebasedPaymentArrangementsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="SharebasedPaymentArrangementsMember" xlink:title="SharebasedPaymentArrangementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypesOfSharebasedPaymentArrangementsAxis" xlink:to="SharebasedPaymentArrangementsMember" xlink:title="definition: TypesOfSharebasedPaymentArrangementsAxis to SharebasedPaymentArrangementsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="CategoriesOfRelatedPartiesAxis" xlink:title="CategoriesOfRelatedPartiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="EntitysTotalForRelatedPartiesMember" xlink:title="EntitysTotalForRelatedPartiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CategoriesOfRelatedPartiesAxis" xlink:to="EntitysTotalForRelatedPartiesMember" xlink:title="definition: CategoriesOfRelatedPartiesAxis to EntitysTotalForRelatedPartiesMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:title="RangesOfExercisePricesForOutstandingShareOptionsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:title="RangesOfExercisePricesForOutstandingShareOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:title="definition: RangesOfExercisePricesForOutstandingShareOptionsAxis to RangesOfExercisePricesForOutstandingShareOptionsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="CategoriesOfFinancialAssetsAxis" xlink:title="CategoriesOfFinancialAssetsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="FinancialAssetsCategoryMember" xlink:title="FinancialAssetsCategoryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CategoriesOfFinancialAssetsAxis" xlink:to="FinancialAssetsCategoryMember" xlink:title="definition: CategoriesOfFinancialAssetsAxis to FinancialAssetsCategoryMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:label="CategoriesOfFinancialLiabilitiesAxis" xlink:title="CategoriesOfFinancialLiabilitiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesCategoryMember" xlink:label="FinancialLiabilitiesCategoryMember" xlink:title="FinancialLiabilitiesCategoryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CategoriesOfFinancialLiabilitiesAxis" xlink:to="FinancialLiabilitiesCategoryMember" xlink:title="definition: CategoriesOfFinancialLiabilitiesAxis to FinancialLiabilitiesCategoryMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis_1" xlink:title="ifrs-full_ClassesOfOrdinarySharesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember_1" xlink:title="ifrs-full_OrdinarySharesMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis_1" xlink:to="ifrs-full_OrdinarySharesMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ClassesOfOrdinarySharesAxis_1 To ifrs-full_OrdinarySharesMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_1" xlink:title="dei_LegalEntityAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_1" xlink:title="dei_EntityDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="dei_LegalEntityAxis_1" xlink:to="dei_EntityDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:dei_LegalEntityAxis_1 To dei_EntityDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AssetAcquisitionsAxis" xlink:label="aciu_AssetAcquisitionsAxis_1" xlink:title="aciu_AssetAcquisitionsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SignificantAssetAcquisitionsTotalDomain" xlink:label="aciu_SignificantAssetAcquisitionsTotalDomain_1" xlink:title="aciu_SignificantAssetAcquisitionsTotalDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="aciu_AssetAcquisitionsAxis_1" xlink:to="aciu_SignificantAssetAcquisitionsTotalDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:aciu_AssetAcquisitionsAxis_1 To aciu_SignificantAssetAcquisitionsTotalDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="ifrs-full_UnobservableInputsAxis_1" xlink:title="ifrs-full_UnobservableInputsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnobservableInputsMember" xlink:label="ifrs-full_UnobservableInputsMember_1" xlink:title="ifrs-full_UnobservableInputsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_UnobservableInputsAxis_1" xlink:to="ifrs-full_UnobservableInputsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_UnobservableInputsAxis_1 To ifrs-full_UnobservableInputsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SignificantAssetAcquisitionsAxis" xlink:label="aciu_SignificantAssetAcquisitionsAxis_1" xlink:title="aciu_SignificantAssetAcquisitionsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AllSignificantAssetAcquisitionsDomain" xlink:label="aciu_AllSignificantAssetAcquisitionsDomain_1" xlink:title="aciu_AllSignificantAssetAcquisitionsDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="aciu_SignificantAssetAcquisitionsAxis_1" xlink:to="aciu_AllSignificantAssetAcquisitionsDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:aciu_SignificantAssetAcquisitionsAxis_1 To aciu_AllSignificantAssetAcquisitionsDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_1" xlink:title="srt_StatementScenarioAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_1" xlink:title="srt_ScenarioUnspecifiedDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="srt_StatementScenarioAxis_1" xlink:to="srt_ScenarioUnspecifiedDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:srt_StatementScenarioAxis_1 To srt_ScenarioUnspecifiedDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" xlink:title="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LineItemsByFunctionMember" xlink:label="ifrs-full_LineItemsByFunctionMember_1" xlink:title="ifrs-full_LineItemsByFunctionMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" xlink:to="ifrs-full_LineItemsByFunctionMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1 To ifrs-full_LineItemsByFunctionMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis_1" xlink:title="ifrs-full_GeographicalAreasAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember_1" xlink:title="ifrs-full_GeographicalAreasMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_GeographicalAreasAxis_1" xlink:to="ifrs-full_GeographicalAreasMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_GeographicalAreasAxis_1 To ifrs-full_GeographicalAreasMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis_1" xlink:title="ifrs-full_ClassesOfFinancialAssetsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="ifrs-full_FinancialAssetsMember_1" xlink:title="ifrs-full_FinancialAssetsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis_1" xlink:to="ifrs-full_FinancialAssetsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ClassesOfFinancialAssetsAxis_1 To ifrs-full_FinancialAssetsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" xlink:title="ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="ifrs-full_FinancialLiabilitiesMember_1" xlink:title="ifrs-full_FinancialLiabilitiesMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" xlink:to="ifrs-full_FinancialLiabilitiesMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_ClassesOfFinancialLiabilitiesAxis_1 To ifrs-full_FinancialLiabilitiesMember_1" order="1" />
  </link:definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesAddressTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentType" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityRegistrantName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentRegistrationStatement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityCentralIndexKey" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentPeriodEndDate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentFiscalYearFocus" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_AmendmentFlag" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_CurrentFiscalYearEndDate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentAnnualReport" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentTransitionReport" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentShellCompanyReport" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityFileNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressAddressLine1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressAddressLine2" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressPostalZipCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressCityOrTown" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressCountry" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_ContactPersonnelName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="22" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_CityAreaCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="23" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_LocalPhoneNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="24" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_Security12bTitle" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="25" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_TradingSymbol" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="26" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_SecurityExchangeName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="27" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="28" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="29" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityVoluntaryFilers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="30" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityCurrentReportingStatus" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="31" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityInteractiveDataCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="32" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityFilerCategory" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="33" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityEmergingGrowthCompany" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="34" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="35" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentAccountingStandard" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="36" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityShellCompany" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="37" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_AuditorFirmId" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="38" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_AuditorName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="39" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_AuditorLocation" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity" xlink:type="extended" xlink:title="00400 - Statement - Condensed Consolidated Statements of Changes in Equity" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_IssuedCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharePremiumMember" xlink:label="ifrs-full_SharePremiumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_SharePremiumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_TreasurySharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="ifrs-full_RetainedEarningsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_RetainedEarningsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ProfitLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_OtherComprehensiveIncome" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ComprehensiveIncome" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssuedAbstract" xlink:label="ifrs-full_NumberOfSharesIssuedAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_NumberOfSharesIssuedAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" xlink:label="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" xlink:label="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IssueOfEquityRestrictedShareAwards" xlink:label="aciu_IssueOfEquityRestrictedShareAwards" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="aciu_IssueOfEquityRestrictedShareAwards" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" xlink:type="extended" xlink:title="40302 - Disclosure - Summary of significant accounting policies, Right-of-use assets and lease liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_BuildingsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="ifrs-full_OfficeEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_OfficeEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_EstimatedLeaseTerm" xlink:label="aciu_EstimatedLeaseTerm" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="aciu_EstimatedLeaseTerm" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" xlink:type="extended" xlink:title="40303 - Disclosure - Summary of significant accounting policies, Property, plant and equipment (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LaboratoryEquipmentMember" xlink:label="aciu_LaboratoryEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="aciu_LaboratoryEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" xlink:label="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" xlink:label="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails" xlink:type="extended" xlink:title="40401 - Disclosure - Property, plant and equipment (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="ifrs-full_FixturesAndFittingsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_FixturesAndFittingsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LaboratoryEquipmentMember" xlink:label="aciu_LaboratoryEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="aciu_LaboratoryEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="ifrs-full_LeaseholdImprovementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_LeaseholdImprovementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="ifrs-full_ConstructionInProgressMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_ConstructionInProgressMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AssetsUnderConstructionMember" xlink:label="aciu_AssetsUnderConstructionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="aciu_AssetsUnderConstructionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageIncreaseInPropertyPlantAndEquipment" xlink:label="aciu_PercentageIncreaseInPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="aciu_PercentageIncreaseInPropertyPlantAndEquipment" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_BuildingsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="ifrs-full_OfficeEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_OfficeEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="ifrs-full_AdditionsToRightofuseAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="ifrs-full_AdditionsToRightofuseAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RightOfUseLeasedAssetsAbstract" xlink:label="aciu_RightOfUseLeasedAssetsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="aciu_RightOfUseLeasedAssetsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_RightOfUseLeasedAssetsAbstract" xlink:to="ifrs-full_RightofuseAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_RightOfUseLeasedAssetsAbstract" xlink:to="ifrs-full_DepreciationRightofuseAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DispositionsOfRightOfUseAssets" xlink:label="aciu_DispositionsOfRightOfUseAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_RightOfUseLeasedAssetsAbstract" xlink:to="aciu_DispositionsOfRightOfUseAssets" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" xlink:type="extended" xlink:title="40503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:to="ifrs-full_MaturityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_NotLaterThanOneYearMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:label="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:to="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="ifrs-full_GrossLeaseLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:to="ifrs-full_GrossLeaseLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfDepositsInEscrowAccounts" xlink:label="aciu_NumberOfDepositsInEscrowAccounts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:to="aciu_NumberOfDepositsInEscrowAccounts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_EscrowDepositAmount" xlink:label="aciu_EscrowDepositAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:to="aciu_EscrowDepositAmount" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureAssetAcquisitionDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Asset acquisition (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AssetAcquisitionsAxis" xlink:label="aciu_AssetAcquisitionsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="aciu_AssetAcquisitionsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SignificantAssetAcquisitionsTotalDomain" xlink:label="aciu_SignificantAssetAcquisitionsTotalDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="aciu_AssetAcquisitionsAxis" xlink:to="aciu_SignificantAssetAcquisitionsTotalDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" xlink:label="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_SignificantAssetAcquisitionsTotalDomain" xlink:to="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" xlink:label="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="ifrs-full_UnobservableInputsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_UnobservableInputsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnobservableInputsMember" xlink:label="ifrs-full_UnobservableInputsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_UnobservableInputsAxis" xlink:to="ifrs-full_UnobservableInputsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DiscountRateMeasurementInputMember" xlink:label="ifrs-full_DiscountRateMeasurementInputMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_UnobservableInputsMember" xlink:to="ifrs-full_DiscountRateMeasurementInputMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SharesTransferredAsConsiderationInAssetAcquisition" xlink:label="aciu_SharesTransferredAsConsiderationInAssetAcquisition" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="aciu_SharesTransferredAsConsiderationInAssetAcquisition" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" xlink:label="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantUnobservableInputAssets" xlink:label="ifrs-full_SignificantUnobservableInputAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_SignificantUnobservableInputAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="aciu_CashAcquiredAsPartOfAssetAcquisition" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TotalAssetsAcquiredInAssetAcquisition" xlink:label="aciu_TotalAssetsAcquiredInAssetAcquisition" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="aciu_TotalAssetsAcquiredInAssetAcquisition" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureIntangibleAssetsDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Intangible assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_InProcessResearchAndDevelopmentIPRDAssetMember" xlink:label="aciu_InProcessResearchAndDevelopmentIPRDAssetMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="aciu_InProcessResearchAndDevelopmentIPRDAssetMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="ifrs-full_UnobservableInputsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_UnobservableInputsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnobservableInputsMember" xlink:label="ifrs-full_UnobservableInputsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_UnobservableInputsAxis" xlink:to="ifrs-full_UnobservableInputsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DiscountRateMeasurementInputMember" xlink:label="ifrs-full_DiscountRateMeasurementInputMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_UnobservableInputsMember" xlink:to="ifrs-full_DiscountRateMeasurementInputMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantUnobservableInputAssets" xlink:label="ifrs-full_SignificantUnobservableInputAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xlink:to="ifrs-full_SignificantUnobservableInputAssets" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAndCashEquivalentsTable" xlink:label="aciu_CashAndCashEquivalentsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="aciu_CashAndCashEquivalentsTable" xlink:to="srt_CurrencyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CurrencyAxis" xlink:to="currency_AllCurrenciesDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CHF" xlink:label="currency_CHF" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_CHF" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="currency_EUR" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_EUR" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="currency_USD" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_USD" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAndCashEquivalentLineItems" xlink:label="aciu_CashAndCashEquivalentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="aciu_CashAndCashEquivalentLineItems" xlink:to="aciu_CashAndCashEquivalentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAbstract" xlink:label="ifrs-full_CashAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_CashAndCashEquivalentLineItems" xlink:to="ifrs-full_CashAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CashAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_CashAbstract" xlink:to="ifrs-full_ClosingForeignExchangeRate" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Prepaid expenses and accrued income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PrepaidExpensesAndAccruedIncomeTable" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember" xlink:label="aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GrantsMichaelJFoxFoundationMember" xlink:label="aciu_GrantsMichaelJFoxFoundationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember" xlink:to="aciu_GrantsMichaelJFoxFoundationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PrepaidExpensesAndAccruedIncomeLineItems" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeLineItems" xlink:to="aciu_PrepaidExpensesAndAccruedIncomeTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeLineItems" xlink:to="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" xlink:to="ifrs-full_CurrentPrepaidExpenses" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" xlink:to="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfAccruedIncome" xlink:label="aciu_PercentageOfAccruedIncome" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" xlink:to="aciu_PercentageOfAccruedIncome" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" xlink:type="extended" xlink:title="41001 - Disclosure - Other current receivables (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfOtherCurrentReceivablesTable" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:to="ifrs-full_TradeAndOtherReceivablesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MiscellaneousOtherCurrentReceivables" xlink:label="aciu_MiscellaneousOtherCurrentReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="aciu_MiscellaneousOtherCurrentReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WithholdingTaxReceivables" xlink:label="aciu_WithholdingTaxReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="aciu_WithholdingTaxReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="ifrs-full_OtherCurrentReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_OtherCurrentReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MaturityPeriodOtherCurrentReceivables" xlink:label="aciu_MaturityPeriodOtherCurrentReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:to="aciu_MaturityPeriodOtherCurrentReceivables" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalNarrativesDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Share capital - Narratives (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_OrdinarySharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_IssuedCapital" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails" xlink:type="extended" xlink:title="41102 - Disclosure - Share capital - Capital Structure (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_IssuedCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharePremiumMember" xlink:label="ifrs-full_SharePremiumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_SharePremiumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_TreasurySharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_OrdinarySharesMember" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_TreasurySharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:label="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="ifrs-full_NumberOfSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:to="ifrs-full_NumberOfSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions" xlink:label="aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:to="aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:to="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xlink:label="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" xlink:label="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xlink:to="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ChangesInEquityAbstract" xlink:label="ifrs-full_ChangesInEquityAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_ChangesInEquityAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ChangesInEquityAbstract" xlink:to="ifrs-full_Equity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ChangesInEquityAbstract" xlink:to="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions" xlink:label="aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ChangesInEquityAbstract" xlink:to="aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ChangesInEquityAbstract" xlink:to="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" xlink:label="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_ChangesInEquityAbstract" xlink:to="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_ChangesInEquityAbstract" xlink:to="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_ParValuePerShare" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails" xlink:type="extended" xlink:title="41104 - Disclosure - Share capital - Conditional share capital for bonds and similar debt instruments (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember" xlink:label="aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConditionalShareCapitalAbstract" xlink:label="aciu_ConditionalShareCapitalAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_ConditionalShareCapitalAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" xlink:label="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" xlink:label="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="ifrs-full_ParValuePerShare" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" xlink:type="extended" xlink:title="41105 - Disclosure - Share capital - Conditional share capital for employee benefit plans (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" xlink:label="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConditionalShareCapitalAbstract" xlink:label="aciu_ConditionalShareCapitalAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_ConditionalShareCapitalAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" xlink:label="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" xlink:label="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="ifrs-full_ParValuePerShare" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails" xlink:type="extended" xlink:title="41106 - Disclosure - Share capital - Shelf registration statement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" xlink:label="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails" xlink:type="extended" xlink:title="41107 - Disclosure - Share capital - At the market equity offering (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AtTheMarketEquityOfferingMember" xlink:label="aciu_AtTheMarketEquityOfferingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="aciu_AtTheMarketEquityOfferingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SecondOpenMarketSalesAgreementMember" xlink:label="aciu_SecondOpenMarketSalesAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="aciu_SecondOpenMarketSalesAgreementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AtTheMarketEquityOfferingAbstract" xlink:label="aciu_AtTheMarketEquityOfferingAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_AtTheMarketEquityOfferingAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="ifrs-full_NumberOfSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="ifrs-full_ParValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" xlink:label="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SaleOrIssueOfTreasurySharesShares" xlink:label="aciu_SaleOrIssueOfTreasurySharesShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="aciu_SaleOrIssueOfTreasurySharesShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xlink:label="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CommissionsPaidForIssuanceOrdinaryShares" xlink:label="aciu_CommissionsPaidForIssuanceOrdinaryShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="aciu_CommissionsPaidForIssuanceOrdinaryShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="ifrs-full_ShareIssueRelatedCost" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails" xlink:type="extended" xlink:title="41108 - Disclosure - Share capital - Convertible note agreement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConvertibleNoteAgreementMember" xlink:label="aciu_ConvertibleNoteAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="aciu_ConvertibleNoteAgreementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="srt_StatementScenarioAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IfNotesAreConvertedMember" xlink:label="aciu_IfNotesAreConvertedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="aciu_IfNotesAreConvertedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis" xlink:label="ifrs-full_CounterpartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_CounterpartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember" xlink:label="ifrs-full_CounterpartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AthosServiceGmbHMember" xlink:label="aciu_AthosServiceGmbHMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CounterpartiesMember" xlink:to="aciu_AthosServiceGmbHMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FirstCapitalPartnerGmbHMember" xlink:label="aciu_FirstCapitalPartnerGmbHMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_CounterpartiesMember" xlink:to="aciu_FirstCapitalPartnerGmbHMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConvertibleNoteAgreementAbstract" xlink:label="aciu_ConvertibleNoteAgreementAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_ConvertibleNoteAgreementAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfConvertibleNoteAgreements" xlink:label="aciu_NumberOfConvertibleNoteAgreements" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_NumberOfConvertibleNoteAgreements" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AggregatePrincipalAmountOfEachConvertibleNote" xlink:label="aciu_AggregatePrincipalAmountOfEachConvertibleNote" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_AggregatePrincipalAmountOfEachConvertibleNote" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" xlink:label="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromIssueOfConvertibleDebt" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_ProceedsFromIssueOfConvertibleDebt" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" xlink:label="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" xlink:type="extended" xlink:title="41201 - Disclosure - Trade and other payables and accrued expenses (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable" xlink:label="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" xlink:label="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" xlink:to="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CurrentAccruedResearchAndDevelopmentCosts" xlink:label="aciu_CurrentAccruedResearchAndDevelopmentCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" xlink:to="aciu_CurrentAccruedResearchAndDevelopmentCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OtherAccruedExpenses" xlink:label="aciu_OtherAccruedExpenses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" xlink:to="aciu_OtherAccruedExpenses" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AccrualsForPerformanceRelatedRemuneration" xlink:label="aciu_AccrualsForPerformanceRelatedRemuneration" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" xlink:to="aciu_AccrualsForPerformanceRelatedRemuneration" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AccruedStampDuty" xlink:label="aciu_AccruedStampDuty" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" xlink:to="aciu_AccruedStampDuty" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" xlink:type="extended" xlink:title="41301 - Disclosure - Contract revenues, Contract Revenue Attributable to Licensing Arrangements (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementWithLillyMember" xlink:label="aciu_CollaborationAgreementWithLillyMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_CollaborationAgreementWithLillyMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2012GenentechMember" xlink:label="aciu_CollaborationAgreementOf2012GenentechMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_CollaborationAgreementOf2012GenentechMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ContractRevenueAbstract" xlink:label="aciu_ContractRevenueAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="aciu_ContractRevenueAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ContractRevenueAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="ifrs-full_PercentageOfEntitysRevenue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ContractRevenueAbstract" xlink:to="ifrs-full_PercentageOfEntitysRevenue" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails" xlink:type="extended" xlink:title="41302 - Disclosure - Contract revenues and other operating income - Licensing and collaboration agreement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xlink:label="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" xlink:type="extended" xlink:title="41303 - Disclosure - Contract revenues, Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_ProductsAndServicesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TauMorphomerSmallMoleculeMember" xlink:label="aciu_TauMorphomerSmallMoleculeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="aciu_TauMorphomerSmallMoleculeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementWithLillyMember" xlink:label="aciu_CollaborationAgreementWithLillyMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_CollaborationAgreementWithLillyMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementWithLillyFirstAmendmentMember" xlink:label="aciu_CollaborationAgreementWithLillyFirstAmendmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CollaborationAgreementWithLillyMember" xlink:to="aciu_CollaborationAgreementWithLillyFirstAmendmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementWithLillySecondAmendmentMember" xlink:label="aciu_CollaborationAgreementWithLillySecondAmendmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_CollaborationAgreementWithLillyMember" xlink:to="aciu_CollaborationAgreementWithLillySecondAmendmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="ifrs-full_PerformanceObligationsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_PerformanceObligationsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="ifrs-full_PerformanceObligationsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_PerformanceObligationsAxis" xlink:to="ifrs-full_PerformanceObligationsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" xlink:label="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MilestonePaymentsCommercialMember" xlink:label="aciu_MilestonePaymentsCommercialMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="aciu_MilestonePaymentsCommercialMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ResearchAndDevelopmentMember" xlink:label="aciu_ResearchAndDevelopmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="aciu_ResearchAndDevelopmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RightOfUseLicenseMember" xlink:label="aciu_RightOfUseLicenseMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="aciu_RightOfUseLicenseMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_MaturityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Quarter32019Member" xlink:label="aciu_Quarter32019Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_Quarter32019Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_March312020Member" xlink:label="aciu_March312020Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_March312020Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" xlink:label="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementPotentialValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" xlink:label="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_ReceivablesFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities" xlink:label="ifrs-full_ContractLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_ContractLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" xlink:label="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractAssets" xlink:label="ifrs-full_ContractAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_ContractAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails" xlink:type="extended" xlink:title="41304 - Disclosure - Contract revenues, Anti-Abeta Antibody in AD - 2006 Agreement with Genentech (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_ProductsAndServicesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AntiAbetaAntibodyInADMember" xlink:label="aciu_AntiAbetaAntibodyInADMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="aciu_AntiAbetaAntibodyInADMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2006GenentechMember" xlink:label="aciu_CollaborationAgreementOf2006GenentechMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_CollaborationAgreementOf2006GenentechMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="ifrs-full_PerformanceObligationsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_PerformanceObligationsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="ifrs-full_PerformanceObligationsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_PerformanceObligationsAxis" xlink:to="ifrs-full_PerformanceObligationsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ClinicalMilestonesAchievedPriorTo1January2017Member" xlink:label="aciu_ClinicalMilestonesAchievedPriorTo1January2017Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="aciu_ClinicalMilestonesAchievedPriorTo1January2017Member" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementPotentialValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementCumulativePaymentsReceived" xlink:label="aciu_CollaborativeAgreementCumulativePaymentsReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementCumulativePaymentsReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities" xlink:label="ifrs-full_ContractLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_ContractLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfMilestonePaymentsReceived" xlink:label="aciu_NumberOfMilestonePaymentsReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_NumberOfMilestonePaymentsReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementUpfrontPaymentsReceived" xlink:label="aciu_CollaborativeAgreementUpfrontPaymentsReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementUpfrontPaymentsReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails" xlink:type="extended" xlink:title="41305 - Disclosure - Contract revenues, Anti-Tau Antibody in AD - 2012 Agreement with Genentech (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_ProductsAndServicesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AntiTauAntibodyInADMember" xlink:label="aciu_AntiTauAntibodyInADMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="aciu_AntiTauAntibodyInADMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2012GenentechMember" xlink:label="aciu_CollaborationAgreementOf2012GenentechMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_CollaborationAgreementOf2012GenentechMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementPotentialValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementCumulativePaymentsReceived" xlink:label="aciu_CollaborativeAgreementCumulativePaymentsReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementCumulativePaymentsReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities" xlink:label="ifrs-full_ContractLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_ContractLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfMilestonePaymentsReceived" xlink:label="aciu_NumberOfMilestonePaymentsReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_NumberOfMilestonePaymentsReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" xlink:type="extended" xlink:title="41306 - Disclosure - Contract revenues, Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_ProductsAndServicesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TauVaccineInADMember" xlink:label="aciu_TauVaccineInADMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="aciu_TauVaccineInADMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementPotentialValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementCumulativePaymentsReceived" xlink:label="aciu_CollaborativeAgreementCumulativePaymentsReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementCumulativePaymentsReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities" xlink:label="ifrs-full_ContractLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_ContractLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementUpfrontPaymentsReceived" xlink:label="aciu_CollaborativeAgreementUpfrontPaymentsReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementUpfrontPaymentsReceived" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" xlink:type="extended" xlink:title="41307 - Disclosure - Contract revenues, Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_ProductsAndServicesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TauPETImagingAgentMember" xlink:label="aciu_TauPETImagingAgentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="aciu_TauPETImagingAgentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="ifrs-full_PerformanceObligationsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_PerformanceObligationsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="ifrs-full_PerformanceObligationsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_PerformanceObligationsAxis" xlink:to="ifrs-full_PerformanceObligationsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ClinicalMilestonesMember" xlink:label="aciu_ClinicalMilestonesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="aciu_ClinicalMilestonesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RegulatoryAndSalesBasedMilestonesMember" xlink:label="aciu_RegulatoryAndSalesBasedMilestonesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="aciu_RegulatoryAndSalesBasedMilestonesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementPotentialValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementCumulativePaymentsReceived" xlink:label="aciu_CollaborativeAgreementCumulativePaymentsReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementCumulativePaymentsReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" xlink:type="extended" xlink:title="41308 - Disclosure - Contract revenues - Grants from the Michael J. Fox Foundation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GrantRevenueMember" xlink:label="aciu_GrantRevenueMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_GrantRevenueMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GrantsMichaelJFoxFoundationMember" xlink:label="aciu_GrantsMichaelJFoxFoundationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_GrantRevenueMember" xlink:to="aciu_GrantsMichaelJFoxFoundationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis" xlink:label="ifrs-full_CounterpartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_CounterpartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember" xlink:label="ifrs-full_CounterpartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SkaneUniversityHospitalMember" xlink:label="aciu_SkaneUniversityHospitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CounterpartiesMember" xlink:to="aciu_SkaneUniversityHospitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_ProductsAndServicesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" xlink:label="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AdvanceSmallMoleculePdProgramsMember" xlink:label="aciu_AdvanceSmallMoleculePdProgramsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="aciu_AdvanceSmallMoleculePdProgramsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="dei_LegalEntityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="dei_EntityDomain" xlink:to="aciu_SkaneUniversityHospitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" xlink:label="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FollowOnGrantFundingReceived" xlink:label="aciu_FollowOnGrantFundingReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_FollowOnGrantFundingReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfGrants" xlink:label="aciu_NumberOfGrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_NumberOfGrants" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementPotentialValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_ReceivablesFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementJointResearchCollaborationPeriod" xlink:label="aciu_CollaborativeAgreementJointResearchCollaborationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementJointResearchCollaborationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="ifrs-full_OtherOperatingIncomeExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_OtherOperatingIncomeExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureExpensesByCategoryDetails" xlink:type="extended" xlink:title="41401 - Disclosure - Expenses by category (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LineItemsByFunctionMember" xlink:label="ifrs-full_LineItemsByFunctionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="ifrs-full_LineItemsByFunctionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ResearchAndDevelopmentExpensesMember" xlink:label="aciu_ResearchAndDevelopmentExpensesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_LineItemsByFunctionMember" xlink:to="aciu_ResearchAndDevelopmentExpensesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_LineItemsByFunctionMember" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="ifrs-full_OperatingExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_OperatingExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseByNature" xlink:label="ifrs-full_ExpenseByNature" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_ExpenseByNature" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AverageNumberOfEmployees" xlink:label="ifrs-full_AverageNumberOfEmployees" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_AverageNumberOfEmployees" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_GeneralAndAdministrativeExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FinancialResultNetAbstract" xlink:label="aciu_FinancialResultNetAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="aciu_FinancialResultNetAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_FinancialResultNetAbstract" xlink:to="ifrs-full_FinanceIncome" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_FinancialResultNetAbstract" xlink:to="ifrs-full_FinanceCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_FinancialResultNetAbstract" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_FinancialResultNetAbstract" xlink:to="ifrs-full_FinanceIncomeCost" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes" xlink:label="aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_FinancialResultNetAbstract" xlink:to="aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" xlink:type="extended" xlink:title="41601 - Disclosure - Income taxes - Summary of Income Tax Expense (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageMember" xlink:label="ifrs-full_WeightedAverageMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_WeightedAverageMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_GeographicalAreasAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH" xlink:label="country_CH" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_CH" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeferredTaxAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="ifrs-full_DeferredTaxLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeferredTaxLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="ifrs-full_ApplicableTaxRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_ApplicableTaxRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccountingProfit" xlink:label="ifrs-full_AccountingProfit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_AccountingProfit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="ifrs-full_TaxEffectOfTaxLosses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_TaxEffectOfTaxLosses" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" xlink:type="extended" xlink:title="41602 - Disclosure - Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesMember" xlink:label="ifrs-full_UnusedTaxLossesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="ifrs-full_UnusedTaxLossesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" xlink:label="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RetirementBenefitPlanMember" xlink:label="aciu_RetirementBenefitPlanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="aciu_RetirementBenefitPlanMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_MaturityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312024Member" xlink:label="aciu_December312024Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_December312024Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312025Member" xlink:label="aciu_December312025Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_December312025Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312026Member" xlink:label="aciu_December312026Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_December312026Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312027Member" xlink:label="aciu_December312027Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_December312027Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312028Member" xlink:label="aciu_December312028Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_December312028Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312029Member" xlink:label="aciu_December312029Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_December312029Member" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:to="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TaxLossesSplitByExpiryDateAbstract" xlink:label="aciu_TaxLossesSplitByExpiryDateAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="aciu_TaxLossesSplitByExpiryDateAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_TaxLossesSplitByExpiryDateAbstract" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" xlink:label="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_TaxLossesSplitByExpiryDateAbstract" xlink:to="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" xlink:type="extended" xlink:title="41701 - Disclosure - Retirement benefit plan - Summary of Benefit Plan (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:label="ifrs-full_PresentValueOfDefinedBenefitObligationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:to="ifrs-full_PresentValueOfDefinedBenefitObligationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SurplusDeficitInPlanAbstract" xlink:label="ifrs-full_SurplusDeficitInPlanAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="ifrs-full_SurplusDeficitInPlanAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SurplusDeficitInPlanAbstract" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="ifrs-full_PlanAssetsAtFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_SurplusDeficitInPlanAbstract" xlink:to="ifrs-full_PlanAssetsAtFairValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SurplusDeficitInPlan" xlink:label="ifrs-full_SurplusDeficitInPlan" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_SurplusDeficitInPlanAbstract" xlink:to="ifrs-full_SurplusDeficitInPlan" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" xlink:type="extended" xlink:title="41703 - Disclosure - Retirement benefit plan, Changes in Defined Benefit Obligation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:label="ifrs-full_PresentValueOfDefinedBenefitObligationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:to="ifrs-full_PresentValueOfDefinedBenefitObligationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" xlink:type="extended" xlink:title="41704 - Disclosure - Retirement benefit plan, Changes in Fair Value of Plan Assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsMember" xlink:label="ifrs-full_PlanAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:to="ifrs-full_PlanAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:label="aciu_ChangesInFairValueOfPlanAssetsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="aciu_ChangesInFairValueOfPlanAssetsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:label="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" xlink:type="extended" xlink:title="41707 - Disclosure - Retirement benefit plan, Actuarial Assumptions and Sensitivity Analysis (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="ifrs-full_ActuarialAssumptionsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="ifrs-full_ActuarialAssumptionsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsMember" xlink:label="ifrs-full_ActuarialAssumptionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ActuarialAssumptionsAxis" xlink:to="ifrs-full_ActuarialAssumptionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRatesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ActuarialAssumptionsMember" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRatesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ActuarialAssumptionsMember" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ActuarialAssumptionsMember" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ActuarialAssumptionsMember" xlink:to="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="ifrs-full_TypesOfRisksAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" xlink:label="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRates" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:to="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:label="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:to="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:to="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails" xlink:type="extended" xlink:title="41801 - Disclosure - Share-based compensation, Plans Outstanding (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_StockOptionPlanC1Member" xlink:label="aciu_StockOptionPlanC1Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="aciu_StockOptionPlanC1Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Two016ShareOptionAndIncentivePlanMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_EmployeesMember" xlink:label="aciu_EmployeesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="aciu_EmployeesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ShareBasedPlansOutstandingAbstract" xlink:label="aciu_ShareBasedPlansOutstandingAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aciu_ShareBasedPlansOutstandingAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ShareBasedPlansOutstandingAbstract" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ShareBasedPlansOutstandingAbstract" xlink:to="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" xlink:label="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ShareBasedPlansOutstandingAbstract" xlink:to="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" xlink:type="extended" xlink:title="41803 - Disclosure - Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Chf0.15Member" xlink:label="aciu_Chf0.15Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="aciu_Chf0.15Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Chf9.53Member" xlink:label="aciu_Chf9.53Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="aciu_Chf9.53Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Usd5.04ToUsd12.30Member" xlink:label="aciu_Usd5.04ToUsd12.30Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="aciu_Usd5.04ToUsd12.30Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Usd2.76ToUsd4.57Member" xlink:label="aciu_Usd2.76ToUsd4.57Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="aciu_Usd2.76ToUsd4.57Member" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:label="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:to="ifrs-full_NumberOfOutstandingShareOptions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" xlink:type="extended" xlink:title="41804 - Disclosure - Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageAssumptionsAbstract" xlink:label="aciu_WeightedAverageAssumptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="aciu_WeightedAverageAssumptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails" xlink:type="extended" xlink:title="41805 - Disclosure - Share-based compensation, Non-vested Share Awards (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RestrictedSharesAndRestrictedShareUnitsMember" xlink:label="aciu_RestrictedSharesAndRestrictedShareUnitsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="aciu_RestrictedSharesAndRestrictedShareUnitsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RestrictedStockUnitsMember" xlink:label="aciu_RestrictedStockUnitsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="aciu_RestrictedStockUnitsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RestrictedStockUnitsFirstVestingConditionsMember" xlink:label="aciu_RestrictedStockUnitsFirstVestingConditionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_RestrictedStockUnitsMember" xlink:to="aciu_RestrictedStockUnitsFirstVestingConditionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RestrictedStockUnitsSecondVestingConditionsMember" xlink:label="aciu_RestrictedStockUnitsSecondVestingConditionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_RestrictedStockUnitsMember" xlink:to="aciu_RestrictedStockUnitsSecondVestingConditionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_BoardOfDirectorsMember" xlink:label="aciu_BoardOfDirectorsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="aciu_BoardOfDirectorsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ExecutiveManagementMember" xlink:label="aciu_ExecutiveManagementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="aciu_ExecutiveManagementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ShareBasedPaymentArrangementAbstract" xlink:label="aciu_ShareBasedPaymentArrangementAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aciu_ShareBasedPaymentArrangementAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ShareBasedPaymentArrangementAbstract" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ShareBasedPaymentArrangementAbstract" xlink:to="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" xlink:label="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ShareBasedPaymentArrangementAbstract" xlink:to="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfNonVestedSharesAbstract" xlink:label="aciu_NumberOfNonVestedSharesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aciu_NumberOfNonVestedSharesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_NumberOfNonVestedSharesAbstract" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_NumberOfNonVestedSharesAbstract" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_NumberOfNonVestedSharesAbstract" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" xlink:label="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_NumberOfNonVestedSharesAbstract" xlink:to="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_NumberOfNonVestedSharesAbstract" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_NumberOfNonVestedSharesAbstract" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageExercisePriceAbstract" xlink:label="aciu_WeightedAverageExercisePriceAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aciu_WeightedAverageExercisePriceAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails" xlink:type="extended" xlink:title="41901 - Disclosure - Commitments and contingencies (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" xlink:to="ifrs-full_MaturityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_NotLaterThanOneYearMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanFiveYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xlink:to="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CommitmentsAbstract" xlink:label="aciu_CommitmentsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xlink:to="aciu_CommitmentsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ContractualCapitalCommitmentsOtherThanForLeases" xlink:label="aciu_ContractualCapitalCommitmentsOtherThanForLeases" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CommitmentsAbstract" xlink:to="aciu_ContractualCapitalCommitmentsOtherThanForLeases" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RentalContractPeriodForNoticeOfCancellation" xlink:label="aciu_RentalContractPeriodForNoticeOfCancellation" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_CommitmentsAbstract" xlink:to="aciu_RentalContractPeriodForNoticeOfCancellation" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractualCapitalCommitments" xlink:label="ifrs-full_ContractualCapitalCommitments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_CommitmentsAbstract" xlink:to="ifrs-full_ContractualCapitalCommitments" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails" xlink:type="extended" xlink:title="42101 - Disclosure - Financial instruments and risk management (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="ifrs-full_TypesOfRisksAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="ifrs-full_CurrencyRiskMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_CurrencyRiskMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CreditRiskMember" xlink:label="ifrs-full_CreditRiskMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_CreditRiskMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiquidityRiskMember" xlink:label="ifrs-full_LiquidityRiskMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_LiquidityRiskMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateRiskMember" xlink:label="ifrs-full_InterestRateRiskMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_InterestRateRiskMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="ifrs-full_FinancialAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_FinancialAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RightOfUseFinancialAssetsMember" xlink:label="aciu_RightOfUseFinancialAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="aciu_RightOfUseFinancialAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LongTermFinancialAssetsMember" xlink:label="aciu_LongTermFinancialAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="aciu_LongTermFinancialAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OtherCurrentReceivablesMember" xlink:label="aciu_OtherCurrentReceivablesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="aciu_OtherCurrentReceivablesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ShortTermFinancialAssetsMember" xlink:label="aciu_ShortTermFinancialAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="aciu_ShortTermFinancialAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashOnHandAndCashEquivalentsMember" xlink:label="aciu_CashOnHandAndCashEquivalentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="aciu_CashOnHandAndCashEquivalentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="ifrs-full_FinancialLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_FinancialLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LongTermLeaseLiabilitiesMember" xlink:label="aciu_LongTermLeaseLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="aciu_LongTermLeaseLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TradeAndOtherPayablesMember" xlink:label="aciu_TradeAndOtherPayablesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="aciu_TradeAndOtherPayablesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AccruedExpensesMember" xlink:label="aciu_AccruedExpensesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="aciu_AccruedExpensesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ShortTermLeaseLiabilitiesMember" xlink:label="aciu_ShortTermLeaseLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="aciu_ShortTermLeaseLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FinancialAssetsAndLiabilitiesAbstract" xlink:label="aciu_FinancialAssetsAndLiabilitiesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="aciu_FinancialAssetsAndLiabilitiesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets" xlink:label="ifrs-full_FinancialAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_FinancialAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_FinancialAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_FinancialAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_FinancialLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FinancialRisksAbstract" xlink:label="aciu_FinancialRisksAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="aciu_FinancialRisksAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_FinancialRisksAbstract" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:label="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates" xlink:label="aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" xlink:label="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LiquidityManagementRollingForecastPeriod" xlink:label="aciu_LiquidityManagementRollingForecastPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_LiquidityManagementRollingForecastPeriod" priority="1" use="optional" />
  </definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>56
<FILENAME>aciu-20221231_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.2.0.4 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/15/2023 5:39:21 PM-->
<!--Modified on: 3/15/2023 5:39:21 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cover [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Addresses [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Addresses, Address Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AddressTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Address Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Contact [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Addresses [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Registration Statement</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Period Focus</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Year Focus</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Fiscal Year End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Annual Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Transition Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Shell Company Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Country</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contact Personnel Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Common Stock, Shares Outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Well-known Seasoned Issuer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Voluntary Filers</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Current Reporting Status</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Interactive Data Current</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Filer Category</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ICFR Auditor Attestation Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Accounting Standard</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Shell Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Firm ID</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Location</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condensed Consolidated Balance Sheets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAbstract" xlink:to="ifrs-full_AssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ASSETS</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment, end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment, beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance, end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance, beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible asset</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:to="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current restricted cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term financial assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total non-current assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="ifrs-full_CurrentAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaidExpenses" xlink:to="ifrs-full_CurrentPrepaidExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepaidExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentPrepaidExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current accrued income including current contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="ifrs-full_OtherCurrentReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentReceivables" xlink:to="ifrs-full_OtherCurrentReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total other current receivables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:to="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term deposits, not classified as cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term financial assets due in one year or less</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents at end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Company's cash position</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total current assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="ifrs-full_Assets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract" xlink:to="ifrs-full_EquityAndLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SHAREHOLDERS' EQUITY AND LIABILITIES</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shareholders' equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued share capital</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharePremium" xlink:label="ifrs-full_SharePremium" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremium" xlink:to="ifrs-full_SharePremium_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharePremium_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share premium</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasuryShares" xlink:label="ifrs-full_TreasuryShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasuryShares" xlink:to="ifrs-full_TreasuryShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TreasuryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TreasuryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reserve of exchange differences on translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency translation differences</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated losses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance, end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance, beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total shareholders' equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term lease liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:to="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current provisions for employee benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net employee defined benefit liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total non-current liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other current payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other payables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current accrued expenses and other current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current deferred income including current contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term lease liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total current liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Liabilities" xlink:label="ifrs-full_Liabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="ifrs-full_EquityAndLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAndLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAndLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total shareholders' equity and liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="ifrs-full_IncomeStatementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeStatementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeStatementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condensed Consolidated Statements of Income/(Loss)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueAbstract" xlink:label="ifrs-full_RevenueAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueAbstract" xlink:to="ifrs-full_RevenueAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from contracts with customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total contract revenues</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Revenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Revenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total revenue</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ExpensesOperatingAbstract" xlink:label="aciu_ExpensesOperatingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ExpensesOperatingAbstract" xlink:to="aciu_ExpensesOperatingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ExpensesOperatingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expenses, Operating [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ExpensesOperatingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research &amp; development expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeneralAndAdministrativeExpense" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General &amp; administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and administrative expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherOperatingIncomeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other operating income (expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income from grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other operating income/(expense), net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="ifrs-full_OperatingExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OperatingExpense" xlink:to="ifrs-full_OperatingExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OperatingExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="ifrs-full_OperatingExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OperatingExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Profit (loss) from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating loss</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncome" xlink:to="ifrs-full_FinanceIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinanceIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_FinanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exchange differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign exchange gains (losses)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncomeCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance income (cost)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinanceIncomeCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance result, net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income/(loss) before income tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss before tax</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective income tax rate (benefit)/expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net income/(loss) for the period</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="ifrs-full_EarningsPerShareAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss per share:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="ifrs-full_BasicEarningsLossPerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic loss per share for the period attributable to equity holders</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Diluted loss per share for the period attributable to equity holders</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_StatementOfComprehensiveIncomeAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condensed Consolidated Statements of Comprehensive Income/(Loss)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Items that may be reclassified to income or loss in subsequent periods (net of tax):</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income, net of tax, exchange differences on translation of foreign operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency translation differences</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Items that will not to be reclassified to income or loss in subsequent periods (net of tax):</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Remeasurement gains on defined-benefit plans (net of tax)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total other comprehensive gain</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income/(loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total comprehensive loss, net of tax</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="ifrs-full_StatementOfChangesInEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityAbstract" xlink:to="ifrs-full_StatementOfChangesInEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condensed Consolidated Statements of Changes in Equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement of changes in equity [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Components of equity [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_EquityMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued capital [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharePremiumMember" xlink:label="ifrs-full_SharePremiumMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremiumMember" xlink:to="ifrs-full_SharePremiumMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharePremiumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Premium [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharePremiumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share premium</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasurySharesMember" xlink:to="ifrs-full_TreasurySharesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TreasurySharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TreasurySharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="ifrs-full_RetainedEarningsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarningsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained earnings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarningsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated losses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reserve of exchange differences on translation [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency Translation Differences</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement of changes in equity [line items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through share-based payment transactions, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payments</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:to="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) in equity from sale or issue of treasury shares net of underwriting fees and transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale or issue of treasury shares net of underwriting fees and transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssuedAbstract" xlink:label="ifrs-full_NumberOfSharesIssuedAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="ifrs-full_NumberOfSharesIssuedAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssuedAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" xlink:label="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" xlink:to="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) in equity resulting from purchase of IPR&amp;D assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through purchase of in process research and development asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPR&amp;D asset purchase</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" xlink:label="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" xlink:to="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">'The increase (decrease) in equity resulting from the issuance of shares as part of an asset acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through acquisition of assets, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset acquisition - common shares</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:to="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through conversion of convertible instruments, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conversion note agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conversion of note agreements, net of transaction costs</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:to="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through treasury share transactions, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares to be held as treasury shares, net of transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Held as treasury shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IssueOfEquityRestrictedShareAwards" xlink:label="aciu_IssueOfEquityRestrictedShareAwards" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IssueOfEquityRestrictedShareAwards" xlink:to="aciu_IssueOfEquityRestrictedShareAwards_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IssueOfEquityRestrictedShareAwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase in equity through the issue of restricted share awards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IssueOfEquityRestrictedShareAwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issue of Equity, Restricted Share Awards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IssueOfEquityRestrictedShareAwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted share awards</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through exercise of options, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise of options</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_StatementOfCashFlowsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Condensed Consolidated Statements of Cash Flows</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) operating activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to reconcile profit (loss) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to reconcile net loss for the period to net cash flows:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for depreciation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation of property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets" xlink:label="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets" xlink:to="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for depreciation expense for right-of-use assets to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for depreciation expense, right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation of right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="ifrs-full_AdjustmentsForFinanceIncomeCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:to="ifrs-full_AdjustmentsForFinanceIncomeCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForFinanceIncomeCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for finance income (cost)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForFinanceIncomeCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance (income)/expense, net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for increase (decrease) in employee benefit liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in net employee defined benefit liability</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="ifrs-full_AdjustmentsForInterestExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForInterestExpense" xlink:to="ifrs-full_AdjustmentsForInterestExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForInterestExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for interest expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForInterestExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for gain (loss) on disposals, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Gain)/loss on sale of fixed assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ChangesInWorkingCapitalAbstract" xlink:label="aciu_ChangesInWorkingCapitalAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ChangesInWorkingCapitalAbstract" xlink:to="aciu_ChangesInWorkingCapitalAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ChangesInWorkingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in working capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ChangesInWorkingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in working capital:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for decrease (increase) in prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Increase)/decrease in prepaid expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for decrease (increase) in accrued income including contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease/(increase) in accrued income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for decrease (increase) in other operating receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease/(increase) in other current receivables</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses" xlink:label="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses" xlink:to="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for increase (decrease) in accrued expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for increase (decrease) in accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Decrease)/increase in accrued expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for increase (decrease) in deferred income including contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Decrease)/increase in deferred income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for increase (decrease) in trade accounts payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Decrease)/increase in trade and other payables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperations" xlink:label="ifrs-full_CashFlowsFromUsedInOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperations" xlink:to="ifrs-full_CashFlowsFromUsedInOperations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash used in operating activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:to="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest received, classified as operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest received</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="ifrs-full_InterestPaidClassifiedAsOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestPaidClassifiedAsOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest paid, classified as operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestPaidClassifiedAsOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest paid</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:label="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:to="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance costs paid, classified as operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance expenses paid</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash flows used in operating activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) investing activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investing activities</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" xlink:label="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" xlink:to="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments (proceeds) from purchases (sales) of short-term financial assets, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments (proceeds) from purchases (sales) of short-term financial assets, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term financial assets, net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchase of property, plant and equipment, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchases of property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sales of property, plant and equipment, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAdvancesForRentDeposit" xlink:label="aciu_CashAdvancesForRentDeposit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CashAdvancesForRentDeposit" xlink:to="aciu_CashAdvancesForRentDeposit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CashAdvancesForRentDeposit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash outflow or inflow for deposit of rent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CashAdvancesForRentDeposit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Advances for Rent Deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_CashAdvancesForRentDeposit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rental deposits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash flows provided by/(used in) investing activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) financing activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financing activities</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromIssueOfConvertibleDebt" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ProceedsFromIssueOfConvertibleDebt" xlink:to="aciu_ProceedsFromIssueOfConvertibleDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash inflow from the issuing of convertible debt.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issue of convertible debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of convertible loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net proceeds</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="ifrs-full_PaymentsForShareIssueCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsForShareIssueCosts" xlink:to="ifrs-full_PaymentsForShareIssueCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsForShareIssueCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsForShareIssueCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs on issuance of shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" xlink:to="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:to="aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issue of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of common shares - asset acquisition, net of transaction costs</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfOptions" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of common shares - option plan, net of transaction costs</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments of lease liabilities, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Principal payments of lease obligations</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" xlink:label="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" xlink:to="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for share issue costs associated with issuance of shares in relation to asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for share issue costs associated with issuance of shares in relation to asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs associated with issuance of shares in relation to asset acquisition previously recorded in Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfCurrentBorrowings" xlink:label="ifrs-full_RepaymentsOfCurrentBorrowings" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfCurrentBorrowings" xlink:to="ifrs-full_RepaymentsOfCurrentBorrowings_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepaymentsOfCurrentBorrowings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayments of current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RepaymentsOfCurrentBorrowings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayment of short-term financing obligation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:label="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:to="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to acquire or redeem entity's shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payment for the issuance of treasury shares</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash flows (used in)/provided by financing activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in cash and cash equivalents before effect of exchange rate changes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net decrease in cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of exchange rate changes on cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exchange gain on cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SupplementalNonCashActivityAbstract" xlink:label="aciu_SupplementalNonCashActivityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SupplementalNonCashActivityAbstract" xlink:to="aciu_SupplementalNonCashActivityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SupplementalNonCashActivityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supplemental non-cash activity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_SupplementalNonCashActivityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supplemental non-cash activity</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" xlink:label="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" xlink:to="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of property plant and equipment acquired through noncash investing activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchase of property, plant and equipment, classified as noncash investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital expenditures in Trade and other payables or Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" xlink:label="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" xlink:to="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The Issuance of shares for purchase of IPR&amp;D asset in asset acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares for purchase of IPR&amp;D asset in asset acquisition</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareIssueRelatedCost" xlink:to="ifrs-full_ShareIssueRelatedCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share issue related cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs associated with issuance of shares in relation to the asset acquisition recorded in Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RepaymentOfConvertibleDebtEquitySettlementAmount" xlink:label="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount" xlink:to="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The gross value of the settlement of convertible debt that is settled via shares of entity's common shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayment of convertible debt, Equity Settlement, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Settlement of convertible notes recorded within Shareholders' equity</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GeneralInformationAbstract" xlink:label="aciu_GeneralInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_GeneralInformationAbstract" xlink:to="aciu_GeneralInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_GeneralInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General information</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" xlink:label="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" xlink:to="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The entire disclosure for general information about the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of general information about the entity explanatory [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General information</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_BasisOfPreparationAbstract" xlink:label="aciu_BasisOfPreparationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_BasisOfPreparationAbstract" xlink:to="aciu_BasisOfPreparationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_BasisOfPreparationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of preparation and changes to the Company' accounting policies</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of basis of preparation of financial statements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of preparation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of significant accounting policies</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of significant accounting policies [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of significant accounting policies</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_PresentationOfLeasesForLesseeAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets, long-term financial assets and lease liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfLeasesExplanatory" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of leases [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets, long-term financial assets and lease liabilities</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AssetAcquisitionsAbstract" xlink:label="aciu_AssetAcquisitionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AssetAcquisitionsAbstract" xlink:to="aciu_AssetAcquisitionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AssetAcquisitionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AssetAcquisitionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset acquisition</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfAssetAcquisitionsTextBlock" xlink:label="aciu_DisclosureOfAssetAcquisitionsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfAssetAcquisitionsTextBlock" xlink:to="aciu_DisclosureOfAssetAcquisitionsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfAssetAcquisitionsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The entire disclosure for asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfAssetAcquisitionsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of asset acquisitions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfAssetAcquisitionsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset acquisition</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="ifrs-full_DisclosureOfFinancialAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents and financial assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" xlink:label="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" xlink:to="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of cash and cash equivalents and short-term deposits not classified as cash equivalents.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of cash and cash equivalents and short-term deposits not classified as cash equivalents [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents and short-term financial assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:to="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and accrued income</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" xlink:label="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" xlink:to="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of prepaid expenses and accrued income including contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of prepaid expenses and accrued income including contract assets [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and accrued income</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OtherCurrentReceivablesAbstract" xlink:label="aciu_OtherCurrentReceivablesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OtherCurrentReceivablesAbstract" xlink:to="aciu_OtherCurrentReceivablesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OtherCurrentReceivablesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfOtherCurrentReceivablesTextBlock" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesTextBlock" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of other current receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of other current receivables [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of share capital, reserves and other equity interest [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" xlink:label="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" xlink:to="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of trade and other payables and accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of trade and other payables and accrued expenses [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other payables and accrued expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of revenue [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract revenues</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ExpensesByCategoryAbstract" xlink:label="aciu_ExpensesByCategoryAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ExpensesByCategoryAbstract" xlink:to="aciu_ExpensesByCategoryAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ExpensesByCategoryAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expenses by category [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfExpensesExplanatory" xlink:label="ifrs-full_DisclosureOfExpensesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfExpensesExplanatory" xlink:to="ifrs-full_DisclosureOfExpensesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfExpensesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of expenses [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfExpensesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expenses by category</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related-party transactions [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of related party [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related-party transactions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retirement benefit plan</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:to="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of defined benefit plans [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retirement benefit plan</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of share-based payment arrangements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CommitmentsAndContingenciesAbstract" xlink:label="aciu_CommitmentsAndContingenciesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CommitmentsAndContingenciesAbstract" xlink:to="aciu_CommitmentsAndContingenciesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CommitmentsAndContingenciesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and contingencies [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of commitments and contingent liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and contingencies</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings per share</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial instruments and risk management [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of financial risk management [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial instruments and risk management</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xlink:to="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital risk management [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:to="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of objectives, policies and processes for managing capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital risk management</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent events</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of events after reporting period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent events</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for functional currency [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Functional and reporting currency</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" xlink:label="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" xlink:to="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The description of the entity's accounting policy for judgments that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognized in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for accounting judgments and estimates [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Critical judgments and accounting estimates</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:to="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of consolidation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for foreign currency translation [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign currency transactions</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" xlink:label="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" xlink:to="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The description of the entity's accounting policy for the basis for how the entity classifies assets and liabilities as current and non-current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for classification of assets and liabilities [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current vs. non-current classification</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for recognition of revenue [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue recognition</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for research and development expense [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and administrative expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GrantIncomePolicyTextBlock" xlink:label="aciu_GrantIncomePolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_GrantIncomePolicyTextBlock" xlink:to="aciu_GrantIncomePolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_GrantIncomePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The description of the entity's accounting policy for grant income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_GrantIncomePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grant income [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_GrantIncomePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grant income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leases</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for intangible assets other than goodwill [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for fair value measurement [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value of financial assets and liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for issued capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital and public offerings</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for treasury shares [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury Shares</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for employee benefits [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee benefits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for provisions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Provisions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for income tax [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Taxation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings per share</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for segment reporting [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment reporting</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" xlink:label="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" xlink:to="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The description of the entity's accounting policy for changes to accounting policies recently adopted by the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure Of Accounting Policy For Changes In Accounting Policies Recently Adopted [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting policies, new standards, interpretations and amendments adopted by the Company</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:label="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:to="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of effect of changes in foreign exchange rates [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of exchange rates used for translation of financial statements</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" xlink:label="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" xlink:to="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about the estimated lease term by right-of-use asset by category.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of information about contract lease term by right-of-use asset categories [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated Lease Term by Right-of-use Asset Categories</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:label="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about the useful life of property, plant and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of information about property, plant and equipment useful life [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated useful life</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of movement in the net book values of property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of quantitative information about right-of-use assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of the movements in the net value book value of right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" xlink:label="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" xlink:to="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of right-of-use assets impact on the company's statements of income/(loss) and statements of cash flows.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of right-of-use assets impact on statements [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of impact on condensed consolidated statements of income/(loss) and cash flows</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" xlink:label="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" xlink:to="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tabular disclosure of information related to the contractual undiscounted cash flows.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of contractual undiscounted cash flows [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of contractual undiscounted cash flows for lease obligations</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfAssetAcquisitionsTableTextBlock" xlink:label="aciu_DisclosureOfAssetAcquisitionsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfAssetAcquisitionsTableTextBlock" xlink:to="aciu_DisclosureOfAssetAcquisitionsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfAssetAcquisitionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tabular disclosure of asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfAssetAcquisitionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of asset acquisitions [table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfAssetAcquisitionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Transferred Assets acquired</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of net book value of intangible assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" xlink:label="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" xlink:to="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of cash and cash equivalents by currency</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of cash and cash equivalents by currency [table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of cash and cash equivalents by currency</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" xlink:label="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" xlink:to="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of short-term deposits not classified as cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of short-term deposits not classified as cash equivalents [table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of short-term financial assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" xlink:to="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about prepaid expenses and accrued income including contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about prepaid expenses and accrued income including contract assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and accrued income</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" xlink:to="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about other current receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about other current receivables [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of classes of share capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of capital structure</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AccruedExpensesAbstract" xlink:label="aciu_AccruedExpensesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AccruedExpensesAbstract" xlink:to="aciu_AccruedExpensesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AccruedExpensesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AccruedExpensesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other payables and accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" xlink:to="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about trade payables and accrued liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about trade payables and accrued liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of trade and other payables and accrued expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of revenue from contracts with customers [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of contract revenues</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory" xlink:label="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory" xlink:to="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Explanation of effect that timing of satisfaction of performance obligations and typical timing of payment have on contract assets and contract liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of contract revenue of performance obligations satisfied</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of research and development expense [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of general and administrative expense [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and Administrative</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of finance income (cost) [text block]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" xlink:label="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" xlink:to="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key management compensation</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" xlink:to="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about income tax reconciliation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about income tax reconciliation [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax expense reconciled to loss</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of temporary difference, unused tax losses and unused tax credits [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized deductible temporary differences, unused tax losses and unused tax credits</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" xlink:to="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about the expiration of income tax losses that may be carried forward.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about income tax losses expiry [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax losses carry forwards and respective expiry dates</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" xlink:label="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" xlink:to="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of amounts recognised in balance sheet from defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of amounts recognised in balance sheet from defined benefit plans [table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of amounts recognized in balance sheet from defined benefit plans</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" xlink:to="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of amounts recognised in statement of profit and loss from defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of amounts recognised in statement of profit and loss from defined benefit plans [table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of amounts recognized in statement of profit and loss from defined benefit plans</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of net defined benefit liability (asset) [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of changes in defined benefit obligations, fair value of plan assets and net defined benefit liability</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" xlink:to="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of amounts recognised in statement of other comprehensive income from defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of amounts recognised in statement of other comprehensive income from defined benefit plans [table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of amounts recognized in statement of other comprehensive income from defined benefit plans</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of sensitivity analysis for actuarial assumptions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumptions and sensitivity analysis</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of terms and conditions of share-based payment arrangement [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation plans outstanding</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of number and weighted average exercise prices of share options [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number and weighted average exercise prices of options under share option programs</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding options, exercise price range and expiry dates</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted-average assumptions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of number and weighted average exercise prices of other equity instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of non-vested share awards (restricted share and restricted share units)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of commitments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of commitments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="ifrs-full_EarningsPerShareExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareExplanatory" xlink:to="ifrs-full_EarningsPerShareExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of earnings per share</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock" xlink:label="aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock" xlink:to="aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of instruments (including contingently issuable shares) that could potentially dilute basic earnings per share in the future.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dilutive effect of convertible instruments [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of antidilutive securities</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xlink:to="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about carrying amounts of financial assets and financial liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about carrying amounts of financial assets and financial liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying amounts of financial assets and financial liabilities</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfTechnologyPlatforms" xlink:label="aciu_NumberOfTechnologyPlatforms" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfTechnologyPlatforms" xlink:to="aciu_NumberOfTechnologyPlatforms_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfTechnologyPlatforms_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of unique proprietary platform technologies to discover, design and develop medicines and diagnostics to target misfolded proteins.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfTechnologyPlatforms_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of technology platforms</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfTechnologyPlatforms_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of proprietary technology platforms</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GoingConcernAbstract" xlink:label="aciu_GoingConcernAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_GoingConcernAbstract" xlink:to="aciu_GoingConcernAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_GoingConcernAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Going Concern [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_GoingConcernAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Going concern [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ForeignExchangeRatesAbstract" xlink:label="ifrs-full_ForeignExchangeRatesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ForeignExchangeRatesAbstract" xlink:to="ifrs-full_ForeignExchangeRatesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ForeignExchangeRatesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Functional and reporting currency [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClosingForeignExchangeRate" xlink:to="ifrs-full_ClosingForeignExchangeRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClosingForeignExchangeRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Closing rate, USD 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ClosingForeignExchangeRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Translation rate into CHF</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AverageForeignExchangeRate" xlink:label="ifrs-full_AverageForeignExchangeRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AverageForeignExchangeRate" xlink:to="ifrs-full_AverageForeignExchangeRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AverageForeignExchangeRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exchange rate, USD 1</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of quantitative information about right-of-use assets [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of property, plant and equipment [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BuildingsMember" xlink:to="ifrs-full_BuildingsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BuildingsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Buildings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BuildingsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Buildings [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="ifrs-full_OfficeEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OfficeEquipmentMember" xlink:to="ifrs-full_OfficeEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OfficeEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Office Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OfficeEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Office Equipment [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComputerEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IT Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComputerEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IT Equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of quantitative information about right-of-use assets [line items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of quantitative information about leases for lessee [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets and lease liabilities:</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_EstimatedLeaseTerm" xlink:label="aciu_EstimatedLeaseTerm" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_EstimatedLeaseTerm" xlink:to="aciu_EstimatedLeaseTerm_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_EstimatedLeaseTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The estimated lease term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_EstimatedLeaseTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated lease term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_EstimatedLeaseTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated lease term</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about property, plant and equipment [table]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LaboratoryEquipmentMember" xlink:label="aciu_LaboratoryEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_LaboratoryEquipmentMember" xlink:to="aciu_LaboratoryEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_LaboratoryEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for a class of property, plant and equipment representing laboratory equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_LaboratoryEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Laboratory equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_LaboratoryEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lab Equipment</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" xlink:label="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" xlink:to="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement and fixtures and fittings that are not permanently attached to real property.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leasehold improvements and fixtures and fittings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leasehold Improvements/Furniture [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about property, plant and equipment [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" xlink:label="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" xlink:to="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property plant and equipment estimated useful life [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated useful life [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Useful life measured as period of time, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated useful life</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncomeTaxLossCarryforwardPeriod" xlink:label="aciu_IncomeTaxLossCarryforwardPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncomeTaxLossCarryforwardPeriod" xlink:to="aciu_IncomeTaxLossCarryforwardPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncomeTaxLossCarryforwardPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The period or time limit over which financial losses of the entity for preceding years can be deducted from the taxable revenue for a period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncomeTaxLossCarryforwardPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax loss, Carryforward period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncomeTaxLossCarryforwardPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax loss carryforward period</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of operating segments [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment reporting [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OperatingSegmentsNumber" xlink:label="aciu_OperatingSegmentsNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OperatingSegmentsNumber" xlink:to="aciu_OperatingSegmentsNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_OperatingSegmentsNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of operating segments reported by the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OperatingSegmentsNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating segments, number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_OperatingSegmentsNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of operating segments</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ReportableSegmentsNumber" xlink:label="aciu_ReportableSegmentsNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ReportableSegmentsNumber" xlink:to="aciu_ReportableSegmentsNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ReportableSegmentsNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of reportable segments reported by the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ReportableSegmentsNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reportable segments, number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ReportableSegmentsNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of reportable segments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="ifrs-full_FixturesAndFittingsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FixturesAndFittingsMember" xlink:to="ifrs-full_FixturesAndFittingsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FixturesAndFittingsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Furniture</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="ifrs-full_LeaseholdImprovementsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseholdImprovementsMember" xlink:to="ifrs-full_LeaseholdImprovementsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseholdImprovementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leasehold Improvements</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="ifrs-full_ConstructionInProgressMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConstructionInProgressMember" xlink:to="ifrs-full_ConstructionInProgressMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConstructionInProgressMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Construction in progress [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ConstructionInProgressMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets under construction</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AssetsUnderConstructionMember" xlink:label="aciu_AssetsUnderConstructionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AssetsUnderConstructionMember" xlink:to="aciu_AssetsUnderConstructionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AssetsUnderConstructionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for assets under construction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AssetsUnderConstructionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets Under Construction</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying amount, accumulated depreciation, amortization and impairment and gross carrying amount [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_CarryingAmountMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying amount [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross carrying amount [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross Carrying Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquisition Cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated depreciation and amortisation [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Amortization</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of changes in property, plant and equipment [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions other than through business combinations, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through transfers from construction in progress, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transfers</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disposals, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disposals</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageIncreaseInPropertyPlantAndEquipment" xlink:label="aciu_PercentageIncreaseInPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PercentageIncreaseInPropertyPlantAndEquipment" xlink:to="aciu_PercentageIncreaseInPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PercentageIncreaseInPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The percentage of increase in property, plant and equipment during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PercentageIncreaseInPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage increase in property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PercentageIncreaseInPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of increase in equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfAssetsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of assets [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="ifrs-full_ClassesOfAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsToRightofuseAssets" xlink:to="ifrs-full_AdditionsToRightofuseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions and remeasurements</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:to="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average incremental borrowing rate</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RightOfUseLeasedAssetsAbstract" xlink:label="aciu_RightOfUseLeasedAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RightOfUseLeasedAssetsAbstract" xlink:to="aciu_RightOfUseLeasedAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RightOfUseLeasedAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use leased assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RightOfUseLeasedAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use of leased assets:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRightofuseAssets" xlink:to="ifrs-full_DepreciationRightofuseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation, right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation of right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DispositionsOfRightOfUseAssets" xlink:label="aciu_DispositionsOfRightOfUseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DispositionsOfRightOfUseAssets" xlink:to="aciu_DispositionsOfRightOfUseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DispositionsOfRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of decrease in right-of-use assets from disposals.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DispositionsOfRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dispositions of right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_DispositionsOfRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dispositions</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract" xlink:label="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract" xlink:to="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impact on statements of income/(loss) and cash flows [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statements of income/(loss) and cash flows</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense on lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense on lease liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:to="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense relating to short-term leases for which recognition exemption has been used</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense for short-term leases and leases of low value</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ExpenseRelatingToLeases" xlink:label="aciu_ExpenseRelatingToLeases" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ExpenseRelatingToLeases" xlink:to="aciu_ExpenseRelatingToLeases_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ExpenseRelatingToLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The expense for leases recognized through profit and loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ExpenseRelatingToLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense relating to leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="aciu_ExpenseRelatingToLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashOutflowForLeases" xlink:label="ifrs-full_CashOutflowForLeases" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashOutflowForLeases" xlink:to="ifrs-full_CashOutflowForLeases_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashOutflowForLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash outflow for leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashOutflowForLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total cash outflow for leases</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of maturity analysis of operating lease payments [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturity [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_AggregatedTimeBandsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AggregatedTimeBandsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregated time bands [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotLaterThanOneYearMember" xlink:to="ifrs-full_NotLaterThanOneYearMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotLaterThanOneYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less than one year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NotLaterThanOneYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Within 1 Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NotLaterThanOneYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2019 [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">1-3 years</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">3-5 years</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of maturity analysis of operating lease payments [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:label="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:to="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual undiscounted cash flows for lease liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual undiscounted cash flows for lease liabilities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="ifrs-full_GrossLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossLeaseLiabilities" xlink:to="ifrs-full_GrossLeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GrossLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual undiscounted cash flows for lease liabilities</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfDepositsInEscrowAccounts" xlink:label="aciu_NumberOfDepositsInEscrowAccounts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfDepositsInEscrowAccounts" xlink:to="aciu_NumberOfDepositsInEscrowAccounts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfDepositsInEscrowAccounts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of deposits in escrow accounts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfDepositsInEscrowAccounts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of deposits in escrow accounts</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_EscrowDepositAmount" xlink:label="aciu_EscrowDepositAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_EscrowDepositAmount" xlink:to="aciu_EscrowDepositAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_EscrowDepositAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of deposits held in escrow.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_EscrowDepositAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Escrow deposit, amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_EscrowDepositAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Escrow deposits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about intangible assets [table]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AssetAcquisitionsAxis" xlink:label="aciu_AssetAcquisitionsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AssetAcquisitionsAxis" xlink:to="aciu_AssetAcquisitionsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AssetAcquisitionsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AssetAcquisitionsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset acquisitions [axis]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SignificantAssetAcquisitionsTotalDomain" xlink:label="aciu_SignificantAssetAcquisitionsTotalDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SignificantAssetAcquisitionsTotalDomain" xlink:to="aciu_SignificantAssetAcquisitionsTotalDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_SignificantAssetAcquisitionsTotalDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant asset acquisitions, total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SignificantAssetAcquisitionsTotalDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant asset acquisitions, total [Domain]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" xlink:label="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" xlink:to="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents the acquisition of the program portfolio of therapeutics targeting a-syn from Affiris</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Program portfolio of therapeutics targeting asyn from Affiris [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Program portfolio of therapeutics targeting asyn from Affiris</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of intangible assets other than goodwill [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets other than goodwill [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" xlink:label="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" xlink:to="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents the IPR&amp;D intangible asset associated with ACI 7104.056</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPR&amp;D intangible asset associated with ACI 7104.056 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPR&amp;D intangible asset associated with ACI 7104.056</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="ifrs-full_UnobservableInputsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnobservableInputsAxis" xlink:to="ifrs-full_UnobservableInputsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnobservableInputsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unobservable inputs [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnobservableInputsMember" xlink:label="ifrs-full_UnobservableInputsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnobservableInputsMember" xlink:to="ifrs-full_UnobservableInputsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnobservableInputsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unobservable inputs [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DiscountRateMeasurementInputMember" xlink:label="ifrs-full_DiscountRateMeasurementInputMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DiscountRateMeasurementInputMember" xlink:to="ifrs-full_DiscountRateMeasurementInputMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DiscountRateMeasurementInputMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount rate, measurement input [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DiscountRateMeasurementInputMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount rate, measurement input</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about intangible assets [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SharesTransferredAsConsiderationInAssetAcquisition" xlink:label="aciu_SharesTransferredAsConsiderationInAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SharesTransferredAsConsiderationInAssetAcquisition" xlink:to="aciu_SharesTransferredAsConsiderationInAssetAcquisition_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_SharesTransferredAsConsiderationInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares transferred as consideration in asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SharesTransferredAsConsiderationInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares transferred as consideration in asset acquisition</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" xlink:label="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" xlink:to="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total consideration transferred, acquisition-date fair value, asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total consideration transferred, acquisition-date fair value, asset acquisition</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantUnobservableInputAssets" xlink:label="ifrs-full_SignificantUnobservableInputAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SignificantUnobservableInputAssets" xlink:to="ifrs-full_SignificantUnobservableInputAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SignificantUnobservableInputAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant unobservable input, assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SignificantUnobservableInputAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount rate</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CashAcquiredAsPartOfAssetAcquisition" xlink:to="aciu_CashAcquiredAsPartOfAssetAcquisition_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash acquired as part of asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash acquired as part of asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" xlink:to="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets acquired as part of asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets acquired as part of asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPR&amp;D asset</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TotalAssetsAcquiredInAssetAcquisition" xlink:label="aciu_TotalAssetsAcquiredInAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TotalAssetsAcquiredInAssetAcquisition" xlink:to="aciu_TotalAssetsAcquiredInAssetAcquisition_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TotalAssetsAcquiredInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets acquired in asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TotalAssetsAcquiredInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets acquired in asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="aciu_TotalAssetsAcquiredInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets acquired</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_InProcessResearchAndDevelopmentIPRDAssetMember" xlink:label="aciu_InProcessResearchAndDevelopmentIPRDAssetMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_InProcessResearchAndDevelopmentIPRDAssetMember" xlink:to="aciu_InProcessResearchAndDevelopmentIPRDAssetMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_InProcessResearchAndDevelopmentIPRDAssetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for an intangible asset that is a clinically-validated active vaccine candidate for the treatment of Parkinson's disease.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_InProcessResearchAndDevelopmentIPRDAssetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquired IPR&amp;D Asset</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of intangible assets material to entity [abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAndCashEquivalentsTable" xlink:label="aciu_CashAndCashEquivalentsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CashAndCashEquivalentsTable" xlink:to="aciu_CashAndCashEquivalentsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CashAndCashEquivalentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of cash and cash equivalent balances, including foreign currencies in which the balances are denominated.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CashAndCashEquivalentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_AllCurrenciesDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_AllCurrenciesDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">All Currencies [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CHF" xlink:label="currency_CHF" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_CHF" xlink:to="currency_CHF_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_CHF_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Switzerland, Francs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="currency_CHF_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CHF [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="currency_EUR" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_EUR" xlink:to="currency_EUR_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_EUR_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Euro Member Countries, Euro</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="currency_EUR_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">EUR [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="currency_USD" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_USD" xlink:to="currency_USD_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_USD_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">United States of America, Dollars</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="currency_USD_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">USD [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAndCashEquivalentLineItems" xlink:label="aciu_CashAndCashEquivalentLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CashAndCashEquivalentLineItems" xlink:to="aciu_CashAndCashEquivalentLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CashAndCashEquivalentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CashAndCashEquivalentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalent [Line Items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAbstract" xlink:label="ifrs-full_CashAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAbstract" xlink:to="ifrs-full_CashAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PrepaidExpensesAndAccruedIncomeTable" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeTable" xlink:to="aciu_PrepaidExpensesAndAccruedIncomeTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule disclosing information related to details of Prepaid expenses and accrued income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid Expenses and Accrued Income [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfContractsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Types of contracts [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="ifrs-full_TypesOfContractsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfContractsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Types of contracts [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember" xlink:label="aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember" xlink:to="aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents grants from the Michael J. Fox Foundation and Target ALS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grants, Michael J. Fox Foundation and Target ALS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grants, Michael J. Fox Foundation and Target ALS</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GrantsMichaelJFoxFoundationMember" xlink:label="aciu_GrantsMichaelJFoxFoundationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_GrantsMichaelJFoxFoundationMember" xlink:to="aciu_GrantsMichaelJFoxFoundationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_GrantsMichaelJFoxFoundationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Funding provided for certain types of expenditures in connection with research and development activities over a contractually-defined period from the Michael J. Fox Foundation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_GrantsMichaelJFoxFoundationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grants, Michael J. Fox Foundation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_GrantsMichaelJFoxFoundationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grant from Michael J. Fox Foundation</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PrepaidExpensesAndAccruedIncomeLineItems" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeLineItems" xlink:to="aciu_PrepaidExpensesAndAccruedIncomeLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid Expenses and Accrued Income [Line Items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" xlink:to="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and accrued income, Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and accrued income [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xlink:to="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current prepayments and current accrued income including current contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total prepaid expenses and accrued income</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfAccruedIncome" xlink:label="aciu_PercentageOfAccruedIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PercentageOfAccruedIncome" xlink:to="aciu_PercentageOfAccruedIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PercentageOfAccruedIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage that represents the percentage of total accrued income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PercentageOfAccruedIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of Accrued Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PercentageOfAccruedIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of accrued income</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfOtherCurrentReceivablesTable" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesTable" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule disclosing information related to other current receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of other current receivables [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Range [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_RangesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ranges [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Top of Range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Top of Range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of other current receivables [Line Items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_TradeAndOtherReceivablesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other receivables [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables [abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MiscellaneousOtherCurrentReceivables" xlink:label="aciu_MiscellaneousOtherCurrentReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_MiscellaneousOtherCurrentReceivables" xlink:to="aciu_MiscellaneousOtherCurrentReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_MiscellaneousOtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Miscellaneous other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_MiscellaneousOtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Miscellaneous other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_MiscellaneousOtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivable</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentValueAddedTaxReceivables" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current value added tax receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Swiss VAT</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WithholdingTaxReceivables" xlink:label="aciu_WithholdingTaxReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WithholdingTaxReceivables" xlink:to="aciu_WithholdingTaxReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WithholdingTaxReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Withholding tax receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WithholdingTaxReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Withholding tax receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WithholdingTaxReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Withholding tax</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MaturityPeriodOtherCurrentReceivables" xlink:label="aciu_MaturityPeriodOtherCurrentReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_MaturityPeriodOtherCurrentReceivables" xlink:to="aciu_MaturityPeriodOtherCurrentReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_MaturityPeriodOtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturity period, other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_MaturityPeriodOtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturity period, other current receivables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of classes of share capital [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of share capital [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_ClassesOfShareCapitalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Capital [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ClassesOfShareCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_OrdinarySharesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OrdinarySharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ordinary shares [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OrdinarySharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OrdinarySharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Shares</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of classes of share capital [line items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares issued (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares in entity held by entity or by its subsidiaries or associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares outstanding at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares outstanding at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of treasury shares outstanding</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:label="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:to="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of number of shares outstanding [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="ifrs-full_NumberOfSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares outstanding at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares outstanding at beginning of period</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions" xlink:label="aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions" xlink:to="aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in number of shares through issuance as consideration in asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in number of shares through issuance as consideration in asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset purchase agreement, net of transaction costs (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase in the number of ordinary shares issued under a convertible debt arrangement upon conversion of the debt.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in number of ordinary shares issued under conversion of convertible debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conversion of note agreement, net of transaction costs (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued through conversion of convertible notes</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase in the number of ordinary shares issued under incentive plans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in number of ordinary shares issued under incentive plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares - incentive plans, net of transaction costs (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:to="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) in equity shares resulting from treasury share transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through treasury share transactions, equity, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares to be held as treasury shares, net of transaction costs (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares to be held as treasury shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xlink:label="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xlink:to="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of number of treasury shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of number of treasury shares outstanding [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" xlink:label="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" xlink:to="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease in number of treasury shares from sales or issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease in number of treasury shares from sales or issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ChangesInEquityAbstract" xlink:label="ifrs-full_ChangesInEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ChangesInEquityAbstract" xlink:to="ifrs-full_ChangesInEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ChangesInEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in equity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ChangesInEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in equity</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions" xlink:label="aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions" xlink:to="aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in equity through issuance of shares in asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase through issuance of shares in asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset purchase agreement, net of transaction costs</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" xlink:label="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" xlink:to="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase in equity resulting from the issue of shares under incentive plans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase through shares issued under incentive plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares - incentive plans, net of transaction costs</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ParValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Par value per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ParValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nominal value per share (in CHF per share)</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" xlink:label="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" xlink:to="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional share capital that Board of Directors are authorized to issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional share capital that Board of Directors are authorized to issue</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" xlink:label="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" xlink:to="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of additional shares that Board of Directors are authorized to issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of additional shares that Board of Directors are authorized to issue</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember" xlink:label="aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember" xlink:to="aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for share capital of the conditional share capital for bonds and similar debt instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conditional share capital for bonds and similar debt instruments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bonds and Similar Debt Instruments [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConditionalShareCapitalAbstract" xlink:label="aciu_ConditionalShareCapitalAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="aciu_ConditionalShareCapitalAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ConditionalShareCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conditional share capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ConditionalShareCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conditional Share Capital [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" xlink:label="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" xlink:to="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential increase is equity through conversion of debt instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential increase is equity through conversion of debt instruments</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" xlink:label="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" xlink:to="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential number of shares issued from conversion of debt instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential number of shares issued from conversion of debt instruments</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" xlink:label="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" xlink:to="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for share capital of the conditional share capital for employee benefit plans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conditional share capital for employee benefit plans [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee Benefit Plans [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" xlink:label="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" xlink:to="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The potential increase in equity from share-based payment transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential increase is equity through share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum aggregate amount of ordinary shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" xlink:label="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" xlink:to="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The total number of potential shares issued through share-based payment transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential number of shares issued from share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of ordinary shares (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" xlink:label="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" xlink:to="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital authorized to be issued under shelf registration statement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital authorized to be issued under shelf registration statement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital authorized to be issued under Shelf Registration Statement</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AtTheMarketEquityOfferingMember" xlink:label="aciu_AtTheMarketEquityOfferingMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AtTheMarketEquityOfferingMember" xlink:to="aciu_AtTheMarketEquityOfferingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AtTheMarketEquityOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">An "at-the-market" offering is an offering of securities into an existing trading market for outstanding shares of the same class at other than a fixed price on, or through the facilities of, a national securities exchange, or to or through a market maker otherwise than on an exchange.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AtTheMarketEquityOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">At the Market Equity Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AtTheMarketEquityOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">At the Market Equity Offering [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SecondOpenMarketSalesAgreementMember" xlink:label="aciu_SecondOpenMarketSalesAgreementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SecondOpenMarketSalesAgreementMember" xlink:to="aciu_SecondOpenMarketSalesAgreementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_SecondOpenMarketSalesAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for entity entered into a second Open Market Sales Agreement (the "New Sales Agreement") with Jefferies to continue the ATM program.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SecondOpenMarketSalesAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Second Open Market Sales Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_SecondOpenMarketSalesAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Sales Agreement [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AtTheMarketEquityOfferingAbstract" xlink:label="aciu_AtTheMarketEquityOfferingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="aciu_AtTheMarketEquityOfferingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AtTheMarketEquityOfferingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">At the Market Equity Offering [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AtTheMarketEquityOfferingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">At the Market Equity Offering [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" xlink:label="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" xlink:to="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of common shares authorized for sale in the open market.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares authorized for issuance sales in in open market</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares authorized for sale</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SaleOrIssueOfTreasurySharesShares" xlink:label="aciu_SaleOrIssueOfTreasurySharesShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SaleOrIssueOfTreasurySharesShares" xlink:to="aciu_SaleOrIssueOfTreasurySharesShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_SaleOrIssueOfTreasurySharesShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of treasury shares issued or sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SaleOrIssueOfTreasurySharesShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale or issue of treasury shares, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_SaleOrIssueOfTreasurySharesShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of treasury share issued (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xlink:label="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xlink:to="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale or issue of treasury shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CommissionsPaidForIssuanceOrdinaryShares" xlink:label="aciu_CommissionsPaidForIssuanceOrdinaryShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CommissionsPaidForIssuanceOrdinaryShares" xlink:to="aciu_CommissionsPaidForIssuanceOrdinaryShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CommissionsPaidForIssuanceOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of commissions paid for issuance ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CommissionsPaidForIssuanceOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commissions paid for issuance ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CommissionsPaidForIssuanceOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commissions paid</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConvertibleNoteAgreementMember" xlink:label="aciu_ConvertibleNoteAgreementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ConvertibleNoteAgreementMember" xlink:to="aciu_ConvertibleNoteAgreementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ConvertibleNoteAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The member represents to convertible note agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ConvertibleNoteAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible Note Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ConvertibleNoteAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible Note Agreement with Lilly [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_ConvertibleNoteAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible note agreements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Domain]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IfNotesAreConvertedMember" xlink:label="aciu_IfNotesAreConvertedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IfNotesAreConvertedMember" xlink:to="aciu_IfNotesAreConvertedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IfNotesAreConvertedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents the scenario that notes get converted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IfNotesAreConvertedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">If notes are converted [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IfNotesAreConvertedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">If notes are converted</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis" xlink:label="ifrs-full_CounterpartiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CounterpartiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Counterparties [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember" xlink:label="ifrs-full_CounterpartiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CounterpartiesMember" xlink:to="ifrs-full_CounterpartiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CounterpartiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Counterparties [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AthosServiceGmbHMember" xlink:label="aciu_AthosServiceGmbHMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AthosServiceGmbHMember" xlink:to="aciu_AthosServiceGmbHMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AthosServiceGmbHMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents Athos Service GmbH</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AthosServiceGmbHMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Athos Service GmbH [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FirstCapitalPartnerGmbHMember" xlink:label="aciu_FirstCapitalPartnerGmbHMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_FirstCapitalPartnerGmbHMember" xlink:to="aciu_FirstCapitalPartnerGmbHMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_FirstCapitalPartnerGmbHMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents First Capital Partner GmbH</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_FirstCapitalPartnerGmbHMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">First Capital Partner GmbH [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConvertibleNoteAgreementAbstract" xlink:label="aciu_ConvertibleNoteAgreementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_ConvertibleNoteAgreementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ConvertibleNoteAgreementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible Note Agreement [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfConvertibleNoteAgreements" xlink:label="aciu_NumberOfConvertibleNoteAgreements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfConvertibleNoteAgreements" xlink:to="aciu_NumberOfConvertibleNoteAgreements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfConvertibleNoteAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of convertible note agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfConvertibleNoteAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of convertible note agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfConvertibleNoteAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of separate convertible note agreements</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AggregatePrincipalAmountOfEachConvertibleNote" xlink:label="aciu_AggregatePrincipalAmountOfEachConvertibleNote" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AggregatePrincipalAmountOfEachConvertibleNote" xlink:to="aciu_AggregatePrincipalAmountOfEachConvertibleNote_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AggregatePrincipalAmountOfEachConvertibleNote_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate principal amount of each convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AggregatePrincipalAmountOfEachConvertibleNote_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate principal amount of each convertible note</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" xlink:label="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" xlink:to="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash inflow from conversion of convertible debt, per individual note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from conversion of convertible debt, per individual note</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" xlink:label="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" xlink:to="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding equity or cash consideration due under convertible note agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding equity or cash consideration due under convertible note agreements</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable" xlink:label="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable" xlink:to="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule disclosing information related to details of trade and other payables and accrued liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other payables and accrued liabilities [Table]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The 2014 contractual research agreement associated with collaboration with Janssen Pharmaceuticals.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration agreement of 2014, Janssen Pharmaceuticals [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2014 Agreement with Janssen Pharmaceuticals [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Janssen</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" xlink:label="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" xlink:to="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other payables and accrued liabilities [Line Items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CurrentAccruedResearchAndDevelopmentCosts" xlink:label="aciu_CurrentAccruedResearchAndDevelopmentCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CurrentAccruedResearchAndDevelopmentCosts" xlink:to="aciu_CurrentAccruedResearchAndDevelopmentCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CurrentAccruedResearchAndDevelopmentCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of current accrued research and development costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CurrentAccruedResearchAndDevelopmentCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current accrued research and development costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CurrentAccruedResearchAndDevelopmentCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued research and development costs</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term employee benefits accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrual of performance-related remuneration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued payroll expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OtherAccruedExpenses" xlink:label="aciu_OtherAccruedExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OtherAccruedExpenses" xlink:to="aciu_OtherAccruedExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_OtherAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OtherAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AccrualsForPerformanceRelatedRemuneration" xlink:label="aciu_AccrualsForPerformanceRelatedRemuneration" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AccrualsForPerformanceRelatedRemuneration" xlink:to="aciu_AccrualsForPerformanceRelatedRemuneration_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AccrualsForPerformanceRelatedRemuneration_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accruals for performance related remuneration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AccrualsForPerformanceRelatedRemuneration_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accruals for performance related remuneration</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AccruedStampDuty" xlink:label="aciu_AccruedStampDuty" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AccruedStampDuty" xlink:to="aciu_AccruedStampDuty_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AccruedStampDuty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of current accrued stamp duty.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AccruedStampDuty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued stamp duty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AccruedStampDuty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued stamp duty</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of disaggregation of revenue from contracts with customers [table]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration and License Revenue Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration and License Revenue [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration and License Revenue Agreements [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementWithLillyMember" xlink:label="aciu_CollaborationAgreementWithLillyMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborationAgreementWithLillyMember" xlink:to="aciu_CollaborationAgreementWithLillyMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborationAgreementWithLillyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The collaboration agreement with Lilly for research and development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborationAgreementWithLillyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration Agreement with Lilly [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborationAgreementWithLillyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lilly [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_CollaborationAgreementWithLillyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2018 License Agreement with Eli Lilly and Company [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2012GenentechMember" xlink:label="aciu_CollaborationAgreementOf2012GenentechMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborationAgreementOf2012GenentechMember" xlink:to="aciu_CollaborationAgreementOf2012GenentechMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborationAgreementOf2012GenentechMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The 2012 contractual research agreement associated with collaboration with Genentech.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborationAgreementOf2012GenentechMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration agreement of 2012, Genentech [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborationAgreementOf2012GenentechMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2012 Agreement with Genentech [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_CollaborationAgreementOf2012GenentechMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Genentech [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:to="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The 2014 contractual research agreement associated with collaboration with Life Molecular Imaging.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">License and collaboration agreement of 2014, Life Molecular Imaging [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Life Molecular Imaging [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of disaggregation of revenue from contracts with customers [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ContractRevenueAbstract" xlink:label="aciu_ContractRevenueAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ContractRevenueAbstract" xlink:to="aciu_ContractRevenueAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ContractRevenueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract Revenue [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ContractRevenueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract Revenue [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="ifrs-full_PercentageOfEntitysRevenue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfEntitysRevenue" xlink:to="ifrs-full_PercentageOfEntitysRevenue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfEntitysRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of entity's revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PercentageOfEntitysRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of contract revenues</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:to="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amounts included in the contract liability at the beginning of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amounts included in the contract liability at the beginning of the period</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xlink:label="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xlink:to="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance obligations satisfied in previous periods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance obligations satisfied in previous periods</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Products and services [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="ifrs-full_ProductsAndServicesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Products and services [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TauMorphomerSmallMoleculeMember" xlink:label="aciu_TauMorphomerSmallMoleculeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TauMorphomerSmallMoleculeMember" xlink:to="aciu_TauMorphomerSmallMoleculeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TauMorphomerSmallMoleculeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The research and development of medicines for the treatment of Alzheimer's disease and other neurodegenerative diseases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TauMorphomerSmallMoleculeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tau Morphomer Small Molecule [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TauMorphomerSmallMoleculeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Morphomer Tau Small Molecule [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementWithLillyFirstAmendmentMember" xlink:label="aciu_CollaborationAgreementWithLillyFirstAmendmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborationAgreementWithLillyFirstAmendmentMember" xlink:to="aciu_CollaborationAgreementWithLillyFirstAmendmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborationAgreementWithLillyFirstAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The first amendment to the collaboration agreement with Lilly for research and development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborationAgreementWithLillyFirstAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration Agreement with Lilly, First Amendment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborationAgreementWithLillyFirstAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2018 License Agreement with Eli Lilly, First Amendment [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementWithLillySecondAmendmentMember" xlink:label="aciu_CollaborationAgreementWithLillySecondAmendmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborationAgreementWithLillySecondAmendmentMember" xlink:to="aciu_CollaborationAgreementWithLillySecondAmendmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborationAgreementWithLillySecondAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The second amendment to the collaboration agreement with Lilly for research and development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborationAgreementWithLillySecondAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration Agreement with Lilly, Second Amendment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborationAgreementWithLillySecondAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2018 License Agreement with Eli Lilly, Second Amendment [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="ifrs-full_PerformanceObligationsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PerformanceObligationsAxis" xlink:to="ifrs-full_PerformanceObligationsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PerformanceObligationsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance obligations [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="ifrs-full_PerformanceObligationsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="ifrs-full_PerformanceObligationsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PerformanceObligationsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance obligations [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" xlink:label="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" xlink:to="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Refers to a milestone payment arrangement related to clinical and regulatory milestones.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Milestone payments, clinical and regulatory milestones [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Clinical and Regulatory [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MilestonePaymentsCommercialMember" xlink:label="aciu_MilestonePaymentsCommercialMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_MilestonePaymentsCommercialMember" xlink:to="aciu_MilestonePaymentsCommercialMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_MilestonePaymentsCommercialMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Refers to a milestone payment arrangement related to certain commercial milestones.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_MilestonePaymentsCommercialMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Milestone payments, commercial [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_MilestonePaymentsCommercialMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commercial [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ResearchAndDevelopmentMember" xlink:label="aciu_ResearchAndDevelopmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ResearchAndDevelopmentMember" xlink:to="aciu_ResearchAndDevelopmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ResearchAndDevelopmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance obligation related to research and development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ResearchAndDevelopmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ResearchAndDevelopmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RightOfUseLicenseMember" xlink:label="aciu_RightOfUseLicenseMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RightOfUseLicenseMember" xlink:to="aciu_RightOfUseLicenseMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RightOfUseLicenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance obligation related to right-of-use license.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RightOfUseLicenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use license [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RightOfUseLicenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use License [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Quarter32019Member" xlink:label="aciu_Quarter32019Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Quarter32019Member" xlink:to="aciu_Quarter32019Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Quarter32019Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents Quarter 3 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Quarter32019Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Quarter 3, 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Quarter32019Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Quarter 3, 2019</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_March312020Member" xlink:label="aciu_March312020Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_March312020Member" xlink:to="aciu_March312020Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_March312020Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents March 31, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_March312020Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">March 31, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_March312020Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">March 31, 2020</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" xlink:label="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" xlink:to="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents the time upon which the first patient is dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Upon first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Upon first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of disaggregation of revenue from contracts with customers [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract revenues</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementPotentialValue" xlink:to="aciu_CollaborativeAgreementPotentialValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementPotentialValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The total potential value of the collaborative agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementPotentialValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, potential value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborativeAgreementPotentialValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total potential collaboration agreement value</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" xlink:label="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" xlink:to="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of installments for satisfying a milestone payment associated with a collaborative agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, milestone payment, number of installments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of installments</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payment(s) received for milestone payments associated with a collaborative agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, Milestone payment received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Milestone payment received</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReceivablesFromContractsWithCustomers" xlink:to="ifrs-full_ReceivablesFromContractsWithCustomers_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receivables from contracts with customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Milestone payment receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Eligible grant amount receivable</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities" xlink:label="ifrs-full_ContractLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContractLiabilities" xlink:to="ifrs-full_ContractLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContractLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ContractLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Up-front consideration received</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction price allocated to remaining performance obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total potential collaboration agreement value remaining</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected transaction price allocation</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, Notice of contract termination period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period to provide notice of termination of agreement</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" xlink:label="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" xlink:to="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of representatives in a joint steering committee by each party as per the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of representatives in joint steering committee by each party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of representatives in joint steering committee by each party</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractAssets" xlink:label="ifrs-full_ContractAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContractAssets" xlink:to="ifrs-full_ContractAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred research and development costs</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AntiAbetaAntibodyInADMember" xlink:label="aciu_AntiAbetaAntibodyInADMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AntiAbetaAntibodyInADMember" xlink:to="aciu_AntiAbetaAntibodyInADMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AntiAbetaAntibodyInADMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The research and development of medicines for the treatment of Alzheimer's disease.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AntiAbetaAntibodyInADMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Anti-Abeta antibody in AD [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AntiAbetaAntibodyInADMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Anti-Abeta Antibody in AD [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2006GenentechMember" xlink:label="aciu_CollaborationAgreementOf2006GenentechMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborationAgreementOf2006GenentechMember" xlink:to="aciu_CollaborationAgreementOf2006GenentechMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborationAgreementOf2006GenentechMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The 2006 contractual research agreement associated with collaboration with Genentech.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborationAgreementOf2006GenentechMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration agreement of 2006, Genentech [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_CollaborationAgreementOf2006GenentechMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2006 Agreement with Genentech [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bottom of Range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ClinicalMilestonesAchievedPriorTo1January2017Member" xlink:label="aciu_ClinicalMilestonesAchievedPriorTo1January2017Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ClinicalMilestonesAchievedPriorTo1January2017Member" xlink:to="aciu_ClinicalMilestonesAchievedPriorTo1January2017Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ClinicalMilestonesAchievedPriorTo1January2017Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Clinical milestones achieved prior to 1 January 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ClinicalMilestonesAchievedPriorTo1January2017Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Clinical milestones achieved prior to 1 January 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ClinicalMilestonesAchievedPriorTo1January2017Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Clinical milestones achieved prior to 1 January 2017</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementCumulativePaymentsReceived" xlink:label="aciu_CollaborativeAgreementCumulativePaymentsReceived" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementCumulativePaymentsReceived" xlink:to="aciu_CollaborativeAgreementCumulativePaymentsReceived_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementCumulativePaymentsReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cumulative payments received related to revenue from upfront license fees, milestone payments and revenue from research agreements associated with a collaborative agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementCumulativePaymentsReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, Cumulative payments received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_CollaborativeAgreementCumulativePaymentsReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cumulative payments received</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfMilestonePaymentsReceived" xlink:label="aciu_NumberOfMilestonePaymentsReceived" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfMilestonePaymentsReceived" xlink:to="aciu_NumberOfMilestonePaymentsReceived_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfMilestonePaymentsReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of times payment(s) received for milestone payments associated with a collaborative agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfMilestonePaymentsReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of milestone payments received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfMilestonePaymentsReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of milestone payments received</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementUpfrontPaymentsReceived" xlink:label="aciu_CollaborativeAgreementUpfrontPaymentsReceived" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementUpfrontPaymentsReceived" xlink:to="aciu_CollaborativeAgreementUpfrontPaymentsReceived_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementUpfrontPaymentsReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, upfront payments received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementUpfrontPaymentsReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, upfront payments received</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, Notice of contract termination period in case of material breach of contract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, Notice of contract termination period in case of material breach of contract</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AntiTauAntibodyInADMember" xlink:label="aciu_AntiTauAntibodyInADMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AntiTauAntibodyInADMember" xlink:to="aciu_AntiTauAntibodyInADMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AntiTauAntibodyInADMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The research and development of medicines for the treatment of Alzheimer's disease.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AntiTauAntibodyInADMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Anti-tau antibody in AD [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AntiTauAntibodyInADMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Anti-tau Antibody in AD [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TauVaccineInADMember" xlink:label="aciu_TauVaccineInADMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TauVaccineInADMember" xlink:to="aciu_TauVaccineInADMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TauVaccineInADMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The research and development of a vaccine for the treatment of Alzheimer's disease.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TauVaccineInADMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tau Vaccine in AD [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TauVaccineInADMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tau Vaccine in AD [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TauPETImagingAgentMember" xlink:label="aciu_TauPETImagingAgentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TauPETImagingAgentMember" xlink:to="aciu_TauPETImagingAgentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TauPETImagingAgentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The research and development of medicines for the treatment of Alzheimer's disease through molecular imaging.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TauPETImagingAgentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tau-PET imaging agent [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TauPETImagingAgentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tau-PET Imaging Agent [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ClinicalMilestonesMember" xlink:label="aciu_ClinicalMilestonesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ClinicalMilestonesMember" xlink:to="aciu_ClinicalMilestonesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ClinicalMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents clinical milestones</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ClinicalMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Clinical milestones [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ClinicalMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Clinical milestones</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RegulatoryAndSalesBasedMilestonesMember" xlink:label="aciu_RegulatoryAndSalesBasedMilestonesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RegulatoryAndSalesBasedMilestonesMember" xlink:to="aciu_RegulatoryAndSalesBasedMilestonesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RegulatoryAndSalesBasedMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents regulatory and sales-based milestones</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RegulatoryAndSalesBasedMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Regulatory and sales-based milestones [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RegulatoryAndSalesBasedMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Regulatory and sales-based milestones</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GrantRevenueMember" xlink:label="aciu_GrantRevenueMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_GrantRevenueMember" xlink:to="aciu_GrantRevenueMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_GrantRevenueMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue earned from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_GrantRevenueMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grant revenue [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_GrantRevenueMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grant revenue [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SkaneUniversityHospitalMember" xlink:label="aciu_SkaneUniversityHospitalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SkaneUniversityHospitalMember" xlink:to="aciu_SkaneUniversityHospitalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_SkaneUniversityHospitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Skane University Hospital is a university hospital in Scania, Sweden.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SkaneUniversityHospitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Skane University Hospital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_SkaneUniversityHospitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Skane University Hospital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_SkaneUniversityHospitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Skane University Hospital</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" xlink:label="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" xlink:to="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Alpha Synuclein PET Imaging Diagnostic Agent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Alpha-synuclein PET imaging diagnostic agent</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AdvanceSmallMoleculePdProgramsMember" xlink:label="aciu_AdvanceSmallMoleculePdProgramsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AdvanceSmallMoleculePdProgramsMember" xlink:to="aciu_AdvanceSmallMoleculePdProgramsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AdvanceSmallMoleculePdProgramsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents advance small molecule PD programs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AdvanceSmallMoleculePdProgramsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Advance small molecule PD programs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AdvanceSmallMoleculePdProgramsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Advance small molecule PD programs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Legal Entity [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity [Domain]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" xlink:label="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" xlink:to="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Follow-on grant funding received, total for joint arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Follow-on grant funding received, total for joint arrangement</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FollowOnGrantFundingReceived" xlink:label="aciu_FollowOnGrantFundingReceived" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_FollowOnGrantFundingReceived" xlink:to="aciu_FollowOnGrantFundingReceived_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_FollowOnGrantFundingReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Follow-on grant funding received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_FollowOnGrantFundingReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Follow-on grant funding received</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfGrants" xlink:label="aciu_NumberOfGrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfGrants" xlink:to="aciu_NumberOfGrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of grants received.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of grants received</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementJointResearchCollaborationPeriod" xlink:label="aciu_CollaborativeAgreementJointResearchCollaborationPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementJointResearchCollaborationPeriod" xlink:to="aciu_CollaborativeAgreementJointResearchCollaborationPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementJointResearchCollaborationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The period over which collaborating entities are contracted to perform research, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementJointResearchCollaborationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, Joint research collaboration period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborativeAgreementJointResearchCollaborationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period of joint research agreement</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about borrowings [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Attribution of expenses by nature to their function [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LineItemsByFunctionMember" xlink:label="ifrs-full_LineItemsByFunctionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LineItemsByFunctionMember" xlink:to="ifrs-full_LineItemsByFunctionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LineItemsByFunctionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items by function [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ResearchAndDevelopmentExpensesMember" xlink:label="aciu_ResearchAndDevelopmentExpensesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ResearchAndDevelopmentExpensesMember" xlink:to="aciu_ResearchAndDevelopmentExpensesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ResearchAndDevelopmentExpensesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents research and development expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ResearchAndDevelopmentExpensesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ResearchAndDevelopmentExpensesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Selling, general and administrative expense [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and administrative expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about borrowings [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" xlink:to="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee benefits expense excluding share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee benefits expense excluding share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payroll expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense from share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseByNature" xlink:label="ifrs-full_ExpenseByNature" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseByNature" xlink:to="ifrs-full_ExpenseByNature_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseByNature_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expenses, by nature</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ExpenseByNature_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total expenses by category</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AverageNumberOfEmployees" xlink:label="ifrs-full_AverageNumberOfEmployees" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AverageNumberOfEmployees" xlink:to="ifrs-full_AverageNumberOfEmployees_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AverageNumberOfEmployees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Average number of employees</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FinancialResultNetAbstract" xlink:label="aciu_FinancialResultNetAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_FinancialResultNetAbstract" xlink:to="aciu_FinancialResultNetAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_FinancialResultNetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial Result, net [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_FinancialResultNetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial result, net [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes" xlink:label="aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes" xlink:to="aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gains (losses) on conversion features related to convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gains (losses) on conversion features related to convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gains on conversion features related to convertible notes</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfPersonsKeyManagementBoardOfDirectors" xlink:label="aciu_NumberOfPersonsKeyManagementBoardOfDirectors" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfPersonsKeyManagementBoardOfDirectors" xlink:to="aciu_NumberOfPersonsKeyManagementBoardOfDirectors_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfPersonsKeyManagementBoardOfDirectors_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of persons that are the included in Board of Directors excluding the Chief Executive Officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfPersonsKeyManagementBoardOfDirectors_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of persons, key management, Board of Directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfPersonsKeyManagementBoardOfDirectors_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of individuals, Board of Directors</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfPersonsKeyManagementExecutiveManagement" xlink:label="aciu_NumberOfPersonsKeyManagementExecutiveManagement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfPersonsKeyManagementExecutiveManagement" xlink:to="aciu_NumberOfPersonsKeyManagementExecutiveManagement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfPersonsKeyManagementExecutiveManagement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of persons that comprise key management of the entity that are Executive Management.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfPersonsKeyManagementExecutiveManagement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of persons, key management, Executive Management</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfPersonsKeyManagementExecutiveManagement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of individuals, Executive Management</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term employee benefits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Post-employment benefits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key management personnel compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total compensation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageMember" xlink:label="ifrs-full_WeightedAverageMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageMember" xlink:to="ifrs-full_WeightedAverageMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Geographical areas [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="ifrs-full_GeographicalAreasMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Geographical areas [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH" xlink:label="country_CH" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CH" xlink:to="country_CH_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CH_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SWITZERLAND</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="ifrs-full_DeferredTaxLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="ifrs-full_ApplicableTaxRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ApplicableTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Applicable tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ApplicableTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Applicable tax rate</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of accounting profit multiplied by applicable tax rates [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax expense reconciled to Income / (loss) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccountingProfit" xlink:label="ifrs-full_AccountingProfit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccountingProfit" xlink:to="ifrs-full_AccountingProfit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccountingProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccountingProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss before income tax</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax (benefit)/expense calculated at the domestic rates applicable in the respective countries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax benefit calculated at the domestic rates applicable in the respective countries</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" xlink:to="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax effect of income not subject to tax and expenses not deductible for tax purposes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax effect of income not subject to tax and expenses not deductible for tax purposes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Income not subject to tax)/expenses not deductible for tax purposes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfTaxLosses" xlink:to="ifrs-full_TaxEffectOfTaxLosses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectOfTaxLosses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax effect of tax losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxEffectOfTaxLosses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of unused tax losses and tax offsets not recognized as deferred tax assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary difference, unused tax losses and unused tax credits [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary difference, unused tax losses and unused tax credits [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesMember" xlink:label="ifrs-full_UnusedTaxLossesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedTaxLossesMember" xlink:to="ifrs-full_UnusedTaxLossesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnusedTaxLossesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unused tax losses [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_UnusedTaxLossesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax Losses</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" xlink:label="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" xlink:to="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Right of use assets and lease liabilities, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right of use assets and lease liabilities, net [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right of use assets and lease liabilities, net</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RetirementBenefitPlanMember" xlink:label="aciu_RetirementBenefitPlanMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RetirementBenefitPlanMember" xlink:to="aciu_RetirementBenefitPlanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RetirementBenefitPlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for retirement benefit plan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RetirementBenefitPlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retirement benefit plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RetirementBenefitPlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retirement benefit plan</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312024Member" xlink:label="aciu_December312024Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_December312024Member" xlink:to="aciu_December312024Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_December312024Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents December 31, 2024</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_December312024Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2024 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_December312024Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2024</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312025Member" xlink:label="aciu_December312025Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_December312025Member" xlink:to="aciu_December312025Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_December312025Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents December 31, 2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_December312025Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2025 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_December312025Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2025</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312026Member" xlink:label="aciu_December312026Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_December312026Member" xlink:to="aciu_December312026Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_December312026Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents December 31, 2026</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_December312026Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2026 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_December312026Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2026</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312027Member" xlink:label="aciu_December312027Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_December312027Member" xlink:to="aciu_December312027Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_December312027Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents December 31, 2027</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_December312027Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2027 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_December312027Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2027</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312028Member" xlink:label="aciu_December312028Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_December312028Member" xlink:to="aciu_December312028Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_December312028Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents December 31, 2028</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_December312028Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2028 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_December312028Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2028</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312029Member" xlink:label="aciu_December312029Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_December312029Member" xlink:to="aciu_December312029Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_December312029Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents December 31, 2029</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_December312029Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2029 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_December312029Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2029</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of temporary difference, unused tax losses and unused tax credits [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized deductible temporary differences, unused tax losses and unused tax credits [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:to="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deductible temporary differences for which no deferred tax asset is recognised</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TaxLossesSplitByExpiryDateAbstract" xlink:label="aciu_TaxLossesSplitByExpiryDateAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TaxLossesSplitByExpiryDateAbstract" xlink:to="aciu_TaxLossesSplitByExpiryDateAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TaxLossesSplitByExpiryDateAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax losses split by expiry date [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TaxLossesSplitByExpiryDateAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax losses split by expiry date [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unused tax losses for which no deferred tax asset recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecorded tax loss carryforwards</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" xlink:label="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" xlink:to="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in tax losses available for offset against future taxable profits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in tax losses available for offset against future taxable profits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of net defined benefit liability (asset) [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net defined benefit liability (asset) [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net defined benefit liability (asset) [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:label="ifrs-full_PresentValueOfDefinedBenefitObligationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:to="ifrs-full_PresentValueOfDefinedBenefitObligationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PresentValueOfDefinedBenefitObligationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Present value of defined benefit obligation [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PresentValueOfDefinedBenefitObligationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Benefit Obligation [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of net defined benefit liability (asset) [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees" xlink:to="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit plans, percentage of contributions by employees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit plans, percentage of contributions by employees</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer" xlink:to="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit plans, percentage of contributions by employer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit plans, percentage of contributions by employer</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SurplusDeficitInPlanAbstract" xlink:label="ifrs-full_SurplusDeficitInPlanAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SurplusDeficitInPlanAbstract" xlink:to="ifrs-full_SurplusDeficitInPlanAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SurplusDeficitInPlanAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Surplus (deficit) in plan [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SurplusDeficitInPlanAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit pension plan amount recognized in balance sheet [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit obligation, at present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential defined benefit obligation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="ifrs-full_PlanAssetsAtFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PlanAssetsAtFairValue" xlink:to="ifrs-full_PlanAssetsAtFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PlanAssetsAtFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plan assets, at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PlanAssetsAtFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value of plan assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SurplusDeficitInPlan" xlink:label="ifrs-full_SurplusDeficitInPlan" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SurplusDeficitInPlan" xlink:to="ifrs-full_SurplusDeficitInPlan_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SurplusDeficitInPlan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Surplus (deficit) in plan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_SurplusDeficitInPlan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total liability</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans" xlink:label="aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans" xlink:to="aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current and past service cost (gain), defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current and past service cost (gain), defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Service cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:label="ifrs-full_InterestExpenseDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:to="ifrs-full_InterestExpenseDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestExpenseDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestIncomeDefinedBenefitPlans" xlink:label="ifrs-full_InterestIncomeDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestIncomeDefinedBenefitPlans" xlink:to="ifrs-full_InterestIncomeDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestIncomeDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest income, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestIncomeDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:to="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Post-employment benefit expense in profit or loss, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net pension cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in net defined benefit liability (asset) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in defined benefit obligation [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in net defined benefit liability [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net defined benefit liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">At end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">At beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net defined benefit liabilities, end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net defined benefit liabilities, beginning of period</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome" xlink:to="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in net defined benefit liability (asset) resulting from current and past service costs (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in net defined benefit liability (asset) resulting from current and past service costs (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Service cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of changes in demographic assumptions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in demographic assumptions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of changes in financial assumptions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in financial assumptions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in experience assumptions</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xlink:to="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in net defined benefit liability (asset) resulting from benefits deposited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in net defined benefit liability (asset) resulting from benefits deposited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Benefits deposited</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan by plan participants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employees' contributions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsMember" xlink:label="ifrs-full_PlanAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PlanAssetsMember" xlink:to="ifrs-full_PlanAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PlanAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plan assets [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PlanAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value of Plan Assets [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:label="aciu_ChangesInFairValueOfPlanAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="aciu_ChangesInFairValueOfPlanAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ChangesInFairValueOfPlanAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in fair value of plan assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ChangesInFairValueOfPlanAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in fair value of plan assets [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease (increase) in net defined benefit liability (asset) resulting from resulting from contributions to plan by employer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employer's contribution</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employer's contributions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Return on plan assets excluding interest income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Return on plan assets excluding interest income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:label="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:to="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimate of contributions expected to be paid to plan for next annual reporting period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" xlink:label="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" xlink:to="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net pension cost through statement of income/(loss)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Remeasurement through other comprehensive income/(loss)</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OtherComprehensiveGainsLossesAbstract" xlink:label="aciu_OtherComprehensiveGainsLossesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract" xlink:to="aciu_OtherComprehensiveGainsLossesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OtherComprehensiveGainsLossesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive gains (losses) [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_OtherComprehensiveGainsLossesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive gains/(losses) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial gains (losses) arising from changes in demographic assumptions, net of tax, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of changes in demographic assumptions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial gains (losses) arising from changes in financial assumptions, net of tax, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of changes in financial assumptions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial gains (losses) arising from experience adjustments, net of tax, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of changes in experience assumptions</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" xlink:to="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Return on plan assets excluding interest income or expense, net of tax, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Return on plan assets excluding interest income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:label="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:to="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average duration period for defined benefit obligation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of sensitivity analysis for actuarial assumptions [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="ifrs-full_ActuarialAssumptionsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionsAxis" xlink:to="ifrs-full_ActuarialAssumptionsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumptions [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsMember" xlink:label="ifrs-full_ActuarialAssumptionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionsMember" xlink:to="ifrs-full_ActuarialAssumptionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumptions [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRatesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRatesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of discount rates [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRatesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount rate</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of expected rates of salary increases [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Future salary increase</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of expected rates of pension increases [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Future pension cost</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" xlink:to="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for the interest rate on savings capital used as actuarial assumptions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of interest rate on savings capital [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate on savings capital</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Types of risks [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_TypesOfRisksMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risks [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" xlink:to="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible increase in actuarial assumption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">+0.5% Increase [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" xlink:label="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" xlink:to="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible decrease in actuarial assumption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">-0.5% Decrease [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of sensitivity analysis for actuarial assumptions [line items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of sensitivity analysis for actuarial assumptions [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumptions [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of discount rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount rate</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of expected rates of salary increases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rate of future increase in compensations</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of expected rates of pension increases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rate of future increase in current pensions</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" xlink:to="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The expected rate of interest rates on retirement savings capital is used as a significant actuarial assumption to determine the present value of a defined benefit obligation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of interest rate on retirement savings capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate on retirement savings capital</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:label="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:to="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sensitivity analysis, actuarial assumptions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sensitivity analysis [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible increase in actuarial assumption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage increase in actuarial assumption</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible decrease in actuarial assumption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage decrease in actuarial assumption</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease/(increase) from actual defined benefit obligation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease/(increase) from actual defined benefit obligation</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfEquityBasedInstrumentPlans" xlink:label="aciu_NumberOfEquityBasedInstrumentPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfEquityBasedInstrumentPlans" xlink:to="aciu_NumberOfEquityBasedInstrumentPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfEquityBasedInstrumentPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of equity-based instrument plans approved by the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfEquityBasedInstrumentPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Equity-based Instrument Plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfEquityBasedInstrumentPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of equity-based instrument plans</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of terms and conditions of share-based payment arrangement [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Types of share-based payment arrangements [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payment arrangements [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_StockOptionPlanC1Member" xlink:label="aciu_StockOptionPlanC1Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_StockOptionPlanC1Member" xlink:to="aciu_StockOptionPlanC1Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_StockOptionPlanC1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">A share-based payment arrangement that existed at any time during the reporting period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_StockOptionPlanC1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock option plan C1 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_StockOptionPlanC1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Option Plan C1 [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Two016ShareOptionAndIncentivePlanMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Two016ShareOptionAndIncentivePlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Two016ShareOptionAndIncentivePlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 Share Option and Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Two016ShareOptionAndIncentivePlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 SOIP [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting tranche one of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 Share Option and Incentive Plan, Vesting Tranche One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 SOIP, Vesting Condition 1 [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting tranche two of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 Share Option and Incentive Plan, Vesting Tranche Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 SOIP, Vesting Condition 2 [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting tranche three of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 Share Option and Incentive Plan, Vesting Tranche Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 SOIP, Vesting Condition 3 [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Categories of related parties [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity's total for related parties [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Executives and Directors [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_EmployeesMember" xlink:label="aciu_EmployeesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_EmployeesMember" xlink:to="aciu_EmployeesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_EmployeesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Refers to personnel employed by the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_EmployeesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employees [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of terms and conditions of share-based payment arrangement [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ShareBasedPlansOutstandingAbstract" xlink:label="aciu_ShareBasedPlansOutstandingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ShareBasedPlansOutstandingAbstract" xlink:to="aciu_ShareBasedPlansOutstandingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ShareBasedPlansOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based plans outstanding [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ShareBasedPlansOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based plans outstanding [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted during the year (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of options awarded (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xlink:to="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">For vesting requirements for a type of share-based payment arrangement that existed at any time during the period, this element represents the period which an employees' right to exercise an award is no longer contingent on satisfaction of a service condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting requirements for share-based payment arrangement, award vesting period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting conditions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting conditions</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" xlink:label="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" xlink:to="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The maximum term of options granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum term of options granted for share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual life of options</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number and weighted average exercise prices of options under the share option programs [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfOptionsAbstract" xlink:label="aciu_NumberOfOptionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfOptionsAbstract" xlink:to="aciu_NumberOfOptionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Options [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of options [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding Options (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding at end of period (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding at beginning of period (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of share options forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forfeited during the year (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of share options expired in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expired during the year (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised during the year (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercisable (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageExercisePriceAbstract" xlink:label="aciu_WeightedAverageExercisePriceAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageExercisePriceAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageExercisePriceAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Exercise Price [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageExercisePriceAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_WeightedAverageExercisePriceAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average grant date fair value [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding at end of period (in CHF per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding at beginning of period (in CHF per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forfeited during the year (in CHF per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expired during the year (in CHF per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised during the year (in CHF per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted during the year (in CHF per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price for options granted (in CHF/USD per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercisable (in CHF per share)</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageRemainingAbstract" xlink:label="aciu_WeightedAverageRemainingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageRemainingAbstract" xlink:to="aciu_WeightedAverageRemainingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageRemainingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Remaining [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_WeightedAverageRemainingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining term (years) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining contractual life of outstanding share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining term (years), options outstanding</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" xlink:label="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" xlink:to="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining contractual life of share options exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining contractual life of share options exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining term (years), options exercisable</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of number and weighted average remaining contractual life of outstanding share options [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ranges of exercise prices for outstanding share options [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ranges of exercise prices for outstanding share options [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Chf0.15Member" xlink:label="aciu_Chf0.15Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Chf0.15Member" xlink:to="aciu_Chf0.15Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Chf0.15Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for CHF 0.15</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Chf0.15Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CHF 0.15 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Chf0.15Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CHF 0.15</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Chf9.53Member" xlink:label="aciu_Chf9.53Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Chf9.53Member" xlink:to="aciu_Chf9.53Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Chf9.53Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for CHF 9.53</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Chf9.53Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CHF 9.53 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Chf9.53Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CHF 9.53</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Usd5.04ToUsd12.30Member" xlink:label="aciu_Usd5.04ToUsd12.30Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Usd5.04ToUsd12.30Member" xlink:to="aciu_Usd5.04ToUsd12.30Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Usd5.04ToUsd12.30Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for USD 5.04 to USD 12.30</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Usd5.04ToUsd12.30Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">USD 5.04 to USD 12.30 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Usd5.04ToUsd12.30Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">USD 5.04 to USD 12.30</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Usd2.76ToUsd4.57Member" xlink:label="aciu_Usd2.76ToUsd4.57Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Usd2.76ToUsd4.57Member" xlink:to="aciu_Usd2.76ToUsd4.57Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Usd2.76ToUsd4.57Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for USD 2.76 to USD 4.57</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Usd2.76ToUsd4.57Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">USD 2.76 to USD 4.57 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Usd2.76ToUsd4.57Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">USD 2.76 to USD 4.57</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:label="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:to="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding Options Exercise Price Range and Expiry Dates [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding options, exercise price range and expiry dates [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average share price for share options in share-based payment arrangement exercised during period at date of exercise</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average share price of common share options exercised (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of range of exercise prices of outstanding share options [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of range of exercise prices of outstanding share options [line items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:to="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average fair value at measurement date, share options granted</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageAssumptionsAbstract" xlink:label="aciu_WeightedAverageAssumptionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="aciu_WeightedAverageAssumptionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageAssumptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Assumptions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageAssumptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average assumptions [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise price (in USD per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average share price, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share price (weighted average)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk free interest rate, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk free interest rate</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected volatility, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected volatility</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Option life, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected term</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dividend yield</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RestrictedSharesAndRestrictedShareUnitsMember" xlink:label="aciu_RestrictedSharesAndRestrictedShareUnitsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RestrictedSharesAndRestrictedShareUnitsMember" xlink:to="aciu_RestrictedSharesAndRestrictedShareUnitsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RestrictedSharesAndRestrictedShareUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RestrictedSharesAndRestrictedShareUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Shares and Restricted Share Units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RestrictedSharesAndRestrictedShareUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-vested Share Awards [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RestrictedStockUnitsMember" xlink:label="aciu_RestrictedStockUnitsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RestrictedStockUnitsMember" xlink:to="aciu_RestrictedStockUnitsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RestrictedStockUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for equity instruments that are convertible to stock after a specified period of time.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RestrictedStockUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_RestrictedStockUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RestrictedStockUnitsFirstVestingConditionsMember" xlink:label="aciu_RestrictedStockUnitsFirstVestingConditionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RestrictedStockUnitsFirstVestingConditionsMember" xlink:to="aciu_RestrictedStockUnitsFirstVestingConditionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RestrictedStockUnitsFirstVestingConditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Restricted Stock Units, first vesting conditions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RestrictedStockUnitsFirstVestingConditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units, first vesting conditions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RestrictedStockUnitsFirstVestingConditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units, first vesting conditions</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RestrictedStockUnitsSecondVestingConditionsMember" xlink:label="aciu_RestrictedStockUnitsSecondVestingConditionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RestrictedStockUnitsSecondVestingConditionsMember" xlink:to="aciu_RestrictedStockUnitsSecondVestingConditionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RestrictedStockUnitsSecondVestingConditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Restricted Stock Units, second vesting conditions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RestrictedStockUnitsSecondVestingConditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units, second vesting conditions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RestrictedStockUnitsSecondVestingConditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units, second vesting conditions</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_BoardOfDirectorsMember" xlink:label="aciu_BoardOfDirectorsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_BoardOfDirectorsMember" xlink:to="aciu_BoardOfDirectorsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_BoardOfDirectorsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key managers of an entity who collectively have responsibility of governing the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_BoardOfDirectorsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Board of Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_BoardOfDirectorsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Directors [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ExecutiveManagementMember" xlink:label="aciu_ExecutiveManagementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ExecutiveManagementMember" xlink:to="aciu_ExecutiveManagementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ExecutiveManagementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key managers, or ranking officers of an entity, appointed to their position by the board of directors.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ExecutiveManagementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Executive Management [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_ExecutiveManagementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Executives [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ShareBasedPaymentArrangementAbstract" xlink:label="aciu_ShareBasedPaymentArrangementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ShareBasedPaymentArrangementAbstract" xlink:to="aciu_ShareBasedPaymentArrangementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ShareBasedPaymentArrangementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payment arrangement [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted during the year (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of non-vested share awards granted (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" xlink:label="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" xlink:to="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The maximum term of other equity instruments (ie other than share options) granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum Term Of Other Equity Instruments Granted For Share Based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual life of options</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfNonVestedSharesAbstract" xlink:label="aciu_NumberOfNonVestedSharesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfNonVestedSharesAbstract" xlink:to="aciu_NumberOfNonVestedSharesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfNonVestedSharesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Non-vested Shares [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfNonVestedSharesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of non-vested shares [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-vested at end of period (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-vested at beginning of period (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forfeited during the year (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments expired in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expired during the year (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" xlink:label="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" xlink:to="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of other equity instruments (ie other than share options) exercised in a share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised during the year (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments exercised or vested in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vested during the year</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vested and exercisable (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, non-vested at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, non-vested at beginning of period</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, forfeited during the year</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, expired during the year</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, exercised during the year</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, granted during the year</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, vested during the year</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments vested and exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments vested and exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, vested and exercisable</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense from share-based payment transactions with employees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense charged against the income statement</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" xlink:to="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of disclosing information related to commitments and contingencies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of information about commitments and contingencies [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanFiveYearsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanFiveYearsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">More Than 5 Years [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xlink:to="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of information about commitments and contingencies [Line Items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CommitmentsAbstract" xlink:label="aciu_CommitmentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CommitmentsAbstract" xlink:to="aciu_CommitmentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CommitmentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CommitmentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and contingencies [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ContractualCapitalCommitmentsOtherThanForLeases" xlink:label="aciu_ContractualCapitalCommitmentsOtherThanForLeases" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ContractualCapitalCommitmentsOtherThanForLeases" xlink:to="aciu_ContractualCapitalCommitmentsOtherThanForLeases_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ContractualCapitalCommitmentsOtherThanForLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual capital commitments other than for leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ContractualCapitalCommitmentsOtherThanForLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual capital commitments other than for leases</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RentalContractPeriodForNoticeOfCancellation" xlink:label="aciu_RentalContractPeriodForNoticeOfCancellation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RentalContractPeriodForNoticeOfCancellation" xlink:to="aciu_RentalContractPeriodForNoticeOfCancellation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RentalContractPeriodForNoticeOfCancellation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The period of time required by the lessee in a lease agreement to provide notice of cancellation of a lease to the lessor, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RentalContractPeriodForNoticeOfCancellation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rental contract, period for notice of cancellation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RentalContractPeriodForNoticeOfCancellation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Notice period for cancellation of rental contract</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractualCapitalCommitments" xlink:label="ifrs-full_ContractualCapitalCommitments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContractualCapitalCommitments" xlink:to="ifrs-full_ContractualCapitalCommitments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContractualCapitalCommitments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual capital commitments</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsPerShareAbstract" xlink:label="ifrs-full_BasicEarningsPerShareAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsPerShareAbstract" xlink:to="ifrs-full_BasicEarningsPerShareAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic earnings per share [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BasicEarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic income/(loss) per share (EPS) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Profit (loss), attributable to ordinary equity holders of parent entity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Numerator</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net loss attributable to equity holders of the Company</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsPerShareAbstract" xlink:to="ifrs-full_DilutedEarningsPerShareAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Diluted income/(loss) per share (EPS) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:label="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:to="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Denominator</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageShares" xlink:label="ifrs-full_WeightedAverageShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average number of ordinary shares used in calculating basic earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted-average number of shares outstanding used to compute EPS basic attributable to equity holders</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average number of ordinary shares used in calculating diluted earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted-average number of shares outstanding used to compute EPS diluted attributable to equity holders</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AntidilutiveSecuritiesAbstract" xlink:label="aciu_AntidilutiveSecuritiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AntidilutiveSecuritiesAbstract" xlink:to="aciu_AntidilutiveSecuritiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AntidilutiveSecuritiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive securities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AntidilutiveSecuritiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive securities</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding" xlink:label="aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding" xlink:to="aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of dilutive share options that relate to the assumed exercise of the entity's share options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dilutive effect of share options issued and outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share options issued and outstanding (in-the-money)</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting" xlink:label="aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting" xlink:to="aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of dilutive restricted share awards subject to future vesting that relate to the assumed exercise of the entity's incentive share options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dilutive effect of Restricted share awards subject to future vesting</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted share awards subject to future vesting</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:to="ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dilutive effect of convertible instruments on number of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:to="aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options and potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dilutive effect of share options and convertible instruments on number of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total potentially dilutive securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of nature and extent of risks arising from financial instruments [table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="ifrs-full_CurrencyRiskMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrencyRiskMember" xlink:to="ifrs-full_CurrencyRiskMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrencyRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrencyRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign Currency Exchange Risk [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CreditRiskMember" xlink:label="ifrs-full_CreditRiskMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CreditRiskMember" xlink:to="ifrs-full_CreditRiskMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CreditRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Credit risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CreditRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Credit Risk [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiquidityRiskMember" xlink:label="ifrs-full_LiquidityRiskMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiquidityRiskMember" xlink:to="ifrs-full_LiquidityRiskMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiquidityRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liquidity risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LiquidityRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liquidity Risk [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateRiskMember" xlink:label="ifrs-full_InterestRateRiskMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateRiskMember" xlink:to="ifrs-full_InterestRateRiskMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestRateRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestRateRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Rate [member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of financial assets [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="ifrs-full_FinancialAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="ifrs-full_FinancialAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial assets, class [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RightOfUseFinancialAssetsMember" xlink:label="aciu_RightOfUseFinancialAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RightOfUseFinancialAssetsMember" xlink:to="aciu_RightOfUseFinancialAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RightOfUseFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for right-of-use financial assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RightOfUseFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right of use financial assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RightOfUseFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_RightOfUseFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LongTermFinancialAssetsMember" xlink:label="aciu_LongTermFinancialAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_LongTermFinancialAssetsMember" xlink:to="aciu_LongTermFinancialAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_LongTermFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents financial assets classified as long-term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_LongTermFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Financial Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_LongTermFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term financial assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OtherCurrentReceivablesMember" xlink:label="aciu_OtherCurrentReceivablesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OtherCurrentReceivablesMember" xlink:to="aciu_OtherCurrentReceivablesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_OtherCurrentReceivablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OtherCurrentReceivablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ShortTermFinancialAssetsMember" xlink:label="aciu_ShortTermFinancialAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ShortTermFinancialAssetsMember" xlink:to="aciu_ShortTermFinancialAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ShortTermFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents financial assets classified as short-term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ShortTermFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term Financial Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ShortTermFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term financial assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashOnHandAndCashEquivalentsMember" xlink:label="aciu_CashOnHandAndCashEquivalentsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CashOnHandAndCashEquivalentsMember" xlink:to="aciu_CashOnHandAndCashEquivalentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CashOnHandAndCashEquivalentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CashOnHandAndCashEquivalentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash on hand and cash equivalents [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CashOnHandAndCashEquivalentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_CashOnHandAndCashEquivalentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of financial liabilities [axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="ifrs-full_FinancialLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="ifrs-full_FinancialLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial liabilities, class [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LongTermLeaseLiabilitiesMember" xlink:label="aciu_LongTermLeaseLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_LongTermLeaseLiabilitiesMember" xlink:to="aciu_LongTermLeaseLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_LongTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Long-term lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_LongTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term lease liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_LongTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term lease liabilities</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TradeAndOtherPayablesMember" xlink:label="aciu_TradeAndOtherPayablesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TradeAndOtherPayablesMember" xlink:to="aciu_TradeAndOtherPayablesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TradeAndOtherPayablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for trade and other payables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TradeAndOtherPayablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and Other Payables [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TradeAndOtherPayablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other payables</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AccruedExpensesMember" xlink:label="aciu_AccruedExpensesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AccruedExpensesMember" xlink:to="aciu_AccruedExpensesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AccruedExpensesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for accrued expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AccruedExpensesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AccruedExpensesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ShortTermLeaseLiabilitiesMember" xlink:label="aciu_ShortTermLeaseLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ShortTermLeaseLiabilitiesMember" xlink:to="aciu_ShortTermLeaseLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ShortTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for short-term lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ShortTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term lease liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ShortTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term Lease Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_ShortTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term lease liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of nature and extent of risks arising from financial instruments [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FinancialAssetsAndLiabilitiesAbstract" xlink:label="aciu_FinancialAssetsAndLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_FinancialAssetsAndLiabilitiesAbstract" xlink:to="aciu_FinancialAssetsAndLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_FinancialAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial assets and liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_FinancialAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial assets and liabilities [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets" xlink:label="ifrs-full_FinancialAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial liabilities</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FinancialRisksAbstract" xlink:label="aciu_FinancialRisksAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_FinancialRisksAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_FinancialRisksAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial risks [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_FinancialRisksAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial risks [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:label="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:to="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible strengthening or weakening of reporting currency against other relevant currencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible strengthening or weakening of reporting currency against other relevant currencies</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:to="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in profit (loss) resulting from reasonably possible strengthening or weakening of reporting currency against other relevant currencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in profit (loss) resulting from reasonably possible strengthening or weakening of reporting currency against other relevant currencies</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates" xlink:label="aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates" xlink:to="aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents subject to negative interest rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents subject to negative interest rates</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:to="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible increase or decrease in interest rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible increase or decrease in interest rates</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:to="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in profit (loss) resulting from reasonably possible increase or decrease in interest rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in profit (loss) resulting from reasonably possible increase or decrease in interest rates</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" xlink:label="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" xlink:to="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of financial institutions holding the entity's deposits of cash and cash equivalents and short-term financial assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of financial institutions holding, cash and cash equivalents and short-term financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of financial institutions holding cash and cash equivalents and short-term financial assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LiquidityManagementRollingForecastPeriod" xlink:label="aciu_LiquidityManagementRollingForecastPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_LiquidityManagementRollingForecastPeriod" xlink:to="aciu_LiquidityManagementRollingForecastPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_LiquidityManagementRollingForecastPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The periodic interval in which the entity performs a rolling forecast of the entity's cash position, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_LiquidityManagementRollingForecastPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liquidity management, rolling forecast period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_LiquidityManagementRollingForecastPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash position rolling forecast period</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>57
<FILENAME>aciu-20221231_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.2.0.4 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/15/2023 5:39:21 PM-->
<!--Modified on: 3/15/2023 5:39:21 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DocumentDocumentAndEntityInformation" roleURI="http://acimume.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#StatementCondensedConsolidatedStatementsOfIncomeLoss" roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss" roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#StatementCondensedConsolidatedStatementsOfChangesInEquity" roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#StatementCondensedConsolidatedStatementsOfCashFlows" roleURI="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureGeneralInformation" roleURI="http://acimume.com/role/DisclosureGeneralInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureBasisOfPreparation" roleURI="http://acimume.com/role/DisclosureBasisOfPreparation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSummaryOfSignificantAccountingPolicies" roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosurePropertyPlantAndEquipment" roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureAssetAcquisition" roleURI="http://acimume.com/role/DisclosureAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureIntangibleAssets" roleURI="http://acimume.com/role/DisclosureIntangibleAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets" roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosurePrepaidExpensesAndAccruedIncome" roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureOtherCurrentReceivables" roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapital" roleURI="http://acimume.com/role/DisclosureShareCapital" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureTradeAndOtherPayablesAndAccruedExpenses" roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenues" roleURI="http://acimume.com/role/DisclosureContractRevenues" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureExpensesByCategory" roleURI="http://acimume.com/role/DisclosureExpensesByCategory" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRelatedPartyTransactions" roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureIncomeTaxes" roleURI="http://acimume.com/role/DisclosureIncomeTaxes" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlan" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlan" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareBasedCompensation" roleURI="http://acimume.com/role/DisclosureShareBasedCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureCommitmentsAndContingencies" roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingencies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureEarningsPerShare" roleURI="http://acimume.com/role/DisclosureEarningsPerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureFinancialInstrumentsAndRiskManagement" roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureCapitalRiskManagement" roleURI="http://acimume.com/role/DisclosureCapitalRiskManagement" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSubsequentEvents" roleURI="http://acimume.com/role/DisclosureSubsequentEvents" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosurePropertyPlantAndEquipmentTables" roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureAssetAcquisitionTables" roleURI="http://acimume.com/role/DisclosureAssetAcquisitionTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureIntangibleAssetsTables" roleURI="http://acimume.com/role/DisclosureIntangibleAssetsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables" roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosurePrepaidExpensesAndAccruedIncomeTables" roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureOtherCurrentReceivablesTables" roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivablesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalTables" roleURI="http://acimume.com/role/DisclosureShareCapitalTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureTradeAndOtherPayablesAndAccruedExpensesTables" roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesTables" roleURI="http://acimume.com/role/DisclosureContractRevenuesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureExpensesByCategoryTables" roleURI="http://acimume.com/role/DisclosureExpensesByCategoryTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRelatedPartyTransactionsTables" roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactionsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureIncomeTaxesTables" roleURI="http://acimume.com/role/DisclosureIncomeTaxesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanTables" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareBasedCompensationTables" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureCommitmentsAndContingenciesTables" roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureEarningsPerShareTables" roleURI="http://acimume.com/role/DisclosureEarningsPerShareTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureFinancialInstrumentsAndRiskManagementTables" roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureGeneralInformationDetails" roleURI="http://acimume.com/role/DisclosureGeneralInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureBasisOfPreparationGoingConcernDetails" roleURI="http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosurePropertyPlantAndEquipmentDetails" roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureAssetAcquisitionDetails" roleURI="http://acimume.com/role/DisclosureAssetAcquisitionDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureIntangibleAssetsDetails" roleURI="http://acimume.com/role/DisclosureIntangibleAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosurePrepaidExpensesAndAccruedIncomeDetails" roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureOtherCurrentReceivablesDetails" roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalNarrativesDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalNarrativesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalCapitalStructureDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalAuthorizedCapitalDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalShelfRegistrationStatementDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalAtMarketEquityOfferingDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareCapitalConvertibleNoteAgreementDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureExpensesByCategoryDetails" roleURI="http://acimume.com/role/DisclosureExpensesByCategoryDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRelatedPartyTransactionsDetails" roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" roleURI="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" roleURI="http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareBasedCompensationPlansOutstandingDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureShareBasedCompensationNonVestedShareAwardsDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureCommitmentsAndContingenciesDetails" roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureEarningsPerShareDetails" roleURI="http://acimume.com/role/DisclosureEarningsPerShareDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20221231.xsd#DisclosureFinancialInstrumentsAndRiskManagementDetails" roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <presentationLink xlink:role="http://acimume.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable_638144987574466774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressesTable_638144987574466774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis_638144987574476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesTable_638144987574466774" xlink:to="dei_EntityAddressesAddressTypeAxis_638144987574476773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain_638144987574476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis_638144987574476773" xlink:to="dei_AddressTypeDomain_638144987574476773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember_638144987574476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AddressTypeDomain_638144987574476773" xlink:to="dei_BusinessContactMember_638144987574476773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems_638144987574476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesTable_638144987574466774" xlink:to="dei_EntityAddressesLineItems_638144987574476773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638144987574476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_DocumentType_638144987574476773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638144987574516777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityRegistrantName_638144987574516777" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement_638144987574516777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_DocumentRegistrationStatement_638144987574516777" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638144987574516777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityCentralIndexKey_638144987574516777" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638144987574516777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_DocumentPeriodEndDate_638144987574516777" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus_638144987574516777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_DocumentFiscalPeriodFocus_638144987574516777" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus_638144987574526774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_DocumentFiscalYearFocus_638144987574526774" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638144987574526774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_AmendmentFlag_638144987574526774" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_638144987574526774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_CurrentFiscalYearEndDate_638144987574526774" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport_638144987574526774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_DocumentAnnualReport_638144987574526774" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport_638144987574526774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_DocumentTransitionReport_638144987574526774" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport_638144987574526774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_DocumentShellCompanyReport_638144987574526774" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638144987574526774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityFileNumber_638144987574526774" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638144987574526774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityIncorporationStateCountryCode_638144987574526774" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638144987574526774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityAddressAddressLine1_638144987574526774" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_638144987574526774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityAddressAddressLine2_638144987574526774" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638144987574526774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityAddressPostalZipCode_638144987574526774" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638144987574526774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityAddressCityOrTown_638144987574526774" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry_638144987574536796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityAddressCountry_638144987574536796" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName_638144987574536796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_ContactPersonnelName_638144987574536796" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638144987574536796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_CityAreaCode_638144987574536796" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638144987574536796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_LocalPhoneNumber_638144987574536796" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638144987574536796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_Security12bTitle_638144987574536796" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638144987574536796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_TradingSymbol_638144987574536796" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638144987574536796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_SecurityExchangeName_638144987574536796" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding_638144987574536796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityCommonStockSharesOutstanding_638144987574536796" order="26" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer_638144987574536796" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityWellKnownSeasonedIssuer_638144987574536796" order="27" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers_638144987574546772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityVoluntaryFilers_638144987574546772" order="28" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus_638144987574546772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityCurrentReportingStatus_638144987574546772" order="29" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent_638144987574546772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityInteractiveDataCurrent_638144987574546772" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_638144987574546772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityFilerCategory_638144987574546772" order="31" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638144987574546772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityEmergingGrowthCompany_638144987574546772" order="32" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag_638144987574546772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_IcfrAuditorAttestationFlag_638144987574546772" order="33" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard_638144987574546772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_DocumentAccountingStandard_638144987574546772" order="34" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany_638144987574546772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_EntityShellCompany_638144987574546772" order="35" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId_638144987574556773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_AuditorFirmId_638144987574556773" order="36" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName_638144987574556773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_AuditorName_638144987574556773" order="37" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation_638144987574556773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638144987574476773" xlink:to="dei_AuditorLocation_638144987574556773" order="38" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - Condensed Consolidated Balance Sheets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract_638144987574556773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_AssetsAbstract_638144987574556773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="ifrs-full_NoncurrentAssetsAbstract_638144987574556773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsAbstract_638144987574556773" xlink:to="ifrs-full_NoncurrentAssetsAbstract_638144987574556773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment_638144987574556773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_638144987574556773" xlink:to="ifrs-full_PropertyPlantAndEquipment_638144987574556773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets_638144987574556773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_638144987574556773" xlink:to="ifrs-full_RightofuseAssets_638144987574556773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_638144987574556773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_638144987574556773" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_638144987574556773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_638144987574556773" xlink:to="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_638144987574566772" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_638144987574556773" xlink:to="ifrs-full_NoncurrentAssets_638144987574566772" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="ifrs-full_CurrentAssetsAbstract_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsAbstract_638144987574556773" xlink:to="ifrs-full_CurrentAssetsAbstract_638144987574566772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_638144987574566772" xlink:to="ifrs-full_CurrentPrepaidExpenses_638144987574566772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_638144987574566772" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638144987574566772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="ifrs-full_OtherCurrentReceivables_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_638144987574566772" xlink:to="ifrs-full_OtherCurrentReceivables_638144987574566772" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_638144987574566772" xlink:to="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638144987574566772" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_638144987574566772" xlink:to="ifrs-full_CashAndCashEquivalents_638144987574566772" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_638144987574566772" xlink:to="ifrs-full_CurrentAssets_638144987574566772" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="ifrs-full_Assets_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsAbstract_638144987574556773" xlink:to="ifrs-full_Assets_638144987574566772" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAndLiabilitiesAbstract_638144987574566772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_638144987574566772" xlink:to="ifrs-full_EquityAbstract_638144987574566772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_638144987574566772" xlink:to="ifrs-full_IssuedCapital_638144987574566772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharePremium" xlink:label="ifrs-full_SharePremium_638144987574566772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_638144987574566772" xlink:to="ifrs-full_SharePremium_638144987574566772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasuryShares" xlink:label="ifrs-full_TreasuryShares_638144987574576770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_638144987574566772" xlink:to="ifrs-full_TreasuryShares_638144987574576770" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_638144987574576770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_638144987574566772" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_638144987574576770" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings_638144987574576770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_638144987574566772" xlink:to="ifrs-full_RetainedEarnings_638144987574576770" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_638144987574576770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_638144987574566772" xlink:to="ifrs-full_Equity_638144987574576770" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_638144987574576770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_638144987574566772" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_638144987574576770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_638144987574576770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract_638144987574576770" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_638144987574576770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_638144987574576770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract_638144987574576770" xlink:to="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_638144987574576770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities_638144987574576770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract_638144987574576770" xlink:to="ifrs-full_NoncurrentLiabilities_638144987574576770" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_638144987574576770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_638144987574566772" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_638144987574576770" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_638144987574576770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_638144987574576770" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_638144987574576770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_638144987574586769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_638144987574576770" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_638144987574586769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638144987574586769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_638144987574576770" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638144987574586769" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities_638144987574586769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_638144987574576770" xlink:to="ifrs-full_CurrentLeaseLiabilities_638144987574586769" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities_638144987574586769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_638144987574576770" xlink:to="ifrs-full_CurrentLiabilities_638144987574586769" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Liabilities" xlink:label="ifrs-full_Liabilities_638144987574586769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_638144987574566772" xlink:to="ifrs-full_Liabilities_638144987574586769" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="ifrs-full_EquityAndLiabilities_638144987574586769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_638144987574566772" xlink:to="ifrs-full_EquityAndLiabilities_638144987574586769" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss" xlink:type="extended" xlink:title="00200 - Statement - Condensed Consolidated Statements of Income/(Loss)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueAbstract" xlink:label="ifrs-full_RevenueAbstract_638144987574586769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_RevenueAbstract_638144987574586769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638144987574586769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RevenueAbstract_638144987574586769" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638144987574586769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RevenueAbstract_638144987574586769" xlink:to="ifrs-full_Revenue_638144987574596770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ExpensesOperatingAbstract" xlink:label="aciu_ExpensesOperatingAbstract_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="aciu_ExpensesOperatingAbstract_638144987574596770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ExpensesOperatingAbstract_638144987574596770" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_638144987574596770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ExpensesOperatingAbstract_638144987574596770" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_638144987574596770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="ifrs-full_OtherOperatingIncomeExpense_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ExpensesOperatingAbstract_638144987574596770" xlink:to="ifrs-full_OtherOperatingIncomeExpense_638144987574596770" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="ifrs-full_OperatingExpense_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ExpensesOperatingAbstract_638144987574596770" xlink:to="ifrs-full_OperatingExpense_638144987574596770" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_638144987574596770" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_FinanceIncome_638144987574596770" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_FinanceCosts_638144987574596770" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638144987574596770" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_FinanceIncomeCost_638144987574596770" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossBeforeTax_638144987574596770" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_638144987574596770" order="9" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_638144987574596770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLoss_638144987574596770" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="ifrs-full_EarningsPerShareAbstract_638144987574606775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_EarningsPerShareAbstract_638144987574606775" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="ifrs-full_BasicEarningsLossPerShare_638144987574606775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract_638144987574606775" xlink:to="ifrs-full_BasicEarningsLossPerShare_638144987574606775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare_638144987574606775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract_638144987574606775" xlink:to="ifrs-full_DilutedEarningsLossPerShare_638144987574606775" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:type="extended" xlink:title="00300 - Statement - Condensed Consolidated Statements of Comprehensive Income/(Loss)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="StatementOfComprehensiveIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_638144987574606775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_ProfitLoss_638144987574606775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_638144987574606775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_638144987574606775" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_638144987574606775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_638144987574606775" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_638144987574606775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_638144987574606775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_638144987574606775" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_638144987574606775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_638144987574606775" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_638144987574606775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome_638144987574606775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_OtherComprehensiveIncome_638144987574606775" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome_638144987574606775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_ComprehensiveIncome_638144987574606775" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity" xlink:type="extended" xlink:title="00400 - Statement - Condensed Consolidated Statements of Changes in Equity" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="ifrs-full_StatementOfChangesInEquityAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable_638144987574606775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityAbstract" xlink:to="ifrs-full_StatementOfChangesInEquityTable_638144987574606775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable_638144987574606775" xlink:to="ifrs-full_ComponentsOfEquityAxis_638144987574616773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638144987574616773" xlink:to="ifrs-full_IssuedCapitalMember_638144987574616773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharePremiumMember" xlink:label="ifrs-full_SharePremiumMember_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638144987574616773" xlink:to="ifrs-full_SharePremiumMember_638144987574616773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638144987574616773" xlink:to="ifrs-full_TreasurySharesMember_638144987574616773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="ifrs-full_RetainedEarningsMember_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638144987574616773" xlink:to="ifrs-full_RetainedEarningsMember_638144987574616773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638144987574616773" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_638144987574616773" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638144987574616773" xlink:to="ifrs-full_EquityMember_638144987574616773" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable_638144987574606775" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems_638144987574616773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638144987574616773" xlink:to="ifrs-full_Equity_638144987574616773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638144987574616773" xlink:to="ifrs-full_ProfitLoss_638144987574616773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638144987574616773" xlink:to="ifrs-full_OtherComprehensiveIncome_638144987574616773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638144987574616773" xlink:to="ifrs-full_ComprehensiveIncome_638144987574616773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638144987574616773" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_638144987574616773" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638144987574616773" xlink:to="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_638144987574616773" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssuedAbstract" xlink:label="ifrs-full_NumberOfSharesIssuedAbstract_638144987574616773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638144987574616773" xlink:to="ifrs-full_NumberOfSharesIssuedAbstract_638144987574616773" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" xlink:label="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset_638144987574626773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract_638144987574616773" xlink:to="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset_638144987574626773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" xlink:label="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity_638144987574626773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract_638144987574616773" xlink:to="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity_638144987574626773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_638144987574626773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract_638144987574616773" xlink:to="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_638144987574626773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_638144987574626773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract_638144987574616773" xlink:to="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_638144987574626773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IssueOfEquityRestrictedShareAwards" xlink:label="aciu_IssueOfEquityRestrictedShareAwards_638144987574626773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract_638144987574616773" xlink:to="aciu_IssueOfEquityRestrictedShareAwards_638144987574626773" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_638144987574626773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract_638144987574616773" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_638144987574626773" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_638144987574626773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638144987574616773" xlink:to="ifrs-full_Equity_638144987574626773" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00500 - Statement - Condensed Consolidated Statements of Cash Flows" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638144987574626773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638144987574626773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_638144987574626773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638144987574626773" xlink:to="ifrs-full_ProfitLoss_638144987574626773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638144987574626773" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638144987574636772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638144987574636772" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense_638144987574636772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets" xlink:label="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638144987574636772" xlink:to="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_638144987574636772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="ifrs-full_AdjustmentsForFinanceIncomeCost_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638144987574636772" xlink:to="ifrs-full_AdjustmentsForFinanceIncomeCost_638144987574636772" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638144987574636772" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_638144987574636772" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638144987574636772" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_638144987574636772" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="ifrs-full_AdjustmentsForInterestExpense_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638144987574636772" xlink:to="ifrs-full_AdjustmentsForInterestExpense_638144987574636772" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638144987574636772" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_638144987574636772" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ChangesInWorkingCapitalAbstract" xlink:label="aciu_ChangesInWorkingCapitalAbstract_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638144987574626773" xlink:to="aciu_ChangesInWorkingCapitalAbstract_638144987574636772" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInWorkingCapitalAbstract_638144987574636772" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_638144987574636772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInWorkingCapitalAbstract_638144987574636772" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_638144987574636772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInWorkingCapitalAbstract_638144987574636772" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_638144987574636772" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses" xlink:label="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInWorkingCapitalAbstract_638144987574636772" xlink:to="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_638144987574636772" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_638144987574636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInWorkingCapitalAbstract_638144987574636772" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_638144987574636772" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_638144987574646770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInWorkingCapitalAbstract_638144987574636772" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_638144987574646770" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperations" xlink:label="ifrs-full_CashFlowsFromUsedInOperations_638144987574646770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638144987574626773" xlink:to="ifrs-full_CashFlowsFromUsedInOperations_638144987574646770" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_638144987574646770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638144987574626773" xlink:to="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_638144987574646770" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="ifrs-full_InterestPaidClassifiedAsOperatingActivities_638144987574646770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638144987574626773" xlink:to="ifrs-full_InterestPaidClassifiedAsOperatingActivities_638144987574646770" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:label="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_638144987574646770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638144987574626773" xlink:to="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_638144987574646770" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_638144987574646770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638144987574626773" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_638144987574646770" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_638144987574646770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_638144987574646770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" xlink:label="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_638144987574646770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_638144987574646770" xlink:to="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_638144987574646770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_638144987574646770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_638144987574646770" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_638144987574646770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_638144987574646770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_638144987574646770" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_638144987574646770" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAdvancesForRentDeposit" xlink:label="aciu_CashAdvancesForRentDeposit_638144987574646770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_638144987574646770" xlink:to="aciu_CashAdvancesForRentDeposit_638144987574646770" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_638144987574656770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_638144987574646770" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_638144987574656770" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638144987574656770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638144987574656770" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromIssueOfConvertibleDebt" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_638144987574656770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638144987574656770" xlink:to="aciu_ProceedsFromIssueOfConvertibleDebt_638144987574656770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="ifrs-full_PaymentsForShareIssueCosts_638144987574656770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638144987574656770" xlink:to="ifrs-full_PaymentsForShareIssueCosts_638144987574656770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_638144987574656770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638144987574656770" xlink:to="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_638144987574656770" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_638144987574656770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638144987574656770" xlink:to="aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_638144987574656770" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_638144987574656770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638144987574656770" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_638144987574656770" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_638144987574656770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638144987574656770" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_638144987574656770" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_638144987574656770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638144987574656770" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_638144987574656770" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" xlink:label="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_638144987574666773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638144987574656770" xlink:to="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_638144987574666773" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfCurrentBorrowings" xlink:label="ifrs-full_RepaymentsOfCurrentBorrowings_638144987574666773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638144987574656770" xlink:to="ifrs-full_RepaymentsOfCurrentBorrowings_638144987574666773" order="9" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:label="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_638144987574666773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638144987574656770" xlink:to="ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_638144987574666773" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987574666773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638144987574656770" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_638144987574666773" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_638144987574666773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_638144987574666773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_638144987574666773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents_638144987574666773" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_638144987574666773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_638144987574666773" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_638144987574676771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents_638144987574676771" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SupplementalNonCashActivityAbstract" xlink:label="aciu_SupplementalNonCashActivityAbstract_638144987574676771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="aciu_SupplementalNonCashActivityAbstract_638144987574676771" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" xlink:label="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities_638144987574676771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SupplementalNonCashActivityAbstract_638144987574676771" xlink:to="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities_638144987574676771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" xlink:label="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition_638144987574676771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SupplementalNonCashActivityAbstract_638144987574676771" xlink:to="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition_638144987574676771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost_638144987574676771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SupplementalNonCashActivityAbstract_638144987574676771" xlink:to="ifrs-full_ShareIssueRelatedCost_638144987574676771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RepaymentOfConvertibleDebtEquitySettlementAmount" xlink:label="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount_638144987574676771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SupplementalNonCashActivityAbstract_638144987574676771" xlink:to="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount_638144987574676771" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureGeneralInformation" xlink:type="extended" xlink:title="10101 - Disclosure - General information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GeneralInformationAbstract" xlink:label="GeneralInformationAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" xlink:label="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock_638144987574686772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationAbstract" xlink:to="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock_638144987574686772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureBasisOfPreparation" xlink:type="extended" xlink:title="10201 - Disclosure - Basis of preparation" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_BasisOfPreparationAbstract" xlink:label="BasisOfPreparationAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_638144987574686772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPreparationAbstract" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_638144987574686772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="extended" xlink:title="10301 - Disclosure - Summary of significant accounting policies" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_638144987574686772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_638144987574686772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosurePropertyPlantAndEquipment" xlink:type="extended" xlink:title="10401 - Disclosure - Property, plant and equipment" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="DisclosureOfPropertyPlantAndEquipmentAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_638144987574696775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_638144987574696775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities" xlink:type="extended" xlink:title="10501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_638144987574696775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory_638144987574696775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureAssetAcquisition" xlink:type="extended" xlink:title="10601 - Disclosure - Asset acquisition" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AssetAcquisitionsAbstract" xlink:label="aciu_AssetAcquisitionsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfAssetAcquisitionsTextBlock" xlink:label="aciu_DisclosureOfAssetAcquisitionsTextBlock_638144987574696775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AssetAcquisitionsAbstract" xlink:to="aciu_DisclosureOfAssetAcquisitionsTextBlock_638144987574696775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIntangibleAssets" xlink:type="extended" xlink:title="10701 - Disclosure - Intangible assets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="DisclosureOfIntangibleAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_638144987574696775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_638144987574696775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets" xlink:type="extended" xlink:title="10801 - Disclosure - Cash and cash equivalents and short-term financial assets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="DisclosureOfFinancialAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" xlink:label="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock_638144987574696775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialAssetsAbstract" xlink:to="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock_638144987574696775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome" xlink:type="extended" xlink:title="10901 - Disclosure - Prepaid expenses and accrued income" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:label="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" xlink:label="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock_638144987574706770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:to="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock_638144987574706770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureOtherCurrentReceivables" xlink:type="extended" xlink:title="11001 - Disclosure - Other current receivables" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OtherCurrentReceivablesAbstract" xlink:label="OtherCurrentReceivablesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfOtherCurrentReceivablesTextBlock" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTextBlock_638144987574706770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherCurrentReceivablesAbstract" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesTextBlock_638144987574706770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapital" xlink:type="extended" xlink:title="11101 - Disclosure - Share capital" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_638144987574706770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_8" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_638144987574706770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses" xlink:type="extended" xlink:title="11201 - Disclosure - Trade and other payables and accrued expenses" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="TradeAndOtherCurrentPayablesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" xlink:label="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock_638144987574716772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TradeAndOtherCurrentPayablesAbstract" xlink:to="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock_638144987574716772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenues" xlink:type="extended" xlink:title="11301 - Disclosure - Contract revenues" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory_638144987574716772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfRevenueExplanatory_638144987574716772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureExpensesByCategory" xlink:type="extended" xlink:title="11401 - Disclosure - Expenses by category" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ExpensesByCategoryAbstract" xlink:label="ExpensesByCategoryAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfExpensesExplanatory" xlink:label="ifrs-full_DisclosureOfExpensesExplanatory_638144987574716772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesByCategoryAbstract" xlink:to="ifrs-full_DisclosureOfExpensesExplanatory_638144987574716772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRelatedPartyTransactions" xlink:type="extended" xlink:title="11501 - Disclosure - Related-party transactions" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_638144987574716772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_638144987574716772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxes" xlink:type="extended" xlink:title="11601 - Disclosure - Income taxes" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="MajorComponentsOfTaxExpenseIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_638144987574726772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_638144987574726772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlan" xlink:type="extended" xlink:title="11701 - Disclosure - Retirement benefit plan" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_638144987574726772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_638144987574726772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensation" xlink:type="extended" xlink:title="11801 - Disclosure - Share-based compensation" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_638144987574726772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_638144987574726772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCommitmentsAndContingencies" xlink:type="extended" xlink:title="11901 - Disclosure - Commitments and contingencies" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CommitmentsAndContingenciesAbstract" xlink:label="CommitmentsAndContingenciesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_638144987574726772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesAbstract" xlink:to="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_638144987574726772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureEarningsPerShare" xlink:type="extended" xlink:title="12001 - Disclosure - Earnings per share" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_638144987574736770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_638144987574736770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement" xlink:type="extended" xlink:title="12101 - Disclosure - Financial instruments and risk management" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:label="DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_638144987574736770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_638144987574736770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCapitalRiskManagement" xlink:type="extended" xlink:title="12201 - Disclosure - Capital risk management" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xlink:label="DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_638144987574736770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xlink:to="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_638144987574736770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSubsequentEvents" xlink:type="extended" xlink:title="12301 - Disclosure - Subsequent events" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_638144987574736770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_638144987574736770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" xlink:title="20302 - Disclosure - Summary of significant accounting policies (Policies)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_638144987574746770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_638144987574746770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" xlink:label="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock_638144987574746770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock_638144987574746770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_638144987574746770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_638144987574746770" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_638144987574746770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_638144987574746770" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" xlink:label="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock_638144987574746770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock_638144987574746770" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_638144987574746770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_638144987574746770" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_638144987574746770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_638144987574746770" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_638144987574746770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_638144987574746770" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GrantIncomePolicyTextBlock" xlink:label="aciu_GrantIncomePolicyTextBlock_638144987574746770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_GrantIncomePolicyTextBlock_638144987574746770" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_638144987574746770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_638144987574746770" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_638144987574746770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_638144987574746770" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_638144987574746770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_638144987574746770" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_638144987574756769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_638144987574756769" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_638144987574756769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_638144987574756769" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_638144987574756769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_638144987574756769" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_638144987574756769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_638144987574756769" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_638144987574756769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_638144987574756769" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_638144987574756769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_638144987574756769" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_638144987574756769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_638144987574756769" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_638144987574756769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_638144987574756769" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" xlink:label="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock_638144987574756769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock_638144987574756769" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" xlink:title="30303 - Disclosure - Summary of significant accounting policies (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:label="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_638144987574766785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_638144987574766785" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" xlink:label="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock_638144987574766785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock_638144987574766785" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:label="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock_638144987574766785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock_638144987574766785" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables" xlink:type="extended" xlink:title="30403 - Disclosure - Property, plant and equipment (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="DisclosureOfPropertyPlantAndEquipmentAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_638144987574766785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_638144987574766785" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables" xlink:type="extended" xlink:title="30503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_638144987574766785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_638144987574766785" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" xlink:label="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock_638144987574766785" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock_638144987574766785" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" xlink:label="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock_638144987574776779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock_638144987574776779" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureAssetAcquisitionTables" xlink:type="extended" xlink:title="30603 - Disclosure - Asset acquisition (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AssetAcquisitionsAbstract" xlink:label="aciu_AssetAcquisitionsAbstract_2" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfAssetAcquisitionsTableTextBlock" xlink:label="aciu_DisclosureOfAssetAcquisitionsTableTextBlock_638144987574776779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AssetAcquisitionsAbstract_2" xlink:to="aciu_DisclosureOfAssetAcquisitionsTableTextBlock_638144987574776779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIntangibleAssetsTables" xlink:type="extended" xlink:title="30703 - Disclosure - Intangible assets (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="DisclosureOfIntangibleAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_638144987574776779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_638144987574776779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables" xlink:type="extended" xlink:title="30803 - Disclosure - Cash and cash equivalents and short-term financial assets (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="DisclosureOfFinancialAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" xlink:label="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock_638144987574776779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialAssetsAbstract" xlink:to="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock_638144987574776779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" xlink:label="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock_638144987574786776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialAssetsAbstract" xlink:to="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock_638144987574786776" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables" xlink:type="extended" xlink:title="30903 - Disclosure - Prepaid expenses and accrued income (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract_1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock_638144987574786776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract_1" xlink:to="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock_638144987574786776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureOtherCurrentReceivablesTables" xlink:type="extended" xlink:title="31003 - Disclosure - Other current receivables (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OtherCurrentReceivablesAbstract" xlink:label="OtherCurrentReceivablesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock_638144987574786776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherCurrentReceivablesAbstract" xlink:to="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock_638144987574786776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalTables" xlink:type="extended" xlink:title="31103 - Disclosure - Share capital (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_7" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_638144987574786776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_7" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_638144987574786776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables" xlink:type="extended" xlink:title="31203 - Disclosure - Trade and other payables and accrued expenses (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AccruedExpensesAbstract" xlink:label="aciu_AccruedExpensesAbstract_1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock_638144987574796768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AccruedExpensesAbstract_1" xlink:to="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock_638144987574796768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesTables" xlink:type="extended" xlink:title="31303 - Disclosure - Contract revenues (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_638144987574796768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_638144987574796768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory" xlink:label="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory_638144987574796768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory_638144987574796768" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureExpensesByCategoryTables" xlink:type="extended" xlink:title="31403 - Disclosure - Expenses by category (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ExpensesByCategoryAbstract" xlink:label="ExpensesByCategoryAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_638144987574796768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesByCategoryAbstract" xlink:to="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_638144987574796768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_638144987574806771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesByCategoryAbstract" xlink:to="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_638144987574806771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_638144987574806771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesByCategoryAbstract" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_638144987574806771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRelatedPartyTransactionsTables" xlink:type="extended" xlink:title="31503 - Disclosure - Related-party transactions (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory" xlink:label="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_638144987574806771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory_638144987574806771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxesTables" xlink:type="extended" xlink:title="31603 - Disclosure - Income taxes (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="MajorComponentsOfTaxExpenseIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock_638144987574806771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock_638144987574806771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_638144987574806771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_638144987574806771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock_638144987574806771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock_638144987574806771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanTables" xlink:type="extended" xlink:title="31703 - Disclosure - Retirement benefit plan (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" xlink:label="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock_638144987574816769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock_638144987574816769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock_638144987574816769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock_638144987574816769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_638144987574816769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_638144987574816769" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock_638144987574816769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock_638144987574816769" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_638144987574816769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_638144987574816769" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationTables" xlink:type="extended" xlink:title="31803 - Disclosure - Share-based compensation (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_638144987574816769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_638144987574816769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_638144987574816769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_638144987574816769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_638144987574816769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_638144987574816769" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_638144987574826770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_638144987574826770" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_638144987574826770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_638144987574826770" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables" xlink:type="extended" xlink:title="31903 - Disclosure - Commitments and contingencies (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CommitmentsAndContingenciesAbstract" xlink:label="CommitmentsAndContingenciesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_638144987574826770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesAbstract" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory_638144987574826770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureEarningsPerShareTables" xlink:type="extended" xlink:title="32003 - Disclosure - Earnings per share (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="ifrs-full_EarningsPerShareExplanatory_638144987574826770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareExplanatory_638144987574826770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock" xlink:label="aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock_638144987574826770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock_638144987574826770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables" xlink:type="extended" xlink:title="32103 - Disclosure - Financial instruments and risk management (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:label="DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_638144987574836768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:to="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_638144987574836768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureGeneralInformationDetails" xlink:type="extended" xlink:title="40101 - Disclosure - General information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GeneralInformationAbstract" xlink:label="GeneralInformationAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfTechnologyPlatforms" xlink:label="aciu_NumberOfTechnologyPlatforms_638144987574836768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationAbstract" xlink:to="aciu_NumberOfTechnologyPlatforms_638144987574836768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails" xlink:type="extended" xlink:title="40201 - Disclosure - Basis of preparation - Going concern (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GoingConcernAbstract" xlink:label="aciu_GoingConcernAbstract_638144987574836768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_GoingConcernAbstract_638144987574836768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_638144987574836768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_GoingConcernAbstract_638144987574836768" xlink:to="ifrs-full_CashAndCashEquivalents_638144987574836768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638144987574836768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_GoingConcernAbstract_638144987574836768" xlink:to="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638144987574836768" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails" xlink:type="extended" xlink:title="40301 - Disclosure - Summary of significant accounting policies - Functional and reporting currency (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ForeignExchangeRatesAbstract" xlink:label="ifrs-full_ForeignExchangeRatesAbstract_638144987574846771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_ForeignExchangeRatesAbstract_638144987574846771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate_638144987574846771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ForeignExchangeRatesAbstract_638144987574846771" xlink:to="ifrs-full_ClosingForeignExchangeRate_638144987574846771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AverageForeignExchangeRate" xlink:label="ifrs-full_AverageForeignExchangeRate_638144987574846771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ForeignExchangeRatesAbstract_638144987574846771" xlink:to="ifrs-full_AverageForeignExchangeRate_638144987574846771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" xlink:type="extended" xlink:title="40302 - Disclosure - Summary of significant accounting policies, Right-of-use assets and lease liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638144987574846771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638144987574846771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638144987574846771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638144987574846771" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638144987574846771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_638144987574846771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638144987574846771" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_638144987574846771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember_638144987574846771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574846771" xlink:to="ifrs-full_BuildingsMember_638144987574846771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="ifrs-full_OfficeEquipmentMember_638144987574846771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574846771" xlink:to="ifrs-full_OfficeEquipmentMember_638144987574846771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember_638144987574846771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574846771" xlink:to="ifrs-full_ComputerEquipmentMember_638144987574846771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_638144987574856769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638144987574846771" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_638144987574856769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638144987574856769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_638144987574856769" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638144987574856769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_EstimatedLeaseTerm" xlink:label="aciu_EstimatedLeaseTerm_638144987574856769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638144987574856769" xlink:to="aciu_EstimatedLeaseTerm_638144987574856769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" xlink:type="extended" xlink:title="40303 - Disclosure - Summary of significant accounting policies, Property, plant and equipment (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638144987574856769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638144987574856769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638144987574856769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638144987574856769" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638144987574856769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_638144987574856769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638144987574856769" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_638144987574856769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember_638144987574856769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574856769" xlink:to="ifrs-full_ComputerEquipmentMember_638144987574856769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LaboratoryEquipmentMember" xlink:label="aciu_LaboratoryEquipmentMember_638144987574856769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574856769" xlink:to="aciu_LaboratoryEquipmentMember_638144987574856769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" xlink:label="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_638144987574906777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574856769" xlink:to="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_638144987574906777" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_638144987574906777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638144987574856769" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_638144987574906777" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" xlink:label="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract_638144987574906777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_638144987574906777" xlink:to="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract_638144987574906777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_638144987574906777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract_638144987574906777" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_638144987574906777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" xlink:type="extended" xlink:title="40304 - Disclosure - Summary of significant accounting policies, Income taxes (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_638144987574916774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_638144987574916774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncomeTaxLossCarryforwardPeriod" xlink:label="aciu_IncomeTaxLossCarryforwardPeriod_638144987574916774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_638144987574916774" xlink:to="aciu_IncomeTaxLossCarryforwardPeriod_638144987574916774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets_638144987574916774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_638144987574916774" xlink:to="ifrs-full_DeferredTaxAssets_638144987574916774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" xlink:type="extended" xlink:title="40305 - Disclosure - Summary of significant accounting policies, Segment reporting (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract_638144987574916774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsAbstract_638144987574916774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OperatingSegmentsNumber" xlink:label="aciu_OperatingSegmentsNumber_638144987574916774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract_638144987574916774" xlink:to="aciu_OperatingSegmentsNumber_638144987574916774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ReportableSegmentsNumber" xlink:label="aciu_ReportableSegmentsNumber_638144987574916774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract_638144987574916774" xlink:to="aciu_ReportableSegmentsNumber_638144987574916774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails" xlink:type="extended" xlink:title="40401 - Disclosure - Property, plant and equipment (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="DisclosureOfPropertyPlantAndEquipmentAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638144987574916774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638144987574916774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638144987574916774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638144987574916774" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638144987574916774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_638144987574916774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638144987574916774" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_638144987574916774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="ifrs-full_FixturesAndFittingsMember_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574916774" xlink:to="ifrs-full_FixturesAndFittingsMember_638144987574926779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574916774" xlink:to="ifrs-full_ComputerEquipmentMember_638144987574926779" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LaboratoryEquipmentMember" xlink:label="aciu_LaboratoryEquipmentMember_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574916774" xlink:to="aciu_LaboratoryEquipmentMember_638144987574926779" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="ifrs-full_LeaseholdImprovementsMember_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574916774" xlink:to="ifrs-full_LeaseholdImprovementsMember_638144987574926779" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="ifrs-full_ConstructionInProgressMember_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574916774" xlink:to="ifrs-full_ConstructionInProgressMember_638144987574926779" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AssetsUnderConstructionMember" xlink:label="aciu_AssetsUnderConstructionMember_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574916774" xlink:to="aciu_AssetsUnderConstructionMember_638144987574926779" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638144987574916774" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_638144987574926779" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_638144987574926779" xlink:to="ifrs-full_CarryingAmountMember_638144987574926779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_638144987574926779" xlink:to="ifrs-full_GrossCarryingAmountMember_638144987574926779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_638144987574926779" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_638144987574926779" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638144987574916774" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_638144987574926779" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_638144987574926779" xlink:to="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638144987574926779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638144987574926779" xlink:to="ifrs-full_PropertyPlantAndEquipment_638144987574926779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_638144987574926779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638144987574926779" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_638144987574926779" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_638144987574936778" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638144987574926779" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_638144987574936778" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_638144987574936778" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638144987574926779" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_638144987574936778" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_638144987574936778" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638144987574926779" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment_638144987574936778" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment_638144987574936778" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638144987574926779" xlink:to="ifrs-full_PropertyPlantAndEquipment_638144987574936778" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageIncreaseInPropertyPlantAndEquipment" xlink:label="aciu_PercentageIncreaseInPropertyPlantAndEquipment_638144987574936778" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638144987574926779" xlink:to="aciu_PercentageIncreaseInPropertyPlantAndEquipment_638144987574936778" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638144987574936778" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638144987574936778" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis_638144987574936778" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638144987574936778" xlink:to="ifrs-full_ClassesOfAssetsAxis_638144987574936778" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember_638144987574936778" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis_638144987574936778" xlink:to="ifrs-full_ClassesOfAssetsMember_638144987574936778" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_638144987574936778" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_638144987574936778" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_638144987574936778" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember_638144987574936778" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574936778" xlink:to="ifrs-full_BuildingsMember_638144987574936778" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="ifrs-full_OfficeEquipmentMember_638144987574936778" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574936778" xlink:to="ifrs-full_OfficeEquipmentMember_638144987574936778" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember_638144987574946773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638144987574936778" xlink:to="ifrs-full_ComputerEquipmentMember_638144987574946773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_638144987574946773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638144987574936778" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_638144987574946773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638144987574946773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_638144987574946773" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638144987574946773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="ifrs-full_AdditionsToRightofuseAssets_638144987574946773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638144987574946773" xlink:to="ifrs-full_AdditionsToRightofuseAssets_638144987574946773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_638144987574946773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638144987574946773" xlink:to="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_638144987574946773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RightOfUseLeasedAssetsAbstract" xlink:label="aciu_RightOfUseLeasedAssetsAbstract_638144987574946773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638144987574946773" xlink:to="aciu_RightOfUseLeasedAssetsAbstract_638144987574946773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets_638144987574946773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_RightOfUseLeasedAssetsAbstract_638144987574946773" xlink:to="ifrs-full_RightofuseAssets_638144987574946773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets_638144987574946773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_RightOfUseLeasedAssetsAbstract_638144987574946773" xlink:to="ifrs-full_DepreciationRightofuseAssets_638144987574946773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DispositionsOfRightOfUseAssets" xlink:label="aciu_DispositionsOfRightOfUseAssets_638144987574946773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_RightOfUseLeasedAssetsAbstract_638144987574946773" xlink:to="aciu_DispositionsOfRightOfUseAssets_638144987574946773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets_6381449875749467731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_RightOfUseLeasedAssetsAbstract_638144987574946773" xlink:to="ifrs-full_RightofuseAssets_6381449875749467731" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" xlink:type="extended" xlink:title="40502 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract" xlink:label="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638144987574946773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638144987574946773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets_638144987574956771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638144987574946773" xlink:to="ifrs-full_DepreciationRightofuseAssets_638144987574956771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_638144987574956771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638144987574946773" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_638144987574956771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_638144987574956771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638144987574946773" xlink:to="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_638144987574956771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ExpenseRelatingToLeases" xlink:label="aciu_ExpenseRelatingToLeases_638144987574956771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638144987574946773" xlink:to="aciu_ExpenseRelatingToLeases_638144987574956771" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashOutflowForLeases" xlink:label="ifrs-full_CashOutflowForLeases_638144987574956771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638144987574946773" xlink:to="ifrs-full_CashOutflowForLeases_638144987574956771" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" xlink:type="extended" xlink:title="40503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_638144987574956771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_638144987574956771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis_638144987574956771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_638144987574956771" xlink:to="ifrs-full_MaturityAxis_638144987574956771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember_638144987574956771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis_638144987574956771" xlink:to="ifrs-full_AggregatedTimeBandsMember_638144987574956771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember_638144987574956771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987574956771" xlink:to="ifrs-full_NotLaterThanOneYearMember_638144987574956771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_638144987574956771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987574956771" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_638144987574956771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_638144987574956771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987574956771" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_638144987574956771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_638144987574956771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_638144987574956771" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_638144987574956771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:label="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_638144987574956771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_638144987574956771" xlink:to="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_638144987574956771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="ifrs-full_GrossLeaseLiabilities_638144987574966769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_638144987574956771" xlink:to="ifrs-full_GrossLeaseLiabilities_638144987574966769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfDepositsInEscrowAccounts" xlink:label="aciu_NumberOfDepositsInEscrowAccounts_638144987574966769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_638144987574956771" xlink:to="aciu_NumberOfDepositsInEscrowAccounts_638144987574966769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_EscrowDepositAmount" xlink:label="aciu_EscrowDepositAmount_638144987574966769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_638144987574956771" xlink:to="aciu_EscrowDepositAmount_638144987574966769" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureAssetAcquisitionDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Asset acquisition (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AssetAcquisitionsAbstract" xlink:label="aciu_AssetAcquisitionsAbstract_1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable_638144987574966769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AssetAcquisitionsAbstract_1" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable_638144987574966769" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AssetAcquisitionsAxis" xlink:label="aciu_AssetAcquisitionsAxis_638144987574966769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638144987574966769" xlink:to="aciu_AssetAcquisitionsAxis_638144987574966769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SignificantAssetAcquisitionsTotalDomain" xlink:label="aciu_SignificantAssetAcquisitionsTotalDomain_638144987574966769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AssetAcquisitionsAxis_638144987574966769" xlink:to="aciu_SignificantAssetAcquisitionsTotalDomain_638144987574966769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" xlink:label="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_638144987574966769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SignificantAssetAcquisitionsTotalDomain_638144987574966769" xlink:to="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_638144987574966769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_638144987574966769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638144987574966769" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_638144987574966769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_638144987574966769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_638144987574966769" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_638144987574966769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" xlink:label="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_638144987574966769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_638144987574966769" xlink:to="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_638144987574966769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="ifrs-full_UnobservableInputsAxis_638144987574966769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638144987574966769" xlink:to="ifrs-full_UnobservableInputsAxis_638144987574966769" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnobservableInputsMember" xlink:label="ifrs-full_UnobservableInputsMember_638144987574966769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnobservableInputsAxis_638144987574966769" xlink:to="ifrs-full_UnobservableInputsMember_638144987574966769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DiscountRateMeasurementInputMember" xlink:label="ifrs-full_DiscountRateMeasurementInputMember_638144987574966769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnobservableInputsMember_638144987574966769" xlink:to="ifrs-full_DiscountRateMeasurementInputMember_638144987574966769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638144987574976774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638144987574966769" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638144987574976774" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SharesTransferredAsConsiderationInAssetAcquisition" xlink:label="aciu_SharesTransferredAsConsiderationInAssetAcquisition_638144987574976774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638144987574976774" xlink:to="aciu_SharesTransferredAsConsiderationInAssetAcquisition_638144987574976774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" xlink:label="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition_638144987574976774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638144987574976774" xlink:to="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition_638144987574976774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantUnobservableInputAssets" xlink:label="ifrs-full_SignificantUnobservableInputAssets_638144987574976774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638144987574976774" xlink:to="ifrs-full_SignificantUnobservableInputAssets_638144987574976774" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition_638144987574976774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638144987574976774" xlink:to="aciu_CashAcquiredAsPartOfAssetAcquisition_638144987574976774" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_638144987574976774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638144987574976774" xlink:to="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_638144987574976774" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TotalAssetsAcquiredInAssetAcquisition" xlink:label="aciu_TotalAssetsAcquiredInAssetAcquisition_638144987574976774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638144987574976774" xlink:to="aciu_TotalAssetsAcquiredInAssetAcquisition_638144987574976774" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIntangibleAssetsDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Intangible assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="DisclosureOfIntangibleAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable_638144987574976774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable_638144987574976774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_638144987574976774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638144987574976774" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_638144987574976774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_638144987574976774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_638144987574976774" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_638144987574976774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_InProcessResearchAndDevelopmentIPRDAssetMember" xlink:label="aciu_InProcessResearchAndDevelopmentIPRDAssetMember_638144987574976774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_638144987574976774" xlink:to="aciu_InProcessResearchAndDevelopmentIPRDAssetMember_638144987574976774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_638144987574986782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638144987574976774" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_638144987574986782" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember_638144987574986782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_638144987574986782" xlink:to="ifrs-full_CarryingAmountMember_638144987574986782" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember_638144987574986782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_638144987574986782" xlink:to="ifrs-full_GrossCarryingAmountMember_638144987574986782" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_638144987574986782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_638144987574986782" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_638144987574986782" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="ifrs-full_UnobservableInputsAxis_638144987574986782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638144987574976774" xlink:to="ifrs-full_UnobservableInputsAxis_638144987574986782" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnobservableInputsMember" xlink:label="ifrs-full_UnobservableInputsMember_638144987574986782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnobservableInputsAxis_638144987574986782" xlink:to="ifrs-full_UnobservableInputsMember_638144987574986782" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DiscountRateMeasurementInputMember" xlink:label="ifrs-full_DiscountRateMeasurementInputMember_638144987574986782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnobservableInputsMember_638144987574986782" xlink:to="ifrs-full_DiscountRateMeasurementInputMember_638144987574986782" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638144987574986782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638144987574976774" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638144987574986782" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract_638144987574986782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638144987574986782" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract_638144987574986782" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_638144987574986782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract_638144987574986782" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_638144987574986782" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantUnobservableInputAssets" xlink:label="ifrs-full_SignificantUnobservableInputAssets_638144987574986782" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract_638144987574986782" xlink:to="ifrs-full_SignificantUnobservableInputAssets_638144987574986782" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="DisclosureOfFinancialAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAndCashEquivalentsTable" xlink:label="aciu_CashAndCashEquivalentsTable_638144987574996769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialAssetsAbstract" xlink:to="aciu_CashAndCashEquivalentsTable_638144987574996769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis_638144987574996769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CashAndCashEquivalentsTable_638144987574996769" xlink:to="srt_CurrencyAxis_638144987574996769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain_638144987574996769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CurrencyAxis_638144987574996769" xlink:to="currency_AllCurrenciesDomain_638144987574996769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CHF" xlink:label="currency_CHF_638144987574996769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="currency_AllCurrenciesDomain_638144987574996769" xlink:to="currency_CHF_638144987574996769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="currency_EUR_638144987574996769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="currency_AllCurrenciesDomain_638144987574996769" xlink:to="currency_EUR_638144987574996769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="currency_USD_638144987574996769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="currency_AllCurrenciesDomain_638144987574996769" xlink:to="currency_USD_638144987574996769" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAndCashEquivalentLineItems" xlink:label="aciu_CashAndCashEquivalentLineItems_638144987574996769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CashAndCashEquivalentsTable_638144987574996769" xlink:to="aciu_CashAndCashEquivalentLineItems_638144987574996769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAbstract" xlink:label="ifrs-full_CashAbstract_638144987574996769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CashAndCashEquivalentLineItems_638144987574996769" xlink:to="ifrs-full_CashAbstract_638144987574996769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_638144987574996769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashAbstract_638144987574996769" xlink:to="ifrs-full_CashAndCashEquivalents_638144987574996769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate_638144987574996769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashAbstract_638144987574996769" xlink:to="ifrs-full_ClosingForeignExchangeRate_638144987574996769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" xlink:type="extended" xlink:title="40802 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="DisclosureOfFinancialAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638144987574996769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialAssetsAbstract" xlink:to="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638144987574996769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Prepaid expenses and accrued income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:label="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PrepaidExpensesAndAccruedIncomeTable" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeTable_638144987575006774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:to="aciu_PrepaidExpensesAndAccruedIncomeTable_638144987575006774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638144987575006774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeTable_638144987575006774" xlink:to="ifrs-full_TypesOfContractsAxis_638144987575006774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638144987575006774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638144987575006774" xlink:to="ifrs-full_TypesOfContractsMember_638144987575006774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember" xlink:label="aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember_638144987575006774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638144987575006774" xlink:to="aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember_638144987575006774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GrantsMichaelJFoxFoundationMember" xlink:label="aciu_GrantsMichaelJFoxFoundationMember_638144987575006774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember_638144987575006774" xlink:to="aciu_GrantsMichaelJFoxFoundationMember_638144987575006774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PrepaidExpensesAndAccruedIncomeLineItems" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeLineItems_638144987575006774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeTable_638144987575006774" xlink:to="aciu_PrepaidExpensesAndAccruedIncomeLineItems_638144987575006774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_638144987575006774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeLineItems_638144987575006774" xlink:to="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_638144987575006774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses_638144987575006774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_638144987575006774" xlink:to="ifrs-full_CurrentPrepaidExpenses_638144987575006774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638144987575006774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_638144987575006774" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638144987575006774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets_638144987575006774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_638144987575006774" xlink:to="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets_638144987575006774" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfAccruedIncome" xlink:label="aciu_PercentageOfAccruedIncome_638144987575006774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_638144987575006774" xlink:to="aciu_PercentageOfAccruedIncome_638144987575006774" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" xlink:type="extended" xlink:title="41001 - Disclosure - Other current receivables (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OtherCurrentReceivablesAbstract" xlink:label="OtherCurrentReceivablesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfOtherCurrentReceivablesTable" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTable_638144987575016781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherCurrentReceivablesAbstract" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesTable_638144987575016781" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575016781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesTable_638144987575016781" xlink:to="ifrs-full_RangeAxis_638144987575016781" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575016781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575016781" xlink:to="ifrs-full_RangesMember_638144987575016781" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638144987575016781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575016781" xlink:to="ifrs-full_TopOfRangeMember_638144987575016781" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesLineItems_638144987575016781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesTable_638144987575016781" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesLineItems_638144987575016781" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract_638144987575016781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesLineItems_638144987575016781" xlink:to="ifrs-full_TradeAndOtherReceivablesAbstract_638144987575016781" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MiscellaneousOtherCurrentReceivables" xlink:label="aciu_MiscellaneousOtherCurrentReceivables_638144987575016781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract_638144987575016781" xlink:to="aciu_MiscellaneousOtherCurrentReceivables_638144987575016781" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables_638144987575016781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract_638144987575016781" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables_638144987575016781" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WithholdingTaxReceivables" xlink:label="aciu_WithholdingTaxReceivables_638144987575016781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract_638144987575016781" xlink:to="aciu_WithholdingTaxReceivables_638144987575016781" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="ifrs-full_OtherCurrentReceivables_638144987575016781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract_638144987575016781" xlink:to="ifrs-full_OtherCurrentReceivables_638144987575016781" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MaturityPeriodOtherCurrentReceivables" xlink:label="aciu_MaturityPeriodOtherCurrentReceivables_638144987575016781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesLineItems_638144987575016781" xlink:to="aciu_MaturityPeriodOtherCurrentReceivables_638144987575016781" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalNarrativesDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Share capital - Narratives (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575026776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575026776" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_638144987575026776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_638144987575026776" xlink:to="ifrs-full_ClassesOfShareCapitalMember_638144987575026776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638144987575026776" xlink:to="ifrs-full_OrdinarySharesMember_638144987575026776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575026776" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575026776" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575026776" xlink:to="ifrs-full_IssuedCapital_638144987575026776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575026776" xlink:to="ifrs-full_NumberOfSharesIssued_638144987575026776" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575026776" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_638144987575026776" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails" xlink:type="extended" xlink:title="41102 - Disclosure - Share capital - Capital Structure (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_9" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575026776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575026776" xlink:to="ifrs-full_ComponentsOfEquityAxis_638144987575026776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638144987575026776" xlink:to="ifrs-full_EquityMember_638144987575026776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityMember_638144987575026776" xlink:to="ifrs-full_IssuedCapitalMember_638144987575026776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharePremiumMember" xlink:label="ifrs-full_SharePremiumMember_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityMember_638144987575026776" xlink:to="ifrs-full_SharePremiumMember_638144987575026776" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember_638144987575026776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityMember_638144987575026776" xlink:to="ifrs-full_TreasurySharesMember_638144987575026776" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_638144987575036780" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575026776" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_638144987575036780" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_638144987575036780" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_638144987575036780" xlink:to="ifrs-full_ClassesOfShareCapitalMember_638144987575036780" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember_638144987575036780" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638144987575036780" xlink:to="ifrs-full_OrdinarySharesMember_638144987575036780" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember_638144987575036780" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OrdinarySharesMember_638144987575036780" xlink:to="ifrs-full_TreasurySharesMember_638144987575036780" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575036780" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575026776" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575036780" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:label="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638144987575036780" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575036780" xlink:to="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638144987575036780" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="ifrs-full_NumberOfSharesOutstanding_638144987575036780" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638144987575036780" xlink:to="ifrs-full_NumberOfSharesOutstanding_638144987575036780" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions" xlink:label="aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions_638144987575036780" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638144987575036780" xlink:to="aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions_638144987575036780" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_638144987575036780" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638144987575036780" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_638144987575036780" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans_638144987575036780" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638144987575036780" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans_638144987575036780" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_638144987575036780" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638144987575036780" xlink:to="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_638144987575036780" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="ifrs-full_NumberOfSharesOutstanding_6381449875750367801" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638144987575036780" xlink:to="ifrs-full_NumberOfSharesOutstanding_6381449875750367801" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xlink:label="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_638144987575036780" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575036780" xlink:to="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_638144987575036780" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_638144987575046774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_638144987575036780" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_638144987575046774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_638144987575046774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_638144987575036780" xlink:to="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_638144987575046774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" xlink:label="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance_638144987575046774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_638144987575036780" xlink:to="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance_638144987575046774" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_6381449875750467741" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_638144987575036780" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_6381449875750467741" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ChangesInEquityAbstract" xlink:label="ifrs-full_ChangesInEquityAbstract_638144987575046774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575036780" xlink:to="ifrs-full_ChangesInEquityAbstract_638144987575046774" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_638144987575046774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInEquityAbstract_638144987575046774" xlink:to="ifrs-full_Equity_638144987575046774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_638144987575046774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInEquityAbstract_638144987575046774" xlink:to="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_638144987575046774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions" xlink:label="aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions_638144987575046774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInEquityAbstract_638144987575046774" xlink:to="aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions_638144987575046774" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_638144987575046774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInEquityAbstract_638144987575046774" xlink:to="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_638144987575046774" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" xlink:label="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans_638144987575046774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInEquityAbstract_638144987575046774" xlink:to="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans_638144987575046774" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_638144987575056773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInEquityAbstract_638144987575046774" xlink:to="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_638144987575056773" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_638144987575056773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInEquityAbstract_638144987575046774" xlink:to="ifrs-full_Equity_638144987575056773" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare_638144987575056773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575036780" xlink:to="ifrs-full_ParValuePerShare_638144987575056773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails" xlink:type="extended" xlink:title="41103 - Disclosure - Share capital - Authorized capital (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" xlink:label="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue_638144987575056773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_1" xlink:to="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue_638144987575056773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" xlink:label="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue_638144987575056773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_1" xlink:to="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue_638144987575056773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare_638144987575066770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_1" xlink:to="ifrs-full_ParValuePerShare_638144987575066770" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails" xlink:type="extended" xlink:title="41104 - Disclosure - Share capital - Conditional share capital for bonds and similar debt instruments (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575066770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_2" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575066770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_638144987575066770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575066770" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_638144987575066770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_638144987575066770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_638144987575066770" xlink:to="ifrs-full_ClassesOfShareCapitalMember_638144987575066770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember" xlink:label="aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_638144987575066770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638144987575066770" xlink:to="aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_638144987575066770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575066770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575066770" xlink:to="ifrs-full_RangeAxis_638144987575066770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575066770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575066770" xlink:to="ifrs-full_RangesMember_638144987575066770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638144987575066770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575066770" xlink:to="ifrs-full_TopOfRangeMember_638144987575066770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575066770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575066770" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575066770" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConditionalShareCapitalAbstract" xlink:label="aciu_ConditionalShareCapitalAbstract_638144987575066770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575066770" xlink:to="aciu_ConditionalShareCapitalAbstract_638144987575066770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" xlink:label="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments_638144987575066770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConditionalShareCapitalAbstract_638144987575066770" xlink:to="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments_638144987575066770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" xlink:label="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments_638144987575066770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConditionalShareCapitalAbstract_638144987575066770" xlink:to="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments_638144987575066770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare_638144987575066770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConditionalShareCapitalAbstract_638144987575066770" xlink:to="ifrs-full_ParValuePerShare_638144987575066770" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" xlink:type="extended" xlink:title="41105 - Disclosure - Share capital - Conditional share capital for employee benefit plans (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575076774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_3" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575076774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_638144987575076774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575076774" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_638144987575076774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_638144987575076774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_638144987575076774" xlink:to="ifrs-full_ClassesOfShareCapitalMember_638144987575076774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" xlink:label="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_638144987575076774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638144987575076774" xlink:to="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_638144987575076774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575076774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575076774" xlink:to="ifrs-full_RangeAxis_638144987575076774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575076774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575076774" xlink:to="ifrs-full_RangesMember_638144987575076774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638144987575076774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575076774" xlink:to="ifrs-full_TopOfRangeMember_638144987575076774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575076774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575076774" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575076774" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConditionalShareCapitalAbstract" xlink:label="aciu_ConditionalShareCapitalAbstract_638144987575076774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575076774" xlink:to="aciu_ConditionalShareCapitalAbstract_638144987575076774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" xlink:label="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions_638144987575076774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConditionalShareCapitalAbstract_638144987575076774" xlink:to="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions_638144987575076774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" xlink:label="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions_638144987575076774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConditionalShareCapitalAbstract_638144987575076774" xlink:to="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions_638144987575076774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare_638144987575076774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConditionalShareCapitalAbstract_638144987575076774" xlink:to="ifrs-full_ParValuePerShare_638144987575076774" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails" xlink:type="extended" xlink:title="41106 - Disclosure - Share capital - Shelf registration statement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575086774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_4" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575086774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575086774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575086774" xlink:to="ifrs-full_RangeAxis_638144987575086774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575086774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575086774" xlink:to="ifrs-full_RangesMember_638144987575086774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638144987575086774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575086774" xlink:to="ifrs-full_TopOfRangeMember_638144987575086774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575086774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575086774" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575086774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" xlink:label="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement_638144987575086774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575086774" xlink:to="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement_638144987575086774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails" xlink:type="extended" xlink:title="41107 - Disclosure - Share capital - At the market equity offering (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575086774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_5" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575086774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_638144987575086774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575086774" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_638144987575086774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_638144987575086774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_638144987575086774" xlink:to="ifrs-full_ClassesOfShareCapitalMember_638144987575086774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AtTheMarketEquityOfferingMember" xlink:label="aciu_AtTheMarketEquityOfferingMember_638144987575086774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638144987575086774" xlink:to="aciu_AtTheMarketEquityOfferingMember_638144987575086774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SecondOpenMarketSalesAgreementMember" xlink:label="aciu_SecondOpenMarketSalesAgreementMember_638144987575086774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638144987575086774" xlink:to="aciu_SecondOpenMarketSalesAgreementMember_638144987575086774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575096769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575086774" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575096769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AtTheMarketEquityOfferingAbstract" xlink:label="aciu_AtTheMarketEquityOfferingAbstract_638144987575096769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575096769" xlink:to="aciu_AtTheMarketEquityOfferingAbstract_638144987575096769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_638144987575096769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638144987575096769" xlink:to="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_638144987575096769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued_638144987575096769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638144987575096769" xlink:to="ifrs-full_NumberOfSharesIssued_638144987575096769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare_638144987575096769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638144987575096769" xlink:to="ifrs-full_ParValuePerShare_638144987575096769" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" xlink:label="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket_638144987575096769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638144987575096769" xlink:to="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket_638144987575096769" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SaleOrIssueOfTreasurySharesShares" xlink:label="aciu_SaleOrIssueOfTreasurySharesShares_638144987575096769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638144987575096769" xlink:to="aciu_SaleOrIssueOfTreasurySharesShares_638144987575096769" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xlink:label="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_638144987575096769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638144987575096769" xlink:to="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_638144987575096769" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CommissionsPaidForIssuanceOrdinaryShares" xlink:label="aciu_CommissionsPaidForIssuanceOrdinaryShares_638144987575096769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638144987575096769" xlink:to="aciu_CommissionsPaidForIssuanceOrdinaryShares_638144987575096769" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost_638144987575096769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638144987575096769" xlink:to="ifrs-full_ShareIssueRelatedCost_638144987575096769" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails" xlink:type="extended" xlink:title="41108 - Disclosure - Share capital - Convertible note agreement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575096769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_6" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575096769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575096769" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_638144987575106769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_638144987575106769" xlink:to="ifrs-full_ClassesOfShareCapitalMember_638144987575106769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConvertibleNoteAgreementMember" xlink:label="aciu_ConvertibleNoteAgreementMember_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638144987575106769" xlink:to="aciu_ConvertibleNoteAgreementMember_638144987575106769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575096769" xlink:to="ifrs-full_RangeAxis_638144987575106769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575106769" xlink:to="ifrs-full_RangesMember_638144987575106769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575106769" xlink:to="ifrs-full_TopOfRangeMember_638144987575106769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575096769" xlink:to="srt_StatementScenarioAxis_638144987575106769" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_638144987575106769" xlink:to="srt_ScenarioUnspecifiedDomain_638144987575106769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IfNotesAreConvertedMember" xlink:label="aciu_IfNotesAreConvertedMember_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638144987575106769" xlink:to="aciu_IfNotesAreConvertedMember_638144987575106769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis" xlink:label="ifrs-full_CounterpartiesAxis_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575096769" xlink:to="ifrs-full_CounterpartiesAxis_638144987575106769" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember" xlink:label="ifrs-full_CounterpartiesMember_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesAxis_638144987575106769" xlink:to="ifrs-full_CounterpartiesMember_638144987575106769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AthosServiceGmbHMember" xlink:label="aciu_AthosServiceGmbHMember_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesMember_638144987575106769" xlink:to="aciu_AthosServiceGmbHMember_638144987575106769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FirstCapitalPartnerGmbHMember" xlink:label="aciu_FirstCapitalPartnerGmbHMember_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesMember_638144987575106769" xlink:to="aciu_FirstCapitalPartnerGmbHMember_638144987575106769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638144987575096769" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575106769" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ConvertibleNoteAgreementAbstract" xlink:label="aciu_ConvertibleNoteAgreementAbstract_638144987575106769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638144987575106769" xlink:to="aciu_ConvertibleNoteAgreementAbstract_638144987575106769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfConvertibleNoteAgreements" xlink:label="aciu_NumberOfConvertibleNoteAgreements_638144987575116777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConvertibleNoteAgreementAbstract_638144987575106769" xlink:to="aciu_NumberOfConvertibleNoteAgreements_638144987575116777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AggregatePrincipalAmountOfEachConvertibleNote" xlink:label="aciu_AggregatePrincipalAmountOfEachConvertibleNote_638144987575116777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConvertibleNoteAgreementAbstract_638144987575106769" xlink:to="aciu_AggregatePrincipalAmountOfEachConvertibleNote_638144987575116777" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" xlink:label="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote_638144987575116777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConvertibleNoteAgreementAbstract_638144987575106769" xlink:to="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote_638144987575116777" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ProceedsFromIssueOfConvertibleDebt" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_638144987575116777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConvertibleNoteAgreementAbstract_638144987575106769" xlink:to="aciu_ProceedsFromIssueOfConvertibleDebt_638144987575116777" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_638144987575116777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConvertibleNoteAgreementAbstract_638144987575106769" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_638144987575116777" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" xlink:label="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements_638144987575116777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConvertibleNoteAgreementAbstract_638144987575106769" xlink:to="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements_638144987575116777" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" xlink:type="extended" xlink:title="41201 - Disclosure - Trade and other payables and accrued expenses (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AccruedExpensesAbstract" xlink:label="aciu_AccruedExpensesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable" xlink:label="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable_638144987575116777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AccruedExpensesAbstract" xlink:to="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable_638144987575116777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638144987575116777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable_638144987575116777" xlink:to="ifrs-full_TypesOfContractsAxis_638144987575116777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638144987575126772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638144987575116777" xlink:to="ifrs-full_TypesOfContractsMember_638144987575126772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_638144987575126772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638144987575126772" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_638144987575126772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems" xlink:label="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems_638144987575126772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable_638144987575116777" xlink:to="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems_638144987575126772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_638144987575126772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems_638144987575126772" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_638144987575126772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CurrentAccruedResearchAndDevelopmentCosts" xlink:label="aciu_CurrentAccruedResearchAndDevelopmentCosts_638144987575126772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems_638144987575126772" xlink:to="aciu_CurrentAccruedResearchAndDevelopmentCosts_638144987575126772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_638144987575126772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems_638144987575126772" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals_638144987575126772" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OtherAccruedExpenses" xlink:label="aciu_OtherAccruedExpenses_638144987575126772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems_638144987575126772" xlink:to="aciu_OtherAccruedExpenses_638144987575126772" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_638144987575126772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems_638144987575126772" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_638144987575126772" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AccrualsForPerformanceRelatedRemuneration" xlink:label="aciu_AccrualsForPerformanceRelatedRemuneration_638144987575126772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems_638144987575126772" xlink:to="aciu_AccrualsForPerformanceRelatedRemuneration_638144987575126772" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_6381449875751267721" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems_638144987575126772" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals_6381449875751267721" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AccruedStampDuty" xlink:label="aciu_AccruedStampDuty_638144987575126772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems_638144987575126772" xlink:to="aciu_AccruedStampDuty_638144987575126772" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" xlink:type="extended" xlink:title="41301 - Disclosure - Contract revenues, Contract Revenue Attributable to Licensing Arrangements (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575136767" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575136767" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638144987575136767" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575136767" xlink:to="ifrs-full_TypesOfContractsAxis_638144987575136767" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638144987575136767" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638144987575136767" xlink:to="ifrs-full_TypesOfContractsMember_638144987575136767" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575136767" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638144987575136767" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575136767" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementWithLillyMember" xlink:label="aciu_CollaborationAgreementWithLillyMember_638144987575136767" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575136767" xlink:to="aciu_CollaborationAgreementWithLillyMember_638144987575136767" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2012GenentechMember" xlink:label="aciu_CollaborationAgreementOf2012GenentechMember_638144987575136767" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575136767" xlink:to="aciu_CollaborationAgreementOf2012GenentechMember_638144987575136767" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_638144987575136767" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575136767" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_638144987575136767" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_638144987575136767" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575136767" xlink:to="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_638144987575136767" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575136767" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575136767" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575136767" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ContractRevenueAbstract" xlink:label="aciu_ContractRevenueAbstract_638144987575136767" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575136767" xlink:to="aciu_ContractRevenueAbstract_638144987575136767" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638144987575136767" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ContractRevenueAbstract_638144987575136767" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638144987575136767" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="ifrs-full_PercentageOfEntitysRevenue_638144987575136767" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ContractRevenueAbstract_638144987575136767" xlink:to="ifrs-full_PercentageOfEntitysRevenue_638144987575136767" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails" xlink:type="extended" xlink:title="41302 - Disclosure - Contract revenues and other operating income - Licensing and collaboration agreement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueAbstract" xlink:label="ifrs-full_RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575146772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RevenueAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575146772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638144987575146772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575146772" xlink:to="ifrs-full_TypesOfContractsAxis_638144987575146772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638144987575146772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638144987575146772" xlink:to="ifrs-full_TypesOfContractsMember_638144987575146772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_638144987575146772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638144987575146772" xlink:to="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_638144987575146772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575146772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575146772" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575146772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_638144987575146772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575146772" xlink:to="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_638144987575146772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xlink:label="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_638144987575146772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575146772" xlink:to="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_638144987575146772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638144987575146772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575146772" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638144987575146772" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" xlink:type="extended" xlink:title="41303 - Disclosure - Contract revenues, Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575146772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575146772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis_638144987575146772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575146772" xlink:to="ifrs-full_ProductsAndServicesAxis_638144987575146772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember_638144987575146772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis_638144987575146772" xlink:to="ifrs-full_ProductsAndServicesMember_638144987575146772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TauMorphomerSmallMoleculeMember" xlink:label="aciu_TauMorphomerSmallMoleculeMember_638144987575146772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesMember_638144987575146772" xlink:to="aciu_TauMorphomerSmallMoleculeMember_638144987575146772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638144987575146772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575146772" xlink:to="ifrs-full_TypesOfContractsAxis_638144987575146772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638144987575156774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638144987575146772" xlink:to="ifrs-full_TypesOfContractsMember_638144987575156774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575156774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638144987575156774" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575156774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementWithLillyMember" xlink:label="aciu_CollaborationAgreementWithLillyMember_638144987575156774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575156774" xlink:to="aciu_CollaborationAgreementWithLillyMember_638144987575156774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementWithLillyFirstAmendmentMember" xlink:label="aciu_CollaborationAgreementWithLillyFirstAmendmentMember_638144987575156774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAgreementWithLillyMember_638144987575156774" xlink:to="aciu_CollaborationAgreementWithLillyFirstAmendmentMember_638144987575156774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementWithLillySecondAmendmentMember" xlink:label="aciu_CollaborationAgreementWithLillySecondAmendmentMember_638144987575156774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAgreementWithLillyMember_638144987575156774" xlink:to="aciu_CollaborationAgreementWithLillySecondAmendmentMember_638144987575156774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="ifrs-full_PerformanceObligationsAxis_638144987575156774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575146772" xlink:to="ifrs-full_PerformanceObligationsAxis_638144987575156774" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="ifrs-full_PerformanceObligationsMember_638144987575156774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsAxis_638144987575156774" xlink:to="ifrs-full_PerformanceObligationsMember_638144987575156774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" xlink:label="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_638144987575156774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsMember_638144987575156774" xlink:to="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_638144987575156774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MilestonePaymentsCommercialMember" xlink:label="aciu_MilestonePaymentsCommercialMember_638144987575156774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsMember_638144987575156774" xlink:to="aciu_MilestonePaymentsCommercialMember_638144987575156774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ResearchAndDevelopmentMember" xlink:label="aciu_ResearchAndDevelopmentMember_638144987575156774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsMember_638144987575156774" xlink:to="aciu_ResearchAndDevelopmentMember_638144987575156774" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RightOfUseLicenseMember" xlink:label="aciu_RightOfUseLicenseMember_638144987575156774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsMember_638144987575156774" xlink:to="aciu_RightOfUseLicenseMember_638144987575156774" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis_638144987575156774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575146772" xlink:to="ifrs-full_MaturityAxis_638144987575156774" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember_638144987575156774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis_638144987575156774" xlink:to="ifrs-full_AggregatedTimeBandsMember_638144987575156774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Quarter32019Member" xlink:label="aciu_Quarter32019Member_638144987575166771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987575156774" xlink:to="aciu_Quarter32019Member_638144987575166771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_March312020Member" xlink:label="aciu_March312020Member_638144987575166771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987575156774" xlink:to="aciu_March312020Member_638144987575166771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" xlink:label="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_638144987575166771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987575156774" xlink:to="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_638144987575166771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575166771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575146772" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575166771" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575166771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575166771" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575166771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue_638144987575166771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575166771" xlink:to="aciu_CollaborativeAgreementPotentialValue_638144987575166771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" xlink:label="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments_638144987575166771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575166771" xlink:to="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments_638144987575166771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_638144987575166771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575166771" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived_638144987575166771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers_638144987575166771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575166771" xlink:to="ifrs-full_ReceivablesFromContractsWithCustomers_638144987575166771" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities" xlink:label="ifrs-full_ContractLiabilities_638144987575166771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575166771" xlink:to="ifrs-full_ContractLiabilities_638144987575166771" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638144987575176774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575166771" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638144987575176774" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638144987575176774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575166771" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638144987575176774" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" xlink:label="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty_638144987575176774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575166771" xlink:to="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty_638144987575176774" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractAssets" xlink:label="ifrs-full_ContractAssets_638144987575176774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575166771" xlink:to="ifrs-full_ContractAssets_638144987575176774" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638144987575176774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575166771" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638144987575176774" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638144987575176774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575166771" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638144987575176774" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails" xlink:type="extended" xlink:title="41304 - Disclosure - Contract revenues, Anti-Abeta Antibody in AD - 2006 Agreement with Genentech (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575186768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575186768" xlink:to="ifrs-full_ProductsAndServicesAxis_638144987575186768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis_638144987575186768" xlink:to="ifrs-full_ProductsAndServicesMember_638144987575186768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AntiAbetaAntibodyInADMember" xlink:label="aciu_AntiAbetaAntibodyInADMember_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesMember_638144987575186768" xlink:to="aciu_AntiAbetaAntibodyInADMember_638144987575186768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575186768" xlink:to="ifrs-full_TypesOfContractsAxis_638144987575186768" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638144987575186768" xlink:to="ifrs-full_TypesOfContractsMember_638144987575186768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638144987575186768" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575186768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2006GenentechMember" xlink:label="aciu_CollaborationAgreementOf2006GenentechMember_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575186768" xlink:to="aciu_CollaborationAgreementOf2006GenentechMember_638144987575186768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575186768" xlink:to="ifrs-full_RangeAxis_638144987575186768" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575186768" xlink:to="ifrs-full_RangesMember_638144987575186768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575186768" xlink:to="ifrs-full_BottomOfRangeMember_638144987575186768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575186768" xlink:to="ifrs-full_TopOfRangeMember_638144987575186768" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="ifrs-full_PerformanceObligationsAxis_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575186768" xlink:to="ifrs-full_PerformanceObligationsAxis_638144987575186768" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="ifrs-full_PerformanceObligationsMember_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsAxis_638144987575186768" xlink:to="ifrs-full_PerformanceObligationsMember_638144987575186768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ClinicalMilestonesAchievedPriorTo1January2017Member" xlink:label="aciu_ClinicalMilestonesAchievedPriorTo1January2017Member_638144987575186768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsMember_638144987575186768" xlink:to="aciu_ClinicalMilestonesAchievedPriorTo1January2017Member_638144987575186768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575196773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575186768" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575196773" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575196773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575196773" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575196773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue_638144987575196773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575196773" xlink:to="aciu_CollaborativeAgreementPotentialValue_638144987575196773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638144987575196773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575196773" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638144987575196773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementCumulativePaymentsReceived" xlink:label="aciu_CollaborativeAgreementCumulativePaymentsReceived_638144987575196773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575196773" xlink:to="aciu_CollaborativeAgreementCumulativePaymentsReceived_638144987575196773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_638144987575196773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575196773" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived_638144987575196773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities" xlink:label="ifrs-full_ContractLiabilities_638144987575196773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575196773" xlink:to="ifrs-full_ContractLiabilities_638144987575196773" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfMilestonePaymentsReceived" xlink:label="aciu_NumberOfMilestonePaymentsReceived_638144987575196773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575196773" xlink:to="aciu_NumberOfMilestonePaymentsReceived_638144987575196773" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638144987575196773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575196773" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638144987575196773" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638144987575196773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575196773" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638144987575196773" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementUpfrontPaymentsReceived" xlink:label="aciu_CollaborativeAgreementUpfrontPaymentsReceived_638144987575196773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575196773" xlink:to="aciu_CollaborativeAgreementUpfrontPaymentsReceived_638144987575196773" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract_638144987575206774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575196773" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract_638144987575206774" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails" xlink:type="extended" xlink:title="41305 - Disclosure - Contract revenues, Anti-Tau Antibody in AD - 2012 Agreement with Genentech (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575206774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575206774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis_638144987575206774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575206774" xlink:to="ifrs-full_ProductsAndServicesAxis_638144987575206774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember_638144987575206774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis_638144987575206774" xlink:to="ifrs-full_ProductsAndServicesMember_638144987575206774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AntiTauAntibodyInADMember" xlink:label="aciu_AntiTauAntibodyInADMember_638144987575206774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesMember_638144987575206774" xlink:to="aciu_AntiTauAntibodyInADMember_638144987575206774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638144987575206774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575206774" xlink:to="ifrs-full_TypesOfContractsAxis_638144987575206774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638144987575206774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638144987575206774" xlink:to="ifrs-full_TypesOfContractsMember_638144987575206774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575206774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638144987575206774" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575206774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2012GenentechMember" xlink:label="aciu_CollaborationAgreementOf2012GenentechMember_638144987575206774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575206774" xlink:to="aciu_CollaborationAgreementOf2012GenentechMember_638144987575206774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575206774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575206774" xlink:to="ifrs-full_RangeAxis_638144987575206774" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575216773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575206774" xlink:to="ifrs-full_RangesMember_638144987575216773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_638144987575216773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575216773" xlink:to="ifrs-full_BottomOfRangeMember_638144987575216773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638144987575216773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575216773" xlink:to="ifrs-full_TopOfRangeMember_638144987575216773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575216773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575206774" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575216773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575216773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575216773" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575216773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue_638144987575216773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575216773" xlink:to="aciu_CollaborativeAgreementPotentialValue_638144987575216773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638144987575216773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575216773" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638144987575216773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementCumulativePaymentsReceived" xlink:label="aciu_CollaborativeAgreementCumulativePaymentsReceived_638144987575216773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575216773" xlink:to="aciu_CollaborativeAgreementCumulativePaymentsReceived_638144987575216773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_638144987575216773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575216773" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived_638144987575216773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities" xlink:label="ifrs-full_ContractLiabilities_638144987575216773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575216773" xlink:to="ifrs-full_ContractLiabilities_638144987575216773" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfMilestonePaymentsReceived" xlink:label="aciu_NumberOfMilestonePaymentsReceived_638144987575216773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575216773" xlink:to="aciu_NumberOfMilestonePaymentsReceived_638144987575216773" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638144987575216773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575216773" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638144987575216773" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638144987575226774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575216773" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638144987575226774" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract_638144987575226774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575216773" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract_638144987575226774" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" xlink:type="extended" xlink:title="41306 - Disclosure - Contract revenues, Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575226774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575226774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis_638144987575226774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575226774" xlink:to="ifrs-full_ProductsAndServicesAxis_638144987575226774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember_638144987575226774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis_638144987575226774" xlink:to="ifrs-full_ProductsAndServicesMember_638144987575226774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TauVaccineInADMember" xlink:label="aciu_TauVaccineInADMember_638144987575226774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesMember_638144987575226774" xlink:to="aciu_TauVaccineInADMember_638144987575226774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638144987575226774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575226774" xlink:to="ifrs-full_TypesOfContractsAxis_638144987575226774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638144987575226774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638144987575226774" xlink:to="ifrs-full_TypesOfContractsMember_638144987575226774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575226774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638144987575226774" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575226774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_638144987575236774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575226774" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_638144987575236774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575236774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575226774" xlink:to="ifrs-full_RangeAxis_638144987575236774" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575236774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575236774" xlink:to="ifrs-full_RangesMember_638144987575236774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_638144987575236774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575236774" xlink:to="ifrs-full_BottomOfRangeMember_638144987575236774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638144987575236774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575236774" xlink:to="ifrs-full_TopOfRangeMember_638144987575236774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575236774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575226774" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575236774" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575236774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575236774" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575236774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue_638144987575236774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575236774" xlink:to="aciu_CollaborativeAgreementPotentialValue_638144987575236774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638144987575236774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575236774" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638144987575236774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementCumulativePaymentsReceived" xlink:label="aciu_CollaborativeAgreementCumulativePaymentsReceived_638144987575236774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575236774" xlink:to="aciu_CollaborativeAgreementCumulativePaymentsReceived_638144987575236774" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_638144987575236774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575236774" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived_638144987575236774" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractLiabilities" xlink:label="ifrs-full_ContractLiabilities_638144987575236774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575236774" xlink:to="ifrs-full_ContractLiabilities_638144987575236774" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638144987575246775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575236774" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638144987575246775" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638144987575246775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575236774" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638144987575246775" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementUpfrontPaymentsReceived" xlink:label="aciu_CollaborativeAgreementUpfrontPaymentsReceived_638144987575246775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575236774" xlink:to="aciu_CollaborativeAgreementUpfrontPaymentsReceived_638144987575246775" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" xlink:type="extended" xlink:title="41307 - Disclosure - Contract revenues, Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575246775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575246775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis_638144987575246775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575246775" xlink:to="ifrs-full_ProductsAndServicesAxis_638144987575246775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember_638144987575246775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis_638144987575246775" xlink:to="ifrs-full_ProductsAndServicesMember_638144987575246775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TauPETImagingAgentMember" xlink:label="aciu_TauPETImagingAgentMember_638144987575246775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesMember_638144987575246775" xlink:to="aciu_TauPETImagingAgentMember_638144987575246775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638144987575246775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575246775" xlink:to="ifrs-full_TypesOfContractsAxis_638144987575246775" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638144987575246775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638144987575246775" xlink:to="ifrs-full_TypesOfContractsMember_638144987575246775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575256779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638144987575246775" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575256779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_638144987575256779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638144987575256779" xlink:to="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_638144987575256779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575256779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575246775" xlink:to="ifrs-full_RangeAxis_638144987575256779" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575256779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575256779" xlink:to="ifrs-full_RangesMember_638144987575256779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638144987575256779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575256779" xlink:to="ifrs-full_TopOfRangeMember_638144987575256779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="ifrs-full_PerformanceObligationsAxis_638144987575256779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575246775" xlink:to="ifrs-full_PerformanceObligationsAxis_638144987575256779" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="ifrs-full_PerformanceObligationsMember_638144987575256779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsAxis_638144987575256779" xlink:to="ifrs-full_PerformanceObligationsMember_638144987575256779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ClinicalMilestonesMember" xlink:label="aciu_ClinicalMilestonesMember_638144987575256779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsMember_638144987575256779" xlink:to="aciu_ClinicalMilestonesMember_638144987575256779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RegulatoryAndSalesBasedMilestonesMember" xlink:label="aciu_RegulatoryAndSalesBasedMilestonesMember_638144987575256779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsMember_638144987575256779" xlink:to="aciu_RegulatoryAndSalesBasedMilestonesMember_638144987575256779" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575256779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575246775" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575256779" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575256779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575256779" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575256779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue_638144987575256779" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575256779" xlink:to="aciu_CollaborativeAgreementPotentialValue_638144987575256779" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638144987575266775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575256779" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638144987575266775" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementCumulativePaymentsReceived" xlink:label="aciu_CollaborativeAgreementCumulativePaymentsReceived_638144987575266775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575256779" xlink:to="aciu_CollaborativeAgreementCumulativePaymentsReceived_638144987575266775" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638144987575266775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575256779" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638144987575266775" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_638144987575266775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575256779" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived_638144987575266775" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638144987575266775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575256779" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638144987575266775" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" xlink:type="extended" xlink:title="41308 - Disclosure - Contract revenues - Grants from the Michael J. Fox Foundation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575266775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575266775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638144987575266775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575266775" xlink:to="ifrs-full_TypesOfContractsAxis_638144987575266775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638144987575346771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638144987575266775" xlink:to="ifrs-full_TypesOfContractsMember_638144987575346771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GrantRevenueMember" xlink:label="aciu_GrantRevenueMember_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638144987575346771" xlink:to="aciu_GrantRevenueMember_638144987575356745" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GrantsMichaelJFoxFoundationMember" xlink:label="aciu_GrantsMichaelJFoxFoundationMember_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_GrantRevenueMember_638144987575356745" xlink:to="aciu_GrantsMichaelJFoxFoundationMember_638144987575356745" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesAxis" xlink:label="ifrs-full_CounterpartiesAxis_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575266775" xlink:to="ifrs-full_CounterpartiesAxis_638144987575356745" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CounterpartiesMember" xlink:label="ifrs-full_CounterpartiesMember_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesAxis_638144987575356745" xlink:to="ifrs-full_CounterpartiesMember_638144987575356745" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SkaneUniversityHospitalMember" xlink:label="aciu_SkaneUniversityHospitalMember_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesMember_638144987575356745" xlink:to="aciu_SkaneUniversityHospitalMember_638144987575356745" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575266775" xlink:to="ifrs-full_ProductsAndServicesAxis_638144987575356745" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis_638144987575356745" xlink:to="ifrs-full_ProductsAndServicesMember_638144987575356745" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" xlink:label="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesMember_638144987575356745" xlink:to="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_638144987575356745" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AdvanceSmallMoleculePdProgramsMember" xlink:label="aciu_AdvanceSmallMoleculePdProgramsMember_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesMember_638144987575356745" xlink:to="aciu_AdvanceSmallMoleculePdProgramsMember_638144987575356745" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575266775" xlink:to="ifrs-full_RangeAxis_638144987575356745" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575356745" xlink:to="ifrs-full_RangesMember_638144987575356745" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575356745" xlink:to="ifrs-full_BottomOfRangeMember_638144987575356745" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575266775" xlink:to="dei_LegalEntityAxis_638144987575356745" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_638144987575356745" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis_638144987575356745" xlink:to="dei_EntityDomain_638144987575356745" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SkaneUniversityHospitalMember" xlink:label="aciu_SkaneUniversityHospitalMember_638144987575366777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain_638144987575356745" xlink:to="aciu_SkaneUniversityHospitalMember_638144987575366777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575366777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638144987575266775" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575366777" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575366777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638144987575366777" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575366777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" xlink:label="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement_638144987575366777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575366777" xlink:to="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement_638144987575366777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FollowOnGrantFundingReceived" xlink:label="aciu_FollowOnGrantFundingReceived_638144987575366777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575366777" xlink:to="aciu_FollowOnGrantFundingReceived_638144987575366777" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfGrants" xlink:label="aciu_NumberOfGrants_638144987575366777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575366777" xlink:to="aciu_NumberOfGrants_638144987575366777" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue_638144987575366777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575366777" xlink:to="aciu_CollaborativeAgreementPotentialValue_638144987575366777" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers_638144987575366777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575366777" xlink:to="ifrs-full_ReceivablesFromContractsWithCustomers_638144987575366777" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CollaborativeAgreementJointResearchCollaborationPeriod" xlink:label="aciu_CollaborativeAgreementJointResearchCollaborationPeriod_638144987575366777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575366777" xlink:to="aciu_CollaborativeAgreementJointResearchCollaborationPeriod_638144987575366777" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638144987575366777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575366777" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638144987575366777" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="ifrs-full_OtherOperatingIncomeExpense_638144987575366777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575366777" xlink:to="ifrs-full_OtherOperatingIncomeExpense_638144987575366777" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638144987575376776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575366777" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638144987575376776" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638144987575376776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638144987575366777" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638144987575376776" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureExpensesByCategoryDetails" xlink:type="extended" xlink:title="41401 - Disclosure - Expenses by category (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ExpensesByCategoryAbstract" xlink:label="ExpensesByCategoryAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_638144987575376776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesByCategoryAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_638144987575376776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_638144987575376776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_638144987575376776" xlink:to="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_638144987575376776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LineItemsByFunctionMember" xlink:label="ifrs-full_LineItemsByFunctionMember_638144987575376776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_638144987575376776" xlink:to="ifrs-full_LineItemsByFunctionMember_638144987575376776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ResearchAndDevelopmentExpensesMember" xlink:label="aciu_ResearchAndDevelopmentExpensesMember_638144987575376776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LineItemsByFunctionMember_638144987575376776" xlink:to="aciu_ResearchAndDevelopmentExpensesMember_638144987575376776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_638144987575376776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LineItemsByFunctionMember_638144987575376776" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_638144987575376776" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638144987575376776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_638144987575376776" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638144987575376776" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="ifrs-full_OperatingExpense_638144987575386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638144987575376776" xlink:to="ifrs-full_OperatingExpense_638144987575386771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_638144987575386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638144987575376776" xlink:to="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_638144987575386771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_638144987575386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638144987575376776" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_638144987575386771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseByNature" xlink:label="ifrs-full_ExpenseByNature_638144987575386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638144987575376776" xlink:to="ifrs-full_ExpenseByNature_638144987575386771" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_638144987575386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638144987575376776" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_638144987575386771" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AverageNumberOfEmployees" xlink:label="ifrs-full_AverageNumberOfEmployees_638144987575386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638144987575376776" xlink:to="ifrs-full_AverageNumberOfEmployees_638144987575386771" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_638144987575386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638144987575376776" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_638144987575386771" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FinancialResultNetAbstract" xlink:label="aciu_FinancialResultNetAbstract_638144987575386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638144987575376776" xlink:to="aciu_FinancialResultNetAbstract_638144987575386771" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome_638144987575386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialResultNetAbstract_638144987575386771" xlink:to="ifrs-full_FinanceIncome_638144987575386771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts_638144987575386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialResultNetAbstract_638144987575386771" xlink:to="ifrs-full_FinanceCosts_638144987575386771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638144987575386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialResultNetAbstract_638144987575386771" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638144987575386771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost_638144987575386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialResultNetAbstract_638144987575386771" xlink:to="ifrs-full_FinanceIncomeCost_638144987575386771" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes" xlink:label="aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes_638144987575386771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialResultNetAbstract_638144987575386771" xlink:to="aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes_638144987575386771" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails" xlink:type="extended" xlink:title="41501 - Disclosure - Related-party transactions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfPersonsKeyManagementBoardOfDirectors" xlink:label="aciu_NumberOfPersonsKeyManagementBoardOfDirectors_638144987575396774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="aciu_NumberOfPersonsKeyManagementBoardOfDirectors_638144987575396774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfPersonsKeyManagementExecutiveManagement" xlink:label="aciu_NumberOfPersonsKeyManagementExecutiveManagement_638144987575396774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="aciu_NumberOfPersonsKeyManagementExecutiveManagement_638144987575396774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_638144987575396774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_638144987575396774" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_638144987575396774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_638144987575396774" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_638144987575396774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_638144987575396774" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_638144987575396774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_638144987575396774" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" xlink:type="extended" xlink:title="41601 - Disclosure - Income taxes - Summary of Income Tax Expense (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638144987575396774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638144987575396774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575396774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638144987575396774" xlink:to="ifrs-full_RangeAxis_638144987575396774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575396774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575396774" xlink:to="ifrs-full_RangesMember_638144987575396774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_638144987575396774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575396774" xlink:to="ifrs-full_BottomOfRangeMember_638144987575396774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageMember" xlink:label="ifrs-full_WeightedAverageMember_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575396774" xlink:to="ifrs-full_WeightedAverageMember_638144987575406769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575396774" xlink:to="ifrs-full_TopOfRangeMember_638144987575406769" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638144987575396774" xlink:to="ifrs-full_GeographicalAreasAxis_638144987575406769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis_638144987575406769" xlink:to="ifrs-full_GeographicalAreasMember_638144987575406769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH" xlink:label="country_CH_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_638144987575406769" xlink:to="country_CH_638144987575406769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638144987575396774" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638144987575406769" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638144987575406769" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_638144987575406769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638144987575406769" xlink:to="ifrs-full_DeferredTaxAssets_638144987575406769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="ifrs-full_DeferredTaxLiabilities_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638144987575406769" xlink:to="ifrs-full_DeferredTaxLiabilities_638144987575406769" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="ifrs-full_ApplicableTaxRate_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638144987575406769" xlink:to="ifrs-full_ApplicableTaxRate_638144987575406769" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638144987575406769" xlink:to="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638144987575406769" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccountingProfit" xlink:label="ifrs-full_AccountingProfit_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638144987575406769" xlink:to="ifrs-full_AccountingProfit_638144987575406769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638144987575406769" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_638144987575406769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_638144987575406769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638144987575406769" xlink:to="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_638144987575406769" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="ifrs-full_TaxEffectOfTaxLosses_638144987575416776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638144987575406769" xlink:to="ifrs-full_TaxEffectOfTaxLosses_638144987575416776" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_638144987575416776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638144987575406769" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_638144987575416776" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" xlink:type="extended" xlink:title="41602 - Disclosure - Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="MajorComponentsOfTaxExpenseIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638144987575416776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638144987575416776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_638144987575416776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638144987575416776" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_638144987575416776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_638144987575416776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_638144987575416776" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_638144987575416776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesMember" xlink:label="ifrs-full_UnusedTaxLossesMember_638144987575416776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_638144987575416776" xlink:to="ifrs-full_UnusedTaxLossesMember_638144987575416776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" xlink:label="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_638144987575416776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_638144987575416776" xlink:to="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_638144987575416776" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RetirementBenefitPlanMember" xlink:label="aciu_RetirementBenefitPlanMember_638144987575416776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_638144987575416776" xlink:to="aciu_RetirementBenefitPlanMember_638144987575416776" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis_638144987575416776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638144987575416776" xlink:to="ifrs-full_MaturityAxis_638144987575416776" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember_638144987575416776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis_638144987575416776" xlink:to="ifrs-full_AggregatedTimeBandsMember_638144987575416776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312024Member" xlink:label="aciu_December312024Member_638144987575426771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987575416776" xlink:to="aciu_December312024Member_638144987575426771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312025Member" xlink:label="aciu_December312025Member_638144987575426771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987575416776" xlink:to="aciu_December312025Member_638144987575426771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312026Member" xlink:label="aciu_December312026Member_638144987575426771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987575416776" xlink:to="aciu_December312026Member_638144987575426771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312027Member" xlink:label="aciu_December312027Member_638144987575426771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987575416776" xlink:to="aciu_December312027Member_638144987575426771" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312028Member" xlink:label="aciu_December312028Member_638144987575426771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987575416776" xlink:to="aciu_December312028Member_638144987575426771" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_December312029Member" xlink:label="aciu_December312029Member_638144987575426771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987575416776" xlink:to="aciu_December312029Member_638144987575426771" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638144987575426771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638144987575416776" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638144987575426771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_638144987575426771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638144987575426771" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_638144987575426771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_638144987575426771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_638144987575426771" xlink:to="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_638144987575426771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TaxLossesSplitByExpiryDateAbstract" xlink:label="aciu_TaxLossesSplitByExpiryDateAbstract_638144987575426771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638144987575426771" xlink:to="aciu_TaxLossesSplitByExpiryDateAbstract_638144987575426771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_638144987575426771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TaxLossesSplitByExpiryDateAbstract_638144987575426771" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_638144987575426771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" xlink:label="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits_638144987575426771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TaxLossesSplitByExpiryDateAbstract_638144987575426771" xlink:to="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits_638144987575426771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" xlink:type="extended" xlink:title="41701 - Disclosure - Retirement benefit plan - Summary of Benefit Plan (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638144987575436768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638144987575436768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638144987575436768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638144987575436768" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638144987575436768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638144987575436768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638144987575436768" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638144987575436768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:label="ifrs-full_PresentValueOfDefinedBenefitObligationMember_638144987575436768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638144987575436768" xlink:to="ifrs-full_PresentValueOfDefinedBenefitObligationMember_638144987575436768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638144987575436768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638144987575436768" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638144987575436768" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees_638144987575436768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638144987575436768" xlink:to="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees_638144987575436768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer_638144987575436768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638144987575436768" xlink:to="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer_638144987575436768" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SurplusDeficitInPlanAbstract" xlink:label="ifrs-full_SurplusDeficitInPlanAbstract_638144987575436768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638144987575436768" xlink:to="ifrs-full_SurplusDeficitInPlanAbstract_638144987575436768" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_638144987575436768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SurplusDeficitInPlanAbstract_638144987575436768" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue_638144987575436768" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="ifrs-full_PlanAssetsAtFairValue_638144987575436768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SurplusDeficitInPlanAbstract_638144987575436768" xlink:to="ifrs-full_PlanAssetsAtFairValue_638144987575436768" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SurplusDeficitInPlan" xlink:label="ifrs-full_SurplusDeficitInPlan_638144987575436768" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SurplusDeficitInPlanAbstract_638144987575436768" xlink:to="ifrs-full_SurplusDeficitInPlan_638144987575436768" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" xlink:type="extended" xlink:title="41702 - Disclosure - Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans" xlink:label="aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans_638144987575446773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans_638144987575446773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:label="ifrs-full_InterestExpenseDefinedBenefitPlans_638144987575446773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_InterestExpenseDefinedBenefitPlans_638144987575446773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestIncomeDefinedBenefitPlans" xlink:label="ifrs-full_InterestIncomeDefinedBenefitPlans_638144987575446773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_InterestIncomeDefinedBenefitPlans_638144987575446773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_638144987575446773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_638144987575446773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" xlink:type="extended" xlink:title="41703 - Disclosure - Retirement benefit plan, Changes in Defined Benefit Obligation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638144987575446773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638144987575446773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638144987575446773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638144987575446773" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638144987575446773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638144987575446773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638144987575446773" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638144987575446773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:label="ifrs-full_PresentValueOfDefinedBenefitObligationMember_638144987575446773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638144987575446773" xlink:to="ifrs-full_PresentValueOfDefinedBenefitObligationMember_638144987575446773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638144987575446773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638144987575446773" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638144987575446773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575446773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638144987575446773" xlink:to="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575446773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638144987575446773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575446773" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638144987575446773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome_638144987575446773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575446773" xlink:to="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome_638144987575446773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_638144987575456771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575446773" xlink:to="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_638144987575456771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_638144987575456771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575446773" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_638144987575456771" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_638144987575456771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575446773" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_638144987575456771" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_638144987575456771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575446773" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_638144987575456771" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_638144987575456771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575446773" xlink:to="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_638144987575456771" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_638144987575456771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575446773" xlink:to="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_638144987575456771" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638144987575456771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575446773" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638144987575456771" order="9" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" xlink:type="extended" xlink:title="41704 - Disclosure - Retirement benefit plan, Changes in Fair Value of Plan Assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638144987575456771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638144987575456771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638144987575456771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638144987575456771" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638144987575456771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638144987575456771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638144987575456771" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638144987575456771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PlanAssetsMember" xlink:label="ifrs-full_PlanAssetsMember_638144987575456771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638144987575456771" xlink:to="ifrs-full_PlanAssetsMember_638144987575456771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638144987575466769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638144987575456771" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638144987575466769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:label="aciu_ChangesInFairValueOfPlanAssetsAbstract_638144987575466769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638144987575466769" xlink:to="aciu_ChangesInFairValueOfPlanAssetsAbstract_638144987575466769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638144987575466769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638144987575466769" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638144987575466769" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_638144987575466769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638144987575466769" xlink:to="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_638144987575466769" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_638144987575466769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638144987575466769" xlink:to="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_638144987575466769" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_638144987575466769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638144987575466769" xlink:to="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_638144987575466769" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_638144987575466769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638144987575466769" xlink:to="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_638144987575466769" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_638144987575466769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638144987575466769" xlink:to="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_638144987575466769" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_6381449875754667691" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638144987575466769" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_6381449875754667691" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:label="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_638144987575466769" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638144987575466769" xlink:to="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_638144987575466769" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails" xlink:type="extended" xlink:title="41705 - Disclosure - Retirement benefit plan, Change in Net Defined Benefit Liability (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575476773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638144987575476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575476773" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638144987575476773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" xlink:label="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_638144987575476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575476773" xlink:to="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_638144987575476773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_638144987575476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575476773" xlink:to="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_638144987575476773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_638144987575476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575476773" xlink:to="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_638144987575476773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_6381449875754767731" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638144987575476773" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_6381449875754767731" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" xlink:type="extended" xlink:title="41706 - Disclosure - Retirement benefit plan - Change in other comprehensive gains (losses) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OtherComprehensiveGainsLossesAbstract" xlink:label="aciu_OtherComprehensiveGainsLossesAbstract_638144987575476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="aciu_OtherComprehensiveGainsLossesAbstract_638144987575476773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_638144987575476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract_638144987575476773" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_638144987575476773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_638144987575476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract_638144987575476773" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_638144987575476773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_638144987575476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract_638144987575476773" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_638144987575476773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_638144987575476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract_638144987575476773" xlink:to="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_638144987575476773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_638144987575476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract_638144987575476773" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_638144987575476773" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:label="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_638144987575476773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract_638144987575476773" xlink:to="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_638144987575476773" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" xlink:type="extended" xlink:title="41707 - Disclosure - Retirement benefit plan, Actuarial Assumptions and Sensitivity Analysis (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_638144987575486771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_638144987575486771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="ifrs-full_ActuarialAssumptionsAxis_638144987575486771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_638144987575486771" xlink:to="ifrs-full_ActuarialAssumptionsAxis_638144987575486771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionsMember" xlink:label="ifrs-full_ActuarialAssumptionsMember_638144987575486771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ActuarialAssumptionsAxis_638144987575486771" xlink:to="ifrs-full_ActuarialAssumptionsMember_638144987575486771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRatesMember_638144987575486771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ActuarialAssumptionsMember_638144987575486771" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRatesMember_638144987575486771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_638144987575486771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ActuarialAssumptionsMember_638144987575486771" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_638144987575486771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_638144987575486771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ActuarialAssumptionsMember_638144987575486771" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_638144987575486771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_638144987575486771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ActuarialAssumptionsMember_638144987575486771" xlink:to="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_638144987575486771" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis_638144987575486771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_638144987575486771" xlink:to="ifrs-full_TypesOfRisksAxis_638144987575486771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember_638144987575486771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis_638144987575486771" xlink:to="ifrs-full_TypesOfRisksMember_638144987575486771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_638144987575486771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_638144987575486771" xlink:to="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_638144987575486771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" xlink:label="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_638144987575486771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_638144987575486771" xlink:to="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_638144987575486771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_638144987575486771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_638144987575486771" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_638144987575486771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_638144987575496772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_638144987575486771" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_638144987575496772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates_638144987575496772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_638144987575496772" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRates_638144987575496772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_638144987575496772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_638144987575496772" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_638144987575496772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_638144987575496772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_638144987575496772" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_638144987575496772" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital_638144987575496772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_638144987575496772" xlink:to="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital_638144987575496772" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:label="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638144987575496772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_638144987575486771" xlink:to="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638144987575496772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_638144987575496772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638144987575496772" xlink:to="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_638144987575496772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_638144987575496772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638144987575496772" xlink:to="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_638144987575496772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_638144987575496772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638144987575496772" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue_638144987575496772" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_638144987575496772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638144987575496772" xlink:to="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_638144987575496772" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_638144987575496772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638144987575496772" xlink:to="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_638144987575496772" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails" xlink:type="extended" xlink:title="41801 - Disclosure - Share-based compensation, Plans Outstanding (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfEquityBasedInstrumentPlans" xlink:label="aciu_NumberOfEquityBasedInstrumentPlans_638144987575506770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="aciu_NumberOfEquityBasedInstrumentPlans_638144987575506770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638144987575506770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638144987575506770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_638144987575506770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638144987575506770" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_638144987575506770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_638144987575506770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_638144987575506770" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_638144987575506770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_StockOptionPlanC1Member" xlink:label="aciu_StockOptionPlanC1Member_638144987575506770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_638144987575506770" xlink:to="aciu_StockOptionPlanC1Member_638144987575506770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Two016ShareOptionAndIncentivePlanMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanMember_638144987575506770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_638144987575506770" xlink:to="aciu_Two016ShareOptionAndIncentivePlanMember_638144987575506770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_638144987575506770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember_638144987575506770" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_638144987575506770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_638144987575506770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember_638144987575506770" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_638144987575506770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_638144987575506770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember_638144987575506770" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_638144987575506770" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_638144987575506770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638144987575506770" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_638144987575506770" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_638144987575506770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_638144987575506770" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_638144987575506770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_638144987575506770" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_638144987575506770" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_638144987575506770" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_EmployeesMember" xlink:label="aciu_EmployeesMember_638144987575516773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_638144987575506770" xlink:to="aciu_EmployeesMember_638144987575516773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638144987575516773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638144987575506770" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638144987575516773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ShareBasedPlansOutstandingAbstract" xlink:label="aciu_ShareBasedPlansOutstandingAbstract_638144987575516773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638144987575516773" xlink:to="aciu_ShareBasedPlansOutstandingAbstract_638144987575516773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_638144987575516773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ShareBasedPlansOutstandingAbstract_638144987575516773" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_638144987575516773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_638144987575516773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ShareBasedPlansOutstandingAbstract_638144987575516773" xlink:to="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_638144987575516773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" xlink:label="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement_638144987575516773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ShareBasedPlansOutstandingAbstract_638144987575516773" xlink:to="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement_638144987575516773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails" xlink:type="extended" xlink:title="41802 - Disclosure - Share-based compensation, Weighted Average Exercise Prices (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638144987575526771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfOptionsAbstract" xlink:label="aciu_NumberOfOptionsAbstract_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638144987575526771" xlink:to="aciu_NumberOfOptionsAbstract_638144987575526771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfOptionsAbstract_638144987575526771" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_638144987575526771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfOptionsAbstract_638144987575526771" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_638144987575526771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfOptionsAbstract_638144987575526771" xlink:to="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_638144987575526771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfOptionsAbstract_638144987575526771" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_638144987575526771" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfOptionsAbstract_638144987575526771" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_638144987575526771" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_6381449875755267711" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfOptionsAbstract_638144987575526771" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_6381449875755267711" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfOptionsAbstract_638144987575526771" xlink:to="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_638144987575526771" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageExercisePriceAbstract" xlink:label="aciu_WeightedAverageExercisePriceAbstract_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638144987575526771" xlink:to="aciu_WeightedAverageExercisePriceAbstract_638144987575526771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575526771" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_638144987575526771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575526771" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_638144987575526771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575526771" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_638144987575526771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575526771" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_638144987575526771" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_638144987575526771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575526771" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_638144987575526771" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_638144987575536776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575526771" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_638144987575536776" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_638144987575536776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575526771" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_638144987575536776" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageRemainingAbstract" xlink:label="aciu_WeightedAverageRemainingAbstract_638144987575536776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638144987575526771" xlink:to="aciu_WeightedAverageRemainingAbstract_638144987575536776" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_638144987575536776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageRemainingAbstract_638144987575536776" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_638144987575536776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" xlink:label="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable_638144987575536776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageRemainingAbstract_638144987575536776" xlink:to="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable_638144987575536776" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" xlink:type="extended" xlink:title="41803 - Disclosure - Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_638144987575536776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_638144987575536776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_638144987575536776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_638144987575536776" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_638144987575536776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_638144987575536776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_638144987575536776" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_638144987575536776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Chf0.15Member" xlink:label="aciu_Chf0.15Member_638144987575536776" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_638144987575536776" xlink:to="aciu_Chf0.15Member_638144987575536776" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Chf9.53Member" xlink:label="aciu_Chf9.53Member_638144987575546773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_638144987575536776" xlink:to="aciu_Chf9.53Member_638144987575546773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Usd5.04ToUsd12.30Member" xlink:label="aciu_Usd5.04ToUsd12.30Member_638144987575546773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_638144987575536776" xlink:to="aciu_Usd5.04ToUsd12.30Member_638144987575546773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_Usd2.76ToUsd4.57Member" xlink:label="aciu_Usd2.76ToUsd4.57Member_638144987575546773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_638144987575536776" xlink:to="aciu_Usd2.76ToUsd4.57Member_638144987575546773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575546773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_638144987575536776" xlink:to="ifrs-full_RangeAxis_638144987575546773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575546773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575546773" xlink:to="ifrs-full_RangesMember_638144987575546773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_638144987575546773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575546773" xlink:to="ifrs-full_BottomOfRangeMember_638144987575546773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638144987575546773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575546773" xlink:to="ifrs-full_TopOfRangeMember_638144987575546773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_638144987575546773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_638144987575536776" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_638144987575546773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:label="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_638144987575546773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_638144987575546773" xlink:to="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_638144987575546773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_638144987575546773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_638144987575546773" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_638144987575546773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_638144987575546773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_638144987575546773" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_638144987575546773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_638144987575546773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_638144987575546773" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_638144987575546773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" xlink:type="extended" xlink:title="41804 - Disclosure - Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_638144987575556772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_638144987575556772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575556772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_638144987575556772" xlink:to="ifrs-full_RangeAxis_638144987575556772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575556772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575556772" xlink:to="ifrs-full_RangesMember_638144987575556772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_638144987575556772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575556772" xlink:to="ifrs-full_BottomOfRangeMember_638144987575556772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638144987575556772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575556772" xlink:to="ifrs-full_TopOfRangeMember_638144987575556772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_638144987575556772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_638144987575556772" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_638144987575556772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638144987575556772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_638144987575556772" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638144987575556772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_638144987575556772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638144987575556772" xlink:to="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_638144987575556772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageAssumptionsAbstract" xlink:label="aciu_WeightedAverageAssumptionsAbstract_638144987575556772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638144987575556772" xlink:to="aciu_WeightedAverageAssumptionsAbstract_638144987575556772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_638144987575556772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageAssumptionsAbstract_638144987575556772" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_638144987575556772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_638144987575556772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageAssumptionsAbstract_638144987575556772" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_638144987575556772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_638144987575556772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageAssumptionsAbstract_638144987575556772" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_638144987575556772" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_638144987575556772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageAssumptionsAbstract_638144987575556772" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_638144987575556772" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_638144987575566774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageAssumptionsAbstract_638144987575556772" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_638144987575566774" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_638144987575566774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageAssumptionsAbstract_638144987575556772" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_638144987575566774" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails" xlink:type="extended" xlink:title="41805 - Disclosure - Share-based compensation, Non-vested Share Awards (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638144987575566774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638144987575566774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_638144987575566774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638144987575566774" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_638144987575566774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_638144987575566774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_638144987575566774" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_638144987575566774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RestrictedSharesAndRestrictedShareUnitsMember" xlink:label="aciu_RestrictedSharesAndRestrictedShareUnitsMember_638144987575566774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_638144987575566774" xlink:to="aciu_RestrictedSharesAndRestrictedShareUnitsMember_638144987575566774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RestrictedStockUnitsMember" xlink:label="aciu_RestrictedStockUnitsMember_638144987575566774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_638144987575566774" xlink:to="aciu_RestrictedStockUnitsMember_638144987575566774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RestrictedStockUnitsFirstVestingConditionsMember" xlink:label="aciu_RestrictedStockUnitsFirstVestingConditionsMember_638144987575566774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_RestrictedStockUnitsMember_638144987575566774" xlink:to="aciu_RestrictedStockUnitsFirstVestingConditionsMember_638144987575566774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RestrictedStockUnitsSecondVestingConditionsMember" xlink:label="aciu_RestrictedStockUnitsSecondVestingConditionsMember_638144987575566774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_RestrictedStockUnitsMember_638144987575566774" xlink:to="aciu_RestrictedStockUnitsSecondVestingConditionsMember_638144987575566774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_638144987575566774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638144987575566774" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_638144987575566774" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_638144987575566774" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_638144987575566774" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_638144987575566774" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_BoardOfDirectorsMember" xlink:label="aciu_BoardOfDirectorsMember_638144987575576775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_638144987575566774" xlink:to="aciu_BoardOfDirectorsMember_638144987575576775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ExecutiveManagementMember" xlink:label="aciu_ExecutiveManagementMember_638144987575576775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_638144987575566774" xlink:to="aciu_ExecutiveManagementMember_638144987575576775" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638144987575576775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638144987575566774" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638144987575576775" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ShareBasedPaymentArrangementAbstract" xlink:label="aciu_ShareBasedPaymentArrangementAbstract_638144987575576775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638144987575576775" xlink:to="aciu_ShareBasedPaymentArrangementAbstract_638144987575576775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_638144987575576775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ShareBasedPaymentArrangementAbstract_638144987575576775" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_638144987575576775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_638144987575576775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ShareBasedPaymentArrangementAbstract_638144987575576775" xlink:to="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_638144987575576775" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" xlink:label="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement_638144987575576775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ShareBasedPaymentArrangementAbstract_638144987575576775" xlink:to="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement_638144987575576775" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfNonVestedSharesAbstract" xlink:label="aciu_NumberOfNonVestedSharesAbstract_638144987575576775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638144987575576775" xlink:to="aciu_NumberOfNonVestedSharesAbstract_638144987575576775" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_638144987575576775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638144987575576775" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_638144987575576775" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_638144987575576775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638144987575576775" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_638144987575576775" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_638144987575576775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638144987575576775" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_638144987575576775" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" xlink:label="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement_638144987575576775" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638144987575576775" xlink:to="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement_638144987575576775" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_638144987575586771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638144987575576775" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_638144987575586771" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_638144987575586771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638144987575576775" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_638144987575586771" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_638144987575586771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638144987575576775" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_638144987575586771" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_638144987575586771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638144987575576775" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_638144987575586771" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageExercisePriceAbstract" xlink:label="aciu_WeightedAverageExercisePriceAbstract_638144987575586771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638144987575576775" xlink:to="aciu_WeightedAverageExercisePriceAbstract_638144987575586771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_638144987575586771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575586771" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_638144987575586771" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited_638144987575586771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575586771" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited_638144987575586771" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired_638144987575586771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575586771" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired_638144987575586771" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised_638144987575586771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575586771" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised_638144987575586771" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted_638144987575596773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575586771" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted_638144987575596773" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested_638144987575596773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575586771" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested_638144987575596773" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable_638144987575596773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575586771" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable_638144987575596773" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_638144987575596773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638144987575586771" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_638144987575596773" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_638144987575596773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638144987575576775" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_638144987575596773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails" xlink:type="extended" xlink:title="41901 - Disclosure - Commitments and contingencies (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CommitmentsAndContingenciesAbstract" xlink:label="CommitmentsAndContingenciesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_638144987575606773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesAbstract" xlink:to="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_638144987575606773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis_638144987575606773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_638144987575606773" xlink:to="ifrs-full_MaturityAxis_638144987575606773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember_638144987575606773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis_638144987575606773" xlink:to="ifrs-full_AggregatedTimeBandsMember_638144987575606773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember_638144987575606773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987575606773" xlink:to="ifrs-full_NotLaterThanOneYearMember_638144987575606773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_638144987575606773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987575606773" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_638144987575606773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_638144987575606773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987575606773" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_638144987575606773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember_638144987575606773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638144987575606773" xlink:to="ifrs-full_LaterThanFiveYearsMember_638144987575606773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems_638144987575606773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_638144987575606773" xlink:to="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems_638144987575606773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CommitmentsAbstract" xlink:label="aciu_CommitmentsAbstract_638144987575606773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems_638144987575606773" xlink:to="aciu_CommitmentsAbstract_638144987575606773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ContractualCapitalCommitmentsOtherThanForLeases" xlink:label="aciu_ContractualCapitalCommitmentsOtherThanForLeases_638144987575606773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CommitmentsAbstract_638144987575606773" xlink:to="aciu_ContractualCapitalCommitmentsOtherThanForLeases_638144987575606773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RentalContractPeriodForNoticeOfCancellation" xlink:label="aciu_RentalContractPeriodForNoticeOfCancellation_638144987575606773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CommitmentsAbstract_638144987575606773" xlink:to="aciu_RentalContractPeriodForNoticeOfCancellation_638144987575606773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContractualCapitalCommitments" xlink:label="ifrs-full_ContractualCapitalCommitments_638144987575606773" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CommitmentsAbstract_638144987575606773" xlink:to="ifrs-full_ContractualCapitalCommitments_638144987575606773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureEarningsPerShareDetails" xlink:type="extended" xlink:title="42001 - Disclosure - Earnings per share (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsPerShareAbstract" xlink:label="ifrs-full_BasicEarningsPerShareAbstract_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ifrs-full_BasicEarningsPerShareAbstract_638144987575616777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BasicEarningsPerShareAbstract_638144987575616777" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_638144987575616777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_638144987575616777" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_638144987575616777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ifrs-full_DilutedEarningsPerShareAbstract_638144987575616777" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:label="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DilutedEarningsPerShareAbstract_638144987575616777" xlink:to="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_638144987575616777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageShares" xlink:label="ifrs-full_WeightedAverageShares_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_638144987575616777" xlink:to="ifrs-full_WeightedAverageShares_638144987575616777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="ifrs-full_AdjustedWeightedAverageShares_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_638144987575616777" xlink:to="ifrs-full_AdjustedWeightedAverageShares_638144987575616777" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="ifrs-full_BasicEarningsLossPerShare_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_638144987575616777" xlink:to="ifrs-full_BasicEarningsLossPerShare_638144987575616777" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_638144987575616777" xlink:to="ifrs-full_DilutedEarningsLossPerShare_638144987575616777" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AntidilutiveSecuritiesAbstract" xlink:label="aciu_AntidilutiveSecuritiesAbstract_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="aciu_AntidilutiveSecuritiesAbstract_638144987575616777" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding" xlink:label="aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AntidilutiveSecuritiesAbstract_638144987575616777" xlink:to="aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding_638144987575616777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting" xlink:label="aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AntidilutiveSecuritiesAbstract_638144987575616777" xlink:to="aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting_638144987575616777" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AntidilutiveSecuritiesAbstract_638144987575616777" xlink:to="ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_638144987575616777" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares" xlink:label="aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares_638144987575616777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AntidilutiveSecuritiesAbstract_638144987575616777" xlink:to="aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares_638144987575616777" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails" xlink:type="extended" xlink:title="42101 - Disclosure - Financial instruments and risk management (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:label="DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638144987575626777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638144987575626777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis_638144987575626777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638144987575626777" xlink:to="ifrs-full_TypesOfRisksAxis_638144987575626777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember_638144987575626777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis_638144987575626777" xlink:to="ifrs-full_TypesOfRisksMember_638144987575626777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="ifrs-full_CurrencyRiskMember_638144987575626777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_638144987575626777" xlink:to="ifrs-full_CurrencyRiskMember_638144987575626777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CreditRiskMember" xlink:label="ifrs-full_CreditRiskMember_638144987575626777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_638144987575626777" xlink:to="ifrs-full_CreditRiskMember_638144987575626777" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiquidityRiskMember" xlink:label="ifrs-full_LiquidityRiskMember_638144987575626777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_638144987575626777" xlink:to="ifrs-full_LiquidityRiskMember_638144987575626777" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateRiskMember" xlink:label="ifrs-full_InterestRateRiskMember_638144987575626777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_638144987575626777" xlink:to="ifrs-full_InterestRateRiskMember_638144987575626777" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638144987575626777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638144987575626777" xlink:to="ifrs-full_RangeAxis_638144987575626777" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638144987575626777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638144987575626777" xlink:to="ifrs-full_RangesMember_638144987575626777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638144987575626777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638144987575626777" xlink:to="ifrs-full_TopOfRangeMember_638144987575626777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis_638144987575626777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638144987575626777" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis_638144987575626777" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="ifrs-full_FinancialAssetsMember_638144987575626777" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis_638144987575626777" xlink:to="ifrs-full_FinancialAssetsMember_638144987575626777" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_RightOfUseFinancialAssetsMember" xlink:label="aciu_RightOfUseFinancialAssetsMember_638144987575636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialAssetsMember_638144987575626777" xlink:to="aciu_RightOfUseFinancialAssetsMember_638144987575636772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LongTermFinancialAssetsMember" xlink:label="aciu_LongTermFinancialAssetsMember_638144987575636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialAssetsMember_638144987575626777" xlink:to="aciu_LongTermFinancialAssetsMember_638144987575636772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_OtherCurrentReceivablesMember" xlink:label="aciu_OtherCurrentReceivablesMember_638144987575636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialAssetsMember_638144987575626777" xlink:to="aciu_OtherCurrentReceivablesMember_638144987575636772" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ShortTermFinancialAssetsMember" xlink:label="aciu_ShortTermFinancialAssetsMember_638144987575636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialAssetsMember_638144987575626777" xlink:to="aciu_ShortTermFinancialAssetsMember_638144987575636772" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashOnHandAndCashEquivalentsMember" xlink:label="aciu_CashOnHandAndCashEquivalentsMember_638144987575636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialAssetsMember_638144987575626777" xlink:to="aciu_CashOnHandAndCashEquivalentsMember_638144987575636772" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_638144987575636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638144987575626777" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis_638144987575636772" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="ifrs-full_FinancialLiabilitiesMember_638144987575636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis_638144987575636772" xlink:to="ifrs-full_FinancialLiabilitiesMember_638144987575636772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LongTermLeaseLiabilitiesMember" xlink:label="aciu_LongTermLeaseLiabilitiesMember_638144987575636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_638144987575636772" xlink:to="aciu_LongTermLeaseLiabilitiesMember_638144987575636772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_TradeAndOtherPayablesMember" xlink:label="aciu_TradeAndOtherPayablesMember_638144987575636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_638144987575636772" xlink:to="aciu_TradeAndOtherPayablesMember_638144987575636772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_AccruedExpensesMember" xlink:label="aciu_AccruedExpensesMember_638144987575636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_638144987575636772" xlink:to="aciu_AccruedExpensesMember_638144987575636772" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_ShortTermLeaseLiabilitiesMember" xlink:label="aciu_ShortTermLeaseLiabilitiesMember_638144987575636772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_638144987575636772" xlink:to="aciu_ShortTermLeaseLiabilitiesMember_638144987575636772" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_638144987575646772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638144987575626777" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_638144987575646772" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FinancialAssetsAndLiabilitiesAbstract" xlink:label="aciu_FinancialAssetsAndLiabilitiesAbstract_638144987575646772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_638144987575646772" xlink:to="aciu_FinancialAssetsAndLiabilitiesAbstract_638144987575646772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets" xlink:label="ifrs-full_FinancialAssets_638144987575646772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialAssetsAndLiabilitiesAbstract_638144987575646772" xlink:to="ifrs-full_FinancialAssets_638144987575646772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities_638144987575646772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialAssetsAndLiabilitiesAbstract_638144987575646772" xlink:to="ifrs-full_FinancialLiabilities_638144987575646772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_FinancialRisksAbstract" xlink:label="aciu_FinancialRisksAbstract_638144987575646772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_638144987575646772" xlink:to="aciu_FinancialRisksAbstract_638144987575646772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638144987575646772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638144987575646772" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638144987575646772" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:label="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_638144987575646772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638144987575646772" xlink:to="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_638144987575646772" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_638144987575646772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638144987575646772" xlink:to="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_638144987575646772" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates" xlink:label="aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates_638144987575646772" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638144987575646772" xlink:to="aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates_638144987575646772" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates_638144987575656771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638144987575646772" xlink:to="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates_638144987575656771" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates_638144987575656771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638144987575646772" xlink:to="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates_638144987575656771" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" xlink:label="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets_638144987575656771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638144987575646772" xlink:to="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets_638144987575656771" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20221231.xsd#aciu_LiquidityManagementRollingForecastPeriod" xlink:label="aciu_LiquidityManagementRollingForecastPeriod_638144987575656771" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638144987575646772" xlink:to="aciu_LiquidityManagementRollingForecastPeriod_638144987575656771" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717910078064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AC IMMUNE SA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001651625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">V8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">EPFL INNOVATION PARK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building B<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">1015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lausanne<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares, nominal value CHF 0.02 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ACIU<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">83,620,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers SA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Lausanne, Switzerland<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">EPFL INNOVATION PARK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building B<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">1015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lausanne<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Andrea Pfeifer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">21 345 91 21<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917891136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">SFr 4,259<span></span>
</td>
<td class="nump">SFr 5,116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">2,808<span></span>
</td>
<td class="nump">2,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible asset</a></td>
<td class="nump">50,416<span></span>
</td>
<td class="nump">50,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentRestrictedCashAndCashEquivalents', window );">Long-term financial assets</a></td>
<td class="nump">361<span></span>
</td>
<td class="nump">363<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">57,844<span></span>
</td>
<td class="nump">58,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="nump">4,708<span></span>
</td>
<td class="nump">3,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets', window );">Accrued income</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other current receivables</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents', window );">Short-term financial assets</a></td>
<td class="nump">91,000<span></span>
</td>
<td class="nump">116,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">31,586<span></span>
</td>
<td class="nump">82,216<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">128,094<span></span>
</td>
<td class="nump">202,634<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">185,938<span></span>
</td>
<td class="nump">261,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">1,797<span></span>
</td>
<td class="nump">1,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium</a></td>
<td class="nump">431,323<span></span>
</td>
<td class="nump">431,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Treasury shares</a></td>
<td class="num">(124)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Currency translation differences</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated losses</a></td>
<td class="num">(264,015)<span></span>
</td>
<td class="num">(200,942)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total shareholders' equity</a></td>
<td class="nump">168,991<span></span>
</td>
<td class="nump">231,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Long-term lease liabilities</a></td>
<td class="nump">2,253<span></span>
</td>
<td class="nump">2,340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisionsForEmployeeBenefits', window );">Net employee defined benefit liabilities</a></td>
<td class="nump">3,213<span></span>
</td>
<td class="nump">7,098<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">5,466<span></span>
</td>
<td class="nump">9,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="nump">929<span></span>
</td>
<td class="nump">2,003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses</a></td>
<td class="nump">9,417<span></span>
</td>
<td class="nump">16,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities', window );">Deferred income</a></td>
<td class="nump">587<span></span>
</td>
<td class="nump">717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Short-term lease liabilities</a></td>
<td class="nump">548<span></span>
</td>
<td class="nump">570<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">11,481<span></span>
</td>
<td class="nump">20,026<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">16,947<span></span>
</td>
<td class="nump">29,464<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total shareholders' equity and liabilities</a></td>
<td class="nump">SFr 185,938<span></span>
</td>
<td class="nump">SFr 261,443<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued income including current contract assets. [Refer: Accrued income including contract assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.
Effective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisionsForEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisionsForEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentRestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentRestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2021-01-01<br> -Paragraph 52<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_52_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An entity&#8217;s own equity instruments, held by the entity or other members of the consolidated group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717918452208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income/(Loss) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Contract revenue</a></td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 15,431<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">3,935<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ExpensesOperatingAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research &amp; development expenses</a></td>
<td class="num">(60,336)<span></span>
</td>
<td class="num">(62,282)<span></span>
</td>
<td class="num">(59,487)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General &amp; administrative expenses</a></td>
<td class="num">(15,789)<span></span>
</td>
<td class="num">(17,910)<span></span>
</td>
<td class="num">(18,557)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other operating income/(expense), net</a></td>
<td class="nump">1,343<span></span>
</td>
<td class="nump">1,182<span></span>
</td>
<td class="nump">1,353<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Total operating expenses</a></td>
<td class="num">(74,782)<span></span>
</td>
<td class="num">(79,010)<span></span>
</td>
<td class="num">(76,691)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss</a></td>
<td class="num">(70,847)<span></span>
</td>
<td class="num">(79,010)<span></span>
</td>
<td class="num">(61,260)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">6,485<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expense</a></td>
<td class="num">(355)<span></span>
</td>
<td class="num">(581)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Exchange differences</a></td>
<td class="nump">393<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="num">(555)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Finance result, net</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">6,017<span></span>
</td>
<td class="num">(661)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before tax</a></td>
<td class="num">(70,740)<span></span>
</td>
<td class="num">(72,993)<span></span>
</td>
<td class="num">(61,921)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">SFr (70,753)<span></span>
</td>
<td class="num">SFr (72,996)<span></span>
</td>
<td class="num">SFr (61,921)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic loss per share for the period attributable to equity holders</a></td>
<td class="num">SFr (0.85)<span></span>
</td>
<td class="num">SFr (0.97)<span></span>
</td>
<td class="num">SFr (0.86)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per share for the period attributable to equity holders</a></td>
<td class="num">SFr (0.85)<span></span>
</td>
<td class="num">SFr (0.97)<span></span>
</td>
<td class="num">SFr (0.86)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ExpensesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ExpensesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 67<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 67<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2021-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2021-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909867360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income/(Loss) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfComprehensiveIncomeAbstract', window );"><strong>Condensed Consolidated Statements of Comprehensive Income/(Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">SFr (70,753)<span></span>
</td>
<td class="num">SFr (72,996)<span></span>
</td>
<td class="num">SFr (61,921)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Items that may be reclassified to income or loss in subsequent periods (net of tax):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency translation differences</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Items that will not to be reclassified to income or loss in subsequent periods (net of tax):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Remeasurement gains on defined-benefit plans (net of tax)</a></td>
<td class="nump">4,426<span></span>
</td>
<td class="nump">956<span></span>
</td>
<td class="nump">726<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="nump">4,436<span></span>
</td>
<td class="nump">956<span></span>
</td>
<td class="nump">726<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss, net of tax</a></td>
<td class="num">SFr (66,317)<span></span>
</td>
<td class="num">SFr (72,040)<span></span>
</td>
<td class="num">SFr (61,195)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909514624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Equity - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Share capital</div></th>
<th class="th"><div>Share premium</div></th>
<th class="th"><div>Treasury shares</div></th>
<th class="th"><div>Accumulated losses</div></th>
<th class="th"><div>Currency Translation Differences</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, beginning of period at Dec. 31, 2019</a></td>
<td class="nump">SFr 1,437<span></span>
</td>
<td class="nump">SFr 346,526<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="num">SFr (75,521)<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 272,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income/(loss) for the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(61,921)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(61,921)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income/(loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">726<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">726<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(61,195)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(61,195)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,088<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssuedAbstract', window );"><strong>Common shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions', window );">Held as treasury shares</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IssueOfEquityRestrictedShareAwards', window );">Restricted share awards</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(222)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period at Dec. 31, 2020</a></td>
<td class="nump">1,538<span></span>
</td>
<td class="nump">346,890<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="num">(132,850)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">215,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income/(loss) for the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(72,996)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(72,996)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income/(loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">956<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">956<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(72,040)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(72,040)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,126<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,097<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssuedAbstract', window );"><strong>Common shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset', window );">IPR&amp;D asset purchase</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">49,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity', window );">Asset acquisition - common shares</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">4,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments', window );">Conversion note agreement</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">16,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions', window );">Held as treasury shares</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IssueOfEquityRestrictedShareAwards', window );">Restricted share awards</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">1,082<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period at Dec. 31, 2021</a></td>
<td class="nump">1,794<span></span>
</td>
<td class="nump">431,251<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="num">(200,942)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">231,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income/(loss) for the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(70,753)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(70,753)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income/(loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,426<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">4,436<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(66,327)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(66,317)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,330<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssuedAbstract', window );"><strong>Common shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IssueOfEquityRestrictedShareAwards', window );">Restricted share awards</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period at Dec. 31, 2022</a></td>
<td class="nump">SFr 1,797<span></span>
</td>
<td class="nump">SFr 431,323<span></span>
</td>
<td class="num">SFr (124)<span></span>
</td>
<td class="num">SFr (264,015)<span></span>
</td>
<td class="nump">SFr 10<span></span>
</td>
<td class="nump">SFr 168,991<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>'The increase (decrease) in equity resulting from the issuance of shares as part of an asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from purchase of IPR&amp;D assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IssueOfEquityRestrictedShareAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of restricted share awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IssueOfEquityRestrictedShareAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity from sale or issue of treasury shares net of underwriting fees and transaction costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the conversion of convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssuedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssuedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917637824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">SFr (70,753)<span></span>
</td>
<td class="num">SFr (72,996)<span></span>
</td>
<td class="num">SFr (61,921)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments to reconcile net loss for the period to net cash flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationExpense', window );">Depreciation of property, plant and equipment</a></td>
<td class="nump">1,793<span></span>
</td>
<td class="nump">1,897<span></span>
</td>
<td class="nump">1,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets', window );">Depreciation of right-of-use assets</a></td>
<td class="nump">566<span></span>
</td>
<td class="nump">509<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFinanceIncomeCost', window );">Finance (income)/expense, net</a></td>
<td class="num">(559)<span></span>
</td>
<td class="num">(6,769)<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation expense</a></td>
<td class="nump">3,330<span></span>
</td>
<td class="nump">4,126<span></span>
</td>
<td class="nump">4,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities', window );">Change in net employee defined benefit liability</a></td>
<td class="nump">541<span></span>
</td>
<td class="nump">590<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForInterestExpense', window );">Interest expense</a></td>
<td class="nump">355<span></span>
</td>
<td class="nump">573<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment', window );">(Gain)/loss on sale of fixed assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ChangesInWorkingCapitalAbstract', window );"><strong>Changes in working capital:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses', window );">(Increase)/decrease in prepaid expenses</a></td>
<td class="num">(1,718)<span></span>
</td>
<td class="nump">791<span></span>
</td>
<td class="num">(1,304)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets', window );">Decrease/(increase) in accrued income</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="num">(507)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables', window );">Decrease/(increase) in other current receivables</a></td>
<td class="nump">36<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses', window );">(Decrease)/increase in accrued expenses</a></td>
<td class="num">(6,114)<span></span>
</td>
<td class="nump">5,214<span></span>
</td>
<td class="num">(757)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities', window );">(Decrease)/increase in deferred income</a></td>
<td class="num">(130)<span></span>
</td>
<td class="nump">425<span></span>
</td>
<td class="num">(4,157)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">(Decrease)/increase in trade and other payables</a></td>
<td class="num">(1,073)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
<td class="nump">2,177<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperations', window );">Cash used in operating activities</a></td>
<td class="num">(73,159)<span></span>
</td>
<td class="num">(65,216)<span></span>
</td>
<td class="num">(59,247)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities', window );">Interest received</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities', window );">Interest paid</a></td>
<td class="num">(470)<span></span>
</td>
<td class="num">(465)<span></span>
</td>
<td class="num">(339)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities', window );">Finance expenses paid</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash flows used in operating activities</a></td>
<td class="num">(73,568)<span></span>
</td>
<td class="num">(65,689)<span></span>
</td>
<td class="num">(59,517)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities', window );">Short-term financial assets, net</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="num">(51,000)<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(1,239)<span></span>
</td>
<td class="num">(2,635)<span></span>
</td>
<td class="num">(1,706)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Proceeds from sale of property, plant and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CashAdvancesForRentDeposit', window );">Rental deposits</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash flows provided by/(used in) investing activities</a></td>
<td class="nump">23,763<span></span>
</td>
<td class="num">(53,664)<span></span>
</td>
<td class="nump">28,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromIssueOfConvertibleDebt', window );">Proceeds from issuance of convertible loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">23,463<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Transaction costs on issuance of shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,121<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from issuance of common shares - asset acquisition, net of transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,599<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Proceeds from issuance of common shares - option plan, net of transaction costs</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">1,082<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Principal payments of lease obligations</a></td>
<td class="num">(569)<span></span>
</td>
<td class="num">(513)<span></span>
</td>
<td class="num">(432)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions', window );">Transaction costs associated with issuance of shares in relation to asset acquisition previously recorded in Accrued expenses</a></td>
<td class="num">(776)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfCurrentBorrowings', window );">Repayment of short-term financing obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(514)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares', window );">Payment for the issuance of treasury shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash flows (used in)/provided by financing activities</a></td>
<td class="num">(1,346)<span></span>
</td>
<td class="nump">40,746<span></span>
</td>
<td class="num">(803)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges', window );">Net decrease in cash and cash equivalents</a></td>
<td class="num">(51,151)<span></span>
</td>
<td class="num">(78,607)<span></span>
</td>
<td class="num">(31,991)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">82,216<span></span>
</td>
<td class="nump">160,893<span></span>
</td>
<td class="nump">193,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Exchange gain on cash and cash equivalents</a></td>
<td class="nump">521<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="num">(703)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at end of the period</a></td>
<td class="nump">31,586<span></span>
</td>
<td class="nump">82,216<span></span>
</td>
<td class="nump">160,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SupplementalNonCashActivityAbstract', window );"><strong>Supplemental non-cash activity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities', window );">Capital expenditures in Trade and other payables or Accrued expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition', window );">Issuance of shares for purchase of IPR&amp;D asset in asset acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,416<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Transaction costs associated with issuance of shares in relation to the asset acquisition recorded in Accrued expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">776<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_RepaymentOfConvertibleDebtEquitySettlementAmount', window );">Settlement of convertible notes recorded within Shareholders' equity</a></td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 16,920<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation expense for right-of-use assets to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in accrued expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CashAdvancesForRentDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow or inflow for deposit of rent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CashAdvancesForRentDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ChangesInWorkingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ChangesInWorkingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Issuance of shares for purchase of IPR&amp;D asset in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for share issue costs associated with issuance of shares in relation to asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments (proceeds) from purchases (sales) of short-term financial assets, classified as investing activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ProceedsFromIssueOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ProceedsFromIssueOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of property plant and equipment acquired through noncash investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_RepaymentOfConvertibleDebtEquitySettlementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of the settlement of convertible debt that is settled via shares of entity's common shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_RepaymentOfConvertibleDebtEquitySettlementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SupplementalNonCashActivityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SupplementalNonCashActivityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for the decrease (increase) in accrued income including contract assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Accrued income including contract assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for the increase (decrease) in deferred income including contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income including contract liabilities; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for interest expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash from (used in) the entity's operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A__IAS07_IE_A_TI<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for finance costs paid, classified as operating activities. [Refer: Finance costs]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for share issue costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire or redeem entity's shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsToAcquireOrRedeemEntitysShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfCurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for repayments of current borrowings. [Refer: Current borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfCurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717912371216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_GeneralInformationAbstract', window );"><strong>General information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock', window );">General information</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">AC Immune SA</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Notes&#160;to the Consolidated Financial Statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">(In CHF thousands except for share and per share data)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">1.</b></span>General information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune SA was founded in 2003. The Company controls a fully-owned subsidiary, AC Immune USA,&#160;Inc. (&#8220;AC Immune USA&#8221; or &#8220;Subsidiary&#8221; and, together with AC Immune SA, &#8220;AC Immune,&#8221; &#8220;ACIU,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; &#8220;us&#8221;), which was registered and organized under the laws of Delaware, USA in June&#160;2021. The Company and its Subsidiary form the Group.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune SA is a clinical-stage biopharmaceutical company leveraging our two proprietary technology platforms to discover, design and develop novel proprietary medicines and diagnostics for prevention and treatment of neurodegenerative diseases (NDD) associated with protein misfolding. Misfolded proteins are generally recognized as the leading cause of NDD, such as Alzheimer&#8217;s disease (AD) and Parkinson&#8217;s disease (PD), with common mechanisms and drug targets, such as amyloid beta (Abeta), Tau, alpha-synuclein (a-syn) and TDP-43. Our corporate strategy is founded upon a three-pillar approach that targets (i)&#160;AD, (ii)&#160;focused non-AD NDD including Parkinson&#8217;s disease, ALS and NeuroOrphan indications and (iii)&#160;diagnostics. We use our two unique proprietary platform technologies, SupraAntigen (conformation-specific biologics) and Morphomer (conformation-specific small molecules), to discover, design and develop novel medicines and diagnostics to target misfolded proteins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company was initially incorporated as a limited liability company on February&#160;13, 2003 in Basel, and effective August&#160;25, 2003 was transformed into a stock company. The Company&#8217;s corporate headquarters are located at EPFL Innovation Park Building B, 1015 Lausanne, Switzerland.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_GeneralInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_GeneralInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717918339120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of preparation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_BasisOfPreparationAbstract', window );"><strong>Basis of preparation and changes to the Company' accounting policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">Basis of preparation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.</b></span>Basis of preparation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Going concern</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company believes that it will be able to meet all of its obligations as they fall due for at least 12&#160;months from the filing date of this Form 20-F, after considering the Company&#8217;s cash position of CHF 31.6 million and short-term financial assets of CHF 91.0 million as of December&#160;31, 2022. Hence, these consolidated financial statements have been prepared on a going-concern basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, the Company has financed its cash requirements primarily from its public offerings, share issuances, contract revenues from license and collaboration agreements (LCAs) and grants. The Company is a clinical stage company and is exposed to all the risks inherent to establishing a business. Inherent to the Company&#8217;s business are various risks and uncertainties, including the substantial uncertainty as to whether current projects will succeed and our ability to raise additional capital as needed. These risks may require us to take certain measures such as delaying, reducing or eliminating certain programs. The Company&#8217;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;successfully move its product candidates through clinical development, (iv)&#160;attract and retain key personnel and (v)&#160;acquire capital to support its operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Statement of compliance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). These consolidated financial statements were approved for issue by the Board of Directors on March&#160;15, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Basis of measurement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements have been prepared under the historical cost convention except for items that are required to be accounted for at fair value.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_BasisOfPreparationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_BasisOfPreparationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for the preparation of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913450288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract', window );"><strong>Summary of significant accounting policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">Summary of significant accounting policies</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">3.</b></span>Summary of significant accounting policies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The principal accounting policies adopted in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the&#160;years presented, unless otherwise stated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Functional and reporting currency</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These consolidated financial statements and accompanying notes are presented in Swiss Francs (CHF), which is AC Immune SA&#8217;s functional currency and the Group&#8217;s reporting currency. The Company&#8217;s subsidiary has a functional currency of the U.S. Dollar (USD). The respective functional currency represents the primary economic environment in which the entities operate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following exchange rates have been used for the translation of the financial statements of AC Immune USA:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">CHF/USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Closing rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.933</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.923</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">N/A</p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted average exchange rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.965</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.929</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">N/A</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The results and financial position of AC Immune USA are translated into the presentation currency as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">i.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">assets and liabilities for each balance sheet presented are translated at the closing rate at the date of that balance sheet;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">ii.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">income and expenses for each statement of income/(loss) are translated at average exchange rates; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">iii.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all resulting exchange differences are recognized in other comprehensive income/(loss), within cumulative translation differences.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Basis of consolidation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The annual closing date of the individual financial statements is December&#160;31. The Company fully-owns its Subsidiary and fully consolidates its financial statements into these consolidated financial statements. All intercompany transactions have been eliminated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Foreign currency transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Foreign currency transactions are translated into the respective functional currency using prevailing exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at&#160;year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the consolidated statements of income/(loss). Any gains or losses from these translations are included in the consolidated statements of income/(loss) in the period in which they arise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Current vs. non-current classification</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company presents assets and liabilities in the consolidated balance sheets based on current/non-current classification. The Company classifies all amounts to be realized or settled within 12&#160;months after the reporting period to be current and all other amounts to be non-current.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Revenue recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 15&#160;<i style="font-style:italic;">Revenue from Contracts with Customers</i>. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under IFRS 15, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of IFRS 15, the entity performs the following five steps: (i)&#160;identify the contract(s)&#160;with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of IFRS 15, the Company assesses the goods or services promised within each contract, and determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company enters into LCAs which are within the scope of IFRS 15, under which it licenses certain rights to its product candidates and intellectual property to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees, development, regulatory and/or commercial milestone payments;&#160;payments for research and clinical services the Company provides through either its full-time employees or third-party vendors, and royalties on net sales of licensed products commercialized from the Company&#8217;s intellectual property. Each of these payments results in license, collaboration and other revenues, which are classified as contract revenue on the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Licenses of intellectual property</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are sold in conjunction with a related service, the Company uses judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If the performance obligation is settled over time, the Company determines the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, upfront fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Milestone payments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the inception of each arrangement that includes development, regulatory and/or commercial milestone payments, the Company evaluates whether the milestones are considered highly probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant cumulative revenue reversal would not occur in future periods, the associated milestone value is included in the transaction price. These amounts for the performance obligations under the contract are recognized as they are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments recorded would affect contract revenues and earnings in the period of adjustment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development services</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has certain arrangements with our collaboration partners that include contracting our employees for research and development programs. The Company assesses if these services are considered distinct in the context of each contract and, if so, they are accounted for as separate performance obligations. These revenues are recorded in contract revenue as the services are performed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Sublicense revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has certain arrangements with our collaboration partners that include provisions for sublicensing. The Company recognizes any sublicense revenues at the point in time it is highly probable to obtain and not subject to reversal in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Contract balances</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company receives payments and determines credit terms from its customers for its various performance obligations based on billing schedules established in each contract. The timing of revenue recognition, billings and cash collections results in billed other current receivables, accrued income (contract assets), and deferred income (contract liabilities) on the consolidated balance sheets. Amounts are recorded as other current receivables when the Company&#8217;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be 1&#160;year or less.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For a complete discussion of accounting for contract revenue, see &#8220;Note&#160;13. Contract revenues.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Given the stage of development of the Company&#8217;s products, all research and development expenditure is expensed as incurred as it does not meet the capitalization criteria outlined in IAS 38 <i style="font-style:italic;">Intangible Assets</i>. The Company has not capitalized any R&amp;D expenses to date. Research and development expenditures include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the cost of acquiring, developing and manufacturing active pharmaceutical ingredients for product candidates that have not received regulatory approval, clinical trial materials and other research and development materials;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees and expenses incurred under agreements with contract research organizations, investigative sites and other entities in connection with the conduct of clinical trials and preclinical studies and related services, such as administrative, data-management and laboratory services;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees and costs related to regulatory filings and activities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">costs associated with preclinical and clinical activities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">employee-related expenses, including salaries and bonuses, benefits, travel and share-based compensation expenses; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all other allocated expenses such as facilities and information technology (IT) costs.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For external research contracts, expenses include those associated with contract research organizations, or CROs, or contract manufacturing organizations, or CMOs. The invoicing from CROs or CMOs for services rendered do not always align with work performed. We accrue the cost of services rendered in connection with CRO or CMO activities based on our estimate of the &#8220;stage of completion&#8221; for such contracted services. We maintain regular communication with our CRO or CMO vendors to gauge the reasonableness of our estimates and accrue expenses as of the balance sheet date in the consolidated financial statements based on facts and circumstances known at the time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Registration costs for patents are part of the expenditure for research and development projects. Therefore, registration costs for patents are expensed when incurred as long as the research and development project concerned does not meet the criteria for capitalization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">General and administrative expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">General and administrative expenses are expensed as incurred and include personnel costs, expenses for outside professional services and all other allocated expenses. Personnel costs consist of salaries, cash bonuses, benefits and share-based compensation. Outside professional services consist of legal, accounting and audit services, IT and other consulting fees. Allocated expenses consist of certain IT, facilities and depreciation expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Grant income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has received grants, from time to time, from the Michael J. Fox Foundation (MJFF), the Target ALS Foundation (Target ALS) and other institutions to support certain research projects. Grants are recorded at their fair value in the consolidated statements of income/(loss) within other operating income/(expenses), net when there is reasonable assurance that the Company will satisfy the underlying grant conditions and the grants will be received. In certain circumstances, grant income may be recognized before formal grantor acknowledgement of milestone achievements. To the extent required, grant income is deferred and recognized on a systematic basis over the periods in which the Company expects to recognize the related expenses for which the grants are intended to compensate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 16 <i style="font-style:italic;">Leases</i>, which provides the model for lessee accounting in which all leases, other than short-term and low-value leases, are accounted for by the recognition on the consolidated balance sheet of a right-of-use asset and a lease liability, and the subsequent amortization of the right-of-use asset over the earlier of the end of the useful life or the lease term. In accordance with IFRS 16, the Company (i)&#160;does not recognize right-of-use assets and lease liabilities for leases of low value (i.e. approximate fair value of USD 5,000). For a complete discussion of accounting, see &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Right-of-use assets and lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception of a leasing contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#8217;s incremental borrowing rate. The lease liabilities are classified as current or non-current based on the due dates of the underlying principal payments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Lease payments generally are fixed for the contract term. The lease liability is measured at amortized cost using the effective interest method. The lease liability is re-measured if there is a change in the estimated lease term, a change in future lease payments arising from a change in an index or rate, a change in the Company&#8217;s estimate of the amount expected to be payable under a residual value guarantee or a change in assessment of whether it will exercise a purchase, extension or termination option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception, the right-of-use asset comprises the initial lease liability and any initial direct costs. The right-of-use asset is depreciated over the shorter of the lease term or the useful life of the underlying asset. The right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain re-measurements of the lease liability performed on as certain potential triggering events may arise (e.g. lease modifications). When the lease liability is re-measured, a corresponding adjustment is made to the carrying amount of the right-of-use asset or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The estimated lease term by right-of-use asset categories are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Buildings</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Office equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Both the right-of-use-assets and lease liabilities are recognized in the consolidated balance sheets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Equipment is shown at historical acquisition cost, less accumulated depreciation and any accumulated impairment losses. Historical costs include expenditures that are directly attributable to the acquisition of the property, plant and equipment. Depreciation is calculated using a straight-line method to write off the cost of each asset to its residual value over its estimated useful life as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Laboratory equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Leasehold improvements/furniture</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The assets&#8217; residual values and useful lives are reviewed, and adjusted if appropriate, at each balance sheet date. Where an asset&#8217;s carrying amount is greater than its estimated recoverable amount, it is written down to its recoverable amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Gains and losses on disposals are determined by comparing the disposal proceeds with the carrying amount and are included in the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune&#8217;s acquired in process research and development (IPR&amp;D) asset is stated at cost less any impairments. The Company does not deem this asset ready for use until the asset obtains market approval. Therefore, during the development period after the date of acquisition until market approval, the IPR&amp;D asset is not amortized. Upon market approval, the Company will determine the useful life of the asset, reclassify it from IPR&amp;D and commence amortization. If the associated R&amp;D effort is abandoned, the related IPR&amp;D will likely be written off and we will record the relevant impairment charge. Finally, the Company will not capitalize future development costs in respect to this IPR&amp;D asset until they meet the criteria for capitalization of research and development costs in accordance with IAS 38 <i style="font-style:italic;">Intangible Assets</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our IPR&amp;D asset is subject to impairment testing at least annually or when there are indications that the carrying value may not be recoverable until the completion of the development process. The determination of the recoverable amounts include key estimates which are highly sensitive to, and dependent upon, key assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company uses a discounted cash flow method to determine the fair value less costs to sell (recoverable amount) of our IPR&amp;D intangible asset. The Company starts with a forecast of all the expected net cash flows, which incorporates the consideration of a terminal value and then the Company applies a discount rate to arrive at a risk-adjusted net present value amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any impairment losses are recognized immediately in the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Fair value of financial assets&#160;and liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s financial assets and liabilities are composed of receivables, short-term financial assets, cash and cash equivalents, trade payables and lease liabilities. The fair value of these financial instruments approximates their </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">respective carrying values due to the short-term maturity of these instruments, and are held at their amortized cost in accordance with IFRS 9, unless otherwise explicitly noted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Receivables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Receivables are recognized at their billing value. An allowance for doubtful accounts is recorded for potential estimated losses when there is evidence of the debtor&#8217;s inability to make required payments and the Company assesses on a forward-looking basis the expected credit losses associated with these receivables held at amortized cost.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Short-term financial assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Short-term financial assets are held with external financial institutions and comprise fixed-term deposits with maturities ranging from more than 3 through 12&#160;months in duration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company assesses whether there is objective evidence that financial assets are impaired annually or whenever potential impairment triggers may occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents include deposits held with external financial institutions and cash on hand. All cash and cash equivalents are either in cash or in deposits with original duration of less than 3&#160;months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Trade payables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Trade payables are amounts due to third parties in the ordinary course of business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share capital and public offerings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Common shares are classified as equity. Share issuance costs are capitalized as incurred and will be shown in equity as a deduction, net of tax, from the proceeds received from existing or future offerings. Should a planned equity offering not be assessed as probable, the issuance costs would be expensed immediately in the consolidated statements of income/(loss). See &#8220;Note&#160;11. Share capital.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Treasury shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Treasury shares are recognized at acquisition cost and deducted from shareholders&#8217; equity at the time of acquisition, until they are subsequently resold, distributed or cancelled. Where such shares are subsequently sold, any consideration received is included in shareholders&#8217; equity. See &#8220;Note&#160;11. Share capital.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Employee benefits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Post-employment benefits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates the mandatory pension schemes for its employees in Switzerland. The schemes are generally funded through payments to insurance companies. The Company has a pension plan designed to pay pensions based on accumulated contributions on individual savings accounts. However, this plan is classified as a defined benefit plan under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The net defined benefit liability is the present value of the defined benefit obligation at the balance sheet date minus the fair value of plan assets. Significant estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. The defined benefit obligation is calculated annually with the assistance of an independent actuary using the projected unit credit method, which reflects services rendered by employees to the date of valuation, incorporates assumptions concerning employees&#8217; projected salaries and pension increases as well as discount rates of highly liquid corporate bonds that have terms to maturity approximating the terms of the related liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To the extent that the fair value of the plan assets is greater than the present value of the defined benefit obligation as calculated by our independent actuary, the Company accounts for the effect of the asset ceiling test under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Re-measurements of the net defined benefit liability, which comprise actuarial gains and losses and the return on plan assets (excluding interest) are recognized immediately in the consolidated statements of other comprehensive income/(loss). Past service costs, including curtailment gains or losses, are recognized immediately as a split in research and development and general and administrative expenses within the operating results. Settlement gains or losses are recognized in either research and development and/or general and administrative expenses within the operating results. The Company determines the net interest expense/(income) on the net defined benefit liability for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period or in case of any significant events between measurement dates to the then-net defined benefit liability, considering any changes in the net defined benefit liability during the period as a result of contributions and benefit payments. Net interest expense/(income) and other expenses related to defined benefit plans are recognized in the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates an equity-settled, share-based compensation plan. The fair value of the employee services received in exchange for the grant of equity-based awards is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the instruments granted, excluding the impact of any non-market vesting conditions. Non-market vesting conditions are included in assumptions about the number of instruments that are expected to become exercisable. At each balance sheet date, the Company revises its estimates of the number of instruments that are expected to become exercisable. It recognizes the impact of the revision of original estimates, if any, prospectively in the consolidated statements of income/(loss), and a corresponding adjustment to equity over the remaining vesting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Stock options granted under the Company&#8217;s stock option plans C1 and the 2016 Stock Option and Incentive Plan are valued using the Black-Scholes option-pricing model (see &#8220;Note&#160;18. Share-based compensation&#8221;). This valuation model as well as parameters used such as expected volatility and expected term of the stock options are partially based on management&#8217;s estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We estimate the fair value of restricted share units using a reasonable estimate of market value of the common shares on the date of the award. We classify our share-based payments as equity-classified awards as they are settled in common shares. We measure equity-classified awards at their grant date fair value and do not subsequently re-measure them. Compensation costs related to equity-classified awards are equal to the fair value of the award at grant date amortized over the vesting period of the award using the graded method. We reclassify that portion of vested awards to share capital and share premium as the awards vest.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Provisions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events where it is more likely than not that an outflow of resources will be required to settle the obligation, and a reliable estimate of the amount can be made.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Taxation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Current income tax assets and liabilities for the period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the tax amounts are those that are enacted or substantively enacted, at the reporting date in accordance with the fiscal regulations of the respective country where the Company operates and generates taxable income. Deferred tax is provided using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the&#160;year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date. If required, deferred taxation is provided in full using the liability method, on all temporary differences at the reporting dates. It is calculated at the tax rates that are expected to apply to the period when it is anticipated the liabilities will be settled, and it is based on tax rates (and laws) that have been enacted or substantively enacted at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized. Although the Company has substantial tax loss carry-forwards, historically, due to the fact that the Company had limited certainty on the achievement of key milestones, it has not recognized any deferred tax assets as the probability for use is low.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As disclosed in &#8220;Note&#160;16. Income taxes,&#8221; the Company has tax losses that can generally be carried forward for a period of 7&#160;years from the period the loss was incurred. These tax losses represent potential value to the Company to the extent that the Company is able to create taxable profits before the expiry period of these tax losses. The Company has not recorded any deferred tax assets in relation to these tax losses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Earnings per share</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company presents basic earnings per share for each period in the consolidated financial statements. The earnings per share are calculated by dividing the earnings of the period by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential dilution that could occur if dilutive securities such as share options or non-vested restricted share units were vested or exercised into common shares or resulted in the issuance of common shares that would participate in net income. Anti-dilutive shares are excluded from the dilutive earnings per share calculation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Critical judgments and accounting estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The areas where AC Immune has had to make judgments, estimates and assumptions relate to (i)&#160;revenue recognition on LCAs, (ii)&#160;clinical development accruals, (iii)&#160;net employee defined benefit liability, (iv)&#160;income taxes, (v)&#160;share-based compensation, (vi)&#160;right-of-use assets and lease liabilities and (vii)&#160;our IPR&amp;D asset. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Segment reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is managed and operated as one business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. Accordingly, the Company views its business and manages its operations as one operating segment. Non-current assets are located in, and revenue is allocated and recorded within, the Company&#8217;s country of domicile, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Accounting policies, new standards, interpretations and amendments adopted by the Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">There are no new IFRS standards, amendments or interpretations that are mandatory as of January 1, 2022 that are relevant to the Company. Additionally, the Company has not adopted any standard, interpretation or amendment that has been issued but is not yet effective. Such standards are not currently expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913324992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">4.</b></span>Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables show the movements in the net book values of property, plant and equipment for the&#160;years ended December&#160;31, 2022 and 2021, respectively:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Laboratory</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Leasehold</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets under</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">improvements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">construction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquisition cost:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 265</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,754</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 810</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,666</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 151</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 576</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 184</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 936</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Transfers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 47</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 646</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (697)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 285</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,765</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,640</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 13,602</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (106)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,316)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,739)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (389)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,550)</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (53)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (283)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,278)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (179)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,793)</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (159)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,599)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,017)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (568)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,343)</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amount:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 159</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 438</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 421</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,116</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,072</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,259</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Laboratory</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Leasehold</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets under</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">improvements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">construction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquisition cost:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 214</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,497</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,681</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 464</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 277</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,133</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,268</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,610</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Transfers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 270</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (277)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Disposals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (77)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (77)</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 265</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,754</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 810</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,666</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (61)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (970)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,405)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (281)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,717)</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (45)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (346)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,398)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (108)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,897)</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Disposals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 64</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 64</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (106)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,316)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,739)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (389)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,550)</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amount:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 153</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 527</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,276</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 183</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 277</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,416</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 159</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 438</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 421</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,116</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune continues to enhance its laboratory equipment to support its R&amp;D functions. This effort has continued for the&#160;year ended December&#160;31, 2022, with CHF 0.8 million invested in lab equipment, including the expansion of our leased lab space, and IT equipment, representing an increase of 7%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company incurred CHF 1.8 million, CHF 1.9 million and CHF 1.5 million in depreciation expenses, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913193248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets, long-term financial assets and lease liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Right-of-use assets, long-term financial assets and lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">Right-of-use assets, long-term financial assets and lease liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">5.</b></span>Right-of-use assets, long-term financial assets and lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company recognized additions and remeasurements of right-of-use of leased assets for buildings or for office equipment totaling CHF 0.5 million and CHF 1.2 million for the&#160;years ended December&#160;31, 2022 and 2021, respectively. In 2022, these increases are predominantly associated with the remeasurement of our leased office space.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Regarding lease liabilities, the amortization depends on the rate implicit in the contract or the incremental borrowing rate for the respective lease component. The weighted averages of the incremental borrowing rates as of December&#160;31, 2022 are 3.5% (2.5% for 2021) for buildings, 5.3% (5.3% for 2021) for office equipment and 2.6% (2.6% for 2021) for IT equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables show the movements in the net book values of right-of-use of leased assets for the&#160;years ended December&#160;31, 2022 and 2021, respectively:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Office</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,776</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 40</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,914</p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions and remeasurements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 460</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 460</p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (528)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (24)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (566)</p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 74</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,808</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Office</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">2,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">63</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">54</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,223</p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions and remeasurements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,144</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 71</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,215</p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Dispositions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (15)</p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (474)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (509)</p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,776</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 40</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,914</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;years ended December&#160;31, 2022, and 2021, the impact on the Company&#8217;s consolidated statements of income/(loss) and consolidated statements of cash flows is detailed in the table below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Statements of income/(loss)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation of right-of-use assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 566</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 509</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest expense on lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 68</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 63</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expense for short-term leases and leases of low value </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 723</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,384</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,295</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Statements of cash flows</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total cash outflow for leases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,388</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,299</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table presents the contractual undiscounted cash flows for lease liabilities as of December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Less than one year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 638</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 638</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">1-3 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,230</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,260</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">3-5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,187</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,203</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,055</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,101</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company also has two deposits in escrow accounts totaling CHF 0.4 million for the lease of the Company&#8217;s premises as of December&#160;31, 2022 and 2021, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Section Presentation<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913221904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset acquisition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AssetAcquisitionsAbstract', window );"><strong>Asset acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfAssetAcquisitionsTextBlock', window );">Asset acquisition</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">6.</b></span>Asset acquisition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2021, the Company closed its acquisition with Affiris AG (Affiris) for the program portfolio of therapeutics targeting a-syn, notably ACI-7104.056 (previously PD01), a clinically-validated active vaccine candidate for the treatment of Parkinson&#8217;s disease (the Transferred Assets). The Company acquired the Transferred Assets and USD 5.0 (CHF 4.6) million in cash in exchange for 7,106,840 shares of the Company at closing, for a total value of USD 58.7 (CHF 55.1) million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">With the closing of this transaction, the Company recorded an IPR&amp;D intangible asset associated with ACI-7104.056 for USD 53.7 (CHF 50.4) million. The Company used a risk-adjusted discounted cash flow method to determine the fair value of the intangible asset using a discount rate of 15%. See &#8220;Note&#160;7. Intangible assets&#8221; for further details on assumptions used.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As the Company transferred its own equity instruments in consideration for the asset transferred, the acquisition was assessed in accordance with IFRS 2 <i style="font-style:italic;">Share-based Payment</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company determined that the acquisition of the Transferred Assets did not qualify as a business combination in accordance with IFRS 3 <i style="font-style:italic;">Business Combinations</i> and therefore was accounted for as an asset acquisition. Most of the fair value of the Transferred Assets is attributable to a single identifiable asset which is the in-process research and development asset. The purchase consideration for the Transferred Assets was allocated based on their relative fair values.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes the amounts of the Transferred Assets acquired:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:86.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4,634</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IPR&amp;D asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">50,416</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">55,050</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AssetAcquisitionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AssetAcquisitionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfAssetAcquisitionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfAssetAcquisitionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917829568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">Intangible assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">7.</b></span>Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">AC Immune&#8217;s acquired IPR&amp;D asset is a clinically-validated active vaccine candidate for the treatment of Parkinson&#8217;s disease. The asset is not yet ready for use until the asset obtains market approval. The carrying amount and net book value are detailed below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net book</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net book</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> value</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Acquired IPR&amp;D asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total intangible assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with IAS 36 <i style="font-style:italic;">Impairment of Assets</i>, the IPR&amp;D asset is reviewed at least annually for impairment by assessing the fair value less costs to sell (recoverable amount) and comparing this to the carrying value of the asset. The valuation is considered to be Level&#160;3 in the fair value hierarchy in accordance with IFRS 13 <i style="font-style:italic;">Fair Value Measurement</i> due to unobservable inputs used in the valuation. The Company has determined the IPR&amp;D asset was not impaired as of December&#160;31, 2022 and 2021, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The key assumptions used in the valuation model in accordance with an income approach to determine the recoverable amount include observable and unobservable key inputs as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Anticipated research and development costs;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Anticipated costs of goods and sales and marketing expenditures;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Target indication prevalence and incidence rates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Anticipated market share;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">General commercialization expectations such as anticipated pricing and uptake;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Expected patent life and market exclusivity periods; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Other metrics such as the tax rate.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s valuation model calculates the risk-adjusted, net cash flows through the projected period of market exclusivity across target sales regions. The Company uses a discount rate of 17% (15% for 2021), based on the assumed cost of capital for the Company over the forecast period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Note&#160;6. Asset acquisition&#8221; for further details.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913370256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents and short-term financial assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Cash and cash equivalents and financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock', window );">Cash and cash equivalents and short-term financial assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.</b></span>Cash and cash equivalents and short-term financial assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s cash and cash equivalents are maintained in the following respective currencies as of December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,586</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 82,216</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,586</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 82,216</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">By currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 24,418</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 64,941</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">EUR</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,313</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,253</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,855</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,022</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,586</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 82,216</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, the Company&#8217;s funds were held in CHF, EUR and USD currencies. Funds held in EUR and USD were translated into CHF at a rate of 0.994 and 0.933 and 1.045 and 0.923, respectively, for each currency and&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes the Company&#8217;s short-term financial assets as of December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets due in one year or less</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,000</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total short-term financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and cash equivalents and short-term deposits not classified as cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917804768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid expenses and accrued income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract', window );"><strong>Prepaid expenses and accrued income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock', window );">Prepaid expenses and accrued income</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">9.</b></span>Prepaid expenses and accrued income</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Prepaid expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,015</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 408</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 975</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total prepaid expenses and accrued income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,116</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">3,990</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s prepaid expenses relate mainly to research contracts with down-payments at contract signature with the related activities to start or continue into 2023 as well as prepaid payroll-related expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Accrued income consists of CHF 0.4 million as of December&#160;31, 2022 associated with our MJFF grants and Target ALS (see &#8220;Note&#160;13.2. Grant income&#8221;). This amount represents 100% of our total accrued income as of December&#160;31, 2022. As of December&#160;31, 2021, the Company recorded CHF 0.9 million of accrued income associated with our MJJF grants. This amount represented 87% of our total accrued income as of December&#160;31, 2021.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of prepaid expenses and accrued income including contract assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913190976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OtherCurrentReceivablesAbstract', window );"><strong>Other current receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfOtherCurrentReceivablesTextBlock', window );">Other current receivables</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">10.</b></span>Other current receivables</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 124</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 101</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Swiss VAT</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 249</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 327</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Withholding tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other current receivables</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 392</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 428</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The maturity of these assets is less than <span style="-sec-ix-hidden:Hidden_P_0I_UaePkyj8OXHk3ZeUg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3&#160;months</span></span>. The Company considers the counterparty risk as low and the carrying amount of these receivables is considered to approximate their fair value.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfOtherCurrentReceivablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other current receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfOtherCurrentReceivablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913236320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Share capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Share capital</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">11.</b></span>Share capital</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2022 and 2021, the issued share capital amounted to CHF 1,796,675 and CHF 1,794,013, respectively, and is composed of outstanding common shares of 83,620,364 and 83,479,013, respectively, and treasury shares of 6,214,021 and 6,221,617, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The table below summarizes the Company&#8217;s capital structure:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">premium</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 76,936,738</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,000,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 346,890</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (100)</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,171,543</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,097</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 24</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Asset purchase agreement, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,106,840</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 54,328</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Conversion of note agreements, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,026,634</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 61</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 16,683</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares &#8211; incentive plans, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 237,258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,253</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares to be held as treasury shares, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,393,160</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,393,160)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">48</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (48)</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 89,700,630</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,221,617)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,794</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 431,251</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (124)</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,596</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares &#8211; incentive plans, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 133,755</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 89,834,385</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,214,021)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 431,323</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (124)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The common shares and treasury shares have nominal values of CHF 0.02 per share. All shares have been fully paid. These treasury shares held by the Company are not considered outstanding shares as of December&#160;31, 2022 or 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Authorized capital</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s Board of Directors is authorized to increase the share capital, in one or several steps, until June 24, 2024, by a maximum amount of CHF&#160;400,000 by issuing a maximum of 20,000,000 registered shares with a par value of CHF&#160;0.02 each, to be fully paid up. An increase of the share capital (i) by means of an offering underwritten by a financial institution, a syndicate or another third party or third parties, followed by an offer to the then-existing shareholders of the Company and (ii) in partial amounts, shall also be permissible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Conditional share capital for bonds and similar debt instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s share capital may be increased by a maximum aggregate amount of CHF&#160;100,000&#160;through the issuance of a maximum of 5,000,000 registered shares, payable in full, each with a nominal value of CHF&#160;0.02&#160;per share, through the exercise of conversion and/or option or warrant rights granted in connection with bonds or similar instruments, issued or to be issued by the Company or by subsidiaries of the Company, including convertible debt instruments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Conditional share capital for employee benefit plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s share capital may be increased by a maximum aggregate amount of CHF&#160;96,000&#160;through the issuance of not more than&#160;4,800,000&#160;common shares, payable in full, each with a nominal value of CHF&#160;0.02&#160;per share, by the exercise of options rights that have been granted to employees, consultants, members of the board of directors, or other person providing services to the Company or a subsidiary.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Shelf registration statement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April&#160;28, 2021, the Company filed a Shelf Registration Statement on Form&#160;F-3 (Reg. No.&#160;333-255576) (the &#8220;Shelf Registration Statement&#8221;) with the SEC. The Shelf Registration Statement was declared effective by the SEC on May&#160;5, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Shelf Registration Statement allows the Company to offer and sell, from time to time, up to USD 350,000,000 of common shares, debt securities, warrants, purchase contracts, units, subscription rights or any combination of the foregoing in one or more future public offerings. The terms of any future offering would be determined at the time of the offering and would be subject to market conditions and approval by the Company&#8217;s Board of Directors. Any offering of securities covered by the Shelf Registration Statement will be made only by means of a written prospectus and prospectus supplement authorized and filed by the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">At the market equity offering</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q3 2020, AC Immune issued 5,000,000 common shares with a nominal value of CHF 0.02, which became treasury shares. The Company also established an &#8220;at the market offering program&#8221; (&#8220;ATM&#8221;) for the sale of up to USD 80.0 (CHF 74.6) million worth of our common shares issued from time to time by entering into an Open Market Sale Agreement (&#8220;Sales Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;) as the sales agent under a prior registration statement on Form&#160;F-3 which expired in Q2 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q2 2021, the Company filed a new registration statement on Form&#160;F-3 and an accompanying prospectus supplement in order to renew its ATM program. The Company also entered into a second Open Market Sale Agreement (the &#8220;new Sales Agreement&#8221;) with Jefferies to continue the ATM program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q3, 2021, the Company issued 2,393,160 common shares with a nominal value of CHF 0.02 to be held as treasury shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Through December 31, 2022, the Company has sold 1,179,139 common shares previously held as treasury shares pursuant to the new Sales Agreement, raising USD 13.3 (CHF 12.1) million, net of underwriting fees and transaction costs. We have paid commissions to Jefferies totaling USD 0.4 (CHF 0.4) million through December 31, 2022, for share issuances in accordance with our ATM programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, the Company has expensed issuance costs of nil, nil and CHF 0.5 million, respectively, in the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Convertible note agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Concurrently with the Asset Purchase Agreement, the Company entered into two separate Convertible Note&#160;Agreements with entities affiliated with each of Athos Service GmbH and First Capital Partner GmbH, both of which entities are shareholders of Affiris.&#160;Each Convertible Note&#160;Agreement provided for the sale of an unsecured subordinated Convertible Note&#160;of the Company with an aggregate principal amount of USD 12.5 (CHF 11.7) million for total net proceeds of USD 25 (CHF 23.5) million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2021, the affiliated entities exercised their options to convert their respective USD 12.5 (CHF 11.7) million notes. As a result of these conversions, 1,513,317 <span style="-sec-ix-hidden:Hidden_7EVt20oUeEOLG5MQiq_Hiw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">common</span></span> shares were issued to each Investor, totaling 3,026,634 common shares. The Company recorded an increase to its share capital for the nominal value of its shares and share premium for the difference associated with settlement of this liability. The Company also settled its derivative financial assets, which were embedded conversion features associated with the convertible debt, via an offset to its share premium. These convertible notes and derivative financial assets were fully settled in 2021 and there is no further equity or cash consideration due to the affiliated entities thereunder.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917604208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade and other payables and accrued expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Accrued expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock', window );">Trade and other payables and accrued expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">12.</b></span>Trade and other payables and accrued expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 929</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,003</p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total trade and other payables</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 929</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,003</p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued research and development costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,360</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,361</p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,898</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,562</p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other accrued expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,159</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,813</p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total accrued expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,417</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 16,736</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">An accrual of CHF 2.1 million and CHF 2.3 million was recognized for performance-related remuneration within accrued payroll expenses for 2022 and 2021, respectively. In 2021, an accrual of CHF 3.7 million was recorded as part of our cost sharing arrangement with Janssen within accrued research and development costs and CHF 0.8 million was recorded as accrued stamp duty for the issuance of shares as part of the Company&#8217;s asset acquisition within other accrued expenses.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other payables and accrued expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717910061456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueExplanatory', window );">Contract revenues</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">13.</b></span>Contract revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, AC Immune generated contract revenues of CHF 3.9 million, nil and CHF 15.4 million, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables provide contract revenue amounts from its LCAs for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Lilly</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,348</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Janssen </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,083</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Life Molecular Imaging</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total contract revenues</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,431</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">LMI accounted for 100% of our contract revenues in 2022 and Lilly accounted for 93% of our contract revenues in 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">During the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company recognized the following contract revenues as a result of changes in the contract asset and the contract liability balances in the respective periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Revenues recognized in the period from:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Amounts included in the contract liability at the beginning of the period </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,477</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Performance obligations satisfied in previous periods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">13.1</b></span> Licensing and collaboration agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Morphomer Tau small molecule&#160;&#8211; 2018 license agreement with Eli Lilly and Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2018, we entered into an exclusive, worldwide licensing agreement with Eli Lilly and Company (Lilly) to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases. More specifically, this is an exclusive license with the right to Lilly to grant sublicenses under the ACIU Patents, the ACIU know-how, and ACIU&#8217;s interests in the Joint Patents and the joint know-how to Exploit the Licensed Compounds and Licensed Products. The agreement became effective on January&#160;23, 2019 (the &#8220;effective date&#8221;) when the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired. In Q3 2019, the Company and Lilly entered into the first amendment to divide the first discretionary milestone payment under the agreement of CHF 60 million into two installments, with the first CHF 30 million paid in Q3 2019 and the second CHF 30 million to be paid on or before March&#160;31, 2020 unless Lilly terminated the agreement earlier. In Q1 2020, the Company and Lilly entered into a second amendment to replace the second CHF 30 million to be paid on or before March&#160;31, 2020 with two milestone payments, one of CHF 10 million to be paid on or before March&#160;31, 2020 and the other of CHF 60 million following the first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Per the terms of the agreement, the Company received an initial upfront payment of CHF 80 million in Q1 2019 for the rights granted by the Company to Lilly. To date, the Company has completed a Phase 1 clinical study with ACI-3024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, the Company and Lilly have continued candidate characterization across the research program, identifying new and highly differentiated candidates with desired cerebrospinal fluid exposure and selectivity for pathological aggregated Tau. These will be broadly developed in Tau-dependent neurodegenerative diseases by Lilly. Lilly is responsible for leading and funding further clinical development and will retain global commercialization rights for all indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Per the terms of the agreement, the Company may become eligible to receive additional milestone payments totaling up to approximately CHF 880 million for clinical and regulatory milestones and CHF 900 million upon achievement of certain commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the low double-digits to the mid-teens. The agreement will terminate by the date of expiration of the last royalty term for the last licensed product. However, under the terms of the agreement, Lilly may terminate the agreement at any time by providing <span style="-sec-ix-hidden:Hidden_K168Qe9Bi02hpV05wXH75Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3&#160;months</span></span>&#8217; prior notice to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Lilly is a customer. The Company identified the following significant performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;research and development activities outlined in the development plan. Per the agreement, the Company was responsible for the preclinical and Phase 1 activities for the first clinical candidate, ACI-3024, which the Company determined was distinct and capable of being completed by Lilly or a third party. Preclinical activities for which AC Immune was responsible prior to their completion in Q2 2019 included final manufacturing of materials for use in the regulatory submission of the protocol and in the Phase 1 study. For the completed Phase 1, AC Immune was responsible for leading the study design, obtaining relevant regulatory agency approvals, arranging necessary third-party contracts, completing patient selection, ensuring patient treatment, following up with patients, drafting the clinical study report </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">development and other relevant clinical activities to ensure that the primary objective of the study was completed. The Company used CMOs for certain of its preclinical activities and CROs to complete certain Phase 1 activities and to issue the final clinical study report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s preclinical and Phase 1 activities did not represent integrated services with the licensed intellectual property for which Lilly contracted. Lilly purchased a license to the Company&#8217;s Tau therapeutic small-molecule program, which was delivered at commencement of the agreement, and AC Immune&#8217;s preclinical and Phase 1 activities did not affect the form or functionality of this license. The Company&#8217;s objective for the Phase 1 activity was to assess safety and tolerability and did not modify or customize ACI-3024. The completion of these preclinical and Phase 1 activities does not affect the licensed intellectual property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Finally, per the agreement, each party has three representatives on a joint steering committee (JSC). Depending upon the agenda, additional field experts can attend the JSC to provide the technical and scientific contribution required. The JSC meets on a regular basis depending on agreements between the representatives. The JSC is responsible for serving as the forum to (i)&#160;discuss, review and approve certain activities by reviewing and discussing the development progress with updates on back-up candidates, (ii)&#160;discuss, review and approve all amendments to the global development plan, (iii)&#160;periodically discuss and review commercialization of licensed products and (iv)&#160;review and approve reports related to development costs among other activities. The JSC is intended to ensure that communication between the parties remains consistent and that the development plan is progressing as intended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The valuation of each performance obligation involves estimates and assumptions with revenue recognition timing to be determined by either delivery or the provision of services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company used the residual approach to estimate the selling price for the right-of-use license and an expected cost plus margin approach for estimating the research and development activities. The right-of-use license was delivered on the effective date. The research and development activities were delivered over time as the services were performed. For these services, revenue was recognized over time using the input method, based on costs incurred to perform the services, as the level of costs incurred over time is thought to best reflect the transfer of services to Lilly. The Company determined the value of the research and development activities to be CHF 6.9 million and deferred this balance from the effective date. To date, the Company has cumulatively recognized CHF 6.9 million in contract revenue, resulting in no deferred income (contract liability) on the consolidated balance sheets. The remaining CHF 73.1 million from the upfront payment was allocated to the right-of-use license and recognized on the effective date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception of the agreement, none of the clinical, regulatory or commercial milestones had been included in the transaction price, as all milestone amounts were fully constrained. To date, the Company has recognized CHF 40 million from milestone payments triggered in Q3 2019 and Q1 2020 related to the right-of-use license for intellectual property as there were no further constraints related to these milestones. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors to determine that these milestones are not highly probable to obtain, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Lilly and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we have recognized nil, nil and CHF 14.3 million, respectively, from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Anti-Abeta antibody in AD&#160;&#8211; 2006 agreement with Genentech, a member of the Roche Group</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In November&#160;2006, we signed an exclusive, worldwide licensing agreement for crenezumab, our humanized monoclonal therapeutic antibody targeting misfolded Abeta. The agreement was amended March&#160;2009, January&#160;2013, May&#160;2014 and May&#160;2015. The agreement also provides for the development of a second therapeutic product for a non-</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">AD indication based on the same intellectual property and anti-Abeta antibody compound. The value of this partnership is potentially greater than USD 340 (CHF 317) million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The term of the agreement commenced on the effective date and, unless sooner terminated by mutual agreement or pursuant to any other provision of the agreement, terminates on the date on which all obligations between the parties with respect to the payment of milestones or royalties with respect to licensed products have passed or expired. Either party may terminate the agreement for any material breach by the other party, provided a cure period of 90&#160;days from the date when that notice is given.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Genentech commenced a first Phase 3 clinical study in March&#160;2016 for crenezumab&#160;(CREAD). In March&#160;2017, Genentech started a second Phase 3 clinical trial (CREAD 2). Since 2013, crenezumab has also been studied in a Phase 2 preventive trial in individuals who carry the PSEN1 E280A autosomal-dominant mutation and do not meet the criteria for mild cognitive impairment due to AD or dementia due to AD and are, thus, in a preclinical phase of&#160;AD&#160;(autosomal dominant AD (ADAD)). In 2019, Genentech initiated a Tau Positron Emission Tomography (PET) substudy to the ongoing Phase 2 trial in ADAD to evaluate the effect of crenezumab on Tau burden, which may also increase the understanding of disease progression in the preclinical stage of ADAD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If crenezumab receives regulatory approval, we will be entitled to receive royalties that are tied to annual sales volumes with different royalty rates applicable in the U.S. and Europe ranging from the mid-single digits to mid-teens. To date, we have received total milestone payments of USD 65 (CHF 70.1) million comprised of an upfront payment of USD 25 (CHF 31.6) million and of USD 40 (CHF 38.2) million for clinical development milestones achieved all-in prior to January&#160;1, 2017. Genentech may terminate the agreement at any time by providing <span style="-sec-ix-hidden:Hidden_EdaFR7KmDE28JCeL6L0nxw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3&#160;months</span></span>&#8217; notice to us. In such event all costs incurred are still refundable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Genentech is a customer. The Company identified the following performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;conducting of research under a research plan. The Company considered the research and development capabilities of Genentech and Genentech&#8217;s right to sublicense to conclude that the license has stand-alone functionality and is distinct. The Company&#8217;s obligation to perform research does not significantly impact or modify the licenses&#8217; granted functionality.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At execution of the agreement, the transaction price included the upfront consideration received of USD 25 (CHF 31.6) million. At inception, none of the clinical or regulatory milestones had been included in the transaction price, as all milestone amounts were fully constrained. The Company has received three milestone payments since inception, totaling USD 40 (CHF 38.2) million. The Company could receive greater than USD 275 (CHF 256.4) million or more for further regulatory milestones for this exclusive, worldwide alliance. In assessing that future regulatory milestones are fully constrained, the Company considered numerous factors, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts. Any consideration related to royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Genentech and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In January 2019, we announced that Roche, the parent of Genentech, is discontinuing the CREAD and CREAD 2 (BN29552 and BN29553) Phase 3 studies of crenezumab in people with prodromal-to-mild sporadic AD. The decision came after an interim analysis conducted by the Independent Data Monitoring Center (IDMC) indicated that crenezumab was unlikely to meet its primary endpoint of change from baseline in CDR-SB Score. This decision was not related to the safety of the investigational product. No safety signals for crenezumab were observed in this analysis and the overall safety profile was similar to that seen in previous trials.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we have recognized no revenues from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Anti-Tau antibody in AD&#160;&#8211; 2012 agreement with Genentech, a member of the Roche Group</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In June&#160;2012, we entered into a second agreement with Genentech to research, develop and commercialize our anti-Tau antibodies for use as immunotherapeutics and diagnostics. The agreement was amended in December&#160;2015. The value of this exclusive, worldwide alliance is potentially greater than CHF 400 million and includes upfront and clinical, regulatory and commercial milestone payments. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the mid-single digits to low-double digits. The agreement also provides for collaboration on at least one additional therapeutic indication outside of AD built on the same anti-Tau antibody program as well an anti-Tau diagnostic product.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The term of the agreement commenced on the effective date and, unless sooner terminated by mutual agreement or pursuant to any other provision of the agreement, terminates on the date on which all obligations between the parties with respect to the payment of milestones or royalties with respect to licensed products have passed or expired. Either party may terminate the agreement for any material breach by the other party, provided a cure period of 90&#160;days from the date when that notice is given.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, we have received payments totaling CHF 59 million, including a milestone payment of CHF 14 million received and <span style="-sec-ix-hidden:Hidden_751hiZiX7EinZNcM4zz_ew;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">recognized</span></span> in Q4 2017 associated with the first patient dosing in a Phase 2 clinical trial for AD with an anti-Tau monoclonal body known as semorinemab, a milestone payment of CHF 14 million recognized in Q2 2016 and <span style="-sec-ix-hidden:Hidden_5oAu63RdGkGFjzGDsCTBog;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">received</span></span> in July&#160;2016, associated with the announcement of the commencement of the Phase 1 clinical study of semorinemab, and a milestone payment of CHF 14 million received in 2015 in connection with the ED-GO decision. As we met all performance obligations on reaching these milestones, we have recognized revenue in the respective periods. Genentech may terminate the agreement at any time by providing <span style="-sec-ix-hidden:Hidden_lTC6TFzT5kGupQPYn0M3yQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3&#160;months</span></span>&#8217; notice to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Genentech is a customer. The Company identified the following performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;conduct of research under a research plan. The Company considered the research and development capabilities of Genentech and Genentech&#8217;s right to sublicense to conclude that the license has stand-alone functionality and is distinct. The Company&#8217;s obligation to perform research does not significantly impact or modify the licenses&#8217; granted functionality.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At execution of the agreement, the transaction price included an upfront consideration received of CHF 17 million. At inception, none of the clinical or regulatory milestones had been included in the transaction price, as all milestone amounts were fully constrained. The Company has received three milestones since inception totaling CHF 42 million. The Company could also receive up to an additional CHF 368.5 million in clinical, regulatory and commercial milestones. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Genentech and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In September 2020, the Company reported that Genentech informed us of top line results from a Phase 2 trial of the anti-Tau antibody, semorinemab, in early (prodromal to mild) Alzheimer&#8217;s disease (AD) which show that semorinemab did not meet its primary efficacy endpoint of reducing decline on CDR-SB compared to placebo. The primary safety endpoint was however met. Two secondary endpoints, Alzheimer&#8217;s Disease Assessment Scale-Cognitive Subscale 13 (ADAS-Cog13) and Alzheimer&#8217;s Disease Cooperative Study Group&#160;&#8211; Activities of Daily Living Inventory (ADCS-ADL), were not met.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In August 2021, the Company reported that Genentech had informed the Company that the Lauriet study had met one of its co-primary endpoints, ADAS-Cog 11. The second co-primary endpoint, ADCS-ADL, was not met. Safety data showed that semorinemab was well tolerated with an acceptable safety profile and no unanticipated safety signals. In November 2021, the Company reported that Genentech had presented the full top-line data from the Lauriet study during a late-breaking session at the 14<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Clinical Trials on Alzheimer&#8217;s Disease conference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we have recognized no revenues from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Tau vaccine in AD&#160;&#8211; 2014 agreement with Janssen Pharmaceuticals,&#160;Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2014, we entered into an agreement with Janssen Pharmaceuticals,&#160;Inc. (Janssen), part of the Janssen Pharmaceutical Companies of Johnson&#160;&amp; Johnson, to develop and commercialize therapeutic anti-Tau vaccines for the treatment of AD and potentially other Tauopathies. The value of this collaboration is potentially up to CHF 500 million and includes upfront and clinical, regulatory and commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the high-single digits to the mid-teens for the phospho-Tau vaccine program. In April&#160;2016, July&#160;2017, January&#160;2019, November&#160;2019 and December 2022, the companies entered into the first, second, third, fourth and fifth amendments, respectively. These amendments allow for the alignment of certain payment and activity provisions with the Development Plan and Research Plan activities. We and Janssen have completed the co-development of the second-generation lead therapeutic vaccines, ACI-35.030 and JACI-<span style="white-space:pre-wrap;">35.054, through Phase 1b/2a. In November 2022, it was announced that ACI-35.030 was selected to advance into further development based on interim data from the ongoing Phase 1b/2a trial. AC Immune and Janssen will jointly share research and development costs until the completion of the first Phase 2b (AC Immune&#8217;s contribution to the first Phase 2b trial is capped). From Phase 2b and onwards, Janssen will assume responsibility for the clinical development, manufacturing and commercialization of ACI-35.030.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the terms of the agreement, Janssen may terminate the agreement at any time after completion of the first Phase 1b clinical study in 2016 by providing 90&#160;days&#8217; notice to us. If not otherwise terminated, the agreement shall continue until the expiration of all royalty obligations as outlined in the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The agreement also allows for the expansion to a second indication based on the same anti-Tau vaccine program and based on intellectual property related to this program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company received an upfront, non-refundable license fee of CHF 25.9 million, which we recognized as revenue in 2014. In May&#160;2016, we received a payment of CHF 4.9 million for reaching a clinical milestone in the first Phase 1b study. As we met all performance obligations on reaching the milestone, we have recognized this income as revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Janssen is a customer. The Company identified the following performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;research and development services including a development and chemistry, manufacturing and controls work plan. The Company considered the research and development capabilities of Janssen, Janssen&#8217;s right to sublicense, and the fact that the research and development services are not proprietary and can be provided by other vendors, to conclude that the license has stand-alone functionality and is distinct. The Company&#8217;s obligation to perform research and development services does not significantly impact or modify the licenses&#8217; granted functionality. Based on these assessments, the Company identified the license and the research and development services as the performance obligations at the inception of the arrangement, which were deemed to be distinct in the context of the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At execution of the agreement, the transaction price included only the upfront consideration received of CHF 25.9 million. At inception, none of the clinical, regulatory or commercial milestones has been included in the transaction price, as all milestone amounts were fully constrained. The Company did receive a payment of CHF 4.9 million for reaching a clinical milestone in the first Phase 1b study in May&#160;2016. The Company could also receive up to more than CHF 458 million in clinical, regulatory and commercial milestones as well as tiered, high-single digits to mid-teen royalties on aggregate net sales for the phospho-Tau vaccine program. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors to determine that these milestones are not highly probable to obtain, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Janssen and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we have recognized nil, nil and CHF 1.1 million, respectively, from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Tau-PET imaging agent&#160;&#8211;2014 agreement with Life Molecular Imaging (LMI) (formerly Piramal Imaging SA)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2014 (as amended in June 2022), we entered into an agreement, our first diagnostic partnership, with LMI, the former Piramal Imaging SA. The partnership with LMI is an exclusive, worldwide licensing agreement for the research, development and commercialization of the Company&#8217;s Tau protein PET tracers supporting the early diagnosis and clinical management of AD and other Tau-related disorders and includes upfront and sales milestone payments totaling up to EUR 160 (CHF 159) million, plus royalties on sales at a&#160;percentage rate ranging from mid-single digits to low-teens. LMI may terminate the LCA at any time by providing 3&#160;months&#8217; notice to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with this agreement, AC Immune received a payment of EUR 500 (CHF 664) thousand, which was fully recognized in 2015. In Q1 2017, we recorded a milestone payment of EUR 1 (CHF 1.1) million related to the initiation of &#8220;Part&#160;B&#8221; of the first-in-man Phase 1 study. In Q3 2019, the Company recognized EUR 2 (CHF 2.2) million in connection with the initiation of a Phase 2 trial of Tau-PET tracer in patients with mild cognitive impairment and mild&#8211;to-moderate AD in comparison with non-demented control participants. In Q3 2022, the Company recognized EUR 4 (CHF 3.9) million linked to the progression of the Tau-PET tracer into late-stage development in AD. The Company is eligible to receive additional variable consideration related to the achievement of certain clinical milestones totaling EUR 4 (CHF 4) million should the compound make it through Phase 3 clinical studies. We are also eligible to receive potential regulatory and sales-based milestones totaling EUR 148 (CHF 138) million. Finally, the Company is eligible for royalties from the mid-single digits to low-teens.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that LMI is a customer. The Company has identified that the right-of-use license as the only performance obligation. The Company determined that transaction price based on the defined terms allocated to each performance obligation specified in the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The upfront payment constitutes the amount of consideration to be included in the transaction price and has been allocated to the license. None of the clinical, regulatory or commercial milestones has been included in the transaction price as these variable consideration elements are considered fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as these amounts have been determined to relate predominantly to the license granted to LMI and therefore are recognized at the later of when the performance obligation is satisfied or the related sales occur. The Company considered LMI&#8217;s right to sublicense and develop the Tau protein PET tracers, and the fact that LMI could perform the research and development work themselves within the license term without AC Immune, to conclude that the license has stand-alone functionality and is distinct. The Company believes that the contracted amount represents the fair value. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company has recognized CHF 3.9 million, nil and nil, respectively, from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">13.2</b></span> Grant income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Grants from the Michael J. Fox Foundation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In May&#160;2020, the Company, as part of a joint arrangement with Sk&#229;ne University Hospital (Sk&#229;ne) in Sweden, was awarded a USD 3.2 (CHF 3.0) million grant from the MJFF&#8217;s Ken Griffin Alpha-synuclein Imaging Competition. As part of this grant, AC Immune is eligible to receive USD 2.5 (CHF 2.3) million directly from the MJFF. Sk&#229;ne will receive USD 0.7 (CHF 0.7) million of the total grant directly from the MJFF over <span style="-sec-ix-hidden:Hidden_CDAuGzNdHk259o1JNxYdiA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two</span></span>&#160;years to conduct and support the clinical arm of the project. In August 2022, the Company received follow-on grant funding as part of its joint </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">arrangement with Sk&#229;ne in Sweden totaling USD&#160;0.5&#160;(CHF&#160;0.5) million for the continued development of its alpha-synuclein PET imaging diagnostic agent. As part of this grant, AC Immune received USD&#160;0.4&#160;(CHF&#160;0.4) million directly from the MJFF. Sk&#229;ne will receive USD&#160;0.1&#160;(CHF&#160;0.1) million of the total grant directly from the MJFF over the duration of the grant period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The MJFF expects that AC Immune and Sk&#229;ne will complete tasks according to the agreed timelines. AC Immune&#8217;s funding is variable depending on the satisfactory achievement of these specific tasks within a specific period of time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2021, the Company announced that it had been awarded two grants totaling USD 1.5 (CHF 1.4) million to advance small molecule PD programs. One award will support an existing early-stage program to develop small molecules that can prevent intracellular aggregation and spreading of a-syn. The other award will fund research on the therapeutic potential of chemically and mechanistically novel, brain penetrant small molecule inhibitors of NLRP3 inflammasome activation for the treatment of PD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company has recognized CHF 1.2 million, CHF 1.1 million and CHF 1.3 million, respectively, from its MJFF grants. As of December&#160;31, 2022, the Company recorded CHF 0.3 million in accrued income and CHF 0.5 million in deferred income, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717912961744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Expenses by category<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ExpensesByCategoryAbstract', window );"><strong>Expenses by category [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfExpensesExplanatory', window );">Expenses by category</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">14.</b></span>Expenses by category</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">Research and development</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Operating expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 41,166</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 44,289</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 43,787</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 17,548</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 16,465</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 14,424</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,528</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,276</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total research and development expenses </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 60,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 62,282</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 59,487</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company incurred CHF 60.3 million, CHF 62.3 million and CHF 59.5 million in research and development expenses, respectively. The decrease in 2022 is mainly driven by decreases in direct R&amp;D expenditures across various programs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company had 122.4, 108.6 and 115.3 FTEs in our research and development functions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">General and administrative</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Operating expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,207</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,471</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,874</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,281</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,274</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,598</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,812</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total general and administrative expenses </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,789</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 17,910</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18,557</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company incurred CHF 15.8 million, CHF 17.9 million and CHF 18.6 million in general and administrative expenses, respectively. The decrease in 2022 compared with the prior&#160;year predominantly relates to certain transaction costs associated with our prior year asset acquisition which did not repeat in 2022 as well as a reduction in headcount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company had 22.5, 27.3 and 26.7 FTEs in our general and administrative functions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">Financial result, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 69</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,485</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 78</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (355)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (581)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (184)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exchange differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 393</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (555)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Finance result, net </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (661)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our finance result primarily consists of interest expense associated with our short-term financial assets and lease liabilities as well as foreign currency exchange differences.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2022, the decrease in financial result, net related primarily to the prior year CHF 6.5 million gain on the conversion features related to the Company&#8217;s convertible notes due to certain Affiris affiliated entities that did not recur.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ExpensesByCategoryAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ExpensesByCategoryAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfExpensesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfExpensesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913324944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-party transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Related-party transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related-party transactions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">15.</b></span>Related-party transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Board of directors and executive management compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Key management includes the board of directors and executive management. For 2022, there were eight members (2021: eight and 2020: seven) of the Board (excluding the CEO) and seven members (2021: six and 2020: five) of executive management (including the CEO). Compensation was as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term employee benefits </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,187</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,497</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Post-employment benefits </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 295</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 266</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 214</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,503</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,578</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,666</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,289</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913218416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Income taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income taxes</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">16.</b></span>Income taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Group recognized less than CHF 0.1 million, less than CHF 0.1 million and nil in income taxes and no deferred tax asset or <span style="-sec-ix-hidden:Hidden_bwx-SbM9sEqAKiboMtvBTg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">liability</span></span> positions for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively. The Group&#8217;s expected tax expense for each&#160;year is based on the applicable tax rates in each jurisdiction. In 2022, these rates ranged from 13.6% to 33.8% (13.6% - 32.9% for 2021 and 13.6% for 2020) in the Group&#8217;s respective tax jurisdictions. The weighted average tax rate applicable to the Group was 13.6% (13.6% for 2021 and 2020, respectively). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Group&#8217;s income tax expense for each&#160;year can be reconciled to loss before tax as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Loss before income tax </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (70,740)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (72,993)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (61,921)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Tax benefit calculated at the domestic rates applicable in the respective countries </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,616)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,930)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,441)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">(Income not subject to tax)/expenses not deductible for tax purposes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (375)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 462</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of unused tax losses and tax offsets not recognized as deferred tax assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,174</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,308</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,979</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Effective income tax rate (benefit)/expense </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Swiss tax rate used for the 2022 reconciliations is the corporate tax rate of 13.6% (13.6% in 2021 and 2020, respectively) payable by corporate entities in the Canton of Vaud, Switzerland on taxable profits under tax law in that jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The below table details the total unrecognized deductible temporary differences, unused tax losses and unused tax credits:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrecognized deductible temporary differences, unused tax losses and unused tax credits</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Tax losses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 264,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 197,152</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 121,948</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Deductible temporary differences related to:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;">Right-of-use assets and lease liabilities, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;">Retirement benefit plan </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,098</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,464</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 267,302</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 204,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 129,412</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table details the tax losses carry forwards of the Company and their respective expiry dates:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Tax losses split by expiry date:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,231</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 48,894</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 48,894</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 48,894</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 57,824</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 57,824</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 57,824</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 75,204</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 75,204</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 66,936</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total unrecorded tax loss carryforwards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 264,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 197,153</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 121,949</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The tax losses available for future offset against taxable profits have increased by CHF 66.9&#160;million from 2021, representing the amount of tax losses that are additionally available as an offset, subject to expiration as disclosed in the table above, against future taxable income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Consistent with prior&#160;years, the Company has not recorded any deferred tax assets in relation to the past tax losses available for offset against future profits as the recognition criteria were not met at the balance sheet date.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717918323040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract', window );"><strong>Retirement benefit plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory', window );">Retirement benefit plan</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">17.</b></span>Retirement benefit plan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company participates in a collective foundation covering all of its employees including its executive officers. In addition to retirement benefits, the plan provides death or long-term disability benefits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Contributions paid to the plan are computed as a&#160;percentage of salary, adjusted for the age of the employee and shared approximately 47% and 53% by employee and employer, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This plan is governed by the Swiss Law on Occupational Retirement, Survivors and Disability Pension Plans (BVG), which requires contributions to be made to a separately administered fund. The fund has the legal form of a foundation and it is governed by a board of trustees, which consists of an equal number of employer and employee representatives of its members. The board of trustees is responsible for the administration of the plan assets and for the definition of the investment strategy. The Company has no direct influence on the investment strategy of the foundation board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The assets are invested by the pension plan, to which many companies contribute, in a diversified portfolio that respects the requirements of the Swiss BVG. Therefore, disaggregation of the pension assets and presentation of plan assets in classes that distinguish the nature and risks of those assets is not possible. Under the plan, both the Company and the employee share the costs. The structure of the plan and the legal provisions of the BVG mean that the employer is exposed to actuarial risks. The main risks are investment risk, interest risk, disability risk and the life expectancy of pensioners. Through our affiliation with the pension plan, the Company has minimized these risks, as they are shared between a much greater number of participants. On leaving the Company, a departing employee&#8217;s retirement savings are transferred to the pension institution of the new employer or to a vested benefits institution. This transfer mechanism may result in pension payments varying considerably from&#160;year to&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The pension plan is exposed to Swiss inflation, interest rate risks and changes in the life expectancy for pensioners. For accounting purposes under IFRS, the plan is treated as a defined benefit plan in accordance with IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table sets forth the status of the defined benefit pension plan and the amount that is recognized in the consolidated balance sheets:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (32,410)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33,889)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (30,213)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Fair value of plan assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29,197</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 26,791</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 22,749</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total liability </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,213)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,098)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,464)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following amounts have been recorded as net pension cost in the consolidated statements of income/(loss):</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Service cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,648</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,626</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 79</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 71</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (87)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (48)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (42)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net pension cost </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,655</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The changes in defined benefit obligation, fair value of plan assets and unrecognized gains/(losses) are as follows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">A. Change in defined benefit obligation</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Defined benefit obligation as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33,889)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (30,213)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (26,624)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Service cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,712)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,648)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,626)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (126)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (79)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (71)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in demographic assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,428</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in financial assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,397</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 156</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (71)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in experience assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,726)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (252)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (931)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Benefits deposited </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,327)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (894)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,467)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees&#8217; contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,056)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (959)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (851)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Defined benefit obligation as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (32,410)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33,889)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (30,213)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Change in fair value of plan assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of plan assets as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 26,791</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 22,749</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 19,139</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 87</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 48</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 42</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees&#8217; contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,056</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 959</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 851</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employer&#8217;s contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,210</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 950</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Benefits deposited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,327</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 894</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,467</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Return on plan assets excluding interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,274)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,052</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 300</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of plan assets as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29,197</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 26,791</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 22,749</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period amount to approximately CHF 1.2 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Change in net defined benefit liability</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net defined benefit liabilities as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,098</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,464</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,485</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net pension cost through statement of income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,655</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Remeasurement through other comprehensive income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,426)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (956)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (726)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employer&#8217;s contribution </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,210)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,089)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (950)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net defined benefit liabilities as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,098</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,464</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Other comprehensive gains/(losses)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in demographic assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,428</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in financial assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,397</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 156</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (71)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in experience assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,726)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (252)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (931)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Return on plan assets excluding interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,274)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,052</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 300</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other comprehensive gain</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,426</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 956</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 726</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The change in experience assumptions results from an increased sum of insured salaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the plan assets is the cash surrender value of the insurance with the insurance company (AXA). The investment strategy defined by the board of trustees follows a conservative profile.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The plan assets are primarily held within instruments with quoted market prices in an active market, with the exception of real estate and mortgages.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The weighted-average duration of the defined benefit obligation is 14.9&#160;years and 17.1&#160;years as of December&#160;31, 2022 and 2021, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The actuarial assumptions used for the calculation of the pension cost and the defined benefit obligation of the defined benefit pension plan for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively, are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:48.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:48.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Discount rate </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Rate of future increase in compensations </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Rate of future increase in current pensions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest rate on retirement savings capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Mortality and disability rates </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In defining the benefits, the minimum requirements of the Swiss BVG and its implementing provisions must be observed. The BVG defines the minimum pensionable salary and the minimum retirement credits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2022 is shown below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interest&#160;rate&#160;on</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Discount&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;salary&#160;increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;pension&#160;cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">savings&#160;capital</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assumptions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="17" style="padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In&#160;CHF&#160;thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Potential defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 30,201</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 34,916</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 32,940</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,841</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 33,601</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,322</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 33,322</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,545</p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Decrease/(increase) from actual defined benefit obligation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,209</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,506)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (530)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 569</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,191)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,088</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (912)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 865</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2021 is shown below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interest&#160;rate&#160;on</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Discount&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;salary&#160;increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;pension&#160;cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">savings&#160;capital</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assumptions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="17" style="padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in&#160;CHF&#160;thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Potential defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,190</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 37,006</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 34,578</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 33,176</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,497</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 32,435</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 34,822</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 33,007</p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Decrease/(increase) from actual defined benefit obligation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,699</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,117)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (689)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 713</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,608)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,454</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (933)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 882</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The sensitivity analyses above are subject to limitations and have been determined based on a method that extrapolates the impact on net defined benefit obligation as a result of reasonable changes in key assumptions occurring at the end of the reporting period.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of defined benefit plans. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 138<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_138&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717918098032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Share-based compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">Share-based compensation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">18.</b></span>Share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Share-based option awards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2022, there are equity-based instruments outstanding that the Company has granted under two different plans.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s 2016 Share Option and Incentive Plan (SOIP) was approved by the shareholders at the ordinary shareholders&#8217; meeting in November&#160;2016. The 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights. The Company only grants equity-based instruments from the SOIP as of December&#160;31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes equity-settled share option grants for plans that existed during the period:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">options&#160;awarded</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td></tr><tr><td style="vertical-align:bottom;width:40%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plan</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(since&#160;inception)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vesting&#160;conditions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">life&#160;of&#160;options</b></p></td></tr><tr><td style="vertical-align:bottom;width:40%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share option plan C1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,775,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from grant date</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">2016 SOIP:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:top;width:40%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executives and directors</p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,277,044</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">1 year</span><span style="font-size:10pt;">, </span><span style="font-size:10pt;">3 year</span><span style="font-size:10pt;"> and </span><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, quarterly and annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees</p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,811,687</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The number and weighted-average exercise prices (in CHF) of options under the share option programs for Plans C1 and the 2016 SOIP are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">exercise&#160;price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">remaining</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(CHF)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">term&#160;(years)</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,981,629</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.93</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 8.3</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (53,591)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expired during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (26,729)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.38</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (73,669)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,073,027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,900,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 8.2</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,099,015</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.49</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.0</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,900,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 8.2</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (207,331)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (218,561)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,110,914</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.34</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,585,689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.8</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,613,242</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 6.8</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,585,689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.8</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (304,738)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (110,250)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,090,316</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,261,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.6</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,345,648</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.41</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 6.6</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The outstanding stock options as of December&#160;31, 2022 have the following range of exercise prices:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">expiration</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&#160;options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">dates</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range of exercise prices</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF 0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 97,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2022&#8211;2026</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF 9.53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 223,646</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2027</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 5.04 to USD 12.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,864,408</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2028&#8211;2031</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 2.76 to USD 4.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,075,088</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2032</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total outstanding options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,261,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The weighted-average exercise price for options granted in 2022, 2021 and 2020 is USD 3.44 (CHF 3.18), USD 6.95 (CHF 6.34) and USD 7.11 (CHF 6.29), respectively. The range of exercise prices for outstanding options was CHF 0.15 to CHF 9.53 for awards previously granted in CHF (prior to 2018) and USD 2.76 to USD 12.30 for awards granted in USD as of December&#160;31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For awards issued in 2022, the volatility is based on the Company&#8217;s actual volatility for the period congruent with the expected term of the underlying option. The risk-free interest rate is based on yields of long-dated U.S. Treasury notes that align with the expected term of the award. The weighted-average share price of common share options exercised in 2022 is USD 3.55 (CHF 3.28).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The weighted-average grant date fair values of the options granted in 2022, 2021 and 2020 are USD 2.38 (CHF 2.20), USD 5.23 (CHF 4.78) and USD 5.25 (CHF 4.65), respectively. The following table illustrates the weighted-average assumptions for the Black-Scholes option-pricing model used in determining the fair value of these awards:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercise price (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">2.76-4.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">5.31-7.72</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">5.04-9.16</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share price (weighted average)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6.95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7.11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">0-2.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">0 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">0 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">67-80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expected term (in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">5.5 - 6.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">5.1 - 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">5.5 - 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Restricted share awards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A summary of non-vested share awards (restricted share and restricted share units) activity as of&#160;December&#160;31, 2022&#160;and changes during the&#160;year then ended is presented below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">life&#160;of&#160;non-</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">share&#160;awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">vested&#160;share</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grantee type</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">granted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vesting&#160;conditions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">awards</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restricted share units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Directors</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 159,025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">1 year</span><span style="font-size:10pt;"> service from date of grant, annually</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:top;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executives</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 274,872</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">3 year</span><span style="font-size:10pt;"> and </span><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, quarterly and semi-annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">non-vested</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">grant</b>&#160;<b style="font-weight:bold;">date&#160;fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">value&#160;(CHF)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at January 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 42,763</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.52</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,828)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.47</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expired during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,804)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.52</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (84,638)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.51</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (23,269)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.52</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 19,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.51</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 49,289</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.47</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 19,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.51</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,471)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.46</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (18,697)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.52</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.41</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 65,515</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.48</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.41</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 239,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.06</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (23,505)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.28</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 216,486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.06</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 89,020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7.84</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The weighted-average grant date fair values of the remaining non-vested share awards as of the respective&#160;year end for the restricted share units were CHF 3.06, CHF 9.41 and CHF 9.51 for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively. The fair values of these non-vested share awards granted were determined using a reasonable estimate of market value of the common shares on the date of the award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The expense charged against the income statement was CHF 3.3 million, CHF 4.1 million and CHF 4.1 million for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively. The expense is revised by the Company based on the number of instruments that are expected to become exercisable.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 44<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913220576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAndContingenciesAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory', window );">Commitments and contingencies</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">19.</b></span>Commitments and contingencies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s commitments and contingencies relate to its ongoing operating activities, mainly research and development programs, as well as its leased corporate space.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the normal course of business,&#160;we conduct product research and development programs through collaborative programs that include, among others, arrangements with universities, contract research organizations and clinical research sites. We have contractual arrangements with these organizations. As of December&#160;31, 2022, we have contractual obligations, other than for leases (see below), totaling CHF 23.0&#160;million for 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We lease our corporate, laboratory and other facilities under multiple leases at the EPFL Innovation Park in Ecublens, near Lausanne, Canton of Vaud, Switzerland. Our lease agreements have no termination clauses longer than a 12-month contractual notice period. The Company recognizes a right-of-use asset for its leases, except for short-term and low-value leases as indicated in Note&#160;3<i style="font-style:italic;">.</i> See &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities&#8221; for the contractual undiscounted cash flows for lease obligations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Within 1 year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 19,785</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Between 1 and 3 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18,516</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,620</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Between 3 and 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,229</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 243</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">More than 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,407</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 51</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 52,488</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23,699</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CommitmentsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CommitmentsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717918106944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Earnings per share</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">20.</b></span>Earnings per share</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.07212067%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands except for share and per share data</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss per share (EPS)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerator</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net loss attributable to equity holders of the Company</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (70,753)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (72,996)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (61,921)</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominator</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted-average number of shares outstanding used to compute EPS basic and diluted attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 83,554,412</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 74,951,833</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 71,900,212</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted loss per share for the period attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.85)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.97)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.86)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In periods for which we have a loss, basic net loss per share is the same as diluted net loss per share. We have excluded from our calculation of diluted loss per share all potentially dilutive in-the-money (i)&#160;share options, (ii)&#160;non-vested restricted share awards and (iii)&#160;shares that were issued upon conversion of two different convertible notes as their inclusion would have been anti-dilutive. The weighted-average number of potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share options issued and outstanding (in-the-money)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 135,827</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,140,388</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 412,191</p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Restricted share awards subject to future vesting</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,292</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,264</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,418</p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Convertible shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,461</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total potentially dilutive securities </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 253,119</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,188,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 440,609</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717918452112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments and risk management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract', window );"><strong>Financial instruments and risk management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory', window );">Financial instruments and risk management</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">21.</b></span>Financial instruments and risk management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s activities expose it to the following financial risks: market risk (foreign exchange and interest rate risk), credit risk and liquidity risk. The Company&#8217;s overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company&#8217;s financial performance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table shows the carrying amounts of financial assets and financial liabilities:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,808</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,914</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 361</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 363</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 392</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 428</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 91,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 116,000</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,586</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 82,216</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 126,147</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 201,921</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,253</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,340</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 929</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,003</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,417</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 16,736</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 548</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 570</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 13,147</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 21,649</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Foreign exchange risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is exposed to foreign exchange risk arising from currency exposures, primarily with respect to the EUR, USD and to a lesser extent to GBP, DKK and SEK. The currency exposure is not hedged. However, the Company has a policy of matching its cash holdings to the currency structure of its expenses, which means that the Company holds predominately CHF, with lesser balances of EUR and USD (see &#8220;Note&#160;8. Cash and cash equivalents and short-term financial assets&#8221;). The Company recognized a gain of CHF 0.5 million and losses of CHF 0.1 million and CHF 0.7 million for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively, within &#8220;Finance result, net.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2022, if the CHF had strengthened/weakened by 10% against the EUR and the USD with all other variables held constant, the net loss for the period would have been lower/higher by CHF 0.7 million (2021: CHF 1.7 million), mainly as a result of foreign exchange gains/losses on predominantly EUR/USD denominated cash and cash equivalents and short-term financial assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Interest rates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s CHF cash holdings (inclusive of those held in short-term financial assets) were subject to negative interest rates at certain counterparty thresholds through the first three quarters of 2022. However, with the increase in interest rates, no current CHF cash holdings (inclusive of those held in short-term financial assets) are subject to negative interest rates with our counterparties. As of December&#160;31, 2022 if the interest rates charged by the counterparties had increased/decreased by 10%, the net income for the period would have been higher/lower by less than CHF 0.2 million. Interest income and interest expense are recorded within finance results, net in our consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Credit risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company maintains a formal treasury risk and investment management policy to limit counterparty credit risk. As of December&#160;31, 2022, the Company&#8217;s cash and cash equivalents and short-term financial assets are held with five financial institutions, each with a high credit rating ranging from A+ to BBB assigned by international credit-rating agencies. The maximum amount of credit risk is the carrying amount of the financial assets. Other receivables are fully performing, not past due and not impaired (see &#8220;Note&#160;8. Cash and cash equivalents and short-term financial assets&#8221; and &#8220;Note&#160;10. Other current receivables&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Liquidity risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Inherent in the Company&#8217;s business are various risks and uncertainties, including the high uncertainty that new therapeutic concepts will succeed. AC Immune&#8217;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;acquire and keep key personnel employed and (iv)&#160;acquire additional capital to support its operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s approach of managing liquidity is to ensure sufficient cash to meet its liabilities when due. Therefore, management closely monitors the cash position on rolling forecasts based on expected cash flow to enable the Company to finance its operations for at least 18&#160;months. The Company has CHF 0.9 million in trade and other payables, and CHF 9.4 million in accrued expenses which are due within 12&#160;months from the reporting date. Finally, as it relates to the Company&#8217;s lease liabilities please see &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities&#8221; for detail of when corresponding lease liabilities are due.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the entity's financial risk management practices and policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialRiskManagementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717910042928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital risk management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract', window );"><strong>Capital risk management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory', window );">Capital risk management</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">22.</b></span>Capital risk management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s objectives when managing capital are to safeguard the Company&#8217;s ability to continue as a going concern and to preserve the capital on the required statutory level in order to succeed in developing a cure against (i)&#160;AD, (ii)&#160;focused non-Alzheimer&#8217;s neurodegenerative diseases including NeuroOrphan indications and (iii)&#160;diagnostics.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information that enables users of financial statements to evaluate the entity's objectives, policies and processes for managing capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913242880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Subsequent events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Subsequent events</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">23.</b></span>Subsequent events</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Management has evaluated subsequent events after the balance sheet date, through the issuance of these consolidated financial statements, for appropriate accounting and disclosures. The Company has determined that there were no other such events that warrant disclosure or recognition in these consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909906928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract', window );"><strong>Summary of significant accounting policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory', window );">Functional and reporting currency</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Functional and reporting currency</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These consolidated financial statements and accompanying notes are presented in Swiss Francs (CHF), which is AC Immune SA&#8217;s functional currency and the Group&#8217;s reporting currency. The Company&#8217;s subsidiary has a functional currency of the U.S. Dollar (USD). The respective functional currency represents the primary economic environment in which the entities operate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following exchange rates have been used for the translation of the financial statements of AC Immune USA:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">CHF/USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Closing rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.933</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.923</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">N/A</p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted average exchange rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.965</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.929</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">N/A</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The results and financial position of AC Immune USA are translated into the presentation currency as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">i.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">assets and liabilities for each balance sheet presented are translated at the closing rate at the date of that balance sheet;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">ii.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">income and expenses for each statement of income/(loss) are translated at average exchange rates; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">iii.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all resulting exchange differences are recognized in other comprehensive income/(loss), within cumulative translation differences.</span></td></tr></table><div style="margin-top:12pt;"/><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock', window );">Critical judgments and accounting estimates</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Critical judgments and accounting estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The areas where AC Immune has had to make judgments, estimates and assumptions relate to (i)&#160;revenue recognition on LCAs, (ii)&#160;clinical development accruals, (iii)&#160;net employee defined benefit liability, (iv)&#160;income taxes, (v)&#160;share-based compensation, (vi)&#160;right-of-use assets and lease liabilities and (vii)&#160;our IPR&amp;D asset. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory', window );">Basis of consolidation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Basis of consolidation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The annual closing date of the individual financial statements is December&#160;31. The Company fully-owns its Subsidiary and fully consolidates its financial statements into these consolidated financial statements. All intercompany transactions have been eliminated.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory', window );">Foreign currency transactions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Foreign currency transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Foreign currency transactions are translated into the respective functional currency using prevailing exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at&#160;year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the consolidated statements of income/(loss). Any gains or losses from these translations are included in the consolidated statements of income/(loss) in the period in which they arise.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock', window );">Current vs. non-current classification</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Current vs. non-current classification</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company presents assets and liabilities in the consolidated balance sheets based on current/non-current classification. The Company classifies all amounts to be realized or settled within 12&#160;months after the reporting period to be current and all other amounts to be non-current.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue recognition</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Revenue recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 15&#160;<i style="font-style:italic;">Revenue from Contracts with Customers</i>. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under IFRS 15, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of IFRS 15, the entity performs the following five steps: (i)&#160;identify the contract(s)&#160;with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of IFRS 15, the Company assesses the goods or services promised within each contract, and determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company enters into LCAs which are within the scope of IFRS 15, under which it licenses certain rights to its product candidates and intellectual property to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees, development, regulatory and/or commercial milestone payments;&#160;payments for research and clinical services the Company provides through either its full-time employees or third-party vendors, and royalties on net sales of licensed products commercialized from the Company&#8217;s intellectual property. Each of these payments results in license, collaboration and other revenues, which are classified as contract revenue on the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Licenses of intellectual property</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are sold in conjunction with a related service, the Company uses judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If the performance obligation is settled over time, the Company determines the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, upfront fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Milestone payments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the inception of each arrangement that includes development, regulatory and/or commercial milestone payments, the Company evaluates whether the milestones are considered highly probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant cumulative revenue reversal would not occur in future periods, the associated milestone value is included in the transaction price. These amounts for the performance obligations under the contract are recognized as they are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments recorded would affect contract revenues and earnings in the period of adjustment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development services</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has certain arrangements with our collaboration partners that include contracting our employees for research and development programs. The Company assesses if these services are considered distinct in the context of each contract and, if so, they are accounted for as separate performance obligations. These revenues are recorded in contract revenue as the services are performed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Sublicense revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has certain arrangements with our collaboration partners that include provisions for sublicensing. The Company recognizes any sublicense revenues at the point in time it is highly probable to obtain and not subject to reversal in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Contract balances</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company receives payments and determines credit terms from its customers for its various performance obligations based on billing schedules established in each contract. The timing of revenue recognition, billings and cash collections results in billed other current receivables, accrued income (contract assets), and deferred income (contract liabilities) on the consolidated balance sheets. Amounts are recorded as other current receivables when the Company&#8217;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be 1&#160;year or less.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For a complete discussion of accounting for contract revenue, see &#8220;Note&#160;13. Contract revenues.&#8221;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory', window );">Research and development expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Given the stage of development of the Company&#8217;s products, all research and development expenditure is expensed as incurred as it does not meet the capitalization criteria outlined in IAS 38 <i style="font-style:italic;">Intangible Assets</i>. The Company has not capitalized any R&amp;D expenses to date. Research and development expenditures include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the cost of acquiring, developing and manufacturing active pharmaceutical ingredients for product candidates that have not received regulatory approval, clinical trial materials and other research and development materials;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees and expenses incurred under agreements with contract research organizations, investigative sites and other entities in connection with the conduct of clinical trials and preclinical studies and related services, such as administrative, data-management and laboratory services;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees and costs related to regulatory filings and activities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">costs associated with preclinical and clinical activities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">employee-related expenses, including salaries and bonuses, benefits, travel and share-based compensation expenses; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all other allocated expenses such as facilities and information technology (IT) costs.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For external research contracts, expenses include those associated with contract research organizations, or CROs, or contract manufacturing organizations, or CMOs. The invoicing from CROs or CMOs for services rendered do not always align with work performed. We accrue the cost of services rendered in connection with CRO or CMO activities based on our estimate of the &#8220;stage of completion&#8221; for such contracted services. We maintain regular communication with our CRO or CMO vendors to gauge the reasonableness of our estimates and accrue expenses as of the balance sheet date in the consolidated financial statements based on facts and circumstances known at the time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Registration costs for patents are part of the expenditure for research and development projects. Therefore, registration costs for patents are expensed when incurred as long as the research and development project concerned does not meet the criteria for capitalization.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory', window );">General and administrative expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">General and administrative expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">General and administrative expenses are expensed as incurred and include personnel costs, expenses for outside professional services and all other allocated expenses. Personnel costs consist of salaries, cash bonuses, benefits and share-based compensation. Outside professional services consist of legal, accounting and audit services, IT and other consulting fees. Allocated expenses consist of certain IT, facilities and depreciation expenses.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_GrantIncomePolicyTextBlock', window );">Grant income</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Grant income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has received grants, from time to time, from the Michael J. Fox Foundation (MJFF), the Target ALS Foundation (Target ALS) and other institutions to support certain research projects. Grants are recorded at their fair value in the consolidated statements of income/(loss) within other operating income/(expenses), net when there is reasonable assurance that the Company will satisfy the underlying grant conditions and the grants will be received. In certain circumstances, grant income may be recognized before formal grantor acknowledgement of milestone achievements. To the extent required, grant income is deferred and recognized on a systematic basis over the periods in which the Company expects to recognize the related expenses for which the grants are intended to compensate.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 16 <i style="font-style:italic;">Leases</i>, which provides the model for lessee accounting in which all leases, other than short-term and low-value leases, are accounted for by the recognition on the consolidated balance sheet of a right-of-use asset and a lease liability, and the subsequent amortization of the right-of-use asset over the earlier of the end of the useful life or the lease term. In accordance with IFRS 16, the Company (i)&#160;does not recognize right-of-use assets and lease liabilities for leases of low value (i.e. approximate fair value of USD 5,000). For a complete discussion of accounting, see &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Right-of-use assets and lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception of a leasing contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#8217;s incremental borrowing rate. The lease liabilities are classified as current or non-current based on the due dates of the underlying principal payments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Lease payments generally are fixed for the contract term. The lease liability is measured at amortized cost using the effective interest method. The lease liability is re-measured if there is a change in the estimated lease term, a change in future lease payments arising from a change in an index or rate, a change in the Company&#8217;s estimate of the amount expected to be payable under a residual value guarantee or a change in assessment of whether it will exercise a purchase, extension or termination option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception, the right-of-use asset comprises the initial lease liability and any initial direct costs. The right-of-use asset is depreciated over the shorter of the lease term or the useful life of the underlying asset. The right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain re-measurements of the lease liability performed on as certain potential triggering events may arise (e.g. lease modifications). When the lease liability is re-measured, a corresponding adjustment is made to the carrying amount of the right-of-use asset or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The estimated lease term by right-of-use asset categories are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Buildings</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Office equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Both the right-of-use-assets and lease liabilities are recognized in the consolidated balance sheets.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Equipment is shown at historical acquisition cost, less accumulated depreciation and any accumulated impairment losses. Historical costs include expenditures that are directly attributable to the acquisition of the property, plant and equipment. Depreciation is calculated using a straight-line method to write off the cost of each asset to its residual value over its estimated useful life as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Laboratory equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Leasehold improvements/furniture</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The assets&#8217; residual values and useful lives are reviewed, and adjusted if appropriate, at each balance sheet date. Where an asset&#8217;s carrying amount is greater than its estimated recoverable amount, it is written down to its recoverable amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Gains and losses on disposals are determined by comparing the disposal proceeds with the carrying amount and are included in the consolidated statements of income/(loss).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Intangible assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune&#8217;s acquired in process research and development (IPR&amp;D) asset is stated at cost less any impairments. The Company does not deem this asset ready for use until the asset obtains market approval. Therefore, during the development period after the date of acquisition until market approval, the IPR&amp;D asset is not amortized. Upon market approval, the Company will determine the useful life of the asset, reclassify it from IPR&amp;D and commence amortization. If the associated R&amp;D effort is abandoned, the related IPR&amp;D will likely be written off and we will record the relevant impairment charge. Finally, the Company will not capitalize future development costs in respect to this IPR&amp;D asset until they meet the criteria for capitalization of research and development costs in accordance with IAS 38 <i style="font-style:italic;">Intangible Assets</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our IPR&amp;D asset is subject to impairment testing at least annually or when there are indications that the carrying value may not be recoverable until the completion of the development process. The determination of the recoverable amounts include key estimates which are highly sensitive to, and dependent upon, key assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company uses a discounted cash flow method to determine the fair value less costs to sell (recoverable amount) of our IPR&amp;D intangible asset. The Company starts with a forecast of all the expected net cash flows, which incorporates the consideration of a terminal value and then the Company applies a discount rate to arrive at a risk-adjusted net present value amount.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory', window );">Fair value of financial assets and liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Fair value of financial assets&#160;and liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s financial assets and liabilities are composed of receivables, short-term financial assets, cash and cash equivalents, trade payables and lease liabilities. The fair value of these financial instruments approximates their </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">respective carrying values due to the short-term maturity of these instruments, and are held at their amortized cost in accordance with IFRS 9, unless otherwise explicitly noted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Receivables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Receivables are recognized at their billing value. An allowance for doubtful accounts is recorded for potential estimated losses when there is evidence of the debtor&#8217;s inability to make required payments and the Company assesses on a forward-looking basis the expected credit losses associated with these receivables held at amortized cost.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Short-term financial assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Short-term financial assets are held with external financial institutions and comprise fixed-term deposits with maturities ranging from more than 3 through 12&#160;months in duration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company assesses whether there is objective evidence that financial assets are impaired annually or whenever potential impairment triggers may occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents include deposits held with external financial institutions and cash on hand. All cash and cash equivalents are either in cash or in deposits with original duration of less than 3&#160;months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Trade payables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Trade payables are amounts due to third parties in the ordinary course of business.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory', window );">Share capital and public offerings</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share capital and public offerings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Common shares are classified as equity. Share issuance costs are capitalized as incurred and will be shown in equity as a deduction, net of tax, from the proceeds received from existing or future offerings. Should a planned equity offering not be assessed as probable, the issuance costs would be expensed immediately in the consolidated statements of income/(loss). See &#8220;Note&#160;11. Share capital.&#8221;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory', window );">Treasury Shares</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Treasury shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Treasury shares are recognized at acquisition cost and deducted from shareholders&#8217; equity at the time of acquisition, until they are subsequently resold, distributed or cancelled. Where such shares are subsequently sold, any consideration received is included in shareholders&#8217; equity. See &#8220;Note&#160;11. Share capital.&#8221;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory', window );">Employee benefits</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Employee benefits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Post-employment benefits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates the mandatory pension schemes for its employees in Switzerland. The schemes are generally funded through payments to insurance companies. The Company has a pension plan designed to pay pensions based on accumulated contributions on individual savings accounts. However, this plan is classified as a defined benefit plan under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The net defined benefit liability is the present value of the defined benefit obligation at the balance sheet date minus the fair value of plan assets. Significant estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. The defined benefit obligation is calculated annually with the assistance of an independent actuary using the projected unit credit method, which reflects services rendered by employees to the date of valuation, incorporates assumptions concerning employees&#8217; projected salaries and pension increases as well as discount rates of highly liquid corporate bonds that have terms to maturity approximating the terms of the related liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To the extent that the fair value of the plan assets is greater than the present value of the defined benefit obligation as calculated by our independent actuary, the Company accounts for the effect of the asset ceiling test under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Re-measurements of the net defined benefit liability, which comprise actuarial gains and losses and the return on plan assets (excluding interest) are recognized immediately in the consolidated statements of other comprehensive income/(loss). Past service costs, including curtailment gains or losses, are recognized immediately as a split in research and development and general and administrative expenses within the operating results. Settlement gains or losses are recognized in either research and development and/or general and administrative expenses within the operating results. The Company determines the net interest expense/(income) on the net defined benefit liability for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period or in case of any significant events between measurement dates to the then-net defined benefit liability, considering any changes in the net defined benefit liability during the period as a result of contributions and benefit payments. Net interest expense/(income) and other expenses related to defined benefit plans are recognized in the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates an equity-settled, share-based compensation plan. The fair value of the employee services received in exchange for the grant of equity-based awards is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the instruments granted, excluding the impact of any non-market vesting conditions. Non-market vesting conditions are included in assumptions about the number of instruments that are expected to become exercisable. At each balance sheet date, the Company revises its estimates of the number of instruments that are expected to become exercisable. It recognizes the impact of the revision of original estimates, if any, prospectively in the consolidated statements of income/(loss), and a corresponding adjustment to equity over the remaining vesting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Stock options granted under the Company&#8217;s stock option plans C1 and the 2016 Stock Option and Incentive Plan are valued using the Black-Scholes option-pricing model (see &#8220;Note&#160;18. Share-based compensation&#8221;). This valuation model as well as parameters used such as expected volatility and expected term of the stock options are partially based on management&#8217;s estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We estimate the fair value of restricted share units using a reasonable estimate of market value of the common shares on the date of the award. We classify our share-based payments as equity-classified awards as they are settled in common shares. We measure equity-classified awards at their grant date fair value and do not subsequently re-measure them. Compensation costs related to equity-classified awards are equal to the fair value of the award at grant date amortized over the vesting period of the award using the graded method. We reclassify that portion of vested awards to share capital and share premium as the awards vest.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Provisions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Provisions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events where it is more likely than not that an outflow of resources will be required to settle the obligation, and a reliable estimate of the amount can be made.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Taxation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Taxation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Current income tax assets and liabilities for the period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the tax amounts are those that are enacted or substantively enacted, at the reporting date in accordance with the fiscal regulations of the respective country where the Company operates and generates taxable income. Deferred tax is provided using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the&#160;year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date. If required, deferred taxation is provided in full using the liability method, on all temporary differences at the reporting dates. It is calculated at the tax rates that are expected to apply to the period when it is anticipated the liabilities will be settled, and it is based on tax rates (and laws) that have been enacted or substantively enacted at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized. Although the Company has substantial tax loss carry-forwards, historically, due to the fact that the Company had limited certainty on the achievement of key milestones, it has not recognized any deferred tax assets as the probability for use is low.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As disclosed in &#8220;Note&#160;16. Income taxes,&#8221; the Company has tax losses that can generally be carried forward for a period of 7&#160;years from the period the loss was incurred. These tax losses represent potential value to the Company to the extent that the Company is able to create taxable profits before the expiry period of these tax losses. The Company has not recorded any deferred tax assets in relation to these tax losses.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory', window );">Earnings per share</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Earnings per share</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company presents basic earnings per share for each period in the consolidated financial statements. The earnings per share are calculated by dividing the earnings of the period by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential dilution that could occur if dilutive securities such as share options or non-vested restricted share units were vested or exercised into common shares or resulted in the issuance of common shares that would participate in net income. Anti-dilutive shares are excluded from the dilutive earnings per share calculation.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory', window );">Segment reporting</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Segment reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is managed and operated as one business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. Accordingly, the Company views its business and manages its operations as one operating segment. Non-current assets are located in, and revenue is allocated and recorded within, the Company&#8217;s country of domicile, Switzerland.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock', window );">Accounting policies, new standards, interpretations and amendments adopted by the Company</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Accounting policies, new standards, interpretations and amendments adopted by the Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">There are no new IFRS standards, amendments or interpretations that are mandatory as of January 1, 2022 that are relevant to the Company. Additionally, the Company has not adopted any standard, interpretation or amendment that has been issued but is not yet effective. Such standards are not currently expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for judgments that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognized in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for the basis for how the entity classifies assets and liabilities as current and non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for changes to accounting policies recently adopted by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_GrantIncomePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for grant income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_GrantIncomePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for fair value measurement. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for the currency of the primary economic environment in which the entity operates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for issued capital. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for consolidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfConsolidationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717912934304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract', window );"><strong>Summary of significant accounting policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory', window );">Schedule of exchange rates used for translation of financial statements</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following exchange rates have been used for the translation of the financial statements of AC Immune USA:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">CHF/USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Closing rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.933</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.923</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">N/A</p></td></tr><tr><td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted average exchange rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.965</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.929</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">N/A</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock', window );">Estimated Lease Term by Right-of-use Asset Categories</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Buildings</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Office equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock', window );">Estimated useful life</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Laboratory equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Leasehold improvements/furniture</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about the estimated lease term by right-of-use asset by category.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about the useful life of property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the effect of changes in foreign exchange rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS21_g51-57_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717918105680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of movement in the net book values of property, plant and equipment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables show the movements in the net book values of property, plant and equipment for the&#160;years ended December&#160;31, 2022 and 2021, respectively:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Laboratory</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Leasehold</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets under</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">improvements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">construction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquisition cost:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 265</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,754</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 810</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,666</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 151</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 576</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 184</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 936</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Transfers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 47</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 646</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (697)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 285</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,765</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,640</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 13,602</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (106)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,316)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,739)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (389)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,550)</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (53)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (283)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,278)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (179)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,793)</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (159)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,599)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,017)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (568)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,343)</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amount:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 159</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 438</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 421</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,116</p></td></tr><tr><td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,072</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,259</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Laboratory</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Leasehold</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets under</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">improvements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">construction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquisition cost:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 214</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,497</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,681</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 464</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 277</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,133</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,268</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,610</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Transfers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 270</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (277)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Disposals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (77)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (77)</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 265</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,754</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 810</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,666</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (61)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (970)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,405)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (281)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,717)</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (45)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (346)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,398)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (108)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,897)</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Disposals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 64</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 64</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (106)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,316)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,739)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (389)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,550)</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amount:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 153</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 527</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,276</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 183</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 277</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,416</p></td></tr><tr><td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 159</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 438</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 421</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,116</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917603792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets, long-term financial assets and lease liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Right-of-use assets, long-term financial assets and lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Schedule of the movements in the net value book value of right-of-use assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables show the movements in the net book values of right-of-use of leased assets for the&#160;years ended December&#160;31, 2022 and 2021, respectively:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Office</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,776</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 40</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,914</p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions and remeasurements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 460</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 460</p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (528)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (24)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (566)</p></td></tr><tr><td style="vertical-align:bottom;width:61.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 74</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,808</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Office</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">2,106</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">63</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">54</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,223</p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions and remeasurements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,144</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 71</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,215</p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Dispositions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (15)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (15)</p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (474)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (509)</p></td></tr><tr><td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,776</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 40</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,914</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock', window );">Schedule of impact on condensed consolidated statements of income/(loss) and cash flows</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;years ended December&#160;31, 2022, and 2021, the impact on the Company&#8217;s consolidated statements of income/(loss) and consolidated statements of cash flows is detailed in the table below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Statements of income/(loss)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation of right-of-use assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 566</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 509</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest expense on lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 68</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 63</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expense for short-term leases and leases of low value </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 723</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,384</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,295</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Statements of cash flows</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total cash outflow for leases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,388</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,299</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock', window );">Schedule of contractual undiscounted cash flows for lease obligations</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table presents the contractual undiscounted cash flows for lease liabilities as of December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Less than one year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 638</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 638</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">1-3 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,230</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,260</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">3-5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,187</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,203</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,055</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,101</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of right-of-use assets impact on the company's statements of income/(loss) and statements of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to the contractual undiscounted cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913164784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset acquisition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AssetAcquisitionsAbstract', window );"><strong>Asset acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfAssetAcquisitionsTableTextBlock', window );">Schedule of Transferred Assets acquired</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes the amounts of the Transferred Assets acquired:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:86.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4,634</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IPR&amp;D asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">50,416</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">55,050</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AssetAcquisitionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AssetAcquisitionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfAssetAcquisitionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfAssetAcquisitionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909538288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Schedule of net book value of intangible assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net book</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net book</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> value</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Acquired IPR&amp;D asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td></tr><tr><td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total intangible assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717918106944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents and short-term financial assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Cash and cash equivalents and financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock', window );">Schedule of cash and cash equivalents by currency</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s cash and cash equivalents are maintained in the following respective currencies as of December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,586</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 82,216</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,586</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 82,216</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">By currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 24,418</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 64,941</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">EUR</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,313</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,253</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,855</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,022</p></td></tr><tr><td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,586</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 82,216</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock', window );">Schedule of short-term financial assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes the Company&#8217;s short-term financial assets as of December&#160;31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets due in one year or less</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,000</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total short-term financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,000</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of cash and cash equivalents by currency</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of short-term deposits not classified as cash equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717912989712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid expenses and accrued income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract', window );"><strong>Prepaid expenses and accrued income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock', window );">Prepaid expenses and accrued income</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Prepaid expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,015</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 408</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 975</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total prepaid expenses and accrued income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,116</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">3,990</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about prepaid expenses and accrued income including contract assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909515808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OtherCurrentReceivablesAbstract', window );"><strong>Other current receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock', window );">Other current receivables</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 124</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 101</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Swiss VAT</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 249</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 327</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Withholding tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other current receivables</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 392</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 428</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about other current receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909757952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Share capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory', window );">Summary of capital structure</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The table below summarizes the Company&#8217;s capital structure:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">premium</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 76,936,738</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,000,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 346,890</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (100)</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,171,543</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,097</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 24</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Asset purchase agreement, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,106,840</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 54,328</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Conversion of note agreements, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,026,634</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 61</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 16,683</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares &#8211; incentive plans, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 237,258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,253</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares to be held as treasury shares, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,393,160</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,393,160)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">48</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (48)</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 89,700,630</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,221,617)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,794</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 431,251</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (124)</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,596</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares &#8211; incentive plans, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 133,755</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 89,834,385</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,214,021)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 431,323</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (124)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of classes of share capital. [Refer: Share capital [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917629280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade and other payables and accrued expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AccruedExpensesAbstract', window );"><strong>Trade and other payables and accrued expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock', window );">Schedule of trade and other payables and accrued expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 929</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,003</p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total trade and other payables</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 929</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,003</p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued research and development costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,360</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,361</p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,898</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,562</p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other accrued expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,159</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,813</p></td></tr><tr><td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total accrued expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,417</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 16,736</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AccruedExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AccruedExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about trade payables and accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913242592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory', window );">Schedule of contract revenues</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables provide contract revenue amounts from its LCAs for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Lilly</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,348</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Janssen </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,083</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Life Molecular Imaging</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total contract revenues</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,431</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory', window );">Schedule of contract revenue of performance obligations satisfied</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">During the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company recognized the following contract revenues as a result of changes in the contract asset and the contract liability balances in the respective periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Revenues recognized in the period from:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Amounts included in the contract liability at the beginning of the period </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,477</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Performance obligations satisfied in previous periods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue from contracts with customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Section Presentation<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g105-109_TI<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g110-129_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The explanation of the effect that the timing of satisfaction of performance obligations and the typical timing of payment have on the contract assets and the contract liabilities. [Refer: Performance obligations [member]; Contract assets; Contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913146960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Expenses by category (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ExpensesByCategoryAbstract', window );"><strong>Expenses by category [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory', window );">Research and Development</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">Research and development</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Operating expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 41,166</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 44,289</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 43,787</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 17,548</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 16,465</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 14,424</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,528</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,276</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total research and development expenses </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 60,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 62,282</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 59,487</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory', window );">General and Administrative</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">General and administrative</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Operating expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,207</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,471</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,874</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,281</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,274</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,598</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,812</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total general and administrative expenses </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,789</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 17,910</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18,557</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">Disclosure of finance income (cost) [text block]</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">Financial result, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 69</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,485</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 78</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (355)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (581)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (184)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exchange differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 393</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (555)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Finance result, net </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (661)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ExpensesByCategoryAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ExpensesByCategoryAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of finance income (cost). [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of general and administrative expenses. [Refer: Administrative expenses]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of research and development expense. [Refer: Research and development expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717911216816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-party transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Related-party transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory', window );">Key management compensation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Key management includes the board of directors and executive management. For 2022, there were eight members (2021: eight and 2020: seven) of the Board (excluding the CEO) and seven members (2021: six and 2020: five) of executive management (including the CEO). Compensation was as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term employee benefits </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,187</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,497</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Post-employment benefits </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 295</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 266</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 214</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,503</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,578</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,666</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,289</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of amounts incurred by the entity for provision of key management personnel services that are provided by separate management entities. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 18A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18A&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717912906480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Income taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock', window );">Income tax expense reconciled to loss</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Group&#8217;s income tax expense for each&#160;year can be reconciled to loss before tax as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Loss before income tax </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (70,740)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (72,993)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (61,921)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Tax benefit calculated at the domestic rates applicable in the respective countries </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,616)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,930)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,441)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">(Income not subject to tax)/expenses not deductible for tax purposes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (375)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 462</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of unused tax losses and tax offsets not recognized as deferred tax assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,174</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 10,308</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,979</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Effective income tax rate (benefit)/expense </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory', window );">Unrecognized deductible temporary differences, unused tax losses and unused tax credits</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The below table details the total unrecognized deductible temporary differences, unused tax losses and unused tax credits:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrecognized deductible temporary differences, unused tax losses and unused tax credits</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Tax losses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 264,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 197,152</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 121,948</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Deductible temporary differences related to:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;">Right-of-use assets and lease liabilities, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;">Retirement benefit plan </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,098</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,464</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 267,302</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 204,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 129,412</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock', window );">Tax losses carry forwards and respective expiry dates</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table details the tax losses carry forwards of the Company and their respective expiry dates:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Tax losses split by expiry date:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15,231</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 48,894</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 48,894</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 48,894</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 57,824</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 57,824</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 57,824</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 75,204</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 75,204</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 66,936</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total unrecorded tax loss carryforwards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 264,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 197,153</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 121,949</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about the expiration of income tax losses that may be carried forward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about income tax reconciliation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909725392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract', window );"><strong>Retirement benefit plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock', window );">Schedule of amounts recognized in balance sheet from defined benefit plans</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table sets forth the status of the defined benefit pension plan and the amount that is recognized in the consolidated balance sheets:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (32,410)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33,889)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (30,213)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Fair value of plan assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29,197</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 26,791</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 22,749</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total liability </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,213)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,098)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,464)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock', window );">Schedule of amounts recognized in statement of profit and loss from defined benefit plans</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following amounts have been recorded as net pension cost in the consolidated statements of income/(loss):</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Service cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,648</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,626</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 79</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 71</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (87)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (48)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (42)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net pension cost </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,655</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory', window );">Schedule of changes in defined benefit obligations, fair value of plan assets and net defined benefit liability</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The changes in defined benefit obligation, fair value of plan assets and unrecognized gains/(losses) are as follows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">A. Change in defined benefit obligation</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Defined benefit obligation as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33,889)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (30,213)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (26,624)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Service cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,712)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,648)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,626)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (126)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (79)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (71)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in demographic assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,428</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in financial assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,397</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 156</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (71)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in experience assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,726)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (252)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (931)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Benefits deposited </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,327)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (894)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,467)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees&#8217; contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,056)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (959)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (851)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Defined benefit obligation as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (32,410)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33,889)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (30,213)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Change in fair value of plan assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of plan assets as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 26,791</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 22,749</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 19,139</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 87</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 48</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 42</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees&#8217; contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,056</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 959</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 851</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employer&#8217;s contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,210</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 950</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Benefits deposited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,327</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 894</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,467</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Return on plan assets excluding interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,274)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,052</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 300</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of plan assets as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29,197</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 26,791</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 22,749</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period amount to approximately CHF 1.2 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Change in net defined benefit liability</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net defined benefit liabilities as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,098</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,464</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,485</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net pension cost through statement of income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,655</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Remeasurement through other comprehensive income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,426)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (956)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (726)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employer&#8217;s contribution </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,210)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,089)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (950)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net defined benefit liabilities as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,098</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,464</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock', window );">Schedule of amounts recognized in statement of other comprehensive income from defined benefit plans</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Other comprehensive gains/(losses)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in demographic assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,428</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in financial assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,397</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 156</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (71)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in experience assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,726)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (252)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (931)</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Return on plan assets excluding interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,274)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,052</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 300</p></td></tr><tr><td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other comprehensive gain</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,426</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 956</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 726</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory', window );">Actuarial assumptions and sensitivity analysis</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The actuarial assumptions used for the calculation of the pension cost and the defined benefit obligation of the defined benefit pension plan for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively, are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:48.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:48.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Discount rate </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Rate of future increase in compensations </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Rate of future increase in current pensions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest rate on retirement savings capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Mortality and disability rates </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2022 is shown below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interest&#160;rate&#160;on</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Discount&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;salary&#160;increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;pension&#160;cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">savings&#160;capital</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assumptions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="17" style="padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In&#160;CHF&#160;thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Potential defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 30,201</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 34,916</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 32,940</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,841</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 33,601</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,322</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 33,322</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,545</p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Decrease/(increase) from actual defined benefit obligation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,209</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,506)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (530)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 569</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,191)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,088</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (912)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 865</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2021 is shown below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interest&#160;rate&#160;on</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Discount&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;salary&#160;increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;pension&#160;cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">savings&#160;capital</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assumptions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="17" style="padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in&#160;CHF&#160;thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Potential defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,190</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 37,006</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 34,578</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 33,176</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,497</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 32,435</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 34,822</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 33,007</p></td></tr><tr><td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Decrease/(increase) from actual defined benefit obligation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,699</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,117)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (689)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 713</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,608)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,454</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (933)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 882</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of amounts recognised in balance sheet from defined benefit plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of amounts recognised in statement of other comprehensive income from defined benefit plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of amounts recognised in statement of profit and loss from defined benefit plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 145<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_145&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909725520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Share-based compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory', window );">Share-based compensation plans outstanding</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes equity-settled share option grants for plans that existed during the period:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">options&#160;awarded</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td></tr><tr><td style="vertical-align:bottom;width:40%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plan</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(since&#160;inception)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vesting&#160;conditions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">life&#160;of&#160;options</b></p></td></tr><tr><td style="vertical-align:bottom;width:40%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share option plan C1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,775,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from grant date</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">2016 SOIP:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:top;width:40%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executives and directors</p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,277,044</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">1 year</span><span style="font-size:10pt;">, </span><span style="font-size:10pt;">3 year</span><span style="font-size:10pt;"> and </span><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, quarterly and annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees</p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,811,687</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Number and weighted average exercise prices of options under share option programs</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The number and weighted-average exercise prices (in CHF) of options under the share option programs for Plans C1 and the 2016 SOIP are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">exercise&#160;price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">remaining</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(CHF)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">term&#160;(years)</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,981,629</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.93</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 8.3</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (53,591)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expired during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (26,729)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.38</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (73,669)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,073,027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,900,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 8.2</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,099,015</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.49</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.0</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,900,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 8.2</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (207,331)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (218,561)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,110,914</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.34</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,585,689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.8</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,613,242</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 6.8</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,585,689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.8</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (304,738)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (110,250)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,090,316</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,261,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.6</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,345,648</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.41</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 6.6</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory', window );">Outstanding options, exercise price range and expiry dates</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The outstanding stock options as of December&#160;31, 2022 have the following range of exercise prices:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">expiration</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&#160;options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">dates</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range of exercise prices</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF 0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 97,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2022&#8211;2026</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF 9.53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 223,646</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2027</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 5.04 to USD 12.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,864,408</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2028&#8211;2031</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 2.76 to USD 4.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,075,088</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2032</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total outstanding options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,261,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Weighted-average assumptions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercise price (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">2.76-4.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">5.31-7.72</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">5.04-9.16</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share price (weighted average)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6.95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7.11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">0-2.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">0 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">0 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">67-80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expected term (in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">5.5 - 6.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">5.1 - 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;">5.5 - 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory', window );">Summary of non-vested share awards (restricted share and restricted share units)</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A summary of non-vested share awards (restricted share and restricted share units) activity as of&#160;December&#160;31, 2022&#160;and changes during the&#160;year then ended is presented below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">life&#160;of&#160;non-</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">share&#160;awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">vested&#160;share</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grantee type</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">granted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vesting&#160;conditions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">awards</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restricted share units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Directors</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 159,025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">1 year</span><span style="font-size:10pt;"> service from date of grant, annually</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:top;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executives</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 274,872</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">3 year</span><span style="font-size:10pt;"> and </span><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, quarterly and semi-annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">non-vested</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">grant</b>&#160;<b style="font-weight:bold;">date&#160;fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">value&#160;(CHF)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at January 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 42,763</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.52</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,828)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.47</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expired during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,804)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.52</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (84,638)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.51</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (23,269)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.52</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 19,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.51</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 49,289</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.47</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 19,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.51</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,471)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.46</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (18,697)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.52</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.41</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 65,515</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.48</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9.41</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 239,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.06</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (23,505)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.28</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 216,486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.06</p></td></tr><tr><td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 89,020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7.84</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the general terms and conditions of share-based payment arrangements. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717913221600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAndContingenciesAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsExplanatory', window );">Schedule of commitments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Within 1 year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 19,785</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Between 1 and 3 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18,516</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,620</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Between 3 and 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,229</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 243</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">More than 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,407</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 51</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 52,488</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23,699</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CommitmentsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CommitmentsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717911335440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareExplanatory', window );">Schedule of earnings per share</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.07212067%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands except for share and per share data</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss per share (EPS)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerator</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net loss attributable to equity holders of the Company</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (70,753)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (72,996)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (61,921)</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominator</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted-average number of shares outstanding used to compute EPS basic and diluted attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 83,554,412</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 74,951,833</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 71,900,212</p></td></tr><tr><td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted loss per share for the period attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.85)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.97)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.86)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock', window );">Schedule of antidilutive securities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share options issued and outstanding (in-the-money)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 135,827</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,140,388</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 412,191</p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Restricted share awards subject to future vesting</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,292</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,264</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,418</p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Convertible shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,461</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total potentially dilutive securities </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 253,119</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,188,113</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 440,609</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of instruments (including contingently issuable shares) that could potentially dilute basic earnings per share in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717918455632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments and risk management (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract', window );"><strong>Financial instruments and risk management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock', window );">Carrying amounts of financial assets and financial liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table shows the carrying amounts of financial assets and financial liabilities:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,808</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,914</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 361</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 363</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 392</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 428</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 91,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 116,000</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 31,586</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 82,216</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 126,147</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 201,921</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,253</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,340</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 929</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,003</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 9,417</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 16,736</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 548</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 570</p></td></tr><tr><td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 13,147</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 21,649</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about carrying amounts of financial assets and financial liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908935648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>General information (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>item</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_GeneralInformationAbstract', window );"><strong>General information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfTechnologyPlatforms', window );">Number of proprietary technology platforms</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_GeneralInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_GeneralInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfTechnologyPlatforms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of unique proprietary platform technologies to discover, design and develop medicines and diagnostics to target misfolded proteins.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfTechnologyPlatforms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917652640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of preparation - Going concern (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_GoingConcernAbstract', window );"><strong>Going concern [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Company's cash position</a></td>
<td class="nump">SFr 31,586<span></span>
</td>
<td class="nump">SFr 82,216<span></span>
</td>
<td class="nump">SFr 160,893<span></span>
</td>
<td class="nump">SFr 193,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents', window );">Short-term financial assets</a></td>
<td class="nump">SFr 91,000<span></span>
</td>
<td class="nump">SFr 116,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_GoingConcernAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_GoingConcernAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908953840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies - Functional and reporting currency (Details) - SFr / $<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ForeignExchangeRatesAbstract', window );"><strong>Functional and reporting currency [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Closing rate, USD 1</a></td>
<td class="nump">0.933<span></span>
</td>
<td class="nump">0.923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageForeignExchangeRate', window );">Weighted average exchange rate, USD 1</a></td>
<td class="nump">0.965<span></span>
</td>
<td class="nump">0.929<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClosingForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClosingForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ForeignExchangeRatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ForeignExchangeRatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909914576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies, Right-of-use assets and lease liabilities (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_EstimatedLeaseTerm', window );">Estimated lease term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_EstimatedLeaseTerm', window );">Estimated lease term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">IT Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_EstimatedLeaseTerm', window );">Estimated lease term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_EstimatedLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated lease term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_EstimatedLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717911228608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies, Property, plant and equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">IT Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract', window );"><strong>Estimated useful life [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember', window );">Lab Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract', window );"><strong>Estimated useful life [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LeaseholdImprovementsAndFixturesAndFittingsMember', window );">Leasehold Improvements/Furniture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract', window );"><strong>Estimated useful life [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LeaseholdImprovementsAndFixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LeaseholdImprovementsAndFixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909927008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies, Income taxes (Details)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Income taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncomeTaxLossCarryforwardPeriod', window );">Tax loss carryforward period</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncomeTaxLossCarryforwardPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period or time limit over which financial losses of the entity for preceding years can be deducted from the taxable revenue for a period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncomeTaxLossCarryforwardPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717918493712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies, Segment reporting (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Segment reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OperatingSegmentsNumber', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ReportableSegmentsNumber', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OperatingSegmentsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments reported by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OperatingSegmentsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ReportableSegmentsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reportable segments reported by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ReportableSegmentsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717906895376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">SFr 5,116<span></span>
</td>
<td class="nump">SFr 4,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">4,259<span></span>
</td>
<td class="nump">5,116<span></span>
</td>
<td class="nump">SFr 4,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Acquisition Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">12,666<span></span>
</td>
<td class="nump">10,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">936<span></span>
</td>
<td class="nump">2,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">13,602<span></span>
</td>
<td class="nump">12,666<span></span>
</td>
<td class="nump">10,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="num">(7,550)<span></span>
</td>
<td class="num">(5,717)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(1,793)<span></span>
</td>
<td class="num">(1,897)<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="num">(9,343)<span></span>
</td>
<td class="num">(7,550)<span></span>
</td>
<td class="num">(5,717)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Furniture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Furniture | Acquisition Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Furniture | Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="num">(159)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">IT Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">438<span></span>
</td>
<td class="nump">527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="nump">527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">IT Equipment | Acquisition Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">1,754<span></span>
</td>
<td class="nump">1,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">1,909<span></span>
</td>
<td class="nump">1,754<span></span>
</td>
<td class="nump">1,497<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">IT Equipment | Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="num">(1,316)<span></span>
</td>
<td class="num">(970)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(283)<span></span>
</td>
<td class="num">(346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="num">(1,599)<span></span>
</td>
<td class="num">(1,316)<span></span>
</td>
<td class="num">(970)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember', window );">Lab Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">3,403<span></span>
</td>
<td class="nump">3,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">SFr 2,748<span></span>
</td>
<td class="nump">3,403<span></span>
</td>
<td class="nump">3,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PercentageIncreaseInPropertyPlantAndEquipment', window );">Percentage of increase in equipment</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember', window );">Lab Equipment | Acquisition Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">SFr 9,142<span></span>
</td>
<td class="nump">7,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">576<span></span>
</td>
<td class="nump">1,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">9,765<span></span>
</td>
<td class="nump">9,142<span></span>
</td>
<td class="nump">7,681<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember', window );">Lab Equipment | Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="num">(5,739)<span></span>
</td>
<td class="num">(4,405)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(1,278)<span></span>
</td>
<td class="num">(1,398)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="num">(7,017)<span></span>
</td>
<td class="num">(5,739)<span></span>
</td>
<td class="num">(4,405)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">1,072<span></span>
</td>
<td class="nump">421<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold Improvements | Acquisition Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">810<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">1,640<span></span>
</td>
<td class="nump">810<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold Improvements | Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="num">(389)<span></span>
</td>
<td class="num">(281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(179)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="num">(568)<span></span>
</td>
<td class="num">(389)<span></span>
</td>
<td class="num">(281)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Assets under construction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Assets under construction | Acquisition Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="num">(697)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_AssetsUnderConstructionMember', window );">Assets Under Construction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">695<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">695<span></span>
</td>
<td class="nump">277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_AssetsUnderConstructionMember', window );">Assets Under Construction | Acquisition Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">SFr 695<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(277)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">695<span></span>
</td>
<td class="nump">SFr 277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_AssetsUnderConstructionMember', window );">Assets Under Construction | Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PercentageIncreaseInPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of increase in property, plant and equipment during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PercentageIncreaseInPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers from construction in progress. [Refer: Property, plant and equipment; Construction in progress]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_AssetsUnderConstructionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_AssetsUnderConstructionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909573936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets, long-term financial assets and lease liabilities (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions and remeasurements</a></td>
<td class="nump">SFr 460<span></span>
</td>
<td class="nump">SFr 1,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_RightOfUseLeasedAssetsAbstract', window );"><strong>Right-of-use of leased assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, beginning of period</a></td>
<td class="nump">2,914<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation</a></td>
<td class="num">(566)<span></span>
</td>
<td class="num">(509)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DispositionsOfRightOfUseAssets', window );">Dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, end of period</a></td>
<td class="nump">2,808<span></span>
</td>
<td class="nump">2,914<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions and remeasurements</a></td>
<td class="nump">SFr 460<span></span>
</td>
<td class="nump">SFr 1,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16', window );">Weighted average incremental borrowing rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_RightOfUseLeasedAssetsAbstract', window );"><strong>Right-of-use of leased assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, beginning of period</a></td>
<td class="nump">SFr 2,776<span></span>
</td>
<td class="nump">SFr 2,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation</a></td>
<td class="num">(528)<span></span>
</td>
<td class="num">(474)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, end of period</a></td>
<td class="nump">2,708<span></span>
</td>
<td class="nump">2,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OfficeEquipmentMember', window );">Office Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions and remeasurements</a></td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16', window );">Weighted average incremental borrowing rate</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_RightOfUseLeasedAssetsAbstract', window );"><strong>Right-of-use of leased assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, beginning of period</a></td>
<td class="nump">SFr 98<span></span>
</td>
<td class="nump">SFr 63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DispositionsOfRightOfUseAssets', window );">Dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, end of period</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_ComputerEquipmentMember', window );">IT Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions and remeasurements</a></td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16', window );">Weighted average incremental borrowing rate</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_RightOfUseLeasedAssetsAbstract', window );"><strong>Right-of-use of leased assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, beginning of period</a></td>
<td class="nump">SFr 40<span></span>
</td>
<td class="nump">SFr 54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, end of period</a></td>
<td class="nump">SFr 26<span></span>
</td>
<td class="nump">SFr 40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DispositionsOfRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of decrease in right-of-use assets from disposals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DispositionsOfRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_RightOfUseLeasedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_RightOfUseLeasedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph C12<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_C12_a&amp;doctype=Appendix&amp;subtype=C<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717911229312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract', window );"><strong>Statements of income/(loss) and cash flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation of right-of-use assets</a></td>
<td class="nump">SFr 566<span></span>
</td>
<td class="nump">SFr 509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest expense on lease liabilities</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed', window );">Expense for short-term leases and leases of low value</a></td>
<td class="nump">750<span></span>
</td>
<td class="nump">723<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ExpenseRelatingToLeases', window );">Total</a></td>
<td class="nump">1,384<span></span>
</td>
<td class="nump">1,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Total cash outflow for leases</a></td>
<td class="nump">SFr 1,388<span></span>
</td>
<td class="nump">SFr 1,299<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ExpenseRelatingToLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense for leases recognized through profit and loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ExpenseRelatingToLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOutflowForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOutflowForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917737344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)<br> SFr in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract', window );"><strong>Contractual undiscounted cash flows for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Contractual undiscounted cash flows for lease liabilities</a></td>
<td class="nump">SFr 3,055<span></span>
</td>
<td class="nump">SFr 3,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfDepositsInEscrowAccounts', window );">Number of deposits in escrow accounts | item</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_EscrowDepositAmount', window );">Escrow deposits</a></td>
<td class="nump">SFr 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract', window );"><strong>Contractual undiscounted cash flows for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Contractual undiscounted cash flows for lease liabilities</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">1-3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract', window );"><strong>Contractual undiscounted cash flows for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Contractual undiscounted cash flows for lease liabilities</a></td>
<td class="nump">1,230<span></span>
</td>
<td class="nump">1,260<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">3-5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract', window );"><strong>Contractual undiscounted cash flows for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Contractual undiscounted cash flows for lease liabilities</a></td>
<td class="nump">SFr 1,187<span></span>
</td>
<td class="nump">SFr 1,203<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_EscrowDepositAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deposits held in escrow.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_EscrowDepositAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfDepositsInEscrowAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of deposits in escrow accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfDepositsInEscrowAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 58<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_58&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph B11D<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B11D_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909872512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset acquisition (Details) - Program portfolio of therapeutics targeting asyn from Affiris<br> SFr in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SharesTransferredAsConsiderationInAssetAcquisition', window );">Shares transferred as consideration in asset acquisition | shares</a></td>
<td class="nump">7,106,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition', window );">Total consideration transferred, acquisition-date fair value, asset acquisition</a></td>
<td class="nump">$ 58.7<span></span>
</td>
<td class="nump">SFr 55,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CashAcquiredAsPartOfAssetAcquisition', window );">Cash</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">4,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition', window );">IPR&amp;D asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,416<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TotalAssetsAcquiredInAssetAcquisition', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AssetAcquisitionsAxis=aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember', window );">IPR&amp;D intangible asset associated with ACI 7104.056</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition', window );">IPR&amp;D asset</a></td>
<td class="nump">$ 53.7<span></span>
</td>
<td class="nump">SFr 50,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AssetAcquisitionsAxis=aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember', window );">IPR&amp;D intangible asset associated with ACI 7104.056 | Discount rate, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputAssets', window );">Discount rate</a></td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CashAcquiredAsPartOfAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash acquired as part of asset acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CashAcquiredAsPartOfAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible assets acquired as part of asset acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SharesTransferredAsConsiderationInAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares transferred as consideration in asset acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SharesTransferredAsConsiderationInAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_TotalAssetsAcquiredInAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total assets acquired in asset acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_TotalAssetsAcquiredInAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total consideration transferred, acquisition-date fair value, asset acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AssetAcquisitionsAxis=aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AssetAcquisitionsAxis=aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917796064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible assets (Details)<br> SFr in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">SFr 50,416<span></span>
</td>
<td class="nump">SFr 50,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">50,416<span></span>
</td>
<td class="nump">50,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_InProcessResearchAndDevelopmentIPRDAssetMember', window );">Acquired IPR&amp;D Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">SFr 50,416<span></span>
</td>
<td class="nump">SFr 50,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_InProcessResearchAndDevelopmentIPRDAssetMember', window );">Acquired IPR&amp;D Asset | Discount rate, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputAssets', window );">Discount rate</a></td>
<td class="nump">0.17<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_InProcessResearchAndDevelopmentIPRDAssetMember', window );">Acquired IPR&amp;D Asset | Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">SFr 50,416<span></span>
</td>
<td class="nump">SFr 50,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_InProcessResearchAndDevelopmentIPRDAssetMember', window );">Acquired IPR&amp;D Asset | Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_InProcessResearchAndDevelopmentIPRDAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_InProcessResearchAndDevelopmentIPRDAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909801536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)<br> SFr in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>SFr / &#8364; </div>
<div>SFr / $</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr) </div>
<div>SFr / $ </div>
<div>SFr / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAbstract', window );"><strong>Cash and cash equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">SFr 31,586<span></span>
</td>
<td class="nump">SFr 82,216<span></span>
</td>
<td class="nump">SFr 160,893<span></span>
</td>
<td class="nump">SFr 193,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Translation rate into CHF | SFr / $</a></td>
<td class="nump">0.933<span></span>
</td>
<td class="nump">0.923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CHF', window );">CHF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAbstract', window );"><strong>Cash and cash equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">SFr 24,418<span></span>
</td>
<td class="nump">SFr 64,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">EUR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAbstract', window );"><strong>Cash and cash equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">SFr 1,313<span></span>
</td>
<td class="nump">SFr 2,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Translation rate into CHF | SFr / &#8364;</a></td>
<td class="nump">0.994<span></span>
</td>
<td class="nump">1.045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">USD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAbstract', window );"><strong>Cash and cash equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">SFr 5,855<span></span>
</td>
<td class="nump">SFr 15,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Translation rate into CHF | SFr / $</a></td>
<td class="nump">0.933<span></span>
</td>
<td class="nump">0.923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClosingForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClosingForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CHF">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CHF</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717910021872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Cash and cash equivalents and financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents', window );">Short-term financial assets due in one year or less</a></td>
<td class="nump">SFr 91,000<span></span>
</td>
<td class="nump">SFr 116,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909998624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid expenses and accrued income (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract', window );"><strong>Prepaid expenses and accrued income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="nump">SFr 4,708<span></span>
</td>
<td class="nump">SFr 3,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets', window );">Accrued income</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">975<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets', window );">Total prepaid expenses and accrued income</a></td>
<td class="nump">5,116<span></span>
</td>
<td class="nump">3,990<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember', window );">Grants, Michael J. Fox Foundation and Target ALS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract', window );"><strong>Prepaid expenses and accrued income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets', window );">Accrued income</a></td>
<td class="nump">SFr 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PercentageOfAccruedIncome', window );">Percentage of accrued income</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember', window );">Grants, Michael J. Fox Foundation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract', window );"><strong>Prepaid expenses and accrued income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets', window );">Accrued income</a></td>
<td class="nump">SFr 300<span></span>
</td>
<td class="nump">SFr 900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PercentageOfAccruedIncome', window );">Percentage of accrued income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PercentageOfAccruedIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage that represents the percentage of total accrued income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PercentageOfAccruedIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued income including current contract assets. [Refer: Accrued income including contract assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current prepayments and current accrued income including current contract assets. [Refer: Prepayments; Accrued income including contract assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917661920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current receivables (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Other current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MiscellaneousOtherCurrentReceivables', window );">Other current receivable</a></td>
<td class="nump">SFr 124<span></span>
</td>
<td class="nump">SFr 101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentValueAddedTaxReceivables', window );">Swiss VAT</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WithholdingTaxReceivables', window );">Withholding tax</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Total other current receivables</a></td>
<td class="nump">SFr 392<span></span>
</td>
<td class="nump">SFr 428<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Other current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MaturityPeriodOtherCurrentReceivables', window );">Maturity period, other current receivables</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_MaturityPeriodOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maturity period, other current receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_MaturityPeriodOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_MiscellaneousOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Miscellaneous other current receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_MiscellaneousOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WithholdingTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Withholding tax receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WithholdingTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentValueAddedTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current value added tax receivables. [Refer: Value added tax receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentValueAddedTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917698544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share capital - Narratives (Details) - CHF (SFr)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Issued share capital</a></td>
<td class="nump">SFr 1,797,000<span></span>
</td>
<td class="nump">SFr 1,794,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates', window );">Number of treasury shares outstanding</a></td>
<td class="nump">6,214,021<span></span>
</td>
<td class="nump">6,221,617<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Common Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Issued share capital</a></td>
<td class="nump">SFr 1,796,675<span></span>
</td>
<td class="nump">SFr 1,794,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares</a></td>
<td class="nump">83,620,364<span></span>
</td>
<td class="nump">83,479,013<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Associates [member]; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908371312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Capital Structure (Details) - CHF (SFr)<br> SFr / shares in Units, SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract', window );"><strong>Treasury shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates', window );">Treasury shares outstanding at beginning of period</a></td>
<td class="num">(6,221,617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates', window );">Treasury shares outstanding at end of period</a></td>
<td class="num">(6,214,021)<span></span>
</td>
<td class="num">(6,221,617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInEquityAbstract', window );"><strong>Changes in equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, beginning of period</a></td>
<td class="nump">SFr 231,979<span></span>
</td>
<td class="nump">SFr 215,478<span></span>
</td>
<td class="nump">SFr 272,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">12,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments', window );">Conversion of note agreements, net of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions', window );">Issuance of shares to be held as treasury shares, net of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period</a></td>
<td class="nump">SFr 168,991<span></span>
</td>
<td class="nump">SFr 231,979<span></span>
</td>
<td class="nump">SFr 215,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share)</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract', window );"><strong>Common shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Common shares outstanding at beginning of period</a></td>
<td class="nump">89,700,630<span></span>
</td>
<td class="nump">76,936,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions', window );">Asset purchase agreement, net of transaction costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,106,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt', window );">Conversion of note agreement, net of transaction costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,026,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans', window );">Issuance of shares - incentive plans, net of transaction costs (in shares)</a></td>
<td class="nump">133,755<span></span>
</td>
<td class="nump">237,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares', window );">Issuance of shares to be held as treasury shares, net of transaction costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,393,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Common shares outstanding at end of period</a></td>
<td class="nump">89,834,385<span></span>
</td>
<td class="nump">89,700,630<span></span>
</td>
<td class="nump">76,936,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract', window );"><strong>Treasury shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares', window );">Issuance of shares to be held as treasury shares, net of transaction costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,393,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_TreasurySharesMember', window );">Treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract', window );"><strong>Common shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares', window );">Issuance of shares to be held as treasury shares, net of transaction costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,393,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract', window );"><strong>Treasury shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates', window );">Treasury shares outstanding at beginning of period</a></td>
<td class="num">(6,221,617)<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares', window );">Issuance of shares to be held as treasury shares, net of transaction costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,393,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs (in shares)</a></td>
<td class="nump">7,596<span></span>
</td>
<td class="nump">1,171,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates', window );">Treasury shares outstanding at end of period</a></td>
<td class="num">(6,214,021)<span></span>
</td>
<td class="num">(6,221,617)<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember', window );">Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInEquityAbstract', window );"><strong>Changes in equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, beginning of period</a></td>
<td class="nump">SFr 1,794<span></span>
</td>
<td class="nump">SFr 1,538<span></span>
</td>
<td class="nump">SFr 1,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions', window );">Asset purchase agreement, net of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments', window );">Conversion of note agreements, net of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseThroughSharesIssuedUnderIncentivePlans', window );">Issuance of shares - incentive plans, net of transaction costs</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions', window );">Issuance of shares to be held as treasury shares, net of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period</a></td>
<td class="nump">1,797<span></span>
</td>
<td class="nump">1,794<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember', window );">Share premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInEquityAbstract', window );"><strong>Changes in equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, beginning of period</a></td>
<td class="nump">431,251<span></span>
</td>
<td class="nump">346,890<span></span>
</td>
<td class="nump">346,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">12,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions', window );">Asset purchase agreement, net of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments', window );">Conversion of note agreements, net of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseThroughSharesIssuedUnderIncentivePlans', window );">Issuance of shares - incentive plans, net of transaction costs</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">1,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions', window );">Issuance of shares to be held as treasury shares, net of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period</a></td>
<td class="nump">431,323<span></span>
</td>
<td class="nump">431,251<span></span>
</td>
<td class="nump">346,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_TreasurySharesMember', window );">Treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInEquityAbstract', window );"><strong>Changes in equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, beginning of period</a></td>
<td class="num">(124)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions', window );">Issuance of shares to be held as treasury shares, net of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period</a></td>
<td class="num">SFr (124)<span></span>
</td>
<td class="num">SFr (124)<span></span>
</td>
<td class="num">SFr (100)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in number of treasury shares from sales or issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from treasury share transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in the number of ordinary shares issued under a convertible debt arrangement upon conversion of the debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in the number of ordinary shares issued under incentive plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in number of shares through issuance as consideration in asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in equity through issuance of shares in asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseThroughSharesIssuedUnderIncentivePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity resulting from the issue of shares under incentive plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseThroughSharesIssuedUnderIncentivePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of number of treasury shares outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity from sale or issue of treasury shares net of underwriting fees and transaction costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the conversion of convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Associates [member]; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_TreasurySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_TreasurySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_TreasurySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_TreasurySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717912829584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Authorized capital (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>SFr / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Share capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue', window );">Additional share capital that Board of Directors are authorized to issue | SFr</a></td>
<td class="nump">SFr 400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue', window );">Number of additional shares that Board of Directors are authorized to issue | shares</a></td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share) | SFr / shares</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional share capital that Board of Directors are authorized to issue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares that Board of Directors are authorized to issue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908748016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Conditional share capital for bonds and similar debt instruments (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>SFr / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConditionalShareCapitalAbstract', window );"><strong>Conditional Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share)</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember', window );">Bonds and Similar Debt Instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConditionalShareCapitalAbstract', window );"><strong>Conditional Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share)</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember', window );">Bonds and Similar Debt Instruments [Member] | Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConditionalShareCapitalAbstract', window );"><strong>Conditional Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments', window );">Potential increase is equity through conversion of debt instruments | SFr</a></td>
<td class="nump">SFr 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments', window );">Potential number of shares issued from conversion of debt instruments | shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ConditionalShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ConditionalShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential increase is equity through conversion of debt instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential number of shares issued from conversion of debt instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908750976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Conditional share capital for employee benefit plans (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>SFr / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConditionalShareCapitalAbstract', window );"><strong>Conditional Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share)</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember', window );">Employee Benefit Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConditionalShareCapitalAbstract', window );"><strong>Conditional Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share)</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember', window );">Employee Benefit Plans [Member] | Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConditionalShareCapitalAbstract', window );"><strong>Conditional Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions', window );">Maximum aggregate amount of ordinary shares | SFr</a></td>
<td class="nump">SFr 96,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions', window );">Issuance of ordinary shares (in shares) | shares</a></td>
<td class="nump">4,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ConditionalShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ConditionalShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The potential increase in equity from share-based payment transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total number of potential shares issued through share-based payment transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717911346288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share capital - Shelf registration statement (Details)<br></strong></div></th>
<th class="th">
<div>Apr. 28, 2021 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement', window );">Capital authorized to be issued under Shelf Registration Statement</a></td>
<td class="nump">SFr 350,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital authorized to be issued under shelf registration statement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909610432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - At the market equity offering (Details)<br> SFr / shares in Units, SFr in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>SFr / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>CHF (SFr) </div>
<div>SFr / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>SFr / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AtTheMarketEquityOfferingAbstract', window );"><strong>At the Market Equity Offering [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share) | SFr / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Issuance costs | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 776<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_AtTheMarketEquityOfferingMember', window );">At the Market Equity Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AtTheMarketEquityOfferingAbstract', window );"><strong>At the Market Equity Offering [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares', window );">Issuance of shares to be held as treasury shares | shares</a></td>
<td class="nump">2,393,160<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share) | SFr / shares</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
<td class="nump">SFr 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket', window );">Shares authorized for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 74,600<span></span>
</td>
<td class="nump">$ 80.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Issuance costs | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_SecondOpenMarketSalesAgreementMember', window );">New Sales Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AtTheMarketEquityOfferingAbstract', window );"><strong>At the Market Equity Offering [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfTreasurySharesShares', window );">Number of treasury share issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,179,139<span></span>
</td>
<td class="nump">1,179,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares', window );">Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 12,100<span></span>
</td>
<td class="nump">$ 13.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommissionsPaidForIssuanceOrdinaryShares', window );">Commissions paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 400<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AtTheMarketEquityOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AtTheMarketEquityOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CommissionsPaidForIssuanceOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commissions paid for issuance ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CommissionsPaidForIssuanceOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of common shares authorized for sale in the open market.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from treasury share transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SaleOrIssueOfTreasurySharesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of treasury shares issued or sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SaleOrIssueOfTreasurySharesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale or issuing of treasury shares. [Refer: Sale or issue of treasury shares; Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_AtTheMarketEquityOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aciu_AtTheMarketEquityOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_SecondOpenMarketSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aciu_SecondOpenMarketSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908309824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Convertible note agreement (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>agreement</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConvertibleNoteAgreementAbstract', window );"><strong>Convertible Note Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromIssueOfConvertibleDebt', window );">Net proceeds | SFr</a></td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 23,463,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConvertibleNoteAgreementMember', window );">Convertible note agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConvertibleNoteAgreementAbstract', window );"><strong>Convertible Note Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfConvertibleNoteAgreements', window );">Number of separate convertible note agreements | agreement</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AggregatePrincipalAmountOfEachConvertibleNote', window );">Aggregate principal amount of each convertible note</a></td>
<td class="nump">SFr 11,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote', window );">Proceeds from conversion of convertible debt, per individual note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 11,700,000<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt', window );">Number of shares issued through conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,026,634<span></span>
</td>
<td class="nump">3,026,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements', window );">Outstanding equity or cash consideration due under convertible note agreements | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConvertibleNoteAgreementMember', window );">Convertible note agreements | Athos Service GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConvertibleNoteAgreementAbstract', window );"><strong>Convertible Note Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt', window );">Number of shares issued through conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,513,317<span></span>
</td>
<td class="nump">1,513,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConvertibleNoteAgreementMember', window );">Convertible note agreements | First Capital Partner GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConvertibleNoteAgreementAbstract', window );"><strong>Convertible Note Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt', window );">Number of shares issued through conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,513,317<span></span>
</td>
<td class="nump">1,513,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConvertibleNoteAgreementMember', window );">Convertible note agreements | Top of Range [Member] | If notes are converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConvertibleNoteAgreementAbstract', window );"><strong>Convertible Note Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromIssueOfConvertibleDebt', window );">Net proceeds</a></td>
<td class="nump">SFr 23,500,000<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AggregatePrincipalAmountOfEachConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate principal amount of each convertible note</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AggregatePrincipalAmountOfEachConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ConvertibleNoteAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ConvertibleNoteAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in the number of ordinary shares issued under a convertible debt arrangement upon conversion of the debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfConvertibleNoteAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of convertible note agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfConvertibleNoteAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Outstanding equity or cash consideration due under convertible note agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from conversion of convertible debt, per individual note</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ProceedsFromIssueOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ProceedsFromIssueOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConvertibleNoteAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aciu_ConvertibleNoteAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=aciu_AthosServiceGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=aciu_AthosServiceGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=aciu_FirstCapitalPartnerGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=aciu_FirstCapitalPartnerGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=aciu_IfNotesAreConvertedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=aciu_IfNotesAreConvertedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909873152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade and other payables and accrued expenses (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems', window );"><strong>Trade and other payables and accrued liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="nump">SFr 929<span></span>
</td>
<td class="nump">SFr 2,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CurrentAccruedResearchAndDevelopmentCosts', window );">Accrued research and development costs</a></td>
<td class="nump">5,360<span></span>
</td>
<td class="nump">10,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsAccruals', window );">Accrued payroll expenses</a></td>
<td class="nump">2,898<span></span>
</td>
<td class="nump">3,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OtherAccruedExpenses', window );">Other accrued expenses</a></td>
<td class="nump">1,159<span></span>
</td>
<td class="nump">2,813<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities', window );">Total</a></td>
<td class="nump">9,417<span></span>
</td>
<td class="nump">16,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AccrualsForPerformanceRelatedRemuneration', window );">Accruals for performance related remuneration</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsAccruals', window );">Accrual of performance-related remuneration</a></td>
<td class="nump">SFr 2,898<span></span>
</td>
<td class="nump">3,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AccruedStampDuty', window );">Accrued stamp duty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember', window );">Janssen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems', window );"><strong>Trade and other payables and accrued liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CurrentAccruedResearchAndDevelopmentCosts', window );">Accrued research and development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 3,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AccrualsForPerformanceRelatedRemuneration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accruals for performance related remuneration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AccrualsForPerformanceRelatedRemuneration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AccruedStampDuty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued stamp duty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AccruedStampDuty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CurrentAccruedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CurrentAccruedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OtherAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other accrued expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OtherAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917684048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues, Contract Revenue Attributable to Licensing Arrangements (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractRevenueAbstract', window );"><strong>Contract Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total contract revenues</a></td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 15,431<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillyMember', window );">Lilly [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractRevenueAbstract', window );"><strong>Contract Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total contract revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">14,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of contract revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember', window );">Janssen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractRevenueAbstract', window );"><strong>Contract Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total contract revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">1,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember', window );">Life Molecular Imaging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractRevenueAbstract', window );"><strong>Contract Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total contract revenues</a></td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of contract revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ContractRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ContractRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfEntitysRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of the entity's revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfEntitysRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908553232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues and other operating income - Licensing and collaboration agreement (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod', window );">Amounts included in the contract liability at the beginning of the period</a></td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 4,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods', window );">Performance obligations satisfied in previous periods</a></td>
<td class="nump">3,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Contract revenue</a></td>
<td class="nump">3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">15,431<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember', window );">License and collaboration agreement of 2014, Life Molecular Imaging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Contract revenue</a></td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from performance obligations satisfied (or partially satisfied) in previous periods. [Refer: Performance obligations [member]; Revenue from contracts with customers]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 116<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_116_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue that was included in the contract liability balance at the beginning of the period. [Refer: Contract liabilities; Revenue from contracts with customers]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 116<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_116_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717907309216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues, Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">42 Months Ended</th>
<th class="th" colspan="1">47 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>CHF (SFr) </div>
<div>installment</div>
</th>
<th class="th">
<div>Jan. 23, 2019 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>CHF (SFr) </div>
<div>installment</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 15,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="nump">717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 587<span></span>
</td>
<td class="nump">SFr 587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillyMember', window );">2018 License Agreement with Eli Lilly and Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly and Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementMilestonePaymentReceived', window );">Milestone payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod', window );">Period to provide notice of termination of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty', window );">Number of representatives in joint steering committee by each party | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 14,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly and Company [Member] | Clinical and Regulatory [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Expected transaction price allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">880,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">880,000<span></span>
</td>
<td class="nump">880,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly and Company [Member] | Commercial [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Expected transaction price allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly and Company [Member] | Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractAssets', window );">Deferred research and development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 6,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 6,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly and Company [Member] | Right-of-use License [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 73,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly, First Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementPotentialValue', window );">Total potential collaboration agreement value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments', window );">Number of installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly, First Amendment [Member] | Quarter 3, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Milestone payment receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly, First Amendment [Member] | March 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Milestone payment receivable</a></td>
<td class="nump">SFr 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly, Second Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments', window );">Number of installments | installment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly, Second Amendment [Member] | March 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Milestone payment receivable</a></td>
<td class="nump">SFr 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly, Second Amendment [Member] | Upon first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Milestone payment receivable</a></td>
<td class="nump">SFr 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of installments for satisfying a milestone payment associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementMilestonePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment(s) received for milestone payments associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementMilestonePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementPotentialValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total potential value of the collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementPotentialValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of representatives in a joint steering committee by each party as per the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s right to consideration in exchange for goods or services that the entity has transferred to a customer, when that right is conditioned on something other than the passage of time (for example, the entity&#8217;s future performance).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReceivablesFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s right to consideration in exchange for goods or services that the entity has transferred to a customer that is unconditional. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReceivablesFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PerformanceObligationsAxis=aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PerformanceObligationsAxis=aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PerformanceObligationsAxis=aciu_MilestonePaymentsCommercialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PerformanceObligationsAxis=aciu_MilestonePaymentsCommercialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PerformanceObligationsAxis=aciu_ResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PerformanceObligationsAxis=aciu_ResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PerformanceObligationsAxis=aciu_RightOfUseLicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PerformanceObligationsAxis=aciu_RightOfUseLicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillyFirstAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillyFirstAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_Quarter32019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_Quarter32019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_March312020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_March312020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillySecondAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillySecondAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717907131232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues, Anti-Abeta Antibody in AD - 2006 Agreement with Genentech (Details)<br> SFr in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
<th class="th" colspan="2">194 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>payment</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers | SFr</a></td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 15,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_AntiAbetaAntibodyInADMember', window );">Anti-Abeta Antibody in AD [Member] | 2006 Agreement with Genentech [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod', window );">Period to provide notice of termination of agreement</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementCumulativePaymentsReceived', window );">Cumulative payments received</a></td>
<td class="nump">SFr 70,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 70,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementMilestonePaymentReceived', window );">Milestone payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 38,200<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Up-front consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 31,600<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfMilestonePaymentsReceived', window );">Number of milestone payments received | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementUpfrontPaymentsReceived', window );">Collaborative agreement, upfront payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 31,600<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract', window );">Collaborative agreement, Notice of contract termination period in case of material breach of contract</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_AntiAbetaAntibodyInADMember', window );">Anti-Abeta Antibody in AD [Member] | 2006 Agreement with Genentech [Member] | Clinical milestones achieved prior to 1 January 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementMilestonePaymentReceived', window );">Milestone payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,200<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_AntiAbetaAntibodyInADMember', window );">Anti-Abeta Antibody in AD [Member] | 2006 Agreement with Genentech [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementPotentialValue', window );">Total potential collaboration agreement value</a></td>
<td class="nump">SFr 317,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">317,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Total potential collaboration agreement value remaining</a></td>
<td class="nump">SFr 256,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 256,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementCumulativePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative payments received related to revenue from upfront license fees, milestone payments and revenue from research agreements associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementCumulativePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementMilestonePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment(s) received for milestone payments associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementMilestonePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative agreement, Notice of contract termination period in case of material breach of contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementPotentialValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total potential value of the collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementPotentialValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementUpfrontPaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative agreement, upfront payments received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementUpfrontPaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfMilestonePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of times payment(s) received for milestone payments associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfMilestonePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aciu_AntiAbetaAntibodyInADMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aciu_AntiAbetaAntibodyInADMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2006GenentechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2006GenentechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PerformanceObligationsAxis=aciu_ClinicalMilestonesAchievedPriorTo1January2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PerformanceObligationsAxis=aciu_ClinicalMilestonesAchievedPriorTo1January2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908470528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues, Anti-Tau Antibody in AD - 2012 Agreement with Genentech (Details)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
<th class="th" colspan="1">127 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2016 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>payment</div>
</th>
<th class="th">
<div>Jun. 30, 2012 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 15,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_AntiTauAntibodyInADMember', window );">Anti-tau Antibody in AD [Member] | 2012 Agreement with Genentech [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod', window );">Period to provide notice of termination of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementCumulativePaymentsReceived', window );">Cumulative payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 59,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 59,000<span></span>
</td>
<td class="nump">SFr 59,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementMilestonePaymentReceived', window );">Milestone payment received</a></td>
<td class="nump">SFr 14,000<span></span>
</td>
<td class="nump">SFr 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractLiabilities', window );">Up-front consideration received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 17,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfMilestonePaymentsReceived', window );">Number of milestone payments received | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 14,000<span></span>
</td>
<td class="nump">SFr 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract', window );">Collaborative agreement, Notice of contract termination period in case of material breach of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_AntiTauAntibodyInADMember', window );">Anti-tau Antibody in AD [Member] | 2012 Agreement with Genentech [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementPotentialValue', window );">Total potential collaboration agreement value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_AntiTauAntibodyInADMember', window );">Anti-tau Antibody in AD [Member] | 2012 Agreement with Genentech [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Total potential collaboration agreement value remaining</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 368,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 368,500<span></span>
</td>
<td class="nump">SFr 368,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementCumulativePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative payments received related to revenue from upfront license fees, milestone payments and revenue from research agreements associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementCumulativePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementMilestonePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment(s) received for milestone payments associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementMilestonePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative agreement, Notice of contract termination period in case of material breach of contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementPotentialValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total potential value of the collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementPotentialValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfMilestonePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of times payment(s) received for milestone payments associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfMilestonePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aciu_AntiTauAntibodyInADMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aciu_AntiTauAntibodyInADMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2012GenentechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2012GenentechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717907104704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues, Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>May 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>May 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 15,431<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember', window );">2014 Agreement with Janssen Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauVaccineInADMember', window );">Tau Vaccine in AD [Member] | 2014 Agreement with Janssen Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod', window );">Period to provide notice of termination of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementMilestonePaymentReceived', window );">Milestone payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 25,900<span></span>
</td>
<td class="nump">SFr 4,900<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementUpfrontPaymentsReceived', window );">Collaborative agreement, upfront payments received</a></td>
<td class="nump">SFr 25,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauVaccineInADMember', window );">Tau Vaccine in AD [Member] | 2014 Agreement with Janssen Pharmaceuticals [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Total potential collaboration agreement value remaining</a></td>
<td class="nump">458,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">458,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauVaccineInADMember', window );">Tau Vaccine in AD [Member] | 2014 Agreement with Janssen Pharmaceuticals [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementPotentialValue', window );">Total potential collaboration agreement value</a></td>
<td class="nump">SFr 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementMilestonePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment(s) received for milestone payments associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementMilestonePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementPotentialValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total potential value of the collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementPotentialValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementUpfrontPaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative agreement, upfront payments received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementUpfrontPaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aciu_TauVaccineInADMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aciu_TauVaccineInADMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717907582256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues, Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)<br> &#8364; in Thousands, SFr in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>May 31, 2014 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>May 31, 2014 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 15,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember', window );">2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauPETImagingAgentMember', window );">Tau-PET Imaging Agent [Member] | 2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod', window );">Period to provide notice of termination of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">SFr 664<span></span>
</td>
<td class="nump">&#8364; 500<span></span>
</td>
<td class="nump">SFr 3,900<span></span>
</td>
<td class="nump">&#8364; 4,000<span></span>
</td>
<td class="nump">SFr 2,200<span></span>
</td>
<td class="nump">&#8364; 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 3,900<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementMilestonePaymentReceived', window );">Collaborative agreement, Milestone payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 1,100<span></span>
</td>
<td class="nump">&#8364; 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauPETImagingAgentMember', window );">Tau-PET Imaging Agent [Member] | 2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member] | Clinical milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Total potential collaboration agreement value remaining</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauPETImagingAgentMember', window );">Tau-PET Imaging Agent [Member] | 2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member] | Regulatory and sales-based milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Total potential collaboration agreement value remaining</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 138,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 148,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauPETImagingAgentMember', window );">Tau-PET Imaging Agent [Member] | 2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member] | Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementPotentialValue', window );">Total potential collaboration agreement value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 159,000<span></span>
</td>
<td class="nump">&#8364; 160,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementMilestonePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment(s) received for milestone payments associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementMilestonePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementPotentialValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total potential value of the collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementPotentialValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aciu_TauPETImagingAgentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aciu_TauPETImagingAgentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PerformanceObligationsAxis=aciu_ClinicalMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PerformanceObligationsAxis=aciu_ClinicalMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PerformanceObligationsAxis=aciu_RegulatoryAndSalesBasedMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PerformanceObligationsAxis=aciu_RegulatoryAndSalesBasedMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717906980752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues - Grants from the Michael J. Fox Foundation (Details)<br> SFr in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 15,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Income from grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,343<span></span>
</td>
<td class="nump">1,182<span></span>
</td>
<td class="nump">1,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets', window );">Accrued income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408<span></span>
</td>
<td class="nump">975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="nump">717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember', window );">Grant from Michael J. Fox Foundation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">SFr 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets', window );">Accrued income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember', window );">Grant from Michael J. Fox Foundation | Alpha-synuclein PET imaging diagnostic agent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FollowOnGrantFundingReceivedTotalForJointArrangement', window );">Follow-on grant funding received, total for joint arrangement</a></td>
<td class="nump">SFr 500<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FollowOnGrantFundingReceived', window );">Follow-on grant funding received</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementPotentialValue', window );">Total potential collaboration agreement value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 3,000<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Eligible grant amount receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember', window );">Grant from Michael J. Fox Foundation | Alpha-synuclein PET imaging diagnostic agent | Skane University Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Eligible grant amount receivable</a></td>
<td class="nump">SFr 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 700<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember', window );">Grant from Michael J. Fox Foundation | Alpha-synuclein PET imaging diagnostic agent | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementJointResearchCollaborationPeriod', window );">Period of joint research agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember', window );">Grant from Michael J. Fox Foundation | Advance small molecule PD programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfGrants', window );">Number of grants received | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementPotentialValue', window );">Total potential collaboration agreement value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember', window );">Grant from Michael J. Fox Foundation | Skane University Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Eligible grant amount receivable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementJointResearchCollaborationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period over which collaborating entities are contracted to perform research, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementJointResearchCollaborationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementPotentialValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total potential value of the collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementPotentialValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_FollowOnGrantFundingReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Follow-on grant funding received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_FollowOnGrantFundingReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_FollowOnGrantFundingReceivedTotalForJointArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Follow-on grant funding received, total for joint arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_FollowOnGrantFundingReceivedTotalForJointArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued income including current contract assets. [Refer: Accrued income including contract assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReceivablesFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s right to consideration in exchange for goods or services that the entity has transferred to a customer that is unconditional. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 105<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReceivablesFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aciu_AlphaSynucleinPetImagingDiagnosticAgentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aciu_AlphaSynucleinPetImagingDiagnosticAgentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=aciu_SkaneUniversityHospitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=aciu_SkaneUniversityHospitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aciu_AdvanceSmallMoleculePdProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aciu_AdvanceSmallMoleculePdProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=aciu_SkaneUniversityHospitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=aciu_SkaneUniversityHospitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908590800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Expenses by category (Details)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>employee</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr) </div>
<div>employee</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr) </div>
<div>employee</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="nump">SFr 74,782<span></span>
</td>
<td class="nump">SFr 79,010<span></span>
</td>
<td class="nump">SFr 76,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">60,336<span></span>
</td>
<td class="nump">62,282<span></span>
</td>
<td class="nump">59,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">15,789<span></span>
</td>
<td class="nump">17,910<span></span>
</td>
<td class="nump">18,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialResultNetAbstract', window );"><strong>Financial result, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">6,485<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expense</a></td>
<td class="num">(355)<span></span>
</td>
<td class="num">(581)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Exchange differences</a></td>
<td class="nump">393<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="num">(555)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Finance result, net</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">6,017<span></span>
</td>
<td class="num">(661)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes', window );">Gains on conversion features related to convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=aciu_ResearchAndDevelopmentExpensesMember', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="nump">41,166<span></span>
</td>
<td class="nump">44,289<span></span>
</td>
<td class="nump">43,787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation', window );">Payroll expenses</a></td>
<td class="nump">17,548<span></span>
</td>
<td class="nump">16,465<span></span>
</td>
<td class="nump">14,424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based compensation</a></td>
<td class="nump">1,622<span></span>
</td>
<td class="nump">1,528<span></span>
</td>
<td class="nump">1,276<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseByNature', window );">Total expenses by category</a></td>
<td class="nump">SFr 60,336<span></span>
</td>
<td class="nump">SFr 62,282<span></span>
</td>
<td class="nump">SFr 59,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageNumberOfEmployees', window );">Average number of employees | employee</a></td>
<td class="nump">122.4<span></span>
</td>
<td class="nump">108.6<span></span>
</td>
<td class="nump">115.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_SellingGeneralAndAdministrativeExpenseMember', window );">General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="nump">SFr 6,207<span></span>
</td>
<td class="nump">SFr 7,031<span></span>
</td>
<td class="nump">SFr 7,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation', window );">Payroll expenses</a></td>
<td class="nump">7,874<span></span>
</td>
<td class="nump">8,281<span></span>
</td>
<td class="nump">8,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based compensation</a></td>
<td class="nump">1,708<span></span>
</td>
<td class="nump">2,598<span></span>
</td>
<td class="nump">2,812<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseByNature', window );">Total expenses by category</a></td>
<td class="nump">SFr 15,789<span></span>
</td>
<td class="nump">SFr 17,910<span></span>
</td>
<td class="nump">SFr 18,557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageNumberOfEmployees', window );">Average number of employees | employee</a></td>
<td class="nump">22.5<span></span>
</td>
<td class="nump">27.3<span></span>
</td>
<td class="nump">26.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee benefits expense excluding share-based compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_FinancialResultNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_FinancialResultNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains (losses) on conversion features related to convertible notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of personnel employed by the entity during a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2021-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=aciu_ResearchAndDevelopmentExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=aciu_ResearchAndDevelopmentExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_SellingGeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_SellingGeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917727488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-party transactions (Details)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>person</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr) </div>
<div>person</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr) </div>
<div>person</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Related-party transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfPersonsKeyManagementBoardOfDirectors', window );">Number of individuals, Board of Directors | person</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfPersonsKeyManagementExecutiveManagement', window );">Number of individuals, Executive Management | person</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Short-term employee benefits</a></td>
<td class="nump">SFr 4,187<span></span>
</td>
<td class="nump">SFr 4,403<span></span>
</td>
<td class="nump">SFr 3,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits', window );">Post-employment benefits</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based compensation</a></td>
<td class="nump">2,503<span></span>
</td>
<td class="nump">2,997<span></span>
</td>
<td class="nump">2,578<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total compensation</a></td>
<td class="nump">SFr 6,985<span></span>
</td>
<td class="nump">SFr 7,666<span></span>
</td>
<td class="nump">SFr 6,289<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfPersonsKeyManagementBoardOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of persons that are the included in Board of Directors excluding the Chief Executive Officer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfPersonsKeyManagementBoardOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfPersonsKeyManagementExecutiveManagement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of persons that comprise key management of the entity that are Executive Management.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfPersonsKeyManagementExecutiveManagement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909478448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Summary of Income Tax Expense (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="num">SFr (13)<span></span>
</td>
<td class="num">SFr (3)<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract', window );"><strong>Income tax expense reconciled to Income / (loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccountingProfit', window );">Loss before income tax</a></td>
<td class="num">(70,740)<span></span>
</td>
<td class="num">(72,993)<span></span>
</td>
<td class="num">SFr (61,921)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Tax benefit calculated at the domestic rates applicable in the respective countries</a></td>
<td class="num">(9,616)<span></span>
</td>
<td class="num">(9,930)<span></span>
</td>
<td class="num">(8,441)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes', window );">(Income not subject to tax)/expenses not deductible for tax purposes</a></td>
<td class="nump">455<span></span>
</td>
<td class="num">(375)<span></span>
</td>
<td class="nump">462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Effect of unused tax losses and tax offsets not recognized as deferred tax assets</a></td>
<td class="nump">9,174<span></span>
</td>
<td class="nump">10,308<span></span>
</td>
<td class="nump">7,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Effective income tax rate (benefit)/expense</a></td>
<td class="nump">SFr 13<span></span>
</td>
<td class="nump">SFr 3<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_CH', window );">SWITZERLAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="nump">13.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="nump">13.60%<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_WeightedAverageMember', window );">Weighted average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="nump">13.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="num">SFr (100)<span></span>
</td>
<td class="num">SFr (100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="nump">33.80%<span></span>
</td>
<td class="nump">32.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract', window );"><strong>Income tax expense reconciled to Income / (loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Effective income tax rate (benefit)/expense</a></td>
<td class="nump">SFr 100<span></span>
</td>
<td class="nump">SFr 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax effect of income not subject to tax and expenses not deductible for tax purposes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccountingProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccountingProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfTaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfTaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717907293856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract', window );"><strong>Unrecognized deductible temporary differences, unused tax losses and unused tax credits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Deductible temporary differences for which no deferred tax asset is recognised</a></td>
<td class="nump">SFr 267,302<span></span>
</td>
<td class="nump">SFr 204,250<span></span>
</td>
<td class="nump">SFr 129,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">264,089<span></span>
</td>
<td class="nump">197,153<span></span>
</td>
<td class="nump">121,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits', window );">Increase (decrease) in tax losses available for offset against future taxable profits</a></td>
<td class="nump">66,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aciu_December312024Member', window );">December 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">15,231<span></span>
</td>
<td class="nump">15,231<span></span>
</td>
<td class="nump">15,231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aciu_December312025Member', window );">December 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">48,894<span></span>
</td>
<td class="nump">48,894<span></span>
</td>
<td class="nump">48,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aciu_December312026Member', window );">December 31, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aciu_December312027Member', window );">December 31, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">57,824<span></span>
</td>
<td class="nump">57,824<span></span>
</td>
<td class="nump">57,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aciu_December312028Member', window );">December 31, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">75,204<span></span>
</td>
<td class="nump">75,204<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aciu_December312029Member', window );">December 31, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">66,936<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember', window );">Tax Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract', window );"><strong>Unrecognized deductible temporary differences, unused tax losses and unused tax credits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Deductible temporary differences for which no deferred tax asset is recognised</a></td>
<td class="nump">264,089<span></span>
</td>
<td class="nump">197,152<span></span>
</td>
<td class="nump">121,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember', window );">Right of use assets and lease liabilities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract', window );"><strong>Unrecognized deductible temporary differences, unused tax losses and unused tax credits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Deductible temporary differences for which no deferred tax asset is recognised</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aciu_RetirementBenefitPlanMember', window );">Retirement benefit plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract', window );"><strong>Unrecognized deductible temporary differences, unused tax losses and unused tax credits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Deductible temporary differences for which no deferred tax asset is recognised</a></td>
<td class="nump">SFr 3,213<span></span>
</td>
<td class="nump">SFr 7,098<span></span>
</td>
<td class="nump">SFr 7,464<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in tax losses available for offset against future taxable profits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_TaxLossesSplitByExpiryDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_TaxLossesSplitByExpiryDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_December312024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_December312024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_December312025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_December312025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_December312026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_December312026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_December312027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_December312027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_December312028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_December312028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_December312029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_December312029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aciu_RetirementBenefitPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aciu_RetirementBenefitPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717912728688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan - Summary of Benefit Plan (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees', window );">Defined benefit plans, percentage of contributions by employees</a></td>
<td class="nump">47.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer', window );">Defined benefit plans, percentage of contributions by employer</a></td>
<td class="nump">53.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember', window );">Defined Benefit Obligation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlanAbstract', window );"><strong>Defined benefit pension plan amount recognized in balance sheet [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation</a></td>
<td class="num">SFr (32,410)<span></span>
</td>
<td class="num">SFr (33,889)<span></span>
</td>
<td class="num">SFr (30,213)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets</a></td>
<td class="nump">29,197<span></span>
</td>
<td class="nump">26,791<span></span>
</td>
<td class="nump">22,749<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlan', window );">Total liability</a></td>
<td class="num">SFr (3,213)<span></span>
</td>
<td class="num">SFr (7,098)<span></span>
</td>
<td class="num">SFr (7,464)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined benefit plans, percentage of contributions by employees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined benefit plans, percentage of contributions by employer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PlanAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PlanAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SurplusDeficitInPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of any plan assets, less the present value of the defined benefit obligation. [Refer: Plan assets [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SurplusDeficitInPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SurplusDeficitInPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SurplusDeficitInPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717912785312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract', window );"><strong>Retirement benefit plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans', window );">Service cost</a></td>
<td class="nump">SFr 1,712<span></span>
</td>
<td class="nump">SFr 1,648<span></span>
</td>
<td class="nump">SFr 1,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseDefinedBenefitPlans', window );">Interest cost</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestIncomeDefinedBenefitPlans', window );">Interest income</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans', window );">Net pension cost</a></td>
<td class="nump">SFr 1,751<span></span>
</td>
<td class="nump">SFr 1,679<span></span>
</td>
<td class="nump">SFr 1,655<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current and past service cost (gain), defined benefit plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense arising from defined benefit plans. [Refer: Interest expense; Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestIncomeDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income arising from defined benefit plans. [Refer: Interest income; Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestIncomeDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 5<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_5&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908267456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan, Changes in Defined Benefit Obligation (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract', window );"><strong>Changes in defined benefit obligation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At beginning of period</a></td>
<td class="num">SFr (7,098)<span></span>
</td>
<td class="num">SFr (7,464)<span></span>
</td>
<td class="num">SFr (7,485)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At end of period</a></td>
<td class="num">(3,213)<span></span>
</td>
<td class="num">(7,098)<span></span>
</td>
<td class="num">(7,464)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember', window );">Defined Benefit Obligation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract', window );"><strong>Changes in defined benefit obligation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At beginning of period</a></td>
<td class="num">(33,889)<span></span>
</td>
<td class="num">(30,213)<span></span>
</td>
<td class="num">(26,624)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome', window );">Service cost</a></td>
<td class="num">(1,712)<span></span>
</td>
<td class="num">(1,648)<span></span>
</td>
<td class="num">(1,626)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset', window );">Interest cost</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset', window );">Change in demographic assumptions</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Change in financial assumptions</a></td>
<td class="nump">8,397<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset', window );">Change in experience assumptions</a></td>
<td class="num">(1,726)<span></span>
</td>
<td class="num">(252)<span></span>
</td>
<td class="num">(931)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited', window );">Benefits deposited</a></td>
<td class="num">(2,327)<span></span>
</td>
<td class="num">(894)<span></span>
</td>
<td class="num">(1,467)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Employees' contributions</a></td>
<td class="num">(1,056)<span></span>
</td>
<td class="num">(959)<span></span>
</td>
<td class="num">(851)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At end of period</a></td>
<td class="num">SFr (32,410)<span></span>
</td>
<td class="num">SFr (33,889)<span></span>
</td>
<td class="num">SFr (30,213)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in net defined benefit liability (asset) resulting from benefits deposited</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in net defined benefit liability (asset) resulting from current and past service costs (income)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717917686176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan, Changes in Fair Value of Plan Assets (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ChangesInFairValueOfPlanAssetsAbstract', window );"><strong>Changes in fair value of plan assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At beginning of period</a></td>
<td class="num">SFr (7,098)<span></span>
</td>
<td class="num">SFr (7,464)<span></span>
</td>
<td class="num">SFr (7,485)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset', window );">Employer's contributions</a></td>
<td class="nump">1,210<span></span>
</td>
<td class="nump">1,089<span></span>
</td>
<td class="nump">950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At end of period</a></td>
<td class="num">(3,213)<span></span>
</td>
<td class="num">(7,098)<span></span>
</td>
<td class="num">(7,464)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan', window );">Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember', window );">Fair Value of Plan Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ChangesInFairValueOfPlanAssetsAbstract', window );"><strong>Changes in fair value of plan assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At beginning of period</a></td>
<td class="nump">26,791<span></span>
</td>
<td class="nump">22,749<span></span>
</td>
<td class="nump">19,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset', window );">Interest income</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Employees' contributions</a></td>
<td class="nump">1,056<span></span>
</td>
<td class="nump">959<span></span>
</td>
<td class="nump">851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset', window );">Employer's contributions</a></td>
<td class="nump">1,210<span></span>
</td>
<td class="nump">1,089<span></span>
</td>
<td class="nump">950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited', window );">Benefits deposited</a></td>
<td class="nump">2,327<span></span>
</td>
<td class="nump">894<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset', window );">Return on plan assets excluding interest income</a></td>
<td class="num">(2,274)<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At end of period</a></td>
<td class="nump">SFr 29,197<span></span>
</td>
<td class="nump">SFr 26,791<span></span>
</td>
<td class="nump">SFr 22,749<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ChangesInFairValueOfPlanAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ChangesInFairValueOfPlanAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in net defined benefit liability (asset) resulting from benefits deposited</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimate of the expected contributions to be made to a defined benefit plan for the next annual reporting period. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 147<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_147_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 148<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_148_d_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [member]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908446112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan, Change in Net Defined Benefit Liability (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract', window );"><strong>Change in net defined benefit liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net defined benefit liabilities, beginning of period</a></td>
<td class="nump">SFr 7,098<span></span>
</td>
<td class="nump">SFr 7,464<span></span>
</td>
<td class="nump">SFr 7,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss', window );">Net pension cost through statement of income/(loss)</a></td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">1,679<span></span>
</td>
<td class="nump">1,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement through other comprehensive income/(loss)</a></td>
<td class="num">(4,426)<span></span>
</td>
<td class="num">(956)<span></span>
</td>
<td class="num">(726)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset', window );">Employer's contribution</a></td>
<td class="num">(1,210)<span></span>
</td>
<td class="num">(1,089)<span></span>
</td>
<td class="num">(950)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net defined benefit liabilities, end of period</a></td>
<td class="nump">SFr 3,213<span></span>
</td>
<td class="nump">SFr 7,098<span></span>
</td>
<td class="nump">SFr 7,464<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from expense (income) included in profit or loss. [Refer: Net defined benefit liability (asset); Profit (loss)] [Contrast: Post-employment benefit expense in profit or loss, defined benefit plans]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908394880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan - Change in other comprehensive gains (losses) (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OtherComprehensiveGainsLossesAbstract', window );"><strong>Other comprehensive gains/(losses) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans', window );">Effect of changes in demographic assumptions</a></td>
<td class="nump">SFr 29<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 1,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans', window );">Effect of changes in financial assumptions</a></td>
<td class="nump">8,397<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans', window );">Effect of changes in experience assumptions</a></td>
<td class="num">(1,726)<span></span>
</td>
<td class="num">(252)<span></span>
</td>
<td class="num">(931)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans', window );">Return on plan assets excluding interest income</a></td>
<td class="num">(2,274)<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Total other comprehensive gain</a></td>
<td class="nump">SFr 4,426<span></span>
</td>
<td class="nump">SFr 956<span></span>
</td>
<td class="nump">SFr 726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration period for defined benefit obligation</a></td>
<td class="text">14 years 10 months 24 days<span></span>
</td>
<td class="text">17 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OtherComprehensiveGainsLossesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OtherComprehensiveGainsLossesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, resulting from the return on plan assets, excluding amounts included in interest expense (income) arising from defined benefit plans. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average duration of a defined benefit obligation. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 147<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_147_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717907061008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement benefit plan, Actuarial Assumptions and Sensitivity Analysis (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract', window );"><strong>Actuarial assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount rate</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases', window );">Rate of future increase in compensations</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases', window );">Rate of future increase in current pensions</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital', window );">Interest rate on retirement savings capital</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember', window );">+0.5% Increase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Percentage increase in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember', window );">-0.5% Decrease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Percentage decrease in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember', window );">Discount rate | +0.5% Increase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Percentage increase in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 30,201<span></span>
</td>
<td class="nump">SFr 31,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="num">SFr (2,209)<span></span>
</td>
<td class="num">SFr (2,699)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember', window );">Discount rate | -0.5% Decrease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Percentage decrease in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 34,916<span></span>
</td>
<td class="nump">SFr 37,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="nump">SFr 2,506<span></span>
</td>
<td class="nump">SFr 3,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember', window );">Future salary increase | +0.5% Increase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Percentage increase in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 32,940<span></span>
</td>
<td class="nump">SFr 34,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="nump">SFr 530<span></span>
</td>
<td class="nump">SFr 689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember', window );">Future salary increase | -0.5% Decrease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Percentage decrease in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 31,841<span></span>
</td>
<td class="nump">SFr 33,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="num">SFr (569)<span></span>
</td>
<td class="num">SFr (713)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember', window );">Future pension cost | +0.5% Increase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Percentage increase in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 33,601<span></span>
</td>
<td class="nump">SFr 35,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="nump">SFr 1,191<span></span>
</td>
<td class="nump">SFr 1,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember', window );">Future pension cost | -0.5% Decrease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Percentage decrease in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 31,322<span></span>
</td>
<td class="nump">SFr 32,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="num">SFr (1,088)<span></span>
</td>
<td class="num">SFr (1,454)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember', window );">Interest rate on savings capital | +0.5% Increase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Percentage increase in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 33,322<span></span>
</td>
<td class="nump">SFr 34,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="nump">SFr 912<span></span>
</td>
<td class="nump">SFr 933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember', window );">Interest rate on savings capital | -0.5% Decrease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Percentage decrease in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 31,545<span></span>
</td>
<td class="nump">SFr 33,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="num">SFr (865)<span></span>
</td>
<td class="num">SFr (882)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected rate of interest rates on retirement savings capital is used as a significant actuarial assumption to determine the present value of a defined benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SensitivityAnalysisActuarialAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 144<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected rate of increases in pension that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 144<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 144<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a defined benefit obligation that would have been caused by a decrease in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717906845152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation, Plans Outstanding (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">74 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Options </div>
<div>plan</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Options</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Options</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Options</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Share-based compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfEquityBasedInstrumentPlans', window );">Number of equity-based instrument plans | plan</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options awarded (in shares)</a></td>
<td class="nump">1,090,316<span></span>
</td>
<td class="nump">1,110,914<span></span>
</td>
<td class="nump">1,073,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_StockOptionPlanC1Member', window );">Share Option Plan C1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options awarded (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,775,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement', window );">Contractual life of options</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanMember', window );">2016 SOIP [Member] | Executives and Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options awarded (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,277,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement', window );">Contractual life of options</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanMember', window );">2016 SOIP [Member] | Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options awarded (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,811,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement', window );">Contractual life of options</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember', window );">2016 SOIP, Vesting Condition 1 [Member] | Executives and Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember', window );">2016 SOIP, Vesting Condition 2 [Member] | Executives and Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember', window );">2016 SOIP, Vesting Condition 3 [Member] | Executives and Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum term of options granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfEquityBasedInstrumentPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity-based instrument plans approved by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfEquityBasedInstrumentPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ShareBasedPlansOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ShareBasedPlansOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For vesting requirements for a type of share-based payment arrangement that existed at any time during the period, this element represents the period which an employees' right to exercise an award is no longer contingent on satisfaction of a service condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_StockOptionPlanC1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_StockOptionPlanC1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909615824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation, Weighted Average Exercise Prices (Details)<br></strong></div></th>
<th class="th" colspan="7">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Options </div>
<div>$ / shares </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Options </div>
<div>SFr / shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Options </div>
<div>$ / shares </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfOptionsAbstract', window );"><strong>Number of options [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="nump">3,585,689<span></span>
</td>
<td class="nump">3,585,689<span></span>
</td>
<td class="nump">2,900,667<span></span>
</td>
<td class="nump">2,900,667<span></span>
</td>
<td class="nump">1,981,629<span></span>
</td>
<td class="nump">1,981,629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited during the year (in shares)</a></td>
<td class="num">(304,738)<span></span>
</td>
<td class="num">(304,738)<span></span>
</td>
<td class="num">(207,331)<span></span>
</td>
<td class="num">(207,331)<span></span>
</td>
<td class="num">(53,591)<span></span>
</td>
<td class="num">(53,591)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement', window );">Expired during the year (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,729)<span></span>
</td>
<td class="num">(26,729)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised during the year (in shares)</a></td>
<td class="num">(110,250)<span></span>
</td>
<td class="num">(110,250)<span></span>
</td>
<td class="num">(218,561)<span></span>
</td>
<td class="num">(218,561)<span></span>
</td>
<td class="num">(73,669)<span></span>
</td>
<td class="num">(73,669)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted during the year (in shares)</a></td>
<td class="nump">1,090,316<span></span>
</td>
<td class="nump">1,090,316<span></span>
</td>
<td class="nump">1,110,914<span></span>
</td>
<td class="nump">1,110,914<span></span>
</td>
<td class="nump">1,073,027<span></span>
</td>
<td class="nump">1,073,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">4,261,017<span></span>
</td>
<td class="nump">4,261,017<span></span>
</td>
<td class="nump">3,585,689<span></span>
</td>
<td class="nump">3,585,689<span></span>
</td>
<td class="nump">2,900,667<span></span>
</td>
<td class="nump">2,900,667<span></span>
</td>
<td class="nump">1,981,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable (in shares)</a></td>
<td class="nump">2,345,648<span></span>
</td>
<td class="nump">2,345,648<span></span>
</td>
<td class="nump">1,613,242<span></span>
</td>
<td class="nump">1,613,242<span></span>
</td>
<td class="nump">1,099,015<span></span>
</td>
<td class="nump">1,099,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted average exercise price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at beginning of period (in CHF per share) | SFr / shares</a></td>
<td class="nump">SFr 6.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 5.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 5.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Forfeited during the year (in CHF per share) | SFr / shares</a></td>
<td class="nump">6.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019', window );">Expired during the year (in CHF per share) | SFr / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised during the year (in CHF per share) | SFr / shares</a></td>
<td class="nump">0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted during the year (in CHF per share) | (per share)</a></td>
<td class="nump">3.18<span></span>
</td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="nump">6.34<span></span>
</td>
<td class="nump">$ 6.95<span></span>
</td>
<td class="nump">6.29<span></span>
</td>
<td class="nump">$ 7.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at end of period (in CHF per share) | SFr / shares</a></td>
<td class="nump">5.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 5.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercisable (in CHF per share) | SFr / shares</a></td>
<td class="nump">SFr 6.41<span></span>
</td>
<td class="nump">$ 6.41<span></span>
</td>
<td class="nump">SFr 6.13<span></span>
</td>
<td class="nump">$ 6.13<span></span>
</td>
<td class="nump">SFr 5.49<span></span>
</td>
<td class="nump">$ 5.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageRemainingAbstract', window );"><strong>Weighted average remaining term (years) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining term (years), options outstanding</a></td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">8 years 2 months 12 days<span></span>
</td>
<td class="text">8 years 2 months 12 days<span></span>
</td>
<td class="text">8 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable', window );">Weighted average remaining term (years), options exercisable</a></td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageRemainingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageRemainingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual life of share options exercisable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717907154208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)<br></strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Options </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Options </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Options </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Options</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Options (in shares)</a></td>
<td class="nump">4,261,017<span></span>
</td>
<td class="nump">4,261,017<span></span>
</td>
<td class="nump">3,585,689<span></span>
</td>
<td class="nump">3,585,689<span></span>
</td>
<td class="nump">2,900,667<span></span>
</td>
<td class="nump">2,900,667<span></span>
</td>
<td class="nump">1,981,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price for options granted (in CHF/USD per share) | (per share)</a></td>
<td class="nump">SFr 3.18<span></span>
</td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="nump">SFr 6.34<span></span>
</td>
<td class="nump">$ 6.95<span></span>
</td>
<td class="nump">SFr 6.29<span></span>
</td>
<td class="nump">$ 7.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019', window );">Weighted average share price of common share options exercised (in dollars per share) | (per share)</a></td>
<td class="nump">3.28<span></span>
</td>
<td class="nump">3.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price for options granted (in CHF/USD per share) | (per share)</a></td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">2.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price for options granted (in CHF/USD per share) | (per share)</a></td>
<td class="nump">SFr 9.53<span></span>
</td>
<td class="nump">$ 12.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Chf0.15Member', window );">CHF 0.15</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Options (in shares)</a></td>
<td class="nump">97,875<span></span>
</td>
<td class="nump">97,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Chf9.53Member', window );">CHF 9.53</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Options (in shares)</a></td>
<td class="nump">223,646<span></span>
</td>
<td class="nump">223,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd5.04ToUsd12.30Member', window );">USD 5.04 to USD 12.30</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Options (in shares)</a></td>
<td class="nump">2,864,408<span></span>
</td>
<td class="nump">2,864,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd2.76ToUsd4.57Member', window );">USD 2.76 to USD 4.57</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Options (in shares)</a></td>
<td class="nump">1,075,088<span></span>
</td>
<td class="nump">1,075,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price at the date of exercise for share options that are exercised in a share-based payment arrangement. [Refer: Share-based payment arrangements [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Chf0.15Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Chf0.15Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Chf9.53Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Chf9.53Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd5.04ToUsd12.30Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd5.04ToUsd12.30Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd2.76ToUsd4.57Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd2.76ToUsd4.57Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717907110720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Y </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Y </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Y </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract', window );"><strong>Number and weighted average exercise prices of options under the share option programs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Weighted average fair value at measurement date, share options granted</a></td>
<td class="nump">$ 2.38<span></span>
</td>
<td class="nump">$ 5.23<span></span>
</td>
<td class="nump">$ 5.25<span></span>
</td>
<td class="nump">SFr 2.20<span></span>
</td>
<td class="nump">SFr 4.78<span></span>
</td>
<td class="nump">SFr 4.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageAssumptionsAbstract', window );"><strong>Weighted average assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Share price (weighted average)</a></td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="nump">$ 6.95<span></span>
</td>
<td class="nump">$ 7.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageAssumptionsAbstract', window );"><strong>Weighted average assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price (in USD per share)</a></td>
<td class="nump">$ 2.76<span></span>
</td>
<td class="nump">$ 5.31<span></span>
</td>
<td class="nump">$ 5.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected term | Y</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageAssumptionsAbstract', window );"><strong>Weighted average assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price (in USD per share)</a></td>
<td class="nump">$ 4.57<span></span>
</td>
<td class="nump">$ 7.72<span></span>
</td>
<td class="nump">$ 9.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected term | Y</a></td>
<td class="nump">6.25<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717906947424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation, Non-vested Share Awards (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">74 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>EquityInstruments</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr) </div>
<div>EquityInstruments</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr) </div>
<div>EquityInstruments</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>EquityInstruments</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average grant date fair value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Expense charged against the income statement | SFr</a></td>
<td class="nump">SFr 3,300,000<span></span>
</td>
<td class="nump">SFr 4,100,000<span></span>
</td>
<td class="nump">SFr 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_BoardOfDirectorsMember', window );">Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPaymentArrangementAbstract', window );"><strong>Share-based payment arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedSharesAndRestrictedShareUnitsMember', window );">Non-vested Share Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPaymentArrangementAbstract', window );"><strong>Share-based payment arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of non-vested share awards granted (in shares)</a></td>
<td class="nump">239,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfNonVestedSharesAbstract', window );"><strong>Number of non-vested shares [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Non-vested at beginning of period (in shares)</a></td>
<td class="nump">797<span></span>
</td>
<td class="nump">19,494<span></span>
</td>
<td class="nump">42,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement', window );">Forfeited during the year (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,828)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement', window );">Expired during the year (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,804)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement', window );">Exercised during the year (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,471)<span></span>
</td>
<td class="num">(84,638)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the year (in shares)</a></td>
<td class="nump">239,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Vested during the year</a></td>
<td class="num">(23,505)<span></span>
</td>
<td class="num">(18,697)<span></span>
</td>
<td class="num">(23,269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Non-vested at end of period (in shares)</a></td>
<td class="nump">216,486<span></span>
</td>
<td class="nump">797<span></span>
</td>
<td class="nump">19,494<span></span>
</td>
<td class="nump">216,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Vested and exercisable (in shares)</a></td>
<td class="nump">89,020<span></span>
</td>
<td class="nump">65,515<span></span>
</td>
<td class="nump">49,289<span></span>
</td>
<td class="nump">89,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average grant date fair value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding', window );">Weighted average grant date fair value, non-vested at beginning of period | SFr</a></td>
<td class="nump">SFr 9.41<span></span>
</td>
<td class="nump">SFr 9.51<span></span>
</td>
<td class="nump">SFr 9.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited', window );">Weighted average grant date fair value, forfeited during the year | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired', window );">Weighted average grant date fair value, expired during the year | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised', window );">Weighted average grant date fair value, exercised during the year | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.46<span></span>
</td>
<td class="nump">9.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted', window );">Weighted average grant date fair value, granted during the year | SFr</a></td>
<td class="nump">3.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested', window );">Weighted average grant date fair value, vested during the year | SFr</a></td>
<td class="nump">3.28<span></span>
</td>
<td class="nump">9.52<span></span>
</td>
<td class="nump">9.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable', window );">Weighted average grant date fair value, vested and exercisable | SFr</a></td>
<td class="nump">7.84<span></span>
</td>
<td class="nump">9.48<span></span>
</td>
<td class="nump">9.47<span></span>
</td>
<td class="nump">SFr 7.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding', window );">Weighted average grant date fair value, non-vested at end of period | SFr</a></td>
<td class="nump">3.06<span></span>
</td>
<td class="nump">9.41<span></span>
</td>
<td class="nump">9.51<span></span>
</td>
<td class="nump">3.06<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average grant date fair value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding', window );">Weighted average grant date fair value, non-vested at beginning of period | SFr</a></td>
<td class="nump">9.41<span></span>
</td>
<td class="nump">9.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding', window );">Weighted average grant date fair value, non-vested at end of period | SFr</a></td>
<td class="nump">SFr 3.06<span></span>
</td>
<td class="nump">SFr 9.41<span></span>
</td>
<td class="nump">SFr 9.51<span></span>
</td>
<td class="nump">SFr 3.06<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsMember', window );">Restricted Stock Units | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPaymentArrangementAbstract', window );"><strong>Share-based payment arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of non-vested share awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement', window );">Contractual life of options</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfNonVestedSharesAbstract', window );"><strong>Number of non-vested shares [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the year (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsMember', window );">Restricted Stock Units | Executives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPaymentArrangementAbstract', window );"><strong>Share-based payment arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of non-vested share awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement', window );">Contractual life of options</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfNonVestedSharesAbstract', window );"><strong>Number of non-vested shares [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the year (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsFirstVestingConditionsMember', window );">Restricted Stock Units, first vesting conditions | Executives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPaymentArrangementAbstract', window );"><strong>Share-based payment arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsSecondVestingConditionsMember', window );">Restricted Stock Units, second vesting conditions | Executives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPaymentArrangementAbstract', window );"><strong>Share-based payment arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum term of other equity instruments (ie other than share options) granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfNonVestedSharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfNonVestedSharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ShareBasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ShareBasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For vesting requirements for a type of share-based payment arrangement that existed at any time during the period, this element represents the period which an employees' right to exercise an award is no longer contingent on satisfaction of a service condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value, other equity instruments exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value, other equity instruments expired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value, other equity instruments forfeited</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value, other equity instruments granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value, other equity instruments outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value, other equity instruments vested</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value, other equity instruments vested and exercisable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_BoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_BoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedSharesAndRestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedSharesAndRestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_ExecutiveManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_ExecutiveManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsFirstVestingConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsFirstVestingConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsSecondVestingConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsSecondVestingConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908901520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_RentalContractPeriodForNoticeOfCancellation', window );">Notice period for cancellation of rental contract</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractualCapitalCommitments', window );">Contractual capital commitments</a></td>
<td class="nump">SFr 52,488<span></span>
</td>
<td class="nump">SFr 23,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Within 1 Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractualCapitalCommitmentsOtherThanForLeases', window );">Contractual capital commitments other than for leases</a></td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractualCapitalCommitments', window );">Contractual capital commitments</a></td>
<td class="nump">23,336<span></span>
</td>
<td class="nump">19,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">1-3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractualCapitalCommitments', window );">Contractual capital commitments</a></td>
<td class="nump">18,516<span></span>
</td>
<td class="nump">3,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">3-5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractualCapitalCommitments', window );">Contractual capital commitments</a></td>
<td class="nump">9,229<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">More Than 5 Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractualCapitalCommitments', window );">Contractual capital commitments</a></td>
<td class="nump">SFr 1,407<span></span>
</td>
<td class="nump">SFr 51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CommitmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CommitmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ContractualCapitalCommitmentsOtherThanForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual capital commitments other than for leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ContractualCapitalCommitmentsOtherThanForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_RentalContractPeriodForNoticeOfCancellation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time required by the lessee in a lease agreement to provide notice of cancellation of a lease to the lessor, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_RentalContractPeriodForNoticeOfCancellation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractualCapitalCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of capital commitments for which the entity has entered into a contract. [Refer: Capital commitments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractualCapitalCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717909327696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (Details) - CHF (SFr)<br> SFr / shares in Units, SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity', window );">Net loss attributable to equity holders of the Company</a></td>
<td class="num">SFr (70,753)<span></span>
</td>
<td class="num">SFr (72,996)<span></span>
</td>
<td class="num">SFr (61,921)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted-average number of shares outstanding used to compute EPS basic attributable to equity holders</a></td>
<td class="nump">83,554,412<span></span>
</td>
<td class="nump">74,951,833<span></span>
</td>
<td class="nump">71,900,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted-average number of shares outstanding used to compute EPS diluted attributable to equity holders</a></td>
<td class="nump">83,554,412<span></span>
</td>
<td class="nump">74,951,833<span></span>
</td>
<td class="nump">71,900,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic loss per share for the period attributable to equity holders</a></td>
<td class="num">SFr (0.85)<span></span>
</td>
<td class="num">SFr (0.97)<span></span>
</td>
<td class="num">SFr (0.86)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per share for the period attributable to equity holders</a></td>
<td class="num">SFr (0.85)<span></span>
</td>
<td class="num">SFr (0.97)<span></span>
</td>
<td class="num">SFr (0.86)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AntidilutiveSecuritiesAbstract', window );"><strong>Antidilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding', window );">Share options issued and outstanding (in-the-money)</a></td>
<td class="nump">135,827<span></span>
</td>
<td class="nump">1,140,388<span></span>
</td>
<td class="nump">412,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting', window );">Restricted share awards subject to future vesting</a></td>
<td class="nump">117,292<span></span>
</td>
<td class="nump">6,264<span></span>
</td>
<td class="nump">28,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares', window );">Convertible shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">41,461<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares', window );">Total potentially dilutive securities</a></td>
<td class="nump">253,119<span></span>
</td>
<td class="nump">1,188,113<span></span>
</td>
<td class="nump">440,609<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AntidilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AntidilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive restricted share awards subject to future vesting that relate to the assumed exercise of the entity's incentive share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options and potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive share options that relate to the assumed exercise of the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 67<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 67<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139717908158864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments and risk management (Details)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>Institution</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">SFr 126,147<span></span>
</td>
<td class="nump">SFr 201,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">13,147<span></span>
</td>
<td class="nump">21,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialRisksAbstract', window );"><strong>Financial risks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange gains (losses)</a></td>
<td class="nump">393<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="num">SFr (555)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_LongTermLeaseLiabilitiesMember', window );">Long-term lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">2,253<span></span>
</td>
<td class="nump">2,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_TradeAndOtherPayablesMember', window );">Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">929<span></span>
</td>
<td class="nump">2,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_AccruedExpensesMember', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">9,417<span></span>
</td>
<td class="nump">16,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_ShortTermLeaseLiabilitiesMember', window );">Short-term lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">548<span></span>
</td>
<td class="nump">570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_RightOfUseFinancialAssetsMember', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">2,808<span></span>
</td>
<td class="nump">2,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_LongTermFinancialAssetsMember', window );">Long-term financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">361<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_OtherCurrentReceivablesMember', window );">Other current receivables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_ShortTermFinancialAssetsMember', window );">Short-term financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">91,000<span></span>
</td>
<td class="nump">116,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_CashOnHandAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">31,586<span></span>
</td>
<td class="nump">82,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Foreign Currency Exchange Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialRisksAbstract', window );"><strong>Financial risks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange gains (losses)</a></td>
<td class="nump">SFr 500<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="num">SFr (700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies', window );">Percentage of reasonably possible strengthening or weakening of reporting currency against other relevant currencies</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies', window );">Increase (decrease) in profit (loss) resulting from reasonably possible strengthening or weakening of reporting currency against other relevant currencies</a></td>
<td class="nump">SFr 700<span></span>
</td>
<td class="nump">SFr 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember', window );">Credit Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialRisksAbstract', window );"><strong>Financial risks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets', window );">Number of financial institutions holding cash and cash equivalents and short-term financial assets | Institution</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialRisksAbstract', window );"><strong>Financial risks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_LiquidityManagementRollingForecastPeriod', window );">Cash position rolling forecast period</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity Risk [Member] | Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">SFr 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity Risk [Member] | Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">9,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest Rate [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialRisksAbstract', window );"><strong>Financial risks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates', window );">Cash and cash equivalents subject to negative interest rates</a></td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates', window );">Percentage of reasonably possible increase or decrease in interest rates</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest Rate [member] | Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialRisksAbstract', window );"><strong>Financial risks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates', window );">Increase (decrease) in profit (loss) resulting from reasonably possible increase or decrease in interest rates</a></td>
<td class="nump">SFr 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents subject to negative interest rates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_FinancialAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_FinancialAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_FinancialRisksAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_FinancialRisksAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in profit (loss) resulting from reasonably possible increase or decrease in interest rates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in profit (loss) resulting from reasonably possible strengthening or weakening of reporting currency against other relevant currencies</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_LiquidityManagementRollingForecastPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The periodic interval in which the entity performs a rolling forecast of the entity's cash position, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_LiquidityManagementRollingForecastPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of financial institutions holding the entity's deposits of cash and cash equivalents and short-term financial assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reasonably possible increase or decrease in interest rates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reasonably possible strengthening or weakening of reporting currency against other relevant currencies</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35H<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35I<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35M<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35N<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2021-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_LongTermLeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_LongTermLeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_TradeAndOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_TradeAndOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_AccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_AccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_ShortTermLeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_ShortTermLeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_RightOfUseFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aciu_RightOfUseFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_LongTermFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aciu_LongTermFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_OtherCurrentReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aciu_OtherCurrentReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_ShortTermFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aciu_ShortTermFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_CashOnHandAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aciu_CashOnHandAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>aciu-20221231x20f_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:aciu="http://acimume.com/20221231"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:currency="http://xbrl.sec.gov/currency/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aciu-20221231.xsd" xlink:type="simple"/>
    <context id="Duration_1_1_2019_To_12_31_2019__3yCVTKZ40i5IsvT7P2jug">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_Zmu3hDypz0e9GA3GfssWMQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LeaseholdImprovementsAndFixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312029Member_QW1lvp6gWEmt2TrWCNAUrg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312028Member_yPNEVvCqsUC9xeMHzwQNIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312027Member_8GigSLJKwkiTlMz-iLjIGQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312026Member_aD29x0JbzEyAG4T_DshrpQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312025Member_luIzCS1YKk2F6EECmOmb-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312024Member_1EtLVXZQK0KhtJMXjvu1hg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312029Member_-U2cl_yo202fnY3GwpirTA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312028Member_IyrHXjhaIkqLqkdVnSu1Fg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312027Member_YDYkyf-UMU2_t8n-OPDZOw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312026Member_pgGd2X_5zkuQ-hULGalqJw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312025Member_iFzt3h4AUU63S9gjge_aaA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312024Member_YtAAUPDrRUyZqBsdM7bZLg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312029Member_L1w97ZJiBU-clbQi3YmL-Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312028Member_KCaq0o_GCU-ldbixSPpiMw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312027Member_ng3b4z76MU6jDCmNuN3LKQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312026Member_GVWpRLlroE6SQnZZlZUS2g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312025Member_n-US4waEG0KkXB44U7M1XA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312024Member_QmNnwUouwUmJ-s32bbnIQQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_VYzjzXZlKEGZio3O0wX8zQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RegulatoryAndSalesBasedMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_kiAkuYc_KUS-yeLR_XxzfA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:RegulatoryAndSalesBasedMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsCommercialMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_gCSsL-ubc0eIq6zJNtwUCg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:MilestonePaymentsCommercialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_Y_oiYfNYLEWs_ZiE9phKFg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:MilestonePaymentsClinicalAndRegulatoryMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_y5HiWeAgl0qm7JANOOw7-w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ClinicalMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_350QXz6QwEuA8d1zj8O5MA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_VADeMQ-kG0C2-xdkdCMoZg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_OOBltWlETEyOu2fA06kbxw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:IprDIntangibleAssetAssociatedWithAci7104.056Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_I4XyGj16C0a9vD480ormzw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_MzzzRCGt_kGIsmMdhb2czw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_HnlGa1Cxjk2eh1urgNWWVw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_xamDkF4k5UGlV-TCDgu2Lg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_P7gp9D6sWEu1SR6hOkR0lQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_b6irc3wm8kOfDWxn7KoryA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_QcaBM9HUnUiKIdtAR3VBHA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_AwHLCp1Cek68-TW5KoaDqA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_8Nxn7kPDD0muRctLMCmLRQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_bV6SNnGs5EKwPEWegvAkHA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_IESnhrGhEk-QtuGTRv7ddw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_NSSv8GcEaEejbU2PgDrGqw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_P-n3rHIzjEG1HspwzCx_Og">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_UeTtu2AuZkiuL6oBS69STw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_wQPmFr31yUS_jOij507kbA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_YRhyIua2j02nlUUm4X31Sw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_7_1_2022_To_9_30_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_exnjXylyHUGgFwmQMBb9bQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_DHftPCO4NE2baGCu__fDLw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_OXAjfAuKLkGrxwLJeL_h4g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_cTOwJWsTfU2wP__TQVaSgw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_E0eBhnZuvkCP7QsmGzZ-7g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_DhDLnGHqvEOBmhLvYjbgNQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_gScL_dC77kCsTG776ERWNA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_WmrQJ8yOykaDFuA8S-ALTg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_p0DVrOsbeESsVkNWccV14A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_cyiz-Q_qC0uLMdJoM0Mbdw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_S211XVhLiUqZCj3v114p0Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_PrKPmhCrP0ePfbwTC-yXHA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_UUY8TErzyUuTQ6n10-1E8g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_z90wXTf3ike4CAeXE1FQtA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_UT-qr7yDeESe7RDDN5ti-Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_qwYRZkjqJkCgDZXe1ke0Iw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_JA3yekIlVkiUYduc0Mu4Qw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_R5HPjrhD7kOQFT3FLpl0VQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_HVTIaNw_0UOjUkO5CiRYEA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2019_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_X7pFxFGHnkKllf5M2sGd6w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:RightOfUseLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_IS1IteWIxESboEBvGakY4g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_23_2019_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_boFHM2vJ60aWug_NKJAQTA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-23</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_23_2019_To_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_1Vi83gAQRUCn92QFpovc7Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:RightOfUseLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-23</startDate>
            <endDate>2019-01-23</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2016_To_6_30_2016_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_otQ-b1w0b0OqUhWtsoKp6Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-01</startDate>
            <endDate>2016-06-30</endDate>
        </period>
    </context>
    <context id="Duration_12_31_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_9CqaxvHCr0-iuqlmAvYvdw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-12-31</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="Duration_12_1_2014_To_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_Of8RE1HgdEy1bhmDA0BgDw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-12-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="Duration_5_1_2014_To_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_Z_bscP2Znk-KSY2VCxYJ7g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-05-01</startDate>
            <endDate>2014-05-31</endDate>
        </period>
    </context>
    <context id="As_Of_8_31_2022_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_d5f6dTO6oUOtx2ATln4mKQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aciu:SkaneUniversityHospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2020_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_EU9FlszNzkOBH2Bx99PAbQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aciu:SkaneUniversityHospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2020_ifrs-full_CounterpartiesAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7QQTH7tA1kOhyo9N6XlPwQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:SkaneUniversityHospitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_Bwy5dQAXAEWqqXyDPqgE6Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillySecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_g8PQeK6MBUOy01cnGHEgHg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:March312020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillySecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_UrnH6A3xZ0GUsbQYZdWO-A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:March312020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_Quarter32019Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_pnlTLBAOqUyJSsbJhyKKYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:Quarter32019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_3QZoZDHthk6fXZD1NuNlOg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:March312020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_cOXYr6K5yUCrOP0RZAWdQA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember__8JB9cGo30u4RAuroNxHDw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_8IXKK-Pok0S7I58W7DYXDA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_nA1-BCOTy0m_IaGz1dZgKQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_U0WcEJ-m006w1FYFbGzFkg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_t0ttw0E3hEGRszBl1CyKPw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_kGz2G5hG2EuGvNwjXNMtGA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_kqXlzseNsUiz1AZXFdEaQA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_mXP7xiRLEUu8xic9Xuihlw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_aJviOm4nfE-pOaFV9E4vvw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_6conGXdyckSywzGr6GYvYw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_TH62pZBB7kqAgUulrAHeSg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fhXMqa9W-EWHXNdjUYd4iQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_W-8vm1symkWu1TlXlu9m7A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_JOWNVGG_6E2-S4NAWhBdqw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_hqctdwrQN0uGHFmoDmoBSw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_5w-XoX-NLkKHmafT1-bTSA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_6aK9qrKczkWLN0-zGicz-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_83P7y6bpZ0ylYnfrkgwFyw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_mkfTmtvQQUWvXn7SCNipKA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:AssetsUnderConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_imtm7cUr8kaCmHg-oP5Uew">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_ue4pbGVEbUiq7HJx_qTxVA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_pC0gtLj5kE29rdJ-dYf0BA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_GKWsPI-X0kGuJ_LvETs99g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_gFCLb69mDUaqMTblzP_RkQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_gixeq8TJOUiwQnCqzoWt6w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_nVWm-PIICk2ruKe56loHrQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_SVIwZpKI3kGqF_IYNCWEhg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_j5TopbyK0kGaK2cIgBD9LA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_IQoL60CqzUKkayULIGl1UQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:AssetsUnderConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_k8dVeftSAkW4_0WfOoafTQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_yBmrsz9Gz0-30C8ID2gxpA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Hnlt3D1SKEW7_IrRvWNKhg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_omADz3BlkU228JQA39U9eA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_624VtAuprEmOudOGdH0CPQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:AssetsUnderConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9GjiWU9dvUSudZWJ_vB8OQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_9-9lvpw-wEGlSeFf0lhfgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_rNFrcrnlfke5jyKkmnfYew">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_U-F3h1Ni3kikwgDZTjR8Ag">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9sg6mWi1F0CGpbkEmid_yw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_at5lR_LjGEWOpLXOSdQYAQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Y1uZQ6hoDkCelbD4WC21cw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember__RC_i4sK7Eajf16KAEb9Lw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_Q_e4dEXGxkup2NsrXRT1FQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_TY4Gkd3GwUKatV9IO3cpXg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_MiutPukQMU-yrYKpy0R5CQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:AssetsUnderConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_H4N7gZJ3j0Kt81LUUCEMUg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_wxgSXXB0oEWC6elN_wYlOw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_6EKzgKAJoUG3jfS4LKnOcA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_g3mEpN007U6ktZW8iOkmGg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_5kIFcqQdLECCxjdGCPTLvw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_NC-GY6fYlkqMWQ13ktqxIQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_4fT5bJuBykulzw1ivTHO9Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForEmployeeBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_kNbENWSt0ES3TXF_cT2ONw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_4oE23j2SoEGdWq3PS9cPew">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_nMf-S3Qo30yK_F2kNXsH8Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_t849aft53kyGDr1KoWgmHg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_11_1_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_8NZA0QmhLU-9P-5sBxKJYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_1_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_u_sWTIPrdUK25sXxSWqZ-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_1_2016_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_vLy61BZC6kiaUiucvTN5rA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:StockOptionPlanC1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd5.04ToUsd12.30Member_gtKWlOCngE27VpysbvaH2g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Usd5.04ToUsd12.30Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd2.76ToUsd4.57Member_m38zUhm5wkSL12bhBb3aJA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Usd2.76ToUsd4.57Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf9.53Member_HuWh2wiS0UufmuyDmPt1XQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Chf9.53Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf0.15Member_Mjn-Ndi9XEOlgiCMgrFRAQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Chf0.15Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_11_16_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_8IofwfDJNUGt5LoOfv2Txw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-16</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_16_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_EUWOkY3BskaxAia9Z8ewEQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-16</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_0QrduY45dEG6M-eOa0J7zw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_s2KGkJGHQE24IlcU01BatQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_kCoLjsydz025fO14lloWZg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_V6HzKpLdRUKQbql6k-eSiw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_eZxk80f7rkOIMW9Uz-QjMQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_UV3ix4h--E6wHiAOGaJNtA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_uTemqh0x5kCnk8dGyhg2yw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_QO4vamUaPEWTe-Dnq2T7Yw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_K6sJGDsSb0Ki6Q9DK_HssA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_9SsycfPkpUG2RWbLatkFMg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_VCafjbK1YkmLYTpqX9O2Qg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_Rm5syNGJAkK02zxsPeiygw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_LpgnYOYCIE6nbkxvmDUYKg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_OwVmQS-jlUGVZMlyx50qAA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_tvR74klj-EuU1efHxw9Lag">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_nL6LiSdtTEm6pKYWuxJXrQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_-0isfSi3C0iv0Hr9h6SsDw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_IE1TM485zUWn_r_T4BeXIQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_MbfX1IXrrEG58WLwK0Know">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_XuWosC4Fe0qG8LleE6GLdg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:AccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_Cts4m1NVYEm1s8XilN-05w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:TradeAndOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_cmRGUa_u70epa2FW1Q5Q3Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:ShortTermLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_o6gi3zRMsky95yqQAXrXPA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:LongTermLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_grbXW83sNUKs9oRc5DlqvA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:AccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_AsEKpSzsIUOKQll1k7zGDw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:TradeAndOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_iojyYGBhoEmu6MX20T28CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:ShortTermLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_pWcmO-NRyEKwdZu9PbvzLQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:LongTermLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_BhAuKtG8w0aQWiwhMKyIUA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:AccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_C2-Rix-rrUWBxTMIugjLZw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:ShortTermFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_jyOi4fu8akSFRaaUIvyLtQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:RightOfUseFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_5zN3E_yoh02M-AfcBPl9vA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:OtherCurrentReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_Oa3BLbYryUWJpolylXf_QQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:LongTermFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_FcEj2KvmMkOH2QDFyl4MuA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:CashOnHandAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_DhXQ_kkBwUi5-evVk0nMVg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:ShortTermFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_3Jy3_8RbZUWAnkkvJgLO9w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:RightOfUseFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_Bl-K4Rg37EyEPpGUWgJdww">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:OtherCurrentReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_tJzQntMdsU6d1iyuTo4P6w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:LongTermFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_4ePuupbrrEqstdW7npGYxg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:CashOnHandAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_hgoBF8GS-k-cs9msKZyyhA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_8sJpe0LyAECOfOJdgZOKPQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_y4uYlYwmHUaTK3M_16Tcuw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_GwujP39d00mK3lHW3oUw4A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_gp09PWsb8EavwbWAh0p_Sg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Vs0uaVlFREaW6ng6T8fgEg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_dfNJO7LfcEOZT4w2RTRitw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_frCDFRM6oU2SCVSiDhf4Lw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_fNeupebFFUOPOyeQrvkYqA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember__r0D1g51PUiGX0X1UUsNSA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_vuCe_vLKgECevKYNBCd4Lw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_ktuzkw64AEa5vdg54I-VCQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_6vGDOwBrDUW56Z7aTT9Kzg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_utVQr_YxtkaiCKmZyUEcCw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_os5Hp8MAI02VjWPk90WB7w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_BAlgAaqeAE69FaWxkpf59A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_-v01eNbu4EqyiH1CP4pFSw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_KQlk7o6AQ0uDnZr3pfWlIg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_ZFh_VMBp4USCi-ehy5idcg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_XSLfDSRIbEupuWixpadOuw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_bdfGLGB28E2kpb5ujlICfA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:AssetsUnderConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_dIb050VtY0uPI1cKwRn8HA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_3yeVGHwDfEeZEDJ901taIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_o09LprTCLE6hH9f1Mj3oqQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_IvbcDwQUuEm16jkIYakaCg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_v887EZj_rEmNcfMBDtK6TA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Jvt1fjwr5USz9GJD5wEKOQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_-tmtXopEr0G-p32hjhwk6Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_E57IJ4sHdEW4PL45jFGApQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_hZnR1ixhfkeMTt56nYyaxw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fkSn02nK3EO6v-wrUGc0vg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_X7iW-2Dlq0SBvALqlsP7Iw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_XIymoY2OjEyn8SkwhnAMgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_AmEhYNpaWkGu_syMP9yeMg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_XbtQeThTw0KgJUgpaxvnvg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_59E483uZ40Gsz3BGEndqFA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember__QV6BS-X-EirLtUuhoaxaw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Cu7DGnbLpU-gF7D6W8XXoQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_htkFexGKi0SyGdCClk5r-A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_uLVqkw8R0Ey9u3gY5ML4tg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hYMeoCWTDUeHBblD-WbM1g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_sfVRDOORkUqhr6UilmXrJw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_pxqAUVjcWEiJf_4UkIPnRg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lnas20UeVUe0l9IofWvilw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_E-R1Y--G10q88hvRsrSnzA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hnNvq_N4vkyRlPiVGvD9xg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_HHYHWrkgo0um-ugZPCUcJA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_ITqbxgmA8kaKhSS6Qx6Lag">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_CIf08U-iBESSEaFfP0e5oQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Ky5hPC5l-kqMi9huZQTdgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8YTwmrejmUmiuJSTgOn0zQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember__6JmM8XcBUip-56hZCA8ig">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_HYAe7T3bM0uPnVmhnuk0NQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_EoGHAaH_W0-vpWcrDQJuvg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_A7q7sukpmEWmgYEeU6xd9A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RightOfUseAssetsAndLeaseLiabilitiesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_e71liqGpk0eD9wSTTRy_TA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RetirementBenefitPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_e7xgizML2UqtqmEk-xbYOg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_qNySDLxJmUaC4_AlxO6kDw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RightOfUseAssetsAndLeaseLiabilitiesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_wwQem1YNxUG0LWJSPUL00w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RetirementBenefitPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_nBhQeOZ19k-ztz29OTwlBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_MB9hMQrj1E-MnICLBN--Tg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RightOfUseAssetsAndLeaseLiabilitiesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_X_YAkgPZKU2ZgwftPJ68hQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RetirementBenefitPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_YpfuJbR9Jku9LQlMY-CQVg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_KqUnpfq9E0mC3M7Pc6ReGA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_Aq4Gh5QzC0O-z-Hkxgg7bw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_3B9uzJLVRE-wKxtJvPSkOg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_OgtSEFz6OUOEyh01YeW-4Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_IDSltZ9zlUuxs8MqNPseTA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_EG_KIXGerkW5heSXWG1y5Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_93lXqdNkAkGE1eTi254vCQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_pevi1fpI-0qT5MFTaLocdA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_bmdNVxjd7kCcxLTi4MiPYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2012_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_p2DjH8za9kC0HB1u8L2hcw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-06-30</instant>
        </period>
    </context>
    <context id="As_Of_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_WVjiu2AWkUC7_73wPEZNAg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-23</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_CurrencyAxis_currency_USD_15GIrBDN9Uil-oruYpMkuQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_CurrencyAxis_currency_EUR_V7Jj-YDCCEGGn-_yEgdDMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_CurrencyAxis_currency_CHF_38ToDnEBNEuS9ddM0NrYgg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_CurrencyAxis_currency_USD_Ukgt6dYs9EGXQlarniLKig">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_CurrencyAxis_currency_EUR_o_IBIzyApEiyeRWQLrx-UA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_CurrencyAxis_currency_CHF_iiYbXla8tU-iyk_i32DP4A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_C854zoDUpkSi-bE7TYeEJw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_JZHuDFkEnky2R3mcEBTRxw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_GeographicalAreasAxis_country_CH_O7nfFWb_I0mZqhS-eJcjZg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_hGZYF059eky85mjSvMDTyw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_5cL5m8nGCEqTrf8_CtRG_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_o6mJetXegkqD7qoBcZZJvQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_CH__P8ouC3DKUKhYNxSsLCgfg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2021_zfFR7ittfki9YYbWT5hYdg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_EEXqAl-oB0aAgMV2CcairA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_1pD5gJTd5k6uFaeNrpHvig">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_EjvNM_4FNkWLoJE65UD5VQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_mo8rLVJA4Uq7FhG33cplbQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember__-gTB9L7ZEG7ut5ju4_TaA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_3oznLzHXWUmnOSp1oShnUQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_sn3ARiGlaESnktZbl7jycA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_w37wZNsSyU6H8HKH0QpE5A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_-BoX8YxE_EaZXZMovx0g2A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_1wINY-2riE6PzcI88FzqMQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_M05pHmbc10iqCZT547GuuA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9ZTaVEBXDUiyQ4EQFRSYhQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Mexed_kNUESyEPioMdSpUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_OgqSUQcKz0SKU75eNdUCVQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_amPvhMdQjUCNH0XSkOd83g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_BknOUverm029TXOB6lUTWA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:AssetsUnderConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_aBSKY_-UsUGANDeuLjypnQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_8n96kGPIAEKNlTtnDkaFpA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_dxwmB62u-UWekqoEuPazhg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_nWByIEwhSEGf6j1j19xN3w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_qn53IASnuk6FLPf7LUu5zw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_YWfuOV2LMUGsWQqsGR6J5w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_qvzjOcNNJ0e61xUNnj-VJQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_o6xYJQLm0U2_P1h1Nvrt4Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_i1QiIMeQy0WwrJUKG5kvUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_gs4FuwKFqUy6IZN8tQRJ-w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanVestingTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsSecondVestingConditionsMember_tIRug6aVk0eTDxYXCAEY0g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsSecondVestingConditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsFirstVestingConditionsMember_gGDNEFbPMkKnisGaecdtgg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsFirstVestingConditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ZVoQVJGhW0GvwsXTKPLhYw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:BoardOfDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_QuVxNqREZ0mnvgP8iz8Hbw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_StatementScenarioAxis_aciu_IfNotesAreConvertedMember_-lcYAWhYg0-zLgqjshlyjw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">aciu:IfNotesAreConvertedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_wv9xrxx7O0K2GfFqTGYv0g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_IhkhXgeEj0KYRe-nXMqtgw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForEmployeeBenefitPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_7CFGeyENHkKB9xvCXPYVaA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_Jgm2mZ4FRUuDSrQ2ymoSAg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember_0GfBuDA_dU26TA2qx6IcSA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJ.FoxFoundationAndTargetAlsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_vFwwP69K-kujKmPJkq_WBw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_VKLmDDFNFkKleBMvIA9FfQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_Xwss63i4rkeKVevtj3Tcag">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_my1TIm6ojUaJIKTSB0t2ng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_T-iM5RqNsUG9c1FH7HG0Xg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AdvanceSmallMoleculePdProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_CuCfm2CCOUSB6f8RZI257g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_UZGF3O0NRECj0iuX4vHtKQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_0Lc-koCQpEeU6K6OjBCTKA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_c832R2YNRkeTmCmOUNmglA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_nm_abkjtNku82k2BFZcwmA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_qes1Nya84kCyFEAE3XIdpQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:StockOptionPlanC1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember__MJ0ad-Uz0G9j3cZ1MV7Iw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_BZyLB7dngU2QjWI8noII-w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:IprDIntangibleAssetAssociatedWithAci7104.056Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_7Z_nhIBrX0a27ZxFck0DEg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_FirstCapitalPartnerGmbHMember_C_e589-KYkWofUUwrPs_Ng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:FirstCapitalPartnerGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_AthosServiceGmbHMember_MrNll2L240y5mdXUd6AkjQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:AthosServiceGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_jtRNTBzMHEaZ7YlAIWrXwg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2021_To_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_hFMd3XCjHE2krVkPJCUtig">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_GjUP2pWxo0OYX2B-S44KPA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_hAdDmGPrWE6JWyIjdtUDJA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_cPKR_v8WT0anxPEPSrhgGA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_v5r8G2UC80OzCevY1QNAVQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_2QmGkCKydUCnCVZUxjhf3w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_BOCVhHLarUK1ofHh5lJzgQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_6CpwH38OB0GxFoomh9oxsw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7U3WtCFvFkm-psn0Ha35Tw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OfficeEquipmentMember_9AyXpdV_hkmm2dtMcUeW5w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Ozer3KElnU6POId_CcOTBg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_Wu9NkzJdPUaZrVXUx5z-UA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_V234l1xFRUG6YB4I0Vptfw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_IzCNAkBBO0a8Nlx67vKOBg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">aciu:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9o_550cVrU6jieJwj_AJUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_rUIgTjQ7OkGwKJ7QeHVyyw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">aciu:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6WGIoNrd4USstG13uKvUOQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_LMCpazElS0WvFLxSamO-Xw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">aciu:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_LgP-ND0OA0CGPBZ4f_J4DA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_D82Lcnr-PUGdxCD-xTUAMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_Ot-xQ2KPP06Rv7mi7NpE9w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_NiF-yrOtAky2RdqkvIAwfw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_-yIL5uUOREqnWUjN-WEKug">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_z3C9c0ddSEGQe_CGaFlGBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_jTjTRUZmlk6W61qANQJmqg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:SecondOpenMarketSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_12_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_tyfTe8DeCUaagdCn6T7Ejg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zNVkSV70P0yTTv0hw3xQ6Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_VzztEIOlRE2c1SoXK6RQgg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_4CLZPTp1GUqRjsICkJnChA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AdvanceSmallMoleculePdProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_8o7ayFkxUESxL5ih3O1fWA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_COp1pU_2c0K0ifwsTtZrJw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_gQeJGG83pUqW7L5LjJMSiw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-05-31</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2012_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_W_xvSn3aIUSy0b2g6uFBPw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-06-30</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_H7MVafWwHEm7SebhAlCksg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_vJPsPHg5JUivymFY6lpR6A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_AnT6Y1xoZUO8xgP2BhtXpg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_8iFSlULEHU-tuNl09k6RZA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__hddlRQFkkqifIU3xGWEIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_3_31_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_bzzbrZyzREe8dKLr1q4pcA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="Duration_10_1_2017_To_12_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_MJWKVhi5Mke2_vbucOqWPQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2017_To_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_p7AlCw_1wU-ARo-yBLe5DA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-03-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2016_To_7_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_GqrdTpaZwEmYea7JqiwIuQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-31</endDate>
        </period>
    </context>
    <context id="Duration_5_1_2016_To_5_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_GSgSGJWKA0qol0w8MEEp6A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2016-05-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_FNJ-cLjT602Qc6SGy47cbA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="Duration_6_1_2012_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_wmwel6uA20-BMX_QzPDtJg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-06-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_1_2006_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesAchievedPriorTo1January2017Member_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_bi-vVw0ymkK92cjHErDo8Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ClinicalMilestonesAchievedPriorTo1January2017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2006-11-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_1_2006_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__PSR-FnhukSI5DOP7kxVxw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2006-11-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_3_31_2020_To_3_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_POa8drBe6UafiI7IoFhEXw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillySecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-31</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_g_GGnY_Mek66JNJPv8qF7g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_Ssvb6k-KGUuY9cOGiA1XzQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_Xs05KeXY_USgX2n0OcnZ7Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiTauAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2012GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_AEaXqV6uYU2YSJVL94SJpg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AntiAbetaAntibodyInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2006GenentechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_uJn6GJFgd0C7AUHONVqWvA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_4_28_2021_To_4_28_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_S6KglnLJ6EOK616omN_TFQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-28</startDate>
            <endDate>2021-04-28</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_Z8Cvgi6srkG50kHoFl7dWQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="Unit_Standard_Institution_SROTVTXUBkGGrhJAF8DeMQ">
        <measure>aciu:Institution</measure>
    </unit>
    <unit id="Unit_Standard_payment_b5_XsToWrkW99sPOvgoheg">
        <measure>aciu:payment</measure>
    </unit>
    <unit id="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">
        <measure>aciu:EquityInstruments</measure>
    </unit>
    <unit id="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ">
        <measure>aciu:person</measure>
    </unit>
    <unit id="Unit_Standard_segment_9jTtSCng3EmNVBiAOMwlNw">
        <measure>aciu:segment</measure>
    </unit>
    <unit id="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w">
        <divide>
            <unitNumerator>
                <measure>iso4217:CHF</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:USD</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw">
        <measure>aciu:employee</measure>
    </unit>
    <unit id="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">
        <divide>
            <unitNumerator>
                <measure>iso4217:CHF</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Divide_CHF_EUR_oaL03aUr-0uB3BBQW7LmbA">
        <divide>
            <unitNumerator>
                <measure>iso4217:CHF</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:EUR</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA">
        <measure>aciu:Y</measure>
    </unit>
    <unit id="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">
        <measure>iso4217:CHF</measure>
    </unit>
    <unit id="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">
        <measure>aciu:Options</measure>
    </unit>
    <unit id="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_Standard_installment_mxjM2Rh-sk6ny-HGf2rDww">
        <measure>aciu:installment</measure>
    </unit>
    <unit id="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">
        <measure>shares</measure>
    </unit>
    <unit id="Unit_Standard_agreement_6AbCKkYWeEm1dt5Jp7cROw">
        <measure>aciu:agreement</measure>
    </unit>
    <unit id="Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ">
        <measure>aciu:item</measure>
    </unit>
    <unit id="Unit_Standard_plan_lCCE6LMjkEKlKdQ1vpJjNA">
        <measure>aciu:plan</measure>
    </unit>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Hidden_KsMgbS3xG0qi3jvsMdG5Ow"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">-0.85</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="2"
      id="Hidden_jsBeHvTR-kSgucIdm-PyEA"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">-0.97</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Hidden_tmBaFLxF8EqhVJkDdhdDFw"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">-0.86</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Hidden_E9IAUiBXwEe80tmH-4EHnA"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">83554412</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="INF"
      id="Hidden_ygCYsmYiB06ntb7irePY4g"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">74951833</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="INF"
      id="Hidden_i-Hoy8t6aUGmNrMEVl37eA"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">71900212</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Hidden_qNCRjMCoBEWX70xtv--h7w"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">-0.85</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="2"
      id="Hidden_5par6rAS-0SS1VELqhjwGg"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">-0.97</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Hidden_aZVD85ojDUemcKl4x6wfKw"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">-0.86</ifrs-full:DilutedEarningsLossPerShare>
    <dei:EntityCentralIndexKey
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_Z_ZwThMSSU2XUg1LCvHu2A_2_1">0001651625</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_Ap4lYaip50e7PGHKMBYU-Q_3_1">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_fxGJv6qQdUW3iNWmqRRb1Q_4_1">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_BBa5r-ClgkyjiVsisgUdcQ_5_1">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_3TLN0YpSu0iZgBG4nXIAzg_6_1">false</dei:AmendmentFlag>
    <aciu:MaturityPeriodOtherCurrentReceivables
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g"
      id="Hidden_P_0I_UaePkyj8OXHk3ZeUg">P3M</aciu:MaturityPeriodOtherCurrentReceivables>
    <aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_FirstCapitalPartnerGmbHMember_C_e589-KYkWofUUwrPs_Ng"
      decimals="0"
      id="Hidden_7EVt20oUeEOLG5MQiq_Hiw"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">1513317</aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt>
    <aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_AnT6Y1xoZUO8xgP2BhtXpg"
      id="Hidden_K168Qe9Bi02hpV05wXH75Q">P3M</aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod>
    <aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__hddlRQFkkqifIU3xGWEIw"
      id="Hidden_EdaFR7KmDE28JCeL6L0nxw">P3M</aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_10_1_2017_To_12_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_MJWKVhi5Mke2_vbucOqWPQ"
      decimals="-6"
      id="Hidden_751hiZiX7EinZNcM4zz_ew"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">14000000</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_7_1_2016_To_7_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_GqrdTpaZwEmYea7JqiwIuQ"
      decimals="-6"
      id="Hidden_5oAu63RdGkGFjzGDsCTBog"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">14000000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_8iFSlULEHU-tuNl09k6RZA"
      id="Hidden_lTC6TFzT5kGupQPYn0M3yQ">P3M</aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod>
    <aciu:CollaborativeAgreementJointResearchCollaborationPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_Ssvb6k-KGUuY9cOGiA1XzQ"
      id="Hidden_CDAuGzNdHk259o1JNxYdiA">P2Y</aciu:CollaborativeAgreementJointResearchCollaborationPeriod>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-5"
      id="Hidden_bwx-SbM9sEqAKiboMtvBTg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DeferredTaxLiabilities>
    <dei:DocumentType
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_eLLKO5k3x0KgJch5rmuInQ">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_oHdYDI2r4E6rcLGlgoZu3Q_1_1">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_wBYyx1_LrESjj2YH5YPfjQ_1_0">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_uzT3TJlyPkuT2E-TDKBaAw">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_9UzHUMS7x0msQXVlVVxEdg_1_0">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_mX_-c-NtFkWOOJh7ZEzDbQ_1_0">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_n48-cDBvzEe7qAFIxr7n-w">001-37891</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_SjRL44o-40GZowDzsKpLNg">AC IMMUNE SA</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_sAX1e0SewEGOs_py3fkdeQ">V8</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_ZeGaG5ls-Eykvl0ncjpYyQ">EPFL INNOVATION PARK</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_cTwfrbEPnkG_XlwXNDxLww">Building B</dei:EntityAddressAddressLine2>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_ahi79EkJV0SKnHu_ZcOpDw">1015</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_Q-jpVCBXmUii2yYtj-flig">Lausanne</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_p7HvuHC6SkWloCPcN0m8Dw">CH</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA"
      id="Narr_V77s93hBzEeyuBGBBGW3bg">Andrea Pfeifer</dei:ContactPersonnelName>
    <dei:CityAreaCode
      contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA"
      id="Narr_U4-pwQHuh0KKsE5tIJWK0A">41</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA"
      id="Narr_TaLkVPqnCk-EPn5VThyc5Q">21 345 91 21</dei:LocalPhoneNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA"
      id="Narr_vWQQodNdYESqSXf0Kmby3Q">EPFL INNOVATION PARK</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA"
      id="Narr_COkZeAXgLUuuVPHHn-ud4A">Building B</dei:EntityAddressAddressLine2>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA"
      id="Narr_T3-aTzC1F0qairn4n7LKjg">1015</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA"
      id="Narr_rv3lJVAhNEurixVmD16FGw">Lausanne</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="Duration_1_1_2022_To_12_31_2022_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_vSuGpYZ6wkGSvr7h9_CLQA"
      id="Narr_ajFeHY5Q2Ue1jmUySAiDAg">CH</dei:EntityAddressCountry>
    <dei:Security12bTitle
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_w1mnrZKTgEyKpwdPJw-JLw_2_0">Common Shares, nominal value CHF 0.02 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_Ol0nwcTsoUqHqmtjoH6sxw_2_2">ACIU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_e4kHbhUmg0yhZrykURqoBA_2_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="INF"
      id="Narr_WKciTITyvUSo57UuFf753g"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">83620364</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_DoE_TAQd6EGrp04nSoHrKQ">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_JNbpzXoVuEeXB_I1j2nlNQ">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_dtVfqo3szkK5zESpzQLOxA">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_dnorbpp9AUGDq3rGykPpgQ">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_yIbwWcTp9kG9PrF95R2gkg">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_61EaPGLda02D7xykPhoOuw">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_WO4uJzai90WES6zXu0vXww">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentAccountingStandard
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_2sZgeK2tv0a8rMJJU12zhQ">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_XLmgvd6LsUywSx1tXamCmQ">false</dei:EntityShellCompany>
    <dei:AuditorFirmId
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_sg9wkt23cEWsLTcmrNbXFA">1358</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_srqwE32MOk-DUHtQaFV4VA">PricewaterhouseCoopers SA</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_fCIkblbIc0So8CT1xj0QJw">Lausanne, Switzerland</dei:AuditorLocation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_2-ZOv6Hbf0mzJ9KgV1fPYQ_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4259000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_NbbRfwD2REuMeX9PoHO0TQ_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">5116000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_mpPDb92PmUiPA2rEj1_XrA_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2808000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_GKl3o0pObEu4P82cZYgxkw_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2914000</ifrs-full:RightofuseAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_fW47LL3ksEqoDEKFSwOIKA_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_IXxAKemAS0e324vtsTB8mA_8_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:NoncurrentRestrictedCashAndCashEquivalents
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_qneZma9WaUGBOtsGXroDMA_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">361000</ifrs-full:NoncurrentRestrictedCashAndCashEquivalents>
    <ifrs-full:NoncurrentRestrictedCashAndCashEquivalents
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_LHK-6rXjxU2hVUfOB7-XoQ_9_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">363000</ifrs-full:NoncurrentRestrictedCashAndCashEquivalents>
    <ifrs-full:NoncurrentAssets
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_oQeneVC400K5S4w9nrg5SQ_10_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">57844000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_0pDnZisVS0mG0ceIdALtOQ_10_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">58809000</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_Ea9G5s4PAkm3nAufnAg7IA_13_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4708000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_KdKmlHF5d0OV4apVmmEGOA_13_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3015000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_TR716T28K0S8_2Ll-YkEwA_14_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">408000</ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets>
    <ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_sDjjWVQARk-nmq-ew4WNKQ_14_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">975000</ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets>
    <ifrs-full:OtherCurrentReceivables
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_kthV6bBFskCKlG3P_Be0mA_15_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">392000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_Qrb7iyA9-kGc-3oXIdo2fw_15_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">428000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_Irw1PvhWi0Kb1Ra8EPJLfg_16_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">91000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_mzQ_Qb4V70uwINMSed67RA_16_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">116000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_bxFInVj8dkWUONz-P3jDlg_17_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">31586000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_MaW4aEqYwkS0c8pmucSVVQ_17_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">82216000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentAssets
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_t4-7eXFyiEulNG0M-IgJLw_18_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">128094000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_FMoDPyxId0yeWMSrMdhN-Q_18_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">202634000</ifrs-full:CurrentAssets>
    <ifrs-full:Assets
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_OKIqVYwoHE6WJ36d0W3HsQ_19_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">185938000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_Kak4bkmS1EeNYlk4y86IMQ_19_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">261443000</ifrs-full:Assets>
    <ifrs-full:IssuedCapital
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_-7VjQF-lgUal_3CHl4V_Kg_24_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1797000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_yWgrh8BnF02C5yIZMraAhw_24_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1794000</ifrs-full:IssuedCapital>
    <ifrs-full:SharePremium
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_--Efd-lxfU6K400INIO5_Q_25_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">431323000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_1LIdr7G1Sk2aD-jtSTBN2Q_25_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">431251000</ifrs-full:SharePremium>
    <ifrs-full:TreasuryShares
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_C_faaBwOrkeF5qgNvG-FFQ_26_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">124000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc__c26yhL85UaqZFl_64zNLQ_26_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">124000</ifrs-full:TreasuryShares>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_i-2bBNWg7kOUyoJ4cteB-Q_27_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">10000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:RetainedEarnings
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_rf9UpMWVnEeLl3XU8E7xwg_28_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-264015000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_-Dj7nSafIEeLbemj4AzHFg_28_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-200942000</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_x86t9yur5U27IO_xNvqmjw_29_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">168991000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_yPE0xMvjjUe5NB4tfuJqiQ_29_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">231979000</ifrs-full:Equity>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_fM74czxBh0CxwquF6v2itw_32_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2253000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_ubE288h4z0Cnq_biGgl9Uw_32_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2340000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentProvisionsForEmployeeBenefits
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_UE8Qt0l5U0SwUDlTOWMMzQ_33_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3213000</ifrs-full:NoncurrentProvisionsForEmployeeBenefits>
    <ifrs-full:NoncurrentProvisionsForEmployeeBenefits
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_eUBmXI3gj0mP4JSPko8gew_33_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7098000</ifrs-full:NoncurrentProvisionsForEmployeeBenefits>
    <ifrs-full:NoncurrentLiabilities
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_yvyTixviGUGzbLgogB9_VQ_34_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">5466000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_34yXTa7ouE6y42cl9Sl-ww_34_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9438000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_Z7nnRURb80evWTcW_GU98g_37_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">929000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_ju4KSQWeZECM0jF2liFj0Q_37_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2003000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_KbaDIzmyek6FUVdQB_wmhA_38_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9417000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_-i5c1WzU1Eito3X4fee7Gw_38_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">16736000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_-nMusDDJ7UiANdDrbFwsDg_39_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">587000</ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities>
    <ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_FZRbKzN3a0qGW5PwPInfhQ_39_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">717000</ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_xFLxYtWq0Uq2IgVfaVOh_A_40_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">548000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_Cor0qHEEgECYSz4930fAqQ_40_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">570000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_PDcmw1Qyb0SrU95rPM4dPA_41_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">11481000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_BTkmvSj6SkCrYWJrpYS0tQ_41_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">20026000</ifrs-full:CurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_-QyconXJnEaOrwYCzxJWhw_42_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">16947000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_3CrbmMNjNEueeZp-yDY-WQ_42_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">29464000</ifrs-full:Liabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_whRwxFqqtkSvgLIBo3KiXw_43_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">185938000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_sx638RD_7EuMsELsqH5zog_43_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">261443000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_zGy4PAQr-0SUJCIG9LKSPw_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3935000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_x8pm2bZqOUe6evhjShOF9w_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_8XvCTimeXkifiR_atqFqAQ_5_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">15431000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:Revenue
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_jtRnHz--z0Wv3dE5_qXwCg_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3935000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_07z2sT7HlE-yVkIYPM4Q4g_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_b-GE7--kwEKl-7fCt77kPA_6_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">15431000</ifrs-full:Revenue>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_Dm_bdN2CMEKI4ITJzmZkyQ_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">60336000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_t9mO7yJRP0e7glgxhtaK4Q_9_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">62282000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_YKuqxe2PCUiubUwWu9kzSg_9_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">59487000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_K4Kx6uVzsUOj3FVyL76-vA_10_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">15789000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_t6EmHf3rnUyHxC9EA7NGVA_10_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">17910000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_pTlHOpcu3UGkBi0cp861cw_10_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">18557000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_D0izSft0Mkybn8jsOLZcFA_11_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1343000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_c52I9JdQukKsBuz8Mo-pJA_11_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1182000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_uc8CVjwiu0yA4csr11bN5g_11_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1353000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_dZOaXkBos06l57Ojo_vB6Q_12_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">74782000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_xImgqJ1qxUKIpl0eTsU9Bg_12_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">79010000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_9D7DTdZoHkiRHpDciinrFA_12_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">76691000</ifrs-full:OperatingExpense>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_qfm7iC3ZoEypEm-WQKvqCA_13_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-70847000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_Uf6TufWmyUafxx-2gDRO3w_13_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-79010000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_TeWvDWvfQUC6WBuwONuxrg_13_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-61260000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_yNra75o6kkq_3FVeTwkCog_15_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">69000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_z1B0yH2cckqNS1yeqdVZVQ_15_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">6485000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_aC-VIhjCmEeyepTeNEubGw_15_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">78000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_yHdHqJYuZkyZMwddYw8aMw_16_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">355000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_NR12Qz9kEUWNqDbvtyzTGg_16_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">581000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_9dYQQnAAiUK-8pq-1QBrkA_16_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">184000</ifrs-full:FinanceCosts>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_y_nhqxqBXEm9qG4NYW2OlQ_17_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">393000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_D6qQheInL0Wkxsq7Dxylcw_17_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">113000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_B0zQyi6_ok2pkymzYHgsEg_17_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-555000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_8XrOY3eTxEKrZSzzNA1aWA_18_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">107000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_h8gd-wogqUSbvLgUdD7AwA_18_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">6017000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_xwsSwlfw00uArpUUpIbXVw_18_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-661000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_l5tneeEbRUiCDtOGwc8rmg_20_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-70740000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_TOwCXRLRY0uIBizf7Y1mFA_20_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-72993000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_qHIGwX4gFUuhKn0OS0TuQA_20_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-61921000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_ggdVEg2yF0anGsfm2JoYfQ_21_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">13000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_XTAyLgX7ikO-yELYi4WdMg_21_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_Fisy5jlSU0GybsHNhPHO5g_21_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_RuglUhmD90W1pCpHVMtZng_22_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-70753000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_WxKZkx0Om0qmujFqrYWwIQ_22_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-72996000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_MggWWFeQ_EqWLKyXUNe6yg_22_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-61921000</ifrs-full:ProfitLoss>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Tc_pFqEk1xse0mkr4in5PqK1A_25_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">-0.85</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="2"
      id="Tc_y6gmuG6thECk1AgCH1DO1w_25_6"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">-0.97</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Tc_3zNPYG4rHk2DCOyiPSif8w_25_8"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">-0.86</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_6yYWy9YNd0aTCpDlRgvGjw_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-70753000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_GLlOcKNLhkmdrx18wRATpw_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-72996000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_bevJVIw_uUy7UdIjW2lV0A_4_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-61921000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_pbzXn30En0yDNWxEjqu5zQ_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">10000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_vc2D0XuXL0S3OBVcN6kRTQ_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_MT-LyDaVjk6A9A7IwGauAg_6_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_wbo21fUAlkmd2PjX13nqIg_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4426000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_AKgaIN69N0WQ3v7lKOONOw_8_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">956000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_p2SZvCfVVUS6mLhVQnnlSg_8_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">726000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_5vwg_9jr-0Sd6zzOvqdxJA_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4436000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_eDWd93WdfkOnLef4ZqC1JA_9_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">956000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_1LtWIx51C0GEzC1TmzplLw_9_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">726000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_PzJy0XKXyES8Qmp1ppQoxA_10_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-66317000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_N4A8kAu8SkWpFeb72PQlVQ_10_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-72040000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_ETwqHeLwVUuPSr7xjKIwQA_10_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-61195000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_XSLfDSRIbEupuWixpadOuw"
      decimals="-3"
      id="Tc_X6qRsCvZ0EuidDrUU9tEUg_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1437000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_-v01eNbu4EqyiH1CP4pFSw"
      decimals="-3"
      id="Tc_0d6C_ATSokSMF3KQmDhoFQ_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">346526000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_BAlgAaqeAE69FaWxkpf59A"
      decimals="-3"
      id="Tc_NZhNw4x4Jk2aGBu9Sw65uQ_4_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_KQlk7o6AQ0uDnZr3pfWlIg"
      decimals="-3"
      id="Tc_RpVQ59j_9kSGuCGBPYmhuA_4_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-75521000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_ZFh_VMBp4USCi-ehy5idcg"
      decimals="-3"
      id="Tc_ENyiFIfTXUKigkTyW_j0ww_4_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2019_C854zoDUpkSi-bE7TYeEJw"
      decimals="-3"
      id="Tc_1WHGtyPQCUWFXACJwtX9Pw_4_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">272442000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng"
      decimals="-3"
      id="Tc_CzSdTG_ePE-z6sIutDc9Ng_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg"
      decimals="-3"
      id="Tc_Rd_e2ZF7HkyrzR7s72wNDg_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g"
      decimals="-3"
      id="Tc_AQUQ2V-P30OCpUyU1Jrweg_5_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ"
      decimals="-3"
      id="Tc_M3_Kbpc0V0uFEQWQxYA0ZQ_5_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-61921000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw"
      decimals="-3"
      id="Tc_aqTryChCtkWvA-GZk9iGxg_5_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_Pudn4ZcCl0yeiQ9d2ejK-w_5_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-61921000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng"
      decimals="-3"
      id="Tc__7Fa9kuTGUi6a17401Kyyg_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg"
      decimals="-3"
      id="Tc_C938x7RSj0eltV0AdP-WGA_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g"
      decimals="-3"
      id="Tc__gG5j5IStUWWSlVKmKv_KA_6_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ"
      decimals="-3"
      id="Tc_9TiifR4CWE2DltEdQqYIuw_6_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">726000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw"
      decimals="-3"
      id="Tc_JF6Wed0a-U-qCC3GbiRklw_6_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_5wb5JB3aY0uuLA3gqVbs9g_6_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">726000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng"
      decimals="-3"
      id="Tc_vzoeYoDSOUSioDYk3QU0FQ_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg"
      decimals="-3"
      id="Tc_XTdhRss8j0mrL0LNMqxVFg_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g"
      decimals="-3"
      id="Tc_njp_5cRFbEiGOSXZCJH0eQ_7_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ"
      decimals="-3"
      id="Tc_VYdRtxkkM0OATl2ZBvFhJg_7_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-61195000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw"
      decimals="-3"
      id="Tc_6RVC6K_ofUKOliDsM7zuew_7_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_M7btXXswg0aW_1QGWwT5-w_7_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-61195000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng"
      decimals="-3"
      id="Tc_gJolmr2l4k2WdNGg6RRb3Q_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg"
      decimals="-3"
      id="Tc_sIPvr7e0-06ERaqn4AHZdg_9_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g"
      decimals="-3"
      id="Tc_w4zmgsgou02lzcDX2AIlKA_9_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ"
      decimals="-3"
      id="Tc_m-X3T41Ia0eBu1ZaXvjiiA_9_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4088000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw"
      decimals="-3"
      id="Tc_jxWsKCZh80Wu8NVDwbOm0g_9_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_d2ochesFOEq8wq2_fZlWlw_9_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4088000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng"
      decimals="-3"
      id="Tc_tse7WfVDEky-ZqVj00vvIg_11_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">100000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg"
      decimals="-3"
      id="Tc_rRvAt_FAwkmVyBcmM9gi6A_11_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g"
      decimals="-3"
      id="Tc_NSMaZZV6QUiD70j5wq7SuA_11_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-100000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ"
      decimals="-3"
      id="Tc_q74yVGyJ40-Sxk8hlukZhg_11_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw"
      decimals="-3"
      id="Tc_tGc-U5q-S0CszqJhxijybA_11_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_gTtdyxHK4EGaw0xvDeYbBg_11_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng"
      decimals="-3"
      id="Tc_QPeDsoPFA0e4qDTsbpmF4A_12_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg"
      decimals="-3"
      id="Tc_DdozEVcglk2b_U4OdIRzSw_12_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">222000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g"
      decimals="-3"
      id="Tc_qYpCv7j7OEKH3ksz8z-BbQ_12_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ"
      decimals="-3"
      id="Tc_4s7MpvmNU06P7dlZ0sRMmA_12_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-222000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw"
      decimals="-3"
      id="Tc_ufR7PoMsf0W-elNXhk_qKw_12_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_rCmHQP3g50aEFO1gld5j0g_12_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:IssueOfEquityRestrictedShareAwards>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_3NK1C138UEeDf8L291zLng"
      decimals="-3"
      id="Tc_ZhQ0qUTU0ES7tKq2Z962eA_13_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_Riz4Z5W3jk26iYfDrF79bg"
      decimals="-3"
      id="Tc_uu2Z7QSUyUm-Ly7p9satEw_13_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">142000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_eQ3IhS9KQ0-wvye8Yrat2g"
      decimals="-3"
      id="Tc_CeGZdeVUn02wU6ggvg-wuw_13_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_WScEmWZHlUmRdrwDB2mxnQ"
      decimals="-3"
      id="Tc_vAxKqltp90W1tdgapWtWsg_13_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_e1rObX1d6USjg6hP_hz-kw"
      decimals="-3"
      id="Tc_0RUpU4cMoUCN8ShaPKgn2Q_13_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_kSH4KALevUCIKyhk_V7Zkg_13_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">143000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_os5Hp8MAI02VjWPk90WB7w"
      decimals="-3"
      id="Tc_BWHPZg-PNk6YjCzbPuVinA_14_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1538000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_ktuzkw64AEa5vdg54I-VCQ"
      decimals="-3"
      id="Tc_7-KRUKz1f0u-98BKYW-GJg_14_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">346890000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_vuCe_vLKgECevKYNBCd4Lw"
      decimals="-3"
      id="Tc_yxHNmr73JUKu_6eBFYbeiw_14_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-100000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_6vGDOwBrDUW56Z7aTT9Kzg"
      decimals="-3"
      id="Tc_GDNHf8CUB0GhJ_fS1tKeYQ_14_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-132850000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_utVQr_YxtkaiCKmZyUEcCw"
      decimals="-3"
      id="Tc_5AhjIGPeNEWVbUv6kvPJEg_14_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="-3"
      id="Tc_1tnn4HYDlkaNZJFuArG1Iw_14_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">215478000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_os5Hp8MAI02VjWPk90WB7w"
      decimals="-3"
      id="Tc_yEHdSyC6lUSoJ06BsZFgyA_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1538000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_ktuzkw64AEa5vdg54I-VCQ"
      decimals="-3"
      id="Tc_kD3B1QYvqUaqh4-E2Wavqw_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">346890000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_vuCe_vLKgECevKYNBCd4Lw"
      decimals="-3"
      id="Tc_aXxV3pdxaUum16emqIrHdw_4_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-100000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_6vGDOwBrDUW56Z7aTT9Kzg"
      decimals="-3"
      id="Tc_d97wFLRmfEKFI7c1IRndQw_4_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-132850000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_utVQr_YxtkaiCKmZyUEcCw"
      decimals="-3"
      id="Tc_-vbf7oAS_0WcpQoxyDm24A_4_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="-3"
      id="Tc_h0si_71kuEKxFqulBvS2zA_4_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">215478000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_D94LqDzy-0uPRM8JML_7ag_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_w6ek7D7Z8Umpk3VXXM9ONw_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg"
      decimals="-3"
      id="Tc_AkhAmxwzJUexraWEh4mHAg_5_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA"
      decimals="-3"
      id="Tc_blQNSs2K902AJHq-IV5rlQ_5_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-72996000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw"
      decimals="-3"
      id="Tc_mwHLvt4ixEGWaoDzzL4cmA_5_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_-Abn1Of3ekWf3BWt740NKA_5_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-72996000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_j1wkb5eoJUy9ciCISIJ8Vw_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_fFPo5t2cyUCzfRhpSZpo7Q_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg"
      decimals="-3"
      id="Tc_lTMj8Ja3mUuz42HCQTR8Sw_6_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA"
      decimals="-3"
      id="Tc_Y93sGMdMoEeTrYJGhRWuAQ_6_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">956000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw"
      decimals="-3"
      id="Tc_f8dPJe_u1UeJRGo-xfWVsQ_6_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_a54UcHq6FkqjyX1uhYaC0g_6_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">956000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_MdCPb6suPEi1ENY3ehhBzg_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_1_qiMQsxEEansi9pFiGvIg_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg"
      decimals="-3"
      id="Tc_gjc9h8r2FEKlZwlYopuCtA_7_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA"
      decimals="-3"
      id="Tc_5_kKSrCPKUim4zSWplHxaQ_7_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-72040000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw"
      decimals="-3"
      id="Tc_5ObIe81dU0aRuoPdtVjRFQ_7_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_oN7Xpi8W_0eBNu1Dy6zkJQ_7_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-72040000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_njMNCq0OeEmC_ZldWBWn8A_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_RkV2uheB-EOonCG5HrEIRg_9_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg"
      decimals="-3"
      id="Tc_tNd6m9zixEys7VfVLuioqA_9_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA"
      decimals="-3"
      id="Tc_zVr9TtfrekGruehRzOiYfA_9_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4126000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw"
      decimals="-3"
      id="Tc_P2kqqsXn1k2tPXpzV8DyUw_9_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_FKQa7BUKhUexxj1e4R8Rsg_9_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4126000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_neFRkkVFZUqacgyUsdw1xA_10_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">12097000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg"
      decimals="-3"
      id="Tc_RuQPaoTvgkei3N0ab3Y9Vw_10_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">24000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_fyj7dD-ujkS1LeME0hJhiw_10_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">12121000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_EZEFlSAlwkCVC_QfBB0XUQ_12_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">130000</aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset>
    <aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_6kjQW5yaL0ekZNlzisQ7xA_12_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">49741000</aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset>
    <aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_z7iCSsG0i0q3wBODBQ7Ujw_12_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">49871000</aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset>
    <aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_66qmzsKjg0WTog3tbeZGNQ_13_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">12000</aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity>
    <aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_ZG0ykchD3kep7AMvB2CKug_13_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4587000</aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity>
    <aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_9fTfucUu10y5dGpDMwfBGg_13_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4599000</aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_0Ui67obYOUChbnLEuSYKHg_14_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">61000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_GC2WBh5faUaGZkazymkjWQ_14_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">16683000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_fyrTHDiFfEe633fEGd1tbw_14_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">16744000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_CnI7VZnkhUqacVynTyV8oQ_15_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">48000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_CFUY_O38J0e-8bvYZdBkhw_15_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg"
      decimals="-3"
      id="Tc_lxeRYKDl8EyPDMf4YXiCFg_15_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-48000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA"
      decimals="-3"
      id="Tc_cQ32CGRS0UmBrG19jx3TEQ_15_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw"
      decimals="-3"
      id="Tc_4ucqKmLIY0-c54n8F-iwlw_15_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_MULY12MZRUevHchHACZ4rw_15_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_kKsJ49Ty_UycL3Hcj_EqUA_16_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_eO9qauTaHUK4MfqVXHNJRQ_16_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">171000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg"
      decimals="-3"
      id="Tc_-PfYVXgaCUyL0KNqiNFVbA_16_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA"
      decimals="-3"
      id="Tc_I0mmp2xRaEGjDH4xJQBEJw_16_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-178000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw"
      decimals="-3"
      id="Tc_SwJNGNrcGUyn3NHEp0j1KA_16_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_QIHqVaC3uUaK3xDnROVArw_16_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-6000</aciu:IssueOfEquityRestrictedShareAwards>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_v6AD0xlmM0ym4_sFTjpDGw_17_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_vocwJyXei0SnKAij_slR4A_17_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1082000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg"
      decimals="-3"
      id="Tc_zJeCtDpNvECZMzltRYhnEw_17_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_bXl5Z3aBfE-AWESd5-ldJA"
      decimals="-3"
      id="Tc_UA3ZTXZOPUyGAbeNTYOqXQ_17_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_jltEx6DCb062G_F-8z4Ljw"
      decimals="-3"
      id="Tc_72jnHeK4_Umq7gd6ghRyww_17_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_Cag5IKgQT0C_kON-m5jOCw_17_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1086000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember__r0D1g51PUiGX0X1UUsNSA"
      decimals="-3"
      id="Tc_IafOP9CfhECxgvOBPTdyzw_18_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1794000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_dfNJO7LfcEOZT4w2RTRitw"
      decimals="-3"
      id="Tc_9H2fQiHn1EqiAfUTqZjxDQ_18_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">431251000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Vs0uaVlFREaW6ng6T8fgEg"
      decimals="-3"
      id="Tc_q04YeUnzTE2GKYfkb8sRAg_18_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-124000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_frCDFRM6oU2SCVSiDhf4Lw"
      decimals="-3"
      id="Tc_mO_KMzY-90ihRHdiLBen_Q_18_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-200942000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_fNeupebFFUOPOyeQrvkYqA"
      decimals="-3"
      id="Tc_FO4Es08wxUOJCOqu7xxpgg_18_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_WKTpB7g7XEOG2KJx7MncuQ_18_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">231979000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember__r0D1g51PUiGX0X1UUsNSA"
      decimals="-3"
      id="Tc_GSnM5QoEcUOnMb4CITl5og_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1794000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_dfNJO7LfcEOZT4w2RTRitw"
      decimals="-3"
      id="Tc_ArXjdvLQhEqaCcLoETvrDw_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">431251000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Vs0uaVlFREaW6ng6T8fgEg"
      decimals="-3"
      id="Tc_vllY7o38gES0MbS4V3ZsBw_4_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-124000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_frCDFRM6oU2SCVSiDhf4Lw"
      decimals="-3"
      id="Tc_rHoWR73bZkq0IqRMUdFM9Q_4_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-200942000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_zjIzU5NTPEG8eUz-qyunDA_4_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">231979000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg"
      decimals="-3"
      id="Tc_0LRBTY0SiEisj4f6z-lGHg_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA"
      decimals="-3"
      id="Tc_NUgsBS8ZCUuDR_RwoCPWqg_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg"
      decimals="-3"
      id="Tc_CFif-0qX0E6Imx8WM3eUDA_5_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw"
      decimals="-3"
      id="Tc_9u9rBN0CekW7EAFdEa_ovA_5_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-70753000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ"
      decimals="-3"
      id="Tc_6QdmQ4T8tEOrBCOoJ7BKmQ_5_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_XGfOX-sirUWUZxvJmuy-AQ_5_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-70753000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg"
      decimals="-3"
      id="Tc_Pqg3JbflT0-CRcSn8DeYjQ_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA"
      decimals="-3"
      id="Tc_68intEz-0E2g1uinUmaX3Q_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg"
      decimals="-3"
      id="Tc_llSECF-pzUKZ-fCW9ojqXQ_6_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw"
      decimals="-3"
      id="Tc_gyPDElpKD0a-yuEa_sOiTQ_6_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4426000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ"
      decimals="-3"
      id="Tc_zWcC3hsGf0aDTwY2kxopfQ_6_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">10000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_6-aSYkFJd0e18fBnhbDyUw_6_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4436000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg"
      decimals="-3"
      id="Tc_FpWcOPXZiEOu4Oi0AbyGLw_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA"
      decimals="-3"
      id="Tc_Bu11iqjuLESfkM025mr6rA_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg"
      decimals="-3"
      id="Tc_6-zGBWXOiEapS56RuWjnAQ_7_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw"
      decimals="-3"
      id="Tc_pwfnKWAdEEWs-V9h0qpK2g_7_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-66327000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ"
      decimals="-3"
      id="Tc_y9T-p4euL0WAq5nXVzHH7g_7_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">10000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_v6VIzMJJ1E-ZYV1NFLiopw_7_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-66317000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg"
      decimals="-3"
      id="Tc_bFskihkLIkquZcH4Hy4Rww_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA"
      decimals="-3"
      id="Tc_54Lu0b8pLkWtNeuPpgKrpg_9_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg"
      decimals="-3"
      id="Tc_iEklsXiXL0mtoKpQhtY83A_9_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw"
      decimals="-3"
      id="Tc_sZtzBhzQrEerpNZ0bJhHNA_9_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3330000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ"
      decimals="-3"
      id="Tc_AYNEpqePv0OT1O95Hv4dJA_9_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_cokNQePFsUOq2qNB0NN2WQ_9_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3330000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA"
      decimals="-3"
      id="Tc_QMMoW1Ze8k6LOuyaxonqPg_10_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-8000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg"
      decimals="-3"
      id="Tc_jjsso6_xAUCBImYeAeOs7A_10_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_wcH4j-ITVEi6bsHbbMubsA_10_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-8000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg"
      decimals="-3"
      id="Tc_kcjRqYzywEOaEvgN89OUsQ_12_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA"
      decimals="-3"
      id="Tc_S_Ngp913RkqOaEriSRai3w_12_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">76000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg"
      decimals="-3"
      id="Tc_b9Q2T3tLB0qr5zORDF0vlw_12_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw"
      decimals="-3"
      id="Tc_-b71oSXtLUSNGFLNum3-5w_12_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-76000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ"
      decimals="-3"
      id="Tc_b83Ti97n90Occaw_GaP_Fw_12_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_Wy-ykgQlNUK7y6-GSDxbiA_12_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:IssueOfEquityRestrictedShareAwards>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg"
      decimals="-3"
      id="Tc_-94iye2yGUGiyYwX0JZiaQ_13_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA"
      decimals="-3"
      id="Tc_oxVpqoXzJkekWd7OSzTuLg_13_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg"
      decimals="-3"
      id="Tc_aPiSd82fgkSdzuIlu1oVeA_13_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_0lyLvb3iw0GL9FhUFjQUbw"
      decimals="-3"
      id="Tc_mBmvsexDF0-Vdf8TcDVJLA_13_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_-aNQF1bJ2USp-7jp2y93VQ"
      decimals="-3"
      id="Tc_X4tfOvxyh0WFcmXEdyeNBw_13_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_cbeHiSeYm0a6lVZReNrExg_13_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_gp09PWsb8EavwbWAh0p_Sg"
      decimals="-3"
      id="Tc_d8bwB5EvlkqEZhFBTKOxIA_14_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1797000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_8sJpe0LyAECOfOJdgZOKPQ"
      decimals="-3"
      id="Tc_m5xdQSbcP0q8kw4LYOnqBA_14_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">431323000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_hgoBF8GS-k-cs9msKZyyhA"
      decimals="-3"
      id="Tc_yWwx4K2Xuk6QeoZYbwZLAQ_14_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-124000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_y4uYlYwmHUaTK3M_16Tcuw"
      decimals="-3"
      id="Tc_k6Pu_ZRSFUmwhdEo__MXyw_14_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-264015000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_GwujP39d00mK3lHW3oUw4A"
      decimals="-3"
      id="Tc_WI7YPVo6O0CoHE8JQJ8UrA_14_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">10000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_qrWSjihy2EWSFFHSF3gsfQ_14_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">168991000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_Jb0TEZFDG0q0m6tjBpwBZA_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-70753000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_gGLhwZq_5U-F2wMelrX7Mw_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-72996000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_R_7CXlykbEGdspOFLUCqfw_5_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-61921000</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_Bk5wApfHa02ZNB5lZrKyyg_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1793000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_3pIuv-CWW0uEouy-bqgy5Q_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1897000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_NR3cK3PpfkqmrqZDCHiMwQ_7_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1535000</ifrs-full:AdjustmentsForDepreciationExpense>
    <aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_Oo5nrX8SvU--MfvhGE7GLw_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">566000</aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets>
    <aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc__LLCZAnz7kaLqeGttgYBCA_8_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">509000</aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets>
    <aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_j0kaEsZimEKmRYtl5rfCbA_8_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">432000</aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_tpaJJfjqzU2xjvY1abWcUw_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">559000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_czEWj6theEWedHzFTlTXvw_9_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">6769000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_JCgBVRBLt06d19KwHxloAQ_9_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-376000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_6ghfBa8FUEGg0ChoxrnmWw_10_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3330000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_2bZzZ-Y-c0mvIxtVP_cJeA_10_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4126000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_JU7YBoDHZUi4bF5fKDWfvA_10_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4088000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_KxC4W4qaaU-dzrRSZtEQXg_11_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">541000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_-IVNNSq1E0mmRfm5cjpuZQ_11_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">590000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_vAuDaKtrc0a8DnFGRgyShQ_11_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">705000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_Bz6kAY0FnkKQOM9EGlD7Pg_12_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">355000</ifrs-full:AdjustmentsForInterestExpense>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_dMO4SuUYP0yGrheZIZQTSw_12_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">573000</ifrs-full:AdjustmentsForInterestExpense>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_m3JFBs6_aEyCj9tpae0HRA_12_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">175000</ifrs-full:AdjustmentsForInterestExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_GP_fos7N7EC0vSUla65_nQ_13_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_3Espc9q0ikegNRyqXspHJw_13_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-13000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_0w--WwpQoEaGTkyPtO2mag_13_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">64000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_Llq7Jn61aEa7P-KGMEdnxA_15_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-1718000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_a_aOJ0ZZrEOM8Weq9H54nA_15_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">791000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_TRvqMRAg5kWI-LGNiUWSJg_15_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-1304000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_yfoP8bnYqkif0_yfSXUCcg_16_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">567000</ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_3aMIepX9NEyjkA28STiLww_16_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">594000</ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_Y_koJJ9S1E670NK_KBIZ4w_16_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-507000</ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_zyXUz1fHRUmxVmlQ0vs7sg_17_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">36000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_Z5FWMU8NGU-gp39rqCGtnQ_17_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-99000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_PtyK2GksPEG0ekyR5tqRqg_17_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-25000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_FIksIYNNUUSlEZXH4q3gpg_18_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">6114000</aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses>
    <aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_MYKakNCa4ESYsoKjd8SI7Q_18_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-5214000</aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses>
    <aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_Dx02XaqAdUySLGPBSRQJVw_18_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">757000</aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_7hTgbaSdM0W4vPqQOWkVfg_19_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-130000</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_LFVWfMGY0Eq4hWkQEGFfuw_19_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">425000</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc__OfjjOKPW0OgFyb_SDwekA_19_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-4157000</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_B0bGHioph0aCPEhswrK3FQ_20_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-1073000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_27yR8Sk6f0CFxNyrrFmpug_20_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-84000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_tjC46Kj2hEu3d3rFHJ4lPg_20_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2177000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_29NYA65vakqrHJwrrPk5DQ_21_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-73159000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_aV9EPP_go0yeK4t6Y7Wc4Q_21_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-65216000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_HiCmfqpSdU6UrowAPTjVVw_21_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-59247000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_XK9tstmekUKtvxt0mDj7hw_22_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">69000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_KjrmxMVfi0KvqWR-UGyICQ_22_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_K47NNx-OE06-Jju74Kf7Cg_22_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">78000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_l6JyDBcF2EWZSK2B24WyTA_23_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">470000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_u9X0U3kfHEuP4AtMOHe0hQ_23_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">465000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_C2pzzByMi0eGHA7r5rh4oQ_23_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">339000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_6lAhCdscRUam8i67Xu8Pug_24_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">8000</ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities>
    <ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_EYUQsnKCPEW3ZNJz-jM-kQ_24_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">8000</ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities>
    <ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_F92KR8zIlkizV7J6jtrAuQ_24_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9000</ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_mHZzbsh1J0G2xfYzIJEFtw_25_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-73568000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_-DCvnVTR3EOdsaCFQQbAvw_25_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-65689000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc__vAi909cF0eS3lzFpk-lsA_25_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-59517000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_bGUfPTCHjUqDqJbYJFCIBg_28_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-25000000</aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities>
    <aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_xleZWOXAkkaQVE3kidyRsA_28_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">51000000</aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities>
    <aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_1nToXc_850iMTezDhqfeHw_28_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-30000000</aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_zoRI0ArPNkmF9p21v8sVkA_29_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1239000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_TcAW1ttxwE2Il16g57_7dw_29_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2635000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_2JI8xQKnm0u2ZVhVkNnTrA_29_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1706000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_mvMiIWA3TUeVAJ3a1YM0fQ_30_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_VO2OSxoHDECL-azDgQUd3w_30_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_oh6Q3E1wak6lgrtitWDXkQ_30_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">64000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <aciu:CashAdvancesForRentDeposit
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_uWxUx0j_0kSK71WIWUrhmg_31_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-2000</aciu:CashAdvancesForRentDeposit>
    <aciu:CashAdvancesForRentDeposit
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_bIeVtMNHeEyuzhUXi0ql0A_31_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">29000</aciu:CashAdvancesForRentDeposit>
    <aciu:CashAdvancesForRentDeposit
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_2QVJHGEWoE2Xnb5tB7FzFw_31_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">29000</aciu:CashAdvancesForRentDeposit>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_dIz5NWlIrEmzDak_uLQ88w_32_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">23763000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_zzT-m4R_dEi_x0vpfBxmdQ_32_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-53664000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_0y2dSahD7kOzcd3sRPTsNg_32_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">28329000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <aciu:ProceedsFromIssueOfConvertibleDebt
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_QZhhRSjvhEmT1OobCnQJmQ_35_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:ProceedsFromIssueOfConvertibleDebt>
    <aciu:ProceedsFromIssueOfConvertibleDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_q96bxHxuckau9K3M1i8Wgw_35_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">23463000</aciu:ProceedsFromIssueOfConvertibleDebt>
    <aciu:ProceedsFromIssueOfConvertibleDebt
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_h5sz9faHik2yKBuJlgYF8Q_35_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:ProceedsFromIssueOfConvertibleDebt>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_-ebijTdP2EadkdoWm5V05g_36_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_cKsl0j2ubEW_4cye_qx8vw_36_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">6000</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_wLno5Ojqq0mklcr32hcwnQ_36_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:PaymentsForShareIssueCosts>
    <aciu:ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_J9J9dc415EmwMGLCHED9bw_37_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-8000</aciu:ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_kNk4ATLHV06Vs4JwFFbj5A_38_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_WV1nIi95zkqMnBBURykA2g_38_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">12121000</aciu:ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_jR2g8RKuCUCg-J_NwB9aJw_38_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">100000</aciu:ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_uToFqYoUikeNNwonmJDHdw_39_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_UpF887K7K0eIBX_wHdO3xQ_39_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4599000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_vX3JpusWjkSuLKOdqVpMLg_39_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_7uD3iMpqVEW7ejbg7Q5diA_40_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_zgmmGdxlok2DttzMn-vfZg_40_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1082000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_FZbuednykE21cifOkwulnA_40_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">143000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_EbqHtP3NRUqGxM4qJDl72Q_41_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">569000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_SCopM4SsmUazoKIzhKLrLw_41_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">513000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_68OwILXl-kCVfS84sclqKw_41_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">432000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <aciu:PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_Ye5XrSCPkUq221QYHoRamg_42_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">776000</aciu:PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions>
    <ifrs-full:RepaymentsOfCurrentBorrowings
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_VTazu9e4OU6sMUv1tfP-4g_43_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RepaymentsOfCurrentBorrowings>
    <ifrs-full:RepaymentsOfCurrentBorrowings
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_6jSEDb7WikWPDnsmnfTndQ_43_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RepaymentsOfCurrentBorrowings>
    <ifrs-full:RepaymentsOfCurrentBorrowings
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_x5zB42bD3EGkCL3qUegF_A_43_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">514000</ifrs-full:RepaymentsOfCurrentBorrowings>
    <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_5-7ESsswkkeRZcxiUkqX8g_44_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
    <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_wWUlsS2z-k2n9WsQ9gvr0w_44_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
    <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_llEAIngy2E2cC45E1gIsww_44_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">100000</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_ePQrpzLf4UOT2mWr6RYJkQ_45_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-1346000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_3lER2wGtWk-1ljk0XSSeUA_45_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">40746000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_sK0xjiGvs0aN_3KTTGWkBw_45_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-803000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_P4bbh3pQhUOaGxPki8YjAQ_47_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-51151000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_jKD6pdZuI0qpzGDi4OeEVQ_47_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-78607000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_74jnoyJsJ02AVttvG3TA4A_47_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-31991000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_bG-uh7pWPUiTAToHMPg3Mw_49_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">82216000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="-3"
      id="Tc_Fd88g__d20usrKCPjPUo5A_49_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">160893000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2019_C854zoDUpkSi-bE7TYeEJw"
      decimals="-3"
      id="Tc_00j80jzGm0C8-5iv7O-fCg_49_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">193587000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_tBqlLMYc-02_wLXtVXA7Hg_50_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">521000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_fsA1cu_pvk2tYH09rLyTiA_50_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-70000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_cmUKNpwrBkuRg_BTNdKTaw_50_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-703000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_TL0hcvlzpkmN7J2cnyO31Q_51_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">31586000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_maWG9rf1YUaDJrNK_s-SLg_51_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">82216000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="-3"
      id="Tc_xiVxEAOjDUCAIBso4M6fAQ_51_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">160893000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc__daJV9dXlkyRZBji0464eQ_53_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-51151000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_Z5VcVcDJtEmm3_pUd0rO2g_53_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-78607000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_OmM2vtQEz02vrrZxPEQxIw_53_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-31991000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_Q_E9miQUg0uBPA4dv0rjiA_56_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities>
    <aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_xMBIJnPB50mtRUP5AUo3iA_56_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">303000</aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities>
    <aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_qXvtUNk4z0u-J5HZivw5wQ_56_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">328000</aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities>
    <aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_PMsSI_ol7ES7NJrfIxVDIQ_57_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition>
    <aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_NpopDYkDeUKc8EA1GiZGTA_57_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">50416000</aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition>
    <aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_2GHe9E0MSEKvivT8YJTyYA_57_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_juqXW8GvvkmMXGBx7XF0VA_58_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_dmkkK1vk_ki91fI1kbkYaA_58_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">776000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_K2aKAre_kkaS2eLnXl6-0w_58_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ShareIssueRelatedCost>
    <aciu:RepaymentOfConvertibleDebtEquitySettlementAmount
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_fPytKBSij0O3I5qzc4cm_A_59_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:RepaymentOfConvertibleDebtEquitySettlementAmount>
    <aciu:RepaymentOfConvertibleDebtEquitySettlementAmount
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_3dujkd8DDky6-uuynQe1hA_59_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">16920000</aciu:RepaymentOfConvertibleDebtEquitySettlementAmount>
    <aciu:RepaymentOfConvertibleDebtEquitySettlementAmount
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_oZRhjB8Dtk6BLBqzpnweHQ_59_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:RepaymentOfConvertibleDebtEquitySettlementAmount>
    <aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_gF2eBXaQV0aFWJwKhncuZw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;AC Immune SA&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;Notes&#160;to the Consolidated Financial Statements&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;(In CHF thousands except for share and per share data)&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;1.&lt;/b&gt;&lt;/span&gt;General information&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune SA was founded in 2003. The Company controls a fully-owned subsidiary, AC Immune USA,&#160;Inc. (&#x201c;AC Immune USA&#x201d; or &#x201c;Subsidiary&#x201d; and, together with AC Immune SA, &#x201c;AC Immune,&#x201d; &#x201c;ACIU,&#x201d; &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; &#x201c;ours,&#x201d; &#x201c;us&#x201d;), which was registered and organized under the laws of Delaware, USA in June&#160;2021. The Company and its Subsidiary form the Group.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune SA is a clinical-stage biopharmaceutical company leveraging our two proprietary technology platforms to discover, design and develop novel proprietary medicines and diagnostics for prevention and treatment of neurodegenerative diseases (NDD) associated with protein misfolding. Misfolded proteins are generally recognized as the leading cause of NDD, such as Alzheimer&#x2019;s disease (AD) and Parkinson&#x2019;s disease (PD), with common mechanisms and drug targets, such as amyloid beta (Abeta), Tau, alpha-synuclein (a-syn) and TDP-43. Our corporate strategy is founded upon a three-pillar approach that targets (i)&#160;AD, (ii)&#160;focused non-AD NDD including Parkinson&#x2019;s disease, ALS and NeuroOrphan indications and (iii)&#160;diagnostics. We use our two unique proprietary platform technologies, SupraAntigen (conformation-specific biologics) and Morphomer (conformation-specific small molecules), to discover, design and develop novel medicines and diagnostics to target misfolded proteins.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company was initially incorporated as a limited liability company on February&#160;13, 2003 in Basel, and effective August&#160;25, 2003 was transformed into a stock company. The Company&#x2019;s corporate headquarters are located at EPFL Innovation Park Building B, 1015 Lausanne, Switzerland.&lt;/p&gt;</aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock>
    <aciu:NumberOfTechnologyPlatforms
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="INF"
      id="Narr_wLnwBUdHf0GfBvNsNzHLQQ"
      unitRef="Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ">2</aciu:NumberOfTechnologyPlatforms>
    <aciu:NumberOfTechnologyPlatforms
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="INF"
      id="Narr_tOmYt-Dpx0G5Lv6GFHjzNQ"
      unitRef="Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ">2</aciu:NumberOfTechnologyPlatforms>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_i1fEu7DHnEyVMyyxznD9LA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;2.&lt;/b&gt;&lt;/span&gt;Basis of preparation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Going concern&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company believes that it will be able to meet all of its obligations as they fall due for at least 12&#160;months from the filing date of this Form 20-F, after considering the Company&#x2019;s cash position of CHF 31.6 million and short-term financial assets of CHF 91.0 million as of December&#160;31, 2022. Hence, these consolidated financial statements have been prepared on a going-concern basis.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;To date, the Company has financed its cash requirements primarily from its public offerings, share issuances, contract revenues from license and collaboration agreements (LCAs) and grants. The Company is a clinical stage company and is exposed to all the risks inherent to establishing a business. Inherent to the Company&#x2019;s business are various risks and uncertainties, including the substantial uncertainty as to whether current projects will succeed and our ability to raise additional capital as needed. These risks may require us to take certain measures such as delaying, reducing or eliminating certain programs. The Company&#x2019;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;successfully move its product candidates through clinical development, (iv)&#160;attract and retain key personnel and (v)&#160;acquire capital to support its operations.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Statement of compliance&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). These consolidated financial statements were approved for issue by the Board of Directors on March&#160;15, 2023.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Basis of measurement&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The consolidated financial statements have been prepared under the historical cost convention except for items that are required to be accounted for at fair value.&lt;/p&gt;</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-5"
      id="Narr_UVysGpVs1UWArFpZYJFcjQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">31600000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-5"
      id="Narr_C-mVVDe-ckCvj2iVbTayTg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">91000000.0</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_kWrgqHMI4E-AERaRyItnUQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;3.&lt;/b&gt;&lt;/span&gt;Summary of significant accounting policies&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The principal accounting policies adopted in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the&#160;years presented, unless otherwise stated.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Functional and reporting currency&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;These consolidated financial statements and accompanying notes are presented in Swiss Francs (CHF), which is AC Immune SA&#x2019;s functional currency and the Group&#x2019;s reporting currency. The Company&#x2019;s subsidiary has a functional currency of the U.S. Dollar (USD). The respective functional currency represents the primary economic environment in which the entities operate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following exchange rates have been used for the translation of the financial statements of AC Immune USA:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;CHF/USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Closing rate, USD 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.933&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.923&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;N/A&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average exchange rate, USD 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.965&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.929&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;N/A&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The results and financial position of AC Immune USA are translated into the presentation currency as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;i.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;assets and liabilities for each balance sheet presented are translated at the closing rate at the date of that balance sheet;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;ii.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;income and expenses for each statement of income/(loss) are translated at average exchange rates; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;iii.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;all resulting exchange differences are recognized in other comprehensive income/(loss), within cumulative translation differences.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Basis of consolidation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The annual closing date of the individual financial statements is December&#160;31. The Company fully-owns its Subsidiary and fully consolidates its financial statements into these consolidated financial statements. All intercompany transactions have been eliminated.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Foreign currency transactions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Foreign currency transactions are translated into the respective functional currency using prevailing exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at&#160;year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the consolidated statements of income/(loss). Any gains or losses from these translations are included in the consolidated statements of income/(loss) in the period in which they arise.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Current vs. non-current classification&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company presents assets and liabilities in the consolidated balance sheets based on current/non-current classification. The Company classifies all amounts to be realized or settled within 12&#160;months after the reporting period to be current and all other amounts to be non-current.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Revenue recognition&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company applies IFRS 15&#160;&lt;i style="font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/i&gt;. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under IFRS 15, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of IFRS 15, the entity performs the following five steps: (i)&#160;identify the contract(s)&#160;with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of IFRS 15, the Company assesses the goods or services promised within each contract, and determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company enters into LCAs which are within the scope of IFRS 15, under which it licenses certain rights to its product candidates and intellectual property to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees, development, regulatory and/or commercial milestone payments;&#160;payments for research and clinical services the Company provides through either its full-time employees or third-party vendors, and royalties on net sales of licensed products commercialized from the Company&#x2019;s intellectual property. Each of these payments results in license, collaboration and other revenues, which are classified as contract revenue on the consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Licenses of intellectual property&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;If the license to the Company&#x2019;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are sold in conjunction with a related service, the Company uses judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If the performance obligation is settled over time, the Company determines the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, upfront fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Milestone payments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At the inception of each arrangement that includes development, regulatory and/or commercial milestone payments, the Company evaluates whether the milestones are considered highly probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant cumulative revenue reversal would not occur in future periods, the associated milestone value is included in the transaction price. These amounts for the performance obligations under the contract are recognized as they are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments recorded would affect contract revenues and earnings in the period of adjustment.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Research and development services&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has certain arrangements with our collaboration partners that include contracting our employees for research and development programs. The Company assesses if these services are considered distinct in the context of each contract and, if so, they are accounted for as separate performance obligations. These revenues are recorded in contract revenue as the services are performed.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Sublicense revenues&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has certain arrangements with our collaboration partners that include provisions for sublicensing. The Company recognizes any sublicense revenues at the point in time it is highly probable to obtain and not subject to reversal in the future.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Contract balances&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company receives payments and determines credit terms from its customers for its various performance obligations based on billing schedules established in each contract. The timing of revenue recognition, billings and cash collections results in billed other current receivables, accrued income (contract assets), and deferred income (contract liabilities) on the consolidated balance sheets. Amounts are recorded as other current receivables when the Company&#x2019;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be 1&#160;year or less.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For a complete discussion of accounting for contract revenue, see &#x201c;Note&#160;13. Contract revenues.&#x201d;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Research and development expenses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Given the stage of development of the Company&#x2019;s products, all research and development expenditure is expensed as incurred as it does not meet the capitalization criteria outlined in IAS 38 &lt;i style="font-style:italic;"&gt;Intangible Assets&lt;/i&gt;. The Company has not capitalized any R&amp;amp;D expenses to date. Research and development expenditures include:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;the cost of acquiring, developing and manufacturing active pharmaceutical ingredients for product candidates that have not received regulatory approval, clinical trial materials and other research and development materials;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;fees and expenses incurred under agreements with contract research organizations, investigative sites and other entities in connection with the conduct of clinical trials and preclinical studies and related services, such as administrative, data-management and laboratory services;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;fees and costs related to regulatory filings and activities;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;costs associated with preclinical and clinical activities;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;employee-related expenses, including salaries and bonuses, benefits, travel and share-based compensation expenses; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;all other allocated expenses such as facilities and information technology (IT) costs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For external research contracts, expenses include those associated with contract research organizations, or CROs, or contract manufacturing organizations, or CMOs. The invoicing from CROs or CMOs for services rendered do not always align with work performed. We accrue the cost of services rendered in connection with CRO or CMO activities based on our estimate of the &#x201c;stage of completion&#x201d; for such contracted services. We maintain regular communication with our CRO or CMO vendors to gauge the reasonableness of our estimates and accrue expenses as of the balance sheet date in the consolidated financial statements based on facts and circumstances known at the time.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Registration costs for patents are part of the expenditure for research and development projects. Therefore, registration costs for patents are expensed when incurred as long as the research and development project concerned does not meet the criteria for capitalization.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;General and administrative expenses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;General and administrative expenses are expensed as incurred and include personnel costs, expenses for outside professional services and all other allocated expenses. Personnel costs consist of salaries, cash bonuses, benefits and share-based compensation. Outside professional services consist of legal, accounting and audit services, IT and other consulting fees. Allocated expenses consist of certain IT, facilities and depreciation expenses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Grant income&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has received grants, from time to time, from the Michael J. Fox Foundation (MJFF), the Target ALS Foundation (Target ALS) and other institutions to support certain research projects. Grants are recorded at their fair value in the consolidated statements of income/(loss) within other operating income/(expenses), net when there is reasonable assurance that the Company will satisfy the underlying grant conditions and the grants will be received. In certain circumstances, grant income may be recognized before formal grantor acknowledgement of milestone achievements. To the extent required, grant income is deferred and recognized on a systematic basis over the periods in which the Company expects to recognize the related expenses for which the grants are intended to compensate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Leases&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company applies IFRS 16 &lt;i style="font-style:italic;"&gt;Leases&lt;/i&gt;, which provides the model for lessee accounting in which all leases, other than short-term and low-value leases, are accounted for by the recognition on the consolidated balance sheet of a right-of-use asset and a lease liability, and the subsequent amortization of the right-of-use asset over the earlier of the end of the useful life or the lease term. In accordance with IFRS 16, the Company (i)&#160;does not recognize right-of-use assets and lease liabilities for leases of low value (i.e. approximate fair value of USD 5,000). For a complete discussion of accounting, see &#x201c;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#x201d;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Right-of-use assets and lease liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At inception of a leasing contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#x2019;s incremental borrowing rate. The lease liabilities are classified as current or non-current based on the due dates of the underlying principal payments.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Lease payments generally are fixed for the contract term. The lease liability is measured at amortized cost using the effective interest method. The lease liability is re-measured if there is a change in the estimated lease term, a change in future lease payments arising from a change in an index or rate, a change in the Company&#x2019;s estimate of the amount expected to be payable under a residual value guarantee or a change in assessment of whether it will exercise a purchase, extension or termination option.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At inception, the right-of-use asset comprises the initial lease liability and any initial direct costs. The right-of-use asset is depreciated over the shorter of the lease term or the useful life of the underlying asset. The right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain re-measurements of the lease liability performed on as certain potential triggering events may arise (e.g. lease modifications). When the lease liability is re-measured, a corresponding adjustment is made to the carrying amount of the right-of-use asset or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The estimated lease term by right-of-use asset categories are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Office equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Both the right-of-use-assets and lease liabilities are recognized in the consolidated balance sheets.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Property, plant and equipment&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;Equipment is shown at historical acquisition cost, less accumulated depreciation and any accumulated impairment losses. Historical costs include expenditures that are directly attributable to the acquisition of the property, plant and equipment. Depreciation is calculated using a straight-line method to write off the cost of each asset to its residual value over its estimated useful life as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Leasehold improvements/furniture&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The assets&#x2019; residual values and useful lives are reviewed, and adjusted if appropriate, at each balance sheet date. Where an asset&#x2019;s carrying amount is greater than its estimated recoverable amount, it is written down to its recoverable amount.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Gains and losses on disposals are determined by comparing the disposal proceeds with the carrying amount and are included in the consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Intangible assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune&#x2019;s acquired in process research and development (IPR&amp;amp;D) asset is stated at cost less any impairments. The Company does not deem this asset ready for use until the asset obtains market approval. Therefore, during the development period after the date of acquisition until market approval, the IPR&amp;amp;D asset is not amortized. Upon market approval, the Company will determine the useful life of the asset, reclassify it from IPR&amp;amp;D and commence amortization. If the associated R&amp;amp;D effort is abandoned, the related IPR&amp;amp;D will likely be written off and we will record the relevant impairment charge. Finally, the Company will not capitalize future development costs in respect to this IPR&amp;amp;D asset until they meet the criteria for capitalization of research and development costs in accordance with IAS 38 &lt;i style="font-style:italic;"&gt;Intangible Assets&lt;/i&gt;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Our IPR&amp;amp;D asset is subject to impairment testing at least annually or when there are indications that the carrying value may not be recoverable until the completion of the development process. The determination of the recoverable amounts include key estimates which are highly sensitive to, and dependent upon, key assumptions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company uses a discounted cash flow method to determine the fair value less costs to sell (recoverable amount) of our IPR&amp;amp;D intangible asset. The Company starts with a forecast of all the expected net cash flows, which incorporates the consideration of a terminal value and then the Company applies a discount rate to arrive at a risk-adjusted net present value amount.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Any impairment losses are recognized immediately in the consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Fair value of financial assets&#160;and liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The Company&#x2019;s financial assets and liabilities are composed of receivables, short-term financial assets, cash and cash equivalents, trade payables and lease liabilities. The fair value of these financial instruments approximates their &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;respective carrying values due to the short-term maturity of these instruments, and are held at their amortized cost in accordance with IFRS 9, unless otherwise explicitly noted.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Receivables&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Receivables are recognized at their billing value. An allowance for doubtful accounts is recorded for potential estimated losses when there is evidence of the debtor&#x2019;s inability to make required payments and the Company assesses on a forward-looking basis the expected credit losses associated with these receivables held at amortized cost.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Short-term financial assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Short-term financial assets are held with external financial institutions and comprise fixed-term deposits with maturities ranging from more than 3 through 12&#160;months in duration.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company assesses whether there is objective evidence that financial assets are impaired annually or whenever potential impairment triggers may occur.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Cash and cash equivalents include deposits held with external financial institutions and cash on hand. All cash and cash equivalents are either in cash or in deposits with original duration of less than 3&#160;months.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Trade payables&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Trade payables are amounts due to third parties in the ordinary course of business.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Share capital and public offerings&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Common shares are classified as equity. Share issuance costs are capitalized as incurred and will be shown in equity as a deduction, net of tax, from the proceeds received from existing or future offerings. Should a planned equity offering not be assessed as probable, the issuance costs would be expensed immediately in the consolidated statements of income/(loss). See &#x201c;Note&#160;11. Share capital.&#x201d;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Treasury shares&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Treasury shares are recognized at acquisition cost and deducted from shareholders&#x2019; equity at the time of acquisition, until they are subsequently resold, distributed or cancelled. Where such shares are subsequently sold, any consideration received is included in shareholders&#x2019; equity. See &#x201c;Note&#160;11. Share capital.&#x201d;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Employee benefits&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Post-employment benefits&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company operates the mandatory pension schemes for its employees in Switzerland. The schemes are generally funded through payments to insurance companies. The Company has a pension plan designed to pay pensions based on accumulated contributions on individual savings accounts. However, this plan is classified as a defined benefit plan under IAS 19.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The net defined benefit liability is the present value of the defined benefit obligation at the balance sheet date minus the fair value of plan assets. Significant estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. The defined benefit obligation is calculated annually with the assistance of an independent actuary using the projected unit credit method, which reflects services rendered by employees to the date of valuation, incorporates assumptions concerning employees&#x2019; projected salaries and pension increases as well as discount rates of highly liquid corporate bonds that have terms to maturity approximating the terms of the related liability.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;To the extent that the fair value of the plan assets is greater than the present value of the defined benefit obligation as calculated by our independent actuary, the Company accounts for the effect of the asset ceiling test under IAS 19.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Re-measurements of the net defined benefit liability, which comprise actuarial gains and losses and the return on plan assets (excluding interest) are recognized immediately in the consolidated statements of other comprehensive income/(loss). Past service costs, including curtailment gains or losses, are recognized immediately as a split in research and development and general and administrative expenses within the operating results. Settlement gains or losses are recognized in either research and development and/or general and administrative expenses within the operating results. The Company determines the net interest expense/(income) on the net defined benefit liability for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period or in case of any significant events between measurement dates to the then-net defined benefit liability, considering any changes in the net defined benefit liability during the period as a result of contributions and benefit payments. Net interest expense/(income) and other expenses related to defined benefit plans are recognized in the consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Share-based compensation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company operates an equity-settled, share-based compensation plan. The fair value of the employee services received in exchange for the grant of equity-based awards is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the instruments granted, excluding the impact of any non-market vesting conditions. Non-market vesting conditions are included in assumptions about the number of instruments that are expected to become exercisable. At each balance sheet date, the Company revises its estimates of the number of instruments that are expected to become exercisable. It recognizes the impact of the revision of original estimates, if any, prospectively in the consolidated statements of income/(loss), and a corresponding adjustment to equity over the remaining vesting period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Stock options granted under the Company&#x2019;s stock option plans C1 and the 2016 Stock Option and Incentive Plan are valued using the Black-Scholes option-pricing model (see &#x201c;Note&#160;18. Share-based compensation&#x201d;). This valuation model as well as parameters used such as expected volatility and expected term of the stock options are partially based on management&#x2019;s estimates.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;We estimate the fair value of restricted share units using a reasonable estimate of market value of the common shares on the date of the award. We classify our share-based payments as equity-classified awards as they are settled in common shares. We measure equity-classified awards at their grant date fair value and do not subsequently re-measure them. Compensation costs related to equity-classified awards are equal to the fair value of the award at grant date amortized over the vesting period of the award using the graded method. We reclassify that portion of vested awards to share capital and share premium as the awards vest.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Provisions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events where it is more likely than not that an outflow of resources will be required to settle the obligation, and a reliable estimate of the amount can be made.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Taxation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Current income tax assets and liabilities for the period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the tax amounts are those that are enacted or substantively enacted, at the reporting date in accordance with the fiscal regulations of the respective country where the Company operates and generates taxable income. Deferred tax is provided using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the&#160;year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date. If required, deferred taxation is provided in full using the liability method, on all temporary differences at the reporting dates. It is calculated at the tax rates that are expected to apply to the period when it is anticipated the liabilities will be settled, and it is based on tax rates (and laws) that have been enacted or substantively enacted at the reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized. Although the Company has substantial tax loss carry-forwards, historically, due to the fact that the Company had limited certainty on the achievement of key milestones, it has not recognized any deferred tax assets as the probability for use is low.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As disclosed in &#x201c;Note&#160;16. Income taxes,&#x201d; the Company has tax losses that can generally be carried forward for a period of 7&#160;years from the period the loss was incurred. These tax losses represent potential value to the Company to the extent that the Company is able to create taxable profits before the expiry period of these tax losses. The Company has not recorded any deferred tax assets in relation to these tax losses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Earnings per share&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company presents basic earnings per share for each period in the consolidated financial statements. The earnings per share are calculated by dividing the earnings of the period by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential dilution that could occur if dilutive securities such as share options or non-vested restricted share units were vested or exercised into common shares or resulted in the issuance of common shares that would participate in net income. Anti-dilutive shares are excluded from the dilutive earnings per share calculation.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Critical judgments and accounting estimates&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The preparation of financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The areas where AC Immune has had to make judgments, estimates and assumptions relate to (i)&#160;revenue recognition on LCAs, (ii)&#160;clinical development accruals, (iii)&#160;net employee defined benefit liability, (iv)&#160;income taxes, (v)&#160;share-based compensation, (vi)&#160;right-of-use assets and lease liabilities and (vii)&#160;our IPR&amp;amp;D asset. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Segment reporting&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company is managed and operated as one business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. Accordingly, the Company views its business and manages its operations as one operating segment. Non-current assets are located in, and revenue is allocated and recorded within, the Company&#x2019;s country of domicile, Switzerland.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Accounting policies, new standards, interpretations and amendments adopted by the Company&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;There are no new IFRS standards, amendments or interpretations that are mandatory as of January 1, 2022 that are relevant to the Company. Additionally, the Company has not adopted any standard, interpretation or amendment that has been issued but is not yet effective. Such standards are not currently expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions.&lt;/p&gt;</ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_RhEZkc_5gE6jmYPrsz5rUg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Functional and reporting currency&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;These consolidated financial statements and accompanying notes are presented in Swiss Francs (CHF), which is AC Immune SA&#x2019;s functional currency and the Group&#x2019;s reporting currency. The Company&#x2019;s subsidiary has a functional currency of the U.S. Dollar (USD). The respective functional currency represents the primary economic environment in which the entities operate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following exchange rates have been used for the translation of the financial statements of AC Immune USA:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;CHF/USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Closing rate, USD 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.933&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.923&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;N/A&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average exchange rate, USD 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.965&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.929&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;N/A&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The results and financial position of AC Immune USA are translated into the presentation currency as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;i.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;assets and liabilities for each balance sheet presented are translated at the closing rate at the date of that balance sheet;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;ii.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;income and expenses for each statement of income/(loss) are translated at average exchange rates; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;iii.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;all resulting exchange differences are recognized in other comprehensive income/(loss), within cumulative translation differences.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;</ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory>
    <ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_uCL6uChV7EapB8Yt8z1Bdg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following exchange rates have been used for the translation of the financial statements of AC Immune USA:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;CHF/USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Closing rate, USD 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.933&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.923&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;N/A&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.98%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average exchange rate, USD 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.965&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.929&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;N/A&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="3"
      id="Tc_63MihMDHe0-xX0RnZGeOCQ_5_2"
      unitRef="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w">0.933</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="3"
      id="Tc_env1iXWA60-2HjWUJVcFNA_5_4"
      unitRef="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w">0.923</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="3"
      id="Tc_99abvZrbwEafptuMAvlXPA_6_2"
      unitRef="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w">0.965</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="3"
      id="Tc_R71Pb4pNxki02QzmCzvsvw_6_4"
      unitRef="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w">0.929</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:DisclosureOfBasisOfConsolidationExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_EQ76wnftH0iu7zlCU7hNiQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Basis of consolidation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The annual closing date of the individual financial statements is December&#160;31. The Company fully-owns its Subsidiary and fully consolidates its financial statements into these consolidated financial statements. All intercompany transactions have been eliminated.&lt;/p&gt;</ifrs-full:DisclosureOfBasisOfConsolidationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_3Cb0RXBV80y1gJYX8fFErA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Foreign currency transactions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Foreign currency transactions are translated into the respective functional currency using prevailing exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at&#160;year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the consolidated statements of income/(loss). Any gains or losses from these translations are included in the consolidated statements of income/(loss) in the period in which they arise.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <aciu:DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_Ga6O9dWCdUext4nxr1Ls_Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Current vs. non-current classification&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company presents assets and liabilities in the consolidated balance sheets based on current/non-current classification. The Company classifies all amounts to be realized or settled within 12&#160;months after the reporting period to be current and all other amounts to be non-current.&lt;/p&gt;</aciu:DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_D9nzu-m90USUkzobHLAf8w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Revenue recognition&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company applies IFRS 15&#160;&lt;i style="font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/i&gt;. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under IFRS 15, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of IFRS 15, the entity performs the following five steps: (i)&#160;identify the contract(s)&#160;with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of IFRS 15, the Company assesses the goods or services promised within each contract, and determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company enters into LCAs which are within the scope of IFRS 15, under which it licenses certain rights to its product candidates and intellectual property to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees, development, regulatory and/or commercial milestone payments;&#160;payments for research and clinical services the Company provides through either its full-time employees or third-party vendors, and royalties on net sales of licensed products commercialized from the Company&#x2019;s intellectual property. Each of these payments results in license, collaboration and other revenues, which are classified as contract revenue on the consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Licenses of intellectual property&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;If the license to the Company&#x2019;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are sold in conjunction with a related service, the Company uses judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If the performance obligation is settled over time, the Company determines the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, upfront fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Milestone payments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At the inception of each arrangement that includes development, regulatory and/or commercial milestone payments, the Company evaluates whether the milestones are considered highly probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant cumulative revenue reversal would not occur in future periods, the associated milestone value is included in the transaction price. These amounts for the performance obligations under the contract are recognized as they are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments recorded would affect contract revenues and earnings in the period of adjustment.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Research and development services&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has certain arrangements with our collaboration partners that include contracting our employees for research and development programs. The Company assesses if these services are considered distinct in the context of each contract and, if so, they are accounted for as separate performance obligations. These revenues are recorded in contract revenue as the services are performed.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Sublicense revenues&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has certain arrangements with our collaboration partners that include provisions for sublicensing. The Company recognizes any sublicense revenues at the point in time it is highly probable to obtain and not subject to reversal in the future.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Contract balances&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company receives payments and determines credit terms from its customers for its various performance obligations based on billing schedules established in each contract. The timing of revenue recognition, billings and cash collections results in billed other current receivables, accrued income (contract assets), and deferred income (contract liabilities) on the consolidated balance sheets. Amounts are recorded as other current receivables when the Company&#x2019;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be 1&#160;year or less.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For a complete discussion of accounting for contract revenue, see &#x201c;Note&#160;13. Contract revenues.&#x201d;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
    <ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_zeyFHlPGa0GE-Ceq8kY8AA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Research and development expenses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Given the stage of development of the Company&#x2019;s products, all research and development expenditure is expensed as incurred as it does not meet the capitalization criteria outlined in IAS 38 &lt;i style="font-style:italic;"&gt;Intangible Assets&lt;/i&gt;. The Company has not capitalized any R&amp;amp;D expenses to date. Research and development expenditures include:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;the cost of acquiring, developing and manufacturing active pharmaceutical ingredients for product candidates that have not received regulatory approval, clinical trial materials and other research and development materials;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;fees and expenses incurred under agreements with contract research organizations, investigative sites and other entities in connection with the conduct of clinical trials and preclinical studies and related services, such as administrative, data-management and laboratory services;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;fees and costs related to regulatory filings and activities;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;costs associated with preclinical and clinical activities;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;employee-related expenses, including salaries and bonuses, benefits, travel and share-based compensation expenses; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;all other allocated expenses such as facilities and information technology (IT) costs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For external research contracts, expenses include those associated with contract research organizations, or CROs, or contract manufacturing organizations, or CMOs. The invoicing from CROs or CMOs for services rendered do not always align with work performed. We accrue the cost of services rendered in connection with CRO or CMO activities based on our estimate of the &#x201c;stage of completion&#x201d; for such contracted services. We maintain regular communication with our CRO or CMO vendors to gauge the reasonableness of our estimates and accrue expenses as of the balance sheet date in the consolidated financial statements based on facts and circumstances known at the time.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Registration costs for patents are part of the expenditure for research and development projects. Therefore, registration costs for patents are expensed when incurred as long as the research and development project concerned does not meet the criteria for capitalization.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForExpensesExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_eV-gsG9iAkSC2TV6lTCjZQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;General and administrative expenses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;General and administrative expenses are expensed as incurred and include personnel costs, expenses for outside professional services and all other allocated expenses. Personnel costs consist of salaries, cash bonuses, benefits and share-based compensation. Outside professional services consist of legal, accounting and audit services, IT and other consulting fees. Allocated expenses consist of certain IT, facilities and depreciation expenses.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForExpensesExplanatory>
    <aciu:GrantIncomePolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_Q--lkoTAyEyQIwo2hoLqMA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Grant income&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has received grants, from time to time, from the Michael J. Fox Foundation (MJFF), the Target ALS Foundation (Target ALS) and other institutions to support certain research projects. Grants are recorded at their fair value in the consolidated statements of income/(loss) within other operating income/(expenses), net when there is reasonable assurance that the Company will satisfy the underlying grant conditions and the grants will be received. In certain circumstances, grant income may be recognized before formal grantor acknowledgement of milestone achievements. To the extent required, grant income is deferred and recognized on a systematic basis over the periods in which the Company expects to recognize the related expenses for which the grants are intended to compensate.&lt;/p&gt;</aciu:GrantIncomePolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_j-2-iEGRSkq2eo06E8ATtg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Leases&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company applies IFRS 16 &lt;i style="font-style:italic;"&gt;Leases&lt;/i&gt;, which provides the model for lessee accounting in which all leases, other than short-term and low-value leases, are accounted for by the recognition on the consolidated balance sheet of a right-of-use asset and a lease liability, and the subsequent amortization of the right-of-use asset over the earlier of the end of the useful life or the lease term. In accordance with IFRS 16, the Company (i)&#160;does not recognize right-of-use assets and lease liabilities for leases of low value (i.e. approximate fair value of USD 5,000). For a complete discussion of accounting, see &#x201c;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#x201d;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Right-of-use assets and lease liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At inception of a leasing contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#x2019;s incremental borrowing rate. The lease liabilities are classified as current or non-current based on the due dates of the underlying principal payments.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Lease payments generally are fixed for the contract term. The lease liability is measured at amortized cost using the effective interest method. The lease liability is re-measured if there is a change in the estimated lease term, a change in future lease payments arising from a change in an index or rate, a change in the Company&#x2019;s estimate of the amount expected to be payable under a residual value guarantee or a change in assessment of whether it will exercise a purchase, extension or termination option.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At inception, the right-of-use asset comprises the initial lease liability and any initial direct costs. The right-of-use asset is depreciated over the shorter of the lease term or the useful life of the underlying asset. The right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain re-measurements of the lease liability performed on as certain potential triggering events may arise (e.g. lease modifications). When the lease liability is re-measured, a corresponding adjustment is made to the carrying amount of the right-of-use asset or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The estimated lease term by right-of-use asset categories are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Office equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Both the right-of-use-assets and lease liabilities are recognized in the consolidated balance sheets.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <aciu:ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_rSFAXGobG0mW9eOGYEv7tQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Office equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock>
    <aciu:EstimatedLeaseTerm
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_Wu9NkzJdPUaZrVXUx5z-UA"
      id="Tc_l6gA2bgxX0CyIIP2xWeEBQ_1_2">P5Y</aciu:EstimatedLeaseTerm>
    <aciu:EstimatedLeaseTerm
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OfficeEquipmentMember_9AyXpdV_hkmm2dtMcUeW5w"
      id="Tc_6Al0dUJZUESDxv3fwrRybw_2_2">P5Y</aciu:EstimatedLeaseTerm>
    <aciu:EstimatedLeaseTerm
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Ozer3KElnU6POId_CcOTBg"
      id="Tc_iVzKsYCaIUOHsiK6ZBpj6w_3_2">P5Y</aciu:EstimatedLeaseTerm>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_lcFyl4Tiq0mfLKr3RSfv2w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Property, plant and equipment&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;Equipment is shown at historical acquisition cost, less accumulated depreciation and any accumulated impairment losses. Historical costs include expenditures that are directly attributable to the acquisition of the property, plant and equipment. Depreciation is calculated using a straight-line method to write off the cost of each asset to its residual value over its estimated useful life as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Leasehold improvements/furniture&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The assets&#x2019; residual values and useful lives are reviewed, and adjusted if appropriate, at each balance sheet date. Where an asset&#x2019;s carrying amount is greater than its estimated recoverable amount, it is written down to its recoverable amount.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Gains and losses on disposals are determined by comparing the disposal proceeds with the carrying amount and are included in the consolidated statements of income/(loss).&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <aciu:ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_bHQ63vCDdkmIoEqzQlv_9w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Leasehold improvements/furniture&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Ozer3KElnU6POId_CcOTBg"
      id="Tc_776nTVusEEiFw67mRGEo1w_1_2">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_VKLmDDFNFkKleBMvIA9FfQ"
      id="Tc_yLm5tlCSh0q6N_zU4wselg_2_2">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_Zmu3hDypz0e9GA3GfssWMQ"
      id="Tc_k7Gtlx8I7kKC8b8U-nGgrg_3_2">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_txXVR-n1CEykgzV8oZdNiA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Intangible assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune&#x2019;s acquired in process research and development (IPR&amp;amp;D) asset is stated at cost less any impairments. The Company does not deem this asset ready for use until the asset obtains market approval. Therefore, during the development period after the date of acquisition until market approval, the IPR&amp;amp;D asset is not amortized. Upon market approval, the Company will determine the useful life of the asset, reclassify it from IPR&amp;amp;D and commence amortization. If the associated R&amp;amp;D effort is abandoned, the related IPR&amp;amp;D will likely be written off and we will record the relevant impairment charge. Finally, the Company will not capitalize future development costs in respect to this IPR&amp;amp;D asset until they meet the criteria for capitalization of research and development costs in accordance with IAS 38 &lt;i style="font-style:italic;"&gt;Intangible Assets&lt;/i&gt;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Our IPR&amp;amp;D asset is subject to impairment testing at least annually or when there are indications that the carrying value may not be recoverable until the completion of the development process. The determination of the recoverable amounts include key estimates which are highly sensitive to, and dependent upon, key assumptions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company uses a discounted cash flow method to determine the fair value less costs to sell (recoverable amount) of our IPR&amp;amp;D intangible asset. The Company starts with a forecast of all the expected net cash flows, which incorporates the consideration of a terminal value and then the Company applies a discount rate to arrive at a risk-adjusted net present value amount.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_HUQmUFo2w0evTvUZSQkebQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Fair value of financial assets&#160;and liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The Company&#x2019;s financial assets and liabilities are composed of receivables, short-term financial assets, cash and cash equivalents, trade payables and lease liabilities. The fair value of these financial instruments approximates their &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;respective carrying values due to the short-term maturity of these instruments, and are held at their amortized cost in accordance with IFRS 9, unless otherwise explicitly noted.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Receivables&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Receivables are recognized at their billing value. An allowance for doubtful accounts is recorded for potential estimated losses when there is evidence of the debtor&#x2019;s inability to make required payments and the Company assesses on a forward-looking basis the expected credit losses associated with these receivables held at amortized cost.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Short-term financial assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Short-term financial assets are held with external financial institutions and comprise fixed-term deposits with maturities ranging from more than 3 through 12&#160;months in duration.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company assesses whether there is objective evidence that financial assets are impaired annually or whenever potential impairment triggers may occur.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Cash and cash equivalents include deposits held with external financial institutions and cash on hand. All cash and cash equivalents are either in cash or in deposits with original duration of less than 3&#160;months.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Trade payables&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Trade payables are amounts due to third parties in the ordinary course of business.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_5mrLbQytm0GCdQJyq21Z2Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Share capital and public offerings&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Common shares are classified as equity. Share issuance costs are capitalized as incurred and will be shown in equity as a deduction, net of tax, from the proceeds received from existing or future offerings. Should a planned equity offering not be assessed as probable, the issuance costs would be expensed immediately in the consolidated statements of income/(loss). See &#x201c;Note&#160;11. Share capital.&#x201d;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_TOiAQ_sEN0CrkWR6dCyW6Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Treasury shares&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Treasury shares are recognized at acquisition cost and deducted from shareholders&#x2019; equity at the time of acquisition, until they are subsequently resold, distributed or cancelled. Where such shares are subsequently sold, any consideration received is included in shareholders&#x2019; equity. See &#x201c;Note&#160;11. Share capital.&#x201d;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_8wRQY5EgqES2yY4bCcZaJw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Employee benefits&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Post-employment benefits&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company operates the mandatory pension schemes for its employees in Switzerland. The schemes are generally funded through payments to insurance companies. The Company has a pension plan designed to pay pensions based on accumulated contributions on individual savings accounts. However, this plan is classified as a defined benefit plan under IAS 19.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The net defined benefit liability is the present value of the defined benefit obligation at the balance sheet date minus the fair value of plan assets. Significant estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. The defined benefit obligation is calculated annually with the assistance of an independent actuary using the projected unit credit method, which reflects services rendered by employees to the date of valuation, incorporates assumptions concerning employees&#x2019; projected salaries and pension increases as well as discount rates of highly liquid corporate bonds that have terms to maturity approximating the terms of the related liability.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;To the extent that the fair value of the plan assets is greater than the present value of the defined benefit obligation as calculated by our independent actuary, the Company accounts for the effect of the asset ceiling test under IAS 19.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Re-measurements of the net defined benefit liability, which comprise actuarial gains and losses and the return on plan assets (excluding interest) are recognized immediately in the consolidated statements of other comprehensive income/(loss). Past service costs, including curtailment gains or losses, are recognized immediately as a split in research and development and general and administrative expenses within the operating results. Settlement gains or losses are recognized in either research and development and/or general and administrative expenses within the operating results. The Company determines the net interest expense/(income) on the net defined benefit liability for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period or in case of any significant events between measurement dates to the then-net defined benefit liability, considering any changes in the net defined benefit liability during the period as a result of contributions and benefit payments. Net interest expense/(income) and other expenses related to defined benefit plans are recognized in the consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Share-based compensation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company operates an equity-settled, share-based compensation plan. The fair value of the employee services received in exchange for the grant of equity-based awards is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the instruments granted, excluding the impact of any non-market vesting conditions. Non-market vesting conditions are included in assumptions about the number of instruments that are expected to become exercisable. At each balance sheet date, the Company revises its estimates of the number of instruments that are expected to become exercisable. It recognizes the impact of the revision of original estimates, if any, prospectively in the consolidated statements of income/(loss), and a corresponding adjustment to equity over the remaining vesting period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Stock options granted under the Company&#x2019;s stock option plans C1 and the 2016 Stock Option and Incentive Plan are valued using the Black-Scholes option-pricing model (see &#x201c;Note&#160;18. Share-based compensation&#x201d;). This valuation model as well as parameters used such as expected volatility and expected term of the stock options are partially based on management&#x2019;s estimates.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;We estimate the fair value of restricted share units using a reasonable estimate of market value of the common shares on the date of the award. We classify our share-based payments as equity-classified awards as they are settled in common shares. We measure equity-classified awards at their grant date fair value and do not subsequently re-measure them. Compensation costs related to equity-classified awards are equal to the fair value of the award at grant date amortized over the vesting period of the award using the graded method. We reclassify that portion of vested awards to share capital and share premium as the awards vest.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_WS7gneyR70aQGYmjCMJOPg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Provisions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events where it is more likely than not that an outflow of resources will be required to settle the obligation, and a reliable estimate of the amount can be made.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_Ue8KFD5BuEOpVQhKcPg9-w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Taxation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Current income tax assets and liabilities for the period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the tax amounts are those that are enacted or substantively enacted, at the reporting date in accordance with the fiscal regulations of the respective country where the Company operates and generates taxable income. Deferred tax is provided using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the&#160;year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date. If required, deferred taxation is provided in full using the liability method, on all temporary differences at the reporting dates. It is calculated at the tax rates that are expected to apply to the period when it is anticipated the liabilities will be settled, and it is based on tax rates (and laws) that have been enacted or substantively enacted at the reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized. Although the Company has substantial tax loss carry-forwards, historically, due to the fact that the Company had limited certainty on the achievement of key milestones, it has not recognized any deferred tax assets as the probability for use is low.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As disclosed in &#x201c;Note&#160;16. Income taxes,&#x201d; the Company has tax losses that can generally be carried forward for a period of 7&#160;years from the period the loss was incurred. These tax losses represent potential value to the Company to the extent that the Company is able to create taxable profits before the expiry period of these tax losses. The Company has not recorded any deferred tax assets in relation to these tax losses.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <aciu:IncomeTaxLossCarryforwardPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_5kt15i-T6UKV15TaoAVoMQ">P7Y</aciu:IncomeTaxLossCarryforwardPeriod>
    <ifrs-full:DeferredTaxAssets
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Narr_SoEuX3Grh0y03C0i5WZDsg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_Vm4ysA5Gf0mcb3YIjLEZGA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Earnings per share&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company presents basic earnings per share for each period in the consolidated financial statements. The earnings per share are calculated by dividing the earnings of the period by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential dilution that could occur if dilutive securities such as share options or non-vested restricted share units were vested or exercised into common shares or resulted in the issuance of common shares that would participate in net income. Anti-dilutive shares are excluded from the dilutive earnings per share calculation.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
    <aciu:DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_r9_t3pYhfEip7ZHJUA9ITQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Critical judgments and accounting estimates&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The preparation of financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The areas where AC Immune has had to make judgments, estimates and assumptions relate to (i)&#160;revenue recognition on LCAs, (ii)&#160;clinical development accruals, (iii)&#160;net employee defined benefit liability, (iv)&#160;income taxes, (v)&#160;share-based compensation, (vi)&#160;right-of-use assets and lease liabilities and (vii)&#160;our IPR&amp;amp;D asset. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.&lt;/p&gt;</aciu:DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_JHq8NfyNOUyTv7Fxf3mabg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Segment reporting&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company is managed and operated as one business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. Accordingly, the Company views its business and manages its operations as one operating segment. Non-current assets are located in, and revenue is allocated and recorded within, the Company&#x2019;s country of domicile, Switzerland.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory>
    <aciu:OperatingSegmentsNumber
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Narr_6aEdC-5jD06U1rUgSxiaXQ"
      unitRef="Unit_Standard_segment_9jTtSCng3EmNVBiAOMwlNw">1</aciu:OperatingSegmentsNumber>
    <aciu:ReportableSegmentsNumber
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Narr_AQYgmpEPE0mgk25SWbe4Ow"
      unitRef="Unit_Standard_segment_9jTtSCng3EmNVBiAOMwlNw">1</aciu:ReportableSegmentsNumber>
    <aciu:OperatingSegmentsNumber
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Narr_qYi4gEK4CEOeEbgB-0JzWg"
      unitRef="Unit_Standard_segment_9jTtSCng3EmNVBiAOMwlNw">1</aciu:OperatingSegmentsNumber>
    <aciu:DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_9jMhvq6Uhk6qxpdXhOMdfQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Accounting policies, new standards, interpretations and amendments adopted by the Company&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;There are no new IFRS standards, amendments or interpretations that are mandatory as of January 1, 2022 that are relevant to the Company. Additionally, the Company has not adopted any standard, interpretation or amendment that has been issued but is not yet effective. Such standards are not currently expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions.&lt;/p&gt;</aciu:DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_A_wfoBWaTUOP4cScMwFkiQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;4.&lt;/b&gt;&lt;/span&gt;Property, plant and equipment&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following tables show the movements in the net book values of property, plant and equipment for the&#160;years ended December&#160;31, 2022 and 2021, respectively:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Laboratory&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Leasehold&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assets under&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Furniture&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;improvements&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;construction&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Acquisition cost:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 265&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,754&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,142&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 810&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12,666&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 20&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 151&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 576&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 184&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 936&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Transfers&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 47&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 646&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (697)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 285&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,909&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,765&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,640&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 13,602&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated depreciation:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (106)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,316)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,739)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (389)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,550)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (53)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (283)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,278)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (179)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,793)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (159)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,599)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,017)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (568)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,343)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying amount:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 159&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 438&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,403&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 421&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,116&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 126&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,748&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,072&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,259&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Laboratory&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Leasehold&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assets under&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Furniture&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;improvements&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"&gt;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;construction&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Acquisition cost:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 214&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,497&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,681&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 464&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 277&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,133&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 51&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,268&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 346&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,610&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Transfers&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 270&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (277)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposals&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (77)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (77)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 265&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,754&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,142&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 810&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12,666&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated depreciation:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (61)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (970)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,405)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (281)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,717)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (45)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (346)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,398)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (108)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,897)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposals&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 64&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 64&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (106)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,316)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,739)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (389)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,550)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying amount:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 153&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 527&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,276&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 183&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 277&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 159&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 438&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,403&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 421&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,116&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune continues to enhance its laboratory equipment to support its R&amp;amp;D functions. This effort has continued for the&#160;year ended December&#160;31, 2022, with CHF 0.8 million invested in lab equipment, including the expansion of our leased lab space, and IT equipment, representing an increase of 7%.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company incurred CHF 1.8 million, CHF 1.9 million and CHF 1.5 million in depreciation expenses, respectively.&lt;/p&gt;</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_AEOLhy4R-E-4o9Kwo3bUdQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following tables show the movements in the net book values of property, plant and equipment for the&#160;years ended December&#160;31, 2022 and 2021, respectively:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Laboratory&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Leasehold&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assets under&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Furniture&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;improvements&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;construction&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Acquisition cost:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 265&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,754&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,142&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 810&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12,666&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 20&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 151&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 576&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 184&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 936&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Transfers&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 47&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 646&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (697)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 285&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,909&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,765&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,640&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 13,602&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated depreciation:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (106)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,316)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,739)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (389)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,550)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (53)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (283)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,278)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (179)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,793)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (159)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,599)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,017)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (568)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,343)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying amount:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 159&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 438&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,403&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 421&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,116&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 126&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,748&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,072&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,259&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Laboratory&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Leasehold&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assets under&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Furniture&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;improvements&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"&gt;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;construction&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Acquisition cost:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 214&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,497&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,681&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 464&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 277&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,133&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 51&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,268&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 346&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,610&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Transfers&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 270&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (277)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposals&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (77)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (77)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 265&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,754&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,142&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 810&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12,666&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated depreciation:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (61)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (970)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,405)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (281)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,717)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (45)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (346)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,398)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (108)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,897)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposals&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 64&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 64&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (106)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,316)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,739)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (389)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,550)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying amount:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 153&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 527&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,276&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 183&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 277&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:41.6%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 159&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 438&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,403&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 421&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,116&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_hqctdwrQN0uGHFmoDmoBSw"
      decimals="-3"
      id="Tc_VrcbeYaGdEKrOECL2G87zQ_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">265000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_6aK9qrKczkWLN0-zGicz-g"
      decimals="-3"
      id="Tc_MHMt6R1VRkGyFgWQGPBFfQ_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1754000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_83P7y6bpZ0ylYnfrkgwFyw"
      decimals="-3"
      id="Tc_3d-7V_zJqESIADRy0Id8uA_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9142000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_JOWNVGG_6E2-S4NAWhBdqw"
      decimals="-3"
      id="Tc_6jjX2zxTIky0eLgiZ0n3MA_5_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">810000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_5w-XoX-NLkKHmafT1-bTSA"
      decimals="-3"
      id="Tc_tH34vYA4ykKWSEvkjJjHLA_5_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">695000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_tvR74klj-EuU1efHxw9Lag"
      decimals="-3"
      id="Tc_Edlg30mI_EK6u6DUc4hyjQ_5_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">12666000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_sn3ARiGlaESnktZbl7jycA"
      decimals="-3"
      id="Tc_yFzLefc8G0GAFoaSEq84cA_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">20000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_-BoX8YxE_EaZXZMovx0g2A"
      decimals="-3"
      id="Tc_Aytzubu_xkqstpG2MNlu2A_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">151000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_1wINY-2riE6PzcI88FzqMQ"
      decimals="-3"
      id="Tc_MqPRKUkMQkW7HOYrxqTrYQ_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">576000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_3oznLzHXWUmnOSp1oShnUQ"
      decimals="-3"
      id="Tc_3fEpXa82nkSFoVW9-voifQ_6_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">184000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_w37wZNsSyU6H8HKH0QpE5A"
      decimals="-3"
      id="Tc_rgbRUvNKcUOi6A3b2xFY1A_6_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">5000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_M05pHmbc10iqCZT547GuuA"
      decimals="-3"
      id="Tc_6j4OwFmtok6tHrSrkHDd1A_6_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">936000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_sn3ARiGlaESnktZbl7jycA"
      decimals="-3"
      id="Tc_HIegY4VcjUC_VxY5BXAliA_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_-BoX8YxE_EaZXZMovx0g2A"
      decimals="-3"
      id="Tc_paP2oN2rKkmzdczytIh0RA_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_1wINY-2riE6PzcI88FzqMQ"
      decimals="-3"
      id="Tc_MjZi7j9r-0CvW8KFhWfAlQ_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">47000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_3oznLzHXWUmnOSp1oShnUQ"
      decimals="-3"
      id="Tc_z3jZqw8BsU6UZZoin1u6Gg_7_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">646000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_w37wZNsSyU6H8HKH0QpE5A"
      decimals="-3"
      id="Tc_AYUgaVPIuECw2tULEyk-Bw_7_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-697000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_M05pHmbc10iqCZT547GuuA"
      decimals="-3"
      id="Tc_8tz4HS4GE0W_ioJzzM9JhQ_7_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember__8JB9cGo30u4RAuroNxHDw"
      decimals="-3"
      id="Tc_Jd7qI6tei0OD9SihKZ7sXA_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">285000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_nA1-BCOTy0m_IaGz1dZgKQ"
      decimals="-3"
      id="Tc_UlqeueFcuk6mUvuKp4l7LQ_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1909000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_U0WcEJ-m006w1FYFbGzFkg"
      decimals="-3"
      id="Tc_wbKnAb-j9kaLhulv2dNXsQ_8_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9765000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_cOXYr6K5yUCrOP0RZAWdQA"
      decimals="-3"
      id="Tc_raJKBzdZwE28wtqyIMKusw_8_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1640000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_8IXKK-Pok0S7I58W7DYXDA"
      decimals="-3"
      id="Tc_oYhk6VVthkKtePyw1UQ2MA_8_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_9SsycfPkpUG2RWbLatkFMg"
      decimals="-3"
      id="Tc_n6SedwwhLUqs-jIzSHHV2g_8_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">13602000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_ue4pbGVEbUiq7HJx_qTxVA"
      decimals="-3"
      id="Tc_hnA5lQL96kysBPnJ3XDHzA_11_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-106000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_pC0gtLj5kE29rdJ-dYf0BA"
      decimals="-3"
      id="Tc_zwnKc2bbqEWXM_sJdHMAyw_11_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-1316000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_GKWsPI-X0kGuJ_LvETs99g"
      decimals="-3"
      id="Tc_EcurSRdFwE2hi4S-54Yjtg_11_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-5739000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_imtm7cUr8kaCmHg-oP5Uew"
      decimals="-3"
      id="Tc_AF-4NBs0v0KWvTP7g5TZ8w_11_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-389000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_nL6LiSdtTEm6pKYWuxJXrQ"
      decimals="-3"
      id="Tc_pfFv00GopEmmoAfQgvL9mw_11_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-7550000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_IvbcDwQUuEm16jkIYakaCg"
      decimals="-3"
      id="Tc_YK6ec9H6bEi7yCcjGZ0mMw_12_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">53000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_v887EZj_rEmNcfMBDtK6TA"
      decimals="-3"
      id="Tc_g0LNC66p6Uq6D8VJRw9eMQ_12_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">283000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Jvt1fjwr5USz9GJD5wEKOQ"
      decimals="-3"
      id="Tc_AlskLzatS0eBHbOmt-mu1g_12_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1278000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_o09LprTCLE6hH9f1Mj3oqQ"
      decimals="-3"
      id="Tc_pgXMuLq9m0Sg1c8aV8Ecjw_12_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">179000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_-tmtXopEr0G-p32hjhwk6Q"
      decimals="-3"
      id="Tc_K-6oZ_C15kyiJ5C_ggyG-A_12_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1793000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_kGz2G5hG2EuGvNwjXNMtGA"
      decimals="-3"
      id="Tc_2wu1nkgYM0u6exQDCTMjOQ_13_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-159000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_kqXlzseNsUiz1AZXFdEaQA"
      decimals="-3"
      id="Tc_E1xEsVJL20ei7la6wNriZA_13_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-1599000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_mXP7xiRLEUu8xic9Xuihlw"
      decimals="-3"
      id="Tc_nzxJfSJwrkWMAVp_269d2Q_13_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-7017000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_t0ttw0E3hEGRszBl1CyKPw"
      decimals="-3"
      id="Tc_7jwVYGypskyLGJhc1kiFLA_13_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-568000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_VCafjbK1YkmLYTpqX9O2Qg"
      decimals="-3"
      id="Tc_GszK_ctfpUuqJ1Qo2P73Pw_13_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-9343000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_gixeq8TJOUiwQnCqzoWt6w"
      decimals="-3"
      id="Tc_PO4f66Stx0SnpAhcWFcmtg_16_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">159000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_SVIwZpKI3kGqF_IYNCWEhg"
      decimals="-3"
      id="Tc_S6ZzXXvFYka6KYiwikUQtQ_16_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">438000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_j5TopbyK0kGaK2cIgBD9LA"
      decimals="-3"
      id="Tc_1_DYdtYySEKEwiNF4qJLdQ_16_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3403000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_gFCLb69mDUaqMTblzP_RkQ"
      decimals="-3"
      id="Tc_cE3-Hr_CFUmqdcJEXXYzpw_16_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">421000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_nVWm-PIICk2ruKe56loHrQ"
      decimals="-3"
      id="Tc_THGTVeieaUmZfcOnPZ1cUw_16_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">695000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_adIBrbuiOk2yEv2kYHxe-w_16_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">5116000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_6conGXdyckSywzGr6GYvYw"
      decimals="-3"
      id="Tc_eRzIWfwQQE2686h4DIxVFg_17_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">126000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fhXMqa9W-EWHXNdjUYd4iQ"
      decimals="-3"
      id="Tc_G7ToucfHlEublfuXvoItlg_17_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">310000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_W-8vm1symkWu1TlXlu9m7A"
      decimals="-3"
      id="Tc_Eo-7Qaq2J0Wko5JLFU6ZDA_17_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2748000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_aJviOm4nfE-pOaFV9E4vvw"
      decimals="-3"
      id="Tc_hPo506_kXkCosJzhh67i3Q_17_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1072000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_TH62pZBB7kqAgUulrAHeSg"
      decimals="-3"
      id="Tc_KJY8Rcn0nUKMQueC2Y_0Ig_17_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_t0uMbLxOAkqdszXhVVv7Gw_17_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4259000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_yBmrsz9Gz0-30C8ID2gxpA"
      decimals="-3"
      id="Tc_X-GAMaHq6kWcLQyRHSnOHg_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">214000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Hnlt3D1SKEW7_IrRvWNKhg"
      decimals="-3"
      id="Tc_t3zSwJQVV0-looJCSeYsUQ_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1497000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_omADz3BlkU228JQA39U9eA"
      decimals="-3"
      id="Tc_yKbal18FNkicZ31vKOOkwQ_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7681000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_k8dVeftSAkW4_0WfOoafTQ"
      decimals="-3"
      id="Tc_kLq3pjNbpkuLBRn8mABkeA_5_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">464000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_624VtAuprEmOudOGdH0CPQ"
      decimals="-3"
      id="Tc_C0uawgasD0q-5GGLwAEbFg_5_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">277000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_at5lR_LjGEWOpLXOSdQYAQ"
      decimals="-3"
      id="Tc_1pGAXRvCXU62pv3hlM2zeQ_5_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">10133000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Mexed_kNUESyEPioMdSpUw"
      decimals="-3"
      id="Tc_qFq-_Xu3TkqKM5JD03CbBA_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">51000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_OgqSUQcKz0SKU75eNdUCVQ"
      decimals="-3"
      id="Tc_H1IlR89X1Ue2OkWZuXJSLQ_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">250000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_amPvhMdQjUCNH0XSkOd83g"
      decimals="-3"
      id="Tc_GTaGQKEcaU68Pvg0IXqPMQ_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1268000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9ZTaVEBXDUiyQ4EQFRSYhQ"
      decimals="-3"
      id="Tc_sr_cg99CCUGLJRGfLYU4zw_6_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">346000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_BknOUverm029TXOB6lUTWA"
      decimals="-3"
      id="Tc_rgWJAqmREEGNOydsYATUvA_6_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">695000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_aBSKY_-UsUGANDeuLjypnQ"
      decimals="-3"
      id="Tc_v3ZP0VR6qkm8yVqY6-Te5A_6_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2610000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_OgqSUQcKz0SKU75eNdUCVQ"
      decimals="-3"
      id="Tc_vTyH8sOFqU2MTVEC6A94xA_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_amPvhMdQjUCNH0XSkOd83g"
      decimals="-3"
      id="Tc_TCsaU2mC1ECcOyoPPV9Ang_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">270000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_BknOUverm029TXOB6lUTWA"
      decimals="-3"
      id="Tc_oV-yiim1e0aw-nAvfA_yOQ_7_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-277000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Mexed_kNUESyEPioMdSpUw"
      decimals="-3"
      id="Tc_60Pl1ZJOWU-gu-y3IZ7vig_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_OgqSUQcKz0SKU75eNdUCVQ"
      decimals="-3"
      id="Tc_BqH0Wx7Tmka0GWc6E_6_Pg_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_amPvhMdQjUCNH0XSkOd83g"
      decimals="-3"
      id="Tc_eFpEVWwBHkCOb9-zkUNlcA_8_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">77000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9ZTaVEBXDUiyQ4EQFRSYhQ"
      decimals="-3"
      id="Tc_4tK3BOSJDUKVuoNpD-esaw_8_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_BknOUverm029TXOB6lUTWA"
      decimals="-3"
      id="Tc_1KPdZ1-BjkCCtnNJrjcUAg_8_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_aBSKY_-UsUGANDeuLjypnQ"
      decimals="-3"
      id="Tc_DTRtvMJGO0GGTUFx4-WnCg_8_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">77000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_hqctdwrQN0uGHFmoDmoBSw"
      decimals="-3"
      id="Tc_ZxGFKcdR1E-XDIyfKb6Ptw_9_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">265000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_6aK9qrKczkWLN0-zGicz-g"
      decimals="-3"
      id="Tc_YuDeMgwD7ES1PRvozlpCqQ_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1754000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_83P7y6bpZ0ylYnfrkgwFyw"
      decimals="-3"
      id="Tc_E3sSdMV61ESPF1dc80Pvsw_9_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9142000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_JOWNVGG_6E2-S4NAWhBdqw"
      decimals="-3"
      id="Tc_mU1cvS5gmEuzjqFirkpHaw_9_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">810000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_mkfTmtvQQUWvXn7SCNipKA"
      decimals="-3"
      id="Tc_PftQmIGR2US3PCch7cl0zQ_9_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">695000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_tvR74klj-EuU1efHxw9Lag"
      decimals="-3"
      id="Tc_GLFrmFYgI0etsWWKmdAorA_9_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">12666000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_9-9lvpw-wEGlSeFf0lhfgA"
      decimals="-3"
      id="Tc_49Q1PxBXfUyqmwAhvBuE7g_12_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-61000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_rNFrcrnlfke5jyKkmnfYew"
      decimals="-3"
      id="Tc_1EcOZ-A3vESorH9JE056cQ_12_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-970000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_U-F3h1Ni3kikwgDZTjR8Ag"
      decimals="-3"
      id="Tc_4oYDLY5YvUuhbCVTcmlVng_12_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-4405000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9GjiWU9dvUSudZWJ_vB8OQ"
      decimals="-3"
      id="Tc_y30Sd1vVMEuhnaC_dC7Hvw_12_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-281000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_Q_e4dEXGxkup2NsrXRT1FQ"
      decimals="-3"
      id="Tc_7WN4J3-Olk6g3eCoVeUXoQ_12_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-5717000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_hZnR1ixhfkeMTt56nYyaxw"
      decimals="-3"
      id="Tc_8Pkir6A0rUCz0czCXoxORA_13_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">45000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fkSn02nK3EO6v-wrUGc0vg"
      decimals="-3"
      id="Tc_KBTmZFqxkUSfXoWMV3OHVQ_13_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">346000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_X7iW-2Dlq0SBvALqlsP7Iw"
      decimals="-3"
      id="Tc_qar8h0ofKUWH_Tvk9Bec8A_13_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1398000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_E57IJ4sHdEW4PL45jFGApQ"
      decimals="-3"
      id="Tc_aAC69eBiiEG_qKfPFbin5Q_13_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">108000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_XIymoY2OjEyn8SkwhnAMgA"
      decimals="-3"
      id="Tc_VWCzuxOQA0OEZpqme-unYw_13_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1897000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_hZnR1ixhfkeMTt56nYyaxw"
      decimals="-3"
      id="Tc_-ZZH9KMqC06S32CM26DVqg_14_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fkSn02nK3EO6v-wrUGc0vg"
      decimals="-3"
      id="Tc_nMDtKQuZ90i4Z81dYA_89A_14_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_X7iW-2Dlq0SBvALqlsP7Iw"
      decimals="-3"
      id="Tc_SUlGOyK_AUadSnHyp4dcTw_14_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-64000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_E57IJ4sHdEW4PL45jFGApQ"
      decimals="-3"
      id="Tc_xYSEsf_ykk-ZiGb1kMIwGw_14_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_bdfGLGB28E2kpb5ujlICfA"
      decimals="-3"
      id="Tc_TAAivu6syUCX6nX-Q-fxrQ_14_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_XIymoY2OjEyn8SkwhnAMgA"
      decimals="-3"
      id="Tc_N144x_P_9kiCVjLARfpsnA_14_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-64000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_ue4pbGVEbUiq7HJx_qTxVA"
      decimals="-3"
      id="Tc_kKgREdpylEuxUYbVxpyE6A_15_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-106000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_pC0gtLj5kE29rdJ-dYf0BA"
      decimals="-3"
      id="Tc_EDbCA0zbUEiybOZKXtvr3A_15_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-1316000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_GKWsPI-X0kGuJ_LvETs99g"
      decimals="-3"
      id="Tc_S8Wyn8m0gkG3sf46SZL_dQ_15_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-5739000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_imtm7cUr8kaCmHg-oP5Uew"
      decimals="-3"
      id="Tc_BVCDzKZqV0aNBMV8LWzM-A_15_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-389000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_nL6LiSdtTEm6pKYWuxJXrQ"
      decimals="-3"
      id="Tc_XsUkNnb3-Em-T_flmYSKcg_15_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-7550000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Y1uZQ6hoDkCelbD4WC21cw"
      decimals="-3"
      id="Tc_rpnYsHbpWkCJb6dxnTV_Qw_18_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">153000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember__RC_i4sK7Eajf16KAEb9Lw"
      decimals="-3"
      id="Tc_gHoXSP8v8EqOzpGQsW2-AA_18_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">527000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_TY4Gkd3GwUKatV9IO3cpXg"
      decimals="-3"
      id="Tc_D9J35jF8yUeFM5Ay2kxhMA_18_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3276000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_9sg6mWi1F0CGpbkEmid_yw"
      decimals="-3"
      id="Tc_jdiST5zCaU6XNtFmeXjisg_18_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">183000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_MiutPukQMU-yrYKpy0R5CQ"
      decimals="-3"
      id="Tc_Ch_O-1gHPUyiS8O9ZLO_Iw_18_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">277000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="-3"
      id="Tc_D6sYlwJ1K02nmv393EYbYw_18_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4416000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_gixeq8TJOUiwQnCqzoWt6w"
      decimals="-3"
      id="Tc_GJNJTyFyO0KIsoRxboqprw_19_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">159000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_SVIwZpKI3kGqF_IYNCWEhg"
      decimals="-3"
      id="Tc_8S8K9kYZlEGiWd9nxb3RVA_19_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">438000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_j5TopbyK0kGaK2cIgBD9LA"
      decimals="-3"
      id="Tc_mo9nHhquXU-jv-ZREd92vA_19_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3403000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_gFCLb69mDUaqMTblzP_RkQ"
      decimals="-3"
      id="Tc_pMu-_KhqK0iMdedO4St3SQ_19_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">421000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_AssetsUnderConstructionMember_IQoL60CqzUKkayULIGl1UQ"
      decimals="-3"
      id="Tc_V1fqgjUgUECZsLFv3x9V5g_19_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">695000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_lqjClVXbokG9NhC9AUxaTw_19_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">5116000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_VKLmDDFNFkKleBMvIA9FfQ"
      decimals="-5"
      id="Narr_a8oHZ1OWFEC0FPY8ddgasA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">800000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <aciu:PercentageIncreaseInPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_VKLmDDFNFkKleBMvIA9FfQ"
      decimals="3"
      id="Narr_RfIsmD7ad0-ahHKd7rLoOg"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.07</aciu:PercentageIncreaseInPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_-tmtXopEr0G-p32hjhwk6Q"
      decimals="-5"
      id="Narr_mWggt8_yQUGEP8szc_aH_w"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1800000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_XIymoY2OjEyn8SkwhnAMgA"
      decimals="-5"
      id="Narr_OTX8lKcNVUyBOd8AiL363A"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1900000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_AmEhYNpaWkGu_syMP9yeMg"
      decimals="-5"
      id="Narr_MTph0V8YuUOUh9iaijNE5g"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1500000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfLeasesExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_0EodyhH9o0WY4TilYe4pfA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;5.&lt;/b&gt;&lt;/span&gt;Right-of-use assets, long-term financial assets and lease liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company recognized additions and remeasurements of right-of-use of leased assets for buildings or for office equipment totaling CHF 0.5 million and CHF 1.2 million for the&#160;years ended December&#160;31, 2022 and 2021, respectively. In 2022, these increases are predominantly associated with the remeasurement of our leased office space.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Regarding lease liabilities, the amortization depends on the rate implicit in the contract or the incremental borrowing rate for the respective lease component. The weighted averages of the incremental borrowing rates as of December&#160;31, 2022 are 3.5% (2.5% for 2021) for buildings, 5.3% (5.3% for 2021) for office equipment and 2.6% (2.6% for 2021) for IT equipment.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following tables show the movements in the net book values of right-of-use of leased assets for the&#160;years ended December&#160;31, 2022 and 2021, respectively:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Office&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Buildings&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,776&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 98&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 40&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,914&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions and remeasurements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 460&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 460&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (528)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (24)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (14)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (566)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 74&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 26&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,808&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Office&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Buildings&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;2,106&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;63&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;54&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,223&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions and remeasurements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,144&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 71&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,215&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Dispositions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (15)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (15)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (474)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (21)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (14)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (509)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,776&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 98&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 40&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,914&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;For the&#160;years ended December&#160;31, 2022, and 2021, the impact on the Company&#x2019;s consolidated statements of income/(loss) and consolidated statements of cash flows is detailed in the table below.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Statements of income/(loss)&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation of right-of-use assets &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 566&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 509&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest expense on lease liabilities &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 68&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 63&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expense for short-term leases and leases of low value &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 750&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 723&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,384&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,295&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Statements of cash flows&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total cash outflow for leases&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,388&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,299&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table presents the contractual undiscounted cash flows for lease liabilities as of December&#160;31, 2022 and 2021:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Less than one year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 638&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 638&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;1-3 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,230&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,260&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;3-5 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,187&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,203&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,055&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,101&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company also has two deposits in escrow accounts totaling CHF 0.4 million for the lease of the Company&#x2019;s premises as of December&#160;31, 2022 and 2021, respectively.&lt;/p&gt;</ifrs-full:DisclosureOfLeasesExplanatory>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-5"
      id="Narr_FIp5qixj4UG9Gcba9J_vXA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">500000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-5"
      id="Narr_wlNsA65W00myre8ZLtEJSw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1200000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_bV6SNnGs5EKwPEWegvAkHA"
      decimals="3"
      id="Narr_N8krS655BEKavcUz9_7Lcw"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.035</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_P-n3rHIzjEG1HspwzCx_Og"
      decimals="3"
      id="Narr_hIxAwPAl3UeMrPVIYQ9K_w"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.025</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_AwHLCp1Cek68-TW5KoaDqA"
      decimals="3"
      id="Narr_7Pf-7Cg-cE28PjXr_YS8FQ"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.053</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_IESnhrGhEk-QtuGTRv7ddw"
      decimals="3"
      id="Narr_aNKr_jo9jUS8EvMwHoFD-g"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.053</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_8Nxn7kPDD0muRctLMCmLRQ"
      decimals="3"
      id="Narr_WVGuh67xVkqKIM6ir71uYg"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.026</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_NSSv8GcEaEejbU2PgDrGqw"
      decimals="3"
      id="Narr_UXzXmz3G6UGrVWhm9ZOnig"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.026</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_3x1W27H1cUGjqeg1VxjdKw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following tables show the movements in the net book values of right-of-use of leased assets for the&#160;years ended December&#160;31, 2022 and 2021, respectively:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.44%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Office&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Buildings&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,776&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 98&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 40&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,914&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions and remeasurements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 460&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 460&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.44%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (528)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (24)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (14)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (566)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 74&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 26&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,808&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Office&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Buildings&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;2,106&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;63&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;54&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,223&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions and remeasurements&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,144&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 71&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,215&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Dispositions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (15)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (15)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (474)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (21)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (14)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (509)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,776&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 98&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 40&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,914&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_P-n3rHIzjEG1HspwzCx_Og"
      decimals="-3"
      id="Tc_NRgL1j08dECBh2E5e19zCQ_3_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2776000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_IESnhrGhEk-QtuGTRv7ddw"
      decimals="-3"
      id="Tc_Mu3BItdYEUK__oNIpsK9Ww_3_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">98000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_NSSv8GcEaEejbU2PgDrGqw"
      decimals="-3"
      id="Tc_aoVd0jlTIEuGbZbTZ142HA_3_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">40000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_NaJkhwjyT0OhjpXLEyUBUw_3_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2914000</ifrs-full:RightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_EjvNM_4FNkWLoJE65UD5VQ"
      decimals="-3"
      id="Tc_umGhIgReAUCq3ULy3hylSw_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">460000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_EEXqAl-oB0aAgMV2CcairA"
      decimals="-3"
      id="Tc_-b92U9XPmUe6VEi4T_aUuQ_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_1pD5gJTd5k6uFaeNrpHvig"
      decimals="-3"
      id="Tc_kw6RS0j4f0yqq6Jxf8o3WA_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_WMF8yvwu6kKLQpmOTnftxw_4_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">460000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_EjvNM_4FNkWLoJE65UD5VQ"
      decimals="-3"
      id="Tc_AX1_A6z9fE-7pKcfPrsPlg_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">528000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_EEXqAl-oB0aAgMV2CcairA"
      decimals="-3"
      id="Tc_xcpVk52eFEeAC9FOHBYMig_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">24000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_1pD5gJTd5k6uFaeNrpHvig"
      decimals="-3"
      id="Tc_xlJPyhTIyU-5Cp38uk9grg_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">14000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_lhvg5h5jAESxHn6cA06a2A_5_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">566000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_bV6SNnGs5EKwPEWegvAkHA"
      decimals="-3"
      id="Tc_jhA1veOwy0ehuA9yaSl5dQ_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2708000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_AwHLCp1Cek68-TW5KoaDqA"
      decimals="-3"
      id="Tc_L2I3YTQBYUuUrrymjwwv9g_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">74000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_8Nxn7kPDD0muRctLMCmLRQ"
      decimals="-3"
      id="Tc_7ZEZztBg5EuYXRPMnTnbgQ_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">26000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_Z7rmoIyuQUmOBD1Ysx4V2A_6_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2808000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_YRhyIua2j02nlUUm4X31Sw"
      decimals="-3"
      id="Tc_nZA-hHRD9UWsRfT32Im2-g_3_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2106000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_UeTtu2AuZkiuL6oBS69STw"
      decimals="-3"
      id="Tc_88kEY0Yya0e6kR-AjDcWYA_3_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">63000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_wQPmFr31yUS_jOij507kbA"
      decimals="-3"
      id="Tc_vMC3kJdUMkifILAUjXT0jQ_3_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">54000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="-3"
      id="Tc_gB9yIbrzZU6VYsRj7CnUVA_3_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2223000</ifrs-full:RightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember__-gTB9L7ZEG7ut5ju4_TaA"
      decimals="-3"
      id="Tc_ClW-S6EJZEOyAZxhQQ-khQ_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1144000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_LgP-ND0OA0CGPBZ4f_J4DA"
      decimals="-3"
      id="Tc_l7EQeaaf206-3Ki6SFEZ8g_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">71000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_mo8rLVJA4Uq7FhG33cplbQ"
      decimals="-3"
      id="Tc_P0LMM3FolEaA_Sr8jR3Dsw_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_Iws6tlZuj0qxEa2XyBNuQQ_4_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1215000</ifrs-full:AdditionsToRightofuseAssets>
    <aciu:DispositionsOfRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_LgP-ND0OA0CGPBZ4f_J4DA"
      decimals="-3"
      id="Tc_2d_uKV-GtUyPxM9FTBIuTA_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">15000</aciu:DispositionsOfRightOfUseAssets>
    <aciu:DispositionsOfRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_Q4sEEy_0t06oGiy8lBXktA_5_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">15000</aciu:DispositionsOfRightOfUseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember__-gTB9L7ZEG7ut5ju4_TaA"
      decimals="-3"
      id="Tc__7eigLo5XUaVvpjTpncMHA_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">474000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_LgP-ND0OA0CGPBZ4f_J4DA"
      decimals="-3"
      id="Tc_8ZuoYibKbEypt7KX6D4Y_w_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">21000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_mo8rLVJA4Uq7FhG33cplbQ"
      decimals="-3"
      id="Tc_vOlOPyzULU6279ZSAy34hQ_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">14000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_1LvUL4e3ME2HMiAVt1izjw_6_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">509000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_P-n3rHIzjEG1HspwzCx_Og"
      decimals="-3"
      id="Tc_0lcizEg-iUyro0ESZJtm1A_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2776000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_IESnhrGhEk-QtuGTRv7ddw"
      decimals="-3"
      id="Tc_egWqfXBjX0iXTOBM3unrSQ_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">98000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_NSSv8GcEaEejbU2PgDrGqw"
      decimals="-3"
      id="Tc_hv70Stad4k6s5HC8kf6JHA_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">40000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_BYR-Id2wQU2NY_kJrr8fOw_7_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2914000</ifrs-full:RightofuseAssets>
    <aciu:DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_TzN4NnkGsEWj6w_OMbFVXA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;For the&#160;years ended December&#160;31, 2022, and 2021, the impact on the Company&#x2019;s consolidated statements of income/(loss) and consolidated statements of cash flows is detailed in the table below.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Statements of income/(loss)&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation of right-of-use assets &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 566&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 509&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest expense on lease liabilities &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 68&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 63&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expense for short-term leases and leases of low value &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 750&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 723&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,384&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,295&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Statements of cash flows&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total cash outflow for leases&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,388&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,299&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_so3VFZXgl0WoL2MxRSTC9w_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">566000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_jRL9H_oqHkSe5NcV1CEadg_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">509000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_Sqn9xnxsM02eDnuj7ZumAw_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">68000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_KZBtanU9jUe2vsXLVUkyvA_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">63000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_PeaBqcJt-kaozJllxR-GNA_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">750000</ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_1h50MezXl0qOrOudiG7k7g_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">723000</ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed>
    <aciu:ExpenseRelatingToLeases
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_6ITzFlqIXE6yCLMOufdlaw_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1384000</aciu:ExpenseRelatingToLeases>
    <aciu:ExpenseRelatingToLeases
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_jJ7a_MjRakmrMJFswzVhzQ_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1295000</aciu:ExpenseRelatingToLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_jMpimJHyFUKgR5cdz1hZuQ_11_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1388000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_YkzUMvOFUkStaIOWpu9RaA_11_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1299000</ifrs-full:CashOutflowForLeases>
    <aciu:ScheduleOfContractualUndiscountedCashFlowsTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_Xl3q1d-0EkWXx0yyD2k9vA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table presents the contractual undiscounted cash flows for lease liabilities as of December&#160;31, 2022 and 2021:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Less than one year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 638&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 638&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;1-3 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,230&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,260&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;3-5 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,187&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,203&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,055&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,101&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:ScheduleOfContractualUndiscountedCashFlowsTableTextBlock>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_-yIL5uUOREqnWUjN-WEKug"
      decimals="-3"
      id="Tc_-MvLZYXC7UOWAL-MgzGRbg_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">638000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_IDSltZ9zlUuxs8MqNPseTA"
      decimals="-3"
      id="Tc_Cr6Y6hafL0GiLFWfTCq0rA_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">638000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_3B9uzJLVRE-wKxtJvPSkOg"
      decimals="-3"
      id="Tc_-C4V_yfO0U-3ChIFW9xgyA_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1230000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_93lXqdNkAkGE1eTi254vCQ"
      decimals="-3"
      id="Tc_Qogy4zxgREWwaVz8NREgIg_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1260000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_Aq4Gh5QzC0O-z-Hkxgg7bw"
      decimals="-3"
      id="Tc_XlOzdJlZ30mD8FR0t5aZyw_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1187000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_EG_KIXGerkW5heSXWG1y5Q"
      decimals="-3"
      id="Tc_ru9U41tS90SJdxL5Dm7AuQ_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1203000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_cFy6uE7XU0-O26lG3kJGXg_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3055000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_Rmgpp10UuU-uaiUP9-0ZwA_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3101000</ifrs-full:GrossLeaseLiabilities>
    <aciu:NumberOfDepositsInEscrowAccounts
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="INF"
      id="Narr_YseDLFMFpUGiVgxQ86EwHQ"
      unitRef="Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ">2</aciu:NumberOfDepositsInEscrowAccounts>
    <aciu:EscrowDepositAmount
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-5"
      id="Narr_HJoKn331BUyOeyB7Bbw8IA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">400000</aciu:EscrowDepositAmount>
    <aciu:DisclosureOfAssetAcquisitionsTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_gva7C9vLE0ucMcfamAdkHg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;6.&lt;/b&gt;&lt;/span&gt;Asset acquisition&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In 2021, the Company closed its acquisition with Affiris AG (Affiris) for the program portfolio of therapeutics targeting a-syn, notably ACI-7104.056 (previously PD01), a clinically-validated active vaccine candidate for the treatment of Parkinson&#x2019;s disease (the Transferred Assets). The Company acquired the Transferred Assets and USD 5.0 (CHF 4.6) million in cash in exchange for 7,106,840 shares of the Company at closing, for a total value of USD 58.7 (CHF 55.1) million.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;With the closing of this transaction, the Company recorded an IPR&amp;amp;D intangible asset associated with ACI-7104.056 for USD 53.7 (CHF 50.4) million. The Company used a risk-adjusted discounted cash flow method to determine the fair value of the intangible asset using a discount rate of 15%. See &#x201c;Note&#160;7. Intangible assets&#x201d; for further details on assumptions used.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As the Company transferred its own equity instruments in consideration for the asset transferred, the acquisition was assessed in accordance with IFRS 2 &lt;i style="font-style:italic;"&gt;Share-based Payment&lt;/i&gt;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company determined that the acquisition of the Transferred Assets did not qualify as a business combination in accordance with IFRS 3 &lt;i style="font-style:italic;"&gt;Business Combinations&lt;/i&gt; and therefore was accounted for as an asset acquisition. Most of the fair value of the Transferred Assets is attributable to a single identifiable asset which is the in-process research and development asset. The purchase consideration for the Transferred Assets was allocated based on their relative fair values.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table summarizes the amounts of the Transferred Assets acquired:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;4,634&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IPR&amp;amp;D asset&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;50,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;55,050&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfAssetAcquisitionsTextBlock>
    <aciu:CashAcquiredAsPartOfAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA"
      decimals="-5"
      id="Narr_RUxMdWLTqEi9IImfsGnP9A"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">5000000.0</aciu:CashAcquiredAsPartOfAssetAcquisition>
    <aciu:CashAcquiredAsPartOfAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA"
      decimals="-5"
      id="Narr_cxxEyz4flkuZb7niT00X0Q"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4600000</aciu:CashAcquiredAsPartOfAssetAcquisition>
    <aciu:SharesTransferredAsConsiderationInAssetAcquisition
      contextRef="Duration_1_1_2021_To_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_QuVxNqREZ0mnvgP8iz8Hbw"
      decimals="INF"
      id="Narr_N5c23Ijv1k2vh950ZEteeg"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">7106840</aciu:SharesTransferredAsConsiderationInAssetAcquisition>
    <aciu:TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA"
      decimals="-5"
      id="Narr_Br9iDBJtK0u4UrNEloupQQ"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">58700000</aciu:TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition>
    <aciu:TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA"
      decimals="-5"
      id="Narr_bIreZjyfdEqmWsLs7ZBKyQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">55100000</aciu:TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition>
    <aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_BZyLB7dngU2QjWI8noII-w"
      decimals="-5"
      id="Narr_xnnzh4zyH0W6EvjxROZNQA"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">53700000</aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition>
    <aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_BZyLB7dngU2QjWI8noII-w"
      decimals="-5"
      id="Narr_H1FzRuc_BUOmmLQdSq3Lsw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">50400000</aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition>
    <ifrs-full:SignificantUnobservableInputAssets
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_OOBltWlETEyOu2fA06kbxw"
      decimals="2"
      id="Narr_ZPmtHxUfsEyt4F3TEhFs3w"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.15</ifrs-full:SignificantUnobservableInputAssets>
    <aciu:DisclosureOfAssetAcquisitionsTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_1RkswImw0U-QQra2XBR3IQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table summarizes the amounts of the Transferred Assets acquired:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;4,634&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IPR&amp;amp;D asset&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;50,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;55,050&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:DisclosureOfAssetAcquisitionsTableTextBlock>
    <aciu:CashAcquiredAsPartOfAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA"
      decimals="-3"
      id="Tc_H-zTrs3Cp0WZrCT_1okATQ_2_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4634000</aciu:CashAcquiredAsPartOfAssetAcquisition>
    <aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA"
      decimals="-3"
      id="Tc_Xs4lhzfbU0iY6pe14uBR1g_3_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">50416000</aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition>
    <aciu:TotalAssetsAcquiredInAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_qOmdSN5X902FUlIttEtEFA"
      decimals="-3"
      id="Tc_l7Vv7kiuTUiQSew49BfqLA_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">55050000</aciu:TotalAssetsAcquiredInAssetAcquisition>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_k3XvDAnGZk-lWQ4rINaeag">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;7.&lt;/b&gt;&lt;/span&gt;Intangible assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;AC Immune&#x2019;s acquired IPR&amp;amp;D asset is a clinically-validated active vaccine candidate for the treatment of Parkinson&#x2019;s disease. The asset is not yet ready for use until the asset obtains market approval. The carrying amount and net book value are detailed below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net book&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net book&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amortization&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amortization&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Acquired IPR&amp;amp;D asset&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total intangible assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In accordance with IAS 36 &lt;i style="font-style:italic;"&gt;Impairment of Assets&lt;/i&gt;, the IPR&amp;amp;D asset is reviewed at least annually for impairment by assessing the fair value less costs to sell (recoverable amount) and comparing this to the carrying value of the asset. The valuation is considered to be Level&#160;3 in the fair value hierarchy in accordance with IFRS 13 &lt;i style="font-style:italic;"&gt;Fair Value Measurement&lt;/i&gt; due to unobservable inputs used in the valuation. The Company has determined the IPR&amp;amp;D asset was not impaired as of December&#160;31, 2022 and 2021, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The key assumptions used in the valuation model in accordance with an income approach to determine the recoverable amount include observable and unobservable key inputs as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Anticipated research and development costs;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Anticipated costs of goods and sales and marketing expenditures;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Target indication prevalence and incidence rates;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Anticipated market share;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;General commercialization expectations such as anticipated pricing and uptake;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Expected patent life and market exclusivity periods; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"/&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Other metrics such as the tax rate.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"/&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s valuation model calculates the risk-adjusted, net cash flows through the projected period of market exclusivity across target sales regions. The Company uses a discount rate of 17% (15% for 2021), based on the assumed cost of capital for the Company over the forecast period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;See &#x201c;Note&#160;6. Asset acquisition&#x201d; for further details.&lt;/p&gt;</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_4R2HpvyLbkOcG1FhGmvlMg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net book&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net book&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amortization&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amortization&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Acquired IPR&amp;amp;D asset&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total intangible assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_QO4vamUaPEWTe-Dnq2T7Yw"
      decimals="-3"
      id="Tc_UYT5Z1tXsEi1FBuGzgqdAA_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_K6sJGDsSb0Ki6Q9DK_HssA"
      decimals="-3"
      id="Tc_0iBEqFKeCkSIluE-3PfxJg_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_Rm5syNGJAkK02zxsPeiygw"
      decimals="-3"
      id="Tc_Prqgx6vnfUSU9h_DKTzeJg_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_LpgnYOYCIE6nbkxvmDUYKg"
      decimals="-3"
      id="Tc_o6hlNH6BIEu0Qyz55AA5kg_5_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_OwVmQS-jlUGVZMlyx50qAA"
      decimals="-3"
      id="Tc_Y6ohjPaYMEy5vdv1rkBG4g_5_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_-0isfSi3C0iv0Hr9h6SsDw"
      decimals="-3"
      id="Tc_2Nap76AmR0uHL1EkRCIwHg_5_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_9SsycfPkpUG2RWbLatkFMg"
      decimals="-3"
      id="Tc_BzgPBAgypESnDUYGw5Py0A_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_VCafjbK1YkmLYTpqX9O2Qg"
      decimals="-3"
      id="Tc_0XXxFi0Ua0mOJyDqpDvAeg_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_6CvkkqwKmE6iBA_oVeCHXg_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_tvR74klj-EuU1efHxw9Lag"
      decimals="-3"
      id="Tc_KASx9z0eEkSR-T3aPylU4Q_6_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_nL6LiSdtTEm6pKYWuxJXrQ"
      decimals="-3"
      id="Tc_ANudIXLPPEaM6ZVTzOvemw_6_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_3YHXYyJotEeSdHi61O9WbQ_6_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:SignificantUnobservableInputAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_VADeMQ-kG0C2-xdkdCMoZg"
      decimals="2"
      id="Narr_SzdwxVq5EUywcsIasmZJ_w"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.17</ifrs-full:SignificantUnobservableInputAssets>
    <ifrs-full:SignificantUnobservableInputAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_I4XyGj16C0a9vD480ormzw"
      decimals="2"
      id="Narr_QDCBHXTXdkGnhEj2vQv7NQ"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.15</ifrs-full:SignificantUnobservableInputAssets>
    <aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_uS1DNd8IRE2-4C12MYpIzQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;8.&lt;/b&gt;&lt;/span&gt;Cash and cash equivalents and short-term financial assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The Company&#x2019;s cash and cash equivalents are maintained in the following respective currencies as of December&#160;31, 2022 and 2021:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 82,216&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 82,216&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;By currency&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 24,418&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 64,941&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,313&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,253&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,855&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,022&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 82,216&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2022 and 2021, the Company&#x2019;s funds were held in CHF, EUR and USD currencies. Funds held in EUR and USD were translated into CHF at a rate of 0.994 and 0.933 and 1.045 and 0.923, respectively, for each currency and&#160;year.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table summarizes the Company&#x2019;s short-term financial assets as of December&#160;31, 2022 and 2021:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term financial assets due in one year or less&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 116,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total short-term financial assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 116,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock>
    <aciu:ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_OBAlHBuKYEW9UidZrx_wDQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The Company&#x2019;s cash and cash equivalents are maintained in the following respective currencies as of December&#160;31, 2022 and 2021:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 82,216&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 82,216&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;By currency&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 24,418&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 64,941&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,313&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,253&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,855&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,022&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.11%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 82,216&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_7hGhpHX2jkWfRh3CM-Miig_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">31586000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_fX6FdGAk2EC4YggutkZS_A_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">82216000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_Lba80mEkwEO3efItmCpeUQ_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">31586000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_ZOYDfmj_U0qlmomjvg4nZw_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">82216000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_CHF_38ToDnEBNEuS9ddM0NrYgg"
      decimals="-3"
      id="Tc_KB6N50PcBkWmOsiUMQX5oQ_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">24418000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_srt_CurrencyAxis_currency_CHF_iiYbXla8tU-iyk_i32DP4A"
      decimals="-3"
      id="Tc_8xGaJIShdEiipmSj4Tasig_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">64941000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_EUR_V7Jj-YDCCEGGn-_yEgdDMA"
      decimals="-3"
      id="Tc_Sq6kkkXReUKfFg7qhM4IrA_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1313000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_srt_CurrencyAxis_currency_EUR_o_IBIzyApEiyeRWQLrx-UA"
      decimals="-3"
      id="Tc_GqojWA9J7UmEfsbqosjuUQ_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2253000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_USD_15GIrBDN9Uil-oruYpMkuQ"
      decimals="-3"
      id="Tc_5bZfGhU-LE2EHuASOMw3gg_9_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">5855000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_srt_CurrencyAxis_currency_USD_Ukgt6dYs9EGXQlarniLKig"
      decimals="-3"
      id="Tc_LHK7p3D2OE2VDkrdZN8aTg_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">15022000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_O4QJkw9V1UimihuBf0vmWA_10_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">31586000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_1lKsKH0ZmUqB3wUE_934yg_10_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">82216000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_EUR_V7Jj-YDCCEGGn-_yEgdDMA"
      decimals="3"
      id="Narr_hHWVNZhzHEiaXEzUB0EqPw"
      unitRef="Unit_Divide_CHF_EUR_oaL03aUr-0uB3BBQW7LmbA">0.994</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_USD_15GIrBDN9Uil-oruYpMkuQ"
      decimals="3"
      id="Narr_848M0jbHSEusCzxGxXv95A"
      unitRef="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w">0.933</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2021_srt_CurrencyAxis_currency_EUR_o_IBIzyApEiyeRWQLrx-UA"
      decimals="3"
      id="Narr_0mys_ltbtE6Qr2XMnFVlWg"
      unitRef="Unit_Divide_CHF_EUR_oaL03aUr-0uB3BBQW7LmbA">1.045</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2021_srt_CurrencyAxis_currency_USD_Ukgt6dYs9EGXQlarniLKig"
      decimals="3"
      id="Narr_aCz-yb-VeUOdcI_xKxSCkA"
      unitRef="Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w">0.923</ifrs-full:ClosingForeignExchangeRate>
    <aciu:ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Group_ZSDw2PgY9kWELP1OP4W0dg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table summarizes the Company&#x2019;s short-term financial assets as of December&#160;31, 2022 and 2021:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term financial assets due in one year or less&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 116,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total short-term financial assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 116,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_r5LpckzLpUiOGvTWM7QXkQ_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">91000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_qTRKlJO2OkOesJnULtv3DQ_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">116000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_GQN18YsdZkG9IXfTsQqPCw_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">91000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_Y0Vhh3GCLk-GeF4-F24vLw_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">116000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_VI538uIptUW1hvvRcJIwdQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;9.&lt;/b&gt;&lt;/span&gt;Prepaid expenses and accrued income&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Prepaid expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,015&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued income&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 408&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 975&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total prepaid expenses and accrued income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,116&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;3,990&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s prepaid expenses relate mainly to research contracts with down-payments at contract signature with the related activities to start or continue into 2023 as well as prepaid payroll-related expenses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Accrued income consists of CHF 0.4 million as of December&#160;31, 2022 associated with our MJFF grants and Target ALS (see &#x201c;Note&#160;13.2. Grant income&#x201d;). This amount represents 100% of our total accrued income as of December&#160;31, 2022. As of December&#160;31, 2021, the Company recorded CHF 0.9 million of accrued income associated with our MJJF grants. This amount represented 87% of our total accrued income as of December&#160;31, 2021.&lt;/p&gt;</aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock>
    <aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_NL1qT6EpS0GomV-uibT6oA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Prepaid expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,015&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued income&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 408&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 975&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total prepaid expenses and accrued income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,116&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;3,990&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_SAlY7xyjKUiGwJWL3AY7iA_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4708000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_h9UTrVNP5EeqMjeaNWo2dw_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3015000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_xXWMzx38ZEKd9MJ71Dsrig_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">408000</ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets>
    <ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_xUx1tgijVEKviC_oywoVVA_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">975000</ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets>
    <ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_xoM0lk5l9E-dI31VbzR3MA_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">5116000</ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets>
    <ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_-rVEsPLY_0GtZE8W7VdpFA_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3990000</ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets>
    <ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember_0GfBuDA_dU26TA2qx6IcSA"
      decimals="-5"
      id="Narr_C5PSZIHACkiuh6m8SmGU_Q"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">400000</ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets>
    <aciu:PercentageOfAccruedIncome
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember_0GfBuDA_dU26TA2qx6IcSA"
      decimals="2"
      id="Narr_hJeXgm9XNkm1KNfKek8Anw"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">1</aciu:PercentageOfAccruedIncome>
    <ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_vFwwP69K-kujKmPJkq_WBw"
      decimals="-5"
      id="Narr_3Aa4nQwrXEW8Mqr3OrKiGA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">900000</ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets>
    <aciu:PercentageOfAccruedIncome
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_vFwwP69K-kujKmPJkq_WBw"
      decimals="3"
      id="Narr_y_rsJsty6kW-PDGqSxpSXQ"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.87</aciu:PercentageOfAccruedIncome>
    <aciu:DisclosureOfOtherCurrentReceivablesTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_Ov5Db8SGT0acbXYDfECVOw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;10.&lt;/b&gt;&lt;/span&gt;Other current receivables&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other current receivable&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 124&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 101&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Swiss VAT&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 249&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 327&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Withholding tax&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total other current receivables&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 392&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 428&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The maturity of these assets is less than &lt;span style="-sec-ix-hidden:Hidden_P_0I_UaePkyj8OXHk3ZeUg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;3&#160;months&lt;/span&gt;&lt;/span&gt;. The Company considers the counterparty risk as low and the carrying amount of these receivables is considered to approximate their fair value.&lt;/p&gt;</aciu:DisclosureOfOtherCurrentReceivablesTextBlock>
    <aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_BVxvDoE-U0KU-oiDEMSgww">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other current receivable&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 124&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 101&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Swiss VAT&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 249&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 327&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Withholding tax&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total other current receivables&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 392&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 428&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock>
    <aciu:MiscellaneousOtherCurrentReceivables
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_U0aCk0osC0aAV43h5_8ShQ_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">124000</aciu:MiscellaneousOtherCurrentReceivables>
    <aciu:MiscellaneousOtherCurrentReceivables
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_ph3M4LoGwkaajxNY3zHN9g_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">101000</aciu:MiscellaneousOtherCurrentReceivables>
    <ifrs-full:CurrentValueAddedTaxReceivables
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_X6gEgxepPEKg1zgpuEf3oA_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">249000</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentValueAddedTaxReceivables
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_NYXAxHmfkECharSx3VAK4A_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">327000</ifrs-full:CurrentValueAddedTaxReceivables>
    <aciu:WithholdingTaxReceivables
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_k4NP3TY6dk2Vkhij_slpJA_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">19000</aciu:WithholdingTaxReceivables>
    <aciu:WithholdingTaxReceivables
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_X1CVtInW4EWIdU9thXAfww_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:WithholdingTaxReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_1PF25hlXP0CB5JQMgg9hsw_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">392000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_nRfzGzpuW0qxfArSIpbY_A_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">428000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_6yMr3JttsUWsS4TKUWVe0g">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;11.&lt;/b&gt;&lt;/span&gt;Share capital&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December&#160;31, 2022 and 2021, the issued share capital amounted to CHF 1,796,675 and CHF 1,794,013, respectively, and is composed of outstanding common shares of 83,620,364 and 83,479,013, respectively, and treasury shares of 6,214,021 and 6,221,617, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The table below summarizes the Company&#x2019;s capital structure:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Common&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Treasury&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Treasury&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;capital&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;premium&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 76,936,738&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,000,000)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 346,890&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (100)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,171,543&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12,097&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 24&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Asset purchase agreement, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,106,840&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 142&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 54,328&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Conversion of note agreements, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,026,634&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 61&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 16,683&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Issuance of shares &#x2013; incentive plans, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 237,258&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,253&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Issuance of shares to be held as treasury shares, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,393,160&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,393,160)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;48&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (48)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 89,700,630&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,221,617)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,794&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 431,251&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (124)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,596&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (8)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Issuance of shares &#x2013; incentive plans, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 133,755&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 89,834,385&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,214,021)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,797&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 431,323&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (124)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The common shares and treasury shares have nominal values of CHF 0.02 per share. All shares have been fully paid. These treasury shares held by the Company are not considered outstanding shares as of December&#160;31, 2022 or 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Authorized capital&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s Board of Directors is authorized to increase the share capital, in one or several steps, until June 24, 2024, by a maximum amount of CHF&#160;400,000 by issuing a maximum of 20,000,000 registered shares with a par value of CHF&#160;0.02 each, to be fully paid up. An increase of the share capital (i) by means of an offering underwritten by a financial institution, a syndicate or another third party or third parties, followed by an offer to the then-existing shareholders of the Company and (ii) in partial amounts, shall also be permissible.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Conditional share capital for bonds and similar debt instruments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s share capital may be increased by a maximum aggregate amount of CHF&#160;100,000&#160;through the issuance of a maximum of 5,000,000 registered shares, payable in full, each with a nominal value of CHF&#160;0.02&#160;per share, through the exercise of conversion and/or option or warrant rights granted in connection with bonds or similar instruments, issued or to be issued by the Company or by subsidiaries of the Company, including convertible debt instruments.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Conditional share capital for employee benefit plans&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s share capital may be increased by a maximum aggregate amount of CHF&#160;96,000&#160;through the issuance of not more than&#160;4,800,000&#160;common shares, payable in full, each with a nominal value of CHF&#160;0.02&#160;per share, by the exercise of options rights that have been granted to employees, consultants, members of the board of directors, or other person providing services to the Company or a subsidiary.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Shelf registration statement&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On April&#160;28, 2021, the Company filed a Shelf Registration Statement on Form&#160;F-3 (Reg. No.&#160;333-255576) (the &#x201c;Shelf Registration Statement&#x201d;) with the SEC. The Shelf Registration Statement was declared effective by the SEC on May&#160;5, 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Shelf Registration Statement allows the Company to offer and sell, from time to time, up to USD 350,000,000 of common shares, debt securities, warrants, purchase contracts, units, subscription rights or any combination of the foregoing in one or more future public offerings. The terms of any future offering would be determined at the time of the offering and would be subject to market conditions and approval by the Company&#x2019;s Board of Directors. Any offering of securities covered by the Shelf Registration Statement will be made only by means of a written prospectus and prospectus supplement authorized and filed by the Company.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;At the market equity offering&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In Q3 2020, AC Immune issued 5,000,000 common shares with a nominal value of CHF 0.02, which became treasury shares. The Company also established an &#x201c;at the market offering program&#x201d; (&#x201c;ATM&#x201d;) for the sale of up to USD 80.0 (CHF 74.6) million worth of our common shares issued from time to time by entering into an Open Market Sale Agreement (&#x201c;Sales Agreement&#x201d;) with Jefferies LLC (&#x201c;Jefferies&#x201d;) as the sales agent under a prior registration statement on Form&#160;F-3 which expired in Q2 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In Q2 2021, the Company filed a new registration statement on Form&#160;F-3 and an accompanying prospectus supplement in order to renew its ATM program. The Company also entered into a second Open Market Sale Agreement (the &#x201c;new Sales Agreement&#x201d;) with Jefferies to continue the ATM program.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In Q3, 2021, the Company issued 2,393,160 common shares with a nominal value of CHF 0.02 to be held as treasury shares.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Through December 31, 2022, the Company has sold 1,179,139 common shares previously held as treasury shares pursuant to the new Sales Agreement, raising USD 13.3 (CHF 12.1) million, net of underwriting fees and transaction costs. We have paid commissions to Jefferies totaling USD 0.4 (CHF 0.4) million through December 31, 2022, for share issuances in accordance with our ATM programs.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31,&#160;2022, 2021 and 2020, the Company has expensed issuance costs of nil, nil and CHF 0.5 million, respectively, in the consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Convertible note agreement&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Concurrently with the Asset Purchase Agreement, the Company entered into two separate Convertible Note&#160;Agreements with entities affiliated with each of Athos Service GmbH and First Capital Partner GmbH, both of which entities are shareholders of Affiris.&#160;Each Convertible Note&#160;Agreement provided for the sale of an unsecured subordinated Convertible Note&#160;of the Company with an aggregate principal amount of USD 12.5 (CHF 11.7) million for total net proceeds of USD 25 (CHF 23.5) million.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In 2021, the affiliated entities exercised their options to convert their respective USD 12.5 (CHF 11.7) million notes. As a result of these conversions, 1,513,317 &lt;span style="-sec-ix-hidden:Hidden_7EVt20oUeEOLG5MQiq_Hiw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;common&lt;/span&gt;&lt;/span&gt; shares were issued to each Investor, totaling 3,026,634 common shares. The Company recorded an increase to its share capital for the nominal value of its shares and share premium for the difference associated with settlement of this liability. The Company also settled its derivative financial assets, which were embedded conversion features associated with the convertible debt, via an offset to its share premium. These convertible notes and derivative financial assets were fully settled in 2021 and there is no further equity or cash consideration due to the affiliated entities thereunder.&lt;/p&gt;</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:IssuedCapital
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_UV3ix4h--E6wHiAOGaJNtA"
      decimals="0"
      id="Narr_FqPysMG9MkyzhLFlajziGw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1796675</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_uTemqh0x5kCnk8dGyhg2yw"
      decimals="0"
      id="Narr_2vthpQh9a0aEDV3kLYEnaA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1794013</ifrs-full:IssuedCapital>
    <ifrs-full:NumberOfSharesIssued
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_UV3ix4h--E6wHiAOGaJNtA"
      decimals="0"
      id="Narr_tptvr67UsUy_r1hbnxlIig"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">83620364</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_uTemqh0x5kCnk8dGyhg2yw"
      decimals="0"
      id="Narr_DjgMUPirFkW6h1QmpHUQ7w"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">83479013</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="0"
      id="Narr_QTcmf9e1xUGY08QJczlM2A"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">6214021</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="0"
      id="Narr_ql5hF6WyZk-Gwb0x3dSboA"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">6221617</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_dnExLU16tUCbxeU8U4M9NQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The table below summarizes the Company&#x2019;s capital structure:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Common&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Treasury&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Treasury&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;capital&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;premium&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 76,936,738&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,000,000)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,538&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 346,890&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (100)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,171,543&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 12,097&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 24&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Asset purchase agreement, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,106,840&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 142&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 54,328&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Conversion of note agreements, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,026,634&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 61&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 16,683&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Issuance of shares &#x2013; incentive plans, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 237,258&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,253&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Issuance of shares to be held as treasury shares, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,393,160&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,393,160)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;48&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (48)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 89,700,630&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,221,617)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,794&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 431,251&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (124)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,596&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (8)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Issuance of shares &#x2013; incentive plans, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 133,755&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 89,834,385&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,214,021)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,797&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.93%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 431,323&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (124)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_t849aft53kyGDr1KoWgmHg"
      decimals="INF"
      id="Tc_0UOI49X-XkKvz53r0e_mDA_4_2"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">76936738</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="As_Of_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_xamDkF4k5UGlV-TCDgu2Lg"
      decimals="INF"
      id="Tc_r4YY55CkG0yShudceXqp0A_4_4"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">5000000</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_os5Hp8MAI02VjWPk90WB7w"
      decimals="-3"
      id="Tc_7b2nn_qlhkmgJjyYwSNNVQ_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1538000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_ktuzkw64AEa5vdg54I-VCQ"
      decimals="-3"
      id="Tc_xSDpVm-tkUuXf3yyL4JQEA_4_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">346890000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_vuCe_vLKgECevKYNBCd4Lw"
      decimals="-3"
      id="Tc_l3h7anFUREq8F963Fp3hVA_4_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-100000</ifrs-full:Equity>
    <aciu:DecreaseInNumberOfTreasurySharesFromSalesOrIssuance
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_Ot-xQ2KPP06Rv7mi7NpE9w"
      decimals="INF"
      id="Tc_QJTdpKLQA0axmRjREQFT4w_5_4"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">1171543</aciu:DecreaseInNumberOfTreasurySharesFromSalesOrIssuance>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_d5FMtPcZWUWGR45BEwdLwQ_5_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">12097000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg"
      decimals="-3"
      id="Tc_MA1k6pqrWUOXPbYsjsp02A_5_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">24000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_GjUP2pWxo0OYX2B-S44KPA"
      decimals="INF"
      id="Tc_QtlyYrr17ECYAiciACmirw_6_2"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">7106840</aciu:IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions>
    <aciu:IncreaseThroughIssuanceOfSharesInAssetAcquisitions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_uQiN_s06rEq_bYCkwkoS3w_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">142000</aciu:IncreaseThroughIssuanceOfSharesInAssetAcquisitions>
    <aciu:IncreaseThroughIssuanceOfSharesInAssetAcquisitions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_9i56Jai7gE2ulCd8DzWsPA_6_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">54328000</aciu:IncreaseThroughIssuanceOfSharesInAssetAcquisitions>
    <aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_GjUP2pWxo0OYX2B-S44KPA"
      decimals="INF"
      id="Tc_XnByor3ukUKoBdambxnVXg_7_2"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">3026634</aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_PxDma2vlaUCcMRluSGr7lQ_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">61000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_9V8g_oIWeEiQ6RahMz97Jg_7_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">16683000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_GjUP2pWxo0OYX2B-S44KPA"
      decimals="INF"
      id="Tc_2BOPfH1vJEWNMGKLycBrBA_8_2"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">237258</aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans>
    <aciu:IncreaseThroughSharesIssuedUnderIncentivePlans
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_64sv2Yh_9U-rXzgBWUri6Q_8_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">5000</aciu:IncreaseThroughSharesIssuedUnderIncentivePlans>
    <aciu:IncreaseThroughSharesIssuedUnderIncentivePlans
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_yHe5bwZUdEunpu01NZzlsA"
      decimals="-3"
      id="Tc_ubvfwfqoEEu71Qt3bsIdHQ_8_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1253000</aciu:IncreaseThroughSharesIssuedUnderIncentivePlans>
    <aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_GjUP2pWxo0OYX2B-S44KPA"
      decimals="INF"
      id="Tc_xUYPBcYgfUKn-4iNcDEsJQ_9_2"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">2393160</aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares>
    <aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_Ot-xQ2KPP06Rv7mi7NpE9w"
      decimals="INF"
      id="Tc_7RdNn3bBkE-2dZyMBsuetg_9_4"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">2393160</aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_l5d5QtmM80yJKKOE0oeHLw"
      decimals="-3"
      id="Tc_XAbgNXRupk-zcm66seMkDA_9_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">48000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_oQvkO2WCV0mDsStVm7fLeg"
      decimals="-3"
      id="Tc_frCB5lHKAUaaRsbWV64N1Q_9_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-48000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_uTemqh0x5kCnk8dGyhg2yw"
      decimals="INF"
      id="Tc_S9Ificgr9kmr_O2HzHPG2Q_10_2"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">89700630</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_HnlGa1Cxjk2eh1urgNWWVw"
      decimals="INF"
      id="Tc_6YETfa1lU0G--Ag1eWKGQw_10_4"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">6221617</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember__r0D1g51PUiGX0X1UUsNSA"
      decimals="-3"
      id="Tc_IHKV4_Q2lES5pWEtIWp4Vw_10_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1794000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_dfNJO7LfcEOZT4w2RTRitw"
      decimals="-3"
      id="Tc_HOfIvV-3x064gttFvejWFA_10_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">431251000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Vs0uaVlFREaW6ng6T8fgEg"
      decimals="-3"
      id="Tc_0ExwMC-k-E2TXLCEKvgtXg_10_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-124000</ifrs-full:Equity>
    <aciu:DecreaseInNumberOfTreasurySharesFromSalesOrIssuance
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_D82Lcnr-PUGdxCD-xTUAMA"
      decimals="INF"
      id="Tc_RgCD8CPQ1kW0w9xnveCesA_11_4"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">7596</aciu:DecreaseInNumberOfTreasurySharesFromSalesOrIssuance>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA"
      decimals="-3"
      id="Tc__3guI930LUSIvDP9icGfxw_11_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-8000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_IrEBighZF0ag5653APCyMg"
      decimals="-3"
      id="Tc_f2x9ViGgyUqA1eoDl_toTA_11_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_7Z_nhIBrX0a27ZxFck0DEg"
      decimals="INF"
      id="Tc_zlGMZiFbMUeh6WwLxKdO5A_12_2"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">133755</aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans>
    <aciu:IncreaseThroughSharesIssuedUnderIncentivePlans
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_vuXklPJSGky_M1X76To6cg"
      decimals="-3"
      id="Tc_XReT9migu06fJwnNkCoKxw_12_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3000</aciu:IncreaseThroughSharesIssuedUnderIncentivePlans>
    <aciu:IncreaseThroughSharesIssuedUnderIncentivePlans
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_wJvIxLqRWE2P_gQee1jOKA"
      decimals="-3"
      id="Tc_67d_UtGa1UuAnubbLJA1vQ_12_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">80000</aciu:IncreaseThroughSharesIssuedUnderIncentivePlans>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_UV3ix4h--E6wHiAOGaJNtA"
      decimals="INF"
      id="Tc_czGiRLXjzES5E6XZisUIJQ_13_2"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">89834385</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_MzzzRCGt_kGIsmMdhb2czw"
      decimals="INF"
      id="Tc_yxKGsnkmgEqW7xEoKM5fuQ_13_4"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">6214021</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_gp09PWsb8EavwbWAh0p_Sg"
      decimals="-3"
      id="Tc_ExmZ0JIanEOX6IlPfYzFxA_13_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1797000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_8sJpe0LyAECOfOJdgZOKPQ"
      decimals="-3"
      id="Tc_D7Kc_kF9XUW-Jc0Mec2J5g_13_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">431323000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_hgoBF8GS-k-cs9msKZyyhA"
      decimals="-3"
      id="Tc_1Q0T5E7LDEe2zn7cCI7k3g_13_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-124000</ifrs-full:Equity>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="2"
      id="Narr_kJfiqlk2z0ianf_yQvx0YQ"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">0.02</ifrs-full:ParValuePerShare>
    <aciu:AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="0"
      id="Narr_rhX6qfL3-ECFvmIN5yvw4Q"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">400000</aciu:AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue>
    <aciu:NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="INF"
      id="Narr_xIbsfZeXwEGURhLUnHrDdw"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">20000000</aciu:NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="2"
      id="Narr_w7E1ZyDVsUSmEaXao3kMHg"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">0.02</ifrs-full:ParValuePerShare>
    <aciu:PotentialIncreaseIsEquityThroughConversionOfDebtInstruments
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_7CFGeyENHkKB9xvCXPYVaA"
      decimals="0"
      id="Narr_WdCUAXRzJ0aObNucAenxqA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">100000</aciu:PotentialIncreaseIsEquityThroughConversionOfDebtInstruments>
    <aciu:PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_wv9xrxx7O0K2GfFqTGYv0g"
      decimals="INF"
      id="Narr_34b4m79zhUy9uekbTr4FvQ"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">5000000</aciu:PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_kNbENWSt0ES3TXF_cT2ONw"
      decimals="2"
      id="Narr_tRIbUa8_5EC2J3AVDvxCFA"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">0.02</ifrs-full:ParValuePerShare>
    <aciu:PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_IhkhXgeEj0KYRe-nXMqtgw"
      decimals="0"
      id="Narr_SUxiy2t5GUeePbn7lybSYA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">96000</aciu:PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions>
    <aciu:PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_IhkhXgeEj0KYRe-nXMqtgw"
      decimals="INF"
      id="Narr_liw6WEwtrUG1_W4s9YAPVA"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">4800000</aciu:PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_4fT5bJuBykulzw1ivTHO9Q"
      decimals="2"
      id="Narr_vQCa0Apja02euzeDPVJPEw"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">0.02</ifrs-full:ParValuePerShare>
    <aciu:CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement
      contextRef="Duration_4_28_2021_To_4_28_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_S6KglnLJ6EOK616omN_TFQ"
      decimals="0"
      id="Narr_VpXtBg_FkUKaWKypePq81w"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">350000000</aciu:CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement>
    <aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares
      contextRef="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_z3C9c0ddSEGQe_CGaFlGBA"
      decimals="INF"
      id="Narr_SRUOyuoTrkGi3sx-z8Yzug"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">5000000</aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_nMf-S3Qo30yK_F2kNXsH8Q"
      decimals="2"
      id="Narr_qiwBxBjvA0qwR7dyEXVKLA"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">0.02</ifrs-full:ParValuePerShare>
    <aciu:CommonSharesAuthorizedForIssuanceSalesInInOpenMarket
      contextRef="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_z3C9c0ddSEGQe_CGaFlGBA"
      decimals="-5"
      id="Narr_nSVpmmVESECgHzxoQmKMXA"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">80000000.0</aciu:CommonSharesAuthorizedForIssuanceSalesInInOpenMarket>
    <aciu:CommonSharesAuthorizedForIssuanceSalesInInOpenMarket
      contextRef="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_z3C9c0ddSEGQe_CGaFlGBA"
      decimals="-5"
      id="Narr_aZcJJaSJbkOp3XBSr8FORw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">74600000</aciu:CommonSharesAuthorizedForIssuanceSalesInInOpenMarket>
    <aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares
      contextRef="Duration_7_1_2021_To_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_hFMd3XCjHE2krVkPJCUtig"
      decimals="0"
      id="Narr_7f8QJcmkeEu6O2QOW3z_Aw"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">2393160</aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_4oE23j2SoEGdWq3PS9cPew"
      decimals="2"
      id="Narr_wZe_5nUSV0yUCKqLCFs1lg"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">0.02</ifrs-full:ParValuePerShare>
    <aciu:SaleOrIssueOfTreasurySharesShares
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_jTjTRUZmlk6W61qANQJmqg"
      decimals="INF"
      id="Narr_nhAfIrTrMUmtc3xBjCOP_w"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">1179139</aciu:SaleOrIssueOfTreasurySharesShares>
    <ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_jTjTRUZmlk6W61qANQJmqg"
      decimals="-5"
      id="Narr_MIu9WO8xwkanL0DvjDZ2Mg"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">13300000</ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares>
    <ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_jTjTRUZmlk6W61qANQJmqg"
      decimals="-5"
      id="Narr_EHqrFnlFpkyhrfkjIgT6ww"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">12100000</ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares>
    <aciu:CommissionsPaidForIssuanceOrdinaryShares
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_jTjTRUZmlk6W61qANQJmqg"
      decimals="-5"
      id="Narr_YjZQkRZ7WUuVfLcyUrZo1g"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">400000</aciu:CommissionsPaidForIssuanceOrdinaryShares>
    <aciu:CommissionsPaidForIssuanceOrdinaryShares
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_jTjTRUZmlk6W61qANQJmqg"
      decimals="-5"
      id="Narr_eeQH422p6E6CoK5ZBU6qfQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">400000</aciu:CommissionsPaidForIssuanceOrdinaryShares>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_P7gp9D6sWEu1SR6hOkR0lQ"
      decimals="-5"
      id="Narr_5z6cSj7QO0S-r9xi5P6w7g"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_b6irc3wm8kOfDWxn7KoryA"
      decimals="-5"
      id="Narr_b7FkudKMv0CwEvCEhJVJKg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_QcaBM9HUnUiKIdtAR3VBHA"
      decimals="-5"
      id="Narr_h_hP2FinEkySbcBeMSBMTw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">500000</ifrs-full:ShareIssueRelatedCost>
    <aciu:NumberOfConvertibleNoteAgreements
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_Z8Cvgi6srkG50kHoFl7dWQ"
      decimals="INF"
      id="Narr_QXkXCybEyUawf8X0WskJ4w"
      unitRef="Unit_Standard_agreement_6AbCKkYWeEm1dt5Jp7cROw">2</aciu:NumberOfConvertibleNoteAgreements>
    <aciu:AggregatePrincipalAmountOfEachConvertibleNote
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_Z8Cvgi6srkG50kHoFl7dWQ"
      decimals="-5"
      id="Narr_1bEcS20ZnEmxeWmtX36Ziw"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">12500000</aciu:AggregatePrincipalAmountOfEachConvertibleNote>
    <aciu:AggregatePrincipalAmountOfEachConvertibleNote
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_Z8Cvgi6srkG50kHoFl7dWQ"
      decimals="-5"
      id="Narr_D449JaK3A0iFWIFaFJH03w"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">11700000</aciu:AggregatePrincipalAmountOfEachConvertibleNote>
    <aciu:ProceedsFromIssueOfConvertibleDebt
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_StatementScenarioAxis_aciu_IfNotesAreConvertedMember_-lcYAWhYg0-zLgqjshlyjw"
      decimals="-6"
      id="Narr_cBXarKp7f02gWc7L32fzXA"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">25000000</aciu:ProceedsFromIssueOfConvertibleDebt>
    <aciu:ProceedsFromIssueOfConvertibleDebt
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_StatementScenarioAxis_aciu_IfNotesAreConvertedMember_-lcYAWhYg0-zLgqjshlyjw"
      decimals="-5"
      id="Narr_8enWReTRS0OYyZqmfnDtng"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">23500000</aciu:ProceedsFromIssueOfConvertibleDebt>
    <aciu:ProceedsFromConversionOfConvertibleDebtPerIndividualNote
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_jtRNTBzMHEaZ7YlAIWrXwg"
      decimals="-5"
      id="Narr_1QkJttEqdEW6uZTWBpQaew"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">12500000</aciu:ProceedsFromConversionOfConvertibleDebtPerIndividualNote>
    <aciu:ProceedsFromConversionOfConvertibleDebtPerIndividualNote
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_jtRNTBzMHEaZ7YlAIWrXwg"
      decimals="-5"
      id="Narr_CZAmA-h0CU6FP_unfGeskw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">11700000</aciu:ProceedsFromConversionOfConvertibleDebtPerIndividualNote>
    <aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_AthosServiceGmbHMember_MrNll2L240y5mdXUd6AkjQ"
      decimals="0"
      id="Narr_lIb5WAX2mEiQM2JFh6WI8A"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">1513317</aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt>
    <aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_jtRNTBzMHEaZ7YlAIWrXwg"
      decimals="0"
      id="Narr_939GZs7RqE2HOHHh8bldoQ"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">3026634</aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt>
    <aciu:OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_Xwss63i4rkeKVevtj3Tcag"
      decimals="0"
      id="Narr_eMojipr1SUmHNSCp4Z-wVg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements>
    <aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_atY-H4C3m0ieX__rfuJHvQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;12.&lt;/b&gt;&lt;/span&gt;Trade and other payables and accrued expenses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade and other payables &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 929&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,003&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total trade and other payables&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 929&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,003&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued research and development costs &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,360&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,361&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued payroll expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,898&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,562&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other accrued expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,159&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,813&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total accrued expenses&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,417&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 16,736&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;An accrual of CHF 2.1 million and CHF 2.3 million was recognized for performance-related remuneration within accrued payroll expenses for 2022 and 2021, respectively. In 2021, an accrual of CHF 3.7 million was recorded as part of our cost sharing arrangement with Janssen within accrued research and development costs and CHF 0.8 million was recorded as accrued stamp duty for the issuance of shares as part of the Company&#x2019;s asset acquisition within other accrued expenses.&lt;/p&gt;</aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock>
    <aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_h6qxRYqIc0CkeWw6A5AC9A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade and other payables &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 929&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,003&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total trade and other payables&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 929&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,003&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued research and development costs &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 5,360&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,361&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued payroll expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,898&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,562&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other accrued expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,159&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,813&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total accrued expenses&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,417&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 16,736&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_QdyjAvhK9EKJJghRDgYhlQ_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">929000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_jzjitRYHZ0-HR7Ac6uFb6Q_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2003000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_bnB3IX2JIEOCN_UMCCifJg_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">929000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_upJNMoxnDUiANwnAzvS-mA_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2003000</ifrs-full:TradeAndOtherCurrentPayables>
    <aciu:CurrentAccruedResearchAndDevelopmentCosts
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_Qter3VD0KkymaWh8A3J_Hw_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">5360000</aciu:CurrentAccruedResearchAndDevelopmentCosts>
    <aciu:CurrentAccruedResearchAndDevelopmentCosts
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_mhkFD4bFRky6Ng38A-cABA_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">10361000</aciu:CurrentAccruedResearchAndDevelopmentCosts>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_MzhHPA6nxEqSj22h0XH0XA_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2898000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_dFsRI-tlhUaBXGDrsoC1Tw_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3562000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <aciu:OtherAccruedExpenses
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_BDd_SZYUAUiuKRQsKRi7tw_9_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1159000</aciu:OtherAccruedExpenses>
    <aciu:OtherAccruedExpenses
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_wqV2dHG3kEq5gjgnBFYYlA_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2813000</aciu:OtherAccruedExpenses>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_BE71bd5MgEGh6hPiI95BCA_10_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9417000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_Z4qCjp3HYU--rRKa4VS7iQ_10_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">16736000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <aciu:AccrualsForPerformanceRelatedRemuneration
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-5"
      id="Narr_bRRgxfTxeU-KBBE8mnL3wQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2100000</aciu:AccrualsForPerformanceRelatedRemuneration>
    <aciu:AccrualsForPerformanceRelatedRemuneration
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-5"
      id="Narr_jRApHMiejE-5wTEzBABZfA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2300000</aciu:AccrualsForPerformanceRelatedRemuneration>
    <aciu:CurrentAccruedResearchAndDevelopmentCosts
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_NiF-yrOtAky2RdqkvIAwfw"
      decimals="-5"
      id="Narr_ePTbrCeEI0KqOMTjNjeebQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3700000</aciu:CurrentAccruedResearchAndDevelopmentCosts>
    <aciu:AccruedStampDuty
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-5"
      id="Narr_FsJxE8TG_kKAMCrHCSS_rA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">800000</aciu:AccruedStampDuty>
    <ifrs-full:DisclosureOfRevenueExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_IYFZWAySZ0aXb2pUAxAitw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;13.&lt;/b&gt;&lt;/span&gt;Contract revenues&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2022, 2021 and 2020, AC Immune generated contract revenues of CHF 3.9 million, nil and CHF 15.4 million, respectively. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following tables provide contract revenue amounts from its LCAs for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Lilly&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,348&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Janssen &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,083&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Life Molecular Imaging&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total contract revenues&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,431&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;LMI accounted for 100% of our contract revenues in 2022 and Lilly accounted for 93% of our contract revenues in 2020.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;During the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company recognized the following contract revenues as a result of changes in the contract asset and the contract liability balances in the respective periods:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Revenues recognized in the period from:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Amounts included in the contract liability at the beginning of the period &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,477&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Performance obligations satisfied in previous periods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;13.1&lt;/b&gt;&lt;/span&gt; Licensing and collaboration agreements&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Morphomer Tau small molecule&#160;&#x2013; 2018 license agreement with Eli Lilly and Company&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In December&#160;2018, we entered into an exclusive, worldwide licensing agreement with Eli Lilly and Company (Lilly) to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases. More specifically, this is an exclusive license with the right to Lilly to grant sublicenses under the ACIU Patents, the ACIU know-how, and ACIU&#x2019;s interests in the Joint Patents and the joint know-how to Exploit the Licensed Compounds and Licensed Products. The agreement became effective on January&#160;23, 2019 (the &#x201c;effective date&#x201d;) when the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired. In Q3 2019, the Company and Lilly entered into the first amendment to divide the first discretionary milestone payment under the agreement of CHF 60 million into two installments, with the first CHF 30 million paid in Q3 2019 and the second CHF 30 million to be paid on or before March&#160;31, 2020 unless Lilly terminated the agreement earlier. In Q1 2020, the Company and Lilly entered into a second amendment to replace the second CHF 30 million to be paid on or before March&#160;31, 2020 with two milestone payments, one of CHF 10 million to be paid on or before March&#160;31, 2020 and the other of CHF 60 million following the first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Per the terms of the agreement, the Company received an initial upfront payment of CHF 80 million in Q1 2019 for the rights granted by the Company to Lilly. To date, the Company has completed a Phase 1 clinical study with ACI-3024.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Additionally, the Company and Lilly have continued candidate characterization across the research program, identifying new and highly differentiated candidates with desired cerebrospinal fluid exposure and selectivity for pathological aggregated Tau. These will be broadly developed in Tau-dependent neurodegenerative diseases by Lilly. Lilly is responsible for leading and funding further clinical development and will retain global commercialization rights for all indications.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Per the terms of the agreement, the Company may become eligible to receive additional milestone payments totaling up to approximately CHF 880 million for clinical and regulatory milestones and CHF 900 million upon achievement of certain commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the low double-digits to the mid-teens. The agreement will terminate by the date of expiration of the last royalty term for the last licensed product. However, under the terms of the agreement, Lilly may terminate the agreement at any time by providing &lt;span style="-sec-ix-hidden:Hidden_K168Qe9Bi02hpV05wXH75Q;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;3&#160;months&lt;/span&gt;&lt;/span&gt;&#x2019; prior notice to us.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Lilly is a customer. The Company identified the following significant performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;research and development activities outlined in the development plan. Per the agreement, the Company was responsible for the preclinical and Phase 1 activities for the first clinical candidate, ACI-3024, which the Company determined was distinct and capable of being completed by Lilly or a third party. Preclinical activities for which AC Immune was responsible prior to their completion in Q2 2019 included final manufacturing of materials for use in the regulatory submission of the protocol and in the Phase 1 study. For the completed Phase 1, AC Immune was responsible for leading the study design, obtaining relevant regulatory agency approvals, arranging necessary third-party contracts, completing patient selection, ensuring patient treatment, following up with patients, drafting the clinical study report &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;development and other relevant clinical activities to ensure that the primary objective of the study was completed. The Company used CMOs for certain of its preclinical activities and CROs to complete certain Phase 1 activities and to issue the final clinical study report.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s preclinical and Phase 1 activities did not represent integrated services with the licensed intellectual property for which Lilly contracted. Lilly purchased a license to the Company&#x2019;s Tau therapeutic small-molecule program, which was delivered at commencement of the agreement, and AC Immune&#x2019;s preclinical and Phase 1 activities did not affect the form or functionality of this license. The Company&#x2019;s objective for the Phase 1 activity was to assess safety and tolerability and did not modify or customize ACI-3024. The completion of these preclinical and Phase 1 activities does not affect the licensed intellectual property.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Finally, per the agreement, each party has three representatives on a joint steering committee (JSC). Depending upon the agenda, additional field experts can attend the JSC to provide the technical and scientific contribution required. The JSC meets on a regular basis depending on agreements between the representatives. The JSC is responsible for serving as the forum to (i)&#160;discuss, review and approve certain activities by reviewing and discussing the development progress with updates on back-up candidates, (ii)&#160;discuss, review and approve all amendments to the global development plan, (iii)&#160;periodically discuss and review commercialization of licensed products and (iv)&#160;review and approve reports related to development costs among other activities. The JSC is intended to ensure that communication between the parties remains consistent and that the development plan is progressing as intended.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The valuation of each performance obligation involves estimates and assumptions with revenue recognition timing to be determined by either delivery or the provision of services.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company used the residual approach to estimate the selling price for the right-of-use license and an expected cost plus margin approach for estimating the research and development activities. The right-of-use license was delivered on the effective date. The research and development activities were delivered over time as the services were performed. For these services, revenue was recognized over time using the input method, based on costs incurred to perform the services, as the level of costs incurred over time is thought to best reflect the transfer of services to Lilly. The Company determined the value of the research and development activities to be CHF 6.9 million and deferred this balance from the effective date. To date, the Company has cumulatively recognized CHF 6.9 million in contract revenue, resulting in no deferred income (contract liability) on the consolidated balance sheets. The remaining CHF 73.1 million from the upfront payment was allocated to the right-of-use license and recognized on the effective date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At inception of the agreement, none of the clinical, regulatory or commercial milestones had been included in the transaction price, as all milestone amounts were fully constrained. To date, the Company has recognized CHF 40 million from milestone payments triggered in Q3 2019 and Q1 2020 related to the right-of-use license for intellectual property as there were no further constraints related to these milestones. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors to determine that these milestones are not highly probable to obtain, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#x2019;s efforts. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Lilly and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we have recognized nil, nil and CHF 14.3 million, respectively, from this arrangement.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Anti-Abeta antibody in AD&#160;&#x2013; 2006 agreement with Genentech, a member of the Roche Group&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;In November&#160;2006, we signed an exclusive, worldwide licensing agreement for crenezumab, our humanized monoclonal therapeutic antibody targeting misfolded Abeta. The agreement was amended March&#160;2009, January&#160;2013, May&#160;2014 and May&#160;2015. The agreement also provides for the development of a second therapeutic product for a non-&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;AD indication based on the same intellectual property and anti-Abeta antibody compound. The value of this partnership is potentially greater than USD 340 (CHF 317) million.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The term of the agreement commenced on the effective date and, unless sooner terminated by mutual agreement or pursuant to any other provision of the agreement, terminates on the date on which all obligations between the parties with respect to the payment of milestones or royalties with respect to licensed products have passed or expired. Either party may terminate the agreement for any material breach by the other party, provided a cure period of 90&#160;days from the date when that notice is given.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Genentech commenced a first Phase 3 clinical study in March&#160;2016 for crenezumab&#160;(CREAD). In March&#160;2017, Genentech started a second Phase 3 clinical trial (CREAD 2). Since 2013, crenezumab has also been studied in a Phase 2 preventive trial in individuals who carry the PSEN1 E280A autosomal-dominant mutation and do not meet the criteria for mild cognitive impairment due to AD or dementia due to AD and are, thus, in a preclinical phase of&#160;AD&#160;(autosomal dominant AD (ADAD)). In 2019, Genentech initiated a Tau Positron Emission Tomography (PET) substudy to the ongoing Phase 2 trial in ADAD to evaluate the effect of crenezumab on Tau burden, which may also increase the understanding of disease progression in the preclinical stage of ADAD.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;If crenezumab receives regulatory approval, we will be entitled to receive royalties that are tied to annual sales volumes with different royalty rates applicable in the U.S. and Europe ranging from the mid-single digits to mid-teens. To date, we have received total milestone payments of USD 65 (CHF 70.1) million comprised of an upfront payment of USD 25 (CHF 31.6) million and of USD 40 (CHF 38.2) million for clinical development milestones achieved all-in prior to January&#160;1, 2017. Genentech may terminate the agreement at any time by providing &lt;span style="-sec-ix-hidden:Hidden_EdaFR7KmDE28JCeL6L0nxw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;3&#160;months&lt;/span&gt;&lt;/span&gt;&#x2019; notice to us. In such event all costs incurred are still refundable.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Genentech is a customer. The Company identified the following performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;conducting of research under a research plan. The Company considered the research and development capabilities of Genentech and Genentech&#x2019;s right to sublicense to conclude that the license has stand-alone functionality and is distinct. The Company&#x2019;s obligation to perform research does not significantly impact or modify the licenses&#x2019; granted functionality.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At execution of the agreement, the transaction price included the upfront consideration received of USD 25 (CHF 31.6) million. At inception, none of the clinical or regulatory milestones had been included in the transaction price, as all milestone amounts were fully constrained. The Company has received three milestone payments since inception, totaling USD 40 (CHF 38.2) million. The Company could receive greater than USD 275 (CHF 256.4) million or more for further regulatory milestones for this exclusive, worldwide alliance. In assessing that future regulatory milestones are fully constrained, the Company considered numerous factors, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#x2019;s efforts. Any consideration related to royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Genentech and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In January 2019, we announced that Roche, the parent of Genentech, is discontinuing the CREAD and CREAD 2 (BN29552 and BN29553) Phase 3 studies of crenezumab in people with prodromal-to-mild sporadic AD. The decision came after an interim analysis conducted by the Independent Data Monitoring Center (IDMC) indicated that crenezumab was unlikely to meet its primary endpoint of change from baseline in CDR-SB Score. This decision was not related to the safety of the investigational product. No safety signals for crenezumab were observed in this analysis and the overall safety profile was similar to that seen in previous trials.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we have recognized no revenues from this arrangement.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Anti-Tau antibody in AD&#160;&#x2013; 2012 agreement with Genentech, a member of the Roche Group&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In June&#160;2012, we entered into a second agreement with Genentech to research, develop and commercialize our anti-Tau antibodies for use as immunotherapeutics and diagnostics. The agreement was amended in December&#160;2015. The value of this exclusive, worldwide alliance is potentially greater than CHF 400 million and includes upfront and clinical, regulatory and commercial milestone payments. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the mid-single digits to low-double digits. The agreement also provides for collaboration on at least one additional therapeutic indication outside of AD built on the same anti-Tau antibody program as well an anti-Tau diagnostic product.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The term of the agreement commenced on the effective date and, unless sooner terminated by mutual agreement or pursuant to any other provision of the agreement, terminates on the date on which all obligations between the parties with respect to the payment of milestones or royalties with respect to licensed products have passed or expired. Either party may terminate the agreement for any material breach by the other party, provided a cure period of 90&#160;days from the date when that notice is given.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;To date, we have received payments totaling CHF 59 million, including a milestone payment of CHF 14 million received and &lt;span style="-sec-ix-hidden:Hidden_751hiZiX7EinZNcM4zz_ew;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;recognized&lt;/span&gt;&lt;/span&gt; in Q4 2017 associated with the first patient dosing in a Phase 2 clinical trial for AD with an anti-Tau monoclonal body known as semorinemab, a milestone payment of CHF 14 million recognized in Q2 2016 and &lt;span style="-sec-ix-hidden:Hidden_5oAu63RdGkGFjzGDsCTBog;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;received&lt;/span&gt;&lt;/span&gt; in July&#160;2016, associated with the announcement of the commencement of the Phase 1 clinical study of semorinemab, and a milestone payment of CHF 14 million received in 2015 in connection with the ED-GO decision. As we met all performance obligations on reaching these milestones, we have recognized revenue in the respective periods. Genentech may terminate the agreement at any time by providing &lt;span style="-sec-ix-hidden:Hidden_lTC6TFzT5kGupQPYn0M3yQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;3&#160;months&lt;/span&gt;&lt;/span&gt;&#x2019; notice to us.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Genentech is a customer. The Company identified the following performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;conduct of research under a research plan. The Company considered the research and development capabilities of Genentech and Genentech&#x2019;s right to sublicense to conclude that the license has stand-alone functionality and is distinct. The Company&#x2019;s obligation to perform research does not significantly impact or modify the licenses&#x2019; granted functionality.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At execution of the agreement, the transaction price included an upfront consideration received of CHF 17 million. At inception, none of the clinical or regulatory milestones had been included in the transaction price, as all milestone amounts were fully constrained. The Company has received three milestones since inception totaling CHF 42 million. The Company could also receive up to an additional CHF 368.5 million in clinical, regulatory and commercial milestones. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Genentech and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In September 2020, the Company reported that Genentech informed us of top line results from a Phase 2 trial of the anti-Tau antibody, semorinemab, in early (prodromal to mild) Alzheimer&#x2019;s disease (AD) which show that semorinemab did not meet its primary efficacy endpoint of reducing decline on CDR-SB compared to placebo. The primary safety endpoint was however met. Two secondary endpoints, Alzheimer&#x2019;s Disease Assessment Scale-Cognitive Subscale 13 (ADAS-Cog13) and Alzheimer&#x2019;s Disease Cooperative Study Group&#160;&#x2013; Activities of Daily Living Inventory (ADCS-ADL), were not met.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In August 2021, the Company reported that Genentech had informed the Company that the Lauriet study had met one of its co-primary endpoints, ADAS-Cog 11. The second co-primary endpoint, ADCS-ADL, was not met. Safety data showed that semorinemab was well tolerated with an acceptable safety profile and no unanticipated safety signals. In November 2021, the Company reported that Genentech had presented the full top-line data from the Lauriet study during a late-breaking session at the 14&lt;sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"&gt;th&lt;/sup&gt; Clinical Trials on Alzheimer&#x2019;s Disease conference.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we have recognized no revenues from this arrangement.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Tau vaccine in AD&#160;&#x2013; 2014 agreement with Janssen Pharmaceuticals,&#160;Inc.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In December&#160;2014, we entered into an agreement with Janssen Pharmaceuticals,&#160;Inc. (Janssen), part of the Janssen Pharmaceutical Companies of Johnson&#160;&amp;amp; Johnson, to develop and commercialize therapeutic anti-Tau vaccines for the treatment of AD and potentially other Tauopathies. The value of this collaboration is potentially up to CHF 500 million and includes upfront and clinical, regulatory and commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the high-single digits to the mid-teens for the phospho-Tau vaccine program. In April&#160;2016, July&#160;2017, January&#160;2019, November&#160;2019 and December 2022, the companies entered into the first, second, third, fourth and fifth amendments, respectively. These amendments allow for the alignment of certain payment and activity provisions with the Development Plan and Research Plan activities. We and Janssen have completed the co-development of the second-generation lead therapeutic vaccines, ACI-35.030 and JACI-&lt;span style="white-space:pre-wrap;"&gt;35.054, through Phase 1b/2a. In November 2022, it was announced that ACI-35.030 was selected to advance into further development based on interim data from the ongoing Phase 1b/2a trial. AC Immune and Janssen will jointly share research and development costs until the completion of the first Phase 2b (AC Immune&#x2019;s contribution to the first Phase 2b trial is capped). From Phase 2b and onwards, Janssen will assume responsibility for the clinical development, manufacturing and commercialization of ACI-35.030.  &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Under the terms of the agreement, Janssen may terminate the agreement at any time after completion of the first Phase 1b clinical study in 2016 by providing 90&#160;days&#x2019; notice to us. If not otherwise terminated, the agreement shall continue until the expiration of all royalty obligations as outlined in the contract.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The agreement also allows for the expansion to a second indication based on the same anti-Tau vaccine program and based on intellectual property related to this program.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company received an upfront, non-refundable license fee of CHF 25.9 million, which we recognized as revenue in 2014. In May&#160;2016, we received a payment of CHF 4.9 million for reaching a clinical milestone in the first Phase 1b study. As we met all performance obligations on reaching the milestone, we have recognized this income as revenue.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Janssen is a customer. The Company identified the following performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;research and development services including a development and chemistry, manufacturing and controls work plan. The Company considered the research and development capabilities of Janssen, Janssen&#x2019;s right to sublicense, and the fact that the research and development services are not proprietary and can be provided by other vendors, to conclude that the license has stand-alone functionality and is distinct. The Company&#x2019;s obligation to perform research and development services does not significantly impact or modify the licenses&#x2019; granted functionality. Based on these assessments, the Company identified the license and the research and development services as the performance obligations at the inception of the arrangement, which were deemed to be distinct in the context of the contract.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At execution of the agreement, the transaction price included only the upfront consideration received of CHF 25.9 million. At inception, none of the clinical, regulatory or commercial milestones has been included in the transaction price, as all milestone amounts were fully constrained. The Company did receive a payment of CHF 4.9 million for reaching a clinical milestone in the first Phase 1b study in May&#160;2016. The Company could also receive up to more than CHF 458 million in clinical, regulatory and commercial milestones as well as tiered, high-single digits to mid-teen royalties on aggregate net sales for the phospho-Tau vaccine program. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors to determine that these milestones are not highly probable to obtain, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#x2019;s efforts. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Janssen and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we have recognized nil, nil and CHF 1.1 million, respectively, from this arrangement.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"&gt;&lt;i style="font-style:italic;"&gt;Tau-PET imaging agent&#160;&#x2013;2014 agreement with Life Molecular Imaging (LMI) (formerly Piramal Imaging SA)&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In May&#160;2014 (as amended in June 2022), we entered into an agreement, our first diagnostic partnership, with LMI, the former Piramal Imaging SA. The partnership with LMI is an exclusive, worldwide licensing agreement for the research, development and commercialization of the Company&#x2019;s Tau protein PET tracers supporting the early diagnosis and clinical management of AD and other Tau-related disorders and includes upfront and sales milestone payments totaling up to EUR 160 (CHF 159) million, plus royalties on sales at a&#160;percentage rate ranging from mid-single digits to low-teens. LMI may terminate the LCA at any time by providing 3&#160;months&#x2019; notice to us.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In connection with this agreement, AC Immune received a payment of EUR 500 (CHF 664) thousand, which was fully recognized in 2015. In Q1 2017, we recorded a milestone payment of EUR 1 (CHF 1.1) million related to the initiation of &#x201c;Part&#160;B&#x201d; of the first-in-man Phase 1 study. In Q3 2019, the Company recognized EUR 2 (CHF 2.2) million in connection with the initiation of a Phase 2 trial of Tau-PET tracer in patients with mild cognitive impairment and mild&#x2013;to-moderate AD in comparison with non-demented control participants. In Q3 2022, the Company recognized EUR 4 (CHF 3.9) million linked to the progression of the Tau-PET tracer into late-stage development in AD. The Company is eligible to receive additional variable consideration related to the achievement of certain clinical milestones totaling EUR 4 (CHF 4) million should the compound make it through Phase 3 clinical studies. We are also eligible to receive potential regulatory and sales-based milestones totaling EUR 148 (CHF 138) million. Finally, the Company is eligible for royalties from the mid-single digits to low-teens.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that LMI is a customer. The Company has identified that the right-of-use license as the only performance obligation. The Company determined that transaction price based on the defined terms allocated to each performance obligation specified in the contract.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The upfront payment constitutes the amount of consideration to be included in the transaction price and has been allocated to the license. None of the clinical, regulatory or commercial milestones has been included in the transaction price as these variable consideration elements are considered fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#x2019;s efforts.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as these amounts have been determined to relate predominantly to the license granted to LMI and therefore are recognized at the later of when the performance obligation is satisfied or the related sales occur. The Company considered LMI&#x2019;s right to sublicense and develop the Tau protein PET tracers, and the fact that LMI could perform the research and development work themselves within the license term without AC Immune, to conclude that the license has stand-alone functionality and is distinct. The Company believes that the contracted amount represents the fair value. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company has recognized CHF 3.9 million, nil and nil, respectively, from this arrangement.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;13.2&lt;/b&gt;&lt;/span&gt; Grant income&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Grants from the Michael J. Fox Foundation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;In May&#160;2020, the Company, as part of a joint arrangement with Sk&#xe5;ne University Hospital (Sk&#xe5;ne) in Sweden, was awarded a USD 3.2 (CHF 3.0) million grant from the MJFF&#x2019;s Ken Griffin Alpha-synuclein Imaging Competition. As part of this grant, AC Immune is eligible to receive USD 2.5 (CHF 2.3) million directly from the MJFF. Sk&#xe5;ne will receive USD 0.7 (CHF 0.7) million of the total grant directly from the MJFF over &lt;span style="-sec-ix-hidden:Hidden_CDAuGzNdHk259o1JNxYdiA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;two&lt;/span&gt;&lt;/span&gt;&#160;years to conduct and support the clinical arm of the project. In August 2022, the Company received follow-on grant funding as part of its joint &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;arrangement with Sk&#xe5;ne in Sweden totaling USD&#160;0.5&#160;(CHF&#160;0.5) million for the continued development of its alpha-synuclein PET imaging diagnostic agent. As part of this grant, AC Immune received USD&#160;0.4&#160;(CHF&#160;0.4) million directly from the MJFF. Sk&#xe5;ne will receive USD&#160;0.1&#160;(CHF&#160;0.1) million of the total grant directly from the MJFF over the duration of the grant period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The MJFF expects that AC Immune and Sk&#xe5;ne will complete tasks according to the agreed timelines. AC Immune&#x2019;s funding is variable depending on the satisfactory achievement of these specific tasks within a specific period of time.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In December&#160;2021, the Company announced that it had been awarded two grants totaling USD 1.5 (CHF 1.4) million to advance small molecule PD programs. One award will support an existing early-stage program to develop small molecules that can prevent intracellular aggregation and spreading of a-syn. The other award will fund research on the therapeutic potential of chemically and mechanistically novel, brain penetrant small molecule inhibitors of NLRP3 inflammasome activation for the treatment of PD.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company has recognized CHF 1.2 million, CHF 1.1 million and CHF 1.3 million, respectively, from its MJFF grants. As of December&#160;31, 2022, the Company recorded CHF 0.3 million in accrued income and CHF 0.5 million in deferred income, respectively.&lt;/p&gt;</ifrs-full:DisclosureOfRevenueExplanatory>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-5"
      id="Narr_vo9mI_8pH0OzU2yTF2pC7g"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-5"
      id="Narr_tyAd-OYe5ky-EjaHZBrU0Q"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-5"
      id="Narr_RiFt_Cc8cEq66zDLEF3I8w"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">15400000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_IrTso-g8kkeLlIHkXs5rEQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following tables provide contract revenue amounts from its LCAs for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Lilly&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,348&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Janssen &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,083&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Life Molecular Imaging&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total contract revenues&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,431&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_OXAjfAuKLkGrxwLJeL_h4g"
      decimals="-3"
      id="Tc_ep8Z4z_sTUa90H8CFxilAA_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_NC-GY6fYlkqMWQ13ktqxIQ"
      decimals="-3"
      id="Tc_ZHbcREX1cECjqfXRYi6xVg_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_R5HPjrhD7kOQFT3FLpl0VQ"
      decimals="-3"
      id="Tc_R025y4xIwUmXOCkm9T4y9A_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">14348000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_cTOwJWsTfU2wP__TQVaSgw"
      decimals="-3"
      id="Tc_O1ir0WPI-E60Y6c-GH89MQ_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_cyiz-Q_qC0uLMdJoM0Mbdw"
      decimals="-3"
      id="Tc_Or72Zub9CkyomvR8Zvhg4w_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_HVTIaNw_0UOjUkO5CiRYEA"
      decimals="-3"
      id="Tc_r3UTzTUuvUuQ4bdD9_QXng_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1083000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_5kIFcqQdLECCxjdGCPTLvw"
      decimals="-3"
      id="Tc_vA6fHyqxtUqH_a4XVULPUg_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3935000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_WmrQJ8yOykaDFuA8S-ALTg"
      decimals="-3"
      id="Tc_zHdvynl-8U-j920giK70bA_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_qwYRZkjqJkCgDZXe1ke0Iw"
      decimals="-3"
      id="Tc_gvpTMlEV10GABgR62A4ljg_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_DLwdtCkPQ0eAp_FHhorfMA_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3935000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_8iJ56c-I4UCApjN2GEtAAA_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_jJJR1Fvk9kSVz14IiLDD1w_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">15431000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_5kIFcqQdLECCxjdGCPTLvw"
      decimals="2"
      id="Narr_rB7Rx2ZcZ0Kt06CQK2-PoQ"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">1</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_NC-GY6fYlkqMWQ13ktqxIQ"
      decimals="2"
      id="Narr_wmnqxICdW0GZYQni4WrxBQ"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.93</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_WTpBIBaDhEO4HOpdfl4Hrw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;During the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company recognized the following contract revenues as a result of changes in the contract asset and the contract liability balances in the respective periods:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Revenues recognized in the period from:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Amounts included in the contract liability at the beginning of the period &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,477&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Performance obligations satisfied in previous periods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory>
    <ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_lQzDCjqqp0yBD4cQu9x1mA_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
    <ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_QFLBBnp-mUiW6RglGrULjg_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4477000</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
    <ifrs-full:RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_lgM3oTo8i0umOYBGFwX1Ng_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3935000</ifrs-full:RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods>
    <ifrs-full:RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_7mErEwNUaE68laGlCAUS1A_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">10000000</ifrs-full:RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_COp1pU_2c0K0ifwsTtZrJw"
      decimals="-6"
      id="Narr_FiA59yKKUkSyYLMzDW9GMg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">60000000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementMilestonePaymentNumberOfInstallments
      contextRef="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_g_GGnY_Mek66JNJPv8qF7g"
      decimals="INF"
      id="Narr_M-4rc_hzzka6KkVDZi2zBw"
      unitRef="Unit_Standard_installment_mxjM2Rh-sk6ny-HGf2rDww">2</aciu:CollaborativeAgreementMilestonePaymentNumberOfInstallments>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_Quarter32019Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_pnlTLBAOqUyJSsbJhyKKYA"
      decimals="-6"
      id="Narr_OlwSC1OUrUO_wCoS0efpqQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">30000000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_3QZoZDHthk6fXZD1NuNlOg"
      decimals="-6"
      id="Narr_kXrWS5DCR0Ca2Jm5Qld5Fg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">30000000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_UrnH6A3xZ0GUsbQYZdWO-A"
      decimals="-6"
      id="Narr_dTPvIpdjDUuhvZO3xf-gDA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">30000000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <aciu:CollaborativeAgreementMilestonePaymentNumberOfInstallments
      contextRef="Duration_3_31_2020_To_3_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_POa8drBe6UafiI7IoFhEXw"
      decimals="INF"
      id="Narr_kWCDh8vj70CEU9TRsm5HTQ"
      unitRef="Unit_Standard_installment_mxjM2Rh-sk6ny-HGf2rDww">2</aciu:CollaborativeAgreementMilestonePaymentNumberOfInstallments>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_g8PQeK6MBUOy01cnGHEgHg"
      decimals="-6"
      id="Narr_YN1v5ClHXUS19uni9P2fYg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">10000000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_Bwy5dQAXAEWqqXyDPqgE6Q"
      decimals="-6"
      id="Narr_P7vm4Zj-DUygbxMA8i05fA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">60000000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_1_1_2019_To_3_31_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_bzzbrZyzREe8dKLr1q4pcA"
      decimals="-6"
      id="Narr_-HJONFkrb0ClKUe1xEzBhQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">80000000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_Y_oiYfNYLEWs_ZiE9phKFg"
      decimals="-6"
      id="Narr_l38hPz-9RUeXOHsBNm5OAg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">880000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsCommercialMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_gCSsL-ubc0eIq6zJNtwUCg"
      decimals="-6"
      id="Narr_Rxu-nr8Y8k6izh-NV2crNw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">900000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <aciu:NumberOfRepresentativesInJointSteeringCommitteeByEachParty
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_AnT6Y1xoZUO8xgP2BhtXpg"
      decimals="INF"
      id="Narr_3jgZ3FZ0PUutj7aJyYJmnQ"
      unitRef="Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ">3</aciu:NumberOfRepresentativesInJointSteeringCommitteeByEachParty>
    <ifrs-full:ContractAssets
      contextRef="As_Of_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_WVjiu2AWkUC7_73wPEZNAg"
      decimals="-5"
      id="Narr_1n_acJep70eZL_duseG90g"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">6900000</ifrs-full:ContractAssets>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_23_2019_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_boFHM2vJ60aWug_NKJAQTA"
      decimals="-5"
      id="Narr_TQvfTNrFm0OA0jN2AQpHuw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">6900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_YpfuJbR9Jku9LQlMY-CQVg"
      decimals="-6"
      id="Narr_JtO6ykEKv0eBBzazgkk2JA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_23_2019_To_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_1Vi83gAQRUCn92QFpovc7Q"
      decimals="-5"
      id="Narr_pvfmMFImMkaZjMaI8PMAVQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">73100000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_7_1_2019_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_X7pFxFGHnkKllf5M2sGd6w"
      decimals="-6"
      id="Narr_Mut-PwUrykKUMojVTSp0mQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">40000000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_AnT6Y1xoZUO8xgP2BhtXpg"
      decimals="-5"
      id="Narr_iw2sIEGDUk6kYP8S2qJ_Dg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_gScL_dC77kCsTG776ERWNA"
      decimals="-5"
      id="Narr_pI2mEGEijESpx7kxVUUw-Q"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_UT-qr7yDeESe7RDDN5ti-Q"
      decimals="-5"
      id="Narr_-GzRdPOK9EWhNfR5igtCUw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">14300000</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_VzztEIOlRE2c1SoXK6RQgg"
      decimals="-6"
      id="Narr_K2dsqN__fUGYSMICn5Xpzg"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">340000000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_VzztEIOlRE2c1SoXK6RQgg"
      decimals="-6"
      id="Narr_4ohJ8SM42UKnXVMzQHRjeA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">317000000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__hddlRQFkkqifIU3xGWEIw"
      id="Narr_XThi9KlNvkq5DaoZuwWQZQ">P90D</aciu:CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract>
    <aciu:CollaborativeAgreementCumulativePaymentsReceived
      contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_AEaXqV6uYU2YSJVL94SJpg"
      decimals="-6"
      id="Narr_gFBwD0n52U2GP3UZsII3dQ"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">65000000</aciu:CollaborativeAgreementCumulativePaymentsReceived>
    <aciu:CollaborativeAgreementCumulativePaymentsReceived
      contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_AEaXqV6uYU2YSJVL94SJpg"
      decimals="-5"
      id="Narr_LYMAcbl27EC4BGZgt72A2Q"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">70100000</aciu:CollaborativeAgreementCumulativePaymentsReceived>
    <aciu:CollaborativeAgreementUpfrontPaymentsReceived
      contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__PSR-FnhukSI5DOP7kxVxw"
      decimals="-6"
      id="Narr_XT9gxTKjHkq5xoNv_PdqtA"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">25000000</aciu:CollaborativeAgreementUpfrontPaymentsReceived>
    <aciu:CollaborativeAgreementUpfrontPaymentsReceived
      contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__PSR-FnhukSI5DOP7kxVxw"
      decimals="-5"
      id="Narr_NdAoD8DnxUOGNaWr9jMQSA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">31600000</aciu:CollaborativeAgreementUpfrontPaymentsReceived>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesAchievedPriorTo1January2017Member_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_bi-vVw0ymkK92cjHErDo8Q"
      decimals="-6"
      id="Narr_XoRMprpRkU-BEoBnLB4jKQ"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">40000000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesAchievedPriorTo1January2017Member_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_bi-vVw0ymkK92cjHErDo8Q"
      decimals="-5"
      id="Narr_bRtagAdsL0uk_8r2L5TWFA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">38200000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <ifrs-full:ContractLiabilities
      contextRef="As_Of_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_bmdNVxjd7kCcxLTi4MiPYg"
      decimals="-6"
      id="Narr_kzTgRojOYUeVMb_5UunyEQ"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">25000000</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="As_Of_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_bmdNVxjd7kCcxLTi4MiPYg"
      decimals="-5"
      id="Narr_7W4psCdHiUC1nBAdGVuVNw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">31600000</ifrs-full:ContractLiabilities>
    <aciu:NumberOfMilestonePaymentsReceived
      contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__PSR-FnhukSI5DOP7kxVxw"
      decimals="INF"
      id="Narr_upVaXWhVgkiyNK9TVOX2fQ"
      unitRef="Unit_Standard_payment_b5_XsToWrkW99sPOvgoheg">3</aciu:NumberOfMilestonePaymentsReceived>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__PSR-FnhukSI5DOP7kxVxw"
      decimals="-6"
      id="Narr_F3ZNKQsKhUiSDeOMyL10Aw"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">40000000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_11_1_2006_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember__PSR-FnhukSI5DOP7kxVxw"
      decimals="-5"
      id="Narr_0joF8rPjTEGN8pA9IrYV-g"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">38200000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_VzztEIOlRE2c1SoXK6RQgg"
      decimals="-6"
      id="Narr_vpBYDTVG9k2XsQ_ukht8Rg"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">275000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_VzztEIOlRE2c1SoXK6RQgg"
      decimals="-5"
      id="Narr_QcCySBJ6Uk-C8x-Mx42FMw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">256400000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_PrKPmhCrP0ePfbwTC-yXHA"
      decimals="-6"
      id="Narr_nSV4O9pDqEu-KEGsokwdtA"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">0</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_6_30_2012_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_W_xvSn3aIUSy0b2g6uFBPw"
      decimals="-6"
      id="Narr_OEGzmAvYc0WNqhP3bhrQNA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">400000000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_8iFSlULEHU-tuNl09k6RZA"
      id="Narr_JnIwxikGckOxHBrwqfP47A">P90D</aciu:CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract>
    <aciu:CollaborativeAgreementCumulativePaymentsReceived
      contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_Xs05KeXY_USgX2n0OcnZ7Q"
      decimals="-6"
      id="Narr_fSIwXQiqykuebiyjvAo9gw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">59000000</aciu:CollaborativeAgreementCumulativePaymentsReceived>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_10_1_2017_To_12_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_MJWKVhi5Mke2_vbucOqWPQ"
      decimals="-6"
      id="Narr_pHFaluSoz0awOQWB2OQCBQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">14000000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_4_1_2016_To_6_30_2016_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_otQ-b1w0b0OqUhWtsoKp6Q"
      decimals="-6"
      id="Narr_z2DiRnP55k6sCGtGM_Qaig"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">14000000</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_1_1_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_FNJ-cLjT602Qc6SGy47cbA"
      decimals="-6"
      id="Narr_jq6dKrbkckiAyKKDpUtmIg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">14000000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <ifrs-full:ContractLiabilities
      contextRef="As_Of_6_30_2012_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_p2DjH8za9kC0HB1u8L2hcw"
      decimals="-6"
      id="Narr_FUCrKKqDjUG3GOWUKsRtwQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">17000000</ifrs-full:ContractLiabilities>
    <aciu:NumberOfMilestonePaymentsReceived
      contextRef="Duration_6_1_2012_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_wmwel6uA20-BMX_QzPDtJg"
      decimals="INF"
      id="Narr_Nkd6uw4egUWFY_NPfSms7A"
      unitRef="Unit_Standard_payment_b5_XsToWrkW99sPOvgoheg">3</aciu:NumberOfMilestonePaymentsReceived>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_6_1_2012_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_wmwel6uA20-BMX_QzPDtJg"
      decimals="-6"
      id="Narr_E3w-67vVQ06z02026zPFUA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">42000000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_350QXz6QwEuA8d1zj8O5MA"
      decimals="-5"
      id="Narr_uyqhMEqqGUCDzPLmR7M6dQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">368500000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_S211XVhLiUqZCj3v114p0Q"
      decimals="-6"
      id="Narr_wHYm6jx7U0y52cahY_kDlw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zNVkSV70P0yTTv0hw3xQ6Q"
      decimals="-6"
      id="Narr_YSG_8QkNpUmwDswacIHToA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">500000000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_H7MVafWwHEm7SebhAlCksg"
      id="Narr_ZIRQcI2ZvUS1zKIsTpw2hQ">P90D</aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_12_1_2014_To_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_Of8RE1HgdEy1bhmDA0BgDw"
      decimals="-5"
      id="Narr_UBOwX4kClkK80gl-C_pjqQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">25900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_5_1_2014_To_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_Z_bscP2Znk-KSY2VCxYJ7g"
      decimals="-5"
      id="Narr_ph_g5pxk9EmCUKoLDu4x4w"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4900000</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementUpfrontPaymentsReceived
      contextRef="Duration_12_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_tyfTe8DeCUaagdCn6T7Ejg"
      decimals="-5"
      id="Narr_1JJdv4MkjE-HCnmszcfGfg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">25900000</aciu:CollaborativeAgreementUpfrontPaymentsReceived>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_5_1_2016_To_5_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_GSgSGJWKA0qol0w8MEEp6A"
      decimals="-5"
      id="Narr_AFB3G1nUIUi8RrBOuwhSsA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4900000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_VYzjzXZlKEGZio3O0wX8zQ"
      decimals="-6"
      id="Narr_lAP1Tzh7TEG3xIgtQ3mymw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">458000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_H7MVafWwHEm7SebhAlCksg"
      decimals="-5"
      id="Narr_EYIkTJ5Or0WAwhB-_238tA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_E0eBhnZuvkCP7QsmGzZ-7g"
      decimals="-5"
      id="Narr_grPIrSQO7UepoL-NxkKUcw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_UUY8TErzyUuTQ6n10-1E8g"
      decimals="-5"
      id="Narr_BhX9AqrYA0e3jJPzigELMA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1100000</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_gQeJGG83pUqW7L5LjJMSiw"
      decimals="-6"
      id="Narr_Znq3tDIaSEyK3XZCsxbWTw"
      unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA">160000000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_gQeJGG83pUqW7L5LjJMSiw"
      decimals="-6"
      id="Narr_wBQ1cydFXUWRYgAiC1HU2g"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">159000000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_vJPsPHg5JUivymFY6lpR6A"
      id="Narr_jvXdHUTIuEyusIjK4UfzQw">P3M</aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_12_31_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_9CqaxvHCr0-iuqlmAvYvdw"
      decimals="-3"
      id="Narr_VVaLq2sNs0ahHnqW0Tx4LQ"
      unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA">500000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_12_31_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_9CqaxvHCr0-iuqlmAvYvdw"
      decimals="-3"
      id="Narr_k3hhQv8XgEuQoIopsLnvBA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">664000</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_1_1_2017_To_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_p7AlCw_1wU-ARo-yBLe5DA"
      decimals="-6"
      id="Narr_x3QSRP4VYU2AsjhW0-b1gg"
      unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA">1000000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_1_1_2017_To_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_p7AlCw_1wU-ARo-yBLe5DA"
      decimals="-5"
      id="Narr_MdSDnuJ5Vkas_wFAX_Nd0A"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1100000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_IS1IteWIxESboEBvGakY4g"
      decimals="-6"
      id="Narr_Pee-0a9_hESEFehyjBUxZg"
      unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA">2000000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_IS1IteWIxESboEBvGakY4g"
      decimals="-5"
      id="Narr_OAsQjtjdakuj1QnS_guPuQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2200000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_7_1_2022_To_9_30_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_exnjXylyHUGgFwmQMBb9bQ"
      decimals="-6"
      id="Narr_pYrfD9Hoh0KeTX6FbSnmYQ"
      unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA">4000000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_7_1_2022_To_9_30_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_exnjXylyHUGgFwmQMBb9bQ"
      decimals="-5"
      id="Narr_dUdj_8jm8EGAK5Oln49Tdw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_y5HiWeAgl0qm7JANOOw7-w"
      decimals="-6"
      id="Narr_GR8EB6bEJU2wAil-xowniQ"
      unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA">4000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_y5HiWeAgl0qm7JANOOw7-w"
      decimals="-6"
      id="Narr_FQFo9pbZIUubyNFFkJTbQw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RegulatoryAndSalesBasedMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_kiAkuYc_KUS-yeLR_XxzfA"
      decimals="-6"
      id="Narr_HdkCcyGAP0SQr_wGBG7vsQ"
      unitRef="Unit_Standard_EUR_sAPopMAvo0-qWc_0UwUWBA">148000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RegulatoryAndSalesBasedMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_kiAkuYc_KUS-yeLR_XxzfA"
      decimals="-6"
      id="Narr_x-PoUfxfOECJtMGGde95kA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">138000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_vJPsPHg5JUivymFY6lpR6A"
      decimals="-5"
      id="Narr_3I_bAhLDGkis-jAqRnfL2A"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_DhDLnGHqvEOBmhLvYjbgNQ"
      decimals="-5"
      id="Narr_LxGw5KY_yUWL1lS6Zbmygg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_z90wXTf3ike4CAeXE1FQtA"
      decimals="-5"
      id="Narr_6loym18mGkaGQeoZsaFp9A"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_8o7ayFkxUESxL5ih3O1fWA"
      decimals="-5"
      id="Narr_lfdfmU23-0ea_kf4pEJiuw"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">3200000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_8o7ayFkxUESxL5ih3O1fWA"
      decimals="-5"
      id="Narr_PNE-7wwlL0qTcMz7G_bQyQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3000000.0</aciu:CollaborativeAgreementPotentialValue>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_8o7ayFkxUESxL5ih3O1fWA"
      decimals="-5"
      id="Narr_Lz1r-spvx02OPKuJXvAoww"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">2500000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_8o7ayFkxUESxL5ih3O1fWA"
      decimals="-5"
      id="Narr_pR96c5Eevkmt4BAyWm4k5g"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2300000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_5_31_2020_ifrs-full_CounterpartiesAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7QQTH7tA1kOhyo9N6XlPwQ"
      decimals="-5"
      id="Narr_i4fUPCrVrkmT7uI-FmQZbg"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">700000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_5_31_2020_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_EU9FlszNzkOBH2Bx99PAbQ"
      decimals="-5"
      id="Narr_tW60-YQtv02qoHCD1Vle4w"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">700000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_5_31_2020_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_EU9FlszNzkOBH2Bx99PAbQ"
      decimals="-5"
      id="Narr_bJCRdDLvIEOKdb_uBg7Wow"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">700000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <aciu:FollowOnGrantFundingReceivedTotalForJointArrangement
      contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7U3WtCFvFkm-psn0Ha35Tw"
      decimals="-5"
      id="Narr_exbe_TyoZ0GRTho0v0CNGA"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">500000</aciu:FollowOnGrantFundingReceivedTotalForJointArrangement>
    <aciu:FollowOnGrantFundingReceivedTotalForJointArrangement
      contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7U3WtCFvFkm-psn0Ha35Tw"
      decimals="-5"
      id="Narr_ICoY_7ZCzUOx0wX63v2o-Q"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">500000</aciu:FollowOnGrantFundingReceivedTotalForJointArrangement>
    <aciu:FollowOnGrantFundingReceived
      contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7U3WtCFvFkm-psn0Ha35Tw"
      decimals="-5"
      id="Narr_PsA0wTXFLkGuSz4BHA3MRA"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">400000</aciu:FollowOnGrantFundingReceived>
    <aciu:FollowOnGrantFundingReceived
      contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_7U3WtCFvFkm-psn0Ha35Tw"
      decimals="-5"
      id="Narr_G6WDFU6ZKUOkdA4BmKTyKg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">400000</aciu:FollowOnGrantFundingReceived>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_8_31_2022_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_d5f6dTO6oUOtx2ATln4mKQ"
      decimals="-5"
      id="Narr_-nqhMscUEEaZNsWr9TFVSA"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">100000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_8_31_2022_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_d5f6dTO6oUOtx2ATln4mKQ"
      decimals="-5"
      id="Narr_az5aHRAwj0CuQ3YcVDpG0g"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">100000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <aciu:NumberOfGrants
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_T-iM5RqNsUG9c1FH7HG0Xg"
      decimals="INF"
      id="Narr_VTgmtoSWDUmvxfW9MKC6iw"
      unitRef="Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ">2</aciu:NumberOfGrants>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_4CLZPTp1GUqRjsICkJnChA"
      decimals="-5"
      id="Narr_jHk3xpEgaECFoRgoBcIw1g"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">1500000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_4CLZPTp1GUqRjsICkJnChA"
      decimals="-5"
      id="Narr_jUWk6oqSO0CIOONGgOpG-w"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1400000</aciu:CollaborativeAgreementPotentialValue>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_DHftPCO4NE2baGCu__fDLw"
      decimals="-5"
      id="Narr_ZlvMCyEhd06v36FLBAxB1w"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1200000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_p0DVrOsbeESsVkNWccV14A"
      decimals="-5"
      id="Narr_Cj5rqhDj_EeUWvUOP5yDGQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1100000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_JA3yekIlVkiUYduc0Mu4Qw"
      decimals="-5"
      id="Narr_WAnCPO56Rk2o9gbKPmKdZg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1300000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_KqUnpfq9E0mC3M7Pc6ReGA"
      decimals="-5"
      id="Narr_mxDckugLT0C1KM3N-nAdxw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">300000</ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets>
    <ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_KqUnpfq9E0mC3M7Pc6ReGA"
      decimals="-5"
      id="Narr_YSD3OZZgNEyTfs8gPTmFmQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">500000</ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities>
    <ifrs-full:DisclosureOfExpensesExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_lBe-O8TBzEq8ENE1bIhtPg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;14.&lt;/b&gt;&lt;/span&gt;Expenses by category&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;"&gt;Research and development&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Operating expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 41,166&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 44,289&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 43,787&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Payroll expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 17,548&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 16,465&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 14,424&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,622&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,528&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,276&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total research and development expenses &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 60,336&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 62,282&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 59,487&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company incurred CHF 60.3 million, CHF 62.3 million and CHF 59.5 million in research and development expenses, respectively. The decrease in 2022 is mainly driven by decreases in direct R&amp;amp;D expenditures across various programs. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company had 122.4, 108.6 and 115.3 FTEs in our research and development functions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;"&gt;General and administrative&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Operating expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,207&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,031&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,471&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Payroll expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,874&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,281&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,274&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,598&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,812&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total general and administrative expenses &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,789&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 17,910&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 18,557&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company incurred CHF 15.8 million, CHF 17.9 million and CHF 18.6 million in general and administrative expenses, respectively. The decrease in 2022 compared with the prior&#160;year predominantly relates to certain transaction costs associated with our prior year asset acquisition which did not repeat in 2022 as well as a reduction in headcount.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2022, 2021 and 2020, the Company had 22.5, 27.3 and 26.7 FTEs in our general and administrative functions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;"&gt;Financial result, net&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Financial income&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 69&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,485&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 78&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Financial expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (355)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (581)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (184)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exchange differences&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 393&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (555)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Finance result, net &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 107&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (661)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Our finance result primarily consists of interest expense associated with our short-term financial assets and lease liabilities as well as foreign currency exchange differences.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;year ended December&#160;31, 2022, the decrease in financial result, net related primarily to the prior year CHF 6.5 million gain on the conversion features related to the Company&#x2019;s convertible notes due to certain Affiris affiliated entities that did not recur.&lt;/p&gt;</ifrs-full:DisclosureOfExpensesExplanatory>
    <ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_pbd7FUdXiEy4AWrLDlU5cQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;"&gt;Research and development&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Operating expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 41,166&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 44,289&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 43,787&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Payroll expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 17,548&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 16,465&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 14,424&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,622&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,528&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,276&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total research and development expenses &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 60,336&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 62,282&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 59,487&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_IzCNAkBBO0a8Nlx67vKOBg"
      decimals="-3"
      id="Tc_T0kmEycIC0yihek8aQD9Dg_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">41166000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_rUIgTjQ7OkGwKJ7QeHVyyw"
      decimals="-3"
      id="Tc_ysdDdUr3Uk2wl7yiGBo47g_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">44289000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_LMCpazElS0WvFLxSamO-Xw"
      decimals="-3"
      id="Tc_IDHVLAnhpU2s3eOBeEH61g_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">43787000</ifrs-full:OperatingExpense>
    <aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_IzCNAkBBO0a8Nlx67vKOBg"
      decimals="-3"
      id="Tc_Evn2pSkHOUuEhPY5xH_ZXw_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">17548000</aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation>
    <aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_rUIgTjQ7OkGwKJ7QeHVyyw"
      decimals="-3"
      id="Tc_diET6wtgmU-d3uEDOj051A_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">16465000</aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation>
    <aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_LMCpazElS0WvFLxSamO-Xw"
      decimals="-3"
      id="Tc_ws_xy6Hv6k-wvM01hX_pTQ_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">14424000</aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_IzCNAkBBO0a8Nlx67vKOBg"
      decimals="-3"
      id="Tc_Z6Zc1SPmqEiaVifqvqjqvQ_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1622000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_rUIgTjQ7OkGwKJ7QeHVyyw"
      decimals="-3"
      id="Tc_qUBEmJEwAUy22FgHoBgXLg_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1528000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_LMCpazElS0WvFLxSamO-Xw"
      decimals="-3"
      id="Tc_mr1Pk2cJ0kal0SjXyLphVA_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1276000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseByNature
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_IzCNAkBBO0a8Nlx67vKOBg"
      decimals="-3"
      id="Tc_1tCT0s8pGkeDoyC6VoeblQ_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">60336000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_rUIgTjQ7OkGwKJ7QeHVyyw"
      decimals="-3"
      id="Tc_kZuGGGtYyEqvkvtjcZN6bw_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">62282000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_LMCpazElS0WvFLxSamO-Xw"
      decimals="-3"
      id="Tc_QB5yyJYS5E68k40yH7l6PQ_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">59487000</ifrs-full:ExpenseByNature>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-5"
      id="Narr_nM4rZRaSu0mznLzAxZKkHA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">60300000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-5"
      id="Narr_pKUKZWogpki1FrEKFCnaqQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">62300000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-5"
      id="Narr_2nrtzDBNUE24ceJ5QIhCbA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">59500000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_IzCNAkBBO0a8Nlx67vKOBg"
      decimals="1"
      id="Narr_2PadqyOau0uJvgdq5YvIGA"
      unitRef="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw">122.4</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_rUIgTjQ7OkGwKJ7QeHVyyw"
      decimals="1"
      id="Narr_MMl4T5bx1U-T7FQshrql8A"
      unitRef="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw">108.6</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_LMCpazElS0WvFLxSamO-Xw"
      decimals="1"
      id="Narr_VGIe3gCyQEGbsi7mVB5UKQ"
      unitRef="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw">115.3</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_-MBbQvsxa0eLFcj9V4OJvg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;"&gt;General and administrative&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Operating expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,207&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,031&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,471&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Payroll expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,874&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,281&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,274&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,598&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,812&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total general and administrative expenses &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,789&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 17,910&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 18,557&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_V234l1xFRUG6YB4I0Vptfw"
      decimals="-3"
      id="Tc_qLS4gVlzZ0itDc0681ZUUg_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">6207000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9o_550cVrU6jieJwj_AJUw"
      decimals="-3"
      id="Tc_mjHhn26aJECuFxcoRtDhKA_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7031000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6WGIoNrd4USstG13uKvUOQ"
      decimals="-3"
      id="Tc_kH7GA4MniUGO6Pcf0VaOKA_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7471000</ifrs-full:OperatingExpense>
    <aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_V234l1xFRUG6YB4I0Vptfw"
      decimals="-3"
      id="Tc_-LwA9eIxgUqvEz4bkimLpA_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7874000</aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation>
    <aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9o_550cVrU6jieJwj_AJUw"
      decimals="-3"
      id="Tc_7B1gVkpHbUibO48DL04t1g_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">8281000</aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation>
    <aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6WGIoNrd4USstG13uKvUOQ"
      decimals="-3"
      id="Tc_ZJsVx8DWEUuMh8ZSu08HAg_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">8274000</aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_V234l1xFRUG6YB4I0Vptfw"
      decimals="-3"
      id="Tc_eqaYs6cY-UKaEAg8wEo6qQ_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1708000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9o_550cVrU6jieJwj_AJUw"
      decimals="-3"
      id="Tc_3SuOcixZakGVbyjJ2_GJpQ_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2598000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6WGIoNrd4USstG13uKvUOQ"
      decimals="-3"
      id="Tc_9fdtctSSxEaKmbpB--I6ew_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2812000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseByNature
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_V234l1xFRUG6YB4I0Vptfw"
      decimals="-3"
      id="Tc_9PMsn0gad0eC5JKLMsFkAw_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">15789000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9o_550cVrU6jieJwj_AJUw"
      decimals="-3"
      id="Tc_ZSgXB6QYu0KnaMfmOQWHlA_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">17910000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6WGIoNrd4USstG13uKvUOQ"
      decimals="-3"
      id="Tc_fI_q3FBuQ02jrnO4g4AN8w_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">18557000</ifrs-full:ExpenseByNature>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-5"
      id="Narr_XnHFjtYB40Cm9QQMtHdpkQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">15800000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-5"
      id="Narr_aXIv4EB-AEizHDKhki-uQA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">17900000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-5"
      id="Narr_KV0f1HutGUKvc4chBeQfEg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">18600000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_V234l1xFRUG6YB4I0Vptfw"
      decimals="1"
      id="Narr_9yCeSwJN_UC7zkCHREYJCA"
      unitRef="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw">22.5</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9o_550cVrU6jieJwj_AJUw"
      decimals="1"
      id="Narr_rQHNz9147U6jaj60kDBpxQ"
      unitRef="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw">27.3</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6WGIoNrd4USstG13uKvUOQ"
      decimals="1"
      id="Narr_SwE4FO_UKkODcV2fX9rfcQ"
      unitRef="Unit_Standard_employee_V-PxGhL5fUWnoN1jEEWPuw">26.7</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_4vQDI36Wbk-Rg0lHZVsemA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;"&gt;Financial result, net&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Financial income&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 69&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,485&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 78&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Financial expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (355)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (581)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (184)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exchange differences&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 393&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (555)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Finance result, net &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 107&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (661)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <ifrs-full:FinanceIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_GqiOtIIl_ka68DZGuuWCzg_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">69000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_u024CqwldkasNGEIiQggXg_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">6485000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_SVonLTx5U0-Ym9SLY0uchw_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">78000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_HdR6YtRd_k6hdnTVIu7b0A_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">355000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_hgtUvHjh10-Y65DdV_-w_w_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">581000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_zLbEtnkUDEWNd2gl6K_2ig_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">184000</ifrs-full:FinanceCosts>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_zHEXnwGeb0qhUS_GHHtrNw_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">393000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_zLJPzvSD0EWgG4QuncdMZw_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">113000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_9irVMPJn50OgwEDyxRnnqw_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-555000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_sG9CRE1Sj0aJNDS9iTMrpQ_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">107000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_DEN3mbQSPEm1LUBpaxaQKA_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">6017000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_YvcFw7HDZ0OagGLELbjEig_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-661000</ifrs-full:FinanceIncomeCost>
    <aciu:GainsLossesOnConversionFeaturesRelatedToConvertibleNotes
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-5"
      id="Narr_jZ5tIgo-kEyZVDAXpZxfsw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">6500000</aciu:GainsLossesOnConversionFeaturesRelatedToConvertibleNotes>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_-BxnynLuu0CsXKBsImkr8A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;15.&lt;/b&gt;&lt;/span&gt;Related-party transactions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Board of directors and executive management compensation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;Key management includes the board of directors and executive management. For 2022, there were eight members (2021: eight and 2020: seven) of the Board (excluding the CEO) and seven members (2021: six and 2020: five) of executive management (including the CEO). Compensation was as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term employee benefits &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,187&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,403&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,497&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Post-employment benefits &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 295&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 266&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 214&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,503&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,578&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total compensation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,666&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,289&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_UzmqImMQj0OHA-D2jT8Tsg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;Key management includes the board of directors and executive management. For 2022, there were eight members (2021: eight and 2020: seven) of the Board (excluding the CEO) and seven members (2021: six and 2020: five) of executive management (including the CEO). Compensation was as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term employee benefits &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,187&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,403&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,497&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Post-employment benefits &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 295&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 266&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 214&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,503&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,578&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total compensation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,666&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,289&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory>
    <aciu:NumberOfPersonsKeyManagementBoardOfDirectors
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Narr_H1LMswPBeUGQmHDgTcGSfQ"
      unitRef="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ">8</aciu:NumberOfPersonsKeyManagementBoardOfDirectors>
    <aciu:NumberOfPersonsKeyManagementBoardOfDirectors
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="INF"
      id="Narr_aRf8JRXQuEKDukf84uK1YA"
      unitRef="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ">8</aciu:NumberOfPersonsKeyManagementBoardOfDirectors>
    <aciu:NumberOfPersonsKeyManagementBoardOfDirectors
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="INF"
      id="Narr_RB54QVLe8EOrwXZHbFSC9A"
      unitRef="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ">7</aciu:NumberOfPersonsKeyManagementBoardOfDirectors>
    <aciu:NumberOfPersonsKeyManagementExecutiveManagement
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Narr_tTZpGBQVA06Vgya0Yoz33A"
      unitRef="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ">7</aciu:NumberOfPersonsKeyManagementExecutiveManagement>
    <aciu:NumberOfPersonsKeyManagementExecutiveManagement
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="INF"
      id="Narr_RrFGPndjBEqibfvN85Znow"
      unitRef="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ">6</aciu:NumberOfPersonsKeyManagementExecutiveManagement>
    <aciu:NumberOfPersonsKeyManagementExecutiveManagement
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="INF"
      id="Narr_Jg3NeT7BdUixJjclH7d2TA"
      unitRef="Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ">5</aciu:NumberOfPersonsKeyManagementExecutiveManagement>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_VOQPVM0hl0KSK9x3W8B1xQ_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4187000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_rtjW9UHcLk-kO0uQcyvvOQ_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4403000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_kr3UpyXIUEu23Tq2LVwbLA_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3497000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_RQsjdRP_Jku4LRiwYBQZJA_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">295000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_edTRhZEeO0CKpzyCBlKrEg_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">266000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_F-aMii67zkW_cqtwkDkRTw_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">214000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_YmuV8gw9hk2m76X4RCSEwQ_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2503000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_8V9u1X04pka2gdGhxNmpKQ_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2997000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_39RHW3a_fUGtGU_WKLoKEA_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2578000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_9rsjFocyakmpqInZZAN0WQ_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">6985000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_xJkIL-794EuLDkWg9fEmmA_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7666000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_pAix2GJgsEmmNKKILBmKuQ_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">6289000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_wbqLh1pvOke2iytedDMh3w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;16.&lt;/b&gt;&lt;/span&gt;Income taxes&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group recognized less than CHF 0.1 million, less than CHF 0.1 million and nil in income taxes and no deferred tax asset or &lt;span style="-sec-ix-hidden:Hidden_bwx-SbM9sEqAKiboMtvBTg;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;liability&lt;/span&gt;&lt;/span&gt; positions for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively. The Group&#x2019;s expected tax expense for each&#160;year is based on the applicable tax rates in each jurisdiction. In 2022, these rates ranged from 13.6% to 33.8% (13.6% - 32.9% for 2021 and 13.6% for 2020) in the Group&#x2019;s respective tax jurisdictions. The weighted average tax rate applicable to the Group was 13.6% (13.6% for 2021 and 2020, respectively). &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The Group&#x2019;s income tax expense for each&#160;year can be reconciled to loss before tax as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Loss before income tax &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (70,740)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (72,993)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (61,921)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Tax benefit calculated at the domestic rates applicable in the respective countries &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,616)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,930)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (8,441)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;(Income not subject to tax)/expenses not deductible for tax purposes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 455&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (375)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 462&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of unused tax losses and tax offsets not recognized as deferred tax assets &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,174&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,308&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,979&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Effective income tax rate (benefit)/expense &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Swiss tax rate used for the 2022 reconciliations is the corporate tax rate of 13.6% (13.6% in 2021 and 2020, respectively) payable by corporate entities in the Canton of Vaud, Switzerland on taxable profits under tax law in that jurisdiction.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The below table details the total unrecognized deductible temporary differences, unused tax losses and unused tax credits:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unrecognized deductible temporary differences, unused tax losses and unused tax credits&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;Tax losses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 264,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 197,152&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 121,948&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;Deductible temporary differences related to:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;"&gt;Right-of-use assets and lease liabilities, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;"&gt;Retirement benefit plan &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,213&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,098&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,464&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 267,302&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 204,250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 129,412&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table details the tax losses carry forwards of the Company and their respective expiry dates:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Tax losses split by expiry date:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,231&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,231&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,231&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 48,894&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 48,894&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 48,894&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 57,824&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 57,824&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 57,824&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2028&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 75,204&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 75,204&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2029&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 66,936&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total unrecorded tax loss carryforwards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 264,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 197,153&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 121,949&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The tax losses available for future offset against taxable profits have increased by CHF 66.9&#160;million from 2021, representing the amount of tax losses that are additionally available as an offset, subject to expiration as disclosed in the table above, against future taxable income.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Consistent with prior&#160;years, the Company has not recorded any deferred tax assets in relation to the past tax losses available for offset against future profits as the recognition criteria were not met at the balance sheet date.&lt;/p&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g"
      decimals="-5"
      id="Narr_kB8Ymrarskir7WrcrZdsrg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">100000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_hGZYF059eky85mjSvMDTyw"
      decimals="-5"
      id="Narr_tpP2LIh-mkGnZX-JuaFK-A"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">100000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-5"
      id="Narr_JZF2WpAqD02lSa-D1GdKng"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:DeferredTaxAssets
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-5"
      id="Narr_YqN7677pqEaE6FJMzoxmfQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ"
      decimals="3"
      id="Narr_GONhTQbn6ky4CGqEbp70Mw"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g"
      decimals="3"
      id="Narr_ozXdQtBqSEqfIWo4OfsYXQ"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.338</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_5cL5m8nGCEqTrf8_CtRG_A"
      decimals="3"
      id="Narr_VLizXDiSiUGLQKer9MKkpA"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_hGZYF059eky85mjSvMDTyw"
      decimals="3"
      id="Narr_kfDp3U1zoU2wgHcwW0lOig"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.329</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="3"
      id="Narr_qa5L2FOrxk22L1wLg9D8VQ"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_JZHuDFkEnky2R3mcEBTRxw"
      decimals="3"
      id="Narr_UVk5zujjCUW9S4Yr9oXjJg"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2020_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_o6mJetXegkqD7qoBcZZJvQ"
      decimals="3"
      id="Narr_77t889k2_ke9-dx2TfZUdA"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.136</ifrs-full:ApplicableTaxRate>
    <aciu:DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_N97X4lXGNUyXPXdBn_eGGQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The Group&#x2019;s income tax expense for each&#160;year can be reconciled to loss before tax as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Loss before income tax &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (70,740)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (72,993)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (61,921)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Tax benefit calculated at the domestic rates applicable in the respective countries &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,616)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,930)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (8,441)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;(Income not subject to tax)/expenses not deductible for tax purposes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 455&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (375)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 462&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of unused tax losses and tax offsets not recognized as deferred tax assets &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,174&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 10,308&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,979&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Effective income tax rate (benefit)/expense &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock>
    <ifrs-full:AccountingProfit
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_4QfJemKJD0-t8n6KrJcGPQ_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-70740000</ifrs-full:AccountingProfit>
    <ifrs-full:AccountingProfit
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_N5gcNv3XvUS35dBMNUAecw_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-72993000</ifrs-full:AccountingProfit>
    <ifrs-full:AccountingProfit
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_jOsoy-b42Eq0XcPkSN4lbw_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-61921000</ifrs-full:AccountingProfit>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_6fXIsKu-AUOmDYYWFvfJEg_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-9616000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_ee8gb4r8QUOtYStIsPS2hA_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-9930000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_AN1D1Yh_AEy-6MVUUV_CYw_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-8441000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_vTrdM2tackeqpRIk3aUgTw_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">455000</aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes>
    <aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_MVAjInqsAUiKl0sdJ8VwGg_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-375000</aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes>
    <aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_qfENDo3eQkGqz0aSStCKWA_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">462000</aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_RmmLlQNdAUGjSGARq3mHlw_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9174000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_pDcmXRxpUE6lWQDu2n7YIQ_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">10308000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_IyxnY5mpIkatLSNe_9sVag_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7979000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_Y14rfSaDqU6j3hyO-ppzLg_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">13000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_K95qW4kHOUuki4i6N0T19Q_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_ELZzG1yjeUWbkAFFJ8gcLg_8_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_GeographicalAreasAxis_country_CH_O7nfFWb_I0mZqhS-eJcjZg"
      decimals="3"
      id="Narr_qMO4qSqRMUCXkqeR1hCQxA"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2020_To_12_31_2021_zfFR7ittfki9YYbWT5hYdg"
      decimals="3"
      id="Narr_qdxmTB01b0iWgON4QeU6WQ"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2020_To_12_31_2021_ifrs-full_GeographicalAreasAxis_country_CH__P8ouC3DKUKhYNxSsLCgfg"
      decimals="3"
      id="Narr_ixzrf86-qESNW7FDotwbnQ"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_c-IvpZYKlUKY9Yvo6xuAjw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The below table details the total unrecognized deductible temporary differences, unused tax losses and unused tax credits:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unrecognized deductible temporary differences, unused tax losses and unused tax credits&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;Tax losses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 264,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 197,152&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 121,948&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;Deductible temporary differences related to:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;"&gt;Right-of-use assets and lease liabilities, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;"&gt;Retirement benefit plan &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,213&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,098&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,464&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 267,302&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 204,250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 129,412&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_EoGHAaH_W0-vpWcrDQJuvg"
      decimals="-3"
      id="Tc_0uCW8194GE-RhZc7QQhfXQ_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">264089000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_e7xgizML2UqtqmEk-xbYOg"
      decimals="-3"
      id="Tc_AnM7hW-0EketA_ziTZhghQ_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">197152000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_nBhQeOZ19k-ztz29OTwlBA"
      decimals="-3"
      id="Tc_eTEnW3ku-0SVsDskxRO8xg_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">121948000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_A7q7sukpmEWmgYEeU6xd9A"
      decimals="-3"
      id="Tc_qD37tc4-xkKUEbVZhTzLKQ_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_qNySDLxJmUaC4_AlxO6kDw"
      decimals="-3"
      id="Tc_7dgse28RCkiY7eeMwUblZQ_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_MB9hMQrj1E-MnICLBN--Tg"
      decimals="-3"
      id="Tc_qENPF0cfuE-HOdXVQu_bFw_8_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_e71liqGpk0eD9wSTTRy_TA"
      decimals="-3"
      id="Tc_ibQ9wLbgDEuo06SifTw_6Q_9_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3213000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_wwQem1YNxUG0LWJSPUL00w"
      decimals="-3"
      id="Tc_kyfi51RJHkKZ7fp0jiMegQ_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7098000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2020_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_X_YAkgPZKU2ZgwftPJ68hQ"
      decimals="-3"
      id="Tc_P1WWmHDm5U2wTJU4_zbFwA_9_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7464000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_6PC9ATSN20-lP9c3SNLFbQ_10_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">267302000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc__sN1im9TbEexjcBBALjynA_10_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">204250000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="-3"
      id="Tc_d1r6oklXcUmi1uHFx9Ca5A_10_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">129412000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <aciu:DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_BdfpwG3yuUeRFQ3Hali-xw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table details the tax losses carry forwards of the Company and their respective expiry dates:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Tax losses split by expiry date:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,231&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,231&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 15,231&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 48,894&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 48,894&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 48,894&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 57,824&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 57,824&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 57,824&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2028&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 75,204&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 75,204&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2029&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 66,936&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total unrecorded tax loss carryforwards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 264,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 197,153&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 121,949&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312024Member_1EtLVXZQK0KhtJMXjvu1hg"
      decimals="-3"
      id="Tc_u0CcR6Ns1kaQvg91ls_lDQ_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">15231000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312024Member_YtAAUPDrRUyZqBsdM7bZLg"
      decimals="-3"
      id="Tc__rkk-2PWvEa3J9CUR_JqTw_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">15231000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312024Member_QmNnwUouwUmJ-s32bbnIQQ"
      decimals="-3"
      id="Tc_eTlPu1fDI0iP7hLCoptfcw_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">15231000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312025Member_luIzCS1YKk2F6EECmOmb-g"
      decimals="-3"
      id="Tc_q1jvs9YTx0G3Rt72eho_8Q_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">48894000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312025Member_iFzt3h4AUU63S9gjge_aaA"
      decimals="-3"
      id="Tc_iPqREpbbgUO41GIKosb0wg_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">48894000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312025Member_n-US4waEG0KkXB44U7M1XA"
      decimals="-3"
      id="Tc_osr2ZrWcU0KzL80h_VZQFQ_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">48894000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312026Member_aD29x0JbzEyAG4T_DshrpQ"
      decimals="-3"
      id="Tc_O5048nm0_kC0kKMD4_KULw_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312026Member_pgGd2X_5zkuQ-hULGalqJw"
      decimals="-3"
      id="Tc_HeYrJycNv021TwCkqta2Vw_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312026Member_GVWpRLlroE6SQnZZlZUS2g"
      decimals="-3"
      id="Tc_tTX1KVfGPEeoadRn11lztw_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312027Member_8GigSLJKwkiTlMz-iLjIGQ"
      decimals="-3"
      id="Tc_uiDgMJMBBESsmMsZCa3waw_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">57824000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312027Member_YDYkyf-UMU2_t8n-OPDZOw"
      decimals="-3"
      id="Tc_YVm8KHoLPUmH4AIhH0wfTg_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">57824000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312027Member_ng3b4z76MU6jDCmNuN3LKQ"
      decimals="-3"
      id="Tc_qFg_gc8Qe0iq_f07gt_6dA_8_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">57824000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312028Member_yPNEVvCqsUC9xeMHzwQNIw"
      decimals="-3"
      id="Tc_1H3VjhqPJkSyv5USqKDqwg_9_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">75204000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312028Member_IyrHXjhaIkqLqkdVnSu1Fg"
      decimals="-3"
      id="Tc_EwJbH7izEEeX5PhmzajQmg_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">75204000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312028Member_KCaq0o_GCU-ldbixSPpiMw"
      decimals="-3"
      id="Tc_BSBs3B-ugE2UP_bZBQT_0A_9_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312029Member_QW1lvp6gWEmt2TrWCNAUrg"
      decimals="-3"
      id="Tc_76N1AD8VLk2pjSlp7KBg4Q_10_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">66936000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312029Member_-U2cl_yo202fnY3GwpirTA"
      decimals="-3"
      id="Tc_nmTI7LUtz0WLW2s5j9hsNw_10_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2020_ifrs-full_MaturityAxis_aciu_December312029Member_L1w97ZJiBU-clbQi3YmL-Q"
      decimals="-3"
      id="Tc_LLWQvu-tDUinJ2rJ6bKXFw_10_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_aaDa8c4sr0uEBAu51eAWeg_11_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">264089000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_aZtXOiHbg0qBVptP2VYtQA_11_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">197153000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="-3"
      id="Tc_laFisiXUuki4RbAWMpElpQ_11_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">121949000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <aciu:IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-5"
      id="Narr_rXs1Nh5KeEutfQdt2K5qeg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">66900000</aciu:IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits>
    <ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_BKxrJjx3A0mxMNfgsqIkOQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;17.&lt;/b&gt;&lt;/span&gt;Retirement benefit plan&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company participates in a collective foundation covering all of its employees including its executive officers. In addition to retirement benefits, the plan provides death or long-term disability benefits.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Contributions paid to the plan are computed as a&#160;percentage of salary, adjusted for the age of the employee and shared approximately 47% and 53% by employee and employer, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;This plan is governed by the Swiss Law on Occupational Retirement, Survivors and Disability Pension Plans (BVG), which requires contributions to be made to a separately administered fund. The fund has the legal form of a foundation and it is governed by a board of trustees, which consists of an equal number of employer and employee representatives of its members. The board of trustees is responsible for the administration of the plan assets and for the definition of the investment strategy. The Company has no direct influence on the investment strategy of the foundation board.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The assets are invested by the pension plan, to which many companies contribute, in a diversified portfolio that respects the requirements of the Swiss BVG. Therefore, disaggregation of the pension assets and presentation of plan assets in classes that distinguish the nature and risks of those assets is not possible. Under the plan, both the Company and the employee share the costs. The structure of the plan and the legal provisions of the BVG mean that the employer is exposed to actuarial risks. The main risks are investment risk, interest risk, disability risk and the life expectancy of pensioners. Through our affiliation with the pension plan, the Company has minimized these risks, as they are shared between a much greater number of participants. On leaving the Company, a departing employee&#x2019;s retirement savings are transferred to the pension institution of the new employer or to a vested benefits institution. This transfer mechanism may result in pension payments varying considerably from&#160;year to&#160;year.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The pension plan is exposed to Swiss inflation, interest rate risks and changes in the life expectancy for pensioners. For accounting purposes under IFRS, the plan is treated as a defined benefit plan in accordance with IAS 19.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table sets forth the status of the defined benefit pension plan and the amount that is recognized in the consolidated balance sheets:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Defined benefit obligation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (32,410)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (33,889)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (30,213)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Fair value of plan assets &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29,197&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 26,791&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 22,749&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total liability &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,213)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,098)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,464)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following amounts have been recorded as net pension cost in the consolidated statements of income/(loss):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Service cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,712&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,648&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,626&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 126&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 79&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 71&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (87)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (48)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (42)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net pension cost &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,655&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The changes in defined benefit obligation, fair value of plan assets and unrecognized gains/(losses) are as follows.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;A. Change in defined benefit obligation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Defined benefit obligation as of January 1 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (33,889)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (30,213)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (26,624)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Service cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,712)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,648)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,626)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (126)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (79)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (71)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in demographic assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,428&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in financial assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,397&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 156&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (71)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in experience assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,726)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (252)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (931)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Benefits deposited &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,327)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (894)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,467)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&#x2019; contributions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,056)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (959)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (851)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Defined benefit obligation as of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (32,410)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (33,889)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (30,213)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;B.&lt;/b&gt;&lt;/span&gt;Change in fair value of plan assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair value of plan assets as of January 1 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 26,791&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 22,749&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 19,139&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 87&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 48&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 42&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&#x2019; contributions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,056&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 959&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 851&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employer&#x2019;s contributions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,210&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 950&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Benefits deposited&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,327&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 894&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,467&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Return on plan assets excluding interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,274)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,052&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 300&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair value of plan assets as of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29,197&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 26,791&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 22,749&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period amount to approximately CHF 1.2 million.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;C.&lt;/b&gt;&lt;/span&gt;Change in net defined benefit liability&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net defined benefit liabilities as of January 1 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,098&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,464&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,485&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Net pension cost through statement of income/(loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,655&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Remeasurement through other comprehensive income/(loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,426)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (956)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (726)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employer&#x2019;s contribution &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,210)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,089)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (950)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net defined benefit liabilities as of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,213&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,098&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,464&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;D.&lt;/b&gt;&lt;/span&gt;Other comprehensive gains/(losses)&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of changes in demographic assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,428&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of changes in financial assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,397&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 156&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (71)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of changes in experience assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,726)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (252)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (931)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Return on plan assets excluding interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,274)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,052&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 300&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total other comprehensive gain&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,426&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 956&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 726&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The change in experience assumptions results from an increased sum of insured salaries.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The fair value of the plan assets is the cash surrender value of the insurance with the insurance company (AXA). The investment strategy defined by the board of trustees follows a conservative profile.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The plan assets are primarily held within instruments with quoted market prices in an active market, with the exception of real estate and mortgages.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The weighted-average duration of the defined benefit obligation is 14.9&#160;years and 17.1&#160;years as of December&#160;31, 2022 and 2021, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The actuarial assumptions used for the calculation of the pension cost and the defined benefit obligation of the defined benefit pension plan for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively, are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:48.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:48.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2.25&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.30&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.20&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Rate of future increase in compensations &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Rate of future increase in current pensions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest rate on retirement savings capital&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2.25&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Mortality and disability rates &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;BVG 2020-CMI&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;BVG 2020-CMI&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;BVG 2020-CMI&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In defining the benefits, the minimum requirements of the Swiss BVG and its implementing provisions must be observed. The BVG defines the minimum pensionable salary and the minimum retirement credits.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2022 is shown below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Interest&#160;rate&#160;on&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Discount&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;salary&#160;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;pension&#160;cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;savings&#160;capital&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assumptions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:0pt;visibility:hidden;"&gt;&lt;td colspan="17" style="padding:0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In&#160;CHF&#160;thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Potential defined benefit obligation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 30,201&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 34,916&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 32,940&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,841&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 33,601&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,322&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 33,322&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,545&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Decrease/(increase) from actual defined benefit obligation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,209&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,506)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (530)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 569&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,191)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,088&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (912)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 865&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2021 is shown below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Interest&#160;rate&#160;on&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Discount&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;salary&#160;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;pension&#160;cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;savings&#160;capital&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assumptions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:0pt;visibility:hidden;"&gt;&lt;td colspan="17" style="padding:0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in&#160;CHF&#160;thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Potential defined benefit obligation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,190&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 37,006&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 34,578&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 33,176&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 35,497&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 32,435&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 34,822&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 33,007&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Decrease/(increase) from actual defined benefit obligation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,699&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,117)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (689)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 713&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,608)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,454&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (933)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 882&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The sensitivity analyses above are subject to limitations and have been determined based on a method that extrapolates the impact on net defined benefit obligation as a result of reasonable changes in key assumptions occurring at the end of the reporting period.&lt;/p&gt;</ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory>
    <aciu:DefinedBenefitPlansPercentageOfContributionsByEmployees
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Narr_A6kI9KwAYUytauxzdQJ0XA"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.47</aciu:DefinedBenefitPlansPercentageOfContributionsByEmployees>
    <aciu:DefinedBenefitPlansPercentageOfContributionsByEmployer
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Narr_wo2ufb79WEWNaJCgqEGjnw"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.53</aciu:DefinedBenefitPlansPercentageOfContributionsByEmployer>
    <aciu:DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_-DrVMqy1C0S26flgu-tYMQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table sets forth the status of the defined benefit pension plan and the amount that is recognized in the consolidated balance sheets:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Defined benefit obligation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (32,410)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (33,889)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (30,213)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Fair value of plan assets &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29,197&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 26,791&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 22,749&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total liability &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,213)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,098)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,464)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_pxqAUVjcWEiJf_4UkIPnRg"
      decimals="-3"
      id="Tc_Ri475JBjGES8RvdJDhZjEQ_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">32410000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember__6JmM8XcBUip-56hZCA8ig"
      decimals="-3"
      id="Tc_oVwP3CDMdUa-WCiW9gcVhQ_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">33889000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_HYAe7T3bM0uPnVmhnuk0NQ"
      decimals="-3"
      id="Tc_o_T8-Xm2vU2hYW-6YxwSFQ_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">30213000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_pxqAUVjcWEiJf_4UkIPnRg"
      decimals="-3"
      id="Tc_tG6oEwTTS0aggCsLTY9ahA_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">29197000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember__6JmM8XcBUip-56hZCA8ig"
      decimals="-3"
      id="Tc_NbXDhe5r70muVlaBMTOauw_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">26791000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_HYAe7T3bM0uPnVmhnuk0NQ"
      decimals="-3"
      id="Tc_d44YZKMhhECGvwygp_R7AQ_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">22749000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:SurplusDeficitInPlan
      contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_pxqAUVjcWEiJf_4UkIPnRg"
      decimals="-3"
      id="Tc_YBQ25jnCkUmMW2mm3MuS3g_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-3213000</ifrs-full:SurplusDeficitInPlan>
    <ifrs-full:SurplusDeficitInPlan
      contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember__6JmM8XcBUip-56hZCA8ig"
      decimals="-3"
      id="Tc_HwU8UbPuLU-omajHwKgmIg_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-7098000</ifrs-full:SurplusDeficitInPlan>
    <ifrs-full:SurplusDeficitInPlan
      contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_HYAe7T3bM0uPnVmhnuk0NQ"
      decimals="-3"
      id="Tc_UX38vcXu2k6NiTuEF1zMYA_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-7464000</ifrs-full:SurplusDeficitInPlan>
    <aciu:DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_UQGLWWCuVUShtXuIKZy7jQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following amounts have been recorded as net pension cost in the consolidated statements of income/(loss):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Service cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,712&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,648&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,626&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 126&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 79&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 71&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (87)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (48)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (42)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net pension cost &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,655&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock>
    <aciu:CurrentAndPastServiceCostGainDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_Sr0bPHyDjkeGcpmq2hWK-Q_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1712000</aciu:CurrentAndPastServiceCostGainDefinedBenefitPlans>
    <aciu:CurrentAndPastServiceCostGainDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_nbH1mS2phEKoZ0-I6g_NfA_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1648000</aciu:CurrentAndPastServiceCostGainDefinedBenefitPlans>
    <aciu:CurrentAndPastServiceCostGainDefinedBenefitPlans
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_gfb7XdTCjk6TmW8GYATQOw_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1626000</aciu:CurrentAndPastServiceCostGainDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_oDdet3vyIkO6jjM2n4iLEA_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">126000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_T7sslvVzU0Sf8sAAO2TQJw_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">79000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_0putQUiytEu9GNR-iQ6dNQ_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">71000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestIncomeDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_LKJRNrnlPEKl5CmVnsQE8g_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">87000</ifrs-full:InterestIncomeDefinedBenefitPlans>
    <ifrs-full:InterestIncomeDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_OfqQUiR4NEeomuxudVwp0Q_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">48000</ifrs-full:InterestIncomeDefinedBenefitPlans>
    <ifrs-full:InterestIncomeDefinedBenefitPlans
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_-YjpNS9FhU2G4D81n6PuYQ_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">42000</ifrs-full:InterestIncomeDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_oZuUVNynnker7w2XZwqmEA_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1751000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_IqG_ILDaR0ut7-3ki94uxw_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1679000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_sr_uAtLn_kyhOpqWRSECmQ_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1655000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb__W5_MtXYPUO8d12QVZjL8Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The changes in defined benefit obligation, fair value of plan assets and unrecognized gains/(losses) are as follows.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;A. Change in defined benefit obligation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Defined benefit obligation as of January 1 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (33,889)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (30,213)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (26,624)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Service cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,712)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,648)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,626)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (126)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (79)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (71)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in demographic assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,428&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in financial assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,397&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 156&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (71)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in experience assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,726)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (252)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (931)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Benefits deposited &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,327)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (894)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,467)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&#x2019; contributions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,056)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (959)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (851)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Defined benefit obligation as of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (32,410)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (33,889)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (30,213)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;B.&lt;/b&gt;&lt;/span&gt;Change in fair value of plan assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair value of plan assets as of January 1 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 26,791&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 22,749&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 19,139&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 87&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 48&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 42&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&#x2019; contributions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,056&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 959&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 851&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employer&#x2019;s contributions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,210&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 950&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Benefits deposited&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,327&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 894&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,467&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Return on plan assets excluding interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,274)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,052&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 300&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair value of plan assets as of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29,197&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 26,791&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 22,749&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period amount to approximately CHF 1.2 million.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;C.&lt;/b&gt;&lt;/span&gt;Change in net defined benefit liability&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net defined benefit liabilities as of January 1 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,098&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,464&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,485&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Net pension cost through statement of income/(loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,655&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Remeasurement through other comprehensive income/(loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,426)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (956)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (726)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employer&#x2019;s contribution &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,210)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,089)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (950)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net defined benefit liabilities as of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,213&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,098&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7,464&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember__6JmM8XcBUip-56hZCA8ig"
      decimals="-3"
      id="Tc_lj--de1MlUy6XX_2IRstng_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">33889000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_HYAe7T3bM0uPnVmhnuk0NQ"
      decimals="-3"
      id="Tc__4Ew7VaFzkq3ehv9NGTuDg_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">30213000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2019_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_V6HzKpLdRUKQbql6k-eSiw"
      decimals="-3"
      id="Tc_jSPDOKBQdUG_GR-0ekVgcg_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">26624000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w"
      decimals="-3"
      id="Tc_EnmlQGRmQ06GF6-I9B64yA_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1712000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ"
      decimals="-3"
      id="Tc_YV0RQ8lH60qpRNDH4S0XgA_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1648000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A"
      decimals="-3"
      id="Tc_FabK-5aeYE6gR3ng1Idctw_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1626000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w"
      decimals="-3"
      id="Tc_CjJdIjUvQU-s7WdhJ6ihVQ_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">126000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ"
      decimals="-3"
      id="Tc_Q72mQHPto0CQuG8eZKboZw_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">79000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A"
      decimals="-3"
      id="Tc_U-qvuQffOEqPvx1qqUneqw_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">71000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w"
      decimals="-3"
      id="Tc_7b2dA4MpGUKLK1daCUtpjQ_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">29000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ"
      decimals="-3"
      id="Tc_vVDyU83tCU6UbnPLsFoGKg_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A"
      decimals="-3"
      id="Tc_Wmzv6ywDeEOocgJXaQEwfw_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1428000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w"
      decimals="-3"
      id="Tc_Q4uD5rBEB0qFy0UvZQnc8A_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">8397000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ"
      decimals="-3"
      id="Tc_Ip6UYXm4KU-QjPxGrUPZtA_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">156000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A"
      decimals="-3"
      id="Tc_v9_k4RqW-kOm-4DReqmPnw_8_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-71000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w"
      decimals="-3"
      id="Tc_VSARNLRWi0yM0ZUxoRTcyQ_9_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-1726000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ"
      decimals="-3"
      id="Tc_gC31Z88ZuEmQb8dbP78kHg_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-252000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A"
      decimals="-3"
      id="Tc_QOrRJSsf_UeO4eB_aCJP7g_9_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-931000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w"
      decimals="-3"
      id="Tc_Ot_w3LYZ3Eu3f3vPC5huEw_10_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2327000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ"
      decimals="-3"
      id="Tc_1653RACepUWJLXB4h3JH6g_10_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">894000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A"
      decimals="-3"
      id="Tc_s-sI3S1BKkuMUwH0ynje8g_10_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1467000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_hR2cmq4JwEy_6zNCnO2s-w"
      decimals="-3"
      id="Tc_AxnW45dbqESU7HiND3NEpw_11_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-1056000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_qaLl5nwG3U-8_osZlx3SpQ"
      decimals="-3"
      id="Tc_yjwGKmoBYUS8DO0kikfV7g_11_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-959000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_2cIP47qwBE-srM-UInA48A"
      decimals="-3"
      id="Tc_3RgEq1uiE0CV_cz20trtWw_11_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-851000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_pxqAUVjcWEiJf_4UkIPnRg"
      decimals="-3"
      id="Tc_ajqTJlsexU6vsn6p1fhHPA_12_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">32410000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember__6JmM8XcBUip-56hZCA8ig"
      decimals="-3"
      id="Tc_iCt8eSmm80q9ZQcRZXbELw_12_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">33889000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_HYAe7T3bM0uPnVmhnuk0NQ"
      decimals="-3"
      id="Tc_tzDswNjcCkO83TFplf0FmQ_12_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">30213000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_s2KGkJGHQE24IlcU01BatQ"
      decimals="-3"
      id="Tc_Zr1ZjESfp0m5adu5tTq-XA_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-26791000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_kCoLjsydz025fO14lloWZg"
      decimals="-3"
      id="Tc_-aPhp42RnEq-GDAGBnhVvQ_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-22749000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2019_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_eZxk80f7rkOIMW9Uz-QjMQ"
      decimals="-3"
      id="Tc_e0BTUG3osUKPJvy_-rMnmg_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-19139000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_2QmGkCKydUCnCVZUxjhf3w"
      decimals="-3"
      id="Tc_NwIycw2h6kKoMzVJRFJiuQ_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-87000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_BOCVhHLarUK1ofHh5lJzgQ"
      decimals="-3"
      id="Tc_xPnGT0dFY0-2JYb-9QkmJQ_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-48000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_6CpwH38OB0GxFoomh9oxsw"
      decimals="-3"
      id="Tc_Wc9MkTTg9UaDGIjzHwSrdQ_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-42000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_2QmGkCKydUCnCVZUxjhf3w"
      decimals="-3"
      id="Tc_nDVJBRieGUWvoj75HlTiJw_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1056000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_BOCVhHLarUK1ofHh5lJzgQ"
      decimals="-3"
      id="Tc_CgVABafuV06Yk1FKwAqE7w_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">959000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_6CpwH38OB0GxFoomh9oxsw"
      decimals="-3"
      id="Tc_Lb0MdrghfkO9E4YI79cwaQ_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">851000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_2QmGkCKydUCnCVZUxjhf3w"
      decimals="-3"
      id="Tc_aoxc5Ez5e02sFEaJ05CPmg_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1210000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_BOCVhHLarUK1ofHh5lJzgQ"
      decimals="-3"
      id="Tc_RtfKPl9OZkGAXJInFzYyPQ_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1089000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_6CpwH38OB0GxFoomh9oxsw"
      decimals="-3"
      id="Tc_0dwXqSAWB0mE9822LtSAmQ_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">950000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_2QmGkCKydUCnCVZUxjhf3w"
      decimals="-3"
      id="Tc_VxwKUFKCmkGzQ2pW-F1-Rw_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-2327000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_BOCVhHLarUK1ofHh5lJzgQ"
      decimals="-3"
      id="Tc_BdxG26sBrE6InA29ow_lSA_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-894000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_6CpwH38OB0GxFoomh9oxsw"
      decimals="-3"
      id="Tc_xBKjRpiNBE-JyCspfxOsJw_8_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-1467000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_2QmGkCKydUCnCVZUxjhf3w"
      decimals="-3"
      id="Tc_NZ8Wjs4zOE6ds6UX8RRzgQ_9_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-2274000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_BOCVhHLarUK1ofHh5lJzgQ"
      decimals="-3"
      id="Tc__fxvo00DI02C_9YWmvW2YQ_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1052000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_6CpwH38OB0GxFoomh9oxsw"
      decimals="-3"
      id="Tc_yuU9a4n-mkuCjNXsGzIWWA_9_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">300000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_0QrduY45dEG6M-eOa0J7zw"
      decimals="-3"
      id="Tc_j0kYKqZkh0qfCLP6w2MpzQ_10_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-29197000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_s2KGkJGHQE24IlcU01BatQ"
      decimals="-3"
      id="Tc_3XgXH6LhYUeViDu-4N2WFg_10_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-26791000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_kCoLjsydz025fO14lloWZg"
      decimals="-3"
      id="Tc_PItMXpydjUacRNRrW8-vOA_10_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-22749000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-5"
      id="Narr_ek67CRoqC0Ce8d6gBfGciw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1200000</ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_G_8DqSTBgUCYR6nT9-4X1g_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7098000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="-3"
      id="Tc_RViinZEPJEq46ibkp-dWNA_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7464000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2019_C854zoDUpkSi-bE7TYeEJw"
      decimals="-3"
      id="Tc_JmxERBy35UmytEcSz3INYQ_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7485000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_z9cw1K0SjUWd5rBpWhVjcw_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1751000</ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_5VYka6zk_Em0RYOYkp1zFw_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1679000</ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_18waOaoCP0C9gcpnf2pZog_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1655000</ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_SqJFxlssFkKHoEO0FovTBg_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4426000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_8bpW-5sA7EqlEIxUPRyfaQ_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">956000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_B5zfoNUnZk23wGNbuA9otw_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">726000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_dNNIRdMcIUC_fjquJzvZDA_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1210000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_v9khCxeN5UOh3JWoVMCIAg_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1089000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_mitwugzfUEGHHqyR91dNZA_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">950000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_eUFh8B5_YUOEolSfzhv5CQ_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3213000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_xkokMCFD3024Z4749bbvcQ_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7098000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="-3"
      id="Tc_0zKfXFkvqkuHyuvXvtVMVQ_8_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7464000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <aciu:DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_wAZDuW16bUeCJmXRrAGZOw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;D.&lt;/b&gt;&lt;/span&gt;Other comprehensive gains/(losses)&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of changes in demographic assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 29&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,428&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of changes in financial assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 8,397&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 156&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (71)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of changes in experience assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,726)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (252)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (931)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Return on plan assets excluding interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,274)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,052&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 300&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.23%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total other comprehensive gain&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 4,426&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 956&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 726&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_6N2K_SGJykKVY8cVF5hxlw_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">29000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_HGpVqFAkQUy7sibEOn2szw_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_Ktn7LVOM0UWvvcjiswlHxg_4_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1428000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_M14iQxDBw0Op4Ik0tlv-0w_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">8397000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_CfHKUa7hFk6iGeSm1qqzCg_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">156000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_R8zUYspdE0KZoCa5eyVueQ_5_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-71000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_rD0z-8sOoEStJ0RKSJ_uqw_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-1726000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_FpKpICinxU2lBiRxsZuBjw_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-252000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_b4qNw_hjHUmhNdzZTz8_aw_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-931000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_ihGa2zb-OEey2PNWY_8ltA_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-2274000</ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_wjKsthBuVEKd3w-AUDMe5A_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1052000</ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_WiPNCmCw7UKbF6xEe2CXnA_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">300000</ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_zoCDvAQJdUGXp3WL6rjoMA_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4426000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_ZbkINlwyR0yG3pXnzSYQzQ_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">956000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_tC_G9yLT4EqE2pdZBxU05A_8_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">726000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_Ofvm7oroMEec2bGmAq_JzQ">P14Y10M24D</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      id="Narr_2cuQtji2akiO6SV2DgTbMQ">P17Y1M6D</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Group_nNF-lzH50UOSL4ATmZIL1g">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The actuarial assumptions used for the calculation of the pension cost and the defined benefit obligation of the defined benefit pension plan for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively, are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:48.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:48.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2.25&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.30&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.20&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Rate of future increase in compensations &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Rate of future increase in current pensions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest rate on retirement savings capital&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2.25&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 0.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:48.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Mortality and disability rates &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;BVG 2020-CMI&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;BVG 2020-CMI&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.3%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;BVG 2020-CMI&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2022 is shown below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Interest&#160;rate&#160;on&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Discount&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;salary&#160;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;pension&#160;cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;savings&#160;capital&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assumptions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:0pt;visibility:hidden;"&gt;&lt;td colspan="17" style="padding:0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In&#160;CHF&#160;thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Potential defined benefit obligation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 30,201&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 34,916&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 32,940&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,841&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 33,601&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,322&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 33,322&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,545&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Decrease/(increase) from actual defined benefit obligation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,209&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,506)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (530)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 569&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,191)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,088&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (912)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 865&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2021 is shown below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Interest&#160;rate&#160;on&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Discount&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;salary&#160;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;pension&#160;cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;savings&#160;capital&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assumptions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:0pt;visibility:hidden;"&gt;&lt;td colspan="17" style="padding:0pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in&#160;CHF&#160;thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Potential defined benefit obligation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,190&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 37,006&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 34,578&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 33,176&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 35,497&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 32,435&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 34,822&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 33,007&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Decrease/(increase) from actual defined benefit obligation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,699&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,117)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (689)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 713&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,608)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,454&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (933)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 882&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="4"
      id="Tc_pG40Qxk5n0WR0Nv9HiPqzg_4_2"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.0225</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="4"
      id="Tc_InRyTT6K8UW-wErx_HD1XA_4_4"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.0030</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="4"
      id="Tc_Lnb8yxB6R0iMpztrmf2fTw_4_6"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.0020</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="4"
      id="Tc_E6pFC8uCb0Wn5WbS0qEJ-g_5_2"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.0175</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="4"
      id="Tc_sCsO_7vX6UqNZHddnS8TaA_5_4"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.0175</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="4"
      id="Tc_rSKztFVHWEOMcKngJjnxeQ_5_6"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.0175</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="4"
      id="Tc_asF69yBlNkq9g1LG91HfGg_6_2"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.0000</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="4"
      id="Tc_wlWtTsLMtUaUmD7ploHDqA_6_4"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.0000</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="4"
      id="Tc_Zp0caYtWAE-GlPU-ybh6Hg_6_6"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.0000</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="4"
      id="Tc_nQNSLv56kUKdTJYw7fkWJQ_7_2"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.0225</aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital>
    <aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="4"
      id="Tc_njUC2T8hu06BAMWyOcyUsA_7_4"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.0075</aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital>
    <aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="4"
      id="Tc_Y0PZOvC9VUOtDmMPWYg_Yw_7_6"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.0050</aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_htkFexGKi0SyGdCClk5r-A"
      decimals="3"
      id="Tc_HAZhg8UoF0aolUQ6FQme2g_3_2"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_6EKzgKAJoUG3jfS4LKnOcA"
      decimals="3"
      id="Narr_vRpaRy5BA0eCxRPDvPnoBQ"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_uLVqkw8R0Ey9u3gY5ML4tg"
      decimals="3"
      id="Tc_r87LdrBWGUyKfXRqbrVNeQ_3_4"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_H4N7gZJ3j0Kt81LUUCEMUg"
      decimals="3"
      id="Narr_4PebLXd4MES-hqQd6xXlpA"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_XbtQeThTw0KgJUgpaxvnvg"
      decimals="3"
      id="Tc_vxNpMC3aNEa_krrMt0c2zQ_3_6"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_6EKzgKAJoUG3jfS4LKnOcA"
      decimals="3"
      id="Narr_HK-Qf6w2L0-QAQXgzh8gxg"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_59E483uZ40Gsz3BGEndqFA"
      decimals="3"
      id="Tc_IwfvqEe8t0etPce7z2vbvg_3_8"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_H4N7gZJ3j0Kt81LUUCEMUg"
      decimals="3"
      id="Narr_LL8mb7sq50OvRfSfZ3iOPA"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember__QV6BS-X-EirLtUuhoaxaw"
      decimals="3"
      id="Tc_iyEPY0f5PkGV2n3cwqioBA_3_10"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_6EKzgKAJoUG3jfS4LKnOcA"
      decimals="3"
      id="Narr_IW6NVtZ6p0eg2Aei5m1Cpw"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Cu7DGnbLpU-gF7D6W8XXoQ"
      decimals="3"
      id="Tc_eYmSrQU31kyG_1J_Sf2dIA_3_12"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_H4N7gZJ3j0Kt81LUUCEMUg"
      decimals="3"
      id="Narr_rHpYkTZag0WQPVR-5a1l9Q"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hYMeoCWTDUeHBblD-WbM1g"
      decimals="3"
      id="Tc_RjdAgbVPW0WC5e0HhI-a8A_3_14"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_6EKzgKAJoUG3jfS4LKnOcA"
      decimals="3"
      id="Narr_RWHVl7VxL02auERqNMXG7g"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_sfVRDOORkUqhr6UilmXrJw"
      decimals="3"
      id="Tc_ai7wU3eUEEe_oIL24ASP3g_3_16"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_htkFexGKi0SyGdCClk5r-A"
      decimals="-3"
      id="Tc_YY43nj-Rxkyvq3q_z8t0Wg_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">30201000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_uLVqkw8R0Ey9u3gY5ML4tg"
      decimals="-3"
      id="Tc_1qLmyjGg9kOgoRlBK-gqVg_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">34916000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_XbtQeThTw0KgJUgpaxvnvg"
      decimals="-3"
      id="Tc_mrGa_qvgekefUGfXdDekfQ_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">32940000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_59E483uZ40Gsz3BGEndqFA"
      decimals="-3"
      id="Tc_GLydYEp_PEGfkviKDL5EQA_6_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">31841000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember__QV6BS-X-EirLtUuhoaxaw"
      decimals="-3"
      id="Tc_KumCu_qOl0y_93HQCNMdXA_6_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">33601000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Cu7DGnbLpU-gF7D6W8XXoQ"
      decimals="-3"
      id="Tc_gxuaYwKMrEm7KFobjFt-kg_6_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">31322000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hYMeoCWTDUeHBblD-WbM1g"
      decimals="-3"
      id="Tc_Dj-odfi8kkeZmPPrQNJbnw_6_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">33322000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_sfVRDOORkUqhr6UilmXrJw"
      decimals="-3"
      id="Tc_EJyv2oIvBkCTu6QFWodW5w_6_16"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">31545000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_htkFexGKi0SyGdCClk5r-A"
      decimals="-3"
      id="Tc_f1Dpk6Yr-0eFsekUFdEWYw_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-2209000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_uLVqkw8R0Ey9u3gY5ML4tg"
      decimals="-3"
      id="Tc_bSDcWYzS-Ey-5q4x-EeWHA_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2506000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_XbtQeThTw0KgJUgpaxvnvg"
      decimals="-3"
      id="Tc_7LeFgJ8lkU-oRFtYmF-Spg_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">530000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_59E483uZ40Gsz3BGEndqFA"
      decimals="-3"
      id="Tc_5GysAOu-4UqRIbtl-t1HgA_7_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-569000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember__QV6BS-X-EirLtUuhoaxaw"
      decimals="-3"
      id="Tc_XxUE55DhcEecqVB8RG9DWw_7_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1191000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Cu7DGnbLpU-gF7D6W8XXoQ"
      decimals="-3"
      id="Tc_s01Qnyyr90mbnVKh1LX-hA_7_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-1088000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hYMeoCWTDUeHBblD-WbM1g"
      decimals="-3"
      id="Tc_Nf9p9DTv-kOHJFNDyjUB1A_7_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">912000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_sfVRDOORkUqhr6UilmXrJw"
      decimals="-3"
      id="Tc_SY2r2N3LgkuIJLi2dGQvkw_7_16"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-865000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_wxgSXXB0oEWC6elN_wYlOw"
      decimals="3"
      id="Narr_V8NYy2yU_UmDNTvwekatng"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_ITqbxgmA8kaKhSS6Qx6Lag"
      decimals="3"
      id="Tc_5rhxnM_21k6ggIJm63vQ7A_3_2"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_g3mEpN007U6ktZW8iOkmGg"
      decimals="3"
      id="Narr_ev9R2Q5PekOOyjzxu3P5tQ"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_CIf08U-iBESSEaFfP0e5oQ"
      decimals="3"
      id="Tc_syGmnNjjHEaha-RjuQvLAA_3_4"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_wxgSXXB0oEWC6elN_wYlOw"
      decimals="3"
      id="Narr_X1XW-tblWk6Qu1g989rE1g"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lnas20UeVUe0l9IofWvilw"
      decimals="3"
      id="Tc_VsWYrGUCnk-3MxwKGnlg7A_3_6"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_g3mEpN007U6ktZW8iOkmGg"
      decimals="3"
      id="Narr_Q8twMEkSsE2Vfxl-UT4H6A"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_E-R1Y--G10q88hvRsrSnzA"
      decimals="3"
      id="Tc_AP2QtZ5XcE-0BIXeMnwFGw_3_8"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_wxgSXXB0oEWC6elN_wYlOw"
      decimals="3"
      id="Narr_Sdogre-1JUuakgUQcAOrGg"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hnNvq_N4vkyRlPiVGvD9xg"
      decimals="3"
      id="Tc_muEEL1K-cEGZE3oJyoAwZA_3_10"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_g3mEpN007U6ktZW8iOkmGg"
      decimals="3"
      id="Narr_Xapfq1JBf0OE0F2TgLmn5w"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_HHYHWrkgo0um-ugZPCUcJA"
      decimals="3"
      id="Tc_WdO5skX1D0-WPuZMLPRuFA_3_12"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_wxgSXXB0oEWC6elN_wYlOw"
      decimals="3"
      id="Narr_M8_2oYBldE2yuDXguksavw"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Ky5hPC5l-kqMi9huZQTdgA"
      decimals="3"
      id="Tc_cMBsviTYN0mCwjue0Bj2Ew_3_14"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_g3mEpN007U6ktZW8iOkmGg"
      decimals="3"
      id="Narr_wURb92puo0qg3Bkwv-NvFA"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8YTwmrejmUmiuJSTgOn0zQ"
      decimals="3"
      id="Tc_FQVZqufKx0Kit3zU1DpMeQ_3_16"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_ITqbxgmA8kaKhSS6Qx6Lag"
      decimals="-3"
      id="Tc_xYN6lm1OGE-EnhC0J8W0qQ_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">31190000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_CIf08U-iBESSEaFfP0e5oQ"
      decimals="-3"
      id="Tc_sEXVTx8iLEWRA5iIJvncRA_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">37006000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lnas20UeVUe0l9IofWvilw"
      decimals="-3"
      id="Tc_xp6l8ufBVEajtdspLQuOcQ_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">34578000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_E-R1Y--G10q88hvRsrSnzA"
      decimals="-3"
      id="Tc_NqG1Yyy6b0iAOYTM_K6t3A_6_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">33176000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hnNvq_N4vkyRlPiVGvD9xg"
      decimals="-3"
      id="Tc_JgV5q5wqDkSkhm1XEan9FQ_6_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">35497000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_HHYHWrkgo0um-ugZPCUcJA"
      decimals="-3"
      id="Tc_TNKtgR0WDUyvRj0m_HaXPg_6_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">32435000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Ky5hPC5l-kqMi9huZQTdgA"
      decimals="-3"
      id="Tc_PxPgeJaNo0SoL42yZyjWiA_6_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">34822000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8YTwmrejmUmiuJSTgOn0zQ"
      decimals="-3"
      id="Tc_DJgnjWsnQE2rDN9jI57p7A_6_16"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">33007000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_ITqbxgmA8kaKhSS6Qx6Lag"
      decimals="-3"
      id="Tc__QiroZcNnkSedLDDGt-Jdg_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-2699000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_CIf08U-iBESSEaFfP0e5oQ"
      decimals="-3"
      id="Tc_KpG3KDFjGEmLRdoxPPzqmg_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3117000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lnas20UeVUe0l9IofWvilw"
      decimals="-3"
      id="Tc_U_HlW48pCE6BQJzch8nEeQ_7_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">689000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_E-R1Y--G10q88hvRsrSnzA"
      decimals="-3"
      id="Tc_8PWs4mSI5U-e-DbdhXjNQA_7_8"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-713000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_hnNvq_N4vkyRlPiVGvD9xg"
      decimals="-3"
      id="Tc_1Yk0ziO0RUWkKYB2_RQNVQ_7_10"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1608000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_HHYHWrkgo0um-ugZPCUcJA"
      decimals="-3"
      id="Tc_35LT4jx5S0a9LFzk3wzy0g_7_12"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-1454000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Ky5hPC5l-kqMi9huZQTdgA"
      decimals="-3"
      id="Tc_VXNNU9lqGkSXQnsRCx4mDw_7_14"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">933000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2021_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8YTwmrejmUmiuJSTgOn0zQ"
      decimals="-3"
      id="Tc_YDgng3it_0OYec0UI-PNHg_7_16"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-882000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_iFJK4IV2S0a-M7_Izzp38Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;18.&lt;/b&gt;&lt;/span&gt;Share-based compensation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Share-based option awards&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December&#160;31, 2022, there are equity-based instruments outstanding that the Company has granted under two different plans.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s 2016 Share Option and Incentive Plan (SOIP) was approved by the shareholders at the ordinary shareholders&#x2019; meeting in November&#160;2016. The 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights. The Company only grants equity-based instruments from the SOIP as of December&#160;31, 2022.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table summarizes equity-settled share option grants for plans that existed during the period:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;options&#160;awarded&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractual&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Plan&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(since&#160;inception)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vesting&#160;conditions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;life&#160;of&#160;options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share option plan C1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,775,250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from grant date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;2016 SOIP:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:40%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Executives and directors&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,277,044&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;1 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;3 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, quarterly and annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,811,687&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The number and weighted-average exercise prices (in CHF) of options under the share option programs for Plans C1 and the 2016 SOIP are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;exercise&#160;price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;remaining&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(CHF)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"&gt;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;term&#160;(years)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at January 1, 2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,981,629&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.93&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 8.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (53,591)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.03&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expired during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (26,729)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4.38&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (73,669)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,073,027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.29&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at December&#160;31,&#160;2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,900,667&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.90&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 8.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable at December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,099,015&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.49&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at January 1, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,900,667&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.90&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 8.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (207,331)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (218,561)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4.97&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,110,914&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.34&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at December&#160;31,&#160;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,585,689&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.21&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,613,242&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 6.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at January 1, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,585,689&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.21&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (304,738)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.32&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (110,250)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.15&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,090,316&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at December&#160;31,&#160;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,261,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.65&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,345,648&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.41&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 6.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The outstanding stock options as of December&#160;31, 2022 have the following range of exercise prices:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Range&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;expiration&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;dates&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Range of exercise prices&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF 0.15&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 97,875&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2022&#x2013;2026&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF 9.53&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 223,646&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2027&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD 5.04 to USD 12.30&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,864,408&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2028&#x2013;2031&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD 2.76 to USD 4.57&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,075,088&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2032&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total outstanding options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,261,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The weighted-average exercise price for options granted in 2022, 2021 and 2020 is USD 3.44 (CHF 3.18), USD 6.95 (CHF 6.34) and USD 7.11 (CHF 6.29), respectively. The range of exercise prices for outstanding options was CHF 0.15 to CHF 9.53 for awards previously granted in CHF (prior to 2018) and USD 2.76 to USD 12.30 for awards granted in USD as of December&#160;31, 2022.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For awards issued in 2022, the volatility is based on the Company&#x2019;s actual volatility for the period congruent with the expected term of the underlying option. The risk-free interest rate is based on yields of long-dated U.S. Treasury notes that align with the expected term of the award. The weighted-average share price of common share options exercised in 2022 is USD 3.55 (CHF 3.28).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The weighted-average grant date fair values of the options granted in 2022, 2021 and 2020 are USD 2.38 (CHF 2.20), USD 5.23 (CHF 4.78) and USD 5.25 (CHF 4.65), respectively. The following table illustrates the weighted-average assumptions for the Black-Scholes option-pricing model used in determining the fair value of these awards:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercise price (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;2.76-4.57&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;5.31-7.72&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;5.04-9.16&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share price (weighted average)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3.44&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6.95&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7.11&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;0-2.4&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;67-80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;5.5 - 6.25&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;5.1 - 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;5.5 - 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Restricted share awards&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;A summary of non-vested share awards (restricted share and restricted share units) activity as of&#160;December&#160;31, 2022&#160;and changes during the&#160;year then ended is presented below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractual&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;life&#160;of&#160;non-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;share&#160;awards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;vested&#160;share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Grantee type&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;granted&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vesting&#160;conditions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;awards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Restricted share units&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Directors&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 159,025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;1 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; service from date of grant, annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Executives&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 274,872&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;3 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, quarterly and semi-annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;non-vested&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;grant&lt;/b&gt;&#160;&lt;b style="font-weight:bold;"&gt;date&#160;fair&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;value&#160;(CHF)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at January 1, 2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 42,763&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.52&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,828)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.47&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expired during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,804)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.52&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (84,638)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.51&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (23,269)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.52&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 19,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.51&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vested and exercisable at December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 49,289&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.47&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 19,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.51&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,471)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.46&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (18,697)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.52&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 797&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.41&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vested and exercisable at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 65,515&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.48&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 797&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.41&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 239,194&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3.06&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (23,505)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3.28&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 216,486&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3.06&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vested and exercisable at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 89,020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7.84&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The weighted-average grant date fair values of the remaining non-vested share awards as of the respective&#160;year end for the restricted share units were CHF 3.06, CHF 9.41 and CHF 9.51 for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively. The fair values of these non-vested share awards granted were determined using a reasonable estimate of market value of the common shares on the date of the award.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The expense charged against the income statement was CHF 3.3 million, CHF 4.1 million and CHF 4.1 million for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively. The expense is revised by the Company based on the number of instruments that are expected to become exercisable.&lt;/p&gt;</ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
    <aciu:NumberOfEquityBasedInstrumentPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Narr_xa_5K5xyCkeabyj-ii_awQ"
      unitRef="Unit_Standard_plan_lCCE6LMjkEKlKdQ1vpJjNA">2</aciu:NumberOfEquityBasedInstrumentPlans>
    <ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_TiQv_NV-CkWstgq9B5zzTg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table summarizes equity-settled share option grants for plans that existed during the period:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;options&#160;awarded&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractual&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Plan&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(since&#160;inception)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vesting&#160;conditions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;life&#160;of&#160;options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share option plan C1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,775,250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from grant date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;2016 SOIP:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:40%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Executives and directors&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,277,044&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;1 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;3 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, quarterly and annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.19%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,811,687&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_11_1_2016_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_vLy61BZC6kiaUiucvTN5rA"
      decimals="INF"
      id="Tc_bPzGByeq1kSUF5_Abow77A_4_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">6775250</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_qes1Nya84kCyFEAE3XIdpQ"
      id="Narr_0vHVoj24NE-OpXay55ZxdA">P4Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_qes1Nya84kCyFEAE3XIdpQ"
      id="Tc_ci-7QyW4RESqqPl9kBezNA_4_6">P10Y</aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_11_1_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_8NZA0QmhLU-9P-5sBxKJYg"
      decimals="INF"
      id="Tc_bZ6td8dXY0C35JP_mjmSVw_6_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">3277044</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_gs4FuwKFqUy6IZN8tQRJ-w"
      id="Narr_fEE2GYVyLUupgtMx0MWJHA">P1Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_o6xYJQLm0U2_P1h1Nvrt4Q"
      id="Narr_lJ7m_vj9dkmPQCcFCHSDNQ">P3Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_i1QiIMeQy0WwrJUKG5kvUw"
      id="Narr_gDC_lU_q-kGM1hnq6bYpsg">P4Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_c832R2YNRkeTmCmOUNmglA"
      id="Tc_gA5_35cX40mqkJgjAl_puw_6_6">P10Y</aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_11_1_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_u_sWTIPrdUK25sXxSWqZ-g"
      decimals="INF"
      id="Tc_0vOWNDUYEk6sdcZYyd-d5g_7_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">1811687</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_nm_abkjtNku82k2BFZcwmA"
      id="Narr_TEght7r9eUOm5RFRmyVQCw">P4Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_nm_abkjtNku82k2BFZcwmA"
      id="Tc_aZF9lu9SkEavNcLhEjy88w_7_6">P10Y</aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_CA0Wc0mdkE6shXg1hOP62w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The number and weighted-average exercise prices (in CHF) of options under the share option programs for Plans C1 and the 2016 SOIP are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;exercise&#160;price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;remaining&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(CHF)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"&gt;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;term&#160;(years)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at January 1, 2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,981,629&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.93&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 8.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (53,591)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.03&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expired during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (26,729)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4.38&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (73,669)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,073,027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.29&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at December&#160;31,&#160;2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,900,667&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.90&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 8.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable at December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,099,015&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.49&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at January 1, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,900,667&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.90&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 8.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (207,331)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (218,561)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4.97&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,110,914&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.34&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at December&#160;31,&#160;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,585,689&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.21&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,613,242&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 6.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at January 1, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,585,689&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.21&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (304,738)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.32&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (110,250)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.15&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,090,316&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at December&#160;31,&#160;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,261,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.65&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,345,648&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.58%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.41&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 6.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2019_C854zoDUpkSi-bE7TYeEJw"
      decimals="INF"
      id="Tc_Ya2G58Z8TUCAJpM0DjM7nA_5_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">1981629</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2019_C854zoDUpkSi-bE7TYeEJw"
      decimals="2"
      id="Tc_AIbRGxEuIEypDzpZ0KBebQ_5_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">5.93</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2019_To_12_31_2019__3yCVTKZ40i5IsvT7P2jug"
      id="Tc_FS20OUKh5kqf-xu-k7H26w_5_6">P8Y3M18D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="INF"
      id="Tc_tBPbdUzigU24pX-KqP9bUA_6_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">53591</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Tc_yzoTogEqbEWBgdEKR8vBEQ_6_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">6.03</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="INF"
      id="Tc_KrM27KCDuUeGu8J22aeNmQ_7_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">26729</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Tc_Vd-ZVqoYqE2Zn3pxjCF74w_7_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">4.38</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="INF"
      id="Tc_I400CApmzk6QiWcAcCrZPw_8_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">73669</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Tc_uEQ9quZdsUKOnRRUawdI-A_8_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">2.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="INF"
      id="Tc_4I6yX8uJqUCvR0hpphjK7A_9_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">1073027</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Tc_xKoC_RMJbEGbQAzuHoNLNQ_9_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">6.29</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="INF"
      id="Tc_FvSW3VPs8EO_DvbiXzNUsQ_10_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">2900667</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="2"
      id="Tc_ir1stb9W90CXx9b0yl84uA_10_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">5.90</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      id="Tc_Sg3KaYP1skG_IWVSaIq9fQ_10_6">P8Y2M12D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="INF"
      id="Tc_wwGQwrmsGUyywj4Tv3Wj0w_11_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">1099015</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="2"
      id="Tc_qdhRinHYX0-VYT5UgNENKA_11_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">5.49</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      id="Tc_Xnixj8WcKEuPAK-KX6eonQ_11_6">P7Y</aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="INF"
      id="Tc_NjqX1u-JPUGYS1hRn0R_dA_12_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">2900667</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="2"
      id="Tc_W8KP5BPg0UyJHGJXU3FP5w_12_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">5.90</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      id="Tc_dHTcy-pfp0ucNc1V0h9JvQ_12_6">P8Y2M12D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="INF"
      id="Tc_rcDcLKQr8UCELprswB0vqg_13_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">207331</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="2"
      id="Tc_6fC12UrF7UKD0atxlpGluw_13_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">6.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="INF"
      id="Tc_3yVmoz0saUCEav2VpP8N1g_14_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">218561</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="2"
      id="Tc_kcaToJmEyUu2aQLMg0Oe2w_14_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">4.97</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="INF"
      id="Tc__P9kzsyNg0-IJTRLyPhsKQ_15_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">1110914</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="2"
      id="Tc_GmDthJbadU-8het2KByMoA_15_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">6.34</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="INF"
      id="Tc_NrN9yjLJn0qOjEIoGKoQlQ_16_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">3585689</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="2"
      id="Tc_wI4BbPAfwkO6JkcKhhH-SQ_16_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">6.21</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      id="Tc_h1dlIi5WUEmESSiuEF_1gQ_16_6">P7Y9M18D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="INF"
      id="Tc_mwymqKw4g0mPBn-CAs7GQw_17_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">1613242</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="2"
      id="Tc_6JJJ63mwWEuC_PRLBhisZQ_17_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">6.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      id="Tc_wWqjQUuk4Uusp2xo2SwsOQ_17_6">P6Y9M18D</aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="INF"
      id="Tc_hcTqrIXCLEGBiCXXu9zy6w_18_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">3585689</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="2"
      id="Tc_QaPAlMD_WUirpkY03GCM3Q_18_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">6.21</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      id="Tc_BlRgVzK7Ckq4qP1q2tsN1w_18_6">P7Y9M18D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Tc_A4A5DHBqp0uyZnudhcAQDg_19_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">304738</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Tc_XYdOkmUTSUW0VcdcFChBxg_19_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">6.32</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Tc_GzW3LbbxgkmGdJoLD-tnDw_20_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">110250</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Tc_ON0aP1DpPUSEi3_x8bBHzA_20_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">0.15</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Tc_AqzF4Cws80ixBUAQHj8_5Q_21_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">1090316</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Tc_xwEMJe1v50mDqrlV2a5yZw_21_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">3.18</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="INF"
      id="Tc_xcuTfsOOYE-mw8TfjPU9RQ_22_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">4261017</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="2"
      id="Tc_QYVyLuj0Hk-d5JKVoFiOrg_22_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">5.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_dQWlnM8D-kC9X4vMkmN_Eg_22_6">P7Y7M6D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="INF"
      id="Tc___bIXKYnw0Sd4uxF8pzJIg_23_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">2345648</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="2"
      id="Tc_StINWgIm20KD66pkjObXtQ_23_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">6.41</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tc_q8D5bQQI7EKSozmTTjKxmQ_23_6">P6Y7M6D</aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_QTFbSEkhuEWYXo0qSg0nrw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The outstanding stock options as of December&#160;31, 2022 have the following range of exercise prices:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Range&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;expiration&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;dates&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Range of exercise prices&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF 0.15&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 97,875&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2022&#x2013;2026&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF 9.53&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 223,646&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2027&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD 5.04 to USD 12.30&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,864,408&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2028&#x2013;2031&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD 2.76 to USD 4.57&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,075,088&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2032&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total outstanding options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,261,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf0.15Member_Mjn-Ndi9XEOlgiCMgrFRAQ"
      decimals="INF"
      id="Tc_UXNNI-xnd0ilI51m5GFCSg_5_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">97875</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf9.53Member_HuWh2wiS0UufmuyDmPt1XQ"
      decimals="INF"
      id="Tc_bgLtAIMdb0m_cudiCdaf4g_6_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">223646</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd5.04ToUsd12.30Member_gtKWlOCngE27VpysbvaH2g"
      decimals="INF"
      id="Tc_xW1ib7YKtkm_xF5YRCBiNQ_7_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">2864408</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2022_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd2.76ToUsd4.57Member_m38zUhm5wkSL12bhBb3aJA"
      decimals="INF"
      id="Tc_6Qa3wMrKaUmlukQjeif08A_8_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">1075088</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="INF"
      id="Tc_GZiqpKpyE0unreCBv-2LVA_9_2"
      unitRef="Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA">4261017</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Narr__0_f0sTPbECyFaKA6wdZ-w"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">3.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Narr_2-9YSXjCFkSo8wM09mPVuQ"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">3.18</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="2"
      id="Narr_X7nD34nJykOA7GKJKv0kpA"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">6.95</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="2"
      id="Narr_HIXS77qQP0uNVdWJI_-bVg"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">6.34</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Narr_gvIRFIExRE6PrvKwsAsXkg"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">7.11</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Narr_T1L34eAFlEyKCz_VXRw8bw"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">6.29</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ"
      decimals="2"
      id="Narr_bUz70ksDa0GFXt0fOkzTMA"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">0.15</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g"
      decimals="2"
      id="Narr_qyR-D-rylUSAtWsm2FGzhg"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">9.53</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ"
      decimals="2"
      id="Narr_NTnBRf1g5kmKX6S3XVxhmQ"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">2.76</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g"
      decimals="2"
      id="Narr_DPfxS_VUnkG_YBv2XMXn0w"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">12.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Narr_1qFPCv3pXkKCMHcaPqfv_g"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">3.55</ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Narr_871i4RhqWkKM_TKyivJ9JQ"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">3.28</ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="2"
      id="Narr_FynhiRmPGEOlxNML8gzVdw"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">2.38</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="2"
      id="Narr_v0_MyjvDdUOdgOCQLxzV2g"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2.20</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="2"
      id="Narr_7tSj1iS7r0at2dO31B9HlA"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">5.23</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="2"
      id="Narr_-EZ0I-1LtUuctfQFoxyzCA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4.78</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="2"
      id="Narr_R10XUplMgUuIYirpDPoANA"
      unitRef="Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA">5.25</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="As_Of_12_31_2020_gSbFr_e9pkGWT1N3sKqHgA"
      decimals="2"
      id="Narr_Be6CGiVATkqKZeOR8ogXuw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4.65</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_uJxApwuJikGRHfD_2jihYA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercise price (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;2.76-4.57&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;5.31-7.72&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;5.04-9.16&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share price (weighted average)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3.44&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 6.95&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7.11&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;0-2.4&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;67-80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;5.5 - 6.25&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;5.1 - 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt;5.5 - 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.77%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.62%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ"
      decimals="2"
      id="Narr_0kl8QiMF40WHmEqylYw6sg"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">2.76</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g"
      decimals="2"
      id="Narr_YQpbiH6Knk6SlRQxM4VDhw"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">4.57</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_5cL5m8nGCEqTrf8_CtRG_A"
      decimals="2"
      id="Narr_2fbGwGRFAkeHCnl80nXKRg"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">5.31</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_hGZYF059eky85mjSvMDTyw"
      decimals="2"
      id="Narr_WWbdPx-5gUWEz2AuRN9Zpg"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">7.72</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_3yeVGHwDfEeZEDJ901taIw"
      decimals="2"
      id="Narr_eiZhk7b4V0aJf7XDs4f09A"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">5.04</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_dIb050VtY0uPI1cKwRn8HA"
      decimals="2"
      id="Narr_3if4zJBzO0abn-4omDajBA"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">9.16</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Tc_FS7qpTTRoU6kvfUoUlCVUA_5_2"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">3.44</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="2"
      id="Tc_H5dlbjwPwEaGleTKpT8EPg_5_4"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">6.95</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Tc_PlwKWOtJlkeUp_sxKyY4TA_5_6"
      unitRef="Unit_Divide_USD_shares_dlxVqycv4UO-g8Qds7Mv9Q">7.11</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ"
      decimals="2"
      id="Narr_OJo-GCc96Ee4PqpluJtRFg"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g"
      decimals="3"
      id="Narr_ntEGZJBVmkSFzKtgDHc0yQ"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.024</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="2"
      id="Tc_9Lg_-BSZNkmZew4rWzPdrw_6_4"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Tc_9SPV6XUJ2kuTKjKdXkkz_A_6_6"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ"
      decimals="2"
      id="Narr_tHOeZ7-vv06Ml1gvM1y_hQ"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.67</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g"
      decimals="2"
      id="Narr_V9Jki2qIg0y5TK0Q0B6mvA"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.80</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="2"
      id="Tc_Gek5OCj_bEuWiyleiYtiVQ_7_4"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.80</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Tc_vylN4i3q3ECiwFgMzpCAdw_7_6"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.80</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_mC8vRO3haECHvYC0oVAaDQ"
      decimals="1"
      id="Narr_4FZGbDyCZEWRhn_tlPuaXw"
      unitRef="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA">5.5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_y2ZW6DaaS0mnQ_UgJgid1g"
      decimals="2"
      id="Narr_9-mNsytaHUWLmiB6aZ4UzQ"
      unitRef="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA">6.25</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_5cL5m8nGCEqTrf8_CtRG_A"
      decimals="1"
      id="Narr_FDoTS-Qb00G8LqcU7L_0Aw"
      unitRef="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA">5.1</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_hGZYF059eky85mjSvMDTyw"
      decimals="0"
      id="Narr_rJLx-OSwl0eaLdsfPi8ljA"
      unitRef="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA">6</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_3yeVGHwDfEeZEDJ901taIw"
      decimals="1"
      id="Narr_nW-UPrPhOUGqdJvKNzs9xQ"
      unitRef="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA">5.5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_dIb050VtY0uPI1cKwRn8HA"
      decimals="0"
      id="Narr_OrCpYgE_KE-0FHtgKbNdlg"
      unitRef="Unit_Standard_Y_GeUympoxb0e7D5mmdQKEbA">6</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Tc_23IFDKxwMkqIDQDF3ryjYg_9_2"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="2"
      id="Tc_dRJ1KMTUTk6GnqFwvhBw-w_9_4"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Tc_GDZVqdUJy0WqYNhfDn6nlg_9_6"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_2y0M8vvn0UOb4nPgx1cxYg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;A summary of non-vested share awards (restricted share and restricted share units) activity as of&#160;December&#160;31, 2022&#160;and changes during the&#160;year then ended is presented below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractual&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;life&#160;of&#160;non-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;share&#160;awards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;vested&#160;share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Grantee type&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;granted&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vesting&#160;conditions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;awards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Restricted share units&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Directors&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 159,025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;1 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; service from date of grant, annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Executives&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 274,872&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;3 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, quarterly and semi-annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;non-vested&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;grant&lt;/b&gt;&#160;&lt;b style="font-weight:bold;"&gt;date&#160;fair&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;value&#160;(CHF)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at January 1, 2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 42,763&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.52&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (11,828)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.47&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expired during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,804)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.52&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (84,638)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.51&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (23,269)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.52&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 19,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.51&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vested and exercisable at December&#160;31,&#160;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 49,289&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.47&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 19,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.51&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,471)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.46&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (18,697)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.52&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 797&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.41&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vested and exercisable at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 65,515&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.48&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 797&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9.41&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 239,194&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3.06&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (23,505)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3.28&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 216,486&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3.06&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vested and exercisable at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 89,020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 7.84&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_11_16_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_EUWOkY3BskaxAia9Z8ewEQ"
      decimals="0"
      id="Tc_l7fOZp6fi0eGABMseXuvMA_6_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">159025</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ZVoQVJGhW0GvwsXTKPLhYw"
      id="Narr_ku4Zq9V1GUGUe5grb_aR-A">P1Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_0Lc-koCQpEeU6K6OjBCTKA"
      id="Tc_WGS0iNeFQEujkyvxZWvpew_6_6">P10Y</aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_11_16_2016_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_8IofwfDJNUGt5LoOfv2Txw"
      decimals="0"
      id="Tc_Prc-TVdP80mSdeyvV4qBeg_7_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">274872</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsFirstVestingConditionsMember_gGDNEFbPMkKnisGaecdtgg"
      id="Narr_r7E4FY0CJEm40jkEMn5dxQ">P3Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsSecondVestingConditionsMember_tIRug6aVk0eTDxYXCAEY0g"
      id="Narr_i0nUyrzBVEeBzWTL8JGFng">P4Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_UZGF3O0NRECj0iuX4vHtKQ"
      id="Tc_ZmDE7Fh9u0WWKst7FYr-rg_7_6">P10Y</aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_YWfuOV2LMUGsWQqsGR6J5w"
      decimals="INF"
      id="Tc_NPrhgMEWqEuMMpDfkOf3Uw_5_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">42763</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2019_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_YWfuOV2LMUGsWQqsGR6J5w"
      decimals="2"
      id="Tc_QMr6C4OrgEasjt7lHKO7BQ_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.52</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw"
      decimals="INF"
      id="Tc_X40iCP-7-ky7YQ_5gWBcMQ_6_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">11828</ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw"
      decimals="2"
      id="Tc_WUDZrttuH0CDm5zJDPT68g_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.47</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw"
      decimals="INF"
      id="Tc_yO5uRSrsgE60aeTC_r93aw_7_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">7804</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw"
      decimals="2"
      id="Tc_uyzkRcb0TEqBV1QZbZ-QeQ_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.52</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired>
    <aciu:NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw"
      decimals="INF"
      id="Tc_tiwbgKu_mkadW6-d8w06Lg_8_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">84638</aciu:NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw"
      decimals="2"
      id="Tc_336WtSVjCESqk6Dej_RxHQ_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.51</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw"
      decimals="INF"
      id="Tc_O3CBsPG2CkONsG_xuWgcTg_9_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">0</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw"
      decimals="2"
      id="Tc_FBYwf54jY0qK9qOcgKbsjg_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw"
      decimals="INF"
      id="Tc_I2bof4Q_IkOPXOIWsHMz-Q_10_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">23269</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_EVjlO8npIEyu8MrfcqJYsw"
      decimals="2"
      id="Tc_8azCLBOEHUeSqGZy5LQwMQ_10_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.52</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ"
      decimals="INF"
      id="Tc_gJowsJnot0yTm3WzRIvhLw_11_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">19494</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ"
      decimals="2"
      id="Tc_ckpzeVjHkEyL667RMidE1Q_11_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.51</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ"
      decimals="INF"
      id="Tc_hrrQ_gAosUCJ7tPj3yddpg_12_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">49289</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ"
      decimals="2"
      id="Tc_GhuHuFLrCki_8fqTqXad6g_12_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.47</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ"
      decimals="INF"
      id="Tc_QrXijpK56Eim6DZB6yOB9Q_13_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">19494</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_I5nySsOPV0C1_LXPIK23CQ"
      decimals="2"
      id="Tc__ZLtCM_US0G1PWfB6m8VfA_13_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.51</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <aciu:NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_my1TIm6ojUaJIKTSB0t2ng"
      decimals="INF"
      id="Tc_wVmnPtM4YEu29MArsYiwmA_14_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">2471</aciu:NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_my1TIm6ojUaJIKTSB0t2ng"
      decimals="2"
      id="Tc_D0FZG29Ci0m1nGq0rw6P4g_14_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.46</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_my1TIm6ojUaJIKTSB0t2ng"
      decimals="INF"
      id="Tc_uIsqZkweqUuPQ-QKOCXZlQ_15_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">18697</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_my1TIm6ojUaJIKTSB0t2ng"
      decimals="2"
      id="Tc_ircD4vKY30WmPgwBE6u6zA_15_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.52</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg"
      decimals="INF"
      id="Tc_zO3X0bY8TUSaDbgyidgBNw_16_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">797</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg"
      decimals="2"
      id="Tc_B4GoMEKFyk2XMrhuGeGFLg_16_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.41</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg"
      decimals="INF"
      id="Tc_x1w2UH_LREiUrI7d7DI3JA_17_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">65515</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg"
      decimals="2"
      id="Tc_M93Q_TIgTUWI0RAhlyvcaQ_17_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.48</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg"
      decimals="INF"
      id="Tc_CSugA_FL3kadsI2iM_treg_18_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">797</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_3XlFSQW9F0m_HsDdnAVVOg"
      decimals="2"
      id="Tc_uAqhSRPENEyovMwAEstoQQ_18_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.41</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_qvzjOcNNJ0e61xUNnj-VJQ"
      decimals="INF"
      id="Tc_yF5hVpkOh0SLDRmtEjF0mA_19_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">239194</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_qvzjOcNNJ0e61xUNnj-VJQ"
      decimals="2"
      id="Tc_u2MHEbu9uEy2wUT44OJCiA_19_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3.06</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_qvzjOcNNJ0e61xUNnj-VJQ"
      decimals="INF"
      id="Tc_5gaouFNaik6y4nYR6B-HTA_20_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">23505</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_qvzjOcNNJ0e61xUNnj-VJQ"
      decimals="2"
      id="Tc_93PZJA1BjkKnCs3VRB8qvw_20_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3.28</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_dxwmB62u-UWekqoEuPazhg"
      decimals="INF"
      id="Tc_nVrqrCtKOUCC8pxl_igvsQ_21_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">216486</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_dxwmB62u-UWekqoEuPazhg"
      decimals="2"
      id="Tc_cfjZjYi8jkSzAFJrABA64w_21_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3.06</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_dxwmB62u-UWekqoEuPazhg"
      decimals="INF"
      id="Tc_BjcOUkDVtkK-WcZrk36cAg_22_2"
      unitRef="Unit_Standard_EquityInstruments_T1683InydEKtHTIHh0Kd6g">89020</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_dxwmB62u-UWekqoEuPazhg"
      decimals="2"
      id="Tc_Vi_lTNOCBke7g_HA3k4VxA_22_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">7.84</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_8n96kGPIAEKNlTtnDkaFpA"
      decimals="2"
      id="Narr_dTKaz9acx0Sk77cMfUDffQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3.06</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_nWByIEwhSEGf6j1j19xN3w"
      decimals="2"
      id="Narr_5B9fen5Cd0Cytn7umILlrA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.41</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_qn53IASnuk6FLPf7LUu5zw"
      decimals="2"
      id="Narr_OXjglx-EdE2hJf53LvS6Gw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9.51</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-5"
      id="Narr_OG54UZ9MqEmq9RxV12ZV4g"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3300000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-5"
      id="Narr_qqabJaNL-U-6_PwM02DL0Q"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4100000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-5"
      id="Narr_utWBOaScT02JbnsXwhvi4A"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">4100000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_Lz7jZzGuZkOEYXn86xFIdQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;19.&lt;/b&gt;&lt;/span&gt;Commitments and contingencies&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s commitments and contingencies relate to its ongoing operating activities, mainly research and development programs, as well as its leased corporate space.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In the normal course of business,&#160;we conduct product research and development programs through collaborative programs that include, among others, arrangements with universities, contract research organizations and clinical research sites. We have contractual arrangements with these organizations. As of December&#160;31, 2022, we have contractual obligations, other than for leases (see below), totaling CHF 23.0&#160;million for 2023.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;We lease our corporate, laboratory and other facilities under multiple leases at the EPFL Innovation Park in Ecublens, near Lausanne, Canton of Vaud, Switzerland. Our lease agreements have no termination clauses longer than a 12-month contractual notice period. The Company recognizes a right-of-use asset for its leases, except for short-term and low-value leases as indicated in Note&#160;3&lt;i style="font-style:italic;"&gt;.&lt;/i&gt; See &#x201c;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities&#x201d; for the contractual undiscounted cash flows for lease obligations.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Within 1 year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 23,336&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 19,785&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Between 1 and 3 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 18,516&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,620&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Between 3 and 5 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,229&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 243&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;More than 5 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,407&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 51&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 52,488&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 23,699&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory>
    <aciu:ContractualCapitalCommitmentsOtherThanForLeases
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_-yIL5uUOREqnWUjN-WEKug"
      decimals="-5"
      id="Narr_iFi2z1mVZEOJfJ8Vu8a7iw"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">23000000.0</aciu:ContractualCapitalCommitmentsOtherThanForLeases>
    <aciu:RentalContractPeriodForNoticeOfCancellation
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Narr_R78Z8_fPIkqSiRFtghoi8A">P12M</aciu:RentalContractPeriodForNoticeOfCancellation>
    <ifrs-full:DisclosureOfCommitmentsExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_yHHKoNvxR0CB6_dlFwzzkQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Within 1 year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 23,336&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 19,785&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Between 1 and 3 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 18,516&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 3,620&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Between 3 and 5 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,229&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 243&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;More than 5 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 1,407&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 51&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 52,488&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 23,699&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfCommitmentsExplanatory>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_-yIL5uUOREqnWUjN-WEKug"
      decimals="-3"
      id="Tc_Q-Ok58MWzEmAmSbcuFt69w_4_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">23336000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_IDSltZ9zlUuxs8MqNPseTA"
      decimals="-3"
      id="Tc_7Cf9XS77IkuBP5bXwZd3Sg_4_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">19785000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_3B9uzJLVRE-wKxtJvPSkOg"
      decimals="-3"
      id="Tc_VRS36rnWXku0uyHQHbAPXg_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">18516000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_93lXqdNkAkGE1eTi254vCQ"
      decimals="-3"
      id="Tc_rbksl_JmXUeupgLBmGj1Ug_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">3620000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_Aq4Gh5QzC0O-z-Hkxgg7bw"
      decimals="-3"
      id="Tc_5BM20r1aGU2y3f4Qs5Ky8g_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9229000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_EG_KIXGerkW5heSXWG1y5Q"
      decimals="-3"
      id="Tc_lYRapN9LXU-ngnyOxzREAg_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">243000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_OgtSEFz6OUOEyh01YeW-4Q"
      decimals="-3"
      id="Tc_3BfYxbpIFEiZ0j4owOrBLQ_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1407000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_pevi1fpI-0qT5MFTaLocdA"
      decimals="-3"
      id="Tc_0NJ17RlJ_0mljkZeZJ1YLA_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">51000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_ABh-75yGc0SArjIsbfwx0g_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">52488000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_HuVi2pfAWEq7W9dRJ3o92g_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">23699000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_Cv6kUMUpsEu4_xtrLKBk9Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;20.&lt;/b&gt;&lt;/span&gt;Earnings per share&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.07212067%;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands except for share and per share data&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Loss per share (EPS)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Numerator&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Net loss attributable to equity holders of the Company&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (70,753)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (72,996)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (61,921)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Denominator&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted-average number of shares outstanding used to compute EPS basic and diluted attributable to equity holders&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 83,554,412&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 74,951,833&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 71,900,212&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted loss per share for the period attributable to equity holders&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.85)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.97)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.86)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;In periods for which we have a loss, basic net loss per share is the same as diluted net loss per share. We have excluded from our calculation of diluted loss per share all potentially dilutive in-the-money (i)&#160;share options, (ii)&#160;non-vested restricted share awards and (iii)&#160;shares that were issued upon conversion of two different convertible notes as their inclusion would have been anti-dilutive. The weighted-average number of potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share options issued and outstanding (in-the-money)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 135,827&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,140,388&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 412,191&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Restricted share awards subject to future vesting&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,292&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,264&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 28,418&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 41,461&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total potentially dilutive securities &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 253,119&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,188,113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 440,609&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <ifrs-full:EarningsPerShareExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_UFiKnaOMtE6NtiXbVBIvtA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.07212067%;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.6%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands except for share and per share data&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Loss per share (EPS)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Numerator&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Net loss attributable to equity holders of the Company&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (70,753)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (72,996)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (61,921)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Denominator&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted-average number of shares outstanding used to compute EPS basic and diluted attributable to equity holders&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 83,554,412&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 74,951,833&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 71,900,212&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted loss per share for the period attributable to equity holders&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.85)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.97)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.86)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:EarningsPerShareExplanatory>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="-3"
      id="Tc_NtJbh4l_k0SshP693G1NNQ_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-70753000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="-3"
      id="Tc_lJc1J6n-5U-3ySk2jOOEfQ_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-72996000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="-3"
      id="Tc_Nuvcl4eRK0eMoPc7fB3uQw_6_6"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-61921000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:WeightedAverageShares
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Tc_KP10tQaXQkKXBT02eQzppw_8_2"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">83554412</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="INF"
      id="Tc_KzXpem7sQEODF6qeLRviOQ_8_4"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">74951833</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="INF"
      id="Tc_gy7MNbpffkWpTk7hdVksLg_8_6"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">71900212</ifrs-full:WeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="2"
      id="Tc_cgp8j1AeEUmfZpatouq7ZA_9_2"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">-0.85</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="2"
      id="Tc_6lkk_ENClEutyAUziECTYg_9_4"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">-0.97</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="2"
      id="Tc_9G0jXxEEEEeDDYr3mRS2UA_9_6"
      unitRef="Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg">-0.86</ifrs-full:BasicEarningsLossPerShare>
    <aciu:DilutiveEffectOfConvertibleInstrumentsTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_ADJEDSvG2kuUnMa9cu4B2A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share options issued and outstanding (in-the-money)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 135,827&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,140,388&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 412,191&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Restricted share awards subject to future vesting&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,292&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,264&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 28,418&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 41,461&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:67.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total potentially dilutive securities &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 253,119&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,188,113&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 440,609&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:DilutiveEffectOfConvertibleInstrumentsTextBlock>
    <aciu:DilutiveEffectOfShareOptionsIssuedAndOutstanding
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Tc_1WCco1uqf0GFoqA8Acw9uw_4_3"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">135827</aciu:DilutiveEffectOfShareOptionsIssuedAndOutstanding>
    <aciu:DilutiveEffectOfShareOptionsIssuedAndOutstanding
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="INF"
      id="Tc_a6MeE9OglE6Dq4sB_2F7uw_4_5"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">1140388</aciu:DilutiveEffectOfShareOptionsIssuedAndOutstanding>
    <aciu:DilutiveEffectOfShareOptionsIssuedAndOutstanding
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="INF"
      id="Tc_GsBwmmyxFk612I-E55EWWw_4_7"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">412191</aciu:DilutiveEffectOfShareOptionsIssuedAndOutstanding>
    <aciu:DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Tc_mzcEHNGT_kqdzS5ML2HVlg_5_3"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">117292</aciu:DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting>
    <aciu:DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="INF"
      id="Tc_Csjpm3-o50GZPSPcSwNMYA_5_5"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">6264</aciu:DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting>
    <aciu:DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="INF"
      id="Tc_KVRCWHEU50O1Vvn2YYP64Q_5_7"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">28418</aciu:DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting>
    <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Tc_Agdtt9RtkEGh2L2lFFeaIA_6_3"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">0</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
    <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="INF"
      id="Tc_OdYb_qblYEmvv3-H3Leg3g_6_5"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">41461</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
    <ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="INF"
      id="Tc_p27p7x0vh0uJ8CjW_0UyMQ_6_7"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">0</ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares>
    <aciu:DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      decimals="INF"
      id="Tc_Xmb9SYSVnkWKF3yN66Q5cQ_7_3"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">253119</aciu:DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares>
    <aciu:DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares
      contextRef="Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA"
      decimals="INF"
      id="Tc_UFdXa1PTdkmTkWDycyHH6w_7_5"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">1188113</aciu:DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares>
    <aciu:DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares
      contextRef="Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w"
      decimals="INF"
      id="Tc_cHL_TpnICkGK6yGgyqgcOw_7_7"
      unitRef="Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg">440609</aciu:DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares>
    <ifrs-full:DisclosureOfFinancialRiskManagementExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_1QdQk0hoTE2R6ogBGrLHsA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;21.&lt;/b&gt;&lt;/span&gt;Financial instruments and risk management&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s activities expose it to the following financial risks: market risk (foreign exchange and interest rate risk), credit risk and liquidity risk. The Company&#x2019;s overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company&#x2019;s financial performance.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table shows the carrying amounts of financial assets and financial liabilities:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Financial assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,808&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,914&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term financial assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 361&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 363&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other current receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 392&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 428&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term financial assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 116,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 82,216&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total financial assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 126,147&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 201,921&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,253&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,340&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade and other payables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 929&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,003&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,417&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 16,736&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 548&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 570&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 13,147&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 21,649&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Foreign exchange risk&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company is exposed to foreign exchange risk arising from currency exposures, primarily with respect to the EUR, USD and to a lesser extent to GBP, DKK and SEK. The currency exposure is not hedged. However, the Company has a policy of matching its cash holdings to the currency structure of its expenses, which means that the Company holds predominately CHF, with lesser balances of EUR and USD (see &#x201c;Note&#160;8. Cash and cash equivalents and short-term financial assets&#x201d;). The Company recognized a gain of CHF 0.5 million and losses of CHF 0.1 million and CHF 0.7 million for the&#160;years ended December&#160;31, 2022, 2021 and 2020, respectively, within &#x201c;Finance result, net.&#x201d;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December&#160;31, 2022, if the CHF had strengthened/weakened by 10% against the EUR and the USD with all other variables held constant, the net loss for the period would have been lower/higher by CHF 0.7 million (2021: CHF 1.7 million), mainly as a result of foreign exchange gains/losses on predominantly EUR/USD denominated cash and cash equivalents and short-term financial assets.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Interest rates&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s CHF cash holdings (inclusive of those held in short-term financial assets) were subject to negative interest rates at certain counterparty thresholds through the first three quarters of 2022. However, with the increase in interest rates, no current CHF cash holdings (inclusive of those held in short-term financial assets) are subject to negative interest rates with our counterparties. As of December&#160;31, 2022 if the interest rates charged by the counterparties had increased/decreased by 10%, the net income for the period would have been higher/lower by less than CHF 0.2 million. Interest income and interest expense are recorded within finance results, net in our consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Credit risk&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company maintains a formal treasury risk and investment management policy to limit counterparty credit risk. As of December&#160;31, 2022, the Company&#x2019;s cash and cash equivalents and short-term financial assets are held with five financial institutions, each with a high credit rating ranging from A+ to BBB assigned by international credit-rating agencies. The maximum amount of credit risk is the carrying amount of the financial assets. Other receivables are fully performing, not past due and not impaired (see &#x201c;Note&#160;8. Cash and cash equivalents and short-term financial assets&#x201d; and &#x201c;Note&#160;10. Other current receivables&#x201d;).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Liquidity risk&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Inherent in the Company&#x2019;s business are various risks and uncertainties, including the high uncertainty that new therapeutic concepts will succeed. AC Immune&#x2019;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;acquire and keep key personnel employed and (iv)&#160;acquire additional capital to support its operations.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s approach of managing liquidity is to ensure sufficient cash to meet its liabilities when due. Therefore, management closely monitors the cash position on rolling forecasts based on expected cash flow to enable the Company to finance its operations for at least 18&#160;months. The Company has CHF 0.9 million in trade and other payables, and CHF 9.4 million in accrued expenses which are due within 12&#160;months from the reporting date. Finally, as it relates to the Company&#x2019;s lease liabilities please see &#x201c;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities&#x201d; for detail of when corresponding lease liabilities are due.&lt;/p&gt;</ifrs-full:DisclosureOfFinancialRiskManagementExplanatory>
    <aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_-KXK7j3-sU6Dk8BJilnTRQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table shows the carrying amounts of financial assets and financial liabilities:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Financial assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,808&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,914&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term financial assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 361&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 363&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other current receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 392&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 428&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term financial assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 116,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 82,216&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total financial assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 126,147&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 201,921&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:18.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,253&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,340&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade and other payables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 929&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 2,003&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 9,417&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 16,736&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 548&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 570&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 13,147&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"&gt; 21,649&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_jyOi4fu8akSFRaaUIvyLtQ"
      decimals="-3"
      id="Tc__XVhnRtqpkySY4HdeJjphg_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2808000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_3Jy3_8RbZUWAnkkvJgLO9w"
      decimals="-3"
      id="Tc_yDK3kwfzLEekTvTZnMqWyQ_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2914000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_Oa3BLbYryUWJpolylXf_QQ"
      decimals="-3"
      id="Tc__wjWzbsFgE6D7mx50VaTXw_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">361000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_tJzQntMdsU6d1iyuTo4P6w"
      decimals="-3"
      id="Tc_jwB6uA_t6UGIFtVSgV9uLw_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">363000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_5zN3E_yoh02M-AfcBPl9vA"
      decimals="-3"
      id="Tc_FYtzZsXCb0SLAsC4MAPXVw_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">392000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_Bl-K4Rg37EyEPpGUWgJdww"
      decimals="-3"
      id="Tc_NcDeslUdEkyDXVV9b3yN7A_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">428000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_C2-Rix-rrUWBxTMIugjLZw"
      decimals="-3"
      id="Tc_h6vzZ-ae5kWDybQG4Y_A_A_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">91000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_DhXQ_kkBwUi5-evVk0nMVg"
      decimals="-3"
      id="Tc_rgb2aUlwbEi3MbOjwQhesg_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">116000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_FcEj2KvmMkOH2QDFyl4MuA"
      decimals="-3"
      id="Tc_wYdSBatQj0GiVLje6ltOEA_9_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">31586000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_4ePuupbrrEqstdW7npGYxg"
      decimals="-3"
      id="Tc_H3yI67VmV02zhr0tXs0_nw_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">82216000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_-eIIzzKDR0CF7BK6DDLmWQ_10_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">126147000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_m8t3f3UkY0GVBV9qnIO1vQ_10_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">201921000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_o6gi3zRMsky95yqQAXrXPA"
      decimals="-3"
      id="Tc_HELm0CoaWkmM-Cr6-gIttw_5_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2253000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_pWcmO-NRyEKwdZu9PbvzLQ"
      decimals="-3"
      id="Tc_I2vLEZM7pUGp-NAClyfRbA_5_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2340000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_Cts4m1NVYEm1s8XilN-05w"
      decimals="-3"
      id="Tc_811PNfDrYUeSxR40zJladA_6_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">929000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_AsEKpSzsIUOKQll1k7zGDw"
      decimals="-3"
      id="Tc_j20ne54LBE2Ap1fo-A_gnA_6_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">2003000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_grbXW83sNUKs9oRc5DlqvA"
      decimals="-3"
      id="Tc_q1hPTHbzrUmYFd0R8kU9Vg_7_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9417000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_BhAuKtG8w0aQWiwhMKyIUA"
      decimals="-3"
      id="Tc_mAGA8771OEipZ7tWrt_xXA_7_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">16736000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_cmRGUa_u70epa2FW1Q5Q3Q"
      decimals="-3"
      id="Tc_oLJiS4A3Hk62ZNPDaSA6qw_8_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">548000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_iojyYGBhoEmu6MX20T28CA"
      decimals="-3"
      id="Tc_9-mkgk6EAU6gHEJNvxxpJg_8_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">570000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg"
      decimals="-3"
      id="Tc_Qirll4KWYEWMJhPGCzZuwQ_9_2"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">13147000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA"
      decimals="-3"
      id="Tc_0m60w6svCEiBBiWWTMFKbA_9_4"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">21649000</ifrs-full:FinancialLiabilities>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_hAdDmGPrWE6JWyIjdtUDJA"
      decimals="-5"
      id="Narr_4er9bB0waEqnUdA3yq-y2g"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">500000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_cPKR_v8WT0anxPEPSrhgGA"
      decimals="-5"
      id="Narr_MtKW5JnfdUmmt5ORT9HZrg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-100000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2020_To_12_31_2020_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_IE1TM485zUWn_r_T4BeXIQ"
      decimals="-5"
      id="Narr_ZRxLZDBp_ECnMpTKgYxnyQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">-700000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <aciu:PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_hAdDmGPrWE6JWyIjdtUDJA"
      decimals="2"
      id="Narr_hRZTvxPKg0mdIWC7Pk5Wdw"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.10</aciu:PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies>
    <aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_hAdDmGPrWE6JWyIjdtUDJA"
      decimals="-5"
      id="Narr_jeOLE6sW_U2mUx8aQiBzLQ"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">700000</aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies>
    <aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_cPKR_v8WT0anxPEPSrhgGA"
      decimals="-5"
      id="Narr_UHVebD-rSkKdE4Gl0c0SUA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">1700000</aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies>
    <aciu:CashAndCashEquivalentsSubjectToNegativeInterestRates
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_uJn6GJFgd0C7AUHONVqWvA"
      decimals="-5"
      id="Narr_CLSfpr8QFk2487tqQrYQlg"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">0</aciu:CashAndCashEquivalentsSubjectToNegativeInterestRates>
    <aciu:PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_Jgm2mZ4FRUuDSrQ2ymoSAg"
      decimals="2"
      id="Narr_dSiY6hDwMkCFv3ZSU4j5Wg"
      unitRef="Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA">0.10</aciu:PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates>
    <aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_v5r8G2UC80OzCevY1QNAVQ"
      decimals="-5"
      id="Narr_aRlRIIuX7Ei-XIPzRk9R3g"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">200000</aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates>
    <aciu:NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_CuCfm2CCOUSB6f8RZI257g"
      decimals="INF"
      id="Narr_yhW1O6JC6k-yTxR1UcngzQ"
      unitRef="Unit_Standard_Institution_SROTVTXUBkGGrhJAF8DeMQ">5</aciu:NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets>
    <aciu:LiquidityManagementRollingForecastPeriod
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember__MJ0ad-Uz0G9j3cZ1MV7Iw"
      id="Narr_3gwVKpT1SkajwQ3sCiyyBw">P18M</aciu:LiquidityManagementRollingForecastPeriod>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_MbfX1IXrrEG58WLwK0Know"
      decimals="-5"
      id="Narr_D5OEfsXeAU29Z1EC9RhWDA"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">900000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_XuWosC4Fe0qG8LleE6GLdg"
      decimals="-5"
      id="Narr_0sAIN8rauUminvTEKfuc9Q"
      unitRef="Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A">9400000</ifrs-full:FinancialLiabilities>
    <ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_aUcBFX7aP0C7T96E9QXCfw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;22.&lt;/b&gt;&lt;/span&gt;Capital risk management&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s objectives when managing capital are to safeguard the Company&#x2019;s ability to continue as a going concern and to preserve the capital on the required statutory level in order to succeed in developing a cure against (i)&#160;AD, (ii)&#160;focused non-Alzheimer&#x2019;s neurodegenerative diseases including NeuroOrphan indications and (iii)&#160;diagnostics.&lt;/p&gt;</ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory
      contextRef="Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g"
      id="Tb_Kad823u_V0qBxqOuNEbDEA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;23.&lt;/b&gt;&lt;/span&gt;Subsequent events&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Management has evaluated subsequent events after the balance sheet date, through the issuance of these consolidated financial statements, for appropriate accounting and disclosures. The Company has determined that there were no other such events that warrant disclosure or recognition in these consolidated financial statements.&lt;/p&gt;</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>161
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
MTCMP5K$.(]Z:!@  2Q\  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6RM
M66%3XS80_2N:=*;3S@"Q92>$*S!CPJ67.0@IX;BY=OI!V$KBP;9222;07]^U
M'4>!.BMS[1>P'>OY:26]MRN=KH5\5$O.-7E.DTR==99:KSYTNRI<\I2I(['B
M&?PR%S)E&F[EHJM6DK.H;)0F7>HX_6[*XJQS?EH^F\KS4Y'K),[X5!*5IRF3
M+Q<\$>NSCMNI']S&BZ4N'G3/3U=LP6=<?UE-)=QUMRA1G/),Q2(CDL_/.H'[
MX<(?% W*-^YCOE8[UZ3HRH,0C\7-.#KK. 4CGO!0%Q ,_CWQ(4^2 @EX_+4!
M[6R_633<O:[11V7GH3,/3/&A2+[&D5Z>=08=$O$YRQ-]*]:?^*9#O0(O%(DJ
M_Y)U]:[O=TB8*RW236-@D,99]9\];P*QVV"PIP'=-* E[^I#)<M+IMGYJ11K
M(HNW :VX*+M:M@9R<5:,RDQ+^#6&=OK\4H0Y!%D3ED7D8Z9C_4+&637:$+73
MKH:/%*]VPPW@105(]P"ZE%R+3"\5H$4\>@W0!79;BK2F>$%1Q$L>'A'//2#4
MH92H)9-<(;#>MN=>">OM@=UT-H@BP%-<D3^NX TRUCQ5?S;UNX+SF^&*U?-!
MK5C(SSJP/!273[QS_N,/;M_Y!2'K;\GZ&+H9IKN7%6\BAS>GSN$(8=';LNBA
M,)N0W?)%K+1D0&?"TD8Z.$XP)./KZR^3CV06(+3Z6UK]=L&IB97K?:89#"4\
M;N*' \Y9HCA"['A+[+A-O(9 0K($UE7$G\EG_M+$"$=R',?M]]P^[2&T!EM:
M@W;QFG(9BV+91P3$HW$@+4CUTBS7)D+M9$OMI!VU4:Q""-F&X0@>JR9Z.-KH
M&T+)=8Q$.N\B]8TSN9^2!<P2*'='N%U\$0&EJ**5L$4C$QS -LM=:JA0%&F8
M2_DV/MBDLL ='KKTT',Q:D;D7526S=@%698#MUN^$K)1$BQ 6N9HL(R2NVVE
M'!14Q:56(:QP,.L8&FEW<4W>TIHM(44B0Y&N6/:",</QK,R,NKNX&F]4=!0G
MG$SR]('+1CHX".CGH7<\.$%GE=%UMY6PC[-02(A/:3@'E>,0(2%X.2@^"+^(
MFN<_CGX_P$@:E7=Q<7Z=X!S4%Z1,<VZR9F86R.GHBHPGDYO[X&Y\,R'3X/8S
MQM7(OHLK-<KU;BT:N>*0%WF<1'&V(!=8#FI,@.*Z_9;A5"@->O)[O-H[S!9$
MUW$Q-Z?&"2@NY&^I#8L[F(9W8MV8P%O@KEBN6/9V?KSF9JR!XEK^+V[5TFBD
M93&93Q@A8P@4U_&[6(..B#EQZ4\//Y,9#W,)#!L)X4@@D6F19Y8%R0')!)1G
M,".>6))S,OPT(LZ10\F*RZIFP=@;\Z"XWH-GE'-Z]I(^B*21- X0#,=?,";&
M+RBN[W7@R,?G<,FR!=];"UB )L'L,O@-XV2<@K9RBGI@M @?#S;C0VYR#0LV
M*Z+72+)"[I7(Q5;&T_G ZU/'Z_NGW:<F5L8L:"NS^ JV>OB8P9J$2<>4R'A$
MQDKES79FP9P(+&#&(F@KB[@7":Q*)BN3E8UIK04))V1\@+;R@3JAK+*/<L*#
MMS;GVQ;$;_AF@=%_KY7^CS/-9;655*2WK*;:N&& (UJ8&?GW6LE_.71D""G(
M0C0+K 4G"$,.$  056 8.V, 7BL#^)ARN2@&\E= T,LZOVRDB0/:$DMO9P,(
M%_#Q<'1+@CR*-9AEH#4'@2C3\7T%E07/4B)X1N6]EB4"#$GAEYL%D$5,1HV\
M<+ARSF9EU\"?1N!261AO:Z%=<'1"&FOP6FT3O2HD&FG_MPK",[[@X;Y0C_$H
MEBD97S9RP1%<KX<EY9XQ P\7[IK*/K.T-)_*..1K6*)R*?)B+UI ?J'P;33/
MV(&'BWA-[DJ$>W=_+1!U\@B^NX[UWUPF,+,P<L8:/%L^K^ )U 1# 5X5:O+'
M-2^*P>:]6A3K>S=KC5GXSO^[M^RC5O&]?(V%^.^K(-J4BC;(]Y6*OC$4_WT5
M19M2T0+9JE3TC:_XN ]\1ZEH0;24BO[.,0)N!>\M%2UP+4I%W]B&W\HVVI2*
M%B2T5/2-;?BXZ-=",P6)%=#+9*]J6X""#+K$R'3.XSF:5OG&1WS<",J!"PK4
MO5,*!_"QG3#?6(9OT7M1;M,OH9Q!-N<L(-0EGM\C)RZAC:RZ.^>;11Y9GN(J
M4N9&U5'G]NGVI#BHSD?-Z]4Q\S4KTE!%$CZ'IL[1,<PD69W<5C=:K,K3T@>A
MM4C+RR5G$9?%"_#[7 A=WQ0?V)Z?G_\#4$L#!!0    ( -([<%8[*GXUR04
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M$F>DL;>CJW)NROI>\[+AW87K5#:JW2H[MMCH'5P\8VQ>LHPA2&52O#/,V-5
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MLI5&PJ75D;8,Z>\$D1G]/38Z@%H0.[<''O955;2WQP*IE+*<=_W8E1STUI7
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M=<:5=]08%<5Q$FJA0^YP,D-C#;JT"64!6\8U9+%BMLS47.@<%1"Z?5J5U@4
M"4FRJ-%;"#OU?BQ'W%E1E"XL66Z]*[A,-2?W@KAF='>4P:?I=)=4" X%(L62
ME *WD<%FK</"F0*!]>FJ^\:6U2IPH"PZHQ TTI:[LDL4DIBRA'M32,E5&UB
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M)3@=-W A5R2"V+)P\6D)+<5PX18,)_+F03 =3T2O3F2%D2(N!/FEF \]C:1
M\G<"O]WQIT<>AOS=?7>:QFYDYTZ:U.>[>[70;$E//CU6^3NG!H,D'XDSNJB
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M]'S=DBK1/[" _Y7$[_\/4$L#!!0    ( -([<%9@:*TX1P4  ,00   9
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M L?#%P3R1B"/=B=%T<H///#QJ;/WS!$WHM%'=#5*HW'24%)N@T.J1+DPGIK
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M+30:G1P%H/LQTAND&M^Z"T5V$/AM:2<O:A=@SY=*T<9P%PRS//L#4$L#!!0
M   ( -([<%:@X*8\W H  %(>   9    >&PO=V]R:W-H965T<R]S:&5E=#$W
M+GAM;,59:W/;-A;]*QAUIF//L#(?>CE./.,X39M.'VF=;C]#%"1A0Q(L -K1
M_OH]%R!!4K:5=*<[_6"9!(&+^SCWW ORY8/2'\U>",L^E45E7DWVUM8O+BY,
MOA<E-U-5BPI/MDJ7W.)6[RY,K07?N$5E<9'&\>*BY+*:7+]T8^_U]4O5V$)6
MXKUFIBE+K@^O1:$>7DV223?PF]SM+0U<7+^L^4[<"?M[_5[C[B)(V<A25$:J
MBFFQ?36Y25Z\GM%\-^%?4CR8P34C2]9*?:2;=YM7DY@4$H7(+4G@^'<O;D51
MD""H\6<K<Q*VI(7#ZT[Z6V<[;%ES(VY5\8?<V/VKR6K"-F++F\+^IAZ^%ZT]
M<Y*7J\*X7_;@YR:S"<L;8U79+H8&I:S\?_ZI]<-@P2I^9D':+DB=WGXCI^4;
M;OGU2ZT>F*;9D$87SE2W&LK)BH)R9S6>2JRSUW=[K@7+>2TM+UY>6(BD!Q=Y
MN_RU7YX^LSQ)V4^JLGO#OJTV8C,6< %=@D)II]#K]*3$-R*?LBR)6!JGZ0EY
M63 P<_*R_]5 OWSV]'+*B1>FYKEX-0'HC=#W8G+]]5?)(KXZH=PL*#<[)?WS
MRIU>GB13=F.8VC)X391KH8/G&*\V=(%;NQ=,&M.(#3/#_1@O55-9#%O%;K]_
MRY)H>;F(%LNY6]R-S*(XR2(DH*F%2Z'B$+D)TK!<E;4RD  5D/'&8EQ6.QHO
MD7)N.Z??*HL6:1QEBYE;BMO9\O(YP1;L8AI]&*Q?1&D"1=+$3< =#%LDR_'J
M*?L 4RU?%X*MB6Y:JI'_@1#RPBW4Y=7AZZ]6:;*\,L$1QNHFMXT6+Q@]B[.K
M?_S_N\H%P.Y58V"R"0]NO6L_=#[R$/*_8?!86NO(9VX[-W3W 'HIF_)X^C'&
M8K9<1)?9(EIF*W8VC^(XIK]SH&:.D6RVB%:7,3M+:.R]5KD0L&.K5<D,1X@0
MUN-(RXK5S;J0.1YNA0:43,0JE";,;4 P^D%+2P#;"LSV6.&5X9[A<V6LMRI)
MKZ!%LH0FLZP?2:/X<LG2&9+&0&C=Z'P/1F=\IX5 I;%AL\=BEU$2PZ!9W(N;
MI6P^B[)T%89N574OM"M8$%(I.Y!M3@CO/)T!XLC ;!8D+A*68&356_$.J<RK
MW/EO$,@DN8+[<FR$7&!U@2V^8,,T6T;IO#=@#K>E\Y.;@2S6@NU%L6'<'$?P
MQ)9IE%UF$8B3G87+<S;K]SZ;K<X?@2QAJ\MH"60M,BP,B7_NJ8G-,M(W <C2
MV3\!LLZ/RVA^N1BEW?#I&0SKKN._)X!)ED7+^?S9+;-PM8H?37I<+>#D508L
MK^;.R9YKO9.7SLE9FK5.[H01UXYY_BGNWG,84RET+B"8>UXTGL^)V^)IG+(:
M6KBIJ&1%,5JU%J)BVZ8H#JSF<N/8'<GZ: ="XOHP)'A&9(CL@W[H'A%1JE"#
M\M3I^TSI5-HA#QHUX%\J'YO D1^>*".O%=>N!+Z1&K5(:4.UD?>+D3*(+.DM
MG)JC,AP1(%4E:%LC0!^N((D:T4=UE@7[H<'#=.:4PR],Y=0!RA(4[4MXY]&9
M9V":0@6?3.VG8DX:=R2-NKF3V$5W38%!WVGWF%YS[>,T"I/@^3YJ4[\/"6MJ
M.*GJC2.H'MO'SN0Y:50*8)AF\"HD7I]O%K%VEFV!E"J76"<K8Z5M"/3H"Y@Y
M('@YM\Y1'-'=(V9V+^%ZZ&P/--S?2N*BK2K0!0@'CVY7,H)TQ%_UC?@$)P1$
M[%4!;4QG10 38'TF8001!XD.K1.VP$+ EA?&N09H+N%YB0YD2L5@(TE[7AQY
M!&<IME94U4FVD:4LX/6-6%MGM&Y<O7@2:V-!)3_0MIW_-T?@V*'V[,AC8Y@D
M+0;L7JMFMP\-8D=*(\S,GX=,!'<<7+<E?:)&#B<=DD99_W321R,=Q">A<^EA
ME/>5%#ZZ@,-4[>@/5P]<@P\MTW3B,FQ'-U!*$C=657O<<TIX)U-BM3X>N#?J
MFF*E6V"W]T=<0K$"V31K,(E$,RF. 4()G!=-V_B2VI8 \"B>GT.$*.M"'001
M7R6VTOH:\']# 5K]4R @^BR5ID1!ZLRB58N"$>7_'0AHW3T,O@^UZ0(,#>R@
M)'3Q1M ZET$1HGJ<Q+F+;.D8/01JW1'TIB/HB,+J*02J&!A4:W4O?77 (4_F
MOM,Y @+O<8#3QAU*S[9-"\T=ZE!BK.OVV"\5NZDUZ#M=18.#6"=L*PN8P%L9
MOPUEW 49N*%7#^SM-RB^F#-E/RL<CK/LFW0^GR\7Y^R,9!(LTOCJE"@W);DZ
M]Y&A17??WOKSTDD-'E C-R)'ZD!; ?YT1ZTN9I!!.OX$_,VCMF9^5B0G3AZ=
MQ\C1GIL='0J"D>O@K"R%BP+^HQK6=/W[W1N6S?M"YKAB!$F7=T;D#;5Q--#R
M!:&UZ_B!%FB66U=DI2-R!#;7TI-,"SQ7: XD?PT<V[:M)\V1KV*G""U]\7;9
MLFWH'/FHP6R/IB@/;0D\=#-#*7Q0#34RQ!LT#T=]X,/Z6D5^:'<.\\E780VT
M_S=B0P["@?>C<*V/YQI?9'A- $<NCMGM1 ]#E?W0;T?-:O II-^[0M !X22&
M)"HD="SY!NI7Z!U&W0#KRC\4=&?YQFL\N#5-71<M>OJNBB;Y-!K;!,6]VUI/
MB#\;:0>6X&C]:^8.L!&[N67ORI(:K);\^W(W[FT_QVA V5Z"^=8BY^6C)G4Z
M9''?+0A#+RJDV3M+NASF(\V#RO %6*]LLYB=M;-O/OP4$GOKVA\13CU]MJR@
M'SLC19>S*3@#E;!P%5)IV.3>W.@C:UMG/$I"\C2BX)62%4:A^B^U( YP&M_1
M[C?=D3<H2L.F'Q^ST0_"F8D)/_YX&Y:$T3"9FV @$+(C^:Y]I*952YC_#!,/
M6=0'27RJI?8=PZ]IRUOOPO731%V)AR_9P.4:O6S._?HV>D\@F8A#;WQ#J@6)
M!P\QA+2+]E.@J7S_Y5U/"8DL/QF 07V@+;XP$)!.#"FKQA]81EJY_'FJIK6H
MZ0_Z?RV%3K]9(&_X3N71@6VL!?B=&73R[@70991DET=ZU%K<2]48$-$S>U&=
MH$[(=BW $ZZ+F.;24'@IQY)LFOD<2])I$G+LK[Y7F+(_A.]TW/&*]*;C!)$X
M-!G&!WU?MW<\G?FM<=%GMWW>6T05OH/L&C[W4H0PJS>N_W.A(EH8!![*O6TY
MYB XFBM!;_R?DI]V[VD]QQX'!]DG*FI30[OI7VE0TRE1^O$37D#'TWGOR_&;
M8EDYR=3WJ4)N.+6$(2>=-#3$JA079X4RYGS:OISSO?GXU1P]0FE#%EJ (K1(
M_BWA^ZYG&(1^:-(H)^V#0E;BE$C]]G##GVG#(*%-!GK7X\HIWX)FI#/!/Z F
M&A;<H-@9=N<;4O9=N?[>>>:MU 9*M^W_>YQ)*P2 'J.=5I[46Z8+.VCQZ)![
M@UVU1%R_I>V>U[;MC:D@'!49,%U3N;: G-^L@1]JE'#S2-K1H=J3034XG8##
M<>ZOP^&:5KC42H$!GUK)=-D#W.E">>!RK.Y>_;6KTG9-FDWG88WCKIZW!EX/
M?NJ.(1N:(74XBGA&))/:!ST83VI)0#/N*PVG)3BAM)[P36A[QD7_F43S)(NR
M9-FRU5-?ERX&W_E*H7?N:R8U8W"7_^071L,'TQO_G;"?[K^VHESL<#9EA=AB
M:3Q=SB>^Z^UNK*K=5T/@R:K27>X%.CA-$_!\JV!9>T,;A,_(U_\%4$L#!!0
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M&0S*8B]#6M3YK/,>B@WJFQ0E2@0!S&1.:[UD/!8!9Y.Z^(F\@G,(>%>.*]W
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M:PMT_CT]+?CP]-0YE='9<2NOEAN\USD?38_[>P!B-QO'^5SGS]#"#ZDI4RJ
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MR37L#/L>J+JCUX*1E>NB*VFH)[MI1H\@*FM ZZF4YB#8#9IG=?X34$L#!!0
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M2]Z[7EL I:?4P%Y'KSM#^F%=O8.W-*?_SO,"HA5B3ZW=ALF5LJJM]SNKW8?
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M2J%E 3I?&TI>NV #W<_9\A]02P,$%     @ TCMP5KX"+CMU!   1 L  !D
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MFHI,$WA*H30$GX]&%L'5@TB28=%V2#;;_4G8GP3DD]2]^)#![=W#66?QI2I
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MWF[:S5J1_PMO1^65</Q*GN]FQ:G]WBD/%]>.G]8@6T?)+RWQ (G;DB<VNA#
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MU&3ZZ2P",TR/P7#4AH[=D>/^#]N:!RX:'\#G)9$[&/Z"<81G?P!02P,$%
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M_W<1.U'<<N6;JCAO@+Y0SBY*%% F!12X2;0?6)B(Z^TBV)-%9 D>19!8O)X
M)WUFQ\_Q-UUTF#%P>7H^P(\VJ\B*DF:O^A/7R%[3]9U+.:PT!]@'L7+387?:
MD9FC8 8AQITFNWA$J0LM*Z&E2@8*#G^YKF:U@$7M:> I9$'18HK<@VK<D'9N
MH6JT7$4FTE33UE/IHS!H(!6(&-%6(<D,6LL^C*H5XP@U)UQ!4?Q(V\1S>_K\
M3JJ1U9);9C^U]]#&"PD#\'8((B<B-3^8*,7/20X23OSE4SD#Q.+1X5-991V"
M,_GYZ5M1X[!RV$Q5)SET8S]U4M%;6UMP%0(VZDA)9S?Q%$/6T^(<6J KGBT5
MN98A;JD1]CA&;YG2T,L439K4(BO-$C:[42-0R!";]XY:8Z[:L\#!47RD,7YO
M6OGP*VY.2I.LT.-@FWV45-="+R[KIXW4.I9H@)VA<ZN:JX .:X_I1(%#U!NR
M8* TAK(H3%ST&,%:9<IY2UO'1%, +:E>-V1S<42NM;_WB$;0_Q//G16:AD[J
MB@0=N$/!0%UD&7=82/,:.Q[JP05WT) 5S_+P@3Y/X=-*+1]A.O! 8Q(]"/3_
M5TR2$ 5=2LM]R0<7/RE ,H?.BC6DPB*)G6:D2M@]1)QMPO-OYK/7)\6 T91W
M:I3R41HWS4B$^7UT(SP7+\;;F7MOW0U6#_+P(-/Y2;;/!X<_+K/7"$TI&UAA
M;^BR(%-RR*N:E<]DW-/B%&C2.T>._)#%19C32"I^7W]$?7(T "<45FJ'(S2]
M'[(U'4EUF"=6S^842!@>\/E0)0F-=!($Z,E7_.AR%V=R,;Y_\K3NB9KGN8M0
M@GW[*)L5Q?M8,4 0Z+B&CU10COR[1CM0F7UDE)X5U)E[J&)YG_1*:LV&=3=&
M7*5U62I:$;,\_P!_F2TH%=E[K0+RGN%I1$4)'TOR]%)G1->D(P,C\R(>B!+*
MPWX]>6%1SY>11M0[-6=J?/[\M9MC/4VSEF%NCM^YCBQ9'&^* GQ'XHQA(F>D
M-\TRG]15XG&IYT4*7C:7W7($M'S,+8QRR'W=N[8_M^PSQW,SO OH:Z/N-%EB
M\^&2Z3ZHA'$ZO-8([O!0<<"4(09Z@BCF1PB?HD: 5E0=:B;/M@]UUT0LISX^
M2!PG@S]OVU%XKQEYZB3?>X#.EURD171<+JTE;W"CN9+M2+9^.NWBCDO9XE1\
MT'J?!\.K(2Z@3;$H.E"&";">LEB2!R*4FI')8A'K3_?W-3Y]O-2+@+< A9$4
MB:E<C.>4N(CIAK9XI^6"GE:B.24'H]*CYY7O7UQZ(^#JT>437?*WG:_/>47W
MU;">><VF0:<C5N)BW>_KO'AW?E.0YXOKXI?/,1P$#VS;TM79V4%S]M?'A88Z
MPCR=O>J#F:MK1=8HYEIL'0^J8Z5B[9">&.Y:.!*^!C(0"9<KRLWW"1JMG4R*
MG[T'&!I7#RI*5;D>AJ<TBL4:=[XH*1JF$@70V$402NZ3@-V9C-'4)-O#T&@$
M>W9;C=LPEB ^CI6?2LNC+X0]%#_0)W1M3,2\+%R6WM<Y15TA<36M"9=8B!5)
M%-&JH./R6TA=AL<7#L"DCM5 2$E8U/$\]IM%;"<S=W3^%?=K1OM+[Z0:&\=7
MLGR-J D&-D(/&V:MS?N( TWGD1VS73+7>>UUT+I\?'N!#:6FQS0#/PDX(PA#
MUN28#DI>#DR[1MR[] 7>?[BXAH.E*L\E$H&()0.H!W1Y2(?:!*DOX/534?&K
M,''AZO1TA-=^YLM<0.NC7\ZB'R>FSW2PAP6,U&'DICSM'($6DF1-ZBG&YMP.
M_HQ:GS+>7*K(.'.D-2OLE8*P1)FA?7C@F@%A2>*+PL4=4YJRXQH!4+PPO ?!
ME Q1777 K'PK8L.088SU4%I\\G)"4^G5Z?;/M_G[HX-I/_+5S$;4AAGJI[Y4
M(3:C.W?0JC)?XZ\E%19\YN[>RL\J' R2?"3.Z*(\-V Q^[7DW^K\OO?>##38
MJ&*5P8YFRDCK?+!5&FGNEJE%"":I.:$?+.P 83B8M5E/\]8L*<B[XB;^]6@S
MCKU1$[+K@*;;*Q'&!!Z9Y>;^LD=$B #UR$V@$-:&.M+AJMZFCL8R);@Y-E 0
MXP>V" AU^^2+(<P1,V3=YCI<\%B)@Q@I53>M?A0Z"*G&:)R:C2R<Q>7D/"<J
M*Z9$%<A@UO9DO]?L0AYOXR6*+[2*9Q>G> M3'!=1!Y'?\2RFO(=1<$V&K'^
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M,<)!7&3^&T2PS\R"XE[$&1=.LOI657O#)P@M[HS?[O5;P\[M.ZQ"[,@\TG&
M..#U#D*R).FJFBL&9@#37)T\[FFTQ M\S\PV7".BPVM7^B%F<KG"RL@L4B&+
MFK>N/<3J;AUQQ^]AP.DC/,1)O?N,9_5//.].?9$0U/7U+#*#*'J889?Z%HZ
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MIR7]2*!V G2>*V5W"^>@_S69_P902P,$%     @ TCMP5N:1]1Z5!   ) \
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ML9BC:H[745 G/ =+'70O_KJ]=,@?9_>8;@5,;[Z33EEI(M2-E9-@Z>'S)"&
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M  5N2,W,@]S=XCZ?ON/+)=/^"[O&-^T'D-?:2+X'6P6<BF8EK_MW. *,H@\
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MN]#DZ/0X M,MADXAW81AG&ERHQV.E=NE:+R#NY]K36O%)^BW<_X'4$L#!!0
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M?)N!=@QXOE/8?</&*9A>>^O_ 5!+ P04    " #2.W!6/7>R2)H"  "4!@
M&0   'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6RM55%/VS 0_BNG(*%-BDCB
MM*6%-A*%(7A 0\"V9S>Y-A%.G-D.A7_/V4E#-V@U;7N)?>>[[[Z[B\_3M52/
M.D<T\%R*2L^\W)CZ) ATFF/)]9&LL:*3I50E-R2J5:!KA3QS3J4(6!B.@I(7
ME9=,G>Y6)5/9&%%4>*M -V7)U<L<A5S/O,C;*.Z*56ZL(DBF-5_A/9IO]:TB
M*>A1LJ+$2A>R H7+F7<6G<P'UMX9?"]PK;?V8#-92/EHA>MLYH66$ I,C47@
MM#SA.0IA@8C&SP[3ZT-:Q^W]!OW2Y4ZY++C&<RE^%)G)9][8@PR7O!'F3JZO
ML,MG:/%2*;3[PKJU'9)QVF@CR\Z9&)1%U:[\N:O#EL,XW.' .@?F>+>!',L+
M;G@R57(-REH3FMVX5)TWD2LJVY1[H^BT(#^3/"B>(? J VER5%#S%[X0J)V*
MIZEJ, -\IG] D_+3@SO\/ T,Q;8(0=K%F;=QV(XX$8,;69E<PY<JP^Q7@(!(
M]\S9AOF<[46\P/0(XL@'%C*V!R_N*Q$[O/A_5.*C K3P@X_A[>4ZT35/<>;1
M[=&HGM!+#@^B47BZA_R@)S_8AY[<TV7-&H$@EV#^-9']H0X/QBR,3^%OUS-M
M2?ZNI6YBN2"VMJ/7%9Q?78+)9:.)M.ZM;*NWA0AV=FW")L#\,(SA01HN=E?E
MS?"/,^AJ:-O(59H[U R?:,+5-*\,I%(;#4,_'H40A;1$O0^%55*(MRO%_/%D
M#+$_'#'XZIB]NW61'PTMQW&T2>:=R<0?1,<0C?SC>+3A^=%O%6Q-BA+5RLU#
M382;RK1#H]?V(_>LG31OYNV\ON%J550:!"[)-3PZ'GJ@VAG8"D;6;NXLI*$I
MYK8Y/1NHK &=+Z4T&\$&Z!^BY!502P,$%     @ TCMP5HGMLK]R P  APD
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MSU/:ZZI[=70=(U?M33^7AMX-[6])#S54UH#F%U*:7<<&&)Y^LW\!4$L#!!0
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M80"Z:<N-857M6^%&66JL?EK02X;:.=!^KI1],%R ]FU<_@102P,$%     @
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MQ)_[0NT,Q?L-$4L6IN$YG$V0!@;T#4R6SY\%B7]R &8\P(P/61_!9'"+S#.
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M)?['<R(J@".PG7'2F.]*R1(!"63RGF#ZF&3C:W_<<+*2!9BLJ-;$(!:(YL
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M6C&%^$,J%2Q=;(3A"/S77*3EX@3]\E-,L7?ZOZ]_;/(;+E"YW)NID$G$[ID
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M_EK1AD7M',B^4,KN!)>@V]GY'U!+ P04    " #2.W!6+?LJ*,H#  "B"0
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M,@[H+O,=JIM8M?-=8:TL]1@_+*FIHW8&M+]1RAXG+D#_-V'Q'5!+ P04
M" #2.W!6.*<]I^\!   1!   &0   'AL+W=O<FMS:&5E=',O<VAE970U,"YX
M;6R-E-N.TS 0AE_%,A(""=4Y["Y0DDAT*PX7H&I7P+6;3A)K?0CVM-F^_=I.
M&A6IN^*F\=CS?_[''K<8C'UP'0"21R6U*VF'V"\9<W4'BKN%Z4'[E<98Q=&'
MMF6NM\!W4:0DRY+DABDN-*V*.+>Q56'V*(6&C25NKQ2WQQ5(,Y0TI:>).]%V
M&"985?2\A7O 7_W&^HC-E)U0H)TPFEAH2OHY7:[RD!\3?@L8W-F8A$JVQCR$
MX/NNI$DP!!)J# 3N/P>X!2D#R-OX.S'IO&40GH]/]"^Q=E_+ECNX-?*/V&%7
MT@^4[*#A>XEW9O@&4SW7@5<;Z>(O&<;<JYR2>N_0J$GL'2BAQR]_G,[A3)!^
M?$:038(L^AXWBB[7''E56#,0&[(]+0QBJ5'MS0D=+N4>K5\57H?55]!@N21"
MCQ<<3NK-&I +Z=X6#/T6(9'5$VXUXK)G<&NH%R1/WY$LR3(B$-2_#.;MS1ZS
MV6,6H?G_>[SD;(1<78:$YEZZGM=04M^]#NP!:/7Z57J3?'K!8CY;S%^B5S_W
M:@N6F(;TUO16^ .T1X)0=]I(TQY)+SD&]^Z2\Y%]'=GA%1VJK&"'<SOL[(;#
M8_G!;2NT(Q(:KTD6[[W8C@TX!FCZ>.E;@[Z%XK#S;Q9L2/#KC3%X"D(?S?\"
MU1-02P,$%     @ TCMP5D84*>V< @  ( @  !D   !X;"]W;W)K<VAE971S
M+W-H965T-3$N>&ULK5;);MLP%/P50@7:!&BBU8Z=R@(2RTEZ*!#$70Y%#[3\
M9!&A2)6D[>3O2U**X$4.7, 7B<O,D/.>^*AXS<6S+  4>BDIDR.G4*JZ=EV9
M%5!B><DK8'HFYZ+$2G?%PI65 #RWI)*Z@>?UW1(3YB2Q'7L42<R7BA(&CP+)
M95EB\7H+E*]'CN^\#3R11:',@)O$%5[ %-2/ZE'HGMNJS$D)3!+.D(!\Y-SX
MUY/(X"W@)X&UW&@CXV3&^;/I?)V/',]L""ADRBA@_5K!&"@U0GH;?QM-IUW2
M$#?;;^IWUKOV,L,2QIS^(G-5C)R!@^:0XR553WS] (V?GM'+.)7VB=8U]JKO
MH&PI%2\;LMY!25C]QB]-'#8(?G2 $#2$X%A"V!#"8PE10XB.)?0:@K7NUMYM
MX%*L<!(+OD;"H+6::=CH6[:.%V'F.YDJH6>)YJGD%DLB$<^1_LHJ++#-W@6Z
MYX0M4,99!H*ALQ04)E2>ZYGQPQTZF]Z)<Z0?B##TO>!+B=E<QJ[2&S*R;M8L
M?ELO'AQ8/(7L$H7^9Q1X0=!!'Q]/]SOHZ?%TKX,^.9KN#[?IKDY"FXF@S41@
M]<(#>MLA_WTSDTKH8_2G*ZRU4M2M9$K+M:QP!B-'9U6"6(&3?/S@][TO74$^
MI5AZ2K')B<2VTA&VZ0C?4T_&O*PP>_TD489E@2HNB3D;7=FHA?I6R-3E51+Z
MO4$_=E>;8=Y'#8+ WT&E^RCM9S ,MV&3#M@P[ VN6MB6YZCU'+WK>5IPH2X4
MB!+EA&&6$4P1EA)4Y^&.]C8Q]#W/V_&]C_*UI5U8^N[._O?#.9%8'41WH[J:
MN_,;%@O")**0:WGO\DI79%'?1W5'\<H6W!E7NGS;9J&O<! &H.=SSM5;Q]3P
M]J<@^0=02P,$%     @ TCMP5NH0H>Z2 @  H 8  !D   !X;"]W;W)K<VAE
M971S+W-H965T-3(N>&ULK55=;]HP%/TK5]DT;5)'OH"U'40JL*I[J%05=7V8
M]F"2F\2J8V>V@?;?SW9"1E&@>Q@/Q';N.3[G)CZ9;(5\4B6BAN>*<37U2JWK
M2]]7:8D540-1(S=W<B$KHLU4%KZJ)9+,@2KF1T$P]BM"N9=,W-J=3"9BK1GE
M>"=!K:N*R)<9,K&=>J&W6[BG1:GM@I],:E+@$O5#?2?-S.]8,EHA5U1PD)A/
MO:OP<CZR]:[@!\6MVAN#=;(2XLE.OF=3+[""D&&J+0,QEPW.D3%+9&3\;CF]
M;DL+W!_OV*^==^-E113.!7NDF2ZGWKD'&>9DS?2]V-Y@Z\<)3 53[A^V;6W@
M0;I66E0MV"BH*&^NY+GMPQX@'!\!1"T@.@0,CP#B%A [HXTR9VM!-$DF4FQ!
MVFK#9@>N-PYMW%!NG^)22W.7&IQ.ELW3 Y&#H@6G.4T)UZ:[J5AS37D!M6 T
MI:C@,URON6L^84!X9AYB+:2K2==2(D]?X.,"-:%,?3+5RVL)/KR?^-KHM+OY
M::MIUFB*CF@*([@57)<*OO$,L]<$OC'8N8QV+F?12<8%I@.(PS.(@BCJ$33_
M=WAX0D[<-3UV?/$1OK?[^/-JI;0T[_BOOO8U[,-^=GON+U5-4IQZYF KE!OT
MD@_OPG'PM<_Z?R)[U8AAUXCA*?9DSH2ROB71> 8/RP6$?7X;DG-'8F-IDP2#
MBS@.]GX&M]EWU0N)XJ[JE=Q1)W=T4NZC"P7,@&Q0FHP#?$Y+PLW@#0.C/C7C
MT8'FWJKHXD"SOW?8*Y2%RT %[KPV)Z);[6+VRJ7+P?K,Q&^3EG]IFNR^);*@
M7 '#W% &@R]&F6SRL)EH4;M(60EM LH-2_,)06D+S/U<"+V;V VZCU+R!U!+
M P04    " #2.W!6%%7SSJ0"  !U"0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970U,RYX;6RUEEM/VS 4Q[^*E4G3)@&Y] 9=&XD"$SR@(=CE8=J#FYPD%KX$
MVZ'P[6<[:>BDUDR(OB2^G;]_YQS9Q[.5D/>J M#HB5&NYD&E=3T-0Y55P+ Z
M$C5P,U,(R; V75F&JI: <V?$:)A$T3ADF/ @G;FQ&YG.1*,IX7 CD6H8P_)Y
M 52LYD$<K =N25EI.Q"FLQJ7< ?Z1WTC32_L57+"@"LB.))0S(/3>+J(G8%;
M\9/ 2FVTD75E*<2][5SE\R"R1$ ATU8"F]\CG &E5LEP/'2B0;^G-=QLK]6_
M.N>-,TNLX$S07R37U3PX#E .!6ZHOA6K2^@<&EF]3%#EOFC5K8T"E#5*"]89
M&P)&>/O'3UT@-@SB\0Z#I#-(''>[D:,\QQJG,RE62-K51LTVG*O.VL 1;K-R
MIZ69)<9.IW=M-I HD"(E)P7),-<F6)EHN":\1+6@)".@#I!+V:$H#AL%""L%
M6B',<T3!A 51@I>$$FV6HD_GH#&AZO,LU ;2;A5F'="B!4IV ,4)NA9<5PI=
M\!SR?P5"XUWO8K)V<9%X%<\A.T*#^  E49)X] 9]R 9.;[A#;]$0FIO(*/3[
M&M@2Y)]M7GHU[%F;JAIG, _,85(@'R%(/WZ(Q]$7#^&P)QPZ]<$.PO].U'0;
M^7 /Y*.>?.2-[872Q!PU6+-JD&P;HU]EA)X!2^7A&?<\8Z_2M\(<"$ 7#PVI
MS5VDO2GW2KTQ<),>=++'E$_V0'[<DQ^_2\K]*J^G_*3G.?$J77U_2?<V#J_U
M&V,51R_7=;3'/'?B[PR_46OB=TGU*S*>7(<;E9"!+%V]5\@5L[8H]J/]F^*T
MK:0OR]L'R366)>'*H!;&-#J:F#M'MC6^[6A1N[JZ%-I4:=>LS+L(I%U@Y@LA
M]+IC-^A?6NE?4$L#!!0    ( -([<%9N).%.L (  %D)   9    >&PO=V]R
M:W-H965T<R]S:&5E=#4T+GAM;+666T_;,!3'O\I1)DV;A,BE-V!M) I,0QI2
M!;L\3'MPDY/&PK&#[5#X]K.=-'12:R147A+?SM^_<T[BX^E:R'M5(FIXJAA7
MLZ#4NCX+0Y656!%U+&KD9J80LB+:=.4J5+5$DCNCBH5)%(W#BE >I%,WMI#I
M5#2:48X+":JI*B*?Y\C$>A;$P6;@EJY*;0?"=%J3%=ZA_EDOI.F%O4I.*^2*
M"@X2BUEP'I_-8V?@5ORBN%9;;;"N+(6XMYWK?!9$E@@99MI*$/-ZQ MDS"H9
MCH=.-.CWM(;;[8WZ5^>\<69)%%X(]IOFNIP%)P'D6)"&Z5NQ_H:=0R.KEPFF
MW!/6W=HH@*Q16E2=L2&H*&_?Y*D+Q)9!/-YCD'0&B>-N-W*4ET23="K%&J1=
M;=1LP[GJK T<Y38K=UJ:66KL='K79@-$ 8JN."UH1K@VP<I$PS7E*Z@%HQE%
M=00+:3X&J9^/H&9N$<\!'QI:FRQI^'2)FE"F/D]#;<"L?)AU$/,6(MD#$2=P
M([@N%5SQ'//_!4+C4>]6LG%KGG@5+S$[AD%\!$F4)!Z]01^F@=,;[M&[_@%7
M&T]W^>>UMG_6F:I)AK/ _#H*Y2,&Z<</\3CZXF$;]FQ#IS[8PW:E-#6?)^;0
M*"P:!HP6"'_.ETI+\]'_W<4[? ?>4<\[\L9R)^\N2+_, )Z12.4!&O= 8Z_2
M=[+T9]=K_L9H37JXR<&S.WD'WI.>]^0PV?7+C%[-[FD/=.K/+II#NQ0LA^NJ
MEN(1;995^+61G.I&FEC>8+5$N3.27NDW1C*.7L[FZ."Y[R0/C+Q53N+#I/\5
M'4_^PZUJ5Z%<N9JNP!6LMO#UH_V]X;RMEB_+VTO'#9$KRA4P+(QI=#PQ1XYL
MZWC;T:)VM7,IM*G$KEF:NP]*N\#,%T+H3<=NT-^FTG]02P,$%     @ TCMP
M5JZ[VO-A @  7@4  !D   !X;"]W;W)K<VAE971S+W-H965T-34N>&UL?511
M3]LP$/XKITR:0$(D30M,+(U$Z1 \("'*MH=I#VYR22P<._.Y3?GWV$Z:%:GD
M)?;9=]]]W\5W2:OT*U6(!G:UD#0/*F.:ZS"DK,*:T;EJ4-J;0NF:&6OJ,J1&
M(\M]4"W".(HNPYIQ&:2)/WO2::(V1G")3QIH4]=,ORU0J'8>3(+]P3,O*^,.
MPC1I6(DK-#^;)VVM<$#)>8V2N)*@L9@'-Y/KQ87S]PZ_.+9TL >G9*W4JS,>
M\GD0.4(H,#,.@=EEB[<HA .R-/[UF,&0T@4>[O?H=UZ[U;)FA+=*_.:YJ>;!
MMP!R+-A&F&?5WF.OQQ/,E"#_A;;WC0+(-F14W0=;!C67W<IV?1T. N+9)P%Q
M'Q![WETBSW+)#$L3K5K0SMNBN8V7ZJ,M.2[=3UD9;6^YC3/IJOL9H H@7DI>
M\(Q)8XN5J8TT7);0*,$SCG0&#S)3-8)A.R0X6:)A7- IK.XT< DOE=H0DSDE
MH;'$''R8]206'8GX$Q*3&!Z5-!7!#YEC_A$@M(H&6?%>UB(>15QB=@[3R1G$
M41S#[?T=G%B:IR/(TZ%@4X\\_03Y0Q'^W*S):/NR_AX3W0'-C@.Y;KNFAF4X
M#VP[$>HM!NG7+Y/+Z/L(S=E <S:&GKZP'0A%!!G3^LTV;\MT#@UJKO)C7,?1
MKN -F:817A<#KXM1I"46J#7FKH# B- <?2\=R*4'<7-EFT9)N#W,&QZ\^1IU
MZ3O;RG7/MGO^P^DP/&ZZGOGOWDV>1Z9++@D$%C8T.K^RV777S9UA5.,[:*V,
M[4>_K>P 1.T<['VAE-D;+L$P4M-W4$L#!!0    ( -([<%8F'.=:0@(  $@%
M   9    >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;(U4VX[3,!#]%<M("*15
M<VF[BTH2J=V"X&%1M17P@'APDDEBK6,'VVF6O\>7-!31%EX2CSUSYIP9CY-!
MR"?5 &CTW#*N4MQHW:V"0!4-M$3-1 ?<G%1"MD0;4]:!ZB20T@6U+(C#\#9H
M">4X2]S>3F:)Z#6C''82J;YMB?RY 2:&%$?XN/%(ZT;;C2!+.E+#'O3G;B>-
M%4PH)6V!*RHXDE"E>!VM-DOK[QR^4!C4R1I9);D03];X6*8XM(2 0:$M C&_
M ]P#8Q;(T/@Q8N(II0T\71_1WSOM1DM.%-P+]I66NDGQ&XQ*J$C/]*,8/L"H
MQQ$L!%/NBP;O>Q=C5/1*BW8,-@Q:ROV?/(]U. F(+P7$8T#L>/M$CN66:)(E
M4@Q(6F^#9A=.JHLVY"BW3=EK:4ZIB=/9WC<#B0HI6G-:T8)P;8I5B)YKRFO4
M"48+"NH&[:$V[="F%YV0[NS5%C2A3+U. FW(6,B@&!-O?.+X0N(H1@^"ZT:A
M=[R$\D^ P*B8I,1'*9OX*N(6BAF:1S<H#N,8*4_V"NY\*M'<X<XOE>@OV=_6
MN=+27*COYW1[M,5Y-#MD*]61 E)LIDB!/ #.7KZ(;L.W5[@N)JZ+:^C9I[[-
M0=INFK&5Q+$=*Z'.<?5H2X=FY_>014EP.$-@.1%8_B<!7RZ2,[C*8/E/!L')
M[6Y!UFZ&%7(7U%_T:7=Z)M9^.GZ[^S?F@<B:<H485"8TG-V9O-+/K3>TZ-RL
MY$*;R7/+QCQU(*V#.:^$T$?#)I@>S^P74$L#!!0    ( -([<%9B[Y]G@@P
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MLTT+)$B K]KH6HQM96ME+<V]9$K*@Z0*WDH8 M['*6#64S#KT3!+DCU==O"
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M\.[YD;T'\@.0%'P[T!.7?GSA"LE8/=?=%NSN<W:H@QU$X M-Q8&#CVF$HSJ
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MGYCK((N>L9AHL<G;KJ70IHG+AXGILT%: [,>"Z$?)[:3JSKW\"]02P,$%
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MBRC[MG*@>%:T/FNNH)$J'B/H=:G0$^![R+EZ'>@%ZNYY]C=02P,$%     @
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M*LPOVK6QD\!!>2,D*SNP4E"2JOW'3UT=!@ _>@<0=(#@HX"P X3&:*O,V+K
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MHIF_ZT$T;A&-!Q$M6HVM&HU=6HV]Z6CLTS46:U2]9 XZ_T<R)RWTR4$$,#D
MYFF+>7I  4S_0@"G+:+3_R4 N(-WL@2Y@5LFMC@HC,&@_TCR69O2V4&$<78
MS&'P4!J"P8NXD8;8YH22BX1*OD;@&O!KQ<UW,)F2U3:#1(H=*E>DZ1I^*0=W
M]EO;6PKJV)..=,+ _OK%$W8*6OB'J$5EQ6!A-5]ZKG6%*6R4+'Z/NZ\L--!K
M .,.]''0A]WOU.4"U=9U'YI"5\+4);I=;3N<B[JN/QROVZ-KIK:$#W+<D&EP
M/*7HJNXXZHF1I:OR:VFH9W##C+HT5/8 [6\D\=),;("V[XM_ %!+ P04
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M9 6/AF%3EL*\+D#IPYP/^7%A+7<%N84@B6NQ@PW0M_K16"_H43)90H525\Q
M/N>WP]EB[.)]P'<)!SRQF5.RU?K9.5^R.0\=(5"0DD,0]K.')2CE@"R-7QTF
M[TNZQ%/[B'[GM5LM6X&PU.J'S*B8\QO.,LA%HVBM#_?0Z9DXO%0K]&]V:&.G
MUYRE#9(NNV3+H)15^Q4O71].$J+QF82H2X@\[[:09[D2))+8Z ,S+MJB.<-+
M]=F6G*S<3]F0L;O2YE&R*80!EHI:DE#L$]L4H'+;[9U$,L(W#DD0V/] [&H%
M)*3"#W% MK9#"-*NSJ*M$YVI<UN; 8MN/K(HC(9L>7_'KC9WYA^@P)+O%42]
M@L@CC\\@?]4UTSE;BVH'[.D!RBV8GV\1O CCAG^&M4AASNUT(Y@]\.3]N^$T
M_'R!Y*@G.?+HHS,D5Q)3I;&QO;9<4R40 9V)?_7_R>4Q:=N-;TH8_0<)XU["
M^&*?EQU'T5"AC?P-&2/-MI8N8F.=ILK =/.S/IV?S7%^WE+4UISZFNX"V2>C
M2=@^<; _I1N<#+F[+QZ$V<D*F8+<YH:#ZPEGICV#K4.Z]G._U61/D3<+>VV!
M<0%V/]>:CHX[2OU%F/P!4$L#!!0    ( -([<%:Q_ )VD@4  -0G   9
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M@HN1D45$0^JK#$'TKP>ZHF&8D70<WTOHJ/*9&38_/]'=?/)Z,FLBZ8J'_[)
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MB?XE 6$,]/L9Y^JE80Z]Y4_.^#=02P,$%     @ TCMP5CJ;74RG P  Z!(
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M.OPV8;$E6,NW8>/;T.8<&MHTT28LM@1KF7C9F'AI:PY5H,'+TV-^^>H$>L[
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M#M= 4N Z0%U?,B;W)_H&S>96]!]02P,$%     @ TCMP5E\\)4J3 P  UPP
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MYHEW;@MHU S5?*A&H5H U1A4"Z%:A-+T1FS29QMPQ:\-#9&AF@?5?*A&H5H
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M/;)B]W0;B<_\R675!8URWI)'6?&7/%5EM1Y9;C/!X\I8>A"'2?E+OU<WXL#
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M,Z&:!=5LJ.9 -1>J>5#-1VGRG*A+G)JZQFFG490^?Q:[D^5VGR-V+\7N@[.
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MFWS[)$_7Y5VH'],\3^/RX8K1.>-% _'[12K.::HGQ0)V=XB?_0=02P,$%
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M>(6R6'RD3^]P.:"1P@MIS/-?\%3:V@,09ES0I'26$20D+?[1<TG$CH,S/N
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M7&BL8U4WPZ<)2!. ZPLA]'9@-F@?._%?4$L#!!0    ( -([<%8':]<H- 0
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M:8G2U[IIW9@A")T80B=N0K_:[T2F(A3)LP&@3JCN/D3G77E05(=2J]IK4)V
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M O3GZUA/G^)-]A#RX2GUQ?]02P,$%     @ TCMP5EA#*;-^!0  KR\  !D
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M^8EPJ1V[355Q4K>Z6YTZO\[/6K^X/\5787%VO,841]EO6+:*]#J*^5(C_8M
MU\BL.!U>7"BQR8\_/PBE1))_7'.VX)EIH+]?"J'V%Z:#ZHS^Y']02P,$%
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M:))_W1"\)"PSD/]?42I>+[(&JJ.QL_\ 4$L#!!0    ( -([<%8]V_P5L@@
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M'79T,JZO;Y$;CXVG=8*N(12I48JTLU34B[U(ESV6^4DSYN@XF(SKC#7M&N5
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M-\SL!_&ZUV5PQ[V=@RK>4=$X%IKM0B/Q@VL^SAJ@/L^*BA:AHG$L--M-YB)
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M5/>*J#8GJH7BI?V^7W.E>&$/,R I"&.@KV\X5Z\+$Z#9(HK_ U!+ P04
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MT_X(T_/#^@5*QV(BIBL:CZNNG$_+IJ,;.FKU 8==9%)^[ CF8S [ A@6!U.
M^1@O+,[_-)\^.A^#8=KZ5J2/^O11'^-E0\;E%XMC]XGTQS[3* J",,0R.AY;
M%8RQO(4A_-G9,&W@@<6!2'^6:WRU\0K97P?8FNZK$&RF>"5B,\5S#8@];^ 1
M1?;5QN* ![8*6.U ?'L<J"F[3Q# JF+:L!V,(U&$(5"+]AH-0R0[(7SMZX/M
MDB"((CL"F%U!$& ([$8<P12 !@P)@O(YN/,\\C;/*:_Y]_SH-U!+ P04
M" #2.W!6EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M>757&%U59X/I=L<W8:PL7FV^<Y#W?-%T6RQ?W'( .1LD$SCA4IK&=D=TY^?
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MKWI[@-Y>]?8 O7WUL!N@MU>]/4!OKWI[@-Y>]?8 O;WJ[0%Z>]7; _0.JG<
MZ!U4[P#0.ZC> :!W4+T#0.^@>@> WJ'ZLQ*@=U"] T#OH'H'@-Y!]0X O8/J
M'0!Z1]4[ O2.JG<$Z!U5[PC0.ZK>$:!W5+TC0.^H>D> WK':; +0.ZK>$:!W
M5+TC0.^H>D> WDGU3@"]D^J= 'HGU3L!]$ZJ=P+HG53O!- [J=X)H'=2O1-
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M7+]/T_X?QR_/>*B[\34_6?[/>?,34$L! A0#%     @ TCMP5@=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " #2.W!6-19/DNT    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " #2.W!6F5R<(Q &  "<)P  $P
M        @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( -([
M<%:Q#B/>F@8  $L?   8              " @0P(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " #2.W!6.RI^-<D%  "K&@  &
M        @('<#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%
M  @ TCMP5@=&!FSY!   7Q4  !@              ("!VQ0  'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( -([<%9?X-HNIP,  #<-   8
M              " @0H:  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"
M% ,4    " #2.W!6$RFDK.('  !Z,@  &               @('G'0  >&PO
M=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ TCMP5I;+4=XL"@
M?#,  !@              ("!_R4  'AL+W=O<FMS:&5E=',O<VAE970V+GAM
M;%!+ 0(4 Q0    ( -([<%9V:X&78 4  -T+   8              " @6$P
M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " #2.W!6,">(
MI'\%  !7#   &               @('W-0  >&PO=V]R:W-H965T<R]S:&5E
M=#@N>&UL4$L! A0#%     @ TCMP5F3=+0@9(P  ,7$  !@
M ("!K#L  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( -([
M<%9@:*TX1P4  ,00   9              " @?M>  !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&UL4$L! A0#%     @ TCMP5J'X,^2"!0  P!   !D
M         ("!>60  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
M    " #2.W!62T7U%'($  #E"0  &0              @($R:@  >&PO=V]R
M:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( -([<%:8'@QQ$ 4  (@,
M   9              " @=MN  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL
M4$L! A0#%     @ TCMP5FP8PWA, P  !@D  !D              ("!(G0
M 'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " #2.W!6.K\T
MODH#   V"   &0              @(&E=P  >&PO=V]R:W-H965T<R]S:&5E
M=#$U+GAM;%!+ 0(4 Q0    ( -([<%;T%&#U>0(  -<%   9
M  " @29[  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @
MTCMP5J#@ICS<"@  4AX  !D              ("!UGT  'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6Q02P$"% ,4    " #2.W!6BOM:G4H#  !&"   &0
M            @('IB   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4
M Q0    ( -([<%9 [J2A "   !IY   9              " @6J,  !X;"]W
M;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ TCMP5M[YQ*0W!0
M60X  !D              ("!H:P  'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6Q02P$"% ,4    " #2.W!6]OG-$AP#  !B!P  &0              @($/
ML@  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( -([<%9-
MP:J5& 8   T0   9              " @6*U  !X;"]W;W)K<VAE971S+W-H
M965T,C(N>&UL4$L! A0#%     @ TCMP5CQP_(<]#   N2@  !D
M     ("!L;L  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -([<%8#-HE%QP(   \&   9              "
M@7#E  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ TCMP
M5MW[OCF& @  S@4  !D              ("!;N@  'AL+W=O<FMS:&5E=',O
M<VAE970R.2YX;6Q02P$"% ,4    " #2.W!6;"6L924D  !'>P  &0
M        @($KZP  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0
M   ( -([<%9/<B'G0@,  *8(   9              " @8</ 0!X;"]W;W)K
M<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ TCMP5N:1]1Z5!   ) \
M !D              ("! !,! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q0
M2P$"% ,4    " #2.W!6.NI@+*X$  #G#@  &0              @(',%P$
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( -([<%;) " <
M8 (  $\%   9              " @;$< 0!X;"]W;W)K<VAE971S+W-H965T
M,S0N>&UL4$L! A0#%     @ TCMP5JKY$$J* @  %@<  !D
M ("!2!\! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " #2
M.W!62'>;8Q0#  "B"   &0              @($)(@$ >&PO=V]R:W-H965T
M<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( -([<%;:MN",4 (  + %   9
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M970T,2YX;6Q02P$"% ,4    " #2.W!6E_;&(Y4#   &"@  &0
M    @('E- $ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (
M -([<%:$PK4X' ,  "<'   9              " @;$X 0!X;"]W;W)K<VAE
M971S+W-H965T-#,N>&UL4$L! A0#%     @ TCMP5F. (J_-!   'PX  !D
M             ("!!#P! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"
M% ,4    " #2.W!6IC/_2MP'  !,'P  &0              @($(00$ >&PO
M=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( -([<%97;E:)R0<
M %0;   9              " @1M) 0!X;"]W;W)K<VAE971S+W-H965T-#8N
M>&UL4$L! A0#%     @ TCMP5B#M2@V* @  OP4  !D              ("!
M&U$! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " #2.W!6
M+?LJ*,H#  "B"0  &0              @('<4P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0X+GAM;%!+ 0(4 Q0    ( -([<%:;\$>P/ ,  #((   9
M      " @=U7 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%
M  @ TCMP5CBG/:?O 0  $00  !D              ("!4%L! 'AL+W=O<FMS
M:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " #2.W!61A0I[9P"   @"
M&0              @(%V70$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+
M 0(4 Q0    ( -([<%;J$*'ND@(  * &   9              " @4E@ 0!X
M;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ TCMP5A15\\ZD
M @  =0D  !D              ("!$F,! 'AL+W=O<FMS:&5E=',O<VAE970U
M,RYX;6Q02P$"% ,4    " #2.W!6;B3A3K "  !9"0  &0
M@('M90$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( -([
M<%:NN]KS80(  %X%   9              " @=1H 0!X;"]W;W)K<VAE971S
M+W-H965T-34N>&UL4$L! A0#%     @ TCMP5B8<YUI" @  2 4  !D
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M=#8P+GAM;%!+ 0(4 Q0    ( -([<%8?*35V_@,  $D/   9
M  " @>F& 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @
MTCMP5N&_U$N] P  L14  !D              ("!'HL! 'AL+W=O<FMS:&5E
M=',O<VAE970V,BYX;6Q02P$"% ,4    " #2.W!61?$P&_(#  "<&   &0
M            @($2CP$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4
M Q0    ( -([<%9X&Q">-0(  (L%   9              " @3N3 0!X;"]W
M;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ TCMP5AG3D7@P P
MHPT  !D              ("!IY4! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX
M;6Q02P$"% ,4    " #2.W!6^F;6G?D"  !?"@  &0              @($.
MF0$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( -([<%;4
MXR'QOP(  !L)   9              " @3Z< 0!X;"]W;W)K<VAE971S+W-H
M965T-C<N>&UL4$L! A0#%     @ TCMP5APD0[1!"   7C\  !D
M     ("!-)\! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -([<%:Q_ )VD@4  -0G   9              "
M@7BS 0!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ TCMP
M5F:4N22^!0  <BP  !D              ("!0;D! 'AL+W=O<FMS:&5E=',O
M<VAE970W-"YX;6Q02P$"% ,4    " #2.W!6,E1'XEL#  #P#   &0
M        @($VOP$ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0
M   ( -([<%8ZFUU,IP,  .@2   9              " @<C" 0!X;"]W;W)K
M<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @ TCMP5E\\)4J3 P  UPP
M !D              ("!IL8! 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q0
M2P$"% ,4    " #2.W!6M?5  U8+  !RDP  &0              @(%PR@$
M>&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( -([<%;XGIP_
M#0<  ")!   9              " @?W5 0!X;"]W;W)K<VAE971S+W-H965T
M-SDN>&UL4$L! A0#%     @ TCMP5EBF=*ZD!@  .4$  !D
M ("!0=T! 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q02P$"% ,4    " #2
M.W!6!?3B?Y0%  "-+P  &0              @($<Y $ >&PO=V]R:W-H965T
M<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    ( -([<%8SU?G?$0@  $%A   9
M          " @>?I 0!X;"]W;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#
M%     @ TCMP5IZ=0V.'"   +5X  !D              ("!+_(! 'AL+W=O
M<FMS:&5E=',O<VAE970X,RYX;6Q02P$"% ,4    " #2.W!6GC]UTZ(%  #6
M&P  &0              @('M^@$ >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM
M;%!+ 0(4 Q0    ( -([<%:0FZ7G30,  -0*   9              " @<8
M @!X;"]W;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @ TCMP5H_<
MZU$W!@  XRH  !D              ("!2@0" 'AL+W=O<FMS:&5E=',O<VAE
M970X-BYX;6Q02P$"% ,4    " #2.W!6U' DQOP%  #_*@  &0
M    @(&X"@( >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    (
M -([<%;8EPB]I ,  )@-   9              " @>L0 @!X;"]W;W)K<VAE
M971S+W-H965T.#@N>&UL4$L! A0#%     @ TCMP5F;? 8CC @  ^ @  !D
M             ("!QA0" 'AL+W=O<FMS:&5E=',O<VAE970X.2YX;6Q02P$"
M% ,4    " #2.W!6!VO7*#0$  !Q$0  &0              @('@%P( >&PO
M=V]R:W-H965T<R]S:&5E=#DP+GAM;%!+ 0(4 Q0    ( -([<%8F"C% <P0
M $(2   9              " @4L< @!X;"]W;W)K<VAE971S+W-H965T.3$N
M>&UL4$L! A0#%     @ TCMP5C 5R+9> P  90H  !D              ("!
M]2 " 'AL+W=O<FMS:&5E=',O<VAE970Y,BYX;6Q02P$"% ,4    " #2.W!6
ML8OEZ9\#  "J"P  &0              @(&*) ( >&PO=V]R:W-H965T<R]S
M:&5E=#DS+GAM;%!+ 0(4 Q0    ( -([<%:>C4'0*@<  +$^   9
M      " @6 H @!X;"]W;W)K<VAE971S+W-H965T.30N>&UL4$L! A0#%
M  @ TCMP5EA#*;-^!0  KR\  !D              ("!P2\" 'AL+W=O<FMS
M:&5E=',O<VAE970Y-2YX;6Q02P$"% ,4    " #2.W!6I&QCGX0&  #K+0
M&0              @(%V-0( >&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+
M 0(4 Q0    ( -([<%8E<MM=908  ,8[   9              " @3$\ @!X
M;"]W;W)K<VAE971S+W-H965T.3<N>&UL4$L! A0#%     @ TCMP5BO+B>GG
M!0  )BL  !D              ("!S4(" 'AL+W=O<FMS:&5E=',O<VAE970Y
M."YX;6Q02P$"% ,4    " #2.W!6/=O\%;((  #?3   &0
M@('K2 ( >&PO=V]R:W-H965T<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    ( -([
M<%8A@=]%P0,  "X2   :              " @=11 @!X;"]W;W)K<VAE971S
M+W-H965T,3 P+GAM;%!+ 0(4 Q0    ( -([<%;CGK'T;00  .P0   :
M          " @<U5 @!X;"]W;W)K<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4
M Q0    ( -([<%9BDQ])O0@  "U)   :              " @7): @!X;"]W
M;W)K<VAE971S+W-H965T,3 R+GAM;%!+ 0(4 Q0    ( -([<%:;:ZRZ=0,
M *L7   -              "  6=C @!X;"]S='EL97,N>&UL4$L! A0#%
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K @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !N &X /!X  #1U @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>410</ContextCount>
  <ElementCount>419</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>122</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>21</UnitCount>
  <MyReports>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00100 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00200 - Statement - Condensed Consolidated Statements of Income/(Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss</Role>
      <ShortName>Condensed Consolidated Statements of Income/(Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00300 - Statement - Condensed Consolidated Statements of Comprehensive Income/(Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income/(Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00400 - Statement - Condensed Consolidated Statements of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00500 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>10101 - Disclosure - General information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureGeneralInformation</Role>
      <ShortName>General information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>10201 - Disclosure - Basis of preparation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureBasisOfPreparation</Role>
      <ShortName>Basis of preparation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>10301 - Disclosure - Summary of significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>10401 - Disclosure - Property, plant and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosurePropertyPlantAndEquipment</Role>
      <ShortName>Property, plant and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>10501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities</Role>
      <ShortName>Right-of-use assets, long-term financial assets and lease liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>10601 - Disclosure - Asset acquisition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureAssetAcquisition</Role>
      <ShortName>Asset acquisition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>10701 - Disclosure - Intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIntangibleAssets</Role>
      <ShortName>Intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>10801 - Disclosure - Cash and cash equivalents and short-term financial assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets</Role>
      <ShortName>Cash and cash equivalents and short-term financial assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>10901 - Disclosure - Prepaid expenses and accrued income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome</Role>
      <ShortName>Prepaid expenses and accrued income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>11001 - Disclosure - Other current receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureOtherCurrentReceivables</Role>
      <ShortName>Other current receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>11101 - Disclosure - Share capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapital</Role>
      <ShortName>Share capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>11201 - Disclosure - Trade and other payables and accrued expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses</Role>
      <ShortName>Trade and other payables and accrued expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>11301 - Disclosure - Contract revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenues</Role>
      <ShortName>Contract revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>11401 - Disclosure - Expenses by category</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureExpensesByCategory</Role>
      <ShortName>Expenses by category</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>11501 - Disclosure - Related-party transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRelatedPartyTransactions</Role>
      <ShortName>Related-party transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>11601 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>11701 - Disclosure - Retirement benefit plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlan</Role>
      <ShortName>Retirement benefit plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>11801 - Disclosure - Share-based compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensation</Role>
      <ShortName>Share-based compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>11901 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>12001 - Disclosure - Earnings per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureEarningsPerShare</Role>
      <ShortName>Earnings per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>12101 - Disclosure - Financial instruments and risk management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement</Role>
      <ShortName>Financial instruments and risk management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>12201 - Disclosure - Capital risk management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCapitalRiskManagement</Role>
      <ShortName>Capital risk management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>12301 - Disclosure - Subsequent events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>20302 - Disclosure - Summary of significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>30303 - Disclosure - Summary of significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>30403 - Disclosure - Property, plant and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables</Role>
      <ShortName>Property, plant and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosurePropertyPlantAndEquipment</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>30503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables</Role>
      <ShortName>Right-of-use assets, long-term financial assets and lease liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>30603 - Disclosure - Asset acquisition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureAssetAcquisitionTables</Role>
      <ShortName>Asset acquisition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureAssetAcquisition</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>30703 - Disclosure - Intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIntangibleAssetsTables</Role>
      <ShortName>Intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureIntangibleAssets</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>30803 - Disclosure - Cash and cash equivalents and short-term financial assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables</Role>
      <ShortName>Cash and cash equivalents and short-term financial assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>30903 - Disclosure - Prepaid expenses and accrued income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables</Role>
      <ShortName>Prepaid expenses and accrued income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>31003 - Disclosure - Other current receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureOtherCurrentReceivablesTables</Role>
      <ShortName>Other current receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureOtherCurrentReceivables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>31103 - Disclosure - Share capital (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalTables</Role>
      <ShortName>Share capital (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureShareCapital</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>31203 - Disclosure - Trade and other payables and accrued expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables</Role>
      <ShortName>Trade and other payables and accrued expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>31303 - Disclosure - Contract revenues (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesTables</Role>
      <ShortName>Contract revenues (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureContractRevenues</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>31403 - Disclosure - Expenses by category (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureExpensesByCategoryTables</Role>
      <ShortName>Expenses by category (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureExpensesByCategory</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>31503 - Disclosure - Related-party transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRelatedPartyTransactionsTables</Role>
      <ShortName>Related-party transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureRelatedPartyTransactions</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>31603 - Disclosure - Income taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureIncomeTaxes</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>31703 - Disclosure - Retirement benefit plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanTables</Role>
      <ShortName>Retirement benefit plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureRetirementBenefitPlan</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>31803 - Disclosure - Share-based compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensationTables</Role>
      <ShortName>Share-based compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureShareBasedCompensation</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>31903 - Disclosure - Commitments and contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>32003 - Disclosure - Earnings per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureEarningsPerShareTables</Role>
      <ShortName>Earnings per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureEarningsPerShare</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>32103 - Disclosure - Financial instruments and risk management (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables</Role>
      <ShortName>Financial instruments and risk management (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>40101 - Disclosure - General information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureGeneralInformationDetails</Role>
      <ShortName>General information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureGeneralInformation</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>40201 - Disclosure - Basis of preparation - Going concern (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails</Role>
      <ShortName>Basis of preparation - Going concern (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>40301 - Disclosure - Summary of significant accounting policies - Functional and reporting currency (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails</Role>
      <ShortName>Summary of significant accounting policies - Functional and reporting currency (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>40302 - Disclosure - Summary of significant accounting policies, Right-of-use assets and lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails</Role>
      <ShortName>Summary of significant accounting policies, Right-of-use assets and lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>40303 - Disclosure - Summary of significant accounting policies, Property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails</Role>
      <ShortName>Summary of significant accounting policies, Property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>40304 - Disclosure - Summary of significant accounting policies, Income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesDetails</Role>
      <ShortName>Summary of significant accounting policies, Income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>40305 - Disclosure - Summary of significant accounting policies, Segment reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails</Role>
      <ShortName>Summary of significant accounting policies, Segment reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>40401 - Disclosure - Property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails</Role>
      <ShortName>Property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>40501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails</Role>
      <ShortName>Right-of-use assets, long-term financial assets and lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>40502 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails</Role>
      <ShortName>Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>40503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails</Role>
      <ShortName>Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>40601 - Disclosure - Asset acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureAssetAcquisitionDetails</Role>
      <ShortName>Asset acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureAssetAcquisitionTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>40701 - Disclosure - Intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIntangibleAssetsDetails</Role>
      <ShortName>Intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureIntangibleAssetsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>40801 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails</Role>
      <ShortName>Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>40802 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails</Role>
      <ShortName>Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>40901 - Disclosure - Prepaid expenses and accrued income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails</Role>
      <ShortName>Prepaid expenses and accrued income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>41001 - Disclosure - Other current receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails</Role>
      <ShortName>Other current receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureOtherCurrentReceivablesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>41101 - Disclosure - Share capital - Narratives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalNarrativesDetails</Role>
      <ShortName>Share capital - Narratives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>41102 - Disclosure - Share capital - Capital Structure (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails</Role>
      <ShortName>Share capital - Capital Structure (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>41103 - Disclosure - Share capital - Authorized capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails</Role>
      <ShortName>Share capital - Authorized capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>41104 - Disclosure - Share capital - Conditional share capital for bonds and similar debt instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails</Role>
      <ShortName>Share capital - Conditional share capital for bonds and similar debt instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>41105 - Disclosure - Share capital - Conditional share capital for employee benefit plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails</Role>
      <ShortName>Share capital - Conditional share capital for employee benefit plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>41106 - Disclosure - Share capital - Shelf registration statement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails</Role>
      <ShortName>Share capital - Shelf registration statement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>41107 - Disclosure - Share capital - At the market equity offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails</Role>
      <ShortName>Share capital - At the market equity offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>41108 - Disclosure - Share capital - Convertible note agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails</Role>
      <ShortName>Share capital - Convertible note agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>41201 - Disclosure - Trade and other payables and accrued expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails</Role>
      <ShortName>Trade and other payables and accrued expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>41301 - Disclosure - Contract revenues, Contract Revenue Attributable to Licensing Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails</Role>
      <ShortName>Contract revenues, Contract Revenue Attributable to Licensing Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>41302 - Disclosure - Contract revenues and other operating income - Licensing and collaboration agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails</Role>
      <ShortName>Contract revenues and other operating income - Licensing and collaboration agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>41303 - Disclosure - Contract revenues, Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails</Role>
      <ShortName>Contract revenues, Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>41304 - Disclosure - Contract revenues, Anti-Abeta Antibody in AD - 2006 Agreement with Genentech (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails</Role>
      <ShortName>Contract revenues, Anti-Abeta Antibody in AD - 2006 Agreement with Genentech (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>41305 - Disclosure - Contract revenues, Anti-Tau Antibody in AD - 2012 Agreement with Genentech (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails</Role>
      <ShortName>Contract revenues, Anti-Tau Antibody in AD - 2012 Agreement with Genentech (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>41306 - Disclosure - Contract revenues, Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails</Role>
      <ShortName>Contract revenues, Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>41307 - Disclosure - Contract revenues, Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails</Role>
      <ShortName>Contract revenues, Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>41308 - Disclosure - Contract revenues - Grants from the Michael J. Fox Foundation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails</Role>
      <ShortName>Contract revenues - Grants from the Michael J. Fox Foundation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>41401 - Disclosure - Expenses by category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureExpensesByCategoryDetails</Role>
      <ShortName>Expenses by category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureExpensesByCategoryTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>41501 - Disclosure - Related-party transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails</Role>
      <ShortName>Related-party transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureRelatedPartyTransactionsTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>41601 - Disclosure - Income taxes - Summary of Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails</Role>
      <ShortName>Income taxes - Summary of Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>41602 - Disclosure - Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails</Role>
      <ShortName>Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>41701 - Disclosure - Retirement benefit plan - Summary of Benefit Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails</Role>
      <ShortName>Retirement benefit plan - Summary of Benefit Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>41702 - Disclosure - Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails</Role>
      <ShortName>Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>41703 - Disclosure - Retirement benefit plan, Changes in Defined Benefit Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails</Role>
      <ShortName>Retirement benefit plan, Changes in Defined Benefit Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>41704 - Disclosure - Retirement benefit plan, Changes in Fair Value of Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails</Role>
      <ShortName>Retirement benefit plan, Changes in Fair Value of Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>41705 - Disclosure - Retirement benefit plan, Change in Net Defined Benefit Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails</Role>
      <ShortName>Retirement benefit plan, Change in Net Defined Benefit Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>41706 - Disclosure - Retirement benefit plan - Change in other comprehensive gains (losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails</Role>
      <ShortName>Retirement benefit plan - Change in other comprehensive gains (losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>41707 - Disclosure - Retirement benefit plan, Actuarial Assumptions and Sensitivity Analysis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails</Role>
      <ShortName>Retirement benefit plan, Actuarial Assumptions and Sensitivity Analysis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>41801 - Disclosure - Share-based compensation, Plans Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails</Role>
      <ShortName>Share-based compensation, Plans Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>41802 - Disclosure - Share-based compensation, Weighted Average Exercise Prices (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails</Role>
      <ShortName>Share-based compensation, Weighted Average Exercise Prices (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>41803 - Disclosure - Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails</Role>
      <ShortName>Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>41804 - Disclosure - Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails</Role>
      <ShortName>Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>41805 - Disclosure - Share-based compensation, Non-vested Share Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails</Role>
      <ShortName>Share-based compensation, Non-vested Share Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>41901 - Disclosure - Commitments and contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments and contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>42001 - Disclosure - Earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureEarningsPerShareDetails</Role>
      <ShortName>Earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureEarningsPerShareTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="aciu-20221231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>42101 - Disclosure - Financial instruments and risk management (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails</Role>
      <ShortName>Financial instruments and risk management (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 19 fact(s) appearing in ix:hidden were eligible for transformation: aciu:CollaborativeAgreementJointResearchCollaborationPeriod, aciu:CollaborativeAgreementMilestonePaymentReceived, aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod, aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt, aciu:MaturityPeriodOtherCurrentReceivables, dei:CurrentFiscalYearEndDate, ifrs-full:AdjustedWeightedAverageShares, ifrs-full:DeferredTaxLiabilities, ifrs-full:DilutedEarningsLossPerShare, ifrs-full:RevenueFromContractsWithCustomers -  aciu-20221231x20f.htm 9</Log>
  </Logs>
  <InputFiles>
    <File doctype="20-F" original="aciu-20221231x20f.htm">aciu-20221231x20f.htm</File>
    <File>aciu-20221231.xsd</File>
    <File>aciu-20221231_cal.xml</File>
    <File>aciu-20221231_def.xml</File>
    <File>aciu-20221231_lab.xml</File>
    <File>aciu-20221231_pre.xml</File>
    <File>aciu-20221231xex12d1.htm</File>
    <File>aciu-20221231xex12d2.htm</File>
    <File>aciu-20221231xex13d1.htm</File>
    <File>aciu-20221231xex13d2.htm</File>
    <File>aciu-20221231xex15d1.htm</File>
    <File>aciu-20221231xex4d17.htm</File>
    <File>aciu-20221231xex4d6.htm</File>
    <File>aciu-20221231xex8d1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>aciu-20221231x20f001.jpg</File>
    <File>aciu-20221231x20f002.jpg</File>
    <File>aciu-20221231x20f003.jpg</File>
    <File>aciu-20221231x20f004.jpg</File>
    <File>aciu-20221231x20f005.jpg</File>
    <File>aciu-20221231x20f006.jpg</File>
    <File>aciu-20221231x20f007.jpg</File>
    <File>aciu-20221231x20f008.jpg</File>
    <File>aciu-20221231x20f009.jpg</File>
    <File>aciu-20221231x20f010.jpg</File>
    <File>aciu-20221231x20f011.jpg</File>
    <File>aciu-20221231x20f012.jpg</File>
    <File>aciu-20221231x20f013.jpg</File>
    <File>aciu-20221231x20f014.jpg</File>
    <File>aciu-20221231x20f015.jpg</File>
    <File>aciu-20221231x20f016.jpg</File>
    <File>aciu-20221231x20f017.jpg</File>
    <File>aciu-20221231x20f018.jpg</File>
    <File>aciu-20221231x20f019.jpg</File>
    <File>aciu-20221231x20f020.jpg</File>
    <File>aciu-20221231x20f021.jpg</File>
    <File>aciu-20221231x20f022.jpg</File>
    <File>aciu-20221231x20f023.jpg</File>
    <File>aciu-20221231x20f024.jpg</File>
    <File>aciu-20221231x20f025.jpg</File>
    <File>aciu-20221231x20f026.jpg</File>
    <File>aciu-20221231x20f027.jpg</File>
    <File>aciu-20221231x20f028.jpg</File>
    <File>aciu-20221231x20f029.jpg</File>
    <File>aciu-20221231x20f030.jpg</File>
    <File>aciu-20221231x20f031.jpg</File>
    <File>aciu-20221231x20f032.jpg</File>
    <File>aciu-20221231x20f033.jpg</File>
    <File>aciu-20221231x20f034.jpg</File>
    <File>aciu-20221231x20f035.jpg</File>
    <File>aciu-20221231x20f036.jpg</File>
    <File>aciu-20221231x20f037.jpg</File>
    <File>aciu-20221231x20f038.jpg</File>
    <File>aciu-20221231x20f039.jpg</File>
    <File>aciu-20221231x20f040.jpg</File>
    <File>aciu-20221231x20f041.jpg</File>
    <File>aciu-20221231x20f042.jpg</File>
    <File>aciu-20221231x20f043.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1209">http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full</BaseTaxonomy>
    <BaseTaxonomy items="43">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>167
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "aciu-20221231x20f.htm": {
   "axisCustom": 1,
   "axisStandard": 28,
   "baseTaxonomies": {
    "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full": 1209,
    "http://xbrl.sec.gov/dei/2021q4": 43
   },
   "contextCount": 410,
   "dts": {
    "calculationLink": {
     "local": [
      "aciu-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "aciu-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "aciu-20221231x20f.htm"
     ]
    },
    "labelLink": {
     "local": [
      "aciu-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aciu-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "aciu-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 733,
   "entityCount": 1,
   "hidden": {
    "http://acimume.com/20221231": 7,
    "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full": 11,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 23
   },
   "keyCustom": 136,
   "keyStandard": 283,
   "memberCustom": 78,
   "memberStandard": 39,
   "nsprefix": "aciu",
   "nsuri": "http://acimume.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://acimume.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10401 - Disclosure - Property, plant and equipment",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://acimume.com/role/DisclosurePropertyPlantAndEquipment",
     "shortName": "Property, plant and equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:RentalContractPeriodForNoticeOfCancellation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41901 - Disclosure - Commitments and contingencies (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails",
     "shortName": "Commitments and contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:RentalContractPeriodForNoticeOfCancellation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42001 - Disclosure - Earnings per share (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://acimume.com/role/DisclosureEarningsPerShareDetails",
     "shortName": "Earnings per share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:FinancialAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "42101 - Disclosure - Financial instruments and risk management (Details)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
     "shortName": "Financial instruments and risk management (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:FinancialAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities",
     "shortName": "Right-of-use assets, long-term financial assets and lease liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfAssetAcquisitionsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10601 - Disclosure - Asset acquisition",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://acimume.com/role/DisclosureAssetAcquisition",
     "shortName": "Asset acquisition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfAssetAcquisitionsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10701 - Disclosure - Intangible assets",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://acimume.com/role/DisclosureIntangibleAssets",
     "shortName": "Intangible assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10801 - Disclosure - Cash and cash equivalents and short-term financial assets",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets",
     "shortName": "Cash and cash equivalents and short-term financial assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10901 - Disclosure - Prepaid expenses and accrued income",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome",
     "shortName": "Prepaid expenses and accrued income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfOtherCurrentReceivablesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11001 - Disclosure - Other current receivables",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://acimume.com/role/DisclosureOtherCurrentReceivables",
     "shortName": "Other current receivables",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfOtherCurrentReceivablesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11101 - Disclosure - Share capital",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://acimume.com/role/DisclosureShareCapital",
     "shortName": "Share capital",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11201 - Disclosure - Trade and other payables and accrued expenses",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses",
     "shortName": "Trade and other payables and accrued expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11301 - Disclosure - Contract revenues",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://acimume.com/role/DisclosureContractRevenues",
     "shortName": "Contract revenues",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00100 - Statement - Condensed Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:NoncurrentRestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfExpensesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11401 - Disclosure - Expenses by category",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://acimume.com/role/DisclosureExpensesByCategory",
     "shortName": "Expenses by category",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfExpensesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11501 - Disclosure - Related-party transactions",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://acimume.com/role/DisclosureRelatedPartyTransactions",
     "shortName": "Related-party transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11601 - Disclosure - Income taxes",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://acimume.com/role/DisclosureIncomeTaxes",
     "shortName": "Income taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11701 - Disclosure - Retirement benefit plan",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlan",
     "shortName": "Retirement benefit plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11801 - Disclosure - Share-based compensation",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://acimume.com/role/DisclosureShareBasedCompensation",
     "shortName": "Share-based compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11901 - Disclosure - Commitments and contingencies",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://acimume.com/role/DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "12001 - Disclosure - Earnings per share",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://acimume.com/role/DisclosureEarningsPerShare",
     "shortName": "Earnings per share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "12101 - Disclosure - Financial instruments and risk management",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement",
     "shortName": "Financial instruments and risk management",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "12201 - Disclosure - Capital risk management",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://acimume.com/role/DisclosureCapitalRiskManagement",
     "shortName": "Capital risk management",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "12301 - Disclosure - Subsequent events",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://acimume.com/role/DisclosureSubsequentEvents",
     "shortName": "Subsequent events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00200 - Statement - Condensed Consolidated Statements of Income/(Loss)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss",
     "shortName": "Condensed Consolidated Statements of Income/(Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "20302 - Disclosure - Summary of significant accounting policies (Policies)",
     "menuCat": "Policies",
     "order": "30",
     "role": "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of significant accounting policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30303 - Disclosure - Summary of significant accounting policies (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of significant accounting policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30403 - Disclosure - Property, plant and equipment (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables",
     "shortName": "Property, plant and equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables",
     "shortName": "Right-of-use assets, long-term financial assets and lease liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "aciu:DisclosureOfAssetAcquisitionsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfAssetAcquisitionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30603 - Disclosure - Asset acquisition (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://acimume.com/role/DisclosureAssetAcquisitionTables",
     "shortName": "Asset acquisition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "aciu:DisclosureOfAssetAcquisitionsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfAssetAcquisitionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30703 - Disclosure - Intangible assets (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://acimume.com/role/DisclosureIntangibleAssetsTables",
     "shortName": "Intangible assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30803 - Disclosure - Cash and cash equivalents and short-term financial assets (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables",
     "shortName": "Cash and cash equivalents and short-term financial assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30903 - Disclosure - Prepaid expenses and accrued income (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables",
     "shortName": "Prepaid expenses and accrued income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "aciu:DisclosureOfOtherCurrentReceivablesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31003 - Disclosure - Other current receivables (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://acimume.com/role/DisclosureOtherCurrentReceivablesTables",
     "shortName": "Other current receivables (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "aciu:DisclosureOfOtherCurrentReceivablesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31103 - Disclosure - Share capital (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://acimume.com/role/DisclosureShareCapitalTables",
     "shortName": "Share capital (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00300 - Statement - Condensed Consolidated Statements of Comprehensive Income/(Loss)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income/(Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31203 - Disclosure - Trade and other payables and accrued expenses (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables",
     "shortName": "Trade and other payables and accrued expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31303 - Disclosure - Contract revenues (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://acimume.com/role/DisclosureContractRevenuesTables",
     "shortName": "Contract revenues (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31403 - Disclosure - Expenses by category (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://acimume.com/role/DisclosureExpensesByCategoryTables",
     "shortName": "Expenses by category (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31503 - Disclosure - Related-party transactions (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://acimume.com/role/DisclosureRelatedPartyTransactionsTables",
     "shortName": "Related-party transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31603 - Disclosure - Income taxes (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://acimume.com/role/DisclosureIncomeTaxesTables",
     "shortName": "Income taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31703 - Disclosure - Retirement benefit plan (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanTables",
     "shortName": "Retirement benefit plan (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31803 - Disclosure - Share-based compensation (Tables)",
     "menuCat": "Tables",
     "order": "46",
     "role": "http://acimume.com/role/DisclosureShareBasedCompensationTables",
     "shortName": "Share-based compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "31903 - Disclosure - Commitments and contingencies (Tables)",
     "menuCat": "Tables",
     "order": "47",
     "role": "http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables",
     "shortName": "Commitments and contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "32003 - Disclosure - Earnings per share (Tables)",
     "menuCat": "Tables",
     "order": "48",
     "role": "http://acimume.com/role/DisclosureEarningsPerShareTables",
     "shortName": "Earnings per share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "32103 - Disclosure - Financial instruments and risk management (Tables)",
     "menuCat": "Tables",
     "order": "49",
     "role": "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables",
     "shortName": "Financial instruments and risk management (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_XSLfDSRIbEupuWixpadOuw",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00400 - Statement - Condensed Consolidated Statements of Changes in Equity",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity",
     "shortName": "Condensed Consolidated Statements of Changes in Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2019_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_KQlk7o6AQ0uDnZr3pfWlIg",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "aciu:NumberOfTechnologyPlatforms",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40101 - Disclosure - General information (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://acimume.com/role/DisclosureGeneralInformationDetails",
     "shortName": "General information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "aciu:NumberOfTechnologyPlatforms",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_item_yiPeTtQRgkWT9N2X90zVLQ",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40201 - Disclosure - Basis of preparation - Going concern (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails",
     "shortName": "Basis of preparation - Going concern (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ClosingForeignExchangeRate",
      "reportCount": 1,
      "unitRef": "Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40301 - Disclosure - Summary of significant accounting policies - Functional and reporting currency (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails",
     "shortName": "Summary of significant accounting policies - Functional and reporting currency (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "3",
      "lang": null,
      "name": "ifrs-full:AverageForeignExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Divide_CHF_USD_LfzKPl4gLE6qfE_Egvi89w",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_Wu9NkzJdPUaZrVXUx5z-UA",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:EstimatedLeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40302 - Disclosure - Summary of significant accounting policies, Right-of-use assets and lease liabilities (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails",
     "shortName": "Summary of significant accounting policies, Right-of-use assets and lease liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_Wu9NkzJdPUaZrVXUx5z-UA",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:EstimatedLeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Ozer3KElnU6POId_CcOTBg",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40303 - Disclosure - Summary of significant accounting policies, Property, plant and equipment (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails",
     "shortName": "Summary of significant accounting policies, Property, plant and equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Ozer3KElnU6POId_CcOTBg",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:IncomeTaxLossCarryforwardPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40304 - Disclosure - Summary of significant accounting policies, Income taxes (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesDetails",
     "shortName": "Summary of significant accounting policies, Income taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:IncomeTaxLossCarryforwardPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "aciu:OperatingSegmentsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_segment_9jTtSCng3EmNVBiAOMwlNw",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40305 - Disclosure - Summary of significant accounting policies, Segment reporting (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails",
     "shortName": "Summary of significant accounting policies, Segment reporting (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "aciu:OperatingSegmentsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_segment_9jTtSCng3EmNVBiAOMwlNw",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40401 - Disclosure - Property, plant and equipment (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
     "shortName": "Property, plant and equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_M05pHmbc10iqCZT547GuuA",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AdditionsToRightofuseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
     "shortName": "Right-of-use assets, long-term financial assets and lease liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AdditionsToRightofuseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DepreciationRightofuseAssets",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40502 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails",
     "shortName": "Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:InterestExpenseOnLeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00500 - Statement - Condensed Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AdjustmentsForDepreciationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfContractualUndiscountedCashFlowsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:GrossLeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails",
     "shortName": "Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfContractualUndiscountedCashFlowsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:GrossLeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "aciu:DisclosureOfAssetAcquisitionsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_QuVxNqREZ0mnvgP8iz8Hbw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "aciu:SharesTransferredAsConsiderationInAssetAcquisition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40601 - Disclosure - Asset acquisition (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
     "shortName": "Asset acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "aciu:DisclosureOfAssetAcquisitionsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_QuVxNqREZ0mnvgP8iz8Hbw",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "aciu:SharesTransferredAsConsiderationInAssetAcquisition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40701 - Disclosure - Intangible assets (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://acimume.com/role/DisclosureIntangibleAssetsDetails",
     "shortName": "Intangible assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_9SsycfPkpUG2RWbLatkFMg",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40801 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails",
     "shortName": "Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock",
       "aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_srt_CurrencyAxis_currency_CHF_38ToDnEBNEuS9ddM0NrYgg",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40802 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails",
     "shortName": "Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentPrepaidExpenses",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40901 - Disclosure - Prepaid expenses and accrued income (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails",
     "shortName": "Prepaid expenses and accrued income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock",
       "aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock",
       "aciu:DisclosureOfOtherCurrentReceivablesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "aciu:MiscellaneousOtherCurrentReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41001 - Disclosure - Other current receivables (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails",
     "shortName": "Other current receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock",
       "aciu:DisclosureOfOtherCurrentReceivablesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "aciu:MiscellaneousOtherCurrentReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IssuedCapital",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41101 - Disclosure - Share capital - Narratives (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails",
     "shortName": "Share capital - Narratives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_UV3ix4h--E6wHiAOGaJNtA",
      "decimals": "0",
      "lang": null,
      "name": "ifrs-full:IssuedCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates",
      "reportCount": 1,
      "unitRef": "Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41102 - Disclosure - Share capital - Capital Structure (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
     "shortName": "Share capital - Capital Structure (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_GjUP2pWxo0OYX2B-S44KPA",
      "decimals": "INF",
      "lang": null,
      "name": "aciu:IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "aciu:AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41103 - Disclosure - Share capital - Authorized capital (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails",
     "shortName": "Share capital - Authorized capital (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "aciu:AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10101 - Disclosure - General information",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://acimume.com/role/DisclosureGeneralInformation",
     "shortName": "General information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ParValuePerShare",
      "reportCount": 1,
      "unitRef": "Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41104 - Disclosure - Share capital - Conditional share capital for bonds and similar debt instruments (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails",
     "shortName": "Share capital - Conditional share capital for bonds and similar debt instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember_kNbENWSt0ES3TXF_cT2ONw",
      "decimals": "2",
      "lang": null,
      "name": "ifrs-full:ParValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ParValuePerShare",
      "reportCount": 1,
      "unitRef": "Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41105 - Disclosure - Share capital - Conditional share capital for employee benefit plans (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
     "shortName": "Share capital - Conditional share capital for employee benefit plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_4fT5bJuBykulzw1ivTHO9Q",
      "decimals": "2",
      "lang": null,
      "name": "ifrs-full:ParValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_4_28_2021_To_4_28_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_S6KglnLJ6EOK616omN_TFQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "aciu:CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41106 - Disclosure - Share capital - Shelf registration statement (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails",
     "shortName": "Share capital - Shelf registration statement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_4_28_2021_To_4_28_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_S6KglnLJ6EOK616omN_TFQ",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "aciu:CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ParValuePerShare",
      "reportCount": 1,
      "unitRef": "Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41107 - Disclosure - Share capital - At the market equity offering (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
     "shortName": "Share capital - At the market equity offering (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_7_1_2021_To_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_hFMd3XCjHE2krVkPJCUtig",
      "decimals": "0",
      "lang": null,
      "name": "aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_shares_ihmD6FhLPkS50QHWOqooNg",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "aciu:ProceedsFromIssueOfConvertibleDebt",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41108 - Disclosure - Share capital - Convertible note agreement (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
     "shortName": "Share capital - Convertible note agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_Z8Cvgi6srkG50kHoFl7dWQ",
      "decimals": "-5",
      "lang": null,
      "name": "aciu:AggregatePrincipalAmountOfEachConvertibleNote",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:TradeAndOtherCurrentPayables",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41201 - Disclosure - Trade and other payables and accrued expenses (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails",
     "shortName": "Trade and other payables and accrued expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock",
       "aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "lang": null,
      "name": "aciu:CurrentAccruedResearchAndDevelopmentCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41301 - Disclosure - Contract revenues, Contract Revenue Attributable to Licensing Arrangements (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
     "shortName": "Contract revenues, Contract Revenue Attributable to Licensing Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_NC-GY6fYlkqMWQ13ktqxIQ",
      "decimals": "2",
      "lang": null,
      "name": "ifrs-full:PercentageOfEntitysRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41302 - Disclosure - Contract revenues and other operating income - Licensing and collaboration agreement (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails",
     "shortName": "Contract revenues and other operating income - Licensing and collaboration agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41303 - Disclosure - Contract revenues, Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
     "shortName": "Contract revenues, Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2019_To_3_31_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_bzzbrZyzREe8dKLr1q4pcA",
      "decimals": "-6",
      "lang": null,
      "name": "aciu:CollaborativeAgreementMilestonePaymentReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41304 - Disclosure - Contract revenues, Anti-Abeta Antibody in AD - 2006 Agreement with Genentech (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
     "shortName": "Contract revenues, Anti-Abeta Antibody in AD - 2006 Agreement with Genentech (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AntiAbetaAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2006GenentechMember_AEaXqV6uYU2YSJVL94SJpg",
      "decimals": "-6",
      "lang": null,
      "name": "aciu:CollaborativeAgreementCumulativePaymentsReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10201 - Disclosure - Basis of preparation",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://acimume.com/role/DisclosureBasisOfPreparation",
     "shortName": "Basis of preparation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41305 - Disclosure - Contract revenues, Anti-Tau Antibody in AD - 2012 Agreement with Genentech (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
     "shortName": "Contract revenues, Anti-Tau Antibody in AD - 2012 Agreement with Genentech (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_10_1_2017_To_12_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_AntiTauAntibodyInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2012GenentechMember_MJWKVhi5Mke2_vbucOqWPQ",
      "decimals": "-6",
      "lang": null,
      "name": "aciu:CollaborativeAgreementMilestonePaymentReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41306 - Disclosure - Contract revenues, Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
     "shortName": "Contract revenues, Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_H7MVafWwHEm7SebhAlCksg",
      "decimals": null,
      "lang": "en-US",
      "name": "aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41307 - Disclosure - Contract revenues, Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
     "shortName": "Contract revenues, Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_vJPsPHg5JUivymFY6lpR6A",
      "decimals": null,
      "lang": "en-US",
      "name": "aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41308 - Disclosure - Contract revenues - Grants from the Michael J. Fox Foundation (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
     "shortName": "Contract revenues - Grants from the Michael J. Fox Foundation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_DHftPCO4NE2baGCu__fDLw",
      "decimals": "-5",
      "lang": null,
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OperatingExpense",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41401 - Disclosure - Expenses by category (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
     "shortName": "Expenses by category (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2021_To_12_31_2021_TTsKLJUGqkObQT95bWBcRA",
      "decimals": "-5",
      "lang": null,
      "name": "aciu:GainsLossesOnConversionFeaturesRelatedToConvertibleNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "aciu:NumberOfPersonsKeyManagementBoardOfDirectors",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41501 - Disclosure - Related-party transactions (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails",
     "shortName": "Related-party transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "aciu:NumberOfPersonsKeyManagementBoardOfDirectors",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_person_8KU3FQmnRUi2T5OFtX5LBQ",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IncomeTaxExpenseContinuingOperations",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41601 - Disclosure - Income taxes - Summary of Income Tax Expense (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
     "shortName": "Income taxes - Summary of Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2020_To_12_31_2020_K2KU9z0Z-U2ENaRcdQD07w",
      "decimals": "3",
      "lang": null,
      "name": "ifrs-full:ApplicableTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41602 - Disclosure - Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails",
     "shortName": "Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "aciu:DefinedBenefitPlansPercentageOfContributionsByEmployees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41701 - Disclosure - Retirement benefit plan - Summary of Benefit Plan (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails",
     "shortName": "Retirement benefit plan - Summary of Benefit Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "aciu:DefinedBenefitPlansPercentageOfContributionsByEmployees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "aciu:CurrentAndPastServiceCostGainDefinedBenefitPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41702 - Disclosure - Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails",
     "shortName": "Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "aciu:CurrentAndPastServiceCostGainDefinedBenefitPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10301 - Disclosure - Summary of significant accounting policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of significant accounting policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41703 - Disclosure - Retirement benefit plan, Changes in Defined Benefit Obligation (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
     "shortName": "Retirement benefit plan, Changes in Defined Benefit Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2019_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_V6HzKpLdRUKQbql6k-eSiw",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41704 - Disclosure - Retirement benefit plan, Changes in Fair Value of Plan Assets (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails",
     "shortName": "Retirement benefit plan, Changes in Fair Value of Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-5",
      "lang": null,
      "name": "ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "reportCount": 1,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41705 - Disclosure - Retirement benefit plan, Change in Net Defined Benefit Liability (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails",
     "shortName": "Retirement benefit plan, Change in Net Defined Benefit Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41706 - Disclosure - Retirement benefit plan - Change in other comprehensive gains (losses) (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails",
     "shortName": "Retirement benefit plan - Change in other comprehensive gains (losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ActuarialAssumptionOfDiscountRates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41707 - Disclosure - Retirement benefit plan, Actuarial Assumptions and Sensitivity Analysis (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails",
     "shortName": "Retirement benefit plan, Actuarial Assumptions and Sensitivity Analysis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ActuarialAssumptionOfDiscountRates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_pure_Ykok3XSdSECF8uu0vVcpiA",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "aciu:NumberOfEquityBasedInstrumentPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_plan_lCCE6LMjkEKlKdQ1vpJjNA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41801 - Disclosure - Share-based compensation, Plans Outstanding (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails",
     "shortName": "Share-based compensation, Plans Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "aciu:NumberOfEquityBasedInstrumentPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_plan_lCCE6LMjkEKlKdQ1vpJjNA",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2021_Kmjevc5nEE2HqKcKFf6gbA",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "reportCount": 1,
      "unitRef": "Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41802 - Disclosure - Share-based compensation, Weighted Average Exercise Prices (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails",
     "shortName": "Share-based compensation, Weighted Average Exercise Prices (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "2",
      "lang": null,
      "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "reportCount": 1,
      "unitRef": "Unit_Standard_Options_dOptxMEgoUyqJvYdP2xREA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41803 - Disclosure - Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
     "shortName": "Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "2",
      "lang": null,
      "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Divide_CHF_shares_Ad27XRfQokug-HXhLBxZsg",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41804 - Disclosure - Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails",
     "shortName": "Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "As_Of_12_31_2022_lQp7XCbMQ06p0FqAR9hHzg",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_USD_jrVEBb4k90qeG2W2V1oFGA",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41805 - Disclosure - Share-based compensation, Non-vested Share Awards (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
     "shortName": "Share-based compensation, Non-vested Share Awards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aciu-20221231x20f.htm",
      "contextRef": "Duration_1_1_2022_To_12_31_2022_lAEW2C5tvEmjcHpRfHJa-g",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Standard_CHF_6EOTduT9yEe4teLw5UJm1A",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 122,
   "tag": {
    "aciu_AccrualsForPerformanceRelatedRemuneration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accruals for performance related remuneration",
        "label": "Accruals for performance related remuneration"
       }
      }
     },
     "localname": "AccrualsForPerformanceRelatedRemuneration",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_AccruedExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued expenses",
        "label": "Trade and other payables and accrued expenses"
       }
      }
     },
     "localname": "AccruedExpensesAbstract",
     "nsuri": "http://acimume.com/20221231",
     "xbrltype": "stringItemType"
    },
    "aciu_AccruedExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for accrued expenses.",
        "label": "Accrued Expenses [Member]",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedExpensesMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_AccruedStampDuty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of current accrued stamp duty.",
        "label": "Accrued stamp duty",
        "terseLabel": "Accrued stamp duty"
       }
      }
     },
     "localname": "AccruedStampDuty",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expected rate of interest rates on retirement savings capital is used as a significant actuarial assumption to determine the present value of a defined benefit obligation.",
        "label": "Actuarial assumption of interest rate on retirement savings capital",
        "terseLabel": "Interest rate on retirement savings capital"
       }
      }
     },
     "localname": "ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the interest rate on savings capital used as actuarial assumptions.",
        "label": "Actuarial assumption of interest rate on savings capital [member]",
        "terseLabel": "Interest rate on savings capital"
       }
      }
     },
     "localname": "ActuarialAssumptionOfInterestRateOnSavingsCapitalMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional share capital that Board of Directors are authorized to issue",
        "label": "Additional share capital that Board of Directors are authorized to issue"
       }
      }
     },
     "localname": "AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for depreciation expense for right-of-use assets to reconcile profit (loss) to net cash flow from (used in) operating activities.",
        "label": "Adjustments for depreciation expense, right-of-use assets",
        "terseLabel": "Depreciation of right-of-use assets"
       }
      }
     },
     "localname": "AdjustmentsForDepreciationExpenseRightOfUseAssets",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in accrued expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.",
        "label": "Adjustments for increase (decrease) in accrued expenses",
        "negatedLabel": "(Decrease)/increase in accrued expenses"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInAccruedExpenses",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_AdvanceSmallMoleculePdProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents advance small molecule PD programs",
        "label": "Advance small molecule PD programs [Member]",
        "terseLabel": "Advance small molecule PD programs"
       }
      }
     },
     "localname": "AdvanceSmallMoleculePdProgramsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_AggregatePrincipalAmountOfEachConvertibleNote": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate principal amount of each convertible note",
        "label": "Aggregate principal amount of each convertible note"
       }
      }
     },
     "localname": "AggregatePrincipalAmountOfEachConvertibleNote",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_AlphaSynucleinPetImagingDiagnosticAgentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Alpha Synuclein PET Imaging Diagnostic Agent.",
        "label": "Alpha-synuclein PET imaging diagnostic agent"
       }
      }
     },
     "localname": "AlphaSynucleinPetImagingDiagnosticAgentMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_AntiAbetaAntibodyInADMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The research and development of medicines for the treatment of Alzheimer's disease.",
        "label": "Anti-Abeta antibody in AD [Member]",
        "terseLabel": "Anti-Abeta Antibody in AD [Member]"
       }
      }
     },
     "localname": "AntiAbetaAntibodyInADMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_AntiTauAntibodyInADMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The research and development of medicines for the treatment of Alzheimer's disease.",
        "label": "Anti-tau antibody in AD [Member]",
        "terseLabel": "Anti-tau Antibody in AD [Member]"
       }
      }
     },
     "localname": "AntiTauAntibodyInADMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_AntidilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive securities [Abstract]",
        "terseLabel": "Antidilutive securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_AssetAcquisitionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisitions",
        "label": "Asset acquisition"
       }
      }
     },
     "localname": "AssetAcquisitionsAbstract",
     "nsuri": "http://acimume.com/20221231",
     "xbrltype": "stringItemType"
    },
    "aciu_AssetAcquisitionsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table.",
        "label": "Asset acquisitions [axis]"
       }
      }
     },
     "localname": "AssetAcquisitionsAxis",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_AssetsUnderConstructionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for assets under construction.",
        "label": "Assets Under Construction"
       }
      }
     },
     "localname": "AssetsUnderConstructionMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_AtTheMarketEquityOfferingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "At the Market Equity Offering [Abstract]",
        "terseLabel": "At the Market Equity Offering [Abstract]"
       }
      }
     },
     "localname": "AtTheMarketEquityOfferingAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_AtTheMarketEquityOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An \"at-the-market\" offering is an offering of securities into an existing trading market for outstanding shares of the same class at other than a fixed price on, or through the facilities of, a national securities exchange, or to or through a market maker otherwise than on an exchange.",
        "label": "At the Market Equity Offering [Member]",
        "terseLabel": "At the Market Equity Offering [Member]"
       }
      }
     },
     "localname": "AtTheMarketEquityOfferingMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_AthosServiceGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents Athos Service GmbH",
        "label": "Athos Service GmbH [Member]"
       }
      }
     },
     "localname": "AthosServiceGmbHMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_BasisOfPreparationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of preparation and changes to the Company' accounting policies"
       }
      }
     },
     "localname": "BasisOfPreparationAbstract",
     "nsuri": "http://acimume.com/20221231",
     "xbrltype": "stringItemType"
    },
    "aciu_BoardOfDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Key managers of an entity who collectively have responsibility of governing the entity.",
        "label": "Board of Directors [Member]",
        "verboseLabel": "Directors [Member]"
       }
      }
     },
     "localname": "BoardOfDirectorsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital authorized to be issued under shelf registration statement",
        "label": "Capital authorized to be issued under shelf registration statement",
        "terseLabel": "Capital authorized to be issued under Shelf Registration Statement"
       }
      }
     },
     "localname": "CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_CashAcquiredAsPartOfAssetAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "aciu_TotalAssetsAcquiredInAssetAcquisition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash acquired as part of asset acquisition",
        "label": "Cash acquired as part of asset acquisition",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashAcquiredAsPartOfAssetAcquisition",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_CashAdvancesForRentDeposit": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow or inflow for deposit of rent.",
        "label": "Cash Advances for Rent Deposit",
        "negatedLabel": "Rental deposits"
       }
      }
     },
     "localname": "CashAdvancesForRentDeposit",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_CashAndCashEquivalentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Cash and cash equivalent [Line Items]"
       }
      }
     },
     "localname": "CashAndCashEquivalentLineItems",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_CashAndCashEquivalentsSubjectToNegativeInterestRates": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalents subject to negative interest rates",
        "label": "Cash and cash equivalents subject to negative interest rates"
       }
      }
     },
     "localname": "CashAndCashEquivalentsSubjectToNegativeInterestRates",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_CashAndCashEquivalentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash and cash equivalent balances, including foreign currencies in which the balances are denominated.",
        "label": "Cash and cash equivalents [Table]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsTable",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_CashOnHandAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.",
        "label": "Cash on hand and cash equivalents [Member]",
        "terseLabel": "Cash and Cash Equivalents [Member]",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashOnHandAndCashEquivalentsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_ChangesInFairValueOfPlanAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in fair value of plan assets [Abstract]",
        "terseLabel": "Changes in fair value of plan assets [Abstract]"
       }
      }
     },
     "localname": "ChangesInFairValueOfPlanAssetsAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_ChangesInWorkingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in working capital [Abstract]",
        "terseLabel": "Changes in working capital:"
       }
      }
     },
     "localname": "ChangesInWorkingCapitalAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_Chf0.15Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for CHF 0.15",
        "label": "CHF 0.15 [Member]",
        "terseLabel": "CHF 0.15"
       }
      }
     },
     "localname": "Chf0.15Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_Chf9.53Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for CHF 9.53",
        "label": "CHF 9.53 [Member]",
        "terseLabel": "CHF 9.53"
       }
      }
     },
     "localname": "Chf9.53Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_ClinicalMilestonesAchievedPriorTo1January2017Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical milestones achieved prior to 1 January 2017",
        "label": "Clinical milestones achieved prior to 1 January 2017 [Member]",
        "terseLabel": "Clinical milestones achieved prior to 1 January 2017"
       }
      }
     },
     "localname": "ClinicalMilestonesAchievedPriorTo1January2017Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_ClinicalMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents clinical milestones",
        "label": "Clinical milestones [Member]",
        "terseLabel": "Clinical milestones"
       }
      }
     },
     "localname": "ClinicalMilestonesMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_CollaborationAgreementOf2006GenentechMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2006 contractual research agreement associated with collaboration with Genentech.",
        "label": "Collaboration agreement of 2006, Genentech [Member]",
        "verboseLabel": "2006 Agreement with Genentech [Member]"
       }
      }
     },
     "localname": "CollaborationAgreementOf2006GenentechMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_CollaborationAgreementOf2012GenentechMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2012 contractual research agreement associated with collaboration with Genentech.",
        "label": "Collaboration agreement of 2012, Genentech [Member]",
        "terseLabel": "2012 Agreement with Genentech [Member]",
        "verboseLabel": "Genentech [Member]"
       }
      }
     },
     "localname": "CollaborationAgreementOf2012GenentechMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2014 contractual research agreement associated with collaboration with Janssen Pharmaceuticals.",
        "label": "Collaboration agreement of 2014, Janssen Pharmaceuticals [Member]",
        "terseLabel": "2014 Agreement with Janssen Pharmaceuticals [Member]",
        "verboseLabel": "Janssen"
       }
      }
     },
     "localname": "CollaborationAgreementOf2014JanssenPharmaceuticalsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_CollaborationAgreementWithLillyFirstAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The first amendment to the collaboration agreement with Lilly for research and development.",
        "label": "Collaboration Agreement with Lilly, First Amendment [Member]",
        "terseLabel": "2018 License Agreement with Eli Lilly, First Amendment [Member]"
       }
      }
     },
     "localname": "CollaborationAgreementWithLillyFirstAmendmentMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_CollaborationAgreementWithLillyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The collaboration agreement with Lilly for research and development.",
        "label": "Collaboration Agreement with Lilly [Member]",
        "terseLabel": "Lilly [Member]",
        "verboseLabel": "2018 License Agreement with Eli Lilly and Company [Member]"
       }
      }
     },
     "localname": "CollaborationAgreementWithLillyMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_CollaborationAgreementWithLillySecondAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The second amendment to the collaboration agreement with Lilly for research and development.",
        "label": "Collaboration Agreement with Lilly, Second Amendment [Member]",
        "terseLabel": "2018 License Agreement with Eli Lilly, Second Amendment [Member]"
       }
      }
     },
     "localname": "CollaborationAgreementWithLillySecondAmendmentMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_CollaborationAndLicenseRevenueAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaboration and License Revenue Agreements [Member]",
        "terseLabel": "Collaboration and License Revenue [Member]",
        "verboseLabel": "Collaboration and License Revenue Agreements [Member]"
       }
      }
     },
     "localname": "CollaborationAndLicenseRevenueAgreementsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_CollaborativeAgreementCumulativePaymentsReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative payments received related to revenue from upfront license fees, milestone payments and revenue from research agreements associated with a collaborative agreement.",
        "label": "Collaborative agreement, Cumulative payments received",
        "verboseLabel": "Cumulative payments received"
       }
      }
     },
     "localname": "CollaborativeAgreementCumulativePaymentsReceived",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_CollaborativeAgreementJointResearchCollaborationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period over which collaborating entities are contracted to perform research, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Collaborative agreement, Joint research collaboration period",
        "terseLabel": "Period of joint research agreement"
       }
      }
     },
     "localname": "CollaborativeAgreementJointResearchCollaborationPeriod",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of installments for satisfying a milestone payment associated with a collaborative agreement.",
        "label": "Collaborative agreement, milestone payment, number of installments",
        "terseLabel": "Number of installments"
       }
      }
     },
     "localname": "CollaborativeAgreementMilestonePaymentNumberOfInstallments",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aciu_CollaborativeAgreementMilestonePaymentReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment(s) received for milestone payments associated with a collaborative agreement.",
        "label": "Collaborative agreement, Milestone payment received",
        "terseLabel": "Milestone payment received"
       }
      }
     },
     "localname": "CollaborativeAgreementMilestonePaymentReceived",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Collaborative agreement, Notice of contract termination period",
        "terseLabel": "Period to provide notice of termination of agreement"
       }
      }
     },
     "localname": "CollaborativeAgreementNoticeOfContractTerminationPeriod",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aciu_CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative agreement, Notice of contract termination period in case of material breach of contract",
        "label": "Collaborative agreement, Notice of contract termination period in case of material breach of contract"
       }
      }
     },
     "localname": "CollaborativeAgreementNoticeOfContractTerminationPeriodInCaseOfMaterialBreachOfContract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aciu_CollaborativeAgreementPotentialValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total potential value of the collaborative agreement.",
        "label": "Collaborative agreement, potential value",
        "terseLabel": "Total potential collaboration agreement value"
       }
      }
     },
     "localname": "CollaborativeAgreementPotentialValue",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_CollaborativeAgreementUpfrontPaymentsReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative agreement, upfront payments received",
        "label": "Collaborative agreement, upfront payments received"
       }
      }
     },
     "localname": "CollaborativeAgreementUpfrontPaymentsReceived",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_CommissionsPaidForIssuanceOrdinaryShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commissions paid for issuance ordinary shares.",
        "label": "Commissions paid for issuance ordinary shares",
        "terseLabel": "Commissions paid"
       }
      }
     },
     "localname": "CommissionsPaidForIssuanceOrdinaryShares",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_CommitmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments [Abstract]",
        "terseLabel": "Commitments and contingencies [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_CommitmentsAndContingenciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesAbstract",
     "nsuri": "http://acimume.com/20221231",
     "xbrltype": "stringItemType"
    },
    "aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of common shares authorized for sale in the open market.",
        "label": "Common shares authorized for issuance sales in in open market",
        "terseLabel": "Shares authorized for sale"
       }
      }
     },
     "localname": "CommonSharesAuthorizedForIssuanceSalesInInOpenMarket",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_ConditionalShareCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conditional share capital [Abstract]",
        "terseLabel": "Conditional Share Capital [Abstract]"
       }
      }
     },
     "localname": "ConditionalShareCapitalAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for share capital of the conditional share capital for bonds and similar debt instruments.",
        "label": "Conditional share capital for bonds and similar debt instruments [Member]",
        "terseLabel": "Bonds and Similar Debt Instruments [Member]"
       }
      }
     },
     "localname": "ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for share capital of the conditional share capital for employee benefit plans.",
        "label": "Conditional share capital for employee benefit plans [Member]",
        "terseLabel": "Employee Benefit Plans [Member]"
       }
      }
     },
     "localname": "ConditionalShareCapitalForEmployeeBenefitPlansMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_ContractRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract Revenue [Abstract]",
        "terseLabel": "Contract Revenue [Abstract]"
       }
      }
     },
     "localname": "ContractRevenueAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_ContractualCapitalCommitmentsOtherThanForLeases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual capital commitments other than for leases",
        "label": "Contractual capital commitments other than for leases"
       }
      }
     },
     "localname": "ContractualCapitalCommitmentsOtherThanForLeases",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual undiscounted cash flows for lease liabilities [Abstract]",
        "terseLabel": "Contractual undiscounted cash flows for lease liabilities:"
       }
      }
     },
     "localname": "ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_ConvertibleNoteAgreementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Note Agreement [Abstract]"
       }
      }
     },
     "localname": "ConvertibleNoteAgreementAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_ConvertibleNoteAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represents to convertible note agreement.",
        "label": "Convertible Note Agreement [Member]",
        "terseLabel": "Convertible Note Agreement with Lilly [Member]",
        "verboseLabel": "Convertible note agreements"
       }
      }
     },
     "localname": "ConvertibleNoteAgreementMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_CurrentAccruedResearchAndDevelopmentCosts": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of current accrued research and development costs.",
        "label": "Current accrued research and development costs",
        "terseLabel": "Accrued research and development costs"
       }
      }
     },
     "localname": "CurrentAccruedResearchAndDevelopmentCosts",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_CurrentAndPastServiceCostGainDefinedBenefitPlans": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current and past service cost (gain), defined benefit plans",
        "label": "Current and past service cost (gain), defined benefit plans",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "CurrentAndPastServiceCostGainDefinedBenefitPlans",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_December312024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents December 31, 2024",
        "label": "December 31, 2024 [Member]",
        "terseLabel": "December 31, 2024"
       }
      }
     },
     "localname": "December312024Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_December312025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents December 31, 2025",
        "label": "December 31, 2025 [Member]",
        "terseLabel": "December 31, 2025"
       }
      }
     },
     "localname": "December312025Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_December312026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents December 31, 2026",
        "label": "December 31, 2026 [Member]",
        "terseLabel": "December 31, 2026"
       }
      }
     },
     "localname": "December312026Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_December312027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents December 31, 2027",
        "label": "December 31, 2027 [Member]",
        "terseLabel": "December 31, 2027"
       }
      }
     },
     "localname": "December312027Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_December312028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents December 31, 2028",
        "label": "December 31, 2028 [Member]",
        "terseLabel": "December 31, 2028"
       }
      }
     },
     "localname": "December312028Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_December312029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents December 31, 2029",
        "label": "December 31, 2029 [Member]",
        "terseLabel": "December 31, 2029"
       }
      }
     },
     "localname": "December312029Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in number of treasury shares from sales or issuance",
        "label": "Decrease in number of treasury shares from sales or issuance",
        "terseLabel": "Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs (in shares)"
       }
      }
     },
     "localname": "DecreaseInNumberOfTreasurySharesFromSalesOrIssuance",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plans, percentage of contributions by employees",
        "label": "Defined benefit plans, percentage of contributions by employees"
       }
      }
     },
     "localname": "DefinedBenefitPlansPercentageOfContributionsByEmployees",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plans, percentage of contributions by employer",
        "label": "Defined benefit plans, percentage of contributions by employer"
       }
      }
     },
     "localname": "DefinedBenefitPlansPercentageOfContributionsByEmployer",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for judgments that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognized in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year.",
        "label": "Description of accounting policy for accounting judgments and estimates [Policy Text Block]",
        "terseLabel": "Critical judgments and accounting estimates"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for the basis for how the entity classifies assets and liabilities as current and non-current.",
        "label": "Description of accounting policy for classification of assets and liabilities [Policy Text Block]",
        "terseLabel": "Current vs. non-current classification"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of instruments (including contingently issuable shares) that could potentially dilute basic earnings per share in the future.",
        "label": "Dilutive effect of convertible instruments [Text Block]",
        "terseLabel": "Schedule of antidilutive securities"
       }
      }
     },
     "localname": "DilutiveEffectOfConvertibleInstrumentsTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of dilutive restricted share awards subject to future vesting that relate to the assumed exercise of the entity's incentive share options.",
        "label": "Dilutive effect of Restricted share awards subject to future vesting",
        "terseLabel": "Restricted share awards subject to future vesting"
       }
      }
     },
     "localname": "DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options and potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments.",
        "label": "Dilutive effect of share options and convertible instruments on number of ordinary shares",
        "totalLabel": "Total potentially dilutive securities"
       }
      }
     },
     "localname": "DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of dilutive share options that relate to the assumed exercise of the entity's share options.",
        "label": "Dilutive effect of share options issued and outstanding",
        "terseLabel": "Share options issued and outstanding (in-the-money)"
       }
      }
     },
     "localname": "DilutiveEffectOfShareOptionsIssuedAndOutstanding",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for changes to accounting policies recently adopted by the entity.",
        "label": "Disclosure Of Accounting Policy For Changes In Accounting Policies Recently Adopted [Text Block]",
        "terseLabel": "Accounting policies, new standards, interpretations and amendments adopted by the Company"
       }
      }
     },
     "localname": "DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of amounts recognised in balance sheet from defined benefit plans",
        "label": "Disclosure of amounts recognised in balance sheet from defined benefit plans [table text block]",
        "terseLabel": "Schedule of amounts recognized in balance sheet from defined benefit plans"
       }
      }
     },
     "localname": "DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of amounts recognised in statement of other comprehensive income from defined benefit plans",
        "label": "Disclosure of amounts recognised in statement of other comprehensive income from defined benefit plans [table text block]",
        "terseLabel": "Schedule of amounts recognized in statement of other comprehensive income from defined benefit plans"
       }
      }
     },
     "localname": "DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of amounts recognised in statement of profit and loss from defined benefit plans",
        "label": "Disclosure of amounts recognised in statement of profit and loss from defined benefit plans [table text block]",
        "terseLabel": "Schedule of amounts recognized in statement of profit and loss from defined benefit plans"
       }
      }
     },
     "localname": "DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfAssetAcquisitionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of asset acquisitions",
        "label": "Disclosure of asset acquisitions [table text block]",
        "terseLabel": "Schedule of Transferred Assets acquired"
       }
      }
     },
     "localname": "DisclosureOfAssetAcquisitionsTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfAssetAcquisitionsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for asset acquisitions",
        "label": "Disclosure of asset acquisitions [text block]",
        "terseLabel": "Asset acquisition"
       }
      }
     },
     "localname": "DisclosureOfAssetAcquisitionsTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents and short-term deposits not classified as cash equivalents.",
        "label": "Disclosure of cash and cash equivalents and short-term deposits not classified as cash equivalents [text block]",
        "terseLabel": "Cash and cash equivalents and short-term financial assets"
       }
      }
     },
     "localname": "DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about carrying amounts of financial assets and financial liabilities.",
        "label": "Disclosure of detailed information about carrying amounts of financial assets and financial liabilities [Table Text Block]",
        "terseLabel": "Carrying amounts of financial assets and financial liabilities"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about the expiration of income tax losses that may be carried forward.",
        "label": "Disclosure of detailed information about income tax losses expiry [Table Text Block]",
        "terseLabel": "Tax losses carry forwards and respective expiry dates"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about income tax reconciliation.",
        "label": "Disclosure of detailed information about income tax reconciliation [Table Text Block]",
        "terseLabel": "Income tax expense reconciled to loss"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about other current receivables.",
        "label": "Disclosure of detailed information about other current receivables [Table Text Block]",
        "terseLabel": "Other current receivables"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about prepaid expenses and accrued income including contract assets",
        "label": "Disclosure of detailed information about prepaid expenses and accrued income including contract assets [Table Text Block]",
        "terseLabel": "Prepaid expenses and accrued income"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about trade payables and accrued liabilities.",
        "label": "Disclosure of detailed information about trade payables and accrued liabilities [Table Text Block]",
        "terseLabel": "Schedule of trade and other payables and accrued expenses"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for general information about the entity.",
        "label": "Disclosure of general information about the entity explanatory [Text Block]",
        "terseLabel": "General information"
       }
      }
     },
     "localname": "DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureGeneralInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Disclosure of information about commitments and contingencies [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of disclosing information related to commitments and contingencies.",
        "label": "Disclosure of information about commitments and contingencies [Table]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutCommitmentsAndContingenciesTable",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_DisclosureOfOtherCurrentReceivablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Disclosure of other current receivables [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfOtherCurrentReceivablesLineItems",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_DisclosureOfOtherCurrentReceivablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to other current receivables.",
        "label": "Disclosure of other current receivables [Table]"
       }
      }
     },
     "localname": "DisclosureOfOtherCurrentReceivablesTable",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_DisclosureOfOtherCurrentReceivablesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of other current receivables.",
        "label": "Disclosure of other current receivables [Text Block]",
        "terseLabel": "Other current receivables"
       }
      }
     },
     "localname": "DisclosureOfOtherCurrentReceivablesTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of prepaid expenses and accrued income including contract assets",
        "label": "Disclosure of prepaid expenses and accrued income including contract assets [Text Block]",
        "terseLabel": "Prepaid expenses and accrued income"
       }
      }
     },
     "localname": "DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of right-of-use assets impact on the company's statements of income/(loss) and statements of cash flows.",
        "label": "Disclosure of right-of-use assets impact on statements [Text Block]",
        "verboseLabel": "Schedule of impact on condensed consolidated statements of income/(loss) and cash flows"
       }
      }
     },
     "localname": "DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of trade and other payables and accrued expenses",
        "label": "Disclosure of trade and other payables and accrued expenses [text block]",
        "terseLabel": "Trade and other payables and accrued expenses"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_DispositionsOfRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of decrease in right-of-use assets from disposals.",
        "label": "Dispositions of right-of-use assets",
        "negatedLabel": "Dispositions"
       }
      }
     },
     "localname": "DispositionsOfRightOfUseAssets",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee benefits expense excluding share-based compensation",
        "label": "Employee benefits expense excluding share-based compensation",
        "terseLabel": "Payroll expenses"
       }
      }
     },
     "localname": "EmployeeBenefitsExpenseExcludingShareBasedCompensation",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_EmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to personnel employed by the entity.",
        "label": "Employees [Member]"
       }
      }
     },
     "localname": "EmployeesMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_EscrowDepositAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of deposits held in escrow.",
        "label": "Escrow deposit, amount",
        "terseLabel": "Escrow deposits"
       }
      }
     },
     "localname": "EscrowDepositAmount",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_EstimatedLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated lease term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Estimated lease term",
        "terseLabel": "Estimated lease term"
       }
      }
     },
     "localname": "EstimatedLeaseTerm",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aciu_ExecutiveManagementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Key managers, or ranking officers of an entity, appointed to their position by the board of directors.",
        "label": "Executive Management [Member]",
        "verboseLabel": "Executives [Member]"
       }
      }
     },
     "localname": "ExecutiveManagementMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_ExpenseRelatingToLeases": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense for leases recognized through profit and loss.",
        "label": "Expense relating to leases",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "ExpenseRelatingToLeases",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_ExpensesByCategoryAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses by category [Abstract]"
       }
      }
     },
     "localname": "ExpensesByCategoryAbstract",
     "nsuri": "http://acimume.com/20221231",
     "xbrltype": "stringItemType"
    },
    "aciu_ExpensesOperatingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses, Operating [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "ExpensesOperatingAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_FinancialAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets and liabilities [Abstract]",
        "terseLabel": "Financial assets and liabilities [Abstract]"
       }
      }
     },
     "localname": "FinancialAssetsAndLiabilitiesAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_FinancialResultNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Result, net [Abstract]",
        "terseLabel": "Financial result, net [Abstract]"
       }
      }
     },
     "localname": "FinancialResultNetAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_FinancialRisksAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial risks [Abstract]",
        "terseLabel": "Financial risks [Abstract]"
       }
      }
     },
     "localname": "FinancialRisksAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_FirstCapitalPartnerGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents First Capital Partner GmbH",
        "label": "First Capital Partner GmbH [Member]"
       }
      }
     },
     "localname": "FirstCapitalPartnerGmbHMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_FollowOnGrantFundingReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow-on grant funding received",
        "label": "Follow-on grant funding received"
       }
      }
     },
     "localname": "FollowOnGrantFundingReceived",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_FollowOnGrantFundingReceivedTotalForJointArrangement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow-on grant funding received, total for joint arrangement",
        "label": "Follow-on grant funding received, total for joint arrangement"
       }
      }
     },
     "localname": "FollowOnGrantFundingReceivedTotalForJointArrangement",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_GainsLossesOnConversionFeaturesRelatedToConvertibleNotes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gains (losses) on conversion features related to convertible notes",
        "label": "Gains (losses) on conversion features related to convertible notes",
        "terseLabel": "Gains on conversion features related to convertible notes"
       }
      }
     },
     "localname": "GainsLossesOnConversionFeaturesRelatedToConvertibleNotes",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_GeneralInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General information"
       }
      }
     },
     "localname": "GeneralInformationAbstract",
     "nsuri": "http://acimume.com/20221231",
     "xbrltype": "stringItemType"
    },
    "aciu_GoingConcernAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Going Concern [Abstract]",
        "terseLabel": "Going concern [Abstract]"
       }
      }
     },
     "localname": "GoingConcernAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_GrantIncomePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for grant income.",
        "label": "Grant income [Policy Text Block]",
        "terseLabel": "Grant income"
       }
      }
     },
     "localname": "GrantIncomePolicyTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_GrantRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue earned from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.",
        "label": "Grant revenue [Member]",
        "terseLabel": "Grant revenue [Member]"
       }
      }
     },
     "localname": "GrantRevenueMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_GrantsMichaelJ.FoxFoundationAndTargetAlsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents grants from the Michael J. Fox Foundation and Target ALS",
        "label": "Grants, Michael J. Fox Foundation and Target ALS [Member]",
        "terseLabel": "Grants, Michael J. Fox Foundation and Target ALS"
       }
      }
     },
     "localname": "GrantsMichaelJ.FoxFoundationAndTargetAlsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_GrantsMichaelJFoxFoundationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Funding provided for certain types of expenditures in connection with research and development activities over a contractually-defined period from the Michael J. Fox Foundation.",
        "label": "Grants, Michael J. Fox Foundation [Member]",
        "terseLabel": "Grant from Michael J. Fox Foundation"
       }
      }
     },
     "localname": "GrantsMichaelJFoxFoundationMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_IfNotesAreConvertedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents the scenario that notes get converted",
        "label": "If notes are converted [Member]",
        "terseLabel": "If notes are converted"
       }
      }
     },
     "localname": "IfNotesAreConvertedMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impact on statements of income/(loss) and cash flows [Abstract]",
        "terseLabel": "Statements of income/(loss) and cash flows"
       }
      }
     },
     "localname": "ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_InProcessResearchAndDevelopmentIPRDAssetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for an intangible asset that is a clinically-validated active vaccine candidate for the treatment of Parkinson's disease.",
        "label": "Acquired IPR&amp;D Asset"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentIPRDAssetMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_IncomeTaxLossCarryforwardPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period or time limit over which financial losses of the entity for preceding years can be deducted from the taxable revenue for a period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Income tax loss, Carryforward period",
        "terseLabel": "Tax loss carryforward period"
       }
      }
     },
     "localname": "IncomeTaxLossCarryforwardPeriod",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in net defined benefit liability (asset) resulting from benefits deposited",
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from benefits deposited",
        "negatedLabel": "Benefits deposited"
       }
      }
     },
     "localname": "IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in net defined benefit liability (asset) resulting from current and past service costs (income)",
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from current and past service costs (income)",
        "negatedLabel": "Service cost"
       }
      }
     },
     "localname": "IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromCurrentAndPastServiceCostsIncome",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in profit (loss) resulting from reasonably possible increase or decrease in interest rates",
        "label": "Increase (decrease) in profit (loss) resulting from reasonably possible increase or decrease in interest rates"
       }
      }
     },
     "localname": "IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in profit (loss) resulting from reasonably possible strengthening or weakening of reporting currency against other relevant currencies",
        "label": "Increase (decrease) in profit (loss) resulting from reasonably possible strengthening or weakening of reporting currency against other relevant currencies"
       }
      }
     },
     "localname": "IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in tax losses available for offset against future taxable profits",
        "label": "Increase (decrease) in tax losses available for offset against future taxable profits"
       }
      }
     },
     "localname": "IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "'The increase (decrease) in equity resulting from the issuance of shares as part of an asset acquisition.",
        "label": "Increase (decrease) through acquisition of assets, equity",
        "terseLabel": "Asset acquisition - common shares"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughAcquisitionOfAssetsEquity",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from purchase of IPR&amp;D assets.",
        "label": "Increase (decrease) through purchase of in process research and development asset",
        "terseLabel": "IPR&amp;D asset purchase"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in equity shares resulting from treasury share transactions.",
        "label": "Increase (decrease) through treasury share transactions, equity, shares",
        "terseLabel": "Issuance of shares to be held as treasury shares, net of transaction costs (in shares)",
        "verboseLabel": "Issuance of shares to be held as treasury shares"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in the number of ordinary shares issued under a convertible debt arrangement upon conversion of the debt.",
        "label": "Increase in number of ordinary shares issued under conversion of convertible debt",
        "terseLabel": "Conversion of note agreement, net of transaction costs (in shares)",
        "verboseLabel": "Number of shares issued through conversion of convertible notes"
       }
      }
     },
     "localname": "IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in the number of ordinary shares issued under incentive plans.",
        "label": "Increase in number of ordinary shares issued under incentive plans",
        "terseLabel": "Issuance of shares - incentive plans, net of transaction costs (in shares)"
       }
      }
     },
     "localname": "IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aciu_IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in number of shares through issuance as consideration in asset acquisitions",
        "label": "Increase in number of shares through issuance as consideration in asset acquisitions",
        "terseLabel": "Asset purchase agreement, net of transaction costs (in shares)"
       }
      }
     },
     "localname": "IncreaseInNumberOfSharesThroughIssuanceAsConsiderationInAssetAcquisitions",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aciu_IncreaseThroughIssuanceOfSharesInAssetAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in equity through issuance of shares in asset acquisitions",
        "label": "Increase through issuance of shares in asset acquisitions",
        "terseLabel": "Asset purchase agreement, net of transaction costs"
       }
      }
     },
     "localname": "IncreaseThroughIssuanceOfSharesInAssetAcquisitions",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_IncreaseThroughSharesIssuedUnderIncentivePlans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in equity resulting from the issue of shares under incentive plans.",
        "label": "Increase through shares issued under incentive plans",
        "verboseLabel": "Issuance of shares - incentive plans, net of transaction costs"
       }
      }
     },
     "localname": "IncreaseThroughSharesIssuedUnderIncentivePlans",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "aciu_TotalAssetsAcquiredInAssetAcquisition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets acquired as part of asset acquisition",
        "label": "Intangible assets acquired as part of asset acquisition",
        "terseLabel": "IPR&amp;D asset"
       }
      }
     },
     "localname": "IntangibleAssetsAcquiredAsPartOfAssetAcquisition",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents the IPR&amp;D intangible asset associated with ACI 7104.056",
        "label": "IPR&amp;D intangible asset associated with ACI 7104.056 [Member]",
        "terseLabel": "IPR&amp;D intangible asset associated with ACI 7104.056"
       }
      }
     },
     "localname": "IprDIntangibleAssetAssociatedWithAci7104.056Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Issuance of shares for purchase of IPR&amp;D asset in asset acquisition.",
        "label": "Issuance of shares for purchase of IPR&amp;D asset in asset acquisition"
       }
      }
     },
     "localname": "IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_IssueOfEquityRestrictedShareAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in equity through the issue of restricted share awards.",
        "label": "Issue of Equity, Restricted Share Awards",
        "terseLabel": "Restricted share awards"
       }
      }
     },
     "localname": "IssueOfEquityRestrictedShareAwards",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing laboratory equipment.",
        "label": "Laboratory equipment [Member]",
        "terseLabel": "Lab Equipment"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_LeaseholdImprovementsAndFixturesAndFittingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement and fixtures and fittings that are not permanently attached to real property.",
        "label": "Leasehold improvements and fixtures and fittings [Member]",
        "terseLabel": "Leasehold Improvements/Furniture [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsAndFixturesAndFittingsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2014 contractual research agreement associated with collaboration with Life Molecular Imaging.",
        "label": "License and collaboration agreement of 2014, Life Molecular Imaging [Member]",
        "terseLabel": "2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member]",
        "verboseLabel": "Life Molecular Imaging [Member]"
       }
      }
     },
     "localname": "LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails",
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_LiquidityManagementRollingForecastPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The periodic interval in which the entity performs a rolling forecast of the entity's cash position, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Liquidity management, rolling forecast period",
        "terseLabel": "Cash position rolling forecast period"
       }
      }
     },
     "localname": "LiquidityManagementRollingForecastPeriod",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aciu_LongTermFinancialAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents financial assets classified as long-term.",
        "label": "Long-term Financial Assets [Member]",
        "terseLabel": "Long-term financial assets"
       }
      }
     },
     "localname": "LongTermFinancialAssetsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_LongTermLeaseLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Long-term lease liabilities",
        "label": "Long-term lease liabilities [Member]",
        "terseLabel": "Long-term lease liabilities"
       }
      }
     },
     "localname": "LongTermLeaseLiabilitiesMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_March312020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents March 31, 2020",
        "label": "March 31, 2020 [Member]",
        "terseLabel": "March 31, 2020"
       }
      }
     },
     "localname": "March312020Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_MaturityPeriodOtherCurrentReceivables": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturity period, other current receivables",
        "label": "Maturity period, other current receivables"
       }
      }
     },
     "localname": "MaturityPeriodOtherCurrentReceivables",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum term of options granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum term of options granted for share-based payment arrangement",
        "terseLabel": "Contractual life of options"
       }
      }
     },
     "localname": "MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum term of other equity instruments (ie other than share options) granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Term Of Other Equity Instruments Granted For Share Based Payment Arrangement",
        "terseLabel": "Contractual life of options"
       }
      }
     },
     "localname": "MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to a milestone payment arrangement related to clinical and regulatory milestones.",
        "label": "Milestone payments, clinical and regulatory milestones [Member]",
        "terseLabel": "Clinical and Regulatory [Member]"
       }
      }
     },
     "localname": "MilestonePaymentsClinicalAndRegulatoryMilestonesMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_MilestonePaymentsCommercialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to a milestone payment arrangement related to certain commercial milestones.",
        "label": "Milestone payments, commercial [Member]",
        "terseLabel": "Commercial [Member]"
       }
      }
     },
     "localname": "MilestonePaymentsCommercialMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_MiscellaneousOtherCurrentReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Miscellaneous other current receivables",
        "label": "Miscellaneous other current receivables",
        "terseLabel": "Other current receivable"
       }
      }
     },
     "localname": "MiscellaneousOtherCurrentReceivables",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares that Board of Directors are authorized to issue",
        "label": "Number of additional shares that Board of Directors are authorized to issue"
       }
      }
     },
     "localname": "NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aciu_NumberOfConvertibleNoteAgreements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of convertible note agreements",
        "label": "Number of convertible note agreements",
        "terseLabel": "Number of separate convertible note agreements"
       }
      }
     },
     "localname": "NumberOfConvertibleNoteAgreements",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aciu_NumberOfDepositsInEscrowAccounts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of deposits in escrow accounts.",
        "label": "Number of deposits in escrow accounts"
       }
      }
     },
     "localname": "NumberOfDepositsInEscrowAccounts",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aciu_NumberOfEquityBasedInstrumentPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity-based instrument plans approved by the entity.",
        "label": "Number of Equity-based Instrument Plans",
        "terseLabel": "Number of equity-based instrument plans"
       }
      }
     },
     "localname": "NumberOfEquityBasedInstrumentPlans",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of financial institutions holding the entity's deposits of cash and cash equivalents and short-term financial assets.",
        "label": "Number of financial institutions holding, cash and cash equivalents and short-term financial assets",
        "terseLabel": "Number of financial institutions holding cash and cash equivalents and short-term financial assets"
       }
      }
     },
     "localname": "NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aciu_NumberOfGrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants received.",
        "label": "Number of grants",
        "terseLabel": "Number of grants received"
       }
      }
     },
     "localname": "NumberOfGrants",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aciu_NumberOfMilestonePaymentsReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of times payment(s) received for milestone payments associated with a collaborative agreement.",
        "label": "Number of milestone payments received",
        "terseLabel": "Number of milestone payments received"
       }
      }
     },
     "localname": "NumberOfMilestonePaymentsReceived",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aciu_NumberOfNonVestedSharesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Non-vested Shares [Abstract]",
        "terseLabel": "Number of non-vested shares [Abstract]"
       }
      }
     },
     "localname": "NumberOfNonVestedSharesAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_NumberOfOptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Options [Abstract]",
        "terseLabel": "Number of options [Abstract]"
       }
      }
     },
     "localname": "NumberOfOptionsAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercised in a share-based payment arrangement.",
        "label": "Number of other equity instruments exercised in share-based payment arrangement",
        "negatedLabel": "Exercised during the year (in shares)"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "aciu_NumberOfPersonsKeyManagementBoardOfDirectors": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of persons that are the included in Board of Directors excluding the Chief Executive Officer.",
        "label": "Number of persons, key management, Board of Directors",
        "terseLabel": "Number of individuals, Board of Directors"
       }
      }
     },
     "localname": "NumberOfPersonsKeyManagementBoardOfDirectors",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aciu_NumberOfPersonsKeyManagementExecutiveManagement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of persons that comprise key management of the entity that are Executive Management.",
        "label": "Number of persons, key management, Executive Management",
        "terseLabel": "Number of individuals, Executive Management"
       }
      }
     },
     "localname": "NumberOfPersonsKeyManagementExecutiveManagement",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of representatives in a joint steering committee by each party as per the agreement.",
        "label": "Number of representatives in joint steering committee by each party",
        "terseLabel": "Number of representatives in joint steering committee by each party"
       }
      }
     },
     "localname": "NumberOfRepresentativesInJointSteeringCommitteeByEachParty",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aciu_NumberOfTechnologyPlatforms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of unique proprietary platform technologies to discover, design and develop medicines and diagnostics to target misfolded proteins.",
        "label": "Number of technology platforms",
        "terseLabel": "Number of proprietary technology platforms"
       }
      }
     },
     "localname": "NumberOfTechnologyPlatforms",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureGeneralInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aciu_OperatingSegmentsNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments reported by the entity.",
        "label": "Operating segments, number",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "OperatingSegmentsNumber",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aciu_OtherAccruedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other accrued expenses",
        "label": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedExpenses",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_OtherComprehensiveGainsLossesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive gains (losses) [Abstract]",
        "terseLabel": "Other comprehensive gains/(losses) [Abstract]"
       }
      }
     },
     "localname": "OtherComprehensiveGainsLossesAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_OtherCurrentReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current receivables [Abstract]"
       }
      }
     },
     "localname": "OtherCurrentReceivablesAbstract",
     "nsuri": "http://acimume.com/20221231",
     "xbrltype": "stringItemType"
    },
    "aciu_OtherCurrentReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents other current receivables",
        "label": "Other current receivables [Member]"
       }
      }
     },
     "localname": "OtherCurrentReceivablesMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding equity or cash consideration due under convertible note agreements",
        "label": "Outstanding equity or cash consideration due under convertible note agreements"
       }
      }
     },
     "localname": "OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Options Exercise Price Range and Expiry Dates [Abstract]",
        "terseLabel": "Outstanding options, exercise price range and expiry dates [Abstract]"
       }
      }
     },
     "localname": "OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for share issue costs associated with issuance of shares in relation to asset acquisitions",
        "label": "Payments for share issue costs associated with issuance of shares in relation to asset acquisitions",
        "negatedLabel": "Transaction costs associated with issuance of shares in relation to asset acquisition previously recorded in Accrued expenses"
       }
      }
     },
     "localname": "PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments (proceeds) from purchases (sales) of short-term financial assets, classified as investing activities",
        "label": "Payments (proceeds) from purchases (sales) of short-term financial assets, classified as investing activities",
        "negatedLabel": "Short-term financial assets, net"
       }
      }
     },
     "localname": "PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_PercentageIncreaseInPropertyPlantAndEquipment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of increase in property, plant and equipment during the period.",
        "label": "Percentage increase in property, plant and equipment",
        "terseLabel": "Percentage of increase in equipment"
       }
      }
     },
     "localname": "PercentageIncreaseInPropertyPlantAndEquipment",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aciu_PercentageOfAccruedIncome": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage that represents the percentage of total accrued income.",
        "label": "Percentage of Accrued Income",
        "terseLabel": "Percentage of accrued income"
       }
      }
     },
     "localname": "PercentageOfAccruedIncome",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation.",
        "label": "Percentage of reasonably possible decrease in actuarial assumption [Member]",
        "terseLabel": "-0.5% Decrease [Member]"
       }
      }
     },
     "localname": "PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation.",
        "label": "Percentage of reasonably possible increase in actuarial assumption [Member]",
        "terseLabel": "+0.5% Increase [Member]"
       }
      }
     },
     "localname": "PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of reasonably possible increase or decrease in interest rates",
        "label": "Percentage of reasonably possible increase or decrease in interest rates"
       }
      }
     },
     "localname": "PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of reasonably possible strengthening or weakening of reporting currency against other relevant currencies",
        "label": "Percentage of reasonably possible strengthening or weakening of reporting currency against other relevant currencies"
       }
      }
     },
     "localname": "PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential increase is equity through conversion of debt instruments",
        "label": "Potential increase is equity through conversion of debt instruments"
       }
      }
     },
     "localname": "PotentialIncreaseIsEquityThroughConversionOfDebtInstruments",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The potential increase in equity from share-based payment transactions.",
        "label": "Potential increase is equity through share-based payment transactions",
        "terseLabel": "Maximum aggregate amount of ordinary shares"
       }
      }
     },
     "localname": "PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential number of shares issued from conversion of debt instruments",
        "label": "Potential number of shares issued from conversion of debt instruments"
       }
      }
     },
     "localname": "PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of potential shares issued through share-based payment transactions.",
        "label": "Potential number of shares issued from share-based payment transactions",
        "verboseLabel": "Issuance of ordinary shares (in shares)"
       }
      }
     },
     "localname": "PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and accrued income, Disclosure [Abstract]",
        "terseLabel": "Prepaid expenses and accrued income [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpensesAndAccruedIncomeDisclosureAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_PrepaidExpensesAndAccruedIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Prepaid Expenses and Accrued Income [Line Items]"
       }
      }
     },
     "localname": "PrepaidExpensesAndAccruedIncomeLineItems",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_PrepaidExpensesAndAccruedIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to details of Prepaid expenses and accrued income.",
        "label": "Prepaid Expenses and Accrued Income [Table]"
       }
      }
     },
     "localname": "PrepaidExpensesAndAccruedIncomeTable",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from conversion of convertible debt, per individual note",
        "label": "Proceeds from conversion of convertible debt, per individual note"
       }
      }
     },
     "localname": "ProceedsFromConversionOfConvertibleDebtPerIndividualNote",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs",
        "label": "Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs",
        "terseLabel": "Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_ProceedsFromIssueOfConvertibleDebt": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuing of convertible debt.",
        "label": "Proceeds from issue of convertible debt",
        "terseLabel": "Proceeds from issuance of convertible loan",
        "verboseLabel": "Net proceeds"
       }
      }
     },
     "localname": "ProceedsFromIssueOfConvertibleDebt",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs",
        "label": "Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs",
        "terseLabel": "Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs"
       }
      }
     },
     "localname": "ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents the acquisition of the program portfolio of therapeutics targeting a-syn from Affiris",
        "label": "Program portfolio of therapeutics targeting asyn from Affiris [Member]",
        "terseLabel": "Program portfolio of therapeutics targeting asyn from Affiris"
       }
      }
     },
     "localname": "ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property plant and equipment estimated useful life [Abstract]",
        "terseLabel": "Estimated useful life [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of property plant and equipment acquired through noncash investing activities.",
        "label": "Purchase of property, plant and equipment, classified as noncash investing activities",
        "terseLabel": "Capital expenditures in Trade and other payables or Accrued expenses"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_Quarter32019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents Quarter 3 2019",
        "label": "Quarter 3, 2019 [Member]",
        "terseLabel": "Quarter 3, 2019"
       }
      }
     },
     "localname": "Quarter32019Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of number of treasury shares outstanding",
        "label": "Reconciliation of number of treasury shares outstanding [abstract]",
        "terseLabel": "Treasury shares"
       }
      }
     },
     "localname": "ReconciliationOfNumberOfTreasurySharesOutstandingAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_RegulatoryAndSalesBasedMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents regulatory and sales-based milestones",
        "label": "Regulatory and sales-based milestones [Member]",
        "terseLabel": "Regulatory and sales-based milestones"
       }
      }
     },
     "localname": "RegulatoryAndSalesBasedMilestonesMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_RentalContractPeriodForNoticeOfCancellation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time required by the lessee in a lease agreement to provide notice of cancellation of a lease to the lessor, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Rental contract, period for notice of cancellation",
        "terseLabel": "Notice period for cancellation of rental contract"
       }
      }
     },
     "localname": "RentalContractPeriodForNoticeOfCancellation",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aciu_RepaymentOfConvertibleDebtEquitySettlementAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of the settlement of convertible debt that is settled via shares of entity's common shares.",
        "label": "Repayment of convertible debt, Equity Settlement, Amount",
        "terseLabel": "Settlement of convertible notes recorded within Shareholders' equity"
       }
      }
     },
     "localname": "RepaymentOfConvertibleDebtEquitySettlementAmount",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_ReportableSegmentsNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reportable segments reported by the entity.",
        "label": "Reportable segments, number",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "ReportableSegmentsNumber",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aciu_ResearchAndDevelopmentExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents research and development expenses",
        "label": "Research and development expenses [Member]",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensesMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_ResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance obligation related to research and development.",
        "label": "Research and development [Member]",
        "terseLabel": "Research and Development [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_RestrictedSharesAndRestrictedShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Shares and Restricted Share Units [Member]",
        "terseLabel": "Non-vested Share Awards [Member]"
       }
      }
     },
     "localname": "RestrictedSharesAndRestrictedShareUnitsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_RestrictedStockUnitsFirstVestingConditionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Restricted Stock Units, first vesting conditions",
        "label": "Restricted Stock Units, first vesting conditions [Member]",
        "terseLabel": "Restricted Stock Units, first vesting conditions"
       }
      }
     },
     "localname": "RestrictedStockUnitsFirstVestingConditionsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_RestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for equity instruments that are convertible to stock after a specified period of time.",
        "label": "Restricted Stock Units [Member]",
        "verboseLabel": "Restricted Stock Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_RestrictedStockUnitsSecondVestingConditionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Restricted Stock Units, second vesting conditions",
        "label": "Restricted Stock Units, second vesting conditions [Member]",
        "terseLabel": "Restricted Stock Units, second vesting conditions"
       }
      }
     },
     "localname": "RestrictedStockUnitsSecondVestingConditionsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_RetirementBenefitPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for retirement benefit plan",
        "label": "Retirement benefit plan [Member]",
        "terseLabel": "Retirement benefit plan"
       }
      }
     },
     "localname": "RetirementBenefitPlanMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Right of use assets and lease liabilities, net",
        "label": "Right of use assets and lease liabilities, net [Member]",
        "terseLabel": "Right of use assets and lease liabilities, net"
       }
      }
     },
     "localname": "RightOfUseAssetsAndLeaseLiabilitiesNetMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_RightOfUseFinancialAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for right-of-use financial assets.",
        "label": "Right of use financial assets [Member]",
        "terseLabel": "Right-of-use Assets [Member]",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "RightOfUseFinancialAssetsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_RightOfUseLeasedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use leased assets [Abstract]",
        "terseLabel": "Right-of-use of leased assets:"
       }
      }
     },
     "localname": "RightOfUseLeasedAssetsAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_RightOfUseLicenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance obligation related to right-of-use license.",
        "label": "Right-of-use license [Member]",
        "terseLabel": "Right-of-use License [Member]"
       }
      }
     },
     "localname": "RightOfUseLicenseMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in equity from sale or issue of treasury shares net of underwriting fees and transaction costs",
        "label": "Sale or issue of treasury shares net of underwriting fees and transaction costs",
        "terseLabel": "Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs"
       }
      }
     },
     "localname": "SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_SaleOrIssueOfTreasurySharesShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of treasury shares issued or sold.",
        "label": "Sale or issue of treasury shares, shares",
        "verboseLabel": "Number of treasury share issued (in shares)"
       }
      }
     },
     "localname": "SaleOrIssueOfTreasurySharesShares",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash and cash equivalents by currency",
        "label": "Schedule of cash and cash equivalents by currency [table text block]",
        "terseLabel": "Schedule of cash and cash equivalents by currency"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to the contractual undiscounted cash flows.",
        "label": "Schedule of contractual undiscounted cash flows [Table Text Block]",
        "terseLabel": "Schedule of contractual undiscounted cash flows for lease obligations"
       }
      }
     },
     "localname": "ScheduleOfContractualUndiscountedCashFlowsTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about the estimated lease term by right-of-use asset by category.",
        "label": "Schedule of information about contract lease term by right-of-use asset categories [Table Text Block]",
        "terseLabel": "Estimated Lease Term by Right-of-use Asset Categories"
       }
      }
     },
     "localname": "ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about the useful life of property, plant and equipment.",
        "label": "Schedule of information about property, plant and equipment useful life [Table Text Block]",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of short-term deposits not classified as cash equivalents",
        "label": "Schedule of short-term deposits not classified as cash equivalents [table text block]",
        "terseLabel": "Schedule of short-term financial assets"
       }
      }
     },
     "localname": "ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aciu_SecondOpenMarketSalesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for entity entered into a second Open Market Sales Agreement (the \"New Sales Agreement\") with Jefferies to continue the ATM program.",
        "label": "Second Open Market Sales Agreement [Member]",
        "terseLabel": "New Sales Agreement [Member]"
       }
      }
     },
     "localname": "SecondOpenMarketSalesAgreementMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_SensitivityAnalysisActuarialAssumptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sensitivity analysis, actuarial assumptions [Abstract]",
        "terseLabel": "Sensitivity analysis [Abstract]"
       }
      }
     },
     "localname": "SensitivityAnalysisActuarialAssumptionsAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_ShareBasedPaymentArrangementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payment arrangement [Abstract]"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_ShareBasedPlansOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based plans outstanding [Abstract]",
        "terseLabel": "Share-based plans outstanding [Abstract]"
       }
      }
     },
     "localname": "ShareBasedPlansOutstandingAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_SharesTransferredAsConsiderationInAssetAcquisition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares transferred as consideration in asset acquisition",
        "label": "Shares transferred as consideration in asset acquisition"
       }
      }
     },
     "localname": "SharesTransferredAsConsiderationInAssetAcquisition",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "aciu_ShortTermFinancialAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents financial assets classified as short-term.",
        "label": "Short-term Financial Assets [Member]",
        "terseLabel": "Short-term financial assets"
       }
      }
     },
     "localname": "ShortTermFinancialAssetsMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_ShortTermLeaseLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for short-term lease liabilities.",
        "label": "Short-term lease liabilities [Member]",
        "terseLabel": "Short-term Lease Liabilities [Member]",
        "verboseLabel": "Short-term lease liabilities"
       }
      }
     },
     "localname": "ShortTermLeaseLiabilitiesMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_SignificantAssetAcquisitionsTotalDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant asset acquisitions, total",
        "label": "Significant asset acquisitions, total [Domain]"
       }
      }
     },
     "localname": "SignificantAssetAcquisitionsTotalDomain",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_SkaneUniversityHospitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Skane University Hospital is a university hospital in Scania, Sweden.",
        "label": "Skane University Hospital [Member]",
        "terseLabel": "Skane University Hospital [Member]",
        "verboseLabel": "Skane University Hospital"
       }
      }
     },
     "localname": "SkaneUniversityHospitalMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_StockOptionPlanC1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A share-based payment arrangement that existed at any time during the reporting period.",
        "label": "Stock option plan C1 [Member]",
        "terseLabel": "Share Option Plan C1 [Member]"
       }
      }
     },
     "localname": "StockOptionPlanC1Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_SupplementalNonCashActivityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental non-cash activity [Abstract]",
        "terseLabel": "Supplemental non-cash activity"
       }
      }
     },
     "localname": "SupplementalNonCashActivityAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_TauMorphomerSmallMoleculeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The research and development of medicines for the treatment of Alzheimer's disease and other neurodegenerative diseases.",
        "label": "Tau Morphomer Small Molecule [Member]",
        "terseLabel": "Morphomer Tau Small Molecule [Member]"
       }
      }
     },
     "localname": "TauMorphomerSmallMoleculeMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_TauPETImagingAgentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The research and development of medicines for the treatment of Alzheimer's disease through molecular imaging.",
        "label": "Tau-PET imaging agent [Member]",
        "terseLabel": "Tau-PET Imaging Agent [Member]"
       }
      }
     },
     "localname": "TauPETImagingAgentMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_TauVaccineInADMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The research and development of a vaccine for the treatment of Alzheimer's disease.",
        "label": "Tau Vaccine in AD [Member]",
        "terseLabel": "Tau Vaccine in AD [Member]"
       }
      }
     },
     "localname": "TauVaccineInADMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax effect of income not subject to tax and expenses not deductible for tax purposes",
        "label": "Tax effect of income not subject to tax and expenses not deductible for tax purposes",
        "terseLabel": "(Income not subject to tax)/expenses not deductible for tax purposes"
       }
      }
     },
     "localname": "TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_TaxLossesSplitByExpiryDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax losses split by expiry date [Abstract]",
        "terseLabel": "Tax losses split by expiry date [Abstract]"
       }
      }
     },
     "localname": "TaxLossesSplitByExpiryDateAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_TotalAssetsAcquiredInAssetAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total assets acquired in asset acquisition",
        "label": "Total assets acquired in asset acquisition",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "TotalAssetsAcquiredInAssetAcquisition",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total consideration transferred, acquisition-date fair value, asset acquisition",
        "label": "Total consideration transferred, acquisition-date fair value, asset acquisition"
       }
      }
     },
     "localname": "TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.",
        "label": "Trade and other payables and accrued liabilities [Line Items]"
       }
      }
     },
     "localname": "TradeAndOtherPayablesAndAccruedLiabilitiesLineItems",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to details of trade and other payables and accrued liabilities.",
        "label": "Trade and other payables and accrued liabilities [Table]"
       }
      }
     },
     "localname": "TradeAndOtherPayablesAndAccruedLiabilitiesTable",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_TradeAndOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for trade and other payables.",
        "label": "Trade and Other Payables [Member]",
        "terseLabel": "Trade and other payables"
       }
      }
     },
     "localname": "TradeAndOtherPayablesMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_Two016ShareOptionAndIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.",
        "label": "2016 Share Option and Incentive Plan [Member]",
        "terseLabel": "2016 SOIP [Member]"
       }
      }
     },
     "localname": "Two016ShareOptionAndIncentivePlanMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting tranche one of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.",
        "label": "2016 Share Option and Incentive Plan, Vesting Tranche One [Member]",
        "terseLabel": "2016 SOIP, Vesting Condition 1 [Member]"
       }
      }
     },
     "localname": "Two016ShareOptionAndIncentivePlanVestingTrancheOneMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting tranche three of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.",
        "label": "2016 Share Option and Incentive Plan, Vesting Tranche Three [Member]",
        "terseLabel": "2016 SOIP, Vesting Condition 3 [Member]"
       }
      }
     },
     "localname": "Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting tranche two of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.",
        "label": "2016 Share Option and Incentive Plan, Vesting Tranche Two [Member]",
        "terseLabel": "2016 SOIP, Vesting Condition 2 [Member]"
       }
      }
     },
     "localname": "Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents the time upon which the first patient is dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.",
        "label": "Upon first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU. [Member]",
        "terseLabel": "Upon first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU."
       }
      }
     },
     "localname": "UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_Usd2.76ToUsd4.57Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for USD 2.76 to USD 4.57",
        "label": "USD 2.76 to USD 4.57 [Member]",
        "terseLabel": "USD 2.76 to USD 4.57"
       }
      }
     },
     "localname": "Usd2.76ToUsd4.57Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_Usd5.04ToUsd12.30Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for USD 5.04 to USD 12.30",
        "label": "USD 5.04 to USD 12.30 [Member]",
        "terseLabel": "USD 5.04 to USD 12.30"
       }
      }
     },
     "localname": "Usd5.04ToUsd12.30Member",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For vesting requirements for a type of share-based payment arrangement that existed at any time during the period, this element represents the period which an employees' right to exercise an award is no longer contingent on satisfaction of a service condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Vesting requirements for share-based payment arrangement, award vesting period",
        "terseLabel": "Vesting conditions",
        "verboseLabel": "Vesting conditions"
       }
      }
     },
     "localname": "VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aciu_WeightedAverageAssumptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Assumptions [Abstract]",
        "terseLabel": "Weighted average assumptions [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageAssumptionsAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_WeightedAverageExercisePriceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted average exercise price [Abstract]",
        "verboseLabel": "Weighted Average grant date fair value [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value, other equity instruments exercised",
        "label": "Weighted average grant date fair value, other equity instruments exercised",
        "terseLabel": "Weighted average grant date fair value, exercised during the year"
       }
      }
     },
     "localname": "WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value, other equity instruments expired",
        "label": "Weighted average grant date fair value, other equity instruments expired",
        "terseLabel": "Weighted average grant date fair value, expired during the year"
       }
      }
     },
     "localname": "WeightedAverageGrantDateFairValueOtherEquityInstrumentsExpired",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value, other equity instruments forfeited",
        "label": "Weighted average grant date fair value, other equity instruments forfeited",
        "terseLabel": "Weighted average grant date fair value, forfeited during the year"
       }
      }
     },
     "localname": "WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value, other equity instruments granted",
        "label": "Weighted average grant date fair value, other equity instruments granted",
        "terseLabel": "Weighted average grant date fair value, granted during the year"
       }
      }
     },
     "localname": "WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value, other equity instruments outstanding",
        "label": "Weighted average grant date fair value, other equity instruments outstanding",
        "periodEndLabel": "Weighted average grant date fair value, non-vested at end of period",
        "periodStartLabel": "Weighted average grant date fair value, non-vested at beginning of period"
       }
      }
     },
     "localname": "WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value, other equity instruments vested",
        "label": "Weighted average grant date fair value, other equity instruments vested",
        "terseLabel": "Weighted average grant date fair value, vested during the year"
       }
      }
     },
     "localname": "WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value, other equity instruments vested and exercisable",
        "label": "Weighted average grant date fair value, other equity instruments vested and exercisable",
        "terseLabel": "Weighted average grant date fair value, vested and exercisable"
       }
      }
     },
     "localname": "WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aciu_WeightedAverageRemainingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining [Abstract]",
        "verboseLabel": "Weighted average remaining term (years) [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageRemainingAbstract",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual life of share options exercisable",
        "label": "Weighted average remaining contractual life of share options exercisable",
        "terseLabel": "Weighted average remaining term (years), options exercisable"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLifeOfShareOptionsExercisable",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aciu_WithholdingTaxReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Withholding tax receivables",
        "label": "Withholding tax receivables",
        "terseLabel": "Withholding tax"
       }
      }
     },
     "localname": "WithholdingTaxReceivables",
     "nsuri": "http://acimume.com/20221231",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "country_CH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWITZERLAND"
       }
      }
     },
     "localname": "CH",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CHF": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Switzerland, Francs",
        "terseLabel": "CHF [Member]"
       }
      }
     },
     "localname": "CHF",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "EUR [Member]"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "USD [Member]"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r252",
      "r253",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r252",
      "r253",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r252",
      "r253",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r253",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r252",
      "r253",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r252",
      "r253",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ifrs-full_AccountingProfit": {
     "auth_ref": [
      "r38",
      "r39"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accounting profit",
        "terseLabel": "Loss before income tax"
       }
      }
     },
     "localname": "AccountingProfit",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "auth_ref": [
      "r52",
      "r269",
      "r279",
      "r280",
      "r281"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated depreciation and amortisation [member]",
        "terseLabel": "Accumulated depreciation",
        "verboseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails",
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRates": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of discount rates",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "ActuarialAssumptionOfDiscountRates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRatesMember": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the discount rates used as actuarial assumptions. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of discount rates [member]",
        "verboseLabel": "Discount rate"
       }
      }
     },
     "localname": "ActuarialAssumptionOfDiscountRatesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected rate of increases in pension that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of pension increases",
        "terseLabel": "Rate of future increase in current pensions"
       }
      }
     },
     "localname": "ActuarialAssumptionOfExpectedRatesOfPensionIncreases",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the expected rates of pension increases used as actuarial assumptions. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of pension increases [member]",
        "verboseLabel": "Future pension cost"
       }
      }
     },
     "localname": "ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of salary increases",
        "terseLabel": "Rate of future increase in compensations"
       }
      }
     },
     "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreases",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the expected rates of salary increases used as actuarial assumptions. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of salary increases [member]",
        "verboseLabel": "Future salary increase"
       }
      }
     },
     "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ActuarialAssumptionsAxis": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumptions [axis]"
       }
      }
     },
     "localname": "ActuarialAssumptionsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ActuarialAssumptionsMember": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all actuarial assumptions. Actuarial assumptions are the entity\u2019s unbiased and mutually compatible best estimates of the demographic and financial variables that will determine the ultimate cost of providing post-employment benefits. It also represents the standard value for the 'Actuarial assumptions' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumptions [member]"
       }
      }
     },
     "localname": "ActuarialAssumptionsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of changes in demographic assumptions",
        "terseLabel": "Change in demographic assumptions"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial gains (losses) arising from changes in demographic assumptions, net of tax, defined benefit plans",
        "terseLabel": "Effect of changes in demographic assumptions"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of changes in financial assumptions",
        "terseLabel": "Change in financial assumptions"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial gains (losses) arising from changes in financial assumptions, net of tax, defined benefit plans",
        "terseLabel": "Effect of changes in financial assumptions"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Change in experience assumptions"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial gains (losses) arising from experience adjustments, net of tax, defined benefit plans",
        "terseLabel": "Effect of changes in experience assumptions"
       }
      }
     },
     "localname": "ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, property, plant and equipment",
        "verboseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "auth_ref": [
      "r142"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions and remeasurements"
       }
      }
     },
     "localname": "AdditionsToRightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share",
        "verboseLabel": "Weighted-average number of shares outstanding used to compute EPS diluted attributable to equity holders"
       }
      }
     },
     "localname": "AdjustedWeightedAverageShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets": {
     "auth_ref": [
      "r283"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for the decrease (increase) in accrued income including contract assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Accrued income including contract assets; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in accrued income including contract assets",
        "terseLabel": "Decrease/(increase) in accrued income"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": {
     "auth_ref": [
      "r283"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in other operating receivables",
        "terseLabel": "Decrease/(increase) in other current receivables"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses": {
     "auth_ref": [
      "r285"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in prepaid expenses",
        "terseLabel": "(Increase)/decrease in prepaid expenses"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInPrepaidExpenses",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDepreciationExpense": {
     "auth_ref": [
      "r285"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for depreciation expense",
        "terseLabel": "Depreciation of property, plant and equipment"
       }
      }
     },
     "localname": "AdjustmentsForDepreciationExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForFinanceIncomeCost": {
     "auth_ref": [
      "r285"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for finance income (cost)",
        "negatedLabel": "Finance (income)/expense, net"
       }
      }
     },
     "localname": "AdjustmentsForFinanceIncomeCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r285"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for gain (loss) on disposals, property, plant and equipment",
        "negatedLabel": "(Gain)/loss on sale of fixed assets"
       }
      }
     },
     "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities": {
     "auth_ref": [
      "r283"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for the increase (decrease) in deferred income including contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income including contract liabilities; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in deferred income including contract liabilities",
        "terseLabel": "(Decrease)/increase in deferred income"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": {
     "auth_ref": [
      "r285"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in employee benefit liabilities",
        "terseLabel": "Change in net employee defined benefit liability"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "auth_ref": [
      "r283"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade accounts payable",
        "terseLabel": "(Decrease)/increase in trade and other payables"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForInterestExpense": {
     "auth_ref": [
      "r285"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for interest expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest expense; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "AdjustmentsForInterestExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss) [abstract]",
        "terseLabel": "Adjustments to reconcile net loss for the period to net cash flows:"
       }
      }
     },
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "auth_ref": [
      "r284"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for share-based payments",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsForSharebasedPayments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AggregatedTimeBandsMember": {
     "auth_ref": [
      "r17",
      "r134",
      "r146",
      "r147",
      "r170",
      "r194",
      "r195",
      "r196",
      "r202",
      "r215",
      "r233",
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Aggregated time bands [member]"
       }
      }
     },
     "localname": "AggregatedTimeBandsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ApplicableTaxRate": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      },
      "en-us": {
       "role": {
        "label": "Applicable tax rate",
        "terseLabel": "Applicable tax rate"
       }
      }
     },
     "localname": "ApplicableTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_Assets": {
     "auth_ref": [
      "r14",
      "r119",
      "r120",
      "r122",
      "r184",
      "r187"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": {
     "auth_ref": [
      "r259",
      "r261"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Attribution of expenses by nature to their function [axis]"
       }
      }
     },
     "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AverageForeignExchangeRate": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exchange rate, USD 1"
       }
      }
     },
     "localname": "AverageForeignExchangeRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_AverageNumberOfEmployees": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The average number of personnel employed by the entity during a period."
       }
      },
      "en-us": {
       "role": {
        "label": "Average number of employees"
       }
      }
     },
     "localname": "AverageNumberOfEmployees",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "auth_ref": [
      "r82",
      "r83"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      },
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share",
        "terseLabel": "Basic loss per share for the period attributable to equity holders"
       }
      }
     },
     "localname": "BasicEarningsLossPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_BasicEarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings per share [abstract]",
        "terseLabel": "Basic income/(loss) per share (EPS) [Abstract]"
       }
      }
     },
     "localname": "BasicEarningsPerShareAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BottomOfRangeMember": {
     "auth_ref": [
      "r124",
      "r161",
      "r196",
      "r225",
      "r226",
      "r290"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Bottom of Range [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "BottomOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BuildingsMember": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Buildings",
        "terseLabel": "Buildings [Member]"
       }
      }
     },
     "localname": "BuildingsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "auth_ref": [
      "r45",
      "r49",
      "r89",
      "r90",
      "r94",
      "r95",
      "r96",
      "r97",
      "r98",
      "r167",
      "r174",
      "r175",
      "r292",
      "r293"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortization and impairment and gross carrying amount [axis]",
        "terseLabel": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      }
     },
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails",
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CarryingAmountMember": {
     "auth_ref": [
      "r49",
      "r90",
      "r94",
      "r96",
      "r97",
      "r167",
      "r174",
      "r175",
      "r246",
      "r247"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount [member]"
       }
      }
     },
     "localname": "CarryingAmountMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails",
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash [abstract]",
        "terseLabel": "Cash and cash equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashAndCashEquivalents": {
     "auth_ref": [
      "r11",
      "r104",
      "r117"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of the period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "terseLabel": "Company's cash position",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails",
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "auth_ref": [
      "r99",
      "r105"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash flows (used in)/provided by financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities [abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "auth_ref": [
      "r99",
      "r105"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Net cash flows provided by/(used in) investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities [abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "auth_ref": [
      "r99",
      "r105"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "totalLabel": "Net cash flows used in operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities [abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperations": {
     "auth_ref": [
      "r222",
      "r223"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash from (used in) the entity's operations."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operations",
        "totalLabel": "Cash used in operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashOutflowForLeases": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for leases."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash outflow for leases",
        "terseLabel": "Total cash outflow for leases"
       }
      }
     },
     "localname": "CashOutflowForLeases",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      }
     },
     "localname": "CategoriesOfRelatedPartiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ChangesInEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in equity [abstract]",
        "terseLabel": "Changes in equity"
       }
      }
     },
     "localname": "ChangesInEquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in net defined benefit liability (asset) [abstract]",
        "terseLabel": "Changes in defined benefit obligation [Abstract]",
        "verboseLabel": "Change in net defined benefit liability [Abstract]"
       }
      }
     },
     "localname": "ChangesInNetDefinedBenefitLiabilityAssetAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "auth_ref": [
      "r87",
      "r88",
      "r123",
      "r144"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]"
       }
      }
     },
     "localname": "ClassesOfAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsMember": {
     "auth_ref": [
      "r87",
      "r123",
      "r144"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets [member]"
       }
      }
     },
     "localname": "ClassesOfAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "auth_ref": [
      "r178",
      "r179",
      "r193",
      "r203",
      "r204",
      "r205"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesAxis": {
     "auth_ref": [
      "r178",
      "r179",
      "r193",
      "r204"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial liabilities [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialLiabilitiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]"
       }
      }
     },
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      }
     },
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      }
     },
     "localname": "ClassesOfShareCapitalAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalMember": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share Capital [member]",
        "terseLabel": "Share capital [member]"
       }
      }
     },
     "localname": "ClassesOfShareCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClosingForeignExchangeRate": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery."
       }
      },
      "en-us": {
       "role": {
        "label": "Closing rate, USD 1",
        "terseLabel": "Translation rate into CHF"
       }
      }
     },
     "localname": "ClosingForeignExchangeRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      }
     },
     "localname": "ComponentsOfEquityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Items that may be reclassified to income or loss in subsequent periods (net of tax):"
       }
      }
     },
     "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]",
        "terseLabel": "Items that will not to be reclassified to income or loss in subsequent periods (net of tax):"
       }
      }
     },
     "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncome": {
     "auth_ref": [
      "r0",
      "r30",
      "r107",
      "r109",
      "r114",
      "r224"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "totalLabel": "Total comprehensive loss, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComputerEquipmentMember": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "IT Equipment",
        "terseLabel": "IT Equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ConstructionInProgressMember": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Construction in progress [member]",
        "terseLabel": "Assets under construction"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ContractAssets": {
     "auth_ref": [
      "r125",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of an entity\u2019s right to consideration in exchange for goods or services that the entity has transferred to a customer, when that right is conditioned on something other than the passage of time (for example, the entity\u2019s future performance)."
       }
      },
      "en-us": {
       "role": {
        "label": "Contract assets",
        "terseLabel": "Deferred research and development costs"
       }
      }
     },
     "localname": "ContractAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContractLiabilities": {
     "auth_ref": [
      "r125",
      "r128"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of an entity\u2019s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer."
       }
      },
      "en-us": {
       "role": {
        "label": "Contract liabilities",
        "terseLabel": "Up-front consideration received"
       }
      }
     },
     "localname": "ContractLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContractualCapitalCommitments": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of capital commitments for which the entity has entered into a contract. [Refer: Capital commitments]"
       }
      },
      "en-us": {
       "role": {
        "label": "Contractual capital commitments"
       }
      }
     },
     "localname": "ContractualCapitalCommitments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from resulting from contributions to plan by employer",
        "negatedLabel": "Employer's contribution",
        "verboseLabel": "Employer's contributions"
       }
      }
     },
     "localname": "ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan by plan participants",
        "terseLabel": "Employees' contributions"
       }
      }
     },
     "localname": "ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CounterpartiesAxis": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Counterparties [axis]"
       }
      }
     },
     "localname": "CounterpartiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CounterpartiesMember": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Counterparties [member]"
       }
      }
     },
     "localname": "CounterpartiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CreditRiskMember": {
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r231"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Credit risk [member]",
        "terseLabel": "Credit Risk [Member]"
       }
      }
     },
     "localname": "CreditRiskMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CurrencyRiskMember": {
     "auth_ref": [
      "r181",
      "r197",
      "r198",
      "r199",
      "r200"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Currency risk [member]",
        "terseLabel": "Foreign Currency Exchange Risk [Member]"
       }
      }
     },
     "localname": "CurrencyRiskMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [
      "r263"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current accrued expenses and other current liabilities",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets": {
     "auth_ref": [
      "r263",
      "r265"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets",
       "weight": 1.0
      },
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current accrued income including current contract assets. [Refer: Accrued income including contract assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current accrued income including current contract assets",
        "terseLabel": "Accrued income"
       }
      }
     },
     "localname": "CurrentAccruedIncomeIncludingCurrentContractAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssets": {
     "auth_ref": [
      "r18",
      "r110",
      "r224"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "CurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets [abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "CurrentAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities": {
     "auth_ref": [
      "r263",
      "r265"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current deferred income including current contract liabilities",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "CurrentDeferredIncomeIncludingCurrentContractLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current lease liabilities",
        "terseLabel": "Short-term lease liabilities"
       }
      }
     },
     "localname": "CurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilities": {
     "auth_ref": [
      "r19",
      "r112",
      "r224"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities [abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentPrepaidExpenses": {
     "auth_ref": [
      "r261"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets",
       "weight": 1.0
      },
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised."
       }
      },
      "en-us": {
       "role": {
        "label": "Current prepaid expenses",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "CurrentPrepaidExpenses",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets": {
     "auth_ref": [
      "r263",
      "r265"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current prepayments and current accrued income including current contract assets. [Refer: Prepayments; Accrued income including contract assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current prepayments and current accrued income including current contract assets",
        "totalLabel": "Total prepaid expenses and accrued income"
       }
      }
     },
     "localname": "CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and accrued income"
       }
      }
     },
     "localname": "CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentValueAddedTaxReceivables": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current value added tax receivables. [Refer: Value added tax receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current value added tax receivables",
        "terseLabel": "Swiss VAT"
       }
      }
     },
     "localname": "CurrentValueAddedTaxReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deductible temporary differences for which no deferred tax asset is recognised"
       }
      }
     },
     "localname": "DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxAssets": {
     "auth_ref": [
      "r13",
      "r15",
      "r41"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "auth_ref": [
      "r13",
      "r15",
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DefinedBenefitObligationAtPresentValue": {
     "auth_ref": [
      "r277"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_SurplusDeficitInPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]"
       }
      },
      "en-us": {
       "role": {
        "label": "Defined benefit obligation, at present value",
        "negatedTerseLabel": "Defined benefit obligation",
        "terseLabel": "Potential defined benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitObligationAtPresentValue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r48",
      "r51"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, property, plant and equipment",
        "negatedLabel": "Depreciation expense"
       }
      }
     },
     "localname": "DepreciationPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails": {
       "order": 1.0,
       "parentTag": "aciu_ExpenseRelatingToLeases",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, right-of-use assets",
        "negatedLabel": "Depreciation",
        "terseLabel": "Depreciation of right-of-use assets"
       }
      }
     },
     "localname": "DepreciationRightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for earnings per share [text block]",
        "terseLabel": "Earnings per share"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for employee benefits [text block]",
        "terseLabel": "Employee benefits"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for expenses."
       }
      },
      "en-us": {
       "role": {
        "label": "General and administrative expenses"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForExpensesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for fair value measurement. [Refer: At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for fair value measurement [text block]",
        "terseLabel": "Fair value of financial assets and liabilities"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for foreign currency translation."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for foreign currency translation [text block]",
        "terseLabel": "Foreign currency transactions"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for the currency of the primary economic environment in which the entity operates."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for functional currency [text block]",
        "terseLabel": "Functional and reporting currency"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for income tax."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for income tax [text block]",
        "terseLabel": "Taxation"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for intangible assets other than goodwill [text block]",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for issued capital. [Refer: Issued capital]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for issued capital [text block]",
        "terseLabel": "Share capital and public offerings"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIssuedCapitalExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "Leases"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for property, plant and equipment [text block]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for provisions. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for provisions [text block]",
        "terseLabel": "Provisions"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for recognition of revenue [text block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for research and development expense [text block]",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for segment reporting."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for segment reporting [text block]",
        "terseLabel": "Segment reporting"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for treasury shares. [Refer: Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for treasury shares [text block]",
        "terseLabel": "Treasury Shares"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForTreasurySharesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "Expected volatility, share options granted",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The option life of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Option life, share options granted",
        "terseLabel": "Expected term"
       }
      }
     },
     "localname": "DescriptionOfOptionLifeShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Risk free interest rate, share options granted",
        "terseLabel": "Risk free interest rate"
       }
      }
     },
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "auth_ref": [
      "r82",
      "r83"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share",
        "terseLabel": "Diluted loss per share for the period attributable to equity holders"
       }
      }
     },
     "localname": "DilutedEarningsLossPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_DilutedEarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted income/(loss) per share (EPS) [Abstract]"
       }
      }
     },
     "localname": "DilutedEarningsPerShareAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares": {
     "auth_ref": [
      "r278"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureEarningsPerShareDetails": {
       "order": 3.0,
       "parentTag": "aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of dilutive potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Dilutive effect of convertible instruments on number of ordinary shares",
        "terseLabel": "Convertible shares"
       }
      }
     },
     "localname": "DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of amounts incurred by the entity for provision of key management personnel services that are provided by separate management entities. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [text block]",
        "terseLabel": "Key management compensation"
       }
      }
     },
     "localname": "DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfBasisOfConsolidationExplanatory": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for consolidation."
       }
      },
      "en-us": {
       "role": {
        "label": "Basis of consolidation"
       }
      }
     },
     "localname": "DisclosureOfBasisOfConsolidationExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for the preparation of the financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of basis of preparation of financial statements [text block]",
        "terseLabel": "Basis of preparation"
       }
      }
     },
     "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureBasisOfPreparation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share capital"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [text block]",
        "terseLabel": "Summary of capital structure"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [line items]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails",
      "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalTable": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to classes of share capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [table]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails",
      "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of commitments and contingent liabilities [text block]",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfCommitmentsExplanatory": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of commitments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of commitments [text block]",
        "terseLabel": "Schedule of commitments"
       }
      }
     },
     "localname": "DisclosureOfCommitmentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement benefit plan"
       }
      }
     },
     "localname": "DisclosureOfDefinedBenefitPlansAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of defined benefit plans. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [text block]",
        "terseLabel": "Retirement benefit plan"
       }
      }
     },
     "localname": "DisclosureOfDefinedBenefitPlansExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [line items]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of borrowings."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [text block]",
        "verboseLabel": "Schedule of net book value of intangible assets"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [text block]",
        "terseLabel": "Schedule of movement in the net book values of property, plant and equipment"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [abstract]",
        "terseLabel": "Contract revenues"
       }
      }
     },
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [line items]"
       }
      }
     },
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [table]"
       }
      }
     },
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of earnings per share [text block]",
        "verboseLabel": "Earnings per share"
       }
      }
     },
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for the effect of changes in foreign exchange rates."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of effect of changes in foreign exchange rates [text block]",
        "terseLabel": "Schedule of exchange rates used for translation of financial statements"
       }
      }
     },
     "localname": "DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of events after reporting period [text block]",
        "terseLabel": "Subsequent events"
       }
      }
     },
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfExpensesExplanatory": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of expenses."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of expenses [text block]",
        "terseLabel": "Expenses by category"
       }
      }
     },
     "localname": "DisclosureOfExpensesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of finance income (cost) [text block]"
       }
      }
     },
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents and financial assets"
       }
      }
     },
     "localname": "DisclosureOfFinancialAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's financial risk management practices and policies."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial risk management [text block]",
        "terseLabel": "Financial instruments and risk management"
       }
      }
     },
     "localname": "DisclosureOfFinancialRiskManagementExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of general and administrative expenses. [Refer: Administrative expenses]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of general and administrative expense [text block]",
        "terseLabel": "General and Administrative"
       }
      }
     },
     "localname": "DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      },
      "en-us": {
       "role": {
        "label": "Income taxes"
       }
      }
     },
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]",
        "terseLabel": "Weighted-average assumptions"
       }
      }
     },
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of significant accounting policies"
       }
      }
     },
     "localname": "DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for intangible assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets [text block]",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [line items]"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets material to entity [abstract]"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsMaterialToEntityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [table]"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfLeasesExplanatory": {
     "auth_ref": [
      "r149",
      "r150"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for leases."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of leases [text block]",
        "terseLabel": "Right-of-use assets, long-term financial assets and lease liabilities"
       }
      }
     },
     "localname": "DisclosureOfLeasesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [line items]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the maturity analysis of operating lease payments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [table]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial instruments and risk management [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of nature and extent of risks arising from financial instruments [line items]"
       }
      }
     },
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable": {
     "auth_ref": [
      "r172",
      "r173"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the nature and extent of risks arising from financial instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of nature and extent of risks arising from financial instruments [table]"
       }
      }
     },
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [text block]",
        "verboseLabel": "Schedule of changes in defined benefit obligations, fair value of plan assets and net defined benefit liability"
       }
      }
     },
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [line items]"
       }
      }
     },
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the net defined benefit liability (asset)."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [table]"
       }
      }
     },
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent events"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average exercise prices of other equity instruments [text block]",
        "terseLabel": "Summary of non-vested share awards (restricted share and restricted share units)"
       }
      }
     },
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average exercise prices of share options [text block]",
        "terseLabel": "Number and weighted average exercise prices of options under share option programs"
       }
      }
     },
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]",
        "terseLabel": "Number and weighted average exercise prices of options under the share option programs [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]",
        "terseLabel": "Outstanding options, exercise price range and expiry dates"
       }
      }
     },
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]"
       }
      }
     },
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the number and weighted average remaining contractual life of outstanding share options."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [table]"
       }
      }
     },
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital risk management [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of information that enables users of financial statements to evaluate the entity's objectives, policies and processes for managing capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of objectives, policies and processes for managing capital [text block]",
        "terseLabel": "Capital risk management"
       }
      }
     },
     "localname": "DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureCapitalRiskManagement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [abstract]",
        "terseLabel": "Segment reporting [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment."
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of property, plant and equipment [text block]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [line items]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about leases for lessee [abstract]",
        "terseLabel": "Right-of-use assets and lease liabilities:"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [text block]",
        "terseLabel": "Schedule of the movements in the net value book value of right-of-use assets"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [line items]"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to right-of-use assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [table]"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of range of exercise prices of outstanding share options [line items]"
       }
      }
     },
     "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the range of exercise prices of outstanding share options."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of range of exercise prices of outstanding share options [table]"
       }
      }
     },
     "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of related party [text block]",
        "terseLabel": "Related-party transactions"
       }
      }
     },
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of research and development expense. [Refer: Research and development expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of research and development expense [text block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "DisclosureOfResearchAndDevelopmentExpenseExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRevenueExplanatory": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of revenue [text block]",
        "terseLabel": "Contract revenues"
       }
      }
     },
     "localname": "DisclosureOfRevenueExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenues"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": {
     "auth_ref": [
      "r135",
      "r136"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue from contracts with customers."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of revenue from contracts with customers [text block]",
        "terseLabel": "Schedule of contract revenues"
       }
      }
     },
     "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [abstract]",
        "terseLabel": "Actuarial assumptions [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [text block]",
        "terseLabel": "Actuarial assumptions and sensitivity analysis"
       }
      }
     },
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [line items]"
       }
      }
     },
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the sensitivity analysis for actuarial assumptions."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [table]"
       }
      }
     },
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share capital, reserves and other equity interest [text block]",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapital"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share-based payment arrangements [text block]",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for significant accounting policies applied by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of significant accounting policies [text block]",
        "terseLabel": "Summary of significant accounting policies"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [abstract]",
        "terseLabel": "Unrecognized deductible temporary differences, unused tax losses and unused tax credits [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [text block]",
        "terseLabel": "Unrecognized deductible temporary differences, unused tax losses and unused tax credits"
       }
      }
     },
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]"
       }
      }
     },
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]"
       }
      }
     },
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the general terms and conditions of share-based payment arrangements. [Refer: Share-based payment arrangements [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [text block]",
        "terseLabel": "Share-based compensation plans outstanding"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related-party transactions [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DiscountRateMeasurementInputMember": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a discount rate used as a measurement input used in valuation techniques based on a present value calculation."
       }
      },
      "en-us": {
       "role": {
        "label": "Discount rate, measurement input [member]",
        "terseLabel": "Discount rate, measurement input"
       }
      }
     },
     "localname": "DiscountRateMeasurementInputMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_DisposalsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disposals, property, plant and equipment",
        "negatedLabel": "Disposals"
       }
      }
     },
     "localname": "DisposalsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share",
        "terseLabel": "Loss per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EarningsPerShareExplanatory": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Earnings per share [text block]",
        "terseLabel": "Schedule of earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "auth_ref": [
      "r101",
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "terseLabel": "Exchange gain on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for related parties [member]"
       }
      }
     },
     "localname": "EntitysTotalForRelatedPartiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Equity": {
     "auth_ref": [
      "r14",
      "r22",
      "r106",
      "r108",
      "r119",
      "r120",
      "r122"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "Equity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' equity"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityAndLiabilities": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Total shareholders' equity and liabilities"
       }
      }
     },
     "localname": "EquityAndLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS' EQUITY AND LIABILITIES"
       }
      }
     },
     "localname": "EquityAndLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityMember": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity [Member]"
       }
      }
     },
     "localname": "EquityMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan": {
     "auth_ref": [
      "r66",
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The estimate of the expected contributions to be made to a defined benefit plan for the next annual reporting period. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Estimate of contributions expected to be paid to plan for next annual reporting period",
        "terseLabel": "Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period"
       }
      }
     },
     "localname": "EstimateOfContributionsExpectedToBePaidToPlan",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExercisePriceShareOptionsGranted2019": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The exercise price of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Exercise price (in USD per share)"
       }
      }
     },
     "localname": "ExercisePriceShareOptionsGranted2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Dividend yield"
       }
      }
     },
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ExpenseByNature": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Expenses, by nature",
        "totalLabel": "Total expenses by category"
       }
      }
     },
     "localname": "ExpenseByNature",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "auth_ref": [
      "r166"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions with employees",
        "verboseLabel": "Expense charged against the income statement"
       }
      }
     },
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails": {
       "order": 3.0,
       "parentTag": "aciu_ExpenseRelatingToLeases",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease."
       }
      },
      "en-us": {
       "role": {
        "label": "Expense relating to short-term leases for which recognition exemption has been used",
        "terseLabel": "Expense for short-term leases and leases of low value"
       }
      }
     },
     "localname": "ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The explanation of the effect that the timing of satisfaction of performance obligations and the typical timing of payment have on the contract assets and the contract liabilities. [Refer: Performance obligations [member]; Contract assets; Contract liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Explanation of effect that timing of satisfaction of performance obligations and typical timing of payment have on contract assets and contract liabilities [text block]",
        "terseLabel": "Schedule of contract revenue of performance obligations satisfied"
       }
      }
     },
     "localname": "ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_FinanceCosts": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": 3.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance costs",
        "negatedLabel": "Financial expense"
       }
      }
     },
     "localname": "FinanceCosts",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r286"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for finance costs paid, classified as operating activities. [Refer: Finance costs]"
       }
      },
      "en-us": {
       "role": {
        "label": "Finance costs paid, classified as operating activities",
        "negatedLabel": "Finance expenses paid"
       }
      }
     },
     "localname": "FinanceCostsPaidClassifiedAsOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncome": {
     "auth_ref": [
      "r267"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Financial income",
        "terseLabel": "Financial income"
       }
      }
     },
     "localname": "FinanceIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncomeCost": {
     "auth_ref": [
      "r267"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income or cost associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income (cost)",
        "totalLabel": "Finance result, net"
       }
      }
     },
     "localname": "FinanceIncomeCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssets": {
     "auth_ref": [
      "r171",
      "r174",
      "r175",
      "r176",
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets"
       }
      }
     },
     "localname": "FinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsMember": {
     "auth_ref": [
      "r178",
      "r179",
      "r193",
      "r203",
      "r204",
      "r205"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets, class [member]"
       }
      }
     },
     "localname": "FinancialAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialLiabilities": {
     "auth_ref": [
      "r171"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities"
       }
      }
     },
     "localname": "FinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialLiabilitiesMember": {
     "auth_ref": [
      "r178",
      "r179",
      "r193",
      "r204"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities, class [member]"
       }
      }
     },
     "localname": "FinancialLiabilitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FixturesAndFittingsMember": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Furniture"
       }
      }
     },
     "localname": "FixturesAndFittingsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ForeignExchangeRatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Functional and reporting currency [Abstract]"
       }
      }
     },
     "localname": "ForeignExchangeRatesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income",
        "negatedLabel": "Remeasurement through other comprehensive income/(loss)"
       }
      }
     },
     "localname": "GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r8",
      "r69"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Exchange differences",
        "verboseLabel": "Foreign exchange gains (losses)"
       }
      }
     },
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r261"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": 3.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to general and administrative activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "General and administrative expense",
        "negatedLabel": "General &amp; administrative expenses",
        "verboseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GeographicalAreasAxis": {
     "auth_ref": [
      "r191",
      "r214",
      "r228",
      "r244"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]"
       }
      }
     },
     "localname": "GeographicalAreasAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_GeographicalAreasMember": {
     "auth_ref": [
      "r191",
      "r214",
      "r228",
      "r244"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [member]"
       }
      }
     },
     "localname": "GeographicalAreasMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "auth_ref": [
      "r45",
      "r89",
      "r95",
      "r98",
      "r167",
      "r175",
      "r176",
      "r232",
      "r292",
      "r293"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross carrying amount [member]",
        "terseLabel": "Gross Carrying Amount",
        "verboseLabel": "Acquisition Cost"
       }
      }
     },
     "localname": "GrossCarryingAmountMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails",
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GrossLeaseLiabilities": {
     "auth_ref": [
      "r145",
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross lease liabilities",
        "terseLabel": "Contractual undiscounted cash flows for lease liabilities"
       }
      }
     },
     "localname": "GrossLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Statements of Income/(Loss)"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "auth_ref": [
      "r33",
      "r37",
      "r38",
      "r39",
      "r80",
      "r118",
      "r183"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income tax expense",
        "negatedLabel": "Income tax expense",
        "totalLabel": "Effective income tax rate (benefit)/expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseContinuingOperations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes",
        "totalLabel": "Net decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by a decrease in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease/(increase) from actual defined benefit obligation"
       }
      }
     },
     "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption",
        "terseLabel": "Decrease/(increase) from actual defined benefit obligation"
       }
      }
     },
     "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from expense (income) included in profit or loss. [Refer: Net defined benefit liability (asset); Profit (loss)] [Contrast: Post-employment benefit expense in profit or loss, defined benefit plans]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss",
        "terseLabel": "Net pension cost through statement of income/(loss)"
       }
      }
     },
     "localname": "IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the conversion of convertible instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through conversion of convertible instruments, equity",
        "terseLabel": "Conversion note agreement",
        "verboseLabel": "Conversion of note agreements, net of transaction costs"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughConversionOfConvertibleInstruments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of options."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through exercise of options, equity",
        "terseLabel": "Exercise of options"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughExerciseOfOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "auth_ref": [
      "r3"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through share-based payment transactions, equity",
        "terseLabel": "Share-based payments"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment": {
     "auth_ref": [
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers from construction in progress. [Refer: Property, plant and equipment; Construction in progress]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through transfers from construction in progress, property, plant and equipment",
        "terseLabel": "Transfers"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions": {
     "auth_ref": [
      "r4"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through treasury share transactions, equity",
        "terseLabel": "Issuance of shares to be held as treasury shares, net of transaction costs",
        "verboseLabel": "Held as treasury shares"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTreasuryShareTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r10",
      "r90"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible asset",
        "terseLabel": "Intangible Assets",
        "verboseLabel": "Intangible asset"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": {
     "auth_ref": [
      "r91",
      "r217",
      "r230"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill [member]"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwillMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InterestExpenseDefinedBenefitPlans": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest expense arising from defined benefit plans. [Refer: Interest expense; Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense, defined benefit plans",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "InterestExpenseDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)",
        "negatedLabel": "Interest cost",
        "negatedTerseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestExpenseIncomeNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails": {
       "order": 2.0,
       "parentTag": "aciu_ExpenseRelatingToLeases",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense on lease liabilities",
        "terseLabel": "Interest expense on lease liabilities"
       }
      }
     },
     "localname": "InterestExpenseOnLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestIncomeDefinedBenefitPlans": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest income arising from defined benefit plans. [Refer: Interest income; Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest income, defined benefit plans",
        "negatedLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestPaidClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as operating activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest paid, classified as operating activities",
        "negatedLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidClassifiedAsOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestRateRiskMember": {
     "auth_ref": [
      "r181",
      "r197",
      "r198",
      "r199",
      "r200"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest rate risk [member]",
        "terseLabel": "Interest Rate [member]"
       }
      }
     },
     "localname": "InterestRateRiskMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InterestReceivedClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from interest received, classified as operating activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest received, classified as operating activities",
        "terseLabel": "Interest received"
       }
      }
     },
     "localname": "InterestReceivedClassifiedAsOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapital": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital",
        "terseLabel": "Share capital",
        "verboseLabel": "Issued share capital"
       }
      }
     },
     "localname": "IssuedCapital",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapitalMember": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital [member]",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "IssuedCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation",
        "totalLabel": "Total compensation"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensation",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Post-employment benefits"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based compensation"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Short-term employee benefits"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Executives and Directors [Member]"
       }
      }
     },
     "localname": "KeyManagementPersonnelOfEntityOrParentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r202",
      "r233",
      "r237",
      "r239"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "More Than 5 Years [Member]"
       }
      }
     },
     "localname": "LaterThanFiveYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember": {
     "auth_ref": [
      "r233",
      "r235",
      "r239"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than three years."
       }
      },
      "en-us": {
       "role": {
        "label": "1-3 years"
       }
      }
     },
     "localname": "LaterThanOneYearAndNotLaterThanThreeYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember": {
     "auth_ref": [
      "r233",
      "r236",
      "r239"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three years and not later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "3-5 years"
       }
      }
     },
     "localname": "LaterThanThreeYearsAndNotLaterThanFiveYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement."
       }
      },
      "en-us": {
       "role": {
        "label": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Liabilities": {
     "auth_ref": [
      "r14",
      "r119",
      "r120",
      "r122",
      "r184",
      "r188"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilityAssetOfDefinedBenefitPlans": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset)",
        "negatedPeriodEndLabel": "At end of period",
        "negatedPeriodStartLabel": "At beginning of period",
        "periodEndLabel": "Net defined benefit liabilities, end of period",
        "periodStartLabel": "Net defined benefit liabilities, beginning of period"
       }
      }
     },
     "localname": "LiabilityAssetOfDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LineItemsByFunctionMember": {
     "auth_ref": [
      "r259",
      "r261"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value of the \u2018Attribution of expenses by nature to their function' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Line items by function [member]"
       }
      }
     },
     "localname": "LineItemsByFunctionMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LiquidityRiskMember": {
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r231"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liquidity risk [member]",
        "terseLabel": "Liquidity Risk [Member]"
       }
      }
     },
     "localname": "LiquidityRiskMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes [Abstract]",
        "terseLabel": "Income taxes [Abstract]"
       }
      }
     },
     "localname": "MajorComponentsOfTaxExpenseIncomeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MaturityAxis": {
     "auth_ref": [
      "r17",
      "r134",
      "r146",
      "r147",
      "r170",
      "r177",
      "r194",
      "r195",
      "r196",
      "r202",
      "r215",
      "r233"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      }
     },
     "localname": "MaturityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NetDefinedBenefitLiabilityAssetAxis": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset) [axis]"
       }
      }
     },
     "localname": "NetDefinedBenefitLiabilityAssetAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NetDefinedBenefitLiabilityAssetMember": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the net defined benefit liability (asset). It also represents the standard value for the 'Net defined benefit liability (asset)' axis if no other member is used. [Refer: Net defined benefit liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset) [member]"
       }
      }
     },
     "localname": "NetDefinedBenefitLiabilityAssetMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncurrentAssets": {
     "auth_ref": [
      "r18",
      "r111",
      "r224"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets [abstract]",
        "terseLabel": "Non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current lease liabilities",
        "terseLabel": "Long-term lease liabilities"
       }
      }
     },
     "localname": "NoncurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilities": {
     "auth_ref": [
      "r19",
      "r113",
      "r224"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities [abstract]",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentProvisionsForEmployeeBenefits": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current provisions for employee benefits",
        "terseLabel": "Net employee defined benefit liabilities"
       }
      }
     },
     "localname": "NoncurrentProvisionsForEmployeeBenefits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentRestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r263"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current restricted cash and cash equivalents",
        "terseLabel": "Long-term financial assets"
       }
      }
     },
     "localname": "NoncurrentRestrictedCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "auth_ref": [
      "r16",
      "r146",
      "r147",
      "r202",
      "r233",
      "r239"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "Less than one year",
        "terseLabel": "Within 1 Year",
        "verboseLabel": "2019 [Member]"
       }
      }
     },
     "localname": "NotLaterThanOneYearMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": {
     "auth_ref": [
      "r165",
      "r289"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments granted in share-based payment arrangement",
        "terseLabel": "Granted during the year (in shares)",
        "verboseLabel": "Number of non-vested share awards granted (in shares)"
       }
      }
     },
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments exercisable in share-based payment arrangement",
        "periodEndLabel": "Vested and exercisable (in shares)"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments exercised or vested in share-based payment arrangement",
        "negatedLabel": "Vested during the year"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments expired in share-based payment arrangement",
        "negatedLabel": "Expired during the year (in shares)"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments forfeited in share-based payment arrangement",
        "negatedLabel": "Forfeited during the year (in shares)"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of other equity instruments outstanding in share-based payment arrangement",
        "periodEndLabel": "Non-vested at end of period (in shares)",
        "periodStartLabel": "Non-vested at beginning of period (in shares)"
       }
      }
     },
     "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "auth_ref": [
      "r152",
      "r157",
      "r161"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Outstanding Options (in shares)",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "NumberOfOutstandingShareOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options exercisable in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options exercisable in share-based payment arrangement",
        "terseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options exercised in share-based payment arrangement",
        "negatedLabel": "Exercised during the year (in shares)"
       }
      }
     },
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options expired in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options expired in share-based payment arrangement",
        "negatedLabel": "Expired during the year (in shares)"
       }
      }
     },
     "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options forfeited in share-based payment arrangement",
        "negatedLabel": "Forfeited during the year (in shares)"
       }
      }
     },
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Granted during the year (in shares)",
        "verboseLabel": "Number of options awarded (in shares)"
       }
      }
     },
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfSharesIssued": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares issued",
        "terseLabel": "Number of shares",
        "verboseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "NumberOfSharesIssued",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_NumberOfSharesIssuedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common shares"
       }
      }
     },
     "localname": "NumberOfSharesIssuedAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares outstanding",
        "periodEndLabel": "Common shares outstanding at end of period",
        "periodStartLabel": "Common shares outstanding at beginning of period"
       }
      }
     },
     "localname": "NumberOfSharesOutstanding",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_OfficeEquipmentMember": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Office Equipment",
        "terseLabel": "Office Equipment [Member]"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OperatingExpense": {
     "auth_ref": [
      "r267"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0
      },
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of all operating expenses."
       }
      },
      "en-us": {
       "role": {
        "label": "Operating expense",
        "negatedTotalLabel": "Total operating expenses",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OrdinarySharesMember": {
     "auth_ref": [
      "r82",
      "r266"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ordinary shares [member]",
        "terseLabel": "Common Shares [Member]",
        "verboseLabel": "Common Shares"
       }
      }
     },
     "localname": "OrdinarySharesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "auth_ref": [
      "r2",
      "r29",
      "r34",
      "r116"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income",
        "terseLabel": "Other comprehensive income/(loss)",
        "totalLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": {
     "auth_ref": [
      "r20",
      "r34"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, net of tax, exchange differences on translation of foreign operations",
        "terseLabel": "Currency translation differences"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans": {
     "auth_ref": [
      "r20",
      "r34",
      "r271"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans",
        "terseLabel": "Remeasurement gains on defined-benefit plans (net of tax)",
        "totalLabel": "Total other comprehensive gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentReceivables": {
     "auth_ref": [
      "r209"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current other receivables. [Refer: Other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current receivables",
        "totalLabel": "Total other current receivables"
       }
      }
     },
     "localname": "OtherCurrentReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "auth_ref": [
      "r267"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other operating income (expense)",
        "terseLabel": "Income from grants",
        "verboseLabel": "Other operating income/(expense), net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ParValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Par value per share",
        "terseLabel": "Nominal value per share (in CHF per share)"
       }
      }
     },
     "localname": "ParValuePerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails",
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_PaymentsForShareIssueCosts": {
     "auth_ref": [
      "r282"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for share issue costs."
       }
      },
      "en-us": {
       "role": {
        "label": "Payments for share issue costs",
        "negatedLabel": "Transaction costs on issuance of shares"
       }
      }
     },
     "localname": "PaymentsForShareIssueCosts",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedLabel": "Principal payments of lease obligations"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsToAcquireOrRedeemEntitysShares": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow to acquire or redeem entity's shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Payments to acquire or redeem entity's shares",
        "negatedLabel": "Payment for the issuance of treasury shares"
       }
      }
     },
     "localname": "PaymentsToAcquireOrRedeemEntitysShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PercentageOfEntitysRevenue": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of the entity's revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of entity's revenue",
        "terseLabel": "Percentage of contract revenues"
       }
      }
     },
     "localname": "PercentageOfEntitysRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of reasonably possible decrease in actuarial assumption",
        "terseLabel": "Percentage decrease in actuarial assumption"
       }
      }
     },
     "localname": "PercentageOfReasonablyPossibleDecreaseInActuarialAssumption",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of reasonably possible increase in actuarial assumption",
        "terseLabel": "Percentage increase in actuarial assumption"
       }
      }
     },
     "localname": "PercentageOfReasonablyPossibleIncreaseInActuarialAssumption",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PerformanceObligationsAxis": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Performance obligations [axis]"
       }
      }
     },
     "localname": "PerformanceObligationsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_PerformanceObligationsMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all performance obligations. A performance obligation is a promise in a contract with a customer to transfer to the customer either: (a) a good or service (or a bundle of goods or services) that is distinct; or (b) a series of distinct goods or services that are substantially the same and that have the same pattern of transfer to the customer. This member also represents the standard value for the 'Performance obligations' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Performance obligations [member]"
       }
      }
     },
     "localname": "PerformanceObligationsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PlanAssetsAtFairValue": {
     "auth_ref": [
      "r277"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_SurplusDeficitInPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Plan assets, at fair value",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "PlanAssetsAtFairValue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PlanAssetsMember": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for defined benefit plan assets. Plan assets comprise: (a) assets held by a long-term employee benefit fund; and (b) qualifying insurance policies."
       }
      },
      "en-us": {
       "role": {
        "label": "Plan assets [member]",
        "terseLabel": "Fair Value of Plan Assets [Member]"
       }
      }
     },
     "localname": "PlanAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans": {
     "auth_ref": [
      "r271",
      "r276"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Post-employment benefit expense in profit or loss, defined benefit plans",
        "totalLabel": "Net pension cost"
       }
      }
     },
     "localname": "PostemploymentBenefitExpenseDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PresentValueOfDefinedBenefitObligationMember": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the present value of a defined benefit obligation. The present value of a defined benefit obligation is the present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods."
       }
      },
      "en-us": {
       "role": {
        "label": "Present value of defined benefit obligation [member]",
        "terseLabel": "Defined Benefit Obligation [Member]"
       }
      }
     },
     "localname": "PresentValueOfDefinedBenefitObligationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PresentationOfLeasesForLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, long-term financial assets and lease liabilities"
       }
      }
     },
     "localname": "PresentationOfLeasesForLesseeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProceedsFromExerciseOfOptions": {
     "auth_ref": [
      "r282"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of options."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of options",
        "terseLabel": "Proceeds from issuance of common shares - option plan, net of transaction costs"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssueOfOrdinaryShares": {
     "auth_ref": [
      "r282"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issue of ordinary shares",
        "verboseLabel": "Proceeds from issuance of common shares - asset acquisition, net of transaction costs"
       }
      }
     },
     "localname": "ProceedsFromIssueOfOrdinaryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares": {
     "auth_ref": [
      "r282"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the sale or issuing of treasury shares. [Refer: Sale or issue of treasury shares; Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from sale or issue of treasury shares",
        "terseLabel": "Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs"
       }
      }
     },
     "localname": "ProceedsFromSaleOrIssueOfTreasuryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from sales of property, plant and equipment, classified as investing activities",
        "terseLabel": "Proceeds from sale of property, plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "auth_ref": [
      "r189",
      "r227"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Products and services [axis]"
       }
      }
     },
     "localname": "ProductsAndServicesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProductsAndServicesMember": {
     "auth_ref": [
      "r189",
      "r227"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Products and services [member]"
       }
      }
     },
     "localname": "ProductsAndServicesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r28",
      "r100",
      "r107",
      "r109",
      "r184",
      "r186",
      "r224",
      "r242",
      "r245"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      },
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      },
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Loss for the period",
        "terseLabel": "Loss for the period",
        "totalLabel": "Loss for the period",
        "verboseLabel": "Net income/(loss) for the period"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share",
        "terseLabel": "Net loss attributable to equity holders of the Company"
       }
      }
     },
     "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to ordinary equity holders of parent entity [abstract]",
        "verboseLabel": "Numerator"
       }
      }
     },
     "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "auth_ref": [
      "r168",
      "r206",
      "r207",
      "r240",
      "r241"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income/(loss) before income tax",
        "totalLabel": "Loss before tax"
       }
      }
     },
     "localname": "ProfitLossBeforeTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "auth_ref": [
      "r216",
      "r267"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) from operating activities",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "ProfitLossFromOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "auth_ref": [
      "r9",
      "r49"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period."
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment",
        "periodEndLabel": "Property, plant and equipment, end of period",
        "periodStartLabel": "Property, plant and equipment, beginning of period",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r50",
      "r217",
      "r230"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, classified as investing activities",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RangeAxis": {
     "auth_ref": [
      "r124",
      "r161",
      "r196",
      "r225",
      "r226",
      "r290"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesMember": {
     "auth_ref": [
      "r124",
      "r161",
      "r196",
      "r225",
      "r226",
      "r290"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges [member]"
       }
      }
     },
     "localname": "RangesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [axis]"
       }
      }
     },
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [member]"
       }
      }
     },
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ReceivablesFromContractsWithCustomers": {
     "auth_ref": [
      "r125",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of an entity\u2019s right to consideration in exchange for goods or services that the entity has transferred to a customer that is unconditional. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due."
       }
      },
      "en-us": {
       "role": {
        "label": "Receivables from contracts with customers",
        "terseLabel": "Milestone payment receivable",
        "verboseLabel": "Eligible grant amount receivable"
       }
      }
     },
     "localname": "ReceivablesFromContractsWithCustomers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of accounting profit multiplied by applicable tax rates [abstract]",
        "terseLabel": "Income tax expense reconciled to Income / (loss) [Abstract]"
       }
      }
     },
     "localname": "ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of changes in property, plant and equipment [abstract]",
        "terseLabel": "Property, plant and equipment:"
       }
      }
     },
     "localname": "ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of number of shares outstanding [abstract]",
        "terseLabel": "Common shares"
       }
      }
     },
     "localname": "ReconciliationOfNumberOfSharesOutstandingAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RepaymentsOfCurrentBorrowings": {
     "auth_ref": [
      "r282"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for repayments of current borrowings. [Refer: Current borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Repayments of current borrowings",
        "negatedLabel": "Repayment of short-term financing obligation"
       }
      }
     },
     "localname": "RepaymentsOfCurrentBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": 2.0,
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Research and development expense",
        "negatedLabel": "Research &amp; development expenses",
        "verboseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of exchange differences on translation",
        "terseLabel": "Currency translation differences"
       }
      }
     },
     "localname": "ReserveOfExchangeDifferencesOnTranslation",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": {
     "auth_ref": [
      "r70",
      "r208"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of exchange differences on translation [member]",
        "terseLabel": "Currency Translation Differences"
       }
      }
     },
     "localname": "ReserveOfExchangeDifferencesOnTranslationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RetainedEarnings": {
     "auth_ref": [
      "r210",
      "r211"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings",
        "terseLabel": "Accumulated losses"
       }
      }
     },
     "localname": "RetainedEarnings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RetainedEarningsMember": {
     "auth_ref": [
      "r5",
      "r208"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings [member]",
        "terseLabel": "Accumulated losses"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, resulting from the return on plan assets, excluding amounts included in interest expense (income) arising from defined benefit plans. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Return on plan assets excluding interest income or expense, net of tax, defined benefit plans",
        "terseLabel": "Return on plan assets excluding interest income"
       }
      }
     },
     "localname": "ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [member]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Return on plan assets excluding interest income",
        "terseLabel": "Return on plan assets excluding interest income"
       }
      }
     },
     "localname": "ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Revenue": {
     "auth_ref": [
      "r31",
      "r115",
      "r168",
      "r182",
      "r185",
      "r189",
      "r190",
      "r192",
      "r206",
      "r207",
      "r224"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue",
        "totalLabel": "Total revenue"
       }
      }
     },
     "localname": "Revenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract revenues",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RevenueFromContractsWithCustomers": {
     "auth_ref": [
      "r126",
      "r127"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss": {
       "order": 1.0,
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue from contracts with customers",
        "terseLabel": "Contract revenue",
        "verboseLabel": "Total contract revenues"
       }
      }
     },
     "localname": "RevenueFromContractsWithCustomers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue from performance obligations satisfied (or partially satisfied) in previous periods. [Refer: Performance obligations [member]; Revenue from contracts with customers]"
       }
      },
      "en-us": {
       "role": {
        "label": "Performance obligations satisfied in previous periods",
        "terseLabel": "Performance obligations satisfied in previous periods"
       }
      }
     },
     "localname": "RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue that was included in the contract liability balance at the beginning of the period. [Refer: Contract liabilities; Revenue from contracts with customers]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amounts included in the contract liability at the beginning of the period",
        "terseLabel": "Amounts included in the contract liability at the beginning of the period"
       }
      }
     },
     "localname": "RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssets": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "RightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r259",
      "r261"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount of expense relating to selling, general and administrative activities of the entity. This member is used to attribute an expense by nature to a functional line item in the statement of profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expense [member]",
        "terseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpenseMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ShareIssueRelatedCost": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cost related to the issuance of shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Share issue related cost",
        "terseLabel": "Issuance costs",
        "verboseLabel": "Transaction costs associated with issuance of shares in relation to the asset acquisition recorded in Accrued expenses"
       }
      }
     },
     "localname": "ShareIssueRelatedCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharePremium": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      },
      "en-us": {
       "role": {
        "label": "Share premium"
       }
      }
     },
     "localname": "SharePremium",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharePremiumMember": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      },
      "en-us": {
       "role": {
        "label": "Share Premium [Member]",
        "terseLabel": "Share premium"
       }
      }
     },
     "localname": "SharePremiumMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based payment arrangements [member]"
       }
      }
     },
     "localname": "SharebasedPaymentArrangementsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Associates [member]; Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares in entity held by entity or by its subsidiaries or associates",
        "negatedPeriodEndLabel": "Treasury shares outstanding at end of period",
        "negatedPeriodStartLabel": "Treasury shares outstanding at beginning of period",
        "terseLabel": "Number of treasury shares outstanding"
       }
      }
     },
     "localname": "SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents": {
     "auth_ref": [
      "r263"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Short-term deposits, not classified as cash equivalents",
        "terseLabel": "Short-term financial assets",
        "verboseLabel": "Short-term financial assets due in one year or less"
       }
      }
     },
     "localname": "ShorttermDepositsNotClassifiedAsCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails",
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShorttermEmployeeBenefitsAccruals": {
     "auth_ref": [
      "r265"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]"
       }
      },
      "en-us": {
       "role": {
        "label": "Short-term employee benefits accruals",
        "terseLabel": "Accrual of performance-related remuneration",
        "verboseLabel": "Accrued payroll expenses"
       }
      }
     },
     "localname": "ShorttermEmployeeBenefitsAccruals",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SignificantUnobservableInputAssets": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The value of significant unobservable input used in the measurement of the fair value of assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Significant unobservable input, assets",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "SignificantUnobservableInputAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Statements of Cash Flows"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Statements of Changes in Equity"
       }
      }
     },
     "localname": "StatementOfChangesInEquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Statements of Comprehensive Income/(Loss)"
       }
      }
     },
     "localname": "StatementOfComprehensiveIncomeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Balance Sheets"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SurplusDeficitInPlan": {
     "auth_ref": [
      "r277"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of any plan assets, less the present value of the defined benefit obligation. [Refer: Plan assets [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Surplus (deficit) in plan",
        "totalLabel": "Total liability"
       }
      }
     },
     "localname": "SurplusDeficitInPlan",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SurplusDeficitInPlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Surplus (deficit) in plan [abstract]",
        "terseLabel": "Defined benefit pension plan amount recognized in balance sheet [Abstract]"
       }
      }
     },
     "localname": "SurplusDeficitInPlanAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TaxEffectOfTaxLosses": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax effect of tax losses",
        "terseLabel": "Effect of unused tax losses and tax offsets not recognized as deferred tax assets"
       }
      }
     },
     "localname": "TaxEffectOfTaxLosses",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax (benefit)/expense calculated at the domestic rates applicable in the respective countries",
        "terseLabel": "Tax benefit calculated at the domestic rates applicable in the respective countries"
       }
      }
     },
     "localname": "TaxExpenseIncomeAtApplicableTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      }
     },
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [member]"
       }
      }
     },
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TopOfRangeMember": {
     "auth_ref": [
      "r124",
      "r161",
      "r196",
      "r225",
      "r226",
      "r290"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Top of Range [Member]",
        "terseLabel": "Top of Range [Member]",
        "verboseLabel": "Maximum"
       }
      }
     },
     "localname": "TopOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other current payables",
        "terseLabel": "Trade and other payables"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TradeAndOtherReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other receivables [abstract]",
        "terseLabel": "Other current receivables [abstract]"
       }
      }
     },
     "localname": "TradeAndOtherReceivablesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations": {
     "auth_ref": [
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Transaction price allocated to remaining performance obligations",
        "terseLabel": "Total potential collaboration agreement value remaining",
        "verboseLabel": "Expected transaction price allocation"
       }
      }
     },
     "localname": "TransactionPriceAllocatedToRemainingPerformanceObligations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TreasuryShares": {
     "auth_ref": [
      "r81",
      "r210"
     ],
     "calculation": {
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "ifrs-full_Equity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      },
      "en-us": {
       "role": {
        "label": "Treasury shares",
        "negatedLabel": "Treasury shares"
       }
      }
     },
     "localname": "TreasuryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TreasurySharesMember": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      },
      "en-us": {
       "role": {
        "label": "Treasury shares [Member]",
        "terseLabel": "Treasury shares"
       }
      }
     },
     "localname": "TreasurySharesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementCondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfContractsAxis": {
     "auth_ref": [
      "r229",
      "r243"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of contracts [axis]"
       }
      }
     },
     "localname": "TypesOfContractsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails",
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfContractsMember": {
     "auth_ref": [
      "r229",
      "r243"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of contracts [member]"
       }
      }
     },
     "localname": "TypesOfContractsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesAndOtherOperatingIncomeLicensingAndCollaborationAgreementDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiAbetaAntibodyInAd2006AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesAntiTauAntibodyInAd2012AgreementWithGenentechDetails",
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails",
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfRisksAxis": {
     "auth_ref": [
      "r169",
      "r172",
      "r173",
      "r197",
      "r198",
      "r199",
      "r201"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of risks [axis]"
       }
      }
     },
     "localname": "TypesOfRisksAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfRisksMember": {
     "auth_ref": [
      "r169",
      "r172",
      "r173",
      "r197",
      "r198",
      "r199",
      "r201"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Risks [member]"
       }
      }
     },
     "localname": "TypesOfRisksMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      }
     },
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_UnobservableInputsAxis": {
     "auth_ref": [
      "r121",
      "r288"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Unobservable inputs [axis]"
       }
      }
     },
     "localname": "UnobservableInputsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_UnobservableInputsMember": {
     "auth_ref": [
      "r121",
      "r288"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all the unobservable inputs. It also represents the standard value for the 'Unobservable inputs' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Unobservable inputs [member]"
       }
      }
     },
     "localname": "UnobservableInputsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Unused tax losses for which no deferred tax asset recognised",
        "terseLabel": "Unrecorded tax loss carryforwards"
       }
      }
     },
     "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_UnusedTaxLossesMember": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit."
       }
      },
      "en-us": {
       "role": {
        "label": "Unused tax losses [member]",
        "verboseLabel": "Tax Losses"
       }
      }
     },
     "localname": "UnusedTaxLossesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Useful life measured as period of time, property, plant and equipment",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average duration of a defined benefit obligation. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average duration period for defined benefit obligation"
       }
      }
     },
     "localname": "WeightedAverageDurationOfDefinedBenefitObligation2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement",
        "terseLabel": "Exercisable (in CHF per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Exercised during the year (in CHF per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expired during the year (in CHF per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Forfeited during the year (in CHF per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Granted during the year (in CHF per share)",
        "terseLabel": "Weighted average exercise price for options granted (in CHF/USD per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average share price at the date of exercise for share options that are exercised in a share-based payment arrangement. [Refer: Share-based payment arrangements [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average share price for share options in share-based payment arrangement exercised during period at date of exercise",
        "terseLabel": "Weighted average share price of common share options exercised (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r152",
      "r157"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement",
        "periodEndLabel": "Outstanding at end of period (in CHF per share)",
        "periodStartLabel": "Outstanding at beginning of period (in CHF per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average fair value at measurement date, share options granted"
       }
      }
     },
     "localname": "WeightedAverageFairValueAtMeasurementDateShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16",
        "terseLabel": "Weighted average incremental borrowing rate"
       }
      }
     },
     "localname": "WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_WeightedAverageMember": {
     "auth_ref": [
      "r124",
      "r196",
      "r225",
      "r226",
      "r290"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an average in which each quantity to be averaged is assigned a weight that determines the relative effect of each quantity on the average."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average [member]",
        "terseLabel": "Weighted average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life of outstanding share options",
        "terseLabel": "Weighted average remaining term (years), options outstanding"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average share price, share options granted",
        "verboseLabel": "Share price (weighted average)"
       }
      }
     },
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageShares": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share",
        "verboseLabel": "Weighted-average number of shares outstanding used to compute EPS basic attributable to equity holders"
       }
      }
     },
     "localname": "WeightedAverageShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]",
        "verboseLabel": "Denominator"
       }
      }
     },
     "localname": "WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 21
  }
 },
 "std_ref": {
  "r0": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r10": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r100": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r110": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Clause": "ix",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r120": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "14",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "105",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_105&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "113",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_113_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "114",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "116",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_116_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "116",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_116_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r130": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "116",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_116_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "117",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "119",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "120",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "120",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS15_g110-129_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Section": "Presentation",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS15_g105-109_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r140": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_g&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "58",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_58&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "94",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "97",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "C12",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_C12_a&doctype=Appendix&subtype=C",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "56",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r150": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Section": "Presentation",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "44",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_v&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r160": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "21C",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r170": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35I",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42I",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r180": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B52",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B52&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Defined terms",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "69",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r190": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "9",
   "Paragraph": "7.2.34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "120",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "124",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "125",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "127",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r20": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "7",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r200": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "C32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "9",
   "Paragraph": "7.2.42",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r207": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r208": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r209": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r21": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r210": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r211": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "IG6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r212": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_g&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r213": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_h&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r214": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r215": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r216": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "IE33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r217": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "127",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r218": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r219": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r22": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r220": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r221": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r222": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r223": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A__IAS07_IE_A_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r224": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r225": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "B6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r226": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "IE63",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r227": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r228": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r229": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r23": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r230": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r231": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r232": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35N",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r233": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r234": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11D",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11D_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r235": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_e&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r236": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_f&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r237": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r238": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r239": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG31A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r24": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r240": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r241": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r242": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r243": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r244": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r245": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r246": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r247": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_a&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r248": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r249": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r25": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_vi&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r250": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r251": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r252": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r253": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r254": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r255": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r256": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r257": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r258": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r259": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "104",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r26": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r260": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r261": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r262": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r263": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r264": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r265": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r266": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r267": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "85",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r268": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r269": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r27": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r270": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r271": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "135",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_135_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r272": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r273": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r274": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "144",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_144&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r275": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "145",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_145&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r276": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "5",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_5&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r277": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "57",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_57_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r278": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r279": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r28": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r280": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r281": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r282": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r283": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r284": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r285": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r286": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r287": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r288": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_h&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r289": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r29": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r290": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r291": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r292": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r293": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r3": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r30": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "99",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r40": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r50": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_140_a_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_140_a_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_140_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c_i&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r60": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c_iii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_f&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "145",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_145_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "145",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_145&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "148",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_148_d_iii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "134",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_134&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r70": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "21",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS21_g51-57_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18A&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19_f&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Section": "Disclosures",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r80": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "67",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "126",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r90": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "126",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "76",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "50",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "10",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2021-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>168
<FILENAME>0001558370-23-003963-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-23-003963-xbrl.zip
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MRV/)K.+CK"*;N&B+<R#4^2$A=9AM]$8I36#L_AFS4/9=8TIU8,T&\.'DM&P
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M^.Z.S>D]]RG>@A&W*[+0[8'LCLI.7=?S\BL)8/D)IDLB5L2E0)<+4VN7H6U
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M]55<R(VL?LH3;_?M 55U).% GRYVR<-BWF/[-@<CAW3O$@+%$,*F_Z:;>Q)
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M?ER2 !8]>0Y=V+OLVO)@9%)SJ[WBC1K@;/0\TW>)C2_$F@!M9"Y_AO  =/,
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M?)'7[=("H?]\C#(/86):D;_]?U!+ P04    " #3.W!6=A'E7Y,3  #*' $
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M@+1LPQ8XYI>*;&">A*(8<!B+(DLN8$^T*/)0CGXNIF7D?@:+G"KW1-! @"
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M/Z_.CR+4&^)C]A@59W$_TO^ EGX4$R>,644SJ>27FW5*[[=UY;\,?:]TWXG
M#B@V\3[BHA!T2?M..?&NON1+T "P%"X1>W0AN*4G_&__AK;2M7#4KE,6O*^[
M&([ ![$:[A&%@MI?WA45"<4J*+7KE/0?ZDM_"7P0I+_Q(]<)4LANZ'>B\X^B
M;:<L^+$^"P0H &+#?R*'F#$AU[)3%OS4% MR"/3*@"D%R>-@!<Y29-06?^^4
MV#]7)W8)[%Y)G+[>E>.[7-'+FW9KUIY6I[P<!1"*9AJ&B1,\H TFJO-FL5FW
MQ*]A\8K!!T'X.;5 TA1!+?&/FW;+@"9,W",40##A<86"X!*O-TZXU;)!U+A;
M1M2P?55( #"W;OP ?4XDGLWC)MV2O8:A>PPZ &+?ABXFK 3UWNSF[S:0[27V
MY%X?3:]N65+;\-5@ X!+&2;9?PR=,REOA&V[Y4@->UB! T@^G%OPX;QK/M0P
MBA4XP.'#/8YB)_A__D:IK,2-N^5$#=M8A00<5ES2CS,RQU_E][,%+;ME0@V;
M68H!( ZD>Y:6_+MFW4;&:EC-8O#[=5ND\>E[1"(<ABB0A,C$S;HE? V+60Q^
MOX1G@!/D2!1^\>=N"5W#,BZ"W2N![S#S@:]P*#?!CIMT2^@:EN\QZ+T2^Q&Y
M"9O\[/QISC(&!<0^;M(ML6O8N\>@]TKL.7%X!<?M^@D' DJ7?N^6S#5LV!+<
M( 3Z^IN[8M4T)?NBN%FW%*]AHXK!!W 2O,3K-?-@8/>OM.!4KG*I/&M!V:E;
MIM0V6-7( &#1'R@(_BVDIL,C<NBI"GFW490H/)W2]MTRIK;]*L4# $]^QP$U
M*AS"?;-$GN5YU*Y;'M0V7X_@!T#[+"2:AA_8-A8[L3#'0=V\V[3#VL:L# T
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MCC;]:-./-OUHTX\V?>\V?7;02N(5/3G]-_+F^ +E+O#)#S1"<[_&:,/W!-1
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MDCAN#,-\:%LK'./==_[.EY"DV7S_C;R#$ K.19'^8&2;\G.N2OGY89(';7*
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MG801P:\T?<A9PSX*6AT#/QS:5VD-%^T-@!L@1Y#3V+\E+R**Y*$C0M#4W]'
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M>G1#BA-]!<_/'S7Z(/3^WJP;U\,NC4'"*#P7!BR'(5]6\Y0S02*_S52&?H6
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M-B.Q#*@^OEXX*=TR=MN.!UM;(W5'33'S&$G=%*'SZ7)L:GH9:?+TRE;"@OC
M4\!IYIF,\;X337,_I*;=6W3U5-/0":&Y]^?=SF2#( *=3O0FG\?KZ*4'.I./
M-'VA-)3O?]XY,92KZ77TU8?:HD"AMYK44*%-:C$ TE\B\^<:.=GS Z/["JO?
M?-Q%S*HEK;SV7\*I^B[*D3I4T+:8:^RX&"?IXM_6LDZ\DRT<!-MT.Y8.U+"
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MQ8.:_%[I86%:MZU3VRNL;93=YVP+_N@$/X?@09#' D54DMTU#-IGJ[DW+<Q
M/U1%#9O(_0AAA_K!<IG?FWHZ!DY<P_MR^!G3@/M6&DF@S_DCQQ*#\R'Y;+HK
M0Y.&6K!M]2+7%N2YB./9Z"GPMR+1;ZP$=)C&5NYO1S_AK\QI('6_[IC!V4 1
MS;G@[7VQ0[")*'915V0<.*5A9\RX'ED#EQV2DR\I!\O9=C@FUT@9'_F;]!L:
MQPP25[*:)XS,_HUW"U>U2UXO[VSK *R=+E+$M:ZZ_L==+407LV4[1+;1#[=.
M*[./OE';LGK'H\ RPE5/KL2:PT)A]NXE.@LP5R$/<N&TCHT.NP4?7\5#Z.YK
MKR5Z7UI(,<F*BIJ6Z+T(88\/!\ME9>$$ZZ-\)XL6H_/\7SG^;,MOY'K!$5,N
M1U^C /##+HI32!"^I(>(1=+)YRB]"!CB^QN?>JNDIHT^>#R4]#+@V8H"&]!Z
M$-WE@+<=,6WX8 *<G/.[!Y[DA8112MR<&Q8(G3CH7."^=+UA W^4^JR_(3+2
M=JLZGXX>'-_+GO=F<^/*=>,C-(23//;_P='SPVVV<RV6*/WV:D<>&_,<,O5/
MT+A+/.; V&>AR?4P01XOYY90R:XHQ" 8SNI2^AG+Q;6[9G29;G?['\I'<AJY
MF!_EKEO7$T^6_)5$L51,H18+BQ28Q)9F0UWB2Y_N>BFQUWRF1?E;F+#Z"3K)
M-4;Q$*K8QDAY52O)U(PYAO.J3WM.4:IN.?/%-!I=JQ2%]X"6+R]I FM/)Z9]
MWE;L1P3II#!,*>ISUBX*BSE4U1;$#@JY8CBQ!5%^$Q#;M9;1]?)PW.^=^%5L
MS L=)&E\=-.C68%H150IP^8\D'Y*>+S<A+/JIDB=6T? /'Y3M,,>C76Q/:#@
M(E_&9&N;:8.DL:1ZC!V/\F6:B&D.SJL(9,HK-Y7((Z_=.&]WDJ%B07M;O-9L
M9QEG, YF_QY3M;T6=WT'P8XLH\H\3>4:[NV-/EYZ QWA^F]RM6HO!?54NIQU
MX>2:KEQ+'GLVFF8)>4^?:7BDUPR3L^W6Y!<_W5T<DS3:LY^H[W*R)T&DLY,]
M9:F7F7VH+6;):224I:NW8F@"OV!^.)*0%S8Z<;/AT:U%)U58TY6M3&_(0"H3
MFS^3(FHV/^Z<]-'?^^&6K=S9-\F&L<^_OZ,QGQJ8/Z^+NV5L2GA\/?BN$V2]
MV&0!8=.?G&>Z#JO'2Y"WEQ7<+"80'?3#R"EZ6,6HM :\1L<FZHD K[:,:Q<6
M$I7JWJ=,*))R_OAF9TDN7K&KD*Q\U95'AJD0KM3[(.0C.R:@K(10.=;G2;UY
M>>-RG(Y@)OOV?O&V*;+MQQ5&X&.^SW=/$\I &E+4+YE 0925MH,U2O\X7YL8
M^LEHB)+:XGL]2J@A?9! MN)Z,2Q'0J\8.%M=HP#"6?1T7]9,:2B\$/03#6GL
M!+!9XS&P]^%H (K+&8)0+W*+@J'^BE(#D3ZMQ4"1@4AVP&@K!A:[?)6AT<+1
MA+KZJ:2=ZF!X(>F:7Y&@(O?4$(>Z:2P*?#15HD:<#@*+@1E=.>Q@B[BL0[-,
M[S=NE*1O6^$$CQ>M]E#P*6&:@@0Z[^/K%7]B]#J*[^+HV4_X O _Z>LGIKHM
MK^C'5H-)%(8T>*#QL^_2A#?TH.\#/3CP0%K1F%/3W(^;G:U%^?I\/YP:/J;G
M:3&(-*-J+%6&$@( R'$)X'ZZ>(Z8%X@[9%) VU_I*]GGO,'6BY"$)%(4T=P3
M5!(I3;D+E?*@"\H6^#O^9_77@ +!;#[DVU\39UN)^?C1^7I/ >_\P.??V4FQ
MTB6.%.7'46*O9"HMRM]"!E4_02=)FY*Q(XOOX I#B2F$F5+3J*]'E2^%ZI:3
M$36-1F\*165['IG"1%EAJ,^-=ZGR2/>'*';BUTM_LZ%0&(?^',)+S$QOMU$B
M;J3FGURPV=GO7^/0PB!()YAQE:I>% P=83$AOC5![2!FFK'#)J&,GS-RY.-S
M# @X3WS/K_2I*_A"%WC/KMV?0P#+;>C_C<)QEG=T4U_4L3G5<Z*OZ+E"<*$S
MIB _UJBU:(\T4G0<0X%FP;>:[C<5>FN(.=E+NQ2XR).%2O&D]%R>-[1W7LD3
MW(V,8ZALQ>B\.+&'.3P?4<4FP;E4)E?VZP)C\S$MME /V-=K9EUBTF!R'ZB;
MG56"\N"1G=&>8! [7/=BLDM (1^=  XX'G:4II#P?$DW?DB]CS1D?Z3PZ&;?
M=QKLC+&4N<2F2IM??+ PP))F%ZORVMT?CW.>X,W#)\$528 M<</!$XRQN81S
MQE^'G?-]B6]-E3CJ2Z)3<3D_MJ;@OPVSU?'FG?P9N_7F+HX8 VR)![/P6'/0
MT/$6/!]94;7NW#1HL(7/4W9D'Q-H\[<;Y2OFX/@0AD* NI0I[)O5\B)FMWFU
MWSW36;)P/$<CGVE:U6MVR>:57[_I>PC2BQS22<^6HM0'&_JT%G.$82"2'8R$
M5XCJ/I?=F7LE;_B5NO:42BN:ZOUZTX0*JUQPVS$:%)*Q3K16NMMV1C:.'Q</
M.P$OY=N)K4J?)<H7%2.C_2&F.QHF_K-,X9T@X!\Z-%(8G.,',%@&#!KWVUD1
MV%'#9&&KK%%;YC?;\%_>.N'O0?=+6SW,^YOT7$A8\08\:XH'$"'UGR&6"9W@
M-?&3ZRA>P5OAL>\$++XY[@\\SNB[O#"EC'2*'4%]ZD6'$=G%K#^&26<'>Y."
M!Q8E"R;X%0<G8P-BZ(P/='E2\ZAPU:@;6&0TJ1,OZ,$[8+)8B2<>%Y?%ID%,
M3Q8X6<4Q++]D<8">Z:5#Z"\* "VHLBVIU)CX8L#0AHRV4DD9)UE!(\E+7BW^
MG+.3ET-R"H;08>.<&GTHZ:I\!4L&YM$Q9<%D",\GX47'S\?]$XV9 G^A_G:7
M4F_U3&-G2Z^^TMAEP?M=#/?;I$[79L'A\#$6A9*65-JR2SUL@,6@I2TY+>UG
M<VXX9+Y(?H@C&")4<D0.G*7BV8T(:4@YMVH_]U-FIL9CZ+%>9=7"6=\V=O:(
M U"5KN_IWO'#TN-Z1R>X]3>LQ[J8.<; W8$#?Q-@;$/Y_1%ZR*B+AVTKPH^/
MY7'&9EYSDO%) L8H1Z*"U85"_*P_0VF(3'%G-< G/%;GO\W0U/AI\/V&B1-3
M-_U$'?A ;'-?.W[\WW!*N][\%$5>LHZS6A'BV3SJE57\$Y.9_4*7QY@IYH[&
M?N3U!?LIN%@4\D_VLZBG@=%96,R<,)TF[$P0ON27[ N&>5VP2O;%%K@F45P4
MP8DEXV>UR6$KF"<>YQ[*YS#VT4T9^'^E;"X[SV;KTMXTWAE"=[7%ST:O?COZ
MZ>M-"*\4PB\PVG:+SFB+0GSK:AZ^!=,YU&(0W+[$LVS+B!-]ROEC*)\SB Z+
M\>B[]()J&(7GSS0!'8OYS1%76M\PA:2,H=(7XI)K]<-CZ*?)6[PX?1'M]WYJ
M!+K*KHM"T'8%M#S3W-AO,=C6P;ZE)YF+0="!S4@*J#[@D0^!"P"NG!AV0Q(6
MK/) 5NN=J=8^Z%U>0^3:VTOJ#JB=7(=OX_>()&U8S,GY#8-;CRERV9_IB?A6
MKQ<$1UX7GS]C!/@4LNB'%V<J!3D=UP3ZDD#JMD,44DK;[]4??_J]F3CVR@^5
MEPYO_- -CEYV9,#^RSX.V/(B28X\-YN[1_)6%!URHV/@D4.40D%D)PB@R!B3
MAA(VE.\V^!5D)4-)H\TQ98-/7IUH6DUGXV7ONXFGO[(AJRNVN0L-3:N92NHZ
M,QTOTU1"W6/,2TQ/7'CN NH:,5N5"?_9&PTB)56\$)=_TOE&O.HVP=B#XT;]
MB7^$7N7MK(R,?Z:96A&3E,AS)<OY)9C\S1.9\)U=*"T^++UWB;!"'H[?0+N&
MWC#]+Z?2'HZ?Y6*0MBW.JF)3%[*6W5T8!='V]2YP4E!9TJ3A]N:89RX-0?.Y
MIJ4M]ME!A_4A>"X/-YBY'D/_MR,<9$2'V&?.%K]"ECD?BJ39Z  -:<1G@8C%
MHF<,@1)_&Y9?ZR1[ZOFN'\KBQ9[O;,,H27V7]V1TMS0E>S_91 &\Y<+&2RD+
MNB=&_#'U^CG7::ZW0I?C7&5NQ]%IA"U;CH[@ U#NITADE[DT9K- PI/,F@17
MM,.,:VVBY8#6U CA-FDWK\9O3P)1(JF2+QG=.8*4$>5S.^6;]V#C.HHI0_^K
MKZ*TS#UD42K<4;L34M_L)W3U;*.M!T*O[<FXJ8E?'T,7HA[Y@FQ,#U&<<JN'
M1])"]Q6MV5^P-0ECM$$[2DVV=D%O\MT"5PU>W1ZUN6NP;;P^%*0)/-QW1GY^
MN"3OYSJ^&U'*Q]@)DT#L0O#'&?V0A?P7?[K&Y;\RSZF/_[9V0>^_W0)7_5?=
M'K7_:K ]-"NXE/@GJ+=Y-)ZTL_\ZPGE.RA]GKV^@W8-DT>:84+%AQG?&M')Z
M3*BB]Q4K:E/GL?4FB=KC[$AF9R_\M]+X#?OA,;!P'FW.&1/9AJPH;(8NN@3N
M$EX%^4#C%/9J0BB&#"FX!UYLXJM?W\PUZ([>$_LIHAZ!ZO1%[5L]13"/3/DP
MV08>#'3&RXN(ZM8T&XQ\<=APR'Q%J9I/%'8EE;KM[H?>.S1%K[I%1R?4_J#+
MNZDCW+5;_YZ/@LS^/Q[] ++"D@Y[/VV'WKX5HE7MN=8(M?VJ>#6UUYS>7!L)
MHPE$OGS"Z&SKS<9WJ>X4HVJ-WO%:Q:RZ7V-3U$[8SK%QS0E.E>1DY_+(::1#
MZIY0\?F8BIN*.@ZJ;H_>13M$K2V%FANC=M,NGDU-^>9Q?B>=0[9E[D3>^B&]
M2>E)YII=RNB]W9KZ[.Q*YF11(X@]Z>;;G62T6%M@!ME4JZO<6\HT 97$;RD3
MB7:FA@RG^\TX<X?JS%Q90?2;<.0NV29QXX SP0O_!YP-\L69)S4-CP+O&Z"-
MOYL(XY6SX/]H,4'T*DE])AOUN%10PKNF'W4KI!#2(5:>&GK:!'N*>PO'0S+;
M:4966AK4HS^#FZ[?WX5_#C^%EX_AG]A_'KXGP@_.N-O2K\[^$- SUNK]GW__
MZ?V/E]]#:AH3G(J7?"!+C='<..+J:,2FZ%?JQ*PW0,(^"M-=<L8-/-WYK"D-
MB>>\3IW>/H).KQKT.4.Z[4R2X0FXE.<@^HD;G2208N 0A:@CIO;^BPF.-,48
M_>)AQRFR><J%8JIG2!'%O/I(^\Y?9V.D1J\G9#[_*UMB#P.Z&3>/!OR$B/-;
MPFM#RZ>YB NY#]V9#_G\#QF\0<YFT6+BR7T\3=TV"*?<[I]@LA]5TF';I2HT
M@@AB%P7>S9X9U3.O<"ON('^%VBKBSS15GMD;$T&-7J9**5"M+P7T:&<L$ H4
M]$M<P[5>N:[?T<"33Z@X,IAVMC$5Q:W%]7<AGOR'$%!4+8(Z1&&40E6BO1.*
M^D9.FCI0E :&B*D3Y"Q.C;B3_UKYB%55JW4X)TK/J)WRD.^NCW'HPY!(CZBU
MPO5^IUY:9)#.#4,58["D6][A50]1YE[:#3RO4D142@7DVS8_)Y2I#5Z8::L%
M8$@'J>\,5DT>6ID00>@]PV49FCC<Z!3%+O21CRR>>9JU8,$L2KKJJ8=Y)^I"
M ?*A$F^5B*=&UIM'?T^5*E1"^A"*2"'(HKJJ,[DQ.82P9%,J4]_[N>1Q\K4A
MCZW8LC>"H$X1&_^L?7J?Z_AZ/K4U0I;%P.8F=*,]?72^WD9)P@O(L7@+7KL0
MXC5!=W<7I%C11^ \,NEHCWV+1Y?](8?<F0O'W(69A>[]E$!E-O*R\]U=N=Q@
ME%WS@TK/L(W#(A;8 #K BV*\M#2<8R?$=4+R1-DRP#ORAU7@!^1]V,S*:T+&
M])F&1RIWCP0'@P_688"E'*Z/_<,*^J!O_JN=D?(84N$SQ(VCV[.45Y0N;1=W
MYGT<NJ$QFXD8QR)K5+V2;VB)%*(UQ*MMN-2;H0Z_U-P:;YM(BMQ1Q08X,C,M
M;2.MF1\YL 7[0+=B?[9/,FY;;_SFW$<-ZCU%95?<9M]+ CL[B%$V#DGD0,C2
M8,=3A"18JF8W;(M#L70X$4!486V:M=5-D3JNCH#Y$D'1#OO2H(OMX<5X&WPP
M#Z^?7DMK@(ECY[$D7Y_(>R9K6\\0*<_Q\UI$EWMN*+#6ZX:7EK:8\:5+Q!Q@
M5 VQ(TPGW\-M,,Z'0(8QH\E^?RKQC"@SST^,:XFCFU:GUP,I8O40MU9X&FEV
M7/N29;RTH3P_")<1-^9/=9AQ>Q_TAJPA<M646SJ@-F8=ONUFP>&R[8N(OU3(
M*[W?A'=QM&4Z[C+NCD[HK5M'Z'J1%G4/U/:MQ;AQ;<H2<3A@.DCRRFI\4VTF
MC2JUV)Z6:=1N:22+2SPQQL\P1%D6]96$K@Y(?5)?V'S%U]H:^[)/CWG;5PA4
M!COQNF]<X:5;<O+D8J!;CCCA5MY#7+G,8(X!9+%<PF&[ZXN"#WO8G4[$WR'$
M)HX?\Y+"H?=3G!WO%E1:"TZ/-R!24)E.V;4@8:31< <88PMM')Q4G_P\(T[!
M&_%*S)U!"\;>WV0J?<CO]$@&^3^W<9[V4!!4%-R>+,3Y9O2>6-$[)E3O6CXU
M-UX8FK8NEQI:+@C%;"V/ZH:+LD9Y PYTV&];#_1&W"ENU9*5S5&;<S?7IC;]
M4S,DS[S>'UO>W),%[5'$?*;Q4S2?H"OWMZ.?^'PJOH@29"5J5?%-Z)5#G [<
MZDD$/929**7VD%P/"J@!ST@0<U=I#FAYS%J):>?&111JF0\M9Q-_55I0X@+2
M>PK0X@="$^O-!7\E,>&;Y(I7K+H2D0>11 ^RPQ56A5QS>J@!V()8YED_Y:$A
M+48\_9G((ZG6-]/F3GN>46^M#VH9%?L=,?[S/!Z:)NMT1^-'IJ3'71P=M[N/
MQ\0/*8N)H_V3'W(E)OUO?ULCCQ[.["JR%DU:H8T:YBR+:!QK9&R0"/B  ETA
M^S_."7F2K!"WQ,L<M\?U8C1D&L6%>S>A&T,6T245_Y6ZX0^Y;]CL<LW<NSG9
MH3\(CC,6>D0<4<55>!QA(-18.::\ ZYN<U[(&T]R]3;'S31C3%RI=Q7)34CK
M<&#4=CXX+E M[P7TATG=WNB!KY<:ZE?+-;JB!J=^$IA?02\?=T^(&W\0.@CI
MEC_%@$P5A'X]T#!!EN9_Z2>'*'$"@]!)JRM^0-!6P,DM_(Y^N*% G_T!]^_%
M$'A!8$(EV"P^2IDRPM39TBS^:=DYJPEO1 "I$YLKHZ@SVJ<W]CQK,V$&5OJ2
M(\(.M)^M,SJWH+UC#(D%:5XL;.*D[&DU58RFKZ(Y2K#.I92:Z2AU,'.V([Q(
M0)/U1N3<MZ>?-[9%"J-:(M92'4\;HHYVVO@U3G04-,%ZL[=Q,>;H5B7O2M)5
MM%Z:Y;:FZ38U79+UVKTZA#,_-S^9>(SJCV%W'ZHT]D%OPAHB*TX>3SN@-F<=
MOH>?$4(T%5-961KA'?1?*,A.O=4SC5D0)-XW3GCDQ8/\X&,4Q]$+"Y/OV4)V
M=3@$/O4>(WZ]_K9XGQA2*;:AGS!"Z25KN-[<A.P+)^ ]7)E@<7-]__#^7Y2_
MR#R\H/?(&7^BJJ?/P AJ!)E3'Z;(E/%,',&T?(O]^T2L?03?Y"ECG,2,(>((
MUN&EL9.7R1FZ9>P3ARVIH3U?27$11%<WSPX#*<C[?YGKH.Z;^,74/Y3-.G<P
MZ'KS,Y,;A/?DBJ7E#:'.'DB!MH>X1>6[UN8(0:L/U\:YH$#^/-J<'P$A^ CY
MDG3.-WVF%)M!7$5R9*F<Y8- [05-1R>D;MU/:/41^Z+6-%J,VSE0C\MFWUSA
M?9YC]%'EGJU"]U0"\LJ6W3_M@,A"'$7*O--- <Z-**37 RD$]1 WCRS:FV,_
M^M/D?LA9G[SUS!_C+ YK&DQ69!)ZV<'WQ$=[(VNB3%[39<=&XZG%MOG:V/[
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MHA>59C0Z88\F>LDPZ#$(1XX"@?J!C<-O\\P;!_P]"-]1)F<J#=C,":KM3YE
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M=K+%6\"5)(&R_\T%Z+.H[Z9!=5DXV:*B,ZG<LS%3*_6 ?1ZUG6)[&I$G*I+
MG*2>@[* M<TB]&AQ)E1E"50$UTC"&4P,\QPX6$GY!&A,"?OL-URP,1)S>N3
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MRZR-'"X;#.D>XALF$ X2^B@@.0_AW8"'+3! _'YWN=[XX8Y5I^TW%X74@6P
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MN"=0V:XW\FZP*9^[;A4]\0\"^_X(X;1)U$/),):;TL/E<LF\1%Z[+Y^)Y*K
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MRR3FCP%?<H^*@I4G2>TG=Q3/V=V8'T8['KK^T^",B':&V%%4M#XR/0:#BCW
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MVNM+<G/W=GV"IQ;6E\%"[PQO"--A-T",S<+YTWW\83"X2VB4H$+A@3WR0$X
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MN+*XTK0QN6-00^U2RG=O?OQ!ZOV/-^]^;&24ZI+(":7!O#*?5!2; )TT:>V
M3:"YK"="BX.3B0M[JPP;F4J&,A/7II^3<Y!K'K"KA*WK]^>=-XN4((<&?H"S
MOKQ-U)N2 YF.^,Q/-,8(!VUM;G66D#FXW"JW?>6FK$!:WDO?7="$-;ZJUDL:
M4I>W!%,^;S(7A=!!;5ED\Q&H@]21LGGIBTH!(C48-Z,D$L12;CD[O-<4Y9 Q
M!=FB!3)48?T-]YF:+S'E5^TOY W;&YF6:Y8 _L5IF*5+DO8T04J;"#Z/Z<5*
M2VH@I&L,:%B+R53SH^(6]_Y\J?WZ9>EIA/1*?9J(CZ8I9TM'T4@N.TS],PE$
MO7"]#H/:1RK@WN<B]'T:Q6BOWI?7(G*H/HR5L! X:R87_5A@";KZ9;&!4-0\
M;<LV.PM;-3&L"-&97KBJ.;#==L?,99^P,W?8YS(4?*).[6K'RM"Q>^Y)#;8D
M_$!Y]"N\'3!+/C(*1L.D"&8_%4F)="=C786B]V<;H#6NN3I)1.W!5@RS-L4N
MO8TAUB[K0@.YCCD[\-HTRY6[:\BS.-ZNTR!]_8PJU;60.DU'L^LN"U=40=CM
MNVIN+;-*J1%4+P Y-3YS:JIE_+C#[-ZLI8+J&C=+-2LC90 S$/:'1YV:"/G
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MXUF0UC4Q6DR*W2+_S7:C8'J\"D,5UF7:?-XRYL'?M)1"BOHLQ7M=@/NW^M?
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M0QPY" S>Z6;@<Q/X;^AM"3SIWV/XZJ%E#4(^(2F4LO/V>HEFL:\K0 R.+S"
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M,S=[2^C<)"&V3@X2>R3BW#14/O&-3QVI9%$8Q.9.ID@&T!,R%X)ZB=2\!6_
M"];8_>+Z>7I?"M&;36>) C0,;A/[O S"&+W8ZFZU]H(- -? !W.(9HH8*MMC
M>Y[:.TTG5ELH%&W[*.OER(K-8L J<0AJJ)5RG>D4D%-<;6*QEET[RWYV&[8J
MC\P%H-D9R)*"3&>:8F04;07% <Z]4IG:G#G,^R"<@7 >H-6D[^2]@I[ *O&S
MW0EF*%KD9M/)H@"-SO=Q^O=5AYWZG!K%L-98=-#^K8/LNA2?Y]A>K6^3>,/9
M_]I>,Q[?4J?TT#JXY2'1)[0D]!,05?X]B>,0OB8QAO E>(0.&G=Q"[PPQ*7B
M9$=<;G?X?']W.'^D%6;O\//N1]EK6,7WL.+ VKZ)57R5(?=_RP&G[SKO_5:7
M\:28I([^;F>II20])WOI+%TPC;S_#N/E31+%P0HQ7+RW6S/1Y2_T_/+JLJ==
M3(9QV84:"O4=Q]YERQWN'KG1.0&:[7R/BCT*=KZU8)"P69ON?&O "J&=;]]-
M9P@@][S;!#[1_>XZ"0.P/N=%N;O<C53OO<.$5$8$=IV/T/,VLND/E1NU88$J
M,PJE/XB ,"P^D(2.L\]H%>_'P%DV2HJIWCY.;HA#H<%138/)HAH5>^1QZ617
M40F5,J 09#R%'^$<?$%OX"2>'3ZL[ 7WD..V,DVG5B?X:%"NIFD4YU&J'4=S
M\=K0MI<5>X<8:GA.;S4,S>_L0;O4-+;P3;@WN(ICTOM$O?.8.AM4IL>JO5,;
M>DG;F^9<FJFK03I[=]R9@=#!)ER@C_7.CV&\B3*4F*1AWV(66R3U["R1]$!;
MHOE.\G1-<D?\Q8./[@*[S5#6/%-V9_2L=F>T4$,;Y&]C0?(ZZ/+=IBB^S"F^
MDQEG9/%G YSK='$J ]HMO="A;JN7?=.+_JO[!K-OJ@5+.B) LWW34;%'P;ZI
M%@P2-FO3?5,-6#'8 *66#.&\:*?12 V(I.GTJ)\PI!;D/.  V"&&9A8X9Z"\
M+.WX=SM"2T<O0:N_!S]'*,]&WES;'JY5F,37 'W\/OK^IW.TTH:!6[?.:2/;
M-#;S*<:)?2D'4:]JZX,$60LE-]-7#Z9&BY[1'Q$^W&8:XK;VT/:\S?9G#_XL
M!&\P2*(42J&0K(KG'(E_"$ [B/WI_A%TN],P<J)*0*0H)Z2&>@>*07\)PO42
MZ_IB)\\K]"%F:P6 U@X?\Q5&,3WOSH,D0X\L.U9KV]_(1J//!>ITMJ]EH?>R
M(OQBUBI[,W0'?CG+2]^N$('^CM[/0B]HD3<DP>KL'<T-3A]#TH,.21\#T<KW
M5\/ 37"HS7>SHZSXL6C&]=HPI)?5N PHHZ%135":>8>&5)*QKR _- TJLOH2
MVLEVCE&:]["#SS6W#,/*XN'E)NH:G/)UW-\\Z/ZF8<':#O8W/R"\+OIF4.?[
MFYF6&HX@_=:%:FE]SHM6!A<%JFN0)*I!96B//%!E2"XU9$ 8+"/( ;T3]",7
M_[@Q/VAB=&:+C&WE2"*,1.\3UF:$>09.X+OM&4.5,T[*B$-A</]B^G8=/WS&
MO$4;'O4309/#1>VIE7KSJ2Z.QKE)0TY)&EJ<*\-:#GV!'D ?B@]F]H;,^&[0
M/;B\'DT*G\ B\;"DS?8JSK*HF:3!,$-\Q%((A*[SG'T5@Q7RM0ZT/1F"5&X:
M!1=$=.Y]JL(P._W("+;%>=<;:&QI=3M(25%C9[A8QM/YMR@K:N3LKC N-=&Z
M$IHJ:@ZBXUKCBQTG..>)N[HH7J0A%0ZXGJA%0NUY&+JP9))!"MP7N +7MN_6
M+1^8=VC(GUJCTI@@IZ"&2X7_2NP0>:3SLY/33^P!8?^JLGZ72+^>C@%H:HO*
M0""HH;9S=SQ%.3]%OSCAS-6K%YEF1#$%=9V(?UL'/@F6SQ#DN+-$$)$,_*4=
M@;-\N?D<)^YF.L]F*VZ65?+@?WL?O9^&=\E[MOE5RC>-.9UCT_NJ0-/DXL=>
M"CJU(.S "SK+Q&Y[WI9F4]U6@-6VKE$BW31&\VFFG-5<&'6=YA7V3=]V"1VS
M($;_A[;WF^WM=2X3OL\T/G$-S-Z/EL-G6$2I!JZ_)GB^,IT_^%%L>QZ)98O3
M1T3:D53*4--UV2*FYA-P /I]M<U! PE'2K5"RN"%2*HW.0BP48VVP-TC)9\*
ME S>/JEV$>$>_[Q_[>A))8J)JK.=-:302VC[$8( *30+H0,F'GD!X+X$3V!E
M0]R)AK[9R2Y<:2RR#/Z5#KLSAR6D8N@4'3G=;3)\84+Q-8B1TKMBDA<0KJ!/
M%*0VJVHC:J1<4PY9!\=.*V%8OKYY CM;OH'HP?\U@'[\' .DDK_ &50P1O^X
MWMS9SA)W(J*>2=U<VIAYIABUSHZ_[G\8SK&>1!'8BX6P+ALIM:3@R#CSR4#.
M'*PMV B9U0RA/"I[8M:FU$T28OO<9BJD)U2DO2RQ^TY_*[46;2AP]+14"ES.
MUHZ;B![L()483EY!;.._O ;NYL&?N.@E+TME?MNC0V4;UET(-*S#3WY'WL'*
M7\*"OC6Y)=WJ3BZM[:ND7>JV+W/L3#>LC?;#=J;[>'EU^7%$G>DR?4?34JQ]
M9[H>&=(Y#6B,DP%E-#12TYE."RK)V%>0'QQ=-<R.ITUF;MD9MIS+AV%=SKM6
M0DJRJO:>*#.8;G1:<.. @X@P(L=N=()MOK1@D+!913@QK%&CWVYT6EI??&!1
MH'KO8XU4(RE\--C)Y38&(=L_BGJ[-HQ095(N2>2AT* [78>1(-M? .XD9'N%
M-CSI9>;!A\',+E!$Y[I)1O$B#2G"MQO3TKK.(KHS]G40H^\"?3=8_1J;4Z[5
MU?1B X6\:KW/&SI<901K,1I4+S2% T)Z]5YB,<ANDEJ0XI!1;SE<S.P%TW$W
M22TX)6EH<:YH.A%A+5N]M/W!KKGA!,&&OBEWAK,,7H+37VT_L</-V<GI%6?Y
M*B]F,)R06+DJ0L'@N<H ^TE\NKRZ.N^;F@<< CO$\-A/0HM^$L-G-)]FREG-
MA;%W;]U[/XGA\XEK8'9\6@Z?81&EOSJQ(YV:0M9[C$.*83?)"K=61S_*>VW+
M-Y)@RSARJB56BO9(#E;8>JBN)$<J22)U; XAU@AA-,22QZ3WYA U!=![IT;P
MG$_M32.E10MP%#5AT-'%:-P\9#3,[ RZWAL[&% Y/4(6-D-(46N'CK)I"[/+
M;VL$KQ\W7Q4R!(R4-XJ 4M3EP6,6,?<3QGKP;^P(7? %>?$0VMYU"&QGN;M!
M89BK[E$EV,].#"V]5QH&:P2IXA82_=;CO]A)N1K_]$Q--?X'T6I\] :T6OS3
MLV,MOC[3L>'4XO?I^/JHQ:]Z);,VQ[NHQ3=@:&33@)II)@'*:&BDI!9?#RK)
MV%>0'QQ=-4Q#W)_(U%3B4R\>AF4Y[UJ9$\LIVGMZP5"J\/5@Q@&'#V%$CE7X
M8N7->C!(V*PBG!C6>-%K%;Z>UA<?5A2HWOM8(UV%?WK6J@I_[W9M&*'*I%R2
MR$/1.T/TJ\'7PV\<<-[!A^%8@T_Y>DYUV)3BVXUI:9Y"9D8E5-;@:V1ZGB%I
MUA=5S> Q04T-_H Y(*27HO6EGJUYAE?:J ?=#C@AZ1!#,SL!#*VTT0!&\VFF
MG-5<&'L?L/LN;32 3UP#"R7A". S+*+T5MIXI%-CR(ZEC8STS".GY+$ZEC8>
MJ:0$J6-IHU 9WWB()8_)B$L;QT.+%N <2QM[*&T<#S,[@^Y8VMBZM/'L;/ ;
MQM(L;(;08$H;AUN.-AHN'AS2S@LK#U2-]F(GO]F.@^/7:2':1:D0[5<TO*#'
MS98V&D <D,2X56HD6Y5V*5"5A@O2LC<IUJ-=5.O1LC>R*J]TK$X;UC[38:O3
M>O2#O52GE9V480D\G52G#7^D9-. QC@94$9#(S75:5I02<:^@OS@Z*IAM4%I
M8L,I3*-=-PQ[<MZU,C$6UK'W+>'!E*-I08H#CA?"B!S+T03K?+1@D+!913@Q
MK &BWW(T+:TO/J(H4+WWL4:^'.V"'@YI5)O&E54&['S A6HB]&F)2^]$TK!J
MK4?*]#(]X<-PK%K3RZN(VHUIZ0.X \V,K;1J31_3\PQ)L[ZH:@:/"8JJUH;+
M 2&]CE5K>E6M:4&W TY(.L3P6+6F1=7:\!G-IYER5G-A['W [KUJ;?A\XAI8
M*%=' )]A$:6_JK4CG9I"=JQ:8V6W'SDEC=6Q:NU()25(':O6Q"JT1D,L>4QZ
MKUH;9572!0+_P[@(J1@Z@ZOI#E:5-$(6-D-(40E<]U5)!SEP;3R\4024VJ*V
M7NN"9B!^6-D+Y*LG"R1YKS;H$<[!%R3%0>NA,+OR'KET$'J;&0SME>UE/WVV
M92N&KL0JAM[-[EXLF#[$LO%;6N]H14/X5:WMNUK9:UE_FV>O:V7ON_W-\^3O
MQXJB8>T!'+:BJ$>_V$M%4=F]&99<T4E%T?!'3C8-:(R3 64T-%)34:0%E63L
M*\@/CJX:)HSC*='=2W%*Q*TJHEX[#+MRWK4R89;2L_>MN\%4%VE!C ..'<*(
M'*N+!,LVM&"0L%E%.#&LP:+?ZJ(/")=/NEE??%11H'KO8PV#%YDJ2"E>#0PM
MM,)F2EN9VG!'E?$K=.H$G]X)IF'5D19NYX#3%CX,QZHCO;R+J-V8EC[ >*.9
ML175FNAC=+%10U(O@X<"^BX]/SC*O$5#4APR/BJ'BYE5'G00ZJ*DG)LTY)2D
MH<6YHNGPPUH!HTMPZ?XVRY&WUF5<.QCKBB]&I%3M?61AV/8)+' 2=!!N<-38
M1II<VQ%P14PM>*N!EF^C>>\U"9IN^C_V4LRJ!1T/.'7I$$-%.<F:37,&5\PZ
M?$;S:::<U5P8=1VV#U?,.GP^<0W,WJ^0PV=81.FOF/52A]W,GNG4#++>)X[:
M%K,>.26-E0;%K :4XHR&>&T1ZC,$JF71]&B8HPHIM:M+2C5._VY+X\K7T="U
M,^@ZJ'SMKZ3L,\(FCC#87Z"SM('WZWWPXSY(?)<\0;9$[&-MB1CZ6?I,"Y/"
MBI? RIYL_?K>0@^W=D\_5GL-*TAVV&JO'CU9+]5>9?=C6E*+VES]X8]R; )0
MASA11,;!GO:Y^N=XY^6T;P8)FU6$$QPM-<Q4().$["MA;USO7U76#\T*+WKW
M Q*&J*RV!-73-6*=3O2H$\L:D_)NTL;",B:B&59:R=[MW&6[L<1'[X7 QIVR
MN*/__J7:,**7L5\0#S.K],K*UXS[M(LUY(Z@0>NYT+TK43GB/_]I^^";#]_0
M%P#CS;^": UCVV./%-P;M+>K^& AKZ?! T47;4'TH,<!APP94,RLF.JJ+8@>
M5)*QKR _AC663+SUTG[>^(GC >COFJ;=0GOA!U$,G9I>(5("AL$ \0&GO?(Z
M4L)]P[L[SRO;\[*28C!S$4Z+T%YQ<N-%[C.. $UU[CVS2;\";#WH<,#)!1\&
M,TOHVA5@ZT$1OMV8EM9U9M"=L54>^ZB1Z<7&!WG5M%B,1CD5(N"\7P1OO[@
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M?)EIQ/MU (--UK5PDI0Y6Z!,=>+@U+V5];<1]5\73!:\1G<H9MN!Q4= -$J
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M9HNK6?U9$MZ??>OU3T?M]J3>[:E71XEIR1K)&*K/Z(% I#-L$#P#U9E4>02
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M:(KIHQ W7#_CTQJK1Q5[!]Z<;9(G8>Y,F*+N>OXQOJALH<$41\VZ4;5UCY6
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M,LYJY3-ESFPSN(SQ3J]*MEMJ8L/.![J^&KT.6.EN#/O#O@DC%78RJ92Y9,N
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M_*CH#D%N:K!= 6NDO.JLI,) SW<;\UVKQC!;TTR/'M5;*#E%BS.JG=-**QB
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MOFUTCX\O3H#+M)X%LOLS>[LF1P0KX-@FHF$[U\P,:;>0%R:[9#!@@C-N8M$
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M'52(1),FWYOB#VU?\V4$H.!;'+LWH2DFWQ-D?.FIE-WYA*-W:5D$O2K*LYR
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M\A+IC9A)NI<KU<6UQ*MKC-I(29 :]&80R:&(7 =8NX^4+%"5A/ CNDW8E+(
M47,($,2!*R;0$%P-4+&LR(0UPS/$X(+DLYD]P^ICH$MY[MBCBXEE.N!6X]Q-
M^(H6%80P5WPNF39H3 %=68_$ K"<H2<F9P"+#%'9R.&"(@>5D@7J$KYWQ1SZ
M- #=$+0;4?WLBCO>C"3WJ_-_LNGL[<%K&# (4>T$ZT#.R;$O8:83S[/PI: <
M@4X4D!28<S@E9,XP:[$QWO";T'IHUZ9Q.0/2(.6V)GN9HUM^$QD<D\(@N=/&
MW]UVZ'@ J+IA?_#0'MF)Y(K$3BX//?=09I$>R&+^S>!93 $(5\RO(>P/;.;R
MQR:JC<L?8C:4&2Y_*E3,Y4]Q7Y<_$^K=RJAPIZ9K9H9*YQIA,_-0UP3ZC7\/
MW!>)GZK?/Z9&]A"V<KCYP(610_(%A<\0F ,<(^R7N='Z$ H0"3:AYB/MH<+L
M *F'9([D-K,$VG;@'G34(]1TA4@.#7&@@J#SQDUSAO<-68"&K$MC3E>K?8CA
MQ5T".R&2<'^A45#QC[C5IYH JCU7#$QYE+$@+=,C@PF'5+PT#;#B\9Z2<+4#
M:<!%+H)@X1J%Q'!H"F8H/!^"$:(!9]DCU$Z0V'R;E"Z9BH!,"?8"?AM(6QWL
M!EM=R1NOKY3SRGV C-SS=9XG#FSYL,0[M4LM;"=)XUT873AIRGGC T^U2:7]
M+KT]R!OGL'SU0G47-F@]H""BMVC]?BG2,J:P4ZAMJD'?T&42&I#R,Y-3>(]8
M]RS@;]0_WCY%P$D/!FB>7[QA-*D], W! G\SLJ^YI;M]E>M:^&/3A13DSQKB
MNZ5XX8/XQ;+9CMP";??Y!(Y]+YC!!7_C>G.?S=YJDTA''?_YCV:MWGR[/*^E
MT.1C!&$29>]VOS/> 2D\E?"F2[U1B"L#?5474,]),\.&?XD8#]U_<I?1=U,D
M3B8 [\O:@'C8HQPA[J,N PNB4:_ >$)-QGC5:G?WRM5\H5S(&?CO4B5?J!7H
M2?RS7BS !]4:F(0@/3S3(?,/Q>30PXD:KP(^!>7,Y5,VI*? -'#YCPC^?"U4
M$)N-75 X;#!07_59M'?6Z:/[ 2Z6<0;OJY7$V]A>L' -[4M\?;%4;31?JW4P
M PTA^$KZ47 EP(SBS4MTL"3PM1+Z_>77-/9(I$*/V3U]YGNJ$P[1;7P%"4>=
M,_AH!'^#/4Z"(!273][J5:T_H[B,XFZA.,7 8[-N.N-@)H,"@<P-O2J8*9)3
M1ALIH"G.+9\@AQ?1'RJ3B+C&GTX]/Q8^Z&]>"%-ZS@W+RX@S(\X;B),X&MGW
M:"Q(_T%"A\0=5U2(C 5F5/;3+% 9<J90@]'7Q(5!R*PK;,J7(P,OL'V!X/#A
M3^'P%P0$SZ-<YB89[PX39N+/T^/OC84J9E"H# KUJZ!0&6O/6#LY*A+W1.R3
M(#57^E!ER,0V4R"#0(1W-WM(,J4BH[R[4Y[$EJ4]8XB<HT\$=&:$P"F.GO9P
M8OL645J"E<E1&,!QN'"+QPBJ&)?C(RI-X9GFGN]8&8EF)'IW$O490CA,-K-#
MH*_YA+N&R[E$8M#6"Y<M(ENBM*FE1W/AL['/$%J1]A(([@DZLN>'&?/,*/,G
M*).%Z'D7S-/GQ#J_ P\4<3<^G3G>0A7#N^0+ _ABX+DN=S(JRZCL-M>GL.$1
MSB=1&8>(-4%2.O"CL=&RP"BC>DW$OEX='K1$U$<#R:K2$GJ@*PHGGBQ !B8.
M6/U,A*IE&$W D>;\EB@<<EMBL*B+RK@:D 9Y&PA,B, _V'P%L!207@2Z9*2?
MD?XM#%:1[<RWKS!=0%;(>W5XUGU- (DH$%A[QQ-18Y$E,2<\NLQ;,:) QG$1
MIDT6$S[1N39%O;.6F<!++&^*2"$S*35/N1J8HT".7(9X*#&>[8)Q9@0P.W+)
M@59!2-2<#JVENT#(/ 3!N$'FYLUH_E::!\*2Z3$V 9K2>&8B=C;7B%V42),<
M6N75L-&(V;*+JX9*TJ!(FG"0MT.DQR2O3Z!)R,,)'[?-U%O(B/?Y=17![7P-
M-$:QV8@P;P^$G^4E_FPS$:[W7!-;B[WFOQZV20!PA,;=@/!#T*%V(ST748LQ
M]!\C,N+?JW!M4O32D$4=\DEPO-P2%F\)/0FV<6#Z]C ^(H)BR3)C&]"B&(H*
M'6X]'$VHP6Z30:IYXU3 H*48U;O 7-E\KIHV4A99DLB)GW(GX'-, =L$5-SG
M0I#?<AZVBX,0@/0N>-!THB9H!#(?;N9SK.4F,)]@$RHP)N5WI)XA "Q?>+&^
M35UP<@:P+SW'SL>,0_+ W494@7HY'23BN 7"G&K)!2*E1_Q;J#>V;T;3@$P-
MRGA%1Y[TK0AE;-.;4,3(Y3)S@EAO6JUGFA*%MP24)>3WS5!9.-MO\>MOQL?F
M,;>5"_S'7.'GN4BN@?5YSA7^GKM7MN^Y O2+-SW%I58!J[@F&-\'%5%,"Q@"
M)1W%ZJ =8KXMKGL&ZJ<M[2P=U4]>53H!D3M]XQNQX Q:>GAN4G<E'/YRKB.A
M4L1K02>@=U#7,]B_:"98A4^W!*6\N[A;7@"2NNWFT*=&+!QS-^5Q(>%0$A/L
MF7:K<VEJRAE"GUXF(R0#E7SU6,#Y6^K'4(2PL3[>F]7[@&]+68P[BW'_XG(?
M)J\5*XQ;@V+#*@XJHWIET&#EVJ!LFH51D]?-2K&9RD>D0I>#2K%>JFYU'1"8
MIM!9NEKZ)94CZQYT3OK=_M?3PX/N>:?=/SWO]3HG72P)<M)Z1QF*OWAAFY>!
M$Q;+*.8--7&L:Q)//6>(R1O)[*G42>O@4[?7.>]IJV\=@.PB*4<-9EP;B4T)
MQ4&S4BTTJUNS\M2E446J;)=&&#J>>;E2)BMM' Y_@8U%:Q(-X8?_EA<TWF-9
M]@)W6=,]MB1'[00+.L0*C)ZAO-^R4$7Q@T&I5&E62QE!_#Q![.L$H?9SZT^^
M3;WP@'(']6*I4*IE)__S)]].G;S<SZT_^4&Q5!W!H=<&%B]BT:]A8]!H# N#
M<F%4*Y>KE6:E::6T )1+I=/#0Q P6&NKU^^V>R!U.E_.0"IU#OK=XTZ_M7_4
MV1H:2@1I*6_0Q(UDYB0PU=R->/*ZZ#Q%FYCZ7%/:UZ#<*#1K&7-\J+2D;362
M?=WZJ[)_#(:X9X%L%PG4W$+' SDZX185J\6,)AXJ,,4."Y^AW&,CWN2M)Y!!
MHUDJ%YA5&+!BL3"H\!I6>&D.!\5F!3ZM%T96TUSAI>4/G:]:6<(!4%*ELCT2
M..&>Z$;N?%TIH2BYY#G'.F]@398*Y6+]5Q>G^2VN0HH]_J_:T/_365!; .TD
M, YS0V#>0[@F6,=E4*\V&\ULYQ_(A-)[+%$RR2YO/1MJGW,68$M/SP\GW$,Q
M"VN( OCGS/=,SJU@4&M4LROZ4"5?[C.%&"C42AH-11%$D1ZUW5M/,@<8!I1A
MD$&MUBPU,^JX!W4<I*A#"RUM"0'\RU[CBB9>9\*W7Y.@ILE\+K*NL?B9K2+0
MFRK))-'J(7<DL##!'N@5@-:'KF7:]Y1=BN R_.R*BXI_*M2)H'!X/IC S (P
MX^ C5;XLIX6B$?IHBV1,?T,U-!'I''(]RDD!49&RB7]12B;&.4683<3\XTHZ
M%$-5Y8:2H)Q  DU%A=R9CQ5OD]3X9.XJTDKE&@24$Z/)XE.'<$!85=<G.">.
ML! 0)+4A&"->K13E!%Y2P.Z&\"(A2&$PS[G:>)QYH\?CZM"J.M21'*N7Q'A5
MA!_/XH[1Y/0^Z]BGN%*9BB[?&DC7@Z%R]C$NY5]_VH_9IN$A[ LC^N)68!4;
MN$HX\R":PA-:_0W5JEV/1[_9DA6<$YDLY2>KR_=,Q:*>$6NVIKKSRT*>/>("
M[AC1_,R!W\VPQO.$LRL[!LLL5Y?2*]CDUI1(RJ7*W*BJ(6\>!C_[O8$%Y0Q8
MD $+=B=Y_@G$0+7R$L0 RV^U!#A-Y^:)^N<ACW-!J9ENA*!-F2\2(^J$'YC4
M#L(N4@<.^+7/'.&67' J8$[-"J24P5*C>C$T+<=*21SQ&BHV+G6SH9B?3+Y2
MOY-01^3"\$8#IGV%]5V"10"JJ/&J?=)[;= )X2_CN4O 8_YADNFWO$Z95O58
M=^H\,6_A"H!2M;D&H,P?U$#!"H9\Q344LC3?'JA0_99D^QM*@5]!HV>JLA\Y
M'H()LEK2'*X($XVQO27"Q08M1,WQ)WHM9Z1>&B6(L)ZE3:58J,(E/:AJ7 (O
M1FO5AQF"JKIZ$:2#RE=^IP78W+:CU:)=5XP^X^99/M;#M:"XUJ4BYS'2FW0;
M:HGE!!U<2%;-I]0C9KC0RVR^>#;]%-FM&9^^%V5V0/U&=[>G4^AF7DB^[D4Z
MR4CV,0(:G7#FA!-3='<BGR<JZ#,P$T4/%!%,F*("0BY[;-X'AL$-_#6CU>>C
MU>'V6Y:QL19("Y#*J0O+3;,Z5VL2BP8P8<*!*?ZDZLVCJ:E?".I/-4);#Y\C
M@S,N; 3#CX05&&)9@9A/8RB*XAR,FD5P43!9><_3;7(<1JEM%'?#<<8BY7MH
M>[,)@^6:/ ICY7[I(ZV;HBIQ()4NO*1DYXY]CCI1$BV#6\S-26(O3"(X%U2W
M8-$FOTG?>?[[N+,JOKEMHJ.EZ20B11,=UJ*L!Q.>'ML4&8OR:E&,SX4KAD_(
MR_7BE>M?6*ICRRCR)?A*/G-=64GJRJ.EB+QXK#"GS(T;*,7M>>D[O34OU5%$
M9HXQ7.*AL*#Q K-_0\0Z;#?KS"AURRE52Y>?P)=.8O6AVX0<VFQF6_@Y)GB+
MQLE6%(2^G7C0D=PE0 (A-$(A4!H0-:B22A"1>[KJ(GYT[^X,6TW[F4-[BTG_
M-&ED.?:]>2B:/FH*O*!)!28(4,47E1T5RTX5<I2A']./;*'76P(:!MIN4@@R
M^76BAT\YUFJ)40F=:VY&=/7:<$?L,.0/#>QL*:9G327K5$WA;<'Z9 )LFV]Q
M=X1R0/G35=GJG !DBH8K(6'B7#ZR0:J@=9S[R=KJ\H=D!ZO&H(IU.+9)%KCH
M\[*V0";5SEF#&94.5QVPN (*W6KQEMV,;;X9T@@).+\D?Q%\K@NEA.R!]&Q1
MJR=5GE5< %#J8D3$VD8QLA322 -1K+UX N4P2=Z62R$[U\*J<VNJ<\<UOZ3
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M4A853#5<TZNS@]=YHP5J"BU9VP6ISFB5A):)2N*0\%>TM:CL) @#:JRJ>QU
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MA[A)6_*Y"KM*UK&&+Z2+\CQB@CZ]:VG_I0*EWIY+*EVD&9J?L$><K9(7&'9
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M^ K,_>([=]6-)>3LH$. 7H$_634W)6"H^0)(+N1G<P>1;+'XQ].WKQ8;;#O
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M5YSF\+:BZ;=5+R$T_.ZFZL8^U4]5:IY YHIUQ8"Q@#>#4*F$5U_6+=W.?Q!
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M,C97PX;M<7[1-?$CN>.Z!^IUNCT^9XGPD<+'5I;OF*#TN:]>(R7<_#>9 &#
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M:9F(__^S_ZE7&O*,W@'I3IOLNI$BLB?VD3OU\=ATU77KW>>>&CB]6[K7Q.U
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M#A+(7 (<;?M_ $#WZ5,/E@+=E#]TIC/UB%SCM#P,.S#S;V[JE*FH6F(Y.*S
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M"ULVW39FNKHO9\UWG 0+NK9W<\L2+F89-:$F\/Y2YY>NC!O!8O G*:N8_$=
M@-$:H)TGXZX[K& ?@\B0A<F?V97&<C5W^5W0V$87A\5BC[JK=(88L7'VJA(Y
M'8P!Z"4!3J,DL;GWL(L&\/XJQ%/>^G$IT?51>C[T_1> &H%ZWP7F,[<R[.S^
MXSF'7!FEC[XVQ\ZUO!J24*7<,E/Q&Z:51U%*GG+*,/<"OR+<1O"QQMV/QD/3
ME<&,F+)ZOIQ&+R$+-;(I\6M8"U,D%_$>^&IJE+4)[RY\.6#8Z)FC@X+]Z/C
M,>,0/YV1E"+BB4%+ UQO1=(UY,K6Z610)/@+O3@N*..%V_ZWM%"3X_@."9,?
MD#S$M$JE9;D^H^SPT7HI+R(MXZ!@C$5'XB[!-(H/<9>Y40#H5 /M3T@/2@@=
M+DO_T"X!%@5$J,7BV[I:?%^AO()?R<_:[0["TP?XJX?%XN_>2O;>W+V.Y" 8
MU?&B65XN'O!''K(CLKC[N\)<R</E;\@/QN'CW]M-XX^ Q7^4V]TW\E/A7V/M
M%B_;VI$TQ0OO<\/V??/4O\[+%P\7#Z# C07TUU57 I5^^,A#VU^YCH8Y\'>&
M 0\EVKA8.=WO6H^<#=C9 ;]-Z.(#E^;$L6-P'+Y]9K6AF7_RZ-%7:(I0_=!O
M5OWSPLA4 JBP[>K5'M#^?F5 :H*J07[8W?^.V_**K_;X"5X-RPD"WD/^2^ M
M,0\S=5 @YWGQMASQ'U?M2JA%L141X#0^C,1)+W="#//<&UG8+19VOB?(#;JP
M\J3E=><(VH(C0'N(R"4G!2PH+>TV4-Y?P,/T6XC4MK12#=EII"[\]+FMY8'$
MRLJQ24=J:E+1[A</_O'\^4/6CXS4@&@H\-CTAN.?CV$@OR9N(^JU*Z.QP[>0
MW6?\7_(;[* .5@Y(!OC&>V *A)U[&8N?I!?S7VUWI3?9SM N<<:3E8,'L]_T
M0?V&)F_>I/-$QHAQ1?Y78=B]Q=NB(:FKJZ[L5"'VJL(EY(-W:1*%ES%+I%R\
M_O8MX'V6 , E*G\[R'KDXQE*6\0VW 05(FJTT67#.V?LE9.*1,=)4(! NHQ)
M)73,YU#S>_+H7/,[U_P^V9J?5+FXMXW2IQB=&'<-3Q+UO HT=8$]YW3?))B>
M'KMCD@,+V,J(-!D"1:-'0>$A\A>3Q,7I9-[&A]&2Q5$%L-L]IBS\Z[XD3?[:
MMJM;G._<;+Z7JTFG]A;0'XC%XU26(3T2X!NLIYG8Z-^QS(15&W7J*JH^].,5
M4M_P48]BY/_.>R\WT*T!)"7PU;$7_>V*NN(FFAU"/N8/_.581Y4E?_$#G\_D
M*;5[;>/#9)@>X"<HW+WG^KYO\G>W;(/O2R*8;"?>4>KMS*X!' M8!M+^B^X4
MSS/GUJA;;,$0K<9PT6M[8A%W.22:.4N<)E,QT_2A+2-'N1\I*F/F5XJCA-B7
MJFHN\X5_!9%L*HW/C8EJ2';0\OBO$3A5[#/+*W.R0W/^)J#BA<R(A,F>F7%6
M\<80GP Q)?0Z(7$O*Y>RM#:!Q+$D4<0^/XR)\OP'BA77V[A!_?\0$FC,,@#B
MC8NU@0G0/.N-$_+(R\6W+#!N1\ 0C+)V0Z/9.VU!BJ]GAAV;&PV^D0*A0Q%
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M:+J7?A40\?:-N,^&.YJ6AV./1* X"&8^00/[9Z&S?"(>3M?6D&8=23E]HR8
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M@4T=1L)ADP'!DCRYNC/Q^EVBZGE,9?C*NH(3%M:9IF2*#.^5X>CBT*:85U^
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M!U<E0'CA7/&'E1,M1?X$A>[(KO.S'^I^52V3;HEV)\LI_2+E2BC9Z(<)@X-
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M$S88&Z? 1R@5RKDTZ3X/M&S1NY<L-<V9)0(/V16F<-15]!C3WCDD#ALH+XM
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M:F6G:O0'*X*((7R\';D25Q$C:@_DWIB<;]MW"]12#TW\V(("KA/*AVA)"YL
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M9.9$^_!$$_\8_9,!)A?.C M[:%QDI&-$9B/332.0960]WS=N&HD4A";6@(2
M:97M7.ET"YFFH,CO3$]!M)[[4AB!PL(P$MW\M)\!$\*7C\[8CC.VXY-E0HBZ
M]S09>H7]K3[R&PFOSU21#1Z1&#;.MC*CG\61OY$(\1$-4!FLE,MPO L](R4;
M2)EX[^[TQ0Y(X$;JMU?H9'!VPV-R?(R.39QB\WX^#@:W!2L5K7T_']R T!*Y
MHRJS5)-"88-FE3V*4Y[:L"Z%IHE=>8A.5_]0E/Q9E5LB!H*&&LCTKHD/+V5G
MSFIIG32IR")!]#^NKB>ZB?X:>.!)KI"B#J*BC!K92;$TJ,=>N4QZ97K,Q"VF
M2%%//@K&G91F)A9232Q%69U(;Z2S?QD@\,?Q,01WFA+LXF_.C@ZFOC0L,BP>
M>V>D@H6RN_31DG.K=@L*QI3<!@HT[<UBX=>T;?E8GW265AN^,+UL)4T;@^.4
M78O)7V"7Z)#& ZL0BT .)SV]G-&"\(L)X5;0,-,%T6#CSL3L&#F"PH7(\6A9
MP>9_9!["!.B.R2WBV54[!M%9.T.B>Y-;8# &R/P"/"LD6(URCVA!P(%+V 9"
M]>N(+Q=L:XV9ID YDOB$.G4SF5NQ84G.:5I (_5J,#H<D!FEY"#P&?+8Y%;#
MOJ)GR(U<9?#G/?5(1S;TO@2I;R>C0>=/'+NP$3$GTE79DV!Y(A5'9U433Q)/
MO_21)$6!6.D;5-.'R\6WT'Q?K6VACWAE^4DZ2G> O@)^HR!ITVX0K42'"RO2
MU^2BFX_C%B+"V;NL087+XRE5+,P)Q84>&I?5/,\F;-P<U^9=R1/B$OG\SHT6
M7=)?I]Y$YC7ORQI\K:L/$T#3Q::G(&_0JOEY;#03SJII_OBG)%8'ZV4=3X\M
MQV"FZ;TF)/$6,CB&$QV_YT$CE18AO7.Z%R@9S^N;J8E9T2U.'J@X,?3#2HOS
M7ERC,OJT=[G]V_%QX*>VO ZX5N$T#5E_RE?&--0O:/]R@F*-UU<OD.PB<9,'
M Q(F<Y)X2ITU]M&B-OW.P<2*]X8;S(?)7>,..DU*FP+% 7)'P_T+O(LV2L,X
MKQP5#HA/'CYIJ4!P:=!BLU.J;EN6I4.[IJ^8]KRO6#-0BXCF/9&O"DE0Q3O%
MR?-'#[9]'Q4P3V #P>#<!3K0WR_LP)V@-^S46J<K(GAG(=ECVB6)N$BJ9A0-
MM5!P-NX: U"$6WV4"(U;W0'7";9'X@[2' "RUQ8D=%6;DH N^FH;[_F!/+"/
M)UI>7BNW)&"4*0\CQ,A;""P=NQ4*"L=%'@J,6?2!ZM!E?>@'9EJ!TAAB%*18
M*)2"JO0!DDD\4=Z*G*Y\BTQ:7;54TPVV';0[0*3EWDS1&\./EFI5X#L:(^-/
M.RG8!HM.-@>]<O5F@PI /I.M L"XZ3#R6;6%"AF8UO]^[)77#$6^Q2&#YO<Y
M7@X]O[!W71YYY:"^)VGA1=UZ:]ZQ;A6M0#"A\CPXRXFO3X[.!;A\0OEDRLWK
M=NF=BT"^X^= Q-4#IP911@U#'8BZR24TX0N79& DO"&_=@.)%!#I?2RZC=>[
MJMKDMW[JQYYH]_TI@ 9=9BG*G6 $Q+0?H/9C!8".1T-7,>N'J5R88SHFGK3B
M=&EN(M&$S]0WJZ8:6$6#_"2@*AHU$.5[F+E7$V%-PUV <K'KC'AT7HA$0H$,
M5A]OY>DG-S^1.ONQ\F$0G8IU/R*!*AS<?>=W%Y4E1P89!^6F^6,T/35%^"5Z
ME!/NX$V5NW:IFI"ZP'!'IU?L[D'I*E!K8X_,4"F,F14P>7-Y;[M:C4"KO=^T
M),T"I3U@HO$#H6)C;1?T /4"4(UOR%N7P>4-$AL/2#E.+(K:NE05TIX9<%NI
MP=L_Q(FY@9),5@;AV%*C*#F_UEA3A*%Y$3 O<<^T]2D(BM%F]LL!$7:D5VC1
M$3/;(J3!S1-_#O6XQ^=ZW+D>]\G6XZR*^FVG6RQF&-&!3,^B&6TXFX[(RE+.
M&+-"NBR$&E*,$&<N(NLIV8SY%])\1W(DXG.L<U+%EXOO@Y/%IC*J'I!^DM%.
M"QFIB-@,"WPBM:2BJY*Z2L1==^4!/I:6WF*JLINR'G%A'@=4HM/?MTWCZN)7
M-%!$666BP8N+E_IN/!+1^QE/->5"MVD=BGG0RX='\\N*@@H:E23?QJE+61'W
M)<2,8BC59*ZP!H4AAH\$EZS7RUCR67_@J#L /I$DS"BQJ=4!_S%L:2)O($&E
MY9<+^"B_(,USQ'>("&%5_)O]:NQ+I)5MNK!>I33@TXG@KG\KW Y0C2OH1:H;
M9],<_=QCL+]":6  Q&.:>L^:-/0JQP?!Q*+2!>/J]45X?D8+FFLE0MM&C5=Y
M%OGW6 K!RN]5ETG53_E/V;18=\S?_$#7Z^Q>@^%'6T3,@^0?1KWQ^^S@Y.4A
M?L.-=$)L=M*IQ7'?3S,$UK=HDX;. *Q!0]T+!LA[PO7JOIB-[Y ]O@@\SQ-]
M/JT1-EEJ_P:YT(,"8>YE0UG#7V%3755<U:'*!Z;\!#]RO/.C(:6!<#=_&VBT
M"!5X7O18C4'BL9[2C5#UWA"EKGYX4F2^J[SB;=#I(1%:M)**T7,\DZ[JP5!:
MS_"E)S*ID+K9X6FU#&J*2D@QF9YTP HE0A:.=6I,;KN(9MT_$"+N9V[1&(%I
MG 9UL&PQ-Y2A6N#$! ^#)6"I/2UH%XC,G"@H*&L+#DZP-_N-(]^)99&GHA63
M!4+/&CP2&A>PU14WEB"P@4)Y6?M2K^"^DE7<AY7K\B7U$5RL94_/74A(NX-*
M%IQ3+07(HC\0FEPPS@]L9$8149.ZW&'>PV8;,B_.('42:0E=46$EW$&N !9H
MG+0>6;0@*F-S=806C+]_-/<)*S\JOAN!VQAR+RK"]4'E'J9O:#AK*<5 [?5\
M?\Q BW*JX+@[*S.?*R$2BVX'+UJY])FGCP"".%;:PR\A>#&_SWO0P;ZF'5\.
M\6Y_*YV#LK4.FOM4]N'H/8)XH0E=3G4EM(P.7S7ZRY%)<5M:PRJP\&N$;Y)N
M NU%O"]GWDMIDJ2Z KZ<"MA",N^N$K:W'5IRD"3&$%LB@5I89-!Q@PIIN&S4
M@DS*<JQ+D#Z2OQO8N_DH'U#K\H9=QD1X1M&@43Q<)&ROF5J2KOGD<5ANQ*C*
M7%6M::*2=9PB;]XYB$U6%2Q'B,@H,XB&?* -G8 !MAF9;WIB(@>U2@[S?!VY
MKN+7IG2!*5,R.$8Q]):9+/0< HQ?.Y@8M3@Q[D2 !Z=HJ=-#$!-TS#*D V]2
M4OEY*E9#M]J-0V0PRH'*3O[C5XY6*\*DRD'.,>:/<$(-P7@H,P 1UL]<$%X6
MZELJU,*/T+4W[3N7N"K4^0FO.4$+8<^GV"RP2IRZ@(T*WM)8V=YC*E()P--9
MA+#(Q&[]?,*)M/=1!X1$I+U>6+L80$#^?4$[KL)2Q^7B*<K'^9_ %[,SDBR.
MH[N^[ B6K2ZPALQRMAD]J3(R.>'!3,NO*=$="T(-B?OOS=+^F]?.7JR#B#(4
M QF)C(:K*;>L5(7G;7 7V%!QP;69\:6OQ@J)4+9@NI;M=5.)SQ0TN;5'#%PS
M6@A\5\@3=24H'/.DIC"6:2/3I.%N5K/F7I3)\$@$B.TJ#']L!,#=9L])G"'I
M_O>[9T>]Q3!>Q<*? ]Y;_4?9K\I_+?Y:MU=^X;XDA8'^L/63+1)/Q"1$@SQ!
M-8.6T0 )5!8-YD]?.^AHW&W0Y?YI ZA@<=>NG)]_P:]V[KJB)@>.6>0<-1<@
M/BO^?5AV HA&YRX'0Y\9HKTH/\'2N GP3D:]8TO_" !U1LP,&*I)-381F;>M
M$DS@$U'UQ)Z_RG%V>,UHD%Z%KEQZ3LZV,XJ@!^]AR<I=!,FV,&KXVZ+=B4^7
M!=79%N%(\9*"W^6[Y('AU,17HH0\_YJ>U.Q^Q7_1"A%\^@;JT 3N-3A?TEP!
M[Q9^\N&6=U=PN31^BRPIS<51Y(KQ1R8>@(?"DP3O')U.F030YU"7?'*N2Y[K
MDI]L77)"= 98AUF_HP@-R(UC\Y%W*,HM) $"7$-;X."@&7VDLV6,Q(S;X9W1
M@?0^BQ0#DBD:$N9^U?K7BIYVU4(R30[6R*8*2)8ZL.2H\P=5Y6^F\!,#TJ(7
M1?>'6Z8DLB+H-&CSEBL.!5E'"*!(8X\F/4VX*G 5<L,Z3.'IH\?-]K=<=90!
M WJE/8WM6L, ./,QI,\<(_039V>"SP*24W$T.7L$^1/JADDT .>('!V%*56&
M?);R_$R7B#;E'/=UC[JSDCU*":Q.]#CQH,T%.7H<2THJ)1"S;87QHT=K3F.?
MD(L*P>))H;'T/B3,1@QZSC7NO#>^FWG._BTP[_>K0I&-^L''W-&(Q_2)@;,#
M!Z;<06 5B;;?Z_H:"0,*EY"_-@2]E*.CM<PIR$T%2/*#F3>_\4 UW9&;!LMG
M6>U(+,:XT0QE==0HO81.9?R2,K% 9L<'-23G2S)^]R1=.3<Z<_C!P^7B305E
MDR>/'GUIL  2%WGK [7MU6+<>>^=40T3#3W3172D:UT##32XRDF*>>61"#=H
MXJ"P@N.>)EBSLZB?;/SQP1/U8.76Z*TCY1S]&OG5JJM1F9#"$0!S^HS&XR'Z
M*G_[;O&G1Y?_"6]:2[CJ/Q1:8!< =E@MGOOA@6H)_>'+QX4?QR=/DJ,+WPLH
M['R0,=*.Y,?D6SWYZ@^7C_1>)?Y^YLKW9)F]"GN"EPE82*3V]=/AMQ2$<[@F
M9K4VN9.M#\RWW!\>EP;*E7>7.1J_<?HMG/D@O#G=L<>63=KMVU-[ 5\"_;O9
MI^:33_,7S+E,%22\W$Q7?"(+[_T-6 M@GBCFY]:!;%,W<2S<6];DMRTJ11=V
M'_EU(7RZ@/D9@!+!'R\K< 'M00,KQE^YDO4"G^2&)*0=HXXC[-#![#'KHJ;6
M@RU0K !K+5$B 8NI'EI%7&(T533)P:RS3?9ZP#30\L^KEN3+#\GCR)3U90U+
M]B\3(XS.</PK^8Y==<ABN?%SXT<)'(V1PA^B>QNHJ[:T8I1)1RCUV:#@7__.
M6R?MV.[A%<K:M/:C3PJ_+?S?X9R[G1-<211VU4T+CH2R_/7#N))B+Y_)4ZJQ
M$X8;F\2O*RSCRGC+4&/[I7;S9(;]H\UI/TT/X[#4XF5VR]F<N(&G[)%P&!]9
MY)G!UD0@?8U /&OJV[YGM,E'1C<U+K_#*/^VYB=K?5[%P?ED'Q'-[@:I&&36
MZ-.$[>RU#2NB[S&0Y>F['NFUCY@2U81,>0X+R]P1>KV8604/3D.66&1X%4YK
MV?_)24'<A 4\2-@Q.+_HQZ86=V7TWZUO-YE'G( UR#U/B ?F**SGIY6]D2./
M+=.Z<>5-11V2=GJ/SR1/'[A26PR[H$W1@N@![@*C*;"BH3V+$)^%82@IG-O[
MM,>,VYUEH)[=P 4D]0*36G[Q%H*J!)P=^T!G\:OS4CVR5(.H1.[<T3!0UFIN
M8<;MF3?E<@GA[>+!TV<O+K[\X^6C+Q\5"_CWDS]</OKJ$:Y]^/%/CQ_Y7_SQ
MJX= N-"TRQH)J^!PNFK1JW[0.W^H^6MMRRO:,3X4=?\[^A\?<C:TO&[:WL^,
M__#;<KQX_>U;R+TNO=_PVM_OJR=TM_*B/S0+\T>X_>,G?_S/KQ\61+DB)8P3
M X$T /ALY7"__/)<"CV70L]RN.?SZO<ZKPS4MQ2N%N6VZ_TKXP\QER2KO*"I
M1U]>(M#<::;]%GPL]N-NQR7$^*JT,ML&VKM4OR'">$+-!2@FA0Z4&0.6$DR)
M>(.B(!]46"8? >/K?U-+/1FJW@\C8#X\58OHT1D9DQ!) JFM4-#,^98 ">5!
M.?N+Y_UW9/_5Y=@L-Y*0M3%\GG0^\:\H+S!U-0OA?%Y5G5MRDSLIFBRLM!=W
MNE.AJ^W.B_6\6.\0W(A43+,\DBJ#&/JFHB*J<D;CLI-H@X5MSKK2Y]5W;/7Y
MNW?^J!>R"6TG,XV"4B/3DSJ0")X7UWEQ'5E<(CI(W490]>_IG]B5R^?S%X&Q
M@71"]QE[=UYHYX5V9*&)4!MR(T(K9=#3EJZT*%U6!-D+PYHJV-I(HAO;Y-4W
MQ+YDS$:=%^1Y0<XO2!.<%Z8-.3%]3$.J??Q"%7 ;\8Q-9^<;A/'JPNZ'1>'[
MO%X?G9?K!_8"!R'E+1:;L#Q!HYY"$TSTH-:*DH1=SJ^H?+H9K9*FNC\\^$1$
M5QA[VHA.7H>X;0(26/I=C/2G&-[3X&/%M,< L*B=-,$ZZ$W'YQC\*42L+I1E
M(V- #,2K&+&YW[B&6&?7A0*G39M!%DG"W0-RG24K'M -_+</+1DF;WJD^5(;
M)+2ID3LCOWO^E "'W[Y\:KNY Z+BVC5+)CKP\SA0)Q\WY1-.9 -G+??39!*B
MS'$%W7NN@W9232>"1%"CN<7087/8$:I7@&\)9QX1( C6/*CE!,0)0H>1!2;P
MB4R9[$+<GD&0]*:;YB3L2\&05P**R$0JH1M2G4'.ME"9&]2/EL4KK4@,S[&4
M*%%NZWH&\4*S2)D'0A OG2+M^6GY,P'FPHDRY*(IKQV;C&I[!11!E.0=T/?"
MRQ6R9%4V;2\D=-H^SUTJ:^FIE?<XB(R;(<9!F Q%KZ16ZU<K>6R!T\7@CPE@
M#$MPJS!98 YF42C;\VO'Q_3[PG6EZU7XT&F?T-5"(F;7[ECXRWP)+ZWRX,C+
ML3GT?LE!\GW35DONG9*+7(\^?*JQ2JUKVPX50]W6PO(7&HT4?F3?/\(@$?8H
M 36#?"=3-\IH)-P*<3-30!6F+<="?0"W$6+.M)YQ;X#3/]U649_(0L\KTQ@&
M4@&E@[D[ADD/@\YT_S+">1A@--(1U^9JQMZG2E#YCC11%$!^$3X+XLO )@$_
MH/.;DE+?9=. <WI5]A5CX(#!%.FKVZ,+A#B*5H[O W\!DM)(<4':B/A\\K^H
MNK2WL2N!%HI;IPHA]8^:Z-HN;BH(O6-^;6.;.="2\>-E'X(>@%P%[XVB<#V<
M(-S[#\L$OG+X0)KROSGBV7#1&L*3H-:V'C%BT86$RLDH]C.2"7. -FR"X/P4
M2K\C5>L^+Z!W/Y239YJZC+\ 5"]*X7<$?"0,B]DZJ-:4AO::3\:TH&2,48Q7
M,M"CPN".<-LPM.AA0G+LG_M!@#D5$<9)04^$.K+=/<?;<<25G/8 T?Y&'\&'
M#$0>H8QI;4-Z2Y8L,**JHB.;4X1'(4]V@_-5;=N#$A!!<E'^X/=L'OP5CTJQ
M>-EVNPTT?B_>EF,1@;9TM.+;>'=>Y_HV%*726M^3OB) Y1]I?M-..N\?,T04
M_@%Q@;>>HEH$#75?/K[\BKZK376 ?O#NE(^:G??C0RLLI(;#%[]^;!KQ(CJ2
MTB^K ;78I(M):4WXNX^?/+G\2KZ,*SAL6)$X#-H*HJKX.?"!_.$,@CN#X#Y9
M/I#0/J]T TAU%]*DRE4Q;1LJ--Z.V3:WSBF1PL_$7A6Z6*/^22P2_/-+L)!_
M"/V,Q!0Q $^MQ)WH1??]N-TE,KP8'+'?C"(^R@K.VIJ_;+P'2H\S>=E%WX+F
M=5#I4IM'YW?2"XTI%^2A1,ZE?N!^SC!:5;.NN5""9*?H_!+;8[GZ69XC#$LO
M4L/P <Q:]93OP"=*'P?BRI^,[+9PLI [G[B:DY<SG4$K<C2  002=Q(*$WE\
M;_BV,#.!P[\FYY.U/^$M(E":<45R?4'M."Q;H93S<]]!>LL%-=RX<(Y(/224
M(6V=>Q3Q2M>V95P0F0$S ;+2C@:]2BDPW]?U_]C[UN:XC23;OX*8C=T@(T":
MI!Z6K=V-H/48:\:RM)(\$_?3!+H;36*$!GKP(-7SZV_ER<RJ+ #=I/R0*+MO
MW'M';G8#]<C*RL?)D^Q3"(_!MHJKV]=R2_NC941.G)7N'EIL$L_Q/%VPS=WO
MIJUKS.VR1GQP6,&VY6F1;9V&D-!T$?R$LZ/&LRE=U+=$\="4@S9IP*6E 62F
MUI6GK6'HJ5EH]\5^S@$ 'K"PIOD YY9Y.R]Y>!YM](!X/_DR@77F1)8,+0H(
MI/31(!>+2"[3YO$68E'Q5, [H0 6$>EGK)%SCL'T8U^#BA[8K.ZYB2';F#X.
M /*"_&+C ZGL99":R)31AAOUL>*S\S:A+QN3U6Z6;LV[WE-8Z)'1B&SFH_K:
M7%N^4+3"!3[0SI,Q#K,,^GO4G>/;5 YX=O)8WL0OQF>GC]75]H,OP.1PF2]B
M,3!(W*@YIW3EE /LZ3LE:!3%7Y"-@"Y'VV[#$Q4:6OR&L8(O--KRQBTA#NM8
MZ8:;=U&4O:8O_*Y0OTV4TQ'O6%-H^_/ C61:(O.!H9[=E?O ^6N!.VT[,6Z(
M7&KLN*7H].JN169^0KDOSA:=,D.>(*0B665"XH:20<6-F0M\X?9 BPM_AE1;
MJ^-)<AXB.W2AK&8DR.*+HE'ZQK)G+/)9IRXO/F#V"]:#ME ]LD<"8<9$$"6Z
MQ+B!P5O*WP2OW=FC)S$CB+\A4*P^J3K\J%6'')R_>WGHLT$:U._7M#H_O7V:
M/#IQ#OL!^'KN'S\\]+[[M3N:EY-M?B5%0#J1,G+TOS,!U@@]>TVC>^4TE#+/
MOJ77GOMV0 =OD<+P'QSRDOPEQ]C=7W[XX4ERX/_S$*OS?V=DH9]B@YDL-T-(
MR'+-0IW+55(ESYW+Q$OY_.@>7['".<]CQ,\'0^&CACZH O+H<BEV< NI"LT6
MNS,M1[4)?/VT6D77Y?SKAM0"V_JTG+@P!QWB#;4A2&Z&5K2_P49&MK?Q1);M
M'K,8@^D%X <TB"=!#I@IWT&:&VA(WR8,*N6@>.@OY/MF^/PF*3;M@"2)RY5>
MI6UN^U,SLRTY*+D<PU%#V]SM-=GCXE:-6.8VAC42]SZKT.E&U,G3Z,!R^8F:
M.ZD,!TPO]I0J.R&&28G1"NVY4'\O67U5UQ-<C1VQ[!.W#-F+2:9D]>K/,,G6
MX+:@[:#A@']&]](TN6^%%9#\=/<-M$H%X\#$77)7'!1Q%Z;=01]-C[1?JA8>
M+9Q3/^+2ULU6>]DSKF-!+>1O7";E3P].*C$\-%D53@&ZDYC;U7?<^Z77[%WE
M_QOP7:#3;/:!&=[F;BTW1^ZV("I_W%MOW8+^.V]*Y:6A=D],2'%7!.[&B+?3
MY^XR(_VZ99JXT'Q$VW YN6></A1*$GH<M_'I&W<>.0GA5H<>Y_E,B=MTQ>LI
M:<GLXH+:L1%-DT<$*67=J=ZV<;^.R#<C\5LN6W>)BJ"Y9TM6EEX%ZUX:!C,+
MO]G.7&C1G48A0_)K.S.$? >4?+Y3$SK0H16S<@,ZE<K.&EM2S$C"0S",[<RQ
MQ0TKM)7=UE6W0Z.CRGEI"O0U2JDZH&77!9'FR*N;%H<'QC.EG=NQ6[JI7ZXS
M\NR#H+&8O*:DB($X$W1NU3J)>5NW$[-.<)U^_F8)/WFWV:=_!F10&J9B=?4^
M'W3["&?0TTZQCG-R\=Q="_,41C']^ME/;XZ3\Q!AD-"K\BW:]2TT3#JG**G9
MAM9);7=-G1'H()C7F!9 \DM<5.A5P)N$!E9A*-IO9M ;BE/9$]VA;*P;6XRY
M\)9KNSD_YJ(=CL_R^#+( AV3D$1G<U*M:/,C'R^1A@=T$./E8-)8"AO;&.8
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MJ&_[;.4[MUY?FOC@>#/_OV=.L(_.)D5<W[ )75HA5R_/TYT#_0@A,&4Y?A'
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M1%_#/PA.V9<761>,G+'_APB<@@Q8UZ+LC,V56.&)&KY)I8Y5XRA!YG.'L?0
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MS7P9-(%\[XZ7DF-%%;2!5(&B[ NJ+U+HQ#*[<EZVI$#ZO=3OI?ZFLE<0?FA
M"6ZK)ID&]62(HSF!SM=6F$?-$%AO:R7I^($<]_8?; G"V[!QE*:4^"+B?8!
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MF&'  MP# (%JO5F!/9O3)4C26N7N$ =\W9.LZMC#^IMSS-,8_O2R;G+*-E$
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M-4]<O9V<B[6<"SH!?!6)P>\CN,S,"-UEL#%%)43&P?WEC;>SX9"H)Z6>TWE
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MP&7AF32GP[_%%_[$IM+N"B,$?-P%,T^N4 !\1U0)V(EJRK&TW#M=6)++F#C
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M" O<BDRQ3-VPLCFU?Q*6QHGKHN BV\"YJ;<&/<;8P=K.2FR@>DW#Z2N^AR4
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MYE?^7%Q.^R?L_'!E4_0$!*)>\X:,:-1W"Z_:_V)XU:[DME8V;W4?)_31^<8
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MEMV\%@0G M$+*Y:1<O^F.?E#5Y,/?I\0XNV[<ZL7?5^4K).SQ!]]=QZ+_J'
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M8D+U8/;JS#GF*6(6Q>(T"8JE!8.&J]HWDQ'H9KB.!LE$2]%<"3X[[<\#('&
M",_*H(3N_ O&.-,<^J;&8->@89+^&*W(N]MT\#8=_.SIX*-]>LAOF@[^UHG
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M3,PFLRLEYK#0X%R%K&<X3UV*LKW$;0;$).<C^B-9[]8M67 8)5EQLO],5\+
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MI=G337%A.P>?><^NW)-1\737VJW\U>C=2Z3FA&CW)_VEB*9@6>Z>=$0CB>9
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M$-WC6GP^+SR%M(N9G?6M]L>CG \;D+MX2T=MW>7@?%[_7%J7?*3;(^4<YT7
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ML67YPE^*#G _[CF1R R6AI,KR6[2(E<CAQO5L8;F=@SL?TAI9SD"S:@B7A9
M,O4W()>P!P=/4?T'I6KS6@$MHD(N@!"VQ6.XVZAN_WG"(__GL1Q[:]+!!I1Y
MEB53WH&)]AA>$6%P3 <M. :]!EMBH:?0N?"54)&WV_OA*IRH?2']"?UU@EM3
M*W<V_)58];2O5 S'9\$)7;6NW;V0E6,?P0%MGG,0 L8"LHA;5X'&J0MLP"''
MF]NJE(Y/=ZR0+&;$3?!_A- 9OZYW)#0&F$-5#=U/K<X8J:FG\B8]Z,2N@Q8
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M,#GW@,?EO8U3A+_*PAF_T5;^^"AZN++D.J$1R;Z-Z/T&XL9[ LWR,DDEHQU
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M-?+2H80//(K$3YOK=H-/2?-PH&>&_I^F/)LIZ2RW-[$PFY1G?)_Y#$AWB;
M(B_FN/,4+$67V,&?W*W$2VM-HCSKRX^\";0JPO M-563N)DICG:X:Q>I\U49
M^-E^&^#9+JU^PZ4\/F;KE%OAJDE]RDC3ZER$$V*5)9J&VS(A'% @W_#FF*(1
MK.J/N7,@)5Z&"T]78(PGB=I@@Q^M8:7\/W9O=0GFG0'/<P9+?EWZT/Q8.CIU
M3]J6CPL>6.EW*%Q(M9#@%G#'E3&?VE<^V"EE8S[4%\1>4<^"TG*<.-$+:6]"
MVL-K+[\D) VEZQ1?GOL0&;K8+D<GZ"$$>& M%?S W(-.RD3A8,076A[$JR 2
MXS ..M2N%)  \JODJC#191)AQISK@&Q[1>7>0\UQ,\ZTC6_24K@BA7\>'HW[
M4[CTC,!YQ,:D9H<H,52D:6$Z-S%D9XWE."8K>R[MPIT2X<&@""HG_QMSQ0GY
M$<-^X,H/*7\H215'R>P1[YWS8+2##[4R>$%J%9H/04@<U\"D)/E&A.HKP[4;
MP]1,)8>/U:<3/?HH[4V[,8>ABZGJOI*R^Y2/UI.@.$C"3^;T:[4*;7R'F6X+
M?)NEKZ;0!>N)$SC$VDA2L'\.558$67"7PET547U,4E;72;/WI1<ZGA^^C'R+
M.4,@LH3*E+D07&#56)=/B/6@C(XOSIQ%Q1^C/I"*1>X4"B? I0=?)U7%^*@X
M.E$Y^RXA6S>13Y'LH?4+C7IK:Y$6>Z6)_[(#IX $,<*&S>*)9:@%],R6#:U9
MF5EY 3Y:C#QY9H-4)>C U_$Y'GML][<(DCMW#L0>;',?0L--]BD.TLE:"M29
MX[?QA88'9S)DS)3'_<"DCBO!:J.RGK4RMB3L)!W2\A^[\I=<A.C/XU;T4GCH
MN(2J6_59ZIJPOM\TJFWFU_!NC/.D-')'@(,JE,+]4*DB)>94LVPTWAO2IT0,
M^0[$.HS;D6O@*IVG6B<&?CMU;UY$&^]>GE^"@T5>.0H>_D["():PI%UC1$PF
M1,^YJA&("#^_7I1@$F';";@<=::?DTU#49I$/2;.IV#.G-(/-::DM#8-;@K&
M"(@ET*"E$"QUG2-&5'$:'K!J2MUPR!$&XF8*B:SR?&H4!"V8D!II+;33%%DW
MV-?$,5SG"]\PKU$[["@8A'E!(E?*X^51";%!$5@[U-9(-]2%.9YM]H9+7, E
M^H4$H6S=<DQ(AQ)2H(VDO\@,$KUD["OG 2Y-C;$-[J7F=TX=-I57$$/'4@%&
M9S^[3L?P<V*[/1QL[SYOIU#^O/FBG76^:)TO^K'R168VC]'8E<@7.;8D)3$N
M^K\B<LMF J2MGBW*H, ] <JP(RKJ-8X)"D\ "7P81R?[=,!9C9@GEO?<#]@3
M)C' @9S1)K45>UT2MC"Q!5/Y4"Y?X6CC\N)X<ROZ;<[$3VHEAUD:^([49YBY
M-R(+ 9)8W\0XV(P>X),E3".%(<Q>=*T4Q!SQX5J*JSHNXDS<;^>*. (=CR>T
M "GA%IAC)$F@P[1JMN0PY/LA3Q.]]C( A>%]J3A%-V[@OIS'KJ5!&+=RSE4X
M2_4 U#YWP#N*'U$]&)GARJQEBF\Z'TB >DJ C;!G=:_CE1HAD)H>.8>OV"G7
MB#,V!,_0Y;_B"AJI3)+J'5<+R>S-5-*-.!*\.#VQV# C:T@VW$_ 5HPY;.TX
M"MM>=0S&8T>QYB1.ISXFM_!UAS8MIL?*46*Y#*84Q(.Y.YM[X\^Z#1*Q<9$3
M^W*"KEJ,86-=V31EU**%;T_ SF7:"0]:Q</G_L FJ/U5CKD_-VQT?4KR@L,7
MHEBAG4SDW6[8+E?DHP"QBPE(V0^8[+ ;R4<*E[J%1.F$X4:3M QY/TTRFU=O
MXE[1I..,@^R6.0L<!\ XNB-BU-_JE0G.Q!)<%\*8I!(@=<AIOF^\0S#'^%'M
MVD=6:F\IUM\/V!3A%*Z(0O-A<QZG@,Z:C+17*(1=KL-0"!.?+<VM&Q#219Y5
M$#ER!TN6Z> 0=]-HT9&3TM18JD FR:WFWP;;VSVPA4VA:M ,G.^@_&S&K+B?
M_I56AQ4)2U5/?,@,^R,)VKH(@V:3Q5'5>*,$4N-&6,UFP]PK.:O%J0<&XW>M
MAL;@4(3?4#:?% IV=&DQG@0X5CF3^IG=4%\L[$#[G$YH9<-!6 4A2#HCFA#K
M>C8?*;[,/E1?F7H%;- @ ?&J-(PK<O 02RUG9S2EJ !K+*0<<9; G;-S@1\*
M]2\8CSU& 8QHF)2R*>5U7E2"[AG78>&\B6%WM=Y9,8Z^H/*(CN>UR5B:9?'E
MZ%/'4EJ:M.HK3F+Q)#7CVGDD S)P1LX3#JAQ""RK+YZ&*4N(QMD!O36M2[B3
M6 /818_*@;DXLVDHHG1@ >$#KF6C1J",9\E=8LN17./W&ESG!P$<770K'!VM
MLVNDLC7.%N/!NI6PM;?^D2M!V)X4MB-C('4MFV56@BU6NWNY1$F9*AWC;;*F
M^%(T$^G1GJ KS3!605NL@\LI4U9GG ' 6;+$G]12$YY3"7.+2:I$PZ:*/_I+
MQ#$K5TTA,( M"FIC43$5[SM3W[+B6O-]G(*4+@0NQ"D,W9).YGG\0);*DMF:
M9:-""&K5TS[)M,OZ.Y3V@DAS@_C,=[9$D1V/9!R)BVN:CSYHCL"M09XU.[^4
MK?/'G5I&;FUEBF7PH/L<^!BS>Q-B6@F=JG1)[QF\NLX6-+@R?+W05FL]F1N=
M"UM^ZIIA60Q+%RF?#%1F@X$R:^Z"$V !#MUO>8"\B(9%'H_5@+@5#\RR3Z:!
M$7X_<>5VG@8N;'2R'B]_8\$(X@*<-SIO!)TDO6CJ\>0',*#?:_"4D%;YD2.X
MCVSIGK):KHLPP$'00.N K8AVO&1GIVP/MHPV#.^TUM#S1YM"@M\74\"0L@=E
M/HP'0FO%U242LRWF4)+"!130C/$@J*5+AAZ_=V!->LTHC)Z0QJ-YTNNHKNUQ
M,1*./R P[,GK&$[!: 3/S6.3/3$ED9UIV1RN=+N4*$*#ID:R1S(;M_:.="6'
M'UWIK-S*\"\M>5Y:M#;+Y3JDJ>=6%)[$QD-TM>77 NTF$ /A\JJ4>:DS1NAP
MCJAH8-;#+B<>'Z603=-1JW+L,HY\HZBGV%8$Q3BO-S4H:Z51"79&J^F-4!QT
M7P] "U;-H3-7,$_2PT6=>!.#=#CAEX2MU+'"FBXY&4XANHJ+S-8K.P9)>[2'
MUB[7VLT:\4(-;G [HWD^1507[<LL_AV#)M(UY7?0.AGO3T;ZQL-J_$&RUZ@N
MF#$L)N;PT"+UGH1YN?0ZHXA/)4@O%,1"C#%=Z*N%Z'@6,XQA@D#?P*#AE#,=
M5UQ]]4FL:^?77(N],2H+>N0J,<$RN<U7A41!EN.F_^S)L,$Z&;9.AOW4R;"+
MH &$U0LK8C^=DIH(<*%LMS.&A*(S15G'C+:P(816@03R!<8.681>1)K54ORE
M%;66*-;96=WXD38628&7":+I^Q^29$X_)M][3$DN08KVO)<14 <1]4R5NGK@
MN7:CD'R.H85S+#6.PL-P)[JTTW%  0*>, 8-&P4\KO[#67@NF# >:T\[6^CL
M<%N*EI&\5Z^UX,2!9=C7;1C+$>(1UHF)2V1#>@K_=PY^RV#!^$NK7Y&G40R*
M-3S:F";FOUT$9!+C@*69:@K#*H!FC4A89Z,88PN36YD0G;6,I"N>FW=@?)/C
M:>@]G9%E?J#VD$=Q.3H3A'>Y3H:=+@D;UXT-<@=7L]XE,_-C)UV%"W;<9KY5
M=8:AN9I:"5@$:IN677-G[L&TH8P1)VB418G[ P=66'AC0E"KH^.@+E$(<J/P
MIOIMM+:$NW=H87<M?(J9H]]L[J<S.6!HX//M,9!UPQT9>E@BU8K"=Y7#6P+6
M72J_)4.<ID=6/#*G6+))VE9A[K%E.W+M*"/:S-]18>!U"N*.0X#AN6J5D3*0
MFZ&25 ]C:H^P2";\N:-L +&0:#<. 86B+,N214]1:<BDH$0IZ.:83+ZNS3]/
M.#Z;,@<$+83?_%6YJV^9N"SH64!ATB;Z-.BAY+\]:1WH()U@-E0NFO0,$K]$
MEX?U+*7QP6E.$'0P&M6%28WZ0!A"*[0, T7R5O2:6S$K"XE4/7HX (-%W*,%
MVNH4D(]P'+^DG<0[7J7(Z8M7JD1_4:*MP@E(O&"=K/9R/1/.C4\LJY-/_"]9
M(@T=*X,33J'40'^@.YTJY+:I#%G@Q'/@/J>>KJC-1W4'$-20E9A'"Y07-RIX
M;BB<55TK!I<FH/T9$27L.^"]I2]Z1Q:1U[R^OOE!ES7$E)3"&2=>$[DXZ#%-
MXWF9/--_//\:OH*ZH=2JWC@R>*5H5/UIO,CKZMDD_9B,K1>CGAB[%U4!_S?6
M*<C7V%+^GR?5V'[X10*"S#S87G%D23S >)^#F5(E?? [1NBLW!;Q_+D9A+AU
M,MB__M?1_L'1\^:XPB^U/:%'<#SN<J."0^88NUPM10.!W^+I<O4,(5F:E3>M
M3G&%C<G'TVGI ;VX-$]P4Y_0*5@?T?41_<O?, &%!1 Q,VY/J>R%I.XUN,]T
M:L.^B$UAO#Y?Z_-UIPB<U*676]);4)$#VNF(2KX;G /^:\3&P*J=N;=+4>5@
M@N0^4*^"#YS0!$NX7.QC?4371_2.(^KPLDGZ'\I?%91FS]A(I6/&9Y@=;<20
M$BIB1HQU"*7\R/]R1[!\#G]>Y4.WO3YSW_?,I=GO=39R(40]3]YK&:4W*;$N
MC0JB9J&N</&T8C[192>K.X-!(L9E3[Z_5Z_X_U: R.!'>J;\<'DDV%RYR'4G
MGT_CD6_;K5ZXQLX74D(-3Z O31<.$^/4C0WP<K:8V'>*L8\CB!&N+K O2#8N
M<$AC)0E]C;8Q1QM2CZ-++!P@T_BVE/"VCW+!(Z_38>K*'H+IYY-)GUZ& 20-
M#C(L(?/E#0X!3[3FU,D6)-ET818B>(ZNDV54LD4:VMMEA:$Q%]B@LJ(:$7+V
M<Y._]CZ8 1!]/XK7TT3M(!=6Y):=/8>&[04EMJ4@8EJ8L[IL MA,PRGI!".?
M$^AY3HODMCMHR6F:&+B%)+84LKX\F1+!UR\*;+*K"7I=9]F#]_C3=V8/I"7U
MSM'A'J:.D(5.NMIPY.S7N!I=]_\=?\26%\=:,M3\JRACAESZ,4J3*.5UJ>?X
M%TMHC&\AA%Q6>H!A,$LMC2"^XQ*;NKL&PI8,"E$/S=Z=8:S<(5+F2TZC(&EY
MM *;P:@C5S8+#;?^>I@L<KK>%3$+X KNV7FY8$"S9MF-SO?'7#8@SB10G-7Q
ME>1XFN/IQ.''D?S.,C+Z[@G*RB/5:HYDS9/TF&\00\X<[E_W4Y?^R/([F.,?
M!V14#B?<9)#P,R26+.W'%;;.]GA31VE&X5(^IC\%'F1WC0=9XT%^+#S( \AT
MDX_(TE F)-O'8,R@70:R\6W& D\%I&%3$J90F]NE:HIV'VM1DEO12_UGZ7B7
M)'W5!+C1:?0Y>Z=G'?LCCD-8%%T[+7 \TT:;21EUYO#@<;2_W1_'"Y5[(8%:
MHS+$4?KQ%"4CW*(!8A7RV^7%^[<]HA1$3IJIY$EM_KHG0K<T: ?)CK5XRK%\
MN-/4R NKH;:B?S-4PELX#(''%"GX1W/L6M3D/T:@,&> <6M;'Q.8E-'F26:3
M<[H2!$E'_EA7)N[+PS,[U$DP!U?V:K9&RJ*%MMF-0,X.K/8PE2(3F1=3@:U*
M1O;,PDRQ 3I7X<_GXD<MLRL(+6+,3P_YS&\S9V66FC*4QTS32:)FCR"1ZX+J
M0\S1YZ;B8V=$BPG-A8+HBR79%=;U=#  >+],NERVH!YM>D%7/PR6R'-?5\.8
M8SPCV)M"V'^88^9:2(,)<>,/B]82JD0@$,"J[#->\!=2M%(N,>\;[1!@?0;;
MVT>^<2.;WDK@R#8J? GI.&5_"2AM2W1,$0LY*&)U!U2CC&Z["NJ*R$SVXWTM
M(>#C5C,$3!AK,4Z[4$_ R'K] WQY (>3A@\)>R_BNL3\7]1"RI =@)S8&?1Q
M^NWY4G6D.O@N0LXD!9Y,$D>LQ2O"O?C_V7L7WKB-+6OTKQ!G\ TDH*7HY5=\
M[@$468YU)G8TEC/!W(N+@-W-EAAWDWWXD*SSZ[]:^U&UBV1+LN/$[:0'.!-+
MZB:+Q:I=^['V6A4#U^A@\I#YF5(*=D8A$/OX303P B?,!;H_?(4.H%P'&A@I
M16SG@2/M&G]QS7F81\.CU!B U\*#QLRMU@?[)R_?'NX?[>[O/1U%D: $2-$;
M4=)GLRNQ9B97V8*EUQ041HM&-52PX?E4690YT A^2:U:0Q)!UP)0>K3W:&N\
M+<M%@DH[K'%:U9WU05-.3()A!F%FCD7YA2^Y=2#B?BN$0<PIX_O"XD?!A[UF
MX:-N*USQD/O9)F!N""1!:)*=2\[^ASH- K4]=;C/\SID'R@-'U0.CQX\",M7
M9Q_U(^^_F[PNJXS%C@+'>]0LZX;AD4ET)+I3['%$74MLIF:AZ7'2W:R!^5=:
M7025(^2Q&%P8@^F/&<A2F@Z.(4@/J _[]_?DK.9L>M*QX:7IM;,/I3YP))QW
M!_] =Q<</-E*Y=51BNLDV%H6D&OI.?'RYO-L'IS-WBG3,[7EBOD>Q:2I:YS2
M?.,.3CH50W9X3;R%,WCI4SX(-2-6W(:#J6T@?J"O@(DAW.')[U15$BP&K6A=
MT &&=O@9UVEU:Z#I/>P>UB,Y<9/2G2">+M'V<%I^')'%&PU1%'.>U2N0KR!+
M[!%LKI -&]GHB3DBAN#"MM^8PIO&B%N[:9(FZAXE@ $)]B93OL-==<#\@=,J
M= .H<C>W+TKTFH$QRTRR/ N==@+*O6$7ERF+)P.RXJ754.L38NA=[GA3SBBI
MG,""(C:1CV=29\ H6V**3\= $'1MH_<<.2017X2$>N6)"ZQKO>KI3Z,XDZ@
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M$T DD5[ (^+YFQ 'DW8 =WDL5_@SJ\'#]WANUA7^<DU>IS]%*".*YSV8A!]
M:EH@%PN%+B]-VN<8,?)#E)R$&SG/^.S=/]K:WR<AWH],"N-6\97VMO8#PT-
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M)\];Q!]':MLL,&9[%:HYO93'":UZQ9Z)X6&Y6Y'^4\^$ZG(K?!/X]EQ^HF5
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M:'F3]1!GZ\))#V>/UJ.^FV,\^7_)DY-KBL8K[5"IA[6@WQ>$))6.2/#7.1\
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MG4]R=[">:R+CHBV0"2&76$M!7GN1BX423W<R C.M?$XSFJ81D@CS\A(VJ8X
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M[DY-5;]PPOBCN:Q,@![Z+_2L<$?>Y+T\!YT:5$\Q$^^O3R=A_^CKQ242LU>
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M$/K4L.>\FZ1"^NPR&ZWNPEJ?4 C)TV1:+F!<)XI!I=B;@V8LEV 6!KN9O3V
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M.\?CK$GIG^-2U)C5(9Q4[J'^W2[2L3=2U+8N<NMUF'02E7=CH$<]UM^N"V7
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M,&+4!S_EVM1E(TC7_L/.B*MT&LX)^P6O??!#ZMR0K)'2(3Z_R+@B[MX$7F]
M)0W-7+*_+WWL'%4.?'IDY]6]&IW6Y(+?&X&6<%SH\.V!<:.U\Z:<"V>N+^(2
M'3E'H'PE=U;-@.W!NRQ*Y[Y;6F_Y#,!DSB$C=U")&#YR0@.XBH+MED:WW*'E
M30_C78YX<J?"+92 )I5M.3NP0F3/+V3_Z.]UN^P;I">D Q4M(!@%C7H'=*;^
M]H_FRIF;=OF/L.7>P0L@=[%_BK^04WSB$6#KR_*B[&XQ/W(]8L?OK)BL#UL)
MW*S_8;:H%>"KHW4$7_4)"(<Y/H<) %>_EV1+/K,]HH! 7=+A;\J&% C\ (^?
M_&J$TV$UP*O+?Q)Q"]Y)-V7Q5AQ^O+.,2GT$5PPXZ""V& Q)J)G/#M7Z@A M
M\(SW,Q>:TJ".-3_)RZNR=O^S;T"!4O0 OQ>MY4AS.+*<HH7LLZ8C.<CPZ;R:
MHB8"#B]F]<IG^!<@?<(R8+M]:2T *^C_COC;!4'ZX&28=74IZ[>&VH31P97R
M1@#:-87L'G+SPG2=G<]37C2JXRR_X>^KL!/GBGE3=<C.!&W<H=@)R>$=Y55S
MBV$NZBM^_P1*3F'AW#O<XYOISX^.1CX5(U7C\3<':>_,=>\D%YQDW%IC+GQ#
M8"RDYJ0;<WK-4$B\-N57LP_BLWS(Z3E7I',DE\5EB;5KQL6A\:Z[:W(&E&<\
M=;1K?H4C _ YB0JLEJZBI!&D4>9^M;D9EVI[2,U+3#YV ;/>TY_")%.0CUO=
MQ /?XE >MB9=+K/I]F[R$H_G_T[9J0+:)?4H?@X22LE"PHMUP7S.:Z!L/L",
M.$S9&M[9NCC,[R)_S@,-U<*."$/NXCL7@I,7J;2(LTQ)ZY.#1[L&W<B9#:*)
M]E"_M/:B @R:.Z)E;@FOF-XKC* +P#L*]Z!702DO]A0',!*"M-?UR[ZE6[RD
MA ;?G=I/LXJ$8X@#WF0 ">,G5V?S+)<==1Z+CK)PT_"4Z_1R-]Q9?Z[:U0;L
MMUDTZUWP7'/N+&_;U;TTY9O!<V,TB"OON!ON2#H8?[,26#?JW#LK*K<3Z'K.
M"<SJ*Q?:^]OW+^W_;8/!^&/?'-X_SL-PK4-_J=1<0@_*/PJ<F/K1Q/!\[T9T
MK^+&(&JB\]MNJ\,0\(H(JKUWAX0E/.)<:I@V8%2R'^\:][HDX"-O[-[&[OT)
M 9*&\6?D:;H,CBJ.X7\7/.1J/-@P0]> S4'8J0\\OO7;WNWXME;[Z^*+982+
MQG,/V('!.3'PM8T=V-B!OS!\TY"',J>3=:B&$Z^K=\R?'>OP=(-UV& =_BBL
MPY<_?C9PXPW<N$<[^2"\,1%+,CEAH)/\S/CASU6&^_,#C-5_O@N+BHD'4B8'
MMP..H7O*.?OC;B,^%P0>PV%GL"K>E@6G2M%'L:CDS;L89$88&:HVWT"YRH]P
M.NJ,L;XBHIR2"75,Y8F@MT%.SWU(5ZDM!T" MVTPU2I[[U6RUQ?Z<:^ZXSHA
M/TA8,I>QN9U;-%\'^N/393H+N\] K,-[Q/*=!.64D1?LY)7-KW7@I0KBSVBN
M>*5/%'<^4C.' ^,.+Y"OPP^6-PTXS)=J83M5,PGO681#D[I= CWF^:@(22T3
MD->=+O&T<,MB4.,,RX?<GPP\0S5Y$O5JL @?%P.Y \_6PNB3TY_>)N[-,L_M
M_J-GVZ' N713^!O.H)7]*\Q93&^K;W%_.#F.;&UD+0]%J-P]Y-6PN5R3/;.I
M1_[YG-M-/7*S:-8[(EKS>N0]Q%6!2D1ICG$X&^P9.OV W@*4BYP/9_+E<"7A
M0Y_:KMOQ(F<8M67XEZ/^]"<*M'Q>'G#,9LZ7ZTET#AR@H2=PN,1GG^)V5=5@
MLXTWV_BK+:])KT7!'=-ONU6V9.O-B^-M@:3VZ\[8$?W*P?!&W>R2S2[Y>HI/
MJA'C&:8ENU>@Z8=#IT79%G<V[7_Y=;W):J]%5OO;Y(NLXG7/:@]F%>CF/K.P
M#@GKSYOD/)WGHM9.6B&<>%J;Q.;KLEI>E0O.475$['OYS:<>6+^&><Y>E]O3
MP93F@[.+M'4&7UZR1;_:MISDMH$DN6M2[^Y1XW1AD;55.<TT?((@ C=TN@UY
M?D\])&Y]#:T2N0@+#,AI(7OX-/2P@?)XG[1R0H85+Z5.+MV.;@(YE>] +GF.
M=A-/.&W_[ (KT["4KN(ZIOFFUI.]@Z/=9$T6UK&'=4$%TCX67A<O#6G)4BF$
MP,$YN4I1@'&#$B_'2$3XA2.ENE&28SSYC$B*"O=PN 'J@)1Q%CD\)K#Q=Y"N
MLFE6@YT%T)9L[.ZP)&V#V;S-26>BK)'(I,0R4X9>:ZL0FA_+>7G)E*>7;A5=
MT@W<LM4F.&TU=-=-IQ@*KW$N'R"O/<V@J8"EM'K98L7($N$I&Z#J07>:MB6A
MD8=.CFY(WTWPT^BJC  ]E_-RG,X'<OZR>E5O(@3R7RSE#++9C]C'.(''F7NP
MX8Y/ SV\OV9 H=R''+0\[CU0X6#W63(6(7MM[OTRS:?HL12=CQ5%[RZ1DIL5
M$/9G;GL0\)-J6D;MZZ]!4_-L ]W:0+?^M#0U0O3E#$^:4R56Z,%:CPUYE5;-
MSL7$;>&=MZ5;,64"L9RF L/*V0*IJXQMX?&$')[]9T](KT$KX:/ ;^9,WW\?
MBE#@\&D_W&T>FL6)OB 'GYGY*^0#*\*;I$.90?,LP;:)9_;8>F:XY4WI_E$[
MHSZ7)I:XP80T3\-WEFG.*A;\5/0@ACNT\VEW?4*[YQ07N@-SG+EC,TM>PU5A
M*WY(TJ<'>V[,[BEJF94 ;.D\A>C4\\SN#Y"BK9C9H AD)[;*B#?H,ST!S]Q-
M.7!LCI0XAT[(3[N\3C4[]?W7&6M=]910V,4:$$+QVB!IC[AO92IV+9SI56W<
M'Q6;O'0N;LP:05F*MI:EY_S*?(H,!GDZ*4M'N;=++H\LG#DY1,L*V(,HQND4
M;)G, 4'CDFD+0 O V I^RG 3(OOEN^@;74DN8.D=WJVZ->@2IL['NJ8](5F:
MX.C _9=OWW\;;BHS5P.A%L/A:IF2ZCJ?9%XDK6*B*>YW:2@0T(^,?)?\#?62
M^T;S<-&VUBG(BV5+'%%7I;.R/N'$[ HY=\DQ'1C?,AK,2$?G<U.=[X4[YO@@
M6"H:WJ'4:#>;$Q,FA=II4<]X$_I']6'K&NV.KUOT9I-]_I+9Y^,ODG,N$G4P
M_]"']6D\M9=?*.5N4F)M,"GBSVFKD=O+@$\.4U,'MBM+T)+U\(M9(.=%KDD(
MBW^_5*/R_KB-R]XWLJ7DD12W#P-#/"1C_^6-UJ84O*:XIR^RG^MO>UP G48!
MWN!+JQ45_"P)32F'^7'>/;XR3#/PD9[^^A:G-SMM TU: 4U").X6]&-+]\Z=
M.L/<_!:/A/-HU>[@;6<$4CB@&_Z"'M<FGVYJ!7>WVG?8!S;;<+,-OQ[L4P<@
M>$>G?*<S90.&VJSSKZ7%][=BH?!S3R?E,P.D'E  70> U&_-<MTEA(.G9>V;
M6:?UE28((N_Z#O$]'^+27[KO9S=YQ>H!(U-A655Q9\?^X_J(A]+^7V?7F] ,
M"]AI7I?=<LRD+,A284^Y![#S0DR_]Y;B\:9^NGB1/)*&Q4=[NX?;H1B"/2 8
MD3,57?=%N'#K-^[6/*?',51+1MXZRY^2/74_R9@YUB)6?U\L&UX%Q+Z:BO".
M(0+'96IJK#P</=Y_-#H\>*I9'9R.V.O@$Y;\>5[7+:>U%1>%J]"DT7]O2&K@
M-JFSAII7I%!4R9\]["7[5PNDCINW25I?81AU/M6.FFF;A7P3?9N6^&?O]OY$
MV./W2(S5:]AZKL#'?'*5.BO_3]0X/KC_@3NX4>+>\[1ZGS-!O70(*T'W%Q67
M,KW<G3(JU4H"62*Q7"=IA1/&[)&+]__Y'P<'SYZ[C?!3D=.:=NOK%1!C;DJ3
MK?#W;>R8BYO,C86U/E*04!-^#WOX</> -_'A[E[8PY0,#:?9ZW^^?.GG[[^R
M(OG>S<(,P@GSY56Z4]\6[62.CFMM#L>S9 W%7K01 X]D+N##D:'V=K\;@B!A
M> >[CWAX!];$3'/W&5 R1B/<M;,B>+)PI;W=)WPE]X]P)3$;!*V2IQZ^N)2H
M;DI^;;>D@><&B\HUHDX"Y4D;7,3;G58+O8L[3'[-<)9%3E1 \WS['S/ZO^<=
M89F#%6!03DSMA/<E8#NS@.!YW+^$/++,310_W][N(_X'ILS_RAAYWWZG8,D.
M<7U.7/OQZD _?A_@]*=%<QWN;=!<&S37GQ;-=;\14XX5PS-"="LKCX1!*V=L
MTE'?)AW]IE-!K[+?O_#^IQ\2"'S:.-SA;W%18=>:A2\?+PQT7'25MSI2('E#
MFEMCZ):J-P'P%3UD'9TFR;X>X/OV51G1D+C2F9R_4!R]"\E_A,P!;L OSK>9
M%ZS+3<S6(')Q^P^AN'S1R@YUZZ@T_HF[P)*P+\@6$T/,?-Z"/%:1\YI@KMW'
M&,P.9PQ'&2-UN.1JAH:C-^!W)/O0&(46KSA$Z)>K;"&!#6G,9LZ#+?! _+O"
M+:/Y*!E7I$:3%5E#JZ<S4WEQE8_SIJPH^'GSP]OS0^C*S=/%(JV!,*=J5O"$
M>^7C\Q?K2"@E7OWWL0?ZSGTR:Y+C'RZ,@[\^&XCQD/O6J>V[VNZ<5 _T8-#5
M#@\I@69PZVJ*VRV"R H'6P0F?CYS4:Y;39<IK0X1L7N5I?/L-CDAKX96!&;3
M_?%U6M?IY*I%$%N3KE[EEFF()5Y__XHZI-!PSH)_;.+Z2D5=,B9 (R"VA\Q!
MCFDI<:O;FG=H U"7@!1VC*HSX&.TIM^].-\YPJ).3BY>TL.-YV4)5B64<@5R
MI\\>S7=4^BG=JX6_+M.9%[$(E4]G.)NO[V<_,E6>R\TZ\6L2G9]4>2.UZPFZ
MF@D.6;KMA\PEF3#GRJ(-&H_^:SN]%.YJ]Q>%4JYQ;/]6 (H"3ERO31_QL?&!
M>79\\9TFC<Y>OKU(]A\EG61]-#GA"<D P#=$GYFDN$]<_ =$4#TB2)0(B -%
MS6C*RS:?TAE*Q=/P_EEK@*XKDM.3^,(3O;#8&1JJ(+)9V5U4#SQ"U!VP4&IE
MT0CZ./.=X7;NH9/]_7N>TST:0R*QI_QSXK%&?(&G#YPH? 6K]SIUOE1;LZ38
M$IUC7[01K)\==_.JLX8R]SQGI*J20PZ]#K0O@-2#WF#X$#DM8)N7XCI!:R>H
M6B-S2:Z(?S\CYR5AE=1HPZL!O<V+VCFC;IF,NAC4D!&H14RO<)\C'3-Z6?27
MW82I.V4YC\C[0E/&;8 ,![TM:O$@B5IY)BG[BX9:2>Z/,Z&+',G]2V?-2<0^
M (4)EB8,#?S@ O^M-=]@,J=>,5<&Q.CNVB:1<FH4OL*#BA=4UEG_QMSQFG&]
M(/./8^P.;S([9?Q:_&SX;]<KWY6?0S-FP4O7PK6H4*,9!E\WV;+^-MG*M]G0
M:&-IQ JZ5<M?6837S_QS][W!+ZX2(NNPC=+W]0)A:CP*.^6]3-A[?/9:/@J%
MQ8DZ";U/:AWLP8/ PMS2:_L5%R^X+;R:>MM.:^VN5\_H$%QQK]A]\#N4L";7
MV0[FWCG;TVRN+@!OQK* % PO<Y(2K<HQQ?;=Q4AQ 7:<8M?CM<O?MK17_:4Z
ML%#Q/07!^Z*BOG(76#=^J+#0SI90K:,LI-4F_+$."W8JS3#W+ED_634$DF6V
M^D/T^ULN2/S^>N>1=#?XS<([TMNX%0N#O^9O[%X %U92;KP.]L2,A!Z2XD0D
M7>W;;O#^C/DRBH%416+SHW%_?PU3%,QBHI-45#"E442@0RN>H[]>5WP.IX<L
MX>FZG&GWGO"\M&0F<5#'LTZ11\UER!].CFN57;K77'+)ES^<^^)P'11;39PA
M/>+83TWM06&FT9[)6E< N$EAEG)3OJ?'UA?12!0= ;=+B=F%_M5W/,F"T$?'
M08TVM,J9E- 3XLW]MQW=RY'OH#("F/4HEOB*]8>_*:M!)8S0""?0!<N@%W4<
M!;"J;ZPQ3\"5\( F3[*<=B!F&470'2JF9RXR*V^SK&8DJYO,'4SF;>*6Q+2L
M9!M'V(K RV1Q&1%@/L T$B8IH(Q,%/OZF'/PU>XFIT%CI#8]]5P?KKFJ3+?N
M>4D>8:\NM5VVD[DS23DV:9+6P;JJ,?%\BT7M8K(IB]X[3U66#^HD!=@ OMF:
MEW6]_059#.[>VS_HCJ,1#TPP;7;A'!" ARS<>"/<_9H&3R6UX$8OF%['2@^"
M?9T\\*>;+=O+,7<<6(F75NU&[,*^U?>-?MK?K+] ,YN<U57XN'>--5WC?X$C
M18J@K?0LCK,BF^7FX96!EAKZO"7TQZ=;9_3<;LG]VA9\:(ECJ+S5LKWCJ6AQ
ME;]$56Y_4Y7;5.7^M%4Y3?%1JH&\9=KF11KWHB[&9&%7.)^-C875U7[(%ZW7
M:IIZX>Z"'7A)2 189?=;$M6XQP,66)6_4FRSHB BXUX"YP<B]N1&93SO(DMK
MEDFG\A FA B3VLJ],#[1]!C@W@23C[OK&.BXMM?IO"7WDD">=,],<AU\4XI4
MJDQ%"$)_$6F&%IGSMVKGOT)_\->V;OH7,K-$/I18\X%4Q=<1+[P>;%T1)^*8
M0V8?PGH)10MCX3!,=1=^DV\<K:OP,NW:-VJ2Y/E)-)]Y;B^?"7!C'6>\F-R0
M!1;HL^TVPF0/1Q[!^RO]@#/TX2]*0L>^!^>37(37.FTG3BITQ\/.050)F+2+
MEJV464" D;GI84YNDKN93*C;U3GX9#YXT<ILF8I-F%#,'/D]]SZ3TI()&6L0
M05KAU@78K_>R\1H,;0%S#-RR&^1CY^18LS)3OXCJ=EQG_VHYP1WOR*Z#N!/O
M;)[3?$YHSIFT6'B6%TJ]VG4B/4JZ5R>4!'<1JV1!AC<^(BI/<R$6&Q80F>.!
M:3PN;B7G2]_7N&924BF,7V9*6-Y>?")UH+0JK"RKF"8\GK_BUV%2WJXBT-"(
MUE@8:[V)V%![QFQ\3YXS8X-M3*B:-Y$%\K-+P:G[3HB%>Z&V'5N .T3Y2,UT
MY1JS^JB\8WU\?&12IVY"_6(/VT7.FKH<A8TB92,NNV(+U9E[.JR\%1M1]VU8
M0K(+*]GMO2"XRTR21L0D7\7"NFC'&M/I<_^N2XF2+379/;R66F_OEE:\3&P.
MD^Q ;YQ:_H]\KU4'12GE&EJD. '<!7^E_'49S@?MR*0SX>MX?SXW.4[G6- 0
M^,G_T7][4C6JC<ASG*R>N!V'##SE!,E'M,4N?EOXC58G5YUFODN)^!J=P:CA
M*!!$R9E^]S+R^HJW4[2')2.9+P22-.#\C?22(FK%_0:4:J$[FXP7/IAI=BM4
M?#$%6 Y(UDTF54OC(,[*K6!+G&UJZFU-YDN"H_>Q><Z'99[5VX/),'D?B7O:
M#+7&8_$&(J,"2;Q58PQ)EVZ&B>)@J=W8N@M<":"V!1X2[Z=IF5%_A\9.Z@"F
MP:QAA\?.E-1-T6CI+N-.?FPT/K>Y(BF9Q*':#(4Y.+U]^4B.7\7W:$)9.JID
M>\O1[3TKH402%V5%=;63KZ)..F8 W0^H]H087.O/6DC_S*B08UF5*X]48I=:
M$\/TLRYDOYFP)BAI9YC&A)&LUEZDAU"!2>N!TCB'7+N6OR1E7_F,M1XOSN>&
M_<#*]F5U*I-0P)I%K!6*(QK^I:[GP'=##0B&%NWW>WZVH5[4*%PIE.]L21)3
MX::J;6A_WV;8A->E^^N4K=B-#\3$X5*.LO[ [[=DPFE,-:V5S^*OEW]DF4!<
M,!X@>7%Q<.>MT'VSJ2-8EU/\GL5BWTO4YSOT[F_*ZKVA*^?WZ"Y-;XE3XMHL
M&!^ZVEE(56E3#@R[Z+J<7V==Q(9;8@CE-M*!Z]HT_T=WKB/CU!;$.N*6A_?_
M"6DRH?7ACOJZ+ J&F'B,CBF_I@USTA/4WL=,1%C:@K'T*IW/;'9)LT2^[]T?
M!?Z[ZC:8] UQ87HN1DW$Z%?)P7+&D0:BII,&I/83+D-01D9/-.=_D1^A^A[M
MV.?KS#"QV2U?>K>8%4QI,]A_:O PAR2'S^:0#(A%<URFM<]]1(<RLQ'X<V-&
M<"[R8O)JTBYJTE*KD_=N_@HNP6KLC)"9D&CKO(0W)"E?> 5SX!8("V9YM5"#
MG"*3GDYNU2,+U0 Z%UC.@W$N[++S)J#\J[M&7"/ZC=0A?_8"_\&FP+\I\'_E
M!?Z/B)E./W [%!UZ/@ZZ/^@D[_(FDTA+8]]-^+(YSGCK$-:-]!&<+W3R]L=:
MBCM%9E!E$7LJ(HOR0PYS>GE[9_)H$PMLEMY#EU[NFUFI)29OLL&5N%EBFR7V
MR=;M];!UDW+*5-H6Q7<?Z"E8.L^_PI7^U;J98N4_ZN%+J8?:JP;6M)H+X)(V
M\>1FB=X33U;ES 5\W,2NV;B9XDF0!VGG/E_2 7=__?22/W.JAJ-E]EG954WG
MM7]:5'>[=2E)CH8(6^JB/JUJ!(NF8#DL*Q0 /I#XY13 T+I-BR;N^B-SL,!\
M.U<[.-?HD\V;EBOKD:-##A.SC1B&,#=I("I9-69.Z')%.J2VN@U(H6IQC8:G
MJ,';CEKN>*LDB,[ M04  [ZF/"/-F>1<P0Z,L2/R$'^[, ?<>J.I,S!+:*LQ
M36\[07IBULZ3K*A*UC2C@B)3Y8>"=<S$WZ'(-XS$R8]MU:]EPN6<EF#U+!KJ
MNZ(<=-+6AI^3?@_X#;&TS:+>Q*"(=%:$+*/=7JPV;'6F"#*CL+AKWXH6K2HM
MI?<S[3X9SVM-0)]^P2G&0\B! .-T]Y^6E&OW10$N>FG,)D6!R[9@#PDP32!/
MZ*OT%@. L*(A1\_3+0_4MK:@($NIQC8=S2@J87!:WX>2$P(9,@<OK\=H!ZY+
M==&+&MMJ!AZB<@L4=8RHB$J-N#[M')F3]#X @I\9)I=->S!3PV<K])\Q2M_?
MC@;+LK'N(O]J<VDD6J3O,S]&X+:B,480+>S0FTQU9\&1DC&XTY#C$TB)?92Q
MZL0@I=X2@,3  R@%/P0%T!XYG9$  5A#( FOAPLPO>YP00!&R;VRS\TKU!_P
MQP!=?B2(T+H@62Q."OUZTDTKY+8[TJPQ8@+=@6E-EO-4NNYG:5X)5EQ.9P7+
M#AS3@WWQ1.6#C<(WY[L1_T_-FM06%B["?]0V1P Z8G*+,/CR]VF@<*.H,W1J
MQ*V)8YRJI.0=* WZ#V5H-%1R?<2Z]5.OJ^?FDW<6IA4-)^X%O,\:?WL/57,'
MXIN[_DQ $ N[3^NZ72SE;WY7%RTQ'Q&F)(S.]P]Z@42:%E:J_H"^B1K.(Z'I
M5U36NLCYZYRJ=@;,[EVQWSB&L\;B7N-9Y"Y\!L^2O:KR2Q)1-Q8UI\D>P:<(
M2A\?"\(10@+W^8H%T)EZU2/F2:Q2:)]U25790B10XL6U+@?DSQV_)U[1U'_@
M[KV#P6.GZ-KR[U7IWGEWAJ:5[^;IY/W.Q>2JI#PU?6\'[0OX '%L[";_E=U&
M*]:]#MUO7GHI&@Z9&3\(E6]SOOB<.[GZ-^9.#A+JX/8P@_<RO?@?FP'GN4=I
M1:8==8,)UQLT@J8Z#BC-]1=<Q*'?1+6>O1"<RF?Z-;BFTH'I>Y:0VT>NG:"8
M(WJYRL'ND\?_QS9_=\)<$QZ:RV,-(USX]BJ?NJ7D?]Y!9/TM%\9NW#3=6Y R
MV07_T73LMES;9'] (>K@:7?]/[VWL(@L@S,HW/:C$X"LP=.#O</G*ZJ-W63"
M7:_DT?[NT=/-.UFK=W*P^WA_\TK6ZI4<'>[N'V[>R1_T3BAG&&=Q?\NQ\CMY
M-]'A^60724SK\.SPKV*JDW$T%!L\_DUZ@OK__^_?C&6>/J-9_ST]OB$PS0.>
M_]B[8)_RQ/<9S=^=#N'.-_AQSW*OM5G#M_?:TQXHG++['M=N5]^#%;H'[[7"
M0FH-Z^E'V+^UVM=?X:S\_GO_*YR4/\"(K-6L?))YL>(1DTF6S6;KXT=$AO@^
MS\+7D3_)GJS#-$2/<^K1A"$CE[&<46DRTQ]M(];A0>\Y93_Q3<IV7X<'C![G
M(E\LY]R5PZFO-78(UG5[?N&]J#OPND1L"FO\@.<@(,R7],Q_UVWV9=^(*8=Y
MS@$IC(=W9&F-4$6:E,5EU7H-MD 18&PK?DDU_#GAR,JEKTENCM@_VQ'[-J_?
M[\RJ+&,=@PRBN.[$_82MO0Z/]M<Z5/\WS^939BUVNWJ'*X8_[4*\IR+>OEM2
MBJTW9^W7>M9.<V#.BNE#_-S-4?O[O9#_-ZO*1#3746[V[R7 N+A#/LU_JV>[
M#E9F#3;@.DQ#]#@ORVJ6Y01GJ]+(J&Y.R+4](5_E=5-6OCG,>[JS\#+=J9EV
MMJSBU/_PU-AGS(7]R5NL#S<MUIL6ZZ^KQ?JW(7'?NLC,&3+"!!+NK"WR=:*8
MNP.V5PT.7=!Y0*:G=5G0.[2DPPHSM7!6$!J5!5_%DZ IYH]8+H"_)<HWT46Y
M);RX!00'8LU:L;M60X4!O!&3LW# >_H7,P:ZE7*DK[X: 5]SU?^D 9LI(NQ^
MJ6RGP@L])^YGO;3[^F*7DCT>R\S]$:8/:?7M>6SI?#5.F(6$W3C-"-,%&@;^
M?0<B.?IR %NZ:TQ]GE?Y]_1U$,:66A$8'BM03AFJ&R OD665+?)VH;T]\F?^
M\+HHG[[%AW;*V0Y)I1 ?*;U+TCVTS*-KLDLC=F=1FV.%J\?W2%_^0$J.K)7)
MG4=&C"D3D;J9\'9FF94"S0L5*YK/O2)D*9SV,/57;BWL4.:1YJZ\V>&5J9_M
M<T0+$:F51KR7#Y'@P\S(&KTQP5#'K^QVY%NG#%&[[(=(57W@@GZS0!@\#ZRH
M0O].N=4Z0Y?:/)]EVNW$ \ T:%M81!0HKRE&N'M51L\9:]0)'[HVY;6EHD3A
MYE\LPU:^F^VRI,4'-LJQV8!@\:.1<Z:V60DH]52'( 2?M+4"X,-B&"58'/!6
M#_:>ORF;C(?_:#<9V$HC3FK1R@BMB'<]RBY=>?_YFIB',R#,B9%Q=9O6UMGY
MV_],%\OG+[;YT=;/5)C2@C1_^3'+BF>=6;+BS'Q+9H#:2= 6D5<BXXINRJ'O
M!H;O\'&W%?BH21MZT=BH14O$5F7E*9=A&JCG9$HDAX#A>Q;C25I55+[@%8L.
M-D[3T"Z!F@$\#BS,^4!3*#D6,4<^WJ2(.= 1EJN8E^^Q]^R?PHG:.T!S2S=K
MK  W!6FW06QAS&#UXMHU\-YY*(;'RVO"":MZ#;YVXJQH2N7)I@9:,-:.Z-NF
MWV%=6D#L*44MK7AK88JUI;#'MIPPT>U2EE)#LM*=U>;?]JWS3C)9)U7NICU/
MA^@2V'F]@^)YB-058M*']XE)GQ5-6ESF>*O'9-*(S7]-+-<;-S6^'6Z:S;CA
M3'3@UMNO\6V!Y)= DIHD>. VXX6"Y'Z1!9;\H)#A7N2%>WW_SBKG-4QY0^JG
ML:<NW>-79'^@Q@2/6U0H?3Q!?="B=$W6)"WRKDH34[?K:-".Z.873;_LPKMK
MZ1\-OS"H^T@L)Q.^ZWPL#?]@;R\H%PWOODZOF76?#]S:M/C2;J#;N?_&DI%I
M[PW3Y[@3GX31GZV3:8!8YZHE2?*-3)GB=FW1"1Z[WS)*7W)D#)!U.G/<U@-!
M$\T1.R.[R87IV@[VF"+=F@/';B-9W&?F[,<2<AQ!K&B2SB<DCQ0. ETTD22Q
M\$'C$%TBJ.+&T+Q8MB+8B(FE-G]F+F_3RJ_).^8#BT1&0#0"<O)ZQ #6#[.5
M<M_HP&UN34#H#L]?.>^*R%\E+#@^U&?P(NNF_;9@?1GW1&&?2@BK0;_OJ!O9
M>:RC"9Y ?)H4AL)UQ*LQ0ZO=RZ^TEUPGVUVS8M^86MCG<R[^U+3!N Z 4<B!
M.\^=AX0]*L-(QB5*1(%%F8DTJ'D>1/7-K?&O=;(LV88/[_T*7YNM6 ITI/$Z
M:,.9!;-1L*PNW70V&OM]TE:-EN:8\SL#RZ^C%RXFT:-A,M:CT@P&>0>3+"<E
M%+B>:V'_*.VG.2#?!-S<9P5U2^$,JG)BK:&-[XZ(RS07GABT$&>!$J7*W(*D
M.-J^L*W0*J[HD.VNZ%F^6+CM[-[&@SJ8148%(\NNL,FNLZZTP#F\?:5#(2]K
M)!XOM9NWD#9B;A=^&L2O]#"CNX;&FBG+>=XD=RDBX&<YZH4 %U8;FFGD2'M:
M#:,6SBX'J^V1LHT[$"AE.#3&WA +E;&^:TB0#_SMH[*.2$>YLB Q"L'_R.6^
MV>(7XW5S[CYZ.SBS,>>8;M6L14:3ST78P9#??,CYG+F-48CR$.U;.IE\.I*4
M B?$V<1L!G^)4MC1IA2V*85]7:6PCXA%+2,2J,,@O"+"5.9@3)@%49Q#][]B
MYYXC4C6YF+[NUK(MW6_KIJPR9,P='2]"<P9.L2A,LS+J&B[N)F_NM+F!T<A;
M=U/K&0K9ALZ6C^$369?LPUO1AZ,F#Q%-6Z]4@XNW=_:?)9?S<HS3Q[VJ;)%/
M*+AG'AB@Y$5_CPX]BBM\)>3X)#F#,$NF<G)SD[?PU%8-'#99.PBED%(-\\&G
MN;K?I5S9#PW93J&D:849SI#G]3)H/I(D94\_J+;P0I(DY%=( A4$>%S/9>);
M* U,040TB@CYW"Z)(MBR;>A$&0EOW756B8JMCGN41.ZYLSG\V*3CPNE=9A?4
M,34()_S7UR8X,HX61IN3#"9*M!QU(//DWZE\ #/!KC?Y=^FR\;R&>2.D,1G+
M/B'A@-#[8.]@/U#)P?B /H_/ K-4X#W-6K<")JE;$!P?$)FD6VCXI//,JG:I
MLNO$ BECH]JMB+UBC&X]SU48ULND8*@J. O%*U:BPON:9"N7+TU&0:X?Y=WS
MD#XM9\[:4ZSB8FDO-DZN1F0"R?CJUJ.1N(N% 92ITBIYW2.O=!ILJS.'[[,K
M9Z!(A\Y=%*1V=9,M:S+-G.AS;FI.],\\%)HW9**)+RL36FC9;3*#ZLR/PGY6
ME5US]Z%]O89+V)<7@V6@%5=6FCY!/B.C ).GP9_$97%9XGV@UL &;3<Y]K1_
M\TZ4#@,ZK=I+RF91>7H%(Y?[ *V23%E2I?"HMU/;&7(VAFM0[C"6!):_UYVW
MD/R:O\.DO"+65LL?*G<E&6.K8:T5K.8*;1:X6/[!<(5V(C,RULX-A$HWY_#<
M0)FYL7"OOGLW4(GQDFP77.1V5]^A"_.CW<+D7\4&O,[<JP0#Z<O_R]Z7-;>-
M).N^GXCS'Q">.Q-V7(C-39M]IB-DR8MZO&@L=?>9^S)1!(LBVB# P2*9_>MO
M+E6% @E2&RD!%!YFVB*)0E565FZ5^:5?L@WY-IN=9]J R@C ":!(=[JHJA2.
M9+$3(S4/QFGL@(7E8V@QR38 R7A/6^.]N5BV9!/>MUWY\KJ"L)$J&<QT$\Y[
M05=":GQ C<T95RG"# ,_6E9&$?:4XQD<7YZ9/L+$\!K?/!&!1N%=;!R?,I:J
MU9X.K?DK:F$$>BWV X5,;/J)Z\;4W#?4[H%M(1KC)9&"'UX"M0Y,K(T[6F4R
MW[2T ,-LK;\JLKV<GD1'&XMV%&2>LCR2/*ME:B19WK$WF7=_TK'=(]H@*H,5
M-_;A?2;2QN;-G]*T2\M_JOPD,D&4]&%E8#'+M31<E(/^+MU9L@/H+?"V3SZ)
MO0\2NY1*5-2_@ >52+:_/GT^U6$W&I=N%E.[ 31^PV;TDF[J),8U"7EZ5HOC
M-++^6$X\,FM,/]$<F=JR(8P_64%I9?RYU1C%%3D62^>9=[DU&*W41X';5;JZ
M#S%>B1$LI'V1I!QTS&9B)L';:&URN,9NHA!W*JE)>L;&(AQ$--5!DW+, 4>S
M89*1:T-N=//R].*5CI1;-D^APP1S"\*[YG=I5!(!EGUJ3"V-LZS]OMMT05[L
M!8JI?OP^^%?D&0 ':O1K.JR;?I\E?2]N):HIQR9(H@+F[$V(V!;8_$0,9=XX
M0R7;2']*NUC:NWR0W^@NITQ<S C2.2<1+&=Q4!6R(9SAJNB'XX)=5VCR7&CL
M?'-39_(?N;N7+K_!72T:CC8OY2CPNJ.X[GUL-]M61>X/ZZ]<;)10[!&%+7YH
M\N::A*\;K&:R)O\#3&T?:XS0Z^1& W;[ 2*-28=42HBB?B%?7*CVNTP>]?%B
MRP%A/"IR(\EGM(RLN=PU-L<+;*9[[B)!ACM$Q1$[(QC/01E!30HP>F,U\'@&
MMR>[S>U)<WM2\]N3.\CVSP7GG"(+( T>)..+\9RB]Z^3))6FYV84L;S$] VT
MA"C]Y0I$WB!+R^R LGX8RC"7X1@%O<F](_%&P\GAW"QT&K:^'XF';,+=6X&I
MY$+K%4^DP[07ET\&M$55[(BOE)F#-3M$U-N9DW:N!]U>E3C2*YQS#"&.3=%O
M,./( -G.B97LQ7IO$E'J <B)?1"Z:E#5FH$S"_(L"N+DEG.C,X.-5E1*TQSS
M\]4%33@/#Q?N2S!% OSLV<+@2]=;L/?GGL!H80F%C*-\GDUC<036Z:6BT.<H
MGHZC"3J5<#R1AW/#86[LL@YT5MNJF_WP&_UO73>FZED$!457.VA6S9XF>LLQ
MQBQW=U)>4LG!T?XV.RYEF=YJ'Q=.];QGJ"Y=Z05X4O&(^X7&3T>ISGL#@1DE
M9H-+FM?D65P</IZ(/S"^C%F)3:?<N\FR[6W4=W32-!MM&&15L]'(H\ %QG^.
M3IPO)R>6FCT3>&D*CJ@I]0)-A%G/KG/TZ9R$XA>9Q=%74 ^<ZZVKK9H6H@WC
MK6:\H2\N0]!POK<5#4'534115R_M;Q^9[ _5))%J">9[XQE<&OP1%A>!#S:(
M(X'YYWF?*F6[FDP=NE_07:?LZ5!6L+RD9.P1?H-W[QA]:,R%QS^4+_U7%3N0
MU]+B-BIRH)P73*N)=SB@N)2SJ4)2W0PL=\'@7]SA3#GC;IY88_JZ8C"\]&J5
MLSDFV&O-E&$VMDUEN+F*[$R24%\TL4^/4I0""!$PNZ\P2W3^%7PHAE<48"GQ
M;%/J-JM_W+!>=5BOLKQG%/MJLT#U^8Y";87;L 6Y-6Z9VHFZ/C(F5&-O5XDC
MKZK+D'[J4[JJ94!B.-!J&T^_\*_L'$L.0R.S8OFN;NFLY2>5Q08B#.VVT]8X
M6V3>$T7R6+ RU&\(/\Z)@BLK68BZG5/B&,XO3TBFB-[.%!X4<6ZWT]O982=I
M86!^CDY<!U4P_[4AEYZ^(VFKL(4*#ESE4HR4=/AP<W%D12Y%;C%3@^^2IP>H
ML+7Y!5KB($^Q@@EME9&D]((\=2"Y11[.67'TLA0F%ZLIQUC&GE%]K<YFHM&7
M==G&A,U5,[/>$\A+$;@V7!A-.T-X /U[USF]L +S^'06T&\QOZGE'"TLS7Z#
M=E=.+TPJE4[-&N)%C>>KT@K[QF_.:X>3:J6/F[?,I>WE5T6,\9$-@*L5#LC,
MOM4JJ^>:+X*@9*0L0)P"/(0X775KRMF8G"5X_NY8(Y5%>=$KXP<1Q3T$&>#<
M=M6^/-)%2)2DF_\ Y7_*N'TOOXAD*/Z#_:7S5>?()GKZKKK;BV)>" N/_-XB
MW[(Y-B=%4L89%98O7VDA^1;KPCE%#*!56!GLKIOFJH]'8B5*FUI K.Z)\%#H
M*^81)KWP&2%LR,2ZLD2FH^M$9,;/O[Q_CSE'%S QF:*:>1X)1'M- E&30%2O
M!*(U"T<NHI%*%U9)%.;E/5JZA<-%,VL@PN^<+#TO_$!IQIAR! :\SS?_^%NR
MRL$"@SF%)O_>S6NY%]^U,# E2)!IQ9!3B4KO+E:#+SRV"'E)T)L@?JUR JY:
M/)&>1->/O^AUW+Q<U"H1%X1/8N!3V4; BX,"C@\5UK#R7D3BG)MB>DVW'N1A
MXV&@!C1. CQ%=HXRQXY&(S_VX6GX;\!/%Q/1A_Z0JH0BSZ,L(IY?7GQ!=A6C
M(G(&-]?;M9R*<-X[;7 -_=$(-C6<LWPU^QC##*PCL)^]W >+"\@_B\@]RFWW
M$[OVA5A*HM8?RX SZXEFWLS&W#V_]I/$>8_V')KX:D^6)NS8.4JKLWI,.H^I
MHN') ,4B K:4]IRH>&#9K,C#D &G:TTS\+L9#EC=?AD$)S\_BOFP%;8D+\0/
M8=JI/3V?YE@$1236',.,MV4DA^BVHD,8IF2U<VD&/HN)_&I5KH;@I-)K=PY5
MT76.Z6D\ +^!E^=BR2F]'#YXYX'')!'4+D0I]DED"0:;3 TZ57I8,]2O)%QV
MXJ(_P)E)$)A 151S7E'H"C0?RMI"_+"8JUY_#7UDL?-4@:@BJ"S5LH^!U6<[
MT34&O+!<V!_Z&!?SBXA]54FV5%0B*1I0V0G>'_/F!>*:;Z,1$A>/"Z.]@Z^H
M9(G);9NO7=XO%/EQ#3%6Z!/0=69 K7!@GQ_GH4E:I3IR!EM%GCHYKJ6*J:MJ
M0X?X6QJ5)[NC1DPX%(>RY/CC>Z>[UV]UL!XN0 9X2742RIGD<KDW^3A^PF@I
MOH(#L+0?Z',F$/Y89.#0Q+JDR2/<_QU8JED,,ASJ&X700E7;,9V;T"BV5(7O
M="1V0M>>>24Y^KU^JFN):#B\AL56C7]*=?>TC (HZ;(@J K#7=@P'9:\4-8/
MKH+^?KE:=+Q21^Z:^7<(>L+SJ=U"8A6B=WJMO;]69>7,Q[^($'$&F8V9B]O%
M.GH$88D1/#[AJW/\!:T]/Q:%X\4TDX$O1_B"O?9?C;J+LF!('$.%@T,5F$(Z
M<\&T2+DB#I6F#Q0! 4I^F^X]D4MJ=8AY(S@PC9SL)_K-_"XPS[ 3I"3(;U4;
MA^;I90[I@M'%/.V5 FIXGV]?#Y1'RN= /!0\)[7F6+H,2CU0D$VYV,<8NCJ5
M"N4NCT>HPCX96C1>!.,MPEI012##XWDD4!BGA $K,867)N@,HA].,DM2[,E1
MK'X0&MT^R4"([C!%? [#=SMOB"4&DB,I2MR" X'58F6 3ZOJ+^ [EET@LX!/
M*Y/T;T$. RG1-,/I @GDT.9O V[,->6&K#D?D1(?12MN5#6D.]C0$@;;;?_5
M( U=$5:S80X6NT#Y$6?\:S&K)E-\:54H^25*T:A&F)*\&J)$S+ISWZCB4\)"
M!L5+J/R"93&0I]WJ]-J[?W5>+C7D8%>(E1.%L,\*3DEQ]0/]DK6"ACV$6+]Q
M)YWA4+'9R]^.+EZ1#B$7GG&T@2.P#8X_(E1*+L9E/T-=3:C";+(,8("=6%Z"
MO\8@Q JK!PV9;V0J7J$U:/@8KR N(\2=Q5*F O:LPI?!L!,"DH-]I#=CO[4/
M.T$H"(6OBG>)((,.6IV_XH[D>L=AE=,WZ)P% -W2ZF5</T%J8.0^XKL5 R -
M8DB;(W2U4&87(? 4267D#Z /%XXBZH'RS\S #ND3+Q#^A$8U4KE\W(J@P50=
M>8XO\Q$ $=NT+ *?F#@ W: Q6GP._9>';BP00%,Z#W: 9$N,@BVP?T=< O5-
M(O"1@@S/&[OP')*QMDR 5?'",8*#I6^P$GF+"5#<B_J \-'T.41 X/R@-V()
M)O4 [2@515$,.GD>EPO[S>5"<[E0P\N%>PI@4IFQGQC,2-L_6A'7[I(8P0!W
M=0-_\YA=3X<I?Z<K@ZYKX97FF%T8A>FU#DT,AFNWYR"E.$BO;P9"/S @X7;X
MGH--, #NG_%%57UDPMTE=%;5:/[%K)=&X$!%UV0D<PID-L&+[3_1ARH%N\H!
M?._,8:^?;N,*4J,D%_B6O8'OD";*4T51JV:)<L1C^5,4[.T\05))]46%F\;Z
MK7K-*NWS5CVF]]HM<%Q6-)2V))\U/OJ"(^ .31+]]PZF=[YF-7@-1+A1_5@I
MKN:G8@#F39;*1U [IANTD2Y(CQLMB3PA][Y-I-7_WZH9^++\V2[U=&^VKH9;
MUP%IN]?L72WWKCEVM=VZ W*)FJVKX=8UIZZV6]=IMSK[S=X]Y=Y1Y5"Q$.Q!
M7D%UZ'3P(#IM5"1M&9' B<4/__ZB]^*^!.NW]@\W2K&#,H(MC1V7DW!0F(0=
MF:(H#T<P3)#C7U*HC]YAH.-_?AHTK/5(Y^]&O;)-5&HD^/9(\#L*I#K(=!7Q
MU('3Z0^'KB@=?6E68YF_$+KF?]1;TE>'!>LE^RM"M_MI@RT^I*<A76*EXP@S
MW(=)<SJ?]'1R>'N+^0UO+QL>>TH>XUCN=K-8IV&Q"A@96\QCQU0G6>2R>]H6
M)EWN]5\\3\K1:*/\UKZK\UF:*;2.4U6%A=^-(]A_6?S_-2K^19H\X2&ZD6:4
M6F.3K+=2-MFKG\:2[B/@-T[//9SK?%,_]MJ<'*==>%I;X5ER)8&5==<>-&O$
M7HFA\"P9K%SL52]>?6>38:7E=$$HAL:8J(F9?F<:K-TR>*[GH6&**OKP-5?"
MV\D53^]V5T!U:IC?C1=;W6"Q+V&!>YCP3U_N6=ZC/6_/7NS./@=%RKB>X25A
M/B]#;')OTZ4];P!W4YOVNQ85E=?E7!,4""'OS,-$Z,:WOBD.<RY$MG/V[L*Y
M@$%D[)R=[G3WNFWN(H'/JGX6-F8 8H^=8,T1U\EJ:JBF=)]/JX@<Q1Q1^S;J
M-C8L(A5AM[\4JX$5TKBNL%?H9[J+(O?:_ -+Q6>ZZTBQ(U_+.::_[?8DRYI+
M:BRS8@MJQ!N+"\!XIJX?I(W$TGH#>U)HPJRA>TWO902_PH:E3BJ2[XF#2[HL
MM&TWE?#%;M,,_P%+@X,PC!"IY.MB#\4XQA HGTNJ_M;@<FGQ.Y@5@3,K.NFB
MNUMUE*P*H,/ODI>8]T;%^7[[FYA,WYP@F1D4 [8:ZUOU>G( N@+I%KK47I>.
M[D4[9;CN,+QN3JE)>49H!YW!3UVL]\V&OL'DIN]!9\H,[ CG2G@>,C4649[N
M]'9;[1Y# /VB_][MMZP"2_I*O8M (/Z(?$*FX?V\ 5A'MYJ7<TQ)W:8(T(?G
MW1TX+\T[#4(\26-_D*4*]Z;D*>[7CJ@:8CJ5PU<@]I&=S??$Q"'!5;G%=8@D
MR2:T@"FB^+ .SLM!2YJ\SK<2UC EA=9 >G6@\:)PN*/J4_$+3?G*($+^+@G?
M,QP6>H'93*W;F,X!:B*.#O>KT2<7>6>_T^X#]^SA"5B*]F^D"C[1A=_OM35A
M\O[U_G"'<25SC5FV'[#7?GYZ\AY2"P#I>CFDE^#3+"Y!5L55P0^ 1=0NXBSS
M!K2@V74/'E;GH+0)-SQ*66G D5C2P,!NB:LQRC76!;TE[VA@VOQ41>C9%,Z9
M993%#'T/,@!;RL9DBL%*%"*^WBP&5I?F;TNH.Z>AV2)UMI$[;*6A8-FG8%^F
M# I.$*(,\UK8\]+N&$4FOK$9AMMTPU@C, Q7=#,D"X$A#@EOB I/AM&U.6"K
M]8?=I&#HQ])J5+WL@;)N[Y;=OKS?MP$[NT&E(;Y7WKR"9Q50<QK3STLK$082
M0#UV)?,^S:4X-G=Z*5I3VJHS+]78T1+T;#2S29)WMW>=?QX97.< H6QQ'GC&
MP$B=Z8[BOR/H(;\RP7;WM%&$!(W"5 VJS59JS,']P74O#G=I(PZK58,RA6!2
M&N-*0>RJ;M>\VWEK"YKT*!9P##/J*J\H0_)^"-;T,+,D?=Z;<B ]D24,&,BD
M05AM/.)*^.I'\.YAJMI.S*:J5_M0TA,@=+P8 3 GV.AC&JS8KZ( WW8TH(,&
M#:A! WH4-""+E)U.:W=SL<H[VD=W##+=ID<OV# *SV8/&,\ VA2Q:^CKKO7U
M?8!L$%6T@&/3;;57X]B89]-52LLLIM*H-@49:.]YN[#E-Y<XI(+P@5>30_L=
M@QD'CXI:7F$UFKO0C5<8;2K7I*90/OOMUEY3(E_/$OENJ]MKMJZ66[??VNTW
M6U?+K6M.76VWKCEUM=VZYM35=NO@U'6;K:L1D,^-/D%UZ'0P+8$Y?C)<B-4B
MJLIU%INAX\.!(CK[K5ZG ?^I O>M@5 ;+*:X2<E4_? ]*K)#(^"K><2>KX#?
MXFKI32,!U9LGG^@H-^KB[NIBB\_HQH" ZGTXJZ)X.6ZWQ?RW5F"@AN<:GKL=
MSZT/*:CAN?59)5O,<VM #M+&2 60)%:1X<1/*/MUMI +7B@26\>YJP+82\V@
M791PKP /K;\\N+/G'AP<KCOJ405:/4H=^5:SQJ%[N-=K6.-AZKD"RUW%&JOE
M[S+6>-ESV_O]5S6(+-]Y_X\WIGD;-?NP?)OZ"$XX'>O7J94Z)6M6H-NPZ7WW
M8+_;;'HUXNF/I0<[[OY!;UUZL JVPBJ2?,#:/V>4A5ZA2K&NIN'VZ,SG"0K9
M<7?W^XU[TG#.G3GGL-M$/-;NUCX#OMGK/QB$MHHN[RU :!700 $BAE1_G6^$
MZJGK"\>L!\=L&&583+I%YZP'JGVW\:4:KBARQ:Z[O[=V@V]KN6+A;KCJ7'%/
M%[SO=CO=Y^*"GXE9' 7-M7"%]'$%.&8#OO6^N]L_:)RDAC7*,@;Z>VMM/O#<
M6*,&U\+WC<BU#Q83!K; 0SY?@M17"RMT>W3M5AR1O6[CV3ZW/=_MKMV6VMH]
MK]K-\#VO&!8#%=OID7XE(%J$;S;(NW4U"K='43[/ZYE#=Z_37 @WG'-WSCD
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M:Y91"#2%?X[PD,)T6LY184RPW882J ]_P^SH(XUZ!P<0QLP-,IZ^>AA_I(U
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MPC')>QLPE'2P%GM*6SA2&/%"@GL:1RBD0)['I =&&<8"$EP(VN91093K0;3
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MH"%E!B^%<6'ZD@2%"*9CL9/,PLP+I!\^)1$MY5Y4J9WN[1V?1YAZYV"Z$ ;
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MSMF["^<"GI>Q<W:ZT]WKMF%0> 2%'6P7]L,<PL!!1,X+OO#HA,0I: ?0"LX
MS4!M^R&0?*)?*'_@K%)_HL2;4BDP=7#1HA!F)&:DN%U4.A3R\%(T3"3UV$ M
MQ/,$B7T-ZW4D-HJ"]TW$$,AX2:&== QF"_P&7HP3BJ@+".DQH PR1OX^T*T2
MIP(BP1M+].P\#\X_?(2.'6B:C&9*(UX;U:V,-# >D1M1)RTN@+:2%7<V5;I
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M@TE/:.),0"]9-S^HRC'I2=^_ 7_*\!+SP<G9%BE5"<'R1U'@1^R)6XG7;FD
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M':V%LZ6R7!> MFB/U16<7\2/!:$ML'*8F"Q/PQ-9L/-1AK$/;B0*^+0(IL
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MS=7@\[D:O$"I/,&:!X?[R6%Q"IKF2B0/9@Z8V&1N<R/)*=?\(VI8"D*$B\-
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MADRK%1O&C^9SV.!?.2$-AVM6<EB_%6*<"5MV20/R]D A(<"KSC>CYM-)29.
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MGG"?!.FGC7@Q6QOJ F";?A)1^Y>U\Q002J@"'2HG#Q<Q1&Q+#/AS58)RIMC
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M"428QIX?PQNB.-/+W%BE78<JM]1+R9(<4WX)KH/?#0<(&D^7D3\_[Y[#%0^
MN *K2>&P+N'-L'!;, \K7XK_P!9<)JD)J_^)#'TM07JLX-DRFDO?2ZLW!,3G
MVP"?1',8;$]GDSIUOKE3;BJ$H\W#3%^(TX\?VM[')("/@GQ3O\&7G,M5)I&9
M^%6]3G?4HK_;4JO"LRGW?F>]*3_,K8!'5C:E-W"OKP+\"NY!L6&B:Y/P&?U1
M&ZQE_ Z(S.[/N)C"RENXO96N\VY[VP7(P^KT"ZODY74G>BG=07OPLR;HUF:+
M\M)*F>]H#F(&,_D!*"2UCM1;)/'2&^.+8(_C]N3NU[1U#4GK7L43]--,SE'
M5' ,, +63I@:[R#*)9'[)@+F;7?O7@\R'5;[RCEQD]?G$^A],ZOBCGMWNH75
M;R15I(<2FP'TO4 RA& RJ%\5-ZJ*@=Z+U!=_>6_"> ;4!M;[)+.V=\I_)!:]
MD6YW3@JD]D:M2:?3 O^RS#,LII&JE1_@;\.!4$4];#BY28(,3PY,E31'P5'Q
M1VR,Z.Z_\F(PC\ R"F,NAV-#I^W]>150(4XD]>G*S[!I7$2!.>C=Q>4$SC;O
M)Z;F8*&)("H^V9?Z-I1$%CZ<ZJ^BN2[DKR((/#=W%U,C9OMG'JX-GXU+?):!
M0TLMX?!FO/[55@OS4NI\L)*GNL0OMS-5M]7MC%NCR?"K,-)%/3C I11S@O "
M___\]/H,/77I8ZO/.DM$E((MB*;^M#<>]D>3GS@.\/R&32&T@6U%H5C_&D3T
MA%D(]MN&&^5T6\+79T^W@ZTQ%=K33_]X#02>_4.%411]]XC GDOAFMS']R#C
MZF*]GL**EVSN9:J2U(&#@$MM,2-@*7"5\*K5A(X?0$@=H*<=2BYC3=,8?!S:
M1R+_RF$?>!U!@@1JEVNE5^Z P5 R!VLZL0</5H3R!<3),LA08,(U#\4-J"SI
M45R8*CZ=UVAB"G#BB& I%S[>Y^6NJ#@\56V :;P@"SU+X;/S.(]2&4['X\%X
MT&G$Q</%Q:$K+@R-D844E97E272N";._!^]9K%8A\-8LE#]&TF3<)$V:I,FW
M2IJPR)V.Q*R_/^_,ID(,_>F@U]^?SCKP/T*.NMW9_GRXZ':5S.5OG%X<OQN?
MG+X_>']X>O#;Z?N3#V?O#BY./[R?]H?]_J ^]APNE WC<=LS"_:<%3NJYP##
MU'$8^&A*8<LRZS&0BQ2%6P015J^+L#:[>T'JY\!5/RZ=/4MH)]AJ:.WV6M3$
M?#PQ:[-+KXG"/ >?5D$TG,+*5" .6;]BS2V%VJ B@1AT N<P57ZP<T*+BB][
MJT0BG  %K,4<P][D)Y+-=WIR=EX78_\W>0D+7R7Q7$J*]-7DJ$XPWIC!X\GR
MQO][(U4B )QLB<V3<7C-] W+>^ >.9$$J=2Q%S@ .*9DC29<0GZX:=#5P5G\
M&)XH_QM[WZ(($S)G<A4GF<KT7%-C&*Q"8CN3\B=CS$:L1( QCS4\8RE4@!SX
M))+D:/+)AZ!C+MD1H"5>B92S1QXFCA+D(>%C!Q]X$8L%?!-C><APEL>THFI[
M[V-/I&F>$&/-0=+-I'<)FDL]>Y%3M-5YY4T0AK1ZVL87O?//*]PWYKI6\,W,
MD+?*)50QF=0#2SI@$=72IZ@R01A/3ZY5=N1>]PH[<U>2P[O.UJQHG(<B6-8F
M$W047 ? [K[VZ/@G("@8[>N:7#6=\(DD-J?[$BB(@@L(#3HS2X)9CJ?AFYTH
M]IBK,#[E[<CQ182:B&)WB:1 FL!6V6L1A&2H+7)-![PEBCW!'HLX<!@L\/<M
M_#I^DJ\C+"F,5Q3+X\@#Z$?=WHJ+,$WV^%?@+3\F!A=1%F!J*)-V#]QVO78V
MHG@7,5U2*=4:<54@$>P*?9FAEQ_I( )%DG"5I=/DZS5#_O;A=F6\@2"= S'<
M%<>"L\ E]_[Y^>!WC*=B&SN0,Q0WK0*UO"4F76%W=/FO.>*!^W&#I1011D>&
M[SK^6>3P$P90Z/MPOQ=!LF0!Q?31- 2)$J>8C-Y&)OHRV#H4B^%5$FX._(UB
M+PIA#%[IQ'^"".0,B&_!XNM ?='Y)8FCE5@7&#Q<(SL&+*#3'*,R ?7I:V8B
M9H$U+S!)-@-/$PB.C'2#JZ9<&8-!R.L@SE/+IFO@]]3;^9^@PM7!VQ3,X2 2
M4C@>INYG?_];K]]_%?'_P> 0*.C@'[MX.^T*B\LR0O6NU_!#U8>Q+7KP"F3J
MC-*GJ9;Y]+H6W%.P@>!5DH@TY_/'S=,!LYT:^2+$7(T]EID(23NE5U@\8&PB
M-Y)O^(TE [K?*#=BCI>E+$W4&E4$CQNR"]^CE3CG+IRX'PDW4MB^]/,Y+!9A
MJBHIAA4/ES*2"0$YS>+X$[Q,!HR-E6K;<8&Y$?T=;24^B-A$97N2]M'JJ<Q"
M6L(2@ 2),"#(/=\'US3&J)4O]6/H;<[.&6XBSQ@I  6<2J3K+^@<>,#(%>+R
M,@%#*Y/FT]<B9!0KX5XHH_95&DCG>E05!TE'NF%PB#=BS=\OO!AHB^>$-]9-
MDCA5%:H&83H<3KK]7N-P/C(]4E&O4A.==$ :-$^USB=<M2W5-:XYH,SA!88
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M(C)"B!:V&\8TT13]<4H.ZE _9X;4J"K=&O:5RB?^_E<>9Z\J,NK\A]W=NK2
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M0LV%:9FE+GT:98@DNN(.8&P:)3G+!G._RXF>(DR!=N^N@L2WB2!G,<R>H41
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MK!9X%7]90GQ")T,G$&=K[*R@/A9*FK["*-UVGOO>R]D&33E;4\[VK<K9GE^
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MJE3N?])6+'*\!WO<X<I,U!080%93%4D78JNO2+ EAB"\KF48KU3]DA'Z#L/
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MI$5A<Z"4$?(8@6$*[J"F>QZ5X$$-O#(A&0!;I5B&H"C!U'>V;E!/3L_.+4+
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M)85-;Z)Y$_>VY(D9V8%Q_(@JR XH4G<DYQ+3YFPB]KLM@O<OK8#&SQ(BW><
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M?;PZ9>F5<&6+L'V'L$.E<Q'L\(?@> FL/N1S HJ$H$JUKAB.N40@#>H0C96
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M_%6N-_^?,I[\FT=B\!7]WTA?#25=^(B!EJ8'Z0Q(FEB[@R AMP0(MHH6UL6
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M'S'7)^XJQF_;,&_%(L<HSKSU \-".1P,B@_Z<# (!X-2G&#TQOH/>R<X#IN
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MW_\B5S_Y;*75Z(''0NZ.?"K2IE%\(AN(JX.\4Y)\+W4IG6Y]5E4='V@$6$R
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MJ1CWT/8*RA93(G<AO5OD"[,\#HC%QJSZ),N["YX1FWE9*/AW;N'6G5YS*WN
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M=N.RD3$, WPB;0WG>>(\3\P0F"%.P! XS3=1:;Y-X +%48?$_U/&DW\)#<R
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M)<%"21A3)=;LQ4QU0*9J.T$9^B7FJUCQU=%C1L?FJZRJ^F/?1(4*#L9:9PD
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MQUP4/T\/*ZQ#P!$N<0;@MPLUZ ^5?PZ^UJSV<R)=A-/'XE#NWEU-V$XK9V3
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M=6FD8;RQ)]6I$:"+1;GM3IL#BWDJ_?I-%#O5<7^Q: T-=6&ZN#[Q^]7IZJG
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M:<TFQT:#3I!U8SH[IZ#*FEMW?^MT=9[ZG;9E3TV:QVZKA7+%Q7R"]FH=W78
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M8<PR-(@I!0H_'33TJQT&GE0CK_'.<UT%BF5"CU0LJ@MU/9J',Z2UT*6!B.*
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MZB4Y)OR?L_J/](RB^:.P=H'B_I\QSUZ4<_!SK#%C_6S^W\_9N,<_BK$.-"9
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MU4^7/YJQQE)YC?U'6575Y:5ZK,%BO1Z.-OLUMQVCO+UDK4%K.Q!Q\DLN_Z5
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M88_Z6K](Q-XK#FOTOQNUG\D2G^LA@=J,N.J2GNK&M%^UO*VEC2UE )! 021
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MI;[:'[C.L:,1 C_&ME.7&LY;QD DDKF^Z -.W+)FY[O@Y]F41Z;PD\G@Z5H
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MK:#-(V ]B%'K@>RWAX!-%B,7/A$(4IC#P8E-U9J"H#=!)NBK^!-D@3=5M2;
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M9ES./LSNKDQKDS%[XV,2Z#L8Y1G1>2=D2C#7EV1VX/"@_,M0%A_B0/"YBW9
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M/KW,:Y!'N6+G_B*[VZ4X\9<,4FASQ,JW R."_K]>'>?MB5BO"2(CP0_@;,*
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ML#4BVUISC38]/AB)#+\SX9ZE[0 +AV)UU%=$35_4UL_MRT3)('V.D>5HY'5
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MD! VJ$*R%P?W;L$BQLFM (57@)QQ$<:4"+RIZ P0D-4YU7$GP89O;L ^AS?
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M9)^TV.?K_48C?F5,A4ZNGLG?YDIW_=)'T:QQ-YEF;V[LR;1AHZOU*M%K)R]
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M;KQUH\6@#79D+>8RXAG#%13^0<>ENS1]^@!XI$ 9SW:.9SO_1 D4D>#VB0=
M(:-1D:[4%EF4ZA!XMH93N=Y"X3$RGO<<SWN.D1^=F/:)<6_4<FZEY8UH5"5'
M:4P:,GR:9B#NXQG0/V@&=(S[JXYDOP?Y+Z;R=#B]T/ K/,,)4L<H^A8IB=T5
M% '4KS_4&8>RW";ZXP'1/QW^YPICGUCUKX<=UIGPOJ8A([4PQK1::54(<!\/
MC8YNN#H6*S]5K+QC!L18FA2JA0R>9G'-&B>]F5[*3BXY1[K+,.K2HQR?RPXH
M8X"TD,G:;D&9$@^2_DF#I&/D7_0.XTOV?QTCR37?Y&E-S?9F5:8]L1PC" '
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MG*&'=,QY)[->;ICSSL!XYS6'8\:[#<8[33MS//I5;2<IXT%/:OA>^,A.=EV
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M@7J;>#8D!.1<0=4=.($=+/+"^7Q. (*HV ",\T3!NWN1"QCD,5? =P.<[/H
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M\X*E44QM(=61@=1?,,=&4#:]"3\>YGN.5BBEUPH[H#2JO6V ^FSWBC;ETZJ
M< VGM#%3:H>K%I6P]>/3E64LM>%S$K] LVEOC$]G&V3)P6\_."=L[*F$6N%5
M+9L9#ZN3?,,H\'#EP3FEFQMKA?5S'KH8.V2CX! J5H0K#\]IR*/C6L%:VRS
MN*ZK7A$WIRNX]&!/#=%;+&;I59_SLI*G$^!(*\G5L0&<?JTAC@9)14*S[5%]
M-I53BY6]VAO >:[D@L?4JOT,@^<>&KNV=,$07-/V'[(+-&*PS#%& ?"+WF^1
M=JDNR,*V1$,U/.#.N:^LV\[PC"L*OU!1F-JO*#S(3?NFK"B87I9-E.9SSY ?
MRNH>"N6>A;V"/*"S5O*%.4 /7P8SJWSP(_BLY >/\AP9>#ZNJN^ELIEC5P!/
M2X!=:3#5R;)L$[Q9^"Q1L&T_R#4-\E."U",#K!J;IK;->Q)L>9L&"/.'9'C)
M>M8,H>,@SFW?H&2$;A!X/#,V/?<]X";;>-%:^M6QUA +6'Y:F"_UVCD*@&\M
MY6;[ A&:WDJ2]VB<'G"EJ1WW5)R5<YVDH^*DG&LE78RZJR4=?4_$I+M.TL6H
MNUK24??I.._[.DD7H^YJ21=;F%=+NAAU5TNZV,*\6M+%J+M:TL46YG>3[H-)
MDV]&G:-S3E&:HOV6B+K6R="BJ<,C^G^_DK\^FW5*/:831;(8ZJLE<\SQ)LGA
M#R<</GYV%CLI,+^,PYCSOLQY7QM>'FN":,(T2J6N;X4R(@^A8&C&M0CH$QS&
M&7GA+0?[3.+B@\P0"Y"(L]%;'F/,1C$;Q9HIYH58,\4B)=9,[V"CW8MDP3/&
MM@J^N"CK2QGN'+Z$8#C(44)\C<EB9_,F$!FMF- /-05VE0O78@V<61U^$QN=
MW8HX>[A0%+VYI\,JG9B3OE<@G=F0.#<GU;=E4S$;Q7HMUFM7SD:Q7HLY*=9K
MK^BUS[FR-WSO?*8FP;$S^VZE?\/,%5;G7S=+7;L@#TV"VV8R<" ;(9S@';/:
M=]L,-\QJ86N1F,EBI1DKS9MFLEAIQJP6*\WS*<U/NN$1;W?-O-!A[63@NO !
MG*P("OUV<^&MQN'7-L?@S".]\?V9Q]O(/A/8)7L!VIQLV3(<8PR;V@7ZQ E_
M-J32W!)4&S8&!/\(LM^>/>7I$.,C*TXS>MEHAD-*V]L9I>!M<H\32@%,<\$S
MME_6:I!+8<X)3;;?E9&<L<"[J>'JP_W,'SL!OOFJ1QJ:<\-N<H2Y X=5L7S&
M*VR4A<0P?/)=4Q6N2[Y\6,">.(LPE@J1E@HO/=20]I_['8*B0CGE0L[IC-&*
M2K7H7(4O.LZK@P\VLFU*@C,]C8Q U0R[R%?DK-8IZ1Z+$,W)NJP &4&&&A3#
M_XF%Q*DL\UA(?%Y(G!^*[7G2\>N%,J-54'RS=IJRZBN7UME->Z&LJ:4QX3H<
M/>5SE>Y&#O!(Q3K[Q%4@,1P_.@+H)UKR54LQAHUAML12QEA;+^<Y;EA1+BP5
M3&JJUXM4IL1Z:,O?)),,D]2@5$C'4B&VY'^25(BN)=]8]>:M#C+3N4)O5-/]
M=1)=,!>TY(>4.9TUA6&-]9-+:8G96J9 0AD!9Y[$IGQLRD=&2IP?BPBJ.I..
M2F11=8D6;7I*=9S<I4UYO"Y8*8J9MU&O6,58K9TMK8H!(,\PU?0"E7(?QMS;
M(TP3ZN&8FVN^0;S.&XWKGGMZ6Y'*E[T>NN/XXJ2I65P!;_?'5<'5\K5+.R*9
MC=+,,(IOL1T#.$*%5;+IHPQ/7>)*(5*R[=1>1XS!Z&#P0SY&+RM,9N,*-M3F
MU6'76@SH!MYZ%98G#N /!NN\BG(".F^4_=S"RBT960&(O$0 _S8A>2R/)H;D
M<TCJ+2LUR(YK+92RT/R":=/3XN;2^HC*+C5ML:K,64K-,+S9D[/% >3^"X3+
M;Y7Y8YLP8C&OEVU"=]E.D9H^0UB/P^1)<;VBJ\*E,5AA.FMZ@\JLUFDC74)H
M^CI'M@ &+Q"<ODT,QC9AY##X(9O0J%)5M2.Y779.695AWUN7!W;K<C8A4_>D
MTJ#:;+)"C1KUNIO&4I[#\=,7"07?)B9CH_ ]F*S,9_)23!HLBQ<7%;&2GU#*
M^-5+D#,H)&)8' S]LNFR<D<JJA36H/MCJ)#>'WC]3S! ^)8F(O_GR;3J[Q@E
M'H!S;S1[R4@(H@@ )1BBG%BI[C118CH)@@)<^O0XX,^_51=PN0@_]R"Y89]S
M9ALV5O_<!2._CXPDM^6E*J_@$'(WH<N" X=\&QX<4!Z,#%<?GS?V@T\Y#AP(
M#I\V 7_93@'7P:\!\SNNDW#-A"/K>N+?0 _ (23!L.FPV.KO8("X:()GVN%#
MU&"]NS]J/'P@>/F'&>7A+'+X^T"/P+<&.'-4(&S >X//C^5$%=YW;-NY)U3C
M^?M-5? BMCCUX=\.#C;?[B0PXHV3S<.G]8*GU< Y>;8,3P6>;4("OP.OX1GF
M&'#",MBQ:E@>. W/ :^X?9^''80;RL)S,/S$5'#@!'79G@-^D8[2:26$X]Q#
M:D!B'6]CGX#.9W#(4.#< >(ZEAP,E]?]^X#3OY^SX=8U.> E;V[!XWCAE!)S
M4Y+U8P0#$D$U !O)X;AZ09S"XW\XP^ QA]P'/Z-[$N"M1RK!HWI"-OAF6]*!
M,YZ8NFZNG-\?'9M^8EGX<&^*/UZ'N*85B,C@K1!=\$W/_3U1U[*T/Z0G?,V=
M+'UZ8[9=E@[_]LP ^!)[/+,> N8 [_N*;90^, G^[U\TE:+_>?Y>S^R&%SMW
M?O25]Q!O0 6L/^E7N?W5KS^, 3:F6M#2A> *;EL#)I(>[UM#.?BH7P[T9LQ(
M,2/M,U*H-X$\5X#9Y@3LY "K+?P)4$F37:@8Y;4E&Y+J LT3<U?,7:]Q5],V
MQT)H]T*^ @I2!68>X"$1D YN.6 M6U:@TV[:_A/Q!=Y,=ES3 "]V1/>*X- $
M%2I@R7-<\-&Q;(A3R*4Q4\9,^1I3=L'A0Y\#R# Q-/ LX'P 00=Y"_(CL,^
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MG<9DAUHG:!8/*PWX@BT :M54<2K(>OD^;Z[S4"*'90:&U 5[DUU&=VK!+3A
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M!X]!V$^X?XG1G]+DV%$#W&R-Z4!FO%YHO"T@#N&V_[&]HFMYVB,S5M'-LY3
M9,Q>JE)!VJUCI>G%-+UICS9UBYUSDZ6IRP,-0Y1CI>FI7&>NHU-69SM>I[<9
M&'5A[2K'2M-%#G/K'2&]8+T>+5OJIMAD)JUCI>E:OVW.4 )IL@N5G%G>F,KH
M9NM8:?JF27B\MUA4T&S=KU6;$Y-,%U?'2M/%KB@55PVSS'4F(]- *Q,UVSU:
MFLX9WH) _ &I468_/\BZ_)IO,7NEZ0\K/4MT2U3=G'+JB"7&64N;5T8,G[I\
M$7L#V#'V5CVW@2Q6EY YCU2I-Y;)W#C=*71101P/AKD)F^TU5G'=^0?KSH&$
MW"L\#TY_.^X*VB$/YQ^-<O.7F.-X/7FFMU[F3!;AT J'F&J.K764U3DX)"K!
MG;B>/*ZQBUYY9%S9>K6DB^O)KY9T,>JNEG1Q/?EWDRYZ2:JW6!-VJW5.<3UY
M7$]^NZ"*^*G%]>1O@S.N)X_KR2,#V"LM*XGKR;_=SKK2,HRXGOPTF< OW57$
MJ=!Q77FD*@:"ZZV:ZHBRK@N&#,R'%^ZQCJ0P<ZB0U5#3R:("TR.):9)/=Z;;
MD4X8?IA7&#-_7%X>J3S_KS"_-25J9-4LK#1!F*WK0V)3K-/*=CX3BMUVE7EG
MI3I.HL=TK\$"_';E]:/!>K[:MIZ@>S(#G#BI*ZQ?!^N 4EAE+5M-MJ)@&\7R
MV EA,F&U.$X>)LO&;/VE2Z ?P-;GJS7[ %O7AP-F79Q/-#8[%>S.FN@Q%7);
M^DW@ASG&M^YU]55W.@6.)GB+A"NL8WLSGK=[52HNL$?WF/A- :"1]2;1'5*2
MAO>TJ3KC'=TJ;VNQL3.JM1\$B'B@[F64XT:V34EPII_&P@#+]MR2T2?9?DGB
M:'<Z8":K55A0'13OXO_<ME/VCL8GYLLIU-<1S?]^W7C=#1BN11,^6L7OC\A@
MS3R>G.J#)IK-),NMFJ+04V?%IZ R)&@\=O+BF;A14'0GXW>C/=D4-I;71Q?K
M"6-W2M9XR,.Z**#P2/RU%GAQ_Y +]@^9P\8>X-5A#2.@K2-O)]0G5"<!".N
M7X*S>7)"B".+B+I&PLW^+@;_QS=YM,1S@MS4_%FZ,2AJQ$CFE*.G>YZJK(>:
M3"(4,G/PM^EC/6;P?[!8_+'6/VCH >2'$W0 $&$!N6Q;@@U.PU8=#98UZ^8J
M:!41+!!LVX?.^[;6_.'$]BP5>&R[Q\H2[(DB6)9MK@&:7!DN5^W$1 #_6<(X
MRO':Z+"TD,?'4@J;"")/4&.,)U,DQJ>3(C 8*9*2!%$BI(GXO!A1SS(,PX[P
MF=:1B,QX[G0W;!G.'::>KYS5ZU5M,,/'G)H:4WEF1D\XXFAQIZ=O>C@S$Y-L
MAY&9$>=*R@9=@94'A9C#1:6]Z)*;&5K1.EQ6(J:+X@@^\^#;L\V:.TUJ:0E5
MR1K>9+UAN=F$*]//5_Y_]KZT1U5LW_O]D]SO8/;-378G6@=!4;M/=H**\ZRH
MY1N#@(H@((/3IW_6 (I*69-6:;7).;VK+ 36^L_3;]%QH@XV-NVP$KT<]W)<
MQI R\.G1DTE,5DC3SXZ^:1).Q)B5Y4(EEFX$SI8"/41/LIQ=Y'K#56R0I.6(
MG \\]KC>S'3,^MA9$/GTL#>.5:R\5&? E2=+XGOY8F<I2#%V/I=*T4*<[J[0
M\<PG2QHV-IW)0&H)1(1MQMCG'K6$Z5XJ8$E-5JJ6(\-TF:#CO5:S/XF4MWS@
MJ<OJRNAFQX,.J6R2%4;5U 61V0:.ME*#2&R]7+<YCJY6IDYL4F-KS2;.-A]>
M67G>J-MT91Y3ZN5FK4.1^:',P2M/%N_0=#LCV%J%R"?C_7FN[_0[=#-H7';%
M+T3+CAH,*^M2L9>=+EK3U 3'04<;.HPGLWUG$>?J)KT>3>P(G1W"B.ETF[9-
MCN[.\P.;X/N*U"BMS%93;OIF<'=76DPS-BAG5C&E;<RZL6J;5-A.$UNEH\5O
M12!P<U9BYPDB-9WI@TR=A/8K@$K5LDBSU26OT+%DE^:)7+=',,/DZ>,KHMCI
M-:O-*=N+,DQFEF37:P=>>?+X2?.YLMJDJTMNPXG&\ZC3 <XKO/+T\0(QTM0!
M9>H*/6_EZ5;![(@99I@Z?7RY5$GTBNE-BR/KJ;1@;P;TL-T$5Y[PZ((GXU6Y
MM4@1=:*0M];45,FM5^#AIS<E&C4F;=:7-2*C5R-KNYF@GW6@<Z*GER[2I;*4
MB"Q)11*W?.<Y36=JZR:\](3W=%$GNMD5PQ/YR$2VU+'5H_OHTA/FZVY'ZI9?
M5Q-</K->%^,9CDR83>@&G;Q >Z-L.-5>K=A,FR1J5*-0KZW0I2<$R/ 4K4L]
ME>#*W>AJ6E6(;64X@9>>4F!D]AO%89.I*:26$_K:NCC.F,PP2EU]"'SOF?F'
M@-M3WI0RO"&#J+H%+)2Y1 =,(^>-73C W!>AJ9,LFUT;*J_QMFYN=L._]*9J
M4B7;MKB>U8YURERO*Q&3TT/,@Z^[F4/,C[V=>YHLC_HGRQ$U@?>!R'DKT&AG
ML;> P[1'5I(M"T+%6/Y5N"X4]I"^%DLMHT('USH4$H37L[^F;H)(D3<WZ!(/
M)8OK4O(Z-HU$6'I5D)EZGB_5[(-8BGA7*%5$^^*^P"Z (GSX/+E%8V-5\ZFJ
MLME.*SF5GVV!FP+8(YQ(T6$Z #T9;?W7(E=]>#^=CC1?3(EU7,EHP!/,;Z83
M<K.ZYGZ22WMJ-*<IGN#9;)=2*L^LQC-X/V-A(DJ=[&<8HB4:$@0YE-1-&&TO
M\O#GAFX![D6@2+8%MQ,&!N!S$'5@5D<"\D8RX"\,Y>D\2^>FE8;2CA/-0J^^
MT/7:Y/XX&Y@Y<%OW/2Q,ET""V(:]-.D$9W&;H1F=CK2U6I0GO_XDJ3!-$F&*
M#D#_@R2X^K;>)(._>5NSLTF5:\AF3NG1TVAS;A2X9F*%MC662+V9T6U3XH$_
ML?E:?GX]1?N^77-W2V.!\V)O"I(JIC?XY[J9WA1MJ^V,0+@N\Z8,B&PR'MJ<
M%;BUS8XP'Z>DZ)K+/Q/)9DG8JE42J! Z3$:!"B%/.^N^BF%?3_5]Y[XMU/@T
M1_<V R627XV(-26V1SK>-^ GT-'3;I!#CGRZ*HI.L!<=*/A!#K.HL>L*%Z5M
M+C-:2UR2BU53M>:57.#W>&UNC@^#VXPDF,RRG#GX.[B;Y8>]W,$'>_Z9!=Y9
M@)"_?U_(X;R5+.S/!?J)$T^)!_C!?>)61)_HLT/K#]+=+NF(I_B#=/=)NH?4
MW2WIB >JW=W2[B%V]TJZ^%,R\2#=79+N(75W2[K$4^IAZ^Z3= ^INUO2T0\$
MU_O"DGPU 78[^W1+>%"OJ:C'KGTD[7.E73O77OZ>;7SPV@UOTFNYC:OC:+W.
M6H?H8@^^^"#29OS#2)O4$_VS4?S.8T8^7(,?H:[O"O[PZB;_VB*50>UIE]J-
M;^&-"^[&];GEFZWX9S>HX_9_/1CF2QCFM=SZS>\/:I-Z,,N7,,MK*>&;WY\'
MLWP=L[R6R;SY_0FV1(\8X$?$ #]SUU"L\(/#<]RJ?B\*_-5DZENVXRZX[H>?
M)/)@NQMD.QRY_&"NV\W>/MCNAM@.QT _F.T,4YK+SOS!=C?%=O1//S\IR,9^
M+-:Z=2#6CQSU1A(D<5&)O/5-NER1%\=$-[#<LR!]3_'C';C^^"YQB7ES.QE+
M\6,[3BF;?-:,EO7>9%XXF)PNUG*?F#BO[Y$.CF=\(0P05R_&4OU(7RDOMW'*
M)*3A/,O@XW82=#A%T>$$=0[V[R%&[POR;F"][VH9"?V^.3'R\HH'8K3FYUDE
M%U/B7%[M1CJ9[,0A*Y\2HXN-T@,Q,V//S_%X1LD3X*T=49#Z"X-@\,$^\3#P
M/.#_3Z3LKX>8?3"HO8'E7LE:?1#[YT#&( Z.!MQ-(&885^Q(P XP>5SYTJUX
MP4A6F2)!=F>]AI(B>NG$ZA.8M/C) 1"TB1&I:<.%.E7FD])L\[QJUVI=B)Y(
M0\R?^,,:72X(OX'EWK&8( /1P-&^*R6*[6R5%1UC6#Z^%"?Q6#'2S32O(27K
M=M;HSB.VPCG],;795&*E)@LM2O+7'RI&AY.I4WORD),/9@UN8+G7<=J^0DP"
MW;6EDY&&RTIYPF:D9?FYELZ(L<I%S G8(?#E (E1J6F"UW)<BUTD<RF:RAG4
MM LE!B*#1L^[7[=7M'ZW3#1,';"N:(7&ICX/66!S$!3V$5J8K(4,9Z3* OCC
M&#Q4FUCAD"8AV&S _Y*Y,F4;@N:-)7 UQAOC-<OE,D&W;.LNDI[?G4^Y*?T1
M9&=WI]L\B/FM[:*WF@H[AFZ+'D"WO1>),=!&U.W(NDF6&PV";BT3<SE1,]C4
MZOTA/3KU*2L)\!E24?/28X?/S &MV 9*$43R,/SA-4$*B..;I8YHE"M-AN#7
M\]:LQ39SG=@*'XX8#4<3(#Z)G<(T/H3H>UMH'QKQJR/+FR?FA?WC=VC##T25
MFX(4'ZT&G,@ZFN$0T=I@JUH?/)D<ZCBLXJ1C%5B3[/J8\SEY.0D!T'?V'EX&
M.G@!OK48SU7MAC#H<;U\*Q9/LRNQLH)G3H!H-$J&B=2Y<V,?<O0=W;\_78X"
M70J]N53J9"_3)>99JVUWYXEQ1?K@F:K7D:0J$U5H8V'VN'J_,7JV9I9!D/!$
M&!BEDJ?(VC^]V,_ <ZU 3&H*4QX><S4Q)6D.R+Z+2J\7?][ZUCQ*_#<?UP16
M_/,SKD$:O;5.U)_[9#K2CL7*#>:#<4U1.XYK\+,Z4T#*R=2+91@KXYYOAE97
MU)!<,0+0G!BE)JAJV;35S;-I1A-LYIF1!9G)S&5SA4^"3H2C!!U.QAY9YG]-
M;\!7!$6WL >/0O6=NGQ!=6LU+L:;]KR:)#:E<KG.$KI4^$"AX4#7'NG6W=D>
M9Y3JWL%SFG)M:!&TR2Z&H^>,LE+T-@65*BQOQZYRHO"_3+0>Q>V[RTI<1+)2
M<IPN\7)BPI*.FA&3V6W/:C! LI*__L1C8>KL\<4/X?I)%?$WN2H_H*@+G'KP
MRA;4%2 4UG3;%R%;7Q BW\. ,=K5;QTHOGG1>(31IV'TX3.Q:XE2>GN9JX_Q
MS[8\4J6L-+(#8NB^EM[H)N4H7%E/B_Q\M-:Z_<DP 6-H*DR0=)BFSF7U;EA
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MU/F$V N2\9$,&5XQB!#!*PK785ZP,L2\L@9> WR0-$Z8-TKN6+<SE0#GS>>
M9]T.%3Q!<CB#,N674DC3YR!\5D-+7G7 9_HX!-CY%>.0E9>R*"&^=X,41B03
M_=:XJ2O.)%+H3ROI]<!Z+4A1FT:BGQE5FP1M$+D%TTI-"]L#+XA\%_<V>+,+
M5]&03"0FQV%#C3?-H5(:RPM5(;>$S&OCX::Y7!//S5]_@.B?'E =,B03[]93
MB%'5@XT;29(6@L_=A Q>%I]"8-,MZ723(?3L:!.R 4F@E//:)@3^  \TA;L#
MXAW)E,20OD\H[$B&J'&2=0O!O0OI)OPW^H08\#(,AW^%-_H;NJJR\,])$O",
MM!VS(./84]T$-Q=# O9]+_BJGY4-EQ HA9OXQPJE=:#'T6[+IB38NFF%9$"
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M[)A5;FX+% @N,O7&< 5'=:.)5#A*I5X38L.4EK+N6.KF)>Z"V2SH5-E>!C_
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M,W$FDV*NP$"W<NH!.L9A5Q;'1WT(NJKRAB7][?W@?W%817:?#$ND BZM>B^
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M@>^LE2!(T%['2!?3?';*UF.%NB&.U5C!7-T&)"C8?80%^@E$3Q_RO/]0"?L
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MRW,$)7,N:[SM L'LW0'@UZJR9&(7)1H (?."B\)[''C@H9@2B.\$Z4LXE I
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MX99X,><R"#:SC%9*25'-C!?0_**9IW0ZIOE],(K+AZ+Y_0VN(KE8AT:Y.'-
M[(CDYUF&:3AE<:%!ZKWT\WGJZ+&(?O]$7/RPLDK1N21%J]MRH3;5U*3+0,I(
M\OD\[GTXJM\_D5BMC\AHV75*;&TEI(1I3F)D6H'^-(IC\XCL]QU[^7?1_<)#
M31Y"W%.=J0_^A:7NFO>A^P"_2Z()OH W''V3\,E$@#-SS(0 0@L>?(YS2.R
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MR@FX&P=&8^_W5OPQG>%KAGZJDRA1AR/"B!2?)=,XP4DHRG,I7L*YK"BFN(S
M9Z6T@)*B@+\<5*56E,&24 6)+>E#I;)8-Y#<0HD:$=8JI4;59GVDLZI*]A2C
MNL2-*14U(FQA<2VD*>*F-FC0:JT]G\"]5=2(,)(CL\VDV"&0FFSB.6_&CNUQ
MY(@P5"H4VHT-F=/<;MZ958MH,YF,'!&VMK$&E1)*BC;G-T)CNY[I0IZ)&A$F
M4S.N)^A$&2F-%+;5S(HDHE)1(\)RXR+*;<4.QVY2WJ23;PP'TR05-2+,:LF4
M,"1["RU9<4Q$L8I%MQ(Y(@P?+6<4,>%G&D^+E%V:34=.E3D:$;:_<MZJ6CFF
MAGE:LE_3[7PMW6\C#)=Y<27'8QE>2,LHAZ31#)<B,QC'\UF<D[,9?I)*97 )
M.9,K37"=FH$R/02SUDBI.)?==BYR1!QFCI.IUCQ?T+K95DX>>,VJ0D6.B)LD
M*:>*#NP6K4Z'4GZPWI#K=J3^RUN])4RD0@?IML9(:\MM,V,A4O^NC>*R@;<F
M[#POEN;F%)@7&:E_TQY-6V.OJ"%SC!)4<\ODJ4VD_B4NV^_RGC>EEYI97)#X
M4K7RD?JW5ZHT2J/61EM.RIDT[Q06@[P2I?]!<5#S4E;-TN8%SA@TRP8[+U-1
M^A\"JRQK9;6-U-J;XFIMS,E&+5+_9J,UV:Z1_)0=Y.U171GI?:OHG>D?7"F.
M<@-^DF^6-,EHB\U>9[@T.@J7/;^R@]8E6RO(,[;549.%V52II884AR(OC8K@
MB30P'YG#20(8%8Z@W(00LUR&%"8\ELH(Z31_IJQM>>G*KL,C<\8T64H3:L0X
MTJ@*V4'+;E4$6NN*$L/6AK7-9A;I5'KY"CT;]-(-NCLG*RPBC3RP3XDTJMP"
M&2'ZTD66#;RQKBN46:I144:5=%=I5A\.FXAK*>:HF_4FC*Q$&15M(06W7Y,5
MMFM-:GRIWS7R'A5E5(W2B*7FY4V:Y2TS/4":77JR5J*,JE^S:&SD9!E6+:XU
M*NL(V9S%1!F52EJ+H=;U)+JTJ";)64^3C6VD4RF-,QHJY99-I#35TD-/5-*C
MO!)E5-M.9D9T*!L850D=;)?31J8J1!K54.**Z9*!EA"ITZ:K'4Q9CH$V(XQ*
MX]A"V>(\7I,FGMS75J/FI,.<&Q6XE,F4)#'-%$9TLC3-=]:=U";'@$O1XPF)
MQX,PWSZUW)U&?N#L$EK#M4YC_9DPQP>Q!<GA55T2*T80C(-/IB:FZ^SS]1T)
M?+O@CPD%?_,CAAZXEQP\L-R?V#:SY#"E#TM-=C-L#\6<P4FE$G,;L^;.$[F'
M(X*WTK@""*<FDG^^")\_&+<*Q&:#5^$@X#"7?CJMYNK1X1N5#&\4^?P!T]AC
MS]V)">WOD] ^GD5PMZJ+)X#<K>IBU-VMZF+4W:WJ8M3=K>H ZHA8=7<V=^<[
M&*7OBS_ZQ]-N7V3<1^JZ-#_W/W<G!F(,Q*\"X@.3X5]K[@[^T%*[U[D[%Y#+
M]3G!']=L[FE^3FPJWVTJ=S,'Y^9-A7AT4_G\/)L[8*VJ'QVK'IW.QJQ=CSE[
MX^SYWUW3?+/,.Y0@ 'D[0*YMRY15R+D%'AU\3 2Q0HJ1J]*\5BT@22=C$#6K
M*I3:X5@:$GDB4\A9J?(_,11B*-P)\<Y'H-!,*T)SA0]7;!=/B[E&DZ4DP0NF
MS)"0RO&<##6&PI_&23?PN+<%A:OS[GP$"K.6;6Z2DQ1&+Y&AT-:ZS90^\8*A
M,03ZE,7.*0+^N>4TZX?-O0<BOG!43 +<MN#JO-]EYOB=9"(("FWP/&%3]%&K
M6=C&=M2XY@O=4J5XXLS]C=QXP-CPP'H15-523E0WVZN.@9"'%;OF)BFV-2^,
M1H/B2J[Z<S9 N)A](M#SQK;++9&QV3^LV5\]#ORDV4M21IFDK S#MIQ1UZG8
M[2XVI8+Q,MFG+'[-3=+#FOV;52D_PNRO'O-]TNRI)EI 1U..HC=)HM%GV3Z7
M'X5C93)/J=05HL!;V!B\91-_AP1TANDD;'<R U&>SR_ K__Y=]C 8?M_%"71
M!3*!0:%/!@0"RH5K+4P[Y*V+-XT/ES_!G]-?S=9ZI7C1;\V"SD.6@8'O*#*;
MIM,-3+YG0CXP0PR=BPW^4MC;>]&TP%_;H;%'N)55SQ(;F .T*2T7G8J&\ZS2
M\X*A,ZGT%2F^;\& 8KP\7IQY6;B\NAPW^M2L8BQMBE5K.F*+U4S?*RG!J!F<
M/,=-G)U\T.SD-RPT5PI5K[O0+&6Z63!QB=%*RRW"=[M.OC8()\ND".RR<V5N
M;:L6B!0RJKB&:X=4D;!G..0BA;^:L@PY/?V ]8B\F+<C6#KC!.:M%PO=A2/Y
MD@QGZ$W CW7?X*,&9L_G=9UIBA1;FG5+5&>)S\NZ%TR:R3ZAY%M#4V/SC\W_
MMB+0#YO_HB#,AYWU@J4)?< 47,P@1Q4F&"Z#(D\X\M;4M=C^;[$ \"[L_TM2
MGN^P_\IF;8S2\T5%XYUZMREQ6;O/*\% &?(I2_YVH,S#93;?+/X,1 K/LX]*
M(GV>U;_#8_)]^C-QT7KB6Y?:5T\)OOEY50\847YH7L31;&TT9<E=OK!DB1D^
MW;22B\6VKG 9&&&B\6#M&#(/'(7^(61JV?1RD-+*+=;5U)1*-)$>FH4DGC##
M&2/F>NG-&#%7CUNWDF6*O#V]&%CH^GA;0C<SB1U,-*I8K&84P5]?B*!=&<7^
M\]ZIB(]#%?C]\QVCQL-U/16.*-O%S'XZ-AP1Y _9V3,[!LR6-IS; _\FF-;"
M]-^R?Z\I?^/X@I)D*L";3*'+H2R)MWW^_:#$=0.PQ;5(0RX.)EP%F8^7TVY2
MJ@JS\?4GQ2P;K=2RN^PTV/Q06TH==)IGUJ]3[7_YU(*M7.R0JN/(FIH=C2:#
M7GHZ$K] +.)ZWLLAZ 11!TJKF6(DEA@P>TK7;QC:\%L#XMH9T\WCA1I;FXZ:
MZZY=SROR]26EKK>6G"&22[K;')#%@NEX$^.UN241%J4:;\YN2"SXC5\?/MD<
M81HX#]51@P%<$.UYWG" -@#"^[PK/D&OX8!50X<?"N=W\6O_,Q9^^;X-M :6
M[.!4A_>"S^"=TR%>WS!-M2?-X>-9FX(JRY(E&8+$^N=/^VP,98C[5_*6)()G
MB9J\*B0KJ\5X5-/9VB@[6IG$VJ5FWNWP^$XDW?02 36MZ#,7!S[;,1U>!\HY
M.D\[J@5S=N))B'OYV$^O'-$=O2H$@HJ9?1<QLV_,NQ:S'<:JBSE&'TQU,>KN
M5G4QZNY6=3'J[E9U,;/O=ZON]LI$+TDH>E8'$#.,WCG#Z!W3CU%V< IFRC^)
MTS>&X*-!\($9 F.2WYCD]X;H.!^>N34F^8U-)2;Y_6)3B4E^OSN^?N,$\@^>
MF+W.0>V]X.W;RW=OJK#P35\2JS-6YX]2Y\T3=$6K\P%6K,+%UB&_S!0H69@F
M##.RJW_*KV QDV2<, !84H)W'$N=N$&)#N2XFDKA@'$HG!@^L3>,U1FK\U[5
M^:,6M]MM<"+\[^P=EK&XJ>LQR=Z^H&>+LKF6'-VX\D=5Z7YOPN$S7KRAX9]U
M<+19*E-\F1L@R=5B(%@%INJN/M-M?(C](F[:+IK6 $9S3;,0QG*0( M&<A6[
M$\1OX"8CNL40-S_(H-E4B4YVIF.!9)BI/&0"TD6,2#TAF;<H#V(LQEC\#!;1
M+\&B1*X5==NH8^S26<YI+;F>C%HWB$7*:)#301*A-<FAN*W:&T^5*1,0.:)9
M\@E-O\5-%V,QYG+\#!:1+\&BD9LR4FN,9K7DUMEBV5;/TW.?H12X$A:E'FT,
M<,U-(MV^7;"U=:>562L!1R2*H4_9U%M,6'>=:R+>E6M*^.6?,&=DQDF?.$L0
MJS-6Y]VJ,T[ZW(1B_8;JO_[;@=<E33D)XH?=:00\Q= E'KR@J[Q?GZG"XPY#
M<N( .-Z,WE)B"%*7<[X)MV36EOQ8$UY<A]9;/QAO4W+"D)@BEZ3M:HLY/9@K
M(UIBB;68?3,D?ITSZ$K1\+* DXZ02JZU&DM/^N-I;UNO,0%GW>\YA6)@QL#\
M_BS1QX&Y;&ZZA?JZ.F?Y?(JC]'6+T I_2.9U)6"2HF)+6*:3U]01*4D-CYWH
MXY 9+P9FG#*ZAY31QX'9R&6G#<::H72R853R]5PSF>R]F=#]^A63;K:+B""[
M=++<$H=]QN4F1>]#+'SWFC_:A?&2HUK27#*<_<ADR.84CPNY\;:#>W \EPS5
M]V::"ZRT#8QT?W"$ZNJRM- 0J9#UNKU>9\/U;C!9K4Z8K%>?* 7:-1&BJ\IP
M;![#96%XCC]AUV25CD'X8T%XR;#\#1!Z'B/-T5%SS9:0^J#:;;-U!/G,*(@K
M@5#;R&H:[53+6FU,R@MDIC8D!8(P!4='(-EX<LJ]=57= P@O&8*_ <(A-Z(T
MI3VNL=A8\62G724R4^;V0-A&!X-YN3!/LYC7J[(I;@NB;@J T)_?DB+>&M_U
M:.GT\#O?ZG+K^:2D\626BV;K8M+\WP7O.K,@A_E)@T&(!5)<4IWLM+R]P8(L
MHIW/4KUN$T.2>CLKX-UFO3AA.!0)JB/))QR)*[)B)'UC!%Z;SZ25D#9H&BLO
M:T*M*!/*Y 9WJ)S=1-5YMC>AI?5,R.6H^FQC4!!)*=A=GGK"TDB,I'B0R_>%
MT4IW4K0X*;O02H,>VL3MVK*LW""21-0B3$T?"NQ<1=UR<9W-\VD?27YE8O8I
MA?YV@O7CSW>YUG #?S#Y\5R#@D_Q+XD5(S -\,G4Q'2=_?">8.-%KQ>JM>GY
M R? G>1T4]#V(PURHKSP2OC&9:5.D<'+ !7)]0V---AW]T:--3BT: F\96T@
M0CP 1!O.J_"G5YASH*5-,%L<?*]U- (C(?EB28B\(\4S#%Z981 /*/AI]+$Q
M:?//4UU,E7ZWJHM1=[>JBU%WMZJ+47>WJHL'%'RWZFZOOBQF1X_9T>,!!3$$
M8PC>* 0?F-TX'E#P)U*[UP$%MX[8.ZU8C0<;Q"9V_R9V-P,1'M;$XD$*W[T/
M^'#YRMLEIH<#8GL!S"<QV1P?^_ZZ&\!]6"Q7GTUS4S4[;SY^K.!8P;&"8]:A
M6RS!W-'=1>8 P'J=NM<RU(L=/2#?ON>X >.YK7K5XP;H!N^X%E##H9-K9\PX
M"NTW;.%"::?>'XZ9&E*;.M7&<+9RT>EGFBY>]):]7M'Z9CVKB^2%#M&T48UG
M5DH6U6U.+S!<&K98H.DG#$<?IBX\!N3C A+]."!'#D6Q[8+583?C9<X6&^1D
M7/]^0'*6IB6Q]F!%\W@UFV<[7'79\P @4P\'R#\,"&-&H2]I9WXGC)AYT_!8
MT_78>35IX]AD8E28S[0F7P9&4D]ONZA<J"!JFYS6\^;"D04((^(=,+KKI-#O
M NKT(V\6'W/O?],!;CIT!+I;V>:[Z*BF846"IO/SUGR2_/[U=(G.5G9VU%LC
M);SCD)@T-;E,.&$EE7G*9-_B)(@!$@/DTP'G#B!J<>O@TQ3%L@3>S2HS1>)X
M_C,MCI<!B-I>=NC%9**PK11:JM1,>X)X2C#V) ;(@R07;SJ4W '$2++=E,?3
M):2F#7.I%$LVT.'W \2T+6QL#006J6WK&63*]<=,D0EFD?P6(#\M74O$F]$X
MI_/E,2@1>A"^@&772'6RI3=4*=7C"O;46KRY&7V=F?8RSJ.51E(98XYP6A[1
M:HU"BJNQ=8\C8^KV&$(W%:7N(+102B(VY-);S6624[9>XO5E]0]9UR\#H;(T
MLJH;H;D"S]/S\MK2X;$^A%!,LAZG1&\ICMU!J-0?+#IUW3)IHLL8X[$^9KO8
M'_*C7P9"3F^(UOIRJ4U+)B]V#!35MPZ$T./3H?\N8"7CS6R<[;E@*$J&3B!3
M4I5NO5KS-+6G-[9)M3ZKE+[_7,15"TJCVLCEZ*X];]CC/(][O!>,$DJ33QDL
MSO;$ +EJH+D#R*@PTC9RDFVP&.=DC&2K71BW/D,L?AF C/KS3*ULUMOLO)RB
M*M,RXLD])1CI$P,D3H=>/XS< <10\$EJ2Q(-EI@5\O.FV\3KM>]?099%A5.$
M#",AZI*3$5)Q.$*D@M$ZOP7(3TN'9N*-:)S+^?(8-!-ZD$V[2?=7^:7-YK-K
MJ5'>>DRS\OU++%K&^[/ILEW5NIM5FNTN:X6EIP3S<LCT$X9<<8F]!;N*870?
MD>H.1I6-51[.IGQ%6]:7FM@WNBY:_/[*%MJK3LJDNJ5I:9AN3^=;?L;,E7#B
M30RC."UZ(_'L#D:U/+]$3*Z49Y.Z.%'7W?9";7SKR4*NF[/Q7-)5:(QM<Y-Q
MCNEQ2#BNYH>G1;/QIO:VV1CNP4E\(&3-[LK)!ZB^6A#*@)X[6,\:Y)L4:WW_
M6DL2390J9/IU#5O,NOJ"K.64U&X4#4$\97$B3@O%"/K.:'6'H"2+"3JW,<%+
MLC'"2]Y"M=Z>FGKM9=:8]RIDG76VR* ^P.ST+#NUFUXX?>;J)_@/BYYX.N,%
M@]0=>NJHER7'537')@5]PJCX:%Y/?FL%6;T^8%9NTBFPJE'%K"HQJ0V+7CAQ
MYEI1ZBUL>/Z<\\8?J^@:%A KP(>XGY(2S$C9C4B)YRY>-*\4S[CZ\KF+EW$P
M/%_@,T+*MA"7SE%N&I6H@:1P*!J,64P](9ELG$F*@?-],?#%QRQ>"#AC9]A2
MRQ,%6>;Z"Z>-]4<.0T'@P%[]+/F$IO$8./%4Q>\+?R\^5?$RP-'YHFJK0];5
MU%1G0@T:"UI?,! X_A!%]"F;>FO%^2%#%+]^X* /8A3;VV?O=,(@O^)5W1^K
M!RPF(;M@0R4E3%D&ZD[P"J\:M@,O]Z]86*:L.G9BRJ^DA&H(EL0#6X#LDY"U
M^L)V_Z=#)8]@D'X'#/SIDY7P6<#NT?^W8NS10.WD V#1\L5"!5(I^J+J!:)I
M!Y+9PX((8-$$6Q/.&MIH<YJN2;3KR(SH8+7T4E)@AO'Y'!"!@P56H4,1RI8Y
M3\#5\BEA20M+LH%^_9F10(?\'/A-QQ\)>="F,^6!VH &H6>$'\CK^N9(QSQ0
MN!&J]REANY.9) #]F@%]J"]O>(T83.,$NE6-<"2E_^Z)N9*>]F81&LO..E1_
M/.?SWNRA,E7#Y4.@^Y-2CD;&"+K$6W"=F+Y %P[M]-(S8UY'310)+9;:+7Y[
MV!23>/KEX)?_^W].9N#L%S,XD]*T?NU6K*,G#;\=\Q<O14H&(W9X&7SW+U[W
M^(T=/CF9?=Y3W?_:+WJXCV7D&4__*W'T,Q31F7SAO,LC*9Z,O S?=CKU<O?B
M;T;]A,IRS,4O#'V&1TYS\&OX8"GTF4Q?07V_<>>^GO"#LOZ7?\6Q_Y686M"Y
M_$^OE8]< N#/ )# :>@G S?"ER#W+K1U@+J\Z<\2M??>GO_OD7V\9NBG.HD2
M]0OD[ ;:>I-E?8HN5BU-PM2-(XF%QA3W.'@I=F6$O&]= ?*P51N*).&ISA0L
M%JH9GD%N@ #LIY/1M5/@90S32>S3.?!%,8PW?(_&PXC#A@XHD X0!?!3\#,6
M?+ F12]A+]:NT$GMEBX^&+%K!9&,_ZF"!6)42^43G@0NA#<UA^]W_ LGO,X;
M@I2PIQ)X$;(KO^;@>%]3')E&)SB20;EL9B)P*01+<SQ.8-R$3Q."F,6S<@;_
M*[ 6?A<Z]7 4'RZ%7(/%/$RJMDJ%3H>G.'^O?GKE:#56]'I>*;#=;&:UQ*?U
M+E6F..S\2JVX+FSG&&9H\S2]GM,SDF*K#(=SR,LKE^6>HXA=NLJZ))V6*VN#
M*(WAE6>?260W*MY.KCRD2PPSU<IX7",6%+@R]?+*='HYLWN9(D?/V:;=%5*%
M8H>$GTF\O#*KC.A2HVY3R-R<:76]/9GU*QZ7.K_/#(EO^H5:IZ4-IMZT)I4+
M Z9/<>GS*P6'S[&-5MY"-NZ$;A5T=;-<>QSQXDJ.S)"I-)[FN12)8.!_6(;C
M,_B$RZ;Y-$^D$5Q.G3U96Q)K#EHBFG1-7[$U6]2ZK,%$Z2I95PL=#*=H>KY-
M\W(NL]8:U4A=B6UI+13$3IHMR3UBNR5[_?+2B](5.F8LO40KC-;=XK-1OX [
M32U25XQ;RGI*ON @Q"2E]GL67DS;7I2NZ!F;7R!B@=#F.%N4)P.JB:2\*%TM
M/#[=S%2PEC;O3;+V:&VGRP,F2E>IWGHJ<\5,3^LZ+N.URGQ!(Y@H7148@>T5
M27NA)?4.9]OD?#:PF3-=@2NGQ?Z68S;<FI4*;K*'%O0F+C,<N;_R6@/*C^;/
MGTPIEX&W%'.2 7YPVL!-P(GDX!_>,:W-81!Y;6U59VL<V/>ZT905>UG16DP0
MZ@+G(8F4\\9UOG]'KS2V_"S+_KL5]LC;GRR=(%P$#[[YI1K^)TS@)/:3I>,H
MHLM$I?H_]02OKMGAR0%*/@>G OXZW9$<U9+F<)F:!*I+0*5=:%#Z)39GNR5R
MP<.,BKJ @]SA,LC#P5-Z..5=AG%FL"H*<&HCW!6 6!\&)G"9D^8+W=Q(_AL%
MW8517O#Z6A)<_P/ ,JD*DF4_)RK&?K< 5UCK3$#AT@W%!-?1E2J"SQ4E'BSR
M8+W531!!@@5T#G<-?+ EWK_S^4;D"H,U2YVX\"%M(%E5W <3\*G@C@EL7A:N
M R,1$"4$<<M"LN"^  3J4*XV" 6L#=C^B#/7AA?":,/?B05_AS_NY ["&1'$
M##P,9O@%$-H:[#D=">S%WKE+7@ ?PXTT4\.'7; VYXL9UT56?6&A7GR;C+UW
MEQSA\=I[";7D$QGG-O3.!/>;XB1VM"NF"*V2K7G4B-TXO+O>BDP5&5)__3=%
MGNV)_^5+\Z<)SHJ6FV=BKCPALP-ZT.2K>65)EV:&]]=_([+2__+G@AQ;9/B+
M!=,)]B)P)?KF5D#:FZIV@$?PKP*]FA%DER"RNIYJVXDZ[R6 [EN"X"[X(+^1
M.'CTIT37M5;JRK1L_W$+!X?4EL#N!+S3%W[B[UR_],]3PH-I3B"*I0L^P/:M
MX^ D@'^82(DY+TKP1["AE(!##C#,BV#+"_<Z$-XR<,3/">BXX4_^Q@;>KRXI
MX-Z@?4#?P!\[;'AK8-EY\9!\8F(" _8]B04=C&3O[E (ME:V_TE& MPO^&A@
M;A,);G?V6CU6L71(&/D[2WNW,LS]D@@[N..S;X0W!4T#?N%N0^6[N/")PQ11
MZ.T"WQGLT^!W[ZX6H;VKQU>J!K@%QU]4_ ^1E$UP!Z?[0;"$6# AI1JR[DIP
MWV4:K[U_]]%'@O4?YW:L6=K+QMH]P<&>%Z%!0AD^00L+5#V'PA!\H:C')BD]
M!2& "'1IV:JL@D]:F)8CF[IJ!FF_$-*[#:YOU%!B]DY2 82 Z?NBMR2@+O"Q
M<-56% N8ZXEJP]L[TN[!G(++CK4/[DW0^4,*$GPH3%2ZJCWU/\[@_5TX_!A+
MM;7PEDQ[+R(U2 <LP(X>&MYS@@5"MO96]I2 ^9.3# +\K),EUU]N_9<$$X E
ML"]@+:X0YK2/;#9\;P!2/Z:Q?="'%P$9 :#P1O P1]]BP1N5U@L_-PK= OAL
MWE+!A_B/%7SGG(=)"_\Q#YKW;1>^"!4)/8>]^_4H;((O'&Y.E27X74"GO"'X
M]AYJ)<2O9;H*",%< 'P0S.EJH!D_^1)A82_ !O$\!X;N?Q?0@W^_3V%^9./?
M>!B_3"3'DR1H?',76"@P%8 _Z\C_[ -5 TJ]90"Q\JM=FCK\SB=HNY)_)?C#
M3F=^I1/Y'_LXZ+3]]P:B U W[%U.R#QY*IC<41WWV&8-@.N]GJ K@FY[A[HP
M(#U^'Y0A4.?N2X#&A2F G3T'&MQ .+DZ=$4'0?*; $\K$ ?"Q_#],C!3?@(6
M!9BK/Z2[P)<??KDEEW1L%2^,.? /T/?ZEG1LJ$#C.XL&U@G%I 2;DBA#A<O
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M@IZ@!?S6LVOU*EM::JT)T\NF)X.<T*&^#2W&I(S.N]AB2M?,,9*L$ K7E*F
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M 6*Z40A-""$)-"#@UW\E"=RVP7:[&S#@NEF+QH54E9E/5E96U9-VN [5?K1
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MEZ>Q\X-5P2>&IIK^8BYO?II.\J/)W%6L%">F [H=)+_959%FCJU&_JK3R8.
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MI  0$4Q>07#<9R3\.^"(YH.@Y]<;@2B+=B&[F+OEPC*7E@F X(#@N-N ^7?
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M/V 3CBF"/\$G+,5ML:_B$<YEEJ$,^AJD#._^+X)E()^483EA]XT+89HZ\#5
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M^N\W>56 K9%0!CS[26^SB,E[.Z9OI4^+&=.DMN;%DI$-#?P)A%()B<.F[?K
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MN3,(] %'L2/;7Q# $,#W"^#3L"U<"L#8LFYO9B6#M5J&VYGG:XBQ[,< )@&
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M_+AW,Y%_MRW]KYO 1P7#,0B@5[0UTA14K"#M9CF9P.D?_S#,>X=[D@,!_Q.
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M5<<^$I!$_S95!U%WLZIC'RDXU]VFZB#J;E9U["..0]7=4-&1CY8$UR.F:R*
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M6U:,E+_;6Y(5N&T5'36W/5/M(1K8!0/N;C-K=Y;:98_'*UNRY@ "/6%'<_K
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M>=(TY7:5F\0@!4&_;AVW9K"F33^,LDT4QL5)/LR-N4%G9@F>T?+%80"[88\
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MF)I>P :AF<7!)ABT-3O>]69**M@9[+2XM=@I%9KLE QL=FH*C'9J!:VV"]D
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MX,_1(^\C7WMY;[5S4,IZH5B 'A)X2Q56R53@@%PO>C_- DM0P)N!=X:<3@7
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MI<J69:^VY>862.2!PJ4X"6Z50GFT8%VU)OJN:%G@:3G1\L!U0,+[HB_?I;I
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M[([(O'4N3J(@W\Q;$P5YS_M6S;FRDDB+X[#2LBI5"U-*G5S2AY;\OH8MINR
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MQMRA!'*'9S*)SIQ!9W;A;0P($#>=.1=PQ*ETINAF ],,UP6=0K%RFB-);C"
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M7-B*[ 43863K8&I.HMS1>N0 OIYAV@L?\]!/+P V4-4ZX)JQ HR,XUNA@V;
MK2RXO<7(@#GQ<P23F/>^;OJ;3?YCOK93VFP=?^NK7__3';V'.^WHU3>=[K#5
MFY8:;%,-M ?YC8W 4^XZF_N DT;?_0%WYO SGOC>M[\ 4$L#!!0    ( -,[
M<%9F.!F!#ID! %*G 0 8    86-I=2TR,#(R,3(S,7@R,&8P,#$N:G!GS+EW
M5)-?UR8<NE*E%RDJ( +2I->H" B(- 6E!>D0 >FA!D%Z$Q"0WGN)2H<0.HCT
M&NDD(+TDE! I8?@]SSLS:V;-'_.]Z_OFFY/[_)%U=JZSKWW.WN<Z=ZY^7ZT
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M8^NG!'OB_+#"W(TH-9R#5QO#'(%M0;J$\>S 0#7O\Z\PUU[JBT]UP/MG+8^
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MI*N;JV3+PQ^CK/+]]29 =9O"+')OU7@Z;YYV,OV$;Y8AL%)C9M?U0_ZS9:X
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MSPI=N!HR;%D)]N$1L&%=X_\GFW7:?<Q[M_?ZM, :6G"^2LYL&NL4O7)4E%,
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MYVM?KT+^7+?K5&;KTIXR^F@7A8=NQBI -J#?^[+NW0J4*3J.*^89*8.01]?
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M;4=NQ_6"[LKS6<\X-LWD8]F_$IC"X(TQ19X2(DIOX 13R:*(@I_UF.6:HAL
ML#I?(*KAJ"$SP8.,Q76-PV^8D,?/NBME+LFB'44A N2XQ\&X];"_M(=4.^9!
M.-R9(%6N]HWB?6GOVON2.E]5M#+-CVK$527H#\, H97OJ2Z+/&;+@7\LYETS
M)LV61HHL[]UI:58S^'#U)06-,[&I0BZ@W<:UZ\.@KJ#45WE0BYAW*;7?1&\
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ME*/LY2S&):R.,\'ZVSK9S;=SI6%3<LKY*NX">"'RNZ>SCNL+BT6_+O5O_X-
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M,S7'L*<!?[AUL%G?(8LPX.+GI?X@0_.#@*OD7HD-#FJ*3?Q6AYAWG9LU8^R
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MJOA5"W*_.;4$UUJP[^674;[1<_C:@NDO_4OGO>1D/H]R0=6W0++$DI+S&1]
M&%GCX[KFY*11T%BQK]65@7_%ECJEF_52Q:3UJ6#B.Q=J7Q"O^OL7F84^9QQL
M#$31IKP[6_AE?P$UD:A?^\2F-2PLWC^L_D.858@=AYZ;K#7[JN*(8VH[EE:D
MZJZTV<5:ZZS-@T$6J/&/[@!(CJ<N>>AJVJXM\+I+IKBI!57#M-R;CW"E!#FH
M21@P_D':MGKVI<KK[=H*0F1[3%KI\^7#@0$YBVYQ(\QBT$>$/WCCCW93;(VN
M>W-9V_X$"^"F&Y:#LY]FDYEKIF^(/I-"3976T*U$EHT=.PX:^P;!7M&:5K[X
MGZJ\S3P$[  "O5X(>6S#4&2)L'8SP:Q89[.HO]?\P"6H'X!F RXINJUTKAU<
M O&1@3< V[R-ZK]#BGJ_KNJCIC*,B7)@<QOC/LPD$0XX X$Z2+E!2<=WIH-7
M:>^:61_K=B9 <@LIX Q'@\ /[E4IPX/2.L5SM8-N!QT<0O@G[!18DLANCO>.
M#+,N@QG>E\.*]X]*WL0/*YL0A5$9F+_=*'_Y;8TVO=6V5*6&K_BY>,54F4%3
MSAYZAD^>YG@O(,#--)@1)^G@4?#KM&YE6<9FJ>O#[L?#DK5?HXI=61WYR*1[
MD))>\^:,2^VPWXO<<_Q6O<\NV\PN+DR?K%'%R&2&HYIA4;)0M +JRB=A#XKT
MVDT<J()D(D$W@!BQFKUF_KT&T(NFS<8IY%]N^4_L)0U1G%E:5N.O@'[2Y79\
M6F]*OK=O>WFM&-4$P5KGO:6)F/B:T21,\L#%0);O.)W >T@73NSK>O-1(I#/
MXSK'2VF2,(++16P_Q#'@]58@!R:F5_"A/I9H>$TQ1BGG!O#0W*XHGU=G8)MG
MY6)Z9W1[N-)U*@+AF5IG<@#=:7WB]0DKD)A9NF-CDE(F4>':P"&?+\QZQJ(#
MQ#^[ :0FK1U<X/4VK7)\\NXKKA?BH->=#\]G:9DS. 7XW!)_O[-Z06?/*^G2
M;EOZ/ULNKP>"MH]"JD+.$ORCT?QHAJXDICI1+C*27MYNUL23"U?\:8"3[-LP
MJ>W!23B' >XK]KXM[4XP*R8W9VT3-M' )Z^Y?Q*5)]0B'4\ZSHU>Q9!(CWI=
MZ/6!'^)JD)T?X;IIKDT*'*V8]OZKT?#S<<[GK;$]JY%"*9%O99S%"/:6%7'J
M:^.Q<Q;O<CFC#D_9%)3Y?36#^$WJ7CP*Y]=Z.11V5]*[NE])'P @Z"(,Y?M7
MQ7 ZP) 5E5EFO<M.&D1ET*;M46#NIGLQ6BZ[9\[J[$#=[=)%1#@7MP4WQO8.
MGEX(Q<)-OV\%D%]33X)M]1($_V6CZ\7<:32OWSRT<SB3XB;?; 0$D:I7,=8\
M^HF+1(50![Z9;:!X/J+R267"H:&YK:6-YNN&>2&_0PP?,45WKR1[RZY-L*);
M@OM(_P6H<?WZ00L,/CVEEZT\)5C2,EVIHOE3K/[Q"W=6&KA/E_1WJE)LXK0=
ME-I6<-N6+E 34\WQ2>8LIMH;NFLFOE[?\&DT@TX[VLAHA3LB(H*7"/5M7[QJ
M=04193EJ:C0)%N>X#QFXD!=!O:D'$UL//7-X,*+,*<TMS!K%RLI.# AB6F#[
M,:#>",GL6HD/N 'T[6X5-T_C'Y9OURLY9E#<W7?LF%IAHM:F;5D.B4B!$7F7
MA;BZXO7 CJNU:R,C9"I",2"N3'3!6[9/":'G[QQ%SS[NR.B3--@13-V)AYH.
MMYHFRD%7H35Q61M?[0N6MQ"Z+9L[G!?^$5/7VY+%S:R/6)-MI5<=VKTY'H2X
M$99 6H,8U&?Q+&MKCJ[$TY.XGI,U8$:Z9*5^P0,U!B:OY'NL^B03JH2(>$($
M_#Y5TC(7=MH&D-1-S\R;UW=Z!A9#?$O5)*Y8P*PS_A(15!Z06??D$T5FHA\B
M;:,O9O.=SG+)IHJF[#0I\W[HR<TAOBYDNKP-3;OO_(B)0'[L&>$6GG" 6)"O
MEP-YEAAHB[06TL2XIQ2HP:[9HJV "6Z:6@OU/^^*<$D''C,23N?.)-1<SP@Y
MKQU0J''T7C-B*7^<&5B/(X$#VF0\,%#J89'8U_<@0"*E#B"(\:Z,0>)*<2!V
M[0#AN6GS!X28.68S-(1A*4H2_'V*QH[^CM(N/8FL(Y7ZA9CO9MNI03-@'_8_
M-,.K8&839^GUMTWH35_NV$J]'N$OME966\4(#WIE 2[4V;"X/Z\@Q =]ERO1
MB)IXP1-Y+AWXW'OO(#$FL=,L<7AS^CQ7TJ83XBO7-^>T;W-Z' G!7!#%WFON
M3FQ(M'>5RAZS1V=#=F_=4)TYB:6OYKV@WFK,"R6Y^X"3,!'Y'UV<<. JN+\*
MBC0>S_8IQ_%93KV#'9G#)?V?M=2GQ;_B%UG/;>:76$U,K\=V(FT*,9NZMX0H
MK_?B[=+OB9$*7,;!<$-3SSI%G&IJ/?N=&J0+X93P BU!HD=_X$3I]=0UY_0U
MNUM >F)>P0YB*:H=6!@K$(\UM^'O_[#%?4=U=X4K_I O^  %BY,C71:9PCN4
MN#)8S":Y@OT=KV*Y*XC_9*DPJRT[:27CB%L?>,4!S@(IOR S"=FD:NY@EC83
M\DZC,<?LHN&:<9N7=TXU\E13;1]_=#F,K_-JT<-Z2Z/H%O$ZV+'.(N U.Z8S
M BVVC5>I/)^LO*A-VVOZH]J6,^]P_N40 $AL^4ZE.@!UQA32'8Z'X57*+'=-
M0Q8NC.-;JP;[2$'%RF(U;&U7.2'^]\@[OA)\9#V\5X;WN30$=E!@[W[GSNPA
M(TXXF%_H#7'+VC2%G!$?,>4+T*J&)U=*[;L0;N.]#M1M@+UX<ZS?H*@;.W\K
MQC>A8-G%AB&&K!,M76R9W1)O8Z_A&UA.IS&V7[3J4*4?C:+JTZ,%9@381C6L
M4!0EK56 ?*$Y^F/4;-?';C\\O19X$C5' =!3DN_%CY@QHY*HI%B\7PGN96]/
MEDD:& ER&@!>#HF[/@'*TD;B84@YN:_!#$0F?K&*+J-^O>PTTX:&4V(Y0GVM
M3K7T22'0#X<=Z>^Y=;:]^]6_</'AY1X$Y!X3'#\51=R&]N_;%!,(1MD^#"28
M:20+,NTQI:E::A6L6+L<*H&U1#2/_:'<6O E(.^CSEJ8[GAF"R$QQ8[V;R25
M+./B9A>T82:UKH7:"V6?.'F71QL)J>,!'W2]E-AQ2L?;6J_\!083.SAQ'#VY
MO--PR[4E/H/,U[67CD77[!EZ3WTWO?E3'S[BZUZ\2SHFC<S'<6 -;7 )8JG+
M;LOWY[QGPT<?XMX>VLH@=!5];EWT['*>D:L8 +U+P%AXY[])RO^V52WHX4Z3
MKB;,C-M<;P#L$S> UF=WW)X5A-[_3SMW/MVTIFM(NG\# .E5+/2>MOA*I'!K
M_8/73VLH<6%KRBI08-RSZ7&JZ$!6$\9_BNZ?\=CHP?VDU\?5KXVN<GBU>N._
M<8@LXB1?87S;?^".U Y+8<U-L#:"?8?61-E\>GQX-X_4@!*)?$7U--[W$_:E
MO$$5OD1S/6Y?:=XU_4MXLD>\$&,)1']E&]$179$-A4(M%[J)O)[4E7FMD("_
MR^]&8FV*$JJM6<R<OFAZ/7959J%UESNY-EZ#FC[71"#B0/OCKW$M^8^B9'\M
MF[.IIQY1=2PZ6DKM4^T:7H]QT/M046YG7>>P36<V20X+/-5$7ULZRGENEG%]
M'&=/+UP[7\7FA5:E=_CCTQP_H*=EO)@NT =H&[ZBX5PF+,^I@YEJTZ'&JZ$,
M=57;[(SW[);R4M7#[L+EY0)%AJX[4+JFK\AV5ZX94,/(:>032-6Z1!WH[3WR
MD5 2MD2ETQ+8QQ.6BFA@&D51ZK/S T$Z1_*59\-A?1?.K%FGX,A;Q5R,\U^[
MU&$QF>A8>@<3&><N]RM4VE'0#Z ?_W&G58?,>D+.2-PRC]+R!M C#71/T60=
M*54U%]F,%$@F 6N=&=M$'/K(C7?EDLY>DP%/KY_")X5\*EP?0[U<'4O:I]]1
MA]U;)-W-C?"R+FE'9H-L=6;=A8ZAG13;]6)D#L[EST(KP I.=YH^*'/PHN(6
MVR8%]]$(5_BKLA6+Y^Z'HZ>C78<?4M!$'*^9CY9L^X.I)VLR]>(VK"G/D\8]
M09]UCD?*N':\+,O?E)6KB53<#Y#PO3CKJ:!X:OU8[/+/X^D-:N604F5V0KO
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M*/FJ[-> )SP+NMO>,HI4*T#$W2274;LCI?@)E%X..'59G(-W^4YRYT?QCS5
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MMLX#CRY-KFX 5"$+MNM\FQ<7A/]35[WRG[KJ\U/0]9E0YGKP2J_B(7_IS@U
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MBN9BLQ[Z-I=U1.'<RNNY-5#[AKQGANX5W/&G:Z2D))U%7,S?*L-!^T9L,]$
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MX%2F>_G+(8%3F0*2Z(7O;!#=!447.PUE"-2?7$_^R&]D52W+Q$XFU[XDC2:
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M4>_$875=#F(=(T#(6"NK3085?(D\I36&[Z;$;!&<<S#_3D0 W9ZB@X:HE\<
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MQZU)%V#)? 4\!_0 ?$>DL4D#BT&''\:0"MD(OSO5J$7MZ>MP:FG-9?'QI Y
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M3>,2%$\<1O@=R/EH 32>6'PMJ33C\)5EI)_(H<K1NOUA_>1<("[',^R[DEW
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M?*<]==7*4O_S3[WVE6C[TK17H5DO[TW4*'EU<G)4MV$XNE=J\>+3*+7KKT;
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MC?ZXK_;()YLF?5L,3Y/G_P3[ 0]6>*)C8JO/-06IO,_@)TX^&.M\6Z1-GNK
MO5PLQ(RI%ND/Q61.=[':S4UWYFV.O4)MNOJ$..(O 8?O] Y&)1J&M(0VFRYH
M-">>7#G1JFYA6I:ZNSK%MQ]CWA0\C7NY8^UT(OAN^ F2MN3)UYZ""<@+-A;
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M#[XJ- 3M7(#U_WT(Z5,5 @?9): 4>K[\@CS_E'@[\6((?QK7"9)PQK@JLK@
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M,7HM>N&_B) 26D>K\<:+?ED4]CH;2)VG4I](R4/JK]! <HZE<S!-A&=,P9<
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M6&+]OP1$<$TK\PXCM<9:NX6577Z$0E*J@D/,[7>&<X*O577JE>AG2:M/9?;
M@MK?3B(?DT"G'_4=V#;-VFB'F8SM5NXZ<K?4)VW.<[K3_B['KA4NIL?T-$ ^
M@>@\G&]XQW2>.67D-B,,ZH^/3XPR>ONO\$9%51TDPXI(6TP0@63>_$:-X**1
MD(*UKZ,:'F\DIP=DEI+H%&Y9ZLZ(W\W'Q2T:MY@A.Q]L>+:/=NK7-,0]ODK;
MR4:="9$CS:YX.SC2_O"-WJOYEWM^&X[ S#;$&CW6>>EFP2*(;7I=G_,N9BC,
MW%C<5;KWDT5<9Y/R^!.*K5VM "$+0RP\ NZAQ-:9R9;VN %1,-96(^8AOY2X
M?6PIL#]B[#H#87$BKP O-33KO44+_9 :(K4U$ZQJJ[M%%2?\PN31S/+ST0#<
MZ:_I7VOAJ^ZP,((HSH"XXB84Y-F^\,Y$BX@?;DU3B,;/]\^*I8;>2P"4QAN0
M?8A^_]T?Z:6X4*SPXGN,A*G1Q-3F&5PM9_T2<!/HQA_A+W@OI[B3,>0H_< (
MJAK]7$-8C?IEUB(/F36B8$3Y/LX9VI2$&CQ63:0M^&^<O7=44]_6+AR*HO0J
MO0@(*+UW@B)-I".]2B\AM #2@B"]"0@H**%WB/3>FXCT)J&'#@*)M" 0+O[.
M>>^Y]XYQO_>.[X\UQMY[[;GJS)S/S%CSV582RVJS=I8F^0XZG'@SWN8W@'<=
M+"Z&-P#BTP1N_70I\007C?+RMT1':IP?K\=_TA,*B9Y6677#B$_--!:T&_T#
ML @-(K_GK:UHS@R/V@M[@M3[KP'26+8FF@G&>7.T)U,VPG+,]61APQ=UY8<R
MWQEA*>5 "DI3FVI^4O%X;@L>5?5HYF@W:<.,K,GR!DHOZ*0\;PM=7(CF+TS;
M4%Q0)RS3>KHGG!R>G1:UMH+G$N#3@2<RST["JY5-5"&#/5@2 G1O<S=5B3[[
MBF8-#S+)6S!S\G3)_&!JOYOR8TF5$3^P\OOWC8.=7@YYT9,RZ3$-[1A#;TPD
M%?-2*>HD\V5F<CMG/ ABOBU'3)4<O_$J@15Y'G$ZW2J1,9E>_VY1SFM!@[%.
MJ3RO)FS_L!D.!-X[O:@[:TCFS\\$":R9I"O::,0(&-K05BT+?PZ84R_^Z1_5
M9_EDZA1*OI..9:Z>K"Q*"+?D'/"%(#P;(^*)85D$Q=0X"%:Z7;;=\ ,E+)?N
M)]#7XBW%UF$6!1T"[]C1\9#'_N"^S.*SX(AC^6YB6Y%N3F<AYI?NWVFZ;@!V
MF<?PJ&4Z*/4@TD"C+N-E76PPHWI+0MSCA-$S:^C\]V+F"*55JPA$879YD7*I
MDTS$UZGW)9W-:*8,B<LP&A)BQD31G6X/$D" 9D8_F'B/8772NM.AQ9E8G>,I
M>S=G>!E?H:^HAS^!G)[)E1%JYCSZ;@+)<?O:AZXJT 9YVS_5#UA"M]HZ>SKO
M0S0%]:<J!.MD+^-<>6%B+MI(=85O7=+VD 9B-7>8P+CH<ATHB H91\;(AU#)
M>I-C*H[.1AJ?1L"T,D4NO/@7MHULKL?;LHM"Y5MBGTZF_XOV^/]GD6,\^[*?
M<VV/?=9FIC8E" E^QFBA0"\@L'@50[L\!F^<;2_^GR\8:<RXGYCM'/&Y<]8W
MQV_:Q:\F81OK 0&1^:7. 9:)8IT,%B2!>G0&&FP,@<(K/DOW69>VFC6UN]Q!
MB:5K"]V5SD/'PE%QT< 5K7R6O,H;@/L.B\0%Y)N1\DR2IMX$$/+P-(U NZ1B
M_YK("@/U(\T%BW)J_I!)B,_*>P]MD[HB 9C4H'\%)-08^Q=]VW_P3:)P\DN&
M1]*9%2:JNG@1\WM!N3%0\/Z\Q"=&$GB)=E3KA^  MC,:GKDZ,H:KS!.-?)?B
MHG(G6,O[&\"4\:!V20%#8U00Q4 :@W^4$3/XD/PZFP/;P]H6/$:-HZ^!>C2R
MV7C6T.K?HO!QV[.Y9<ND<]&R(GB_8N(41!HLHBG:0ZOT=.9G&JU,[%O^R?6\
MX6_QL)=&C* B_SBD1.ZCZ4GY'KB(I87"3QNKTC75KY6L!T!2#-O!%$=2G\RM
MC1\^Z('F/UOY]?!R>Q&MR%356N BPU7(WU!*_-42K[GM4,,14[NB4%_[GTC:
M.'.T,1A)=-XV+6"YM_FG-3M\G+07T8"EA0X]&P?N'_#@[9E 9SLO!]H&SU(7
M%>Y@ON40WP!L0+F).-)T<*V,:]<;0)MK-GHN_$ .NL:LWSLWM6AFND?^D3-S
M^NT3O"5U?,<]$D#0#6"]],KU46>8X)7]&IAL)YMQJM[L\>;T";_BTO)SKSQ@
M6EZ22RT-\5-N?)0KJP4F=[V3>G^9=UK,9OWGPHOIHIHID)Q\GI)G87-TJ')O
MY]A#V\^K51/Q#NUAPV<A$8<5C%;HSM@K,QM;,>_>(I<Y(2*P\#T>D]<Q1-9O
MNZ5*Q6\ \\=JL_7M>G\6^EC8QW^=^AV+:W*_:#>N!)O1\77EVG$24\8WYY")
M8A+6M9F>EN\BLML%XZ]8UTK%RIU3P(0_E7T:YMQ$198Y>!6HUP$X R[+F'IX
MPC(>VB!$=+J>'XBER,IJR!R@5G,WE-#$Q-D*D8;\QOM<@D<'5T63=06+&LP\
MN &HH0FBY1YRF*K:>K)$^,8P_Z"(9V_YEHB#Q^&UNGI:?FO<\>LT1?51:8?)
M@:5.\+4F2\2RK/J'RCX!)3EOL"$??:0ZG?21(A,X,41Z%\N-@B+D.()+$8O=
MI3\'Q3),S<^BAE,@>OEC"7YV=DQ>\N6Q<^)CS!)Q:-'^<<RY?FU2+\-BM;&S
MKA*1V1#E.[Z432(AZ:YNNG-XWI7GZKXVJS.%,R*B_X='/X0$4<<G"4[H+;EX
MN\Z1N5T50K33:$F'=G\W9Y0WU=?H96G19+?"V*3S+*@);Y/Y:0[AY%4 :MHT
MR^D&@!:1&0]5WTC@VO^V_)K2=NSW59OWG"]O!D:SV'^A7T8U*@CBN5X>%PV!
MN)8OX6XM ZL'W2\;5._.+-<(#J<[L+WWA[LT-CPXHS")\@N32F>NFK_S+&(C
M^,Z;[(A+>:< TD9G/Y9:N/FN+ZV@GTW.HF5D=>VGF$?)SR*E^-0,7]_UI\9!
M6K*@+<M!J\![.PQ:M<A[CUJ:9MP?3;4]?)VZYU6VK$9S-?0TD>>M7(J(>E>E
M!>N@%15D+(+AG>^V57/'Y)4:(OAJUG-!O?)1M,Z@$]YWYT@5-699AW8E+'VG
M2GVXNHQ1=-#3G)7=GDU:W2EW#O7"V#<OX52'"1^JU@< '+-Q5O/YO::^,8'%
MQGL!FZDCI226C!@P=++2/>Q A#-"ZV QA4E(6KX$+W*R#8+D!Z\!8VQ0VC%!
M3Y%0"A/S9RQSQE.V];-N-K8QU'<)4Q3PJ%\W?1L4G\:.8<6B3*;KOSRZ,D&"
M#/\L/3"<N+(M*JS*=1TE BN_2K[?M<H4<&PFC!TSI6[A@CN6NB"V:DM=DJA3
M]QLS0JUXGWM3J"B_THQZC[L^)UZ]"GXWFTT\ZPXI_^)M@E9IEL.=N]0P^\*B
MMD;@E_Z6@IHX5'U 2V:<(-Y_?Z#C,:JS3]X22N,?UX\EF^1HTRVTW TP-VJA
M;^P"[M+I<_WVPTO7D2I?%IN5LX#[)R$M1E/7LZXY7J"PGUQ+?BK;,+U,^?[:
M\2*N/.2@.B4_==\"VWXIOVNZ7%FVJ(H$4MY:>#CWEU(G7\FR!C\W16)C$5J+
M+L SD:U&@AY^&MK^^]090DI((IX*[E@)BZ_]3 [B%!L>OMD7NXHLFFLK=!AX
M;\=#E%9AA?^ A<I<ORG-:.X;UT P@\G/(>:F-%/RN'8#'[;T,?$A#!1IE% 9
MI+Y::>ZR+#1]<N#Z*G;R<-VDNK%N4H C0THBV?KE7:%7,7*D 7.=YD&TXV#:
MWOO>CZ91.PP^+>84H@+SN2F"C]M&90Z8JT>\#3MK6>+()]+W^UFX9]@G!%XW
M3>:VMZLD?E/Q?ZX3[C$XG#&,,QX+.(:%?KH!1,#SSJ_'HF\ )^V\LT G$D?+
M23E@#G<4Q&CBZ @RK"'J%<UZ[HZQ-D"I\*KV ._46=W%1"X8U[1VI&\M@=/T
M?)]];/FHP>61@^K"&=-JK@H?8"&J05>8FOO5C%'NGJ/V*-[@XTZJ>.5LL,@[
MX6V/:&"I6GE78EKT@E[.)C2^XT=.\U69+B\N+LHEUUYX2V9$1E-+O7HE=XIL
M828P11L-C)'+?[ 4Z$1!BC[E[9[70&U5R=.WMK;X-ZJ3S<Y=XT$ N^SZW48H
MH5C6\ V ?JE]Y&=JO^$$8CG"OL\E^AMQD(?'8)4KU2L,3J%%PJT+ZU-@0XV<
M9L,>9#PZ3/))'O(#T?44Y"9_@)V%XMNMQ@+0*ICZB@47A':LN# -MC[7R9*M
M(<4XU<5\",SG5 -BEK2F) B:A?=V,ET]C>H+H6M/64&2UKJ6RB18ROL]CUS1
MBF#VWEIH"9J(D%J+LS.J-@XB0!5E<:6P-7XT=49 9C,;4A1.LF7#B"L?<WA+
M<TB/>1M<\:+P7J &2HO,AY"L%*Z^IAK@R9-*PU.[^AJIG@,</(5Q#\G:UZ'2
M\ B4_PJ2I JV7H_N[V\S,HUO;9,5;W/H=ILT3!H&"* %:&7/;;D+'5R@Y&WJ
M!#UD<0QYKI*\);NF,_WM:=\6.I;%Y^N-XJWM3@DJ?;^&C#&0='0(TAK-0:O[
MT=-SO3 W/"VS+PMM([E^ZWZRDJ QETIDTGRQ(EH3V\K7LMQI7^RJ1Q0WPCYY
M8#AQ" !HUN7*-C$Y.G,D*[(\+;]Z/B?W*!BYKTFW9X5@.(\] +&LJ]>9E?=I
M?U7Y36<+_M ,>)M]UWO$1X$5;=3_--=_3'/BY(AV6<Z0R+/ "M.K%;F,TFSC
M2WYLSAGEO-B,AV^]U0[4Q>"MC>@-FX:Y?E%^- U?FYX]O-_G/;^H3#F01(0S
M@!L^ZIV*R')&$2C):#6Z5NPA5F+ $'_#Y6V#Z2,"A*&XM'+\0%GU 3AKTU*-
M?@3@!<.1 YVM4%GN-&+YT*#1$OZVN?$@UR+5.]-N!>XICY-?64@/C)/*;#5@
M@1BXSL1<[Q_#3Q4N9[0R:;V1=:B9L"671K7R%+9E0A6".U]JWTY5NF,$5P_@
M[TXW9H^"E.'^<,/(N_4-S7/N>DJN5+9> R71TEW#Y-K,+MM]@A&S4'(!G_*C
M Y!^[Y^.]-'9S.RD)YSH*#K(Q<R'<M*<6,#%8M!+]#4\-,BQZ(NM\50]B-=B
MJI*OZK2P,1"3][G*$,SGYMXN1$I*XI/-@QZ,4R!QR9:=-.NG[> 5<O+8,Y24
M:=,%-WS9HF ]=<DI_G%/3VI0W^*@\=?46JL9Z/7#TGU19M.]R3^'KEEIZ2;<
M;QL)^(:OS'%EK '"%BJ=J*QG:&!T/<A,SZ0JL;CP-G P-ZW%H8@*N4J4O#L6
M-$Z0L9--/7O%?:F(86<VZV]<YC,Y";S ;XGWY$M6KY=\)UR6Q'>&3RFO"0Z9
M3,^,N"Y^"ZIK11>NC" U#&)1 ZQ#G)(_J%%JS*++#7+,*$9-5%*<V V  AC=
M]A3N8OB@9MZL ^Z3\NYM%XLQ#@%1(IG^8N8R)@,U^!)36&1LXN)G-.ML[Y]1
MK5'\@_V]VB>$G_4Z_G;2"P!:FP93VP\CHQU@H872+.]76HLM[/.;HMEIG5+-
MWW@I<\T0]L:'US$Q&5X.(6\ ,0&=B?6:P(%S+$TC:O,DG2'DBRTQ%[VE5&_M
MXI'>*%T#X([''8CO#:#V,+KE;J5-8/F^3/M9I1S5\K[D<?[2R,97IZF'N$_B
M?0AELD^.:(+P)H,TJ_9DXAG.H\7NG8(Z$0T,RLA^<(DUZ$=HZ1//;AZ#Y-E0
M.?D0@7T]*Y<.OAIRD_V6P4@Q5\C[(DQ.IFMC]%#=*6 SM&J_K^4&$*N YWKV
MU1Q3JX-N@)7N-DY]F.6(U@![XJLH3GR<@?K^Y' >E=IJQ]U?%7QWQ*B7J.$<
MD7"6!L[/HMN89Q+JZ<]W^L88'N;]^:R, =I-I$V:H&28I3-S]::*Z+[;K\$8
MP5?I4O,>-L^B<_T\B-Z;,>_@O9TJ0 ]&GL(C:<\[@)VS!T':DEDEQF/$ZI2B
M9G5E[P]TGMN^K4OQ)Q GB+@R0\*CA?TY>H:060<DIX^FC^#U@9QQ!]I,5!_4
M\OD*C<HV#N0(AS"VJ 63Z:O@U:&"B2#7@I_^_L.<$Y@B'U<S-MLG#6?VBJ("
MZ^<+W$Y,9W"KYFO8B=&XF!D1OY7)Q%'=F^WL0>.I[>>MT3]^3 J\H+:7C>[6
M1X1*0V-T@EZ@X&_K9*5.@VTMU>!+$ NCW@?54)<L.2I&/B_<B.XNK_)O&S@6
MVEU V@7_\I[S.+)8B""5AK/WYM!UHS7?T8&("/LG1<8D/48G E0!["QD/"GR
MY$!BSG#.Y^!9S\'1VEPE'#HUTANOSB'ZV'!1ZHF1NPR.!6NH I/Q%3!*QPE<
M3V*K-VUO H=H&MH\ZA_F0;3&1N@ 5N\ O!69[?^+6O+_*(0P?Z-GO-E_O]7S
MGR/E#^D+NHMU%>_' OKI"VQC >:QSA4CC'T-#%<M[WQ%Z3-[5A&+) 5N[WDX
MO:37HM@+:F8/P$='%6L"CC7V)HTJW_,]OO521%Z)/G,JOL\UI7RL6NFX;WJ0
M%/4K83G7*[UA;49NB(SQXYKJ=,H=2_[X/^,5FE^:*W.:MC[GQY8'0TFS[.67
M>MW"\$5DK3_ST'/3*&&IF!_*B=)&<[8G,K.K/=ATM_\N,$"/OYW\^61?>7"8
MU]M,R2D^MLJ-33(.<N:?\#TW7O,KF&C._;#IK,J[%T@M)XW</[8MMFQN15A8
M-S6F$$"839['MD8UC4#,2LAS/$=$_#F:(Y!I#XP707:0.\9^^"QU!\LS^IJS
M?*<^GRJV-2(B#<-4E-Y7M1OMB2I2&CN?(2P*?!M\QQ%F*D+ON^F>Z^Y0>SP9
M$>N4YUE1),VKK8.1&^^# QJ\WU0Z2C? -CGL0G%5.;+O[1J=Z^"5%!UM%WI;
M/L&DKMT [IHK@<N6ZXPH2R&1=)R?SA(K7E&_[]B.!>SN5)F]PGQ::V=5KIEQ
M%^=TY5T,_E0Y4>3<>E426CTHW;5.DU_DW_ABUN=AA<EROT2F037,=SPG^&!^
M1]7C#35.M;+W]F F':H&$[]'D4"?&K#$%&&3DH]'+\V!QQRHYZ\_V"*88-,4
MS/YK=/;7 ^."&&2*2( ]TUWZ7YZ*S"0T;ZLPVRJH::/)/=J09\8]W$W6\3UB
MW(#/>'-3\+L5B_XPK09-$=5F?99"]GZ7[T3W32)5A*36FW-(7'B9V\P*!6.,
M>K<.5*K&@PO,K#<&/SO* PF_HP7[@208;9T',A''<2.Y",; -]QV^A.?52KK
M C_K$)@I>\ET]H.)=UK<OY1HEXC-9L:PSVI(<38="]V7HBB5L\:^ O=TDHL!
MZ2_67[0=%X;?-7Z4L):&L_-"BACGM!_@XV.HD(9<XC6=@<A+C!YPMT^9Z.VQ
MW1-.IV=6E0LPE&A%@WN6F68XIXX@_(W"MB/DW9SEI-#M?/;W,!0[#UYU7KF)
M57<)HM_;]8FYV<O<]72)Q:KB7'Q(\>*2JB.8\U@HD6>ZM7H'L.>$Z\++_0RM
ME8&T(&6VU6K52)!X)=#(5-+%R;2-;TM0:;T+HPOBKG"9V)UMR7FS"4J656)7
M$@W@+'PF?(8_3N"L;&WAOZU2BQT_KFH(#G-:;;I>8$[BDB#]O,U1:#D-N>3G
MVON.V-)+M?SV^BUN^G*W!D77>FC ^-T$&@WU67[(L';=_/='4=X/I=@B]</N
MR87=*Z\#_/L#F?]KP5E=J3NR(-@7_$VS]NKD:  69=J81)IQ_1%T YB(.SK>
MF)^C&[S;-HBE7^D/:8%B\5FQ7*%R XURDNO\&KV/UAN2'6I38]RJ:(-$R"#
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MZ*%QJD*3SAV /[89FX4Z'O0V+PF,@3C$OK*9H,Y1_@.2OM)\-8W0ON/?VJM
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M;5 3%20Y]J"\4B*K2.GC !>NX+(FSR >&V$7R-L(;?1K":5QD+F<X^X>I-<
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M[)@2G0(WS$R]Z[P:\$)U?EU9KQT;:%KB0O=LOGWZ^-N4G?:M/M3F=TAUE]^
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M!HN#+)T&4NFLUZ_MRL=:<^E3D( A7:[7=GX.@I?/C5:[;'W?W B0'EPQ/J[
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MO<U-?'5VQEWD&@#R6Z&.OFU*'F?]7 )+Q8'!9:/LK?G9IF]'ENE'9*G\TP=
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MH_SJ1QL3'F6 SUI.X,1SC/<;3(K3)3$+N-D?A@!=-^3M;+YY'^V8>AB>KD[
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MDV78E>YXB9,9AOU%H7^('(XO?ZB!L7CWP1C4;T*?.JPXRPAM^(9P+?Q-R,W
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M$)#U2[;)]=2&#T!Y"$$BEG$BS3)5>:_[* 3."+Y2)\GY$*<3-DVUUC@)Q&0
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MHWLJ40?FSD("&/"FJ&EGC1I,?,2FZ#[!<.D5J@4A_B/[VD_NM^O?>#2ZU!\
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MY/Z7'J_.+/LGQP]U4@9BSSW^QN-/?/D%1@(X?;)7VHSN&>]O&'OR7OA>W"H
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MWM3ZQ?V*3.%,>@7B!):\Y-V#1\#1SD(D@#T'YS ?03A/Y"$!K4U0_,OFBU'
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M:TH</EP.$Z]8)G)(@*WITP\S.N]]DT0=>X_8URPTT4]0W1$MBG8S-S$1L:]
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MV!L20T<\WP1U#7^\N4FX1@0D"(QMA0_ENDB9Y5S8->CLG/%+(KE NF\UPXF
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MWW2,L#91?Q0AM J,IR9Q$V_T]B0MGJ#= 7M#&J]*ZXSP!)+IVA'44G0M:XD
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M'R!F=(S!5L_^RP/0_V!P"JO)GT;P_)-\H<V_.2%V"?K?H$3]6;JB4(%%.^1
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M(5F^*G,I#/JH656C6OE2G1^)TY&&]PY/F(,;% KM25#)9TT2Y7K'M^(^>+B
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MGLMD@5%2XG+#RC'*( KOLG)47FM;P0S$D^;9,6V 913YEKGH#2@G=AGP?@P
MBX!-UEIEEA0O[<Z^-=!O'QCW9;G"7,T>MSMV$7\K6E+B8'T6.TSO^,%\:ZR=
MJ_UMA&Z!5PN]?@Y'@>ZL%JK48N*+X6IWP9*<@P-C&&6?SIBQ&M=C@/\OC\>U
MS6T1UD>^/R>D2'L>F";@OVPIA;"F,/,8Y@0ZF)"+)E;1]46YGOJ4"S>^!D1C
M*NG(X;.;LDU<W 4=&D#H6Q>_,] 4VRS"H:K! EV!*%RB <SEV=6U0)+Y@_&@
MAOA7.2?O=P@+.AAFZZQ@["-.4BM42B0%KW5*WF2'<8;P>BN4#^9T$[A.O+IN
M(-KJB?#5OX58S?K_/5,;6=H^HJF_&//6XBX33(,9<!"M2+'X@,K*/1T=T\LO
M=.D2LBC5\F-G2BJSP[A^PYZ=&[&!C"I["T)S$&E>A09[$^YI!G/231M(S\7I
M\+:7&BJ5%,PLWQQ_K_M/ME=G_Y!X^9"G/L*4*1!0,+&!E2_)C!D<.R&O(X1Y
M)ND+;_^K]SBQJT)YG^*%J!;>_'G98L-W98M(.[WN3UU @&%$1!:K3^&$63:%
M^X]/%#WJ\+^'DM%SV2M\4IEQ2-IRZ@/MB[!CKG>$@6OFHKWQH4;8P*!C;H$'
MUHH(=2B7=+4VSYP=I'_></3"_@/\YQ]X)E?%)!I@ B:U\F6<O)>#@DGV2$!N
MOHRMLY<#%XVL"CXU>A[X9/6PEBW:1-^Z*U9N@+?4Z=@5 9PA0&*F8%]KE;1Y
MJM2Y904H.\T4A5*XLIQ(8/FEP!M&E]5$_&+ER&"DX#"\3,KF=!%GKO21NVE7
MTBI]T[>PS\,L\$,21M3N@?^(CYP4P)VG6_G'*G,-,H4-H0(S4)"/25)*DOV)
M!GS0J=I\]D$TU&-M@(50%.^\3.U*'5$%)]HPS%JWHT;L=(?FZLSK+5I46C1;
M%U<K8 ;)':<,V,MBR$O_(?R]W=[Q$&SN!WS&:,!S?83TOKC\3I>(44BY2]M;
MY/8$K".%>G'BVMJCW,R#+BW=GLPI*N$$^$B"<.W^93O\\'KN:FX8RNUK8TAL
M6YK/8O\F,C/7M('L@/^?K/6_S7 HH'J:IWTUY&T61 E<(2=,=+0,T%OX#6QZ
MIRI,*E4@AO+M&X)2D6>>FN9A9:BIC:5+.DTFV'['&Y0&D?]K+!1#@_YFERY/
MIQSF1:]C]W+Q>KWG_6UFH,R1/;SP.KQAN&"EJDF*5$ME)_#?A)2:P2S_JQY.
MOUAE*X +6;^1^RQT8V J._+KD8,0&[BYL)]^\WQ/YPA*IY^.;--"+KF@FLHY
M3/8*S(KV9# T%323*N[Q,_VE/&X1$.V0G2/[P<,K-&"]J[07YO.![VY)P1(-
M.$B/I$)*HIP3W\:M[MKQE-;7W* !&5&KC=$4!SE?$FJ77$>:&2Z"&7K .\FH
MC@1!57C&RE&.I)VU=0;",L(O+.KN_<EE*;;ZSS>/R4C=Q,4'R_65.!0=U9:*
M%@(ZFQVO$@1W.XS.F%+7PP,#GE P.\G&G/RYP,SWS<6;KYY;DZ^WJ%V1$/6Y
MK[U^2\7JM+\D#22 YH_?<SN49B_KBR[JO!GBA+_RGX,T ]6.#%@D"":R,)&/
MA96O\U]^ )._K,H)+IWC=T9UE/=+,Y,%1Q_OE+78G,_X%F 0FK;H;(7R]"DT
M?^YYPG W\L/I0DQ+C2(ZP_[EY#*1]G=-)"Y9XRKIQ+SIW=NYTQ \OU:R["HT
M()K,Z)HNZ89Z-XB&6&$]%M4NP_W9D+RN+5>OX7*%+ =^E;EV\*(E&+GK!MYE
MF;*38-RKA]M&FF=$XXEE_X"4F)2"NXAR=D)8Z;N@RBC.<FUWI\]3+.?<AS Y
M&3F:5S 4EB/(N4I9>F)HRT^W</#&TN[\C35_.!I :M1;>,"QJ?O)36_^#@WP
MZ+A% WZ=S#N3)10A"A0GM?M?0>7Z[RL#[, #SO<.^DM6B_T1*[\KE2NUS4GT
MS=GHTX+!9O>R6>H%'U?"M^/NUFZ>3I:$UFXV,=;OQIZ=W"8*+.5 RTSHJ"<:
M=+NZ% :UCB/H*=;N[^9,BLG>8P)<2Y'//]:-OPILJ_[JX@;T&"LJHUZ-9Z49
M]>K8[^?VC$DHFD*8(J[!;_Y)JEO_95VRXVU:I*^WM+2@TQ2U#>\QD9S!<10_
MR"Y7Z]N?G=QK.(C;_,QW(3!F4*<X?]C%R@E7OO4!DBR!S1%$GU1H96S7"=?:
MF#,/^YLN!3+(,FN@)YEG;I.UW9.X0K$JQ_V_@!@7Y754KTUD*)V_4LDQ)#@U
M0T*/+Q0MNMVLJ+O>BQ69C*(!8!.?9B2(,R9"==LUV.SVAF8B?7N-Q4[-JPTE
M=TF+!A!=A+[0'OJ,AYQ[7K]UZTH6[0,J1LBKN]MM9?Y-Y_J\-,UPW"@.7*6\
MU;S<B;B89]+\:50_,-PH@R-$7ZJ,CY@3]X NC9BL:ILV_/BS7H(+C5U'@?ST
M+PUP[PDGST0JT0"]-.1^J^<YN'/ZD-]&0R"<+$,]QQS4YUE"F%TQ1[RNT!MT
M!1T8T,G O!_2:" DE-QT,*@2HBI?)!//$V!KVH86%@OHDZ\0 GN5KY2?6VIA
MIG\E1LR9ZK-@M*I!9Y.$Z^J%J5"[8J;[X 0WETRZ<WDGO7<VX?HQ!8K'B1W_
MS%;E^<__D//_]#KP,KJ<ZB5".MMWC-:8PWUC;&4%)P:Z:X5_H0&PW[..1;C>
MBLS:DT7 (.[[R%2NQ#0H=FKZ1Y +QR7G,]\"8!XY"EAG_@@ZZ^4,/)L*QCSP
MATQ6W<[0+"7OWF8RS6V*I')!VN#U&59+QN:MMJCWV#+WN+\X<>^]OH-G=5=>
M7&G8;5JV*I(>;H9JRQ\92&:(DXT51/'WW8V(@-LPP9)J/!'.04#X=0-R=YEH
M2[UD$FSIL]DJX'+%L&RCHJ)G\-'C6>(358LQ:>F!(M"WDV+A1<N%A[3Y6?)_
M2:YWTO)]WIIXYE%V>7=G%C,<<D;[VHL 'FVM3F*)XIR2\/)16M.00@,2M=Z$
MS"-QT0#J'9=O#?[WP+]'ZAR#KW6+46Y&>1W/BU(%4MEDJ#2QB/>?.JQB-[ZC
M2/+4'PG&X21R_<SL:SILUU>^YRL8I0"IVD\\R5LE()"[)BH0KSGISQ*@"+O@
M"F@TT%-<N4H>L"26EF/\*D0W^A8/#2!)=WE4E3Y]I)G9VI)!6C0$>4=?G[XD
MD:0'FC]@+[4C1"2N&3;0R$;MJ5,$"\/NAKPJ.M;MW<M2#R)R!$8HLG;4"SA5
M[5-K'N*DD?(O=<8ADWM68D5T[Y?@K0BX?Y@(*IZ#*EC";+-QA^C8O.QYQ4(S
M.):$*XYQW#]/" J)XL7#QFI0U6EZI<P"<02-],XV',/.Q2.>$MWX\"0]5(XD
MR&^H9>ZXXIO4,V5+#/Y))TGAW"*S0(GQ);#%(LU$V@O&<QR[*S=P3?KW;#8!
MU275ZNE4*!>H\'4J.>_?&-ER4]O]/_1$545M&9U+&[9SJ%KQ$%-:U;D7ZVW>
M&<T&4['[P(E-T^MI\)-KAL);+=VS5[*CA\2DWVIH 5Q[11J1VDXYFR43"7A1
M1"A:%S*(*92.1SUMJ&:Z[/56W]$OI?+YRS\"61I*N9SE5HZ*'E9F[/*$DYHF
MS_WB)ANY03U:[2^F"3/R[)[%:CF;@^2B<AM.?U_N@S,[(NZEZ +CZ^T'GFZ6
M1'"@ >H%)0S*=KI&F!8="[=VB]\4X_0!'V*&I"5V41V1#IIQ92I?_*<J;N@S
M<&6(Y*!67!W5D&W)7&^)NCH-T Z%XMR@9#6C3[_FO?*&@;Y#+F^Q='%(#H;Z
M5PRE[.:]B4!6"RY:,M!T^8G*,L<3P#>X_EJ(F(U=;DVG=?;^D?M70A*^)8?+
M*]K9S_3TLZU?/C7732TN-C!A4[* 6\;!?ZI!5"84@JP"?]$ [/W1$&,&GMKB
M&].=E@L9X\=E9D[.-EG-03I=Q[PY08R><,T#09G3HZ" "&Y&W+]O)GE?C5R^
MK"W)I[VZOCX3MG+D\#V^.G_(Y:4#[-EA@/_42I^:]H)R]^4LK+>2$U9U#+28
MD;^4__H4HU+*%ZP6M%_26R%W]6UB?(L]2A.TA1T+BEH+U2-(EYV_/ZQ W63L
M[^ZQPT>W G^_FOT\,2K<KMVOSQ'1T]:7W\$KE!N;S+84JAWA:*#J[?=*7GW2
M(:BKXA=EB.F'VML$JZ@B9O01GINY3(Z-UB2/QXF^*#MHMQ,D<)NUI)IK9\L^
M:Q'^0QLWPKHRC1*>QLZHWW4N#+',8\9&XB"(^EHO52](/=N(#X8BJVRS)WEK
M[.#W'[MT^46ZQ2]G"D&^8KEQQS5NULX2*0)+G%A?BA\5KF/\(5WR<C_Z*FOR
M)>8W7K$H7FP+^Z1ZCFU!1DCYP<APP2<'E$"#E_B';K7Z+J6R&K<*>Z*J/<TZ
MY><R@D$!5SO6UPQ-ZN(:+?X7)89O_4?'V8QGF5@8_,IQNZ0ZDV5=326,;-96
M;Z&M^^<)>+$J=PJWYF5!!012[,(G%&C XWZC=1H5NH2_?^S/K'$6I+F*2^UP
MW[\X11:4_-R!"]08!N*>38:=B:6K-QV,W* >-KB6Y-"_B3=5+69H!3DEI<Y>
M34$&&L#]_;-@TJ&H^8VF@%5?A$>NG73$P5@LCH:#$UFIM%R>; Z=SCP[0VBY
MVQ?X96"[Y@0]$FEZ8XH&M$=?C-C7/'=B2W%@7AY$WB0W(3U]20/_8,7]$$V%
M6WU_GOA+4_Q6QTSH0&7MU&ANV6;%?5BKR3JW2I?GVN1]/YP;14;:SCG[L@[D
MVJ1:,6NF6(VQR]L/"QNKKFN:3B-WG5Q& VK#SX@0Q-#F2(8_9M%IQ0D.T8FK
M+X5PIANH@/)]D%E0ATN;+RR[8L;^8"UL*B\!#:A0^W5FNJQGDBBN$R1WK\P/
M_R6T9W!Z^C*>:#D]^J/]0SE3DUEOH^:+^\X"O)A8Z$@ITS32:T:U2_/P9>U<
M\YR+;>7+(LPU) (#E6WL'-P[;<JV&Q^PBL&$[L<PSRN^U$]:EZ(!T[J21'<Q
M?DC.62[WK;41YE2=[+MG=VN7-YDJ'L8N>?5++>8-%U\%7]R^@9;@AXS)J:%N
MR0XI"W-K?AIU$-BASC"5='S;#SLP9/BGUH)A2%_S>*ZBW3_(IV+/3PR3;^DS
MV%8KZ^Q*N5!DF.YZ<J:0PSN'B\_J/A] ELQ2*6I>O>G8&<A>_Z;:QG>'L!U\
M?X@W/>I2S+,]BR;(X,..6XE<HZ],V.$ET9.]Z\1LH2P%8=(MUD  X]UMV,[K
M5JHBO<V>\96*[(S(&WJ@;NC&P=2$56ND<5CW+*(4 KF)U46,??%_9+'1;&1H
M:K</E)^K@]?%-S[O%R@ZUG'CV6XJ%]E>]7H>7N)A@]S4Y]F9NLSG6'Y+*%.8
M1ZMH8;&VAM0OVF!7UU(X1I5Z1M;]U;(OK1RH[ENA(I0L HU<C%B=R)'D585_
M"V:1S5V_ TA9+2 F]SEP%J%1%M&:@?*5]V^=# -X?UDZ68QQYC_*U=N<\64S
ME]*JGN:^I/Q4?U9:=#3M1;Q8JN5I69+SU[+W?U;G![\]ZSG62&9GPWNK)([C
MB>EPH6' IU8_^\JXM39>T8[S6(8.#>C>TRQZF=I,H\1=Q/7 DSA"_J.\5N)3
MK+.7J;5XG%5WKF?B,8F][//8:JCR*RZC_WC8-L,7ZN!0NUIQU56JTJT(@59'
MF?0?K3OB3N=?KQ9!XH=K?Q9GPA:4CO)6Y;;:<B/TAL4<FVZC41V4FRZIWK/7
M=G;\GEQXN?%VEG4N"R5&OM&W35,'NF3Y+39;^OFRHX,4)R^N@%-9)_J0C%*$
M4$ANPO<J6I:X1Q.F4_8W.1+]7+LR\B=\7PQ6%Q>S[CZ?=@4X;3>JW,ZHY^;>
M3-6<H+X[\Y*$7=DXR33<N(KM:&<*YU&<ZNCK+._\-;;NG!B[GDA*L.M^.GX[
MNQT)DR/!7410'24[N,8DN* !Y3%7U\QG9'JJ(ABO%JWGB/\JN>[!DR(@]K[*
M V%YW^8<<02).;_>1Q3$BLMN8EZ\;.WEF,J <=]9>\5&<*G*.RRU1V^!SWTM
M+K3SY& ZS"ZQ[Z@TU7[)%/+?GA^(AI?12X.HL!RJAO4&GH1 OH@4W3H<Z0["
M] (Q1Z;>^A@WJ@*_<(U'<3[U6N3KSWR<#6Z9\5E+F9GZ%F,B[?:U.(<U],^C
M)G-X[=K9V&=A-" _"0]G]ZGI?FK9<3V6FR*MZY^=P],=0O B6^'5'_JF/#$#
M_K85[;UU*[F[6QYU-(")6UD--=.1BDRS:?[YRW8=MU\3#?"C]_VA2;!X(#S2
MJK!U%6LB?6*?D^[CH#17L#JAAP9@/);#N?XA1C0&Z:HT;_SN-.*=R$,F($C9
MYEES8(]P;RSCW[7I+W\;<Q62-'S"PI+1OJ4L=/N]UC_XBWJ0ZEO<7="OL(V$
M8(&Z[)&&OPTH@%@/_8],F9W[_3>(%'G]./XR22FG3].%Y69O.EG":>15%'"G
M3G@Q?U\+O!"@[0VPJ7R$$)7<RURH^ 3=]0 ' 2WLB$#4S;O-,W77_I>S-B6F
M9;U;.,+K+!!G5,+V&B6W+XV%X:MF'W(T0'=2S%M[ -85RC))101L^WPT.,;,
M>*XC8A/8W\=#/;)Q$D;/T3XIH ?*GEVE49 ]VDC N/FL1ILX<+%YFWKBR^C.
MI8XP+MVG%SO]7F5I,IF=H2 S\PT?>UVJ3V40VPAS+FXM56:[CI>RM1^'8SK
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M$T.<#7%';DP503[ILZR0_'EX>KKGG+XOVSPL7#369P@-B/0U[;JY>HZ1^$K
M:H@HI07D8[/I"TG=BNN!(ELMSRVBVG"#]DEFCYS(D6?E]Q3,ORC3X^+FRNP&
M86VZM\HO)]DUT( F+$71Z$T<*-=8[5IH)MW[BL)Y*\'HZ9Y \A=H0+19!\-0
MLY?=(D[WE0/NT05H@)F.1"!29O.I3P8ATU!V76]AP>;)#3T],T^O7,65^<LV
M[AM44.^9>YX-]?&V7FV@AUG4)TV5@SH9Y7[^$1;W.*VIO,0IU7/3P4BH91!\
M[Z=61 3M=DW:5=B$CJR(X6_)HS,P7&,,X0232/J]3U%>+Q@T:==$?3AT'K.V
M'#U4GT3\K3B[_O7>21L:P(QK=A-0-(3XEEL_H8-ZZ1;FK5'B3M'SI9<N5T6.
MUFOF-6PMB.7^C__8;!8:$(@&0*./Y\%K_FA KR9/SPG5DCO,* PU^Z0,)HLE
M];W/\8GP.D0WQ9O8#IRS-Z>BGQ=\K[#9VISH,XJK\^X41XE(_KZ$+'7;/<*5
M2=CPI>'HZ_W1H3D%A067 QNB\H* +ADB>?=;KHS=B_;FC@,G-=0#?0H#MABC
M ;Y$: "9S#T/&D *=NU&W3.@.(L*NN^X#(#J=]]S2"A[:Q.OLVB+Y.0>Q)UI
M.N3C9*D%&D"X'H7B$I>5><FS.K,=IH7](Z011HF9=7DD3QG%&I_#4#KH!/8R
M=Z.S\;+*R!RQ_KNE\#(LOBULZJYE-S/ITM#W$^2TXUX%N41T=PI&% ,WP(B<
MNWJ&ZW4T *Z18+FN'6'CF)1X&QF16",;5Q@+Y(;MOX.Q1&RZ"D!@1$\7+7R9
MHI6K6\]A%E#634UL?'8Q^)C^*5=BN6F/NL6=!_1;PB3B;K]L16!&?S?H.4>1
MVD)?6%L:PLMN[US$"&&$8D<=!2,1P'L-AO_>B]$FA(X+5GV D31W 0G?F$!K
MC(=5>%,:B" F*L"EN'_C])F,&[+*VGFV#E3CRA2'Y_?3KX:*)6ZR-I$O%+J8
M8%D"]O$ M2^6M"5I?NC>K*Y1AU5<&V6FV>5,.8'^'\-=_0UA:],['7?P+D9/
MDO3MS:I^@%"<Z*,??!!XT7$[\7[B 4 'YF$H"XNA9I.*Z/A &2%$=W51<%G.
M85FG:;N2"]&L[W!&[4SP>A'$Z)Y&+]]#[ 2NL]& ?S=(]'^/VQ3<U:XC,<S:
M7H,]TWK>UAC+9:GCSSAX QB\ZC5L1M@\CC8N:4-EA8=;;"0"F%P(:&$$C0-B
MIG2%43RAN>EMK:7-YR7>8BNW>07OG=]^F[R2/RG@.K%=&0;_Y[.:5N@-E*W#
MCQ:Y79*K/X]=!$#E/L62/HV ,3H-2M21-73+;9Z9-$Z7E;W>CM4V:;!8"1?S
MD5Y_@W&9"T__G+]>,K*D'.K6H)G:LGAE]WN6X>66JC,,#?AQ8U1@6[]4-(_@
M@\F$N)R0[C7[#-207S_'\OGU:UXBV,6KUSOE=$8>@09(X10VJ1CIS.U[/XGN
M_4XI,M4[[62EJ>4V.8"(8NL:[X)R] 60JD4K?\D.@Y4+1'[L6IQZG<5GL.?&
MD[S%R4?10)^9F7 K+A^6D5Y_'YV0(ZV1IN)Y=;+K*I!4XAXV)=58'[;;_&3P
MT?LF*33 _:J,Q26&;#I(DPJ+]B=G>5&>'H@\TLZ%_D+,?[SH$J>J&"+(T]1$
M>D,Z5[<T$'L\-*?F/]P8)!H2+>1"()'=9.#4V;<(K)WGCV*Z:?VYXQFMO7:"
M>92N[FEV-.=_*3#%D\=G>08N3$8# &@ D<I2(;3%L&[$PN3YMB;H1 :4H$^;
MQ%)!47R(!@RBV%)V&1;K&4!-D\<2,UC65$?YPWP<)W-Q<^-(4-6XMX9-:6!D
M\,)QR%A\_XLV^4PT0"FGL33\*S\#=>O'K8866L(_$%3'>=&#+O<YG)NU4##W
MKN3H-$5>B*?[UHW)*<7K!=5[5IR)@IHUMA,4A6.MC'*.71+Z$=W:%'PODP"6
MCMVCVD$*] /B8VI'ZG$]B[F)7(\4:+@(>:()*<8KKA_RI/SXJ6'8;SJI\<B%
M9X\W82T0U\N2!*-2W0R)EN0//[L,ZPQLJL]1'>4W]:N$;=/F/&+?^\@9&U)>
M7@E=O)?W/W:Z*%]2GEJ?/%)=77DGW1'*UL365,*OI<CY+*_43:@$6JPUJ>?Z
MH->;"3^*]N#1?&K#*8A?&VK=4#(V<F88:L/O50OW>01OB5^4* @[OS0HIAC'
M,'PM?+?GP? QB6=%<-N3*' >&'PHBP9DNB-!FDTGF,NES4R]D$R<;\9[HU+.
M OLJWM/0^VB:Y_2Z4X;6[-DQR9R))@#:6$_-?J%:3=;K".<T$JVC#U!)-.#5
M47\R6 D'"LKL@!]M]6D.+7!KH3R5W#J09T(,H0*#:F32F6=W4?O:G)>ND4F9
MP4ZO!K',-ETB<5B3UXGZFLH4^NLU[V('=5&&:7$A_3,M**KRE\<>=3CG/&RQ
M>\W1 M4YNVTX6W)V6-=S3VQ Q*FNN_X_<(K$ ST2>,_3MG++$!T')^*>.C9"
M7C,&:  VTJ>W3+F'.JB0U\FYZYT0^=5Z-L16V&ZTGI_GT: +]7"A;5TP W>M
M# C\)V3O@JQI8PRW.^>H,3T\[1!<RKRE;$;7W@;**MM=7X;4]HBV][]CIO_=
MEDFEXX8&\)POP_(03E2_;G0C!AFN#05,@ \R:W+J_GG>_*^3)ZWQ8+K!M1M"
M_[.R6ZYZ(5U>-Q6Q&U/>YYI.2. +L@_L&@",<<+I6A4#&4H5*5+ _V@167Y8
MW^C[:EZ+\>8M#Q@<YA!XQ@_M'$1HYI&1!)C#N9*H1JE[YV'W'S>,6/ C19:Q
M,$DD*7>0ZZ*IVS/^YG0R6&XXJVVJU9=&A O[36[*G-X._-Z"L /$'$3OR=^;
M(F1_27"_8[E\\TTZ=^O9XE_6G])!*O>RGD@9<%]S&4WO3^BGGY=8CE6+U07+
MIB>[($S5\0K^_)>?^#XN6L3'(*)R;C2P'1AO*$G>^*9O-V:IYCW1LV.>R!#1
M3EX# P_.'I(([*C5U(6F H*EVKLLE6!\,2A<GC]Z1H,@MV AD5[I]>(_^%#1
M-08I"2Z2T>%^LIL=MKS]G_VE((3$<0NZUP/GM!!5K7V_'; !<(R=F%YW=H/_
MM)54EFM!L>.#E>IFN(-OOZ>)C#'<R?MJ&67A7)0'*[5'JU8%;3,G;WWI7FS:
MNXMU1H$FT(!.T2J&M@#0]<1MQ;GFS7+-/S^:=)%IKFE4MS0EKN(WOFP,B6%1
M&2H=D/GR7IC,JK&"7$_*#%J&=XN;*)H4GUO-&5$=6S*&O !QQMGK#^QER0OD
MKJ_6N]Y8N=:J?8R ,;L5>+I8.?WKH4BRDQ.3J=+MIC2W!)(DFS#M=4^,P7)M
M1+_J3-0(@UQ,?+K''#, _ _3,U]LH9;OLX^_2HB9DL\3L6SZF'+3)G&"8,/W
MV/!QW2S/<G&BF]ED3(8%+KY3668F "@KR<"T\9GTASEBQ&H)2/67A[G>,/H'
M,3ZGPG(6VC.LTQ$I"'[E0J78'53?U/?T[].J4W'E#Q*_Y^CT62_][VXS$PBZ
M5H\T"A0L[9(NSX7@!>)#MB*9D+<,)_N.,5_P144]A#LF-NQ./E"[(7GE&#5G
M?/N_F\PTP&GS&7/K/08Q"7X[:@-PE!2=Y39H+B/ /5TK-,UE58M ^.U6!"V*
M<G5MSN4FX[RX2"_3M>.R#@*-"$2-L5TWW&8,H $%(",.L,;8@::N,D&N#OFU
M8)+X[Z21U[XM(0"OB\*Z#)%SF6=!3?69EA"K3TQ?M<'$=_T 0C1 63=.<<I\
M+L\L<!&?Q:9:G[!41D-IX=)VI6E/(44A+L'H!/EYR3^X=L>[76DMUL@O%&QC
MYO 66;PZN^#4Q,U(Q3;E<#>& $C4.5+%JHMBONYCU_A5A.7:N6<0<74E03[Y
MVKRA0?:^<=B\1-1UV(4EW:6<]>/B8O:O[QE1[Z*J9?L+IJL$,G0-!TO:=/(X
MU[2C0A<L*I">+N1ZC2]LJA6I>:FZWY >_OS]$U<<]\2@W/]W?][>JOI0[+*\
MV^CF-S[Z-<EQ'RZ&7@G:^LK:N"]5$7J4[999$<9T7NG.6"X#]R YXP)*)]3C
M9[V3&<K?VY4[;FCI:X%3T:W,#/ZT: "OMG+WN8%FQ?<Y8JX>3$5B%J(3_QDP
MPS:VTP@@C56XLU/UC?HM\6*[&AF%4DF2M,\[:E ,&0Z/GJX0T&;LVECX7MOT
MAGKT68A\TL#@GR]O__H 3O2:;7+T/HTP]E0_TP$WB_)LW(\H4;]V\6AF*AEQ
M3'J2KUJ5'^=GV"W6W>]M?EJC!3>/8)[SUH*&TQCA[38PV-;6U]=K;WWZS/MV
MU./+&Z>("%6KG?6QWC'*O3D*W2M_J**Y>0S(G+RX^HGP*T"HWK8XJ!(QC :P
M)/497>$VHP$3BD8/%;[Z/>95\"D%)@JHU7#WU,#9@K,R?FG^9G'^,S=>%$E^
MP1&U7>K9C$W;U6Z]S"*86(*N?STZQ$V">Z:5E2)2C('%X7=#R/.7L<6 FQ=W
MI>GF!;XKH&5OX:+=YK&?QFVGIW[.'D<+9;.K+ZC9.P<6 9TX/[F(H S=2' _
M12)<!S%ZWMW\(B!O)". :WM4[F";7MTT0G,MN)6YP)VBLVK7\[-MHF9E<T'R
M4D;HX*O^)I:Y%(/5^#8J'</'^41OBO>FZCA ;L-N+Z<FRCS<)G4+ZH.Y3ON[
MWKA/]8",'0]_X4:4?]FHY/US?[ (W/C@KH9R7T$#UA6T,KPQ&A)YJ&4-.9[Y
MQ-Q\8W0QTKU]W:[WL]JZ@RK!2U\#=U1_3#/.=:KIDE8F&7J*6#/_4!)A76^>
MC@9T!9P6W,-;T( _B3DH4K9 X$[D&@JKSE. [+IC?U49#7A?^="G<K:V1!5\
MCP8DK8X)/ZBO)QO*-["'LN7'K0WWICJ=;N=*4R8V\,D45>%@L!!>UJ/S33B8
MD5^2K:_M:&[[!+1L6MH6I3W% 7CBC7H+Q-<WV5>N&;F 8^K$=JCCFTH4; 2\
M(/S>NJ>)D/43XFZS_-)P3+W2 -FM43GFHEM-)O=NE6A%<N:A,^R<!32@9&?X
M^[+'F/YU17ZKS.F!)-SL;&7?51JZ\46:4O[@;$?H#_-L=<>&' *(\K-Y<)'D
M08'>9(KZG;-%E&GQI'-,I4T8E(GJ2/?/&3<F/:Z\V(/F<"B)MK!5^.B<;ZU%
M7'(MR7'GG7DWR)J*FG;V&#EU=$C4V?@R@_#=7\LLW$\XVC8%1VZ]<Q[[[%KA
M_A *M@>Z?HO=@,)Z$'R]*F@ GG(G&G"!;W>/&_>@8<I=.M.E*/Y6\;9#K QH
M0(?7=B?OO#_&UYE+&SF>&8UL1F.D]7M&A#!'<2EH8Y&\?]'@;_) 47VJ(*T^
M5G4G82=V=2!QV7Z[IT>5[UG#Q.RX(O/\V-C";AE0I) 'Y;M+OH8@9OL7@<0!
MQ$$#QKD[3IF449SYWF0]9&1Y(?X+]ZHK-E?.#1]R>CS4#6#R1HX''8O[[GE)
M/6FA+@H>/- P_$^Q<E367ZE>[7^T)93]ZO73-T S O+,>9#G:XC,6TNXCD!1
M;[H> W=+LINIQ97U=87N_Q1SQ0<(/IR%"7J@YN8V,SRL'&Q#<9,>.UH=*EKL
M9!CJ<W=2(L;3ZRL<IY.ZS\5_5EH0A3N60JGU\G4 MI"A%YX)XO8,>C:D5[@1
MF97 DK@]^ZR!Y&B=I)]9Z IP7>'V/X^XSBF86"FG^*#KY&ZR_NB!6KFBKE?2
M9(!#IMC8\IJ&"M4/86^'#;C8A<9(/FW5%<,=8DG8HB /);"E_5K>8WK)G=H%
MZ;^-G%QFF;U2)AUG><S#C%<<S/[^8:>OH@'_;EVI@[OB3L'(1TMHP",6- !:
MHKO,UI.PN52!U<+&96.W=2@E=LV>7UHDUWZEM8J\RR3H>';))S:IB)VPEL+T
MM\C!KLDT1IW=F6I]W8>SU5=P1M5+> $6"])A2:";8JE!0I?/C=X_;-%_-T;A
M_Q@!+;[U4:9$1/(U(N_!O^$5_04'0M7Z')XFUX9S5S&:C2)N&)(L6LTQO[VF
M'*B 4-R(I/GR\VI*B5?_3R<,+#Y*-)YZR'5!3S( %R:GSJ-5SU[. [LT3+PN
M8N" ?%=W$ADODN*/K:\_V9S7H+-:'3U0S!0]"[=I>#5J3[$F'FE8"B:3,G_]
M"PVPNWM?IZD)KN'BL_<A?1Z=YU.GR(@&J.WLEDR'S?FFW4=QR<"?;J>0SM8G
M*0A$.'HX+.OKU4]D)@M3WE)G3O50;VV.46;"QE3!CN&/#ST#&$DD F9CX!7!
M+Z92)U?94NGRI)J7*E>.?HK./ 5VZ0:BXE\S$ L)!XTZ1/#8I9UP>=UIQ5A:
M4CMM7YA/-!!YNA05KNS]3>Q(&BM((<SS\B@]K&_.!+Y[WO(ML8_#T].<\OI1
M"\_3_0DK$6]9EL?;+$]>F9]PT#J*(T&_0'L9BIEY6$D_7WLWV3=\ ==&"3F<
MK,UFIV)'L1]'Y$.G:64*/\;',B/G^CG!\H4:SIO;=2?@@]L#4Y%:9DV\M*FZ
M>J0@&A#4U 1+IK)]9?MEHV\+RS,Z&<RY=_AZ]G:()K!OX9D@69?!ZCZ%@UXG
M7[\;M2SMYS66,'%XMR]E>7AG$E5UZG2FS28CT94R\^V<(F>81D9SNG;8:R'W
ME97^,_#DVWN%O/P,WYI/[Y968NEPI.*F?4"@+@HCBPE3:6%WRIXU/]A%H;>5
MNF4E$90O'RA2ME[0<QL /F)&!<76B2DF?8ESL?>>7 %W^Q9H//#5;/<-*;*,
M0G=_I<E."@H'YNB;[S1.D.PH*S-6,@]1"DIYVPFM[X+1KZOL0%9$MX."E5>Z
MF_NS9<5R95:/]W[U4I</Y-BU4C1)[$Q6B4E"Z?BZFC\O9E;Y/$XI^!C];G_O
M2CI%B,ITLMVW-L.S(DYO-[HHB\A82EI73]-JWHI"1&IGL4S^F)GDTPX^X_6%
MQ&413Y2 #E\UERQ.HR71.=GY/; N^$=<KYJ%9][,;'"*=XN!TBVM]FK4".U!
M0N=UKPL]/V)FPPA;9U4LZ:!X3;<GKCXAKWK,'=XA(]MY$R0\<&0 5.^?<,C-
M8ATIG@*GI)7XEWA&]BY]G"R OZP0>E'W.,)3DJ1@7U(@S=[P<!MJ::N,%/S5
M>!]-=M87=P=2>%U5I#^V43MSST80$+Y";6)GG7W95._]AKF)5FM2@A(NG0)3
M)IH_\!2?7+5LB E]D2))1;]^1E2G)(H1V9D+YW7U=9NK.;S/2''_K$3=8N6O
M9:AY<U/!]P608_6C6)00FU1-&Z4!K9DB%\IK;@Q;Q5[C+ZNCN(48&Z9L(!\]
M?3PUK)QIOJT3LC6&\-+D^7&A$;6\[UC^/=F$$1P([)DS,I+TZRZ4651PNV$0
M3#9)WSHTKEX;>:C8#U*G3:WWOW;&JE4C>]B=N;E>\:P/K]:TA*>AL3PH;#27
M3+:Q1E>#5=[*0:Q33_@2!XL>]ZKDG9O3WKE'_23E\B6=1GMV,]*T^Y=5P!"D
ML;G_=H;!:R'8<]/.VI:_?\F%.,+\D>20X#@:$.E>QSX:WJ&T,SY9H?RL;*[A
MLFG. O4B6(V) R?.*;I1^>EQ01MH+DU7/M90CW,HQ+OWQ> ?0\^=BPI9.AS/
MB\H9 ^UVV^"8\"SJM_IM4O\<25K_%R6WU)*&!CS>/^'B6]UU4VX!Q8[9[A2J
M>A:)_?#UKQ37B+R@3BC6UY.O^0![$3\=UTL[WOPY#/[F1<(?3AGOG3J/\CPW
MRPT#1=;3X\((,_O8O2U=;67K(,, 3P+(EKYC7/?!%9ALUS-^O:HD@4O1I3YZ
M=@D(;+W8YXHQHC/$[CQMKQ"-AM9'RC/8&_Q"??WBR\1=G=@^[E)"V:\%^LB.
M.7UC5LFE;*?<L?Y7(L\HU^Y<ZZ[<95KS>Q)4D4]GZ4IA(.\[3<"W(V_/(R%@
MGN7LD+S\7GIUP.^;;Z5=8>S%C*/P9VJ_K?3@#8=G+FB \^SWB).<U;S:#NZV
MLYOQS.'7?$R^0'<?O<E21,S(?/TD3#CVJ#\9QR+^YR;2W0A!9C3M/%#'Q6SW
M4HORF\O=1.5=J7AGN6MZ_K*;C#5+EN('+WDTX)1A53^[JO;(1,$CMEM]X>D>
M5%B&>!ECQ8>H^)(>ECI?EL/*FC4B)"3*"PJ%RW>7N(=Q$7'8YC^K2*)IX2Q)
M7#8(^V6?I>4W9T]W4#!3Y^Y<2%KY5OG%TM-FADQ-U/Y#ZA\G5/R* "J"2I;*
MK ZLDT@2HP0-DP>6M9"Q[S$72*]+.>^.U(R 'VL(VN+-#"Z6IJV\A6MB $U)
M6 _R)*LK<>?4Y;'D QF:TR'X@*LJ\*H3\,4@G+>_2"S5AZR4HXL!3[AXKD@/
M]B]O0;WYU]7,=SD@@!].EVH-7UJFT!]D'*5H%Q)#D?FA ;BOKN=14[.O;8/5
MJ$\[BI@ORHN/-ZR/\C)F4DP_;#(=FP#&,)O*'=?Z$\]_@ZOTXXU_322O17>6
MQ!;GC=SUWV1&T6L'XAQJC0ZA 5[OG-M(QF0^<!OC_@584AZ[WE;MG.XISPC(
M\H<+-J9GY 1*49G;#N4T"40"(Y\;WXD'_HT%3WUEDKQDV3E[7,./9-KIY8M4
MT(K')\,9CG0L/C@D^B11D'AEB.=BDL1*YH9@R@F.LRUG7?#E&8A6F"J_U_-@
M/1JF+#/:,I>^&R(B[@,W T/OTF'3;N17\,6N7UWAM+*/BMG_8(YKJJ,X)DN#
M$V@/^ J[NJW:C>GG#7'V="A6.3I:L+F_DA-GBBU4GJ'PA!A"@?(A0PG8;6NJ
MQ1_:.?*&A\GJ+M" 8#K8TT_ZR]T%TFZX ZG>KOW+1D5B2)PVMH#:CGIE9!$[
M<LC,1OWZ<!(L>12W6E-K@%W7[] T^X?WO(#[?%G0GFA7[Y1^Y<*AE+>8*4 *
MP.GW \=839ZP%EEZM8<$ZZ9J%=&*\Q@K'LQ=WG1T6HB4[+_+ONJ"KC0KT+RX
ME^;L)=L5</GNOM=8.['U[MAPD6G-RY;2D[@3*5EH:VUSG,Y?6=*(DHB\B0(I
M:]>(N-:X85#*V$D 76P[XLS/R3Y?5B2E<[LK9%W99QP)/?#X^:7%*HLL==.9
MYH9MCR)%H4R.R,GJ:EUFA882&D5QRWZ_ST6F,N&^TQ#*6J*@=HQI_C(;GDD;
MSZ[]V2&0U\=7+]6H: PZ;Y09SY<D$F[Z3_'[/.VZ*\(SR>'DU9/Y:07ZH>86
MS&^%#'+M<RITD1\1)Z?98S!@MX%6=Q(&R=[4:'6C\5\*_"'!*3$&$]!YQ94C
M @,,YX()WC/?CJ0G+OH&\\;I:E+.,UM[Z%RZTLC4*WHBY-34S<$I&S!CC;G
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ML>Z !KSY/W9(4!<:\.Q"F=) P2YON76R)VV>_W,R5;^# ;<GPEN#P$Q BTA
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M#AS*5L,ISJ; NH H#X&V?35=3XZ.E-K4[(C^S8&J1CT.^CFY/6=%TSOD&U$
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M,OA*IOKKP7U8\3:MA-IB8ZB6Z@GQ9Z#L%&Z!5<*<KK+Q"V2<+<J+!%>CXV:
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M;16O/"UF, "I@NT"RW$FF(5J8(1335-4C,C93L^VHA<I+_6?3V4^S$K@X8(
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M/1-1=W )L+)%&]E.$ ^T&Z&_FCA-?R4 _AK$?/<P/I9QF>Y$#03>G,*)N[+
M_3U_U,/VQ:-:S'T\N>JCKG2CW'K!/'&I8\7@J%,FK"<ZQNR$\;*-JKD:7E.7
M(-CVJ6)1DXA%]XPT0YVM=\&YA@B=?8\  ,E9*& )@(-WO_<0\AQ9P(?S6QQ;
M=7OQF[ZZ#TE< 9;>E7)/WCQ8B=PE .Q89]&(Y<6N)B 95T31+'(KI=IL1KW(
M461>TY%=<@8<<Q/$6-'.R-S['C2V#[1>#)- GDS5G'IOE\R!R*#B2/-GKJ+*
MJXT/@)/2G_I&IMHZAF>JK\/_'?'0YA%/(4KQ=+Y>ASR+;82$M&=DY5]^FKW9
MAX$DS)4O6$PNE0)G63$_\4]F[86L4:67&J=]XLWIEX50MN2@E-A)-D^MAFNY
M7_78N:/ZFOS/NG<U&D3)ODU9 %0V8U+#9!4=<BP<[8R%YR4;9E>;/_EP4$A$
M!RWY?FAA11OL.&$( '1JU GKPZTJT&F==&J\"]1C_H,?2+WN:S!58D<1J&JY
MF#7$?A[?ST+<4G,@WAR_)2.K4&H"DJAO^?@C_/FY+?C<8)6>>8-X;3^VK88
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MK3E^ER>V;OFVI'3+1]"!T?2(EVH(\1#55Z=;8 1.!!$*V> NA2S^:</.?R(
M: -)-Q;)<<\:DT-6<4?T*2)U_"&?(//:%F_7FK-/DZ\#NU^V^G<"(!/\?> !
M0Q:+>S2% ZM9LAW=Q?26[I:>LT!IWA#^$8YB-) -K+OEC4C%O.6VKYV5OO6[
M1[I8?/::O B [?!!OFU7N&M'B)F$S600 -UM\;YF;8?4VSYY)%\Z=3L[W(*<
M?@ZZ1P?<]S3VV()3S2<DH(3NFX!E7L+'G#A23/P^O6I>H9626@>0C]7RB"J!
MYJ)UG^0Q)QQ2<_-6N_]H\JVTSQ^D+Q&EN>:W-W^+U?SKZ23J=7,>[#:J[0XH
ME4'O8I'QEW!37]U<<S3&W0B(&0\DQZ\5$0"?LZ^27=490X-=DQ4]?#']PB=/
MBNZ*.&S5R#E''FIB'=I(" #W=P3 ;TU\?]R_KQ9M8RW.L:V'UVS$G?7\0*C^
MI)&O#X@JQ+%>#5[3(R+@)>^_K\FWA5P+Z*A]\AW37KR_^IZ<T#7I&PR47)XX
MOC1[R2Z3X)QC="-;.][5*!M3+LM# +R:NB9AG[6OU;9XY_6CU, "+].S\3<@
MI[J0?U/1^U8)YI'IUX:XCMZOEBALL'KKX&-ZZ((D4:P8E?6\R1"0W!+39))'
M!UV^D[]>?BN +!\GAZE!ZF7$H 9YTG)>&<XH)WK%.9[_6&:-%5MDQA:2*;^A
M#*>@CFG&GCY_>=P'LQX'.@B1&FU.5:@T)H#1NN\%P'\ $-]F?\Z/_*[B&<AJ
M>-L2JUZ:E3O#]_O\/$JFF_(@\RL).0;$[T"&ROI8]&+GA0UECS=')5*IK&CB
MH21TZ[]YLBV_EC]]&A-5.>=9E8(:^(S].&GZ[Y<#]B_+<23T_SS=_]8B#H:"
MK*,O.R]IA:_7A>(RSB2W.0G/X-). ,Q-$  82@*@"O8" XGZZ.^4TUVRV:$-
M8A>!9?Q@9%LZ2#(>Z]:""AJ[:V1,1S?1?@VK@:EV.WG%-#Z])J*2_]NQD&O_
M_'DK-TGLPV>:R#>CZ0#C:S>V)[+_;YK_Y2,_ ZD#=KSJ>B1PA]:3 ,@U;I1>
ME^> ],D>*%\%[;4=JVO=[KEV$[8FX 4Z^^(.[/Y![^Z[''L(!01%Z4(^!V(0
M@*\P>$'+;Q0B^]?>OW9-9MMC9SH4'A*-/'8)#Y2,0]5UR)ET53V.WT2Z9#(0
M98XY$=V6FX:"0U,O@1:.P"J:G'R?#R[TVZX$0,=+,2B^2AW=86-ZL71SO4%\
M6%^GC5]B\>)$]DW 1V6)J@Z<JI2<D$=MW%4S 7!S.,?? )U]'5TPT#5XJ>;M
MA+R9\G/F=\0<2[?TF"IE 5)<E?)4_B!,;X\)WR8.*/<[I4<Q=FWLE/CF@3.]
M_E-(2.BG@-).G*@#.@X9U2U/ZT*-==?"$ !!_L)4WK2UOOE<["6.5I^4.J?$
MI( 1S-B3.X%T6Q="NT_Q8F/+=9KD6XW<TR=:-G?7T,^OQF_V I\2BWU;Y<HP
M:+IRU) U?U*SK!\-\?2H]0Y874FJFC6SL+8^_8P=MKT$^O-,R;K_<DA-'RQ/
M'WE<5<'+]>VOR*L<[X?RQT'-U9I73<WL9>!K).X-\;ABU&FL/R@,:MR1>*62
MPLAI;Y?\_GL*:GBF@.G3\W5)F.)582#U5C:#_",+L(%R?0V\M;YMO#Q%?<V*
MYJ_?M-TGM6(I/DJB7IUKT'[N+WWUI?G=D@M3.9RK(=_<9!:<I-58J<#1M'L<
M5MD4-#8=N,^8J%[+84?7=S.++_],,P\'O'SK+S?A),O# D5G4G9>K(?OLC76
MC);#03Y<5D*//H\V*,^Y414_CGN#$%YJFY7X'<@_A7\"[<DKL@]DQ)@=;M9)
M[^64FI1H2LFH& :[Z DDZP/]2P$B?.WOKT+Q7!O:6 %9N1*PG]+$CE@,^]L)
MSUD-M0U2A@'<0D!4!\:\?"Z\[]#(O6]9?-$14N42[7%Y'?(?VA]AW2Z-X-@X
MUV4GX)L)!MV:IKK$B1>/,Z=$K),#[?3OHDQ8B@ LH]R[U"B9.#HPB?)8.6KJ
MGYT0I./ULJZ&#.@8]3+GLJL8G7DOQDI32W5;;;+6DG=J0'K/%EC'954++3:]
M&.XC3_;#ER;80/<,T?4JQE*LWOTSGV9D'RTT?_A[RG;P(?>T3KJP+F\SR5&Y
MVUNZC,$B_7U%JG[0T[S8<5Z)_$#SM0_3AM4/I<I!7185ZUW[X31\5]6>2XOD
M<PX+Y%68^41[ ]K'SH75+4%HB;3F AZF*%(ZLQZ13L9?Q-M>5S_Q#-Q?K _2
M#A;#>D/RZR^?./9J1;\87V?1W[DB $Y]+_4T0RQ8<1('FJ@UZ+(AIQE?YX7G
MR6Y^75WJHW-.@?RGXQ%4R8=_&+\,JYWOJU\E-/OE(#>R^*JB.L?!4[W=B>#0
M %K=*1>7LO)E/\TJM'HQN]!Z26;[%%LS4:R$@8(=1J:+ +@'?+\8&4@UD5<Y
M<;+[:M&L-1;16=G'\7KN/)%#^['6#&,%+4F=,>"TB14IA/(J*MAJS(1U"9%I
M%CEH4%B8%1:31D[_>1'GY]P1R@'PI>P6;[,G $*BY+^08H-1[8*M01H"#PH>
M2D2:_K0_7Z&]]7)#Y?=:ZYNH4PGLEP.3=N. TSK:$'^@)*8VY"=R,R7W4RK-
MZ5G*F;NJ!_2A<.MT]'LVNML?_EHB?OJ;7WWSMT5K4N)4X)C?F#RL-9JY(*1@
M=:J,TZ2%S&FBZ()?E=Z(JGBAM%&NRGT0X#L4=6F,XY]<.>A-0\_+J(>U(\/'
MQ55/&+^C7G];NM'P,5GPC>62;<)G)OTF7 "FU/'BU>Q6HRTB#,[,LFUL\5"Y
M9#8@36#I*7-EFY_0X-]?O$TJ[Q_PK2W2!_8L/A1G5K<($-E7>HX!]Y#3;NK$
MZ*.'UHZC7M<F+OBP?_U.=TNPJAQ7N:JD6KQ+ +P'4BN@[#_^;![EWRO"%(77
M-/UJG?5T95AT%&$OY4\L]GI9O6X=7<G!-@0@F60AP=8MP2)2&;ZR4!Z8QZ&E
MRIX'%(LU_5E_MD>O,ZOZ6R[N+1\4=ANK? G<:GN Y^]$.Q2.]:1GW1GW%[.L
MOE\5D#O_5V;9GO&.+-/ZM$'SR/]?E-$@)7#L9ESH^$,5H$-8#@'@V/*V&7::
M<$WU0!)7_M<\(\?@@<S55%&>7'0V7HD*V-4FND( 7"-DZ^+9:-X 9+_NZMBA
MQF"M#OB37^9?JO9'=)Y>K!AVC7+$T@7)P?QWV_NR#6!VX&^0\:?3)*W6G?4N
M/=VG0U!8_X_+6-%_[>+^UUC3A+TY@YJXFUB'\L11CX8I[&8;$OB1UN7SY86/
MC?7M6F=98.ZVN>B$('ME?<U$F9 346/D"EICR>9C#RW+',+WM\95 98 L)A:
MC^#?^F:!F8<&9HZ9>3E=G+/*A['YE[\X%2,U) #^*ET/OG1Q!9.<&BZF(8@\
M4FIL"AYJ(2_N%F6#=U;>Q])]7,;6_]H7*U6IT7![5*A:9BH8X?RG1TG$J8]5
M<#1>YD!SB\+XR&'CTN("WF<T_WSGY[Z?<ULZ@@ (JYLO7FJU)@ "VO;SE*^)
M\J++Y<882TWRJNG%RX5_;3>HD6*]=-$\G\7+L^/9KU!&)WX*!$#\0O;UT!\1
M !NORH$43W+/.#<"=EGG+'X6O;.^C#JFVKK2Q8/^YQU#"F,I\<<_R6/QLI ^
MS<G6" +@)R+;X"?N&H(2LTL#KFG*2Y@\;* 2LD\M9[$&>;4*V1.#=++V,0RC
MG!0]9#0,7W'4-":@X_IEYJI.^K_$RUTC_=<3#1WF5RI.:8&=#[-LOE$%Y"\Y
MZ8@LAOB2? E\LLG"@EE+=I*;&%DPAL]*I-YC+AB_\Y*% $@V9*41@*!H+#W5
M.V&9_+,!1=;G62YI]8%'FXOBHPQT7M\R+IR*;"\R1'NLOV6P*^%/DA"@%B_D
M7[\3V;/7&/,"6&/O1S;5=%?GQ_6I?Y-<Z2_S/<Y*3O%TK5EXT'/=NG0.;RY4
MM&.[[RZ'_\+TMGD[:W?V@[3=PL1#5/ZE1ME10ZV;8;Z?61Q3!MX3@"W*-<Y3
MYJH+*!WH\^KSD:LN?<5!IQ+JYIIU=<OAY*-XZCY0Z.@9?J1W'H\ZOPYM,B:'
MLDFFF(4\5*>C^#UW9V<KRA[2K:+" '*XG"Q?L7R8:^D/=^8,"HZ/-OV5 N..
M"7_.J"? B!XOWY/U4)>0E8NP:52$(/^Z,J.1RGRH,Z/\Y)S& :CS@'XM5:]E
MRCH=S_>KS [N21-.=(NJ$NF5I?2,S(Z!BE.*6X:S=KX-^FCT'7UT"*^3=G/6
MA7R<4TWCUO&)[,L=P=SW,"?I9V9=8F_N6)@K:_KJC9?/]T,+.I\1188;QI,K
M1'O WH>A4R)</*T< DK,L9%#JG:7MKN33:4<0F-L1?R?(.1JHZR,8H^\;3WI
M4Z:6!G16QVC8%!@2:"37I9B\"BMJ6$X,3H[JC@=6OR_K3W_ $P"3%D7.\\/W
MI .FTYX\K[MA0&\X(- 0]HNNK_2TE7(2YA'5HL;'8SPVI1BIC_0FD0M:YEX<
M:P&^QE;;5#BXF6^=L2*U[X6O--;7)@;\&DR^6<JWS#HO1>TE%-EXIVEB.<IX
M @I=::IK,+*)53ZJ)0#*M$C8**_VP.MBRZ&=+6::?^&7(6\Z&;+Y[>7D+)#5
MFY..;>S=L6F^K%;5#>1U7N/$ZR[EPN,+>>JJ*R%K*IQ@+52^89^>_#H=]0Z>
M!=MG^Z  IAY0/,3BURX.G>RB?'N3'6\4HJS36L_M\BM/ YN#VO"7\G-$U#U2
M]:9"[1HC-:+8F8JUH!4\9_<73OCNO=PJ*6]I&RCZ;OUD![-?B-@JO_"8/9)U
MOQ0\XY7O=4^1M)@#<L_&.E;SZ+,%W5D*>J;H9[O?8Z*?@C79INU[E#B\@])7
MO!L.^$8T*PDT/MQG<DQI1$3!09=< @ZNG\:4NI]3D%=N&NKGJ:4W<T.V$1<-
MLU^[W_/]38$+ZH%.#L=M%S$?F /<+Z4)@#ZA*@*@?!RR\:%5"58.L;,XYSRU
M.$&Z7-U'%"42 ,UMRN=YZ_5->,5MG/JA7>&H(O49]_*_^SS3Z&);>MJ* _Q7
M)=+X.?*3H=WM&CX9,P(@CN.ZX]%_@LMG22<06CGDF$QG6;.I93)DL.GCISB^
M^Y=,DT)84Q;R:^6S:W>4B@,-!7* WYFT'/14RK7&063)I7@X],O[.R?^H4CX
MA["'!, (R3_"20J(3<=[#$@NAF.P_34.6F^%D]3G4OHV)ZX,R#IG-(P?%DO'
M[G)=K3:9A\&O)<,2!H(C $# C+9EDZE ?LSN>@BL^;6GP*M%U2H#OXCU%.U*
M+=M8(H[E:8.A14P(. S_63H;3]1' '0A2L$6OR]J&S#J78$LAP^R?VT]FE-X
MV*8<\=+JLTF0Z_'MUKBOV"*9P2/64NO-IYW)38=]CE G$]FR?:Z_%9*:3J$_
MW!HM*"")T@$R:.4@<2=EA8J: ]EJ,Y!7* &@&>/,?84C+EV)?KITM6/PVME#
ML39R:?OK2V$^IB*=<]/@(*+Y8*S!8,PE"_A;\V>0[Z?7E+/&-#XJH9,)=Q5J
MGIZK1Q # K==LY*;<O #QB&M35:E6Q<NH>^KZK+6-FO(1"02Q^8'2)F<[C9;
MTO*'?-\UI1!.&@P<"?3W4RI&:]ZWGZJ<F\>&))(*LL,I.(_^R/9>1GHE15]D
MW!UC5[OGV&L0+[!(LW[Y FUQ)N_R S/H7X?9/_V @ \_V$CU1LI_R3'>J:"5
M_A1JN-JB4NC X5=C?[ 6/^MU2"[%YFI2!ZS*:GU25_L5[.@'R;J3M:'>IARU
M&R>B:G/#4K[GKL%*N_;1HVY P&U!CU<#>::<R4$5^+$5BD]$YXU).BIBO[)6
M60T26*:)16I_O@QG^='JDBI_<O2MK7)U>7./K"VL8,)X:)=A3]%IW^T,Q"]2
M[>/#:7V_J;%8DDF7 O]'_LD/[8,W25M>$A'%-YZDFZ2P^-9LLG,<1/G'WX@G
M3;@*"K(G'FN66]8 &6.+?')#$C5NB:ZJDW5%=TMU-75Z2)HW,Q, 0O/B<PYX
M=DSM+\0]![3>]]FY'U+/MUX[??>,2UEM"?'P%8QS^+GY/#T@IHQ&/V6T3'MV
M5HD]4ISX<PD $'#+OQU- ,S8=4N7@DZ-G>*"QM^T30C"K!K2N4RZ1$1JG)I?
MJ'UK-RN9;B>1??]9/BHQ@(:',^:DJNIUNXW^1/A3U=\WG9>SI'+61]\#6FNU
MZ(R7:";"!T"3^+-Y.BDY25A:*[L_30M&/ CD@O)CI3:?!X?Z-7T7.-X4TE?W
M>6P;/40A^E@X2_>6)7UC]%JI/_#JF^Q+'W>4D[4NV*FL)^WNH)TK=[+KAPX:
M!?(4JX _WH>M[Q^\U4U(!UQ$=1[^C^Z^,ZJIKELW%$5!BD@5 04I4D7@I2D!
M%!%X*8(:.BI-B$@W("4JO0L(2 <IH0>$T$FDA=X1E)X@2B>A!A*2&[_OWG$_
M/6V,\^^<'_O'\V.-.=::>\WY/&NO/>>J@,28-,) [%&.\?@6* #$9J,F&?\"
MK$-DD3TZ:J5NP!(@NM'M;39C*\$/MZ"#(^>!BRSFOG8OJXSI\Q2V40!FGE$0
MI4=+)3>S$7/&\FK_.BY^0QGU\\<A!4!;0 %<'/WX6LY'6L1UCUABU]3*DJ!V
MC6B*T[@*J0"_E'7CNY#X@!W*""^G 'J$#LD-0/);%W];PD'T21NIF-;B%R_Y
M_1@"I&/ULS/^2"Q;G$I0K:?(D2Z +D(R7E*/H(V+-L$[?J)/L?!Y#146EF\T
M+F$;?OF4&P_G/,E2!U(9W$-J2#E'J' M=%8Z'HIFB%!0=KW0>^U"]>F)[Z2M
M? ;^NY,D6?*8^OE)=2'P I.W6ME94PPZ1]XWN#,]@W.'UE(;J6SE!)2;F^&G
MIJ)8S_4@T5$%U+3HKHWJ"T09(2&U(UVA<38]L/%D(&&I:-+$,O=*Y-KLB8WU
MF_R(O%XU+Z/*3>"GU(J"A>1XF59GK8!^!\(AZ4O+< /YKZ")U/G3^,QL%IQ2
M, Q_&/E<RO+A%TS84F]4^Y>[08YM S&JL@UK]SC7%AB#KJY"N9$"*T$RHX<5
M<24O1,T*T(2,JS==X]8^!^_!0X,$?>-VC7%<X1BW\&.B2PX76=JJM\PWHS.J
MT'ZL@JXJ]=:X(^\#_VJ>/I #4=PW7Y_ 3=0@A"\6HN*>X$'A/T-FS?0(MUV+
M)055OWK>Q;:\@YU*JNXIC.AW1H?D&_CCIBJ^IR2Z?0017KJ*JOI&JL#$\O=&
M]TA*ZLL%#,)1.T;3<&S6<+O@FR"1*84N/])M!6'#4=>G?(4-$S(\VB\B6LVV
MW=W5KL'CU-D"G/!.&\M$( F$<V@M:GQ227A8CG#ELN4SQV[=4CVXAVUL3N1T
M7+AT(3I-^?GCF*7T(]-QX+T5^&L9J,OVI:]K07(CTNIBSRRVPI]@C5B?.>,9
M^65HW&"6-MKRLU8]G#%2;4OW.MB%3Z%U[IL03 _>$>!X5M.1 +F\ ,U1@4#]
M[NGNL"7\+63XI6H#.^?'J6>%M%'.GI" MKK$#H*'AF#@?=OL>?:3:J2LBX#,
M)$QN]3B]$WDYAF!RV^[2 ;KMZHZ%^)C=RRT+A5WZZE AJZ+K\GKC!\-XQYC4
MLSYX\%V\=&'WFTT?U":SI,9;T+B/6D:_[Z/9XC1AM3OE^8,.W]J2E+_3[3U*
M02DNGN2J7R;=L:71+R,<W[IX2Q#[/OU2/?%YM0]@? !_4ECQ_:^MMN@BMHVK
MP?V7*U@9R-,4 #=\,T"GLM;"$59_=\IM.&P9+)*AGSCZ[<E9#GG%\=</I#YZ
MF^CV+1HSK"#O>F0[@['0;W9=Q^'1*)?!%VL4 %8@"W\11(#"AJ;C4NG=M2_H
M>EMUFHA*)C0'=[A*\"4D)3-LWE]"$-+\V?#H<,B!6Z18.].BP_A';L_5+>-
MF*^;O/>3M&":FO-U&P< 8ET40;@#6 OLBM7!;+]&5$"P K%Y9KZ[MDWC(-M
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M95_L#=XJS*H8F]]:MX]9<]?@\^BV^LE3EB+(LR\I>:_B8OLT=E)9.+SO1K^
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M.7GMK'\>*,4"5YS&4+A["Z0DG=^0!K<] 8(QKQV%]6(J^#?HNL41X#,QFB.
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MH08(R>6W][WG[KV_<\YSOEZ>;V:-?[)F>=^9.<9ZYQPK^%_X)>"FAHJZ"D!
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MDO78@#PVY11$5X)HH+4]@:RH\M#2ZHNMZE-67,ZU A?4;&_"3Q,>6V7KP?#
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MN*V"]TVBZZA7F2_H:KR.XADGMO9*!RZ$6<$'4:=\TWV;.DAQ[Y1<O<YG^,8
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MW:K<(,L;\ME<&65[$(J$] Y_NACP>V_3G7F' */]R486D2[;Q(KDP(U+<Z>
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MOE2DQ$:N 8[DC>>!'0M,APF<8-GI,& ['%SQ$K)67*.PD,&15#PUN](;TBC
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MK]8?P=%<9C!!?'^OQH_D7B.\C7C(IAE9X;8/H8[FTWZBWQY(3%44(E&[X=J
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ML$B<ML#.\!80(P@F7[$]WOFEC#=_\"$K K^3FAEQ \16-'NTO?*P++Z;8-B
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MKN2[U01!3^LEA_#J7;6R5NT7H70&N2_J:* 31]7@UH+MZ^4,_CS0!:/UT(K
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ML*"UUT%YM]<F'XENR)A,J;MS)</%@QFGEQ,%>EJ[Z=XA=C?,4"P^11+E"!S
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M^AP;BA,F(&HRG#TDSF("OKRIX_5\4-;G49<FU^7J5[8[]*6WOA'@F]HT_9(
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M9FG@*A%R9MEKVG/=KK"7=0]VV->IF%5W6Q,+XI8%8F+K9VA#XB,18 H[*',
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M"X0O8E36&=A'7;<L4EH0+0I<N.)X5(H%%MQU<$W8'ESKE-(7"V!(Q$%3S[!
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M_M341>LH_='IG5&ANZW).@>=&,T8+F%/TM+<\,$"%KK06T ][DY+<\A1.W/
M2Y=\,TB<6DU9O8VA8&[SDWO/"BX&ES^0."/=_9O[G==+%33VSOTS.I%=8W[V
ML*VSX^,KNA-5_0I36]XF_9X^K/97N]P>US#>#8E/KVH(C_8@Y]2H'G6IGA49
MT&KHGMS>%N)4S?WPX?-2V8Q[F]A7KF.R5/G^:)W(OI>=Q@(UI4XYZF_MD0XI
MM]C)>!JB-:Z\6BBTY:>@N"K=R0&I5$PQ=:(3+Y8^2&*2<9OM<B9A C=^VGZU
MOZ:>8!;RPEOLBR7K@VFCFF"O_!Z%5M_Q2TF+&92.@LBI#7H;&*F10,XS);'[
MGN0LEL_B7#7#NS"L]>.Q<0P18@6>=Y=%[Z:4BYT$]I@%U=ZG^-Q_!^G=#CZ+
MVH+"_;.,UK6F[#D[LC'$=2[CM7G,:E,-COW0Q&K,OMNXYY06>>])'K3??-[]
M*]N5)&B#HFLZ!:3(]^'I'K31 L_0D1G<OC-EJXI(A3"3^6N2V_ 95LOZ.QQ
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M"T&FET>W;K.<5A'YRA\O!W0:3DS+6#-,'<<AD@NG+=>480F!&>6C-D+$W9=
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MM@>% RV3P1-!2H,.?"$)9U7A1QH1IHUPH< XFUP]BACCZ)V W LRU( L!A.
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MMP44!9H_UO'O %QM(&?11R#TQ>$*BK^=E0.>^OE>W!3-RO 6I8WR3[U2"RM
M6!F13DH&CD7D>4;QGILN#]1\KRV\XKE<N?)<BITJWWS>W!O\>4R&X4:I$C]?
M;]Y;F4'V!(<'%UX^7X@.IHMCEE@3%9I1>T#52 8S#)J_?[N\C]32Z4PF=:CS
MC4V1SZ55T>[*2_<Z45Q6?\T+T,-M;/'^$M.==FF/*G,LX#P< ;:TR68_+BYC
M;4_+L#JC<^9^/CM@1?9D7VZNKOT0^=CG"K_?5Z$CEM*+QN8L@$QV]G.-HOU@
M4$&GT,P;I6=?*F-=;.D)M<8*^<K=DT,>EXP+,P#%Y)Y2AX73]]_-)[L>.^HM
M/O/HF 76-A->:U,54B^;LYZ4^CYWPY!IZ-6*C\EH9FFP-+%"^RUXB331Z@VE
M[C8S#R=T F]QXT6/YP,>5\HVD_8B]EX,$Z1\&W@0+7:1>8+V:KHZBRAMB.B>
M?F4VTM8%VO1Z4P#1T:PK<!%UC3)LAWF@PM),0'",7XJD/&!1-5&@>(TVR*Z#
M0B0<^(HO&$PJ&U'>8]TLR9#<:LA <S64BT37J;+6YN%RR\DDTU=R]- '\_3K
M>+,SF X:WKK<K0X#N%&P8Y&Y;MT0>_6([>1<;R3M)?_*XW4R5B4?G^DV9WYC
M^1XKE[1C!5A?J,2CI?MO;/2TRD=0C_(M)X=%XB%DG=FS.K*EEVSV_1TV62Y?
MD5NW[O:P1]H@DA=.6HFQ &(#A-B83AUL_+.!IT, ]/UJS'ILF$!\#Y7V4@OY
M:W@"2P"=6;DC<(JXS<20,LG9WR$(]@*^;'@>J=&;RVD44M\F;RL1?:/G_2O.
MO9EVE>MXTQO 4O:@0S1(?LRV7JK(JI&I<C1G#"*D6$:8G*??:64#=2$3TG@<
MOJ!VSB<2-<J6AKSH0D-Z>6.28#>WT$K7)BW0MIZ_U#E$9SYI7MF45=58^K5P
M= >=G[Y-[D[1(N@:8DD5MAJW@*9^,<PM]+Z<1X?7-KN*;-P<_2J'(/3Y>"=2
M7+*7(D2H#\%\G "_$)'IP0;7B@KH_>3I.!]AWJKUQE(L?$!*4+6#/$I@R*J#
M)=<.<*BRT&N!/WJH,I[9HJOL7TGNXJ=9GX8T:]&Q3@>9VL27/Q]X?,OWXI(Z
M>_Q-9WZ6V,'&4"("C^@\S#B&#Y8;>.0.O8;@DPM236@N=1F3CE(>>9G*[N-D
M-KD0KO#T >NC!KQG7^E%]S!7/=SAP'!)MDU)(OCW:3AL,)<W0ZVCL1MB_@D<
M3"E=K@)[$?RWHD?>9*D2>L+3%AB2X67-LBVZ12LS ;E3-B"/+9Y4,P2;O+I'
M4SB9-X,8>>B!2@2P!!S8*.12IS4&J9<NVB"W.O,0\]P6OF2U=4OZ9LQ]"#<?
M"YC_U%<@B([F (3O-<3 4<5  SL)%+SHJ"3;VL@&)_'M7C1P6WT!.I9QFEFE
MFJCTR+WF$T!%9,T&GF3OP +(/, PX#/82EQC<OYLVK4)*['K9^4;V3U"A3;4
MT1/D#J'9Q!]O?TC%.6RC$IY("HM4\6&4WEU$7VNM9MKBIU?%1S8"7R=/*2F%
MTQ\_75DP5_-75=.^W:%PQJ]EY;/.-4\:SEB.@2Q%!37>&./AJ0!>WA)+"Y1X
M^FU2$RJAJCNMT_Y57R8_XU6I*?UQJ3ESTLPHU!),L0&\= 2ZXE(E2_RI>5Z1
MCUS'RHTRF)<Y=9',.*2U+'AD*=D^</H](7OJ,OZN&-=BVF6OX;1K'D)YJ =*
M5GWR8Q,2*B\6TJYHM]EQW[X^=NVQJA)_>!KW)9&['TI>^;1SI8] K?>H)S;C
MO:X&?:%A=MF1," ,X-,XN@TM>]?S:JC#CLZ79]F&48#B:X>A-,#36EIS*&)@
M:"<"YF]XJK@6]N:)._S ID_<_H/Y!XTD ->5L:<WJMQ\::T_ <$GF?ZEZ)$]
MO;BT[*BY3<:C.2S 5!< .I[$ OI2]C#X2<#*,8S''AA&-W+*&LE3-_/,;K(N
MF%K2-]_06M<K3>"1H[L-B L]'&\J WR@!)!%5T(/UMRQ ._5J)T*G&,@/H<B
M%/JHHR'/ A!/4I6BIA+$2_F'-)D=%3<=+U,RLW_L > ^PC80U.DL%C OFH69
M,CK=;\ "FNQU]=W5V@#FX+\_RT3:@-=Z3[  O!Z+NYS>\OCL=&>#B]YWH7_3
M>> /4>5V,ASXXG\48)RRQ@(DG:&(*]:RUXW_Q\I(%.@A/#,1W?J-PZ"GQ[?#
M_"<9N^=)'Y*H8P$!K M0O3W414:4DB&<K[6!_4OJ+6A)0^1&SBPDT>1R-?/P
MY\(]A"$# Q:0*A:$/C7"<$*%.[K],!7/MAJ[)V<.#,>@>J=I>H$Z>R51(Z>G
M/-F556^Q ,130]JC1AQ^/K]EJ"52;/&JFD-<!2*2S%%\I*3@/OI'&!3D^Z_G
M7R_UZ:9Q'V-E,'[.M#P6H$*(!7R)@<T5G6#.DW[/P?DSVZ'O&Q&Z8UPV&4]6
MP(C\7Z]$JRDQ'S!XMBQ80*[?]_0?+J!1)!9PCO!'JO7;?"1G<^#Y!]^3S'_?
M/_,^%B#A2(K<AZ(T&'^]_%T=0!49> CG$<&RZD6V/+$ '_P?*:NO)P2B05 8
M$Q@NV/<K2%&_7D;:$N 4 7KKA0 WYO\$SX@[Q$^2(5#Q><X)F7Q)V;T-/TS/
MCQU66^8..E1Q(0(7%M"FX0Z)$#O?9]M-<<P<Z_J-:X@0_4L= Z#_-N2R(N>P
M@*&T)I[6M$,8^&=L+'ZQC[L8RJ @Z%ID.A;@I?5]C.+/U\D^X(V^^1N+*F<N
MP)^A ?_4A.__7#&U'S>@!UTH\!3%][_LJ_-&9_8(@NI83"KI+_(9?P&_>+%K
MG^?A(&TBG?SE?'HJYPLYD((HXI=W0]^]?FMYRMSJVFM*:6ZH9?AJ'OS/&]^Z
M,:, K?X5YS>3,2*(*(]'37$QT<K)!])?B*Q;,!<&ZV\2;&FSY,AGWDPUGWV-
M-__Z#E=6WBYX:1)T0GM*L_D%=OS,M[!@X7-_^&@/JX.)GF#[(M.&1A$[Y4#I
M?7&,! \6,,W85:CA^<>Y5G^JMIKT=<!/!YXR\/2R/A8P1O7]AW=7[D]K0_[B
MU/]I[;MZ!1@!!YUM,&+"=6O=^O\<- #<-.Z+%ZVA/>71G M_K(K_2!S7@3*J
MAK/FMO!=ZUZ@FC2Z5I1)*R25,-.N<&6;T@Y_F&B;4*WW_M8J&KS4$5Z$BQFO
MZ>HWILP/Y4[7"^MZ97^<,U)TO0KD_J+M]>3.,D$O5RRYIN""I;B1$K!GW9-!
M-L&8?SSNJ;\)G]D26[93:H$L52Y;:F]7I^T >)XR#$.&<&\1!IN."LX VYZV
MTFK$ZK]]]*D3%_[P/(G@I4)-M%_A#UW&W/4:N)$J"6=$,:52C(!DPILB]+3Z
M=U)W-]<92"KRU(;7+CQ\L-4K=C!['Q&Q&!5R)IF<XU+0A'M; W!.16%"([?!
M%>LJEX3<F C&]]=L7<&&_#W.6FD4A9*4'G=36Q88?8X\#7G$Z(2S>9.YA0=B
M7@^*W]-Z'R+Z)=P3 *&=LG]VK*# KUBF=*I[<F2^"9ZPBA06#5 @*PC^Q):1
M_50@E]#]M@*$CV=H\*K5YF36=A("M'#_I%6<F.^RT4:_"_["ZH>G(,3C^13&
M9\.?WT#<NNRI6,[)LF"TI^ )'5E#Z="A>E*&9.L,B]O+5I)LPQK0LD*%<)[Z
MBUFT(2Y-TO=.BHE;O;B3G\)NE'QR46EQ@P0WLEF)*>A:S7(,.>@4+D9*G%MP
M7N*F7*&E9/%V)^I#Z#$&O.(6O'04+)1&8S7YZL&&U_5!06+_TJ&5W6\L&J3\
M0#<=*J13NL:*U?64Y*V5 3[E@5/GZZ4GP>$E+HB:=K)R2PYH2$'7FSJ; V"@
M8U*M5HPE)VC0@P2^ISWH09T313TI7^@RI&G)Z[!#*E>A79S:A]'I%HN?NLAT
M8[H5P#_:0#@_UZ:-N>/RU,:6Y]:27*1X#<]Y^Z[2$"(3[LCZ.VO4],V0=_7,
MCJX0*P;VA X>B(Z1U=@@B>+C@?*PA!%'%L(3IU6;NEM5:NW#H.1/][GZ44"D
M&KOW4=$S!3AE "O,*+"\^NF00O_BYQC%SNQ-@%UP$-77OF?#'Y(& _G;VD92
M,BOKSJJ&SC0W$66IE!':(X'X)#T&%5QM%==3X;GTU^,FY;,&%9.>*>M'G\7_
M'C@>J 2X[45Z:(*$(-<MXU/I!WGCP&4.-MD08]S;6)ARX*T-OG#O>&_#S?EL
M%0MP:OBJI!XE8.1ZRL!'PDUOJ?HAUMI+R]%K3%?\U8ZC9[)$Y1A:[JP*XV^E
M&_KWL_ZE?[48:(^FFUI6M:OE/(._5H0EM%2V!4@DU+,6Z,%EDFL%-:XKK;#N
MM+7=88J<9Q3@*Q.<DHAIC27;,506CDTZ?C$8[RUY'^&)O&IE2)_0IG46/GN-
M4BPHD#201S#Q%6BWO(4RB65.;-I L,Y+0R-4E$+-OORP'0MHAHY#E&"'L[?K
MX,.ZFOF.93EXV1L"1L0N2F'O;[[KL1/O8][C]#)K4M=8UAIV4"5,050=>R+
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M:7>[(UUY:UU^I6E-7><-VA]$>WQ!J3%YY#!26";1*A$!&X.5]55L%WL=LUO
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M"9Z:6!(V;0/%_Q:B^!Z.:@<=!R^J^A&!0U_!F#G0S\_#T54%K3@_PKE3>D1
M*MNSEPC,AG?E_AH?V6>",:/S!VUQDZ8-'V<0[FGXS\^K[>-#,P09(L! =9 (
M34MJD0AL_-;VOC]4/<\5R^MQ.4A9K9;>F^(U+S1M[.E5Z%+:GU>B6^*_HA+_
M@@(4=LQL5WX-MGSI'P-%9,,<H7OG-VU^C5G<BB6PRDXKX"E1T"FC5B+ D?KS
M,_9ZN=.W2,^F6QW@A<^JE6!<Q%[IK_&2^\I$@#H9E4IX@0&C^$F3<)CZ'U[@
MWQI4'D0\(L^:P3:7,\9!!$7<R*_!FO@+1"! #4.BN>4!PC"3_,Y6GC^^(73F
MC1\$N*+IBQ![VQI?PXD EQ?DP4&X*.\?JI^NBKWD<4F1Z^'T,;)C3:#2,3?0
MOM5?B,"9HN_ BE)W3(HR&MY"SCJC7AQY2\:]YLP!P^YI0!MY/$BU29:BPU&1
M7.N9U]!?[9CNW]V,#ZI^DC0L_5W=.9]A&7#7H;2+S+4\M2]:77.:? =$9 P>
MM%* UAA@Z;S+QSO[<Y/Z"]@&1R[X3K!;IH8)L6BJ5P!2OB4KBSQ]FE:9_('(
MC_D/-81:-)L'L*IRPXXF7(SJ<D]<S_YW7L'^W>=_/4MVL?C+F2MN9'%[JDW0
M$H57CG14\)=";>=J!H6'UPO62D;CQ8,S2_#GNN6#NS9F7 9.B>O-NNH<?2#U
M($GG<VYR3]8L0Y<K#D0F02,:N+7&KH>:?XMTEQ291\XWV<1<'6<W%2HX?]GV
M'C"AZ5S'VLU#WM*_$XOQR:_/L!Y1",1)VJ6TGO(N1TVJBALI.V<^L2CSLV5Z
MSM4KLHN8J-<8D$%US B$L.M5U@SE;M.QIJ1]S8'0^:>^_L1G7H.5C&/A5&<O
MB#U<9,M]^5J8\LDM#RERU'A-I<PIGW2%XX9RCH5Y[Q_>[KW\_CY9>'70RVPW
M[VP*&86 ZB/3!4??MR6Y0._VWG]8)M>_=M[[QL2Z+R-U:)_BI([I6 ]%QP08
MGU1Z^MF,N3\^2B#($4Z[>+,[(;V;KZ0#MKHR_-5,LTHYY[4L<&KI''\+=#MD
M?$!S!U82_JJ:"HH48+ .3\,$-\3NQY1?B('9N'/%15=K,US_2M5I1>EN?K^:
MOC_GU +$4ZJ6ID?C-J'%Z%2=E=3#^-5SPQ()\ZI7RSI-'9Z:W.B>22R%O??@
M19D$KI>R=PDVZ',F.&?)S1HC;#)DV<<5WD5'^,ZU*$W->TN9!.\$8[)F5&XL
M;BQ50OV<"M8\;PAW=56_S(*<B72=YN%^?N5#76M7>^!]1:T;PI,X.GP*3@DM
MCO1*3C:VTHY8+%ZBR5N*== W-! K%[Q\2^EM\>5/!157PR0@-ZC%"O3Z"+0N
M5+?[<DNZQ.N]0!_Z<PN.)D.L(.FR'&J&88<_)=L7/9BQ7SB]W/JBE@DC6"?J
M+&K,BHH)G%Z)_^7VII6;HS:"AZ\B@"<I(M%U79KSXF2I5 Z_O[/$S>>PG7'>
MM5-N;X8E,H5/5;K;\-Z(N=J-.,^_<=6^RLWNL*F+PDX2&A%<TM)W_@-J(@+I
M.%"0ESZPC1#I;F!WUWT4J6,I,6B/3=?=V:M^^":B),^3R1DUVN"\+Y+WWA!C
MH5#15VH5MZ!6%--R,6!#NV7IPJV*Y^(Z5X;!/%NYPU+'/,3C;Y?VPNH2V3S/
M#<ZLV>N*1)#Y7OI \2:KV-(#$"6+ S82!&<F0X7S[HDAP^MV;LHG2)8&I#*U
M?%@3QC?6%7]Z\ABX)!?Z^9?K4=R=4G=M\TWNXI.ESD+-FCU3E]@XXB2HTA$N
MPN(='_,S8&IOWT*2Q<2?-Z'I=7])\_5ON;9EAF@@ A3&+D$J7M#CB\4V10;L
MH@.S'UZ.E1Q^T/)XM,J6DJ7[JH/.&91 (-\CW>0>QR^I>M,?C\6\!&+.Y)R<
M ;D>.J,Q<(1E21IT3=]K@,"+3B_/_](VO20!GE;.45&SVB_R8T1?R'3"*KYN
MEPUP'"TUO>\?>\65::NUL49^5Q=%$6"WS3<Y(JIOEKLK'D 7U\LKI6"KE$NC
M,:7C6TJYS9J' V<L"5KWOQ^I'H&\NZJ<Y0^9,&H*JDJ@)+='2(H/>64S D>!
MK:0C?^%-(OJ(P- _+NLN=()"'CUD9F:0-O]%#A0W[?QQ,552:8LI(I\T)3=*
M,=<$(731M-%I1NUD850KB\G.AV?.&OF _3WZL5I=2-67B8)&Y U>+#5HB43&
M(L*@5:[=&J0Y(&4/RUL>?R[F<A8OQ/#=3%!GC]1Y'"]ZO3DG_*3+5SO*48-E
M+_H/,3>J%7=2'Z?H:;OT=\]&V[<_WV4DVV$?EST-3^Q+J2]W?J-[I#7?[5%B
M$6^FV8.Z$%_:I[RSBB5# ^!'JJ??Z^C$Z02V#5SLY2J'7HJZ=V*>+\VGR6)^
MM$6$J94EWT8;W1HJ!";'R:#Y?69J-+1*>T;O]0MM1VZ06]E!KEQCS9]0I_*M
MNV9W-4"K7EP%\&RL,!5CV<X<669*>'@]*=K'+.3#F/2R=($?\XQJ\!KNJ&,5
M[*5VN-VS_ L)Z85F2*R>MM &I]+9BD&V-M-[FDP;2&>QT8@(P_'8)HB[7K\0
M@MG(XW95<+/(!-M@[JIMWGK*-4,)48=L^H(3>UT? KH_CY?J9B;1]=8T#JA'
M("1YD4YHG7")LTB51S)H9I.AHX%(OHOM5.PS3QY]5&[N;!/Y$OW&XBN@8^O2
MY1 ':C5YY5S&R37 A>YZP=QO%1=2[F:]@IHPLNIKT94W+5+F$O$_=OQVT8>'
M>*0<X.77\8R17:+MON0J@_-55M,>.K>8VI-HZI%<+YX>1[L3'O)#!4)X<4/4
MSOO*T.VY:@&.V,N$1\6Y=VKUS(YH;DF0FSB%O09*?IH'?_]X-*.C=G(^8,30
MATCNPD?4^$3.Q8$*[&U1JQ/3@7>9+E; ,"ZTI&GMUCV2!?JQP#%!&XC19P3E
M9B* =Y/!A;HP>0R>9S=F,F/IN(T]O[L:^V(CQ-Q(ED$_>HXG?5(H!G[1DT1(
M1]8'750: *-,F4D80P$G0:%$ D[<:D2@/L0$)^=A(O>,"%@^ L>C%$H):8^A
MFR1W9>H^$1!<H_NY>/#TU$U5/.7-0 +UP1HR+W*?A]#3!!6=\L/?^40$%DA>
M3UT:P6($A$*=YB:\2) E D>O0=&,T,8Z1]C^"2<Z' NI[DTZS5OJ^.27!+MZ
MBOUH$EI Q)*PD#(.4?(3?Q+ "_1> F]Q+8,PUX))\+ @>#$5*\N F_2EV^8]
M3P)+)#?J4.P>S/*G C1%P>7=4>)UC?5NOGMV<,(MAF>MV&AT'B/T6SME_DV:
MJ?ZS<DV8>Q5V L[OP0^#EK5)N$S*A'!$8%.JY^<"4@F<Y.])(#(J$SK5(D X
M5RN0$KY&K;#I=0P\D!M.\(#CCIO,_]%V5&)W"'V/7_6X<*L=>9T/+7GT%3Q6
M$&+YIW4U-_":=%.IJ7: ';&F5K^U@)7G)Z'5J/]<P7]FM* 1EO!Y'#TT2P^$
MVX-B&.&=6-F?N(?_K%A,;1"XY!JH"W/F(*,H>(_DWZ,N0=_N!/[,_R?-,J$]
M_VM-9U@9Z['$>Y"_&^5OS>*H.8I/9F9!8#FW1?_=6OJ?[23] OXPUBUXJ!?5
MQ\]/^-[W+Y15*?)?,8]X[!*V??DI</CJK,.RN$X&9^E>/?:*2ZL&:JC9@$:J
M_1+_D^T89>6*DTEJ]8,F&++3GI0%O832]:F5RJV/:95C.)V@ZRZ/A_U2E:<B
MY\/*K2"V^T)KLZ3!V!ET[K_>5<FP.YQ^)3A#_6/%L6J/UI$TK,3DYBXW'@6;
MEC[9J^:9:+>'C2)@5%&IJYM0Q!ALM^'7]'T[KO"%KZK8:7!#>'$7$0 _A4Y2
M$AC)))DHADDEP#Z"UU\0@>-2"%$<OHT(>'!CU YO_1K3EOK/$M01=J*11&#I
MJ2,!26+K[KVDK-=XKXH())$,9W=9X" %/S9W!GO_"0G2W(!CXH#>E&)X\5>?
MUIWWD[M??_U_P?YQ52+@A3Q(0T\N']2%/3+H@,\1@:Z\,\&I".QX#N&/<!,!
MN ,4+426*F=!([6X]?DB>*>;1.V3803:"SJ@3OF-NIN J&S%^9O_1N#IN\)*
M^!P/VC[XM;>09>[ZZ@K\U_)2OV7'[_Y'9<'_'_W YKMC85;@XOR#'5HP?C_\
M( Y)'^+?&X=E>]U(\KX1/'M[.O@X8#ALD.5QS.T@H<C[U"'99!Z.;>MZ.EY4
M/0*SK[XZJMR<1K:%IA6'!CV>G8J>B8HKQB<X$P$94O=;'X >)-<?@FXQP@AX
MTD#=U'-D^$R8KCZWG,L;"$\=O4+Z92K(Y?;VH[X3?<?./BQ-#;N@=9ZE'C#-
M8*+;<9K\5>KJWVX#L"!!TY[[4.PVB B<E#XF(?H^])KC^FH'>'7[;,S0ZM(<
M^;O9B]>&$E\O>8#3[VFV9>@K:@7G+])/OZP_'Y91P_VW[$Z6Q9IW=D+.7.G,
M;VKZ> 7NF'@SK+547DA2S+SRM:X!I6T=,^U9HW[3],WP>'27(/;F.L&7-$I,
M9A*!@]L&OA=@$B6_D)'4FI%Y85FTB>5#KLOU9?BQV6=A$]'/26;W_2]3?V3S
MJUW^'_\#C,Y.&49U!LR*LX /"(&HEMUJPH>3P]=._6*G4O=4,+%T!HQ"F)R$
M+LH.05&D2:_ )+T,5:(3N\*5)^XZZ?F:O/\+F?95R2.N6M>7G2[.SVZ#%>L<
M6@3)_#/\_7E*#T>/KV=TXDC>5X ;)O[@B#W)LKWA>#?P=&+MQ8/S^J2Z39'F
M9F.XJKWD$19.WR)"1P8.@1*'(\_.P!<ZP1MVF^"K\)]_'8ZQ*'@%WSJ[ L=0
MD<:)@OXQ.AEYBJ14+#]L$UP'_A])&T<$BG>;,ML#4"(5:6%'(6ZP;K@J2O*(
MQ@"P^:0"M!*X(00UZR=88"APMR6<<7N!!!6"Q;PS3G"H:7*??GL2=X0(K!P$
M>6RC10DO)$E]E@RZO[WO[K/(4[?%^">DS/__)>T37=U%7].,FE)Q!*XKE9+>
M#"WM4"1E?I7&"HW154Q^ZL7'JN[!ID!H>O3DYCQH3W0/]B8+*^6A'$$NX./4
M<O_ZL=*5?9)7W2CIH7(0*D(:?NI,"#5><4MUGKZ3/KL4&SDD8PU?K81V?CM#
M\C(PC#0%7B4";?#_D+G_6W.H Y$,/O6LS!3$O@*(Q@J<X4S 9TW^/)Q<\\$7
M/JLC AH'>9U)"OYU #B(>5K?VZ3#Q>,0G0(_=KM4 NL*T@Y_S&V=0/)0MU>V
M=LE[U/\-*&/@9F ?_4#OK5"-IHD+_1?[2ZO>GB\I+:U4*9(Y%B%Z[73P.R^J
M=1,-SE)E'63]/_(>&J>QJ:<>.0:#F;N&/AEBDC#RG.M]$CE\)B6(U[3]^QO,
M__+^&L.?3RO\CAJS_RPSM-P_OP)_=[D)Y<A'B0?.!0@B0$,8=BZ'ES&<\+C=
M;X'B3T9:X4[2^>$6:WMMEP[MN07T;JZZ)_5^!?/3]=5BJ\J88R+KC&9.G+V%
M?G?U4XO,JDT+^XXXYH'7B5$/22.&E+Z\X0MA!+%KF;DYX,0+6&V)+H+%A>*U
M/F^)T88LM.Q.R)#4&4RP J8X$R?IUYAXL1)%B$KYLA13+N*MOTK']R5"N?WQ
ME7L]BTP.(?-E7IQ>/652)S'!:%\$TB2\9!QTM]]#UBK=2B#7L-F"_F+#)2[%
M<H;/;^.MKLB[#6G-P+X,30^%X[0R;6(["O1.ZT5L)X@K#=GFYCJ92Q\J'6"X
MH40+')XZ.2D\[&(WI>/G<2W')8@PJ10VK_+T*WO'FW4MV_-*YWP>J/+ITGN?
MXT%Z2P@VN*F&\A,!:[R"8J\7+R:G28H=M1:XDU_\,*LF8YBFN<VN</ALV!'[
M9*WQ5UQKQVZ^&Z+RQ$I[&*$H2'#;RAUQ8D7?:>$53E DFO8M;?S1)T*-3L>0
M9V8<XY5S3D6M,W4S<NA\X:3'F"1CN)NE^-!'XSEF[J/E!D3U7T3=-124HW]U
MB&Y:+35I-U=Y<GB]WBVOM4E)F$;*!H-S^\!??GB7VO2U'%UDHB[+-5S-P(+$
M=A+=VS52N:"3.(IP9(:?A"P2@5$IQ5_&*A>B6E*11\N+W8.#5YR?1E4>EN%0
M8?]D +SX-(NL OF".3UD!5;9H6@ZM:$':+O@$D]!K8J*ZG'V5]R^>F5'=5&,
M$,TS#TZG>3XSCIX&#U--VP54"WJF&&/,02RRGHX"MK8>QM R_@MO33<B0F+)
MPMM GRH6!9>M)BCQ4020AP1JYVV2I;9.#!M-BO'[$4.=D)B1P!$?/9HQ&Q\Q
M+7&UVCL L,A#/@\11W*WLO.1MTC1]N!4LG"WT,]SIB "S6PJ Q'Z!H;#1D8=
M<YV__)(%BDE:5]MK&7MF.%&(O8530$V^*"$"AYJS<+=-. U=2AT]G[)VQV8N
M[T3@?QD[IZ<8T6I[.YMQW?XYS?"JS3+DY,YYC$$*1K3)F T"UAS(=?J45)X(
M4=:IJ/CHR\+N5*)VIZN2Z]5'Z0Q?"D/- BPS3CBV+G0ZHWS06'X@5N\FUD:4
M0D>T_GE>ZZBH:WR#1XV#K[R8$!D<RX=97D%RDX9+6NO]@%*' FMWL[+JZIK^
MYE!$ F-N2-2MW/8B_O%<S:E?%.MN%.CD6TPC&O,HIE7]MDBS*<:V<]A*Y,XH
MPYR5T?";XJJJ$]VK386/GBKEQWE_/U#\N*#<\^-M]E1;YK7JF!X[X8(1"K6^
MR=L8?Z2-I0>8NFRPEAI-OE0XTMGW8?/"H8WQ>_9B9_<=,ZO)4"O&Z(PF@56Z
MEQ-GT.+6;CH!5^8>]^%47"W/OUUX;?O,ALOJBL\A7K'#)][O)M'E;BJ;G,,)
ME:'AH1X*R282L?MK,:]R5-+YRQW.Q<0<XZ^UL"+/'QI^_8BA>OS%Z0RQ?0$D
M(A316!#HMO!2?;7/AO<9EXG=]6/!6VJWK;N?NO-P;3&2#?6:"'M<QF<YB<8W
M[<!/"(W62*GP*ZL6(TRG@S$7WUKHG/>,+.TL]#8][\Z0..T>0P1*N$/F,7D.
M*<8C7UR@BM714[W_3WG?'=;DLO7[*BH*2.@=HH)4$6FBE 0+341 *0)"%)1>
M! 4" K%!Z!$04) F7:1*D1JE5Y$NH?<N"0H$",E]L\_>YZC[M'OO<^YWOWO_
MR,-#\LZL-6O6S*S?O&M^(]A[7V+9GCM0[DKL(EGCQ:>[3B."KD\^(9,AZ;;Y
MSZUWLTBND[SF*CX*F;9,YEO;'E$^[J*9R(E>FX34:%6M/;C'"D[57A9>N7 Z
MOVX_J>KJJNYU,W[VU>]#_.9?;=X%W ZV6^$Y%1K<S1)8>\4@YBR?/."KH.8S
M,#X6!F<B"U^XEV5'(-KH?I;;,;N^+NJ\O]9"^T1_K8E0V;.S!O3O]ZL;276V
MO\^7QQNOJ!'VMEWJ+@Z#GL<2SG2_79G&QNAP[.C';<U&7L['==5[#!DB[6CF
M/N]1A;KH(P05FI(")=XN\B#\<XOI#4,7<4_7EG*\/(:<JEX79K$^3G_"=-<C
M7Z\ZO& WG>22L\"#";E?K52W0>;\G%J@&). %%8HTU&V7>.ZP\ARJK+Q<_,.
MWLL4V X/WK*NVWA!:(PK7/+>+?./JE,8P,4DV/%!;<,G:<L8KIJDG1C/<:H3
MSS#.$DGW^EJYHT6Z1O! O['C7?$YB^)9J(C.RY!3JE9NV5=&AV$*,(L2E!)D
M29*Z2]Z3",#F7]=(XV,;H8$P[N[U_7U?BU<<SO6N^UK6T@B:T\_?#I ]5A8_
M.V'5?$0]F9T/G<NOM)%-J.X,=#IQ'W[(W-Y;/:Z48^#9QY0Q\ZJ5$YK=9[#?
M?+(\7+A8)&(^MM$!VQO!6YL3GDVZ' X4@/UKE?SDC@.4,2CMO3G\<KQZ58!6
MI(Q'E<+,*&Z>G?>%<..-[V?RD[/^6#IIVM=!E.7'@L_ HJQRD?%:W2X*Z!V5
M%=S%'<WQ\<1H#3(GI@Z[+5"E0MVPH@"--;*[9?#I*@0XX-*@S0./K*O$!T,7
M#)ZS&:&7O1 T$ZY$\>O9_9'WM :/]^Z"(-U_"K]*1N=#4..-<$+JK[5A)=^I
M.T!7+B6U8JZ1CXY"R*BVKQJ+NB0I*!KU707Y@+K;]=MYJRH_?C"26Y]8)7$U
MD>6WG.)D-3;2=6?.40"F55H* )_9%%P7^;5V#-$"S@B"26_\)IG!B@+PD$H[
MN%-WKF:N)8.AGR>5VWIM)V(;1)?T31-CNQ + >IV'FI*XU?Y?F;6H5V[V=>V
M]%#U2E1"[2W?YC\U[DW9&&^-0%6IOX_KQ :]J C/4Q\&J#?IPW]0Y-^UIRVY
M-YN4!9_DI_*&DVJF_=(H0"V!"(*2"P-H+-X*2CU(]K-T1,Q@JAS*WH!L "4P
MXE'?R @W^%74!)*D!(*)I;HQHC2&>@3H)]GY;8Y=<? 2<90XA(A&PK<H@%0Y
M-!O^<T_)H7Z6/#!3:ML!Q47#HVE)%ZJ@) H0.XSI3?JUG\*GIM!UI67/(7Q$
MG\A0@"?4#SV*/?EWFI9RG>1"1,;H22"GZA8_ D<6I0E-_9G_!S6%_VPDA[4A
M.6L,U9^?_)>YLR^T<0R=:I#0&:X,+ZA_J+#Q%"G$T>E=]F]U^A1Q"+]AQR%'
M:$*/#/L;\H1Z">%I35?.[=M[]@ 6NKV^@'B-*D(U)!%-X(R61=7Q[?W?]4K+
ME# =0LC=X:1 +MBB0]FA\(UOTY'OYGUBF?'!+05=#;=FYWAQQJ6Q@PO=V[Y-
MI5UJ[$O0.'\V_=]2]-E^HD'O^SD=YJ\\JWNN2&?9\Z1WE*3%%*0QJT]W\IZU
M'*KFLN*U[]PX#0)FN#>*3 ,&] T]5',)'LBA #<DP?4__1JQDG#01XSHFD?,
M?<N8(?=^7^-G[1ENF<7W(T\PU8GH],MI*9QBCF'S>MG!N71LAC/"D>9#'F8+
MY0X[O*:@1:OA()B?_BU?LK$?.[>J"R)K+SBQ8DL4M*)V"BU9:QA+/(,@RR+4
M24>(0] &EZ<=4T]2:Z)Y=G/<8W'[.@)-'M4YZ7\:NR)[X[GK<VF6Z4P)K+JO
M@$WM8*/..4O7WK-'1O([.',J%X2W9;/(#7_(L -EA$,@#J>X7;UN^K3P7(BW
M.R,"7=DQLD'#Q%!.VM,C"Y(9-]C+(FA&/\K(:!\)]9FO/]"RDQFSDHBSF31Z
MXM8@MW)^S#!&Z8MC1OBG._?H-7?V.'O;P"/R>F:TX(4E^5L[/10 +T#-V%UV
M<B#[@0$7B1:<ET(RU0B"M3V#]IP1Q"=7(@=T;Y9=S:V-#HQZ%/45*9#Y2!^<
M35KPFX.@%^U8U.T<O<FZ6V5^-'16'</UR6\M(G$N_/5#_MVP7%3G:!*(P]>H
M";16#HAOF^"P'%=.(IF[#%H,+1H]&S'MY.\H;A8*MWTAHQCQ[!S_N>QYFI<_
M&_EG/2OL1?_U YAG]CQ^F4Y.GL??MBAJ?OC(>_3J^W6K)=/MOR#$;"*:K'Y8
M@ERN2XK)^PL)._#WCM3;@HOCN&.-(E%*G[#L!WEBD%"2[6Q3]+3DZ9*#2ONA
M&EO!<K$9Y<#,$\'UF%S L]>8G\ Z.1?@QZ%[RV62-Z0Y7RHU[L$#)4G%R;6)
MR4 :N9H;FNV"JNJS@C3R40HKD'&N%.QS!R=Q$PI@O7IJL)ULBSUB4JPJM<IQ
MWC7Z4_=!1R9;FJ[Y?*ENK)TN&C<7F%NLI&(]M[)I^A;')M.6/MSDB'NJ]L3,
M:_DQ7'9&Z.3J"S?%OJ3'L&,$J>#B!&\*8-&W[)[#UI=WHKBR4E)A6?CZ32NV
M2)E#MVEE3SRZXBVL:P&H"/Q.*!\+_>T8S*=E9GJ!A\8M<4D-_'ZKFA3@Z9.+
MV$KP3TZC:=],3-3^L*<*4:8+IZ6.P2/?=; =K&_L?M=*;$^^59J5G]..+QIO
MX]Z'0AK'VR7M]>'R.<H94*66L0 [T>WDKIU[J?&P::N846^'<I23WN!.AK'>
M, OC80"IZP^#(<&A)?*$=%82&[BBK%AHZ]U8]G9QS>[N\.7^TDWUT:Y^^8@4
M$R&Z3T,F43-.Y?NL]HXU"L@0T($#UP?D.2O-+:0.$_T0C#5)?#&%PSH\" 3;
M>4\7IN_<GZ[3/,M!F WZG,9?B<^XL="?R-?E='\G!+Z\X'2S..C8 Z=/HUIZ
MTC.S)HRC24JN'3 (.O%P"8%U"3_/HVS:T\*7FW6\V-*-4-\ER-GH5EB9K'*^
MD%^4I@$F3/[L_34WW2X.Y7\?RX8T-BUWB(\/\;V@6L;9=F>O6.1M3D_FH=>T
MD<>E! 72]HM$>$YTKLA[/<#GU,4U!=\WO]0ZN7G1Z>I4O5,FU_?KUUC8O#*,
M;PGH,[\X.4Z/UVSPG@N#\2$E)F6^Y =7G7V-#'.\+6MV^&JWQ"/ZB,?&R#/-
M2TNF,=Z,_IGSS+8>_:>9;+O.;1CT3 7MHV<\O75+T:F)JU%:%2J^ .6#"1*U
M50G[5T-(%^PV=CE\CWTS*"SO.1+FY.1\\G''"4ZF9D*';=>)=.Y"\1=K(ZYF
MFV/LL&/(3.-W(5<&WI(D,NR-XF(#E;>*^]['M&GY7Y6P*L$S1#9/.I;MN3+,
MQ[<-"83;P ^.$.V4)2:65'AK8<Q5E69A]\ XOMF*W!OFQ<RYSW'?PT.X)F?5
MH5>8BU7X?+3\H;S9BAZYI2#G90KP[JN YK.73D6ZD:/9D7X6S_=,#F#YP'F<
MSN<D46,*SJKK<L<AQPLQ].7A?C')- PK8X;,;6;^5.52W#>IH+%BJ?HQAGE.
MXX(Q78<LVPWZG,52HPJ5U ;K31GI=^_>Q\PBWW^IO*Z:+P&[JP'L.N4@C>N\
M-Z(<TA=-+>)1&;@6M@+3&[48-EWF \*&@D"VGD;&?BMBS@2T;HQO2=]!X!@^
M%EW2821:]6+5G?>@S<MK9^FX'YVAC9CWUJ,-!:>_$4)X3LXH,5B7<SZ1M_M[
MA\T.AQ1=6V;03)]0L%#DC,_(J*6F&_FZ_L,L[B<'IA+Z8:+$4030DF-![*F+
MZQL(+M;,RZTZ*A 7ZKA_N+#!ONV(3^O#5G929\V@6#&#<?=='T6\>5EHGK(9
M)_K^=9*N*V?$Z8+2"/IL5BY<MY4KUU3^%45#%=8)SKJQPW7W.*(FI" +A<.C
MPBDRIM<;N"(G>-TN#:FV2;A!K)J3(8EC4[KA5;*PI,F#Z[S<RL+;_>F9UXGV
MA^5I8 EW]CV:E?TZ\EZEV/]\Z,V']R+\B4Z$"Y,B88XE[WT>.&[@.#(GO-R]
M(J=V3D,*5NDL=TZ55L79';UC+7"[-2UZ'W-DZD*([@&B:;W=Y)A&]P2/MS9_
MLB83O7L4[.85F-[@V:8;KP8$O?"<'YF1WM_.?;Z?(%%; <MT>V??CY-_Y=&D
MI^IFZ7&9*??S^G@!UR=;FGOCN2,@&JF%[+^QJ!9'-N?HF+41>B?M[Z:ETGEM
MU3S]'%LIOC$+PW+LX=YL8,_\?J654V!<;$ !:OP!;36UC1>HN3>HL?.8XCH*
MH'*-O,VV1])F ;6T#ME>I1+]F>U<AG_K@Z^F&,BU!3[=W(H^F[13MY.CRH"N
M-;TL(%).8/"PK^AH*#+5=B\OZI+@,&QT_2CTO<,-=F8WR0="X*S7,.__/C37
MIU.!J]HP;5B)?<DD]-3]\6UC;I%5FOYJFK]I [5#D[TS=[^+TBBHXS-B)_(/
M#\TKRC]7O!+M1#NXLI++V:891?OU44_VV:5$!R$?V:Y\&!15R_M6"$<.Q_-Z
M!:1+: NU:L%EYSR\QN<$:1(ELOY070-WBP(D9E, 7SI@R@_JPXGWK!VJW,$>
MMCM0N[8KJ%V9?7+N?=RTL >W@+&UFXSZI%83=\-5,!ZF'0_1Y=:=7)+<RT52
M7XM/C\@3V5' >:RPQM\E&[]\2/N"U8_6=)7< R&MZ^[,Z_]ARX?*.1/Y'R1E
MZQ(%7BIKN-QZXV <-X4,GW7@FGZ\OVJ83LZATH--?'?2S4W7M'P2,I@YD1]L
M<#)S ND,[\ZL/.YL$UH5!1QG,%(UX=OS_.R%\.@%^!^V^:-)J@+W1);'\)/F
M]Z[TQ=<Q\0X=/%KV,"3HZ2U+\T(.C%_3;3Z)BAB+>@-.[#M('?_Y.9U$%)UJ
M9V9]P<77L^Y:@L8GLV4.[?V4$G3D$M=>9+[.W[54,E%JO-)L)_Y+L6CD[*12
M8/HS;9'V=U.?N$8P\?;?%\*E38RA[SSK'N1::??.X.LA[AD-^T[1*(]>.R'(
MM%7H,BBM.R$CP?QE(-4W [JUF+3Y.?4'UT,VU6$&S6H%V'2,EJYWOUU/0.@G
M$C+>WQ,+;+@[77#]9:L@^U&3OG..;@ZZNKO1,(Z%&,_^ST@3CS&S]/3ZHK$1
M+=GZ<'[.#COML+<'AD\-A3+0K>O^U87_$)C,>!1V ,DOUV8.W]G/TXV;=,B*
MR!.V/!Y]^M),R'2,!:,6:=%_=7D"/Z4_L"P?CV$X=WS]^5TUZ.HL\YFGEM#3
M1\@W&H M4S5+)9[O+G^G=LXZZ)ZJ0^-C;!V3DE!5;96K&I&JM9,V 1Q1NU9J
M]&?#CXW56QF** ^@]/^>"?[!Z&/G_%LGP'YW+3W:V<V5<@IP?)("D*N/D-6K
MZ-FW<_)(\GA42,G2SJY-G:EZH5>5",YYY:HQCI;&E5\\B20ZAD9\/T8$\=-^
M NC,2,.BA;YLL6Q)W2]K-6=JQT\9W'V7*CP>65%V86V(S1(+0E=UDB*(RL 9
MDBB%(8&ANC\O?HG\% $"PAHX_BV*ROFFHDL,? '?(DA5HUYN.05+(T!(F.K'
MC_H< L(RSB8R&ZHVC.A. <Y+@8@0 27J4WG6GJ'J+U+1>)#O$JFSS5$_^#=,
M_F/EJ60VE[K\;68?$(<\)H+3V6_\=$_(QX0A9!_M5<2LGYEEJ#$("G]I%/07
MX7=ZR;>A!.93J&^3"#"BD_V[+1-/W_P(00=))B-HYNEX]!CEB%M<L-X_E?U&
M^V]8Y3<&/NKQD2 JDF39&=A*BOF2RD[=JZ!3F!C8/5A#!8X^J F-/ZE.)8.C
M)5V\#"418T>Q[:32!JY\$"OK8QFQ\VH@6J6? NN _R*>2A;8#)\\=A/$\O4U
MZV2;F5+1AM\V*WXV^Y_$4VGKJ <]6*FW?!W?S/\&ERQ4EP#Q\J^&_U4!:J]#
M_GFGL_,W?5A%.[B("1S $X]R/98C[D)*_M2^"FK[>"&/* #C:.L!%QJD[XMD
MH00PF-TV_%\1^M_!T_Y=;_&%@@Z)-DR 3]!^/GWPF3^Y$P-$#JX848!_V?UE
M ^E^:'(+ZA!VX@9)$:-7_:2M?[V@[-I7J)S^U*8K&9C>*<Q;@1WT40[KZ_DP
M"C6^RGW=CC#-W*PB40*( @Q[/M.MU([[/MV:_KH-/5[O8_'NE4SMQ/@$QZK$
MD)EC\8*OGZ:IZ.MJJV]ZOV]^[OW31;N_\A;\]14#:]W8VBE[['KM& 6P-Q@]
MBS>*)7#6>L>BY;/2XK5[!9FO1%RRLJQ\<K<NHIE?' I!-7]\0P$&Z%&[V=H$
MUNL5> KP1-[\?.NYP[W, 6&#%P#//9\)H^72T0L3=_LD^HQ#+8>^7UI>JA7/
M9];1BSVQ%9W8[]DUUI*H0 $8>/$8\B/36/+A3"KC1*_/47S4!3QMW1"&ENAE
M7=0CI.U_32Y7"5S\[]T)UY5\95VE1W(E>*"F16C)-!ID]N4QB(]QMD,28Y)Q
M921O_'?6Z)-&7%]2E"XPUX8?T/$Y?:[!ZXI["-+QL)BZO>1(HYB)/$ZW M:C
MDIY8=S#Q3K"[V#=)OG1)Q^7EOLJ7,"A1]/XK;I?O\P62SYM2%R2L^!Z+1>IT
M[Q%TN??.UC$L)1Z8?7N==.P]9MG.-T]R6-'GKIG)6R-M^N-5;A(K;ERK]PK5
M)XH96#B%^IQH)X7S,R0[24+<515#A\P5^66TE:(CM:Y*9O$/"H?*9HWF?USJ
M-7I(;')B+ZG?].;(OOELJ%/8F0%0?M9:J,,$LY9YV_:-A6WMW)G\+MV'TNZZ
M =[]F/2AD:$Q?I>KW=VXPS)*#J*6T@VLTU[!:_NC"P=F0UVC<?8(".ED_YUN
M2:F\=:[O*[Y"#OX0^\@FOH!9NW/WC>G<WC$9FCUIM@KM^4X!0GJ0X3N7HJZ4
M[<@GM!?6G5#09,BB ';2FC)OSW'Q,4>,YCH@6$KXH?6)PCWD3A=QLZ&+]S\^
MYM&.,6QWZ124.3I%NR>+!MOM)%S8XY3[]>3^7D*R\4M+9EKG:=$)C1*S?*4>
MF+A<OZ)7DG9EM 6O[==U3?W]:0K7+H9G/][!:V<>85(0%<G5_TQ6MOTVMN!M
M2+Y*=K UG;R-K!7JW-MJH(%M;X2,TAFP'+#;LVA@+)**)-H'9<IMGT[-"#OO
M<G)HY3Q\]*A_N@G,V'%OECJD_1 0//V5K+*PK:C2\?W$K8I(61L@4O2&NM-4
M=%MQI'@D/7Y/2S/  ZP'B^>]S/J8LU!:UM]N@9L5BA,6W)<#G&MR/FR:S.A0
M#U\[98=8;T5-E]S[_4)F.!,%:/Z8CAH0HP"1?1W__!6\Z)DC4[#&&J<>U&V'
M(9>0;9<PERHSIS>2X66^;R#%=MW\YVU/IB##W@V_;#8(A'^MMTUF3'[%_#V,
M;<\W- 9NF7]X25$X*0/IK.T@H6V7D9!,X!FQQU9'L%_\/,S[M/Q1S\TC0BD0
M@M@1GH9*XAY/"D _-+Y2K)._Q(-Z6IQ. 9ZB+7J3)9S>\%K-+BQVLUPL>OMU
MSO93 U\2XHUMT]E550'F3')[U)=Y,F\A^'"D@B(<,T<HCUIV5.Z+U$(L?QG[
M*&"ML'9FIVJ@?&CH@AU3\$&KQT>TF.L?L;%H*3.>%8KZJJ.E!K#S?SA,\WC/
M/K?#6K^G%_0W!F5.D94EL:NMX$PJM2%,)7([/;8Y@ZK-8WQN$P=D[@91V;;"
MRG:W$.#LRDIEV^)UV5G#3A@?:N!.ID-]B4.1B$.HL6CJJE(H1P&V"*44 "M!
M9K]W-E^.^'%'DZ1(I+^7-H2<0O@*3!FRE#R7MMLT=CF%<5[;QWR6:[C:M?^A
M$@58UH&3?9S^H@?TQTH)U:@-'%%B(I>VSK1O-2Q21Z'>5>=TK'QX@I>',X<P
MO50;PXE6@X)]I_9Y&\".[+ZOH0=Q=<7)RAQDT6R;5K]EI(/$2SE)#<9 LAG'
MWC'IB8!3$UJ+,J(T..R/VK*A+*G,;U-.%,#/F"01A7=I'-M'W/R F5(1-#\W
M\=13H]>=ZWC!18FP(?]:P3W-TZ$"?4,Y 7H:YV6['XK_5%B47$_EC6L<(I/R
MB8;M!'7D/S>37/$>[1\-J_%3+W2ILOT31<57V'XN;" W(O QH^9 ZY=)'\AP
M_J8QKNQG/L2Q+Q6>/VAR?_6OBA!B5R(FJ_V&)@^O9[S,6=P^/IN4FCX:\^S&
MXNU1W?(07NT'*A&567K\>?R]!Q!1W")=,%EB2!,NLY9W:Q774UO!JV8CQ[,1
MZ^OKZ7HW+<6](@!W,+TTZ-'-M0L2,HP:!;1=\'\L6@>+J3).]1$%%Z1@.>3Z
MBU[$#:*=GOUF7'3N',[0:'3QD+.A,++?,EDV;Z;N8?T](TR C]9$/M/8:,,D
M@A-A;XH(D1MA&6OOR\,-KL2-"L6?BOGR<?!ER#--Y<>B-,N=R^9*?_4NO<JH
MNE+%]/#XNW)$>?H5"G"G-())ZW3#\)"ZS-T](K@:P:A)SV!W#,."J4?(&V*B
MCHTF?C3%)7?+=20HY:7S9_@)K/(2Q^3[X2\?^=5LB6V&,G9Q*JL?5W0;8$<X
M<G(23F]>5_"\',G+,2PYDW Y[TE4B^/9H[HW]VQXI%4PAA?(+QN=?NT5.2IX
MXI)"<Q-=:GA:WT_J^4CA.^LM1)WXIWM\S+QR[ [GV 6VW3KY[E2XU=%O3VX@
M^*<+*( )"^F-:K/%\U*-1C('/B#JP>LE/^GJWO55AM'A1>M)\M<U-=NO'R ,
MSM?5CM5?%U4]Q!\T^Q V1V[HP?[NF/J[(9FHW\=UOG_)*I>=A^?=DY@I*1[(
M4TSN0A>__OKAB^W7WR;9AY^=I@":MGBFFD-TNERS!56>($ABZYQ(X-1U<JCW
M4$0-EM G0185HT=SYRSJBS#OWFC87C4+(D36^+P0>VQ8\9EVI*QBX*G<RCE'
M9^?B0*G+!#-Z3VGTM]N=,2^6R@ON*DWF5<Q++Q8NA+$'C[4P)TBV.U0_8Z+?
M$_XP G$ A_2 <"('='C\!P*/#90,81DL+'381X9EE:V%69O3^ L3QO>V/$Y+
M5'>PTB/0UOM*U2E^39K8U:Y7D+6+\4XOR;G1Z:Z<L]>\GH9C5HO?RH9N3'8J
MY4PRI!S[@_^Q8;_$_<TSB8?D??T0_A5AM3[GGB-OR3^XQ]HX*JCXP"=L]L+)
MUW,KKJG\:44L61]H>H-W:#<\"/L'@OR8;15BO7W)"2<;0S6R1MN\!-\4TA_K
M$'\;*<AHF*97;P4KWC/Z3R8)G.C>V!]'/>;'V=#\]4.Q_XVR9S6/!./6=H^%
M'3NG,*)&I^A-5QB'QX2BF'W4)E!0Q*"==Y3ID)/&6KWF<$1+FYA\/1BRSQ.2
M=@^,D4EJ%*!^ &VFD**>EMUZ<JF'U%E0BZ^1Y3S//G$F_;BO&7;:URQ.%B&&
M^JD$]45N:B/J.R]JA\!) 5BO4P!G$'''(-!;"8A%/Z6MB4TL^>)VF9QU#743
MJ&L*OGT8NTL,H296DSDU0BG _&D*L#E)/::PT@Y?HUZM#:+Z:X2Q3D@U!5@3
MZ2M/E5^+)9W$<%. SZ!-5NL1)!THOD+9A@*<*P.[E!E%D$/](1.]G11.1OJN
M4H (6&X'=_YS[,1]9"?YB0MHS&/4DP*_ZK!S#T(J(L';X;TDSV]UJRA2T+JS
M?6(RZL$=,"9'K\FO;?XB^K1NJ)_T\Q0GNQ;U8>S[$!!Z^'3MEJ/))G[06>C?
M&HS][]1@VPZ?]%_Z4>-7!89>H&9B)\BWR)E3V$0H".2F=7/NJ3O,2!'-!60I
M0/(0!1@+Q!+CX+_()P_748 36,@WR#J<GX3? ='+,="1@L%Y)E6'/(421$C\
MXH3="HTNW(K1BD//U ^N_>,ZM#.AW^E1U+SBL_G/!8EM4Z*I!CIVM5D?!"Z:
MPU?!,?X?;8":%_HC(H@3=JJXHK#/>1\NO?P;Q_F4RQ%)-X%QPI9QYD#)^2II
MMK[KCIV1C>.+XQ)M$#/W3>_DU\$2R9-4-"?61 &.AB1M3U%S> U F/ZLH7/7
M%;-5<N-/S'1TIE@2LFSW/H8"J$N:J]C_"3+^E3I!]T?09\[PN4E9AR^K2'V8
M_>Y!^*.\!S\"2$-$B,(FSJ:NPWE))\96RNHI5UK9IW6E@0R5=R:&D?YG+UU:
M$'8Y'Y]KRO9Z>;H;FP.BP$*YL2U"">B 8F1VB84-ZUHS]3+TLIN@T+/GO-R:
M=7L5;X;.UIR!,Y%\HT '2G"AWLXN7+TTL;Z1/PEYK!@:]SS6&/>\P**18?%R
M;IT_5Z/N38GFCU:BEN)KUS);5ZHCOK_,T ILRQ+OL\^62+^#@I'1.FDD%7S)
M8[F8PJK%,"83$6S,5 MS<Y%ZH/F0)=I0R1@8O\U3F46"?78WL]K?$"_C_+(W
M;4U04%N\=?GM6[K2=:-]?-E\EE5%W;5U+47O\1BT<,]31;>ZK%-=%OUG7[4=
MJ)=NX0GB=Q5TQGF$KLGJ#2%[&E??.#C<.YWOE%$I?)O<)BD?N9MI%7CNZ0G,
MS#./_/C=\>NAT/M;%_KNCP74"'2;"I>]B_)QVUI<&]&6X%;N/%5H;:DE%7-V
M/2<VD:[+95V^5Z2(Q3R]=N2$_U"0D2"3HPW4-;#I"CKK0%6.#H$V9-U):B7&
M]%..W&EMM\7;/5;&E;>K1;/%M[RNS>RERS):_<B58RQPE!"BDRM9,ONV+(=]
M+HEA&^;T]E+S_DK5-@'K$]6/HH[$?!"T4_6TFD@*R%UU<H$U$JJ++@9B[9]?
MO&S/<MIVT]'3\ /#AX*IQ/U:#OB!NGYCO'F=S0D7!CN>^I/I:V;V^XR098X>
M=,#PAU>,)3.G/1-%^AC#4-[R+X5/?S,[^/5$_;/.D$H/Q@]#*=#*88,B=93'
ME3-S73 ^^[B,%-?LPU>7#.)6S&3-+!9J1^E-% H&&>(YV\TKO=HVE,H;@!N8
M"01:L*?A66G%&L?M1-F-G3 "^]4W63N;Q_9;FP>?'X\(Y3E.-)S(?!<P>"*C
M3-,C<!2W9GM;K_#MK0NI 3A]-N97?/<ZW'OU]AGU=PT.J>V3*!)]=DQT.?DF
M74RP*$T< 4(*Y3'>=4O:DKSQEXO-=?^,#O\%0^-?/S*H=:GOF3TB% "<N2\!
M&]H!=TJ?O8Z]F_8F^Z,(O\2WG0T_1&CJE+)W<K>/;CHU*ZZXK-1" F/@JRBI
M9GW8.E9!1CKX7%GJD!K/OBUCKT_P<QJ7I%6A2=CB4C1A<?-ZU[KD%:6MDGFY
M['V*+H^F^M*[CY>S?@W]>,]Y2;)ZT(+>O+Y_Q[5S-+>O@$!**A$(&C=K2S#M
M/-][$<%L$R2O$+%R.[@C=Z[ ,LTY=$0.\G ORQ5./N/A-.OR,$ZP\Y55IB0=
M&F)XY*L$!/N9C]7TDJWCKO=\S9@5L6>PL1^W>04B/&+3N,(CF CRZM0&JM\#
MV;P4%YU1YC(9/?!U-:-4I["]W\&3+[2-#LV\<M0P'"DB7TZ@GQA;H9E*"L,>
M<G:7O'81;Q-X8F6].*H^D;D[LZ]X25- ]+2&^,A3>J&G9[A5WK=T^):H 7[N
MI!O$X_DD@)!?&U@%S_;1[I5<7EYO67=A1PK6V65;M'AYRLG B!==V&RG3[,Q
M[B4,#^23$*5@3(?YHFU27/".D!DHOQ3B(F9%$ AU7(^/X3PRJWV]R[7ILFCK
M0]^E)5-1FCG=(?1$?PI!9,.$(!"5::> &WT3839\P>KV;=GFEF.RMY@>S]FZ
MQ+Y*'&SP4LE_4G4E;J QGW4>!PW_>K.GF%\1?L"N&V'/<3OV783PFM6+5^V,
MG[53%5^AF//?SR=#.L;VVT&YG)19";RZI26$*5L6A"VG@W,I+B%WN%0H(CLW
M%C?S ",+.-?EE!TW="M?J!&=MY![CT\*N(6_DD#@&9BH6/+,V!ZH=UV,Y:R\
M3+.\_ S77/&PA&7Z3?.'@(^WBFIV&KB2(<'D0Z2SQ"=Y/B9$MS'FVP2GF<27
MXZ7E<0^R\W*//"!X,]"[%;;JSU[7;*V45G(;/)M?8OMOIAS3Q:%#Y';A]17.
M_H*7MJ._N^GPZ1^]&7%D*^U>E_%Q8]C;_6;=[KNR]<SMV]:I#EEI,EQW'+3Z
M]7G#WS1HU4$N=""A#5+T2SQS#7#>!6_?@2_RNDQ$L>7O9NBHFRQIF1V&*IA/
MZ/GR^<-N8^]$ZJI=)IPV<M\.$Z\U;-Q<Z,?=CO$TPDD6M8B_;],X')P<8;6%
M]97X*GZ%+=*69O[P@XOXI%!E1)HO5E\[U_C">TZFA>QLIASI&ZDMSOGH.Q_O
M##-*1QC5B/A<ZH(Q(V5V&@2.1B+OQTMFV)0%MHYST!W4;YD>:(8R6O4XPLX0
M)8_@?:O[L79OEP8X+<1[\IQ$G$PNW^-_<_6"H,R,X"U1/7^@\UA-Z&Y*E<(;
MTB6BU/'PV%1SW0=>Q]-R,W4*K=6^L2<@9G%TH7,,WJYQP'S5!=!G_;A[?03O
M>*&.QC> RRQ+#]OEUJ69K?@OW]6&PG7S)%AK4<5H_RJS20E)&7I)C]:!J]'C
MW>MA%T 8>/B2VB>C0QA$Q9=AMM.P&P0+[A0?-N+31,FN/'<52">Z;IM8V)T6
M<P?9^*+&\;$U;Q%;;-A!OLF3T0ZU%AP$"O!4^5P&-D 9,HDY-(S3.8'[&B=O
MFU<E>_^%I5\=0U1E:N7-++40.ZO*1\VT6#.2*SZWOW!*19P^),BE2HRG+4MC
M.N*9L>?7E@G"AS/C++*7\:BFP[0-[^SZR>:-29X/E'!IUYZ[LYYPD(JY'?;2
MD^UF'6VBABF^<S^)CA@UCF(E7JCW#G@C_T7^J*M-GIVI7Q+_JWY]"ZCT2":K
M='QKE&TSS=,I^6'2.:)O)E%6%P]%*\.*:K+=)W.T9Q)5,XR8G_5H>HAG[96;
MHZ.=U#HBT#0I=<#.3ZRRZZO[00N3^_$EU<42$L(MJD=8GWQC]!:0<+'=),WS
MB]GND5XGS3=(L@'QR"9X EOQS\>RP0]M,[R8D_0<#-"VYZ!K^0KYJ>1C/CSQ
M37ZGL+U11N$M;H5;.LXW\(K3I_+ND;GCIL@!7"@\,Y980?2Q, _."7PU09^Q
MD_\-?K/UVW EY''ZI5PS+:&X8FPS05%B"#[Q,@\^?PM- ?;P4H"0U)\JF":W
M-:)$)K'MZ_!^Y1PRRH^% @C6S^<[4H  Z_<4("4 2MKG0CZ)(5H[8+:YP)C\
M@_IOB7J_%_N_IU1*TH;S^T<3"*+F41?I#513JFO33B_JSA0\BH"8A2X)&%(
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M5UK3QTE8O(+)X&+(:]D'ZK0U@D-9:,&N#"I_C<I1P4$I&??W]./5!UY#4SI
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M$8!9V+Q!!LY01170WC\>."0 Q#E:"B'8#TISQ$LA!QE8%F);QZ([^.\"+QU
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MC_S8%3+ ;^YZ/JFT6$@K;2  MP^LL2J5<^9S_Y#- ];&\_YHE@#\@U$DG(8
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MK$/<J=XUV*-!Q$IK>61VB]VKKMX#.FN%@.;&(-2DS%L(0(5Z&R)T<J0>$:I
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M1@* ^*/%&4*(%^V-[W\F  D^&/#Q/@$X4A3:O=QL)X$7WSLQ/2%#;N,B+Q.
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M0LPZ?]SZP#/2"^(#,O $H(< =.I2]+-$$TO24.(QI0$" %O\X_8',6VH:!*
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M57:#3ZFS[#PBSQVWMA2S+LP<&]'F5$EFB_$8)$83F=ZA,4=P=$0J9S26#]V
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M< +/T47RA. 7R$#$"[HF)+C3!U\J@B^<+?\*9!##K,F /(*X"6]!+!M"=W_
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MS5V @+,$+7[])=-\F3^WD:)EEVD8_VFL;B@/!MWDS CK>%2)XW@UR6=\1V9
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MBYZ(B7%:R:?N-/\?CT,NT)UR1TF#%13\H@SRX%KK?!EPPLW.C. U*>>@N+@
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M>QI-:/HW2W:"+?M,EZ)]D@8G:H^[C'8.D420VU=:Y7A/Y&8YZ-F;=)PWNQS
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M',OG#3XF$T:@N']5J-3<@1^>,89-78=%F!T)@[9;5([F]/;NJRR&P_;;4L[
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M/#\:Q'8]OGT1"@"? 3:TUL?@N8#92=NHI.J^"<&V?5F\N4_05<.V)$S_3RN
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M5VC!K;Q6V4R7(OMD0E4+UGC JAO+M8\25!S<IY?/>1$G\!Q*;R%#4/1]%G@
MKJ. .R9X_\W(;*PK'HCQ\L(#YH\(ZC![01[GBZ96[MBJ[HQC9_2Z+IKH*(KM
M-<+2'\*HY\L5K<^ZBS/T)\::[!4J,>&8OM;@ >7$Y\>'L;^GU9UNY\M_1HCA
M ;.K>."0.F$:IS&$!QY:P;>G.</^S$;/_\+71SV-PVDX@2,S!-T6W9IP$0[*
MVP.;]G:8W%Y.ATUF_IY;=[*UG77YQ%C7CE_%P[I>>HMAQ71\<+Z2FT>[ K_7
M+#C5M'!7 ZT&P?# -5>L2IO*M\*N U245BEF.>?XLYAR9UU]N5> [)CTV':
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MVJU8E9?T:10@V]O/&T-^;59Y,VW237F]U'GR?#)G\?+N=,>!G#2_I=,=;K7
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M8S8-VE&=74&LXZ\E=:B<TE][]ZK5C=9>JV7E6DSMM^ KK@QA?17#?:TWWRV
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M4@]\BX ?N@,4\,!C[48\ .'-^UL'TZS@=6SGI<82[3DI) !RQKM=(K0"QOC
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M9QW,G]RBS)=6F*Z7J#'CFF]'A)V;M,.(33'>FKJK(%^/MR;4[@^(/6!]@!Q
M:O.WOS):'__39LDC21M6W23KL@1(/"8(_*'TXP]!$[BPX\ 7<[?2MW\]<94)
M^_U?],25Q7I<;?,^C0.T>'K6L0YEGOEC&O8'7?$-()](AB_XZEAF,*FG5V^
M 3+@89[/RSRTIG:Z[>Q(9QOKBAR/7Y+U!LB[-J1N24VGH_40'0+M!'U87B+=
MRQ[D_SSCD'=5CJ-=WI>_[;48WX>G.P-7R;BV$7 Y##@?8Z S7LN".HWBZ1)K
M;;FK-FV3=;^\L\\F]IG3U8<2L(!J3[9O3!M)@$DGF!ZTDNV3@>M(!9]+ENZ9
M89R7!+!)M-<AO_2W\8!J;4"//U;:#Y;SQNVBVTWE+/.8J7D!2C[K,]-U(JM0
M[>LB%W 0'\].E.+VC7:8Z6AW/3*(&\L_DA.H.H!TQH9H%CTY&.@L;B<[@A-3
MOO]\6S@O(<;$.+#-)M/@FV$L*9ELPK3@&7/T^9K;%0S+$B*2?5NSKB[*_"W_
M1.9C@2C,0E%O_=4V8_35*/?%5M=3S6; PDQC1,8JDJOW*R=.XJO/G45#6R_!
MUG2A^T.;=F)9DBSDO3ZMP\K_C*QNX0&]VM'=]*63-0Y-KQML]I]N41WURYO\
MP /5,"ST(>2$-I'@K)I5'GH8ISYT"IE3P0,YT>?/ZO+R@Y-51G<P5.<A7>NZ
MV;^3&DWF/'_ZC'4B#7JI9/?2[HV*/HD5X;6S$P  6K[T*3@KRC4%6N1(BN,(
MC%56Q0/3JOMRU]H97&:VB'H<YT0QJ7#'^NF:::\=_9GGSW@/7E2)J<JT,VAT
MN;C97FVVB5LMW+T+;U1$7AAC:>_Z/JR![[P9+C1AF1Q<>%O_H[=J@ESR4OAV
M,VVQV<V:]@9J6:B PL/# YSD.O+S?33WUV5+D-KHWNX1QO5HO-DN@4@DY6E_
M[[,3GEB/>I;J3=G"KN;X51UWJC?7UY]PL6*S$PI#CTJ*XS07S2Q+SV\?B><E
M#I@9)C2K?VE9R:M(V;K8\0^XWNM%H445=4^;^-Z']N1(ZVO;.G"><45>)_?^
M7$<I!DJ60!GAPL^4Q&_>JE%\%5'JM9K*;\-\7/+^&: X\JV./7\N^W4^"_.J
ML5(/DF(VV..<'3+-F'PZAB,[2[R,B@IHR@_:+VC:71T;.&G</C+B8I\^'^VV
M&7=CP&T\^+YY[8/H,(^@ $^6^YPB6JJV  /OG-9.]*"N'-?DK1DA!TZ/E\<D
MI_2K\FE\!<:TFS9\/46KNHP]'?N]O"<G-?;S3RSC<-%H.W1O3*HV6@(QS2R#
MPJ[)\#&WS&)GW&,6U4B02A[++O:6XUBYO$V1JS!OB+7(GG ^=(@>SDO1\FJ%
M&Y<\R.DEX^F-/:X/6L^33V]YF.12_GLN1<-L<ZHP'W<XZ@#G'0_B<VYRBPC0
MH1HF.YG\Z,ZHNB;=TV_4WS[MQTEL@(GL">)%]23FE0_-BF^QCP?WH$U3F(MK
M-065$GEM(T#<@CY;Z@_M<R_-ZBY^/V?6^N"BNK4[Y70\HG'A,K _/W#.7:KB
MSD,3H%.Z;>!DG%XFUE!G*VK5FC%#/DZ8W9TA=^%1Q_-TZFCNX<YIK1TIXT/'
M>4=?VWJ&))<]\9B8RPG683_DMNZ)4ZZ.B9M<)F)J(K"E2(9OJ6*NKA8^?>%9
M.ZQ4,KJ5\N[TJ^F@-XFWQY61F99H/O<M%AE0N"]S.5JDZZW3>6U=ULT?:74W
M&<T\AD^*R>;N#>+*&&A _:4F?DE-O5W[Q'/#KB>)6M9[*.D;>0%3K/+'%=[0
ML)J0K=2Y'6^UVZ6D0Z9?&LW' GF_U^\U@_\;>^\=U.37[8\&45$1$>E=!:6#
M=!!(1*0+"$AO*B $I/<:E"^@=$% 0(KTFDB7&J07D1**A)K02R"A!@C)C>=]
MS[GG_;YG[OSNS)T[OSMS_\A,9I>UU]YK[;4^ZWGVVL^NDI[>^/:AH^(9^W>Q
M.[,F/QL2-1HYU91[P,=I]:<^-;-SLZK.;MQBPK_HF+]XZE%FX(9H>Y$1\,XS
ML\6,3KV6QG&[MT]\TX5S:0\];G?*\D %LPN7E$RZK"_B*B-+@GNKZ"Y^7+S9
MI_S1W^YB&(0M </B:27B A&!S:\.WBW;G&Y6U50];I"(FTP-A..I&E6D_.AX
MJQX.TH<-K'M6*"GO/D,Z^0;^E=SK['=IL'WFGJG=#5LW-0 V)"X@,@X-NNG_
MRH9*-<C+Q:_(Z8=(=XO[MN-5@,!<<G/)\)*I,5 TYT<B'KTW*9VT:65V.\9_
MH%2A\;;/(I=@-E"\)JD!TK2L?J\4:'_U_L%*_:^]%;^V2:7)Z'T8!1YN <<Q
M(%T+DN?-I8!O3##%2B4F+ ,W9P,7SXP6N/#%S[]->8M0JR>Q.[=JSOB,][>H
MY8\&'4-3HL,+,6\P00$+;GI=^RNID_$\F\<F=;MCD\U!-MHNSB><AEM(.S??
MN!*D$))FZIK#LY=<L.%!_$2Y\V>WV_%! 0;^=NQ)&K\EOAU>]('=J&J"C_E
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M_!GI%X:IW:4SV[JP">:KK[*X&7MY\AE@UG^K^WDKWMX^1.S]LG-SQ$-DWD^
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M\:X;4N@H&@&D6M=FT) &,2S0I+*]XDC2NZ#>>T>9H+GHQS,,<MB=GM%OG;)
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MVOT,P6><;D;ODP U6'A? AF&6WV/(KY;.58G)'R$H&:Y:$F K^66)$#;2Q(
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MWC<(Z@F!/(%<"<BB-PE \&Q[C<_,G_:']&;TY!0_N5W][EF5&D?;:"U705(
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M:GZ"/*HDS1RW^O4]IN(5E\/TL;>?_OBI6&AQ],_S+Y#7@PG7%D )P4&2SES
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MY1R7W!] K3(]@V,]U>6AJRV#*,5C\]2:\LV'XTU_S=_-N&*;.+?AH!>IX./
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ML?(-$I8W.R;&?#O! ^B.G:2VM>NT;II@'&5?/M=_>R.5^/28S<5Q#C75#:3
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M'EJ^8SV>/5;RIGHVO =11LL0K/JH^P9"LI5H_5HSJ*<QL'!I*$J**J;T*&K
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M]-ZL%PR>\RJF6?'R+5T/P2HC+_I3U6>;_&PZ/DPSKP!46&31)H'4:,MP9[$
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M>$#_GQ0#D=".5X[ (P%3Z*(N%"WZ'W=_3J(MGE&^)!C% ]K>X@%LY1=:0#P
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MGP>)Q1.%:)RTZ64D+ ,JUE  BF9,KS538H34I#^-D:Q%B>I=$>.@TV&/DM1
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M:@*SZEZ_Z%!\)M!VK9V 8[T1N"=#3PGQXX"L?N&28%E7%3;,6'W77.OU+'%
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M!(R+!O9Z,E/5!R5\;-S4,^I<*_JY\1\KCS[R$6FH65/M:>LE@WN,OD_QN)W
M7]4$%1H:1<QS!76 QD><;NLV1+'L#]I+1)'/1B5SHT9B(%%&!G6-E2HG8BR*
MV:\_?&M*#^#I9>>/9L-L^-7L81HI?#,:@9"^GYJ/AMP=XK^MJVP)V'_,:$;Z
M=K(R63$]WHR=*0&:KF]J[7I+9D3DVF4\;T8.1U^N]<&HUJ-.B0<V?R?9EP2T
M.,O05\AY%4O3'-;8N/UPDZ34G#EVIWG.8Q8"^#K^8).DK]+Q/7$1K>LJ9GUI
M61N2MQJV$_ID^G ]<9EN,VPM#0!3C-:<KNB1U9H(X/S' J$'B 3! @&16[.O
M\-2$G"A,FM_Z]+ITO<1]OM4&"<""ND@61?[C#-&#5G:@F0+,,^C8;=E'IV%"
MH)#JS:G1FUC^P)$. Z///ACQX2/%A3V$.H::1JN.R2T/I_/?\F4M9*HXGM;F
MCR8RU#S++463&F@T0@)::&^YOOZZ1G%-)WP&?YV_VDE-E!FBT.(.)D0CPSUN
M00N8<%>)'$*UM((43XF9!TMU=ENZ.T8V^%(P&8I64/ /:PP4O5(A-U&_>O*'
MIAS*+._)B+%%O:!AO>VDGSYB@-8AT/(D6P ^F<I$J/K>T3/W%['V1^2;'Q7'
MW99.SZ:,G;-O&7PQWI%7;?%P/#E#J-4^8*H-9@P1#&=^K"T;D#V&&U=_ C="
M$J, 65.F5_OJR&<Q_WRL0ZX,@':Y,Y$X#&=\R.%>T"A:>Z[Q(*)[PC? $$?X
M*V20)FBU4!J>(OW/I[K*S!L\-(D)[$5TW@K3H0!2K&CH#CX5I^:(1K,\,(3H
MA@"-V?US4(!UZ_\AX%]R)3I<\D3 ,Y'WT'KZT+I4'(E6V%^D=P4I[V[B_]K6
M_F_/MS[/T<5O!,%I04/25<ZK9^L@.!X*P%3QZW_RJS%'A_G(S^BF6T/3NA?_
MU_^KK>C1>D-DKX -._WO_0>"_:".56CHW?U?:,W]]L]A ?]\S/#YKF2P_I^E
M-W 0M2U01P$P0)NZ,)SV3/R#W!R55WE+&;Z+_.56R_XGFQBE-OX,P-7VX:;.
M1BBXSD2N9+R-:9(@]IKDHK3I?U+'9?%=$!'=%G5'%1*U!/7M?-T7H*"J/XC:
M;D=[XW!'62O&IKW?GQT%<!55].??;V7X803/[ZR:KU\;OO<M?\DJ"/[(&!S:
MR@3TZ5KC2LRE3 -M?>D=C(<2S$*'K49A1NV>F@):MF.J-.X*@7,,;27.A@@&
MW)JQD;J]_'?TKVMM&%V1>V^EE3>14]T6-Y S]L=?05Q*\OS7:MS#U_6I?FK1
M'/!ZY>^Y*\_KT=7!97IL5?WY09\H^1#B7Y KA=331JC7<A9PG4M^WMMH2>&9
M\U[(6VDF/4&&:'Y@3,="= (HCWUI2::/M=8Q22I777VD ?;.->GCBP3HCX3#
M?652%1V1VDFEY[(U5W,+,83KA7KY)C%@;.:5:"Z.B[=U$-<!- Q%&DB;_^>Z
M@:0XQ#^SP*918*$[O5I+Q=DM$6*9S+A\[]O$6@-@)WA#<A\O"@])TB?A\QZ\
M'R=BR$@H*_^-_.Y!*8?.[+&@'9W0Q.MP-LZGO*\KGE/ULR17JNG'CT[FVB\@
M%%M"QNVW)ZMOYY #B3&7W[\EDSRN/.Z,_*;J=X<_R:W]--@SIBI"65U["<(B
M[<Y1YJVT7.=._DO*,H^(;%^YLFK;]L#*NE_DP$>2TJ*($4J8E6+RT\>9SYCY
M_O0ONT'%NI:?'WE9Z]YX'!@UGFNM CVHM+I([ Q?ZP6Y'U;T7T;HLLOHXFS/
M^56-\+X[-Q%.F4&\F]]+<8\3D*<J^1D6J?53M+.(=U2M2YL:')$_+0#Y0)Z0
MF&QI3MHLQ%OY\#'^O>X?\3$ESN.]$"?X\P_OKHO3BW-*EU/VXV/.7+GM)6=K
MZ@J#2_2(B]@6'4;Z?5/!=N*>1C&PQ%R;PG?HWFZ1P'+*N1&()EJX"2/W'&DJ
M(LWK?"^[7<\U3;G"NE3(#77RXAQK>VODX[*QU<2?_ KG^#[UAY <_ON\YY;Z
M%]-3S6KUFUT4X(:K:+\1F0&M0\H)@@\VT-SFH[]LC^D)&D"TWY27\JPCH^ZJ
MUKCDS,;M:Q8+7JH2E R#,_O<.0>2:9*U>7$?+,G0'507\] <4$<'0GP.[MC;
M:SC@+[T\^FD4%;E_IMHBAFN4[+/CZS!+_ =\'VYG5N6$;-.I??C9FH'_HFBY
MY<NE10[!L]TO+N>X0N"^>S'\='(^<DXH "%":UV=>'G_8>D>IEKPQW ?3XJ)
M#FU1T++P#W\KG0?Z98#6";Z\IG  QREZ7$$!$ EE-* YARL40*'%/TMO"P7H
M1@&N.4R$4(#RY1-DC+<UH7RXSMM#<GG]-(#X[.H*_5V:/]4<4%RY85: YG7]
M+:?\]O;VOG[[MX(1?R>,_CR<-C*]70;$<\= %.!LXQ=H;1P,/_)5A^FI3;K%
M?$4R58[/"$RLM<1R)5*N?'X![#3?]-E&=_M+?C1'*2P S3&:WM$1^$45V1GZ
M!UH[U(C?VHM-O="27!HD-3^G^1&8 M_Y9U2?F*-76)XF#\:>I@BD4$DHY3/U
M,H;H:G$_>'*!Y9'3=I[.T".&\]7*VJW$575J6[,ANZHI6A=S*OA9J5!-?E8S
M%^C3KU&DE%*R0FR/O[^_B>AVL]'&29   R90;;([@VZ\6$"=V$;X<M3..7^1
MF>C9WKUJU7*"@;9OVML-H"C#X.,J""B<PF.]IT-<U:3CN0F'X*H[#:.Y\I*#
M*$?_*%[T^1>_AW8;ID2FJC8$M2UY[U0\,ZL4R#<_39H].00@YMKW]HP$3T<R
MZC+Q$2 899?P%;5'CH1HKN% >6]NCG@$<ZMAEZR4QI+7XE6E:_B>KS LWU35
ML[/"V+1W_;&[U2EWR9& P1&X:OE[@C,3OMC]CCCG]M$:#-==:HX=%5!D!O]$
M*PDX^H)C6.S@*(GH@UE>K^4 J7JUP'/FZ,?Q5_H)F!,US;PP3R/Z9Q%OZJ>T
MNA+K//B'+_L$O Y;NR7LZN^O=C*Y8(RX-(]12LYD*ZTG*C$ID6Q&!NP7/WPK
M+Z_@P-&&$(=Q]!:ME6$!>[6G! :;Z!R.%V8VWH0,93,J*X=A-;5>RHCTB%Z6
M@ ,3Q5KJHI L@I>%Y)M,^FSCN061U1G:5OXN3D*PF%X!C$,B=WR7KRO:!KA)
M<T,8"V)IWD2&*N*#?B]G.%(--AIJ$U[U"G#3T:F_?+ 6#HMRZ=5S7. [UK]0
MC!M$DE1NSRU\]BW9)%O.R#U=K%A]?*+/@']Q0@44A\QVTAQ$O5)K'!=\7GS>
M,QDW5ORMEV<@FF5YD/#AXVZ 'Y6<[\9OA,^LPW&SBD^^K=!,[)Y>_,*"]7".
MNM-LJPJY_61!!\7[MO>TSBG[;C$,P*I>4Y+L28&B5#\\1617Q8R)^""/$.3-
M_+-'9]R$8AG=WJXR[RX-.;8=2?S'Z)],<-;0&=TZ*M_*I:,[K:^XS<<KF9>L
M)%%7UMWD ^DK =]$) CWFA4VP.2(ES"/^)_[W@[QN;LP0R6\98/DS=BM *5R
M1"=>VN;%YL> AOV3 L->/[KXI8ZZN*>Q7$,!B@-BY28Y^-%^^]V^5_:PAKS&
M,5^E ALAY7&XX]N6QD7<ZD%.PM_CW<^W-'_0B]'S3V1!P;WJQ$N#D**#U%UW
MBVFK</$2ZDGY^J_S.2U45A)20Z6N ?** MBCOW;+,E$ B#,P6.*#^X=".V_3
M$.[U:>H%.DK]R:UHCH@/SS!9Y@:J^'P[,:G:-D3+/L)66EPAF??W;TJ^>YPM
M&RY6QW)-'>#+-5%X/,&F4Y>LD!G>CZ;Y6JK1S,=<\-"XKRTRZ+/(N>":%#6\
MI70_@V_\_'&SJD4)=XV-"_:0F,0WEK0]^BT+2_LJ;A^K.A.[@KL?7(Y'2#+]
MFJ-3XYZS-Q]TOLA_I#>[][!_.3X>OAX@:;B]32/NQ5J?\.2S(/=I7[N.S+Z2
M!(;.VDSU;2&IB.-1KF? NU\Y ]V_))D!]-H[)VYEI+#$I@VBK_14\ CN>)\/
M9MDVJIYYN9$S>4K<S3F,NGP.-*(C+XB4=XYK5.8ER.F3S"[%GR=!FBE?H@"'
MOZ\ V)$"/G!QY4TSB4<94[@[K43T0/.V9_2,$V^>F5:%22U33+)>\3>=N(@<
M##O,]IN00-.WD]?+0ER,5VWB]L:!+AO:MR(33+@5^?,1G_F'@ITDALS-?@X[
M[)E6R[>XY^ZU,MUJ>XXMOWL:WYFX(-B;3-<DQ5?WN%.L< G8ONDS1BGUXU>S
M%I)"./SCM!2C[17EC#/<L4//$7>>)6^O]'-;G#V?P[67^PY.X7DIJ%.:%J'
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M=HFY-WOR+C#'+A?4+6SA!T0-R OSO)FM-R=)@QV8>)7ZND!74K/@G6\KDFM
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M>"=5<('.E-HPY@1=I&K'B(T1;=K[6H;0P*W7!QJ@[LEA6/Z7 1XM9+'I4L_
MAQ3#LK#+B,L ED!QDA;S>MN$:IQ6VE>OMO7GA. 2:S4+#>(2BVDJ\VUJ\F]N
MP3>W^;FX<OFYO&,?N(RY'F5R>:KN7+S*H$0S>90O?4@\D+'9I$S(S6UZOZQ)
MRK<Y5CL<M[]M2-7A0+HYQXG<7/A,JC5C.)7VX&REUMFGP7%XX1'ZWH>[] OT
MX[,^_$A?4_CGKZ(.;X[6K3.KGM"X X)E*KK==/RJJGFNMZQK78S;?5E*R+R)
M!)T,JDVZP^<]-2MBK^-+;8<#2+0#H?4K#' %?0]B;1>E_01!,G%N.'$R;TYC
MT%G#*'(&S*'(]FDF$7LY'Y'EG?2"B1#E6]8[=DOA2]N=C0&7/0?N.%:VX7=P
M,YKK$\VG*8X0\-IPF.]LP @7:=3,&TB$AFWZ\Y%;A.X&IN]CKZN*$]EUO1;D
M;-8B5?&E4DE5KP.D/5ER[01-7&$K+\QK27',URYI]1.^I.,@C1&*6PKV3$%*
MOFS:9@K6)HYZMU0O^!FH,8"M=@V* CZ^'M)$ !$NR7.;U9(;%^)NOZHJX, !
MG;WZ /PCI[.5Y&<VISA26FY7G4$X+1\_LS$!\\)Q5&LO"B&Y\D".X?Y@C;LO
M.^Z*W4-E.$DCZ)O2K/W2!,_-:62$)L0]T3?I1MU[GP3@NSL5>E^=3V7L3<,2
M66BLOD<9^'JW&?SX;6VL1^V2C@ES_OX<;PZ^U!F)*@..L7)K@(\0RX%1:TCU
MQR:%E$5[TK>RCSGO5KV93NLX4%6W^=ZPZ$O;@>BBK\C5V1KN<&><UV?^2E9
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M)Y*W/?,"\?G]#SAY<5X<^/0'BRS0G!=6&XH<O1N!M?VH[@R5XHKD,+T9X!_
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M/0S$2OL #+_E@&9,.N_\E^W15&MIHQXXX&& (0/H O,\2@8$;VBBP@"/G3"
M?P(400XMT7UXB?_SOKW8GSL ^KJPCXICR38U-*Y8YN<=YJMP[4N\+O25 6SV
MHPYM6X$;_UI5QE;5T!4OYH]HL4CQI5'M%SQ8CY+Z>3Z4!5JVF0(<XJ.:XU%+
M:#'BP/19?AKB7Q*9/ZN#&^-C5A/5F-Y^4&X9[*638E-#6"BS,ZH,EJT6/W^[
M+JM"P3AJ2!_9EITW[K;+*?M!VE,D\,E#P,SYV@G#S>>JD2A)Z"H2.I\,1J:L
MI9L&Y;$1O<M.V5A)0 WD!)<+YM'8E<OJ9A=FW/'PP0!]< S0R@]%"!7F2Z17
MV:W_Z*^2^?#"\?$I09RV'&UPAU)\E$[/B;HRFB1Y<5O=8)QAY%"98J,4-S<(
M5C2C^Q5W-ZXVO9G4K5<ML"DM\I;S\(UA>;M=553U)2DO3!]T!CFGZ9L>0;N=
M9E]^P #OXM5TM1]J"8\*_I)T0+%E\JG^'70_[PE8SW]>!SI(IX$!\+2-4?8-
M<Z9!$56EM!@@#)I<U#9ILY5ZD=P@8Y(ZC8L!N-Q4412&4$2CM+LI!A#_69O%
MUHQACWC.+D$H0NA[='$H!LAPV+.\I!B\+&M'>VRU(CD;,<"RJ^]O:M"7"ZWK
M1U X"]KTV$ .=0%U$27BS+@P#$$AQJ%P;3>L3V[*_-R[FBB:CR;::T7.@OYW
M)[[:-S& Y/S,P#DGP6XMZ+#K.=8[-"<Q &T^\:XXM.\?PL3LWJ5"H6/05UO[
M)?\#V"I%I! MV=EB$72A:!L#1(U.:HQVH3Z-@^&:/WO=0 ]_A0YBXV%!"=6^
M51]S=H)>@ZCI%A=;+Z-U;#*0'+_"1Y1L_JUZ_]](PS/\?-)@- 3U>>OOSV@R
M3!YA8_#!.58<>PR '/\7\O21/Y?NT'/$ $F^/R6@@J)LTL65\LG.W+'HU-RQ
MZ K^!3K1<(*PHT5LTS!LTP]^-OW((Q\[3F?8_=J(,<KF7ZC!_&4A0?C1_MG)
M&#:4?FVZ$+K(-=JZ/OU3ES)87=+D7,AAPQ*<@P$"> [)BI; Z],7R104#U$L
MC3\AVJG^'6(,4LD5V]!_!E%:!AN-A/9I6"G_ 1($3]R</]S%FB%['VL&M<L<
M['"1,8R-SJ2SD'$GT.'N9?_GOZU<XR3Q:%6EXSY^C $<(UK10G(H5DK0X7X1
MMH]__^Y,]B<,L,B+_<KPU?X'U%^XP.OSFC]%G/]W(C;(8'V[S13[)7E>_@^P
M[[%!TE*,G>%^!7 238R&RF%3:^,UD&8'=+#N5, YO!T#O&YK1_L>&Z/(L5,D
MH@C\^^[_I3N&8%43'(*ZP,8&^V>LISR'_K[S?^'YO9QDZ-O$9&>GV&CYF]K_
MT'FUH_'A.1AY"SMJGI<QH7U;&U+?:H%^K[H_=/X'5W[(7@+^O=Y^U_>_,+F]
MF@[T=TK[RVI_6>TOJ_W?L)HF-T0^R&BDK/JB=-ZJ7IIVYY$M2/KY'U3RNY9+
MMLP=*4PYW#B^=A8+]=>HKCUW1+Y74.2-A_1\2$*QDQ%[S4/G$7\_P@6W;:YN
M_A2%358F_LQBQGR7$6VMAULQ:"6T5<5EUH=?#^2Y'8_-,7$6'?3W+]"_[M:4
M\M"?N$!C@!@T:^/\GPG=N6A\=HQU I:?.>#0=V@Z-*P'VN8/KRL]O<0 H)^'
MT62*<V_[8@ H-D&\;>CPI[HW@Y>CSK'>B(7U'OK2"CP([EAI_6=0,<AG])3'
M+=@4;1F;#)75_9D/5'AHHWVQ_?1 ^\'5 AGK&4O.QK\!)??/.IW4_U-7G&KB
MQ-:Q':VTKH%@U(.'@P@1GM^ RD&3$P0W.[3N_[P@ E+ZIS&Q8T2!K3^''A@?
MDNV2K)^M(_]'AI8[X2'" (-%X#.>LY"3-RZH0Y2*TC]#>OD;DV]#_W2(H J&
MKH^#4$G89%U:!.V)9J4,@+NTHVG'=VLXI=U/4IUUQ7L>&SV^&^D]Z?)G(Y5V
M30"ZJ\^Z44=$X[7^9X5.2,WI@3A*;A+AK%&6QUH]+N#<,'@')3F$\J8K@FB-
MJG!'W$F9.X!8&K:3/'RZ)<]PG;!3]<]LY 7^QWB1W/?W&.;T>+@X%[QP9RWF
M:>#6G(BF9OP2>FE5RBC@::7P7'.%(;>%KD?\"'J5(9SV^-5W$IA;A\*H>%4F
M+D*HV/!YL7HYO8VZNM%/GAVY^3VU>E2UGQ-KZKM8!KR[1'9QS0"Z\:W\TQ]_
MZA3'JM&Y#>L4:+D-<6HT0A_%><CW<[>K'5CG]Z=E"C7Q+45@@&M;P\:;!SMQ
M*M2T[^*\BZ\OM>3"5:-*Q)UR(S[+$O*;J-JKZ+&>GH@OG);'0?3;Z=E:X8FE
M=.@,UA[M-]*G+XRVVNO+AQ\I110[[CI8:!VT]VQ]AGI)^DX::ZQ6]4>G6ZNF
MTVCJ2Z)5CW9\K<HVM.88*B#>P>M%\@3](6/:T9 4NN\!7A.3G(//G4X-O,*/
M5:\B85U=-(JS,+KXLJLG.\[##_/KCR2VT)\SIST">TKWJ-(+&2ZZ?66@3]<\
M+6E#>8>_+>1^2&EZ41N_@P&*\W/ 7&UFVQ;OTD$W4A2P4(S#%MT*%_=O&"!?
MG5F]WI/NB+O='G,XES-Q)):&?URZIT$WW#7KM,4IV<JBTH+?/+[\J#7%:EI(
M]:9JD^X^C7"%79E.WGB5O73[_:W\H?&(U!>-D3DQ64?EM[&T+?2!CX07F_\_
M&FU.D)O@KNEC::CQ[?;@\"H\$KIXH)2F/E#HS='X7+\,#3D?0G*U\Z03^< G
M>*RF>]Z?"@]"[LF!I*?&-$=FIEG&+.[ZDCD97 Y4P;K5NH9.A,HXB38D+>!Q
MLI4%):>4L-727)*FZ.6)NM+5Z"W>S='Z/<[4PE+[]!'E7H^]YJ@[!AK99Q;P
M\!H*-4-[5V\\6H(\_KG%!^;70Z*7ZPLAFQKJVG)O1U7Z[;_*?MU5R7[_9H?^
MK2W]N[BE9FG]4==R,:GAW6.L@_/R_+!W\.M.]>QSF$)%/^H2V3;RQ J[3!;N
M8^X$E<  0=6S9$]'A6A+Q9Z-O4  L5_@?+IW[@5(/UB<=%Q. 8Y+ Z.R*T!=
MZ331;4KK",JWM6I**\T]+:&R\5#'VAW\DVVM<BSIWFPT\'HW5VH.R9?'4>HI
M4[MGXF7:\W5PPE_P5;AP^#)* >'2UD(9\CAE7Z<*XFN_HZ>G2M%O*?R(N65W
M:JH>^/2=F'V/8RYC^3,/Q]EQ1*F W(VY&7WISQKACSF>>CI[3$VMQJ[DNTC1
M"0]ORN)9\H2[:@VWUN*7F[A^L-I=6A6/M*(^%*@K;U;*@YP;-9;![/.L"TI,
ME5(5)IYEO7F>EKO,%+<M1?6)O=/3ON+B"=)KY%2M<A3&+7NJ,L%UE%J@/")7
M-QAW,\_ GN59_7<IZCO=Y8]'4,HYVXFC,YN-I=%9#CB,NJ7VZL\CH^7-<@.0
M0_C1]R$/91 /XI;D5Q,4QFUKGH;5=D]H$_)*;R@F!*EMS7$.5XMT-I^4FEJX
M+MQ9:&R43SN]1843[<D0<"2(4RKC?*X=8TOVYNA2P[!IY(BUB4635B-<)^)%
M5"%/;YG'KF[Z/61#+A+:V4(SDIO>4[UK1GMFK 49D[>+JGM+E,ZKP+^\3T*Q
MGPZ(-7*&(]B^@8B01MOML;,V$Y6D7LO=52FTH3"!KV)]]M^^\\6ERU.,V>C-
MI>5TT<[/PZ9R<U]#DA-Y5^Z;X3!;$1&>7WEY99<B#A1Q=-^U^YAYHGI]-!?*
M_6!B3X!8F! &>L06],V;)AQ*YV$/(Q;YB+C^COQAD/"(Q(YBU<D9H4,J/).T
MES,!&H8&Q2SQ(UG*S0WM2EI@-[K]S?V&009G(8G3,8T">EISO,/'\@X8H-+-
M4.QY?96LM6E=4U3M#;+KC\5$Z%05 5AV0P0XE$9<CS+-M]0F127*R05"VA$K
MF7<[U\^DFYA5RNV[E"/O5'>ILD;'N7"8.<5>3K'.E&Y? %WG>*\<[<H+T_?^
M+W%5POM:$%H1'_6E73Q+=/3T^]_(YZ6OWF1^'%D9[RC5W4.?'=:DD3V]L5FL
M5#PEDR<I/"_1>XU6@G=E%YP&V*@9:(?[\2(UVKS\(GS=2O14K8KGNTSMG!R<
M:+_I1A,GSD9%C*>*O_ :-\9'F0\WJ19 :K7=A45EOF>4*N=,RPB=4S4?C C?
M8HS-SQ"@E=U+4WF)VYK=,/"P<YN[*U0EETMPFIMCX<F#UFKS6'Y;K5GV+P<J
M*L(5WWF]QS=\M+,--O:+94JL#S85TB9[7-_@=1G4BT'U@/'L0FO1B8SR'Q'-
M_.AIM1KS (G</H[;Z(-XCI!(G\?@-]7O]W9+2^U7(.]-^&;G6;*!/?+8G6O,
MN+'-.G#1(?Q5BDAQJ\5#*&G2R5[JR8_9G/#I7:>S>%Z[/$V7^,=7;XA%:H)"
MC6\*.KS1(]J"S:"5JP;I*OU[J=.F<*(ZKHMF2!%F7D\//[PD7A8.*?*(,!JU
MWQ>\%*8E#F6H_ISZ+,8.&7^/X>77+DLZ8BN&2=UB9(XL'!7+6E@\95WNZ$0T
M9Y K*[V1%3JX*$7S]KF&0;N= TO'2.XSV3=R[Z;P-'&9XSUPZ;93)24KFB>K
M^T@9MY7&L^OCEAL2Z=1Y^&=>SV3*\K]@&[H9, "X"6I)U$6Z$D^O5=9-"O[8
MIU1E*5WZ')5[RR0M^/'W/3(Z#Z%^E "R*QOU!/XMN:#/S31W2[NB[_Z(T25S
MBI "'6%7KWR;E9BL@!3=,44/2AR9D8E2K6AI'-I+=*WZG#BB^2"OCHEBUE^U
M=XI%84ND]"DB.H %)7R_S+K46X!?SK;.*9GN[3N3X@_QUQ@"AH*D:,FU9#!
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MP&'ATX"3OW,:NT?!R@]E0_P&[7=D_SU@'_Z7D/T=V#]PS0%XF!@WRL,D!J2
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M/4-4WVC9(6R9&-%3_WB^&0^Q\P]+^\7X;WF3P]M.8T%A%U.1%)E$4YS'UFA
M;'>NV:G'D>KP9]G!.*\Q\"(6UW]8C&ZF:OSOXA1>_O?BK,S^@\%%_3N#:WKR
MZ"^J?U']WY_J0.M#L/Y19QMALTRQ+KBL6]G+S((5GL(M^^B-</_\D.>0PS)=
MVUHLN.FZ8QP-/-E__RX^3;GR2K5H,M%00$3-U\KWU;U'V;7BHW\+N .14#3
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M;G5/#5H6V2R;ATPVF'(MPL7'X48-O9A^E-O22.IA9S/^E#>P6;DZ(3C^*<Y
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M0:ZUR/R7ZH2W!*=U9+(Y/NQ9Z5K@EQ.N363]+J4J1%ZYZ4EX(H<PO/#WJ'M
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MO">AUK]"T%VSRC?*UT4=M/< 9LOX,UEJ\$W<\]"%T8(K3:'6HE8!6>W+W7O
MQ73Q9/I=@-SMJ7,%BJ0Y;A-R*;=3? ]84TK^CQ\4_@_X?\#_ _[_$;CUUAU^
M$0GYH[#;YNO@-2P&\][SAO6S[BY/LQ&S56[ZE FE*5&;KFQXV:4[(_< &9:[
M*V'_D]!)Y7M 9R+ I\GHV?]K8) 2'_D@0TRYNHU)L2!E"-)\ZQX@B.N,_>]"
MR.'WYCT@/_D>$$P/6,CJ#9#>ITW7BE!@<+<82R,QO@>(A5[O7LVPX.].N+&Z
MBJX4/:)PYE":HL6ZE"+%D%47_%>9YH!M=D?&QT DU^@ZN&,DKO&Q@]O_1J[<
M?+&F.M,#U#9L9WR>P).F^OYXY&;B_7^NDCFHX/?T/>"X6)Z!.I_^!PAJ4^^@
MV$\^:I^B@;6Z!;8) ^PG> [BE8I(/RM6VMTK,^,ICJ6* +PF_B6'N0Y=4VH(
M^N]$(:XJ(-HSRA(RUWZ/ QU72%WY:/;HK?W=@W'9SU":W@!)E\$<-U'6Q!!M
M."F$]'J?$ZEI\Y_K41"M8>KHUU'W9<LVOW0X>=<IN3&?K7G ,>MCKUP.]-.8
M>?:;M_H]*#A"NK_E4EE! X3J3+<5SR:6Q2_1>]10OM+SX>4NEITX<UG]?]\M
M)4)JV@]W]<RJ\=1 )W/QWR]?;[E),-\#N.]>E:,NHEVE1<J?E19^P%O-U*!)
MN:H'V)P$&HH5<-Z<_B'$]'\2&$O[GS-G>(.J)7*/;O0(ZUG>944$5RWLB_Q]
M8B[OCX;R+K_C"M'YHZ.;Q%_]/6<^,]2%Y3&2!94#).R+19A-$NW1Q/KY>'G:
M>KM^+4D48MX97F<.NY!MJ7N*T44X-Z.5>ZUHDFE6D<S<:/Y6F;)6QV<HGQ?4
MC\)Z28=?:(D/:7C7@:1]4.D]?[P&CJ:L 7KBVL9GWQNZ%Q@ZY?U9WR4K&&>S
M'*RAH'VF _E594#9WDF=Q@R["(3,=;'G,!N?I8SY,Y-Y'PK#-N1-U\CM#E(B
ME'RKQ?P[+1<T2S(AO<G:?F*RW>T\:-K])_Z?G?O/':X7%.\!*3+1MQ[_5O$Z
M$+)X#SA1$+&ZNF[Z6W%;U,;? U@#2:_@?Q>YMOVOCG)H4->F[NN[SK?W@!G'
M+(>B.*3TWQ$9K-H_5F [CB(=[Q" 5-^2!56^8=>***!9[JE9,NO[ALST0IH2
M_1C4W8SB^DIGGO9QZ94<TU]&WS'[?6!9?I1O?9&I$\NB$))ZTD4 Q](Q1KSO
M<7L6)TY2<:WS1%/78F"?)?4L1* 2XU*66+DG2 I:CEFU.L1/L'V6^&7D\RK!
MICW.J7@A+E!N8(TBR+5\=Y4'JJ\0C*T'&3J7CMF3-O3GVOYZ\:Y3Z3!<DM$>
MY!-*<.-:@9G"M#@](+O-0!"N"*Z-O.IJC7M5V9Z>.:1O;,K2P^?7Y[5WY9NS
ML;\O@/=KY?8[\5,&8;.P5K[-G+SE 4AZ4_G*I==J.;3+/IE8E;^<,^9)<K^
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M(988^M!(B'.%$TRQ)K^F!-BH 7TW(SS#O^+*Z?QJVOW)ZW%#>SI:G:$(^1'
ME5;<2>!:@M>^SO)NFT7"%6="X7RU=^OIA/:87Y1$W"@4FT%2,L<V;S8BQ&$T
M][&SK!P-IJMGC0PB5[+?5AWR)%AO3&=6A$E HYZHS>4%O BH5I>]GO8#?D%C
MG9I )L\\K>A?T'</2*:72Y;V^0Z4.C"25(X5WJ<%,21*(@/]G\5QX3]Z9ESB
M17$S[*M"]:-[@VKOR_].V%CJ!6DB2&-"R2"V\!4\<V:&1E3!8HU=OI3*3N;V
MB;-/2Q\!UH-G2<9 <R%J][_>V?,/;>""X9.QND"_0>J3+&:&YHY\ =(]HX (
MPD;IU.'N/HJVP5</OG4/>J8I%)(Z%77J0VZ+CTKG(>+9"TDN-UCP6W53-%,.
M,B#WA<F+I)\.\_.B-$X/9&DW!:,XH53'DNXQ;ZR(^$$KG!:RTF\;\D^@.O7&
MY==N<W:*"6:U0R,,2E.J%\)8B]-6$F8W[Q>\!; L0AV05Q7HCGY3<\^]J_,,
MXN]+,ENSOJO>#C&ETY:O,^R&?V$-^G<%H@4&Z/WBC>#P^<]M_5>WG04D;?.I
M!(;3![;MOB_#M[YBA1?CN;U JK SA@6>4?4'L:.UOB%"29T(JM2R)),ROEOL
MZ9L/T2:8^PM2F8@F438<LI,(Y;[SM.@ _/.8/TL9>X0 ;9!6)QHT%'FV%(R[
MU'?UI4TVSYTO6R,+_&(PRK"5[S?^>+7U \%R)^H17@#@G)YGR#LTT8B:A4+Z
M?2$P:?X>8)?G7C:&0R^;Z%]1+2#,"^51Q^$K^,NSA8O5GFHK&^^0S?.[)9 O
MR +-HX'Q+T>N,K3,T1]='/B&.K2:01\57NNM?Y!5"R-1^L,VSHH?%]A,.E$/
M0GM%:A>1 37]9#D63FA=>*I)E%V_/$_0YXQ'#])HQ'&RT7R!&]$Q04(52%G:
M:,,LBWQM2E-,P*0%&+J1Z>W;%)CS5[]N.,,(;4RA.)9&%80I,86TM**68GTG
MSAUB (]O%6'8FN4_.&/(X?!K%EW )T-5>E(#3.39I&0-:6WA5>W_/$KZWRYT
M*"$F:TB.4EHF>(.4>)_:UW#_NX7I7@#37-MM_C:A<Q;8VE,4^A02Q45+V2VO
MXQK$-%<3(C-B4T!1<R8.4A40EM';7M)V)GYP@J2,=7V2BCU&I/65Y#BWV3,!
M'0>XH.?9"J8X#Z?/BCTXO0?0!!G-A+ 00 2*D9FHY;'W+@M^-#QBN4:'W.H
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M*-B3X-1/FEO7--I!1YV'3D<;C,ELK]'"@,SON <0UA!0=$W.[R:X".@MS??
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M?Z(J:Z7?$&7IJI*6$?5'TPP'N\D=I$,/3")7C %&R1+VDY4';4^A3"K(@+$
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M3N_IIM_PHIEP0MWE" OL]NM9(@V(^:9:=S(I9VKICB&#D3"K-MVQ3B,)NO7
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M"0OO5^I[2@,$=(#?#W 0*X3$=%)!(PJ>;D09V^LQWSJ9#>>#[9],LG'0@+A
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M-"2GZWP7C%7K%SN3C(45*Y.%983/O;2/*6*%W6EA'O/YCVRXX.,_114/\FB
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M>C4G&4=Q@/2R>Q.V=OOBMWG\%4Q]U.3$E1:KB-(-F>NZDSX4._)1RI5;JTP
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MW<F]&-':I/,@]1&_-X]G-(8+#UBN]H<@L<(M6.]B/  S)8$#"A+HZ5'E'AY
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M9%>9BLCA*F-]#EBZ+;,1.7A6+7]2;&(VKE5\Y++@(^_H?MWTF6>1/*)#JU7
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MAO&&V<!#\( :+V?FD8%4W##15F\2]B@Y]-/>SZIAR(>X-?&)6@B3A=GJB$:
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M^RGSOX'W%#0>#[1?/XQ'E9H<W/H^(5EAWHWCF91R?D;II)#QA4^8J7S.-K&
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MD2:+PW(*'JS@)I$='P0DQ(W#]S]9)8O,R;\>XA_*.28M?J^@@_F*\C_Q,%$
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M_OK"R%_XP@2JMAG?#2\=^&NR8:Q2?=#6#W&QJA9W$D;O<J@3?K@<VNQ+.I#
MO19[3#> 6992Q'2HV8YN&8CR.S@Q]LRQ8#X#9,N. B,1QR:*?N3PU(V$!Y)?
MU@$<LZ;S?B3.O'C"^6?<!(&>/F%T;DFALYW^**4V"VVR89VIJ1V>39Z(2O5>
MG#"%*3QT@#O@\R:<]%CQJ_Z-<9/_,T!KI?7:>XC>[!T2VT*]N=GXN(R.@JN-
MI>%.,L:C*Z6 T[H\G_U7#^ +BFI!])T;O.=_^DBN:)S+;Q[>WIM'Y3X)I3&:
M]U/Z93*^^=:R4\A9I;RHEIV?@?5E.(NSF,N J49A:/0GQ_-2-<V%WB^F,<7Z
M1<=R!-G>R2GUZ=]]ZP_EOI0KO00<J7BK173Q^O'->E142/!K" UISF'Y=M<9
M0F(7K;#>K_)YBT>I8VGO).A?CFLK;,URY^H6Y0I&Q<ACC=;T#J/.+8YR0:K#
M)(E6CMH8HMQ-*!\DWF<!66'B"@L7O'LON)(_.%IJ;VE-90?Q^2SL)_J;#BD'
M?'<6#TB]4(L]NSHG07;#N-8&QG-S)",$;,R\?X$+MI6?_L3\T5$,ZW"I:[%D
M3K,_ZS6>+U^G2QELWB"ZPG?2G6/MG'5WD(0M-ZS)@;E@K78ZGKF"&AUIZG);
ML\T"*)<[UU.K:'H_%=_7>! $U_3L$)T1^O0O='@5@CT\,.?V,T=PR:+V<PWT
M/IAT./PBNSYUR\724!B>X./8RR-3*T.&S P9M\\%;C$:!.+IKAGIZ2/#57C4
M9]8*.1==>.[*E*YN[TO$7+0DV=:DM_%I!NM7#3>,;/85IW@<%LX\X]+'/&\S
M/H=I,SXL;8.D_W'D1)]NTQR/$\14*2QM?$$4KVE&[EOJJA _&P'O7!DC/:$@
M>/.*ZH%C3T7/J<&@F_XHTVA^168+WTZU*V3E5$,LZW.CM(!?[3 O?S;MSN;5
M7FV'6K6=_E..1=7*JKCU$Q]"?GE.I7S4%'6ICZ2(Z':8JD"OZ+UKON,JAO<X
MBMNAMQ]A@2&XC9!DU-QBX73KG8P+\PP1,6UH$]\*620S.6ZRR 2[/\F F%6D
M8Z.2+_;8K$TZR*R-WH GG7O OY71:M="E(IV,?,!)4)CMAIH4+RZ<3BC"S7L
MN_;G'M7-^NP@FH$-AMI\,L /ZG5U29E]W5%M,'/Y 43=(<T3R>-^3F1#G9';
M8W"D(<553#Y-N?2A$C6#TD$\>.(=&^J1KX3Q^HUZ5UT<-[D=7X@,2T,4U2J?
MD#B;S@U458SVLR0+@CMKBX[@K\[\F6Q)CG6X8HFY);1PZ87:%-[BF,]Y5&-,
M'I&=D$\)Q+O(!II6_5/?=F; =>HQ\ZW#C^'HY<<I[Q=E3 R^$'4DI%!7;\E/
M#MZ5X>'Q"VRB6E/3K6 QQY*MN]XQ!J%N=5TRQQG 9O08^A<[B]^Z& ]RA3(O
M\+D-0ETL:R7Z*;3=#!1?)A)GZ)$I#&L.<ICHS9]>BF-VM"I%1.&4D2_,J#XD
M8A +<GH#-YU%@3IC],RZ#V]A"62R%L F<NW,R?"O/-<1MZ_7I?%VZ^0("&!N
MZR7(')A-"0(TD%!C.TMY:CJ5%##NOA0VWG>.:O,[&6M"+-8R2#(!81+=T(UF
M+>PS4>OL('"LA<_Y6\@_/U&,C?G"%R>KG_[U; =7P>H1%#("M;G^LZ<D'O*^
MN@KPIDL-F>Y4"D[8VN]_].VGGE^E?U,W7UP3,M^(^2&:S/R"D?R^B2R1;AFJ
MR*D =#G9:"3/L"OSPT-@M6F,XN&R$S&]H7S7*\($DAE E;#?W&:Z+ P>!'V\
ME1E(TP^OV#ZG.%18F+;)I:MM-.*J[M!S*\&EQ)/MFOE)]+#QX\OPSO87NJ/F
MZ!7=.=,$@[FK"B=R&A["Y4GW-N'(W5G'AGVV,2>N^=2OWQ6#-CI04P=Y!UZT
M7GV0?#6[OUCEKGLF8^LY)>\FV*+Y/6XYE3+;+#E6[!F #0&XF; C$]1FG1Z,
MMO%=AXP#\3?6D3+*K:$Z<X[FL3\SBC5FV)M(7+^A_;I59/ZRL^@ )]^^IQG4
M/X_@MJ^ZK-BM^R?T9:KH=%0M5G4FPG8>3^R'RIO1 /+OK5'GSOS\"Z#(WX1X
M5*4I>FE$HN&XBN8*V\Q!,PKE&N\^)@H39;L880V9)OSNTD46FST#L$K[>:*>
M&*=5!G*K,8*MWK5'>^OV[2FR*[%I#("E$WF#8X,(;"=CN$Z Z!5#I4@>PZ[.
MFGD__E^&1VS0HN:@;Y&4CLW\M7*6(JM%&&NS\0#)N+D'4.FQCH__^&E+2[I:
MUBGYRG+3T!LL_&81YA<NB2YS;OI:O7[$\('2B"=ZZ^:72EXN7K^65HR,5HW7
M1ITO1J:Y#;B'Z'RXT;T:\/Z_N:_9".&^0!SPS!Y-3F"?OERS"U:_ZQ'YIXD#
M"90O"E61<(X^CX38)[9IQRXFVYF50PVPTV]AN6DNC;>2B[Y,TB1R79:/2<',
MY=C09<S\(4;ZZBHP0U_7FUFNAE.3][,>XKA?J7$-VC^DB412TGR.Y<:D]2Q/
MS\/S>_7+!K?8$&DBWS)+;MEJ(,II9IVF?;3U<9/WZMC8%-9-"Q[MFQK?.J>,
MHS:K/M"/7? 2HW5[[V 5OMK>O[76' =)37385?ULKL40\01"-'\#"L*/"%_*
M%*[:^)Q];[KN-B?Q+Y@!G\1.WTZ,??BY(/0'Q;.63EX ZSKJ 7]K)4N">\8(
M5R5Y\6.294T8A,2BL'K-.OS=-T\FLH^C6R:A[BO['0WPDA@[SQM<]]D^4V+1
M# /7/RW<7B\4)\NJ*%20?97KUB!,'N/U8:5M;"*G>3,_.?RB% :.O>T]=4F'
MU0"/"/CY=D14AP7LEWM,ZX-XJ2T%KFN]M?"[5?TC,;-\)\XD#A3/5E2O-(HJ
MZ0& KVS"-W<)(1C45^7U(-1.DS=$ 3*OSR/:K-00/'A-9>\!S"PM]Q.!ES1_
MN1:+"+_,.A9N\UT(@8T(RX@3ZQL2Q>VDI!VY&<J?=+M5KCW0SSIZ5""O:**X
MN6-="T0<\JP37^[FQ-#U1@)-/\:ZI/3G03$'[ISZ(* !_7SX S;DR*'(I@;2
MV*M+9YFJ#W.M&E@<#4M(BR9P^>OJC'+JZB< _]ZD9OE$.0T=WZ/ =[3_RIOQ
MPMOT^G1P,X_;7Z3LI -SJU-8OGD&(H OM*+<G.-H6A\^3<RVJ[U:QQX<U!/D
MMB@(6S!I $66PINC=YKJZA>=&FSL1VRA 5G@M#@G\51O_;7ZM^].O@['NN(D
MRJDR)VQW1U7YX7,7%JV"#?H7]XWJ9B#<[C=I(I9ZRY^C?EKR&;0E@[^Z8DCM
MDZ*<N/E)P@>&HDCZ^9!>'U.,WN,<.5A1M:#AH>Z9>4IMBT+P??N@)M$"?]Q/
MS50;Y]UO7?;TUW_7#2Z)4FFCT5(C.NVV03% 0B\(V$N_;D;0A(1M]AE0QUJK
MYP!QQ%_=0R>NX*_S=BQ*ICPS_@'\+,F-_+,-BB!?9Y]M_"6@HJ9?,Q7?7FJD
M*\,I=%$P5JM(6EM?_X(J'8\&35@Z&G!E8!(>0%S;D+:PTD<MV]E01NLJ0_;=
M-KZV"]D+^!+FJFOU<Z]Q9^KRL)%*$+.VR?>0ZVGXAHLX@YKV[&+4C,55<67V
M34>N6I2D.'R]M>S0IRJUV"Z]#NRZ;SS+Y6Z>)LSW'E'6Z'"R<F&I+!8V03@Z
MTYK#<)W>U?!OF 4A<C=]T =][1_-(1O*BB>.FRU66(R94-<9M-71^^G@7LH)
M-E0H$ 1?^1U TG%O'+,%85)H@Q[OZR[+XVY%<O+ET](22(0IPD 1ZY0(O]\.
M7GUMQK5LL1^8N^OC+;%HG UK@([[](U[#+B2PD<!K(@Q>OHY1W>(HWC[6^ZT
MFP^S9Z?),PHC9]%JH%>A&",MC#F05++32[S^A0>BK7/BPW<V/DT1I;;Z]C1^
M%4KMGY/9X.^$RB@I:5T4?R%I^MJZ0@FB_'_:-/L(O/J@[[>0U$!T>M^N'HOG
MV0,984-]\;>'GFH.*$$0ZK9URKW](12#2TQ)!+K.)T:60"/'YT-PF>('@O??
MT97$L48T-,\X,.M!3E2R Y2Y2]F'?_RN$16E_6N$3HHRDA!FC$<=-HZ$YT;S
M5%F0J+EROB969/RRM=RTD],CY"\ER/Z?X/>!V7%LQ3':'O*O<B%K$R:)>4<E
M'UM7U?SVVO394*G/>S/1'TN*[=P*#F_(H=FY#B=\*TPLHYOX,R_>#>$4LMX7
MSI3 ;\+=$[!M1DL/,HURD[Y6&AKH]M0,M5R)?T9).=9W_V\+]?XO&!LAQ#=/
M)-_\%>2B,VN<%_O#L*:44%WH>W-^;%PH"[ZMTOPVX3R)&QLA8+*>YWX'.CSP
M^E+;""?3L@=6/@,P=R:CS^T=!59:'1RW?'TCXQ>C9?O>0C8PP,\ ;;CLPCV5
MWZB5:-J,AK+3$^:JSO2Z,-*C& Q;I'"Y%8[D)5N5\HXY\9>O?>38-Z%Z$%T
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M0C#]_-8S .^0GF0VK4]VEO,RBX4EK/,[+MZ7W%+;('Z]9@9\()-7954U*%S
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ME :4U3GMZ\'/;&+_2.D76UW"K;6&ZN:Z.OXZ&AMMFIM+SPY/6Z'..1\-T'@
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MQ.(!_16-"I3Z6P6=_[AF[+\DD.TN^P*+MP5I!/?KR#1^EH;?$]U9B;ABS96
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ME 0>U5>%O5/Z:-A'Z@GX@57PGT+>P6I4SA2<V(.KZZ/-Q*E&E;<,/SY6,@N
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MJ9S'FZ[_!<?J+)+U,K<F-C5PB/D*L7!_? .4%'N;3M5!U+7XJ>GLTX(Y8BX
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MBY;@Z[,M:WR[KQIQX!=_XTO;'V*0,/M*C]=*A^5^UEX4&J,;M^5=Q56:G"S
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M09M7+A\GANB5TRO+S49]RK=>95#?D#.6)-?C&K&\(A#S"%9D-H8%[G&<*H_
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M?5U#5FKEM#A%Y)M\RYX"$UQ4@R6AYVF&)=KE(I17*QQ6K-O0=<LC\AOU4?C
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MU_(RXW]2'CG.ER>R*S-E<*,Y+RM&70POM@#YOK=<?>VU[# A7':ESXD3;)Z
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M2(SZ_+-5;6:KP[C0Y*P_(B.!Q%T2:!SCOP#PD?MV=[:(Z43W7@K;(''+;"A
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M6C[/VV+]J\W+G6AY==4T9M/OQ#_=1(8UP3N<4S<1\DPKZR!J ;]=PC<MNE7
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M(FBF*+JP_^7@=3>[#@+(%;ZER$'YMMQ9J A/WD%*\ILTLP22.6*M/!H2!7-
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MRM/_P%3JC37EJ_D4L+)GE*P+T-<-PE=\L?"_V2/@_^=@^;OZ?P%02P,$%
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M6H3A-1=>MX6>%L*=V919+6(59DRQ)=GB]]PV[[(3V*XVLL?9 KRA(1(L[S
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MS2DS-M.'EP>M<&*EV\0V8E'+%CW']$="=0&;7%?CUG?$1V15GRI &J&/;T/
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M9\@5"B)_6VKJ(&:I[.2:HFXK-7M$0_92[[W17-!%4TX>C7-+Y@JNZ17LOMZ
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ME+5J4#W;L^!F >L)*9&*0K,0,YW7Q)]/F%#W-OOT]6:K_A_<O6547-&V)EI
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M\WM%I7>VVVY9(@@EF/GU$&PRZWIU1+MI,;R>5>#<J;+]A?RHR /DF8_NGR<
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MC(@&'><")'^!@3#K>WQD=YKW !/HWJWTL$K8YO+(M5ZUR-#K05:4J_G6S&0
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M O Y$7@6.(%(PI-\<!S^FGTJ]"S;8[B3?FW3W\93_EH-D;JEC_8$^#)4W+W
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M'8VO%3%WJ@,_?=ZBW-X,%#<!C83T+EF.5Z19Z (9+J!8]1'2DBU,*+51GQ^
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M$*6+5V6Z%[0]7K+Q/](6%%3KX1%R[D@*X;J,?D?IT;>H>AR'WKUG7NX/8<%
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M9D>%82HM1^XA1<:^\3OZ$]"*^O"63Q5Y"HO2].X)Z9\5:$Y3+(\HE1HF;^2
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M^LTB0DFHDT"6D^BS3)(99IW*!S!D>3-N)0W>6-TV&5QUFYVGS-NH(2A$E3A
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M?D&5,545[X8?/@8"@U[6.ACH-]6'=]J!Q.+HZE]'=\J4;@E3U:E2VSQ*#A?
M?PK,%$Z0&3NU^:UKSY[7TI (3;+*6+?&^NKX*5B$(1,LL$Z+!_+U5AQW&_0E
M02#/-6-?-2<Q"?Y$D))^%=-="<=N")Y'H=-IO"A:.2V*$'@A0%!L)RJ?0\3\
M8_Y7#19246D@NI[M$5]"^B.^3N(0TT.&[CH2;OW'IX]-0P=V-7RVR=B4-P_F
M2_$.?W3>=&;C:;R[J"^V\:,\4ME;+!.L 17I]_.[ZV=^M7>BC\NRHA!0HQ%/
MW/#<QC=_#W9=Q8^ GI+&;!J]5JM*Z@*&M4_#7_+O>+^,\^ T?('!-^*:M ;U
M()%ZXM8PHR9:L)FS^M+)H:V?L:F\=+=R/2.R2A,E(7U-Y$!+8WDD3O1=:D5!
MV<[VV:CUT\F*H-M,P;[E-"W/99_AA(Y-?V$)TE5(>%K/]!F)Z% ;"W 'N\1,
M&4HW*\/)(/WMN4NID9*P"$N4J[XQWD5RJ8'1=DF9W<FB,K!PT)LYI<P6\J$I
M1K%/,=)N#WQT-\X0\PY82(O./["_QPGBL-:?MJ@+-+"X!G5Q'^<;%7PLELP)
MI:1S<=:G$.H:EE*9E)SU+K'SNAEPG/Y\#[ ;J<8R<VHI)=81Z1BPSQ0=P\P
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MH\-<5/21.K:1CTOG#:N*Z_6HO.94)48"8]8G" 0U<,4=#I]$D+.%0;8%/9$
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MJ5=:!\AD!WFCU_=D&&34C95-W*&2:/U>?7ZV988V*MR1]N60VF?Q*52,*+4
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M6D$F18*(+,P,'Q.WF00Y&Y=9PBKL\B:ZW*C0BT]. 9O:?6O!DBK_G^>@SI3
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MZ@]IYX2S"GSCWH3@?C,VW'66X"6/46VR$257F[N*X'ADYR"<?# MW!U#E,>
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MYLZK'*U!2%F-78C8IIG,X&U:0O:)%^H4:.N Q<X$3\Z?>*FDUM2=:D#CC<\
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MA32YX5HN2W^;,X5+-A:6^$TU(5Z@6HE 29?DYJJ'0L?^2/4Z?'?TB*4=?<[
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MPO&:A65.HKDFCT!<41SHYZD$L=KK*WXQ.]]EKGO<="2WHFZX?,'@EWKG!];
MP4!0-(%FY" ,B6"'*G,8')@- "-L2&R'/[=Q/9EU/EFO'_;1(:W6W*L3Y;[6
M&I5U2'R$!8)_IP&MD[!J9X +9X 'SGZ9<&0A;I79(')],]<\Y^,%\KRK)<U+
M'UQZ X;RV/HIH)!9&V0!,>X,\#35*.T<_CNT$_?[KQ<;1'*I\0_=<N).^T%
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M7,;$CF79PRV@H:K$(G_.VM+Q-10]5'UOKO[XYF,K=TUHQ].9XV=QN54!"O-
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MAKVL;RJD=P 4HX42(A\L<^B_"; GOH5Q72=>?T2(>Y/&"RN"]7T,NSS.$\\
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M/Y."^CGY=.F.+T];#\8E0$IBU<GOEEV)C#L9=PQ2I]*[3V?[9/<*,!Q;?2I
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M46-_E2=R=T>5_PCXOXKB>[]3GQVUBR[^9<[D)5J'KC$V?6K_H]-&!L^>I\S
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MCAM%?HB?3/!$#4D"4]H-.G_DFK$)Q1G>71J#'VEKV'6U?[7G%\TS(7/I+:;
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MT!GCA1%:M"Z(3UYK)U%3?+YC'O>(J@4%&?)T+V U 21472[+J*ODISL]S?
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MJ=E9I'@80XFDJ?["F#\M[ER_ I W2CEF&6Y2=AVE?4BOF0 [90F?6/IIUB3
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M$V6WTY:FDVC8.,T="N>YIU@^]@4H]E$D8,WA9E6+.@R1??-D37MA'U[/U)T
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M3""XKF?!6EB)+Z'/-5HTLDA5OKC%B0PS^1SMD[I=8$^Y [+\HB3SG'SZG0A
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MT43-JTX9G-"U:A#7$Q?L%==[2 O-,)P2RZM0+R_G.Y9VB/_9&I4H#=!P!BH
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MVJX;P?5&2$)(2$! 2$9,3$1"049!04Y&3DY)14M-245#14Y.S4A-0T?/P,!
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M8X'9*BX#KZ42:DC?T05[C&2Z*7.67"/L7RB+9TSM2]Z5TG@$T=TTA?I_9\]
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M"1Y!)P9E PZ ^48K"[J9,^"B9B\'ZSR=FAJPYY+R)^=5?9S6[<N^$RV<T5;
MGC/NX)#C6N//Y[#_9Z]*N5=9#Y$1.>02(D10,+9TI5S$TEE-'V,QE*-85"C>
M@WR90NY!^[9N'6^<,O(8=7.ZY*\WTM*=PR'B.'EL+\:G9VS[VV(WZOV@XKJ
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MA$<I<D[ORC]9_B49"]:MG:B);- V,X@CU9E+2VX+(->(LGX($*IT67N\Q'J
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MZ 9L8J#%5I+@?JP,-[ZUT_1UNU2#)R4X=A6INO>-M_>6D\-WDHFC86JV.K!
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MT'W2R\)QS'R/)IV%1D @ &[P7FR9<J/0:?W6G#+1TAK_+I9WI(TI@O3]81Y
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M]2%J"Y$$K9<"70RIO@+Z_S3>X >C;"<8RM@>5GQ^N2-^.2ON=IZ(R 440!3
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M!$-LN!,_(?0T][FJ8H.UK+3.V3F81Z]36,)MO!;U/8! L>';(^X^MHS:5^5
M1IQ9*9S!?",# X@%?3T_?P%!#,ZU<W7U^92%BV]45K/?>9+2KDI?MA9$LA4M
M<F=',I+C&IAI&"7!CMH0=.3VS&3I<A\D[2S&&^PHE^6G]2U:J-(5ZYV"*> "
M^JL[@IFY3_7X4\ GDUQG&SJ1.F].BM>-G<L>J_ -ULR\NZ669":A1C,20WH4
MU+PVG\C$W-.Z'B?^UM\BT%"A/T81Q5O;,8ITW4T>6/UM%P=4C$2XP%S J5.#
MP'R8F(6+OYAPWY=P$5VZE$V/=,K]6+$N'+O?>+7;IBA M[Z*.LMY.0DD:+B
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M@N/9&%6)!"G1OATU#LQIWA O07ZYV<!D1VOD$\H?0@3[Z@+M0YVT[3_HNK\
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M7V]Q9I575A*<KYPO?5=2,>U^-D*"7%'L? MA0SSNE<-,PDNJ6=V7*.)_0Q-
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MK"Z1XHY$M\?4QL]J-<0-J&*=Y-UO%;;SP]II*FK_ >9;2U]P-A[Q:'9(_%^
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MBJ1B297!TMKM76ZW^&@#*QLYB+US*]5Z59\YL*\Y]@)[ABB13"0XJVK$!&$
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M1[1\3"[4H(OE8</&0\09LSF,4;[RBL:Q>%LO ..CB@[)6(4BNVB/,)C,[V=
M]S-@AQ-S).@UHFH;_;JB&P+S"/^P9+9H<<G<*6&5GES[[<-EO'M\H?VMT_*!
M^(_AWRR!SL/">N(J]B0FE!!C-9YRI/#O)7SK>(Q(&2%( ]O-HJ-V+][PCN+
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MF6OFROC>@05'#[2>EL1U2.=U8E+1<.+U1+W@!,7\:_,]NGXU5DM!J+:WA1+
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MN/(,4.]XD)S"BE1:YZ^-GE1"R_ <9PS#->$L*= .8TU5Q/_KQ9<O+@!DIAS
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M+5.<76H08Z3VWXV=@:$-Q703!U=O:E0I5AO;?Q2\$]&PU_(E*\Q0=6:T3P0
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M)EQ^=#$RIY)DB3G4M>L*+:180X#<0OL%X:,P%"Y<O]ILK.K$FHCNM).@';/
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MZC-?6P;#YEX7_%+F/P.FU<!U?[_]'*F;/T+#8]U,"ZRM!+8"[V.H(?:F$'"
M OI1E>1&0ER%\,/\C+<2!K@E.AD&3U?I_AWLQA_87CU?O^HY8EM5.4L>. _?
M ':7O7I""_DWT!)+0KQ S1=9M;5_@5):\VB=#_\EOJ:.^E_AUMVWP;OUA"=0
M!#87R/]GZ0/,5",&@0Y'Z3D\N#7Q)Z6X?=ZX0_)!2*A^P5O"PL^AKV:R/N&
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M3YS,PQ^,TW\;A)9"3$2(_G':*M\$R;Z-&"LC?L7,Z!>]RY9265[XY:GD@M2
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MM<@EO-Z3N$D_D_.1F0MWU3$\$6P&GVY+]V><K&6,CXPO:2<=RI[C=#QFEWS
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M0?Z'TR($#('^"C_S/\!P]K&B1F[$;ZFH"03S@!4+H%:'_-42;G#AK;B!@E@
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MZ?+NZPY.G+SG^\1$&LDQS=GQ)3JE0/.:_/5K]I#^G>URYCOJXB[7*TX9RGM
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M6($J2,QE4L]E\F4GC\&5Y4=.HA+@^.]QWO)UZ#B LR5%_+.01X&6N4K(PGM
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M$T\WOT;]06C1#"%3NM(BL(1+-\6-2+/SYA0E^D&\;-G;0KR\VINW%H+K:QK
M_,&HSGNZH[R@I:%"+7[U+7?"#M^E/ ";P8J)R-.4N:NIE"1FB1,I/%>=JSUY
M %D-YS75MZ5YTUX...L07LKG=J"D>)X T GE1$L;&Z"L4>,N\C- ;RY4.'KL
M_DZ,]HQR-8<,U28;)26+F%^T@'H-0E'JAT(M$L/,GG%:PTG/I+!H9;,#>@*7
MURRCTF7PCEU*?SK19<,*]X%<X!#MAAC:\B>)DMYEJWK/9?22T3 2M!PP&E+6
M2N?;/D+X D5]OCOY,Z7>%@I1NQ>$:Z/)*R@2JPR1_%B)6>&%2+V5XBKR;3)
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M=.C 9UJ:7H^(K&,0NFOHU51?5]LCA[?7VAK7MV 82 U#\B7.%UJ#D=_R:SB
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MC?.KDO3SD>WA04L:Y"86B/<0W@G*/;CNH+:[6%/OKZM-8.+-W0"J;"KG2IA
M"O&)NS%&]O=<+>F?EB0..B@/C9A.^LS,'V_H=<JS))^'A7X+%0.\X]**H:"N
M*CRP.5+B2X%E?S$LNRW4MN?SUCZ:WM3Z6&:^2R"Q[%CMZ-$N9\V*$Q]VF"!F
M_><-%#@L).(^",)?&/GYRHUZEN&"OL+MO$=F=YIKWI%G*]XN2NGY=M>3L%VN
M].G*XZT.>/S(5X8Z#;Q3UG"$LE<<.3;:7HU7;Y!?28GX:HFXOD^<GHN%YXGZ
MJ#;J34DG34R,T-1WN+JT\&G+=-OQQA&.;\QI-]P#:+XS6-QK_MW:16KQVB2U
M^B3."N(ZDWQ#C]RI'S\\$&;%@L!*#S62O9\)2(I,I,RPK<%;@,]T':;6O#RM
M/_UR)UDSGU,6$=MGE/@9. XRFY,\'S/3.,@;R[!FC^C1RDQ\KJUA4>HYM5RT
MMIT?<Z'-QD70_6G'%#*26[";U@:B=CZB(SL)CU'CR T,%FXRW@NR]D.DU9P0
M[%(9=FI+)9#9BCTG]L_^=E;^2IO[6\FOI5/U4?TKF.O+D2SI-0[A$"_1HGA/
M[2.'AD)'$7_&&)/9]MKI?C7CB6\# [>:YODQ.W$VN#\Z3'BCR#\7<SR3K)4/
ML@:7F+; %L@6VA]R/7%]@=SV:9 OF/M,L=CAM#8!PS5^]?4JGKB4J,V.F9"A
M1X%6@7OR]'3KR&(Y3/D31(PM9?RR3N/*V4;HJCPQOW>\Z[8A,)H\Z LW>Y1_
M:!]MG_/D'A2N5&QFL2Q[83KB7>;3_;*CX8^6-I#(49_:V_#J/3;]%];Z#^=J
M^B]NXNWW=^6##RVX4V:V@FY=YH+''Z'6I@\@,H;SQ_S-;M+=P$=M394M(+5O
M'XO5;-#JP)AK.;UEJ%?FS,3&:E[>E]6#Y+\FQ #97=YB9R.R^!LRO"AWOV9L
MJW&%>3,3T6SV9OLW7T+%,7:RUN!?C_?4D4P1*QIV<686YAI/LI\T?@U5-5&F
M>(&3@]H9]M5^9$A;^KYD,%5/:Z<6&AQ[?)2W?PO,.ID2FS3:<AIFNWC(J)GZ
M\J<M/TAI%*. 8[Q>M*8TM+78QG-_+MO%?IPS!FO2:\'JFR;*"Y-?X=E4:DL.
MB V,*B;,H3?(QN8\KXQHCZ<7"M?4E*N+_U1J)5#)QD"6(,L/C))D)A2A@Z@.
M/%,6G3F>T%S**28FP>)69LD65ZH?F-?NL_!>_GUX=HWRTN LAPP*"91O<!=J
MR40G&8)$N^#GQ1]K8H.4![Y"-C%#NPB_,Y &=5 6 E.?_?R\)C8@-.YC)BOT
MSB"B6%R^5.@B /KX@>'U_E8=A7*BBI'TO3+8D_8@36I-,*"G4=ITT]&[]]K/
M!+UD?N2=]B_?=:/2F<@;#1B2#2B9S'6@\^38)<^-0(I_C\QDB,58O3%^0VOB
M":%WLBH%VO8] /]\$=2]A#7N9>'-I0KE>YS@)>*LWBC Q44JU\60%?9)&@0I
M9UXY2(-:K_0CIM;YKO]H9@AW:B%-#V_'A3Z>5!(L&+G]HRN+14F1_D[!6$W(
M0=\VRNJ%;/^/-U/[;UL#.(_ 2T@*0;.RG[:O_<D;1C@IQUP>J-WZ'Q5[*]^M
M/E..KD0B( A^NVN\,SV8]H9 ,*<_1ORM-'J"IM]1NR5<40.UXP4Q-7,T,E7:
MS#+4YO4F9HO\B#^?'KK@7ES\!D1K6$S[4PMX.L=8<VR<4>^'R,/>Z1UHC=FJ
M&%.BK.S^UW.$@85('-4QF"RM;[%Y1+MW8T[T=V"-__ -/"O)7.TQVG?^7@8
M]FI81);;P;ET4GS9"C]Z)<V,E;1<'^6I2C>C6<?,,CDL6_VTPW!FW&&CNR[9
M20/#?)@LT??$':U31MZUI0Y#^*RGIE2X6?<Q/"'LLPT-YFO,FK\:).NM3(G&
M]:ASJ JTK_CFCCD>/-V3G0J)GVP*'%X)O <$/':;H-PSV$J[!SQDY,L77//W
M@!WS2>P^R6MI7TNUWS!FYI;(]R)0Z@^\SK][^6LIX#HX%0,W>W.@P3O<D+[+
M;NUK.M>'C_@<?Z/S>PE;\T-0M33JI%5DK:L';O,).2X0U4/R)N5K,I@FE-I9
M<T>XLT]U*@])V&*S"J\L/3Z>B3B_!R30Q=?"BLU&"Q=J7FT-!U5;. /XX0LV
M3]PF$D _4:>K+7Q&2)RN 5=GGL/O*1914W!]0E.6<G5FY].8C4#^E>M;$((P
M&61X4*SIX1/@Y^J$/)@G?]7)^!!U$OOV7VVVNDJ6?$RO+E;&-\SRN6NJWJER
MHGCWQ2@NWE%IA%QK9-AD9]#>Q\7PID;:HWL:R#DVH2Y#:B$!XE(BU?R^=)@X
M%&?U3$W9.Q4C#Y-Y"\(7YVD60MZW^@?&Y2M<8OVHSY[UP(\T6:#A>MGS6!SQ
M_3>?,'VLBH7I& \O(B@2X=S'5\ A#KBB2S$X/DPOUW3DS2N>7_K_^'K+N"BC
M]]UW#$)2E&ZEI+M+5%I J2$'%<DAI!N4[@XEI9NA!F2 0;H;!AA@Z&9@Z*&/
MO__>^YP=GWU>/&_7FV>M=7VOM>[[6NHVS.DHU7RB<0E)'*V/9NH:3;W9V6G;
M!Y7'V[ZN93KVVEV0T+M3>W=4:6-]XJ6LQSB+4N2&8EH4KXS#S),2 Q06M$Z,
M2'JGO3H>N"8(PRQGJS@H>8JZO#T:"5F5U?HP:2=*O3%EQVI=9;= O?&&1+CF
M.YL?]5<FHVD-T*@6"![ZO&-8.3L'7I%A>YAZRU84>^6^CQ3;<"'77*%]4Z;R
M;A?5*;O7 6?UM4XSP()7-VLP/1!SL<Q!>\&I1#8M8>\#A8V^WA>:WN8,>RCN
M+EY?R<]KQJ1,GLXG.K1@6[F7?U0&T$)R+Z.K/WAG^NMM;1*XY'-]NU8M]X =
M^/QZUJE4#HD(F:)GFU$<@N0MO65:SNE]66U+BW,74Z)%^4OHK:-3P<Z)Z4,Z
M'M^)[R&2.Y/15\!R[%Y/.E]HM0VL)Z?43-$_D[<H0W3 7**37*?^#JJ^W!!C
M7H2E'=A%3-#Y9/P%K1J,X:8$">#$^1(<@HD:,E%F:L(V*.YB=?NM7$,XQ^,3
MR:E"Q6[V0QLCM(U;?D.CG[_R<PAV2POK%I"_?8)<R*#Y9)]&5CZ@8PG0:1\U
M,[G6D>/P-9J 4UL[HU#*HMWMC5YH-$*<D/-1B!#."R$5&CGHP@S;J@:[Q$N$
MU705?&8EHQQ(E4H%:$ )O"&;C<4_JTJ'SY#22+1Y%$6.Z9\!S2)/E'$I/:6@
MI=?>]O.K:D:CH'1I^5&8=[;;M>2-5E"7!VUQ& HA+1V>(DK=WT0T$>%E\:2>
M*>E1MDMV8.M "]X*QP\9XM6?5?I^+X4KYM_7*4OP)!:H.3'VZB3$AC'FM>J8
MQ/4(>.8-;*EDO&\>,V'UT*>R'1]F&O)0IP]BSB0[3KB157(QH>&UDH$G0X8J
MP9"9L;.Z76JCIF0$[>EIL\XXZ-^2.+(]JU764W31\7TWQNL+DA%T\3G7^#QM
M]*J*Q7K"-_H'70)TM)KU3@EF=#&5SSVW[UNH)FI]#$L _S(U-=HY,QT#/CC*
M-_$3[HBQHN?F-CN,B6*"Y:H_D\523'A.4!_(<)?V<J-ZZ=XX7[E09/KDT@>9
M<>TQLD_7:X6A:"<UR\N&/4ILB<\O(>PV^FZ#)3&$ 21CPG&KN'"P;$]'**,K
M?26GXGPY"M&8/;/3=)8IG>+G7@$NQO1SRRL=!G"[HQ9/K^;_\6D\9=8] #3^
MC_A?0F8B? %'6K$',OR%R#T4+;RIT>NK%AH<]7/-<ZT?:<2.W'C]%T=AU.CP
MP)_=!@$2TB)>L$%V ;6E>BGF)@O%$BE-8FJ_*^&]T0($[8 6"3 IK_IW?!QS
M-\QK6Q2)3(W(ZA<<;A&%>3[;IZ?N_DKPXI4,>W6=AJEW=4A4^W>VP#?-29*O
M.G/Q=MZEM^[3'L_U%PX@A'YLF+U9^6OW-0Q4?K:9[FOSFP^.I /K/ZF(#NAJ
M/?B@Z2PD$+Q^-/H0&CQ>'_*HU&E:8=V?_#;:84/UN.$ ;>^;<YKS:ZM_.E"M
MA4Y_XD)?R[*EV2$,ESCSZ;=O3LC4VLH;87.;BO[2^?QV%S[?C9@^5=6#P;$<
M;X>T4EOM)9-Y6UIKJ$J[YT%>LHPVGR=#N)W[RU*]9*,8@[D&-!AZXCZY=?%+
MRBG1(0.F;CPGGPAOX_^S>2?">X5EW/21GH:J9,O+B07+9U;LYKHD-#X.RO;^
M H.0='HXYLX6GLW"F\E(A5:^D.')NM0_CQMI@D0E]3IAYG42.2D-9O^^_;>A
M+O4N $V+[P&](8VWSF;KW(E9V7+Y9OVD(U:YVEK74IE&9O0P;C1C\]E=113%
MD.=,EW=.&&7W/@]SBWI$ZL(ORU=ZLRL^KGNFLEZC/=+#7R:(B7;&Y@8)S7J'
M.ZL=);[V2-P]#^W?FZ0P3-[2(I3LT!"==FQ+MS2T?S73W9&9:',Q;G\L2_*(
MY2U-RALU74H]2<!:0KJ?HJVEV#C=]RA)A4W\$5TQR1X?RT*(HIT7Q/V?E@OB
M?/*\LI=;:C=:AU4VF]KTV["8O([6*WA=S(6_DV.T5!%'M>N>SA\"!>]AB:=3
M6BL2-0 FE^'D&TZ'$]_EW+ 6*QE:)-BU3G%DVO=]$;"?MLYMBI=%>6MGSYVQ
MP$)AWR==QM< X)3HB5:'EPQGON>@)BRHW=U;KC0@@"W9'K>BT7*!^IGNMR86
M(IKV^8ZUI&$_WO_"(8HS?-!JQ^:KM5"@YR]]Z1\_9^-?$\G#?*Z!/WUQZE,[
MVT$L#=F$ZH:Y,Z+4*$(<;D>Z)_C<3YD_/Z#^^*.'>ZHJ3Q5=%*O$39>K;_&E
MX*$D<ZPR NY?<Y3ORX$57=,PUOCA1E%WQ(9NX781ECL3IWLDO%Y'3[^>F;U9
M5RJJ2>(\Q^#Y7O8]Z&4V8V1+T02H<HXQY%KF'M!/C@F[]83<!8/'N=L#S)>8
M3#R;5Q;2=1$)?].?Q"(X6;Z\+U.PJY8EG6C=K>[0T")]HEQ[(R(+8NZ<ZMB<
M3=?3RY')Z6^&M.</R2A%!ECSXV;ER\]1;15??T2(=_IIGFAC:U;)V,M]OB4T
MAX4-1'TVJ8Y6>1/8_,U]C:97LA)"=G3]&BM^UTYU#[@B=TO"9 #O4%CH6LS;
M/LJ.U5$M)VK)O[-+HY5>%"MH0=<TV4HQ-&I<'=.VZC-NALGB_(.:HH39>$^8
M^CD6.[Z=XWXYV9F:+CI\MIF!'[JZH6K]-B4DI\0^_[OJ[NM*;^[%K%>ZMMI&
ME3F.;U?,M3]H*&Y?G)P)G1)K'^HT!#3:3.S,?!3K9W&FH;[*)\F#<C44%AOO
MG@L;+O:P-2;;NW+0'!IJ/_%ERGT5R+UH\R+@EV'G4,W)9-&^MUN%Y):"_XE!
M807L9L(4!FFB<^ZHNT4E.BI.'CJV!;1FB(,"YBRO!:(7]N4^I$F+F\?,;M'L
M1:ZT4)2KKPY;HVPCK--# E7B>VU'CTN=HX?H8M7H?2R;P82S9W2O'/)(6%+>
MEB2H-9"6R$2NPLF-#>G\]'=?]ER@G=O%7+X_CA[ NST#^;/!?K;(F/.[G8C!
MI V+6A![A]L>GR="*9N3_38L_,LN-.0Y&I<]_A&G3U@LA;%V4^1(QZI-0D'(
MT[J\%\[*OS_.[.A;ER;:BT1&J1:-,*T4B &S*1)[-"1Z&PR)QDV0R4!B%HJ5
ML.'CM9V_5:%KKX]=@VLF^.1KWMG#Q )%+>@3%71FD]!&IT 2)CP"$18EHS]5
MQI4,<,V]]8NI_<JH%*.)<H;G'G739EOYU]$^K6^NWTY4HGQLH!'MA,+_[-L]
MH.5IXS8Q*$P[T,"^P/U:V@1@'AF0T-_C5'^28PO5%8W!TYI!=TF%%'A\+!TX
MI"\]PRNIS.1J%]=84OQZ#Q@%7BSTJV4B]2B@TY#C<?]W%Q@-%RL>_0O<"4L3
MGH'<2"831F*GG"=5&8:3CE"?7]F;=S8M$86>*7++U(\8E.@@#+M+7=302N&.
M.\>P*A!5?1SX=4T$[;N_-(_7 W\_-^G]2Q>C<1J%K6+Y7,SSXW="&HU+%E;V
M&OC#C.(>0$@N<!P,IY$_0.<;G5ZD(.&MO] ?.P,Z3&V/$E'<U_.[#7OYM>YC
M9]ZO\N %EW__^PW7(_XNF$@V\WB5ZVDS6% JV8OB459QH("?K2FA1IK*A'W%
M!DP\YN'^L]K';,H*/[8%N&XIPJK#H.?G%Y7V*%2&/RX*Z3\X>YNQ9-%6M6*"
MUQ-'BK2%DZ9?63C6S_IB8)GF+J\^^<4QI7B<_8)XNO=V-7R9^1!3]%T,'<7"
MS+'TV++)A5Y\1B!%8(=]/1V(O&4RS2Y6PB,[,]&00M?G'1:=[\+!"K[2OXT\
MS54:)^U20EJ8EVOZ63,3 YX;Z>'$)!NY%>B/'1SGTP%]*"4N.))T9BQ><>FN
MX9>S)M;.>;&D5BRJ#CA[V!]<_'-U^D7_9>U 5JN.(5=9A]&0,[38FG*3^+CB
M\_F]5-RU_EE\1AU<.H5=('TV>)+[K]RK;61PP-.J)>V9^AD,=/"MCUN!5@6T
MH -_5;!F[G9XRV-PJF14%B#+M$(91!7:(NWW*8W7Z:6M.+$8+RV2>IT_5<7<
M(2%VEI7)Z(![%([;ZPI_$*H>H\:@1E/%GCC3URP.=GS@4LLD<GP-Z&W4G-X6
M^:]:J.@W@:I_Z1/!W7*"V!/]2=%Y'VY>2U[&=M\(RL_V6R+[W9U<69WQ8I\^
M!:ILMFIU3[13_G ZSZBQ("17CN][SER-XQS0(B3KM9:.J337@GD=OIQL>6(N
M6QG,J)_E4?*.KU!/=4+DTPC=D^HTQ@'!B729"M^-P7YB6?ZK@'0!7P8VZ%)L
MHC3:7"=-.VU0O4ENX:OU38_U"T,Z'-,3EJRH8PZ6)$,S/-$8VD7@AR.>I5GD
M>=RWC2(O=]$IGI7IGS67&;9DQQ@%P /3E+"(4V7,701[.:3;HQRYV.WFY"(#
M>E^ME$;S85S@L1+]@X0>;Q?59=)0$,U1;U2:85M-^EVG9MJU5"?Z?25Y$36F
MJW>L:LM9N.^3'V?VLWQM4>92$53SY3P0C';,.)O<;C8.;FX(]1PQ3WE4>L[R
MLK!(\9G",V7:X!B GAXU@.2[SJY6#>@_?UR@2GHUK=N1].8%9@@VTNK* M)'
M30@1S6B;!\?XY/@'E?ZMR(D)H*]G"O1G,AY6C4$5.U,;['RK/G$P(&G;_\UJ
M$??^0@)O;?01EK#G'M# %,=ZQ!3.SSC_NC&^4W3UX<L?#_H;H* 0F(/Y9&G_
M7P@_5;1K0<D'DVG&P<:,_;CR 6>#59L6=RG0*"G#DJ'\1IS')5DG7ER /7\X
MZFOP#HPXXU/U(-(FX8HD4'76XTZ-^X IU(Q(A"D8117T;LS^G4#QL&CG=\NF
MI)9$<>< 9@GJA_6^5,N5="L78;PBLK@]LO(:#2:LJM,1NT/>=<_[.9*,4PS>
MTW:B"I6'M8W;QMV5#.$N/-ZQ=*1,5F%AG3B7</1_2B,33OZ7-#Y=4?074E)K
M[]AREYPZ@WE5%SY4\T=U>O^'$(1C!&7_C7097R%9AJ98;=3/%,*TJ,^HA[&:
M0!F2^@<G8=&B7I J5WDJLQN9\:UF*:_IP_6?-9[+SW'>X$N;!EO0$0FWGW;[
M23MRC3J2EW9(A9KE4ARWPNM6KN?QZ\%+T0G#RWUJ0<6B2<INK%S.+VRD$L:>
M/>BC[O9C6;X'4.S("8WK?!CG$)=R7R-WOK3[T8!Q^O-0V>[Z ^Y@7[BN,%>J
MQ =-(3\<YG1ASFBI7^1??\O\V(L\C@N_>E_C:X3U*H'GNXDX[PIU,R0)/'V#
M4[<>\BB5U8WUB@B8@S5$IZTR_@AXW-YBZK8:HS3_\:&V!5A/^=+4Y4)/#Y\!
M%Z\0X,?)L/[<1..QB]))!WD_;37/KQ$A:2N\8XA$Z]3G\3L),/""KB7*#+];
M)D-)<[HI*Q9O3!L+;H>S8N1J5F]!XHU'##UYU:I$#DL6-AO:UXV"?$]Q/N'A
M?9?Z4B,B7.8)63UO Z]J,,J2J,<1*MN-&2\19G;-/">^[N C'>JD7J,Y5$4A
MJ;32LES0?GY$9G-IJT4Q:Z1DGO-:->H%?UJF#D1+;K8[XE[,D3]\RY3!ZG0U
M,R9Z$K:?LTQ*N@,+BY)1+)"=I#ZL$LEPD0ZZBZ85?QSMMU^RV1K5X1T056_<
M^D;61[]VQG6L&<T1.MOIEIE97B*-WR.@).1#<%*M7;IOCJ8X](NK7?6F5OZE
M?U71I*OKFG*PF.@^@;3Q@6ZX1-_F557MYV'TNH-YG?PH_\0]5A$"*9"'O&8X
M=OI@/>8)E6/!^J]]B!Q9/3LMP9E4Y4^=/1[3O-;[1C=DV1$KN. *D;S]+2=O
M Q3WIZJO#=.9%(WAUXV\\SRTBW8DB!E00NSZQ/;*@N=$C.6QS4S(P,\\1D7I
M#E^HVW5O)[[[82%4-!(("(F&O3:=;./,:./0V48H)&W#59\],4Z$"[FSN)N5
MM%UQN'7!L%E38+R7[MK@H=!2*CADIY<<J_#8E1GABNQB? :=K'3CSHB8O@>X
MG5\^WR">'V+)E14VGNK_HKKV-8'RG0-!=9]\B!^#FKA#H30G<F9)'35L&O 7
M'K;ENCOW2A=!U=HV>#7U39*&@:O<1M\^X'P%C-]&]K-[+,;W;W'#OA4]B6Q9
M<KY!4!>9B+_B2!P7VE6>)UZ R9-I%6\"^B6%W70<UM?$PN4L)/&RZKD>G8;(
MY-XEA'_/26(@*],"MG,IOX>1N.6_>\:/:X/<6 IW\X3>"DU0-36D\ 8#%72%
MA21,6#X!'E!?G$&R[YYY!FEB)X\(31-'M@S&^-_/4)U/=HVG1'P];G\DV9F5
MY45-<6996:Q<O@-,?1Y0!@M9]@UP2RZ]<UMA>BQ',HM5-CYBGCC3J@,9OS__
M#F#HP;_=I#Z5%^C= U%^*2H;RZ<^483?0A?K#V>O,W,80D()Z4"09M.2DOI*
M\@8/56,0C#$)XZ*<I(8QK9.][5XUR1%ER:'[Q"#&CO<^T.M PT,T:D6>5'7%
MCXV']O(P+_INO^6S&G\Q@U=EV=DW\@UE0K7,Z?1(#6_^7T>S5P-PKD+=@PR'
M\\9+'$ML(B$XZ]&'V&,:!UXCW).7/SQ4.AG(/>12"A7=1KB<G!)A5O2L*VQL
M8T>C/\X%&3B,LSL0/J8FXJEU2QT=LL5LNJ[]CWW_NDI -"9%U9,G4TUMJ5T'
M?W D*V<2.?A0R(55RR" G0&7#Q;O ;-OMNX!2NG;;KQ"DP:UB1/GBWSVZ]36
MZS1X]P#((8@2&'I.S07JU/)PB&EUN+J96?7Q*F(7/8+*YDUF^"'5-<2N?[$V
M5)O(./((#AQEC=>5L&F5R)9G1K4W-F0+)QDW'#'F-7@P'1T5: [RUC'\P96)
M[AUC2C[1/PRY"#W=>U4?Q82FLY93_>P5EU77T.&=L*UA7Y#;L;7Q);=!_.,9
M!"04H^K<;Z0V6@G74C^_&=_J<7NE"'/6%-)P]?8J]O$P"Y(9[;X'4!=B]"#A
M=%T@RFF[?9XD 3/DI4NG<\S+GC_2:6!+A>/&3UYHD'V^9UZG(=:PO' S,O$>
M\ GOZ5*UOJ?OZL&$R\5K/)L>K2W0WM'S#DHY&8QE<>ZNTD<KY\B1S_:5R6X)
MWP)0"J!'YH4V5U1_F<(]/D<_-\M7&A;)?P8K(G^UEM7:-")LQI^N4RKSE5,2
M*12B&7DK,C^^U'<]E&K -:OEG!%C9J-AO5B!5*UT+'.!3=O6-RPI8O57#GPE
MBV52CXTE?I#W\HD3 83;#Q'0<OG.BP^@[51AXV'Z(Q'.B)>?!CP9NJV!B$F3
MZDB'*Z:LF3N>^@;(FTR88O1%PF*_A2/;E!6G]+O"J6LQ(6[*M96V,#Y?/:H(
M)LWY2J7V[BF7OE_2[C<#%11_SG!AMIQ_E(SS2E?!VFUU&4#]<6C^HK<7?3(*
M!R8G3'LJQXG(#<DRTF =@EC_Y5O,);CYO<:!5Z5AD-[9+8])KCC:30=CW<))
MS7DSO';%3AI>8R7ERDUY*>1&9*677*RBR]##5M;'>Q2-B[!_'D_.!3MTX4\^
M%9O-LS)1+ZMD/R9"]7[0>3<WW'H47YDCED2VO!K+?:3?V<7XW)-)6T/Y0QV)
M/E)LT8755NL%":$Y]6.K'Z;*/<RDG94Z<:M!]P#E7F,$DC++A>]7J?IG>_9<
M,,DL'XI-J(OF6[LQ#2#V#R0M-_6:"%%I*UR[;N0Z#<_6AYW877G/Q3*1)4\6
M@]):AV:$_+ZD5NVT>8EDPXSV\K1MO&^S*[]<.(G$=\5 [R;IWGTX:B?"@TPT
M:44!!8G%7YMSX4C5DY"L7+RVRRE^6;6#Q O/1T -1+.4>DTQT(GZ^';1AOF?
M!@WOK)BX?S,\Z?S&W0%GQL:U>R>G!LQ*U;N_81)T<&U.296T-Z!OKA48B/U^
MBRL\K.\2T?7A[^""MONAE4^E-F)O4_-CVANXJ)1&/;1%)Q&HI;2?[E-I;K[[
M6@$0%.\3:=2#^:+,%.SZF7BV+7BN:WR1<V"@4(%(>#90$&TL>GJZOH4_H#9<
MV<ST0I]QQ#G,<NP_#1D_@<^/Y'N2L%^(F31K)M(,I]R:VRTH*J(?^PB\CY[;
M)W>]J$*VC*[ECN6/G?:?^3D$$)O.+UXB_2&/B?GG-@G\,8#UIRKM>Z_I\0)7
MH9BT[K$O&+FD(AN@=R4B"5PZ'WJ">*?=N6$>0O3[.)^>]HH/;H\YC/$596PS
MAV![5RLAX?-:"^=B^@TQ1$Y] PH)R0\-&Q)Q7_=H5?H]R0.+P5],V+MQLUO5
M-RFP:FY_J,T.PTMX3273)41]4841;I19FR%/&*:?;VD$(MVSBB7D4E:>S^XR
M,F CCMC09]R+;S_*41O_K&)GADG:J)7A  !_  !I#_8Z.0)#8T@X<5S(X;,)
MNB4\PV$_&;QA R@NCWCUB,S0LV].KYG>L"+2H?5]<<0+C^N%RN)W55:2[WY'
M'LL_L*$E,B.1\;(H11KU_C;:2R_Q!+W8>/M,Q2FD!W<,5T#B;[>-)UCIB*K#
M["&HV[X8"9Y@SW5RVLB U'(9UU@)4;U\GXTW&'VSJ"FYZ<^P1ZL<#G^"G?PX
M8V4JK3)UIJ&D'O$RN3K&(BFO84P+!6#(EPNL*\7(:Q:#R,3#BU+NV!JN3T_0
MF_Q_S<(J[9</'V(SWK:8<AGR!'M7EL0)FO4VA5L"HM6>K%RM!26 QO/!5Q[A
M]ALY&JVAYZ\*K5FM3<1Z=4)UMA70)F;[)_< 5IT.IK/5MBNRRB@T;>??-DP\
M-D/U'ZVV-2NF[X[T5SO0R$=\R&K&:&KI]U8ZKZSM;[?W@MGO#L+:,J8]ASK)
M-.L<;)VCQ>X\"C(:E?/MD8AY!^5>6/CXG0C6^:;J"/Q[5\=^%#6_D>F?O!3:
M:.: [5P#Y[Q2V+*Y^IIM=&K2I2EO]/=(JTM6['J5-*A%I^A!R>Q@[I*(4V.?
MP:^7VA7XRT'Q2M*Z.21WK%@7O=O?+9]MP"4L"[:"Q@I@:B5&\_;GEV42=PS%
MD&**S;(QSQ&0?^D\@F_DSAW:MLQXTOZ%TEA^4;HG2F.OF/<K$ER8,M]F-9=]
MJ$@.'&/*^ ?[K^E[NXB%K@[?)IZH9:\RZ ^_3[U[NQ:@,0#,_R;%>-;I^S@-
M:#6=NL-Z_4CL]ICO28:$@P]&\@I8#:3#W)TO:6$JNRYTNNT?+IDXI%KAYPO%
M"VE1G!AD/DL%OWU6-)U<!9,V]-<R>^='PD3%OX_\X_#N8#5I%^)Q62EK./=1
M;Q]*:*I&*C6Q25?B$B?TY%&5GQ!7MQ_?UFC]ZCXB]Y_Y^!\=-@\;\GUNL\Q%
M1Q-$1U.;6S+<B%E\ "K]-^ ,K#G/WHHG+Y^=0X5E QNUR6_32]8-+TGZ&6-%
M9[6@U)>BEW#RZ5;[.Y7=& O:9_F#S9IW:?< ,?*/BFZ9N?]_H>(@FS6S,&^V
M[-Q54EHS8[%2(:/" :0,]XM8:_)]S_ZM(CE0\#%X8J_O[)!XUG-I51]:W%V.
MK47Y<!L4P>Z&IXU0"'$+NI>Z=R>O%K0TK1]!L!;+V!NZE00 +/'<9R[[;M6&
MQ>!"E7-A5G%%N;JJX8]\$)5^HQQ9BGT1@C65L+_RX,L,'WS<B:C/'>9XD$]#
M?59U_)T@<G=3FMO&ZE>@(FV:I>SW4G ,MHEB'X[7?$V2G5Y1RJJ)<&9VXL+#
M2<.+S2FR%B[EP)?D"QLT8_3U@G@>7TU^@#?F*&-DA'\W1$P'+:TJ2G[%D_@J
M243^HV\$_!L##&,;JR^?9_#HUK+)50 3KQ,S] @3.J0J'G_8T#W\./)-F0',
MO<KTW1[B_V+6!!NXV"*9#Z9U[BX.!A+:B,>_CK+]!*C%<5 99:@S[?U^]W0)
M"Q]\VW@T$NQ8^8+J \U<^I-G+^KZ%[3?5]N9+W EZ8UA^S[O3G6I%:1L-!Q.
M&MM!-6PF_4:I,!LW_E1C^P<'E>D&Z(%?Q;!(FPGM6F'ES3Y=_L1:)H$\!Y[7
M--W>C:%NAU1S6$AGV)O)]:1. 9L2ONZA&D6NEL3FEH/"VE!-DE7<!SW"QDR4
M_@0V=R35.5U2(D*#X,=?38Q%XGA*"4K--P99Q-,2 :R?EC-I3[CI&FND,A9M
MQ1(O@:0>KHUV; \0$D%-;_ZJW9E?.D5H=B.UV(.R!2$A9273X^5V]P!C.W19
MS6E:%)ROV_RW+?_*"F5K^5M*\]!IUFSFK=^6"I,L-'A[D2=FH3F4CG:^=$[%
MPP&BO;$O%MEZ<LH;TUZT\Z ,/'HHO/8F.;)3?#HC;ELQ=PNFN]\,>69X F?T
M8CD+;8(2-JH-*>@"J1\<E[!,M)P8!74VIMNO7\B1UOK,LA_GP_[47;-&'PV4
M,^N&;/!2M^,T;UGW[S(6L9"!A&/ <\8GI\UMI7LSR)F8%I_/*V@KU<F#Y4F.
MQOAAXI#=SA>^WVD::YTZS1]C;"M'8HZ(YM7/C7F]I2O#!KS<K TICHY3&;WZ
M1H3;(6:8VC*LB\83NH[L-RF1BEQ]?U94F)^^7DLP@F(NPPBUAP2UN]6IC(CG
M5:8V8K/UY29"N71WE/@$O1W&3RZZ#N>H-+'0HT?J1Z"F5;IV&>N&JY"L C"]
M^%-.GH0BY_%C34U5YDQ[F9FF[72VL#"1#%-A]?K(7BVH KT8AF]*D>%[^11P
M9C)7,\DY</K@JNU7H9T#"YD:N>WPG\X5TZ?_Y+OI_ZB4^,_GU19QHX7I5$+0
M@Y65--Z9%-;'L/U.Z!IJ>A"N$RN@*D,BI.C-HQ9%B]\1_I?NS6FO'7#H*BQ$
MAG.5G]YS"9TMI$$<LMZ M@B@Q^\[]@+Y)M0X&\C8?E0%%&E*N9Q"RUCUQPJ4
M76V_<XXX"W8#E-V*D*A1>]GN%A<-NXWEA*GG=&2!NN<2K+I/L0'O&Z<+IU].
MHO.G"DUK32O4V#YO&]/(XFT8_6>385G)D+AA.2KNG@%Z*\;&X9V3SF>Y7KX/
M=+U^7S!PJ==9K9/0M^P,GB_?PCEB^N'+?23<ZV'!QS)^#ZCQK=1\<H,^T;S0
MYOGQN. 9OL5U,+^)1TEF\I=Y=ZEO4Q:@"IL./J"-H6/YSJ8;4QUQ=PPJ;'4^
MA@\7.EDTLY6(HJ+^&I-"$"CD!;B:J9N)\A]&]D2YHB3J)_@JUT/<=C8#J<TD
M&E^\$;@'6$4_0H,F36:UEI6O=GU,WJ4/<YN*-ES?<+MLY2"-5]CCUN1I/#D^
MMOYIC5R].V>@_.CX$N>II:KX*RY_WYJMA-CI):S9R@ADI=6;KL^-V]">14CI
MF<I<9M<^B7"FU0;CM-8:. X=%Q;)H)?6)5##>CM><V>.-MT*$?$2(25%&@P*
M_$EE[BZ@:>?ICA4^@_!Y2DE$6VPPA1D7@V5YTO?\S/I.:R13V24U:9-*W6S8
M*"&%2'<TF.U$=#LO\NK1:F#-[S'[4^X8Y0_5D3H\VU_!(DED_<Q;S(R/&'_]
MI_!,IY V1@QJ+(<*C2]]Q9XT?M#\"X;;C!=NAS/TA/6=8*R*Y1L(76R9HE,;
ML6M);^2-5:GC4&5)OV,= \!^[L;E"JBUIL)GU@D<M7!BJSAB4?^9S"0,V% Y
ME5N8B;X;C:,HCJQ:B:2)R[#M]-$\('O[:&356?6.9=BW1YB"UN"&G1;64H7T
M8=]'(.^D;/WD"(G*E@7==M0&^HW]^/U .3-KIPSD'\T,?']_5%1T88V?'SAZ
M9Y6@FQ+]5)SI?79R1NV?B>::H1OQ>T \P])M,%_ J4U559-\F#LR)3;+R[%D
M9_A+SZ;JV"^]B[ OLVM%$E6U+?L-]P"=@G2;^3*;VZ&#WOD]/5J;O?&E(P5#
MH^+0"JCQGO'<XWC4/-G&PNMK)FM)I)_N!2[4NFHW>45?!DHQWD^05'#Y>W]$
MN?M.1([*N*;$II%I#DWV%&6\,OTSVOYSSV12CZ?HP U?S9B,!^:.ETIW\O.4
M=L=*@:=#/E'A7%;*WRM!FJN9W_^V[G,4QQC?Z5Y>!R>5=/QQ 7V@/)E)8WL.
MT;PUG)JJIKGEHNL7H>L#P^0'-_< VDM8?'<%*MT]A8/F$#9MZC5W/-_?G*.L
M!&>D^;I!V%.6;&]YH3IW:3,<(,V0'9,WZ^FC&=GYOCZR9X!G/Q '&964]..L
MO/ZCF6:B6M]EJ9I.4G+6_/]X>@3OT5&S?MWD#8X;SO#0MV$W5M6'DNT)P25=
MI":O.#!5C9VPK*J:7 .4P0+;=$4-IVJ^I#[ /.@,-P;<B70,SXWE51OA[ENS
MWZZ-1DOTV/;D%,_;Z'\T,NQH.!\G+GU&A,,XW4X@JL_GEM5DHKWG1^>?I:7F
MMMU"_HKU<BK#QU@W#:*(306WWP.L T)45^VMU!%?8+'C!RQ2;TO">'I,$EY(
M;CD(1EY$_L/5:*KS<X01@;J0TCT &3\(C27I)FZ"![&<5)FL"J02%-?/:PT=
M]#F)8IJ".<+<4\OAJ5*0)]96G8SDXZ[F_-FN>Z_L91;, ])HB_;=1X2-IF;7
M#<V!2D31C[A)@AE/=\]6$U5YXT@*-K2=,R\<#J=>Y47F"Y0ADQ&I5WY=C>AG
M<\HT7NF^=OBXJI)K%)9-D BPY3V ].:-Z".!6C&ARYZ%1\RFQ=+.KT>G(@%;
M(DQD-P(M1Z*Q685\,;=U'@YIJ?T4\4K6<QZ<Q-6 ;J_Y^%DT*,%,SI<?$Q;Z
M=:J>6,7S8-1@&K2]^^Q-!)'0@LKG)P1VVFKX,P$#+<]ZQX!CK@_T1 95SI[P
MIR+96A(%GX^0.W[%>Z%Z2B-*DK2"YE=X3BRN":U^+G8I-TS0VW*520)^$PG(
MKU+<LH8%^Y@VSO<UFT>K]')Y<Z[$-7IC D*NQ*)\,#IZXV<[FS75&6;9<_H&
MJ0C]I!$S/K'HAT]3 >0,DH"C](MA;7[Y]\WA"N>)&-CE0RW^H8&<- _,5I$/
M,,17:+P^XH; =='46-'3U]@5D1Z ])UH)),6ZMRDO\QPS\F +VRE#U15@T^D
MJ_G3GFL";4<NC,O!;ML>_WLE><OAN=<]()%SA?3JR.P6?R9/]_,]((A4\9)!
MLO<FND9^+><N>30*SGLC?$1QB&;^KB&6954VDCBKX2AU,)O'YI<O_P+E$^=+
MNX#A^,M]2[<VTNQ4Z)G6WS:&XJY/]U%@_FG"[:A$UP8;$I)U%OPGQLTI]X"0
MLQ5._U'6")RL[CI+X4Z5/KVTV-=(9Q\]"%Y OR<V[!X 2O>XB[*]W!5YI=LU
M7 J:;,S?<#RYKO!/T D7'.2+>87D_#Q]JB&/4J)%7??ZQZ*SOF;+CU?>?)(1
M=)%&VDXHL?UP8.%DZ)-]I^GY1?J[R]6,\H=1"T<75B&-Q]K]A(XQ68_('7YI
M>S,YF6S^LEFME.].&_8IF=L%T609&;SMWC U$O.,VZ S%<SY>;-D=*4^P&_J
M<'>H<WR@)FKN[9C2(U5TQS&3II65<6AYJJRC:('UZ+K2BN*1F\]?:B\Q=G@%
MPAM!,.C&_KZFG:I\K@U49EV1TOZ6;E,Y.9[L-NC3W/K\0V!'0.V2NN-+XQ'Y
MC<P0%?UM;WK&T!;^]G1[5!,FJF=BCXI%=])(^N=JXQ^]%^QA_A<]TK #O%E7
MR._R+CCC/: ?[\CCUF/Z'G#Z%;JQ:JWD&:YGOT-C,VGLX*>DHZ^+@9)KM]47
M5D*-^K<OC/E[F^9]GT_RBHP&9S\U5O=$!R,U"H[QI_@N:<EY>J>2^D7G9U@P
M87>JXH%M^T\L[@%YSV"[AWF5:F+[<52"2:EB=4G-FVF;'9%<J77$Z)X4#\8L
M-X:4$Z5WXL^Z-RL<8ZF+E%;0"4:M9.WDA:P9C;_<(T^6 KU'PV\T5EC*L6$Z
MT#:?7X6QU.A*F;A7BCP)8IIKS>Y_?<R+1;?UR#?+%#1X1S)!-,M[HZ2<[*O[
MR-:JQD6._,E/>9'<;^-?Y34M,6"1,ROW@+ -!+\=!&+_HC_9!A,!$B4P:'ZH
M1 YP=M'A?,7!:6>O%+TW%<.E=NS-ZJJK+Q_<HDX5=4IG;T0H/8CO\("3^.:-
MY&L\0,ICC'>L-YDQ^:2V:IZM3@HGS$7?9N[JGR=]/_1_>R.)N]V?%YNA-7X#
MK%3/-053PMGK:PS='D\>?&J,-$@A+'44-7;!D?VH2@.8:05FW;S%P&M6(ZQ"
M-:@ZKHKBRXCLR^OAMD<GS_0T42Y](@\\EN\!H8<M@LM]OZ= */7R"-!1]F+6
M( W)JFE.JK-J_U_&[P3HO1$XCJW +B-1I@)=-P/T]+Q=<6VQ\YBA*53Y,MJ*
MAN8"HOA?[8X$1D4QGRO_QN]2?@-U13-HNQ)1A#EEAU9Q!7\H>UA"#7!]F%IN
M*Q9Z#]!J:GA6SVZ-%'SIM]'7H_@0"E6.N %APY&QE558 @8MU>A=2@TPK42*
M5:Q^G-,@0"=>:4SRZA3"?B26MK+(\F:L1;+"&G<2^,=ZX\^4([/ANQC6: :9
M'6J!CX.X)FNR7)#N@">>2YIU:2I^M++>JP/ZB?-=[OB;'\0=.%E8;OY\D,,R
M,X&@004WW$=,$3>F'"&N41&.W15PB[OB;]HJN<35M;U_+-0VPO VT=W:<L]I
M0(5JM7%L&WE&'M=25[(ZT#A@ R8UBK0+K3L[)]U;I'";;T^DY<CJM$"=WRGT
M:JGI9U#2=Z>E2N7EPS X^[2;/.G\KO[7/E95-\*H#$J#(>M E3&5"MS'F<D
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M"M7RMT5&BF6J-!&'SW ,?PF13"Q_C?[NA 99'1'(4_CR8P-6*VU[N\6->E,
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M77!ZPV1S2>$]4*FEW1PS:OLL-%YP9@-+]/7:/?#DN9](DN@A+F@V[B)LND-
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M,A]7E'T,^S =H-L%[<&!M]&(ZPZ%W%X'KO7-X,^U!'S9<X/N<RA.%U)M?E@
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M.+'97"2 QL,(,84[9) )V_S&5&E\T%J>Y_+])#*&W4XV%+UG?%</2OEU1-Z
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M@A2^!YC<6NZ!<]K2>V#L2[%$/4%@ZK&V%\$]\&F._I;U7:(OU1E_EV^]YCV
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M-4P@_/I$CZU+*>M<Z/<*>/2+E4;$]ZJ;>X Y-9,E \H^I*ZO< ]$F=\#7O?
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M2\<'?36W[H>^MV',6SIT JQ\Z'P\]'I;532I30<!%5)Q=:N3E:$+"A*&70G
M--(7BG9GD'!B;++R#(ZX (&%&50W]\Q*: YX.O\Q,0OG:5HS"ZAX%*B$349R
M*44L#\&ZIO%TJ:90=J/:E /)*1^A_GLFLQP&&M;87?G7;4 33$=8+:LJHLM@
M1G*';"?=3WI&1H,EP:EPBH^WSMT=<KRC45FY$8M T(ERC_\P4F'5X'LON)]E
MF#*>JM'8YC,!T]D@@Z#;)JS'\]O:@QQTZD?YQBIM+DP#T@KC5U[N+B*9%3;B
M(X<;L1J^RZRDXTM(^:U%I@2RY$QK>7USWNHVRASU+Q]?&3RZ(QAP3WE8#5R
MW>AJ7D_V+'&YV,\(*IIS&FEN:%:+%?*>_[D<+)GJ%*<@4^%R:+MU<9H6X,@2
M13:O[!7'U,(B^(T$D*!Z2\3Y3!+J_^?LTX1:WMBI+ 4(V1 K246^8+T5S#5Q
MOS<9D>=ZM@@I@[V>EU"M^BX=MRAXZWD7<0LP<8:N8!ET"]O1=9'46U6VN-G0
MW-X K=X!.8::H2+O+(MUL=;KF'^Z-0#2LQPUO::'9/*_V%]&'N!I8KAVJX<A
M">[U?54%K'HLA_.Q@HOP%1@5-/@",6 X([FG=+C#]IQ>1H-Y(//VJ(ZV"/3@
MW95%V[D?Z\FU^#OS5NA2Q3Y&#<D1 "_0N-3AKP0 Y7&%AK>\NL%=4"UE_XLJ
MRZ:1Y"JKN.\>3S]$IO6 R/$<T/;M@RY$7/AQ5!S1PB)9BF. *7Z2^N[-C_/W
MGD-O/8U00K-&T.WXAQ8YY<]%'+CEU+YO[N5.^27PFH._?U\#$ 2^K<O(%UZK
MU1)WRWJ+C:O]HS+[-_=?ORA5EX<CU]095UA+FKA?\$\6P^D*]H*CIG;CI)JO
MO@N]J8/?M7)NY\!0M(7&%Z<U"8M(#7R+N3_PY25MOQ'/O!/#GV16=, 2$Y;S
MK+N=9ZR.V;(LP'FWW'W/;(0^U5<GOE3ZEW3C+4IE+J[(7VA8=Q8=F)XII+<N
M;]-".JS0>L@I*."J?'>LUN&;WF@Q,.&Q$+!N'.>-''+K<?>Z\M5IKW69GG6Z
M[@G/@"R"K]A;-1A8M5^XJEJRTJ&ET(?OOKJ[#4G!M<K*SMFTT&K+(C7HI>O&
M7D"B\?%@X98G7@?D/(-O%ZKLGH_G5QJ;OWUBQ, <)UL),[I*P6G[K>S$V.DB
MP8UI-G'FVC:'TTY3F5(9KQ[T/M7,+8V)-/*@4P7PL1V@6-U>U71HLQV.+OVU
MKW0 ^XDL\@B:4?'R4@[.V[UZZSFBZ=@14SL'NN."V&^".>0KO[OISITX+_@\
M]L]=O>[EY=5@VO.DW9<_3EB,$MH6*F:L39>NO&0/8J81==-5Z"M)8%F L!E8
M7*IUYFV*/;G0AKRU,@D88/3%0R+^=WF+[J=%_DGXFY.E>Z[-CB/A^3-O3N2[
MJV+5]^P;&F+&[,-\S..&+3T='O<Q;$PL]5J0NO@@$L$F9$56'^V:9036-$*$
M?.K?OJ6+&V7* <5YE65(Z$[65EBJMTU4BDPO5*:>/X=V"E>%/I/M(^L+AN9E
M*G;_."DXM84TG^(HF7M@E,$<O'4H61Q7I;./!7L$\V K1&?:7*0\7TQ(!PVQ
M@R?IO<5VTL6@0+/U.Z91-J/+DT(SORX*(XK^XJ]8*QV:JM_\4F<PB0E;9"3Y
MT6=QS$Z.<T!WA <^) #NLJ36Q684D44(9VJE-?[* WXA>K/\ /"(+1KHUPI!
MGHSOU7%5;*WH-LW_^WO4:4E/#U/>J%+Z.5KTH#+%^]'W2(.W&=*I/G.EFU#V
M3QV.:5=DSS OV[)":B&Z1A/L+QJLR:W/S5Z;B )?[/J7HLL^[-B$H-P_(S+K
MD*+A3$8R/A&@<+C!^NQ\_=\IAP_J@2*>W],*_2/WLS'PL/U:^FGD]/&YE]?P
MSG'3LQLK4T=QTQ7.P0_'<=IV#0C5/'#)K)B@B#"ON5[\I*,&[63B;(IFC'J1
M@$I^1F9&@'\ZO!M. D9,(MAJD. =,MU[F^._1WG+F-O*MSC?> 5]%L=\O+/?
MV"<ULI-%U1H0Y(*L"*;P54GN2WUF%2J!4&_V^C$2@[:W'"3R40O;]DF/2XM=
MT<1&(:U]S9O&)0^HMTPO"G[P@H$!OQ?-?NXT*?_ND>]:NA<HAIJ;*U.\WRWW
M&NX+QK>3 1O7H$U]@[0)CTO%9-TI OEF]J2T^2RGZX!D;<X[!CM,\;4Q*Y_=
M:J6W:#E6O^2Y"RDK9+FNB ;RG8*B+TS#UILLT]JTC*9.9@VF6-N'G!2SOL ?
M"@+D>Q?;U.'JV"Q,,%4HHB]L=[5:YLN25O.%8R*[7=T15]2(_;Q?0O9>[PJB
M5B%H96>$TG9+3CHD+P/6;0'_/GW:Z\[+D/N$;$CRN[P>3=Y[#2' [?<*)4JW
MH<TK:N.[K;;E+HC8#SF;,Q?/?2YX:LN\I5J_H:02*3(F[F5#&(A9W$981KJH
MZ*!QJ+AN*BJS+.HM1%MLB*,?\8*+G/50[?0@FB%!*Y&?M'HU;J%0]1D+QN9G
MUGV<1I[S(M#]/M18<L_P&@JF7H+E"QNK6U5,Y4T<F)+L#&]I;I!P<;8L4)G*
M=81)7NGGBJ65J>^_T#BBF_]0'V?3F$V5$4AV*0J-ZL(+CTD!NY! ^8 [;GM.
M6>IU*>ZB)LY,(#D7;C[/?8ZDX47+VV7@CNK8MDIGI?L!FSB!BAU_WF^I7);;
M8!^AU89H_+JQ\ZRU8Z\OI=%&M$.6UFBP&/@(NZ(R5C="UI4_!\YTJ58_P,UM
MTMUK!!=+4_$_8GW&0D/46<9&CTU!P1Y V_>G1S1&3;M.+V)Z$JTTRAK;7X6J
MQN2;W33C\D@/) !B %[LE.TL<U ^9%WRYS4M<P[U5['.>WFO/I]'#R*-4\)M
MO\=JP.5A[S,YLI#!#3GSVZ?TJ6M[4TWF;@^>010+VKM#%R&-0>411WMX/K>V
M*V:4:*RH G>JRK?X @JPS;1(3$52?N*YF*-^QJ):)R*R5.,G7_:-IDO=R,R'
M3:-2LAU(&KY>IJ +EPF7^ 7W>A,O&J'UH XA>4I4CX><@X(>2296[?0-!A26
M-[._TH1NCRJ9M]JZB$V['>7(:6XY;^F7HG$/-QC+<N-\(4%'EG%?2C<,KXC1
M#=D3\<[P?*[+X-*<Z]KL.HM0E\2:4R?^">H;]';T'7BK;/_A\,BB:R6S(BA7
MXZ8-:UT+1G^* *A:KJV95!A@S#_\7*C\[D=@9(KPX2I=+Z6*#SMEJW<0JDFJ
M0L9BW%0%<SOF[1<;BQY0%AG)$TP_RW>#/W\"WBO?I'["J(>5Z95;RPK=5] M
M<9'8KF<:G2R,TXE4WUOY_(S[I>R X_>US@&'DF,Z+37LL^NQW$'DXFMJ,BAY
M_ZTH$Z_[HE#]D<IE*]SJ#Y7L)GC*.9LJI9T)W^^!Y>N3T\E1A(?,Z([S'F5/
M"N4TX\>:?SY\_F%-[&'_S202V4V)O@KH2&<F=RNF, -%1;[M'Q2]]#)1N]5:
ME>3K'?.N""Y256MU!;'.(=]C(TU!U\'-'!NHW]&O.:G2YIG^3,DLDE85IP*S
M6<NEK6HNJ >$\GAHW4W(5])#]<E64_N;V R@P24RM!H1M8BP-HM(-JCM"']A
MZ[[_9I";1=2W\R)@IGC,_/(.UZA?/:_./F*IR!<VL:\ ZLJB#.9!N%R<Q%9X
M(N5S*I^];4!$V[I<6E5BQ/OZB9Y6/B&]#1B^K:M("R*3XJ]U9S1/*S/DK2N:
MLWCRLYXZKYZ:9MZ+^Y6#@FF1OH9>I(E@(22\A _($_"FHD8[6&NU/+ #XV0Q
MB1,KQI;]2A6I<&%I/FD4+5QP:1!?& (^J8IW_BTMUSYZ]PWD\3$\WXO97,A+
M6 YA7V\&R8OI]0PE)<(;!T=Z;7EH_+F,C^XK-V;R^BJTTC)A^JJ99\R[H_@?
MQZRN,B%T<0$REQOGI"U&M5G84_>SD4,ZG_>DY^PH$"XN]>PJ6 .WLQ/YOR4Q
M(#K0JFW8M83 (T9&&R6NMN%8F)%GDF+,:FK07MND\HL?ZM6%F/@O'N+RL8*D
M7OH*A_GO2GP]Z(R\N8_I<#,D_/VR[J-7KAJ2D_5RL'O0&BML4K&9Y3SGO%6)
M6!==,V3>[,*T+/ I&9+J4[V%\.J \'$$BV#3L/K#-+:!"9!FVS(!<*L3W=)E
ML%TS.U"RX_9)K)/1Q\!?]?O6/OBW@B=?!$X%)EU1[C+S#0TG9;MMAK1"WU;;
M6>QXW6W8\Q9O:TL=NUX6W?-TQ">'I"41#Q9NMIPF (@TO3P5C.7,P$]#&*W?
M-!7,BBRE_!Y3H<-671!M$P U1;B8U+@K/_8KAJ1CGL"S2SG8[]EB F FG@ 8
MB[!]:GH"#P,=ZDX0 +0=$A@V( $0G]Y&O^I9<18WW=J%BOMXDA4>+(Q>3(,$
M%#O+*:6MNR9L3_,*$P N#.H.^IR-LA1<+'!V$4KPQ-P!>P5/<'K@A^7ZI=NM
MSW+-H'-=#Q!)TU6.I9)R>Z%E)>=/*G,3REK=N$BE:U287_$SO#Z8*:K%-'2S
MT]BZI+ZQN=.$;HD*GS.8$MW/3EUX:4 >!5 5?FAWYU:26/IICW\&+=%:,WO7
ME>O^1,]IG^DD3H!G(X*OHZ%EXL5M#7LQU;RKE[((=<4/YV!Z5&$*BL)@^*S+
M=)$HJN]4'%'NKU,A\%ZJM5<1SM/I0?KH7:L"<"+ZAH3-K%5#*)[+Q4:@O;:N
M)G;M5=-'%)*\&#!'CM?:N'G44M10I)G,G9%2+F!40L]?5M"!(@!4_4@B@MEL
M7&:DGW7;DN_B@=8P>XNMG?+]\)'3\,GR3'<$^YWROK<)8HVO5N];#X5]/+'%
M&@XL,S?F@_O0EQ;2N5:2=P6>?E38>,?%E>Y 7.'/5E/:E>-\ADCZZ>GN1#RO
MSL7XLK@@EJ3REF$C1E(?ZD;AR@R<VWP=*T"S.,XN[E%-1[PV IE50!,IEBS8
M=!]J)6<BWD"_M2$) ":<D=Q+6ZR(XD-)5O$])@J;+1M6S6VSYYR2C]J1U-8;
M[P3]; 0K(] 9K;JE-B)IZ'71T ?:V38N,FX5-]*V^)Y<TWR=DZ=D?G&ACS>!
MFQ=#,X$J15A7Q.**0>.#,5U/BG1(;?V6X]MX..#D-;$BB?\K-EUDD'Q/IC#&
M],-P$S*B51Z"Y%_SVW=JC'S>V@CV=,L%1.L,RDM;"6R*6=VN669GML%V@;&>
M9@+L45Q33%K,+99!/!4AH^_X(\2XJW<!#=\E6M[U+YN.+3)A(,F1!=,.->9)
MM67GDENX-6+QW#*:1CY@& MF*7(NFXHT$1E;F,DP[A"F1KTM!MVY?&FB_:'[
M]E[_]_2CRUSY#0:&/:MY/ E&@>W!.(Y)B;VB&^$4SCD9%]Z*52BYOY?IH,LP
MDK+^]27#(Q:W\SC 95$WB.TO3@I=>[&? PX(<&?Y\5/X&/NYYO?A[ZK<W 1Q
M+=D5J0$H; 4?4[XTY!"4C4WNDBD#"\\_ E\X6*3E1_BJ<W)_&221_0V*SZ;H
M8(=F];#1=TSPC;6*\45*ECPP:OOX1WU\7T#)5B!YT/MI5J!,\'>X^ ^L-BHF
MN._G!6^.=P#RNR2T:&JC?7PUY(^M!M<=I*V8F71WPE.=Q7R[F0:LKU7#=<0]
M'GHYJEZ?&E+K^S;B"27UI/@^()V%>K'6F;@3HD2%C5,>Q]DCRYCG8DSN[MMA
M*)-+74,YF'":W-\$;MH_(<>470\[SWE3?9<5W7 V_LGC-B7V6U98;1HDN^&D
M-_-WOL]/BT19B!AJDB]S4@P!&ZQED\795+SHD:X*CPUMC'7-CES19\=FC.)B
MSJWA5#L7O@])3S<&-0"&_9M4?X!<J.E$%(5_GSZZ9Z,+&^A^LSY7F-DB/MNV
M1G,LQ$^$[(?SO.Q2,]VJG1VU3?P**,*"Y/WZ!.3$<C2Y.6G0I+[^7>"$YKCL
M$Y]3/5TA*+L!T5@M1K'@(%)*^+;45YN_ELK>0/&8$![QFYW#&E<33G&: /02
M?:!\:]VD6"5.K J;Y2L= ;9_T$BNZIU!_4U7?H_J\$8?-.%AR_KCFY'[A6B;
M"C^T7RN)N/K%^U&:N4M--0IB'7JWP8UW'.\]H^U.AGS:N3'!&4@)9V]&)OY]
MA8GU]]+=\=V'+4TCI'14"H<J'NTD6&0N=,/&FE-1PFK,;3VD4JBC_GB]3FLS
MF3F3)A@-^'3]2_?^24*$JKC?>^U;:#M:04[3A<EX7MNQ?*&LJ\1J,#R4^WHL
M/IB"I2<]MN^[G8T^^'6YYVG>D=;53F[[*=Q+H[9?!!6[D(ER891NC"3I"O]5
MS_I=;&F.[MCX]982Y\3)7(;!8N^RKDB*YZE\':E:LDAW4&MLL#GMZBO/)VR*
MZ!VD;BR.%:,Y?HU4W:?^R6$5DF:[8;/'1G6F*CZS@.Y!(SA%"PE7G/]/#'N7
M+L-?;++U5&T&UYX^UG]G;Y&EP3Q)93#9\#S9[A6NT:IX6 G3$W37L32H1F]2
M6*G?F^3O OU(JG"5=A/Q:VD\A\2G364Z6PN,5&$(+&]VOKQ"I,P#PB%6S"$;
MLWK>M&Q/!9?-ILI2,$:G]2C13WL!A_CP-, !9QR(,E$,O?M-R6.P\D#@BW4)
M,TN[AF%ZK#*J&18*(CW1)8?F_3)8-!MB8?(-V7_S^4R&>EZQ=MR:J]QR[![-
M?2[!]X!'5/ J,%/?Z9,:T,O6MDOM/Y:PG*YU/\N:R[Z-->58RSIG/9(_,"JE
M>]@^M:E68*[K6VS.WK&BACO;7N7QR03E],MQ59/[;WLZ.?+L,E;I#VPR,&&_
M_*^6HFIM[[F0E0W05>375S8S(Z**9V=UED5H2VZ2L]R#[LM6'J!(XKPZ0ML9
M&F>\88\K.+VB5=ZDK<4O?"S-77VUBG\R!6/$J4\$TB__Q6D)U^V7.0*??.DJ
M^,6;Z2 AV$OM(9'0U>8D*QB_YN1&12?$:FPBH,A4@Q@R.W+&$:-L*0,5)MR/
M%966L96]^]O7*+03;O,D6?Y3F%BNZFU-=6-E0"61E&$OC$IJCVU_1&?<J\*
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MQNFFUG808:MOS9S(H/$5P/:6 M<OEMLR5;J^[VCY:&[,U8<R#,\ODP-T!*1
M(7B@7'M'8:T-9^:$Z93-E6-U4U7L"/@WZXL8;HAX,SDE<5!G W%1JSETO,\X
MH>M2"=CV='%['36Z8/GSA9[&W;=X%UF$#!>_[&/9DXKMK-)KCV0( #-@R>,
MV>.#,>[FXS5<D#!221;=WL:6O')%.M?IT$V!8N1NKI]2^&LB]OVKX&^& \KH
MIA<W[O8!^RN7>MI9)[TIF'^BYQ"UU7]=OQG.%]LIU#ZWV_7PZ^0J\!WNI*UA
MX6?D+7'V7TB.D(S2UM5)VWL@HQ]A_U7 ^H\_RST*U^*"(%\"($SA_+4W=W:3
M:0O<VOJK]TRUI=DA_"Y.L6.\%;C,;ZMQSW;K8GXF&3K;+ FK=>PG2=_72=G;
MLNE3H7O[L; \]H6)2*%XX(E,"RS _<A>A=8D[-X_-@&;[!7A E3PF^6""[4$
M0)QSQP(MT3D!<$U420B A)%< N#O#?8K@2;X][*MI?]SV1QS-%[A2G<[D^&:
M-DHSXQX:(*SJ,B8E"LFZMW<R4T@X<W.;J I=+R0F\(^"1S.YL5-%6]+^NP_$
M5 IK6GG'I9]J 2@]^BYS6W]%"A8]UC[26$C_^T:8A95'C8J.H3)J1*^R:WD#
ME[1$?.V&3Q\!H$G3>+&K1 GKMT:#KL+>P(YS!":P,R6R(V>N'4A8_,6&67,<
M+E@#"WMH:1QU37+[5K/"#NG.U#"SG;C7HR(X?71#-\(QI -Q4"F481<6W7("
M<.I@,;T%^LB+X0;12 D$B@FW(@H3(72?9=YF?WW48.=@14-$%1M63+=/:W(_
MOTC$Z<H=[U01.NB*= G@%VEH;[N&V=,>;)8D=.7GHE!<M_]FY(AE6]UT1<7T
MP\)9,RN5PY]5M9X:;\FZB6]X-+%+/QD&3U\':/,3]D^'FS+2ODQ3OW^$,MJ%
M[JI(EJ=YF!@T"I&NO@)TVZU(+>H;,E''2;>DF0R53I_*1.JDZ6J+@GE\ZF;]
MLV1<FOEB;'^U\YEY ><&_#CKS#H::EMN3KZ:>R126O(U^:7CEP&<,558Z]V*
M)7ADR/"GRJ X@Y:Q!7JK>RFO8Q__'?H:OON$]FIL;L=6:TS_Q+%@[GK4.3F,
ME"(T)7.;4OVM(7\N"0#OH%W,@BVR>:0,9Y *HOJY \OOHLS\=;,[X0XW^?W1
M_=FLW M29*OYLNZ#V9V+&C67BD6+'6F?L>YFQZ207R)SWC&Y*?O*T/=V.J9<
MZWR,0T$R*D8_,,F6,%W<H+.3]Z;FOJ %3V4+/_RJ#M1Z"(NT,.Y)[KRZK]U8
M9VVSSYPALJAE&4%$+\(;H2GQA6@>RAWMF6[< 3!;V,Y4FFQ]KB *^EQ[L(O=
MO=6&Z$ZT5J^T]%.??6],XLR]NH%H(S,<ATB%<X6>WFJ,?9R705?3'=X9WW$;
M@*=S@\\&X&8>PVJ9NN1(Y?K_'-BTM@#GBHP) .)>*5W*G=-V8DRZ">+9_/P\
M-M:R]GTG[;AB4]+=!.YD_I'WFOO[BN!P- 'P":?O0@#<U2FC#ZN;?5?LPI11
MUUZ.CBJK^Z@F7OI9GJYJ3"GI^(0N_<>VMOP> 4""&VXV7]#4^THGV_XZ;2DO
MJIX 6,"9K^+OH1=FHA745EBU;,>D6$D1^(#'Y5\7VMK^?/YDK_2*DE1&[VF#
M:B=?:@$FKY.I(0-)=D#9%7"5E7N.T7 JL)R;U_DP]50]WHJ8V0%\0X?!_;<B
M>-:YS.LE"H7'M\ROA;J89')*H9(2JF,KI=?69I=RCGQ/V0IRG6T>)!J.PKU3
M*@.UI2ZV+#[[5(UP!J4,!S;^C&#GM^(-/L.\PM1 D,(.9M.&UE%=$LXF,NW<
M52U,KW)NEM#J-6LH%'\N?<!]@TB12!$\Y^Z5IOUT_0\*=>L;6(!\>G]VT,VH
MA M_8Q#$U*#W8Z=,GB]#1Q/S4;LP\W1JL=]FH:YN)-/+E@*LQ%R#7EB;^02O
M4P\$P4JZ/(N>QDL,;?0W XN-TX'O.T2YJ1M1I4O.,X@WB <YODA>J#<[[;RK
M"9X1QM_/\K0_;('/[LMWA'93[R[YZGK[E]+D5.W,'%\'SW<W!A2_Q@BWI*_+
M\.M=ZURBU^PQ?&$FU4$=NJ/%&QZ>'AE2<.FADW6?)5U_RPI(KM/((C=:-$)!
MI<#5XC0EQQKKS^C= E&1-%MI""B*E+60_O+K,N>(C X2D[X[[/G).JLS@\2J
M*JK[(NE8[JN!ZVW1FKX*93"$JYKKQA!%]>X3C[S'W"%['VQJ5*R<^0=2-Z0"
M%RL"%7[L4VO,V90 77SA*DV'[!\#R5 #6>S8I]<B_5<F1X,6OWO%R<TF+7E%
M:=Z$:96[;M]PX0,L?I^=XCMWK/DZ0:38LB>8TT1R"\H:IVRS.6UW>6CF>'_F
MD'1,%<*Z.W#6J+I8_OTM(Q;2BY>16PKW?TGI?LI\B$U"Z3*!Z8-Y)A5$W4MO
MCQET"E44WC=3O6,R6-PCT_)G28"%3O%)5RU6 8+<H;J+S6E5]*S83E6LZ TI
M<_F]F4S_ *4RZWD;11=Q&%^?(,X2.[5?JT<2<\V\8I1XH(9]9 3 G;:EL%H-
M+^8R+5:0H1%^M+4%^M<-$?LG7&F3D2?**=I4.Q>JUETUAWV]S4YKX^)3;P%I
ME=B\/;R0\TTECB0P.E1E [!G?P8]L+ZB)5H&O<10Q;8_A)J<VH8E0@V[_:^Y
MHQE&3$Q(8J[<+90A7U5<)\$QV!0@BDSM'@]F_Q.HG>LR#2/3#6U]9E\9=3GR
M8*Y:JO6'4,^J@+R\-E]J/OSK"K'?,;S0.9M*!!M^,7@6S(!Q2T0.7#W5I=J6
M ;[+Q^^).#5 %Q\DW+,$>YOJJ?\^EHHO6( VC^A@0-$P)/DWTVEO!@M=2JM^
MQE9IZE^<?,SU?D7,]0]ZQ2523R/YB=>MF3OQG&,G47$LSIEWF\>.Y2$FS&6V
MMXJ2*(9':@8H!K=H&KXE@%+#[.RS@(G#X,EV6G,P4VP;:NG!]L7S"Y+3^=,M
ME\)%\;3PY5#A#P6DFF42#^2591G@ZO_W4PVD_FO&J\0%A-E=.LA:%=P#T!V"
MNF'G[%('%[C$\YF9_SV)"A:$_>Z@PH.NZK)RWCI=3MFB\<4;@OA/9?6?RA&N
M N2>;;4?56)MF]6WLOI2<U1@TN,E<E)<)FFUN1,V90XG*;^D.)'"F6'EL"X5
ML.TQ9?5U=.WHK<;I8LJ,,#H1GH56YA8]Y,NWH6=N#!QG2E,;7J:3TZCY(VI-
M(U=4_@KWA(5K9LP;:.WAB^:O4^KZ&A4FEU=(%5K3WYG(_[>S5+XK5:-IW394
M4=UGR2;![-[MEY:60]R:?V@4[C(I/'IQ\IBU:;TMHAUS,7T-\F&0.HH S:E\
M/Y,-'8T$;@/I1U_Y(5V,>.IHZJ6*X$0#D7=K-K8IRW9BU+]FC!V#:.M]?-^Y
MF.\X^;;5*MG-''"RD4T<#T3-I<%N#E58$0"O;7=D?/5_3D?1?)]"*&@N_Q[W
MLT]1)GVL8)P5UBS<$&.'MOE4NK!@NZ6WS=3-*94*5?CM<(C@>0Q[Q'OGH7E$
M+Q%O>VENTS?ZQ1986-%RP"&*9+?IH7:1S\'05(F(>QAJQB2UQ9)K9>LZEF%K
M"EQ'73^.F"OQ:&FE2;SS%498UO8JUKP*U[_SD_1^#@-?A9?_J^9R.>+VL'4*
M(RC,XO)QE'P7S(72E&65?(7EPG1B4N]'?4<KG<2)%-UN,+,[<!->]*MV!J(;
MKP"8Z"&)--3J&.>9R'K2CA]KF)"B4$77YH*25B^?!S@D/F8@SU]%O[-IPS"9
MAIU":Z$+>>]N)X<:?L*WDYX@@!9&0<F&0X,UH#T2M*5-Y0'8=1>.MV 'PC_N
MXB=05$Q1;1J!RHXK(S66FLV??_'G@!OSH-W*]1!'GY&!+/]C743>\[$3][!F
M2&\+<WVR0Z7+T8)Z=3]#)/';*"#-YWLW)#SGBCL!,]7ZUGR? Q.O0<?DVP4L
M&N?B$!"<&INX<L=0Z]OBA7$D?\H>7>C/.5O_QS=_7-.%'@\;P2:, +:IPDJ[
MV/G41E+;)31!M(Y5W]WDK_I-(%VM6*OH?0Y&9$U3E-T&^[NQ)VSZER_4/&5^
MK6IIY-6W0IPTS KC%;ICAG#,9I6JRY24XA+;@IDUZ)7N!FIK\.(CC$IA\X5J
MAO\;8:\KT5W]/NXOXI*Q+ZH?R),!Q$D&_6>JQIZP\SHKL>F&,HE^#%3.[:]8
MW+;H^^3.U]$0>J$6T! YSOB0.L_-Z!5W*<2**);"H^-.?FU4=VHYDTSDDS@C
M=-N.C6Z>U-5L*#*P];'+? JO]:!/;ZE:$6?[0NY[)2XLN-0U53<,%U2 %<N9
MK&1_[F=HA#XM@'G>>%%9EL+5>"NWT=%'-B9N7H&&J++FU-8%A0WC=&&*C1!)
M.#6 N<RY,&66!#6_-748."T^51/QO4$LP)%)"=PAY2<>5)+?^N;0=>&-K7UO
M*UV7_\NMM6K]*_W8E[2JC.R$=Q.)-IX85RIB7<RG;K*5*S6]JG%8M9#"!\@[
M!6J%RWV?;\[JO,K#/7PDPIU][)K7]4J,/NNNZ2DRWU82#BBH0V>%6JP?!BEK
MI+2>>K0[*YQ_)/,6HGJ<G-J#AO?"*'!:,\S=$N!OAN#ZYJ#E:[(5XE42M?"\
MD'-X__*MTZL7$$ IU0'3=9@#8#M.?=OJZK #R!*O(1_FI3UKI4W7>//Y)2MB
MN5RYB-5&2(6(;SHG[R-H)YVO.;HH+!L3%BUIEM_T8UJ*BG6KWY/%-)&[PEY<
MU:-#ABBCD#DY<_8GPR5E). <A,JN1E<41=;>&?@+A8+EK#\-*>YUF]37[]@5
MG1VJI&C2E+8^$AIL<FN*6O;^=1-]%5*?*R6LU->;J/9ZDX^Z7+A((DY(9XCW
MEWDX3ZQG?">\XCH"26-G)>/5EH-B^UMZI$GG=,3%STD0K;Y(^,<]24NJL&#Q
MAK;)X;9B;.QV[[:Y]]W,Q\(I^P2 Y]J#O[0,D]%$OX>"3%4 T+ >,)P&.H'R
MB4<>W+%TGCG$>A"7;NOO) ZP_O!+0C78+@!ID,_A'\7.M-]1H"P[2 *Y$KML
M)+X-=^FA8>&2=8VIBZH!L"JI08]GG!* 'N.[+^*S%HZ&@K2O;1?F8<BZLAA;
M+9<OJ>XLLOH#R<[:VR>%IKJE?X1S/RVT(I=/ 0!8EN\C6N!$..%Q)5:;[9HM
MB6UA5@+@JT+4@BIJZZ79* ?9>@O;@O\*<?:-%B9^XA514IFP?T 6JZ%Y,BH5
M&XE\4V&PON(^VU'[BC+W6M52I V(D9"\'6$HE>NM@?#U 2'6WO8.<-&HE>K4
MSGUWQS;+9YYK+Y6;["(?V#;?8&,([#ZRM86*=IX&WQI53;07.K*,BHK*F"$O
M.-.6&.SB('H_?D]VD\2FKN4).Q>46&<<)URZ9>$;TM"%NJ.@7,FSEJ<K%%U-
M%I#WAM$ZG%'[LP/<,''(#G<[T40W(I@=*J7-O5,M3Q',?Z)H@;IP%*O'>-X<
M\Q/[\I<#EWT/P*=P!5<!!&:ACY#3:>!<G-RT29!.T+-N2%#1]FMK3>3T^D)V
M(Z=PVFFQ05E,-K45;UD>UF &*?K18,2RJJ:AEIYZT<5B83_O5M[2FL+@")F;
MQE?R.\.F-Y<IZ\ZL:8FZ JFF*KT[0FQ8FEMKVVJR=A?UX_12"E,^BAE[[)8.
M,@!^?KE[TVFZ)97_OS;_-T! *PC1,Q7[_]3RV914*/J?[$0XH^F<J5;]')BK
MZ[VYBG+/H&H4RW/&[R)<\6JF#NE.606>[.C>)9*.33T"X$_&!@' 5IF,ZNL9
MP1H?ND1=)5T5G8X]'$$$5J1)$P _9H</W))^PKK,89-E!$ 2.W[*1B70Y':2
M&FG]^DX! ?!L]X<D-+22C:9S,K5H?$JHUF?,$PA>A<"ZF /9"("<9P2 H&\6
MSC\.Z^#^:>F8'[:F<T0 Q)F(XJ22KS0[SO4)@#VC_V[>+,A7^)  ^&E[SKID
M@LHZ/S<D &Y?B^WU&9Q80^?!!2WHL,COFH1<LX10::PB ? T#&]T ,*>O"0
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ML7,HWP@%)Y0N\3S45'?&M.O,WZAY?4_N8OKO?/6;;H\(#1YZCD<,"^OD;!0
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M"@UCV]R906+*O#_B@W^0TG\ARSXU*@L>6V 6]J:A7I]VCSRDI"P/LJ=L,L/
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M/S6DZ:B*S62*KW#A27DQZN)S5B $LZ4<@[XMY2G>SGY(S!?PG"P9@CIZC9=
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M/CZF=\Z5PTU&>,\$J1GA23_"?YECVGS\_=A?]"4E(3^\A1SD4U/W+4[&'0Z
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MPT_#4>%RHG M#R<T.',L,W6K8L:2+]EW&B7L9V.P^:YMI3FK/7.BQ!^K2T$
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MRO()$>CY,8TCV"&G06-'?=R"A.\JNZW4<97!Y="_WFASV*?_-Q" DPG%"(]
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M@ *TZSFQ,L#_7UK)A%5+K7%<<.&HITA^6L)\]KRL=M#;%XGF&4(_VTH,GOS
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M#. S2Q0]U<2I >"S-OI/FFF@"'"T'3-GC-_8MYN.HO)YU(/#YXPA,:^:7*=
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M:LCS,DPF!XG?V?<^R3 WX_"E3R$'/"'G4/CZ(1#G6R'$X5HN&AN.#T><]&0
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MUQ;_WV0.4Z2D:THV^K%)"OH/[(==]Q0?U+.S)VI28[!2J%Z79=E!^;GVA++
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M84!T]X&*&,U,13FS#DU7I_1K*2X8B,8+Q4M_+$.&P$W8YHR5+3\E:<AB1ZI
M,?Q,.*5E^DO'_ T\HC4_H(KB$YS44+EV:>KFY^J&RC3WJJ\);K&VBXO-IY,^
MJG7_0Z&CFB'[TF("X(R<:NBQ#NZM4+ K!7:1#." ">-@,Y\S>X#IW=[LT+K[
MP&SG%4H56<P #H,\F6S8!MNA<('Z:+EN,1_*7=DN\$7UTL\[WBR[0]>_(@N.
M46<90)"HW4\T\6K//I^.&P. ?0:M=@2;/W@Z 7O60_DM_$CRP_N' KZ-^^8^
MPHM/;)U;?_1XQ=G;@HZWZJ,_I#&WH/?/D[!@=/6+^VU;W_!S>F+9FWUBV6YX
MF#NUTNS)^;:\@WN9.X6: W&O)E*6>[IRA2T^MCI]65J"981 LK2MR.?;JE1?
MWYJI?3-:WLO&I+;* *H%6S$G$ $SD-#2>A5",87S[+Z$A\1 V<]F3169CK%'
M?^[918ZC?EZK-T6-@2'6;PW[2/:)C3QOWR5#>Z>ZLQ'T$*'(+VHLA=]W>+K
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M+]9)KT>M+8[H@?83KZ$%PU*@^G101W5H$FMH86NX;9L!O7-_NR1%6OC"WW?
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MX.<6 ]B7N<  =I8+Z:D2RW!4A^";0$SO_@9ACYJ[<@F, 3"#WDXKSB,%4-]
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M6JT6QN7(1I'%"Z?;CSJ,+L@D7LY)S)7_EA0V>'M2*%\$\-P]9S%.,!-BG'J
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MP:%+OY"D]S0@,]]RWBE7$\6ZK W$:7S?!@W([*PXA6J%C@-T61T!6*E4&9C
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MAV1B.E84 A'XF4L/GD-1QAC\WG4G]+2IV+)MD-<VR+,C[B6[SU=FEH4.KM-
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M+PT8G*#]@AZ$1 682_9:1>!''?J+I*-R!V\]L521JD\NORW^Q/:MU@;&>-B
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M,MM DW]_,GW%^3_<J/X__E?!_6OJOP!02P,$%     @ TSMP5BC;LH2=A
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MO!@)G3"VNJ4P7A+P"@;&!7_@'FDJ<VC\)[LWK6)@0L@P;56VS.S$-3/YTZH
M?0;?[N\6* ^A+UANM%TF\ ZNM#NS'0(S@>]:I1S3\SC1^\LF^W R2\VZ&1DM
M-+TK7+X<XDD.>/[9W]7!*6)T=T5.H9I8G/1;! 78<J=I$CWF0SU3('??BO>E
MQ4Y"")Q*Z^>K ?LMU<U-(E!+N:N&@Z"G>LK=J4"O3EZVL=J8^Y1]O(HXNY)L
MFQ-J5M:MM:!P<C^W03ZT1Y@U;G^G:66C713/@ML/DQFF;B]=3I!=>3!><11
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M=XW*_FT653KT92T6%YO#?<<>!CPMF9"1K&YM>"'])5I\_772A\WOUJ157KV
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MJ*<C4.9'U6$N!]ZXN;4N97'I"4Y:SO?Q;0Q<(Z&DRR*H=< .]H&S"9>!J4_
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M +KEP> 9&CAH=U5L^DGR<^Q>67-$/-LQ3NH&'8HO2_9)0BS31Y[(IZ6\2")
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MLP.!"H)QGXGK>ZD9JD19LOG+I8%5]#W,^661SO6[7"T?/?I"7[.JF#'U\UT
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MZN9\=0]FE4=RF$<O3P0B'X%7SJN(^U]5A.D8BG=&@K;[89!##0*$"* E;8A
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MO0!$%M8O1^%O>CT30(IA@/%KV44.D;N9SU-E_TCQ93?X8NV57Z+,78C67DX
MT4T0&+<(U.T84)8;:M=@H'E6T>IZEKA4E1!.LG4I=?UZ2_P#[5/&4M@Z#@B9
M(_0BFLOBCN )+,W1']P;<+OB]'8GBAP'$@MWKW.28 A5&A1*+\AKOO5T4U80
M9A&-VKMW<6I;=IQH1+^;=5\@14S5)T>B>67('[DCOFBMCV)QY-][V^*86TS%
M)&(&7?>B,+C!$.!Y"8BIAX@@@;#;Z-E0M?N/TK8,DJAIYZ&&]5J^WT;IGK7/
M*=FP;!ZJP:*4U3CQ[)JK8I$7 %<@-TP<;= ;-$P0A)ZD^-LV*"@!&@BWAVAD
M$V5 )G+V423>RT"C,CSK;$^;=$\UG2UV_B%&.PYOBG1CF5,U:%IV;:NLRG@1
M)W#H1$1W)AD,$:YW5I#FA9FAH%2L[@5 ^ (PB,#Q5EX COK>F+^=_0*LO=O0
ME*,T0/5VRH?>ZB[&__-2Q>/WWQ; ^'OR?8>:[_45YE:+#AV>A=(@:<*.@O^^
M<%'$:C6_,Y@.+_S>OZ3_+$\%%/'VME-[9Z&JO<;0+6J1-( AM4@HR97FBI\&
M\]X]+C@MPIC -;1 \MSG@F:YNYY/#S9X8E*O?_U8)>QK034WK[,@2R)X0 XP
M0',2:)C1'B>)F'JL=A]/XW%3V]:N&[3",A?>]#[<^N--P9<DJ@]X 7G//7?!
M]&ZH9O3Y2KQ(+#_DX?!=4O#FX9GYZOJ.*HX5=A]MOLN+K.;$'O99K4>^D*:W
M#6X9?E&1&R<M8OHH=?!R4HM(TD"-XGHY"J&+]\:98,5.W+&6[[ I@Y[0)D/B
MMUD.SIENT'M7VI%FW?HC7GG.8EQ)EG]9C@[@/1$*BBGNTCO/@:^\(4(&L(OZ
MD],[M9.-NY3]-[2<4O1;:H.:6V/MO0?=^LX7$L,IY :U/(\98E"\$*:!ZYFU
MD#NU-6:<,ZQS+,&1PV]2/', D__H8%@<-O.Z_G(X89ZC])J 8.A\OG(H!T3<
MK5)1^^R#D_*Z*+2I"HSBW_'ULV-B@3;SB!56];%\8)8//WI5*O0=K37]S,ES
M^"/#S:K>OR\Q(9&#&>I;E$;15S9VE?M460VY_[RC(H" OVD5L5\/TBUV$OBD
MP^]I \?+&43"-Z1_ESL,X%CX+Y50=3,$.7RE7$ 4,[V_ZX>"2K,N0.Z^M>""
MUTCF?[,N?9UT;X1J,]/MQROO]N=B/[K/,_YZ9]B,,^X"\&0L*D11L:S?K$!\
M]G,)9[-*8;+/?*%HLJQ)\.:</[_Z5=)>L-.B]V"!$+&<,<.^/1UB65QPU4?R
M![A)28_(?7XJN<[4GC[RRY_LX.&U?0L@VDQZ#H'B[%97Z@GA0?/CN_CA3**?
M!Y8:+UW+?:;/Q=3?SQ\CG2G\<_ K%=GZ/#$H?U_NS0'N8#"*![,FF-:TL=ZY
MO'%MS]5=7W]=/=U[,?%Z,]IV%$9_E/,Q:0RXX37.H[J8\0\G']=AW%+B\-KT
M[7+S])#!G,\;S5XW[!1R=J<455&A(&>BL?J$&3@S2.7SJC2U_[YQ;G]%B75?
MD,L'FW>'7U7K&F1OD(9XMNJN1Z\EVA]9=<&P/C@JV&6L0=F8"U("R(H-<+_7
M..D"DINYKC]Z];*5!OF$!!/U$)_#K.T%@&Z2B%5I?]?9?2E$K/K@ST1I[C(B
M'.;\#8=C@$0XG&^74.3LN\0S7BG?KBM]I:G10$II2OII1WX,SOO^ODC,XK?"
M0,#7/Z'N0K"[]%RTP7?5E4C"]=K))].-[>TM1XN*2VNI@.SI7%BNCJBI43()
MMR!=XL^NB&IE[#F:M1?1$-,71 2$V#9JR(-6(9T]R3R1DXEJ"9%G&CV44TQ:
M&L-70D%LYT1S5MXN*6#7,6]GD<O]ZJIZV8VO?KHI&4U4SE'$6XR_D1DN?27+
MIM6S$D[A70#6<W=[W=&<N802*: V'!(QONKH(TRNH\:DS56=#G:$8*_,]NU_
MAP[68]O&3*?P1BAF5@T7S_+KSIFQR_[%@KBU1^YB;Y]3Z =[W@(*^@<1J"W1
MC'UPUM>8C*Z4]V-K-@DM\KRYNV?/C$E;G^?"!@V?WVY([ !H\)G/=@, I #C
M\7]8-_RIU+Q\ >C1[J!>I:TF\9=&P4.O?RE%%4;GH*"C#DS#3QOG<<@&KVZW
MQ!J^'<;D6]5)OS4)R&LQ,^7(>9RD*G(OJ=35CV.?326T*Q-2/VQ^28/;*(UZ
MF.R8]&9U\P7 HWH>:'R>T@%$=FKKH7\@8J5\YA,2[BIQ:C$_&^%RA)&YX9L?
MJ/A4?R;BB@L VM@-V VDX^Q5*20B+O\ZU!ZWN=6,@L3"PC;+QT^'>L\'*9XZ
M/56W6 UEO!0*2B0N2FW"[)SH4L(;/&GGN/7]:;?B]J[)X\?>/Z6*?VH76'Q7
M3$I\UY_(0C/H'0[RF/R(?WN>WW7999E)"OPD0O[J,I/;,;\K8P/YXO.Y.\P+
M_<6Z,IDDAE='P%L+F'1(A3S 3"P>QHP<XYOK@Z+T2?4PY W2/^\R5#CR?]3"
M#OY@>$,:KG77;?P6GV\4VHF8,Z..+13T>;N7>"84)+SN*V6JW.V0T](1]VTK
M$A9,[=G0=\56="_Q8A;3OF.S^LX@L6YL:36N34:+6M3;4:DZE1^ODKY"I_3N
M4\#  <!> O/7#L6#I*HYK5SZ<L\-6"-W.1[^9@E:0#_]01X';UP:H]9Y3?C6
M.J'4I U\UF26PWBZ:@Q7^2WW1"#&(6I@A(^;'(Y4&V,P]UCF F //0CP58*E
MI#T]>-I[ 9A7VISXD^;3UT8@O2[&Z<&T&Z@/SI@P^2F"P,+[.<C]A:UDS)D/
M2N1@C2G$A]>[QO$ASVD.VN.[=A\<'3N"<2+FY$B3OB7J@]^*3T+HAB[W?+?V
MNQ/SI_HG0;"]+R?G$_A/RT'[P(!_/PQ%TSR77Y"9VOAC@2-!F$RKX.ZM3X$D
MZ2,G%8+A))2"LRNG>':H":9Q=M<31>O!IH#::$)WJX'I(L_SK+C2)9DVT\6R
M6XX7J-3)0_+A/7(*TCRNA76,D>N8^L51GY]?VEXTKV4O]8/W]%A'@/[7P-V<
M35=)M^+_<X+XE7MR?OZ'] 4 "HDP.V.(*]=XBTW0Z>+)+/"@YCAL24HM?AEZ
M+[SJ>3<?D^K3KNSB4+ B>"5_&?T S$<8NP!PBF!C,#3;!O4%'V>@^N#[DWNP
M$[\_GKF(/%*,HK(@)TM[\$!F;%/]'V^@48JM?G>*7^\MICV7[0<UT@PKL)-]
M*;!Y,\#P$&42JL&E3#]F/V,NNHJSW*OJ$%MSX6AKSJKL$TGRPND74Y5^VCRD
M:SLB+>#"V+K]0TG&W\,?LEN" ?="&!%.!K&*(2(8COSB):@=W]2._#RT/4K7
M0RQ(E]T^3J56-'3%,S7/O,I?>U"%,Z4#[%*%]3"OGY4/:EPF/XX<O6[,^-0D
M'O^*Z'']>&9L3#G,;A(&=RO=4ED.&TSB?]=2'_<S13]-,;64)6HL\P-5\#K@
M0.Y@=A*"U@5&"JA@3="LUNF#ON8Y\BHSY2>?Y7019LG.3YC%&RIYO7*'5_B
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MO3EI>]!<OO1=4T4K7 =56^O_,TVP)\,^KL]MD&H $'3::_ +2%"X 'Q;]+@
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M/!1<(H:_)]^]=&>$3OR[VP"&!SE*3'UGH [ODZ#662EB5HV'L+C,A:1_:$Y
M'N[*5_R2KIPDB 0:VM:KW:AW]$U_-4N6.LP-&KH%9(/WW/VM8LI*&$['/ICO
MU;PUY:/^Y*9#NO[,B];U>9X; A[Y_%/66@\N/7NVDM_'!0824RQY,;9.39UN
MLQA[K;&IQ2&M?\,O?/$R#4U+(4Y;-$[DV4$WP,GSB\0^>#[EA&,"_LP->"?;
MIPD]%B]O(".I0$I9R)9ZTWA<5^"'B*,&&9.&6)4G1&81WL/<D([>6YI91NEW
M8^ILY.NV9%WZ=F3OW+ITF>%\ZV$X[//ZS9MVKP '0=582<Z!/[[NO&T>5V.7
MJCK0:3;S<O:+H[LJ4YMF]([E1YT7C=2"S\T20V+4&(=9)MR?=*@C/NG]3J?*
MP^WGUWVA^,6(QW>\Z#42L_G23&7RO&<Z60?AZ+OMZDI(0@I#U"J]]4-,_*==
MN!]_$N*[:&+47 5;%O.KDQ7\_$)>7MB@#/[W:0@_%[SDZ[ZB9?^"V?X;UVP?
M;)W-/DB;V\@<=BZQ7AE_Q/>HWHGT]8@@GW0"$<K60MB.;<5THV>UT6Y3D?-+
M=B(YH@N7EE"\84*#2>=%A"= 2>HG3,C8;F&%(*O?9N,MFZ$:;S8*:!#FS=HM
M2H'\/Q 9,D"5*XMW3]_MK+N %]FGL*L$JN/K<UJA72SM&/6F4CH7CHHK%1YE
MNORCW+*3=UBP7"?EW8F97\8/+^F6PUQ^F\R9I7(377D:_V+T1;CR\>7RN<UF
MR>L1^Z,<\VMSC*<,GN=;@+7&Y=_3FV![6_DHB;?'*BDU_DK WI'$J O'[:+A
M,(KBE:@GM]SZ?.7"\HRW@6@KZ?B9LWG-M\Y+=%T3&O=M%S:4GC_0(/4\B"Y>
MC<BCQZ^\&.-/24"L)->Z@JY,S/>II,3+NU$-T9G7;F6V^7SJR;B5]O!%IU&T
M8--$F?L#)3J:+35]HJ5:7_?5/,C../L3.I5Z]6L^._H]$NNP(>D0>3W]8._Y
M/5CKQA3)#Y4R/$<$JA01][2I9@+&'53T <=JF'6K(QZ)&I->@SO74')?AHW=
M3YT_7N\!"3=C4B+D^4,F?DB[*=B"ELYX7Z%DKI=?=]U"TLH8:I(VU HKCVQ#
M\GCV\<QB&AW8I)//TBC1Q9APD=Q/;K+6S)([+GFOTH*1!D5>V?Q]YIO:,6K@
MQT@PHTN@0(:[Y(M.V1D)"1T2$6TZ9V9.L?0HPYM'1?0\?ZZ:U().JL[?R%=_
MMUY9*EG-?]"K;_4P1U657T7IX//G3]ES46C?=S2?'C#2/*?NKLXDHDA&K/BS
MP@;(0"X\AB")SB^+:>0W<E Q_9G[_.#.7OR7)ZDV#BSQ_3>413W#4B'F(9.(
M^JXHG!%,:*J#MMI&_S'?@>CGMZ_=E71=O")W7EY#1M->,YFV.&"@(N(R9>+J
MLG9!U&L/4.&#4(R<*9Q0#FJ10!N.$ZTY7E^?JQ-=M@F*@X\H >YBZ8F 8.0_
M2QJ7,13#2S98G22R[6)^+VX]:BMP#>J:]IP_;MX[J2P"L6D;[ EF&4AM1T/F
MGTR5"O<S<3'DW:*5SE"<5-26\?ERP\NLW?5/Y#_\Z'D1>*46CJXB2+N&<*/-
M(YZIZ14YGUZ9V#9I[W2 -FO&J>6'1AEZD?)_'_0,ER!.5,RR'9"/] ) ,TB.
M]ETI!3=8;/%ZGC:['1P6^*[.^P4>P>> !&K24I@==NB]_UA?P4T01\W,WMRI
M\:339->$L9-JJ;^%3H<<R[S%<]VU1)*/0*P01[*:;[UT_WS?RB(N*==E].0<
ML7#8_&P;;ZW>=%K$\!N2AZ] :=^Y5KZ'2=4&<<1= .HG)DU\4D4()'*R3*-;
M#Z\=L7U6)= &5U5''XLBL/9E(ZA+VR?<DHW4'%/7Q/QR2O58*&0:H[WG^?8W
MEM&:\_)3/B85L(<%UJ2\57G7CUZF512V3'*\C*9=-.=MEYT*=,(SG9$@\_45
M@/'N2Y>=3!XK-*61?W"5:[F7=/FIY"!-W>X0QI""?@S/@>L7ZYV)\T"/WH>P
M!'P^R2Y%O/S^JF6^%L# =9A72\I_& ;J),9OQ SW"^]BO'1M4N0]'P7$5'ZS
M;GKK8_$(UU4R#K+#1,_T,A^B#X(H>S-=/# & J*L<C:C4AFYBK&KKL742M%\
M^('8FQOB@XC?#S5XED@E8(R=[_5SF@2=B^C^U$W/BC(S:K '"'-LYB^^(Y6%
M8"7/M_UG.%*046W^VEYQ]L&Z.1< =XJ?9G/"PS=[4\> -[:--H%H&WH] @N]
M1J-!U$S,G6N7Z^(G31Y[)47\B.-/AY)VBSZTOPE8I2S*(E!%O&'DG1_E[-_N
M0P(^3EKIEDG/#W,M5%P-CA!3?I+GM%?0R)%*- T\68QA*)HK&^#-3:(:$JQ+
MGM6SV#,=!EFFYF@9LZT*DK0#^V[Q#^W\WHVT(99BOS#NH]UV\NC*E.@JGVCG
MH\K;O9LYPC?(8AW,][H?6PA8DWI\DC@"=5&?IQ C>L:9Q\XRQFQY:.DR)A;C
M7OZ6FB(#ZO;$[7'4XCUNA]'6IW.?+B4"'G@]ESEM_+<6R*]Y'.0"T&,NBJ7$
MQ%\ ND&,Z*BR6,=Q2_MIZ6.)K"2Z4M-$(W$Z?%&H3?J76W:R\#L5*P9SJP1J
M@[>$<2"'.SX(.<;-2 W9*N4UK6^M43+2%7H'493EITE[+ULFF)>7B H%E9UG
M@\";X(;9GL^<0VUWW^2\\&M'MM1F-S<V8&HM67TID*DOG\M2*?-+C, ]@/-O
M9T]4QN4EH/S4:MJH2K]/0=;6<8EF:$UNPX/A6R)K-21:<B/#0Z 1G J>ZBOB
MZ7)DH%AH!UBD63'0WR]S;_7<\=.7@3>IM=TC:B1? :KF&81Y(J#92\+98^%W
M%RO!T3"#8OG"QU.1 C #OER_@>M!?[R\=XV,KWR,4L200GJ'$Q?0@WO\?7O.
MO:QH"#G&OA''=Z@!E<E<0E&*WHFU<-1Y1&)24!3N'78\ *O&T1-ZK0QVO-]"
MLXRA22@XV_9MY2H?$LI4-L/7HD^2E&36\C+%Q$C#XL_^FZY/^A=W&LX<O]27
MV'ZW<IW-8?^T6:>N;:!C%>1]OL:J+>)P >A*5']'.@IVZN0X[%NZC!UX#*]V
M%;C2EC" WI]6L-A-0SW;"#3BC>HPNJ,8SN:6Y&^4EY>^X[-:6+^4$(#<9\(_
MJ4',-C*RVMY%8?VV<C[XCG@JOE"_FM2[=+685X-&<;#CZI<'NB<J_U2"\I^-
MU2XANR$G'R3)E5;/XH"S'1GQ'E8=:=UX8\EE,C>S03^^Q*+5 E6>'VH!US$V
MV(<:[UR:2([?F6F\>W?EQ<&/*U>]RECR+E'U]#:KIYC_'VU@_)?'[[8T-_8"
MT!O"4Q.#+(MX@H''^^C5.C'.5X6,V9=5#=K[>)W?AS;0)QS*"#) )[;#L#V8
M]6X(X"B(WWR((!31EQ-\]'-F*0"5J2'2KN=V2<'^*^M8*<!_%L_:?!*'B=F5
M0^M98L!)21&N)R%"+1-?-YM^<G6\6VGV/$@+6)0X/*HF@\_/HF9W)7%ZKA!J
MPB4K?V_-B8:?+;+8K'YF];X1-CKFO4OE<^\^F1KYUJK^D=9ZV1G>(TA0\V>\
M@_6 HY=.^PVML?-6&-/CO<(W7*72:F"'T'TZSD=<T78?&#\&5_2"GP:8$Z@7
M<2_\HY=1GS@#.6,4>'EWQ2?MTN9T)7]&K<<[N[,5IWWL93=I8"E%=S^N^0W'
M8W:OX?0)(V?+44>06#O)B48#&FS4]R^=*_-4E3Y <:%B?WNY0<S@RKU$:LV\
MQ!NJM1MP]+WE!#MA;/ZJ04K-5I?B+-ZE:#,P(]XY'3H7F67 7Z\;PIX5T)MU
M)[$)\&5\Z%('+8%&#U.M<=[0X8$>Z@:3@Z8QI":3<WN6:Y.2C@>G7QX_O&5K
M'L5<+U>8JDG73)_2"**%]]P,X<3?0)NE>IRX^0[U5S]VS5D\B4/E/QB0=B])
M8;QLX:21M'O9*"QTB*N(T?YO-:.3-I?KX&%'[9^-?RZ;8-:\MLR%MI#I*(:.
MJ#6F(:KK9D><JD(:K:.* )M=4R/X7_6U_JSX^I];DBG8IX6_1:,A*$H"'_RW
M:+0/(+"2_0<$_1GT6SD:T<^(5R;\5H[> B-S8$2C-."Q0*PG7O,",#+U6VUV
M;$GN/.]9$088.GEWNNMROJ*;ZYV9CS#-V6^TX)WM&=N!ZKJ270F7CROKI,HB
M O7_<X9EP/ODL=J$\ L $QB]BHVY *2_^^M^ZK_+,OVG]F#)OVIH*S@:7I^4
M,1LC#>P_:^Y7F(INK'ASVR V\ Q86U7BU0231'/A;D10EG.)I.D6,1;]Z1J5
M_VR%T;_<G]3^6UWE^(/JOYXNX%_/U)]%I/]JNO[&3/WYOI>_(B:)K8*_#WYD
M9,;2R]M:H[@GG\Z\T7]6UJ\>'%I/^-+IN&"%$P=--.55,3R7"]< G%'\SYGV
MM^:0H6RHR9RS&<2. Z6[O/^E,B4[/.M%IOA..$MNZ)#^2RN P=]^B,\G8XT3
M45<=IG"E"3HZQF>;ZQ+53P&/M1/TIBMB$KF_#/M (GAC/7W;[&_8]S^XTOZ.
M2QR>Y.*4ORL-0)@UO"M@1*,BC>1M98X.0BYO(^E7#4*DT+TX3Y#5]S76L$'
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M@TJ0^M^7QL,OR5Y?GC_8W*C]=3_$\H:U^V1JM'3#VJ/92>"E+C5_@Y-X-)N
M)#KRU.#1 9=H<U?S#1OK>X K-YE.^ZY]3'LC0%V= 5+ WR1"P)4+0-C9<C\.
M/!=EMZTS ;&TEI"\]&59MT ^Y1-3]ZKGY6AV[@@/42^*/6*06<D&-EX $B\
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M7P$>OY=3E /0T $ [>$%W,\#[P ,=/1_KH>&^7!AX6)A86)B/<+!P<8E>$1
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M[F6U2O>$,;=%FA:[3U'KAS\Q70\Y-HD?;T_-P4-]+>U7!P1\EA]UF4/$S-9
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MQ"G2.S60XT1-U"^3B[THL!;TGIB;P/G0G#@8O";6X($Z)'N2*:*;< ]\W&'
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M8A_[RY,L?G23V,HV$3/=_98 =Q8A8U'OC"D?X/_6/3!F4W3V,_.28^GVS:@
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M5%C>MB3QK?AJ6F1CS2(WC0TW?(HDL5>Q'3,CCSF=@"!U?-15E(%H9U3/IF[
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M=HEH':*<K\'$C#'G=2_#JK+X)7".6\\.W&#38+Y@[IM#+O+3J'N@1C6J[!Z
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M)+T#9J%!S[72 19X!S'AGL&/HA+#!4_>'@K7&+U4KYJ9ZIM?#2R9Y Q"C%7
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M@O0FO0<%1*4)@G0"*M)$1#I($Y FO84:0'H7!)5>!:1$>N]=>HV$GB"])-0
M(3F\:Y]U[;/>]UWG['W.=3X\'YY<\USWS&3FGO]O[IG[<X.P4G>FH^,R+6:8
M)%Z.YVET)=BJAXMPT@E;UD(Z4CTXN0_W87H#_9M?JG-$F39N9=2\$A$D 4:<
M=[,=1F#UBNR-Y;X"'68HC*_3CQ PMSO\#^]]_MN:&,'Q1.05QY&5Z"E:HNE+
M<4&KB5]A=AKL=>1K&A+U4*^=UU1"@A?I+9J.=K5G3D9G,VB7>"!G^P/<"![
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M1O@_$TP@VK-H+LO)T<L)0>KT5K?)5*L'+3C5=2\EV("RTZI1QQ!(YNE&$W4
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MNI_;"L2HNB;-IUW.UK2*87<%Z#;;9ZPP;(>[@S=\/1Y<WU&;T[E"!^:RHC2
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M\>2"!EUH:P\2U$MEWDV_5<\F\[N!&1>0*,YD[NAE.,-!>B3O*[U*N-RF\"O
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MJ7@ %QZP+7"%!TS_Q=HK'^2;]7(^OOT%4@BL%3D :66@RC<@S+:&"]2Q(7@
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MJ1'4C\'0FV4R0J ##\@_1AO@ <0H"#H=L-KA0#./7$L+01Z&,%VZ!)]0L$@
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M"GIW:?!Y&1S;YP.A") ],[7,T6^<J>1I;/;_L\^E&U^T9M1%F+M*V%FX=*/
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M"2E VH[9 7(K0*09G5QW;B =;9!\J"KKU<;.^X1B<*,^L591D@Z&![!B% /
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MB5-K4IYO>2<8E<"1+_>(Z_I3 'M$AQ7W$-=Y!V8U5\5\L.X?7-^--RRS$O"
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M$=B;^H*^):0XF]@X+M3#R?IM;6O+6%F%H).615TFH7?<]10[6X;-<@:[YJ0
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M.6[$[18UC*"3:(LH6@I^2):0R1:KB^S*S,@S*\_I&(!(">;YSKY8P+YI]1%
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MZ8\OLE"\-!TXZ*. 0 3;,=VJP\+Q!KTB/-%,PA9'K7E](P55&*N/9<A+,"*
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MK^O;OSBD3(;963$,8?OV#!,I,IIP2B.1[WOK-"#;!KMDEPM"V@FV$Q;1)3(
MI;O$MO.+3;KA9+>Y72)PR[W5,HONRJ3!T'D?;8_-F55J:'#!E-,"O#RS8/8:
M@Z\'M]^4#1VP5%0Q6V9=EV*(?KHK:\\:<02(D/ +M)7N*P3)2_:7>B3=F9EI
M1_L7"C$8?_]M\6'RXZW?TPD=G%PN[9@]L-* SH\UF9G]K<%9,Y6T*9<B[LV%
M';,3#5#%W.0>/!K=?0Z\6Y+Z@BVP$MO)[&DNWL4V1Z(YPEU/H5M%<0F>#V2,
M>M%/33!DQBU!\X>U$"?Y,)YHIUS#[KSRCN',L24-!>ZL/7G(\_EC_P>_&+E(
MDDYH0N$& 4.$&GCTO5[LO4%^[N^@ I!R:4.8)@@)*NV3E[#Q$1H1U^3W$N#]
MW.H3 YZ:,&F'N@@WC)(J":4)2*)S'I(!\Z&[4-[YHPAV4V-(/8]UZTKP?I$6
M=_TH_<EK4EFU9?5V[@2FR0>+EWH%U[H$LZQWEM-FK$XXY _T=ROGX'NR]]%!
MS1PTL-!3-%M;HCE;^V%<:L(AG>=';7D-=WPG+1<^!P! )$F_L&G-8-8-X\,\
MQ!J!_>.,"<2#OH B;F3S$;0BB%;P+B\+:*F#3.[1G8:8[S'Z-L611""B[4!3
MOL8GJ)? @]-;T YA\-@)+=ZO5:""7"@;RK8NG15"O[9ZF':T>TM JI2.L1=@
MRH9MH-PB&N[/KDOW$*)L4(+)FO>$Q:=8DH>K(8FC*%X>RW ZPSWF7-:T+S%D
MZB<BH9"9\AK;NN09(F!\=</S )^@U"R$ET%'L>"?)8.P:1^WO!ZBVC C;5%B
M#1D4S3)J=^[;"0Y<F:E<=0KWU3R+]Y+SIH\NV/ HZK*5NJC<OVFONTTS/A$?
M*45V5F(4A:#;2HI/M"H<US;_(V_BFAB7*ZO"U5A#/0)?-K*W)6@-%8F',0H5
M0E^7E/J2.H"FVC@C)=@NYLY3O7Y\Y/HGEA7<DZR8"(R&^(1MJR;,>MT;+N]1
M0M?1!I148(7K) _=/)NMZ)>NWF+]P'B$%_R <6OLH]4LL!8L@)D6(7]"LRG<
M"V%)"SH52>;D3Y!6_K]EJ"M9=TBN/07&!O=UU.?&['$.]?#BE>X:\(<Z&Y0W
MAV%OLB<*?GW*VF!@=BV!>7Y8:/E3TQ.X17A,_[>'LG$+X>SE62@D&:X2W1Z(
MIX466,<3F >=B^Z\-7TL./QEIFX4>M'=.H,OW4+(;7X1N+ !5C$!M;J1?M*F
MT20-?;$0K228QWC+OY%L, QB_6YKP6^6R^_*YSO*S &Z+WX!E #[Y]F\G-$Y
MQ'$8!-2'K3QFI\N 2;4SKV+8@PIQKF/*/S!?.V5K,@W6!&:_?+=>N-&6X1C8
M"_*Y-Y14^@U_#TL1U$P$ I),*O@2:NCSV$;P;RSN\/U*X+KQ?L[K_?W1^J90
M-S=D"N%-27E=T>X8ON_K/E6@F=0@'DJS5F/:'K!_-&R9K),Z!-IS+BAP%5(+
M[0FQ7GKG!WM^+D?"YL$?9GDPNSBW9H,:NIZ9^&BO&,ER![3-;--3<\<.[ 19
M5^>1CTZZ8F<G(B\W+ZH6XGPFR5J_,9>WE_!1GAFWTSPK,S2E,6B!J?B:E)G
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MQY\#APJS\-_P ,!BP'ANXBX1<"<"]P@WX1;-9ROX=MSSR__#_/]Q9E*/O^S
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M=K8S]5N5PM\T3#S$*$#<UQ&/R[SHD33%J!3=Q25%;_0==*02#]9(R3'C%XA
M+DBC%[$K2V<$P[E59O):/75]@0"1/6BN4#6.'('2JP+JBECJ:).PL,9 O+M<
MX1H2T0X*!&7UE-J=:NYB8PM>DG%,['716Y3$-U \]>L:/[V&1'-@WX%BX<V;
M,24\@_)UJHC?9W42H94TH,OU]DC$XD1MF3I'%59CLTL1X1!L  PO2B9HL_)$
M>F&G<"?^D&$D!FEQ6Q,H]'&Y"4XK(L(<H^)>%\+&(!>;+J\1=='*$#:B3G6;
MXV]TM3J47$ T_@74&6_T>C&<?4/$6U-*+/EM3BE-S7!#G=N489'IWK]H<[$8
MWFT :DZG16_")CVR!@MPQI5V?2&;2ROKPFP'2N3Z>R8Y._XL"U=&4-(KQEPB
M^KQ<9-$&D]^3M<G8?FXYKTT?.53SZI,BG?Q,1H[<JC@Z'ZV3%>*L)[_ @@(^
M]=P.L]#=OKQM6 ,&QHZ3;?"!]]0ITAV)<1&_ P_YF5-X)I)ATX%,MK_A\G&Z
M&8P2;\G&X#2M? _A.$?T[4UM/%7V[/P-R&36A;7R>Y]($#JEP9D#V>I:.?JO
MJM>:<EQQKZ)05=_WLZ.\*/<"+<+E7QDUSE7-P0XV@'YT V82&;CX#ZUT*5-B
M%>CQ'V/.\U-5F,=ER6.L69@DA:8"P_'=3;2,^+Y\-*U>,3&1%>P5.=="H4VM
ME4JXP OT<$;3'+S>'&S=LII90*N+3#_.E^[6VU"BX-P.(1 Z7;A91BD.G.YS
MT,+'4V-(5*(TZ< EZ+'!C7LXY#^8]DBOX^QLCKMJ<V%O39(@4E??-TNX3'Z;
M/W.1+M_\_G?=2V2S= ?C6JO>G877"+S8&>O&P7/1;&?DSVPWX%(007AYJ/_H
MM1OO=MXW=N!OYCN/:?S9OUA? X<1O_,[#?O!ZL_M[']OXO.S[L&JC]J/*95'
M/\Z('%O:IUQ7]2FES%G.XW"M2YV>60:(Y#=9%XAVURL5/,^IL]F^[^$&)4V)
MV)45#8RFQA<1OH0MHVD0H./75LM4LJ_2LQ$V3<6>O\,^HL6[S<-Z5*)OFO=N
M_1XU-D2V4B"9QXK""!5)&=T[^)'O4!+.H[MG2!Z. #<M/-!T;_PN7\H@4G*;
M%=+T(IVS5!)WW9 2.L+?CX4(&9Y/:.<;9A^"";;?611YDW-X]3XO-!Z<3UJE
MDB3N-=XDN0[MC_P%&#$BI>2E0+[U"!6G;<H;)-LH#L35LPU)P?,Q3C!92HOU
M"3YD$,$,!Y;6/I(3N1TH!/]\ES$-H"FZDXA7\/,357\MJL7P Y-3,S7=+ !7
M(@-%3-69S"GL9!1NWYI.;H5-.<5)C]L+GDF!_-R;SR*S26/Z*&^-EKO?XTVS
M>L2KNZ2OH#@@[CTF"=E\\VJO!M\L0+QZGI^SN&,3O0V\/R"D9&++Q$(5.0WP
M'GTH?NMY1-KVJG/YH:&7HV!I:223O,ASG"UL"%-,Z2+'FJ&9DZ_LNQGRDZ5.
M8?D>VA&6:%XU84_?<><NU0BL#^FZEKJK_3HP9=JI(R#H559MS@=V*CR>5YXM
M4Z]N9;6EEP5BPS_Z.J*C;RN4JGD9'FK%+A(;?Y>,&%]1HQ1%BJ3RK3J=M-H-
M7DJ4MCYT(/QTE7!\^XS=5GPD[C4,#F(308/M#<BO'T:QE///E9=5+I#",BD@
MA653D_="F]ND6$"G=;P)8=_;N^IL6OQAIIEDOQ!^3:G/M!E4</&_@!UC@?%]
M$Y48<NN^Q**/WV\>0JI5]S_]^J3FBQCR?RGS\6[4_;PES:=)))]/RN._%A$W
MRP%.Q(H3G* L#3'O2^9H4/ZU,4:)&N+]0#L6,UL8C\2TG#QUF'._V^9&!XB.
MAR"1CPR;#Q4DD]F 29$P94BTXZCV/,2>2DE(*QEW,K'(Y-!B#J'B)<G290>>
MYY*FQ1B,M29X=_A2^1DM*&>1\/&G2!UB,4]PHI,0Y_X[CSE%12MD5S)6$?O-
M//;HQ)YN%SG?YEN3M^3'>3-SBK/D\/@5+"6.KQVH\'*4;EZE[D&N@;/Q5O#(
MK\U%)!.^7QJ,BB\_#CT >"$9.^K)6I6)9*$\0OL5#;\K$=A(,<8(8#J&[_E[
M##&(TG-L@J1B%"6E*;\96?5#46U;..M:T1W+C)Y:96'1L5LS"%WIS01$H"]M
ME DB# =\XF^7*>Z1!T2II.N*MH1\OZWH5K%[^\XJ"0GDO\_"%M%*L_[)I]%)
M2:39"'3JVS)?:NQIZN[;9G"?1*O9P5*B-,0[6NGW!N\#V1ZE8?I[5-DT$ CX
M[%WY\'[4+SJ629"()YWRLJ(T[I!J.UAXB;-OPW@BGQE[G(XW8.R3#K4B8JXA
M1U?VD*2\T73C6[J1;7>\*_]W=68LV60E7FN7J0 _3Q!&RM:3;M'"?L8$C?Q1
MOFX(KZ]"1JB!=8>WT#V&Z&[2_I9'E6^,@4M<#L'$I\M[4>SRX++N;+LY\E7?
M%**&O)2)X^F0H;I"XY4.;S;-@SL^#N]133OHT!4\ZK@E-5,PIG?*-R*<-R^P
M=M?Y\18A,.K.&3G7- $6&R>%"'W+ 49F *G@T)R%P. )[;,VB'+X%=$<G]-X
ME]?TF#S9%:SEPUI0D[/K_#1!Y#IKFN):D,5A'*W,9E>,D&HYU=158)+CL\X#
M081/X(TRI?7;][:X(B]=PVJ;N[F?W+P/?ZDL<W/PV!I[P$OOX%UZII0J=>D'
MNW,+1BK%.*-(L-9#/YE>46C0;;7^'/T"IVW45=8UB'AH[!!03I<4=DO"19KV
M_'JR+(LKP1;MA7?-F$,MSW\PD3>.2*&VR\>M1XI9HC4DS=:Q.0K'.<QIE'C*
M4[!&A[;8<8P;M[!V9&NLX,U& WE'PR$V:T'WYUMUA<OC'(=F3SGFIR6Z"ORQ
M,*PC,%3J=.M8CSEJ64T?ZE&*P._\.:$1&$DM#\[Q8]DL=W H+SFN-ZE@92TG
MT%TW2.H9_G@SOUG2W-'0/6]:)9F^:@B/*1N0S.]=A?;LN5'?')NII!5-V;<N
M0'WEH0?D')Q?J^K);<EU,>)7ME^']1P)%?%2PKZY<NYN>$X9C!#$1)>*4=8)
M\;\.JQQT=7:F4UQ4GRK_:1-JJ?Q.M1"*?UOS5?6'8C4PUF04R!.SP&'AB2%+
M+B9U^H<DM;0Z??M6WT: AJ:II57Y:^3K:<JHU%8)]K\ '+;;::&-=;TS.4Y-
M+>G8_<\A+.(=7H_:X4QQDNRI5%Q/M&#J:)9JBRW_,.\FXR#^**M61QOK89;T
M'L11H&\5XQM!&_M*/G>?(%,QEG35.24W@V\]OP\P_Q"N6[4I-8GDVC0B\]ME
M>X<+B%L)PQDA_:5S55+698]A+WU719]WBFV/6\I$;>RS3FY_B[.S3GB\RV@,
MG2H5&:'ZM=O>-89C:G KSY6P4Q3V.:/8+3?#/[1VP^4F0?.N^JQX.J.I>0C3
MQL:%(X<V%0)?J\I!Y81(3DO -=C(/[N-Y$=@  04U+['[N4JJ6ZD!"4Q$'[E
M89(L9&<%44J=!]&LE"=9!DC%RHY2KC#C_>E)>=3A>?M^F#NW9< @(\X>O.<I
MA$$[5P#=%"*DC]HVP *PC12"ASF3_8^?M-9Q/-6BR*D4">CHBQ@CATT."GP(
M1#,D^3*U/L@+,=: %UJ<JOD?!<LB"ZY;+2:$7'( E"5@V&9YAPF0E:7M>I^7
M@.G0.26WT $!(Q'X,<?9794\=G\UW&F!;K\30.L-SUGR]AI_%5EOV&XZB3\!
M]1\>?U"80*+SBH,#L0,W<([2JJ:LN'3W$WG2R*=1XA[*N-QLT[ALFNFF5J_W
M-3Q\_P*P@. I_\-N-JID_C@7<6"[0%+7K,$=,[V-O[B%#K<$JRA>ZT;<;KE3
MXH;)RE<RLJX4=F#8UX#Q::D11"*E&%AW2S-\ZOW N!<=F&%L%7LP83+BA2Z0
MHI(:,1@1(7;4P:Q@<&XKHJN1+'DKH@80'^;/:$Y[@OX%+.\Y?7<&<KXJ,C_V
M0S*49I5'!0CGP"O!CQ ,H^2U(U$[U Y'.LRZBN^$G;)^TSL)QX;2"-4B-?MP
MU3*E+,YB   AA%JK#7V;\<;#PDC$XRI=H@.&@U<*.2ROLC5/ZNA2WFLKL#?^
M&E 4"\:SP07*XP;>7.> _ZU;WGC+66H<,%@CNF2%8$/E*!33P?]>8[!N3#ER
M;F-O #D:SH$]V(22A;X70D&%1A<[*@?9!KODSZ8.,XMK^;91AP&MZ_X"*,:A
M/ ^&:J](XXM'NJ/DDQ@;8Q629K^UN9_O04-]:#],M5TAKS4F O\"?J9%7Y (
M?3$(Q:!Z.(6ME2Z4.'(4PO;7V3Y=64:IC H(>\U<HRNH/-18&SI:-29?,2;A
M7D6S#I":V.^SG^;LV9.#$&;! 4(?F1=VB]N6'#,(G32Z"FO?[VK(Y/U<25G_
M"] V \,3<%7?Q5EV"EPU&*\J83HR;C3ROEU7^D.;BHOO&:@[N&#WH[Z.0&3\
M?6^;\3>8-8@.079(E[/G#2^OCG$]#._7RG5#FWS)ZW*&58]59<+9ITB\9CQ5
M3=DJ.G7)WXP=*^>2":Q%%$HNCY/NYG6%DZY3G:, 'C!J]V/;1#8W50/*#4B:
MO@V1\B<SG.@$+[-#A%"13-S#[18XN9H<FI1'+^Z4V:.)U!)=;'!AH2X?8U?6
M?/$DMW.6[HM]7ITYV2Q 15YE=R;C'1N##]G#(J 2M$8[6M[04N7(U55'H\8'
M6OO4_D,T7 K%$05UJ^CPSJC3+%B#P;Q>IU^#XLUGO#*='T.?(%C3:FG[L\Z"
M@6I-5,)F3U5O/GX<;B0/B0M+5 * (=SSS!V5U('.I[7U!!;&K:-1H)CU&LR-
MQKRN81%ULX#:\CZK5/C(9FFFT5>CZJ\704QG#.H-HU0GNIEPU=FQPA^'+"WY
MMY-"H[^RPW ;3$H$*QC2;5$M(GJ!/N*%)6SO*0Y_J\(C,Z7K&ZGK%<:/A/8\
M,5QTOY4@GW$,:D*P['#SOQP)6\?9@Y[O:M6*A19 *0ZQI"UMS?[5^V]0DSJE
M!4:A;[S>(B"%9+5FCS*.]_@XHZZ'2A)I'N,'BH"1GB,,LEJ*!29=*<[1GU^^
M-CH2,3]8GGZ>TA?=N[WG/Y- 3\;L9.<Q%JTE:$]YQ>65@PR&@@VTB]E<.X[D
M?'/P* >7YC8>O^I*CIS-"=-KADV;#HO"XY"FB=-]P:O2N(JSH7H2;!+M:D'V
M85D_:PDEOKAOOI^K\AR1H=/"S3S.N:.)*AMD<\.4$J1L;D5!:WBQ#<)]J#J#
M.;P[SV]I+F"O;;)!9\2BE3P$D?>,#KM+92FF&PLU,XSS#XG.V/;VVR^7G/M3
MBSG.O[E.WSGP\_CU>O0I=.\:HT9(]":V!@%V1ID$9E[G_.!&EJ;Z"R"JG>B'
M!ND=.UH2.:Y).RY5%#C:)-A--%Q8+S3P/@!3H/W?RSCWDMPRSM+S=VP),S9^
M+9)O1S*F#<D+#6.@5QP'?LKW.0Q(P6(@"BDL&/W5B)''/;+_+><2GQRY75F,
MD^,@2R>@V,7%8%.E#"41/>AFX;>PSH)O>]=P,]R[2PQQ;D>$2*8K'$O*>/B<
M[.=&A[1,-NS69%O@F-F;^@T%N56(95&]9;G&\1H4CL]/0)@[QW:M7B.>-_?C
M0E2RQ9F/]%Q9:",ECFYX'/("%[TQE"?*GHDW#/P+T&]N3L0<:QJ:0!9FO9U>
M;K*4LPZN+AI99E"$T9_SAK=1(T<L'T.:N+[NW/@$,.UO^W?VA5JI]HY,X8F
MPZ;AQBDUCW'8M;9\2?7Y"8YL/9=>X6UP1KJE:W!!-;7!/?W<[>-MJTD2T'-L
M<*"4A286C%C07:P/_Y<GUU40,8FZ2FYXBJ$'%(QTR/<=:YBPG!LI]N*P? P-
M# 8]SY]3L%N2>Z(Z<+>-]'$)YYDM3NP=UFH90EUJ.&I<BK]ZGQ*EYGD7D6*
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M]>6DV(9RTP2\HOE-<]A7+" ZYKYI.-.00+CX%>=TK?C"J3H7,.I:Q"]V5_>
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MT*"! ;VAM29[-+8?O<U:CSTCX_?>/[I\18W67+/=/+3A"M:(Z;NJ:N6!9J/
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M>3UINDVD4(9U)>0'#,S9.?3V^E2&%+EBT;K<9#+*K-\SXR N>P!R.E9\_/Z
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MX)S,_.0>R]^>ASS6;>6H7[-!)<B"]GS]F1X1LC8<G(!Z?3K5R'2?(B2R7S.
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M1SGH,8KN(/!]BT$,EQ#.P?Y%6)=OE_-WR,XXZFI4\ Z3<NTT<3PS,IB^0@A
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M!52=P(S@"N._X3>[-Q'.MI:1O']T1HRKTQT#8J1?B#?+.9EL[%)BI3S%B(8
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MJ5VR'<?0_G11BBO0.P__V5!+ P04    " #3.W!6#A%TL2IH  ";:P  &
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MRX6,)ZF&\M4)GXX[ )5 *OY730\:/8_Z!:&I\PPZ$0/O-B/T'VC_@>S_';#
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M^)8M\%?)YO[2L\FE11Y--Z!IL"KBH>S:J(['RF%!FU?&EQ!2%'IP2G7^!7\
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MF[I-'18_\O3%5[(+BM1>;6/G88'^.SA#26%Q74O,%$Y3G%]6$-&?:M! 5NM
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MA W7Q6$G[&Q;G#51N>:'5.,L:M]YSP@*2IP.2DFY*IG_E#\IU+AE^U01#.9
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M?8?%JF7W0+H&)QIL"^B!#(6*H0$?J<-.;EC;/[]+0</@HK,[<V\T[XFK?/B
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MKM)]E:<4*?XQ,R6A%L]G0';$S)*R3F_E 9QU,'-LN21-?PVN<"ZB?\SL]_%
MFM^&1U]4C:IDQ'1;UG%_POMMTX9AK!\V3*3H*9'V:I5ZKOO^2M\/M:[-,'_X
MYS- C5GX:(()?R ;_9^0:\E3:#^91':--;8Z:SZVTD/98<GR.^OE#=4M#=^Y
M>] MEPU9TF*C]!I44'3&C_B2)P#E%;;8F9RAL,^W.]W-M1 1XO3;C=2(TZH$
M?ES)Z,IE3_"&=G>O]!Y#5 SVUM+'5CG%:*^NH)35)<@J><NDV3RO-=&=MYO]
M;0##'>KX(Y>0\'<##U;SG8H7LOS8LJIV0<<,4(/H;VN6IUV0%??]I(P+X9 (
MR#\A_8*[?.$'@SRLA462P1*\3\+HXB'48541NPK"RB,"SD6LVL4YV0%ZH8/8
M?GAW<UUP&3;_%\MH^-\/^" WM&<&.8?459P<]J$"9FXBI/5Q"QAROS]^V<G]
MQ6N$1GHAH^?EK&<_J#V:S7HND6#-8 5L*CW"H),/M@C;-GLG?10C[*S?U3=O
M%-BK@6ZW:"JU$^.2UBN6B?T3?[R&>\#'K)[8@/5<*9WFQJ(-]W?MG885#< .
M#3=[(\;]'3'%;DRN%Y0@.9ZGJE3X:9K(RT458O<W&IAJH TLM4/M6P@&V"IK
M/0/L9I\!^_@VSX  R#,@>N+FQ!X1P--U1^%_M_)_:\"4T6Q-HEIC?<?45A,Q
MXPXP8F^T1PG[S:+P#^2Q16%6^UA9B-KT[HP1/]&JU"EH8EV4;G/ATR.R&0,
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M)ZU,-ZQF_&-'77];Q]N@%R6R14>H+7!+%T2O5'\-1LF:2$:X)E:%Z(PD^X[
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M&^?U2YCA2K4-&>HC?D[>MQC9.!8SY6'Q6"Z2$PND-OP$K[A6B#[3QG*%,6W
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MI91;NBH4&U5R9 364N(6B$)^%MR$6[%DFYT?:!#Y6ST*S8U0_/5)VV$^5,5
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M,6SGP#:J3-!M33[3J)#].U'*3I*6']-/J9H +J-ZOU-L9%=*J(M2:=DPN*8
M'C0SKI@?P91I&6=]2XW^#&AR ;? ")/<V1.,I1LUV!.F"._3V)$Y=CQIZ'=N
M"C:IX4R[X FZ:6[OTLUH( *:*-]LI78:K_*U>9EBYZ=@?4".[)5-#>H/WKG9
MN50R[J YC>4^IJ4\LSUW-*KV)\^R,R'>HK4@8J)WLJ4 =3,29 \?TZ<=M$,F
MF3XL@BR2AH?5M>#X*57"L!K"MS,4"8LG]7]]#,W7X\^'9&JLY^9$R'(T\7H$
M<K$MK4@X7Q''39(:NJ&MDCL&5[LLPC]8U5NY^L5%EL$;P:P3]VWZEDMQWX5R
M/F<OB1B/87E_NG/<&#\VG]25"[]J^)$NR ,<($X)P%5V#E8J(*&@R-RCRQ+M
MR\'4&YN2R=,F)6U*^(C,DID(<?+*7E^'#5@X4QEOY;SUX9YN9+'5MSDHL7&2
M-=C\NA'1B:U61LW7(_IA?(7"I[%JDX6IEVA.Y$T=C*C"T[-T /N$!\$]_Z=\
M&/?#;U34=273UA!A22FK&A^N\[5PEM/\CJF/+ ZKIE J%85E>$_H>SAT:"]1
MM6<=ZQ43)<_$U?ZIR13X*6D%G^F;>M\OTC\>YFCGA?$J[B_&!MW#N:?5/Z9A
MY 3=GJXY52%%T"9LFU,G+4&LG1@(%N<[=!RGF"N=(5? 5ZQMY26:=5@:-7EW
M&OYJ YGH+?L_\W"X];7R2VJJD"A+$ #^&YHT,&^$C&@T^]PCT>6+;Q)VG1F"
M&SP#$I2W1!]?K?KOA^9BU6!&YN7.1PX&[UVHTJW(5O-$.<AP]\ UZW"VJ%&L
MV<JUK";F]1LR[+2#$@*;O'+?BCLN!692;''OIXO"?S'['_WRW__8OK1)E%JQ
M!I<['PVXVIXR2> )DW&K4Z!!)Q@J(D\!O#;>6=\&^*E(4(KG'38.'V73@<_M
MDC>A3C<8&1ERF(K,/(ZDYJ[OBK_6.)_HFSL]9'5T3,PUG,C)MW343G^.J>O7
M!D;GJQG'.0G@'GVA> ; V?PQM:+UKRV:)Y84DP8B,ZR0,M&^46DO7?(<O",@
M9=2RJ-&'FY]#P7F%7R_T.E)*3-*3.TM31F=_T2=_5+@PW:8M^IYK1"5=6M-.
MN0&2G3N^-2#MR!*Q_SUI^)G(8[G6=RG0+H)G)7/'Z[K,-1;SSKZ?J Q4>N=T
M<XI2ERJ_ %0QKBI\2\5SWVGD5J,7)RF&E@Z(6-JJ^75FTI"RI)ZP2YXDHZ$%
MHC.+X<4(!PHZ1/#FTM8B&6$SWE3!#/L$J.J]2PST%;%6:H:VM?^J;R_&?)#"
M"(VKK(N+D*-<$9A5.L<)5"Y@V&!*ZW?GT ^.(274D2'5OP7,F[.0488R)5,X
M*K2<4X=P8]GKS-A?L7Q''*D;F5].*M1M\A4\+?YZQ?-!O-UG <&:A&1G'XW
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M?SY8:#29S_A?;.I4RS47TOBJAQ1$9MLW!_)G^+>:3)L,F$1QDR:F$;5IXQE
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MNK#(#=';LG+R=^XJJ#_0T-1ZJ*UC_,3$U,S<PM+NA?U+!T<G9T\O;Q]?/_^
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M=RL27!I?:6..OJEBJHE"%7$OF/+?)_7>SJAW_&R<''O4#? 7-)\N%$9,M9.
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M?]Y:K-M2Z<2FVI[C['W'2KS:;YQH0#'?VR6S3(8!5L*EYW7]W@L#E%?.*::
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MK4WIDP"*9,+@6HVAAC=?B :[ 079J,S V&WYT\ACLSCB?SUY0%=9PWMJ9G=
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M#?MTJY:[WD7"Q=9HW_IVR9,>;H3@MKC?&H7LOFHGF,8OH4.!)J*%#;_:$Q
ME4'3.T%\&E_$>."^#[[=+D@[>^HB3-?4>N<RPO8L5TFL0JZ!'%T]DQ=2A-^N
M8EP.NSI/! 7I7&VS0#?2E;#-=Z[XGB_M;[D%51MM=2(!E!L@!I3RG/Y%)[.
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M0Y%]U=KUKEM?&Q0BKUJ_9Z@P5@[G?NW>+;R"Q%2ULN_'GN>-:R')192EBWT
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M&19V6&CF&SX6I%-23JB,2V2[6ML6C+ON6"P=BIWK1-+DE\4#F1'A\&+99#<
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M]!@9H*K?9LX"+8XDYW6[.,X D1"V\32+$?H0G Z-<9K:>#7^>$0X?)RW3Y;
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M3GHUQ!Q@X#_@.?;WQU8LX00OW&(+4*Q:%*0S:FHTZ9&?:-$ADB/8&J/ZXGM
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M)(1> $24\P+)/P[@_SI(2(DR4E!>O$1%3;RA_C) 2D)&1DI.]H?4Q*M!Q.L
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MIH$'C"@5.MA%KO$S'4U4+<<^!GM%K2E=JGH-6_DPOYR^J@M#_4I8*V^U4AC
M^$[L[SQV'F2Y)AB>:J#:2EZ\=[-VDH[>[3'< 3FOTV,.^]F^%F2_(I]PA9H
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M10UYT6,+=>$8H&%0Y\@:B@X!@E28^7HX=KM%YK79N&_/O-& 5Z:>4^V>^Q"
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M;41>[1OCVPOO.5T>BI$\__SA2^*7PE^C--1N TXZS)1E#WLU;Q8)>F95PM[
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M/,4M01;]<.K#P1GG<UC/\6W1GW3'U;\6MI(78TL( $T].@ ?$Q5.G+3T* D
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MFSZGQWTC]G>GBZ/?'9S4?=3I]KE,(C&J0J]<?QCQ;QGP$#L3U6UB!+ J&1*
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MO%='J53*@- 6?TH1)V4>*?]H.Q!$IA[8M9(T#^IKU%P]_%&B'%;>M3;\=I<
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MU#GCZ$78RB$!P"X%43ZNSW+JZ9FW[2\H7>JSL7%M_=Z4%9I/;Z!W'T#G8!_
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M?9L2,Y;_U;YWAC6U=>LN0 &W($H5$()(1V"#( B!((BT3;$@B$)4E"ID4X2
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MEDY]]$'(9,AR7G4ZK0QY0K;)E# K8G7"5WV^\NT!59? 6&\K<(R6Z[5*2@]
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M^5P^YMIXY=]"ZO\__M\,V-[8_P)02P,$%     @ TSMP5MWN6Q9^4P  NF$
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M!6"D)B,[)4!.Q@.<8B0C9R0CM@/<)#Y/D_U^@+\\9*=(/%)24=/0TI$(JAB
M4V3DY*<HR']Q37KK3WH/4#">9KHL?HORG+XU%<]S9HE7L1G4O+<_M[#<'\3P
M23YZ$4A#R\K&SL')?T5 4.BJE+2,[ TY>94[JFKJ&IIW#1X8&AF;F)K9/+9]
M8F?OX.CF[N'I!?7V"7H='!(:%AX1%_\N(3'I_8?DS*SLG-R\_(+"\HK*JNJ:
MVKKZUK;VCLZNK]T]0\,CH\BQ'^,3<ZCYA<6EY975->SVSN[>_@'N\.B77&0
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M-CPBLREQ2.Z^@GF!*$<.X/KXQB.YU32S)+[D-S[E%U#9F=/%<_^%^?03Y/$
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M]P;DE&\HN,A#OIK+=T E3D2D'\H=FP)9QUUFBH2R P ATPGN*)G#P&.R7OU
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MZ4M>VKW2MZ<NMH7H8W=(>N5654K"P4&9C&@HK>3.<NN HZ$_!S0U!5N@WPC
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MD!QU"2Z2N[3:(M6JD?<3)N+VB(&2FZH$-F/(R7<5JTP [*+[E1IR\S</70D
M&N[SYYCN)5;!R.C*8 !8HF\@G?+<9*XFG'%[^)=EO/K]3XZY8.8.\8O,X^;E
M1)?KZ/4NYY?/O@LE] Z59"X%?DW@)P =Y5L@WF#Z6LQT?4 IM,L(94 %0E1F
M7Q2G!@N$[PD-DXD+N-UQY$IUN7:\:=L?C5-_AG1C'=2;D$B9[ANFVLV+48]D
MN%<Z$@Q0(LW4%[1<-J'X6>CN8L#54Z%+]8T$ $P ON?R;2[6GH:-]-%QZ:1V
MI:=LS*A?R7K45I?",VJ[>/-[F:=2CN"GRX+='9;N@IPC6"N,@"86C,I]8]T8
M?^RQDV6!#3T)WSJVK4&M^N5=8\HN7QSO0.;7>9U6M1$ 7NB WB(_<\B<NE1W
M!@%(QAGEXE6P(UH8 M %N[S-RS8I,(E8[PTTV?2_1:KPL%&_U?VNBI;02 -X
M@WK==Y%T<T$ HQ56!:J;T,^KJYE%I//>^[E=.RP>GV%V\XOW:YZF$8'\4FOA
MU@8"0 Z_MU"I+AXJ@8=_,-9D!OZ+0H(,99S!BP9K3@;;>A9#HKL16EG%D*A3
MG8;&7)V4 )4F/F='3^EPHZ\L8] N10P4'PVB)=+=<!!>Y\MB;0D.@KM' *H7
M+0G V#$"6]Y7 WF^Q6Z/WFNL#(AI&RB:NUGZ:9E6_XHS62H!>..-(@ 75SHX
M"$ G.1R7K(T3R&4C !N^Z!$\E1 !6(E=<5=W5<9VB&DCGRW9/K&I>_IA]G:@
MKNW<&ZNYQL:%TQ'7XR1J[ *(:5'?323J>(A=,/1IUN,&RV7WNP@J^Q'%_L^R
M)#^(JOV?QUF 9QB)(P!'2E@GHIH8"<"!IB><)U3,=8$5VX[<I[N_K*C"4SB_
MD:$4,>)1(%D@."$XEE]%76U</U<LSH1<W[V.:E65>=R.:<@0ZJR=J%B-I0F"
M[-AY2\SWB+Y"^9N%V=U!>?&\?IA;I.=2)+7M![_WR=H-:EU( $PGH$AN+)P
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MMQ%;)X,G"</-$IRDP^6=?]YRFYNY!HEYE3GNP!R:(P,[NMY_F6T5GW6_H/7
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MGD0&E+UM:]=C[A2ZI\P^!Q9_^>K*E2#.5!0?[I-4%]_9Z30!.'K LLI[!>,
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MM'4.?KF3:NU4YT.S^F:W6G19.S]C2#-)Z[<D_+T O:8!6/:?>)EIV@ &+ [
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MGT4KS35"SC1,>!5K:_@O.V@#]1;\:M*1Z.P-X[*!_NFP1('T(C@TWC-]!/?
M"EQF465C8S(=IBO(XEIE,:\M4A5L+4?P7!29C]C7Q=!=ZKUAX7./^&>D>&9R
MFYX$R!AYW<^R"TOPB4S@0E"$N-H'*YU/?DMUY1'$L?2U:8DSEP]<-?A:) ;Q
M*B7K6+T+J00QX^%'J"=C(5R!Y<@*5Q[^CZ+;BH_K2@A!'CRO?JJ>G6FI(*/%
MY#G7Z^?IUD^M,2%*.)8BB\R8:N/ASX->LG::<[#9<<709S&"^I3"8#>/WTEN
MG.J^P7= NM7PBHJVG,'UEA?-7T]50S.Q90-CX*HL>&MC@)*XR>C=AEEE,/?#
M*846[<R7[_J;35CV05TD0/3N0@T0SX-6DM3UT7<W$6A /#5!__"TG?G9\>+9
MZNW!:"XS1DB-O;M(=QCYT],G>Y Z33VXW\'OML10O@^X6TI RO/R%8(=S@AI
M(Y*&A%M?(*ZT*NA+"\6L9^/N+#_-H!\D[RTD+__XL=+86RZ]/E6^G-50X^ZW
M/D($AW*,?2QGSS*I;A86L3B:''3)'25,'CTYLKA=T+:_02>*.R9DBK^![K@A
M3F^*C%?\3>3X3_)RD0&0:]3D$EZMG(;F4"IS"'9F/A(0"ML*>W5>V#>][[EW
M;.^IG(TJ0Z40G/%09S\H,,$(;5*!11G5-;*NG"JILNFG2CO9K4[K?LB[,KW2
M\9S.)EUR7UAH&'2)("(>A7 =X!83PE5M3<*R*OK.ZP*"I5-=4Q\*?,OS33#X
M(?O!2UM)FRL:O"-\DK< VJ9!([A#'O&PR1R%@;!3FC<S>Z=H$KMSWNN5/RX,
MK%CN-PN_?SE!K@]@.L92B'_1BJC97*W-FK-!H [W+AQD4?Y?B<4^D+,^'H=_
M0P+8MU]LY\+-R<V_F]8 -7SX9$P5DRY^$+O[N 61-+7#45V2-JA@R*KCRB#9
M^SJ#U[0:]1/$?K<!E"P?]@:Z>$$8-B:Q/1[,;M.B(;UO4]Y=H3"8UO%_L) J
MET\7B ,E'R"H^VAJ)=WDOW3NP,9>FO[,-=R@="0!7!:")YEMZ"9; V2G6NUD
M?Q_\7 '2_NX/:0V:>7S/ ;25<!%RW9J&(^>I#EH\KYIOA+$A)@CW*^RJQ&T>
MI@;N=6YS<?"]V#Q^CW&]8?K*#\B#]W7:U*G%Z7X[#)6W_39CCQIXMP4Z_I5/
M.SG4/Z_7$#<UR;Z]C;8N8W[,8AP$$ ["2"7'AW&/5W>GS^R[R.?I?]TTD"XJ
M(@&^V5XC ;"7P%^9-$9.7H^7'+_&[.?3BF. A+>,4-1R"?&]H#\ROT8$OXQI
M(]?]M>4;>*A%45(Z;RG84,ZXL^STT >FH*&0?>U0^GG_/=53 _+2O[93+(Z.
MD.Y)!45]V=U+:@DZR7M:BR]#SR>:>+N9CD#D1Z5:XO6S!NVS^^A[S,ASM>X,
MD"7X;MHXR==]81>DO+74>&C9EOD3MW]7[?,U;X-7K][[6Q?E5OT1%ZE; S)
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MKRK(U.)D?\&D&0WB@$A)9\;YZMXL;H7GZFBY3Z(W;@7.)JFF 6XL>?^*.PC
M.Y:ZA6S,R>%8YLO-=;GCH$O,)A?;IO12J,]B8Q),<B/+?2:79?S##GB:DJ$P
MSYP?Q$_D5S[L@_62+00OC1&>!92X8>O<DTU^%='V$ELL+YG3P3. CS?<E:GP
MDG.J=Z= 1T7(RJRJ+EA1WIG;3Y&"&(U?(=*N BEFZU/6]>#F6;XD9@.%M'!
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MMCQXQ#/LX7MX=^+/]9(-UJ]=R7R/[!)ROD2RT&0[T,HDK/*U?Z^AP7G&'Y(
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MVL7_ZF]A(2\'TCWNZ:J1GSX];_UYJ>KD8T#(S*"TO_CR'_6-E1S];Q6IYQB
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MCN'&\,!I(<5C@&TLZWP4\9/S ^VTB[OO,9+0#@<"Q>G(2TVB2M/\E?%U ^*
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M=*,$$^'D;_@V)SSKD8+#N&91U*1G,M4&T9TP^@1Z85P[%V9]+;GYH+7@#:)
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MSZHYJ2*?]UE"/<VNMJ'YTRWSMJF4^O@#,=5H!Q7?/!I&/(<X[;D(F!Z*SLK
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MV;%W>IEPR3S_K.:4U[28Z6E@C"-S%\X9.XX<?\--TH;1CG&=HO0?C%U8=&<
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M^^0:;B1N;$@H!SCD:$92?&@=$GAI0@#\G+!G:</8NI[EF]@F).0*0(OXE?!
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M,)7A>Z>BD?R]+H/*B-E05%4K -@YHAQB3$OC[_< G3;7YQ;5<JWU]R9')(Q
M([<)1.W7S3JN^]??L@_J/DH>JLV,>9KP4W[&/Z,K$)?+@*-\B8(R.G&K&#)T
MW9W /9/3-RIS---Y:R,H0)6BOJ4<GS\@H@0KP+/B9.NQ=H7+E@.EUA"+G'S/
MN99T6*EL=MS03P"H,2P/4)[_#   F#RURCEJNGPZO0?R]IN?;WV$D$]9/(*
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MH&G/GU>,@"/)6XA*:II\S86"WL3K"-ER4@R_MKX^!"N#, >SYXO$6?91%EO
MHG.F=Z3*)%\\FG"E7D_?DR4JN*<8TG"QT("':)_"9"U@JFIK^V?;V$#/7%JH
M RPJ]T9#=H)9]S)[N#X\DRK4[[/DLC%C2O)UKG>BANA^)O>[,*V"6+\_!+PW
M)AG#W\;13X;>=IJ5\E+MCT-)2;_T*O*/,^"3D3O3]K;Y8?CPX7#-E@2\(6:E
M(5+)'A)#3US_'2"MOAY]DS@08SQY?]*<9.[O%]6(OU39"1<7+UL\\)-Z5]>-
M*9YA.^03I./RI!C<DE4VZ_9;9IG#";CEX\>X%1NFO:$WL!G&#AD#R2FTT0*'
MI%^6FASLCBIO]663VI:\4#NM-&3%2FA@\+'GVM%'V2"'1WZZU UK+Z<#:^Q>
MYKRCH]&BG]*SSCA3O@* >)X$]B/\8,=7 $!)&>X6.K(!9KX=F!1Q%'1I/TCD
M4FKU<T"HE]=[D8\L4JUA>@H  +B321'7$!C[?WC!\[>A&@S#\1P_U 0WU50N
MY&:M1:910=!&\T<3E^4LI %F1/YI&DI$+=QI"Y-:G!+DEO\6!VZ8TY4MG N:
MT=&IPK!@B^7T-OCG\D/29*'O!BW >RS#(]SJP[<$,#!6K%35MIK49<'>"K;G
M1%6 4,F/YAK1)S&.E8V*"M5,5HC%.UX"2D1ZQPG^JKJP2O&VK)#*N9IE71?*
MI<[*9"NY%T,<C8IDKGDWJ=[,$4=?5./A(570R;. ^0+K@Z;C]MU+G[.2*.1^
M9 <#.KTJH-PQE'U*+D'O:&-CKW_XKEWV)]Q.^?7?LRUZ_^=B(!I#U-]S>6AP
M('350!1.W^ZD58S"?RTAWFM13\G\U7O/Q)+WW2VJLEW>[0I30T)9WDTQ?.:N
M@K(Z2'5V>Y6ZFYZ&3TT="U_\_9@#('9K5F+;O&I/P/Q%)I7GPQZ^#_%TA/'-
M1?EU?39;@6P&&HSNE:%HYTN=[U\8H2_KA8.J)#9^U;12M35ROZ09>MN3/_P;
MZ#IY?TI/GR 0 ($E+,\@E!+K36F[+S-&B/)E-67#&V5EQ9>8G@C^<PW OZT#
MB%L%=U*H"3I;F,6I*(=V,&-3\QG.S:(+W^D>Y+:[N><>S++>9%:)7Z.#S$J9
MVC6\L_JJVJDNZ#A3GCX@2/SX6I#M3/V3>E/U8[^_3Q/?2@89?ED:L+EGL=SV
MN,90,O35 !\YA'GP%U%7_T/(BDZ]E/4&#]8AE]D_<'D1I1B[7S3C ^9V]I3H
M*U\<X!\\]8W_:9\+$._,"U!WV(,!\QJ&@G6P)LC<. Z3JJ@8[_4V2^6/^U+2
M]-^]%L;>,:>(L5(E##P)N&FL*P;:G9LZQ;?NG,OM[\V[3<^=7W0<G8VZG=AA
M'5!@ID5LJ@FZN&JOB2Y>=5J7GS*56T$.4T&:&7F-*K;7K"2,"7 -\(>,7U3K
MQIVPVT.C]\HOK^L01N?!'15=9)5$_SWFO;BJGQKE3F:U;*Y2TD]4//FV*.2_
M!W-C003:$-[]U=^3ELXY\"25>J0C*ZLB1K"V\>[\ZZ\V7@6>3,V"Q-?<R?R>
M/:EO;R$H_;GQ5O*JZG_;YWB0-+ (Y0PFP\:A:!,L'B9? 2AY]#)T65Q*?JU9
M^8<\8=S0J/%R'?C]@4RF2XGW10A(1_V%!CMYJ;R4ZNP58$I,OF[QW"$FF K[
M%,EEL_+YD\6'!<5>2QFZ7_JP981\O9<Y:,D*^'&?Z37%,](5FD(WE8WVJ(>3
MWH3 W4P_]\VP<?NR>;+]E=-2)_UN(5C+!$!T5&[-B+:/6 '=/MJG=3)MD0\?
M%QIJK(O7YOFXV[SHN&+["6-I4NB,WXL[QS7>T5T$@8_/"'EL_.2?Y_F]LWUQ
M!.-&G^[@U;AP-M\P?F^.1>NYR*V6\8+H^:8E-[^[3]=_=;U5R?0*^WGVW$'@
MKOP.P3_!@]SE77]YM+7\A0E6H%]-%6MSF8MD-_5)W)-(,--B^"@X^_K]AK[<
M)R]Z]UN/E7BDU87;TV/3JXU]'89R 8G)%QK!3S,&%+AOUJ$)DI.OY)>_43!0
M\G8QKDYW/7/J0.@B^2&=I..2Y^A$[ DBZ@I0U]0#BVC9.1^/:)-Q*=J2K>!-
M$TK7BF!;3V'RE;B1^L/FAFJ%]2)2.U(R5/"7_\'T8Y90X9:Z"^JE'ZWU$!\V
M7EA6V*ZO%5VE!B_#'5"(A:_> O#0!=[>B(.]DFK9O (06>XM8@AY\;Z[^0K
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M^T5[+1I_+F+[K]9?V>C6A-# [PFJ?^O>YD%#N!T?K"#U-V+ZNW.;?LY.=""
ML0/7N_P:5X_2"6XV\69P6F ,F&)ZS8%:1]-&MAXNU[B*CZPCFS[=)EO7@A[J
M("8/% )4ZK'12,@=[,4OK3<G(1)>(T?WS/RBA#_W>JX!W@[<HK"[F_HC^#F5
M#LIM!FHT>:!#NV'(*1ZCC?-%F6M)NI@JR=JG>]E>>)*HY+X&2.Q_RG11BOL#
M7<8)?31S8Y(Y<"F(540^9',V$+JTM54V_6U/#)G'&WKHCWWB()6G_/(3Q7/1
M6]W^:#\Q-.FT\IT!4(M')&ZU7R1X\ GPUW#F/T;))N(J7%#."#*GN^!'=O73
M+&+O5H/=<]X+R)/%AS=N"MIQ.GQ9]!2<(,!EGKF4E9D[3.?VX^_48SE@(?M?
MFXWO#5=^XE*8>*W#?YW[M7MLQF9)7F1OJJ#"ZQ2@G;;$N&O_M#\BY[VN,J-*
MKH7=Z1-H'SFVEQ!J2TSY-ZZ50"*'G&_/ %\0_44E+L"5,:XCYF/]B7_.4$@-
M^L:UI]0L0SQ8)*8,6A1;&)_>@?918]9/IZ$G($F ?]:_= ^@^E[8B69KZ]GV
MC/;^+Q)D+0).E:!]E-A=0H@K8M\8]@BF0,A%K(;ACHAM]98GPB,4-LO#Q\RU
MB).#F-_MVO.-%]C/ (D!FF< F!%B_YR)Q!^S3CKQQCA;Q+7:BBM]<(:B.#'S
MSU.AD9#%.[-/JH_!<W>;7*4]$Y3,5+L2@H-XIINM8%M!5-ARQ6L)W:P0?]<6
M-\_"F,Y;*M?UG'U^,?2_XZZV"RTEYVA@1._K5<,1%7HZ&#7?J3/ 5/P9('WI
M9'U[L=S!]T3Y#- IQMRY-#!K?E[LZAS\,/UP/W7LWA,]P>-$=,:](25Z_9T?
M6K[9;+B 8H@ 3HSY36U:JBD5OWH24L;^1I_ I>ZL2"*?M=%IQJZ04+?EGM 6
MU\&Z-#'8J?+@UQG@]1E BKCWLG:/Q, 1//&F2\SX1"")EW^_];NQ6?1N60CN
M @EF=4@L_/#2[R[LUDV;2O]I)TO2DH%&<=$**[+@M-<M)O(R L#&M,JN'YO$
MV<\-DVTZ[;[&&SNNY%!N(-&OOZ;65QU')L7>VWM(@;U8ZZT@.FSR.6/@:6WX
MR9!5G69 9%?BER&_9^UK!34U]>-HZSKX:SEGAW<\K[IR=:]Y :@!Y6C%@,7Y
MN@5[P3BHZ^IJ2U9=77WK$=KUS82NLH/W'YW3-$^-H'U-N$5B\_090*70?Y)D
M*E8D4]E=@9[\LB2PIFSI_RG.9WAUX?YH!=[N#'"I-BW &[:]\HGPH90$"5;\
MJ98*BD<L%9O'G2L*Q0GR(MA3+2PTK)G+&34KM'A5_2/+BVF1_75CY/H@V^-F
M1+_L.>.^VLDT*($7?M0DEJ[.E[F/GR1!2LVT2- =\+.GH>WU3"9Y"TA<JV&,
MRI<0EL(^(PMKS_B+7^=63T#VEI00P&?L#R(<H]/F7QSN94J#,WSV[:1E/B>Z
M?+?8;,;LP<=9%=\B"X.ML=:-RBB>5N;"_7UQK87A:D3%0H[WZ^C;Y?U_ZTJJ
M<@9(3L.""-$G]L1W"Z!24.K/Q3T/HN 9H,KR"<DU9O8?"/X7OJ)!+ J#Z]CJ
MJ'!9<MP6/AB(B;0^=<VC5'4^]XHWY1EN_AFO_A)#;,8#[UI0WS242?$&SF<6
MM1/FB!+#/5$-6QI?X*)7+E:I1O:))WHR\#PO2+CZ7#WX_MRY:ZT4A(^2<8^F
MM<<.=)@>NEAQ-GF_6A"92&+3]<Y3NE6N)_5#_Z*CYN-RP%S)MU:XYH*/!6)Z
M?2W9"16T.3V.0>!IS#D2RF^7"+M5P.7NBV[OW&J$9Y$GZE!&J%^+#3=DIPU4
MUE&S^L/B+4])[]A'C54]?0O=>.R]R?CC#% [C'^[>PW:0$%\I_J ,Y/FI.#W
MY(3?PQ(_Z?QC2.+OO4L[K"!M'A3K=DI"^)-GC'^<GO]S1_LGI_L-X9AP?"/[
M_AG@\\N<L1:IYH'#]R2 NKR2<'JQCW";;!3]'PYPDJH8[Z]$))$.P8Q_6M;>
M\$PH4<TW KC01/IH#6436P/ %S0D."-Y*/_=,X#&VD>:9__+@./?UU]\WG0N
M*)LXLKCW"!]P!GAN"B,P.9!5_9DQE^]20[^V%)X!ILLM3P 5K/]\J7]U)<Z&
MU<TDY+[UNZ>PA2?TY\5@&;=@R[W'>)(2?Q[C1F 2:JVD^*MG*?G?/N[O<19]
M4&>:8VDH&^D),LX /R=@)C!>0CEP=1[O1OI?SF> ?+T6IS\[HF/GP[AD TQ$
M3PNP1P^L8X -+.=D_E*-03G6Q7D)>Q>]R]K))UCLWRUYBSE_YRNLU(EMX$NY
M2T&V_656 6MULH^#]A*M?&AGH@"L;V/-S'1&!'U<?.*\"O'$9"[SXV]PT2I>
MPCD_&:EDZ+9@KVJ8@-BC).$"[&A/IU-4P.N[X@H#9>>20T@$KD;H6[/,Z2,P
MJ%M6M;-%H\OBO;POMVIA65?N2#F]-F2)9?OXEFOZ.N,&?%1JUM>0Y" Z(;'6
M277UH]!._/S!&>!&7C16!]G9F2V$C0B6B*/IR##?^734./]QPOKS)+3&ELG)
M>)6 L[,E_U0ZD]KI59X);P&A!ND;T%Z@SGM.J8U!"2Z8?)W/6.802=)&L6XT
MJD:YK&-%I@J%3+08GE#!5[X.E4JXHX\U$E-9+K9$+/7IA"$8B,(X;FU9TA</
MJQ4RES8<+^?T@Q752],-KG72):9_9[CTO.&^L/M4J5!9!6*)_QC8OJT):01N
MH@MQL '/FG\G<<L(RF8[KGBH PVS$]W/DZ'(TN5Y6:Z:K50Q1YGN[IDYN@9!
MW^=<3P.%YDK_<0M['+"RW@.,XKHBKRQ:>;(8[I5U\X M@(JL0YHI''7:Y?3$
MVIXA"M3W\NNCDD<7Y^H\M;%'O8L,N&<K<R; PZR*UL2+Q38O%KB21I^D&=Z;
M[>,=Q*7MWGX#<TN[\O!'N(2B-$0!!\-R:V"+0V:U,0LD\DI[WUS:K.E#IV(<
MI6 XU26EM<9[J:J&Y$GBL: \B#K.[1-XN).5)DQD)Y]5/JF3NBE0/ >N8\?Z
M(^\)]9-OG^(][L02!NE:\O#3&P$GW@='/@]%D#LY W"$CDZ ^^*%H!N#*_/W
MB*=/)[:1.WL_=H7WP0MW%5)"GS]<NWU<O>3WIAZ_W[8$*I@>RJ$&VL]#.X!,
MVP?IN6,B^UE21X9-6AIC2H>##\6N^+WJ;P(81(H=O8>4!=^U5!X?ZZOLF$(K
M+O_./05E$D<4V7$AJ-WP>B2PT\54>P2OY'=+Y>@DMOKQK?KA74B]VJK03?:+
M2/<D_Q"+1&6^AI3WXS6-\J&'OABQV"!VAV<.LH<1RU3,:B%*)B15(QGHZRVQ
MEP3I_>*(>O0-+%>MSK/6D$-+'&[EG;0_ [RIJ*QU>=8+Q"12F5? F=\Z[CJS
MJE.UO'=GD_VD<GKT4B;QPTK&T8PWI9$H&LW;$"U7%MS#PM'F=W[%W6#3/?&#
MU]=*!E1Q#YIFF7<J\2*,:F*PI,9%:J-I0/F&.)=E\WWVB<E2EDJ_)E/\^!F
M.ZGN5CS3NV(3=64WJ +0<J(! UK&DQ UB/DG)W-C4_S)9L?YZL$KUR*;Y.3(
M*=X&5UVA>2Y47T!.>^FGH[/*SHY7!4D:%-R!B1&*H*L1X'S"5^!^GNS!%1+M
M0=J3?&LT<"Z4Y$BY/])H11#TH(T"^U^AD_S_VM&91"<,27""P-43!J $@>@6
MI^9_QXC_O-/[7Q;CG[BP1>:?J/*[<S\/_Q%]#!\G*I $BCLT1>O!!3^QKC,
M!T3C,U:^$12"%RK0L;$IACHL;&7S-J<N3 X943H\=NCJ"Q,>^FY _LK3 FXI
M3AP;A>AA<V*V\?R%8 ;C*45FR<]IH,:1 TU*TPKM1]"5<?$YE='NA-8' _:
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M%OJ[^*7],4N7H9?KD"KYY"E%/A+:6P#<$=LK_<2F@]N/('03#?[)41C_0AM
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MDY[.Y:&6I4#+S@4:V:P3)W&Q[Q(.>?&H5RYVY.>[0;$[,MQA"EMCP.7;B#/
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M](>?-AD+J+L\'@*;Y<6O:7)+*B7,%7>0R(4 2L<*=!;/:X&;AFI9BBNWN:^
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MOLFJ^=,7=+CU"NE5?9QPOEZP\I6B2X&M36AB<FP. )>+$=-JP Y_AUQ?=JR
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MG^/;W^BYRK3U4$PU]@LI?5R7H-+IF@ZB8LYHC; K!J?U)R*JT;O?,&[DVY;
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M!+WW>/-ME\>CVY=S<MROFWEF+>J(=4V*_G_5O7=<D]VR/QH%04% J=)5FHB
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MUH,R>^N +':P:1B%-:XL"U,L= I@7W=O<\X-)?8\87N1+>U\K6 ^-U-/:":
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M(1"TOZ%\)J-(!9]\$-B//,&N1LZ1K>*NO^_>1?)U=MI%;Y<',]_'?;ITQ'5
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M3*OK'NM7Q,=\DSRMSM*DUS#Y -O5:V8V0DPF]/%M'^$^E4;K_-7.X_H.FZ<
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MCM,=AS1#!6E>3T=IRKZ,3T:F_\/TU [^X9BY_P7#&P?W4^$2.(9N@%S229H
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M FZ.0N].H_)NFIXT8?-N\%Y_Z?.^E[F%[/I'JO53P*OH8W!SX#Q+!NM2(FO
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MP88?3MF?>&IO@\;SR7!4=A.+F4%=>]>&A6N_GAV*9</"7P5<"C:5A%:(^[9
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MV($54I;[@8R/^UN*PU?NQG$ LB^ <U%#(D^W?ARN322C3@'FE2[P<5(3]$Q
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MV.V.SMAS6_R:.XU *Y"*4-Q"NO2F??[VZ.Z)I8X8JN_E:RN7?0_A[,";XEV
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M[,38P& 59W7(0WL#=@>597T>3<;*:6)<Q=/R0B[JD,MUU>@N*N@U8)%$^AI
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M"TZ4NH9.O^,J4Q"=CU$GN#T7X,>+-)QVE]4+#4PA4O#N[PEO1"Y 232L@DY
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MC/'^-+ER#5] EO=,_X?]]5N?N>PI;)9B97Z=V6]!O@UHE0M !)+>*?F:Z=\
MEJN%1UUPHJ^+60TQ5[WT:6&6(-'5E3<7JN K2.0SC1N "17O<" ME@\5%(D3
M\%>8!='4J!;!#(?MYGW#@\L)\<=C1WFI6 I3A5F(OI=K;*Y_6)BSV5T-)K2+
M!)'KZTU(TUWG5HGD1IJ^Z)H4:" CF* ::+-;*B[N27JA%V;5+/LX=IC/QF+@
M:T+'9'09PNV;? H=3-!SU>!HZGJT2:LUE8;M5]E\*D]N?3EM*4V@7>D$E4=N
M)S2 <373WI1;>@U'"6;$2B: 8T58$";LXK@UU(I<D1SN]-R_^<(N)L'<I"L<
M9%N"65!657C=43]7I8\<;V@FQCNL$DHQ7R&_?UI#O8PX+UQ7LJS#I-B"2[M_
ML<8,2)@+EJCX^>1M'NBC^S:EF!O\Y5!M?=*<'<PLTX*Y?8%/TF5+.O+&?R@]
MVP7U_'*OA4;#^O6<>,W1$DH?1T?!6;Z^U9*LVV[BQ#9F]OZN?I*K,JAANX,Y
M&9^ DOB3_Q=NVMLA)X- ,CQUZIT?F%+YA-I(T LZ8?DN6,X$>T3;6^.@.MX.
MU% <E(S>7JG<SK<CI]1JQ:?Q.'PIJ+6O(M<RA%L[7\(Q%W)A6(MACO^U56I*
M!128WC\-0@7H3)7^&\Z@?PE"[;^PT_@O9FK<\^12/W;3/B8^]A_/+5;7("K3
M_\01FSQ)2,4/>*PA!_ /N]*#1 R,H65[+((>0)*"'MB9<DW:S-A.6S=>21=[
MLT]?ECC/5&*C_9LG:Z8/#X<VWTB6SF)EO:]L=X0<?)D:<\W!<%55D;UO#60O
MCUBO=!)M/7Z#"D@)5QK=%Z(W.U_@)@,Y)@,%''T%DLLZ(_(P\B3/CS1:P:2=
MQ79;FZOI1QQZ)."'!0#Z)^-$DDT_OTF%+<2<\H//1R?W/:YM>L\OWJ%2R^]>
M-W3T@E*31%<3M5->CU#@/6&&Y-FV_MO-3OB7U+4Z_\L _JE&\O\/3K!(/",_
M->S(4!A2575)P)P7JYW[?UH-GNDX?JFAK*.C)4E#U7W6:%I]'OF\#SR?G@$8
M/^CQ5V.Y4?-=$+ MZJ"AL3 K3E8]O5K@]=F)Q=(06O3W_Y$3M-\]2H*FC$?K
M1Y^R;;]SX3]3+?$YQO .^CX,S8/T&I4M%*=%F1OU2\,^^GQ,J*0I!PZ9"J'^
MEBVTD_#O*U\<@42]FAS/CJT>#6.X'(X"__O-X)'*[J1>0%[B(FP7.DJO!L0G
MQE=JC^)J;@ #[@E3@<\@MB9MU.]WO>9;X]VN<\OJ#5;Q=S;?50RA"*$<Z+*(
M(:].:C$!L(#(HB?[-T70]\111FMU_ZU7OI:A>F<=K&_0HOD-<_NGUYJ_;P"C
M##^GM;&9HB>!E2@'$Z+SZ/H6%#AJ,.)C*]_?L+B.?M. +#RV:%8G[48X<8ZC
MY%U6XL>QSG=^5$I I^LZ*YUE9$ZD5+H>I"*+-9]GELRR+;QHKTG-.=5T[.H]
MW0U@0 #)%B%-[S)5YJ%^JIJ]9EU@+X+( -+[Z_']'WD_)_0P"V$">]4)'1PK
M[8F&46N1-3FO8JZ7_=KI*"?Y,A=6'9SQD=I>AM6-P<@V E1XA] B6%B%;<83
M_P:@=L%(G'NY!3?[?5;[[H4K=T_&LX#?>OFRCV>-+0Y;2W$FP)S8RW87(Q!H
MH3$N<TGIL*V<GZWS+&"<LL^,%GI@JZ-*J56?VPMC=R%,J/H>K12P[O8U.P!I
M$?"J!OGO02,-$42&"1KTU<YP:;&UKM#OXF#X4H6W/[JJ[\5*X%5#@WO41>TO
M>8EEKU% Q-');)FA21:.D&:'R["/L!X;8IDEPYV-0J-U_]KZY8V__KB3B:UJ
M9:3Q:.O:5BNV$SGS/X?HRGA4[B#)O?ZE]*F:]AL &211WNSM_&-9UP#D2UZ>
M&T #P[._NEVA[6#SVW"C^N:W:+N2MYN=IM?[Y?QTA&4/B.)S@@4OW52YVJ%;
M0Y=)%ZN^;JGFR/,N+,D-0-CQWS\=3_V7YY^8D9["_QQ;ZA3Y@ A-,O]Y0N1>
M7\EUD9$ZFJ/2O1+B("F#9Y_1WDHU%+6@H63UO47^OE5;XWUBZOUMNS2_#U3>
M.O(K4H/MO%K3@7RJR#7Z9?LE8%^'Y.N.8Q7#U$)+4-TN"NH4)B"FV +I_<H2
M?-?$U8<'("4,!\=UP:W]7Z FH@?ROM//9]_%-%!<%@@*X3NO!;?1[05G[#H"
M>Y9>HBX^GSKS+>W,RX]/<Y$T)CX('^>O(/S]_OKWX+/*WQ:-7( J(/- WL0Z
M^)$"(O$!:M1^ 5^;ANX8-[S9E-W&B+391V; :FP17G%5D 1X5[1'+9G):\M:
M,WMOL7F:%XK,7-N0=$M; G)M(;J?,K+3GT#NYP[U*.8V3P3'C[2!I<%&/CZ6
M=.DGO6N.)H(7U=:;O$]#\9]EA3]IL7;>=H7? .IM6LH@WN=&&#>!-+A?%Z4R
M>R%KCR7?(Q'E3MGF=!-Y<7S =L9V(#Z6$"T8GC;PW;[5JQ+EIS@K,B8V_MC9
MD,3V_95U2Y 8G#UY3"=RT#*6U;/OF>+P=O[U-ZQ!/@9X;H@!NR& CUX7]O G
MAK^LM8EGX8WXDD4A\>5!=TD^3\Z^H/?R1[CN8ZL*;:4!#^?B$_M23!J.#1N(
M%@S&2BS(H"H;'!WW(L@-I5:^J .^AK@_:?)VS;NC1/1'<GXHO%-D#\8[677F
M2!;&S.*H7 0+-XH1_^8>\K"]HH_@T4\J6[/KPDYZ3)!\VZS9D-B+<I?,L8ZX
M7UKJG'5/-A,:3-439$A6J8;ZI8#$^,1K;TC)&H"+OV<O<T6[^FX @%.8SU<)
MGJ0^K6VU@RNEI8GBEMJ90-L%514P^2Y.!$U=7[*\0_T"QM26^2YUX_>HU'<C
MG_Z>1R4?ZA[0,![(9@%-TS]B'>:@_(;+*IGJ,08M)RZI=O.4C!-1 NU=@M=9
M;V)ZFV ;H9_\HMI]EV;_.DF3IR[WF[E ,RX%,M"6C4+R>W0/]QA<+ Z"!PE)
MU2W5-3!C^7:9:5K)&M"<EZ HFA&%]WOTPURZC.*QSS=J-5_1@;2O91]Q'C8%
MKJ$DJ!A/\&D_ZO8-##C;S-^ZKZ/N=&M=EZJ1K;BT\&[NTE^ISV(98N5,,P)7
MRW0&3S,]HDO$53Z[).*[?'AQ#A106[F61-K4WXMPIE^W:W*/L=M,UG;CZ;8^
M-ABK_"3>PNY+*@UNR^(^J,$)0;Q&)-,YFF<+XSF%>H^<J%R^O3.75GJ"'T%
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MG]7J3OK+D$84+OY>^CG91_SNDP+]$S; @VYCJ[-:>4B6J.^#-]S:'<M&HC<
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MKG>T]X@ZM'"C39YH%K#^S0;XP3_Q=U'X[)S*= 'NE6#K9@YZMCLLFAC$?0.
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M*81S>1IECEZ-@FGC?&F/>E?$=$673PHK@'RI%L&LFH5LSGPA^W^3_[<3V-T
MPA*<;P!O:O(OEVX Z*5+-1)AD^3^UJ_>093507#FM/=\(4#*IY)+A%\&RV33
MXE*(%5?B-BB\@1EUGZ4E%47!#=@WTPT&A\X6(3*< T*&!4+DH4^=/[Q-=,ZZ
M 3S\:>S"1_JXCJA^7Q!C\,QY^=8:&PNA64BQYAO U.PF)IN^Q1HU7L(8:R5:
M$W3JZ5_;9=K17C>S@>Z(BP^E6DCG[T$[J?OPUTN5'RO7D)XJUF@WL[JE;0Y"
MAMKKT0W%\>G@4JSB]':J6&-SQB%RX)V5P;SXVU5]PKAT]MXOKU:>%;H]N=U\
M;P:M-L>_.!$!GE]C2/^5&BRTJYX=ZS<K@VH26>1OOP'L*Z<U.75EGL<\CV"D
M;!L?HAL,V-L,8'B3N@9_$>O/ZXXPN1^SRF=@?_Y"FBUZER/S>3JCT U BR$\
MZBWDB1,GXXEZO^G#!K1-OM^3N78A^!B91F?XEO.=/M-@:A:&)>L+N09O\7#-
M-^NNZ<-L(3U> 38W !H/:)AM  7<G( KO88O!#\)0+*-+&/=):' FLPPHZLW
MI@1(?N\1&1M<ANYV!CHB,P7QE^QQU$V3@\7YIJL[N;;')1*K-=,1ZN1?2CR3
MN'5LKN1//<?95XHHQVOBBI8Q[CB*Q3.C6K)=V_>-S;P<:17Z/DY'UH]?6\JK
M0T.WY%\QNP">( '3WXW_SIM%I>JBVY,P-G^Y)JUS%* Z&KM*F7<*FS'5)8;R
MT\9V-&+H<D#[C$%!B/PKMK'8Q#$?CO(RB&-_$-G"ZWFL1I&IL9(UL;<Z::5+
MB0'R?G\X6[R5RO']GHU'ICKW0DO:50459T&.< C4D4F-24X@Z7A\RQI<ITS)
ME$QH()86!_C"6$'29K]X=_&LSO\=-)%JIO?B,!9/5Q?Z)'0R=-O]#58)ZG^
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M3%"O:%'0),\MGG@S6-X!&;@2UOX&4!C==1OZ955OT^4_OCSC1)?BXGEN #>
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M/0Z<N  PZ.'5+S-/>&3[P!;JWX,%)F(!.=)<A2"^JM_BO1//)S\UI<W_'I3
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M>P(0 NT:H_2_K2I+MF=;.G)]GP=1^YM;F,JQ==W9,Q!^]B0UPE-3*"$00(K
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MK"'Z1\.<HF#X"<D;S0W9G^-O]JH;TOF\'<R@G=Q1,^"(<" ^LJL95Y7&&3E
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MB$-%H:XAD#DL1''7.46[*^U9/4A06R/TN;.J;"HD*M/G,=M UD>/Z]<"W *
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M7__ V/C$Y-3TCYG9E=6UG^L;FUO;.\<GIV?G%Y=7US>_[$("4)#^X_IO[2)
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M*)@[BHJ. .+1D56\L#IA%!NN?-6*_:!/B^$,I X '$B4=6C2J4'FA+Z:W..
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M AJ%J)C58U77M=V4E,HJYVS?QJ*#Q[I=+LN_DM.7BQ5OLZQ1NG0UB,XYK.=
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MR[^[,3G*;G>9LBY[C.AK3A&GD(QJ.-"J!"."='@@*NW(+&0I#W$08"?]=Q+
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MZ5V.L&TWT;3UR(:ARC=-+^"SM%]XK!#?YBQ3M%M6_@X_R2)[G&Q55<LQ3K5
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M*^?G>W@!2;M"20B?/,<>@,9_)%7^JW$XL6&^?\T) _QW0Z+_:7\5*,$#X(?
MW[-YV)6->=1_<T/%Z5<.5W%IX;^'"QO>_7N*2K@4T' !YU.YI65GEKJ3I8/B
MX8!^.NZNI0VRY"IN/I0''6W!,:[2W9@IZ= A:*Z26/H(1_QL,NC3W<>@I/SA
MVF^F^+'PYP!Q=F/KQ#M"KU <]/,M_AB)FD-3PL2E-H_'$1#UF-2_'M5+K<;:
M%R^F2LUI=P^#O]-FFWL:["1\R'?T<%@:[[F4"44%Q%XRQ3P *$*%0>^W_]AM
M\6KLS#24!,A81 TZ5R^U8=X4Y7W^_J>9MF?S+&6=O2E&X:\RE5%?$U.(49YW
M=\U0[6C/^36)Q2M<?! 6\%B.B]E,LC4O+<WJM<O&$RFA>F/0EY$'@):8(81W
M]*I;5T6E@(1'WN/Z977[J!<$EEP  #-3UE58*1+>/AISDVN.OS> =0+M\3W8
M4)AQ%H_JJ2_[ISRY*W_?$;]8DG4Z(_WYY[2^<=V9=C$5NOBC+7Y<L]V8MQ2:
M!'GF0?TAKW55HO"WIB>H_*#W%2K@0R_S= ,Z_4B]*Q":3PBSL\<?Q8:5#0\=
M=6 *#"I9".Y7XD989C$=+VY&I;^9=<F0;SWEXK5?V'7B9>TT)!LE>+=%T98Q
M*I_H6XJN02:B([_(/&M"7GZ"YI1WE<EM'<7!\&-(Y&W+HI& 5[Y$0[YC(UKD
M&"W(HZ'.Z:&PF'2@C*NI_I^\+&5UB'C ;]%[._;NVEK/"7W<4?DTR^=;&K@G
M$%ID2J1(+F+ZJ;/8QE-8@H6:QAO=.1=\8CB;PN=Z09I959V(\QWJAG)A0LKE
M05/&W-+O%5F.-FX,M?C)L?$487+F(V7(L,'.@IB*6;ADE_&[A1]+NGMS)]L=
M;=T!?/.*7+M$)IU>[Y75 +_'Y6?JI&S!)H5 4G,+9TO"63__&5/U."'7V8VW
M:5.U1.I#32S<]*DXDHN3WM-#02QR.\"C2M>-(;CMD)]"?L[^.&0$4Q!JO,6;
MCI\]Z'@F$2ZH$>Q0<2.%%M*;A2;QP#=,30\:55W*I^Z-2SO>*V_P&!$1V:LR
M[5FOJ7+V^,+W!]?HAGR&KJ_VG&SGZX7;3^1MV:+M#3*>2 @8/"&V*3 %#,[T
MLOYLNN5:%%GC^'(%'Q_,S%#X8_'+TF""8_WI%TX:<791^A_(_N7LH[\:J)<%
M)*F(/%CBG*GGZ]9?FK3S*7>>7U6MJ!DZ_U;GDFCI65U-,6">[HW#O0+F1%ZK
M(<.BZZ'&&B-%'H%LZ>L:5>K[X[YS7(:"HCBA!@8'LXK>_GTM5N^/CRWQHAOV
MHS_ #PFKWRX'!0UVC27#=7U(^?:^)+\<?55(1#2X/3H41C=6[DSK?9"#/>@L
MD;]7%%CEW%+SC;><A'4 7Q ::NWYW:-3.6BW-E0<W=4?1@BFU825'090]C+-
M>[@?+[_MZ.SLNOC\R"%-$V']-%$RW:+9$SN$>&OZPSH]LK35^SM"TZ&UJ4"+
M='6UNX''1X7M\U?C]-,I0>,+\P]AS6T1NOW&CF9 3#>*TJ4*H\_*7O0\;Q]I
M$T_93I%) S#SM*6)F.XIK1+MEBXGF;X(.$F\0;3V5&N)7$);?D<O^6J_I+<>
M:S^5QM66U /+HO2&6BT%EV[-@@.=_S+1_'FT[[J)*IVC5EMGFV2I\EH$;$UU
M)RW#<M(9&3,H*I%T\LN_!3_WJ\>S[,E!AC'?PPO4]R:=2 3,JX D% .QCI8U
MG^OF=BW>L9P[Z98&Y40=%S@D?Q-H?$N&Z_LU[_DF1-")1.R6C]!-!K,OV?3+
M\HV\3CNBS/0KC:UQ1>>Y&ZVESS4-0U/B?J)1/EBI&Q60(.6\U0! 9UXK]F2\
M15E"KO7D[5@0AT_5W82;8A(F?JL):XRHR++Z#X<05Z*I%)>DR/X9Q&[.9-%=
M&D_O='I?ER*&I_(+I1DY^O<8M828FUG1PCC03Y3W?_YLZ&J8_>V^-WU[S^Q#
M7+%2NM(KZ\KA-[_(,?KO9]:?HRPK[':F\=$.;J(CRVK(Q,ZRVRR4Y)@W.VGQ
M,!DW,3\^7>M](%Q@J4.R+T&&!>F?7:-:]'V@XOMP[6<10GOAL4M^;H=<)]28
ML$ ODJ$ J%*"1P[N>-7@BDY Z@TRD?-AP5<#QEGATE$#\V?O6F\L6N@_<WQ7
M^K7V%;?H3TY-]2T6LKZ:W5>B/-N/?7Q-9"^[<MQ#QA)O,TWL^4T2O<[['AGS
MRT)B?MA=:;=B+:@)YQ/0H^KG4E8K+?CJC_LG'^^V7K"7\#*))8$R;47>DQJ"
MU KQKQ7#J+\L8W(;T44H?B#S_,:@O/:*TC0D$25'?U7323U\E)J%C8I^@D,L
M;YF->_P V$3P.GRYGYHZ'>$6<AW4@/6D2]) UMX,L#5BPM8  +)ES%?#^M"[
M'#"AFZ@E0J<K@J6KK:VE<Z$\?7V)+E4!)<_H&;LR3?\>A_A1^,QYC17<:LC'
MN3,T4P3?!"P74DVGG'M/4C/<.6]G9B?\/D26??R'FY+A"R->"/<L8H>HC:I?
M8/OWKX\P%)G$"GO=@J[\X_QZQ4XUG<8C&C:9^:^X%&5,QR=;"HV@R9$.CM)E
M@36^+HXZ(1>O;J_/)2M>^0.&HN\0\P0^><LJ?01@"2D F'*)0XN8FK#+;(Q;
MJ)'3RXY9,N'T=]N^9$<A,<2]EP4]OE4PQ$_QL^VZ-2"490E6HVY3O>(L1J4]
M@!44EC/5ZC0\GH<-IV,PSCG(NHI'\<;$/.M:%(YUA1$JJ^4YIZI[L''LZ,8C
MS4Z^[WNJ4JJ4&LB^I(LXL%A@:LGZX%;K;F?BU]<V'<A8Z)>Y6"[QWIS-@3V-
M<VI7QH3K]69R,>P!L*6&5H2>X:W(Y)T/;IE-GQ#RC$FVC'I%3R0/[;U1IY1L
MR8B$ATLY$*>$/D?Q[I6YL:?DEYB/53D38_>F^-# SFT_A2ZX3Y]^%DYKU0Z9
M&4R7*QGHHY8R*4<3+9NTT-J!M+X,*L]Y'->S^/?T"BEZ['U+/_U"<3'O\NE?
MEMJRN^!1]PL(:]<25L!-/6-@4@SBQPVYCV841XZX$.R='R>/M"I]3GU!R\;[
MG25AQ"6T1Z'EAN^(O#?5U$*D\1]+[>A:'Z%$_0#P=10GQ]@3"V/H#MLZ(^"/
M@PG/U$-/-$0J?6^X@8&4ZH&N2XY1/[R')-H_1&OCS"D1JH3R@;7F^"YQ%^JE
M1+R<R\+L+-;881^K+X8K7^H](?WQ/"&=?C\ \U&G1TQ?BTQ"J9.8#BCEQ#2S
MR%^$^EW"R7D/E&1MG#FU/R9V;?:C$,91_)E'+QG:1X<V%K+D0(7Z/NS5ZD^7
M.7':-EH^]^KR[#4C7<7]O"7W N^EM"V#@+MPMNNER8G;5(K/D^]T^FE%@7RY
MUSYQ!.]>FKOQ"$"<>T51&T/ ->X;T@> T1RO"$<[<KV.<"_7^06+?$! TTG^
MV^R0VLB]KZNE[W& RV17H4A0[\+^RT-B[%]BGB$19[NBF36^>.VB?^?G[>]7
MK.6: CE]VUJ1C+2HMU0ZZXH!=*NF)BLT)_60YZSJ)@2MN]0A2T9LIX?!,SB<
MPP5DZ+);9=S(6V[1;/M F9B0&HMU%VVIRMGA5I$H"A/_3,?=<_^(F;WNZWXF
MRLMI8C!UI[$=+%V+V(F1(=CAL] 9L,P@*W!Z,A%E.;XS'25!-630Z&:\H>CC
MD"[/L%X NIJ'ZG*9V#J^P6<-%WM^%!ZT+%EY/RF#LS#\7KJUA+"N[%-=.*QM
MP3Z99KO5;6G$'I=4V/$T [T7_HHIIH_Q5GF'*992^P'@"(4P+,"XC_!.YE4Z
MDFKM(DJ-]X-;[Q:Z)A0$*^D"ZA\/5-^+H1H2NI^CNH92#P*N]$8KX4XY#KG.
MP?B?W1PZ('Y",G1Y6-ZO 6U?!04LBTIN:9#KD3NX*(H<*][I?.D)4:T05A,S
M#;$_![;A^973&>G2F@)_B4C @ <!>L.T:]%/I8%P;3'/4#<WN"U.)5Z>31!0
ML9LIQE:3K*0!T$-R)OOEYO./+$%8,C0SC)%E/S);K/H)867??N-+>;^T'6&&
M]=MD))*9M_5/)]+N)W<[5O[,Z5G+K ',;BYN]C;.G?+88N\*=.MD)SLF6I-P
M8<I\^AG*A+;8>@ 0H?5TD;^TM8)MJK-S=3*T\RL@O\LLFH6;Q7C44,> $0%]
M,#[2;G"#V,^NVKG9)<LTK4GCY9I+T(<LK:MW;K-#8GG8\O,,.$Z8>Y^0"O>"
M*/ZD93ET0-4JJ!\T%]8,0O'-X?&D<20EFTVNORFT__XTLHMB=K+0#&TTVH?\
M! PB61(^*J#@N=H@[9:NC.F ;8@GN9X6NBN\&!VSSLVBWV0$'H01@?0TD<6'
MW.5#J# G*_7*57=O1$7J^V.A&7HB22/JC9:-R)0$,ZMS/VS>(!&QN2SMC\X-
M_D1;DF:.-B']8F\=\QPB5E%6X1#,%(,E*I,.M)QS=3M*J7QT1/?P)[M&UCP&
M9ZKF3@O&ZZMZNC<HCIHMIJ@E"--BPWZ!%DHLMN[2C6C/2++DD\@G]1KI]<_X
M+"E*86I_?%3O\KKY"X&1>O.7_.0F8H@"G1MZT\LO<!J(/.O]OJ1_IJW:#OU2
M_@.@?QK7!4(Q"Y;T*Q>&6R95\358UPD%IIK7UG%YWH5>B"J_(>+"SPL8D25#
MW)J@GZ.P0$#3)5^\7S5F#:WC5X]Y.?+8-$>XX 98W$\%#R""&#1U=Y*#05%G
M25(,=</EPQ1E]5G4!3JDY8[$;E"E\:2;3[&(J54ALBGNF6[%8CBZ1G[!-TG5
M%,C[9EW=[(/1"U,QW5H,^N3'>[4F<&4;>P\@'@LUJW$)UH\H;<#^3RZ2K7M.
M=,..NEN82=_<5 I3U"\/,A.0^_;4(2ZPXW:0*E_B*S4VZQ2&GO-7K QS^Y@3
MN1W\!B*77N84]>2];R%TV@O'12&,>^O2TIMT1:I\3#_:3:C>ZU&[9U,L@98W
M+9NV-Q($7+Y\&UE6D8 EUW 4X91)N?Y=?O W8X[W]:K-70HKU/)?OU)\'[R1
M1 N*+-J]=!$TV8"OFN#3^-%8KD_1('S'W&C$8U\=I13V%PI+[0\5T'=[;.8B
M_G[#6=G:4998D(O)H:G#)ZE9A*(?P?E7VA7C[CJFE>]\>&OM9(FT)\)]\7]N
M'P 8W>K;XSW2-LM0IP8%H)<S+]3(C0C< :[X/6MN?2*5'%A?,-2'VRVV79.+
MJ/E:O]W70?FY!]H)<HRH:_M-JG#HG=AKEYA<%/NJQM^*0)B.&&,-),?2GJ'4
MG6Q\VGV3E1XX49K-L,O6Y,^6OH"QTX"RVO:/J[9Z #BOHET.QU7:9R$GO+5E
MJGPL?7YZI*0_F!.\F*<" AZ5H8R&S\A<_C+P7U>MP>KX)^[S0U[2WY1&QVYH
M-78%"?LCSPDNELN"%A\ 7_J(#I,J<Q.<C0^9;&Z45KZ[W[#B_&,?<$*"EQ@J
MCL\VQS7\]PTHE\_'Q!"BIN-AW*:(!!C+#T4226W5]HSD?99PJ>JCG;#X;C*W
MK6#Y&F>)AA4W7Z<&5^NY4\X<#VCLXH\<3W_35 :U:!XS&FE%V[_.-9F4,O)^
MU6KC+G+(="@KYY@V9.* +52=00D?-)M\\?E:Y?$.LSY&_-5?$^I C,VB3-?:
M)OR$UV0SP^CSJ%0K AQ7:K[UXW5\48H]S8&IUHT,2'#;PJ"^MMZ#>2%I)1.^
M?0+GNI_[>A$(+,C@IVT?77-7!'C"LX8> +&=1HD96Q=K3F3H;!A0TNJDR9X%
M$9*Y!P^4_RSV0R7)?9"NL;]JNT=L\SK!CY\63;JALV2XXF=<7U_K;CJI-L@Z
M(#ED09ZN+SJQF9&XZ$$$)D5.1U= .Z,\SF!T(7)^6B<,2G_4$[(=C7/(!55&
M>6KH*/!G')<Z4PA 5EK(Z,_PT&PR>9=E,@N* #[PV#O!5V.7#IP,E9BF\5S_
MY2]6_]'^O3;%_WZE"OH%C^)Y'CX/CND,#[*W-TJ:BS3B3'+FQ(/3*8Q4Z/S:
ML;*?Y;_6E!^WRSJWG2];/_,;VT^S.*VR8:RJL%A1,5;T(?NR&Q3^38[UHD$<
M;7<CZ\3TY'+%S^W%^?WVMKJ/J^'!8I;SL_WP5YN&%-)MT!3VCB#(%;:]%J;%
M#GU/+V0*$;CZ+7*(-M?\%KP6YJF4N6D<R?P 4&1:J7P =-V?3:E[K7=,$]R&
MH"@+R@^\QK9^^O%2J6D\F398XES ZTA7_UD\E#;<&/UB[M&*32IHKTN+'HS#
MR+=\F7O#1'442@M=WDK>,)^'SCY.T%:P"#_UY24CE\1GQHKO"T#**K6W+IT4
M=W3"6A?Y?HVWD)MYX7X'%SWA4%YC8<>5.O>R4)Z&>+BA;DSG;L6JF8A UD<;
MWRF-<GKK[BIJ7GZRI?(92AM"$%W)J+<2/:K$9-ONLD,M<&1YA?%E5F$QLK3-
MK,;%?5%]HN9P<,O\%;'! ,Q&Q]R(JOZE6_RQ+$A(3XVQRW60P<G'&<1GKVJV
M%G6)-[M9/Q!L]9CU1$O/<A I5X'O;_2A"WQ@N6K$P4F@<ZTY.I"2U>6ZZ4V3
M$!6B#X@]8+XC%8_Y)FM@ VZZL=T0S^O;Y%8^2EEAQU=2D2^I?:,_JTS');!6
M/L.26E,#>,R@Y,VMK(O>JEH!I=^KW$IC0?#G8=^[7P54YW[ABYK_J,<BWX;#
MGJ[P1MW]1^I+;L>MY0$8.K!RE">4?1%F(3&U6.L[*?A3(77EM;'H:G$D-P$V
M,3,;UZB/ 8PXPM"HEZ=]8:JK:K1HS27M*,N23HYIQ;$OD6]%_60=XT6B-D/9
M1R933/EH*WC8$&U85!$*IV&SDM?U4D/P0GO6MG6A>\R=<27<J?P;!N.EY,?W
M(&IQD1:Q40]R$^#!YE'?X^^*.XBN7-\FJ(9JSD#=;K1)XIS&[JD5KW6:R9N\
M1G-/8'S+7>[MZU#L:;<J%U-(U38(JMY%R*^4HV(H+7#*L<:?Q1)N$A^.X>V?
MC!W$<C_]QEL$6$!U),8HK%X3W&5%)J7]^ 3\&<(6JT U[G2E_LQ:><(\8XJ+
MD"C( XX_#'F6!G7#_"*J6F_V_5#79>]&[SEE 6_I^MOWHB09?*I&FCAR^^1G
M>.#@I5H9*DNKHYQW8CFM<5N3K/H0E?HXJJ2 M#&X:"JYP$X5*\Q_G01-5XI6
MVZK7O;^_/W63.1\YWS[("D&L:>U/>_[ B.'MQWR" Z WXI8];L*>2B/Z?"^V
MK#OY"V'QXHXE?BUT@[ VZJ0MO^#Y:__\]G5<80R&Z=$D[^V]2WXI <*&Z/V>
M1:AZ\$V(REU=/:]-IL:-J W)A[<8!"9FN-2U83%6--V*;MNODFN ])"G^;_P
M)0-W>YT=&ZG\F0?'/F)<O]*>T#*<#%)<'B#D.]*('FLXP_)R:?O3:-/"H=Z^
MFZQX<*W_=BC@*TT]\;9R?T(N$P8H11FYXV(ZCTYX.P_E;\J,%FX)]C4N62"(
M(7C"\M[ )QT'&Z.HZ:_6#[IJNGD%#!5&[D)-W0MOIB .G\.MJ5A$<B4U\2M7
M<23$3#.7=Y*AG1-ZYFCW12F.SFV00X@:]_8R?I!GM&)L(0[&\_-S8S&P;9=;
MP%9F?NTM3]BC4:DE6N?YG?F=]E;,B0_/M),+WPL^B9S&Z4A@"G^).%I:SI+A
M7/00+EW0,\M5<-I2=[YDUY:94['HIV2T263HZK@JQ)-Y#O;I0(>@<)60$Z:A
M.1ON49PFL!"%%?QF^_,)RGKMD7FNW_%=?'( 1Y$,9,-V7YS[K59(,2AZ:=TG
MH!Z89FH^Z&D\2)C]IND3E_AOI*S$D0PGF"IE.V0>OX'$Q9#68.*Q6Z6S=JGN
M0 !M[R7KA*Y-QBM&6YO8G4:1%)\;R<J%BMYY*9M:IV5<O:X%WAPX%SV"=PZK
M(]Q#K\/*R7KRXCD]+>!B@Q$<@E)."J4^O(90S<R-K,\-:G8LBE L$ 10>O@(
M/FWDLBIPM>-3M63"%#D,8AHQ6NHV*$=[.G,3-7!457W?Z.?XVA(_@;GO^_O#
M>Y67X@\ DQ/SD^GCNO(P&\7B[Z &\SEHE:L;CQ_7L_/<&T6W7%]^5L'T6IDC
MMY&M<*#=7Y<]_)1J)VR(B7'#Z?SG P N@'#VU]%ZT9'/8K6^AJW[YC%>W&NI
MM*=L3P!UVQY)\/V8;HMM/.7H9[E?0AG[&IL68'9@PYV[YW:#PT2K+Q._=478
M#&QWJ#? ,XRAL,;T"[D988':]77$@= 1+4(><]#I.$-="&_LS<13EL1]+T[J
M^JC>)X>,'.B2'0TMPT48G2S^ADN0W_;/F<])O6573JPOS%,M )]>OF;UU,E9
MZ4(3N^;P17J4@B*U9_TL2(/'7"]!1='.C]8DI5#=WL^5=%5&:;#)9VBI)<).
M1"BK"NG0PJ)F"3VB7V[4H.D[>]WIVP=UECP1#P">/9T+@ET3L\0EPI23&.=@
MGTI5PNC< &NW2QI7EI:%[O&UI?CCT$7*B3?-L0AGK)V_3+!D&LFMT+4HPWA(
M1963-+G\?CS7V9V#5/ITEPF%5/F-W%012'S)4,."N/)I@47JSF<-P4=O65L0
MZXB5G]4LQJY12^ Y:KX#KX[6QX_Q_\FLE!^VHKT-D4GG*9F!KN%:4/TA7 BU
M+)U79D\ZZ9>G:\OZE/%")QS+)@ZGSBF,WJ_O>/S(BA $O'%QXY"6-U@,@_DY
M$*4J!TN]$;>R63_953$P>U)=Z-"50G9+V(QB@MNG&/?->S#.OVV-WL-.2B2T
M$\LEB#!^.M0TB#E D2)[O.R46<>8M=WCJ)AY2%>CH094_ "[@UX32PX-?/SP
M8J[=R/PE@=.CZ+\R<Q@TTIVQ@G; 07I<36;&PTLV2'PM#_%VXQ5C'$2K/ADT
MKYQR^^P4C)B=?4@=EJ(,XH;7E2ZG3]:Y?)F>/'\ [$9U8CNF&]*P)I4D0ESN
M^OI[2*>F@.IF"35 $Y$N:2]FBU*%J]E1>B\BF2T2/I]ICA)T%E(&L2T6RV1X
MO['@^ZI>N$K8;,".G,\!YL_S1CA^A&.<*?NERN8,:PX3E*.!KX.G"62)C?S4
M6E5Q$"#QL>V'!4[W^^=VOA\X\+1$Y.UC8/K(E*%I<O39=D.XA[LP=+:;O>:@
MLVXQ-1K];5FE5SMQ51F*#;8?P0?0T4SZBX8]^E6CP;*C=1/R(TVKZN!/2<N'
MZ6QG>IWB7S>US!8;>O&1 P6/GB$]$H3K3&5)#Z^O)(2I##LU4[Q9;J0_BF%1
MO?Y65(#]6G<H5;S0D:D.;(X:C>YE1L]K0F=K_= ;YG._W$BGS*["E:XI)YF=
MB3/]ZXV\6#GSGF0,RL*D3*^3"F>3HC\CS3?,#P3D[*M^=[Y?>]W0 2$MY.%#
MJ<3O-LOH]N/L=/2AA=Q"4#A6Y P.?T32[\?UW$1TA:C@;B6@M$$[?QHF;)]D
M#(J\@I:[CT&0XI*AH"]H]U-U1!3R%X?X5CRPS"_[0W6O'=\[?WU; Y.6[]:8
M$V"-&S50@1FR+^Y8.%9*%KC-31>,C_XQ!RMH9>_V7B\5E!.*17+0#" Z/$=Q
M(R -]U3320W=*CD.N9M)@L:GE^-_J?^*N59-,Z:?2]2Z*FZF%]&"UXC9,Z](
M0[<^^W']68]:=[!5S9JZ: I1@H<G;UT19>J@A 8^FU.$>LVS,>N Z_H^!;2T
M??'Z 56,;E=7YSRLZR08'!_/T=Z9E*[=3T3NP8:Q_L^NZ1GB!7P=H97O.RFZ
M.EJ&. PJ^W15M6M^?Z4L3YB#)1/<D'DR-:,T\TID01&%&!*#WPQ21?/L(&_A
MBQLQ;B)4"W33P95;SJQIQ2M1<:TG4IFX310.B"OGYKDB:(P*2A-6,G!E7.O'
M#GMZML"<;)0NU:$[^_*"(6#TO?[.>B?HGN@@+3?L5U=Q(SK:@R3J=V".@KW3
MGY!^ZIV^'H"7!%.R2-4#P/X!0 S*&.K:6SQ5C(-H2*!* J7&VV?$LJ%V9X3C
MB21IZ]!N9E27.0HW4;A+_2\],SWX@]/PU[,Q2#HVVE./%,F5,=G^_J@D%D%M
M*T>?# S60HNY 9'UR_U9M),G5P5 82WLU3C:B:9ASQ9EFOX!3"?S';;@Q7S.
M+<;\4JVM Y;N3I_BPZP_M9)7]^?J?4)!;4Q^X*615YL.X5(7.V'#Q.12H:QS
MW?SEQ<Y_&$ZSW2J/'J&'?>@S-,A("&Q4[/6MJ3-I-D;5IK*NZMS"M!>A:Y3+
M*A[0^@I@F>"A8@,K!/X*+WWO:4%GTFT%7([M:0>32$"O*!K?8X<A]/Z>G_00
MS@ZI8J_] \E]QR)@.>[ZS=;;1)WS"<7[M'8,R,<<JWZS$$Z]KI?H#$-:_#M8
M'92"A(>RP9=:#?'E+/71L0Y]:ND=%^;8/17X+8HJTI<77S7R;<$0(^>2D5)X
MOIYE)C!,]!0>.-&UAO^,T=(8$+09,FMFVG;B_<<MZ:.NLZET= =#S^Y(F7/5
MX;V"^A4P.J*X->3#M].OP][D=C1'EC%EMUASPOF."@O%"_P0M^>_]N.8')9%
M_><0HUTIVR:?6R4CXB>[[O+J=-9#F(9I>R-")"UYU]9*/;NFL2<'-5'@PS<4
M_F[I_!,=TDZ,,0P[LDF]SU"E$O;34= 6YRUC*9UBYVO3%DOJ^I7==!HV.3QS
MZM9O3:UF;!DCV$%B0PVQ]QS(C83:6]FM% (X<%GW0,QT:,YR(U<_69R!?.1E
M4E8(VK(_&51[IW<5T-RSG'ZZ/-0YE5_:6F9?N_JSB7J=+G?<(H(]P)[_ F\^
M*#*:-<!4*ZZ P&^# 6PP>_;K+D 'N93-%'/F>U-S)ZXPL6=2+*-J@C&B8QR#
M^4+)YW6B&3%<=]^\]0'P(44-"=?8E#3+Q9>6UX5<V/_P7JU]^]8SBCF=5<JF
MN3\OSW>O] $ ;>TI=4H'=O9%GM0)JU=>&LS]B-$1U!!>>J/$_>(8@](@[ENJ
M*O4/;^ZRA"N/69ZSS>A!XX5?&T^$KXS$(+0QXT!@1YT!)97CBW>6+"E!58,?
M:<X@'EO7Q_LB#X#H1$;119AZ>TN-LEM1EP)SX\V[YIIOR9$^ G'WVD,?5KU>
M_Q*180:K]^:.T!)%.J5__RU1'N''@WSKXT6!T&1\)-LI5;21=S7L9?GRKEQ*
M-; 0/:@^7R?,*SLD^D<8GE]P%=K,M]M\OJ\"EZRKU&&';X7K#E9*"UG<9]V(
M(T;]/?P**(\L6?J<A:^ "671K,W3DT\+22J?X&6WD8RQ2@/%-.\^0H]XF:%C
MW0:U%G#E$G,GT;3?E"A\H+,)]5,2G-_D(Q7![]J",-_P<F^/QFK%7?(3.$D0
M2%0D<"YP!A8OP(S,N.RBX6NE[\)XFJ,#/U$\NF2/H]#5@L<8]LV?BB2Q?GDZ
M77208Y]953T64!GH\Z5%@TU0D12+>5TT+ED5$'%F(7D_W6LP?547DR@2PC_,
ML:T>O<R[%=X59Q/_O$1 \"/\"[G7B$&T<IEQZUU^MZS=5C[P#;2K]_VH_ER=
M</9C>T>%B+6A\+3Q+I7AN!V(P&NHM+ZWQ ]_86A":B'C(#D4[[]4R/JOV_]B
M>2ZCGN88G59@<.Q08]^Z_'H\%Z;0_=-)JGLPZ^WT/S71\!P2'@"OT0\ H7MA
MG=>XM\PY_'>8._\#+.CY ^ S."S[7Y78\&?#?C(Q[86-Q',!_HJJD.(#H/ _
M,(+_&N/_GV#_L^?^;V$%>/\:$S'VS\('P%<9V8D'0!*Y-L;?$5O&_><1AWVA
M*7X S/P[^F_S\?_1_V,4 *8J+O@=,_J[ %5R_[3G/V11$<"$C';J^T6<<B&[
MH_QO@OC_)& (_>M_?'?6$V[-',=OA*OMIRF28Y0HDFOC/JS\)U!+ P04
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M15-&EUFV!7PNZGN3:6-2#M?DD1A.[,%:O*#QHS\UIIO,;AP^8)T! WLQ7#B
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MJ$-UII^A*1S"82_\G42MB^?M3TH29OJZ0BE-$Q#2K>AJ"G9>R&="65@$:<O
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MT3%8:J)6/#_\E*E\.M['0]M<<W=A)^0"5-(^_-Q U:_TZW\[4+.! ]1319P
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M78N+-/D/\;=CTB@/NFZA6-J$H>>-GD<L4\?/QBUP.;P7S9N<V!-1M0V\?83
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MXO)9:.3I<^EF/^@'# )(3)=3-=651D>E:4WD4I8[S'S/)J;V"^E_YX^25_R
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MIJ**<]&QNC\0T(T&_]\P=G7>MI,(C2M,M_>J^(RQXI^\L]J*_>JSIP\^>)2
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MRBVH<YG+*"B05%5F#6JNV*YK:OBP4VDOM<GJ\*4<M%?ZL1O][KD>9!T[$KI
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M^S3H2+]IS -! ;;8?)*FTSB^:K["P2W\W0OJH?QU^9ZVNQ2;0Y)F< ]*@RK
MQ<L_UE:26ZORGZ^$1,N'/;J;32,P.O)ZFE/M.MEB[L+&SMI<MR@$O([XZM#
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MATWH%:,L!3!.X'E:^V+A7&?Y6/_PT4L5"7JA'V:J$""28P.AY/7^C@?NZLS
M*-NIG;# 8YC@&]_8(/56P/OVU.0=FY[99POWJ2XK3[:/34UA DJR*$"1]OJ?
M0A?S#/K'O#&MU#WTIX2@^@N%!EC]!@?(KQ/BVJ_,^?_*GP'>C[,EC8#5;SO:
M;V1]IH((<:^]L)CP59)QNL-60I*8BN.1G>-YXN,6T.MRXDEG2U5WNZ-8Y 69
MI6PBS_&-MDER05Y+/IX"$<XF7-%*O%41O;@R8B7U\)E--AYPX3\/])P>UWQL
M>OPOT#;S7P2)C?&RM[?<N7;AQTBGR+MV\>EG,.;E;-\.C_Y.]S^34I9I# ]2
M;]I?AQW6I7<_\&,7L'I/$T3TBR.5Z 1!11(YF6/+LC,,RPYKZ4=X!8-.@*!#
M(_:D$PA^"I"FE+.WF^'/Z>)S[?DN"&[8UK:3'>$^X\;MK& [9UA=:KJ$74D\
MG3,^/J&FJ#M>P)B?_DK9..BB7M2'(G'OK9MX<.-LMW=[;,2N[ZK31<08#;JL
M4$<Z 6/CV")J!HEK-B=;*,,>A2QM0(G*)"4*H.RKL[NM]IWI[,D-R\H/7_:@
M6Y?QPE79/)<>#[T3KT:YN=T=5!,8YY,1TC0VL)"]!JMXPZM07NIJF(J;'M-L
M0[ 1FJ)F8&*O^06J:P<V<C<<"E,6Z&%30Y#GIX[B*TJ2/OD]XM(\>A$ %'JY
MS/PN$#WM::;#UTD7<1'&$YW'=KKG9,,$K(4,,FT/SI868%WC/\+LX+C!4;6F
M),W;Z_J7'/6O.?O0L[P_$/?T3B&UA[R\HI[7) 4H66KVZ7R,M':C@;M@?4Q*
M0M<%RA_?J*J(_K+'!RM:D42,.1^^(^5U-O5TCW%BH'NW3CZY<^K@B(=OE.R"
MO\UX-ZS E#7QH?&U="0?:06L72"M4<D;56=XA+YDGU+!S&W3&[25% #CJ6F(
M_Q14R2#@DS?N^, SS2.TU^O=,=_)P%-K=PX9/[_%-!=P4=J< EA8[?EWQFGL
MLL'E,U-T0DG&CHJ+>>WN]V"YJCP3:KG2XEY1H7?9WS,$I,&ZQFL8:JH(-2VF
MYJ[+N*&D"U>RK^#HYP(O>4T8% I5Q [<OK5YA*7_Z<NOG+TF*T@<-7Y[CVH5
MLCYIT(3'!%>64:'+!XMH7K]S8TXQ4.PR77LU]Z6SE#=)Q^#M%K>7M]I3(FKK
M6M\"WK;D<>6EW0('2-F&&\-$E[_<,]/KI?5?MW(-0$UW>QZA0%+RLZF(XCO;
MK2EL@\'":YW:56QO2Z_:85-LHEK_1V<%!: #/<9\9G:D (C%ZJFY,8$'X2W?
MX^.!;*7%K>]08Y'3]5?D<@M!/^!6&N.2&"WY*(09V<<_2-[K_U[QYP,PM]:1
M!UM%:4L<XJ*IJO6^[ZQXK#0KSU_V/G)?]NW$O1ZQ9 Q1Z=44T>FKNNF+7;54
M@SA3K>M3MJ8%OIW/W@I%A<=_T\!2BS%F.!ZTJY+XZ=/#BT4SM:6#'Q-PX9=C
M88;Q@0DG512?Y'=2EXI4W??BER+*Y8\M&258".+])[-?<";LP&4T[35OB5=*
M%X+H&.XR6*>(4M?@O8,+22QI*IEC&HJ$C"[I1#FW)N>P3*]88QL7P'AR+!K@
M4@2DQ%SKE)B5\?9AE06PFVI!UX<]QN.G:>;C,OO>UG48##VYIL++/^S[<^2#
MEFYZMR'XAT1?<L!6ZO8:ZCO U/\().H_0!Z8>E7Z'5% /ZL/^+LY^6-SF5:U
M+,NWH3_;>4)D:TNS63P>@!Q5 -[W(]@=L,? C.%3FIVHUB<:AU)BW]*=G/D2
MH='YON4\%6?'PF:V(^CPB@>&"Q,F/+R9;()37"_%.AG=<9"F /)!HL$PQI!F
M3B]8&LR\H-UF&7&2J('++C6'FN&SGWK2!6_=V=8+!%5V:%-WUG5LBD1&AO>5
M4H!'[OG$A.VV:B,+$)I $[M>/Y!6%[:69G$1'N2J]U52%XS?S/&:;%[[_$-$
M,@]ML@?] H9?0$#5J&JYW_3^B0/D9\B!'V=5F6?(D/G[%?YGR/O^X_:NIM(J
M"B#3H0X['1&.,TK@KS=3C1(8G:8N9<F=;SAGR757-N0,VD:46B8+O][,+=DZ
M3;-HP8[?S*WHWWB#SCU%I=*A(;@*V,1JR,_%&==K)09X+GJ*5G;VRW!)=]V0
MZW)4O/]" ^C2N!Q75JLHR^B A5]JW=XJG< N5LO)#IZ(/?V**E95X.33:+H3
M<RS:N*%%T7]3+K80S/T>N[EKL,IW</O(><&K+3<C[YG^SB?.MS95$+#.K7O5
M;&M<N[IW&GSWIMP'R@DS)>O[]K;?8V:5^6C8>V?;H=/[];'^'-D1"2_8W8'L
M?94D]M$^00PBJ3=[H_BEB;?K;2>2M),SIZ&]N4Y]XV,3C:\:7PC"0Q8%H[;K
M&+8Y(S]%5WWB/[GW@F2*[RK>0(7L(#*\TUIPR6R7P[>4M$Y@X+-#:Y\:S\6<
MA:!9>C@E/O>MGZ&CAOEKH=B12+7]*<>6 G"?^]DMM<T=VDWBQ#<H;KL-$[5S
M#R]/>$#,,(Y].\( GZL@*,I.6]6B]).SDXAK5AZQQB\\J6TR@VU;+[CQAA3A
M!6:W0_V$9AN862:6F@13EM9:'5;&]0-%);(C3,)G>RKLDDE/JLL^LI;.SD/%
MG\NE5GV'QS5%@[T]$/E;(LEQ^E:[:TKJPR_[4U2;6Q0J??6+GX%LP.B#_4[)
M7A.NSV>JXW@5-!9K-OD<X\NK77/V9G><0X)B88,L2I68GD',Q^Y^9!DM-M)O
MK*BMK1J66$UTT2G0R-3A9:-Z6,D5^5"C@_OJHL7P#P#06.:'ZBR/]@Z6:8Q-
MCQ+V%%%1,I@0)!M)"!^HR7?_JP5FJ K*1-2G2]0?84H71(AH*=.GG#(/A^DQ
M7! ^&MPK>*ZD?CFU,QR#R=B?&<]3@"A.@M'V!G)W 4K(OX^9W4.:G[UNJ'!8
M[ <R>5Q]>F;D?X+A\+T4X'',"/(#OY5YUZ-)!V4P81!F14U8MNH][XQI;0E)
MXY!=7_N*VAL2.M=B9FD=NF85F>3=V$AB0S)N1X@--YOZ9!@:3?5'TY/%I<4^
MBTMRZ%2^](^_$T/6^7AAQ>Y&9='7TR6FO^]HVF'(X;.>JW+-2?Z8T/<Y^M<2
M&=Q/:2@HVUH?N+'X1;'@>/,*^OC!N4TE3W?B/U_*X#]#)J,H@-\[LO1X;?6/
M8<B\D/:JCO3/FNC_/FK@LV@Q\CM%UC]74<"/-:8Q!89_^EW".5#_75OIQ9\3
M+ 0&)#:ZKXU)GG7-.-?M)NSU)B?_I9=2YX.>'T0V/!QD_0ZMA&\PC&N&TJ%%
M\AWZ.K,===N$:_@_/[^YTD]-TT1UZ4GW?!E#3&@I7'H]A'R8(/(8+.[,(>6X
MTY&89C8!G702SW>2W39,C-64)5ITWV2]YN./&[XKA0%3,^O\OMF"^[":96(X
M]O:/ \JT5U']0:ZH_B8I_V"1^S?8$K"GY>QU&3GT@Y?A(JTZ@0K=A8C3@V@M
MW&+T<\\,1AG<T$)U+)<0FX9DO-V)2TU=S^DI@,8>3I ZI@$\CR]1;<!/MX'H
M'+F#3V%WVM0KJVJ#I:QXPPZ+2:C1'F3I9+?_?2B3]W<2&%++TOJ>!P40^#&]
ME/\V>'?&F(_NY4.JJI_!*KY^8Q F65=KBSG]>V[3_1<^$,K8?P%02P,$%
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MGW_$</Z%]E(L?40$UWI8G<>DLPK7,1XYGT:MK9UE3QQV8GH1S%"/L=BR>>]
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MJU>'>*= J"'*?=IBS RN"[O561D_?3%W+C7_0O5M!"KO;??)9^.(,'=30]J
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M4.%7X;]\*>R]?!\5A\P\"T)2AYW&*$"46Z;=$YU+;(])7Z44)3M!ZR*(*0I
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M/+W_DGI)GR-^ZB3NO_7<X%M98G0:A DWC63_^:#IZ9^_>Y^;(SY#9K[G7KR
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M/&3:4T=/RJP[WY=/5&V>OAQ3?W"CFE!;5SUGY.@?-?=[Q:!#60AKV\Q*BHL
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MS1WW2L#?N1N/1I2@^1-F,XMCELV49)2RT5>T+>\LS;4I:,OOT?-X S'&GW;
M->-A7J(AQM<)\?I-'%Z<5X ';*U<C!I^JL \,LG/:V2_4&.34DDRSC4G2P2&
M)C[&^//].0UR;=EK3#BN,UAG_EJCO6*44G?<NK/UQ@,*.K6I1ALH<D[C;D-%
M-=L3R8K,,\>)S0=?'U 2(+VT(MYQ?T;*#9$PDV2%DLBG7;^WRABS(*]K^N@S
MVO.F*FJO6*%.E2N?36=5-UMF;* 2EW?\PZ+$9I 4?5C5:8,'R)Q!M'\";6%?
M=UO"^T<L/T#<8EY44HUEFFF[;R7_)9)CNQ_R3CG+NW@%-V@67+M&H4!GA#Z,
M]BZK:VT2\3(_T-GW)7EN8@W5DPRO'!47B%,U%N=FDN;9(#25@X'CL01SN2>+
M.++-1JM[5RFN\L8,%7B !$LC&EY5IT7E-M>7:D4=BJ1YL.67]TM:R_84.I'_
MTNJI3."M1QD'%8%BEX+.H-N+W0\#A5%*,QTS?#EI5*N?&0?,OT^-)DZ(Q'8F
M3WTE&'BX '"NAK0C1><7E=!$OW-1J9C$7NU,U=J?4@JR8P<%D0:UH:9VBX_N
M#M?653;GS[]19R::/<V\?.@HZ]XGW:::L57/E^1>H8T4!%,,"8$73B\*2X=X
M)Y%B CSJ&W<]0K(_4T,96LYQ_L%<45ZX5ECN*A@/1+S W,4#S]S7\ ".]A2$
M=8['O#X,Y3I6Q7'A@3516SPP4#[C6$B2 NOE#[R%!_(?H_# ]6('<.&DU+#B
MOMTT%]PP&CR 2JO& ^N&NW4O_V_H_YFAX,1.E-$XZ6\P&1YP/*1VXB2=\,(#
M-W<DH'J(/^8T-(A!6Z(DMI%^<<FWQ'J;NO35+#VE^X*GN$Z&SM5ZV)$7CA$/
M5(O/X0$M>"GAB?[I"SR09()YC =L[&/Q0.'#N:]S*<%#*T<N7#>O&>?Y1.=Q
M!.N)&7 _/_I?+IB-B5V_'\P1"$*+1E<)VW6$*4^Y20D(O[JC(=[+IJZK]8K
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M;>;6 A6I:O[K7IB=CM#L9L<+K;;Q+5A #*1"F_M48ZI-M-S1%\>&/HR1?X2
M)#H=*5LKY&G]9OP3\*7V//6/SKCG_6$&.?7#,8KQBRGL #9>%^.[O@B*6N:
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M\0TE?].83D0N60<_QJ4OF'6Z30--#?&G$#2HGQ8:';5I(B!3?O3KG62.Y]/
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M+D&-@3(>E1:K/7C>6N#M?:*?H%-E^P8NCP&C.Y]A:DOWC,Q4,RL71@K5[[9
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MD7&EHOO^;E#SYO4:=_TM&#E9.-N,W^;6B[X/YSE^&GW_"PW)53-H8QZKCP?
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MUL_UD=L]M$V!*T22118:V:][V.J-.WZD"3VY:42(:#J,RKVAR/$[EQ5'[=3
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M=H2;RC;T "8=9;%C 6)4>T-JU_406A1]V*)P4RJ7 2Q3++X%O)?(Y#2F*O@
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M]Z*3WTM#K.:Y:LXFKNI +^'F"[[W8("='B<EIT=>'Q.@[-LS&K*/9)W92C2
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ML]U/E%+XAUY_8!^(+(-RB-Z+01]@#!"+GFAU5$;/5<N?<R8:Y,%ZHT4?5)*
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M/>\8Q[/;P@S8+S/4VRUX;DQ09%:>T17)5/B*T5K,ERR6N4TT)GJJT;UKZQK
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M)G/'5IH>:1S _'.\/'>L+-O\;E[89LZ9N,2Q01A;HD.<,EN<JG?=_HUEYHA
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ME6T6A9 9N;)WZ9S^8A]S(+E Y=S@4X.*?M%"YS"UXQ949/C.OQFU_R\FY#]
MW:2?R=2^T*)G^Z"G]Z,FCI])Q&P.9#31"OS^50."NPH^)GY52_17!5FK1SC6
M1RAJ!6E*.FIT$HX]M./%!=0!JY2$%@ >I(PD81<O>L5Z_!4<XY2<R(>>)NJH
M,\DVR8N(BQUDO5W)#DG@.2MI,%$M2*BMJCWWG*]ZM3L5]59[)]^&_FSI\ J.
M4P:BC/!$-UWA!"&<L$_XH*>-EVWVX'^_V30L?Z:%5KOILSY&]!KPP3KJ&I#W
M?+ID.N&?1/C,$#""NO=34B9[V1YBXUU$],;0 ES8:5V?9#L\,_KQMR_)V;'
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M$X:Z@E+70!\6Q_SAPXIPD]BGUA!6@5GZA2UYTJE*>RFR\8$G[C@1CQ()YW:
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MVMO#9J N/IRW[XX]8)B5':&O[?_>:M8CX7=3U6.$[)0;B-+T$SBO]XYAQOF
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MNF-"L\:K9#/\CJR8 :9\8&?H[/5:+_8S-C^(X9G6'_]MEPW,Z7!^9O'\@C]
M#?F;"Z5]=6@Q6 #FT= F,5M:Y.??-OO;A*5KMTK*A21UN5C\.:;RU+ICE$'N
MO +I8MZ"R ZRMR]\H5FUCAOH07/4QQS)X=IXVFQI" E%JG31(5"%P-HEX?QM
MXAZ*I!.:L_ N;?(Y1SE6TZ?9DMOU\;SLI EGZ/W?GNUU2Z@_G;7-H7:DMO;O
M J6,FB#,B'+#Z[2VF@8U)PJ$L@_:X>EDC,UR/8L*OU)E_U>(V[C'C2M%>(JE
MU!$RD+S["X4>RBA-HV 5PMKR\[Z3@(,9N>_9-@)6* ="T[?,UC9KN2N]N!1L
M8%*Y=!\VF;HC>(/ZK/Q3*E_Q\+E2$I.;.#3IC6&WU/#NCK[@@YB'+E/PAQ8U
M,RWB[S9DB?588>].S>0IKN<Z\#;8&]@?^3MNQR^X=QDN0",_MJ@4*E5KSCZB
MXRF5B-,DVT>)07G.)#9 9'=<9"P&2:^R7P(DNQX,QT\TN42LT+#RHF3A3BRO
M92_#C]KFG8(2WWT:F;L8C$)8TQ%)M(XO,SSEY/R%M*8N+WCS>8I95_\K@/81
MN1JL/( 8S-G&A!9J0CX;]['@G/GE5.0"%-'Y^>BW7)J>I2R:&_&U31P5E+LK
M6+DNVG6, 7@PYXPQ7M]LI!3AIB>?V%?A_D0<IL[Q16737*RWZU-CP;/939=M
M]>L0,YF;RI9"WT8T?DG:<"%A"J#JWM2P [Y:;F<.O]_$U;1 O]G:#V#A]5<P
MESQ35,:K5O#Q)I?[@S=6N^G7).O.">7@%/')%GG<8JO?66#)_@*_-V9"M=LL
MQKV&%5E3-2H9$"K$)FT[)3^C1'2O)/EF'#6"=R) :&>!;Z: :LFLIP!P.P;3
M0H1W:PETG9A9N_.>!6PU@"+:R9^=W:2=^YV?LG],9E&%::DDR))KVY5JB1?$
MI]52A#718  1*8Y.UH]M1E ZJKRCE;P[.41@MNY7B(]M!@-9,;9"GEQ1IRYD
MNX8+827>G](AWEYZ$J\!@Z2?''<$[CDGA:5B-7<E9UW#7RN7]=^[QGV9[U>?
M:?W54_)Y@VC'AK#FO)EJ4?#F2=;X]H=?15X("R:"' V&HQ3@M_S[RE9_I0_2
M@D;41AR/PG[&=RU8;]V\52:2)M#9M93<EWN( 83 C\!Z*LE4AJ#VG*RV_5XE
M,U%)Q00^32N3@,FL=H]G1Y9JTQZM-@N4KOD.$<_.WP@1^S@%M=P$FK2]1-T@
MMK3#@92B))S*M,+U.4Z/F86>$\2/M/:K(7%0!/I(NE!1V[1RZ]B-8#73/7QA
M0Y"=EO0=K4N'"SFXCH;*TO[C3#UIWI? GPP80+_CUE\Z6OBHL2BG!\1?B5H_
MAO<(-*>R)I2;P[J'=!-*<565V!^\^WP*BVX1S6]KAI-):\?0.F9$K'=@ /:!
M=[77)96K_8BR^V7.G6L(WC\8[R*78@D4O-[Z1M\FASSO:X3)97S$-C%5J^&!
M#BH:RP%_):U31(+6'TW;/NG6?;$7(6?M<K1VGZ:.B$"9[7WQ2SSE\MBU64J/
M/=WKW6T+M7U=(D".@XYI;TV/2?OE,O,>"*]]Q6F0*/@DVPWOK$&.1*\?&JDV
M:BY:/*L88;+'?;N];T9WF+P1,=MEXA)2_N3AWNS)DQ=N!D*2:'<+L@T*%E2Z
MQK[?(=?3HE&!S(1"51SZSC.8+LIX31)M6RP><WYZD1J&_2A*980X!GEM.+4Q
MRDGK!G>E[-;SY+P53D",=D?+:FC>8.F]GPDRKE2X2HM@ ):4KH@C5"=$R#1[
M>5IK\Z-%%,OP]1+0H;X6/W+5"G8>+,O\ZG"N9+I\^S>>"_B]7,./H)GU47TK
MJU-93T_0%#.ST;A^]X2KZ]\='^J]Z>2RI[N+Z'BG\39V.1@"I#'E46 ZL+(B
M;8O5MH'7*>NOY+B;M(,!D,L0!AOG2GU^,2&WD6+#7@(+YT#&52-&59->318F
MW4AN"A'6KPEP90:(S@UNW )[?)D)>AAC1S)(HWYPD'H/C()THJYB:^2"Z""/
M2X=+47G&2!7!T8LP51OMYD#5C1-8N59H?)] 6*J4<Q'Q4.KS;SFW!Q\H4? 6
MJ%8[@KQQC; &1F3V,I6VE"6/FV93XF\\##32^G#-:?#-:,ENO#OUNJJGX!<5
MA8D0X5,N^&CW34Y8@.14#5,@='SIP JMEO39S-_?$@/ (QFS^H5*+7(@!#@V
MOV6ZPR9 S?ZA#N3.C0+\HSR.TFHNE;J$KUOB/@&*-V(+/)5PJYD!O+O0X%5B
M$0R U$X0U=U+668:A@&H5('VG=] B>,:SB5D[7 J[GF"3:RD1Q(<1*N9(B:(
M[BQ<:SC#F6BUTK_](>*";SIJM=9.VBU".QC:TF#&?A/G;?0-5=V77A2Y^="A
MM.[:C.0N]GT194]KPY'__H#G,>N*(]WXKJ^S69T1XJPP\*(:N=V3+3BYG6.(
M)+B0^G!0\Q- ZO_&]KQ2;AL>FV^4BWS7,)7SV%"CA.4SZSRQJW$;#DH/&//1
MQ6K*.I&IH?-V,ACKDJ%R506Q# N5P;IX>FCU\(7[%LUF0C"9K\A/T2=?"W)E
M]K[-*35TFN=EMS8C:<L^>I+X Y1;OK#KC.[K.)K(-5JO?_,$+BMM"X5%-O F
MXH-A1HC5R+BB=1W1K]+9K*Q/Z/GBU4]EK8QG6DP]W4GFOCTV?D$X:K!IT[QB
MJ<YS:<OAFFPK+9)2J!TCDF74L2 B5;$$<JI-T+]*R.ZQE9F5+D2M3[]KJL_>
M&AX8<F)*[KQ3;M6 XUZRLDUZ'!-U$N%V4"[%4;\EG4U#Y2G6(0J_RLC1G#,5
M]G\U</^Y/=.P__;*?/W7<GB9I(*?9<1E>RBPYJY@?>[P *+,I#]ICIB=9_UH
M<8"/+Q?<*K!AV]7*=$^E@U<-)S0?2D8/40#EWIY=8P"AD'=6:ZM4.UZ6#DV:
M+_4_"+"SALR6WXU8,C-URCVZZVI+R)"? O[!&J4]2;C&N74<_FI-,,A9,L^@
MK+Z;PP+.4<SH3O^[DB.5##:#B:9:O@Y8!!)S('*B'II&ZB^L"$I_<3U$[_^]
M#@X.%')5\N7J' TS8@7-;AAB\W+'714FA2BQJ,E]Q5H(&(5B:\>*TDS5VBO%
MI;K<##Q)#34 SK3%(BEZWZ E"[* \@*%.Z\A8;OR5$M8_:R!=S0#J/!>6J]K
MT;;4PBX^B*P-(?$KLL&@R]7%0KGDM0 A5*I<D;1I3T]/;.CBDM]K M=RB&)5
MO$ZBEAQMNM=-H6+KMSO1R$]WSULHGAGF6$7I-<N*!Q@,H642X.T-4_P'Z8Z>
M'00@H1/)74M#.\: +/@PZ_R7A)N?>NT.9X@Y;8?&_#L5%M^CV*P:F?8.$/G9
MH<5RI:AQ?E,6_AOIA,^[O=IP[7 I_JR2W4O7N= X287W&@^6XAI%CP)84?Y.
MA1S5+0Y_FXJ/3>H#B&MG:[82[0*CY+QN>1?>@)6?&K.^1'Z=6FT99;B/=8=X
MH;&;A@G1=@5J4;EQWT ;%GX;HP06X' S#7-90R8B>:@,*;!HUP)UH@CIUWA>
M_<0+0!=(0%,!!X5MWSV82YE8*IBR_0M9BTJ;")E.7]*@87P88SJ]NPF9A:'I
M[R,D7;?07I(C52]WO%M/OW2[>N>8"__!6EWCU"%GW(3EN5L</6L/XQDTTN@!
M"[U]ZJGLX0+7TI[[6>6J/*(*7-9Y_:DUA(.$E2;3?Q5BA*?)S%4N(DL$MPZ+
M2M;2&4?CHI#XOX3 7#UZ)!D^7PL*-OM36+#%VS6-1H"UJUWQ*,46<]';\I>F
MZK?R:\'"Z?%]3:*K81 U@7GQ7E(W&Z8"ID]KB*ZV8"3WYXN@VQR.*0;W\EU7
M'^&8S40IX" -_ \__]"9%:=$B8I- $1'=]E4-JOGR^_G.UX).OHI_U0G6!QW
M7.;CUW11?;<M"K#G58C;G-%G)X@&X%WIR6A( $X#*G(C%J0:Y,;QQ45BA*[5
MWQR99%&/B/N2C36>]FB\YJ]A^Q?7[3\JR]<4&6R!XA!79"[O( $" P@#C,N(
M TY:4'T<3?U%9J2W%#1P"ZZ96@V^9\-%\\[U%I4]2:.-DD5HF9\Y_8QSWBIW
M0R%K8G+GOA?UZQ+;D]M58>1BZ!:C D7\?7Y[NSBIAF]=9M&&/BZ=TCX056OQ
M7SZS_/U,U2>&MCW SY?U=X^SX8L>B0^3"#LZ8/8H\[6T&@R \N67EU9"%%E9
MG_"\+-@0YZ&5,'?>E6?>SXB3LBDF6GW!)J[!17S:/)52ZOFM.2\A_>N@<,.F
MK(:ZMO@/7_"[Q"L=QY,Z1_-0LA6XQ(;R[_&47;.%KZ=Y=_K#(2]G!AC:C/!?
MW#0R8P#G^W-HVI_@SPK)FGYF_%X2FXP[%Z^WQBFU*8WFZO7*QJX4^RS(IB"/
MK3\N>&YVV7YJ>W.77+:VK&TQ59%UKO&D(8S]L]2Y7EPCS0'='5'KK.@&60_9
M+^&?"?TF<U4(892&:O:,B&ZJRL<\F;79+!G2)\<LY+/17V675[=L(-*W>1G=
MM-LJ]XRG NS9[F6AR?#8(B<"/>QS?*B"4'SE+[7:%T %<A@_2O6C;WJ\_5D7
MK8Z@9L6OTGHQ+C\YP-1]CM]L.3]H4#?[S/,8=T]<[4E:J4G:QQ]?SI+BDZ%L
MCCTEK_3_#LJ.*L?:&87+B,E1[RIY6CYL 8H'M=B7V L_-0Q[@:\L,5!I6"7V
M3U6464I'_G_UUP?^Z&>1IS(:\ H!S4@-V:&];ZQI6^TO($HB<M0SAR*U:>\F
MT0+Y(?+*WNI[1E??84D8@%4\.9GWAF$2+T!W*&UD/6$L?M]B&3EHYMBJ:%E?
M!=_7G<H/U&AQXJDXB4>#QPAH$-N6B-'(8U$^+OU8J^PM6W>9S\Q'LH2P_#;*
MN5W:&6\I:8=!;]JEE^(?@G8MU.Z]8($_MFAN$16N_*;P:<-2J;,AUW0XR_Z,
MC"P"JG8"GZIAL(H-P@",&9C]C";7=YL^J:LDZ9;S6"9G7ZWSX8]T32P0'N(V
M[PO @9\/COG9C74T'<B?"T<M(I9,LN("$P_,QY],/O&1.Q^: [=K(_%&?E@S
M,52R<S)E!J4??/WJ(;,@\O=IXU'":=ROM1L^*/S[K[0\N[P0'BYYX3C'N0 :
MB*0EGI:;PC..G?Q$/+=$".LT%RKF,L?NY%!B0;Z3=7H.A0' :<(#<[1JLKX-
M^CP*$Y(ZPP#V#77'LV-DSXY&%1MQ-"8WO[Q,\NXVBD.K3-LT=E:UQ<TW_Y!@
M:_6/7MH5.Z0F59#78$2NTJ %:\U=S\O*0NR(!@Q!7I67SV-\'B:?RVFC-LI?
M7:;$_VTY6?@C;EZZ[L/.?$=S "4YTC- ^@>/UAYX'K*4_V8^^OH1!W0Y4!X?
MQPJL1\JENML7F'V/MYMG:5@:47F5_ ?]<&9[4E2;PK^6%#1O4N[0V4=H7I$S
MTP9E(F#,7&;8&TMMR(6,(T%=)V#Q?JFV)+9#L=.JH$.S6K_M0]B/6*X-KSPA
M?JI#W(TX22XT;\?^B)1VZ;W'08DXTF&1,GJNY#MG@^(G6>%8R#O\"D<ZBE*[
MDH(^H\/TD=Q+79EPE'$5P>16Y>"%:R3DZ<TS<+@^/=7*T -H1QV?STS6=PI:
MU++(8D::T^'!(5SGF7J D4Z<ML-$)O-6;E.")'=OG;\]HEDK7'N,[^PF/R3E
M-4#SP7/>\8\B(;69:L1.+'^*L=LL$.)!D'?K((;YXVE^418>E\:6E([1"G]9
M3V]WW!?3:K$?=&DZ[SS//SGQBEKU98ES7%F?<$->S10B4D,JSTUYO9I2EKT_
M'O4OM&ROS_:!R-'.DW*=D-Q1'2#'S(08N7\C[ 7R[U#J"C7MD)F,)7@C'-X.
M:A/L%@AJ\:3]4:!YD=CP, F(*Z:-,F)]TIP['=<D\G7]N$*[R0E-L0X*H]4S
M&Y R->U/(U&_:YDE6&M?D)OM9P5)O8HM^OWQ\0B_MC*[W/D)M/<XLFDTYO'X
M]Z:6+[T7GIPD_G#Y =&SHH/]-1)_QFZM%-&%EQ8?8&.-CR[+G\*7U4XZF=1C
M]#WG+M]5#!8OF57T3=6O\=^=.ZQJU4;-J%F^YPGN#%<_C8^ZKIHS[G3%IO^C
M]EMO:CJ#S.W&"!'9<".\CK_ZC#EE% .H;.4>U(LJ$*4W_0"YN=&>,[5P9'0Z
MAZ4\.O4:&IS*C+]K=88P(8XO<KJ/(^1(T]"HNQ&ND'I9 Z;XD6*T.HJ]> 7E
M>V/2U) M2&L;1YNTJ3-+7Z$]/['%*T _WV--<5M=*/5\5)FL'I@X&Q3SV<#4
MT;V9=&U]D, /B+\L/S-+];*;-$:!AL8+RB "0BG?<8-3M?KP6@\BY )G&<P(
M= [:JU3"'O:"F$4D. ']1#Z_Y8H+PD]@-0&2CB36I>$M^OBBG&I6'8?]ZE?2
M%W0@I'^Y\B>MEG_J<&734'N!AQ9[ 8_\"#<$9!+IT;6;R7HQ&  /X-3_H78[
M$A;E_*1!-_UC=1J[KH2SX.W3=OJ*1Y.5SPY_Q#(K=[MQKV%9K"(6NW.=^%>D
M,X1=?)BM^XY<^]5[:A%4J-2>]'+OGZ$QZ,[1.C#LE83*[XRE 7WM,1D:N/G#
M'BG.KR#;,,E/;-S*Q, "KR;K+K#IJRD/)#B6T.:DXZ.5:+=##I[365EQI9-+
M]E3W*:"(':1^*D#=6[I[]R3YG$QIA@LOC_<+(>OT3F>QZ%#R"+,2X?NG#;+Q
M=LCDO8J5<.<)04.G;J[@3_9U%VZ]\#PJ30.N&#J"V?2_:! RNC-5RC,_@'>\
ML*%YLF\S\SE3H 2+_O4,770 7WT$Q.0:%DXK+4T?J!_9=H'O>U;Y;83*NW%H
M9^2!_EJ-= XM6FCBZ/R#\>*0<DPC"T#&: 1*^3T. ^A%=-J57WA5/9,FT-S^
MB7;<V8\-N&_UQ<4FI%K94D780K^=SM(,[:X"\H-MV[)W1GG:,U\)#OO,Q0AE
M-G[W6B^RX_ZSI5SQHSY<1M@)]L:Y-N4!EJ K"FB1O&M9U1]5>51Y0*4VEQ9-
M]]%[^[,Y,/R.6:T<C*.?#5]1CO=ZK,PLN-4RN][6Z+DV&F&X0)JRR\SG?A&A
M>J6Z86]VASN;$Y%WD/[5,&:G0$>_J:VX]CXRLDZX<H6) EH2V!Z>+5H^,%J%
MUO<(.[23>31?6I[3588S'^+&4$RTX58*?_JG,GNO.%-W!&!&%C^=ANE:7)>#
M"DG(_!)Y]W?T*X(-"Z1<(S RV.%2T#^QB[NEC-<BFE0QC_(6#JCD[="!?H#@
MURJ9QY<[O']*X:5$B$+WVJ(-D0JG[\9JQO2KBC_Z2[W&IXAK,;]M+/:/6_B;
M5Z]7^SS@W... N6,L*>]CGF7813U5H59B(I7O&.5)+1UN>*N%*Y[V";1L7L.
M,[&9E9'GJIV4*2[/@PH0/O]#H)<YVQC29>P^97(F\P<5^B2/H,A0 >[/MJ\A
MUO1]RJ0/RFL?)Q=[X,C2HE!I9N]6<%N401WH8RV)UO+V"L"A["><.NH9XQIB
M_[*YU63=/O9,Y"EG0]23EY)KGV.,2IR\)07^U,;^R:'P("D6B>!,?JG4X13H
MF:>)\"IRAS=';]4)+CR_^;:GXBLR&M.D!:]>$'G/J_!'L(-]H:X&M$"@-</Q
M;?%ET&.)1YGN!M9.Y"9)E?F;>?YR\)SHEJ>N3O9B/^P= I8V"//=+?0JP&X;
MZE5Q&Z_CG0ZJG <8V%H7=5'IHCX'FP_ZPQ]CWSK,-*[?^'M-*+=0QI#&?!'L
MY:3C]&XHAEO3<P\;9]M_)Q*-)S!;U$3VNO#K%+Q+)"@>];W" 'H62,#B/48/
ME$T<G]*+&#&L)7S.&3(:D^.>%8&2[^K8JQ%F%4@+-KBGG\9'LK)$#7;L/DW3
M+UFF-JU2D>RX=8RG4] O&JI7;G!(++ TS\< 'DZUO#3:V#ZH9YGZ'%!1\$.M
MN>[LM1ILM!'^7)O#:9J^!$WF7W_#N;_OB@$097]^RD>S'+]@]6J^.^7N19L8
MTDQ.)=)3%1E;KQL#[8B%C)^%?;#[D/#:\SV>OU7NKOW:,;[='6L=$[\HO=QB
ML7K+\_C8DAQEBIRN-J,)-F&'.CM\#<W/0,1C2V.(8K,4182SCO9($]\/UM4&
M=<!)>V2 N-\\M.K [34SC<4VFI== V5>ND?9[=KRK,J]'NAA>-RU2FZZMU#M
M0%?%7BVYP!!.<[:5M;[,I%(3YO-$DYO4ZX&2;X,F3QFK#_.;&/7<*:<RF?YU
M[ZZ,GKJ6N^D/V"_G/M,3%(GNL3)-/$8XIW]D_S;(/X3/'GIM,--:G\QXILY6
M%=XHP[C5HH$4T'*E%M.)_"L[-5O[YWMRO!R_059VR?&F1]W#/5\1-A]GR$SJ
M(U[6^4H,H,M[O#!]P&UQ12%%QU)F!;RM/[VM"J\W+YE<: 6J(#F70UOSW;CY
MV,A6IG6R5@II$..O#4WOP@MN$_^L3&>O+&LD-4LK*VF4:XOVA;,I8P R$?(7
M,'XD04]9+)M\BF6K5:?FN2A=. 1:H>''6?C#I>G)7V;6P.G&_I+^<TFQ# L;
MFR1$J67]J'_I8D:J-Z=QDY5LV;BG1H8+.2J ]XW3AFE@LP[]&9JW8/)\4*V"
MO2Y;MCSO<21,%MGV36Y2K-J;5T20-#^@QJVWK%JJ\DUDJ2=-^0@.7"SD[A$B
M=LGMN\;OD?,$>=P;XK[;;RU:Y,GPT_6K-P/6L,4:W9?;1W\H4)RF]:UMLZ)S
ME97.K"L32MP)<70L90,>^[LR>,CW(^LLW][LJ7=D"S'<.U2U461\D4=IP:;?
MG,"RVKC+$!QJUT[ %2S'ZR@% 5->A4Y1N#D.[>]"%W/D_5PB*1V)A<G0"LF!
M&[/7L\,T&ZP_=92HL<YS#C1^+.YZ67 C_7\S3!X"![FJG23N/ =KLT9[R)S!
M6PESR[]GW4(E):QR]LUS#FY$O(#5 K%<2P;92C%?_-4I]M]8XMLVAO>-"CV^
M$>I*$#[O!]XZ[/S T\U_/^2HUI7ANK2*$K?GSW'B_ +EU_#Y$_(NV&BF+73\
MF:)V$[@;DD<3!I$MZO9T*MVS$8I8%; R)P8O*K=,?:BN>UQ@3?* I6SO!XT6
M=][?;5W/\[^3C6.+N[]^>NG^_"*GBT_FLU*[GN%O:9AB7/A,QTU?<'_?/+N"
M=#]_N KRY\$AX$ST9!O-T2:# $97"C.GMV4(>WS\J;-[:"#^9QSLX.R:TL2R
M$KF&$G6A%ODX%,+LS)%)?,'D)#7:=6(ZURVB; 04M(J931Y&4IFS+9AF.)&+
MM)],UUV597ZAV#"S#$.#X!@ /;B)Q;M'7(M9\#<CDZ<$P'92E-A[VF'X#L9[
M(FX]#M0>E7'R)&7C("4<Q)JI:G%W8:8@^^WY0>?TT7E!7;98G?U?_PJ@W/GP
M(FI4<PJV&3VB1D,?CA?F:QAOF"&# 7QH3-)VZ3D!T1AK(:5[B8J&;D3 (S,Q
M5$+^4.)3%I%AQ#&<+RBBX6ZHQ4CSU]\W!_UWLI:J%CL+AB52R[NS;"LZ$DN-
M.*V02Z3S6[DGYH_Z'O2>^J('+.3D2!*T*T9M\72G9;]Z&/+?K:1SUN;T2/.]
M6L4Y1$02XK!B #-M%K#[7-XYH_C(N>61T>V[7Z30![Q_U1'Q'_^IRG[:5<(I
MH,:ZC/]W3FFT D486%X]I8->,.1@ $H5$(9__14%Z@9T-I%-C\:*#AL#:%.\
M!+8DSS>*MDUA]J[P45H[5_NQBJFN]:-[:O+H4/*6M_0V^! ;PH]L^4V0WILJ
MB_P;M7;'L-K_#DGW*@7ND_+&B4:'35>#BL*,>"5&OU1);LO >O"5]N]K\ME>
M<L]F"@K'!>/:NJ0@D0BQ[3'&2TL*,(7Z.'N,,0.N&]D--.16$@9"#!' 20GK
M#4$VSR4>;QX?IU^\43=94'&B&*[U*L/ZPKMO4 [9;,S,3;J)\*1-)./9(X2,
MF;!1LR:?8  'B[2%]Z<_VF1V7)4//5G/<=[K[U"MX&A3QB/:G3 B;22Y3D%@
M?^VR>&Q@N+ %-W0K\)'Q+LF43.>/M<;CK2!I\L_76^IC];0%=0:E7UE>_*HY
MD7L&YDAS==KFYE%A6)I> B?UIO<E("T':XU2_A .-EC@@RO#X:E=J#9N.Q.;
M8J*'QII))>R9M@G7Z<\6JI3<%RPF7HW_VO%V_STS9MK1$)%;;%UIV[-*\1V)
MGSY3M?RG]3>S[6*%U[5/Q&[*.I:T@;[K@%PMC#7A0;TX5=V1)$YQ:75C9BE'
MQ:^3OB89$&+79&)B3,L_AP_2F?@& 3*Y*NH5=F1]B)0K(,^C=I6=-ZT1S*9+
M")H<FUUFE7'DU>&;;LL46#9]1+,=A2K; $6ZR+S;.(O2>GHV]_.!\&6?5(#!
MEA4\2V35O9E$8&6>;Z8 NMC5"_/4)MG?IZ>T,&9S9LWCNI[]0W.I?:C]@\7[
MPAKA7/E\U*[TS4;.MR!+$G)56+9LTB&0P,$[W?8@(U_^+66O-P1_ ZV>+P85
M-,4 </-B)PT:&W^=RLUZ#3+/C2 ;D"C] -ZJQ,D+)Y2]K0OM'*<QHPJ+<"WR
ME@<XOZV?JCY^Y,PTU"KXY\\C6>KM"E\)X(: 8CP-FGT_EF=AH5OC32;/TC/+
MYB4"EGV2KL0E\&>=](4]I^H?$J\E>MVIP$>+O9I(AR=.CS<LO]03@\\+T7S)
M(J"'FMLZ-^#D-N45^L" Y#,*]^$B!NX!OE'=:8CLIKUNF6I5-;:LJV5.#DL+
M5J4C]"'?P<0R!C!A8!6S$32  3#>DB%5(@]J;MF,&J"/#33HN#Y;2IG?$S$2
M@CXI_06WX)3J\@G5'BH#U8\4E63NLWF,PU[*4SSJF0)Z7A D4G&-O_J[B;T1
M1_E<R&.EF\4P+&"!OR?"MCOU-=APX>G77H&O6,M3AFP[Z7&U/Y8M'3[19'?K
M)NJKX0L3>;,S7/3ZAG_VC#97/^%^F\YE*;"UX*,7E0X&*YQR6AG/-MG[9L;W
MY&!#'<"^NXQ>H;ER[]466WV..RVI':"+I[OU'VUJ []PX/Q]9#1^)R7EC7YD
MDDEGK2_U(.GI]@]8*@3'VX=OILC11:)^\K Z.D67)$#V>E9#76ALJ^CI[.>8
ME/!<B/V4<R6$QH^FH"2K,B$OACQ+,&>FS1C%6V9N9TF-%B0;(T1:9AB^=N^,
M7;R:'4^Q$(Q6,Y]<:BMR^5D<[>PU.VS!T!"V#Y]B+"@^^1']AKQXB?5U_+[%
MJ[<U,7&97,V272NV&0'3KO1MTN BP6^#9M5O+Z_B13=KS[P/5]>/#W)BZ^D<
MFG5/ECFN,^L<MQF1VIJ7JW/I7- X*;\?[!^$DC  B!CO=$M :NHJ:^Z;9*X$
M:TF"4!RV1A"*:_JK'EICANLMZ=A<$J5L)"F9QPKI3(;Y[??:9'MBV:2AC'CI
M#"@&8-+$K9)>;I06ZR,Q\375:DID_]9%>Y8ON2)/[&]7VXHV*-1O^K)[4(M=
M\V[:U'->Y+WRVU9\83/M$-$?%8[V+C[VK3AKJ@2:Q)<5WHHWMI\YXU;>[W.8
MOK28@Y76BY[)>16H*"B= KE1N0S.SM:-H48'FX?ZE?S0$"E8;Y8N'Z]6C9%=
MWW96 ['VQSN:,[I0"&U378EH7,DSP[$^\HEM!M$)"'V&&LH5;FXEWYK-D94S
M4OVMH3N,BX=B#22UG47?*=EK'FK6]2FLO]N2&FH#>H!B-XO7;)H[Z'!:TA[.
M]( W-5/,>QNA?&@J"RI,H#VU<((AR9O^V3-8BQS;&[![;QO[A"C+"X!U]:-*
M4/S<-$7<BLB8IV78Y/Q0<:K>QV!Z-_'-3%O6>1@%D2D3SR^#GTLE1\?U:4._
M:H_+CUI9B_H%%_@J=6F[OC-AD_-.W3&*9C?<QPXFEU@%;_:P@0HF4(A7DTOX
MNV4OV"=D&?>[S$R/(C!%=[C"A">?SDB?(<GO_=\P'YV_MM7G#2-\^?:HR[XO
M:(FZX(%'PL:JS2FB"@.P^#O>?1TUN+^X:11#!?U0>44,0*V/]PA*8V*R;\$0
MK9,]_\$C0HA?<M<2"(%.V#8AODUQAICTN\B=*4S!?_5.;N>C:P6[IM3M%PT/
M1IHOPGY!*0,&3S6]1Y#:S!';B=V)]\R [;FJK%+ #_33Q-F^G.KA&GZ\/\LO
M=@S" ?>9E^A5!EQ#QQI.IK[L&G'$H1!O(WK*U6)[GZ8!#&+EQH]A[X+P+92)
M\8Q@.K<9$$&**#E>^^=F314M3EMMQ_(JJ#&".M1L]_$:+&P%=R('>]?6UJ[_
MM5=2$LHHUL(A40-)K3DS+*ERE<>,;H2!4>?E2J >%Y)=_IL>RK1-@'LB@^L5
MEIE 7!N->6=)482(P'/ CW2B+\$!:;WZYNGO'?;Z'8M,H%V*VTOS6IM-?8)8
M.HG@-<.Z0^V7")/:F!<DAW_S5R0=3E?Q(:83'N+:A\-RUDWQ?SMT)>_?IN 2
MG4V'=(J,6S8D FP/7WW2;H05A#U)5LY-.ZTRX!Y-35BX.9/9NX2SPBI66UQ3
MXM[0?0R*PW?$=W*X6QDRL30GG'!3PXO3KG6[>XQ\E@Z*%; .FGDS_^ODA+"C
M0HM*$FU0!K73(#J! WC@+1B BZ1&BBR%JS*115^Y6,JU9\AU4G!"4"V[#;MW
M(S#45R 00O2N9.?AGM?=AZH_C=+T03D%2KF0)SG]%:1TQ$Z'"J2]UPF6*JB'
MG;39#R:2M.-$GR><;+6:?$I:M1KN@;]3W^6M'@P HB5:A?N]2Y9_K^C11CWL
MNP_0JWW7G(?'X1PW''%5VPRZCJ7-8DA+9J?(!TXR,_C5&YX3-3<YC_.RE20,
M9*)VU3BMABZJ2N3 %8<_-KQ9&>/F3"M0?ADSCV+[DRO\#@5>2<D>&*UIN(T!
M^=E_*\35*AHB:=J:O9D3<5PD)=^W!@3'>A$=UYB6H=[[>42QM7W(Z>/ED[2T
M\AV8<FV+VWYX\R3)&VDC_?AIO'_F+U50:ZA,0.U:#KW(KSRTZFR%4:ZY'(A*
MRT_[((*S%75*/;<0J Z^I/F[6F,2BNJ%/P?@'!($63ZZE$N9X;K-1N-"G#::
MM9^_GY@..1'<#=T&%OAN]S+5(HWB6U2??6D1F_DE7]X:*"]X;02ZX4,5J8Z?
M5?BN'*9(3Q0CJ22=P=@PB(A?QC$EJM2T4$/:,3+#?W@6@/WJ.3G1QL07!A"^
MC/@[_XN^IF;!I0^A\5Y8UQ0F%X.FL< 7" Q@;F7]Z,F7M;(3E7V+  P RV/
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MUG<8-LEED8?F#6>M4&,O(N/W:3QH9J$X5*0Y-0,[;YUX9EE7:7/G48EMQ!>
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M=Q2WT&&2YJ(C Q"$1!I%.38:O,.<8=1-XGQ],8V0%P'&[/\_M$\J P'Q(5>
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MGYBUK!R7/8T";=);;I02;F/)DK&(Q=$@.<S.+6*^O[=#C9/B(>X0]!:#+86
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M0(2V--B.Z>A%@_4<"^ZY])2GK9 \,M%0KU6Q)=]G>5$D=NG15MH']57*I$:
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M_AX];WU>D69C\ VJ;)5Q/JDR66X3CV_EEW<:D&S)S 9*^5I+=+52>VV-(^2
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M:D*;=>7X:T2<OX7 ]4SI\^880;/)G"'D1!?8B?X;F../US6MM&2#] LCLEX
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M, Q),5>-P5,0?#Q..GUA]VOI&4@V$S"!Q4M JSQF5LW^=_EV:.><UR/NN4M
MB#?X^@6%S=8BXVC;@DA%0B?-_4/[9DS79&ID8LP#N<21^_Q2=]P;8\5,B9<
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M<H#8+LQ7P]!'?MC@^/:K2(*AL?[CA<^9-19!GWWF_94OP#T[RBF19_P4@P_
M1)'$B9D.^6N]"0>!@\R7 #KZ8Q:6''JW!^KS&24FMH>]4?[N*)->N!N<!D@'
M=1LK>0[/6LROT>#F_*BM7 RA#?0]M]V(PBH#( 'MX33)XS-H,_<BI>?*\<AX
MT..-UO\L*K4G)\-X$#Q0@W*)W"T0_=&/J5B #6+#%.6DS"08J?1H,\6)IC34
MR(.=,J;@X!*@\X\&+?8+(8\)@7C#*..[D]5_%8QN*[V4O@0<;X5,7'"O^Z^U
M?,^K[B6&. 1$V*G&;&O+#N%4>$K/Y:V) ;;[@^D/2V46M*G$R>L_#Y#>")WQ
M12Q/C'^JE_64$&[G1JVP;+/4 7*[$B_3UD0;O<'TI&+L;6#)(,QH#VSD N;A
MU(X0?F<L3_P*[VJ^>V@WQB)TA"TJB?O:A=D<:Y=,&E6$P</_KF?<K1C-CK'I
MKQ7M8KL$R!8N"!%1]IA <<'TAFP_Z>L"*/DF11A:[EL3:!13)H ^F*]^S#2)
M!!:_P.=UQIC\$T2&._,:G$Z\G./W[&N'W,=.'Q14!T;CO@W4]"C2-^Y=**RG
M<$"1+*TT##)45^VE0O8G<2LIT23B[L>;X1]HN-Y?@WE!3+"!\R5)"BGNJT^
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M6(L!7Y^%*A ]BUIHZ%?4W21# N3;+=;6M9&1DE&E>9M5YL_>J$IH:9:P 3?
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M:%5B(XAQ3%^WNL4SSJ/^K=F0C)K$/C(^B#'H3S,W(3.JQ*;NHW5YE,'#AEL
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MX,-'P.]@ (A3%9]P&!S=><5JV?<]2;AH4T3?&R#'B??[:2EL87AD,71O5,E
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ME<KJ/?@3DH7F2X#_6$'J^W7XK%]4N (A@LW>N4OUX L7_?L6<B%0-R FA*-
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MW*QC<LVK03FXQ-:[M.Q$#EK9,DDK]L3HJ ,YW"4:CC$LV+FI!2Q_9.77$NY
M$^^XX*'?OW=FF\7)>1091&R&TC>]ZGC(9L^YKENTR!&O)6D#_.YG%T!^SFG[
M>' G^7UM:/#B/?BY_Q]N;'>Z6Z%,O^<'/YIRY7,%:87I(YZTL)/=1^!:V;#9
M*TG+Y&':TN^TG8/F4208/GW$,(@7G9<6'L[_I+.>JO8U9A7< 8UNOMR$-T3D
MF<%./$(ON!CGZQE4(YIV'@$?^D[-C^85$FZL:-;<ZV(=[SF*WN-^\<*WWSN#
M@_P%KNB68V\ZHK#I'U[7L)NG.TV]%K4+82&]&"D6/^#05J"P.:UP0;]QW3!2
M?FAV3HV">,5#E12L1Z2?[H9E..IVBQES030!IX,+ZJ%.E7.1)_*_JO5=WMS*
MRCKH4@RZWPAMI]!6$YAFOM;5.<F8L%HET%S<IPDU7T)MO52"8C<"M,B6D\*^
MF:R);3UJ0A!ZDAF^TG3K>Z9IU3/XDJCX) VU%-5VYAU/)S,5(E>]:)W6M[J>
ML/Y;"XN+*YE6EH+SB(C) **>J+1=Q.2*7=+N ,0M!I,#=R#G*0$#LZ?LV0WK
MK+P2+79SUKT)4"5B-$[LG=*#UC<E:ISII;.NG0"?62YR6J7JJ%JB6X'9H%2*
M9WV5N\F-X).#Q*(S0)L6/E,W:19W%<GP-FK*JNF]I(7;1,3#$R,:_!G %%VY
MP]CM XZ-;V5^?APMMH4BXI&ND-A)M>A""$TDR2S?X<EBJ(=,OM!/YNU'O*?Z
MVOF>-!GF)-@HTB19>\AEVR>V+A4L8D>Y%-6!D8)\ ,F.IY9?IW[NULOS?@#\
MT+((A^0BPJ=RNW[@9IC7%^29QU@$EY"8RW6,Q,]9&[)]*\2H#GY527/Z+P;U
M"?$5UAK\GEY@:M E^S/ Y*?']K (X,9V?<)&OW=P-:I3&!H!O9K0EFK1VQGL
MGV'R%/S@10XE<9)(C\.TBP-\U?^ Q/\N-4XTC2GFB+U0N ';\UG8Z>3(C#H#
MW/02M31YGD2Q>G;9EU:.M;C+KXXO#O+?!TTE@D[(]@(T%]D!)Q5="A+X[K;!
M2S!9_!TM2.VC=W14515#7,I%PXW!/[5D-V<$HEC0I)[J=EK.3R\7I/>"FDY5
MH;[YV."(1B8_V_>B][V\ZJ[WB:E?M&X.':7P^@:;XC$1^[^]M&X[VT0/Q/36
M @5ZP)H 0O"[H(MU#V;[)7?,?OP2FTY;9-\79X%S1LUR7#4Y6+WI$NR=A&7U
M4Y97"L!4][G-]PN=7-D7#6@_E!EC_<QHP?WPC6L+PA*R9"E.\.FLIX\]J+.M
MQCAMO58IXV*AO:'\2(K*3@,O&]8(SM+&;DR-HW5H*" KQWBW3ZJNS3S$1\-K
M0]U<!>4:#S-%RCBJ"6-U/F@G9VG/AF\=KEGMO9\6Q-21TH4E<,-0;4R)-",S
M)DAOZVTRA[$.=:,B7I(RI5OWV.WV=+&?F@A-?HG_)4QHX\,W\Q)O_(32K48]
M7 ?W1$+P- M1BU+@&)F3I!K0#R'3)PBNCO>&5/KY<B3A+R/%P95>![5</)6)
MMI]D>#]=C%E!2U&MSUXFOKF8K-\T^.'SP<NPF\Y_):;#;GPUM\NUA:L2 UD^
M2N57&:?>+[MO,%G[ZKL/&?8=#^E0!-+X=G6MGP%>#KO<CY(.3Y4QC+E/ [:\
MY%_S =.&N;T^N7@>$;RR226G[[Q#BAC4)%(!2\T7Q7*"[?H-114.2O*XK%Y:
MC8BY3=8.OG<%?VAF@S\E7*YB].C,+VJO3+MP;.E_L%P/O !7'2(ISVMKO6"O
MBOI]Z![YL&#P_-'A<4%\L'I#1(EO4!<Y:UCZ:E*2[R<"]R"P1X>&6YCF\]=K
M%_SUW_['$!?.<WVZ=D[N%_X/<C3Q*)/$9$315)TC1]B= ?["H)=U_M/;4.?R
M41C<Z:>ON(Y6B0(VZY6[D1+[B98Z^3M<F*"O&JU.&$ATQG#25X=WA$XS!*?#
M,Q_)G7>LTA7R-]+5TO!&_$I<YW?ENPTK+HMY1>MSY9YEK!E3W0J.N2>!VV#"
MY+'SH,6("'AA=MLX,JN,Z0<0X44DU+RL93T#. [1#!^BRLW+GPP[<($JGJ!:
M<NN#YZ3S[4^E?=F[9"EHPF9Q^X[(HU>(3MC21Q W,>J1CT,-#7@K-=L-EVZZ
M>E/LAV+H^G((J"[4D C&:P97CIN)H0J^'[]I.OX5&")'ZO3M[CQ/<2US8JPK
M7I6[\A<GKQL>L'^AT=DDPU9DTP3AH?W]DJU81QEOQG+\__3.OC#PK7!Z3?;S
MC.ES/(1MNC3R(OL)N"6S,B(%U\\-ER9P]7LI,G/8-%B=]GQ<N$N /OS["&BP
M/E>1%UXPK1XX+\YAZIBPK 7+$UH/I+I*AHF;$6D(EA2P\("VWD6P>+*[!/%U
MU/$ VK#QU]VI:8V;P!E'(^U<DB7!]O,[E^(7@,V!9Q3/[8[A@(PZ>[P=;JF>
M%SB.$.)NN2[Y*GAAU'8%R]*YT3">4UL1X,?#H=O?9D5#/K ,8-D272CX)+0>
M&4<$+YC41W9GLJWSID@;73PR#R6M-ESEF:+9/&=2Z_I3X+A&ITNEZ3&5]A*V
M7#.T):)V"]"09IHU_34@_6;\BNZ;J?NY=_L2-B&0MF:C425H,0Q,. Z6:O_[
M=4R>-RU#FSN=)IKD442<TPEHTMO6BK1^=LV7:?#O_S3>9MH(OD !K0?325LQ
M+IRJ/_GJ6%OV;?E)/I)I\8L.S>@L']$+FQF53(\3#Z]O6TO-INPN/+.GNS.W
M>;B_HV-",B7FXG?[*V=\'M4VO+\'^!2S?Z0/E;3W[]^.=J]AEI4T>Y[/O>!X
MT[(HBS(:!!K>6JCYIF>A-G-9J:%*DOI@N3)<0P7[NK;0.6ZJ U49U%!D:F$V
MOII@%OCCT:??'%RA539$_L,/&+@XYYB'O3O$Y3[U7;6U9Z@J2L.[AJ?#5[KY
M-[,SQPH0DPFZMU,B(SVA#\X+>R4;Q2MH-E]6NN=0IZK8QQ35#>$B+D 4U",;
ME96K*EZ)?&V%!KT0HGR8!1*-: DNB"I6DCHN+3C;_NFV,<1ZO(5\3MI43R&^
M:/-*F+%S%EITZJ?)#\0Q^V[1UI,5O?2\^I25Q#@M^=_2MPL%2<]K.U5-N-X1
M0A>24 0?PWC8\1^9NS@.N8&;++^ZAQMGHX0EW_^_3OI(#@CVI7A^T:&*#_B;
ML*'*"'@=M]^ *,S)"F%Q4QY<T:@]217X?FDZ4)MJW-,:S*XI0*55MMZ]EQUP
M8V7O_*([R_(4GF/TV_\Q*>J'VC/&X89?E\#]":=;W75%AH<]BZ^-G+#!=/:3
M<7,@&?E].61N^VO6XI<OOV-FW8PZT>W=J0&<#/6U:RL:9X! =MMCB.)7BO3^
M2CCE*A&J)[@RV3NQ\1% 2=P  <G)(. Z79[9U81,C<AS+6.9/;_9^GBDT?$?
M8T/@[=B%-"3@#."?NZM%&GQ?HT%>)JW=V)O.[$(]WQ\<;\<&_@G(?-XP2/8!
MDK3MIR@=P733>[DSE-L(RGV4TI\RAMXI@Q-O4%!F5,IUS8S?:N?%D>X,\'!W
MD>7.%6"LV#$-078%6F1X!OB5WV8OD2ZT=P:X0'.^"K,D(!XR%XI1]%F3S0<E
M\YP!/B+_$#)X%VL%=PWT45^,CC/=WN',F5\EE^D=(XG\B^HI]SV:*@[RR7GN
M$BL:".TNE*TC>#X-?$F,=BY[+O/4'TA2-6DZ [QW@M^L":E?/3H&[N^#B5$$
M:#1)(;?/(9/XS[JV\$3-KU]R;^3C5E+$Z >()VB9FA_(,2A#4"OJBHBLGX+!
M*O788C!!>MF2F_R)PCG.O.MY^HFFN.4,L%FUA6U\]ML->B%S&O7G9).?QE9N
M*D 6^.V?GUH\MD!?G'BJ A-PXA-[K?7>.T(#N@@3*DKB[@I"*B"0I0,SEO33
MD';\TL5]7/.4Z(#K1+9#^/YVU&"MK 1V6E3)4K2SR[EWX&22'&<=)8#T)4K\
M5\>'_']X4(>J,E+]R)FR7*_Y-6GR!",K^>ME+(T(K,))L8N+ 5.R;Y9^SRQ0
MSSI+V+;5CC_O@9L)ZHJ2T9MY%*>I@__[LBKCI8\3:IHNL0G>B@O>P70'Y(<X
MZ+M]!),O5,?)V>*%\N7-9UPP-O PT_C#-"ZU_N^O#@:95M%_W#P-"D?>=GG:
MCQJF.;L=G0$8&]_,7SVH&'%,ZEV\/FO^3:,;FXHI(R-)-OE42Z(HKI_@MCI@
M'$@0CXFJZE<(OM%*Q[HUX2)V]]UWK8_/8UK?R_(L"<DK%_47Y:Z81".$D<+^
M&<J.D<(=P2ST;/[9:\+!4Q7=U1M5S!BN=7!;<>=I(/S1!WPUZJCG/">.XZ/P
M;HS8*">,.6;;M3MLE[4O54X.2A(X^0R>_P&]F7V:A:8< [%&W.<A_ FN74-M
M-WX&V'EW!NC _-XW&C3 IB4U+!>%A0:YJ5>HB[1:G0%"-=3_ E\]/J<E2D2D
MR]'U9#(>3$R-AQ*%^#M3AHJ^W:-W"OTGK>)62R$'X$AD< 'Z#-"BN_FD1--A
M*!'Q4_P\_[/ MZ1%CK/0F4^!6)VUS$I,)Q38[B&3DL=W\NC*EPZ6)=;?\PM5
M\ ;+NE,P<:J=0CUJ.RK]K<$WG?EI')O(ZU3]^GL-V5YR*@EQCQ>D)R 1Y0[@
M]K;6X*F"@[<K)HGT6*/XX_0[^9US'S(DT>)5',H"%A,FI1L?T6^-NY4]$"J6
M_,@-?5A]VE$RZVU-]Q;/?:0I7CRZD1L;RZ_["S5:<J MN3T88#R]%E\1_9Z^
M%Y$FJ(_X^EZX<SM#7BSO[<N<YXM9&7T9E_R)<&:.*\%6VFKDR+B!/9'>M+<+
MPKUNT?7:LW^BH@1*T1W_2>*"PH-;=>!W2C:@-\4RNK4SUL!5*XY==0M]EC L
MDF@($CH#?&=:(1.@P^K1(!KB[6Y9;0^DKW7?R_2T'DO7CB2>BW@8-85-"PLD
MT_H;D7?G2 : 8(4Y?#'\G!D^$AX\Q2'^U[O\A9 DD]O )PS[R-,E%/$G&/NE
M^>898"@R-WA.] S0J4.S5W(>&]V=T'/V= 9H%C@#A-O@D"=4EL%S3&3&,T"[
M(/R\,OZ@USP_>:Y\H[+_Q?X7^U_L?['_Q?X7^U_L?['_Q?X7^U_L_SNV(C46
M$55V!K@KC#K%15$^G@'^-PC=1\"SB?\&4$L#!!0    ( -,[<%;J[U)7K'T
M "B!   8    86-I=2TR,#(R,3(S,7@R,&8P,S(N:G!GG+MU5!S!VS4X! @)
M&MR'! GN#@,$$B! 8().\ 2'P5T&2""X.T&#.Q/"X.X6W"'(X Z##K[YO6?E
M['[?[KZ[M^O^T:>J^SSWU.FG^E8__3CWN IXH:R@I # > ( 8/P[ (^+@+<
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MJ%EKV4++AH%0EP>0_8<:0:PUKXD*_IV$ UBK?CX)-XR49!A,P)GXBLO6<5[
MH6@#4&;K(0.HR__WJ9EH1F,G_M0*H]U%.3>(&I3F+FN/(P3(-VU#OB_^NY89
MM71S,YMSQXJ6+[E3FLZMJPF+%+_._L6@MYS$JMUDE5S10J+BOO)%6?V[P=9!
M\L$J$\(+-S,_<%=GHB.0G"G&^Y9GY=+B9"O&X=*GA#GK(]\QKAG[S32!XN6;
M"*V:6XN$TOH(4'E<@.)LVF9!^@9Q-A<*.INL<WO@N2_9P5Y_N^#O]@CHRI:^
M$SIAZ8NX4S0O6E1LR(_%<3@*OR**T-'C_?I'PBCS52,QFXZYO6Z?YODH0Y!.
M$]K#Y41?/MF\9[G$_</'1CHO_T,=^JUO;N7SNGL>M 7Q9 +O&3*[?6;WQ"Q3
M3%XI%W I:\'28X2:ER]/0<UJ(LG2Y19[>FGSMN:>95W;AB?"M<7%$VJ1[_KW
MSUB+5N4]>[:RQOO?:XY^,4K/1S=Z7>B'PD41E):#<R$ 8&#X8<*E$0I8&N%B
MN9GZFG9,-*<RB^EA.$].&)5$SNIC>'$;X[5>O)I'!4F.L2^_KE4Q>4Y+J$B.
M%7N(&4G<XRO/>U!0_DDA=\_'+#:FL7VKN6B-MY- O\/9OJ'6/"AFB&,CST^J
M[(S#I=W4_.!$+%4KQ6S!85P(?HJK&TU$+&.IYG=ED78WRK/P'+1ZHV&WX7XS
M=<67FO\RJJB^.(SUY^A,0YJ3NZ5?ETA,;^!$2BM868Y/8N*)!%ON5]PX)E8&
M/9/(+(G9/!@_VO<1\%RDS(97*7BJ?D Z<]A!.;),U"Z^R3=^*4%<(8->J8FE
M3+R%H3,M^;=23:V'[-V[SSH%*YTK+Q;G:\8F+3UQ=)DB?]VUPSW1<>L,3W<H
MDAN?!MI^>PD NS!P=;M1'QOB=/+&W.B$F=^'.!M)BC-L-)@3OLCJ!BY?%.C*
MFD=0!G>-N#GX*5R;K=\-L+!N)5].;189N7TN50!5.7AX%/GP9/O[QL3WA=@O
MF$=V:X?U/NOQ8>AZ!'QK=-N*O"F$P^(8,^PT,QCD.'>S(U]X"AJ>V"SIZ^D;
M[.T"'P&(+IJ2OA+&5KN(;HB*4Y'N'&]:Z>T,R-QWR#OM)IJJ:^S/"92O0D[K
MKJ@F1>N@LD6#GLN6N8BY9>Z^H-3/9I?^!?HY,IODTQ^A?13]ABFCJ,:/.P)/
MRG 8BVB(L'7YD@?57&2T+-P U1;I5NS6;QGV\&?W*[%?TNR=R$E2=C2=\5YL
M]UCP/B^UZ4S+'PN((DE+/E<2W*TF>F[-:B2DUL=#VF?,CWX?R.BF@O>\DN[L
MNYP-^ 6,=_9.NJ%YLN@[X=%WR.0#+[H+>1QR.;&31M"87^P^X/9BQS?&Q2 F
MR ]4$5W:>4HYC1CHG<]M[&+HDAEL?<(^_7T;7SIB5<V@.CNS?,IA7,K8I3N8
ME]J(IX6#<_Y<M>9UTR- Y5C:.!DG*+PQB:FJ.+3'EQ+%VOY AXJ:-/:TDR\=
M:>K^U*YSU#J]ZET;YY1GI )UH8[^-/*,,8L54Y](C;SH:9ZPFYM%<]K.^.YX
M:=FDMDG%QI51H5=N@!5<;([M7T+][Y!]1X! ()MJQ IC1W(K"X#Y<A*P35^"
M>F=F#G!6%:H\"'11?#>Q,>VP%D3I9(*C?"N*E)\RQG]@&!7O%ASX2DOW+?SZ
M7\;P8Y F.KGS3E PUFQH__;LMN$X_,(?][ZZUX\BN?=Z1/NNA!IB/^&W*]W;
M6MOZ!O4#5"+N7"*T;7=-VE2WZOEC4R*^J_>%.T0U59H3O5BYYZ)*'OSSTGTS
M^@G0^&^"7AMAJSCT1J3$SMIQ[8@V^-FZN$R4Y=XCH#HEW-:,H_9;8G;<$A6)
M)#!I;P5+QL(G2E+]81Q%6OZB/>N+0%2.@F [:.-F:J;S9).+-K=$KD ,[LX/
MR;Q;F+D_&F4@!>6*@9<JK:\=_$5TT*/%0^6>'%V?M-YW+EWS]HDQYHPC>ORQ
MRZHY'-X.G/>8W[FCN#. =),(?5:-WRM20W8'99TQ(P@AL2-X,ZZVER3_5?VN
M,7^OF(067X-/I^*\_,(^E('[Q^1W]G%'@Y(L5N0Q7N;;-=^D<-9T^RM  \Y7
MP7CHG@P9S*D:[6_)G<$GECSV+!=O1+$$G@+C+S- JZP91MUWX$I/B"9+:670
M01#H$&3W(X"D0ICV]GF<O4F]^>G (^!39GC:?8Q@_^^[,TRU:).&/*PT:\3E
MJ?1$(464C="V!GAI+Y( ?)DU=734E?Z*R[(D]LRH!LE Z0E=%_W.<SYL1"4[
M'YE%#]U>' VXV41\4\Z-7*5DD0&%7S@$^6->^)+>OYJJ;]#0;7_U)'I="GKZ
M=^C[Z7/U@/8!C3**!CJS1?M[^Y65G,UUJ\_:0B<U#))'QRZ;H^$,A*PGA7#/
M\$)]JPV.^/72[? S2XURZ.XC@'PO>6$VXH(;]^+M8A7_6_;5:MP37FI/"P?"
MO019QMB<Z!DF:O*#[1\^.<+J]A-M%35WX*;<(@[BQ*O:(B&%-X6M3J,V3AJ2
MFFJ.+L.PK_T[N;5W_,B&B_TI>873@8UO,VD0]R?@YU;9"VD!U!BG'S=':WR,
M4BITWW+JZ;%'@;*Y^*G$I787'+Y]F72U?E7[L9H<U^#LC*:((FM!H3+;VHG+
MIHGYE>,;^)AS.:A$OC/#J[+E^*V! C!3F2=)$?I@F8V.4&BJ:C+/8M79/_.X
M B+2GF:[^7B1J;\;&7$D(U2"Y]Y)E5JE1?T<%SZ4(%#F/]-;$M4HJO55G*FU
M TGE6)T>3PK5VR[&-<6O5'@-9MK\"$PLKJF8W(KA/%O)]':NVYXZO6^5X)UO
M!%[.-FY>')^*^_@H(DZBJQQ\V*.0OS&QKBH55]U2IV"RB&PA.3QRJ2#HG?PL
M=G!FV9NAID,.)IW=L5G!D]=WUG["@<,-MR#-D@]5[<*'**(9O[R((A6%W2;]
M(?^I+H'\+&VVCL.6-M+\^Y^N4"F!TV6H<QG7]V3@7$7V][,^CU7'L$1I3YV7
M#^1]=YZS.=-W:OM/Z>TF+:3 %4HG*<84#Y3-OQB$*IQH6;>-C(DFNN\5L8-*
M7F\.>?A.'QV>?O!29;!,6G!8 Q_YT&WW&.,8>>IW>WPT>+5@,$#*L*8Y(N],
M8Y<X2_F,C'\;8%KA&U*\ZVW4:HM$T:?M*0/:6;?5]2D7'+K@V#L:*M:Y"KS*
MAQ'.43U-SM"^[BYJ.C/V9J'2841&[MK/NT5[U)G.BD6/<JL@$7A^.L]+WFIF
MXG!\<>02%,Z&@#_SY 4K_;XZ>I?@%/_SG+P3YCY6 9*U>]J6_T;G20X+MF/'
MUVWAR?V9E&7^A@!.S]9A!]N>A6V'F]Y_R_='SL9Q::H]2B.JMKK6-,[0HU3Z
M03ZMN ZF&M]H)@(-+3^X$23"0>=BR_MPG#O^P/L3+E^1FOKV=OJ,L<RI]"OS
MCI<79%TSC8^ ,"/<YA/%,/MRGK73>?V7ER_/>YS)KY/>2[@X^A+D-QBFJLN3
M_W@E3_81X_^-X)B<0JW8R*VO+!^]O6<K8;AH)=%H874?YW2AIK=;RMOHKP><
MPR#) J4*FYD9I\@?^;C8?G$P-K0O='7EZ:=/G8Q<>[\_R 5F24#&S>IY*R!;
M*5WTNN7D*?P#4']\.Y83L[2"3CQH,4;:JY@&*CK>3>T':D_@2O<5HQB/7@=K
M6$C&'2=J[-8"X6_%0/RAT:TMI%QF9HE/]]D#>04]X]IDAS1^U+)\S& HR<9Z
MK"1DRHG'U"B:, I$<E6JDL1S:P^S?*%60?E,=JE_]XX?1:IS$I7GZ0)Y!"B]
M,.>NK+,4>R !.[PUV'P$=+?5#I<KEML0+\I]^6)S&\H<ZU3OSMBL8HRN*D67
M*S?:5=N1I.B"#;Q]9FJS?Q*%-IH%+W]"W/]+5HP3VT&IWKU+,?2<2\B_E5[N
MP(\]8K<*1W\A2)</39B:>'C3X7:7(/T>B8K>G&+F2/7UNFN)[3:]"YG@5LY@
MAV<VN4K*Y4ZURS[?=HW$UZ R!_=&E^)?Z^*>8YM*!EL_T,\F*/UN")",6O;.
M"*;"!.F(]W!52X1,5_F;'S7'J%#&<YF1Q$&TIX/SI#<&8S<#?VU3P_.;B=8S
M22;;&^T3RD90!DOP=/H_EEA\1V";ZTR[R&[L.('G'<!,Z$[;4]B+6I3H]W-?
MYUMUBD:8.N4/G#^ZBE(^D(J@'LW$:1K[ >:47"EPZ2TNA\@X\'KUF%2I$&W4
M>[2O%=FNSW($,'?# > _ B2:UK)IC6R\A:H7B+$188B__L1&:/H@3]X[[C;\
M'N9:9WE'6V[%I,_\J2<R4=4S+0X=::W9:U*L[ (MS;NG[%)BN\;$O82U^N#]
M>F^\9&XCY=D+:4P1S:Z'&[*#IBR'G#N.7ZC6.O$&1[M#:C.2;C^3[@W\65'4
M^NH"5 *[>T9]6W-2&K(@'L\T6#=;=8-[[A^LO$R.#H);N3S]Q(NS4*%$YW05
M[$]SH9(I,G,V?&:B(\":?/W <@[_6:87+$D$SC;R+/([S#MVGE>NI"'7;+2Z
M^]%0%[]L&2T;K!E 9%.^I.H#/A0]N081K3>TCA*KZ,<LOSH<]JR^R9J^UN&(
MZ)I.$AW;R_ R#"U;>L#_M%B;M+4)&\^X"3\)HGX)^7T'1,2_8OX>!USI$A[_
M6EB@/J+_;B+2@;,U!*Y(\YMM)Z>AQQHF<'(8$W%Q;\*9.O/IY\=B?;J$C#-=
M#]S+1M<$P#- !O"B:#6;<E>&\$Z<*^6#] H_%R.X>7IW?3W5WWS&DYP7*DK5
ME^)S]GHE7LEFE%2ZA"5(:[=P^W5Y\K;4&OB)@?6H#T7&@\.\!8L<W?H.-.^$
MT\!S4)^3MNF;M0?U[7%[+&'>OM9A,Y2G!J\VF]JGJ5! 1)%X>^;704TU\MY_
ML%G@?7[\1#0M:_T-9 ^MK9SQLJSF4$O3P=>V\N%,3*<422?I=U\CT&8%99ZX
MH/ZIN$3S)3;Z/LJS-;!$B:+ OB-T#IFXO=QRM;8=[.  XI?.*390!'&47IX%
M#K%+$<".A5!ZF'0RS<Y^UU3PB&'^^& .82;.XMW]_3V?Q&(.+7+Q?=\'2T44
MSB?]0V<EI%,PIJ0DG8NA:,= Q%[5M;&@(/:"E[@4RLCHZ@DX*8QW#SHMC5VF
M:S-A9/K'T_UWK_C2J,W&4)7?(BVUWA#45>6SZ^<="7ZC/1WIL*Q^M+N2FY2<
MK% ,U8O73MF=#?2O+%$\O]P,E45H7#\X-B"KYHC WK;+3 VH:/CO2T&735*:
MSHH:"'W,^L?]+,XI&"MC3XDUJJ:,'?<7B=@!YW$1%VT%B%6X5-58T6*Z[L/U
M0FJ2G@.!N.ZB?-6>#+'=#!A7=T_/5OG55]ZCN#?84F)E63C3+UOJ7@@^%91K
M"C]M #[4;&0!T<<N3E8+4DN1#":QASK,F3\O*V)P#/_N4E;OHF"_.M@:PE+=
ML$YQ5J&G&7"V/\Y_Z0V G-K/Q>4@;4)&#Q[@-B<SI[) ETX=G=:2J^,'B[9#
MS)/@R;XL_/2/B*_RI;N#?E^FIYSE8=1.>+*"O5WX^0&<%PKT*;6].-<:F[CU
M3%,F;6*M@FAW!OP[V6G;BK\@)?:7<+6:T53U%K$9H\B;M/'Q]\B=W/ 3M3?_
MX\;*_\B2SV*C#%'RFOKK&0]D,ZO>_@?WIM@KW2TLK+B:?W"V+N#C<]IV:ZF]
M_'7?$KY-M D\ (=Y,M<(I+=(:\TS1>+ZG(SS1=/^BD@S*-D#+'T<#\1ZW1\!
M47XY"1\S0>1KK:]=?4KR;VP\C;N]%!(J#(Q6AG[DWF\TS8D0&?#N< [6')/:
M&(E,K45K<E'P=KM;Q[;I5!R_4%[F1&DNANFI?*+]DRJ*DOEB^!U(_8T[M[G>
M+$@SL\!+>OJ*C*U3&;AWY5US#93W[-2\C(?X$B8@K[I\A7:@S/V8=ABRZVE;
M,"CR/8) '5.),4=<DY3\2[;W(8BA3,G%%Z^_EUZ$Z332[0:BB I4K&T;9VR,
M<AY)3UPG1Z$S!@OUTQ3QPM,3H78;L+Z9[<">7F'ZJ9@(D#^RZTLI^%7J .GZ
MT," 0X5SW.(P33QY+;#>"-OW.5$ 0\^LNX]=VN6R@.%=I5/@L#<^$+LZO'>C
MXPN4CI1'I,K M<\OZ5-D02=L1,GPPEUZ=WU'EE44FBW@Z="A%Q+&P[TVB3G$
M%<BCN 36 '\QFD4:8G8[S^NC/^[9W4>7;8'8OS*P3CDKUMH<A\ $G?+1IIHA
MMS+N::R,T% &Z\7[B:[BRD< LF*X9BL//X[+1[#:ABX(,U(](D^3K5.[M\!+
MWGK_[YF@P<!DE[*6A]BP/[(E*2OK<C# @$<P>GI+@C7LPC@8R!Y.[B*2YL7?
M^A[OGG-WA4S>U,W7#5<!U>SU&=.,#TXU*[0DM*SBXKSH7BEN %\WI.;V_A%M
M3)[J,^)[:7UN.;(*;9P2YY<H 4;E>,)54'Y5^7N.L8NR.O$BUPT:N-EJ-?ON
M=G0VC-%O7X9BL42#U031D-X5HAKTN0.#@9X>7_SS*L9G-YQ$#S6^OCE[_'O$
M;_E4*YQ>N'R;Q2$OE.0)IB122Z;7X]OQM=!5H[+RH;(;NUZ_7#C9^XOV49N:
MEO5,S:-SAX?ETRN";>XQ[RO-%="PEY_Q!(\8@F 8'L !HC/XZ-D@CS"39J-D
M&4]Q="^OQ";EU.RX/Z$KTC*OIQ<_WV4.,IK&8=^L\W L?+[RW8(3N:_[,K(?
M*:U-O] H4"XC3:&J<*3*K,U-OL@R6_.\XOL^(]6J&JF'0H]+*_788H]WM:H7
M7\R?VP80QRW$81T3&)/7!W6Q89WB\2'.#)SXC?#%VO5VU?Q#]7[%38KSF*]F
MQU=A;!)"U<(@>)0"K6RIA!78=D"VR@@DY+,:5NTPP2>]<<Z?HVG#1-9]3(5'
ML['EUQ M222" F;!FF-3>LPD7;CPM/$>MMMR[UE3I#\^/"@>VE=O4GW*R"H^
M[*<;%<W+7F),35.AG:[C4-$HY7H7$U:ZARR0&/0[LQEM.(N)9IRR%_)"[ ?'
M^B;5ABZ*]?I (D9M!P1%)D]1QB8PM;H)^RVY,V8!I:]OZ-9;8&?K!+@3R[L+
M?:[C%,C!I%&DL3Z^S.4,+A6Z+V[(]?:B+L7TO+F:[^8!*%!"*SB2$[6$BH3\
M@HE6^[*_VWR?M,Z"FR4KM1];?3*,3*9FKHEGRPB@CUV-J?#V"W%,>U>%& O!
ME2O-$H7HZ"9S2:E9[\W4'F]X:Q?N:B045HXJGHP&;OP:^S/&3DG7K[21=8%_
MTRPM #ZXUV$.>*^V-%+_EW/LCJ62WN$-D;7]JU3\)TN<Z2C>[ZJ]9?BSH5]P
MXC]^AG0C!5G"_T#[^$.XK91.YY?5SU7<' 1/)3Q#(,0RY9RJ,FEB1+2>E*H3
M0N":N7[RD(]%%V5 S-F>.W=1>Y4/<:D&ZR=/$3#]+U9"G-^_2RK\/($&H)VO
M((P^/AH_2YA= J#G!U5=I 'V+8H\.A?)T<,VV;G219@Z1L/:SG8=1[<,2FA.
MG<8I$"USO+AH:?S;4>TO&9!V8^(/9YX!ERKQ>O[B@0G[:;=#';]::K,].%J/
MQ>,5%*@Z>FE:>=#;G],<HFJL8NUT,GXQZ%W?V1._Q=!/S].17G CFS)PMSJC
M8<MM$Q.7"V?[^>3_RF2Q!8B6/,^!([F"DE#2X2.@6KAF=.Z!>8\&__5V'XU_
MR(<;,J=>H)D#0JZ.I+.>>3"6^GW?2WNFPC<XD<;6L]YFR]J;Y3/Q<4UFJ$1;
M[]5I[ZMLW-T4(/=)3.B=$^I)ER%JZ3+\,EDD37MXHXJ!PYKY3_DJY5QYP1L#
M@N/1G'-5CU71+MX0FJ6:RI+<?8G3/2.VB+?1U&ZR#J^S\6MKSP0&?LMDK5%D
M%)FS$$)^ :YQPV]%'\B)OO&<KP0]O&@]F1YB0@=VT_@>-5FZ;8X*Z/4';EWC
M'GU^*IC9O.IB\ @(D,;SQ.S%;"]NI9Z6KXNQAZ\9*M,KI<D0,I-038D.A%%A
MGVV<\8'J#'/\+@"P"JGRF4Y!(8%WS+*,#AJB[#M=4HHX:3$XU'WDA_X,Y_H#
MYPS!5[67\<.FUJN+Q$YN9&9]U#X1L>GI5+2A8J,&$%VDJO)V[PK X4ZXP!@=
MV$6$',;UE3L5J0,?#&NK=IC0H\WCOH>'3=%_]?A)E*9+_219(R=8EJD";-$4
MQC#2&H!N<5MK85CU2\^'R?I4O.U.N1JSH> SZ#BSFC%Y_3&R'8,ZW9GXV4[Q
M<T"<T?/\GJT_3P6'[11X7-3EY0WGSHV#&M_N97%.V.5I^,,JY\[ITFX9UHS#
M-!@(Y1VLJ:V-R)W?7]>N;Y*O,3QI!:Y8#<F$'7/_R(NF_Z5/2//AY)/'*D1Q
M'4S9K!=46GILO8%A HH-Y\/VN_]6=&&+3]ZR;SLJ0\[>,#1?%G4B&KSY*Z@2
M'FR>]*?2:3I&K#)-GW;8^PC/,;KJ".OH@+/P)+>CV-KB<E>':LK2P;] Z4NQ
MD,?$ -?[7T]I >N[::>.8@>JMMJ*H5=,]"DN6[N0,HWR3%42800O;O:A6%SP
MD%55C5/'52$,.I6O2K!:NW$P5[;#J:F'JHE.^CGL?*J(-43]=[Y]UXC0CW&?
M@<S>GKLB41%*0E*.,_Q:"EP HZ#%C!EQJ8GI5KSZZ&V *OD(C^SEF##:LQ#.
M#JV$$12^2[X*N973T,U5@]5(%U9MH8R*JT)&]KV4''B9,4>E]I?]+5?FW8U#
M21X!-N@TA4"UQ-A?SC1JWMFRQFI+#_TK1"G*%+L_Y9BU%[?*1(Y'A5L]^JCM
MU2,\]2XR"GRU2&RD*VK@!:._2GY\,;G^HC2:XEY1M QCS?/<.M::K+3%"E@>
M2'&M776*E0C4,W[FAD:H&IGI@OIIDTSX1_TXJ]''M](,012D>VG,\2HF##PA
M*1&L\'IX1M3%2'I9GPM^+^E5K3^A+]%,:QY>3)?%'.>MO(0V><+9F2&-!/.O
MZUKJ(:(K!CV#_+3@PKH]?@"UB;=)@PS5;O FOKO[P$9_$5<1:U8#V2,@V)\*
MH6JIH"IP'X]W^ U?S6ER;$8Q!F2=ZVF_)7NYEI#UCFF+/ L<UOW%YA%@.1)X
MY::Q\V#Y!UF@$_D Y_#.&Q#FQ?WK*:,5HUG[Y'U>K%!I%_Y3K[X:7]I5 LT'
MDG05-NX+'(3(^C !-=8 M?CB.?S)E#33)QN1%.P,&2R!*\9R&  %.O.LL2,?
MLL7GGHX6DXJI\3575!V0RT/'5.;OB;DL:GGS'GKY$O1]0\S;;9!RCD"\,R)-
MT] N'PU_\XG!FUH9/5FU4/Z=817VS*1[C!;UM;W2MJ2G1#"+5MK9"N#$D56!
M7+R"\N]?'4_;)-9LB$-X>=^.1V;L&D:>3+V&_G5?A4P\D-6K<G[X5O?DY<>^
MZ]D1/[RPHJEW5J*2 JN0MMJT&[\4%\'/SYF,L-TV>-(ZV([=%U6.&%V7E-WM
M!\I\MQS"'E@R-7NJWN^)*+S!Y5P ,;H^ FBL@:Y^>@,D&_87\!B'(\ ,2]RG
MA/J$;+T]A$.H=W0$'IX.?_(Y""(S[8_@*PTF5([<O:.//W@$_#D1I/OA\XR+
MM7$]5[KBQ#+PZ.+>(**06*]SOO\(^_.=P6S1!$B5/"EI7*1?^DL6MM<C(.@1
M8"6EPTVWH* AWK#T2IP9@E?A.;.M-\/LO@3*OV 5WEH](4>F@NRMQ0:)=2*9
M*N%>@D,=9IZE]3'0<"5YV^C"K=-UO:F':4D*>3&L+&R=EB9$6#67R<8I8+''
M51H/[5,*DVN=/%\"A6KU;8WRWQ9S[F9C/@S?4(:$_[5)(2@>97CY'O#&+VDE
MR\E"/_ZV9MM:5UB-XV@)E#):]':AV_1DWO^(L:&PD;O5P0Q6Y;2V/X!@*Z^T
M Z4+(3_)WD.!IY^.FV,X97@YNHHF6@_3.[S)#R@IG'?'A 2>Y)-1P9/]6&'
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MAYO!(EMQI7^_:].ST2T%E,*%L+H9ZKI)BEI87)I;>1J5M\C\P6G4YAIR&8W
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MF(NGSC7\"8PZ_KC/0,;-L*DTFA)3'YB GL4H\E34GLG\X,Y-(HKZU7XSJUL
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MIPIY$Q<:LTH7YLLM/DW5:O<@"+6@>T!G@U6,0EL,]YD7USY1$L=I+YN@0GZ
M(QD9='=I1AH#HL$#S4:(=?08/E#U<,)/0RT,2NQY#0OA_1D)2?"%M'J%5L21
M;$#?R0KH:>W7I NO:R>88$2)@0)%YEOEB!O)0>]LMO1?8SHCUN\W/Q+5^$^Z
M1DE3S\J7I.UDJJ- +,>:K(+EDUZDPD>2'50$,[)")_,R<:6!@\2\DN$J9>CR
M4XKLC("X3UB%D-6IDY0*(5O[(0+_H/,ZL1/$/]>O/K<T*).DQOY/CU1N&2]4
MVQ6HO61D"FS^5O65/7RW@9K'4^'D!6D-.>GXUTQY8_ZA0S#*IG.$*7V2[WC"
M"G&BU2;VUTW#7SK]_>J^CW6J3\Q=^P%/5)$[V6RUM=BSGWTTUDW18?2;DLC0
M("X\DR;6K+E77XW'<L@TUH?5#>*[N$,A]K/F#A 7$OM(#'N^S_,D-5M8T)=Z
M*I7@]L"Y,;ZV.<AC18O7\]@G/&N?,<'';+]\-*9CJ,Q!*V!!*F@_Y4RV]^1[
MV2F+'%?E.X($%^'_J-NV>>N55(!PPY@\[\S.WY62'PPD?G;HV2:DSH2S]?BS
MY!VWAU_7(2Z@=8CN;5\ML43XG$ZC,/G%AJG5)YHKH@CZ.IMT4ON5,1?7A 4H
MTC71SL#*N-&S<+'/&;*.W/(C:UF),I".R7*X2KQXP$SI#^[+H9)GN .T<8F>
MO[+T].;IXXB';D,B%*B<KD63YIOZJ7M\B@HW.?+]:9.PA_\4JM%M@2(=,0^V
M&T(GN*5<13$4F!^P@#*2;-]6%M(@J7]4 ^X73?KSGXX<U"07-&Y)CCBH(+OX
M"\M7(I-&,GO_4^.9Z)>G8^*(,PO,4J(.L?+[GQ$\6=JJ)07O)CGGTH#S5^@E
M")O"Q[AO\H_&D2Z>[ZQP9:F?&S0^-@HDDP79JTDI'"1![L'N  -5DX0I4VEB
ML;\HG>HBM]7?5=AE%:ZYQ59?E4$C6[4DVM2W=X^O1T].["1 YYG9+5<O8.9H
MTPEY-!]O##3]R1??9V129;F8G*X;4!N*+NV=H96_HL>S+[C@=L[CDS+$F1%6
MK"L%>XLY[[6I;U)YP715MPL1NQTU?Q%Y:*#)>U_(WE"*9?H.D#.%TA .95;F
MDR>B('Q1LZ/FK:T)O -$:@K*@1Z(?'4SS* W1R<W*RQG*R$=QZ#2T;7"/X8Y
M:'DF,H9^'BO[ZG/OJ UF%ZD!^>.UE6F^M_UODMX;V4)1/* G^+(IWU[:@SG.
MUNZ'=3OZ??&JQE,_U'0RLGR4M(8V1^\ M"B6_?)PDXJ4,DS2>6;/GF\9N#VC
ML/:;=,H# C B:'CQ>0B&*/A 5@;.D^[E5*?LDA]8'(*S"RV394'V.[R:>5!N
MO];]L$4=H4.?_3Z0![HMR#._DW?RZ2H&V \[C7*5I[T(7X2HAX#"=6MSK D.
M5DG((>_UG84M-G@O6NS2T'CC1DD!]IHO-CF.^PRKE^#I+D]V9?V"LQW?HQ@U
MS;879PKA+50!BBMFI*M3#,%[-U,@.>"@K-(JBY+IY$'9QB27V?P>Z5'!&4V_
M.7YKP352[FAS7:>KDJNZ?KQT5I5]H$C%I#K FX[_W_IDD:VAX\N)PD;M"HU>
M*/3TX).%<(1.P;KQ8'.:\E8#Z\SRTJRF+,=/\1^BKK[2T7Q93R*799UQV8>=
M0_OBRPK!HBO@75/O4%]'$YNC M<5'QJ$>)R=>RRNSF8WX0:8="_51E3(HTO[
M]R]CE_U#V_/JDYCKV)YUZA=Z9^4Q^T6-<Z-LK^\ K=)!DL/8P[,O(5HM/Y)4
M<-*D\I_VWO#5#PBB&1:.-D<C#B'ED]=8N(/:2G>8_\O9/@R1D25L[OQ+\MI3
M52WEP%P<^I;$S1^3$XQBPYX'#W9E8II5M0Q/%]ZQJ]3$V[ \DT?&M(8K6PQY
MQ#H=\S;#0$\R-T8OSZ718JK>7A#LAZ59U;:EI]466'C;)6T2)M!_B+@ "A;O
ME1J/4!!^O69CLV?(EI: 1K1!JI:BDMK]5-*7Y82^?II307K]O=GH5C*/P=J]
MKL32A7CE,#B&!^51Q,XD'[SQ9<[>+(.ND3/B$U<[45S_Z8PT0<ZC2NOL&<S?
M 5_A$L;^[98@X][;=[WR=H/C-I>53T[R<D7!G<DT_SE[)5&' EXQP/>!^I4S
MXF8^1/8C.EJ_6>#B9!?OPB%I/_U*S$UOT\]+?X5SW!SDP5N5:YY5"+(M"5S'
MP5>BZ82'__+5G)??_*9$</!D@7O.I3T7:7 ,89=+EAQ9?"$/6*O/P__)@4#X
M?FS%"Y)-P[$17VMW(S^KZTLP%XYCV:PEND2]N:$4VZ.ZY2[#>(;5@?612IDW
MT_4+*JRGY>7:[7H\*2K9!.V<PK^!0/HCV,.'L)H7D<943,^LOA&]D8-ND8>Q
M"HZ)7B&!^[8LK[,*=8\P*%,<74AU2W@,?\SB#[X1]@M3 5:1'<38[Y$@KL'<
M"I&BA:Z\CQ+]S]$CX*YVH7_] IU:>H>3G+<GESYF:@,5Z-BH:+N^F4MVNDY-
M+2:)U%$#G^A]>CEH#TH$7[';Z6>J5A16:=>[G6"NL#(\&]2M'!K<-"J#JWF[
M$#F,EN??4:!@-G+ :OH=B4]ZFQ7EH8?69E@?\W5U4Q%JUNUS!=EY0=UG^\UK
MY>&$B99;Z#@9+2&?YJ4U,^QM*"VRR$21^2$8X-S:EG0[&<BSG!-!"9/N<=#M
M2. 5(&L?0?=?AG^5-<&.<4U,<K?49FTX6*[_#EJ. _E%0J)1,&*WHL",]^ZL
MLFQ3J#BA7"6)]D P96Z__Q7:^"01VJ_!.N21.M4E^LN.9A,JOUD2\&8"-8<T
M-06)J-M)Q1@F I %+<M9<.K?8TVJ)0$*]?&_(86H<I4M:^VK3C;]BY9E[A9I
MKZ5(VG,)8MXA]-'/?\0C&7;!\A)05F)\^,HA5:O7&?0_>B+S?3E\PXY$D==M
M.CK$;+H/;[\>=4^[S(;&AB7)Q.C6C_'CIY1MW> ?N3;E-R0+9DI6SOR='84$
M%"]]N1)JB@H8.)-&P&N;^QXX9#N\NJ6SF(T8+]+>X+48_GO>]K@SQAX5V*K;
MU\DMLGZK(.;=4B6XKU]R.UDS@I?Y!W$:N:;CLY\MR]L95?-4#QZ)_OSF0<+M
ME-S+)<);XFE[[VVK_#E?<6V+LK)IJR]H;A1W&(UN2 >&C8^CV/7R*LW 3]_N
M";^$>66%LJ:_R5@0V37KU&FZD.L9%%(^W:8RLM?^WW&^T,9HFIM!P?6-Z;6]
MP#2K4['3\VMJNM7!VBBQ.86']M;<<7FD>;\PJML9^.KZ2[28WUC!NH';>M8^
MPK S0.AT4>?V&/IK_6/AD!:LH6^\<+S*3W#RFS(UF'B'D%K[]?\*+T23R:KN
M35V+XQ:&VP^I9W?B;1+H?1-"SM/JD+7\SDTL5XHP!]OR5,$:4;CT)B6'U37T
M>!ZMC3W'T"*PNQVO'/T\\^CG-B-R4KI_(<&" [P?>3U4#9O1*I&@^CU6";PK
M,D"X!>9::KX)XEFKTTZ(0SJVFZFYLE.4MKZ,I1A^CLK&.U^IX$4PS8G;#6VM
MKC[/]Q.'SID@6Z [0%G](6-07SPTT<P<[XT! H;>&PRRVP#G2.=P2%3[Y*_H
M\"OFVD7AF\?Z\VR'-&BO2^0V*UN>N2*"UN?K\+/M+_&\)J7&Y\:6[WG+5<=E
MP7HY%6D=DIN/*7^K=-]7?,$+YQVOO(EOLCXBK)_\%2[WVI:[P<J$3GW$T#__
MG#P[1=5+H9,U$.Y+,UGB)OKP9;S5IZ)X1X_IKM6!>X^Z#$^09O7_+58E;7Q4
MW9%A/EJC I?N'X=;"U*9F5EI3_RLK27:^#@7"Q1397CIT17:[,?D[^B]OE&_
MUN(2J()[7O/M4,!P^:-=CH7Y(;9_67LTD8T:W_7.>7_EN;:SU#_]W:1;&MGL
M9WB3*ZF.'BY->,>[5P9\4KJG6]7'R"[RV<<=$)J#&>[D:0=UN(_5@Z=U=P#H
M!)I,4!B16LJS#PRBN .(6TAY%(O9X"MK;G);[/5P7RNV6%GFR*)CKGH_6 UR
MQ/6A8$2B\V.QT..B:CMCEWQ5[X&YNO!2:D8@.^$+V;$/TB-$XW> <GB7 AZ,
M$@F6@KPPO!\-\SH GL QY%^=3P,IT9T-],=\@FD!OX42F%A/\9D(B";"K-O-
ME3W2OL?&1@YX8G(F>%/O[+E+C85'B3<G+W%;;S(< *6:-$E&NY>M!G6 J1^:
MF_-DX)&"AC<+E+([)PB28AI5KX;#&Z=;T*])6))*E'ES\+!![;=20WC)X]1A
M=+4O)/KV@3V=\==XQ3]R?16^F;]7_AVHE@;ZK+H2*+'?SHP\7=Q*BA,S9V_L
M'SXI(Y@;*&/@,@"<>&VRIB-'/DE&B\M_=1/5288$CN]SC985G+WZWB=YJ9[_
MTJ^L +]Q!SAS'C?XQ'_JP#^?S5[_A@$NC3F] Y#M*CP^!;K=(#AI_VAQ1;L_
M]$,O9L3^@,+OT7FK?0*<$-S2K.90H!BGH09'+ROKQ=7K!U:9R"L-ZJ+YB17]
M'\V:(\"5CIL)>"1F,1<QRRFM&L,Q89DMIDL='W AYS%;7Q!$#8O"\->AP&'Z
MS QO""!##2;PS](V53$>'*9Y,G\S_U*SG1?/!U"L\-.IC/ZNG10(Q0U9!3_O
MU(/_\T/G*)%S"1CO*G:1EH+2]Q7L!)]6C[\69'_&]L/YN]0#+-(("_HG WD\
M[.AR@JA/?"]").7-L#D-'FD0*[DWP&B0RC],HN!55;Y'Y&&.7"'_VI?*8X!S
M;G.8PL7,B51_]X.?%N'T*Z[+_1UG>2H6-<^B#4KO .]7.JU>?+3RBUOTYVJ4
M:@EM>:S5XD.:$EIAZ%"^.OA=X'[<CB/;[.;J9CCJ88!<'?8\G#OFP.B)^[N8
M_GH6D:7%^I99GK/F47EZ^[@\>[[4PJHB5>*.BCO 9^0 _!N<JAK^S7BM]C)K
M[U_2>@=Y7S!*AD8')=T$Q 3V*!GJ+ Y?[,AE-:K:7\X?63#6=>^7NU5LLRZV
M3%XZE%Z4P@WKT=4FF;OU3RH'UF>^GW-7DAO[BO:%S?G8Y5%K*S_[WQ8,D! 9
MO_A).$R=K/V:+-8@)@1(P_&+9@MU#W^U2AY>*3CMI>;"'VX"317("?,#9VEK
MJG4N""&<XPKWX:[\WDP!\N'VXU_.V_^RI=B:!RW(BV5KCLP9SMT!_AFUI",S
MMI Z#&7B)*-%MSC1[%+!NLO[YV=3^"^>T11[O_Z[81^"=J##LB#<<->MP&)#
M7(0K*_<NM3LUJ-?-E(8FQC2(MZ):/>:Z*]/$7MXHVTY@SRB.,RG1(5G;]#[)
M!S<U90 U&()-:F=DBT8]W_*3B#BU^KV%UOU:U_BDZ'4KNY)$7V@LM<A].JEG
M7\SB.D"AC-Y?5FX\#*)4I@+$Q%)+$=LXAX;L7S1G6YMA.RKQFLQ"X03_,M_1
MM[HT?7S0O87,K\Z9\5!,/5>M'3DU4QSPJVY.;7")E)AQ/N#GJ(OT9*?^Z-1(
MFABT%X00N]:^4L!KH9=/L@7'V7&D#>+?+_-1A?Z!KF(EZ1/<-;$3;?'%Q=\Q
M!L<2*9PYR22 BP'64\>I_?U\-0X/YDCW$@0!8P&IP(JF^(\1-MO;007L!TW_
MY=,J/Y5FZ$W][ZR79$%>K%VH42S=/C]6!(,C]]95;?INQU1S?*!Z2H,?J%56
M$>K4?%AP5L)*B9/<ZID6"WTO1I+"92Z@M]/O.Y[T-:>T&;WIY3./R2:+WBCB
MLEN_"3)0^&2#1;:;Z?A(^T1;&0XO$(:0#V5"L;GMY]LO0-0F/<V MJPX-TA,
MAD)7#IV]=L2^6&-5-/RQ6L+EU F\"AV[R@LVS(S3-?N0+4Q1Y59YT975(OG'
MCD^<_9H^+"T7GJE@E+F<;!R]\4C,61Q#R)%.!&JK<;XEV<IFJ[TR1V*8)$LY
MKOJI>.,0QM>Q<6?E^! 2X>[B7M:5X _+:(72VQ%Y*?1(/CI"D(3J1_%+&B\W
MAAC5V\NQHWQ"0=3!\.!S>62TVUHV>_6V:__U,)J<)FB$C22(>D;]$FJBYD_/
ML4]'^IF\QE<A-$ 9MWIVC,*)#7;6?!X4DM+VX'[#<Q4%88) ??RR_F@T?BLS
M/16N=]W4?U*_F[&9_\AB;4>W,7/1W4476BLRX\N94/V$AI%R4_WHX!2.QCCL
M!CUOP='^XC_XY<$U.1#.SQF39-0=K_;'-V0L+$D2DS[/3CVK,Y/W_ZG4^_\-
M9.WM=P!B67U,W&-3?+CF.&%7VF/UQ@%<7A)]@CF$5_SCD1/8P/GS_A.1Z$B?
M,/FG>&07*TLC6K19%(0PX2LQ.^"(6:= I LF1[?F37^N)"!ZD&2>LPR/S*:J
MP1)]O0-4BP&C2.W:$AQK1K<39INB@FKM"=R!<2E&AG\#IR_TA;)?S^,]<"+_
MV,C@?\NH.HYW/&#J_KM1DBJ9?$H&T$Q8&U**HJ@G'^*[[@Z6 ZJ[Z63H3!?D
M+2*&*? F'U(D^!Q5K]H055B#XL!/?SLI&9A^"A!ZBJ.>C^?6DJ#5'^U7W0%"
M'>Q9@6/.8H8V&:>4KWPM2V]IKERTVZZ%HMJ&R@3I^D4S-685H5NCL="7%@Y2
M%F"16N2:)QNY@NTALZECS?GNBAFPPR""[$9!NQ&VDOQ4E?LE19=(O'[X,W##
MW/4S_%QQ9B933G@0U423H%AU=94Y2WU3YM[9K9*($J?[MZ^8U^:OU>+7WO6I
MD %=5^SVZ;";BM7*+3CEYDJ I+V-0B]PKHIMCFUYX<^23+?XMS@3:-RM!*1S
M7K?#5#EE@^;3A2W=K&[4Z)$6^**4 3]%]0V66B:NY[C"3W 2- 3%-<<!QN"V
MP[,>^XL2C=4C54H\4:6$*=,25K2XX'S9N)PU7NH7/#Y][PZ-J()Z(%5:.3]C
M6.&D]HF&95\]26/\R _DQ\Z?:['=?$Q4"AD'W">7NO)1O&F4)S!V/@YZ;HB8
MFMJ\ \3H0%MJ[?Y%E2Z".S3HAO-+A^\ C,C!.P :)7/6U#(SM'2Z@;C(05F?
MV%MN%UJN]]TX7^2D^X7O\>-<WP_/BOHK=^?O,&Y4D\] ,0_3<Q2T:DV].OLR
M;A[A[/:_8/T_+)W!F68U<C1\NX]CFZPZ<ZI4VTN5X#/7(%<!/TL&U=M>B%V:
M&X@:PW\:S29XTYYQ/7.YH=_.+!19.U4>T').^?A8M3V;&QN&6.%7XQ.CUQ<P
M4^+E<!G2DC'X4XC-Z6S@B:HZ?+RX53FW>_GU4[^SI9%&0Y]P>,B7'*5@&4SC
M,'6 [LC)<%0#^-M^B7.3MIT5ZWI-CKN*]::#%/,^I_BC9ZL9NW;XT>48#0P\
MM,D%+9&JLSWUU]C<:) YS>/]D.WQ!F4YF[ K4;9A;770:'"Q3@TK#1"H5FK0
MO7YQ2T7\>1"X\E=D,Y_!6+C!Q[Q8]4B6K2OHX93L@\).JY)6:IU!DGDEKN8.
M'PI-!DXB-0Y; P8#!H*C/.\2QA-X-"O7J!@0],A>FNS73:7=RKY0R9SNE<@_
M 4Z'M>1]\$7PYV72?QX-39A&T/]J>/'_W[B;^;\ 4$L#!!0    ( -,[<%:?
MGIKMVEL  $%B   8    86-I=2TR,#(R,3(S,7@R,&8P,S,N:G!GK+P'5%/=
MN^X;!*4)"-);D")(5:2)0!0%! 0$I#<1J3$@TDL(B( @'0'ITFM >@_2>R^1
MWGM+*"% 2"[?_^ZSSSYGG'O/W>?NF?5D9(PUUQKS66NN=_[>=XT1PE_"$N".
MFK*J,H#H!@! =/T!$&8!+P#$-V[\LUTWDNOM)MG-FR0D-RE(26^1W::X?9N2
M@I*2BIKN#A4U+34EY1W&.[1WZ1D8&&[3,#$STC/3T3/0_W,2(N+K8TANDM^\
M24Y/14E%_Y]NA#\ 6C(BNAN&Q$3<@!NT1,2T1(0. /!ZG#>)_M4 _]:(;ER/
M\18I&3D%Y76'ZCN &T3$Q#=(B/\9]?5>Z/5^  GM3;I[CY[?NJMM2<KM3"\>
M$)-)QJ-8WLJ@,XKB??S^\Q=R"D8F9A96OOO\ @\$)22EI&6>R+YXJ:2L\DI5
M3?>MGKZ!H9&QU0=K&UL[>P<75S=W#T\O[\"O0<$AWT+#8N-^Q"<D_DQ*SLK.
MR<W++R@LJJBLJJZIK:MO:&OOZ.SJ[NGM&QN?F)Q"_IV>65Y975O?V-S:WD$?
M'9^<8LZPYQ?_^"("$!/]M_:_]$5[[>L&"0DQ">D_OHAN>/S3@9;DYKU'M^B>
M:Y-:.M_E%@\@HU>,R2QO)>=YK(-B>/]YE(*15V*9#_V/M7\Y^_]F[,O_D;-_
M-_;??<T ;A,37=\\8EH "'"EFQ4F /@_4J7D(=VV'W,%N%G_@I*9%/WZ+_]?
MZIQ+"K03D]_$)\5ATN"3U<_>E(US15>*U%HK2L[(SI%VL06UX5K=R59KSZ96
M J"RM7K1^BP=\PH0^XG4>]V-  CSHT?U6B.F]O6U"0#A]TZ2! #?H&_\BD6H
M^7TT^.%$M4_H/:N,RHX%TQ?X&W57X$3A@B=<%.<7TZLSX0H$P)'%!A3!%#AF
MT#EYKH);/ =J[2Q6BP8XJ&U?0$[/.5@P;?G'O5=",2U716Y)JHS>?/$-F,>O
MCH#C#*NR?HFP8D0_)67Q%.BXC1$V0;%3HD#E.?Z&*/$EV$W^P/H5 :#H8FIA
M.N ,O(E_==I242',& ^!':J?-%@$C)CZC?E)_,P0-6%SWDJ8QG^8E+K*]'7M
MYM$+@@;EP)9U3?!#"\(__3 0J<7=1U87(J86T\4=)"XE]D50J1Y8+L@Z6=VD
M_Y!IRM,]/2$$3PP;R63:O[OZ#8_)A/!?3H5> >#J8C,^G>YK7I@&R,CASR10
MG)X7S&:1CO^B64LC$>V&CT_Q0)%VZ?_YN;]7ZD\ I!OP@+ H^L\VT5-'N/89
MU#I$A*9A<<VCP6+?^$]  =:'IW'&%*8,G&J$,&'"48XE>OSU=6-K\J7+]V"'
MN3UER6Y:(>:"HP'@YANG;]P\5X^9CDV1LIM]T=W<53K4!4N%P(!,&\,=ZDF&
M*P/<0_5[O>5A)QPM[4)X#P7LF-N^M-E7]7R+60ME90^3/B P9J4,N7D5O]^5
M)CML[RQ2TO>9-Z#O(4[)VR((9A?%X.F;XU'1#9^)+'9]=%\^U>4\T#R>_2"U
M"L[F#;[RXQ]>P2HV,4DQ9B7&C1( B6M0L))72Z""/-:J,T^&+W6;:;\[QENQ
M4"'LBF8+6CS:>IN(E.N(K.Q7KG&:Y[%N_"A:)I7/E_<JS5.F!;2K;9<5]G>-
M0J"H(3T?G&U_QH1$TL[,F&3&&N7*O-6>&[E9)!06V,UZBE-WMEJ"*X*?*&]9
M)Q^0<2 KF:=K1:$T$@0 5MWW>GHJBBSB;\-AV ; 7D&I-)YND1XV\MV#  @4
MLL"+1OTO^K!>=ID+UI;7Q<M1N7+PV)#L,.Z)W_(F[;V@!D=!!<D0;#2L8J%.
M)A:7#QN9%AV<1'*[?*.$GKIOKLV&XR7[C6LKW-4NI&=?>LN8<G<(U1OO*]E#
MS9%[B+/IQ]-YR4\]S8W,WH?25S:F"@;T\F(8AOD[6LA4Z6/SPTY4PN2<W"8L
M!>ME6)[6]1:E/P&G&2SS?Z,T>=)8/W) 7J/$5UO=Z.OOQL_/7*JU#&I7=84!
MI@D ""*CF/RD$9(0D?7BX\C#;QSP\,0G?]8^*;GFN[D,@^.KAE^,-5G_ H^1
MG0RZ:$Q\$/DMDCOW.?;O?/@#N:6[)_3)4>$X4/:.D"6L=+O&8+ *#A]<<^YS
M.?N4$SCL<+[;_GO:5QYU^(=*YU(MY75M=66\&[G(R33+2DS5T?>-$CM#NFX6
M'KAQ,UHZ4$P.BJ8^,QT5=2L6<=(8OXX<V1"*%8\F[=M]HWGOSTV<B4D=R4DC
MJSJ@= WPN!U(OL@<50&OHGLU';%@ER9Q_,XMST&%RS?58_NXR_Z?$*ZYP@TM
M+J6YCILL<A]B :?WF\K^<'* J.4>_,)F=WJHV_I8+_=#G^K:?NL51?4&\I2J
MQR][<V[*E)3-T"A.(?C QM*!$H-T\@8:D0L076UP8W#U5X5QA@*CETZ)1BRY
MLU'G'_(C!8AGIHY(&WRLTZ7JE:A1(6R3FL]XW0!+QWL.,6B%2$GWL4CX>TDE
MLXV.N?QT)I:A@8.N)]L6"C@)[$]7&/N<@[ET]80$W-R)YN]V+>0JS5E<U<O)
MV34.\B'\2T[\)Y^06P5\J>X*(+NJ>4ZS%]IU:);&N!=(5U+[)3&Q02_J;&;*
M]9L*[ZA-UJ\620$ *'^6Y_?7:+[*.7N/$8L_4>7II+>)W[$[[SV_N -6KG.Z
M94Q#W'\KJ71'"NG'-77 &V];>QW3JIR_*#]Y2Q9VH_0913;+$_XAG%.I9Z$<
MM&CV.;3,9*==ISSDY?A'^-^_IG^E?XCRQK0Q],P[UR<%:(1&?:)Q"]&NKD_L
M"]Y@L9[>^*A*!*GG<2?]^.7Q#I5A690O_S(4K(&ZFL?$%7@FM+\9]141^Z&H
M<"ZZBJBSI QYW0/H[I&YU[O)-563N;(8FM^!X+I_A%]\HS*AA7&5.FZRMZD9
M8_,(]S+726OC9G\U8!@OZ 4@WC%IO(3(\X"+O\$35!EY[5.Y;*V"M--ST@&'
M:HF?5%U$*C383%\6';UD9WHV/?-JAZBUNY3*4[K# C"XTA*8?F/DU,L-:G]8
M#1<%7X;.1PQ81V[&?0Y8WW-4 8C>_&2<D(T&JJ!50ADW9HZ&5B9/(&+ZR*4P
M)9/95U.G00,:K$\%/J-"I1X(&(40)P,NCL+.-;6 V$LE5%[%3,1"M?SD8<B<
MG<[,]OAC55FSUPSEZP=T7LIT1FT';]B(DV=]#NE-^LXN%NI7P!HW=CN2@^ X
MS+?.?9'L1<QSNA+K!*F/Q%PD&3\^$#\#/G? <XWA0/2?=Y+C\U+H(ZHYC]Q"
M#2]N='R8_+MF9&6@3!U.+/2@A^N$"SF(($/4_T;^0I-V7$EA\#/'K]3-[E^<
MJ7O-\*F'U@J/<@,%[:T>/CE7WK,JZ'29,:L-EWN<C4U^V81LDLRR3^><<(M@
MTWB^GHNX+ YTC+U!,U .X>;V>_.6MA, M92<D#JD4Y=PEANLD'0'-+Y+I='U
MUR3-+ 2O[[)!K;I9SX+A<+>RNXN>]I+J3Q(-&P,R&\/6ILVAN;0S#_7EO+A2
M+8WZ"D_:T;!(!6Y#.]0+B,<*S;Z&;&_RC/(7;0Q2?3O.O6?)4LA+N[MEX,,;
MYCO4>R.DR"J#;Y[..#VF2(EF3:B)<5TU GV_T-+9\E-2=>2@CKM_T3[;,[O5
M]LVTO[T]6?[RB#"!7S?^4Q)*07='G42%7&@W36RVU[R4ZAV(D\Z*VAUYJ^F<
MS_2@D1>L%J]V_'9;^<B'U\G,K-T*PM<Y4$A"6[H9JTQ1)*\JN0R[TV+O"7E=
M8\X0X6@-?#!A:S$?=<:$1>1'P;U '5IA,\,=ZEFB.9>B/^$_2[B=HKT901W0
MX26AF/**^DFQ]Y7EM;%'![I?@QGFNA J3"EOBZ[2F906BT_VSS/RUYL>J5 !
MG7Y*+&"VFGWPYKEI3N83<BJ^9PVY>TBD" $@<O_CZE]J?Q\*FXBL'7.>QDO1
M>"MYW-440X]%X1:(%:-%XC>4^=7#[T$&_R&5['0=Y]#JN=BF^6CNMI0Q7[*Q
M/29ZVH3K3Q@]!>B" (C0!/(7&BQV/+4X%./HE/$5Q\@(')N4CIJGX8V]TN\N
METTWOFDD%VTNR/W"J5']BT[U1-@3& P>KP(&+M"A,%,AJI$[UU27@,P?^GA%
M0WQ4.A1VH2;#+G_SH-M"7BN@TY9YS^IJ7<6Q7PGKE_7R^PV24$9>#@9Z :!_
M;E;8H=R[?X--HN<\F9VV#@N<8Z=;X<8):6#?$+Q/!S,>JF2GK9K+9_/VP])Y
MUMZP()IF;W=Y_O7C;1=3N_%3BHB-3@+ MY8');FN((A]M!)%*1Q'J3=9$A?G
M;)7 Y?WCLOVTK&B+E#12J*\LP;(8F@+BV4+YOHAJDZ@_1]J#L0>^$BPF@MZ1
M9#RY'@AB;/^*V V)3YW.5YEY929"><*_8+_G#<Y]#)JPP\L&(3A'.-]\V;33
MMW,GR#/5QWBD#0Z\20!P^/(A?2D1R^.7ZFH<8I )7.!5]4Z+>?KI<?QOYM3;
MS7 FMWF_X@N514N7DA:9D$FTMBHB=G:- %A..CEL)P"^&S-U""@:#4#< /4^
M;%]( B?*;#A73TJG6D BCCDUR4^_>YFS9-^+-?Q;_."4Q+7LEP(S?G0KIC1C
MY5R1Q").KYN9.,?_&DKL_!2J=Y8JW?2*/". ?ADHFI1!['M#U]VEYJU3,X-\
M-^Q%^G'ACGNR5(8S%.K, 4]K8.%+U@U2XAATGK%)\D"3OJF=<DOQ$G%5]Z#;
M;GC93L5#T^@L>W'V%N11>-YP/S[?%/<243-UZFF\J!CT=<8FGM]("S6G*>^3
M!:/1/78]%-JF\:<0R/J_M=[=+D996G:5)P%V]MCPFMZT(0 .]X;F%["E66&A
MNE_W!\JL'-R*=%HJXPP6AI 40D*=QD>>!NVLB&IA$6?.-%O)U9=?;SFS,@F2
M'SB']:)I.M@LJ'&R,,9^L,3H5>S3;R797/T2L3=I%9MK'S<4[,?IOW=S-8AV
ML."49!AM$BNV5Z!.?#M^>FY9&32K'48:O-\?_$7)LE4YXD>&MF8E=KEHT3.2
M %"):DL8U<J?[[1VPZ1Y+_ ;&<NL/;T37G?C&1&>FUJ >$H48MD<D%D7RA]4
MWO"$7CS=I4=2Y//"'304^4U2_GW;1:NPZ$=CZ3>Q223EK\B520J&YWEXA**?
M\=]J2 8(9(4!PM0-K=,?I/-Z90TG\@@()RTM80;5E>@!VO]!>F:ZZE53)[-P
M!?R\:$EIEIWME^?Q,<R6/Z(4J8RS_%GH54E4V1WH)-X49?\B_I4_J@2@U_[/
MRE2E4RNT!D9UHB59,^>0"(#GEOJA\<?> @3 KKZ>H&(X^\9>S&A(^T2G7@2K
MX)$/+4X'"\_'28__=I_?&7]P*?_3"0>]HO=KOND;M:)%MZ,@/)DW46V24-\0
M?2HG2-V7_9LSGKH6OH -?%L_4<T67-^45BL7<4&T1?I,J!)K@$K8[*Z$7V$N
MS6Y(M3JWS\7@'NSO+,;[*CF<'JLAAI+/O,4F,\J6'WIJLK<U3*9M3N*_7R ]
MUJ.6Q$)D:SN$VFK &(B"5,?96%0,-/%R< _$>F';FDXTBB.W6K-/(  0EI>S
M]5X)N@<^-):=$/L9M](8*ZJT^";WFNC2O\O?+-_JA5VD<MY(IS4#BQ( :WYN
MR9N&X4,:TOW4WW&70?3:YDG'F4H,5(/KS<F%=75A<X_^B/?< >9IW-^O&X-,
MW]76NVLXOL8KFFG7<4-S>F2).A\N2Z73M_.<7;IF_)4WKXO072RQ>K)8H6;J
MU':"71&2-2TM)]WT+ &E&KZ78*T;E2DIH:LB]_Y5CJJ5/ ?S0]"W?->3N]_5
M]FFR8N:ME#W>?<OF^[E$M*/Q$IFP[2C*NL)7R\.MRT4&6S+J9'JE*ETNR7#[
MK 8SI6.N+F</9F5A?=_^3KOWR4G6T!&'XAA;L3W)U#%7[!.F[ =;2DP&U=W]
M0BXFB@X"64GWGA/]^$+\@)DK_,OU0RGGM*+RYY4DZ*D.JBTW=[M?]9UGF,49
MJ&%AGJ;:DZ/CKM&\.L2-<G:NHY,W6&^F#TI65B<4A$U!%76OW,Q,HIC>U1:]
MUT@<0@"\U](^G# 8MCJJF]+,9;!W/X .:72X/81K=R+L/'9:!OWX$W!<V'FW
MI<*LL5,/GV;R2(:H 0QB=P=1/%N;"]6VACH5&K]P XN;FKS.7$V0ZOLMWUKV
MQ<U,\.SYQ('$OO*MFJ: FB;(Q1V?P+_('!P3ME7,_S#Q]42.O03Y8NH1Q)
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MXQ#,:=;A_;VL6K]&L8S>QUN?#%\[^NCI;C:$S3<GQA( 8DDGO[C"(^W!?0H
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M/>]K7.XZ"=&<_I9^U+)2-UPG>5P?+VI45%QXF4]DHX9@S3/1WN4PP)KOKA$
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MX]2Z:?=[("E^XASH_*O.M6X!;/;$,$U_TI)U'E_M]Z\]=%/=^OIV/8?O,FG
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MV:T[Z.=B'46@G#2G(E!SA_<G%:<R3@@Y0J%NSY::'0%]OQYM8J?]9X1%Z/X
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M9>"VN' J%A]K3@[M$UR&E;&:WM^/=PZM!CFMHDBN5*P0JI8RV L@!Z7,B6C
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M95>*!<]RS\8E\\4+)8H*R<V5C1U=QGV78O\,I;?5%_0&^P<;TYTM;MPI> M
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M3CY5+UC*,Y\R:'_!_77[.5B2_)G6V(\!UM5)(PI=F!__L<7HK%!IT"!*Z0D
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M='9JGY"S.I)D)X$"#RZ'9_RD86Z<ZY0DY!PW\%43\!Z!.5K1X?8W/3)!4SY
M!4JJ_E)HI]][-'DY<E4?BAZD)D#/3D*SN:13C./D2%-T'*\>6^[2_OY:TF=
M5'EMM?D)?=P='9BT75G+<FZDTR9_3G6)R2(7="J(88WZK_"4"0^O6/EC3"78
M<N]&D:TLIL&N*ZK#:$OUGGHC&+W0>]PB.//(EERV3 ?A&QA/7IH(85N7EMA/
MT+)<O*DF:#M9<3%T?97,E4C]U^,99N(.!)?B%H4*?RUW5H+.RU,1.F_2,]!!
MYD@QQC=7P=VJ1T"V\_K-XK*KV=FP5@0]D\6ORZL_<?).^5_V8,M--/K.%S5H
M3I ?UT\J@!5<?]L(;JV8 ]IM)%B594E"/(T7RQ?]Y($D1'2<@'TDZ-SH>N3A
M*C_)D)J\04:2(F&VY_XU._?NH-%'<P;U4P#1K-G\05V"8ITR:Z(<4_L:7=R,
M]:MQ,!ZOE\3/'X[(7NXMA]+SZ&Z**_[Q$MH\=6K4I$A(S2B@62F\ 6M'$/O<
M$+*S$@\V6P%@&$1$PE -(.7V?EKXWXHQS.%3\XI=T)]5)#W!!9C6OOT3OTB8
M*+\G=T)1O:K*0^Z'M[3J6QLZPCE!#@PVQ1%RZ_4,6+Q)ZWB*^;CX"Y4!!'VN
M7O=Q38^N&TI9HRPAIUC3]%B)BM_)+?;9*KW&?G=D)SOQ/3A&4.1VE;*LNO<3
M[",G13%C^)+5MS1]YLUOX.1\#:XPR]5#[ZNQB=U1"]O)8*9@QWT+HM^W=OE,
MH!UM[LD]AA"OB S>WDT-((:K"G9\F3E-JDX93TVAJUV/2PKMVR"R=NK[Q3J-
M&,0;@&L E_O*'RU&:W=SP[.)J6O%T9@:9V+'1E5>DJEK"T1@\0SI.88\XQ/(
M\NF;_*YY;9WDR''@=7A)XR@T.H>4%OB.D61*L/7/!*[2S@N =61,W)B\K%@7
MT;^I<&DL)(\DL6@TLK"CR](M;J\9)&Q &V%,.V_686!O6Y"[5R%^N/I%D#Z5
M&(F]N"6B'YSH?9Z]]%$2L9,:1!6-FL?']CH[K#W]O$[FPO^\>_.3;U;WID_V
M/0H10E*!E]H'Z-Y/%8$9_;QZ@Y5P>28==,$[100QE$O*X]Q_T>/__77[_Y?5
M,#R5=FJ5PG5W_+C,RL=WX.[4CLISCM>M5(R9[CF3)^K3(FV[ NA[:)).M0Z+
MQZE:VG-?W4]YCU473DZOJ27^"D3LSITQI;$F@GG;N>F#J?#DWR!E0]%"W!(0
M.0LMBNS:BZ]<1%28FLLJIDOYV]@6]:T]I> ;X.WL1#3^95WA[81("1*X?<FD
MQ8X)[M$F36.FFL#GQF/+,$7X\,&JL-"V=?YNNPC UBM&">L9)%RO.JBI]^=E
MPYR4OV&JO<!2EVUEZSW0.K3\QDHIS^N]V_7<MO),X^7"!A+8<(L-9%$EY"BG
M2J+XA9[J+5:!*HQ&-X-&:0%KAVB%S&$&8JU3FY]M#Z%4K"/'* Y*N"HV\ 8Y
M%2);G#MGNZI[:4&^+'=3UV>IUQ(:DS7FB7PV,1<U'AU%-R1 !$V)'C:Y'^[H
MAN,DMEO8P)J2)V_"XXI<M&].1\U_TW*-!SG'\\10_ENG.%1K%>&3\,A-8FI
M<]Z/6G/SOUOU(4P9.Y6B2BN&)>AE];L<9^I&!-6G[:*?.#A4SX/ZNT;#SJ0O
M&0BDR4>!O5R!I&?^:2MWH73Y+,VVNG3UW /^C-=X^JNCI2<8#Z=IO<88(XRZ
M^@%$<*6((LG:TZ %2<@V]H#G%..=]YV$$^7^"(.XK:,$,5Q+/?QUVRS'P?M<
MY2"R%BYZU(_9%V3!J6)46#' T'PW5W7A[BC?X.P>A?O0G]I8S<OE#)72-G7S
MX>U7-&W;$&C=+E=,63X\^5C-Z*U]!;7X*<."8YJV24/3^$FL'8WA%W 2&&FS
MG1_J $[OAWUE('U]?MHO-3GXK)O:0SZR?N<\EU'F12F]>+T&LKK\& +1:E[;
M7^<6OE/]E)3-HZF$'!HZ3X0PYN6[*_$S#T=,=K?+;DE 0) TUZ@(B\C;:72L
MQ5-8DGZ,(664['7%EI\#B'=<@S23]'>3/8;'I.EMN2=]Z+2.O#;3F#$W:>A"
M\*1[^W30U9-LGWY-1.7(#:CXT96-S[1./C56U#17R8JEQJ<T#_V1,=-%+X>$
MD*!C5-$::^*H[F*M7EJ=J$RH%XF,"*%_Z]%F^<R=E,(JQ6$I4F.>XW1.B8=Q
MS!4W4Z.MOYG,;STX/J)18>2/B4K$LSCJ_NF/1N5)E<XKU"F!G)T[A<<FT4+7
MX'C@S-DH.Q"[DQ][CU2I:+"A%S3A0-[*C5V;;9U<&*0F5)JU8QVV?K3?*&KU
M@,"\19?3EC@6.CTAF-PK(,7R.DAH])E_<R70?H@SY:E*/'RXV%GP]]YG9 &2
M>6_?YZ_G@3?R[T)'=ZO'8'4.[B0QTPH9C6.<+/61FK8+A'P>DZ(!?\ 0S" U
M8Q_GW$)UN,F.T2<$SX*UZ=AHAV[S]3$VAQ2Q"_(@)K5?SG-US/!W9NZ0RUV#
MV/RCKCT2Y[5*WXP='NHI">CJ2"T+9K*S%!Y<>7=R.FJH+E(NS?<-J&I+?<'X
MX$T8@=+7!H@%?NJK7YA(?6*("/Q9N,,5<7;'*BWU]?%3.DOL7\\P)?.H$@WE
M&$+BP@_WAIT4?IBZ&B7"]79X/.U=G\+MK)J".0K8,1#Y92E"BG:B9#X18""!
MYXZV,!^YBAI!]D4CE I\@J^&%<P9P_7,OZ9)NG\./ATQDR*7)')WQ+=)%T&R
M:2^N^B8248B:Q>A)8NR-*K/5B>9S!?BU/MIG-<%N8RK/6;K;N^?/KL8#"5@B
M]^I)K(2IWA5XCSY,3Z:C6:V;TM@ONJL0C.@_L*Q5+4%.TC$\47<#E'1%#2U:
MQRIM LCA5EN#'-7,*:0W6:K+$JZBM02Y]<@L-HXW09. ]W)0 "L\2WN!KG-1
M8/P?<'">J<CL'24;#)B_-F=@%39O<%B5?B5T.%=CY.?>L!# :$M!$Q=8(I#Q
M^D,+J2 !8&S",@%^,THOK\L1KVSJ@NT3$5OP&>ZI$JLV7[6T-/5ZZ+6,HM&$
M7OM]LAI$_2\-V5R3D<S<S44_9FR%";<L8VQRQ[+] U4-U0P:*_1X6+^ZC"4:
MQ/_[Y*!USE*FP6 0-)C$Y]LY63DA5B\;YK_%;9C(1H$;?W!&3K F;9^UU:RW
M*D?D&;L_?I/J$1<6+M6[(DV'O_[NU=D5+9*-!%E=1\,\7RL'J!J>RXV)@2IP
M*MJ0BA0D@M!+K*P*-]H!,17:&[T6^LT48LFL8$Z#UT\X3MM*]F]]1.H-TG33
M"Y"0ODQ#ZCN)^][FS*(QXN]?@[)/Q3\?TH(X-[$R>,9&AU%QFSQH\0-8E+:5
M6[=C%?QU24@IODVTL)&F8C$)YDJO.T$ ]R>YCIHP8]RNF"7A1C9/9>TO40[.
MX9Q?Z+8?!WQ)@$/D;/-F]SR,(PFZU+T%]N3]S24#9O:)=UC?+PE#9TY- MX@
M!7?"KT&.@54C)-&>SM8_A]SDYEIPV?'N*L$\#TUBI>:JBD>CDUDO #AYJ"S0
M^O,?+E^?6X]F9_EE>XH&%;ME<L:R7O4BVNG5]A_0RX%0C8[NYU^1IX+.?(3)
M!E]+?^&W,'LD?P)4>:7V%D0D![BP;+"1/MORK#6^JYKX(IK,^,EFL<TBFZWV
M<"E(F+(F@4=OU<AX_,=4NW/(C3UFJ%-;QP/;R7=B))[+G*)#.H\CG93=I\N_
M,S8]T#C>XVF_K[F3-2GF@86Q0<^FFN@\R<[QZ"-B.M5=T,B!U::(+NKB;!_+
MFSKD1!7?5VF6.-(NY:JHNPA"PVJ&2[D)T..!=LQ5)8OB(>3F!O$)3<2A- 4U
MCBS&['T)8]?@()X8X/+4'G(ZY^5RKC[?2!UA;]TQ][,]YX/A8#H&%OAOY[#"
M=S+6OZ*A0R8ID/VFG(/:]$SJ/8],<T/V96[!3.09.EL&,2 _YU>EVH2"=)(!
MA4EX .U?9\.NN+@PV'&(S1>>O6B9;DOMP[T!<&+K781/S/)_<@J^]EFQI8VM
M@AM2IEFN[QCKZL-%OR47U9>BU*7$*^7C&.C ,W:5L96EFO(&-&R'GY5_B(SY
M)-<J;E_*#NO&']('/;2>84OG^SD92?/EW'^\^#W^E ?R+O4N[5:97+"9+4VH
MP-UD_NRVT2O$O[#ZR V-JZKJ:J3XA$E%F-4*8TLG *T8>)R.[/=O9YLB:*[Y
M"4&+JW_\W!HHTJ]:!#OWV=.-K=25?8((F1?2$2:+4@##<'>89:=G6:RPFYY;
MC<#HUIKB,N:;-'K6J$, ))H>O.ZC8UP'BS]4A.DTF3F64&M2VC+&,!*PTR.3
MC/,/@@_%D-CM9TSOERT+O5P')"@7OBZKMC0W=AJPA #QRO[92EU!8W^H^Z:[
M9'VW$U[UH19[NEHX)!E)NSGLVY*AQ8"JA%G$*>WVXGMQOB&@EL&8UY2@ :&[
MHK%*]+4+N0O*AT*R-BD(D8&W2L"3?3PM3<!TY>JZG8COT3WEZOO+=%/CC7V]
M_;"Z:YMMDQ0J<MU_TBJPT,:8?892J:,YY$')/.DIIP^_N;\RWVV43&N$2HO3
M#W_GZ8-]F?5\?JYR[/?J$G:E+?8/)+S>)_E8;B,.-D@I=? QOOO4\*[E2$[V
M[;2S+96VG&J-N*Z]60P2ZN\HS1'J$SPA:LB(]G/'R'!2*4>"%Z!?RJT5IV[Y
M]#W5V5J+Q[NXM0"CE2FA*3:?_[.0[TTUJ28\7"*O]&.%C8/6*:_^ ")>Y4G<
MJR]U0K1B)2UR^3A_8R[_=+\UG*QG@C[VV*7^DB7O2+ GYJT,:S&E(!DII=MV
M*UE]_!QC;VN5]2%S#51H7-XXZBE7+ZBJ(/]:-2?F6C@?<PN?O^*4B2_JI/J,
M?7)Q8(1A5>^I7!.95^C5=\G!BI3XW!QY[,-(SI(L]87]^HY(K12IRZ@0VP\<
M$/;@12(>H_4@X*9BJ8>0<:$:= J9H6["R'+_YF)(1\!R'NP"O\.A#Q!F8=@B
M9N_F4/:9&[LA46;]*=?0]NN,KA)K]"BW<,KQ.Y4S/!$K:X/Y+US.,?_W7\G?
M+N*EF92'[1$"Z:[GPHZ;;T^'=U$Q?B]G'NW,=VK] Q.<[CQK9-(Y82L]N6/4
M%FR6^];'(=$0^CN]K)JO6-KD$AP3R?+G15DV/[PG]PC&GY,(&)EF3NE,ZY #
M/>/)XNTUUW:I+NVV?JL5\OF N9XS:%<+?V,%=MPM3B'!>/TZ:7";I81/$:DU
MF*$6RO85<F5#6!J;Q7VILP47ZP1SUJ9T.]^YUP=KBGVJO.-:ABFC^"JXFFVT
MILL-%:C&43(V&<'#4U_(D&LV)%F/DE+ 2?E;1$6DEJCAPDV;VZH.>+0<S(HY
M-]>CMJ286P='P8DX]S&7HCVQI$Y']7<BIH(F7RY/]SL"63EI0W[E?Z%"=(T8
M7?4:X:\A';0B-!AR+A9OZVCS5?ZH6G6HF!*5[0:A??=0GC+,(T5=19R^,ZFI
M8O)![Z>VWIR>:8KU!A=5'#G#2NHT1/\;H"%'A)"^&Y[S^*ZBJC9Q/4LX3(;]
M?*L6XB \Y0S610@L]YJ:PDR+\4X3L'UOMX32^2W>9E'J;?Q@^[N<B4JA*9',
M:Y%?,)+*>Y7BMNA/D\ZNV.4DY-J<.TJ2TBEP=;1L>XK#6'=*S*CPYF+D^370
M WK#\$I<\T'ZE,9@@6%U[V:HHP_HN6<W=GP<@7NQDF!RM+6U:6Y5;=/\R,NH
M2&1;=A39K_=:F$+'A)0QIG\3I#FX5B?KI+^1)LU.;[6']1C)XR9\?#W<U3.H
M'.TN>=(RJR_^@7G#E705PDHD!#['<2+;U;[S$J/]&N1RSUD%\>*O$"II25["
MC.T1<$O>5-(>%R*@,ZW$U_8VK(]7XP#KFD&V<$:J<N@G2 E%C ?C3=/>#[Y_
M?&CFA@1G+XN"8"%_MU2:2'VH;D6*>W4C*-^UJI 3Y,"!U%V2[7MPTA2?VI P
M]F 6'^MDP5W<8>.?JGJ!N"^@'!>QO=[SB']7BN51G\:A<Z)G\/>HLKJ8[M)9
M,NE&"A>YY6P%M(TP==KDVVM,"4.+/*FJ4>FD/&B,$&:GN'=-'];7Y64=B,^2
M(A\;V];BZF8WU%\QO/-QL#90LF[)W>]L/4P2)(@%AP85)5)Z4O-,VB5$XQ)%
MI8LH]UJW)?]:)JSPOF0L8#;.=M&+" PG@TE154+M;W4DF"CVJTML7<5@795I
M51P3&F-[>(B,3 :F= AKWBAMDS[5B?/-*5^6-1IUF9%YAT_(4V_B>I,60G/M
M6B+Y]?A!XINF!5X.S,TIIOUI\?(?$RS #U9-_ZN;%C*D*[+ZM[W!UIXO'?JA
M *B[RS64GY.))X)-#$7X)J+(3T,4J\,0[V\^%W?ZNHKJ#7S_H;>#2==OP2R0
MGLP3CD9%%23G#HVYKBQL:5K8;59HS!3]IFU:(PI"E&-(:I-?OB83=TW##=>O
M)&&U!;E:(Q.$7:;FZF$9,*4NR*NI^VVZ &3;K@-:>K#F#$NB9<S P&[$N;>?
M?[A]*^XO#]>F<E#$F);9^+8M(:XP7#M$E<YKPJ>+-0P9JXLK:I3+?L/SQB0C
MANJ"$IPHU =8E4%_GF%ZRX5Y(&BN>#L2$+=J-@^_0Z0)$;1HW8LWJL<0QJF#
M*[DR%54)U]:E*2L5Q&S."5Q4?7$+%ZQV<NEG7I?'G9(25RH(W.'EL2,MYK*T
M_S[(O&1@B?CI@GF-WM O(37V;2M0A^PZE)750[IAQ\L0:*.8UIZIC%5G$%60
MI)BAPZR9P9K'YHIJEI#E] >@]84FW]^P9E!^K/5>4@>=$J>]0; A8[0&P@.9
M0J&22\T(A[Q]T,R_0C0;+T##SQA[5HY80^\4\>H=[C5\AW*_V>QMOQ[/?!V#
M8V,.FYW-^YZ5<98,)[?1H=&L<:9"_&U<M@#41\_A1[]%';U.4.'O<>)"HSM"
M-4;PA;YWC<W/ P>\MPT2NK_^D@6Y<(L 1H'A/F'!&/Y\)+^"ZT;K[Q+OTAZQ
M),?B-TAST<5)0\3P_!B<Q8+S$7W=E-Z_DK][WR"<U*5$\&;:)'V>>%+)%=*F
ML2^HRZ.T_\'O>Z7%[S:. K=A:4FQXH40-2=N>3MLF<.AL\O? \0G3D:R7B&B
M]L[DX;&JFFK</] D.WK7BYP'K(-P]0LZJ_CS"&V;24R.6KC$GU;FJT U((@2
M/I9]LW^'+(^AJ( O32CQ*EQ"S[)Y(?2=>*-/V-'7$]?O ZZAZVB;:+7YV/?_
M.[2.TU#,!_P6'U\=84\>998PCW@%-ZR_)]S_(?$7VTY#BHA4:E[GO;.9 PWO
M!^XH2Y?/V?[*=2] ,*U^C>L.-<&%4&&>4GW&Z[4Z8Q1ZC^K%$>I(Q-:>J-MT
M)/5%CO#!"L<;%>'.)A=2#I]?(PGJ@$1!ZW2#7#+W(*Z2R:,-TBIG)TO!YAJE
M]U6%4CZ][KC7)S"K>5<'J<4+@"C1Q.;EJ0S*/UIJU=E$2VY%>_5N?A8OL%>A
MV*O^=R\D:#Q/S^31]N<<#F(TQO7E?Y[VVQP:$?WJ-$&I0>[RXPH>IV#J6S6U
MLSI:&3D!+M0_ZK+V1#[BR2/VK)G$>)P,K@G?G9>#IVNOB"$O@'DD523:<WL/
M?!Z[R#CA]&'D!:  ;NSS,&S2$]D)CP1<97X@%O86 4'A9".F$Q)A]PN'TO,&
MPK4MPAMY&[B[IJ=W]2'^O37X!F\>SE^ GIIG_N$_/81BDKNT410EH95AAUKS
M^)/SRJS:*!_ +)/I4[LN(A:Y!05:8 I-WQ-WC?[EP6'70C0FE$GF=H[J9Q]:
MY98P/@%OJB,2N:*PM39NKDERLK=>1_&L:N&5$FLEAHQ63/,3"8Z.-,B*9^B\
M%K2^6!#)TY8JERV,,8VJ]^1@)3XY[>Q:<C A./?Z#[$UJ^['>=,Y=O/&%F0Y
M&F^+-',EIN@S)<8\5YW2@B"*[6^F(A PE6[DV$Y/S+Y#9Y7,IZ *= ;?E<=9
MVMP/; )S8KU%EO72&BUED/72?%P&Z&8D3&1^,.WRKPA8E^3M,M.<TL+@A'HX
MD[;L5^LWGY"^O=H^=*H.[7UFR-N5S]JE-#*>HE3.H=1/4>6P9N/M&-@?K2\S
M?95="\G-4;7OK.&"4[\ M"8$@2=.72_ K+HZFKOM#@?!P,2#0(HEVO=G"V^G
M-^LKEF.0V>^!O0EEI1"H<3!V)QYSG'EMGV > :9[O]+3SH@QFL3 C,ZB@E@$
M&6.2A7<&46V\F(,+FG0RJEH;$4*6^XXXR<W:R2V%=O:,V7^[66$)Z/0%\*?5
M^G30#BW"+AWA&$ZB_#P\Z9/ :+I6>&K%B_48W,QZ2+XJSI;] H175?T[W5M8
MR=-U\0MP ?(^*]LQP;(7S.7MZ((C[7J?^5DXI+5?5=Y[..Y*A^F^ &HGXCQ2
M-'W8Z:'GUT0MT7R^L<>Q,N.OR#*5.-;H:C7&9%O!5P<U+>%\EZX_?R5Y:]A>
MB,T8R",.,IKJ3C!0U6+!A9\9-COM96:O:+'@%1]AS.E0RB$!_8.,HI^1UKZ4
MMFL[=28=B <O *6\1-/& $Q-/^V+/-P(0I;Z'8FA.:/)?XI+J?>&"&'M*/.K
MB$JF@12E>9KYE,O$Q%#&?R[_F=_A/_4["83P>%I,VUGC=8-UP_>WZOI)#OG?
M>'_510@S[*/TB<-F"(?L%US7AMQIT_F4>!UTUEY'D",3"XGW 0E.;Y FT$9.
MJ8O5,U4>/IXB?WB'SE1"WF3X[P-("V41)X37&:5%0B9)C>W1S3KCV=;&W5OC
MIW00C8H]W?XHTH0]:YO"N09.PE4C2XA?R_4U)I E[H^H[9X?ZZT^\JQYI?<E
MRL02\:Q/E5%@E^?KCP* &Z".IOU?<[[_8\0#CY;0EE@_RVVV2:X^&E8:;!A6
MLORLW:0#"WZIJ9%'WCD6> ;-64YW?B=WLW^5+:-[WB7I[;C 1K<%P+MRFC+U
M=@C@^1&WIT1.G/.N*6K?=1FM2?C3ZZ#\-]1!Q07_0WP4!(GU[ IM5-F%+HU_
M? 'F#JK-"M_<,2!?3U>Y2^+%;_AJBCM;_W1[ 6H.*DG8V%(2S*2(7SFPV$Q3
M)7P@0G0>%G\[TP).[HOG 5O'A,45):+ZJP"\9^^;FKTOSO"^%-GH)=0BI<"U
M]+Z7'9*7D HA<RWS;6NDAG*J\O*L!@D?N3WY/N/[RRQQV*T?)[-O?5DHJD,5
M(H^^B)6AQ*TE1DOJ((?PY9)!J_-V8JTR.$ZU=+L=!9[OR3SX]_O(/849@U05
M#7<4$%L$KGXE^LRI-E!ZOT<1VR@Q31'UM !#FFWYLCKDD\J$Y-7!F6KN6\MM
M&WXLNRJNS^T#+T#!D ^V]W3?K%.M7?_Y+T&#_$L_\)WOXX\.!^^U;(@8I,J'
M_QUWM>>(!$]H[RJEG:<,2K,N^L6&824^LQ>Y.<;>-H @S#^KBP1K4&E?\".J
MLN:K4[;W=71YKZOL8*0CW>H0F"+$&+0-#AYVEJ*VCG1/A>%$6Y<QF@N=61#\
M_(T<\\L;B\P=V30^,E=*3"?5S(O B[.3^(?*UX:JSC3N>HZQB7PB9$?)S>O;
MJE6 ;?P9+7!D>3#O@8HK\.H3\5_B_1< J0=RO*OV%$_:<__V%7#]ZDV-&'QV
MU^;D"MV/PPPR3@MXS0]1GOB)EQH-4 ]D)2+1<I+2*4I!T!X&NA& *Q&V=P,N
MHC9ISBKE<E7&!L/-M[K0\OQ,-\HOYC&*,I\)/OEOYE2H_A^.0F8%1OP8 R#G
M^HL\:T]Z93W+3Z.] ,N+(\\IRL:@DN=)!=66BV5C9; JI^0<^_B9I;E?0X;D
MHE+>9HE\+Q*@J_<"H'? '0<E$%N>%SL[XU?$2R,T0[B29Y>]*#T1G9]VA?D0
M_C3^=Z>C2P W7&/[!8@B332"IPSX>#2Y(@=\TMR48OSR\="&I5F)/_@%P%J$
M-CR'<6"^ ,!2%V<,<*D&MZH)S[NBMS&!HS:M>AGTZW.%-*;.76$+K"G-)_U>
M6IU%I+/:R\8Y:#I.A7H.5(GVB2S'N"M35LGO0@8](1J=RFLCF7S?7H\\%#LP
M&$7%-CJ'TWQ#6/PGK(#_W70E=\\)-KP<*/4XW++B;/<]M$"VSRT(KJU?0+WG
M;9'&O$ZXTL;.,#/F!7Y:G!6#U4UE)T[L=?8D!8X./B]0==Q; B>AOC]JAE"$
ME-V*VX7]MHY436'F^:L62Y453<>LA(Q/L#.$&V*P-+O'K;C4I/$2^\'\UX!)
MD8D4V6);Q7&GOW.(7 8AGY+N",0GK57(DSRBR7E[SQ)J3"[>(#;'[HI2!ZJ1
M^EBN>RYU?TGRGJ6JOG*)[]&V-/4?LN7H[S0MCQ!W^5EFF.(P$Y; QG#ZJUH*
MF4!I1*WL^K:,+IQC1Q$B%\-'IJT1U'KR!N'\-AYA1.OD;?>/0,>BHUO2Y7<<
M73F-(/9YI5L+==[!)U2[^3.+ 2J+)I<>O,:*%P#?1E:ZN4FODE_W@:;8*?TU
M.0>'GNJ1Q:_$T\2*EGBR;%A,AO%TNJO=V^SR(6V/N,75#;:_SQ 3:1A)WFZ5
MZ(.L<CMI&K-"-"<>=3*QD'G1T_XT921:D^T0IFDRMPA$W#YMQ@\%-^2*0U0>
MFA$I7Q>RPY1A%5=-X77Y,#1F%FGV: B9Z[!<+4N8)OHQ^:OMEHN@].W\9ZL-
MT6YC>^,-+A#7'W?:5W4'QQT^WK57+T"U><?]=@ )9'K9 XPK0/M$PM9=(1S2
M^@+$K(K='X;^; DG7K2.L$W]^;DOFA'K!0C<<T"X,]D7/ZZM87@J;&23)(#;
MJ\WS8R)W-+9E0-YUW?X>ZB"B$S;J5038G63= $#1%&$3SL'8".6,2?Z03C!B
MAF=K^GV](HELWZ0B=.6VAHV&#YY_$_&9KVPO>ON2P;:Q/J4\8]3HJ#7@U@&)
M;AOW.V&\OV/?,JF@,>'LSZ[?-VWLN[8>O,3KZM8H$B8/APD?5O)QJ6?%3&#\
MUTT&TSAW2[U&/$'OZ77=971X>,R)T-#+]\P&ZIXI4FZ<.[L7V/W\7<MLMWZ3
M7GC57_^LNUP*9.IL]=KL%"03\X$T^5Q[!_:>P^_A*2^ 1?CY<TQ(D+A,JV24
M)&JC6K0$%Y0EZEHT1P;S'/4O@9V^C]X40XR2\3MR@NKY-H^47H:R0^28L['>
M&L)N>/'V>4(@)L/\:YA."_3,A'3:M=#6=4(UJ:(3QH-[8_G-@65/+,A+:!L*
MB./N;/6?8_HQSY[SU:#_F?F3Z;]QM0J&2DWTG3'1C;%,*(WU;CMQ X"NMK'"
M#M<JUTXT=#DR>6N$U1]EJN9?.(G+.2L\P#AW%^J6CXY]?9:8E+SR2MG)F_CX
M&Z##$@?B/WX!,.R6-DE[FN8Z9?D;1BS\_1%R*;T5^T=G0P3#CUO$(+EL#G5^
M]CO!$#4,NU6,17YJ8G=*ZV:0K.)W64_$VCZ;HK=KM.0#%@RE!T%\?$V=*@*S
M[ACT:8\R(;O*[FR42HT.;S$8685[68KURU<MLVQ70<6%AI->,^^3*+.2L>I3
M 4<7 "6>UPD8^_-V$B#2S?;S#^>4H/U>]" 5H7S\)?74FN=7U!>$F%)+7BK:
M5AQ5K[U71Q+4?9:VVT8$'"(>[?7*GRXLK1CK(?&5*_=?("5VP)_C=)C@8UPW
M[C](KDAX8D[K/,"-?@'P:#:Y) ?B0 )[_\+LKIYHI=V$WV^BB+LP)!NVOL24
MEI^J)\8,,-0JB!K20+F7.4@$-:Z:5D,0W]O*H\$%&N5)_BG$((WLSN?B#=*"
M?>227V#%41[1E1JF]([H\0;S\^^2+!-P2]+77D6/O,0:&GVDML4&/E]MZ(/O
M_Y9-KS;HNR^)Y<>V'\*#Q\HVSC6.V\-HHEU!GH?B^S5I;<G:SVB;M EGJ6<8
MHC0,,)3(L$?),GN?XO[5HW;WQG3/=RWOXX@::$<I+DU")/CG_;2QIZ-VX-&T
MT?_8!WF[O0A-DB>5SN71TJ8FFT&166RMR;=F>=D&ZW-UM*K9_QF@26&<F\K?
MW1H?> T-O,\L,; (UA$9S+LU)R]NA$>$:#(8&JL-1E@4=.;BBSW=+;R6:;2_
M-8MVGIX)) J$]B$C)<4K^*FC(53&IL__XT0HC9XJ14=Z#V^TT"U\5MA:P/XX
MXD+5+,^$UC&;K,Q-O$I$9ISYT4J!C7RY^O*M1\G5/C3 =8WTHMGL\K0R6V2H
MH@J#JL"E''E&:Z=+J"U==C/"&%I*MJXD9US1)/&JZ*\QCUVERP+!\\\ @F37
M7V[AFWP<&_A11K7A48/!6IC)FU:$PI1QZS=_%5G.!!FHN^SLM\BKOJEO*EN_
MM3UEC&%<)R^6TQ.60WOK^9/;EW;<_H'PO:)8SM1KR!X%I47X6\G]FELEVNAB
M$=2(^@_[!FX3^C)NS'=CFCB!ONOO JR7OF,4_;70:WB':5OYVZC0AD637/$^
M..D\6.<ST?$0B8!(0!9BGZVKLR/>&'HF&\)9X-*%G>.5J7!/N]#U;-X+$#^'
MR.^P@:L10YSM]I56/_$I^[JG_07H>Q<(6R4_54-]/I:\075\%I6B+NFO?=]^
MH*J6A2MY,ZH;:"C9?]7XF5\AY*]!=.:7R_?-P]BMTBVO]!J2MOC7U1$,68:-
MK+5G_&AOJ@B>V)MD78FXV:IA[T115DCM22QR@1%Q511/]SV3QJ6VGS8FN',@
M#?6AFU1WKJ_SUM93H]RM1K^*"(PE<+%ST=&\H1?#(,'>7-JFUK ^9V(P&_M'
MI;</J-NNTX;+LH8O0!"[8^,6BDU:>W8WZ$HGB;&J21Y=HV_E0[*(I2H.+UM^
M/F)GS[;GH[^?T@M0UW_[ LA)&_\P-H&*/DMT,[X *SN^_^AD?CX2A&6PAQ#.
M90!5#=^AQE1>YL\C-%[7'^:/DU=F\]*AM.4DCQW!JE3"3T3=+*GR \$D(1(-
ML(8^O+\$7@8[6V%^]N7C[F8['>?XQG9H.A%G7$FK<QANLY>I "M69_W>8<S]
MUN[A8SI7L.0-R:+DU;RKD>.@(X&!S3-Z%\PA:Z<$=OT,3G V*SE2HEKF_84A
M_YD,2IN&AB:$Q:U&A'#IV$=+[E4QXF,H&( +S>N7)#(^<N4CU8_[V57Z'N7$
M2Z](V_\=^GZ6YR_7RVNZ@^XP.#&,10M>LFW;!++^T#3K;J!BH#''6<7ND'F
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MD_MAWU:'I)!#0T@E.AY>_^XK>12"43<UXAL8#$ D\4>HN(<9WFN4&P+EA>&
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MOC.U=6*\7%DTI9Y3"%PX2]& 'EYC>6$.#0B/Q/LI;4E>$K76.-?@/B5%.R+
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M8+#M\<-'RT'R949*F3X]X5,-NZ]7L'O]<ZK^UL@<R3-*I$*OAB877_RT[M#
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M$9D463+47\HQN4N1E5AFL4*:V XL@U6'U*=_3]L]*AN^X1IHZ0N\)#.0.#2
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MNGZ0W4&$ _&$^,%VDI[Q1,U.IP]W"/NFH/7I+6C5;G_=U+6YHVO<OJLOAO"
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M,UH55[:=MB%:O3YH=QAZNA5FM=O(9F-=<!?N8C\Z((0WUY*IP=1/2Z3JJ*V
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MVZQ^4#2.=X;6!O2:GWTF][#M<K/!S*1?8.[M%Z^Q8+64*!U >DZ>TB0,3)R
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M(9J36=_^^?R@M:/@BULTAB/YIF@#"3;O0:H]Y</O0/5,]PMY,;^4$B/^+TJ
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M%E."+$]H?.B,]2=K34!71A9;QJPD]<(Q%WWEA$8UU3<9AAYS'2Y,/C.)G;\
M@FZ%I4>ICC&TEAE@.%W6Q@QQ*"];>>D$?7P"JL+A;(8>]UF?QSG%M8\51TMN
M*42V0E!.IH%MN.%T('R1A:J2NJRE'*RI4]($F>=9%U154LX9D<U;!F96%\U#
M8E=?!\;W%E$!_!HK?FC3AZB_"@Q L^LZMXV^DD2>\ZTVGLKY$W8GDS#R CCY
M/2BXANVSN#FZ<*G1EJ(,?&,@;PG.;+-O6KB(K_ECO3LH$R"AV[];X*$?98_,
M%.E:="J1WH](&3PQM1TW^Q;5*>+?4'12 5. 90.3YZ]6?YB'FKRY+IRTG$'Y
MP-=O38]VF2G%]AM/3I&,UO >MRN[5B_&0?-+N47M. G=>@@TQT8E0HA3D+:[
M[PUZMY?>7]B"W&4/17)L6(LRJ%FC\14[1&Z"OH0CDMS=0'O3TLR63>!RH<D_
MJJUZ)/-<^@1;=<3#)1.D8&!O]7T@H8B,B0?U^F^GE^,W$<^[@Y]1J^B5Y.)@
M([D:E7N3@[1CU\8K<E<. 9EHC\\7$:"#_*>MEN-IB9LFNV&W^\F.MAJ'J!;^
M#<EZDW].>Z:41KB<RY:'_?<"(>C30H7B>B_*V?1U:.HF)V]O'84N-']HPJCI
M<T5,@=6/GK'QIJPH7!0][)SG?AJBRBAJTQ> Y@SM#D>6P_QOT6PG)(9VY,">
MS95F7,P[2_FSVO*Z)NK?U9,M/1^*W;YM9=2$_$Q0%._?RVTYHJ'E:Y^XT3^(
MT$@I,1E0+,QZ:A(WK:O7^GQ(F6BY4!(0K!63JOBNYJ1NY:EFT2]TFBU-B7U<
MXK.'4)$6TK 017X?2<0[*"%3CHSFUH/6EV&=?EJ=:\P/Q7/&"[],D?@@M.F$
MYHD,E(%'\H;9?+9+.L9R>B'7PJXJ- )-2 ['\]"**;=?.&1/N%CB/W6A3EZ]
MX>4(VLU!3,_//\_?*A#P2<LO: 7,[P?3HF4\'_N":X:-:V8;6:^PLI4PNM_R
M)6<.O'*6)=)>*GMM>==QJ_N/X;Y..0;0YTJ*DKHZYY#X>J0@;RS;M+D>OQK-
MULQ>\)Z5A];G=,4Q3K,F6:,95*/<*H=E7NJ1[C^\"6H.4F.Z)<(%S.D:+.[?
M$JK^:*GQY4]H$_TGK&^NXJX_5OU>1R-!<>V-IG20(@ I0<VNL@!4I&[5U*#)
MV;Z,Q2'Q LC[\RQS7O:=2=<.S[#MX$@S(6@GI9/#I9'?6%'HR]=8>M[.P>LK
MH'UA$Z.L[)O?;($!@+^O,F5]N6BQL40F=6_]9]48^LMT=4R;_[W)36P8I-]9
MS%'&>KE:W,%Z# 6#^-J.L>T?1"E-%HG^<(RL+NL 4B3^ZJA@;LB'^BBN'T9_
MZS2H2U2N&UW@8G3@^/BQ'X?RM1H#U+E%EFSJA@N<-EL[?;RRN#@TK5F\>4QD
M4M=:TP;.Y-11_N3LO//;B?V"S!4 D$SVC(WQ$P%5>K#MJI^YY5F7 WUS. 5?
M&4 B4467/80Z,EQ0-AK] R0I6F0W<4E6/+R!7VJQC&J'!"NEZ:T6_A(YMN"Y
M8]&(N,-0*_Q3Y6F5N9Q;=BJ@I3.'_J*\DZ$&D1Z@C20(V=YIWO[DB?@%V2?V
M&M[W1V2[Q$QT9IUT0>(EX'U-10,:&?<W_^V4Q/\(+%$8NOZ*1\=@5P)?X</$
MA-&[28;!N:-R1;*1;\%H$K7#'FUK==&;DOB#Y<LK0"FQ2BFJ^+_[M2V_Q/KZ
M./)AXM)QE*U>V.9WD]UU6>AGQR,P3ZKJ7D)&T.L&5$4K-_3PWW$\!@%;8ZA4
M+P"T*\I6'FJ)-35G$$TE<YW%SS*.1%%1GC_L0;^<>R?31A/75$,$LCCR6Z?R
M0S@(5:0O2ZP"N5#V?A\_DR!)279\.-5/\^]^TG7 7S8\$*@".757%&;4V2Q;
MI]O.11V5ZYPG_(T;S(C"<DYK+/(;-Z3^)\2Y7:LMG;'P!E$^R-D$IADP08K#
M<,-_XE]B"!P3(=5#$;23KHGE/ >D,PEVJ66^$IV4>>_#96MZ]@8&:Z7:T=#B
M9&W[SS _&I%Q0!QJE2EI__06KDAA_^V^;B+086)2?&8F-RG"DE>"%C^/I<F&
MA>3,RJ6[\K?]$M-C8PGT"?T><( 1AZ$XHBW?[+@#6_!Q&#_UL>0*2DE%I_]X
MZLK>\U,++]4CZD]\(JCG6I.W&_"E^RQ;+DA_F;$)R&WTO**#\Y[E O&G56)G
M9=GW0)+4AV$" =J@--%2;VUE18E7XIA.'%REM)?.+_&X?UPDLS_5\!&YZ\WW
M46A+FQA8\0;)5JUT[K0X[/P=KA'L&ZZLCLHS#Y4G7OT?_:F" B#!$<W+\)[W
M)NW\-IIQQN&*P58@?;TA_,W =UFW/+!]VE=+4#L2<6!?.XR=9^AMBOFR9_=@
MOQ_,JKG^?L_;4T)'2ZB;@U_XW37DYL($F+KE+;Y[3+V&2>W^R*,"(7NE [.0
MOBF]8QGDP8J>HVX3.:V!N*N>$T>Y-YE<PW- =%C51GW4JK[=?DY?'L1O:DN-
M#/;K;DEO+^/JQKO:]@E?WT_:99FK-%)6CSD#31& .VS_LYX#$TNMMD\M#?5?
M<-)!0PH%G<$,+X!!>;*>(YRB"O#.-^-+ZC1=.VW2ZF?K OC3:D&V]U??6#S'
M'8.D]:EUD]*4":[1])-J4YAJ>A)<T@<PU>);/+S!R: ..MT,D./K7S2S1O\;
MOD55(AJX.):5KY?J(_:4TB*U4<][&-@B7&B=]",7*&$>HJZ+VXP/H,U(\"T[
M&MAMD6))+Y:%L"<'#ZP0NJ%$9S@?!BZN-%53)7*[PILUL>N;6A,=REX @;?B
MN-Q(7??)6#SMF@F*G-2UBBXFM,.2 W,K.'>0M='0$=M)Z%JL.INNBO0!D&?G
MH]?V8E9G8$SR1-L/CA? =ES*/U4Z^6Y$DC?P88;F450KP"SJ@8OWP5FSI@H]
MJG!ALY_:ZL,96H7(YADT)RKYG;<(?I1%$U/]MD/#.;NT_H]'XT\%PA+0%P#P
M%__Q]4AQH2"PVHBVE:+.I#>'X?<-;>;[_\Q41 /@3+&CJ@](:?*@[X' &$I:
M/I?N9@D1VTI][W(C/@(V,F?2/PK]5B%JD=G I'VS)Q):73)@]J<RL((ECM6"
M6,X#.4'M(YKFQPJOS4V6H&/KF@@U/$,,+@TK6>S,4@T@AQ?WP(&G^)-=;U<9
M5&*T_9;PP,M%!)H[:B\QZ$P7@QHW$DFIU(7'H,<VI,#PQD.<O2LLQ@_[SE9+
MA>U2]@NWF6N*0LU@6-/DNB<E=N7W0+==>[GV!+W@&)&W1--'ELR3E<<B83VX
M*/ONA]:N&[XB[+E&K+NV9CIN'%V.1.BKB3UR(O&&-+3GIV$(O>*E^2\+4'@)
M?PO^TL ,%,XOS\@])-2_X'&\ G=O.0_[:Z078GLV?: H'M&Y_<X&_V^..@/D
M9_&]4IWS(N,)BI[K6C;-'9K"&'\KN)V"?[.V)1+,V9)EQ79>7@JE)\?XV)C4
MB(S5*TS.GQ>:SB,<"\E-3@7CSZ(1S5A'DV<&T0<-#3D"J!7YDX<Y!(R^G/A4
M,BIR]>($3E%7B+R_DKB^)(WU7\MY 6#!:1'2V9V"*4W=V]""]IJ6F>.W<G5!
M']W@1'6W.F(D&G.;0A79G;3UI!V2Q#X*]6?6H<W?FI*'>^?+3[DX%D1%2ZH#
MX@>\*]<5 8*6?3#LN^87 ,I*Y;EDS+6XS]W)8N<S=E.3]^)<Q5K7S,!ITR<#
M3)1VQO5TLKZUV4GK.S%.D:I0AV'5\Q87NQ= \#W5->,]T]%U@L1N76/HS0)E
MNJ<NV#/>.D9;6$^.7!=M+ C[WY<'WY?HSE8EK'/6K;Z)LQP##.;,.!3S9E /
M0-.4HD,RO+[D&:]QD=?6F*W%J($2/-\L3)\6U0=N*W]YOOJ.=4Q\$1;A)W%@
MF*C(#_O!4D>%2#FAQSB.R:-!S$YY%;;RK+X ;$#O"W8*B<2@;^DIM<4II(7[
MCX(3CX3+G[S7]8+%M-SLKV/?[%,DSV\790UC5EZSD$M&NZJ7O0%2.3BSMH^N
MVW; Q>[&O3<X!1; *@X:\',L8%,(E,FMX3)L&9VP9$0(.>UQ\^\H5&T-^DH-
MKX<0")% G=) PW3:CGWO]#QC-Q*[OLS265=I!#+42?GE0/K0 .6<8 )J"@2.
MMCI+XDM0JVPNJ\DDV57OIRPX9LX942E=?(CJT6D+HZ3<.0RE<^7G/^QI3=!5
M>*LRV=PZLH1UM1.W*]3+O\VP?AM346/BK3HE9LS]>KL<?U%UI#TOV81\=5OV
MG9#K6N9BH*A31%NQATRW5U$P!R?SE%G-5,VZ_3E3=%=#\CH*"4AUXK%'0LX8
MN9^EGH7M!.(^=Z7Y)@-/ZHI/C_HLL>,!%MR"85YPR)M_>U[=MV(\_"[JPW*U
M-\ ()<L1;;;DR(ZBNC+77>_-N^+M2ZI>+,G#'4BXK[C1&3D_YUQ!"6=RZDWM
MN"YY=4B;YPM A?*Q36KJV;1V<DK +7YN41Y%!CT865RM1&*G$%;48?X,P_9C
M:;OWXKX35V.N!8(X!8S^H\>*A#1DB9"VLFMH RI:]/(-['3K\>2??C+Q,$UU
MO+L1,H;OK.'7MUF ^^'4"-;4+EI<,>6G9.C^0^;3\'0+K&A^J2RZDK2CSYM
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MCW=_^YY]]KGG&^?>^^M6KQJCNVK67/.IFC7G4S5&W_Z^70'NOY)7D@>PL $
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M\/J3>/OC)@)[*;$0F=PS)X=WV)@H6Z9Y'DV4'$B(")5H+?S\RP.V\A+;-RQ
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MC0J74F6RO 9E'F&X7W0/*JX/4K-M+(:TCW[0D[!+)^AI&2%HFZ(C,EI3.\]
M079A34_UJ1E=O$P(>;B,MM5$D3:O4E<EOYVAQ4FJ#<?$VA-&/9>5@KKN2S-8
M!C7Q>*]F_?YC-:=Y"W3U'"NXA BM-&Z*7J:;H>!\R-.1@&2$=]U95G<LXUL;
MMS-;6V>$Z]1[I6EM]6AL:=,%71:KW5Z?FK/@O.CF* *2:K[YCD BAE=4;SR!
M9[F9=.,6D[A7VTGV,%*Y0>D0==^E'BO0!@\%U*0]DQ'IVYD![G+#L"!+^-HV
M>KM"4)J;*FZ#%UIB'.JJGE1MUYQ:"/?(TY1K9U]$FM3#K(@E2B-AI3\-T-%^
MT!VOE[= #)*^D$KT?N*1/[=#?8@[U:3+*[4484Y:>HH7$:LZ5B(8!BLFXO3B
MJ,KB7GH2K70)<(#67"9A @A[TF5;"!XZJPC]0#OPUV>TB&8<]Y?7!#?C\^6+
M ="^Q1D6JE.33CM;;12>OZ"DLE$UM5CSU'=E9T"SD2'J1"*VH-E6&>'-Y(7R
MXDZT>++"'!E:)\O,4O!+WE:1&3S@!_&<<4U3"UZN'MIH7=4U("$S'!L?G]'.
M"GN?".:BEY+KVTS7QJ\1]PT'TPDM/T![!"_YYZ%]O)ZZ<E2:_OSZY7/$(CTC
M%)[#<](HJ;DPOS37Z8&U2XD*U;J#I:S"-M QL5=;^]E ?R66C::#C<SD"[$Z
M7B",,=CL)N&/= I7P6(\'^;T[HA2-9>(?KK2PNM;F2UZ"_@1'F2/EY1^;.DG
MR>73?Q?[B 6+US,Z)R)I>IB('KI2&\P<P%?#$OVR*%8:#]M/PF2UG/TL$"TO
MW4?B&R_NLS*3YC/90C$)H>M>!3^$>N(E*Z%(OI9/[^70J/\QY09.]VQWMD_F
ME8M3N-EJ(PS"^-\GCCZ,E73+S(%,UKE1SYP=XDZ2+[0S=_8^NZ?#M(*T JW'
MTD,C>CM,B%OP=RY+\N<ZAC>>LB6;VD6NN[;1PC61A_O:R(EN_?6DN'RT?QG/
M(2NY+'E5ACO?%G\?<&T[?G MDKM#':>_:)WD+ESA6QQB134&B9#'U:E%2H5^
M+&/)7):98,X4^!+/*3KUY3+@801P<0L@8CN6":"WP*I]]U4L!=2M4R])TG<P
MPF#082_,#">8/6XD3Q?IDVQYQ7UM@.FP5=1J]V%/QCRY] _SJ'7.NC!E3>F7
MG7=<.X;GVU4/*K^PC%^:XV#-J!M 9>O$-;^-*=A5:1W;<WWS5W-5 (J\KFCA
MKS*J9FF60&DP?R]2M_T6>"AE90^.I;;&TS)X6QH%WA:0K>,<N:PSQ CM+0'H
MARN^P0E*(L$G^(*#X?+3/Y>.!A3R+VAC)*N,JNDL\DI_U=V?ZZ3J^DGQ*LYO
M).8K2X*.XA  0Q7Z3!C?+V^>=N$)I^,;%S(@^!/#^<+.>)\[!_,PNM9L@^9D
MYT5IZZSQ^ E,LK4^=6#M]1C\5#RRE$6M 5&ZMUA%AW7-4H:7Y[E^1S==FG6L
M\ILG['B>1-X8)M_GK/0F8- ^C=;-;CNAQ%)6&-T3)!*JGBA]7UFK8WF_S5_7
MF>*7@Z02.PK^Y*90<+"_B?V;S:A^OY?U]YVS\_//78UI_3H7:8RHZ>;\U"U&
M1=//\OB26Z"^AVL^_JO+#Z$&BLA<89]G/^L_I&ZLLO=-/"(:K"!TJ[_ZIDHF
MU MC0TV'(@.[3.Y+O%BC1TM(^0K7"Y?:.WMB-(W;G_W0C(*R4K* KFVWN*2D
M)P23XDI<K@R$OZP/-7'2.N\XO,B;/"$1T">/EE6K:2%/+Y@SU1.^$0'=>0&/
M>HB1/4*A1XI2SHY5#-(,BS7=>*3%STQH/N?%)Y7G2=:;XH?&0FQ-.8:?M%&2
MIN=Y_9JSR!LJF/U0&V)@B'MD!&+#DZE&*3GGS2X9<#5WEPC,E_%1QH5HQ*23
MQW" NGRM)A?S84+/"%BZ:HWP6-9MVL9:6*#.;;XU>%TIUS(>I/');M-,VJ=C
MLZ0ZBP3RSAT)Z7Z>,V-U^A9Y1UW<7-_2_T*L463;18F19X8N-2W+HDT>PW11
MT_7%^GK+UG3CLT102^V$>QP!?!;,_GVK?A+*7?I4Y]T7$!YT<J?PT5">\>_Y
M6;U7E#\F64.)UZ6:>(7_.-CFHT)[6@G0D2LL6_JND[HMCYK+52!<V+PJ T-^
MC?IW0@I:VR9*\_JRUMBR.$K$BKP5/=^T%;)!>5J1G9ZOZ0)->O/U>F&+G^)Q
M*+**S02QCHV.;H&.?'0P,DL3)?B]4[5V-$LE\](L;#7KT.[#/GHZ*T3"+A^Z
M>5:?="B?;OQ6!F%M:M#7SO=J":;'L4B#[9B9>"*'2;0H,J#WFE?\M/+IM58/
MH]H*],?^"9?8^)LD(B(K"\7K+_&BB7IFN^7W14T^?<%:6:Z<) +O;;L&8:5N
MJK/'%/PRO:XP=D7\SAOUH8;1HUQ_4:CD6*5&=YI\?-E#Z9&+_1+/=-?$5'];
M6(>Z9VYNG-X+EO"GF^;-)APP2V4>+]G_B.DG*>&[BZ+_C(0Q&WX0>W0P2J33
M6!S=B:R<[SROL&4C4<I-.IC8C&%^__&I8QMDT9:SF[J%V#YLB2T19E$" Z->
MNP._-E":$^HXV%7XR^NP2VS);N\7M@AONL&!*^%$"_MUJ91,[4KN'@RR;>5J
M,C4KM+K9.JZ&1'C\(N$@+85:I?5U8 1P;#+;VF/,C,H*X#YHDG5HB)3Q%6K.
M+*K%*,SOS]!_F/6/2H^Y1_HL=I\GP72EA#@+K5CJY95ZIEBZ5A=M%DXM.FFJ
M<0]@\GOC[NE=BHXRG.]V8'FW]41Z_JT+BR19,P#=#'R/=Y:$^A7LL#R;%.@.
M,Y_PH>RM6FOM?DY,QC_#X.#K;MS/E&%+-9G\U(YBH0^[J1UP V6S%WYG%)Y>
MVC (*_T>L_K1(_X[,!*3%JN%'L4+P\Q)U[4-MF5GG5RISMX"2=_+8# D=YYD
M?O(:G.@OLD@),>)"NAA[KLM^D%D\_K#DI2O\?>N$G9"!L[V7+<D"3L#[3-X=
MQ2T':&%3WGR48Y39G!^$!]E2,G>^%XS"TSRB6]Y/C5[L_7+]90%1<3F3"[4\
M:T5;?$=SOJKQMO$X+/WX/GK?M"*E42P;5^9I3,X,U:$U8I];_.G'&=4: R4E
M:ZZN9RQ.GO$_VXO4H0\ZW:I8R]&^RA%O7N@JBW:"=O#U@8OEME3CTD*8 +IJ
MK52_0X5?C5+!4;(TMY,T:9<67W$_3NN:_:880P=50R@$NY3*&L4)<9)P+RUY
MF5=^#8LS WZ(\ZK*"Z3K3@CH=SH2R3VW97TM7"DZ$+<E9Z:P B;NV-E&+#[5
M4Y4EXO#'PUQDDV&CM:AN@=AK913>JATFT,G%6W54SSK5M6,O:0?')&7E\OCB
M2A=P+7W0;OS SA(QTW6C)3/Y&*? _U3!H$FI,>6OYR)PQ\P[JM70]>.;]LL?
M-( #KN7=-N3+N6G=7Y[5,;$;]IDX<SD6P)P)2#-PA78<$ETKC0L.N?= B,<_
MP62=K>D-T]*TW>7GSYT\VD[*CO\:=;FC4=;JU@W:7\2\@T ?=::W* 1IAP%&
M3FD.34<9VFRR-,CCNW2I;A)%-QSJN&;+$WQIEU?"WPL[4V_N^4'CA!,?!33Y
MX4GIKV(H#7L=X3!SJU-)+?T(N^<28B$EWSXT& 79 \^NZX=%MTT,;2#@":'0
MZ,.378/IJ'62+DZVSOVX;LEJ(\F\>"VS3Q9Q$@6^3]WY?5W2G20;U/&"YCHJ
M,+T4\O>Q;@'\*X0CIK_,:?H C TM0*A%U>1;P<26&.C>)'\L&*Q.04REWPF]
M<\RRN72^>C:R)S^R5W[SN6RDZL)L<'Z[+O_ID_&/!97"3OHR3[X:95E")WOK
M)C[QW26#[FOW;^CSLVJDX25Q_X\Y?6N1SRUYP")QF;P;9PR]%8OH=D-+TN?K
M&OF9S@;MR+:S.;N\QK8\4ZML;;[ 26X\X+S;B@KGW2A>@,\OAR"D291J&]&N
M>Q=J9M/FB$M I3%V12VH9FLOK[E\5,) \N:$O/##_<B0P?V=EZ?PJGW!1G'\
M)7';MW9COZM*-(*)U30=)U.Y[EJ)S.QM;4FJ<1+6Y6BT^W<<1/\1F3;7AHC6
MV.(0L810 ?4ZU+T:[^*Y1=]OD%N@0H[^DX<YR\$[SRN4$;@3"MP40#CZZ[C.
ME &&&)_-6Z"H.4T5>9"8,\B:1&>7]R7>^ZS.WXSKE)EX$F6=]-E(Q96QFF_A
M%Y!D$87G(&;1D'XW^U"0TN2I+\/UN]IQH5#DS75J<%WB#ZY*5;.;V6%RM%2T
MW<[=C#>9EJ#!W73<S6O]$KHW>>:F-1%&W$1\Q.F?W17Z1T"II_/>PM/CUGDA
M<QP6*2&):]*ECQB)R&=0A0.!=[O= FU_I67%1( <@H= F/,.0R64<KIJG7.G
MG<1^J;\3^X+W \!([A8A'W8;V:\N+D<(&7!)[L% N)$R9D(+N.R-67A>< GF
M[2C70^/V0JBMXK2YGA )]_#E7U=PYT_Q5)<4I,]VYKH^AR4)O0W8QR_"]M^.
M?05<S"!T.R-YPI<KAQ._+7]X2K]/9N?0)/'@^8'&S +=6@NP"V&=@DBA0^:-
M _MF3H:H!"^>?*&H$K0D8A^-HKM<'5&MF<A^R\6U6N/OLZ>>+0>6%OVQ-O[\
M?;/79)4_#RN],<),@X7LY>]^2JQC&Y\Q"&DF_2+9&FGT73H,&%<(>9LW_B>)
M0%="$/:BG4;29GEOPK9@EXD?-74+!+O,GMP"(76%A/KZACW]Q'4@B&TWO?<D
MLY_T6D$^WJA8<LA)AE7AI."@^%'3TWI_\]X)!R&WI6EZ14V:QXKO98)CA B+
M) %&#A"H$TP*XUNI/_@PZL(HI9CZ9\/Z^?ZT<,*.=*&$F^/*D(OK+? R[1:0
M%AK5>A+R(B[^+](H7NT0&:8@=;S^%L5D1&^;MOF"5,WW]X0G;6S-G&MBG] U
M2.<H_^*%P-X;<2'/PS/JC'6#[C-Z>^[9.NE,S566G1P&<)XR),/65?"!BCWE
M>-O\]_B_B,<RUY6V?+Y@'2]W@IFLI/!.LYB@7MV749[<V9=3/84XR0HVB^W<
MA"G]B+">Q9Q,,5WR;)LXVU80A-]DWF#0#G>I6&*L][D%O>V[@#=' C,H>*DK
M"9[*5"9[R\2^O3%+RMPJU>=OIX8Q4H1:W[9[GJX*4_=PABSR>RC7RNYT,F25
MWK'C4AMU-&A5H3.+>M?&%+F7>G\B]<:?;VY@(,A>JH-4;,;2%.4TT3UW&)&+
MK(VV@UM?&J<8[I+?'W2'$!&Y?#3MP6-ERF_^X"T\OC$Z-V1'7-OMEF*$]5*2
M%]HMW/FJ:GR_NSFQ1/@S:9P,C1S8CR:;+,J5AWYH%1ZLJZL?VOTB"7/6HP$.
MD! H:,?YW">+A85%9]0<L^>8Z1AH1#"Y[P(/O 5 0LKUX\NJE2UUMI'AI!3,
M(.RW9U2G0JTAU6G*]=S9$\\1#5_(65%M$8>9]>_X?>ETD =)EPX3\RK5MECC
MDVWYCX9]-OAFYOPD.-7C>2A\QOF4"@QS1Y>@^J:XO^R^V/5B^8/UA]'L*+-.
M,)$/_1!BF<I$]KMMJN!$[IQW_[S@IN.C'*W!@[5\VZT4017(M-5&2,\<K9G:
M4Z8[]J5UE>W?=O;C4.+NL/508^'OPY8(WYKYA$%.PUH^ 2TE%FKYFD7W4J&=
M+#14H\+KP0_H$1%Z[X]6ROO/O]3O>SJ.C,Z48\;X;H%N(V1*T0E*D"'V-=U9
M8S/W\/5?W*6F]>2B\7R"IF>B6YTL ?P>E$;62<DC1 L&L@ZCHO%L2;S_^Y[P
MG!+K:#EJ7X+N%G@@H<R)KGJ+EEG]L4A[$#S7:UM8!M%[*3* 2<%Q@6O<I#59
MK$K10G4UDDU^JFB*V\[454Y3D['L(V/B/VZ]6&,)-$XKA'HI3[OY6EE/)\^_
M,*ENJ[2[-&?0[N-:J_V;2''\DTBIXWS1D ,H_\>JJ,J!996[*+\#\"DK-41/
M M6:GW)< 2[*M!^+TD1R;#LBZMCCY*DB&@U^Q)KC_^JZATM#^;]_C?_.798F
M^YY*+]A8:(C[/<&5OM#OOU$R]G_2_M]T*$H+!A<JO +TG^*]T@<XOD?\J^8N
M/,4ZS<;34%GLYK:ZLQQ/L!K0D*/\5U7ABE#C)?8:!6W]N&Y7WB $O"E'!#6:
M/.\:\NW!XWYWI^A3==!6+N7?XX12>/0!5\H17G56G ]^8#G>/@%IV-^2Q?=R
MW$@ L0B.;.R(IXTH:=+O$=8?R3SO9/TVDOP(GS96*(+9[@;\?37]2)0V_R+=
M\M[=3R$#=U4Y,3]"CEQV2J!:2R1J8@OX'F$K/ >X4H%3G\YO84UJR098?9B_
M4YC"\$ AA0/K1 O'+VJLZ6^32#Z3</W'TE I:V0JOOQH5P])=*NJL6_(TI*F
M\EF6NCZYP07;9V$\?0**QZ2I(?^_:WEQ1Z6SLHOHIFM<"[8?UFG\M'X4O"C+
MT<[LF)I9V:1U"SS>*+@%C,=]M]B*I"C8]-E$U*I1T?O1S6W3)^L/Y.&QY9G\
M C>753>):SR79-:M:.SE:R-[M(?,J,ORY7GL+2!#]:W<4_N%X+X9QX2.?GKH
MF6Y4ZY9D_BVP0G +K&YA!E#)-WC5R]=84M=&KE=X>?1X>=QNNE5&LWV^%M!!
M3."</0;(PG#'[L%I?4>]5&Z!-NJ[<;OPWY(<SX"<C-!_EZR[!1XJ_.L51+XH
MEY&(%O8&9&C0D\F23MHDJ!F]EF.G8A'TDN[(X'!.P:@)V=+H;(HXK#+J+#!>
MU%,6.-"Q]6C*7\AV'UX17ZT+LA1RB>O5J1'C25)9.%W^=RO^D_7V&.ZF!_(W
M.==**Z7L!FKDTI>8;W8^9N$LD0-F^'41NNT@/-QA,5T-WZO7-AH2([8();8:
MO2?AK-;EO\R"+3[Q]>*!]:=&BS+[>D0;* P:KT>T_DWW?X+_X"ZZS20;^HPW
M?"F!FR*L+?T[@JW9?KL+0NQ9&/EZIS/P]N63Q5HBK4G]'1_;D#]RSB@E+B6/
M>_/'#/R4]L>9MM?CEII0@WX,^]VZ_A]F^!^O^-)]I=G/G8AS"_SFH9J>3\Y\
MNO#]6U V'R?YL>)\.^ @S2[T?+FZMH"MT=74&O'"7#$W7M##XK>2LFM&)5_O
M@.)EA$\/W *--UU^"_RZ"Z63OI5-%G?^L"]R"P &MT!DSA5GC\D)TX0O$K<5
MW; BP7(EU[^ZS*AO=1_J=(2?'R/B]55>^)/*1:_C7'/ABS_3 EJ!U7$3K][L
M<K97??DWOP'/&O/? MEG=QS#C_U.<UD3A^2/WY*<$#?[O1DWI__<S74';>S?
MG/6?3L>P)YEZ,"S['S;=X4:Y_)L+-MP$CD<'CL>X,0VY6S[ZEPY?=(/4?X%6
MUOKN).?N^8=[=FW3939;K#T9%U(>-/B=6R7R;!I),_!YWG&08<:&7JAW\>[$
M0:0S$7L17(>)*FLCIM.D@OSPIM30_/B/X*)IB9V6Y0EX/]I6>6X34E Z;TT]
M/N+,H1U-E*B1U+;K]T*P3##M=Y,JKF;S-%?UJ9;$C^"8*4V/#R>@^K.2F<;)
M4[O!3P$#\QXFDA=N404#6^(,F9C$7]#0'F,:M!?95U\WGE/^, 9+6#Q_U+WY
M,:\COK>JE0&-8XQO'":*A?#9V2Y92B<DM*P+'WM?6;\*X5T@*<M.)XZ%N90F
M)KAQ]IR 8UIH4$'+9E-<F+;N]O!\H)#EV^+O&0]+DK,L*[!R@Y'.;PZ.*D6B
M"J[^Y0F "5?N^5_/BML7YA\$%(<D<[W]V2IU+%;^U):BLROIO%+PH_$<[">Y
M:B--L.AS@4FOZ9\?HP*S\EP*V2O:5J?_?-&2&?'4Z(5-47!1:DCC/MI65O%M
ML *U^UJUABT]KD9)!4/ :-4+EVB3+NX>(S6K#[5^YA39=R$!+\M&XA%2=U7$
M[]HDWWCV6F-20NY;A=2<F_%C+G'>_3\)&04+5/LS>4I7LM=\,Z=9]Z$FO3X4
M=3%7QLBU"F$*X>7J+J=7@;O]U]N9%.@LE$'/TO.).T]"F(@$NXAFB47WE'>)
M%]X"F=*N4IL1P)&=[UIKF ^#SXS8B<C,^;DQX;'=/K>=1>+2TL2O"'Y6;=8@
M\4KH[DBI6RO9M>.J\F%8*UU+;Z'13J>:=H)R52IB/41@/4"BFM4_X?>;0J3-
M88\O#81/MG1;J_N;;9+;F+Z)8HJ":_0+V9U<G\0!GR$I @@S5/1:J:K98 BL
M\S-,IL#FN(>PK[]#+ F'MXWQ+C,C8"QKWI9=Y6S9$-&=5+(N<F&+T9J;LTLK
MN]]\_M7?:$YPK@@OU58WZLJ4OJ'Q.I$[(;T&,S7*5F6?3KQ"HCP418;-'&MJ
M$YD6;7M@9I8HHAX,55J'V'D'Y13L]>X?,DK*OR+=?*=#U7E]TG7ST$2(D3"7
MPS ,?M54=J:=2$<FF"_R7&M=V?T15D F6AT7\+"!06<P8)_IS"<U4T*2+W?;
MY5'/V2)6W>.7^OJR<WZP!OUA2AD1VL["]WEDJ ^300]YP&UU=>G88MT?M-4]
M)&/505V89W$I/9(YH8HL@)$UH^JZX-&U#0>)CK8YN\7V-UF^SZ$*KL2RWPZK
M5^O5_*6PFLPSB="E"#B%_L*L\<Y+<5N#^<\O#?>(OR4VPHE&OE%B;='Y[F?9
M2@Z5[A_ZGRZ*=#S4"F-&$0](Y+.N\!F^ V%00N/7"C?Y[Y /8^Q@?+:(#(6N
MY+K:QT>CUD'B UW(1L>V-G8W7Y"QK%<>[ T*WIDAA9!<]@>_CKD70W Z[< 5
MQ>%S!#XT&V_F[D6<E>;[C%_>RQ7<#7<Q !.G\>PSA@X>RW+,9QF"I!EUVWEB
MDWQIODU_\WZ\V]G0$LL;<JS6_$Z?WSDPG>S@LPP(1\=R7PAE^0;MNC)/<RV*
M\OUD^S#<U%;<KX-BT1#4SNPY0X^\\TU<3-W:+1"=Y,-</NG2_*#K89@=_!%$
MZ[7_;)T\&K)P->DC=1/'M=>$RP4/.#PEBOZP=,GU:L%FQN?39A1YM?"]A0 K
MD/)K-!E*JK,A)*O8^FX;N:JH7@WIM%9-T^97N8P,%S(I,OT&(>&2-]\P?- "
MA._^P^\C%C]L'EC53CL.^>;+"MQDK+&3;DBL16T*;:5:=L.C?!ZUE(^78N@@
MD4Z5'$V3KNS=M6T^[X.<O(MX'EP+3C:I7:G)>O^PFC!$?_+&5N9,*P_J;/;#
M=?>\XY!0K=Z9%O:;HD_O)DXCTY9)U1 RWG;FW.GS LF1I _$W=_%I5NF(J]X
MPNB6(VMN7-"MJYA&Y'GWV7G\DZ3X[2>UJ45D!YV)%XI[[DZ^<V7S9S[HAZO+
M(>!J]K#O#2''5]A<C[U41-Z:_Y(6C*NV(5ACMHQ5MQDN9>]*4Q'70(Y$M=#P
M=$5NQLM5H[ [R>7E15^NO[%C03[V@R2@C9Q+C= /E9)-6B=.5;2_,;D>)*V7
M;FR&:&I[1EG&U/R90/>J3]P"MD9J:@W3GU:1-[4!=6H?SLG.7)@MLCZX;8+*
M."MN4EO -K< <0OE;ZNY^4#?C7[QEZ7U[XB=6/!:^ S9(WSH=HV?W.0T*;A\
M_&0Z)D1&4A.P8R#EPFK!0GNZX4<Q<C8Z83GU+LF>P.8L\_[/ABL&R)//9(_2
MT[%U&;B]C_>-0KND8G4Q%#.NC")RR+M<%:ZK7/5P+GAN.&FTDW:3< 1343$\
MM;D[#'%&JK4S&JA2&Y-.M=S/T(=^JAV$+^R(D,\*BK=@J%"--"N$NRV<4**>
MS,?HQ-5(%2TY%&EKMHIY'-J'1'BKVXSH(_/%)DOZ\0@[XQ9HL@8^5]"9:MFQ
M^*!'YTQD9JA4*LXLMR?;4(F7E9\I&Y#9W#Z!"TVT"*,#>VZ!:K6 Y]R"B[[M
M/Y#*9T,4E[J*^6O/KJ"DD@.!AF=92/>>VF40AG%9W^I!%CE432-UPXANVTV)
M_R'[.A[<?KK![JD/,^ROF^QKVM5FR[:Z%H;QYROQCS]<?"5@2#[9S+<";<'#
MC*7&,710!744=?E>DK!2?1)?_4)"L#93[LR ";6O=2PYM$H1F3IOQ?0$2=XT
M79I*5,79RWA:+VJQU.@M,^?$M]02>)/3PK ,TT!K%&VE:JCM/\_K;JCO:'PT
M/'&ZT>*.]ENF;.% N[=[2MP")/#J'RXJFK,'^:;UN;^E%R)OVOB5LLG>H<.O
MWAB@Q7OH0D.KU0AV,KFR7D4I%ZF\DU:6DZP*C,<S#ERJEI"[TD0[*R/O!:\:
M\0\?&V89^C[K?%5K:*C$?#6@(-KK/%)KV^WS" :>AG&BG+M3JZXEZM'^>=#@
MH.E*?:-!@IH$&HN$0=.CX^6)F--1=-5*:UC3"\1RZ-)CY'(P%V*R25Q\P1#J
M-+"^3N.C*.^D)$'* :H$,Y7!?)&;O0ZUP<5H@2Y/N:!XR>;I=6B_IG9<&P-&
M_NN*?91^5D@+X;7DEVW]K*AKY5(#^;@>MHO<C^9-54J?<V[R\PUL?<E;6-'L
MO;[S$.);(,AS?$T-6GW%#MZ.K]?$9VFM\<#\;0RU+PF&TCI09>86*.>R^TML
M(_%[:Z)'HW6;Y-GE63:9YEBKC;*1<GOFBZE/,''7@EVF^XMG-X\-@C[&I=LE
MRH]#- 5B43\D!*XT#:&!':FQX:Q(TCKK7%E"R?2?2_:Y9M%Q?GBTF.=K5&L^
M%&BEU5+VCF6&ZE-D4MZ[ANZB#.ZYU[_& VB"R!+J0Q"9GAO-XMTMM*C]@KU>
MQ!!G)Z_Q[&X24KJNMK9WL($\MB5\:UG5"N0N<Y/'(\1#;L-$/R5![IL+C><$
M_=#_S37I+F7]VIS#?'@:DB*T;D(*D8+V]H))?5A&X&]MSHIMJ;K&;,Z</, ?
MGDG?EW^)W!'?%.+IX EIF Y%W0+*,SG(_.9\J_CMT@>+-D>T>?SG_.D9]9)X
M5 \#)<!KL61HLM7D .XFL&_D2(V1O@V'B(+#KTX;]D*6K X_2;;E,_\)'WH8
M%9+J9D$?'BY4:C-,55'![W%>]TF=8OCF,JJ.G?4=W0+:\DI>=BW:Z:KSLC>D
M!HR/3IU;6"Q+*W1-91:H)\6ZQK]6\="!(^$]J6J!/B3H.ODQ_5O "!D=H.#Q
M;=CM55LV,2#5Q2\OMLF4. 85Z&SA0V>@_"&/H*&=6M!7@Z\GGE14E]=+M7Y=
M5&2-585F$U;ZS/>Y% _)SR,P-5YF!0L2(N<./WD-_'[C^2PIG:SMFOP%->A*
MRA1 ;F25_$X23BXO&3ND>8<_3-8,&UL9"<&PEM\D89BWM+9T/^_JGKO#<1/D
M8?W:7]VH&(^'.1<P^-NZ#60=621O;:C']8SG9[\KX^001^$QQ^H#%VO*:-2J
M&B[,#OVMH#L''=@KPQZYIV]1\@NEU]-X7CZ\$IBXPB,*5ZJ[*3DI7B:$FG7I
M-' -6C=DYMTDPBR^L&Q79?KW0-YYM/?M[_JW;=\"R H?JFM3=,*J)$^;;LOC
M<5>OL'&^^_,LB<3:$U>#Q_<=)[#S1R'X-FY95:'1JZB_'*SUI^O<(3^Y OVX
M+(9/#"\#FCE "VK=/S?1S6#_YR?3#7$?H_>G+@>PY^%RN([]4OJKMX!U:_C=
MOLPU9D#.!+/'C!BCJ'[7Q)Q.BGS.^ U:ON;$.Q.L;$5Q1Y:@;P&#USNI@[T?
M*YTQ190$/=Z*(S-"XYCQ5L*:$7H#M*\)LBX)\PAY.C.77?=EY77S#*0::P-,
M(2&$8CES1.Y!1*K0"<7H,DZ/'"/EU].&@Z!B!@K_\#F!FP7RWO'&Y5@I>KC+
M2*@P]1)E'\HDK(1N9]9,2C+C9UA30L*UN+PTI&95BN9:%E6U^B&V\+<)&JQ1
M@:RP>M)8([S2]PU_<5T$A2U_8/L39;EWNL9E[<KS$&W;%6^-??Y26;1:SX[:
MNHN([-H+6V;N[>;!RGHTX#FS5U>Z WF$!B.&9+5;ZR?AZPK'W/9LUN;.33%Z
M]4)I*'C'+7#_VGFUE%-Y3&@>3@ 5>F_MRFBB]E.Q#!0C#>9U@*1[WITK%0*N
M-59\@X6GC=E2S>/2:UJR'/&C]V;8.:#]_9OL0D,^4Y[PV%/E#*E.8UID3\4/
MM,\[ULF#ZI_#%UI2.XFW0*CD%LAO'/(".M@I=0_VKG5^?'="WY8@QYKI48:,
M!RB>*&%X%9!(GS%:$3]\>,V"'LM&*VNC?'+6Q,D>;#LM*MP4/G(/6+_?0IX2
M_\,M+B8]1O3'X35M"4P=3>Z+R!!!W,SX'PAZ(!HF2@Z'(9/;_9OU+R0R3\W:
M4A6B[U+6NS&8_:H)@1'49K"CP; 6:6#HS+6P%U7P[J03/.XG"@_3N-9#NV=G
M@:&!O0TA::MI&6]DK1%O\_4^_@GZJ:U!%Q^TEKXFNCOD#JYF]1%08>.AW/&!
M-"'50O9+6*![+E*\1LJ>@QF5=J#U$89:T3^ZH-Q=*7(A</@,A!_EVW&7\@(V
M:-VVJ7V,!^T@$LB73/!E]FN^.]>G.&V-\.0)ISLB(^I?(R.TF28LSF%5-.YQ
M,TGSI65^,+,KS11[)0D--$&)=$CB::!8 [QUK)R.UI4<9],8+!EMQQ5>'9G,
M9K71]79FA>A<NOTL)CFIZG>:_C%KX+#YF.\$KL_(@67USYM"3G&=J\)3H1R]
MN;I%M<)LXCF.[WZ$_U,=0*E=1WHFWW@IW1WO4Z=*X)2W0%]=H>],==8E05',
M5OCU\^UK\5N F5$$TWQ'AD?EK*;=0WW_@/)O@9DFWTO\4CHU-]&]@ B.7'4M
MI0(M$D#!D4&K2^>-PNO FAXY#Y/8%K%K";2CR[1^QF+5HI^L@<%?C'[LGZ6W
M$R:U?*U-PI*E2'UH3);>9M3-X!A(KZ&)W*_OV1Y?M6<23;=P0%M(^$=$Q*+7
MDCWRV0G%JBI.X"E# AXK.PID+T72I.01F=3?4D<SI<!:\5&^3+< JS<"(37'
M@TB.L5^KC%B=(RHT_*C\&]O^4SH%7[JC<4.J:T(VIRWH:3]-M(,3WW7Q<>SJ
M3)NWR<KBD']S?<@143:L,0S+J$0L2G=.JDHJHJQ)%YGS.A7UJT[XJG2QOU]<
M]9XO\1N+KS4P.0]3/HWUU,G>,*@[**!CXA?_7/I)[C[<N? N)44VO4#.=U;9
M7#8Y=-K1=A1UB8B; 5B[$1<F7>#:+FN8:NS*+ENPSYOX/R2_P3+=WF2HS94U
MV'OD8G.0[BWP+G/)1(@VV8F)+X"?\Q=,Y(H<_:&C/W>F1CSM G7L83D0Y0UL
MGI8*$'Q(*.T/'J=>T"-$#(A:Z@JHNO(@\T:[T<Y79F@O@Y:Z"0DEQ+PWF_!G
M#ZVNB-&>WGJ:N[RAK3_WVZ@KF5S&_EF?2+@VUF+<#&2UE0?S%&JF@%R.$3(2
MD6D2F3-J2GN?DK&P%I>)?@$?E9J=YE)=1N"%/M19/FNMBF&]:N=WLT1VF\9O
M0*-4]%,\#PXD53'<?4Y[I$PQXD"]MEKE#>1X-&>\)">#35F1VIQ>1X:&.&>4
M0;OIW4FNL=AXPE)+]74[:RVEYH2U'/#W143'/^Z=.;))A0\QKTH+;@+F;P%Y
M7=.EGU>M%\]JL\Z([&]HC4(]"T9[Z%LU)C7DE,K_OOJ>>..JHC.O6/? Z-7C
MJ')I!]6WZ5C=QI*[&:A7G(M6"/]W]@_]>65&3_$.O9^9[T4&O<GXRG"N7PM_
MP/7WGT#E%2XOI+EI1,X]WT5LPI363(C0>%Q>+MR'G0+/O9KZL3[EW,096NZ3
MKPU9=B:?Z7](<[)[]].O*9KF(E9TUS#9OP5DL\1[5,-EO#>G-Q0Z[*[,+#70
M].IW84-,-/Z2<O'ORU]L>C*F:Y$];]8#9[EFP9$MXM#0[G.PZ=A[+QKP.@'
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M=HO*P37-[PX'<5X4J/Q$G[\"_J[+(!#563W"@UD*V^81!Q3T'=-O%KUR1Z@
M^C)'*($Z&/L]SFL-GXZZ,_#YJ(Q-R>9 7/@K5P\OO,)M,'.'\5L-36JWHODE
M8'-[$FK),]6<+/TUG$I((0T6#HK7^WT:>)O=PGE;: -CER?D7Q8K71X4O[P'
M[ %S=JYJVTJL$_EC2T>%#[74C5YX.=W&\=H%"]/N>7B1".>G83YUF/%D4#T/
M'@PP),IS@^]U*,T8DB&'JU=+<I^,#U^IB]5T0_#(T,7W4#/.+ U67XA)8-='
MIF.#>MC15^%_C(,-!R1>?E*&QDDH.-%$+!$A.:/.5#&LKK)'H#OA;9LS)K@Y
MKPB>K:RD+]7"@@?.H"-XLSE:2(S(=BLJ]1Z/M-S(\_EG0T.37^-#&BV1(RHN
MI]"*.T:01ZDA+>(@*-[]M5]N#+3,AC["D/O@$BMX-ZMI+?D4*6@F6UQ ,GJY
M0"P&9_*T*@&9>GPUB1BWXUMQA2+_HJ'=Y4]Z\M.<@J_Y/A^O)RQD 4SM+WI5
MU<-&$6V12.%[@$9KRQ0?,^\@7\TSHH1/6NXXWM+@-=R%.\WHRJKF6.$$YGJS
MIYZ6)JJE>$\Y"MN()X Z7V"9@3ZC0Q&)1Q/1 _7!"EL63@93/=EAS(3V]9!C
M3;#$/O'R%7?S\[.^14B_YH,CK-"#; _LBTR)![U=O(K*#F-1?@#GF4_3,R(=
MTUED/%M?5$K*P->\*Q-%J8-1>->:8\E;7I^&ZYLX%E$"812F<*X(ZAQ4<*V%
M1&#R."KZR6UA(U+V@> 9%MP#WD'=$8\.$.:1R[=D$M^A3V\+V]>MQMOW)A_<
MD.9>Q2X).;!SU=WZSJ!;V!8UZ_):D&_-.*TR/KJTC\,&BIF85+MF],+J2C;4
MG6AQ0(ZMDM>^)[4Y]CD /;D'];%4NW^5BE.9N]B:OX+-44]P[@W^7?]F*8KQ
ME["7KEE^D2C8O6A1LDK>TV%^G2+HP^/;L1$I'=V"7^,7\J*N!WPMIE5)_=?O
M#>[DY23\ACQ4,^2U+V>O.8 *YQ;V)2 M8?:4$6][JAI)[RT;BUE@Q@T]$C>"
M:U<K3O7<,^G(+)EIZPEV#C7F,(]V^_-OY+WMEGS:RYJM;_M9]!?;[@&<H'@T
M8.;.="M0#]&6!*>P8[@:%_IU#(W@IM$T_GW#W#.0E]_T. >+)(^C55G2-6*K
MULL/.0KIF9SRJ81LUT*S[L@6],OZ0IQV;'.;ZBM:WTI.4 V_M/[^[&BZS0WU
MP!/IU37O 75&5^R@WT.+B)W+C(]=;\_=O^7<3K_;NF61:(TLR"(M0FJNHQ]4
MFG(<%) -6_?O&(G@CEW$NUB,PUSYB>\!9T.0>!UT(B/EOEGVAR\P]A[ 4IU\
M^X@&1[6[^"&B&F;)$&K^#/P?(Y#3 R=D_8E<CC1!:*40=?HNCO".=7]G_?Q]
MN%@[O<.V/)["!:\P$^.?#J#\7XI&70;RC.1ZBDC1ZAY 8P]IE:3(3OC^:13M
M;^):1CX\U;;KK0PP'_L7E&G]U_@X7?;/T5/#];WJJH7BZCW@$K#3?G9 <^?/
MLC<0>I'*.3E%]>!(NP-4[@%0MWO *;Z1Z,U[I,%M>S2TDC?Z,0& ?2'M&]J.
M@<;;HY<"A/M?OU2&/U/AMKX0R^A]F$S>>P!Z#=>B'-O)'^PW<CN'EBAO)-9R
M7]V,*E'S?+]M!W>[F >0G<97KMOHN?:B@>%"1VE*3I0FSMBU+2T=4 8QV&&W
MPHH]:Y9F2]^0XNY,BB;94<:(A9\][G,YHI#/DO]:'KI8XS9RL&SG+M"5QO(!
MG4+[Z,=(??Y;^XP^HA/(_E(;91Q<.4*<OC[*D_E''VG*X3,\I9GMX/ ;UGS4
MLF3SV)F@%GQX TLX?6EM-.R24^,VV#E<V4Y8MA[OW.4FYT_!D%2&;7Z[P-#Q
MS?O*KST?H[D-\)8:0!(=74PE\?""_?G6W):;L1T(H809.T9WW0AD-3=:8?+1
M(7[!59'W4Q$?HN.$O&PC-XA&P_@9YA)KB@43DFL%?^>.[XIO->V- 7;7-/%+
M?;Z%!"0;F.=VZY4S%/TVRX<*)?UADJ;'HV?H:L1CC[2NMN^(E+-=Y8F[EWS,
MNS*\TE$% B,2&9.,H(:$6O)[P*?N_LGHN?'#K>%D]H/A1(<XF-*H0D%Q>OO'
M!6"1FT77%6?W!UOJE4ALM4"E6)62ZU# 7I^)?GQ]V(U8OF*:2%?, #!G^8^9
M1*+"GB@K7*^=8N^\+K%-)C\.DUN5J@ES3,U!OL?'*G[BE[<MH7V\4.92$<,]
M@*3RK'%#"=0UW$:02 >O!W-V&FY9G..7TY?J$J>;ABO6<8D7O3$]H(S-F3P_
M,C2#H@84@0E4P@Q!ZET&^C@#/DG7[<.MY5WPNXQB2]VZZ%60<?[B?/>0M3;Z
MUI,]%+R%\R,J&N)QR(<-HCC\ZK5GAG%".;-@_]PS*$^6U"N_H#K_U);U(:PL
MH*@I?U<2V1-TF_^X+9,IRSUOJU<T\9LTC=T$NN>ZF]J6[LOSC:$4NN"BNI#S
MZ" @D%@Q5:R9(,.7CTWX(K"@$4,#<8)Y<N(=MA$7G06M]Z'0VXEQH_U +E,-
MVQFR+2-4QQ$.&!$_6_NZI'F;I:5^?B0SX7CH%B#J;H8IO=N_?%EF%Q\=>&,%
MAX0ML4]$Q93(%"_H"2Q]TXMIW_,;<KX'5/?MYSVPT"!<2&\R-T<*..Y))'Q]
MH*^1.F"I;=;>D@[VZ^VMY"OSTE=4&.CC[:J=Z\O ;K;W)4(*C%L-=RSIK&AL
M;>GD+[[55PFI$EH)M%$A.$K3L2;V5Z;6ZNPJYB^_"$;\7*$$;B5VW0-PO(RC
MS[^/UF;@6Y%W-S6V:36D.XMK1PO:X!\']KI!)RH:\W\"1:)X]HSLI(FW>^5[
M1#)^P(\WPG[0Y:X-G,NQ0M:,L]S\V)SU9*NK&M# M0#'EQ(7%-<%$V*@(MD!
M?R&,5GL:<O-)=A]2E/^60F6PVN2K6JO7]0T& ]V.XVVO4,#K+UZ&2-5PWEOR
MUP4C((H YZ;1-UV/;H^'YM&CRP@KQJ'*D^$*7661VA[(++KYA&FY[=^4ZGT*
M:^)47DH3/F]T]!6_4-'5@6-S VC>B44Z;Z#@#2]536!%*DZYJQ]UHDW\WB6?
M9(0\T)53532,>BOQ^6*7FHCCMGU/K?8N3JKH$$,* S7=VJPEM5X5=^J@/&6!
M06^54&-6V3 H$XRS,-'HGS"  :1?H_K?,8#G-#1K2]IU5SB,J8C_KVP?.2@=
MJ8CFGKV.GE+;:[P\>W%'4^8DE^=XQUR=OGJZ\SDTC_\"FY5E0-UO1O!Z66'8
MD_P! :#=%D;?: IKWP,*M!Z<:LGLC9@Q1F@;R?Q.OR"V_>?7%M)IN>6L":AX
MQ-T(/#?A0FVI+:U8YMDS\-=F>8/%#[M"4)I8"8H;BDET<T\WM%6_Y<<!5SY\
M)]6I%0U)4S_LR%S$-^-9W-,?15''RY!7M$5#LTYQHQI+4 RPI4'M2@%=+Q9:
MQ6OZ15\ NL<93: R9X0SWDL>/3=/5:O7$JQ&BX]B\"[DU/4M B0L#SBU\6&@
MT7N Q9\%]\&3]WW+XZT!JJW5+751BLS9"4_)M+[YYWI^:?7@*X+37C<NNNQZ
M];+BZF&( /,L4-3@/#>(.LJ5%\@SRU&-Q?JZL1:NH07NVSCD!KG?O>XO(0J0
MG,AO;Y!PWU"G_$AS'GIT8% 2CQ[+%77VRZT//A(LBA7]\D_U$K7/$-A_[J+O
M44U*).;BP._>V**(Y BK$\7?DPBCH'(O43[6E)VUA".UANOW;=J_F#M(:>*]
M!I%-3@VHG&)1V_*,)C+UF._AR<UK$E'BKY$!*: W,.><K[2^-_MBL(9K;RR@
M78V1@D9&4N,@^:67#S]I2#%OXI];$OH!UL_%+5H,\OQEIDYXS0?V)B(NZ3<:
MZT[%@TD6.H_ FJ3]E!EY.HQY7Z5EHQW*_USIJ8S,LK?_!11>&XK!)6#!<HCE
M7L$V&N4\0T5O^J'6>MA8XN!3M5Q*YXXE"99S=E%(IMX]8(;^3O//\LT;1% 1
MO!O)M^1GP=\42Y=]&\?]5/)1ZI4OQH:1P^0"[?YB=']%[5NG/0VW!B&&M-(#
MB[$T'S<HXZ2=ES22I/=J*3P/Y.AF)S_FU;#94"UCM9D4M&]6!7C4:D(*;^G2
M1;2'B;*N&<AUBQ,$#7X*UGQ/TN2]G\_V(>>1S%<\6\PW37@4[S82H"5>/(A-
MJ.,:[H?=.F);\7Z/$/$QX3J EM14/26.<W$R8R^*\\BB8JI%K-C-Y7H_=@G6
MY>.+W;"F7]>+08:>5I"< UG!(W5K[FKJADWGV#TML[=_,A3_[7UK65%H $OZ
MMT/:.,W#&Y(U5:J]NN3$D .G12[>%-;?8/8#!BMR]_SPP84_DK!,EZTXI<<5
MMWELM?A?3!"]U6DJ,R,3& EX\_H 7=XME(.[Z%=E/2,8K5*&TOCAJS%GYB.[
MC?0II^U)]WY1(X\WPA;+>1(R*+L2J^,;9BOB96J*2D_/ VC&3]@EA),R<EGA
M),F+%@YY[#;1M6-%] .6UUM=9-1)6$7#\2%-"O!=_)-</2':+OZ-^SA>$/UD
M_D0M)A]3>6" 9;[H(G; ;TD,#-K4T\*7:QOQ;<%PBC+U=Y,UWHHR-=<V, -X
M8>R'T Y3X\YU$UB%W*\,HL$MMZ3<B36DGG7.)SWVGK*I]YZB98OR?4B3,OG2
M&TXDL#OD1MD3CF:<:[AL.92KHPL34:CTG[]H?O%LT,17V-Q7Y.B%EUP-XK#(
MV(2OIJIU,\.QD/4UJ4:@1E6&8XN/YJ";XGE@!9+O/(ZJ-Z#8<EJXE$&/]7KR
M$7.(P9\<#%ITT8L>D_Z5:"I4AMX$]*S$@'M 1(SX0EF[K(!#5QZ?4(A>#@=8
M8.-:)N1#;)V83HYRS%=<S[&LQ#Q*,CJ\!^3\'%X26K]6>\H9(BZ\L)<H3&!Y
MY5*2KVVPBY0B+F+[+.U.#:?D_(36YU/[@&UH;,Z@!'499IG6]<*63?QR6J%$
MV3K28"$U5[1T5+DU3;"XF+!=4(L(K_#'<5[V=\S32#,[;CC]%[G!"&; U8EF
MBQ3"M=NC/OS)1D)TWG;B&Z3%W>($E#YT3MK?]=U3TOC?ZV>\:*>,'PW=H5YF
M$UY")O#P\&:1: &I=,'<ND_8(YM,3/W[#G(KH-&8#Q&/'.S]O4$#7F:(JFM#
M5%8^2*L7/V<(*U*%X0MVR_N?'T@[-WY2>ZH]7F)$-7Z^TJ^$4=0LYO45U4X5
M&8SF5 4:>J;>!34^K$Q?R-J,J%F^WL[%Z-SL=K@CN-"8Z^4^>\L]H'4^:LKD
M'8JG;&<)#:F5YC ]OEM_C DF%8+5_9Z+E.^C?*E+_0;E#;<Z,WK!'E^;.JW;
M&Y3 SA87;YGW_I5]P'?Y/4ER(SP?[H*06@/6]ZWCSJS8X?.T]A80-S^3UMFG
MQSF%>^F>0&4D)YP*VJ7\%%?E<'CSDKXI;,JX!O!;9_@IAD=O8@<L'%6R>IB9
M35-MF3"#;W!SL[&J89!#>8QKZ?41D7<1;N/$5/K>K/0L7'''J[?O<,U[*$IX
MK1;PE9H7-04IOA%!6IP[/U#10"_%O%+PNF%QHJ8+FK[)JP!@N0\]B!-AS/DY
M22Z,;BC]MG'^+88C^%Q-60+.^>O KAL6';Y51;S*I\BJS7[3_]95[K7Y".57
MJPHOYFECI$\1!^IY('VULMWSM0:#%CV*".^E>T D@)H:H70/(+RCLFPJSRJW
M?K$[H_6UM/K=+OYY@]?!_&3,_/QXJ_,B[S4/W3@^(=?&QO=3@(/\#6L&RBS3
MP W8D<P1YT5H .N@_2X[GT@[.KU4FY]?F;.D_4$A[P_G2_S9MV]\14?D;K-Y
MT_2 M;X[ N<PY?4VY?0RCA$&5U%.P*':AY68I19HMQ'QC4M38C>N[%*??M"\
M$J1R7J_W]3'[B5]K=;^M@WAVD]&3&YSVT?+3%.P13#?K#TX72GL^)C55Q>D4
M@_M;48[334.*J^65CCE>,G414IN@Q"*Q=%-!V",+5TKO"4DB4;RU)%$!"[IT
MADEG1_KRB.3 <6M#'1:R:%*IBV:\7TUV3[WTHWM<Z[42DXD+,A?DP.>_/UUQ
MHE !UP/ 993'::DJB1?#I*B.>]GK!!%/SR%B;*:-884ABB,RTNM&]+.2)IGH
M;F5#BEEGGGS+-V+\>GHZ;+-_CKX.?DNA>Q16@&%YEHEUY=I7N(5\GE2P2TTR
MS>NIK&*,FW<&+RZ-<*PAQ'#86BKK1[8->2E=>>DRY(G'4\W,YDWG1% XI0C.
M[<U$G$*YQGR>N34Z0W#T%ZW(;;AW7"OU#9;["^7MQ7[3N)6O'F_1K6VS-H^W
M<*Y!<8P,+:_T/4PL787#ER(5S-EY+8]:XP9I'V\)"F4^;[RCF]7K@@,;@_1<
M1J.//O[^4RRKF3A[2F31+<X1+H>"N,,I?F[61HGP"$5^."&,7Y4#S[WR5G:W
MZQ;!O%%&1LN/GJ;,%ER;6CO/OOG<RY0%[F^F<:KLZ#PP#$8"?R7><2!:RR.-
M-T+,VFM![5P#T=6Y88<8E+&$.&H80M[(-"\^'U$A<#:(FFG:YA3%48[;5+Y"
M2>#5N\+ZV0))6G[]BYJY'AD=N,_7_"$W#+NAI2?L8Y"1&H1\S2D#?<]#0X*
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M"N:-W]\\T@!PJ^H.B-,AB/-*E!G/$T+M"V5(,EZ?K'%4KHE$BW$M)793/ZI
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MH@%*&CX36R!=NEB)R-I&ZWG4E40H;P-=\JX$CW*\\:<_7Y)< OIR/L] OW4
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MZG7\^W) YWF/&]7<J.WI,HU5K*6ZD5O^A68\[UY@+<?\!6X>75]_S;$'<'K
M3Q;0<5ZJBN,F/O@KW(==L;&ER;,1)YA.Q+D'X#4&OP?@*EJM@0U:-(N436?X
M1^E;HG/8KQ3\WV*54.Y_GELQ*0>5(&:ZYD4R*&]$JJ; #-/[-J(\SAOR);HK
M02?9SUI5),$1DACC;8%N"4JV:K,[,<D?21]3 KSMY\=]Q66G6I@]\;[5:/0,
M!0?S'A%8OS-3Y*PI9=X4#(U@#)*$H*5.UU"_J( $WO$U5:=[>TR;!ZE%YV);
M!K#BU-A'H88_/&K+.4ZT72R)6J-\*1GZ+AXKRQL ]Q4U^=7$$5=VHYRHH<S
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M+]\#"HBUE"S_PPX4YO%_$5=H2OXCH"QICU/OWV7H@;@@SU?[,G1O I3H$"9
MNLO%1X UR;*/=#>C^I2'JK\RE_:*SP*[,/Y/FSZ,._T7_PH_L?I7^$D3%ZLZ
M')6P[H]SUTQQJ>SD9M*MSFBYN-"F%Y-=GV'Z"-"Y,-&U>OV"A'MPU=5X(Q^6
M6/Z=9R>\XJWT3VH,$FIX,(%)1-3O99_0NZ,ZAUBAR3DO;-Y+P>)-S@<AE*I7
M955Z?XCWSRCF)BN*<C_V_%"U"7%&V@,78#P!TZ'I@5\#N0JYE,'>_9CUQ";"
MYF<AI&S!)CN 40UT-MI<=T6R:R9IJGLXPE+&:!RI^8'!9;!TSM6424PA*<_
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M!H4]*_A-H%F:8'XL6)2=FK[R]9_O"DJ];O@T#HZ*&[MA%[%FFZK-L*/U]GK
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MN!/$D<@@"L)L\A/GI?()ID<0'8(F+:J,]&!4;3#HC*XE<ARTEX*=$%KL2#&
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M05BA,Z<$F&1KVPW2E '3EP$2]; 8Q\*CMMG/\NYU_8O>26LQ- /D-S07:_>
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M)"3.O1O[A4.P\L1K3_&)$(]M+E7MV4T)SL.C07X1G S+]G>(R/**X@I;D&V
M_HXG[2LU7W _,.H&&(KD7<&!U7;-4SKR/+L[6T)?%3H-ZRASY/K\+7/VLK)K
M@" \-U7;TZGE&^ILMXV@;#V&V'9V?ULG=[C0_-MA<X>V[]I*"(H;T9:]P$[^
MW.K%4-RPV%A AH(P?;Q<U+7GI0!"A#LX?V0#S^!1ZGRN?4GC%CWJ:L-4Z_S(
MM-;\.RBLA]NA<"O#/UU[5(!)/;K5IM3OYOO*<['_\G]OU+H?TSV ";TW\*)[
M]1X@)[3L27P^&\#3B"R)[SD+_+[/^JM*_.\W8Q@BQ*E0T@3!Z-QGWX=JMFZE
M1786)2WK]-#GOFM0C.>)03>6G#UL,D#1;M:M@>N6E0TM>@5+O./\GCP:SB8,
MS.G0U="K;3WDHM>5"QSY6V;&#55W'I:;(^>?HC5WA:92!G<:)##2H:QOK@G1
M]'VT3_*>[R,I9Q$FNJ.+-WC"M9TJSDQ+-%E$O4PG:>,F=X\?^7O]_6YC<=<)
MZ8W !/(E_!2RE_O9,/RPFD82<?WZ@EK>IRZLV*;4,++<2C5B\>O@ IAKOOW9
M;@"+,K=;9&#-<276ES@T!E&.Q;C9'6V;=D[$AP#S^+$P7B^OTP?C0)^!DN.G
M&#D_IB]G.C(E%END1%*WKC,;Q6[%[@$<BYO^HBF5;VZG&$$H&(#",K?4P$9W
M0FAF[[$*O_XB\;K5Y><9F1K)*@NRMKWMG:T;:*/OP9UG?X."7=/F#^6)4:?H
MPR=N9DBYSJF"W-2NF?0].Z9]!<HP9QTFOW=)],TG@:]GD*8//9II:P\G@)A3
M44:*RIU3'PS7X1QY]E\%V&]. <<54,\#0L#Z7C[C/1AFES]@2C%N@T>&FO(<
M0:)ADK#2>;([CC,J#PF!"2;4LF;1/8!^<=O?@Q3O\PCH5I"'9]N"PTZH9OK%
M:+7*>IAKAI7T;#4&T3LG0\:GPG'.L0/%Q?$JASU:E^I\)@HZ5N/I^SY;!0%C
M)-Z4F*=@@;E *X*G=JLO-N"S,YY6QLK0QB<LO;ZYV(1; \ D<U#!0M:Y=> 2
M[7 !>$]<(V;O]8]/J9L!'W!U_+B4F_F='?862PX%<=$AK;J!7T1H7[3:0]4<
M>T5\YF+M^[/,\'_Z71:H.DF[W ; /OK0X/E:,/^. >EW+U](TG8'X,X++F9A
MVH ,S$]LUI?5]UF/+=Z&-9S""7?@_?XV?OKK4BY<'/V>PLU"LX=@J*&:.J6O
M.XU%K^9W_1_\LF:G6<-M2]RL.,$Q<-EX=/A5F/N= RVYR9]=3_XVQ-1V?5W2
M$V[-S^(TN1R3*,%F<+B?*ESW5K\]$-\(82Z?UYZ%;=I<NC2LQW?[!9G%HWU@
M<A7?'YOM!@V2Y!9M5863:L/ZLUS7*4]PNWZ1^)8N]L<PB"29X>!/J3Y2=QU0
M&:B=;GW7'/BYE1&%VQIA;3!6-D]1]<=^A?'K3_A75<+/W[[RC?F3UZ=2;0=)
M>\$]>XP#=6#'59PD/A%IBWTNML6.'YSL*[CI_I#R#BU4*E.=10%Q$-AJBJIP
MH?-V8KC:/(0S]-<BHM#@C-M!X:A/X\4B7\SGEF^0]G" &5%C-@$>0L ".B)#
MHE).&L4ER9FR9;#:Y\I87=9$^8:;_'L1^;ZS\57?!($1(KKSJO0#I6K)0JOG
MG$J6UP0AIH9T(P.\8L(ZUQ[@MX#9_3/@1 /F)T+A%FE1GIW56Z%\32,1UJP3
M:#R^)78H56K7A\*;+ZA$Q#)5?'-VF1<OSY^MY<,5ZG7.\ZVW(M]57#<YBVO*
MI6[1P/RZU\R<6[)/(S.3][O"7J:N]D\B1.)[9T+ZR'OM#KJ$E1;3, J+\5C8
MB6QU:VAY1?GAE!C]AY O^/+NHGMC9&1] +_"-8]YI"8,&HCQQTO7FZYCSN+;
MK5,UCIZ9:OGAH6O+Z!->#+'.G3JWYOD026"!*0+<2Z&>+@DI;XB8.AZ6#MM?
M7E.RZ#KO,KL'H($])OW$"KT^]AP:&%<O0*[C>9*^)#1]KZ%1WE<6RHU3E/31
MP$SR(NT205$@/CMR&#36Q,O%+1_SG=9NOQH7.$@$;IA4+0H&^^\Y1P%."6*N
MI'D_FTR%)=M7 -?G@OLZ87^BCQ3LES#X:0BI!\0J6+I-,."O_(3G[(7P:+7"
M-1OA\G6G??XB$$MKOS]Z+<I(/0T7__A\?[8X!3PTI\";&;3-3'I8?;%[!?)5
MF@2Y>=P]0"6$TE+G'F"PIMP$6C(/<&NG@&7FVE7LBQ#N'4>SA)<?D2C(C49]
MX;>: 96C*:SP9;*B]TDRK"U;#F]TAQA+6X?61[K:<6]U*I,W:N^E]74DGO5D
MH;DMJ]\#U+/DYR5?BAOU/+F<L?M,CC;[E(6#7H#U9GZRL<STN1?+:_C#1!6N
M*I0ODOK2[MZ0H?PNT+BI:U>4;A)#I%L->T,>)I^^6K$,U+":<42C*JO^N16(
M&XKD&'/GP?6*VZ8E63#<)=4"8M215-E.)>LY/O?8%OQT=TQ@<+6D61\D^:T'
MKP)Q +6(CW3T$_)?CY51K4J<X?XUR-3HR4#'_NTTQOTDK0K.TMF0]:+5/6?O
MBJO(Y@;C!\ZJT-&7(\>732RV[$JM(;G.HA=@[<Z')];+(QYV#^CMP*WK(-EK
M?Y&X?;RH6ZNF/G<+2JC@"\!?8$B>8/$)%9.9JJS#PS[I-[C\P9P.:S_H:F>+
MVQ>K<(=][7D!<&69H+0TBHGAW1$Z]UCUX17+)J"]-8U $2+B#4A0)#.2FCFV
MJ1BGY&Z_8@5?/#]CR.6]5B9_3'$D3;V,2->>/CYI5;6A2;LB)*F?[L*]A <^
M]: B.?;G*%M4P?C?K+I=Y:?)66E3H_KHY >#AWR_2Z<YP7A]J0BH?V:BN*#V
MH^W^O+35%(K1[UTBE+1YBD%X#:("+\_%X&!,IT:;>*(XEF:9L &FV6M(4\A(
M^P1=.;Z\8%YV.&$G$/OBV-3X%%/*=;#/_WGG+FOG1M3A3:],,HWIS/8\G/QT
M(J35&,[2U4Y624I"FIK:L W=VFRL\S:Q:3TMQ;H'9+XO'"5XJZ4*S8IH5DB%
MXIA6VC[GNCN:6QAK48<C/YM;8\HJBSK:WJ1;G^^I!@\0H6HH5Q,(+\@/2VIV
M@'A^KQ"I!?L4EC$0'&5'DLPRBGWA51>4LEEJ/]$)X#VTW(\-+A+C'DB.R#68
M?]\2@O;K#5Q>J.8UMGK^"'OQOB+8V50VPS(-7A8Q.$RN]R'IG#X\XO-T C$5
MU;1IJP^M  *TX=D+)K1^=#.AJ%JT75N?[*"63B\O,$S\E6"#4OTP+OGWOHD,
M(H$TDEM0KW::,<J *8$+OSO3Q _.["3M(#S?J*]ON'>98&C0_=6P_U&>9L6L
MYNX3O<Z#*.!SG+TG[_544FI*COUF<_R B)]V=NOIJC^%5<-^\GEZNENNU69:
MDN.C+08/.H2EJL('>I<%>LXHU5Y>+<J[>OPVZIR2S#-*UNMBB2FD;T^$2+$I
M7>8>/$.]P<'4E(&V$9 CJN B_0%D;9.$/1"JAE]>#(W-P)K:*&6G<IKU*SW<
M3'^.;S,!4HBY^3Z1-',*-T)C%LC")UP]UBIN,XFSSRUB0N<)Z)#J^>X;%1,C
M8SSQ)2/UIRF:SY;6+A[?_L:>F;K*9O]N,.49JAN/";/J-Z5"C(R&]+,R6U^P
M<IDW"9MS.M?Z9B1D#L1,KSX\@[TM9E#FILF<8,Z(=P3HEGS;]BL$R\X-VYU"
M)\VZT1]R#+]_XEROB8R#?LW6 !;WJ?J:.18M*CNZ8P,??\:CC F1VFL^/\D3
M)'*JN_ZTWY+%'Q^/DI[QDV :3\C_J>)U@5/TPKKL>][OOM@2V?&Y3UFVD[/M
M#'[JL(NKR#0I<;M-\9A'B_ZY_(:&DN]3C:P\*+<8P(_G)V\\DFWR#/+KDFMU
M*WGH1;_9HEZ5$U\6'$RWU#[CI#8TT3&>H(.E]O*0[9N(3]4NJZKC%"SI15HF
MXE@]$G/^UO0=%[T?4."G/2OY&NS5OMB]0E-%4EUKN#.['4XO*)5<9=+7 /GV
M?OP0]V:J,")6[*PH;0*+/:DMJ6!BG):\K+3$#B+)MV)J5S7^)O6T_XWN)//;
MQ*J+SHU[ %B/@B"DCE)->AZ*-_Z=QZUT+[^ANOZ'2#A.U^!)2X8_7L!GI"[B
M 0$_3)Y@H?(7W=:UZ6,J+\E;3ZN=OZK[KLU)776QLB!D?B%H5H[>4[CQTB][
M>W/N7:53-U!E];>'D'?P&QTH=N2<"GGY^$TDKPSO72]=YUZZ(!IH0S^Y _&,
M;*KM2*;>FL>_;7IILBJEJ7,3;WNCW>GC$ P]4/YU#_@B;H]!1NF2RQ9IU* E
MG)#6\.#@A7M 5Z98;:B[/9O!#>LLJ48],]LIAHB#$=7<24]@.!PI"H--?9CE
MN=!+'N%LCOFEJ.'#2H?_Q/M[F0[%T'!:;;P=>G#OAZ4/.H5$RO< [.F>[T/3
M':>"64@=S/7"L'O +O4]("'O'@ M+<JS/97*F]?>E4H6F=QTE";?5;-C;9CN
M'M7XPFS#2^ (!8O#XCLI/>=HSHQK*9]MLJ0->%\<3+6-NF53[.7'E*IP\_EF
MN#L1<8P+)/[9&NCAP8M+\\"\\_AV#XC*OP>$VJQWW& &;MK(($KV62L<;:1W
MK*H*D84\_U@5>(Y_#QB<"H2_"^RNA>W<H?_+1G<B[<O$8YK^K-.,&C\!V#HF
MBFGUF@*(8F_=63LY[/B%9)MEGL.[&$.5,D@\,F=[@9[Y: <3<"%TU*L-Q/8J
MWX/:R8FR65^)V;W?52Z)$Q\P2T8H_OT&ZX(6SEJ[@?J3[VX5M27]%^=S_AOG
M:\WKNJ9M%\-K*E*^QL:CW_T*M$PWC7I.;:IP>M@JAYV53J8_D!L8ZZ?MUDZ'
ML()BU,Z\;)IRI[1:;S+M SJ;ED@GCWE-KW>$!]#I"U6TY'?Y?7DO4$'F3^;"
ML>U*E9DI</7URCR@M*?5#L194.GUYU9%)NJ!2086>&1?:KB@: ;%D7!\9LB*
M[MZ-.J,UN9A5A$^O%^2)+'O)E^=+?L/!KQ.)N0=\P+&Q3 S$.9C2YS"/-JQ;
MR5UDR 8+S=P#S,"1!HXDT&XDP?6.\.J.*5/$B,#3VYJHM#/E+&\5/[;XNR.*
ME:'VR$84)<W7U5K3$$$+KCR$-'-6S;BKB>_&"038*\T=62X_O-<<:&<'3'J^
M"_3)L;IE0&JV?&6LUZTOO;MJQ+P&V:UW_%$U;$T3@6-&O*^/EA'TL-6K/!_:
M,_H]?$;1T:*:PE-=-4_:W>1Z.<O!-N3I -ST.PBL4/4727WJO>4:^N;)C_BI
M]NB[S'N ^<&RY?%\;Z;@ET4(!Q;=-.V)\A+I.<WLN4Q/UL)&5Q;N;UK@M"[T
M0G',V_UL$ AF0(>!WZ(# +Q23_P5#'O.8?4_C?5/R>\!M*WR;!]<&D_E+WR1
M+;CU]5%33]=#242_/GFG&?1$-<IZ;6H3].>&-D:Y2=K&P0RABE+!C+@''(1V
MH$+LFH\YOL 2[@'1_P!R>V2LI_^!07K&3 !M^M]7?HK_O/+[3F1/D_1WMQ9-
MTIQ<7-+-:UERSV:NNM%(YE5N"V<ZM[7C?GY_GSGS!).%11S?P;!R^]!7O7@[
MMZ/+'>Q[SG*FMNNE8:%O#LL#6[9CS30+*PK'VNFF!;7!RTL+G9(= EN1[V(\
MQE?+<1Y79YO0Q1?,',PURY#V1D)]3XO0SOB^2H5:>.R9CC>6<;)]+%E@*ETP
M++XIH"DK5,!KCW8A*\_]\K.$7QU886ND4RX#3'_7HNJ%8>[@O8M9_HD ?05/
MJN+M;XP=<XLF/Q^0#BZ>SZ1++DZ>&8A8):;)5E4["Y/^:Q2IZ$XYVY[1^6R)
MXLR**4[504KX'0GME;Q0'8[USJG!]DMAYZU4M)KS<9NY#$A/?X"<J1BBY](&
MSA,A8ZTDZ6U?OMB3EW]4/E3[\7:XMXC,C&P($BB.BBQDZX^5EO=_?GU,B!?>
M.U=*)6]JF6COW3XP)0D?<[UIB"FOS2*R$6>09TRE"%&F<Y+5F\5D*@VD<A[S
M.X";@=(UX. 8&HA:M0WDK8%.R^=$YB:GIS?0%B#M&.T;IJ47JEMEOVLV)%X_
M<CXO;(TD>[*@88ZO+@;&F$)1[Z)P$<EK4@)O\87TR@J;VYL3=6TL94N"A($,
MSC)O0=[P<3:9=;W]>8V3,TY<T#ZIV-U,],N]PX(@B?3HI 8%QI!;54[?(*[@
M1:'QO0#)NO;9(\'B=5\I%5]MC\M3\2PVM(%1N7W_TJ%6^3)EZ"J>5_R DI&^
M).V"P;-QD=)*Q8S ]@'TNX03H_ZF D3 B#8\X_+(NIVNJJ;VMWUG$M:<HFP9
M8MP;%\,:?9^GWG ]/HN&-$5B@-9 TQWG3356+NL 6@\N;6&;'QQ*^Q2AVK7"
M!-L.ATK\.6_#\"44&NN[F$^FOAA>>Y*H0$>%+SLA!(:5S/>X+B*BG&!=:Z#9
M-7'6MJQ/7/RAE#F</N32N\</P*G,:[[/R8NEAR*LP95PPM$R'2**@F^Z(??5
MM'OK(8[A)T):;WY#.JV\-MX; JQH9@=1DXO KBPBAR7"PT(FG^"$J58K[=3N
M25MG>1@*::+('>X!&7[-EO3D.3)66GF1&<7KO;FI@3GMH]OB6&Q]21'I'B(Q
MJ&6NKX<>!@B^V 8K2SH-M"N3B-X#6D<!R(/M=!#,?KN&B/99'8ZOJE*MA.*T
MMD83;_>[?I%:;SK2B4*AK%S3/_OBH)"/\+$SQ;6AV).%@ID"OA[A^7N XIG1
MPX3E/%4XKD4[-VF!WMIC:D]RK@C_J(O.M</I5R"*6#CUKRP\*R]H"=5<*(AA
MIQ(@(=,^,15&!*M=A2()[&&W.BEK@8[+/06FMF8^/,>6F",#W-'CW:Z35O0E
M![1_;L#=L4\PR@MW0?4WT0/%!EY1H%NI,6CQV0NHK +6;6<BYEN/;(+"C61F
M67CS8'@NVV"%%92G%X<V;(4B5;\CSC#B]YQ0V/-4%W_,RB$D1_1=QL6(FFH/
MI.[GS^3\7WK+GZRF'6.7,V) 8J%#HC0E!,0_X,*TSQ!74..4^/6^::;/KQKL
MHNMFDR'+6TG$.M=/F4(V+S8$T?9,Z.#'/]8G, E>J$\!/^Z11]K/^PZ;T]$7
M40^]YT#O624IF!%:E.+0A[67KC>!&QYR]T>2KL^P&%C5I^,&IEH'7LUR(05@
MI3JP^+CRS;;XGILOP@W:>UM)AIVC-)2A,KZV%MY4L1T&'7E>';<,_=(T4ZUB
M<&R9" ^?GSWRPEF<7Y>!-N1:?O< <5[LT(WPBVS\#1W$3-5^PUP:;=B%*:%\
M85/<Z7$O710S.I/<1Y&OXL'&A:%^0(L-/.Q%G>D%",3Y*[5*<T*7+F8.1FOA
M>GAO/*X7IMR,I 14S6!$=LYML0D"Q;G6)6G43?AIKC:P\T1I[UN?CTR0I+(-
M=!5?L41/KRTTZ50LU%CX.CJ3EB9V+DB<W&$M*('Q=[^BQCBF25+U!!%6N_)S
MPMO13H+Q=E=X;29N^L9$A#W2N>BU3<%/FN4UU9'/1-QK[4H[3SIWQ4^=TW;.
M*8\D-/Y6,G>$$VHD$F"-Y"Y+Q:3E%9 Y,!/&LX[V!K<,0A1.3/,!_M30>'((
MXJ/Q<Z;80HI\J/Z;WPFAEH_#I)=T89DRK,K;+"F!\4X#.Z;<>XD+)B8VNC="
M/2L(%1FRUR3I; EYK]I!)R3"4AK"LD=[?8Z&<@%^(,P>#&_I(;MB:LT\QM@Y
MR>8<F1.X+*U<="-Y-U8N]T+W,;ETJU:?I#:;]::BAI-*)1UH6,3D>:WCT_IV
MQJ9XG4!2_U@'LQ_)N:$5D@WR.T'O,AX,[/)<LT*4YGDYI_4H-_C3>YLM,S#R
MJ69)C4\WLJ%O0UQC-M( -_42198*UMO*Q#[5E72Z ?D5_M\.H1#T /,?9LZX
M49*5@3&;Y^"T5KP7$-N;HBFDW#J;?;I\DV^L3/?4!'OCXNG02\[]&()B+4_/
M\C:6'HAG> "IGV1'L&1I[*O]8<.15!<#T]12PC_8@!MJ=P[%K_3+KR8R[%_@
MHMX5G!)(#!,.;-\#7+V6KT$C*/)&Q(<RI&(KG-,@)3I7;P_(K@_A0CH;K0+'
M][!)\6(V60=8TM:1<M!R?*@C@6TSN[6!\?E-7Y,V22G37&GMJ(AWT//*]Z>T
MTB%!TM4/7HRV</>&^G))8SF>G.-%2S7S%R<LH(>^4A=_/C1@L">_:?,8*)'?
M]/41B0+@\]Z)*:]=FF5DWKXIK7SUXJ+=HQ61**&O6*V%]0H>Z&(<K:?.,W.Q
MYRL$K?#C)LQ>?Q5*I9QI>UJE^(<XU;=%-GX9S8CAOY)QW@?P9^":X3UC+":3
MC!W%)#I/L) =[)HY9W?!\^M;_XE!0&.;17 DU%&[:F,)N<@Q#'>R_")S/'+.
M$F]P 0PFZ5&''8,+%4Z%RE-*71T=$OGL$\+7%2NS"53_]PX#<P\@EBZH+67H
M?>11\^$3T=*'UK9[@*>'Z$2=8$7OL)A@2^D$ VPB]CT;V>S'GUI 0;%!3GR7
M/+-ZKQLMP]T5B4Q<M:+7./V=Z'&,_6)[G0?7M[HK8XZN68NJ#KH^S+X^OYL;
MK?U$H$/MD]QU\A,+"R^M449B XQHB]NTR6)^,AM/0]ZDE9FH9%,NN"R<+.ZI
M+E1L7%:C=#T6F_)/C(SGPY!JDC[>XM^MZI.&6(T*,YJ&BP<.-.QH*.&N^ZFI
MS0'Y%)S#FG0N'KV\O(J8+'13F\ C]%(./\[C!@HTH3ZU7*\A1@DA,L;'*705
MO'R3SIH#Z_< LMY^N9)71W24LTGKSO$M W-9],<TLXOK5JX96MN-:A+=T@P-
MM3,;C;.,B=N[>*DOQ_^T.[R*6WI'LD(!;W4NT[*=_$K%E^#Z[2Q$D:& G_72
MKK&MK",Y,P1H8B.WEW ]_T(PD'S\M7+18B=.A2[C\A?RH2%J'VW'5A&HX9BM
M87+;+5/-,-\+E=['Y#UN^[YQ2=>DSLV)*.W&Y30U)$C (L?VLF'N;$QBB?-]
M,9!W/9)QJST#31]D0@DW4V=NZ(AYO:W,8"#1($:FV8C_>:HPP1-3\Q[ MN)P
MD9W5WX15J^9C+Z$<RN2U56NVW:**JI/M5\=DO >87(B$U7(Y#)\N[0M<)\BA
M&97%]"MR D>?'O(*7.0F<.>S)SJ:E6 *:A!W- >R&Y??35_K*G2[_4JU"W1#
MO;-W/,X:#GH1]0]=L^YO$X *FT?#%7!+80ZUARQ"8\V'K"[+)%,:WA:>9C_^
M7['9G1<>_:5_+7UH\BB-4+G@QXXT^CQ/J]#:3W3E5M@V^+*4\BE7_NF:KO$>
M17'7\N#@@6$'+$/U'O!JN^X>$-3S@!4KLE_2=J\F<\^=.PXWN-,O+[UE4'?6
MU4;BFZ((O3MVC>8Z8%0/.#$+EC[VEZWF@6WC+UNAF0_M<&SL;B"[$0RE>0J\
MO@>@ISR ZA7'&U*A+"0F+5*']M\\=?]G'K%U9,Z0S X2W_#?6@+_T1+8[2AR
MAY,V@4*/1[$W_]-26"0'6;03?AJ?&#B!H.I ,I\%3C:5W0/6'A(;:-'_4 C^
M1Z&[!.4DZMTGQ]?7FA,$6Z0/SLJ"B3DBU!["7XZKP3V@T_D>T/?@8ZS>7)3%
MF-T] "W\'D!LK-Y_+I/,/'=N^Y^>9,)P&T K[/-"Y+4'I4^9X\@V2)6(OQ>)
M=3Z&FWSI$,:SW+-]W2ZW-SGWG8PX8VOT.%Q=,JJGZ%?4-XW_*5:@\<GMJ2KY
M:/FB00/X'G!_^L.R5Y$UJ2OT"3& 4C!^C6H.E-/+GC^K,$-=@6915OMZP"N?
M@(AIV,6^WC[#F*+7UFN<I^VP"2J06K'=\T5C>52T4Z7^8L"6OG.BU] Y61D/
MQK(AY&"RK4O'Z%G9\O<X//=YOG1O@].;??*7M[3)=(]I^:I]"/K;P6S:*4].
MU2%W \'QSGH_S:9/)!<E_:VE6#'C;?'\M%#L':Y[65VG4A[3**E?]P"G=[-X
M.?< A?"[+F2)4<;\N0,M0N/<-.':& A5,LB^P4]G&#TIA B,'G#&O-<RGC^N
MVDB4()P"6TF)SZK^-)B:.H;,V45 &YL&PX1%K0:,\"\FS97<;EU]+R?H>>H^
MG2+O/@>,[C@<-UX63M@1+Q'@PO,F!_--Q(CX*Z4BI&PUY0&:J-Y*X6=_TBG-
MK/!_4S<DM6O9W[: R,@Z^\4__DKM,7A[!71E3K5@&@W5W[9SX^X+V..*293P
MT8U)Y-2L:<*.XE?>?2+WH<AP/R5A"3*:2G**FY>044J@8?V(2_O-],7@8XKD
MV(H<@,07D$99:981+_U/YM@/4F7"4_J&0_8X'/(X;_(9V%WR%7B?'L4ENT0!
MP)YF&#D.EU<:\J[H,8+:=.X?C@DP2N76C_AGC)\*'BC)+S!OC 2#QJ5&UOQ6
M8ZU_RY*GHLBGW)7>AUVI5K>&K=*\]239/: 1MW_\/H!8."=7;W_.<NIF>.5T
M<H/7Z V8? "8%*,#*;GY6>NY9SZ=W>+&S\B([)/K$CW?U$ G5*B*Y=+\=#0G
M\0JO.2+IJ=)C"PQI$RRJ=R :RBF'G*8P>^YQZPH]R3VF9O[AGB"]YV>TK@8F
M%X; F?(Z/=RY;_F]<A!^>$;LL)/BF@(K8+IV48W^-]<G^P_5]< 6O-:/@J;9
M5-AZG[C**Y@S*;U^I7W$K:8'3,2EQP?V%WI L*0P&3-G!PFB4=AVX)IXPKW,
M@+M,_4:CXW$^66K6J;*^T:M'4VA2W5]23#D=$A1E!\CIK')*(*#0<W]L&XMI
MMW1J<7W%\<OZH>>!Q1H"!NSKL_I*[ IR1%!K= %M6']".9 ($I=J%BAH-, T
M6ZTT=,Z)SZ&L01^4S8H.0 MB9VH-/:9YDHR[GY/&VT/GP?CN'*V/-O22U$1R
MUD^^R#]+,^H&LK*DMVQ06F9)WRO*J0X<VQLH=Z=(B34KTT]7O>7P/= .>=\4
M:JXN[E?VM+0P6*/+D[@W,<\EMU:M6E[[9W@%02%9-O;1+[V[S!7BFGJEHP@[
MMU/0)TYQ(K(-FME1A,3ZUG@PE%K;>+:N6.C(X.QYWO;R>[V7F!P4)=\0F:AD
MB*8L$?[G@N^2GPLAW_U6949.08X_,D[Z^5HD=\J5FG5^&1D9<97A2 V'9FJ2
MX3UTBJ]?#P T-6B0!UCLM9--"5JSA/6H5%6%;=RY><SM40RA8 "KXH,#[?K(
M]Y>5D+K8&L/7\>R$V$GQU,(Q[\T@^>T=#=-<3,W-/^@:(E4EXYR(/!EG*M_6
M="<R8"JB):?F8+8!WK/T@+$'1'_X">1R=C5@/?DB]]EGQ]'@IQ_Q^D6B#>FK
M:?1QN>30#.^OGS.J!B2#O,MK!@Q"#/^\3V'-2WZAKZSW.YY;D07]C\83U2Q\
M&U"J@!&P0%_-6=#D;>*(0\P$[1590F+[0)2Q:D^S264E%RK=RJ^2JI?[O?)C
MJ[N,S_'=M?(Z_NIS$HA# Z^^I0AS):SK'PK\L@^/\J.?X@L5'QN%)W^L:R4,
M:SC(2\E*R=YHEW^R/WP3LO(T^P6?YW,ZXU&?;W%Y-S/G_ZX%Q.^=N$*:HH!%
M\6AT;!)M9I92YID-Y N\Q]X7]W3HV4]-2L9^=72"3Y,8L41!VTGGV8^B<MW+
M_RST2-8L]Q!I\"KK-3P%ROKC&2G@HU%]'LS&_+_:R_Y_5YK\$4URI]\[!-@&
M5@_IMVN3-H1['$95B6HUDI^8!)M*!/RA/<6&G=QY?KL'R!'-93\LK'B^>8&3
M;=[W@,!_"CF !>-O2!WN 2<W@:%^;0JVUQJTFK20*Z6'!<GC!'4/ ".T GM,
M]C!1%HL=MZB.=5,>RRBQAS9_B3+GW,OW@-6+>P VP9'W@]@6SP>Q\TB.+0CK
MEJS_ZP=E_Q.5]1X0UC9%@!QI"+RZ"^QN-\D5=,F6?@CC8:U3,KO&K?> C@,4
MT5^YM/^1>^T3 XU[ASDC YM/4[S#F?^'-15%<:8T@(S^*TBFN]UX4%!S..@F
M'$5QI?Q@ML_9@]F%"(U NV6Z>\#H/]JG'VS:_R\V_7L  M?!;@GW /Z+G;M[
M ! &3K7.34:[H$4*73Z,V*M_4W,?)"O]1S)H).FOOOC_2M7\KT/+L37\5Y_B
M?QOPN7M 77^RLS/5ZYZK]RU/AGYZ#0WD^]7INJU>/X7< ^;?H3ZFLJ/O3Q"B
M9BBL0B\.VKC57NQ[UON'O?DA*VE5P"'RWTP)]7O(&A(CRP/G'?>,8JF*"!X2
MCH<N/?@4+//7I;2P^>:_XY;UST@9_<IZ$"Z#L%MF0(4>3-RBLM85D4+'"?_I
MZO_1WGO'-?5L>\,;45 I4:17%1"4)EUJ%(0@B &1WA10>I,6:B@"T@4$%)#0
MBQ@B)=0 TD%$>I<6D"J0("5 2%X\OW/O/>?<]SSW>=Y_WG^>/R:?O;+WS%IK
MUIJ9[]HS>P:5)ECPEV['&CR_Q2S@?[,"E."X^9\YS!):>.A,U^$@=.DJ1N@Y
M-LZ ICU>T"4TK*JX_UN[]5@!X0.N<TX?3FMJ7R]2%$E\$/0K>6ULYTQB]HI[
M%Z??4 5ER:G-FTYM;O''YFM_;&YIS[/[A]GN*;,=T"4B6]V0%#[0]F/+QVG^
MH2DS5BSLF^@C^=N'D;5E:1"":!8/OA-1T(0N<##)K^.%UE?Y:(>SU=S^KN#9
M7Z!P5:'Y'Q5\\"]VZ?ZE?+DK,-O4L6;V:OG@KRT47Y6N\$.W]78 ^'Z/"'1X
M68)(3&H%&[,B@UZK3D6ILVU]H5OZ,^QAW6_]X'O%%905?_-C:F+O7Y6:\(]U
M8R'W*8 +$TK'',BK6S/NC#8.>/V\1OTNIU>W"YP='D6B,UN5E]X[J2YU+9')
M6A![%B\0VPIU,WH6X1\M'+P/^E-4 J'H+].)_;,3HJ[AQ5I6,1)C,@?*_)_9
MPU>C%M"PR=ME[G6(W)!^RT<I'D8$+N6XG%ZDJ</840$ROSLY=[J'=2EV\P6K
M^]:=@]QNT./_=;V+)<CS1X0LIE0/?UJHJ)%)E(MGO%AW=6G>,'/P_Z.[_]7D
M_Y,AT\Y/QM/^Q39 BG!HC1=J=\V?MI><U/@L1;*I*#W#6-P)D &'1C//Y2;P
MR5OX4K$V&7BZ!M^]L_&+O?_I?SO9274H]<UN_CYE.\::#/!*DX$33U)HN;8S
M[!2ZGB+GH[63<];<F8:_J_\9O$X//>Y SDNN';#0TKC"?H?ULR+93#7LIDG\
M+/DAG0^^%,% QK4L T92KU/GQ2\^">@JDS0U"9RMWID3+6 WG7KEI*&O/CS-
MC=YGO>56&O&(87;MN-2SOG+%72)%ON^!\W+_G2U_CWMKZAY9Q+WL\584%J6W
M[@H+2#!%@U?+X;5"R\ULL ,L.F&3@RJAT/@'.(QN,U<JQKY.L?"^!)$,/)[3
M/#(Y1;DY?U#N!'?*">@1Y^[3Y.K7Q.,+<1$7D9!;#@$]2#_?G+RB1ABDPY))
MZQD>I-.$;NM=Z*-;CKV<:?:PQ9KH.'N^NXQ#CZ":[W 4@?)U5QK6_JA]=CA@
M$5!Y67SGN&Y=",VM\&-)2LFTRP\2C>&@KT%.SW&]8&/?@$9/W/IRF7&+;F3'
MW;RK W[)DF#88LA>C;@:;_I@/NEQ[YMGOY]H@+>3?)$W,5SV[HLTEI<5OKIL
M.K,/L=8$;>J_$W?RPU$O&&"@"QNN3#!_G<%MG\"D?>90[2)J6@7_:.!W C/Q
M_HAV5Q3*LV?0T_EB7VYB= 0+2RS5)?^KO,HKC!.*<*_YAHUI<Q.-\"IV*18=
M5<9GL@]ASW64C.*%BB,7E).=Y[7@%R'\K1.0ZUI\'2WI/O1\+[R[^#.0VEBQ
M\"EP%,8P;V.\U:!VJ/-ZE.GE9CF.R !N-<!M/WT\CJA5TK+0+6WGF4%P9C[6
MP=RFMB.V:M[_")OWDAX+N($7+<+2T>AJ&\!0HKL;:Y_BEBZ@166X64&_NZ5@
MXPM,D;'HUWMJH]+:]&3@ZPX_0K/N=M4@&7 _@1#&M1;@-/8DT*#(;J,$Z/K0
MY2\"?,FC48I)CWRS01<& I[C3_/<QP5]/MHL[+]D\: H\ ,RXAH/9EI0:7II
M;:CJ&B$..V&5T0:>8OZ]$6E.ZM$VT !T(L1O8,-B%Z-W/X 77J05VLUR#/.F
M+F0/E#6-.VG15A*)LIP)F;L?ZU$M<2"CFM'%VJ35!\6S93DK'3<?7'TGJ#/X
M><DSFU[ D!"&145&F@_N"1&D&R:05EG?=UMYIVS>0")UN\XNERB-OU9DP3-Y
M<?D_B3%W=*4WGU4?;.5]%F$@>'<SL:7L&$+@SS6RKT>C-SMSRLP<$E^7N:*%
MPOA^Y6T%SY2/6.7ANKZ<"+755ZY+.I@4HE^.)5@]*GGYXJ3W\H['A%6PXG0+
M#PO&O&1CBG'X7NG<Y'HRA*NOJAZ2?*[BSO&:H)6&7GRCF@^"ZA?*)4"(-G6\
M<^R\5\9^ED@(YN?O)0Z/Z2P/ Z(T3D$;-X:R]>*N1,Y,3-0E]6O6-]JBJ^_<
MF<J:O--SARCD#R' J<+.O961#]^]9#JK#1O,SQ;N5']QB_@RN^84*E)#?/OR
M)]?*FU,":N;SBC<LZ><@U83']1EFA[C"2LDOQ>T-=$N+L*Z5CD!=/@LG;8[
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M.6QG2NFJ'[HQ*Z=L[H>#Q)EK3;6>$:/R*?J@R)7C5DQ "27?Y:SEN%@J[\S
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M(R*QNC."'%$J@74MQ;NHN"GZ<BQK57=.D\:-#YO.>S>O7A_S-;R:"U:!@5,
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MM/L7LI[R6WF8.G6!GRM1,B$!OGH)0;B$6(3\(Z$VP/U<[7^X'RUN\6ZN$I'
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M1[7'JD/S9/IHO7W]^E;G1)*:UQN_#X6G@W3(Q7T30<H6DD" <$-&E[5YS8
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M+K"0^&5@H>=!48??MFA0 ZZR%OQ#0U_9XSGD\H0>[360W,;OF9$*NN*D5,G
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MB^MH"EE_=:[QMH7;\!QND(%X,K"W!JZ $O?(0!?\:*](0]WARS?25_#O<3+
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M_]U;:X/V+V[J$[]MRG7.D1KM3O&T_./!?P< _G]*<4/1@A1_^J5KZS>1:HS
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MT"OWQ49>%OJ"D$\*?95NR%O8VJI61.YB0D<O7)9;!R2M%8VY%1>8K,,))?H
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MJIF#IU+/;GSBOU6SQ#CW<Z(M<5:2/ !AKIMF5T<!\ \/ %3IECN;]@$8=WT
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MI3GPU"YU[%N4Z5L5F!/!PHI:V4AAK9G9GIZ+B8D] ;$715'Z:Y-EUI@=P!P
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M33-I.+BQS_-1-T_=PD[2@7K+K+% 2^6P;E^WN^EIPKHV]JFL*K4W35V:U_.
MB!79H@TVI_A2]*GVY*6M_8KZ_G%*4^W,;Z..TD&V+$-)_EN)L2_]YBG=>.]V
M*5! !/-GP!U=#/[\"/G[B'%!V5U5OK&ZS9=+I-R 759RK[QCP6H44KL9?:G:
M%_:JN93W8+'_\?P";+#^M *Z=RQ)]>NB.YVB_L=,_=:);6UC9>6^KE1H"X)K
M)K2I4HV AR/>O<L_KKY;D'*KE;()(QYS5;A"(;[H_D[OQ;A]DF]BRO*#QTS!
M\Y2*W4^&B1 ;)P)C.^_DB8WEX"DMS>H!7I56'UY_IV'%?]_+M"JVSVY9D&(
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MRQ8?@IA"5I>+@X_8+ RD<:GIR'#10Y"HH;3W:H=@_YGK [40MKGJ2A*.#5-
M(+ "[/JCE66<>\([4+!CUCP;L,"_L(NXT\7X)]4'0-4Y37C!@C68_F%1@PQ'
M"#NOF)%U.1<&%O%X RD78C+$[1M27]'WY/7FA"Y^EQ?JR5D,&L^FX@^ZSU^0
M1>',?';T!OZV6#O9E*;CM ,2X>ZZSAAZ#1BW0@J56,+1B]D7%E@7A4CW/R.F
MZCD6V<S*^81O9#-'KMY7/H5D0;]LD/2=]?LAVQ_A;Y[_7=N%SM10NBKT.[@A
MFGX*1QSFNQ8*3O$JI0'C5Y#L<^H<8K_LG<FRIP\;X[07EK(+;?TBYP[+TB%S
M=M;S_ !O!="IV.%^;.N]+1^%NHV.;"KN2-N&ND9T=P'M:Z/@."N_!WYF$2+D
M=B@7F;/2L9;B7>^7)KQ,\ !G \TWV;IU$9H.+OVX \F"QS:*@8QY- HS='BP
M<FS6>,>)RM:>6<R8*#X_AX\^VW:/J/U$?<O/5!TMOG*;Q$&> 6$I[O?[1MD,
M$#//XBW?TP'GD]'B/L):@[FZW^;/C6XH/HA2NW7D<4\'5=0H-DU[2M#U7AU\
M?)>E#_XF5>O4]7>DOCJ0ND:(FT2*U;X"^A ;EV7UQ.D@5R-[ST&])]"T5FOV
M&L#U.S @4)SADQM:?6LM^1H@B.5,QY7W/J]PFKI+?>?/ _DC<DJE89W>??-M
MHCS[^@B]1!ME#SD1/!S\ 'G)7Z; @DT=8WLP8XO>O;R_"RN(5W:L884U2,RW
M'7PFX'8'2BB9SZ$O3)(.VS&D\S5S,DHM32FF],,C=Q1NG[N2W<1H%"QM.B:V
MF%ZTV:,N.W\:+=Q3J!M=RAZ/@EX*3V%#NPR"&,?L)V!9RG61++%.1HV2C+<R
M<[%EVABN$/,_]8[>+@LC!\6CD=:[ID-IE2BG\\I2D%\^BYD\U4*'YY.(N_>.
MVT^ QJ/CNWQ>40M\[Y:J59U_?E>Y(WPLN6\Q2NV1W/0+G:YNM.?LI$L68\ V
MO<Y43I3H(FL'@T\IL>=5&0VMCA]6D/#?A,?H.K1&7[9C]VQT'>@Z%,Q_]C\5
M31CZ6MC6-'Q51731]MZ5')KD!A8^^_MOQB.CE20>.E$/'A5=_Q AU=^*[*!E
M5 +0:6PE6V]4X&'2&]TMJ=J2SXH84<NY6U:5&E9OU1CEU>\=$'JE0SNWY;2[
M3HV=&^$9:B&]BU G51[>VL>IPXP %ZES_4'M-G^&&D>*BKU,^LX[;?3E3C9N
MNH\.J_"()9DXYFDHE?X.8.BKUD)@E!@>1?@$H6(+J*C>%$"O_[W-R TPZR'Y
M1^OA0B)C4V173(SKG1C&HU[YGA/LTEUG*7?^&JY&VEOYI*F-C O=M%EO#//2
M9M5FP972IVU-Q!^\8RC\5N-W5_A%9)_0TNT\5Y1QEG3.HP-XK7Y,Y"T4H?%P
MTYY*_6%RJ# #$\1T)-RZ-$>GQ;[V\W=!Y+?[#WB]VNO6DK>[ 2P+$=;SE[RC
MD!M33DMA.-I]%A70E,CE[;ZNKX93\3$^)D#;E"!P$7%5O++J\(4HWG1:6YLI
ML_:3J_2#_>!L)GZ<&)A4+.RV&!D3LD;L&0M1+$J5V6]=1-)FOC."]0ZX<M]P
M:@<B5V#AU%0Q;\!L%D;EZ>O]Q/+^!R*C#R>W@J44B/NK_W[)X0'/X]195KX
M8H;#*J"I=':G8>Y-+$Q_AE"&G.]W,*=%'YL85DU<6I3T5< +?GS@K_AB(*/V
MQL>V/EY$U<X']OR0JGY#D>%R^ 14AWUS 9=9C@WZ#3UZ?+@O=!'DO0#A<IZM
MS+T&F!I> Y[F4+WZ/WU;O%)P^;1=D/)29$K6LG33W535>Z5%_SCSQ;!4HMC
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MRNS<QK+MQ$UFN9-\MYH!5WNR>;74[[5CU26<87%^=G*?/$!]UX#E2@2C^S6
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M(>>1-L$R.+Z9O,W(*X/BP_T#[;\C^[\#%O7_"]G_"^Q_XD("*(D(;A:/B!8
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MJO55_UWHRV4!8"BO',U4A+)9$KH4WURH4;BIT*8\/G]<:<9F<D\QF3,OWF,
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M_%SCL4*/)8V/CPD8L?0W4)<,]E/.(XLDQ1N9'@^*>)_WM29O05BN 6C+P/&
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M=B@*!@LGQJ<)O8*)RH9)FV::-EEO+CA3L5"2BS[ZL9&^TL%UX@MOF96A,AU
MQH3;WC":>.X:S+8>]J,P]+41QG8(&LXU#WX\E6DXXPW;V\LZ_3J_Q)P2W=I,
M*APFXJD])29#)3YG6']#:8M:]Y-D-ZMN 0HI&HTU ?3_)S.S3U32+<<;Z128
MSJR[B7X>/+5 JDN]5GE.G&]4"N(:D%AD,\#"ES\UQ[T"-BW,_<RWAF<L/W4E
M4!4F%\@/H0E9KTDLC3>O% F'^.[]_B#^(F]4@U1W9-QMJ[9F"U^@8VQGNV:/
MY.D-EVN:,A;(GS;M0A8XA5I:\,:G=CH8E+AV^MH5\#!HW7L9.=58;L9@+L,Q
M.9#<C7[-H)PMG!?3/MNY?U5A,S6W41#3R>P&;!3/P0F@[:%7HJ#X7CO1R7;]
MBOG%9>3.X-AJWVMK_2:&.]X4/R)^6A^XI@34<"45-)8/%-S>O@8PNF#+4QH-
M-/I6:8XZJ,\68/XE+6$V-EKRF3+>A:(?.W^35NUUCWJ\+@B;M"^ T $]:5*
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M$F>7B0HU .K/'.\L:LVPR'X*X;B_S$U3)YBMZ3#5]E)XC5I*AYY@$TC<2;4
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M.8LZ.XLB5,RF&F%()O0Q+*&Q(+&3!FN6O/;W*+B&3;UYAG/=P.1W_(^5D&M
MQ9-SNH=','F\QKD06 \[NI'2;A]6;&E4,UQDO8DTBF_WK*5ZPX*06WK\M<2M
MFA/PS*0DA7 !UNY62!,-/UAP1=OWZX+-,7E0BLUP*APE,BT=4H[7FC/5O??A
M2S@N S1Q7^;#PS5,2NZ!"KL%^)\>TTM_0&$N5N8(T<F+AU.MI/I47GYNK#9F
MG/7:CG1^T2RJ"GAICK@)GK%K0*-]]V@0>GP %MN:^JGQ#0BBZZ4N9N>D4#Q
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MZE2Q]>:'-[]%] !QTLM7S:01AHISZ1<O+G/ 81@N)K!.^[1,]2-1^,@U@,;
M93R8U4??I#/865DRC6 'V8DLB@ JC._*XNBF^^5//3W=@]V=,)_D#M23]](+
MFR9?9.B^[-X-^A&N,;QG7^3QH-!D\M__#/1_M^"2KD-?QM4348-K0.G;N=*Y
M7/UK@ "MUS7 L7_US)(*$&+[;Z?[M@[45BE9O_"B23C8J_%&6+(RHYJXY2(C
M2C\+L.>7S#G;K-1< WAJ8Z\!-MZ0#,1SAJEC^P^KT3FBOXO"=YMUCWRJ7+4*
MJR(LZHE8E W$Z,W*__.=]?_8"#: _[Y*_8$EKQ[2804N4QBO </5D^;[T%*
MV+\<-^_JBGX"SUA?5Z.73&GXN!;^W#$]X3GO1X*53%;X[(GDD0_SY@KWAZ)I
M&+HM78U7.U]RKJ(F2MJFJV_QN_A1<@,E;HSQT.&)-S-1V_R<<?J.L4&+IER
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M*!@FEN&C/)79/4-*$+GUC).+^X/WWO:#$3R\WF0/%))*W<\-ARIU.6O</XN
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M<= $[)N'<#I\.Z92BD5T.-\:^W=M&$?(SY$?OE@;?]P@ _1_8MB5W^ 6\'"
M #='Z B4O$(5.J"L(ZCC\RAF%PBT:C#.$.$#O];?=;G<=+)[S.Y 5>(S@%OH
MF(7M77D0 *^D5FU@X&Y$7UB@W+M \4TO^CYE=YF''HR(#F\_Y79+=IV?AIIH
MMPM[\,'C#O:+/&"(35A +@IKH6T,2G_W)67N6(GUM\1B5/C4JZ=TEYV#<K3=
M#Q05;78,:>6G6R6+!DP+K,Z;/R62:BV,480*LV[ WP,$/+,),O]@VY!:8A+0
MCE=<N- ^C]'V\&.]48?2IR=499[4Z]X/2C/LF *2U&O1W^"2A_KOIYE0#-_8
M[K[&\6P\V!65#7=D$97"8L4!=BOCXK06(>[R3!!06K]N I?YTQ@1*V[[NF7W
M:UYST5*ZG+7:@,F';MQ!D& $JQBC8& [$,&(@2[M[2"J77VDMY.6AXZ3K4/1
M[ET?T(@=!1^K:G-N.I#*.YCI:)8YD1_U<V(>,#[R@,FAQK(NFG'*K4H7^N_>
M_;3A=(CS7]1OE-33M2@V5L*B6=_\X__#Z_]H^T?[6^[0'U)X#%4(,,V- DHT
M[*DM*>Q=V.OZ'TTPEY*W;&GD\2-;#U#*LGI:4IN^9DQFS\CO 80@="+LW!^S
M-RTEJ>0U1/AIR&FYC+["AVL#/0+6+,.!PH<L=&<'& >G_TV9D_E^,R?L\VB-
MD2'HZ:"I-1S_ 7^@LM0',:FG-HQA%4(V$4?"^,]RCA\9B4'8EUL4 >L4;0KL
ME7G/!1RLW[I9'A-C>GP'$J'!NLC8-J_X/1HB6^9$\RW$\I>O=%XW'<\N0#.-
M$]SMS!ZXKPU%+IGG7'Z9I$R=LYR EIX36/PZ99GZAGHS9_]P7\(^KHR9[S:+
ML+V4W/1;V=>;@:5^7\=3X9US'0?K)_%+B__5C2=^2%&.\:W!*9AG5QJV.7T3
M9\H?63X<6UA;TO$%UMON1WKLMN-H1(&.\*Q ^ZYEOA -%YJ7&2_9W7)D_+)F
MX94HKHW)LG]HR!=:%]7F_";V:%OC^H%J%*NUA1X^%\%)0)^GWT";XBK\1QVJ
M+2.7_G6"J70%T2):'\CR>#(UA7"18@)"B,XLA"@C@]G[Q6V/A$YC%SS8NYA"
M.HV5-!UL\E$:2O_--Q9SLR-VM0;6"Z6^,:R"N?!%9_$@PP*.>#)=):7YM&(Q
M3)EYM75G8=C$BE@;KJ->' =GR/J+3AK;S8/5)Q %U)OA=X_.8:#E)9W'O7E,
M7]/X XE]V[AF7)<95GLE>,Y3W3L.8/'2K>UZ/;:?GCMXT]&@QOU!R7&!$/7R
M&YI)E^T@.:1Z2'9-2U.3P+C :%NXWQ<B8D=9ALW_<JG_F=!(_5M"PRBRP\6'
M:ZR=SV]0K1-Z_D+_'L!>J0!NEOGRWY;,>>(>,E;J>ZB]G'"]=.>^LBLA1WWY
M]--(OAAK([&HH<!=!H"Z^X9BE#,$*Y\0IO/+?EJ@9:F0Y6",<?"KA7;_ ;Z1
M=[15]5,S?I:@$;/HGV*Q3 ^[EN.=#R/SKMG^JG""'VZ0VNM/^S OY4G$5W,,
MR6+&B_V>:^V3J.H7TU^V02DMS?2L/4=N\#-,G>V.S1U2 ]&$1?M%[Y;^X-33
M\=!')Y4Q6910$'+@/"9FN:^^O*!Y2?>23?:D 2"@NAWO.$,,.@5=7IQ7H-,1
MQ%AZ5FXT$E&6? +'*[4FE]I83., )%XVL2[:"L%Y\Q9.*SGIZ"BU_4QBV?;D
MXQ<Z 9%9S*!#0YR\8H5"?>HMTNH'.$]#-NVO-^6$3RZZ[:GWO,QH=**$]?VJ
M=V78DP;;G[>81A[0E\A(<F<[_S::7%^EMUHEEN)SK;#67UF@PU8.!2E*D[MM
M^?/N^'+\0-$(_JH]\K> U$^]*MHQE 6&V.@DWF"@.PH@"I.%5?6A-FK[ (+X
M$;FA*C%C!:_9_[T@%-OM/.AR;SB8;-ZR="W3_;WWMDMM4TW*B +_>X)?)QS:
M5+B-%#L?_GATDHJG80C[GO"-9%(5._L'7"^P!_W-,%;\I8GF+!KK(U6>>ENX
M$DP,RIG)A&%%QWVT!OTM7HW/()B:>IP ^P,Y*^KN =B\:,P":]%FV]\1PD^=
M;02[GOMU2T,Z)?BQ+(:Z-AALOM^&2=DZHLC6E%$$5\GGY13G'67#-L[%K3'/
MZB6"5V1OMT>RE7Y@ UT 8GW&>]#JW_VTRZI'B-5S*$H]N75:*F&1/<QL^%$*
M*Q.KF3^1@ _7D@PY&FB(Y @L._5[C&X_&0#5\K&HE*\N#F#5X#B])X_;I)5[
MQ+\K2^_&V<=##DC>JO['^-(H]5_*)'==_H=J4 5G6_K-UOC74:Q:SW04J;$8
M'@IOWN&TI,)3(\8#SBCM#])3K&II&W8;6-NJ@"L&FSY*4VW:C< (9P])H^G5
ME["S87J1@Q_>;M[YD0@\)4[4QK:#\+@>:/K-J*^,4DWJ^RVG[IFH9/'?G]R?
MU"<:Z<":;3U3VSEN@%.^+&CM=?791(UG0!^Z'_6PF$XQIM.;_9&;IVNTJX'-
M[- *M*%=7;G WHJXL _O2QKSP?%T(L"FDZ_1^DK#J3W-*FO*'1G*K?#J31%G
M7VR=-=G@;-X K5H)/KM$D<%I12X?"=H;ON%H!>J(>JKT_E6HM);'1X=L8^SN
M"B_OM.*YX+Q1;Z_3%^6I",O9<U5>G5FQY<*62KZ?.P>GHC>B"$/1OK37$BFI
M+JG:B;'47B5'91*A]%U;=5S]OFSZ5D8/?D 'FG&:LQ@;TW%T4P2%"_,U9"<)
M( /7^X&2L^"PCCK%($0,<&2N[*A6G.4I6_-QEK[L0-%O<DC3J;%,7=6VT'2-
M='?D6JLS*NP5,C7@J%7)RA&G@<#X8>*8JPD+?R=VJ(/T/O$:>,#R[H6<'_F"
M_;GM;19U NLJ;8X8%BD&[D( 0XV""7I<MWH"(NWNYU<J$V/SX+=W8W<*V)A:
M7_RTSPF*T^I7A+Y6S=J"]>K0]/6^UK+Q_IH7D4L;.UWW5H.%[D26(4Y!>\:5
MUN?Y;(6=P<"C,^."#EF\[Q(<D;4=CP5C9+8/:3%8+^WR@H)^8K8!;/XC)E5)
M P'0^.?%:._O-AW4KOK#]L&KE! -L@$JFM205B-N;K/.G?A[ ![]_A30)"YL
MNYM2AK<5"N^(E2+T]#(AU5A7=W05Y^T.BHG&D05[78WD)@WB(@L>469C_AWX
M__]_L=D\0P.5@GSY;23TZ5.,GH9;:\^O>>X?#W6\Z[JQF>$*0C?!6T8U%.IG
M3[\L5U@Z^S1/$%4#@)Z,-WA.,MDZTF8'A0VQ'=MHAG9]L6L5DSU)Q>^;'1:M
MX"$5\-"VIX*IAWS?$U\!Y&%*Y4=X=J/LHG>>'RGT)9$BEWF#N@I[O=30EVU%
MNTP%\\RT$SF#CEX;-:[?!!H4IR(PO'9V/*?O/3(?3T(K<HNM03C?RJII;V7F
M3K.[T\.U7Q-_CC3_9*O3LV ? 1&527 F<+(ZZ=DDEP6\C159SZ%7FFI=U)C.
M0<FD^R&'^Z^W6D(P%XPPZRIYNB[9Y&_/=GJ@<VWF0]V+Z@VZ/#R(N@"G5P[9
M"HS^%38(T9YA8+C$RQZ6=,.7\ZV+DCMW-P*^].]/61JSB>S7=+IC*.%;P1<2
M7N-LFQ>"&DYRGQ\XY $ 7#,VP[[4^R#?L!)@F*OA\]6>+';\.%YFA;8]HD19
ME2Z&TAF=DK]'W$8\*,I737']?L;>'F?Z<>2/B:#%2S*PR1%5ZOIU7,S?)1I?
MFWH<1[W5/6"]]X!PWR=3,L\\&%:N>[T^9)RG4H(M([T')W-&6&B[@+P^.YBP
MSSP;M56!>'8,>[H37!I,&/E,3@, @K2JMXM+"NY8SG+,HP21U*SRR<9>)-XS
M7_Z-+]3Y%\K9R_"?2>D)W(+_:9.Q3G]';4?W.*U'):+%FN8/S/FNZ_FV3*L'
M_TO]@":QK^?@J$^R\GN&[D:4KB4BYR>'Z4XU]UZ%?*1'\PLM6V&++:?Z%:(:
M%*5_[2%E;SS[CPZS" Y13GG!8$"#V*?/%VN1EZ+G$6@5A ^PC\:U/L:[#!VE
M&OF")S=SX]M!!-#=3>;W:Q$G_G'K:[<D"JH,.GZ2#2_/3#V^QPBGS^]ZY9PY
MW(?.6_9J)Z_TZP=&FNM+K1#0$!J+4"F?0H\\Q>:&B(=S8UFP%ZE&<<W2\U1K
MH8!KV-@?9P@1-($/+W+YX:&K@22Z!MDG('&9L7U.:081%LO^%QH=JK?,?1;6
MOC13PI67#ZW<=%;/3NP2_79DYSX@DZVGSJ6NO&PN[\+<=*!KU3<]UPIPGT,7
M+8/F\S>B8/1C1!8!VA1YT2>#.476:Y5C:),[K[ \!O5(:/([C[8/-7Z!)[ZA
M\PVBGM3#"#B[UK=_B XSK,Y":>F'NUSFIO S'!6DE^R'[ X(G[9M=T$?@-MW
M6Y_F"GI%4<$N,8QL4%SG[R<@[]S-KQAB3/)87Q-4VCI->)9"OZD^_.JR,W_S
M3"?VN9"GU<+>LN$]@+EZJ(G"8&!QW;.);63!,3+2_FYEWJ6::\\("XJ ]JAY
M[X]'4CKMN!=7E\Q\/LR3[412Q30R1;N6Q06"<<Z Q/I+*V@;Q)-O](>=_$L*
M%)&&API.&%NRBHY9F?L[?'@>;JL]1M33IU\_PVL#YY[2=)&'?C#PJY7ED'8.
M .V2*JJ\_\#12%6I2KEIL BECCCW7?$=6&NI7P2KUR[6AT5"%*?NGJ'MNQ92
M<DS7J>KTX'% B]I)K6>J%\^[?@7B2G-]NXV_44+<FMD\MCXQ7+&<C)G4\$S4
M_K@J4,J@X:3@0UG\*T9Q<DUPW([V#J0_^'9@(G(,>0\(R48N-"\NKXS26ERX
MZQ REW"P^GLYJ>N-?+J10X7=/*UW6);)^V29*!:MY&PW)4CJR6)3"?#642A8
M$IZ#$O1OT8[SNW//[=91,003CM[L!Z';UJ+XJ'HL&;JO;'[IDC?61(N0 04R
MXKFJD1695OF6VO5N(HGS^B];M*A3B:3'.9)D&1-6I&_+@%;EHN<[J3W:.A)E
M*@S5]2E9Y/J0^5&+5D"?XPF.1OK(F))4M,X!*_<A*36E3;PHQJ^+?!$4=7"_
M\(GL J/E$FZAM>H_--UJ?:=SF\U[VN:MV7@WT' /"-90AS$C;T<W4KD;>"37
MJ!^+''(6?"%Y\\;C-)LH%7%Q$]R*=P\PQ>XXMC[]BTTV<D2YAIV'!>CGQI'H
M!VJ\B5EI>VC037'RG)B;\![PXM*W_0N&, 55EL!>.LR9L,N=(&%?G=(A69&T
M_\/8K&0HU14Q") 6&;[\$BMXR%_18=OAKRO:(=[G]H:+[K9+@G'@ H"*PBO>
M'&8!MI>L8O*-D('%N2#7ASJFSTV(YB3#AGR("P!J"HH6T9(<7UN2W1\WFA&#
M"YB:@\,'DXF_7<B8G/A(6SX /2=S?ZAM+R+]?5'WB IWXGHZ&A7F*L!I1OO5
MCAIS9@+KR_N7>T_X$>]EC(=,PD9/S_*O#6CQ+R</"6O<4#$KT#\R)I6_6'I5
MT)6 (9>"'38DK5' U!3QC5PYN''(OV>+(6_.7RJJWRVMH<L[1K_/E[[.4*WG
MY*AQIO8=>P\Y]&2!;,+L=G.@L0*\1GDH77RCA?+I#RFS2G%[/2DT-[60 @ H
M?@@B2QI_>ZG3L93.=2W.G-$C73L?,CEH!D&^/P>JGIS=0N]HY"BFB FL]E-.
M6#^.-@O"0I>_,/10;(V%>,Q$%ZM.[D%O^,^_&DQSE0>5*@GF;NKEYVE)YM<W
M;ZG4H<MI][RT;1+MHXQ(-)[X=0LLW&;/77R^?FJ:N;J\'-/25I.V'=?90=2-
M&BC<]V6>(A)5HD]ID>$_J!CA1^M$JUS3K0ROG\X@4)_]?JD[;_-,JX+N 6[.
M_FZ'? D7->AWY3H4^-X25OL5'<C>S29?I?!SJ'Z_ZI,HQPN>RE6N*P[WI2N8
MPQECIL5>._-4+1_'M9I6[0\RD5^C,_L,)SNBC]-.3I"1+GIXZ-1U$I;KC3T2
M2 =XV?&/PQL^MT*YA]<=2MC2&K2@#,R9@FU$JRXG"(Z5'CWRP;&:JP1EB.>I
M_IX9YQZJ'C%G>UL9JQG57L'CRSO\VV)ZY1DR-F;=YX7>WES5<D\"ZQLB6$2+
MA-BF1J-P?T7Z^BI&H-!BHY1M/M.EK>LSA;93FQWVZT2_SDZ9LQ@X,# M-!U>
MSKOP&Z$4D=>HFR*0(CKY$!/CPG296HS1:/;GC1-:$O%-ZK&#%!!Q#WCL$9/X
M]KQ-XNI*1"?NU_,*9;$U:'?%A[U^NJ/TZ\D8NDI,,/D/5'\?^Z$[-=M^>>K*
MU(GD/M\"L/NG)T]L _U%F.M#CQ3:0:D^#32=?BK#-L6LU2I%*VTIP0(Z3_G+
M/<#]L"KHDI00TG<-O'F(2DE>+^?3GSD<"[*P(ZA(4LVU>A\H<FF<B'%Q6EGB
MRHB-UM'_==',GN#UZ;I<N.P->$=Y&UG1>U0!65:6<'9(V9?7(G17;TH@I;W6
M,])H+)&HLL_&3>M'Q?6.$Z QRE/!LSG366MWNW2"@MYP.2;O+*[-\4AHS>\(
MI=YYNU:V0OW%70'5&.R^+Q$$?V50EF+R&7RNO72*;S[>9O'*<"[M4JI5RMN6
M@$#YHB\=="5B*_@'?Q]8?<O:_N2-DV=%.%M6(MTZQ"!N*J[];B+H=;I:36/\
M3YXR4O&]<9I$/U(NKBX08650*U_^S@]#_*^'<-V\Y*_F!D3*]X!][9\M(9I-
M:2]RZI\LO: 5&X!)%S_XH!E)\5=-0,&_=25MLH]DD(B#5_;<NO=.Z=.N'BSJ
M9/($'9Q <]F/W(X^YDG7I 'V;$;9_HE%*X>(H<8:RCS">K.H4<(%P31;D?4U
MK0L&L7,G/1)-+W/ZU^05F#/..EFH.TMYE0Z)K1U^R5"ETS$XNA/Y?;W9P9S:
M*8P@/Q4_5/ZDB<<!<.5H@$WY,RJ(CF@Z9OGPCS)\O+H'G.U@S+PC*,8D[<3>
MT["O+.#[VC3@]UH3L[C0,VI VLO[EO-$)\O+]3P;=U+]A/(F4D-8&5<<MZCC
M/V\$!EM+]?VDWG!E^ +8>Y:KP$3B1*SAI<'OF(&:%@)</6O_N!%]+'&MR?IN
M8KL-(!%I\37?0LIE%$>!^F?_G\.8.X6741D6T-=OMY[M.,L2Y7[]FZ!UO&=C
MDE<?_>G_>@9(0_C%&WC S-5?Y__&A!WGGU R651J> '<, H*/4O'I8C:9UH&
M+LG_B)!EC1HWRCI=<_Y[9M&(O_QN/)5F()R/[-J+')E\5_>DS;5 .G8_M.DU
MI$3T6]W;<"W?EQYKL)I)689GJ"!X98@9"AHHO"N$CR?\34K^,^@2CJ,E^YD.
M5F   2*73[TF&B<.V&D6BF=Z.HL. Q1QTV\/B,0KE-:3CW=)T&KOTVA+/A_4
M#7M6,$Q-Z:?$R-A_S5<=C8-H$2\H=7X\T,M4TKP&IV[=0J^)-4]$+&CK+ZG[
M/<95 8?K2+NP)R46)>Q)E@WG;J']*QNOI ;+QP1)LX8[$=_ED.O=<_4TAE^,
M&*?S:J:.?.<_/5@L5K.JUO@:Q,CU*6+P3'C4K^>EA^"=KS#XAL0:>!.G="/$
M$03<7O]P#^C"R;L'#)YB3"_=2"%'-^OK[&6"3+AIIB.$.1>PF5&A+\P8>Q5Q
MP:K54O0Y,1]<^?,7".5L93H;9#1/L-N=-RTJQJW7[P'P'"GJ>P"0IO+NH3#C
MG5+>'0U9%_0$]?T>L!;T]AZPX078+?>E]_@X-*U0%R0[C6B8_"1H5<76'%+C
MG%%KBM;@2-A7&.^)PU_1LYYSWJ&!U#?7(O;N*!NT&K0"'WKBR)@/TD%5M_S^
M[X\YH.UJIMU+E4BR$@F]VYK057<R83!+61>+B-/*R)+>:ZOL6268E\_IPPDQ
M(?!B6"]DELW6VS"^!"\/GE9H@1<XNIZ@I*I7K!W[_6LD=R3\/V"6L"XBG]5W
MU+H'V)>O9RW< ]XV!LHUL47)SU#K>@7R(!4 KH(W(LCRL4P?$[ZPVNWJ]I9K
MG]$6_8J?%:(X)[JFJ4L8XP:1#7R!M=1UTDIODY1KO \59_2,#*CDO,,!3(K;
MZ-2DKK,*^7][%>"_O&PVT7=8IPQMM0]%^:GD0WT%Q2CU9P_BJDH!U*;KFU@
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M=E;X\_KY#7O*RA8NDC<1:?!S:Y2,A2(9??G5K@O(N7'UZ"PR=.\8G^IU@^"
M/8G8*E>(P:TZP(/#W\\<C*GQ'=V]KHM4:#^?S<)7J4@Q'#=_&OR]5-!LH/5G
MP#1;VWY9U+D>^AV@YC&:42U:+[!^\<- (G\#W@FDU;%/"#W=5W4W<<Y UR1A
M8$32.G'TVY9TT27UG1IYRIY90OBCTFL$A8YX%^LIYNP.YL_%\_?HU^?'G2O8
M4R"\3R<;X7D4G@)$QZ+&];+B^YT5X'YP#:/_0-0-&UM<P.$?;-B62 ]23M&J
MUH_2.^?N%>5DY?)?LF-N]Z^$MK-!WJ",TA%\M& KFEP]JRS"P'[SJ85)5L-7
M(X8%I.+8,UBRE"9:>*S; ;+T9G[5L.[BM,FD+IJ/PKF>;IL?ND(<8TI.('ET
MQN^4#LJ1&7(;]X!N_ )/&?<%J;:8AM&Q0_3R1<V8UU;;!UJOH/U1"7\IB]Y[
M0/7O'L$<&Z<%-*-&XM76[&0]2^K7$$FYR^IE#]RY[QZ8Y\9H-P@MW/,,B*7'
M7H63:D\7(S'('C&BLO5L^-,;)9:%-HT!G;3EL. ZR3@B^4\R-73<<_O%0Y.=
MM(R>D:6DN 888_Q])A!\U)N2=7"P+P5,N"2O<=:^3,OFFTFT8LS3,=7B';$U
M31R:NZ%5O#DJ. /.5/#;X>U<+(<GKX]6<(YHI;92-.9-X:]R#X !IT64_OCQ
M@]OC &/<RW8[L:TV4-IU?6;C<JS@E+\4KL+M-RG\>P"^&M@[#FLQAI=>9(P+
MS_#3<7Q*ZJCRV %1PA'FI/-"\Y?;Y':R 8I6M35;'M.&I-&0!XV/VU66\MQQ
M68^EK<-";Y00BWS1/SR<]GO?>F3AUC:VS&8':2B;3 78GQK'=KPPI[--^%I/
M'0KH\Q8&>+Z&5C=T>VH=LB)YO^RZ.3N51;\:H+J\LT^/ VWZ,M^-M&/'@HDU
M\M#LRQ5$)3;8,_6YAHB)/[CS(^VM$2X3*O+J02MT_:ARG1C?PVX;C-PJX";9
M/3_D^&4K--/D'>%.X%EV.?^0-LJVQQTW6O-!WS4WA#.22Q?6>05B*[4/>-E(
MTB#.=0(I2IJ>BP!^ @=/]3F3H2E5/(Z@(YDT(LS:ZULF+5M21!H%7HI!)806
M\M._YW39]4L]MDGU17:@3J%#9+-O/&22??VEZCK,&4/ZX4=^</SIF)Z!3:%@
MF2V-HZ26A$,#]^[*>>].(#)<S\_6@V9.<E^MI8/)D#50.6DLGGVI84CD\5_-
M_VK1PWW-?@&MPG[E>\[<(FZ.WZBJ^M?GE9K$,/>-?*[%('(HQEX@H4?H?A_?
MQ^:"P@9'Z_HY+/)Z_^="CE581\:T6W:'&0Z<F)'HG]?"-Z)3K11/IZ4H3.AJ
MK)_\?MY%%]PDP&EN3)L4FW^EXWD/(.A"5NL59K92%M9.<R2S!HM;_$U8X,!,
M"S*K?:&NJ-?'YE#4V-.(H*'%S+.JWS:DEO0UWI]8DMYYV:89Z1Y1U^(74%E>
M$8; ][&3%"]2Y^N=XDY=,<9]M"D1*X"#,:!)"'"<]!TQ>A"%:/NNM.;]?J)<
MR)Q$H"SW8:% <??-+^WYA'XBP86V@9X[ANE6KORN0BOM$@O3A\QBFHF4'-(_
MA==$L]AF3AG#%CABRMJ?KMCX/NVP,;U-8.EB*]BH?MP^)^FJ.:BH&E/DL/A3
M"C8YV!=/*I(H_A?*_(>-JX]CR;/>2'/U<\MP>5CHH.,\B_7T/1*WM7_4^O"N
MJQNR?S![8'@]]()(48D 9XIK_E=\?D#2+ICI!@S51P<@1*=;79HM@@\/"DX^
MKR'O2BR%0^* K*''\NVK;H+A"1K7YOXR3?5?#?7[7JBPD'+:)I9H&YRS5)V7
M.)[=[$OV6)? ;X6U5 KE;*GT>#E.\DUJG:;\J,_L;FU4_<D8P6/1/GX2($X,
M_K.;G0'824&NOQAQ.".)T")U12L_=DIYA0VER.?C7SLI"#V3D"XYEM1/"MMB
MV-6.4P5H-00A^W7/^JLJ&W2ED(*:?HNT-C'['ED#5YO2D),XM@IN5:D,%]JP
M )VG;6C(6\=#ID<293XCY%U?GZ(<,*C4_\%?*CI0R50'0KM&R-6%[W4.MFIL
MZXA7\_3S<9A>,GA!A;W<A@L@P/BEB:L45[FM*-.1R4,.^'IUYV*Z?SDU*8OW
MY^#[NK:/PSUITD<EQ6,\G[GA5MO?JE\R1R<-2.-:M[T_BV$>!T]5"BV_Q&ZN
M:HG(SJ+<V>DA(%ZSQ!PL;^?S4)7V>XOZ=&(CH7X ^M#*H3K#':TU_!F&.]P8
MX>1>8B4K!N3<PZC\%*J0Q9K@7-=I I4WX MO?^CQKF^%?,J%T'QJ_6W=U#>:
M,81-$_:(PD,6L@=4<<ER6&O^ D1<+9%L@:PQ8A\PE*;\Z?\[Z8V\48((I1 7
MO<6NJ]&5$J*B<MT1IC#U*3X^,X]!SI'VU[QX!MOT7HZ1IQ)=J+A ESCZ7;#Q
M["'D5(FT2X!?I;R T4TWGU% [*#SVH55$U<4J330SHC:#CC80.Y;'^OJ%=>1
M[BU\ZDMJTO@2SZ9 ./U]PX=KXB^U2$:;(H_'X?9!GR'BIC[>)7(VC5'E"I/;
M\35/V(:^!SIY8Q@: MAQ.[:-*!'CL8R$4GH5HW ?_=YCM/.'B<KUEC3\G6@"
MT#-#V<NPYWTJ@WL/F4Z,]L$\-UZPRK/5")%A.)1LP8 WM&K4I]#/KCV%)UA
MT*!%)8#.OW^G#-]<R@+3%>##E;NOS?!TJOR,7N18<A%O&J+S6.8M;(;F)-.^
MOYUR5DH_WT93H]*:0U'_:X/E%=OF9LUE"Z:Y,MRX[[4/>5:1<!&2Z CQ!^M3
MAA[9U:VB53939H#G7ZWHWA YR ]B*O-W.LE\MFASA)+? RRQD5LQ998-,HPS
M$&#9TJ^1%'6?BIV4S]0)R:R&5Y&-M#_<,1(B >?$1![I:B@CZ/DR^Z'=X075
M+_\/"6'8>KHXVO1=@,C9"@OX=Z,B?PCPM@"XX$K\H^<\8@3AS') ;<K$"@3V
MXHV7N_P?M]5@G&@</H;S$>K=:"(S+Z<^'];YD=3.I3;754"=O4ND'+J-A'6S
M765TQ9<V2)K>SAY+.Z_-)5CD>O#SE&5M*<M,LM@U3V]70S(L+IQ)5^/DC?A1
M8 1V1T0['PC]>GG1TO?9M/ @MXM^WG<5BZ>AB+Z"%'--08E-$#]-?$']1K1Y
MF\X:;L21E,;:]8FS$"Q)U[H!Y V6AC='_AXREOIE]CP_AS7:N2X9QA,=3_SZ
MK]*I>-3O[D-B!%%R\8)1[[FHZ-S6G.&[-_.$>[V^Q]R+:@!%.8;@N; @"*L4
M;4$%E*'$NWA1D8))K>M1E,?LRS)+YAB )F"=HD,!0*&F,RETZSNR8.TFLA!3
M\C2:TJ&L6%D<U^:!6"7[;9Z,I/4JWKL>&H[@5OY[ %Y8+.2#UYR$8C+;1'W8
M\Y"--+V'DF_)S=:A1: !M#OJNA\D&G9CZHT:Z-*$B(?UO"T8WG=S#_VMWAX2
M< _0^K5B\#CP*VNB9#PG)JP *9/*$54[_CA\15K^S8_T-PVZBY_5",II7_S"
M$?SZCB$#)@<&CE\[0 2JD/;A$(7BT7(K_.SR6EBS>4&^NKWO#P.)?,$R(DRI
MS[J0X0SW+D2QRK4OA+/>>^=H \46G>;3RP\N@(79LXB\58M[COA<])/LR(!_
M.Z$/X,-H0!PE\PCMW2_SU!9T69DG6/;,Q\+>Q;2^0]>@]:7+'4]^PTL!JJ!X
M1P/&F'N +3CT#@/EVP%?5JG[67%*WI#^KO''9%%S?6V@\:-QUJK 4BJL3W&O
M3Z76U1"XAZ[(=?A8%5&FCU^QM8!/J+36D2VM>MHY+?XS(M(M^+H62_1VH.>
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M?V[MGH^??VE=IH'6*@+T/*X["?R)037_N]'20P ]-A7#EUK-!\9>VO2_ R#
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M)EHU-SDR_"J,MZK(/Q!G_2-Z:47<KW>G#X>;U0E<?/=V^8Y_5W>$S3.[\?2
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M[O?R6=J-1U&&Y(L55"J'ZR!E*!^^9DD(98H^BL4D@OH%V1L4;\B',F$UZEO
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MNCN!M4H$*:T2>)R/O9M)2:+1TPG>Z3Y8S5 4+/!/8*@#%)$E^'P7C6A"TB=
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M-*K=L1@RNSB52* 2W0H7EUD.E[K7<WM-)'LF9W"X4ESP<)K@CV<I#/T5RM:
MW8U1T'"\/U;0G+3/J_N]:U25/S_D6^=;P9=ZXN3+ D)'R?@F#!,M1,;(E!G6
MI5&Q8<G[LQ9Y)8233;' Q37=W9B5(3567_(1>=*[<@53U"[:-$Y=22:V-M%F
MMOL7WJLK*" &4;MV,+UJ8FF]2HUK,5"Z^_I5LF1$WN%!= S0B01@PB.Z3_7@
ME?BRWH:&T\=Y$B&OSO24$<1AV>W,WWG*&<;&17S^6%5FUSSA\Z1004CD09W!
MH?VUGS_[&&2#!:3/"R(>U$5V]S-\7SR)XW8)9T**D_?4 E$1Z,LU.,$Q$'$R
M7(;:"'V K80XGJD"#ST8E[PO5/03J^=V;N.V0Q5NX2@+ZY"["!/$!T'4'_FQ
MC^YZT.DNGML8P6YU86(GIWNLQ':C9A>4J]-FCQYB%> ]=;@/PH\,)X_/3'QA
M#;?'(G>&X*Y[WL0:+P'_X[[ ZFZ, 0D0KX8I&B:$(5I(@+&67U1T9ZRP@1*"
M! GPF5WHVU2#50RQ![[G"J,E ;8H+T*<[5I 723&E+U_<?NRAYY!PK+!W01^
M3\<QL<^5J)6:RZ^+YS:X^!(>7-_CJCBJYNIV (XB;^2T<9X9WXK27A(TZ1P/
M^$9.896<U#=63*R@C5,HA4N='6@8"[+Z<4VZF'Q_R[O2X%F:U>T52][O_5LD
M$^[<W-#YI*K)VE2;IGK^B[K<XK9,E^*>;NGLB;9.EO^S'PMF;IDU.#&M7W5O
MQCQW:>T^7$:]^>A2BD%E\E89<[(*H?P<AVN"KY_ZKZGK*C_#F1.'2T\"C (\
MVWX6QKFI?BMX&U[LQ#*?ZS"P_$]6?@$&7VN6C''9SYT43BQV5.&:9!"JI>%8
MKPMZR(CWG#*90,B*-.KYHV@&J+E3PO(*[E0?H?WJPPWA5X7-AE[G 080&EA0
MGYH7%S[)1-QUSR:<I_#M0,M+P2+^T#J,XRO^RVPLVE$W#1^5;]-5;FYZJ'HY
MSG1*=F\<$BMNW/2W6[\W4)UE974P?N!V0>#BCDRYL:9Q<"$97Q@WV,8J6I.O
M/5G_C531N$)+/3)JXE/&V \:]Z_"@6.!CH$/'CQYW7)!X/SG;V'[8S2%Q))^
M7TO7R3)4VO93)_M@L[7/S:REW"&"J()BT,DQS6(=7K$D -\3G'OZC FZ\2GR
M%UE# ''RU?,KBI-G6@OBJ?YO-_?)Q[(W"$I+?77G;ZM"64P#Z#4UF[&2E8)Q
M>V0^KVB,MX?O_+D>]#SL&CX8-SD*8\,_\P OR8?2C[0^9*^!O+*)>RSM G=Z
M;I+>S?^TZL^+O>\%<&7A*S@;3A*@MKY!L6CI?:LM]N-Q-Y(:)UV<[9_U<0'4
M+XJ^WYE-[O?,\3+@C)$ZX*9WHU2@?RI.1@M?$8R5Z$;QUPA8=8[E6O5,[MD:
M)!?T4WY(E;5WOI,XB+QT>-60_Y5^. GP(CFZO1;1)T!G@6-*EF>0T!TYY!3D
MQ-IE#1Z=S0YG*[2VW!\*GW\DK*;CZ=BX" C)@4SRNEO99,PTU,6)&YD&*([3
ML(8;!FBPT^?=IU)8 K$?P.@AIX0Y"!BCVQ!>?4 GZ<;IKQ04LAUN>YOQJYWU
M'%4LM;*$(GN8=QI#D- V (CN@>H!+G:.+J7R14?@WK8HM*8$RHW5@40?6>HL
M"8@Y-5ML9=$=L?=LU7^6?=]XOL*=R;>__VHR3#,9K[4T3 Z5Q+OYV:OU<C9/
M9LFG;U@AI=N1X5H!(HAFUWF_GB><6XT/P]2L3%PQ0/+-;,Z2@+*-4\$OI:)?
MQCU176B^-R\,I%8^:VM1.3+W5X\-<^!X755!T:7CQ9,')4(TODSQJL7-0PF6
M)9\^8?9FMT8':"LN4;S_"D%]^MY?ZL8'9,'+..#C<:.S2PD/M$HAR(5N%#N7
MC?.7J,D-H\SWTM?# &2FXO>,RCMO]K!-AJDB&%Q]+O9I65Q(7@D&R 91ZYQ2
M%8#'*)A<W]CYN<TZ>>(L:]L=("GH5ZQV[22#7YRQPX/C< :'"(>RY+^XH11S
M8")FV/IXN[9"VH_Z6=R?)Q2/K=_1T'!WV*TJX,3Z9<C 'KC5_N-L;9@;7K^K
M62;:ZW#A<C$/[^&'ZYC;NQ1"O\5=[]I]BKSS!$+5.-$*QM9I*F[D2>!3!7-?
M+2XPXUU,DSN;HRH<5V>,+O//H683W] ,?DWG/IF6?<+_DNQ(,+7*]?0\;=XU
M:Q*56"1W;<[&^&O?O;1/Y#>$KX0S%7#X(WU)@'"8U$?B8"@WI^*>C35=E<ZW
MAO<&$,R9TZS%ZS_,MQ@#$85K_U$._W0.ZU$%1?H&5]G:C'OXYDI/J _L>CU_
M_#0VQ'HZC&I\,C)PJD^&%0+NJD=)%Z"!M)L.-_:J!V?ZBR!!J];!@>$?[CF&
M*TW?^<:H3['(GPW(Z8 )77 MTPF1,749C)2P]7B1Z:T9V[EDE?2SC6CZP?[Y
M!_IM_B@XB@2HJ6ZO(:2'+"NE'GTX"7W.^'LV</:#"S^Z%=B%5(W&!/3&/\[I
MTA2IQ4ZFE]2A!M%PFKGU/(=\Z6LL\JQS=Y-;]5>PB0ELJ0[[=X0$F-[ 6!5R
M@QUPK4),[NHW/DI-)E<.+DU,.7X HS*J1M(",Q]F1!J+%B7"*6/M-PIT7:?Q
M3&AXI+J63 ]8AGQV [72HH@06(@"UA?&'N!W=-_5^[]O]_\3\B:P0"Y9;?EW
MS<KI]S@ _G3A"(9_O>3!:PJP?G'47!^+F(6$R!",L]-ZLE]9Z]);Z7SSFM=<
M;C 7_"DG-E0K;<I& E!>PS,%NF+-T4P]E_&YF*;MA"-66)>P=&GT79[FAF2O
MU.6=CI]8I9 EN-O9/!)TL7Q9),! )H0$.#]7(P'N<QZ0'1S\G?].DP 3B%_F
MY7];N>*G*;I2[&0G$F<VA!OXRC,AZ$N<T#;3XID K2W=N<W=\,6ZH>T?VFA.
M5GEL!DNARTL*);Z4 $3(>5@H%?XK$[L1#M9+I,"Z1'NIFY29^!V=7_/0T[AO
MO?I.[>1H7R7JUO3S+K*$A"=L#IT7,M!ACG3PD3^!(\](@!'<5!O^1?K2^:TT
M0\4O/K Y=K*2_VZ5W<$9HV&[2 )$$CP5@!P;@G2C4+O);_%^GX9=&8Y3:%#D
M!CI; ^Z.277K=?N@[=S\%[Q6;Y[@3 D2L$OXFIX:>]2Z:R4$-2#XL^^&R.R*
MG5%M8VP 6^?N';K%9#Z\/D9I6Q@M)3C9W4F\,=*J4/;8+>AYC2,%EWFG_YZR
M1TV%LD2= 3G%<V3:3XF5]AFAKM.L:"^_?5@Q@7>,TP!#'<K1M[8]3&CUW%[?
MM2<!MJ4"G$NAMUK'Z[P$W6!,!VHW6(//=?2O2J_&"!VR:-()-W6%AS4HLY-M
M-'%OZNF&!JXC)?%?JM9#*;'ML5 K-)Q>*[@$C+Q:UVB4>KE*M)9;\4: ]%A3
M>/V* PD@KK$)M,7OXKCZ>-F1-V"<8%6&U2AUCF+PK\?KHY*W0/:F-ZQMT!K%
M]SZQD9F2>_<KYS.-_-BW$^M//A%VD+]@/;K#Q'BWDYL+Z-TD,?P7,+H/=[V.
MU@ASYD7;$/FC^TS=VO 2IZ"AT&: BI><RJ)_->;HS7EUT5=L61+T5B@CU.Y#
M2<D0_*A'DUVJK.&;?O;U_<!DY)9O/F/9HGZ\=*O0A3HIM]9$.N4>Q$,FYIS-
MK^SI!B5WF?)O",J.[5RX0V%3Q=\=;'HM.N33R3;+0*=@906F&9>E'URWBK'(
M6,"+Y0??]9@>@)M@/!#SSBG<6JRDHJPGH)?^[C6V<_1E,D1>3U\5O:^WG_=-
M=@]/JT*OTRED=%-TANJTRM.*7SZ5P?M2[NV(U.D1@T\"6F;4ZN%JHU._\KC_
M'O_]/\,J"6I_7EH+CR!>BS= 8DV3U74E4V(CAZ-:U10+//-) !I?989MAWZ0
M)G'.X=;%#1WK"G0R[&X.;$P5*-LYA[4(U8BN'9U^<.?Y^G:_XQUN6,UQKPD8
M?:$4+)@0-PVZOCQ!;-":_TN4#:32&&YJ6AOM=;LH$3_ /< _-3:QA]ARKEH+
MJJY!*XQ" W#@/L9Z',\U?+J'Y,,[2OS<=%UA7W;#(8B/?S?D:CF,*2%U00 V
M37M& AC.MZAB-"]6>$  -W4>AF@_R%TC?W,>"_PS2N0@ :9IF?Z J_!CKRI1
M$'NG,9$T<1T2H+A5*HIN-J]QR ?T18R0#>IJ/R/3(B0&P1()\E#KI=E<E>=[
M MCO?YR<?(?K M_G\KY+X+!YA/@Q5I>;>PX=UI>NI.5N]KMIFZ$0O%G0#[W:
MDM.;QX3\,K%#25#[H262_NJ-<%' YF@SC(:@,D+@\U;H?>-3NY?@]?Z8 Z35
M^XP@A0?[+4:W-+8U)X%C.^ZDL#X0U_"Y,X#00<B)=2J]*5#W ,YW6BM5@H ;
M_079ST9[)J-8RW9*=T9'@*D8I":^I1(2T)O\U,6+NKY!HLE9V\;N[$CP767S
M5)=XJ_,GG:KXJ9JX;4OK[6R-'XPJG<-"B4$")$#409O9GD1E"UUP_#ODGZ]Z
M/%FX*F8 -S]M\I8K^J,%<01>6_KG@^/'Y3/DIM_%)JD<Y$LL8G*1KQ(K:C]L
M$JAKMK'MIPWY-BX^G%_QHA!9()*1NE]5O],5)UYZY3\UC)%1TU,+7SE2B"["
M"^O\4J!!?))?JZHN_;G.)18Q#KA/M61;:Z5AK$ [%GGOL]E;/Y-B5*AIV;=)
M#C?SA"(:^;QUC?/@2/:']I>UG\79B)/=OO- %7#C13YYU76JDHO=NY=@BG=D
MZFF3[6-!@$.YQR6E=7_G5>;;4TM?3:>\KR.A?RW%X,8U6?B](FS#8A\<^WW?
M>D+(>H)@CKX@4R$Z]E/.B3LN+-73OZC3E$?8V2+O/AS0,$1H%X:Q76IMZ5^X
M!.\3O!$",\ =QQ.80KS=Z[-BE\X:H3GEX[G%_=[TE7QA!OO"U/,$VL.;XN0Y
M^  L":"'MU_<ENOFI6#R*IG67^X331D03C-T"5"OD6/M338SK$[[3\UT"(GS
M\IUJ220 C[(UK./VU,OK9,P IJJQ?E>D"9!Y6Y5;=5VO][D[H6XC8QE4V]L6
M3;@I%73V&)DG0/O]=\FX9+I1O%G<$2.YKFA-PK<VQG$G3]6C?$;;(V^L>A[7
ME)]$-/ZO)*QR]I#5MDZ?S^8SKW<"K_E3\EK., *;"Y48IAD,VBJ,R$\PR+F3
MOE0#83U[&#XO?E@.E0@N%JF4[[R2]**8\9I5.FW5"L?O2#5#GC/-O^>\3V!$
MV@M/>]T:0P(<'^R>*]M.C7/\UPQ6/E-9$0E@V:YUO[2?6!4:GOL_@RZK 6"#
M4.]"#!& N[ U1H(&3K<]\CE.ZO>6DE46KYU5!W6AE9T(/%E;]>P!E?E?[I,$
M2-?&1Y( #E]@:_C-^58Y$N#:T?N_GU]J%X:!VX5"?VUCS<WJ)XDBG>CM2QN/
MT>/NGUKE/)Z/=.=VHG0': 4>>/^.# )V+\0NU*Y4+ YQ@N$)];RZLZB"$-75
M+DN?X<O*M-LIAAU4(HRU6QWGFH5(V'D4\@:^#".T=5P"R>I330BJ;A/=7FZ=
M>F@KVMP8YZ][P@Q0YCB@O/)OZP/_P(G.T<;D@2D'). ^5H05[V6#,W-3M'F'
M;8A5:#P8#-&FS!+E'GA]LWY4\<8PU&KB</]BLRQ :QAUDP#TM6N^\4!JD)MJ
M-0)<TLN4N&6S::+Y:NM\A9I6Y:P''7;Q=S@- Q;PVJNVC2UXKB73-P_M=84R
MO)>J;"1V&^A7&9;[&LG+U5?:'-'#G2 JPLM?V[XPGG732M?)*;H ]AL!"L@9
MJYWZ9WYB E^#]D%L!#8</)%(1OS%M,1W+K.48/.\H'S]U+_ 9=&K09OY-R?S
M$+_9O5\%EG:RE)8HK750(3O9GV;X%@([;(M=CHK^^$*)MR0C8<_.MNVH*E"C
M2SZ"529O]/V]6]SBMJX"N@XXI:TI[' ?;VE\N1N2^4MCT\ABTN2OJY"BQXY7
M^MGZ$CCOFN5'ONQ@29$8$\]G4@?6['9C<"(0//[Y%)&U"NW5X)7N^E:Z4R:C
M97#_$J'0I.5+GQLLB038TX/^HV0[,6]%A<,0#:82@5LLKTB 0E28"NP_-\*U
M[O:_=.C$:-P#MUC&)BSC:L.LU/E/6>(V@,X@ <BK[O8:>#<=@Y7]6.W@P($R
MK[B7M!EGBH^F?8_+FL1<:5PW:&Q>B7E^YD?)?6K?IX<<^X$K]_?C;I>6?4?O
MU#8'^1&1^NWI*_ 9"V<E1F=1CZWAF]C^_DJ#;6/5NO3.Y<C'B?GSM$DJ<T%3
ME>NJ5?4-95K!+E<RYYWG/DF$31$I7V2_?4D"N*BM&[_9D7BOD]PSY;WT^_)"
MMXT&,A?<V$N+>>7G.)?=+Q[EK5=4]$[Y.XVK: LL&IU:[2I9_8G#CM4[)ZCL
M*V@J1WZM,.ZT:*7KO]."BW0__YS>XR"./6R/=O?UXG+-]/X]NW$+W]Z%LJ__
M?)369XCRH*^\U7^<:ON+//OT/A)ZWIAE 0IG4,PIAY091#&839KHF&']>E+=
M.#.?)N?</'%\52[P*"3X6=C-T.^:5\?KJO1!R>;XI6"<'IJZR&I4P93^>JQ?
M:;WI#YR[M<KZ/KVW0^R9#CZK;YX%_[!Z(X^L9G1'818<>)W-;>^KE@=OD9Q1
MG99T-[^8MG=Z'%YN22SF4!0_4[ !9] 4(=CCIJ*D_8*-Z,!P;@=[$Y=@'CTE
M;_E7/64L89]$3NZ(\4^MF\9"@5[H88:-;*E-@\SLQ$_UZ?*2'%VJ&<^*(R(B
M^MG)]EP20F\27*<T*0AB.*HWYC8MC>/N0F8XS:I\Z_72I6N/&T*WI?O3:%24
MZ=(3&,&9.-BV!<9>NVO_,186?]V$JPO).4;0 AYE)GNZ3-D$AJN_"LO7BAQF
MCCR)MO,&Z8 7OF9%*2 H\%;=EJ>[L0<&K2HO)CD;3N^7_;$;=!^L0[_=$M_H
MCM@C7],UPU%M/<7NVZFJ/Q!PU!W;<G\Z)BU_+DWH]:JP^:M1:HWCNBZ]7,JC
MTP_>=P3E\HGC#L!)36&;S>V/G4(1*S@?R /\$]<1')].HUT@";"I/O2[ID&@
M9LAO0:C=T_2-C4Q4*VQQ=@AL81*JH7EL^L*J^WA7Z,-39_(AYJT^@Y.:Y*"#
M>-B,6L<1G"V]+Z6^BC\V\+Q47@L*J]'=&8*[[7G#Y;R$@KU"FE9:@(D2R1%(
M517@WB7D[D6TM7N'7V;+\,(U9&$1Q(X',&&'5 R0;@WUA\7>+4#.]2MJ=6!<
M"N$P:F!XX/>$:>2K1N40"?"?RZ^;1&F\FCG./]TMVY75D#P3[/^R8']!+"$Y
M:*G?JC*J^V<5]:L!*=8-_R=K8P@']DW3-)F :8\6?'^WMU1OR>_V9/F(;_2.
M]>T6AU9V.DJ_8HBE#00%S&^A7KD!L(?:K-O+A*%2A[XGS?&_B]SY8;6R95\4
MX-B:K@8B&W:Z;IP_</=J^G?+.6&J>C"H!\DPJFY-#RY'2:9U!6CY\=P>]ER8
M3]+MOGHJ5.7 6G7OX*KE)Q61R<HOW-DOBVQ\UXVR;ZR=Y?A:7?)C8H4 2(">
M_B&<?O04$;24$-(\$^*<J"?Z\/P/6=NCP^I!PXFMNEEJK]JS<H34=;ZB;$[Z
M3QHQU37OFOY/&[#_%AX&G&E+)XMUMK/K5Z\?GY;"13\G;V7;S>N.??]9*'33
M[$YB3ZFLB B%L/<B[\&]Q5!%O)@9/F)1XIRU:^'>^&*+#L=*<I7\%ULWYM1]
M[3%MZ#=#S.J#[O*;6HOD'9I<A-L3Z@]QC*MW\>5$21+@3?/\?+]E?7/+Y-8A
M77"BYOR:@52 +>K.E^1:$9DKXKRF4B^7+3)":\;K^.SY[C>WM^5*N6\_"US)
M,X],9.=\+O89P 82(ZB?9[S%SYI.BN!M\PF:MCSH--L#G#T1$?AJ67%M5/Z'
M]T?R#SQ&'@,]+NHA5@@'H]*UH,@Y1=F-="TOD0I'KX8?C4^*8Z:\R27U+M^7
M#<QGDAYM=VN//D5$^U4Y;JO6O56U\Q^KJR,F^GGYO>(8W*I+F^=*4!^4(\1^
M9K5-(#<L)TX@ 6-0J5*PEW>E<<.87>=YKD?1W"#,<W(!=[PZ>Y/G&C/6[C/
MV3MW$,X^MJ4>B*F2WN^SF>I>X!!+=C_4$'X,-VZ)&T7-?-KV-(;/3%)M,[3]
M4O_J];8LYSKC(P^+]M(UI"8V.DXZ]'I9MX>7A1?S4-5=J)S'JQ<R6YR+C^.M
MKS.()U"=T>PKMK#OFU=/=E UN(%JD\,.AMG63H7=TN<&*OI=;X*L9TPTWM+Y
M>KNNVMU\AY839//FP93J05N(M'9:Y_%0&)'X]Y(?YA.2'K_?I2F4L_0=XG#\
MR)35%N(!ZJD/>! 2;:SX8+;77W1N\ I*ZEB/A2\PA2F+(LF%2*N+[4:S"U%J
M7L%_](K/.A:DDYM6QAJ]J*\$F =XOM8<!09W$_<UBP3$R7<?_SV%4O%/WPN
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M KMAX]''Q%"[G:9X;"6,"M-T.\\@ <#)%--0Z\E6^@7^W5!A2"C6]GI$(-I
MA/@K<[MFI:?Z<RF^G_\SM[K5_)45)!1+U;F0X($VTC#J![(?I)>AOHNH M]
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M4CV<J$-&5MIOI$JBZJI>YP4.9Y( PD^G$L152  GJ^+0(3B3NNC2;A21;_+
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M2 _!=%!U(*^-/FUHV[LRGOX@<C''OV/T9KGUY;&W!/ L>&EWQF6QO1O!@M_
M]&@*CA%5\+8/QSRO(C] 5C;V?BX\2.$7]_._!F6D]IPX0I9]M%[+]ALZ/Q^W
MM+0<J:VQN[\DG @8>.[8 0C(IWMDQ5 -]<'#EN#TKH+7)EH=BUQ1UZL?/0;-
M_2[4]6LIRS0\:5P5;E  QH3*XMFZLNOC2\&",B.^L^=.E\>J=KP<]9K-$V2=
M]ACUF'12DVK)9JR8<,A7'MCXWGUQRJ+1'?[+:R_?3"#PMGFT%\')/I$9@;_G
M"\<;^0?"IQ? IG6./&?O?WK_5,5\L!#Z6[+H?_7W>_():IS)XGE)@%XD%58F
MH7JUOJ&^:6Q[AQ#OTQOAT3?'TH%&?N#8R^I,CCEV8#]_I\F]CH(&>U;+<S^>
M4R+4\"=GS=<3^' !5MC?@_$#SA,>SE>^VMWKS1JO4.D?*PD-H1^[\>VV;,>H
MB?V\J64Z@8C97LY<"9P45/Z>J":AZXXB(/?756^V1:+=%!_8ZZ;R?_LJ';28
M,!%W?DG*\(;4>YR4<HMLVWDBLLQ%H63\AD;K-S.#.:=;&EK5^MU<8W@K6T'.
M<9' JM]&ZTH^_.^%'3Y_V5E3%=P\6/V:^^-!R\==9S/M).+$?F]_0AT)P(^/
M]6WR+XI//(KG?VHS:@&4B")7=Z129S8)5-X:C0*99:A.M>D[.Y^<KY9%#%8Z
M%IB52-C0[NSN:53V:TH(,F()J.34HV@S%C9ERF1C^+U>O#..%\3?[R<P]-'6
MKC/<^.[;)Z%M#*[XX(>U^,@E8Q"JPL=F_FBD\WSNV\O-#94_0MH21MWS'*,$
M"4_L>F:\>Y)/S^WGCCN&UTM+^%_U=WVZ*:HKY3C1WC)6\6CSR22M[ZI)<]6Z
M="81\6NR,$YB1CWEWWV?CD@&@H50K_H6:$.O]Q:\""(!(@A7'1E3%*B+<6&W
M2[](&'[NI>^=8.[3]*$9Z%.;FO;;:]AVQ0C%G"HE0H4+UA:8U"G1N_2;YB&9
M?+M<GT9%ZU9H:)<>AE\F7W9_DD?#3C9('(37\2N!V!1VJ2 U&$1DJ+"6B.50
M*:A/ROUY\ "9+*HKM?ZZ[E:W6#UX#8;BZA64Q\*Z<E]98CF2W@=6S]H.W,JR
M_-!/6>N6,"0-$)UV?(,1J^A]";JDR84O%?#9V47+=+5':@J<R19G>RQ$;/](
MC_4)\)35;KDC0/MAJAF2TWTT+X%=J2B<EX]U+4<-NLIIS]H)5UBB7KY\>5^<
M_(\ Z.@-/AZ!5UNZ#R^&1#$PV4VU2@2B3?0?J[I;7;9L2'X9^<PKE6.V@OR*
M;V>UK<7YYPN.".\VPV?IC[L?4*NK+9FH]5B=0L;2_":<\[SY>JQ_KJ5(&\S\
M#,;$G<KU@+X"(PA:B[LT:W05X%-#[%#.^J1-Z7OHYWF%RNJ9IZE'S-\V._GT
MZQFL<&);+MBS'E97(S8PKU1&[AM>^]ZHC-"G$69_ZXX;S1 =O_53RWPW#H!K
MHSHJP>U\P7'.VJLF?H2H>G&)19I&7;C!J9=ZT2\;]_?;?_R>W<'4!U;78':W
MZ[#=>MCAY%8A/TVD0OG!V6^-3""C0ZNF:^3;T /=&L^_9[!> )V&R5$$D^2^
MEP.5/;AY$L!-.J:A_TQNNT4QI&Q@-O<,<C8;C%% 05WM_O;!W_ 1Q_$K$D#S
MOZ:P?CL(_TN[W ,JE7*"UB_?*F?YEEPMX=9GEW\71XKE2UXFJXYAUM/ZIK'Y
MG:"+-:E#<""+L\-[7>7##1V=1#MWV \(F^,%,5JT>NU^[.+#=9!IVNF-.K"D
MO0)WV4[=1 @QMXW)BL^(ZGZN6&3Y\O6VS0-8P$GRW[0^_Q.<%?)\L)?SVOR6
MJNJM-+H86_?/!JJJ2L^ #M%7)NO8R;J88ICQ @[#?:>1I9G7S)Y,2CL]]JC^
M%3"@;$CE"WR8:O\\&K&.O#YV==PW47O6_/.[YVJ5AI:/YX)ETQ@@+ML7<6,/
MB%^=I@P%<5L!-CRV>S_T=N_$]25U_[SZ98&:?K'LX?-4HN"F$*#U%I$3%QP?
MHF/>J&2)M"LT<M_FB;7S37$4#3ZDV'<(:$ <MCMNG0^"<GZ<<64X@Z]8I_7)
M?-J?G;%U<#@G[#:8#,%1,D=UOT@ ER$CDS%I^?C<5^:MR<.WM&[V?-']X"FI
M-2#"3Q^JL"%$3[RZ#N-0YRB%Y!CL<WX_U=A(IU<5C#1M5.&WB@J=O="0/PN<
MZER,#4OG-Q $JY*4\L_U(MES:=:7#I[1?!,(F@1M42X"!?%"7:KCH3=KVT9K
M*U8L/X\= LSN OLZF<3+DI0'!JJ5T;<?_!"@C3M C90T5&IFUS],L5K$/X?8
MQ"DW^]1B;H EVFOXMI]GNTJQ-1U&7C#;]9,[?V.L AA80MXEO$N@ERMZEQ<?
MW'5L=?OD<^>GC124>L4'3XO4U\)7$N*VP/M91Q=\-JH! T/M+R&SEDB _T';
M>X8UU75KHT' 4$5 >@E*59IT09HB3400E X1D1H!D18@)!3I'004E*" 2)<2
M.D%Z$^D@G004Z0DUD! .S[OW=\[[/N\^^^SONL[W8_W(=:VYUEQSCG+?8XXQ
M$M4HW3FOW2S]:B-W8XI?NUJL_D6O]?>'YG6#<WA-D,=/6##!L?C<@DZ5HJ\2
MK';NC;TS.S()MZP+"GJVZ*,O$/SEH8ZLCILG$/:2X(]G>@1AHH?N==@)H9\L
MN/M\L%OX;8QN>M37!8>3S C@"IC::3A:0CH&?9G@C%$XG=C*F=5@7*!_NXUE
MZ8IZ)9Q&Q=+!M6;>>HZYIU<QK=^&7H//UQU*WS&9PX@_0#<4Q.GO=T/S&V41
MI3IW>^#0'VIZ.YJ@ A_S+ OR,)I"7:D.)]D3^T(WGE0@NZ:%>)OPZ_BUS"P*
M;I-C='_J?'K9W\X [-FF8" T[P&>U;7JF -B?RNY?;YZ\^5+72 O-V#KNLI4
M3VNMYY8:7GII-=9GBTES&(.K>"VUQ.B/ES89\_ U,  J'\.BKVS9]T@G>X_Q
M3I7!^]*T$+A/C'<UXACQB0:S[T0S.QW-%*2,9"3N&[TI&;-?"30&%KO9B8_X
MN(,-1BL.@G@D31\[&]"+Q[U)A%3%-73J/;3YLK(%O(""+#%%:S"@%FG/ &UW
MT?2$I$ZX#!JOMMT47!J<.GJ/>68MPY62\VD,\"7GMO=1TJT*E+H$)!/-2;#&
MGCH8OK5>5X$G^?N[7]?$".M9IM2^#P^C:,.&J#2*[VGHG'X\ [@&(>A)E_'W
M6B^KRA5+=[Z;O9^DUX!;UV7+9J/PR'G\=%0_O/[3YH-X!Z!@*6)F%5O1AJ"!
M#S>"XPZ"Y7IR!'%4DS*N@?UK<<_2%*9GT"]D/GPTK; +9 D<!OX1?G6$O$+B
M*EQ'3F?:28Q('H!JRS\<ZOO29(!1LI$6BAE#;Q^'L191\9KWS#AWMB8A&-75
M29=Q20EPP3\+$L,D![;Y7_CJX8_5Z7Z:X#X)N3=:8552[?"GW[#-]-BZN,6.
M5B9U$.EIMF'CA".>J<MZD;G'WJ6IL#Z!-G9!B+_@FJ9ZBQCE058LZ0P 0A5V
MUI\!' U9>P[)0F,H$"=,$Z]J)9+I<6YAG3%(13.CZV_$ NS4\EFO*XO6\QZV
M,J@+P9QQ%5MIGTDB^)W$_2'./V68ZPJAO@Z?M.V%.]&OOK@^,6!S/,ZD:=.C
M\PO/ A"E_M=A50,HNI6-)(W[U#VZU\4=MS9Y].JMO4]-UK)W:'W\O7A=OA_4
MOA.]I'LXZIZD37?),I(M5IH&U?Q92R/*XVJL?BCGS&^+?.H@'%#M#V4_&@C3
MP]6B\+=-<6> #F)#!4G)RQV!Y=-QW?2XYC@N)<T<S71#E$KUM< /F2WPG2EJ
MW [&=C'$E[ZD) D$;>H:4+U[U1,K7A+P+'KU]K VU7,E#WW.+=LMP!5SYF!\
M];<9>!0V^)DGRS2?7(<2XNE$^37):[,V6SJ[<&.#/N+/[LXY_YLV'MBO*.F9
M. P\96E>M$L)+AZIQO$X2T_R.7L=HPQT;Q48HN.8--"VI_3I&'I\. PL_J]J
M8UL09H33\X_0PD?&88*&6*T^HTIU&6J]=%+U>4H[HPT>%#LD#0I$=U2]H[GJ
M;7?G#$ M)4#N0FN< 1 /SP!C$2V 8+7_J*I5_(_"D?^(#6+!LSMD XW-XS.
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MGFOAMY*?'Z>LWOKCI0DRM5N;G$&_4TA8N>[MZLT<Z?*<RUR'TU&]DT4\OI+
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MTB_MG!P@3KD/UMD<VEIQ1DGQ9"I<-S)W#<'6?*,Q.)83PPI]9?Z4GOU7\X\
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M>Z)O+RLLP.X/;S?KXS:Z5 S#HM"MH^5E3\V"<WOQLE^$<!?U?H>H/SY-14#
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M/;JF63:/RY99M:96\[.9_W'(7=T&$BT!GN49VGS;Z\NT7K+UM047*Z<*EH$
MS)^"UY0N4NI[KQGZ\T/::+0^U%!X8U8[RNQ1Q%9VZ+8:_T9GE<II)-^M 57N
M9P%V-CGWTF[4RQ[ ;H2Q7:2U[1G[\D5JIVQ34+<A1]S'WV*BX&5NT^7BW)R5
M9,"V(< (K ;S)B25KBO9W<!M(S$#D@X=*M2OS=5%(K&8O'%1U#OAXU)CQJ;E
MW8%SL!V[:0-Z:WV:#S/%BK<8Z1&"/ME8$8*;#2 O*]U.\CT/(=/)#*Y]$AYE
M#*-%SWCW4-9/G3AY,R,TG 9 W&OACPQO&-']1)7T..="PT8MR^5YVL18[\97
M?9K[V6""Y9#DNN7;7FE,T80SP'B^AE^SFB5IYW3W/,ZVJM4[8$_MIRU3*!*X
M[7YPH;P@+_NI<O<HO>RM[P[\9P"'_&G7A)>3?LE6V3$,8YS7'N_Q'CA]6\&/
M[UD@+Y$8/7%[[3C7RS8#P:+9DH.#*^O%1QPLO:,&5Y]0F'M77RX&4 )\RC,+
M )(!25V+T78"PRA)4#OYTNA^BU&72J<YZVQY@\_D89C8W7<48J7?5U_2Y?I+
M/+PR2AX&,2M(1_'31!X]>%(+:?HIX3SI\51N9HU9K\UJV^=2J<.=/R]IJ:-M
M4K!@IE9G'N1ENS;^!F>I#U_6,K-1158&4553EN$U*JB$=CVANH;;T<&)ZB;X
MK\]W9T*87FM<.C?%%8_)8^Y\DN6J<L&2GR3G2SE$./EUB'9Q?HD%E@[)RCI\
M+'K3ERB ZX8\[8&B4>QLHS5!C#)/ZZSU(CX4:_]J;RZ%U# (;+90>YT!@/!+
M';ABQONZZ#CCUM9=AP#)TJY2F0X:^RNN_*NJGJ]LY]^]ZQ/-Y4_0I'X%ND(*
M7+S4+#*3;^8:["_YG=WLZ^"M,)$<5W8Q4I_>559OAMI+0 <KNUMXZL6(9E"I
MVR'WDQ\- 8X0X4XKWUQ^]XX;J<RO-/M.IOJX13L2')9MYV;0)<*?B[X0,D8\
M]Q?9+:P,I%)Q-!.B([[TNLGIVK?QJ:767A>5+],!T*JWD)QP0;<<('X[QK40
MFEMJE;X9:$J;5]4<#ZI:/W1ZTI<P\4!67$KKAOB%0M&U17J2(FXU0G[#.DB2
M7@^5<9UZ8,#Y<X<'_\H7<Z2;&-U6HMYJ+20:!]S$VR\E\3(&>]Z;/!QI_&E)
ME;X2D:^MSP]Y5Y!J^6.<+C?]"1@CFG5P KB16%?\.2IO89U%5VADIGU/WDOJ
M]]/<]Q0;739.WX0NZ&V!!:#9QA-P>>C"[I[-:(54C2&3:9IVFM:HF85O*^/W
M+OA0<7(5LVPM+;7Y+QTACZM= &UL131W9@)JD5Y_V8CA3_6:G42=^"=M^U<>
MU\9KCD=43Q7_U#_9P]W[HMO[(U26A@<=1O#'2;>? 9B:U1MM_-@;:WL3BA?6
MV8T5^E",;Y<"+E!>RP5<.!82ZQ/-VCL#,)#[)B>5 I_\*$ \*[NRX%?(G_G4
MGCLNO]WBIV=*QD^Y&ZI%%P3\^WIYS8>?/@MA9G;0OF=<G >@"*%6^6]:,>4+
MB0F]IUC(:*8__(.TK3MW3%8GM(V6BCK2W+U?W[WX'KY%?9\TO7OD\SM$K>0^
M7C&E?-"+/;O8THUEMG8Z=1(C[)*41RT*W+"RY$?A%CLJ"(Y)](1PPW'TI765
M)ZU)GW"_QJ8K(LN%4^P47E<K8#^;0KL1P>%9RZIL^.QEW1@/=8X90[P3M"=!
M5; (,B7[.>:9W:3!@W0+A'_26P:9EPO?C(%_T-J"*I\RG.ARGZ>^I(8'S\)'
M%]3Q\2#J/#0ASW6)!J:/<=<U'D>Q5=7,>GE3IB=YYA1<?N_#3V!3S"8:0H]Z
M9D#M6QJ6^,',D%+?08['+2UX@:I:VJ(^CZYS&]*6P*ZI=+D9B;D6HGXXYFLM
MZ33B42JUU%+[3#-KYDD*+9#*PT3W8C3*X/K.[\K$;5II>^/=V=+BY]IJ]%*O
M*#8-8><DF>H,L!A,O/XGY\FN:K5A4.TAE6W^.R3+C=W;*Y?2>^']9*K_J[HS
M#8?"[_KX(/M6]EW%V)?(DFTH>_Z(_O8M28PA2Y:)"=EW#2'$V(48V;=FF+$O
M861D9!F*LLY$-3%XNI_[S?/N>>[GU7V_^+[[O3G7N<[O?,_UNW[GH\^I#['.
M(#SHV:];=QEYV]S=]>%':D(!]^B7=#$ 2V4L#QM AFZ7N5W>(FI4$=B=I%.'
M%2A[ GAR336\*21(>_W-0Y0QN:DW>K4]<+#$8'S&#6I!/ <@*GKKF]/,G3)R
M9"20X_1/#K#6!(GUCNS'I,T#)[(G.8?2VW^<U74<2@CHHV5M> !D>PADNWEV
MV7S:_P[C:F']3^V\FEIN"W 8^P>_30VH) <=!Y.D6"4.#:(RG]A"WW/R4&]T
M?XA66(0V85U)^-JF'2%7OOQ@5MG*C!?I*DU'=C< 6LNE57,!U+MDX?[4<J@'
M%G6M &-_L!:%YG>7% IKQ$Y#<8+/I(S\'UQC%#6M=0:<LG3W)(VOF.\#S2YG
M6O3E7+.S$S67CI43:(\2/)K_X-77F6OM2YT-;:E+J75;.LR(VD3KMZ$ST9?:
M]T1#5WFA;W6-/=</DOF+CCIJK>(6%6J-Y2Y(J735,99\Z3Y"^IR^ %V#J9$#
M=T_6D'0C&X$<?D*[!*9VA%&R;>(^BLA1<WFIA>;S_5A0>1QTOSS+]X'3?;BA
M1"6#/>/SFZ+&YAYZ9YBBJ?W&$Q"8Y-;: R[*_%GLMQ_BO"*[Z+6%%HGF/0+^
M2]AZ;PIB\-@A7E<_I@E20/I69)F@J#>UC TP>QXF>0YXM0"'R9^V1O-1/<FA
MT4(S85%?PR ISNOCB@X672TN7Y.=+H-MC.*_3;?_\88@84@,'X@&BL"B1#.5
MPE)S9/?V@$'I(??S'JCPZ;(/!$\+#D.F^M3)M4,>W!4>'",DUJ$5,8@>UZ;P
MN\#!CEGGQBK431O1&DVUDY<TWP/V#,3MF'DRXIB&'Q>QOKXAZ2.XXU%X1G.:
M']@$I#B)(=?<@N_UDFHJSP',7'\IP8&]%TY+E$S66-FHKY=O]*_9PWKH"-OB
M@-# U&@.LG7J1B<)52V*?Q88J+N 5HB5HA@R!C$P:$G(13T 1"/&K@XG3AM<
M'PJ)83V3\Q7GIPIRIL%T=''?N";4Y(&34GS+PB]@#2$ .0A15(+HD]TVS0H3
MTN?1%5]'"U)N#6-MT@(8K;)<>AOD"R6G<JVY;OA7.1H,EF1H230^93[AA2H[
MDI"[V>!RB+O8O%JCJ7;*V5@O ^$ ,G'%>.(4?SE#1>^P"' 4F' .:+-Z1BXZ
M-J/J5%*>?QN75-GA[U'K^,GM'_!&H@1EK_5>98'WPS:"ZTA1>ITA>ZW[D63,
MQ>W\7 _# ![CN)N"+#B=4+M/_6P_M(Z0+] /K>G]S@0I(Q5#:T@FRJ]^%$/;
M[,/D0>? #)_"O=)?DZ<+BWW#<KL,Z^X7+\;IX!&#4Z"S0$+\>DFE(7#^K(XT
M-F>8)*DH60S[ I<8L7W@O1:9!CAA=G,I9_QF^K*;+FCLZW6/4@1K-".EE;A9
M29JV)1TD_T!P[FB> S@"]\(F3O(++ZFSQP[\S \G9#7.A5]C%*#M.^@/FOCC
MP<5@8CTS5-[U )UAOF@Q?.T\L#O+5 A5\3R$'$U.^%(U<L!S+\FF]!I WP+&
M2J8SI:163-1_Q4THYKA9@S<M+V4_'KJ2.1X_'R&+#96 .X,DR.R(1)A>_8[#
M_IA7C?/$DZ#1ZI>F0OSW>4*L>,@K*!:RYNY4W0HE&7-L4DO4,W7 ':TF.LRV
M#O%@./="=K_6@@%3W:EV6EJ;+3!FDNFP&)\0_1 RD6I*CV\GI=O&#W)9=7*U
MOZ\?-PJ>[GLU/<92^RKH1AEG'U66+&]"1F)=.$6^,6SN&*+FDFH#4P0L)8&:
M&:8+P>+8!5V[/_<O9<Z,DDRTO#X8R3OS#A<FP+>^<H\EWU8G?A14]EU^4_GC
MQH9]>155YT_#'7&AW"6+8PE)A57&7A%OMH]IXO_*7$_?E+K_FR7( /ADM*GR
M)TUG5_+/J,X\+#!S^&V=];U$LZ%6MU&O?KV4SU%"@&.3_PNJ(TTNOTV= :><
M].+G['82(Q\2FD%ZTVN%V:Y2<?LX>H'K>IP,72REDFQH,]-G6D%1QN3G:ZZH
MX<N+MFGJQV>="(2A-LO@*QY%EM6S1C;42<<']4F>AV?9%>[0.<QUZ/#/N>&>
M??BZY</-IZ88,<:>9_Y-2$]Q;TU:4AL_E]-M11MXQ,:6<,L[[3\%*D,*'.%,
M<)Y./I,D3!,]1+_B1L!*Q9Z%8:QN)G=LF=7.Z%Q-]2<O9N<;*>70I *.N8G[
MQ0U@,:99?_5YW,+?;1UF4D)J[/2(40UDGO!CH3W6[R'\99( 7SKAM8@D=30C
M3)YT!E^7=;9T7Y%6-5D(" V8KX[(6GT?6.0AIV'6B7CW9>M=1*B- ?V3<T V
MBOW;GS"O+.S^"/# G,EU)(_&.\\V388P#2A(Y$@MLXUU;?FG+)/3CEADZ":C
MF:B:?Y+5('Z) $UWFFOO.F@'JPN;-+=$V65/VJGN9Y9@6F^+W>)9X[^O\HK3
MJB(-4-VPHQV3?/0;^<-B)T!C^");@>9C!9O+TG0*@S1CHI;0K9&8!"Z8PVP5
M6:RD8:S>'1P.?DILU!,$C8A^OY&G%**/UPDPLI=,L+_?]U9]B'J/DG,&I&2?
M YB&EIO@Y:M0+]?.GMEJLMKO6:IAS]Q6!QR32X_YO3L;UV2>Z63H&;=W-A[)
MUTIT,QWJ<71))(V]6F[L7;0&^WC&2,X)IT/H2RX1%AW&=>(2%,Q= ^7*Q*IK
MS(F(;'UVM9/>4UGE(S=[F7VAD3LIR4EV_GGW@NS-/MNJ7K/+C1\*/XJEP>7'
M7GS%5IIW*#T<DY9-YL"O8H]-$]O?&5KF_NW)W2JI@;KBHL7J[F0R(?7C/GRB
M<]+.7$C*=0/IN7% 4(VAWT9)Y2BSFC= 'V-:76XV+B^MO.Y+F2S_A86T%=K9
MO4 46L &Z'BO-L!,2":=&_+Z #\T\Z,V2XV)O<-55-6WE^5)VP1O2%<E'==8
M8<2%&_3%"D'L "\J@"R6WD!!NI,02>I., O2F>4-MW1V8^"34/FDISF.%IN9
MXTW,WHEG#SYN[.?1K>KJ$?=T,$7 _.PJ C"KT%L@:86@L)O*:.QZ1->\9U$&
MUO_HK)[WK+<'#8':2O6^RYTL#:FG>2),IQ"<$R1_*Y:%C,Y "^R&JBWHJA4H
M5O8X<G90BC:_K^ FS,#8QF[XESS!PD(.OFN#7J#"54HFV? N"9UR-,U!B3%(
M]EA0]M\/NT2/K^BP^7W1GX,W30O,# ?<41F3C)6?. <T[Z)]IRG&9THP_9YX
M:S+?JZG )Q64+(8HI_$&V;AM-2VG^X=.E7F/8W\+YWVE@U.TUI>EL2 %DEU!
MPA;"$A^FF@\"DBP^343PQ(]+G]@N?FQ^,,JY5;=X%23\*]9K>XH14V2:Y/W!
M&]?V5>W7AR;++ZN+"[Y%]P&JE^:"652C-DHAK$3^6'$B\MGND5-MW!.<T[Z(
ML_$7%\S<;5S;G7+)-WX>+-=G? B]MP'R*10X^98RH ,!#JS8!@'Q[717.G%'
MK5SC8T+[.;=P/5?KL^_FF &X_*Q38KCX^W%@C7""^J^4L!)[A[1IRV9?^)=%
M8;,M6%,*P,AK;.RK_"M*S)]*0PCG[&^OFN>,# KI6/HW;X<3E1I%"[R0NI6P
M?M63^/&65@#L,TIY+E0'LBI04QE#1(N[NXXU?-4NF7/50Z?N?O9O0B@8Y:G6
M'N<RT<Q4]/A(H;!O2<.Y48T$2I.;D+#U);V4=DB^JQ5<A</SH3B4090CZ''&
M@X62Z/<(=EWOM4QFZXP?OJ6.]T]$\]-KNR$6OODF@5HO#R5QW%VEM!ERV7W6
M+3/_*V+%\A^XZ!?_Q$5;5<1J37$31Q*H:K^055 O$]P*A;<7H@@2L.S7,RK^
M^]$TR@\20POUFWWCS,D)OM.>P0GQ\WJ;:MFG_&LCF_5[981-;!1^CX?F<[3$
MZ4LJ_WI,2JD 67VEQ-__2%1[RS(>NSG.,%>JE2+99LPT*B$AP+NZ?49'PJ-K
M%K\1$,EMC:;6K7)X?&>XB@7/!3;:E/%;&QV 1H(,;59F.1@ETFPA*FW=CMM]
MGI./OZ.@4B<MS5)&DVL>4 ;.CZS&UP;6$&[6N<E5#WT.DINZYM$CVC]!LR2=
MAC8&!&FC!]X)VU/JO#=J<AP/-N: N$=[&A(NJR[=HTXW+Y34PN,_Q;NT0.FP
M&-:_VV=W0[^]V2O%C6^/XV]LMF0."]Z[A^X5PV;[??4MXRR-%CL;%A,A!69=
M(6LT-FV+72O%"Z='N038C@_+Y/GHOP/#4B0T.2(?%00C'R$&CMGG^[N*C>9J
M7KD(JRCDPUN9.!U;3,)C6N<('3)E;+PDSB3NL27B%!!6[.7-IW!?6'':L> +
MD3-,),I!%W0!RFD=]ZU-GPD:@RUZU6Q^(;*TH'+),)CAAYR3P.7+AVZG/#3C
M,$5*<#452!*#$RT%QG]JA[H[3P3=S+>7;-5Y#E 8S($T_(L_=66OR?J6T38?
M4#G+MJ-EY_K,(ZI=K)'@F3Z^HO@:[R3-+_/6]X+D0]( ?[$XRY1=&):_>@[
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M!B8N-@8F#B8:&C8A-@X>/@$! 3H6$3$A/C$N/@'^/XO P+W.@4= 04! P<=
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M@<CXD@EY=;THM-QJYP1?G:=0">G>;[Z]^,>U?_/L_YEC0?^O//M/Q_XOOY8
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M$FTIR'42I36AF<_FH:<B8[2B7)(/_1!(0,I<B$H:Z:W1N5A]AJ;:6"XYA+P
MF_3>8S^KV JP2#T=">^S6IYW])+BO#:%=2_@!ILIA;NFWBO#5IUFD;^AF;-G
MW;F,#+]K-Y,AYEM50=XF?_BL'_IG+&X)JQ_/P-KY8(T@<N]3XSOL%*LE;--$
M3CKMM%GII%W);H.3_F%.?:(P/^[5(S>B5*I%C0F$XH"',?T^YUZ*_L3<*!-J
M4Z01EZ29>.[H3$7: 2A_Z_E9!$C]G'E=;H1A\82F22O?G)VK/SK1A6&T%M%1
MKG<<'TZOJR4"RK*PO+S4'?+M(;DK<&:O,4XAQBAY2QMIR3WD<A7UWDS5]!,G
M(TXOW6=]A&<_V6_KC>LA)Z9-D;=+T+GU;^Y<@M212V:*)WB<3E<F5L3D85)K
M#=?K2WU]?" GNG3S$H2N_LGEY8\X;ZTHHE@R$HB3D<=B'QN2QS'49BVZSU.#
M3V[LF.4ZYTWT[7>]*V+<%>0L$E=/,CNK44._8.*X-!&7P\.1N:1M4!%!@ON7
MY@/]&4*CO=3G"[;[,-,*2^L>:5!@UT@H1?;7+&W9;AA1-W4]W]-E0'MJCH:5
MI5WV#QGS<XWU,*.8J<B.*K(1?KUB(F''X=4)%E0VRQ_:_0K!C3#[:'?2^.RK
M^/^?H)@GT: AY#88VB'[ N2AWLP_%G=&;;$_>;\BKG[!Z]U# *\;G[2+!OUY
M.RBS1RB9K\67IJ;ONO"A2P]:"1*!*##J 20"#$>&VJ#A%X"4E:X-T@$6"2?;
M:S3(W%XN4EOYM!47X;JPJ^& <R1$G"W66,(O;(25DXX5X2-%?\9L,.^G!TOV
M^:=+W-TC2*+(@WQ\'R2="1>JOH<!!379KQP\$(6-5<TL_QJ&NW=N^1L\4T-?
M(4'^R7V-N34=7]%%OS\C=JMT!4%UY?D%*#G2AQ=T"#?_$P76M\I3#:0YU(1S
M.AI-F9@O;H6$%!<,O\\2O5)U%IO'I?FT]3B4!-'XL$9SX59&^R%UZH!C(Y"@
MWMZNX+EXJ^>51ZBDV]>8H;,[@>WD"5)=4%RUA^R'_)5_YZ9JUS5QO05%-:%P
MN7%1J)D3TV8&[=&>5\/JPYT0?02!B'0"&.79.>DXA(UED<1F""J,-SOA+ROG
M=)35X<B];Q^FC 2%J BLWN$54E+/K?'+S&&OZR$ CAQYM9Q#Q+"-)S[*Q97V
MZ^?QAX_AZ'"&>OP/%J[.*=E4'*,[7UO"V_[$[**[O=ZNPG]Q/"\@YNV")V>\
MC-B$%PN24GJAIK0.%;9^:Z\0V9=6F8.$N0L5ZW:VLM+EZK\N!D$4?2XZUNYD
M86+K6--M,T:U ;&!R+1D 7O33=<Q.B^ +#-I-^1G#4R4:4Y?@G2 ?8N_NTWA
MFBV()X1SN7MZZ4?O7% BBE#OQ%65/S:D?'?-^_;1[OC.W ?F]CX>ILF1@PSN
MLF)I+:[(HZ1/,'.3<%E%UPI3[E"2DP2XN2.NX;_@7 5CF'6N-X2?R9O3TL+@
MB4E$ZL#X'"U57A+I6VB&N 2)-3(\;*64??X\MZW)7'%X22EH_1G=^_DA]P)1
MDD3Y\8V2F$Z7'8IIW!__GVQN<9LW^+]\=&*K%\;;RIBR"P]=MMVASYQ-K!:6
M8LM>-:O;]!6<SWPW%3ATC$,AJS,BR[&SQ 5K*.%VRSD^,W"BCU_F"#DPNZJ'
M6J+9BOA9LQ?705W25A60)(4?^* ;BH\T\I?V#GO#E!G!SU[SP;_@3C262=XT
M;SFG3 #!0R:JG3BG"[(_W+;O?>(DY<2FXPEV+Y+6/MJ=\MCI*B6$&I!E2;I%
MA$GRV0]B*5E[VKMF^&;+-)4/(/ZBE3O;Q3%9W@,"?P'?RN\(0[4*-=53V I+
MQT4+ZBJ57XE4W]GN@;/8HN:NC3R9C^($/U5?G(..D7[;7-.]U#M04S+:&NO'
M32_OLQL"K"<ZG?:D%P#OV0X_,V"IJ'>K1/^9Z6]UD3$8-J&R?M&:+,"2W$XH
M3IR[%^G)FO6SE*7,R4]'E-\U3M(!PR!A73":'9M5U9-\I303HYGK[)[PJ8&G
M@]+:S4U*Q M .]_S AC"O7(L'<A5?[3M=4?3C_.#S.!DVX3U!V_-!2^&I[C7
M=^;9!^L9QIKNO1?L\Y3T*R(1T!+^>]3Z#\'DWN(>SD'UT9CBK@Q6_E$6'?_K
MY"36)G;^21M,3/6%2W] ].<=Z$%'JZD4QB1V5%Y]+#C1G1[K*QDH_9;7J%P!
M&Q\]T0OUZO$LW(#L(BR S>&[3LAMJKOS^Y;F9HU(L*P[<CG'J+CCJ,3P:*L(
M!N#TX-Y?@U?<F>(H;3GU2XWX6XI1O=X'5OB@#\1L\O8Q=QP<GKMI#%$.-ZV=
M[$(>3?:RM\F%+?X6]3BR]M,2HD9N#$B[J+Q46?)D;<SZ?\3PKBOX"QK"9.?4
MH,P_9@9_-(\R2!I;?8YY=,./"7_3$T9A[>G'M)_R@+^4.64@^2;;V_.$<AVO
MCT[U?3VBWM9WO6U<3$VD="-'':1^$6OD]QX:NVO3IHIL9';P.HEW4XKDYMK)
M$2NPITG$FSY)'0+529LUD9T2Y=;MICI=QYJUASH?TD-GF[#O,1N8$. I)33W
MA'<\-L!-&>#!),M46;6ZV>N(W!;='T&7"PY9I-+1GMYHB$*K1"1(;-UM%787
M[/(-4SSZRI\CKSY$?0)6I$MU?\2;FKG!Q#^V8WR_&M(1=P1ULUSX+%5&(-9A
M-.*M6$\-!BMK<A15^)W!9RN8( F;%&/Q?!2+2I_/ XN@KC$GAS@4-S:U-E[2
MJA)EV=9SE[*8VG('D0=DVFUO@RK7(>5]BN?7I+/'!R9\"4W-E\+SZFJ^B'H6
M,^F-[;L_#^QH#@E#[&,7B#^U_M@C_IR3D<V?BX5XWM.OC'NP9!'Z#>**YIDH
M(MJ;?):F?E:8*)GT9J/CO<?B)7KHSL/\'RC/?&5EE>N)Y(F%6Y2FY2<WLICR
M :[!GRI]?N((4=C\X^*(79:0."4G/%UEBG.;0-N_UD?4,<,,NZ^;0N1P+K;,
MK.P^QZ2CI>-R&&O[8TUMMCC_*\"'66;SSW9*@14LNF;[<0[JUX<H\S_85Y#4
MQTK0WEN,^4;_G=R*MJ!.O],E$5YF=K\*&=R?Z]PAQDJX"SC);N( T(%WEO^S
MW!2&[#3]DCVZY^($Z=DM[@60)#BJ^M= "]P<WH/ ]!%%>D_2%P2WQ>53LJS=
M&Y<$0%6GF>[*7I$!),Z)YLDJ[CB;2N%9ATQ7 %>.O236BO7['S(4_.#==09-
MQ4#5*$YXF-$GC>FW/9 6L  ;PWIQL'WQ8AA,]WCFX^W64AE;OF^DUT1T<2KA
M T6[^'?C4W*?H>>IY2,]@HG@W/;YW#G[L^I3MKRWS:FCW=ZU0[;@#CAD#A24
MRTV3)ZF]I)D2!Z_2LY0_ELT;F<'1+:H)Z74XLB6[O.Y?@D0CD;>CW0A8./KP
M/^8OGF9B=;U9*-E'$NVIXK#%3;'[,\C5$3&R@D0%;9>W3QW['(3H9WQTD_OA
M<E5/&A?Y322;."ONT[)OQ-Y3NE$+WL<DA7<93E3OH^4&9.Q5M60<T^ W,AU]
MN6\J]^;J/.(;_3M2.! &+\OK[7]]SLXTR9D.X%5;XA:B,V+K7PWHDA>V:.;
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MN8@)'AL.*P75;GM=U+S[^9$ XW\A,O]#ANMUY#MC('V1"A7)?0&JIUZ ?<D
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M#.P]D#FJ\Y9O<0\(D(Q7HC)V!N7Y\@)L(E_L/>.7O "]%$U4Y]\]KJ"1GU^
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M7H#M& \^:&_\"[#/LZ:)=$X%E0,%^Q^38$&#]7?,5?[CVZIFCJ7_I?#1OY<
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M$CJ/^ELFP +_-=?6^66^W=H4=SY>#9DEPD'11,*70\@-%/X:>0P84H3*PU!
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M,OR*%[_F#\ />:S$AIW[#U!+ P04    " #3.W!6-W,+MRHU 0!400$ &
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MB(F)2(C_&?7UV;#K\P 2>E(&GON/;S(:VI'=\V:2>IWZA9Q7M::3V6@<R_?
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M!^^8W@JV9EZ54ZE?C_E:^ZOXC382!I,)R4D0.IR%2,L]LU)E'8Y_+D4M-ZS
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MJ$7Q1DM#?#X7+F!FUCCME%_.-#&>F?"^$!)%QAZ_HI(4QJCN<N0./;NN^!_
M7? _9\3!8NGIF=W0YEX56T&'@7#V4*'I2\Y0?1RHF*:OP&\YSWEAY.8I'VMJ
M>YLZD^?L]S=-:0$NI<S;SPVM;T5%U1MP,\>7)7XKG\)79E:E9XX.D#(9FKZZ
M_GKT;P@%XA9U< $[ ^=.*2DM9F]DH)QXH"WV"G#,T@S]W"?07B."^^Z7F-K$
M+2#UD#B&)/G!B0G3C0/N'Q*H[C[;>NY>]@0]N67:UN6(&*PE:\2MP**PY(W1
M!V_-;R[-R"_) 1@,'H7G?HT'"/TG /LO'X:J($-=T 6D"VXL]EN+>M9/K!]F
M,;KD +3P]A1#U-ZY ; 77^MRF;7VZ^HHXO-I:ZOT@$73'6ZE^ =K4'(",0[T
M:9'V<N;S[+>)4,5O,S9_7<%#S9G#^_TT!XQ-H=UW73Z8A+)CR?KNA+UU*W--
M#:H)Y-K33 GKD:C%[:K=(VY:N;_^=^,&KW+%M@(PRTZX^@HPA?AYLM;S:<!F
M2^$4M!]V!6B[ A#_O=U!A,\[Q%?:3WKNL!C$(+ I@Y>^=C>_/N5/CTK3UVD6
MOT&RG@\1-+_V2L"^E]L,BW@-3IZQJ-'7GI1;[Y\ZYSF_>\UWBTG22-,NV4#F
MJ)A)290K,P+Y\QE:Z;FM'!\8+)N?=XFT53PU/QWJNP+<@.\QNI\TH/SJ[S@7
MJ$0MCT^L!).PWA_EHY=ZT^I&3!K)2QU\6!D&7A9,;H.6XM,N#[HR0'=:;2D+
MZ&8V&Y U.L@)KSD^T:;GAHF ?EZ!CN*O9<LO9O) =WN-$XT2K1N"3VVK&VOU
M3_;K0&"<R@\HZW9#.']C5-]MO?4WAQC9FVEH29@?R1!O;R>?HS@Q?2.?SW.9
ME*@">I#  KYE_?FX9YOH64JLI_2Y^:*A[MN@%UG<CC&@1YYOL>1L-MHW.^JN
M[<'=$^@9XC1;[=U]WXFU1*\J%Q<_[.FLC=;"YC5'[GX$:?C=4)WO..>F2^8:
M;-^7H"+4QG$+:3%!W^7^8"U;5A\O)=E@X<,N!PZB@$NE4&J<;/O*3YD"6K>#
MK6RK,XGC^S6UTRIUX</$C =7@#$M+:]GKX)6BL,>J,M%O]&3O8ZA-VM_Z=%*
M5H(4&O=UY+1#INL,31$RAVNF 1UGLVJK"$X" %=5_:54;3F/!;4VFN-DCTHY
M3I/Y&F1%[^/YLE+0Y)*AXCU ?MZZ#D_7%TS7P\TH"J(?#[4HPF<^J^\( QOG
MJX@/#9F8TA 3[3XO<YS]E3IF%7+$-'V'8E[N(J([:TREYW=4M);Z#!ACO<V2
M$XH<[[4 BF_.G1IW(^H6$SQ PC&_Q;Q@TJZ$Q^)-+=W;E6*S/@^$61P*%/^*
MF.,&UIGV: @D..>"98-8%FB1IEM826#^RK/?CMK+8LRM&41/8TZ39;$42K3R
ML'+7,G,=".((NB]=P.#@TI*B?\&4&=XV>CRI[MA"&%F"O@V7G23(*]&'+"L3
MC:+Z:#2$0AWX!F1Z8L+.GPH5#B?%?: &LST+>]U\KD#@Q,F]:3-A*45S2NT9
M*(1_E/Y9W(),PA?\M3HU3+Z7L$K"L^IMJS%NPB%];[+U5U]#V+LJ_2JYV\7&
M(3[0JL7>Z=UMKP%N^5!CO,5*GG&O[2T_ SHW_P#=LI+,X\?^GHMCMU+_OF78
M?>Z=S(:LX<TUHX!@6='\\+S5_NZ$(-]+L5HD ])HZFLS0U>\;F5M&M6+9?#:
M>M[G^'.1^"P['L'AV4O$\LB&-Y=(-+^.9%)ZQNCE5CQ8.T+D?+XR-*F:0(8[
MB9LTQ>EN7 %F+//6X[Y,D<4<7ECSY*JF?AK0+3YE435O"&L/K(;]*" -U5R>
MUUU>6VV!/!*34=8U_%V8:<1JX+G>14^LU<-V&\,>'R5E,-V1_#6[JQ,$06S.
M9>>J)U08S,CWBIEFSO3V+;(^.?3:/6^LV>?Z@"7KE^U@FQ3C'Q_WXL%:7[[?
M/F[2%R\.$,I:3%:CR_F\Z[Z7$$X.P6Z<<:2X<*4[V"UI'[:>?_OY8:"YT[.8
M=V[W0>Y'TZW@0UC%)OG/XB,=-_-QG/C]W\;>R9B- O )M+7A.B>LP&8F>_9P
M="N"T3+LG@)]79R\71'V39=C6<Y4,90Q1I])G-?)7SWBSOPSQ<3R?=9KWRY9
M;-Y?B(U0;CF=)*@CZ[6S?V#5Q9;D9YH'TBIVA(57[1U<^YD6NMO_69;_7\5:
MJ $:MSS&X.K?R#AKN8D,#RB0Z9QM='=ZV;/DN&2J7-JK&X%)<M3!S6^^M +/
MHH8<B3.D:(MV.P'KQ;[!8S$J<()VH;L^[I.HTCSV9T[CGFKA[)L1GV!$UR9T
M%UZ&@?' Y3)93F2W[ITZN,9(_O C0W5025KL /5+&,W+&C(RO8\5O#!#8Q/(
MO]/'H$S*_1GC1,C&J<EB@4KQWA"R(2<[&]9S(:C9UM&0S]Z?-HH&NBE]>^-4
M1%*]F,/GO5G@\&R&8#&^)UZ%&6DH]-J?H[*@/IXUI=#NJHR5)SGN"\-92(6*
M_=Z#[L*@,HHN34T=#6T1(BPF7*:O/CN>X4QW06QS3QL_V_2 QBM*2D!J7=4@
M6Q@G)&=;25>XN2_;L+7670Z^.ET.KO_: :V>#>'XHJX^NCL$;M^!3;8O_D0F
MH 5R).)6QA-9:X;XDI@"&-0:V#@U>< /E>G<85\)AA/PH7-%<T\_<O59*35O
M)79[%ZLU-<=5'*JV,IQU 1R8-FF4<8;R]@P\ ?*J+H3&SYRR#6Q(20*(JZPF
M.SCGS&?P7HQ![)PB6[JQ/'1[Q"ZO-Z<;"M^AA4>/A+\5"Q9GU+0K@\2D_3@)
MF6,*'VN_]8WG>"V$H"PQ\YI[,DH&*]O<E%NW9JPL%^:M=*GT*]S(/ZS9-*_Z
M;F^:U,/B%<1A/FL:C=["#9!O:]ESY3H))PT!?*\4_.5'#*KQJM:V/>^WW%ZF
M%ODS6@8Y:?,UR7N<44\3$8"M8&MQ_M_3@G63SC52&F\91O5O!]-"/$S"[\:(
M>+UE*BO]6CL5TAZ4<?+A"M!H-J8@O3]@&%\F4.IIO7!VV)AF^\#6 %]<N#"[
M)37$_#??P]YB-7F?,_D9EC)2_]5+%7IMP5X:61J1D.T$3OT_:J+>,FW3LTY#
M%Q,W7SX^EHEVP,;X)1B!<V:?R_F[07.T*.W&WP!S/S3EOC*P_-.!#6^M=D/3
M&)LU9$UO411J>1YK)+ -'-F#YU:2@1D9@G%KNB<?,>(68*WZ^34OZ'5] ;90
MG%^8K2K5%#$^$?3S"[-!V2QL(ZP7LD/_MN)S2F=$5?4430ZR>96FMR%98H5S
MCX(TPI]YI_Y&?S#"%Q=MGD@P@&T7WS;J-F2,TMTG>2K%D9L(4%B?SK3%^A?[
M5=HLNBF\92E L0Q!?#-O9<FS=0N0=[]('>.:&BF-DH% ;[E;AJ=+UG^_'&JL
ME6,UW=D6NO%:Y#%QX/:<ST2^!&N!W?K."GLI4*"0-8QOTN8$+ C<WV]G[HJF
M;J@,*L(4HUIW86$*UL60>?<==VN"<8(^$I:F)=@VL5(?LR50VRB^;,XPNGZ7
ME)B[('A\.ES([0[?+]$:FQ'J,HZ8O[<?,-E=[J*USI:<*[JQFU6,9O'L\/WJ
MPV^'&R?"@YZJK2DPR\ZI#MI%]\?OM_SWV!\3">>S.$<7 L)WUBG9.7#Y$,JI
MINQHX9;GOXMF(=  "POKH>=($>L/IYF40>K:_?E69?QA1^-!KB>G>5QPG)G6
MN#C,+E"BVFBX?,3;\^9&^NQ7%C[J@P*#T-]5.$4-:V_?[N/<+%-BO[7P92>[
M+I8Q&TT/G^FV[5Y+[CA&(V0]F%-A5U?9*)"?0:P!/]/)!O)ZF=#W,FBE,;R6
M+IK&$P8?U+,_AKYJU'>NU1:_<7L0V/#(2+-$TWV].,?[IB"C_+/BP#YMQ;[I
MDY)*&+^?$\M"BC5<-I]*M%!'JDS9LF7Z9$(Y(QFSV9"O<9R'HWLZI?18X .)
M7+[]3QQ51NR)Z/:4F@O,YK.9H14GHGNH!^>H4)G94,%D1J>2!86N63TE7^83
M4?W.5>RS-U"]WX$4+OOT/-H 0SY3!K).7RE]L@@^ D6P4TOSTU4H5D"V3^Y^
MC0?.*_WZIPZM!J)3$HZXR=VF&=U2NT4GYX+4G8U^)!7AHAZB6RW70ZV737'2
M+8\91;6=_!MI*YL7/M]Z1-CN'75#ER^Y&W?*EBM:5$V7[^TV;[S@U[C]2?<6
MC#1D<?RR]/X5@$IA:[L_6"/+XWN$D]4CF%)ET7<?1NU(GW[VD.#IOWDX">W?
M>R04S#O:(C^GD0\>&0$_1V;LSRIA*=:97W\)Y?:\%T*6=B1PR\J #R$\5-B[
M5I[RE!)1&JK0D:PGA;H"&,>OZ$Z\C9J0_P(4GBM^WNI"YJH<N3D2ZG^SE*&S
MT9*;:<_%.2TTVS;+@G^L7.] K/+HQ)M^T*GXH2>[GUGX<:O[[-H"2J75?K$?
MY=ECJ?3:Y<G4O31SBU^A\0G-C3[]7%GE*+F>"V[SF-VP3'_3XU\Y;V3F%(VT
M.M<^1OD<;H_I#(Q?<FQ-RUE*-DUY+DSJ)+M^I@<O#[:DDZ1I\3GZ]S/;3"YS
M[/J1M"$:XZER3!MF2W_8T?:L:FWFM39Q^U(C=?J\V5<_NHHW&J2'Q1T9S1;D
MK)THY5&7^0@:CU=<NX--SU// X4"2OR!/LZWKAO".0+OT>&3M.ZOB>=*EM3B
MQ97?2>FUYM7YO>NQ*[;7A1H56V_6#?O5UT/4?'<]%]<7J&2$9_]Q$&B#=MOE
M^O%S7%2D019"_J//(F>/06L]-\3$6G=YI!<[W;6@48"Z\Y8UX:/*W10VXUUO
M:RE805O'QQ62"ANKP2''HI52&;B;&+=UYE,3I1K[4E;!G9VJBGEX>![SPF)0
M./>[.[XM>E-[?XY(TJY3"?\'\!6@B(SWKL=8J7*(,2,Z)E4\!1K&(5<[H(3Q
MY$Q\Z=7DQKI'\WGE]9@M,GYL&L1ALSCG_J$S@I*]%0\CD>H;81?Y8I0&>'QW
M7=F]/;9K=D1@>D)7675&A@HXX_79X<:^_T^ HQ"MIKXD)-L\GS=)DU1;OF@*
MPQEV[L,_@N!'&>C^F3$<M K*/6J9M%V;V6R4S5SH:T,P'OZ^'#'?@0.S]L;S
MA7@:AB/+NH'"O"0^F'[+T A&WR 9IUH*_WMNEX,2PV0[?=!=Z)@5;I+K, -$
M_SL&4>2.2B[)1+*\U^4H4F7T#L]YM$&&D,GB[M;M25.DP\A? ;XSG&/0=((G
MYW5- H05K[ ZL [B%E!'LL73=84),\1Y<>(XFX[R[!M$M@]/*=5LK$V&=.Q!
M TS33%O,6ML3&B*8#T/:58'0NL6N-"MX*:KXS2T*C4=&/_*;5K9'15*BPT4T
M(T196G(9-;V]0_B+ F[]4&]ZT7./17"/2R$X.3UUV988<J>X+.8,^GW3<&O?
MAMU-;'!XS1S3S;VLQ)7^O8"ZVDQ[LHJ48(?Q,_Z61<3UV-X_)3P8F1G3Z\W%
M;]SS;>.#OQMPOE_7QQ,RTZI\^&>G0E.D:$V[/0S<<+:PD GV+(/9X=B?(I 1
MM3UR[[6ZU)@..FN%HUS\)W/S8[]QTCPN#36:\ .>ZSHU(J+%A_/5A[$>,>KJ
MHJ/L2HG"E9[<R]8+>94H6RL;L'58 8;2PMY.>OO>]].YF@'VIHW[5B?1]7H^
MIE/2UA+/OK<U3![^W/TBP5\61[X@^_B\2\OG@*Z%;&4Z-L?ET$DG+]CTX[IC
M,]0O.%@V+_UC:35LOF-PQURTUOU5J>*W_G9X_;$>I-[WX)1S.@=GIO9;;^8*
MH -/)K^SJNU-.Y7-OS40Y7/&!5'KRI>IQ06/'$-"6LWB@$RML79.7HE-?/1X
MY,/EO>BZC6TIF>F"VRQ5GM33J-!P!T;"*Q8R[WZ2ES2N@>P_&FU8?\/$=\4]
MX[+YX\ 63\95R1]*U*<1<WO0&C!O+=U7>BSRFT4\S3!@?=RMI,#M:-*S-3<P
MV\(^VM9.SL_+^C),D;.8R=#6/_3/?]]*\7\-0?UQE\IX<'>X<-A-LY;FMMB(
M_.E?K,GW:K(H,W9G-1\_XDI1-QKW2S"XY2:;G?ZV"SVXQ9_-9E8HS':S^M<-
M=:9G_X"$M?&[V_0':^NG&<>_O@3QIT:5"VUI*Y.^ M'CAY;V.+8FW+)EX9Q3
M^T1#C'VX+"8_X3::/\=GAQ4%3/5!H8^Q>SUW?%DFYD>\73?>JRYSCGWFXX*L
M70'H EE[03(XKS=0NS TF&RR2 STI<P-XBXJV=3%01C)E_U%-B-MJOGV,&2$
MN/LX@_6L$C4_Q_,V\X22>6V(0>J&\@UB;%7P?]00U1'/\='+GK1'.T<2#!MG
M8:BP#7$8.E[]K$+R7H,H% /7E:_>J;9OA6<%:"K1<G($QW#0'WZF^J_W ?P'
M7 (3C#U9N\_R/[^VJ!)SRKW)1E+.LEY:' [&)UQ2%N(R^GN,S3?S;V,]UYJ,
M^3Q\M_OL\TM9S4<AA^MH5D(<2.!:$)S&+N/="4^Q<N_JJU2,G/*68P)7A)Q>
M/(AZ>+R9C3V@G'(=!8T<!H?U]^)H'>*&BBD_,@8K%N__/EK$AT#[23.T%KNX
M*#748N9+;1*Y0^>G$J!XH%Q?V9M=+.+U)"?='Z\KP*EXAS&N)Q,DC%L=WW@/
MG_[$3H0!6>.W5,],N!DL#$K^_M$8%\GKS2D[0^;64>Y[1T] L?(K.6B!SSGU
M13#(5KL!W .Q5-6A="Y6'V#)&IU_4< 8)"MW3U*Y[I6>Z]P5H%/_4G1V(4./
MN]/L3NBW.S>M01BKX-B1!64%L_7*X-#:@>B[:6'!9J_$!<<)Q-[E VR?9N:*
M#!BBK(1'P9R/BHWI+7.,DC1V,2[K-6/O^NPWF\Y%1IH5P?JMX)KC^48"TS8Z
M$=MZ!7B!UWSS.D$1AKP0:%J,C\":T25PD2$F,=(8LDY6J1&*#&]006!H72[@
MOB]PC?T*D!#.R.+/L)FJ7"AZPZMJ. EH(*?XB>CF^&0\3H(I,&JEYZP-V4A"
MZ"<OQ6L6^RUMH;>G_G[+M6\]4JS-S/K=XX-VXB<-XS;>O?8HI(5XE#Y9=!N1
MP0OI[;W+IQ5BU[^]QQ_6G,9VYI-2).XJ.!VK'-9VB& S\DAT,M.$@BBZ8M@H
M-8-WJY4< E1B#&(7J(R=&PL\#H:!ZRQ_S+PN6Q\*0F$RFU-5I@PZ]"U'RFT:
M#@K&STK93S;"^*\#H! _FQ\JMD1'8%V,V'<*(>N"X8$=%6B,K*(M0^>R+=TV
M1E)=#.+;4%W:\;3?2QF%D"08%O="7O+'4K$3O52\\T-%:FD"IF^>'5J3\V:W
M4;;'. ,473:5+K>@>"E<\#V"Z0JP5!; 3>NK^*EJE\ #"TQV%!BDD65;CU+1
MR,H(+]B)H@G=C5BJ+V"_\0.+B*2[Z(8A3J4ZB(E=Y6&EF9<4D[@T;*A<@?XO
M=J,:'+R(]=G"(XH4@P/&8:!OQ%H^X]^!I4,.G 8CG3$=K66ZU6+ V4W;MQ5O
MB@>,ZLL[]AN7/5.LKP"Q$Z&>5X OX!_<>(F.*\#JH,KR80%[Q(8IENR2:N_Z
M<757 *C!'[G.B-K&KD52B()FPATH_3!IQI=2FPY;P\R,D$],=*EF/#KYDHQY
M,_/88O_YPDG/PCT$/DRP;_&,N>W&%2#J_'JVJ@N7^PDL+FC^DT3I;2A;8$@7
M2S#)WMJ<M=NT'(3OX9+*R*MNP!$:(2?<V;3E+I"[M!)B6S[75^EDFONY:&IZ
MV^]ORKP>XW$7#A$GWCN27AI3K022T[[XG#&)"8S5-'+N)#RPH4+OX44T>T:
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MD_[['NQ_@9BN7ZLVD+='9.FCI\*2)*?WFDRX8/>R =V(]'ZO,Y\?GZCQ+2T
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MXATJH >H^UV]'9XWJ'6F4-8_8_WLHW6I/"_)T0N:T!@-FK!YG/$Q&&^\Y*E
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M@_6F6%J</,5C<&"[_W@!9R!A'K_]P]*W9;ZSP*3^XT7^KMK!1]Z/4*C.P14
M,Z^B,3$Q_V"=/E;]-MD6Y'/!\Y A0=;]N@;0TUQ2 G"D[4EJ2<D:^]U(;[Q9
M4M27D6"C&<6B!I"::/>!^J^"KAPWL7;6U'F\SXK3PIN6F_51NIIQ73.)CL*'
M_=Z6P6.][*5O9%.MM>WI:,=O,2;2ABE74"VQQDC#6 G/)GPQ]B;QTQJCW(5<
M78@G]MCJ^&E>S<L>N*>"Y#WS;)XW^?"E]=MMXN!WB<Q<SE,+#9=9^TIZ.6O-
M-\69UF)]/J8O-)@2O,:&V=LU#GJ0N"=93=F:J$B_5WH!5P" F$,-_A,LE$3*
M0AUXB5U6B^8E.3NP0'!*<PIVVK+ 6[EIQBY?D\P\2AHV^/T-U%<32H,F/QP)
M<FSSZ!;N222DYA\=F;#WOF#_6EG,J;@5=@1Q>-6W =1X.>XWQ6TB&%<%DQ;&
ME+0E%G=):47NM[YFZPT]*7='[44NQ^HGH7\??IMI^R TNA#L,-$HKF3&:*/<
MD1="^GL=]#0NED?3X13Y<7LL#%H^UQ_ FZ66]NHEL'OP)6VZMH_'41W(A7<P
M[.TZQ6SZS RLUQ\^V))?"H*%\$]U>Z6.AD4>PIY>Y(3:+##B/S@/_WQO_<9K
M[]YU971NEO& [;6HAEGI[1&]4JMZ5F^I0;MNN@7:BCU;XX1N3<:8/+(Z4] D
M^]L8((42T-1(C[L0Q1K+Q*EZZF=>H)\MI\:78][V=I_N,_,^%,.VHNE&%HW9
MM6N*H@@=6.!)_'Y>.$<]?6@\1!?].7[6+']_*@;W\FV9X&9^[F7Z,M?]2; >
MLC1IE[1;EJ,#TU]@;$OU?G4WF7^Z# 3QJ/I#0,1(:?WJ'X2[YXXJ L%>Q6(2
M3]JGO5BHM.ZX@3\3QY]  00IV18=T9]5KY8R?@R,O$30B'OL\!:(ZQV\Z/GL
MMZ,>HAG;]D(4I:@:)1O*,'P_)?CH(-0IS&W2DG<.+>HO82G-G$:(6.+@*ESF
M-.NLL]I*;6Y ];ZM6=,"^,JLY0OB&BK0[&E(RZ3>+NJ5$+-Q%3:)Q'S&UIO/
MW<2?17?[],-#84PT/)U;"G]A?!!F/605\W"]HOPK6^NO./.X:K^2^9OU.R-I
MVB#X-J*..^HNKJ!G2%M\W+E^DAZV&HU8*],W">OT,'M?BPGK2-^TI0+Q=V+[
M3!&-27\[G(T<1IDB TF0-=D:]=@/,9PA(Q9<N]YWCB1EA)=9$?Q.!Z!)[-N6
ML7=M89ZB?]WJ!XA[_;S,3D 6)!Z\$P@=$&TG#:Q+A43-@VBV_\N?HA?^AEZ1
MX>GX"!SK<3T2;BU+\Z";Q#4#=DLNP/ * $L?#: ^YCB&H?9FUH8+ .%LK0S#
M"[<G*03+5)R2VT#L0S7R*F[&MSX&53EMAHUQOZY-M+'&N*/34J2TU;TJ%V!C
MQK]<O\:?^QQ%_D\\$: R@B7PS25]&*6GYL]S@PQ<:3K".>!G&9*L9.<0 V8>
M(3SYM:NDN0QL!TWS2$\JJ?"\^/PMG:T9] .9DZ7?KD03M!P1]T60'7@^[3\)
MWIX8WN[2R*UA6@$OO3([[$!$7ICUT;MQW9T\W%RFHAEI:Z1[Y?@C[N[ J??8
MNID3#I1.'MF^HR/0"/DV,#9RBTU<.;*:U1!OS)S?#!6(M6,NKOLSIZ9X6I1R
M_U?T4EK(<3EPV8!Q2\5>MTH ^*1V?'WR5]7$P]3AD,>82 ,DY_;*6HZ+?'"Z
MG3&=_VJS1[$0ZA>BK9!3YD.K+KC*(Z2"-++BM@ZS9TFCF^+Y]'CC#%"PH5U_
M\9+%+'K8ZPHPZY_S++(_ J8#_X:?5)UP:8S9>]X8I1M-QU 7MJ9,]PMY[0+)
M98N;Z69X3T-E?9</8(RWP@W'](,/*VD"ED_B81XCN?XU2A).'J\+F[2^C[]N
MYEN1>D4KY9_XYK>IS$'E<32;[E;;Q*:K =+$_V@&E&)6@C(>VM]*9SB>MH8*
M7=[Q71R#VNJUX=9C#\^GZYNGJKXTF]'7>_WA2=&I0R>%2U!ML+;DEOU-"!P2
M?=RPYQ7?C/F08GEP\?\Q]M9!44?OV_ B*@+2W2@E4H)TK8"T@'2S(LU*=RTA
M72NMI!(B$@O"TB'=M90LO72Z2RZPP.OW>7[O/.]3,^\?9^8S9T[<YYSYW'-=
M]W5"]3=CY6S:.K7Y,^2^+MC&^4U<)F&#G]3ZMWU+ML16B1_8Y/[74T_M(Z8U
M?EE9< CN= D:  (W:_8D82I2R2[2],G.M'D=?HYMB]L/@G8.TNV7XU3,=LL&
MT)^?39<X9R7=[,-_)=H>NEYXF+=4;8[2]4TZ6]&VSKJZ<-:"A40MD-$GK.+0
MU)?A^?)Y8)GN.P#E/RYR*.@*)WFN)3[+!ZKGZM+@25:[3OH-8+O)AX/4T/DM
M7_?RGT0O[U@N.),3%K:T/GK5V/?(V\)=1>35H8F94'>2T9&+(??4&GHF;RF\
M(9L)#!67B1OD5"-W#POT'2/0AXK['YS)2D=RC:1/I\77%5>EYZ9ZJ,_+<3V
M-6^B\SRZ[48-/5,;FJ=:FK7GU"5\9\L->;Z7N?H$.B3"7?2V9J5DY3Q*YU>*
M<LS_"MOS]AD,T^._XRAH#9';<[OG;W\'Z-8I+SGLLB1."!<9(R_7\"494]GJ
MTW';#>/S#]2A*^G+L?;[/F_Z!\D]G%#CL753_(RHA1I@+!=P(\V*:,/5Q\PN
M"IO$&:3O-CA('KM1%S?IQ3M?U#I?.2)G+AN;\SLUDKAH&-R&+NL#99;F+T$;
M^;W4NB #_V__5ZXNA]/!@.*\_Y([![ZNE[\?L8S)$UC0RZ$C8[+E:UQ*+/
M*1J/WO*A[4N*L1U]0D'H92 +BZ>;>+\!?Z++]%==AD5"K6(?^MU7K$OHOPJ-
MZ([P.KGG>YM"@@(">CSYP.8-TN6BB3EEBY7N$**+;GG\">]*%1WQ*P1"\OL[
M3WR\"5;L;H'S[K-_SDB,Q55 J8^5%ZHW"V&W&G4K4Z=V68M.1W*:,.D3^;_S
MPS^E.;,,H,?*H$:!QC-'=6ZQGKOBS4D+2_!L)X]F#@D+NS; X+KD5[)7:'45
M=&:ZC8M"T3$=V+GI6I?M=$KVZ*P8\VUFZO6)Z&LGV--L7D9J'Y5,,7=+/.LP
MM?M>5X8WI&-_=1 " C"8=DD M;5=BW#L2.52?3(! O:6(#588EK6O'3)PMGJ
M1?Z^-L*F%NCH8N5_+^1K\UKA(_G7Q*W6G\]T_Z3MR+-BOG]$C8LZ(MORB]]?
M[[L]>]^^X=/?%L!V*$V^XO]X#Z6_BBD3GHG8MG?/M\+YW@%,K^:$O64Y[P"L
ML@\AS*K.OX2^W'SWSE@@2PE[>-CJP%2+]?M*5OK/SP+0*T@A/1>)'LB#5#G/
MA:YCXB_CYR,U 3#7Q_X<;CX?5K>;6/@*L7+EZF66>T]NGRY@M]\_.?[VRSRT
M]CB \Z4#$-'LQKJ,E7@#KV_$A"$BF>)?716KK<MU'1&<_FP'S+82_!SW;2=U
M8?FNK.]QDT6DXKN=M/!J/!!P^!^=]-+<9(YC6M8+]0<NX- _!W/Y4>=>0"Q:
M8)<L4![YO'3SW_KL]X8PK.HS^2NI"XL78B[QP<[S_S7UL+RS%2I3K&IO/N<U
M3R^+DI)YPBY/8ZT.:6N-*@_@TQ(9$1Y'%=].Z+V54"<L4+WE%A$"&@L''2(4
M-D3_84[J6^:KMP_/O&YEYTY!I/[&;YLQ#Q!()QTJ);[<S8\1+:^84[V0S43'
M(*1^MW1'O"Q=26_1[NA/'9>?W3X"S=66DX7MGCKT&V1]8;*AW>*L-.VSIWF,
M*[WR[)/>U_T-H%KG;),X'[S[45^)!540(@\]QF2,Y]C?&8]V4/L 68/?3'D'
M\=ZR+#IZS#M_ HGM[Q$*_LX)IT<V7L^/!1DC-"]4$6&T_Y<@&FDHBC@6]P!E
M;!-E*;*1=@?XD-U!)63<G>T7 Y?S#=%BOQ:H^:SX@M%8]AG(R@,$!]+< 38R
ML?VWO^<*KI[L7T*SC\"C[=Z(-W1A++\>^ <D6V$0'_4]-(-\S-A>YFSLBY9I
M:!?%)_UU+5O0^?W7]7%@(AM8Z^M0GPI^+55^AI7IIZ?K'U=D48W#X/E*\Q=#
MF (;?0OG"V,@WXC:*<"X*3J[>]*[R0U2JOB[L87G6ULI[C6&)_)(J A]VQ%:
MU.US/%8O04*>U2"C5F6]&<#IX"MXX#G6SP4M$V/P2-O7>)D,SM./-$]5EVC:
MZ4KD7>KCE6C9NU%_?[E LX(3FX##&)Q3=J[D$I8U E*RHN*\+CZ?WFN]I31L
MW)^P;]]!0W+LT/UK@BENA7)19[VK=%G&L_MMQ5ELWO52^&$$KCI>5MK6\5?-
MB1P8]7F0W=9X!NK-^+4$&:O)B;;KY$&!WTZ +8CDS"TZ7P;QX+P 7(E\>?1%
M8(OR&4L"1&S%^7PN*SMC+?/)/8J6H80,G5>\&' 6V$6T1+:T\9*E&=<>%NAA
M0KX_]T(#440CQ==XRB&VII)O;=50W^P9WP ;P-57!JN(E4UK9C^?L_1IHMVU
MB3?GL4_EC5'=(5BW(,G+:X?]L#!;4&-]9_*\5/?0JA>8*'I#UF7L#D_TRY+^
M&(:0'$__O.WP#<9U+9]3:A72H!F'V%I+> ]:Y?BQ7@-3)8[O;1K2@_)L(.4L
MZKW2G25H"[1'+_.^YZ&]M%JF7C-6%H[Z\(?RU70FYJ/@[?3!'(UHP9(J9;L
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M5UU2>93T>NQGQ1X8OS\>P*6!S-+7N1<N=-HUW-/2"UIL2B=ON?:DQ7-H$C_
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M,/LPO)D2&,-0]3P@2P:",%*WNKDAY>]@TV8>IN"B[[6ZF+D4$HF.J=0L[..
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MAE@05,@H9R"]N9N/WY.TD>"CI=A*3P?="C;D=%YP2]Q3D&5H+=>[T[4TF:\
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M/S"#(+*YHV)1F#$H27TFIU1_&G]:1D0 M<UV5')@[C'X2.>AU?*>%15"$"Y
MT2KV0PO,G+;SE]\S1^(Y86RK;9&+K)TZLP>(]K:/C476V@$%?>0/[I/>CN)!
M]R<$,R_S(@Y.P?1U&Q.F]DG*^=2XU>+YX<U?;3K<[3L-C?%'][,)*1TM7-4Y
MW@UU3U/,AG'"GF!3D6W?*SFS"WK$T7WYN_RSF6:6J771SZ:\:EMLTY*[ :D
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MQ/5QP-A*:*G-Y1P3BL7JF6#$RV>#G8"+<:S-\5>BC^OI E.=^?QRV)K_](2
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M=2Z'B]7GVCHFE7X:#,Y(271 5?2A3"O9X3VE E.[])1/Q/MUX#O&UDUF;2&
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MF?,.MQB2 [5I_[BFL6V\J+GI]U"864565Y<4(4GZJ<,Y8A6)6(8Q[O9H=V2
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MLY7R?$<_*._JL6&ZV::'55(F^;5AOKY[A;L^!#?":*&S-_RHH=2)K%3$[08
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M '[A?;]N -TPC*F+)*P;[!%S? /X0E]IP8 I/M7#]6%V5T$(+.5MU"\\P$K
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M(S[(3VPWUH]O9JFIF)8H)U2B'OK40STY3>2VHE?QXLM'QS+Z!,ZZB=?9K]8
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M_FQ]CSCNJ'>R;3OV@(06\.] 3R81RP\GCBM-NZ??"HNUT.TW@Z<G7NRZL?I
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M.;)H 9:>!H]@Q10R(\YW5+I?1,$+H]U_>_AU[G[!:A1RJ;Z*:LG.C5M!9 ^
M[OLNKFQ^\CH$XG2Z] >7=2A5$QP8)-[5')"EL2FM-\2([H^,*4G1K<(*;7U'
M)KZ*T]HPEVH7RBK( B=N '@.!8H;P)89IO$:, O#BHL$BN-@C\,@I#C[K\><
MVHV<-P E^(;775\%C<O%)0:DSOU^S*92?=39WD7,/0&7XW-;TA_$P%W5@UQT
M9.;&5$T+:?TSRJ*6@GU7^;2C.>5L2Q$G$7AXC\S(J;VLZ:CM.; R?#DGF 3_
M,YOE!M#EA;@!T&@E+2-ZMCIN *%M8CF']J>K-P ;^  P]E\;7 [IS$VW0*QH
MO>&Z3J_[]8QKSR9^++]_(9NYB8'S3N+-2WW37R'S_>3/D039+WZ?59E1^D#H
MOS^KDY9N;0>[UD[^_6BF&].K&^J T[$-<EH[2-7YT:C@^6^_ (\$<+=Y#Q"X
M]:L;S@>SK\C; V($_!5][_IO3XU6FLZP.=R;#.U9K[[BJ^I(Y@E52IYY,O8L
MS&F?\)9C[&NR\%W^0(Q>$QP:C%REAQB<W;*?8.@QO <1[O*Q@Q'3 U1Z[P([
M-?' 2^/\@ L81!AXMW@V_BH%D3FLUGN6SMYVM.V3."NSY!H9M?$=#>5TO.:*
MX,DO'?4D49#UJJ1_7)?N0+K0<@TIW>JGB\B(CA7_>0-H.SQSORX^=KP!W*/J
MB;]@D!.X_5*)1;P622>$8A1"Z6OZ'Z%Z;<_\8BW1/FVEY:HX8:',#SAQ]C]\
M+0;K)L0L7H>.DL&6*!IO'0$9OB=V8DEU-]Y^3<%^#::9@X%?L]X QAJ787A
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M8-9IW:A SAM V)%>O<,IYD4'?,]DYFM8IO@<8=Y08EI#7$+&-Z,"@^5Y#OX
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M[TA_R?Q9E_C4WA%VC^(_>*I62G\<L\%;B9J7S]O,,,_@Q*0O$!X6VT#R]\B
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M'"53SOUX!5X_\Z]9K,:WGG9*H^$%F.#XKE_]P0G4;!MR]_3;&?_[J^?(LQM
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M-;W59C\3[<RTB-7^7Y5;C\H^K/V0]UI#5607[_G6R- F^12/,.361A=\_#8
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MK\)@QK<KHG3ZZ'=B%K[,U;GTQ26' 9)YD Y)'#<X\07&K6+;F[8^E96[+B9
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M&PALZ4G!P7!/W4/!,M?*WQV_B2\?+7_90GN 2L\^J[A0O'MI&.:+!8"9I_+
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MV)C<]:%.%)#3562CR X0:>UN\F@Y X-""O=>)H5?WQ\OQXA6.5E32QDRR>F
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M6V8UXP@'"!6)RR_H"D-.7%W1[(%O=W"!V?H6AE+^1@4F.>[:T!#& @B[9K"
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MLH LP-N[_OJZ^(XTWF/%M[ZV*+NZ\_%Z^;([N^M8BA0PI^._FWQ;]W3\FAJ
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M7A.A4Y>E$BT[KCEH,^F$(30'.6?OI?(<H2[W?GJTH6\G?WW$B?M6"1#;E_C
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M;G^NM^":^1"%!4QU(- 2-[<#J/[$;"C'?J47([.TA@7 (Z#_.()): ]$+Q8
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MA9D33<ZRT/^BBA0N=N:_ 5!+ P04    " #3.W!6LU?D4DD# 0"S"@$ &
M &%C:74M,C R,C$R,S%X,C!F,#0R+FIP9YR[95@<0=0F.D!P"^Z2X R0X! L
MD& A>' ++L/@[A(([A+<W8([!'?W&=PEP PZ^,WW/7M7GKM[[^X]76__J*KN
MY[S57:?..5W]LORR"7C]149>!H"$#  @_3L +U# )P *,O)_E'_RZE]!Q4!%
M??4*%0L='0T#!PL'!QL+&QL7C_ U+AX!'C;V:]+7!$3$)"0D./ADY*3$Y(3$
M),3_<1,DE'_7O$+%1$7%),;%QB7^/Y:7/P "#"02E'84I+< 9 (D% *DEWX
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M>Z=5V]*GZ_WRF^)M0S:+%5[VE?%6B\4_RM^R?""F=8(^)1M]'XY\R%&VN:R
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M+*<%#\)#A<I%7.5:BCD3EV#TD&LZSL?>P:\U*[_=R9Q\W>ET ;=T(72$?"^
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M'15IGM39(HM-:=ZFUFYOVCB]/1W,->3FDUPX6R,.@M !]RX53>Z__:UD<5M
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M<X\77NW6D_I7V%Y,EF>N]86UKI[NFW PIQF[(:/TFX],Q%=3-)[\D[(/'(_
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M <M@I[WR4DWC7;4?\Y%6>F>_[D3#;RCD&#[B^#YT(G.S'ZR/G]KQZ;?NWQ>
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M3E_ECUCUB!P[9',EK%_NO LXM?^9;'?O5].DLND#M1TY.8I=;/(#ZAS=KT=
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MGPUUUD_MJ^AO@5TW1?K[V#>&%[3J961@&HU9[S#XD0<VWC$2#/)&'#4<\KT
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MC&&5H4(3C*VP.#EYL]5F\H\;@$ZY'4WSS\=R"L9KDG^+:["-?B+P^1E@4A'
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M98_[2AQ8;%_X*3[5;3R>0&H[\7U@A%D!^=3'Z;L1[G1&MR7+G@LI\@G> G$
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MCU#KFK,&3XYF$<?8[ZH@8&^+I6M=:(BR"WJIBD_9D KI?E]"H<':8:J1CT%
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MMRU.-EB -VN.2*K,YL\]/-U;+5LBJLQ,^RP 8J\]F',OX)6BG<&S [+TBZC
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M&@/RW2P?A>UL6:CG2!"C$2)R#TH?2=#_(G6T6FH,I0>5A28HY;&I9M;L,2\
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M.<9J<S.1;VO C&9J)9] D?HWB\A&M?NT)L6USNQA]XQA9[.,Q&,8S'WX):X
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M?*# DTFH_N.'D_*$86>1+^ZXX;/A?$ODFC-V7<U3O,XB@X):<[\%"?JP\3$
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M-A5G,U)G<IG_ZT#'%I<$#5WUF6?OZ-S9Q^F3.WKK5<NG"WO6@\4+,(C&#5?
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M6;7GG&.,6GO-Q588,@T (,-R*NQX;,D]%F[F""&0[WLIH:ETVLH$(:,;U*@
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M2LC)!@MC_FH(ZP)_DPN=@LT@O.51R2QOPO-0.<)II6IRD4*7,:589':<<$P
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M/[IL<2.!VE/;4-;1KQT<WV@9QS%VY6EVM7%E&FWA W.2YNXJT^^SW7=TM5\
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M?+W?'\@_X^]2+%A6</3V2)!='#+LK?H92/ C,;#@1]AU3>&1:.*Q:9:!8K3
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M54AY.SO[T,BR27\VSE#5&XW0Y),-;AM2[YG[DL-E8=L9[OU)=1JX>V\/9!K
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M*T<,8SR2<WI\/>:8N%4ZQ8=O_<CI9=4/HPS=H#R;T)\,*)*GW="<1I9ERXX
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M9!]CUQ+>(#?^A$<^\92D4;+?V W?[)4NYF;SW* =8BY[>,#YJRW1*</9(9_
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M^A?N$'6RECF#M__&*,DNBSTGL>_"/TPJBWS7CZVMI2[Y\G>;[6\[:BYEU/"
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M.[7*L=WG.+J?#33-;?? /<5>H*8[5TAU[\0/?'BW ?A1\:ET#VUBJ@7IO#/
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M!S74WV164=<J=X>D8"3/(IVTT%A?3"!FW>GU:27J![L%IJ.S_2%&)OK*?E[
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M&#_.'5DM%=>.N:EL.'?@=A**4RSW8&O-6J'(]JP\7M<(. 6&*[-/E;MM!?+
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M_Q#_:=P!#; IG'X"$K.OU7;%5/7)FQ6@^\9#*Q1MR-L37:8E0SXNW0*<A^0
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MR.Y&GP,#';ES)('M"DB1(K/GFDS<SM3:.?V.$TFDS\PFMY7C3U5LM]]_$HX
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MKQ/-HS6J$I8EE=?NB4O39M=5IA_?9_=CYC*_ MV<]YH9KBGBL+-\*6E[2:;
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MS]*>7$&Z!N*GVJLM]OTG/5GU$K2<Q,0D=5+6#YY).J>\U'S&:3CZ\!EY.^.
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M?AEAWOI0KO% XQN[GM>[*R//B\.%6EX<]E#V;#8+52\9JV?**EA0RFQP<5]
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M'U9@'1?3B^T^4W->3,<]+OW[XZ@JD0^?^ZKOD>8S(<N(\$5+_N2A4,:LC\?
M4SOZ^R?V:1B]OHR1(,!;B4.O.5$79=L#L(/T0P*T/V:PMM3MYQ#-I&W BS+!
M#B^7K=E4"<6M;W%5^:4F0@;?X\5UD$4\ GC_5W%,16LUUD!!21R8,(KJX2V7
M<H[[0Y(07<V!R3$V_E,FB_[GFCK)OAEU%_EA-RF2"A3C!-8%<UMY)=.<XXBR
M=TORH0-/,5;"^5-,$TR5[]YOR+C#*@8DJ5.AIJUIAM,GOUY/-<9YDR9;HL9
M^+!<AE'XL) ]!%)DDKC@5QT(SU)$OLXL4K6+9;;IP'G=,?9BT4F3%]O4L%2A
M1=Q7_"']8.[<]:^=>\61&V)_@/(JH=0O1&?VU+ECA2H?R^3/FTU90)(IRXFU
M[\=TC=9>@(7\AV4XWA =-<+WZN.4./F\*6TW;+U^AL_ (.B;BNG\-+O'::EJ
MS^?"F(D5C+<%==[+ [L G.Y_:Q]0@X;@W4EBAW8WV@TFR2B0;2\)@/#>A30*
MC&6_$'HA*+[%Q2C'F%=@M=YY\K\!"O8HQ,XV-R5";4LMUMLU)IBF&6Z6>%R
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M37F7L'?L!&AED+7T6 V2E:+]#R60IO]4*Y%Z_D:1E,G.!R.>SP "J#;;9A[
MZ*(]://N_77)&7"DT96LVC1S40CX8F!B$,,_1FQN09XZP9Z3OQT3QV7A5XQ@
MWS&P=&]*.;E@J)3 $,T40%GT2X8&4\&B8_PKC[Y<91<=O''X;6RZ;L*D\:YU
MR""N9S?LDN'[+[!5 2)9L6%.H-.V7V/&E<'@^.2X6E.A."E:)SVL%\V7Y-SN
MF'WG%'A@AB:NY0X7V^2.VX))A1$^O!7P76I[IS_!>8G*,A"%NTM!XP?X,H7
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MH0S9N=OJOD_ZT7W+L-W)%2KNNE/R]ZX4Z8A0VP:A3<+)!D3!HH,M8?OZ3C"
MMV4E8QAYA?.RE,5'!7%JW>2^FO" Y+[3Z =JV"<Z_ Y9?]PD&YI4-2;==[72
M84E7?WMP0TF% =APPPV:Q@TZ1[H72%D[6+=VW2^P+P>FP-BQ(FH_U:GFTG-]
MZP*W%YHH]"GQ4PAEJ^U[H:V:&$YP4*G!81=?_ B93D=MLC7A9/+GTIZ='U*
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M;$]XS4/<\?4#NN$C +X<?G?%AUCQM'''1$IVXC Y10AEM(R0/P+RFFZ9[^3
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MU<UX"6^W&^N?6TD/G)_K,$(NT>\#DYS(0CA0/_GB#5TXGCK36=2'$*\#$NX
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M8 "RO+=<RT>;_I49/5&CJL^(VTLE%07P3'B%G(<D<GK:2=&/=/9O 9%SR,(
M0OYDUC\2N_'%RC_19SGJ%0!IO+9^.0A]3.QZ$>#[C4)X@.?__E<-DHE4[<O!
M1AF H-;0.TU69;NQ3$#[O&EN2]8@7/+"H2Z1O7YO#" F+D&"JY3>2VX;1N[P
M_O Z!\X0P+%;'-^C7<Q17S:@&7<@,+E7KJ%&;!56J:[R($1M/]W[B@X4BWH'
MVFXD,P2:]UQ(<7TK^/2[(>Z84S'"=Z6=1 H+4$J%WRS"G+Z6!@OOH]=[DH@F
MLDF.L-#!.]O#[0W%+_XJ+LR\*Q9BB(\2&-N_99W<P!^35[V=?-#U:_\?3!^
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M\S\F2GEKCTD$_UZ?_S#WG[M\5 HN3CB-_'L:[S=JKN<&C3DW39#6.?.JHAC
MY__2&:7B'V#=MB(W^B=8(+2HXE\H.9[-287@N?5+^T\Q@"M528^SDY7NH^@
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MG_%RE[+6&;TT0 U.TP,3A8+J+BL@U<L<U33XN;1@SVR_Z9."4B@"W#ZUFWK
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M>.3<.8O'Q0#L9;=65@3GVH_O3>/UVG-F9F<W3,1_;H(C,0!C!%=58Z.+C9B
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M[7YP!DK(LU05SAC93**S]]Q+48=(\%J?6#J]W*OYCH%U;+):#7=)_&.0R(S
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MLI;8[?D]8#IOL9^ Z>-5KVQ..LX-E>ED-+5_'*=3X<,2)>Q.["7')=\_P0K
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MJU8<&X88BK_+"#_T./TO4$L#!!0    ( -,[<%:V8B"?8 0  *X0   8
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M/SCYG'3TU<H"5Q_M3=Q=[2=_ 5!+ P04    " #3.W!6?]UAW7<$   %$0
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MS<MB!'N(@;XF2T5CPTS)9"IIP)A2Q-HO?*0*TM8PD1*#'<M5K<;>TFLJ/3
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M@ F0PV6VE"JOQJ!E2AR,$31\S?! ;0.U/0)C"YMIM'TPU/(J!!0;*&Z@N >
M^C*D@DM!:=/:YNZOZ&'=YY+3]=U?R549-'Z]K>GK0,X#.=^?G D9W3!JKD5,
M=XHB&R.^L.IV!)*!$ ="?( DQXJ^?A?-4,4W$-@C$IAMY$Y1W&39&[D;J&R@
MLGNJAQYX6E$T"O]&X2NG[!%X%)>$6C6R$X@9R&\@OT<@/ZHP8@RYW$*5]L;]
MU*@LU.!>'JCNWCZ_H%2(LSZ#</+&W,^![@:Z>S"WRR-5CDQ="EA"IAK?P6Q-
M8L9 > /AW8OP,-7UQJ@^QPE0F N!H+</\QU;@9"5"(C+C.E BTA0#BP2_.7T
M-#H^//US1!U+")Z/8=F$M*/G]K&!U@=:?USA/BN",N!4SW*&,Z0B=:=A6NOF
M+B5RZVCYY-5 S ,Q_RY.($G]1YR[L%==&]G3PXD.3NV!W!ZG]I*ZT$J19>CE
M'@K?!O)Z<%HKYJMC)"\7XA(Y>OQ=],R2EGGL@?44,+0= GVU 01C^T<OT]X&
M;>)KJ]##XJD*]MZE[07E(8C)DBUCC,_^1Y &X.M4$;=DA%QJ8.BWAXL@2+]#
M T6)V:+ /IFXY.AN68>*9KJ<($HTJ(/TMZC=@4> .=W3>[[6Z@JLI=]TF7$F
M#D?X.ACK/],KJSAZ*V^'OUZ3^50(H#63U75@4IU3MD1L2S'X%?A"6 NM+3@[
M??'D#.%[FZS"-3GWW9ULQZ#S^1R;?,)X/E%@^T#@W'=3<].#W>[PCCDYQ"$+
MPWUZCB42HZ8"G;K"D#UN*!5.WM*+Q/8FXW86.OJ5RXY:=!5\!2@,^*DTP]R$
MUWP071>,@ Q3UM1% P9BQQ7=4"\,W_4I^":^Z?WYU=OS?T;_$(?BIP8^^N+;
MDZ-GR5[<T[62.D!04RT[%; JL,ANM(35XCY1JG\J/&=;IJ*D6E)6 DM<I3.K
M9'!3>T[-53"6O8#,H[)!B?A0&D5=))^?,$[Z^P)WX0^M*3OSZ.SK,;X%F=NU
M$I42ZS4%PV8<Y1J(O%+E,G;EV X?U98MG1Q%J5I6%G0[;#(65"IQ<>H6B.?A
MX%Q'U)P6% E+JU*BS4CPQ1B,"TS;XFX*?.RP&032G!049SQP/MT?[ -_4[_I
MFD<); OX(79.^=1IPA+68BM@;-S\!]DEC\_5T,Z4H91(O8]_X[G*F&G\6V&F
M<SV;KP"V"(SP<*KB#<6_W-(#"[L59[PYY4!:^JJ9CQ!P31@^FN#!PNT"CG+Q
M!?F<=>Y2"A/>$1:*1QB#P+EC"YJX79(>G.:AZO:_JNJ6V8M4+%(CHBX]6\ ;
MI$^0%$SZ> Q,Q81D!:+F%H6D3HE \01][Q)U[CMJ<E@4:K_ELCFY;Z0T9#Z(
MWA<># K'Z!QNG>+'8%@!X@6?2E;7?/,./IXV[335(_)UD*P3^0]GI,EJ[E>.
M*0L[ZD=PGCD?>+'(9=EZ<!P*WZ6(.J>A&"BB@A1?NU8*.U_'%/S>@KM9ZD#;
M/%M:>J&1D.J9M74BUW:25GUCYXIG*FIR@RJROVM/:&_E0B_,AH L,-(!4'DT
M,JQN=/!P6Y GOCG0O"EO#.R87=PMJ3:VVI1H1ALWIE71QL '<D^G*O@):T;G
M?%H^,?K%;LON/P:-WOL!2*C'7!G-4*]I;]UB6E#SM-F(O.SN(E&HVSL6I-CY
M _</^[XZK0E?C8K[M!_B KY*;5XQ_NK:"JZ4<KNW4>MIVU Z)J*V "-$6ZC$
M _>2YH5]_(MT^.V[O!Q$Y[Y)$I7S!WT5[==:"@SK. @2#0I<8A!K8.0:+?%P
M!"&%4AT8S -WIB3M2A!00#_5YL;7P0=M\T@7=&JG[13H<5Q 3TU4AD,I5Q36
ML2D1X" 7=E&Z],6453+YFNM/<_J*$K>++TO6VLBP6E!OIXP[0UI7=P  T]>*
MT8DC1B2D]VZ_!]=3WZK*@KQ@W">F/:$FD=9'PWM (BP6SFM;T[!&2X)PJ/H?
MW*,;W:/1J#1ZC+WF7*F"Q1ZQ#A*X9N&9X)"/J/%I'1ZX.Z$/\4%7U!M4E(.T
MX5I(<B>XSUHINN7+ARC4< X>ADF 5C5C=J<IB/R*^OO!A:6X*M9U'UQ%A!&3
M8X6F!QH=:/2!--H@/I0'S.AJ2!Z\D6L?T7 &XQQ-D=X>E@,Q#L1X;V(D5R,[
M+)GNNFR0"W71I')D-W2#&2CNGHDB1=*@:8:Z8-7,J<'6V':@SY29(2_T7$_<
M+U,S'RANH+C[&4<Y!H.P9XOMGXZV.<K>CA1%S;"EZ T92P/5W=\D]UXHHBMF
M=38"2RYK#A"V@QL5V^5UT><8O-79%1,/)>S-T'_DHRB@.%[YRB0TD2Z^2'M9
MC+>:BIR%E'EP_%SMO_S:LH5:6-9FU9S#LY^G%-9"U+K$</?05E9&.X;5TLKC
M588!?\\R#ELM6PH\/6DJ_B3'F;J9+7?8B>=XRR&026MO=N&?_X"I-0P2[3P\
MW"4S7FWCVFF?*6D*+A5*+ML,B)E*X9X;93)BJ^S!IB8R^"Y)=6C[H6HRY%?]
MS7D198H[F:O<)4/,2\-!R2T0<P^BJPXAE!KWST+ <Z12I\%&.S#QIQOI$;QE
MSO7::9SG0OS@06 3$8EKS-C"+"8Y7QAKR!GP..Z &.-=K> +N]Z#0!S&>;&)
M6X7P]^*8-\);J4S=$B:S3(9V<83@%4_:\R+/:./U%UTF1F""VS'/(&DP7_+8
MM*[V,%K25,V8D-DY!VPQ+6B$.F>R[?5((7DG3;T/-,TACU3#KS-S:Y(03A.C
M8+*8J9OK=MWL+7F'(,3RK96>RW:/GC$_@.6A]!;_Q(9O[:&\DJ7OS?'A!$?,
M.A,< >*;>,J I]HN%K\QJX%IJH3*;'ALDAO9A^V3 1EEG5@N4X=K73UECV$T
MIS AM7=),,5N,=4T7DHL38I)#J2/Q><VF@A"O2ASO=PE<[X5F)NB9CFF95!W
MPX:CFKPB1#)+SB]@>LH$%=S^*Y;4 /P;HKI2LP%8/;ZOZZG"WQP0. .#%5D;
M?S-Z)LFJ;_@J$NR5+4;!/-2]E69B6!P(%[\[>7%V^F<7"!9!W:6CH"\$,N^6
M'H7I96@0V/PR.-F<:B5VP2U+5#6C&;*?ED!1/KO6V18KTY)PKBXQTT93\P\X
MWDQ1J$FLI&A@_K')S:R9X==\*'4*Z^<CV%Q#F8%='3'#QV LJ-9JHMN/91AU
M_?8($Z")4:W*Q3!I3QYJ#=0&P=T@JEH^05U<K6_REM63+3@^@:W+ZRF!;27:
M=AW98@R6QUGRIF0-"F?9_8XMF=')C*/_%*"'A>5X1-:!NKQ HH<?\49\SI;X
M=3=5T(T7)LN83:)$PL6N2$XQGQ)FTBI\1>+2#I2"TJ]:I:X@B3A/CY#N:.Q.
M)061,Q/T,9?!KMJ[8@=TJT#A<0:XN)C_TSJ/Z[N5*-HWF\*%^8R5ZXG*!X<2
M<NQ9&.'O\-TFXQSV@^@\=:"5OMJW\DEG;<7.(0/*:,>6E\@2 ^=P\G5'S+:E
M?9&20:BOKZ<FA<?)+'UY<G1ZME,UZSZ#'')$_UMR1!]@*;R5YL=LG'Z@H_?6
M5![;<Z=DC8K.&BYENR)U60JG7/FFSHZAI,&LD(6R&,/,2-!K@26#H-?9V*F;
MDDP?/'00V<6"9Y><+FF;N[22L8/V(MMU=MF<Q7F/OBZ=EE]4*V/K!VR^$G:C
M\1E6;LVLD\H:;CU;@ ^#CDB2@+/[V^UCD)IN*<_9$2__A42IJS4" :^9F"@1
MU9X$,@&=5 82P,5 5P6L"PAMFAM==GVPI"J!M0E36?#;F-/ 0!AK>G<BE0MV
M*U!]#9IRK>G&A7K37*%4GP=)D\$D* =B3)9DEA6)<B+:C:_E&6Q56MU20PC6
MT0W&I<$& ]6G08MO1]OF&!+M0JO[F"]\&A7%9YBA-G3:8<W%Y!B7VC\CYD;T
MK%,\VF*3W_P 1N3)Z>F9?"<S('RHSI-L?/]J>2L3@S5!6LC(6WY/D<\84[?L
M:^AK!Q$3+%DR'\C5B;1CF85;B#O,)IKP/W+^ UZC>6)J1CWN@6I\.=@)M]_S
M&N9=S*QGYD ?Q/8=G >Y-ID6/T&5;JG]QA[Y&7.?0_K"C47\DG(:K5NQU(*Z
MH:J5%6)]]\T'U"K)HFLJ]B0D)7Q?>95U]<%W38D$A?4V</R2J53X4 '4PJG]
MSZS'  Y84S% .^()F]2H<HE-P.  Z:HM4]K43':*W0987K2%B[QM+LGWG:E'
M)I@?!HP6EQ7-=B:9V_I.^BI#\N<2ZCQ;/Z7&?;&N71F>SU1A=ULPAUUS!9:#
MC%,N1-0F5R+%.Y @K^:>FRVRU84D08OCC)S8["L,2N6ZIX0R)5%SH+:3:O5*
M4.KY%#4(SG'NMECKK6L,68(2RQ[XF:R:KPHBP=<*";3T$,H,<*4P0)6BL91Z
MAA0\;I#5VW:3*1P1(V5[?DF%)]V98P5^9?>8<Y/B\972.T[XYW1_)@'JL>K:
M[G)1L"BBK%E1:7MM9CQ4+^>MRZ=3?S!N?8+JHW2%1\V 0B"^%ZJEQ._D<+9X
M65"CW6_F]CT@/:@VD:QWC.-LY:UU0(9=4EW;$I8V<8(X2++KOOBR]T4A1<EN
M;*X/1<^/YC6LK!<%8W&>0JP:NPPK,&)7*[0HK!O*>IK8X^Q=4'&$X:QJS'@!
M1(*E17A<6D^1*85$[>&PD^JM)!'RH1,\8R\[$0QK:_K+W)2!]PLVFFB$O$8[
M="WW[+$+251!C7&81N9L!PE(D/<-:+9$9U-@9,+B-!5'$=)&2]77DB1A!797
M[19GA=&0-BJ,L6[S)29QZW03XRPFXZZ_E)C1/?5=<]:I:+)E*@!E_=K ),G1
MZTQ-[) !4R03\0E'"4.L"79;[[X3*RUIDP?85616S3;IN&E9@%ZW#WQ.@Y'$
M*FT8SK-0A66[N+VJS"3'?3JPCGN60ACT,'5#\32D?& R-)0 \'7#@.!QG@T^
MSLIV:D01OWUX"U)[A;/YB$<&6AEE&*P93QB>*(,P6' +IB:@=FDJUE]ZLA5:
MWW)0>(YIOKN\.C^P17K1"Z>1K[$@I<C2,^<69.3:J;AVVYE.)QYUM[IE-RB%
MVN*Q<'%7W]@]%D8X$/1WE$8#ER?XOHQR"EABSK3B-[API",9IQZR4;$[\_A?
MK5";R!P?OPXDCFJ%79^M!*SW*")*)O_M(>M-%B?=5V(H&ZG.X21)F \E'7P;
M6246<<12 M@MZ,!(NZ@0;'0%X25C>]2O)(7LX2:V)TH?[01 OL88ZJ]-4?>$
M4.GG(8(Z1%"'".H?%T'=$8[$5Q%=?60]]=)G!P(A_%@4GUE%^$2L:K=*:]M!
MVQ8[4Q)$+A5-DAS[Q&F7=9. 7+30M+UT:+L9'$H4_FZ%/KT@'(J5>N^+%@%L
M/T06F".W]MY!B6$-9^CR\ZC$6F42C%R2Y>TT+N%56V#+C)8]'J@UB,P!0B![
M7<9ZT@@;L*$LF\P*NF.I=W:.AZ2"(:G@B2<5$'%\TT59[2CZ5^+5O0RQG@@1
M=3? DJL.:K&#PQ1ST:<5!0TRCAE1(A.G.=F*C,#'*HK8?YIT8F$<.]_AFHR0
MY7:2%+9A=PS2B$L*'X[0$5FQ*:=<-K!WI">N?H +FM8";UUNQVLERZNRUC-E
M %"$7(KV.I-SKM73+K:+=^!M1&'R0#E24D R+0%.#0LAVAU\XA^JJ52>@Z48
M0*W&_44!! >+ 5549/N7:^LU*37*DTHL)O$HKP,F\JG&I':ZN"7*VJ1+-2T7
M<0LNB)<"%V#3)*[=G:344O"*;0IK.]GB&%A78ATXRD0A7.!GS%FY_6R#K3)3
M2(6&+7 \UGZ(JR*8C\!,VXKW-8(:=="F[.^>8/(QZJOBX<4<!;E[G:7.4I^L
M*'Z27X,Q^\^:56)8[9FU9+ED9]6Y;->RJIVWJ'6(HD719"$L+<(_<JX%I]XW
MHJ11-"CWF9(NA]+::WXCGK#"?3<LX9WJ*#]:?8[AP (D9=9S*[ ?,V!,+21H
MC@<['.;40S+7/9#,-GI.S:N=W[#:DP@?)J%@/#(HU^!PEL=KQILH>T-X;+K.
M\QJ ]Z[Z+[MOC1U4GL#C]87Q@(PQTI$*-K_1A!X61" =U+6#O?8AZ2!RZ-A9
MO2@8(KAJ\;. ^ZW#J5R'+J1&I-ZOAKA70O3]7W/<7,:O)J5F/F#=SPB6N- W
M!/Y"N5V4G]$J87-!(_9WD.5R(TP;TS*JY6RFL042C,>N5.Q7Y=51R.77;8;S
M\I/A[B! 7(U0NY*'XJHV][IW?FX%^T<G!B4Y'7=DYS#-MC#7Q51T6!-(7+D+
M6SC_% <546CTNY;:IR+X O/RE2/H0A&N9VE168M&DC>*_421!U+2NX!S3_=!
M1;1)7/"@7*E 7NO?='A1-D<$KIN.N'(KH!"7!Q6":MO$G4OQ@\(P_+OM2QOG
M9%B95I$D#8E>='[RZ6G5K78LXM5W)R39*JT_$PHLQK9O"9KW^!M7WQF'BDQ>
M&03"ER?&['-S&71POE-@-R!&[3I21%BD),S*;F];-:1*+8E(PP&"C\G[NF]K
M?]_LRMQO9>(VW214]E5DQ.+L/#+R!F,*&5!*S7$"E;F,7))%+KN0D\ZL)FD$
MYLVQ[V)\&_M>@2C:R,A_)R[^;TFA:SO1PF21()&5:Q0=3C=W/FHZDCZ.?*FF
M*^F;AO"+-:K=Z"NCS ^CTP&$<4!\V(SXD*#MAS2WXE9$6D)@9ALTX P90T2F
M@1O!84CH,)N9-(P@4L-(;,XPB[8+!4H.DS?T=P3V5B[1#3/AD'@'F+J!FA].
MS5Z<Q('G)D7@ZUK01B3/@4WB?NN%(@:^?L$U:^%""+$<!Y"=@4CO1Z3BD\3(
ML%-</(DZ"M4*[B\_2RE.J9EB+31/'\UV*163!F-*X-,J9=)G-!EY9ZN*3+#+
MNR$KO&\,.D\>>&.Y7 QY?&9]1N'GOSH$GC&[G/MZ9K5]*+'ME5Z4/1%)GV(O
MBCNF,4O-06H]=1U#W9 !$8K+/H/%L[(>FV7SL .]4ZJXNKY]>-8GD_6XKX.4
M6;)0#.?X.Q$OE1[%N#4_MEX1AJ(*QLMO-()I@?['S9X?ZU^P'J">E@=+H6^?
MH\[I)S;2%%EX#+ *01D9CSM^4CF1A+O/"$DCXN!@E-F.12X%08;CG#6!QMXN
M2_E/4U%FMW%(0SAW7G$"YW K[H;E/J[*2"PGJYS5,MZ#Z#R73#0Z>R-VZ6&M
M2] ^ B94^TR#6PG7MU,!HS:1;@.T>E1!$1A =R*V)^P5_M'Z\M]:7_[.:X,W
MY)W>%JT0FB$' :,$>AN92@ULHM&,8=-5'N7H;>#XQJX<"==3-X(-N1!$^!;G
MAOR+ MKC4'RVK =A9RD8(*9(@>O6)G/L)=,M1U SJC"014EC=T"8Y\&9B;%H
M8*7>MPVT#B("D-H85+)52':2/JGN<5V?]PZ4?\3TNFIWD?'K_G6S $C>(Y(7
M^7ZJD9.1D,IQ+6$.FH4690GRMJ4-)N$._I)!>=]&><<(&;=P\IFEG68QPK0P
MC"VL@C 777X;4ZVY&3J8#^3X8"AT4<Y;5D$;=+4H)RJ7?,5-!#=DO?VQ66_#
M 1\.^ 9Y$YQ>AS_!Y6\PLCCPS]AB&T)U<;^";9F3D[U:5M1ZDI.A@S:5:R79
M()T&XGT8\4KBG\OQ2$V%:7\<RK6E&W"Q;"J7:T_DR)BT:3L3<2#-@30?78^O
M&J##FY:3<A-A!G1(S;(##Z#4OV#)%H<^9_/,M%/C&.FJW]\32X"4$RX#.$HY
M/8/=,)#_XY _4J;)VEH%HU%9<'Q7NTZ@;7RG33G;QAOFL$(H]9T@!ET?Y(%^
M!_I]: S54V40)^KMY%"XNH2[0@CYXMN5#VQV6OO" *IVJ&NMA\R!@>H?U(6Q
M$#"9U9!JF.K=;36- 5?4=\C%/F)\CZ\J2K_&Z4\P2 1C$G$-K\N#Y@Y%R"*L
M)7&;..(JJ!SAM^BLAR46K,7Q\:TL,H; '-@06G0I"'# '9I2$E;G)>(4"",2
MI /\KGM( !DQ++<>DHS*TZ8FL["0QK9VO6-X Z.V&0$&.I65\/)@/4IM<18#
M3X#OF.R[3JPX&'VZ@@4X<,$\S@<N(M6J,@O6SL_QV5L9&7<>H0QO0C1#)5E7
M+;#8KD>DHR4+[.'Z9B.[B5E][(.[I26V $0GFQ"(</]@_S.?-,2+9FO'I!@>
M\QC2AH _&WP)I^)7T:]-438SZ_?A'!X;:L1B(-G#[M+2.Y[HHJ[A"<P/JI8A
M1[87_JPHJ8^[GUA=MANV^6QR>F7G_B<1?+V$E9GE+1%PX;2,G]NG-TANV%6L
M]LH7;015 H[F7VV-NL6MM5;F3N*O*4L[94*O+C?G%<3]19M" 08!G8R_R^IT
M*D58G@JD@Q2)3A2FUP'C4R1U&+W+5%+JFQ1Y+BDXSO8'@J1<F=S!\\#'F$&[
M5HZ)0@6O7L920=+"^4UOZ%E6+U$9Y45+]5CGKI&3PI*ZJC'$X7UJDTW5:VNJ
MG<7J6YBG4VMB]760K7EBYD(R3%L:!'Q!M6\63%Q^DC2W4>#V)H00)J=E<*/V
M>UI4E>"5N'6&3S86=H]VRCUE'%+;7+N"8$>B?HM]^5,P6%\%YZ%&9-Q/.(?J
M39&/X1*%#"ZE0VD<LJ#K0(G:+1JC$[@NTXT0.%5 35*A&MA[B<RO<OA^&G/O
M?K+EER0Y/E#,!2D&$XO<6TC]=L6GJT>N7LU]ZN5'"(-DD5\ZSF]&1+3C<@Z7
M@H@6R8V2]H"(5%8OK1I(OR74*2Z__[ P=1(+F+"QHZF"4G*B[JHN"CI?J:E^
M!3T/#]B=&0[C8+%;U<R5!4^PR:2"+^'@ZGSBXHS1?=H?]%]@7(628V"L'-#(
MD8-SK4I3N=;.&%SFEG\U(3;Z.N9.0PI/8(X:@IIG/O-</=,>%WJ?O:MYHB8]
M75-EHT,A5>I@O"UE?"6[U^YJ]W4>:Y@RP=4,7HYX"DWEREBY#2BK@7!/KB=@
M3^/W;TS1<ALZ[M8Q:'I6)3PCX;*X)B2$Y8EB+E]V+ T/ MI)46_!,>!S@@<5
M ,4QIEZ^7&V&&CP?BP9-^9'M 5%M_"SHQI=/ZFD<X(53)G=[,QRDX)K/H8SF
M[1XIT%L4#/%IX203GE9:S"G1$F:5DL+B0 J _2->-#>"!7,M<7BS-W2^X/04
M,+&2&L3"@]P]N KK&'&U8+'33!QO_1SWZ4K CRT=Q.Y]US^XFFOL3F6?YKY3
M2=EKIL:KE2%<SV^S;\/"_CMZ2)U]-A78PWY"C 467K+A#6.1=J)S'?]%FWVL
M;Q/74-DL&+@QE2#DKE>PJ@Q5HUNXW#[O,I&\YP.8@$_*Y80K= 7,4VX6F>OJ
M=,+^.84#P5G]"+T?I&F2$0 FI7H'=SU3"&H^)E@E-"'$Y#A^WL85^$")S&@[
M6!7WX@OF(R+YM>@608H,+>L;"[2Q%TW@( =]4IW$68<8BTXSL<NV2_+NM\>
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M44ZI0E3]S$IYYA]K/+;/6N2-C5%\H54G45V%+V?)B@8SMJ]WCAKK04 ,Z^Z
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M?%.8=)-1?#@JTB7\,:UGV0__'U!+ P04    " #3.W!6E4B8[K(D   U)P$
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M- (MZXDB48(2%N/NFI%E=(*A57"ENN(W(&XT#Q(0\;GT KU,GD;!ZWUELZ>
MO=LO[!ZZRI$A2NW'=S73-H'SQH8*F;WV9( -]24(P%)""OH$HAD>3]"2ET5<
M)([P8CAX>L3K6#-A"#84[%=/H4_0 )5.=)+ \4)@WPP:A_=3-0!^PM=A*.Z8
MZO#IZ,PR=X:VYN!=B@+)@JPG!#Q@7CKZ&S/39S@R0_[*\@WUJA(!">#YAR1
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M-#KI*M+W]C/Y&MGBR25Y\ C[V]PX?*%%P"T/E,^E;QIQ+IU1/$7IQ,'YRJ,
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MVIQO+T$!4$(3;1E5\P9!:23Y_DN+@B%^7;&&M'8B/N)%J:X@RRK2F;KV7IK
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MBF[RR^_V3#R%_X;Y*'GQ_U!+ P04    " #3.W!6^N.J-!@#   ]"P  %P
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M);B#WQ4MP,%N#</E&G38L/_E>Z5\7^>:5XRGCN7*>*TS*OEC+=HN)*[!N%6
M;-5O=Z=[% VWL?&_#7,+R_H*4)\.^.G=R3XZEVFXC55_)0O?AZGD;L6Z,W;3
MJIXU!=>#8K6:;,D$\\'X>Z[74XRF/S*M[$?_[&S8V'?:C&:>]6P@[I0(FO]1
M:ZKYG:HUUEJD]0)7T@R"Q.ZK/P(ZLZ4F]%[9X\4W>S (>P=OA\VD];2HWOG\
M8EAOFN.?4$L! A0#%     @ TSMP5L^&WUE@*0  \^,! !$
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M2P$"% ,4    " #3.W!69C@9@0Z9 0!2IP$ &               @ $5? @
M86-I=2TR,#(R,3(S,7@R,&8P,#$N:G!G4$L! A0#%     @ TSMP5N><O_JI
M+P$ PUP! !@              ( !614* &%C:74M,C R,C$R,S%X,C!F,# R
M+FIP9U!+ 0(4 Q0    ( -,[<%:-[Q(V%MT  %[L   8              "
M 3A%"P!A8VEU+3(P,C(Q,C,Q>#(P9C P,RYJ<&=02P$"% ,4    " #3.W!6
M)6\?9T_C   !!0$ &               @ &$(@P 86-I=2TR,#(R,3(S,7@R
M,&8P,#0N:G!G4$L! A0#%     @ TSMP5L1&>ZQ\]0  34\! !@
M     ( !"08- &%C:74M,C R,C$R,S%X,C!F,# U+FIP9U!+ 0(4 Q0    (
M -,[<%8^C@>NFZ0  'K:   8              "  ;O[#0!A8VEU+3(P,C(Q
M,C,Q>#(P9C P-BYJ<&=02P$"% ,4    " #3.W!6QMH(S_ V 0 &9P$ &
M            @ &,H X 86-I=2TR,#(R,3(S,7@R,&8P,#<N:G!G4$L! A0#
M%     @ TSMP5O9#X )MY@  02(! !@              ( !LM</ &%C:74M
M,C R,C$R,S%X,C!F,# X+FIP9U!+ 0(4 Q0    ( -,[<%9V%+RRK  ! "X5
M 0 8              "  56^$ !A8VEU+3(P,C(Q,C,Q>#(P9C P.2YJ<&=0
M2P$"% ,4    " #3.W!6ND#3@+VP  !$TP  &               @ $WOQ$
M86-I=2TR,#(R,3(S,7@R,&8P,3 N:G!G4$L! A0#%     @ TSMP5@F!IO"W
MI@  :NT  !@              ( !*G 2 &%C:74M,C R,C$R,S%X,C!F,#$Q
M+FIP9U!+ 0(4 Q0    ( -,[<%;N=R.655T  /YP   8              "
M 1<7$P!A8VEU+3(P,C(Q,C,Q>#(P9C Q,BYJ<&=02P$"% ,4    " #3.W!6
M@5/H:G1D  #'<   &               @ &B=!, 86-I=2TR,#(R,3(S,7@R
M,&8P,3,N:G!G4$L! A0#%     @ TSMP5@6_-\_B-0$ JT4! !@
M     ( !3-D3 &%C:74M,C R,C$R,S%X,C!F,#$T+FIP9U!+ 0(4 Q0    (
M -,[<%9N4Q1<'C ! (9! 0 8              "  60/%0!A8VEU+3(P,C(Q
M,C,Q>#(P9C Q-2YJ<&=02P$"% ,4    " #3.W!68SK7&RR7  "WL   &
M            @ &X/Q8 86-I=2TR,#(R,3(S,7@R,&8P,38N:G!G4$L! A0#
M%     @ TSMP5BC;LH2=A   W9H  !@              ( !&M<6 &%C:74M
M,C R,C$R,S%X,C!F,#$W+FIP9U!+ 0(4 Q0    ( -,[<%9@FM,[1P4! *D=
M 0 8              "  >U;%P!A8VEU+3(P,C(Q,C,Q>#(P9C Q."YJ<&=0
M2P$"% ,4    " #3.W!6(/8LO;YS  !/=   &               @ %J81@
M86-I=2TR,#(R,3(S,7@R,&8P,3DN:G!G4$L! A0#%     @ TSMP5@X1=+$J
M:   FVL  !@              ( !7M48 &%C:74M,C R,C$R,S%X,C!F,#(P
M+FIP9U!+ 0(4 Q0    ( -,[<%8 3A\EO6@   9S   8              "
M ;X]&0!A8VEU+3(P,C(Q,C,Q>#(P9C R,2YJ<&=02P$"% ,4    " #3.W!6
M1(XP[-99  !J:0  &               @ &QIAD 86-I=2TR,#(R,3(S,7@R
M,&8P,C(N:G!G4$L! A0#%     @ TSMP5MWN6Q9^4P  NF$  !@
M     ( !O0 : &%C:74M,C R,C$R,S%X,C!F,#(S+FIP9U!+ 0(4 Q0    (
M -,[<%:'N_<_K(0! !&S 0 8              "  7%4&@!A8VEU+3(P,C(Q
M,C,Q>#(P9C R-"YJ<&=02P$"% ,4    " #3.W!6KC<&/26B   *J0  &
M            @ %3V1L 86-I=2TR,#(R,3(S,7@R,&8P,C4N:G!G4$L! A0#
M%     @ TSMP5K?TLTH_>   O8H  !@              ( !KGL< &%C:74M
M,C R,C$R,S%X,C!F,#(V+FIP9U!+ 0(4 Q0    ( -,[<%8(9M=Q V(  )!M
M   8              "  2/T' !A8VEU+3(P,C(Q,C,Q>#(P9C R-RYJ<&=0
M2P$"% ,4    " #3.W!6R(7S@4Y9  !K;   &               @ %<5AT
M86-I=2TR,#(R,3(S,7@R,&8P,C@N:G!G4$L! A0#%     @ TSMP5M.[X>DF
M6@  W&@  !@              ( !X*\= &%C:74M,C R,C$R,S%X,C!F,#(Y
M+FIP9U!+ 0(4 Q0    ( -,[<%8#%FXZJLH  $C:   8              "
M 3P*'@!A8VEU+3(P,C(Q,C,Q>#(P9C S,"YJ<&=02P$"% ,4    " #3.W!6
M6-S,7U(S 0#830$ &               @ $<U1X 86-I=2TR,#(R,3(S,7@R
M,&8P,S$N:G!G4$L! A0#%     @ TSMP5NKO4E>L?0  *($  !@
M     ( !I @@ &%C:74M,C R,C$R,S%X,C!F,#,R+FIP9U!+ 0(4 Q0    (
M -,[<%:?GIKMVEL  $%B   8              "  8:&( !A8VEU+3(P,C(Q
M,C,Q>#(P9C S,RYJ<&=02P$"% ,4    " #3.W!6/*J+0WR$  !1AP  &
M            @ &6XB  86-I=2TR,#(R,3(S,7@R,&8P,S0N:G!G4$L! A0#
M%     @ TSMP5BE%;4^=@@  S8<  !@              ( !2&<A &%C:74M
M,C R,C$R,S%X,C!F,#,U+FIP9U!+ 0(4 Q0    ( -,[<%;/PVJ<A$ ! &92
M 0 8              "  1OJ(0!A8VEU+3(P,C(Q,C,Q>#(P9C S-BYJ<&=0
M2P$"% ,4    " #3.W!67JJJAS**   4D   &               @ '5*B,
M86-I=2TR,#(R,3(S,7@R,&8P,S<N:G!G4$L! A0#%     @ TSMP5LLREES.
MA@  48X  !@              ( !/;4C &%C:74M,C R,C$R,S%X,C!F,#,X
M+FIP9U!+ 0(4 Q0    ( -,[<%:(Y.QI,IH  (2G   8              "
M 4$\) !A8VEU+3(P,C(Q,C,Q>#(P9C S.2YJ<&=02P$"% ,4    " #3.W!6
M5?J*0^E:  #%8@  &               @ &IUB0 86-I=2TR,#(R,3(S,7@R
M,&8P-# N:G!G4$L! A0#%     @ TSMP5C=S"[<J-0$ 5$$! !@
M     ( !R#$E &%C:74M,C R,C$R,S%X,C!F,#0Q+FIP9U!+ 0(4 Q0    (
M -,[<%:S5^1220,! +,* 0 8              "  2AG)@!A8VEU+3(P,C(Q
M,C,Q>#(P9C T,BYJ<&=02P$"% ,4    " #3.W!6RDK^<KQ' 0 J7@$ &
M            @ &G:B< 86-I=2TR,#(R,3(S,7@R,&8P-#,N:G!G4$L! A0#
M%     @ TSMP5J4$ERE\!P  92(  !@              ( !F;(H &%C:74M
M,C R,C$R,S%X97@Q,F0Q+FAT;5!+ 0(4 Q0    ( -,[<%9@N">;E <  +PB
M   8              "  4NZ* !A8VEU+3(P,C(Q,C,Q>&5X,3)D,BYH=&U0
M2P$"% ,4    " #3.W!6MF(@GV $  "N$   &               @ $5PB@
M86-I=2TR,#(R,3(S,7AE>#$S9#$N:'1M4$L! A0#%     @ TSMP5G_=8=UW
M!   !1$  !@              ( !J\8H &%C:74M,C R,C$R,S%X97@Q,V0R
M+FAT;5!+ 0(4 Q0    ( -,[<%95)VYX>0,  &()   8              "
M 5C+* !A8VEU+3(P,C(Q,C,Q>&5X,35D,2YH=&U02P$"% ,4    " #3.W!6
MHNA!YNXZ  !)BP$ &               @ $'SR@ 86-I=2TR,#(R,3(S,7AE
M>#1D,3<N:'1M4$L! A0#%     @ TSMP5I5(F.ZR)   -2<! !<
M     ( !*PHI &%C:74M,C R,C$R,S%X97@T9#8N:'1M4$L! A0#%     @
MTSMP5OKCJC08 P  /0L  !<              ( !$B\I &%C:74M,C R,C$R
B,S%X97@X9#$N:'1M4$L%!@     Y #D ?@\  %\R*0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
